Entry,Entry_Name,Gene_Names_OL,Gene_Name,GO_IDs,InterPro,Interacts_With,Gene_Names_Prim,Domain_FT,Protein_Names,GO,PubMed,3D,Function_CC,Sequence,Mass,Length,Protein_Families,GO_BP,GO_MF,GO_CC,Gene_SYN,Gene_Name_ORF,SeqVersion
P9WHB1,RL28A_MYCTU,Rv0105c,rpmB1 rpmB Rv0105c MTCY251.24c,GO:0003735; GO:0006412; GO:0022625,IPR034704; IPR026569; IPR037147; IPR001383; ,,rpmB1,,50S ribosomal protein L28-1,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230,,,MSARCQITGRTVGFGKAVSHSHRRTRRRWPPNIQLKAYYLPSEDRRIKVRVSAQGIKVIDRDGHRGRRRAARAGSAPAHFARQAGSSLRTAAIL,"10,530",94,Bacterial ribosomal protein bL28 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],rpmB,MTCY251.24c,1
P9WH79,RL9_MYCTU,Rv0056,rplI Rv0056 MTCY21D4.19,GO:0003723; GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0019843; GO:0022625,IPR000244; IPR009027; IPR020594; IPR020069; IPR036791; IPR020070; IPR036935; ,,rplI,,50S ribosomal protein L9,cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds to the 23S rRNA. {ECO:0000255|HAMAP-Rule:MF_00503}.,MKLILTADVDHLGSIGDTVEVKDGYGRNFLLPRGLAIVASRGAQKQADEIRRARETKSVRDLEHANEIKAAIEALGPIALPVKTSADSGKLFGSVTAADVVAAIKKAGGPNLDKRIVRLPKTHIKAVGTHFVSVHLHPEIDVEVSLDVVAQS,"16,170",152,Bacterial ribosomal protein bL9 family,translation [GO:0006412],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY21D4.19,1
P9WH13,RMLA_MYCTU,Rv0334,rmlA rfbA Rv0334,GO:0000287; GO:0005618; GO:0005886; GO:0006006; GO:0008879; GO:0019305; GO:0040007; GO:0045226; GO:0046075,IPR005907; IPR005835; IPR029044; ,,rmlA,,Glucose-1-phosphate thymidylyltransferase (EC 2.7.7.24) (dTDP-glucose pyrophosphorylase) (dTDP-glucose synthase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; glucose-1-phosphate thymidylyltransferase activity [GO:0008879]; magnesium ion binding [GO:0000287]; dTDP-rhamnose biosynthetic process [GO:0019305]; dTTP metabolic process [GO:0046075]; extracellular polysaccharide biosynthetic process [GO:0045226]; glucose metabolic process [GO:0006006]; growth [GO:0040007],9084178; 9634230; 17784859; 21969609,X-ray crystallography (2),"FUNCTION: Catalyzes the formation of dTDP-glucose, from dTTP and glucose 1-phosphate, as well as its pyrophosphorolysis. Involved in the biosynthesis of the dTDP-L-rhamnose which is a component of the critical linker, D-N-acetylglucosamine-L-rhamnose disaccharide, which connects the galactan region of arabinogalactan to peptidoglycan via a phosphodiester linkage. {ECO:0000269|PubMed:17784859, ECO:0000269|PubMed:9084178}.",MRGIILAGGSGTRLYPITMGISKQLLPVYDKPMIYYPLTTLMMAGIRDIQLITTPHDAPGFHRLLGDGAHLGVNISYATQDQPDGLAQAFVIGANHIGADSVALVLGDNIFYGPGLGTSLKRFQSISGGAIFAYWVANPSAYGVVEFGAEGMALSLEEKPVTPKSNYAVPGLYFYDNDVIEIARGLKKSARGEYEITEVNQVYLNQGRLAVEVLARGTAWLDTGTFDSLLDAADFVRTLERRQGLKVSIPEEVAWRMGWIDDEQLVQRARALVKSGYGNYLLELLERN,"31,492",288,Glucose-1-phosphate thymidylyltransferase family,dTDP-rhamnose biosynthetic process [GO:0019305]; dTTP metabolic process [GO:0046075]; extracellular polysaccharide biosynthetic process [GO:0045226]; glucose metabolic process [GO:0006006]; growth [GO:0040007],glucose-1-phosphate thymidylyltransferase activity [GO:0008879]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; plasma membrane [GO:0005886],rfbA,,1
P9WGT5,SDHL_MYCTU,Rv0069c,sdaA Rv0069c MTV030.12c,GO:0003941; GO:0005886; GO:0006094; GO:0046872; GO:0051539,IPR029009; IPR004644; IPR005130; IPR005131; ,,sdaA,,L-serine dehydratase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-SD),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]; gluconeogenesis [GO:0006094]",9634230; 21969609,,,MTISVFDLFTIGIGPSSSHTVGPMRAANQFVVALRRRGHLDDLEAMRVDLFGSLAATGAGHGTMSAILLGLEGCQPETITTEHKERRLAEIAASGVTRIGGVIPVPLTERDIDLHPDIVLPTHPNGMTFTAAGPHGRVLATETYFSVGGGFIVTEQTSGNSGQHPCSVALPYVSAQELLDICDRLDVSISEAALRNETCCRTENEVRAALLHLRDVMVECEQRSIAREGLLPGGLRVRRRAKVWYDRLNAEDPTRKPEFAEDWVNLVALAVNEENASGGRVVTAPTNGAAGIVPAVLHYAIHYTSAGAGDPDDVTVRFLLTAGAIGSLFKERASISGAEVGCQGEVGSAAAMAAAGLAEILGGTPRQVENAAEIAMEHSLGLTCDPIAGLVQIPCIERNAISAGKAINAARMALRGDGIHRVTLDQVIDTMRATGADMHTKYKETSAGGLAINVAVNIVEC,"48,576",461,Iron-sulfur dependent L-serine dehydratase family,gluconeogenesis [GO:0006094],"4 iron, 4 sulfur cluster binding [GO:0051539]; L-serine ammonia-lyase activity [GO:0003941]; metal ion binding [GO:0046872]",plasma membrane [GO:0005886],,MTV030.12c,1
I6X8R5,RV203_MYCTU,Rv0203 RVBD_0203,Rv0203 RVBD_0203 P425_00212,GO:0005576; GO:0015886; GO:0020037; GO:0046872,IPR030937; IPR032407; IPR038378; ,,,,Heme-binding protein Rv0203,extracellular region [GO:0005576]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; heme transport [GO:0015886],9634230; 21969609; 22283334; 23760277; 21383189,X-ray crystallography (1),"FUNCTION: Part of a heme-iron acquisition system. Acts by binding heme and delivering it to the membrane proteins MmpL3 and MmpL11. Can use free heme or heme from host hemoglobin. {ECO:0000269|PubMed:21383189, ECO:0000269|PubMed:22283334, ECO:0000269|PubMed:23760277}.",MKTGTATTRRRLLAVLIALALPGAAVALLAEPSATGASDPCAASEVARTVGSVAKSMGDYLDSHPETNQVMTAVLQQQVGPGSVASLKAHFEANPKVASDLHALSQPLTDLSTRCSLPISGLQAIGLMQAVQGARR,"13,901",136,,heme transport [GO:0015886],heme binding [GO:0020037]; metal ion binding [GO:0046872],extracellular region [GO:0005576],,P425_00212,1
P9WH49,RS181_MYCTU,Rv0055,rpsR1 rpsR Rv0055 MTCY21D4.18,GO:0003735; GO:0006412; GO:0019843; GO:0022627,IPR001648; IPR018275; IPR036870; ,,rpsR1,,30S ribosomal protein S18 1,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: Binds as a heterodimer with protein S6 to the central domain of the 16S rRNA, where it helps stabilize the platform of the 30S subunit. {ECO:0000255|HAMAP-Rule:MF_00270}.",MAKSSKRRPAPEKPVKTRKCVFCAKKDQAIDYKDTALLRTYISERGKIRARRVTGNCVQHQRDIALAVKNAREVALLPFTSSVR,"9,543",84,Bacterial ribosomal protein bS18 family,translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627],rpsR,MTCY21D4.18,1
P9WH31,RS6_MYCTU,Rv0053,rpsF Rv0053 MTCY21D4.16,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0022627; GO:0070181,IPR000529; IPR020815; IPR020814; IPR035980; IPR014717; ,,rpsF,,30S ribosomal protein S6,cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Binds together with S18 to 16S ribosomal RNA. {ECO:0000250}.,MRPYEIMVILDPTLDERTVAPSLETFLNVVRKDGGKVEKVDIWGKRRLAYEIAKHAEGIYVVIDVKAAPATVSELDRQLSLNESVLRTKVMRTDKH,"10,935",96,Bacterial ribosomal protein bS6 family,translation [GO:0006412],small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY21D4.16,1
O07434,RICR_MYCTU,Rv0190 RVBD_0190,ricR Rv0190 RVBD_0190 LH57_01055 P425_00198,GO:0000976; GO:0001217; GO:0005737; GO:0006351; GO:0032993; GO:0045892; GO:0046688; GO:0046872,IPR003735; IPR038390; ,,ricR,,Copper-sensing transcriptional repressor RicR (Regulated in copper repressor),"cytoplasm [GO:0005737]; protein-DNA complex [GO:0032993]; bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription, DNA-templated [GO:0045892]; response to copper ion [GO:0046688]; transcription, DNA-templated [GO:0006351]",21166899; 9634230; 21969609; 24549843,,"FUNCTION: Under low copper conditions, represses the expression of lpqS, Rv2963, mymT, socA, socB, mmcO and its own expression. In the presence of copper, RicR dissociates from DNA, leading to the expression of the target genes. Members of the RicR regulon are important for copper resistance during infections and full virulence in a mouse model of infection. {ECO:0000269|PubMed:21166899, ECO:0000269|PubMed:24549843}.",MTAAHGYTQQKDNYAKRLRRVEGQVRGIARMIEEDKYCIDVLTQISAVTSALRSVALNLLDEHLSHCVTRAVAEGGPGADGKLAEASAAIARLVRS,"10,365",96,CsoR family,"negative regulation of transcription, DNA-templated [GO:0045892]; response to copper ion [GO:0046688]; transcription, DNA-templated [GO:0006351]","bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]",cytoplasm [GO:0005737]; protein-DNA complex [GO:0032993],,LH57_01055 P425_00198,1
L0T550,RIP2_MYCTU,Rv0359,rip2 Rv0359,GO:0005886; GO:0008237; GO:0016021; GO:0046872,,,rip2,,Putative zinc metalloprotease Rip2,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],9634230; 21969609,,,MSETGQRESVRPSPIFLGLLGLTAVGGALAWLAGETVQPLAYAGVFVMVIAGWLVSLCLHEFGHAFTAWRFGDHDVAVRGYLTLDPRRYSHPMLSLGLPMLFIALGGIGLPGAAVYVHTWFMTTARRTLVSLAGPTVNLALAMLLLAATRLLFDPIHAVLWAGVAFLAFLQLTALVLNLLPIPGLDGYAALEPHLRPETQRALAPAKQFALVFLLVLFLAPTLNGWFFGVVYWLFDLSGVSHRLAAAGSVLARFWSIWF,"28,121",259,Peptidase M50B family,,metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WH69,RIR2H_MYCTU,Rv0233,nrdB Rv0233,GO:0005506; GO:0005829; GO:0016491; GO:0030145; GO:0042802; GO:0055114,IPR009078; IPR033908; IPR012348; IPR000358; ,Itself,nrdB,,R2-like ligand binding oxidase (EC 1.-.-.-) (Ribonucleotide reductase R2 subunit homolog) (Ribonucleotide reductase small subunit homolog),cytosol [GO:0005829]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230; 21969609; 19321420,X-ray crystallography (2),FUNCTION: Probable oxidase that might be involved in lipid metabolism. {ECO:0000269|PubMed:19321420}.,MTRTRSGSLAAGGLNWASLPLKLFAGGNAKFWHPADIDFTRDRADWEKLSDDERDYATRLCTQFIAGEEAVTEDIQPFMSAMRAEGRLADEMYLTQFAFEEAKHTQVFRMWLDAVGISEDLHRYLDDLPAYRQIFYAELPECLNALSADPSPAAQVRASVTYNHIVEGMLALTGYYAWHKICVERAILPGMQELVRRIGDDERRHMAWGTFTCRRHVAADDANWTVFETRMNELIPLALRLIEEGFALYGDQPPFDLSKDDFLQYSTDKGMRRFGTISNARGRPVAEIDVDYSPAQLEDTFADEDRRTLAAASA,"35,656",314,"Ribonucleoside diphosphate reductase small chain family, R2-like ligand binding oxidase subfamily",oxidation-reduction process [GO:0055114],identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; oxidoreductase activity [GO:0016491],cytosol [GO:0005829],,,1
P9WHI9,RECF_MYCTU,Rv0003,recF Rv0003 MTCY10H4.01,GO:0000731; GO:0003697; GO:0005524; GO:0005829; GO:0005886; GO:0006260; GO:0006302; GO:0009432,IPR001238; IPR018078; IPR027417; IPR003395; ,,recF,,DNA replication and repair protein RecF,cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; SOS response [GO:0009432],8733228; 9634230; 21969609,,"FUNCTION: The RecF protein is involved in DNA metabolism; it is required for DNA replication and normal SOS inducibility. RecF binds preferentially to single-stranded, linear DNA. It also seems to bind ATP (By similarity). {ECO:0000250}.",MYVRHLGLRDFRSWACVDLELHPGRTVFVGPNGYGKTNLIEALWYSTTLGSHRVSADLPLIRVGTDRAVISTIVVNDGRECAVDLEIATGRVNKARLNRSSVRSTRDVVGVLRAVLFAPEDLGLVRGDPADRRRYLDDLAIVRRPAIAAVRAEYERVLRQRTALLKSVPGARYRGDRGVFDTLEVWDSRLAEHGAELVAARIDLVNQLAPEVKKAYQLLAPESRSASIGYRASMDVTGPSEQSDIDRQLLAARLLAALAARRDAELERGVCLVGPHRDDLILRLGDQPAKGFASHGEAWSLAVALRLAAYQLLRVDGGEPVLLLDDVFAELDVMRRRALATAAESAEQVLVTAAVLEDIPAGWDARRVHIDVRADDTGSMSVVLP,"42,212",385,RecF family,DNA replication [GO:0006260]; DNA synthesis involved in DNA repair [GO:0000731]; double-strand break repair [GO:0006302]; SOS response [GO:0009432],ATP binding [GO:0005524]; single-stranded DNA binding [GO:0003697],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY10H4.01,1
P9WHW5,PSTP_MYCTU,Rv0018c,pstP mstp ppp Rv0018c,GO:0000287; GO:0004647; GO:0004721; GO:0004722; GO:0005618; GO:0005887; GO:0006469; GO:0006470; GO:0016021; GO:0030145; GO:0043085; GO:0043086; GO:0043392,IPR015655; IPR036457; IPR001932; ,,pstP,DOMAIN 9 238 PPM-type phosphatase. {ECO:0000255|PROSITE-ProRule:PRU01082}.,PP2C-family Ser/Thr phosphatase (EC 3.1.3.16) (Mycobacterial Ser/Thr phosphatase) (Mstp) (Possible serine/threonine phosphatase Ppp),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of catalytic activity [GO:0043086]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of catalytic activity [GO:0043085]; protein dephosphorylation [GO:0006470],9634230; 14575702; 12950916; 15967413; 16436437; 19099550; 21969609; 15530359,X-ray crystallography (2),"FUNCTION: The only predicted protein phosphatase in M.tuberculosis, it dephosphorylates at least 5 protein kinases (PknA, PknB, PknD, PknE and PknF) and the penicillin-binding protein PBPA. {ECO:0000269|PubMed:12950916, ECO:0000269|PubMed:14575702, ECO:0000269|PubMed:15967413, ECO:0000269|PubMed:16436437}.",MARVTLVLRYAARSDRGLVRANNEDSVYAGARLLALADGMGGHAAGEVASQLVIAALAHLDDDEPGGDLLAKLDAAVRAGNSAIAAQVEMEPDLEGMGTTLTAILFAGNRLGLVHIGDSRGYLLRDGELTQITKDDTFVQTLVDEGRITPEEAHSHPQRSLIMRALTGHEVEPTLTMREARAGDRYLLCSDGLSDPVSDETILEALQIPEVAESAHRLIELALRGGGPDNVTVVVADVVDYDYGQTQPILAGAVSGDDDQLTLPNTAAGRASAISQRKEIVKRVPPQADTFSRPRWSGRRLAFVVALVTVLMTAGLLIGRAIIRSNYYVADYAGSVSIMRGIQGSLLGMSLHQPYLMGCLSPRNELSQISYGQSGGPLDCHLMKLEDLRPPERAQVRAGLPAGTLDDAIGQLRELAANSLLPPCPAPRATSPPGRPAPPTTSETTEPNVTSSPASPSPTTSAPAPTGTTPAIPTSASPAAPASPPTPWPVTSSPTMAALPPPPPQPGIDCRAAA,"53,812",514,,negative regulation of catalytic activity [GO:0043086]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of catalytic activity [GO:0043085]; protein dephosphorylation [GO:0006470],magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphoprotein phosphatase activity [GO:0004721]; phosphoserine phosphatase activity [GO:0004647]; protein serine/threonine phosphatase activity [GO:0004722],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887],mstp ppp,,1
P9WGD5,SSB_MYCTU,Rv0054,ssb Rv0054 MTCY21D4.17,GO:0003697; GO:0005576; GO:0005886; GO:0006260; GO:0006974; GO:0046677,IPR012340; IPR000424; IPR011344; ,P9WMR3,ssb,DOMAIN 1 110 SSB. {ECO:0000255|HAMAP-Rule:MF_00984}.,Single-stranded DNA-binding protein (SSB),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; response to antibiotic [GO:0046677],9634230; 10491108; 20724443; 12888346; 21969609,X-ray crystallography (4),,MAGDTTITIVGNLTADPELRFTPSGAAVANFTVASTPRIYDRQTGEWKDGEALFLRCNIWREAAENVAESLTRGARVIVSGRLKQRSFETREGEKRTVIEVEVDEIGPSLRYATAKVNKASRSGGFGSGSRPAPAQTSSASGDDPWGSAPASGSFGGGDDEPPF,"17,353",164,,cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260]; response to antibiotic [GO:0046677],single-stranded DNA binding [GO:0003697],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY21D4.17,1
O53699,STF0_MYCTU,Rv0295c LH57_01610,stf0 Rv0295c LH57_01610,GO:0005618; GO:0005886; GO:0005991; GO:0008146; GO:0042803; GO:0046506; GO:0050427; GO:0050656,IPR027417; IPR015124; IPR024628; ,,stf0,,Trehalose 2-sulfotransferase (EC 2.8.2.37),cell wall [GO:0005618]; plasma membrane [GO:0005886]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; protein homodimerization activity [GO:0042803]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; sulfolipid biosynthetic process [GO:0046506]; trehalose metabolic process [GO:0005991],9634230; 15258569; 21969609,,"FUNCTION: Catalyzes the sulfuryl group transfer from 3'-phosphoadenosine-5'-phosphosulfate (PAPS) to trehalose, leading to trehalose-2-sulfate (T2S). The sulfation of trehalose is the first step in the biosynthesis of sulfolipid-1 (SL-1), a major cell wall glycolipid and the most abundant sulfated metabolite found in Mycobacterium tuberculosis, that is a potential virulence factor thought to mediate host-pathogen interactions. {ECO:0000269|PubMed:15258569}.",MSRAVRPYLVLATQRSGSTLLVESLRATGCAGEPQEFFQYLPSTGMAPQPREWFAGVDDDTILQLLDPLDPGTPDTATPVAWREHVRTSGRTPNGVWGGKLMWNQTALLQQRAAQLPDRSGDGLRAAIRDVIGNEPVFVHVHRPDVVSQAVSFWRAVQTQVWRGHPDPKRDSQAVYHAGAIAHIIRNLRDQENGWRAWFAEEGIDPIDIAYPVLWRNLTAIVASVLDAIGQDPKLAPAPMLERQANQRSDEWVDRYRAEAPRLGLPT,"29,775",267,Stf0 sulfotransferase family,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; sulfolipid biosynthetic process [GO:0046506]; trehalose metabolic process [GO:0005991],3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; protein homodimerization activity [GO:0042803]; sulfotransferase activity [GO:0008146],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WFV1,SYL_MYCTU,Rv0041,leuS Rv0041 MTCY21D4.04,GO:0002161; GO:0004823; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006429; GO:0040007,IPR001412; IPR002302; IPR025709; IPR013155; IPR015413; IPR014729; IPR009080; IPR009008; ,,leuS,,Leucine--tRNA ligase (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823]; growth [GO:0040007]; leucyl-tRNA aminoacylation [GO:0006429],9634230; 21969609,X-ray crystallography (3),,MTESPTAGPGGVPRADDADSDVPRYRYTAELAARLERTWQENWARLGTFNVPNPVGSLAPPDGAAVPDDKLFVQDMFPYPSGEGLHVGHPLGYIATDVYARYFRMVGRNVLHALGFDAFGLPAEQYAVQTGTHPRTRTEANVVNFRRQLGRLGFGHDSRRSFSTTDVDFYRWTQWIFLQIYNAWFDTTANKARPISELVAEFESGARCLDGGRDWAKLTAGERADVIDEYRLVYRADSLVNWCPGLGTVLANEEVTADGRSDRGNFPVFRKRLRQWMMRITAYADRLLDDLDVLDWPEQVKTMQRNWIGRSTGAVALFSARAASDDGFEVDIEVFTTRPDTLFGATYLVLAPEHDLVDELVAASWPAGVNPLWTYGGGTPGEAIAAYRRAIAAKSDLERQESREKTGVFLGSYAINPANGEPVPIFIADYVLAGYGTGAIMAVPGHDQRDWDFARAFGLPIVEVIAGGNISESAYTGDGILVNSDYLNGMSVPAAKRAIVDRLESAGRGRARIEFKLRDWLFARQRYWGEPFPIVYDSDGRPHALDEAALPVELPDVPDYSPVLFDPDDADSEPSPPLAKATEWVHVDLDLGDGLKPYSRDTNVMPQWAGSSWYELRYTDPHNSERFCAKENEAYWMGPRPAEHGPDDPGGVDLYVGGAEHAVLHLLYSRFWHKVLYDLGHVSSREPYRRLVNQGYIQAYAYTDARGSYVPAEQVIERGDRFVYPGPDGEVEVFQEFGKIGKSLKNSVSPDEICDAYGADTLRVYEMSMGPLEASRPWATKDVVGAYRFLQRVWRLVVDEHTGETRVADGVELDIDTLRALHRTIVGVSEDFAALRNNTATAKLIEYTNHLTKKHRDAVPRAAVEPLVQMLAPLAPHIAEELWLRLGNTTSLAHGPFPKADAAYLVDETVEYPVQVNGKVRGRVVVAADTDEETLKAAVLTDEKVQAFLAGATPRKVIVVAGRLVNLVI,"107,595",969,Class-I aminoacyl-tRNA synthetase family,growth [GO:0040007]; leucyl-tRNA aminoacylation [GO:0006429],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; leucine-tRNA ligase activity [GO:0004823],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY21D4.04,1
P0CW29,VAPB1_MYCTU,Rv0064A,vapB1 Rv0064A,GO:0006355,IPR010985; ,,vapB1,,Putative antitoxin VapB1,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC1. {ECO:0000305|PubMed:15718296}.,MATIQVRDLPEDVAETYRRRATAAGQSLQTYMRTKLIEGVRGRDKAEAIEILEQALASTASPGISRETIEASRRELRGG,"8,718",79,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WFC1,VAPC1_MYCTU,Rv0065,vapC1 Rv0065,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC1,,Ribonuclease VapC1 (RNase VapC1) (EC 3.1.-.-) (Toxin VapC1),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296; 22539524,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. The cognate antitoxin is VapB1 (By similarity). Has ribonuclease activity. {ECO:0000250, ECO:0000269|PubMed:22539524}.",MDECVVDAAAVVDALAGKGASAIVLRGLLKESISNAPHLLDAEVGHALRRAVLSDEISEEQARAALDALPYLIDNRYPHSPRLIEYTWQLRHNVTFYDALYVALATALDVPLLTGDSRLAAAPGLPCEIKLVR,"14,372",133,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P0CW33,VPB25_MYCTU,Rv0277A,vapB25 Rv0277A,GO:0006355,IPR002145; IPR010985; ,,vapB25,,Antitoxin VapB25,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC25. {ECO:0000269|PubMed:20011113}.,MRTTVSISDELLATAKRRARERGQSLGAVIEDALRRELAAARTGGARPTVPVFDAGTGPRPGIDLTSNTVLSEVLDEGLELNSRK,"9,059",85,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WFL1,Y004_MYCTU,Rv0004,Rv0004 MTCY10H4.02,,IPR007922; IPR023007; ,,,,UPF0232 protein Rv0004,,8733228; 9634230,,,MTGSVDRPDQNRGERSMKSPGLDLVRRTLDEARAAARARGQDAGRGRVASVASGRVAGRRRSWSGPGPDIRDPQPLGKAARELAKKRGWSVRVAEGMVLGQWSAVVGHQIAEHARPTALNDGVLSVIAESTAWATQLRIMQAQLLAKIAAAVGNDVVRSLKITGPAAPSWRKGPRHIAGRGPRDTYG,"19,934",187,UPF0232 family,,,,,MTCY10H4.02,1
P9WMI7,Y0081_MYCTU,Rv0081,Rv0081,GO:0003677; GO:0003700; GO:0005886; GO:0006351,IPR011991; IPR001845; IPR036388; IPR036390; ,,,DOMAIN 2 97 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,Uncharacterized HTH-type transcriptional regulator Rv0081,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 11416222; 12953092; 18474359; 18400743; 19553548; 21969609,,,MESEPLYKLKAEFFKTLAHPARIRILELLVERDRSVGELLSSDVGLESSNLSQQLGVLRRAGVVAARRDGNAMIYSIAAPDIAELLAVARKVLARVLSDRVAVLEDLRAGGSAT,"12,356",114,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,1
P9WM95,Y030_MYCTU,Rv0030,Rv0030 MTCY10H4.30,,IPR024296; ,,,,Uncharacterized protein Rv0030,,9634230; 21969609,,,MVSGSDSRSEPSQLSDRDLVESVLRDLSEAADKWEALVTQAETVTYSVDLGDVRAVANSDGRLLELTLHPGVMTGYAHGELADRVNLAITALRDEVEAENRARYGGRLQ,"11,858",109,,,,,,MTCY10H4.30,1
P9WIW3,Y051_MYCTU,Rv0083,Rv0083 MTCY251.01 MTV030.27,GO:0005886; GO:0008137; GO:0016021; GO:0042773,IPR003918; IPR001750; ,,,,Uncharacterized protein Rv0083,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; ATP synthesis coupled electron transport [GO:0042773],9634230,,,MTAAPTAGGVVTSGVGVAGVGVGLLGMFGPVRVVHVGWLLPLSGVHIELDRLGGFFMALTGAVAAPVGCYLIGYVRREHLGRVPMAVVPLFVAAMLLVPAAGSVTTFLLAWELMAIASLILVLSEHARPQVRSAGLWYAVMTQLGFIAILVGLVVLAAAGGSDRFAGLGAVCDGVRAAVFMLTLVGFGSKAGLVPLHAWLPRAHPEAPSPVSALMSAAMVNLGIYGIVRFDLQLLGPGPRWWGLALLAVGGTSALYGVLQASVAADLKRLLAYSTTENMGLITLALGAATLFADTGAYGPASIAAAAAMLHMIAHAAFKSLAFMAAGSVLAATGLRDLDLLGGLARRMPATTVFFGVAALGACGLPLGAGFVSEWLLVQSLIHAAPGHDPIVALTTPLAVGVVALATGLSVAAMTKAFGIGFLARPRSTQAEAAREAPASMRAGMAIAAGACLVLAVAPLLVAPMVRRAAATLPAAQAVKFTGLGAVVRLPAMSGSIAPGVIAAAVLAAALAVAVLARWRFRRRPAPARLPLWACGAADLTVRMQYTATSFAEPLQRVFGDVLRPDTDIEVTHTAESRYMAERITYRTAVADAIEQRLYTPVVGAVAAMAELLRRAHTGSVHRYLAYGALGVLIVLVVAR,"65,628",640,Complex I subunit 4 family,ATP synthesis coupled electron transport [GO:0042773],NADH dehydrogenase (ubiquinone) activity [GO:0008137],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.01 MTV030.27,1
P9WG17,Y072_MYCTU,Rv0072,Rv0072,GO:0005576; GO:0005886; GO:0005887; GO:0009405,,,,,Uncharacterized ABC transporter permease Rv0072,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 21969609,,FUNCTION: Probably part of an ABC transporter complex. Probably responsible for the translocation of the substrate across the membrane (By similarity). {ECO:0000250}.,MLFAALRDMQWRKRRLVITIISTGLIFGMTLVLTGLANGFRVEARHTVDSMGVDVFVVRSGAAGPFLGSIPFPDVDLARVAAEPGVMAAAPLGSVGTIMKEGTSTRNVTVFGAPEHGPGMPRVSEGRSPSKPDEVAASSTMGRHLGDTVEVGARRLRVVGIVPNSTALAKIPNVFLTTEGLQKLAYNGQPNITSIGIIGMPRQLPEGYQTFDRVGAVNDLVRPLKVAVNSISIVAVLLWIVAVLIVGSVVYLSALERLRDFAVFKAIGTPTRSIMAGLALQALVIALLAAVVGVVLAQVLAPLFPMIVAVPVGAYLALPVAAIVIGLFASVAGLKRVVTVDPAQAFGGP,"36,410",349,ABC-4 integral membrane protein family,pathogenesis [GO:0009405],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WQK5,Y073_MYCTU,Rv0073,Rv0073,GO:0005524; GO:0016887,IPR003593; IPR003439; IPR017871; IPR018490; IPR018488; IPR000595; IPR027417; IPR014710; ,,,DOMAIN 4 242 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv0073,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 20066036; 21969609,,FUNCTION: Probably part of an ABC transporter complex. Probably responsible for energy coupling to the transport system (By similarity). {ECO:0000250}.,MGDLSIQNLVVEYYSGGYALRPINGLNLDVAAGSLVMLLGPSGCGKTTLLSCLGGILRPKSGAIKFDEVDITTLQGAELANYRRNKVGIVFQAFNLVPSLTAVENVMVPLRSAGMSRRASRRRAEELLARVNLAERMNHRPGDLSGGQQQRVAVARAIALDPPLILADEPTAHLDFIQVEEVLRLIRELADGERVVVVATHDSRMLPMADRVVELTPDFAETNRPPETVHLQAGEVLFEQSTMGDLIYVVSEGEFEIVHELADGGEELVKVAGPGDYFGEIGVLFHLPRSATVRARSDATAVGYTVQAFRERLGVGGLRDLIEHRALAND,"35,801",330,ABC transporter superfamily,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
P9WM75,Y085_MYCTU,Rv0085,Rv0085 MTCY251.03,GO:0005886; GO:0016021; GO:0040007,IPR038730; ,,,,Uncharacterized protein Rv0085,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550,,,MSNANFSILVDFAAGGLVLASVLIVWRRDLRAIVRLLAWQGAALAAIPLLRGIRDNDRALIAVGIAVLALRALVLPWLLARAVGAEAAAQREATPLVNTASSLLITAGLTLTAFAITQPVVNLEPGVTINAVPAAFAVVLIALFVMTTRLHAVSQAAGFLMLDNGIAATAFLLTAGVPLIVELGASLDVLFAVIVIGVLTGRLRRIFGDADLDKLRELRD,"23,042",220,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.03,1
P9WM73,Y088_MYCTU,Rv0088,Rv0088 MTCY251.06,GO:0005618; GO:0005886,IPR019587; IPR023393; ,,,,Uncharacterized protein Rv0088,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MSVYKHAPSRVRLRQTRSTVVKGRSGSLSWRRVRTGDLGLAVWGGREEYRAVKPGTPGIQPKGDMMTVTVVDAGPGRVSRSVEVAAPAAELFAIVADPRRHRELDGSGTVRGNIKVPAKLVVGSKFSTKMKLFGLPYRITSRVTALKPNELVEWSHPLGHRWRWEFESLSPTLTRVTETFDYHAAGAIKNGLKFYEMTGFAKSNAAGIEATLAKLSDQYARGRA,"24,649",224,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY251.06,1
P9WK03,Y089_MYCTU,Rv0089,Rv0089 MTCY251.07,GO:0005618; GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized methyltransferase Rv0089 (EC 2.1.1.-),cell wall [GO:0005618]; methyltransferase activity [GO:0008168],9634230,,,MDQPWNANIHYDALLDAMVPLGTQCVLDVGCGDGLLAARLARRIPYVTAVDIDAPVLRRAQTRFANAPIRWLHADIMTAELPNAGFDAVVSNAALHHIEDTRTALSRLGGLVTPGGTLAVVTFVTPSLRNGLWHLTSWVACGMANRVKGKWEHSAPIKWPPPQTLHELRSHVRALLPGACIRRLLYGRVLVTWRAPV,"21,596",197,Methyltransferase superfamily,,methyltransferase activity [GO:0008168],cell wall [GO:0005618],,MTCY251.07,1
Q10891,Y095_MYCTU,Rv0095c,Rv0095c MTCY251.14c,,IPR003870; ,,,,Putative uncharacterized protein Rv0095c,,9634230,,,MLANSREELVEVFDALDADLDRLDEVSFEVLSTPERLRSLERLECLARRLPAAQHTLINQLDTQASEEELGGTLCCALANRLRITKPEAGRRSAEAKP,"10,947",98,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,,,MTCY251.14c,2
P9WM61,Y104_MYCTU,Rv0104,Rv0104 MTCY251.23,GO:0005886; GO:0016021,IPR018490; IPR000595; IPR036291; IPR014710; ,,,,Uncharacterized protein Rv0104,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MTPVTTFPLVDAILAGRDRNLDGVILIAAQHLLQTTHAMLRSLFRVGLDPRNVAVIGKCYSTHPGVVDAMRADGIYVDDCSDAYAPHESFDTQYTRHVERFFAESWARLTAGRTARVVLLDDGGSLLAVAGAMLDASADVIGIEQTSAGYAKIVGCALGFPVINIARSSAKLLYESPIIAARVTQTAFERTAGIDSSAAILITGAGAIGTALADVLRPLHDRVDVYDTRSGCMTPIDLPNAIGGYDVIIGATGATSVPASMHELLRPGVLLMSASSSDREFDAVALRRRTTPNPDCHADLRVADGSVDATLLNSGFPVNFDGSPMCGDASMALTMALLAAAVLYASVAVADEMSSDHPHLGLIDQGDIVASFLNIDVPLQALSRLPLLSIDGYRRLQVRSGYTLFRQGERADHFFVIESGELEALVDGKVILRLGAGDHFGEACLLGGMRRIATVRACEPSVLWELDGKAFGDALHGDAAMREIAYGVARTRLMHAGASESLMV,"53,451",504,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.23,1
P9WPI5,Y106_MYCTU,Rv0106,Rv0106 MTCY251.25,,IPR011629; IPR003495; ,,,DOMAIN 235 351 CobW C-terminal.,Uncharacterized protein Rv0106,,9634230; 21969609,,,MRTPVILVAGQDHTDEVTGALLRRTGTVVVEHRFDGHVVRRMTATLSRGELITTEDALEFAHGCVSCTIRDDLLVLLRRLHRRDNVGRIVVHLAPWLEPQPICWAIDHVRVCVGHGYPDGPAALDVRVAAVVTCVDCVRWLPQSLGEDELPDGRTVAQVTVGQAEFADLLVLTHPEPVAVAVLRRLAPRARITGGVDRVELALAHLDDNSRRGRTDTPHTPLLAGLPPLAADGEVAIVEFSARRPFHPQRLHAAVDLLLDGVVRTRGRLWLANRPDQVMWLESAGGGLRVASAGKWLAAMAASEVAYVDLERRLFADLMWVYPFGDRHTAMTVLVCGADPTDIVNALNAALLSDDEMASPQRWQSYVDPFGDWHDDPCHEMPDAAGEFSAHRNSGESR,"43,700",398,,,,,,MTCY251.25,1
P9WQ19,TRES_MYCTU,Rv0126,treS Rv0126,GO:0000023; GO:0000272; GO:0004556; GO:0005509; GO:0005829; GO:0005886; GO:0005977; GO:0005978; GO:0005991; GO:0005992; GO:0016161; GO:0045227; GO:0047471; GO:0103025,IPR006047; IPR013780; IPR017853; IPR032091; IPR012810; ,,treS,,Trehalose synthase/amylase TreS (EC 3.2.1.1) (EC 5.4.99.16) (Maltose alpha-D-glucosyltransferase) (MTase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; beta-amylase activity [GO:0016161]; calcium ion binding [GO:0005509]; maltose alpha-D-glucosyltransferase activity [GO:0047471]; capsule polysaccharide biosynthetic process [GO:0045227]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; maltose metabolic process [GO:0000023]; polysaccharide catabolic process [GO:0000272]; trehalose biosynthetic process [GO:0005992]; trehalose metabolic process [GO:0005991],9634230; 19099550; 18505459; 20305657; 21969609; 27513637,,"FUNCTION: Catalyzes the reversible interconversion of maltose and trehalose by transglucosylation (PubMed:18505459). Also displays amylase activity, catalyzing the endohydrolysis of (1->4)-alpha-D-glucosidic linkages in glycogen and maltooligosaccharides such as maltoheptaose, to produce maltose which then can be converted to trehalose (PubMed:18505459). TreS plays a key role in the utilization of trehalose for the production of glycogen and alpha-glucan via the TreS-Pep2 branch involved in the biosynthesis of maltose-1-phosphate (M1P) (PubMed:18505459, PubMed:27513637). Might also function as a sensor and/or regulator of trehalose levels within the cell (PubMed:18505459). Thus, when trehalose levels in the cell become dangerously low, TreS could expedite the conversion of glycogen to maltose via its amylase activity and then convert the maltose to trehalose; but this enzyme also could expedite or promote the conversion of trehalose to glycogen when cytoplasmic trehalose levels become too high (PubMed:18505459). {ECO:0000269|PubMed:18505459, ECO:0000269|PubMed:27513637}.",MNEAEHSVEHPPVQGSHVEGGVVEHPDAKDFGSAAALPADPTWFKHAVFYEVLVRAFFDASADGSGDLRGLIDRLDYLQWLGIDCIWLPPFYDSPLRDGGYDIRDFYKVLPEFGTVDDFVALVDAAHRRGIRIITDLVMNHTSESHPWFQESRRDPDGPYGDYYVWSDTSERYTDARIIFVDTEESNWSFDPVRRQFYWHRFFSHQPDLNYDNPAVQEAMIDVIRFWLGLGIDGFRLDAVPYLFEREGTNCENLPETHAFLKRVRKVVDDEFPGRVLLAEANQWPGDVVEYFGDPNTGGDECHMAFHFPLMPRIFMAVRRESRFPISEIIAQTPPIPDMAQWGIFLRNHDELTLEMVTDEERDYMYAEYAKDPRMKANVGIRRRLAPLLDNDRNQIELFTALLLSLPGSPVLYYGDEIGMGDVIWLGDRDGVRIPMQWTPDRNAGFSTANPGRLYLPPSQDPVYGYQAVNVEAQRDTSTSLLNFTRTMLAVRRRHPAFAVGAFQELGGSNPSVLAYVRQVAGDDGDTVLCVNNLSRFPQPIELDLQQWTNYTPVELTGHVEFPRIGQVPYLLTLPGHGFYWFQLTTHEVGAPPTCGGERRL,"68,593",601,"Glycosyl hydrolase 13 family, TreS subfamily",capsule polysaccharide biosynthetic process [GO:0045227]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; maltose metabolic process [GO:0000023]; polysaccharide catabolic process [GO:0000272]; trehalose biosynthetic process [GO:0005992]; trehalose metabolic process [GO:0005991],alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; beta-amylase activity [GO:0016161]; calcium ion binding [GO:0005509]; maltose alpha-D-glucosyltransferase activity [GO:0047471],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WFY9,TRMB_MYCTU,Rv0208c,trmB Rv0208c MTCY08D5.03c,GO:0008176; GO:0036265; GO:0040007; GO:0043527,IPR029063; IPR003358; ,,trmB,,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; growth [GO:0040007]; RNA (guanine-N7)-methylation [GO:0036265],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the formation of N(7)-methylguanine at position 46 (m7G46) in tRNA. {ECO:0000255|HAMAP-Rule:MF_01057}.,MVHHGQMHAQPGVGLRPDTPVASGQLPSTSIRSRRSGISKAQRETWERLWPELGLLALPQSPRGTPVDTRAWFGRDAPVVLEIGSGSGTSTLAMAKAEPHVDVIAVDVYRRGLAQLLCAIDKVGSDGINIRLILGNAVDVLQHLIAPDSLCGVRVFFPDPWPKARHHKRRLLQPATMALIADRLVPSGVLHAATDHPGYAEHIAAAGDAEPRLVRVDPDTELLPISVVRPATKYERKAQLGGGAVIELLWKKHGCSERDLKIR,"28,547",263,"Class I-like SAM-binding methyltransferase superfamily, TrmB family",growth [GO:0040007]; RNA (guanine-N7)-methylation [GO:0036265],tRNA (guanine-N7-)-methyltransferase activity [GO:0008176],tRNA methyltransferase complex [GO:0043527],,MTCY08D5.03c,1
P9WMI3,Y023_MYCTU,Rv0023,Rv0023 MTCY10H4.23,GO:0006351; GO:0006355; GO:0043565,IPR001387; IPR010982; ,,,DOMAIN 10 64 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Uncharacterized HTH-type transcriptional regulator Rv0023,"sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 16483748; 21969609,,,MSRESAGAAIRALRESRDWSLADLAAATGVSTMGLSYLERGARKPHKSTVQKVENGLGLPPGTYSRLLVAADPDAELARLIAAQPSNPTAVRRAGAVVVDRHSDTDVLEGYAEAQLDAIKSVIDRLPATTSNEYETYILSVIAQCVKAEMLAASSWRVAVNAGADSTGRLMEHLRALEATRGALLERMPTSLSARFDRACAQSSLPEAVVAALIGVGADEMWDIRNRGVIPAGALPRVRAFVDAIEASHDADEGQQ,"27,188",256,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",sequence-specific DNA binding [GO:0043565],,,MTCY10H4.23,1
P9WM99,Y027_MYCTU,Rv0027,Rv0027 MTCY10H4.27,GO:0009306,IPR022536; ,,,,Uncharacterized protein Rv0027,protein secretion [GO:0009306],9634230,,,MTDRIHVQPAHLRQAAAHHQQTADYLRTVPSSHDAIRESLDSLGPIFSELRDTGRELLELRKQCYQQQADNHADIAQNLRTSAAMWEQHERAASRSLGNIIDGSR,"11,910",105,,protein secretion [GO:0009306],,,,MTCY10H4.27,1
P9WM93,Y034_MYCTU,Rv0034,Rv0034 MTCY10H4.34,,IPR032710; IPR037401; ,,,,Uncharacterized protein Rv0034,,9634230; 21969609,,,MTDDADLDLVRRTFAAFARGDLAELTQCFAPDVEQFVPGKHALAGVFRGVDNVVACLGDTAAAADGTMTVTLEDVLSNTDGQVIAVYRLRASRAGKVLDQREAILVTVAGGRITRLSEFYADPAATESFWA,"13,968",131,,,,,,MTCY10H4.34,1
P9WM91,Y036_MYCTU,Rv0036c,Rv0036c MTCY10H4.36c,GO:0005618; GO:0005886; GO:0046872,IPR017517; IPR017518; IPR034660; IPR024344; IPR013917; ,,,,Uncharacterized protein Rv0036c,cell wall [GO:0005618]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872],9634230; 21969609,,,MADPGPFVADLRAESDDLDALVAHLPADRWADPTPAPGWTIAHQIGHLLWTDRVALTAVTDEAGFAELMTAAAANPAGFVDDAATELAAVSPAELLTDWRVTRGRLHEELLAVPDGRKLAWFGPPMSAASMATARLMETWAHGLDVADALGVIRPATQRLRSIAHLGVRTRDYAFIVNNLTPPAEPFLVELRGPSGDTWSWGPSDAAQRVTGSAEDFCFLVTQRRALSTLDVNAVGEDAQRWLTIAQAFAGPPGRGR,"27,546",257,,,metal ion binding [GO:0046872],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY10H4.36c,1
P9WFK5,Y038_MYCTU,Rv0038,Rv0038 MTCY10H4.38,GO:0005886,IPR003774; ,,,,UPF0301 protein Rv0038,plasma membrane [GO:0005886],9634230; 21969609,,,MVAPHEDPEDHVAPAAQRVRAGTLLLANTDLLEPTFRRSVIYIVEHNDGGTLGVVLNRPSETAVYNVLPQWAKLAAKPKTMFIGGPVKRDAALCLAVLRVGADPEGVPGLRHVAGRLVMVDLDADPEVLAAAVEGVRIYAGYSGWTIGQLEGEIERDDWIVLSALPSDVLVGPRADLWGQVLRRQPLPLSLLATHPIDLSRN,"21,808",202,UPF0301 (AlgH) family,,,plasma membrane [GO:0005886],,MTCY10H4.38,1
P9WM85,Y049_MYCTU,Rv0049,Rv0049 MTCY21D4.12,,IPR035169; ,,,,Uncharacterized protein Rv0049,,9634230; 21969609,,,MDYTLRRRSLLAEVYSGRTGVSEVCDANPYLLRAAKFHGKPSRVICPICRKEQLTLVSWVFGEHLGAVSGSARTAEELILLATRFSEFAVHVVEVCRTCSWNHLVKSYVLGAARPARPPRGSGGTRTARNGARTASE,"15,032",137,,,,,,MTCY21D4.12,1
P9WM69,Y093_MYCTU,Rv0093c,Rv0093c MTCY251.12c,GO:0005618; GO:0005886; GO:0016021,IPR027383; ,,,,Uncharacterized protein Rv0093c,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MLAQATTAGSFNHHASTVLQGCRGVPAAMWSEPAGAIRRHCATIDGMDCEVAREALSARLDGERAPVPSARVDEHLGECSACRAWFTQVASQAGDLRRLAESRPVVPPVGRLGIRRAPRRQHSPMTWRRWALLCVGIAQIALGTVQGFGLDVGLTHQHPTGAGTHLLNESTSWSIALGVIMVGAALWPSAAAGLAGVLTAFVAILTGYVIVDALSGAVSTTRILTHLPVVIGAVLAIMVWRSASGPRPRPDAVAAEPDIVLPDNASRGRRRGHLWPTDGSAA,"29,631",282,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.12c,1
P9WG83,Y097_MYCTU,Rv0097,Rv0097 MTCY251.16,GO:0046872; GO:0051213,IPR003819; ,,,,Putative dioxygenase Rv0097 (EC 1.-.-.-),dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],9634230; 21969609,,,MTLKVKGEGLGAQVTGVDPKNLDDITTDEIRDIVYTNKLVVLKDVHPSPREFIKLGRIIGQIVPYYEPMYHHEDHPEIFVSSTEEGQGVPKTGAFWHIDYMFMPEPFAFSMVLPLAVPGHDRGTYFIDLARVWQSLPAAKRDPARGTVSTHDPRRHIKIRPSDVYRPIGEVWDEINRTTPPIKWPTVIRHPKTGQEILYICATGTTKIEDKDGNPVDPEVLQELMAATGQLDPEYQSPFIHTQHYQVGDIILWDNRVLMHRAKHGSAAGTLTTYRLTMLDGLKTPGYAA,"32,641",289,TfdA dioxygenase family,,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],,,MTCY251.16,1
P9WM67,Y098_MYCTU,Rv0098,Rv0098 MTCY251.17,GO:0005886; GO:0006633; GO:0047617,IPR022598; ,,,,Uncharacterized protein Rv0098,plasma membrane [GO:0005886]; acyl-CoA hydrolase activity [GO:0047617]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,X-ray crystallography (2),,MSHTDLTPCTRVLASSGTVPIAEELLARVLEPYSCKGCRYLIDAQYSATEDSVLAYGNFTIGESAYIRSTGHFNAVELILCFNQLAYSAFAPAVLNEEIRVLRGWSIDDYCQHQLSSMLIRKASSRFRKPLNPQKFSARLLCRDLQVIERTWRYLKVPCVIEFWDENGGAASGEIELAALNIP,"20,529",183,,fatty acid biosynthetic process [GO:0006633],acyl-CoA hydrolase activity [GO:0047617],plasma membrane [GO:0005886],,MTCY251.17,1
P9WFJ1,Y153_MYCTU,Rv0145,Rv0145,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0145 (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MSSLPSSRRTAGDTWAITESVGATALGVAAARAVETAATNPLIRDEFAKVLVSSAGTAWARLADADLAWLDGDQLGRRVHRVACDYQAVRTHFFDEYFGAAVDAGVRQVVILAAGLDARAYRLNWPAGTVVYEIDQPSVLEYKAGILQSHGAVPTARRHAVAVDLRDDWPAALIAAGFDGTQPTAWLAEGLLPYLPGDAADRLFDMVTALSAPGSQVAVEAFTMNTKGNTQRWNRMRERLGLDIDVQALTYHEPDRSDAAQWLATHGWQVHSVSNREEMARLGRAIPQDLVDETVRTTLLRGRLVTPAQPA,"33,709",311,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
P71592,WHB5A_MYCTU,Rv0022c,whiB5 Rv0022c,GO:0003677; GO:0005618; GO:0005737; GO:0006351; GO:0006355; GO:0009405; GO:0046872; GO:0051539,IPR034768; IPR003482; ,,whiB5,DOMAIN 4 77 4Fe-4S Wbl-type.,Transcriptional regulator WhiB5,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19016840; 22733573,,"FUNCTION: A transcription factor that is probably redox-responsive. Probably plays a role in immunomodulation and reactivation after chronic infection. Its induction results in transcription of a number of genes including sigM, and the genes for 2 type VII secretion systems ESX-2 and ESX-4. Seems to negatively regulate its own expression. The apo-form has been shown to act as a protein disulfide reductase. The apo- but not holo-form probably binds DNA. {ECO:0000269|PubMed:19016840, ECO:0000269|PubMed:22733573}.",MAHPCATDPELWFGYPDDDGSDGAAKARAYERSATQARIQCLRRCPLLQQRRCAQHAVEHRVEYGVWAGIKLPGGQYRKREQLAAAHDVLRRIAGGEINSRQLPDNAALLARNEGLEVTPVPGVVVHLPIAQVGPQPAA,"15,178",139,WhiB family,"pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]",cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
P9WJY1,Y037_MYCTU,Rv0037c,Rv0037c MTCY10H4.37c,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv0037c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 21969609,,,MPRVEVGLVIHSRMHARAPVDVWRSVRSLPDFWRLLQVRVASQFGDGLFQAGLAGALLFNPDRAADPMAIAGAFAVLFLPYSLLGPFAGALMDRWDRRWVLVGANTGRLALIAGVGTILAVGAGDVPLLVGALVANGLARFVASGLSAALPHVVPREQVVTMNSVAIASGAVSAFLGANFMLLPRWLLGSGDEGASAIVFLVAIPVSIALLWSLRFGPRVLGPDDTERAIHGSAVYAVVTGWLHGARTVVQLPTVAAGLSGLAAHRMVVGINSLLILLLVRHVTARAVGGLGTALLFFAATGLGAFLANVLTPTAIRRWGRYATANGALAAAATIQVAAAGLLVPVMVVCGFLLGVAGQVVKLCADSAMQMDVDDALRGHVFAVQDALFWVSYILSITVAAALIPEHGHAPVFVLFGSAIYLAGLVVHTIVGRRGQPVIGR,"45,866",441,Major facilitator superfamily,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.37c,1
P9WMG9,Y043_MYCTU,Rv0043c,Rv0043c MTCY21D4.06c,GO:0003677; GO:0003700; GO:0006351,IPR008920; IPR000524; IPR036388; IPR036390; ,,,DOMAIN 7 74 HTH gntR-type. {ECO:0000255|PROSITE-ProRule:PRU00307}.,Uncharacterized HTH-type transcriptional regulator Rv0043c,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPKKYGVKEKDQVVAHILNLLLTGKLRSGDRVDRNEIAHGLGVSRVPIQEALVQLEHDGIVSTRYHRGAFIERFDVATILEHHELDGLLNGIASARAAANPTPRILGQLDAVMRSLRNSKESRAFAECVWEYRRTVNDEYAGPRLHATIRASQNLIPRVFWMTYQNSRDDVLPFYEEENAAIHRREPEAARAACIGRSELMAQTMLAELFRRRVLVPPEGACPGPFGAPIPGFARSYQPSSPVP,"27,328",244,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTCY21D4.06c,1
P9WM63,Y102_MYCTU,Rv0102,Rv0102 MTCY251.21,GO:0005886; GO:0016021; GO:0040007,IPR019108; IPR008457; ,,,,Uncharacterized protein Rv0102,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550; 21969609,,,MGTHGATKSATSAVPTPRSNSMAMVRLAIGLLGVCAVVAAFGLVSGARRYAEAGNPYPGAFVSVAEPVGFFAASLAGALCLGALIHVVMTAKPEPDGLIDAAAFRIHLLAERVSGLWLGLAATMVVIQAAHDTGVGPARLLASGALSDSVAASEMARGWIVAAICALVVATALRLYTRWLGHVVLLVPTVLAVVATAVTGNPGQGPDHDYATSAAIVFAVAFATLTGLKIAAALAGTTPSRAVLVTQVTCGALALAYGAMLLYLFIPGWAVDSDFARLGLLAGVILTSVWLFDCWRLLVRPPHAGRRRGGGSGAALAMMAAMASIAAMAVMTAPRFLTHAFTAWDVFLGYELPQPPTIARVLTVWRFDSLIGAAGVVLAIGYAAGFAALRRRGNSWPVGRLIAWLTGCAALVFTSGSGVRAYGSAMFSVHMAEHMTLNMFIPVLLVLGGPVTLALRVLPVTGDGRPPGAREWLTWLLHSRVTTFLSHPITAFVLFVASPYIVYFTPLFDTFVRYHWGHEFMAIHFLVVGYLFYWAIIGIDPGPRRLPYPGRIGLLFAVMPFHAFFGIALMTMSSTVGATFYRSVNLPWLSSIIADQHLGGGIAWSLTELPVIMVIVALVTQWARQDRRVASREDRHADSDYADDELEAYNAMLRELSRMRR,"70,357",661,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.21,1
P9WF87,VPC24_MYCTU,Rv0240,vapC24 Rv0240,GO:0004540; GO:0005886; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC24,DOMAIN 4 123 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC24 (RNase VapC24) (EC 3.1.-.-) (Toxin VapC24),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB24 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MLSIDTNILLYAQNRDCPEHDAAAAFLVECAGRADVAVCELVLMELYQLLRNPTVVTRPLEGPEAAEVCQTFRRNRRWALLENAPVMNEVWVLAATPRIARRRLFDARLALTLRHHGVDEFATRNINGFTDFGFSRVWDPITSDG,"16,426",145,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],plasma membrane [GO:0005886],,,1
P9WJ41,VPB24_MYCTU,Rv0239,vapB24 Rv0239,,,,vapB24,,Putative antitoxin VapB24,,9634230; 20011113,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC24. {ECO:0000305|PubMed:20011113}.,MIRTQVQLPDELYRDAKRVAHEHEMTLAEVVRRGLEHMVRIYPRRDAASDTWQPPTPRRLGPFRASEETWRELANEA,"9,138",77,,,,,,,1
P9WF85,VPC25_MYCTU,Rv0277c,vapC25 Rv0277c,GO:0004540; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC25,DOMAIN 3 139 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC25 (RNase VapC25) (EC 3.1.-.-) (Toxin VapC25),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB25. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MFLIDVNVLLAAHRGDHPNHRTVRPWFDRLLAADDPFTVPNLVWASFLRLTTNRRIFEIPSPRADAFAFVEAVNAQPHHLPTSPGPRHLVLLRKLCDEADASGDLIPDAVLGAIAVEHHCAVVSLDRDFARFASVRHIRPPI,"15,887",142,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
L0T5V6,VPC51_MYCTU,Rv0229c RVBD_0229c,vapC51 Rv0229c RVBD_0229c P425_00238,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC51,DOMAIN 5 120 PINc.,Ribonuclease VapC51 (RNase VapC51) (EC 3.1.-.-) (Toxin VapC51),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB51. {ECO:0000305}.,MALKYLLDTSVIKRLSRPAVRRAVEPLAEAGAVARTQITDLEVGYSARNETEWQRLMVALSAFDLIESTASHHRRALGIQRLLAARSQRGRKIPDLLIAAAGEEHGLVVLHYDADFDLIAAVTGQPCQWIVPAGTID,"15,025",137,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,P425_00238,2
P9WMB1,Y0026_MYCTU,Rv0026,Rv0026 MTCY10H4.26,,IPR019710; ,,,,Uncharacterized protein Rv0026,,9634230,,,MAFDAAMSTHEDLLATIRYVRDRTGDPNAWQTGLTPTEVTAVVTSTTRSEQLDAILRKIRQRHSNLYYPAPPDREQGDAARAIADAEAALAHQNSATAQLDLQVVSAILNAHLKTVEGGESLHELQQEIEAAVRIRSDLDTPAGARDFQRFLIGKLKDIREVVATASLDAASKSALMAAWTSLYDASKGDRGDADDRGPASVGSGGAPARGAGQQPELPTRAEPDCLLDSLLLEDPGLLADDLQVPGGTSAAIPSASSTPSLPNLGGATMPGGGATPALVPGVSAPGGLPLSGLLRGVGDEPELTDFDERGQEVRDPADYEHSNEPDERRADDREGADEDAGLGKSESPPQAPTTVTLPNGETVTAASPQLAAAIKAAASGTPIADAFQQQGIAIPLPGTAVANPVDPARISAGDVGVFTATPLPLALAKLFWTARFNTSQPCEGQTF,"46,475",448,,,,,,MTCY10H4.26,1
P96825,Y0148_MYCTU,Rv0148,Rv0148,GO:0005618; GO:0005886; GO:0016491; GO:0070490,IPR036291; IPR020904; IPR002347; ,,,,Putative short-chain type dehydrogenase/reductase Rv0148 (EC 1.1.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; protein pupylation [GO:0070490],9634230; 20066036; 21969609,,,MPGVQDRVIVVTGAGGGLGREYALTLAGEGASVVVNDLGGARDGTGAGSAMADEVVAEIRDKGGRAVANYDSVATEDGAANIIKTALDEFGAVHGVVSNAGILRDGTFHKMSFENWDAVLKVHLYGGYHVLRAAWPHFREQSYGRVVVATSTSGLFGNFGQTNYGAAKLGLVGLINTLALEGAKYNIHANALAPIAATRMTQDILPPEVLEKLTPEFVAPVVAYLCTEECADNASVYVVGGGKVQRVALFGNDGANFDKPPSVQDVAARWAEITDLSGAKIAGFKL,"29,779",286,Short-chain dehydrogenases/reductases (SDR) family,protein pupylation [GO:0070490],oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
P0DMM2,Y028A_MYCTU,Rv0028A,Rv0028A,,,,,,Uncharacterized protein Rv0028A,,9634230; 21969609,,,MADSALQQQLDEVRALLTRARELFGPNPIEPPTDIAPDPDSTKTWLI,"5,232",47,,,,,,,1
P9WM97,Y028_MYCTU,Rv0028,Rv0028 MTCY10H4.28,,IPR024426; ,,,,Uncharacterized protein Rv0028,,9634230; 21969609,,,MTDANPAFDTVHPSGHILVRSCRGGYMHSVSLSEAAMETDAETLAEAILLTADVSCLKALLEVRNEIVAAGHTPSAQVPTTDDLNVAIEKLLAHQLRRRNR,"10,904",101,,,,,,MTCY10H4.28,1
P9WM89,Y039_MYCTU,Rv0039c,Rv0039c MTCY10H4.39c MTCY21D4.02c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv0039c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MFLAGVLCMCAAAASALFGSWSLCHTPTADPTALALRAMAPTQLAAAVMLAAGGVVAVAAPGHTALMVVIVCIAGAVGTLAAGSWQSAQYALRRETASPTANCVGSCAVCTQACH,"11,292",115,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.39c MTCY21D4.02c,1
P9WFL5,Y064_MYCTU,Rv0064,Rv0064 MTV030.07,GO:0005576; GO:0005618; GO:0005886; GO:0016021,IPR005372; ,,,,UPF0182 protein Rv0064,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,METGSPGKRPVLPKRARLLVTAGMGMLALLLFGPRLVDIYVDWLWFGEVGFRSVWITVLLTRLAIVAAVALVVAGIVLAALLLAYRSRPFFVPDEPQRDPVAPLRSAVMRRPRLFGWGIAVTLGVVCGLIASFDWVKVQLFVHGGTFGIVDPEFGYDIGFFVFDLPFYRSVLNWLFVAVVLAFLASLLTHYLFGGLRLTTGRGMLTQAARVQLAVFAGAVVLLKAVAYWLDRYELLSSGRKEPTFTGAGYTDIHAELPAKLVLVAIAVLCAVSFFTAIFLRDLRIPAMAAALLVLSAILVGGLWPLLMEQFSVRPNAADVERPYIQRNIEATREAYRIGGDWVQYRSYPGIGTKQPRDVPVDVTTIAKVRLLDPHILSRTFTQQQQLKNFFSFAEILDIDRYRIDGELQDYIVGVRELSPKSLTGNQTDWINKHTVYTHGNGFVAAPANRVNAAARGAENISDSNSGYPIYAVSDIASLGSGRQVIPVEQPRVYYGEVIAQADPDYAIVGGAPGSAPREYDTDTSKYTYTGAGGVSIGNWFNRTVFATKVAQHKFLFSREIGSESKVLIHRDPKERVQRVAPWLTTDDNPYPVVVNGRIVWIVDAYTTLDTYPYAQRSSLEGPVTSPTGIVRQGKQVSYVRNSVKATVDAYDGTVTLFQFDRDDPVLRTWMRAFPGTVKSEDQIPDELRAHFRYPEDLFEVQRSLLAKYHVDEPREFFTTNAFWSVPSDPTNNANATQPPFYVLVGDQQSAQPSFRLASAMVGYNREFLSAYISAHSDPANYGKLTVLELPTDTLTQGPQQIQNSMISDTRVASERTLLERSNRIHYGNLLSLPIADGGVLYVEPLYTERISTSPSSSTFPQLSRVLVSVREPRTEGGVRVGYAPTLAESLDQVFGPGTGRVATARGGDAASAPPPGAGGPAPPQAVPPPRTTQPPAAPPRGPDVPPATVAELRETLADLRAVLDRLEKAIDAAETPGG,"107,369",979,UPF0182 family,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV030.07,1
P9WJX7,Y191_MYCTU,Rv0191,Rv0191,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv0191,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MTAPTGTSATTTRPWTPRIATQLSVLACAAFIYVTAEILPVGALSAIARNLRVSVVLVGTLLSWYALVAAVTTVPLVRWTAHWPRRRALVVSLVCLTVSQLVSALAPNFAVLAAGRVLCAVTHGLLWAVIAPIATRLVPPSHAGRATTSIYIGTSLALVVGSPLTAAMSLMWGWRLAAVCVTGAAAAVALAARLALPEMVLRADQLEHVGRRARHHRNPRLVKVSVLTMIAVTGHFVSYTYIVVIIRDVVGVRGPNLAWLLAAYGVAGLVSVPLVARPLDRWPKGAVIVGMTGLTAAFTLLTALAFGERHTAATALLGTGAIVLWGALATAVSPMLQSAAMRSGGDDPDGASGLYVTAFQIGIMAGALLGGLLYERSLAMMLTASAGLMGVALFGMTVSQHLFENPTLSPGDG,"42,911",413,Major facilitator superfamily,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WLB1,Y236A_MYCTU,Rv0236.1,Rv0236.1 Rv0236A,,IPR022566; ,,,,Putative secreted protein Rv0236.1,,9634230; 12368430; 21969609,,,MNRIVAPAAASVVVGLLLGAAAIFGVTLMVQQDKKPPLPGGDPSSSVLNRVEYGNRS,"5,834",57,,,,,,Rv0236A,1
P9WGG5,SIGG_MYCTU,Rv0182c,sigG Rv0182c,GO:0001666; GO:0003677; GO:0003700; GO:0006352; GO:0009415; GO:0016987,IPR032710; IPR014284; IPR014305; IPR000838; IPR007627; IPR013249; IPR013325; IPR013324; IPR037401; IPR036388; ,,sigG,,ECF RNA polymerase sigma factor SigG (ECF sigma factor SigG) (Alternative RNA polymerase sigma factor SigG) (RNA polymerase sigma-G factor) (Sigma-g factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; response to hypoxia [GO:0001666]; response to water [GO:0009415]",9634230; 10027986; 16483748; 21169493; 21969609,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by a cognate anti-sigma factor until released, although no anti-sigma factor is known for this protein. May be involved in host intracellular survival after infection (strains H37Rv and CDC 1551). A role in the SOS response is controversial; it has been seen in strain CDC 1551 (PubMed:18039768) but not in H37Rv (PubMed:21169493). {ECO:0000269|PubMed:16483748, ECO:0000269|PubMed:21169493}.",MRTSPMPAKFRSVRVVVITGSVTAAPVRVSETLRRLIDVSVLAENSGREPADERRGDFSAHTEPYRRELLAHCYRMTGSLHDAEDLVQETLLRAWKAYEGFAGKSSLRTWLHRIATNTCLTALEGRRRRPLPTGLGRPSADPSGELVERREVSWLEPLPDVTDDPADPSTIVGNRESVRLAFVAALQHLSPRQRAVLLLRDVLQWKSAEVADAIGTSTVAVNSLLQRARSQLQTVRPSAADRLSAPDSPEAQDLLARYIAAFEAYDIDRLVELFTAEAIWEMPPYTGWYQGAQAIVTLIHQQCPAYSPGDMRLISLIANGQPAAAMYMRAGDVHLPFQLHVLDMAADRVSHVVAFLDTTLFPKFGLPDSL,"40,983",370,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; response to hypoxia [GO:0001666]; response to water [GO:0009415]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
P9WN35,TRPG_MYCTU,Rv0013,trpG Rv0013,GO:0000162; GO:0004049; GO:0005886; GO:0005950; GO:0006541,IPR029062; IPR017926; IPR006221; ,,trpG,DOMAIN 2 198 Glutamine amidotransferase type-1. {ECO:0000255|PROSITE-ProRule:PRU00605}.,"Anthranilate synthase component 2 (AS) (ASII) (EC 4.1.3.27) (Anthranilate synthase, GATase component) (Anthranilate synthase, glutamine amidotransferase component)",anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886]; anthranilate synthase activity [GO:0004049]; glutamine metabolic process [GO:0006541]; tryptophan biosynthetic process [GO:0000162],9634230; 19099550; 21969609,,"FUNCTION: Part of a heterotetrameric complex that catalyzes the two-step biosynthesis of anthranilate, an intermediate in the biosynthesis of L-tryptophan. In the first step, the glutamine-binding beta subunit (TrpG) of anthranilate synthase (AS) provides the glutamine amidotransferase activity which generates ammonia as a substrate that, along with chorismate, is used in the second step, catalyzed by the large alpha subunit of AS (TrpE) to produce anthranilate. In the absence of TrpG, TrpE can synthesize anthranilate directly from chorismate and high concentrations of ammonia (By similarity). {ECO:0000250}.",MRILVVDNYDSFVFNLVQYLGQLGIEAEVWRNDDHRLSDEAAVAGQFDGVLLSPGPGTPERAGASVSIVHACAAAHTPLLGVCLGHQAIGVAFGATVDRAPELLHGKTSSVFHTNVGVLQGLPDPFTATRYHSLTILPKSLPAVLRVTARTSSGVIMAVQHTGLPIHGVQFHPESILTEGGHRILANWLTCCGWTQDDTLVRRLENEVLTAISPHFPTSTASAGEATGRTSA,"24,627",232,,glutamine metabolic process [GO:0006541]; tryptophan biosynthetic process [GO:0000162],anthranilate synthase activity [GO:0004049],anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886],,,1
P9WGA3,TAM_MYCTU,Rv0294,tam Rv0294 MTV035.22,GO:0005737; GO:0008757; GO:0030798; GO:0032259; GO:0044119,IPR029063; IPR023506; IPR023149; ,,tam,,Probable trans-aconitate 2-methyltransferase (EC 2.1.1.144),cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; trans-aconitate 2-methyltransferase activity [GO:0030798]; growth of symbiont in host cell [GO:0044119]; methylation [GO:0032259],9634230; 21969609,,FUNCTION: Catalyzes the S-adenosylmethionine monomethyl esterification of trans-aconitate. {ECO:0000255|HAMAP-Rule:MF_00560}.,MWDPDVYLAFSGHRNRPFYELVSRVGLERARRVVDLGCGPGHLTRYLARRWPGAVIEALDSSPEMVAAAAERGIDATTGDLRDWKPKPDTDVVVSNAALHWVPEHSDLLVRWVDELAPGSWIAVQIPGNFETPSHAAVRALARREPYAKLMRDIPFRVGAVVQSPAYYAELLMDTGCKVDVWETTYLHQLTGEHPVLDWITGSALVPVRERLSDESWQQFRQELIPLLNDAYPPRADGSTIFPFRRLFMVAEVGGARRSGG,"29,268",261,"Methyltransferase superfamily, Tam family",growth of symbiont in host cell [GO:0044119]; methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; trans-aconitate 2-methyltransferase activity [GO:0030798],cytoplasm [GO:0005737],,MTV035.22,1
P9WMF7,Y377_MYCTU,Rv0377,Rv0377 MTV036.12,GO:0003677; GO:0003700; GO:0006351,IPR005119; IPR000847; IPR036388; IPR036390; ,,,DOMAIN 1 58 HTH lysR-type. {ECO:0000255|PROSITE-ProRule:PRU00253}.,Uncharacterized HTH-type transcriptional regulator Rv0377,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MTPAQLRAYSAVVRLGSVRAAAAELGLSDAGVSMHVAALRKELDDPLFTRTGAGLAFTPGGLRLASRAVEILGLQQQTAIEVTEAAHGRRLLRIAASSAFAEHAAPGLIELFSSRADDLSVELSVHPTSRFRELICSRAVDIAIGPASESSIGSDGSIFLRPFLKYQIITVVAPNSPLAAGIPMPALLRHQQWMLGPSAGSVDGEIATMLRGLAIPESQQRIFQSDAAALEEVMRVGGATLAIGFAVAKDLAAGRLVHVTGPGLDRAGEWCVATLAPSARQPAVSELVGFISTPRCIQAMIPGSGVGVTRFRPKVHVTLWS,"33,637",321,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTV036.12,1
P9WI85,Y181_MYCTU,Rv0181c,Rv0181c MTCI28.21c,GO:0005829; GO:0005886; GO:0008127; GO:0046872,IPR012093; IPR003829; IPR014710; IPR011051; ,,,,"Putative quercetin 2,3-dioxygenase Rv0181c (Putative quercetinase) (EC 1.13.11.24) (Pirin-like protein Rv0181c)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]",9634230; 21969609,,"FUNCTION: Putative quercetin 2,3-dioxygenase. {ECO:0000250}.",MTATVEIRRAADRAVTTTSWLKSRHSFSFGDHYDPDNTHHGLLLVNNDDQMEPASGFDPHPHRDMEIVTWVLRGALRHQDSAGNSGVIYPGLAQRMSAGTGILHSEMNDSATEPVHFVQMWVIPDATGITASYQQQEIDDELLRAGLVTIASGIPGQDAALTLHNSSASLHGARLRPGATVSLPCAPFLHLFVAYGRLTLEGGGELADGDAVRFTDADARGLTANEPSEVLIWEMHAKLGDSAT,"26,286",244,Pirin family,,"metal ion binding [GO:0046872]; quercetin 2,3-dioxygenase activity [GO:0008127]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCI28.21c,1
P9WJZ9,Y224_MYCTU,Rv0224c,Rv0224c,GO:0008168; GO:0040007,IPR013216; IPR029063; ,,,,Uncharacterized methyltransferase Rv0224c (EC 2.1.1.-),methyltransferase activity [GO:0008168]; growth [GO:0040007],9634230; 19099550; 21969609,,,MAVTDVFARRATLRRSLRLLADFRYEQRDPARFYRTLAADTAAMIGDLWLATHSEPPVGRTLLDVGGGPGYFATAFSDAGVGYIGVEPDPDEMHAAGPAFTGRPGMFVRASGMALPFADDSVDICLSSNVAEHVPRPWQLGTEMLRVTKPGGLVVLSYTVWLGPFGGHEMGLSHYLGGARAAARYVRKHGHPAKNNYGSSLFAVSAAEGLRWAAGTGAALAVFPRYHPRWAWWLTSVPVLREFLVSNLVLVLTP,"27,511",254,Methyltransferase superfamily,growth [GO:0040007],methyltransferase activity [GO:0008168],,,,1
P9WJ09,Y298_MYCTU,Rv0298,Rv0298,GO:0006355; GO:0045927,IPR002145; ,,,,Antitoxin Rv0298,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin Rv0299. {ECO:0000269|PubMed:20011113}.,MTKEKISVTVDAAVLAAIDADARAAGLNRSEMIEQALRNEHLRVALRDYTAKTVPALDIDAYAQRVYQANRAAGS,"8,130",75,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WKB7,Y221_MYCTU,Rv0221,Rv0221 MTCY08D5.16,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv0221 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv0221),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has very weak wax synthase activity, incorporating palmityl alcohol into wax esters in the presence of palmitoyl-CoA.",MKRLSGWDAVLLYSETPNVHMHTLKVAVIELDSDRQEFGVDAFREVIAGRLHKLEPLGYQLVDVPLKFHHPMWREHCQVDLNYHIRPWRLRAPGGRRELDEAVGEIASTPLNRDHPLWEMYFVEGLANHRIAVVAKIHHALADGVASANMMARGMDLLPGPEVGRYVPDPAPTKRQLLSAAFIDHLRHLGRIPATIRYTTQGLGRVRRSSRKLSPALTMPFTPPPTFMNHRLTPERRFATATLALIDVKATAKLLGATINDMVLAMSTGALRTLLLRYDGKAEPLLASVPVSYDFSPERISGNRFTGMLVALPADSDDPLQRVRVCHENAVSAKESHQLLGPELISRWAAYWPPAGAEALFRWLSERDGQNKVLNLNISNVPGPRERGRVGAALVTEIYSVGPLTAGSGLNITVWSYVDQLNISVLTDGSTVQDPHEVTAGMIADFIEIRRAAGLSVELTVVESAMAQA,"51,862",469,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY08D5.16,1
O53672,Y250_MYCTU,Rv0250c,Rv0250c,,,,,,Uncharacterized protein Rv0250c,,9634230; 17259624; 21969609,,,MSTTAELAELHDLVGGLRRCVTALKARFGDNPATRRIVIDADRILTDIELLDTDVSELDLERAAVPQPSEKIAIPDTEYDREFWRDVDDEGVGGHRY,"10,896",97,,,,,,,1
P9WFI9,Y293_MYCTU,Rv0281,Rv0281,GO:0005886; GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0281 (EC 2.1.1.-),plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MRTEGDSWDITTSVGSTALFVATARALEAQKSDPLVVDPYAEAFCRAVGGSWADVLDGKLPDHKLKSTDFGEHFVNFQGARTKYFDEYFRRAAAAGARQVVILAAGLDSRAYRLPWPDGTTVFELDRPQVLDFKREVLASHGAQPRALRREIAVDLRDDWPQALRDSGFDAAAPSAWIAEGLLIYLPATAQERLFTGIDALAGRRSHVAVEDGAPMGPDEYAAKVEEERAAIAEGAEEHPFFQLVYNERCAPAAEWFGERGWTAVATLLNDYLEAVGRPVPGPESEAGPMFARNTLVSAARV,"32,998",302,UPF0677 family,,methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
O07226,Y299_MYCTU,Rv0299,Rv0299,GO:0045926,,,,,Toxin Rv0299,negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin Rv0298/MT0312. {ECO:0000269|PubMed:20011113}.,MIAPGDIAPRRDSEHELYVAVLSNALHRAADTGRVITCPFIPGRVPEDLLAMVVAVEQPNGTLLPELVQWLHVAALGAPLGNAGVAALREAASVVTALLC,"10,442",100,,negative regulation of growth [GO:0045926],,,,,1
P9WP09,Y364_MYCTU,Rv0364,Rv0364 MTCY13E10.26,GO:0005886; GO:0016021,IPR032818; IPR032816; ,,,,Uncharacterized membrane protein Rv0364,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSTAVTAMPDILDPMYWLGANGVFGSAVLPGILIIVFIETGLLFPLLPGESLLFTGGLLSASPAPPVTIGVLAPCVALVAVLGDQTAYFIGRRIGPALFKKEDSRFFKKHYVTESHAFFEKYGKWTIILARFVPIARTFVPVIAGVSYMRYPVFLGFDIVGGVAWGAGVTLAGYFLGSVPFVHMNFQLIILAIVFVSLLPALVSAARVYRARRNAPQSDPDPLVLPE,"24,489",227,DedA family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY13E10.26,1
P9WMA7,Y007_MYCTU,Rv0007,Rv0007 MTCY10H4.05,GO:0005618; GO:0005887,IPR021949; ,,,,Uncharacterized protein Rv0007,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MTAPNEPGALSKGDGPNADGLVDRGGAHRAATGPGRIPDAGDPPPWQRAATRQSQAGHRQPPPVSHPEGRPTNPPAAADARLNRFISGASAPVTGPAAAVRTPQPDPDASLGCGDGSPAEAYASELPDLSGPTPRAPQRNPAPARPAEGGAGSRGDSAAGSSGGRSITAESRDARVQLSARRSRGPVRASMQIRRIDPWSTLKVSLLLSVALFFVWMITVAFLYLVLGGMGVWAKLNSNVGDLLNNASGSSAELVSSGTIFGGAFLIGLVNIVLMTALATIGAFVYNLITDLIGGIEVTLADRD,"31,073",304,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,MTCY10H4.05,1
P9WMA5,Y0080_MYCTU,Rv0080,Rv0080,GO:0048037,IPR024747; IPR012349; ,,,,Uncharacterized protein Rv0080,cofactor binding [GO:0048037],9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,,MSPGSRRASPQSAREVVELDRDEAMRLLASVDHGRVVFTRAALPAIRPVNHLVVDGRVIGRTRLTAKVSVAVRSSADAGVVVAYEADDLDPRRRTGWSVVVTGLATEVSDPEQVARYQRLLHPWVNMAMDTVVAIEPEIVTGIRIVADSRTP,"16,574",152,,,cofactor binding [GO:0048037],,,,1
P9WMA3,Y010_MYCTU,Rv0010c,Rv0010c MTCY10H4.10c,GO:0005886; GO:0016021,IPR019692; ,,,,Uncharacterized protein Rv0010c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MQQTAWAPRTSGIAGCGAGGVVMAIASVTLVTDTPGRVLTGVAALGLILFASATWRARPRLAITPDGLAIRGWFRTQLLRHSNIKIIRIDEFRRYGRLVRLLEIETVSGGLLILSRWDLGTDPVEVLDALTAAGYAGRGQR,"15,167",141,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.10c,1
P9WMA1,Y025_MYCTU,Rv0025,Rv0025 MTCY10H4.25,,IPR019710; ,,,,Uncharacterized protein Rv0025,,9634230; 21969609,,,MSEQAGSSVAVIQERQALLARQHDAVAEADRELADVLASAHAAMRESVRRLDAIAAELDRAVPDQDQLAVDTPMGAREFQTFLVAKQREIVAVVAAAHELDRAKSAVLKRLRAQYTEPAR,"13,100",120,,,,,,MTCY10H4.25,1
P9WM87,Y048_MYCTU,Rv0048c,Rv0048c MTCY21D4.11c,GO:0005618; GO:0005886; GO:0005887,IPR012551; ,,,,Uncharacterized protein Rv0048c,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MAKWLGAPLARGVSTATRAKDSDRQDACRILDDALRDGELSMEEHRERVSAATKAVTLGDLQRLVADLQVESAPAQMPALKSRAKRTELGLLAAAFVASVLLGVGIGWGVYGNTRSPLDFTSDPGAKPDGIAPVVLTPPRQLHSLGGLTGLLEQTRKRFGDTMGYRLVIYPEYASLDRVDPADDRRVLAYTYRGGWGDATSSAKSIADVSVVDLSKFDAKTAVGIMRGAPETLGLKQSDVKSMYLIVEPVKDPTTPAALSLSLYVSSDYGGGYLVFAGDGTIKHVSYPS,"30,817",289,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY21D4.11c,1
P9WM77,Y057_MYCTU,Rv0057,Rv0057 MTCY21D4.20,,,,,,Uncharacterized protein Rv0057,,9634230,,,MPVVTAVGRRRGFAMPWVSTARSGAVMLANYSAGVCGRVSSPGLNVRKMCLKANTPGAVTWLDTPKRFLSTQTASRCMAVNSSDVVTGRIDPQVLHTPLNTDVDGYAHAMHSSINSGPLEYLPATFSVFPALGDVGDLGGGVGAATYALDRLSNMRSGACVGGGESPWRSLMT,"18,063",173,,,,,,MTCY21D4.20,1
P9WM71,Y090_MYCTU,Rv0090,Rv0090 MTCY251.08,GO:0005886; GO:0016021,IPR014511; IPR021125; ,,,,Uncharacterized protein Rv0090,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MAKNQNRIRNRWELITCGLGGHVTYAPDDAALAARLRASTGLGEVWRCLRCGDFALGGPQGRGAPEDAPLIMRGKALRQAIIIRALGVERLVRALVLALAAWAVWEFRGARGAIQATLDRDLPVLRAAGFKVDQMTVIHALEKALAAKPSTLALITGMLAAYAVLQAVEGVGLWLLKRWGEYFAVVATSIFLPLEVHDLAKGITTTRVVTFSINVAAVVYLLISKRLFGVRGGRKAYDVERRGEQLLDLERAAMLT,"27,838",256,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.08,1
P9WM65,Y100_MYCTU,Rv0100,Rv0100 MTCY251.19,,IPR036736; IPR009081; ,,,DOMAIN 1 78 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Uncharacterized protein Rv0100,,9634230; 21969609,,,MRDRILAAVCDVLYIDEADLIDGDETDLRDLGLDSVRFVLLMKQLGVNRQSELPSRLAANPSIAGWLRELEAVCTEFG,"8,693",78,,,,,,MTCY251.19,1
P9WFJ3,Y146_MYCTU,Rv0146,Rv0146,GO:0005829; GO:0005886; GO:0008168; GO:0052556,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0146 (EC 2.1.1.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MRTHDDTWDIKTSVGATAVMVAAARAVETDRPDPLIRDPYARLLVTNAGAGAIWEAMLDPTLVAKAAAIDAETAAIVAYLRSYQAVRTNFFDTYFASAVAAGIRQVVILASGLDSRAYRLDWPAGTIVYEIDQPKVLSYKSTTLAENGVTPSAGRREVPADLRQDWPAALRDAGFDPTARTAWLAEGLLMYLPAEAQDRLFTQVGAVSVAGSRIAAETAPVHGEERRAEMRARFKKVADVLGIEQTIDVQELVYHDQDRASVADWLTDHGWRARSQRAPDEMRRVGRWVEGVPMADDPTAFAEFVTAERL,"34,016",310,UPF0677 family,positive regulation by symbiont of host immune response [GO:0052556],methyltransferase activity [GO:0008168],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WME1,Y196_MYCTU,Rv0196,Rv0196,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 2 62 HTH tetR-type.,Uncharacterized HTH-type transcriptional regulator Rv0196,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,,MQGPRERMVVSAALLIRERGAHATAISDVLQHSGAPRGSAYHYFPGGRTQLLCEAVDYAGEHVAAMINEAEGGLELLDALIDKYRQQLLSTDFRAGCPIAAVSVEAGDEQDRERMAPVIARAAAVFDRWSDLTAQRFIADGIPPDRAHELAVLATSTLEGAILLARVRRDLTPLDLVHRQLRNLLLAELPERSR,"21,241",194,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
P9WFM5,Y205_MYCTU,Rv0205,Rv0205 MTV033.13,GO:0005215; GO:0005887; GO:0040007; GO:0055085,IPR002549; ,,,,Putative transport protein Rv0205,integral component of plasma membrane [GO:0005887]; transporter activity [GO:0005215]; growth [GO:0040007]; transmembrane transport [GO:0055085],9634230; 21969609,,,MSASLDDASVAPLVRKTAAWAWRFLVILAAMVALLWVLNKFEVIVVPVLLALMLSALLVPPVDWLDSRGLPHAVAVTLVLLSGFAVLGGILTFVVSQFIAGLPHLVTEVERSIDSARRWLIEGPAHLRGEQIDNAGNAAIEALRNNQAKLTSGALSTAATITELVTAAVLVLFTLIFFLYGGRSIWQYVTKAFPASVRDRVRAAGRAGYASLIGYARATFLVALTDAAGVGAGLAVMGVPLALPLASLVFFGAFIPLIGAVVAGFLAVVVALLAKGIGYALITVGLLIAVNQLEAHLLQPLVMGRAVSIHPLAVVLAIAAGGVLAGVVGALLAVPTVAFFNNAVQVLLGGNPFADVADVSSDHLTEV,"38,038",367,Autoinducer-2 exporter (AI-2E) (TC 2.A.86) family,growth [GO:0040007]; transmembrane transport [GO:0055085],transporter activity [GO:0005215],integral component of plasma membrane [GO:0005887],,MTV033.13,1
O07227,VAPB2_MYCTU,Rv0300,vapB2 Rv0300,GO:0006355; GO:0045727; GO:0060701,IPR013321; IPR002145; IPR010985; ,,vapB2,,Antitoxin VapB2,"negative regulation of ribonuclease activity [GO:0060701]; positive regulation of translation [GO:0045727]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 20011113; 21969609; 23011806,X-ray crystallography (1),"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC2. The C-terminal helix of the antitoxin may obstruct the toxin's RNA-binding groove, blocking access to the active sites. Additionally, the C-terminal arginine of the antitoxin may remove Mg(2+) ions from the toxin active sites. {ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:23011806, ECO:0000305|PubMed:15718296}.",MSDVLIRDIPDDVLASLDAIAARLGLSRTEYIRRRLAQDAQTARVTVTAADLRRLRGAVAGLGDPELMRQAWR,"8,088",73,,"negative regulation of ribonuclease activity [GO:0060701]; positive regulation of translation [GO:0045727]; regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WFB9,VAPC2_MYCTU,Rv0301,vapC2 Rv0301,GO:0004540; GO:0017148; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC2,DOMAIN 7 129 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC2 (RNase VapC2) (EC 3.1.-.-) (Toxin VapC2),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of translation [GO:0017148],9634230; 15718296; 20011113; 21969609; 23011806,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Acts as an RNase. Upon expression in M.smegmatis inhibits translation, growth and colony formation. All its toxic effects are neutralized by coexpression with cognate antitoxin VapB2. {ECO:0000269|PubMed:20011113}.",MTDQRWLIDKSALVRLTDSPDMEIWSNRIERGLVHITGVTRLEVGFSAECGEIARREFREPPLSAMPVEYLTPRIEDRALEVQTLLADRGHHRGPSIPDLLIAATAELSGLTVLHVDKDFDAIAALTGQKTERLTHRPPSA,"15,746",141,PINc/VapC protein family,negative regulation of translation [GO:0017148],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WNM9,EFGL_MYCTU,Rv0120c,Rv0120c MTCI418B.02c,GO:0003924; GO:0005525; GO:0005618; GO:0005886; GO:0006790,IPR009022; IPR035647; IPR035649; IPR000640; IPR004161; IPR027417; IPR020568; IPR014721; IPR005225; IPR000795; IPR009000; IPR005517; ,,,DOMAIN 21 289 tr-type G. {ECO:0000255|PROSITE-ProRule:PRU01059}.,Elongation factor G-like protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; sulfur compound metabolic process [GO:0006790],9634230; 19099550; 21969609,,,MADRVNASQGAAAAPTANGPGGVRNVVLVGPSGGGKTTLIEALLVAAKVLSRPGSVTEGTTVCDFDEAEIRQQRSVGLAVASLAYDGIKVNLVDTPGYADFVGELRAGLRAADCALFVIAANEGVDEPTKSLWQECSQVGMPRAVVITKLDHARANYREALTAAQDAFGDKVLPLYLPSGDGLIGLLSQALYEYADGKRTTRTPAESDTERIEEARGALIEGIIEESEDESLMERYLGGETIDESVLIQDLEKAVARGSFFPVIPVCSSTGVGTLELLEVATRGFPSPMEHPLPEVFTPQGVPHAELACDNDAPLLAEVVKTTSDPYVGRVSLVRVFSGTIRPDTTVHVSGHFSSFFGGGTSNTHPDHDEDERIGVLSFPLGKQQRPAAAVVAGDICAIGKLSRAETGDTLSDKAEPLVLKPWTMPEPLLPIAIAAHAKTDEDKLSVGLGRLAAEDPTLRIEQNQETHQVVLWCMGEAHAGVVLDTLANRYGVSVDTIELRVPLRETFAGNAKGHGRHIKQSGGHGQYGVCDIEVEPLPEGSGFEFLDKVVGGAVPRQFIPNVEKGVRAQMDKGVHAGYPVVDIRVTLLDGKAHSVDSSDFAFQMAGALALREAAAATKVILLEPIDEISVLVPDDFVGAVLGDLSSRRGRVLGTETAGHDRTVIKAEVPQVELTRYAIDLRSLAHGAASFTRSFARYEPMPESAAARVKAGAG,"75,631",714,"TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-G/EF-2 subfamily",sulfur compound metabolic process [GO:0006790],GTPase activity [GO:0003924]; GTP binding [GO:0005525],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCI418B.02c,1
P9WIG3,PG03_MYCTU,Rv0278c,PE_PGRS3 Rv0278c MTV035.06c,,IPR000084; ,,PE_PGRS3,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS3,,9634230,,,MSFVIAAPEVIAAAATDLASLGSSISAANAAAAANTTALMAAGADEVSTAIAALFGAHGQAYQALSAQAQAFHAQFVQALTSGGGAYAAAEAAAVSPLLDPINEFFLANTGRPLIGNGANGAPGTGANGGDGGWLIGNGGAGGSGAAGVNGGAGGNGGAGGNGGAGGLIGNGGAGGAGGVASSGIGGSGGAGGNAMLFGAGGAGGAGGGVVALTGGAGGAGGAGGNAGLLFGAAGVGGAGGFTNGSALGGAGGAGGAGGLFATGGVGGSGGAGSSGGAGGAGGAGGLFGAGGTGGHGGFADSSFGGVGGAGGAGGLFGAGGEGGSGGHSLVAGGDGGAGGNAGMLALGAAGGAGGIGGDGGTLTAGGIGGAGGAGGNAGLLFGSGGSGGAGGFGFADGGQGGPGGNAGTVFGSGGAGGNGGVGQGFAGGIGGAGGTPGLIGNGGNGGNGGASAVTGGNGGIGGTGVLIGNGGNGGSGGIGAGKAGVGGVSGLLLGLDGFNAPASTSPLHTLQQNVLNVVNEPFQTLTGRPLIGNGANGTPGTGADGGAGGWLFGNGANGTPGTGAAGGAGGWLFGNGGNGGHGATNTAATATGGAGGAGGILFGTGGNGGTGGIATGAGGIGGAGGAGGVSLLIGSGGTGGNGGNSIGVAGIGGAGGRGGDAGLLFGAAGTGGHGAAGGVPAGVGGAGGNGGLFANGGAGGAGGFNAAGGNGGNGGLFGTGGTGGAGTNFGAGGNGGNGGLFGAGGTGGAAGSGGSGITTGGGGHGGNAGLLSLGASGGAGGSGGASSLAGGAGGTGGNGALLFGFRGAGGAGGHGGAALTSIQQGGAGGAGGNGGLLFGSAGAGGAGGSGANALGAGTGGTGGDGGHAGVFGNGGDGGCRRVWRRYRRQRWCRRQRRADRQRRQRRQRRQSRGHARCRRHRRAAARRERTQRLAIAGRPATTRGVEGISCSPQMMP,"81,904",957,"Mycobacterial PE family, PGRS subfamily",,,,,MTV035.06c,1
P9WI49,PPE01_MYCTU,Rv0096,PPE1 Rv0096 MTCY251.15,GO:0005886; GO:0016021,IPR000030; IPR038332; ,,PPE1,,Uncharacterized PPE family protein PPE1,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MAIPPEVHSGLLSAGCGPGSLLVAAQQWQELSDQYALACAELGQLLGEVQASSWQGTAATQYVAAHGPYLAWLEQTAINSAVTAAQHVAAAAAYCSALAAMPTPAELAANHAIHGVLIATNFFGINTVPIALNEADYVRMWLQAADTMAAYQAVADAATVAVPSTQPAPPIRAPGGDAADTRLDVLSSIGQLIRDILDFIANPYKYFLEFFEQFGFSPAVTVVLALVALQLYDFLWYPYYASYGLLLLPFFTPTLSALTALSALIHLLNLPPAGLLPIAAALGPGDQWGANLAVAVTPATAAVPGGSPPTSNPAPAAPSSNSVGSASAAPGISYAVPGLAPPGVSSGPKAGTKSPDTAADTLATAGAARPGLARAHRRKRSESGVGIRGYRDEFLDATATVDAATDVPAPANAAGSQGAGTLGFAGTAPTTSGAAAGMVQLSSHSTSTTVPLLPTTWTTDAEQ,"46,895",463,Mycobacterial PPE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.15,1
P9WI81,PKNB_MYCTU,Rv0014c,pknB Rv0014c MTCY10H4.14c,GO:0004672; GO:0004674; GO:0005524; GO:0005618; GO:0005886; GO:0008360; GO:0009252; GO:0009405; GO:0010698; GO:0016021; GO:0030145; GO:0032091; GO:0040007; GO:0042802; GO:0043085; GO:0043086; GO:0043388; GO:0045717; GO:0046777; GO:0052572,IPR011009; IPR005543; IPR000719; IPR017441; IPR008271; ,Itself; P71590; P9WJA9,pknB,DOMAIN 11 274 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.; DOMAIN 356 422 PASTA 1. {ECO:0000255|PROSITE-ProRule:PRU00528}.; DOMAIN 423 490 PASTA 2. {ECO:0000255|PROSITE-ProRule:PRU00528}.; DOMAIN 491 557 PASTA 3. {ECO:0000255|PROSITE-ProRule:PRU00528}.; DOMAIN 558 626 PASTA 4. {ECO:0000255|PROSITE-ProRule:PRU00528}.,Serine/threonine-protein kinase PknB (EC 2.7.11.1),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; acetyltransferase activator activity [GO:0010698]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; growth [GO:0040007]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein binding [GO:0032091]; pathogenesis [GO:0009405]; peptidoglycan biosynthetic process [GO:0009252]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; protein autophosphorylation [GO:0046777]; regulation of cell shape [GO:0008360]; response to host immune response [GO:0052572],9634230; 12950916; 10531215; 15967413; 15985609; 15978616; 15987910; 16817899; 16980473; 16436437; 19826007; 19121323; 20025669; 21134645; 21969609; 21423706; 21829358; 22000520; 22275220; 24706757; 25224505; 24409094; 12551895; 12548283; 16674948; 19008858; 20462494,NMR spectroscopy (4); X-ray crystallography (13),"FUNCTION: Protein kinase that regulates many aspects of mycobacterial physiology, and is critical for growth in vitro and survival of the pathogen in the host (PubMed:24706757). Is a key component of a signal transduction pathway that regulates cell growth, cell shape and cell division via phosphorylation of target proteins such as GarA, GlmU, PapA5, PbpA, FhaB (Rv0019c), FhaA (Rv0020c), MviN, PstP, EmbR, Rv1422, Rv1747 and RseA (PubMed:15978616, PubMed:15985609, PubMed:15987910, PubMed:16436437, PubMed:16817899, PubMed:16980473, PubMed:19121323, PubMed:19826007, PubMed:20025669, PubMed:21423706, PubMed:22275220). Also catalyzes the phosphorylation of the core proteasome alpha-subunit (PrcA), and thereby regulates the proteolytic activity of the proteasome (PubMed:25224505). Is a major regulator of the oxygen-dependent replication switch since PknB activity is necessary for reactivation of cells from the hypoxic state (PubMed:24409094). Shows a strong preference for Thr versus Ser as the phosphoacceptor. Overexpression of PknB alters cell morphology and leads to cell death (PubMed:24706757) (PubMed:24409094). {ECO:0000269|PubMed:15978616, ECO:0000269|PubMed:15985609, ECO:0000269|PubMed:15987910, ECO:0000269|PubMed:16436437, ECO:0000269|PubMed:16817899, ECO:0000269|PubMed:16980473, ECO:0000269|PubMed:19121323, ECO:0000269|PubMed:19826007, ECO:0000269|PubMed:20025669, ECO:0000269|PubMed:21423706, ECO:0000269|PubMed:22275220, ECO:0000269|PubMed:24409094, ECO:0000269|PubMed:24706757, ECO:0000269|PubMed:25224505}.",MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLSGPRTDPLPRQDLDDTDRDRSIGSVGRWVAVVAVLAVLTVVVTIAINTFGGITRDVQVPDVRGQSSADAIATLQNRGFKIRTLQKPDSTIPPDHVIGTDPAANTSVSAGDEITVNVSTGPEQREIPDVSTLTYAEAVKKLTAAGFGRFKQANSPSTPELVGKVIGTNPPANQTSAITNVVIIIVGSGPATKDIPDVAGQTVDVAQKNLNVYGFTKFSQASVDSPRPAGEVTGTNPPAGTTVPVDSVIELQVSKGNQFVMPDLSGMFWVDAEPRLRALGWTGMLDKGADVDAGGSQHNRVVYQNPPAGTGVNRDGIITLRFGQ,"66,510",626,"Protein kinase superfamily, Ser/Thr protein kinase family",growth [GO:0040007]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein binding [GO:0032091]; pathogenesis [GO:0009405]; peptidoglycan biosynthetic process [GO:0009252]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; protein autophosphorylation [GO:0046777]; regulation of cell shape [GO:0008360]; response to host immune response [GO:0052572],acetyltransferase activator activity [GO:0010698]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.14c,1
P9WHW3,PPIA_MYCTU,Rv0009,ppiA Rv0009 MTCY10H4.08,GO:0003755; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006457; GO:0010039,IPR029000; IPR024936; IPR020892; IPR002130; ,,ppiA,DOMAIN 13 181 PPIase cyclophilin-type. {ECO:0000255|PROSITE-ProRule:PRU00156}.,Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin) (Rotamase A),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457]; response to iron ion [GO:0010039],9634230; 17141764; 21969609; 15479239,X-ray crystallography (1),"FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. {ECO:0000269|PubMed:15479239, ECO:0000269|PubMed:17141764}.",MADCDSVTNSPLATATATLHTNRGDIKIALFGNHAPKTVANFVGLAQGTKDYSTQNASGGPSGPFYDGAVFHRVIQGFMIQGGDPTGTGRGGPGYKFADEFHPELQFDKPYLLAMANAGPGTNGSQFFITVGKTPHLNRRHTIFGEVIDAESQRVVEAISKTATDGNDRPTDPVVIESITIS,"19,239",182,Cyclophilin-type PPIase family,protein folding [GO:0006457]; response to iron ion [GO:0010039],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY10H4.08,1
P9WI47,PPE02_MYCTU,Rv0256c,PPE2 Rv0256c,GO:0005886,IPR000030; IPR038332; ,,PPE2,,Uncharacterized PPE family protein PPE2,plasma membrane [GO:0005886],9634230; 19099550; 21969609,,,MTAPIWMASPPEVHSALLSSGPGPGPLLVSAEGWHSLSIAYAETADELAALLAAVQAGTWDGPTAAVYVAAHTPYLAWLVQASANSAAMATRQETAATAYGTALAAMPTLAELGANHALHGVLMATNFFGINTIPIALNESDYARMWIQAATTMASYQAVSTAAVAAAPQTTPAPQIVKANAPTAASDEPNQVQEWLQWLQKIGYTDFYNNVIQPFINWLTNLPFLQAMFSGFDPWLPSLGNPLTFLSPANIAFALGYPMDIGSYVAFLSQTFAFIGADLAAAFASGNPATIAFTLMFTTVEAIGTIITDTIALVKTLLEQTLALLPAALPLLAAPLAPLTLAPASAAGGFAGLSGLAGLVGIPPSAPPVIPPVAAIAPSIPTPTPTPAPAPAPTAVTAPTPPPGPPPPPVTAPPPVTGAGIQSFGYLVGDLNSAAQARKAVGTGVRKKTPEPDSAEAPAAAAAPEEQVQPQRRRRPKIKQLGRGYEYLDLDPETGHDPTGSPQGAGTLGFAGTTHKASPGQVAGLITLPNDAFGGSPRTPMMPGTWDTDSATRVE,"56,952",556,Mycobacterial PPE family,,,plasma membrane [GO:0005886],,,1
P9WI45,PPE03_MYCTU,Rv0280,PPE3 Rv0280,,IPR000030; IPR038332; ,,PPE3,,Uncharacterized PPE family protein PPE3,,9634230; 19099550; 21969609,,,MTLWMASPPEVHSALLSSGPGPGSVLSAAGVWSSLSAEYAAVADELIGLLGAVQTGAWQGPSAAAYVAAHAPYLAWLMRASETSAEAAARHETVAAAYTTAVAAMPTLVELAANHTLHGVLVATNFFGINTIPIALNEADYARMWTQAASTMATYQAVAEAAVASAPQTTPAPPILAAEAADDDHDHDHDHGGEPTPLDYLVAEILRIISGGRLIWDPAEGTMNGIPFEDYTDAAQPIWWVVRAIEFSKDFETFVQELFVNPVEAFQFYFELLLFDYPTHIVQIVEALSQSPQLLAVALGSVISNLGAVTGFAGLSGLAGMQPAAIPALAPVAAAPSTLPAVAMAPTMAAPGAAVASAAAPASAPAASTVASATPAPPPAPGAAGFGYPYAIAPPGIGFGSGMSASASAQRKAPQPDSAAAAAAAAAVRDQARARRRRRVTRRGYGDEFMDMNIDVDPDWGPPPGEDPVTSTVASDRGAGHLGFAGTARREAVADAAGMTTLAGDDFGDGPTTPMVPGSWDPDRDAPGSAEPGDRG,"54,707",536,Mycobacterial PPE family,,,,,,1
P9WI43,PPE04_MYCTU,Rv0286,PPE4 Rv0286,GO:0005886; GO:0016021; GO:0040007,IPR000030; IPR038332; ,,PPE4,,PPE family protein PPE4,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550; 21969609; 26729876,,FUNCTION: Important for the siderophore-mediated iron-acquisition function of ESX-3. {ECO:0000269|PubMed:26729876}.,MAAPIWMASPPEVHSALLSNGPGPGSLVAAATAWSQLSAEYASTAAELSGLLGAVPGWAWQGPSAEWYVAAHLPYVAWLTQASADAAGAAAQHEAAAAAYTTALAAMPTLAELAANHVIHTVLVATNFFGINTIPITLNEADYVRMWLQAAAVMGLYQAASGAALASAPRTVPAPTVMNPGGGAASTVGAVNPWQWLLALLQQLWNAYTGFYGWMLQLIWQFLQDPIGNSIKIIIAFLTNPIQALITYGPLLFALGYQIFFNLVGWPTWGMILSSPFLLPAGLGLGLAAIAFLPIVLAPAVIPPASTPLAAAAVAAGSVWPAVSMAVTGAGTAGAATPAAGAAPSAGAAPAPAAPATASFAYAVGGSGDWGPSLGPTVGGRGGIKAPAATVPAAAAAAATRGQSRARRRRRSELRDYGDEFLDMDSDSGFGPSTGDHGAQASERGAGTLGFAGTATKERRVRAVGLTALAGDEFGNGPRMPMVPGTWEQGSNEPEAPDGSGRGGGDGLPHDSK,"51,788",513,Mycobacterial PPE family,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WIM9,PR28_MYCTU,Rv0040c,mtc28 Rv0040c MTCY21D4.03c,GO:0005576,IPR019674; ,,mtc28,,Proline-rich 28 kDa antigen,extracellular region [GO:0005576],9393781; 9634230; 12368430; 21969609,X-ray crystallography (2),,MIQIARTWRVFAGGMATGFIGVVLVTAGKASADPLLPPPPIPAPVSAPATVPPVQNLTALPGGSSNRFSPAPAPAPIASPIPVGAPGSTAVPPLPPPVTPAISGTLRDHLREKGVKLEAQRPHGFKALDITLPMPPRWTQVPDPNVPDAFVVIADRLGNSVYTSNAQLVVYRLIGDFDPAEAITHGYIDSQKLLAWQTTNASMANFDGFPSSIIEGTYRENDMTLNTSRRHVIATSGADKYLVSLSVTTALSQAVTDGPATDAIVNGFQVVAHAAPAQAPAPAPGSAPVGLPGQAPGYPPAGTLTPVPPR,"31,924",310,,,,extracellular region [GO:0005576],,MTCY21D4.03c,1
O53695,MYCP3_MYCTU,Rv0291,mycP3 Rv0291 LH57_01590,GO:0004252; GO:0005576; GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR000209; IPR036852; IPR022398; IPR015500; IPR023834; ,,mycP3,DOMAIN 86 389 Peptidase S8. {ECO:0000255}.,Mycosin-3 (EC 3.4.21.-) (MycP3 protease),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; growth [GO:0040007],9634230; 10974545; 21969609,,,MIRAAFACLAATVVVAGWWTPPAWAIGPPVVDAAAQPPSGDPGPVAPMEQRGACSVSGVIPGTDPGVPTPSQTMLNLPAAWQFSRGEGQLVAIIDTGVQPGPRLPNVDAGGDFVESTDGLTDCDGHGTLVAGIVAGQPGNDGFSGVAPAARLLSIRAMSTKFSPRTSGGDPQLAQATLDVAVLAGAIVHAADLGAKVINVSTITCLPADRMVDQAALGAAIRYAAVDKDAVIVAAAGNTGASGSVSASCDSNPLTDLSRPDDPRNWAGVTSVSIPSWWQPYVLSVASLTSAGQPSKFSMPGPWVGIAAPGENIASVSNSGDGALANGLPDAHQKLVALSGTSYAAGYVSGVAALVRSRYPGLNATEVVRRLTATAHRGARESSNIVGAGNLDAVAALTWQLPAEPGGGAAPAKPVADPPVPAPKDTTPRNVAFAGAAALSVLVGLTAATVAIARRRREPTE,"46,127",461,Peptidase S8 family,growth [GO:0040007],serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,LH57_01590,1
P9WK09,MYMT_MYCTU,Rv0186A,mymT Rv0186A,GO:0005507; GO:0008270; GO:0010043; GO:0010045; GO:0032025; GO:0046686; GO:0046688; GO:0055070,,,mymT,,Metallothionein (MT) (Copper-binding metallothionein) (Cu(I)-binding metallothionein) (Mycobacterial metallothionein),copper ion binding [GO:0005507]; zinc ion binding [GO:0008270]; copper ion homeostasis [GO:0055070]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to copper ion [GO:0046688]; response to nickel cation [GO:0010045]; response to zinc ion [GO:0010043],9634230; 18724363; 21969609; 21166899; 24549843,,"FUNCTION: Metallothioneins are small proteins that have a high content of cysteine residues wich allow them to bind heavy metal ions through clusters of thiolate bonds. MymT binds up to seven ions of Cu(+), with a preference for four to six Cu(+) ions, in a solvent-shielded core. MymT protects M.tuberculosis from copper toxicity. {ECO:0000269|PubMed:18724363}.",MRVIRMTNYEAGTLLTCSHEGCGCRVRIEVPCHCAGAGDAYRCTCGDELAPVK,"5,719",53,Metallothionein superfamily,copper ion homeostasis [GO:0055070]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to copper ion [GO:0046688]; response to nickel cation [GO:0010045]; response to zinc ion [GO:0010043],copper ion binding [GO:0005507]; zinc ion binding [GO:0008270],,,,1
P9WJM3,MTNN_MYCTU,Rv0091,mtnN mtn Rv0091 MTCY251.10,GO:0008782; GO:0009116; GO:0019509,IPR000845; IPR035994; ,,mtnN,,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTA/SAH nucleosidase) (MTAN) (EC 3.2.2.9) (5'-methylthioadenosine nucleosidase) (MTA nucleosidase) (S-adenosylhomocysteine nucleosidase) (AdoHcy nucleosidase) (SAH nucleosidase) (SRH nucleosidase),adenosylhomocysteine nucleosidase activity [GO:0008782]; L-methionine salvage from methylthioadenosine [GO:0019509]; nucleoside metabolic process [GO:0009116],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the irreversible cleavage of the glycosidic bond in both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH/AdoHcy) to adenine and the corresponding thioribose, 5'-methylthioribose and S-ribosylhomocysteine, respectively. {ECO:0000250}.",MAVTVGVICAIPQELAYLRGVLVDAKRQQVAQILFDSGQLDAHRVVLAAAGMGKVNTGLTATLLADRFGCRTIVFTGVAGGLDPELCIGDIVIADRVVQHDFGLLTDERLRPYQPGHIPFIEPTERLGYPVDPAVIDRVKHRLDGFTLAPLSTAAGGGGRQPRIYYGTILTGDQYLHCERTRNRLHHELGGMAVEMEGGAVAQICASFDIPWLVIRALSDLAGADSGVDFNRFVGEVAASSARVLLRLLPVLTAC,"27,340",255,"PNP/UDP phosphorylase family, MtnN subfamily",L-methionine salvage from methylthioadenosine [GO:0019509]; nucleoside metabolic process [GO:0009116],adenosylhomocysteine nucleosidase activity [GO:0008782],,mtn,MTCY251.10,1
P9WJ99,INIA_MYCTU,Rv0342,iniA Rv0342,GO:0005618; GO:0005886; GO:0015562; GO:0016021; GO:0046677,IPR022812; IPR027417; ,,iniA,,Isoniazid-induced protein IniA,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; response to antibiotic [GO:0046677],9634230; 10714983; 15752203; 17590082; 21969609,,"FUNCTION: Participates in the development of tolerance to both isoniazid and ethambutol. May function through a MDR-pump like mechanism, although it does not appear to directly transport isoniazid from the cell. {ECO:0000269|PubMed:15752203}.",MVPAGLCAYRDLRRKRARKWGDTVTQPDDPRRVGVIVELIDHTIAIAKLNERGDLVQRLTRARQRITDPQVRVVIAGLLKQGKSQLLNSLLNLPAARVGDDEATVVITVVSYSAQPSARLVLAAGPDGTTAAVDIPVDDISTDVRRAPHAGGREVLRVEVGAPSPLLRGGLAFIDTPGVGGLGQPHLSATLGLLPEADAVLVVSDTSQEFTEPEMWFVRQAHQICPVGAVVATKTDLYPRWREIVNANAAHLQRARVPMPIIAVSSLLRSHAVTLNDKELNEESNFPAIVKFLSEQVLSRATERVRAGVLGEIRSATEQLAVSLGSELSVVNDPNLRDRLASDLERRKREAQQAVQQTALWQQVLGDGFNDLTADVDHDLRTRFRTVTEDAERQIDSCDPTAHWAEIGNDVENAIATAVGDNFVWAYQRSEALADDVARSFADAGLDSVLSAELSPHVMGTDFGRLKALGRMESKPLRRGHKMIIGMRGSYGGVVMIGMLSSVVGLGLFNPLSVGAGLILGRMAYKEDKQNRLLRVRSEAKANVRRFVDDISFVVSKQSRDRLKMIQRLLRDHYREIAEEITRSLTESLQATIAAAQVAETERDNRIRELQRQLGILSQVNDNLAGLEPTLTPRASLGRA,"70,083",640,,response to antibiotic [GO:0046677],efflux transmembrane transporter activity [GO:0015562],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53638,LDT1_MYCTU,Rv0116c RVBD_0116c,ldtA Rv0116c RVBD_0116c P425_00122,GO:0005576; GO:0008360; GO:0016746; GO:0018104; GO:0042597; GO:0071555; GO:0071972,IPR005490; IPR038063; ,,ldtA,DOMAIN 129 249 YkuD.,"L,D-transpeptidase 1 (LDT 1) (EC 2.3.2.-) (Ldt(Mt1))","extracellular region [GO:0005576]; periplasmic space [GO:0042597]; peptidoglycan L,D-transpeptidase activity [GO:0071972]; transferase activity, transferring acyl groups [GO:0016746]; cell wall organization [GO:0071555]; peptidoglycan-protein cross-linking [GO:0018104]; regulation of cell shape [GO:0008360]",9634230; 11929527; 18408028; 21969609; 22615283; 23519798; 24041897; 23999293,X-ray crystallography (4),"FUNCTION: Generates 3->3 cross-links in peptidoglycan, catalyzing the cleavage of the mDap(3)-D-Ala(4) bond of a tetrapeptide donor stem and the formation of a bond between the carbonyl of mDap(3) of the donor stem and the side chain of mDap(3) of the acceptor stem. Is specific for donor substrates containing a stem tetrapeptide since it cannot use pentapeptide stems. Is thought to play a role in adaptation to the nonreplicative state of M.tuberculosis. {ECO:0000269|PubMed:18408028, ECO:0000269|PubMed:24041897}.",MRRVVRYLSVVVAITLMLTAESVSIATAAVPPLQPIPGVASVSPANGAVVGVAHPVVVTFTTPVTDRRAVERSIRISTPHNTTGHFEWVASNVVRWVPHRYWPPHTRVSVGVQELTEGFETGDALIGVASISAHTFTVSRNGEVLRTMPASLGKPSRPTPIGSFHAMSKERTVVMDSRTIGIPLNSSDGYLLTAHYAVRVTWSGVYVHSAPWSVNSQGYANVSHGCINLSPDNAAWYFDAVTVGDPIEVVG,"26,916",251,,cell wall organization [GO:0071555]; peptidoglycan-protein cross-linking [GO:0018104]; regulation of cell shape [GO:0008360],"peptidoglycan L,D-transpeptidase activity [GO:0071972]; transferase activity, transferring acyl groups [GO:0016746]",extracellular region [GO:0005576]; periplasmic space [GO:0042597],,P425_00122,1
O07436,LDT4_MYCTU,Rv0192 RVBD_0192,Rv0192 RVBD_0192 P425_00200,GO:0005576; GO:0008360; GO:0009252; GO:0016746; GO:0071555,IPR005490; IPR038063; ,,,DOMAIN 226 348 YkuD.,"L,D-transpeptidase 4 (LDT 4) (EC 2.3.2.-) (Ldt(Mt4))","extracellular region [GO:0005576]; transferase activity, transferring acyl groups [GO:0016746]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 24041897,,"FUNCTION: Generates 3->3 cross-links in peptidoglycan, catalyzing the cleavage of the mDap(3)-D-Ala(4) bond of a tetrapeptide donor stem and the formation of a bond between the carbonyl of mDap(3) of the donor stem and the side chain of mDap(3) of the acceptor stem. Is specific for donor substrates containing a stem tetrapeptide since it cannot use pentapeptide stems. {ECO:0000269|PubMed:24041897}.",MPHWAEERHRRESNYVALEAGLDEGESIRRSEHSRSGCGADAGCWRCRGGPGRGSRRSRRSRGPGGTAGPVDPPAVDLLAPPPDPLALPPALDPLAPPPPDPLAPPPPDPLAVPVAAGPVAGQDPTSFVGPPPFRPPTFNPVDGAMVGVAKPIVINFAVPIADRAMAESAIHISSIPPVPGKFYWMSPTQVRWRPFEFWPANTAVNIDAAGTKSSFRTGDSLVATADDATHQMTITRNGVVQKTFPMSMGMVSGGHQTPNGTYYVLEKFATVVMDSSTYGVPVNSAQGYKLTVSDAVRIDNSGNFVHSAPWSVADQGKRNVTHGCINLSPANAKWFYDNFGSGDPVVVKNSVGTYNKNDGAQDWQI,"38,904",366,,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"transferase activity, transferring acyl groups [GO:0016746]",extracellular region [GO:0005576],,P425_00200,1
P9WI83,PKNA_MYCTU,Rv0015c,pknA Rv0015c MTCY10H4.15c,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0006468; GO:0008360; GO:0009405; GO:0016021; GO:0040007; GO:0043085; GO:0043086; GO:0043388; GO:0045717; GO:0046777; GO:0051055,IPR011009; IPR000719; IPR008271; ,,pknA,DOMAIN 13 272 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknA (EC 2.7.11.1),cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; growth [GO:0040007]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of lipid biosynthetic process [GO:0051055]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360],9634230; 15985609; 16817899; 16739134; 19121323; 21190553; 20066037; 21969609; 21423706; 21829358; 25224505; 25713147; 25665034; 25586004,X-ray crystallography (3),"FUNCTION: Protein kinase that regulates many aspects of mycobacterial physiology, and is critical for growth in vitro and survival of the pathogen in the host (PubMed:25713147). Is a key component of a signal transduction pathway that regulates cell growth, cell shape and cell division via phosphorylation of target proteins such as FtsZ, Wag31, GlmU, FhaB, PstP, EmbR and Rv1422 (PubMed:15985609, PubMed:16817899, PubMed:19121323, PubMed:20066037, PubMed:21190553, PubMed:21423706). Also catalyzes the phosphorylation of the proteasome alpha-subunit (PrcA) and unprocessed proteasome beta-subunit (pre-PrcB), which results in the inhibition of processing of pre-PrcB and assembly of the proteasome complex, and thereby enhances the mycobacterial resistance to H(2)O(2); PknA thus plays an important role in the oxidative stress response by impeding the formation of holo-proteasome in M.tuberculosis under H(2)O(2) stress (PubMed:25224505). Shows a strong preference for Thr versus Ser as the phosphoacceptor. {ECO:0000269|PubMed:15985609, ECO:0000269|PubMed:16817899, ECO:0000269|PubMed:19121323, ECO:0000269|PubMed:20066037, ECO:0000269|PubMed:21190553, ECO:0000269|PubMed:21423706, ECO:0000269|PubMed:25224505, ECO:0000269|PubMed:25713147}.",MSPRVGVTLSGRYRLQRLIATGGMGQVWEAVDNRLGRRVAVKVLKSEFSSDPEFIERFRAEARTTAMLNHPGIASVHDYGESQMNGEGRTAYLVMELVNGEPLNSVLKRTGRLSLRHALDMLEQTGRALQIAHAAGLVHRDVKPGNILITPTGQVKITDFGIAKAVDAAPVTQTGMVMGTAQYIAPEQALGHDASPASDVYSLGVVGYEAVSGKRPFAGDGALTVAMKHIKEPPPPLPPDLPPNVRELIEITLVKNPAMRYRSGGPFADAVAAVRAGRRPPRPSQTPPPGRAAPAAIPSGTTARVAANSAGRTAASRRSRPATGGHRPPRRTFSSGQRALLWAAGVLGALAIIIAVLLVIKAPGDNSPQQAPTPTVTTTGNPPASNTGGTDASPRLNWTERGETRHSGLQSWVVPPTPHSRASLARYEIAQ,"45,597",431,"Protein kinase superfamily, Ser/Thr protein kinase family",growth [GO:0040007]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of lipid biosynthetic process [GO:0051055]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.15c,1
P9WKD1,PBPA_MYCTU,Rv0016c,pbpA Rv0016c MTCY10H4.16c,GO:0005829; GO:0005886; GO:0008360; GO:0008658; GO:0009252; GO:0016021; GO:0071555,IPR012338; IPR001460; ,,pbpA,,Penicillin-binding protein A (PBPA),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; penicillin binding [GO:0008658]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 16436437; 21969609,X-ray crystallography (5),FUNCTION: Cell wall formation. Plays an important role in cell division and cell shape maintenance by cross-linking adjacent peptidoglycan chains through transpeptidation.,MNASLRRISVTVMALIVLLLLNATMTQVFTADGLRADPRNQRVLLDEYSRQRGQITAGGQLLAYSVATDGRFRFLRVYPNPEVYAPVTGFYSLRYSSTALERAEDPILNGSDRRLFGRRLADFFTGRDPRGGNVDTTINPRIQQAGWDAMQQGCYGPCKGAVVALEPSTGKILALVSSPSYDPNLLASHNPEVQAQAWQRLGDNPASPLTNRAISETYPPGSTFKVITTAAALAAGATETEQLTAAPTIPLPGSTAQLENYGGAPCGDEPTVSLREAFVKSCNTAFVQLGIRTGADALRSMARAFGLDSPPRPTPLQVAESTVGPIPDSAALGMTSIGQKDVALTPLANAEIAATIANGGITMRPYLVGSLKGPDLANISTTVGYQQRRAVSPQVAAKLTELMVGAEKVAQQKGAIPGVQIASKTGTAEHGTDPRHTPPHAWYIAFAPAQAPKVAVAVLVENGADRLSATGGALAAPIGRAVIEAALQGEP,"51,576",491,Transpeptidase family,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],penicillin binding [GO:0008658],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.16c,1
Q79G04,PE03_MYCTU,Rv0159c,PE3 Rv0159c LH57_00895,GO:0005576; GO:0005618; GO:0009405,IPR029058; IPR000084; IPR013228; ,,PE3,DOMAIN 1 92 PE. {ECO:0000255}.,PE family protein PE3,cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 23708146,,FUNCTION: Plays significant roles in mycobacterial persistence during infection and modulates host immune response. {ECO:0000269|PubMed:23708146}.,MSYVIAAPEMLATTAADVDGIGSAIRAASASAAGPTTGLLAAAADEVSSAAAALFSEYARECQEVLKQAAAFHGEFTRALAAAGAAYAQAEASNTAAMSGTAGSSGALGSVGMLSGNPLTALMMGGTGEPILSDRVLAIIDSAYIRPIFGPNNPVAQYTPEQWWPFIGNLSLDQSIAQGVTLLNNGINAELQNGHDVVVFGYSQSAAVATNEIRALMALPPGQAPDPSRLAFTLIGNINNPNGGVLERYVGLYLPFLDMSFNGATPPDSPYQTYMYTGQYDGYAHNPQYPLNILSDLNAFMGIRWVHNAYPFTAAEVANAVPLPTSPGYTGNTHYYMFLTQDLPLLQPIRAIPFVGTPIAELIQPDLRVLVDLGYGYGYADVPTPASLFAPINPIAVASALATGTVQGPQAALVSIGLLPQSALPNTYPYLPSANPGLMFNFGQSSVTELSVLSGALGSVARLIPPIA,"48,608",468,Mycobacterial PE family,pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576],,LH57_00895,1
P9WHN9,PHP_MYCTU,Rv0230c,php Rv0230c MTCY08D5.26c,GO:0008270; GO:0009056; GO:0016788,IPR017947; IPR032466; IPR001559; ,,php,,Phosphotriesterase homology protein,"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056]",9634230; 19099550; 21969609; ,X-ray crystallography (1),,MPELNTARGPIDTADLGVTLMHEHVFIMTTEIAQNYPEAWGDEDKRVAGAIARLGELKARGVDTIVDLTVIGLGRYIPRIARVAAATELNIVVATGLYTYNDVPFYFHYLGPGAQLDGPEIMTDMFVRDIEHGIADTGIKAGILKCATDEPGLTPGVERVLRAVAQAHKRTGAPISTHTHAGLRRGLDQQRIFAEEGVDLSRVVIGHCGDSTDVGYLEELIAAGSYLGMDRFGVDVISPFQDRVNIVARMCERGHADKMVLSHDACCYFDALPEELVPVAMPNWHYLHIHNDVIPALKQHGVTDEQLHTMLVDNPRRIFERQGGYQ,"35,886",326,"Metallo-dependent hydrolases superfamily, Phosphotriesterase family",catabolic process [GO:0009056],"hydrolase activity, acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]",,,MTCY08D5.26c,1
P71707,PBP1A_MYCTU,Rv0050,ponA1 Rv0050 MTCY21D4.13,GO:0005886; GO:0008360; GO:0008658; GO:0008955; GO:0009002; GO:0009252; GO:0016021; GO:0030288; GO:0071456; GO:0071555,IPR012338; IPR001264; IPR023346; IPR036950; IPR001460; ,,ponA1,,Penicillin-binding protein 1A (PBP-1A) (Penicillin-binding protein 1*) [Includes: Penicillin-insensitive transglycosylase (EC 2.4.1.129) (Peptidoglycan TGase); Penicillin-sensitive transpeptidase (EC 3.4.16.4) (DD-transpeptidase)],integral component of membrane [GO:0016021]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886]; penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002]; cell wall organization [GO:0071555]; cellular response to hypoxia [GO:0071456]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 11802794; 20686708; 21969609,X-ray crystallography (2),"FUNCTION: Cell wall formation. Synthesis of cross-linked peptidoglycan from the lipid intermediates. The enzyme has a penicillin-insensitive transglycosylase N-terminal domain (formation of linear glycan strands) and a penicillin-sensitive transpeptidase C-terminal domain (cross-linking of the peptide subunits) (By similarity). Has little peptidoglycan hydrolytic activity; however it inhibits the synergistic peptidoglycan hydrolysis of RipA plus RpfB. {ECO:0000250, ECO:0000269|PubMed:20686708}.",MNSDGRHHQSSSGAPRGPANPGQRGQVPPDDRLTAILPPVTDDRSAPHADSIEAVKAALDGAPPMPPPRDPLEEVTAALAAPPGKPPRGDQLGGRRRPPGPPGPPGSSGQPAGRLPQPRVDLPRVGQINWKWIRRSLYLTAAVVILLPMVTFTMAYLIVDVPKPGDIRTNQVSTILASDGSEIAKIVPPEGNRVDVNLSQVPMHVRQAVIAAEDRNFYSNPGFSFTGFARAVKNNLFGGDLQGGSTITQQYVKNALVGSAQHGWSGLMRKAKELVIATKMSGEWSKDDVLQAYLNIIYFGRGAYGISAASKAYFDKPVEQLTVAEGALLAALIRRPSTLDPAVDPEGAHARWNWVLDGMVETKALSPNDRAAQVFPETVPPDLARAENQTKGPNGLIERQVTRELLELFNIDEQTLNTQGLVVTTTIDPQAQRAAEKAVAKYLDGQDPDMRAAVVSIDPHNGAVRAYYGGDNANGFDFAQAGLQTGSSFKVFALVAALEQGIGLGYQVDSSPLTVDGIKITNVEGEGCGTCNIAEALKMSLNTSYYRLMLKLNGGPQAVADAAHQAGIASSFPGVAHTLSEDGKGGPPNNGIVLGQYQTRVIDMASAYATLAASGIYHPPHFVQKVVSANGQVLFDASTADNTGDQRIPKAVADNVTAAMEPIAGYSRGHNLAGGRDSAAKTGTTQFGDTTANKDAWMVGYTPSLSTAVWVGTVKGDEPLVTASGAAIYGSGLPSDIWKATMDGALKGTSNETFPKPTEVGGYAGVPPPPPPPEVPPSETVIQPTVEIAPGITIPIGPPTTITLAPPPPAPPAATPTPPP,"85,969",820,Glycosyltransferase 51 family; Transpeptidase family,cellular response to hypoxia [GO:0071456]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],penicillin binding [GO:0008658]; peptidoglycan glycosyltransferase activity [GO:0008955]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002],integral component of membrane [GO:0016021]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,MTCY21D4.13,3
P9WIH3,PCKG_MYCTU,Rv0211,pckG pck1 pckA Rv0211 MTCY08D5.06,GO:0004613; GO:0005525; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006094; GO:0010106; GO:0046872; GO:0052572,IPR018091; IPR013035; IPR008209; IPR035077; IPR035078; IPR008210; ,,pckG,,Phosphoenolpyruvate carboxykinase [GTP] (PEP carboxykinase) (PEPCK) (EC 4.1.1.32) (GTP-dependent phosphoenolpyruvate carboxykinase) (GTP-PEPCK),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; cellular response to iron ion starvation [GO:0010106]; gluconeogenesis [GO:0006094]; response to host immune response [GO:0052572],9634230; 16691317; 20439709; 21969609,X-ray crystallography (2),"FUNCTION: Involved in the gluconeogenesis, in growth on fatty acids and is important for initiation of infection in the macrophages. Catalyzes the GTP-dependent conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. {ECO:0000269|PubMed:16691317, ECO:0000269|PubMed:20439709}.",MTSATIPGLDTAPTNHQGLLSWVEEVAELTQPDRVVFTDGSEEEFQRLCDQLVEAGTFIRLNPEKHKNSYLALSDPSDVARVESRTYICSAKEIDAGPTNNWMDPGEMRSIMKDLYRGCMRGRTMYVVPFCMGPLGAEDPKLGVEITDSEYVVVSMRTMTRMGKAALEKMGDDGFFVKALHSVGAPLEPGQKDVAWPCSETKYITHFPETREIWSYGSGYGGNALLGKKCYSLRIASAMAHDEGWLAEHMLILKLISPENKAYYFAAAFPSACGKTNLAMLQPTIPGWRAETLGDDIAWMRFGKDGRLYAVNPEFGFFGVAPGTNWKSNPNAMRTIAAGNTVFTNVALTDDGDVWWEGLEGDPQHLIDWKGNDWYFRETETNAAHPNSRYCTPMSQCPILAPEWDDPQGVPISGILFGGRRKTTVPLVTEARDWQHGVFIGATLGSEQTAAAEGKVGNVRRDPMAMLPFLGYNVGDYFQHWINLGKHADESKLPKVFFVNWFRRGDDGRFLWPGFGENSRVLKWIVDRIEHKAGGATTPIGTVPAVEDLDLDGLDVDAADVAAALAVDADEWRQELPLIEEWLQFVGEKLPTGVKDEFDALKERLG,"67,253",606,Phosphoenolpyruvate carboxykinase [GTP] family,cellular response to iron ion starvation [GO:0010106]; gluconeogenesis [GO:0006094]; response to host immune response [GO:0052572],GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],pck1 pckA,MTCY08D5.06,1
P9WIJ5,PCP_MYCTU,Rv0319,pcp Rv0319 MTCY63.24,GO:0005829; GO:0006508; GO:0008234; GO:0016920,IPR000816; IPR016125; IPR036440; IPR029762; IPR033694; IPR033693; ,,pcp,,Pyrrolidone-carboxylate peptidase (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrase),cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508],9634230; 21969609,,FUNCTION: Removes 5-oxoproline from various penultimate amino acid residues except L-proline. {ECO:0000250}.,MSKVLVTGFGPYGVTPVNPAQLTAEELDGRTIAGATVISRIVPNTFFESIAAAQQAIAEIEPALVIMLGEYPGRSMITVERLAQNVNDCGRYGLADCAGRVLVGEPTDPAGPVAYHATVPVRAMVLAMRKAGVPADVSDAAGTFVCNHLMYGVLHHLAQKGLPVRAGWIHLPCLPSVAALDHNLGVPSMSVQTAVAGVTAGIEAAIRQSADIREPIPSRLQI,"23,193",222,Peptidase C15 family,proteolysis [GO:0006508],cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920],cytosol [GO:0005829],,MTCY63.24,1
L7N695,PE05_MYCTU,Rv0285,PE5 Rv0285 LH57_01560,GO:0005576; GO:0009405; GO:0009986; GO:0031975,IPR000084; ,,PE5,DOMAIN 3 92 PE. {ECO:0000255}.,PE family immunomodulator PE5,cell surface [GO:0009986]; envelope [GO:0031975]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 21969609; 23284742; 26729876,,"FUNCTION: Important for the siderophore-mediated iron-acquisition function of ESX-3 (PubMed:26729876). May play a pivotal role in the evasion of host immune response by M.tuberculosis. Mediates production of IL-10 via activation of the p38 and ERK1/2 mitogen-activated protein kinase (MAPK) signaling pathways (PubMed:23284742). {ECO:0000269|PubMed:23284742, ECO:0000269|PubMed:26729876}.",MTLRVVPEGLAAASAAVEALTARLAAAHASAAPVITAVVPPAADPVSLQTAAGFSAQGVEHAVVTAEGVEELGRAGVGVGESGASYLAGDAAAAATYGVVGG,"9,566",102,Mycobacterial PE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; envelope [GO:0031975]; extracellular region [GO:0005576],,LH57_01560,1
O07427,MGLL_MYCTU,Rv0183,Rv0183 LH57_01015,GO:0005618; GO:0005886; GO:0006629; GO:0009405; GO:0016020; GO:0016298; GO:0046503; GO:0047372; GO:0052151,IPR029058; IPR000073; IPR022742; ,,,,Monoacylglycerol lipase (MGL) (EC 3.1.1.23),cell wall [GO:0005618]; membrane [GO:0016020]; plasma membrane [GO:0005886]; acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298]; glycerolipid catabolic process [GO:0046503]; lipid metabolic process [GO:0006629]; pathogenesis [GO:0009405]; positive regulation by symbiont of host apoptotic process [GO:0052151],9634230; 17784850; 21969609; 22405030,,"FUNCTION: Involved in the hydrolysis of exogenous host lipids during chronic infection. Catalyzes the hydrolysis of both monoacylglycerols (MAG) and diacylglycerols (DAG). It hydrolyzes 2-MAG, 1-3-MAG and MAG with short, medium and long chain fatty acids such as 1-monobutyroyl-rac-glycerol (MC4), 1-mono-octanoyl-rac-glycerol (MC8), 1-monodecanoyl-rac-glycerol (MC10), 1-monolauroyl-rac-glycerol (MC12), 1-monomyristoyl-rac-glycerol (MC14) and 1-mono-oleyl-rac-glycerol (MC18:1) (PubMed:17784850). Also able to hydrolyze DAG with short (DiC6) and medium (DiC10) fatty acid chains, but not whith a longest chain fatty acids (PubMed:17784850). Can also hydrolyze vinyl laurate (VC12), vinyl butyrate (VC4) and vinyl propionate (VC3) (PubMed:17784850). {ECO:0000269|PubMed:17784850, ECO:0000305|PubMed:22405030}.",MTTTRTERNFAGIGDVRIVYDVWTPDTAPQAVVVLAHGLGEHARRYDHVAQRLGAAGLVTYALDHRGHGRSGGKRVLVRDISEYTADFDTLVGIATREYPGCKRIVLGHSMGGGIVFAYGVERPDNYDLMVLSAPAVAAQDLVSPVVAVAAKLLGVVVPGLPVQELDFTAISRDPEVVQAYNTDPLVHHGRVPAGIGRALLQVGETMPRRAPALTAPLLVLHGTDDRLIPIEGSRRLVECVGSADVQLKEYPGLYHEVFNEPERNQVLDDVVAWLTERL,"30,262",279,AB hydrolase superfamily,glycerolipid catabolic process [GO:0046503]; lipid metabolic process [GO:0006629]; pathogenesis [GO:0009405]; positive regulation by symbiont of host apoptotic process [GO:0052151],acylglycerol lipase activity [GO:0047372]; lipase activity [GO:0016298],cell wall [GO:0005618]; membrane [GO:0016020]; plasma membrane [GO:0005886],,LH57_01015,2
P9WJT9,MMPLB_MYCTU,Rv0202c,mmpL11 Rv0202c MTV033.10c,GO:0005618; GO:0005829; GO:0005886; GO:0009405; GO:0016021,IPR004869; IPR000731; ,,mmpL11,,Heme uptake protein MmpL11,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 15908378; 21969609; 21383189; 23760277; 23836904,X-ray crystallography (1),"FUNCTION: Part of a heme-iron acquisition system. Receives heme from the heme-binding protein Rv0203 and transports it into the mycobacterial cell. Contributes to virulence. {ECO:0000269|PubMed:15908378, ECO:0000269|PubMed:21383189, ECO:0000269|PubMed:23760277}.; FUNCTION: Could also transport the mycolic acid-containing lipids monomeromycolyl diacylglycerol (MMDAG) and mycolate ester wax (WE) to the bacterial surface. {ECO:0000303|PubMed:23836904}.",MMRLSRNLRRCRWLVFTGWLLALVPAVYLAMTQSGNLTGGGFEVAGSQSLLVHDQLDAHYPDRGAPALALVAAPRPDASYQDIDNAVALLRQIASELPGVTEAPNPTQRPPQPDRPYVVSLRLDARNAGTSDVAKKLRDRIGVKGDQSGQTANGKVRLYVIGQGALSAAAAANTKHDIANAERWNLPIILMVLVAVFGSLAAAAIPLALAVCTVVITMGLVFVLSMHTTMSVFVTSTVSMFGIALAVDYSLFILMRYREELRCGRRPPDAVDAAMATSGLAVVLSGMTVIASLTGIYLINTPALRSMATGAILAVAVAMLTSATLTPAVLATFARAAAKRSALVHWSRRPASTQSWFWSRWVGWVMRRPWITALAASTVLLVMAAPATLMVLGNSLLRQFDSSHEIRTGAAAAAQALGPGALGPVQVLVRFDAGGASAPEHSQTIAAIRHRIAQAPNVVSVAPPRFADDNGSALLSAVLSVDPEDLGARDTITWMRTQLPRVAGAAQVDVGGPTALIKDFDDRVSATQPLVLVFVAVIAFLMLLISIRSVFLAFKGVLMTLLSVAAAYGSLVMVFQWGWARGLGFPALHSIDSTVPPLVLAMTFGLSMDYEIFLLTRIRERFLQTGQTRDAVAYGVRTSARTITSAALIMIAVFCGFAFAGMPLVAEIGVACAVAIAVDATVVRLVLVPALMAMFDRWNWWLPRWLAHILPSVDFDRPLPKVDLGDVVVIPDDFAAAIPPSADVRMVLKSAAKLKRLAPDAICVTDPLAFTGCGCDGKALDQVQLAYRNGIARAISWGQRPVHPVTVWRKRLAVALDALQTTTWECGGVQTHRAGPGYRRRSPVETTNVALPTGDRLQIPTGAETLRFKGYLIMSRNSSHDYADFADLVDTMAPETAAAVLAGMDRYYSCQAPGRQWMATQLVGRLADPQPSDLGDQSPGADAQAKWEEVRRRCLSVAVAMLEEAR,"103,502",966,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",pathogenesis [GO:0009405],,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV033.10c,1
O07177,MAK1_MYCTU,Rv0127,mak Rv0127,GO:0005524; GO:0005829; GO:0005886; GO:0005978; GO:0005992; GO:0016301; GO:0040007; GO:0046835,IPR011009; ,,mak,,Maltokinase (MaK) (EC 2.7.1.175) (Maltose-1-phosphate synthase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; carbohydrate phosphorylation [GO:0046835]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]; trehalose biosynthetic process [GO:0005992],9634230; 20507595; 20305657; 21969609,X-ray crystallography (2),"FUNCTION: Catalyzes the ATP-dependent phosphorylation of maltose to maltose 1-phosphate (By similarity). Is involved in a branched alpha-glucan biosynthetic pathway from trehalose, together with TreS, GlgE and GlgB. {ECO:0000250, ECO:0000269|PubMed:20305657}.",MTRSDTLATKLPWSDWLSRQRWYAGRNRELATVKPGVVVALRHNLDLVLVDVTYTDGATERYQVLVGWDFEPASEYGTKAAIGVADDRTGFDALYDVAGPQFLLSLIVSSAVCGTSTGEVTFTREPDVELPFAAQPRVCDAEQSNTSVIFDRRAILKVFRRVSSGINPDIELNRVLTRAGNPHVARLLGAYQFGRPNRSPTDALAYALGMVTEYEANAAEGWAMATASVRDLFAEGDLYAHEVGGDFAGESYRLGEAVASVHATLADSLGTAQATFPVDRMLARLSSTVAVVPELREYAPTIEQQFQKLAAEAITVQRVHGDLHLGQVLRTPESWLLIDFEGEPGQPLDERRAPDSPLRDVAGVLRSFEYAAYGPLVDQATDKQLAARAREWVERNRAAFCDGYAVASGIDPRDSALLLGAYELDKAVYETGYETRHRPGWLPIPLRSIARLTAS,"49,879",455,Aminoglycoside phosphotransferase family,carbohydrate phosphorylation [GO:0046835]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]; trehalose biosynthetic process [GO:0005992],ATP binding [GO:0005524]; kinase activity [GO:0016301],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O53645,MDREP_MYCTU,Rv0194 RVBD_0194,Rv0194 RVBD_0194 P425_00203,GO:0005524; GO:0005618; GO:0005886; GO:0015562; GO:0016021; GO:0034040; GO:0042891; GO:0046677,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 21 301 ABC transmembrane type-1 1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 334 568 ABC transporter 1. {ECO:0000255|PROSITE-ProRule:PRU00434}.; DOMAIN 628 910 ABC transmembrane type-1 2. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 942 1177 ABC transporter 2. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Multidrug efflux ATP-binding/permease protein Rv0194 (EC 3.6.3.-),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; lipid-transporting ATPase activity [GO:0034040]; antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],9634230; 18458127; 21969609,,"FUNCTION: Overexpression in M. smegmatis increases resistance to erythromycin, ampicillin, novobiocin and vancomycin. It also reduces accumulation of ethidium bromide in the cell. {ECO:0000269|PubMed:18458127}.",MRTNCWWRLSGYVMRHRRDLLLGFGAALAGTVIAVLVPLVTKRVIDDAIAADHRPLAPWAVVLVAAAGATYLLMYVRRYYGGRIAHLVQHDLRMDAFQALLRWDGRQQDRWSSGQLIVRTTNDLQLVQALLFDVPNVLRHVLTLLLGVAVMTWLSVPLALLAVLLVPVIGLIAHRSRRLLAAATHCAQEHKAAVTGVVDAAVCGIRVVKAFGQEERETVKLVTASRALYAAQLRVARLNAHFGPLLQTLPALGQMAVFALGGWMAAQGSITVGTFVAFWACLTLLARPACDLAGMLTIAQQARAGAVRVLELIDSRPTLVDGTKPLSPEARLSLEFQRVSFGYVADRPVLREISLSVRAGETLAVVGAPGSGKSTLASLATRCYDVTQGAVRIGGQDVRELTLDSLRSAIGLVPEDAVLFSGTIGANIAYGRPDATPEQIATAARAAHIEEFVNTLPDGYQTAVGARGLTLSGGQRQRIALARALLHQPRLLIMDDPTSAVDAVIECGIQEVLREAIADRTAVIFTRRRSMLTLADRVAVLDSGRLLDVGTPDEVWERCPRYRELLSPAPDLADDLVVAERSPVCRPVAGLGTKAAQHTNVHNPGPHDHPPGPDPLRRLLREFRGPLALSLLLVAVQTCAGLLPPLLIRHGIDVGIRRHVLSALWWAALAGTATVVIRWVVQWGSAMVAGYTGEQVLFRLRSVVFAHAQRLGLDAFEDDGDAQIVTAVTADVEAIVAFLRTGLVVAVISVVTLVGILVALLAIRARLVLLIFTTMPVLALATWQFRRASNWTYRRARHRLGTVTATLREYAAGLRIAQAFRAEYRGLQSYFAHSDDYRRLGVRGQRLLALYYPFVALLCSLATTLVLLDGAREVRAGVISVGALVTYLLYIELLYTPIGELAQMFDDYQRAAVAAGRIRSLLSTRTPSSPAARPVGTLRGEVVFDAVHYSYRTREVPALAGINLRIPAGQTVVFVGSTGSGKSTLIKLVARFYDPTHGTVRVDGCDLREFDVDGYRNRLGIVTQEQYVFAGTVRDAIAYGRPDATDAQVERAAREVGAHPMITALDNGYLHQVTAGGRNLSAGQLQLLALARARLVDPDILLLDEATVALDPATEAVVQRATLTLAARRTTLIVAHGLAIAEHADRIVVLEHGTVVEDGAHTELLAAGGHYSRLWAAHTRLCSPEITQLQCIDA,"129,251",1194,"ABC transporter superfamily, Lipid exporter (TC 3.A.1.106) family",antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562]; lipid-transporting ATPase activity [GO:0034040],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,P425_00203,1
P9WGB5,METZ_MYCTU,Rv0391,metZ Rv0391,GO:0003962; GO:0004123; GO:0009086; GO:0030170; GO:0071268,IPR000277; IPR006234; IPR015424; IPR015422; IPR015421; ,,metZ,,O-succinylhomoserine sulfhydrylase (OSH sulfhydrylase) (OSHS sulfhydrylase) (EC 2.5.1.-),cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; pyridoxal phosphate binding [GO:0030170]; homocysteine biosynthetic process [GO:0071268]; methionine biosynthetic process [GO:0009086],9634230; 21969609; ,X-ray crystallography (1),FUNCTION: Catalyzes the formation of L-homocysteine from O-succinyl-L-homoserine (OSHS) and hydrogen sulfide. {ECO:0000255|HAMAP-Rule:MF_02056}.,MTDESSVRTPKALPDGVSQATVGVRGGMLRSGFEETAEAMYLTSGYVYGSAAVAEKSFAGELDHYVYSRYGNPTVSVFEERLRLIEGAPAAFATASGMAAVFTSLGALLGAGDRLVAARSLFGSCFVVCSEILPRWGVQTVFVDGDDLSQWERALSVPTQAVFFETPSNPMQSLVDIAAVTELAHAAGAKVVLDNVFATPLLQQGFPLGVDVVVYSGTKHIDGQGRVLGGAILGDREYIDGPVQKLMRHTGPAMSAFNAWVLLKGLETLAIRVQHSNASAQRIAEFLNGHPSVRWVRYPYLPSHPQYDLAKRQMSGGGTVVTFALDCPEDVAKQRAFEVLDKMRLIDISNNLGDAKSLVTHPATTTHRAMGPEGRAAIGLGDGVVRISVGLEDTDDLIADIDRALS,"43,345",406,"Trans-sulfuration enzymes family, MetZ subfamily",homocysteine biosynthetic process [GO:0071268]; methionine biosynthetic process [GO:0009086],cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; pyridoxal phosphate binding [GO:0030170],,,,1
P9WJV5,MMPL3_MYCTU,Rv0206c,mmpL3 Rv0206c MTCY08D5.01c MTV033.14c,GO:0005576; GO:0005618; GO:0005887; GO:0015920; GO:0040007; GO:0071555; GO:0071766,IPR004869; IPR000731; ,,mmpL3,,Trehalose monomycolate exporter MmpL3 (TMM exporter MmpL3),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; lipopolysaccharide transport [GO:0015920],9634230; 21969609; 21383189; 22577943; 22024828; 22252828; 22344175; 24352433; 23613759; 25136022; 24325728,,"FUNCTION: Transports trehalose monomycolate (TMM) across the inner membrane (PubMed:22252828, PubMed:22344175). Could also be part of a heme-iron acquisition system (PubMed:21383189). {ECO:0000269|PubMed:22252828, ECO:0000269|PubMed:22344175, ECO:0000305|PubMed:21383189}.; FUNCTION: Is the target of the antitubercular drug SQ109. {ECO:0000269|PubMed:22252828}.",MFAWWGRTVYRYRFIVIGVMVALCLGGGVFGLSLGKHVTQSGFYDDGSQSVQASVLGDQVYGRDRSGHIVAIFQAPAGKTVDDPAWSKKVVDELNRFQQDHPDQVLGWAGYLRASQATGMATADKKYTFVSIPLKGDDDDTILNNYKAIAPDLQRLDGGTVKLAGLQPVAEALTGTIATDQRRMEVLALPLVAVVLFFVFGGVIAAGLPVMVGGLCIAGALGIMRFLAIFGPVHYFAQPVVSLIGLGIAIDYGLFIVSRFREEIAEGYDTETAVRRTVITAGRTVTFSAVLIVASAIGLLLFPQGFLKSLTYATIASVMLSAILSITVLPACLGILGKHVDALGVRTLFRVPFLANWKISAAYLNWLADRLQRTKTREEVEAGFWGKLVNRVMKRPVLFAAPIVIIMILLIIPVGKLSLGGISEKYLPPTNSVRQAQEEFDKLFPGYRTNPLTLVIQTSNHQPVTDAQIADIRSKAMAIGGFIEPDNDPANMWQERAYAVGASKDPSVRVLQNGLINPADASKKLTELRAITPPKGITVLVGGTPALELDSIHGLFAKMPLMVVILLTTTIVLMFLAFGSVVLPIKATLMSALTLGSTMGILTWIFVDGHFSKWLNFTPTPLTAPVIGLIIALVFGLSTDYEVFLVSRMVEARERGMSTQEAIRIGTAATGRIITAAALIVAVVAGAFVFSDLVMMKYLAFGLMAALLLDATVVRMFLVPSVMKLLGDDCWWAPRWARRLQTRIGLGEIHLPDERKRPVSNGRPARPPVTAGLVAARAAGDPRPPHDPTHPLAESPRPARSSPASSPELTPALEATAAPAAPSGASTTRMQIGSSTEPPTTRLAAAGRSVQSPASTPPPTPTPPSAPSAGQTRAMPLAANRSTDAAGDPAEPTAALPIIRSDGDDSEAATEQLNARGTSDKTRQRRRGGGALSAQDLLRREGRL,"100,904",944,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; lipopolysaccharide transport [GO:0015920],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTCY08D5.01c MTV033.14c,1
P9WJM5,MSRA_MYCTU,Rv0137c,msrA Rv0137c MTCI5.11c,GO:0005829; GO:0006979; GO:0008113; GO:0033744; GO:0051409; GO:0052060,IPR002569; IPR036509; ,,msrA,,Peptide methionine sulfoxide reductase MsrA (Protein-methionine-S-oxide reductase) (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase),cytosol [GO:0005829]; L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO:0033744]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979],9634230; 21969609,X-ray crystallography (1),FUNCTION: Has an important function as a repair enzyme for proteins that have been inactivated by oxidation. Catalyzes the reversible oxidation-reduction of methionine sulfoxide in proteins to methionine. {ECO:0000255|HAMAP-Rule:MF_01401}.,MTSNQKAILAGGCFWGLQDLIRNQPGVVSTRVGYSGGNIPNATYRNHGTHAEAVEIIFDPTVTDYRTLLEFFFQIHDPTTKDRQGNDRGTSYRSAIFYFDEQQKRIALDTIADVEASGLWPGKVVTEVSPAGDFWEAEPEHQDYLQRYPNGYTCHFVRPGWRLPRRTAESALRASLSPELGT,"20,485",182,MsrA Met sulfoxide reductase family,evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979],L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO:0033744]; peptide-methionine (S)-S-oxide reductase activity [GO:0008113],cytosol [GO:0005829],,MTCI5.11c,1
P9WKJ5,ILVD_MYCTU,Rv0189c,ilvD Rv0189c MTCI28.28c,GO:0004160; GO:0005886; GO:0009082; GO:0009097; GO:0009099; GO:0040007; GO:0046872; GO:0051539,IPR004404; IPR000581; IPR020558; IPR037237; ,,ilvD,,Dihydroxy-acid dehydratase (DAD) (EC 4.2.1.9),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; dihydroxy-acid dehydratase activity [GO:0004160]; metal ion binding [GO:0046872]; branched-chain amino acid biosynthetic process [GO:0009082]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099]",9634230; 21969609,,,MPQTTDEAASVSTVADIKPRSRDVTDGLEKAAARGMLRAVGMDDEDFAKPQIGVASSWNEITPCNLSLDRLANAVKEGVFSAGGYPLEFGTISVSDGISMGHEGMHFSLVSREVIADSVEVVMQAERLDGSVLLAGCDKSLPGMLMAAARLDLAAVFLYAGSILPGRAKLSDGSERDVTIIDAFEAVGACSRGLMSRADVDAIERAICPGEGACGGMYTANTMASAAEALGMSLPGSAAPPATDRRRDGFARRSGQAVVELLRRGITARDILTKEAFENAIAVVMAFGGSTNAVLHLLAIAHEANVALSLQDFSRIGSGVPHLADVKPFGRHVMSDVDHIGGVPVVMKALLDAGLLHGDCLTVTGHTMAENLAAITPPDPDGKVLRALANPIHPSGGITILHGSLAPEGAVVKTAGFDSDVFEGTARVFDGERAALDALEDGTITVGDAVVIRYEGPKGGPGMREMLAITGAIKGAGLGKDVLLLTDGRFSGGTTGLCVGHIAPEAVDGGPIALLRNGDRIRLDVAGRVLDVLADPAEFASRQQDFSPPPPRYTTGVLSKYVKLVSSAAVGAVCG,"59,352",575,IlvD/Edd family,branched-chain amino acid biosynthetic process [GO:0009082]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],"4 iron, 4 sulfur cluster binding [GO:0051539]; dihydroxy-acid dehydratase activity [GO:0004160]; metal ion binding [GO:0046872]",plasma membrane [GO:0005886],,MTCI28.28c,1
P9WJ95,INIC_MYCTU,Rv0343,iniC Rv0343,GO:0005829; GO:0005886,IPR022812; IPR027417; ,,iniC,,Isoniazid-induced protein IniC,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 10714983; 17590082; 21969609,,,MSTSDRVRAILHATIQAYRGAPAYRQRGDVFCQLDRIGARLAEPLRIALAGTLKAGKSTLVNALVGDDIAPTDATEATRIVTWFRHGPTPRVTANHRGGRRANVPITRRGGLSFDLRRINPAELIDLEVEWPAEELIDATIVDTPGTSSLACDASERTLRLLVPADGVPRVDAVVFLLRTLNAADVALLKQIGGLVGGSVGALGIIGVASRADEIGAGRIDAMLSANDVAKRFTRELNQMGICQAVVPVSGLLALTARTLRQTEFIALRKLAGAERTELNRALLSVDRFVRRDSPLPVDAGIRAQLLERFGMFGIRMSIAVLAAGVTDSTGLAAELLERSGLVALRNVIDQQFAQRSDMLKAHTALVSLRRFVQTHPVPATPYVIADIDPLLADTHAFEELRMLSLLPSRATTLNDDEIASLRRIIGGSGTSAAARLGLDPANSREAPRAALAAAQHWRRRAAHPLNDPFTTRACRAAVRSAEAMVAEFSARR,"53,019",493,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WKI1,INO1_MYCTU,Rv0046c,ino1 Rv0046c MTCY21D4.09c,GO:0004512; GO:0005829; GO:0006021; GO:0008270; GO:0008654; GO:0009405; GO:0010125,IPR002587; IPR017815; IPR013021; IPR036291; ,,ino1,,Inositol-3-phosphate synthase (IPS) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase),cytosol [GO:0005829]; inositol-3-phosphate synthase activity [GO:0004512]; zinc ion binding [GO:0008270]; inositol biosynthetic process [GO:0006021]; mycothiol biosynthetic process [GO:0010125]; pathogenesis [GO:0009405]; phospholipid biosynthetic process [GO:0008654],9634230; 20066036; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the conversion of glucose 6-phosphate to 1D-myo-inositol 3-phosphate. {ECO:0000250}.,MSEHQSLPAPEASTEVRVAIVGVGNCASSLVQGVEYYYNADDTSTVPGLMHVRFGPYHVRDVKFVAAFDVDAKKVGFDLSDAIFASENNTIKIADVAPTNVIVQRGPTLDGIGKYYADTIELSDAEPVDVVQALKEAKVDVLVSYLPVGSEEADKFYAQCAIDAGVAFVNALPVFIASDPVWAKKFTDARVPIVGDDIKSQVGATITHRVLAKLFEDRGVQLDRTMQLNVGGNMDFLNMLERERLESKKISKTQAVTSNLKREFKTKDVHIGPSDHVGWLDDRKWAYVRLEGRAFGDVPLNLEYKLEVWDSPNSAGVIIDAVRAAKIAKDRGIGGPVIPASAYLMKSPPEQLPDDIARAQLEEFIIG,"40,094",367,Myo-inositol 1-phosphate synthase family,inositol biosynthetic process [GO:0006021]; mycothiol biosynthetic process [GO:0010125]; pathogenesis [GO:0009405]; phospholipid biosynthetic process [GO:0008654],inositol-3-phosphate synthase activity [GO:0004512]; zinc ion binding [GO:0008270],cytosol [GO:0005829],,MTCY21D4.09c,1
P9WJ97,INIB_MYCTU,Rv0341,iniB Rv0341,,,,iniB,,Isoniazid-induced protein IniB,,9634230; 10714983; 17590082; 21969609,,,MTSLIDYILSLFRSEDAARSFVAAPGRAMTSAGLIDIAPHQISSVAANVVPGLNLGAGDPMSGLRQAVAARHGFAQDVANVGFAGDAGAGVASVITTDVGAGLASGLGAGFLGQGGLALAASSGGFGGQVGLAAQVGLGFTAVIEAEVGAQVGAGLGIGTGLGAQAGMGFGGGVGLGLGGQAGGVIGGSAAGAIGAGVGGRLGGNGQIGVAGQGAVGAGVGAGVGGQAGIASQIGVSAGGGLGGVGNVSGLTGVSSNAVLASNASGQAGLIASEGAALNGAAMPHLSGPLAGVGVGGQAGAAGGAGLGFGAVGHPTPQPAALGAAGVVAKTEAAAGVVGGVGGATAAGVGGAHGDILGHEGAALGSVDTVNAGVTPVEHGLVLPSGPLIHGGTGGYGGMNPPVTDAPAPQVPARAQPMTTAAEHTPAVTQPQHTPVEPPVHDKPPSHSVFDVGHEPPVTHTPPAPIELPSYGLFGLPGF,"43,921",479,,,,,,,1
P9WPM3,CP138_MYCTU,Rv0136,cyp138 Rv0136 MTCI5.10,GO:0004497; GO:0005506; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002401; IPR036396; ,,cyp138,,Putative cytochrome P450 138 (EC 1.14.-.-),"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MSEVVTAAPAPPVVRLPPAVRGPKLFQGLAFVVSRRRLLGRFVRRYGKAFTANILMYGRVVVVADPQLARQVFTSSPEELGNIQPNLSRMFGSGSVFALDGDDHRRRRRLLAPPFHGKSMKNYETIIEEETLRETANWPQGQAFATLPSMMHITLNAILRAIFGAGGSELDELRRLIPPWVTLGSRLAALPKPKRDYGRLSPWGRLAEWRRQYDTVIDKLIEAERADPNFADRTDVLALMLRSTYDDGSIMSRKDIGDELLTLLAAGHETTAATLGWAFERLSRHPDVLAALVEEVDNGGHELRQAAILEVQRARTVIDFAARRVNPPVYQLGEWVIPRGYSIIINIAQIHGDPDVFPQPDRFDPQRYIGSKPSPFAWIPFGGGTRRCVGAAFANMEMDVVLRTVLRHFTLETTTAAGERSHGRGVAFTPKDGGRVVMRRR,"49,261",441,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCI5.10,1
P9WNK3,ESXH_MYCTU,Rv0288,esxH cfp7 Rv0288 MTV035.16,GO:0005576; GO:0009405; GO:0046872,IPR036689; IPR010310; ,O53692,esxH,,ESAT-6-like protein EsxH (10 kDa antigen CFP7) (CFP-7) (Low molecular weight protein antigen 7) (Protein TB10.4),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; pathogenesis [GO:0009405],9634230; 10603390; 12228269; 15336430; 16714570; 18430736; 19876390; 19854905; 20085764; 21969609; 24204276; 24280763; 21730061,NMR spectroscopy (1),"FUNCTION: EsxH, in complex with EsxG, disrupts ESCRT function and impairs host phagosome maturation, thereby promoting intracellular bacterial growth. The complex acts by interacting, via EsxH, with the host hepatocyte growth factor-regulated tyrosine kinase substrate (HGS/HRS), a component of the ESCRT machinery. {ECO:0000269|PubMed:24204276}.",MSQIMYNYPAMLGHAGDMAGYAGTLQSLGAEIAVEQAALQSAWQGDTGITYQAWQAQWNQAMEDLVRAYHAMSSTHEANTMAMMARDTAEAAKWGG,"10,391",96,"WXG100 family, ESAT-6 subfamily",pathogenesis [GO:0009405],metal ion binding [GO:0046872],extracellular region [GO:0005576],cfp7,MTV035.16,1
P9WNA9,ECCC3_MYCTU,Rv0284,eccC3 Rv0284,GO:0003677; GO:0005524; GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR003593; IPR023836; IPR023837; IPR002543; IPR027417; ,,eccC3,DOMAIN 456 662 FtsK 1. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 811 1000 FtsK 2. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 1090 1280 FtsK 3. {ECO:0000255|PROSITE-ProRule:PRU00289}.,ESX-3 secretion system protein EccC3 (ESX conserved component C3) (Type VII secretion system protein EccC3) (T7SS protein EccC3),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; growth [GO:0040007],9634230; 12065475; 17098899; 19099550; 19684129; 19876390; 21969609; 24155985,,"FUNCTION: Part of the ESX-3 specialized secretion system, which is important for iron and zinc uptake or homeostasis. {ECO:0000269|PubMed:19684129, ECO:0000269|PubMed:24155985}.",MSRLIFEARRRLAPPSSHQGTIIIEAPPELPRVIPPSLLRRALPYLIGILIVGMIVALVATGMRVISPQTLFFPFVLLLAATALYRGNDKKMRTEEVDAERADYLRYLSVVRDNIRAQAAEQRASALWSHPDPTALASVPGSRRQWERDPHDPDFLVLRAGRHTVPLATTLRVNDTADEIDLEPVSHSALRSLLDTQRSIGDVPTGIDLTKVSPITVLGERAQVRAVLRAWIAQAVTWHDPTVLGVALAARDLEGRDWNWLKWLPHVDIPGRLDALGPARNLSTDPDELIALLGPVLADRPAFTGQPTDALRHLLIVVDDPDYDLGASPLAVGRAGVTVVHCSASAPHREQYSDPEKPILRVAHGAIERWQTGGWQPYIDAADQFSADEAAHLARRLSRWDSNPTHAGLRSAATRGASFTTLLGIEDASRLDVPALWAPRRRDEELRVPIGVTGTGEPLMFDLKDEAEGGMGPHGLMIGMTGSGKSQTLMSILLSLLTTHSAERLIVIYADFKGEAGADSFRDFPQVVAVISNMAEKKSLADRFADTLRGEVARREMLLREAGRKVQGSAFNSVLEYENAIAAGHSLPPIPTLFVVADEFTLMLADHPEYAELFDYVARKGRSFRIHILFASQTLDVGKIKDIDKNTAYRIGLKVASPSVSRQIIGVEDAYHIESGKEHKGVGFLVPAPGATPIRFRSTYVDGIYEPPQTAKAVVVQSVPEPKLFTAAAVEPDPGTVIADTDEQEPADPPRKLIATIGEQLARYGPRAPQLWLPPLDETIPLSAALARAGVGPRQWRWPLGEIDRPFEMRRDPLVFDARSSAGNMVIHGGPKSGKSTALQTFILSAASLHSPHEVSFYCLDYGGGQLRALQDLAHVGSVASALEPERIRRTFGELEQLLLSRQQREVFRDRGANGSTPDDGFGEVFLVIDNLYGFGRDNTDQFNTRNPLLARVTELVNVGLAYGIHVIITTPSWLEVPLAMRDGLGLRLELRLHDARDSNVRVVGALRRPADAVPHDQPGRGLTMAAEHFLFAAPELDAQTNPVAAINARYPGMAAPPVRLLPTNLAPHAVGELYRGPDQLVIGQREEDLAPVILDLAANPLLMVFGDARSGKTTLLRHIIRTVREHSTADRVAFTVLDRRLHLVDEPLFPDNEYTANIDRIIPAMLGLANLIEARRPPAGMSAAELSRWTFAGHTHYLIIDDVDQVPDSPAMTGPYIGQRPWTPLIGLLAQAGDLGLRVIVTGRATGSAHLLMTSPLLRRFNDLQATTLMLAGNPADSGKIRGERFARLPAGRAILLTDSDSPTYVQLINPLVDAAAVSGETQQKGSQS,"145,170",1330,,growth [GO:0040007],ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WNX9,GABD1_MYCTU,Rv0234c,gabD1 Rv0234c,GO:0005886; GO:0006099; GO:0009013,IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; ,,gabD1,,Succinate-semialdehyde dehydrogenase [NADP(+)] 1 (SSADH 1) (SSDH 1) (EC 1.2.1.79),plasma membrane [GO:0005886]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; tricarboxylic acid cycle [GO:0006099],9634230; 16027371; 21969609,,"FUNCTION: Catalyzes the NADP(+)-dependent oxidation of succinate semialdehyde to succinate. It is believed to be the main source of succinate semialdehyde dehydrogenase activity in Mycobacterium. NAD(+) can substitute for NADP(+), but enzymatic activity is three times reduced. {ECO:0000269|PubMed:16027371}.",MPIATINPATGETVKTFTAATDDEVDAAIARAHRRFADYRQTSFAQRARWANATADLLEAEADQAAAMMTLEMGKTLAAAKAEALKCAKGFRYYAENAEALLADEPADAAKVGASAAYGRYQPLGVILAVMPWNFPLWQAVRFAAPALMAGNVGLLKHASNVPQCALYLADVIARGGFPDGCFQTLLVSSGAVEAILRDPRVAAATLTGSEPAGQSVGAIAGNEIKPTVLELGGSDPFIVMPSADLDAAVSTAVTGRVQNNGQSCIAAKRFIVHADIYDDFVDKFVARMAALRVGDPTDPDTDVGPLATEQGRNEVAKQVEDAAAAGAVIRCGGKRLDRPGWFYPPTVITDISKDMALYTEEVFGPVASVFRAANIDEAVEIANATTFGLGSNAWTRDETEQRRFIDDIVAGQVFINGMTVSYPELPFGGVKRSGYGRELSAHGIREFCNIKTVWIA,"48,545",457,Aldehyde dehydrogenase family,tricarboxylic acid cycle [GO:0006099],succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013],plasma membrane [GO:0005886],,,1
P9WPD1,CLPB_MYCTU,Rv0384c,clpB Rv0384c MTV036.19c,GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0009408; GO:0019538; GO:0040007; GO:0042026,IPR003593; IPR003959; IPR017730; IPR019489; IPR004176; IPR036628; IPR001270; IPR018368; IPR028299; IPR027417; ,,clpB,,Chaperone protein ClpB,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth [GO:0040007]; protein metabolic process [GO:0019538]; protein refolding [GO:0042026]; response to heat [GO:0009408],9634230; 11567012; 21969609,,"FUNCTION: Part of a stress-induced multi-chaperone system, it is involved in the recovery of the cell from heat-induced damage, in cooperation with DnaK, DnaJ and GrpE. Acts before DnaK, in the processing of protein aggregates. Protein binding stimulates the ATPase activity; ATP hydrolysis unfolds the denatured protein aggregates, which probably helps expose new hydrophobic binding sites on the surface of ClpB-bound aggregates, contributing to the solubilization and refolding of denatured protein aggregates by DnaK (By similarity). {ECO:0000250}.",MDSFNPTTKTQAALTAALQAASTAGNPEIRPAHLLMALLTQNDGIAAPLLEAVGVEPATVRAETQRLLDRLPQATGASTQPQLSRESLAAITTAQQLATELDDEYVSTEHVMVGLATGDSDVAKLLTGHGASPQALREAFVKVRGSARVTSPEPEATYQALQKYSTDLTARAREGKLDPVIGRDNEIRRVVQVLSRRTKNNPVLIGEPGVGKTAIVEGLAQRIVAGDVPESLRDKTIVALDLGSMVAGSKYRGEFEERLKAVLDDIKNSAGQIITFIDELHTIVGAGATGEGAMDAGNMIKPMLARGELRLVGATTLDEYRKHIEKDAALERRFQQVYVGEPSVEDTIGILRGLKDRYEVHHGVRITDSALVAAATLSDRYITARFLPDKAIDLVDEAASRLRMEIDSRPVEIDEVERLVRRLEIEEMALSKEEDEASAERLAKLRSELADQKEKLAELTTRWQNEKNAIEIVRDLKEQLEALRGESERAERDGDLAKAAELRYGRIPEVEKKLDAALPQAQAREQVMLKEEVGPDDIADVVSAWTGIPAGRLLEGETAKLLRMEDELGKRVIGQKAAVTAVSDAVRRSRAGVSDPNRPTGAFMFLGPTGVGKTELAKALADFLFDDERAMVRIDMSEYGEKHTVARLIGAPPGYVGYEAGGQLTEAVRRRPYTVVLFDEIEKAHPDVFDVLLQVLDEGRLTDGHGRTVDFRNTILILTSNLGSGGSAEQVLAAVRATFKPEFINRLDDVLIFEGLNPEELVRIVDIQLAQLGKRLAQRRLQLQVSLPAKRWLAQRGFDPVYGARPLRRLVQQAIGDQLAKMLLAGQVHDGDTVPVNVSPDADSLILG,"92,568",848,ClpA/ClpB family,growth [GO:0040007]; protein metabolic process [GO:0019538]; protein refolding [GO:0042026]; response to heat [GO:0009408],ATP binding [GO:0005524],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV036.19c,1
P9WMA9,DATIN_MYCTU,Rv0079,Rv0079,GO:0005618; GO:0005886; GO:0009405; GO:0022627; GO:0043022; GO:0043024; GO:0045900,IPR032528; IPR038416; ,,,,Dormancy associated translation inhibitor (DATIN),cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; negative regulation of translational elongation [GO:0045900]; pathogenesis [GO:0009405],9634230; 11416222; 12953092; 18474359; 18400743; 19795912; 21969609; 22719925; 23819907,,"FUNCTION: Involved in translation regulation (PubMed:19795912, PubMed:22719925). Inhibits protein synthesis and decreases bacterial growth when expressed in E.coli (PubMed:22719925). Can also stimulate macrophages and peripheral blood mononuclear cells (PBMC) to secrete important cytokines that may be significant in granuloma formation and its maintenance. Increases secretion of IFN-gamma, TNF-alpha, IL-1 beta and IL-8 through human Toll-like receptor 2 (TLR2) signaling pathway (PubMed:23819907). {ECO:0000269|PubMed:22719925, ECO:0000269|PubMed:23819907, ECO:0000305|PubMed:19795912}.",MEPKRSRLVVCAPEPSHAREFPDVAVFSGGRANASQAERLARAVGRVLADRGVTGGARVRLTMANCADGPTLVQINLQVGDTPLRAQAATAGIDDLRPALIRLDRQIVRASAQWCPRPWPDRPRRRLTTPAEALVTRRKPVVLRRATPLQAIAAMDAMDYDVHLFTDAETGEDAVVYRAGPSGLRLARQHHVFPPGWSRCRAPAGPPVPLIVNSRPTPVLTEAAAVDRAREHGLPFLFFTDQATGRGQLLYSRYDGNLGLITPTGDGVADGLA,"29,507",273,,negative regulation of translational elongation [GO:0045900]; pathogenesis [GO:0009405],ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022],cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,,1
P9WP17,DCDB_MYCTU,Rv0321,dcd Rv0321 MTCY63.26,GO:0004170; GO:0006226; GO:0006229; GO:0008829; GO:0033973,IPR011962; IPR029054; IPR036157; IPR033704; ,,dcd,,"dCTP deaminase, dUMP-forming (EC 3.5.4.30) (Bifunctional dCTP deaminase:dUTPase) (DCD-DUT)",dCTP deaminase (dUMP-forming) activity [GO:0033973]; dCTP deaminase activity [GO:0008829]; dUTP diphosphatase activity [GO:0004170]; dUMP biosynthetic process [GO:0006226]; dUTP biosynthetic process [GO:0006229],9634230; 21969609; 18164314; ,X-ray crystallography (3),FUNCTION: Bifunctional enzyme that catalyzes both the deamination of dCTP to dUTP and the hydrolysis of dUTP to dUMP without releasing the toxic dUTP intermediate. It also acts as a dUTP diphosphatase. Affinity for dCTP and dUTP are very similar. {ECO:0000269|PubMed:18164314}.,MLLSDRDLRAEISSGRLGIDPFDDTLVQPSSIDVRLDCLFRVFNNTRYTHIDPAKQQDELTSLVQPVDGEPFVLHPGEFVLGSTLELFTLPDNLAGRLEGKSSLGRLGLLTHSTAGFIDPGFSGHITLELSNVANLPITLWPGMKIGQLCMLRLTSPSEHPYGSSRAGSKYQGQRGPTPSRSYQNFIRST,"20,870",190,DCTP deaminase family,dUMP biosynthetic process [GO:0006226]; dUTP biosynthetic process [GO:0006229],dCTP deaminase (dUMP-forming) activity [GO:0033973]; dCTP deaminase activity [GO:0008829]; dUTP diphosphatase activity [GO:0004170],,,MTCY63.26,1
P9WNV9,DNAJ1_MYCTU,Rv0352,dnaJ1 Rv0352 MTCY13E10.12,GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006260; GO:0006457; GO:0009408; GO:0010468; GO:0031072; GO:0040007; GO:0046872; GO:0051082; GO:2000679,IPR012724; IPR002939; IPR001623; IPR018253; IPR008971; IPR001305; IPR036410; IPR036869; ,,dnaJ1,DOMAIN 10 75 J. {ECO:0000255|HAMAP-Rule:MF_01152}.,Chaperone protein DnaJ 1,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; DNA replication [GO:0006260]; growth [GO:0040007]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408],3126487; 17640840; 9634230; 19099550; 21969609,,"FUNCTION: Participates actively in the response to hyperosmotic and heat shock by preventing the aggregation of stress-denatured proteins and by disaggregating proteins, also in an autonomous, DnaK-independent fashion. Unfolded proteins bind initially to DnaJ; upon interaction with the DnaJ-bound protein, DnaK hydrolyzes its bound ATP, resulting in the formation of a stable complex. GrpE releases ADP from DnaK; ATP binding to DnaK triggers the release of the substrate protein, thus completing the reaction cycle. Several rounds of ATP-dependent interactions between DnaJ, DnaK and GrpE are required for fully efficient folding. Also involved, together with DnaK and GrpE, in the DNA replication of plasmids through activation of initiation proteins. {ECO:0000255|HAMAP-Rule:MF_01152}.",MAQREWVEKDFYQELGVSSDASPEEIKRAYRKLARDLHPDANPGNPAAGERFKAVSEAHNVLSDPAKRKEYDETRRLFAGGGFGGRRFDSGFGGGFGGFGVGGDGAEFNLNDLFDAASRTGGTTIGDLFGGLFGRGGSARPSRPRRGNDLETETELDFVEAAKGVAMPLRLTSPAPCTNCHGSGARPGTSPKVCPTCNGSGVINRNQGAFGFSEPCTDCRGSGSIIEHPCEECKGTGVTTRTRTINVRIPPGVEDGQRIRLAGQGEAGLRGAPSGDLYVTVHVRPDKIFGRDGDDLTVTVPVSFTELALGSTLSVPTLDGTVGVRVPKGTADGRILRVRGRGVPKRSGGSGDLLVTVKVAVPPNLAGAAQEALEAYAAAERSSGFNPRAGWAGNR,"41,345",395,DnaJ family,DNA replication [GO:0006260]; growth [GO:0040007]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein folding [GO:0006457]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY13E10.12,1
P9WG47,GYRA_MYCTU,Rv0006,gyrA Rv0006 MTCY10H4.04,GO:0000287; GO:0003677; GO:0003918; GO:0005524; GO:0005618; GO:0005694; GO:0005737; GO:0005886; GO:0006265; GO:0016887; GO:0034335; GO:0046677,IPR005743; IPR006691; IPR035516; IPR013760; IPR002205; IPR013758; IPR013757; ,,gyrA,DOMAIN 504 516 EF-hand. {ECO:0000305|PubMed:22844097}.,DNA gyrase subunit A (EC 5.99.1.3) (Type IIA topoisomerase subunit GyrA),cell wall [GO:0005618]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA supercoiling activity [GO:0034335]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; DNA topological change [GO:0006265]; response to antibiotic [GO:0046677],8031045; 22972833; 9634230; 8294019; 8035042; 15047530; 16377674; 16876125; 17015625; 18426901; 19060136; 21969609; 22844097; 23268609; 24126580; 19787774; 20805881; 22457352; 23869946,X-ray crystallography (13),"FUNCTION: A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to maintain chromosomes in an underwound state, while in the absence of ATP it relaxes supercoiled dsDNA (PubMed:15047530, PubMed:16377674, PubMed:16876125, PubMed:17015625, PubMed:18426901, PubMed:19060136, PubMed:22844097, PubMed:20805881). Also catalyzes the interconversion of other topological isomers of dsDNA rings, including catenanes (PubMed:16876125, PubMed:19060136, PubMed:22457352). Gyrase from M.tuberculosis has higher decatenation than supercoiling activity compared to E.coli; as M.tuberculosis only has 1 type II topoisomerase, gyrase has to fulfill the decatenation function of topoisomerase IV as well (PubMed:16876125, PubMed:22457352, PubMed:23869946). At comparable concentrations M.tuberculosis gyrase cannot introduce as many negative supercoils into DNA as the E.coli enzyme, and its ATPase activity is lower, perhaps because it does not couple DNA wrapping and ATP binding as well as E.coli (PubMed:22457352). {ECO:0000269|PubMed:15047530, ECO:0000269|PubMed:16377674, ECO:0000269|PubMed:16876125, ECO:0000269|PubMed:17015625, ECO:0000269|PubMed:18426901, ECO:0000269|PubMed:19060136, ECO:0000269|PubMed:20805881, ECO:0000269|PubMed:22457352, ECO:0000269|PubMed:22844097, ECO:0000269|PubMed:23869946}.; FUNCTION: Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Type II topoisomerases break and join 2 DNA strands simultaneously in an ATP-dependent manner.",MTDTTLPPDDSLDRIEPVDIEQEMQRSYIDYAMSVIVGRALPEVRDGLKPVHRRVLYAMFDSGFRPDRSHAKSARSVAETMGNYHPHGDASIYDSLVRMAQPWSLRYPLVDGQGNFGSPGNDPPAAMRYTEARLTPLAMEMLREIDEETVDFIPNYDGRVQEPTVLPSRFPNLLANGSGGIAVGMATNIPPHNLRELADAVFWALENHDADEEETLAAVMGRVKGPDFPTAGLIVGSQGTADAYKTGRGSIRMRGVVEVEEDSRGRTSLVITELPYQVNHDNFITSIAEQVRDGKLAGISNIEDQSSDRVGLRIVIEIKRDAVAKVVINNLYKHTQLQTSFGANMLAIVDGVPRTLRLDQLIRYYVDHQLDVIVRRTTYRLRKANERAHILRGLVKALDALDEVIALIRASETVDIARAGLIELLDIDEIQAQAILDMQLRRLAALERQRIIDDLAKIEAEIADLEDILAKPERQRGIVRDELAEIVDRHGDDRRTRIIAADGDVSDEDLIAREDVVVTITETGYAKRTKTDLYRSQKRGGKGVQGAGLKQDDIVAHFFVCSTHDLILFFTTQGRVYRAKAYDLPEASRTARGQHVANLLAFQPEERIAQVIQIRGYTDAPYLVLATRNGLVKKSKLTDFDSNRSGGIVAVNLRDNDELVGAVLCSAGDDLLLVSANGQSIRFSATDEALRPMGRATSGVQGMRFNIDDRLLSLNVVREGTYLLVATSGGYAKRTAIEEYPVQGRGGKGVLTVMYDRRRGRLVGALIVDDDSELYAVTSGGGVIRTAARQVRKAGRQTKGVRLMNLGEGDTLLAIARNAEESGDDNAVDANGADQTGN,"92,274",838,Type II topoisomerase GyrA/ParC subunit family,DNA topological change [GO:0006265]; response to antibiotic [GO:0046677],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA supercoiling activity [GO:0034335]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY10H4.04,1
P9WMT5,GRPE_MYCTU,Rv0351,grpE Rv0351 MTCY13E10.11,GO:0000774; GO:0005618; GO:0005737; GO:0006457; GO:0009267; GO:0040007; GO:0042803; GO:0051082; GO:0051087,IPR000740; IPR013805; IPR009012; ,,grpE,,Protein GrpE (HSP-70 cofactor),cell wall [GO:0005618]; cytoplasm [GO:0005737]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to starvation [GO:0009267]; growth [GO:0040007]; protein folding [GO:0006457],9634230; 19099550; 21969609,,"FUNCTION: Participates actively in the response to hyperosmotic and heat shock by preventing the aggregation of stress-denatured proteins, in association with DnaK and GrpE. It is the nucleotide exchange factor for DnaK and may function as a thermosensor. Unfolded proteins bind initially to DnaJ; upon interaction with the DnaJ-bound protein, DnaK hydrolyzes its bound ATP, resulting in the formation of a stable complex. GrpE releases ADP from DnaK; ATP binding to DnaK triggers the release of the substrate protein, thus completing the reaction cycle. Several rounds of ATP-dependent interactions between DnaJ, DnaK and GrpE are required for fully efficient folding. {ECO:0000255|HAMAP-Rule:MF_01151}.",MTDGNQKPDGNSGEQVTVTDKRRIDPETGEVRHVPPGDMPGGTAAADAAHTEDKVAELTADLQRVQADFANYRKRALRDQQAAADRAKASVVSQLLGVLDDLERARKHGDLESGPLKSVADKLDSALTGLGLVAFGAEGEDFDPVLHEAVQHEGDGGQGSKPVIGTVMRQGYQLGEQVLRHALVGVVDTVVVDAAELESVDDGTAVADTAENDQADQGNSADTSGEQAESEPSGS,"24,533",235,GrpE family,cellular response to starvation [GO:0009267]; growth [GO:0040007]; protein folding [GO:0006457],adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY13E10.11,1
P9WG45,GYRB_MYCTU,Rv0005,gyrB Rv0005 MTCY10H4.03,GO:0000287; GO:0003677; GO:0003918; GO:0005524; GO:0005618; GO:0005694; GO:0005737; GO:0005886; GO:0006265; GO:0007059; GO:0009295; GO:0034335; GO:0040007; GO:0046677,IPR002288; IPR011557; IPR003594; IPR036890; IPR020568; IPR014721; IPR001241; IPR013760; IPR013759; IPR013506; IPR018522; IPR006171; IPR034160; ,,gyrB,DOMAIN 453 567 Toprim. {ECO:0000255|HAMAP-Rule:MF_01898}.,DNA gyrase subunit B (EC 5.99.1.3),cell wall [GO:0005618]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoid [GO:0009295]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA supercoiling activity [GO:0034335]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]; growth [GO:0040007]; response to antibiotic [GO:0046677],8031045; 9634230; 15047530; 16377674; 16876125; 18426901; 19060136; 21969609; 22457352; 22844097; 23268609; 23869946; 24126580; 19596812; 20805881; 24015710,X-ray crystallography (15),"FUNCTION: A type II topoisomerase that negatively supercoils closed circular double-stranded (ds) DNA in an ATP-dependent manner to maintain chromosomes in an underwound state, while in the absence of ATP it relaxes supercoiled dsDNA (PubMed:15047530. PubMed:16876125, PubMed:19060136, PubMed:16377674, PubMed:18426901, PubMed:22844097, PubMed:19596812, PubMed:20805881). Also catalyzes the interconversion of other topological isomers of dsDNA rings, including catenanes (PubMed:16876125, PubMed:19060136, PubMed:22457352). Gyrase from M.tuberculosis has higher decatenation than supercoiling activity compared to E.coli; as M.tuberculosis only has 1 type II topoisomerase, gyrase has to fulfill the decatenation function of topoisomerase IV as well (PubMed:16876125, PubMed:22457352, PubMed:23869946). At comparable concentrations M.tuberculosis gyrase cannot introduce as many negative supercoils into DNA as the E.coli enzyme, and its ATPase activity is lower, perhaps because it does not couple DNA wrapping and ATP binding as well as E.coli (PubMed:22457352, PubMed:24015710). {ECO:0000269|PubMed:15047530, ECO:0000269|PubMed:16377674, ECO:0000269|PubMed:16876125, ECO:0000269|PubMed:18426901, ECO:0000269|PubMed:19060136, ECO:0000269|PubMed:19596812, ECO:0000269|PubMed:20805881, ECO:0000269|PubMed:22457352, ECO:0000269|PubMed:22844097, ECO:0000269|PubMed:23869946, ECO:0000269|PubMed:24015710}.; FUNCTION: Negative supercoiling favors strand separation, and DNA replication, transcription, recombination and repair, all of which involve strand separation. Type II topoisomerases break and join 2 DNA strands simultaneously in an ATP-dependent manner.",MAAQKKKAQDEYGAASITILEGLEAVRKRPGMYIGSTGERGLHHLIWEVVDNAVDEAMAGYATTVNVVLLEDGGVEVADDGRGIPVATHASGIPTVDVVMTQLHAGGKFDSDAYAISGGLHGVGVSVVNALSTRLEVEIKRDGYEWSQVYEKSEPLGLKQGAPTKKTGSTVRFWADPAVFETTEYDFETVARRLQEMAFLNKGLTINLTDERVTQDEVVDEVVSDVAEAPKSASERAAESTAPHKVKSRTFHYPGGLVDFVKHINRTKNAIHSSIVDFSGKGTGHEVEIAMQWNAGYSESVHTFANTINTHEGGTHEEGFRSALTSVVNKYAKDRKLLKDKDPNLTGDDIREGLAAVISVKVSEPQFEGQTKTKLGNTEVKSFVQKVCNEQLTHWFEANPTDAKVVVNKAVSSAQARIAARKARELVRRKSATDIGGLPGKLADCRSTDPRKSELYVVEGDSAGGSAKSGRDSMFQAILPLRGKIINVEKARIDRVLKNTEVQAIITALGTGIHDEFDIGKLRYHKIVLMADADVDGQHISTLLLTLLFRFMRPLIENGHVFLAQPPLYKLKWQRSDPEFAYSDRERDGLLEAGLKAGKKINKEDGIQRYKGLGEMDAKELWETTMDPSVRVLRQVTLDDAAAADELFSILMGEDVDARRSFITRNAKDVRFLDV,"74,091",675,Type II topoisomerase GyrB family,chromosome segregation [GO:0007059]; DNA topological change [GO:0006265]; growth [GO:0040007]; response to antibiotic [GO:0046677],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA supercoiling activity [GO:0034335]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoid [GO:0009295]; plasma membrane [GO:0005886],,MTCY10H4.03,1
P9WQ85,BIOF2_MYCTU,Rv0032,bioF2 Rv0032,GO:0005618; GO:0008710; GO:0009058; GO:0030170,IPR016181; IPR001917; IPR004839; IPR038740; IPR015424; IPR015422; IPR015421; ,,bioF2,,Putative 8-amino-7-oxononanoate synthase 2 (AONS) (EC 2.3.1.47) (7-keto-8-amino-pelargonic acid synthase) (7-KAP synthase) (KAPA synthase) (8-amino-7-ketopelargonate synthase),cell wall [GO:0005618]; 8-amino-7-oxononanoate synthase activity [GO:0008710]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],9634230; 21969609,,"FUNCTION: Catalyzes the decarboxylative condensation of pimeloyl-[acyl-carrier protein] and L-alanine to produce 8-amino-7-oxononanoate (AON), [acyl-carrier protein], and carbon dioxide. {ECO:0000250}.",MPTGLGYDFLRPVEDSGINDLKHYYFMADLADGQPLGRANLYSVCFDLATTDRKLTPAWRTTIKRWFPGFMTFRFLECGLLTMVSNPLALRSDTDLERVLPVLAGQMDQLAHDDGSDFLMIRDVDPEHYQRYLDILRPLGFRPALGFSRVDTTISWSSVEEALGCLSHKRRLPLKTSLEFRERFGIEVEELDEYAEHAPVLARLWRNVKTEAKDYQREDLNPEFFAACSRHLHGRSRLWLFRYQGTPIAFFLNVWGADENYILLEWGIDRDFEHYRKANLYRAALMLSLKDAISRDKRRMEMGITNYFTKLRIPGARVIPTIYFLRHSTDPVHTATLARMMMHNIQRPTLPDDMSEEFCRWEERIRLDQDGLPEHDIFRKIDRQHKYTGLKLGGVYGFYPRFTGPQRSTVKAAELGEIVLLGTNSYLGLATHPEVVEASAEATRRYGTGCSGSPLLNGTLDLHVSLEQELACFLGKPAAVLCSTGYQSNLAAISALCESGDMIIQDALNHRSLFDAARLSGADFTLYRHNDMDHLARVLRRTEGRRRIIVVDAVFSMEGTVADLATIAELADRHGCRVYVDESHALGVLGPDGRGASAALGVLARMDVVMGTFSKSFASVGGFIAGDRPVVDYIRHNGSGHVFSASLPPAAAAATHAALRVSRREPDRRARVLAAAEYMATGLARQGYQAEYHGTAIVPVILGNPTVAHAGYLRLMRSGVYVNPVAPPAVPEERSGFRTSYLADHRQSDLDRALHVFAGLAEDLTPQGAAL,"86,243",771,"Class-II pyridoxal-phosphate-dependent aminotransferase family, BioF subfamily",biosynthetic process [GO:0009058],8-amino-7-oxononanoate synthase activity [GO:0008710]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618],,,1
P9WPN1,C135A_MYCTU,Rv0327c,cyp135A1 Rv0327c MTCY63.32c,GO:0004497; GO:0005506; GO:0005618; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002401; IPR036396; ,,cyp135A1,,Putative cytochrome P450 135A1 (EC 1.14.-.-),"cell wall [GO:0005618]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MASTLTTGLPPGPRLPRYLQSVLYLRFREWFLPAMHRKYGDVFSLRVPPYADNLVVYTRPEHIKEIFAADPRSLHAGEGNHILGFVMGEHSVLMTDEAEHARMRSLLMPAFTRAALRGYRDMIASVAREHITRWRPHATINSLDHMNALTLDIILRVVFGVTDPKVKAELTSRLQQIINIHPAILAGVPYPSLKRMNPWKRFFHNQTKIDEILYREIASRRIDSDLTARTDVLSRLLQTKDTPTKPLTDAELRDQLITLLLAGHETTAAALSWTLWELAHAPEIQSQVVWAAVGGDDGFLEAVLKEGMRRHTVIASTARKVTAPAEIGGWRLPAGTVVNTSILLAHASEVSHPKPTEFRPSRFLDGSVAPNTWLPFGGGVRRCLGFGFALTEGAVILQEIFRRFTITAAGPSKGETPLVRNITTVPKHGAHLRLIPQRRLGGLGDSDPP,"50,011",449,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618],,MTCY63.32c,1
P9WQN9,A85C_MYCTU,Rv0129c,fbpC mpt45 Rv0129c MTCI5.03c,GO:0004144; GO:0005576; GO:0005618; GO:0006869; GO:0009247; GO:0016747; GO:0035375; GO:0046677; GO:0050348; GO:0071769,IPR029058; IPR000801; ,,fbpC,,Diacylglycerol acyltransferase/mycolyltransferase Ag85C (DGAT) (EC 2.3.1.122) (EC 2.3.1.20) (Acyl-CoA:diacylglycerol acyltransferase) (Antigen 85 complex C) (85C) (Ag85C) (Fibronectin-binding protein C) (Fbps C),"cell wall [GO:0005618]; extracellular region [GO:0005576]; diacylglycerol O-acyltransferase activity [GO:0004144]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]; glycolipid biosynthetic process [GO:0009247]; lipid transport [GO:0006869]; mycolate cell wall layer assembly [GO:0071769]; response to antibiotic [GO:0046677]",1715324; 9634230; 2403534; 1830294; 9162010; 10200974; 19099550; 21969609; 10655617; 15192106; 19668859,X-ray crystallography (16),"FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria to fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. {ECO:0000269|PubMed:1830294, ECO:0000269|PubMed:9162010}.",MTFFEQVRRLRSAATTLPRRLAIAAMGAVLVYGLVGTFGGPATAGAFSRPGLPVEYLQVPSASMGRDIKVQFQGGGPHAVYLLDGLRAQDDYNGWDINTPAFEEYYQSGLSVIMPVGGQSSFYTDWYQPSQSNGQNYTYKWETFLTREMPAWLQANKGVSPTGNAAVGLSMSGGSALILAAYYPQQFPYAASLSGFLNPSEGWWPTLIGLAMNDSGGYNANSMWGPSSDPAWKRNDPMVQIPRLVANNTRIWVYCGNGTPSDLGGDNIPAKFLEGLTLRTNQTFRDTYAADGGRNGVFNFPPNGTHSWPYWNEQLVAMKADIQHVLNGATPPAAPAAPAA,"36,771",340,Mycobacterial A85 antigen family,glycolipid biosynthetic process [GO:0009247]; lipid transport [GO:0006869]; mycolate cell wall layer assembly [GO:0071769]; response to antibiotic [GO:0046677],"diacylglycerol O-acyltransferase activity [GO:0004144]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]",cell wall [GO:0005618]; extracellular region [GO:0005576],mpt45,MTCI5.03c,1
P9WQG9,AAC2_MYCTU,Rv0262c,aac Rv0262c MTCY06A4.06c,GO:0005886; GO:0030649; GO:0034069; GO:0046677; GO:0047921,IPR016181; IPR000182; ,,aac,DOMAIN 11 162 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,Aminoglycoside 2'-N-acetyltransferase (EC 2.3.1.-) (AAC(2')-Ic),plasma membrane [GO:0005886]; aminoglycoside 2'-N-acetyltransferase activity [GO:0047921]; aminoglycoside N-acetyltransferase activity [GO:0034069]; aminoglycoside antibiotic catabolic process [GO:0030649]; response to antibiotic [GO:0046677],9159528; 9634230; 21969609; 12161746,X-ray crystallography (4),"FUNCTION: May catalyze the coenzyme A-dependent acetylation of the 2' hydroxyl or amino group of a broad spectrum of aminoglycosides and confer resistance to aminoglycosides (By similarity). In vitro assays show no significant increase of resistance to aminoglycosides, possibly due to low expression in a heterologous system (PubMed:9159528). {ECO:0000250|UniProtKB:P94968, ECO:0000269|PubMed:9159528}.",MHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIAHAAVIQRRLIYRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSARARRLYASRGWLPWHGPTSVLAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDVW,"20,038",181,AAC(2')-I acetyltransferase family,aminoglycoside antibiotic catabolic process [GO:0030649]; response to antibiotic [GO:0046677],aminoglycoside 2'-N-acetyltransferase activity [GO:0047921]; aminoglycoside N-acetyltransferase activity [GO:0034069],plasma membrane [GO:0005886],,MTCY06A4.06c,1
P9WQ91,AAT_MYCTU,Rv0337c,aspC Rv0337c MTCY279.04c,GO:0004069; GO:0005737; GO:0005886; GO:0009058; GO:0030170; GO:0040007,IPR004839; IPR015424; IPR015422; IPR015421; ,,aspC,,Probable aspartate aminotransferase (AspAT) (EC 2.6.1.1) (Transaminase A),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; growth [GO:0040007],9634230; 21969609,,,MDNDGTIVDVTTHQLPWHTASHQRQRAFAQSAKLQDVLYEIRGPVHQHAARLEAEGHRILKLNIGNPAPFGFEAPDVIMRDIIQALPYAQGYSDSQGILSARRAVVTRYELVPGFPRFDVDDVYLGNGVSELITMTLQALLDNGDQVLIPSPDYPLWTASTSLAGGTPVHYLCDETQGWQPDIADLESKITERTKALVVINPNNPTGAVYSCEILTQMVDLARKHQLLLLADEIYDKILYDDAKHISLASIAPDMLCLTFNGLSKAYRVAGYRAGWLAITGPKEHASSFIEGIGLLANMRLCPNVPAQHAIQVALGGHQSIEDLVLPGGRLLEQRDIAWTKLNEIPGVSCVKPAGALYAFPRLDPEVYDIDDDEQLVLDLLLSEKILVTQGTGFNWPAPDHLRLVTLPWSRDLAAAIERLGNFLVSYRQ,"47,350",429,Class-I pyridoxal-phosphate-dependent aminotransferase family,biosynthetic process [GO:0009058]; growth [GO:0040007],L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY279.04c,1
P9WQA3,ALF_MYCTU,Rv0363c,fba Rv0363c MTCY13E10.25c,GO:0004332; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0008270; GO:0035375,IPR013785; IPR000771; IPR006411; ,,fba,,"Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase)",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; zymogen binding [GO:0035375]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],9634230; 19099550; 21969609,X-ray crystallography (8),"FUNCTION: Catalyzes the aldol condensation of dihydroxyacetone phosphate (DHAP or glycerone-phosphate) with glyceraldehyde 3-phosphate (G3P) to form fructose 1,6-bisphosphate (FBP) in gluconeogenesis and the reverse reaction in glycolysis. {ECO:0000250}.",MPIATPEVYAEMLGQAKQNSYAFPAINCTSSETVNAAIKGFADAGSDGIIQFSTGGAEFGSGLGVKDMVTGAVALAEFTHVIAAKYPVNVALHTDHCPKDKLDSYVRPLLAISAQRVSKGGNPLFQSHMWDGSAVPIDENLAIAQELLKAAAAAKIILEIEIGVVGGEEDGVANEINEKLYTSPEDFEKTIEALGAGEHGKYLLAATFGNVHGVYKPGNVKLRPDILAQGQQVAAAKLGLPADAKPFDFVFHGGSGSLKSEIEEALRYGVVKMNVDTDTQYAFTRPIAGHMFTNYDGVLKVDGEVGVKKVYDPRSYLKKAEASMSQRVVQACNDLHCAGKSLTH,"36,544",344,Class II fructose-bisphosphate aldolase family,gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],fructose-bisphosphate aldolase activity [GO:0004332]; zinc ion binding [GO:0008270]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY13E10.25c,1
P96419,AFTD_MYCTU,Rv0236c,aftD Rv0236c,GO:0005886; GO:0016021; GO:0016740; GO:0040007; GO:0045227,IPR021798; IPR000421; IPR008979; ,,aftD,DOMAIN 700 883 F5/8 type C. {ECO:0000255|PROSITE-ProRule:PRU00081}.,Alpha-(1->3)-arabinofuranosyltransferase (EC 2.4.2.47) (Arabinofuranan 3-O-arabinosyltransferase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; capsule polysaccharide biosynthetic process [GO:0045227]; growth [GO:0040007],9634230; 21969609,,"FUNCTION: Involved in the biosynthesis of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the addition of an arabinofuranosyl (Araf) residue from the sugar donor decaprenyl-phospho-arabinose (DPA) on the C-3 of an alpha-(1->5)-linked Araf from the arabinan backbone of AG. {ECO:0000250}.",MAPLSRKWLPVVGAVALALTFAQSPGQVSPDTKLDLTANPLRFLARATNLWNSDLPFGQAQNQAYGYLFPHGTFFVIGHLLGVPGWVTQRLWWAVLLTVGFWGLLRVAEALGVGGPSSRVVGAVAFALSPRVLTTLGSISSETLPMMLAPWVLLPTILALRGTSGRSVRALAAQAGLAVALMGAVNAIATLAGCLPAVIWWACHRPNRLWWRYTAWWLLAMALATLWWVMALTQLHGVSPPFLDFIESSGVTTQWSSLVEVLRGTDSWTPFVAPNATAGAPLVTGSAAILGTCLVAAAGLAGLTSPAMPARGRLVTMLLVGVVLLAVGHRGGLASPVAHPVQAFLDAAGTPLRNVHKVGPVIRLPLVLGLAQLLSRVPLPGSAPRPAWLRAFAHPERDKRVAVAVVALTALMVSTSLAWTGRVAPPGTFGALPQYWQEAADWLRTHHAATPTPGRVLVVPGAPFATQVWGTSHDEPLQVLGDGPWGVRDSIPLTPPQTIRALDSVQRLFAAGRPSAGLADTLARQGISYVLVRNDLDPETSRSARPILLHRSIAGSPGLAKLAEFGAPVGPDPLAGFVNDSGLRPRYPAIEIYRVSAPANPGAPYFAATDQLARVDGGPEVLLRLDERRRLQGQPPLGPVLMTADARAAGLPVPQVAVTDTPVARETDYGRVDHHSSAIRAPGDARHTYNRVPDYPVPGAEPVVGGWTGGRITVSSSSADATAMPDVAPASAPAAAVDGDPATAWVSNALQAAVGQWLQVDFDRPVTNAVVTLTPSATAVGAQVRRILIETVNGSTTLRFDEAGKPLTAALPYGETPWVRFTAAATDDGSAGVQFGITDLAITQYDASGFAHPVQLRHTVLVPGPPPGSAIAGWDLGSELLGRPGCAPGPDGVRCAASMALAPEEPANLSRTLTVPRPVSVTPMVWVRPRQGPKLADLIAAPSTTRASGDSDLVDILGSAYAAADGDPATAWTAPQRVVQHKTPPTLTLTLPRPTVVTGLRLAASRSMLPAHPTVVAINLGDGPQVRQLQVGELTTLWLHPRVTDTVSVSLLDWDDVIDRNALGFDQLKPPGLAEVVVLSAGGAPIAPADAARNRARALTVDCDHGPVVAVAGRFVHTSIRTTVGALLDGEPVAALPCEREPIALPAGQQELLISPGAAFVVDGAQLSTPGAGLSSATVTSAETGAWGPTHREVRVPESATSRVLVVPESINSGWVARTSTGARLTPIAVNGWQQAWVVPAGNPGTITLTFAPNSLYRASLAIGLALLPLLALLAFWRTGRRQLADRPTPPWRPGAWAAAGVLAAGAVIASIAGVMVMGTALGVRYALRRRERLRDRVTVGLAAGGLILAGAALSRHPWRSVDGYAGNWASVQLLALISVSVVAASVVATSESRGQDRMQ,"146,280",1400,,capsule polysaccharide biosynthetic process [GO:0045227]; growth [GO:0040007],transferase activity [GO:0016740],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
P9WPS5,CTPI_MYCTU,Rv0107c,ctpI Rv0107c MTCY251.26c,GO:0005388; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0043231; GO:0046872,IPR006068; IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR001757; ,,ctpI,,Probable cation-transporting ATPase I (EC 3.6.3.-),cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],9634230; 21969609,,,MKIPGVATVLGGVTNGVAQTVRAGARLPGSAAAAVQTLASPVLELTGPVVQSVVQTTGRAIGVRGSHNESPDGMTPPVRWRSGRRVHFDLDPLLPFPRWHEHAAMVEEPVRRIPGVAEAHVEGSLGRLVVELEPDADSDIAVDEVRDVVSAVAADIFLAGSVSSPNSAPFADPGNPLAILVPLTAAAMDLVAMGATVTGWVARLPAAPQTTRALAALINHQPRMVSLMESRLGRVGTDIALAATTAAANGLTQSLGTPLLDLVQRSLQISEAAAHRRVWRDREPALASPRRPQAPVVPIISSAGAKSQEPRHSWAAAAAGEASHVVVGGSIDAAIDTAKGSRAGPVEQYVNQAANGSLIAAASALVAGGGTEDAAGAILAGVPRAAHMGRQAFAAVLGRGLANTGQLVLDPGALRRLDRVRVVVIDGAALRGDNRAVLHAQGDEPGWDDDRVYEVADALLHGEQAPEPDPDELPATGARLRWAPAQGPSATPAQGLEHADLVVDGQCVGSVDVGWEVDPYAIPLLQTAHRTGARVVLRHVAGTEDLSASVGSTHPPGTPLLKLVRELRADRGPVLLITAVHRDFASTDTLAALAIADVGVALDDPRGATPWTADLITGTDLAAAVRILSALPVARAASESAVHLAQGGTTLAGLLLVTGEQDKTTNPASFRRWLNPVNAAAATALVSGMWSAAKVLRMPDPTPQPLTAWHALDPEIVYSRLAGGSRPLAVEPGIPAWRRILDDLSYEPVMAPLRGPARTLAQLAVATRHELADPLTPILAVGAAASAIVGSNIDALLVAGVMTVNAITGGVQRLRAEAAAAELFAEQDQLVRRVVVPAVATTRRRLEAARHATRTATVSAKSLRVGDVIDLAAPEVVPADARLLVAEDLEVDESFLTGESLPVDKQVDPVAVNDPDRASMLFEGSTIVAGHARAIVVATGVGTAAHRAISAVADVETAAGVQARLRELTSKVLPMTLAGGAAVTALALLRRASLRQAVADGVAIAVAAVPEGLPLVATLSQLAAAQRLTARGALVRSPRTIEALGRVDTICFDKTGTLTENRLRVVCALPSSTAAERDPLPQTTDAPSAEVLRAAARASTQPHNGEGHAHATDEAILAAASALAGSLSSQGDSEWVVLAEVPFESSRGYAAAIGRVGTDGIPMLMLKGAPETILPRCRLADPGVDHEHAESVVRHLAEQGLRVLAVAQRTWDNGTTHDDETDADAVDAVAHDLELIGYVGLADTARSSSRPLIEALLDAERNVVLITGDHPITARAIARQLGLPADARVVTGAELAVLDEEAHAKLAADMQVFARVSPEQKVQIVAALQRCGRVTAMVGDGANDAAAIRMADVGIGVSGRGSSAARGAADIVLTDDDLGVLLDALVEGRSMWAGVRDAVTILVGGNVGEVLFTVIGTAFGAGRAPVGTRQLLLVNLLTDMFPALAVAVTSQFAEPDDAEYPTDDAAERAQREHRRAVLIGPTPSLDAPLLRQIVNRGVVTAAGATAAWAIGRWTPGTERRTATMGLTALVMTQLAQTLLTRRHSPLVIATALGSAGVLVGIIQTPVISHFSGVPRWDRSPGRASSAPRQEPPQSQRWHRSGWQAQSVSCNLMNALTTRKTLTRVDRTYRRPR,"169,607",1632,Cation transport ATPase (P-type) (TC 3.A.3) family,,ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],,MTCY251.26c,1
P9WPU1,CTPA_MYCTU,Rv0092,ctpA Rv0092 MTCY251.11,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0006825; GO:0016021; GO:0019829; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR000579; IPR036412; IPR023214; IPR017969; IPR006121; IPR036163; IPR027256; IPR001757; ,,ctpA,DOMAIN 15 79 HMA. {ECO:0000255|PROSITE-ProRule:PRU00280}.,Copper-exporting P-type ATPase (EC 3.6.3.54) (Copper-exporting P-type ATPase A),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825],9634230; 21035536; 21969609; 25967101,,FUNCTION: Involved in copper export. Could be involved in the copper detoxification of mycobacterial cells. {ECO:0000269|PubMed:25967101}.,MTTAVTGEHHASVQRIQLRISGMSCSACAHRVESTLNKLPGVRAAVNFGTRVATIDTSEAVDAAALCQAVRRAGYQADLCTDDGRSASDPDADHARQLLIRLAIAAVLFVPVADLSVMFGVVPATRFTGWQWVLSALALPVVTWAAWPFHRVAMRNARHHAASMETLISVGITAATIWSLYTVFGNHSPIERSGIWQALLGSDAIYFEVAAGVTVFVLVGRYFEARAKSQAGSALRALAALSAKEVAVLLPDGSEMVIPADELKEQQRFVVRPGQIVAADGLAVDGSAAVDMSAMTGEAKPTRVRPGGQVIGGTTVLDGRLIVEAAAVGADTQFAGMVRLVEQAQAQKADAQRLADRISSVFVPAVLVIAALTAAGWLIAGGQPDRAVSAALAVLVIACPCALGLATPTAMMVASGRGAQLGIFLKGYKSLEATRAVDTVVFDKTGTLTTGRLQVSAVTAAPGWEADQVLALAATVEAASEHSVALAIAAATTRRDAVTDFRAIPGRGVSGTVSGRAVRVGKPSWIGSSSCHPNMRAARRHAESLGETAVFVEVDGEPCGVIAVADAVKDSARDAVAALADRGLRTMLLTGDNPESAAAVATRVGIDEVIADILPEGKVDVIEQLRDRGHVVAMVGDGINDGPALARADLGMAIGRGTDVAIGAADIILVRDHLDVVPLALDLARATMRTVKLNMVWAFGYNIAAIPVAAAGLLNPLVAGAAMAFSSFFVVSNSLRLRKFGRYPLGCGTVGGPQMTAPSSA,"78,851",761,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",copper ion transport [GO:0006825],ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.11,1
P9WP57,CRGA_MYCTU,Rv0011c,crgA Rv0011c MTCY10H4.11c,GO:0005886; GO:0007049; GO:0008360; GO:0016021; GO:0051301,IPR009619; ,P9WJF3; P9WN95,crgA,,Cell division protein CrgA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell shape [GO:0008360],9634230; 21531798; 23002219,NMR spectroscopy (1),"FUNCTION: Involved in cell division. Plays an important role in septal peptidoglycan synthesis and cell shape morphogenesis. May facilitate the recruitment of the peptidoglycan synthesis machinery to poles and septal zones and coordinate peptidoglycan synthesis at these sites. {ECO:0000255|HAMAP-Rule:MF_00631, ECO:0000269|PubMed:21531798, ECO:0000269|PubMed:23002219}.",MPKSKVRKKNDFTVSAVSRTPMKVKVGPSSVWFVSLFIGLMLIGLIWLMVFQLAAIGSQAPTALNWMAQLGPWNYAIAFAFMITGLLLTMRWH,"10,430",93,CrgA family,cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell shape [GO:0008360],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.11c,1
P9WP95,COBQ_MYCTU,Rv0255c,cobQ cbiP Rv0255c MTV034.21c,GO:0003824; GO:0006541; GO:0009236,IPR029062; IPR017929; IPR002586; IPR033949; IPR004459; IPR011698; IPR027417; ,,cobQ,DOMAIN 253 432 GATase cobBQ-type.,Cobyric acid synthase,catalytic activity [GO:0003824]; cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541],9634230; 21969609,,"FUNCTION: Catalyzes amidations at positions B, D, E, and G on adenosylcobyrinic A,C-diamide. NH(2) groups are provided by glutamine, and one molecule of ATP is hydrogenolyzed for each amidation (By similarity). {ECO:0000250}.",MSGLLVAGTTSDAGKSAVTAGLCRALARRGVRVAPFKAQNMSNNSMVCRGPDGTGVEIGRAQWVQALAARTTPEAAMNPVLLKPASDHRSHVVLMGKPWGEVASSSWCAGRRALAEAACRAFDALAARYDVVVAEGAGSPAEINLRAGDYVNMGLARHAGLPTIVVGDIDRGGVFAAFLGTVALLAAEDQALVAGFVVNKFRGDSDLLAPGLRDLERVTGRRVYGTLPWHPDLWLDSEDALDLQGRRAAGTGARRVAVVRLPRISNFTDVDALGLEPDLDVVFASDPRALDDADLIVLPGTRATIADLAWLRARDLDRALLVHVAAGKPLLGICGGFQMLGRVIRDPYGIEGPGGQVTEVEGLGLLDVETAFSPHKVLRLPRGEGLGVPASGYEIHHGRITRGDTAEEFLGGARDGPVFGTMWHGSLEGDALREAFLRETLGLAPSGSCFLAARERRLDLLGDLVERHLDVDALLNLARHGCPPTLPFLAPGAP,"52,135",494,"CobB/CobQ family, CobQ subfamily",cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541],catalytic activity [GO:0003824],,cbiP,MTV034.21c,1
P9WPT9,CTPB_MYCTU,Rv0103c,ctpB Rv0103c MTCY251.22c,GO:0005524; GO:0005829; GO:0005886; GO:0016021; GO:0019829; GO:0030001; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR000579; IPR036412; IPR023214; IPR017969; IPR006121; IPR036163; IPR027256; IPR001757; ,,ctpB,DOMAIN 16 79 HMA. {ECO:0000255|PROSITE-ProRule:PRU00280}.,Cation-transporting P-type ATPase B (EC 3.6.3.-),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872]; metal ion transport [GO:0030001],9634230; 21969609,,,MAAPVVGDADLQSVRRIRLDVLGMSCAACASRVETKLNKIPGVRASVNFATRVATIDAVGMAADELCGVVEKAGYHAAPHTETTVLDKRTKDPDGAHARRLLRRLLVAAVLFVPLADLSTLFAIVPSARVPGWGYILTALAAPVVTWAAWPFHSVALRNARHRTTSMETLISVGIVAATAWSLSSVFGDQPPREGSGIWRAILNSDSIYLEVAAGVTVFVLAGRYFEARAKSKAGSALRALAELGAKNVAVLLPDGAELVIPASELKKRQRFVTRPGETIAADGVVVDGSAAIDMSAMTGEAKPVRAYPAASVVGGTVVMDGRLVIEATAVGADTQFAAMVRLVEQAQTQKARAQRLADHIAGVFVPVVFVIAGLAGAAWLVSGAGADRAFSVTLGVLVIACPCALGLATPTAMMVASGRGAQLGIFIKGYRALETIRSIDTVVFDKTGTLTVGQLAVSTVTMAGSGTSERDREEVLGLAAAVESASEHAMAAAIVAASPDPGPVNGFVAVAGCGVSGEVGGHHVEVGKPSWITRTTPCHDAALVSARLDGESRGETVVFVSVDGVVRAALTIADTLKDSAAAAVAALRSRGLRTILLTGDNRAAADAVAAQVGIDSAVADMLPEGKVDVIQRLREEGHTVAMVGDGINDGPALVGADLGLAIGRGTDVALGAADIILVRDDLNTVPQALDLARATMRTIRMNMIWAFGYNVAAIPIAAAGLLNPLIAGAAMAFSSFFVVSNSLRLRNFGAQ,"77,509",752,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",metal ion transport [GO:0030001],ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY251.22c,1
P9WJF3,CWSA_MYCTU,Rv0008c,cwsA Rv0008c MTCY10H4.07c,GO:0005886; GO:0005887; GO:0007049; GO:0008360; GO:0051301,IPR024245; ,P9WP57,cwsA,,Cell wall synthesis protein CwsA (Cell wall synthesis and cell shape protein A),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell shape [GO:0008360],9634230; 21969609; 23002219,,"FUNCTION: Required for regulated cell division, cell wall synthesis and the maintenance of cell shape. {ECO:0000255|HAMAP-Rule:MF_00927, ECO:0000269|PubMed:23002219}.",MSEQVETRLTPRERLTRGLAYSAVGPVDVTRGLLELGVGLGLQSARSTAAGLRRRYREGRLAREVAAAQETLAQELTAAQDVVANLPQALQDARTQRRSKHHLWIFAGIAAAILAGGAVAFSIVRRSSRPEPSPRPPSVEVQPRS,"15,671",145,CwsA family,cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of cell shape [GO:0008360],,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY10H4.07c,1
P9WGG1,GMHA_MYCTU,Rv0113,gmhA lpcA Rv0113 MTV031.07,GO:0005737; GO:0005975; GO:0008968; GO:0046872; GO:0097367; GO:2001061,IPR035461; IPR004515; IPR001347; ,,gmhA,DOMAIN 38 196 SIS. {ECO:0000255|HAMAP-Rule:MF_00067}.,Phosphoheptose isomerase (EC 5.3.1.28) (Sedoheptulose 7-phosphate isomerase),cytoplasm [GO:0005737]; carbohydrate derivative binding [GO:0097367]; D-sedoheptulose 7-phosphate isomerase activity [GO:0008968]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]; D-glycero-D-manno-heptose 7-phosphate biosynthetic process [GO:2001061],9634230; 12101286,,FUNCTION: Catalyzes the isomerization of sedoheptulose 7-phosphate in D-glycero-D-manno-heptose 7-phosphate. {ECO:0000255|HAMAP-Rule:MF_00067}.,MCTARTAEEIFVETIAVKTRILNDRVLLEAARAIGDRLIAGYRAGARVFMCGNGGSAADAQHFAAELTGHLIFDRPPLGAEALHANSSHLTAVANDYDYDTVFARALEGSARPGDTLFAISTSGNSMSVLRAAKTARELGVTVVAMTGESGGQLAEFADFLINVPSRDTGRIQESHIVFIHAISEHVEHALFAPRQ,"20,923",196,"SIS family, GmhA subfamily",carbohydrate metabolic process [GO:0005975]; D-glycero-D-manno-heptose 7-phosphate biosynthetic process [GO:2001061],carbohydrate derivative binding [GO:0097367]; D-sedoheptulose 7-phosphate isomerase activity [GO:0008968]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],lpcA,MTV031.07,1
P9WGI7,GLYA2_MYCTU,Rv0070c,glyA2 Rv0070c MTV030.13c,GO:0004372; GO:0005737; GO:0005886; GO:0006544; GO:0006563; GO:0019264; GO:0030170; GO:0035999; GO:0042803,IPR015424; IPR015422; IPR015421; IPR001085; IPR019798; ,,glyA2,,Serine hydroxymethyltransferase 2 (SHM2) (SHMT 2) (Serine methylase 2) (EC 2.1.2.1),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glycine hydroxymethyltransferase activity [GO:0004372]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; tetrahydrofolate interconversion [GO:0035999],9634230; 12913008; 21969609,,"FUNCTION: Catalyzes the reversible interconversion of serine and glycine with tetrahydrofolate (THF) serving as the one-carbon carrier. This reaction serves as the major source of one-carbon groups required for the biosynthesis of purines, thymidylate, methionine, and other important biomolecules. Also exhibits THF-independent aldolase activity toward beta-hydroxyamino acids, producing glycine and aldehydes, via a retro-aldol mechanism. Thus, is able to catalyze the cleavage of L-allo-threonine. {ECO:0000269|PubMed:12913008}.",MNTLNDSLTAFDPDIAALIDGELRRQESGLEMIASENYAPLAVMQAQGSVLTNKYAEGYPGRRYYGGCEFVDGVEQLAIDRVKALFGAEYANVQPHSGATANAATMHALLNPGDTILGLSLAHGGHLTHGMRINFSGKLYHATAYEVSKEDYLVDMDAVAEAARTHRPKMIIAGWSAYPRQLDFARFRAIADEVDAVLMVDMAHFAGLVAAGVHPSPVPHAHVVTSTTHKTLGGPRGGIILCNDPAIAKKINSAVFPGQQGGPLEHVIAAKATAFKMAAQPEFAQRQQRCLDGARILAGRLTQPDVAERGIAVLTGGTDVHLVLVDLRDAELDGQQAEDRLAAVDITVNRNAVPFDPRPPMITSGLRIGTPALAARGFSHNDFRAVADLIAAALTATNDDQLGPLRAQVQRLAARYPLYPELHRT,"45,526",425,SHMT family,glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; tetrahydrofolate interconversion [GO:0035999],glycine hydroxymethyltransferase activity [GO:0004372]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV030.13c,1
P9WN99,FTSWL_MYCTU,Rv0017c,rodA Rv0017c MTCY10H4.17c,GO:0005886; GO:0007049; GO:0016021; GO:0051301; GO:0052556,IPR018365; IPR001182; ,,rodA,,Uncharacterized FtsW-like protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,,MTTRLQAPVAVTPPLPTRRNAELLLLCFAAVITFAALLVVQANQDQGVPWDLTSYGLAFLTLFGSAHLAIRRFAPYTDPLLLPVVALLNGLGLVMIHRLDLVDNEIGEHRHPSANQQMLWTLVGVAAFALVVTFLKDHRQLARYGYICGLAGLVFLAVPALLPAALSEQNGAKIWIRLPGFSIQPAEFSKILLLIFFSAVLVAKRGLFTSAGKHLLGMTLPRPRDLAPLLAAWVISVGVMVFEKDLGASLLLYTSFLVVVYLATQRFSWVVIGLTLFAAGTLVAYFIFEHVRLRVQTWLDPFADPDGTGYQIVQSLFSFATGGIFGTGLGNGQPDTVPAASTDFIIAAFGEELGLVGLTAILMLYTIVIIRGLRTAIATRDSFGKLLAAGLSSTLAIQLFIVVGGVTRLIPLTGLTTPWMSYGGSSLLANYILLAILARISHGARRPLRTRPRNKSPITAAGTEVIERV,"50,611",469,SEDS family,cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation by symbiont of host immune response [GO:0052556],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10H4.17c,1
P9WMV3,GMHBA_MYCTU,Rv0114,gmhB Rv0114 MTV031.08,GO:0000287; GO:0005737; GO:0005975; GO:0008270; GO:0034200,IPR036412; IPR006549; IPR023214; IPR004446; IPR006543; ,,gmhB,,"D-glycero-alpha-D-manno-heptose-1,7-bisphosphate 7-phosphatase (EC 3.1.3.83) (D,D-heptose 1,7-bisphosphate phosphatase) (HBP phosphatase)","cytoplasm [GO:0005737]; D,D-heptose 1,7-bisphosphate phosphatase activity [GO:0034200]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]",9634230; 12101286,,"FUNCTION: Converts the D-glycero-alpha-D-manno-heptose 1,7-bisphosphate intermediate into D-glycero-alpha-D-manno-heptose 1-phosphate by removing the phosphate group at the C-7 position. {ECO:0000250}.",MVAERAGHQWCLFLDRDGVINRQVVGDYVRNWRQFEWLPGAARALKKLRAWAPYIVVVTNQQGVGAGLMSAVDVMVIHRHLQMQLASDGVLIDGFQVCPHHRSQRCGCRKPRPGLVLDWLGRHPDSEPLLSIVVGDSLSDLELAHNVAAAAGACASVQIGGASSGGVADASFDSLWEFAVAVGHARGERG,"20,511",190,GmhB family,carbohydrate metabolic process [GO:0005975],"D,D-heptose 1,7-bisphosphate phosphatase activity [GO:0034200]; magnesium ion binding [GO:0000287]; zinc ion binding [GO:0008270]",cytoplasm [GO:0005737],,MTV031.08,1
P9WNW3,DNAA_MYCTU,Rv0001,dnaA Rv0001 MTV029.01,GO:0003688; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006172; GO:0006270; GO:0006275; GO:0016311; GO:0016887,IPR003593; IPR001957; IPR020591; IPR018312; IPR013317; IPR013159; IPR027417; IPR010921; ,,dnaA,,Chromosomal replication initiator protein DnaA,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA replication origin binding [GO:0003688]; ADP biosynthetic process [GO:0006172]; dephosphorylation [GO:0016311]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275],8733228; 9634230; 7557482; 16629667; 21969609,,FUNCTION: Plays an important role in the initiation and regulation of chromosomal replication. Binds to the origin of replication; it binds specifically double-stranded DNA at a 9 bp consensus (dnaA box): 5'-TTATC[CA]A[CA]A-3'. DnaA binds to ATP and to acidic phospholipids (By similarity). Binds its own promoter. {ECO:0000250}.,MTDDPGSGFTTVWNAVVSELNGDPKVDDGPSSDANLSAPLTPQQRAWLNLVQPLTIVEGFALLSVPSSFVQNEIERHLRAPITDALSRRLGHQIQLGVRIAPPATDEADDTTVPPSENPATTSPDTTTDNDEIDDSAAARGDNQHSWPSYFTERPHNTDSATAGVTSLNRRYTFDTFVIGASNRFAHAAALAIAEAPARAYNPLFIWGESGLGKTHLLHAAGNYAQRLFPGMRVKYVSTEEFTNDFINSLRDDRKVAFKRSYRDVDVLLVDDIQFIEGKEGIQEEFFHTFNTLHNANKQIVISSDRPPKQLATLEDRLRTRFEWGLITDVQPPELETRIAILRKKAQMERLAVPDDVLELIASSIERNIRELEGALIRVTAFASLNKTPIDKALAEIVLRDLIADANTMQISAATIMAATAEYFDTTVEELRGPGKTRALAQSRQIAMYLCRELTDLSLPKIGQAFGRDHTTVMYAQRKILSEMAERREVFDHVKELTTRIRQRSKR,"56,567",507,DnaA family,ADP biosynthetic process [GO:0006172]; dephosphorylation [GO:0016311]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV029.01,1
P9WMR3,DNAB_MYCTU,Rv0058,dnaB Rv0058 MTCY21D4.21,GO:0003677; GO:0003678; GO:0004519; GO:0005524; GO:0005618; GO:0005829; GO:0006268; GO:0006269; GO:0006314; GO:0006974; GO:0016539; GO:0040007; GO:1990077,IPR003593; IPR036185; IPR007692; IPR007694; IPR007693; IPR016136; IPR003586; IPR003587; IPR036844; IPR027434; IPR006142; IPR030934; IPR004042; IPR006141; IPR004860; IPR027417; ,P9WGD5,dnaB,DOMAIN 195 462 SF4 helicase; first part. {ECO:0000255|PROSITE-ProRule:PRU00596}.; DOMAIN 582 660 DOD-type homing endonuclease. {ECO:0000255|PROSITE-ProRule:PRU00273}.; DOMAIN 612 874 SF4 helicase; second part. {ECO:0000255|PROSITE-ProRule:PRU00596}.,Replicative DNA helicase (EC 3.6.4.12) [Cleaved into: Endonuclease PI-MtuHIP (EC 3.1.-.-) (Mtu dnaB intein)],"cell wall [GO:0005618]; cytosol [GO:0005829]; primosome complex [GO:1990077]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA unwinding involved in DNA replication [GO:0006268]; growth [GO:0040007]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]",9634230; 19099550,X-ray crystallography (1),FUNCTION: Participates in initiation and elongation during chromosome replication; it exhibits DNA-dependent ATPase activity. {ECO:0000250}.; FUNCTION: The intein is an endonuclease. {ECO:0000305}.,MAVVDDLAPGMDSSPPSEDYGRQPPQDLAAEQSVLGGMLLSKDAIADVLERLRPGDFYRPAHQNVYDAILDLYGRGEPADAVTVAAELDRRGLLRRIGGAPYLHTLISTVPTAANAGYYASIVAEKALLRRLVEAGTRVVQYGYAGAEGADVAEVVDRAQAEIYDVADRRLSEDFVALEDLLQPTMDEIDAIASSGGLARGVATGFTELDEVTNGLHPGQMVIVAARPGVGKSTLGLDFMRSCSIRHRMASVIFSLEMSKSEIVMRLLSAEAKIKLSDMRSGRMSDDDWTRLARRMSEISEAPLFIDDSPNLTMMEIRAKARRLRQKANLKLIVVDYLQLMTSGKKYESRQVEVSEFSRHLKLLAKELEVPVVAISQLNRGPEQRTDKKPMLADLRESGCLTASTRILRADTGAEVAFGELMRSGERPMVWSLDERLRMVARPMINVFPSGRKEVFRLRLASGREVEATGSHPFMKFEGWTPLAQLKVGDRIAAPRRVPEPIDTQRMPESELISLARMIGDGSCLKNQPIRYEPVDEANLAAVTVSAAHSDRAAIRDDYLAARVPSLRPARQRLPRGRCTPIAAWLAGLGLFTKRSHEKCVPEAVFRAPNDQVALFLRHLWSAGGSVRWDPTNGQGRVYYGSTSRRLIDDVAQLLLRVGIFSWITHAPKLGGHDSWRLHIHGAKDQVRFLRHVGVHGAEAVAAQEMLRQLKGPVRNPNLDSAPKKVWAQVRNRLSAKQMMDIQLHEPTMWKHSPSRSRPHRAEARIEDRAIHELARGDAYWDTVVEITSIGDQHVFDGTVSGTHNFVANGISLHNSLEQDADVVILLHRPDAFDRDDPRGGEADFILAKHRNGPTKTVTVAHQLHLSRFANMAR,"96,917",874,"Helicase family, DnaB subfamily","cellular response to DNA damage stimulus [GO:0006974]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA unwinding involved in DNA replication [GO:0006268]; growth [GO:0040007]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; endonuclease activity [GO:0004519],cell wall [GO:0005618]; cytosol [GO:0005829]; primosome complex [GO:1990077],,MTCY21D4.21,1
P9WNU1,DPO3B_MYCTU,Rv0002,dnaN Rv0002 MTCY10H4.0 MTV029.02,GO:0003677; GO:0003887; GO:0005576; GO:0005618; GO:0005737; GO:0006260; GO:0008408; GO:0009360; GO:0046677,IPR001001; IPR022635; IPR022637; IPR022634; ,,dnaN,,Beta sliding clamp (Beta clamp) (Sliding clamp) (Beta-clamp processivity factor) (DNA polymerase III beta sliding clamp subunit) (DNA polymerase III subunit beta) (Mtb beta-clamp),cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA polymerase III complex [GO:0009360]; extracellular region [GO:0005576]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]; response to antibiotic [GO:0046677],8733228; 9634230; 21969609; 21219854; 22545130; 26045430,X-ray crystallography (4),"FUNCTION: Confers DNA tethering and processivity to DNA polymerases and other proteins. Acts as a clamp, forming a ring around DNA (a reaction catalyzed by the clamp-loading complex) which diffuses in an ATP-independent manner freely and bidirectionally along dsDNA. Initially characterized for its ability to contact the catalytic subunit of DNA polymerase III (Pol III), a complex, multichain enzyme responsible for most of the replicative synthesis in bacteria; Pol III exhibits 3'-5' exonuclease proofreading activity. The beta chain is required for initiation of replication as well as for processivity of DNA replication (By similarity). Binds ds-and ssDNA (PubMed:22545130). Binds the antibiotic griselimycin and its derivatives with high affinity (1.0 x 10(-10) to 2.0 x 10(-10) M s(-1)) (PubMed:26045430). Binding occurs in a hydrophobic cleft between domains 2 and 3, which have been shown to be responsible for binding DNA polymerases and other DNA-modifying proteins (PubMed:26045430). {ECO:0000250|UniProtKB:P0A988, ECO:0000269|PubMed:22545130, ECO:0000269|PubMed:26045430}.",MDAATTRVGLTDLTFRLLRESFADAVSWVAKNLPARPAVPVLSGVLLTGSDNGLTISGFDYEVSAEAQVGAEIVSPGSVLVSGRLLSDITRALPNKPVDVHVEGNRVALTCGNARFSLPTMPVEDYPTLPTLPEETGLLPAELFAEAISQVAIAAGRDDTLPMLTGIRVEILGETVVLAATDRFRLAVRELKWSASSPDIEAAVLVPAKTLAEAAKAGIGGSDVRLSLGTGPGVGKDGLLGISGNGKRSTTRLLDAEFPKFRQLLPTEHTAVATMDVAELIEAIKLVALVADRGAQVRMEFADGSVRLSAGADDVGRAEEDLVVDYAGEPLTIAFNPTYLTDGLSSLRSERVSFGFTTAGKPALLRPVSGDDRPVAGLNGNGPFPAVSTDYVYLLMPVRLPG,"42,113",402,Beta sliding clamp family,DNA replication [GO:0006260]; response to antibiotic [GO:0046677],3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA polymerase III complex [GO:0009360]; extracellular region [GO:0005576],,MTCY10H4.0 MTV029.02,1
P9WNR3,ECCB3_MYCTU,Rv0283,eccB3 Rv0283,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0005887; GO:0016787; GO:0040007,IPR007795; ,,eccB3,,ESX-3 secretion system ATPase EccB3 (EC 3.6.-.-) (ESX conserved component B3) (Type VII secretion system protein EccB3) (T7SS protein EccB3),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; growth [GO:0040007],9634230; 12065475; 17098899; 19684129; 19876390; 21969609; 24155985,,"FUNCTION: An ATPase (By similarity). Part of the ESX-3 specialized secretion system, which is important for iron and zinc uptake or homeostasis. {ECO:0000250|UniProtKB:P9WNR7, ECO:0000269|PubMed:19684129, ECO:0000269|PubMed:24155985}.",MTNQQHDHDFDHDRRSFASRTPVNNNPDKVVYRRGFVTRHQVTGWRFVMRRIAAGIALHDTRMLVDPLRTQSRAVLMGVLIVITGLIGSFVFSLIRPNGQAGSNAVLADRSTAALYVRVGEQLHPVLNLTSARLIVGRPVSPTTVKSTELDQFPRGNLIGIPGAPERMVQNTSTDANWTVCDGLNAPSRGGADGVGVTVIAGPLEDTGARAAALGPGQAVLVDSGAGTWLLWDGKRSPIDLADHAVTSGLGLGADVPAPRIIASGLFNAIPEAPPLTAPIIPDAGNPASFGVPAPIGAVVSSYALKDSGKTISDTVQYYAVLPDGLQQISPVLAAILRNNNSYGLQQPPRLGADEVAKLPVSRVLDTRRYPSEPVSLVDVTRDPVTCAYWSKPVGAATSSLTLLAGSALPVPDAVHTVELVGAGNGGVATRVALAAGTGYFTQTVGGGPDAPGAGSLFWVSDTGVRYGIDNEPQGVAGGGKAVEALGLNPPPVPIPWSVLSLFVPGPTLSRADALLAHDTLVPDSRPARPVSAEGGYR,"55,943",538,EccB family,growth [GO:0040007],ATP binding [GO:0005524]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WNQ3,ECCD3_MYCTU,Rv0290,eccD3 Rv0290,GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR006707; IPR024962; ,,eccD3,,ESX-3 secretion system protein EccD3 (ESX conserved component D3) (Type VII secretion system protein EccD3) (T7SS protein EccD3),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 12065475; 17098899; 19099550; 19684129; 19876390; 21969609; 24155985,,"FUNCTION: Part of the ESX-3 specialized secretion system, which is important for iron and zinc uptake or homeostasis. {ECO:0000269|PubMed:19684129, ECO:0000269|PubMed:24155985}.",MSGTVMQIVRVAILADSRLTEMALPAELPLREILPAVQRLVVPSAQNGDGGQADSGAAVQLSLAPVGGQPFSLDASLDTVGVVDGDLLVLQPVPAGPAAPGIVEDIADAAMIFSTSRLKPWGIAHIQRGALAAVIAVALLATGLTVTYRVATGVLAGLLAVAGIAVASALAGLLITIRSPRSGIALSIAALVPIGAALALAVPGKFGPAQVLLGAAGVAAWSLIALMIPSAERERVVAFFTAAAVVGASVALAAGAQLLWQLPLLSIGCGLIVAALLVTIQAAQLSALWARFPLPVIPAPGDPTPSAPPLRLLEDLPRRVRVSDAHQSGFIAAAVLLSVLGSVAIAVRPEALSVVGWYLVAATAAAATLRARVWDSAACKAWLLAQPYLVAGVLLVFYTATGRYVAAFGAVLVLAVLMLAWVVVALNPGIASPESYSLPLRRLLGLVAAGLDVSLIPVMAYLVGLFAWVLNR,"47,944",472,EccD/Snm4 family,growth [GO:0040007],,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WJE5,ECCE3_MYCTU,Rv0292,eccE3 Rv0292,GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR021368; ,,eccE3,,ESX-3 secretion system protein EccE3 (ESX conserved component E3) (Type VII secretion system protein EccE3) (T7SS protein EccE3),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 12065475; 17098899; 19684129; 19876390; 21969609; 24155985,,"FUNCTION: Part of the ESX-3 specialized secretion system, which is important for iron and zinc uptake or homeostasis. {ECO:0000269|PubMed:19684129, ECO:0000269|PubMed:24155985}.",MNPIPSWPGRGRVTLVLLAVVPVALAYPWQSTRDYVLLGVAAAVVIGLFGFWRGLYFTTIARRGLAILRRRRRIAEPATCTRTTVLVWVGPPASDTNVLPLTLIARYLDRYGIRADTIRITSRVTASGDCRTWVGLTVVADDNLAALQARSARIPLQETAQVAARRLADHLREIGWEAGTAAPDEIPALVAADSRETWRGMRHTDSDYVAAYRVSANAELPDTLPAIRSRPAQETWIALEIAYAAGSSTRYTVAAACALRTDWRPGGTAPVAGLLPQHGNHVPALTALDPRSTRRLDGHTDAPADLLTRLHWPTPTAGAHRAPLTNAVSRT,"35,932",331,EccE family,growth [GO:0040007],,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WNP3,ECH1_MYCTU,Rv0130,Rv0130,GO:0004300; GO:0006633; GO:0018812,IPR029069; IPR002539; ,,,DOMAIN 11 132 MaoC-like.,Probable enoyl-CoA hydratase 1 (EC 4.2.1.17) (N-related protein) (Nodulation protein),3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609; 16963641,X-ray crystallography (1),FUNCTION: May be involved in the hydration of fatty acids for production of polyhydroxylalkanoates. {ECO:0000269|PubMed:16963641}.,MRTFESVADLAAAAGEKVGQSDWVTITQEEVNLFADATGDHQWIHVDPERAAAGPFGTTIAHGFMTLALLPRLQHQMYTVKGVKLAINYGLNKVRFPAPVPVGSRVRATSSLVGVEDLGNGTVQATVSTTVEVEGSAKPACVAESIVRYVA,"16,007",151,Enoyl-CoA hydratase/isomerase family,fatty acid biosynthetic process [GO:0006633],3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; enoyl-CoA hydratase activity [GO:0004300],,,,1
Q6MX43,DODEC_MYCTU,Rv0379 RVBD_0379,secE2 Rv0379 RVBD_0379,GO:0005618; GO:0005886; GO:0046872,IPR009923; IPR025543; IPR036694; ,,secE2,,Calcium dodecin,cell wall [GO:0005618]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872],9634230; 21969609; 21370306,X-ray crystallography (1),FUNCTION: Binds calcium ions. May play a role in sequestering additional small ligands. {ECO:0000269|PubMed:21370306}.,MSVYKVIDIIGTSPTSWEQAAAEAVQRARDSVDDIRVARVIEQDMAVDSAGKITYRIKLEVSFKMRPAQPR,"7,966",71,Dodecin family,,metal ion binding [GO:0046872],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WMJ9,DNAK_MYCTU,Rv0350,dnaK Rv0350 MTCY13E10.10,GO:0001968; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006457; GO:0009408; GO:0009986; GO:0010756; GO:0035375; GO:0040007; GO:0042603; GO:0044044; GO:0046677; GO:0046688; GO:0046777; GO:0051082; GO:0071451; GO:0097691; GO:2000679,IPR012725; IPR018181; IPR029048; IPR029047; IPR013126; ,,dnaK,,Chaperone protein DnaK (HSP70) (Heat shock 70 kDa protein) (Heat shock protein 70),bacterial extracellular vesicle [GO:0097691]; capsule [GO:0042603]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; unfolded protein binding [GO:0051082]; zymogen binding [GO:0035375]; cellular response to superoxide [GO:0071451]; growth [GO:0040007]; interaction with host via substance in symbiont surface [GO:0044044]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autophosphorylation [GO:0046777]; protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to copper ion [GO:0046688]; response to heat [GO:0009408],9634230; 11567012; 15809303; 19470749; 21364279; 21969609,,"FUNCTION: Acts as a chaperone. {ECO:0000255|HAMAP-Rule:MF_00332}.; FUNCTION: Recombinant extracellular protein activates expression of NF-kappa-B in immortalized human dermal endothelial cells in a TLR2- and TLR4-dependent manner. Activation occurs via MYD88-dependent and -independent pathways and requires TIRAP, TRIF and TRAM (some experiments done in mouse cells, mice do not usually catch tuberculosis) (PubMed:15809303). {ECO:0000269|PubMed:15809303}.",MARAVGIDLGTTNSVVSVLEGGDPVVVANSEGSRTTPSIVAFARNGEVLVGQPAKNQAVTNVDRTVRSVKRHMGSDWSIEIDGKKYTAPEISARILMKLKRDAEAYLGEDITDAVITTPAYFNDAQRQATKDAGQIAGLNVLRIVNEPTAAALAYGLDKGEKEQRILVFDLGGGTFDVSLLEIGEGVVEVRATSGDNHLGGDDWDQRVVDWLVDKFKGTSGIDLTKDKMAMQRLREAAEKAKIELSSSQSTSINLPYITVDADKNPLFLDEQLTRAEFQRITQDLLDRTRKPFQSVIADTGISVSEIDHVVLVGGSTRMPAVTDLVKELTGGKEPNKGVNPDEVVAVGAALQAGVLKGEVKDVLLLDVTPLSLGIETKGGVMTRLIERNTTIPTKRSETFTTADDNQPSVQIQVYQGEREIAAHNKLLGSFELTGIPPAPRGIPQIEVTFDIDANGIVHVTAKDKGTGKENTIRIQEGSGLSKEDIDRMIKDAEAHAEEDRKRREEADVRNQAETLVYQTEKFVKEQREAEGGSKVPEDTLNKVDAAVAEAKAALGGSDISAIKSAMEKLGQESQALGQAIYEAAQAASQATGAAHPGGEPGGAHPGSADDVVDAEVVDDGREAK,"66,831",625,Heat shock protein 70 family,cellular response to superoxide [GO:0071451]; growth [GO:0040007]; interaction with host via substance in symbiont surface [GO:0044044]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein autophosphorylation [GO:0046777]; protein folding [GO:0006457]; response to antibiotic [GO:0046677]; response to copper ion [GO:0046688]; response to heat [GO:0009408],ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; unfolded protein binding [GO:0051082]; zymogen binding [GO:0035375],bacterial extracellular vesicle [GO:0097691]; capsule [GO:0042603]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY13E10.10,1
P9WPI3,ECCA3_MYCTU,Rv0282,eccA3 Rv0282 MTV035.10,GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0010106; GO:0033214; GO:0040007; GO:0055069; GO:0055072,IPR003593; IPR003959; IPR000641; IPR027417; IPR023835; IPR011990; ,,eccA3,,ESX-3 secretion system protein EccA3 (ESX conserved component A3) (Type VII secretion system protein EccA3) (T7SS protein EccA3),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cellular response to iron ion starvation [GO:0010106]; growth [GO:0040007]; iron assimilation by chelation and transport [GO:0033214]; iron ion homeostasis [GO:0055072]; zinc ion homeostasis [GO:0055069],9634230; 12065475; 17098899; 19684129; 19876390; 21969609; 24155985,,"FUNCTION: Part of the ESX-3 specialized secretion system, which is important for iron and zinc uptake or homeostasis (PubMed:19684129, PubMed:24155985). EccA3 exhibits ATPase activity and may provide energy for the export of ESX-3 substrates (By similarity). {ECO:0000250|UniProtKB:P9WPH9, ECO:0000269|PubMed:19684129, ECO:0000269|PubMed:24155985}.",MAGVGEGDSGGVERDDIGMVAASPVASRVNGKVDADVVGRFATCCRALGIAVYQRKRPPDLAAARSGFAALTRVAHDQCDAWTGLAAAGDQSIGVLEAASRTATTAGVLQRQVELADNALGFLYDTGLYLRFRATGPDDFHLAYAAALASTGGPEEFAKANHVVSGITERRAGWRAARWLAVVINYRAERWSDVVKLLTPMVNDPDLDEAFSHAAKITLGTALARLGMFAPALSYLEEPDGPVAVAAVDGALAKALVLRAHVDEESASEVLQDLYAAHPENEQVEQALSDTSFGIVTTTAGRIEARTDPWDPATEPGAEDFVDPAAHERKAALLHEAELQLAEFIGLDEVKRQVSRLKSSVAMELVRKQRGLTVAQRTHHLVFAGPPGTGKTTIARVVAKIYCGLGLLKRENIREVHRADLIGQHIGETEAKTNAIIDSALDGVLFLDEAYALVATGAKNDFGLVAIDTLLARMENDRDRLVVIIAGYRADLDKFLDTNEGLRSRFTRNIDFPSYTSHELVEIAHKMAEQRDSVFEQSALHDLEALFAKLAAESTPDTNGISRRSLDIAGNGRFVRNIVERSEEEREFRLDHSEHAGSGEFSDEELMTITADDVGRSVEPLLRGLGLSVRA,"68,107",631,CbxX/CfxQ family,cellular response to iron ion starvation [GO:0010106]; growth [GO:0040007]; iron assimilation by chelation and transport [GO:0033214]; iron ion homeostasis [GO:0055072]; zinc ion homeostasis [GO:0055069],ATP binding [GO:0005524],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV035.10,1
P9WJC7,ESPG3_MYCTU,Rv0289,espG3 Rv0289,GO:0005737; GO:0040007,IPR025734; ,,espG3,,ESX-3 secretion-associated protein EspG3,cytoplasm [GO:0005737]; growth [GO:0040007],9634230; 19876390; 21969609; 25275011,X-ray crystallography (1),FUNCTION: Specific chaperone for cognate PE/PPE proteins. Plays an important role in preventing aggregation of PE/PPE dimers. {ECO:0000250|UniProtKB:O53943}.,MDATPNAVELTVDNAWFIAETIGAGTFPWVLAITMPYSDAAQRGAFVDRQRDELTRMGLLSPQGVINPAVADWIKVVCFPDRWLDLRYVGPASADGACELLRGIVALRTGTGKTSNKTGNGVVALRNAQLVTFTAMDIDDPRALVPILGVGLAHRPPARFDEFSLPTRVGARADERLRSGVPLGEVVDYLGIPASARPVVESVFSGPRSYVEIVAGCNRDGRHTTTEVGLSIVDTSAGRVLVSPSRAFDGEWVSTFSPGTPFAIAVAIQTLTACLPDGQWFPGQRVSRDFSTQSS,"31,559",295,EspG family,growth [GO:0040007],,cytoplasm [GO:0005737],,,1
O53692,ESXG_MYCTU,Rv0287,esxG Rv0287 LH57_01570,GO:0005576; GO:0009405,IPR036689; IPR010310; ,P9WNK3,esxG,,ESAT-6-like protein EsxG (Conserved protein TB9.8),extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 15336430; 18430736; 19876390; 19854905; 20085764; 21969609; 24204276; 21730061,NMR spectroscopy (1),"FUNCTION: EsxG, in complex with EsxH, disrupts ESCRT function and impairs host phagosome maturation, thereby promoting intracellular bacterial growth. The complex acts by interacting, via EsxH, with the host hepatocyte growth factor-regulated tyrosine kinase substrate (HGS/HRS), a component of the ESCRT machinery. EsxG stabilizes EsxH in the host cytosol. {ECO:0000269|PubMed:24204276}.",MSLLDAHIPQLVASQSAFAAKAGLMRHTIGQAEQAAMSAQAFHQGESSAAFQAAHARFVAAAAKVNTLLDVAQANLGEAAGTYVAADAAAASTYTGF,"9,778",97,"WXG100 family, CFP-10 subfamily",pathogenesis [GO:0009405],,extracellular region [GO:0005576],,LH57_01570,1
P71590,FHAA_MYCTU,Rv0020c,fhaA TB39.8 Rv0020c,GO:0003729; GO:0005618; GO:0005829,IPR022128; IPR000253; IPR008984; ,P9WI81,fhaA,DOMAIN 455 504 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.,FHA domain-containing protein FhaA,cell wall [GO:0005618]; cytosol [GO:0005829]; mRNA binding [GO:0003729],9634230; 15987910; 21969609; 21134638; 22000520; 22275220,NMR spectroscopy (2); X-ray crystallography (3),FUNCTION: Regulates cell growth and peptidoglycan synthesis by binding to MviN. May inhibit the late stages of peptidoglycan synthesis. {ECO:0000269|PubMed:22275220}.,MGSQKRLVQRVERKLEQTVGDAFARIFGGSIVPQEVEALLRREAADGIQSLQGNRLLAPNEYIITLGVHDFEKLGADPELKSTGFARDLADYIQEQGWQTYGDVVVRFEQSSNLHTGQFRARGTVNPDVETHPPVIDCARPQSNHAFGAEPGVAPMSDNSSYRGGQGQGRPDEYYDDRYARPQEDPRGGPDPQGGSDPRGGYPPETGGYPPQPGYPRPRHPDQGDYPEQIGYPDQGGYPEQRGYPEQRGYPDQRGYQDQGRGYPDQGQGGYPPPYEQRPPVSPGPAAGYGAPGYDQGYRQSGGYGPSPGGGQPGYGGYGEYGRGPARHEEGSYVPSGPPGPPEQRPAYPDQGGYDQGYQQGATTYGRQDYGGGADYTRYTESPRVPGYAPQGGGYAEPAGRDYDYGQSGAPDYGQPAPGGYSGYGQGGYGSAGTSVTLQLDDGSGRTYQLREGSNIIGRGQDAQFRLPDTGVSRRHLEIRWDGQVALLADLNSTNGTTVNNAPVQEWQLADGDVIRLGHSEIIVRMH,"56,880",527,,,mRNA binding [GO:0003729],cell wall [GO:0005618]; cytosol [GO:0005829],TB39.8,,1
P9WJB5,FHAB_MYCTU,Rv0019c,fhaB fipA Rv0019c,GO:0005576; GO:0005886; GO:0006979; GO:0016021; GO:0044119; GO:0051301,IPR000253; IPR008984; IPR032030; ,,fhaB,DOMAIN 83 132 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.,FHA domain-containing protein FhaB (FtsZ-interacting protein A),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell division [GO:0051301]; growth of symbiont in host cell [GO:0044119]; response to oxidative stress [GO:0006979],9634230; 19826007; 20066037; 21969609,,FUNCTION: Regulates growth and cell division. Probably required for divisomal protein assembly under oxidative stress. {ECO:0000269|PubMed:20066037}.,MQGLVLQLTRAGFLMLLWVFIWSVLRILKTDIYAPTGAVMMRRGLALRGTLLGARQRRHAARYLVVTEGALTGARITLSEQPVLIGRADDSTLVLTDDYASTRHARLSMRGSEWYVEDLGSTNGTYLDRAKVTTAVRVPIGTPVRIGKTAIELRP,"17,152",155,,cell division [GO:0051301]; growth of symbiont in host cell [GO:0044119]; response to oxidative stress [GO:0006979],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],fipA,,1
P96809,FHMAD_MYCTU,Rv0132c LH57_00740,fgd2 Rv0132c LH57_00740,GO:0005886; GO:0006629; GO:0016705; GO:0031975,IPR031017; IPR019945; IPR011251; IPR036661; ,,fgd2,,F420-dependent hydroxymycolic acid dehydrogenase (fHMAD) (EC 1.1.98.-) (FGD2),"envelope [GO:0031975]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]",9634230; 10879539; 23110042; 24349169,,"FUNCTION: Catalyzes the coenzyme F420-dependent oxidation of hydroxymycolic acids (H-MAs) to ketomycolic acids (K-MAs), a lipid class making up the mycobacterial pseudo-outer membrane and over one-third of the dry weight of M.tuberculosis (PubMed:24349169). Does not exhibit F420-dependent glucose-6-phosphate dehydrogenase (FGD) activity (PubMed:23110042). {ECO:0000269|PubMed:23110042, ECO:0000269|PubMed:24349169}.",MTGISRRTFGLAAGFGAIGAGGLGGGCSTRSGPTPTPEPASRGVGVVLSHEQFRTDRLVAHAQAAEQAGFRYVWASDHLQPWQDNEGHSMFPWLTLALVGNSTSSILFGTGVTCPIYRYHPATVAQAFASLAILNPGRVFLGLGTGERLNEQAATDTFGNYRERHDRLIEAIVLIRQLWSGERISFTGHYFRTDELKLYDTPAMPPPIFVAASGPQSATLAGRYGDGWIAQARDINDAKLLAAFAAGAQAAGRDPTTLGKRAELFAVVGDDKAAARAADLWRFTAGAVDQPNPVEIQRAAESNPIEKVLANWAVGTDPGVHIGAVQAVLDAGAVPFLHFPQDDPITAIDFYRTNVLPELR,"38,445",360,F420-dependent hydroxymycolic acid dehydrogenase family,lipid metabolic process [GO:0006629],"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",envelope [GO:0031975]; plasma membrane [GO:0005886],,,1
P9WQ55,FAD10_MYCTU,Rv0099,fadD10 Rv0099,GO:0005524; GO:0005737; GO:0005886; GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD10,,Putative fatty-acid--CoA ligase FadD10 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase)) (EC 6.2.1.-),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 15882420; 21969609,,,MGGKKFQAMPQLPSTVLDRVFEQARQQPEAIALRRCDGTSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLPIAAIERFCQITDPAAALVAPGSKMASSAVPEALHSIPVIAVDIAAVTRESEHSLDAASLAGNADQGSEDPLAMIFTSGTTGEPKAVLLANRTFFAVPDILQKEGLNWVTWVVGETTYSPLPATHIGGLWWILTCLMHGGLCVTGGENTTSLLEILTTNAVATTCLVPTLLSKLVSELKSANATVPSLRLVGYGGSRAIAADVRFIEATGVRTAQVYGLSETGCTALCLPTDDGSIVKIEAGAVGRPYPGVDVYLAATDGIGPTAPGAGPSASFGTLWIKSPANMLGYWNNPERTAEVLIDGWVNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACYEIPDEEFGALVGLAVVASAELDESAARALKHTIAARFRRESEPMARPSTIVIVTDIPRTQSGKVMRASLAAAATADKARVVVRG,"56,590",540,,metabolic process [GO:0008152],ATP binding [GO:0005524]; ligase activity [GO:0016874],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WQM7,ANSP2_MYCTU,Rv0346c,ansP2 Rv0346c MTCY13E10.06c,GO:0005576; GO:0005886; GO:0006865; GO:0016021; GO:0022857,IPR004841; IPR002293; IPR004840; ,,ansP2,,L-asparagine permease 2 (L-asparagine transport protein 2),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865],9634230; 21969609,,,MPPLDITDERLTREDTGYHKGLHSRQLQMIALGGAIGTGLFLGAGGRLASAGPGLFLVYGICGIFVFLILRALGELVLHRPSSGSFVSYAREFYGEKVAFVAGWMYFLNWAMTGIVDTTAIAHYCHYWRAFQPIPQWTLALIALLVVLSMNLISVRLFGELEFWASLIKVIALVTFLIVGTVFLAGRYKIDGQETGVSLWSSHGGIVPTGLLPIVLVTSGVVFAYAAIELVGIAAGETAEPAKIMPRAINSVVLRIACFYVGSTVLLALLLPYTAYKEHVSPFVTFFSKIGIDAAGSVMNLVVLTAALSSLNAGLYSTGRILRSMAINGSGPRFTAPMSKTGVPYGGILLTAGIGLLGIILNAIKPSQAFEIVLHIAATGVIAAWATIVACQLRLHRMANAGQLQRPKFRMPLSPFSGYLTLAFLAGVLILMYFDEQHGPWMIAATVIGVPALIGGWYLVRNRVTAVAHHAIDHTKSVAVVHSADPI,"52,195",487,"Amino acid-polyamine-organocation (APC) superfamily, Amino acid transporter (AAT) (TC 2.A.3.1) family",amino acid transport [GO:0006865],transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY13E10.06c,1
P95225,Y268_MYCTU,Rv0268c,Rv0268c LH57_01465,,IPR006442; IPR036165; ,,,,Putative antitoxin Rv0268c,,9634230; 25467293,,"FUNCTION: Putative antitoxin component of a type II toxin-antitoxin (TA) system; however the expected toxin coding sequence is not found adjacent to this gene. {ECO:0000305|PubMed:25467293, ECO:0000305|PubMed:9634230}.",MGTRSKSRTRQLKQSNGCTATTSGASDRRRRARRRTAPAWLREDEWLRHHLPHPPRQLSRCLHRRRRSACHHRYSRRTPKGGLPMTSSLVPISEARAHLSRLVRESADDDVVLMNHGRPAAILISAERYESLMEELEDLRDRLSVHEREHVTMPLDKLGAELGVDIGRV,"19,460",169,PhD/YefM antitoxin family,,,,,LH57_01465,2
P9WL03,Y313_MYCTU,Rv0313,Rv0313,,,,,,Uncharacterized protein Rv0313,,9634230; 17259624; 21969609,,,MGDYGPFGFDPDEFDRVIREGSEGLRDAFERIGRFLSSSGAGTGWSAIFEDLSRRSRPAPETAGEAGDGVWAIYTVDADGGARVEQVYATELDALRANKDNTDPKRKVRFLPYGIAVSVLDDPVDEAQ,"13,948",128,,,,,,,1
P9WHN3,PURA_MYCTU,Rv0357c,purA Rv0357c MTCY13E10.19c,GO:0004019; GO:0005525; GO:0005737; GO:0040007; GO:0044208; GO:0046040; GO:0046872,IPR018220; IPR033128; IPR001114; IPR027417; ,,purA,,Adenylosuccinate synthetase (AMPSase) (AdSS) (EC 6.3.4.4) (IMP--aspartate ligase),cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; 'de novo' AMP biosynthetic process [GO:0044208]; growth [GO:0040007]; IMP metabolic process [GO:0046040],9634230; 20066036; 21969609,,FUNCTION: Plays an important role in the de novo pathway of purine nucleotide biosynthesis. Catalyzes the first committed step in the biosynthesis of AMP from IMP. {ECO:0000255|HAMAP-Rule:MF_00011}.,MPAIVLIGAQWGDEGKGKATDLLGGRVQWVVRYQGGNNAGHTVVLPTGENFALHLIPSGVLTPGVTNVIGNGVVIDPGVLLNELRGLQDRGVDTAKLLISADAHLLMPYHIAIDKVTERYMGSKKIGTTGRGIGPCYQDKIARIGIRVADVLDPEQLTHKVEAACEFKNQVLVKIYNRKALDPAQVVDALLEQAEGFKHRIADTRLLLNAALEAGETVLLEGSQGTLLDVDHGTYPYVTSSNPTAGGAAVGSGIGPTRIGTVLGILKAYTTRVGSGPFPTELFDEHGEYLSKTGREFGVTTGRRRRCGWFDAVIARYAARVNGITDYFLTKLDVLSSLESVPVCVGYEIDGRRTRDMPMTQRDLCRAKPVYEELPGWWEDISGAREFDDLPAKARDYVLRLEQLAGAPVSCIGVGPGREQTIVRRDVLQDRP,"46,823",432,Adenylosuccinate synthetase family,'de novo' AMP biosynthetic process [GO:0044208]; growth [GO:0040007]; IMP metabolic process [GO:0046040],adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY13E10.19c,1
P9WHK9,PYRE_MYCTU,Rv0382c,pyrE umpA Rv0382c MTV036.17c,GO:0004588; GO:0044205,IPR023031; IPR004467; IPR000836; IPR029057; ,,pyrE,,Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10),orotate phosphoribosyltransferase activity [GO:0004588]; 'de novo' UMP biosynthetic process [GO:0044205],9634230; 19099550; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes the transfer of a ribosyl phosphate group from 5-phosphoribose 1-diphosphate to orotate, leading to the formation of orotidine monophosphate (OMP). {ECO:0000255|HAMAP-Rule:MF_01208}.",MAGPDRAELAELVRRLSVVHGRVTLSSGREADYYVDLRRATLHHRASALIGRLMRELTADWDYSVVGGLTLGADPVATAIMHAPGRPIDAFVVRKSAKAHGMQRLIEGSEVTGQRVLVVEDTSTTGNSALTAVHAVQDVGGEVVGVATVVDRATGAAEAIEAEGLRYRSVLGLADLGLD,"18,892",179,"Purine/pyrimidine phosphoribosyltransferase family, PyrE subfamily",'de novo' UMP biosynthetic process [GO:0044205],orotate phosphoribosyltransferase activity [GO:0004588],,umpA,MTV036.17c,1
P96812,P96812_MYCTU,Rv0135c,Rv0135c,GO:0003677; GO:0003700; GO:0005886; GO:0006355,IPR009057; IPR001647; ,,,DOMAIN 14 74 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MTAVAAGALVVETDSFRLRLLDGLVASIGERGYRATTVSDIVRHARTSKRTFYDRFTSKEQCFLELLLADNETLGNSIRAAVDPNADWHDQIRQAVEAYVTHIESRPAVTLSWIREFPSLGAAAYPVQRRGMEQLTSLLIELSASPGFRRANLPPLNVPLAVILLGGLRELTALTVEDGQPIRNIVEPAVDASIALLGPRS,"21,975",201,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,2
P71701,P71701_MYCTU,Rv0044c,Rv0044c,GO:0005886; GO:0016705,IPR022480; IPR011251; IPR036661; ,,,,Possible oxidoreductase,"plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTSLVRPDLPVRIGVQLQPQHAPHYRAVRDAVRRCEDIGVDIAFTWDHFFPLYGDPDGPHFECWTVLGAWAEQTSHIEIGALVTCNSYRNPELLADMARTVDHISGGRLILGIGSGWKQKDYDEYGYRFGTAGSRLDDLAAALPRIKARLGKLNPPPTRDIPVLIGGGGERKTLRLVAEYADIWHSFTAGDSYLAKSAVLSTHCSTVGRNPATIERSAAVDGGGLIASAEALAGLGVTLLTVGCDGPDYDLSAAAALCRWRDGR,"28,524",264,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",plasma membrane [GO:0005886],,,1
O07238,O07238_MYCTU,Rv0311,Rv0311,GO:0009405; GO:0040007,,,,,Uncharacterized protein,growth [GO:0040007]; pathogenesis [GO:0009405],9634230; 21969609,,,MSQSRYAGLSRSELAVLLPELLLIGQLIDRSGMAWCIQAFGRQEMLQIAIEEWAGASPIYTKRMQKALNFEGDDVPTIFKGLQLDIGAPPQFMDFRFTLHDRWHGEFHLDHCGALLDVEPMGDDYVVGMCHTIEDPTFDATAIATNPRAQVRPIHRPPRKPADRHPHCAWTVIIDESYPEAEGIPALDAVRETKAATWELDNVDASDDGLVDYSGPLVSDLDFGAFSHSALVRMADEVCLQMHLLNLSFAIAVRKRAKADAQLAISVNTRQLIGVAGLGAERIHRAMALPGGIEGALGVLELHPLLNPAGYVLAETSPDRLVVHNSPAHADGAWISLCTPASVQPLQAIATAVDPHLKVRISGTDTDWTAELIEADAPASELPEVLVAKVSRGSVFQFEPRRSLPLTVK,"44,611",409,,growth [GO:0040007]; pathogenesis [GO:0009405],,,,,1
O53605,O53605_MYCTU,Rv0060,Rv0060,GO:0005829; GO:0040007,IPR002589; ,,,,Uncharacterized protein,cytosol [GO:0005829]; growth [GO:0040007],9634230; 21969609; 27939941,X-ray crystallography (1),,MITYGSGDLLRADTEALVNTVNCVGVMGKGIALQFKRRYPEMFTAYEKACKRGEVTIGKMFVVDTGQLDGPKHIINFPTKKHWRAPSKLAYIDAGLIDLIRVIRELNIASVAVPPLGVGNGGLDWEDVEQRLVSAFQQLPDVDAVIYPPSGGSRAIEGVEGLRMTWGRAVILEAMRRYLQQRRAMEPWEDPAGISHLEIQKLMYFANEADPDLALDFTPGRYGPYSERVRHLLQGMEGAFTVGLGDGTARVLANQPISLTTKGTDAITDYLATDAAADRVSAAVDTVLRVIEGFEGPYGVELLASTHWVATREGAKEPATAAAAVRKWTKRKGRIYSDDRIGVALDRILMTA,"38,563",352,,growth [GO:0040007],,cytosol [GO:0005829],,,1
Q6MX51,Q6MX51_MYCTU,Rv0296c,Rv0296c,GO:0004065; GO:0005618; GO:0008152; GO:0035635; GO:0044650; GO:0046872,IPR017849; IPR017850; IPR024607; IPR000917; ,P10145,,,Probable sulfatase,cell wall [GO:0005618]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; adhesion of symbiont to host cell [GO:0044650]; entry of bacterium into host cell [GO:0035635]; metabolic process [GO:0008152],9634230; 21969609,,,MTSERATGQRENLLIVHWHDLGRYLGVYHHPDVYSPRLDRLAAEGILFTRAHATAPLCTPSRGSLFTGRYPQSNGLVGLAHHGWEYRTGVQTLPQLLSESGWYSALFGMQHETSYPKRLGFDEFDVSNSYCEYVVAKAQDWLHNRVPALDGQRFLLTAGFFETHRPYPHERYRPADSAAVELPDYLPDTPEVRQDVAEFYGSIATADEAVGRLLDTLADTGLDASTWVVFVTDHGPAFPRAKSTLYDAGTGIALIIRPPTRRAMAPRVYDELFSGVDLVPTLLDLLRLEVPADVEGVSHAPALLAPDTENAAVRDHVYTAKTYHDSFDPIRAIRTKEYSYIENYAPRPLLDLPWDIQESPAGMAVAPLVKAPRPQRELYDLRADPTETNNLLAGDDSTQGVAAIAADLAVRLHDWRQRTADVIPSDFAGSRIAERYTETYLRIHRKTPTGRSAIAADRGIDEHCS,"51,846",465,,adhesion of symbiont to host cell [GO:0044650]; entry of bacterium into host cell [GO:0035635]; metabolic process [GO:0008152],arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872],cell wall [GO:0005618],,,1
L0T4W6,L0T4W6_MYCTU,Rv0279c,PE_PGRS4 Rv0279c,,IPR000084; ,,PE_PGRS4,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS4,,9634230,,,MSFVIAAPEVIAAAATDLASLESSIAAANAAAAANTTALLAAGADEVSTAVAALFGAHGQAYQALSAQAQAFHAQFVQALTSGGGAYAAAEAAATSPLLAPINEFFLANTGRPLIGNGTNGAPGTGANGGDGGWLIGNGGAGGSGAAGVNGGAGGNGGAGGLIGNGGAGGAGGRASTGTGGAGGAGGAAGMLFGAAGVGGPGGFAAAFGATGGAGGAGGNGGLFADGGVGGAGGATDAGTGGAGGSGGNGGLFGAGGTGGPGGFGIFGGGAGGDGGSGGLFGAGGTGGSGGTSIINVGGNGGAGGDAGMLSLGAAGGAGGSGGSNPDGGGGAGGIGGDGGTLFGSGGAGGVCGLGFDAGGAGGAGGKAGLLIGAGGAGGAGGGSFAGAGGTGGAGGAPGLVGNAGNGGNGGASANGAGAAGGAGGSGVLIGNGGNGGSGGTGAPAGTAGAGGLGGQLLGRDGFNAPASTPLHTLQQQILNAINEPTQALTGRPLIGNGANGTPGTGADGGAGGWLFGNGGNGGHGATGADGGDGGSGGAGGILSGIGGTGGSGGIGTTGQGGTGGTGGAALLIGSGGTGGSGGFGLDTGGAGGRGGDAGLFLGAAGTGGQAALSQNFIGAGGTAGAGGTGGLFANGGAGGAGGFGANGGTGGNGLLFGAGGTGGAGTLGADGGAGGHGGLFGAGGTGGAGGSSGGTFGGNGGSGGNAGLLALGASGGAGGSGGSALNVGGTGGVGGNGGSGGSLFGFGGAGGTGGSSGIGSSGGTGGDGGTAGVFGNGGDGGAGGFGADTGGNSSSVPNAVLIGNGGNGGNGGKAGGTPGAGGTSGLIIGENGLNGL,"68,986",837,,,,,,,1
O07171,O07171_MYCTU,Rv0121c,Rv0121c,GO:0048037,IPR019967; IPR011576; IPR012349; ,,,DOMAIN 10 106 Putative_PNPOx. {ECO:0000259|Pfam:PF01243}.,Conserved protein,cofactor binding [GO:0048037],9634230; 21969609,,,MGEFDPKLRFAQSPVARLATSTPDGTPHLVPVVFALGARRPAEATGADVIYTAVDAKRKTTQRLRRLANLEHNPRASVLVDSYADDWTQLWWVRADGVAAIHRDGEVMRAAYRLLRAKYAQYQSVPLNGPVIAIAVQRWASWHA,"16,045",144,,,cofactor binding [GO:0048037],,,,1
O07229,O07229_MYCTU,Rv0302,Rv0302,GO:0000976; GO:0003700; GO:0005829,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 13 73 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR/AcrR-family),cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 26362239,X-ray crystallography (2),,MGVPAKKKQQQGERSRESILDATERLMATKGYAATSISDIRDACGLAPSSIYWHFGSKEGVLAAMMERGAQRFFAAIPTWDEAHGPVEQRSERQLTELVSLQSQHPDFLRLFYLLSMERSQDPAVAAVVRRVRNTAIARFRDSITHLLPSDIPPGKADLVVAELTAFAVALSDGVYFAGHLEPDTTDVERMYRRLRQALEALIPVLLEET,"23,397",210,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O53608,O53608_MYCTU,Rv0063,Rv0063,GO:0005576; GO:0016614; GO:0050660,IPR012951; IPR016166; IPR036318; IPR016167; IPR006094; IPR006093; IPR006311; ,,,,Possible oxidoreductase,"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MAREISRQTFLRGAAGALAAGAVFGSVRATADPAASGWEALSSALGGKVLQPDDGPQFATAKQVFNTNYNGYTPAVIVTPTSQLDVQKAMAFAAANNLKVAPRGGGHSYVGASTANGAMVLDLRQLPGDINYDATTGRVTVTPATGLYAMHQVLAAAGRGIPTGTCPTVGVAGHALGGGLGANSRHAGLLCDQLTSASVVLPSGQAVTASATDHPDLFWALRGGGGGNFGVTTSLTFATFPSGDLDVVNLNFPPQSFAQVLVGWQNWLRTADRGSWALADATVDPLGTHCRILATCPAGSGGSVAAAIVSAVGTQPTGTENHTFNYLDLVRYLAVGNLNPSPLGYVGGSDVFTTITPATAQGIASAVDAFPRGAGRMLAIMHALDGALATVSPGATAFPWRRQSALVQWYVETSGSPSEATSWLNTAHQAVRAYSVGGYVNYLEVNQPPARYFGPNLSRLSAVRQKYDPSRVMFSGLNF,"49,301",479,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",extracellular region [GO:0005576],,,1
O53634,O53634_MYCTU,Rv0112,gca Rv0112,GO:0016491; GO:0040007,IPR016040; IPR036291; IPR020904; ,,gca,,"Possible GDP-mannose 4,6-dehydratase Gca (GDP-D-mannose dehydratase)",oxidoreductase activity [GO:0016491]; growth [GO:0040007],9634230; 21969609,,,MKVWITGAGGMMGSHLAEMLLAAGHDVYATYCRPTIDPSDLQFNGAEVDITDWCSVYDSIATFRPDAVFHLAAQSYPAVSWARPVETLTTNMVGTAIVFEALRRVRPHAKIIVAGSSAEYGFVDPSEVPINERRELRPLHPYGVSKAATDMLAYQYHKSYGMHTVVARIFNCTGPRKVGDALSDFVRRCTWLEHHPEQSAIRVGNLKTKRTIVDVRDLNRALMLMLDKGEAGADYNVGGSIAYEMGDVLKQVIAACKRDDIVPEVDPALLRPTDEKIIYGDCSKLAAITGWQQEICLTQTIADMFDYWRSKSESALMV,"35,280",318,,growth [GO:0040007],oxidoreductase activity [GO:0016491],,,,1
I6X8S7,I6X8S7_MYCTU,Rv0223c,Rv0223c,GO:0016620,IPR016161; IPR016163; IPR029510; IPR016162; IPR015590; ,,,,Probable aldehyde dehydrogenase,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",9634230; 21969609,,,MSDSATEYDKLFIGGKWTKPSTSDVIEVRCPATGEYVGKVPMAAAADVDAAVAAARAAFDNGPWPSTPPHERAAVIAAAVKMLAERKDLFTKLLAAETGQPPTIIETMHWMGSMGAMNYFAGAADKVTWTETRTGSYGQSIVSREPVGVVGAIVAWNVPLFLAVNKIAPALLAGCTIVLKPAAETPLTANALAEVFAEVGLPEGVLSVVPGGIETGQALTSNPDIDMFTFTGSSAVGREVGRRAAEMLKPCTLELGGKSAAIILEDVDLAAAIPMMVFSGVMNAGQGCVNQTRILAPRSRYDEIVAAVTNFVTALPVGPPSDPAAQIGPLISEKQRTRVEGYIAKGIEEGARLVCGGGRPEGLDNGFFIQPTVFADVDNKMTIAQEEIFGPVLAIIPYDTEEDAIAIANDSVYGLAGSVWTTDVPKGIKISQQIRTGTYGINWYAFDPGSPFGGYKNSGIGRENGPEGVEHFTQQKSVLLPMGYTVA,"51,157",487,Aldehyde dehydrogenase family,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,1
O53715,O53715_MYCTU,Rv0380c,Rv0380c,GO:0003723; GO:0006396; GO:0008173,IPR029028; IPR001537; IPR029026; ,,,DOMAIN 34 170 SpoU_methylase. {ECO:0000259|Pfam:PF00588}.,Possible RNA methyltransferase (RNA methylase),RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],9634230; 21969609,,,MLLRDGDARNVVDAYRYWTREAIIADIDTRRHPLHVAIENFGHDANIGSVVRTANAFAVHTVHIVGRRRWNRRGAMVTDRYQRLCHHDSTTGLLEFAAGAGLTVVAVDNVPGAARLEQTALPRECLLLFGQEGPGITDDARAGAAVTVSIAQFGSTRSINAGVAAGIAMHAWIRQHADLGRAW,"19,912",183,,RNA processing [GO:0006396],RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173],,,,1
P96407,P96407_MYCTU,Rv0225,Rv0225,GO:0016757,IPR001296; IPR028098; ,,,,Possible conserved protein,"transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 21969609,,,MSALRSVLLLCWRDIGHPQGGGSEAYLQRIGAQLAASGIAVTLRTARYPGAPRHELVDGVRISRAGGRYSVYLWALLAMAAARCGLGPLRRVRPDVVVDTQNGWPFVARLLYGRRSLVLVHHCHREQWPVAGRMMGRLGWYVESMLSPRLHRRNQYVTVSLPSARDLIALGVDSERIAVVRNGLDEAPSPTLSGPRAPTPRVVVLSRLVPHKQIEDALAAVAELQPRIPGLHLDIVGGGWWRQRLVDHVHRLDIADAVTFHGHVDDVTKHHVLQSSWVHLLPSRKEGWGLAVIEAAQHGVPTIGYRSSGGLADSIVDGVTGILVDDRAELVAWLEQLLSDSVLRDQLGAKAQARSGEFSWRQSAEALRSVLEAVQASRFVSGVV,"42,054",384,,,"transferase activity, transferring glycosyl groups [GO:0016757]",,,,1
P96400,P96400_MYCTU,Rv0218,Rv0218,GO:0016021; GO:0042128,IPR000572; IPR036374; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; nitrate assimilation [GO:0042128],9634230,,,MSDPARGAEAEDAYGFPAGLWRWLQRHPPPALHRLTRFRSPLRGPWLTSVFGLVLLVALPFVIITGLLSYIAYAPQLGQAIPGDVGWLRLPAFTWPTRPSWLYRLTQGLHVGLGLVIIPVVLAKLWSVIPRLFVWPPARSIAQVLERLSVLMLVGGILFQIVTGVLNIQYDYIFGFSFYTGHYFGAWVFIAGFLLHIVVKIPHMVTGLRSIPMREVLGTNVADTRAQPCDPDGLVSVNPGEATLSRRGALGLVGAGVLLIGVLTVGQTLGGFTRKAALLLPRGRVVSPGDFPVNKTAAAAGITAEAIGPDWRLVLCGGPAEVVLDRATLAGLPQRTARLPLACVEGWSAVRTWSGVPLAELALLAGVPAARSARVTSLQRGGAFGEAKLAANQIADPDALLALRVDGADLSLDHGYPARIIVPALPGVHNTKWVAGIEFHKR,"47,362",442,,nitrate assimilation [GO:0042128],,integral component of membrane [GO:0016021],,,1
O06299,O06299_MYCTU,Rv0348,Rv0348,,,,,,Possible transcriptional regulatory protein,,9634230; 21969609,,,MTISFSSSNLRDDATSGNGDYRLDKLPETTPSTSVFDRADVTYRQFTELHGQARDTRREAHVVELESKTGERARCAPMHALEQLADYGFAWRDIARVVGVSVPAITKWRKGAGVTGENRLKIARLLALIDMLSDRFIGEPASWLEMPIQAGVGITRMDLLERGRYDLVLALASTHTGDGTVEYVLNETDKDWRETVVDNAFESYTAEDGVISIRPKR,"24,251",217,,,,,,,1
O07428,O07428_MYCTU,Rv0184,Rv0184,,IPR024498; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTNDKMLARIAALLRQAEGTDNPHEADAFMSTAQRLATAASIDLAVARSHAGNRSPAQAPTQRTITIGAAGTRGLRTYVQLFVLIAAANDVRCDVASNSTFVYAYGFAEDIDTSHALYASLVVQMVRASDAYLASGAHRPTPTITARLNFQLAFGARVGQRLADAREQTRQEATKDRDRPPGTAIALRDKDIELHEYYRRSSKARGAWRASRATAGYSSAARRAGDRAGRQARLGNNPELPGARAALGR,"26,826",249,,,,,,,1
O33269,O33269_MYCTU,Rv0339c,Rv0339c,GO:0003677; GO:0006351; GO:0006355,IPR027417; IPR016032; IPR000792; IPR036388; ,,,DOMAIN 756 821 HTH luxR-type. {ECO:0000259|PROSITE:PS50043}.,Possible transcriptional regulatory protein,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MQHRGCKNRGQAYDASVTDSLTEVPPAARRALLELANAPTVPVKVLITGGIGTGKTTVLAAARDTLRRSGLTVLACPPPDGEPPETALVIDDAQLLTDTELLRLTERVADSRLTVVAAAEAREHHRALRALTMALERDRPRISLGPLPVAEHLRDCTAGLPFLIHAVSARAQAPAQAAKVALIERLRRLDEPTLDTLLMMSLTHELGVSDVAAALGISVTDARGLVDRAHASGLIESSHTAAFLQSVHDAIAQIVGNAHHHEVETSLLRSQLDISPVSAELALRLAEHGLRDERLADILTRYAADTRDASVRCARLYRAAVHAGAKGLTVRLADALARTGDCTAAATLADDLLSSPDATERAAAVRVAASVAVHDGNTGHAAELFGWLGPHPDTMVSSAATIVFAANGDLATARATLRLKDAGPPTMAARCARNLAEGLLLTMDQPYPVAMAKLGQAIATEQSLSQVIPDSPAALVTLAAIHAGDPVRARSVIGRAVRAGADPLFQRRHLLLSGWIKMQEGQLPSASADVAAASAGTHLHRRDALWAAALQTAISRRTGDIGALQQHWYAAMEALAEYSLDLFALLPLGELWVAAARMRQVDQLQHTLDQALTLLDSLGNPALWSNSLHWAGVHAGILANSPESVAPHGQALGAMVAHSTLAQALSDAGRTWLRVLAENVDADEVTAAARSLSHVGLTSDATRLAGQAALQTSDARVSGAMLQLARDLKLGNDFGEPPSGAGDTEPASGTPPAPRQPPAGSPLSDREREVAELLLLGMPYRDIGARLFISAKTVEHHVARIRQRLGAGSRSEMLSMLRAMLAPESLTADERR,"87,776",832,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,,1
O07432,O07432_MYCTU,Rv0188,Rv0188,GO:0016021,IPR005530; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSTVHSSIDQHPDLLALRASFDRAAESTIAHFTFGLALLAGLYVAASPWIVGFSATRGLPTCDLIVGIAVAYLAYGFASALDRTHGMTWTLPVLGVWVIFSPWVLPGVAVTAGMMWSHIIAGAVVAVLGFYFGMRTRAAANQG,"15,125",143,,,,integral component of membrane [GO:0016021],,,1
O07420,O07420_MYCTU,Rv0176,Rv0176,GO:0005886; GO:0016021; GO:0044117; GO:0044119,IPR010432; ,,,,Probable conserved Mce associated transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MTVVVEKTPTTLPQATPNGAAPWHVRAGAFAIDVLPGLAVAATMALTALTVPPGSAWRWLCACLLGLTILLLAVNRLLLPTITGWSLGRALTGIRVVRRDGSAIGPWRLLVRDLAHLVDTLSLFVGWLWPLWDSRRRTFADLLLRTEVRRVEPVQRPAVIRRLTAAVALAAAGACASATAVGAAVVYVNEWQTDHTRAQLATRGPKLVVDVLSYDPETVQRDFERARSLATDRYRPQLSIQQDSVRESGPVRNQYWVTDSAVLSATPAQATMLLFMQGERGTPPNQRYIQSTVRAIFQKSRGQWRLDDLAVVMKPRQPTGEK,"35,437",322,,growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P96817,P96817_MYCTU,Rv0140,Rv0140,GO:0005576,IPR007361; ,,,,Conserved protein,extracellular region [GO:0005576],9634230; 21969609,,,MSNRIVLEPSADHPITIEPTNRRVQVRVNGEVVADTAAALCLQEASYPAVQYIPLADVVQDRLIRTETSTYCPFKGEASYYSVTTDAGDIVDDVMWTYENPYPAVAAIAGHVACYPDKAEISIFPG,"13,766",126,,,,extracellular region [GO:0005576],,,1
P96815,P96815_MYCTU,Rv0138,Rv0138,,IPR032710; IPR037401; ,,,DOMAIN 24 125 SnoaL-like. {ECO:0000259|Pfam:PF12680}.,Uncharacterized protein,,9634230; 21969609,,,MSASEFSRAELAAAFEKFEKTVARAAATRDWDCWVQHYTPDVEYIEHAAGIMRGRQRVRAWIQETMTTFPGSHMVAFPSLWSVIDESTGRIICELDNPMLDPGDGSVISATNISIITYAGNGQWCRQEDIYNPLRFLRAAMKWCRKAQELGTLDEDAARWMRRHGGP,"18,972",167,,,,,,,2
O53650,O53650_MYCTU,Rv0199,Rv0199,GO:0005576; GO:0005887; GO:0044121,,,,,Probable conserved membrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; growth of symbiont in host organelle [GO:0044121],9634230; 21969609,,,MPDGEQSQPPAQEDAEDDSRPDAAEAAAAEPKSSAGPMFSTYGIASTLLGVLSVAAVVLGAMIWSAHRDDSGERTYLTRVMLTAAEWTAVLINMNADNIDASLQRLHDGTVGQLNTDFDAVVQPYRQVVEKLRTHSSGRIEAVAIDTVHRELDTQSGAARPVVTTKLPPFATRTDSVLLVATSVSENAGAKPQTVHWNLRLDVSDVDGKLMISRLESIR,"23,520",219,,growth of symbiont in host organelle [GO:0044121],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
P96418,P96418_MYCTU,Rv0235c,Rv0235c,GO:0016021; GO:0051604,IPR009613; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; protein maturation [GO:0051604],9634230; 21969609,,,MGWFSAPEYWLGRLALERGTAIIYLIAFVAAAQQFRPLIGEHGMLPVPRYLAGQSFWRTPSIFHFRYSDRVFAGVCWLGAVLSAAVVAGAASFVPLWATMLIWLTLWVLYLSIVNVGQAWYSFGWESLLLETGFLMIFLGNERTAPPILTLLLARWLLFRVEFGAGLIKMRGDSCWRSLTCLYYHHETQPMPGPLSWFFHHLPKPLHRIEVAGNHFAQLVVPFGLFTPQPAASIAAAIIVVTQLWLVASGNFSWLNWLTILLACSAIDTSSAAALLPMPAQPALSAPPQWFAGLVVVFTAAVLLLSYWPARNLLSSHQRMNMSFNPFHLVNTYGAFGSICRTRREVVIEGTDESPITEQTVWKAYEFKGKPGDPRRLPRQWAPYHLRLDWLMWFAAISPGYALPWMTPFLNRLLRNDPATLKLLRHNPFPQSPPRYVRAQLYQYRFTTVAELRRDRAWWHRTLIGRYVPPMSLRKVASPPAD,"54,837",482,,protein maturation [GO:0051604],,integral component of membrane [GO:0016021],,,1
O07424,O07424_MYCTU,Rv0180c,Rv0180c,GO:0005618; GO:0005886; GO:0005887,IPR022703; ,,,,Probable conserved transmembrane protein,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MSQAQPRPAAPNPKRNVKAIRTVRFWMAPIATTLALMSALAALYLGGILNPMTNLRHFPIALVNEDAGPAGQQIVDGLVSGLDKNKFDIRVVSPDEARRLLDTAAVYGSALIPPTFSSQLRDFGASAVTPTRTDRPAITISTNPRAGTLAASIAGQTLTRALTVVNGKVGERLTAEVAAQTGGVALAGAAAAGLASPIDVKSTAYNPLPNGTGNGLSAFYYALLLLLAGFTGSIVVSTLVDSMLGYVPAEFGPVYRFAEQVNISRFRTLLVKWAVMVVLALLTSGVYLAIAHGLGMPIPLGWQVWLYGVFAIIAVGVTSSSLIAVLGSMGLLVSMLIFVILGLPSAGATVPLEAVPAFFRWLAQFEPMHQVFLGVRSLLYLNGNADAGLSQALTMTSIGLIIGLLLGGFITHLYDRSSFHRIPGAVEMAIAVEHQAQYQARQSARESSSEQP,"47,593",452,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P95198,P95198_MYCTU,Rv0390,Rv0390,,IPR001763; IPR036873; ,,,,Conserved protein,,9634230; 21969609,X-ray crystallography (1),,MSYAGDITPLQAWEMLSDNPRAVLVDVRCEAEWRFVGVPDLSSLGREVVYVEWATSDGTHNDNFLAELRDRIPADADQHERPVIFLCRSGNRSIGAAEVATEAGITPAYNVLDGFEGHLDAEGHRGATGWRAVGLPWRQG,"15,392",140,,,,,,,2
P96391,P96391_MYCTU,Rv0209,Rv0209,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MRGQGHQIFVDELARFATSSADQRVVAIAQRAAEPLRVAVRGRPGVGCRTVARALQGAGSSSGMTVTPQARAADSDVDLVVYVTVEVVKPEDREAIAATRRPVVAVLNKADLAGPLSGAGPIVMAQARCAQFSTLLGVPMESMIGLLAVAALDDLDDTLRAVLRALAAHPDGFDALDRAVAGFLAAALPVPTEVRLRLLDTLDLFGIALGMAAFRPGRPSRTPAQLRTLLRRVSGVDAVIDKVTAAGSEVRYRRLLDAVAELEALAAQAKEIGGPIGEFLRDDDTVLARMAAAVDVALAVGLDVGPLDDPAAHLPRAVRWHRYSLDNGDMHRTCGADIARGSLRLWSLAGGMPLHRYRKSS,"38,132",361,,,,plasma membrane [GO:0005886],,,1
P96408,P96408_MYCTU,Rv0226c,Rv0226c,GO:0005886; GO:0016021; GO:0040007,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MRWFRPGYALVLVLLLAAPLLRPGYLLLRDAVSTPRSYVSANALGLTSAPRATPQDFAVALASHLVDGGVVVKALLLLGLWLAGWGAARLVATALPAAGAAGQFVAITLAIWNPYVAERLLQGHWSLLVGYGCLPWVATAMLTMRTTVGAGWFGLFGLAFWVALAGLTPSGLLLAATVAVVCVAMPGAGRPRWQCGVAALGSALVGALPWLTASALGSSLTSHTAANQLGVTAFAPRAEPGLGTLGSLASLGGIWNGEAVPSSRTTLFAVASAVVLLAMVAIGLPTVARRPVAVPLLTLAAVSVMVPAVLATGPGLHALRVVVDAAPGLGVLRDGQKWVALAVPGYTLSGAGTVLTLRRWLRPATAAVVCCLALVLTLPDLAWGVWGKVAPVHYPSGWAAVAAAINADPRTVAVLPAGTMRRFSWSGSAPVLDPLPRWVRADVLTTGDLVISGVTVPGEDAHARAVQELLLTGPHPSTLAAAGVGWLVVESDSAGDMGAAARTLGRLAAAHRDDELALYRVGGQTSGASSARLKATMLAHWAWLSMLLVGGAGAAGYWVRRHLHHCEDTPASRAQD,"59,139",576,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
O53664,O53664_MYCTU,Rv0241c,htdX Rv0241c,GO:0004312; GO:0005835; GO:0005886; GO:0006631; GO:0006633; GO:0018812; GO:0019171; GO:0055114,IPR003965; IPR029069; IPR002539; ,,htdX,,Probable 3-hydroxyacyl-thioester dehydratase HtdX,fatty acid synthase complex [GO:0005835]; plasma membrane [GO:0005886]; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; fatty acid synthase activity [GO:0004312]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; oxidation-reduction process [GO:0055114],9634230; 21969609; ,X-ray crystallography (2),,MTQPSGLKNLLRAAAGALPVVPRTDQLPNRTVTVEELPIDPANVAAYAAVTGLRYGNQVPLTYPFALTFPSVMSLVTGFDFPFAAMGAIHTENHITQYRPIAVTDAVGVRVRAENLREHRRGLLVDLVTNVSVGNDVAWHQVTTFLHQQRTSLSGEPKPPPQKKPKLPPPAAVLRITPAKIRRYAAVGGDHNPIHTNPIAAKLFGFPTVIAHGMFTAAAVLANIEARFPDAVRYSVRFAKPVLLPATAGLYVAEGDGGWDLTLRNMAKGYPHLTATVRGL,"30,195",280,,fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; oxidation-reduction process [GO:0055114],3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; fatty acid synthase activity [GO:0004312],fatty acid synthase complex [GO:0005835]; plasma membrane [GO:0005886],,,1
P96819,P96819_MYCTU,Rv0142,Rv0142,GO:0005618; GO:0005737; GO:0006285; GO:0006307; GO:0008725; GO:0032131; GO:0032993; GO:0043916,IPR011257; IPR003265; ,,,,Uncharacterized protein,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; protein-DNA complex [GO:0032993]; alkylated DNA binding [GO:0032131]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-7-methylguanine glycosylase activity [GO:0043916]; base-excision repair, AP site formation [GO:0006285]; DNA dealkylation involved in DNA repair [GO:0006307]",9634230,,,MRSIDVVVEAVVTFAGAAGFAHTLAPLRRGQQDPCFRVPGDGTIWRTSLLPTGPVTARISRAGRDAARCVAWGSGAEEFVDMAPAMLGAADDASDFVPLHPAVAAAHRRLPNLRLGRTGQVLEALIPAVIEQRVPGADAFRSWRLLVSKYGTQAPGPAPPGMRVPPSAEVWRHIPSWEFHRANVDPGRARAVVGCAQRAASLERLVSLPAARAAEALTSLPGVGVWTAAETTQRVFGDADAVSVGDYHIPKMIGWTLVGRPVDDAGMLELLEPMRPHRHRVVRLLEASGLAREPRRGPRLPVQNIRAL,"33,055",308,,"base-excision repair, AP site formation [GO:0006285]; DNA dealkylation involved in DNA repair [GO:0006307]",alkylated DNA binding [GO:0032131]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-7-methylguanine glycosylase activity [GO:0043916],cell wall [GO:0005618]; cytoplasm [GO:0005737]; protein-DNA complex [GO:0032993],,,2
P96392,P96392_MYCTU,Rv0210,Rv0210,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MIRAASDDPAGVDELVAAIAPGLAGLGLPVINRREVVLVTGPWLAGVSGVRAALAERLPQRRFVETAELGPGDAPVAVVFVVSAATALTESDCVLLDTAAEHTDAVVAVVSKIDVHRGWRDVLTSNRDRLAARASRYARVPWVGAAAAPELGEPYLDDLVAAIQKQLADPAVARRNMLRAWESRLLMVARRFDGDAQSAGRRARVDALRQQRRTVLRQGRQSKSEHTIALRAQIQHARVKLSYFARNRCSLLRVELQEHVAGLSRKDIARFAAYTRGRVQEVVAEVGEGAVAHLADVAQLLGVPVQPPVLENLPAVLPTVVAPPLTSRRLEIRLTTLLGAGFGLGIALTLSRLVAGLTPGLAASGMVAGVAIGLAVTAWVVNARALLHDRVVVDRWTGEVTASLRSVVEQLVATRVVAVETLLSTAISERDDAENARVADQVSIIDGELREHAVAAARAAALRDREMPAVRAALEAVRAELGEPGAPTTGLF,"52,346",492,,,,integral component of membrane [GO:0016021],,,2
O53676,O53676_MYCTU,Rv0254c,cobU Rv0254c,GO:0005525; GO:0009236; GO:0016779; GO:0043752,IPR003203; IPR027417; ,,cobU,,Probable bifunctional cobalamin biosynthesis protein CobU: cobinamide kinase + cobinamide phosphate guanylyltransferase,adenosylcobinamide kinase activity [GO:0043752]; GTP binding [GO:0005525]; nucleotidyltransferase activity [GO:0016779]; cobalamin biosynthetic process [GO:0009236],9634230; 21969609,,,MRILVTGGVRSGKSTHAEALLGDAADVVYVAPGRPAAGSDPDWDARVALHRARRPPTWLTVETADVATALSEARSPVLVDCLGTWLTAIMDGEALWSAATADVYAVLEARLDGLCAALTGLPTAIVVTNEVGLGVVPSHSSGVLFRDLLGTINRRVAAVCDEVHLVIAGRVLKL,"18,142",174,,cobalamin biosynthetic process [GO:0009236],adenosylcobinamide kinase activity [GO:0043752]; GTP binding [GO:0005525]; nucleotidyltransferase activity [GO:0016779],,,,1
L0T643,L0T643_MYCTU,Rv0323c,Rv0323c,,IPR003737; IPR024078; ,,,,Uncharacterized protein,,9634230; 21969609,,,MNSCNRLPCAHEVLAVFAHPDDESFGLGAVLGDFTAQGTRLRGLCFTHGEASTLGRTDRNLGEVRREELAAAAQVLGVDHVQLLAYPDNGLAQIPLNELTQRVVDALAGADLLLVFDDNGVTGHPDHRRATEAALAAASTPSIPVLAWALPQPIADRLNAEFSASFGGRGHGHLDIMIEVDRSRQLAAIGCHFTQSADNPVLWRRLELLGDREYLRWLRRSVP,"24,211",223,,,,,,,1
I6Y7N2,I6Y7N2_MYCTU,Rv0375c,Rv0375c,GO:0016614; GO:0050660,IPR005107; IPR036683; IPR016166; IPR036318; IPR016167; IPR002346; ,,,DOMAIN 1 169 FAD-binding PCMH-type. {ECO:0000259|PROSITE:PS51387}.,Probable carbon monoxyde dehydrogenase (Medium chain),"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230,,,MDHAIGLLDRLGEGARVVAGGHSLLPMMKLRIANPEYLVDINDLAPELGYVVVGGINNPNLVRLGAMTRHREILDSDALAAVCPIFRDAERVIADPVVRNRGTLGGSLCQADPAEDLSTVCTVLDAVCLAKGPSGEREIAIDDFLVGPYETALAHNEVLIEVRIPLRHNTSSAYAKVERRVGDWAITAAGAAVTLDGQTILAARVGLTAVNPDPVALAELSAGLVGQPATEEVFAEAGRRAAQACTPVTDVRGTAEYKRHLAGELTVRTLRTAAGRVLGAPAAPEA,"29,997",286,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,2
O33270,O33270_MYCTU,Rv0340,Rv0340,GO:0005576,,,,,Conserved protein,extracellular region [GO:0005576],9634230; 21969609,,,MANSLLDFVISLVRDPEAAARYAANPERSIAEAHLTDVTRADVNSLIPVVSDSLSMSEPIGAAGGAHAGDRGNVWASGAATAALDAFAPHADAGVVQQHGAVGSVLNQPTPPGPGVTPTDPRPFRAGPHETSALLTSAEIPDTTSEDGGLPTDHPAVWNHPVVDPHTVEPDHHGYDIHG,"18,383",179,,,,extracellular region [GO:0005576],,,1
O06315,O06315_MYCTU,Rv0365c,Rv0365c,GO:0003824; GO:0005886; GO:0044119,IPR008928; IPR005198; IPR014512; ,,,,Conserved protein,plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MNLANRAASAETAVTQRHLRRLWALPGTQLAVVAWPSTRRDRLFGSWHYWWQAHLLDCLVDAQLRDPQPQRRARINRQVRSHRVRNNFSWLNSYYDDMAWLALALERADRVAGVRRRRALPKLTNQFVEAWVPEDGGGIPWRKQDQFFNAPANGPAGLFLARYPDQYGKRLKRAEQMADWIDRTLIDPETHLVFDGIKAGSLVRAQYTYCQGVVLGLETELAVRTGPAARARHCARVHRLVAAVNEHMAPLGVLRGAGGGDGGLFAGITARYLALVATTLPGDSADDAAARDTARAIVLASAQSAWDYRQTVDGLPVFGAFWDREAELPTAGGEQARSVRGAVHSSAIAERDLSVQLSGWMLMEAAHSAAAVSSLG,"41,504",376,,growth of symbiont in host cell [GO:0044119],catalytic activity [GO:0003824],plasma membrane [GO:0005886],,,2
O53720,O53720_MYCTU,Rv0386,Rv0386,GO:0003677; GO:0004016; GO:0004383; GO:0005618; GO:0005622; GO:0005886; GO:0006171; GO:0006351; GO:0006355; GO:0009405; GO:0030145; GO:0035556,IPR001054; IPR029787; IPR027417; IPR016032; IPR011990; IPR000792; IPR036388; ,,,DOMAIN 11 119 Guanylate cyclase. {ECO:0000259|PROSITE:PS50125}.; DOMAIN 1020 1085 HTH luxR-type. {ECO:0000259|PROSITE:PS50043}.,Probable transcriptional regulatory protein (Probably LuxR/UhpA-family),"cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; DNA binding [GO:0003677]; guanylate cyclase activity [GO:0004383]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSKLLPRGTVTLLLADVEGSTWLWETHPDDMGAAVARLDKAVSGVIAAHDGVRPVEQGEGDSFVLAFACASDAVAAALDLQRARLAPIRLRIGVHTGEVALRDEGNYAGPTINRTARLRDLAHGGQTVLSGVTESLVIDRLPDKAWLVDLGTHALRDLSRPERVMQLCHPELRIDFPPLRVANDDVAHGLPVHLTRFVGRGAQITEVHRLVTDNRLVTLTGAGGVGKTRLAAQLAAQIAGEFGRAWFVDLAPITDPDLVPVTVAGALGLHDQPGRSTTDTVLRFLGGRPALVVLDNCEHLLDATAALVLALVKACRGVRLLATCREPLRVEGEVSYRVPSLSLSDEAVEMFCYRAQRVRPDFRLTDDNSAAVTEICKRLDGLPLAIELAAARLRSMTLDEIIDGLRDRFALLTGGARTAAHRQQTLWASVDWSYTLLTEPERTLFRRLAVFVGCFFVDDAQAVACSGDVQRYQVLDEITLLVDKSLVMADDNSGRTCYRLCETMRHYALEKLSEAGEVDAVFARHRDYYTALAARVDNPGPSDYSHCLDQAETEIDNLRAAFVWNRENSDTEGALALASSLLRVWMTRGRIQEGRAWFDSILADENARHLEVAAAVRARALADKALLDIFVDAAAGMEQAQQALVIAREVDEPALLSRALTACGLIAVAVARADAAASYFAEAIDLARAVDDRWRLAQILTFQAVDAVVAGDPVAARPAAQEARELAAAIGDHSNALWCRWCLGYAQLMRGELAAAAAQFGEVVDEAEASQEVLHKANSLQGLAFALAYQGELSAARAAADAALEAAELGEYFAGMGYSALTTAALAAGDVQTAQHASEAAWRNLSLALPLSAAVQRAFNAQAALAGGDLSAARRWCDDAVQSMTGHHLAMALATRARIAVAEGKREEAERDAHKALACAAESGAHLDLPDVLECLAGLASDAGTHHAAARLFGAAEAIRQQIGSVRFAIYRSDYVQSVTALRDAMGEKDFDAAWAEGAALSIKETIAYAQRGHSWRKRPATGWESLTPTEIDVVRLVGEGLANKDIATRLFVSPRTVQTHLTHVYTKLGFTSRLQLAQAAARRT,"116,792",1085,,"cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",adenylate cyclase activity [GO:0004016]; DNA binding [GO:0003677]; guanylate cyclase activity [GO:0004383]; manganese ion binding [GO:0030145],cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,3
O06312,O06312_MYCTU,Rv0362,mgtE Rv0362,GO:0005886; GO:0015095; GO:0016021; GO:0046872,IPR000644; IPR006668; IPR038076; IPR038048; IPR006669; IPR006667; IPR036739; ,,mgtE,,Magnesium transporter MgtE,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion transmembrane transporter activity [GO:0015095]; metal ion binding [GO:0046872],9634230,,FUNCTION: Acts as a magnesium transporter. {ECO:0000256|RuleBase:RU362011}.,MSIRPAENSTLDIRHVIGIGTPKAVDLWLDVVTELPDRARELGSLSKAELGKLGPLLDGTNAVELFESIDDKLAAEALHAMDPSLAATFLEALDSDHAANILREFKEPKREALLTLLPLERAMVLRGLLSWPEDCAAAHMVPETLTVRPNMTVSQAVASVRERASGLRSDARTTAYVYVTDADSHLLGVIAFRALVLANPEQRVRELMGDDLIVVSPLTDKELAAQTIMGHNLMAVPVVDADNRLLGIIAEDEAIDIAEEEATEDAERQGGSAPLEVPYLRASPWLLWRKRVVWLLVLFAAEAYTGSVLRAFSDEMEAVIALAFFIPLLIGTGGNTGTQIATTLVRAMATGQVRFRDVPAVLAKELSTGVLVGLTMAAAAVVRAWTLGVGPQVTLTVALTVAAIVVWSSLVAAVLPPLLKKLRIDPAIVSGPMIATIVDGTGLLIYFLVAHLTLTELHGL,"49,317",460,SLC41A transporter family,,magnesium ion transmembrane transporter activity [GO:0015095]; metal ion binding [GO:0046872],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
Q10883,Q10883_MYCTU,Rv0086,hycQ Rv0086,GO:0016021; GO:0040007,IPR001750; ,,hycQ,,Possible hydrogenase HycQ,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230,,,MTGLLLAAILAPLAASIASLITGWRRTTATLTALSATTVLACAVAMGFWMGSGAQFGLGGLLRADALTVVMLVVIGIVGTLATAASIGYIDTELAHGHIDGRSARLYGVLTPAFLCAMVLAVCANNIGVIWVAIEATTVITAFLVGHRRTRTALEATWKYVVICSVGIAVAFLGTVLLYFAARDSGAAAAGALNLDILAEHAAGLDPGVARLAGGLLLIGYGAKAGLFPFHTWLADAHSQAPAPVSALMSGVLLAVAFSVLIRLRPILDAVSGPAYLRNGLLVVGLATLLVAVLMLTVTGDVKRMLAYSSMEHMGLIAIAAAAGTTLAIAALLLHVLAHGIGKTVLFLAGGQLQAAHDSTAIADITGVMRRSRLIGVSFAVGLIVLLGLPPFAMFASELAIARSLANERLAWVLGAALLLIAIGFTALARNSGRMLLGTPAAGAPAITVPATAAAALMVGIVVSAALGITAGPLADLLGIAASNVGLP,"49,227",488,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,1
P96827,P96827_MYCTU,Rv0150c,Rv0150c,,,,,,Uncharacterized protein,,9634230,,,MLTLPDDRAPTGLPDPGIEALAHTKIASTISTVVADGYAVVLSTADIANSLLANAIGYPIAASVALVTPAAGANSSCWPADPSQHHRIAESRACA,"9,563",95,,,,,,,1
P96404,P96404_MYCTU,Rv0222,echA1 Rv0222,GO:0004300; GO:0006635,IPR029045; IPR018376; IPR001753; IPR014748; ,,echA1,,Probable enoyl-CoA hydratase EchA1 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609; ,X-ray crystallography (1),,MSSESDAANTEPEVLVEQRDRILIITINRPKAKNAVNAAVSRGLADAMDQLDGDAGLSVAILTGGGGSFCAGMDLKAFARGENVVVEGRGLGFTERPPTKPLIAAVEGYALAGGTELALAADLIVAARDSAFGIPEVKRGLVAGGGGLLRLPERIPYAIAMELALTGDNLPAERAHELGLVNVLAEPGTALDAAIALAEKITANGPLAVVATKRIITESRGWSPDTMFAEQMKILVPVFTSNDAKEGAIAFAERRRPRWTGT,"27,280",262,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],,,,1
L7N677,L7N677_MYCTU,Rv0117,oxyS Rv0117,GO:0000986; GO:0003700; GO:0005829; GO:0006351,IPR005119; IPR000847; IPR036388; IPR036390; ,,oxyS,DOMAIN 1 57 HTH lysR-type. {ECO:0000259|PROSITE:PS50931}.,Oxidative stress response regulatory protein OxyS,"cytosol [GO:0005829]; bacterial-type proximal promoter sequence-specific DNA binding [GO:0000986]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MLFRQLEYFVAVAQERHFARAAEKCYVSQPALSSAIAKLERELNVTLINRGHSFEGLTREGERLVVWAKRILAEHAAFKAEVDAVRSGITGTLRLGTVPTASTTASLVLSAFCSAHPLAKVQVCSRLAATELYRRLREFELDAVIVHPETQDSDDVDLVPLYEEQYVLLSPADMLPPGTSTLVWRDAAQLPLALLTADMRDRQVIDAAFADHAVSAIPQVETDSVASLFAQVATGNWASIVPHTWLWAMPMSGPTGGEIRAVELVDPVLKAQIALATNALGPGSPVARALITCAQALALNEFFDTQLRGITRRR,"34,223",314,,"transcription, DNA-templated [GO:0006351]",bacterial-type proximal promoter sequence-specific DNA binding [GO:0000986]; DNA binding transcription factor activity [GO:0003700],cytosol [GO:0005829],,,1
I6WXK4,I6WXK4_MYCTU,Rv0153c,ptbB Rv0153c,GO:0004725; GO:0005737,IPR029021; IPR026893; IPR000387; ,,ptbB,,Phosphotyrosine protein phosphatase PTPB (Protein-tyrosine-phosphatase) (PTPase),cytoplasm [GO:0005737]; protein tyrosine phosphatase activity [GO:0004725],9634230; 21969609,,,MAVRELPGAWNFRDVADTATALRPGRLFRSSELSRLDDAGRATLRRLGITDVADLRSSREVARRGPGRVPDGIDVHLLPFPDLADDDADDSAPHETAFKRLLTNDGSNGESGESSQSINDAATRYMTDEYRQFPTRNGAQRALHRVVTLLAAGRPVLTHCFAGKDRTGFVVALVLEAVGLDRDVIVADYLRSNDSVPQLRARISEMIQQRFDTELAPEVVTFTKARLSDGVLGVRAEYLAAARQTIDETYGSLGGYLRDAGISQATVNRMRGVLLG,"30,154",276,,,protein tyrosine phosphatase activity [GO:0004725],cytoplasm [GO:0005737],,,1
P96811,P96811_MYCTU,Rv0134,ephF Rv0134,GO:0005886; GO:0016787,IPR029058; IPR000073; IPR000639; ,,ephF,DOMAIN 34 281 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Possible epoxide hydrolase EphF (Epoxide hydratase) (Arene-oxide hydratase),plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MIALPALEGVEHRHVDVAEGVRIHVADAGPADGPAVMLVHGFPQNWWEWRDLIGPLAADGNRVLCPDLRGAGWSSAPRSRYTKTEMADDLAAVLDGLGVAKVKLVAHDWGGPVAFIMMLRHPEKVTGFFGVNTVAPWVKRDLGMLRNMWRFWYQIPMSLPVIGPRVISDPKGRYFRLLTGWVGGGFRVPDDDVRLYLDCMREPGHAEAGSRWYRTFQTREMLRWLRGEYNDARVDVPVRWLHGTGDPVITPDLLDGYAERASDFEVELVDGVGHWIVEQRPELVLDRVRAFLAAGTEQRD,"33,797",300,,,hydrolase activity [GO:0016787],plasma membrane [GO:0005886],,,1
O53611,O53611_MYCTU,Rv0066c,icd2 Rv0066c,GO:0000287; GO:0004448; GO:0004450; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006097; GO:0006099; GO:0006102; GO:0042803,IPR004436; ,,icd2,,Probable isocitrate dehydrogenase [NADP] Icd2 (Oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609; ,X-ray crystallography (1),,MSAEQPTIIYTLTDEAPLLATYAFLPIVRAFAEPAGIKIEASDISVAARILAEFPDYLTEEQRVPDNLAELGRLTQLPDTNIIKLPNISASVPQLVAAIKELQDKGYAVPDYPADPKTDQEKAIKERYARCLGSAVNPVLRQGNSDRRAPKAVKEYARKHPHSMGEWSMASRTHVAHMRHGDFYAGEKSMTLDRARNVRMELLAKSGKTIVLKPEVPLDDGDVIDSMFMSKKALCDFYEEQMQDAFETGVMFSLHVKATMMKVSHPIVFGHAVRIFYKDAFAKHQELFDDLGVNVNNGLSDLYSKIESLPASQRDEIIEDLHRCHEHRPELAMVDSARGISNFHSPSDVIVDASMPAMIRAGGKMYGADGKLKDTKAVNPESTFSRIYQEIINFCKTNGQFDPTTMGTVPNVGLMAQQAEEYGSHDKTFEIPEDGVANIVDVATGEVLLTENVEAGDIWRMCIVKDAPIRDWVKLAVTRARISGMPVLFWLDPYRPHENELIKKVKTYLKDHDTEGLDIQIMSQVRSMRYTCERLVRGLDTIAATGNILRDYLTDLFPILELGTSAKMLSVVPLMAGGGMYETGAGGSAPKHVKQLVEENHLRWDSLGEFLALGAGFEDIGIKTGNERAKLLGKTLDAAIGKLLDNDKSPSRKTGELDNRGSQFYLAMYWAQELAAQTDDQQLAEHFASLADVLTKNEDVIVRELTEVQGEPVDIGGYYAPDSDMTTAVMRPSKTFNAALEAVQG,"82,550",745,,glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],isocitrate dehydrogenase (NADP+) activity [GO:0004450]; isocitrate dehydrogenase activity [GO:0004448]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P71704,P71704_MYCTU,Rv0047c,Rv0047c,,IPR005149; IPR036388; IPR036390; ,,,,Conserved protein,,9634230; 21969609,,,MLELAILGLLIESPMHGYELRKRLTGLLGAFRAFSYGSLYPALRRMQADGLIAENAAPAGTPVRRARRVYQLTDKGRRRFGELVADTGPHNYTDDGFGVHLAFFNRTPAEARMRILEGRRRQVEERREGLREAVARASSSFDRYTRQLHQLGLESSEREVKWLNELIAAERAAPNPAEQT,"20,408",180,,,,,,,1
L7N661,L7N661_MYCTU,Rv0160c,PE4 Rv0160c,,IPR029058; IPR000084; IPR013228; ,,PE4,,PE family protein PE4,,9634230,,,MSHLVTAPDMLATAAAHVDEIASTLRAANAAAAGPTCNLLAAAGDEVSAATAALFSAYGREYQAVVKQAAAFHSEFTRTLEAAGNAYAHAEAANAARVSHALDTINAPIRTLLGRAPLSPNGSSGAGGLPAIAQLAAESPITALIMGGTNNPLPDPEYVTDINKAFIQTLFPGAVSQGLFTPEQFWPVTPDLGNLTFNQSVTEGVALLNTAVNNQLALDNKVVAFGYSQSATIINNYINSLMAMGSPNPDDISFVMIGSGNNPVGGLLARFPGFYIPFLDVPFNGATPANSPYPTHIYTAQYDGIAHAPQFPLRILSDINAFMGYFYVHNTYPELMATQVDNAVPLPTSPGYTGNTQYYMFLTQDLPLLQPIRDIPYAGPPIADLFQPQLRVLVDLGYADYGPGGNYADIPTPAGLFSIPNPFAVTYYLIKGSLQAPYGAIVEIGVEAGLIGPEWFPDSYPWVPSINPGLNFYFGQPQVTLLSLMSGGLGNILHLIPPPVFT,"53,055",502,,,,,,,1
O53697,O53697_MYCTU,Rv0293c,Rv0293c,GO:0016787,IPR029058; IPR000073; ,,,DOMAIN 170 301 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Conserved protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MSGTFTADAIGPPVPIPDVPGADAGAEGLPSRSVLSARQRILVESSAIADVALRTAVASVLSATVTPAVVANALRHVNEGSERSNLNFYAELAAAHDPAKSFPAPTELPKVTSRPASPLTEWVARGTVDNIAFASGFRAINPTMRQRWSALTANNIVHAQHWRHRDGPRPTLCVIHGFMGSSYLLNGLFFSLPWYYRSGYDVLLYTLPFHGQRAEKFSPFSGFGYFTSGLSGFAEAMAQAVYDFRSIVDYLRHIGVDRIALTGISLGGYTSALLASVESRLEAVIPNCPVVMPAKLFDEWFPANKLVKLGLRLTNISRDELIAGLAYHGPLNYRPLLPKDRRMIITGLGDRMAPPEHAVTLWKQWDRCALHWFPGSHLLHVSQLDYLRRMTVFLQGLMFD,"43,971",400,,,hydrolase activity [GO:0016787],,,,1
O07237,O07237_MYCTU,Rv0310c,Rv0310c,,IPR032710; IPR037401; ,,,DOMAIN 14 134 SnoaL-like. {ECO:0000259|Pfam:PF13577}.,Conserved protein,,9634230; 21969609,,,MCCNGVVTPGDPADIAAIKQLKYRYLRALDTKHWDDFTDTLAEDVTGDYGSSVGTELHFTNRADLVDYLRQALGPGVITEHRVTHPEITVTGDTATGIWYLQDRVIVAEFNFMLIGAAFYHDQYRRTTDGWRISATGYDRTYEATMSLAGLNFNIRPGRALAD,"18,242",163,,,,,,,1
P95216,P95216_MYCTU,Rv0259c,Rv0259c,GO:0009236; GO:0016852,IPR002762; ,,,,Uncharacterized protein,sirohydrochlorin cobaltochelatase activity [GO:0016852]; cobalamin biosynthetic process [GO:0009236],9634230,,,MNLILTAHGTRRPSGVAMIADIAAQVSALVDRTVQVAFVDVLGPSPSEVLSALSCRPAIVVPAFLSRGYHVRTDLPAHVAASAHPHVTVTPALGPCREIAQIVTQQLVESGWRPGDSVILAAAGASDRRARADLHTTRTLVSELTGSWVDMGFAGTGGPDVRTAVQRARDRAEANRGARRVAVASFLLAEGLFQERLRASGADVVTRPLGTHPGLAQLVANRFRSAVARQQRLHRWHGTPTPVTLDL,"26,250",247,,cobalamin biosynthetic process [GO:0009236],sirohydrochlorin cobaltochelatase activity [GO:0016852],,,,1
Q10881,Q10881_MYCTU,Rv0084,hycD Rv0084,GO:0016021; GO:0016829; GO:0055114,IPR001694; ,,hycD,,Possible formate hydrogenlyase HycD (FHL),integral component of membrane [GO:0016021]; lyase activity [GO:0016829]; oxidation-reduction process [GO:0055114],9634230,,,MSYLAGAAQIGGVMVGAPLVIGMTRQVRARWEGRAGAGLLQPWRDLLKQLGKQQITPAGTTIVFAAAPVIVAGTTLLIAAIAPLVATGSPLDPSADLFAVVGLLFLGTVALTLAGIDTGTSFGGMGASREITIAALVEPTILLAVFALSIPAGSANLGALVASTIDHPGHVVSLAGVLAFVALVIVIVAETGRLPVDNPATHLELTMVHEAMVLEYAGPRLALVEWAAGMRLTVLLALLANLFLPWGIAGAAPTALDVLTGVVAVAAKVAILAVLLATFEVFLAKLRLFRVPELLAGSFLLALLAVTAANFFTVGA,"32,153",316,,oxidation-reduction process [GO:0055114],lyase activity [GO:0016829],integral component of membrane [GO:0016021],,,1
O53619,O53619_MYCTU,Rv0074,Rv0074,GO:0005886; GO:0016810; GO:1901575,IPR006680; IPR011059; IPR032466; ,,,,Conserved protein,"plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; organic substance catabolic process [GO:1901575]",9634230; 21969609,,,MGDLSISQVSARPGRIGIRARQMFDGYRFQRGPVLVVVEDGRISAVDFAGSACPDMNLVDLGESTLLPGLVDAHAHLCWDPDGRPEDLAGDPHAVLVGRARRHAAAALRSGITTIRDLGDRDYAALALREEYRQKTTVGPELVVSGPPLTRSGGHCWFLGGVADSVEELVDAVQERAARGADWIKVMATGGFVTTASDPWQPQYGSGQLAAVVAAAEQVGLPVTAHAHATAGIAAAVAAGVDGIEHCTFLSEGSAAASPDVVEAIVAQGVWCGMTIPRVYPEMPENLVAVVQDGWRNIRRLIDAGARVALSTDAGVAPGRRHDVLPDDLVYLSRHGFTSTEVLTGATAAAAASCGLGHRKGRIAPGYDADLLAVAAGVDHDPAGLCDVKAVWRSGTQVPLQASAVGYNTPS,"42,791",411,,organic substance catabolic process [GO:1901575],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",plasma membrane [GO:0005886],,,1
L0T6B3,L0T6B3_MYCTU,Rv0388c,PPE9 Rv0388c,,IPR000030; IPR038332; ,,PPE9,,PPE family protein PPE9,,9634230,,,MDFGALPPEINSARIYSGPGSRPLMQAAAAWQRLANELTATAASYSSVISGLTGDDWLGPSALSMAAAAVPYVAWMRATAASAEQAAAQAVAAANAYESAYAATVPPTVIAANRRTMLSLVQTNVFGQNTPAIATSETHYGEMWAHDILAMDGYAGASGAASQLRRSPATGDHQRGRVAE,"18,587",180,Mycobacterial PPE family,,,,,,1
O07406,O07406_MYCTU,Rv0161,Rv0161,GO:0004458; GO:0019516; GO:0022904; GO:0031234; GO:0051990; GO:0071949,IPR016166; IPR036318; IPR016167; IPR016164; IPR004113; IPR006094; IPR016171; ,,,,Possible oxidoreductase,extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],9634230; 21969609,,,MLTSLVSAVGSHHVTTDPDVLAGRSVDHTGRYRGRASALVRPGSAEEVAEVLRVCRDAGAYVTVQGGRTSLVAGTVPEHDDVLLSTERLCVVSDVDTVERRIEIGAGVTLAAVQHAASTAGLVFGVDLSARDTATVGGMASTNAGGLRTVRYGNMGEQVVGLDVALPDGTVLRRHSRVRRDNTGYDLPALFVGAEGTLGVITALDLRLHPTPSHRVTAVCGFAELAALVDAGRMFRDVEGIAALELIDGRAAALTREHLGVRPPVEADWLLLVELAADHDQTDRLADLLGGARMCGEPAVGVDAAAQQRLWRTRESLAEVLGVYGPPLKFDVSLPLSAISGFARDAVALVHRHVPDSPEALPLLFGHIGEGNLHLNVLRCPPDREPALYAKMMGLIAECGGNVSSEHGVGSRKRAYLGMSRQANDVAAMRRVKAALDPTGYLNAAVLFD,"47,356",449,,lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],(R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949],extrinsic component of cytoplasmic side of plasma membrane [GO:0031234],,,2
O07251,O07251_MYCTU,Rv0326,Rv0326,GO:0005737; GO:0005829; GO:0008757; GO:0032259,IPR029063; ,,,,Uncharacterized protein,cytoplasm [GO:0005737]; cytosol [GO:0005829]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230,,,MVATDFSDVAVAQLRRSAQARGVSARVQPIVHDLRQPLPVKTGSIDGAFAHMALCMALSTSEIHAVVAEVGRVLRPGGKFIYTVRHTGDAHYGAGQAHGDDIFECAGFAVHFFRRELVARLATGWVLEEVHDFEEGELPRRLWRVTVTKPA,"16,558",151,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737]; cytosol [GO:0005829],,,1
I6X8E6,I6X8E6_MYCTU,Rv0061c,Rv0061c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MKLKFARLSTAILGCAAALVFPASVASADPPDPHQPDMTKGYCPGGRWGFGDLAVCDGEKYPDGSFWHQWMQTWFTGPQFYFDCVSGGEPLPGPPPPGGCGGAIPSEQPNAP,"11,813",112,,,,,,,1
P96833,P96833_MYCTU,Rv0156,pntAb Rv0156,GO:0005886; GO:0006740; GO:0008750; GO:0016021; GO:0050661; GO:0051287,IPR024605; ,,pntAb,,Probable NAD(P) transhydrogenase (Subunit alpha) PntAb [second part integral membrane protein] (Pyridine nucleotide transhydrogenase subunit alpha) (Nicotinamide nucleotide transhydrogenase subunit al...,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740],9634230; 21969609,,,MYNELLENLAILVLSGFVGFAVISKVPNTLHTPLMSGTNAIHGIVVLGALVVFGEIEHPSLVLQVILFVAVVFGTLNVIGGFIVTDRMLGMFKAKKPAVPAKPDRDEALR,"11,782",110,,NADPH regeneration [GO:0006740],NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD binding [GO:0051287]; NADP binding [GO:0050661],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53651,O53651_MYCTU,Rv0200,Rv0200,GO:0005886; GO:0016021,,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MRNAWRLVVFDVLAPLATIAALAAIGVLLGWPLWWVSTCSVLVLLVVEGVAINFWLLRRDSVTVGTDDDAPGLRLAVVFLCAAAISAAVVTGYLRWTTPDRDFNRDSREVVHLATGMAETVASFSPSAPAAAVDRAAAMMVPEHAGGFKEQYAKSSADLARRGVTAQAATLAAGVEAIGPSAASVAVILRVSQSIPGQPTSQAARALRVTLTKRGSGWLVLDVTPINAR,"24,029",229,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53702,O53702_MYCTU,Rv0367c,Rv0367c,,IPR021831; ,,,,Uncharacterized protein,,9634230,,,MPKAVDRVTRVAADLVDSAAAEGARQSRSAKQQLDHWARVGRAVSNQHTASRRRVEAALAGHLPMTDLTLEEGVVFNAEISAAIEERLSRTNYGDVLAAQGITTVALNDAGDIVEHRPDGTSVVLAATP,"13,680",129,,,,,,,1
O07252,O07252_MYCTU,Rv0328,Rv0328,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 5 65 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Possibly TetR/AcrR-family),cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MQQQRTNRDKLLDGALACLRERGYGNTSSRDIARAAGVNIASINYHFGSKDALLDDALGRCFSTWNQRVQEAFDHSRAAGPAGQILAVLEATVDSFEQIRPAVYACVESYAPALRSEALRERLAAGYADVRQHSVDLAGAALAGTDIAPPENLSTIVSVLMAVIDGLMIQWIADPSATPRSTEVIRALASIGAVVTSQLR,"21,411",200,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P95224,P95224_MYCTU,Rv0267,narU Rv0267,GO:0005886; GO:0005887; GO:0015112; GO:0015514; GO:0015707,IPR011701; IPR020846; IPR036259; IPR004737; ,,narU,,Probable integral membrane nitrite extrusion protein NarU (Nitrite facilitator),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514]; nitrite transport [GO:0015707],9634230,,,MALTTAPAIDYALPRQQDEGDHWIDDWRPEDPVFWETIGRPIARRNLIFSIFAEHVGFSVWMLWSIVVVQMTAAAPGHPAASGWALSASQALCLVAVPSGVGAFLRLPYTFAIPIFGGRNWTTVSAALLVIPCLLLAWAVSHPSLPFAVLVVIAATAGFGGGNFASSMANISFFYPEKDKGWALGLNAAGGNIGVAVVQKIIPPIVVAGSGVALSRAGLFFVPLAVAAAVCAFLFMNNLTEAKADVKPVWQSLRHADTWIMSLLYIGTFGSFIGYSAAFPTLLKTVFGRGDIALGWAFLGAGIGSLVRPLGGKLADRIGGARITAASFVMLAAGAAAALWSVQSVNLPVFFVSFMFLFVATGIGNGSSYRMISRIFQVKGEVAGGDPETMVNMRRQAAGALGIISSIGAFGGFVVPLAYAWSKVHFGNIEPALHFYVAFFLALLVVTWYCYLRRTTPMGQVGV,"49,134",463,,nitrite transport [GO:0015707],nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P96818,P96818_MYCTU,Rv0141c,Rv0141c,,IPR032710; IPR037401; ,,,DOMAIN 20 111 SnoaL-like. {ECO:0000259|Pfam:PF12680}.,Uncharacterized protein,,9634230; 21969609,,,MTPFDDPQAELAWMFLQSLCEGGDLDEGFALLSNDFTYWSIVTRTELDKKTFRRAVERRKQVFEVNIELIRCVNEGETVVVEGHCDGVSADRTRYDSPFVCIFETRDGMIISLREYSDTQSLAEVYPVACATPGRC,"15,490",136,,,,,,,1
L7N699,L7N699_MYCTU,Rv0035,fadD34 Rv0035,GO:0005886; GO:0006633; GO:0016874; GO:0070566,IPR000873; ,,fadD34,DOMAIN 17 436 AMP-binding. {ECO:0000259|Pfam:PF00501}.,Probable fatty-acid-CoA ligase FadD34 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MTAALLSPAIAWQQISACTDRTLTITCEDSEVISYQDLIARAAACIPPLRRLDLKRGEPVLITAHTNLEFLSCFLGLMLHGAVPVPIPPREALKTTERFMTRLGPLLRHHRVLICTPAEHDEIRAAASTDCQISRFTALAEAGDEQFGRATAQQLADTATADWPLCTLDDDAYVQYTSGSTAAPRGVVITYRNLLSNMRAMAVGSQFQHGDVMGSWLPLHHDMGLVGSLFAALFNSVSAVFTTPHRFLYDPLGFLRLLTSSGATHTFMPNFALEWLINAYHRRGADIEGIDLHKMRRLIIASEPVHAEGMRRFAATFAGVGLAPTALGSGYGLAEATVAVSMSAPNTGFRTETHAAAEVVTGGRVLPGYEVRIDAAPGARAGTIKLRGDSVAAKAYVGGKKLDALDEEGFCDTHDLGFLVDDEIVILGRQDEVFIVHGENRFPYDIEFIIRGESEQHRTKVACFGVNERVVVVLESPLDSIIDKAEADRLRCQVVAATGLQLDELITVRRGAIPTTTSGKLKRRAVAQAYRDGTLPRLATHAWTADPDSAPKTTRSSLEGAH,"60,962",562,,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
O07233,O07233_MYCTU,Rv0306,Rv0306,GO:0005618; GO:0016491,IPR012825; IPR029479; IPR000415; ,,,DOMAIN 14 178 Nitroreductase. {ECO:0000259|Pfam:PF00881}.,Putative oxidoreductase,cell wall [GO:0005618]; oxidoreductase activity [GO:0016491],9634230,,,MFSAPERRAVYRVIAERRDMRRFVPGGVVSEDVLARLLHAAHAAPSVGLMQPWRFIRITDETLKRRIHALVDDERLLTAEALGAREEEFLALKVEGILDCAELLVVALCDRRGSYIFGRRTLPQMDLASVSCAIQNLWLAARSEGLGMGWVSLFDPQRLAALLAMPADAEPVAILCLGPVPEFPDRPALELDGWAYARPLAEFVSENRWSYPSALATDHHHGE,"24,866",223,,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618],,,1
P95223,P95223_MYCTU,Rv0266c,oplA Rv0266c,GO:0005829; GO:0005886; GO:0006749; GO:0017168,IPR008040; IPR002821; IPR003692; ,,oplA,DOMAIN 8 183 Hydant_A_N. {ECO:0000259|Pfam:PF05378}.; DOMAIN 202 489 Hydantoinase_A. {ECO:0000259|Pfam:PF01968}.; DOMAIN 694 1200 Hydantoinase_B. {ECO:0000259|Pfam:PF02538}.,Probable 5-oxoprolinase OplA (5-oxo-L-prolinase) (Pyroglutamase) (5-OPASE),cytosol [GO:0005829]; plasma membrane [GO:0005886]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; glutathione metabolic process [GO:0006749],9634230; 21969609,,,MVGAGWHFWVDRGGTFTDVVARRPDGRLLTHKLLSDNPARYRDAAVAGIRALLANGEAGTRVDAVRMGTTVATNALLERTGERTLLVITRGFGDALRIAYQNRPRIFDRRIVLPEMLYERVVEVDERVTADGRVLRAPDLEALGEKMRQAHADGIRAVAVVCLHSYLYPGHEREIGTLAQRIGFAQISLSSEVSPLMKLVPRGDTTVVDAYLSPVLRRYINQVADQMRGVRLMFMQSNGGLAQAGHFRGKDAILSGPAGGIVGMVRMSALAGFDHVIGFDMGGTSTDVSHYAGEYERVFTTQVAGVRLRAPMLDIHTVAAGGGSILHFDGSRYRVGPDSAGADPGPACYRGGGPLCVTDANVMLGRIQPTHFPSVFGPSGDQPLDAGTVRRGFTDLAADIAARTGDDRSPEQVAEGYLRIAVANMANAVKKISVQKGHDVTRYALTTFGGAGGQHACAVADALGIRTVLIPPMAGVLSALGIGLADTTAMREQSVEIPLGPAAPQRLASVAESLERAARAELLDEGVPGERIRVVRRVHLRYEGTDTAIPVQLAEIETMATAFESSHRALYTFLLDRPLIAEAISVEATGLTDQPDLSQLGDQANDTTGSSETVRIYSNGLWRDAPLRRREAMRPGDVLTGPAIIAEANATTVVDDGWQATMTETGHLLAQRVVTPPRPDAATRAGFEAGFEADPVLLEIFNNLFMSIAEQMGFRLEATAQSVNIRERLDFSCALFDPDGNLVANAPHIPVHLGSMGTTVKEVIRRRLSGMKPGDVYAVNDPYHGGTHLPDITVITPVFNTGGEDVLFFVASRGHHAEIGGITPGSMPADSREIHEEGVLFDNWLLAENGRFREAETRRLLTEAPFGSRNPDTNLADLRAQIAANQKGVDEVGKMIDHFGRDVVAAYMRHVQDNAEEAVRRVIDRLDNGAYRYRMDSGATIAVRITVDRAARSATIDFTGTSAQLDTNFNAPTSVVNAAVLYVFRTLVADDIPLNDGCLRPLRIVVPEGSMLAPTHPAAVVAGNVETSQAITGALFAALGVQAEGSGTMNNVTFGNERHQYYETVGSGSGAGDGYHGASVVQTHMTNSRLTDPEVLEWRYPVLLREFAVRQGSGGAGRWRGGDGAVRRLEFTEPMTVSTLSGHRRVRPYGMAGGSPGELGRNRVERADGSTVELAGCGSTHVEPGDTLVIETPGGGGYGPASTSARRRR,"129,650",1209,,glutathione metabolic process [GO:0006749],5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O06298,O06298_MYCTU,Rv0347,Rv0347,GO:0005618; GO:0040007,IPR026349; ,,,,Probable conserved membrane protein,cell wall [GO:0005618]; growth [GO:0040007],9634230; 21969609,,,MPGARELTLRVERGALFRRRWAASAASSARAAIRRDPRRCALGTRPRWVSFLVIVLVIMNVVTAHPKYPNDPLALVLIELRHPRTEPPVPSAISILKEELARWTPILEQEEVRQVNLETGEHTAHSQKKLVARDRRTAITFRPDAMTLEVTDYPGWEEFRSIVHAMVTARQDVAPVDGCIRIGLRYINEIRASLAEPSGWAYWVAESLLGPGTQLADLKLTTTAQRHVIQCEGPEPGDSLTLRYAGARGAVIQSTPFLQRLKEPPAEGDFFLIDIDSAWSDPCKGIPALDAHLVDEVAERLHTPIGPLFESLITSELRTKVLQQPGQE,"36,597",328,,growth [GO:0040007],,cell wall [GO:0005618],,,1
O53670,O53670_MYCTU,Rv0248c,Rv0248c,GO:0005618; GO:0005886; GO:0009055; GO:0009061; GO:0016491,IPR003953; IPR036188; IPR037099; IPR015939; IPR027477; ,,,,Probable succinate dehydrogenase [iron-sulfur subunit] (Succinic dehydrogenase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491]; anaerobic respiration [GO:0009061],9634230; 21969609,,,MVEVERHSYDVVVIGAGGAGLRAVIEARERGLKVAVVCKSLFGKAHTVMAEGGCAAAMGNANPKDNWKTHFGDTMRGGKFLNNWRMAELHAKEAPDRVWELETYGALFDRTDDGRISQRNFGGHTYPRLAHVGDRTGLELIRTLQQKVVSLQQEDHAELGDYEARIKVFAECTITELLKDQGAIAGAFGYWRESGRFIVFEAPAVVLATGGIGKSFKVTSNSWEYTGDGHALALRAGATLINMEFVQFHPTGMVWPPSVKGILVTEGVRGDGGVLKNSENSRFMFDYIPPVFKGQYAETEEEADQWLKDNDSARRTPDLLPRDEVARAINSEVKAGRGTPHGGVYLDIASRLTPAEIKRRLPSMYHQFKELAEVDITTQAMEVGPTCHYVMGGVEVDADTGAATVPGLFAAGECAGGMHGSNRLGGNSLSDLLVFGRRAGLGAADYVRALSSRPAVSAEAIDAAAQQALSPFEGPKDGSAPENPYALHMDLQYVMNDLVGIIRNADEISRALTLLAELWSRYHNVLVEGHRQYNPGWNLSIDLRNMLLVSECVARAALQRTESRGGHTRDDHPGMDPNWRRILLVCRATETMGTGGSGSGDSNCHINVTQQLQTPMRPDLLELFEISELEKYYTDEELAEHPGRRG,"70,681",646,,anaerobic respiration [GO:0009061],electron transfer activity [GO:0009055]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P95215,P95215_MYCTU,Rv0258c,Rv0258c,,IPR036271; ,,,,Uncharacterized protein,,9634230,,,MARSQEPSRGLLDPVAKMLRLPFGTPDFIEKIVTGSVNQVGRRTLYVLITTWDAAGGGPFAASAIATTGLAKTAEIVQSMFIGPVFNPLLKMLGADKIAIRASLCAAQLVGLGIMRYGVRSEPLHSMSVEMLVDAIGPTMQRYLVGDIGRG,"16,047",151,,,,,,,1
O53707,O53707_MYCTU,Rv0372c,Rv0372c,GO:0040007,IPR003777; IPR027051; ,,,,Uncharacterized protein,growth [GO:0040007],9634230,,,MSISDRAAQLVAARTPFVRATVVRAQQPTSARPGDEAILLADGTIEGFVGGHCAQNSVRKAAMGVLQAGESVLLRVLPDGDVHFPEAPGACVVVNPCLAGGSLEIFLTPQLPAPLIQIYGETPIADALIELCGLLGYDARRDTDPADTDALPTAIVIASHGGPEAEIIRTALDNGVGYVGLVASTVRGASILDSLDLSDAERARVHTPVGLAIGAKTPAEIAVSIAAELIATLRGGGPRGRKALADENGGA,"25,576",251,,growth [GO:0040007],,,,,1
O06296,O06296_MYCTU,Rv0345,Rv0345,,IPR025877; IPR029044; ,,,DOMAIN 8 116 NTP_transf_3. {ECO:0000259|Pfam:PF12804}.,Uncharacterized protein,,9634230,,,MLPSTVVGVLLAAGAGRWYGKPKVLVDGWLDTAVGALRDGGCNDVILVLGAVEVSAPAGVTAITAPDWQQGLSASVRAGLAQADREHADYAVLHVIDTPDVNAKVVARVLGRALVSRSGLAGRGRIPAHSARRRGC,"13,969",136,,,,,,,3
I6WX95,I6WX95_MYCTU,Rv0033,acpA Rv0033,GO:0000035; GO:0000036; GO:0005829; GO:0009245; GO:0031177,IPR036736; IPR003231; IPR009081; ,,acpA,DOMAIN 1 73 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable acyl carrier protein AcpA (ACP),cytosol [GO:0005829]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; lipid A biosynthetic process [GO:0009245],9634230,,,MKEAINATIQRILRTDRGITANQVLVDDLGFDSLKLFQLITELEDEFDIAISFRDAQNIKTVGDVYTSVAVWFPETAKPAPLGKGTA,"9,613",87,,lipid A biosynthetic process [GO:0009245],acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177],cytosol [GO:0005829],,,1
O53604,O53604_MYCTU,Rv0059,Rv0059,,IPR029494; ,,,,Uncharacterized protein,,9634230; 21969609,,,MITRYKPESGFVARSGGPDRKRPHDWIVWHFTHADNLPGIITAGRLLADSAVTPTTEVAYNPVKELRRHKVVAPDSRYPASMASDHVPFYIAARSPMLYVVCKGHSGYSGGAGPLVHLGVALGDIIDADLTWCASDGNAAASYTKFSRQVDTLGTFVDFDLLCQRQWHNTDDDPNRQSRRAAEILVYGHVPFELVSYVCCYNTETMTRVRTLLDPVGGVRKYVIKPGMYY,"25,580",230,,,,,,,1
P96832,P96832_MYCTU,Rv0155,pntAa Rv0155,GO:0005886; GO:0006740; GO:0008750; GO:0050661; GO:0051287,IPR007886; IPR007698; IPR036291; ,,pntAa,,Probable NAD(P) transhydrogenase (Subunit alpha) PntAa [first part catalytic part] (Pyridine nucleotide transhydrogenase subunit alpha) (Nicotinamide nucleotide transhydrogenase subunit alpha),plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661]; NADPH regeneration [GO:0006740],9634230; 21969609,,,MTDPQTQSTRVGVVAESGPDERRVALVPKAVASLVNRGVAVVVEAGAGERALLPDELYTAVGASIGDAWAADVVVKVAPPTAAEVGRLRGGQTLIGFLAPRNADNSIGALTQAGVQAFALEAIPRISRAQVMDALSSQANVSGYKAVLLAASESTRFFPMLTTAAGTVKPATVLVLGVGVAGLQALATAKRLGARTTGYDVRPEVADQVRSVGAQWLDLGISASGEGGYARELTDDERAQQQKALEEAISGFDVVITTALVPGRPAPTLVTAAAVEAMKPGSVVVDLAGETGGNCELTEPGRTVVKHDVTIAAPLNLPATMPEHASELYSKNITALLDLLIKDGRLAPDFDDEVIAQSCVTRGKDS,"37,694",366,,NADPH regeneration [GO:0006740],NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NAD binding [GO:0051287]; NADP binding [GO:0050661],plasma membrane [GO:0005886],,,1
O07416,O07416_MYCTU,Rv0172,mce1D Rv0172,GO:0005576; GO:0005618; GO:0016021; GO:0044117,IPR005693; IPR003399; IPR024516; ,,mce1D,,Mce-family protein Mce1D,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MSTIFDIRNLRLPQLSRASVVIGSLVVVLALAAGIVGVRLYQKLTNNTVVAYFTQANALYVGDKVQIMGLPVGSIDKIEPAGDKMKVTFHYQNKYKVPANASAVILNPTLVASRNIQLEPPYRGGPVLADNAVIPVERTQVPTEWDELRDSVSHIIDELGPTPEQPKGPFGEVIEAFADGLAGKGKQINTTLNSLSQALNALNEGRGDFFAVVRSLALFVNALHQDDQQFVALNKNLAEFTDRLTHSDADLSNAIQQFDSLLAVARPFFAKNREVLTHDVNNLATVTTTLLQPDPLDGLETVLHIFPTLAANINQLYHPTHGGVVSLSAFTNFANPMEFICSSIQAGSRLGYQESAELCAQYLAPVLDAIKFNYFPFGLNVASTASTLPKEIAYSEPRLQPPNGYKDTTVPGIWVPDTPLSHRNTQPGWVVAPGMQGVQVGPITQGLLTPESLAELMGGPDIAPPSSGLQTPPGPPNAYDEYPVLPPIGLQAPQVPIPPPPPGPDVIPGPVPPTPAPVGAPLPAEAGGGQ,"56,516",530,,growth of symbiont in host [GO:0044117],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
P96414,P96414_MYCTU,Rv0231,fadE4 Rv0231,GO:0005886; GO:0016627; GO:0050660,IPR036250; IPR009075; IPR037069; IPR009100; ,,fadE4,,Probable acyl-CoA dehydrogenase FadE4,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MLLNPNHLTRKYPDRRSGEIMAATVDFFESRGKARLKHDDHERIWYSDFLDFVGRERIFASLLTPASYGADDCRWDTYRISEFAEIMGFYGLSYWYPFQVTALGLGPIWMSANEDAKRKAAAGLEAGEVFAFGLSEQTHGADVYQTDMILTPSDGGWTANGEKYYIGNANVARMVSTFGKIAGTPESQEYVFFVADSQHERYDLIKNVVNSQNYVANYALRDYPVTEADILHRGAEAFHAALNTVNVCKYNLGWGAIGMCTHALYESVTHAANRHLYGTVVTDFSHVRRLLTDAYVRLIAMKLVASRASDYMRSASAADRRYLLYSPLTKAKVTSEGERVITALWDVIAAKGVEKDTFFETVAREIGLLPRLEGTVHINIGLLGKFMPNYLFAPDSTLPVIPRRDDAADDAFLFAQGPTGGLGKVRFHDWRASFDTCAHLPNVALLREQVDVFAELLASATPDAAQQKDIDFAFGVGQLFANVPYAQLILEEARLSGVDEALIDEIFGVLVRDFNTHAVELHGRSATTAEQARFAMRMVRRPVHDPARYDQIWKDHVLALNGAYQMAP,"63,495",568,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,,1
O06307,O06307_MYCTU,Rv0356c,Rv0356c,,IPR029069; IPR006683; ,,,,Conserved protein,,9634230; 21969609,,,MTDASVHPDELDPEYHHHGGFPEYGPASPGAGFGQFVATMRRLQDLAVAADPGDAVWDEAAERAAALVELLSPFEADEGKAPAGRTPGLPGMGSLLLPPWTVTRYGTDGVEMRGSFSRFHVGGNSAVHGGVLPLLFDHMFGMISHAAGRPISRTAFLHVDYRRITPIDVPLIVRGRVTNTEGRKAFVCAELFDSDETLLAEGNGLMVRLLPGQP,"22,911",214,,,,,,,1
O53612,O53612_MYCTU,Rv0067c,Rv0067c,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 13 72 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Possibly TetR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MAPTDRRVRADAARNRARVLEVAYQTFAADGLSVPVDEIARRAGVGAGTVYRHFPTKEALFQAVIADRMHRIIDKGHALLKSKHPGDALFAFLRSMVLQWGATDRGLVEALAGVGIEISSAAPEAEADFLDLLTDLLRAAQRAGTVRPDVDVLEVKTLLVGCQAMQSYNAELAAKVTDVALDGLRANRK,"20,403",189,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
O53621,O53621_MYCTU,Rv0076c,Rv0076c,GO:0016021,,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230,,,MPAVTTPSNHWGDERRKLSHQPPVRGQILGRRQARRLSQHFARVGVEAPPKRLQEMLLGAPAADEEWTDVKFALIVTQLNHEKRVAKFHRLQRRATHSLICLGLVLVALNFLICLAYIFFSLTQHAAAL,"14,649",129,,,,integral component of membrane [GO:0016021],,,1
P96826,P96826_MYCTU,Rv0149,Rv0149,GO:0005886; GO:0008270; GO:0016491,IPR013149; IPR013154; IPR011032; IPR036291; IPR020843; IPR002364; ,,,,Possible quinone oxidoreductase (NADPH:quinone oxidoreductase) (Zeta-crystallin),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],9634230; 21969609,,,MKACVVKELSGPSGMVYTDIDEVSGDGGKVVIDVRAAGVCFPDLLLTKGEYQLKLTPPFVPGMETAGVVRSAPSDAGFHVGERVSAFGVLGGYAEQIAVPVANVVRSPVELDDAGAVSLLVNYNTMYFALARRAALRPGDTVLVLGAAGGVGTAAVQIAKAMQAGKVIAMVHREGAIDYVASLGADVVLPLTEGWAQQVRDHTYGQGVDIVVDPIGGPTFDDALGVLAIDGKLLLIGFAAGAVPTLKVNRLLVRNISVVGVGWGEYLNAVPGSAALFAWGLNQLVFLGLRPPPPQRYPLSEAQAALQSLDDGGVLGKVVLEP,"33,278",322,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],plasma membrane [GO:0005886],,,1
P96399,P96399_MYCTU,Rv0217c,lipW Rv0217c,GO:0009056; GO:0034338,IPR029058; IPR013094; ,,lipW,,Possible esterase LipW,short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],9634230; 21969609,,,MSGNEVHPDLRRIAVVTPRQLVGPRTLPVMRALIVVAGLRMSRTPPDIEVLTLESGVGVRLYRPAGSNEPAPALLWIHAGGYVMGTAQQDDRLCLRFSSRLGITVASVDYRLAPENPYPAALGDCYSALTWLASLPAVDPARVAIGGASAGGGLAAALALLARDRGGITPAFQLLVYPMLDDRPSIAPANPHYRLWNGRANRFGWRAYLGDADARVAVPGRRDDLGGLAPAWIGVGTHDLLHDEDLAYAERLTAAGVPCQVEVVEGAFHGFDRVAPNVGVSQRFFTSQCNSLRAALALSNRT,"32,217",302,,catabolic process [GO:0009056],short-chain carboxylesterase activity [GO:0034338],,,,2
P71594,P71594_MYCTU,Rv0024,Rv0024,GO:0005886,IPR000064; ,,,,Putative secreted protein P60-related protein,plasma membrane [GO:0005886],9634230,,,MNYSEVELLSRAHQLFAGDSRRPGLDAGTTPYGDLLSRAADLNVGAGQRRYQLAVDHSRAALLSAARTDAAAGAVITGAQRDRAWARRSTGTVLDEARSDTTVTAVMPIAQREAIRRRVARLRAQRAHVLTARRRARRHLAALRALRYRVAHGPGVALAKLRLPSPSGRAGIAVHAALSRLGRPYVWGATGPNQFDCSGLVQWAYAQAGVHLDRTTYQQINEGIPVPRSQVRPGDLVFPHPGHVQLAIGNNLVVEAPHAGASVRVSSLGNNVQIRRPLSGR,"30,308",281,,,,plasma membrane [GO:0005886],,,2
P96816,P96816_MYCTU,Rv0139,Rv0139,GO:0005618; GO:0005737; GO:0005886; GO:0048040; GO:0070403,IPR001509; IPR036291; ,,,,Possible oxidoreductase,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040],9634230; 21969609,,,MNAPKLVIGANGFLGSHVTRQLVADCAPQKGEVRAMVRPAANTRSIDDLPLTRFHGDVFDTATVAEAMAGCDDVYYCVVDTRAWLRDPSPLFRTNVAGLRNVLDVATDASLRRFVFTSSYATVGRRRGHVATEEDRVDTRKVTPYVRSRVAAEDLVLQYAHDAGLPAVAMCVSTTYGGGDWGRTPHGAFIAGAVFGRLPFTMRGIRLEAVGVDDAARALILAAERGRNGERYLISERMMPLQEVVRIAADEAGVPPPRWSISVPVLYALGALGSLRARLTGKDTELSLASVRMMRSEADVDHGKAVRELGWQPRPVEESIREAARFWAAMRTVGKDPAAS,"36,976",340,,,NAD+ binding [GO:0070403]; UDP-glucuronate decarboxylase activity [GO:0048040],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P96401,P96401_MYCTU,Rv0219,Rv0219,GO:0005576; GO:0016021,,,,,Probable conserved transmembrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MFDIATRFKNSYGSGPLHLLAMVSGFALLGYIVATARPSALWNQATWWQSIAVWFVAAVVAHDLLLYPLYALADRILARLVGRRDVSAPRRRPELPVRNYIRIPALAAGLTLLVFLPGIIRQGAPTYLDATGQTQEPFLGRWLLLTAVAFGISAAAYAIRLVVAHVRRRRAGCSRVDAIDEE,"20,083",182,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O07429,O07429_MYCTU,Rv0185,Rv0185,,IPR027595; ,,,,Uncharacterized protein,,9634230; 21969609,,,MIGADVPRDSQRARVYAAEAFVRTLFDRVTAHGSPTVEFFGTQLTLPPEGRFGSVASVQRYVDDVLALPAVGQNWPTVSPVRVRARRAATAAHYENHGGTGTIAVPDRHTAGWAMRELVVLHEVAHHLCQVPPPHGPEFVATVCTLTELVMGPEVGHVFRVVYAQEGVR,"18,397",169,,,,,,,1
O07421,O07421_MYCTU,Rv0177,Rv0177,GO:0005886; GO:0044117; GO:0044119,,,,,Probable conserved Mce associated protein,plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MSPRRKFEPGEGALLAPQSIEPSRRWGLPLALTASAVVMAAAISACALMRISHESHQRAAHKDIVMLSDVRSFMTMFTSPDPFHANEYAERVLSHATGDFAKQYHERANDILIRISGVEPTTGTVLDAGVQRWNEDGSANVLVVTQITSKSADGKRVVSNANRWLVTAKQEGNEWKISSLLPVI,"20,164",184,,growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119],,plasma membrane [GO:0005886],,,1
Q6MX48,Q6MX48_MYCTU,Rv0305c,PPE6 Rv0305c,GO:0005618; GO:0005829; GO:0005886,IPR002989; IPR000030; IPR038332; ,,PPE6,,PPE family protein PPE6,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230,,,MDFVVSAPEVNSLRMYLGAGSGPMLAAAAAWDGLADELAVAASWFGSVTSGLADAAWRGPAAVAMARAVAPYLGWLISATAQAEQAAAQARVAVATFEAARAATVHPAIVAANRAVLVSLVSSNLLGFNAPAIAATEAAYERMWAQDVAAMVGYHAGASAAVSALMPFTQQLKKLAGLSERLTSAAAAAAGPPSAAGFNLGLANVGANNVGNGNVGVFNVGFGNLGSYNLGFANLGSDNLGLANLGGHNIGFANTGSNNVGFGNTGSNNVGIGLTGNGQIGFGSFNSGSHNIGLFNSGSGNVGLFNSGTGNFGIGNSGTGNFGLGNTGSTNTGWFNTGDVNTGGFNPGSYNTGNFNTGNYNTGSFNAGNYNTGYFNTGDYNTGVANTGNVNTGAFIAGNYSNGVLWRGDYQGLIGADIALEIPAIPINAQLFSMPIHQVMVMPGSVMTIPGMRLPFTSIVPFVVYYGPVELPQSTLTLPTVTITVGGPTTTIDGNLTGMVGGVSIPLIKIPAAPGFGNSTTSPSSGFFNAGAGTASGFGNFGGGASGFWNLASATSGLSGFGNVGALGSGVANVGNTISGLYNTSTSNLATPAFNSGLLHHSVGTMTLNFGLANVGGNNVGGANAGIFNVGLANLGDYNIGFGNLGGDNLGFAHAGSYNIGFANTGSNNLGFANTGDNNIGFANIGSNNIGIGLTGSGQIGFGSLNSGSHNIGLFNSGDGNIGLFNSGSGNFGIGNAGTGNWGIGNSGAGNFGIGNAGSTNTGLFNSGDLNTGSLNPGSYNTGSVNTGSVNTGGFNAGNYNTGYFNTGDLQHRHGEHRQYQHRRFHLRQPQQRPSVAGRQPGSDRPRHRRRHSRNPDCERRREYPDSHTDHRQLHGHRIQRARSSTEHSRHCYFFRTRRYRPLHRPSDTDNRSHTCGHGGWTHYRDQYRRHCGRRRHQHPDYPYSSDSRLRQLDRRTVVGLLQ,"98,969",963,Mycobacterial PPE family,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53711,O53711_MYCTU,Rv0376c,Rv0376c,,IPR003777; IPR027051; ,,,,Uncharacterized protein,,9634230,,,MAIWAAGDTAGVATVVRTLRSAPRPPGAAMVVAPDGSVSGSVSGGCVEGAVYELAAEVAQTGIPRLEHYGVSDDTAFAVGLTCGGIIDVFVEPVSRATFPELGELADDIGAQRPVAIATVIAHPDERRVGRRLVIRPDTKSPVTGSLGSARADAAVIDDARGLLAVGRSEILEYGPDGQRRGEGMEVFVSSHAPRPRMLVFGAIDFAAALARQGSFLGYRVTVCDARAVFATPARFPTADDVVVAWPHRYLAAQAEAGGIDERTVICVLTHDPKFDVPVLEVALRLGVGYVGAMGSRKTHDDRMDRLRAAGLTDAELSRLSSPIGLDLGARTPEETAVSIAADIIARRWGGGGRPLADIAGRIHHDAQVAGEFKDYLTRH,"39,898",380,,,,,,,1
O33268,O33268_MYCTU,Rv0338c,Rv0338c,GO:0005618; GO:0005886; GO:0005887; GO:0040007; GO:0051536,IPR017896; IPR017900; IPR004017; IPR009051; ,,,,Probable iron-sulfur-binding reductase,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; iron-sulfur cluster binding [GO:0051536]; growth [GO:0040007],9634230; 21969609,,,MTTQTLIRLILGMSMTAVVGVFALRRVWWLYKLVMSGQPASGRTDNLGTRIWTQISEVLGQRRLLKWSIPGLAHFFTMWGFFILLTVYIEAYGLLFEERFHIPVIGRWDALGFLQDFFATAVFLGITTFAIIRILRNPREIGRSSRFYGSHNGGAWLVLLMIFNVIWTYVLVRGSAVNNGTLPYGNGAFLSQLFGAILRPLGQPANEIIETTALLLHIGVMLAFLILVLHSKHLHIFLAPINVTFKRLPDGLGPLLPLEADGKPIDFENPSEDAVFGRGKIEDFTWKGMLDFATCTECGRCQSQCPAWNTGKPLSPKLVIMDLRDHWMAKAPYILGQKDASAGGEAGHQEHHHVPESGFGRVPGHGPEQATRPLVGTEEQGGVIDPDVLWSCVTCGACVEQCPVDIEHVDHIVDMRRYQVMMESEFPSELSVLFKNLETKGNPWGQNASDRTNWIDEVDFDVPVYGQDVDSFDGYEYLFWVGCAGAYDDKAKKTTKAVAELLAVARVKYLVLGAGETCNGDSARRSGNEFLFQQLAQQAVETLDGLFEGVETVDRKIVVTCPHCFNTIGKEYRQLGANYTVLHHTQLLNRLVRDKRLVPVTPVSQDITYHDPCYLGRHNKAYEAPRELIGAAGASLTEMPRHADRSFCCGAGGARMWMEEHIGKRINHERVDEALATDATAIATACPFCRVMVTDGVNDRQEEAGRSGVEVLDVAQVLLGSLDHDKAQLPAKGTAAKQAQERAPKAAPKAAAPVTPVEAPAEAPQAPAPAAPAAPVKGLGMAAGAKRPGAKKAAPTPAAPAAPAAPVKGLGIAAGAKRPGAKKTPPPAPGLAEPAAQPQPEAKPQPEPAAPPKPQTDGDPAAPAAPVKGLGIARGARPPGKR,"95,486",882,,growth [GO:0040007],iron-sulfur cluster binding [GO:0051536],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O53632,O53632_MYCTU,Rv0110,Rv0110,GO:0004252; GO:0016021,IPR022764; IPR035952; ,,,DOMAIN 72 204 Rhomboid. {ECO:0000259|Pfam:PF01694}.,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252],9634230,,,MRVGPVGHQCAECVREGARAVRQPRTPFGGRQRSATPVVTYTLISLNALVFVMQVTVMGLERQLALWPPAVASGQTYRLVTSAFLHYGAMHLLLNMWALYVVGPPLEMWLGRLRFGALYAVSALGGSVLVYLIAPLNTATAGASGAVFGLFGATFMVARRLHLDVRWVVALIVINLAFTFLAPAISWQGHVGGLVTGALVAATYVYAPRERRNLIQATVTITVLVAFVVLIGWRTVDLLALFGGRLNLS,"26,888",249,,,serine-type endopeptidase activity [GO:0004252],integral component of membrane [GO:0016021],,,3
O53646,O53646_MYCTU,Rv0195,Rv0195,GO:0003677; GO:0006351; GO:0006355,IPR016032; IPR000792; IPR036388; ,,,DOMAIN 144 209 HTH luxR-type. {ECO:0000259|PROSITE:PS50043}.,Possible two component transcriptional regulatory protein (Probably LuxR-family),"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,,MAPVNVISVAVVASDPLTRDGALARLSSHRELDVRAWQAGCETSVLLVLATTITAPLLCQIEDVQKDGPSHAPKLVVVADEFSAEQVFRMIKLGLTGLLYRSQSTFDCIVETIRLSAEGRLRLPERVQRYLVGRIKSTPTAEPDTPCAAALAEREVAVLRLLADGLSTHQVAVQLNYCERTIKNIVHDIVTRLKLRNRTHAVAHALRAGLI,"23,074",211,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,,3
O07246,O07246_MYCTU,Rv0320,Rv0320,,,,,,Possible conserved exported protein,,9634230,,,MGRHELARDRRKSSAVLAAVLAPAAVFFATGGDVSTLAARADANPVLGDDAPCCVQIVPVAPLAFSSQISGGEIGTGLAASQFASASRWRIVSRYLPVGVAPEQGLQVKTVLTARSISAAFPEIREIGGVRPDALRWHPNGLALDVMVPNPGTAEGIALGNEIVAFVLKNATRFGMQDVIWRGAYYTPNGARTTGAGHYDHIHITTVGGGYPTGEELYIR,"23,090",220,,,,,,,1
P96394,P96394_MYCTU,Rv0212c,nadR Rv0212c,GO:0000309; GO:0009435; GO:0045892; GO:0052572,IPR016429; IPR004821; IPR038727; IPR006417; IPR027417; IPR014729; ,,nadR,DOMAIN 154 307 AAA_28. {ECO:0000259|Pfam:PF13521}.,Possible transcriptional regulatory protein NadR (Probably AsnC-family),"nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; NAD biosynthetic process [GO:0009435]; negative regulation of transcription, DNA-templated [GO:0045892]; response to host immune response [GO:0052572]",9634230,,,MTHGMVLGKFMPPHAGHVYLCEFARRWVDELTIVVGSTAAEPIPGAQRVAWMRELFPFDRVVHLANENPQRPWEHPDFWDIWKASLQGVLATRPDFVFGAEPYNADFAQVLGARFVAVDHGRTVVPVTATDIRADPLGHWQHIPRCVRPAFVKRVSIIGPESTGKTTLAQAVAEKLRTKWVPERAKMLRELNGGSLIGLEWAEIVRGQIASEEALARDADRVLICDTDPLATTVWAEFLAGGCPQELRDLARRPYDLTLLTTPDVPWDADDGRCVPGARGTFFARCEQALRAAGRSFVVITGGWEERLSVSLRAVEELVRARR,"36,031",323,,"NAD biosynthetic process [GO:0009435]; negative regulation of transcription, DNA-templated [GO:0045892]; response to host immune response [GO:0052572]",nicotinamide-nucleotide adenylyltransferase activity [GO:0000309],,,,2
O53705,O53705_MYCTU,Rv0370c,Rv0370c,GO:0005524; GO:0016887,IPR003593; IPR011704; IPR027417; ,,,,Possible oxidoreductase,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230,,,MTFASPDDVIRRFDEQNYLLDTGTASAIYLAVTLGRPLLLEGEPGVGKTTAAKTLAVVLDTTLIRLQCYEGLTANEALYDWNYQRQLLSIRLAEARGKGISDISEADLYTEAYLVDRPILRCVRHRGPTPPVLLIDEIDRADDEFEALLLEFLGESAVTVPELGTFLAECPPIAVLTSNRSRDLHDALRRRCLYHWIDYPGPDRAAAIVRRTVPGATAPLIENATQFVCTARDLDLDKPPGVAETIDWVAALVALGVADLTAADSSPALASLGALAKTPDDRTQIRDAYQAFTECSHA,"32,538",298,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
I6Y7L4,I6Y7L4_MYCTU,Rv0355c,PPE8 Rv0355c,,IPR002989; IPR000030; IPR038332; ,,PPE8,,PPE family protein PPE8,,9634230,,,MSFAVLPPEINSARLYVGAGLAPMLDAAAAWDGLADELGSAAASFSAVTAGLAGSSWLGAASTAMTGAAAPYLGWLSAAAAQAQQAATQTRLAAAAFEAALAATVHPAIISANRALFVSLVVSNLLGQNAPAIAATEAAYEQMWAQDVAAMFGYHAGASAAVSALTPFGQALPTVAGGGALVSAAAAQVTTRVFRNLGLANVGEGNVGNGNVGNFNLGSANIGNGNIGSGNIGSSNIGFGNVGPGLTAALNNIGFGNTGSNNIGFGNTGSNNIGFGNTGDGNRGIGLTGSGLLGFGGLNSGTGNIGLFNSGTGNVGIGNSGTGNWGIGNSGNSYNTGFGNSGDANTGFFNSGIANTGVGNAGNYNTGSYNPGNSNTGGFNMGQYNTGYLNSGNYNTGLANSGNVNTGAFITGNFNNGFLWRGDHQGLIFGSPGFFNSTSAPSSGFFNSGAGSASGFLNSGANNSGFFNSSSGAIGNSGLANAGVLVSGVINSGNTVSGLFNMSLVAITTPALISGFFNTGSNMSGFFGGPPVFNLGLANRGVVNILGNANIGNYNILGSGNVGDFNILGSGNLGSQNILGSGNVGSFNIGSGNIGVFNVGSGSLGNYNIGSGNLGIYNIGFGNVGDYNVGFGNAGDFNQGFANTGNNNIGFANTGNNNIGIGLSGDNQQGFNIASGWNSGTGNSGLFNSGTNNVGIFNAGTGNVGIANSGTGNWGIGNPGTDNTGILNAGSYNTGILNAGDFNTGFYNTGSYNTGGFNVGNTNTGNFNVGDTNTGSYNPGDTNTGFFNPGNVNTGAFDTGDFNNGFLVAGDNQGQIAIDLSVTTPFIPINEQMVIDVHNVMTFGGNMITVTEASTVFPQTFYLSGLFFFGPVNLSASTLTVPTITLTIGGPTVTVPISIVGALESRTITFLKIDPAPGIGNSTTNPSSGFFNSGTGGTSGFQNVGGGSSGVWNSGLSSAIGNSGFQNLGSLQSGWANLGNSVSGFFNTSTVNLSTPANVSGLNNIGTNLSGVFRGPTGTIFNAGLANLGQLNIGSANLGDFNLGSGNVGSFNVFSGNQGSYNIGPANLGNYNIGFANLGNYNIGFGNAGDFNQGFANTGNNNIGFANTGNNNIGIGLSGDNQQGFNFAGGWNSGTANIGLFNSGTNNVGIGNSGTGNWGIGNSGSGNTGIGNTGSTNTGFFNTGIVNTGVANAGSYNTGWYNTGDTNTGIANLGDFNTGFYNTGNFSTGFANQGDIATGAFITGDMGNGAFWRGDQQGLFSAGYRVHVPEIPAHVTVEVPVNIPITASFTNTVYSGITLEQINFGFTIDIAGIPLLAGAISKAVLPPITGTGPAITVNIGDPGGSTAIRIPATASVGPFDVTFVNIAATTGFFNATTDPSSGFFNGGPGTVSGIANIGANISGFQNVANSATSGFNNYGSLQSGLANLGDTVSGVFNTGIGAPANVSGMFNIGSNLAGFFHDQATGMSMFNLGLGNIGQFNVGFSNVGDSNAGLANIGSFNLGSGNLGSFNVFGGNQGSYNIGPANLGNYNIGLGNLGSYNFGFGNAGDFNLGFANTGNNNIGFANTGNNNIGIGLSGDNQQGFNFAGGWNSGSGNSGLFNSGTNNIGLFNSGTGNIGIGNSGTGNWGIANTGDTNTGIFNTGDVNTGLLNAGNVNTGIFNTGHYNTGSFNAGSFNTAGFNPGSYNTGYLNTGSYNTGLANSGDVNTGGFITGNYSNGFWWRGDYQGLAGISQTITVPDTAVPVKLHVPIFLDIPVTGTLGTFTVHGFRFPEITGDIFLIGIPFNAATLDAFSFPNISIVLPNIGINLGSGPDPLIDIAGTGGLLPIKIPLIDIPAAPGFGNSTTTPSSGFFNAGTGTVSGVGNVGSNSSGFFNLTSGSSGISGVQNFGELISGGFNFGNTVSGLVNASTLGLSMPANLSGGGNVGATVAGFVNNTQILNLGFGNVGSGNVGHGNIGDSNVGLGNLGNANVGHGNIGSFNVFSGNRGSYNIGPANLGNYNIGLGNLGSYNFGFGNAGDFNLGFANSGSNNIGFANTGNNNIGIGLSGHNQQGFGSWNSGTANTGLFNSGTNNIGLFNSGTGNIGIGNSGIGNTGIGNPGVGNTGLGNSGTGNWGLWNPGTGNMGVANVGTYNTGGYNVGSTNTGIANVGIANTGSYNTGSTNTGSFNDGDFNTGFYNTGDYNTGFYNTGDVNTGAFIGGNFSNGAFWQSDHQGQWGAHYAITVPQIPLLNFSLNIPVNIPIHLDFGTLAVNGFQIPAITLRALGVTHFSVGPIIVPRIAGTLPVIDINIGDPGGSSSIPITITSGAGPVVIPLLDIPPAPGFGNSTTGPSSGFFNSGTGSSSGFGNVGANNSGFWNTAFAGIGNSGLQNFGSLQSGWANLGNTVSGFYNTSAADFATPANLSGLSNVGADLTGVLRGPNGSTFNAGLANLGQFNVGSANLGSANLGSANLGSANLGNSNVGFGNIGNANIGGANIGDFNVGIANTGPGLTAAVNNIGIGNTGNYNIGVGNTGNYNIGFGNTGNNNIGIGLSGDNQIGFGPLNAGIANMGLFNLGDNNFGMANAGNFNQGIANTGNNNIGLFNTGNNNVGIGLTGDGLSGFSSLNSGAGNTGFFNSGTANTGLFNSGTGNTGLFNSGTGNVGIGNMGTGGFGVGLSGDSQVGIGGTNSGSFNIGLFNSGTGNVGIGNSGTGNVGIGNTGTGNTGIGNSGNYNTGLLNAGLVNTGIANPGNHNTGLFNIGTFNTGIANPGHYNTGSYNTGSYNTGMANAGDYGTGAFITGSMNNGLLWRADRQGLLAANYTITIERPAAFLNVDIPVNIPITGDITNVSIPAITFPRIDASGSVDIGILSGTVLAPVGPITLHGGDASAPLDTPIEIDFGPSPAINLNIGKPDGSTVINIVGGAGAGPISIPIIDLRPAPGFFNATTGPSSGFLNWGAGSASGLLNFGNNSGLYNFATSSMGNSGFQNYGSLQSGWANLGNSISGIYNTGLGAPANVSGLLNIGTNLAGWLQNGPTETTFSVGLANLGFWNLGSANIGNYNLGSANIGVYNLGSANIGDFNLGSANIGDFNLGSANIGSSNIGFGNVGPGLTAAIGNIGFGNTGNGNIGIGNTGTGNIGFGNTGNGNIGIGLTGDTMTGFGGWNSGTGNIGLFNSGTGNIGFGNSGTGNWGIGNSGDYNTGIGNTGSTNSGFFNTGLVNTGIGNSGDYNTGLFNAGNTNTGSFNPGDYNTGGFNPGNYNTGYFNPGNSNTGIANSGDVNTGAFNSGNYSNGFFWRGDYQGLGGFAYQSAVSEIPWSYDRFQH,"326,902",3300,Mycobacterial PPE family,,,,,,1
O06302,O06302_MYCTU,Rv0353,hspR Rv0353,GO:0000984; GO:0005886; GO:0045892,IPR009061; IPR000551; ,,hspR,DOMAIN 12 81 HTH merR-type. {ECO:0000259|PROSITE:PS50937}.,Probable heat shock protein transcriptional repressor HspR (MerR family),"plasma membrane [GO:0005886]; bacterial-type RNA polymerase regulatory region sequence-specific DNA binding [GO:0000984]; negative regulation of transcription, DNA-templated [GO:0045892]",9634230; 21969609,,,MAKNPKDGESRTFLISVAAELAGMHAQTLRTYDRLGLVSPRRTSGGGRRYSLHDVELLRQVQHLSQDEGVNLAGIKRIIELTSQVEALQSRLQEMAEELAVLRANQRREVAVVPKSTALVVWKPRR,"14,126",126,,"negative regulation of transcription, DNA-templated [GO:0045892]",bacterial-type RNA polymerase regulatory region sequence-specific DNA binding [GO:0000984],plasma membrane [GO:0005886],,,1
O53633,O53633_MYCTU,Rv0111,Rv0111,GO:0005618; GO:0005886; GO:0009103; GO:0016020; GO:0016021; GO:0016747,IPR002656; IPR036514; ,,,DOMAIN 34 385 Acyl_transf_3. {ECO:0000259|Pfam:PF01757}.,Possible transmembrane acyltransferase,"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipopolysaccharide biosynthetic process [GO:0009103]",9634230,,,MPARSVPRPRWVAPVRRVGRLAVWDRPERRSGIPALDGLRAIAVALVLASHGGIPGMGGGFIGVDAFFVLSGFLITSLLLDELGRTGRIDLSGFWIRRARRLLPALVLMVLTVSAARALFPDQALTGLRSDAIAAFLWTANWRFVAQNTDYFTQGAPPSPLQHTWSLGVEEQYYVVWPLLLIGATLLLAARARRRCRRATVGGVRFAAFLIASLGTMASATAAVAFTSAATRDRIYFGTDTRAQALLIGSAAAALLVRDWPSLNRGWCLIRTRWGRRIARLLPFVGLAGLAVTTHVATGSVGEFRHGLLIVVAGAAVIVVASVAMEQRGAVARILAWRPLVWLGTISYGVYLWHWPIFLALNGQRTGWSGPALFAARCAATVVLAGASWWLIEQPIRRWRPARVPLLPLAAATVASAAAVTMLVVPVGAGPGLREIGLPPGVSAVAAVSPSPPEASQPAPGPRDPNRPFTVSVFGDSIGWTLMHYLPPTPGFRFIDHTVIGCSLVRGTPYRYIGQTLEQRAECDGWPARWSAQVNRDQPDVALLIVGRWETVDRVNEGRWTHIGDPTFDAYLNAELQRALSIVGSTGVRVMVTTVPYSRGGEKPDGRLYPEDQPERVNKWNAMLHNAISQHSNVGMIDLNKKLCPDGVYTAKVDGIKVRSDGVHLTQEGVKWLIPWLEDSVRVAS,"74,372",685,,lipopolysaccharide biosynthetic process [GO:0009103],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",cell wall [GO:0005618]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886],,,1
P96821,P96821_MYCTU,Rv0144,Rv0144,GO:0000976; GO:0003700; GO:0005829; GO:0005886; GO:0006351,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 87 147 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Possibly TetR-family),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPHSWTPTSVMTPPLVVAAFRPVGHYRLATDRAGGPCSPPATGAKLTSSVASRPTVGTKPQWWHTLVMSMSLTAGRGPGRPPAAKADETRKRILHAARQVFSERGYDGATFQEIAVRADLTRPAINHYFANKRVLYQEVVEQTHELVIVAGIERARREPTLMGRLAVVVDFAMEADAQYPASTAFLATTVLESQRHPELSRTENDAVRATREFLVWAVNDAIERGELAADVDVSSLAETLLVVLCGVGFYIGFVGSYQRMATITDSFQQLLAGTLWRPPT,"30,643",280,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
Q79G08,Q79G08_MYCTU,Rv0124,PE_PGRS2 Rv0124,,IPR000084; ,,PE_PGRS2,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS2,,9634230,,,MSFVSVAPEIVVAAATDLAGIGSAISAANAAAAAPTTAVLAAGADEVSAAIAALFSGHAQAYQALSAQAAAFHQQFVQTLAGGAGAYAAAEAQVEQQLLAAINAPTQALLGRPLIGNGADGAPGTGQAGGAGGILYGNGGNGGSGAAGQAGGAGGPAGLIGHGGSGGAGGSGAAGGAGGHGGWLWGNGGVGGSGGAGVGAGVAGGHGGAGGAAGLWGAGGGGGNGGNGADANIVSGGDGGLGGAGGGGGWLYGDGGAGGHGGQGAIGLGGGAGGDGGQGGAGRGLWGTGGAGGHGGQGGGTGGPPLPGQAGMGAAGGAGGLIGNGGAGGDGGVGASGGVAGVGGAGGNAMLIGHGGAGGAGGDSSFANGAAGGAGGAGGHLFGNGGSGGHGGAVTAGNTGIGGAGGVGGDARLIGHGGAGGAGGDRAGALVGRDGGPGGNGGAGGQLYGNGGDGAPGTGGTLQAAVSGLVTALFGAPGQPGDTGQPG,"40,891",487,,,,,,,1
O07256,O07256_MYCTU,Rv0332,Rv0332,GO:0005886; GO:0046872,IPR017517; IPR034660; IPR010872; IPR024344; ,,,DOMAIN 20 140 MDMPI_N. {ECO:0000259|Pfam:PF11716}.; DOMAIN 153 253 MDMPI_C. {ECO:0000259|Pfam:PF07398}.,Conserved protein,plasma membrane [GO:0005886]; metal ion binding [GO:0046872],9634230; 21969609,,,MRKPASSLAKVDYSSAYLEQTHAFGELIRNVDQSTPVPTCPGWSLGQLFRHVGRGDRWAAQIVRDRLDHFLDPRSVEGGKPPPDPDDAISWLYGGARLLVDAVEQTGVETPVWTFLGPRPAGWWVRRRLHEVAVHRADVAITVGGEFTLEPNVAADGISEFLERIAVQAGSGGTPLPLEDDDTLHLHATDPGLLEAGEWTVRRDERGVTWSHRHGKGAVALRGGATELLLAMVRRLSVADTGIELLGDAGVWQKWLDRTPL,"28,620",261,,,metal ion binding [GO:0046872],plasma membrane [GO:0005886],,,1
Q10896,Q10896_MYCTU,Rv0101,nrp Rv0101,GO:0003824; GO:0005618; GO:0005829; GO:0005886; GO:0008152; GO:0031177,IPR010071; IPR029058; IPR036736; IPR025110; IPR020845; IPR000873; IPR023213; IPR001242; IPR013120; IPR036291; IPR020806; IPR009081; IPR006162; IPR010080; ,,nrp,DOMAIN 1984 2059 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable peptide synthetase Nrp (Peptide synthase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; phosphopantetheine binding [GO:0031177]; metabolic process [GO:0008152],9634230; 21969609; 22451903; ,X-ray crystallography (2),,MHRVRLSRSQRNLYNGVRQDNNPALYLIGKSYRFRRLELARFLAALHATVLDNPVQLCVLENSGADYPDLVPRLRFGDIVRVGSADEHLQSTWCSGILGKPLVRHTVHTDPNGYVTGLDVHTHHILLDGGATGTIEADLARYLTTDPAGETPSVGAGLAKLREAHRRETAKVEESRGRLSAVVQRELADEAYHGGHGHSVSDAPGTAAKGVLHESATICGNAFDAILTLSEAQRVPLNVLVAAAAVAVDASLRQNTETLLVHTVDNRFGDSDLNVATCLVNSVAQTVRFPPFASVSDVVRTLDRGYVKAVRRRWLREEHYRRMYLAINRTSHVEALTLNFIREPCAPGLRPFLSEVPIATDIGPVEGMTVASVLDEEQRTLNLAIWNRADLPACKTHPKVAERIAAALESMAAMWDRPIAMIVNDWFGIGPDGTRCQGDWPARQPSTPAWFLDSARGVHQFLGRRRFVYPWVAWLVQRGAAPGDVLVFTDDDTDKTIDLLIACHLAGCGYSVCDTADEISVRTNAITEHGDGILVTVVDVAATQLAVVGHDELRKVVDERVTQVTHDALLATKTAYIMPTSGTTGQPKLVRISHGSLAVFCDAISRAYGWGAHDTVLQCAPLTSDISVEEIFGGAACGARLVRSAAMKTGDLAALVDDLVARETTIVDLPTAVWQLLCADGDAIDAIGRSRLRQIVIGGEAIRCSAVDKWLESAASQGISLLSSYGPTEATVVATFLPIVCDQTTMDGALLRLGRPILPNTVFLAFGEVVIVGDLVADGYLGIDGDGFGTVTAADGSRRRAFATGDRVTVDAEGFPVFSGRKDAVVKISGKRVDIAEVTRRIAEDPAVSDVAVELHSGSLGVWFKSQRTREGEQDAAAATRIRLVLVSLGVSSFFVVGVPNIPRKPNGKIDSDNLPRLPQWSAAGLNTAETGQRAAGLSQIWSRQLGRAIGPDSSLLGEGIGSLDLIRILPETRRYLGWRLSLLDLIGADTAANLADYAPTPDAPTGEDRFRPLVAAQRPAAIPLSFAQRRLWFLDQLQRPAPVYNMAVALRLRGYLDTEALGAAVADVVGRHESLRTVFPAVDGVPRQLVIEARRADLGCDIVDATAWPADRLQRAIEEAARHSFDLATEIPLRTWLFRIADDEHVLVAVAHHIAADGWSVAPLTADLSAAYASRCAGRAPDWAPLPVQYVDYTLWQREILGDLDDSDSPIAAQLAYWENALAGMPERLRLPTARPYPPVADQRGASLVVDWPASVQQQVRRIARQHNATSFMVVAAGLAVLLSKLSGSPDVAVGFPIAGRSDPALDNLVGFFVNTLVLRVNLAGDPSFAELLGQVRARSLAAYENQDVPFEVLVDRLKPTRALTHHPLIQVMLAWQDNPVGQLNLGDLQATPMPIDTRTARMDLVFSLAERFSEGSEPAGIGGAVEYRTDVFEAQAIDVLIERLRKVLVAVAAAPERTVSSIDALDGTERARLDEWGNRAVLTAPAPTPVSIPQMLAAQVARIPEAEAVCCGDASMTYRELDEASNRLAHRLAGCGAGPGECVALLFERCAPAVVAMVAVLKTGAAYLPIDPANPPPRVAFMLGDAVPVAAVTTAGLRSRLAGHDLPIIDVVDALAAYPGTPPPMPAAVNLAYILYTSGTTGEPKGVGITHRNVTRLFASLPARLSAAQVWSQCHSYGFDASAWEIWGALLGGGRLVIVPESVAASPNDFHGLLVAEHVSVLTQTPAAVAMLPTQGLESVALVVAGEACPAALVDRWAPGRVMLNAYGPTETTICAAISAPLRPGSGMPPIGVPVSGAALFVLDSWLRPVPAGVAGELYIAGAGVGVGYWRRAGLTASRFVACPFGGSGARMYRTGDLVCWRADGQLEFLGRTDDQVKIRGYRIELGEVATALAELAGVGQAVVIAREDRPGDKRLVGYATEIAPGAVDPAGLRAQLAQRLPGYLVPAAVVVIDALPLTVNGKLDHRALPAPEYGDTNGYRAPAGPVEKTVAGIFARVLGLERVGVDDSFFELGGDSLAAMRVIAAINTTLNADLPVRALLHASSTRGLSQLLGRDARPTSDPRLVSVHGDNPTEVHASDLTLDRFIDADTLATAVNLPGPSPELRTVLLTGATGFLGRYLVLELLRRLDVDGRLICLVRAESDEDARRRLEKTFDSGDPELLRHFKELAADRLEVVAGDKSEPDLGLDQPMWRRLAETVDLIVDSAAMVNAFPYHELFGPNVAGTAELIRIALTTKLKPFTYVSTADVGAAIEPSAFTEDADIRVISPTRTVDGGWAGGYGTSKWAGEVLLREANDLCALPVAVFRCGMILADTSYAGQLNMSDWVTRMVLSLMATGIAPRSFYEPDSEGNRQRAHFDGLPVTFVAEAIAVLGARVAGSSLAGFATYHVMNPHDDGIGLDEYVDWLIEAGYPIRRIDDFAEWLQRFEASLGALPDRQRRHSVLPMLLASNSQRLQPLKPTRGCSAPTDRFRAAVRAAKVGSDKDNPDIPHVSAPTIINYVTNLQLLGLL,"269,409",2512,,metabolic process [GO:0008152],catalytic activity [GO:0003824]; phosphopantetheine binding [GO:0031177],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q79G13,Q79G13_MYCTU,Rv0062,celA1 Rv0062,GO:0005576; GO:0008810; GO:0016021; GO:0030245,IPR016288; IPR036434; ,,celA1,,Glucanase (EC 3.2.1.-),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],9634230; 15824123; 21969609,X-ray crystallography (4),,MTRRTGQRWRGTLPGRRPWTRPAPATCRRHLAFVELRHYFARVMSSAIGSVARWIVPLLGVAAVASIGVIADPVRVVRAPALILVDAANPLAGKPFYVDPASAAMVAARNANPPNAELTSVANTPQSYWLDQAFPPATVGGTVARYTGAAQAAGAMPVLTLYGIPHRDCGSYASGGFATGTDYRGWIDAVASGLGSSPATIIVEPDALAMADCLSPDQRQERFDLVRYAVDTLTRDPAAAVYVDAGHSRWLSAEAMAARLNDVGVGRARGFSLNVSNFYTTDEEIGYGEAISGLTNGSHYVIDTSRNGAGPAPDAPLNWCNPSGRALGAPPTTATAGAHADAYLWIKRPGESDGTCGRGEPQAGRFVSQYAIDLAHNAGQ,"39,974",380,,cellulose catabolic process [GO:0030245],cellulase activity [GO:0008810],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O07431,O07431_MYCTU,Rv0187,Rv0187,GO:0005886; GO:0008171,IPR002935; IPR029063; ,,,,Probable O-methyltransferase,plasma membrane [GO:0005886]; O-methyltransferase activity [GO:0008171],9634230; 21969609,,,MGMDQQPNPPDVDAFLDSTLVGDDPALAAALAASDAAELPRIAVSAQQGKFLCLLAGAIQARRVLEIGTLGGFSTIWLARGAGPQGRVVTLEYQPKHAEVARVNLQRAGVADRVEVVVGPALDTLPTLAGGPFDLVFIDADKENNVAYIQWAIRLARRGAVIVVDNVIRGGGILAESDDADAVAARRTLQMMGEHPGLDATAIQTVGRKGWDGFALALVR,"23,097",220,,,O-methyltransferase activity [GO:0008171],plasma membrane [GO:0005886],,,1
O53674,O53674_MYCTU,Rv0252,nirB Rv0252,GO:0005618; GO:0005829; GO:0005886; GO:0008942; GO:0020037; GO:0042128; GO:0046872; GO:0050660; GO:0050661; GO:0051539,IPR007419; IPR036188; IPR023753; IPR005117; IPR036136; IPR012744; IPR017121; IPR006067; IPR006066; ,,nirB,DOMAIN 15 302 FAD/NAD-binding_dom. {ECO:0000259|Pfam:PF07992}.; DOMAIN 441 488 Fer2_BFD. {ECO:0000259|Pfam:PF04324}.; DOMAIN 573 633 NIR_SIR_ferr. {ECO:0000259|Pfam:PF03460}.; DOMAIN 645 782 NIR_SIR. {ECO:0000259|Pfam:PF01077}.,Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitrite reductase [NAD(P)H] activity [GO:0008942]; nitrate assimilation [GO:0042128]",9634230; 21969609,,,MPTAGSSRAPAAAREIVVVGHGMVGHRLVEAVRARDADGSLRITVLAEEGDAAYDRVGLTSYTESWDRALLALPGNDYAGDQRVRLLLNTRVTQIDRATKSVVTAAGQRHRYDTLVLATGSYAFVPPVPGHDLPACHVYRTFDDLDAIRAGAQRTLDGGHTDGGVVIGGGLLGLEAANALRQFGLQTHVVEMMPRLMAQQIDEAGGALLARMIADLGIAVHVGTGTESIESVKHSDGSVWARVRLSDGEVIDAGVVIFAAGIRPRDELARAAGLAIGDRGGVLTDLSCRTSDPDIYAVGEVAAIDGRCYGLVGPGYTSAEVVADRLLDGSAEFPEADLSTKLKLLGVDVASFGDAMGATENCLEVVINDAVKRTYAKLVLSDDATTLLGGVLVGDASSYGVLRPMVGAELPGDPLALIAPAGSGAGAGALGVGALPDSAQICSCNNVTKGELKCAIADGCGDVPALKSCTAAGTSCGSCVPLLKQLLEAEGVEQSKALCEHFSQSRAELFEIITATEVRTFSGLLDRFGRGKGCDICKPVVASILASTGSDHILDGEQASLQDSNDHFLANIQKNGSYSVVPRVPGGDIKPEHLILIGQIAQDFGLYTKITGGQRIDLFGARVDQLPLIWQRLVDGGMESGHAYGKAVRTVKSCVGSDWCRYGQQDSVQLAIDLELRYRGLRAPHKIKLGVSGCARECAEARGKDVGVIATEKGWNLYVAGNGGMTPKHAQLLASDLDKETLIRYIDRFLIYYIRTADRLQRTAPWVESLGLDHVREVVCEDSLGLAEEFEAAMQRHVANYKCEWKGVLEDPDKLSRFVSFVNAPDAVDSTVTFTERAGRKVPVSIGIPRVRS,"90,353",853,Nitrite and sulfite reductase 4Fe-4S domain family,nitrate assimilation [GO:0042128],"4 iron, 4 sulfur cluster binding [GO:0051539]; flavin adenine dinucleotide binding [GO:0050660]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; nitrite reductase [NAD(P)H] activity [GO:0008942]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
L0T2H7,L0T2H7_MYCTU,Rv0109,PE_PGRS1 Rv0109,,IPR000084; ,,PE_PGRS1,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS1,,9634230,,,MSLLITSPATVAAAATHLAGIGSALSTANAAAAAPTTALSVAGADEVSVLIAALFEAYAQEYQALSAQALAFHDQFVQALNMGAVCYAAAETANATPLQALQTVQQNVLTVVNAPTQALLGRPIIGNGANGLPNTGQDGGPGGLLFGNGGNGGSGGVDQAGGNGGAAGLIGNGGSGGVGGPGIAGSAGGAGGAGGLLFGNGGPGGAGGIGTTGDGGPGGAGGNAIGLFGSGGTGGMGGVGGMGGVGNGGNAGNGGTAGLFGHGGAGGAGGIGSADGGLGGGGGNGRFMGNGGVGGAGGYGASGDGGNAGNGGLGGVFGDGGAGGTGGLGDVNGGLAGIGGNAGFVRNGGAGGNGQLGSGAVSSAGGMGGNGGLVFGNGGPGGLGGPGTSAGNGGMGGNAVGLFGQGGAGGAGGSGFGAGIPGGRGGDGGSGGLIGDGGTGGGAGAGDAAASAGGNGGNARLIGNGGDGGPGMFGGPGGAGGSGGTIFGFAGTPGPS,"42,289",496,,,,,,,1
O53630,O53630_MYCTU,Rv0108c,Rv0108c,GO:0005618,,,,,Uncharacterized protein,cell wall [GO:0005618],9634230; 21969609,,,MVPVETLHSGDPITDVNGGGQRYIVLESKTVGDSCVVLELESRVNHQLQVIEKSFPAGYHVGRAHHRIL,"7,591",69,,,,cell wall [GO:0005618],,,1
O07419,O07419_MYCTU,Rv0175,Rv0175,GO:0005576; GO:0005886; GO:0005887; GO:0044117,,,,,Probable conserved Mce associated membrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MKAADSAESDAGADQTGPQVKAADSAESDAGELGEDACPEQALVERRPSRLRRGWLVGIAATLLALAGGLGAAGYFALRSHQESQSIAREDLAAIEAAKDCVAATQAPDAGAMSASMQKIIECGTGDFGAQASLYTSMLVEAYQAASVHVQVTDMRAAVERNNNDGSVDVLVALRVKVSNTDSDAHEVGYRLRVRMALDEGRYKIAKLDQVTK,"22,356",213,,growth of symbiont in host [GO:0044117],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
L7N657,L7N657_MYCTU,Rv0164,TB18.5 Rv0164,,IPR005031; IPR023393; ,,TB18.5,DOMAIN 25 152 Polyketide_cyc. {ECO:0000259|Pfam:PF03364}.,Conserved protein TB18.5,,9634230; 21969609,,,MTAISCSPRPRYASRMPVLSKTVEVTADAASIMAIVADIERYPEWNEGVKGAWVLARYDDGRPSQVRLDTAVQGIEGTYIHAVYYPGENQIQTVMQQGELFAKQEQLFSVVATGAASLLTVDMDVQVTMPVPEPMVKMLLNNVLEHLAENLKQRAEQLAAS,"17,738",161,,,,,,,1
Q6MX49,Q6MX49_MYCTU,Rv0304c,PPE5 Rv0304c,,IPR002989; ,,PPE5,,PPE family protein PPE5,,9634230,,,MNLVSTTSGMSGFLNVGALGSGVANVGNTISGIYNVGTSDLSTPAVNSGLANIGTNIAGLLRDGAGTAAINLGLANHGNLNVGFASLGGFNFGGATIGHNNVGIGNTGIFDVGLANLGSYNIGFGNLGDDNLGFGNFGSYNIGFGNVGNDNLGFANAGGGNIGFANTGSNNVGFGNTGSNNVGIGLTGNGQIGFGSFNSGSGNIGLFNSGSNNIGFFNSGSGNFGIANSGSFNTGIGNTGNTNTGLFNSGDVNTGAFNPGSFNTGSFNTGSFNTGGFNPGNTNTGYLNIGNYNTGIANTGDVDTGAFITGNYSNGLFLSGDYQGLVGLNLVIDMPLPISLGVNIPIDIPITASAGNITLMGVTIPPTGDIVLSSIAGQRAHFGPITIPNITVVGPTTTVAIGGPNTAITITGGGAIRIPLISIPAAPGFGNSTTNPSSGFFNTGAGGASGFGNFGGANSGFWNLASATSGASGLLNVGALGSGLANVGTTVSGFYNTSTSDLATPAFNSGLANISTSIAGLLRDSTGTMVLNLGLANHGTLNVGIANLGDYNIGFANLGSANFGSANIGGNNIGGANTGIFDIGLANLGSYNIGFGNFGDDNLGFGNLGSYNVGFGNLGNDNLGFANTGSNNIGFANTGSNNIGIGLTGDGQIGFGSLNSGSGNIGLFNSGSGNIGFFNSGNGNVGIGNTGTANFGLGNTGSTNTGFFNSGDVNTGIGNTGSFNTGSFNPGDSNTGDFNPGSYNTGLGNTGDVDTGAFISGSYSNGFLWSGNYQGLIGLHAALAIPEIALTFGVDIPIHIPINIDAGVVTLQGFSIVAAENNIDFTPIIIPTINITLPTAAITVGGPTTSIGITASAGIGSITIPIIDIPATSGFGNSTTSPSSGFFNSGAGSASGFLNVVAGASGISGYLNVGALGSGVTNVGHTVSGFYNASALDLVTPAFASGLMRDGMGTMTLNLGLANLGSNNAGFGNTGIFDVGVANLGNYNIGFGNFGDDNLGFANLGSYNIGVANTGSNNIGFANTGSNNIGIGLTGTGQIGIGALNSGSGNIGLFNSGDGNIGFFNSGTGNFGIGNTGTGNFGIGNSGSTSTGLFNSGDGNTGGFNPGNFNTGNFNTGSFNTGGFNAGNTNTGHFNTGNYNTGIANTGDVSTGAFISGNYSNGILWRGDYQGLIGYSYALTIPEIPAHLDVNIPIDIPITGSFTDLVVDNFTIPIIGFESFAFSFHIHTEPDIGPIIVPSFVLSVPTFAIAVGGPTTAINISATAGLGPITIPIIDIPAAPGIGNSTTSPSSGFFNTGAGTASGFGNVGGNTSGLWNLASAASGVSGLLNVGALGSGVANVGNTISGIYNTSPLDLGTPAFGSGLANIAGLLQGGAGTTILDLAGLGNLNVGLANLGGSNFGIGNTGIFNVGFANVGNHNIGLANLGNYSVGFANSGNYHIGIANTGSANIGFANTGSGNIGIGLTGTGQIGFGSFNSGSHNIGLFNSGDGNVGFFNSGTGNVGIGNTGTANFGIANSGSFNTGLGNTGSTNTGLFNPGNVNTGVGNTGSINTGSINTGSFNTGSTNTGSFNLGDHNTGSFNSGDYNTGYFNAGDYNTGVANTGNVNTGAFISGNYSNGFFWRGDYQGLIGLSTTITIPEIPYRYDLSVPIDIPITGTVVATTPNSFTIPGFQIRVLLGPAAVLVNEMIGPITIDVNQVIAIDSPIQQTISMVGTGGFGPIPIGISIGGTPGFGNSTTGPSSGFFHTGAGHVSGFGNFGAGNMSGSGNFGAGNSGFFNAGGLGNSGLLNFGALQSGLANLGNTISGVYNTSTLDLATPAFGSGIANIGANLAGLFLDNTGNLTLNFGVANQGGLNAGIGNLGSVNIGFVNTGDSNLGIGNLGDLNFGGVNIGGNNIGIANTGIFDIGLANLGSYNIGLANLGDDNLGFGNAGSYNIGFANFGSDNLGFANTGSYNIGFANTGNNNIGVGLTGNGQIGIGSLNSGSNNIGLFNSGSGNIGFFNSGTGNVGIFNTGTGNFGLANSGGFNTGIGNAGSTNTGVFNPGDLNTGSFNPGSFNTGGFNPGSGNTGYLNTGDYNTGVANTGDVDTGAFITGSYSNGFLVSGDYQGLIGLPLLGIPVTPGYFNLTGGPSSGFFNSGAGSVSGFVNSGAGLSGYLNTGALGSGVANVGNTISGWLNASALDLATPGFLSGIGNFGTNLAGFFRG,"215,694",2204,,,,,,,1
O53637,O53637_MYCTU,Rv0115,hddA Rv0115,GO:0005524; GO:0042352; GO:0050201,IPR001174; IPR013750; IPR036554; IPR006204; IPR014606; IPR020568; ,,hddA,DOMAIN 106 169 GHMP_kinases_N. {ECO:0000259|Pfam:PF00288}.; DOMAIN 243 323 GHMP_kinases_C. {ECO:0000259|Pfam:PF08544}.,Possible D-alpha-D-heptose-7-phosphate kinase HddA,ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; GDP-L-fucose salvage [GO:0042352],9634230,,,MAILRGRAPLRLGLGGGGTDVEPYSSQFGGRILSVTIDKYAYAFAERGTGDEIAFRSPDRDRAGQASIDDLASLEEDFPLHVAVYRRVIAEFNGGTPFPLQLATQVDAPPGSGLGSSSALVVAMLLTTCALIGSSPGPYELARLAWEIERVDLGMAGGWQDHYAAAFGGFNFMESRPNGEVVVNPLRIRREVIAELEASLLLYFGGVSRLSSEVIADQQRNVVERDADALAATHSICAEALEMKDLLVVGDIPGFADSLLRGWQAKKRTSTRISNPAIEHAYQVAQSSGMVAGKVSGAGGGGFLMMIVDPRRRIEVARSLERECGGSVAPCLFTKGGAVTWHIPESTAPVRRGVADAVASALGNAGILLCAGCVLATSHSTWRVPV,"40,827",386,,GDP-L-fucose salvage [GO:0042352],ATP binding [GO:0005524]; fucokinase activity [GO:0050201],,,,1
P95200,P95200_MYCTU,Rv0392c,ndhA Rv0392c,GO:0003955; GO:0005829; GO:0005886; GO:0016021; GO:0044119,IPR036188; IPR023753; ,,ndhA,DOMAIN 15 340 FAD/NAD-binding_dom. {ECO:0000259|Pfam:PF07992}.,Probable membrane NADH dehydrogenase NdhA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MTLSSGEPSAVGGRHRVVIIGSGFGGLNAAKALKRADVDITLISKTTTHLFQPLLYQVATGILSEGDIAPTTRLILRRQKNVRVLLGEVNAIDLKAQTVTSKLMDMTTVTPYDSLIVAAGAQQSYFGNDEFATFAPGMKTIDDALELRGRILGAFEAAEVSTDHAERERRLTFVVVGAGPTGVEVAGQIVELAERTLAGAFRTITPSECRVILLDAAPAVLPPMGPKLGLKAQRRLEKMDVEVQLNAMVTAVDYKGITIKEKDGGERRIECACKVWAAGVAASPLGKMIAEGSDGTEIDRAGRVIVEPDLTVKGHPNVFVVGDLMFVPGVPGVAQGAIQGARYATTVIKHMVKGNDDPANRKPFHYFNKGSMATISRHSAVAQVGKLEFAGYFAWLAWLVLHLVYLVGYRNRIAALFAWGISFMGRARGQMAITSQMIYARLVMTLMEQQAQGALAAAEQAEHAEQEAAG,"50,385",470,,growth of symbiont in host cell [GO:0044119],NAD(P)H dehydrogenase (quinone) activity [GO:0003955],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53713,O53713_MYCTU,Rv0378,Rv0378,,,,,,Conserved hypothetical glycine rich protein,,9634230,,,MSGRWEAGNADGNGGSAGLIGSGGAGGDGGSGGATGAGGEGGDAGASGSINGNAGDPGNSGERGAVGKPGAPG,"6,128",73,,,,,,,1
O07254,O07254_MYCTU,Rv0330c,Rv0330c,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; ,,,DOMAIN 7 67 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Uncharacterized protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MARSIPADRFSAIVAASARVFIAHGYQRTQVQDVADALALAKGTLYGYAQGKAALFAAAVRYGDAQEALPLASELPVAAPVAGEIAAVVSARLAGEVTDMRLTHALRATLPPGATTGDARAELAGIVTDLYSRLARHRIALKLVDRCAPELPDLAEVWFGTGRNAQVDAVQAYLVHRERAGLLILPGPAPMVARTIVELCALWAVHLHFDPSPEPWSIVQPGVIDDDAIAATLAEFVVRATTASSD,"25,933",246,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
I6XU97,I6XU97_MYCTU,Rv0045c,Rv0045c,GO:0016787,IPR029058; IPR000073; ,,,DOMAIN 52 289 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Possible hydrolase,hydrolase activity [GO:0016787],9634230; 21969609,,,MLSDDELTGLDEFALLAENAEQAGVNGPLPEVERVQAGAISALRWGGSAPRVIFLHGGGQNAHTWDTVIVGLGEPALAVDLPGHGHSAWREDGNYSPQLNSETLAPVLRELAPGAEFVVGMSLGGLTAIRLAAMAPDLVGELVLVDVTPSALQRHAELTAEQRGTVALMHGEREFPSFQAMLDLTIAAAPHRDVKSLRRGVFHNSRRLDNGNWVWRYDAIRTFGDFAGLWDDVDALSAPITLVRGGSSGFVTDQDTAELHRRATHFRGVHIVEKSGHSVQSDQPRALIEIVRGVLDTR,"32,131",298,,,hydrolase activity [GO:0016787],,,,1
O53668,O53668_MYCTU,Rv0246,Rv0246,GO:0005618; GO:0016021,IPR036259; ,,,,Probable conserved integral membrane protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230,,,MAKTSHRVSSADGMSKRILRLIIAQSGFYSAALQLGNVSIVLPFVVAELDAELWIAALIFPAFTAGGAIGNVVAPPAVAAVPRRHRLFIIVSCLAVLAGVNALCATIGKGSVAGILLVVNVTLIGVVSAISFVAFADLVAAMPSGTARARILLTEVGVGAALTAVVAATLSFVPDQHPLSRNIHLLWTAAVAMAISAAICRALPHRIVPRVHAAPGLHKLVYVGWTAIRTNGWYRRYLLVQVLFGSVVLGSSFHSIRVAAVPGDQPDEVVAVVLFVCVGLLGGIALWNRVRERFGLVGLFVGSALVSIAAAVLSIAFDLAGAWPNVVAIGLVIALVSIANQSVFTAGQLWIARDAEPGLRTSLISFGQLVINAGLVGMGLALGLIAQDHDAVWPVMIVLLLNLTAAYSATRFAPAKSVDVRGLPQVSRTSRPKTGG,"45,326",436,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,3
O53666,O53666_MYCTU,Rv0244c,fadE5 Rv0244c,GO:0005576; GO:0005886; GO:0016627; GO:0050660; GO:0052572,IPR034188; IPR025878; IPR020953; IPR006091; IPR036250; IPR009075; IPR037069; IPR009100; ,,fadE5,,Probable acyl-CoA dehydrogenase FadE5,"extracellular region [GO:0005576]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; response to host immune response [GO:0052572]",9634230; 21969609,,,MSHYRSNVRDQVFNLFEVLGVDKALGHGEFSDVDVDTARDMLAEVSRLAEGPVAESFVEGDRNPPVFDPKTHSVMLPESFKKSVNAMLEAGWDKVGIDEALGGMPMPKAVVWALHEHILGANPAVWMYAGGAGFAQILYHLGTEEQKKWAVLAAERGWGSTMVLTEPDAGSDVGAARTKAVQQADGSWHIDGVKRFITSGDSGDLFENIFHLVLARPEGAGPGTKGLSLYFVPKFLFDVETGEPGERNGVFVTNVEHKMGLKVSATCELAFGQHGVPAKGWLVGEVHNGIAQMFEVIEQARMMVGTKAIATLSTGYLNALQYAKSRVQGADLTQMTDKTAPRVTITHHPDVRRSLMTQKAYAEGLRALYLYTATFQDAAVAEVVHGVDAKLAVKVNDLMLPVVKGVGSEQAYAKLTESLQTLGGSGFLQDYPIEQYIRDAKIDSLYEGTTAIQAQDFFFRKIVRDKGVALAHVSGQIQEFVDSGAGNGRLKTERALLAKALTDVQGMAAALTGYLMAAQQDVTSLYKVGLGSVRFLMSVGDLIIGWLLQRQAAVAVAALDAGATGDERSFYEGKVAVASFFAKNFLPLLTSTREVIETLDNDIMELDEAAF,"66,046",611,Acyl-CoA dehydrogenase family,response to host immune response [GO:0052572],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O07243,O07243_MYCTU,Rv0316,Rv0316,GO:0005618; GO:0006725; GO:0016853,IPR011008; IPR026029; IPR003464; ,,,,Possible muconolactone isomerase,cell wall [GO:0005618]; isomerase activity [GO:0016853]; cellular aromatic compound metabolic process [GO:0006725],9634230; 21969609,,,MEFLVTMTTRVPDSMPADAVERVRAREAARSRELAAQGKLLRLWRPPLRPGEWRTLGLFAADDNGELEQLLASMPPRSWRTDDVTPLGAHPNDPVGQGITIAPGKGPEFLIATTIMVPPGTPAQVVDDTVAREARRAPELAGRGHLVRLWALPDGPDGQRTLGLWRARDPGELMAILESLPLAGWMTIETTPLSPHPDDPIRMP,"22,332",204,,cellular aromatic compound metabolic process [GO:0006725],isomerase activity [GO:0016853],cell wall [GO:0005618],,,1
O06295,O06295_MYCTU,Rv0344c,lpqJ Rv0344c,,,,lpqJ,,Probable lipoprotein LpqJ,,9634230; 21969609,,,MRLSLIARGMAALLAATALVAGCNTTIDGRPVASPGSGPTEPTFPTPRPTTAPPGTTAPTLPTTPVSPTAPAGAIPLPPDSNGYVFIETKSGMTRCQINRDSVGCEAPFTNSPLRDGEHANGIHITAGGSVQWVLGNLGAIPTVSIDYRTYEAQGWTIDATTDGTRFTNNRTGHGMFVSIEKVDTF,"19,309",186,,,,,,,1
O53661,O53661_MYCTU,Rv0238,Rv0238,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 11 71 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MAGGTKRLPRAVREQQMLDAAVQMFSVNGYHETSMDAIAAEAQISKPMLYLYYGSKEDLFGACLNREMSRFIDALRSSINFDQSPKDLLRNTIVSFLRYIDANRASWIVMYTQATSSQAFAHTVREGREQIVQLVAELVRAGTRGPLTDAEIEMMAVALVGAGEAVATRLGIGDTDVDEAAEMMINLFWLGLKGAPVDRLETGH,"22,497",204,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53708,O53708_MYCTU,Rv0373c,Rv0373c,GO:0005507; GO:0005886; GO:0018492; GO:0030151,IPR000674; IPR036856; IPR008274; IPR037165; IPR012780; ,,,,Probable carbon monoxyde dehydrogenase (Large chain),plasma membrane [GO:0005886]; carbon-monoxide dehydrogenase (acceptor) activity [GO:0018492]; copper ion binding [GO:0005507]; molybdenum ion binding [GO:0030151],9634230,,,MTTIESRPPSPEDLADNAQQPCGHGRMMRKEDPRFIRGRGTYVDDVALPGMLHLAILRSPYAHARIVRIDVTAAQAHPKVKAVVTGADLAAKGLAWMPTLANDVQAVLATDKTRFQGQEVAFVVAEDRYSARDACELVDVDYEPRDPVVDARTALDPSAPVIRTDLEGKSDNHIFDWETGDAAATEAVFAKADVVVQQEIVYPRVHPAPMETCGAVADLDPVTGKLTLWTTSQAPHAHRTLYALVAGLPEHKIRVISPDIGGGFGNKVPIYPGYVCAIVASLLLDKPVKWMEDRSENLTSTGFARDYIMVGEIAANRDGKILAIRSNVLADHGAFNAQAAPAKYPAGFFGVFTGSYDIEAAYCHMTAVYTNKAPGGVAYACSFRITEAVYFVERLVDCLAFELKMDPAELRLRNLLRPNQFPYQSKTGWVYDSGDYETTMRKAMNMIGYEALRAEQKQRRARGELMGIGMSFFTEAVGAGPRKDMDILGLGMADGCELRVHPTGKAVLRLSVQTQGQGHETTFAQIVAEELGIAPDDIEVVHGDTDQTPFGLGTYGSRSTPVSGGAAALVARKVRDKAKIIASGMLEVSVADLQWEKGKFHVKGDPSAAVTIADIAMRAHGAGDLPEGIEGGLDAEVCYNPSNLTYPYGAYFCVVDIDPGTAVVKVRRFLAVDDCGTRINPMIIEGQVHGGIVDGIGMALMEMIAFDEDGNCLGGSLMDYLIPTALEVPHLETGHTVTPSPHHPIGAKGIGESATVGSPPAVVNAVVDALAPFGVRHADMPLTPSRVWEAMQGRATPPI,"85,889",799,,,carbon-monoxide dehydrogenase (acceptor) activity [GO:0018492]; copper ion binding [GO:0005507]; molybdenum ion binding [GO:0030151],plasma membrane [GO:0005886],,,1
O53673,O53673_MYCTU,Rv0251c,hsp Rv0251c,GO:0005618; GO:0005886; GO:0009405; GO:0042542; GO:0046677; GO:0071451,IPR002068; IPR008978; ,,hsp,DOMAIN 36 158 SHSP. {ECO:0000259|PROSITE:PS01031}.,Heat shock protein Hsp (Heat-stress-induced ribosome-binding protein A),cell wall [GO:0005618]; plasma membrane [GO:0005886]; cellular response to superoxide [GO:0071451]; pathogenesis [GO:0009405]; response to antibiotic [GO:0046677]; response to hydrogen peroxide [GO:0042542],9634230; 21969609,,,MNNLALWSRPVWDVEPWDRWLRDFFGPAATTDWYRPVAGDFTPAAEIVKDGDDAVVRLELPGIDVDKDVNVELDPGQPVSRLVIRGEHRDEHTQDAGDKDGRTLREIRYGSFRRSFRLPAHVTSEAIAASYDAGVLTVRVAGAYKAPAETQAQRIAITK,"17,786",159,Small heat shock protein (HSP20) family,cellular response to superoxide [GO:0071451]; pathogenesis [GO:0009405]; response to antibiotic [GO:0046677]; response to hydrogen peroxide [GO:0042542],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
L7N6B0,L7N6B0_MYCTU,Rv0237,lpqI Rv0237,GO:0004553; GO:0005975,IPR001764; IPR036962; IPR017853; ,,lpqI,,Probable conserved lipoprotein LpqI,"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MAFPRTLAILAAAAALVVACSHGGTPTGSSTTSGASPATPVAVPVPRSCAEPAGIPALLSPRDKLAQLLVVGVRDAADAQAVVTNYHVGGILIGSDTDLTIFDGALAEIVAGGGPLPLAVSVDEEGGRVSRLRSLIGGTGPSARELAQTRTVQQVRDLARDRGRQMRKLGITIDFAPVVDVTDAPDDTVIGDRSFGSDPATVTAYAGAYAQGLRDAGVLPVLKHFPGHGRGSGDSHNGGVTTPPLDDLVGDDLVPYRTLVTQAPVGVMVGHLQVPGLTGSEPASLSKAAVNLLRTGTGYGAPPFDGPVFSDDLSGMAAISDRFGVSEAVLRTLQAGADIALWVTTKEVPAVLDRLEQALRAGELPMSAVDRSVVRVATMKGPNPGCGR,"39,519",388,,carbohydrate metabolic process [GO:0005975],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",,,,1
I6Y340,I6Y340_MYCTU,Rv0216,Rv0216,,IPR029069; IPR016790; ,,,,Double hotdog hydratase,,9634230; 21969609,,,MASGYGGIRVGGPYFDDLSKGQVFDWAPGVTLSLGLAAAHQSIVGNRLRLALDSDLCAAVTGMPGPLAHPGLVCDVAIGQSTLATQRVKANLFYRGLRFHRFPAVGDTLYTRTEVVGLRANSPKPGRAPTGLAGLRMTTIDRTDRLVLDFYRCAMLPASPDWKPGAVPGDDLSRIGADAPAPAADPTAHWDGAVFRKRVPGPHFDAGIAGAVLHSTADLVSGAPELARLTLNIAATHHDWRVSGRRLVYGGHTIGLALAQATRLLPNLATVLDWESCDHTAPVHEGDTLYSELHIESAQAHADGGVLGLRSLVYAVSDSASEPDRQVLDWRFSALQF,"35,789",337,,,,,,,1
O53701,O53701_MYCTU,Rv0366c,Rv0366c,GO:0005524; GO:0005618; GO:0016301,IPR027417; IPR010488; ,,,,Uncharacterized protein,cell wall [GO:0005618]; ATP binding [GO:0005524]; kinase activity [GO:0016301],9634230,,,MKRLDLVAGPNGAGKSTFVALTLAPLLPGIVFVNADEIAKQRWPDDPTSHAYQAAQVAADTRARLIDLGRPFIAETVFSHPSKLELIRTARTAGYTVVLHVLVIPEGLAVERVRHRVAAGGHDVPETKIRERHRRLAELVAQAITLADGATVYDNSRLAGPRIVAQFSGGGIIGRACWPSWTPPPLMSRWSNRPETA,"21,377",197,,,ATP binding [GO:0005524]; kinase activity [GO:0016301],cell wall [GO:0005618],,,1
O07175,O07175_MYCTU,Rv0125,pepA Rv0125,GO:0004252; GO:0005576; GO:0005618,IPR001478; IPR036034; IPR009003; IPR001940; IPR006311; ,,pepA,DOMAIN 265 316 PDZ. {ECO:0000259|PROSITE:PS50106}.,Probable serine protease PepA (Serine proteinase) (MTB32A),cell wall [GO:0005618]; extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252],9634230; 21969609,,,MSNSRRRSLRWSWLLSVLAAVGLGLATAPAQAAPPALSQDRFADFPALPLDPSAMVAQVGPQVVNINTKLGYNNAVGAGTGIVIDPNGVVLTNNHVIAGATDINAFSVGSGQTYGVDVVGYDRTQDVAVLQLRGAGGLPSAAIGGGVAVGEPVVAMGNSGGQGGTPRAVPGRVVALGQTVQASDSLTGAEETLNGLIQFDAAIQPGDSGGPVVNGLGQVVGMNTAASDNFQLSQGGQGFAIPIGQAMAIAGQIRSGGGSPTVHIGPTAFLGLGVVDNNGNGARVQRVVGSAPAASLGISTGDVITAVDGAPINSATAMADALNGHHPGDVISVTWQTKSGGTRTGNVTLAEGPPA,"34,926",355,,,serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
I6WXK8,I6WXK8_MYCTU,Rv0157A,Rv0157A,,,,,,Conserved protein,,9634230; 21969609,,,MMDPSPDYDVSDEIEFFFRYLTWGLRGVETGDGYPPPAYPPV,"4,828",42,,,,,,,1
P96389,P96389_MYCTU,Rv0207c,Rv0207c,GO:0005886,IPR021139; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MSLTEDVTSQTSESLARHSVLAEDLSQDGLTSLGAPGARVLLVWDAPNLDMGLGSILGRRPTALERPRFDALGRWLLARTAEIVAGRPGISTEPEATVFTNIAPGSAEVVRPWVDALRNVGFAVFAKPKVDEDSDVDRDMLAHIDERYREGLAALVVASADGQAFRQPLEAVARSGTPVQVLGFREHASWALASDTLEFVDLEDIAGVFREPLPRIGLDSLPEQGAWLQPFRPLSSLLTSRV,"26,176",242,,,,plasma membrane [GO:0005886],,,3
P95229,P95229_MYCTU,Rv0272c,Rv0272c,GO:0006629; GO:0016020; GO:0016298,IPR029058; ,,,,Uncharacterized protein,membrane [GO:0016020]; lipase activity [GO:0016298]; lipid metabolic process [GO:0006629],9634230; 21969609,,,MTGRAATPGVIREFVGLPSRTAGRAAAGGHPCQGLYHHSVGRKPKVALIAAHYQIDFSEHYLAEYMAIRGIGFLGWNTRFRGFESSFLLDHALVDIGVGVRWLREVQGVETVVLLGNSGGGSLMAAYQSQAVDPNVTPLDGMRPAAGVTELPAADAYVAAAAHPGRPDVLTAWMDAAVIDENDPVATDPELDLFDERNGPPYSPEFISRYRSAQVKRNHTITDWAESELKRVRAAGFSDRPFSVMRTWADPRMVDPSIEPTKRRPNQCYAGTPVKANRSAHGIAAACTLRGWLGMWSLRVAQTRAAPHLARITCPALVLNAEADTGIFPSDAQQIYDGLASSDKTQVSIDTDHYFTTPGARSEQADTIAKWIAKRWR,"41,077",377,,lipid metabolic process [GO:0006629],lipase activity [GO:0016298],membrane [GO:0016020],,,1
O06308,O06308_MYCTU,Rv0358,Rv0358,,,,,,Conserved protein,,9634230; 21969609,,,MYTAENAPGVAVLLSGDADVPGPLTGLPTHQDNLDTVIGRYSRLIVVGADADLGAVLTRLLRTDRLDVEVGYVPRRRSPATRAYRLPAGRRAARRARCGVARRVPLIRDETGSVIVGRAQWLPAEEQALIHGEAVVDDTVLFDGDVAGVCIEPTLTLPGLRAAVDGAGKWRRWIGGRAAQLGTTGAAVLRDGVAAPRPVRRSTFYRNVEGWLLVR,"23,102",215,,,,,,,1
O07242,O07242_MYCTU,Rv0315,Rv0315,GO:0004553; GO:0005576; GO:0005975; GO:0046872,IPR013320; IPR000757; IPR006311; ,,,DOMAIN 28 294 GH16. {ECO:0000259|PROSITE:PS51762}.,"Possible beta-1,3-glucanase","extracellular region [GO:0005576]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609; 26469317,X-ray crystallography (1),,MLMPEMDRRRMMMMAGFGALAAALPAPTAWADPSRPAAPAGPTPAPAAPAAATGGLLFHDEFDGPAGSVPDPSKWQVSNHRTPIKNPVGFDRPQFFGQYRDSRQNVFLDGNSNLVLRATREGNRYFGGLVHGLWRGGIGTTWEARIKFNCLAPGMWPAWWLSNDDPGRSGEIDLIEWYGNGTWPSGTTVHANPDGTAFETCPIGVDGGWHNWRVTWNPSGMYFWLDYADGIEPYFSVPATGIEDLNEPIREWPFNDPGYKVFPVLNLAVGGSGGGDPATGSYPQEMLVDWVRVF,"32,186",294,,carbohydrate metabolic process [GO:0005975],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; metal ion binding [GO:0046872]",extracellular region [GO:0005576],,,1
O53675,O53675_MYCTU,Rv0253,nirD Rv0253,GO:0008942; GO:0009061; GO:0009344; GO:0015514; GO:0042128; GO:0051537,IPR012748; IPR017881; IPR036922; ,,nirD,,Probable nitrite reductase [NAD(P)H] small subunit NirD,"nitrite reductase complex [NAD(P)H] [GO:0009344]; 2 iron, 2 sulfur cluster binding [GO:0051537]; nitrite efflux transmembrane transporter activity [GO:0015514]; nitrite reductase [NAD(P)H] activity [GO:0008942]; anaerobic respiration [GO:0009061]; nitrate assimilation [GO:0042128]",9634230; 22965870,X-ray crystallography (1),,MTLLNDIQVWTTACAYDHLIPGRGVGVLLDDGSQVALFRLDDGSVHAVGNVDPFSGAAVMSRGIVGDRGGRAMVQSPILKQAFALDDGSCLDDPRVSVPVYPARVTPEGRIQVARVAV,"12,430",118,,anaerobic respiration [GO:0009061]; nitrate assimilation [GO:0042128],"2 iron, 2 sulfur cluster binding [GO:0051537]; nitrite efflux transmembrane transporter activity [GO:0015514]; nitrite reductase [NAD(P)H] activity [GO:0008942]",nitrite reductase complex [NAD(P)H] [GO:0009344],,,1
P95197,P95197_MYCTU,Rv0389,purT Rv0389,GO:0000287; GO:0004644; GO:0005524; GO:0005829; GO:0006189,IPR011761; IPR003135; IPR013815; IPR016185; IPR005862; ,,purT,,Formate-dependent phosphoribosylglycinamide formyltransferase,cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189],9634230; 21969609,,"FUNCTION: Involved in the de novo purine biosynthesis. Catalyzes the transfer of formate to 5-phospho-ribosyl-glycinamide (GAR), producing 5-phospho-ribosyl-N-formylglycinamide (FGAR). Formate is provided by PurU via hydrolysis of 10-formyl-tetrahydrofolate. {ECO:0000256|SAAS:SAAS00701003}.",MIDGWTEEQHEPTVRHERPAAPQDVRRVMLLGSAEPSRELAIALQGLGAEVIAVDGYVGAPAHRIADQSVVVTMTDAEELTAVIRRLQPDFLVTVTAAVSVDALDAVEQADGECTELVPNARAVRCTADREGLRRLAADQLGLPTAPFWFVGSLGELQAVAVHAGFPLLVSPVAGVAGQGSSVVAGPNEVEPAWQRAAGHQVQPQTGGVSPRVCAESVVEIEFLVTMIVVCSQGPNGPLIEFCAPIGHRDADAGELESWQPQKLSTAALDAAKSIAARIVKALGGRGVFGVELMINGDEVYFADVTVCPAGSAWVTVRSQRLSVFELQARAILGLAVDTLMISPGAARVINPDHTAGRAAVGAAPPADALTGALGVPESDVVIFGRGLGVALATAPEVAIARERAREVASRLNVPDSRE,"43,678",419,PurK/PurT family,'de novo' IMP biosynthetic process [GO:0006189],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphoribosylglycinamide formyltransferase activity [GO:0004644],cytosol [GO:0005829],,,2
O06311,O06311_MYCTU,Rv0361,Rv0361,GO:0005576; GO:0005618; GO:0005887,IPR032710; ,,,,Probable conserved membrane protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MSNAPEPDRSAGESGSEPAGERSADPGEERTESYPLVPHDAETETVVITTSDNDAAVTQPEAQRERRFTAPGFDAKETQVIVTAHEAATEVFQTNQAPTTPPRMPTGMPPKTAVPQSIPPRTEATSVRQRTWGWALAVVVIVLALAAIAILGTVLLTRGKHSKMSQEDQVRQAIQSLDIAIQTGDLTALRSLTCGSTRDGYVDYDERDWAETYRRVSAAKQYPVIASIDQVVVNGAHAEANVTTFMAFDPQVRSTRSLDLQFRDDQWKICQSSSN,"29,982",275,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
O07172,O07172_MYCTU,Rv0122,Rv0122,GO:0005618,,,,,Uncharacterized protein,cell wall [GO:0005618],9634230; 21969609,,,MAGSVSAAAGIGWVGLNVTETNRDQCYRVERTTVDALTHPEYRVHTRGVQRVRVTRNARKHRVSKHRIVAAMRHCGVPVIQEDGSLYYQGRDTSGRLTEVVAVEADDGDLIITHAMPKEWKR,"13,694",122,,,,cell wall [GO:0005618],,,1
Q79FZ9,Q79FZ9_MYCTU,Rv0169,mce1A Rv0169,GO:0003779; GO:0005576; GO:0005618; GO:0005886; GO:0007157; GO:0008017; GO:0016021; GO:0030260; GO:0042785; GO:0044117; GO:0044121; GO:0044406; GO:0044409; GO:0085014,IPR005693; IPR003399; IPR024516; ,,mce1A,,Mce-family protein Mce1A,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; active evasion of host immune response via regulation of host cytokine network [GO:0042785]; adhesion of symbiont to host [GO:0044406]; dormancy entry of symbiont in host [GO:0085014]; entry into host [GO:0044409]; entry into host cell [GO:0030260]; growth of symbiont in host [GO:0044117]; growth of symbiont in host organelle [GO:0044121]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],9634230; 21969609,,,MTTPGKLNKARVPPYKTAGLGLVLVFALVVALVYLQFRGEFTPKTQLTMLSARAGLVMDPGSKVTYNGVEIGRVDTISEVTRDGESAAKFILDVDPRYIHLIPANVNADIKATTVFGGKYVSLTTPKNPTKRRITPKDVIDVRSVTTEINTLFQTLTSIAEKVDPVKLNLTLSAAAEALTGLGDKFGESIVNANTVLDDLNSRMPQSRHDIQQLAALGDVYADAAPDLFDFLDSSVTTARTINAQQAELDSALLAAAGFGNTTADVFDRGGPYLQRGVADLVPTATLLDTYSPELFCTIRNFYDADPLAKAASGGGNGYSLRTNSEILSGIGISLLSPLALATNGAAIGIGLVAGLIAPPLAVAANLAGALPGIVGGAPNPYTYPENLPRVNARGGPGGAPGCWQPITRDLWPAPYLVMDTGASLAPYNHMEVGSPYAVEYVWGRQVGDNTINP,"47,786",454,,active evasion of host immune response via regulation of host cytokine network [GO:0042785]; adhesion of symbiont to host [GO:0044406]; dormancy entry of symbiont in host [GO:0085014]; entry into host [GO:0044409]; entry into host cell [GO:0030260]; growth of symbiont in host [GO:0044117]; growth of symbiont in host organelle [GO:0044121]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],actin binding [GO:0003779]; microtubule binding [GO:0008017],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53680,O53680_MYCTU,Rv0274,Rv0274,GO:0008198; GO:0019439; GO:0051213,IPR029068; IPR004360; IPR037523; IPR000486; ,,,DOMAIN 15 166 VOC. {ECO:0000259|PROSITE:PS51819}.,Conserved protein,dioxygenase activity [GO:0051213]; ferrous iron binding [GO:0008198]; aromatic compound catabolic process [GO:0019439],9634230; 21969609,,,MIKPHNTNTEFELGGINHVALVCSDMARTVDFYSNILGMPLIKALDLPGGQGQHFFFDAGNGDCVAFFWFADAPDRVPGLSSPVAIPGIGDITSAVSTMNHLAFHVPAERFDAYRQRLKDKGVRVGPVLNHDDSETQVSAVVHPGVYVRSFYFQDPDGITLEFACWTKEFTTSDAQAVPKTAADRRPPVAADR,"21,082",193,Extradiol ring-cleavage dioxygenase family,aromatic compound catabolic process [GO:0019439],dioxygenase activity [GO:0051213]; ferrous iron binding [GO:0008198],,,,3
L0T545,L0T545_MYCTU,Rv0354c,PPE7 Rv0354c,,,,PPE7,,PPE family protein PPE7,,9634230,,,MSVCVIYIPFKGCVKHVSVTIPITTEHLGPYEIDASTINPDQPIDTAFTQTLDFAGSGTVGAFPFGFGWQQSPGFFNSTTTPSSGFFNSGAGGASGFLNDAAAAVSGLGNVFTETSGFFNAGGVGIRASKTSATCCRAGRT,"14,422",141,,,,,,,1
O33266,O33266_MYCTU,Rv0336,Rv0336,GO:0005618,IPR003870; IPR003615; ,,,,Conserved 13E12 repeat family protein,cell wall [GO:0005618],9634230,,,MPSPEAIAHFDERFECHAPRTTRVSAAFIDRICSATRAENRAAAAQLVALGELFAYRWSRCGGREEWVMDTMAAVAAEVAAALRISQGLAASRLRYARAMRERLPKTAEVFSAGDIGYLMFATIVYRTDLIVDPDVLAAVDAQLAANVARWPSMTKARLAGQVDKIVARADADAVRRRKEYQAQRQFWVGESQDGVCQIGGSLLAVDAHALDARLSALAGTVCEHDPRSREQRRADALGALAGGADRLGCGCGRADCAAGKRPAAPPVVIHLIAEAATINGTGSAPASQMNADGLITAELVAELAKTATLVPLVHPGDAPPEPGYAPSKALADFVRCRDLTCRWPGCDEPATNCDLDHTIPYAAGGPTHASNLKCYCRTHHLVKTFWGWRDQQLPDGTLILTSPSGHTYVSTPGSALLFPSLCHFSGGIPAPEADPPYDHCDQRTAMMPKRRRTRAQDRAYRIATERRQNHAARQRAQVLTQTAAATDTHGPPPDPNDDPPPF,"54,147",503,,,,cell wall [GO:0005618],,,1
P96410,P96410_MYCTU,Rv0228,Rv0228,GO:0009103; GO:0016020; GO:0016021; GO:0016747; GO:0040007,IPR002656; ,,,DOMAIN 38 370 Acyl_transf_3. {ECO:0000259|Pfam:PF01757}.,Probable integral membrane acyltransferase,"integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103]",9634230; 21969609,,,MGPADESGAPIRPQTPHRHTVLVTNGQVVGGTRGFLPAVEGMRACAAVGVVVTHVAFQTGHSSGVGGRLFGRFDLAVAVFFAVSGFLLWRGHAAAARDLRSHPRTGPYLRSRVARIMPAYVVAVVVILSLLPDADHASLTVWLANLTLTQIYVPLTLTGGLTQMWSLSVEVAFYAALPVLALLGRRIPVGARVPAIAALAALSWAWGWLPLDAGSGINPLTWPPAFFSWFAAGMLLAEWAYSPVGLPHRWARRRVAMAVTALLGYLVAASPLAGPEGLVPGTAAQFAVKTAMGSLVAFALVAPLVLDRPDTSHRLLGSPAMVTLGRWSYGLFIWHLAALAMVFPVIGAFPFTGRMPTVLVLTLIFGFAIAAVSYALVESPCREALRRWERRNEPISVGELQADAIAP,"43,296",407,,growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",integral component of membrane [GO:0016021]; membrane [GO:0016020],,,1
O07411,O07411_MYCTU,Rv0166,fadD5 Rv0166,GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD5,,Probable fatty-acid-CoA ligase FadD5 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MTAQLASHLTRALTLAQQQPYLARRQNWVNQLERHAMMQPDAPALRFVGNTMTWADLRRRVAALAGALSGRGVGFGDRVMILMLNRTEFVESVLAANMIGAIAVPLNFRLTPTEIAVLVEDCVAHVMLTEAALAPVAIGVRNIQPLLSVIVVAGGSSQDSVFGYEDLLNEAGDVHEPVDIPNDSPALIMYTSGTTGRPKGAVLTHANLTGQAMTALYTSGANINSDVGFVGVPLFHIAGIGNMLTGLLLGLPTVIYPLGAFDPGQLLDVLEAEKVTGIFLVPAQWQAVCTEQQARPRDLRLRVLSWGAAPAPDALLRQMSATFPETQILAAFGQTEMSPVTCMLLGEDAIAKRGSVGRVIPTVAARVVDQNMNDVPVGEVGEIVYRAPTLMSCYWNNPEATAEAFAGGWFHSGDLVRMDSDGYVWVVDRKKDMIISGGENIYCAELENVLASHPDIAEVAVIGRADEKWGEVPIAVAAVTNDDLRIEDLGEFLTDRLARYKHPKALEIVDALPRNPAGKVLKTELRLRYGACVNVERRSASAGFTERRENRQKL,"59,906",554,,metabolic process [GO:0008152],ligase activity [GO:0016874],,,,1
O07430,O07430_MYCTU,Rv0186,bglS Rv0186,GO:0004553; GO:0005886; GO:0005975,IPR026891; IPR002772; IPR036881; IPR001764; IPR036962; IPR017853; IPR013783; ,,bglS,,Probable beta-glucosidase BglS (Gentiobiase) (Cellobiase) (Beta-D-glucoside glucohydrolase),"plasma membrane [GO:0005886]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MTDDERFSLLVGLTGASDLWPVRDERIPQGVPMCAGYVPGIPRLGVPALLMSDAGLGVTNPGYRPGDTATALPAGLALAASFNPVLARSSGKAIGREARSRGFNVQLAGAINLARDPRNGRNFEYLSEDPLLSATMAAESIIGIQQQGVIATTKHFSLNCNETNRHWLDAVIDPDAHRESDLLAFEIVIERSQPGAVMAAYNKVNGDYAAGNDHLLNDVLKGAWGYRGWVMSDWGGTPSWECALAGLDQECGAQIDAVLWQSEAFTDRLRAAYADGNLPKGRLSDMVRRILRSMFAVGIDRWKPAPAPDMNAHNEIAAQMARQGIVLLQNRGLLPLAPESAGRIAVIGGYAHLGVPAGYGSSAVTPPGGYAGVIPIGGSGLAAGLRNLYLLPSSPLSELRKRLPNAQFEFDPGINPAEAVLAARRADIAIVFAIRAEGEGFDSADLSLPWGQDALIAAVASANANTVVVLETGNPVTMPWRDSVNAIMQAWYPGQAGGQAVAEIVTGQVNPSGRLPITFPVDLGQTPRSQPPELGAPWGTSTTIHYTEGADVGYRWFASTNQTPMFAFGHGLSYTSFEYRDLVVTGGHTVHASFSVTNTGDRSGADVPQLYMIAAPGESRLRLLGFERVELEPGQTRRVRIEADPRLLARYDGEARSWRIEPGGYTVAVGASAVALKLAAKVKLAGRGFGR,"73,520",691,,carbohydrate metabolic process [GO:0005975],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",plasma membrane [GO:0005886],,,1
O53622,O53622_MYCTU,Rv0077c,Rv0077c,GO:0010033,IPR029058; IPR000073; ,,,DOMAIN 23 257 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Probable oxidoreductase,response to organic substance [GO:0010033],9634230; 21969609,,,MSTIDISAGTIHYEATGPETGRPVVFVHGYMMGGQLWRRVSERLAGRGLRCIAPTWPLGAHPKPLRPGADQTIGGVAGIVADVLAALELKDVVLVGNDTGGVVTQLVAVHYPERLGALVLTSCDAFEHFPPPILKPVILAAKSATLFRAAIQVMRAPAARNRAYAGLSHHNIDHLTRAWVRPALSNPAIAEDLRQLSLSLRTEVTTAVAARLPEFDKPALIAWSADDVFFALENGQRLAATIPRARFEVIEGARTFSMVDSPDRLADQLSTVAVRT,"29,686",276,,response to organic substance [GO:0010033],,,,,3
O07415,O07415_MYCTU,Rv0171,mce1C Rv0171,GO:0005576; GO:0044117,IPR005693; IPR003399; ,,mce1C,,Mce-family protein Mce1C,extracellular region [GO:0005576]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MRTLEPPNRMRIGLMGIVVALLVVAVGQSFTSVPMLFAKPSYYGQFTDSGGLHKGDRVRIAGLGVGTVEGLKIDGDHIVVKFSIGTNTIGTESRLAIRTDTILGRKVLEIEPRGAQALPPGGVLPVGQSTTPYQIYDAFFDVTKAASGWDIETVKRSLNVLSETVDQTYPHLSAALDGVAKFSDTIGKRDEQITHLLAQANQVASILGDRSEQVDRLLVNAKTLIAAFNERGRAVDALLGNISAFSAQVQNLINDNPNLNHVLEQLRILTDLLVDRKEDLAETLTILGRFSASFGETFASGPYFKVLLANLVPGQILQPFVDAAFKKRGISPEDFWRSAGLPAYRWPDPNGTRFPNGAPPPPPPVLEGTPEHPGPAVPPGSPCSYTPPADGLPRPWDPLPCANLTQGPFGGPDFPAPLDVATSPPNPDGPPPAPGLPIAGRPGEVPPNVPGTPVPIPQEAPPGARTLPLGPAPGPAPPPAAPGPPAPPGPGPQLPAPFINPGGTGGSGVTGGSEN,"53,817",515,,growth of symbiont in host [GO:0044117],,extracellular region [GO:0005576],,,1
O53639,O53639_MYCTU,Rv0118c,oxcA Rv0118c,GO:0000287; GO:0005618; GO:0005886; GO:0008949; GO:0030976; GO:0033611; GO:0040007,IPR029035; IPR017660; IPR029061; IPR012000; IPR012001; IPR011766; ,,oxcA,,Probable oxalyl-CoA decarboxylase OxcA,cell wall [GO:0005618]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; oxalyl-CoA decarboxylase activity [GO:0008949]; thiamine pyrophosphate binding [GO:0030976]; growth [GO:0040007]; oxalate catabolic process [GO:0033611],9634230; 21969609,,,MTTRSASPCTVLTDGCHLVVDALKANDVDTIYGVVGIPITDLARAAQASGIRYIGFRHEASAGNAAAAAGFLTARPGVCLTTSGPGFLNGLPALANATTNCFPMIQISGSSSRPMVDLQRGDYQDLDQLNAARPFVKAAYRIGQVQDIGRGVARAIRTATSGRPGGVYLDIPGDVLGQAVEASAASGAIWRPVDPAPRLLPAPEAIDRALDVLAQAQRPLLVLSKGAAYAQADNVIREFVEHTGIPFLPMSMAKGLLPDSHPQSAAAARSLAMARADVVLLVGARLNWLLGNGESPQWSADAKFIQVDIEASEFDSNRPIVAPLTGDIGSVMSALLEAAADRSSVASAAWTGELADRKARNSAKMRRRLADDHHPMRFYNALGAIRSVLQRNPDVYVVNEGANALDLARNIIDMHLPRHRLDSGTWGVMGIGMGYAIAAAVETGRPVVAIEGDSAFGFSGMEFETICRYRLPVTVVILNNGGVYRGDEATIFRSAAPVWRHDPAPTVLNAHARHELIAEAFGGKGYHVSTPTELESALTDALASNGPSLIDCELDPADGVESGHLAKLNTTSAATPAISGDG,"61,171",582,TPP enzyme family,growth [GO:0040007]; oxalate catabolic process [GO:0033611],magnesium ion binding [GO:0000287]; oxalyl-CoA decarboxylase activity [GO:0008949]; thiamine pyrophosphate binding [GO:0030976],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O07417,O07417_MYCTU,Rv0173,lprK Rv0173,GO:0005576; GO:0005618; GO:0044117,IPR005693; IPR003399; ,,lprK,DOMAIN 51 124 MlaD. {ECO:0000259|Pfam:PF02470}.,Possible Mce-family lipoprotein LprK (Mce-family lipoprotein Mce1E),cell wall [GO:0005618]; extracellular region [GO:0005576]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MMSVLARMRVMRHRAWQGLVLLVLALLLSSCGWRGISNVAIPGGPGTGPGSYTIYVQMPDTLAINGNSRVMVADVWVGSIRAIKLKNWVATLTLSLKKDVTLPKNATAKIGQTSLLGSQHVELAAPPDPSPVPLKDGDTIPLKRSSAYPTTEQTLASIATLLRGGGLVNLEGIQQEINAIVTGRADQIRAFLGKLDTFTDELNQQRDDITRAIDSTNRLLAYVGGRSEVLNRVLTDLPPLIKHFADKQELLINASDAVGRLSQSADQYLSAARGDLHQDLQALQCPLKELRRAAPYLVGALKLILTQPFDVDTVPQLVRGDYMNLSLTLDLTYSAIDNAFLTGTGFSGALRALEQSFGRDPETMIPDIRYTPNPNDAPGGPLVERGNRQC,"42,240",390,,growth of symbiont in host [GO:0044117],,cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
L7N6B3,L7N6B3_MYCTU,Rv0162c,adhE1 Rv0162c,GO:0008270; GO:0016491,IPR013149; IPR013154; IPR002328; IPR011032; IPR036291; IPR020843; ,,adhE1,DOMAIN 24 373 PKS_ER. {ECO:0000259|SMART:SM00829}.,Probable zinc-type alcohol dehydrogenase (E subunit) AdhE1,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],9634230; 21969609,,,MPAVQPWLYSNMPAIRGAVLDQIGVPRPYWRSKPISVVELHLDPPDRGEVLVRIEAAGVCHSDLSVVDGTRVRPVPILLGHEAAGIVEQVGDGVDGVAVGQRVVLVFLPRCGQCAACATDGRTPCEPGSAANKAGTLLGGGIRLSRGGRPVYHHLGVSGFATHVVVNRASVVPVPHEVPPTVAALLGCAVLTGGGAVLNVGDPQPGQSVAVVGLGGVGMAAVLTALTYTDVRVVAVDQLPEKLSAAKALGAHEIYTPQQATAGGVKAAVVVEAVGHPAALHTAIGLTAPGGRTITVGLPPPDVRISLSPLDFVTEGRSLIGSYLGSAVPSHDIPRFVSLWQSGRLPVESLVTSTIRLDDINEAMDHLADGIAVRQLISFTGDL,"39,365",383,Zinc-containing alcohol dehydrogenase family,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],,,,1
O07244,O07244_MYCTU,Rv0317c,glpQ2 Rv0317c,GO:0006629; GO:0008081,IPR030395; IPR017946; ,,glpQ2,DOMAIN 9 247 GP-PDE. {ECO:0000259|PROSITE:PS51704}.,Possible glycerophosphoryl diester phosphodiesterase GlpQ2 (Glycerophosphodiester phosphodiesterase),phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629],9634230; 21969609,,,MEFLRHGGRIAMAHRGFTSFRLPMNSMGAFQEAAKLGFRYIETDVRATRDGVAVILHDRRLAPGVGLSGAVDRLDWRDVRKAQLGAGQSIPTLEDLLTALPDMRVNIDIKAASAIEPTVNVIERCNAHNRVLIGSFSERRRRRALRLLTKRVASSAGTGALLAWLTARPLGSRAYAWRMMRDIDCVQLPSRLGGVPVITPARVRGFHAAGRQVHAWTVDEPDVMHTLLDMDVDGIITDRADLLRDVLIARGEWDGA,"28,319",256,,lipid metabolic process [GO:0006629],phosphoric diester hydrolase activity [GO:0008081],,,,1
P96810,P96810_MYCTU,Rv0133,Rv0133,GO:0005886; GO:0016740,IPR016181; IPR000182; ,,,,GCN5-related N-acetyltransferase,plasma membrane [GO:0005886]; transferase activity [GO:0016740],9634230; 21969609,,,MTPQARPARRADVRELSRTMARAFYDDPVMSWLLSNDNARTARLTRLFATIVRHQHLAGGGVEVARGAAGIGGAALWDPPDRWRESRRQQLAMTPGFLRVFGFRTAKARAALDVMMRVHPEEPHWYLAAIGSDPTVRGQGFGQVLMRSRLDRCDAEHCPAYLESTKPENVPYYQRFGFRVTREIALPDAGPPLWAMWREPR,"22,827",201,,,transferase activity [GO:0016740],plasma membrane [GO:0005886],,,1
P71601,P71601_MYCTU,Rv0031,Rv0031,,,,,,Possible remnant of a transposase,,9634230,,,MLARHFGAGRKAHSRAVATLKADIQAWHPAGIQTPKPRCESDVFARIGHTSHPSTRKSRVGPGASEAPLA,"7,450",70,,,,,,,1
O86361,O86361_MYCTU,Rv0243,fadA2 Rv0243,GO:0005618; GO:0005829; GO:0005886; GO:0008152; GO:0016747; GO:0044119,IPR002155; IPR016039; IPR020610; IPR020617; IPR020616; ,,fadA2,,Probable acetyl-CoA acyltransferase FadA2 (3-ketoacyl-CoA thiolase) (Beta-ketothiolase),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; growth of symbiont in host cell [GO:0044119]; metabolic process [GO:0008152]",9634230; 21969609,,,MAPAAKNTSQTRRRVAVLGGNRIPFARSDGAYADASNQDMFTAALSGLVDRFGLAGERLDMVVGGAVLKHSRDFNLMRECVLGSELSPYTPAFDLQQACGTGLQAAIAAADGIAAGRYEVAAAGGVDTTSDPPIGLGDDLRRTLLKLRRSRSNVQRLKLVGTLPASLGVEIPANSEPRTGLSMGEHAAVTAKQMGIKRVDQDELAAASHRNMADAYDRGFFDDLVSPFLGLYRDDNLRPNSSVEKLATLRPVFGVKAGDATMTAGNSTPLTDGASVALLASEQWAEAHSLAPLAYLVDAETAAVDYVNGNDGLLMAPTYAVPRLLARNGLSLQDFDFYEIHEAFASVVLAHLAAWESEEYCKRRLGLDAALGSIDRSKLNVNGSSLAAGHPFAATGGRILAQTAKQLAEKKAAKKGGGPLRGLISICAAGGQGVAAILEA,"46,107",440,Thiolase family,growth of symbiont in host cell [GO:0044119]; metabolic process [GO:0008152],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O07241,O07241_MYCTU,Rv0314c,Rv0314c,GO:0016021,IPR021417; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MIVVWEHLCMNPEDDPEARIRELERPLADVARASELGGSQSGGYTYPPGPPPPPYSYGGPFGGPSPRSSSGNRAWWILAAVVVVGVLVLVGGIAAFSAQRLSQGNFVVLSPTPSVSRAVPTPTAQPATTLPPAGASLSVSGVNVNRTIACNDSIVSVSGMSNTVVITGHCTSLTVSGMRNSVTVDSVDTIEAAGFNNEVTYHSGSPKISNAGGSNSVQQG,"22,531",220,,,,integral component of membrane [GO:0016021],,,1
P95228,P95228_MYCTU,Rv0271c,fadE6 Rv0271c,GO:0005618; GO:0005886; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE6,,Probable acyl-CoA dehydrogenase FadE6,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MSIAITPEHYELADSVRSLVARVAPSEVLHAALESPVENPPPYWQAAAEQGLQGVHLAESVGGQGFGILELAVVLAEFGYGAVPGPFVPSAIASALIAAHDPQAKVLAELATGAAIAAYALDSGLTATRHGDVLVIRGEVRAVPAAAQASVLVLPVAIESRDEWVVLRNDQLEIEAVKSLDPLRPIAHVRANAVDVSDDALLSNLTMTTAHALMSTLLSAEAVGVARWATDTASAYAKIREQFGRPIGQFQAIKHKCAEMIADTERATAAVWDAARALDDAGESSSDVEFAAAVAATLAPATAQRCTQDCIQVHGGIGFTWEHDTNVYYRRALMLAACFGRGSEYPQRVVDTATTAGMRPVDIDLDPSTEKLRAQIRAEVAALKAMPREPRTVAIAEGGWVLPYLPKPWGRAASPVEQIIIAQEFTAGRVKRPQIAIATWIVPSIVAFGTDNQKQRLLPPTFRGDIFWCQLFSEPGAGSDLASLATKATRVDGGWRITGQKIWTTGAQYSQWGALLARTDPSAPKHNGITYFLLDMKSEGVQVKPLRELTGKEFFNTVYLDDVFVPDELVLGEVNRGWEVSRNTLTAERVSIGGSDSTFLPTLGEFVDFVRDYRFEGQFDQVARHRAGQLIAEGHATKLLNLRSTLLTLAGGDPMAPAAISKLLSMRTGQGYAEFAVSSFGTDAVIGDTERLPGKWGEYLLASRATTIYGGTSEVQLNIIAERLLGLPRDP,"78,477",731,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53682,O53682_MYCTU,Rv0276,Rv0276,GO:0005886,IPR018713; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAISLVAHQPIPHVERPMADPPRLQLARRRRSAAGPGGNEDSLMGVALLAGPANVIMELAMPGVGYGVLESRVESGRLDRHPIKRARTTFTYVAVAVAGSDDQKAAFRRAVNKVHAQVYSTPESPVSYHAFDPELQLWVAACLYKGGVDVYRTFVGEMDDEEADHHYRAGMAMGTTLQVPPQMWPPDRAAFDRYWRQSLDRVHIDDVVRDYLYPIVALRIRGIALPGPLRRLSEGIALLITTGFLPQRFRDEMRLPWDATKQRRFDALMAVLRTVNRLMPRFVREFPFNLMLWDLDRRMRRGRPLV,"34,779",306,,,,plasma membrane [GO:0005886],,,1
Q79FZ8,Q79FZ8_MYCTU,Rv0192A,Rv0192A,,,,,,Conserved secreted protein,,9634230,,,MSRWKQGWTRGSLFAALNIAAVVAVLMLGAGVAVADPDAAPGDPGGPGAPGAQRDPSTRRQLTCWRRHPTRWRCRRHLTRWRRRHLTRSRRPRLTRWQCR,"11,474",100,,,,,,,1
L7N694,L7N694_MYCTU,Rv0257,Rv0257,,,,,,Uncharacterized protein,,9634230,,,MTRVSWLPDRCLPRLPACGRGLRGSLPGDSGGTAPDSHRLPASSSPDGKNIGMQSVDLHVERHLPSRGRSHRTVATVTCVTALGDIRSAQLSATGAWPAVLFPSWSWLCGIGGGVDLQKPSCRA,"13,053",124,,,,,,,1
O08446,O08446_MYCTU,Rv0324,Rv0324,GO:0003700; GO:0004792,IPR011991; IPR001845; IPR001763; IPR036873; IPR001307; IPR036388; IPR036390; ,,,DOMAIN 7 101 HTH arsR-type. {ECO:0000259|PROSITE:PS50987}.; DOMAIN 129 218 Rhodanese. {ECO:0000259|PROSITE:PS50206}.,Possible transcriptional regulatory protein (Possibly ArsR-family),DNA binding transcription factor activity [GO:0003700]; thiosulfate sulfurtransferase activity [GO:0004792],9634230; 21969609,,,MAGQSDRKAALLDQVARVGKALANGRRLQILDLLAQGERAVEAIATATGMNLTTASANLQALKSGGLVEARREGTRQYYRIAGEDVARLFALVQVVADEHLADVAVAAADVLGSPEDAITRAELLRRREAGEVTLVDVRPHEEYQAGHIPGAINIPIAELADRLAELTGDRDIVAYCRGAYCVMAPDAVRIARDAGREVKRLDDGMLEWRLAGLPVDEGAPVGHGD,"24,121",226,,,DNA binding transcription factor activity [GO:0003700]; thiosulfate sulfurtransferase activity [GO:0004792],,,,1
I6X8G2,I6X8G2_MYCTU,Rv0078B,Rv0078B,,,,,,Conserved protein,,9634230; 21969609,,,MAVSVAAQKLRLALDMYEVGEQMQRMRLGRERPNADVVEIEAAIDAWRMTRPGAEEGDSAGPTSTRFT,"7,539",68,,,,,,,1
O53613,O53613_MYCTU,Rv0068,Rv0068,GO:0005886; GO:0016491,IPR036291; IPR002347; ,,,,Probable oxidoreductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTKWTAADIPDQTGRTAVITGANTGLGFETAAALAAHGAHVVLAVRNLDKGKQAAARITEATPGAEVELQELDLTSLASVRAAAAQLKSDHQRIDLLINNAGVMYTPRQTTADGFEMQFGTNHLGHFALTGLLIDRLLPVAGSRVVTISSVGHRIRAAIHFDDLQWERRYRRVAAYGQAKLANLLFTYELQRRLAPGGTTIAVASHPGVSNTEVVRNMPRPLVAVAAILAPLMQDAELGALPTLRAATDPAVRGGQYFGPDGFGEIRGYPKVVASSAQSHDEQLQRRLWAVSEELTGVVYPVG,"32,399",303,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
O53718,O53718_MYCTU,Rv0383c,Rv0383c,GO:0005618; GO:0005886; GO:0040007,,,,,Possible conserved secreted protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MVPLWFTLSALCFVGAVVLLYVDIDRRRGRSRRRKSWARSHGFDYERESTEILKRWTRGVMSTVGDVAAHNVVLGQIRGEAVYIFDLEEVATVIALHRKVGTNVVVDLRLKGLKEPRESDIWLLGAIGPRMVYSTNLDAARRACDRRMVTFAHTAPDCAEIMWNEQNWTLVSMPIASTRAQWDEGLRTVRQFNDLLRVLPPLPQEMPQQTGVGPRGAAPGRPVAPGGPAELPPRRAQPDPATTVLPDPARRAPEPIRRDEGRSEGVRRPPPAGRNGQQATNYQH,"31,801",284,,growth [GO:0040007],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53704,O53704_MYCTU,Rv0369c,Rv0369c,GO:0005886; GO:0016021,IPR010419; IPR023393; ,,,,Possible membrane oxidoreductase,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MPGAQLIGHEGDEYLGKVKVKVGPVTSEFSGKVHFVEQDRNQHRAVFDAKGKEARGTGNAAATVAAQLHEVGERTRVTVDTDLKIVGKLAQFGSGMLQQVSEKLLGQFVDSLEAELAAQSSESPQGTPPATEAAPIDLLQLADGGQLKKYGSALLAALTVLLLIWVLRRRR,"18,269",171,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,3
I6XUD2,I6XUD2_MYCTU,Rv0082,Rv0082,GO:0051536; GO:0055114,IPR006137; ,,,,Probable oxidoreductase,iron-sulfur cluster binding [GO:0051536]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MGWVAKIFRVGRVVEPAAPLPAAIAEPPAGVRGSLQIRHVDAGSCNGCEVEISGAFGPVYDAERFGARLVASPRHADALLVTGVVTHNMAGPLRKTLEATPRPRVVIACGDCALNRGVFADAYGVVGAVGEVVPVDVEIAGCPPTPAAIMAALRSVTGK,"16,260",159,,oxidation-reduction process [GO:0055114],iron-sulfur cluster binding [GO:0051536],,,,1
O07408,O07408_MYCTU,Rv0163,Rv0163,,IPR029069; IPR006683; ,,,,Conserved protein,,9634230; 21969609,,,MAALPAPEKLLRSDFPVLWPVGTRWADNDMFGHLNNAVYYQLFDTAINAWINTSTGVDPLAMPVLGIVAESGCRYFSELRFPESLMVGLAVTRLGRSSVTYRLGVFKEPDDAGVITALGHWVHVYVDRTSRRPVPIPEAIRSLLSTACVSG,"16,607",151,,,,,,,1
P95220,P95220_MYCTU,Rv0263c,Rv0263c,,IPR003778; IPR029000; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTTLEILRSGPLALVEDLGRAGLAHLGVGRSGAADRRSHTLANRLVANPDDWATVEVTFGGFSARVRGGDVDIAVTGADTDPTVNGIMVGTNSIHHVRDGQVISLGTPRAGLRTYLAVRGGVCVEPVLGSRSYDVMSAIGPSPLRAGDVLPVGEHTDDYPELDQAPVAAIEEHLVELRVVPGPRDDWLVDPDALVHTIWMASNRSDRVGMRLQGRPLQHRWPDRQLPGEGVTRGAIQVPPNGLPVILGPDHPITGSYPVVGVITDEDIDKVAQIRPGQYVRLHWARPRSRLPGQGVTQAW,"32,203",300,,,,,,,1
Q79G06,Q79G06_MYCTU,Rv0151c,PE1 Rv0151c,GO:0016021,IPR029058; IPR000084; IPR013228; ,,PE1,DOMAIN 40 130 PE. {ECO:0000259|Pfam:PF00934}.; DOMAIN 196 415 PE-PPE. {ECO:0000259|Pfam:PF08237}.,PE family protein PE1,integral component of membrane [GO:0016021],9634230,,,MAPFGFTPKARHNRGVALRSTYRLDGWVMGPVDKEGWGLSYVFAQPSVLAAAATDLAGIGSAINQATAAVAAPTTGLAAAAADEVSTALATLFGAYGQQFQAISAQVAAFHNEFTQRLAAAANAFVNAEATNTSALVQEATAGLFKPTSPPVLPPMFNQNTAIIMGGTGSPIPTPSYVNAITTLFIDPVVSNPVVKALVTPEELYPITGVKSLPFQTSVQLGLQILDGAIWEQINAGNHVTVFGYSQSAVIASLEMQHLISLGPNAPSPSQLNFILIGNEMNPNGGILARIPGLNVTTLGLPFYGATPDNPYPTTTYTLEYDGFADFPRYPLNVLSDINAVFGILTVHTTYADLTPAQIASATQLPTQGTTSNTYYIIETEHLPLLAPLRAIPVIGPPLAALVEPNLEVIVNLGYGDPRFGYSTSPANVPTPFGLFPDVPASVVADALVAGTQQGVNDFMVELPAALNTLPQTPMPAFPPYVPTLLPPPPPPQPATLINIADTFASVVSTGYSILLPTADLGLAFVTILPAYDLTLFVNQLAAGNLRAAIELPLAATIGLAALGGMIEFIAIVVTLADITQQLQSFSI,"61,411",588,,,,integral component of membrane [GO:0016021],,,1
L0T2Q9,L0T2Q9_MYCTU,Rv0168,yrbE1B Rv0168,GO:0043190,IPR030802; ,,yrbE1B,,Conserved integral membrane protein YrbE1B,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230; 21969609,,,MSTAAVLRARFPRAVANLRQYGGAAARGLDEAGQLTWFALTSIGQIAHALRYYRKETLRLIAQIGMGTGAMAVVGGTVAIVGFVTLSGSSLVAIQGFASLGNIGVEAFTGFFAALINVRIAGPVVTGVALAATVGAGATAELGAMRISEEIDALEVMGIKSISFLASTRIMAGLVVIIPLYALAMIMSFLSPQITTTVLYGQSNGTYEHYFQTFLRPDDVFWSFLEALIITAIVMVSHCYYGYAAGGGPVGVGEAVGRSMRFSLVSVQVVVLFAALALYGVDPNFNLTV,"30,281",289,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
I6X8R2,I6X8R2_MYCTU,Rv0198c,zmp1 Rv0198c,GO:0004222,IPR024079; IPR000718; IPR018497; IPR008753; ,,zmp1,,Probable zinc metalloprotease Zmp1,metalloendopeptidase activity [GO:0004222],9634230; 21969609,,,MTLAIPSGIDLSHIDADARPQDDLFGHVNGRWLAEHEIPADRATDGAFRSLFDRAETQVRDLIIQASQAGAAVGTDAQRIGDLYASFLDEEAVERAGVQPLHDELATIDSAADATELAAALGTLQRAGVGGGIGVYVDTDSKDSTRYLVHFTQSGIGLPDESYYRDEQHAAVLAAYPGHIARMFGLVYGGESRDHAKTADRIVALETKLADAHWDVVKRRDADLGYNLRTFAQLQTEGAGFDWVSWVTALGSAPDAMTELVVRQPDYLVTFASLWASVNVEDWKCWARWRLIRARAPWLTRALVAEDFEFYGRTLTGAQQLRDRWKRGVSLVENLMGDAVGKLYVQRHFPPDAKSRIDTLVDNLQEAYRISISELDWMTPQTRQRALAKLNKFTAKVGYPIKWRDYSKLAIDRDDLYGNVQRGYAVNHDRELAKLFGPVDRDEWFMTPQTVNAYYNPGMNEIVFPAAILQPPFFDPQADEAANYGGIGAVIGHEIGHGFDDQGAKYDGDGNLVDWWTDDDRTEFAARTKALIEQYHAYTPRDLVDHPGPPHVQGAFTIGENIGDLGGLSIALLAYQLSLNGNPAPVIDGLTGMQRVFFGWAQIWRTKSRAAEAIRRLAVDPHSPPEFRCNGVVRNVDAFYQAFDVTEDDALFLDPQRRVRIWN,"73,914",663,,,metalloendopeptidase activity [GO:0004222],,,,1
P71708,P71708_MYCTU,Rv0051,Rv0051,GO:0016021; GO:0016758,IPR018584; IPR016570; ,,,,Probable conserved transmembrane protein,"integral component of membrane [GO:0016021]; transferase activity, transferring hexosyl groups [GO:0016758]",9634230; 21969609,,,MTGALSQSSNISPLPLAADLRSADNRDCPSRTDVLGAALANVVGGPVGRHALIGRTRLMTPLRVMFAIALVFLALGWSTKAACLQSTGTGPGDQRVANWDNQRAYYQLCYSDTVPLYGAELLSQGKFPYKSSWIETDSNGTPQLRYDGQIAVRYMEYPVLTGIYQYLSMAIAKTYTALSKVAPLPVVAEVVMFFNVAAFGLALAWLTTVWATSGLAGRRIWDAALVAASPLVIFQIFTNFDALATGLATSGLLAWARRRPVLAGVLIGLGSAAKLYPLLFLYPLLLLGIRAGRLNALARTMAAAAATWLLVNLPVMLLFPRGWSEFFRLNTRRGDDMDSLYNVVKSFTGWRGFDPTLGFWEPPLVLNTVVTLLFVLCCAAIAYIALTAPHRPRVAQLTFLTVASFLLVNKVWSPQFSLWLVPLAVLALPHRRILLAWMTIDALVWVPRMYYLYGNPSRSLPEQWFTTTVLLRDIAVMVLCGLVVWQIYRPGRDLVRTGGPGALPACGGVDDPVGGVFANAADAPPGRLPSWLRPRLGDEHARERTPDAGRDRTFSGQHRA,"61,241",560,,,"transferase activity, transferring hexosyl groups [GO:0016758]",integral component of membrane [GO:0016021],,,3
I6Y748,I6Y748_MYCTU,Rv0204c,Rv0204c,GO:0016021; GO:0044119,IPR022791; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MSHDAPARNLRQRVGALPRTRVGAPPAEGVPPRGKYWWLRWAVLAIVAIVLAIEVALGWDQLAKAWVSLYRAKWWWLLAAVAAAGASMHSFAQIQRTLLKSAGVHVKQWRSEAAFYAANSLSTTLPGGPVLSATFLLRQQRIWGASTVVASWQLVMSGVLQAVGLALLGLGGAFFLGAKNNPFSLLFTLGGFVTLLLLAQAVASRPELIEGIGRRVLSWANSVRGRPADAGLPKWRETLMQLESVSLGRRDLGVAFGWSLFNWIADVACLGFAAYAAGDHASVGGLAVAYAAARAVGTIPLMPGGLLVVEAVLVPGLVSSGMPLPSAISAMLIYRLISWLLIAAIGWVVFFFMFRTESTADSDNDRDPPTDPNLRLVIQPQGTPCDDPVETTPQGPAPTPDLRPEGGETPPR,"44,036",412,,growth of symbiont in host cell [GO:0044119],,integral component of membrane [GO:0016021],,,1
O53667,O53667_MYCTU,Rv0245,Rv0245,GO:0010181; GO:0042602,IPR002563; IPR012349; ,,,,Possible oxidoreductase,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],9634230; 21969609,,,MNSTNNLTPSSLREAFGHFPTGVVAIAAEVDGVRQGLAASTFVPVSLEPPLVSFCVQNTSTTWPKLTGVPMLGISVLGEAHDAAVRTLAAKTGDRFAGLETVSNDAGAVFIKGTSVWLESAIEQLVPAGDHTIVVLRVNQVKVDPNVAPIVFHRSVLRRLGV,"17,039",162,,,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],,,,1
Q6MX50,Q6MX50_MYCTU,Rv0297,PE_PGRS5 Rv0297,,IPR000084; ,,PE_PGRS5,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS5,,9634230; 21969609,,,MSFVIAQPEMIAAAAGELASIRSAINAANAAAAAQTTGVMSAAADEVSTAVAALFSSHAQAYQAASAQAAAFHAQVVRTLTVDAGAYASAEAANAGPNMLAAVNAPAQALLGRPLIGNGANGAPGTGQAGGDGGLLFGNGGNGGSGAPGQAGGAGGAAGFFGNGGNGGDGGAGANGGAGGTAGWFFGFGGNGGAGGIGVAGINGGLGGAGGDGGNAGFFGNGGNGGMGGAGAAGVNAVNPGLATPVTPAANGGNGLNLVGVPGTAGGGADGANGSAIGQAGGAGGDGGNASTSGGIGIAQTGGAGGAGGAGGDGAPGGNGGNGGSVEHTGATGSSASGGNGATGGNGGVGAPGGAGGNGGHVSGGSVNTAGAGGKGGNGGTGGAGGPGGHGGSVLSGPVGDSGNGGAGGDGGAGVSATDIAGTGGRGGNGGHGGLWIGNGGDGGAGGVGGVGGAGAAGAIGGHGGDGGSVNTPIGGSEAGDGGKGGLGGDGGGRGIFGQFGAGGAGGAGGVGGAGGAGGTGGGGGNGGAIFNAGTPGAAGTGGDGGVGGTGAAGGKGGAGGSGGVNGATGADGAKGLDGATGGKGNNGNPG,"49,058",591,,,,,,,1
Q79G00,Q79G00_MYCTU,Rv0165c,mce1R Rv0165c,GO:0003677; GO:0003700; GO:0006351; GO:0052562; GO:0075182,IPR011711; IPR008920; IPR000524; IPR036388; IPR036390; ,,mce1R,DOMAIN 18 85 HTH gntR-type. {ECO:0000259|PROSITE:PS50949}.,Probable transcriptional regulatory protein Mce1R (Probably GntR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; negative regulation by symbiont of host immune response [GO:0052562]; negative regulation of symbiont transcription in response to host [GO:0075182]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MNAPLSAKPRSQLPLRRAQLSDEVAGHLRAAIMSGALRSGTFIRLDETAAELGVSVTPVREALLKLRGEGMVGLEPHRGHVVLPLTRQDIDDIFWLQATIAQELATSATAHITDVEIDELDRINNALAGAIGSGDAKTIASIEFAFHRVFNKASRRIKLAWFLLNAARYMGAGVRGRPAMGRGRGEQSSAADRRAAPPRHSRRNRAHRLAVHRWGTQADGGPG,"24,169",223,,"negative regulation by symbiont of host immune response [GO:0052562]; negative regulation of symbiont transcription in response to host [GO:0075182]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,2
P71699,P71699_MYCTU,Rv0042c,Rv0042c,GO:0003700; GO:0005886; GO:0006351; GO:0006355; GO:0044212,IPR000835; IPR036388; IPR036390; ,,,DOMAIN 52 188 HTH marR-type. {ECO:0000259|PROSITE:PS50995}.,Possible transcriptional regulatory protein (Probably MarR-family),"plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSVVRSIGKKMQRISGPNALAVKGRPTQVYGHTHVRLDCRFMADSEFTAPEVTQLAEGLHRALSKLISMLRRGDPNGAAAGDLTLAQLSILVTLLDQGPIRMTDLAAHERVRTPTTTVAIRRLEKIGLVKRSRDPSDLRAVLVDITPQGRAVHGESLANRRAALAALLSQLPRSDLETLRKALAPLERLASGEPASGPASNSPARKRA,"22,411",208,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],plasma membrane [GO:0005886],,,1
L0T2Z1,L0T2Z1_MYCTU,Rv0197,Rv0197,GO:0016491; GO:0043546; GO:0046872; GO:0051536,IPR009010; IPR006657; IPR006656; IPR006963; ,,,DOMAIN 4 60 4Fe-4S Mo/W bis-MGD-type. {ECO:0000259|PROSITE:PS51669}.,Possible oxidoreductase,iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491],9634230,,,MTSSDWLPTACILCECNCGIVVQVDDRRLARIRGDKAHPGSAGYTCNKALRLDHYQNNRARLSSPMRRRADGTYEEIDWDTAIVEIAEGFKQIRDTHGGDKIFYYGGGGQGNHLGGAYSGAFLKALGSRYRSNALAQEKTGEAWVDFQLYGGHTRGEFENAEVSVFVGKNPWMSQSFPRARVVLNEIAKDPGRSMIVIDPVVTDTAKMADFHLRVQPGCDAWCLAALAAVLVQENLCNEAFLAAHVHGVDTVRAALQEVPVADYAQRCGVDEELLRAAARRIGTAASVSVFEDLGIQQAPNSTVCSYLNKLLWILTGNFAKKGGQHLHSSFAPLFSQVSGRTPVTGAPIIAGLIPGNVVPEEILTEHPDRFRAMIVERGNPAHSLADSAACRAAFQALELMVVVDVAMTETARLAHYVLPAASQFEKPEATFFNFEFPRNGFQLRRPLFPPLPGTLPEPEIWARLVRALGVVDEADLRPLREAAAQGRQAYTEAFLAAAATNPTVAKLTAYVLYETLGPTLPDGLAGAAALWGLAQKTAMAYPDAVRRAGHADGNALFDAILERPSGVTFTVHNYEDDFALISHPDHKIALEIPEMLAEIRSLTQTPSRLTTPQLPIVLSVGERRAYTANDIFRDPSWRKRDANGALRVSVEDAQALGLADGCLARITTAAGSAEATVEVTETMLAGHAALPNGFGLDYTGDDGRTVVAGVAPNALTSTRWRDPYAGTPWHKHVPAAIRRADAESPIWYPKWAILPARGVLA,"82,572",762,Prokaryotic molybdopterin-containing oxidoreductase family,,iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491],,,,1
L7N6A2,L7N6A2_MYCTU,Rv0275c,Rv0275c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR009057; IPR001647; ,,,DOMAIN 18 80 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Possibly TetR-family),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MTRSDRPYRGVEAAERLATRRRQSLSAGLDLLGSDQHDIAELTIRTICRRAGLSVRYFYESFTDKDEFVGRVFDWVVAELVATTQAAVTAVPAREQTRAGMANIVRTITADARVGRLLFSTQLANAVITRKRAESSALFAMLSGQHAVDTLHAPANDHVKAVAHFAVGGVGQTISAWLAGDVRLDPDQLVDQLAALLDELTDPNLSRPRVAATAAKSGANDPQPPEVAGQPPSSARPARRS,"25,949",241,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
L0T243,L0T243_MYCTU,Rv0012,Rv0012,GO:0005887,IPR010273; ,,,,Probable conserved membrane protein,integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MRLTHPTPCPENGETMIDRRRSAWRFSVPLVCLLAGLLLAATHGVSGGTEIRRSDAPRLVDLVRRAQASVNRLATEREALTTRIDSVHGRSVDTALAAMQRRSAKLAGVAAMNPVHGPGLVVTLQDAQRDANGRFPRDASPDDLVVHQQDIEAVLNALWNAGAEAIQMQDQRIIAMSIARCVGNTLLLNGRTYSPPYTIAAIGDAAAMQAALAAAPLVTLYKQYVVRFGLGYCEEVHPDLQIVGYADPVRMHFAQPAGPLDY,"28,337",262,,,,integral component of plasma membrane [GO:0005887],,,1
Q7ARS9,Q7ARS9_MYCTU,Rv0385,Rv0385,GO:0004497; GO:0005344; GO:0019825; GO:0020037; GO:0042602; GO:0046872; GO:0052875,IPR017927; IPR001709; IPR000971; IPR009050; IPR012292; IPR008333; IPR001433; IPR001221; IPR017938; ,,,,Probable monooxygenase,heme binding [GO:0020037]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; riboflavin reductase (NADH) activity [GO:0052875]; riboflavin reductase (NADPH) activity [GO:0042602],9634230; 21969609,,,MGLEDRDALRVLQNAFKLDDPELVRRFYAHWFALDASVRDLFPPDMGAQRAAFGQALHWVYGELVAQRAEEPVAFLAQLGRDHRKYGVLPTQYDTLRRALYTTLRDYLGHPSRGAWTDAVDEAAGQSLNLIIGVMSGAADADDAPAWWDGTVVEHIRVSRDLAVARLQLDRPLHYYPGQYVNVHVPQCPRRWRYLSPAIPADPNGRIEFHVRVVPGGLVSNAIVGETRPGDRWRLSGPHGAFRVDRDGGDVLMVAGSTGLAPLRALIIDLSRFAVNPRVHLFFGARYACELYDLPTLWQIAAHNPWLSVSPVSEYNGDPAWAADYPDVSAPRGLHVRQTGRLPDVVSRYGGWGDRQILICGGPAMVRATKAALIAKGAPPERIQHDPLSR,"43,277",390,Globin family,,heme binding [GO:0020037]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; riboflavin reductase (NADH) activity [GO:0052875]; riboflavin reductase (NADPH) activity [GO:0042602],,,,1
P96831,P96831_MYCTU,Rv0154c,fadE2 Rv0154c,GO:0005886; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE2,DOMAIN 7 123 Acyl-CoA_dh_N. {ECO:0000259|Pfam:PF02771}.; DOMAIN 128 227 Acyl-CoA_dh_M. {ECO:0000259|Pfam:PF02770}.; DOMAIN 240 390 Acyl-CoA_dh_1. {ECO:0000259|Pfam:PF00441}.,Probable acyl-CoA dehydrogenase FadE2,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MSAKAIDYRTRLSDFMTEHVFGAEADYDDYRRAAGPADHTAPPIIEELKTKAKDRGLWNLFLSAESGLTNLEYAPLAEMTGWSMEIAPEALNCAAPDTGNMEILHMFGTEQQRAQWLRPLLDGKIRSAFSMTEPAVASSDARNIETTISRDGADYVINGRKWWTSGAADPRCKILIVMGRTNPDAAAHQQQSMVLVPIDTPGVTIVRSTPVFGWQDRHGHCEIDYHNVRVPATNLLGEEGSGFAIAQARLGPGRIHHCMRALGAAERALALMVNRVRNRVAFGRPLAEQGVVQQAIAQSRNEIDQARLLCEKAAWTIDQHGNKEARHLVAMIKAVAPRVACDVIDRAIQVHGAAGVSDDTPLARLYGWHRAMRIFDGPDEVHLRSIARAELSREKSTFAAAVT,"44,343",403,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,,3
P96402,P96402_MYCTU,Rv0220,lipC Rv0220,GO:0004806; GO:0046503,IPR029058; IPR013094; IPR019826; ,,lipC,DOMAIN 160 369 Abhydrolase_3. {ECO:0000259|Pfam:PF07859}.,Probable esterase LipC,triglyceride lipase activity [GO:0004806]; glycerolipid catabolic process [GO:0046503],9634230; 21969609,,,MNQRRAAGSTGVAYIRWLLRARPADYMLALSVAGGSLPVVGKHLKPLGGVTAIGVWGARHASDFLSATAKDLLTPGINEVRRRDRASTQEVSVAALRGIVSPDDLAVEWPAPERTPPVCGALRHRRYVHRRRVLYGDDPAQLLDVWRRKDMPTKPAPVLIFVPGGAWVHGSRAIQGYAVLSRLAAQGWVCLSIDYRVAPHHRWPRHILDVKTAIAWARANVDKFGGDRNFIAVAGCSAGGHLSALAGLTANDPQYQAELPEGSDTSVDAVVGIYGRYDWEDRSTPERARFVDFLERVVVQRTIDRHPEVFRDASPIQRVTRNAPPFLVIHGSRDCVIPVEQARSFVERLRAVSRSQVGYLELPGAGHGFDLLDGARTGPTAHAIALFLNQVHRSRAQFAKEVI,"44,308",403,,glycerolipid catabolic process [GO:0046503],triglyceride lipase activity [GO:0004806],,,,1
P96808,P96808_MYCTU,Rv0131c,fadE1 Rv0131c,GO:0005829; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE1,DOMAIN 27 141 Acyl-CoA_dh_N. {ECO:0000259|Pfam:PF02771}.; DOMAIN 145 245 Acyl-CoA_dh_M. {ECO:0000259|Pfam:PF02770}.; DOMAIN 262 409 Acyl-CoA_dh_1. {ECO:0000259|Pfam:PF00441}.,Probable acyl-CoA dehydrogenase FadE1,"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MPVRRRAGERLPTVWDFETDPQYQSKLDWVEKFMAEELEPLDLVALDPYDKKNADTMAILRPLQRQVKDQGLWAAHLRPELGGQGFGQVKLALLNEIIGRSRWAPSAFGCQAPDSGNAEILALFGTDEQKARYLRPLLDGEITSCYSMTEPQGGSDPGLFVTAATRDAAGNGDWIINGEKWFSTNAKHASFFIVMAVTKPEARTYEKMSLFIVPADTPGIEIVRNVGVGAESTRHASHGYIRYHDVRVPADHVLGGEGQAFMIAQTRLGGGRIHHAMRTIALARRAFDMMCERALSRQTRHGRLADLQMTQEKIADSWIQIEQFRLLVLRTAWLIDKHHDYQKVRRDIAAVKVAMPQVLHDVVQRAMHLHGALGVSDEMPFVKMMLAAESLGIADGATELHKMTVARRTLREYQPVTTLFPSQHIPTRRAHAEAWLAQRLEHAIAEF,"50,224",447,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cytosol [GO:0005829],,,1
L7N648,L7N648_MYCTU,Rv0335c,PE6 Rv0335c,,IPR000084; ,,PE6,DOMAIN 70 125 PE. {ECO:0000259|Pfam:PF00934}.,PE family protein PE6,,9634230,,,MRSMGFLHRACRAPSSLPAPLMARPGRSVLARPAATPPGPLCATTRPRPPQGNQPPASRISNFPPKRHKTRVLAAAEDEVSAAVAALISAHGRRHHSLNNQAAAFHGQFAQNLNVGAGSCASAETTADAPTQALLGPADRQRRQRRAVRQWLVRWAAHPGRATRGFHNHRQ,"18,420",171,,,,,,,1
P96834,P96834_MYCTU,Rv0157,pntB Rv0157,GO:0005886; GO:0005887; GO:0008750; GO:0050661,IPR029035; IPR012136; IPR034300; ,,pntB,DOMAIN 8 470 PNTB. {ECO:0000259|Pfam:PF02233}.,NAD(P) transhydrogenase subunit beta (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase subunit beta),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661],9634230; 21969609,,FUNCTION: The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane. {ECO:0000256|PIRNR:PIRNR000204}.,MNLHYLVEILYIISFSLFIYGLMGLTGPKTAVRGNLIAAAGMTIAVAATLVMIRHTSQWPLIIAGLVVGVVLGVPPARLTKMTAMPQLVAFFNGVGGGTVALIALSEFIDTTGFSAFQHGESPTVHIVVASLFAAIIGSISFWGSIVAFGKLQEIISGRPIGLGKAQQPINLLLLAVAVAAAVVIGLHAHPGSGGVALWWMIGLLVAAGVLGLMVVLPIGGADMPVVISMLNAMTGLSAAAAGLALNNTAMIVAGMIVGASGSILTNLMAKAMNRSIPAIVAGGFGGGGVAPSGGGDDKHVKATSAADAAIQMAYANQVIVVPGYGLAVAQAQHAVKDLATLLEDRGVPVKYAIHPVAGRMPGHMNVLLAEAEVDYDAMKDMDDINDEFARTDVTIVIGANDVTNPAARNETSSPIYGMPILNVDKSRSVIVLKRSMNSGFAGIDNPLFYADGTTMLFGDAKKSVTEVSEELKAL,"48,858",475,PNT beta subunit family,,NAD(P)+ transhydrogenase (AB-specific) activity [GO:0008750]; NADP binding [GO:0050661],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P95221,P95221_MYCTU,Rv0264c,Rv0264c,GO:0052562,IPR003833; IPR029000; IPR010016; ,,,DOMAIN 7 199 AHS1. {ECO:0000259|SMART:SM00796}.,Uncharacterized protein,negative regulation by symbiont of host immune response [GO:0052562],9634230; 21969609,,,MDAALACTVLDYGDHALMLQCDSTADAMAWTDALRAAALPGVVDIVAASRTVLVKLDAPRYQGVTRQRLRRLRVTPEAVAAADHRCDLVIDVVYDGPDLAEVARCTGLTTAAVINAHTATGWRAGFSGSAPGFAYLIDGDPSLRVPRRPERRTSMPPGSVALADGFSAIYPSQAPSDWQIIGHTDAVLWDVDRPQPALLTPGMWVQFRAA,"22,466",210,,negative regulation by symbiont of host immune response [GO:0052562],,,,,3
O07169,O07169_MYCTU,Rv0119,fadD7 Rv0119,GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD7,DOMAIN 15 427 AMP-binding. {ECO:0000259|Pfam:PF00501}.; DOMAIN 437 510 AMP-binding_C. {ECO:0000259|Pfam:PF13193}.,Probable fatty-acid-CoA ligase FadD7 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MASDFGPRIADLVEVAATRLPEAPALVVTADRIAISHRDLARLVDELAGQLTRSGLLPGDRVALRMGSNAEFVVALLAASRADLVVVPLDPALPITEQRVRSQAAGARVVLIDADGPHDRAEPTTRWWPLTVNVGGDSGPSGGTLSVHLDAATEPNPATSTPEGLRPDDAMIMFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDATVAVMPLYHGHGLIASLLATLASGGAVSLPARGRFSAHTFWDDIKAVGATWYTAVPTIHQILLERSATEPSGRKPAALRFIRSCSAPLTAQAALALQTEFAAPVVCAFGMTEATHQVTTTQIEGIDQTETPVVSTGLVGRSTGAQIRIVGSDGLPLPAGAVGEIWLRGTTVVRGYLGDPTITAANFTDGWLRTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVFGVPHQLYGEAVAAVIVPRESAPPTREELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRRAVAERFGHSV,"55,159",525,,metabolic process [GO:0008152],ligase activity [GO:0016874],,,,4
P96396,P96396_MYCTU,Rv0214,fadD4 Rv0214,GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD4,DOMAIN 42 438 AMP-binding. {ECO:0000259|Pfam:PF00501}.; DOMAIN 447 525 AMP-binding_C. {ECO:0000259|Pfam:PF13193}.,Probable fatty-acid-CoA ligase FadD4 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MPRGELYKRFRLVMGGIAPCGSGRRAATYPRRMQIRPYIGADKPAVILYPSGTVISFDELEARANRLAHWFRQAGLREDDVVAILMENNEHVHAVMWAARRSGLYYVPINTHLTASEAAYIVDNSGAKAIVGSAALRETCHGLAEHLPGGLPDLLMLAGGGLVGWMTYPECVADQPDTPIEDEREGDLLQYSSGTTGRPKGIKRELPHVSPDAAPGMMPALLDFWMDADSVYLSPAPMYHTAPSVWTMSALAAGVTTVVMEKFDAEGALDAIQRYRVTHAQFVPAMFVRMLKLPEAVRNSYDMSSLRRVIHAAAPCPVQIKEQMIHWWGPIIDEYYASSEASGSTLITAEDWLTHPGSVGKPIQGGVHIVGADGSELPPNQPGEIYFEGGYPFEYLNDPAKTAASRNKHGWVTVGDVGYLDDDGYLFLTGRRHHMIISGGVNIYPQEAENLLVAHPKVLDAAVFGVPDDEMGQRVMAAVQTVDSADANDQFAGELLAWLRDRLSHFKCPRSIAFEPQLPRTDTGKLYKSGLVEKYSV,"58,889",537,,metabolic process [GO:0008152],ligase activity [GO:0016874],,,,1
I6Y6S3,I6Y6S3_MYCTU,Rv0052,Rv0052,,IPR029062; IPR002818; ,,,DOMAIN 4 140 DJ-1_PfpI. {ECO:0000259|Pfam:PF01965}.,Conserved protein,,9634230; 21969609,,,MPSFDVVFVGHRRGEVRSDNAMLGLLCDAAFDELTRPDVVIFPGGIGTRTLIHDQTVLDWVREAHRHTLLTTSVCTGGLVLAAAGLLNGLTATTHWRVQDLFNSLGARYVPQRVVEHLPERVITAAGVSSGIDMGLRLVELLVSREAAEASQLMIEYDPQPPVDAGSLAKASPATHRLALEFYQHRL,"20,387",187,,,,,,,2
P96820,P96820_MYCTU,Rv0143c,Rv0143c,GO:0005247; GO:0005886; GO:0016021,IPR014743; IPR001807; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; voltage-gated chloride channel activity [GO:0005247],9634230; 21969609,,,MAPGDWSVFAWHAANLPTMPEAEDIGNEAAGGRFGVSIRSAGYLRKWFLLGITIGVIAGLGAVVFYLALKYTSEFLLGYLADYQIPTPVGEGGHRGSTGFARPWAIPLVTTGGAVLSALIVAKLAPEATGHGTDEAIESVHGDPRAIRGRAVLVKMVASALTIGSGGSGGREGPTAQISAGFCSLLTRRLNLSNEDGRTAVALGIGAGIGAIFAAPLGGAALGASIPYRDDFDYRNLLPGFIASGTAYAVLGAFLGFDPLFGYIDAEYRFEKAWPLLWFVVIGLIAAAVGYLYARVFHASVAITRRLPGGPVLKPAIGGLLVGLLGLPIPQILSSGYGWAQLAADRGTLLSIPLWIVIVLPIAKILATSLSIGTGGSGGLFGPGIVIGAFVGAAIWRLGELTELPGVPHEPGIFVVVAMMACFGSVSRAPLAVMIMVAEMTGSFSVVPGAIIAVGIAALLLSRTNVTIYETQRLNRQTAEAERGGSDRPTTA,"50,808",492,,,voltage-gated chloride channel activity [GO:0005247],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O06310,O06310_MYCTU,Rv0360c,Rv0360c,,IPR014487; ,,,,Conserved protein,,9634230; 21969609,,,MTKRTITPMTSMGDLLGPEPILLPGDSDAEAELLANESPSIVAAAHPSASVAWAVLAEGALADDKTVTAYAYARTGYHRGLDQLRRHGWKGFGPVPYSHQPNRGFLRCVAALARAAAAIGETDEYGRCLDLLDDCDPAARPALGL,"15,329",145,,,,,,,1
Q79G05,Q79G05_MYCTU,Rv0152c,PE2 Rv0152c,GO:0005886,IPR013228; ,,PE2,,PE family protein PE2,plasma membrane [GO:0005886],9634230,,,MRCRPPSRNRSAHTARNTRPCSLKSRRFTVRFHQTLAAAANSYADAEAAIASTRQNQLAVPAAAPTPAAAAMIPPFPANLTTLFFGPTGIPLPPPSMLTPPIRCRSVRRALQAVFTPEELYPLTGVRSLVLNTSVEEGLTILHDAIMVELATTGNAVTVFGWSQSAIIASLEMQRFTAMGGAAPSASDLNFVLVGNEMNPNGGMLARFPDLTLPTLDLTFYGATPSDTIYPTAIYTLEYDGFADFSRYPLNFISDLNAVAGITFVHTKYLDLTPAQVEGATKLPTSPGYTGVTDYYIIRTENRPLLQPLRAVPVIGDPLADLIQPNLKVIVNLGYGDPNYGYSTSYADVRTPFGLWPNVPPQVIADALAAGTQEGILDFTADLQALSAQPLTLPQIQLPQPADLVAAVAAAPTPAEVVNTLARIISTNYAVLLPTVDIALALVTTLPLYTTQLFVRQLAAGNLINAIGYPLAATVGLGTIDSGRRGIAHPPRGGLGHRSKHRGPRHLTDSRRHRRPPTTVYRPRQ,"56,354",525,,,,plasma membrane [GO:0005886],,,1
P96824,P96824_MYCTU,Rv0147,Rv0147,GO:0004030; GO:0005618; GO:0005886; GO:0006081,IPR016161; IPR016163; IPR016160; IPR029510; IPR016162; IPR015590; IPR012394; ,,,DOMAIN 38 477 Aldedh. {ECO:0000259|Pfam:PF00171}.,Aldehyde dehydrogenase,cell wall [GO:0005618]; plasma membrane [GO:0005886]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; cellular aldehyde metabolic process [GO:0006081],9634230; 21969609,,,MSDRVKAVAPPDGRTMMTTESVARKTQKSETEAPREPAPVSDEKQTDVAKTVARLRKTFASGRTRSVEWRKQQLRALQKLMDENEDAIAAALAEDLDRNPFEAYLADIATTSAEAKYAAKRVRRWMRRRYLLLEVPQLPGRGWVEYEPYGTVLIIGAWNYPFYLTLGPAVGAIAAGNAVVLKPSEIAAASAHLMTELVYRYLDTEAIAVVQGDGAVSQELIAQGFDRVMFTGGTEIGRKVYEGAAPHLTPVTLELGGKSPVIVAADADVDVAAKRIAWIKLLNAGQTCVAPDYVLADATVRDELVSKITAALTKFRSGAPQGMRIVNQRQFDRLSGYLAAAKTDAAADGGGVVVGGDCDASNLRIQPTVVVDPDPDGPLMSNEIFGPILPVVTVKSLDDAIRFVNSRPKPLSAYLFTKSRAVRERVIREVPAGGMMVNHLAFQVSTAKLPFGGVGASGMGAYHGRWGFEEFSHRKSVLTKPTRPDLSSFIYPPYTERAIKVARRLF,"55,035",506,Aldehyde dehydrogenase family,cellular aldehyde metabolic process [GO:0006081],aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P96397,P96397_MYCTU,Rv0215c,fadE3 Rv0215c,GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE3,DOMAIN 6 117 Acyl-CoA_dh_N. {ECO:0000259|Pfam:PF02771}.; DOMAIN 122 220 Acyl-CoA_dh_M. {ECO:0000259|Pfam:PF02770}.; DOMAIN 234 356 Acyl-CoA_dh_1. {ECO:0000259|Pfam:PF00441}.,Probable acyl-CoA dehydrogenase FadE3,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MRNELNDDEAMLVATVRAFIDRDVKPTVREVEHANSYPEAWIEQMKHIGIYGLAIDEQYGGSPVSMPCYVQVTQELARGWMSLAGAMGGHTVVAKLLTLFGTEEQRRTYLPPMASGELRATMALTEPGGGSDLQNMSTTALADGPEGSAGLLINGCKTWISNARRSGLFAVLCKTDPNATPRHQGMSIVLVEPGPGLTVSRDLPKLGYKGVESCELSFDNLRVPVSAILGGAMGQGFSQMMKGLETGRIQVAARALGVATAALEDSLAYAQQRESFGRPIWQHQAVGNYLADMATKLTAARQLTRYAAERYDSGQRCDMEAGMAKLFASEVAMEIALNAVRIHGGYGYSTEYDVERR,"38,649",357,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,4
P96409,P96409_MYCTU,Rv0227c,Rv0227c,GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR021424; ,,,,Probable conserved membrane protein,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MLRFAACGAIGLGAALLIAALLLSTYTTSRIAEIPLDIDATLISDGTGTALDSASLATEHIVVNQDVPLVSQQQVTVESPANADVVTLQVGSSLRRTDKQKDSGLLLAIVDTVTLNRKTAMAVSDDTHTGGAVQKPRGLNDENPPTAIPLRHDGLSYRFPFHTEKKTYPYFDPIAQKAFDANYEGEEDVNGLTTYRFTQNVGYTPEGKLVAPLKYPSLYAGDEDGKVTTSAAMWGLPGDPNEQITMTRYYAAQRTFWVDPVSGTIVKETERANHYFARDPLKPEVTFADYQVTSTEETVESQVNAARDERDRLALWSRVLPITFTAAGLVALVGGGLFASFSLRTEGALMAASGDRDDHDYRRGGFEEPVPGAEAETEKLPTQRPDFPREPSGSDPPRLGSAQPPPPPDAGHPDPGPPERR,"45,528",421,,growth [GO:0040007],,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
Q6MX47,Q6MX47_MYCTU,Rv0318c,Rv0318c,GO:0016021; GO:0046873,IPR003689; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; metal ion transmembrane transporter activity [GO:0046873],9634230,,,MSLAVTMFKRARAEIFDRNREVGISNVTTAASLVTFPVLAGILGGVVPSVRTPSAAMVSGVQHFAAGIVMAAVAGEVLPDLRSRGPLWLIVVGFSAGVAVLVALRRFDGHGEHQDGDDVGELPVGFLTVVAVDLFIDGLLVATGATVSSRTAIIITIALTVEVLFLGLAVALRLAGSGMPRIRAAATTSALSLVIAVGGVSGAVALGRAGNTVLTLVLAFAAGALLWLVVEELLVEAHETPERPWMAVMFFAGFLILYGLGVME,"27,226",264,,,metal ion transmembrane transporter activity [GO:0046873],integral component of membrane [GO:0016021],,,1
O06300,O06300_MYCTU,Rv0349,Rv0349,,,,,,Uncharacterized protein,,9634230; 21969609,,,MPELETPDDPESIYLARLEDVGEHRPTFTGDIYRLGDGRMVMILQHPCALRHGVDLHPRLLVAPVRPDSLRSNWARAPFGTMPLPKLIDGQDHSADFINLELIDSPTLPTCERIAVLSQSGVNLVMQRWVYHSTRLAVPTHTYSDSTVGPFDEADLIEEWVTDRVDDGADPQAAEHECASWLDERISGRTRRALLSDRQHASSIRREARSHRKSVKLAD,"24,703",219,,,,,,,1
O53620,O53620_MYCTU,Rv0075,Rv0075,GO:0005576; GO:0005886; GO:0008483; GO:0009058; GO:0030170,IPR004839; IPR015424; IPR015422; IPR015421; ,,,,Probable aminotransferase,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058],9634230; 21969609,,,MQDSIFNLLTEEQLRGRNTLKWNYFGPDVVPLWLAEMDFPTAPAVLDGVRACVDNEEFGYPPLGEDSLPRATADWCRQRYGWCPRPDWVRVVPDVLKGMEVVVEFLTRPESPVALPVPAYMPFFDVLHVTGRQRVEVPMVQQDSGRYLLDLDALQAAFVRGAGSVIICNPNNPLGTAFTEAELRAIVDIAARHGARVIADEIWAPVVYGSRHVAAASVSEAAAEVVVTLVSASKGWNLPGLMCAQVILSNRRDAHDWDRINMLHRMGASTVGIRANIAAYHHGESWLDELLPYLRANRDHLARALPELAPGVEVNAPDGTYLSWVDFRALALPSEPAEYLLSKAKVALSPGIPFGAAVGSGFARLNFATTRAILDRAIEAIAAALRDIID,"42,766",390,,biosynthetic process [GO:0009058],pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O07255,O07255_MYCTU,Rv0331,Rv0331,GO:0016491,IPR036188; IPR023753; ,,,,Possible dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MSKTVLILGAGVGGLTTADTLRQLLPPEDRIILVDRSFDGTLGLSLLWVLRGWRRPDDVRVRPTAASLPGVEMVTATVAHIDIAAQVVHTDNSVIGYDALVIALGAALNTDAVPGLSDALDADVAGQFYTLDGAAELRAKVEALEHGRIAVAIAGVPFKCPAAPFEAAFLIAAQLGDRYATGTVQIDTFTPDPLPMPVAGPEVGEALVSMLKDHGVGFHPRKALARVDEAARTMHFGDGTSEPFDLLAVVPPHVPSAAARSAGLSESGWIPVDPRTLSTSADNVWAIGDATVLTLPNGKPLPKAAVFAEAQAAVVAHGVARHLGYDVAERHFTGTGACYVETGDHQAAKGDGDFFAPSAPSVTLYPPSREFHEEKVAQELAWLTRWKT,"40,788",388,,,oxidoreductase activity [GO:0016491],,,,1
P95217,P95217_MYCTU,Rv0260c,Rv0260c,GO:0000160; GO:0003677; GO:0004852; GO:0005618; GO:0005622; GO:0006355; GO:0010468; GO:0033014,IPR036108; IPR003754; IPR001867; IPR016032; IPR036388; ,,,DOMAIN 281 374 OmpR/PhoB-type. {ECO:0000259|PROSITE:PS51755}.,Possible transcriptional regulatory protein,"cell wall [GO:0005618]; intracellular [GO:0005622]; DNA binding [GO:0003677]; uroporphyrinogen-III synthase activity [GO:0004852]; phosphorelay signal transduction system [GO:0000160]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; tetrapyrrole biosynthetic process [GO:0033014]",9634230; 21969609,,,MAQAHSAPLTGYRIAVTSARRAEELCALLRRQGAEVCSAPAIKMIALPDDDELQNNTEALIADPPDILVAHTGIGFRGWLAAAEGWGLANELLESLSSARIISRGPKATGALRAAGLREEWSPDSESSHEVLEYLLESGVSRTRIAVQLHGAADSWDPFPEFLGGLRFAGAQVVPIRVYRWKPAPLGGVFDHLVTGIARRQFDAVTFTSAPAAAAVLERSRELDIEDQLLAALRTDVHAMCVGPVTSRPLIRKGVPTSAPERMRLGALARHIAEELPLLGSCTFKAAGHVIEIRGTSVLVDDSVKPLSPSGMAILRALVHRPGGVVSRGDLLRVLPGDGSDTHAVDTAVLRLRTALGDKNIVATVVKRGYRLAVDSRHDDV,"40,733",381,,"phosphorelay signal transduction system [GO:0000160]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; tetrapyrrole biosynthetic process [GO:0033014]",DNA binding [GO:0003677]; uroporphyrinogen-III synthase activity [GO:0004852],cell wall [GO:0005618]; intracellular [GO:0005622],,,1
O53671,O53671_MYCTU,Rv0249c,Rv0249c,GO:0016021; GO:0052572,,,,,Probable succinate dehydrogenase [membrane anchor subunit] (Succinic dehydrogenase),integral component of membrane [GO:0016021]; response to host immune response [GO:0052572],9634230; 21969609,,,MSAPTANRPAIGVFTPTRAQIPERTLRTDLWWLPPLLTNLGLLAFICYATTRAFWGSQYWVEKYHYLTPFYSPCVSASCQPGASHLGVWFGHFPGWIPLGAMVLPFLLGFRLTCYYYRKAYYRSVWQSPTSCAVPEPRAHYTGETRLPLIVQNTHRYFFYIAVVVSLINTYDAIAAFHSPSGFGFGLGNVILTINVVLLWAYTISCHSCRHATGGRLKHFSKHPVRYWIWTQVSKLNTRHMQFAWITLGTLALTDFYIMLVASGSITDLRFIG,"31,077",273,,response to host immune response [GO:0052572],,integral component of membrane [GO:0016021],,,1
O07248,O07248_MYCTU,Rv0322,udgA Rv0322,GO:0000271; GO:0003979; GO:0005886; GO:0051287,IPR008927; IPR036291; IPR017476; IPR014027; IPR036220; IPR014026; IPR001732; IPR028357; ,,udgA,,UDP-glucose 6-dehydrogenase (EC 1.1.1.22),plasma membrane [GO:0005886]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; polysaccharide biosynthetic process [GO:0000271],9634230,,,MRCSVFGTGYLGATHAVGMAQLGHEVVGVDIDPGKVAKLAGGDIPFYEPGLRKLLTDNLAAGRLRFTTDYDMAADFADVHFLGVGTPQKIGEYGADLRHVHAVIDALVPRLVRASILVGKSTVPVGTAAELGHRAGALAPRGVDVEIAWNPEFLREGFAVHDTLNPDRIVLGVQDDSTRAEVAVRELYAPLLAAGVPFLVTDLQTAELVKVSANAFLATKISFINAISEVCEAAGADVSQLADALGYDPRIGRQCLNAGLGFGGGCLPKDIRAFMARAGELGADQALTFLREVDSINMRRRTKMVELATTACGGSLLGANIAVLGAAFKPESDDVRDSPALNVAGQLQLNGATVHVYDPKALDNAHRLFPTLNYAVSVAEACERADAVLVLTEWREFIDLEPADLANRVRARVIVDGRNCLDVTRWRRAGWRVFRLGVPRLGH,"47,362",443,UDP-glucose/GDP-mannose dehydrogenase family,polysaccharide biosynthetic process [GO:0000271],NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979],plasma membrane [GO:0005886],,,1
O53641,O53641_MYCTU,Rv0158,Rv0158,GO:0000976; GO:0003700; GO:0005829; GO:0045892,IPR009057; IPR001647; IPR036271; IPR013571; ,,,DOMAIN 10 70 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Possibly TetR-family),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription, DNA-templated [GO:0045892]",9634230; 21969609,,,MPSDTSPNGLSRREELLAVATKLFAARGYHGTRMDDVADVIGLNKATVYHYYASKSLILFDIYRQAAEGTLAAVHDDPSWTAREALYQYTVRLLTAIASNPERAAVYFQEQPYITEWFTSEQVAEVREKEQQVYEHVHGLIDRGIASGEFYECDSHVVALGYIGMTLGSYRWLRPSGRRTAKEIAAEFSTALLRGLIRDESIRNQSPLGTRKET,"24,128",214,,"negative regulation of transcription, DNA-templated [GO:0045892]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O07230,O07230_MYCTU,Rv0303,Rv0303,GO:0000253,IPR036291; IPR002347; ,,,,Probable dehydrogenase/reductase,3-keto sterol reductase activity [GO:0000253],9634230; 21969609,,,MNTGTAVITGASSGLGLQCARALLRRDASWHVVLAVRDPARGRAAMEELGEPNRCSVLEVDLASVRSVRSFVETVRTTPLPPIRALVCNAGLQVVSGIAFTDDGVEMTFGVNHLGHFALVTGILDWLARPARIVVVSSGTHDPSKHTGMPDPRYTCAADLAHPPTDQNTPAEGRRRYTTSKLCNVLFTYELDRRLDHGEQGVMVNAFDPGLMPGSGLARDYPPILRLAYRLLSPMLRVLPFVHSTRVSGEHLAALAVDPRFAGVTGQYFAGAKAIRSSAESYDRAKALDLWETSERLLAQVT,"32,711",302,,,3-keto sterol reductase activity [GO:0000253],,,,1
O53703,O53703_MYCTU,Rv0368c,Rv0368c,GO:0005829; GO:0005886,IPR011195; IPR008912; IPR002035; IPR036465; ,,,,Uncharacterized protein,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230,,,MATPALLPGVDLAAFAAALAARLRDAGIPVSASGQASLVQALQQLVPRTPAALYWGARLTLVSRVDELATFDAVFASLFGVFGSAEPDGANRPPPPIAGPRTPVAGVGHRAKRRSCAAQAQNLPWDTRSLTMASAGQGGPSRTLPDVLPSRIVARADEPFDQFDPDDLRLLGAWLEATMARWPRRRSMRFESSPHGKRIDLRATMNASRSTGWESVLLARIRPRRRPRRVLLLCDVSRSMQPYAAIYLRLMRAAVLRRAGGHPEVFAFSTSLTRLTSVLSHRSAEMALHRANARVTDRYGGTFIGRSVAALLAPPHGNALRGAVVIIASDGWDSDPPDVLVHALTRVRRRAELLVWLNPRAAHPEFQPRAGSMAAALPYCDLFLPAHSLAGLHQLLLALAGAR,"43,556",403,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
L0T2W6,L0T2W6_MYCTU,Rv0174,mce1F Rv0174,GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0044117,IPR005693; IPR003399; ,,mce1F,,Mce-family protein Mce1F,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MLTRFIRRQLILFAIVSVVAIVVLGWYYLRIPSLVGIGQYTLKADLPASGGLYPTANVTYRGITIGKVTAVEPTDQGARVTMSIASNYKIPVDASANVHSVSAVGEQYIDLVSTGAPGKYFSSGQTITKGTVPSEIGPALDNSNRGLAALPTEKIGLLLDETAQAVGGLGPALQRLVDSTQAIVGDFKTNIGDVNDIIENSGPILDSQVNTGDQIERWARKLNNLAAQTATRDQNVRSILSQAAPTADEVNAVFSGVRDSLPQTLANLEVVFDMLKRYHAGVEQLLVFLPQGAAIAQTVLTPTPGAAQLPLAPAINYPPPCLTGFLPASEWRSPADTSPRPLPSGTYCKIPQDAQLQVRGARNIPCVDVLGKRAATPKECRSKDPYVPLGTNPWFGDPNQILTCPAPGARCDQPVKPGLVIPAPSINTGLNPAPADQVQGTPPPVSDPLQRPGSGTVQCNGQQPNPCVYTPTSGPSAVYSPASGELVGPDGVKYAVANSSTTGDDGWKEMLAPAS,"54,037",515,,growth of symbiont in host [GO:0044117],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P96395,P96395_MYCTU,Rv0213c,Rv0213c,GO:0005829; GO:0005886; GO:0008168; GO:0031419; GO:0046872; GO:0051536,IPR006158; IPR006638; IPR034466; IPR007197; IPR023404; ,,,,Possible methyltransferase (Methylase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; cobalamin binding [GO:0031419]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],9634230,,,MSIKAYAKTQGIAVTSVNGLVAGHGSVQETWLAMQSAAALSGTPRLVGFSCIDTFPEVLWLAQRARQAWDGVRIVIGNAMATLNYERILRQHDCFDYVVVGDGEVAFTKLALALANDAAVDDVPGLARRSEQGQILRTPSSLVDLDELPRPARDELPTVLADGFAASVFSTRGCPYRCTFCGTGAMSAMLGKDSYRAKSVDAVVDEIDYLVSDYDVNFLSITDDLFISKHPGSQQRAADFANAVLRRGISVNFMVDIRLDSVVDLDLFKHLHRAGLRRVFIGVETGSYEQLRAYRKQILTRGQDAADTINALQQLGIDVIPGTIMFHPTVQPDELRETVRLLRATKYTVGFKFMSRIVPYPGTPLYQAYSDAGYLTAKWPLGQWEFVDPEASRVYADVVAKVAPDVGISFDEAEAYFLSRLDEWENVIAGRIAEATS,"48,054",437,,,cobalamin binding [GO:0031419]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O07239,O07239_MYCTU,Rv0312,Rv0312,GO:0005576; GO:0005886; GO:0040007,IPR013126; ,,,,Conserved hypothetical proline and threonine rich protein,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MYDPLGLSIGTTNLVAAGNGGPPVTRRAVLTLYPHCAPKIGVPSQNPNLIEPGALMSGFVERIGDAVALVSPDGSVHDPDLLLVEALDAMVLTAGADASSSEIAIAVPAHWKPGAVHALRNGLRTHVGFVRSGMAPRLVSDAIAALTAVNSELGLPHGSVVGLLDFGGSATYVTLVETKSDSRTSDFQPVSATARYQDFSGSQIDQALLLRVIDQFGYGDDVDPASTAAVGQLGQLREQCRAAKERLSTDVATELFAELAGCSSSIEMTREQLEDLIQDPLTGFIYAFDDMLARHNASWADLAAVVTVGGGANIPLVTQRLSFHTRRPVLTASQPGCAAAMGALLLANRGGERDSRTRTSIGLATAAAAGTSVIELPAGDVMVIDHEALTDRELAWSQTDFPSEAPARFEGDSYNEGGPCWSMRLNAVEPPKGPAWRRIRVSQLLIGVSAVVAMTAIGGVALTLTAIERRPSPLPTPIVPGLAPMPPGSVVPSSRAPTPPPPPSTVAPLPSAAPAPTTVAPAPPPPTQVVTTTTAPPVTTTPRPSPTTTTTTAPPSTTTTTEPPVTTTSTIPTIPTTTTTVKMTTEWLHVPFLPVPIPVPIPQNPGAGEPQNPFGSLGSG,"64,144",620,,growth [GO:0040007],,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
L7N686,L7N686_MYCTU,Rv0078A,Rv0078A,,IPR014942; ,,,,Uncharacterized protein,,9634230; 21969609,,,MNAVESTLRRVAKDLTGLRQRWALVGGFAVSARSEPRFTRDVDIVVAVANDDAAESLVRQLLTQQYHLLASVEQDAARRLAAVRLGATADTAANVVVDLLFASCGIEPEIAEAAEEIEILPDLVAPVATTAHLIAMKLLARDDDRRPQDRSDLRALVDAASPQDIQDARKAIELITLRGFHRDRDLAAEWTRLAAKW,"21,613",197,,,,,,,1
O33273,O33273_MYCTU,Rv0333,Rv0333,,IPR032710; IPR037401; ,,,DOMAIN 9 104 SnoaL-like. {ECO:0000259|Pfam:PF12680}.,Uncharacterized protein,,9634230; 21969609,,,MTTSEIATVLAWHDALNAADIETLVALSTDDIDIGDAHGAVQGHDALRGWASSLTTTAELGRMYVHHGVVVVEQKITSGEDPGIARTGAAAFRVVQDHVASVFRHEDLASALAATELTEDDLVD,"13,074",124,,,,,,,1
P96805,P96805_MYCTU,Rv0128,Rv0128,GO:0016021,IPR010699; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MQREIYDGEARLSWVLAALAGILGATAFTHSAGYFVTFMTGNSQRAVLGLFGDDAWMSVTASLLILFFVAGVVIASVCRRHFWAAHPHGPTVLTTFSLIFAAGVDIMLGGWHESMLDFVPILFVVFGIGALNTSFVKDGEVSVPLSYVTGTLVKMGQGIERHLAGGKVEDWLGYFLLHASFVLGAAAGGAISMVVTGPQMLAVAAVVCAATTGYTYLHADRRGLVNQKRPQPGKRLFRALRRGELDSGTSTPATNYGSS,"27,562",259,,,,integral component of membrane [GO:0016021],,,2
O07422,O07422_MYCTU,Rv0178,Rv0178,GO:0005576; GO:0005886; GO:0005887; GO:0044117,,,,,Probable conserved Mce associated membrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117],9634230; 21969609,,,MEDQQSASGDLTQKSVANGESTDTASAATEGHRGEIDAAGEPDERGAAVADSQADEDDSAATAARGGKTRARRSRGRRLAITVGVAAALFVGSAAFAGATVEPYLSERAVVATKLMVARTAANAITTLWTYTPENMDTLADRAANYLSGDFAAQYRRFVDQIAAANKQAKITNDTEVTGAAVESLSGRDAVAIVYTNTTTTSPVTKNIPALKYLSYRLFMKRYDARWLVTRMTTITSLDLTPQV,"25,912",244,,growth of symbiont in host [GO:0044117],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P96415,P96415_MYCTU,Rv0232,Rv0232,GO:0000976; GO:0003700; GO:0005829,IPR023772; IPR009057; IPR001647; IPR036271; ,,,DOMAIN 11 71 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR/AcrR-family),cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MPTVTWARVDPARRAAVVEAAEAEFGAHGFSRGSLNVIARRAGVAKGSLFQYFADKRDLYAFIADIASQRVRSYMEDLIRELDPNRPFFEFLTDLLDGWVAYFAEHPRERALHAAATLEVDTDARISVRSVLHRHYLDVLRPLVRDAHARGDLRADSDTGALMSLLLLIFPHLALAPYMRGLDPILGLDEPTPEQPALAVRRLVAVLAAAFDAQHPATNSAQTRSEEIT,"25,440",229,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
P71591,P71591_MYCTU,Rv0021c,Rv0021c,GO:0018580,IPR013785; IPR004136; ,,,,Uncharacterized protein,nitronate monooxygenase activity [GO:0018580],9634230,,,MVLSTAFSQMFGIDYPIVSAPMDLIAGGELAAAVSGAGGLGLIGGGYGDRDWLARQFDLAAGAPVGCGFITWSLARQPQLLDLALQYEPVAVMLSFGDPAVFADAIKSAGTRLVCQIQNRTQAERALQVGADVLVAQGTEAGGHGHGPRSTLTLVPEIVDLVTARGTDIPVIAAGGIADGRGLAAALMLGAAGVLVGTRFYATVEALSTPQARDPLLAATGDDMCRTTIYDQLRRYPWPQGHTMSVLSNALTDQFEDTELDILHREEAMARYWRAVAARDYSIANVTAGQAAGLVNAVLPAADVITGMAQQAARTLTAMRAV,"33,568",322,,,nitronate monooxygenase activity [GO:0018580],,,,2
L7N6B2,L7N6B2_MYCTU,Rv0265c,Rv0265c,GO:0030288,IPR002491; IPR006311; ,,,,Probable periplasmic iron-transport lipoprotein,outer membrane-bounded periplasmic space [GO:0030288],9634230; 21969609; ,X-ray crystallography (1),,MRQGCSRRGFLQVAEAAAATGLFAGCSSPKPPPGTPGGAAVTITHLFGQTVIKEPPKRVVSAGYTEQDDLLAVDVVPIAVTDWFGDQPFAVWPWAAPKLGGARPAVLNLDNGIQIDRIAALKPDLIVAINAGVDADTYQQLSAIAPTVAQSGGDAFFEPWKDQARSIGQAVFAADRMRSLIEAVDQKFAAVAQRHPRWRGKKALLLQGRLWQGNVVATLAGWRTDFLNDMGLVIADSIKPFAVDQRGVIPRDHIKAVLDAADVLIWMTESPEDEKALLADPEIAASQATAQRRHIFTSKEQAGAIAFSSVLSYPVVAEQLPPQISQILGA,"35,284",330,,,,outer membrane-bounded periplasmic space [GO:0030288],,,1
O07250,O07250_MYCTU,Rv0325,Rv0325,GO:0044119,IPR029063; ,,,,Uncharacterized protein,growth of symbiont in host cell [GO:0044119],9634230,,,MGPKGSLRLVKRQPELLVAQHEHWQDTYRAHPVLYGTRPSEPGVYAAEVFNADGVQRVLELAAGHGRDTLYFAG,"8,229",74,,growth of symbiont in host cell [GO:0044119],,,,,1
O07253,O07253_MYCTU,Rv0329c,Rv0329c,GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized protein,methyltransferase activity [GO:0008168],9634230; 21969609,,,MRLTHPARRYLSSQAARPTGAFGRLLGRIWRAETADVNRIAVELLAPGPGERVCEIGFGPGRTLGLLAAAGAQVSGVEVSTTMIAIAAHHNAKAIAAGLISLYHGDGVTLPVADHSLDKVLGVHNFYFWPDPRASLCDIARALRPGGRLVLTSISDDQPLAARFDPAIYRVPPTLDTAAWLGAAGFIDVGIKRSADHPATVWFTATAT,"21,993",208,,,methyltransferase activity [GO:0008168],,,,1
O53652,O53652_MYCTU,Rv0201c,Rv0201c,GO:0044119,,,,,Conserved protein,growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MTLAAEPHPAPPQQPTVAWSEPDVDRRVEFWPTVAIRSALESGDIATWQRIAAALKRDPYGRTARQVEEVLEGIPATGIANAFWEVLDRARTHLDANERAEVARQVGLLLDRSGLQRQEFASRIGVTAQDLTAYLDGIVSPSASLMIRMRRLSDRFVRAKSVRAADS,"18,516",167,,growth of symbiont in host cell [GO:0044119],,,,,1
P71599,P71599_MYCTU,Rv0029,Rv0029,GO:0005829,,,,,Uncharacterized protein,cytosol [GO:0005829],9634230; 21969609,,,MAIFGRWSARQRLRRATRESLTIPTFSSSLDCTTRVIGGLWPAELSSNTAETATLAEHLKADLHRIVGSANDELMVIWRAGMADSTRRAEEDRVIDRARASAMRRVESAMRELRQITGRVPVEIPRMRGAGGSDLDTTRLMPAVTVVQPADQACTDWPVAAAEDDEARLQRLLAFVARQEPRLNWAVGVHADGTTVLVTDVAHGWIPPGIALPEGVRLLAPARRAGRAPELVGITTCCKTYTPGDSLRRAVDSTAPTSSVQPRALPAIAGLSVELGIATQRHDGLPKIVHAMATAAGNGAAAEEVDLLRVHVDTALHHVLAQYPRVDPALLLNCMLLAATERSVTGDPIAANYHFAWFRELDSRR,"39,591",365,,,,cytosol [GO:0005829],,,2
P95218,P95218_MYCTU,Rv0261c,narK3 Rv0261c,GO:0005887; GO:0015112; GO:0015514; GO:0015707,IPR011701; IPR036259; ,,narK3,,Probable integral membrane nitrite extrusion protein NarK3 (Nitrite facilitator),integral component of plasma membrane [GO:0005887]; nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514]; nitrite transport [GO:0015707],9634230,,,MGRSHQISDWDPEDSVAWEAGNKFIARRNLIWSVAAEHVGFSVWSLWSVMVLFMPTSVYGFSAGDKFLLGATATLVGACLRFPYTFATAKFGGRNWTIFSALVLLIPTVGSILLLANPGLPLWPYLVCGALAGLGGGNFAASMTNINAFFPQRLKGAALALNAGGGNLGVPMVQLVGLLVIATAGDREPYWVCAIYLVLLAVAGLGAALYMDNLTEYRIELNTMRAVVSEPHTWVISLLYIGTFGSFIGFSFAFGQVLQINFIASGQSTAQASLHAAQIAFLGPLLGSLSRIYGGKLADRIGGGRVTLAAFCAMLLATGILISASTFGDHLAGPMPTATMVGYVIGFTALFILSGIGNGSVYKMIPSIFEARSHSLQISEAERRQWSRSMSGALIGLAGAVGALGGVGVNLALRESYLTSGTATSAFWAFGVFYLVASVLTWAIYVRRGLKSAGELVPATTAPAGLAYV,"49,357",469,,nitrite transport [GO:0015707],nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514],integral component of plasma membrane [GO:0005887],,,1
Q10884,Q10884_MYCTU,Rv0087,hycE Rv0087,GO:0005886; GO:0008137; GO:0016151; GO:0048038; GO:0051287,IPR001135; IPR038290; IPR037232; IPR001268; IPR020396; IPR001501; IPR029014; ,,hycE,,Possible formate hydrogenase HycE (FHL),plasma membrane [GO:0005886]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; nickel cation binding [GO:0016151]; quinone binding [GO:0048038],9634230; 21969609,,,MMSASWLRHRVSERGLIATAEQLWADSFRLALVAAHDDGDSLRVVYLFLAGYPDRRVELEYVVPADNPEIRSLAYLSFPAGRFEREMADLYGIRPVGHPKPRRLVRHAHWPDWHPMRTDAGPAPEFTDTGAFPFLAVEGPGVYEIPVGPVHAGLIEPGHFRFSVAGETIVRLKARLWFVHRGIEKLFHGRPATAAVDLAERISGDTSAAHALAHSLAIEDALGIELPHEVHRLRALIVELERLYNHAADLGALANDVGYSLANAHAQRIRENLLRRNAAVTGHRLLRGAIRAGGVALRALPDTDELAALAVDLAEVATLTLANSVVYDRFAGTAVLHPDDASALGCLGYVARASGLRSDARVEHPTIVLPITEIGAPDGDVLARYTVRRDEFAASAALAQHIVESHTGPIEYAATLHPVGAPSSGIGIVEGWRGTIVHRVEIDVDGRITRAKVVDPSWFNWPALPVAMADTIVPDFPLANKSFNQSYAGNDL,"53,490",492,Complex I 49 kDa subunit family,,NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; nickel cation binding [GO:0016151]; quinone binding [GO:0048038],plasma membrane [GO:0005886],,,1
O53616,O53616_MYCTU,Rv0071,Rv0071,,IPR000477; ,,,,Possible maturase,,9634230,,,MSSITVSVDPVDPVDPVDPVDPVDAVVAAGSDGLTVARIESEIGALEFLNELRTELKSGQFRPQPVRERKIPKPGGLGKVRRLGIPTVADRVVQAALKLVLEPIFETDFEPVSYGFRPARRAHDTIAEIHLFGTQEYRWVLDADIKACFDRIDHADLMDRVRHRIKDKRVLRLVNWQRIRHRWNWTDVRRWLTDPTGRWHPISADGITLFNPAAVPIRRYRYRGNTIPTPWTQAV,"26,892",235,,,,,,,1
L0T6I4,L0T6I4_MYCTU,Rv0387c,Rv0387c,,IPR022171; ,,,DOMAIN 99 169 PE_PPE_C. {ECO:0000259|Pfam:PF12484}.,Uncharacterized protein,,9634230,,,MSLLPTLQSFLPPPFDAIPNPIEDLDVLVAAAVAVAAGSLGVSAAQLGEIYRHDVVDEAQKAPHCPAESDQTPAGAAGDGDLPEVGGRVTSPPQPPVAALTGYSANIGGLSVPHSWNLPPAVRQVAAMFPGATPMYMTGSSDGSYAGLAAAGLAGTGLAGLAARGGSAPTPAAAAPAGAGGAGPAATRPAAQQTPAVPAAAAGSAIPGLPPGLPPGVVANLAATLAAIPGATIIVVPPSPNANQ,"23,258",244,,,,,,,1
P95226,P95226_MYCTU,Rv0269c,Rv0269c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSRMAAPVSLDVHGRQVIVTHPGRVVFPAHNDRKGYTKFDLVRYYLAVAEGAMRGVAGRPMILKRFVKGISAEAVFQKRAPANRPDWVDVAELHYASGRSAAEAVIHDAAGLAWVINLGCVDLNPHPVLAGDLDHPDELRVDLDPMPGVAWQRVVEVALVVREVLEDYGLTAWPKTSGSRGFHVYARIAPCWSFPQVRLAAQTVAREVERRLPDAATSRWWKEEREGVFVDFNQNAKDRTVASAYSVRATPDARVSTPLHWEEVPGCDPAVFTMATVPSRLADIGDPWAGMDDAVGRLDRLLMLAEELGPPQKAQSAKPLIEIARAKTRAEAMAALDIWRDRYPGAAALLRPADVLVDGMRGPSSIWYRIRINLQHVPADQRPPQEELIADYSPWPR,"44,040",397,,,,,,,1
O07423,O07423_MYCTU,Rv0179c,lprO Rv0179c,GO:0005576,IPR018711; ,,lprO,,Possible lipoprotein LprO,extracellular region [GO:0005576],9634230; 21969609,,,MWIRAERVAVLTPTASLRRLTACYAALAVCAALACTTGQPAARAADGREMLAQAIATTRGSYLVYNFGGGHPMPLLNAGGHWYEMNNGGHLMIIKNASQRLSPHLLVDTHTGDQARCEHNPGARTGEGLWQASEIYPPLKAWQRMGRPTIAVNANFFDVRGQKGGSWRSTGCSSPLGAYVDNTRGQGRANQAVTGTVAYAGKQGLSGGNELWSSLTTMILPVGGAPYVLRPKSRQDYDLATPVIEDLLNKNARFVAVAGIGLLSPGNTGQLHDGGPSAARTALAYAKQKDEMYIFQGGNYTPDNIQDLFRGLGSDTAILLDGGGSSAIVLRRDTGGMWAGAGSPKGSCDTRQVLCDSHERALPSWLAFN,"39,160",369,,,,extracellular region [GO:0005576],,,1
O53716,O53716_MYCTU,Rv0381c,Rv0381c,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MRILVAWATCGAVVLSGLTGCSGSSHSGRTYGAQSARTGESLAVLGWNMSVSNLRWSGDYVLIDVDASPTDPHAPHAKPEDIRFGLYGALAHPMESAALGSCGDAMAHVRDVVSPLSAPAGRLTGTVCLGPLKERSAVRGVYTYSPRDRIPGTAAAYPAAFPVGMLPTNQNDAGLVVKTTSVSAWRADGMQLGKPQLGDPVAFTGNGYMLLGLEVDAVPDRYRDDSAARGGPMMLLAAPTLPGRGLSPACATYGSSVLILPDALLDAVHISASLCTQGEINEALLYATVATVGTHAALWTSR,"31,235",302,,,,plasma membrane [GO:0005886],,,1
O53669,O53669_MYCTU,Rv0247c,Rv0247c,GO:0005618; GO:0005886; GO:0006099; GO:0009055; GO:0009060; GO:0022904; GO:0051537,IPR036010; IPR001041; IPR006058; IPR017896; IPR012675; IPR009051; IPR004489; IPR025192; ,,,,Probable succinate dehydrogenase [iron-sulfur subunit] (Succinic dehydrogenase),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]",9634230; 21969609,,,MTYSASMRVWRGDESCGELREFTVEVNEGEVVLDVILRLQQTQTPDLAVRWNCKAGKCGSCSAEINGKPRLMCMTRMSTFDEDEIVTVTPMRTFPVIRDLVTDVSFNYQKAREIPSFAPPKELQPSEYRMAQVDVARSQEFRKCIECFLCQNVCHVVRDHEENKDAFAGPRFLMRIAELEMHPLDTRDRRSQAQEEHGLGYCNITKCCTEVCPENIKITDNALIPMKERVADRKYDPVVWLGSKLFRR,"28,626",248,,aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099],"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O07234,O07234_MYCTU,Rv0307c,Rv0307c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MAVIVRKWFGLGRLPADLRCQVEAEGLIYLAEYVAVTRRFTGVIPGLRASHSIASYVGALAFTEQRVLGTLSMVPKLAGRVVDARWDGPQAGAATAEISPTGLQLDLDVADVDPKFSGQLALHFKATIGEDVLSRLPRRSLAFDVPAEYVNLAVGVTYSP,"17,182",160,,,,,,,1
I6Y778,I6Y778_MYCTU,Rv0242c,fabG4 Rv0242c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,fabG4,,Probable 3-oxoacyl-[acyl-carrier protein] reductase FabG4 (3-ketoacyl-acyl carrier protein reductase),oxidoreductase activity [GO:0016491],9634230; 21969609,,,MAPKRSSDLFSQVVNSGPGSFLARQLGVPQPETLRRYRAGEPPLTGSLLIGGAGRVVEPLRAALEKDYDLVGNNLGGRWADSFGGLVFDATGITEPAGLKGLHEFFTPVLRNLGRCGRVVVVGGTPEAAASTNERIAQRALEGFTRSLGKELRRGATTALVYLSPDAKPAATGLESTMRFLLSAKSAYVDGQVFSVGADDSTPPADWEKPLDGKVAIVTGAARGIGATIAEVFARDGAHVVAIDVESAAENLAETASKVGGTALWLDVTADDAVDKISEHLRDHHGGKADILVNNAGITRDKLLANMDDARWDAVLAVNLLAPLRLTEGLVGNGSIGEGGRVIGLSSIAGIAGNRGQTNYATTKAGMIGITQALAPGLAAKGITINAVAPGFIETQMTAAIPLATREVGRRLNSLLQGGQPVDVAEAIAYFASPASNAVTGNVIRVCGQAMIGA,"46,830",454,,,oxidoreductase activity [GO:0016491],,,,1
O07235,O07235_MYCTU,Rv0308,Rv0308,GO:0016021,IPR036938; IPR000326; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTRPQALLAVSLAFVATAVYAVMWVGHSQDWGWLHSFDWSLLNAAHDIGIKNPAWVRFWDGVSLILGPVVLRPLGLLAAMVALAKRKIRIALLLLACLPLNAIMTIAAKSVAHRPRPATALVSAHSTSFPSGHALEATASVLALLTVLLPMLHSRFTRHIAITVGALCVLTVGVARVALNVHHPTDVVAGWALGYLYFLVCLCVFRPPSIFGAQRASHALSPPVEVSRQPEPEVDTAR,"25,613",238,,,,integral component of membrane [GO:0016021],,,1
O07236,O07236_MYCTU,Rv0309,Rv0309,GO:0005576; GO:0005618,,,,,Possible conserved exported protein,cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 21969609,,,MSRLLALLCAAVCTGCVAVVLAPVSLAVVNPWFANSVGNATQVVSVVGTGGSTAKMDVYQRTAAGWQPLKTGITTHIGSAGMAPEAKSGYPATPMGVYSLDSAFGTAPNPGGGLPYTQVGPNHWWSGDDNSPTFNSMQVCQKSQCPFSTADSENLQIPQYKHSVVMGVNKAKVPGKGSAFFFHTTDGGPTAGCVAIDDATLVQIIRWLRPGAVIAIAK,"22,529",218,,,,cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
O53709,O53709_MYCTU,Rv0374c,Rv0374c,GO:0009055; GO:0046872; GO:0051536,IPR002888; IPR036884; IPR036010; IPR001041; IPR012675; ,,,,Probable carbon monoxyde dehydrogenase (Small chain),electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872],9634230,,,MQVNMTVNGEPVTAEVEPRMLLVHFLRDQLRLTGTHWGCDTSNCGTCVVEVDGVPVKSCTMLAVMASGHSIRTVEGLAGPDGQLDPVQEGFMRCHGLQCGFCTPGMLITARALLDRNPDPDEQTIREAISGQICRCTGYTTIVRSIQWAAAHQTVKAQS,"17,215",159,,,electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872],,,,1
O07412,O07412_MYCTU,Rv0167,yrbE1A Rv0167,GO:0005886; GO:0043190,IPR030802; ,,yrbE1A,,Conserved integral membrane protein YrbE1A,ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886],9634230; 21969609,,,MTTSTTLGGYVRDQLQTPLTLVGGFFRMCVLTGKALFRWPFQWREFILQCWFIMRVGFLPTIMVSIPLTVLLIFTLNILLAQFGAADISGSGAAIGAVTQLGPLTTVLVVAGAGSTAICADLGARTIREEIDAMEVLGIDPIHRLVVPRVLASMLVATLLNGLVITVGLVGGFLFGVYLQNVSGGAYLATLTLITGLPEVVIATIKAATFGLIAGLVGCYRGLTVRGGSKGLGTAVNETVVLCVIALFAVNVILTTIGVRFGTGR,"27,775",265,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886],,,1
O07414,O07414_MYCTU,Rv0170,mce1B Rv0170,GO:0005576; GO:0005886; GO:0016021; GO:0044117; GO:0044119; GO:0044121,IPR005693; IPR003399; ,,mce1B,,Mce-family protein Mce1B,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121],9634230; 21969609,,,MKITGTVVKLGIVSVVLLFFTVMIIVIFGQMRFDRTNGYTAEFSNVSGLRQGQFVRASGVEIGKVKALHLVDGGRRVRVEFNIDRSVPLYQSTTAQIRYSDLIGNRYVELKRGEGKGANDLLPPGGLIPLSRTSPALDLDALIGGFKPVFRALDPAKVNNIANALITVFQGQGGTINDILDQTAQLTSQIAERDQAIGEVVKNLNIVLDTTVKHRKEFDETVNNLENLITGLRNHSDQLAGGLAHISNGAGTVADLLAENRTLVRKAVSYLDAIQQPVIDQRVELDDLLHKTPTALTALGRANGTYGDFQNFYLCDLQIKWNGFQAGGPVRTVKLFSQPTGRCTPQ,"37,727",346,,growth of symbiont in host [GO:0044117]; growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53623,O53623_MYCTU,Rv0078,Rv0078,GO:0003677; GO:0003700; GO:0005886; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 13 73 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609; 28416386; 28302858,X-ray crystallography (4),,MEIKRRTQEERSAATREALITGARKLWGLRGYAEVGTPEIATEAGVTRGAMYHQFADKAALFRDVVEVVEQDVMARMATLVAASGAATPADAIRAAVDAWLEVSGDPEVRQLILLDAPVVLGWAGFRDVAQRYSLGMTEQLITEAIRAGQLARQPVRPLAQVLIGALDEAAMFIATADDPKRARRETRQVLRRLIDGMLNG,"21,924",201,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,1
O86342,O86342_MYCTU,Rv0273c,Rv0273c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 10 70 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPDFPTQRGRRTQAAIDAAARTVVVRNGILATTVADITAEAGRSAASFYNYYDSKEAMVRQWALRFRDDANQRALSVIRHGLSDRERAYEAAAAHWYTYRNRLAEAISVSQLAMVSDDFAQYWSEICQIPISFITETVKRAQAHGYCVGDDPQLMAEAIVAMFNQFCYLQLSGKRSRRGQPDDQACIQTLANIYYRAIYSKEDSSN,"23,274",206,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O07173,O07173_MYCTU,Rv0123,Rv0123,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MTKKPRNPADYVIGDDVEVSDVDLKQEEVYVDGERLTDERVEQMASESLRLAREREANLIPGGKSLSGGSAHSPAVQVVVSKATHAKLKELARSRKMSVSKLLRPVLDEFVQRETGRILPRR,"13,624",122,,,,plasma membrane [GO:0005886],,,1
P95227,P95227_MYCTU,Rv0270,fadD2 Rv0270,GO:0005618; GO:0005886; GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD2,,Probable fatty-acid-CoA ligase FadD2 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MPNLTDLPGQAVSKLQKSIGQYVARGTAELHYLRKIIESGAIGLEPPLNYAALAADIRKWGEVGMLPSHNARRAPNRAAVIDEEGTLTFSELDEAAHAVANGLLAKGVRAGDGVAILARNHRWFVIANYGAARVGARIILLNSEFSGPQIKEVSDREGAKVIIYDDEYTKAVSLAQPPLGKLRALGVNPDDDKPSGSSDETLAELIAHSSTAPAPKASRRASIIILTSGTTGTPKGANRNTPPTLAPIGGILSHVPFKAGEVTLLPSPMFHALGYMHAALAMFLGSTLVLRRRFKPALVLEDIEKHKATSMVVVPVMLSRILDQLEKTEPKPDLSSLKIVFVSGSQLGAELATRALGDLGPVIYNMYGSTEVAFATIAGPKDLQFNPSTVGPVVKGVTVKILDENGNEVPQGAVGRIFVGNAFPFEGYTGGGGKQIIDGLLSSGDVGYFDERGLLYVSGRDDEMIVSGGENVFPAEVEDLISGHPDVVEAAAIGVDDKEFGARLRAFVVKKPGADLDEDTIKQYVRDHLARYKVPREVIFLDELPRNPTGKVLKRELRKL,"59,893",560,,metabolic process [GO:0008152],ligase activity [GO:0016874],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O07437,O07437_MYCTU,Rv0193c,Rv0193c,,,,,,Uncharacterized protein,,9634230,,,MIQISRDMSSLGQTATTQALPDNSDGIQLTKFAADDILPLEYAPPIGPELVSQDQLPAAWAYKRFRDLDDKESYRRKLLQELTDALAAQGSEAAEIATAALRDLIDQMAEQGAVVLADIVESDDFLELVKRYDELMAREGSRSFIHRFLDLRRSPGMLTDPAVNGALVHPLMIALISYAVGGPIRMIDARGKDAEPLSVLAQDNMLHIDNTPFNDEYKILITWRRGTAQGPAGQNFTFLPGTHKLARTCFVNEDGVPWSSENASIFTTPDSIRKVFDAQRQLGGQDHPTVIEVTDSERPLSGVFAAGSLVHHRFRTASGSARSCIILVFHRVADNPGRMVSDVEDSSDVSLSELLTRGVPDESYQQRFIATLCAAADEIAELLLKWKKTPQRPVSLPLQTKQIDGARFEEWISAATKAPEVREIRNRELTIPYGEVLSAEEFFDLIWRLMRFDKHGPLDLILYHDNREEPRKWARNLIREMSADRLYERLLGWLADIQQPRPADCLRPLQIHALISEVLKTLPLDEDQDPPADWHFDLLGMSHAEAARSVKHLLEDVAEALLRCEDMAAYLSTSLFAFWAVDAAYSLDGRRNLVVKDCARRLLRHYTMLSLTCFQ,"69,143",615,,,,,,,2
I6WY86,I6WY86_MYCTU,Rv0371c,Rv0371c,,IPR025877; IPR029044; ,,,,Uncharacterized protein,,9634230,,,MTATQITGVVLAAGRSNRLGTPKQLLPYRDTTVLGATLDVARQAGFDQLILTLGGAASAVRAAMALDGTDVVVVEDVERGCAASLRVALARVHPRATGIVLMLGDQPQVAPATLRRIIDVGPATEIMVCRYADGVGHPFWFSRTVFGELARLHGDKGVWKLVHSGRHPVRELAVDGCVPLDVDTWDDYRRLLESVPS,"21,116",197,,,,,,,1
Q50655,Q50655_MYCTU,Rv0094c Rv3467,Rv0094c Rv3467,,IPR003870; IPR003615; ,,,DOMAIN 214 266 HNHc. {ECO:0000259|SMART:SM00507}.,Uncharacterized protein,,9634230,,,MSTRQAAEADLAGKAAQYRPDELARYAQRVMDWLHPDGDLTDTERARKRGITLSNQQYDGMSRLSGYLTPQARATFEAVLAKLAAPGATNPDDHTPVIDTTPDAAAIDRDTRSQAQRNHDGLLAGLRALIASGKLGQHNGLPVSIVVTTTLTDLQTGAGKGFTGGGTLLPMADVIRMTSHAHHYSPASGRYPQAIFDHGTPLALYHTKRLASPAQRIMLFANDRGCTKPGCDAPAYHSQAHHVTAWTSTGRTDITELTLACGPDNRLAEKGWTTHNNTHGHTEWLPPPHLDHGQPRTNTFHHPERFLHNQDDDDKPD,"34,567",317,,,,,,,1
P9WHM9,PUR2_MYCTU,Rv0772,purD Rv0772 MTCY369.17,GO:0004637; GO:0005524; GO:0006189; GO:0009113; GO:0040007; GO:0046872,IPR011761; IPR013815; IPR016185; IPR020561; IPR000115; IPR020560; IPR037123; IPR020559; IPR020562; IPR011054; ,,purD,DOMAIN 107 312 ATP-grasp. {ECO:0000255|HAMAP-Rule:MF_00138}.,Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (GARS) (Glycinamide ribonucleotide synthetase) (Phosphoribosylglycinamide synthetase),ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; 'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleobase biosynthetic process [GO:0009113],9634230; 21969609,,,MRVLVIGSGAREHALLLALGKDPQVSGLIVAPGNAGTARIAEQHDVDITSAEAVVALAREVGADMVVIGPEVPLVLGVADAVRAAGIVCFGPGKDAARIEGSKAFAKDVMAAAGVRTANSEIVDSPAHLDAALDRFGPPAGDPAWVVKDDRLAAGKGVVVTADRDVARAHGAALLEAGHPVLLESYLDGPEVSLFCVVDRTVVVPLLPAQDFKRVGEDDTGLNTGGMGAYAPLPWLPDNIYREVVSRIVEPVAAELVRRGSSFCGLLYVGLAITARGPAVVEFNCRFGDPETQAVLALLESPLGQLLHAAATGKLADFGELRWRDGVAVTVVLAAENYPGRPRVGDVVVGSEAEGVLHAGTTRRDDGAIVSSGGRVLSVVGTGADLSAARAHAYEILSSIRLPGGHFRSDIGLRAAEGKISV,"43,509",422,GARS family,'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleobase biosynthetic process [GO:0009113],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637],,,MTCY369.17,1
P9WMI1,RAMB_MYCTU,Rv0465c,ramB Rv0465c,GO:0001666; GO:0003677; GO:0005886; GO:0006351; GO:0006355; GO:0043565,IPR001387; IPR018653; IPR026281; IPR010359; IPR010982; ,,ramB,"DOMAIN 10 64 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257, ECO:0000269|PubMed:19767422}.",HTH-type transcriptional regulator RamB (icl1 and ramB operon repressor protein),"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 19767422; 21969609; 22916289,,FUNCTION: Involved in the control of the glyoxylate cycle. RamB negatively controls the expression of icl expression during growth on acetate as the sole carbon source. Does not regulate the expression of other genes involved in acetate metabolism. {ECO:0000269|PubMed:19767422}.,MSKTYVGSRVRQLRNERGFSQAALAQMLEISPSYLNQIEHDVRPLTVAVLLRITEVFGVDATFFASQDDTRLVAELREVTLDRDLDIAIDPHEVAEMVSAHPGLACAVVNLHRRYRITTAQLAAATEERFSDGSGRGSITMPHEEVRDYFYQRQNYLHALDTAAEDLTAQMRMHHGDLARELTRRLTEVHGVRINKRIDLGDTVLHRYDPATNTLEISSHLSPGQQVFKMAAELAYLEFGDLIDAMVTDGKFTSAESRTLARLGLANYFAAATVLPYRQFHDVAENFRYDVERLSAFYSVSYETIAHRLSTLQRPSMRGVPFTFVRVDRAGNMSKRQSATGFHFSSSGGTCPLWNVYETFANPGKILVQIAQMPDGRNYLWVARTVELRAARYGQPGKTFAIGLGCELRHAHRLVYSEGLDLSGDPNTAATPIGAGCRVCERDNCPQRAFPALGRALDLDEHRSTVSPYLVKQL,"53,072",474,Short-chain fatty acyl-CoA assimilation regulator (ScfR) family,"regulation of transcription, DNA-templated [GO:0006355]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565],plasma membrane [GO:0005886],,,1
P9WHE3,RL7_MYCTU,Rv0652,rplL Rv0652 MTCY20H10.33,GO:0003735; GO:0005618; GO:0005829; GO:0005840; GO:0005886; GO:0006412; GO:0040007,IPR000206; IPR014719; IPR013823; IPR008932; IPR036235; ,P9WHE7,rplL,,50S ribosomal protein L7/L12,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 19099550; 21969609,,FUNCTION: Forms part of the ribosomal stalk which helps the ribosome interact with GTP-bound translation factors. Is thus essential for accurate translation. {ECO:0000255|HAMAP-Rule:MF_00368}.,MAKLSTDELLDAFKEMTLLELSDFVKKFEETFEVTAAAPVAVAAAGAAPAGAAVEAAEEQSEFDVILEAAGDKKIGVIKVVREIVSGLGLKEAKDLVDGAPKPLLEKVAKEAADEAKAKLEAAGATVTVK,"13,440",130,Bacterial ribosomal protein bL12 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840],,MTCY20H10.33,1
P9WGY9,RPOB_MYCTU,Rv0667,rpoB Rv0667 MTCI376.08c,GO:0000428; GO:0003677; GO:0003899; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0032549; GO:0040007; GO:0046677,IPR019462; IPR015712; IPR007120; IPR037033; IPR010243; IPR007121; IPR007644; IPR007642; IPR037034; IPR007645; IPR007641; IPR014724; ,P9WJG3,rpoB,,DNA-directed RNA polymerase subunit beta (RNAP subunit beta) (EC 2.7.7.6) (RNA polymerase subunit beta) (Transcriptase subunit beta),"cell wall [GO:0005618]; cytosol [GO:0005829]; DNA-directed RNA polymerase complex [GO:0000428]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549]; growth [GO:0040007]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",8031050; 9634230; 8095569; 10921994; 8027320; 21969609; 22904282; 22570422,Electron microscopy (1); X-ray crystallography (13),"FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. {ECO:0000255|HAMAP-Rule:MF_01321, ECO:0000269|PubMed:22570422}.",MLEGCILADSRQSKTAASPSPSRPQSSSNNSVPGAPNRVSFAKLREPLEVPGLLDVQTDSFEWLIGSPRWRESAAERGDVNPVGGLEEVLYELSPIEDFSGSMSLSFSDPRFDDVKAPVDECKDKDMTYAAPLFVTAEFINNNTGEIKSQTVFMGDFPMMTEKGTFIINGTERVVVSQLVRSPGVYFDETIDKSTDKTLHSVKVIPSRGAWLEFDVDKRDTVGVRIDRKRRQPVTVLLKALGWTSEQIVERFGFSEIMRSTLEKDNTVGTDEALLDIYRKLRPGEPPTKESAQTLLENLFFKEKRYDLARVGRYKVNKKLGLHVGEPITSSTLTEEDVVATIEYLVRLHEGQTTMTVPGGVEVPVETDDIDHFGNRRLRTVGELIQNQIRVGMSRMERVVRERMTTQDVEAITPQTLINIRPVVAAIKEFFGTSQLSQFMDQNNPLSGLTHKRRLSALGPGGLSRERAGLEVRDVHPSHYGRMCPIETPEGPNIGLIGSLSVYARVNPFGFIETPYRKVVDGVVSDEIVYLTADEEDRHVVAQANSPIDADGRFVEPRVLVRRKAGEVEYVPSSEVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLVRSEAPLVGTGMELRAAIDAGDVVVAEESGVIEEVSADYITVMHDNGTRRTYRMRKFARSNHGTCANQCPIVDAGDRVEAGQVIADGPCTDDGEMALGKNLLVAIMPWEGHNYEDAIILSNRLVEEDVLTSIHIEEHEIDARDTKLGAEEITRDIPNISDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDEDELPAGVNELVRVYVAQKRKISDGDKLAGRHGNKGVIGKILPVEDMPFLADGTPVDIILNTHGVPRRMNIGQILETHLGWCAHSGWKVDAAKGVPDWAARLPDELLEAQPNAIVSTPVFDGAQEAELQGLLSCTLPNRDGDVLVDADGKAMLFDGRSGEPFPYPVTVGYMYIMKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDTVGRVKVYEAIVKGENIPEPGIPESFKVLLKELQSLCLNVEVLSSDGAAIELREGEDEDLERAAANLGINLSRNESASVEDLA,"129,865",1178,RNA polymerase beta chain family,"growth [GO:0040007]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; ribonucleoside binding [GO:0032549],cell wall [GO:0005618]; cytosol [GO:0005829]; DNA-directed RNA polymerase complex [GO:0000428]; plasma membrane [GO:0005886],,MTCI376.08c,1
P9WGY7,RPOC_MYCTU,Rv0668,rpoC Rv0668 MTCI376.07c,GO:0000428; GO:0003677; GO:0003899; GO:0005618; GO:0005886; GO:0006351; GO:0040007,IPR012754; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; IPR038120; ,,rpoC,,DNA-directed RNA polymerase subunit beta' (RNAP subunit beta') (EC 2.7.7.6) (RNA polymerase subunit beta') (Transcriptase subunit beta'),"cell wall [GO:0005618]; DNA-directed RNA polymerase complex [GO:0000428]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; growth [GO:0040007]; transcription, DNA-templated [GO:0006351]",9634230; 8031050; 11929527; 21969609; 22570422,Electron microscopy (1); X-ray crystallography (12),"FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. {ECO:0000255|HAMAP-Rule:MF_01322, ECO:0000269|PubMed:22570422}.",MLDVNFFDELRIGLATAEDIRQWSYGEVKKPETINYRTLKPEKDGLFCEKIFGPTRDWECYCGKYKRVRFKGIICERCGVEVTRAKVRRERMGHIELAAPVTHIWYFKGVPSRLGYLLDLAPKDLEKIIYFAAYVITSVDEEMRHNELSTLEAEMAVERKAVEDQRDGELEARAQKLEADLAELEAEGAKADARRKVRDGGEREMRQIRDRAQRELDRLEDIWSTFTKLAPKQLIVDENLYRELVDRYGEYFTGAMGAESIQKLIENFDIDAEAESLRDVIRNGKGQKKLRALKRLKVVAAFQQSGNSPMGMVLDAVPVIPPELRPMVQLDGGRFATSDLNDLYRRVINRNNRLKRLIDLGAPEIIVNNEKRMLQESVDALFDNGRRGRPVTGPGNRPLKSLSDLLKGKQGRFRQNLLGKRVDYSGRSVIVVGPQLKLHQCGLPKLMALELFKPFVMKRLVDLNHAQNIKSAKRMVERQRPQVWDVLEEVIAEHPVLLNRAPTLHRLGIQAFEPMLVEGKAIQLHPLVCEAFNADFDGDQMAVHLPLSAEAQAEARILMLSSNNILSPASGRPLAMPRLDMVTGLYYLTTEVPGDTGEYQPASGDHPETGVYSSPAEAIMAADRGVLSVRAKIKVRLTQLRPPVEIEAELFGHSGWQPGDAWMAETTLGRVMFNELLPLGYPFVNKQMHKKVQAAIINDLAERYPMIVVAQTVDKLKDAGFYWATRSGVTVSMADVLVPPRKKEILDHYEERADKVEKQFQRGALNHDERNEALVEIWKEATDEVGQALREHYPDDNPIITIVDSGATGNFTQTRTLAGMKGLVTNPKGEFIPRPVKSSFREGLTVLEYFINTHGARKGLADTALRTADSGYLTRRLVDVSQDVIVREHDCQTERGIVVELAERAPDGTLIRDPYIETSAYARTLGTDAVDEAGNVIVERGQDLGDPEIDALLAAGITQVKVRSVLTCATSTGVCATCYGRSMATGKLVDIGEAVGIVAAQSIGEPGTQLTMRTFHQGGVGEDITGGLPRVQELFEARVPRGKAPIADVTGRVRLEDGERFYKITIVPDDGGEEVVYDKISKRQRLRVFKHEDGSERVLSDGDHVEVGQQLMEGSADPHEVLRVQGPREVQIHLVREVQEVYRAQGVSIHDKHIEVIVRQMLRRVTIIDSGSTEFLPGSLIDRAEFEAENRRVVAEGGEPAAGRPVLMGITKASLATDSWLSAASFQETTRVLTDAAINCRSDKLNGLKENVIIGKLIPAGTGINRYRNIAVQPTEEARAAAYTIPSYEDQYYSPDFGAATGAAVPLDDYGYSDYR,"146,769",1316,RNA polymerase beta' chain family,"growth [GO:0040007]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899],cell wall [GO:0005618]; DNA-directed RNA polymerase complex [GO:0000428]; plasma membrane [GO:0005886],,MTCI376.07c,1
P9WH85,RL4_MYCTU,Rv0702,rplD Rv0702 MTCY210.21,GO:0003723; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0019843; GO:0022626; GO:0040007,IPR002136; IPR023574; IPR013005; ,,rplD,,50S ribosomal protein L4,cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: One of the primary rRNA binding proteins, this protein initially binds near the 5'-end of the 23S rRNA. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome. {ECO:0000255|HAMAP-Rule:MF_01328}.; FUNCTION: Forms part of the polypeptide exit tunnel. {ECO:0000255|HAMAP-Rule:MF_01328}.",MAAQEQKTLKIDVKTPAGKVDGAIELPAELFDVPANIALMHQVVTAQRAAARQGTHSTKTRGEVSGGGRKPYRQKGTGRARQGSTRAPQFTGGGVVHGPKPRDYSQRTPKKMIAAALRGALSDRARNGRIHAITELVEGQNPSTKSARAFLASLTERKQVLVVIGRSDEAGAKSVRNLPGVHILAPDQLNTYDVLRADDVVFSVEALNAYIAANTTTSEEVSA,"23,743",223,Universal ribosomal protein uL4 family,growth [GO:0040007]; translation [GO:0006412],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; plasma membrane [GO:0005886],,MTCY210.21,1
P9WH83,RL5_MYCTU,Rv0716,rplE Rv0716 MTCY210.35,GO:0000027; GO:0000049; GO:0003723; GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR002132; IPR020930; IPR031309; IPR022803; IPR031310; ,,rplE,,50S ribosomal protein L5,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: This is 1 of the proteins that binds and probably mediates the attachment of the 5S RNA into the large ribosomal subunit, where it forms part of the central protuberance. In the 70S ribosome it contacts protein S13 of the 30S subunit (bridge B1b), connecting the 2 subunits; this bridge is implicated in subunit movement. Contacts the P site tRNA; the 5S rRNA and some of its associated proteins might help stabilize positioning of ribosome-bound tRNAs. {ECO:0000255|HAMAP-Rule:MF_01333}.",MTTAQKVQPRLKERYRSEIRDALRKQFGYGNVMQIPTVTKVVVNMGVGEAARDAKLINGAVNDLALITGQKPEVRRARKSIAQFKLREGMPVGVRVTLRGDRMWEFLDRLTSIALPRIRDFRGLSPKQFDGVGNYTFGLAEQAVFHEVDVDKIDRVRGMDINVVTSAATDDEGRALLRALGFPFKEN,"21,019",187,Universal ribosomal protein uL5 family,growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.35,1
P9WH63,RS12_MYCTU,Rv0682,rpsL rps12 Rv0682 MTV040.10,GO:0000049; GO:0003735; GO:0005840; GO:0006412; GO:0015935; GO:0019843; GO:0040007; GO:0046677,IPR012340; IPR006032; IPR005679; ,,rpsL,,30S ribosomal protein S12,ribosome [GO:0005840]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; growth [GO:0040007]; response to antibiotic [GO:0046677]; translation [GO:0006412],7934937; 7968530; 8192450; 9634230; 21969609; ,,"FUNCTION: With S4 and S5 plays an important role in translational accuracy. {ECO:0000250}.; FUNCTION: Interacts with and stabilizes bases of the 16S rRNA that are involved in tRNA selection in the A site and with the mRNA backbone. Located at the interface of the 30S and 50S subunits, it traverses the body of the 30S subunit contacting proteins on the other side and probably holding the rRNA structure together. The combined cluster of proteins S8, S12 and S17 appears to hold together the shoulder and platform of the 30S subunit (By similarity). {ECO:0000250}.",MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG,"13,849",124,Universal ribosomal protein uS12 family,growth [GO:0040007]; response to antibiotic [GO:0046677]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],ribosome [GO:0005840]; small ribosomal subunit [GO:0015935],rps12,MTV040.10,1
P9WHC7,RL1_MYCTU,Rv0641,rplA Rv0641 MTCY20H10.22,GO:0000049; GO:0000470; GO:0003723; GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0006417; GO:0019843; GO:0022625,IPR005878; IPR002143; IPR023674; IPR028364; IPR016095; IPR023673; ,,rplA,,50S ribosomal protein L1,cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; maturation of LSU-rRNA [GO:0000470]; regulation of translation [GO:0006417]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: Binds directly to 23S rRNA. The L1 stalk is quite mobile in the ribosome, and is involved in E site tRNA release. {ECO:0000255|HAMAP-Rule:MF_01318}.; FUNCTION: Protein L1 is also a translational repressor protein, it controls the translation of the L11 operon by binding to its mRNA. {ECO:0000255|HAMAP-Rule:MF_01318}.",MSKTSKAYRAAAAKVDRTNLYTPLQAAKLAKETSSTKQDATVEVAIRLGVDPRKADQMVRGTVNLPHGTGKTARVAVFAVGEKADAAVAAGADVVGSDDLIERIQGGWLEFDAAIATPDQMAKVGRIARVLGPRGLMPNPKTGTVTADVAKAVADIKGGKINFRVDKQANLHFVIGKASFDEKLLAENYGAAIDEVLRLKPSSSKGRYLKKITVSTTTGPGIPVDPSITRNFAGE,"24,756",235,Universal ribosomal protein uL1 family,maturation of LSU-rRNA [GO:0000470]; regulation of translation [GO:0006417]; translation [GO:0006412],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY20H10.22,1
P9WHA3,RL30_MYCTU,Rv0722,rpmD Rv0722 MTCY210.41,GO:0003735; GO:0006412; GO:0022625; GO:0040007,IPR036919; IPR005996; IPR018038; IPR016082; ,,rpmD,,50S ribosomal protein L30,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),,MSQLKITQVRSTIGARWKQRESLRTLGLRRIRHSVIREDNAATRGLIAVVRHLVEVEPAQTGGKT,"7,347",65,Universal ribosomal protein uL30 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],,MTCY210.41,1
P9WH67,RS10_MYCTU,Rv0700,rpsJ rpsX Rv0700 MTCY210.19,GO:0003723; GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0015935; GO:0040007,IPR001848; IPR018268; IPR027486; IPR036838; ,,rpsJ,,30S ribosomal protein S10,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Involved in the binding of tRNA to the ribosomes. {ECO:0000255|HAMAP-Rule:MF_00508}.,MAGQKIRIRLKAYDHEAIDASARKIVETVVRTGASVVGPVPLPTEKNVYCVIRSPHKYKDSREHFEMRTHKRLIDIIDPTPKTVDALMRIDLPASVDVNIQ,"11,431",101,Universal ribosomal protein uS10 family,growth [GO:0040007]; translation [GO:0006412],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935],rpsX,MTCY210.19,1
P9WH57,RS14Z_MYCTU,Rv0717,rpsZ rpsN1 Rv0717 MTCY210.36,GO:0003735; GO:0006412; GO:0015935; GO:0019843; GO:0046872,IPR001209; IPR018271; IPR023053; ,,rpsZ,,30S ribosomal protein S14 type Z,small ribosomal subunit [GO:0015935]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: Binds 16S rRNA, required for the assembly of 30S particles and may also be responsible for determining the conformation of the 16S rRNA at the A site. {ECO:0000255|HAMAP-Rule:MF_01364}.",MAKKALVNKAAGKPRFAVRAYTRCSKCGRPRAVYRKFGLCRICLREMAHAGELPGVQKSSW,"6,825",61,"Universal ribosomal protein uS14 family, Zinc-binding uS14 subfamily",translation [GO:0006412],metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],small ribosomal subunit [GO:0015935],rpsN1,MTCY210.36,1
P9WH37,RS3_MYCTU,Rv0707,rpsC Rv0707 MTCY210.26,GO:0002181; GO:0003735; GO:0005618; GO:0005886; GO:0019843; GO:0022627; GO:0040007,IPR004087; IPR015946; IPR004044; IPR009019; IPR005704; IPR001351; IPR036419; IPR018280; ,,rpsC,DOMAIN 38 106 KH type-2. {ECO:0000255|HAMAP-Rule:MF_01309}.,30S ribosomal protein S3,cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; growth [GO:0040007],9634230; 21969609,,"FUNCTION: Binds the lower part of the 30S subunit head. Binds mRNA in the 70S ribosome, positioning it for translation. {ECO:0000255|HAMAP-Rule:MF_01309}.",MGQKINPHGFRLGITTDWKSRWYADKQYAEYVKEDVAIRRLLSSGLERAGIADVEIERTRDRVRVDIHTARPGIVIGRRGTEADRIRADLEKLTGKQVQLNILEVKNPESQAQLVAQGVAEQLSNRVAFRRAMRKAIQSAMRQPNVKGIRVQCSGRLGGAEMSRSEFYREGRVPLHTLRADIDYGLYEAKTTFGRIGVKVWIYKGDIVGGKRELAAAAPAGADRPRRERPSGTRPRRSGASGTTATGTDAGRAAGGEEAAPDAAAPVEAQSTES,"30,020",274,Universal ribosomal protein uS3 family,cytoplasmic translation [GO:0002181]; growth [GO:0040007],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY210.26,1
P9WH27,RS8_MYCTU,Rv0718,rpsH Rv0718 MTCY210.37,GO:0003735; GO:0006412; GO:0019843; GO:0022627; GO:0040007,IPR000630; IPR035987; ,,rpsH,,30S ribosomal protein S8,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: One of the primary rRNA binding proteins, it binds directly to 16S rRNA central domain where it helps coordinate assembly of the platform of the 30S subunit. {ECO:0000255|HAMAP-Rule:MF_01302}.",MTMTDPIADFLTRLRNANSAYHDEVSLPHSKLKANIAQILKNEGYISDFRTEDARVGKSLVIQLKYGPSRERSIAGLRRVSKPGLRVYAKSTNLPRVLGGLGVAIISTSSGLLTDRQAARQGVGGEVLAYVW,"14,412",132,Universal ribosomal protein uS8 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627],,MTCY210.37,1
P9WH33,RS5_MYCTU,Rv0721,rpsE Rv0721 MTCY210.40,GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0019843; GO:0022627; GO:0040007,IPR000851; IPR005712; IPR005324; IPR020568; IPR014721; IPR013810; IPR018192; ,,rpsE,DOMAIN 42 105 S5 DRBM. {ECO:0000255|HAMAP-Rule:MF_01307}.,30S ribosomal protein S5,cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,FUNCTION: With S4 and S12 plays an important role in translational accuracy. {ECO:0000255|HAMAP-Rule:MF_01307}.; FUNCTION: Located at the back of the 30S subunit body where it stabilizes the conformation of the head with respect to the body. {ECO:0000255|HAMAP-Rule:MF_01307}.,MAEQPAGQAGTTDNRDARGDREGRRRDSGRGSRERDGEKSNYLERVVAINRVSKVVKGGRRFSFTALVIVGDGNGMVGVGYGKAKEVPAAIAKGVEEARKSFFRVPLIGGTITHPVQGEAAAGVVLLRPASPGTGVIAGGAARAVLECAGVHDILAKSLGSDNAINVVHATVAALKLLQRPEEVAARRGLPIEDVAPAGMLKARRKSEALAASVLPDRTI,"22,888",220,Universal ribosomal protein uS5 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY210.40,1
P9WJ67,RSLA_MYCTU,Rv0736,rslA Rv0736,GO:0005886; GO:0006351; GO:0006355; GO:0008270; GO:0009405; GO:0016021; GO:0016989; GO:0040007,IPR027383; ,,rslA,,Anti-sigma-L factor RslA (Regulator of SigL) (Sigma-L anti-sigma factor RslA),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sigma factor antagonist activity [GO:0016989]; zinc ion binding [GO:0008270]; growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 16199577; 16552079; 20600947; 20184899,X-ray crystallography (1),"FUNCTION: An anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigL. ECF sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis (RIP). RIP occurs when an extracytoplasmic signal triggers a concerted proteolytic cascade to transmit information and elicit cellular responses. The membrane-spanning regulatory substrate protein is first cut extracytoplasmically (site-1 protease, S1P), then within the membrane itself (site-2 protease, S2P, Rip1), while cytoplasmic proteases finish degrading the regulatory protein, liberating the sigma factor. {ECO:0000269|PubMed:16552079}.",MTMPLRGLGPPDDTGVREVSTGDDHHYAMWDAAYVLGALSAADRREFEAHLAGCPECRGAVTELCGVPALLSQLDRDEVAAISESAPTVVASGLSPELLPSLLAAVHRRRRRTRLITWVASSAAAAVLAIGVLVGVQGHSAAPQRAAVSALPMAQVGTQLLASTVSISGEPWGTFINLRCVCLAPPYASHDTLAMVVVGRDGSQTRLATWLAEPGHTATPAGSISTPVDQIAAVQVVAADTGQVLLQRSL,"25,938",250,Zinc-associated anti-sigma factor (ZAS) superfamily,"growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",sigma factor antagonist activity [GO:0016989]; zinc ion binding [GO:0008270],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WGX5,RSKA_MYCTU,Rv0444c,rskA Rv0444c,GO:0005618; GO:0005886; GO:0006351; GO:0006355; GO:0006417; GO:0016021; GO:0016989,IPR018764; ,,rskA,,Anti-sigma-K factor RskA (Regulator of SigK) (Sigma-K anti-sigma factor RskA),"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sigma factor antagonist activity [GO:0016989]; regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; transcription, DNA-templated [GO:0006351]",9634230; 17064366; 20600947; 21969609; ,X-ray crystallography (1),"FUNCTION: An anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigK. ECF sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis (RIP). RIP occurs when an extracytoplasmic signal triggers a concerted proteolytic cascade to transmit information and elicit cellular responses. The membrane-spanning regulatory substrate protein is first cut extracytoplasmically (site-1 protease, S1P), then within the membrane itself (site-2 protease, S2P, Rip1), while cytoplasmic proteases finish degrading the regulatory protein, liberating the sigma factor. {ECO:0000269|PubMed:17064366}.",MTEHTDFELLELATPYALNAVSDDERADIDRRVAAAPSPVAAAFNDEVRAVRETMAVVSAATTAEPPAHLRTAILDATKPEVRRQSRWRTAAFASAAAIAVGLGAFGLGVLTRPSPPPTVAEQVLTAPDVRTVSRPLGAGTATVVFSRDRNTGLLVMNNVAPPSRGTVYQMWLLGGAKGPRSAGTMGTAAVTPSTTATLTDLGASTALAFTVEPGTGSPQPTGTILAELPLG,"23,883",232,Anti-sigma-K factor family,"regulation of transcription, DNA-templated [GO:0006355]; regulation of translation [GO:0006417]; transcription, DNA-templated [GO:0006351]",sigma factor antagonist activity [GO:0016989],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WH29,RS7_MYCTU,Rv0683,rpsG rps7 Rv0683 MTV040.11,GO:0000028; GO:0000049; GO:0003729; GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0019843; GO:0022627; GO:0040007,IPR000235; IPR005717; IPR020606; IPR023798; IPR036823; ,,rpsG,,30S ribosomal protein S7,cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; growth [GO:0040007]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],9634230; 7968530; 21969609,,"FUNCTION: One of the primary rRNA binding proteins, it binds directly to 16S rRNA where it nucleates assembly of the head domain of the 30S subunit. Is located at the subunit interface close to the decoding center, probably blocks exit of the E-site tRNA. {ECO:0000255|HAMAP-Rule:MF_00480}.",MPRKGPAPKRPLVNDPVYGSQLVTQLVNKVLLKGKKSLAERIVYGALEQARDKTGTDPVITLKRALDNVKPALEVRSRRVGGATYQVPVEVRPDRSTTLALRWLVGYSRQRREKTMIERLANEILDASNGLGASVKRREDTHKMAEANRAFAHYRW,"17,600",156,Universal ribosomal protein uS7 family,growth [GO:0040007]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],mRNA binding [GO:0003729]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],rps7,MTV040.11,1
P9WH51,RS17_MYCTU,Rv0710,rpsQ Rv0710 MTCY210.29,GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022627; GO:0040007,IPR012340; IPR019984; IPR000266; IPR019979; ,,rpsQ,,30S ribosomal protein S17,cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 19099550; 21969609,,"FUNCTION: One of the primary rRNA binding proteins, it binds specifically to the 5'-end of 16S ribosomal RNA. {ECO:0000255|HAMAP-Rule:MF_01345}.",MAEAKTGAKAAPRVAKAAKAAPKKAAPNDAEAIGAANAANVKGPKHTPRTPKPRGRRKTRIGYVVSDKMQKTIVVELEDRMRHPLYGKIIRTTKKVKAHDEDSVAGIGDRVSLMETRPLSATKRWRLVEILEKAK,"14,741",135,Universal ribosomal protein uS17 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY210.29,1
P9WH45,RS19_MYCTU,Rv0705,rpsS Rv0705 MTCY210.24,GO:0000028; GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022627; GO:0040007,IPR002222; IPR005732; IPR020934; IPR023575; ,,rpsS,,30S ribosomal protein S19,cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Protein S19 forms a complex with S13 that binds strongly to the 16S ribosomal RNA. {ECO:0000250}.,MPRSLKKGPFVDEHLLKKVDVQNEKNTKQVIKTWSRRSTIIPDFIGHTFAVHDGRKHVPVFVTESMVGHKLGEFAPTRTFKGHIKDDRKSKRR,"10,804",93,Universal ribosomal protein uS19 family,growth [GO:0040007]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY210.24,1
P9WHE5,RL11_MYCTU,Rv0640,rplK Rv0640 MTCY20H11.21,GO:0000027; GO:0003735; GO:0005618; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR000911; IPR036796; IPR006519; IPR020783; IPR036769; IPR020785; IPR020784; ,,rplK,,50S ribosomal protein L11,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],9634230; 20066036; 21969609,,FUNCTION: Forms part of the ribosomal stalk which helps the ribosome interact with GTP-bound translation factors. {ECO:0000255|HAMAP-Rule:MF_00736}.,MAPKKKVAGLIKLQIVAGQANPAPPVGPALGQHGVNIMEFCKAYNAATENQRGNVIPVEITVYEDRSFTFTLKTPPAAKLLLKAAGVAKGSAEPHKTKVAKVTWDQVREIAETKKTDLNANDVDAAAKIIAGTARSMGITVE,"15,003",142,Universal ribosomal protein uL11 family,growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625],,MTCY20H11.21,1
P9WMQ3,RECB_MYCTU,Rv0630c,recB Rv0630c MTCY20H10.11c,GO:0003677; GO:0004003; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006281; GO:0008854; GO:0046872,IPR014017; IPR000212; IPR011604; IPR027417; IPR038726; IPR004586; IPR011335; IPR014016; IPR034739; ,,recB,DOMAIN 1 326 UvrD-like helicase ATP-binding. {ECO:0000255|HAMAP-Rule:MF_01485}.; DOMAIN 357 613 UvrD-like helicase C-terminal. {ECO:0000255|HAMAP-Rule:MF_01485}.,RecBCD enzyme subunit RecB (EC 3.1.11.5) (Exonuclease V subunit RecB) (ExoV subunit RecB) (Helicase/nuclease RecBCD subunit RecB),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; exodeoxyribonuclease V activity [GO:0008854]; metal ion binding [GO:0046872]; DNA repair [GO:0006281],9634230; 21969609,,"FUNCTION: A helicase/nuclease that prepares dsDNA breaks (DSB) for recombinational DNA repair. Binds to DSBs and unwinds DNA via a highly rapid and processive ATP-dependent bidirectional helicase activity. Unwinds dsDNA until it encounters a Chi (crossover hotspot instigator) sequence from the 3' direction. Cuts ssDNA a few nucleotides 3' to the Chi site. The properties and activities of the enzyme are changed at Chi. The Chi-altered holoenzyme produces a long 3'-ssDNA overhang and facilitates RecA-binding to the ssDNA for homologous DNA recombination and repair. Holoenzyme degrades any linearized DNA that is unable to undergo homologous recombination. In the holoenzyme this subunit contributes ATPase, 3'-5' helicase, exonuclease activity and loads RecA onto ssDNA. {ECO:0000255|HAMAP-Rule:MF_01485}.",MDRFELLGPLPREGTTTVLEASAGTGKTFALAGLVTRYLAETAATLDEMLLITFNRAASRELRERVRGQIVEAVGALQGDAPPSGELVEHLLRGSDAERAQKRSRLRDALANFDAATIATTHEFCGSVLKSLGVAGDNAADVELKESLTDLVTEIVDDRYLANFGRQETDPELTYAEALALALAVVDDPCAQLRPPDPEPGSKAAVRLRFAAEVLEELERRKGRLRAQGFNDLLIRLATALEAADSPARDRMRERWRIVLVDEFQDTDPMQWRVLERAFSRHSALILIGDPKQAIYGFRGGDIHTYLKAAGTADARYTLGVNWRSDRALVESLQTVLRDATLGHADIVVRGTDAHHAGHRLASAPRPAPFRLRVVKRHTLGYDGTAHVPIEALRRHIPDDLAADVAALLASGATFAGRPVVAADIAVIVEHHKDARACRNALAEAGIPAIYTGDTDVFASQAAKDWLCLLEAFDAPQRSGLVRAAACTMFFGETAESLAAEGDALTDRVAGTLREWADHARHRGVAAVFQAAQLAGMGRRVLSQRGGERDLTDLAHIAQLLHEAAHRERLGLPGLRDWLRRQAKAGAGPPEHNRRLDSDAAAVQIMTVFVAKGLQFPIVYLPFAFNRNVRSDDILLYHDDGTRCLYIGGKDGGAQRRTVEGLNRVEAAHDNLRLTYVALTRAQSQVVAWWAPTFDEVNGGLSRLLRGRRPGQSQVPDRCTPRVTDEQAWAVFAQWEAAGGPSVEESVIGARSSLEKPVPVPGFEVRHFHRRIDTTWRRTSYSDLVRGSEAVTVTSEPAAGGRADEVEIAVVAAPGSGADLTSPLAALPSGASFGSLVHAVLETADPAAPDLAAELEAQVRRHAPWWTVDVDHAQLAPELARALLPMHDTPLGPAAAALTLRQIGVRDRLRELDFEMPLAGGDLRGRSPDVSLADVGELLASHLPGDDPLSPYADRLGSAGLGDQPLRGYLAGSIDVVLRLPGQRYLVVDYKTNHLGDTAADYGFERLTEAMLHSDYPLQALLYVVVLHRFLRWRQRDYAPARHLGGVLYLFVRGMCGAATPVTAGHPAGVFTWNPPTALVVALSDLLDRGRLQS,"118,722",1094,"Helicase family, UvrD subfamily",DNA repair [GO:0006281],ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; exodeoxyribonuclease V activity [GO:0008854]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY20H10.11c,1
P9WHV5,PPX1_MYCTU,Rv0496,ppx1 Rv0496 MTCY20G9.22,GO:0004309; GO:0006793; GO:0016462,IPR003695; ,,ppx1,,Exopolyphosphatase 1 (ExopolyPase 1) (EC 3.6.1.11) (MTB-PPX1),exopolyphosphatase activity [GO:0004309]; pyrophosphatase activity [GO:0016462]; phosphorus metabolic process [GO:0006793],9634230; 21969609; 22880033,,"FUNCTION: Degradation of inorganic polyphosphates (polyP). Releases orthophosphate processively from the ends of the polyP chain. Prefers short-chain length polyphosphates as substrates. Can also hydrolyze ATP and ADP substrates, but lacks GTPase activity. Cannot hydrolyze pppGpp to ppGpp. {ECO:0000269|PubMed:22880033}.",MRLGVLDVGSNTVHLLVVDAHRGGHPTPMSSTKATLRLAEATDSSGKITKRGADKLISTIDEFAKIAISSGCAELMAFATSAVRDAENSEDVLSRVRKETGVELQALRGEDESRLTFLAVRRWYGWSAGRILNLDIGGGSLEVSSGVDEEPEIALSLPLGAGRLTREWLPDDPPGRRRVAMLRDWLDAELAEPSVTVLEAGSPDLAVATSKTFRSLARLTGAAPSMAGPRVKRTLTANGLRQLIAFISRMTAVDRAELEGVSADRAPQIVAGALVAEASMRALSIEAVEICPWALREGLILRKLDSEADGTALIESSSVHTSVRAVGGQPADRNAANRSRGSKP,"36,550",344,GppA/Ppx family,phosphorus metabolic process [GO:0006793],exopolyphosphatase activity [GO:0004309]; pyrophosphatase activity [GO:0016462],,,MTCY20G9.22,1
P9WHQ5,PSD_MYCTU,Rv0437c,psd Rv0437c MTV037.01c,GO:0004609; GO:0005886; GO:0006646,IPR003817; IPR033175; ,,psd,,Phosphatidylserine decarboxylase proenzyme (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase alpha chain; Phosphatidylserine decarboxylase beta chain],plasma membrane [GO:0005886]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646],9634230; 21969609,,FUNCTION: Catalyzes the formation of phosphatidylethanolamine (PtdEtn) from phosphatidylserine (PtdSer). {ECO:0000255|HAMAP-Rule:MF_00664}.,MARRPRPDGPQHLLALVRSAVPPVHPAGRPFIAAGLAIAAVGHRYRWLRGTGLLAAAACAGFFRHPQRVPPTRPAAIVAPADGVICAIDSAAPPAELSMGDTPLPRVSIFLSILDAHVQRAPVSGEVIAVQHRPGRFGSADLPEASDDNERTSVRIRMPNGAEVVAVQIAGLVARRIVCDAHVGDKLAIGDTYGLIRFGSRLDTYLPAGAEPIVNVGQRAVAGETVLAECR,"24,260",231,"Phosphatidylserine decarboxylase family, PSD-A subfamily",phosphatidylethanolamine biosynthetic process [GO:0006646],phosphatidylserine decarboxylase activity [GO:0004609],plasma membrane [GO:0005886],,MTV037.01c,1
P9WHP1,PTA_MYCTU,Rv0408,pta Rv0408 MTCY22G10.04,GO:0005576; GO:0005737; GO:0006085; GO:0008959,IPR010766; IPR016475; IPR027417; IPR004614; IPR002505; IPR028979; ,,pta,,Phosphate acetyltransferase (EC 2.3.1.8) (Phosphotransacetylase),cytoplasm [GO:0005737]; extracellular region [GO:0005576]; phosphate acetyltransferase activity [GO:0008959]; acetyl-CoA biosynthetic process [GO:0006085],9634230; 21969609,,FUNCTION: Involved in acetate metabolism. {ECO:0000250}.,MADSSAIYLAAPESQTGKSTIALGLLHRLTAMVAKVGVFRPITRLSAERDYILELLLAHTSAGLPYERCVGVTYQQLHADRDDAIAEIVDSYHAMADECDAVVVVGSDYTDVTSPTELSVNGRIAVNLGAPVLLTVRAKDRTPDQVASVVEVCLAELDTQRAHTAAVVANRCELSAIPAVTDALRRFTPPSYVVPEEPLLSAPTVAELTQAVNGAVVSGDVALREREVMGVLAAGMTADHVLERLTDGMAVITPGDRSDVVLAVASAHAAEGFPSLSCIVLNGGFQLHPAIAALVSGLRLRLPVIATALGTYDTASAAASARGLVTATSQRKIDTALELMDRHVDVAGLLAQLTIPIPTVTTPQMFTYRLLQQARSDLMRIVLPEGDDDRILKSAGRLLQRGIVDLTILGDEAKVRLRAAELGVDLDGATVIEPCASELHDQFADQYAQLRKAKGITVEHAREIMNDATYFGTMLVHNCHADGMVSGAAHTTAHTVRPALEIIKTVPGISTVSSIFLMCLPDRVLAYGDCAIIPNPTVEQLADIAICSARTAAQFGIEPRVAMLSYSTGDSGKGADVDKVRAATELVRAREPQLPVEGPIQYDAAVEPSVAATKLRDSPVAGRATVLIFPDLNTGNNTYKAVQRSAGAIAIGPVLQGLRKPVNDLSRGALVDDIVNTVAITAIQAQGVHE,"72,949",690,CobB/CobQ family; Phosphate acetyltransferase and butyryltransferase family,acetyl-CoA biosynthetic process [GO:0006085],phosphate acetyltransferase activity [GO:0008959],cytoplasm [GO:0005737]; extracellular region [GO:0005576],,MTCY22G10.04,1
P9WPG1,PSS_MYCTU,Rv0436c,pssA Rv0436c MTCY22G10.33c,GO:0003882; GO:0005576; GO:0005737; GO:0005886; GO:0016021; GO:0046474,IPR004533; IPR000462; ,,pssA,,CDP-diacylglycerol--serine O-phosphatidyltransferase (EC 2.7.8.8) (Phosphatidylserine synthase),cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; glycerophospholipid biosynthetic process [GO:0046474],9634230,,,MIGKPRGRRGVNLQILPSAMTVLSICAGLTAIKFALEHQPKAAMALIAAAAILDGLDGRVARILDAQSRMGAEIDSLADAVNFGVTPALVLYVSMLSKWPVGWVVVLLYAVCVVLRLARYNALQDDGTQPAYAHEFFVGMPAPAGAVSMIGLLALKMQFGEGWWTSGWFLSFWVTGTSILLVSGIPMKKMHAVSVPPNYAAALLAVLAICAAAAVLAPYLLIWVIIIAYMCHIPFAVRSQRWLAQHPEVWDDKPKQRRAVRRASRRAHPYRPSMARLGLRKPGRRL,"31,218",286,CDP-alcohol phosphatidyltransferase class-I family,glycerophospholipid biosynthetic process [GO:0046474],CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY22G10.33c,1
P9WIQ5,RECC_MYCTU,Rv0631c,recC Rv0631c MTCY20H10.12c,GO:0003677; GO:0004003; GO:0004519; GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0006302; GO:0006310; GO:0008854; GO:0009338,IPR013986; IPR027417; IPR006697; IPR011335; ,,recC,,RecBCD enzyme subunit RecC (EC 3.1.11.5) (Exonuclease V subunit RecC) (ExoV subunit RecC) (Helicase/nuclease RecBCD subunit RecC),cell wall [GO:0005618]; exodeoxyribonuclease V complex [GO:0009338]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; exodeoxyribonuclease V activity [GO:0008854]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302],9634230; 21969609,,"FUNCTION: A helicase/nuclease that prepares dsDNA breaks (DSB) for recombinational DNA repair. Binds to DSBs and unwinds DNA via a highly rapid and processive ATP-dependent bidirectional helicase activity. Unwinds dsDNA until it encounters a Chi (crossover hotspot instigator) sequence from the 3' direction. Cuts ssDNA a few nucleotides 3' to the Chi site. The properties and activities of the enzyme are changed at Chi. The Chi-altered holoenzyme produces a long 3'-ssDNA overhang and facilitates RecA-binding to the ssDNA for homologous DNA recombination and repair. Holoenzyme degrades any linearized DNA that is unable to undergo homologous recombination. In the holoenzyme this subunit recognizes the wild-type Chi sequence, and when added to isolated RecB increases its ATP-dependent helicase processivity. {ECO:0000255|HAMAP-Rule:MF_01486}.",MALHLHRAERTDLLADGLGALLADPQPDPFAQELVLVAARGVERWLSQRLSLVLGCGPGRADGVCAGIAFRNPQSLIAEITGTLDDDPWSPEALAWPLLAVIDASLDEPWCRTLASHLGHFATTDAEAELRRGRRYSVARRLAGLFASYARQRPGLLAAWLDGDLGELPGDLAWQPPLWRALVTTVGADPPHVRHDKTIARLRDGPADLPARLSLFGHTRLACTDVQLLDALAVHHDLHLWLPHPSDELWRALAGFQGADGLLPRRQDTSRRAAQHPLLETLGRDVRELQRALPAARATDEFLGATTKPDTLLGWLQADIAGNAPRPAGRSLSDADRSVQVHACHGPARQIDVLREVLLGLLEDDPTLQPRDIVVMCPDIDTYAPLIVAGFGLGEVAGDCHPAHRLRVRLADRALTQTNPLLSVAAELLTIAETRATASQLLNLAQAAPVRAKFGFADDDLDTITTWVRESNIRWGFDPTHRRRYGLDTVVHNTWRFGLDRILTGVAMSEDSQAWLDTALPLDDVGSNRVELAGRLAEFVERLHHVVGGLSGARPLVAWLDALATGIDLLTACNDGWQRAQVQREFADVLARAGSRAAPLLRLPDVRALLDAQLAGRPTRANFRTGTLTVCTMVPMRSVPHRVVCLVGLDDGVFPRLSHPDGDDVLAREPMTGERDIRSEDRQLLLDAIGAATQTLVITYTGADERTGQPRPPAVPLAELLDALDQTTSAPVRERILVTHPLQPFDRKNVTPGALLGAKPFTFDPAALAAAQAAAGKRCPPTAFISGRLPAPPAADVTLADLLDFFKDPVKGFFRALDYTLPWDVDTVEDSIPVQVDALAEWTVGERMLRDMLRGLHPDDAAHSEWRRGTLPPGRLGVRRAKEIRNRARDLAAAALAHRDGHGQAHDVDVDLGDGRRLSGTVTPVFGGRTVSVTYSKLAPKHVLPAWIGLVTLAAQEPGREWSALCIGRSKTRNHIARRLFVPPPDPVAVLRELVLLYDAGRREPLPLPLKTSCAWAQARRDGQDPYPPARECWQTNRFRPGDDDAPAHVRAWGPRAPFEVLLGKPRAGEEVAGEETRLGALAARLWLPLLAAEGSV,"119,501",1097,RecC family,DNA recombination [GO:0006310]; double-strand break repair [GO:0006302],ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; exodeoxyribonuclease V activity [GO:0008854],cell wall [GO:0005618]; exodeoxyribonuclease V complex [GO:0009338]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY20H10.12c,1
P9WHD9,RL14_MYCTU,Rv0714,rplN Rv0714 MTCY210.33,GO:0003735; GO:0005886; GO:0006412; GO:0022625; GO:0040007; GO:0070180,IPR036853; IPR000218; IPR005745; IPR019972; ,,rplN,,50S ribosomal protein L14,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds to 23S rRNA. Forms part of two intersubunit bridges in the 70S ribosome. {ECO:0000255|HAMAP-Rule:MF_01367}.,MIQQESRLKVADNTGAKEILCIRVLGGSSRRYAGIGDVIVATVKDAIPGGNVKRGDVVKAVVVRTVKERRRPDGSYIKFDENAAVIIKPDNDPRGTRIFGPVGRELREKRFMKIISLAPEVL,"13,428",122,Universal ribosomal protein uL14 family,growth [GO:0040007]; translation [GO:0006412],large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.33,1
P9WGE9,SODC_MYCTU,Rv0432,sodC Rv0432 MTCY22G10.29,GO:0004784; GO:0005576; GO:0005615; GO:0005618; GO:0005886; GO:0006979; GO:0033194; GO:0045454; GO:0052059; GO:0052060; GO:0075136,IPR036423; IPR024134; IPR018152; IPR001424; ,,sodC,,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1),cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; superoxide dismutase activity [GO:0004784]; cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; response to host [GO:0075136]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979],9634230; 11563965; 21969609; 15155722,X-ray crystallography (1),FUNCTION: Destroys radicals which are normally produced within the cells and which are toxic to biological systems. May play a role in favoring mycobacterial survival in phagocytes (By similarity). {ECO:0000250}.,MPKPADHRNHAAVSTSVLSALFLGAGAALLSACSSPQHASTVPGTTPSIWTGSPAPSGLSGHDEESPGAQSLTSTLTAPDGTKVATAKFEFANGYATVTIATTGVGKLTPGFHGLHIHQVGKCEPNSVAPTGGAPGNFLSAGGHYHVPGHTGTPASGDLASLQVRGDGSAMLVTTTDAFTMDDLLSGAKTAIIIHAGADNFANIPPERYVQVNGTPGPDETTLTTGDAGKRVACGVIGSG,"23,844",240,Cu-Zn superoxide dismutase family,cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; response to host [GO:0075136]; response to hydroperoxide [GO:0033194]; response to oxidative stress [GO:0006979],superoxide dismutase activity [GO:0004784],cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],,MTCY22G10.29,1
P9WJ59,VAPB3_MYCTU,Rv0550c,vapB3 Rv0550c,GO:0045926; GO:0075136,IPR009956; ,,vapB3,,Antitoxin VapB3,negative regulation of growth [GO:0045926]; response to host [GO:0075136],9634230; 15718296; 20011113; 21673191; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC3. {ECO:0000269|PubMed:20011113}.,MLSRRTKTIVVCTLVCMARLNVYVPDELAERARARGLNVSALTQAAISAELENSATDAWLEGLEPRSTGARHDDVLGAIDAARDEFEA,"9,544",88,,negative regulation of growth [GO:0045926]; response to host [GO:0075136],,,,,1
P9WF19,VAPB5_MYCTU,Rv0626,vapB5 Rv0626,GO:0015643; GO:0045927,IPR006442; IPR036165; ,,vapB5,,Putative antitoxin VapB5,toxic substance binding [GO:0015643]; positive regulation of growth [GO:0045927],9634230; 15718296; 21969609; 25622615; 18952600,X-ray crystallography (1),FUNCTION: Probable antitoxin component of a type II toxin-antitoxin (TA) system. The cognate toxin is VapC5. {ECO:0000269|PubMed:18952600}.,MSEVASRELRNDTAGVLRRVRAGEDVTITVSGRPVAVLTPVRPRRRRWLSKTEFLSRLRGAQADPGLRNDLAVLAGDTTEDLGPIR,"9,493",86,PhD/YefM antitoxin family,positive regulation of growth [GO:0045927],toxic substance binding [GO:0015643],,,,1
O06775,VAPB8_MYCTU,Rv0664,vapB8 Rv0664,,,,vapB8,,Putative antitoxin VapB8,,9634230; 15718296,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC8. {ECO:0000305|PubMed:15718296}.,MEKSRCHAVAHGGGCAGSAKSHKSGGRCGQGRGAGDSHGTRGAGRRYRAASAPHPLAVGAHLRDELAKRSADPRLTDELNDLAGHTLDDL,"9,250",90,,,,,,,1
P96917,VAPC5_MYCTU,Rv0627,vapC5 Rv0627,GO:0000287; GO:0004521; GO:0005576; GO:0040007,IPR029060; IPR002716; IPR022907; ,,vapC5,DOMAIN 9 130 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC5 (RNase VapC5) (EC 3.1.-.-) (Toxin VapC5),extracellular region [GO:0005576]; endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287]; growth [GO:0040007],9634230; 15718296; 19099550; 21969609; 23345537; 25622615; 18952600,X-ray crystallography (1),FUNCTION: Probable toxic component of a type II toxin-antitoxin (TA) system. The cognate antitoxin is VapB5. Has limited RNase activity on substrates; activity is seen with a VapC5-VapB5 complex. {ECO:0000269|PubMed:18952600}.,MSTTPAAGVLDTSVFIATESGRQLDEALIPDRVATTVVTLAELRVGVLAAATTDIRAQRLATLESVADMETLPVDDDAARMWARLRIHLAESGRRVRINDLWIAAVAASRALPVITQDDDFAALDGAASVEIIRV,"14,408",135,PINc/VapC protein family,growth [GO:0040007],endoribonuclease activity [GO:0004521]; magnesium ion binding [GO:0000287],extracellular region [GO:0005576],,,2
P9WFB1,VAPC8_MYCTU,Rv0665,vapC8 Rv0665,GO:0004518; GO:0046872,IPR029060; IPR002716; ,,vapC8,DOMAIN 10 109 PINc.,Ribonuclease VapC8 (RNase VapC8) (EC 3.1.-.-) (Toxin VapC8),metal ion binding [GO:0046872]; nuclease activity [GO:0004518],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB8 (By similarity). {ECO:0000250}.,MTEGEVGVGLLDTSVFIARESGGAIADLPERVALSVMTIGELQLGLLNAGDSATRSRRADTLALARTADQIPVSEAVMISLARLVADCRAAGVRRSVKLTDALIAATAEIKV,"11,590",112,PINc/VapC protein family,,metal ion binding [GO:0046872]; nuclease activity [GO:0004518],,,,1
O07779,VPB27_MYCTU,Rv0599c,vapB27 vapB-mt24 Rv0599c,GO:0003677,IPR007159; IPR037914; ,,vapB27,DOMAIN 1 45 SpoVT-AbrB. {ECO:0000255|PROSITE-ProRule:PRU01076}.,Antitoxin VapB27,DNA binding [GO:0003677],9634230; 20011113; 20876537; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Cognate toxin is VapC27. Upon expression in E.coli partially counteracts the ribonuclease activity of non-cognate toxins MazF6 and MazF9. {ECO:0000269|PubMed:20876537}.,MKAVVDAAGRIVVPKPLREALGLQPGSTVEISRYGAGLHLIPTGRTARLEEENGVLVATGETTIDDEVVFGLIDSGRK,"8,212",78,VapB family,,DNA binding [GO:0003677],,vapB-mt24,,3
O53811,VPB31_MYCTU,Rv0748,vapB31 Rv0748,GO:0006355; GO:0045927,IPR002145; ,,vapB31,,Antitoxin VapB31,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113; 21673191; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC31. {ECO:0000269|PubMed:20011113}.,MRTTVSISDEILAAAKRRARERGQSLGAVIEDALRREFAAAHVGGARPTVPVFDGGTGPRRGIDLTSNRALSEVLDEGLELNSRK,"9,114",85,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,,3
P9WM83,Y0569_MYCTU,Rv0569,Rv0569,GO:0001666; GO:0005618; GO:0005829,IPR015035; ,,,,Uncharacterized protein Rv0569,cell wall [GO:0005618]; cytosol [GO:0005829]; response to hypoxia [GO:0001666],9634230; 11416222; 12057942; 12953092; 18474359; 18400743; 21969609,,,MKAKVGDWLVIKGATIDQPDHRGLIIEVRSSDGSPPYVVRWLETDHVATVIPGPDAVVVTAEEQNAADERAQHRFGAVQSAILHARGT,"9,523",88,,response to hypoxia [GO:0001666],,cell wall [GO:0005618]; cytosol [GO:0005829],,,1
O53803,Y0740_MYCTU,Rv0740 RVBD_0740,Rv0740 RVBD_0740 P425_00771,,,,,,Uncharacterized protein Rv0740,,9634230; 21969609,,,MTGPPRSYTGRRDLIAEKLEPYFQISAMLPKNTRPTSETAEEFWDNSLWCSWGDRETGYTRTVTVSICQVADGEREAEGVRDMMRLECPAGLDLRTPNPEAYEITGQRPGEFVFVLGYLGHVRAIVGNCYIEIMPMGTRVELSKLADVALDIGRSVGCSAYENDFTLPDIPTQWRNQPLGWYTQGLAPYLPGLSDPKDAAEG,"22,531",202,,,,,,P425_00771,2
P9WF79,VPC29_MYCTU,Rv0617,vapC29 Rv0617,GO:0004540; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC29,DOMAIN 3 122 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC29 (RNase VapC29) (EC 3.1.-.-) (Toxin VapC29),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609; 22539524,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Its cognate antitoxin is VapB29 (By similarity). Has ribonuclease activity. {ECO:0000250, ECO:0000269|PubMed:22539524}.",MTVLLDANVLIALVVAEHVHHDAAADWLMASDTGFATCPMTQGSLVRFLVRSGQSAAAARDVVSAVQCTSRHEFWPDALSFAGVEVAGVVGHRQVTDAYLAQLARSHDGQLATLDSGLAHLHGDVAVLIPTTT,"13,970",133,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
O53778,VPB26_MYCTU,Rv0581,vapB26 Rv0581,GO:0006355; GO:0045927,IPR002145; IPR010985; ,,vapB26,,Antitoxin VapB26,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113; 21969609,X-ray crystallography (1),FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC26. {ECO:0000269|PubMed:20011113}.,MDKTTVYLPDELKAAVKRAARQRGVSEAQVIRESIRAAVGGAKPPPRGGLYAGSEPIARRVDELLAGFGER,"7,605",71,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WJ37,VPB29_MYCTU,Rv0616A,vapB29 Rv0616A,GO:0006355,IPR010985; ,,vapB29,,Putative antitoxin VapB29,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113; 21969609,,FUNCTION: Possibly the antitoxic component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC29. {ECO:0000305|PubMed:20011113}.,MRTTIDLPQDLHKQALAIARDTHRTLSETVADLMRRGLAANRPTALSSDPRTGLPLVSVGTVVTSEDVRSLEDEQ,"8,195",75,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
O53779,VPC26_MYCTU,Rv0582,vapC26 Rv0582,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC26,DOMAIN 1 118 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC26 (RNase VapC26) (EC 3.1.-.-) (Toxin VapC26),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB26. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MIIDTSALLAYFDAAEPDHAAVSECIDSSADALVVSPYVVAELDYLVATRVGVDAELAVLRELAGGAWELANCGAAEIEQAARIVTKYQDQRIGIADAANVVLADRYRTRTILTLDRRHFSALRPIGGGRFTVIP,"14,503",135,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WF83,VPC27_MYCTU,Rv0598c,vapC27 vapC-mt24 Rv0598c,GO:0004540; GO:0005576; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC27,DOMAIN 7 125 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC27 (RNase VapC27) (EC 3.1.-.-) (Toxin VapC27),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 20876537; 21969609; 23345537,,FUNCTION: Probably the toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Its cognate antitoxin is VapB27. {ECO:0000250}.,MKPPLAVDTSVAIPLLVRTHTAHAAVVAWWAHREAALCGHALAETYSVLTRLPRDLRLAPMDAARLLTERFAAPLLLSSRTTEHLPRVLAQFEITGGAVYDALVALAAAEHRAELATRDARAKDTYEKIGVHVVVAA,"14,818",137,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],vapC-mt24,,1
P9WF81,VPC28_MYCTU,Rv0609,vapC28 Rv0609 MTCY19H5.13c,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC28,DOMAIN 1 124 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC28 (RNase VapC28) (EC 3.1.-.-) (Toxin VapC28),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB28. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MIVDTSAIIAILRDEDDAAAYADALANADVRRLSAASYLECGIVLDSQRDPVISRALDELIEEAEFVVEPVTERQARLARAAYADFGRGSGHPAGLNFGDCLSYALAIDRREPLLWKGNDFGHTGVQRALDRR,"14,533",133,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY19H5.13c,1
P9WF77,VPC30_MYCTU,Rv0624,vapC30 Rv0624 MTCY20H10.05,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC30,DOMAIN 1 129 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC30 (RNase VapC30) (EC 3.1.-.-) (Toxin VapC30),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,X-ray crystallography (2),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB30. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MVIDTSALVAMLSDEPDAERFEAAVEADHIRLMSTASYLETALVIEARFGEPGGRELDLWLHRAAVDLVAVHADQADAARAAYRTYGKGRHRAGLNYGDCFSYGLAKISGQPLLFKGEDFQHTDIATVALP,"14,250",131,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY20H10.05,1
P9WM81,Y0572_MYCTU,Rv0572c,Rv0572c,,,,,,Uncharacterized protein Rv0572c,,9634230; 11416222; 12953092; 18474359; 18400743,,,MGEHAIKRHMRQRKPTKHPLAQKRGARILVFTDDPRRSVLIVPGCHLDSMRREKNAYYFQDGNALVGMVVSGGTVEYDADDRTYVVQLTDGRHTTESSFEHSSPSRSPQSDDL,"12,811",113,,,,,,,1
P9WGS7,Y0687_MYCTU,Rv0687,Rv0687,GO:0016491,IPR036291; IPR020904; IPR002347; IPR023985; ,,,,Uncharacterized NAD-dependent oxidoreductase Rv0687 (EC 1.-.-.-),oxidoreductase activity [GO:0016491],9634230; 21969609,,,MSARGGSLHGRVAFVTGAARAQGRSHAVRLAREGADIVALDICAPVSGSVTYPPATSEDLGETVRAVEAEGRKVLAREVDIRDDAELRRLVADGVEQFGRLDIVVANAGVLGWGRLWELTDEQWETVIGVNLTGTWRTLRATVPAMIDAGNGGSIVVVSSSAGLKATPGNGHYAASKHALVALTNTLAIELGEFGIRVNSIHPYSVDTPMIEPEAMIQTFAKHPGYVHSFPPMPLQPKGFMTPDEISDVVVWLAGDGSGALSGNQIPVDKGALKY,"29,028",275,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,,1
Q6MX39,UMAA_MYCTU,Rv0469,umaA Rv0469 LH57_02505,GO:0005737; GO:0005886; GO:0008168; GO:0008610,IPR003333; IPR029063; ,,umaA,,S-adenosylmethionine-dependent methyltransferase UmaA (SAM-dependent methyltransferase UmaA) (EC 2.1.1.-),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; lipid biosynthetic process [GO:0008610],9634230; 21969609; 23435098,,"FUNCTION: Methyltransferase that modifies short-chain fatty acids. In vitro, catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of phospholipid-linked oleic acid to produce tuberculostearic acid (10-methylstearic-acid or TSA). {ECO:0000269|PubMed:23435098}.",MTELRPFYEESQSIYDVSDEFFSLFLDPTMAYTCAYFEREDMTLEEAQNAKFDLALDKLHLEPGMTLLDIGCGWGGGLQRAIENYDVNVIGITLSRNQFEYSKAKLAKIPTERSVQVRLQGWDEFTDKVDRIVSIGAFEAFKMERYAAFFERSYDILPDDGRMLLHTILTYTQKQMHEMGVKVTMSDVRFMKFIGEEIFPGGQLPAQEDIFKFAQAADFSVEKVQLLQQHYARTLNIWAANLEANKDRAIALQSEEIYNKYMHYLTGCEHFFRKGISNVGQFTLTK,"33,096",286,CFA/CMAS family,lipid biosynthetic process [GO:0008610],methyltransferase activity [GO:0008168],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,LH57_02505,1
P9WF75,VPC31_MYCTU,Rv0749,vapC31 Rv0749,GO:0004540; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC31,DOMAIN 3 139 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC31 (RNase VapC31) (EC 3.1.-.-) (Toxin VapC31),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 12368430; 20011113; 21673191; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB31 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MFLLDANVLLAAHRGDHPNHRTVRPWFDRLLAADDPFTVPNLVWASFLRLATNRRIFEIPSPRAEAFAFVEAVTAQPHHLPTNPGPRHLMLLRKLCDEADASGDLIPDAVLAAIAVGHHCAVVSLDRDFARFASVRHIRPPL,"15,831",142,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WGH7,SIGK_MYCTU,Rv0445c,sigK Rv0445c,GO:0003677; GO:0003700; GO:0005618; GO:0005886; GO:0006352; GO:0010468; GO:0016987; GO:0019217,IPR014284; IPR007627; IPR007630; IPR013325; IPR013324; IPR036388; ,,sigK,,ECF RNA polymerase sigma factor SigK (ECF sigma factor SigK) (Alternative RNA polymerase sigma factor SigK) (RNA polymerase sigma-K factor) (Sigma-K factor),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]",9634230; 15882422; 20600947; 21969609; ,X-ray crystallography (1),FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis. Sigma-K controls genes such as mpt70 and mpt83. {ECO:0000269|PubMed:15882422}.,MTGPPRLSSDLDALLRRVAGHDQAAFAEFYDHTKSRVYGLVMRVLRDTGYSEETTQEIYLEVWRNASEFDSAKGSALAWLLTMAHRRAVDRVRCEQAGNQREVRYGAANVDPASDVVADLAIAGDERRRVTECLKALTDTQRQCIELAYYGGLTYVEVSRRLAANLSTIKSRMRDALRSLRNCLDVS,"21,035",187,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WGH5,SIGL_MYCTU,Rv0735,sigL Rv0735,GO:0003677; GO:0003700; GO:0006352; GO:0006355; GO:0009405; GO:0016987,IPR014284; IPR000838; IPR007627; IPR007630; IPR013325; IPR013324; IPR036388; ,,sigL,,ECF RNA polymerase sigma factor SigL (ECF sigma factor SigL) (Alternative RNA polymerase sigma factor SigL) (RNA polymerase sigma-L factor) (Sigma-L factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 16199577; 16552079; 20600947; 20184899,X-ray crystallography (1),"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis. Over-expression of SigL induces 19-28 genes including polyketide synthases, secreted and membrane proteins. Might play a minor role in regulating SigB. {ECO:0000269|PubMed:16199577, ECO:0000269|PubMed:16552079}.",MARVSGAAAAEAALMRALYDEHAAVLWRYALRLTGDAAQAEDVVQETLLRAWQHPEVIGDTARPARAWLFTVARNMIIDERRSARFRNVVGSTDQSGTPEQSTPDEVNAALDRLLIADALAQLSAEHRAVIQRSYYRGWSTAQIATDLGIAEGTVKSRLHYAVRALRLTLQELGVTR,"19,538",177,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
P9WGN7,SECE_MYCTU,Rv0638,secE Rv0638 MTCY20H10.19,GO:0005618; GO:0005622; GO:0005886; GO:0005887; GO:0006605; GO:0009306; GO:0015450; GO:0040007,IPR022943; IPR005807; IPR038379; IPR001901; ,,secE,,Protein translocase subunit SecE,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; growth [GO:0040007]; protein secretion [GO:0009306]; protein targeting [GO:0006605],9634230; 21969609,,FUNCTION: Essential subunit of the Sec protein translocation channel SecYEG. Clamps together the 2 halves of SecY. May contact the channel plug during translocation. {ECO:0000255|HAMAP-Rule:MF_00422}.,MSDEGDVADEAVADGAENADSRGSGGRTALVTKPVVRPQRPTGKRSRSRAAGADADVDVEEPSTAASEATGVAKDDSTTKAVSKAARAKKASKPKARSVNPIAFVYNYLKQVVAEMRKVIWPNRKQMLTYTSVVLAFLAFMVALVAGADLGLTKLVMLVFG,"16,956",161,SecE/SEC61-gamma family,growth [GO:0040007]; protein secretion [GO:0009306]; protein targeting [GO:0006605],P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY20H10.19,1
P9WGN3,SECY_MYCTU,Rv0732,secY Rv0732 MTV041.06,GO:0005576; GO:0005886; GO:0015031; GO:0016021; GO:0040007,IPR026593; IPR002208; IPR030659; IPR023201; ,,secY,,Protein translocase subunit SecY,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007]; protein transport [GO:0015031],9634230; 19099550; 21969609,,"FUNCTION: The central subunit of the protein translocation channel SecYEG. Consists of two halves formed by TMs 1-5 and 6-10. These two domains form a lateral gate at the front which open onto the bilayer between TMs 2 and 7, and are clamped together by SecE at the back. The channel is closed by both a pore ring composed of hydrophobic SecY resides and a short helix (helix 2A) on the extracellular side of the membrane which forms a plug. The plug probably moves laterally to allow the channel to open. The ring and the pore may move independently. {ECO:0000255|HAMAP-Rule:MF_01465}.",MLSAFISSLRTVDLRRKILFTLGIVILYRVGAALPSPGVNFPNVQQCIKEASAGEAGQIYSLINLFSGGALLKLTVFAVGVMPYITASIIVQLLTVVIPRFEELRKEGQAGQSKMTQYTRYLAIALAILQATSIVALAANGGLLQGCSLDIIADQSIFTLVVIVLVMTGGAALVMWMGELITERGIGNGMSLLIFVGIAARIPAEGQSILESRGGVVFTAVCAAALIIIVGVVFVEQGQRRIPVQYAKRMVGRRMYGGTSTYLPLKVNQAGVIPVIFASSLIYIPHLITQLIRSGSGVVGNSWWDKFVGTYLSDPSNLVYIGIYFGLIIFFTYFYVSITFNPDERADEMKKFGGFIPGIRPGRPTADYLRYVLSRITLPGSIYLGVIAVLPNLFLQIGAGGTVQNLPFGGTAVLIMIGVGLDTVKQIESQLMQRNYEGFLK,"47,611",441,SecY/SEC61-alpha family,growth [GO:0040007]; protein transport [GO:0015031],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV041.06,1
P9WGK5,SENX3_MYCTU,Rv0490,senX3 Rv0490 MTCY20G9.16,GO:0000155; GO:0005524; GO:0005576; GO:0005622; GO:0005886; GO:0009405; GO:0016021; GO:0018106; GO:0046777,IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,senX3,DOMAIN 164 380 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Sensor-like histidine kinase senX3 (EC 2.7.13.3),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; pathogenesis [GO:0009405]; peptidyl-histidine phosphorylation [GO:0018106]; protein autophosphorylation [GO:0046777],9426136; 9634230; 21969609,,FUNCTION: Probably forms part of a two-component regulatory system senX3/regX3. Phosphorylates regX3 (Probable). {ECO:0000305}.,MTVFSALLLAGVLSALALAVGGAVGMRLTSRVVEQRQRVATEWSGITVSQMLQCIVTLMPLGAAVVDTHRDVVYLNERAKELGLVRDRQLDDQAWRAARQALGGEDVEFDLSPRKRSATGRSGLSVHGHARLLSEEDRRFAVVFVHDQSDYARMEAARRDFVANVSHELKTPVGAMALLAEALLASADDSETVRRFAEKVLIEANRLGDMVAELIELSRLQGAERLPNMTDVDVDTIVSEAISRHKVAADNADIEVRTDAPSNLRVLGDQTLLVTALANLVSNAIAYSPRGSLVSISRRRRGANIEIAVTDRGIGIAPEDQERVFERFFRGDKARSRATGGSGLGLAIVKHVAANHDGTIRVWSKPGTGSTFTLALPALIEAYHDDERPEQAREPELRSNRSQREEELSR,"44,825",410,,pathogenesis [GO:0009405]; peptidyl-histidine phosphorylation [GO:0018106]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY20G9.16,1
P9WGJ3,SERB1_MYCTU,Rv0505c,serB1 Rv0505c MTCY20G9.32c,GO:0004647; GO:0005886; GO:0005887; GO:0046872,IPR036412; IPR006385; IPR023214; ,,serB1,,Phosphoserine phosphatase SerB1 (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; phosphoserine phosphatase activity [GO:0004647],9634230; 12657046; 21969609; 25037224,,FUNCTION: Likely catalyzes the dephosphorylation of O-phospho-L-serine into L-serine. {ECO:0000305|PubMed:25037224}.,MMVSSHLGSPDQAGHVDLASPADPPPPDASASHSPVDMPAPVAAAGSDRQPPIDLTAAAFFDVDNTLVQGSSAVHFGRGLAARHYFTYRDVLGFLYAQAKFQLLGKENSNDVAAGRRKALAFIEGRSVAELVALGEEIYDEIIADKIWDGTRELTQMHLDAGQQVWLITATPYELAATIARRLGLTGALGTVAESVDGIFTGRLVGEILHGTGKAHAVRSLAIREGLNLKRCTAYSDSYNDVPMLSLVGTAVAINPDARLRSLARERGWEIRDFRIARKAARIGVPSALALGAAGGALAALASRRQSR,"32,673",308,"HAD-like hydrolase superfamily, SerB family",,metal ion binding [GO:0046872]; phosphoserine phosphatase activity [GO:0004647],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY20G9.32c,1
P9WGL9,REGX3_MYCTU,Rv0491,regX3 Rv0491 MTCY20G9.17,GO:0000160; GO:0003677; GO:0005622; GO:0006351; GO:0006355; GO:0009405; GO:0019217; GO:0019220; GO:1902882,IPR011006; IPR001867; IPR016032; IPR001789; IPR036388; ,,regX3,DOMAIN 3 116 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Sensory transduction protein regX3,"intracellular [GO:0005622]; DNA binding [GO:0003677]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; regulation of fatty acid metabolic process [GO:0019217]; regulation of phosphate metabolic process [GO:0019220]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9426136; 9634230; 21969609,X-ray crystallography (1),FUNCTION: Probably forms part of a two-component regulatory system regX3/senX3.,MTSVLIVEDEESLADPLAFLLRKEGFEATVVTDGPAALAEFDRAGADIVLLDLMLPGMSGTDVCKQLRARSSVPVIMVTARDSEIDKVVGLELGADDYVTKPYSARELIARIRAVLRRGGDDDSEMSDGVLESGPVRMDVERHVVSVNGDTITLPLKEFDLLEYLMRNSGRVLTRGQLIDRVWGADYVGDTKTLDVHVKRLRSKIEADPANPVHLVTVRGLGYKLEG,"24,849",227,,"pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; regulation of fatty acid metabolic process [GO:0019217]; regulation of phosphate metabolic process [GO:0019220]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],intracellular [GO:0005622],,MTCY20G9.17,1
P9WHA5,RL2_MYCTU,Rv0704,rplB Rv0704 MTCY210.23,GO:0002181; GO:0003723; GO:0003735; GO:0005886; GO:0016740; GO:0019843; GO:0022625; GO:0040007,IPR012340; IPR022666; IPR014722; IPR002171; IPR005880; IPR022669; IPR022671; IPR014726; IPR008991; ,,rplB,,50S ribosomal protein L2,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; transferase activity [GO:0016740]; cytoplasmic translation [GO:0002181]; growth [GO:0040007],9634230; 21969609,Electron microscopy (1),"FUNCTION: One of the primary rRNA binding proteins. Required for association of the 30S and 50S subunits to form the 70S ribosome, for tRNA binding and peptide bond formation. It has been suggested to have peptidyltransferase activity; this is somewhat controversial. Makes several contacts with the 16S rRNA in the 70S ribosome. {ECO:0000255|HAMAP-Rule:MF_01320}.",MAIRKYKPTTPGRRGASVSDFAEITRSTPEKSLVRPLHGRGGRNAHGRITTRHKGGGHKRAYRMIDFRRNDKDGVNAKVAHIEYDPNRTARIALLHYLDGEKRYIIAPNGLSQGDVVESGANADIKPGNNLPLRNIPAGTLIHAVELRPGGGAKLARSAGSSIQLLGKEASYASLRMPSGEIRRVDVRCRATVGEVGNAEQANINWGKAGRMRWKGKRPSVRGVVMNPVDHPHGGGEGKTSGGRHPVSPWGKPEGRTRNANKSSNKFIVRRRRTGKKHSR,"30,577",280,Universal ribosomal protein uL2 family,cytoplasmic translation [GO:0002181]; growth [GO:0040007],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; transferase activity [GO:0016740],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.23,1
P9WHE7,RL10_MYCTU,Rv0651,rplJ Rv0651 MTCY20H10.32,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0019843; GO:0022625; GO:0040007; GO:0042254,IPR022973; IPR002363; IPR001790; ,P9WHE3,rplJ,,50S ribosomal protein L10,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: Forms part of the ribosomal stalk, playing a central role in the interaction of the ribosome with GTP-bound translation factors. {ECO:0000250}.",MARADKATAVADIAAQFKESTATLITEYRGLTVANLAELRRSLTGSATYAVAKNTLIKRAASEAGIEGLDELFVGPTAIAFVTGEPVDAAKAIKTFAKEHKALVIKGGYMDGHPLTVAEVERIADLESREVLLAKLAGAMKGNLAKAAGLFNAPASQLARLAAALQEKKACPGPDSAE,"18,478",178,Universal ribosomal protein uL10 family,growth [GO:0040007]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY20H10.32,1
P9WHD1,RL18_MYCTU,Rv0720,rplR Rv0720 MTCY210.39,GO:0003735; GO:0006412; GO:0008097; GO:0022625; GO:0040007,IPR005484; IPR004389; ,,rplR,,50S ribosomal protein L18,cytosolic large ribosomal subunit [GO:0022625]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: This is one of the proteins that binds and probably mediates the attachment of the 5S RNA into the large ribosomal subunit, where it forms part of the central protuberance. {ECO:0000255|HAMAP-Rule:MF_01337}.",MAQSVSATRRISRLRRHTRLRKKLSGTAERPRLVVHRSARHIHVQLVNDLNGTTVAAASSIEADVRGVPGDKKARSVRVGQLIAERAKAAGIDTVVFDRGGYTYGGRIAALADAARENGLSF,"13,184",122,Universal ribosomal protein uL18 family,growth [GO:0040007]; translation [GO:0006412],5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],,MTCY210.39,1
P9WHB9,RL23_MYCTU,Rv0703,rplW Rv0703 MTCY210.22,GO:0000027; GO:0003723; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR012677; IPR012678; IPR001014; IPR013025; ,,rplW,,50S ribosomal protein L23,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],9634230; 19099550; 21969609,Electron microscopy (1),FUNCTION: One of the early assembly proteins it binds 23S rRNA. One of the proteins that surrounds the polypeptide exit tunnel on the outside of the ribosome. Forms the main docking site for trigger factor binding to the ribosome. {ECO:0000255|HAMAP-Rule:MF_01369}.,MATLADPRDIILAPVISEKSYGLLDDNVYTFLVRPDSNKTQIKIAVEKIFAVKVASVNTANRQGKRKRTRTGYGKRKSTKRAIVTLAPGSRPIDLFGAPA,"10,958",100,Universal ribosomal protein uL23 family,growth [GO:0040007]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.22,1
P9WH81,RL6_MYCTU,Rv0719,rplF Rv0719 MTCY210.38,GO:0002181; GO:0003723; GO:0003735; GO:0005618; GO:0005886; GO:0019843; GO:0022625; GO:0040007,IPR000702; IPR020040; IPR036789; IPR019906; IPR002358; ,,rplF,,50S ribosomal protein L6,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; growth [GO:0040007],9634230; 21969609,Electron microscopy (1),"FUNCTION: This protein binds to the 23S rRNA, and is important in its secondary structure. It is located near the subunit interface in the base of the L7/L12 stalk, and near the tRNA binding site of the peptidyltransferase center. {ECO:0000255|HAMAP-Rule:MF_01365}.",MSRIGKQPIPVPAGVDVTIEGQSISVKGPKGTLGLTVAEPIKVARNDDGAIVVTRPDDERRNRSLHGLSRTLVSNLVTGVTQGYTTKMEIFGVGYRVQLKGSNLEFALGYSHPVVIEAPEGITFAVQAPTKFTVSGIDKQKVGQIAANIRRLRRPDPYKGKGVRYEGEQIRRKVGKTGK,"19,377",179,Universal ribosomal protein uL6 family,cytoplasmic translation [GO:0002181]; growth [GO:0040007],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.38,1
P9WHA7,RL29_MYCTU,Rv0709,rpmC Rv0709 MTCY210.28,GO:0003735; GO:0006412; GO:0022625; GO:0040007,IPR001854; IPR036049; IPR018254; ,,rpmC,,50S ribosomal protein L29,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 17259624; 21969609,Electron microscopy (1),,MAVGVSPGELRELTDEELAERLRESKEELFNLRFQMATGQLNNNRRLRTVRQEIARIYTVLRERELGLATGPDGKES,"8,859",77,Universal ribosomal protein uL29 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],,MTCY210.28,1
P9WH87,RL3_MYCTU,Rv0701,rplC Rv0701 MTCY210.20,GO:0003735; GO:0005829; GO:0005840; GO:0005886; GO:0006412; GO:0019843; GO:0040007,IPR000597; IPR019927; IPR019926; IPR009000; ,,rplC,,50S ribosomal protein L3,cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: One of the primary rRNA binding proteins, it binds directly near the 3'-end of the 23S rRNA, where it nucleates assembly of the 50S subunit. {ECO:0000255|HAMAP-Rule:MF_01325}.",MARKGILGTKLGMTQVFDESNRVVPVTVVKAGPNVVTRIRTPERDGYSAVQLAYGEISPRKVNKPLTGQYTAAGVNPRRYLAELRLDDSDAATEYQVGQELTAEIFADGSYVDVTGTSKGKGFAGTMKRHGFRGQGASHGAQAVHRRPGSIGGCATPARVFKGTRMAGRMGNDRVTVLNLLVHKVDAENGVLLIKGAVPGRTGGLVMVRSAIKRGEK,"23,090",217,Universal ribosomal protein uL3 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840],,MTCY210.20,1
P9WH95,RL332_MYCTU,Rv0634B,rpmG2 Rv0634B MTCY20H10.15A,GO:0003735; GO:0005840; GO:0006412,IPR038584; IPR001705; IPR018264; IPR011332; ,,rpmG2,,50S ribosomal protein L33 2,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 12368430; 21969609,Electron microscopy (1),,MASSTDVRPKITLACEVCKHRNYITKKNRRNDPDRLELKKFCPNCGKHQAHRETR,"6,496",55,Bacterial ribosomal protein bL33 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],ribosome [GO:0005840],,MTCY20H10.15A,1
P9WHD7,RL15_MYCTU,Rv0723,rplO Rv0723 MTCY210.42,GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022625,IPR036227; IPR030878; IPR005749; IPR001196; IPR021131; ,,rplO,,50S ribosomal protein L15,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds to the 23S rRNA. {ECO:0000255|HAMAP-Rule:MF_01341}.,MTLKLHDLRPARGSKIARTRVGRGDGSKGKTAGRGTKGTRARKQVPVTFEGGQMPIHMRLPKLKGFRNRFRTEYEIVNVGDINRLFPQGGAVGVDDLVAKGAVRKNALVKVLGDGKLTAKVDVSAHKFSGSARAKITAAGGSATEL,"15,533",146,Universal ribosomal protein uL15 family,translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.42,1
P9WHD5,RL16_MYCTU,Rv0708,rplP Rv0708 MTCY210.27,GO:0000049; GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR016180; IPR036920; IPR000114; IPR020798; ,,rplP,,50S ribosomal protein L16,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds 23S rRNA and is also seen to make contacts with the A and possibly P site tRNAs. {ECO:0000255|HAMAP-Rule:MF_01342}.,MLIPRKVKHRKQHHPRQRGIASGGTTVNFGDYGIQALEHAYVTNRQIESARIAINRHIKRGGKVWINIFPDRPLTKKPAETRMGSGKGSPEWWVANVKPGRVLFELSYPNEGVARAALTRAIHKLPIKARIITREEQF,"15,692",138,Universal ribosomal protein uL16 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY210.27,1
P9WHC1,RL22_MYCTU,Rv0706,rplV Rv0706 MTCY210.25,GO:0003735; GO:0005618; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR001063; IPR018260; IPR036394; IPR005727; ,,rplV,,50S ribosomal protein L22,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 19099550; 21969609,Electron microscopy (1),"FUNCTION: This protein binds specifically to 23S rRNA; its binding is stimulated by other ribosomal proteins, e.g. L4, L17, and L20. It is important during the early stages of 50S assembly. It makes multiple contacts with different domains of the 23S rRNA in the assembled 50S subunit and ribosome (By similarity). {ECO:0000255|HAMAP-Rule:MF_01331}.; FUNCTION: The globular domain of the protein is located near the polypeptide exit tunnel on the outside of the subunit, while an extended beta-hairpin is found that lines the wall of the exit tunnel in the center of the 70S ribosome. {ECO:0000255|HAMAP-Rule:MF_01331}.",MTAATKATEYPSAVAKARFVRVSPRKARRVIDLVRGRSVSDALDILRWAPQAASGPVAKVIASAAANAQNNGGLDPATLVVATVYADQGPTAKRIRPRAQGRAFRIRRRTSHITVVVESRPAKDQRSAKSSRARRTEASKAASKVGATAPAKKAAAKAPAKKAPASSGVKKTPAKKAPAKKAPAKASETSAAKGGSD,"20,380",197,Universal ribosomal protein uL22 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625],,MTCY210.25,1
P9WHB7,RL24_MYCTU,Rv0715,rplX Rv0715 MTCY210.34,GO:0003735; GO:0005618; GO:0006412; GO:0019843; GO:0022625; GO:0040007,IPR005824; IPR014722; IPR003256; IPR005825; IPR008991; ,,rplX,,50S ribosomal protein L24,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: One of two assembly initiator proteins, it binds directly to the 5'-end of the 23S rRNA, where it nucleates assembly of the 50S subunit. {ECO:0000255|HAMAP-Rule:MF_01326}.; FUNCTION: One of the proteins that surrounds the polypeptide exit tunnel on the outside of the subunit. {ECO:0000255|HAMAP-Rule:MF_01326}.",MKVHKGDTVLVISGKDKGAKGKVLQAYPDRNRVLVEGVNRIKKHTAISTTQRGARSGGIVTQEAPIHVSNVMVVDSDGKPTRIGYRVDEETGKRVRISKRNGKDI,"11,475",105,Universal ribosomal protein uL24 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625],,MTCY210.34,1
P9WG75,THIE_MYCTU,Rv0414c,thiE Rv0414c MTCY22G10.11c,GO:0004789; GO:0005737; GO:0009228; GO:0009229; GO:0046872,IPR013785; IPR036206; IPR022998; IPR034291; ,,thiE,,Thiamine-phosphate synthase (TP synthase) (TPS) (EC 2.5.1.3) (Thiamine-phosphate pyrophosphorylase) (TMP pyrophosphorylase) (TMP-PPase),cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; thiamine-phosphate diphosphorylase activity [GO:0004789]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],9634230; 14569030; 21969609; 21818324; ,X-ray crystallography (1),FUNCTION: Condenses 4-methyl-5-(beta-hydroxyethyl)thiazole monophosphate (THZ-P) and 2-methyl-4-amino-5-hydroxymethyl pyrimidine pyrophosphate (HMP-PP) to form thiamine monophosphate (TMP). {ECO:0000269|PubMed:21818324}.,MHESRLASARLYLCTDARRERGDLAQFAEAALAGGVDIIQLRDKGSPGELRFGPLQARDELAACEILADAAHRYGALFAVNDRADIARAAGADVLHLGQRDLPVNVARQILAPDTLIGRSTHDPDQVAAAAAGDADYFCVGPCWPTPTKPGRAAPGLGLVRVAAELGGDDKPWFAIGGINAQRLPAVLDAGARRIVVVRAITSADDPRAAAEQLRSALTAAN,"23,271",222,Thiamine-phosphate synthase family,thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],metal ion binding [GO:0046872]; thiamine-phosphate diphosphorylase activity [GO:0004789],cytoplasm [GO:0005737],,MTCY22G10.11c,1
P9WKS1,Y739_MYCTU,Rv0739,Rv0739 MTV041.13,GO:0005886,IPR019710; ,,,,Uncharacterized protein Rv0739,plasma membrane [GO:0005886],9634230,,,MVLTRRAREVALTQHIGVSAETDRAVVPKLRQAYDSLVCGRRRLGAIGAEIENAVAHQRALGLDTPAGARNFSRFLATKAHDITRVLAATAAESQAGAARLRSLASSYQAVGFGPKPQEPPPDPVPFPPYQPKVWAACRARGQDPDKVVRTFHHAPMSARFRSLPAGDSVLYCGNDKYGLLHIQAKHGRQWHDIADARWPSAGNWRYLADYAIGATLAYPERVEYNQDNDTFAVYRRMSLPDGRYVFTTRVIISARDGKIITAFPQTT,"29,608",268,,,,plasma membrane [GO:0005886],,MTV041.13,1
P9WJ01,Y480_MYCTU,Rv0480c,Rv0480c MTCY20G9.06c,GO:0005618; GO:0006807; GO:0016787,IPR003010; IPR036526; IPR001110; ,,,DOMAIN 1 251 CN hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00054}.,Hydrolase Rv0480c (EC 3.5.-.-),cell wall [GO:0005618]; hydrolase activity [GO:0016787]; nitrogen compound metabolic process [GO:0006807],9634230; 21969609,,,MRIALAQIRSGTDPAANLQLVGKYAGEAATAGAQLVVFPEATMCRLGVPLRQVAEPVDGPWANGVRRIATEAGITVIAGMFTPTGDGRVTNTLIAAGPGTPNQPDAHYHKIHLYDAFGFTESRTVAPGREPVVVVVDGVRVGLTVCYDIRFPALYTELARRGAQLIAVCASWGSGPGKLEQWTLLARARALDSMSYVAAAGQADPGDARTGVGASSAAPTGVGGSLVASPLGEVVVSAGTQPQLLVADIDVDNVAAARDRIAVLRNQTDFVQIDKAQSRG,"28,995",280,"Carbon-nitrogen hydrolase superfamily, NIT1/NIT2 family",nitrogen compound metabolic process [GO:0006807],hydrolase activity [GO:0016787],cell wall [GO:0005618],,MTCY20G9.06c,1
P9WKV1,Y485_MYCTU,Rv0485,Rv0485 MTCY20G9.11,GO:0003677; GO:0006351; GO:0006355; GO:0009405; GO:0010468,IPR000600; IPR036388; IPR036390; ,,,,Transcriptional regulator Rv0485,"DNA binding [GO:0003677]; pathogenesis [GO:0009405]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19651861; 21969609,,FUNCTION: Positively regulates the expression of PE13 and PPE18. Can also regulate expression of some other genes. Plays a role in modulation of innate immune responses. {ECO:0000269|PubMed:19651861}.,MYSTNRTSQSLSRKPGRKHQLRSHRYVMPPSLHLSDSAAASVFRAVRLRGPVGRDVIAGSTSLSIATVNRQVIALLEAGLLRERADLAVSGAIGRPRVPVEVNHEPFVTLGIHIGARTTSIVATDLFGRTLDTVETPTPRNAAGAALTSLADSADRYLQRWRRRRALWVGVTLGGAVDSATGHVDHPRLGWRQAPVGPVLADALGLPVSVASHVDAMAGAELMLGMRRFAPSSSTSLYVYARETVGYALMIGGRVHCPASGPGTIAPLPVHSEMLGGTGQLESTVSDEAVLAAARRLRIIPGIASRTRTGGSATAITDLLRVARAGNQQAKELLAERARVLGGAVALLRDLLNPDEVVVGGQAFTEYPEAMEQVEAAFTAGSVLAPRDIRVTVFGNRVQEAGAGIVSLSGLYADPLGALRRSGALDARLQDTAPEALA,"46,099",438,ROK (NagC/XylR) family,"pathogenesis [GO:0009405]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,MTCY20G9.11,1
P9WK33,Y488_MYCTU,Rv0488,Rv0488 MTCY20G9.14,GO:0005886; GO:0015181; GO:0016021; GO:1902023,IPR001123; IPR004777; ,,,,Putative amino-acid transporter Rv0488,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transport [GO:1902023],9634230,,,MMTLKVAIGPQNAFVLRQGIRREYVLVIVALCGIADGALIAAGVGGFAALIHAHPNMTLVARFGGAAFLIGYALLAARNAWRPSGLVPSESGPAALIGVVQMCLVVTFLNPHVYLDTVVLIGALANEESDLRWFFGAGAWAASVVWFAVLGFSAGRLQPFFATPAAWRILDALVAVTMIGVAVVVLVTSPSVPTANVALII,"20,951",201,LysE/ArgO transporter (TC 2.A.75) family,L-arginine transport [GO:1902023],arginine transmembrane transporter activity [GO:0015181],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20G9.14,1
P9WKU7,Y493_MYCTU,Rv0493c,Rv0493c MTCY20G9.19c,,,,,,Uncharacterized protein Rv0493c,,9634230; 21969609,,,MGESTTQPAGGAAVDDETRSAALPRWRGAAGRLEVWYATLSDPLTRTGLWVHCETVAPTTGGPYAHGWVTWFPPDAPPGTERFGPQPAQPAAGPAWFDIAGVRMAPAELTGRTRSLAWELSWKDTAAPLWTFPRVAWERELLPGAQVVIAPTAVFAGSLAVGETTHRVDSWRGSVAHIYGHGNAKRWGWIHADLGDGDVLEVVTAVSHKPGLRRLAPLAFVRFRIDGKDWPASPLPSLRMRTTLGVRHWQLEGRIGGREALIRVDQPPERCVSLGYTDPDGAKAVCTNTEQADIHIELGGRHWSVLGTGHAEVGLRGTAAPAIKEGTPA,"35,427",329,,,,,,MTCY20G9.19c,1
P9WMG7,Y494_MYCTU,Rv0494,Rv0494 MTCY20G9.20,GO:0003677; GO:0003700; GO:0006351,IPR011711; IPR008920; IPR000524; IPR036388; IPR036390; ,,,DOMAIN 17 85 HTH gntR-type. {ECO:0000255|PROSITE-ProRule:PRU00307}.,Uncharacterized HTH-type transcriptional regulator Rv0494,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MVEPMNQSSVFQPPDRQRVDERIATTIADAILDGVFPPGSTLPPERDLAERLGVNRTSLRQGLARLQQMGLIEVRHGSGSVVRDPEGLTHPAVVEALVRKLGPDFLVELLEIRAALGPLIGRLAAARSTPEDAEALCAALEVVQQADTAAARQAADLAYFRVLIHSTRNRALGLLYRWVEHAFGGREHALTGAYDDADPVLTDLRAINGAVLAGDPAAAAATVEAYLNASALRMVKSYRDRA,"26,015",242,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTCY20G9.20,1
P9WKU3,Y497_MYCTU,Rv0497,Rv0497 MTCY20G9.23,GO:0005618; GO:0005886; GO:0016021; GO:0044119,,,,,Uncharacterized protein Rv0497,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MTGPHPETESSGNRQISVAELLARQGVTGAPARRRRRRRGDSDAITVAELTGEIPIIRDDHHHAGPDAHASQSPAANGRVQVGEAAPQSPAEPVAEQVAEEPTRTVYWSQPEPRWPKSPPQDRRESGPELSEYPRPLRHTHSDRAPAGPPSGAEHMSPDPVEHYPDLWVDVLDTEVGEAEAETEVREAQPGRGERHAAAAAAGTDVEGDGAAEARVARRALDVVPTLWRGALVVLQSILAVAFGAGLFIAFDQLWRWNSIVALVLSVMVILGLVVSVRAVRKTEDIASTLIAVAVGALITLGPLALLQSG,"33,092",310,,growth of symbiont in host cell [GO:0044119],,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20G9.23,1
P9WKU1,Y498_MYCTU,Rv0498,Rv0498 MTCY20G9.24,,IPR036237; IPR013022; ,,,,Uncharacterized protein Rv0498,,9634230; 21969609,,,MRPAIKVGLSTASVYPLRAEAAFEYADRLGYDGVELMVWGESVSQDIDAVRKLSRRYRVPVLSVHAPCLLISQRVWGANPILKLDRSVRAAEQLGAQTVVVHPPFRWQRRYAEGFSDQVAALEAASTVMVAVENMFPFRADRFFGAGQSRERMRKRGGGPGPAISAFAPSYDPLDGNHAHYTLDLSHTATAGTDSLDMARRMGPGLVHLHLCDGSGLPADEHLVPGRGTQPTAEVCQMLAGSGFVGHVVLEVSTSSARSANERESMLAESLQFARTHLLR,"30,466",280,,,,,,MTCY20G9.24,1
P9WKT5,Y500B_MYCTU,Rv0500B,Rv0500B,,IPR013177; ,,,,Uncharacterized protein Rv0500B,,9634230; 12368430,,,MGSVIKKRRKRMSKKKHRKLLRRTRVQRRKLGK,"4,145",33,,,,,,,1
P9WKT3,Y501_MYCTU,Rv0501,Rv0501 MTCY20G9.28,GO:0003824; GO:0005576; GO:0005829; GO:0005886; GO:0050662,IPR001509; IPR036291; ,,,,Uncharacterized protein Rv0501,cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],9634230; 21969609,,,MSSSNGRGGAGGVGGSSEHPQYPKVVLVTGACRFLGGYLTARLAQNPLINRVIAVDAIAPSKDMLRRMGRAEFVRADIRNPFIAKVIRNGEVDTVVHAAAASYAPRSGGSAALKELNVMGAMQLFAACQKAPSVRRVVLKSTSEVYGSSPHDPVMFTEDSSSRRPFSQGFPKDSLDIEGYVRALGRRRPDIAVTILRLANMIGPAMDTTLSRYLAGPLVPTIFGRDARLQLLHEQDALGALERAAMAGKAGTFNIGADGILMLSQAIRRAGRIPVPVPGFGVWALDSLRRANHYTELNREQFAYLSYGRVMDTTRMRVELGYQPKWTTVEAFDDYFRGRGLTPIIDPHRVRSWEGRAVGLAQRWGSRNPIPWSGLR,"41,064",376,NAD(P)-dependent epimerase/dehydratase family,,catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY20G9.28,1
P9WFK3,Y504_MYCTU,Rv0504c,Rv0504c MTCY20G9.31c,GO:0005618; GO:0005886,IPR029069; IPR016709; ,,,DOMAIN 8 131 MaoC-like.,UPF0336 protein Rv0504c,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MTVPEEAQTLIGKHYRAPDHFLVGREKIREFAVAVKDDHPTHYSEPDAAAAGYPALVAPLTFLAIAGRRVQLEIFTKFNIPINIARVFHRDQKFRFHRPILANDKLYFDTYLDSVIESHGTVLAEIRSEVTDAEGKPVVTSVVTMLGEAAHHEADADATVAAIASI,"18,360",166,UPF0336 family,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY20G9.31c,1
P9WKS9,Y508_MYCTU,Rv0508,Rv0508 MTCY20G9.35,GO:0005886,IPR008554; IPR036249; ,,,,Uncharacterized protein Rv0508,plasma membrane [GO:0005886],9634230; 21969609,,,MSRPQVELLTRAGCAICVRVAEQLAELSSELGFDMMTIDVDVAASTGNPGLRAEFGDRLPVVLLDGREHSYWEVDEHRLRADIARSTFGSPPDKRLP,"10,710",97,,,,plasma membrane [GO:0005886],,MTCY20G9.35,1
P9WKL3,Y559_MYCTU,Rv0559c,Rv0559c,GO:0005576; GO:0005618,IPR007969; ,,,,Uncharacterized protein Rv0559c,cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 16175359; 21969609; 22485172,,,MKGTKLAVVVGMTVAAVSLAAPAQADDYDAPFNNTIHRFGIYGPQDYNAWLAKISCERLSRGVDGDAYKSATFLQRNLPRGTTQGQAFQFLGAAIDHYCPEHVGVLQRAGTR,"12,117",112,,,,cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WKL5,Y560_MYCTU,Rv0560c,Rv0560c,GO:0001666; GO:0005829; GO:0008757; GO:0009751; GO:0010106; GO:0032259,IPR025714; IPR029063; ,,,,Uncharacterized protein Rv0560c,cytosol [GO:0005829]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to iron ion starvation [GO:0010106]; methylation [GO:0032259]; response to hypoxia [GO:0001666]; response to salicylic acid [GO:0009751],9634230; 15528667; 15644891; 16175359; 21969609; 22485172,,,MSTVLTYIRAVDIYEHMTESLDLEFESAYRGESVAFGEGVRPPWSIGEPQPELAALIVQGKFRGDVLDVGCGEAAISLALAERGHTTVGLDLSPAAVELARHEAAKRGLANASFEVADASSFTGYDGRFDTIVDSTLFHSMPVESREGYLQSIVRAAAPGASYFVLVFDRAAIPEGPINAVTEDELRAAVSKYWIIDEIKPARLYARFPAGFAGMPALLDIREEPNGLQSIGGWLLSAHLG,"25,945",241,,cellular response to iron ion starvation [GO:0010106]; methylation [GO:0032259]; response to hypoxia [GO:0001666]; response to salicylic acid [GO:0009751],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytosol [GO:0005829],,,1
P9WFS5,Y625_MYCTU,Rv0625c,Rv0625c MTCY20H10.06c,GO:0005886; GO:0016021,IPR032816; IPR015414; ,,,,TVP38/TMEM64 family membrane protein Rv0625c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSTHNDSAPTSRRRHIVRLVVFAGFLVGMFYLVAATDVIDVAAVRGAVSATGPAAPLTYVVVSAVLGALFVPGPILAASSGLLFGPLVGVFVTLGATVGTAVVASLVGRRAGRASARALLGGERADRTDALIERCGLWAVVGQRFVPGISDAFASYAFGTFGVPLWQMAVGAFIGSAPRAFAYTALGAAIGDRSPLLASCAIAVWCVTAIIGAFAARHGYRQWRAHARGDGADGGVEDPDREVGAR,"25,212",246,TVP38/TMEM64 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20H10.06c,1
P9WMD9,Y472_MYCTU,Rv0472c,Rv0472c,GO:0003677; GO:0003700; GO:0005576; GO:0006351; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 24 83 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv0472c,"extracellular region [GO:0005576]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,,MAERIPAVTVKTDGRKRRWHQHKVERRNELVDGTIEAIRRHGRFLSMDEIAAEIGVSKTVLYRYFVDKNDLTTAVMMRFTQTTLIPNMIAALSADMDGFELTREIIRVYVETVAAQPEPYRFVMANSSASKSKVIADSERIIARMLAVMLRRRMQEAGMDTGGVEPWAYLIVGGVQLATHSWMSDPRMSSDELIDYLTMLSWSALCGIVEAGGSLEKFREQPHPSPIVPAWGQV,"26,418",234,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],extracellular region [GO:0005576],,,1
P9WMD7,Y767_MYCTU,Rv0767c,Rv0767c MTCY369.12c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR023772; IPR009057; IPR001647; ,,,DOMAIN 29 89 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv0767c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSSDVLVTTPAQRQTEPHAEAVSRNRRQQATFRKVLAAAMATLREKSYADLTVRLVAARAKVAPATAYTYFSSKNHLIAEVYLDLVRQVPCVTDVNVPMPIRVTSSLRHLALVVADEPEIGAACTAALLDGGADPAVRAVRDRIGAEIHRRITSAIGPGADPGTVFALEMAFFGALVQAGSGTFTYHEIADRLGYVVGLILAGANEPSTGGSE,"22,572",213,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY369.12c,1
P9WKW3,Y441_MYCTU,Rv0441c,Rv0441c MTV037.05c,,IPR020145; ,,,,Uncharacterized protein Rv0441c,,3029018; 9634230; 21969609,,,MGAKKVDLKRLAAALPDYPFAYLITVDDGHRVHTVAVEPVLRELPDGPDGPRAVVDVGLIGGRTRQNLAHRSEVTLLWPPSDPSGYSLIVDGRAQASDAGPDDDTARCGVVPIRALLHRDAAPDSPTAAKGCLHDCVVFSVP,"15,036",142,,,,,,MTV037.05c,1
P9WMH9,Y474_MYCTU,Rv0474,Rv0474,GO:0005618; GO:0005829; GO:0006351; GO:0006355; GO:0043565,IPR001387; IPR010982; ,,,DOMAIN 26 80 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Uncharacterized HTH-type transcriptional regulator Rv0474,"cell wall [GO:0005618]; cytosol [GO:0005829]; sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,,MSSEEKLAAKVSTKASDVASDIGSFIRSQRETAHVSMRQLAERSGVSNPYLSQVERGLRKPSADVLSQIAKALRVSAEVLYVRAGILEPSETSQVRDAIITDTAITERQKQILLDIYASFTHQNEATREECPSDPTPTDD,"15,364",140,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",sequence-specific DNA binding [GO:0043565],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
P9WGR5,Y484_MYCTU,Rv0484c,Rv0484c MTCY20G9.10c,GO:0005886; GO:0016491,IPR036291; IPR002347; ,,,,Uncharacterized oxidoreductase Rv0484c (EC 1.-.-.-),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTTIGTRKRVAVVTGASSGIGEATARTLAAQGFHVVAVARRADRITALANQIGGTAIVADVTDDAAVEALARALSRVDVLVNNAGGAKGLQFVADADLEHWRWMWDTNVLGTLRVTRALLPKLIDSGDGLIVTVTSIAAIEVYDGGAGYTAAKHAQGALHRTLRGELLGKPVRLTEIAPGAVETEFSLVRFDGDQQRADAVYAGMTPLVAADVAEVIGFVATRPSHVNLDQIVIRPRDQASASRRATHPVR,"26,416",251,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,MTCY20G9.10c,1
P9WKT9,Y499_MYCTU,Rv0499,Rv0499 MTCY20G9.25,GO:0016301,IPR001206; IPR029069; ,,,DOMAIN 68 205 DAGKc. {ECO:0000255|PROSITE-ProRule:PRU00783}.,Uncharacterized protein Rv0499,kinase activity [GO:0016301],9634230; 21969609,,,MNALFTTAMALRPLDSDPGNPACRVFEGELNEHWTIGPKVHGGAMVALCANAARTAYGAAGQQPMRQPVAVSASFLWAPDPGTMRLVTSIRKRGRRISVADVELTQGGRTAVHAVVTLGEPEHFLPGVDGSGGASGTAPLLSANPVVELMAPEPPEGVVPIGPGHQLAGLVHLGEGCDVRPVLSTLRSATDGRPPVIQLWARPRGVAPDALFALLCGDLSAPVTFAVDRTGWAPTVALTAYLRALPADGWLRVLCTCVEIGQDWFDEDHIVVDRLGRIVVQTRQLAMVPAQ,"30,670",291,,,kinase activity [GO:0016301],,,MTCY20G9.25,1
P9WKT1,Y502_MYCTU,Rv0502,Rv0502 MTCY20G9.29,GO:0005886; GO:0008152; GO:0016746,IPR016676; IPR002123; ,,,,Uncharacterized protein Rv0502,"plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; metabolic process [GO:0008152]",9634230; 21969609,,,MGNVAGETRANVIPLHTNRSRVAARRRAGQRAESRQHPSLLSDPNDRASAEQIAAVVREIDEHRRAAGATTSSTEATPNDLAQLVAAVAGFLRQRLTGDYSVDEFGFDPHFNSAIVRPLLRFFFKSWFRVEVSGVENIPRDGAALVVANHAGVLPFDGLMLSVAVHDEHPAHRDLRLLAADMVFDLPVIGEAARKAGHTMACTTDAHRLLASGELTAVFPEGYKGLGKRFEDRYRLQRFGRGGFVSAALRTKAPIVPCSIIGSEEIYPMLTDVKLLARLFGLPYFPITPLFPLAGPVGLVPLPSKWRIAFGEPICTADYASTDADDPMVTFELTDQVRETIQQTLYRLLAGRRNIFFG,"39,288",358,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886],,MTCY20G9.29,1
P9WFK1,Y635_MYCTU,Rv0635,Rv0635 MTCY20H10.16,GO:0005886; GO:0019171; GO:0040007,IPR029069; IPR016709; ,P96927,,,UPF0336 protein Rv0635,plasma membrane [GO:0005886]; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (4),,MALSADIVGMHYRYPDHYEVEREKIREYAVAVQNDDAWYFEEDGAAELGYKGLLAPLTFICVFGYKAQAAFFKHANIATAEAQIVQVDQVLKFEKPIVAGDKLYCDVYVDSVREAHGTQIIVTKNIVTNEEGDLVQETYTTLAGRAGEDGEGFSDGAA,"17,481",158,UPF0336 family,growth [GO:0040007],3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171],plasma membrane [GO:0005886],,MTCY20H10.16,1
P9WFI7,Y751_MYCTU,Rv0726c,Rv0726c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0726c (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 12368430; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MTYTGSIRCEGDTWDLASSVGATATMVAAARAMATRAANPLINDQFAEPLVRAVGVDVLTRLASGELTASDIDDPERPNASMVRMAEHHAVRTKFFDEFFMDATRAGIRQVVILASGLDSRAYRLAWPAQTVVYEIDQPQVMEFKTRTLAELGATPTADRRVVTADLRADWPTALGAAGFDPTQPTAWSAEGLLRYLPPEAQDRLLDNVTALSVPDSRFATESIRNFKPHHEERMRERMTILANRWRAYGFDLDMNELVYFGDRNEPASYLSDNGWLLTEIKSQDLLTANGFQPFEDEEVPLPDFFYVSARLQRKHRQYPAHRKPAPSWRHTACPVNELSKSAAYTMTRSDAHQASTTAPPPPGLTG,"40,876",367,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
P9WGQ9,Y769_MYCTU,Rv0769,Rv0769,GO:0005886; GO:0016491,IPR036291; IPR002347; ,,,,Uncharacterized oxidoreductase Rv0769 (EC 1.-.-.-),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MFDSKVAIVTGAAQGIGQAYAQALAREGASVVVADINADGAAAVAKQIVADGGTAIHVPVDVSDEDSAKAMVDRAVGAFGGIDYLVNNAAIYGGMKLDLLLTVPLDYYKKFMSVNHDGVLVCTRAVYKHMAKRGGGAIVNQSSTAAWLYSNFYGLAKVGVNGLTQQLARELGGMKIRINAIAPGPIDTEATRTVTPAELVKNMVQTIPLSRMGTPEDLVGMCLFLLSDSASWITGQIFNVDGGQIIRS,"25,966",248,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
P9WKW1,Y476_MYCTU,Rv0476,Rv0476 MTCY20G9.02,GO:0016021,IPR019662; ,,,,Uncharacterized protein Rv0476,integral component of membrane [GO:0016021],9634230,,,MLVLLVAVLVTAVYAFVHAALQRPDAYTAADKLTKPVWLVILGAAVALASILYPVLGVLGMAMSACASGVYLVDVRPKLLEIQGKSR,"9,166",87,,,,integral component of membrane [GO:0016021],,MTCY20G9.02,1
P9WKV9,Y477_MYCTU,Rv0477,Rv0477 MTCY20G9.03,GO:0005576,IPR019719; ,,,,Uncharacterized protein Rv0477,extracellular region [GO:0005576],9634230; 21969609,,,MKALVAVSAVAVVALLGVSSAQADPEADPGAGEANYGGPPSSPRLVDHTEWAQWGSLPSLRVYPSQVGRTASRRLGMAAADAAWAEVLALSPEADTAGMRAQFICHWQYAEIRQPGKPSWNLEPWRPVVDDSEMLASGCNPGSPEESF,"15,659",148,,,,extracellular region [GO:0005576],,MTCY20G9.03,1
P9WMV7,Y492_MYCTU,Rv0492c,Rv0492c MTCY20G9.18c,GO:0005829; GO:0016614; GO:0050660,IPR036188; IPR000172; IPR007867; ,,,,Uncharacterized GMC-type oxidoreductase Rv0492c (EC 1.1.-.-),"cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MSRLADRAKSYPLASFGAALLPPELGGPLPAQFVQRVDRYVTRLPATSRFAVRAGLASLAAASYLTTGRSLPRLHPDERARVLHRIAALSPEVAAAVEGLKAIVLLANGADTYAHELLARAQEHDAARPDAELTVILSADSPSVTRADAVVVGSGAGGAMVARTLARAGLDVVVLEEGRRWTVEEFRSTHPVDRYAGLYRGAGATVALGRPAVVLPMGRAVGGTTVVNSGTCFRPSLAVQRRWRDEFGLGLADPDQLGRRLDDAEQTLRVAPVPLEIMGRNGRLLLQAAKSLGWRAAPIPRNAPGCRGCCQCAIGCPSNAKFGVHLNALPQACAAGARIISWARVERILHRAGRAYGVRARRPDGTTLDVLADAVVVAAGATETPGLLRRSGLGGHPRLGHNLALHPATMLAGLFDDDVFAWRGVLQSAAVHEFHESDGVLIEATSTPPGMGSMVFPGYGAELLRWLDRAPQIATFGAMVADRGVGTVRSVRGETVVRYDIAPGEIAKLRVALQAIGRLLFAAGAVEVLTGIPGAPPMRSLPELQDVLRRANPRSLHLAAFHPTGTAAAGADEQLCPVDATGRLRGVEGVWVADASILPSCPEVNPQLSIMAMALAVADQTVAKVVGVR,"66,154",629,GMC oxidoreductase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",cytosol [GO:0005829],,MTCY20G9.18c,1
O06391,Y525_MYCTU,Rv0525,Rv0525,GO:0005886; GO:0040007,IPR013078; IPR029033; ,,,,Uncharacterized protein Rv0525,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550; 20066036; 21969609,,,MPEETQVHVVRHGEVHNPTGILYGRLPGFHLSATGAAQAAAVADALADRDIVAVIASPLQRAQETAAPIAARHDLAVETDPDLIESANFFEGRRVGPGDGAWRDPRVWWQLRNPFTPSWGEPYVDIAARMTTAVDKARVRGAGHEVVCVSHQLPVWTLRLYLTGKRLWHDPRRRDCALASVTSLIYDGDRLVDVVYSQPAAL,"22,212",202,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
P9WKS7,Y628_MYCTU,Rv0628c,Rv0628c MTCY20H10.09c,GO:0005886; GO:0016021; GO:0040007,IPR019494; IPR013702; IPR016741; ,,,,Uncharacterized protein Rv0628c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MRIGVGVSTAPDVRRAAAEAAAHAREELAGGTPALAVLLGSRSHTDQAVDLLAAVQASVEPAALIGCVAQGIVAGRHELENEPAVAVWLASGPPAETFHLDFVRTGSGALITGYRFDRTAHDLHLLLPDPYSFPSNLLIEHLNTDLPGTTVVGGVVSGGRRRGDTRLFRDRDVLTSGLVGVRLPGAHSVSVVSQGCRPIGEPYIVTGADGAVITELGGRPPLHRLREIVLGMAPDEQELVSRGLQIGIVVDEHLAVPGQGDFLIRGLLGADPTTGAIGIGEVVEVGATVQFQVRDAAAADKDLRLAVERAAAELPGPPVGGLLFTCNGRGRRMFGVTDHDASTIEDLLGGIPLAGFFAAGEIGPVAGHNALHGFTASMALFVD,"39,606",383,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20H10.09c,1
P9WKS5,Y634A_MYCTU,Rv0634A,Rv0634A,,IPR019239; ,,,,Uncharacterized protein Rv0634A,,9634230; 11500470; 21969609,,,MGSDCGCGGYLWSMLKRVEIEVDDDLIQKVIRRYRVKGAREAVNLALRTLLGEADTAEHGHDDEYDEFSDPNAWVPRRSRDTG,"9,426",83,,,,,,,1
P9WFJ9,Y637_MYCTU,Rv0637,Rv0637 MTCY20H10.18,GO:0005886; GO:0019171; GO:0030497; GO:0042759,IPR029069; IPR016709; ,P96927,,,UPF0336 protein Rv0637,plasma membrane [GO:0005886]; 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; fatty acid elongation [GO:0030497]; long-chain fatty acid biosynthetic process [GO:0042759],9634230; 21969609,,,MALKTDIRGMIWRYPDYFIVGREQCREFARAVKCDHPAFFSEEAAADLGYDALVAPLTFVTILAKYVQLDFFRHVDVGMETMQIVQVDQRFVFHKPVLAGDKLWARMDIHSVDERFGADIVVTRNLCTNDDGELVMEAYTTLMGQQGDGSARLKWDKESGQVIRTA,"18,930",166,UPF0336 family,fatty acid elongation [GO:0030497]; long-chain fatty acid biosynthetic process [GO:0042759],3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171],plasma membrane [GO:0005886],,MTCY20H10.18,1
P9WKS3,Y738_MYCTU,Rv0738,Rv0738,GO:0046872,IPR017517; IPR017520; IPR034660; IPR024344; ,,,,Uncharacterized protein Rv0738,metal ion binding [GO:0046872],9634230; 17259624; 21969609,,,MDPLMAHQRAQDAFAALLANVRADQLGGPTPCSEWTINDLIEHVVGGNEQVGRWAASPIEPPARPDGLVAAHQAAAAVAHEIFAAPGGMSATFKLPLGEVPGQVFIGLRTTDVLTHAWDLAAATGQSTDLDPELAVERLAAARALVGPQFRGPGKPFADEKPCPRERPPADQLAAFLGRTVR,"19,148",182,,,metal ion binding [GO:0046872],,,,1
P9WFI5,Y756_MYCTU,Rv0731c,Rv0731c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0731c (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 12368430; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MTQTGSARFEGDSWDLASSVGLTATMVAAARAVAGRAPGALVNDQFAEPLVRAVGVDFFVRMASGELDPDELAEDEANGLRRFADAMAIRTHYFDNFFLDATRAGIRQAVILASGLDSRAYRLRWPAGTIVFEVDQPQVIDFKTTTLAGLGAAPTTDRRTVAVDLRDDWPTALQKAGFDNAQRTAWIAEGLLGYLSAEAQDRLLDQITAQSVPGSQFATEVLRDINRLNEEELRGRMRRLAERFRRHGLDLDMSGLVYFGDRTDARTYLADHGWRTASASTTDLLAEHGLPPIDGDDAPFGEVIYVSAELKQKHQDTR,"34,950",318,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
P9WNY3,Y770_MYCTU,Rv0770,Rv0770 MTCY369.15,GO:0004616; GO:0051287,IPR002204; IPR008927; IPR013328; IPR006115; IPR015815; IPR036291; IPR029154; ,,,,Uncharacterized oxidoreductase Rv0770 (EC 1.1.-.-),NAD binding [GO:0051287]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],9634230; 21969609,,,MTAHPETPRLGYIGLGNQGAPMAKRLLDWPGGLTVFDVRVEAMAPFVEGGATAAASVSDVAEADIISITVFDDAQVSSVITADNGLATHAKPGTIVAIHSTIADTTAVDLAEKLKPQGIHIVDAPVSGGAAAAAKGELAVMVGADDEAFQRIKEPFSRWASLLIHAGEPGAGTRMKLARNMLTFVSYAAAAEAQRLAEACGLDLVALGKVVRHSDSFTGGAGAIMFRNTTAPMEPADPLRPLLEHTRGLGEKDLSLALALGEVVSVDLPLAQLALQRLAAGLGVPHPDTEPAKET,"30,446",295,3-hydroxyisobutyrate dehydrogenase family,,NAD binding [GO:0051287]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],,,MTCY369.15,1
P9WKV7,Y479_MYCTU,Rv0479c,Rv0479c MTCY20G9.05c,GO:0005886; GO:0005887; GO:0040007,IPR021373; ,,,,Uncharacterized protein Rv0479c,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550; 21969609,,,MTNPQGPPNDPSPWARPGDQGPLARPPASSEASTGRLRPGEPAGHIQEPVSPPTQPEQQPQTEHLAASHAHTRRSGRQAAHQAWDPTGLLAAQEEEPAAVKTKRRARRDPLTVFLVLIIVFSLVLAGLIGGELYARHVANSKVAQAVACVVKDQATASFGVAPLLLWQVATRHFTNISVETAGNQIRDAKGMQIKLTIQNVRLKNTPNSRGTIGALDATITWSSEGIKESVQNAIPILGAFVTSSVVTHPADGTVELKGLLNNITAKPIVAGKGLELQIINFNTLGFSLPKETVQSTLNEFTSSLTKNYPLGIHADSVQVTSTGVVSRFSTRDAAIPTGIQNPCFSHI,"37,048",348,,growth [GO:0040007],,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY20G9.05c,1
P9WKV5,Y481_MYCTU,Rv0481c,Rv0481c MTCY20G9.07c,GO:0005886; GO:0044119,IPR019639; ,,,,Uncharacterized protein Rv0481c,plasma membrane [GO:0005886]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MPRSFDMSADYEGSVEEVHRAFYEADYWKARLAETPVDVATLESIRVGGDSGDDGTIEVVTLQMVRSHNLPGLVTQLHRGDLSVRREETWGPVKEGIATASIAGSIVDAPVNLWGTAVLSPIPESGGSRMTLQVTIQVRIPFIGGKLERLIGTQLSQLVTIEQRFTTLWITNNV,"19,064",174,,growth of symbiont in host cell [GO:0044119],,plasma membrane [GO:0005886],,MTCY20G9.07c,1
P9WKU9,Y487_MYCTU,Rv0487,Rv0487 MTCY20G9.13,,IPR019660; ,,,,Uncharacterized protein Rv0487,,9634230; 21969609,,,MTSSLPTVQRVIQNALEVSQLKYSQHPRPGGAPPALIVELPGERKLKINTILSVGEHSVRVEAFVCRKPDENREDVYRFLLRRNRRLYGVAYTLDNVGDIYLVGQMALSAVDADEVDRVLGQVLEVVDSDFNALLELGFRSSIQREWQWRLSRGESLQNLQAFAHLRPTTMQSAQRDEKELGG,"20,717",183,,,,,,MTCY20G9.13,1
P9WKU5,Y495_MYCTU,Rv0495c,Rv0495c MTCY20G9.21c,,,,,,Uncharacterized protein Rv0495c,,9634230; 21969609,,,MWRPAQGARWHVPAVLGYGGIPRRASWSNVESVANSRRRPVHPGQEVELDFAREWVEFYDPDNPEHLIAADLTWLLSRWACVFGTPACQGTVAGRPNDGCCSHGAFLSDDDDRTRLADAVHKLTDDDWQFRAKGLRRKGYLELDEHDGQPQHRTRKHKGACIFLNRPGFAGGAGCALHSKALKLGVPPLTMKPDVCWQLPIRRSQEWVTRPDGTEILKTTLTEYDRRGWGSGGADLHWYCTGDPAAHVGTKQVWQSLADELTELLGEKAYGELAAMCKRRSQLGLIAVHPATRAAQ,"32,992",296,,,,,,MTCY20G9.21c,1
P9WMY1,Y539_MYCTU,Rv0539,Rv0539 MTCY25D10.18,GO:0016757,IPR001173; IPR029044; ,,,,Uncharacterized glycosyltransferase Rv0539 (EC 2.4.-.-),"transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 21969609,,,MAGDAVTVVLPCLNEEESLPAVLAAIPAGYRALVVDNNSTDDTATVAARHGAQVVVEPRPGYGSAVHAGVLAATTPIVAVIDADGSMDAGDLPKLVAELDKGADLVTGRRRPVAGLHWPWVARVGTVVMSWRLRTRHRLPVHDIAPMRVARREALLDLGVVDRRSGYPLELLVRAAAAGWRVVELDVSYGPRTGGKSKVSGSLRGSIIAILDFWKVIS,"23,117",218,Glycosyltransferase 2 family,,"transferase activity, transferring glycosyl groups [GO:0016757]",,,MTCY25D10.18,1
P9WHK1,Y0571_MYCTU,Rv0571c,Rv0571c,GO:0005618; GO:0005829; GO:0009116; GO:0016740; GO:0016787,IPR029058; IPR002925; IPR000836; IPR029057; ,,,,Putative phosphoribosyl transferase Rv0571c,cell wall [GO:0005618]; cytosol [GO:0005829]; hydrolase activity [GO:0016787]; transferase activity [GO:0016740]; nucleoside metabolic process [GO:0009116],9634230; 12953092; 18400743; 21969609,,,MKLFDDRGDAGRQLAQRLAQLSGKAVVVLGLPRGGVPVAFEVAKSLQAPLDVLVVRKLGVPFQPELAFGAIGEDGVRVLNDDVVRGTHLDAAAMDAVERKQLIELQRRAERFRRGRDRIPLTGRIAVIVDDGIATGATAKAACQVARAHGADKVVLAVPIGPDDIVARFAGYADEVVCLATPALFFAVGQGYRNFTQTSDDEVVAFLDRAHRDFAEAGAIDAAADPPLRDEEVQVVAGPVPVAGHLTVPEKPRGIVVFAHGSGSSRHSIRNRYVAEVLTGAGFATLLFDLLTPEEERNRANVFDIELLASRLIDVTGWLATQPDTASLPVGYFGASTGAGAALVAAADPRVNVRAVVSRGGRPDLAGDSLGSVVAPTLLIVGGRDQVVLELNQRAQAVIPGKCQLTVVPGATHLFEEPGTLEQVAKLACDWFIDHLCGPGPSG,"46,655",443,Purine/pyrimidine phosphoribosyltransferase family; Dienelactone hydrolase family,nucleoside metabolic process [GO:0009116],hydrolase activity [GO:0016787]; transferase activity [GO:0016740],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
P9WM79,Y0574_MYCTU,Rv0574c,Rv0574c,,IPR019079; ,,,,Probable polyglutamine synthesis accessory protein Rv0574c,,9634230; 11416222; 12953092; 18474359; 18400743; 21969609; 25312955,,"FUNCTION: Could be involved in the biosynthesis, transport or localization of poly-alpha-L-glutamine (PLG), a cell wall component. Contributes to stress tolerance and virulence. {ECO:0000269|PubMed:25312955}.",MAGNPDVVTVLLGGDVMLGRGVDQILPHPGKPQLRERYMRDATGYVRLAERVNGRIPLPVDWRWPWGEALAVLENTATDVCLINLETTITADGEFADRKPVCYRMHPDNVPALTALRPHVCALANNHILDFGYQGLTDTVAALAGAGIQSVGAGADLLAARRSALVTVGHERRVIVGSVAAESSGVPESWAARRDRPGVWLIRDPAQRDVADDVAAQVLADKRPGDIAIVSMHWGSNWGYATAPGDVAFAHRLIDAGIDMVHGHSSHHPRPIEIYRGKPILYGCGDVVDDYEGIGGHESFRSELRLLYLTVTDPASGNLISLQMLPLRVSRMRLQRASQTDTEWLRNTIERISRRFGIRVVTRPDNLLEVVPAANLTSKE,"41,547",380,CapA family,,,,,,1
P9WFB5,VAPC6_MYCTU,Rv0656c,vapC6 Rv0656c,GO:0004540; GO:0046872,IPR022907,,vapC6,DOMAIN 26 120 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC6 (RNase VapC6) (EC 3.1.-.-) (Toxin VapC6),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB6 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MAAATTTGTHRGLELRAAQRAVGSCEPQRAEFCRSARNADEFDQMSRMFGDVYPDVPVPKSVWRWIDSAQHRLARAGAVGALSVVDLLICDTAAARGLVVLHDDADYELAERHLPDIRVRRVVSADD,"13,960",127,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WJ39,VPB28_MYCTU,Rv0608,vapB28 Rv0608,GO:0045927,IPR011660; ,,vapB28,,Antitoxin VapB28,positive regulation of growth [GO:0045927],9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC28. {ECO:0000269|PubMed:20011113}.,MALNIKDPSVHQAVKQIAKITGESQARAVATAVNERLARLRSDDLAARLLAIGHKTASRMSPEAKRLDHDALLYDERGLPA,"8,813",81,,positive regulation of growth [GO:0045927],,,,,1
P9WJ35,VPB30_MYCTU,Rv0623,vapB30 Rv0623,GO:0045927,IPR011660; ,,vapB30,,Antitoxin VapB30,positive regulation of growth [GO:0045927],9634230; 20011113; 21969609,X-ray crystallography (2),FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC30. {ECO:0000269|PubMed:20011113}.,MALSIKHPEADRLARALAARTGETLTEAVVTALRERLARETGRARVVPLRDELAAIRHRCAALPVVDNRSAEAILGYDERGLPA,"9,140",84,,positive regulation of growth [GO:0045927],,,,,1
P9WFB3,VAPC7_MYCTU,Rv0661c,vapC7 Rv0661c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC7,DOMAIN 2 129 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC7 (RNase VapC7) (EC 3.1.-.-) (Toxin VapC7),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB7 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIVLDTTVLVYAKGAEHPLRDPCRDLVAAIADERIAATTTAEVIQEFVHVRARRRDRSDAAALGRVTMPNCSRRYSPSIEATSKRGLTLFETTPGLEACDAVLAAVAASAGATALVSADPAFADLSDVVHVIPDAAGMVSLLGDR,"15,245",145,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WJI7,PNCB2_MYCTU,Rv0573c,pncB2 Rv0573c,GO:0001666; GO:0004514; GO:0004516; GO:0005886; GO:0009435; GO:0019358; GO:0034355; GO:0047280; GO:0075136,IPR013785; IPR007229; IPR006405; IPR036068; ,,pncB2,,Nicotinate phosphoribosyltransferase pncB2 (NAPRTase pncB2) (EC 6.3.4.21),plasma membrane [GO:0005886]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to host [GO:0075136]; response to hypoxia [GO:0001666],9634230; 12953092; 18474359; 18400743; 18490451; 21969609,,"FUNCTION: Involved in the Preiss-Handler pathway, which is a recycling route that permits the salvage of free nicotinamide (NM) and nicotinic acid (Na) involved in the NAD biosynthesis. Catalyzes the synthesis of beta-nicotinate D-ribonucleotide from nicotinate and 5-phospho-D-ribose 1-phosphate at the expense of ATP. It is not able to use nicotinamide. PncB2 appears to be responsible for the increased salvage synthesis of NAD during infection of host tissues. {ECO:0000269|PubMed:18490451}.",MAIRQHVGALFTDLYEVTMAQAYWAERMSGTAVFEIFFRKLPPGRSYIMAAGLADVVEFLEAFRFDEQDLRYLRGLGQFSDEFLRWLAGVRFTGDVWAAPEGTVIFPNEPAVQLIAPIIEAQLVETFVLNQIHLQSVLASKAARVVAAARGRPVVDFGARRAHGTDAACKVARTSYLAGAAGTSNLLAARQYGIPTFGTMAHSFVQAFDSEVAAFEAFARLYPATMLLVDTYDTLRGVDHVIELAKRLGNRFDVRAVRLDSGDLDELSKATRARLDTAGLEQVEIFASSGLDENRIAALLAARCPIDGFGVGTQLVVAQDAPALDMAYKLVAYDGSGRTKFSSGKVIYPGRKQVFRKLEHGVFCGDTLGEHGENLPGDPLLVPIMTNGRRIRQHAPTLDGARDWARQQIDALPPELRSLEDTGYSYPVAVSDRIVGELARLRHADTAEAHPGSNVVGAKAKRP,"50,509",463,NAPRTase family,NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to host [GO:0075136]; response to hypoxia [GO:0001666],nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516],plasma membrane [GO:0005886],,,1
P9WI41,PPE10_MYCTU,Rv0442c,PPE10 Rv0442c MTV037.06c,GO:0042783,IPR002989; IPR000030; IPR038332; ,,PPE10,,Uncharacterized PPE family protein PPE10,active evasion of host immune response [GO:0042783],3029018; 9634230; 21969609,,,MTSPHFAWLPPEINSALMFAGPGSGPLIAAATAWGELAEELLASIASLGSVTSELTSGAWLGPSAAAMMAVATQYLAWLSTAAAQAEQAAAQAMAIATAFEAALAATVQPAVVAANRGLMQLLAATNWFGQNAPALMDVEAAYEQMWALDVAAMAGYHFDASAAVAQLAPWQQVLRNLGIDIGKNGQINLGFGNTGSGNIGNNNIGNNNIGSGNTGTGNIGSGNTGSGNLGLGNLGDGNIGFGNTGSGNIGFGITGDHQMGFGGFNSGSGNIGFGNSGTGNVGLFNSGSGNIGIGNSGSLNSGIGTSGTINAGLGSAGSLNTSFWNAGMQNAALGSAAGSEAALVSSAGYATGGMSTAALSSGILASALGSTGGLQHGLANVLNSGLTNTPVAAPASAPVGGLDSGNPNPGSGSAAAGSGANPGLRSPGTSYPSFVNSGSNDSGLRNTAVREPSTPGSGIPKSNFYPSPDRESAYASPRIGQPVGSE,"47,247",487,Mycobacterial PPE family,active evasion of host immune response [GO:0042783],,,,MTV037.06c,1
P9WI37,PPE12_MYCTU,Rv0755c,PPE12 Rv0755c,GO:0040007,IPR002989; IPR000030; IPR038332; ,,PPE12,,Uncharacterized PPE family protein PPE12,growth [GO:0040007],9634230; 19099550,,,MVGFAWLPPETNSLRMYLGAGSRPLLAAAGAWDGLAEELHAAASSFGSVTSELAGGAWQGPASAAMANAAGPYASWLTAAGAQAELAARQARAAAGAFEEALAGVVHPAVVQANRVRTWLLAVSNVFGQNAPAIAAMESTYEQMWAQDVAVMAGYHAASSAAAAQLASWQPALPNINLGVGNIGNLNVGNGNTGDYNLGNGNLGNANFGGGNGSAFHGQISSFNVGSGNIGNFNLGSGNGNVGIGPSSFNVGSGNIGNANVGGGNSGDNNFGFGNFGNANIGIGNAGPNMSSPAVPTPGNGNVGIGNGGNGNFGGGNTGNANIGLGNVGDGNVGFGNSGSYNFGFGNTGNNNIGIGLTGSNQIGFGGLNSGSGNIGFGNSGTGNIGFFNSGSGNFGVGNSGVTNTGVANSGNINTGFGNSGFINTGFGNALSVNTGFGNSGQANTGIGNAGDFNTGNFNGGIINTGSFNSGAFNSGSFNGGDANSGFLNSGLTNTGFANSGNINTGGFNAGNLNTGFGNTTDGLGENSGFGNAGSGNSGFNNSGRGNSGAQNVGNLQISGFANSGQSVTGYNNSVSVTSGFGNKGTGLFSGFMSGFGNTGFLQSGFGNLEANPDNNSATSGFGNSGKQDSGGFNSIDFVSGFFHR,"62,693",645,Mycobacterial PPE family,growth [GO:0040007],,,,,1
P9WI39,PPE11_MYCTU,Rv0453,PPE11 Rv0453,GO:0005576; GO:0005829,IPR000030; IPR038332; ,,PPE11,,Uncharacterized PPE family protein PPE11,cytosol [GO:0005829]; extracellular region [GO:0005576],9634230,,,MTSALIWMASPPEVHSALLSSGPGPGPVLAAATGWSSLGREYAAVAEELGALLAAVQAGVWQGPSAESFAAACLPYLSWLTQASADCAAAAARLEAVTAAYAAALVAMPTLAELAANHATHGAMVATNFFGINTIPIAVNEADYVRMWLQAATTMATYQAVADSAVRSIPDSVPPPRILKSNAQSQHSSSNNSGGADPVDDFIAEILKIITGGRVIWDPEAGTVNGLPYDAYTNPGTLMWWIARSLELLQDFQEFAKLLFTNPVKAFQFLVDLILFDWPTHMLQLATWLAENPQLLVAALTPAISGLGAVSGLAGLTGLVPQPPVVPAPAPDAVVPTVLPLAGTATPTTAPASAPAAGAAPGPPAGTATATSASVPTSAGGFPPYLVGSGPGIDFDAGTPAGSRRAQPAADNVTAVAAAQVSARHQARRRRRAAAKERGNADEFVDMDSGPAIPPSGERDAWASNSGVGGLGFAGTASNETVAAPAGLTTLADDEFQCGPRMPMLPGAWDLGTWDRGD,"52,837",518,Mycobacterial PPE family,,,cytosol [GO:0005829]; extracellular region [GO:0005576],,,1
P9WIA7,PIT_MYCTU,Rv0545c,pit pitA Rv0545c MTCY25D10.24c,GO:0005315; GO:0005887; GO:0035435,IPR001204; ,,pit,,Probable low-affinity inorganic phosphate transporter,integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435],9634230; 19099550,,FUNCTION: Low-affinity inorganic phosphate transport. {ECO:0000250}.,MNLQLFLLLIVVVTALAFDFTNGFHDTGNAMATSIASGALAPRVAVALPAVLNLIGAFLSTAVAATIAKGLIDANLVTLELVFAGLVGGIVWNLLTWLLGIPSSSSHALIGGIVGATIAAVGLRGVIWSGVVSKVIVPAVVAALLATLVGAVGTWLVYRTTRGVAEKRTERGFRRGQIGSASLVSLAHGTNDAQKTMGVIFLALMSYGAVSTTASVPPLWVIVSCAVAMAAGTYLGGWRIIRTLGKGLVEIKPPQGMAAESSSAAVILLSAHFGYALSTTQVATGSVLGSGVGKPGAEVRWGVAGRMVVAWLVTLPLAGLVGAFTYGLVHFIGGYPGAILGFALLWLTATAIWLRSRRAPIDHTNVNADWEGNLTAGLEAGAQPLADQRPPVPAPPAPTPPPNHRAPQFGVTTRNAP,"42,745",417,"Inorganic phosphate transporter (PiT) (TC 2.A.20) family, Pit subfamily",phosphate ion transmembrane transport [GO:0035435],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of plasma membrane [GO:0005887],pitA,MTCY25D10.24c,1
P9WJL9,MURB_MYCTU,Rv0482,murB Rv0482 MTCY20G9.08,GO:0005737; GO:0007049; GO:0008360; GO:0008762; GO:0009252; GO:0050660; GO:0051301; GO:0071555,IPR016166; IPR036318; IPR016167; IPR003170; IPR011601; IPR036635; IPR006094; ,,murB,DOMAIN 29 202 FAD-binding PCMH-type.,UDP-N-acetylenolpyruvoylglucosamine reductase (EC 1.3.1.98) (UDP-N-acetylmuramate dehydrogenase),cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; UDP-N-acetylmuramate dehydrogenase activity [GO:0008762]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 21969609,X-ray crystallography (1),FUNCTION: Cell wall formation. {ECO:0000250}.,MKRSGVGSLFAGAHIAEAVPLAPLTTLRVGPIARRVITCTSAEQVVAALRHLDSAAKTGADRPLVFAGGSNLVIAENLTDLTVVRLANSGITIDGNLVRAEAGAVFDDVVVRAIEQGLGGLECLSGIPGSAGATPVQNVGAYGAEVSDTITRVRLLDRCTGEVRWVSARDLRFGYRTSVLKHADGLAVPTVVLEVEFALDPSGRSAPLRYGELIAALNATSGERADPQAVREAVLALRARKGMVLDPTDHDTWSVGSFFTNPVVTQDVYERLAGDAATRKDGPVPHYPAPDGVKLAAGWLVERAGFGKGYPDAGAAPCRLSTKHALALTNRGGATAEDVVTLARAVRDGVHDVFGITLKPEPVLIGCML,"38,521",369,MurB family,cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],flavin adenine dinucleotide binding [GO:0050660]; UDP-N-acetylmuramate dehydrogenase activity [GO:0008762],cytoplasm [GO:0005737],,MTCY20G9.08,1
P9WIX9,MUTT3_MYCTU,Rv0413,mutT3 Rv0413,GO:0006260; GO:0006281; GO:0016787; GO:0046872,IPR020476; IPR015797; IPR020084; IPR000086; ,,mutT3,DOMAIN 30 164 Nudix hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00794}.,"Putative 8-oxo-dGTP diphosphatase 3 (8-oxo-dGTPase) (EC 3.6.1.55) (7,8-dihydro-8-oxoguanine-triphosphatase 3) (Mutator protein MutT3) (dGTP pyrophosphohydrolase 3)",hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260],9634230; 16585780; 21969609,,"FUNCTION: May be involved in the GO system responsible for removing an oxidatively damaged form of guanine (7,8-dihydro-8-oxoguanine, 8-oxo-dGTP) from DNA and the nucleotide pool. 8-oxo-dGTP is inserted opposite dA and dC residues of template DNA with almost equal efficiency thus leading to A.T to G.C transversions. MutT specifically degrades 8-oxo-dGTP to the monophosphate (By similarity). {ECO:0000250}.",MPSCPPAYSEQVRGDGDGWVVSDSGVAYWGRYGAAGLLLRAPRPDGTPAVLLQHRALWSHQGGTWGLPGGARDSHETPEQTAVRESSEEAGLSAERLEVRATVVTAEVCGVDDTHWTYTTVVADAGELLDTVPNRESAELRWVAENEVADLPLHPGFAASWQRLRTAPATVPLARCDERRQRLPRTIQIEAGVFLWCTPGDADQAPSPLGRRISSLL,"23,499",217,Nudix hydrolase family,DNA repair [GO:0006281]; DNA replication [GO:0006260],hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,,1
P9WMY5,MGTA_MYCTU,Rv0557,mgtA pimB Rv0557,GO:0000030; GO:0008654; GO:0009247; GO:0009405; GO:0040007; GO:0046488,IPR001296; IPR028098; ,,mgtA,,GDP-mannose-dependent alpha-mannosyltransferase (EC 2.4.1.-) (Guanosine diphosphomannose-dependent alpha-mannosyltransferase),mannosyltransferase activity [GO:0000030]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],10531370; 9634230; 19099550; 19395496,,"FUNCTION: Catalyzes the addition of a mannose residue from GDP-D-mannose to GlcAGroAc2 to generate 1,2-di-O-C16/C18:1-(alpha-D-mannopyranosyl)-(1-4)-(alpha-D-glucopyranosyluronic acid)-(1-3)-glycerol(ManGlcAGroAc2). {ECO:0000269|PubMed:19395496}.",MCGVRVAIVAESFLPQVNGVSNSVVKVLEHLRRTGHEALVIAPDTPPGEDRAERLHDGVRVHRVPSRMFPKVTTLPLGVPTFRMLRALRGFDPDVVHLASPALLGYGGLHAARRLGVPTVAVYQTDVPGFASSYGIPMTARAAWAWFRHLHRLADRTLAPSTATMESLIAQGIPRVHRWARGVDVQRFAPSARNEVLRRRWSPDGKPIVGFVGRLAPEKHVDRLTGLAASGAVRLVIVGDGIDRARLQSAMPTAVFTGARYGKELAEAYASMDVFVHSGEHETFCQVVQEALASGLPVIAPDAGGPRDLITPHRTGLLLPVGEFEHRLPDAVAHLVHERQRYALAARRSVLGRSWPVVCDELLGHYEAVRGRRTTQAA,"41,238",378,"Glycosyltransferase group 1 family, Glycosyltransferase 4 subfamily",glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],mannosyltransferase activity [GO:0000030],,pimB,,1
P9WJV7,MMPL2_MYCTU,Rv0507,mmpL2 Rv0507 MTCY20G9.34,GO:0005618; GO:0005886; GO:0016021; GO:0044119,IPR004869; IPR004707; ,,mmpL2,,Probable transport protein MmpL2,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host cell [GO:0044119],9634230; 21969609; 24737322,,,MSERHAALTSLPPILPRLIRRFAVVIVLLWLGFTAFVNLAVPQLEVVGKAHSVSMSPSDAASIQAIKRVGQVFGEFDSDNAVTIVLEGDQPLGGDAHRFYSDLMRKLSADTRHVAHIQDFWGDPLTAAGSQSADDRAAYVVVYLVGNNETEAYDSVHAVRHMVDTTPPPHGVKAYVTGPAALNADQAEAGDKSIAKVTAITSMVIAAMLLVIYRSVITAVLVLIMVGIDLGAIRGFIALLADHNIFSLSTFATNLLVLMAIAASTDYAIFMLGRYHESRYAGEDRETAFYTMFHGTAHVILGSGLTIAGAMYCLSFARLPYFETLGAPIAIGMLVAVLAALTLGPAVLTVGSFFKLFDPKRRMNTRRWRRVGTAIVRWPGPVLAATCLVASIGLLALPSYRTTYDLRKFMPASMPSNVGDAAAGRRFSRARLNPEVLLIETDHDMRNPVDMLVLDKVAKNIYHSPGIEQVKAITRPLGTTIKHTSIPFIISMQGVNSSEQMEFMKDRIDDILVQVAAMNTSIETMHRMYALMGEVIDNTVDMDHLTHDMSDITATLRDHLADFEDFFRPIRSYFYWEKHCFDVPLCWSIRSIFDMFDSVDQLSEKLEYLVKDMDILITLLPQMRAQMPPMISAMTTMRDMMLIWHGTLGAFYKQQERNNKDPGAMGRVFDAAQIDDSFYLPQSAFENPDFKRGLKMFLSPDGKAARFVIALEGDPATPEGISRVEPIKREAREAIKGTPLQGAAIYLGGTAATFKDIREGARYDLLIAGVAAISLILIIMMIITRSVVAAVVIVGTVVLSMGASFGLSVLVWQDILGIELYWMVLAMSVILLLAVGSDYNLLLISRLKEEIGAGLNTGIIRAMAGTGGVVTAAGMVFAVTMSLFVFSDLRIIGQIGTTIGLGLLFDTLVVRSFMTPSIAALLGRWFWWPLRVRPRPASQMLRPFAPRRLVRALLLPSGQHPSATGAHE,"106,202",968,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",growth of symbiont in host cell [GO:0044119],,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20G9.34,1
P9WJV1,MMPL5_MYCTU,Rv0676c,mmpL5 Rv0676c MTV040.04c,GO:0005576; GO:0005829; GO:0005887,IPR004869; IPR004707; ,,mmpL5,,Siderophore exporter MmpL5,cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],9634230; 12065475; 18851927; 21969609; 23431276; 24590481; 24737322; 25010492,,"FUNCTION: Part of an export system, which is required for biosynthesis and secretion of siderophores. {ECO:0000269|PubMed:23431276}.; FUNCTION: Overexpression of the system confers non-target based resistance to azoles, clofazimine and bedaquiline, via an efflux mechanism. {ECO:0000269|PubMed:18851927, ECO:0000269|PubMed:24590481, ECO:0000269|PubMed:25010492}.",MIVQRTAAPTGSVPPDRHAARPFIPRMIRTFAVPIILGWLVTIAVLNVTVPQLETVGQIQAVSMSPDAAPSMISMKHIGKVFEEGDSDSAAMIVLEGQRPLGDAAHAFYDQMIGRLQADTTHVQSLQDFWGDPLTATGAQSSDGKAAYVQVKLAGNQGESLANESVEAVKTIVERLAPPPGVKVYVTGSAALVADQQQAGDRSLQVIEAVTFTVIIVMLLLVYRSIITSAIMLTMVVLGLLATRGGVAFLGFHRIIGLSTFATNLLVVLAIAAATDYAIFLIGRYQEARGLGQDRESAYYTMFGGTAHVVLGSGLTIAGATFCLSFTRLPYFQTLGVPLAIGMVIVVAAALTLGPAIIAVTSRFGKLLEPKRMARVRGWRKVGAAIVRWPGPILVGAVALALVGLLTLPGYRTNYNDRNYLPADLPANEGYAAAERHFSQARMNPEVLMVESDHDMRNSADFLVINKIAKAIFAVEGISRVQAITRPDGKPIEHTSIPFLISMQGTSQKLTEKYNQDLTARMLEQVNDIQSNIDQMERMHSLTQQMADVTHEMVIQMTGMVVDVEELRNHIADFDDFFRPIRSYFYWEKHCYDIPVCWSLRSVFDTLDGIDVMTEDINNLLPLMQRLDTLMPQLTAMMPEMIQTMKSMKAQMLSMHSTQEGLQDQMAAMQEDSAAMGEAFDASRNDDSFYLPPEVFDNPDFQRGLEQFLSPDGHAVRFIISHEGDPMSQAGIARIAKIKTAAKEAIKGTPLEGSAIYLGGTAAMFKDLSDGNTYDLMIAGISALCLIFIIMLITTRSVVAAAVIVGTVVLSLGASFGLSVLIWQHILGIELHWLVLAMAVIILLAVGADYNLLLVARLKEEIHAGINTGIIRAMGGSGSVVTAAGLVFAFTMMSFAVSELTVMAQVGTTIGMGLLFDTLIVRSFMTPSIAALLGKWFWWPQVVRQRPIPQPWPSPASARTFALV,"104,785",964,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",,,cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTV040.04c,1
I6Y8F7,MMPR5_MYCTU,Rv0678 RVBD_0678,mmpR5 Rv0678 RVBD_0678 LH57_03665 P425_00707,GO:0003677; GO:0006351; GO:0006355,IPR036388; IPR036390; ,,mmpR5,DOMAIN 1 151 HTH marR-type. {ECO:0000305}.,HTH-type transcriptional regulator MmpR5,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 18851927; 21969609; 24590481; 25010492; 24737322,X-ray crystallography (1),"FUNCTION: Controls the expression level of the Mmps2-MmpL2, MmpS4-MmpL4, and MmpS5-MmpL5 transport systems. Also controls its own expression. Acts by binding directly to the promoter regions. {ECO:0000269|PubMed:18851927, ECO:0000269|PubMed:24590481, ECO:0000269|PubMed:24737322}.",MSVNDGVDQMGAEPDIMEFVEQMGGYFESRSLTRLAGRLLGWLLVCDPERQSSEELATALAASSGGISTNARMLIQFGFIERLAVAGDRRTYFRLRPNAFAAGERERIRAMAELQDLADVGLRALGDAPPQRSRRLREMRDLLAYMENVVSDALGRYSQRTGEDD,"18,379",165,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,LH57_03665 P425_00707,1
P9WJS7,MMPS5_MYCTU,Rv0677c,mmpS5 Rv0677c MTV040.05c,GO:0005576; GO:0005886; GO:0009405; GO:0016021,IPR008693; IPR038468; ,,mmpS5,,Siderophore export accessory protein MmpS5,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 12065475; 18851927; 21969609; 23431276; 24737322; 25010492,,"FUNCTION: Part of an export system, which is required for biosynthesis and secretion of siderophores. Essential for virulence. {ECO:0000269|PubMed:23431276}.; FUNCTION: Overexpression of the system confers non-target based resistance to azoles, clofazimine and bedaquiline, via an efflux mechanism. {ECO:0000269|PubMed:18851927, ECO:0000269|PubMed:25010492}.",MIGTLKRAWIPLLILVVVAIAGFTVQRIRTFFGSEGILVTPKVFADDPEPFDPKVVEYEVSGSGSYVNINYLDLDAKPQRIDGAALPWSLTLKTTAPSAAPNILAQGDGTSITCRITVDGEVKDERTATGVDALTYCFVKSA,"15,249",142,MmpS family,pathogenesis [GO:0009405],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV040.05c,1
O06401,MTAP_MYCTU,Rv0535,mtnP Rv0535,GO:0006166; GO:0017061; GO:0019509,IPR010044; IPR000845; IPR035994; ,,mtnP,,S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP),S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],9634230; 21969609; 22225784,,"FUNCTION: Catalyzes the reversible phosphorylation of S-methyl-5'-thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S-adenosylmethionine. Prefers MTA, with 2% activity on adenosine, 0.8% activity on S-adenosyl-L-homocysteine and no activity on other tested nucleosides.",MHNNGRMLGVIGGSGFYTFFGSDTRTVNSDTPYGQPSAPITIGTIGVHDVAFLPRHGAHHQYSAHAVPYRANMWALRALGVRRVFGPCAVGSLDPELEPGAVVVPDQLVDRTSGRADTYFDFGGVHAAFADPYCPTLRAAVTGLPGVVDGGTMVVIQGPRFSTRAESQWFAAAGCNLVNMTGYPEAVLARELELCYAAIALVTDVDAGVAAGDGVKAADVFAAFGENIELLKRLVRAAIDRVADERTCTHCQHHAGVPLPFELP,"27,964",264,"PNP/MTAP phosphorylase family, MTAP subfamily",L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],S-methyl-5-thioadenosine phosphorylase activity [GO:0017061],,,,1
P9WJQ5,MOEA2_MYCTU,Rv0438c,moaE2 Rv0438c MTV037.02c,GO:0005737; GO:0006777; GO:0018315; GO:0032324; GO:0046872; GO:0061598; GO:0061599,IPR036425; IPR001453; IPR038987; IPR005111; IPR036688; IPR005110; IPR036135; ,,moaE2,,Molybdopterin molybdenumtransferase 2 (MPT Mo-transferase 2) (EC 2.10.1.1),cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the insertion of molybdate into adenylated molybdopterin with the concomitant release of AMP. {ECO:0000250}.,MRSVQEHQRVVAEMMRACRPITVPLTQAQGLVLGGDVVAPLSLPVFDNSAMDGYAVRAEDTSGATPQNPVMLPVAEDIPAGRADMLTLQPVTAHRIMTGAPVPTGATAIVPVEATDGGVDSVAIRQQATPGKHIRRSGEDVAAGTTVLHNGQIVTPAVLGLAAALGLAELPVLPRQRVLVISTGSELASPGTPLQPGQIYESNSIMLAAAVRDAGAAVVATATAGDDVAQFGAILDRYAVDADLIITSGGVSAGAYEVVKDAFGSADYRGGDHGVEFVKVAMQPGMPQGVGRVAGTPIVTLPGNPVSALVSFEVFIRPPLRMAMGLPDPYRPHRSAVLTASLTSPRGKRQFRRAILDHQAGTVISYGPPASHHLRWLASANGLLDIPEDVVEVAAGTQLQVWDLT,"42,021",405,MoeA family,molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599],cytoplasm [GO:0005737],,MTV037.02c,1
P9WMY7,MSHA_MYCTU,Rv0486,mshA Rv0486 MTCY20G9.12,GO:0005829; GO:0008375; GO:0010125; GO:0046872; GO:0102710,IPR001296; IPR028098; IPR017814; ,,mshA,,D-inositol 3-phosphate glycosyltransferase (EC 2.4.1.250) (N-acetylglucosamine-inositol-phosphate N-acetylglucosaminyltransferase) (GlcNAc-Ins-P N-acetylglucosaminyltransferase),cytosol [GO:0005829]; acetylglucosaminyltransferase activity [GO:0008375]; D-inositol-3-phosphate glycosyltransferase activity [GO:0102710]; metal ion binding [GO:0046872]; mycothiol biosynthetic process [GO:0010125],9634230; 12754249; 21969609; 26774486; 26637353,,"FUNCTION: Catalyzes the transfer of an N-acetyl-glucosamine moiety to 1D-myo-inositol 3-phosphate to produce 1D-myo-inositol 2-acetamido-2-deoxy-glucopyranoside 3-phosphate in the mycothiol (MSH) biosynthesis pathway (PubMed:12754249). MSH and WhiB3 are probably part of a regulatory circuit that mediates gene expression upon acid stress (like that found in host macrophage phagosomes) (PubMed:26637353). MSH is one of the major redox buffers which protects bacteria against redox stressors and antibiotics; loss of MSH or ergothioneine (ERG, the other major redox buffer in this bacteria) leads to respiratory alterations and bioenergetic deficiencies that negatively impact virulence (PubMed:26774486). {ECO:0000269|PubMed:12754249, ECO:0000305|PubMed:26637353, ECO:0000305|PubMed:26774486}.",MAGVRHDDGSGLIAQRRPVRGEGATRSRGPSGPSNRNVSAADDPRRVALLAVHTSPLAQPGTGDAGGMNVYMLQSALHLARRGIEVEIFTRATASADPPVVRVAPGVLVRNVVAGPFEGLDKYDLPTQLCAFAAGVLRAEAVHEPGYYDIVHSHYWLSGQVGWLARDRWAVPLVHTAHTLAAVKNAALADGDGPEPPLRTVGEQQVVDEADRLIVNTDDEARQVISLHGADPARIDVVHPGVDLDVFRPGDRRAARAALGLPVDERVVAFVGRIQPLKAPDIVLRAAAKLPGVRIIVAGGPSGSGLASPDGLVRLADELGISARVTFLPPQSHTDLATLFRAADLVAVPSYSESFGLVAVEAQACGTPVVAAAVGGLPVAVRDGITGTLVSGHEVGQWADAIDHLLRLCAGPRGRVMSRAAARHAATFSWENTTDALLASYRRAIGEYNAERQRRGGEVISDLVAVGKPRHWTPRRGVGA,"50,541",480,"Glycosyltransferase group 1 family, MshA subfamily",mycothiol biosynthetic process [GO:0010125],acetylglucosaminyltransferase activity [GO:0008375]; D-inositol-3-phosphate glycosyltransferase activity [GO:0102710]; metal ion binding [GO:0046872],cytosol [GO:0005829],,MTCY20G9.12,1
P9WIU9,NUSG_MYCTU,Rv0639,nusG Rv0639 MTCY20H10.20,GO:0005618; GO:0005829; GO:0005886; GO:0006353; GO:0006355; GO:0031564; GO:0032784,IPR006645; IPR036735; IPR014722; IPR001062; IPR015869; IPR008991; ,,nusG,,Transcription termination/antitermination protein NusG,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA-templated transcription, termination [GO:0006353]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription, DNA-templated [GO:0006355]; transcription antitermination [GO:0031564]",9634230; 20026069; 21969609,NMR spectroscopy (1),"FUNCTION: Participates in transcription elongation, termination and antitermination. {ECO:0000255|HAMAP-Rule:MF_00948}.",MTTFDGDTSAGEAVDLTEANAFQDAAAPAEEVDPAAALKAELRSKPGDWYVVHSYAGYENKVKANLETRVQNLDVGDYIFQVEVPTEEVTEIKNGQRKQVNRKVLPGYILVRMDLTDDSWAAVRNTPGVTGFVGATSRPSALALDDVVKFLLPRGSTRKAAKGAASTAAAAEAGGLERPVVEVDYEVGESVTVMDGPFATLPATISEVNAEQQKLKVLVSIFGRETPVELTFGQVSKI,"25,447",238,NusG family,"DNA-templated transcription, termination [GO:0006353]; regulation of DNA-templated transcription, elongation [GO:0032784]; regulation of transcription, DNA-templated [GO:0006355]; transcription antitermination [GO:0031564]",,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY20H10.20,1
P9WHS5,HTPX_MYCTU,Rv0563,htpX Rv0563 MTCY25D10.42 MTV039.01,GO:0004222; GO:0005576; GO:0005887; GO:0046872,IPR022919; IPR001915; ,,htpX,,Protease HtpX homolog (EC 3.4.24.-),extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],9634230; 18342411; 21969609,,,MTWHPHANRLKTFLLLVGMSALIVAVGALFGRTALMLAALFAVGMNVYVYFNSDKLALRAMHAQPVSELQAPAMYRIVRELATSAHQPMPRLYISDTAAPNAFATGRNPRNAAVCCTTGILRILNERELRAVLGHELSHVYNRDILISCVAGALAAVITALANMAMWAGMFGGNRDNANPFALLLVALLGPIAATVIRMAVSRSREYQADESGAVLTGDPLALASALRKISGGVQAAPLPPEPQLASQAHLMIANPFRAGERIGSLFSTHPPIEDRIRRLEAMARG,"30,682",286,Peptidase M48B family,,metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTCY25D10.42 MTV039.01,1
P9WKV3,LDT5_MYCTU,Rv0483,lprQ Rv0483 MTCY20G9.09,GO:0005576; GO:0008360; GO:0009252; GO:0016746; GO:0071555,IPR005490; IPR038063; ,,lprQ,DOMAIN 264 383 YkuD.,"L,D-transpeptidase 5 (LDT 5) (EC 2.3.2.-) (Ldt(Mt5))","extracellular region [GO:0005576]; transferase activity, transferring acyl groups [GO:0016746]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 21969609; 24041897,X-ray crystallography (3),"FUNCTION: Generates 3->3 cross-links in peptidoglycan, catalyzing the cleavage of the mDap(3)-D-Ala(4) bond of a tetrapeptide donor stem and the formation of a bond between the carbonyl of mDap(3) of the donor stem and the side chain of mDap(3) of the acceptor stem. Is specific for donor substrates containing a stem tetrapeptide since it cannot use pentapeptide stems. {ECO:0000269|PubMed:24041897}.",MVIRVLFRPVSLIPVNNSSTPQSQGPISRRLALTALGFGVLAPNVLVACAGKVTKLAEKRPPPAPRLTFRPADSAADVVPIAPISVEVGDGWFQRVALTNSAGKVVAGAYSRDRTIYTITEPLGYDTTYTWSGSAVGHDGKAVPVAGKFTTVAPVKTINAGFQLADGQTVGIAAPVIIQFDSPISDKAAVERALTVTTDPPVEGGWAWLPDEAQGARVHWRPREYYPAGTTVDVDAKLYGLPFGDGAYGAQDMSLHFQIGRRQVVKAEVSSHRIQVVTDAGVIMDFPCSYGEADLARNVTRNGIHVVTEKYSDFYMSNPAAGYSHIHERWAVRISNNGEFIHANPMSAGAQGNSNVTNGCINLSTENAEQYYRSAVYGDPVEVTGSSIQLSYADGDIWDWAVDWDTWVSMSALPPPAAKPAATQIPVTAPVTPSDAPTPSGTPTTTNGPGG,"47,891",451,,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"transferase activity, transferring acyl groups [GO:0016746]",extracellular region [GO:0005576],,MTCY20G9.09,1
P9WI73,PKNG_MYCTU,Rv0410c,pknG Rv0410c MTCY22G10.06c,GO:0001899; GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0006538; GO:0006543; GO:0009405; GO:0040007; GO:0042802; GO:0044413; GO:0046677; GO:0046777; GO:0052027; GO:0052190; GO:0052369,IPR011009; IPR031634; IPR031636; IPR000719; IPR008271; IPR011990; ,Itself; P9WJA9,pknG,DOMAIN 151 396 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknG (EC 2.7.11.1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; avoidance of host defenses [GO:0044413]; glutamate catabolic process [GO:0006538]; glutamine catabolic process [GO:0006543]; growth [GO:0040007]; modulation by symbiont of host phagocytosis [GO:0052190]; modulation by symbiont of host signal transduction pathway [GO:0052027]; negative regulation of cytolysis by symbiont of host cells [GO:0001899]; pathogenesis [GO:0009405]; positive regulation by symbiont of defense-related host reactive oxygen species production [GO:0052369]; protein autophosphorylation [GO:0046777]; response to antibiotic [GO:0046677],9634230; 15186418; 11496007; 19019160; 19528288; 19638631; 21969609; 17616581,X-ray crystallography (3),"FUNCTION: Phosphorylates GarA. May play a role in metabolic regulation via control of the phosphorylation status of GarA. Plays a crucial role in the survival of mycobacteria within host macrophages, by blocking the intracellular degradation of mycobacteria in lysosomes. Required for intrinsic antibiotic resistance. {ECO:0000269|PubMed:17616581, ECO:0000269|PubMed:19019160, ECO:0000269|PubMed:19528288, ECO:0000269|PubMed:19638631}.",MAKASETERSGPGTQPADAQTATSATVRPLSTQAVFRPDFGDEDNFPHPTLGPDTEPQDRMATTSRVRPPVRRLGGGLVEIPRAPDIDPLEALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTDVAASVLQATVLSQPVQTLDSLRAARHGALDADGVDFSESVELPLMEVRALLDLGDVAKATRKLDDLAERVGWRWRLVWYRAVAELLTGDYDSATKHFTEVLDTFPGELAPKLALAATAELAGNTDEHKFYQTVWSTNDGVISAAFGLARARSAEGDRVGAVRTLDEVPPTSRHFTTARLTSAVTLLSGRSTSEVTEEQIRDAARRVEALPPTEPRVLQIRALVLGGALDWLKDNKASTNHILGFPFTSHGLRLGVEASLRSLARVAPTQRHRYTLVDMANKVRPTSTF,"81,577",750,"Protein kinase superfamily, Ser/Thr protein kinase family",avoidance of host defenses [GO:0044413]; glutamate catabolic process [GO:0006538]; glutamine catabolic process [GO:0006543]; growth [GO:0040007]; modulation by symbiont of host phagocytosis [GO:0052190]; modulation by symbiont of host signal transduction pathway [GO:0052027]; negative regulation of cytolysis by symbiont of host cells [GO:0001899]; pathogenesis [GO:0009405]; positive regulation by symbiont of defense-related host reactive oxygen species production [GO:0052369]; protein autophosphorylation [GO:0046777]; response to antibiotic [GO:0046677],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY22G10.06c,1
P9WIG1,PG10_MYCTU,Rv0747,PE_PGRS10 Rv0747 MTV041.21,,IPR000084; ,,PE_PGRS10,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS10,,9634230,,,MSWVMVSPELVVAAAADLAGIGSAISSANAAAAVNTTGLLTAGADEVSTAIAALFGAQGQAYQAASAQAAAFYAQFVQALSAGGGAYAAAEAAAVSPLLAPINAQFVAATGRPLIGNGANGAPGTGANGGPGGWLIGNGGAGGSGAPGAGAGGNGGAGGLFGSGGAGGASTDVAGGAGGAGGAGGNAGMLFGAAGVGGVGGFSNGGATGGAGGAGGAGGLFGAGRERGSGGSGNLTGGAGGAGGNAGTLATGDGGAGGTGGASRSGGFGGAGGAGGDAGMFFGSGGSGGAGGISKSVGDSAAGGAGGAPGLIGNGGNGGNGGASTGGGDGGPGGAGGTGVLIGNGGNGGSGGTGATLGKAGIGGTGGVLLGLDGFTAPASTSPLHTLQQDVINMVNDPFQTLTGRPLIGNGANGTPGTGADGGAGGWLFGNGGNGGQGTIGGVNGGAGGAGGAGGILFGTGGTGGSGGPGATGLGGIGGAGGAALLFGSGGAGGSGGAGAVGGNGGAGGNAGALLGAAGAGGAGGAGAVGGNGGAGGNGGLFANGGAGGPGGFGSPAGAGGIGGAGGNGGLFGAGGTGGAGGGSTLAGGAGGAGGNGGLFGAGGTGGAGSHSTAAGVSGGAGGAGGDAGLLSLGASGGAGGSGGSSLTAAGVVGGIGGAGGLLFGSGGAGGSGGFSNSGNGGAGGAGGDAGLLVGSGGAGGAGASATGAATGGDGGAGGKSGAFGLGGDGGAGGATGLSGAFHIGGKGGVGGSAVLIGNGGNGGNGGNSGNAGKSGGAPGPSGAGGAGGLLLGENGLNGLM,"65,407",801,"Mycobacterial PE family, PGRS subfamily",,,,,MTV041.21,1
Q79FW5,PG11_MYCTU,Rv0754,PE_PGRS11 Rv0754,GO:0000287; GO:0001666; GO:0004619; GO:0005576; GO:0005618; GO:0006096; GO:0009405; GO:0009986,IPR013078; IPR029033; IPR000084; ,,PE_PGRS11,DOMAIN 1 92 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS11 (PE-PGRS phosphoglycerate mutase) (EC 5.4.2.12),cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; magnesium ion binding [GO:0000287]; phosphoglycerate mutase activity [GO:0004619]; glycolytic process [GO:0006096]; pathogenesis [GO:0009405]; response to hypoxia [GO:0001666],9634230; 20558725; 20176745,,"FUNCTION: Induces maturation and activation of human dendritic cells (DCs), via TLR2-dependent activation of ERK1/2, p38 MAPK, and NF-kappa-B signaling pathways, and enhances the ability of DCs to stimulate CD4(+) T cells. By activating DCs, could potentially contribute to the initiation of innate immune responses during tuberculosis infection and hence regulate the clinical course of tuberculosis (PubMed:20176745). Involved in resistance to oxidative stress, via TLR2-dependent activation of the PI3K-ERK1/2-NF-kappa-B signaling pathway and expression of COX-2 and Bcl2. Also abolishes H(2)O(2)-triggered activation of p38 MAPK (PubMed:20558725). {ECO:0000269|PubMed:20176745, ECO:0000269|PubMed:20558725}.",MSFVIVARDALAAAAADLAQIGSAVNAGNLAAANPTTAVAAAAADEVSAALAALFGAHAREYQAAAAQAAAYHEQFVHRLSAAATSYAVTEVTIATSLRGALGSAPASVSDGFQAFVYGPIHATGQQWINSPVGEALAPIVNAPTNVLLGRDLIGNGVTGTAAAPNGGPGGLLFGDGGAGYTGGNGGSAGLIGNGGTGGAGFAGGVGGMGGTGGWLMGNGGMGGAGGVGGNGGAGGQALLFGNGGLGGAGGAGGVDGAIGRGGWFIGTGGMATIGGGGNGQSIVIDFVRHGQTPGNAAMLIDTAVPGPGLTALGQQQAQAIANALAAKGPYAGIFDSQLIRTQQTAAPLANLLGMAPQVLPGLNEIHAGIFEDLPQISPAGLLYLVGPIAWTLGFPIVPMLAPGSTDVNGIVFNRAFTGAVQTIYDASLANPVVAADGNITSVAYSSAFTIGVGTMMNVDNPHPLLLLTHPVPNTGAVVVQGNPEGGWTLVSWDGIPVGPASLPTALFVDVRELITAPQYAAYDIWESLFTGDPAAVINAVRDGADEVGAAVVQFPHAVADDVIDATGHPYLSGLPIGLPSLIP,"56,945",584,"Mycobacterial PE family, PGRS subfamily; Phosphoglycerate mutase family",glycolytic process [GO:0006096]; pathogenesis [GO:0009405]; response to hypoxia [GO:0001666],magnesium ion binding [GO:0000287]; phosphoglycerate mutase activity [GO:0004619],cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WHU7,P5CR_MYCTU,Rv0500,proC Rv0500 MTCY20G9.26,GO:0000287; GO:0004735; GO:0005737; GO:0005886; GO:0006561; GO:0030145; GO:0040007; GO:0055129,IPR008927; IPR036291; IPR028939; IPR029036; IPR000304; ,,proC,,Pyrroline-5-carboxylate reductase (P5C reductase) (P5CR) (EC 1.5.1.2) (PCA reductase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; pyrroline-5-carboxylate reductase activity [GO:0004735]; growth [GO:0040007]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],9634230; 21969609,,FUNCTION: Catalyzes the reduction of 1-pyrroline-5-carboxylate (PCA) to L-proline. {ECO:0000255|HAMAP-Rule:MF_01925}.,MLFGMARIAIIGGGSIGEALLSGLLRAGRQVKDLVVAERMPDRANYLAQTYSVLVTSAADAVENATFVVVAVKPADVEPVIADLANATAAAENDSAEQVFVTVVAGITIAYFESKLPAGTPVVRAMPNAAALVGAGVTALAKGRFVTPQQLEEVSALFDAVGGVLTVPESQLDAVTAVSGSGPAYFFLLVEALVDAGVGVGLSRQVATDLAAQTMAGSAAMLLERMEQDQGGANGELMGLRVDLTASRLRAAVTSPGGTTAAALRELERGGFRMAVDAAVQAAKSRSEQLRITPE,"30,172",295,Pyrroline-5-carboxylate reductase family,growth [GO:0040007]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; pyrroline-5-carboxylate reductase activity [GO:0004735],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY20G9.26,1
I6Y8K5,PG08_MYCTU,Rv0742,PE_PGRS8 Rv0742 LH57_04020,GO:0005576; GO:0005618; GO:0009986,IPR000084; ,,PE_PGRS8,DOMAIN 1 93 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS8,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 27483162,,,MSFVIAAPEAIAAAATDLASIGSTIGAANAAAAANTTAVLAAGADQVSVAIAAAFGAHGQAYQALSAQAATFHIQFVQALTAGAGSYAAAEAASAASITSPLLDAINAPFLAALGRPLIGNGADGAPGTGAAGGAGGLLFGNGGAGGSGAPGGAGGLLFGNGGAGGPGASGGALG,"15,545",175,"Mycobacterial PE family, PGRS subfamily",,,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,LH57_04020,2
P9WJ81,MFTA_MYCTU,Rv0691A,mftA Rv0691A,,IPR023988; ,,mftA,,Putative electron carrier mycofactocin,,9634230; 21223593,,FUNCTION: A putative polypeptide that may function as an electron carrier; the C-terminal 8 residues are highly conserved. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.,MRHHIRPSISALDAILCPDRRIAVETCWRKAIQMDYETDTDTELVTETLVEEVSIDGMCGVY,"7,098",62,,,,,,,1
P9WMX1,MFTF_MYCTU,Rv0696,mftF Rv0696,GO:0005829; GO:0005886; GO:0016021; GO:0016740,IPR001173; IPR023981; IPR029044; ,,mftF,,Putative mycofactocin biosynthesis glycosyltransferase MftF (EC 2.-.-.-),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity [GO:0016740],9634230; 21223593; 21969609,,"FUNCTION: May play a role in the maturation of mycofactocin, a conserved polypeptide that might serve as an electron carrier. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.",MTATRLPDGFAVQVDRRVRVLGDGSALLGGSPTRLLRLAPAARGLLCDGRLKVRDEVSAELARILLDATVAHPRPPSGPSHRDVTVVIPVRNNASGLRRLVTSLRGLRVIVVDDGSACPVESDDFVGAHCDIEVLHHPHSKGPAAARNTGLAACTTDFVAFLDSDVTPRRGWLESLLGHFCDPTVALVAPRIVSLVEGENPVARYEALHSSLDLGQREAPVLPHSTVSYVPSAAIVCRSSAIRDVGGFDETMHSGEDVDLCWRLIEAGARLRYEPIALVAHDHRTQLRDWIARKAFYGGSAAPLAVRHPDKTAPLVISGGALMAWILMSIGTGLGRLASLVIAVLTGRRIARAMRCAETSFLDVLAVATRGLWAAALQLASAICRHYWPLALLAAILSRRCRRVVLIAAVVDGVVDWLRRREGADDDAEPIGPLTYLVLKRVDDLAYGAGLWYGVVRERNIGALKPQIRT,"50,667",470,Glycosyltransferase 2 family,,transferase activity [GO:0016740],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
Q79FX6,MMAA2_MYCTU,Rv0644c,mmaA2 mma2 Rv0644c,GO:0005618; GO:0005886; GO:0008168; GO:0008825; GO:0071768,IPR003333; IPR029063; ,,mmaA2,,Cyclopropane mycolic acid synthase MmaA2 (CMAS) (EC 2.1.1.79) (Cyclopropane-fatty-acyl-phospholipid synthase) (CFA synthase) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cell wall [GO:0005618]; plasma membrane [GO:0005886]; cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; methyltransferase activity [GO:0008168]; mycolic acid biosynthetic process [GO:0071768],9634230; 12502719; 18094751; 19099550; 19439410; 20472794; 21969609; ,X-ray crystallography (1),"FUNCTION: Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:12502719, ECO:0000269|PubMed:20472794}.",MVNDLTPHFEDVQAHYDLSDDFFRLFLDPTQTYSCAHFEREDMTLEEAQIAKIDLALGKLGLQPGMTLLDIGCGWGATMRRAIAQYDVNVVGLTLSKNQAAHVQKSFDEMDTPRDRRVLLAGWEQFNEPVDRIVSIGAFEHFGHDRHADFFARAHKILPPDGVLLLHTITGLTRQQMVDHGLPLTLWLARFLKFIATEIFPGGQPPTIEMVEEQSAKTGFTLTRRQSLQPHYARTLDLWAEALQEHKSEAIAIQSEEVYERYMKYLTGCAKLFRVGYIDVNQFTLAK,"32,724",287,CFA/CMAS family,mycolic acid biosynthetic process [GO:0071768],cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; methyltransferase activity [GO:0008168],cell wall [GO:0005618]; plasma membrane [GO:0005886],mma2,,1
P9WNY5,MMSB_MYCTU,Rv0751c,mmsB Rv0751c MTV041.25c,GO:0004616; GO:0006574; GO:0008442; GO:0051287,IPR002204; IPR008927; IPR013328; IPR006115; IPR011548; IPR015815; IPR036291; IPR029154; ,,mmsB,,Probable 3-hydroxyisobutyrate dehydrogenase (HIBADH) (EC 1.1.1.31),3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; valine catabolic process [GO:0006574],9634230; 21969609,,,MTTIAFLGLGNMGAPMSANLVGAGHVVRGFDPAPTAASGAAAHGVAVFRSAPEAVAEADVVITMLPTGEVVRRCYTDVLAAARPATLFIDSSTISVTDAREVHALAESHGMLQLDAPVSGGVKGAAAATLAFMVGGDESTLRRARPVLEPMAGKIIHCGAAGAGQAAKVCNNMVLAVQQIAIAEAFVLAEKLGLSAQSLFDVITGATGNCWAVHTNCPVPGPVPTSPANNDFKPGFSTALMNKDLGLAMDAVAATGATAPLGSHAADIYAKFAADHADLDFSAVIHTLRARADA,"29,679",294,3-hydroxyisobutyrate dehydrogenase family,valine catabolic process [GO:0006574],3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],,,MTV041.25c,1
P9WQ39,MENE_MYCTU,Rv0542c,menE Rv0542c,GO:0005524; GO:0008756; GO:0009234; GO:0040007,IPR025110; IPR020845; IPR000873; ,,menE,,Probable 2-succinylbenzoate--CoA ligase (EC 6.2.1.26) (OSB-CoA synthetase) (o-succinylbenzoyl-CoA synthetase),ATP binding [GO:0005524]; o-succinylbenzoate-CoA ligase activity [GO:0008756]; growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],9634230; 19099550; 21969609,,FUNCTION: Converts 2-succinylbenzoate (OSB) to 2-succinylbenzoyl-CoA (OSB-CoA). May be involved in the biosynthesis of menaquinone (By similarity). {ECO:0000250}.,MLLPALQRVLGGSDPALVAVPTQHESLLGALRVGEQIDDDVALVVTTSGTTGPPKGAMLTAAALTASASAAHDRLGGPGSWLLAVPPYHIAGLAVLVRSVIAGSVPVELNVSAGFDVTELPNAIKRLGSGRRYTSLVAAQLAKALTDPAATAALAELDAVLIGGGPAPRPILDAAAAAGITVVRTYGMSETSGGCVYDGVPLDGVRLRVLAGGRIAIGGATLAKGYRNPVSPDPFAEPGWFHTDDLGALESGDSGVLTVLGRADEAISTGGFTVLPQPVEAALGTHPAVRDCAVFGLADDRLGQRVVAAIVVGDGCPPPTLEALRAHVARTLDVTAAPRELHVVNVLPRRGIGKVDRAALVRRFAGEADQ,"37,510",370,"ATP-dependent AMP-binding enzyme family, MenE subfamily",growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],ATP binding [GO:0005524]; o-succinylbenzoate-CoA ligase activity [GO:0008756],,,,2
P9WFR3,MENG_MYCTU,Rv0558,menG menH Rv0558 MTCY25D10.37,GO:0005886; GO:0009234; GO:0040007; GO:0102955,IPR029063; IPR004033; IPR023576; ,,menG,,Demethylmenaquinone methyltransferase (EC 2.1.1.163),plasma membrane [GO:0005886]; S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955]; growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],9634230; 19099550; 21969609,,FUNCTION: Methyltransferase required for the conversion of demethylmenaquinol (DMKH2) to menaquinol (MKH2). {ECO:0000255|HAMAP-Rule:MF_01813}.,MSRAALDKDPRDVASMFDGVARKYDLTNTVLSLGQDRYWRRATRSALRIGPGQKVLDLAAGTAVSTVELTKSGAWCVAADFSVGMLAAGAARKVPKVAGDATRLPFGDDVFDAVTISFGLRNVANQQAALREMARVTRPGGRLLVCEFSTPTNALFATAYKEYLMRALPRVARAVSSNPEAYEYLAESIRAWPDQAVLAHQISRAGWSGVRWRNLTGGIVALHAGYKPGKQTPQ,"25,299",234,"Class I-like SAM-binding methyltransferase superfamily, MenG/UbiE family",growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],S-adenosylmethionine:2-demethylmenaquinol-7 methyltransferase activity [GO:0102955],plasma membrane [GO:0005886],menH,MTCY25D10.37,1
P9WP59,MFTE_MYCTU,Rv0695,mftE Rv0695,GO:0016787; GO:0046872,IPR024087; IPR003785; IPR023871; ,,mftE,,Putative mycofactocin system creatinine amidohydrolase family protein MftE (EC 3.5.-.-),hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 21223593; 21969609,,"FUNCTION: May play a role in the maturation of mycofactocin, a conserved polypeptide that might serve as an electron carrier. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.",MNSSYHRRVPVVGELGSATSSQLPSTSPSIVIPLGSTEQHGPHLPLDTDTRIATAVARTVTARLHAEDLPIAQEEWLMAPAIAYGASGEHQRFAGTISIGTEALTMLLVEYGRSAACWARRLVFVNGHGGNVGALTRAVGLLRAEGRDAGWCPCTCPGGDPHAGHTETSVLLHLSPADVRTERWRAGNRAPLPVLLPSMRRGGVAAVSETGVLGDPTTATAAEGRRIFAAMVDDCVRRVARWMPQPDGMLT,"26,580",251,Creatininase superfamily,,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,,1
P9WMB7,MFTR_MYCTU,Rv0691c,mftR Rv0691c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR009057; IPR001647; IPR023851; ,,mftR,DOMAIN 12 72 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Putative mycofactocin biosynthesis transcriptional regulator MftR,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21223593; 21969609,,FUNCTION: May regulate a gene cluster involved in mycofactocin expression. Mycofactocin is a conserved polypeptide that might serve as an electron carrier.,MPHESRVGRRRSTTPHHISDVAIELFAAHGFTDVSVDDIARAAGIARRTLFRYYASKNAIPWGDFSTHLAQLQGLLDNIDSRIQLRDALRAALLAFNTFDESETIRHRKRMRVILQTPELQAYSMTMYAGWREVIAKFVARRSGGKTTDFMPQTVAWTMLGVALSAYEHWLRDESVSLTEALGAAFDVVGAGLDRLNQ,"22,264",198,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
P9WMG5,MCE2R_MYCTU,Rv0586,mce2R Rv0586 MTCY19H5.36c,GO:0003677; GO:0003700; GO:0006351; GO:0032993; GO:0043565; GO:0045892; GO:0052572,IPR011711; IPR008920; IPR000524; IPR036388; IPR036390; ,,mce2R,DOMAIN 9 77 HTH gntR-type. {ECO:0000255|PROSITE-ProRule:PRU00307}.,HTH-type transcriptional regulator Mce2R,"protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; negative regulation of transcription, DNA-templated [GO:0045892]; response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 18329386; 19027363; 21969609,,FUNCTION: Negatively regulates the expression of its operon as well as expression of end (endonuclease 4). {ECO:0000269|PubMed:19027363}.,MALQPVTRRSVPEEVFEQIATDVLTGEMPPGEALPSERRLAELLGVSRPAVREALKRLSAAGLVEVRQGDVTTVRDFRRHAGLDLLPRLLFRNGELDISVVRSILEARLRNFPKVAELAAERNEPELAELLQDSLRALDTEEDPIVWQRHTLDFWDHVVDSAGSIVDRLMYNAFRAAYEPTLAALTTTMTAAAKRPSDYRKLADAICSGDPTGAKKAAQDLLELANTSLMAVLVSQASRQ,"26,509",240,,"negative regulation of transcription, DNA-templated [GO:0045892]; response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],protein-DNA complex [GO:0032993],,MTCY19H5.36c,1
P9WIP3,MENA_MYCTU,Rv0534c,menA Rv0534c MTCY25D10.13c,GO:0004659; GO:0005886; GO:0009234; GO:0016021; GO:0032194; GO:0042371; GO:0046428,IPR004657; IPR000537; IPR026046; ,,menA,,"1,4-dihydroxy-2-naphthoate octaprenyltransferase (DHNA-octaprenyltransferase) (EC 2.5.1.74)","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity [GO:0046428]; prenyltransferase activity [GO:0004659]; menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]",9634230; 21969609,,"FUNCTION: Conversion of 1,4-dihydroxy-2-naphthoate (DHNA) to demethylmenaquinone (DMK). {ECO:0000255|HAMAP-Rule:MF_01937}.",MASFAQWVSGARPRTLPNAIAPVVAGTGAAAWLHAAVWWKALLALAVAVALVIGVNYANDYSDGIRGTDDDRVGPVRLVGSRLATPRSVLTAAMTSLALGALAGLVLALLSAPWLIAVGAICIAGAWLYTGGSKPYGYAGFGELAVFVFFGPVAVLGTQYTQALRVDWVGLAQAVATGALSCSVLVANNLRDIPTDARADKITLAVRLGDARTRMLYQGLLAVAGVLTFVLMLATPWCVVGLVAAPLALRAAGPVRSGRGGRELIPVLRDTGLAMLVWALAVAGALAFGQLS,"30,014",292,"MenA family, Type 1 subfamily","menaquinone biosynthetic process [GO:0009234]; ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate [GO:0032194]; vitamin K biosynthetic process [GO:0042371]","1,4-dihydroxy-2-naphthoate octaprenyltransferase activity [GO:0046428]; prenyltransferase activity [GO:0004659]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY25D10.13c,1
P9WNY9,MENJ_MYCTU,Rv0561c,menJ Rv0561c,GO:0005618; GO:0009234; GO:0009405; GO:0016627; GO:0016628; GO:0071949,IPR002938; IPR036188; IPR011777; ,,menJ,,Menaquinone reductase (MK reductase) (EC 1.3.99.38),"cell wall [GO:0005618]; FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]; menaquinone biosynthetic process [GO:0009234]; pathogenesis [GO:0009405]",9634230; 21969609; 22485172; 26436137,,"FUNCTION: Catalyzes the reduction of a single double bond in the isoprenoid tail of menaquinone (MK-9) in M.tuberculosis, likely the beta-isoprene unit, forming the predominant form of menaquinone found in mycobacteria, MK-9(II-H2). Is required for M.tuberculosis survival in host macrophages. {ECO:0000269|PubMed:26436137}.",MSVDDSADVVVVGAGPAGSAAAAWAARAGRDVLVIDTATFPRDKPCGDGLTPRAVAELHQLGLGKWLADHIRHRGLRMSGFGGEVEVDWPGPSFPSYGSAVARLELDDRIRKVAEDTGARMLLGAKAVAVHHDSSRRVVSLTLADGTEVGCRQLIVADGARSPLGRKLGRRWHRETVYGVAVRGYLSTAYSDDPWLTSHLELRSPDGAVLPGYGWIFPLGNGEVNIGVGALSTSRRPADLALRPLISYYTDLRRDEWGFTGQPRAVSSALLPMGGAVSGVAGSNWMLIGDAAACVNPLNGEGIDYGLETGRLAAELLDSRDLARLWPSLLADRYGRGFSVARRLALLLTFPRFLPTTGPITMRSTALMNIAVRVMSNLVTDDDRDWVARVWRGGGQLSRLVDRRPPFS,"43,870",408,Geranylgeranyl reductase family,menaquinone biosynthetic process [GO:0009234]; pathogenesis [GO:0009405],"FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor [GO:0016628]",cell wall [GO:0005618],,,1
P9WNP5,MENB_MYCTU,Rv0548c,menB Rv0548c,GO:0005886; GO:0008935; GO:0009234; GO:0034214,IPR029045; IPR010198; IPR001753; IPR014748; ,,menB,,"1,4-dihydroxy-2-naphthoyl-CoA synthase (DHNA-CoA synthase) (EC 4.1.3.36)","plasma membrane [GO:0005886]; 1,4-dihydroxy-2-naphthoyl-CoA synthase activity [GO:0008935]; menaquinone biosynthetic process [GO:0009234]; protein hexamerization [GO:0034214]",9634230; 20643650; 21969609; 12909628; 16131752; 21830810,X-ray crystallography (8),"FUNCTION: Converts o-succinylbenzoyl-CoA (OSB-CoA) to 1,4-dihydroxy-2-naphthoyl-CoA (DHNA-CoA). {ECO:0000255|HAMAP-Rule:MF_01934, ECO:0000269|PubMed:12909628}.",MVAPAGEQGRSSTALSDNPFDAKAWRLVDGFDDLTDITYHRHVDDATVRVAFNRPEVRNAFRPHTVDELYRVLDHARMSPDVGVVLLTGNGPSPKDGGWAFCSGGDQRIRGRSGYQYASGDTADTVDVARAGRLHILEVQRLIRFMPKVVICLVNGWAAGGGHSLHVVCDLTLASREYARFKQTDADVGSFDGGYGSAYLARQVGQKFAREIFFLGRTYTAEQMHQMGAVNAVAEHAELETVGLQWAAEINAKSPQAQRMLKFAFNLLDDGLVGQQLFAGEATRLAYMTDEAVEGRDAFLQKRPPDWSPFPRYF,"34,689",314,"Enoyl-CoA hydratase/isomerase family, MenB subfamily",menaquinone biosynthetic process [GO:0009234]; protein hexamerization [GO:0034214],"1,4-dihydroxy-2-naphthoyl-CoA synthase activity [GO:0008935]",plasma membrane [GO:0005886],,,1
P95038,MFTB_MYCTU,Rv0692,mftB Rv0692,,IPR023850; ,,mftB,,Putative mycofactocin system protein MftB,,9634230; 21223593,,"FUNCTION: May function to bind or modify mycofactocin, a conserved polypeptide that might serve as an electron carrier. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.",MWGLLTVPAPAQARRADSSEFDPDRGWRLHPQVAVRPEPFGALLYHFGTRKLSFLKNRTILAVVQTLADYPDIRSACRGAGVDDCDQDPYLHALSVLAGSNMLVPRQTT,"12,076",109,,,,,,,2
P9WJ79,MFTC_MYCTU,Rv0693,mftC Rv0693,GO:0005886; GO:0016740; GO:0046872; GO:0051539,IPR023885; IPR013785; IPR034391; IPR006638; IPR034481; IPR023913; IPR017200; IPR007197; IPR034395; ,,mftC,,Putative mycofactocin radical SAM maturase MftC (EC 2.-.-.-),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]",9634230; 21223593; 21969609,,"FUNCTION: May function to modify mycofactocin, a conserved polypeptide that might serve as an electron carrier. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.",MTSPVPRLIEQFERGLDAPICLTWELTYACNLACVHCLSSSGKRDPGELSTRQCKDIIDELERMQVFYVNIGGGEPTVRPDFWELVDYATAHHVGVKFSTNGVRITPEVATRLAATDYVDVQISLDGATAEVNDAIRGTGSFDMAVRALQNLAAAGFAGVKISVVITRRNVAQLDEFATLASRYGATLRITRLRPSGRGTDVWADLHPTADQQVQLYDWLVSKGERVLTGDSFFHLAPLGQSGALAGLNMCGAGRVVCLIDPVGDVYACPFAIHDHFLAGNVLSDGGFQNVWKNSSLFRELREPQSAGACGSCGHYDSCRGGCMAAKFFTGLPLDGPDPECVQGHSEPALARERHLPRPRADHSRGRRVSKPVPLTLSMRPPKRPCNESPV,"42,448",391,Radical SAM superfamily,,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]",plasma membrane [GO:0005886],,,1
P9WND7,MFTD_MYCTU,Rv0694,mftD lldD1 Rv0694,GO:0005886; GO:0010181; GO:0016491,IPR013785; IPR012133; IPR000262; IPR037396; IPR023989; ,,mftD,DOMAIN 1 383 FMN hydroxy acid dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00683}.,Putative mycofactocin system heme/flavin oxidoreductase MftD (EC 1.-.-.-),plasma membrane [GO:0005886]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],9634230; 21223593; 21969609,,"FUNCTION: May play a role in the maturation of mycofactocin, a conserved polypeptide that might serve as an electron carrier. The genes for mycofactocin and other proteins proposed to function in its maturation are found in a conserved gene cluster.",MAEAWFETVAIAQQRAKRRLPKSVYSSLIAASEKGITVADNVAAFSELGFAPHVIGATDKRDLSTTVMGQEVSLPVIISPTGVQAVDPGGEVAVARAAAARGTVMGLSSFASKPIEEVIAANPKTFFQVYWQGGRDALAERVERARQAGAVGLVVTTDWTFSHGRDWGSPKIPEEMNLKTILRLSPEAITRPRWLWKFAKTLRPPDLRVPNQGRRGEPGPPFFAAYGEWMATPPPTWEDIGWLRELWGGPFMLKGVMRVDDAKRAVDAGVSAISVSNHGGNNLDGTPASIRALPAVSAAVGDQVEVLLDGGIRRGSDVVKAVALGARAVMIGRAYLWGLAANGQAGVENVLDILRGGIDSALMGLGHASVHDLSPADILVPTGFIRDLGVPSRRDV,"42,161",396,FMN-dependent alpha-hydroxy acid dehydrogenase family,,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],lldD1,,1
P9WQL5,MKL_MYCTU,Rv0655,mkl Rv0655 MTCI376.21,GO:0005524; GO:0005618; GO:0005886; GO:0016887; GO:0070508,IPR003593; IPR003439; IPR017871; IPR030296; IPR027417; ,,mkl,DOMAIN 28 264 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Probable ribonucleotide transport ATP-binding protein mkl,cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cholesterol import [GO:0070508],9634230; 21969609,,"FUNCTION: Not known, could be involved in the transport of ribonucleotides.",MRYSDSYHTTGRWQPRASTEGFPMGVSIEVNGLTKSFGSSRIWEDVTLTIPAGEVSVLLGPSGTGKSVFLKSLIGLLRPERGSIIIDGTDIIECSAKELYEIRTLFGVLFQDGALFGSMNLYDNTAFPLREHTKKKESEIRDIVMEKLALVGLGGDEKKFPGEISGGMRKRAGLARALVLDPQIILCDEPDSGLDPVRTAYLSQLIMDINAQIDATILIVTHNINIARTVPDNMGMLFRKHLVMFGPREVLLTSDEPVVRQFLNGRRIGPIGMSEEKDEATMAEEQALLDAGHHAGGVEEIEGVPPQISATPGMPERKAVARRQARVREMLHTLPKKAQAAILDDLEGTHKYAVHEIGQ,"39,394",359,ABC transporter superfamily,cholesterol import [GO:0070508],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCI376.21,1
P9WJV9,MMPL1_MYCTU,Rv0402c,mmpL1 Rv0402c MTCY04D9.15c,GO:0005576; GO:0005618; GO:0005886; GO:0016021,IPR004869; IPR004707; ,,mmpL1,,Probable transport protein MmpL1,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MRSQRLAGHLSAAARTIHALSLPIILFWVALTIVVNVVAPQLQSVARTHSVALGPHDAPSLIAMKRIGKDFQQFDSDTTAMVLLEGQEKLGDEAHRFYDVLVTKLSQDTTHVQHIENFWGDPLTAAGSQSADGKAAYVQLNLTGDQGGSQANESVAAVQRIVDSVPPPPGIKAYVTGPGPLGADRVVYGDRSLHTITGISIAVIAIMLFIAYRSLSAALIMLLTVGLELLAVRGIISTFAVNDLMGLSTFTVNVLVALTIAASTDYIIFLVGRYQEARATGQNREAAYYTMFGGTAHVVLASGLTVAGAMYCLGFTRLPYFNTLASPCAIGLVTVMLASLTLAPAIIAVASRFGLFDPKRATTKRRWRRIGTVVVRWPGPVLAATLLIALIGLLALPKYQTNYNERYYIPSAAPSNIGYLASDRHFPQARMEPEVLMVEADHDLRNPTDMLILDRIAKTVFHTPGIARVQSITRPLGAPIDHSSIPFQLGMQSTMTIENLQNLKDRVADLSTLTDQLQRMIDITQRTQELTRQLTDATHDMNAHTRQMRDNANELRDRIADFDDFWRPLRSFTYWERHCFDIPICWSMRSLLNSMDNVDKLTEDLANLTDDTERMDTTQRQLLAQLDPTIATMQTVKDLAQTLTSAFSGLVTQMEDMTRNATVMGRTFDAANNDDSFYLPPEAFQNPDFQRGLKLFLSPDGTCARFVITHRGDPASAEGISHIDPIMQAADEAVKGTPLQAASIYLAGTSSTYKDIHEGTLYDVMIAVVASLCLIFIIMLGITRSVVASAVIVGTVALSLGSAFGLSVLIWQHILHMPLHWLVLPMAIIVMLAVGSDYNLLLIARFQEEIGAGLKTGMIRAMAGTGRVVTIAGLVFAFTMGSMVASDLRVVGQIGTTIMIGLLFDTLVVRSYMTPALATLLGRWFWWPRRVDRLARQPQVLGPRRTTALSAERAALLQ,"104,838",958,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY04D9.15c,1
P9WJT5,MMPS1_MYCTU,Rv0403c,mmpS1 Rv0403c MTCY04D9.16c,GO:0005576; GO:0005886; GO:0016021,IPR008693; IPR038468; ,,mmpS1,,Probable transport accessory protein MmpS1,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MFGVAKRFWIPMVIVIVVAVAAVTVSRLHSVFGSHQHAPDTGNLDPIIAFYPKHVLYEVFGPPGTVASINYLDADAQPHEVVNAAVPWSFTIVTTLTAVVANVVARGDGASLGCRITVNEVIREERIVNAYHAHTSCLVKSA,"15,261",142,MmpS family,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY04D9.16c,1
P9WII1,MAZF2_MYCTU,Rv0659c,mazF2 mazF-mt4 Rv0659c,GO:0003677; GO:0004519,IPR003477; IPR011067; ,,mazF2,,Probable endoribonuclease MazF2 (EC 3.1.-.-) (Probable toxin MazF-mt4),DNA binding [GO:0003677]; endonuclease activity [GO:0004519],9634230; 16611633; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli partially inhibits cell growth after one cell generation (PubMed:16611633). Its cognate antitoxin is MazE2. Probably an endoribonuclease (By similarity). {ECO:0000250|UniProtKB:P9WIH9, ECO:0000269|PubMed:16611633, ECO:0000305}.",MRRGELWFAATPGGDRPVLVLTRDPVADRIGAVVVVALTRTRRGLVSELELTAVENRVPSDCVVNFDNIHTLPRTAFRRRITRLSPARLHEACQTLRASTGC,"11,320",102,PemK/MazF family,,DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,mazF-mt4,,1
P0CL57,MAZE1_MYCTU,Rv0456B,mazE1 Rv0456B,,,,mazE1,,Probable antitoxin MazE1,,9634230; 15718296,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. {ECO:0000305}.,MTTYYYVLLSVTTWVGLRHEAKRELVYRGRRSIGRMPREWACRRSRRFAANGVDAAR,"6,791",57,,,,,,,1
P9WJP3,MENC_MYCTU,Rv0553,menC Rv0553 MTCY25D10.32,GO:0000287; GO:0009234; GO:0016836; GO:0040007,IPR036849; IPR029017; IPR029065; IPR013342; IPR010196; ,,menC,,o-succinylbenzoate synthase (OSB synthase) (OSBS) (EC 4.2.1.113) (4-(2'-carboxyphenyl)-4-oxybutyric acid synthase) (o-succinylbenzoic acid synthase),hydro-lyase activity [GO:0016836]; magnesium ion binding [GO:0000287]; growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],9634230; 19099550; 21969609,,"FUNCTION: Converts 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC) to 2-succinylbenzoate (OSB). {ECO:0000255|HAMAP-Rule:MF_00470}.",MIPVLPPLEALLDRLYVVALPMRVRFRGITTREVALIEGPAGWGEFGAFVEYQSAQACAWLASAIETAYCAPPPVRRDRVPINATVPAVAAAQVGEVLARFPGARTAKVKVAEPGQSLADDIERVNAVRELVPMVRVDANGGWGVAEAVAAAAALTADGPLEYLEQPCATVAELAELRRRVDVPIAADESIRKAEDPLAVVRAQAADIAVLKVAPLGGISALLDIAARIAVPVVVSSALDSAVGIAAGLTAAAALPELDHACGLGTGGLFEEDVAEPAAPVDGFLAVARTTPDPARLQALGAPPQRRQWWIDRVKACYSLLVPSFG,"33,975",326,"Mandelate racemase/muconate lactonizing enzyme family, MenC type 1 subfamily",growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],hydro-lyase activity [GO:0016836]; magnesium ion binding [GO:0000287],,,MTCY25D10.32,1
P9WK11,MEND_MYCTU,Rv0555,menD Rv0555,GO:0005886; GO:0009234; GO:0030976; GO:0040007; GO:0046872; GO:0070204,IPR004433; IPR029061; IPR012001; ,,menD,,2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (SEPHCHC synthase) (EC 2.2.1.9) (Menaquinone biosynthesis protein MenD),plasma membrane [GO:0005886]; 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acid synthase activity [GO:0070204]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],9634230; 19099550; 21969609,X-ray crystallography (6),FUNCTION: Catalyzes the thiamine diphosphate-dependent decarboxylation of 2-oxoglutarate and the subsequent addition of the resulting succinic semialdehyde-thiamine pyrophosphate anion to isochorismate to yield 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate (SEPHCHC). {ECO:0000255|HAMAP-Rule:MF_01659}.,MNPSTTQARVVVDELIRGGVRDVVLCPGSRNAPLAFALQDADRSGRIRLHVRIDERTAGYLAIGLAIGAGAPVCVAMTSGTAVANLGPAVVEANYARVPLIVLSANRPYELLGTGANQTMEQLGYFGTQVRASISLGLAEDAPERTSALNATWRSATCRVLAAATGARTANAGPVHFDIPLREPLVPDPEPLGAVTPPGRPAGKPWTYTPPVTFDQPLDIDLSVDTVVISGHGAGVHPNLAALPTVAEPTAPRSGDNPLHPLALPLLRPQQVIMLGRPTLHRPVSVLLADAEVPVFALTTGPRWPDVSGNSQATGTRAVTTGAPRPAWLDRCAAMNRHAIAAVREQLAAHPLTTGLHVAAAVSHALRPGDQLVLGASNPVRDVALAGLDTRGIRVRSNRGVAGIDGTVSTAIGAALAYEGAHERTGSPDSPPRTIALIGDLTFVHDSSGLLIGPTEPIPRSLTIVVSNDNGGGIFELLEQGDPRFSDVSSRIFGTPHDVDVGALCRAYHVESRQIEVDELGPTLDQPGAGMRVLEVKADRSSLRQLHAAIKAAL,"57,836",554,"TPP enzyme family, MenD subfamily",growth [GO:0040007]; menaquinone biosynthetic process [GO:0009234],2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylic-acid synthase activity [GO:0070204]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976],plasma membrane [GO:0005886],,,1
P9WPB1,MMAA1_MYCTU,Rv0645c,mmaA1 mma1 Rv0645c MTCY20H10.26c,GO:0008168; GO:0008610; GO:0016859; GO:0071768,IPR003333; IPR029063; ,,mmaA1,,Mycolic acid methyltransferase MmaA1 (EC 2.1.1.-) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cis-trans isomerase activity [GO:0016859]; methyltransferase activity [GO:0008168]; lipid biosynthetic process [GO:0008610]; mycolic acid biosynthetic process [GO:0071768],9634230; 9092547; 19099550; 20472794; 21969609,,"FUNCTION: Involved in the conversion of a cis-olefin into a trans-olefin with concomitant introduction of an allylic methyl branch at the proximal position of the precursor to both the methoxy and ketomycolic acids. It directly affects the cis- to trans ratio and indirectly affects the keto to methoxy ratio. {ECO:0000269|PubMed:20472794, ECO:0000269|PubMed:9092547}.",MAKLRPYYEESQSAYDISDDFFALFLDPTWVYTCAYFERDDMTLEEAQLAKVDLALDKLNLEPGMTLLDVGCGWGGALVRAVEKYDVNVIGLTLSRNHYERSKDRLAAIGTQRRAEARLQGWEEFEENVDRIVSFEAFDAFKKERYLTFFERSYDILPDDGRMLLHSLFTYDRRWLHEQGIALTMSDLRFLKFLRESIFPGGELPSEPDIVDNAQAAGFTIEHVQLLQQHYARTLDAWAANLQAARERAIAVQSEEVYNNFMHYLTGCAERFRRGLINVAQFTMTK,"33,149",286,CFA/CMAS family,lipid biosynthetic process [GO:0008610]; mycolic acid biosynthetic process [GO:0071768],cis-trans isomerase activity [GO:0016859]; methyltransferase activity [GO:0008168],,mma1,MTCY20H10.26c,1
P0CH91,MMAA3_MYCTU,Rv0643c,mmaA3 mma3 Rv0643c,GO:0005886; GO:0008171; GO:0071768,IPR003333; IPR029063; ,,mmaA3,,Methoxy mycolic acid synthase MmaA3 (EC 2.1.1.-) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),plasma membrane [GO:0005886]; O-methyltransferase activity [GO:0008171]; mycolic acid biosynthetic process [GO:0071768],9634230; 9781881; 10852869; 19099550; 21969609,,"FUNCTION: Involved in the biosynthesis of methoxymycolic acid. It catalyzes the O-methylation of the hydroxy group of the hydroxymycolate to form a methyl ether. {ECO:0000269|PubMed:10852869, ECO:0000269|PubMed:9781881}.",MSDNSTGTTKSRSNVDDVQAHYDLSDAFFALFQDPTRTYSCAYFERDDMTLHEAQVAKLDLTLGKLGLEPGMTLLDVGCGWGSVMKRAVERYDVNVVGLTLSKNQHAYCQQVLDKVDTNRSHRVLLSDWANFSEPVDRIVTIEAIEHFGFERYDDFFKFAYNAMPADGVMLLHSITGLHVKQVIERGIPLTMEMAKFIRFIVTDIFPGGRLPTIETIEEHVTKAGFTITDIQSLQPHFARTLDLWAEALQAHKDEAIEIQSAEVYERYMKYLTGCAKAFRMGYIDCNQFTLAK,"33,263",293,CFA/CMAS family,mycolic acid biosynthetic process [GO:0071768],O-methyltransferase activity [GO:0008171],plasma membrane [GO:0005886],mma3,,1
Q79FX8,MMAA4_MYCTU,Rv0642c,mmaA4 hma mma4 Rv0642c,GO:0005618; GO:0005886; GO:0008168; GO:0008757; GO:0071768,IPR003333; IPR029063; ,,mmaA4,,Hydroxymycolate synthase MmaA4 (EC 2.1.1.-) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cell wall [GO:0005618]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; mycolic acid biosynthetic process [GO:0071768],9634230; 10844652; 12473649; 19099550; 18535659; 19183278; 21969609; 16356931; 19439410,X-ray crystallography (5),"FUNCTION: Involved in the biosynthesis of hydroxymycolate, a common precursor of oxygenated mycolic acids (methoxy-mycolate and keto-mycolate). Probably transfers a methyl group from the S-adenosylmethionine (SAM) cofactor and, subsequently or simultaneously, a water molecule onto the double bound of ethylene substrates, leading to the formation of the hydroxylated product at the distal position. Involved in the activation of the antitubercular drug thiacetazone (TAC). {ECO:0000269|PubMed:10844652, ECO:0000269|PubMed:12473649}.",MTRMAEKPISPTKTRTRFEDIQAHYDVSDDFFALFQDPTRTYSCAYFEPPELTLEEAQYAKVDLNLDKLDLKPGMTLLDIGCGWGTTMRRAVERFDVNVIGLTLSKNQHARCEQVLASIDTNRSRQVLLQGWEDFAEPVDRIVSIEAFEHFGHENYDDFFKRCFNIMPADGRMTVQSSVSYHPYEMAARGKKLSFETARFIKFIVTEIFPGGRLPSTEMMVEHGEKAGFTVPEPLSLRPHYIKTLRIWGDTLQSNKDKAIEVTSEEVYNRYMKYLRGCEHYFTDEMLDCSLVTYLKPGAAA,"34,670",301,CFA/CMAS family,mycolic acid biosynthetic process [GO:0071768],methyltransferase activity [GO:0008168]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cell wall [GO:0005618]; plasma membrane [GO:0005886],hma mma4,,1
P9WJV3,MMPL4_MYCTU,Rv0450c,mmpL4 Rv0450c MTV037.14c,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0016021; GO:0040007; GO:0044119,IPR004869; IPR004707; ,,mmpL4,,Siderophore exporter MmpL4,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007]; growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405],9634230; 12065475; 15908378; 21969609; 23431276; 24737322,,"FUNCTION: Part of an export system, which is required for biosynthesis and secretion of siderophores (PubMed:23431276). Essential for normal replication during the active-growth phase of the murine tuberculosis model (PubMed:15908378). {ECO:0000269|PubMed:15908378, ECO:0000269|PubMed:23431276}.",MSTKFANDSNTNARPEKPFIARMIHAFAVPIILGWLAVCVVVTVFVPSLEAVGQERSVSLSPKDAPSFEAMGRIGMVFKEGDSDSFAMVIIEGNQPLGDAAHKYYDGLVAQLRADKKHVQSVQDLWGDPLTAAGVQSNDGKAAYVQLSLAGNQGTPLANESVEAVRSIVESTPAPPGIKAYVTGPSALAADMHHSGDRSMARITMVTVAVIFIMLLLVYRSIITVVLLLITVGVELTAARGVVAVLGHSGAIGLTTFAVSLLTSLAIAAGTDYGIFIIGRYQEARQAGEDKEAAYYTMYRGTAHVILGSGLTIAGATFCLSFARMPYFQTLGIPCAVGMLVAVAVALTLGPAVLHVGSRFGLFDPKRLLKVRGWRRVGTVVVRWPLPVLVATCAIALVGLLALPGYKTSYNDRDYLPDFIPANQGYAAADRHFSQARMKPEILMIESDHDMRNPADFLVLDKLAKGIFRVPGISRVQAITRPEGTTMDHTSIPFQISMQNAGQLQTIKYQRDRANDMLKQADEMATTIAVLTRMHSLMAEMASTTHRMVGDTEEMKEITEELRDHVADFDDFWRPIRSYFYWEKHCYGIPICWSFRSIFDALDGIDKLSEQIGVLLGDLREMDRLMPQMVAQIPPQIEAMENMRTMILTMHSTMTGIFDQMLEMSDNATAMGKAFDAAKNDDSFYLPPEVFKNKDFQRAMKSFLSSDGHAARFIILHRGDPQSPEGIKSIDAIRTAAEESLKGTPLEDAKIYLAGTAAVFHDISEGAQWDLLIAAISSLCLIFIIMLIITRAFIAAAVIVGTVALSLGASFGLSVLLWQHILAIHLHWLVLAMSVIVLLAVGSDYNLLLVSRFKQEIGAGLKTGIIRSMGGTGKVVTNAGLVFAVTMASMAVSDLRVIGQVGTTIGLGLLFDTLIVRSFMTPSIAALLGRWFWWPLRVRSRPARTPTVPSETQPAGRPLAMSSDRLG,"105,234",967,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",growth [GO:0040007]; growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV037.14c,1
P9WJT3,MMPS2_MYCTU,Rv0506,mmpS2 Rv0506 MTCY20G9.33,GO:0005576; GO:0005886; GO:0016021,IPR008693; IPR038468; ,,mmpS2,,Probable transport accessory protein MmpS2,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609; 24737322,,,MISVSGAVKRMWLLLAIVVVAVVGGLGIYRLHSIFGVHEQPTVMVKPDFDVPLFNPKRVTYEVFGPAKTAKIAYLDPDARVHRLDSVSLPWSVTVETTLPAVSVNLMAQSNADVISCRIIVNGAVKDERSETSPRALTSCQVSSG,"15,676",145,MmpS family,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20G9.33,1
P9WJS9,MMPS4_MYCTU,Rv0451c,mmpS4 Rv0451c MTV037.15c,GO:0005886; GO:0009405; GO:0016021,IPR008693; IPR038468; ,,mmpS4,,Siderophore export accessory protein MmpS4 (PGB14T-X),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 9639933; 12065475; 21969609; 24737322; 23431276,NMR spectroscopy (1),"FUNCTION: Part of an export system, which is required for biosynthesis and secretion of siderophores. Essential for virulence. {ECO:0000269|PubMed:23431276}.",MLMRTWIPLVILVVVIVGGFTVHRIRGFFGSENRPSYSDTNLENSKPFNPKHLTYEIFGPPGTVADISYFDVNSEPQRVDGAVLPWSLHITTNDAAVMGNIVAQGNSDSIGCRITVDGKVRAERVSNEVNAYTYCLVKSA,"15,404",140,MmpS family,pathogenesis [GO:0009405],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV037.15c,1
P9WH77,NRDZ_MYCTU,Rv0570,nrdZ Rv0570,GO:0004748; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006260; GO:0031419; GO:0071897,IPR005144; IPR000788; IPR013509; IPR013344; IPR008926; ,,nrdZ,DOMAIN 21 109 ATP-cone. {ECO:0000255|PROSITE-ProRule:PRU00492}.,Vitamin B12-dependent ribonucleoside-diphosphate reductase (B12-dependent RNR) (EC 1.17.4.1) (Ribonucleotide reductase),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260]",9634230; 14573627; 12953092; 19099550; 18474359; 18400743; 21969609,,FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides (By similarity). {ECO:0000250}.,MPGERRRFAQATKSVGVSWPAKVRRRDGTLVPFDIARIEAAVTRAAREVACDDPDMPGTVAKAVADALGRGIAPVEDIQDCVEARLGEAGLDDVARVYIIYRQRRAELRTAKALLGVRDELKLSLAAVTVLRERYLLHDEQGRPAESTGELMDRSARCVAAAEDQYEPGSSRRWAERFATLLRNLEFLPNSPTLMNSGTDLGLLAGCFVLPIEDSLQSIFATLGQAAELQRAGGGTGYAFSHLRPAGDRVASTGGTASGPVSFLRLYDSAAGVVSMGGRRRGACMAVLDVSHPDICDFVTAKAESPSELPHFNLSVGVTDAFLRAVERNGLHRLVNPRTGKIVARMPAAELFDAICKAAHAGGDPGLVFLDTINRANPVPGRGRIEATNPCGEVPLLPYESCNLGSINLARMLADGRVDWDRLEEVAGVAVRFLDDVIDVSRYPFPELGEAARATRKIGLGVMGLAELLAALGIPYDSEEAVRLATRLMRRIQQAAHTASRRLAEERGAFPAFTDSRFARSGPRRNAQVTSVAPTGTISLIAGTTAGIEPMFAIAFTRAIVGRHLLEVNPCFDRLARDRGFYRDELIAEIAQRGGVRGYPRLPAEVRAAFPTAAEIAPQWHLRMQAAVQRHVEAAVSKTVNLPATATVDDVRAIYVAAWKAKVKGITVYRYGSREGQVLSYAAPKPLLAQADTEFSGGCAGRSCEF,"76,106",706,Ribonucleoside diphosphate reductase class-2 family,DNA biosynthetic process [GO:0071897]; DNA replication [GO:0006260],"ATP binding [GO:0005524]; cobalamin binding [GO:0031419]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O06769,NCASE_MYCTU,Rv0669c,Rv0669c,GO:0005618; GO:0017040; GO:0042759; GO:0046512; GO:0046514; GO:0046872; GO:0102121,IPR006823; IPR038445; IPR031331; IPR031329; ,,,,Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase),cell wall [GO:0005618]; ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],9634230; 12368430; 10593963; 20139604; 21969609,,"FUNCTION: Catalyzes the cleavage of the N-acyl linkage of the ceramides (Cers) to yield sphingosine (Sph) and free fatty acid. Also catalyzes the synthesis of Cers from Sph and fatty acid. Cers containning C6-C24 fatty acids are well hydrolyzed, and Cers with mono unsaturated fatty acids are much more hydrolyzed than those with saturated fatty acids. {ECO:0000269|PubMed:10593963, ECO:0000269|PubMed:20139604}.",MLSVGRGIADITGEAADCGMLGYGKSDQRTAGIHQRLRSRAFVFRDDSQDGDARLLLIVAELPLPMQNVNEEVLRRLADLYGDTYSEQNTLITATHTHAGPGGYCGYLLYNLTTSGFRPATFAAIVDGIVESVEHAHADVAPAEVSLSHGELYGASINRSPSAFDRNPPADKAFFPKRVDPHTTLVRIDRGEATVGVIHFFATHGTSMTNRNHLISGDNKGFAAYHWERTVGGADYLAGQPDFIAAFAQTNPGDMSPNVDGPLSPEAPPDREFDNTRRTGLCQFEDAFTQLSGATPIGAGIDARFTYVDLGSVLVRGEYTPDGEERRTGRPMFGAGAMAGTDEGPGFHGFRQGRNPFWDRLSRAMYRLARPTAAAQAPKGIVMPARLPNRIHPFVQEIVPVQLVRIGRLYLIGIPGEPTIVAGLRLRRMVASIVGADLADVLCVGYTNAYIHYVTTPEEYLEQRYEGGSTLFGRWELCALMQTVAELAEAMRDGRPVTLGRRPRPTRELSWVRGAPADAGSFGAVIAEPSATYRPGQAVEAVFVSALPNNDLRRGGTYLEVVRREGASWVRIADDGDWATSFRWQRQGRAGSHVSIRWDVPGDTTPGQYRIVHHGTARDRNGMLTAFSATTREFTVV,"69,490",637,Neutral ceramidase family,ceramide catabolic process [GO:0046514]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],ceramidase activity [GO:0102121]; metal ion binding [GO:0046872]; N-acylsphingosine amidohydrolase activity [GO:0017040],cell wall [GO:0005618],,,1
P9WKF5,KAD_MYCTU,Rv0733,adk Rv0733 MTV041.07,GO:0004017; GO:0004550; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006144; GO:0009123; GO:0009132; GO:0009141; GO:0044209,IPR000850; IPR033690; IPR027417; ,,adk,,Adenylate kinase (AK) (EC 2.7.4.3) (ATP-AMP transphosphorylase) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; AMP salvage [GO:0044209]; nucleoside diphosphate metabolic process [GO:0009132]; nucleoside monophosphate metabolic process [GO:0009123]; nucleoside triphosphate metabolic process [GO:0009141]; purine nucleobase metabolic process [GO:0006144],9634230; 10398370; 20066036; 21969609; 14705932; 16672241,NMR spectroscopy (1); X-ray crystallography (1),"FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Has a broad specificity for nucleoside triphosphates, being highly active with ATP or dATP as phosphate donors, and less active with GTP or UTP. {ECO:0000255|HAMAP-Rule:MF_00235, ECO:0000269|PubMed:10398370}.",MRVLLLGPPGAGKGTQAVKLAEKLGIPQISTGELFRRNIEEGTKLGVEAKRYLDAGDLVPSDLTNELVDDRLNNPDAANGFILDGYPRSVEQAKALHEMLERRGTDIDAVLEFRVSEEVLLERLKGRGRADDTDDVILNRMKVYRDETAPLLEYYRDQLKTVDAVGTMDEVFARALRALGK,"20,125",181,Adenylate kinase family,AMP salvage [GO:0044209]; nucleoside diphosphate metabolic process [GO:0009132]; nucleoside monophosphate metabolic process [GO:0009123]; nucleoside triphosphate metabolic process [GO:0009141]; purine nucleobase metabolic process [GO:0006144],adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV041.07,1
P96264,LPQL_MYCTU,Rv0418,lpqL Rv0418 LH57_02235,GO:0004177; GO:0005576; GO:0005886; GO:0046872,IPR003137; IPR007484; ,,lpqL,DOMAIN 140 231 PA. {ECO:0000255}.,Probable lipoprotein aminopeptidase LpqL (EC 3.4.11.1) (Leucine aminopeptidase) (Lipoprotein LpqL),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872],9634230; 21969609; 24093492,,FUNCTION: An aminopeptidase; acts on free N-terminal amino groups with a very strong preference for Leu in the first position. {ECO:0000250|UniProtKB:Q9HZQ8}.,MVNKSRMMPAVLAVAVVVAFLTTGCIRWSTQSRPVVNGPAAAEFAVALRNRVSTDAMMAHLSKLQDIANANDGTRAVGTPGYQASVDYVVNTLRNSGFDVQTPEFSARVFKAEKGVVTLGGNTVEARALEYSLGTPPDGVTGPLVAAPADDSPGCSPSDYDRLPVSGAVVLVDRGVCPFAQKEDAAAQRGAVALIIADNIDEQAMGGTLGANTDVKIPVVSVTKSVGFQLRGQSGPTTVKLTASTQSFKARNVIAQTKTGSSANVVMAGAHLDSVPEGPGINDNGSGVAAVLETAVQLGNSPHVSNAVRFAFWGAEEFGLIGSRNYVESLDIDALKGIALYLNFDMLASPNPGYFTYDGDQSLPLDARGQPVVPEGSAGIERTFVAYLKMAGKTAQDTSFDGRSDYDGFTLAGIPSGGLFSGAEVKKSAEQAELWGGTADEPFDPNYHQKTDTLDHIDRTALGINGAGVAYAVGLYAQDLGGPNGVPVMADRTRHLIAKP,"52,042",500,"Peptidase M28 family, M28A subfamily",,aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,LH57_02235,1
P9WK21,MAP11_MYCTU,Rv0734,map-1 mapA Rv0734,GO:0005506; GO:0005886; GO:0006555; GO:0016151; GO:0030145; GO:0035551; GO:0050897; GO:0070006,IPR036005; IPR000994; IPR001714; IPR002467; ,,map-1,,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M),plasma membrane [GO:0005886]; cobalt ion binding [GO:0050897]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; nickel cation binding [GO:0016151]; methionine metabolic process [GO:0006555]; protein initiator methionine removal involved in protein maturation [GO:0035551],9634230; 19688379; 20363127; 21969609,,"FUNCTION: Removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). Requires deformylation of the N(alpha)-formylated initiator methionine before it can be hydrolyzed. {ECO:0000255|HAMAP-Rule:MF_01974, ECO:0000269|PubMed:19688379}.",MRPLARLRGRRVVPQRSAGELDAMAAAGAVVAAALRAIRAAAAPGTSSLSLDEIAESVIRESGATPSFLGYHGYPASICASINDRVVHGIPSTAEVLAPGDLVSIDCGAVLDGWHGDAAITFGVGALSDADEALSEATRESLQAGIAAMVVGNRLTDVAHAIETGTRAAELRYGRSFGIVAGYGGHGIGRQMHMDPFLPNEGAPGRGPLLAAGSVLAIEPMLTLGTTKTVVLDDKWTVTTADGSRAAHWEHTVAVTDDGPRILTLG,"27,277",266,"Peptidase M24A family, Methionine aminopeptidase type 1 subfamily",methionine metabolic process [GO:0006555]; protein initiator methionine removal involved in protein maturation [GO:0035551],cobalt ion binding [GO:0050897]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; nickel cation binding [GO:0016151],plasma membrane [GO:0005886],mapA,,1
Q6MX40,MAZF1_MYCTU,Rv0456A,mazF1 mazF-mt2 Rv0456A,GO:0003677; GO:0004519,IPR003477; IPR011067; ,,mazF1,,Probable endoribonuclease MazF1 (EC 3.1.-.-) (Probable toxin MazF1),DNA binding [GO:0003677]; endonuclease activity [GO:0004519],9634230; 15718296; 16611633,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system, its cognate antitoxin is MazE1 (Probable). Probably an endoribonuclease (By similarity). {ECO:0000250|UniProtKB:P9WIH9, ECO:0000305}.",MLRGEIWQVDLDPARGSAANMRRPAVIVSNDRANAAAIRLDRGVVPVVPVTSNTEKVPIPGVVAGSERWPGRRFEGAGPAGWIRRCATSPLPS,"9,925",93,PemK/MazF family,,DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,mazF-mt2,,1
O06779,MAZE2_MYCTU,Rv0660c,mazE2 mazE-mt4 Rv0660c,GO:0006355,IPR002145; ,,mazE2,,Probable antitoxin MazE2,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 16611633,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. {ECO:0000305}.,MLSFRADDHDVDLADAWARRLHIGRSELLRDALRRHLAALAADQDVQAYTERPLTDDENALAEIADWGPAEDWADWADAAR,"9,169",81,,"regulation of transcription, DNA-templated [GO:0006355]",,,mazE-mt4,,1
P9WPB3,CMAS3_MYCTU,Rv0470c,pcaA cma3 cmaA3 CMAS-3 Rv0470c,GO:0005737; GO:0008610; GO:0008825; GO:0009405; GO:0042783; GO:0046500; GO:0052167; GO:0071768,IPR003333; IPR029063; ,,pcaA,,Cyclopropane mycolic acid synthase 3 (CMAS) (EC 2.1.1.79) (Cyclopropane-fatty-acyl-phospholipid synthase) (CFA synthase) (Cyclopropane fatty acid synthase) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cytoplasm [GO:0005737]; cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; active evasion of host immune response [GO:0042783]; lipid biosynthetic process [GO:0008610]; modulation by symbiont of host innate immune response [GO:0052167]; mycolic acid biosynthetic process [GO:0071768]; pathogenesis [GO:0009405]; S-adenosylmethionine metabolic process [GO:0046500],9634230; 10882107; 18094751; 19099550; 19477414; 19439410; 21969609; 22621931; 11756461,X-ray crystallography (1),"FUNCTION: Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:10882107, ECO:0000269|PubMed:22621931}.",MSVQLTPHFGNVQAHYDLSDDFFRLFLDPTQTYSCAYFERDDMTLQEAQIAKIDLALGKLNLEPGMTLLDIGCGWGATMRRAIEKYDVNVVGLTLSENQAGHVQKMFDQMDTPRSRRVLLEGWEKFDEPVDRIVSIGAFEHFGHQRYHHFFEVTHRTLPADGKMLLHTIVRPTFKEGREKGLTLTHELVHFTKFILAEIFPGGWLPSIPTVHEYAEKVGFRVTAVQSLQLHYARTLDMWATALEANKDQAIAIQSQTVYDRYMKYLTGCAKLFRQGYTDVDQFTLEK,"33,028",287,CFA/CMAS family,active evasion of host immune response [GO:0042783]; lipid biosynthetic process [GO:0008610]; modulation by symbiont of host innate immune response [GO:0052167]; mycolic acid biosynthetic process [GO:0071768]; pathogenesis [GO:0009405]; S-adenosylmethionine metabolic process [GO:0046500],cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825],cytoplasm [GO:0005737],cma3 cmaA3 CMAS-3,,1
P9WPB5,CMAS2_MYCTU,Rv0503c,cmaA2 cma2 CMAS-2 Rv0503c MTCY20G9.30c,GO:0001666; GO:0005829; GO:0005886; GO:0008610; GO:0008825; GO:0046500; GO:0052167; GO:0071766; GO:0071768; GO:0071769,IPR003333; IPR029063; ,,cmaA2,,Cyclopropane mycolic acid synthase 2 (CMAS) (EC 2.1.1.79) (Cyclopropane-fatty-acyl-phospholipid synthase) (CFA synthase) (Cyclopropane fatty acid synthase) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cytosol [GO:0005829]; plasma membrane [GO:0005886]; cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; Actinobacterium-type cell wall biogenesis [GO:0071766]; lipid biosynthetic process [GO:0008610]; modulation by symbiont of host innate immune response [GO:0052167]; mycolate cell wall layer assembly [GO:0071769]; mycolic acid biosynthetic process [GO:0071768]; response to hypoxia [GO:0001666]; S-adenosylmethionine metabolic process [GO:0046500],7592990; 9634230; 11092877; 16741578; 18094751; 19099550; 19439410; 20472794; 21969609; 11756461,X-ray crystallography (2),"FUNCTION: Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:11092877, ECO:0000269|PubMed:7592990}.",MTSQGDTTSGTQLKPPVEAVRSHYDKSNEFFKLWLDPSMTYSCAYFERPDMTLEEAQYAKRKLALDKLNLEPGMTLLDIGCGWGSTMRHAVAEYDVNVIGLTLSENQYAHDKAMFDEVDSPRRKEVRIQGWEEFDEPVDRIVSLGAFEHFADGAGDAGFERYDTFFKKFYNLTPDDGRMLLHTITIPDKEEAQELGLTSPMSLLRFIKFILTEIFPGGRLPRISQVDYYSSNAGWKVERYHRIGANYVPTLNAWADALQAHKDEAIALKGQETYDIYMHYLRGCSDLFRDKYTDVCQFTLVK,"34,660",302,CFA/CMAS family,Actinobacterium-type cell wall biogenesis [GO:0071766]; lipid biosynthetic process [GO:0008610]; modulation by symbiont of host innate immune response [GO:0052167]; mycolate cell wall layer assembly [GO:0071769]; mycolic acid biosynthetic process [GO:0071768]; response to hypoxia [GO:0001666]; S-adenosylmethionine metabolic process [GO:0046500],cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825],cytosol [GO:0005829]; plasma membrane [GO:0005886],cma2 CMAS-2,MTCY20G9.30c,1
P9WQ57,FAA30_MYCTU,Rv0404,fadD30 Rv0404,GO:0005524; GO:0005886; GO:0006633; GO:0008610; GO:0016874; GO:0040007; GO:0052556; GO:0070566; GO:0071766,IPR000873; ,,fadD30,,Long-chain-fatty-acid--AMP ligase FadD30 (FAAL) (EC 6.2.1.-) (Acyl-AMP synthetase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; lipid biosynthetic process [GO:0008610]; positive regulation by symbiont of host immune response [GO:0052556],9634230; 15042094; 19099550; 21969609,,"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-adenylates (acyl-AMP), which are then transferred to the multifunctional polyketide synthase (PKS) for further chain extension. {ECO:0000269|PubMed:15042094}.",MSVISTLRDRATTTPSDEAFVFMDYDTKTGDQIDRMTWSQLYSRVTAVSAYLISYGRHADRRRTAAISAPQGLDYVAGFLGALCAGWTPVPLPEPLGSLRDKRTGLAVLDCAADVVLTTSQAETRVRATIATHGASVTTPVIALDTLDEPSGDNCDLDSQLSDWSSYLQYTSGSTANPRGVVLSMRNVTENVDQIIRNYFRHEGGAPRLPSSVVSWLPLYHDMGLMVGLFIPLFVGCPVILTSPEAFIRKPARWMQLLAKHQAPFSAAPNFAFDLAVAKTSEEDMAGLDLGHVNTIINGAEQVQPNTITKFLRRFRPYNLMPAAVKPSYGMAEAVVYLATTKAGSPPTSTEFDADSLARGHAELSTFETERATRLIRYHSDDKEPLLRIVDPDSNIELGPGRIGEIWIHGKNVSTGYHNADDALNRDKFQASIREASAGTPRSPWLRTGDLGFIVGDEFYIVGRMKDLIIQDGVNHYPDDIETTVKEFTGGRVAAFSVSDDGVEHLVIAAEVRTEHGPDKVTIMDFSTIKRLVVSALSKLHGLHVTDFLLVPPGALPKTTSGKISRAACAKQYGANKLQRVATFP,"63,843",585,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; lipid biosynthetic process [GO:0008610]; positive regulation by symbiont of host immune response [GO:0052556],adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
P9WPK9,GCS2_MYCTU,Rv0433,Rv0433 MTCY22G10.30,GO:0004357; GO:0005524; GO:0042398,IPR006336; IPR014746; IPR011793; ,,,,Putative glutamate--cysteine ligase 2 (EC 6.3.2.2) (Gamma-glutamylcysteine synthetase 2) (GCS 2) (Gamma-GCS 2),ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357]; cellular modified amino acid biosynthetic process [GO:0042398],9634230; 21969609,,FUNCTION: ATP-dependent carboxylate-amine ligase which exhibits weak glutamate--cysteine ligase activity. {ECO:0000255|HAMAP-Rule:MF_01609}.,MPARRSAARIDFAGSPRPTLGVEWEFALVDSQTRDLSNEATAVIAEIGENPRVHKELLRNTVEIVSGICECTAEAMQDLRDTLGPARQIVRDRGMELFCAGTHPFARWSAQKLTDAPRYAELIKRTQWWGRQMLIWGVHVHVGIRSAHKVMPIMTSLLNYYPHLLALSASSPWWGGEDTGYASNRAMMFQQLPTAGLPFHFQRWAEFEGFVYDQKKTGIIDHMDEIRWDIRPSPHLGTLEVRICDGVSNLRELGALVALTHCLIVDLDRRLDAGETLPTMPPWHVQENKWRAARYGLDAVIILDADSNERLVTDDLADVLTRLEPVAKSLNCADELAAVSDIYRDGASYQRQLRVAQQHDGDLRAVVDALVAELVI,"42,295",376,"Glutamate--cysteine ligase type 2 family, YbdK subfamily",cellular modified amino acid biosynthetic process [GO:0042398],ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357],,,MTCY22G10.30,1
P9WN63,GAL1_MYCTU,Rv0620,galK Rv0620 MTCY19H5.01c MTCY20H10.01,GO:0004335; GO:0005524; GO:0005534; GO:0005737; GO:0006012; GO:0046872,IPR000705; IPR022963; IPR019741; IPR019539; IPR013750; IPR036554; IPR006204; IPR006206; IPR020568; IPR014721; ,,galK,,Galactokinase (EC 2.7.1.6) (Galactose kinase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; metal ion binding [GO:0046872]; galactose metabolic process [GO:0006012],9634230; 19099550,,FUNCTION: Catalyzes the transfer of the gamma-phosphate of ATP to D-galactose to form alpha-D-galactose-1-phosphate (Gal-1-P). {ECO:0000255|HAMAP-Rule:MF_00246}.,MTVSYGAPGRVNLIGEHTDYNLGFALPIALPRRTVVTFTPEHTGAITARSDRADGSARIPLDTTPGQVTGWAAYAAGAIWALRGAGHPVPGGAMSITSDVEIGSGLSSSAALIGAVLGAVGAATGTRIDRLERARLAQRAENDYVGAPTGLLDHLAALFGAPKTALLIDFRDITVRPVAFDPDACDVVLLLMDSRARHCHAGGEYALRRASCERAAADLGVSSLRAVQDRGLAALGAIADPIDARRARHVLTENQRVLDFAAALADSDFTAAGQLLTASHESMREDFAITTERIDLIAESAVRAGALGARMTGGGFGGAVIALVPADRARDVADTVRRAAVTAGYDEPAVSRTYAAPGAAECR,"37,572",363,"GHMP kinase family, GalK subfamily",galactose metabolic process [GO:0006012],ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY19H5.01c MTCY20H10.01,1
P9WIR3,CFP32_MYCTU,Rv0577,cfp32 cfp30B TB27.3 Rv0577 MTV039.15,GO:0005576; GO:0005886; GO:0009405,IPR029068; IPR004360; IPR037523; ,,cfp32,DOMAIN 11 129 VOC 1. {ECO:0000255|PROSITE-ProRule:PRU01163}.; DOMAIN 143 257 VOC 2. {ECO:0000255|PROSITE-ProRule:PRU01163}.,Putative glyoxylase CFP32 (27 kDa antigen Cfp30B),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 14638775; 20975714; 21969609; 21761124; 22415304; ,X-ray crystallography (1),"FUNCTION: May function as a glyoxylase involved in the methylglyoxal detoxification pathway (PubMed:20975714). Induces maturation of dendritic cells in a TLR2-dependent manner, causing increased expression of cell-surface molecules (CD80, CD86, MHC class I and II) and proinflammatory cytokines (TNF-alpha, IL-6, IL-1 beta and IL-12p70). Acts via both the NF-kappa-B and MAPK signaling pathways. Induces Th1-polarized immune responses (PubMed:22415304). {ECO:0000269|PubMed:20975714, ECO:0000269|PubMed:22415304}.",MPKRSEYRQGTPNWVDLQTTDQSAAKKFYTSLFGWGYDDNPVPGGGGVYSMATLNGEAVAAIAPMPPGAPEGMPPIWNTYIAVDDVDAVVDKVVPGGGQVMMPAFDIGDAGRMSFITDPTGAAVGLWQANRHIGATLVNETGTLIWNELLTDKPDLALAFYEAVVGLTHSSMEIAAGQNYRVLKAGDAEVGGCMEPPMPGVPNHWHVYFAVDDADATAAKAAAAGGQVIAEPADIPSVGRFAVLSDPQGAIFSVLKPAPQQ,"27,343",261,,pathogenesis [GO:0009405],,extracellular region [GO:0005576]; plasma membrane [GO:0005886],cfp30B TB27.3,MTV039.15,1
P9WP03,DEOC_MYCTU,Rv0478,deoC Rv0478 MTCY20G9.04,GO:0004139; GO:0005737; GO:0009264; GO:0016052; GO:0046386,IPR013785; IPR011343; IPR002915; IPR028581; ,,deoC,,Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),cytoplasm [GO:0005737]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],9634230; 19099550; 21969609,,FUNCTION: Catalyzes a reversible aldol reaction between acetaldehyde and D-glyceraldehyde 3-phosphate to generate 2-deoxy-D-ribose 5-phosphate. {ECO:0000255|HAMAP-Rule:MF_00114}.,MLGQPTRAQLAALVDHTLLKPETTRADVAALVAEAAELGVYAVCVSPSMVPVAVQAGGVRVAAVTGFPSGKHVSSVKAHEAAAALASGASEIDMVIDIGAALCGDIDAVRSDIEAVRAAAAGAVLKVIVESAVLLGQSNAHTLVDACRAAEDAGADFVKTSTGCHPAGGATVRAVELMAETVGPRLGVKASGGIRTAADAVAMLNAGATRLGLSGTRAVLDGLS,"22,068",224,"DeoC/FbaB aldolase family, DeoC type 1 subfamily",carbohydrate catabolic process [GO:0016052]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],deoxyribose-phosphate aldolase activity [GO:0004139],cytoplasm [GO:0005737],,MTCY20G9.04,1
P9WHH9,DLDH_MYCTU,Rv0462,lpdC lpd Rv0462 MTV038.06,GO:0004148; GO:0005576; GO:0005829; GO:0005886; GO:0006096; GO:0006099; GO:0009055; GO:0009405; GO:0015036; GO:0016209; GO:0016655; GO:0035375; GO:0040007; GO:0045254; GO:0045454; GO:0050660; GO:0055114; GO:0070404,IPR036188; IPR023753; IPR016156; IPR006258; IPR001100; IPR004099; IPR012999; ,,lpdC,,Dihydrolipoyl dehydrogenase (LPD) (EC 1.8.1.4) (Component of peroxynitrite reductase/peroxidase complex) (Component of PNR/P) (Dihydrolipoamide dehydrogenase) (E3 component of alpha-ketoacid dehydrogenase complexes),"cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]; antioxidant activity [GO:0016209]; dihydrolipoyl dehydrogenase activity [GO:0004148]; disulfide oxidoreductase activity [GO:0015036]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; zymogen binding [GO:0035375]; cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]; tricarboxylic acid cycle [GO:0006099]",9634230; 11560483; 11799204; 16045627; 21238944; 21969609; 16093239; 20078138,X-ray crystallography (3),"FUNCTION: Lipoamide dehydrogenase is an essential component of the alpha-ketoacid dehydrogenase complexes, namely the pyruvate dehydrogenase (PDH) complex, the branched-chain alpha-ketoacid dehydrogenase (BCKADH) complex, and likely also the 2-oxoglutarate dehydrogenase (ODH) complex. Catalyzes the reoxidation of dihydrolipoyl groups which are covalently attached to the lipoate acyltransferase components (E2) of the complexes. Is also able to catalyze the transhydrogenation of NADH and thio-NAD(+) in the absence of D,L-lipoamide, and the NADH-dependent reduction of quinones in vitro.; FUNCTION: Together with AhpC, AhpD and DlaT, Lpd constitutes an NADH-dependent peroxidase active against hydrogen and alkyl peroxides as well as serving as a peroxynitrite reductase, thus protecting the bacterium against reactive nitrogen intermediates and oxidative stress generated by the host immune system.; FUNCTION: Appears to be essential for Mtb pathogenesis.",MTHYDVVVLGAGPGGYVAAIRAAQLGLSTAIVEPKYWGGVCLNVGCIPSKALLRNAELVHIFTKDAKAFGISGEVTFDYGIAYDRSRKVAEGRVAGVHFLMKKNKITEIHGYGTFADANTLLVDLNDGGTESVTFDNAIIATGSSTRLVPGTSLSANVVTYEEQILSRELPKSIIIAGAGAIGMEFGYVLKNYGVDVTIVEFLPRALPNEDADVSKEIEKQFKKLGVTILTATKVESIADGGSQVTVTVTKDGVAQELKAEKVLQAIGFAPNVEGYGLDKAGVALTDRKAIGVDDYMRTNVGHIYAIGDVNGLLQLAHVAEAQGVVAAETIAGAETLTLGDHRMLPRATFCQPNVASFGLTEQQARNEGYDVVVAKFPFTANAKAHGVGDPSGFVKLVADAKHGELLGGHLVGHDVAELLPELTLAQRWDLTASELARNVHTHPTMSEALQECFHGLVGHMINF,"49,239",464,Class-I pyridine nucleotide-disulfide oxidoreductase family,cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]; tricarboxylic acid cycle [GO:0006099],"antioxidant activity [GO:0016209]; dihydrolipoyl dehydrogenase activity [GO:0004148]; disulfide oxidoreductase activity [GO:0015036]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NADH binding [GO:0070404]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; zymogen binding [GO:0035375]",cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254],lpd,MTV038.06,1
P9WIJ3,DEF_MYCTU,Rv0429c,def Rv0429c MTCY22G10.26c,GO:0006412; GO:0018206; GO:0031365; GO:0035601; GO:0040007; GO:0042586; GO:0043686; GO:0046872,IPR023635; IPR036821; ,,def,,Peptide deformylase (PDF) (EC 3.5.1.88) (Polypeptide deformylase),metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586]; co-translational protein modification [GO:0043686]; growth [GO:0040007]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein deacylation [GO:0035601]; translation [GO:0006412],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions (By similarity). {ECO:0000250}.,MAVVPIRIVGDPVLHTATTPVTVAADGSLPADLAQLIATMYDTMDAANGVGLAANQIGCSLRLFVYDCAADRAMTARRRGVVINPVLETSEIPETMPDPDTDDEGCLSVPGESFPTGRAKWARVTGLDADGSPVSIEGTGLFARMLQHETGHLDGFLYLDRLIGRYARNAKRAVKSHGWGVPGLSWLPGEDPDPFGH,"20,939",197,Polypeptide deformylase family,co-translational protein modification [GO:0043686]; growth [GO:0040007]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein deacylation [GO:0035601]; translation [GO:0006412],metal ion binding [GO:0046872]; peptide deformylase activity [GO:0042586],,,MTCY22G10.26c,1
P9WIP9,HBHA_MYCTU,Rv0475,hbhA Rv0475 MTCY20G9.01,GO:0005618; GO:0005829; GO:0005886; GO:0007157; GO:0008201; GO:0009405; GO:0009986; GO:0042802; GO:0044078,IPR020340; ,Itself,hbhA,,Heparin-binding hemagglutinin (Adhesin),cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; pathogenesis [GO:0009405]; positive regulation by symbiont of host receptor-mediated endocytosis [GO:0044078],9770536; 9634230; 11449276; 21969609,,"FUNCTION: Required for extrapulmonary dissemination. Mediates adherence to epithelial cells by binding to sulfated glycoconjugates present at the surface of these cells; binds heparin, dextran sulfate, fucoidan and chondroitin sulfate. Promotes hemagglutination of erythrocytes of certain host species. Induces mycobacterial aggregation. {ECO:0000269|PubMed:11449276}.",MAENSNIDDIKAPLLAALGAADLALATVNELITNLRERAEETRTDTRSRVEESRARLTKLQEDLPEQLTELREKFTAEELRKAAEGYLEAATSRYNELVERGEAALERLRSQQSFEEVSARAEGYVDQAVELTQEALGTVASQTRAVGERAAKLVGIELPKKAAPAKKAAPAKKAAPAKKAAAKKAPAKKAAAKKVTQK,"21,534",199,,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; pathogenesis [GO:0009405]; positive regulation by symbiont of host receptor-mediated endocytosis [GO:0044078],heparin binding [GO:0008201]; identical protein binding [GO:0042802],cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY20G9.01,1
P9WMP7,HEM1_MYCTU,Rv0509,hemA Rv0509 MTCY20G9.36,GO:0006782; GO:0008883; GO:0040007; GO:0050661,IPR000343; IPR015896; IPR015895; IPR018214; IPR036453; IPR036343; IPR036291; IPR006151; ,,hemA,,Glutamyl-tRNA reductase (GluTR) (EC 1.2.1.70),glutamyl-tRNA reductase activity [GO:0008883]; NADP binding [GO:0050661]; growth [GO:0040007]; protoporphyrinogen IX biosynthetic process [GO:0006782],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the NADPH-dependent reduction of glutamyl-tRNA(Glu) to glutamate 1-semialdehyde (GSA). {ECO:0000255|HAMAP-Rule:MF_00087}.,MSVLLFGVSHRSAPVVVLEQLSIDESDQVKIIDRVLASPLVTEAMVLSTCNRVEVYAVVDAFHGGLSVIGQVLAEHSGMSMGELTKYAYVRYSEAAVEHLFAVASGLDSAVIGEQQVLGQVRRAYAVAESNRTVGRVLHELAQRALSVGKRVHSETAIDAAGASVVSVALGMAERKLGSLAGTTAVVIGAGAMGALSAVHLTRAGVGHIQVLNRSLSRAQRLARRIRESGVPAEALALDRLANVLADADVVVSCTGAVRPVVSLADVHHALAAARRDEATRPLVICDLGMPRDVDPAVARLPCVWVVDVDSVQHEPSAHAAAADVEAARHIVAAEVASYLVGQRMAEVTPTVTALRQRAAEVVEAELLRLDNRLPGLQSVQREEVARTVRRVVDKLLHAPTVRIKQLASAPGGDSYAEALRELFELDQTAVDAVATAGELPVVPSGFDAESRRGGGDMQSSPKRSPSN,"49,361",468,Glutamyl-tRNA reductase family,growth [GO:0040007]; protoporphyrinogen IX biosynthetic process [GO:0006782],glutamyl-tRNA reductase activity [GO:0008883]; NADP binding [GO:0050661],,,MTCY20G9.36,1
P9WMP3,HEM3_MYCTU,Rv0510,hemC Rv0510 MTCY20G9.37,GO:0004418; GO:0005737; GO:0005886; GO:0006782; GO:0006783; GO:0018160; GO:0040007,IPR000860; IPR022419; IPR022417; IPR022418; IPR036803; ,,hemC,,Porphobilinogen deaminase (PBG) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; hydroxymethylbilane synthase activity [GO:0004418]; growth [GO:0040007]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],9634230; 21969609,,FUNCTION: Tetrapolymerization of the monopyrrole PBG into the hydroxymethylbilane pre-uroporphyrinogen in several discrete steps. {ECO:0000250}.,MIRIGTRGSLLATTQAATVRDALIAGGHSAELVTISTEGDRSMAPIASLGVGVFTTALREAMEAGLVDAAVHSYKDLPTAADPRFTVAAIPPRNDPRDAVVARDGLTLGELPVGSLVGTSSPRRAAQLRALGLGLEIRPLRGNLDTRLNKVSSGDLDAIVVARAGLARLGRLDDVTETLEPVQMLPAPAQGALAVECRAGDSRLVAVLAELDDADTRAAVTAERALLADLEAGCSAPVGAIAEVVESIDEDGRVFEELSLRGCVAALDGSDVIRASGIGSCGRARELGLSVAAELFELGARELMWGVRH,"31,938",309,HMBS family,growth [GO:0040007]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],hydroxymethylbilane synthase activity [GO:0004418],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY20G9.37,1
P9WMN9,GSA_MYCTU,Rv0524,hemL Rv0524 MTCY25D10.03,GO:0005737; GO:0005886; GO:0006782; GO:0008483; GO:0030170; GO:0040007; GO:0042286,IPR004639; IPR005814; IPR015424; IPR015422; IPR015421; ,,hemL,,"Glutamate-1-semialdehyde 2,1-aminomutase (GSA) (EC 5.4.3.8) (Glutamate-1-semialdehyde aminotransferase) (GSA-AT)","cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glutamate-1-semialdehyde 2,1-aminomutase activity [GO:0042286]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; growth [GO:0040007]; protoporphyrinogen IX biosynthetic process [GO:0006782]",9634230; 21969609,,,MGSTEQATSRVRGAARTSAQLFEAACSVIPGGVNSPVRAFTAVGGTPRFITEAHGCWLIDADGNRYVDLVCSWGPMILGHAHPAVVEAVAKAAARGLSFGAPTPAETQLAGEIIGRVAPVERIRLVNSGTEATMSAVRLARGFTGRAKIVKFSGCYHGHVDALLADAGSGVATLGLCDDPQRPASPRSQSSRGLPSSPGVTGAAAADTIVLPYNDIDAVQQTFARFGEQIAAVITEASPGNMGVVPPGPGFNAALRAITAEHGALLILDEVMTGFRVSRSGWYGIDPVPADLFAFGKVMSGGMPAAAFGGRAEVMQRLAPLGPVYQAGTLSGNPVAVAAGLATLRAADDAVYTALDANADRLAGLLSEALTDAVVPHQISRAGNMLSVFFGETPVTDFASARASQTWRYPAFFHAMLDAGVYPPCSAFEAWFVSAALDDAAFGRIANALPAAARAAAQERPA,"47,516",462,"Class-III pyridoxal-phosphate-dependent aminotransferase family, HemL subfamily",growth [GO:0040007]; protoporphyrinogen IX biosynthetic process [GO:0006782],"glutamate-1-semialdehyde 2,1-aminomutase activity [GO:0042286]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY25D10.03,1
P9WMP5,HEM2_MYCTU,Rv0512,hemB Rv0512 MTCY20G10.02,GO:0004655; GO:0005618; GO:0005829; GO:0006782; GO:0006783; GO:0008270,IPR001731; IPR030656; IPR013785; ,,hemB,,Delta-aminolevulinic acid dehydratase (ALAD) (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),cell wall [GO:0005618]; cytosol [GO:0005829]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],9634230; 21969609,,"FUNCTION: Catalyzes an early step in the biosynthesis of tetrapyrroles. Binds two molecules of 5-aminolevulinate per subunit, each at a distinct site, and catalyzes their condensation to form porphobilinogen (By similarity). {ECO:0000250}.",MSMSSYPRQRPRRLRSTVAMRRLVAQTSLEPRHLVLPMFVADGIDEPRPITSMPGVVQHTRDSLRRAAAAAVAAGVGGLMLFGVPRDQDKDGVGSAGIDPDGILNVALRDLAKDLGEATVLMADTCLDEFTDHGHCGVLDDRGRVDNDATVARYVELAVAQAESGAHVVGPSGMMDGQVAAIRDGLDAAGYIDVVILAYAAKFASAFYGPFREAVSSSLSGDRRTYQQEPGNAAEALREIELDLDEGADIVMVKPAMGYLDVVAAAADVSPVPVAAYQVSGEYAMIRAAAANNWIDERAAVLESLTGIRRAGADIVLTYWAVDAAGWLT,"34,871",329,ALAD family,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY20G10.02,1
O07778,HK1_MYCTU,Rv0600c,Rv0600c,GO:0000156; GO:0004672; GO:0004673; GO:0005524; GO:0005622; GO:0070298,IPR003594; IPR036890; IPR005467; IPR004358; ,,,DOMAIN 1 141 Histidine kinase; second part. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Sensor histidine kinase component HK1 (EC 2.7.13.3),intracellular [GO:0005622]; ATP binding [GO:0005524]; phosphorelay response regulator activity [GO:0000156]; protein histidine kinase activity [GO:0004673]; protein kinase activity [GO:0004672]; negative regulation of phosphorelay signal transduction system [GO:0070298],9634230; 17434492; 19246748,,FUNCTION: Member of the three-protein two-component system HK1/HK2/TcrA. Kinase that binds ATP and catalyzes the transfer of a phosphoryl group from ATP to HK2. {ECO:0000269|PubMed:17434492}.,MPITPLLHESVARFAATGADITTRAEPDLFVSIDPDHLRRILTAVLDNAITHGDGEIAVTAHARDGAVDIGVRDHGPGFADHFLPVAFDRFTRADTARGGRGSGLGLAIVAALTTTHGGHANATNHPDGGAELRITLPTPRPPFHEELPRITSSDTKDPNREHDTSDQ,"17,854",168,,negative regulation of phosphorelay signal transduction system [GO:0070298],ATP binding [GO:0005524]; phosphorelay response regulator activity [GO:0000156]; protein histidine kinase activity [GO:0004673]; protein kinase activity [GO:0004672],intracellular [GO:0005622],,,3
O07777,HK2_MYCTU,Rv0601c,Rv0601c,GO:0000155; GO:0004672; GO:0005622; GO:0005886; GO:0016021; GO:0042803; GO:0070298,IPR003660; IPR003661; IPR036097; ,,,DOMAIN 64 120 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 128 156 Histidine kinase; first part.,Sensor histidine kinase component HK2 (EC 2.7.13.3),integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; phosphorelay sensor kinase activity [GO:0000155]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; negative regulation of phosphorelay signal transduction system [GO:0070298],9634230; 17434492; 19246748,,FUNCTION: Member of the three-protein two-component system HK1/HK2/TcrA. HK2 transfers its phosphoryl group to TcrA. {ECO:0000269|PubMed:17434492}.,MALVLAAAGAVTVVQFRDAAHEADPDGALRGLTDDITADLVRELVTILPIVLVIAAVAAYLLSRAALRPVDRIRAAAQTLTTTPHPDTDAPLPVPPTDDEIAWLATTLNTMLTRLQRALAHEQQFVADASHELRTPLALLTTELELRCAGPDPPTS,"16,595",156,,negative regulation of phosphorelay signal transduction system [GO:0070298],phosphorelay sensor kinase activity [GO:0000155]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672],integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
P9WPM9,C135B_MYCTU,Rv0568,cyp135B1 Rv0568 MTV039.06,GO:0004497; GO:0005506; GO:0005829; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002401; IPR036396; ,,cyp135B1,,Putative cytochrome P450 135B1 (EC 1.14.-.-),"cytosol [GO:0005829]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MSGTSSMGLPPGPRLSGSVQAVLMLRHGLRFLTACQRRYGSVFTLHVAGFGHMVYLSDPAAIKTVFAGNPSVFHAGEANSMLAGLLGDSSLLLIDDDVHRDRRRLMSPPFHRDAVARQAGPIAEIAAANIAGWPMAKAFAVAPKMSEITLEVILRTVIGASDPVRLAALRKVMPRLLNVGPWATLALANPSLLNNRLWSRLRRRIEEADALLYAEIADRRADPDLAARTDTLAMLVRAADEDGRTMTERELRDQLITLLVAGHDTTATGLSWALERLTRHPVTLAKAVQAADASAAGDPAGDEYLDAVAKETLRIRPVVYDVGRVLTEAVEVAGYRLPAGVMVVPAIGLVHASAQLYPDPERFDPDRMVGATLSPTTWLPFGGGNRRCLGATFAMVEMRVVLREILRRVELSTTTTSGERPKLKHVIMVPHRGARIRVRATRDVSATSQATAQGAGCPAARGGGPSRAVGSQ,"50,688",472,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cytosol [GO:0005829],,MTV039.06,1
P9WNH1,BPOC_MYCTU,Rv0554,bpoC Rv0554,GO:0004601,IPR029058; IPR000073; IPR000639; ,,bpoC,,Putative non-heme bromoperoxidase BpoC (EC 1.11.1.18),peroxidase activity [GO:0004601],9634230; 21969609; 20693690,X-ray crystallography (4),,MINLAYDDNGTGDPVVFIAGRGGAGRTWHPHQVPAFLAAGYRCITFDNRGIGATENAEGFTTQTMVADTAALIETLDIAPARVVGVSMGAFIAQELMVVAPELVSSAVLMATRGRLDRARQFFNKAEAELYDSGVQLPPTYDARARLLENFSRKTLNDDVAVGDWIAMFSMWPIKSTPGLRCQLDCAPQTNRLPAYRNIAAPVLVIGFADDVVTPPYLGREVADALPNGRYLQIPDAGHLGFFERPEAVNTAMLKFFASVKA,"28,381",262,Bacterial non-heme bromo- and chloro-peroxidases family,,peroxidase activity [GO:0004601],,,,1
P9WPR5,CCO_MYCTU,Rv0654,Rv0654,GO:0010436; GO:0016118; GO:0046872,IPR004294; ,,,,"Carotenoid cleavage oxygenase (CCO) (EC 1.13.11.-) (Carotenoid 13,14/15,15'-oxygenase)",carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; carotenoid catabolic process [GO:0016118],9634230; 20929460; 21969609,,"FUNCTION: Catalyzes the oxidative cleavage of several carotenoids and apocarotenoids in vitro. In contrast to other carotenoid oxygenases, cleaves substrates at two different sites, namely the central C15-C15' and an excentric double bond at the C13-C14 position, leading to retinal (C20), beta-apo-14'-carotenal (C22) and beta-apo-13-carotenone (C18) from beta-carotene (C40), as well as the corresponding hydroxylated products from zeaxanthin and lutein. Converts beta-apo-10'-carotenal (C27) into beta-apo-13-carotenone (C18) and to minor amounts of beta-apo-15-carotenal (retinal; C20) from the cleavage at the C13-C14 and the C15-C15' double bonds, respectively. Can also cleave beta-apo-8'-carotenal, 3-OH-beta-apo-8'-carotenal and 3-OH-beta-apo-10'-carotenal. Does not use as substrates beta-apocarotenoids that have a chain length shorter than C25. Also cleaves lycopene into apo-13-lycopenone (C18) and apo-15'-lycopenal (acycloretinal, C20). Moreover, is able to cleave 3,3'-dihydroxy-isorenieratene representing aromatic carotenoids synthesized by other mycobacteria. Might be involved in the utilization of carotenoids from host cells to produce compounds required for normal growth. {ECO:0000269|PubMed:20929460}.",MTTAQAAESQNPYLEGFLAPVSTEVTATDLPVTGRIPEHLDGRYLRNGPNPVAEVDPATYHWFTGDAMVHGVALRDGKARWYRNRWVRTPAVCAALGEPISARPHPRTGIIEGGPNTNVLTHAGRTLALVEAGVVNYELTDELDTVGPCDFDGTLHGGYTAHPQRDPHTGELHAVSYSFARGHRVQYSVIGTDGHARRTVDIEVAGSPMMHSFSLTDNYVVIYDLPVTFDPMQVVPASVPRWLQRPARLVIQSVLGRVRIPDPIAALGNRMQGHSDRLPYAWNPSYPARVGVMPREGGNEDVRWFDIEPCYVYHPLNAYSECRNGAEVLVLDVVRYSRMFDRDRRGPGGDSRPSLDRWTINLATGAVTAECRDDRAQEFPRINETLVGGPHRFAYTVGIEGGFLVGAGAALSTPLYKQDCVTGSSTVASLDPDLLIGEMVFVPNPSARAEDDGILMGYGWHRGRDEGQLLLLDAQTLESIATVHLPQRVPMGFHGNWAPTT,"54,944",501,Carotenoid oxygenase family,carotenoid catabolic process [GO:0016118],carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872],,,,1
P9WQH1,ACKA_MYCTU,Rv0409,ackA Rv0409 MTCY22G10.05,GO:0005524; GO:0005737; GO:0006082; GO:0006085; GO:0008776; GO:0046872,IPR004372; IPR000890; IPR023865; ,,ackA,,Acetate kinase (EC 2.7.2.1) (Acetokinase),cytoplasm [GO:0005737]; acetate kinase activity [GO:0008776]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; organic acid metabolic process [GO:0006082],9634230; 21969609,,FUNCTION: Catalyzes the formation of acetyl phosphate from acetate and ATP. Can also catalyze the reverse reaction. {ECO:0000255|HAMAP-Rule:MF_00020}.,MSSTVLVINSGSSSLKFQLVEPVAGMSRAAGIVERIGERSSPVADHAQALHRAFKMLAEDGIDLQTCGLVAVGHRVVHGGTEFHQPTLLDDTVIGKLEELSALAPLHNPPAVLGIKVARRLLANVAHVAVFDTAFFHDLPPAAATYAIDRDVADRWHIRRYGFHGTSHQYVSERAAAFLGRPLDGLNQIVLHLGNGASASAIARGRPVETSMGLTPLEGLVMGTRSGDLDPGVISYLWRTARMGVEDIESMLNHRSGMLGLAGERDFRRLRLVIETGDRSAQLAYEVFIHRLRKYLGAYLAVLGHTDVVSFTAGIGENDAAVRRDALAGLQGLGIALDQDRNLGPGHGARRISSDDSPIAVLVVPTNEELAIARDCLRVLGGRRA,"41,318",385,Acetokinase family,acetyl-CoA biosynthetic process [GO:0006085]; organic acid metabolic process [GO:0006082],acetate kinase activity [GO:0008776]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY22G10.05,1
P9WQC7,ADHB_MYCTU,Rv0761c,adhB Rv0761c MTCY369.06c,GO:0004022; GO:0005737; GO:0005886; GO:0008270,IPR013149; IPR013154; IPR023921; IPR002328; IPR011032; IPR036291; IPR020843; ,,adhB,,Alcohol dehydrogenase B (EC 1.1.1.1),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],9634230; 21969609,,,MKTKGALIWEFNQPWSVEEIEIGDPRKDEVKIQMEAAGMCRSDHHLVTGDIPMAGFPVLGGHEGAGIVTEVGPGVDDFAPGDHVVLAFIPSCGKCPSCQAGMRNLCDLGAGLLAGESVTDGSFRIQARGQNVYPMTLLGTFSPYMVVHRSSVVKIDPSVPFEVACLVGCGVTTGYGSAVRTADVRPGDDVAIVGLGGVGMAALQGAVSAGARYVFAVEPVEWKRDQALKFGATHVYPDINAALMGIAEVTYGLMAQKVIITVGKLDGADVDSYLTITAKGGTCVLTAIGSLVDTQVTLNLAMLTLLQKNIQGTIFGGGNPHYDIPKLLSMYKAGKLNLDDMVTTAYKLEQINDGYQDMLNGKNIRGVIRYTDDDR,"39,748",375,Zinc-containing alcohol dehydrogenase family,,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY369.06c,1
P9WPP5,CP123_MYCTU,Rv0766c,cyp123 Rv0766c MTCY369.11c,GO:0005506; GO:0005886; GO:0006707; GO:0008395; GO:0020037; GO:0036199,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp123,,Putative cytochrome P450 123 (EC 1.14.-.-),plasma membrane [GO:0005886]; cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; cholesterol catabolic process [GO:0006707],9634230; 21969609,,,MTVRVGDPELVLDPYDYDFHEDPYPYYRRLRDEAPLYRNEERNFWAVSRHHDVLQGFRDSTALSNAYGVSLDPSSRTSEAYRVMSMLAMDDPAHLRMRTLVSKGFTPRRIRELEPQVLELARIHLDSALQTESFDFVAEFAGKLPMDVISELIGVPDTDRARIRALADAVLHREDGVADVPPPAMAASIELMRYYADLIAEFRRRPANNLTSALLAAELDGDRLSDQEIMAFLFLMVIAGNETTTKLLANAVYWAAHHPGQLARVFADHSRIPMWVEETLRYDTSSQILARTVAHDLTLYDTTIPEGEVLLLLPGSANRDDRVFDDPDDYRIGREIGCKLVSFGSGAHFCLGAHLARMEARVALGALLRRIRNYEVDDDNVVRVHSSNVRGFAHLPISVQAR,"45,421",402,Cytochrome P450 family,cholesterol catabolic process [GO:0006707],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],plasma membrane [GO:0005886],,MTCY369.11c,1
P9WPP9,CP51_MYCTU,Rv0764c,cyp51 Rv0764c MTCY369.09c,GO:0005506; GO:0005829; GO:0008398; GO:0016125; GO:0016126; GO:0020037,IPR001128; IPR017972; IPR002403; IPR036396; ,,cyp51,,Lanosterol 14-alpha demethylase (EC 1.14.13.70) (CYPLI) (Cytochrome P450 51) (Cytochrome P450-14DM) (Cytochrome P450-LIA1) (Sterol 14-alpha demethylase),cytosol [GO:0005829]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; sterol 14-demethylase activity [GO:0008398]; sterol biosynthetic process [GO:0016126]; sterol metabolic process [GO:0016125],9634230; 9756611; 10430874; 11160374; 21969609; 11248033; 15530358; 17846131; 18367444; 19190730,X-ray crystallography (12),"FUNCTION: Its precise biological substrate is not known. Catalyzes C14-demethylation of lanosterol, 24,25-dihydrolanosterol and obtusifoliol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol. {ECO:0000269|PubMed:10430874, ECO:0000269|PubMed:9756611}.",MSAVALPRVSGGHDEHGHLEEFRTDPIGLMQRVRDECGDVGTFQLAGKQVVLLSGSHANEFFFRAGDDDLDQAKAYPFMTPIFGEGVVFDASPERRKEMLHNAALRGEQMKGHAATIEDQVRRMIADWGEAGEIDLLDFFAELTIYTSSACLIGKKFRDQLDGRFAKLYHELERGTDPLAYVDPYLPIESFRRRDEARNGLVALVADIMNGRIANPPTDKSDRDMLDVLIAVKAETGTPRFSADEITGMFISMMFAGHHTSSGTASWTLIELMRHRDAYAAVIDELDELYGDGRSVSFHALRQIPQLENVLKETLRLHPPLIILMRVAKGEFEVQGHRIHEGDLVAASPAISNRIPEDFPDPHDFVPARYEQPRQEDLLNRWTWIPFGAGRHRCVGAAFAIMQIKAIFSVLLREYEFEMAQPPESYRNDHSKMVVQLAQPACVRYRRRTGV,"50,878",451,Cytochrome P450 family,sterol biosynthetic process [GO:0016126]; sterol metabolic process [GO:0016125],heme binding [GO:0020037]; iron ion binding [GO:0005506]; sterol 14-demethylase activity [GO:0008398],cytosol [GO:0005829],,MTCY369.09c,1
P9WPE7,CH602_MYCTU,Rv0440,groEL2 groEL-2 groL2 hsp65 mtc28 Rv0440 MTV037.04,GO:0001666; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006458; GO:0009408; GO:0040007; GO:0042026; GO:0042603; GO:0044183; GO:0044406; GO:0051082; GO:0061077; GO:1990220; GO:2000679,IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; IPR027410; ,P9WI75,groEL2,,60 kDa chaperonin 2 (65 kDa antigen) (Antigen A) (Cell wall protein A) (GroEL protein 2) (Heat shock protein 65) (Protein Cpn60-2),capsule [GO:0042603]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GroEL-GroES complex [GO:1990220]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; adhesion of symbiont to host [GO:0044406]; chaperone-mediated protein folding [GO:0061077]; growth [GO:0040007]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666],3029018; 9634230; 7848059; 7699930; 15327959; 15809303; 18227175; 20066036; 21969609; 22464736; 15547284; 21802426,X-ray crystallography (2),"FUNCTION: Prevents aggregation of substrate proteins and promotes their refolding (PubMed:15327959). {ECO:0000269|PubMed:15327959}.; FUNCTION: Recombinant extracellular protein activates expression of NF-kappa-B in immortalized human dermal endothelial cells in a TLR4-dependent, TLR2-independent manner. Activation occurs via MYD88-dependent and -independent pathways and requires TIRAP, TRIF, TRAM and MD-2 (some experiments done in mouse cells, mice do not usually catch tuberculosis) (PubMed:15809303). {ECO:0000269|PubMed:15809303}.",MAKTIAYDEEARRGLERGLNALADAVKVTLGPKGRNVVLEKKWGAPTITNDGVSIAKEIELEDPYEKIGAELVKEVAKKTDDVAGDGTTTATVLAQALVREGLRNVAAGANPLGLKRGIEKAVEKVTETLLKGAKEVETKEQIAATAAISAGDQSIGDLIAEAMDKVGNEGVITVEESNTFGLQLELTEGMRFDKGYISGYFVTDPERQEAVLEDPYILLVSSKVSTVKDLLPLLEKVIGAGKPLLIIAEDVEGEALSTLVVNKIRGTFKSVAVKAPGFGDRRKAMLQDMAILTGGQVISEEVGLTLENADLSLLGKARKVVVTKDETTIVEGAGDTDAIAGRVAQIRQEIENSDSDYDREKLQERLAKLAGGVAVIKAGAATEVELKERKHRIEDAVRNAKAAVEEGIVAGGGVTLLQAAPTLDELKLEGDEATGANIVKVALEAPLKQIAFNSGLEPGVVAEKVRNLPAGHGLNAQTGVYEDLLAAGVADPVKVTRSALQNAASIAGLFLTTEAVVADKPEKEKASVPGGGDMGGMDF,"56,727",540,Chaperonin (HSP60) family,'de novo' protein folding [GO:0006458]; adhesion of symbiont to host [GO:0044406]; chaperone-mediated protein folding [GO:0061077]; growth [GO:0040007]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein refolding [GO:0042026]; response to heat [GO:0009408]; response to hypoxia [GO:0001666],ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082],capsule [GO:0042603]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; GroEL-GroES complex [GO:1990220]; plasma membrane [GO:0005886],groEL-2 groL2 hsp65 mtc28,MTV037.04,1
P9WIC9,GPMA_MYCTU,Rv0489,gpmA gpm gpm1 pgm Rv0489 MTCY20G9.15,GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0032991; GO:0042802; GO:0043456; GO:0046538; GO:0051289,IPR013078; IPR029033; IPR001345; IPR005952; ,,gpmA,,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (BPG-dependent PGAM) (PGAM) (Phosphoglyceromutase) (dPGM) (EC 5.4.2.11)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; identical protein binding [GO:0042802]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; regulation of pentose-phosphate shunt [GO:0043456]",9634230; 21969609; 15735341,X-ray crystallography (1),FUNCTION: Catalyzes the interconversion of 2-phosphoglycerate and 3-phosphoglycerate. {ECO:0000255|HAMAP-Rule:MF_01039}.,MANTGSLVLLRHGESDWNALNLFTGWVDVGLTDKGQAEAVRSGELIAEHDLLPDVLYTSLLRRAITTAHLALDSADRLWIPVRRSWRLNERHYGALQGLDKAETKARYGEEQFMAWRRSYDTPPPPIERGSQFSQDADPRYADIGGGPLTECLADVVARFLPYFTDVIVGDLRVGKTVLIVAHGNSLRALVKHLDQMSDDEIVGLNIPTGIPLRYDLDSAMRPLVRGGTYLDPEAAAAGAAAVAGQGRG,"27,216",249,"Phosphoglycerate mutase family, BPG-dependent PGAM subfamily",gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; protein homotetramerization [GO:0051289]; regulation of pentose-phosphate shunt [GO:0043456],"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity [GO:0046538]; identical protein binding [GO:0042802]",cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],gpm gpm1 pgm,MTCY20G9.15,1
P9WN75,GPDA2_MYCTU,Rv0564c,gpsA2 gpdA1 Rv0564c MTV039.02c,GO:0004367; GO:0005975; GO:0006650; GO:0008654; GO:0009331; GO:0036439; GO:0046168; GO:0047952; GO:0051287,IPR008927; IPR013328; IPR006168; IPR006109; IPR011128; IPR036291; ,,gpsA2,,Probable glycerol-3-phosphate dehydrogenase 2 [NAD(P)+] (EC 1.1.1.94) (NAD(P)H-dependent glycerol-3-phosphate dehydrogenase 2),glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; glycerol-3-phosphate dehydrogenase [NADP+] activity [GO:0036439]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,,MAANKREPKVVVLGGGSWGTTVASICARRGPTLQWVRSAVTAQDINDNHRNSRYLGNDVVLSDTLRATTDFTEAANCADVVVMGVPSHGFRGVLVELSKELRPWVPVVSLVKGLEQGTNMRMSQIIEEVLPGHPAGILAGPNIAREVAEGYAAAAVLAMPDQHLATRLSAMFRTRRFRVYTTDDVVGVETAGALKNVFAIAVGMGYSLGIGENTRALVIARALREMTKLGVAMGGKSETFPGLAGLGDLIVTCTSQRSRNRHVGEQLGAGKPIDEIIASMSQVAEGVKAAGVVMEFANEFGLNMPIAREVDAVINHGSTVEQAYRGLIAEVPGHEVHGSGF,"36,153",341,NAD-dependent glycerol-3-phosphate dehydrogenase family,carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654],glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; glycerol-3-phosphate dehydrogenase [NADP+] activity [GO:0036439]; NAD binding [GO:0051287],glycerol-3-phosphate dehydrogenase complex [GO:0009331],gpdA1,MTV039.02c,1
P9WNM7,EFG_MYCTU,Rv0684,fusA Rv0684 MTCY210.01 MTV040.12,GO:0003746; GO:0003924; GO:0005525; GO:0005618; GO:0005737; GO:0005886; GO:0040007,IPR009022; IPR035647; IPR035649; IPR000640; IPR004161; IPR031157; IPR027417; IPR020568; IPR014721; IPR005225; IPR000795; IPR009000; IPR004540; IPR005517; ,,fusA,DOMAIN 11 287 tr-type G.,Elongation factor G (EF-G),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; growth [GO:0040007],9634230; 20066036; 21969609,,"FUNCTION: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome (By similarity). {ECO:0000250}.",MAQKDVLTDLSRVRNFGIMAHIDAGKTTTTERILYYTGINYKIGEVHDGAATMDWMEQEQERGITITSAATTTFWKDNQLNIIDTPGHVDFTVEVERNLRVLDGAVAVFDGKEGVEPQSEQVWRQADKYDVPRICFVNKMDKIGADFYFSVRTMGERLGANAVPIQLPVGAEADFEGVVDLVEMNAKVWRGETKLGETYDTVEIPADLAEQAEEYRTKLLEVVAESDEHLLEKYLGGEELTVDEIKGAIRKLTIASEIYPVLCGSAFKNKGVQPMLDAVVDYLPSPLDVPPAIGHAPAKEDEEVVRKATTDEPFAALAFKIATHPFFGKLTYIRVYSGTVESGSQVINATKGKKERLGKLFQMHSNKENPVDRASAGHIYAVIGLKDTTTGDTLSDPNQQIVLESMTFPDPVIEVAIEPKTKSDQEKLSLSIQKLAEEDPTFKVHLDSETGQTVIGGMGELHLDILVDRMRREFKVEANVGKPQVAYKETIKRLVQNVEYTHKKQTGGSGQFAKVIINLEPFTGEEGATYEFESKVTGGRIPREYIPSVDAGAQDAMQYGVLAGYPLVNLKVTLLDGAYHEVDSSEMAFKIAGSQVLKKAAALAQPVILEPIMAVEVTTPEDYMGDVIGDLNSRRGQIQAMEERAGARVVRAHVPLSEMFGYVGDLRSKTQGRANYSMVFDSYSEVPANVSKEIIAKATGE,"77,203",701,"TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-G/EF-2 subfamily",growth [GO:0040007],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY210.01 MTV040.12,1
P9WNN1,EFTU_MYCTU,Rv0685,tuf Rv0685 MTCY210.02,GO:0001666; GO:0003746; GO:0003924; GO:0005525; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0010039; GO:0035375; GO:0040007,IPR004161; IPR033720; IPR031157; IPR027417; IPR005225; IPR000795; IPR009000; IPR009001; IPR004541; IPR004160; ,,tuf,DOMAIN 10 205 tr-type G.,Elongation factor Tu (EF-Tu),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; zymogen binding [GO:0035375]; growth [GO:0040007]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039],1639483; 9634230; 21969609,,FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. {ECO:0000255|HAMAP-Rule:MF_00118}.,MAKAKFQRTKPHVNIGTIGHVDHGKTTLTAAITKVLHDKFPDLNETKAFDQIDNAPEERQRGITINIAHVEYQTDKRHYAHVDAPGHADYIKNMITGAAQMDGAILVVAATDGPMPQTREHVLLARQVGVPYILVALNKADAVDDEELLELVEMEVRELLAAQEFDEDAPVVRVSALKALEGDAKWVASVEELMNAVDESIPDPVRETDKPFLMPVEDVFTITGRGTVVTGRVERGVINVNEEVEIVGIRPSTTKTTVTGVEMFRKLLDQGQAGDNVGLLLRGVKREDVERGQVVTKPGTTTPHTEFEGQVYILSKDEGGRHTPFFNNYRPQFYFRTTDVTGVVTLPEGTEMVMPGDNTNISVKLIQPVAMDEGLRFAIREGGRTVGAGRVTKIIK,"43,594",396,"TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily",growth [GO:0040007]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY210.02,1
P9WQ13,END4_MYCTU,Rv0670,end nfo Rv0670 MTCI376.04c,GO:0003677; GO:0003906; GO:0006284; GO:0008081; GO:0008270; GO:0008833,IPR001719; IPR018246; IPR036237; IPR013022; ,,end,,Probable endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV),deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],9634230; 19027363; 21969609,X-ray crystallography (1),FUNCTION: Endonuclease IV plays a role in DNA repair. It cleaves phosphodiester bonds at apurinic or apyrimidinic sites (AP sites) to produce new 5'-ends that are base-free deoxyribose 5-phosphate residues. It preferentially attacks modified AP sites created by bleomycin and neocarzinostatin. {ECO:0000255|HAMAP-Rule:MF_00152}.,MLIGSHVSPTDPLAAAEAEGADVVQIFLGNPQSWKAPKPRDDAAALKAATLPIYVHAPYLINLASANNRVRIPSRKILQETCAAAADIGAAAVIVHGGHVADDNDIDKGFQRWRKALDRLETEVPVYLENTAGGDHAMARRFDTIARLWDVIGDTGIGFCLDTCHTWAAGEALTDAVDRIKAITGRIDLVHCNDSRDEAGSGRDRHANLGSGQIDPDLLVAAVKAAGAPVICETADQGRKDDIAFLRERTGS,"26,845",252,AP endonuclease 2 family,base-excision repair [GO:0006284],deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA binding [GO:0003677]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270],,nfo,MTCI376.04c,1
P9WNP7,FADB2_MYCTU,Rv0468,fadB2 Rv0468,GO:0003857; GO:0005618; GO:0005829; GO:0005886; GO:0006635; GO:0008691; GO:0019605; GO:0030497; GO:0052572; GO:0070403,IPR022694; IPR006176; IPR006108; IPR008927; IPR013328; IPR036291; ,,fadB2,,3-hydroxybutyryl-CoA dehydrogenase (EC 1.1.1.157) (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403]; butyrate metabolic process [GO:0019605]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; response to host immune response [GO:0052572],9634230; 11489128; 12081975; 20378648; 21969609,,FUNCTION: Catalyzes the NAD-dependent oxidation of beta-hydroxybutyryl-CoA to acetoacetyl-CoA in vitro at pH 10. Also catalyzes the reverse reaction albeit in a lower pH range of 5.5-6.5. The reverse reaction is able to use NADPH as well as NADH. {ECO:0000269|PubMed:20378648}.,MSDAIQRVGVVGAGQMGSGIAEVSARAGVEVTVFEPAEALITAGRNRIVKSLERAVSAGKVTERERDRALGLLTFTTDLNDLSDRQLVIEAVVEDEAVKSEIFAELDRVVTDPDAVLASNTSSIPIMKVAAATKQPQRVLGLHFFNPVPVLPLVELVRTLVTDEAAAARTEEFASTVLGKQVVRCSDRSGFVVNALLVPYLLSAIRMVEAGFATVEDVDKAVVAGLSHPMGPLRLSDLVGLDTLKLIADKMFEEFKEPHYGPPPLLLRMVEAGQLGKKSGRGFYTY,"30,728",286,3-hydroxyacyl-CoA dehydrogenase family,butyrate metabolic process [GO:0019605]; fatty acid beta-oxidation [GO:0006635]; fatty acid elongation [GO:0030497]; response to host immune response [GO:0052572],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-hydroxybutyryl-CoA dehydrogenase activity [GO:0008691]; NAD+ binding [GO:0070403],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WNG3,FABH_MYCTU,Rv0533c,fabH Rv0533c MTCY25D10.12c,GO:0000062; GO:0004315; GO:0005737; GO:0006633; GO:0008610; GO:0030497; GO:0033818; GO:0035336,IPR013751; IPR013747; IPR004655; IPR016039; ,,fabH,,3-oxoacyl-[acyl-carrier-protein] synthase 3 (EC 2.3.1.180) (3-oxoacyl-[acyl-carrier-protein] synthase III) (Beta-ketoacyl-ACP synthase III) (KAS III) (MtFabH),cytoplasm [GO:0005737]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase III activity [GO:0033818]; fatty-acyl-CoA binding [GO:0000062]; fatty acid biosynthetic process [GO:0006633]; fatty acid elongation [GO:0030497]; lipid biosynthetic process [GO:0008610]; long-chain fatty-acyl-CoA metabolic process [GO:0035336],9634230; 10840036; 19099550; 21969609; 11278743; ,X-ray crystallography (12),"FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for long chain acyl-CoA such as myristoyl-CoA. Does not use acyl-CoA as primer. Its substrate specificity determines the biosynthesis of mycolic acid fatty acid chain, which is characteristic of mycobacterial cell wall. {ECO:0000269|PubMed:10840036}.",MTEIATTSGARSVGLLSVGAYRPERVVTNDEICQHIDSSDEWIYTRTGIKTRRFAADDESAASMATEACRRALSNAGLSAADIDGVIVTTNTHFLQTPPAAPMVAASLGAKGILGFDLSAGCAGFGYALGAAADMIRGGGAATMLVVGTEKLSPTIDMYDRGNCFIFADGAAAVVVGETPFQGIGPTVAGSDGEQADAIRQDIDWITFAQNPSGPRPFVRLEGPAVFRWAAFKMGDVGRRAMDAAGVRPDQIDVFVPHQANSRINELLVKNLQLRPDAVVANDIEHTGNTSAASIPLAMAELLTTGAAKPGDLALLIGYGAGLSYAAQVVRMPKG,"34,873",335,FabH family,fatty acid biosynthetic process [GO:0006633]; fatty acid elongation [GO:0030497]; lipid biosynthetic process [GO:0008610]; long-chain fatty-acyl-CoA metabolic process [GO:0035336],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; beta-ketoacyl-acyl-carrier-protein synthase III activity [GO:0033818]; fatty-acyl-CoA binding [GO:0000062],cytoplasm [GO:0005737],,MTCY25D10.12c,1
P9WNE1,FGD_MYCTU,Rv0407,fgd1 fgd Rv0407,GO:0005618; GO:0005829; GO:0005886; GO:0005975; GO:0016614; GO:0016705; GO:0045454; GO:0052749; GO:0055114; GO:0070967,IPR019944; IPR019945; IPR011251; IPR036661; ,,fgd1,,F420-dependent glucose-6-phosphate dehydrogenase (FGD) (FGD1) (G6PD) (EC 1.1.98.2),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; coenzyme F420 binding [GO:0070967]; glucose-6-phosphate dehydrogenase (coenzyme F420) activity [GO:0052749]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]",9634230; 10879539; 16387854; 17376702; 21969609; 23240649; 18434308,X-ray crystallography (2),"FUNCTION: Catalyzes the coenzyme F420-dependent oxidation of glucose 6-phosphate to 6-phosphogluconolactone (PubMed:18434308). Appears to have a role in resistance to oxidative stress, via its consumption of G6P that serves as a source of reducing power to combat oxidative stress in mycobacteria. More precisely, is likely involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents (PubMed:23240649). {ECO:0000255|HAMAP-Rule:MF_02123, ECO:0000269|PubMed:18434308, ECO:0000305|PubMed:23240649}.; FUNCTION: Is essential for the bioreductive activation of the bicyclic 4-nitroimidazole prodrug PA-824 (a nitroimidazo-oxazine) developed for anti-tuberculosis therapy against both replicating and persistent bacteria. It does not interact directly with PA-824 but, rather, provides reduced F420 to the deazaflavin-dependent nitroreductase Ddn, which in turn activates PA-824. {ECO:0000269|PubMed:10879539}.",MAELKLGYKASAEQFAPRELVELAVAAEAHGMDSATVSDHFQPWRHQGGHAPFSLSWMTAVGERTNRLLLGTSVLTPTFRYNPAVIAQAFATMGCLYPNRVFLGVGTGEALNEIATGYEGAWPEFKERFARLRESVGLMRQLWSGDRVDFDGDYYRLKGASIYDVPDGGVPVYIAAGGPAVAKYAGRAGDGFICTSGKGEELYTEKLMPAVREGAAAADRSVDGIDKMIEIKISYDPDPELALNNTRFWAPLSLTAEQKHSIDDPIEMEKAADALPIEQIAKRWIVASDPDEAVEKVGQYVTWGLNHLVFHAPGHDQRRFLELFQSDLAPRLRRLG,"36,989",336,F420-dependent glucose-6-phosphate dehydrogenase family,carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114],"coenzyme F420 binding [GO:0070967]; glucose-6-phosphate dehydrogenase (coenzyme F420) activity [GO:0052749]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],fgd,,1
P9WNY1,ALDH_MYCTU,Rv0458,Rv0458 MTV038.02,GO:0004029; GO:0005886; GO:0052562,IPR016161; IPR016163; IPR016160; IPR029510; IPR016162; IPR015590; ,,,,Probable aldehyde dehydrogenase (EC 1.2.1.3),plasma membrane [GO:0005886]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; negative regulation by symbiont of host immune response [GO:0052562],9634230; 21969609,,,MTVFSRPGSAGALMSYESRYQNFIGGQWVAPVHGRYFENPTPVTGQPFCEVPRSDAADIDKALDAAHAAAPGWGKTAPAERAAILNMIADRIDKNAAALAVAEVWDNGKPVREALAADIPLAVDHFRYFAAAIRAQEGALSQIDEDTVAYHFHEPLGVVGQIIPWNFPILMAAWKLAPALAAGNTAVLKPAEQTPASVLYLMSLIGDLLPPGVVNVVNGFGAEAGKPLASSDRIAKVAFTGETTTGRLIMQYASHNLIPVTLELGGKSPNIFFADVLAAHDDFCDKALEGFTMFALNQGEVCTCPSRSLIQADIYDEFLELAAIRTKAVRQGDPLDTETMLGSQASNDQLEKVLSYIEIGKQEGAVIIAGGERAELGGDLSGGYYMQPTIFTGTNNMRIFKEEIFGPVVAVTSFTDYDDAIGIANDTLYGLGAGVWSRDGNTAYRAGRDIQAGRVWVNCYHLYPAHAAFGGYKQSGIGREGHQMMLQHYQHTKNLLVSYSDKALGFF,"54,575",507,Aldehyde dehydrogenase family,negative regulation by symbiont of host immune response [GO:0052562],aldehyde dehydrogenase (NAD) activity [GO:0004029],plasma membrane [GO:0005886],,MTV038.02,1
P9WKK7,ACEA_MYCTU,Rv0467,icl Rv0467 MTV038.11,GO:0004451; GO:0005576; GO:0005829; GO:0005886; GO:0006097; GO:0006099; GO:0006102; GO:0009405; GO:0010034; GO:0010447; GO:0035375; GO:0046421; GO:0046872; GO:0052572; GO:0070542; GO:0071456; GO:0075141,IPR006254; IPR018523; IPR015813; ,,icl,,Isocitrate lyase (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase),cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]; methylisocitrate lyase activity [GO:0046421]; zymogen binding [GO:0035375]; cellular response to hypoxia [GO:0071456]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; maintenance of symbiont tolerance to host environment [GO:0075141]; pathogenesis [GO:0009405]; response to acetate [GO:0010034]; response to acidic pH [GO:0010447]; response to fatty acid [GO:0070542]; response to host immune response [GO:0052572]; tricarboxylic acid cycle [GO:0006099],9634230; 10963599; 18275086; 20066036; 21969609; 24354272; 10932251; 19767422; 22916289,X-ray crystallography (4),"FUNCTION: Involved in the persistence and virulence of M.tuberculosis. Catalyzes the reversible formation of succinate and glyoxylate from isocitrate, a key step of the glyoxylate cycle, which operates as an anaplerotic route for replenishing the tricarboxylic acid cycle during growth on fatty acid substrates (PubMed:10932251, PubMed:10963599, PubMed:18275086, PubMed:24354272). It could also catalyze the formation of pyruvate and succinate from 2-methylisocitrate, a key step in the methylcitrate cycle (propionate degradation route) (By similarity). {ECO:0000250|UniProtKB:P9WKK6, ECO:0000269|PubMed:10932251, ECO:0000269|PubMed:10963599, ECO:0000269|PubMed:18275086, ECO:0000269|PubMed:24354272}.",MSVVGTPKSAEQIQQEWDTNPRWKDVTRTYSAEDVVALQGSVVEEHTLARRGAEVLWEQLHDLEWVNALGALTGNMAVQQVRAGLKAIYLSGWQVAGDANLSGHTYPDQSLYPANSVPQVVRRINNALQRADQIAKIEGDTSVENWLAPIVADGEAGFGGALNVYELQKALIAAGVAGSHWEDQLASEKKCGHLGGKVLIPTQQHIRTLTSARLAADVADVPTVVIARTDAEAATLITSDVDERDQPFITGERTREGFYRTKNGIEPCIARAKAYAPFADLIWMETGTPDLEAARQFSEAVKAEYPDQMLAYNCSPSFNWKKHLDDATIAKFQKELAAMGFKFQFITLAGFHALNYSMFDLAYGYAQNQMSAYVELQEREFAAEERGYTATKHQREVGAGYFDRIATTVDPNSSTTALTGSTEEGQFH,"47,087",428,"Isocitrate lyase/PEP mutase superfamily, Isocitrate lyase family",cellular response to hypoxia [GO:0071456]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; maintenance of symbiont tolerance to host environment [GO:0075141]; pathogenesis [GO:0009405]; response to acetate [GO:0010034]; response to acidic pH [GO:0010447]; response to fatty acid [GO:0070542]; response to host immune response [GO:0052572]; tricarboxylic acid cycle [GO:0006099],isocitrate lyase activity [GO:0004451]; metal ion binding [GO:0046872]; methylisocitrate lyase activity [GO:0046421]; zymogen binding [GO:0035375],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV038.11,1
P9WKT7,Y500A_MYCTU,Rv0500A,Rv0500A,GO:0003677,IPR009061; IPR010093; ,,,,Putative DNA-binding protein Rv0500A,DNA binding [GO:0003677],9634230; 12368430; 21969609,,,MTSTNGPSARDTGFVEGQQAKTQLLTVAEVAALMRVSKMTVYRLVHNGELPAVRVGRSFRVHAKAVHDMLETSYFDAG,"8,508",78,,,DNA binding [GO:0003677],,,,1
P9WFK9,Y566_MYCTU,Rv0566c,Rv0566c MTV039.04c,GO:0005829; GO:0005886,IPR007551; IPR035571; IPR035570; IPR036183; ,,,,UPF0234 protein Rv0566c,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MADSSFDIVSKVDRQEVDNALNQAAKELATRFDFRGTDTKIAWKGDEAVELTSSTEERVKAAVDVFKEKLIRRDISLKAFEAGEPQASGKTYKVTGALKQGISSENAKKITKLIRDAGPKNVKTQIQGDEVRVTSKKRDDLQAVIAMLKKADLDVALQFVNYR,"18,078",163,UPF0234 family,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV039.04c,1
O86365,Y584_MYCTU,Rv0584,Rv0584,GO:0000224; GO:0005829; GO:0006515; GO:0006516; GO:0006517; GO:0016798; GO:0030246,IPR008928; IPR005887; IPR014718; IPR012939; ,,,,Uncharacterized glycosidase Rv0584 (EC 3.2.1.-),"cytosol [GO:0005829]; carbohydrate binding [GO:0030246]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]",9634230,,,MRARRLRRALAALLAVAGLFVPFIVGVPTAYDGEPVFVAIPVEHVNTLIGTGTGAAIVGEINNFPGASVPFGMVQYSPDTVDNYAGYDYDNPHSTGFSMTHASVGCPAFGDISMLPTTTPLGSQPWSAWEEIAHDDTEVGVPGYYTVRFPGTGVIAELTATTRTGVGRFRYPRNGWPALFHVRSGASLAGNYAATLQIEDNTTITGSATSGGFCGKKNLYTVYFAMKFSQPFSSYGTWDGYAVYPGSHSMNSSYSGGYVGFPAGSVLEVRTALSYVSVDGARANLDAEGGASFDDIRAATSSEWNAALSRIAVAGRGPGDVDTFYTCLYRSLLHPNTFNDVDGRYIGFDGVIHSVASGHTHYANFSDWDTYRSLAPLQGLLFPQRASDMIQSLVTDAEQSGAYPRWALANSATGMMSGDSVVPLIVNLYAFGARDFDLKSALHYMVNAATQGGVGLDGFLERPGIAAYLRLGYGPQTAEFRANGRIAGASVTLEWSVDDFAISRFADSLGDTATAAVFQNRSQYWQNLFNPTTGYISPRSAAGFFPDGPGFVAYPSGFGQDGYDEGNAEQYLWWVPHNVAGLVTALGGRTAVVKRLDRFTKKLNVGPNEPYLWAGNEPGFGVPWLYNYIGQPWKTQRTVDRVRGLFGPTPGGAPGNDDLGALSSWYVWAALGLYPSTPGTTILTVNTPLFDRAVIALPTGKSIQITAPGASGRNRLKYIDGLTIDRQPSNQTFLPESIVRTGGDLTFSLAGTPNKVWGTAASAAPPSFGAGSSAVTVNIARPIIGIVPGATGTVTVDAQRMIDGVDDYTVTPTSYVVGIAAEPLSGQFDDDGAVSASVAITVARSVPSGYYPIYVTTSAGDSARTLIVLVVVAEAVE,"92,953",877,Glycosyl hydrolase 92 family,glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],"carbohydrate binding [GO:0030246]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]",cytosol [GO:0005829],,,1
P0DN33,Y609B_MYCTU,Rv0609B,Rv0609B,,,,,,Uncharacterized protein Rv0609B,,9634230; 21969609,,,MTDEKCVRCGGDQLVEGAVVWNAPLRFKREGAGHFNRGTQVNAVACETCGHIDLYLESRARGSTK,"7,110",65,,,,,,,1
P9WQI1,Y647_MYCTU,Rv0647c,Rv0647c MTCY20H10.28c,GO:0004672; GO:0005524; GO:0005618; GO:0005829; GO:0005886,IPR011009; IPR000719; IPR004147; ,,,,Uncharacterized protein Rv0647c,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672],9634230; 21969609,,,MRAEIGPDFRPHYTFGDAYPASERAHVNWELSAPVWHTAQMGSTTHREVAKLDRVPLPVEAARVAATGWQVTRTAVRFIGRLPRKGPWQQKVIKELPQTFADLGPTYVKFGQIIASSPGAFGESLSREFRGLLDRVPPAKTDEVHKLFVEELGDEPARLFASFEEEPFASASIAQVHYATLRSGEEVVVKIQRPGIRRRVAADLQILKRFAQTVELAKLGRRLSAQDVVADFADNLAEELDFRLEAQSMEAWVSHLHASPLGKNIRVPQVHWDFTTERVLTMERVHGIRIDNAAAIRKAGFDGVELVKALLFSVFEGGLRHGLFHGDLHAGNLYVDEAGRIVFFDFGIMGRIDPRTRWLLRELVYALLVKKDHAAAGKIVVLMGAVGTMKPETQAAKDLERFATPLTMQSLGDMSYADIGRQLSALADAYDVKLPRELVLIGKQFLYVERYMKLLAPRWQMMSDPQLTGYFANFMVEVSREHQSDIEV,"54,824",488,"Protein kinase superfamily, ADCK protein kinase family",,ATP binding [GO:0005524]; protein kinase activity [GO:0004672],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY20H10.28c,1
P9WML3,YHI1_MYCTU,Rv0759c,Rv0759c MTCY369.04c,GO:0003824,IPR019808; IPR001310; IPR011146; IPR036265; ,,,DOMAIN 3 106 HIT. {ECO:0000255|PROSITE-ProRule:PRU00464}.,Uncharacterized HIT-like protein Rv0759c,catalytic activity [GO:0003824],9634230; 21969609,,,MSIFTKIINRELPGRFVYEDDDVVAFLTIEPMTQGHTLVVPRAEIDHWQNVDPALFGRVMSVSQLIGKAVCRAFSTQRAGMIIAGLEVPHLHIHVFPTRSLSDFGFANVDRNPSPGSLDEAQAKIRAALAQLA,"14,667",133,,,catalytic activity [GO:0003824],,,MTCY369.04c,1
P9WF21,VAPB4_MYCTU,Rv0596c,vapB4 Rv0596c,GO:0045927; GO:0097351,IPR006442; IPR036165; ,,vapB4,,Antitoxin VapB4 (VapB-mt4),toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927],9634230; 15718296; 19016878; 22354968; 25622615,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Antitoxin that counteracts the effect of its cognate VapC4 toxin. Upon expression in situ, in M.smegmatis or E.coli neutralizes the effect of cognate toxin VapC4. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:22354968, ECO:0000269|PubMed:25622615}.",MSATIPARDLRNHTAEVLRRVAAGEEIEVLKDNRPVARIVPLKRRRQWLPAAEVIGELVRLGPDTTNLGEELRETLTQTTDDVRW,"9,681",85,PhD/YefM antitoxin family,positive regulation of growth [GO:0045927],toxin-antitoxin pair type II binding [GO:0097351],,,,1
P9WJ57,VAPB6_MYCTU,Rv0657c,vapB6 Rv0657c,,IPR019239; ,,vapB6,,Putative antitoxin VapB6,,9634230; 15718296,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC6. {ECO:0000305|PubMed:15718296}.,MSVTQIDLDDEALADVMRIAAVHTKKEAVNLAMRDYVERFRRIEALARSRE,"5,905",51,,,,,,,1
O06777,VAPB7_MYCTU,Rv0662c,vapB7 Rv0662c,GO:0005886,,,vapB7,,Putative antitoxin VapB7,plasma membrane [GO:0005886],9634230; 15718296,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC7. {ECO:0000305|PubMed:15718296}.,MSMRLAHRLQILLDDECHRRITAVARERGVPVATVVREAIDRGLVSPAGRRKSAGRRLLDAADMSVPEPRELKQELEALRARRG,"9,451",84,,,,plasma membrane [GO:0005886],,,4
O53732,UFAA1_MYCTU,Rv0447c RVBD_0447c,ufaA1 Rv0447c RVBD_0447c LH57_02385 P425_00460,GO:0006633; GO:0008168; GO:0071555,IPR003333; IPR029063; ,,ufaA1,,Tuberculostearic acid methyltransferase UfaA1 (TSA methyltransferase) (EC 2.1.1.-),methyltransferase activity [GO:0008168]; cell wall organization [GO:0071555]; fatty acid biosynthetic process [GO:0006633],9634230; 24033595,,"FUNCTION: Involved in the biosynthesis of the tuberculostearic acid (10-methylstearic-acid or TSA), a constituent lipid of the mycobacterial cell wall. Catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of oleic acid in phosphatidylethanolamine or phosphatidylcholine to produce TSA. {ECO:0000269|PubMed:24033595}.",MTVETSQTPSAAIDSDRWPAVAKVPRGPLAAASAAIANRLLRRTATHLPLRLVYSDGTATGAADPRAPSLFIHRPDALARRIGRHGLIGFGESYMAGEWSSKELTRVLTVLAGSVDELVPRSLHWLRPITPTFRPSWPDHSRDQARRNIAVHYDLSNDLFAAFLDETMTYSCAMFTDLLAQPTPAWTELAAAQRRKIDRLLDVAGVQQGSHVLEIGTGWGELCIRAAARGAHIRSVTLSVEQQRLARQRVAAAGFGHRVEIDLCDYRDVDGQYDSVVSVEMIEAVGYRSWPRYFAALEQLVRPGGPVAIQAITMPHHRMLATRHTQTWIQKYIFPGGLLPSTQAIIDITGQHTGLRIVDAASLRPHYAETLRLWRERFMQRRDGLAHLGFDEVFARMWELYLAYSEAGFRSGYLDVYQWTLIREGPP,"47,767",427,CFA/CMAS family,cell wall organization [GO:0071555]; fatty acid biosynthetic process [GO:0006633],methyltransferase activity [GO:0008168],,,LH57_02385 P425_00460,3
P9WFB7,VAPC3_MYCTU,Rv0549c,vapC3 Rv0549c,GO:0004540; GO:0045927; GO:0046872; GO:0075136,IPR029060; IPR002716; IPR022907; ,,vapC3,DOMAIN 12 129 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC3 (RNase VapC3) (EC 3.1.-.-) (Toxin VapC3),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; positive regulation of growth [GO:0045927]; response to host [GO:0075136],9634230; 15718296; 20011113; 21673191; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB3. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MRASPTSPPEQVVVDASAMVDLLARTSDRCSAVRARLARTAMHAPAHFDAEVLSALGRMQRAGALTVAYVDAALEELRQVPVTRHGLSSLLAGAWSRRDTLRLTDALYVELAETAGLVLLTTDERLARAWPSAHAIG,"14,700",137,PINc/VapC protein family,positive regulation of growth [GO:0045927]; response to host [GO:0075136],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
O07783,VAPC4_MYCTU,Rv0595c,vapC4 Rv0595c,GO:0003723; GO:0004540; GO:0005576; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC4,DOMAIN 7 130 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC4 (RNase VapC4) (EC 3.1.-.-) (Toxin VapC4) (VapC-mt4),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; negative regulation of growth [GO:0045926],9634230; 15718296; 19016878; 21969609; 22354968; 23345537; 25622615,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Probably exerts its toxic effect by binding to mRNA, inhibiting translation. Binds to, recognizes and cleaves ssRNA at ACGC and AC(A/U)GC sequences, usually between the G and C; cleavage is not very efficient, nor is cleavage required to inhibit protein synthesis. Upon expression in situ, in M.smegmatis or E.coli inhibits cell growth and colony formation; in at least E.coli also causes increased levels of cellular RNA. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB4. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:22354968, ECO:0000269|PubMed:25622615}.",MNVRRALADTSVFIGIEATRFDPDRFAGYEWGVSVVTLGELRLGVLQASGPEAAARRLSTYQLAQRFEPLGIDEAVSEAWALLVSKLRAAKLRVPINDSWIAATAVAHGIAILTQDNDYAAMPDVEVITI,"14,112",130,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723],extracellular region [GO:0005576],,,3
P9WHJ1,RECD_MYCTU,Rv0629c,recD Rv0629c,GO:0003677; GO:0004386; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006302; GO:0006310; GO:0008854; GO:0009338,IPR027417; IPR006344; IPR027785; ,,recD,,RecBCD enzyme subunit RecD (EC 3.1.11.5) (Exonuclease V subunit RecD) (ExoV subunit RecD) (Helicase/nuclease RecBCD subunit RecD),cell wall [GO:0005618]; cytosol [GO:0005829]; exodeoxyribonuclease V complex [GO:0009338]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; exodeoxyribonuclease V activity [GO:0008854]; helicase activity [GO:0004386]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302],9634230; 12657046; 21969609,,FUNCTION: A helicase/nuclease that prepares dsDNA breaks (DSB) for recombinational DNA repair. Binds to DSBs and unwinds DNA via a highly rapid and processive ATP-dependent bidirectional helicase activity. Unwinds dsDNA until it encounters a Chi (crossover hotspot instigator) sequence from the 3' direction. Cuts ssDNA a few nucleotides 3' to the Chi site. The properties and activities of the enzyme are changed at Chi. The Chi-altered holoenzyme produces a long 3'-ssDNA overhang and facilitates RecA-binding to the ssDNA for homologous DNA recombination and repair. Holoenzyme degrades any linearized DNA that is unable to undergo homologous recombination. In the holoenzyme this subunit has ssDNA-dependent ATPase and 5'-3' helicase activity. When added to pre-assembled RecBC greatly stimulates nuclease activity and augments holoenzyme processivity. Negatively regulates the RecA-loading ability of RecBCD. {ECO:0000255|HAMAP-Rule:MF_01487}.,MKLTDVDFAVEASGMVRAFNQAGVLDVSDVHVAQRLCALAGESDERVALAVAVAVRALRAGSVCVDLLSIARVAGHDDLPWPDPADWLAAVRASPLLADPPVLHLYDDRLLYLDRYWREEEQVCADLLALLTSRRPAGVPDLRRLFPTGFDEQRRAAEIALSQGVTVLTGGPGTGKTTTVARLLALVAEQAELAGEPRPRIALAAPTGKAAARLAEAVRREMAKLDATDRARLGDLHAVTLHRLLGAKPGARFRQDRQNRLPHNVIVVDETSMVSLTLMARLAEAVRPGARLILVGDADQLASVEAGAVLADLVDGFSVRDDALVAQLRTSHRFGKVIGTLAEAIRAGDGDAVLGLLRSGEERIEFVDDEDPAPRLRAVLVPHALRLREAALLGASDVALATLDEHRLLCAHRDGPTGVLHWNRRVQAWLAEETGQPPWTPWYAGRPLLVTANDYGLRVYNGDTGVVLAGPTGLRAVISGASGPLDVATGRLGDVETMHAMTIHKSQGSQVDEVTVLMPQEDSRLLTRELLYTAVTRAKRKVRVVGSEASVRAAIARRAVRASGLRMRLQSTGCG,"61,747",575,RecD family,DNA recombination [GO:0006310]; double-strand break repair [GO:0006302],ATP binding [GO:0005524]; DNA binding [GO:0003677]; exodeoxyribonuclease V activity [GO:0008854]; helicase activity [GO:0004386],cell wall [GO:0005618]; cytosol [GO:0005829]; exodeoxyribonuclease V complex [GO:0009338]; plasma membrane [GO:0005886],,,1
P9WG79,THIC_MYCTU,Rv0423c,thiC Rv0423c MTCY22G10.20c,GO:0005829; GO:0005886; GO:0009228; GO:0009229; GO:0016830; GO:0040007; GO:0046872; GO:0051539,IPR037509; IPR025747; IPR038521; IPR002817; ,,thiC,,Phosphomethylpyrimidine synthase (EC 4.1.99.17) (Hydroxymethylpyrimidine phosphate synthase) (HMP-P synthase) (HMP-phosphate synthase) (HMPP synthase) (Thiamine biosynthesis protein ThiC),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; carbon-carbon lyase activity [GO:0016830]; metal ion binding [GO:0046872]; growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229]",9634230; 21969609,,FUNCTION: Catalyzes the synthesis of the hydroxymethylpyrimidine phosphate (HMP-P) moiety of thiamine from aminoimidazole ribotide (AIR) in a radical S-adenosyl-L-methionine (SAM)-dependent reaction. {ECO:0000255|HAMAP-Rule:MF_00089}.,MTITVEPSVTTGPIAGSAKAYREIEAPGSGATLQVPFRRVHLSTGDHFDLYDTSGPYTDTDTVIDLTAGLPHRPGVVRDRGTQLQRARAGEITAEMAFIAAREDMSAELVRDEVARGRAVIPANHHHPESEPMIIGKAFAVKVNANIGNSAVTSSIAEEVDKMVWATRWGADTIMDLSTGKNIHETREWILRNSPVPVGTVPIYQALEKVKGDPTELTWEIYRDTVIEQCEQGVDYMTVHAGVLLRYVPLTAKRVTGIVSRGGSIMAAWCLAHHRESFLYTNFEELCDIFARYDVTFSLGDGLRPGSIADANDAAQFAELRTLGELTKIAKAHGAQVMIEGPGHIPMHKIVENVRLEEELCEEAPFYTLGPLATDIAPAYDHITSAIGAAIIAQAGTAMLCYVTPKEHLGLPDRKDVKDGVIAYKIAAHAADLAKGHPRAQERDDALSTARFEFRWNDQFALSLDPDTAREFHDETLPAEPAKTAHFCSMCGPKFCSMRITQDVREYAAEHGLETEADIEAVLAAGMAEKSREFAEHGNRVYLPITQ,"59,898",547,ThiC family,growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],"4 iron, 4 sulfur cluster binding [GO:0051539]; carbon-carbon lyase activity [GO:0016830]; metal ion binding [GO:0046872]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY22G10.20c,1
P9WG77,THID_MYCTU,Rv0422c,thiD Rv0422c MTCY22G10.19c,GO:0005524; GO:0008902; GO:0008972; GO:0009228; GO:0009229; GO:0040007,IPR004399; IPR013749; IPR029056; ,,thiD,,Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase (EC 2.7.1.49) (EC 2.7.4.7) (Hydroxymethylpyrimidine kinase) (HMP kinase) (Hydroxymethylpyrimidine phosphate kinase) (HMP-P kinase) (HMP-phosphate kinase) (HMPP kinase),ATP binding [GO:0005524]; hydroxymethylpyrimidine kinase activity [GO:0008902]; phosphomethylpyrimidine kinase activity [GO:0008972]; growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the phosphorylation of hydroxymethylpyrimidine phosphate (HMP-P) to HMP-PP, and of HMP to HMP-P. {ECO:0000250|UniProtKB:P76422}.",MTPPRVLSIAGSDSGGGAGIQADMRTMALLGVHACVAVTAVTVQNTLGVKDIHEVPNDVVAGQIEAVVTDIGVQAAKTGMLASSRIVATVAATWRRLELSVPLVVDPVCASMHGDPLLAPSALDSLRGQLFPLATLLTPNLDEARLLVDIEVVDAESQRAAAKALHALGPQWVLVKGGHLRSSDGSCDLLYDGVSCYQFDAQRLPTGDDHGGGDTLATAIAAALAHGFTVPDAVDFGKRWVTECLRAAYPLGRGHGPVSPLFRLS,"27,511",265,ThiD family,growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],ATP binding [GO:0005524]; hydroxymethylpyrimidine kinase activity [GO:0008902]; phosphomethylpyrimidine kinase activity [GO:0008972],,,MTCY22G10.19c,1
P9WG73,THIG_MYCTU,Rv0417,thiG Rv0417 MTCY22G10.14,GO:0005737; GO:0009228; GO:0009229; GO:0016740; GO:0040007,IPR013785; IPR033983; IPR008867; ,,thiG,,Thiazole synthase (EC 2.8.1.10),cytoplasm [GO:0005737]; transferase activity [GO:0016740]; growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],9634230; 21969609,X-ray crystallography (1),"FUNCTION: Catalyzes the rearrangement of 1-deoxy-D-xylulose 5-phosphate (DXP) to produce the thiazole phosphate moiety of thiamine. Sulfur is provided by the thiocarboxylate moiety of the carrier protein ThiS. In vitro, sulfur can be provided by H(2)S. {ECO:0000255|HAMAP-Rule:MF_00443}.",MAESKLVIGDRSFASRLIMGTGGATNLAVLEQALIASGTELTTVAIRRVDADGGTGLLDLLNRLGITPLPNTAGSRSAAEAVLTAQLAREALNTNWVKLEVIADERTLWPDAVELVRAAEQLVDDGFVVLPYTTDDPVLARRLEDTGCAAVMPLGSPIGTGLGIANPHNIEMIVAGARVPVVLDAGIGTASDAALAMELGCDAVLLASAVTRAADPPAMAAAMAAAVTAGYLARCAGRIPKRFWAQASSPAR,"25,878",252,ThiG family,growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],transferase activity [GO:0016740],cytoplasm [GO:0005737],,MTCY22G10.14,1
O07776,TCRA1_MYCTU,Rv0602c,tcrA Rv0602c,GO:0000156; GO:0003677; GO:0005737; GO:0005886; GO:0006351; GO:0006355; GO:0070298,IPR011006; IPR001867; IPR001789; IPR036388; ,,tcrA,DOMAIN 24 138 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Transcriptional regulatory protein TcrA,"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphorelay response regulator activity [GO:0000156]; negative regulation of phosphorelay signal transduction system [GO:0070298]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 17434492; 19099550; 19246748; 21969609,,FUNCTION: Member of the three-protein two-component system HK1/HK2/TcrA. {ECO:0000269|PubMed:17434492}.,MADETTMRAGRGPGRACGRVSGVRILVVEDEPKMTALLARALTEEGHTVDTVADGRHAVAAVDGGDYDAVVLDVMLPGIDGFEVCARLRRQRVWTPVLMLTARGAVTDRIAGLDGGADDYLTKPFNLDELFARLRALSRRGPIPRPPTLEAGDLRLDPSEHRVWRADTEIRLSHKEFTLLEALIRRPGIVHTRAQLLERCWDAAYEARSNIVDVYIRYLRDKIDRPFGVTSLETIRGAGYRLRKDGGRHALPR,"28,170",253,,"negative regulation of phosphorelay signal transduction system [GO:0070298]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; phosphorelay response regulator activity [GO:0000156],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
O07775,O07775_MYCTU,Rv0603,Rv0603,,,,,,Possible exported protein,,9634230; ,NMR spectroscopy (2),,MNRIVQFGVSAVAAAAIGIGAGSGIAAAFDGEDEVTGPDADRARAAAVQAVPGGTAGEVETETGEGAAAYGVLVTRPDGTRVEVHLDRDFRVLDTEPADGDGG,"10,182",103,,,,,,,1
V5QPR5,V5QPR5_MYCTU,Rv0530A,Rv0530A,,,,,,Conserved protein,,9634230; 21969609,,,MLYLLLVLILATLIYLGWRAARAQMNRPKTRVIGPDDDPEFLRRLGHGDNNRS,"6,121",53,,,,,,,1
P95210,P95210_MYCTU,Rv0401,Rv0401,GO:0016021,IPR021414; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MRPRRALAGLAADVVAVLVFCAVGRRSHAEGLSVTGLAATAWPFLTGTGIGWVLARGWRRPTALAPTGVIVWLCTIVVGMVLRKVSSAGVAASFVVVASAVTAVLLLGWRAAVALMAPHRADG,"12,641",123,,,,integral component of membrane [GO:0016021],,,1
P95207,P95207_MYCTU,Rv0399c,lpqK Rv0399c,GO:0040007,IPR001466; IPR012338; ,,lpqK,,Possible conserved lipoprotein LpqK,growth [GO:0040007],9634230; 21969609,,,MPVLRRLGCSVLALGLLAGCAPPRTGPASSPTNNGAKADAVIRIVRDFMTQAHLKAVLVRVTVAGKEVVTRAVGDSMTGVPATTAMHFRNGAVAISYVATLLLKLVDEKKLRLDDKLSRWLPDFPHADRVTLGQLAQMTSGYPDYVLGNEAFDAELYANPFRQWTTQELLDQISSRPLLYDPGTNWNYAHTNYLLLGLALEKAAGQDMPTLLQRKVLSPLGLTATANSDTPAIPEPALHAFTSERRAALKIPAGVPFYEESTFWNPSWTITHGAIQTTTIYDMEATAVGIGSGRLLSADSYKKMVSTELRGKTRAQPGCPTCFEQNDGYSYGLGIVISGHWLLQNPMFAGYAAVEAYLPSQRVAVAVAVTYAPEAFDDQGNYRNQADILFRKIGAEVAPNDAPPMPPGR,"44,309",409,,growth [GO:0040007],,,,,1
I6XVY0,I6XVY0_MYCTU,Rv0671,lpqP Rv0671,GO:0005576; GO:0016787,IPR029058; IPR010126; ,,lpqP,,Possible conserved lipoprotein LpqP,extracellular region [GO:0005576]; hydrolase activity [GO:0016787],9634230,,,MLRRVAILLAAVLAFAGCSGGTRLAAGFGNGNSVHTLDVDGAGRSYRLYKPVGLPSSAPLVVMLHGGFGSAKQAERSYGWDELADSEKFLVAYPDGYHRAWNANGGGCCGRPAREGVDDIGFVRAVVADIANNVSIDPARVYVTGMSNGAIMSYTLACNTSIFAAIGVVSGTQLDPCQSPRPVSVIHIHGTADPLVRYHGGPGAGFARIDGPPVPDLNAFWREVNRCGALDTTTEGPVTTSGATCADNRRVVLLTVDDAGHRWPSFATQTLWRFFAAHFR,"29,579",280,,,hydrolase activity [GO:0016787],extracellular region [GO:0005576],,,1
P96262,P96262_MYCTU,Rv0416,thiS Rv0416,GO:0040007,IPR012675; IPR016155; IPR010035; IPR003749; ,,thiS,,Possible protein ThiS,growth [GO:0040007],9634230,,,MIVVVNEQQVEVDEQTTIAALLDSLGFGDRGIAVALNFSVLPRSDWATKICELRKPVRLEVVTAVQGG,"7,368",68,,growth [GO:0040007],,,,,1
O07772,O07772_MYCTU,Rv0606,Rv0606,,IPR021027; ,,,,Possible transposase,,9634230,,,MPRLEIPNGWCVQAFRFTLDPTAEQAHALARHFGARRKAYNWTVAQLKADIQAWRATGAQTAKPSLRVLRKRWNTVKDEVCVNAETGTVWWPECSKEAYADGIAGAVDAYWNWQQRRAGKRDGKRMGFPRFKKKGRDADRVSFTTGAMRVEPDRRHLTLPVIGCVRTHENTRRIERLIAKDRARVLAITVRRNGTRLDASVRVLVQRPQQPNVELPESRIGVDVGVRRLATVATADGACCPVLVPDG,"27,860",247,,,,,,,1
I6X9F4,I6X9F4_MYCTU,Rv0621,Rv0621,GO:0016021,,,,,Possible membrane protein,integral component of membrane [GO:0016021],9634230,,,MAGDRGADPGPANVTPGADDHAQHASPTVLCPQGHVNAWDYRFCERCGSPIGVVPWPSEESGTRQTAPARSFVPLVVLAATLLVVAVVVTAVGYAVTRPARNDREEPSSARGAATTGVPFAQAEAASCPDDPVLEAESIDLTSDGLAVSAAFMSACAGGDVESNSALEVTVADGRRDVAAGSFDFSADPLRIEPGVPARRTLVFPPGMYWRTPDMLSGAPALAATRKGRSDRSAARGGSARTTMVAAASAAPAYGSINAVAGAVLVELRDSDFPYVRVGIANRWVPQVSSKRVGLVAAGKTWTSADILRDHLALRQRFGGARLVWSGHWTTFSGPDFWVTVVGPAQPTAAEANR,"36,801",354,,,,integral component of membrane [GO:0016021],,,1
I6Y8K3,I6Y8K3_MYCTU,Rv0737,Rv0737,GO:0003700; GO:0006355; GO:0044212,IPR000835; IPR036388; IPR036390; ,,,DOMAIN 27 160 HTH marR-type. {ECO:0000259|PROSITE:PS50995}.,Possible transcriptional regulatory protein,"DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MASDNRDPIAAARANWERSGWGDVSLGMVAVTSVMRAHQILLARVETALRPYDLSFSRFELLRLLAFSRIGALPITKASDRLQVHVTSVTHAIRRLEADGLVRRVPHPTDGRTTLVQITELGRSTVEDATVTLNEQVFANVGMGAEESQALVSAVETLRRNAGDF,"18,079",165,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],,,,1
I6WZ83,I6WZ83_MYCTU,Rv0743c,Rv0743c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTRQQLAHLLRRACAVVGDVDVLVLGSQSILGSFDENELPPQATASQEADIAFVNDPARDKADHVDVAIGEMSDFHRSNGVYAEGVHIDTAILPNGWRDRLVSWTVESSRPAKPRFLEPHDLAVAKLAAGREKDKAFVAALIRSGLLDVGVIQARVLLLPEETDPRIGQRIAAWLNYYGAGNHSS,"20,143",185,,,,,,,1
I6Y8R4,I6Y8R4_MYCTU,Rv0774c,Rv0774c,,IPR029058; IPR000801; IPR006311; ,,,,Probable conserved exported protein,,9634230; 21969609,,,MMARMPELSRRAVLGLGAGTVLGATSAYAIDMLLQPRTSHAAPAAAIGTNVPLAPTPALDPAPPAQAAPTMSTGSFVSAARAGKMTNWAIARPPGQTQALRPVIALHGLGGSASAVMDGGVEQGLAQAVNAGLPPFAVVSVDGGSSYWHQRASGEDAGAMVLNELIPLLDTQRLDTSRVAFLGWSMGGYGALLLGSRLGPARTAAICAVSPALWLSAGSVAPGSFDGPDDWSANSVFGLPALGSIPIRVDCGNSDPFYAATKQFVAQLPHPPAGGFSPGGHNGGFWSAQLPAELTWFAPLLTG,"30,654",303,,,,,,,1
O06773,O06773_MYCTU,Rv0666,Rv0666,GO:0040007,,,,,Possible membrane protein,growth [GO:0040007],9634230,,,MTPRTDEGAAAPCLMPDVTMPVKRGDARGALGVGPALFVVSVSSSLVRARSCRCTAD,"5,849",57,,growth [GO:0040007],,,,,1
I6Y4G1,I6Y4G1_MYCTU,Rv0690c,Rv0690c,,IPR011200; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTGTEHLVHTLRSQGRVCTSSGSPMYRELLELVAADVESGGVFASILADQKGAPEGQAVPLRLLGGLHRMVLDGRAPVLRRWYPSTGGTWQAEAAWPDIVRTATDQPESLRAALDRPPQTNEVGRSAALIGGLLIACLQFDLPIRLFEIGSSAGLNLRPDRYRYRYLGGEWGLADSPVRIDNAWLGELPPTATVRIVERHGYDIAPIDVTSPDGELNALSYIWPDQTDRLERLRGAIAVARNIPADLHRQAAHAAVAGMTLTDDALTVLWHSITWQYLPADERAAIRAGIDALAAQADAHCPFVHLTLEPAHQRPGAQIKYLVRMRSWPGGHARVLGECHPHGPPVTWQ,"38,130",349,,,,,,,1
O53737,O53737_MYCTU,Rv0452,Rv0452,GO:0000976; GO:0003700; GO:0005829,IPR009057; IPR001647; ,,,DOMAIN 22 82 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein,cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MRYPLAVAQLGFQRARTEENKRQRAAALVEAARSLALETGVASVTLTAVAGRAGIHYSAVRRYFTSHKEVLLHLAAEGWARWSGTVCEQLGEPGPMSAPRVAEALANGLAADPLFCDLLANLHLHLEQEVDVDRVIEVKRTSIAAVIALVDAIESALPALGRSGAFDILLAAYSLAATLWQIANPPERLTDAYAEEPELLPPEWNLDFAAALTRLLTATLLGLLAGSPCECRSPTR,"25,357",236,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,3
O07763,O07763_MYCTU,Rv0614,Rv0614,GO:0005618,,,,,Uncharacterized protein,cell wall [GO:0005618],9634230,,,MPAIPFQGEARAGRRPGRPRRCPAGVVRCRPRSMGHVRPGFSPRLGSHRTLRPRWPPYAAASRGLTSGTSRWGWPRLGFGVVTAPTRWTLADGRELLFFSLPGPRTSGTAAERVARHAQAQTFAGDIRQRAIQLVVSEQEVASKITAATAGIATTTFPETPSIDDTIIGNDNRDTGVRLVDVKQDGGTSPPPPFAPWDTPDGTPPPGTGLSPTLQQMILGGDPANLTGQGLADNVQRFVQSLPANDPNTAWLRGQVADLQAHVADIEYARTHCSTNDWIDRTAQFASGAIVFSIGVLTAETGAGVVAAAAGGVGAATAGVSLLQCLVGSK,"34,662",330,,,,cell wall [GO:0005618],,,1
O53813,O53813_MYCTU,Rv0750,Rv0750,,,,,,Uncharacterized protein,,9634230,,,MRAIVGDCVIHIMPMGTGVELSKLADLALDIGRSVGCSAYENDFTLPDIPTQWRNQPLGWYTQGLAPYLPGLSDPKDAAEG,"8,719",81,,,,,,,3
P96274,P96274_MYCTU,Rv0428c,Rv0428c,GO:0016740,,,,,GCN5-related N-acetyltransferase,transferase activity [GO:0016740],9634230; 21969609,,,MVSWPGLGTRVTVRYRRPAGSMPPLTDAVGRLLAVDPTVRVQTKTGTIVEFSPVDVVALRVLTDAPVRTAAIRALEHAAAAAWPGVERTWLDGWLLRAGHGAVLAANSAVPLDISAHTNTITEISAWYASRDLQPWLAVPDRLLPLPADLAGERREQVLVRDVSTGEPDRSVTLLDHPDDTWLRLYHQRLPLDMATPVIDGELAFGSYLGVAVARAAVTDAPDGTRWVGLSAMRAADEQSATGSAGRQLWEALLGWGAGRGATRGYVRVHDTATSVLAESLGFRLHHHCRYLPAQSVGWDTF,"32,650",302,,,transferase activity [GO:0016740],,,,3
P95073,P95073_MYCTU,Rv0725c,Rv0725c,GO:0005618; GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,S-adenosyl-L-methionine-dependent methyltransferase (EC 2.1.1.-),cell wall [GO:0005618]; methyltransferase activity [GO:0008168],9634230,,"FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000256|RuleBase:RU362030, ECO:0000256|SAAS:SAAS00276433}.",MPRAHDDNWDLASSVGATATMVAAGRALATKDPRGLINDPFAEPLVRAVGLDFFTKLIDGELDIATTGNLSPGRAQAMIDGIAVRTKYFDDYFRTATDGGVRQVVILAAGLDARAYRLPWPAGTVVYEIDQPQVIDFKTTTLAGIGAKPTAIRRTVYIDLRADWPAALQAAGLDSTAPTAWLAEGMLIYLPPDPRTGCSTTAPNSVLRAARSLPNLSRALWISTQAGYEKWRIRFASTAWTSTWRRWCIPANAATSSTTCAPRAGTLRAQCGPTYSGAMVCPFPPHTTTIRSAKSSSSAVV,"32,247",301,UPF0677 family,,methyltransferase activity [GO:0008168],cell wall [GO:0005618],,,1
O53756,O53756_MYCTU,Rv0471c,Rv0471c,,,,,,Uncharacterized protein,,9634230,,,MPDAGAGSRLRSWAYALRTTNPPADGPTDTVTRWLVVTRAAVLPMTLVSGLVAGLLAIGEPGLDWRWLVLWWESHAPHIANNLMNDLYDTDVGTDSATYARARYAQHPAATGANRAAYTTPRRTTSCGSPERALEPTTPRWARAVGRSCWRRSPTGCCAPRC,"17,648",162,,,,,,,1
I6Y8I5,I6Y8I5_MYCTU,Rv0712,Rv0712,,IPR016187; IPR005532; ,,,,Conserved protein,,9634230; 21969609,,,MLTELVDLPGGSFRMGSTRFYPEEAPIHTVTVRAFAVERHPVTNAQFAEFVSATGYVTVAEQPLDPGLYPGVDAADLCPGAMVFCPTAGPVDLRDWRQWWDWVPGACWRHPFGRDSDIADRAGHPVVQVAYPDAVAYARWAGRRLPTEAEWEYAARGGTTATYAWGDQEKPGGMLMANTWQGRFPYRNDGALGWVGTSPVGRFPANGFGLLDMIGNVWEWTTTEFYPHHRIDPPSTACCAPVKLATAADPTISQTLKGGSHLCAPEYCHRYRPAARSPQSQDTATTHIGFRCVADPVSG,"32,744",299,,,,,,,1
P95059,P95059_MYCTU,Rv0711,atsA Rv0711,GO:0005886; GO:0008152; GO:0008484; GO:0010033,IPR017849; IPR017850; IPR024607; IPR000917; ,,atsA,,Possible arylsulfatase AtsA (Aryl-sulfate sulphohydrolase) (Arylsulphatase),plasma membrane [GO:0005886]; sulfuric ester hydrolase activity [GO:0008484]; metabolic process [GO:0008152]; response to organic substance [GO:0010033],9634230; 21969609,,,MAPEATEAFNGTIELDIRDSEPDWGPYAAPVAPEHSPNILYLVWDDVGIATWDCFGGLVEMPAMTRVAERGVRLSQFHTTALCSPTRASLLTGRNATTVGMATIEEFTDGFPNCNGRIPADTALLPEVLAEHGYNTYCVGKWHLTPLEESNMASTKRHWPTSRGFERFYGFLGGETDQWYPDLVYDNHPVSPPGTPEGGYHLSKDIADKTIEFIRDAKVIAPDKPWFSYVCPGAGHAPHHVFKEWADRYAGRFDMGYERYREIVLERQKALGIVPPDTELSPINPYLDVPGPNGETWPLQDTVRPWDSLSDEEKKLFCRMAEVFAGFLSYTDAQIGRILDYLEESGQLDNTIIVVISDNGASGEGGPNGSVNEGKFFNGYIDTVAESMKLFDHLGGPQTYNHYPIGWAMAFNTPYKLFKRYASHEGGIADPAIISWPNGIAAHGEIRDNYVNVSDITPTVYDLLGMTPPGTVKGIPQKPMDGVSFIAALADPAADTGKTTQFYTMLGTRGIWHEGWFANTIHAATPAGWSNFNADRWELFHIAADRSQCHDLAAEHPDKLEELKALWFSEAAKYNGLPLADLNLLETMTRSRPYLVSERASYVYYPDCADVGIGAAVEIRGRSFAVLADVTIDTTGAEGVLFKHGGAHGGHVLFVRDGRLHYVYNFLGERQQLVSSSGPVPSGRHLLGVRYLRTGTVPNSHTPVGDLELFFDENLVGALTNVLTHPGTFGLAGAAISVGRNGGSAVSSHYEAPFAFTGGTITQVTVDVSGRPFEDVESDLALAFSRD,"86,214",787,,metabolic process [GO:0008152]; response to organic substance [GO:0010033],sulfuric ester hydrolase activity [GO:0008484],plasma membrane [GO:0005886],,,1
O53745,O53745_MYCTU,Rv0460,Rv0460,GO:0016021,IPR031614; ,,,,Conserved hydrophobic protein,integral component of membrane [GO:0016021],9634230,,,MLVGNAIGLLAGVACSVLVHARIRPDIVIAMVVGIPSAIGLLVILFSGRRWVTMLGAFILALAPGWFGVLVAIQVASSG,"8,081",79,,,,integral component of membrane [GO:0016021],,,3
P95044,P95044_MYCTU,Rv0698,Rv0698,,,,,,Uncharacterized protein,,9634230,,,MGRRGNRRVHVDRVRLTGTERELRAENQSPPIFRPQNTLGDGANGLPLAVCTTTAHTCHTSHTHPSRWTPNPVPATKGVPAGLVQATFIIENLDPGNNDTPTPPTPKLRLARKPGHHRRSEYDADSVLRRKDTSRRCVQADDVRCVQLVQDPRRGRVELGGYRAELTVGRRAAVNCQRPQYGADGWPVRLGCGVGGAARGDQR,"22,325",203,,,,,,,1
P95203,P95203_MYCTU,Rv0395,Rv0395,,,,,,Uncharacterized protein,,9634230,,,MDWMPLGDYETFRHWSGKPRAWGPQESGWRAWFGGKIVDGLCEVLDEHLAVRRRGVPAAIGCVPWLSSEAVAETLLALSVFCVVIDKGTSFPSRLRNPDKGFPNVALLRLRDMAPSEHGSRCSSARGRLCLSMS,"14,843",134,,,,,,,1
O53734,O53734_MYCTU,Rv0449c,Rv0449c,GO:0005886; GO:0016491,IPR002937; IPR036188; ,,,,Uncharacterized protein,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230,,,MQQSLRRSVAVVGSGVAGLTAAYILSGRDRVTLYEADGRLGGHAHTHYLDNGGGPRGTDVVGVDSAFLVHNDRTYPTLCRLFAELGVATQESEMSMSVRADDIGLEYAGALGARGLFACRQSLRPRYLCMLAEILRFHRAAARLLREETDNAEDKPETLEAFLSRHHFSQYFVDYFITPLVAAVWSCGGADALRYPARYLFVFLDHHGMLSVFGSPTWRTVTGGSANYVQAIAAQLDEVSTRTPVHSLRRLPDGVLVGAGDGPSRRFDAAVVAVHPDQALLLLDEPTPAERAVLGAIAYSTNSAQLHTDESVLPRHHRARASWNYLVTPGQHQVVVSYDISRLMRLDGGRRYLVTLGGHDRVDPSSVIAEMTYSHPLYTPESVAAQRLLPTLGDNRVVFAGAYHGWGFHEDGAASGLRAARRLGADWPAAIPQEAMVAC,"47,817",439,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
P95046,P95046_MYCTU,Rv0699,Rv0699,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MGDRRVDLLAAKDSEIRRSMGAVPVGAGSSQVATSWASDRCIRCRAAILSADCANLARANSRGGLAVGGSAVS,"7,391",73,,,,plasma membrane [GO:0005886],,,1
I6WZD9,I6WZD9_MYCTU,Rv0765c,Rv0765c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable oxidoreductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MPRFEPHPARRTTVVAGASSGIGAATATELAGRGFPVALGARRMDKLAELVDKIRADGGEAVAFPLDVTDPESVKSFVAQTVEALGEVELLVSSAGDMLPGQLHEVSTEAFAEQVQIHLVGANRLATAVLPAMVARRRGDLIFVGSDVGLRQRPHMGAYGAAKAGLAAMVTNLQMELEGTGVRASIVHPGPTLTGMGWQLSAEQVGPMLADWAKWGQARHNYFLRPSDLARAIAFVAETPRGCVVVNMEIQPEAPLRDAPAHRQKLVLGEEGMPG,"29,064",275,,,oxidoreductase activity [GO:0016491],,,,1
P71813,P71813_MYCTU,Rv0756c,Rv0756c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MNLGQTLVGIATWPARAGLAAADTGLNMAGAAVDMAKQALGDAGGASGSTSMANMLGIDDTIARANRLARLLDDDMPLGRAIAPNGPMDRMLRPGGVVDLLTQPGGLLDRLTAEGGAMQRALQPGGLADQLLAEDGLIERVLSEDGLADRLLAEGGLIDKITAKDGPLEQLADVADTLARLTPGMEALEPAIATLQDAVIALTMVVNPLSSIAERIPLPGRRPARRSSSRSVRSQRVVDSE,"24,885",241,,,,,,,1
I6XVR9,I6XVR9_MYCTU,Rv0611c,Rv0611c,,IPR032568; ,,,,Uncharacterized protein,,9634230,,,MPDRPQHPTASRQSSMVSWNHGAAGWLHCVQCGSATNPTACLDWLPPIHARSGPMYAEHDVVVLTRDVPDKSLIAGDVGAVVGRYAAGGYEVDFTAANGCTVAVVTLAGDDIRPRRRREIPHVREVA,"13,639",127,,,,,,,1
O33360,O33360_MYCTU,Rv0515,Rv0515,,IPR003870; IPR003615; ,,,,Conserved 13E12 repeat family protein,,9634230,,,MPSPEAIAHFDERFECHAPRTTRVSAAFIDRICSATRAENRAAAAQLVALGELFAYRWSRCGGREEWVMDTMAAVAAEVAAALRISQGLAASRLRYARAMRERLPKTAEVFSAGDIGYLMFATIVYRTDLIVDPDVLAAVDAQLAANVARWPSMTKARLAGQVDKIVARADADAVRRRKEYQAQRQFWVGESQDGVCQIGGSLLAVDAHALDARLSALAGTVCEHDPRSREQRRADALGALAGGADRLGCGCGRADCAAGKRPAAPPVVIHLIAEAATINGTGSAPASQMNADGLITAELVAELAKTATLVPLVHPGDAPPEPGYAPSKALADFVRCRDLTCRWPGCDEPATNCDLDHTIPYAAGGPTHASNLKCYCRTHHLVKTFWGWRDQQLPDGTLILTSPSGHTYVSTPGSALLFPSLCHFSGGIPAPEADPPYDHCDQRTAMMPKRRRTRAQDRAYRIATERRQNHAARQRAQVLTQTAAATDTHGPPPDHNDDPPPF,"54,187",503,,,,,,,3
P95204,P95204_MYCTU,Rv0396,Rv0396,,,,,,Uncharacterized protein,,9634230,,,MRALGWLREDRKPLLNAKLLVLGHLALNVYDPDNGYGEEVLDFEPRTVWWGSANWTVRAGSHLEVGFACDDPTLVEEATAFVADVIAFSEPIDTTCAGPEPNLVQVEFDDAAMAEAMEEMAEPDDDGEDW,"14,384",130,,,,,,,4
O06428,O06428_MYCTU,Rv0562,grcC1 Rv0562,GO:0005618; GO:0005886; GO:0008299; GO:0016740; GO:0040007,IPR008949; IPR000092; IPR033749; ,,grcC1,,Probable polyprenyl-diphosphate synthase GrcC1 (Polyprenyl pyrophosphate synthetase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; growth [GO:0040007]; isoprenoid biosynthetic process [GO:0008299],9634230; 21969609,,,MRTPATVVAGVDLGDAVFAAAVRAGVARVEQLMDTELRQADEVMSDSLLHLFNAGGKRFRPLFTVLSAQIGPQPDAAAVTVAGAVIEMIHLATLYHDDVMDEAQVRRGAPSANAQWGNNVAILAGDYLLATASRLVARLGPEAVRIIADTFAQLVTGQMRETRGTSENVDSIEQYLKVVQEKTGSLIGAAGRLGGMFSGATDEQVERLSRLGGVVGTAFQIADDIIDIDSESDESGKLPGTDVREGVHTLPMLYALRESGPDCARLRALLNGPVDDDAEVREALTLLRASPGMARAKDVLAQYAAQARHELALLPDVPGRRALAALVDYTVSRHG,"35,560",335,FPP/GGPP synthase family,growth [GO:0040007]; isoprenoid biosynthetic process [GO:0008299],transferase activity [GO:0016740],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P96941,P96941_MYCTU,Rv0653c,Rv0653c,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; IPR036271; IPR025996; ,,,DOMAIN 5 65 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MTSQTGVRDELLHAGVRLLDDHGPDALQTRKVAAAAGTSTMAVYTHFGGMRGLIAAIAEEGLRQFDVALTVPQTADPVADLLAIGTAYRRYAIERPHMYRLMFGSTSAHGINVPARDVLTLKVAEIEHQHPSFAHVVRAVHRCLLAGRFATALGADDDTAIVATAAQFWSQIHGFVMLELAGFYGDRGAAVEPVLAAMTVNLLVALGDSPERAQCSLRAEQTQKNTLGRAT,"24,727",231,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,5
P95034,P95034_MYCTU,Rv0688,Rv0688,GO:0005623; GO:0006124; GO:0008860; GO:0009055; GO:0045454; GO:0050660; GO:0051287,IPR036188; IPR023753; IPR016156; IPR028202; ,,,,Putative ferredoxin reductase,cell [GO:0005623]; electron transfer activity [GO:0009055]; ferredoxin-NAD+ reductase activity [GO:0008860]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; cell redox homeostasis [GO:0045454]; ferredoxin metabolic process [GO:0006124],9634230; 21969609,,,MNAHVTSREGVNEFDDGIVIVGGGLAAARTAEQLRRAGYSGRLTIVSDEVHLPYDRPPLSKEVLRSEVDDVALKPREFYDEKDIALRLGSAAVSLDTGEQTVTLADGTVLGYDELVIATGLVPRRIPSLPDLDGIRVLRSFDESMALRKHASAARHAVVVGAGFIGCEVAASLRGLGVDVVLVEPQPAPLASVLGEQIGQLVTRLHRDEGVDVRTGVTVAEVRGKGHVDAVVLTDGTELPADLVVVGIGSTPATEWLEGSGVEVDNGVICDKAGRTSAPNVWALGDVASWRDPMGHQARVEHWSNVADQARVVVPAMLGTDVPTGVVVPYFWSDQYDVKIQCLGEPHATDVVHLVEDDGRKFLAYYERDGVLVGVVGGGMAGKVMKVRGKIAAGAPIAEVLDQTQA,"43,018",406,,cell redox homeostasis [GO:0045454]; ferredoxin metabolic process [GO:0006124],electron transfer activity [GO:0009055]; ferredoxin-NAD+ reductase activity [GO:0008860]; flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287],cell [GO:0005623],,,1
Q79FX1,Q79FX1_MYCTU,Rv0724A,Rv0724A,,IPR029063; ,,,,Uncharacterized protein (Fragment),,9634230,,,SQDRLFDNSTELSVAGSTIATELVPGIVDFDAGRVREMADSFRKHGVDIDMASLVYSGERSHVVDYLRAKGWDVEGTVRTDLFRRNGLPVPAPHDDDPLGEIIFISGRLNG,"12,188",111,,,,,,,1
P96281,P96281_MYCTU,Rv0435c,Rv0435c,GO:0005524; GO:0005618; GO:0005886,IPR003593; IPR009010; IPR003959; IPR003960; IPR003338; IPR027417; ,,,,Putative conserved ATPase,cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524],9634230; 21969609,,,MTHPDPARQLTLTARLNTSAVDSRRGVVRLHPNAIAALGIREWDAVSLTGSRTTAAVAGLAAADTAVGTVLLDDVTLSNAGLREGTEVIVSPVTVYGARSVTLSGSTLATQSVPPVTLRQALLGKVMTVGDAVSLLPRDLGPGTSTSAASRALAAAVGISWTSELLTVTGVDPDGPVSVQPNSLVTWGAGVPAAMGTSTAGQVSISSPEIQIEELKGAQPQAAKLTEWLKLALDEPHLLQTLGAGTNLGVLVSGPAGVGKATLVRAVCDGRRLVTLDGPEIGALAAGDRVKAVASAVQAVRHEGGVLLITDADALLPAAAEPVASLILSELRTAVATAGVVLIATSARPDQLDARLRSPELCDRELGLPLPDAATRKSLLEALLNPVPTGDLNLDEIASRTPGFVVADLAALVREAALRAASRASADGRPPMLHQDDLLGALTVIRPLSRSASDEVTVGDVTLDDVGDMAAAKQALTEAVLWPLQHPDTFARLGVEPPRGVLLYGPPGCGKTFVVRALASTGQLSVHAVKGSELMDKWVGSSEKAVRELFRRARDSAPSLVFLDELDALAPRRGQSFDSGVSDRVVAALLTELDGIDPLRDVVMLGATNRPDLIDPALLRPGRLERLVFVEPPDAAARREILRTAGKSIPLSSDVDLDEVAAGLDGYSAADCVALLREAALTAMRRSIDAANVTAADLATARETVRASLDPLQVASLRKFGTKGDLRS,"75,346",728,AAA ATPase family,,ATP binding [GO:0005524],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
I6Y870,I6Y870_MYCTU,Rv0587,yrbE2A Rv0587,GO:0043190,IPR030802; ,,yrbE2A,,Conserved hypothetical integral membrane protein YrbE2A,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230; 21969609,,,MTTHAVIITYLRDQTQPAVDAIGGFYRTCVLTGKALVRRPFHWREAIEQGWFITSVSLLPTLAVSIPLTVLIIFTLNILLAEFGAADISGAGAALGAVTQLGPLTTVLVIAGAGATAICADLGARTIREEIDAMEVLGIDPIHRLVVPRVVAATIVAALLNGAVITIGLVGGFVFSVFIQHVSAGAYVGTLTLVTGLPEVIISVVKSATFGLIAGLVGCYRGLTTKGGPKGVGTAVNETLVLCVIALFATNVVLTTIGVRFGTGH,"27,327",265,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
I6Y4K0,I6Y4K0_MYCTU,Rv0729,xylB Rv0729,GO:0005975; GO:0016301; GO:0016773,IPR000577; IPR018485; IPR018484; ,,xylB,,Possible D-xylulose kinase XylB (Xylulokinase) (Xylulose kinase),"kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MSRDDVTIGIDIGTTAVKAVAADDNGRVTARVRIGHQLAVPAPDRLEHDADEAWRRGPLAALDRLVGPDTRALAVAAMVPSLTAVDPAGRPITPGLLYGDARGRVPNASVARAQSVPSVGETAEFLRWTAGQALDASGYWPAPAVANYALSGEAVIDYATAVTTLPLFDGTGWNATACADCGVTVDRMPRVETFGVGVGQVRGTGAVLAVGAVDALCEQIVAGADRDGDVLVLCGATLIVWTTISAARQVPGLWTIPHTAPGKSQIGGASNAGGLFLNWVDRVIGPGDPALADPRRVPVWLPYIRGERTPFHEPDRRAVLDGVDLSQDAASVRRAAYEASGFVVRQLIELSGAPVARIVAAGGGTRIQPWMQAIADATGRPVEVSRVAEGAALGAAFLGRLAAGLESSIADAARWASTDRIVEPSADWAGPTKERYRRFLALSGSKLA,"46,576",448,,carbohydrate metabolic process [GO:0005975],"kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]",,,,1
O53744,O53744_MYCTU,Rv0459,Rv0459,,IPR008497; ,,,,Uncharacterized protein,,9634230; 21969609,,,MNAPAGVLITAEAAALLAGLQDRHGPVMFHQSGGCCDGSAPMCYPRADFLVGDRDILLGVLDVGEDGVPVWISGPQYQAWKHTQLIIDVVPGRGGGFSLEAPEGVRFLSRGRVFSDAEKAMREAAPVITGAAYECGERPLVRGLVVDLDDPDATPGVCRASRR,"17,216",163,,,,,,,1
I6X9N8,I6X9N8_MYCTU,Rv0745,Rv0745,,,,,,Uncharacterized protein,,9634230,,,MGPPHRSRPPLPSPGPTCQVLPTTAVIHTVTAEALGRIGIDAPRIPGSLDVAAHAAIGLLPLVAGCDRRHRRPVRGARAGRAAQVSLCMTAIRVEPVSSNAVCTGPAAQVGDQSRSPQRDYAHQALQPDVPRRRARRHRPRRCSAKTGSSSSTMRCTCHQNQCLWSSGVSWALAR,"18,680",175,,,,,,,1
P95206,P95206_MYCTU,Rv0398c,Rv0398c,GO:0005576,,,,,Possible secreted protein,extracellular region [GO:0005576],9634230; 21969609,,,MGVIARVVGVAACGLSLAVLAAAPTAGAEPTGALPPMTSSGSGPVIGDGDAALRQRISQQLFSFGDPTVQEVDGSDAAQFITAAAAVADRDVASVFLPLQRVLGCQQNTAGSGAGFGARAYRRTDGQWGGAMLVVAKSTVSDVDALKACVKSGWRKATAGTPTSMCNNGWTYPPFADTRRGEEGYFVLLAGTASDFCSAPNANYRTTASSWPG,"21,655",213,,,,extracellular region [GO:0005576],,,1
O06403,O06403_MYCTU,Rv0537c,Rv0537c,GO:0016021,,,,,Probable integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGLSSDDTRRREVVRDLAAGALLIGALFFPWNLYFGFRIPDSSKTVFGLLLAVTSLSLASLAVTFAGRRSQLRLGLNVPYLLLVLAFVVFDAIQTIRLGGTVHVPGGVGPGGWLGITGALLSAQPALTGATTDEGSHSRWLRATQFLGYASMLGAALSTGFNLSWRVRYALEPAAGASGFGKQNLAVIDTAVVYGVVALAAVLVASRWLLRPTAAEALSTVALGGSTLIAGSIVWSLPIGREIDAFHGIAQNTSTAGVGYEGYLVWAAAAAMCAPLTLFRSPNAPPIDKTVWRAASRNGLLLIAVWCLGSVAMRLTDLVVAVLLNYPFSRYDSMALAAFDLATAVLAIWLRFNMATEALPARLISSLCGLLCTFTVSRVIVGVVLAPRFQASSGGSAHPVYGNDLAQQITSTFDVVLCGLALSILAAAIVIGRLRQLPQPPHTPALSRPAGSPRIFRSAGSTHPVRPKIYRPPDHSS,"50,203",477,,,,integral component of membrane [GO:0016021],,,1
I6Y8D3,I6Y8D3_MYCTU,Rv0650,Rv0650,GO:0016301,IPR000600; ,,,,Possible sugar kinase,kinase activity [GO:0016301],9634230; 21969609,,,MLTLCLDIGGTKIAAGLADPAGTLVHTAQRPTPAYGGAEQVWAAVAEMIADALGVAGGAVGGVGIASAGPIDLHSGRVSPINIGSWGGFPLRDRVAAAVPGVPVRLGGDGVCMALGEHWLGAGRGARFLLGLVVSTGVGGGLVLDGAPCLGRTGNAGHVGHVVVDPDGSPCPCGGRGCVETIASGPSLARWARANGWSAPPGAGAKELAEAAGAGDPVALRAFRRGAAALAAMIASVGAVCDLDLAVIGGGVAKSGRLLFEPLRAALADHARLDFLAGLRVVPAELGGAAGLVGAARLAAIA,"29,270",302,,,kinase activity [GO:0016301],,,,1
O06418,O06418_MYCTU,Rv0552,Rv0552,GO:0005886; GO:0016810,IPR013108; IPR011059; IPR032466; IPR033932; ,,,,Conserved protein,"plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",9634230; 21969609,,,MADADLVMTGTVLTVDDARPTAEAIAVADGRVIAVGDRSEVAGLVGANTRVIDLGAGCVMPGFVEAHGHPLLEAVVLSDRFVDIRPVTMRDADDVVAAIRGEVARRGPAGAYLVGWDPLLQSGLGEPTLTWLDSLAPNGPLVIIHNSGHKAYFNSHAAWLNGLTRDTADPKGAKYGRDGNGELDGTAEEIGAILPLLAGVADPSNFGAMLRAECARLNRAGLTTCSEMAFDPGYRPMVEAVRAELTVRLCTYEISNARMCTDATPGQGDDMLRQVGIKIWVDGSPWVGNIDLTFPYLDTPATRAIGVPPGSRGCANYTREQLAEIVGAYFPRGWQIACHVHGDGGVDTILDVYEEALRRNPRDDHRLRLEHVGAIRPDQLRRAAELGVTCSIFVDQIHYWGDVIVDDLFGAQRGSRWMPAGSAVAAGMRISLHNDPPVTPEEPLRNISVAATRVAPSGRVLAPEERLTVEQAIRAQTIDAAWQLFAEDAIGSLQVGKYADMVVLSADPRTVPPEQIADLAVRATFLAGRQVYRR,"57,340",534,,,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",plasma membrane [GO:0005886],,,3
O33364,O33364_MYCTU,Rv0519c,Rv0519c,,IPR029058; IPR000801; IPR006311; ,,,,Possible conserved membrane protein,,9634230; 21969609,,,MLRRGCAGNTDRRGIMTPMADLTRRALLRWGAGAGAGAAGVWAFGALVDPLEPQAAPAPFEPPTAGSSLPTRISGSFISAARGGIKTNWVISMPPGQSGQLRPVIALHGKDGNAGMMLDLGVEQGLARLVKEGKPAFAVVGVDGGNTYWHRRSSGGDSGAMVLDELLPMLTSMGMDTSRVGFLGWSMGGYGALLLGARLGPARTAGICAISPALFTSFTGSTPGAFDSYDDYVQHSVLGLPALNSIPLRVDCGTSDRFYFATRQFVNQLHQPPAGSFSPGGHDASYWREQLPGELAWMAS,"31,382",300,,,,,,,1
O06412,O06412_MYCTU,Rv0546c,Rv0546c,,IPR029068; IPR004360; IPR037523; ,,,DOMAIN 3 116 VOC. {ECO:0000259|PROSITE:PS51819}.,Conserved protein,,9634230; 21969609,,,MEILASRMLLRPADYQRSLSFYRDQIGLAIAREYGAGTVFFAGQSLLELAGYGEPDHSRGPFPGALWLQVRDLEATQTELVSRGVSIAREPRREPWGLHEMHVTDPDGITLIFVEVPEGHPLRTDTRA,"14,346",128,,,,,,,1
O07787,O07787_MYCTU,Rv0591,mce2C Rv0591,,IPR005693; IPR003399; ,,mce2C,,Mce-family protein Mce2C,,9634230,,,MRTLTEFNRGRVGMMGAVVTVLVVGVAQSFTSVPMLFATPTYYAQFADTGGINTGDKVEIAGVNVGLVRSLAIRGNRVLIGFSLPGKTIGMQSRAAIRTDTILGRKNLEIEPRGSEPLKPNGFLPLAQTTTPYQIYDAFVDVTKAATGWDIDAVKRSLNVLSETFDQTAPHLSAALEGVKAFSDTVGRRGEQIEQLLANANRIARVLGDRSEQVNGLLVNAKTLLAAFKQRSQALRILLTNVSEASAQVSGLITDNPNLNHVLAQLRTVSEELVKRKNELADVAVLLGRYTAALTEAVGSGPFFKAMVVNLLPYQILQPWVDAAFKKRGIDPENFWRSAGLPEFRWPDPNGTRFPNGAPPAAPPVREGTPKHPGPAVPPGTPCSYTPAAGALPRPDTPLPCAGATVGPFGGPDFPAPLDVQPSPPNPDGPPPTPGILSAGRPGEPAPAVPGIPMPLPPNAPPGARTQPLEPFPDGTGGSNQ,"50,764",481,,,,,,,1
P95205,P95205_MYCTU,Rv0397,Rv0397,,,,,,Conserved 13E12 repeat family protein,,9634230,,,MLATFWGWRAQQLPDGTVIWTLPGDQTYVTTPGSALLFPALCTPTGDPPRPDPARADRRGQRTAMMPRRASTRAQNRAHYIAAERHRNHQARRIAHVVTQTATTAPETNGPPPDPDDDPPPF,"13,500",122,,,,,,,1
P96272,P96272_MYCTU,Rv0426c,Rv0426c,GO:0016021,,,,,Possible transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSVVGGTVRTVGRTVSGAATATTAAAGAVGGAAVSGIVGGVTGAAKGIQKGLSSGSKSTAAAALAIGAIGVAGLVDWPILLAVGGGALLLRKLNRTPEVAAPPVKAKLAPVPDKPAAAKEAPAKASKTTARKTSGRRAGTAELRSTN,"13,930",147,,,,integral component of membrane [GO:0016021],,,1
I6WYU2,I6WYU2_MYCTU,Rv0597c,Rv0597c,,IPR025420; IPR027417; ,,,,Uncharacterized protein,,9634230; 21969609,,,MGVVERAIAPSVLAALADTPVVVVNGARQVGKTTLVARLDYPGSSEVVSLDDVANRDAARDDPRAFVSRPVDTLVIDEAQLEPGLFRAIKAEVDRDRRPGRFLLTGSARLLSAPDMADALVGRVEIIELWPFSQGERAGIADGFVDALFTAPRELIHGSDMRRADLVDRIATGGFPDIVARSPSRRRAWFDNYLTTATQSVIREISPIERLAEMPRVLRLCAARTGAELNVSALANDLSIPARTTAGYLALLEAAFLIHRVPAWSTNLSRKVIRRPKLVVSDSGLACHLLGVTGATLDRPGRPLGPLLETFVANEIRKQLTWSTERPSLWHFRDRGGAEVDLVLEHPDGRVCGIEVKATSTPRAEDLRGLRYLAERLDDRFQFGVLLTAAPEATPFGPTLAALPVSTLWAG,"44,694",411,,,,,,,1
O33359,O33359_MYCTU,Rv0514,Rv0514,GO:0016021,,,,,Possible transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MIARYRAGAELFLACAALAGSAASWSRTRSTVAVAPVIDGQPVTLSVVYHPQPLVLTLLLATIAGVLSVVGTARLRRARAGLNAHPDGLNQRPPGGWCH,"10,323",99,,,,integral component of membrane [GO:0016021],,,1
I6X961,I6X961_MYCTU,Rv0461,Rv0461,GO:0016021,,,,,Probable transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MPDFDTGAHSQRFLSLAGQQDRAGKSWPGSTPKPQEDPVGVAPSASVEVLGSEPAATLAHSVTVPGRYTYLKWWKFVLVVLGVWIGAGEVGLSLFYWWYHTLDKTAAVFVVLVYVVACTVGGLILALVPGRPLITALSLGVMSGPFASVAAAAPLYGYYYCERMSHCLVGVIPY,"18,622",174,,,,integral component of membrane [GO:0016021],,,2
O86336,O86336_MYCTU,Rv0406c,Rv0406c,GO:0008800; GO:0030655; GO:0046677,IPR001279; IPR036866; ,,,DOMAIN 38 245 Lactamase_B. {ECO:0000259|SMART:SM00849}.,Beta lactamase like protein,beta-lactamase activity [GO:0008800]; beta-lactam antibiotic catabolic process [GO:0030655]; response to antibiotic [GO:0046677],9634230; 21969609,,,MVATRGTRLAALALAPRLAGMAELVQITDKVHLARGHAVNWVLVTDDTGVLLIDAGYPGDRAEVLASLNKLGYTPGDVRAIVLTHAHIDHLGSAIWFAREHSTPVYCHAEEVGHAKREYRENASVFDVALRSWRPRVAVWGIHLLRRGGLTGDGIPTAQPLTAEAAAGLPGQPMAIFTPGHTSGHCSYVVDGVLASGDALITGHPMLRHRGPQLLPAVFSHSQQNSIRSLAALALLETNILAPGHGELWHGPIRKATDEALERAQKSNHVFR,"29,220",272,,beta-lactam antibiotic catabolic process [GO:0030655]; response to antibiotic [GO:0046677],beta-lactamase activity [GO:0008800],,,,1
I6Y897,I6Y897_MYCTU,Rv0613c,Rv0613c,GO:0005524; GO:0005829; GO:0005887; GO:0015462; GO:0031522; GO:0043952,IPR004027; ,,,,Uncharacterized protein,cell envelope Sec protein transport complex [GO:0031522]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase-coupled protein transmembrane transporter activity [GO:0015462]; protein transport by the Sec complex [GO:0043952],9634230; 21969609,,,MAEAFDATQAVARILAEHGPLSEDDIARRLLDSGVADPDAVLRALRLETEWPARQLVDDRWVWLPTLLAGRVFTHRLGADEAVHDMLGVTPDLDPITTLCEHEEYGRLADGSAARIVLAGYDEELLERRGIPDEAIDPGGALLLEPGTLATLGAAAGDLVGVRLTAAGLVLERIGTAGADTSVGARLAELVDPDEPAFFPAAVWTACVDDPAAFTEPVAPLREILDQHGLTHEDDWLAPGGFNFDAWRFENRCELLAFRHDLDPNDAVALYTLIKLHETMSLLLEATDPDELPRDVLATAAETATETGSDSLVDLLGDIGAALADPLLAELLVAETVGTDSGGAAALGLLTEMLEPKVPRAARVAVRWLRAVALDRIGDVEAAERELLAAESMDTEWPLPLLDLARIASDRGDAERGLALLRRAGTEPDHPLVRLLERHRAQPRRDLGRNEACWCGSGRKYKKCHLGREALPLAERVDWLYAKASQHALSGDWTGLLAEVSYERFRYADSDDEDALAAALADPLVLDAVLFEGGAFAEFLEVRGSLLPDDERLLAEQWLLVERSVFEVEHVQPGEGVIVRDVRTGDTHEVHERAASRQLRAGQLICARPVPAGDTMVFFGGIEPVALHERAVLIELLDDEPDPVTLVAQLSRRFAPPTLVNTEGDSLAICEASVRVDDPAGIQGALDGVYDRVDGEEPPRWIEHVTNDGMLRVRATLVLDGDTLRVETNSEPRMDRVLATLTRLDPAMTVLDDDRRPLRNTREAAALAEQMPVTGAGAPDPDSPELAAALEEFIRDYETSWLDQPIPALDGHTPRQAADDPTRRADLIKLLDTFPAGAGARGGMDADRLRTALGL,"92,753",855,,protein transport by the Sec complex [GO:0043952],ATPase-coupled protein transmembrane transporter activity [GO:0015462]; ATP binding [GO:0005524],cell envelope Sec protein transport complex [GO:0031522]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887],,,1
Q79FY4,Q79FY4_MYCTU,Rv0618,galTa Rv0618,GO:0008108; GO:0008270; GO:0033499,IPR001937; IPR005849; IPR036265; ,,galTa,DOMAIN 76 220 GalP_UDP_transf. {ECO:0000259|Pfam:PF01087}.,Probable galactose-1-phosphate uridylyltransferase GalTa [first part],UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499],9634230,,,MSATPPPGGLDASVFIANERGRQLDEALPVGFCVVTAPTRWTLADGRDLLFFSLPGHVPAPVSDRRPLPERDPAPSRLRFDRATGQWVIVAAQRQDRTYKPPAARCPLCPGPTGLSSEVPAPDYDVVVFENRFPSLAGAGIAPIGAPDGDGFVSAPGHGRCEVICFSADHTGSFAGLDPAHARLVVHAWRHRTAELTALPGVAQVFCFENRGEEIGVTLPTRTARFTPIRI,"24,735",231,,galactose catabolic process via UDP-galactose [GO:0033499],UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270],,,,1
O86364,O86364_MYCTU,Rv0454,Rv0454,,,,,,Uncharacterized protein,,9634230,,,MKQDFGLDVPQAGNAQNFDGVPEWVQVGVVTFVYRMQMHHVTRPVGAPGSGLAGDSTPVQGRQRVWDLVAGRLTHAPRSSVQAMRPTMFTSAPQRHGIPARGRWWLGYQERSRAWP,"12,935",116,,,,,,,1
O53776,O53776_MYCTU,Rv0579,Rv0579,,IPR002782; IPR027798; ,,,,Uncharacterized protein,,9634230,,,MVGYVDVRAYAELNEFVELQARGLTVRRPFRSHQTVKDVLEAMGIPHTEVDLILVNGDPADFSYRPVAGDRIAAYPMFEALDIGSTARLRPAPLRNPRFVVDVNLGQLARLLRLLGFDTRWSSAADDPTLADISLGEQRILLTRDRGLLKRRAITHGLFVHSQHPEEQALEVLRRLDLNGRLAPLSRCLRCNGELAAVSKDEVIGQLEPLTRRYYESFSRCFGCGRIYWPGSHHARLVRLVERLRDQLTTST,"28,540",252,,,,,,,1
I6Y4E8,I6Y4E8_MYCTU,Rv0675,echA5 Rv0675,GO:0003824; GO:0008152,IPR029045; IPR018376; IPR001753; ,,echA5,,Probable enoyl-CoA hydratase EchA5 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609; 26628360,X-ray crystallography (1),,MSDLVRVERKGRVTTVILNRPASRNAVNGPTAAALCAAFEQFDRDDAASVAVLWGAGGTFCAGADLKAFGTPEANSVHRTGPGPMGPSRMMLSKPVIAAVSGYAVAGGLELALWCDLRVAEEDAVFGVFCRRWGVPLIDGGTVRLPRLIGHSRAMDMILTGRGVPADEALAMGLANRVVPKGQARQAAEELAAQLAALPQQCLRSDRLSALHQWGLPESAALDLEFASIARVAGEALEGARRFAAGAGRHGAPAPRAEQGDTL,"27,441",263,Enoyl-CoA hydratase/isomerase family,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
O06406,O06406_MYCTU,Rv0540,Rv0540,GO:0005618; GO:0005886; GO:0040007,IPR029044; IPR018641; ,,,,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MSCLPVSVLVVAKAPEPGRVKTRLAAAIGDKVAADIAAAALLDTLDAVAAAPVTARAVALTGDLDSAADSAEIRRRLKSFTVFRQRGDAFADRLANAHVDAADGYPVLQIGMDTPQVTAELLADCARLLLQIPAVLGLAFDGGWWVLGIRTPTAAECLRAVPMSQPDTGELTLKALRDNGIDVTLVQRLGDFDIVDDIALVRDCCAPGSRFAQATRAAGL,"22,971",220,,growth [GO:0040007],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O33361,O33361_MYCTU,Rv0516c,Rv0516c,,IPR002645; IPR036513; ,,,DOMAIN 28 139 STAS. {ECO:0000259|PROSITE:PS50801}.,Possible anti-anti-sigma factor,,9634230; 21969609,,,MTTTIPTSKSACSVTTRPGNAAVDYGGAQIRAYLHHLATVVTIRGEIDAANVEQISEHVRRFSLGTNPMVLDLSELSHFSGAGISLLCILDEDCRAAGVQWALVASPAVVEQLGGRCDQGEHESMFPMARSVHKALHDLADAIDRRRQLVLPLISRSA,"16,987",158,,,,,,,3
P96258,P96258_MYCTU,Rv0412c,Rv0412c,GO:0005576; GO:0005887; GO:0040007,,,,,Possible conserved membrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; growth [GO:0040007],9634230; 21969609,,,MTVELAHPSTEPLGSRSPAEPAHPRRWFISTTPGRIMTIGIVLAALGVASAFATSTTIEHRQQVLTAVLDHTEPLSFAAGRLYTTLSVADAAAATAFIAQAEPGGVRLRYEQAITDASVAVTRASSGLTDESLVQLLGRINAELAVYTGLVEIARANNRAGNPVGSSYLSEASGLMQSTILPDAQRLYQATSARVDRETTASTQIPAPVILVVATTVVFGAFAHRWLARRTRRRINPGLVVGALGILVMVVWVGTALTISTTASRSAKDTAAESLKTITNLAITAQQARADETLSLIRRGDEEVRKQAFYQRIDAMQRQLNDYMARRHAVDKPDLQGADQLLVRWRQANDRINSDISVGNYRAATQVALGKGEDDATPAFDKLDEALTKAMGQSRTQLRHDILNAHRGLAGAQVGGVVLSLGAAIAVALGLWPRLKEYR,"47,116",439,,growth [GO:0040007],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,2
I6X9Q1,I6X9Q1_MYCTU,Rv0749A,Rv0749A,,,,,,Uncharacterized protein,,9634230,,,MVRKHAFHWRYDSTEELELLNQLWQLVSLRLNFFTPTKKALGFRP,"5,518",45,,,,,,,1
O06422,O06422_MYCTU,Rv0556,Rv0556,GO:0005886; GO:0016021; GO:0040007,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MISPKPLLHILIHGLSDELPDTRGRIVLRWLRIAVLIVTGLVTLQSVLLVAGAWRNDIAIQRNMGVAQAEVLSAGPRRSTIEFVTPDRITYRPQLGVLYPSELSTGMRIYVEYNKRDPNLVRVQHRNAGLAIIPAGSIAVVAWLIAAAALVVLAVLDKRLERRENSASATG,"18,757",171,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P95201,P95201_MYCTU,Rv0393,Rv0393,,IPR003870; IPR003615; ,,,,Conserved 13E12 repeat family protein,,9634230,,,MAVGRCAIPRFDQAASGSAINGGQVHLSDGSTSPARQLPAPWPGDAGAAAEGRAGVCCRGNRLPHVSDVGVSHRFDHRPAGVGAGGCRAGAAGAGLAVDDPGQLAAAIDRIVAVADPDAVRQVRERARDREVSIWNSADGMGEVYAQLYATDAQALDARLNALVATVCAGDPRSTDQRRADALGALAAGADRLACRCDNPDCAAEGRPVSAVVIHVVAEQASVKGHGQAPAALLGGDGLIPAELVAELAKTAGLQPIPVPAGTEPGYRPSVKLAAFVRARDLTCRAPGCDRPATQCDLDHTIAFADGGATHAANLKCLCRLHHLLATFCGWRAQQLPDGTVIWTLPGNQTYVTTPGSALLFPALCTPTGDPPAPEPARADRRGQRTAMMPRRASTRTQNRAHCIAAERHRNHQARRIAQAAVIATETHGPPPDPDDDPPPF,"45,723",441,,,,,,,1
Q79FX5,Q79FX5_MYCTU,Rv0649,fabD2 Rv0649,GO:0004314; GO:0042759,IPR027304; ,,fabD2,,Possible malonyl CoA-acyl carrier protein transacylase FabD2 (MCT),[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; long-chain fatty acid biosynthetic process [GO:0042759],9634230,,,MSGRSRLPGSSSRRDAARIVAERVVATVAGVAVAVDEVDAAEARLRDGPRAAALPASGTSEGRQLRRWLTQLIVTERVVAAEAAARGLTAAGAPAEADLLPDATARLEIGSVAAAVLADPLARALFAAVTARVAVTDDAVADYHARNPLRFAAPCPGQHGWRAPAAAAPPLDQVRRAITEHLLGAARRRAFRVWLDARRNALVVLAPGYEHPGDPRQPDNTRRH,"23,617",224,,long-chain fatty acid biosynthetic process [GO:0042759],[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314],,,,1
O53764,O53764_MYCTU,Rv0567,Rv0567,GO:0008171; GO:0008757; GO:0019438,IPR031725; IPR016461; IPR001077; IPR029063; IPR036388; IPR036390; ,,,DOMAIN 8 92 Dimerisation2. {ECO:0000259|Pfam:PF16864}.; DOMAIN 103 325 Methyltransf_2. {ECO:0000259|Pfam:PF00891}.,Probable methyltransferase/methylase,O-methyltransferase activity [GO:0008171]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; aromatic compound biosynthetic process [GO:0019438],9634230; 21969609,,,MELSPDRIMAIGGGYGPSKVLLTAVGLGLFTELGDEAMTAEAIADRLGLLKRPAIDFLDALVSLDLLARDGDGPGSHYRNTPETAHFLDEARPTYAGGLLKIWNERNYRFWADLTEALKTGKAQSEVKQTGRPFFEALYADPRRLEAFMAAMDAASRRNIELLAKRFPFERYRRLCDVGCADGLLSRIVAAAHPHLQCVSFDLPAVTEIARRKLTAEGLGERVQACAGDFLADPLPAADVITMGQILHDWNLDRKQQLVAKAYEALSKEGAFIVIETLIDDARRENTTGLMMSLNMLIEFGDAFDYSAADFRGWCGEAGFRSFEVIPLAGGSSAAVAYK,"37,143",339,,aromatic compound biosynthetic process [GO:0019438],O-methyltransferase activity [GO:0008171]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],,,,3
O86335,O86335_MYCTU,Rv0405,pks6 Rv0405,GO:0008610; GO:0009405; GO:0016740; GO:0016788; GO:0031177; GO:0044119,IPR029058; IPR001227; IPR036736; IPR014043; IPR016035; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR020801; IPR020841; IPR020806; IPR020802; IPR009081; IPR006162; IPR001031; IPR016039; ,,pks6,DOMAIN 5 83 Carrier. {ECO:0000259|PROSITE:PS50075}.; DOMAIN 1017 1092 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable membrane bound polyketide synthase Pks6,"hydrolase activity, acting on ester bonds [GO:0016788]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; pathogenesis [GO:0009405]",9634230; 21969609,,,MTDGSVTADKLQKWFREYLSTHIECHPNEVSLDVPIRDLGLKSIDVLAIPGDLGDRFGFCIPDLAVWDNPSANDLIDSLLNQRSADSLRESHGHADRNTQGRGSINEPVAVIGVGCRFPGDIDGPERLWDFLTEKKCAITAYPDRGFTNAGTFAESGGFLKDVAGFDNRFFDIPPDEALRMDPQQRLLLEVSWEALEHAGIIPESLRLSRTGVFVGVSSTDYVRLVSASAQQKSTIWDNTGGSSSIIANRISYFLDIQGPSIVIDTACSSSLVAVHLACRSLSTWDCDIALVGGTNVLISPEPWGGFREAGILSQTGCCHAFDKSADGMVRGEGCGVIVLQRLSDARLEGRRILAILTGSAVNQDGKSNGIMAPNPSAQIGVLENACKSARVDPLEIGYVEAHGTGTSLGDRIEAHALGMVFGRKRPGSGPLMIGSIKPNIGHLEGAAGIAGLIKAVLMVERGSLLPSGGFTEPNPAIPFTELGLRVVDELQEWPVVAGRPRRAGVSSFGFGGTNAHVIVEEAGSVGADTVSGRADVGGSGGGVVAWVISGKTASALAAQAGRLGRYVRARPALDVVDVGYSLVSTRSVFDHRAVVVGQTRDELLAGLAGVVAGRPEAGVVCGVGKPAGKTAFVFAGQGSQWLGMGSELYAAYPVFAEALDAVVDELDRHLRYPLRDVIWGHDQDLLNTTEFAQPALFAVEVALYRLLMSWGVRPGLVLGHSVGELAAAHVAGALCLPDAAMLVAARGRLMQALPAGGAMFAVQAREDEVAPMLGHDVSIAAVNGPASVVISGAHDAVSAIADRLRGQGRRVHRLAVSHAFHSALMEPMIAEFTAVAAELSVGLPTIPVISNVTGQLVADDFASADYWARHIRAVVRFGDSVRSAHCAGASRFIEVGPGGGLTSLIEASLADAQIVSVPTLRKDRPEPVSVMTAAAQGFVSGMGLDWASVFSGYRPKRVELPTYAFQHQKFWLAPAPSVSDPTAAGQIGASDGGAELLASSGFAARLAGRSADEQLAAAIEVVCEHAAAVLGRDGAAGLDAGQAFADSGFNSLSAVELRNRLTAVTAVTLPATAIFDHPTPTELAQYLITQIDGHGSSAAAAANPAERIDALTDLFLQACDAGRDADGWKMVALASNTRERMSSPVRNNVSKNVALLADGISDVVVICIPTLTVLSDQREYRDIANAMTGRHSVYSLTLPGFDSSDALPQNADMIVETVSNAIIDVVGGSCRFVLSGYSSGGVLAYALCSHLSVKHQRNPLGVALIDTYLPSQIANPSMNEGFSPNDTGKGLSREVIRVARMLNRLTATRLTAAATYAAIFQAWEPGRSMAPVLNIVAKDRIATVENLREERINRWRTAAAEAAYSVAEVPGDHFGMMSTSSEAIATEIHDWISGLVRGPHR,"147,613",1402,,growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; pathogenesis [GO:0009405],"hydrolase activity, acting on ester bonds [GO:0016788]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]",,,,1
Q79FY7,Q79FY7_MYCTU,Rv0589,mce2A Rv0589,GO:0016021,IPR005693; IPR003399; IPR024516; ,,mce2A,DOMAIN 45 124 MlaD. {ECO:0000259|Pfam:PF02470}.; DOMAIN 153 404 Mce4_CUP1. {ECO:0000259|Pfam:PF11887}.,Mce-family protein Mce2A,integral component of membrane [GO:0016021],9634230,,,MPTLVTRKNRRAWLYVEGVVLLLVGALVLVLVYKQFRGEFTPKTELTMVAFRAGLVMEAGSKVTYNGVEIGRVGSISEIERDGRPAAKLVLDVNPRYISLIPVNVVADIEAATLFGNKYVALSAPKIPQQQRISSHDVIDVGSVTTEFNTLFETITSIAEKVDPIELNATLSAVAQALDGLGGKFGESIVNGNQILAQLNPRLPQLGYDVRRLADLGEVYVDASPDLWSFLQNALTTARTLTSQQRDLDAALLAATGAGNTGEDVFARGGPYLARAAADLVPTATLLDTYSPELFCMIRNFHDAAPKVADAVGGNGYSLAAAGTILGAPNPYVYPDNLPRVNAHGGPGGRPGCWQTITRELWPAPYLVMDTGASLAPYNHVELGQPMFTEYVWGRQYGENTINP,"43,489",404,,,,integral component of membrane [GO:0016021],,,1
P96273,P96273_MYCTU,Rv0427c,xthA Rv0427c,GO:0004519; GO:0006281; GO:0008853,IPR004808; IPR036691; IPR005135; IPR037493; ,,xthA,DOMAIN 27 281 Endo/exonuclease/phosphatase. {ECO:0000259|Pfam:PF03372}.,Probable exodeoxyribonuclease III protein XthA (Exonuclease III) (EXO III) (AP endonuclease VI),endonuclease activity [GO:0004519]; exodeoxyribonuclease III activity [GO:0008853]; DNA repair [GO:0006281],9634230; 21969609,,,MPDGTIDGGHPQRPASPRLRSPLLRLATWNVNSIRTRLDRVLDWLGRADVDVLAMQETKCPDGQFPALPLFELGYDVAHVGFDQWNGVAIASRVGLDDVRVGFDGQPSWSGKPEVAATTEARALGATCGGIRVWSLYVPNGRALDDPHYTYKLDWLAALRDTAEGWLRDDPAAPIALMGDWNIAPTDDDVWSTEFFAGCTHVSEPERKAFNAIVDAQFTDVVRPFTPGPGVYTYWDYTQLRFPKKQGMRIDFILGSPALAARVMDAQIVREERKGKAPSDHAPVLVDLHAG,"32,108",291,,DNA repair [GO:0006281],endonuclease activity [GO:0004519]; exodeoxyribonuclease III activity [GO:0008853],,,,1
O06404,O06404_MYCTU,Rv0538,Rv0538,GO:0016021,,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MDVALGVAVTDRVARLALVDSAAPGTVIDQFVLDVAEHPVEVLTETVVGTDRSLAGENHRLVATRLCWPDQAKADELQHALQDSGVHDVAVISEAQAATALVGAAHAGSAVLLVGDETATLSVVGDPDAPPTMVAVAPVAGADATSTVDTLMARLGDQALAPGDVFLVGRSAEHTTVLADQLRAASTMRVQTPDDPTFALARGAAMAAGAATMAHPALVADATTSLPRAEAGQSGSEGEQLAYSQASDYELLPVDEYEEHDEYGAAADRSAPLSRRSLLIGNAVVAFAVIGFASLAVAVAVTIRPTAASKPVEGHQNAQPGKFMPLLPTQQQAPVPPPPPDDPTAGFQGGTIPAVQNVVPRPGTSPGVGGTPASPAPEAPAVPGVVPAPVPIPVPIIIPPFPGWQPGMPTIPTAPPTTPVTTSATTPPTTPPTTPVTTPPTTPPTTPVTTPPTTPPTTPVTTPPTTVAPTTVAPTTVAPTTVAPTTVAPATATPTTVAPQPTQQPTQQPTQQMPTQQQTVAPQTVAPAPQPPSGGRNGSGGGDLFGGF,"55,076",548,,,,integral component of membrane [GO:0016021],,,1
P96265,P96265_MYCTU,Rv0419,lpqM Rv0419,GO:0016021,,,lpqM,,Possible lipoprotein peptidase LpqM,integral component of membrane [GO:0016021],9634230; 21969609,,,MHGRGRYRPLVRCVRPRRVAASVRTPIACLAAVVVIAGCTTVVDGRALSILNDPFRVGGLPATNGPSGARPDAPAASGTVINTNNGAIDKLSLLSVNDIEDYWMAVYSESLKGTFRPVGKLVSYDSNDPSSPIVCHIDTYQLVNAFFSSRCNLIAWDRGVFMAVAQEYFGDMSVNGVLAHEFGHALQVMANLVTRKDPTIVREQQADCFAGVYLWWVAEGKSTRFTLSTADGLDHVLAGIITTRDPVMEADAENDDEHGSALDRVSAFQLGFINGTPACAAIDEDEVERRRGDLPTALRVDASGNPETGEVGINEETLSTLMELMGKIFSPKNPPTLSYQPAGCPDAKPSPPAAYCPATNTIVVDLPALARMGKVASAAEHSLPQGDDTSLSIVMSRYALAVQHERGLPMQSPWTALRTACLTGVAHRKMAVPIDLPSGQQLVLTAGDLDEAVSGLLTNRMVASDADGVSVPAGFTRIAAFRAGVGGDMDACYARYPG,"52,949",498,,,,integral component of membrane [GO:0016021],,,1
P96277,P96277_MYCTU,Rv0431,Rv0431,GO:0005618; GO:0016021; GO:0052556,IPR027381; ,,,DOMAIN 78 163 LytR_C. {ECO:0000259|Pfam:PF13399}.,Putative tuberculin related peptide,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,,MLVTVGSMNERVPDSSGLPLRAMVMVLLFLGVVFLLLVWQALGSSPNSEDDSSAISTMTTTTAAPTSTSVKPAAPRAEVRVYNISGTEGAAARTADRLKAAGFTVTDVGNLSLPDVAATTVYYTEVEGERATADAVGRTLGAAVELRLPELSDQPPGVIVVVTG,"16,937",164,,positive regulation by symbiont of host immune response [GO:0052556],,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,2
I6XW38,I6XW38_MYCTU,Rv0730,Rv0730,GO:0003677; GO:0003918; GO:0005524; GO:0016740,IPR016181; IPR000182; IPR013760; IPR013757; ,,,DOMAIN 114 242 N-acetyltransferase. {ECO:0000259|PROSITE:PS51186}.,GCN5-related N-acetyltransferase,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; transferase activity [GO:0016740],9634230; 21969609,,,MHGARTGVSFYAYAMTDHDQTAARREIADALLAALERRHEVADAIVEAANKAAAVEAIVNLLGTSHLAAEAVMSMSFDQLTQDARTKIIAELDDLNKQLSFTVKERPASSGEGLELRPFSPDEDRDIFARRTEEMGAAGDGSGGPAGSVDDEIRAAQKRVDDEEAAWFVAVDSGVKVGMVFGELVHGEVDVRIWIHPDHRKKGYGTAALRKSRSEMAWAFPAVPMVARAPAAQPAQPGSAGR,"25,980",242,,,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; transferase activity [GO:0016740],,,,1
O53789,O53789_MYCTU,Rv0681,Rv0681,GO:0000976; GO:0003700; GO:0005829; GO:0005886; GO:0006351,IPR009057; IPR001647; IPR036271; IPR025996; ,,,DOMAIN 6 66 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Possibly TetR-family),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MARPAKLSRESIVEGALTFLDREGWDSLTINALATQLGTKGPSLYNHVDSLEDLRRAVRIRVIDDIITMLNRVGAGRARDDAVLVMAGAYRSYAHHHPGRYSAFTRMPLGGDDPEYTAATRGAAAPVIAVLSSYGLDGEQAFYAALEFWSALHGFVLLEMTGVMDDIDTDAVFTDMVLRLAAGMERRTTHGGTAST,"21,262",196,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
O06394,O06394_MYCTU,Rv0528,Rv0528,GO:0016021; GO:0040007,IPR007816; ,,,DOMAIN 8 500 ResB. {ECO:0000259|Pfam:PF05140}.,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230; 21969609,,,MWRSLTSMGTALVLLFLLALAAIPGALLPQRGLNAAKVDDYLAAHPLIGPWLDELQAFDVFSSFWFTAIYVLLFVSLVGCLAPRTIEHARSLRATPVAAPRNLARLPKHAHARLAGEPAALAATITGRLRGWRSITRQQGDSVEVSAEKGYLREFGNLVFHFALLGLLVAVAVGKLFGYEGNVIVIADGGPGFCSASPAAFDSFRAGNTVDGTSLHPICVRVNNFQAHYLPSGQATSFAADIDYQADPATADLIANSWRPYRLQVNHPLRVGGDRVYLQGHGYAPTFTVTFPDGQTRTSTVQWRPDNPQTLLSAGVVRIDPPAGSYPNPDERRKHQIAIQGLLAPTEQLDGTLLSSRFPALNAPAVAIDIYRGDTGLDSGRPQSLFTLDHRLIEQGRLVKEKRVNLRAGQQVRIDQGPAAGTVVRFDGAVPFVNLQVSHDPGQSWVLVFAITMMAGLLVSLLVRRRRVWARITPTTAGTVNVELGGLTRTDNSGWGAEFERLTGRLLAGFEARSPDMAEAAAGTGRDVD,"57,131",529,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,1
P95072,P95072_MYCTU,Rv0724,sppA Rv0724,GO:0005618; GO:0005886; GO:0006465; GO:0008233; GO:0016021,IPR029045; IPR004634; IPR004635; IPR002142; ,,sppA,DOMAIN 129 282 Peptidase_S49. {ECO:0000259|Pfam:PF01343}.; DOMAIN 403 554 Peptidase_S49. {ECO:0000259|Pfam:PF01343}.,Possible protease IV SppA (Endopeptidase IV) (Signal peptide peptidase),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; peptidase activity [GO:0008233]; signal peptide processing [GO:0006465],9634230; 21969609,,,MPIFGGFCVCSRALGGRWVRWVNMVAFLPSIPVVEDLRALVGRVDTARHHGVPNGCVLEFNLRSVPPETTGFDPLTVLTGGGRPMALRDAVAAIHRAAEDPRVAGLIARVQLPPSPAGAVQELREAIAAFSAVKPSLAWAETYPGTLSYYLASAFGEVWMQPSGSVGLVGFATNATFLRDALHKAGIEAQFVARGEYKSAANLFTEDGFTDAHREAVTRMLDSLQDQVWQAVAKSRNIGVDALDELADRAPLLRDDAVTCGLIDRIGFRDQAYARMAELVGVEKGSPESSGSQTSPDEKPPRMYLARYASSARPRLTPPVPSIPGRRSKPTIAVVTLEGPIVNGRGGPQFLPLGPSSAGGDTIAAALREVAADDSVSAIVLRVDSPGGSVTASETIWREVARARDRGKPVVASMGAVAASGGYYVSMGADAIVANPGTITGSIGVITGKLVVRDLKDRLGVGSDAVRTNANADAWSIDAPFTPDQQAHREAEADLFYSDFVERVAEGRKMTTDAVDVVARGRVWTGADALDRGLVDELGGLRTAVRRAKVLAGLDEDTEVRIVSYPGSSLWDMVRPRPSSRPAAASLPDAMGALLARSIVGIVEQVEQTLSGASVLWLGESRL,"65,936",623,,signal peptide processing [GO:0006465],peptidase activity [GO:0008233],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6X9S5,I6X9S5_MYCTU,Rv0773c,ggtA Rv0773c,GO:0006751; GO:0036374,IPR000101; IPR029055; ,,ggtA,,Probable bifunctional acylase GgtA: cephalosporin acylase (GL-7ACA acylase) + gamma-glutamyltranspeptidase (GGT),glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],9634230; 21969609,,,MPILATNVVCTSQPLAAQAGLRMLADGGNAVDAAVATAITLTVVEPVSNGIGSDAFSIVWDGQKLHGLNASGRSPSAWTPEYFGGNAVPVLGWNSVTVPGAVSAWVELHARFGRLPFETLFEPAISYGRNGFLVSPTVAAQWAAQVPLFASQPGFADAFMPGGRAPKPGELFTFPDHAATLEKIAATNGEEFYRGELAAKLEAHSAANGGVMRADDLAAHRVDWVDTITGTYRGYTIHQIPPNGQGIVALIALGILEHFDMSSWSVDSAESVHVQIEALKLAFADAQACVADIDYMPVHPKRLLDKEYLRQRATLIDPKRAMPAATGIPRGGTVYLAAADAAGMMVSMIQSNYLGFGSGVVVPGTGISLHNRGSDFTVVPRHPNRVGPRKRPYHTIIPGFVTRDGAPVMSFGVMGGMMQPQGHVQVLVRIADYGQNPQAACDGPRFRWVNGMRVSFENGFPDSTLDELRQRGHDLVAVADYSQFGSCQAIWRLDDGYLAASDPRRDGQAAAC,"54,593",512,,glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,1
O53733,O53733_MYCTU,Rv0448c,Rv0448c,,IPR010775; ,,,,Uncharacterized protein,,9634230,,,MHHSFAYRSYSWYVDVDNLPQLPWWLRPFARFHADDHFADPFSCPPHSSLRDRLDAFFAARGLAVPDGRITALLQARVLGYVFNPLSIFWCHDRDGQLRHVIAEVHNTYGGRHAYLLPPADLPVVTAKNFYVSPFHQLAGYYLIRAPRPDRELDVTVTLHRDRRQVCPEFTATLRGQRRPATTRQIAMMQIISPLAPMVVAARIRIQGIRLWLRRVPVVPR,"25,599",221,,,,,,,3
I6Y4R2,I6Y4R2_MYCTU,Rv0752c,fadE9 Rv0752c,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE9,,Probable acyl-CoA dehydrogenase FadE9,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MFVLNDDERVIVETAAAFAGKRLAPHALEWDAAKHFPVDVLREAAELGMAAIYCRDDVGGSGLRRLDGVRIFEQLAIADPVTAAFLSIHNMCAWMIDSFGTDEQRKDWIPRLATMGVIASYCLTEPGAGSDAGALSTRAVRHGSGKGGDYVLDGVKQFISGAAASDVYVVMARTGAEGPRGVSAFIVEKGTPGLSFGAPEAKMGWHAQPTAQVVLDGVRVPAEAMLGGADGEGAGFGIAMSGLNGGRLNIAACSLGGAQAAFDKAGAYVRDRQAFGGSLLDEPTVRFTLADMATGLQTSRMLLWRAASALDDDDADKVELCAMAKRYVTDTCFEVADQALQLHGGYGYLREYGLEKIVRDLRVHRILEGTNEIMRLVIGRAEAARFRATV,"41,451",390,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
O53780,O53780_MYCTU,Rv0583c,lpqN Rv0583c,GO:0005576; GO:0005618; GO:0005886,IPR019674; IPR016123; ,,lpqN,,Probable conserved lipoprotein LpqN,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MKHFTAAVATVALSLALAGCSFNIKTDSAPTTSPTTTSPTTSTTTTSATTSAQAAGPNYTIADYIRDNHIQETPVHHGDPGSPTIDLPVPDDWRLLPESSRAPYGGIVYTQPADPNDPPTIVAILSKLTGDIDPAKVLQFAPGELKNLPGFQGSGDGSAATLGGFSAWQLGGSYSKNGKLRTVAQKTVVIPSQGAVFVLQLNADALDDETMTLMDAANVIDEQTTITP,"23,682",228,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O53781,O53781_MYCTU,Rv0585c,Rv0585c,GO:0005886; GO:0016021,IPR011009; IPR022791; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MRVDGRDIGVSGNLLQPLTRRTNDIIRAVLAAIYLVAVITSSLITRPQWVALEKSISEIVGVLSPSQSDLVYLGYGLAILALPFVILIGLIVSRQWKLLGAYAAAGLMAVLPLSISSSRIAAPRWHFDLSDRLATLLAQFLDDPRWIAMLAAVLTVSGPWLPARWRHWWWALLLAFVPIHLVVSAIVPARSLLGLAVGWLVGALVVLVVGTPALEVPLDGAIRALAKRGFAVSGLAVVRPAGPGPLVLSAACEQPNAGACSEALIELYGPHQSGGGALRQLWLKLTLRGTETAPLQASMRRAVEHRALMAIAFGDLGMANTTVIAVSPLDRGWTLYAHRPARGIGISECTKTTPTAHVWEALRTLHDQQISHGDLCSAEITVDNGAVLFGGFGEAEYGATDAQLQSDLAQLLVTTSALYDAEAAVTAAIDTFGKQAILAASRRLTKSAVPKRIRESITDPNAVIASTRAEVMRQTGADQIKAETITRFSRGQLIQLVLIGALVYVAYPFISTVPTFFSQLRTANWWWALLGLAVSALTYVGAAAALWACADGLVGFWKLSIMQVANTFAATTTPAGVGGLALSTRFLQKGGLTAVRATAAVALQQSVQVIVHLVLLILFSALAGTSTDLSHFVPNATVLYLIAGVALGIVGTFLFVPKLRRWLATAVRPKLREVTNDLIALAREPKRLALIVLGCAGTTLGAALALWASIEAFGGGTTFVTVTVVTMVGGTLASAAPTPGGVGAVEAALIGGLAAFGVPAALGVPSVLLYRLLTCWLPVFAGWQVMHWLTRHEMI,"84,042",795,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
P96912,P96912_MYCTU,Rv0622,Rv0622,GO:0005618; GO:0016021,IPR007969; ,,,,Possible membrane protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230,,,MSFCVYCGAELADPTRCGACGAYKIGSTWHRTTTPTVGAATTATGWRPDPTGRHEGRYFVAGQPTDLVREGDAEAVDPLGQQQLDQSGAVGVSPSAVSGWVRSGHRRLWWALAGVVAFLGLVGAGVVGTLFLNRDRESIDDKYLAALRRSGLTGEFNSDANAIARGKQVCRQLQDGGEQQGMPVDQVAVQYYCPQFSDGFHILETITVTGSFTLKDESPNVYAPAITVSGSGCSGSAGYADIDRGTQVTVKNGQGDILATAFLQAGQGGRFLCTFPFSFEITEGEDRYVVSVSRRGEMSYSFADLKANGLSLVLG,"33,420",315,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,3
P96257,P96257_MYCTU,Rv0411c,glnH Rv0411c,GO:0005576; GO:0040007,IPR001638; ,,glnH,,Probable glutamine-binding lipoprotein GlnH (GLNBP),extracellular region [GO:0005576]; growth [GO:0040007],9634230; 21969609,,,MTRRALLARAAAPLAPLALAMVLASCGHSETLGVEATPTLPLPTPVGMEIMPPQPPLPPDSSSQDCDPTASLRPFATKAEADAAVADIRARGRLIVGLDIGSNLFSFRDPITGEITGFDVDIAGEVARDIFGVPSHVEYRILSAAERVTALQKSQVDIVVKTMSITCERRKLVNFSTVYLDANQRILAPRDSPITKVSDLSGKRVCVARGTTSLRRIREIAPPPVIVSVVNWADCLVALQQREIDAVSTDDTILAGLVEEDPYLHIVGPDMADQPYGVGINLDNTGLVRFVNGTLERIRNDGTWNTLYRKWLTVLGPAPAPPTPRYVD,"35,406",328,,growth [GO:0040007],,extracellular region [GO:0005576],,,1
Q79FY5,Q79FY5_MYCTU,Rv0609A,Rv0609A,,,,,,Uncharacterized protein,,9634230,,,MEGQRLWAHRRPKGTGSAVIDVSLARRCEAHGYDYFRSDDPVAAAGFVVSAVWSCGRGPGNATGSGRLPKPLRHS,"8,051",75,,,,,,,1
P96923,P96923_MYCTU,Rv0633c,Rv0633c,GO:0016021,,,,,Possible exported protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVDSMGWVLSSWHEVTGVDSGTWLAWAAWAALGLGVVALVVTKRQIQRNRRLAAEQTRPYVAMFMEPHVADWHVIELVVRNFGRTAAYDVRFSFPNPPTVAQYENAANGYADVVELRLPQELPMLAPGQEWRMVWDSALDRAEIGRGIESRFPGTVTYYDRPEQPRRWRFWRRGRRPLETKVVLDWDALPPVARIELMTTHDLAKREKQKLELLRSLLTYFHYASKETRPDVFRSEIDRINRAAAETQDRWRARQVEVPTEVSQRSEGQGPQPTRIPAG,"32,262",279,,,,integral component of membrane [GO:0016021],,,3
I6X9N4,I6X9N4_MYCTU,Rv0741,Rv0741,,IPR002560; ,,,,Probable transposase,,9634230,,,MFSVKGEEGKQALDRWISWARRCRIPVFVELAGGIVRHRQAIDAALDHGLWQGLIESTNTKIRLLTRIAFGFRSPEALIALAMLALGGRRPALPGRTKHPRISQ,"11,625",104,,,,,,,1
P96937,P96937_MYCTU,Rv0648,Rv0648,GO:0004559; GO:0005886; GO:0006013; GO:0006517; GO:0009313; GO:0019377; GO:0030246,IPR018905; IPR011013; IPR011330; IPR011682; IPR015341; IPR037094; IPR000602; IPR027291; IPR028995; ,,,,Alpha-mannosidase,plasma membrane [GO:0005886]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; glycolipid catabolic process [GO:0019377]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517],9634230,,,MMGGTYNEPNTNLTSPETTIRNLVHGIGFQRDVLGAEPATAWQLDVFGHDPQFPGLAADAGLTSSSWARGPHHQWGPAQGGVDRMQFCSEFEWIAPSGRGLLTHYMPAHYSAGWSMDSSTSLADAEAATYALFDQLKKVALTRNVLLPVGTDYTPPNKWVTAIHRDWGARYTWPRFVCALPKEFFAAVRAELAKRGWVPSPQTRDMNPIYTGKDVSYIDTKQANRAAENAVLEAERFAVFAALLTGAEYPQAALAKAWVQLAYGAHHDAITGSESDQVYLDLLTGWRDAWELGRAARDNSLRLLSGAVAASHDRVVVWNPLTQRRTDIVTARVDPPLQAGVRVFDPDGAEVAALVEHDGRSVTWLACDVPSLGWRVYRLVPADEAPGWELVPGTDIANEHYRLAVDPERGGALSSLVQDGRQLIAAGRVANELALYEEYPSHPTQGEGPWHLLPTGPVVCSSACPAQVQAYRGPLGQRLVVRGRIGTLLRYTQTLTLWDGVDRVDCRTSIDEFTGEDRLLRLRWPCPVPGAMPISEVGDAVVGRGFALLHEGPESVDTAQHPWTLDNPAYGWFGLSSAVRVRAGDGVRAVSVAEVVSPTETVSGPMARDLMVALVRAGVTATCSGADKPRYGHLDVDSNLPDARIALGGPDRNTFTKAVLAEAAPAYTAELQRQLAKTGTARVWVPAANPLARAWLPGADLRAPCALPVLVIDGRDEKHLRAAVASLADDLADAEIVVHQRAAPQMEPFEDRTVALLNRGVPSFAVDSEGTLHTALMRSCTGWPSGVWIDQPRRTAPDGSNFQLQHWTHHFDYALVCGGGDWRRAGIPARSAQFSHPLLAVAPRRPQGELPAVGSLLHVEPADSVQLGALKAAGNPLAAGSARPVQPAAVALRLVQTTGADTPVTIGCELGKVGALRPADLLETPLAMARARKSSIDLHGYQVATVLARLDVAADMANVLAADDVALAPHAETAQPQYARYWLHNRGPAPLGGLPAVAHLHPRRVRGQPGDDVVLRLTAASDCTDSVLGGVVDVVCPLGWPATPARLPFTLGAGAHLQADIALSIPAGAPPGPYPVRAQLRVVDTAVPAAWRQVVEDVCVVTVGADSDLEELVYLVDGPADIELAAGDRARLAVTIGSRAHAELALDAHSISPWGTWEWIGPPALGAVLPARGMAKLAFDVTPPAWLEPGQWWALVRVGCAGQLVYSPAVKVSVT,"129,981",1215,,glycolipid catabolic process [GO:0019377]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313]; protein deglycosylation [GO:0006517],alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246],plasma membrane [GO:0005886],,,2
I6Y8H4,I6Y8H4_MYCTU,Rv0697,Rv0697,GO:0016614; GO:0050660,IPR036188; IPR023978; IPR012132; IPR000172; IPR007867; ,,,,Probable dehydrogenase,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230,,,MTAAVRHSDVLVVGAGSAGSVVAERLSMDSSCVVTVLEAGPGLADPGLLAQTANGLQLPIGAGSPLVERYRTRLTDRPVRHLPIVRGATVGGSGAINGGYFCRGLPSDFDRASIPGWAWSDVLEHFRAIETDLDFETPVHGRSGPIPVRRTHEMTGITESFMAAAEDAGFAWIADLNDVGPEMPSGVGAVPLNIVNGVRTSSAVGYLMPALGRPNLTLLARTRAVRLRFSATTAVGVDAIGPGGPVSLSADRIVLCAGAIQSAHLLMLSGVGEEEVLRSAGVKVLMALPVGMGCSDHPEWVMPTNWAVAVDRPVLEVLLSTHDGIEIRPYTGGFVAMTGDGTAGHRDWPHIGVALMQPRARGRITLVSSDPQIPVRIEHRYDSEPADVAALRQGSALAHELCGAATRIGPAVWATSQHLCGSAPMGTDDDPRAVVDPRCRVRGIENLWVIDGSVLPSITSRGPHATIVMLGHRAAEFVQ,"50,291",479,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,1
I6XW93,I6XW93_MYCTU,Rv0762c,Rv0762c,,IPR032710; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAGYPRDELEDVVHRWLQANRTAERRGDWTLLADFYTDDATYGWNVGPNEDVMCVGIDEIRDIALGQEMDGLQGWRYPYQRVVIDEKQGEVVGFWKQVATDANGAEQEVYGIGGSWFRYAGGGKWNWQRDFFDFGHVSALYLELIKAGKLSPGMQKRIERAVSGNKVPGYYPLGKTPVPLW,"20,614",181,,,,,,,1
O06413,O06413_MYCTU,Rv0547c,Rv0547c,,IPR036291; IPR002347; ,,,,Possible oxidoreductase,,9634230; 21969609,,,MSKRPLRWLTEQITLAGMRPPISPQLLINRPAMQPVDLTGKRILLTGASSGIGAAATKQFGLHRAVVVAVARRKDLLDAVADRITGDGGTAMSLPCDLSDMEAIDALVEDVEKRIGGIDILINNAGRSIRRPLAESLERWHDVERTMVLNYYAPLRLIRGLAPGMLERGDGHIINVATWGVLSEASPLFSVYNASKAALSAVSRIIETEWGSQGVHSTTLYYPLVATPMIAPTKAYDGLPALTAAEAAEWMVTAARTRPVRIAPRVAVAVNALDSIGPRWVNALMQRRNEQLNP,"31,867",294,Short-chain dehydrogenases/reductases (SDR) family,,,,,,1
I6X9E2,I6X9E2_MYCTU,Rv0604,lpqO Rv0604,,IPR011094; ,,lpqO,,Probable conserved lipoprotein LpqO,,9634230; 21969609,,,MIRRRGARMAALLAAAALALTACAGSDDKGEPDDGGDRGASLATTSDADWKPVADILGRTGKLNDGSVYKIGFARSDLSVQTKGVTVAPALSLGSWVAFARTPDGQTMLMGDLVVTEDELASVTDAVQAGGLQQTALHKHLLEQSPPIWWTHIAGHGDAADLARAVRSALDATDTPPPASATSGQTSLDLDTAAIDEALGRSGTIAGGVYKFFIARRDPVTMSGMLIPPSMGLATALNFQPTGNGRAAINGDFVMTAAEVQDVVQALRGGGIDIVAIHNHGFDEQPRLFYMHFWAENDAVALARTLRAAVDATAAR,"32,887",316,,,,,,,1
O53772,O53772_MYCTU,Rv0575c,Rv0575c,GO:0005886; GO:0071949,IPR002938; IPR036188; ,,,,Possible oxidoreductase,plasma membrane [GO:0005886]; FAD binding [GO:0071949],9634230; 21969609,,,MKVAISGAGVAGAALAHWLQRTGHTPTVIERAPKFRTGGYMIDFWGVGYQVAKRMGITDQIAAAGYHMEHVRSVGPTGKVKADLGVDVFRRMVGDDFTSLPRGDLAAAIYTTIEDQVETIFDDSIATIDEHRDGVRLTFERTAPRDFDLVIGADGLHSNVRRLVFGPERDFEHYLGCKVAACVVDGYRPRDERSYVLYNTVDRQLARFALRGDRTMFLFVFRAEHDNPGVAPKDELRDQFGDVGWESRDILAALDDVEDLYFDVVSQIRMDRWSRGRVLLIGDAAGCISLLGGEGTGLAITEAYVLAGELARAGGDHRRAFDAYEKRLRPFIEGKQASAAKFIWFFATRTRFGLWFRNVAMRTMNFGPLATLFAGSVRDDFELPDYTW,"43,398",388,,,FAD binding [GO:0071949],plasma membrane [GO:0005886],,,1
O33358,O33358_MYCTU,Rv0513,Rv0513,GO:0016021,IPR016844; ,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTPTGDTKPKLLFYEPGASWYWVLTGPLAAVSVLLLEISSGAGVGLITPAIFLVMVSAFVALQVKAARIHTSVELTHDALRQGTETIRLAEIVKIYPEADGRETSGEEPAKWQSARTLGELVGVPRGRVGIGLKLTGGRTAQAWARRHQQLRAALTPLVQERLGPVDSDVADVNGDDAGPAR,"19,401",182,,,,integral component of membrane [GO:0016021],,,1
O33365,O33365_MYCTU,Rv0520,Rv0520,GO:0005737; GO:0008757; GO:0032259,IPR013216; IPR029063; ,,,,Possible methyltransferase/methylase,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230,,,MGGCSITCLNISEVPNETNRKKNRQAGLDRSIRVIHGSFDDIPEPDSGYDVVWSQDAILHAPDRRKVLEEAFRVLRPGGELIFTDPMQADDVPDGVLQPVYDRLNLRDLGSMRFYA,"13,059",116,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
I6X9D2,I6X9D2_MYCTU,Rv0590A,Rv0590A,,,,,,Mce-family related protein,,9634230,,,MLHSSFGHLEGIQQPLIDELAELDHVLGKLPDAYRIIGRAGGIYGDFFNFYLCDISLKVNGLQPGGPVRTVKLFGQPTGRCTPQ,"9,199",84,,,,,,,1
I6Y3N9,I6Y3N9_MYCTU,Rv0397A,Rv0397A,,,,,,Conserved protein,,9634230; 21969609,,,MHALRLVGLAILTAIAPIAVLIGSSPAHADTDIGQPCSPEGAKLWGNPGPIYCERTADGQLQWVSIPAWALCVAFCDRPGGP,"8,505",82,,,,,,,1
I6WZ58,I6WZ58_MYCTU,Rv0713,Rv0713,GO:0005886; GO:0016021,IPR027948; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MAGSDPPTGGPASQAGSDAGASPEHKHMSRRKHLVLDVCIILGVLIAYVFSLLGYDWLAHTPGPLPQPDVGTTDDTVVLIRFEELHTVANRLDVKVLVLPDDSMIDHRLQVLTTDTSVRLYPENELGDLQYPVGKLPAQVATTIEAHGNPGAWPFDTYTTDTVQADVLVGAGDNRQYVPARVEVTGSLEGWDISAVRVGESSQTSDRPDNVIITLKRAKGPLVFDLGICLVLITLPTLALFVAIQMITGRRKFQPPFGTWYAAMLFAVVPLRTILPGSPPAGAWIDRAVVIWVLIALAAAMVVYIVAWYRESD,"33,925",313,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O06397,O06397_MYCTU,Rv0531,Rv0531,GO:0016021,IPR025323; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MSEAPNDKTTRGVVDILVYATARLLLVVAVSAAIFGVARLIGLTEFPVVVATLFGLIIAMPLGIWVFSPLRRRATAALAVAGERRRAERERLRARLRGESLPEEQ,"11,469",105,,,,integral component of membrane [GO:0016021],,,1
O07771,O07771_MYCTU,Rv0607,Rv0607,GO:0040007,,,,,Uncharacterized protein,growth [GO:0040007],9634230; 21969609,,,MGAWQTADTMGIFQALPDVWGGWRTECWEDRFEEQLIRCNGALRLPELDLAAGMDSAREWLRDRIFQRFSDSPAGQILKLSELLADVGPGLVVSDDAVTNGGARPNNEEWARFVAACDLVRGAHAESA,"14,135",128,,growth [GO:0040007],,,,,1
I6Y461,I6Y461_MYCTU,Rv0593,lprL Rv0593,,IPR005693; IPR003399; ,,lprL,,Possible Mce-family lipoprotein LprL (Mce-family lipoprotein Mce2E),,9634230,,,MRCGVSAGSANGKPNRWTLRCGVSAGHRGSVFLLAVLLAPVVLTSCTWRGIANVPLPVGRGMGPDRMTIYVQMPDTLALNTNSRVRVADVWVGTVRDISLRNWIATLTLELEPTVRLPANATAKIGQTSLLGTQHVELAAPPIPSPQPLKSGDTIGLKNSSAYPTVERTLASVALILTGGGIVNLDVIQTEILNILDGHAGQIREFLERLATFTAELNNQRGDLTRAIDSTNQLLTIIANRNDTLDRVLTDVPPLIEHFADTGQLFADATESLGRFSEVANRALAATRPNLHQTLQSLQRPLRQLERASPYVVGALKLGLTAPFNIDEVPNVIRGDYVNVSATFDVTLSALDNALLSGTGISGMLRALEQAWGRDPDTMIPDVRYTPNPNDAPGGPLVERAE,"43,174",402,,,,,,,1
P95208,P95208_MYCTU,Rv0400c,fadE7 Rv0400c,GO:0016627; GO:0040007; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE7,,Acyl-CoA dehydrogenase FadE7,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; growth [GO:0040007]",9634230; 21969609,,,MSTPTPPALDRDDPLGLDASLSSDEIAVRDTVRRFCAEHVTPHVAAWFEDGDLPVARDLAKQFGELGLLGMQLHGHGCGGASAVHYGLACRELEAADSGIRSLVSVQGSLAMFAIASFGSDEQKRQWLPGMATGDLLGCFGLTEPDVGSDPAAMKTRARRDGPDWVITGGKMWITNGSVADVAIVWAATDDGIRGFIVPTDTPGFTANTIGHKLSLRASITSELVLDNVRLPADAMLPGATGLRAPLACLSEARYGIVWGAMGAARSAWQCALDYARQRTQFGRPIAGFQLTQAKLVDMAVELHKGQLLSLHLGRLKDRVGLRPDQVSFGKLNNTREALKICRTARTILGGNGISLEYPVIRHMVNLESVLTYEGTPEMHQLVLGQAFTGLAAFR,"42,297",395,Acyl-CoA dehydrogenase family,growth [GO:0040007],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,3
I6WZD7,I6WZD7_MYCTU,Rv0760c,Rv0760c,,IPR002075; IPR032710; ,,,,Conserved protein,,9634230; 21969609,,,MTQTTQSPALIASQSSWRCVQAHDREGWLALMADDVVIEDPIGKSVTNPDGSGIKGKEAVGAFFDTHIAANRLTVTCEETFPSSSPDEIAHILVLHSEFDGGFTSEVRGVFTYRVNKAGLITNMRGYWNLDMMTFGNQE,"15,242",139,,,,,,,1
I6Y890,I6Y890_MYCTU,Rv0605,Rv0605,GO:0000150; GO:0003677,IPR006118; IPR006119; IPR036162; ,,,DOMAIN 59 198 Resolvase/invertase-type recombinase catalytic. {ECO:0000259|PROSITE:PS51736}.,Possible resolvase,DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230,,,MACCRNRGMNLAAWAERNGVARVTAYRWFHAGLLPVPARKVGRLILVDELASEAGAQPKTAVYARVSSADQKSDLDRQVARVTSWATAEQIPVDKVVTEVGSVLNGHRRKFPAVLRDLSVTRIVVEHRDRFCRFGSEYVHAALAAQGRELVVVDSAEVDDDLVWDMTEILTSMCARLYGKRAAQNRAKRAVAAAAVDDHEAA,"22,211",202,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],,,,1
L7N670,L7N670_MYCTU,Rv0536,galE3 Rv0536,GO:0005975; GO:0016857; GO:0050662,IPR001509; IPR036291; IPR008089; ,,galE3,,Probable UDP-glucose 4-epimerase GalE3 (Galactowaldenase) (UDP-galactose 4-epimerase) (Uridine diphosphate galactose 4-epimerase) (Uridine diphospho-galactose 4-epimerase),"coenzyme binding [GO:0050662]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MRVLLTGAAGFIGSRVDAALRAAGHDVVGVDALLPAAHGPNPVLPPGCQRVDVRDASALAPLLAGVDLVCHQAAMVGAGVNAADAPAYGGHNDFATTVLLAQMFAAGVRRLVLASSMVVYGQGRYDCPQHGPVDPLPRRRADLDNGVFEHRCPGCGEPVIWQLVDEDAPLRPRSLYAASKTAQEHYALAWSEASGGSVVALRYHNVYGPGMPRDTPYSGVAAIFRSAVEKGKPPKVFEDGGQMRDFVHVDDVAAANLAAVHLGEADRDGFTAVNVCSGRPISILQVATAICDARGGSMSPAITGHYRSGDVRHIVADPARAARVLGFRAAVDPGEGLREFAFAPLR,"36,219",346,,carbohydrate metabolic process [GO:0005975],"coenzyme binding [GO:0050662]; racemase and epimerase activity, acting on carbohydrates and derivatives [GO:0016857]",,,,1
I6XVZ6,I6XVZ6_MYCTU,Rv0686,Rv0686,GO:0016021,,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLARYIKMQLLVLLCGGLVGPIFLVVYFTLGLGSLMSWMFYVGLIITVADVLVALALTNYGAKTAAKTAALERSGVLALAQITGLSETGTRINDQPLVKVHLHISGPGITPFDTEDRVIASVTRLGNLTARKLVVLVNPATQQYLIDWERSALVNGLVPAQFTVAEDNKTYDLSGQTGPLMEILQILKANNVPLNRMVDIRSNPALRQQVQAVVRRAAERQAPAAEPASQGSIAERLAELESLRASGAVNAAEYESKRAQIISEI,"28,575",265,,,,integral component of membrane [GO:0016021],,,1
O06410,O06410_MYCTU,Rv0544c,Rv0544c,GO:0016021,,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MSAWFNYTATLKILIFSLLAGALLPGLFAVGVRLQAAGDGADATARRRPLLVAVSWAIFALVLAVVIIGVLYIARDFIAHHTGWAFLGATPK,"9,780",92,,,,integral component of membrane [GO:0016021],,,1
I6WYT7,I6WYT7_MYCTU,Rv0592,mce2D Rv0592,,IPR005693; IPR003399; ,,mce2D,,Mce-family protein Mce2D,,9634230,,,MSTIFDIRSLRLPKLSAKVVVVGGLVVVLAVVAAAAGARLYRKLTTTTVVAYFSEALALYPGDKVQIMGVRVGSIDKIEPAGDKMRVTLHYSNKYQVPATATASILNPSLVASRTIQLSPPYTGGPVLQDGAVIPIERTQVPVEWDQLRDSINGILRQLGPTERQPKGPFGDLIESAADNLAGKGRQLNETLNSLSQALTALNEGRGDFVAITRSLALFVSALYQNDQQFVALNENLAEFTDWFTKSDHDLADTVERIDDVLGTVRKFVSDNRSVLAADVNNLADATTTLVQPEPRDGLETALHVLPTYASNFNNLYYPLHSSLVGQFVFPNFANPIQLICSAIQAGSRLGYQESAELCAQYLAPVLDALKFNYLPFGSNPFSSAATLPKEVAYSEERLRPPPGYKDTTVPGIFSRDTPFSHGNHEPGWVVAPGMQGMQVQPFTANMLTPESLAELLGGPDIAPPPPGTNLPGPPNAYDESNPLPPPWYPQPASLPAAGATGQPGPGQ,"54,540",508,,,,,,,1
O07762,O07762_MYCTU,Rv0615,Rv0615,GO:0016021,,,,,Probable integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MMDVLAAGIAAGALTLAAWGAWRPHYRAASYLVAGAVELALIGLLVVTGQTLMAISVAFLVALGGPLVVVNHRRAERSRG,"8,254",80,,,,integral component of membrane [GO:0016021],,,3
O53740,O53740_MYCTU,Rv0455c,Rv0455c,GO:0005576,IPR031702; ,,,,Conserved protein,extracellular region [GO:0005576],9634230; 21969609,,,MSRLSSILRAGAAFLVLGIAAATFPQSAAADSTEDFPIPRRMIATTCDAEQYLAAVRDTSPVYYQRYMIDFNNHANLQQATINKAHWFFSLSPAERRDYSEHFYNGDPLTFAWVNHMKIFFNNKGVVAKGTEVCNGYPAGDMSVWNWA,"16,640",148,,,,extracellular region [GO:0005576],,,3
O07761,O07761_MYCTU,Rv0616c,Rv0616c,,,,,,Uncharacterized protein,,9634230,,,MRIPGNRQCLLVQVLRQVDGSAHRLILTSLHRDARADAHRYSNGTDHAGRAADEPAETAHEPCWVAARGLASQASRAMSATYRPSSFI,"9,623",88,,,,,,,1
Q6MX36,Q6MX36_MYCTU,Rv0492A,Rv0492A,,,,,,Uncharacterized protein,,9634230,,,MSFLLDPPLLFVCGVLIERRLPVDRRDAAEAAALGVFFGASFGLYHNVPGLGMLWRPFRAQNGRDFMWNSGVFSVDVARAEWPLHAMAAAIFATYPFFIKLGRRLGRRI,"12,271",109,,,,,,,1
P95075,P95075_MYCTU,Rv0727c,fucA Rv0727c,GO:0005829; GO:0016832; GO:0019323,IPR001303; IPR036409; ,,fucA,,Possible L-fuculose phosphate aldolase FucA (L-fuculose-1-phosphate aldolase),cytosol [GO:0005829]; aldehyde-lyase activity [GO:0016832]; pentose catabolic process [GO:0019323],9634230; 21969609,,,MNFVDAPESAVLAAAKDMLRRGLVEGTAGNISARRSDGNVVITPSSVDYAEMLLHDLVLVDAGGAVLHAKDGRSPSTELNLHLACYRAFDDIGSVIHSHPVWATMFAVAHEPIPACIDEFAIYCGGDVRCTEYAASGTPEVGRNAVRALEGRAAALIANHGLVAVGPRPDQVLRVTALVERTAQIVWGARALGGPVPIPEDVCRNFTGVYGYLRANPL,"23,066",218,,pentose catabolic process [GO:0019323],aldehyde-lyase activity [GO:0016832],cytosol [GO:0005829],,,2
I6XVW9,I6XVW9_MYCTU,Rv0663,atsD Rv0663,GO:0008152; GO:0008484,IPR017849; IPR017850; IPR013320; IPR024607; IPR000917; ,,atsD,,Possible arylsulfatase AtsD (Aryl-sulfate sulphohydrolase) (Arylsulphatase),sulfuric ester hydrolase activity [GO:0008484]; metabolic process [GO:0008152],9634230; 21969609,,,MPQPRTHLPIPSAARTGLITYDAKDPDSTYPPIEQLRPPAGAPNVLLILLDDVGFGASSAFGGPCRTSTAELLAGNGLRYNRFHTTALCSPTRQALLTGRNHHSAGMGGITEIATGAPGYSSVLPNTMSPIARTLKLNGYNTAQFGKCHEVPVWQTSPVGPFDAWPSGGGGFEYFYGFIGGEANQWYPSLYEGTTPVEVNRTPEEGYHFMADMTDKALGWIGQQKALAPDRPFFVYFAPGATHAPHHVPREWADKYRGRFDVGWDALREETFARQKELGVIPADCQLTARHAEIPAWDDMPEDLKPVLCRQMEVYAGFLEYTDHHVGRLVDGLQRLGVLDDTLVFYIIDDNGASAEGTINGTYNEMLNFNGLADIETPRFMTDRLDKFGGPESYNHYSVGWAHAMDTPYQWTKQVASHWGGTRNGTIVHWPNGIAAKGEMRWQFHHVIDVAPTILEAAGLPEPLFVNGVQQHPIEGVSMAYSFDDAQAPDRHETQYFEMFGNRGIYHKGWTAVTKHKTPWILVGEQTVAFDDDVWELYDTTKDWSQAKDLAKEMPEKLHELQRLWLIEATRYNVLPLDDDTASRINPDLAGRPVLIRGNTQVLFSNMGRLSENCVLNLKNKSHTVTAEVEVPETGAEGVIVAQGASIGGWSLYANDGKLKYCYNLGGIKHFYAESADPLPAGAHQVRMEFAYAGGGLGKGGEVTLYVDGQQVGEGHVEATLAIVFSADDGCDVGMDSGSPVSPDYAPGSNAFNGRIKGVQLAIAEAAAAAGHLVDPEHAIRIALARQ,"86,128",787,,metabolic process [GO:0008152],sulfuric ester hydrolase activity [GO:0008484],,,,1
P71820,P71820_MYCTU,Rv0763c,Rv0763c,,,,,,Possible ferredoxin,,9634230,,,MGYRVEADRDLCQGHAMCELEAPEYFRVPKRGQVEILDPEPPEEARGVIKHAVWACPTQALSIRETGE,"7,681",68,,,,,,,3
O53748,O53748_MYCTU,Rv0463,Rv0463,GO:0016021,,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MTRRASTDTPQIIMGAIGGVVTGYILWLAAISVGDGLTTVSQWSRVVLLLSVLVAVCGAAGGLRLRSRGKLAWSAFAFSLPIPPVVLTVAVLADIYL,"10,111",97,,,,integral component of membrane [GO:0016021],,,1
O07788,O07788_MYCTU,Rv0590,mce2B Rv0590,GO:0005886; GO:0016021,IPR005693; IPR003399; ,,mce2B,DOMAIN 39 110 MlaD. {ECO:0000259|Pfam:PF02470}.,Mce-family protein Mce2B,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MKTTGTTIKLGIVWLVLSVFTVMIIVVFGQVRFHHTTGYSAVFTHVSGLRAGQFVRAAGVEVGKVAKVTLIDGDKQVLVDFTVDRSLSLDQATTASIRYLNLIGDRYLELGRGHSGQRLAPGATIPLEHTHPALDLDALLGGFRPLFQTLDPDKVNSIASSIITVFQGQGATINDILDQTASLTATLADRDHAIGEVVNNLNTVLATTVKHQTEFDRTVDKLEVLITGLKNRADPLAAAAAHISSAAGTLADLLGRIVHCCTAASGTSRASSSRS,"29,164",275,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O06407,O06407_MYCTU,Rv0541c,Rv0541c,GO:0016021; GO:0040007,,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230; 21969609,,,MRIGRREGLAVAIGFVLVGAAFVLPRLNLGIKPRSDIGLERFATRAGAAPIFGYWDAHVGWGTAPAVLTAVAVVAWGPVVAHRLPWRVLTLSTWATAAAWAFSLAMIDGWQRGFAGRLTTRDEYLWQVPGIADIPATLRTFTSRILDFQPNSWVTHVSGHPPGALLTFVWLDRIGLRGGGWAGLVCLLVGSSAAAAVLIAVRVLASEQMARRTAPFVAVAPTAIWIAVSADGYFAGVAAWGIALLAVAVHGATRFPALVAAGAGLLLGWGVFLNYGLVLIVLPGMAVLAAADWRPVLRALGPAVLAALVVAVSFAVAGFSWFDGYTLVQQRYWQGIAKDRPFGYWSWANLACVVCAIGLGSVAGLSRVFDRAAISRRSGCHLLLLAVLAAIALADLSMLSKAETERIWLPFTIWLTAAPALLPPRSHRLWLAVNAAGALLLNSIIFTNW,"47,760",449,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,1
O53777,O53777_MYCTU,Rv0580c,Rv0580c,GO:0005618; GO:0005886,IPR016791; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MTDQSYAVDIAHPPAALLRLVNPILRSLLHTPLAGPLRTQLMVVSFTGRKTGRHFSIPLSAHVIDNDLYALTEAGWKHNFSDGAAAQVVYDGKTTAMRGELIRDRAVVSELFLRAAQAYGVKRGQRMLGLSFRDRRIPTLEEFAEAVDRLKLVAIRLTPADNS,"18,035",163,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
I6Y481,I6Y481_MYCTU,Rv0610c,Rv0610c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MDDELRGLLARYARGELSADDARRAILRYPKWRVAEIDGELETVALDDGTPMLIAESSASDGREYSGLELVRDIAPLVGGLSFDPDEPWGSAFRPGALPELQNWARTVELEDAVAKPGPGQRDLLYEGPWWVAVSPGTGRPAVHRADGLDVITIMTAPDAAATFRRTERHRGLDVVRLGPALWGDLAKRSDFDGVRLNPLRPLAQLWPPHVPAMLVAGCDPRPNAEPLPARTVAEIHLWLDQHGARQEKRELSNRATPVGEVTVARAWWNYDRREIAFTRVAPASDTEGLGSVPSRILCAGKLRQSIQSKLAGLPRLTWRADAWHRQRAALAVGWALELEKLVCGERVPFAALRTPEGAHLWHLEPQAFTARAIRKLRDRAASFR,"42,640",385,,,,,,,1
P96276,P96276_MYCTU,Rv0430,Rv0430,GO:0040007; GO:0046688,IPR021678; ,,,,Uncharacterized protein,growth [GO:0040007]; response to copper ion [GO:0046688],9634230; 21969609,,,MDSAMARAIRSGDDAEVADGLTRREHDILAFERQWWKFAGVKEEAIKELFSMSATRYYQVLNALVDRPEALAADPMLVKRLRRLRASRQKARAARRLGFEVT,"11,723",102,,growth [GO:0040007]; response to copper ion [GO:0046688],,,,,3
P71830,P71830_MYCTU,Rv0775,Rv0775,GO:0000976; GO:0003700; GO:0005618; GO:0005829; GO:0005886; GO:0006351,IPR009057; IPR001647; ,,,DOMAIN 12 72 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Uncharacterized protein,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MGVTAAVTPKGERRRYALVSAAAELLGEGGFEAVRHRAVARRAGLPLASTTYYFSSLDDLIARAVEHIGMIEVAQLRARVSALSRRRRGPETTAVVLVDLLVGEMSSPGLAEQLISRYERHIACTRLPDLRESMRRSLRQRAEAVAEAIERSGRSAQIELVCTLICAVDGSVVSALVEGRDPRAAALATVVDLIDVLAPVDQRPVPF,"22,382",207,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O06417,O06417_MYCTU,Rv0551c,fadD8 Rv0551c,GO:0005886; GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD8,DOMAIN 59 461 AMP-binding. {ECO:0000259|Pfam:PF00501}.; DOMAIN 470 552 AMP-binding_C. {ECO:0000259|Pfam:PF13193}.,Probable fatty-acid-CoA ligase FadD8 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),plasma membrane [GO:0005886]; ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MSTAGDDAVGVPPACGGRSDAVGVPQLARESGAMRDQDCSGELLRSPTHNGHLLVGALKRHQNKPVLFLGDTRLTGGQLADRISQYIQAFEALGAGTGVAVGLLSLNRPEVLMIIGAGQARGYRRTALHPLGSLADHAYVLNDAGISSLIIDPNPMFVERALALLEQVDSLQQILTIGPVPDALKHVAVDLSAEAAKYQPQPLVAADLPPDQVIGLTYTGGTTGKPKGVIGTAQSIATMTSIQLAEWEWPANPRFLMCTPLSHAGAAFFTPTVIKGGEMIVLAKFDPAEVLRIIEEQRITATMLVPSMLYALLDHPDSHTRDLSSLETVYYGASAINPVRLAEAIRRFGPIFAQYYGQSEAPMVITYLAKGDHDEKRLTSCGRPTLFARVALLDEHGKPVKQGEVGEICVSGPLLAGGYWNLPDETSRTFKDGWLHTGDLAREDSDGFYYIVDRVKDMIVTGGFNVFPREVEDVVAEHPAVAQVCVVGAPDEKWGEAVTAVVVLRSNAARDEPAIEAMTAEIQAAVKQRKGSVQAPKRVVVVDSLPLTGLGKPDKKAVRARFWEGAGRAVG,"61,066",571,,metabolic process [GO:0008152],ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
O53731,O53731_MYCTU,Rv0446c,Rv0446c,GO:0005576; GO:0005737; GO:0006629; GO:0016021; GO:0016627,IPR001104; IPR010721; ,,,DOMAIN 138 201 S5A_REDUCTASE. {ECO:0000259|PROSITE:PS50244}.,Possible conserved transmembrane protein,"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; lipid metabolic process [GO:0006629]",9634230; 21969609,,,MVTSVSALAVAVVHSVAFAIGRRIGRYNVVDVVWGLGFVAVAVAAATLGHGDPVRRWLLLALVSTWGLRLSWHMYRKTAGQGEDPRYADLLRGATPVQALRKVFGLQGLLTLFVSFPLQLSAVTGPTPKPLLAVGGVGLAVWLVGITFEAVGDWQLWVFKSDPANRGVIMDRGLWAWTRHPNYFGDACVWWGLWLITINDWAPLATVGSPLLMTYLLVDVSGARLTERYLKGRPGFAEYQRRTAYFVPRPPRSARR,"28,253",256,,lipid metabolic process [GO:0006629],"oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
O06392,O06392_MYCTU,Rv0526,Rv0526,GO:0005576; GO:0005886; GO:0016209; GO:0016491; GO:0040007; GO:0045454,IPR000866; IPR036249; IPR017937; IPR013766; ,,,DOMAIN 46 204 Thioredoxin. {ECO:0000259|PROSITE:PS51352}.,Possible thioredoxin protein (Thiol-disulfide interchange protein),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; cell redox homeostasis [GO:0045454]; growth [GO:0040007],9634230; 21969609,,,MQSRATRRSGALTMRRLVIAAAVSALLLTGCSGRDAVAQGGTFEFVSPGGKTDIFYDPPASRGRPGPLSGPELADPARSVSLDDFPGQVVVVNVWGQWCGPCRAEVSQLQRVYDATRGAGVSFLGIDVRDNNRQAPQDFINDRHVTYPSIYDPAMRTLIAFGGKYPTSVIPSTLVLDRQHRVAAVFLRELLAADLQPVVERVAEEEPSGRAPVGAQ,"23,218",216,,cell redox homeostasis [GO:0045454]; growth [GO:0040007],antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O06396,O06396_MYCTU,Rv0530,Rv0530,,IPR002586; IPR027417; ,,,DOMAIN 153 340 CbiA. {ECO:0000259|Pfam:PF01656}.,Conserved protein,,9634230; 21969609,,,MLVTEHPRTGVGAPDSGNGGTDHPTVQLPPVPSVGAPPAAAGGETPTRSVAGFRTQRLDPTAYGAYYSGPDEGPASPAERPPYRLEPVPHTPYPELATTTLLRPVKPPPSEGWRRLLYLLSGRLINAGEGPRAAHLNDLVAQVNRPLRGCYRIAVLSLKGGVGKTTITATLGATFADLRGDRVVAVDANPDRGTLSQKVPLETPATVRHLLRDADGIERYSDVRGYTSKGPSGLEVLASDSDPASSDAFSADDYTRTLDILERFYGLVLTDCGTGLLHSAMSAVLPRSDVLVVVSSGSIDGARSAAATLDWLQAHGHDDQVRNSIAVVNAVRPRAGKVDVGKVVEHFSRRCRAVRVVPFDPHLEEGAEIALDRLRRETREALTELAAVVAAGFPGDPRRCKPSFT,"43,055",405,,,,,,,1
P96270,P96270_MYCTU,Rv0424c,Rv0424c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MAEKNTRRATSQREAVAKIREAETIVMNLPICGQVKIPRPEHLAYYGGLAALAALELIDWPVALVIATGHILANNHHNRVLEELGEAMEEA,"10,010",91,,,,,,,1
P71814,P71814_MYCTU,Rv0757,phoP Rv0757,GO:0000160; GO:0003677; GO:0005622; GO:0005886; GO:0006351; GO:0006979; GO:0009247; GO:0009405; GO:0010628; GO:0044315; GO:0045892; GO:0045893; GO:0046872; GO:0046889,IPR011006; IPR001867; IPR016032; IPR001789; IPR036388; ,,phoP,DOMAIN 22 136 Response regulatory. {ECO:0000259|PROSITE:PS50110}.; DOMAIN 148 245 OmpR/PhoB-type. {ECO:0000259|PROSITE:PS51755}.,Possible two component system response transcriptional positive regulator PhoP,"intracellular [GO:0005622]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; glycolipid biosynthetic process [GO:0009247]; negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription, DNA-templated [GO:0045893]; protein secretion by the type VII secretion system [GO:0044315]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",9634230; 21634789; 21969609; 27079268,X-ray crystallography (2),,MRKGVDLVTAGTPGENTTPEARVLVVDDEANIVELLSVSLKFQGFEVYTATNGAQALDRARETRPDAVILDVMMPGMDGFGVLRRLRADGIDAPALFLTARDSLQDKIAGLTLGGDDYVTKPFSLEEVVARLRVILRRAGKGNKEPRNVRLTFADIELDEETHEVWKAGQPVSLSPTEFTLLRYFVINAGTVLSKPKILDHVWRYDFGGDVNVVESYVSYLRRKIDTGEKRLLHTLRGVGYVLREPR,"27,514",247,,"glycolipid biosynthetic process [GO:0009247]; negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of transcription, DNA-templated [GO:0045893]; protein secretion by the type VII secretion system [GO:0044315]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
O33362,O33362_MYCTU,Rv0517,Rv0517,GO:0005576; GO:0016020; GO:0016021; GO:0016747; GO:0033692,IPR002656; ,,,DOMAIN 38 387 Acyl_transf_3. {ECO:0000259|Pfam:PF01757}.,Possible membrane acyltransferase,"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; cellular polysaccharide biosynthetic process [GO:0033692]",9634230; 21969609,,,MAGGMDQPPGQPRRRTRQQSSDGKNGVRAAEITGEIRALTGLRIVAAVWVVLFHFRPMLGDASPGFRDALAPVLDCGAQGVDLFFILSGFVLTWNYLDRMGRSWSVRANLHFLWLRLARVWPVYLVTLHLAAVWVIFTLHVGHVPSPEAGQLTAISYVRQILLVQLWFQPYFDGSSWDGPAWSISAEWLAYLLFGLLILVIFRMKHATRARGLMWLAFAASLPPVVLLLASGQFYTPWSWLPRIVTQFAAGALACAAVRRLRPTDRARRIAGYLSVLVGVAIVGILYLLHAHPLAGVEDSGGVVDVLFVPLVISLAIGVGSLPALLSTRLMVFGGQISFCLYMVHELVHTAWGWAVQQYELALQDQPWKWNVVGLLAIALGAAILLYHFVEEPGRRWMRRMVDVKAASARSEPGEPVGSTRYQIDDALEGVSARAV,"48,178",436,,cellular polysaccharide biosynthetic process [GO:0033692],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020],,,1
I6X9E8,I6X9E8_MYCTU,Rv0612,Rv0612,,,,,,Uncharacterized protein,,9634230,,,MLGPIRQPRLTVRPGRLPGMIAGVAAKRMNREQFFRAASGLDEDRLRKALWNLYWRGTANMRERIEAELASAGRARPARKIKPPADPDIVGWEVDEFVSLARSGAYLGGDRRVSPRERSRWRFTFKRLAAEAQDALRAEDAEPAASALEQLIDLAREADGYDYFRSDDPVAAAGFVVSDVAAAGHPHFREFAAEIGAAIPP,"22,255",201,,,,,,,1
Q6MX28,Q6MX28_MYCTU,Rv0578c,PE_PGRS7 Rv0578c,,IPR000084; ,,PE_PGRS7,DOMAIN 1 91 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS7,,9634230,,,MSFVIATPEMLTTAATDLAKIGSTITAANTAAAAVAKVLPASADEVSVAVAALFGTHAQEYQTVSAQVATFHDRFVQTLSAAASSYVAAEAVNVEQSLLAAVNAPTQALFGRPLIGNGADGSPGTGQAGGPGGILYGNGGNGGSGAPGQRGGAGGAAGLIGNGGNGGAGGVGTTGGAGGHGGAGGWLYGNGGAGGFGGAGAVGGNGGAGGTAGLFGVGGAGGAGGNGIAGVTGTSASTPGGSGTAGGAGGIGGNGGAGGAGGVLMGNGGNGGAGGEGGPGGAGGAGASGAHATNLGADGQAGGNGGNGGAGGTGGVGGPGGGHGLLGLGGSHGAGGAGGSGGDGGAPGDGGNGATGTWGHNLGAGGTGGNGGNPGAGGAGGAGGASVGGSAHGANGAPGTTSTSGGNGGDGGKGADAISSGQTGANGGRGGDGGQVGNGGAGGAGGRGGAGGLGFGSEAPGRPGGAGGTGGAGGNGGTQAGDGGTGGAGGAGGDGGSGGAGSIGFNASAPGAAGSPGGNGGNGGPGGAGGEGGAGGLALAASGQNGSQGAGGDGGAGGNGGTPGNGGHGAAGALGVNGGVGGAGGHGGDPGVGGAGGQGGSGSTPGANGAPGNTPTSGGNGGNGGRGADATGFGQTGASGGRGGDGGLVGNGGAGGAGGNGSKGLPGLGRLGNPGLDGGTGGNGGAGGSGGAWAGNGGTGGAGGTGGVGGTGGSGSDGVNGSSAGADGHPGGTGGVGGTGGKGGDGGDGGAAPNGVAGSQGPGGAGGDGGTGGVGGNGGRGIDGADGATAGARGQDGGAGGAGGKGGRGGTGGPGGAGPAGTTGSQGAGGNGGSGGTGGDPGDGGNGANGSVFTNNGIGGNGGNGGNAGPSGAGGSGGAGSTFGATGSSSSIHVNGGNGGNGGNGDHALSGNGAAGGNGGNGGNGSLRGSGGAGGHGGNGGNASRGMGGDGGTGGAGGNAGQIGNGGAGGNGGDGGTGSDGNPGAITGSGGRGGDGGVGGQGGSVAGDGADGGRGGAGGTGGTGLRGTTGATGATGTFDAGADGHGGNGGTGGVGGTGGAGGGGGNGGAGGKALSPTGNNGSQGAGGDGGAGGAGGTGGTGGDGGRGAHGTLFSSLAGTGGTGGNGGTGGTGGTGGAGGAGGTGSTLGATGATGAAGRAGNGGVGGSGGLGSAFGPGGTGGMGGAGGTSTVSAGGDGGRGGFGGDGLDASSGGNGGDGGHGGDGFRTAGAGGRGGDGGKGADPGGLFPIPGAGGKGGTGGTGGTAHLGPLAIIGQSGQPGQFGSPGADGRGGAGGAGGGGGAGGSF,"105,963",1306,,,,,,,1
O53773,O53773_MYCTU,Rv0576,Rv0576,GO:0003700; GO:0006950,IPR013538; IPR011991; IPR017517; IPR017520; IPR034660; IPR001845; IPR023393; IPR036388; IPR036390; ,,,DOMAIN 1 84 HTH arsR-type. {ECO:0000259|PROSITE:PS50987}.,Probable transcriptional regulatory protein (Possibly ArsR-family),DNA binding transcription factor activity [GO:0003700]; response to stress [GO:0006950],9634230; 21969609,,,MLEVAAEPTRRRLLQLLAPGERTVTQLASQFTVTRSAISQHLGMLAEAGLVTARKQGRERYYRLDERGVLRLRALMESFWSDELDRLVADAAHYPPSQGDCAMPFEKAVVVPLDPTSTFALITQPDRLRRWMAVAARIELRTGGAYRWTVTPGHSAAGTVIDVDPGKRVVFTWGWEDHGDPPPGGSTVTITLTPVDGGTEVRLVHDGLTAQQAARHAKGWNHFLDRLVVAGQRGDAGPDEWAAAPDPLDELSCAEATLAVLQHVLRGIGASDLTRQTPCTEYDVSQLADHLLRSLAIIGAAAGAQLAPRDVDAPLETQVADAAQAVMEAWRRRGLAGTVELNSNQVPATVPVGILCLEFLVHAWDFAIATGSQVIASEPVSEYVLAVAGKVITPATRNSAGFAAPAAVGSFAPVLDRLIAFTGRQPTAGHVSAT,"46,408",434,,response to stress [GO:0006950],DNA binding transcription factor activity [GO:0003700],,,,3
Q6MX34,Q6MX34_MYCTU,Rv0511,hemD Rv0511,GO:0004851; GO:0004852; GO:0005886; GO:0019354; GO:0040007,IPR000878; IPR035996; IPR036108; IPR003754; IPR014776; ,,hemD,,Probable uroporphyrin-III C-methyltransferase HemD (Uroporphyrinogen III methylase) (Urogen III methylase) (SUMT) (Urogen III methylase) (UROM),plasma membrane [GO:0005886]; uroporphyrin-III C-methyltransferase activity [GO:0004851]; uroporphyrinogen-III synthase activity [GO:0004852]; growth [GO:0040007]; siroheme biosynthetic process [GO:0019354],9634230; 21969609,,,MTRGRKPRPGRIVFVGSGPGDPGLLTTRAAAVLANAALVFTDPDVPEPVVALIGTDLPPVSGPAPAEPVAGNGDAAGGGSAQEHGRAASAVVSGGPDIRPALGDPADVAKTLTAEARSGVDVVRLVAGDPLTVDAVISEVNAVARTHLHIEIVPGLAASSAVPTYAGLPLGSSHTVADVRIDPENTDWDALAAAPGPLILQATASHLAESARSLIDHQLAESTPCVVTAHGTTCQQRSVETTLQGLTDPAVLGATDPACSANGRDSQAGPLIVTIGKTVTSRAKLNWWESRALYGWTVLVPRTKDQAGEMSERLTSYGALPVEVPTIAVEPPRSPAQMERAVKGLVDGRFQWIVFTSTNAVRAVWEKFGEFGLDARAFSGVKIACVGESTADRVRAFGISPELVPSGEQSSLGLLDDFPPYDSVFDPVNRVLLPRADIATETLAEGLRERGWEIEDVTAYRTVRAAPPPATTREMIKTGGFDAVCFTSSSTVRNLVGIAGKPHARTIIACIGPKTAETAAEFGLRVDVQPDTAAIGPLVDALAEHAARLRAEGALPPPRKKSRRR,"58,836",565,,growth [GO:0040007]; siroheme biosynthetic process [GO:0019354],uroporphyrin-III C-methyltransferase activity [GO:0004851]; uroporphyrinogen-III synthase activity [GO:0004852],plasma membrane [GO:0005886],,,1
O07784,O07784_MYCTU,Rv0594,mce2F Rv0594,GO:0005576; GO:0016021; GO:0044121,IPR005693; IPR003399; IPR024516; ,,mce2F,,Mce-family protein Mce2F,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; growth of symbiont in host organelle [GO:0044121],9634230,,,MLTRAIKTQLVLLTVLAVIAVVVLGWYFLRIPSLVGIGRYTLYAELPRSGGLYRTANVTYRGITIGKVTGVEPTERGARATMSIDNGYQIPTDASANVHSVSAVGEQFVDLVSTRTSGPYLRHGQTITTTTVPSQIGPALDAANRGLAVLPKDRVASVLHEASEAVGGLGSSLNRLIEATQAIAHDVRGSLEDIDDIIERSAPIIDSQVNSGNEIARWAANLNTLAAQTAQTDPAVRSILANAAPTADQVNATFSDVRESLPQTLANLEVVIDMLKRYHNGVEQALVFLPQSGAIAQSVTTEFPGQAGLGVGGLALNQPPPCLTGFLPASEWRSPADTSTAPLPKGTYCRIPMDASNVVRGARNNPCVDVPGKRAATPRECRSNEAYVPGGTNPWYGDPNQMLSCPAPAARCDQPVKPGQVIPAPSVNNGINPLPADQLPGTPPPVNDPLQRPGSGTVQCNGQQPNPCVYTPSTFPTTIYDVQSGKVVAPDGVVYSVEASTHAGADGWKVMLAPTG,"54,194",516,,growth of symbiont in host organelle [GO:0044121],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
I6WYY7,I6WYY7_MYCTU,Rv0636,hadB Rv0636,,IPR029069; IPR002539; ,,hadB,,(3R)-hydroxyacyl-ACP dehydratase subunit HadB,,9634230; 21969609; 26081470,X-ray crystallography (4),,MALREFSSVKVGDQLPEKTYPLTRQDLVNYAGVSGDLNPIHWDDEIAKVVGLDTAIAHGMLTMGIGGGYVTSWVGDPGAVTEYNVRFTAVVPVPNDGKGAELVFNGRVKSVDPESKSVTIALTATTGGKKIFGRAIASAKLA,"14,934",142,,,,,,,1
O53749,O53749_MYCTU,Rv0464c,Rv0464c,GO:0005618; GO:0005886; GO:0051920,IPR029032; IPR003779; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; peroxiredoxin activity [GO:0051920],9634230; 21969609,,,MTGQNGQVARISPGKFRQLGPVNWLVAKLAARAVGAPQMHLFTTLGYRQYLFWTFAIYTGRLLHGRLPGVDTELVILRVAHLRSCEYELQHHRRMARRRGLDANTQATIFAWPDVPDGDGPRKVLSARQQALLQATDELIKDRTITAGTWERLATHLDPRLLIEFCLLATQYDAIAATITALAIPPDNPQ,"21,305",190,,,peroxiredoxin activity [GO:0051920],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53807,O53807_MYCTU,Rv0744c,Rv0744c,GO:0003677; GO:0040007,IPR009061; IPR010093; ,,,,Possible transcriptional regulatory protein,DNA binding [GO:0003677]; growth [GO:0040007],9634230; 21969609,,,METLLKTSEAAQILGVSRQHVVNMCDRGEMVCVHVGSHRRVPSSEVERVTSRRLTREEERSLWLHRALLSPLLTEPDTVVSAARENLRRWSGMHRRDGMAGWYFTKWQRVLNDGLDAVMHVLTSPSEDAREMRQNSPFAGILPEATRVAVLRSFKDHWDREHERAMTE,"19,428",168,,growth [GO:0040007],DNA binding [GO:0003677],,,,3
P96261,P96261_MYCTU,Rv0415,thiO Rv0415,GO:0005737; GO:0016491; GO:0040007; GO:0050660,IPR006076; IPR036188; IPR012727; ,,thiO,,Possible thiamine biosynthesis oxidoreductase ThiO,cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; growth [GO:0040007],9634230; 21969609,,,MASDLHTGSLAVIGGGVIGLSVARRAAQAGWPVRVHRSDERGASWVAGGMLAPHSEGWPGEERLLRLGLQSLRLWREGSFLDGLGPQLVTAHESLVVAVDRADVADLRTVADWLSAQGHPVIWESAARDVEPLLAQGIRHGFRAPTELAVDNRALLDALCRDCERLGVRWSSQVSSLSDVDAHTVVIANGIDAPALWPGLPIRPVKGEVLRLRWRPGCMPLPQRVIRARVRGRQVYLVPRSDGVVVGATQYEHGRDTAPVVSGVRDLLDDACTVLPALGEYELAECEAGLRPMTPDNLPLVQRLDSRTLVAAGHGRSGFLLAPWTAEQIVSELVSVGAAS,"36,535",340,,growth [GO:0040007],flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],cytoplasm [GO:0005737],,,1
O06393,O06393_MYCTU,Rv0529,ccsA Rv0529,GO:0005886; GO:0015886; GO:0016021; GO:0017004; GO:0020037; GO:0040007; GO:0055114,IPR002541; IPR017562; ,,ccsA,,Possible cytochrome C-type biogenesis protein CcsA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; cytochrome complex assembly [GO:0017004]; growth [GO:0040007]; heme transport [GO:0015886]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MNTLHVNVGLARYSDWAFTSAVVALVVALLLLAFEFAQVRGRGLAPLAVPAGSVATDSATPGIVADQRHRPFDERVGRGGLAVAYLGIGLLLACVVLRGLATQRVPWGNMYEFINLTCLSGLIAGAVVLRRARYRPLWVFLLVPVLILLTVSGRWLYANAAPVMPALQSYWLPIHVSVVSLGSGVFLVAGVASILFLVRTSRLGEPTGEGALAGMVRRLPDAQTLDGIAYRTTIFAFPVFGFGVIFGAIWAEEAWGRYWGWDPKETVSFVAWVVYAAYLHARSTAGWRDRKAAWINVAGFVAMVFNLFFVNLVTVGLHSYAGVG,"35,053",324,,cytochrome complex assembly [GO:0017004]; growth [GO:0040007]; heme transport [GO:0015886]; oxidation-reduction process [GO:0055114],heme binding [GO:0020037],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
P96280,P96280_MYCTU,Rv0434,Rv0434,GO:0004176; GO:0006515,IPR003111; IPR015947; ,,,,Uncharacterized protein,ATP-dependent peptidase activity [GO:0004176]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],9634230; 21969609,,,MADFAPVELAMFPLESAPLPDEDLPLHIFEPRYAALVRDCMDTADPRFGVVLISRGREVGGGDTRCDVGTLARITECADAGSGRYMLRCRVGERIRVCDWLPDDPYPRAKVRFWPDQPGHPVTAAQLLEVEDRVVALFERIAAARGVRLPAREVVLGYPVVDPADTGQRLYALACRVPMGPADRYAVLATPSAADRLVRLGDALDSVAAMVEFELST,"23,750",217,,protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],ATP-dependent peptidase activity [GO:0004176],,,,3
O53751,O53751_MYCTU,Rv0466,Rv0466,GO:0006633; GO:0016790,IPR002864; IPR029069; ,,,,Conserved protein,thiolester hydrolase activity [GO:0016790]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MSLDKKLMPVPDGHPDVFDREWPLRVGDIDRAGRLRLDAACRHIQDIGQDQLREMGFEETHPLWIVRRTMVDLIRPIEFGDMLRCRRWCSGTSNRWCEMRVRVDGRKGGLIESEAFWIHVNRETEMPARIADDFLAGLHRTTSVDRLRWKGYLKPGSRDDASEIHEFPVRVTDIDLFDHMNNAVYWSVIEDYLASHAELLRGPLRVTIEHEAPVALGDKLEIISHVHPAGSTEIFGPGLVDRAVTTLTYVVGDEPKAVASLFNL,"30,185",264,,fatty acid biosynthetic process [GO:0006633],thiolester hydrolase activity [GO:0016790],,,,1
L7N651,L7N651_MYCTU,Rv0470A,Rv0470A,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MGAGGWEVVLASLPYGLLCTTVLMGKHIDKIGYDEPLGIRTLPVLLGETCARTVTLAMMVGFYLLIAVNVMLAAMPWPRCWSPGRCPGWRKCGPISCDGGPSSRHRRFRCGRCGMPRWPGCTCVRPVRCWLWAWRSVPGGAPGDFR,"16,066",146,,,,integral component of membrane [GO:0016021],,,1
O07178,O07178_MYCTU,Rv0457c,Rv0457c,GO:0004252; GO:0005886; GO:0070008,IPR029058; IPR023302; IPR001375; IPR002470; ,,,,Probable peptidase,plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],9634230; 21969609,,,MTFEPAPDGADPYLWLEDVTGAEALDWVRARNKPTTAAFCDAEFERMRVEALEVLDTDARIPYVNRRGNYLYNFWRDAANPRGLWRRTTLDSYRTDSPGWDVLIDVDELGRADDQKWVWGGAGVIEPDYTRALIGLSPGGSDASIVREFDMLTREFVEDGFQLPPAKSQITWEDPDTVLLGTDFGGDSLTTSGYPRVIKRWRRGKPLADAETIFEGAGTDVRVNASADRTPGFERTLLGRALDFWNEEVYELRGSELIRIEAPTDASVSIHRDWLLIELRTDWTVATTRYTAGSLLAAEYDEFLAGSAELQVVFEPDEHTALYQYAWTRDRLLIVTLADVASRVEIATPGSWRREPLSGIPAATNTVIVSADSHGDEFFLDSSGFDTPSRLMRGTDDGRLAEIKSAPAFFDAENMAVTQYFATSDDGTSIPYFVVRRTDADNPGPTLLNGYGGFETSRTPTYDGVLGRLWLARGGTYALANIRGGGEYGPGWHTQAMREGRDKVAQDFAAVATDLVTRGITTAEQLGARGGSNGGLLMGIMLTGYPEKFGALVCDVPLLDMKRYHLLLAGASWMAEYGDPDNPDDWKFISEYSPYQNISANRKYPPVLMTTSTRDDRVHPGHARKMTAALQAAGHPVWYYENIEGGHAGAADNAQIAFKSALSFAFLWRMLAG,"74,464",673,,,serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],plasma membrane [GO:0005886],,,2
P96271,P96271_MYCTU,Rv0425c,ctpH Rv0425c,GO:0000166; GO:0005388; GO:0005829; GO:0005886; GO:0005887; GO:0040007; GO:0043231,IPR006068; IPR023299; IPR023298; IPR008250; IPR036412; IPR023214; IPR001757; ,,ctpH,DOMAIN 1313 1461 Cation_ATPase_C. {ECO:0000259|Pfam:PF00689}.,Possible metal cation transporting P-type ATPase CtpH,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; calcium-transporting ATPase activity [GO:0005388]; nucleotide binding [GO:0000166]; growth [GO:0040007],9634230; 21969609,,,MPVRAVATGFRATATLTGASITAATAVSATLAKTGVGTGMKVAIIPLRAGAKALSGELSRETLGRNCWRGERRAWIEVRGLRSGGDDELGRVVLNAIQAHPGVGSASLNYPLSRVVVAIDDPDTSLRELCRIVDDAEKAERHRHPDQAADQLAQSPGSLPGDGVLLAVRAVTVAATAAGLGLALGGRALRWPRFPLVIEAAVAAVDHQPLLRRLLEDRIGTEATATVLELAMAAAHTVTLSPAALSVDLTIQALKAAECRAGARAWRRHEPQLALHADEPADQPQSLWPRPARSTQPVQRSVARFALIQALSAVLVGAGTRDADMAATATLVATPKASRTTPEAFAAALGQGLADQHAVLPLRPESLRRLDRVDAIVIDPRVLCTDDLRVARIRGCGADELSTAWNRAQLVLTESGLRPGWHRVPGVSASGSDSAVEALFRPMHDRLASAVVAEAHRTGADLVSVDVDALGELRPVFDDIRPLDDGASGSLDEALARAVAELRQAGRTVAVLSSVGKQALSAADVALGVLPPPGAGAPPWYADVLLPDLGAAWRVLHAIPAARAARQRGNEISGGASALGALLMLPGVRGLGPGPVTTGAAAGLLSGYLLARKVVDAQAPRPAPAHEWHAMSVEQVRKALPSPDEQAPAKAPPSPYPARALAGGLHTAKRGAQITQAPLNALWQLTKAMRAELSDPLTPMLALGAMASAVLGSPVDAVMVGSVLTGNSILAASQRLRAESRLNRLLAQQIPPARKVLAGADDQPRYIEVRAEELRPGDIIEVRTHEVVPADARVIEEVDVEVDESALTGESLSVTKQVEPTPGVDLIERRCMLYAGTTVVSGTAVAVVTAVGPDTQERRAAELVSGDLSSVGLQHQLSRLTNQAWPVSMTGGALVTGLGLLRRRGLRQAVASGIAVTVAAVPEGMPLVATLAQQASARRLSHFGALVRIPRSVEALGRVDMVCFDKTGTLSENRLRVAQVRPVAGHSREEVLRCAAHAAPASNGPQVHATDVAIVQAAAAAAASGTDGAEPGAAEPAAHLPFRSGRSFSASVSGTELTVKGAPEVVLAACEGIGSSMDDAVAELAANGLRVIAVAHRQLTAQQAQSVVDDPDEIARLCRDELSLVGFLGLSDTPRAQAAALLADLHEHDLDIRLITGDHPITAAAIAEELGMQVSPEQVISGAEWDALSRKDQERAVAERVIFARMTPENKVQIVQTLEHSGRVCAMVGDGSNDAAAIRAATVGIGVVAHGSDPARVAADLVLVDGRIESLLPAILEGRQLWQRVQAAVSVLLGGNAGEVAFAIIGSAITGTSPLNTRQLLLVNMLTDALPAAALAVSKPSDPVTPATRGPDQRELWRAVGIRGATTAAAATVAWVMAGFTGLPRRASTVALVALVAAQLGQTLVDSHAWLVVLTALGSLAALATLISIPVVSQLLGCTPLDPLGWAQATAAATAATVAVAVLNRVLTGRDKSGQPNPQPPETDALSRDASPGAPPGPRRRRRATARRKAPVKAPSATRQTTKPKGPPAHRSSSTYPRR,"159,773",1539,,growth [GO:0040007],calcium-transporting ATPase activity [GO:0005388]; nucleotide binding [GO:0000166],cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],,,1
P95202,P95202_MYCTU,Rv0394c,Rv0394c,GO:0016021,,,,,Possible secreted protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTEPRPVFAVVISAGLSAIPMVGGPLQTVFDAIEERTRHRAETTTREICESVGGADTVLSRIDKNPELEPLLSQAIEAATRTSMEAKRRLLAQAAAAALEDDQKVEPASLIVATLSQLEPVHIHALVRLAKAAKSSPDQDEIQRREVMRAASKVEPVPVLAALIQTGVAIATTTVWHGNGTGTPAEESGHILIHDVSDFGHRLLAYLRAADAGAELLILPSGGSAPTGDHPTPHPSTSR,"25,279",239,,,,integral component of membrane [GO:0016021],,,1
I6Y4A5,I6Y4A5_MYCTU,Rv0634c,Rv0634c,GO:0016787,IPR001279; IPR036866; ,,,,Possible glyoxalase II (Hydroxyacylglutathione hydrolase) (GLX II),hydrolase activity [GO:0016787],9634230; 21969609,,,MSKDRLYFRQLLSGRDFAVGDMFATQMRNFAYLIGDRTTGDCVVVDPAYAAGDLLDALESDDMQLSGVLVTHHHPDHVGGSMMGFQLPGLAELLERASVPVHVNTHEALWVSRVTGIPVGDLITHEHGDKVSVGDIDIELLHTPGHTPGSQCFLLDGRLVAGDTLFLEGCGRTDFPGGDSDEMYRSLRQLAELPGDPTVFPGHWYSAEPSASLSEVKRSNYVYRPASLDQWRMLMGG,"25,928",237,,,hydrolase activity [GO:0016787],,,,1
I6Y4F1,I6Y4F1_MYCTU,Rv0680c,Rv0680c,GO:0016021,IPR021417; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MKWNTVAASLAAGVITIAVALAAPPPAAHAKNGDTHVTGQGIERTLDCNESTLLVNGTQNIVTALGTCWAVTVMGSSNTVVADTIINDITVYGWDETVFFRNGDPFIWDRGRELGMVNRLQRVG,"13,199",124,,,,integral component of membrane [GO:0016021],,,1
Q79FW8,Q79FW8_MYCTU,Rv0746,PE_PGRS9 Rv0746,,IPR000084; ,,PE_PGRS9,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS9,,9634230,,,MSFVLAMPEVLGSAATDLAALGSVLGAADAAAAATTTGIVAAAQDEVSAAIAALFSAHGRAYQVASAQAAAVHAQFVEALSAGAGAYASAEAAGAAVLANPAQSVQQDLLAAVNAQSVALTGRPLIGNGANGAPGTGANGAPGGWLLGNGGAGGSAAAGSGLPGGAGGAAGLFGTGGAGGAGGSSTVGDGEAGGAGGSGGWLLGTGGVGGVGGLGAGAGGAGGVGGAGGLLGAGGHGGAGGLGAVTGGVGGTGGAGGLLAGLLAGPGGAGGTGGRGFLNNGGVGGAGGNAGLLFGAGGTGGSGGAGLGGDGGAGGAGGNTGVLFGNAGSGGTGGFGDTDGGAGGAGGDAGWLGSGGVGGAGGFGETGDGGVGGAGGKAGLLIGNGGAGGAGGQGAVTGGTGGAGGDGVLIGNGGNAGIGGTGPTAGDTGAGGISGLLLGADGFNTPASASPLHTLKQQALAAINAPTQTLTGRPLIGNGTPGAVGSGATGAPGGWLLGDGGAGGSGAAGSGAPGGAGGAAGLWGTGGAGGAGGSSAGGGGAGGAGGAGGWLLGDGGAGGIGGASTVLGGTGGGGGVGGLWGAGGAGGAGGTGLVGGDGGAGGAGGTGGLLAGLIGAGGGHGGTGGLSTNGDGGVGGAGGNAGMLAGPGGAGGAGGDGENLDTGGDGGAGGSAGLLFGSGGAGGAGGFGFLGGDGGAGGNAGLLLSSGGAGGFGGFGTAGGVGGAGGNAGWLGFGGAGGVGGSAGLIGTGGNGGNGGTGANAGSPGTGGAGGLLLGQNGLNGLP,"64,158",783,,,,,,,1
I6Y8B5,I6Y8B5_MYCTU,Rv0632c,echA3 Rv0632c,GO:0004165; GO:0008152,IPR029045; IPR001753; ,,echA3,,Probable enoyl-CoA hydratase EchA3 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),dodecenoyl-CoA delta-isomerase activity [GO:0004165]; metabolic process [GO:0008152],9634230; 21969609,,,MSDPVSYTRKDSIAVISMDDGKVNALGPAMQQALNAAIDNADRDDVGALVITGNGRVFSGGFDLKILTSGEVQPAIDMLRGGFELAYRLLSYPKPVVMACTGHAIAMGAFLLSCGDHRVAAHAYNIQANEVAIGMTIPYAALEIMKLRLTRSAYQQATGLAKTFFGETALAAGFIDEIALPEVVVSRAEEAAREFAGLNQHAHAATKLRSRADALTAIRAGIDGIAAEFGL,"24,355",231,,metabolic process [GO:0008152],dodecenoyl-CoA delta-isomerase activity [GO:0004165],,,,1
L7N6B9,L7N6B9_MYCTU,Rv0522,gabP Rv0522,GO:0006865; GO:0016021; GO:0022857,IPR004841; IPR002293; IPR004840; ,,gabP,,Probable GABA permease GabP (4-amino butyrate transport carrier) (GAMA-aminobutyrate permease),integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865],9634230,,,MIAIGGVIGAGLFVGSGVVIRATGPAAFLTYALCGALIVLVMRMLGEMAAANPSTGAFADYAAKALGGWAGFSVGWLYWYFWVIVVGFEAVAGGKVLTYWIDAPLWLASLCLMMMMTATNLVSVSSFGEFEFWFAGVKVATIVGFLVLGTAFAFGLLPGHGMDFSNLSAHGGFFPDGVGAVFAAIVVAIFSMTGTEVVTIAAAEAPDPQRAVQRAMSTVVARIVIFFVGSVFLLTVILPWNSLELGASPYVAALRHMGIGGADQIMNAVVLTAVLSCLNSGLYTASRMLFVLAARQEAPAQLVKVNRRGVPTFAIMGSSVVGFLCVIMAWVSPATVFVFLLNSSGAVILFVYLLIALSQIVLRRQTSGQNLGVRMWLFPGLSIVTVTGIVAVLARMAFDYAARSQLWLSLLSWAVVVGCYLVTTLVRRPLNRPW,"46,031",434,,amino acid transport [GO:0006865],transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021],,,1
I6WZ39,I6WZ39_MYCTU,Rv0689c,Rv0689c,,,,,,Uncharacterized protein,,9634230,,,MLGWTVKPGRVADGWQAPGVHLMARCSGPQPASERRADMDGGDIDAAVARVRAAGALAEPSRQPDDMSAECADDQGARCHLGQL,"8,784",84,,,,,,,1
O53816,O53816_MYCTU,Rv0753c,mmsA Rv0753c,GO:0004491; GO:0005886,IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; ,,mmsA,,Probable methylmalonate-semialdehyde dehydrogenase MmsA (Methylmalonic acid semialdehyde dehydrogenase) (MMSDH),plasma membrane [GO:0005886]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491],9634230; 21969609,,,MTTQISHFIDGQRTAGQSTRSADVFDPNTGQIQAKVPMAGKSDIDAAVASAVEAQKGWAAWNPQRRARVLMRFIELVNDTIDELAELLSREHGKTLADARGDVQRGIEVIEFCLGIPHLLKGEYTEGAGPGIDVYSLRQPLGVVAGITPFNFPAMIPLWKAGPALACGNAFVLKPSERDPSVPVRLAELFIEAGLPAGVFQVVHGDKEAVDAILHHPDIKAVGFVGSSDIAQYIYAGAAATGKRAQCFGGAKNHMIVMPDADLDQAVDALIGAGYGSAGERCMAISVAVPVGDQTAERLRARLIERINNLRVGHSLDPKADYGPLVTGAALARVRDYIGQGVAAGAELVVDGRDRASDDLTFGLPEGDANLEGGFFIGPTLFDHVAAHMSIYTDEIFGPVLCMVRARDYEEALRLPSEHEYGNGVAIFTRDGDAARDFVSRVQVGMVGVNVPIPVPVAYHTFGGWKRSGFGDLNQHGPAAIQFYTKVKTVTSRWPSGIKDGAEFVIPTMS,"54,454",510,,,methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491],plasma membrane [GO:0005886],,,1
Q79FW3,Q79FW3_MYCTU,Rv0755A,Rv0755A,GO:0043565,IPR010921; ,,,,Putative transposase,sequence-specific DNA binding [GO:0043565],9634230,,,MKELSVAEQRYQAVLAVISDGLSISQVAEKVGVSRQTLHTWLARYEAEGLDGLRIGTGTAL,"6,588",61,,,sequence-specific DNA binding [GO:0043565],,,,1
I6Y8F2,I6Y8F2_MYCTU,Rv0673,echA4 Rv0673,GO:0003824; GO:0008152,IPR029045; IPR001753; ,,echA4,,Possible enoyl-CoA hydratase EchA4 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MTHAIRPVDFDNLKTMTYEVTGRIARITFNRPEKGNAIIADTPLELSALVERADLDPGVHVILVSGRGEGFCAGFDLSAYAEGSSSTGGGGAYQGTVLDGKTQAVNHLPNQPWDPMIDYQMMSRFVRGFASLMHADKPTVVKIHGYCVAGGTDIALHADQVIAAADAKIGYPPTRVWGVPAAGLWAHRLGDQRAKRLLFTGDCITGAQAAEWGLAVEAPEPADLDERTERLVARIAALPVNQLIMVKLALNSALLQQGVATSRMVSTVFDGAARHTPEGHAFVADAVEHGFRDAVRRRDEPFGDYGRQASRV,"33,541",312,,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
I6X9R9,I6X9R9_MYCTU,Rv0768,aldA Rv0768,GO:0016620,IPR016161; IPR016163; IPR029510; IPR016162; IPR026460; IPR015590; ,,aldA,,Probable aldehyde dehydrogenase NAD dependent AldA (Aldehyde dehydrogenase [NAD+]),"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",9634230; 21969609,,,MALWGDGISALLIDGKLSDGRAGTFPTVNPATEEVLGVAADADAEDMGRAIEAARRAFDSTDWSRNTELRVRCVRQLRDAMQQHVEELRELTISEVGAPRMLTASAQLEGPVGDLSFAADTAESYPWKQDLGEASPLGIATRRTLAREAVGVVGAITPWNFPHQINLAKLGPALAAGNTVVLKPAPDTPWCAAALGEIIVEHTDFPPGVVNIVTSSSHALGALLAKDPRVDMISFTGSTATGRAVMADAAATIKKVFLELGGKSAFVVLDDADLAAASAVSAFSACMHAGQGCAITTRLVVPRARYEEAVAIAAATMSSIRPGDPNDPGTVCGPLISARQRDRVQGYLDLAVAEGGRFACGGARPADREVGFYIEPTVIAGLTNDARVAREEIFGPVLTVIAHDGDDDAVRIANDSPYGLSGTVYGADPQRAARIASRLRVGTVNVNGGVWYCADAPFGGYKQSGIGREMGLLGFEEYLEAKLIATAAN,"51,184",489,Aldehyde dehydrogenase family,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,1
O06389,O06389_MYCTU,Rv0523c,Rv0523c,GO:0005829; GO:0005886; GO:0016491; GO:0048037,IPR004378; IPR012349; ,,,,Conserved protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MQLPQWLARFNRYVTNPIQRLWAGWLPAFAILEHVGRRSGKPYRTPLNVFSADVDGRAGVAILLTYGPNRDWLKNITAAGGGRMRRYGKTFGVANPRRLTKAEAAPYVSSRWRPVFARLPFDEAVLLTKAD,"14,827",131,,,cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
P71815,P71815_MYCTU,Rv0758,phoR Rv0758,GO:0000155; GO:0005524; GO:0005622; GO:0016021,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,phoR,,Possible two component system response sensor kinase membrane associated PhoR,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155],9634230; 21969609; 28782049,X-ray crystallography (2),,MARHLRGRLPLRVRLVAATLILVATGLVASGIAVTSMLQHRLTSRIDRVLLEEAQIWAQITLPLAPDPYPGHNPDRPPSRFYVRVISPDGQSYTALNDNTAIPAVPANNDVGRHPTTLPSIGGSKTLWRAVSVRASDGYLTTVAIDLADVRSTVRSLVLLQVGIGSAVLVVPGVAGYAVVRRSLRPLAEFEQTAAAIGAGQLDRRVPQWHPRTEVGRLSLALNGMLAQIQRAVASAESSAEKARDSEDRMRQFITDASHELRTPLTTIRGFAELYRQGAARDVGMLLSRIESEASRMGLLVDDLLLLARLDAHRPLELCRVDLLALASDAAHDARAMDPKRRITLEVLDGPGTPEVLGDESRLRQVLRNLVANAIQHTPESADVTVRVGTEGDDAILEVADDGPGMSQEDALRVFERFYRADSSRARASGGTGLGLSIVDSLVAAHGGAVTVTTALGEGCCFRVSLPRVSDVDQLSLTPVVPGPP,"52,016",485,,,ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155],integral component of membrane [GO:0016021]; intracellular [GO:0005622],,,1
O53762,O53762_MYCTU,Rv0565c,Rv0565c,GO:0004499; GO:0005886; GO:0050660; GO:0050661,IPR036188; IPR020946; ,,,,Probable monooxygenase,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",9634230; 21969609,,,MSVTPNAGCVDVVIVGAGISGLGAAYRIIERNPQLTYTILERRARIGGTWDLFRYPGVRSDSSIFTLSFPYEPWTREEGIADGAHIREYLTDMAHKYGIDRHIEFNSYVRAADWDSSTDTWTVTFEQNGVHKHYRSRFVFFGSGYYNYDEGYTPDFGGIEKFGGAVVHPQHWPEDLDYTGKKIVVIGSGATAVTLIPSLTDRAEKVTMLQRSPTYLISASKYSTFAAVVRKALPPKTSHLIVRMYNALLEAVFWFLSRKTPVFVKWLLRRTAIKNLPEGYDIETHFTPRYNPWDQRLCLIPDADLYNAITSGRAEVVTDHIDHFDATGIALKSGGHLDADIIVTATGLQLQALGGAAISLDGVEIDPRDRFVYKAHMLEDVPNLFWCVGYTNASWTLRADMTARATAKLLAHMAAHGHTRAAPHLGDEPMDEKPSWDIQAGYVKRAPYALPKSGTKRPWNVRQNYLADAIDYRFDRIEEAMVFGAA,"54,526",486,,,"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",plasma membrane [GO:0005886],,,1
Q79FY3,Q79FY3_MYCTU,Rv0619,galTb Rv0619,GO:0008108; GO:0008270; GO:0033499,IPR001937; IPR005850; IPR036265; ,,galTb,DOMAIN 33 143 GalP_UDP_tr_C. {ECO:0000259|Pfam:PF02744}.,Probable galactose-1-phosphate uridylyltransferase GalTb [second part] (Fragment),UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499],9634230,,,GDRGDPAHPHGQIYAYPYLTPRTAAMLRQARRHRKRHGDNLFASLLAREVADGSRIVVRGELFTAFVPFAARWPVEVHIYPNRLVRNLTELNDGELDEFARIYLDVLQRFDRMYSSPLPYMSALHQFSEVQRDGYFHVELMSIRRSATKLKYLAAAESAMDAFIADVIPESVATRLRELGP,"20,745",181,,galactose catabolic process via UDP-galactose [GO:0033499],UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270],,,,1
I6Y3V3,I6Y3V3_MYCTU,Rv0473,Rv0473,GO:0016021,IPR007383; ,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVAHRAEVSGSPPPRLNLSTQPTVARRVRASFAESFAAADPEADAARRMALRRMKVVAVGFLVGATGVFLACRWAQADGADHAWLGYLGAAAEAGMVGALADWFAVTALFKHPLGIPIPHTAIIKRKKDQLGEGLGTFVRENFLSPPVVETKLRDAQIPSRLGKWLSEATHAQRVAAETATVLRVLVELLRDEDIQQVIDRMIVRRIAEPQWGPPAGRVLATLLAENRQEAFIQLLADRAFQWSLNAGVVIQRVVERDSPSWSPRFIDHLVGDRIHRELMEFTDKVRRNPDHELRRSATRFLFDFADDLQHDPATVARADAIKEELMARDEIATAAAAAWKTLKRLVLEGVDDPSSALRTRITDAVIRIGESLRDDADLRDKVDSWTVRAAQHLVSEYGVEITAIITETIERWDAEEASRRIELHVGRDLQFIRINGTVVGAMAGLAIYAIAQLLF,"50,589",456,,,,integral component of membrane [GO:0016021],,,1
O06781,O06781_MYCTU,Rv0658c,Rv0658c,GO:0016021,IPR003675; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MEAGRADTVAPSHRWGLGAFLVVELVFLVASTSLAVVLTGHGPVSAGVLALALAAPTVVAAGLAILITRLRGNGLRTDLRLRWSWRGLRLGLMFGFGGMLVTIPASLVYTAIVGPEANSAVVRIFGGVRASWPWALVVFLVVVFVAPLCEEIIYRGLLWGAVDRRWGRWAALVVTTVVFALAHLEFARAPLLVVVAIPIALARFYSGGLLASIVTHQVTNLLPGIVLLLGLTGAISLP,"25,127",238,,,,integral component of membrane [GO:0016021],,,1
I6Y4S7,I6Y4S7_MYCTU,Rv0771,Rv0771,GO:0051920,IPR029032; IPR003779; ,,,DOMAIN 27 100 CMD. {ECO:0000259|Pfam:PF02627}.,Possible 4-carboxymuconolactone decarboxylase (CMD),peroxiredoxin activity [GO:0051920],9634230; 21969609,,,MMDELRRTGLDKMNEVYAWDMPDMPGEFFALTVDHLFGRIWTRPGLSMRDRRMAVIAVLTAQGQSDLLEVQVNAVLHNDELTIDELRELAVFITHYVGFPLGSRLNSAIERVAAKRKQAAENGSLPDTKANVAEVLAKESGKSS,"16,073",144,,,peroxiredoxin activity [GO:0051920],,,,1
L7N6C0,L7N6C0_MYCTU,Rv0521,Rv0521,GO:0008168,IPR023143; IPR029063; ,,,,Possible methyltransferase/methylase,methyltransferase activity [GO:0008168],9634230,,,MREAAQALGFEVLDQRDLVRNLRTHYSRVFEELEARRLELEGKSSQEYLDKMRVGLKNWVEAADNGHSRVGHPTFPRTRLTPICQLPTAAIDSTAGRRRYR,"11,710",101,,,methyltransferase activity [GO:0008168],,,,1
P96266,P96266_MYCTU,Rv0420c,Rv0420c,GO:0016021,,,,,Possible transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MRLHDASAAAPESRMHIARHGEAVNRRQMFIGITGLLLAVIGLMALWFPVYLDQYDAYGIKVTCGSGWRSNLTQALYADGNDNTQALVTRCDTALLVRRAWAIPSVALGWLLVTGFLVMWVHNDQHQGQSYPGYRA,"15,131",136,,,,integral component of membrane [GO:0016021],,,1
P96267,P96267_MYCTU,Rv0421c,Rv0421c,GO:0005829,IPR029058; IPR026555; ,,,,Uncharacterized protein,cytosol [GO:0005829],9634230; 21969609,,,MNLDQIAGVAHQPAGPPHGVVVLTHGAGGSRESTLLQQVCAEWTRRGWLAVRYNLPYRRRRPTGPPSGSGSGDRAGIVEAIQLCRGLAEGPLIAGGHSYGGRQTSMVVAAGQAPVDVLTLFSYPVHPPGKPERVRTEHLPGIAVPTVFTHGTADPFGTLAQVRSAAAMVSAPTEVVEITGARHDLGSKTLDVARLAVDAALRLSAGQIA,"21,738",209,,,,cytosol [GO:0005829],,,1
O33363,O33363_MYCTU,Rv0518,Rv0518,,IPR013830; IPR036514; ,,,,Possible exported protein,,9634230; 21969609,,,MSRPGTYVIGLTLLVGLVVGNPGCPRSYRPLTLDYRLNPVAVIGDSYTTGTDEGGLGSKSWTARTWQMLAARGVRIAADVAAEGRAGYGVPGDHGNVFEDLTARAVQPDDALVVFFGSRNDQGMDPEDPEMLAEKVRDTFDLARHRAPSASLLVIAPPWPTADVPGPMLRIRDVLGAQARAAGAVFVDPIADHWFVDRPELIGADGVHPNDAGHEYLADKIAPLISMELVG,"24,636",231,,,,,,,1
I6X9J0,I6X9J0_MYCTU,Rv0672,fadE8 Rv0672,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR009100; ,,fadE8,,Probable acyl-CoA dehydrogenase FadE8,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MSDTHVVTNQVPPLENYNPASSPVLIEALIQEGGQWGLDEVNEVGAISASCQAQRWGELADRNRPILHTHDAYGYRVDEVEYDPAYHELMRTAITHGMHAAPWADDRPGAHVVRAAKTSVWTVEPGHICPISMTYAVVPALRYNSELAAVYEPLLTSREYDPELKPATTKAGITAGMSMTEKQGGSDVRAGTTQATPNADGSYSLTGHKWFTSAPMCDIFLVLAQAPDGLSCFLLPRVLPDGTRNRMFLQRLKDKLGNHANASSEVEYDGAVAWLVGEEGRGVPTIIEMVNLTRLDCALGSATSMRTGLTRAVHHAQHRKAFGAYLIDQPLMRNVLADLAVEAEAATIVAMRMAGATDNAVRGNETEALLRRIGLAAAKYWVCKRSTAHAAEALECLGGNGYVEDSGMPRLYREAPLMGIWEGSGNVSALDTLRAMATRPACVEVLFDELARSAGQDPRLDGHVERLRPQLGDLDTIGYRARKIAEDICLALQGSLLVRHGHPAVAEAFLATRLGGQWGGAYGTMPAGLDLAPILERALVKG,"58,534",542,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
O53726,O53726_MYCTU,Rv0439c,Rv0439c,GO:0005886; GO:0016491,IPR036291; IPR002347; ,,,,Probable dehydrogenase/reductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTANDNKTRKWSAADVPDQSGRVVVVTGANTGIGYHTAAVFADRGAHVVLAVRNLEKGNAARARIMAARPGAHVTLQQLDLCSLDSVRAAADALRTAYPRIDVLINNAGVMWTPKQVTKDGFELQFGTNHLGHFALTGLVLDHMLPVPGSRVVTVSSQGHRIHAAIHFDDLQWERRYNRVAAYGQAKLANLLFTYELQRRLGEAGKSTIAVAAHPGGSNTELTRNLPRLIRPVATVLGPLLFQSPEMGALPTLRAATDPTTQGGQYYGPDGFGEQRGHPKVVQSSAQSHDKDLQRRLWTVSEELTGVSFGV,"33,650",311,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,3
O06409,O06409_MYCTU,Rv0543c,Rv0543c,,IPR021784; ,,,,Conserved protein,,9634230; 21969609,,,MNRFLTSIVAWLRAGYPEGIPPTDSFAVLALLCRRLSHDEVKAVANELMRLGDFDQIDIGVVITHFTDELPSPEDVERVRARLAAQGWPLDDVRDREEHA,"11,312",100,,,,,,,1
I6WZ30,I6WZ30_MYCTU,Rv0679c,Rv0679c,,IPR021417; ,,,,Conserved threonine rich protein,,9634230; 21969609,,,MVEKPLRADRATHSRLATFALALAAAALPLAGCSSTANPPAATTTPATATTTTATSGPTAAPTVTTGESTTASIQIGDMLTYGSIGTTATLDCADGKSLNVAGSDNTLTVNGTCETVTVGGANNKIAFDRIDERLVVVGLDNTVTYKNGDPTIDNLGAGNRINKE,"16,586",165,,,,,,,1
L7N671,L7N671_MYCTU,Rv0527,ccdA Rv0527,GO:0016021; GO:0017004; GO:0055114,IPR003834; ,,ccdA,,Possible cytochrome C-type biogenesis protein CcdA,integral component of membrane [GO:0016021]; cytochrome complex assembly [GO:0017004]; oxidation-reduction process [GO:0055114],9634230,,,MTGFTEIAAVGPLLVAVGVCLLAGLVSFASPCVVPLVPGYLSYLAAVVGVDEQLPAGVVKPPVAARWRVAGSAALFVAGFTTVFVLGTVAVLGMTTTLITNQLLLQRVGGVLIVVMGLVFVGFIGALQRQARFTPRQLTSVAGAPVLGAVFALGWTPCLGPTLTGVITVASATEGASVARGIVLVIAYCLGLGIPFVLLAFGSAWAVAGLGWLRRHTRAIQIFGGALLIAVGAALVTGVWNDVVSWLRDAFVSDVRLPI,"26,489",259,,cytochrome complex assembly [GO:0017004]; oxidation-reduction process [GO:0055114],,integral component of membrane [GO:0016021],,,1
O07790,O07790_MYCTU,Rv0588,yrbE2B Rv0588,GO:0040007; GO:0043190,IPR030802; ,,yrbE2B,,Conserved hypothetical integral membrane protein YrbE2B,ATP-binding cassette (ABC) transporter complex [GO:0043190]; growth [GO:0040007],9634230,,,MVESSTASAAAVLRARYPRTAASLDRYGGGTARRLERTGTFARFTRISVVQIGWALRRYRRETLRLVAEIGMGTGAMAVVGGTVAIIGFVTLSGGSLIAIQGFASLGNIGVEAFTGFFAALANTRVAAPIVSGVALAATVGAGATAQLGAMRISEEIDALEVMGIKSISFLVSTRILGGLVVIMPLYALALDMAFTSGQVVTTVFYGQSNGTYEHYFRTFLRPEDVGWSVVEVVIIAVVVMITHCYYGYTASGGPVGVGQAVGRSMRFSLVSVVVVVLLAELALYGVDPNFNLTV,"30,968",295,,growth [GO:0040007],,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
I6WZ71,I6WZ71_MYCTU,Rv0728c,serA2 Rv0728c,GO:0016616; GO:0051287,IPR006139; IPR006140; IPR036291; ,,serA2,,Possible D-3-phosphoglycerate dehydrogenase SerA2 (Phosphoglycerate dehydrogenase) (PGDH),"NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",9634230; 21969609,,,MTPRPRALVTAPLRGPGFAQLRRLADVVYDPWIDQRPLRIYSAEQLADRITAVAADVLVVESDSVGGPVFERGLRVVAATRGDPSNVDIPGATAAGIPVLHTPARNADAVAEMTVALLLAVARHLIPADADVRSGNIFRDGTIPYQRFRGAEIAGLTAGLVGLGAVGRAVRWRLSGLGLRVIAHDPYRDDAGHSLDELLAEADIVSMHAAVTDDTIGMIGAQQFAAMRDGAVFLNTARSQLRDTDALVDALRGGKLAAAGLDHFTGEWLPTDHPLVSMPNVVLTPHIGGATWNTEARQARMVADDLGALLSGNRPAHVVNPEVLGS,"34,439",326,D-isomer specific 2-hydroxyacid dehydrogenase family,,"NAD binding [GO:0051287]; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0016616]",,,,1
O07179,O07179_MYCTU,Rv0456c,echA2 Rv0456c,GO:0003677; GO:0003824; GO:0008152; GO:0045734,IPR029045; IPR018376; IPR001753; ,,echA2,,Enoyl-CoA hydratase EchA2 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; DNA binding [GO:0003677]; metabolic process [GO:0008152]; regulation of acetate catabolic process [GO:0045734],9634230; 21969609,,,MPTPDFQTLLYTTAGPVATITLNRPEQLNTIVPPMPDEIEAAIGLAERDQDIKVIVLRGAGRAFSGGYDFGGGFQHWGDAMMTDGRWDPGKDFAMVTARETGPTQKFMAIWRASKPVIAQVHGWCVGGASDYALCADIVIASEDAVIGTPYSRMWGAYLTGMWLYRLSLAKVKWHSLTGRPLTGVQAAEAELINEAVPFERLEARVAEIATELARIPLSQLQAQKLIVNQAYENMGLASTQLLGGILDGLMRNTPDALEFIRTAQTQGVRAAVERRDGPFGDYSQAPPELRPDPTHVITPDGSM,"33,086",304,Enoyl-CoA hydratase/isomerase family,metabolic process [GO:0008152]; regulation of acetate catabolic process [GO:0045734],catalytic activity [GO:0003824]; DNA binding [GO:0003677],,,,2
I6WZ26,I6WZ26_MYCTU,Rv0674,Rv0674,GO:0045892,IPR012906; IPR013225; IPR036388; ,,,,Uncharacterized protein,"negative regulation of transcription, DNA-templated [GO:0045892]",9634230,,,MPAMTARSVVLSVLLGAHPAWATASELIQLTADFGIKETTLRVALTRMVGAGDLVRSADGYRLSDRLLARQRRQDEAMRPRTRAWHGNWHMLIVTSIGTDARTRAALRTCMHHKRFGELREGVWMRPDNLDLDLESDVAARVRMLTARDEAPADLAGQLWDLSGWTEAGHRLLGDMAAATDMPGRFVVAAAMVRHLLTDPMLPAELLPADWPGAGLRAAYHDFATAMAKRRDATQLLEVT,"26,541",240,,"negative regulation of transcription, DNA-templated [GO:0045892]",,,,,1
P96935,P96935_MYCTU,Rv0646c,lipG Rv0646c,GO:0004806; GO:0005886; GO:0046503,IPR029058; IPR000073; ,,lipG,DOMAIN 26 148 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Probable lipase/esterase LipG,plasma membrane [GO:0005886]; triglyceride lipase activity [GO:0004806]; glycerolipid catabolic process [GO:0046503],9634230; 21969609,,,MDIRSGTAVSGDVKLYYEDMGDLDHPPVLLIMGLGAQMLLWRTDFCARLVAKGLRVIRYDNRDVGLSTKTERHRPGQPLATRLVRSWLGLPSQAAYTLEDMAADAAALLDHLDVKHAHVVGASMGGMIAQIFAARFAQRTKTLAVIFSSNNHRFLPPPAPRALLALLTGPPPDSPRDVIVDNAVRVSKIIGSPAYPIPEDQVRAEAAESYDRNFHPWGIAQQFSAILGSGSLLRYDRRIVAPTVVIHGRADKLMRPFGGRAVARAINGARLVLIDGMGHDLPRQLWDRVIGELTRNFSEAG,"32,963",301,,glycerolipid catabolic process [GO:0046503],triglyceride lipase activity [GO:0004806],plasma membrane [GO:0005886],,,4
O53728,O53728_MYCTU,Rv0443,Rv0443,,IPR034660; IPR007061; ,,,,Conserved protein,,9634230; 21969609,,,MASTDAAAQELLRDAFTRLIEHVDELTDGLTDQLACYRPTPSANSIAWLLWHSARVQDIQVAHVAGVEEVWTRDGWVDRFGLDLPRHDTGYGHRPEDVAKVRAPADLLSGYYHAVHKLTLEYIAGMTADELSRVVDTSWNPPVTVSARLVSIVDDCAQHLGQAAYLRGIAR,"18,958",171,,,,,,,3
L0T3X8,L0T3X8_MYCTU,Rv0532,PE_PGRS6 Rv0532,,IPR000084; ,,PE_PGRS6,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS6 (PE_PGRS6),,9634230; ,,,MSNLLVTPELVAAAAADLAGIGSAIGAANAAAGAPTMALLAAGADEVSAAVAAVFSSYAQQYQALSAAAAAFHDQFVRALAAGAGAYAGAEAANVEQQLLNAINAPTLALLGRPLIGNGADGAAGTGQAGGAGGLLYGNGGNGGSGAAGQAGGAGGAAGLIGHGGTGGAVTGVSTTGGPGGHGGDAGLYGFGGAGGAGGFGQSGAAGGAGGAGGWLYGDGGDGGAGDNGGNESGTGVSAVGGVGGAGGAGGLLFGNGGDGGVGGDGGDGSSTQDSGGDGGAGGAGGAGGWLLGNGGAGGAGGAASIKVATGGLGGDGGDAGLFGFGGDGGWGGRGVDARFGAAGGAAGAGGAGGWLYGDGGAGGVGGVGGAVFSLSSGDGGAGGAGGGGGWLFGNGGDGGAGGGGGGRFGSGSGAGGDGAVGGAGGAGAWFGNGGAGGVGGGGGRGTTAIGGDGGAGGAGGAGGWLYGDGGAGGAGGGGGRGGTGNDGGDGGDGGRGGDAQLLGNGGDGGAGGAGGPAGLALPPGPARPAGAAVPAVRCSAAPARPARTADPWLAPIFARSTLRHSHHLGGIAQTGAVADQQGQIAGLGRAGRQ,"50,835",594,,,,,,,1
P9WHM5,PUR3_MYCTU,Rv0956,purN Rv0956,GO:0000287; GO:0004644; GO:0006189; GO:0046653,IPR002376; IPR036477; IPR004607; ,,purN,,Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART),magnesium ion binding [GO:0000287]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; tetrahydrofolate metabolic process [GO:0046653],9634230; 21969609; 19394344,X-ray crystallography (2),"FUNCTION: Catalyzes the transfer of a formyl group from 10-formyltetrahydrofolate to 5-phospho-ribosyl-glycinamide (GAR), producing 5-phospho-ribosyl-N-formylglycinamide (FGAR) and tetrahydrofolate. {ECO:0000255|HAMAP-Rule:MF_01930}.",MQEPLRVPPSAPARLVVLASGTGSLLRSLLDAAVGDYPARVVAVGVDRECRAAEIAAEASVPVFTVRLADHPSRDAWDVAITAATAAHEPDLVVSAGFMRILGPQFLSRFYGRTLNTHPALLPAFPGTHGVADALAYGVKVTGATVHLVDAGTDTGPILAQQPVPVLDGDDEETLHERIKVTERRLLVAAVAALATHGVTVVGRTATMGRKVTIG,"22,416",215,GART family,'de novo' IMP biosynthetic process [GO:0006189]; tetrahydrofolate metabolic process [GO:0046653],magnesium ion binding [GO:0000287]; phosphoribosylglycinamide formyltransferase activity [GO:0004644],,,,1
P9WHB5,RL25_MYCTU,Rv1015c,rplY ctc Rv1015c MTCY10G2.34,GO:0003735; GO:0005829; GO:0006412; GO:0008097; GO:0022625,IPR020056; IPR029751; IPR011035; IPR020057; IPR037121; IPR001021; ,,rplY,,50S ribosomal protein L25 (General stress protein CTC),cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: This is one of the proteins that binds to the 5S RNA in the ribosome where it forms part of the central protuberance. {ECO:0000255|HAMAP-Rule:MF_01334}.,MAKSASNQLRVTVRTETGKGASRRARRAGKIPAVLYGHGAEPQHLELPGHDYAAVLRHSGTNAVLTLDIAGKEQLALTKALHIHPIRRTIQHADLLVVRRGEKVVVEVSVVVEGQAGPDTLVTQETNSIEIEAEALSIPEQLTVSIEGAEPGTQLTAGQIALPAGVSLISDPDLLVVNVVKAPTAEELEGEVAGAEEAEEAAVEAGEAEAAGESE,"22,441",215,"Bacterial ribosomal protein bL25 family, CTC subfamily",translation [GO:0006412],5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625],ctc,MTCY10G2.34,1
P9WHN7,PTH_MYCTU,Rv1014c,pth Rv1014c MTCY10G2.35,GO:0004045; GO:0005737; GO:0005886; GO:0040007,IPR001328; IPR018171; IPR036416; ,,pth,,Peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aminoacyl-tRNA hydrolase activity [GO:0004045]; growth [GO:0040007],9634230; 21969609,NMR spectroscopy (1); X-ray crystallography (7),FUNCTION: The natural substrate for this enzyme may be peptidyl-tRNAs which drop off the ribosome during protein synthesis. {ECO:0000255|HAMAP-Rule:MF_00083}.,MAEPLLVVGLGNPGANYARTRHNLGFVVADLLAARLGAKFKAHKRSGAEVATGRSAGRSLVLAKPRCYMNESGRQIGPLAKFYSVAPANIIVIHDDLDLEFGRIRLKIGGGEGGHNGLRSVVAALGTKDFQRVRIGIGRPPGRKDPAAFVLENFTPAERAEVPTICEQAADATELLIEQGMEPAQNRVHAW,"20,456",191,PTH family,growth [GO:0040007],aminoacyl-tRNA hydrolase activity [GO:0004045],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY10G2.35,1
P9WHQ7,PUR1_MYCTU,Rv0808,purF Rv0808 MTCY07H7A.01c,GO:0004044; GO:0006189; GO:0006541; GO:0009113; GO:0009116; GO:0040007; GO:0046872; GO:0051539,IPR017932; IPR029055; IPR000836; IPR029057; IPR005854; IPR035584; ,,purF,DOMAIN 35 261 Glutamine amidotransferase type-2. {ECO:0000255|HAMAP-Rule:MF_01931}.,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPATase),"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113]",9634230; 21969609,,FUNCTION: Catalyzes the formation of phosphoribosylamine from phosphoribosylpyrophosphate (PRPP) and glutamine. {ECO:0000255|HAMAP-Rule:MF_01931}.,MAVDSDYVTDRAAGSRQTVTGQQPEQDLNSPREECGVFGVWAPGEDVAKLTYYGLYALQHRGQEAAGIAVADGSQVLVFKDLGLVSQVFDEQTLAAMQGHVAIGHCRYSTTGDTTWENAQPVFRNTAAGTGVALGHNGNLVNAAALAARARDAGLIATRCPAPATTDSDILGALLAHGAADSTLEQAALDLLPTVRGAFCLTFMDENTLYACRDPYGVRPLSLGRLDRGWVVASETAALDIVGASFVRDIEPGELLAIDADGVRSTRFANPTPKGCVFEYVYLARPDSTIAGRSVHAARVEIGRRLARECPVEADLVIGVPESGTPAAVGYAQESGVPYGQGLMKNAYVGRTFIQPSQTIRQLGIRLKLNPLKEVIRGKRLIVVDDSIVRGNTQRALVRMLREAGAVELHVRIASPPVKWPCFYGIDFPSPAELIANAVENEDEMLEAVRHAIGADTLGYISLRGMVAASEQPTSRLCTACFDGKYPIELPRETALGKNVIEHMLANAARGAALGELAADDEVPVGR,"56,162",527,Purine/pyrimidine phosphoribosyltransferase family,'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; nucleoside metabolic process [GO:0009116]; purine nucleobase biosynthetic process [GO:0009113],"4 iron, 4 sulfur cluster binding [GO:0051539]; amidophosphoribosyltransferase activity [GO:0004044]; metal ion binding [GO:0046872]",,,MTCY07H7A.01c,1
P9WHN1,PUR7_MYCTU,Rv0780,purC Rv0780 MTCY369.24,GO:0004639; GO:0005524; GO:0005737; GO:0006164; GO:0006189; GO:0040007,IPR028923; IPR001636; IPR018236; ,,purC,,Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleotide biosynthetic process [GO:0006164],8828210; 9634230; 21969609,,,MRPALSDYQHVASGKVREIYRVDDEHLLLVASDRISAYDYVLDSTIPDKGRVLTAMSAFFFGLVDAPNHLAGPPDDPRIPDEVLGRALVVRRLEMLPVECVARGYLTGSGLLDYQATGKVCGIALPPGLVEASRFATPLFTPATKAALGDHDENISFDRVVEMVGALRANQLRDRTLQTYVQAADHALTRGIIIADTKFEFGIDRHGNLLLADEIFTPDSSRYWPADDYRAGVVQTSFDKQFVRSWLTGSESGWDRGSDRPPPPLPEHIVEATRARYINAYERISELKFDDWIGPGA,"32,930",297,SAICAR synthetase family,'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleotide biosynthetic process [GO:0006164],ATP binding [GO:0005524]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639],cytoplasm [GO:0005737],,MTCY369.24,1
P9WHL7,PURL_MYCTU,Rv0803,purL Rv0803 MTCY07H7A.06c,GO:0004642; GO:0005524; GO:0005737; GO:0006164; GO:0006189; GO:0040007; GO:0046872,IPR010074; IPR010918; IPR036676; IPR016188; IPR036921; ,,purL,,Phosphoribosylformylglycinamidine synthase subunit PurL (FGAM synthase) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase subunit II) (FGAR amidotransferase II) (FGAR-AT II) (Glutamine amidotransferase PurL) (Phosphoribosylformylglycinamidine synthase subunit II),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleotide biosynthetic process [GO:0006164],8828210; 9634230; 21969609,,"FUNCTION: Part of the phosphoribosylformylglycinamidine synthase complex involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate. The FGAM synthase complex is composed of three subunits. PurQ produces an ammonia molecule by converting glutamine to glutamate. PurL transfers the ammonia molecule to FGAR to form FGAM in an ATP-dependent manner. PurS interacts with PurQ and PurL and is thought to assist in the transfer of the ammonia molecule from PurQ to PurL. {ECO:0000255|HAMAP-Rule:MF_00420, ECO:0000269|PubMed:8828210}.",MSPLARTPRKTSVLDTVEHAATTPDQPQPYGELGLKDDEYRRIRQILGRRPTDTELAMYSVMWSEHCSYKSSKVHLRYFGETTSDEMRAAMLAGIGENAGVVDIGDGWAVTFKVESHNHPSYVEPYQGAATGVGGIVRDIMAMGARPVAVMDQLRFGAADAPDTRRVLDGVVRGIGGYGNSLGLPNIGGETVFDPCYAGNPLVNALCVGVLRQEDLHLAFASGAGNKIILFGARTGLDGIGGVSVLASDTFDAEGSRKKLPSVQVGDPFMEKVLIECCLELYAGGLVIGIQDLGGAGLSCATSELASAGDGGMTIQLDSVPLRAKEMTPAEVLCSESQERMCAVVSPKNVDAFLAVCRKWEVLATVIGEVTDGDRLQITWHGETVVDVPPRTVAHEGPVYQRPVARPDTQDALNADRSAKLSRPVTGDELRATLLALLGSPHLCSRAFITEQYDRYVRGNTVLAEHADGGMLRIDESTGRGIAVSTDASGRYTLLDPYAGAQLALAEAYRNVAVTGATPVAVTNCLNFGSPEDPGVMWQFTQAVRGLADGCADLGIPVTGGNVSFYNQTGSAAILPTPVVGVLGVIDDVRRRIPTGLGAEPGETLMLLGDTRDEFDGSVWAQVTADHLGGLPPVVDLAREKLLAAVLSSASRDGLVSAAHDLSEGGLAQAIVESALAGETGCRIVLPEGADPFVLLFSESAGRVLVAVPRTEESRFRGMCEARGLPAVRIGVVDQGSDAVEVQGLFAVSLAELRATSEAVLPRYFG,"80,802",766,FGAMS family,'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007]; purine nucleotide biosynthetic process [GO:0006164],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],cytoplasm [GO:0005737],,MTCY07H7A.06c,2
P9WG29,RPFB_MYCTU,Rv1009,rpfB Rv1009 MTC1237.26,GO:0005576; GO:0005886; GO:0009405; GO:0010628; GO:0010629; GO:0016787; GO:0040010; GO:0085016,IPR007137; IPR011098; IPR023346; IPR010618; ,,rpfB,DOMAIN 192 272 G5. {ECO:0000255|PROSITE-ProRule:PRU00437}.,Resuscitation-promoting factor RpfB (EC 3.-.-.-),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; dormancy exit of symbiont in host [GO:0085016]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],9634230; 12410821; 12874362; 12906837; 15207486; 17919286; 18186793; 18463693; 20016836; 19099550; 20686708; 21920450; 15723078; 18992255,NMR spectroscopy (1); X-ray crystallography (5),"FUNCTION: Factor that stimulates resuscitation of dormant cells. Has peptidoglycan (PG) hydrolytic activity. Active in the pM concentration range. Has little to no effect on actively-growing cells. PG fragments could either directly activate the resuscitation pathway of dormant bacteria or serve as a substrate for endogenous Rpf, resulting in low molecular weight products with resuscitation activity.; FUNCTION: Reduces lag phase and enhances the growth of quiescent (1 month-old culture) M.tuberculosis; works best between 8 and 128 pM. Increases the number of bacteria that can be recovered from a 3 month-old culture. Stimulates growth of stationary phase M.bovis (a slowly-growing Mycobacterium) as well as M.smegmatis cells (a fast grower). Binds N,N',N''-triacetylchitotriose (tri-NAG). A fragment (residues 194-362) hydrolyzes an artificial lysozyme substrate 4-methylumbelliferyl-beta-D-N,N',N''-triacetylchitotrioside (MUF tri-NAG). By itself has little activity on cell wall, in combination with RipA is active against cell wall extracts from a number of Actinobacteria; this activity is inhibited by PBP1A (ponA1). Sequential gene disruption indicates RpfB and RpfE are higher than RpfD and RpfC in functional hierarchy.",MLRLVVGALLLVLAFAGGYAVAACKTVTLTVDGTAMRVTTMKSRVIDIVEENGFSVDDRDDLYPAAGVQVHDADTIVLRRSRPLQISLDGHDAKQVWTTASTVDEALAQLAMTDTAPAAASRASRVPLSGMALPVVSAKTVQLNDGGLVRTVHLPAPNVAGLLSAAGVPLLQSDHVVPAATAPIVEGMQIQVTRNRIKKVTERLPLPPNARRVEDPEMNMSREVVEDPGVPGTQDVTFAVAEVNGVETGRLPVANVVVTPAHEAVVRVGTKPGTEVPPVIDGSIWDAIAGCEAGGNWAINTGNGYYGGVQFDQGTWEANGGLRYAPRADLATREEQIAVAEVTRLRQGWGAWPVCAARAGAR,"38,078",362,"Transglycosylase family, Rpf subfamily",dormancy exit of symbiont in host [GO:0085016]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],hydrolase activity [GO:0016787],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTC1237.26,1
P9WG31,RPFA_MYCTU,Rv0867c,rpfA Rv0867c MTV043.60c,GO:0005576; GO:0009405; GO:0010629; GO:0016787; GO:0040010,IPR023346; IPR010618; ,,rpfA,,Resuscitation-promoting factor RpfA (EC 3.-.-.-),extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of growth rate [GO:0040010],9634230; 12410821; 12874362; 15207486; 15882420; 18186793,,"FUNCTION: Factor that stimulates resuscitation of dormant cells. Has peptidoglycan (PG) hydrolytic activity. Active in the pM concentration range. Has little to no effect on actively-growing cells. PG fragments could either directly activate the resuscitation pathway of dormant bacteria or serve as a substrate for endogenous Rpf, resulting in low molecular weight products with resuscitation activity. Stimulates growth of stationary phase M.bovis (a slow-growing Mycobacterium), reduces the lag phase of diluted fast-growers M.smegmatis and Micrococcus luteus. {ECO:0000269|PubMed:12410821}.",MSGRHRKPTTSNVSVAKIAFTGAVLGGGGIAMAAQATAATDGEWDQVARCESGGNWSINTGNGYLGGLQFTQSTWAAHGGGEFAPSAQLASREQQIAVGERVLATQGRGAWPVCGRGLSNATPREVLPASAAMDAPLDAAAVNGEPAPLAPPPADPAPPVELAANDLPAPLGEPLPAAPADPAPPADLAPPAPADVAPPVELAVNDLPAPLGEPLPAAPADPAPPADLAPPAPADLAPPAPADLAPPAPADLAPPVELAVNDLPAPLGEPLPAAPAELAPPADLAPASADLAPPAPADLAPPAPAELAPPAPADLAPPAAVNEQTAPGDQPATAPGGPVGLATDLELPEPDPQPADAPPPGDVTEAPAETPQVSNIAYTKKLWQAIRAQDVCGNDALDSLAQPYVIG,"39,975",407,"Transglycosylase family, Rpf subfamily",negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of growth rate [GO:0040010],hydrolase activity [GO:0016787],extracellular region [GO:0005576],,MTV043.60c,1
P9WGW7,RSMI_MYCTU,Rv1003,rsmI Rv1003 MTCI237.19,GO:0000453; GO:0005737; GO:0005886; GO:0008168,IPR000878; IPR035996; IPR014777; IPR014776; IPR008189; IPR018063; ,,rsmI,,Ribosomal RNA small subunit methyltransferase I (EC 2.1.1.198) (16S rRNA 2'-O-ribose C1402 methyltransferase) (rRNA (cytidine-2'-O-)-methyltransferase RsmI),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; enzyme-directed rRNA 2'-O-methylation [GO:0000453],9634230; 16483748; 21969609,,FUNCTION: Catalyzes the 2'-O-methylation of the ribose of cytidine 1402 (C1402) in 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_01877}.,MSSGRLLLGATPLGQPSDASPRLAAALATADVVAAEDTRRVRKLAKALDIRIGGRVVSLFDRVEALRVTALLDAINNGATVLVVSDAGTPVISDPGYRLVAACIDAGVSVTCLPGPSAVTTALVMSGLPAEKFCFEGFAPRKGAARRAWLAELAEERRTCVFFESPRRLAACLNDAVEQLGGARPAAICRELTKVHEEVVRGSLDELAIWAAGGVLGEITVVVAGAAPHAELSSLIAQVEEFVAAGIRVKDACSEVAAAHPGVRTRQLYDAVLQSRRETGGPAQP,"29,665",285,"Methyltransferase superfamily, RsmI family",enzyme-directed rRNA 2'-O-methylation [GO:0000453],methyltransferase activity [GO:0008168],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCI237.19,1
P9WH07,RSMA_MYCTU,Rv1010,ksgA rsmA Rv1010 MTCI237.27,GO:0000179; GO:0003723; GO:0005737; GO:0052908,IPR001737; IPR023165; IPR020596; IPR020598; IPR011530; IPR029063; ,,ksgA,,"Ribosomal RNA small subunit methyltransferase A (EC 2.1.1.182) (16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase) (16S rRNA dimethyladenosine transferase) (16S rRNA dimethylase) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase)","cytoplasm [GO:0005737]; 16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity [GO:0052908]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]",9634230; 21969609,,FUNCTION: Specifically dimethylates two adjacent adenosines (A1518 and A1519) in the loop of a conserved hairpin near the 3'-end of 16S rRNA in the 30S particle. May play a critical role in biogenesis of 30S subunits. {ECO:0000255|HAMAP-Rule:MF_00607}.,MCCTSGCALTIRLLGRTEIRRLAKELDFRPRKSLGQNFVHDANTVRRVVAASGVSRSDLVLEVGPGLGSLTLALLDRGATVTAVEIDPLLASRLQQTVAEHSHSEVHRLTVVNRDVLALRREDLAAAPTAVVANLPYNVAVPALLHLLVEFPSIRVVTVMVQAEVAERLAAEPGSKEYGVPSVKLRFFGRVRRCGMVSPTVFWPIPRVYSGLVRIDRYETSPWPTDDAFRRRVFELVDIAFAQRRKTSRNAFVQWAGSGSESANRLLAASIDPARRGETLSIDDFVRLLRRSGGSDEATSTGRDARAPDISGHASAS,"34,646",317,"Class I-like SAM-binding methyltransferase superfamily, rRNA adenine N(6)-methyltransferase family, RsmA subfamily",,"16S rRNA (adenine(1518)-N(6)/adenine(1519)-N(6))-dimethyltransferase activity [GO:0052908]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]",cytoplasm [GO:0005737],rsmA,MTCI237.27,1
P9WGM1,PRRA_MYCTU,Rv0903c,prrA Rv0903c MTCY31.31c,GO:0000160; GO:0000287; GO:0003677; GO:0005509; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0044110,IPR011006; IPR001867; IPR001789; IPR036388; ,,prrA,DOMAIN 9 123 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Transcriptional regulatory protein PrrA,"cytosol [GO:0005829]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287]; growth involved in symbiotic interaction [GO:0044110]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 11953357; 21969609,X-ray crystallography (2),FUNCTION: Member of the two-component regulatory system PrrB/PrrA. Involved specifically in early intracellular multiplication of Mycobacterium. {ECO:0000269|PubMed:11953357}.,MDTGVTSPRVLVVDDDSDVLASLERGLRLSGFEVATAVDGAEALRSATENRPDAIVLDINMPVLDGVSVVTALRAMDNDVPVCVLSARSSVDDRVAGLEAGADDYLVKPFVLAELVARVKALLRRRGSTATSSSETITVGPLEVDIPGRRARVNGVDVDLTKREFDLLAVLAEHKTAVLSRAQLLELVWGYDFAADTNVVDVFIGYLRRKLEAGGGPRLLHTVRGVGFVLRMQ,"25,009",233,,"growth involved in symbiotic interaction [GO:0044110]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; magnesium ion binding [GO:0000287],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY31.31c,1
P9WGK7,PRRB_MYCTU,Rv0902c,prrB Rv0902c MTCY31.30c,GO:0000155; GO:0004672; GO:0005524; GO:0005618; GO:0005622; GO:0005887; GO:0042802; GO:0044110; GO:0046777,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,Itself,prrB,DOMAIN 172 222 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 237 446 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Sensor-type histidine kinase PrrB (EC 2.7.13.3),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672]; growth involved in symbiotic interaction [GO:0044110]; protein autophosphorylation [GO:0046777],9634230; 11953357; 21969609,X-ray crystallography (2),FUNCTION: Member of the two-component regulatory system PrrB/PrrA. Involved specifically in early intracellular multiplication of Mycobacterium. Probably phosphorylates PrrA. {ECO:0000269|PubMed:11953357}.,MNILSRIFARTPSLRTRVVVATAIGAAIPVLIVGTVVWVGITNDRKERLDRRLDEAAGFAIPFVPRGLDEIPRSPNDQDALITVRRGNVIKSNSDITLPKLQDDYADTYVRGVRYRVRTVEIPGPEPTSVAVGATYDATVAETNNLHRRVLLICTFAIGAAAVFAWLLAAFAVRPFKQLAEQTRSIDAGDEAPRVEVHGASEAIEIAEAMRGMLQRIWNEQNRTKEALASARDFAAVSSHELRTPLTAMRTNLEVLSTLDLPDDQRKEVLNDVIRTQSRIEATLSALERLAQGELSTSDDHVPVDITDLLDRAAHDAARIYPDLDVSLVPSPTCIIVGLPAGLRLAVDNAIANAVKHGGATLVQLSAVSSRAGVEIAIDDNGSGVPEGERQVVFERFSRGSTASHSGSGLGLALVAQQAQLHGGTASLENSPLGGARLVLRLPGPS,"47,829",446,,growth involved in symbiotic interaction [GO:0044110]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622],,MTCY31.30c,1
P9WQL1,PSTB1_MYCTU,Rv0820,pstB1 phoT Rv0820 MTV043.12,GO:0005315; GO:0005524; GO:0005886; GO:0015415; GO:0044117,IPR003593; IPR003439; IPR017871; IPR015850; IPR027417; IPR005670; ,,pstB1,DOMAIN 5 247 ABC transporter. {ECO:0000255|HAMAP-Rule:MF_01702}.,Phosphate import ATP-binding protein PstB 1 (EC 3.6.3.27) (ABC phosphate transporter 1) (Phosphate-transporting ATPase 1),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; inorganic phosphate transmembrane transporter activity [GO:0005315]; growth of symbiont in host [GO:0044117],9634230; 20933472; 21969609,,"FUNCTION: Part of the ABC transporter complex PstSACB involved in phosphate import (Probable). Responsible for energy coupling to the transport system. {ECO:0000255|HAMAP-Rule:MF_01702, ECO:0000305|PubMed:20933472}.",MAKRLDLTDVNIYYGSFHAVADVSLAILPRSVTAFIGPSGCGKTTVLRTLNRMHEVIPGARVEGAVLLDDQDIYAPGIDPVGVRRAIGMVFQRPNPFPAMSIRNNVVAGLKLQGVRNRKVLDDTAESSLRGANLWDEVKDRLDKPGGGLSGGQQQRLCIARAIAVQPDVLLMDEPCSSLDPISTMAIEDLISELKQQYTIVIVTHNMQQAARVSDQTAFFNLEAVGKPGRLVEIASTEKIFSNPNQKATEDYISGRFG,"28,061",258,"ABC transporter superfamily, Phosphate importer (TC 3.A.1.7) family",growth of symbiont in host [GO:0044117],ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; ATP binding [GO:0005524]; inorganic phosphate transmembrane transporter activity [GO:0005315],plasma membrane [GO:0005886],phoT,MTV043.12,1
P9WQK9,PSTB2_MYCTU,Rv0933,pstB2 pstB Rv0933 MTCY08D9.06c,GO:0005315; GO:0005524; GO:0005886; GO:0015415; GO:0016887,IPR003593; IPR003439; IPR017871; IPR015850; IPR027417; IPR005670; ,,pstB2,DOMAIN 22 262 ABC transporter. {ECO:0000255|HAMAP-Rule:MF_01702}.,Phosphate import ATP-binding protein PstB 2 (EC 3.6.3.27) (ABC phosphate transporter 2) (Phosphate-transporting ATPase 2),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; inorganic phosphate transmembrane transporter activity [GO:0005315],8918249; 9634230; 20933472; 21969609,,"FUNCTION: Part of the ABC transporter complex PstSACB involved in phosphate import (Probable). Responsible for energy coupling to the transport system. {ECO:0000255|HAMAP-Rule:MF_01702, ECO:0000305|PubMed:20933472}.",MACERLGGQSGAADVDAAAPAMAAVNLTLGFAGKTVLDQVSMGFPARAVTSLMGPTGSGKTTFLRTLNRMNDKVSGYRYSGDVLLGGRSIFNYRDVLEFRRRVGMLFQRPNPFPMSIMDNVLAGVRAHKLVPRKEFRGVAQARLTEVGLWDAVKDRLSDSPFRLSGGQQQLLCLARTLAVNPEVLLLDEPTSALDPTTTEKIEEFIRSLADRLTVIIVTHNLAQAARISDRAALFFDGRLVEEGPTEQLFSSPKHAETARYVAGLSGDVKDAKRGN,"29,996",276,"ABC transporter superfamily, Phosphate importer (TC 3.A.1.7) family",,ATPase activity [GO:0016887]; ATPase-coupled phosphate ion transmembrane transporter activity [GO:0015415]; ATP binding [GO:0005524]; inorganic phosphate transmembrane transporter activity [GO:0005315],plasma membrane [GO:0005886],pstB,MTCY08D9.06c,1
P9WG07,PSTC1_MYCTU,Rv0935,pstC1 pstC Rv0935 MTCY08D9.04c,GO:0005315; GO:0005886; GO:0006817; GO:0016021,IPR000515; IPR035906; IPR011864; ,,pstC1,DOMAIN 87 320 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Phosphate transport system permease protein PstC 1,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transport [GO:0006817],8918249; 9634230; 20933472,,FUNCTION: Part of the ABC transporter complex PstSACB involved in phosphate import; probably responsible for the translocation of the substrate across the membrane. {ECO:0000305|PubMed:20933472}.,MLARAGEVGRAGPAIRWLGGIGAVIPLLALVLVLVVLVIEAMGAIRLNGLHFFTATEWNPGNTYGETVVTDGVAHPVGAYYGALPLIVGTLATSAIALIIAVPVSVGAALVIVERLPKRLAEAVGIVLELLAGIPSVVVGLWGAMTFGPFIAHHIAPVIAHNAPDVPVLNYLRGDPGNGEGMLVSGLVLAVMVVPIIATTTHDLFRQVPVLPREGAIALGMSNWECVRRVTLPWVSSGIVGAVVLGLGRALGETMAVAMVSGAVLGAMPANIYATMTTIAATIVSQLDSAMTDSTNFAVKTLAEVGLVLMVITLLTNVAARGMVRRVSRTALPVGRGI,"34,793",338,"Binding-protein-dependent transport system permease family, CysTW subfamily",phosphate ion transport [GO:0006817],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],pstC,MTCY08D9.04c,1
P9WGT9,PSTS2_MYCTU,Rv0932c,pstS2 Rv0932c MTCY08D9.07,GO:0005576; GO:0005886; GO:0006817; GO:0009405; GO:0035435; GO:0042301; GO:0043190,IPR005673; IPR024370; ,,pstS2,,Phosphate-binding protein PstS 2 (PBP 2) (PstS-2),ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; phosphate ion binding [GO:0042301]; pathogenesis [GO:0009405]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],9139906; 9634230; 15731097; 20933472; 21969609,,"FUNCTION: Functions in inorganic phosphate uptake, although probably not the main uptake protein under phosphate starvation (PubMed:15731097, PubMed:20933472). Part of the ABC transporter complex PstSACB involved in phosphate import (Probable). {ECO:0000269|PubMed:15731097, ECO:0000269|PubMed:20933472, ECO:0000305}.",MKFARSGAAVSLLAAGTLVLTACGGGTNSSSSGAGGTSGSVHCGGKKELHSSGSTAQENAMEQFVYAYVRSCPGYTLDYNANGSGAGVTQFLNNETDFAGSDVPLNPSTGQPDRSAERCGSPAWDLPTVFGPIAITYNIKGVSTLNLDGPTTAKIFNGTITVWNDPQIQALNSGTDLPPTPISVIFRSDKSGTSDNFQKYLDGASNGAWGKGASETFNGGVGVGASGNNGTSALLQTTDGSITYNEWSFAVGKQLNMAQIITSAGPDPVAITTESVGKTIAGAKIMGQGNDLVLDTSSFYRPTQPGSYPIVLATYEIVCSKYPDATTGTAVRAFMQAAIGPGQEGLDQYGSIPLPKSFQAKLAAAVNAIS,"37,864",370,PstS family,pathogenesis [GO:0009405]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],phosphate ion binding [GO:0042301],ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY08D9.07,1
P9WGT7,PSTS3_MYCTU,Rv0928,pstS3 phoS2 Rv0928 MTCY21C12.22,GO:0005576; GO:0005618; GO:0005886; GO:0016036; GO:0035435; GO:0042301; GO:0043190; GO:0044117; GO:0052170,IPR005673; IPR024370; ,,pstS3,,Phosphate-binding protein PstS 3 (PBP 3) (PstS-3) (Antigen Ag88),ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; phosphate ion binding [GO:0042301]; cellular response to phosphate starvation [GO:0016036]; growth of symbiont in host [GO:0044117]; negative regulation by symbiont of host innate immune response [GO:0052170]; phosphate ion transmembrane transport [GO:0035435],8843165; 9634230; 9139906; 20844580; 20933472; 21969609; 24615888,X-ray crystallography (1),"FUNCTION: Functions in inorganic phosphate uptake, is probably the main carrier for phosphate uptake, it is the most highly expressed of the 3 PstS proteins under phosphate starvation (PubMed:20933472). Binds phosphate; probably able to bind both H(2)PO(4)(-) and HPO(4)(2-) (PubMed:24615888). Part of the ABC transporter complex PstSACB involved in phosphate import (Probable). Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000269|PubMed:20933472, ECO:0000269|PubMed:24615888, ECO:0000305, ECO:0000305|PubMed:20844580}.",MKLNRFGAAVGVLAAGALVLSACGNDDNVTGGGATTGQASAKVDCGGKKTLKASGSTAQANAMTRFVNVFEQACPGQTLNYTANGSGAGISEFNGNQTDFGGSDVPLSKDEAAAAQRRCGSPAWNLPVVFGPIAVTYNLNSVSSLNLDGPTLAKIFNGSITQWNNPAIQALNRDFTLPGERIHVVFRSDESGTTDNFQRYLQAASNGAWGKGAGKSFQGGVGEGARGNDGTSAAAKNTPGSITYNEWSFAQAQHLTMANIVTSAGGDPVAITIDSVGQTIAGATISGVGNDLVLDTDSFYRPKRPGSYPIVLATYEIVCSKYPDSQVGTAVKAFLQSTIGAGQSGLGDNGYIPIPDEFKSRLSTAVNAIA,"37,953",370,PstS family,cellular response to phosphate starvation [GO:0016036]; growth of symbiont in host [GO:0044117]; negative regulation by symbiont of host innate immune response [GO:0052170]; phosphate ion transmembrane transport [GO:0035435],phosphate ion binding [GO:0042301],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],phoS2,MTCY21C12.22,1
P9WG11,PSTA1_MYCTU,Rv0930,pstA1 Rv0930 MTCY21C12.24,GO:0005315; GO:0005887; GO:0035435; GO:0044117,IPR000515; IPR035906; IPR005672; ,,pstA1,DOMAIN 89 297 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Phosphate transport system permease protein PstA 1,integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; growth of symbiont in host [GO:0044117]; phosphate ion transmembrane transport [GO:0035435],8112854; 8843165; 9634230; 12368430; 20933472,,FUNCTION: Part of the binding-protein-dependent transport system for phosphate; probably responsible for the translocation of the substrate across the membrane. {ECO:0000305|PubMed:20933472}.,MSPSMSIEALDQPVKPVVFRPLTLRRRIKNSVATTFFFTSFVVALIPLVWLLWVVIARGWFAVTRSGWWTHSLRGVLPEQFAGGVYHALYGTLVQAGVAAVLAVPLGLMTAVYLVEYGTGRMSRVTTFTVDVLAGVPSIVAALFVFSLWIATLGFQQSAFAVALALVLLMLPVVVRAGEEMLRLVPDELREASYALGVPKWKTIVRIVAPIAMPGIVSGILLSIARVVGETAPVLVLVGYSHSINLDVFHGNMASLPLLIYTELTNPEHAGFLRVWGAALTLIIVVATINLAAAMIRFVATRRRRLPL,"33,498",308,"Binding-protein-dependent transport system permease family, CysTW subfamily",growth of symbiont in host [GO:0044117]; phosphate ion transmembrane transport [GO:0035435],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of plasma membrane [GO:0005887],,MTCY21C12.24,1
P9WG09,PSTA2_MYCTU,Rv0936,pstA2 Rv0936 MTCY08D9.03c,GO:0005315; GO:0005887; GO:0035435,IPR000515; IPR035906; IPR005672; ,,pstA2,DOMAIN 83 288 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Phosphate transport system permease protein PstA 2,integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435],8918249; 9634230; 20933472; 21969609,,FUNCTION: Part of the binding-protein-dependent transport system for phosphate; probably responsible for the translocation of the substrate across the membrane. {ECO:0000305|PubMed:20933472}.,MGESAESGSRQLPAMSPPRRSVAYRRKIVDALWWAACVCCLAVVITPTLWMLIGVVSRAVPVFHWSVLVQDSQGNGGGLRNAIIGTAVLAIGVILVGGTVSVLTGIYLSEFATGKTRSILRGAYEVLSGIPSIVLGYVGYLALVVYFDWGFSLAAGVLVLSVMSIPYIAKATESALAQVPTSYREAAEALGLPAGWALRKIVLKTAMPGIVTGMLVALALAIGETAPLLYTAGWSNSPPTGQLTDSPVGYLTYPIWTFYNQPSKSAQDLSYDAALLLIVFLLLLIFIGRLINWLSRRRWDV,"32,236",301,"Binding-protein-dependent transport system permease family, CysTW subfamily",phosphate ion transmembrane transport [GO:0035435],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of plasma membrane [GO:0005887],,MTCY08D9.03c,1
P9WG05,PSTC2_MYCTU,Rv0929,pstC2 Rv0929 MTCY21C12.23,GO:0005315; GO:0005886; GO:0006817; GO:0016021; GO:0044117,IPR000515; IPR035906; IPR011864; ,,pstC2,DOMAIN 85 314 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Phosphate transport system permease protein PstC 2,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; inorganic phosphate transmembrane transporter activity [GO:0005315]; growth of symbiont in host [GO:0044117]; phosphate ion transport [GO:0006817],8843165; 9634230; 20933472; 21969609,,FUNCTION: Part of the ABC transporter complex PstSACB involved in phosphate import; probably responsible for the translocation of the substrate across the membrane. {ECO:0000305|PubMed:20933472}.,MVTEPLTKPALVAVDMRPARRGERLFKLAASAAGSTIVIAILLIAIFLLVRAVPSLRANHANFFTSTQFDTSDDEQLAFGVRDLFMVTALSSITALVLAVPVAVGIAVFLTHYAPRRLSRPFGAMVDLLAAVPSIIFGLWGIFVLAPKLEPIARFLNRNLGWLFLFKQGNVSLAGGGTIFTAGIVLSVMILPIVTSISREVFRQTPLIQIEAALALGATKWEVVRMTVLPYGRSGVVAASMLGLGRALGETVAVLVILRSAARPGTWSLFDGGYTFASKIASAASEFSEPLPTGAYISAGFALFVLTFLVNAAARAIAGGKVNG,"34,262",324,"Binding-protein-dependent transport system permease family, CysTW subfamily",growth of symbiont in host [GO:0044117]; phosphate ion transport [GO:0006817],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21C12.23,1
P9WGU1,PSTS1_MYCTU,Rv0934,pstS1 phoS1 Rv0934 MTCY08D9.05c,GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006817; GO:0007155; GO:0009405; GO:0009986; GO:0016036; GO:0035435; GO:0042301; GO:0043190,IPR005673; IPR024370; ,,pstS1,,Phosphate-binding protein PstS 1 (PBP 1) (PhoS1) (PstS-1) (38-kDa glycolipoprotein) (38-kDa lipoprotein) (P38) (Antigen Ag78) (Protein antigen B) (Pab),ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; phosphate ion binding [GO:0042301]; cell adhesion [GO:0007155]; cellular response to phosphate starvation [GO:0016036]; pathogenesis [GO:0009405]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],2545626; 9634230; 1906192; 8294447; 1612766; 10426995; 15731097; 16622205; 19140873; 19362712; 20933472; 21969609; 23719937; 25359607; 25544271; 20234378; 12842040,X-ray crystallography (1),"FUNCTION: Functions in inorganic phosphate uptake, although probably not the main uptake protein under phosphate starvation (PubMed:15731097, PubMed:20933472). Binds phosphate; probably able to bind both H(2)PO(4)(-) and HPO(4)(2-) (PubMed:8294447, PubMed:12842040). Part of the ABC transporter complex PstSACB involved in phosphate import (Probable). {ECO:0000269|PubMed:12842040, ECO:0000269|PubMed:15731097, ECO:0000269|PubMed:20933472, ECO:0000269|PubMed:8294447, ECO:0000305}.; FUNCTION: A host TLR2 agonist (toll-like receptor), shown experimentally for human and mouse (PubMed:1906192, PubMed:19362712). Requires both host TLR1 and TLR2 as coreceptors to elicit host response in mouse (TLR6 may also play a role) neither CD14 or CD36 function as accessory receptors (PubMed:19362712). Protein purified from culture filtrate induces host (human) monocytes to produce TNF-alpha, IL-6 and IL-12 p40 (IL12B) via ERK1/2 (MAPK3 and MAPK1) and p38 MAPK pathways; MEK inhibitors U0126 and PD98059 and p38 inhibitor SB203580 block most cytokine production (PubMed:16622205). Host ERK1/2 and p38 MAPK activation is mediated mainly by TLR2, but also partially by TLR4, and unlike the case for lipoprotein LpqH the protein moiety of PstS1 seems to be the antigenic agent (PubMed:16622205). Greater activation of ERK1/2 and p38 MAPK is seen in patients with active pulmonary tuberculosis than in tuberculin-negative patients (PubMed:16622205). Induces apoptosis when incubated with human monocyte-derived macrophages via TLR2 (PubMed:19140873). Protein purified from culture filtrate acts via TLR2 and TLR4 to induce host macrophage (shown for mouse) endoplasmic reticulum stress-mediated apoptosis via MAPK (at least JNK), C-C motif chemokine 2 (MCP-1, Ccl2) and ZC3H12 endoribonucleases (MCPIP, Zc3h12) (PubMed:25544271). Functions as an adhesin, binds to human and mouse macrophages via mannose residues, binds to the mouse macrophage mannose receptor (possibly Mrc1) and mediates bacterial phagocytosis (PubMed:25359607). {ECO:0000269|PubMed:16622205, ECO:0000269|PubMed:1906192, ECO:0000269|PubMed:19140873, ECO:0000269|PubMed:19362712, ECO:0000269|PubMed:25359607, ECO:0000269|PubMed:25544271}.",MKIRLHTLLAVLTAAPLLLAAAGCGSKPPSGSPETGAGAGTVATTPASSPVTLAETGSTLLYPLFNLWGPAFHERYPNVTITAQGTGSGAGIAQAAAGTVNIGASDAYLSEGDMAAHKGLMNIALAISAQQVNYNLPGVSEHLKLNGKVLAAMYQGTIKTWDDPQIAALNPGVNLPGTAVVPLHRSDGSGDTFLFTQYLSKQDPEGWGKSPGFGTTVDFPAVPGALGENGNGGMVTGCAETPGCVAYIGISFLDQASQRGLGEAQLGNSSGNFLLPDAQSIQAAAAGFASKTPANQAISMIDGPAPDGYPIINYEYAIVNNRQKDAATAQTLQAFLHWAITDGNKASFLDQVHFQPLPPAVVKLSDALIATISS,"38,243",374,PstS family,cell adhesion [GO:0007155]; cellular response to phosphate starvation [GO:0016036]; pathogenesis [GO:0009405]; phosphate ion transmembrane transport [GO:0035435]; phosphate ion transport [GO:0006817],phosphate ion binding [GO:0042301],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],phoS1,MTCY08D9.05c,1
P9WFU5,SYM_MYCTU,Rv1007c,metG metS Rv1007c MTCI237.24,GO:0004825; GO:0005524; GO:0005737; GO:0005886; GO:0006431; GO:0040007,IPR001412; IPR014758; IPR023457; IPR015413; IPR033911; IPR014729; IPR009080; ,,metG,,Methionine--tRNA ligase (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; growth [GO:0040007]; methionyl-tRNA aminoacylation [GO:0006431],9634230; 9607323; 21969609,X-ray crystallography (1),FUNCTION: Is required not only for elongation of protein synthesis but also for the initiation of all mRNA translation through initiator tRNA(fMet) aminoacylation.,MKPYYVTTAIAYPNAAPHVGHAYEYIATDAIARFKRLDRYDVRFLTGTDEHGLKVAQAAAAAGVPTAALARRNSDVFQRMQEALNISFDRFIRTTDADHHEASKELWRRMSAAGDIYLDNYSGWYSVRDERFFVESETQLVDGTRLTVETGTPVTWTEEQTYFFRLSAYTDKLLAHYHANPDFIAPETRRNEVISFVSGGLDDLSISRTSFDWGVQVPEHPDHVMYVWVDALTNYLTGAGFPDTDSELFRRYWPADLHMIGKDIIRFHAVYWPAFLMSAGIELPRRIFAHGFLHNRGEKMSKSVGNIVDPVALAEALGVDQVRYFLLREVPFGQDGSYSDEAIVTRINTDLANELGNLAQRSLSMVAKNLDGRVPNPGEFADADAALLATADGLLERVRGHFDAQAMHLALEAIWLMLGDANKYFSVQQPWVLRKSESEADQARFRTTLYVTCEVVRIAALLIQPVMPESAGKILDLLGQAPNQRSFAAVGVRLTPGTALPPPTGVFPRYQPPQPPEGK,"58,093",519,"Class-I aminoacyl-tRNA synthetase family, MetG type 2B subfamily",growth [GO:0040007]; methionyl-tRNA aminoacylation [GO:0006431],ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],metS,MTCI237.24,1
P9WGC7,SUCD_MYCTU,Rv0952,sucD Rv0952 MTCY10D7.22c,GO:0000166; GO:0004775; GO:0005618; GO:0005829; GO:0005886; GO:0006099; GO:0040007; GO:0048037,IPR017440; IPR033847; IPR003781; IPR005810; IPR005811; IPR036291; IPR016102; ,,sucD,,Succinate--CoA ligase [ADP-forming] subunit alpha (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cofactor binding [GO:0048037]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; growth [GO:0040007]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,,"FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The alpha subunit of the enzyme binds the substrates coenzyme A and phosphate, while succinate binding and nucleotide specificity is provided by the beta subunit. {ECO:0000255|HAMAP-Rule:MF_01988}.",MTHMSIFLSRDNKVIVQGITGSEATVHTARMLRAGTQIVGGVNARKAGTTVTHEDKGGRLIKLPVFGSVAEAMEKTGADVSIIFVPPTFAKDAIIEAIDAEIPLLVVITEGIPVQDTAYAWAYNLEAGHKTRIIGPNCPGIISPGQSLAGITPANITGPGPIGLVSKSGTLTYQMMFELRDLGFSTAIGIGGDPVIGTTHIDAIEAFERDPDTKLIVMIGEIGGDAEERAADFIKTNVSKPVVGYVAGFTAPEGKTMGHAGAIVSGSSGTAAAKQEALEAAGVKVGKTPSATAALAREILLSL,"31,229",303,Succinate/malate CoA ligase alpha subunit family,growth [GO:0040007]; tricarboxylic acid cycle [GO:0006099],cofactor binding [GO:0048037]; nucleotide binding [GO:0000166]; succinate-CoA ligase (ADP-forming) activity [GO:0004775],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY10D7.22c,1
P9WGC5,SUCC_MYCTU,Rv0951,sucC Rv0951 MTCY10D7.23c,GO:0004775; GO:0005524; GO:0005618; GO:0005829; GO:0006099; GO:0040007; GO:0046872,IPR011761; IPR013650; IPR013815; IPR005811; IPR017866; IPR005809; IPR016102; ,,sucC,DOMAIN 9 236 ATP-grasp. {ECO:0000255|HAMAP-Rule:MF_00558}.,Succinate--CoA ligase [ADP-forming] subunit beta (EC 6.2.1.5) (Succinyl-CoA synthetase subunit beta) (SCS-beta),cell wall [GO:0005618]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; growth [GO:0040007]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,,"FUNCTION: Succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of either ATP or GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit. {ECO:0000255|HAMAP-Rule:MF_00558}.",MDLFEYQAKELFAKHNVPSTPGRVTDTAEGAKAIATEIGRPVMVKAQVKIGGRGKAGGVKYAATPQDAYEHAKNILGLDIKGHIVKKLLVAEASDIAEEYYLSFLLDRANRTYLAMCSVEGGMEIEEVAATKPERLAKVPVNAVKGVDLDFARSIAEQGHLPAEVLDTAAVTIAKLWELFVAEDATLVEVNPLVRTPDHKILALDAKITLDGNADFRQPGHAEFEDRAATDPLELKAKEHDLNYVKLDGQVGIIGNGAGLVMSTLDVVAYAGEKHGGVKPANFLDIGGGASAEVMAAGLDVVLGDQQVKSVFVNVFGGITSCDAVATGIVKALGMLGDEANKPLVVRLDGNNVEEGRRILTEANHPLVTLVATMDEAADKAAELASA,"40,926",387,Succinate/malate CoA ligase beta subunit family,growth [GO:0040007]; tricarboxylic acid cycle [GO:0006099],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; succinate-CoA ligase (ADP-forming) activity [GO:0004775],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY10D7.23c,1
P9WP51,Y1077_MYCTU,Rv1077,cbs Rv1077,GO:0004122; GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0019343; GO:0030170,IPR000644; IPR005857; IPR001926; IPR036052; ,,cbs,,Putative cystathionine beta-synthase Rv1077 (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; cystathionine beta-synthase activity [GO:0004122]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process via cystathionine [GO:0019343],9634230; 19099550; 20066036; 21969609,,,MRIAQHISELIGGTPLVRLNSVVPDGAGTVAAKVEYLNPGGSSKDRIAVKMIEAAEASGQLKPGGTIVEPTSGNTGVGLALVAQRRGYKCVFVCPDKVSEDKRNVLIAYGAEVVVCPTAVPPHDPASYYSVSDRLVRDIDGAWKPDQYANPEGPASHYVTTGPEIWADTEGKVTHFVAGIGTGGTITGAGRYLKEVSGGRVRIVGADPEGSVYSGGAGRPYLVEGVGEDFWPAAYDPSVPDEIIAVSDSDSFDMTRRLAREEAMLVGGSCGMAVVAALKVAEEAGPDALIVVLLPDGGRGYMSKIFNDAWMSSYGFLRSRLDGSTEQSTVGDVLRRKSGALPALVHTHPSETVRDAIGILREYGVSQMPVVGAEPPVMAGEVAGSVSERELLSAVFEGRAKLADAVSAHMSPPLRMIGAGELVSAAGKALRDWDALMVVEEGKPVGVITRYDLLGFLSEGAGRR,"48,635",464,Cysteine synthase/cystathionine beta-synthase family,cysteine biosynthetic process via cystathionine [GO:0019343],cystathionine beta-synthase activity [GO:0004122]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WGQ7,Y1144_MYCTU,Rv1144,Rv1144,GO:0005618; GO:0005886; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Uncharacterized oxidoreductase Rv1144 (EC 1.-.-.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MKTKDAVAVVTGGASGLGLATTKRLLDAGAQVVVVDLRGDDVVGGLGDRARFAQADVTDEAAVSNALELADSLGPVRVVVNCAGTGNAIRVLSRDGVFPLAAFRKIVDINLVGTFNVLRLGAERIAKTEPIGEERGVIINTASVAAFDGQIGQAAYSASKGGVVGMTLPIARDLASKLIRVVTIAPGLFDTPLLASLPAEAKASLGQQVPHPSRLGNPDEYGALVLHIIENPMLNGEVIRLDGAIRMAPR,"25,788",250,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P71838,Y0785_MYCTU,Rv0785,Rv0785,GO:0005886; GO:0006694; GO:0016042; GO:0016627,IPR003953; IPR036188; IPR014614; ,,,,KsdD-like steroid dehydrogenase Rv0785 (EC 1.3.99.-),"plasma membrane [GO:0005886]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694]",9634230; 21969609,,FUNCTION: Able to catalyze the elimination of the C-1 and C-2 hydrogen atoms of the A-ring from the polycyclic ring structure of 3-ketosteroids. {ECO:0000250}.,MALTCTDMSDAVAGSDAEGLTADAIVVGAGLAGLVAACELADRGLRVLILDQENRANVGGQAFWSFGGLFLVNSPEQRRLGIRDSHELALQDWLGTAAFDRPEDYWPEQWAHAYVDFAAGEKRSWLRARGLKIFPLVGWAERGGYDAQGHGNSVPRFHITWGTGPALVDIFVRQLRDRPTVRFAHRHQVDKLIVEGNAVTGVRGTVLEPSDEPRGAPSSRKSVGKFEFRASAVIVASGGIGGNHELVRKNWPRRMGRIPKQLLSGVPAHVDGRMIGIAQKAGAAVINPDRMWHYTEGITNYDPIWPRHGIRIIPGPSSLWLDAAGKRLPVPLFPGFDTLGTLEYITKSGHDYTWFVLNAKIIEKEFALSGQEQNPDLTGRRLGQLLRSRAHAGPPGPVQAFIDRGVDCVHANSLRELVAAMNELPDVVPLDYETVAAAVTARDREVVNKYSKDGQITAIRAARRYRGDRFGRVVAPHRLTDPKAGPLIAVKLHILTRKTLGGIETDLDARVLKADGTPLAGLYAAGEVAGFGGGGVHGYRALEGTFLGGCIFSGRAAGRGAAEDIR,"61,252",566,FAD-dependent oxidoreductase 2 family,lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694],"oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,,2
P9WIY9,Y1063_MYCTU,Rv1063c,Rv1063c MTV017.16c,GO:0004622; GO:0016042; GO:0016787; GO:0046470,IPR016035; IPR001423; IPR002641; ,,,DOMAIN 19 179 PNPLA. {ECO:0000255|PROSITE-ProRule:PRU01161}.,Uncharacterized NTE family protein Rv1063c,hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],9634230; 21969609,,,MPAPAALRVRGSSSPRVALALGSGGARGYAHIGVIQALRERGYDIVGIAGSSMGAVVGGVHAAGRLDEFAHWAKSLTQRTILRLLDPSISAAGILRAEKILDAVRDIVGPVAIEQLPIPYTAVATDLLAGKSVWFQRGPLDAAIRASIAIPGVIAPHEVDGRLLADGGILDPLPMAPIAGVNADLTIAVSLNGSEAGPARDAEPNVTAEWLNRMVRSTSALFDVSAARSLLDRPTARAVLSRFGAAAAESDSWSQAPEIEQRPAGPPADREEAADTPGLPKMGSFEVMNRTIDIAQSALARHTLAGYPADLLIEVPRSTCRSLEFHRAVEVIAVGRALATQALEAFEIDDDESAAATIEG,"37,523",360,NTE family,lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622],,,MTV017.16c,1
P9WM55,Y1148_MYCTU,Rv1148c,Rv1148c MTCI65.15c,,IPR003870; IPR003615; ,,,DOMAIN 364 405 HNH.,Uncharacterized protein Rv1148c,,9634230; 21969609,,,MRSDTREEISAALDAYHASLSRVLDLKCDALTTPELLACLQRLEVERRRQGAAEHALINQLAGQACEEELGGTLRTALANRLHITPGEASRRIAEAEDLGERRALTGEPLPAQLTATAAAQREGKIGREHIKEIQAFFKELSAAVDLGIREAAEAQLAELATSRRPDHLHGLATQLMDWLHPDGNFSDQERARKRGITMGKQEFDGMSRISGLLTPELRATIEAVLAKLAAPGACNPDDQTPLVDDTPDADAVRRDTRSQAQRNHDAFLAALRGLLASGELGQHKGLPVTIVVSTTLKELEAATGKGVTGGGSRVPMSDLIRMASHANHYLALFDGAKPLALYHTKRLASPAQRIMLYAKDRGCSRPGCDAPAYHSEVHHVTPWTTTHRTDINDLTLACGPDNRLVEKGWKTRKNAHGDTEWLPPPHLDHGQPRINRYHHPAKILCEQDDDEPH,"49,718",454,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,,,MTCI65.15c,1
O86332,Y0793_MYCTU,Rv0793,Rv0793,GO:0003824; GO:0004497,IPR007138; IPR011008; ,,,DOMAIN 5 93 ABM.,Putative monooxygenase Rv0793 (EC 1.-.-.-),catalytic activity [GO:0003824]; monooxygenase activity [GO:0004497],9634230; 16496224,X-ray crystallography (1),"FUNCTION: Putative monooygenase that might be involved in antibiotic biosynthesis, or may act as reactive oxygen species scavenger that could help in evading host defenses.",MTSPVAVIARFMPRPDARSALRALLDAMITPTRAEDGCRSYDLYESADGGELVLFERYRSRIALDEHRGSPHYLNYRAQVGELLTRPVAVTVLAPLDEASA,"11,192",101,,,catalytic activity [GO:0003824]; monooxygenase activity [GO:0004497],,,,1
P9WFN7,Y1085_MYCTU,Rv1085c,Rv1085c MTV017.38c,GO:0005886; GO:0016021; GO:0019835,IPR004254; IPR005744; ,,,,UPF0073 membrane protein Rv1085c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytolysis [GO:0019835],9634230,,,MSGQADTATTAEARTPAHAAHHLVEGVARVLTKPRFRGWIHVYSAGTAVLAGASLVAVSWAVGSAKAGLTTLAYTAATITMFTVSATYHRVNWKSATARNWMKRADHSMIFVFIAGSYTPFALLALPAHDGRVVLSIVWGGAIAGILLKMCWPAAPRSVGVPLYLLLGWVAVWYTATILHNAGVTALVLLFVGGALYSIGGILYAVRWPDPWPTTFGYHEFFHACTAVAAICHYIAMWFVVF,"26,034",242,UPF0073 (Hly-III) family,cytolysis [GO:0019835],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV017.38c,1
P9WF73,VPC32_MYCTU,Rv1114,vapC32 Rv1114,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC32,DOMAIN 2 112 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC32 (RNase VapC32) (EC 3.1.-.-) (Toxin VapC32),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB32. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MILVDTSVWIEHLRAADARLVELLGDDEAGCHPLVIEELALGSIKQRDVVLDLLANLYQFPVVTHDEVLRLVGRRRLWGRGLGAVDANLLGSVALVGGARLWTRDKRLKAACAESGVALAEEVS,"13,477",124,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
O53871,Y0859_MYCTU,Rv0859,fadA Rv0859,GO:0003988; GO:0005618; GO:0005886; GO:0006635,IPR002155; IPR016039; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; ,,fadA,,Putative acyltransferase Rv0859 (EC 2.3.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 20066036; 21969609,X-ray crystallography (3),,MSEEAFIYEAIRTPRGKQKNGSLHEVKPLSLVVGLIDELRKRHPDLDENLISDVILGCVSPVGDQGGDIARAAVLASGMPVTSGGVQLNRFCASGLEAVNTAAQKVRSGWDDLVLAGGVESMSRVPMGSDGGAMGLDPATNYDVMFVPQSIGADLIATIEGFSREDVDAYALRSQQKAAEAWSGGYFAKSVVPVRDQNGLLILDHDEHMRPDTTKEGLAKLKPAFEGLAALGGFDDVALQKYHWVEKINHVHTGGNSSGIVDGAALVMIGSAAAGKLQGLTPRARIVATATSGADPVIMLTGPTPATRKVLDRAGLTVDDIDLFELNEAFASVVLKFQKDLNIPDEKLNVNGGAIAMGHPLGATGAMILGTMVDELERRNARRALITLCIGGGMGVATIIERV,"42,414",403,Thiolase family,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
A0A089QKZ7,Y155A_MYCTU,Rv1155A LH57_06350,Rv1155A LH57_06350,,IPR035172; ,,,,Uncharacterized protein Rv1155A,,9634230; 21969609,,,MGESKSPQESSSEGETKRKFREALDRKMAQSSSGSDHKDGGGKQSRAHGPVASRREFRRKSG,"6,793",62,,,,,,,1
P9WKQ1,SMASE_MYCTU,Rv0888,spmT Rv0888 MTCY31.16,GO:0005215; GO:0006685; GO:0006811; GO:0009279; GO:0015288; GO:0044179; GO:0046930; GO:0061751; GO:0071396; GO:0071702,IPR036691; IPR005135; ,,spmT,,Sphingomyelinase (SMase) (EC 3.1.4.12),cell outer membrane [GO:0009279]; pore complex [GO:0046930]; neutral sphingomyelin phosphodiesterase activity [GO:0061751]; porin activity [GO:0015288]; transporter activity [GO:0005215]; cellular response to lipid [GO:0071396]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]; organic substance transport [GO:0071702]; sphingomyelin catabolic process [GO:0006685],9634230; 21969609; 26036301,,"FUNCTION: Catalyzes the cleavage of sphingomyelin, a major lipid in eukaryotic cells, into ceramide and phosphocholine, which are then utilized by M.tuberculosis as carbon, nitrogen and phosphorus sources, respectively. Thus, enables M.tuberculosis to utilize sphingomyelin as a source of several essential nutrients for intracellular growth during infection. Furthermore, lyses erythrocytes and constitutes the main hemolytic factor of M.tuberculosis. {ECO:0000269|PubMed:26036301}.",MDYAKRIGQVGALAVVLGVGAAVTTHAIGSAAPTDPSSSSTDSPVDACSPLGGSASSLAAIPGASVPQVGVRQVDPGSIPDDLLNALIDFLAAVRNGLVPIIENRTPVANPQQVSVPEGGTVGPVRFDACDPDGNRMTFAVRERGAPGGPQHGIVTVDQRTASFIYTADPGFVGTDTFSVNVSDDTSLHVHGLAGYLGPFHGHDDVATVTVFVGNTPTDTISGDFSMLTYNIAGLPFPLSSAILPRFFYTKEIGKRLNAYYVANVQEDFAYHQFLIKKSKMPSQTPPEPPTLLWPIGVPFSDGLNTLSEFKVQRLDRQTWYECTSDNCLTLKGFTYSQMRLPGGDTVDVYNLHTNTGGGPTTNANLAQVANYIQQNSAGRAVIVTGDFNARYSDDQSALLQFAQVNGLTDAWVQVEHGPTTPPFAPTCMVGNECELLDKIFYRSGQGVTLQAVSYGNEAPKFFNSKGEPLSDHSPAVVGFHYVADNVAVR,"52,034",490,SpmT family,cellular response to lipid [GO:0071396]; hemolysis in other organism [GO:0044179]; ion transport [GO:0006811]; organic substance transport [GO:0071702]; sphingomyelin catabolic process [GO:0006685],neutral sphingomyelin phosphodiesterase activity [GO:0061751]; porin activity [GO:0015288]; transporter activity [GO:0005215],cell outer membrane [GO:0009279]; pore complex [GO:0046930],,MTCY31.16,1
P9WQ73,SERC_MYCTU,Rv0884c,serC Rv0884c MTCY31.12c,GO:0004648; GO:0004760; GO:0005576; GO:0005777; GO:0005886; GO:0006564; GO:0008453; GO:0008615; GO:0019265; GO:0040007,IPR000192; IPR022278; IPR006272; IPR015424; IPR015422; IPR015421; ,,serC,,Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT),"extracellular region [GO:0005576]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alanine-glyoxylate transaminase activity [GO:0008453]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; serine-pyruvate transaminase activity [GO:0004760]; glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; growth [GO:0040007]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]",9634230; 21969609; 22525753,X-ray crystallography (2),FUNCTION: Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine. {ECO:0000250}.,MADQLTPHLEIPTAIKPRDGRFGSGPSKVRLEQLQTLTTTAAALFGTSHRQAPVKNLVGRVRSGLAELFSLPDGYEVILGNGGATAFWDAAAFGLIDKRSLHLTYGEFSAKFASAVSKNPFVGEPIIITSDPGSAPEPQTDPSVDVIAWAHNETSTGVAVAVRRPEGSDDALVVIDATSGAGGLPVDIAETDAYYFAPQKNFASDGGLWLAIMSPAALSRIEAIAATGRWVPDFLSLPIAVENSLKNQTYNTPAIATLALLAEQIDWLVGNGGLDWAVKRTADSSQRLYSWAQERPYTTPFVTDPGLRSQVVGTIDFVDDVDAGTVAKILRANGIVDTEPYRKLGRNQLRVAMFPAVEPDDVSALTECVDWVVERL,"40,233",376,"Class-V pyridoxal-phosphate-dependent aminotransferase family, SerC subfamily","glycine biosynthetic process, by transamination of glyoxylate [GO:0019265]; growth [GO:0040007]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]",alanine-glyoxylate transaminase activity [GO:0008453]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; serine-pyruvate transaminase activity [GO:0004760],extracellular region [GO:0005576]; peroxisome [GO:0005777]; plasma membrane [GO:0005886],,MTCY31.12c,1
P9WH99,RL32_MYCTU,Rv0979.1c,rpmF Rv0979.1c Rv0979A,GO:0003735; GO:0006412; GO:0015934,IPR002677; IPR011332; ,,rpmF,,50S ribosomal protein L32,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 12368430; 21969609,Electron microscopy (1),,MAVPKRRKSRSNTRSRRSQWKAAKTELVGVTVAGHAHKVPRRLLKAARLGLIDFDKR,"6,507",57,Bacterial ribosomal protein bL32 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],large ribosomal subunit [GO:0015934],,Rv0979A,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WFG9,Y813_MYCTU,Rv0813c,Rv0813c,GO:0005886,IPR012674; IPR014878; IPR022939; ,,,,UPF0678 fatty acid-binding protein-like protein Rv0813c,plasma membrane [GO:0005886],9634230; 12368430; 19099550; 21969609; 17172346,X-ray crystallography (1),FUNCTION: May play a role in the intracellular transport of hydrophobic ligands. {ECO:0000305}.,MSSGAGSDATGAGGVHAAGSGDRAVAAAVERAKATAARNIPAFDDLPVPADTANLREGADLNNALLALLPLVGVWRGEGEGRGPDGDYRFGQQIVVSHDGGDYLNWESRSWRLTATGDYQEPGLREAGFWRFVADPYDPSESQAIELLLAHSAGYVELFYGRPRTQSSWELVTDALARSRSGVLVGGAKRLYGIVEGGDLAYVEERVDADGGLVPHLSARLSRFVG,"23,900",226,UPF0678 family,,,plasma membrane [GO:0005886],,,1
P9WFY3,Y881_MYCTU,Rv0881,Rv0881 MTCY31.09,GO:0003723; GO:0006396; GO:0008173,IPR029028; IPR029064; IPR001537; IPR029026; ,,,,Uncharacterized tRNA/rRNA methyltransferase Rv0881 (EC 2.1.1.-),RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],9634230,,,MTEGRCAQHPDGLDVQDVCDPDDPRLDDFRDLNSIDRRPDLPTGKALVIAEGVLVVQRMLASRFTPLALFGTDRRLAELKDDLAGVGAPYYRASADVMARVIGFHLNRGVLAAAGRVPEPSVAQVVAGARTVAVLEGVNDHENLGSIFRNAAGLSVDAVVFGTGCADPLYRRAVRVSMGHALLVPYARAADWPTELMTLKESGFRLLAMTPHGNACKLPEAIAAVSHERIALLVGAEGPGLTAAALRISDVRVRIPMSRGTDSLNVATAAALAFYERTRSGHHIGPGT,"30,602",288,"Class IV-like SAM-binding methyltransferase superfamily, RNA methyltransferase TrmH family",RNA processing [GO:0006396],RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173],,,MTCY31.09,1
P9WKQ9,Y882_MYCTU,Rv0882,Rv0882 MTCY31.10,GO:0005886; GO:0016021,IPR024244; ,,,,Uncharacterized protein Rv0882,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MNDQRDQAVPWATGLAVAGFVAAVIAVAVVVLSLGLIRVHPLLAVGLNIVAVSGLAPTLWGWRRTPVLRWFVLGAAVGVAGAWLALLALTLGDG,"9,662",94,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.10,1
P9WMV1,Y891_MYCTU,Rv0891c,Rv0891c MTCY31.19c,GO:0005829; GO:0009190; GO:0016849; GO:0035556,IPR001054; IPR029787; ,,,DOMAIN 92 199 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Uncharacterized protein Rv0891c,cytosol [GO:0005829]; phosphorus-oxygen lyase activity [GO:0016849]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],9634230,,,MLFNAVHNSLPPNIDIDHAILRGEDHPPTCAKCVARVRISALGSLDLRYHSLRCYAAPPDVGRCEFVPPRRRVLIANQGLDVSRLPPTGTVTLLLADVEESTHLWQMCPEDMATAIAHLDHTVSEAITNHGGVQPVKRYEGDSFVAAFTRASDAAACALDLQRTSLAPIRLRIGLHTGEVQLRDELYVGPTINRTARLRDLAHGGQVVLSAATGDLVTGRLPADAWLVDLGRHPLRGLPRPEWVMQLCHPDIREKFPPLRTAKSSPTSILPAQFTTFVGRRAQIS,"31,232",285,Adenylyl cyclase class-4/guanylyl cyclase family,cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],phosphorus-oxygen lyase activity [GO:0016849],cytosol [GO:0005829],,MTCY31.19c,1
P9WJ05,Y910_MYCTU,Rv0910,Rv0910,GO:0045926,IPR019587; IPR023393; ,,,,Toxin Rv0910,negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin Rv0909. Does not exert its toxic effect via translation. {ECO:0000269|PubMed:20011113}.,MAKLSGSIDVPLPPEEAWMHASDLTRYREWLTIHKVWRSKLPEVLEKGTVVESYVEVKGMPNRIKWTIVRYKPPEGMTLNGDGVGGVKVKLIAKVAPKEHGSVVSFDVHLGGPALLGPIGMIVAAALRADIRESLQNFVTVFAG,"15,754",144,,negative regulation of growth [GO:0045926],,,,,1
P9WKP1,Y940_MYCTU,Rv0940c,Rv0940c MTCY10D7.34,GO:0005886; GO:0016705,IPR019921; IPR011251; IPR036661; ,,,,Uncharacterized protein Rv0940c,"plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MRFSYAEAMTDFTFYIPLAKAAEAAGYSSMTIPDSIAYPFESDSKYPYTPDGNREFMDGKPFIETFVLTAALGAVTTRLRFNFFVLKLPIRPPALVAKQAGSLAALIGNRVGLGVGTSPWPEDYELMGVPFAKRGKRIDECIEIVRGLTTGDYFEFHGEFYDIPKTKMTPAPTQPIPILVGGHADAALRRAARADGWMHGGGDPDELDRLIARVKRLREEAGKTSPFEIHVISLDGFTVDGVKRLEDKGVTDVIVGFRVPYTMGPDTEPLQTKIRNLEMFAENVIAKV,"31,789",288,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",plasma membrane [GO:0005886],,MTCY10D7.34,1
P9WKN9,Y942_MYCTU,Rv0942,Rv0942 MTCY10D7.32c,,,,,,Uncharacterized protein Rv0942,,9634230,,,MGRSATIAMVPKRRDAMNRHSGPILSSGFIASSSNSCPANSLRMPSALAAETLSFDDRAVRRSTHHPGGGYPQKHAINLQSGLCPAYANASR,"9,737",92,,,,,,MTCY10D7.32c,1
P9WKM5,Y964_MYCTU,Rv0964c,Rv0964c MTCY10D7.10,,,,,,Uncharacterized protein Rv0964c,,9634230,,,MGLLGFGGAAAEAAQVATHHTTVLLDHHAGACEAVARAAEKAAEEVAAIKMRLQVIRDAAREHHLTIAYATGTALPPPDLSSYSPADQQAILNTAIRRASNVCWPTPRPPMRIWPRRFDAPPGPCRASRSMPNSAMRHPQCRRCRRRTATLRRSSGGGIR,"17,317",160,,,,,,MTCY10D7.10,1
P9WKM3,Y965_MYCTU,Rv0965c,Rv0965c MTCY10D7.09,,,,,,Uncharacterized protein Rv0965c,,9634230,,,MRVNRPQCARVPYSAESLVRVEASWYGRTLRAIPEVLSQVGYQQADHGESLLTSHHCCLGAAEGARPGWVGSSAGALSGLLDSWAEASTAHAARIGDHSYGMHLAAVGFAEMEEHNAAALAAVYPTGGGSARCDGVDVS,"14,479",139,,,,,,MTCY10D7.09,1
P9WKL7,Y970_MYCTU,Rv0970,Rv0970 MTCY10D7.04c,GO:0005886; GO:0016021,IPR033458; ,,,,Uncharacterized protein Rv0970,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 16586367,,,MIHDLMLRWVVTGLFVLTAAECGLAIIAKRRPWTLIVNHGLHFAMAVAMAVMAWPWGARVPTTGPAVFFLLAAVWFGATAVVAVRGTATRGLYGYHGLMMLATAWMYAAMNPRLLPVRSCTEYATEPDGSMPAMDMTAMNMPPNSGSPIWFSAVNWIGTVGFAVAAVFWACRFVMERRQEATQSRLPGSIGQAMMAAGMAMLFFAMLFPV,"22,887",210,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10D7.04c,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WKR3,Y877_MYCTU,Rv0877,Rv0877 MTCY31.05,,IPR021391; ,,,,Uncharacterized protein Rv0877,,9634230; 21969609,,,MTGPTEESAVATVADWPEGLAAVLRGAADQARAAVVEFSGPEAVGDYLGVSYEDGNAATHRFIAHLPGYQGWQWAVVVASYSGADHATISEVVLVPGPTALLAPDWVPWEQRVRPGDLSPGDLLAPAKDDPRLVPGYTASGDAQVDETAAEIGLGRRWVMSAWGRAQSAQRWHDGDYGPGSAMARSTKRVCRDCGFFLPLAGSLGAMFGVCGNELSADGHVVDRQYGCGAHSDTTAPAGGSTPIYEPYDDGVLDIIEKPAES,"27,469",262,,,,,,MTCY31.05,1
P9WKR1,Y879_MYCTU,Rv0879c,Rv0879c MTCY31.07c,GO:0005886; GO:0016021,IPR019681; ,,,,Uncharacterized protein Rv0879c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MSVENSQIREPPPLPPVLLEVWPVIAVGALAWLVAAVAAFVVPGLASWRPVTVAGLATGLLGTTIFVWQLAAARRGARGAQAGLETYLDPK,"9,512",91,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.07c,1
P9WMF1,Y880_MYCTU,Rv0880,Rv0880 MTCY31.08,GO:0003677; GO:0003700; GO:0006351,IPR000835; IPR023187; IPR036388; IPR036390; ,,,DOMAIN 5 137 HTH marR-type. {ECO:0000255|PROSITE-ProRule:PRU00345}.,Uncharacterized HTH-type transcriptional regulator Rv0880,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (1),,MLDSDARLASDLSLAVMRLSRQLRFRNPSSPVSLSQLSALTTLANEGAMTPGALAIRERVRPPSMTRVIASLADMGFVDRAPHPIDGRQVLVSVSESGAELVKAARRARQEWLAERLATLNRSERDILRSAADLMLALVDESP,"15,576",143,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTCY31.08,1
P9WKQ7,Y883_MYCTU,Rv0883c,Rv0883c MTCY31.11c,GO:0040007,IPR021421; ,,,,Uncharacterized protein Rv0883c,growth [GO:0040007],9634230; 21969609,,,MRELKVVGLDADGKNIICQGAIPSEQFKLPVDDRLRAALRDDSVQPEQAQLDIEVTNVLSPKEIQARIRAGASVEQVAAASGSDIARIRRFAHPVLLERSRAAELATAAHPVLADGPAVLTMQETVAAALVARGLNPDSLTWDAWRNEDSRWTVQLAWKAGRSDNLAHFRFTPGAHGGTATAIDDTAHELINPTFNRPLRPLAPVAHLDFDEPEPAQPTLTVPSAQPVSNRRGKPAIPAWEDVLLGVRSGGRR,"27,373",253,,growth [GO:0040007],,,,MTCY31.11c,1
P9WKQ5,Y885_MYCTU,Rv0885,Rv0885 MTCY31.13,GO:0005886; GO:0016021,IPR025859; IPR009078; ,,,,Uncharacterized protein Rv0885,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MDRTRIVRRWRRNMDVADDAEYVEMLATLSEGSVRRNFNPYTDIDWESPEFAVTDNDPRWILPATDPLGRHPWYQAQSRERQIEIGMWRQANVAKVGLHFESILIRGLMNYTFWMPNGSPEYRYCLHESVEECNHTMMFQEMVNRVGADVPGLPRRLRWVSPLVPLVAGPLPVAFFIGVLAGEEPIDHTQKNVLREGKSLHPIMERVMSIHVAEEARHISFAHEYLRKRLPRLTRMQRFWISLYFPLTMRSLCNAIVVPPKAFWEEFDIPREVKKELFFGSPESRKWLCDMFADARMLAHDTGLMNPIARLVWRLCKIDGKPSRYRSEPQRQHLAAAPAA,"39,798",340,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.13,1
P9WKP9,Y894_MYCTU,Rv0894,Rv0894 MTCY31.22,GO:0005524; GO:0005829; GO:0040007,IPR027417; ,,,,Uncharacterized protein Rv0894,cytosol [GO:0005829]; ATP binding [GO:0005524]; growth [GO:0040007],9634230; 19099550,,,MPSRATVQEFSDSYPFCHNGFRPIMMPKIVSVQHSTRRHLTSFVGRKAELNDVRRLLSDKRLVTLTGPDGMGKSRLALQIGAQIAHEFTYGRWDCDLATVTDRDCVSISMLNALGLPVQPGLSAIDTLVGVINDARVLLVLDHCEHLLDACAAIIDSLLRSCPRLTILTTSTEAIGLAGELTWRVPPLSLTNDAIELFVDRARRVRSDFAINADTAVTVGEICRRLDGVPLAIELAAARTDTLSPVEILAGLNDRFRLVAGAAGNAVRPEQTLCATVQWSHALLSGPERALLHRLAVFAGGFDLDGAQAVGANDEDFEGYQTLGRFAELVDKAFVVVENNRGRAGYRLLYSVRQYALEKLSESGEADAVLARYRKHLKQPNQVVRAGSGGVRY,"42,873",393,,growth [GO:0040007],ATP binding [GO:0005524],cytosol [GO:0005829],,MTCY31.22,1
P9WJ07,Y909_MYCTU,Rv0909,Rv0909,GO:0045927,IPR028037; ,,,,Antitoxin Rv0909,positive regulation of growth [GO:0045927],9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin Rv0910. {ECO:0000269|PubMed:20011113}.,MGILDKVKNLLSQNADKVETVINKAGEFVDEQTQGNYSDAIHKLHDAASNVVGMSDQQS,"6,403",59,,positive regulation of growth [GO:0045927],,,,,1
P9WGQ5,Y927C_MYCTU,Rv0927c,Rv0927c,GO:0005886; GO:0016491; GO:0052556,IPR036291; IPR020904; IPR002347; ,,,,Uncharacterized oxidoreductase Rv0927c (EC 1.-.-.-),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,,MILDMFRLDDKVAVITGGGRGLGAAIALAFAQAGADVLIASRTSSELDAVAEQIRAAGRRAHTVAADLAHPEVTAQLAGQAVGAFGKLDIVVNNVGGTMPNTLLSTSTKDLADAFAFNVGTAHALTVAAVPLMLEHSGGGSVINISSTMGRLAARGFAAYGTAKAALAHYTRLAALDLCPRVRVNAIAPGSILTSALEVVAANDELRAPMEQATPLRRLGDPVDIAAAAVYLASPAGSFLTGKTLEVDGGLTFPNLDLPIPDL,"26,746",263,Short-chain dehydrogenases/reductases (SDR) family,positive regulation by symbiont of host immune response [GO:0052556],oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
P9WKN1,Y959_MYCTU,Rv0959,Rv0959 MTCY10D7.15c,GO:0005886,IPR002035; IPR036465; ,,,,Uncharacterized protein Rv0959,plasma membrane [GO:0005886],9634230; 21969609,,,MAKSDGDDPLRPASPRLRSSRRHSLRYSAYTGGPDPLAPPVDLRDALEQIGQDVMAGASPRRALSELLRRGTRNLTGADRLAAEVNRRRRELLRRNNLDGTLQEIKKLLDEAVLAERKELARALDDDARFAELQLDALPASPAKAVQELAEYRWRSGQAREKYEQIKDLLGRELLDQRFAGMKQALAGATDDDRRRVTEMLDDLNDLLDKHARGEDTQRDFDEFMTKHGEFFPENPRNVEELLDSLAKRAAAAQRFRNSLSQEQRDELDALAQQAFGSPALMRALDRLDAHLQAARPGEDWTGSQQFSGDNPFGMGEGTQALADIAELEQLAEQLSQSYPGASMDDVDLDALARQLGDQAAVDARTLAELERALVNQGFLDRGSDGQWRLSPKAMRRLGETALRDVAQQLSGRHGERDHRRAGAAGELTGATRPWQFGDTEPWHVARTLTNAVLRQAAAVHDRIRITVEDVEVAETETRTQAAVALLVDTSFSMVMENRWLPMKRTALALHHLVCTRFRSDALQIIAFGRYARTVTAAELTGLAGVYEQGTNLHHALALAGRHLRRHAGAQPVVLVVTDGEPTAHLEDFDGDGTSVFFDYPPHPRTIAHTVRGFDDMARLGAQVTIFRLGSDPGLARFIDQVARRVQGRVVVPDLDGLGAAVVGDYLRFRRR,"74,636",672,,,,plasma membrane [GO:0005886],,MTCY10D7.15c,1
P9WKM9,Y961_MYCTU,Rv0961,Rv0961 MTCY10D7.13c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv0961,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MRVPSQWMISSRVTVAWNIVGYLVYAALAFVGGFAVWFSLFFAMATDGCHDSACDASYHVFPAMVTMWIGVGAVLLLTLVVMVRNSSRGNVVIGWPFVGLLALGLVYVAADAVLH,"12,415",115,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10D7.13c,1
P9WKM7,Y963_MYCTU,Rv0963c,Rv0963c MTCY10D7.11,,IPR029058; IPR010427; ,,,,Uncharacterized protein Rv0963c,,9634230,,,MLQRELTRLQNGWLSRDGVWHTDTDKLADLRALRDTLAAHPGTSLILLDTASDPRKVLAAVGVGDVDNAERVGVTMGGLNTRVSSSVGDMVKEAGIQRAKAAELRERAGWPNYDAVASIAWLGYDAPDGLKDVMHDWSARDAAGPLNRFDKGLAATTNVSDQHITAFGHSYGSLVTSLALQQGAPVSDVVLYGSPGTELTHASQLGVEPGHAFYMIGVNDHVANTIPEFGAFGSAPQDVPGMTQLSVNTGLAPGPLLGDGQLHERA,"28,069",266,,,,,,MTCY10D7.11,1
P9WKM1,Y966_MYCTU,Rv0966c,Rv0966c MTCY10D7.08,GO:0005886,IPR012551; ,,,,Uncharacterized protein Rv0966c,plasma membrane [GO:0005886],9634230; 16586367; 21969609,,,MSNSAQRDARNSRDESARASDTDRIQIAQLLAYAAEQGRLQLTDYEDRLARAYAATTYQELDRLRADLPGAAIGPRRGGECNPAPSTLLLALLGGFERRGRWNVPKKLTTFTLWGSGVLDLRYADFTSTEVDIRAYSIMGAQTILLPPEVNVEIHGHRVMGGFDRKVVGEGTRGVPTVRIRGFSLWGDVGIKRKPRKPRK,"22,210",200,,,,plasma membrane [GO:0005886],,MTCY10D7.08,1
P9WKL9,Y968_MYCTU,Rv0968,Rv0968 MTCY10D7.06c,GO:0005618; GO:0005886,IPR009963; ,,,,Uncharacterized protein Rv0968,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 16586367; 21969609,,,MVWHGFLAKAVPTVVTGAVGVAAYEALRKMVVKAPLRAATVSVAAWGIRLAREAERKAGESAEQARLMFADVLAEASERAGEEVPPLAVAGSDDGHDH,"10,264",98,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY10D7.06c,1
P0CG95,Y814_MYCTU,Rv0814c,sseC2 Rv0814c,GO:0005618; GO:0005886,IPR008969; IPR010814; ,,sseC2,,Uncharacterized protein Rv0814c,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 20066036; 21969609,,,MCSGPKQGLTLPASVDLEKETVITGRVVDGDGQAVGGAFVRLLDSSDEFTAEVVASATGDFRFFAAPGSWTLRALSAAGNGDAVVQPSGAGIHEVDVKIT,"10,165",100,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WJX5,Y849_MYCTU,Rv0849,Rv0849,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv0849,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MGARAIFRGFNRPSRVLMINQFGINIGFYMLMPYLADYLAGPLGLAAWAVGLVMGVRNFSQQGMFFVGGTLADRFGYKPLIIAGCLIRTGGFALLVVAQSLPSVLIAAAATGFAGALFNPAVRGYLAAEAGERKIEAFAMFNVFYQSGILLGPLVGLVLLALDFRITVLAAAGVFGLLTVAQLVALPQHRADSEREKTSILQDWRVVVRNRPFLTLAAAMTGCYALSFQIYLALPMQASILMPRNQYLLIAAMFAVSGLVAVGGQLRITRWFAVRWGAERSLVVGATILAASFIPVAVIPNGQRFGVAVAVMALVLSASLLAVASAALFPFEMRAVVALSGDRLVATHYGFYSTIVGVGVLVGNLAIGSLMSAARRLNTDEIVWGGLILVGIVAVAGLRRLDTFTSGSQNMTGRWAAPR,"44,514",419,Major facilitator superfamily,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WFI3,Y851_MYCTU,Rv0830,Rv0830,GO:0005618; GO:0005886; GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0830 (EC 2.1.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168],9634230; 12368430; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MVRADRDRWDLATSVGATATMVAAQRALAADPRYALIDDPYAAPLVRAVGMDVYTRLVDWQIPVEGDSEFDPQRMATGMACRTRFFDQFFLDATHSGIGQFVILASGLDARAYRLAWPVGSIVYEVDMPEVIEFKTATLSDLGAEPATERRTVAVDLRDDWATALQTAGFDPKVPAAWSAEGLLVYLPVEAQDALFDNITALSAPGSRLAFEFVPDTAIFADERWRNYHNRMSELGFDIDLNELVYHGQRGHVLDYLTRDGWQTSALTVTQLYEANGFAYPDDELATAFADLTYSSATLMR,"33,416",301,UPF0677 family,,methyltransferase activity [GO:0008168],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WKR5,Y876_MYCTU,Rv0876c,Rv0876c MTCY31.04c,GO:0005576; GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized protein Rv0876c,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 21969609,,,MSGRRGDHPGRMAPTPGRRTRNGSVNGHPGMANYPPDDANYRRSRRPPPMPSANRYLPPLGEQPEPERSRVPPRTTRAGERITVTRAAAMRSREMGSRMYLLVHRAATADGADKSGLTALTWPVMANFAVDSAMAVALANTLFFAAASGESKSRVALYLLITIAPFAVIAPLIGPALDRLQHGRRVALALSFGLRTALAVVLIMNYDGATGSFPSWVLYPCALAMMVFSKSFSVLRSAVTPRVMPPTIDLVRVNSRLTVFGLLGGTIAGGAIAAGVEFVCTHLFQLPGALFVVVAITIAGASLSMRIPRWVEVTSGEVPATLSYHRDRGRLRRRWPEEVKNLGGTLRQPLGRNIITSLWGNCTIKVMVGFLFLYPAFVAKAHEANGWVQLGMLGLIGAAAAVGNFAGNFTSARLQLGRPAVLVVRCTVLVTVLAIAAAVAGSLAATAIATLITAGSSAIAKASLDASLQHDLPEESRASGFGRSESTLQLAWVLGGAVGVLVYTELWVGFTAVSALLILGLAQTIVSFRGDSLIPGLGGNRPVMAEQETTRRGAAVAPQ,"59,145",559,,transmembrane transport [GO:0055085],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.04c,1
P9WKQ3,Y887_MYCTU,Rv0887c,Rv0887c MTCY31.15c,,IPR029068; IPR004360; IPR037523; ,,,DOMAIN 25 151 VOC. {ECO:0000255|PROSITE-ProRule:PRU01163}.,Uncharacterized protein Rv0887c,,9634230; 21969609,,,MSLSGPRIGRAHQQQGDTMAINVEPALSPHLVVDDAASAIDFYVKAFDAVELGRVPGPDGKLIHAALRINGFTVMLNDDVPQMCGGKSMTPTSLGGTPVTIHLTVTDVDAKFQRALNAGATVVTALEDQLWGDRYGVVADPFGHHWSLGQPVREVNMDEIQAAMSSQGDG,"18,019",170,,,,,,MTCY31.15c,1
P9WMG1,Y890_MYCTU,Rv0890c,Rv0890c MTCY31.18c,GO:0003677; GO:0005618; GO:0005829; GO:0006351; GO:0006355,IPR027417; IPR016032; IPR011990; IPR000792; IPR036388; ,,,DOMAIN 814 879 HTH luxR-type. {ECO:0000255|PROSITE-ProRule:PRU00411}.,Putative HTH-type transcriptional regulator Rv0890c,"cell wall [GO:0005618]; cytosol [GO:0005829]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 16483748; 21969609,,,MRALLAQNRLVTLCGTGGVGKTRLAIQIASASELRDGLCFVDLAPITESGIVAATAARAVGLPDQPGRSTMDSLRRFIGNRRMLMVLDNCEHLLDACAALVVELLGACPELTILATSREPIGMAGEITWRVPSMSITDEAVELFADRASRVQPGFTIANHNAAAVGEICRRLDGIPLAIEFAAARVRSMSPLEIADGLDDCFRLLAGGVRGAVQRQQTLRASIDWSHALLTETEQILFRRLAPFVGGFDLAAVRAVAAGSDLDPFSVLDQLTLLVDKSLVVADDCQGRTRYRLLETVRRYALEKLGDSGEADVHARHRDYYTALAASLNTPADNDHQRLVARAETEIDNLRAAFAWSRENGHITEALQLASSLQPIWFGRAHLREGLSWFNSILEDQRFHRLAVSTAVRARALADKAMLSTWLATSPVGATDIIAPAQQALAMAREVGDPAALVRALTACGCSSGYNAEAAAPYFAEATDLARAIDDKWTLCQILYWRGVGTCISGDPNALRAAAEECRDLADTIGDRFVSRHCSLWLSLAQMWAGNLTEALELSREITAEAEASNDVPTKVLGLYTQAQVLAYCGASAAHAIAGACIAAATELGGVYQGIGYAAMTYAALAAGDVTAALEASDAARPILRAQPDQVTMHQVLMAQLALAGGDAIAARQFANDAVDATNGWHRMVALTIRARVATARGEPELARDDAHAALACGAELHIYQGMPDAMELLAGLAGEVGSHSEGVRLLGAAAALRQQTRQVRFKIWDAGYQASVTALREAMGDEDFDRAWAEGAALSTDEAIAYAQRGRGERKRPARGWGSLTPTERDVVRLVSEGLSNKDIAKRLFVSPRTVQTHLTHVYAKLGLPSRVQLVDEAARRGSPS,"94,496",882,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY31.18c,1
P9WPR7,Y917_MYCTU,Rv0917,Rv0917 MTCY21C12.11,GO:0005576; GO:0005886; GO:0016021; GO:0022857; GO:0071705,IPR018093; IPR000060; ,,,,Uncharacterized transporter Rv0917,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; nitrogen compound transport [GO:0071705],9634230,,,MSAKERGDQNAVVDALRSIQPAVFIPASVVIVAMIVVSVVYSSVAENAFVRLNSAITGGVGWWYILVATGFVVFALYCGISRIGTIRLGRDDELPEFSFWAWLAMLFSAGMGIGLVFYGVAEPLSHYLRPPRSRGVPALTDAAANQAMALTVFHWGLHAWAIYVVVGLGMAYMTYRRGRPLSVRWLLEPVVGRGRVEGALGHAVDVIAIVGTLFGVATSLGFGITQIASGLEYLGWIRVDNWWMVGMIAAITATATASVVSGVSKGLKWLSNINMALAAALALFVLLLGPTLFLLQSWVQNLGGYVQSLPQFMLRTAPFSHDGWLGDWTIFYWGWWISWAPFVGMFIARISRGRTIREFIGAVLLVPTVIASLWFTIFGDSALLRQRNNGDMLVNGAVDTNTSLFRLLDGLPIGAITSVLAVLVIVFFFVTSSDSGSLVIDILSAGGELDPPKLTRVYWAVLEGVAAAVLLLIGGAGSLTALRTAAIATALPFSIVMVVACYAMTKAFHFDLAATPRLLHVTVPDVVAAGNRRRHDISATLSGLIAVRDVDSGTYIVHPDTGALTVTAPPDPLDDHVFESDRHVTRRNTTSSR,"63,869",593,BCCT transporter (TC 2.A.15) family,nitrogen compound transport [GO:0071705],transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21C12.11,1
P9WKN7,Y943_MYCTU,Rv0943c,Rv0943c MTCY10D7.31,GO:0005886,IPR032371; IPR036188; ,,,,Uncharacterized protein Rv0943c,plasma membrane [GO:0005886],9634230,,,MAGVSEAERRGHRKLVRFQARRAIGPIRPTSAAWDRDFDPAGKRIAVVGTDAAAAHYISRLSESAASVTVFTQAPRRVVTGVPLWTTRAKRWLRRRTGAEHPAVAWATAAIDALTSSGIRTSDGVEHPVDAIIYGTGFAIADQVGDQTLVGAGGVTIRQAWDDGMEPYLGVAVHGFPNYFFITGPDTAAQARCVVECMKLMERTASRRIEVRRSSQQVFNERAQLKPAQPHRQTGGLEAFDLSSAATEDDQTYDGAATLTLAGARFRVRVRLTGHLDPIDGNYHWQGTVFDSLPETSLTHARAATLTIGGRSAPARITEQTPWGTHSVAGVGPPPYARSGPASATT,"37,206",346,,,,plasma membrane [GO:0005886],,MTCY10D7.31,1
P9WGR7,Y945_MYCTU,Rv0945,Rv0945 MTCY10D7.29c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Uncharacterized oxidoreductase Rv0945 (EC 1.-.-.-),oxidoreductase activity [GO:0016491],9634230; 21969609,,,MLTGVTRQKILITGASSGLGAGMARSFAAQGRDLALCARRTDRLTELKAELSQRYPDIKIAVAELDVNDHERVPKVFAELSDEIGGIDRVIVNAGIGKGARLGSGKLWANKATIETNLVAALVQIETALDMFNQRGSGHLVLISSVLGVKGVPGVKAAYAASKAGVRSLGESLRAEYAQRPIRVTVLEPGYIESEMTAKSASTMLMVDNATGVKALVAAIEREPGRAAVPWWPWAPLVRLMWVLPPRLTRRFA,"27,139",253,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,MTCY10D7.29c,1
P9WKN5,Y953_MYCTU,Rv0953c,Rv0953c MTCY10D7.21,GO:0016705,IPR019921; IPR011251; IPR036661; ,,,,Uncharacterized protein Rv0953c,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MHYGLVLFTSDRGITPAAAARLAESHGFRTFYVPEHTHIPVKRQAAHPTTGDASLPDDRYMRTLDPWVSLGAASAVTSRIRLATAVALPVEHDPITLAKSIATLDHLSHGRVSVGVGFGWNTDELVDHGVPPGRRRTMLREYLEAMRALWTQEEACYDGEFVKFGPSWAWPKPVQPHIPVLVGAAGTEKNFKWIARSADGWITTPRDVDIDEPVKLLQDIWAAAGRDGLPQIVALDVKPVPDKLARWAELGVTEVLFGMPDRSADDAAAYVERLAAKLACCV,"30,913",282,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCY10D7.21,1
P9WKN3,Y955_MYCTU,Rv0955,Rv0955 MTCY10D7.19c,GO:0005886; GO:0016021; GO:0040007,,,,,Uncharacterized protein Rv0955,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MNRVSASADDRAAGARPARDLVRVAFGPGVVALGIIAAVTLLQLLIANSDMTGAWGAIASMWLGVHLVPISIGGRALGVMPLLPVLLMVWATARSTARATSPQSSGLVVRWVVASALGGPLLMAAIALAVIHDASSVVTELQTPSALRAFTSVLVVHSVGAATGVWSRVGRRALAATALPDWLHDSMRAAAAGVLALLGLSGVVTAGSLVVHWATMQELYGITDSIFGQFSLTVLSVLYAPNVIVGTSAIAVGSSAHIGFATFSSFAVLGGDIPALPILAAAPTPPLGPAWVALLIVGASSGVAVGQQCARRALPFVAAMAKLLVAAVAGALVMAVLGYGGGGRLGNFGDVGVDEGALVLGVLFWFTFVGWVTVVIAGGISRRPKRLRPAPPVELDADESSPPVDMFDGAASEQPPASVAEDVPPSHDDIANGLKAPTADDEALPLSDEPPPRAD,"46,089",455,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10D7.19c,1
O05598,Y1013_MYCTU,Rv1013,pks16 Rv1013,GO:0005618; GO:0005886; GO:0006633; GO:0016874; GO:0070566,IPR020845; IPR028154; IPR000873; ,,pks16,,Putative ligase Rv1013 (EC 6.2.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 20066036; 21969609,,,MSRFTEKMFHNARTATTGMVTGEPHMPVRHTWGEVHERARCIAGGLAAAGVGLGDVVGVLAGFPVEIAPTAQALWMRGASLTMLHQPTPRTDLAVWAEDTMTVIGMIEAKAVIVSEPFLVAIPILEQKGMQVLTVADLLASDPIGPIEVGEDDLALMQLTSGSTGSPKAVQITHRNIYSNAEAMFVGAQYDVDKDVMVSWLPCFHDMGMVGFLTIPMFFGAELVKVTPMDFLRDTLLWAKLIDKYQGTMTAAPNFAYALLAKRLRRQAKPGDFDLSTLRFALSGAEPVEPADVEDLLDAGKPFGLRPSAILPAYGMAETTLAVSFSECNAGLVVDEVDADLLAALRRAVPATKGNTRRLATLGPLLQDLEARIIDEQGDVMPARGVGVIELRGESLTPGYLTMGGFIPAQDEHGWYDTGDLGYLTEEGHVVVCGRVKDVIIMAGRNIYPTDIERAAGRVDGVRPGCAVAVRLDAGHSRESFAVAVESNAFEDPAEVRRIEHQVAHEVVAEVDVRPRNVVVLGPGTIPKTPSGKLRRANSVTLVT,"58,467",544,ATP-dependent AMP-binding enzyme family,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
P9WFM3,Y1101_MYCTU,Rv1101c,Rv1101c MTV017.54c,GO:0005215; GO:0005887; GO:0055085,IPR002549; ,,,,Putative transport protein Rv1101c,integral component of plasma membrane [GO:0005887]; transporter activity [GO:0005215]; transmembrane transport [GO:0055085],9634230; 21969609,,,MNTEFTLTQKRALAILTLIALLFGAYFLRNYFVLIVVAAVGAYLFTPLFKWFTKRFNTGLSAACTLLSALAAVVVPVGALVGLAIVQIARMVDSVADWVRTTDLSTLGDKILQFVNGLFDRVPFLHITVTADALRKAMISVAQNVGEWLLHFLRDAAGSLAGVITSAIIFVYVFVALLVNREKLRTLIGQLNPLGEDVTDLYLQKMGSMVRGTVNGQFVIAACQGVAGAASIYIAGFHHGFFIFAIVLTALSIIPLGGGIVTIPFGIGMIFYGNIAGGIFVLLWHLLVVTNIDNVLRPILVPRDARLNSALMLLSVFAGITMFGPWGIIIGPVLMILIVTTIDVYLAVYKGVELEQFEAPPVRRRWLPRRGPATSRNAPPPSTAE,"41,717",385,Autoinducer-2 exporter (AI-2E) (TC 2.A.86) family,transmembrane transport [GO:0055085],transporter activity [GO:0005215],integral component of plasma membrane [GO:0005887],,MTV017.54c,1
P9WM59,Y1109_MYCTU,Rv1109c,Rv1109c,GO:0005618; GO:0005829; GO:0005886,,,,,Uncharacterized protein Rv1109c,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 17259624; 21969609,,,MATAPYGVRLLVGAATVAVEETMKLPRTILMYPMTLASQAAHVVMRFQQGLAELVIKGDNTLETLFPPKDEKPEWATFDEDLPDALEGTSIPLLGLSDASEAKNDDRRSDGRFALYSVSDTPETTTASRSADRSTNPKTAKHPKSAAKPTVPTPAVAAELDYPALTLAQLRARLHTLDVPELEALLAYEQATKARAPFQTLLANRITRATAK,"22,957",212,,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WM57,Y1128_MYCTU,Rv1128c,Rv1128c MTCY22G8.17c,GO:0005618; GO:0040007,IPR003870; IPR003615; ,,,,Uncharacterized protein Rv1128c,cell wall [GO:0005618]; growth [GO:0040007],9634230,,,MCSTREEITEAFASLATALSRVLGLTFDALTTPERLALLEHCETARRQLPSVEHTLINQIGEQSTEEELGGKLGLTLADRLRITRSEAKRRVAEAADLGQRRALTGEPLPPLLTATAKAQRHGLIGDGHVEVIRAFVHRLPSWVDLKTLEKAERDLAKQATQYRPDQLAKLAARIMDCLNPDGDYTDEDRARRRGLTLGKQDVDGMSRLSGYVTPELRATIEAVWAKLAAPGMCNPEQKAPCVNGAPSKEQARRDTRSCPQRNHDALNAELRSLLTSGNLGQHNGLPASIIVTTTLKDLEAAAGAGLTGGGTILPISDVIRLARHANHYLAIFDRGKALALYHTKRLASPAQRIMLYAKDSGCSAPGCDVPGYYCEVHHVTPYAQCRNTDVNDLTLGCGGHHPLAERGWTTRKNAHGDTEWLPPPHLDHGQPRVNTFHHPEKLLADDEGDP,"49,275",451,Rv1128c/1148c/1588c/1702c/1945/3466 family,growth [GO:0040007],,cell wall [GO:0005618],,MTCY22G8.17c,1
P9WJ33,VPB32_MYCTU,Rv1113,vapB32 Rv1113,GO:0005576; GO:0045927,IPR019239; ,,vapB32,,Antitoxin VapB32,extracellular region [GO:0005576]; positive regulation of growth [GO:0045927],9634230; 20011113; 21969609; 23345537,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC32. {ECO:0000269|PubMed:20011113}.,MRTTVTVDDALLAKAAELTGVKEKSTLLREGLQTLVRVESARRLAALGGTDPQATAAPRRRTSPR,"6,973",65,,positive regulation of growth [GO:0045927],,extracellular region [GO:0005576],,,1
P9WMQ1,UVRD1_MYCTU,Rv0949,uvrD1 ivrd pcrA Rv0949 MTCY10D7.25c,GO:0000287; GO:0003677; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006268; GO:0006302; GO:0008094; GO:0009650; GO:0016887; GO:0032564; GO:0033202; GO:0040007; GO:0043140; GO:0060543,IPR005751; IPR013986; IPR014017; IPR000212; IPR027417; IPR014016; IPR034739; ,,uvrD1,DOMAIN 21 311 UvrD-like helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00560}.; DOMAIN 312 603 UvrD-like helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00617}.,ATP-dependent DNA helicase UvrD1 (EC 3.6.4.12),cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA helicase complex [GO:0033202]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATPase activity [GO:0016887]; dATP binding [GO:0032564]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; magnesium ion binding [GO:0000287]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; growth [GO:0040007]; negative regulation of strand invasion [GO:0060543]; UV protection [GO:0009650],9634230; 17158674; 20455546; 21969609; 22467787,,"FUNCTION: DNA-dependent ATPase, acting on dsDNA with a 3'-ssDNA tail, unwinding with 3'-to 5'-polarity. A minimal tail of 18 nt is required for activity. Also highly efficient on nicked DNA. Involved in the post-incision events of nucleotide excision repair, as well as in nitrosative and oxidative stress response and possibly in persistence in the host. Inhibits RecA-mediated DNA strand exchange; this does not require ATPase activity. When combined with UvrA greatly inhibits RecA-mediated DNA strand exchange. {ECO:0000269|PubMed:17158674, ECO:0000269|PubMed:20455546, ECO:0000269|PubMed:22467787}.",MSVHATDAKPPGPSPADQLLDGLNPQQRQAVVHEGSPLLIVAGAGSGKTAVLTRRIAYLMAARGVGVGQILAITFTNKAAAEMRERVVGLVGEKARYMWVSTFHSTCVRILRNQAALIEGLNSNFSIYDADDSRRLLQMVGRDLGLDIKRYSPRLLANAISNLKNELIDPHQALAGLTEDSDDLARAVASVYDEYQRRLRAANALDFDDLIGETVAVLQAFPQIAQYYRRRFRHVLVDEYQDTNHAQYVLVRELVGRDSNDGIPPGELCVVGDADQSIYAFRGATIRNIEDFERDYPDTRTILLEQNYRSTQNILSAANSVIARNAGRREKRLWTDAGAGELIVGYVADNEHDEARFVAEEIDALAEGSEITYNDVAVFYRTNNSSRSLEEVLIRAGIPYKVVGGVRFYERKEIRDIVAYLRVLDNPGDAVSLRRILNTPRRGIGDRAEACVAVYAENTGVGFGDALVAAAQGKVPMLNTRAEKAIAGFVEMFDELRGRLDDDLGELVEAVLERTGYRRELEASTDPQELARLDNLNELVSVAHEFSTDRENAAALGPDDEDVPDTGVLADFLERVSLVADADEIPEHGAGVVTLMTLHTAKGLEFPVVFVTGWEDGMFPHMRALDNPTELSEERRLAYVGITRARQRLYVSRAIVRSSWGQPMLNPESRFLREIPQELIDWRRTAPKPSFSAPVSGAGRFGSARPSPTRSGASRRPLLVLQVGDRVTHDKYGLGRVEEVSGVGESAMSLIDFGSSGRVKLMHNHAPVTKL,"85,050",771,"Helicase family, UvrD subfamily",DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]; growth [GO:0040007]; negative regulation of strand invasion [GO:0060543]; UV protection [GO:0009650],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; dATP binding [GO:0032564]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA helicase complex [GO:0033202]; plasma membrane [GO:0005886],ivrd pcrA,MTCY10D7.25c,1
P9WFA9,VAPC9_MYCTU,Rv0960,vapC9 Rv0960 MTCY10D7.14c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC9,DOMAIN 2 115 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC9 (RNase VapC9) (EC 3.1.-.-) (Toxin VapC9),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB9 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIVVDASAALAALLNDGQARQLIAAERLHVPHLVDSEIASGLRRLAQRDRLGAADGRRALQTWRRLAVTRYPVVGLFERIWEIRANLSAYDASYVALAEALNCALVTADLRLSDTGQAQCPITVVPR,"13,859",127,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY10D7.14c,1
P9WI93,PHS_MYCTU,Rv1159.1,Rv1159.1 Rv1159A,GO:0006729; GO:0008124,IPR036428; IPR001533; ,,,,Putative pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96),4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; tetrahydrobiopterin biosynthetic process [GO:0006729],9634230; 12368430; 21969609,,,MAVLTDEQVDAALHDLNGWQRAGGVLRRSIKFPTFMAGIDAVRRVAERAEEVNHHPDIDIRWRTVTFALVTHAVGGITENDIAMAHDIDAMFGA,"10,380",94,Pterin-4-alpha-carbinolamine dehydratase family,tetrahydrobiopterin biosynthetic process [GO:0006729],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124],,,Rv1159A,1
P9WN01,PIME_MYCTU,Rv1159,pimE Rv1159,GO:0004377; GO:0005886; GO:0008654; GO:0009247; GO:0009405; GO:0016021; GO:0043750; GO:0046488,IPR018584; ,,pimE,,Polyprenol-phosphate-mannose-dependent alpha-(1-2)-phosphatidylinositol pentamannoside mannosyltransferase (EC 2.4.1.-) (Alpha-mannosyltransferase) (Alpha-ManT) (PPM-dependent mannosyltransferase) (Polyprenol-phosphate-mannose alpha-mannosyltransferase) (PPM alpha-mannosyltransferase),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]",9634230; 16803893; 21969609,,"FUNCTION: Catalyzes the alpha-1,2 addition of a mannose residue from polyprenol-phosphate-mannose (PPM) to a monoacyl phosphatidylinositol pentamannoside (AcPIM5) to generate a monoacyl phosphatidylinositol hexamannoside (AcPIM6). {ECO:0000269|PubMed:16803893}.",MCRTLIDGPVRSAIAKVRQIDTTSSTPAAARRVTSPPARETRAAVLLLVLSVGARLAWTYLAPNGANFVDLHVYVSGAASLDHPGTLYGYVYADQTPDFPLPFTYPPFAAVVFYPLHLVPFGLIALLWQVVTMAALYGAVRISQRLMGGTAETGHFAAMLWTAIAIWIEPLRSTFDYGQINVLLMLAALWAVYTPRWWLSGLLVGVASGVKLTPAITAVYLVGVRRLHAAAFSVVVFLATVGVSLLVVGDEARYYFTDLLGDAGRVGPIATSFNQSWRGAISRILGHDAGFGPLVLAAIASTAVLAILAWRALDRSDRLGKLLVVELFGLLLSPISWTHHWVWLVPLMIWLIDGPARERPGARILGWGWLVLTIVGVPWLLSFAQPSIWQIGRPWYLAWAGLVYVVATLATLGWIAASERYVRIRPRRMAN,"47,102",431,Glycosyltransferase 87 family,glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WI95,PHOU2_MYCTU,Rv0821c,phoU2 phoY2 Rv0821c MTV043.13c,GO:0005737; GO:0006817; GO:0022611; GO:0030643; GO:0045936,IPR028366; IPR038078; IPR026022; ,,phoU2,,Phosphate-specific transport system accessory protein PhoU homolog 2 (Pst system accessory protein PhoU homolog 2),cytoplasm [GO:0005737]; cellular phosphate ion homeostasis [GO:0030643]; dormancy process [GO:0022611]; negative regulation of phosphate metabolic process [GO:0045936]; phosphate ion transport [GO:0006817],9634230; 20360062; 21969609,,"FUNCTION: Plays a role in the regulation of phosphate uptake. In this role, it may bind, possibly as a chaperone, to PhoR, PhoP or a PhoR-PhoP complex to promote dephosphorylation of phospho-PhoP, or inhibit formation of the PhoR-PhoP transitory complex (By similarity). Important for tolerance to antibiotics. {ECO:0000250, ECO:0000269|PubMed:20360062}.",MRTAYHEQLSELSERLGEMCGLAGIAMERATQALLQADLVLAEQVISDHEKIATLSARAEESAFVLLALQAPVAGDLRAIVSAIQMVADIDRMGALALHVAKIARRRHPQHALPEEVNGYFAEMGRVAVELGNSAQEVVLSHDPEKAAQIREEDDAMDDLHRHLFTVLMDREWKHGVAAAVDVTLLSRFYERFADHAVEVARRVIFQATGAFP,"23,514",213,PhoU family,cellular phosphate ion homeostasis [GO:0030643]; dormancy process [GO:0022611]; negative regulation of phosphate metabolic process [GO:0045936]; phosphate ion transport [GO:0006817],,cytoplasm [GO:0005737],phoY2,MTV043.13c,1
P9WI35,PPE13_MYCTU,Rv0878c,PPE13 Rv0878c MTCY31.06c,GO:0005886; GO:0016021; GO:0044119,IPR002989; IPR000030; IPR038332; ,,PPE13,,Uncharacterized PPE family protein PPE13,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host cell [GO:0044119],9634230,,,MNFMVLPPEVNSARIYAGAGPAPMLAAAVAWDGLAAELGMAAASFSLLISGLTAGPGSAWQGPAAAAMAAAAAPYLSWLNAATARAEGAAAGAKAAAAVYEAARAATAHPALVAANRNQLLSLVLSNLFGQNLPAIAATEASYEQLWAQDVAAMVGYHGGASTVASQLTPWQQLLSVLPPVVTAAPAGAVGVPAALAIPALGVENIGVGNFLGIGNIGNNNVGSGNTGDYNFGIGNIGNANLGNGNIGNANLGSGNAGFFNFGNGNDGNTNFGSGNAGFLNIGSGNEGSGNLGFGNAGDDNTGWGNSGDTNTGGFNSGDLNTGIGSPVTQGVANSGFGNTGTGHSGFFNSGNSGSGFQNLGNGSSGFGNASDTSSGFQNAGTALTRASSTWADSPRAWPIRAPSRLQVWRTRATTARECSIRVIISRVSSTGAPPQKKVGNSG,"43,592",443,Mycobacterial PPE family,growth of symbiont in host cell [GO:0044119],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.06c,1
P9WI31,PPE15_MYCTU,Rv1039c,PPE15 mper1 Rv1039c,,IPR022171; IPR000030; IPR038332; ,,PPE15,,PPE family protein PPE15 (Mycobacterial perilipin-1) (MPER1),,9634230; 27325376,X-ray crystallography (1),FUNCTION: May play a critical role in the homeostasis of triacylglycerol-containing lipid droplets in M.tuberculosis and influence the entry of the pathogen into a dormant state. {ECO:0000269|PubMed:27325376}.,MDFGALPPEINSARMYAGAGAGPMMAAGAAWNGLAAELGTTAASYESVITRLTTESWMGPASMAMVAAAQPYLAWLTYTAEAAAHAGSQAMASAAAYEAAYAMTVPPEVVAANRALLAALVATNVLGINTPAIMATEALYAEMWAQDALAMYGYAAASGAAGMLQPLSPPSQTTNPGGLAAQSAAVGSAAATAAVNQVSVADLISSLPNAVSGLASPVTSVLDSTGLSGIIADIDALLATPFVANIINSAVNTAAWYVNAAIPTAIFLANALNSGAPVAIAEGAIEAAEGAASAAAAGLADSVTPAGLGASLGEATLVGRLSVPAAWSTAAPATTAGATALEGSGWTVAAEEAGPVTGMMPGMASAAKGTGAYAGPRYGFKPTVMPKQVVV,"38,081",391,Mycobacterial PPE family,,,,mper1,,1
P9WI33,PPE14_MYCTU,Rv0915c,PPE14 Rv0915c,,IPR022171; IPR000030; IPR038332; ,,PPE14,,Uncharacterized PPE family protein PPE14,,9634230,,,MDFGLLPPEVNSSRMYSGPGPESMLAAAAAWDGVAAELTSAAVSYGSVVSTLIVEPWMGPAAAAMAAAATPYVGWLAATAALAKETATQARAAAEAFGTAFAMTVPPSLVAANRSRLMSLVAANILGQNSAAIAATQAEYAEMWAQDAAVMYSYEGASAAASALPPFTPPVQGTGPAGPAAAAAATQAAGAGAVADAQATLAQLPPGILSDILSALAANADPLTSGLLGIASTLNPQVGSAQPIVIPTPIGELDVIALYIASIATGSIALAITNTARPWHIGLYGNAGGLGPTQGHPLSSATDEPEPHWGPFGGAAPVSAGVGHAALVGALSVPHSWTTAAPEIQLAVQATPTFSSSAGADPTALNGMPAGLLSGMALASLAARGTTGGGGTRSGTSTDGQEDGRKPPVVVIREQPPPGNPPR,"41,440",423,Mycobacterial PPE family,,,,,,1
P9WI29,PPE16_MYCTU,Rv1135c,PPE16 Rv1135c,,IPR002989; IPR000030; IPR038332; ,,PPE16,,Uncharacterized PPE family protein PPE16,,9634230,,,MSFLVLPPEVNSALMFAGAGSGPTLAAAAAWDGLAAELGQAANSFSSATAALADTAWQGPAATAMAAAAAPYASWLSTAATRALSAAAQAKAAAAVYEAARAATVDPLLVAANRHQLVSLVLSNLFGQNAPAIAATEAAYEQLWAADVAAMVSYHSGASAVAAQLAPWAQAVRALPNPTAPALASGPAALAIPALGIGNTGIGNIFSIGNIGDYNLGNGNTGNANLGSGNTGQANLGSGNTGFFNFGSGNTANTNFGSGNLGNLNLGSGNDGNGNFGLGNIGDGNRGSGNVGSFNFGTANAGSFNVGSANHGSPNVGFANLGNNNLGIANLGNNNLGIANLGNNNIGIGLTGDNMIGIGALNSGIGNLGFGNSGNNNIGLFNSGNNNIGFFNSGDSNFGFFNSGDTNTGFGNAGFTNTGFGNAGSGNFGFGNAGNNNFGFGNSGFENMGVGNSGAYNTGSFNSGTLNTGDLNSGDFNTGWANSGDINTGGFHSGDLNTGFGSPVDQPVMNSGFGNIGTGNSGFNNSGDANSGFQNTNTGAFFIGHSGLLNSGGGQHVGISNSGTGFNTGLFNTGFNNTGIGNSATNAAFTTTSGVANSGDNSSGGFNAGNDQSGFFDG,"60,207",618,Mycobacterial PPE family,,,,,,1
P96374,PPX2_MYCTU,Rv1026,ppx2 Rv1026 LH57_05600,GO:0004309; GO:0005886; GO:0040007,IPR003695; ,,ppx2,,Exopolyphosphatase 2 (ExopolyPase 2) (EC 3.6.1.11),plasma membrane [GO:0005886]; exopolyphosphatase activity [GO:0004309]; growth [GO:0040007],9634230; 21969609; 22880033,,"FUNCTION: Degradation of inorganic polyphosphates (polyP). Releases orthophosphate processively from the ends of the polyP chain. Prefers long-chain length polyphosphates as substrates (By similarity). Can also hydrolyze ATP and ADP substrates, but lacks GTPase activity. Cannot hydrolyze pppGpp to ppGpp (PubMed:22880033). {ECO:0000250|UniProtKB:L7N5A6, ECO:0000269|PubMed:22880033}.",MALTRVAAIDCGTNSIRLLIADVGAGLARGELHDVHRETRIVRLGQGVDATGRFAPEAIARTRTALTDYAELLTFHHAERVRMVATSAARDVVNRDVFFAMTADVLGAALPGSAAEVITGAEEAELSFRGAVGELGSAGAPFVVVDLGGGSTEIVLGEHEVVASYSADIGCVRLTERCLHSDPPTLQEVSTARRLVRERLEPALRTVPLELARTWVGLAGTMTTLSALAQSMTAYDAAAIHLSRVPGADLLEVCQRLIGMTRKQRAALAPMHPGRADVIGGGAIVVEELARELRERAGIDQLTVSEHDILDGIALSLAG,"33,664",319,GppA/Ppx family,growth [GO:0040007],exopolyphosphatase activity [GO:0004309],plasma membrane [GO:0005886],,LH57_05600,2
I6Y9Q3,PRPC_MYCTU,Rv1131 RVBD_1131,prpC Rv1131 RVBD_1131 P425_01180,GO:0005737; GO:0006099; GO:0019679; GO:0036440; GO:0050440,IPR011278; IPR016142; IPR016143; IPR002020; IPR019810; IPR024176; IPR036969; ,,prpC,,"2-methylcitrate synthase (2-MCS) (MCS) (EC 2.3.3.5) ((2S,3S)-2-methylcitrate synthase) (Citrate synthase) (EC 2.3.3.16)","cytoplasm [GO:0005737]; 2-methylcitrate synthase activity [GO:0050440]; citrate synthase activity [GO:0036440]; propionate metabolic process, methylcitrate cycle [GO:0019679]; tricarboxylic acid cycle [GO:0006099]",9634230; 18375549; 21969609; 22365605; 22916289; ,X-ray crystallography (1),"FUNCTION: Involved in the catabolism of short chain fatty acids (SCFA) via the tricarboxylic acid (TCA)(acetyl degradation route) and via the 2-methylcitrate cycle I (propionate degradation route). Catalyzes the Claisen condensation of propionyl-CoA and oxaloacetate (OAA) to yield (2S,3S)-2-methylcitrate (2-MC) and CoA. Also catalyzes the condensation of oxaloacetate with acetyl-CoA. {ECO:0000269|PubMed:18375549, ECO:0000269|PubMed:22365605}.",MTGPLAAARSVAATKSMTAPTVDERPDIKKGLAGVVVDTTAISKVVPQTNSLTYRGYPVQDLAARCSFEQVAFLLWRGELPTDAELALFSQRERASRRVDRSMLSLLAKLPDNCHPMDVVRTAISYLGAEDPDEDDAAANRAKAMRMMAVLPTIVAIDMRRRRGLPPIAPHSGLGYAQNFLHMCFGEVPETAVVSAFEQSMILYAEHGFNASTFAARVVTSTQSDIYSAVTGAIGALKGRLHGGANEAVMHDMIEIGDPANAREWLRAKLARKEKIMGFGHRVYRHGDSRVPTMKRALERVGTVRDGQRWLDIYQVLAAEMASATGILPNLDFPTGPAYYLMGFDIASFTPIFVMSRITGWTAHIMEQATANALIRPLSAYCGHEQRVLPGTF,"42,969",393,Citrate synthase family,"propionate metabolic process, methylcitrate cycle [GO:0019679]; tricarboxylic acid cycle [GO:0006099]",2-methylcitrate synthase activity [GO:0050440]; citrate synthase activity [GO:0036440],cytoplasm [GO:0005737],,P425_01180,1
O06582,PRPD_MYCTU,Rv1130 RVBD_1130,prpD Rv1130 RVBD_1130 P425_01179,GO:0003994; GO:0005618; GO:0005829; GO:0006099; GO:0008203; GO:0010447; GO:0019629; GO:0019679; GO:0047547,IPR036148; IPR005656; ,,prpD,,"2-methylcitrate dehydratase (2-MC dehydratase) (EC 4.2.1.79) ((2S,3S)-2-methylcitrate dehydratase) (Aconitate hydratase) (ACN) (Aconitase) (EC 4.2.1.3)","cell wall [GO:0005618]; cytosol [GO:0005829]; 2-methylcitrate dehydratase activity [GO:0047547]; aconitate hydratase activity [GO:0003994]; cholesterol metabolic process [GO:0008203]; propionate catabolic process, 2-methylcitrate cycle [GO:0019629]; propionate metabolic process, methylcitrate cycle [GO:0019679]; response to acidic pH [GO:0010447]; tricarboxylic acid cycle [GO:0006099]",9634230; 18375549; 21969609; 22365605; 22916289,,"FUNCTION: Involved in the catabolism of short chain fatty acids (SCFA) via the tricarboxylic acid (TCA)(acetyl degradation route) and via the 2-methylcitrate cycle I (propionate degradation route). Catalyzes the stereospecific dehydration of (2S,3S)-2-methylcitrate (2-MC) to yield the cis isomer of 2-methyl-aconitate (PubMed:18375549, PubMed:22365605). Could also catalyze the dehydration of citrate and the hydration of cis-aconitate (By similarity). {ECO:0000250|UniProtKB:P77243, ECO:0000269|PubMed:18375549, ECO:0000269|PubMed:22365605}.",MPDQDTKVRFFRVFCWCPVLRMVRIMLMHAVRAWRSADDFPCTEHMAYKIAQVAADPVDVDPEVADMVCNRIIDNAAVSAASMVRRPVTVARHQALAHPVRHGAKVFGVEGSYSADWAAWANGVAARELDFHDTFLAADYSHPADNIPPLVAVAQQLGVCGAELIRGLVTAYEIHIDLTRGICLHEHKIDHVAHLGPAVAAGIGTMLRLDQETIYHAIGQALHLTTSTRQSRKGAISSWKAFAPAHAGKVGIEAVDRAMRGEGSPAPIWEGEDGVIAWLLAGPEHTYRVPLPAPGEPKRAILDSYTKQHSAEYQSQAPIDLACRLRERIGDLDQIASIVLHTSHHTHVVIGTGSGDPQKFDPDASRETLDHSLPYIFAVALQDGCWHHERSYAPERARRSDTVALWHKISTVEDPEWTRRYHCADPAKKAFGARAEVTLHSGEVIVDELAVADAHPLGTRPFERKQYVEKFTELADGVVEPVEQQRFLAVVESLADLESGAVGGLNVLVDPRVLDKAPVIPPGIFR,"57,783",526,PrpD family,"cholesterol metabolic process [GO:0008203]; propionate catabolic process, 2-methylcitrate cycle [GO:0019629]; propionate metabolic process, methylcitrate cycle [GO:0019679]; response to acidic pH [GO:0010447]; tricarboxylic acid cycle [GO:0006099]",2-methylcitrate dehydratase activity [GO:0047547]; aconitate hydratase activity [GO:0003994],cell wall [GO:0005618]; cytosol [GO:0005829],,P425_01179,1
O06581,PRPR_MYCTU,Rv1129c RVBD_1129c,prpR Rv1129c RVBD_1129c P425_01178,GO:0001666; GO:0006351; GO:0006355; GO:0008203; GO:0019679; GO:0043565; GO:0052572,IPR001387; IPR018653; IPR026281; IPR010359; IPR010982; ,,prpR,DOMAIN 22 76 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,HTH-type transcriptional regulator PrpR (Propionate regulator) (PRPR),"sequence-specific DNA binding [GO:0043565]; cholesterol metabolic process [GO:0008203]; propionate metabolic process, methylcitrate cycle [GO:0019679]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; 22365605; 22916289; 24705740,,"FUNCTION: Plays a key role in regulating expression of enzymes involved in the catabolism of short chain fatty acids (SCFA) via both the glyoxylate (acetyl degradation route) and the methylcitrate cycle (propionate degradation route) (PubMed:22916289, PubMed:24705740). Required for intracellular growth in macrophages and for the assimilation of cholesterol-derived propionate (PubMed:22365605). PrpR acts as a transcriptional activator of prpDC and icl genes when propionate is the main carbon source, and as a ramB repressor (PubMed:22916289). During growth on propionate, PrpR also acts as a transcriptional repressor of dnaA, which encodes the DnaA initiator protein responsible for initiating chromosomal replication (PubMed:24705740). It is possibly involved in the regulation of genes responsible for controlling cholesterol utilization (PubMed:22365605). {ECO:0000269|PubMed:22365605, ECO:0000269|PubMed:22916289, ECO:0000269|PubMed:24705740}.",MTRSNVLPVARTYSRTFSGARLRRLRQERGLTQVALAKALDLSTSYVNQLENDQRPITVPVLLLLTERFDLSAQYFSSDSDARLVADLSDVFTDIGVEHAVSGAQIEEFVARMPEVGHSLVAVHRRLRAATEELEGYRSRATAETELPPARPMPFEEVRDFFYDRNNYIHDLDMAAERMFTESGMRTGGLDIQLAELMRDRFGISVVIDDNLPDTAKRRYHPDTKVLRVAHWLMPGQRAFQIATQLALVGQSDLISSIVATDDQLSTEARGVARIGLANYFAGAFLLPYREFHRAAEQLRYDIDLLGRRFGVGFETVCHRLSTLQRPRQRGIPFIFVRTDKAGNISKRQSATAFHFSRVGGSCPLWVVHDAFAQPERIVRQVAQMPDGRSYFWVAKTTAADGLGYLGPHKNFAVGLGCDLAHAHKLVYSTGVVLDDPSTEVPIGAGCKICNRTSCAQRAFPYLGGRVAVDENAGSSLPYSSTEQSV,"54,087",486,Short-chain fatty acyl-CoA assimilation regulator (ScfR) family,"cholesterol metabolic process [GO:0008203]; propionate metabolic process, methylcitrate cycle [GO:0019679]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",sequence-specific DNA binding [GO:0043565],,,P425_01178,1
Q79FU2,PG17_MYCTU,Rv0978c,PE_PGRS17 Rv0978c LH57_05330,GO:0009405,IPR001258; IPR013017; IPR000084; IPR015943; IPR011964; ,,PE_PGRS17,DOMAIN 1 92 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS17,pathogenesis [GO:0009405],9634230; 16586367; 17687113; 20176745; 23663047,,"FUNCTION: Induces maturation and activation of human dendritic cells (DCs), via TLR2-dependent activation of ERK1/2, p38 MAPK, and NF-kappa-B signaling pathways, and enhances the ability of DCs to stimulate CD4(+) T cells. By activating DCs, could potentially contribute to the initiation of innate immune responses during tuberculosis infection and hence regulate the clinical course of tuberculosis. {ECO:0000269|PubMed:20176745}.",MSFVNVAPQLVSTAAADAARIGSAINTANTAAAATTQVLAAAQDEVSTAIAALFGSHGQHYQAISAQVAAYQQRFVLALSQAGSTYAVAEAASATPLQNVLDAINAPVQSLTGRPLIGDGANGIDGTGQAGGNGGWLWGNGGNGGSGAPGQAGGAGGAAGLIGNGGAGGTGGAVSLARAGTAGGAGRGPVGGIGGAGGVGGAGGAAGAVTTITHASFNDPHGVAVNPGGNVYVTNFGSGTVSVINPATNTVTGSPITIGNGPSGVAVSPVTGLVFVTNFDSNTVSVIDPTTNTVTGSPITVGTAPTGVAVNPVTGEVYVTNFAGDTVSVIS,"31,019",331,"Mycobacterial PE family, PGRS subfamily",pathogenesis [GO:0009405],,,,LH57_05330,1
P9WN05,PMT_MYCTU,Rv1002c,pmt Rv1002c MTCI237.17c,GO:0000030; GO:0004169; GO:0005886; GO:0016021; GO:0035269; GO:0040007,IPR027005; IPR003342; IPR032421; ,,pmt,,Probable dolichyl-phosphate-mannose--protein mannosyltransferase (EC 2.4.1.109),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030]; growth [GO:0040007]; protein O-linked mannosylation [GO:0035269],9634230; 16081738; 21969609,,"FUNCTION: Transfers mannose from Dol-P-mannose to Ser or Thr residues on proteins (Probable). Mannosylates an artificial substrate, probably on a Thr residue, upon expression in M.smegmatis. Glycosylation probably requires the Sec-translocation system. {ECO:0000269|PubMed:16081738, ECO:0000305}.",MTARPPESCVLAKDRPEEPVVPVVSPGPLVPVADFGPLDRLRGWIVTGLITLLATVTRFLNLGSLTDAGTPIFDEKHYAPQAWQVLNNHGVEDNPGYGLVVHPPVGKQLIAIGEAIFGYNGFGWRFTGALLGVVLVALVVRIVRRISRSTLVGAIAGVLLICDGVSFVTARTALLDGFLTFFVVAAFGALIVDRDQVRERMHIALLAGRSAATVWGPRVGVRWWRFGAGVLLGLACATKWSGVYFVLFFGAMALAFDVAARRQYQVQRPWLGTVRRDVLPSGYALGLIPFAVYLATYAPWFASETAIDRHAVGQAVGRNSVVPLPDAVRSLWHYTAKAFHFHAGLTNSAGNYHPWESKPWTWPMSLRPVLYAIDQQDVAGCGAQSCVKAEMLVGTPAMWWLAVPVLAYAGWRMFVRRDWRYAVVLVGYCAGWLPWFADIDRQMYFFYAATMAPFLVMGISLVLGDILYHPGQGSERRTLGLIVVCCYVALVVTNFAWLYPVLTGLPISQQTWNLEIWLPSWR,"57,607",522,Glycosyltransferase 39 family,growth [GO:0040007]; protein O-linked mannosylation [GO:0035269],dolichyl-phosphate-mannose-protein mannosyltransferase activity [GO:0004169]; mannosyltransferase activity [GO:0000030],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCI237.17c,2
P9WIM7,PRA_MYCTU,Rv1078,pra Rv1078 MTV017.31,GO:0005576; GO:0005618; GO:0005886,IPR010432; ,,pra,,Proline-rich antigen homolog,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 19099550; 21969609,,,MTEQPPPGGSYPPPPPPPGPSGGHEPPPAAPPGGSGYAPPPPPSSGSGYPPPPPPPGGGAYPPPPPSAGGYAPPPPGPAIRTMPTESYTPWITRVLAAFIDWAPYVVLVGIGWVIMLVTQTSSCVTSISEYDVGQFCVSQPSMIGQLVQWLLSVGGLAYLVWNYGYRQGTIGSSIGKSVLKFKVVSETTGQPIGFGMSVVRQLAHFIDAIICFVGFLFPLWDAKRQTLADKIMTTVCVPI,"25,076",240,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV017.31,1
P9WJM7,MSHD_MYCTU,Rv0819,mshD Rv0819,GO:0005829; GO:0010125; GO:0010126; GO:0035447; GO:0044119; GO:0070301; GO:0071468,IPR016181; IPR000182; IPR017813; ,,mshD,DOMAIN 4 141 N-acetyltransferase 1.; DOMAIN 152 315 N-acetyltransferase 2.,Mycothiol acetyltransferase (MSH acetyltransferase) (EC 2.3.1.189) (Mycothiol synthase),cytosol [GO:0005829]; mycothiol synthase activity [GO:0035447]; cellular response to acidic pH [GO:0071468]; cellular response to hydrogen peroxide [GO:0070301]; growth of symbiont in host cell [GO:0044119]; mycothiol biosynthetic process [GO:0010125]; mycothiol metabolic process [GO:0010126],9634230; 12375100; 19099550; 21969609; 12930994; 16326705,X-ray crystallography (3),FUNCTION: Catalyzes the transfer of acetyl from acetyl-CoA to desacetylmycothiol (Cys-GlcN-Ins) to form mycothiol. {ECO:0000269|PubMed:12375100}.,MTALDWRSALTADEQRSVRALVTATTAVDGVAPVGEQVLRELGQQRTEHLLVAGSRPGGPIIGYLNLSPPRGAGGAMAELVVHPQSRRRGIGTAMARAALAKTAGRNQFWAHGTLDPARATASALGLVGVRELIQMRRPLRDIPEPTIPDGVVIRTYAGTSDDAELLRVNNAAFAGHPEQGGWTAVQLAERRGEAWFDPDGLILAFGDSPRERPGRLLGFHWTKVHPDHPGLGEVYVLGVDPAAQRRGLGQMLTSIGIVSLARRLGGRKTLDPAVEPAVLLYVESDNVAAVRTYQSLGFTTYSVDTAYALAGTDN,"33,599",315,"Acetyltransferase family, MshD subfamily",cellular response to acidic pH [GO:0071468]; cellular response to hydrogen peroxide [GO:0070301]; growth of symbiont in host cell [GO:0044119]; mycothiol biosynthetic process [GO:0010125]; mycothiol metabolic process [GO:0010126],mycothiol synthase activity [GO:0035447],cytosol [GO:0005829],,,1
P9WJR1,MOAE2_MYCTU,Rv0866,moaE2 Rv0866 MTV043.59,GO:0005829; GO:0006777; GO:0030366; GO:0032324,IPR036563; IPR003448; ,,moaE2,,Molybdopterin synthase catalytic subunit 2 (EC 2.-.-.-) (MPT synthase subunit 2 2) (Molybdenum cofactor biosynthesis protein E 2) (Molybdopterin-converting factor large subunit 2) (Molybdopterin-converting factor subunit 2 2),cytosol [GO:0005829]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],9634230; 21969609,,FUNCTION: Converts molybdopterin precursor Z into molybdopterin. This requires the incorporation of two sulfur atoms into precursor Z to generate a dithiolene group. The sulfur is provided by MoaD (By similarity). {ECO:0000250}.,MTQVLRAALTDQPIFLAEHEELVSHRSAGAIVGFVGMIRDRDGGRGVLRLEYSAHPSAAQVLADLVAEVAEESSGVRAVAASHRIGVLQVGEAALVAAVAADHRRAAFGTCAHLVETIKARLPVWKHQFFEDGTDEWVGSV,"15,048",141,MoaE family,molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],molybdopterin synthase activity [GO:0030366],cytosol [GO:0005829],,MTV043.59,1
P9WIY1,MUTT2_MYCTU,Rv1160,mutT2 Rv1160,GO:0006260; GO:0006281; GO:0016787; GO:0046872,IPR020476; IPR015797; IPR020084; IPR000086; ,,mutT2,DOMAIN 2 131 Nudix hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00794}.,"Putative 8-oxo-dGTP diphosphatase 2 (8-oxo-dGTPase 2) (EC 3.6.1.55) (7,8-dihydro-8-oxoguanine-triphosphatase 2) (Mutator protein MutT2) (dGTP pyrophosphohydrolase 2)",hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260],9634230; 16585780; 21969609,,"FUNCTION: May be involved in the GO system responsible for removing an oxidatively damaged form of guanine (7,8-dihydro-8-oxoguanine, 8-oxo-dGTP) from DNA and the nucleotide pool. 8-oxo-dGTP is inserted opposite dA and dC residues of template DNA with almost equal efficiency thus leading to A.T to G.C transversions. MutT specifically degrades 8-oxo-dGTP to the monophosphate (By similarity). In vitro has 8-oxo-dGTPase activity. {ECO:0000250, ECO:0000269|PubMed:16585780}.",MLNQIVVAGAIVRGCTVLVAQRVRPPELAGRWELPGGKVAAGETERAALARELAEELGLEVADLAVGDRVGDDIALNGTTTLRAYRVHLLGGEPRARDHRALCWVTAAELHDVDWVPADRGWIADLARTLNGSAADVHRRC,"15,160",141,Nudix hydrolase family,DNA repair [GO:0006281]; DNA replication [GO:0006260],hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,,1
P9WJR7,MOAC2_MYCTU,Rv0864,moaC2 Rv0864 MTV043.57,GO:0006777; GO:0061799,IPR023045; IPR036522; IPR002820; ,,moaC2,,Cyclic pyranopterin monophosphate synthase 2 (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C 2),cyclic pyranopterin monophosphate synthase activity [GO:0061799]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],9634230; 21969609; 22684071,X-ray crystallography (1),"FUNCTION: Catalyzes the conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cyclic pyranopterin monophosphate (cPMP). {ECO:0000255|HAMAP-Rule:MF_01224}.",MARASGASDYRSGELSHQDERGAAHMVDITEKATTKRTAVAAGILRTSAQVVALISTGGLPKGDALATARVAGIMAAKRTSDLIPLCHQLALTGVDVDFTVGQLDIEITATVRSTDRTGVEMEALTAVSVAALTLYDMIKAVDPGALIDDIRVLHKEGGRRGTWTRR,"17,598",167,MoaC family,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],cyclic pyranopterin monophosphate synthase activity [GO:0061799],,,MTV043.57,1
P9WJN5,MSCL_MYCTU,Rv0985c,mscL Rv0985c MTV044.13c,GO:0005886; GO:0005887; GO:0006811; GO:0008381; GO:0009992; GO:0022836; GO:0034220; GO:0042802; GO:0055085,IPR036019; IPR019823; IPR001185; IPR037673; ,Itself,mscL,,Large-conductance mechanosensitive channel,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; gated channel activity [GO:0022836]; identical protein binding [GO:0042802]; mechanosensitive ion channel activity [GO:0008381]; cellular water homeostasis [GO:0009992]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; transmembrane transport [GO:0055085],9634230; 21969609; 23875651; 9856938,X-ray crystallography (1),FUNCTION: Channel that opens in response to stretch forces in the membrane lipid bilayer. The force required to trigger channel opening depends on the nature of the membrane lipids; the presence of phosphatidylinositol enhances mechanosensitivity of the channel. May participate in the regulation of osmotic pressure changes within the cell. {ECO:0000269|PubMed:23875651}.,MLKGFKEFLARGNIVDLAVAVVIGTAFTALVTKFTDSIITPLINRIGVNAQSDVGILRIGIGGGQTIDLNVLLSAAINFFLIAFAVYFLVVLPYNTLRKKGEVEQPGDTQVVLLTEIRDLLAQTNGDSPGRHGGRGTPSPTDGPRASTESQ,"16,023",151,MscL family,cellular water homeostasis [GO:0009992]; ion transmembrane transport [GO:0034220]; ion transport [GO:0006811]; transmembrane transport [GO:0055085],gated channel activity [GO:0022836]; identical protein binding [GO:0042802]; mechanosensitive ion channel activity [GO:0008381],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTV044.13c,1
P9WKF3,KDPA_MYCTU,Rv1029,kdpA Rv1029 MTCY10G2.20c,GO:0005618; GO:0005886; GO:0008556; GO:0016021; GO:0030955; GO:0071805,IPR004623; ,,kdpA,,Potassium-transporting ATPase potassium-binding subunit (ATP phosphohydrolase [potassium-transporting] A chain) (Potassium-binding and translocating subunit A) (Potassium-translocating ATPase A chain),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium ion binding [GO:0030955]; potassium-transporting ATPase activity [GO:0008556]; potassium ion transmembrane transport [GO:0071805],9634230; 21969609,,"FUNCTION: Part of the high-affinity ATP-driven potassium transport (or Kdp) system, which catalyzes the hydrolysis of ATP coupled with the electrogenic transport of potassium into the cytoplasm. This subunit binds and transports the potassium across the cytoplasmic membrane. {ECO:0000255|HAMAP-Rule:MF_00275}.",MSGTSWLQFAALIAVLLLTAPALGGYLAKIYGDEAKKPGDRVFGPIERVIYQVCRVDPGSEQRWSTYALSVLAFSVMSFLLLYGIARFQGVLPFNPTDKPAVTDHVAFNAAVSFMTNTNWQSYSGEATMSHFTQMTGLAVQNFVSASAGMCVLAALIRGLARKRASTLGNFWVDLARTVLRIMFPLSFVVAILLVSQGVIQNLHGFIVANTLEGAPQLIPGGPVASQVAIKQLGTNGGGFFNVNSAHPFENYTPIGNFVENWAILIIPFALCFAFGKMVHDRRQGWAVLAIMGIIWIGMSVAAMSFEAKGNPRLDALGVTQQTTVDQSGGNLEGKEVRFGVGASGLWAASTTGTSNGSVNSMHDSYTPLGGMVPLAHMMLGEVSPGGTGVGLNGLLVMAILAVFIAGLMVGRTPEYLGKKIQATEMKLVTLYILAMPIALLSFAAASVLISSALASRNNPGPHGLSEILYAYTSGANNNGSAFAGLTASTWSYDTTIGVAMLIGRFFLIIPVLAIAGSLARKGTTPVTAATFPTHKPLFVGLVIGVVLIVGGLTFFPALALGPIVEQLSTQ,"60,163",571,KdpA family,potassium ion transmembrane transport [GO:0071805],potassium ion binding [GO:0030955]; potassium-transporting ATPase activity [GO:0008556],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10G2.20c,1
P9WKF1,KDPC_MYCTU,Rv1031,kdpC Rv1031 MTCY10G2.18c,GO:0005524; GO:0005886; GO:0008556; GO:0016021,IPR003820; ,,kdpC,,Potassium-transporting ATPase KdpC subunit (ATP phosphohydrolase [potassium-transporting] C chain) (Potassium-binding and translocating subunit C) (Potassium-translocating ATPase C chain),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; potassium-transporting ATPase activity [GO:0008556],9634230; 21969609,,"FUNCTION: Part of the high-affinity ATP-driven potassium transport (or Kdp) system, which catalyzes the hydrolysis of ATP coupled with the electrogenic transport of potassium into the cytoplasm. This subunit acts as a catalytic chaperone that increases the ATP-binding affinity of the ATP-hydrolyzing subunit KdpB by the formation of a transient KdpB/KdpC/ATP ternary complex. {ECO:0000255|HAMAP-Rule:MF_00276}.",MRRQLLPALTMLLVFTVITGIVYPLAVTGVGQLFFGDQANGALLERDGQVIGSAHIGQQFTAAKYFHPRPSSAGDGYDAAASSGSNLGPTNEKLLAAVAERVTAYRKENNLPADTLVPVDAVTGSGSGLDPAISVVNAKLQAPRVAQARNISIRQVERLIEDHTDARGLGFLGERAVNVLRLNLALDRL,"20,028",189,KdpC family,,ATP binding [GO:0005524]; potassium-transporting ATPase activity [GO:0008556],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10G2.18c,1
P9WKD9,KU_MYCTU,Rv0937c,mku Rv0937c,GO:0003690; GO:0006303; GO:0006310; GO:0051351,IPR006164; IPR009187; IPR016194; ,,mku,DOMAIN 10 193 Ku. {ECO:0000255|HAMAP-Rule:MF_01875}.,Non-homologous end joining protein Ku (Mt-Ku),double-stranded DNA binding [GO:0003690]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of ligase activity [GO:0051351],9634230; 12215643; 15499016; 15778718; 16023671; 21969609; 21637345,,"FUNCTION: With LigD forms a non-homologous end joining (NHEJ) repair enzyme. Binds linear dsDNA with 5'- and 3'-overhangs but not closed circular dsDNA nor ssDNA. One dimer binds for every 30 bp. Recruits and stimulates the ligase activity of LigD but not of T4 ligase or a human ligase complex (LIG4/XRCC4). Attenuates the 3'- to 5'-exonuclease activity of LigD. Stimulates the template-directed addition of dNTPs by LigD on 5'-overhangs and nuclease activity on 3'-overhangs. {ECO:0000269|PubMed:12215643, ECO:0000269|PubMed:15499016, ECO:0000269|PubMed:15778718, ECO:0000269|PubMed:16023671}.",MRAIWTGSIAFGLVNVPVKVYSATADHDIRFHQVHAKDNGRIRYKRVCEACGEVVDYRDLARAYESGDGQMVAITDDDIASLPEERSREIEVLEFVPAADVDPMMFDRSYFLEPDSKSSKSYVLLAKTLAETDRMAIVHFTLRNKTRLAALRVKDFGKREVMMVHTLLWPDEIRDPDFPVLDQKVEIKPAELKMAGQVVDSMADDFNPDRYHDTYQEQLQELIDTKLEGGQAFTAEDQPRLLDEPEDVSDLLAKLEASVKARSKANSNVPTPP,"30,904",273,Prokaryotic Ku family,DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; positive regulation of ligase activity [GO:0051351],double-stranded DNA binding [GO:0003690],,,,1
P9WKE3,KPRS_MYCTU,Rv1017c,prs prsA Rv1017c MTCY10G2.32,GO:0000287; GO:0004749; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006015; GO:0009116; GO:0009156; GO:0009165; GO:0016301; GO:0030145; GO:0040007; GO:0045227; GO:0071555,IPR000842; IPR029099; IPR000836; IPR029057; IPR005946; IPR037515; ,,prs,,Ribose-phosphate pyrophosphokinase (RPPK) (EC 2.7.6.1) (5-phospho-D-ribosyl alpha-1-diphosphate) (Phosphoribosyl diphosphate synthase) (Phosphoribosyl pyrophosphate synthase) (P-Rib-PP synthase) (PRPP synthase) (PRPPase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156],9634230; 20066036; 21085589; 21045009; 21969609; 22745722; 28031352,,"FUNCTION: Involved in the biosynthesis of the central metabolite phospho-alpha-D-ribosyl-1-pyrophosphate (PRPP) and of the decaprenylphosphoryl-arabinose (DPA), an essential precursor for the mycobacterial cell wall biosynthesis. Catalyzes the transfer of pyrophosphoryl group from ATP to 1-hydroxyl of ribose-5-phosphate (Rib-5-P) to yield phosphoribosyl diphosphate (PRPP) and AMP. It can also use GTP, CTP and UTP as diphosphoryl donors (PubMed:22745722). {ECO:0000269|PubMed:21045009, ECO:0000269|PubMed:21085589, ECO:0000269|PubMed:22745722}.",MSHDWTDNRKNLMLFAGRAHPELAEQVAKELDVHVTSQDAREFANGEIFVRFHESVRGCDAFVLQSCPAPVNRWLMEQLIMIDALKRGSAKRITAVMPFYPYARQDKKHRGREPISARLIADLLKTAGADRIVTVDLHTDQIQGFFDGPVDHMRGQNLLTGYIRDNYPDGNMVVVSPDSGRVRIAEKWADALGGVPLAFIHKTRDPRVPNQVVSNRVVGDVAGRTCVLIDDMIDTGGTIAGAVALLHNDGAGDVIIAATHGVLSDPAAQRLASCGAREVIVTNTLPIGEDKRFPQLTVLSIAPLLASTIRAVFENGSVTGLFDGDA,"35,477",326,"Ribose-phosphate pyrophosphokinase family, Class I subfamily",5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; ribonucleoside monophosphate biosynthetic process [GO:0009156],ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; ribose phosphate diphosphokinase activity [GO:0004749],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],prsA,MTCY10G2.32,1
P9WNV3,LIGD_MYCTU,Rv0938,ligD Rv0938 MTCY08D9.01c MTCY10D7.36c,GO:0000287; GO:0003677; GO:0003887; GO:0003896; GO:0003899; GO:0003909; GO:0003910; GO:0004652; GO:0005524; GO:0005886; GO:0006269; GO:0006303; GO:0006310; GO:0008310; GO:0016032; GO:0030145,IPR012309; IPR012310; IPR014146; IPR014144; IPR014145; IPR033649; IPR012340; ,,ligD,,Multifunctional non-homologous end joining DNA repair protein LigD (NHEJ DNA repair protein D) (Mt-Lig) (NHEJ DNA polymerase) [Includes: DNA repair polymerase (Pol) (Polymerase/primase); 3'-phosphoesterase (3'-ribonuclease/3'-phosphatase) (PE); DNA ligase (Lig) (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP])],"plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; DNA primase activity [GO:0003896]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; DNA-directed DNA polymerase activity [GO:0003887]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310]; DNA recombination [GO:0006310]; DNA replication, synthesis of RNA primer [GO:0006269]; double-strand break repair via nonhomologous end joining [GO:0006303]; viral process [GO:0016032]",9634230; 12215643; 14985346; 15499016; 16023671; 15778718; 16949369; 21969609; 21637345; 16476729; 17174332; 17947582; 21255731; 24239356,X-ray crystallography (7),"FUNCTION: With Ku forms a non-homologous end joining (NHEJ) repair enzyme which repairs DNA double-strand breaks (DSB) with reduced fidelity. Recognizes, processes and reseals DSBs, including repairs on incompatible DSB which require 3'-resection, gap filling and ligation. Anneals the 3' overhanging strands from opposing breaks to form a gapped intermediate, which then can be extended in trans by using the termini as primers for extension of the annealed break. Binds to the recessed 5'-phosphate moiety of the downstream DNA strand forming a stable synaptic complex even when the 3'-protruding ends of the template DNA strands are not complementary. Has numerous activites; gap filling copies the template strand, and prefers a 5'-phosphate in the gap and rNTPS (PubMed:17174332, PubMed:17947582), DNA-directed DNA or RNA polymerase on 5'-overhangs, terminal transferase (extending ssDNA or blunt dsDNA in a non-templated fashion, preferentially with rNTPs), DNA-dependent RNA primase (synthesizes short RNAs on unprimed closed ssDNA) and 3'- to 5'-exonuclease on ssDNA (PubMed:15499016). Isolated Pol domain (and presumably the holoenzyme) is able to form complexes between 2 noncompatible protruding 3'-ends DNA ends via microhomologous DNA strands, in a end-bridging function to which it adds a templated nucleotide (PubMed:17947582). Minimal primer length is 2 nucleotides (PubMed:21255731). {ECO:0000269|PubMed:15499016, ECO:0000269|PubMed:17174332, ECO:0000269|PubMed:17947582, ECO:0000269|PubMed:21255731}.; FUNCTION: The preference of the polymerase domain for rNTPs over dNTPs may be advantageous in dormant cells, where the dNTP pool is limiting.; FUNCTION: In conjunction with endogenous or Mycobacterium phage Omega Ku (AC Q853W0) can reconstitute NHEJ in Saccharomyces cerevisiae.",MGSASEQRVTLTNADKVLYPATGTTKSDIFDYYAGVAEVMLGHIAGRPATRKRWPNGVDQPAFFEKQLALSAPPWLSRATVAHRSGTTTYPIIDSATGLAWIAQQAALEVHVPQWRFVAEPGSGELNPGPATRLVFDLDPGEGVMMAQLAEVARAVRDLLADIGLVTFPVTSGSKGLHLYTPLDEPVSSRGATVLAKRVAQRLEQAMPALVTSTMTKSLRAGKVFVDWSQNSGSKTTIAPYSLRGRTHPTVAAPRTWAELDDPALRQLSYDEVLTRIARDGDLLERLDADAPVADRLTRYRRMRDASKTPEPIPTAKPVTGDGNTFVIQEHHARRPHYDFRLECDGVLVSWAVPKNLPDNTSVNHLAIHTEDHPLEYATFEGAIPSGEYGAGKVIIWDSGTYDTEKFHDDPHTGEVIVNLHGGRISGRYALIRTNGDRWLAHRLKNQKDQKVFEFDNLAPMLATHGTVAGLKASQWAFEGKWDGYRLLVEADHGAVRLRSRSGRDVTAEYPQLRALAEDLADHHVVLDGEAVVLDSSGVPSFSQMQNRGRDTRVEFWAFDLLYLDGRALLGTRYQDRRKLLETLANATSLTVPELLPGDGAQAFACSRKHGWEGVIAKRRDSRYQPGRRCASWVKDKHWNTQEVVIGGWRAGEGGRSSGVGSLLMGIPGPGGLQFAGRVGTGLSERELANLKEMLAPLHTDESPFDVPLPARDAKGITYVKPALVAEVRYSEWTPEGRLRQSSWRGLRPDKKPSEVVRE,"83,572",759,LigD polymerase family; LigD 3'-phosphoesterase family; ATP-dependent DNA ligase family,"DNA recombination [GO:0006310]; DNA replication, synthesis of RNA primer [GO:0006269]; double-strand break repair via nonhomologous end joining [GO:0006303]; viral process [GO:0016032]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; DNA-directed DNA polymerase activity [GO:0003887]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; DNA primase activity [GO:0003896]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polynucleotide adenylyltransferase activity [GO:0004652]; single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008310],plasma membrane [GO:0005886],,MTCY08D9.01c MTCY10D7.36c,1
P9WPU3,KDPB_MYCTU,Rv1030,kdpB Rv1030 MTCY10G2.19c,GO:0005524; GO:0005886; GO:0008556; GO:0016021; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR006391; IPR001757; ,,kdpB,,Potassium-transporting ATPase ATP-binding subunit (EC 3.6.3.12) (ATP phosphohydrolase [potassium-transporting] B chain) (Potassium-binding and translocating subunit B) (Potassium-translocating ATPase B chain),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; potassium-transporting ATPase activity [GO:0008556],9634230,,"FUNCTION: Part of the high-affinity ATP-driven potassium transport (or Kdp) system, which catalyzes the hydrolysis of ATP coupled with the electrogenic transport of potassium into the cytoplasm. This subunit is responsible for energy coupling to the transport system. {ECO:0000255|HAMAP-Rule:MF_00285}.",MMIARMETSATAAAATSAPRLRLAKRSLFDPMIVRSALPQSLRKLAPRVQARNPVMLVVLVGAVITTLAFLRDLASSTAQENVFNGLVAAFLWFTVLFANFAEAMAEGRGKAQAAALRKVRSETMANRRTAAGNIESVPSSRLDLDDVVEVSAGETIPSDGEIIEGIASVDESAITGESAPVIRESGGDRSAVTGGTVVLSDRIVVRITAKQGQTFIDRMIALVEGAARQQTPNEIALNILLAGLTIIFLLAVVTLQPFAIYSGGGQRVVVLVALLVCLIPTTIGALLSAIGIAGMDRLVQHNVLATSGRAVEAAGDVNTLLLDKTGTITLGNRQATEFVPINGVSAEAVADAAQLSSLADETPEGRSIVVLAKDEFGLRARDEGVMSHARFVPFTAETRMSGVDLAEVSGIRRIRKGAAAAVMKWVRDHGGHPTEEVGAIVDGISSGGGTPLVVAEWTDNSSARAIGVVHLKDIVKVGIRERFDEMRRMSIRTVMITGDNPATAKAIAQEAGVDDFLAEATPEDKLALIKREQQGGRLVAMTGDGTNDAPALAQADVGVAMNTGTQAAREAGNMVDLDSDPTKLIEVVEIGKQLLITRGALTTFSIANDVAKYFAIIPAMFVGLYPVLDKLNVMALHSPRSAILSAVIFNALVIVALIPLALRGVRFRAESASAMLRRNLLIYGLGGLVVPFIGIKLVDLVIVALGVS,"74,634",709,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IA subfamily",,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; potassium-transporting ATPase activity [GO:0008556],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10G2.19c,1
P9WG37,KDC_MYCTU,Rv0853c,kdc Rv0853c,GO:0000287; GO:0005622; GO:0005886; GO:0008152; GO:0016831; GO:0030976,IPR029035; IPR029061; IPR012000; IPR012001; IPR000399; IPR012110; IPR011766; ,,kdc,,Alpha-keto-acid decarboxylase (KDC) (EC 4.1.1.-),intracellular [GO:0005622]; plasma membrane [GO:0005886]; carboxy-lyase activity [GO:0016831]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; metabolic process [GO:0008152],9634230; 12368430; 19099550; 18086676; 21969609,,FUNCTION: Decarboxylates branched-chain and aromatic alpha-keto acids to aldehydes. {ECO:0000269|PubMed:18086676}.,MTPQKSDACSDPVYTVGDYLLDRLAELGVSEIFGVPGDYNLQFLDHIVAHPTIRWVGSANELNAGYAADGYGRLRGMSAVVTTFGVGELSVTNAIAGSYAEHVPVVHIVGGPTKDAQGTRRALHHSLGDGDFEHFLRISREITCAQANLMPATAGREIDRVLSEVREQKRPGYILLSSDVARFPTEPPAAPLPRYPGGTSPRALSLFTKAAIELIADHQLTVLADLLVHRLQAVKELEALLAADVVPHATLMWGKSLLDESSPNFLGIYAGAASAERVRAAIEGAPVLVTAGVVFTDMVSGFFSQRIDPARTIDIGQYQSSVADQVFAPLEMSAALQALATILTGRGISSPPVVPPPAEPPPAMPARDEPLTQQMVWDRVCSALTPGNVVLADQGTSFYGMADHRLPQGVTFIGQPLWGSIGYTLPAAVGAAVAHPDRRTVLLIGDGAAQLTVQELGTFSREGLSPVIVVVNNDGYTVERAIHGETAPYNDIVSWNWTELPSALGVTNHLAFRAQTYGQLDDALTVAAARRDRMVLVEVVLPRLEIPRLLGQLVGSMAPQ,"59,783",560,TPP enzyme family,metabolic process [GO:0008152],carboxy-lyase activity [GO:0016831]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
P9WGL3,KDPD_MYCTU,Rv1028c,kdpD Rv1028c MTCY10G2.21,GO:0000155; GO:0005524; GO:0005737; GO:0005886; GO:0006950; GO:0016021,IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR038318; IPR025201; IPR027417; IPR014729; IPR004358; IPR003852; IPR006016; ,,kdpD,DOMAIN 639 857 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Sensor protein KdpD (EC 2.7.13.3),cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; response to stress [GO:0006950],9634230; 12595424; 12581360; 21969609,,FUNCTION: Member of the two-component regulatory system KdpD/KdpE involved in the regulation of the kdp operon. KdpD may function as a membrane-associated protein kinase that phosphorylates KdpE in response to environmental signals (By similarity). {ECO:0000250}.,MTLLFADLCAIFTPYRWMIEHVTTKRGQLRIYLGAAPGVGKTYAMLGEAHRRLERGTDVVAAVVETHGRNKTAKLLEGIEMIPPRYVEYRGARFPELDVEAVLRRHPQVVLVDELAHTNTPGSKNPKRWQDVQEILDAGITVISTVNIQHLEGLNDVVEQITGIEQKEKIPDEIVRAADQVELVDITPEALRRRLAHGNVYAAERVDAALSNYFRTGNLTALREIALLWLADQVDAALEKYRADKKITATWEARERVVVAVTGGPESETLVRRASRIASKSSAELMVVHVIRGDGLAGVSAPQLGRVRELATSLGATMHTVVGDDVPTALLDFAREMNATQLVVGTSRRSRWARLFDEGIGARTVQEPGGIDVHMVTHPAASRASGWSRVSPRERHIASWLAALVVPSVICAITVAWLDRFMGIGGESALFFIGVLIVALLGGVAPAALSALLSGMLLNYFLTEPRYTWTIAEPDAAVTEFVLLAMAVAVAVLVDGAASRTREARRASQEAELLALFAGSVLRGADLATLLQRVRETYSQRAVTMLRVRQGASTGETVACVGTNPCRDVDSADTAIEVGDDEFWMLMAGRKLAARDRRVLTAVATQAAGLVKQRELAEEAGQAEAIARADELRRSLLSAVSHDLRTPLAAAKVAVSSLRTEDVAFSPEDTAELLATIEESIDQLTALVANLLDSSRLAAGVIRPQLRRAYLEEAVQRALVSIGKGATGFYRSGIDRVKVDVGDAVAMADAGLLERVLANLIDNALRYAPDCVVRVNAGRVRERVLINVIDEGPGVPRGTEEQLFAPFQRPGDHDNTTGVGLGMSVARGFVEAMGGTISATDTPGGGLTVVIDLAAPEDRP,"92,749",860,Universal stress protein A family,response to stress [GO:0006950],ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155],cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY10G2.21,1
O53859,LPQS_MYCTU,Rv0847 RVBD_0847,lpqS Rv0847 RVBD_0847 LH57_04625 P425_00887,GO:0005886; GO:0046688,,,lpqS,,Lipoprotein LpqS,plasma membrane [GO:0005886]; response to copper ion [GO:0046688],9634230; 21166899; 23562345; 24549843; 26768127,,FUNCTION: May play an essential role in M.tuberculosis replication and survival inside the host cell. {ECO:0000269|PubMed:23562345}.,MVWMRSAIVAVALGVTVAAVAAACWLPQLHRHVAHPNHPLTTSVGSEFVINTDHGHLVDNSMPPCPERLATAVLPRSATPVLLPDVVAAAPGMTAALTDPVAPAARGPPAAQGSVRTGQDLLTRFCLARR,"13,519",130,,response to copper ion [GO:0046688],,plasma membrane [GO:0005886],,LH57_04625 P425_00887,3
P9WK59,LPQT_MYCTU,Rv1016c,lpqT Rv1016c MTCY10G2.33,GO:0005618; GO:0005886,IPR019674; ,,lpqT,,Putative lipoprotein LpqT,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MAGRRCPQDSVRPLAVAVAVATLAMSAVACGPKSPDFQSILSTSPTTSAVSTTTEVPVPLWKYLESVGVTGEPVAPSSLTDLTVSIPTPPGWAPMKNPNITPNTEMIAKGESYPTAMLMVFKLHRDFDIAEALKHGTADARLSTNFTELDSSTADFNGFPSSMIQGSYDLHGRRLHTWNRIVFPTGAPPAKQRYLVQLTITSLANEAVKHASDIEAIIAGFVVAAK,"24,081",226,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY10G2.33,1
P9WGU7,LPQW_MYCTU,Rv1166,lpqW Rv1166,GO:0005576; GO:0008654; GO:0009247; GO:0009405; GO:0030288; GO:0040007; GO:0046488,IPR000914; ,,lpqW,,Probable monoacyl phosphatidylinositol tetramannoside-binding protein LpqW,extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,"FUNCTION: May directly or indirectly regulate the accessibility of the key branch point intermediate, monoacyl phosphatidylinositol tetramannoside (AcPIM4), to the elongating alpha-1,6 mannosyltransferases which could regulate the lipoarabinomannans (LAMs) biosynthesis. {ECO:0000250}.",MGVPSPVRRVCVTVGALVALACMVLAGCTVSPPPAPQSTDTPRSTPPPPRRPTQIIMGIDWIGPGFNPHLLSDLSPVNAAISALVLPSAFRPIPDPNTPTGSRWEMDPTLLVSADVTNNHPFTVTYKIRPEAQWTDNAPIAADDFWYLWQQMVTQPGVVDPAGYHLITSVQSLEGGKQAVVTFAQPYPAWRELFTDILPAHIVKDIPGGFASGLARALPVTGGQFRVENIDPQRDEILIARNDRYWGPPSKPGIILFRRAGAPAALADSVRNGDTQVAQVHGGSAAFAQLSAIPDVRTARIVTPRVMQFTLRANVPKLADTQVRKAILGLLDVDLLAAVGAGTDNTVTLDQAQIRSPSDPGYVPTAPPAMSSAAALGLLEASGFQVDTNTSVSPAPSVPDSTTTSVSTGPPEVIRGRISKDGEQLTLVIGVAANDPTSVAVANTAADQLRDVGIAATVLALDPVTLYHDALNDNRVDAIVGWRQAGGNLATLLASRYGCPALQATTVPAANAPTTAPSAPIGPTPSAAPDTATPPPTAPRRPSDPGALVKAPSNLTGICDRSIQSNIDAALNGTKNINDVITAVEPRLWNMSTVLPILQDTTIVAAGPSVQNVSLSGAVPVGIVGDAGQWVKTGQ,"66,130",635,Bacterial solute-binding protein 5 family,glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],,extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],,,1
P9WI79,PKND_MYCTU,Rv0931c,pknD Rv0931c MTCY08C9.08,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0009405; GO:0016036; GO:0030145; GO:0032091; GO:0043085; GO:0043086; GO:0045717,IPR011042; IPR011009; IPR035016; IPR001258; IPR013017; IPR000719; IPR017441; IPR008271; IPR013658; ,,pknD,DOMAIN 15 276 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknD (EC 2.7.11.1),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cellular response to phosphate starvation [GO:0016036]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein binding [GO:0032091]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085],9119030; 9634230; 15967413; 15987910; 16739134; 17242402; 17411339; 20933472; 21969609; 15136047,X-ray crystallography (2),"FUNCTION: Key microbial factor required for central nervous system tuberculosis. Required for invasion of host brain endothelia, but not macrophages, lung epithelia or other endothelia. Phosphorylates the anti-anti-sigma factor homolog Rv0516c, which inhibits binding of Rv0516c to Rv2638, another anti-anti-sigma factor. Can also phosphorylate the FHA domain of Rv1747. {ECO:0000269|PubMed:15987910, ECO:0000269|PubMed:17242402, ECO:0000269|PubMed:17411339}.",MSDAVPQVGSQFGPYQLLRLLGRGGMGEVYEAEDTRKHRVVALKLISPQYSDNAVFRARMQREADTAGRLTEPHIVPIHDYGEINGQFFVEMRMIDGTSLRALLKQYGPLTPARAVAIVRQIAAALDAAHANGVTHRDVKPENILVTASDFAYLVDFGIARAASDPGLTQTGTAVGTYNYMAPERFTGDEVTYRADIYALACVLGECLTGAPPYRADSVERLIAAHLMDPAPQPSQLRPGRVPPALDQVIAKGMAKNPAERFMSAGDLAIAAHDALTTSEQHQATTILRRGDNATLLATPADTGLSQSESGIAGAGTGPPTPGAARWSPGDSATVAGPLAADSRGGNWPSQTGHSPAVPNALQASLGHAVPPAGNKRKVWAVVGAAAIVLVAIVAAAGYLVLRPSWSPTQASGQTVLPFTGIDFRLSPSGVAVDSAGNVYVTSEGMYGRVVKLATGSTGTTVLPFNGLYQPQGLAVDGAGTVYVTDFNNRVVTLAAGSNNQTVLPFDGLNYPEGLAVDTQGAVYVADRGNNRVVKLAAGSKTQTVLPFTGLNDPDGVAVDNSGNVYVTDTDNNRVVKLEAESNNQVVLPFTDITAPWGIAVDEAGTVYVTEHNTNQVVKLLAGSTTSTVLPFTGLNTPLAVAVDSDRTVYVADRGNDRVVKLTS,"69,545",664,"Protein kinase superfamily, Ser/Thr protein kinase family",cellular response to phosphate starvation [GO:0016036]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of protein binding [GO:0032091]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085],ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY08C9.08,1
O05581,PAT_MYCTU,Rv0998,Rv0998,GO:0016407; GO:0016746; GO:0030552; GO:0046872,IPR016181; IPR018490; IPR018488; IPR000595; IPR000182; IPR014710; ,,,DOMAIN 156 318 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,Acetyltransferase Pat (EC 2.3.1.-) (GCN5-like enzyme) (GCN5-related N-acetyltransferase) (GNAT) (Protein acetyltransferase) (Pat),"acetyltransferase activity [GO:0016407]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; transferase activity, transferring acyl groups [GO:0016746]",9634230; 20507997; 21627103; 21969609; 22773105,X-ray crystallography (3),"FUNCTION: Catalyzes specifically the acetylation of the epsilon-amino group of a highly conserved lysine residue in acetyl-CoA synthetase (ACS). This acetylation results in the inactivation of ACS activity and could be important for mycobacteria to adjust to environmental changes. {ECO:0000269|PubMed:20507997, ECO:0000269|PubMed:21627103, ECO:0000269|PubMed:22773105}.",MDGIAELTGARVEDLAGMDVFQGCPAEGLVSLAASVQPLRAAAGQVLLRQGEPAVSFLLISSGSAEVSHVGDDGVAIIARALPGMIVGEIALLRDSPRSATVTTIEPLTGWTGGRGAFATMVHIPGVGERLLRTARQRLAAFVSPIPVRLADGTQLMLRPVLPGDRERTVHGHIQFSGETLYRRFMSARVPSPALMHYLSEVDYVDHFVWVVTDGSDPVADARFVRDETDPTVAEIAFTVADAYQGRGIGSFLIGALSVAARVDGVERFAARMLSDNVPMRTIMDRYGAVWQREDVGVITTMIDVPGPGELSLGREMVDQINRVARQVIEAVG,"35,626",333,,,"acetyltransferase activity [GO:0016407]; cAMP binding [GO:0030552]; metal ion binding [GO:0046872]; transferase activity, transferring acyl groups [GO:0016746]",,,,2
Q79FS8,PE09_MYCTU,Rv1088,PE9 Rv1088,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0009986,IPR000084; ,,PE9,DOMAIN 1 87 PE. {ECO:0000255}.,PE family protein PE9,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 26031846; 26851205,,"FUNCTION: Together with PE10, induces macrophage apoptosis through human Toll-like receptor 4 (TLR4) signaling pathway. Interaction with TLR4 leads to increased levels of phospho-IRF-3, increase in the transcript levels of IFN-beta and pro-apoptotic genes, up-regulation of IL-10, down-regulation of IL-1b and enhanced levels of macrophage apoptosis. {ECO:0000269|PubMed:26031846}.",MSYMIATPAALTAAATDIDGIGSAVSVANAAAVAATTGVLAAGGDEVLAAIARLFNANAEEYHALSAQVAAFQTLFVRTLTGGCGVFRRRRGRQCVTAAEHRAAGAGRRQRRRRSGDGQWRLRQQRHFGCGGQPEFRQHSEHRR,"15,376",144,Mycobacterial PE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
Q79FU0,PG18_MYCTU,Rv0980c,PE_PGRS18 Rv0980c LH57_05345,,IPR011045; IPR001258; IPR013017; IPR000084; IPR015943; IPR011964; ,,PE_PGRS18,DOMAIN 1 92 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS18,,9634230; 16586367,,,MSFVNVAPQLVSTAAADAARIGSAINTANTAAAATTQVLAAAHDEVSTAIAALFGSHGQHYQAISAQVAAYQERFVLALSQASSTYAVAEAASATPLQNVLDAINAPVQSLTGRPLIGDGANGIDGTGQAGGNGGWLWGNGGNGGSGAPGQAGGAGGAAGLIGNGGAGGAGGQGLPFEAGANGGAGGAGGWLFGNGGAGGVGGAGGAGTTFGVAGGDGGTGGVGGHGGLIGVGGHGGDGGTGGTGGAVSLARAGTAGGAGGGPAGGIGGAGGVGGAGGAAGAVTTITHASFNDPHGVAVNPGGNIYVTNQGSNTVSVIDPVTNTVTGSITDGNGPSGVAVSPVTGLVFVTNFDSNTVSVIDPNTNTVTGSIPVGTGAYGVAVNPGGNIYVTNQFSNTVSVIDPATNTVTGSPIPVGLDPTGVAVNPVTGVVYVTNSLDDTVSVITGEPARSVCSAAI,"42,075",457,"Mycobacterial PE family, PGRS subfamily",,,,,LH57_05345,1
P9WIF9,PG20_MYCTU,Rv1068c,PE_PGRS20 Rv1068c MTV017.21c,,IPR000084; ,,PE_PGRS20,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS20,,9634230,,,MSYMIAVPDMLSSAAGDLASIGSSINASTRAAAAATTRLLPAAADEVSAHIAALFSGHGEGYQAIARQMAAFHDQFTLALTSSAGAYASAEATNVEQQVLGLINAPTQALLGRPLIGNGADGTAANPNGGAGGLLYGNGGNGFSQTTAGLTGGTGGSAGLIGNGGNGGAGGAGANGGAGGNGGWLYGSGGNGGAGGAGPAGAIGAPGVAGGAGGAGGTAGLFGNGGAGGAGGAGGAGGRGGDGGSAGWLSGNGGDAGTGGGGGNAGNGGNGGSAGWLSGNGGTGGGGGTAGAGGQGGNGNSGIDPGNGGQGADTGNAGNGGHGGSAAKLFGDGGAGGAGGMGSTGGTGGGGGFGGGTGGNGGNGHAGGAGGSGGTAGLLGSGGSGGTGGDGGNGGLGAGSGAKGNGGNGGDGGKGGDAQLIGNGGNGGNGGKGGTGLMPGINGTGGAGGSRGQISGNPGTPGQ,"39,305",463,"Mycobacterial PE family, PGRS subfamily",,,,,MTV017.21c,1
L0T5T4,PE10_MYCTU,Rv1089,PE10 Rv1089,GO:0005576; GO:0005618; GO:0009405,,,PE10,,PE family protein PE10 (Fragment),cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 26031846,,"FUNCTION: Together with PE9, induces macrophage apoptosis through human Toll-like receptor 4 (TLR4) signaling pathway. Interaction with TLR4 leads to increased levels of phospho-IRF-3, increase in the transcript levels of IFN-beta and pro-apoptotic genes, up-regulation of IL-10, down-regulation of IL-1b and enhanced levels of macrophage apoptosis. {ECO:0000269|PubMed:26031846}.",SFAGAEAANASQLQSIARQVRGAVNAVAGQVTGNGGSGNSGTSAAAANPNSDNTASIADRGTSAIMTTASATASSTGVDGGIAATYAVASQWDGGYVANYTITQFGRDFDDRLAVAIHFA,"11,763",120,Mycobacterial PE family,pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
Q79FU3,PG16_MYCTU,Rv0977,PE_PGRS16 Rv0977,GO:0009986; GO:0046872,IPR000084; IPR021109; ,,PE_PGRS16,DOMAIN 1 91 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS16,cell surface [GO:0009986]; metal ion binding [GO:0046872],9634230; 16672626; 16586367; 18957600; 23923105,X-ray crystallography (1),,MSFVVTAPPVLASAASDLGGIASMISEANAMAAVRTTALAPAAADEVSAAIAALFSSYARDYQTLSVQVTAFHVQFAQTLTNAGQLYAVVDVGNGVLLKTEQQVLGVINAPTQTLVGRPLIGDGTHGAPGTGQNGGAGGILWGNGGNGGSGAPGQPGGRGGDAGLFGHGGHGGVGGPGIAGAAGTAGLPGGNGANGGSGGIGGAGGAGGNGGLLFGNGGAGGQGGSGGLGGSGGTGGAGMAAGPAGGTGGIGGIGGIGGAGGVGGHGSALFGHGGINGDGGTGGMGGQGGAGGNGWAAEGITVGIGEQGGQGGDGGAGGAGGIGGSAGGIGGSQGAGGHGGDGGQGGAGGSGGVGGGGAGAGGDGGAGGIGGTGGNGSIGGAAGNGGNGGRGGAGGMATAGSDGGNGGGGGNGGVGVGSAGGAGGTGGDGGAAGAGGAPGHGYFQQPAPQGLPIGTGGTGGEGGAGGAGGDGGQGDIGFDGGRGGDGGPGGGGGAGGDGSGTFNAQANNGGDGGAGGVGGAGGTGGTGGVGADGGRGGDSGRGGDGGNAGHGGAAQFSGRGAYGGEGGSGGAGGNAGGAGTGGTAGSGGAGGFGGNGADGGNGGNGGNGGFGGINGTFGTNGAGGTGGLGTLLGGHNGNIGLNGATGGIGSTTLTNATVPLQLVNTTEPVVFISLNGGQMVPVLLDTGSTGLVMDSQFLTQNFGPVIGTGTAGYAGGLTYNYNTYSTTVDFGNGLLTLPTSVNVVTSSSPGTLGNFLSRSGAVGVLGIGPNNGFPGTSSIVTAMPGLLNNGVLIDESAGILQFGPNTLTGGITISGAPISTVAVQIDNGPLQQAPVMFDSGGINGTIPSALASLPSGGFVPAGTTISVYTSDGQTLLYSYTTTATNTPFVTSGGVMNTGHVPFAQQPIYVSYSPTAIGTTTFN,"81,604",923,"Mycobacterial PE family, PGRS subfamily",,metal ion binding [GO:0046872],cell surface [GO:0009986],,,1
I6WZK7,MMCO_MYCTU,Rv0846c RVBD_0846c,mmcO Rv0846c RVBD_0846c LH57_04620 P425_00886,GO:0004322; GO:0005507; GO:0005886; GO:0030288,IPR001117; IPR011706; IPR011707; IPR033138; IPR002355; IPR008972; IPR034279; IPR006311; ,,mmcO,DOMAIN 190 349 Plastocyanin-like. {ECO:0000255}.,Multicopper oxidase MmcO (EC 1.16.3.1) (Mycobacterium multicopper oxidase),outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322],9634230; 21969609; 23772064; 24549843,,"FUNCTION: Required for copper resistance. In vitro, oxidizes organic substrates and Fe(2+). May act in vivo by oxidation of toxic periplasmic Cu(+). {ECO:0000269|PubMed:23772064}.",MPELATSGNAFDKRRFSRRGFLGAGIASGFALAACASKPTASGAAGMTAAIDAAEAARPHSGRTVTATLTPQPARIDLGGPIVSTLTYGNTIPGPLIRATVGDEIVVSVTNRLGDPTSVHWHGIALRNDMDGTEPATANIGPGGDFTYRFSVPDPGTYWAHPHVGLQGDHGLYLPVVVDDPTEPGHYDAEWIIILDDWTDGIGKSPQQLYGELTDPNKPTMQNTTGMPEGEGVDSNLLGGDGGDIAYPYYLINGRIPVAATSFKAKPGQRIRIRIINSAADTAFRIALAGHSMTVTHTDGYPVIPTEVDALLIGMAERYDVMVTAAGGVFPLVALAEGKNALARALLSTGAGSPPDPQFRPDELNWRVGTVEMFTAATTANLGRPEPTHDLPVTLGGTMAKYDWTINGEPYSTTNPLHVRLGQRPTLMFDNTTMMYHPIHLHGHTFQMIKADGSPGARKDTVIVLPKQKMRAVLVADNPGVWVMHCHNNYHQVAGMATRLDYIL,"53,796",504,Multicopper oxidase family,,copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322],outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,LH57_04620 P425_00886,1
P9WMQ5,MFD_MYCTU,Rv1020,mfd Rv1020 MTCY10G2.29c,GO:0003684; GO:0004386; GO:0005524; GO:0005829; GO:0005886; GO:0006281,IPR036101; IPR003711; IPR011545; IPR014001; IPR001650; IPR004576; IPR027417; IPR037235; IPR005118; ,,mfd,DOMAIN 663 824 Helicase ATP-binding. {ECO:0000255|HAMAP-Rule:MF_00969}.; DOMAIN 842 999 Helicase C-terminal. {ECO:0000255|HAMAP-Rule:MF_00969}.,Transcription-repair-coupling factor (TRCF) (EC 3.6.4.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; helicase activity [GO:0004386]; DNA repair [GO:0006281],9634230; 21969609; 22904282,,"FUNCTION: Couples transcription and DNA repair by recognizing RNA polymerase (RNAP) stalled at DNA lesions. Mediates ATP-dependent release of RNAP and its truncated transcript from the DNA, and recruitment of nucleotide excision repair machinery to the damaged site. {ECO:0000255|HAMAP-Rule:MF_00969}.",MTAPGPACSDTPIAGLVELALSAPTFQQLMQRAGGRPDELTLIAPASARLLVASALARQGPLLVVTATGREADDLAAELRGVFGDAVALLPSWETLPHERLSPGVDTVGTRLMALRRLAHPDDAQLGPPLGVVVTSVRSLLQPMTPQLGMMEPLTLTVGDESPFDGVVARLVELAYTRVDMVGRRGEFAVRGGILDIFAPTAEHPVRVEFWGDEITEMRMFSVADQRSIPEIDIHTLVAFACRELLLSEDVRARAAQLAARHPAAESTVTGSASDMLAKLAEGIAVDGMEAVLPVLWSDGHALLTDQLPDGTPVLVCDPEKVRTRAADLIRTGREFLEASWSVAALGTAENQAPVDVEQLGGSGFVELDQVRAAAARTGHPWWTLSQLSDESAIELDVRAAPSARGHQRDIDEIFAMLRAHIATGGYAALVAPGTGTAHRVVERLSESDTPAGMLDPGQAPKPGVVGVLQGPLRDGVIIPGANLVVITETDLTGSRVSAAEGKRLAAKRRNIVDPLALTAGDLVVHDQHGIGRFVEMVERTVGGARREYLVLEYASAKRGGGAKNTDKLYVPMDSLDQLSRYVGGQAPALSRLGGSDWANTKTKARRAVREIAGELVSLYAKRQASPGHAFSPDTPWQAELEDAFGFTETVDQLTAIEEVKADMEKPIPMDRVICGDVGYGKTEIAVRAAFKAVQDGKQVAVLVPTTLLADQHLQTFGERMSGFPVTIKGLSRFTDAAESRAVIDGLADGSVDIVIGTHRLLQTGVRWKDLGLVVVDEEQRFGVEHKEHIKSLRTHVDVLTMSATPIPRTLEMSLAGIREMSTILTPPEERYPVLTYVGPHDDKQIAAALRRELLRDGQAFYVHNRVSSIDAAAARVRELVPEARVVVAHGQMPEDLLETTVQRFWNREHDILVCTTIVETGLDISNANTLIVERADTFGLSQLHQLRGRVGRSRERGYAYFLYPPQVPLTETAYDRLATIAQNNELGAGMAVALKDLEIRGAGNVLGIEQSGHVAGVGFDLYVRLVGEALETYRDAYRAAADGQTVRTAEEPKDVRIDLPVDAHLPPDYIASDRLRLEGYRRLAAASSDREVAAVVDELTDRYGALPEPARRLAAVARLRLLCRGSGITDVTAASAATVRLSPLTLPDSAQVRLKRMYPGAHYRATTATVQVPIPRAGGLGAPRIRDVELVQMVADLITALAGKPRQHIGITNPSPPGEDGRGRNTTIKERQP,"132,908",1234,"UvrB family; Helicase family, RecG subfamily",DNA repair [GO:0006281],ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; helicase activity [GO:0004386],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY10G2.29c,1
O53451,MAZE3_MYCTU,Rv1103c,mazE3 mazE-mt6 Rv1103c,GO:0045926; GO:0045927,,,mazE3,,Antitoxin MazE3,negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927],9634230; 15718296; 16611633; 19016878; 20011113; 20705052; 21969609; 23650345; 25608501,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and M.smegmatis neutralizes the effect of cognate toxin MazF3. Overexpression of MazE3 alone decreased persister cells formation in M.smegmatis upon challenge with gentamicin or kanamycin. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20705052, ECO:0000269|PubMed:23650345}.",MYLPWGVVLAGGANGFGAGAYQTGTICEVSTQIAVRLPDEIVAFIDDEVRGQHARSRAAVVLRALERERRRRLAERDAEILATNTSATGDLDTLAGHCARTALDID,"11,395",106,,negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927],,,mazE-mt6,,1
P9WIH9,MAZF3_MYCTU,Rv1102c,mazF3 mazF-mt6 Rv1102c,GO:0003677; GO:0004521; GO:0006402; GO:0016075; GO:0017148; GO:0045892; GO:0045926; GO:0045927,IPR003477; IPR011067; ,,mazF3,,Endoribonuclease MazF3 (EC 3.1.-.-) (23S rRNA endonuclease MazF3) (Toxin MazF3) (mRNA interferase MazF-mt6),"DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of growth [GO:0045927]; rRNA catabolic process [GO:0016075]",9634230; 16611633; 19016878; 20011113; 20705052; 23650345; 25608501,X-ray crystallography (2),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Acts as an mRNA and 23S rRNA interferase, cleaving predominantly after the first 2 Us in the sequence 5'-UUCCU-3'; in 23S rRNA only cleaves once in the ribosomal A site in dissociated but not intact ribosomes. Cleavage of 23S rRNA inhibits protein translation; the 23S rRNA region cleaved is involved in tRNA-binding in the A site, 30S and 50S subunit interaction and ribosome recycling factor association (PubMed:23650345). Upon expression in E.coli and M.smegmatis inhibits cell growth and colony formation. It dramatically increases persister cell formation in M.smegmatis upon challenge with gentamicin or kanamycin. Overexpression leads to bacteriostasis rather than bacteriocide. Its toxic effect is neutralized by coexpression with cognate antitoxin MazE3. {ECO:0000269|PubMed:16611633, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20705052, ECO:0000269|PubMed:23650345, ECO:0000269|PubMed:25608501}.",MRPIHIAQLDKARPVLILTREVVRPHLTNVTVAPITTTVRGLATEVPVDAVNGLNQPSVVSCDNTQTIPVCDLGRQIGYLLASQEPALAEAIGNAFDLDWVVA,"11,050",103,PemK/MazF family,"mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; positive regulation of growth [GO:0045927]; rRNA catabolic process [GO:0016075]",DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521],,mazF-mt6,,1
P96379,MAZG_MYCTU,Rv1021,mazG Rv1021,GO:0000287; GO:0005524; GO:0005618; GO:0006203; GO:0006979; GO:0035539; GO:0046047; GO:0046052; GO:0046061; GO:0046076; GO:0046081; GO:0047693; GO:0051289,IPR004518; IPR011551; ,,mazG,,Nucleoside triphosphate pyrophosphohydrolase (NTP-PPase) (EC 3.6.1.8),"cell wall [GO:0005618]; 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; magnesium ion binding [GO:0000287]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; dTTP catabolic process [GO:0046076]; dUTP catabolic process [GO:0046081]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; TTP catabolic process [GO:0046047]; UTP catabolic process [GO:0046052]",9634230; 20529853; 21969609,,"FUNCTION: Required to maintain the full capacity of the mycobacterium to respond to oxidative stress via the degradation of oxidation-induced damaged nucleotides. Hydrolyzes all canonical (d)NTPs, as well as mutagenic dUTP and 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-oxo-dGTP). Also involved in the transcriptional activation of RelA in response to oxidative stress. {ECO:0000269|PubMed:20529853}.",MIVVLVDPRRPTLVPVEAIEFLRGEVQYTEEMPVAVPWSLPAARSAHAGNDAPVLLSSDPNHPAVITRLAAGARLISAPDSQRGERLVDAVAMMDKLRTAGPWESEQTHDSLRRYLLEETYELLDAVRSGSVDQLREELGDLLLQVLFHARIAEDASQSPFTIDDVADTLMRKLGNRAPGVLAGESISLEDQLAQWEAAKASEKARKSVADDVHTGQPALALAQKVIQRAQKAGLPAHLIPDEITSVSVSADVDAENTLRTAVLDFIDRLRCAERAIAVARRGSNVAEQLDVTPLGVITEQEWLAHWPTAVNDSRGGSKKRKGMR,"35,413",325,Nucleoside triphosphate pyrophosphohydrolase family,dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; dTTP catabolic process [GO:0046076]; dUTP catabolic process [GO:0046081]; protein homotetramerization [GO:0051289]; response to oxidative stress [GO:0006979]; TTP catabolic process [GO:0046047]; UTP catabolic process [GO:0046052],"8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; ATP binding [GO:0005524]; ATP diphosphatase activity [GO:0047693]; magnesium ion binding [GO:0000287]",cell wall [GO:0005618],,,1
P9WGB7,METB_MYCTU,Rv1079,metB Rv1079 MTV017.32,GO:0000096; GO:0003962; GO:0004123; GO:0005829; GO:0005886; GO:0019279; GO:0019343; GO:0030170,IPR000277; IPR015424; IPR015422; IPR015421; ,,metB,,Cystathionine gamma-synthase (CGS) (EC 2.5.1.48) (O-succinylhomoserine (thiol)-lyase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process via cystathionine [GO:0019343]; L-methionine biosynthetic process from L-homoserine via cystathionine [GO:0019279]; sulfur amino acid metabolic process [GO:0000096],9634230; 19428471; 21969609,,"FUNCTION: Catalyzes the formation of L-cystathionine from O-succinyl-L-homoserine (OSHS) and L-cysteine, via a gamma-replacement reaction (By similarity). In the absence of thiol, catalyzes gamma-elimination to form 2-oxobutanoate, succinate and ammonia. {ECO:0000250, ECO:0000269|PubMed:19428471}.",MSEDRTGHQGISGPATRAIHAGYRPDPATGAVNVPIYASSTFAQDGVGGLRGGFEYARTGNPTRAALEASLAAVEEGAFARAFSSGMAATDCALRAMLRPGDHVVIPDDAYGGTFRLIDKVFTRWDVQYTPVRLADLDAVGAAITPRTRLIWVETPTNPLLSIADITAIAELGTDRSAKVLVDNTFASPALQQPLRLGADVVLHSTTKYIGGHSDVVGGALVTNDEELDEEFAFLQNGAGAVPGPFDAYLTMRGLKTLVLRMQRHSENACAVAEFLADHPSVSSVLYPGLPSHPGHEIAARQMRGFGGMVSVRMRAGRRAAQDLCAKTRVFILAESLGGVESLIEHPSAMTHASTAGSQLEVPDDLVRLSVGIEDIADLLGDLEQALG,"40,982",388,Trans-sulfuration enzymes family,cysteine biosynthetic process via cystathionine [GO:0019343]; L-methionine biosynthetic process from L-homoserine via cystathionine [GO:0019279]; sulfur amino acid metabolic process [GO:0000096],cystathionine gamma-lyase activity [GO:0004123]; cystathionine gamma-synthase activity [GO:0003962]; pyridoxal phosphate binding [GO:0030170],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV017.32,1
P9WK07,METE_MYCTU,Rv1133c,metE Rv1133c MTC22G8.22,GO:0003871; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0008270; GO:0008705; GO:0040007; GO:0050667,IPR013215; IPR006276; IPR002629; IPR038071; ,,metE,,"5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (EC 2.1.1.14) (Cobalamin-independent methionine synthase) (Methionine synthase, vitamin-B12 independent isozyme)",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; 5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; growth [GO:0040007]; homocysteine metabolic process [GO:0050667],9634230; 21969609,,FUNCTION: Catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine resulting in methionine formation. {ECO:0000250}.,MTQPVRRQPFTATITGSPRIGPRRELKRATEGYWAGRTSRSELEAVAATLRRDTWSALAAAGLDSVPVNTFSYYDQMLDTAVLLGALPPRVSPVSDGLDRYFAAARGTDQIAPLEMTKWFDTNYHYLVPEIGPSTTFTLHPGKVLAELKEALGQGIPARPVIIGPITFLLLSKAVDGAGAPIERLEELVPVYSELLSLLADGGAQWVQFDEPALVTDLSPDAPALAEAVYTALCSVSNRPAIYVATYFGDPGAALPALARTPVEAIGVDLVAGADTSVAGVPELAGKTLVAGVVDGRNVWRTDLEAALGTLATLLGSAATVAVSTSCSTLHVPYSLEPETDLDDALRSWLAFGAEKVREVVVLARALRDGHDAVADEIASSRAAIASRKRDPRLHNGQIRARIEAIVASGAHRGNAAQRRASQDARLHLPPLPTTTIGSYPQTSAIRVARAALRAGEIDEAEYVRRMRQEITEVIALQERLGLDVLVHGEPERNDMVQYFAEQLAGFFATQNGWVQSYGSRCVRPPILYGDVSRPRAMTVEWITYAQSLTDKPVKGMLTGPVTILAWSFVRDDQPLADTANQVALAIRDETVDLQSAGIAVIQVDEPALRELLPLRRADQAEYLRWAVGAFRLATSGVSDATQIHTHLCYSEFGEVIGAIADLDADVTSIEAARSHMEVLDDLNAIGFANGVGPGVYDIHSPRVPSAEEMADSLRAALRAVPAERLWVNPDCGLKTRNVDEVTASLHNMVAAAREVRAG,"81,582",759,Vitamin-B12 independent methionine synthase family,growth [GO:0040007]; homocysteine metabolic process [GO:0050667],5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTC22G8.22,1
P9WIZ5,MNTH_MYCTU,Rv0924c,mntH Rv0924c MTCY21C12.18c,GO:0005886; GO:0015293; GO:0016021; GO:0034755; GO:0046873; GO:0071421; GO:0071578,IPR001046; ,,mntH,,Divalent metal cation transporter MntH (Mramp),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293]; iron ion transmembrane transport [GO:0034755]; manganese ion transmembrane transport [GO:0071421]; zinc ion import across plasma membrane [GO:0071578],9634230; 10477555; 12117920,,"FUNCTION: H(+)-stimulated, divalent metal cation uptake system. Transports zinc and iron. Can also interact with manganese and copper. {ECO:0000255|HAMAP-Rule:MF_00221, ECO:0000269|PubMed:10477555}.",MAGEFRLLSHLCSRGSKVGELAQDTRTSLKTSWYLLGPAFVAAIAYVDPGNVAANVSSGAQFGYLLLWVIVAANVMAALVQYLSAKLGLVTGRSLPEAIGKRMGRPARLAYWAQAEIVAMATDVAEVIGGAIALRIMFNLPLPIGGIITGVVSLLLLTIQDRRGQRLFERVITALLLVIAIGFTASFFVVTPPPNAVLGGLAPRFQGTESVLLAAAIMGATVMPHAVYLHSGLARDRHGHPDPGPQRRRLLRVTRWDVGLAMLIAGGVNAAMLLVAALNMRGRGDTASIEGAYHAVHDTLGATIAVLFAVGLLASGLASSSVGAYAGAMIMQGLLHWSVPMLVRRLITLGPALAILTLGFDPTRTLVLSQVVLSFGIPFAVLPLVKLTGSPAVMGGDTNHRATTWVGWVVAVMVSLLNVMLIYLTVTG,"45,004",428,NRAMP family,iron ion transmembrane transport [GO:0034755]; manganese ion transmembrane transport [GO:0071421]; zinc ion import across plasma membrane [GO:0071578],metal ion transmembrane transporter activity [GO:0046873]; symporter activity [GO:0015293],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21C12.18c,1
P9WJS1,MOAA2_MYCTU,Rv0869c,moaA2 Rv0869c MTV043.62c,GO:0005525; GO:0005618; GO:0006777; GO:0019008; GO:0046872; GO:0051539; GO:0061798,IPR013785; IPR006638; IPR034481; IPR013483; IPR000385; IPR010505; IPR007197; IPR034395; ,,moaA2,,"GTP 3',8-cyclase 2 (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A 2)","cell wall [GO:0005618]; molybdopterin synthase complex [GO:0019008]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]",9634230; 21969609,,"FUNCTION: Catalyzes the cyclization of GTP to (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate. {ECO:0000255|HAMAP-Rule:MF_01225}.",MTLTALGMPALRSRTNGIADPRVVPTTGPLVDTFGRVANDLRVSLTDRCNLRCSYCMPERGLRWLPGEQLLRPDELARLIHIAVTRLGVTSVRFTGGEPLLAHHLDEVVAATARLRPRPEISLTTNGVGLARRAGALAEAGLDRVNVSLDSIDRAHFAAITRRDRLAHVLAGLAAAKAAGLTPVKVNAVLDPTTGREDVVDLLRFCLERGYQLRVIEQMPLDAGHSWRRNIALSADDVLAALRPHFRLRPDPAPRGSAPAELWLVDAGPNTPRGRFGVIASVSHAFCSTCDRTRLTADGQIRSCLFSTEETDLRRLLRGGADDDAIEAAWRAAMWSKPAGHGINAPDFIQPDRPMSAIGG,"38,986",360,"Radical SAM superfamily, MoaA family",Mo-molybdopterin cofactor biosynthetic process [GO:0006777],"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]",cell wall [GO:0005618]; molybdopterin synthase complex [GO:0019008],,MTV043.62c,1
P9WJQ7,MOEA1_MYCTU,Rv0994,moeA1 moeA Rv0994 MTCI237.08,GO:0005829; GO:0005886; GO:0006777; GO:0018315; GO:0032324; GO:0046872; GO:0061598; GO:0061599,IPR036425; IPR001453; IPR038987; IPR005111; IPR036688; IPR005110; IPR036135; ,,moeA1,,Molybdopterin molybdenumtransferase 1 (MPT Mo-transferase 1) (EC 2.10.1.1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324],9634230; 21969609,,FUNCTION: Catalyzes the insertion of molybdate into adenylated molybdopterin with the concomitant release of AMP. {ECO:0000250}.,MRSVEEQQARISAAAVAPRPIRVAIAEAQGLMCAEEVVTERPMPGFDQAAIDGYAVRSVDVAGVGDTGGVQVFADHGDLDGRDVLTLPVMGTIEAGARTLSRLQPRQAVRVQTGAPLPTLADAVLPLRWTDGGMSRVRVLRGAPSGAYVRRAGDDVQPGDVAVRAGTIIGAAQVGLLAAVGRERVLVHPRPRLSVMAVGGELVDISRTPGNGQVYDVNSYALAAAGRDACAEVNRVGIVSNDPTELGEIVEGQLNRAEVVVIAGGVGGAAAEAVRSVLSELGEMEVVRVAMHPGSVQGFGQLGRDGVPTFLLPANPVSALVVFEVMVRPLIRLSLGKRHPMRRIVSARTLSPITSVAGRKGYLRGQLMRDQDSGEYLVQALGGAPGASSHLLATLAEANCLVVVPTGAEQIRTGEIVDVAFLAQHG,"44,337",426,MoeA family,molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin molybdotransferase activity [GO:0061599],cytosol [GO:0005829]; plasma membrane [GO:0005886],moeA,MTCI237.08,1
P9WGL1,MPRB_MYCTU,Rv0982,mprB Rv0982,GO:0000155; GO:0000160; GO:0004721; GO:0005524; GO:0005576; GO:0005622; GO:0005886; GO:0009405; GO:0016021; GO:0016301; GO:0018106; GO:0040007,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,mprB,DOMAIN 186 238 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 246 466 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Signal transduction histidine-protein kinase/phosphatase MprB (EC 2.7.13.3) (EC 3.1.3.-) (Mycobacterial persistence regulator B),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphoprotein phosphatase activity [GO:0004721]; phosphorelay sensor kinase activity [GO:0000155]; growth [GO:0040007]; pathogenesis [GO:0009405]; peptidyl-histidine phosphorylation [GO:0018106]; phosphorelay signal transduction system [GO:0000160],9634230; 11489128; 11675502; 14638785; 15601704; 16513743; 16586367; 17379732; 19099550; 21969609,,"FUNCTION: Member of the two-component regulatory system MprB/MprA which contributes to maintaining a balance among several systems involved in stress resistance and is required for establishment and maintenance of persistent infection in the host. In response to environmental signals MprB acts as both a membrane-associated protein kinase that undergoes autophosphorylation and subsequently transfers the phosphate to MprA, and a protein phosphatase that dephosphorylates phospho-MprA. MprB/MprA is involved in regulation of numerous stress-responsive genes, including up-regulation of two sigma factors, sigE and sigB as well as pepD and mprA, and repression of multiple genes from regulons associated with hypoxia, starvation and iron metabolism. The majority of genes regulated by MprB/MprA under a particular stress condition are different from those induced during normal growth, but several genes are commonly regulated under more than one condition. {ECO:0000269|PubMed:11675502, ECO:0000269|PubMed:14638785, ECO:0000269|PubMed:15601704, ECO:0000269|PubMed:16513743, ECO:0000269|PubMed:17379732}.",MWWFRRRDRAPLRATSSLSLRWRVMLLAMSMVAMVVVLMSFAVYAVISAALYSDIDNQLQSRAQLLIASGSLAADPGKAIEGTAYSDVNAMLVNPGQSIYTAQQPGQTLPVGAAEKAVIRGELFMSRRTTADQRVLAIRLTNGSSLLISKSLKPTEAVMNKLRWVLLIVGGIGVAVAAVAGGMVTRAGLRPVGRLTEAAERVARTDDLRPIPVFGSDELARLTEAFNLMLRALAESRERQARLVTDAGHELRTPLTSLRTNVELLMASMAPGAPRLPKQEMVDLRADVLAQIEELSTLVGDLVDLSRGDAGEVVHEPVDMADVVDRSLERVRRRRNDILFDVEVIGWQVYGDTAGLSRMALNLMDNAAKWSPPGGHVGVRLSQLDASHAELVVSDRGPGIPVQERRLVFERFYRSASARALPGSGLGLAIVKQVVLNHGGLLRIEDTDPGGQPPGTSIYVLLPGRRMPIPQLPGATAGARSTDIENSRGSANVISVESQSTRAT,"54,408",504,,growth [GO:0040007]; pathogenesis [GO:0009405]; peptidyl-histidine phosphorylation [GO:0018106]; phosphorelay signal transduction system [GO:0000160],ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphoprotein phosphatase activity [GO:0004721]; phosphorelay sensor kinase activity [GO:0000155],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
P9WJQ3,NARG_MYCTU,Rv1161,narG Rv1161,GO:0005576; GO:0005618; GO:0005886; GO:0008940; GO:0009055; GO:0009325; GO:0036294; GO:0042126; GO:0042128; GO:0043546; GO:0043602; GO:0046872; GO:0051539; GO:0071249; GO:0071732,IPR009010; IPR037943; IPR006657; IPR006656; IPR006963; IPR006655; IPR027467; IPR006468; ,,narG,DOMAIN 53 117 4Fe-4S Mo/W bis-MGD-type. {ECO:0000255|PROSITE-ProRule:PRU01004}.,Nitrate reductase alpha subunit (EC 1.7.5.1),"cell wall [GO:0005618]; extracellular region [GO:0005576]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to nitrate [GO:0071249]; cellular response to nitric oxide [GO:0071732]; nitrate assimilation [GO:0042128]; nitrate catabolic process [GO:0043602]; nitrate metabolic process [GO:0042126]",9634230; 14645286; 21969609,,"FUNCTION: The alpha chain is the actual site of nitrate reduction (Probable). Supports anaerobic growth of E.coli on glycerol in an E.coli mutant lacking endogenous nitrate reductase. {ECO:0000269|PubMed:14645286, ECO:0000305}.",MTVTPHVGGPLEELLERSGRFFTPGEFSADLRTVTRRGGREGDVFYRDRWSHDKVVRSTHGVNCTGSCSWKIYVKDGIITWETQQTDYPSVGPDRPEYEPRGCPRGASFSWYSYSPTRVRYPYARGVLVEMYREAKTRLGDPVLAWADIQADPERRRRYQQARGKGGLVRVSWAEASEMVAAAHVHTIKTYGPDRVAGFSPIPAMSMVSHAAGSRFVELIGGVMTSFYDWYADLPVASPQVFGDQTDVPESGDWWDASYLVMWGSNVPITRTPDAHWMAEARYRGAKVVVVSPDYADNTKFADEWVRCAAGTDTALAMAMGHVILSECYVRNQVPFFVDYVRRYTDLPFLIKLEKRGDLLVPGKFLTAADIGEESENAAFKPALLDELTNTVVVPQGSLGFRFGEDGVGKWNLDLGSVVPALSVEMDKAVNGDRSAELVTLPSFDTIDGHGETVSRGVPVRRAGKHLVCTVFDLMLAHYGVARAGLPGEWPTGYHDRTQQNTPAWQESITGVPAAQAIRFAKEFARNATESGGRSMIIMGGGICHWFHSDVMYRSVLALLMLTGSMGRNGGGWAHYVGQEKVRPLTGWQTMAMATDWSRPPRQVPGASYWYAHTDQWRYDGYGADKLASPVGRGRFAGKHTMDLLTSATAMGWSPFYPQFDRSSLDVADEARAAGRDVGDYVAEQLAQHKLKLSITDPDNPVNWPRVLTVWRANLIGSSGKGGEYFLRHLLGTDSNVQSDPPTDGVHPRDVVWDSDIPEGKLDLIMSIDFRMTSTTLVSDVVLPAATWYEKSDLSSTDMHPYVHSFSPAIDPPWETRSDFDAFAAIARAFSALAKRHLGTRTDVVLTALQHDTPDEMAYPDGTERDWLATGEVPVPGRTMSKLTVVERDYTAIYDKWLTLGPLIDQFGMTTKGYTVHPFREVSELAANFGVMNSGVAVGRPAITTAKRMADVILALSGTCNGRLAVEGFLELEKRTGQRLAHLAEGSEERRITYADTQARPVPVITSPEWSGSESGGRRYAPFTINIEHLKPFHTLTGRMHFYLAHDWVEELGEQLPVYRPPLDMARLFNQPELGPTDDGLGLTVRYLTPHSKWSFHSTYQDNLYMLSLSRGGPTMWMSPGDAAKINVRDNDWVEAVNANGIYVCRAIVSHRMPEGVVFVYHVQERTVDTPRTETNGKRGGNHNALTRVRIKPSHLAGGYGQHAFAFNYLGPTGNQRDEVTVVRRRSQEVRY,"136,956",1232,Prokaryotic molybdopterin-containing oxidoreductase family,cellular response to decreased oxygen levels [GO:0036294]; cellular response to nitrate [GO:0071249]; cellular response to nitric oxide [GO:0071732]; nitrate assimilation [GO:0042128]; nitrate catabolic process [GO:0043602]; nitrate metabolic process [GO:0042126],"4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; nitrate reductase activity [GO:0008940]",cell wall [GO:0005618]; extracellular region [GO:0005576]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886],,,1
P9WGM5,NARL_MYCTU,Rv0844c,narL Rv0844c,GO:0000160; GO:0003677; GO:0005737; GO:0006351; GO:0006355,IPR011006; IPR016032; IPR001789; IPR000792; ,,narL,DOMAIN 10 126 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.; DOMAIN 148 213 HTH luxR-type. {ECO:0000255|PROSITE-ProRule:PRU00411}.,Probable transcriptional regulatory protein NarL,"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 12595424; 19099550; 21969609; 19052358,X-ray crystallography (1),FUNCTION: Probable member of the two-component regulatory system NarS/NarL. {ECO:0000269|PubMed:12595424}.,MSNPQPEKVRVVVGDDHPLFREGVVRALSLSGSVNVVGEADDGAAALELIKAHLPDVALLDYRMPGMDGAQVAAAVRSYELPTRVLLISAHDEPAIVYQALQQGAAGFLLKDSTRTEIVKAVLDCAKGRDVVAPSLVGGLAGEIRQRAAPVAPVLSAREREVLNRIACGQSIPAIAAELYVAPSTVKTHVQRLYEKLGVSDRAAAVAEAMRQRLLD,"22,916",216,,"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytoplasm [GO:0005737],,,1
O53857,NARS_MYCTU,Rv0845,narS Rv0845,GO:0000160; GO:0004673; GO:0005622; GO:0005886; GO:0016021,IPR003594; IPR036890; IPR005467; ,,narS,DOMAIN 224 425 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Probable sensor histidine kinase NarS (EC 2.7.13.3),integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; protein histidine kinase activity [GO:0004673]; phosphorelay signal transduction system [GO:0000160],9634230; 12595424; 21969609,,FUNCTION: Probable member of the two-component regulatory system NarS/NarL. May activate NarL by phosphorylation. {ECO:0000269|PubMed:12595424}.,MPSYGNLGRLGGRHEYGVLVAMTSSAELDRVRWAHQLRSYRIASVLRIGVVGLMVAAMVVGTSRSEWPQQIVLIGVYAVAALWALLLAYSASRRFFALRRFRSMGRLEPFAFTAVDVLILTGFQLLSTDGIYPLLIMILLPVLVGLDVSTRRAAVVLACTLVGFAVAVLGDPVMLRAIGWPETIFRFALYAFLCATALMVVRIEERHTRSVAGLSALRAELLAQTMTASEVLQRRIAEAIHDGPLQDVLAARQELIELDAVTPGDERVGRALAGLQSASERLRQATFELHPAVLEQVGLGPAVKQLAASTAQRSGIKISTDIDYPIRSGIDPIVFGVVRELLSNVVRHSGATTASVRLGITDEKCVLDVADDGVGVTGDTMARRLGEGHIGLASHRARVDAAGGVLVFLATPRGTHVCVELPLKR,"45,784",425,,phosphorelay signal transduction system [GO:0000160],protein histidine kinase activity [GO:0004673],integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,3
P9WGG3,NPD_MYCTU,Rv1151c,cobB sir2 Rv1151c MTCI65.18c,GO:0003953; GO:0005618; GO:0005737; GO:0006281; GO:0006476; GO:0016740; GO:0034979; GO:0036054; GO:0036055; GO:0046872; GO:0070213; GO:0070403,IPR029035; IPR003000; IPR026591; IPR027546; IPR026590; ,,cobB,DOMAIN 1 237 Deacetylase sirtuin-type. {ECO:0000255|HAMAP-Rule:MF_01121}.,NAD-dependent protein deacylase (EC 3.5.1.-) (Regulatory protein SIR2 homolog),cell wall [GO:0005618]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD+ nucleosidase activity [GO:0003953]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; transferase activity [GO:0016740]; DNA repair [GO:0006281]; protein auto-ADP-ribosylation [GO:0070213]; protein deacetylation [GO:0006476],9634230; 19747094; 21896569; 21627103; 21969609; 21637345,,"FUNCTION: NAD-dependent lysine deacetylase and desuccinylase that specifically removes acetyl and succinyl groups on target proteins. Modulates the activities of several proteins which are inactive in their acylated form (By similarity). Reactivates acetylated acetyl-CoA synthetase (ACS) through an NAD-dependent deacetylation. Is able to ADP-ribosylate itself. {ECO:0000255|HAMAP-Rule:MF_01121, ECO:0000269|PubMed:21627103, ECO:0000269|PubMed:21896569}.; FUNCTION: Involved in non-homologous end joining (NHEJ) repair of blunt, 5' overhang and 3' overhang DNA double strand breaks (DSB). {ECO:0000305}.",MRVAVLSGAGISAESGVPTFRDDKNGLWARFDPYELSSTQGWLRNPERVWGWYLWRHYLVANVEPNDGHRAIAAWQDHAEVSVITQNVDDLHERAGSGAVHHLHGSLFEFRCARCGVPYTDALPEMPEPAIEVEPPVCDCGGLIRPDIVWFGEPLPEEPWRSAVEATGSADVMVVVGTSAIVYPAAGLPDLALARGTAVIEVNPEPTPLSGSATISIRESASQALPGLLERLPALLK,"25,661",237,"Sirtuin family, Class III subfamily",DNA repair [GO:0006281]; protein auto-ADP-ribosylation [GO:0070213]; protein deacetylation [GO:0006476],metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; NAD+ nucleosidase activity [GO:0003953]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; transferase activity [GO:0016740],cell wall [GO:0005618]; cytoplasm [GO:0005737],sir2,MTCI65.18c,1
P9WGM9,MPRA_MYCTU,Rv0981,mprA Rv0981,GO:0000160; GO:0003677; GO:0005618; GO:0005737; GO:0005886; GO:0006351; GO:0006355; GO:0009405; GO:0010446; GO:0045892; GO:0045893; GO:0090034,IPR011006; IPR001867; IPR001789; IPR036388; ,,mprA,DOMAIN 4 118 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Response regulator MprA (Mycobacterial persistence regulator A),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of transcription, DNA-templated [GO:0006355]; response to alkaline pH [GO:0010446]; transcription, DNA-templated [GO:0006351]",9634230; 11489128; 11675502; 14638785; 15601704; 16513743; 17379732; 21969609,,"FUNCTION: Member of the two-component regulatory system MprB/MprA which contributes to maintaining a balance among several systems involved in stress resistance and is required for establishment and maintenance of persistent infection in the host. Functions as a transcriptional regulator that recognizes a 19-bp nucleotide motif comprizing two loosely conserved 8-bp direct DNA-binding motif repeats separated by a 3-bp spacer region. MprB/MprA is involved in regulation of numerous stress-responsive genes, including up-regulation of two sigma factors, sigE and sigB as well as pepD and mprA, and repression of multiple genes from regulons associated with hypoxia, starvation and iron metabolism. The majority of genes regulated by MprB/MprA under a particular stress condition are different from those induced during normal growth, but several genes are commonly regulated under more than one condition. {ECO:0000269|PubMed:11675502, ECO:0000269|PubMed:14638785, ECO:0000269|PubMed:15601704, ECO:0000269|PubMed:16513743, ECO:0000269|PubMed:17379732}.",MSVRILVVDDDRAVRESLRRSLSFNGYSVELAHDGVEALDMIASDRPDALVLDVMMPRLDGLEVCRQLRGTGDDLPILVLTARDSVSERVAGLDAGADDYLPKPFALEELLARMRALLRRTKPEDAAESMAMRFSDLTLDPVTREVNRGQRRISLTRTEFALLEMLIANPRRVLTRSRILEEVWGFDFPTSGNALEVYVGYLRRKTEADGEPRLIHTVRGVGYVLRETPP,"25,894",230,,"negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of transcription, DNA-templated [GO:0006355]; response to alkaline pH [GO:0010446]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WKG1,ISPH2_MYCTU,Rv1110,ispH2 lytB2 Rv1110 MTV017.63,GO:0019288; GO:0046872; GO:0050992; GO:0051539; GO:0051745,IPR003451; ,,ispH2,,4-hydroxy-3-methylbut-2-enyl diphosphate reductase 2 (HDR 2) (HMBPP reductase 2) (EC 1.17.7.4),"4 iron, 4 sulfur cluster binding [GO:0051539]; 4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity [GO:0051745]; metal ion binding [GO:0046872]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]",9634230; 21969609; 23091471; 26309039,,"FUNCTION: Catalyzes the conversion of 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate (HMBPP) into a mixture of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) (PubMed:23091471). Acts in the terminal step of the DOXP/MEP pathway for isoprenoid precursor biosynthesis. Has a higher activity compared with LytB2 (PubMed:23091471). Is essential for M.tuberculosis growth in vitro (PubMed:26309039). {ECO:0000255|HAMAP-Rule:MF_00191, ECO:0000269|PubMed:23091471, ECO:0000269|PubMed:26309039}.",MVPTVDMGIPGASVSSRSVADRPNRKRVLLAEPRGYCAGVDRAVETVERALQKHGPPVYVRHEIVHNRHVVDTLAKAGAVFVEETEQVPEGAIVVFSAHGVAPTVHVSASERNLQVIDATCPLVTKVHNEARRFARDDYDILLIGHEGHEEVVGTAGEAPDHVQLVDGVDAVDQVTVRDEDKVVWLSQTTLSVDETMEIVGRLRRRFPKLQDPPSDDICYATQNRQVAVKAMAPECELVIVVGSRNSSNSVRLVEVALGAGARAAHLVDWADDIDSAWLDGVTTVGVTSGASVPEVLVRGVLERLAECGYDIVQPVTTANETLVFALPRELRSPR,"36,297",335,IspH family,"dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]","4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity [GO:0051745]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",,lytB2,MTV017.63,1
P9WKG7,ISPE_MYCTU,Rv1011,ispE Rv1011 MTCI237.28,GO:0005524; GO:0016114; GO:0019288; GO:0040007; GO:0050515,IPR013750; IPR036554; IPR006204; IPR004424; IPR020568; IPR014721; ,,ispE,,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (CMK) (EC 2.7.1.148) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase),"4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity [GO:0050515]; ATP binding [GO:0005524]; growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]",9634230; 19099550; 21969609,X-ray crystallography (4),FUNCTION: Catalyzes the phosphorylation of the position 2 hydroxy group of 4-diphosphocytidyl-2C-methyl-D-erythritol. {ECO:0000255|HAMAP-Rule:MF_00061}.,MPTGSVTVRVPGKVNLYLAVGDRREDGYHELTTVFHAVSLVDEVTVRNADVLSLELVGEGADQLPTDERNLAWQAAELMAEHVGRAPDVSIMIDKSIPVAGGMAGGSADAAAVLVAMNSLWELNVPRRDLRMLAARLGSDVPFALHGGTALGTGRGEELATVLSRNTFHWVLAFADSGLLTSAVYNELDRLREVGDPPRLGEPGPVLAALAAGDPDQLAPLLGNEMQAAAVSLDPALARALRAGVEAGALAGIVSGSGPTCAFLCTSASSAIDVGAQLSGAGVCRTVRVATGPVPGARVVSAPTEV,"31,382",306,"GHMP kinase family, IspE subfamily","growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]",4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase activity [GO:0050515]; ATP binding [GO:0005524],,,MTCI237.28,1
P9WK39,LPRP_MYCTU,Rv0962c,lprP Rv0962c MTCY10D7.12,GO:0005886,IPR032018; ,,lprP,,Uncharacterized lipoprotein LprP,plasma membrane [GO:0005886],9634230,,,MKRTSRSLTAALLGIAALLAGCIKPNTFDPYANPGRGELDRRQKIVNGRPDLETVQQQLANLDATIRAMIAKYSPQTRFSTGVTVSHLTNGCNDPFTRTIGRQEASELFFGRPAPTPQQWLQIVTELAPVFKAAGFRPNNSVPGDPPQPLGAPNYSQIRDDGVTINLVNGDNRGPLGYSYNTGCHPPAAWRTAPPPLNMRPANDPDVHYPYLYGSPGGRTRDAY,"24,398",224,,,,plasma membrane [GO:0005886],,MTCY10D7.12,1
P9WK57,LPQV_MYCTU,Rv1064c,lpqV Rv1064c MTV017.17c,GO:0005886,IPR020377; ,,lpqV,,Putative lipoprotein LpqV,plasma membrane [GO:0005886],9634230,,,MRPSRYAPLLCAMVLALAWLSAVAGCSRGGSSKAGRSSSVAGTLPAGVVGVSPAGVTTRVDAPAESTEEEYYQACHAARLWMDAQPGSGESLIEPYLAVVQASPSGVAGSWHIRWAALTPARQAAVIVAARAAANAECG,"14,110",139,,,,plasma membrane [GO:0005886],,MTV017.17c,1
P9WJN1,MCA_MYCTU,Rv1082,mca Rv1082,GO:0008270; GO:0010126; GO:0010127; GO:0016787,IPR003737; IPR024078; IPR017811; ,,mca,,Mycothiol S-conjugate amidase (EC 3.5.1.115),hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; mycothiol metabolic process [GO:0010126]; mycothiol-dependent detoxification [GO:0010127],9634230; 10978158; 14556638; 18020307; 21969609,,"FUNCTION: A mycothiol (MSH, N-acetyl-cysteinyl-glucosaminyl-inositol) S-conjugate amidase, it recycles conjugated MSH to the N-acetyl cysteine conjugate and the MSH precursor. Involved in MSH-dependent detoxification of a number of alkylating agents and antibiotics. Activity is specific for the mycothiol moiety. Has a low but measurable deacetylation activity on GlcNAc-Ins (N-acetyl-glucosaminyl-inositol), and thus can also directly contribute to the production of MSH. {ECO:0000269|PubMed:10978158, ECO:0000269|PubMed:14556638}.",MSELRLMAVHAHPDDESSKGAATLARYADEGHRVLVVTLTGGERGEILNPAMDLPDVHGRIAEIRRDEMTKAAEILGVEHTWLGFVDSGLPKGDLPPPLPDDCFARVPLEVSTEALVRVVREFRPHVMTTYDENGGYPHPDHIRCHQVSVAAYEAAGDFCRFPDAGEPWTVSKLYYVHGFLRERMQMLQDEFARHGQRGPFEQWLAYWDPDHDFLTSRVTTRVECSKYFSQRDDALRAHATQIDPNAEFFAAPLAWQERLWPTEEFELARSRIPARPPETELFAGIEP,"32,732",288,"MshB deacetylase family, Mca subfamily",mycothiol-dependent detoxification [GO:0010127]; mycothiol metabolic process [GO:0010126],hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],,,,1
P9WIC1,CHMU_MYCTU,Rv0948c,Rv0948c MTCY10D7.26,GO:0004106; GO:0005737; GO:0005886; GO:0009095; GO:0046417,IPR036263; IPR010958; IPR036979; IPR002701; ,O53512,,DOMAIN 23 105 Chorismate mutase. {ECO:0000255|PROSITE-ProRule:PRU00515}.,Intracellular chorismate mutase (CM) (EC 5.4.99.5),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; chorismate mutase activity [GO:0004106]; aromatic amino acid family biosynthetic process, prephenate pathway [GO:0009095]; chorismate metabolic process [GO:0046417]",9634230; 15737998; 21969609; 18727669; 19556970,X-ray crystallography (5),"FUNCTION: Catalyzes the Claisen rearrangement of chorismate to prephenate. Probably involved in the aromatic amino acid biosynthesis. {ECO:0000269|PubMed:15737998, ECO:0000269|PubMed:18727669, ECO:0000269|PubMed:19556970}.",MRPEPPHHENAELAAMNLEMLESQPVPEIDTLREEIDRLDAEILALVKRRAEVSKAIGKARMASGGTRLVHSREMKVIERYSELGPDGKDLAILLLRLGRGRLGH,"11,771",105,,"aromatic amino acid family biosynthetic process, prephenate pathway [GO:0009095]; chorismate metabolic process [GO:0046417]",chorismate mutase activity [GO:0004106],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY10D7.26,1
P9WP65,CPDA_MYCTU,Rv0805,cpdA icc Rv0805,GO:0000166; GO:0004115; GO:0005506; GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0006198; GO:0008199; GO:0008663; GO:0009405; GO:0016791; GO:0030145; GO:0042301; GO:0042545,IPR004843; IPR026575; IPR029052; ,,cpdA,,"3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA (3',5'-cyclic AMP phosphodiesterase) (cAMP phosphodiesterase) (EC 3.1.4.53)","cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; 2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; phosphate ion binding [GO:0042301]; cAMP catabolic process [GO:0006198]; cell wall modification [GO:0042545]; pathogenesis [GO:0009405]",9634230; 16313172; 21969609; 17059828; 19801656,X-ray crystallography (5),"FUNCTION: Hydrolyzes cAMP to 5'-AMP. Plays an important regulatory role in modulating the intracellular concentration of cAMP, thereby influencing cAMP-dependent processes. Can also hydrolyze cGMP, p-nitrophenyl phosphate (pNPP), bis-(p-nitrophenyl phosphate) (bis(pNPP)), p-nitrophenyl phenylphosphonate (pNPPP) and 2',3'-cAMP. May play a role in pathogenicity, not only by hydrolyzing cAMP, but also by altering properties of the cell wall. {ECO:0000255|HAMAP-Rule:MF_00905, ECO:0000269|PubMed:16313172, ECO:0000269|PubMed:19801656}.",MHRLRAAEHPRPDYVLLHISDTHLIGGDRRLYGAVDADDRLGELLEQLNQSGLRPDAIVFTGDLADKGEPAAYRKLRGLVEPFAAQLGAELVWVMGNHDDRAELRKFLLDEAPSMAPLDRVCMIDGLRIIVLDTSVPGHHHGEIRASQLGWLAEELATPAPDGTILALHHPPIPSVLDMAVTVELRDQAALGRVLRGTDVRAILAGHLHYSTNATFVGIPVSVASATCYTQDLTVAAGGTRGRDGAQGCNLVHVYPDTVVHSVIPLGGGETVGTFVSPGQARRKIAESGIFIEPSRRDSLFKHPPMVLTSSAPRSPVD,"34,233",318,CAMP phosphodiesterase class-III family,cAMP catabolic process [GO:0006198]; cell wall modification [GO:0042545]; pathogenesis [GO:0009405],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ferric iron binding [GO:0008199]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; nucleotide binding [GO:0000166]; phosphatase activity [GO:0016791]; phosphate ion binding [GO:0042301]",cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],icc,,1
P9WPD5,CISY1_MYCTU,Rv0896,gltA2 gltA Rv0896 MTCY31.24,GO:0004108; GO:0005829; GO:0005886; GO:0006099,IPR016142; IPR016143; IPR002020; IPR019810; IPR024176; IPR036969; IPR010953; ,,gltA2,,Citrate synthase 1 (EC 2.3.3.16),cytosol [GO:0005829]; plasma membrane [GO:0005886]; citrate (Si)-synthase activity [GO:0004108]; tricarboxylic acid cycle [GO:0006099],9634230; 20066036; 21969609,X-ray crystallography (1),,MADTDDTATLRYPGGEIDLQIVHATEGADGIALGPLLAKTGHTTFDVGFANTAAAKSSITYIDGDAGILRYRGYPIDQLAEKSTFIEVCYLLIYGELPDTDQLAQFTGRIQRHTMLHEDLKRFFDGFPRNAHPMPVLSSVVNALSAYYQDALDPMDNGQVELSTIRLLAKLPTIAAYAYKKSVGQPFLYPDNSLTLVENFLRLTFGFPAEPYQADPEVVRALDMLFILHADHEQNCSTSTVRLVGSSRANLFTSISGGINALWGPLHGGANQAVLEMLEGIRDSGDDVSEFVRKVKNREAGVKLMGFGHRVYKNYDPRARIVKEQADKILAKLGGDDSLLGIAKELEEAALTDDYFIERKLYPNVDFYTGLIYRALGFPTRMFTVLFALGRLPGWIAHWREMHDEGDSKIGRPRQIYTGYTERDYVTIDAR,"47,978",431,Citrate synthase family,tricarboxylic acid cycle [GO:0006099],citrate (Si)-synthase activity [GO:0004108],cytosol [GO:0005829]; plasma membrane [GO:0005886],gltA,MTCY31.24,1
P9WPD3,CISY2_MYCTU,Rv0889c,citA Rv0889c MTCY31.17c,GO:0005829; GO:0006099; GO:0046912,IPR016142; IPR016143; IPR002020; IPR019810; IPR036969; ,,citA,,Putative citrate synthase 2 (EC 2.3.3.16),"cytosol [GO:0005829]; transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer [GO:0046912]; tricarboxylic acid cycle [GO:0006099]",9634230; 21969609,,,MTVVPENFVPGLDGVVAFTTEIAEPDKDGGALRYRGVDIEDLVSQRVTFGDVWALLVDGNFGSGLPPAEPFPLPIHSGDVRVDVQAGLAMLAPIWGYAPLLDIDDATARQQLARASVMALSYVAQSARGIYQPAVPQRIIDECSTVTARFMTRWQGEPDPRHIEAIDAYWVSAAEHGMNASTFTARVIASTGADVAAALSGAIGAMSGPLHGGAPARVLPMLDEVERAGDARSVVKGILDRGEKLMGFGHRVYRAEDPRARVLRAAAERLGAPRYEVAVAVEQAALSELRERRPDRAIETNVEFWAAVVLDFARVPANMMPAMFTCGRTAGWCAHILEQKRLGKLVRPSAIYVGPGPRSPESVDGWERVLTTA,"40,147",373,Citrate synthase family,tricarboxylic acid cycle [GO:0006099],"transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer [GO:0046912]",cytosol [GO:0005829],,MTCY31.17c,1
P9WPA7,COAA_MYCTU,Rv1092c,coaA Rv1092c MTV017.45c,GO:0004594; GO:0005524; GO:0005829; GO:0005886; GO:0015937; GO:0040007,IPR027417; IPR004566; IPR006083; ,,coaA,,Pantothenate kinase (EC 2.7.1.33) (Pantothenic acid kinase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594]; coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (29),,MSRLSEPSPYVEFDRRQWRALRMSTPLALTEEELVGLRGLGEQIDLLEVEEVYLPLARLIHLQVAARQRLFAATAEFLGEPQQNPDRPVPFIIGVAGSVAVGKSTTARVLQALLARWDHHPRVDLVTTDGFLYPNAELQRRNLMHRKGFPESYNRRALMRFVTSVKSGSDYACAPVYSHLHYDIIPGAEQVVRHPDILILEGLNVLQTGPTLMVSDLFDFSLYVDARIEDIEQWYVSRFLAMRTTAFADPESHFHHYAAFSDSQAVVAAREIWRTINRPNLVENILPTRPRATLVLRKDADHSINRLRLRKL,"35,657",312,Prokaryotic pantothenate kinase family,coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007],ATP binding [GO:0005524]; pantothenate kinase activity [GO:0004594],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV017.45c,1
P9WNL1,ENO_MYCTU,Rv1023,eno Rv1023 MTCY10G2.26c,GO:0000015; GO:0000287; GO:0004634; GO:0005576; GO:0005618; GO:0005886; GO:0006096; GO:0009986; GO:0040007,IPR000941; IPR036849; IPR029017; IPR034390; IPR020810; IPR020809; IPR020811; ,,eno,,Enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (2-phosphoglycerate dehydratase),cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 21969609,,FUNCTION: Catalyzes the reversible conversion of 2-phosphoglycerate into phosphoenolpyruvate. It is essential for the degradation of carbohydrates via glycolysis. {ECO:0000255|HAMAP-Rule:MF_00318}.,MPIIEQVRAREILDSRGNPTVEVEVALIDGTFARAAVPSGASTGEHEAVELRDGGDRYGGKGVQKAVQAVLDEIGPAVIGLNADDQRLVDQALVDLDGTPDKSRLGGNAILGVSLAVAKAAADSAELPLFRYVGGPNAHILPVPMMNILNGGAHADTAVDIQEFMVAPIGAPSFVEALRWGAEVYHALKSVLKKEGLSTGLGDEGGFAPDVAGTTAALDLISRAIESAGLRPGADVALALDAAATEFFTDGTGYVFEGTTRTADQMTEFYAGLLGAYPLVSIEDPLSEDDWDGWAALTASIGDRVQIVGDDIFVTNPERLEEGIERGVANALLVKVNQIGTLTETLDAVTLAHHGGYRTMISHRSGETEDTMIADLAVAIGSGQIKTGAPARSERVAKYNQLLRIEEALGDAARYAGDLAFPRFACETK,"44,962",429,Enolase family,glycolytic process [GO:0006096]; growth [GO:0040007],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634],cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886],,MTCY10G2.26c,1
P0DOA6,ESXI_MYCTU,Rv1037c,esxI Rv1037c MTCY10G2.12,GO:0005576; GO:0005618,IPR009416; IPR036689; IPR010310; ,,esxI,,ESAT-6-like protein EsxI (Antigen Mtb9.9B),cell wall [GO:0005618]; extracellular region [GO:0005576],10662800; 9634230; 19876390; 22291682,,,MTINYQFGDVDAHGAMIRAQAGSLEAEHQAIISDVLTASDFWGGAGSAACQGFITQLGRNFQVIYEQANAHGQKVQAAGNNMAQTDSAVGSSWA,"9,833",94,"WXG100 family, ESAT-6 subfamily",,,cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY10G2.12,1
P9WF31,EX7L_MYCTU,Rv1108c,xseA Rv1108c MTV017.61c,GO:0003676; GO:0005618; GO:0005737; GO:0006308; GO:0008855; GO:0009318,IPR003753; IPR020579; IPR025824; ,,xseA,,Exodeoxyribonuclease 7 large subunit (EC 3.1.11.6) (Exodeoxyribonuclease VII large subunit) (Exonuclease VII large subunit),cell wall [GO:0005618]; cytoplasm [GO:0005737]; exodeoxyribonuclease VII complex [GO:0009318]; exodeoxyribonuclease VII activity [GO:0008855]; nucleic acid binding [GO:0003676]; DNA catabolic process [GO:0006308],9634230; 21969609,,"FUNCTION: Bidirectionally degrades single-stranded DNA into large acid-insoluble oligonucleotides, which are then degraded further into small acid-soluble oligonucleotides. {ECO:0000255|HAMAP-Rule:MF_00378}.",MTQNSAENPFPVRAVAIRVAGWIDKLGAVWVEGQLAQITMRPDAKTVFMVLRDPAADMSLTVTCSRDLVLSAPVKLAEGVQVVVCGKPSFYTGRGTFSLRLSEIRAVGIGELLARIDRLRRLLDAEGLFDPRLKRPIPYLPNMIGLITGRASAAERDVTTVASARWPAARFAVRNVAVQGPNAVGQIVEALRELDRDPDVDVIVLARGGGSVEDLLPFSDETLCRAIAACRTPVVSAVGHEPDNPLCDLVVDLRAATPTDAAKKVVPDTAAEQRLIDDLRRRSAQALRNWVSREQRAVAQLRSRPVLADPMTMVSVRAEEVHRARSTLRRNLTLMVAAETERIGHLAARLATLGPAATLARGYAIVQTVAQTGPEGGSEPQVLRSVHDAPEGTKLRVRVADGALAAVSEGQTNGL,"44,628",415,XseA family,DNA catabolic process [GO:0006308],exodeoxyribonuclease VII activity [GO:0008855]; nucleic acid binding [GO:0003676],cell wall [GO:0005618]; cytoplasm [GO:0005737]; exodeoxyribonuclease VII complex [GO:0009318],,MTV017.61c,1
P9WF29,EX7S_MYCTU,Rv1107c,xseB Rv1107c MTV017.60c,GO:0005737; GO:0006308; GO:0008855; GO:0009318,IPR003761; IPR037004; ,,xseB,,Exodeoxyribonuclease 7 small subunit (EC 3.1.11.6) (Exodeoxyribonuclease VII small subunit) (Exonuclease VII small subunit),cytoplasm [GO:0005737]; exodeoxyribonuclease VII complex [GO:0009318]; exodeoxyribonuclease VII activity [GO:0008855]; DNA catabolic process [GO:0006308],9634230; 21969609,,"FUNCTION: Bidirectionally degrades single-stranded DNA into large acid-insoluble oligonucleotides, which are then degraded further into small acid-soluble oligonucleotides. {ECO:0000250}.",MVCDPNGDDTGRTHATVPVSQLGYEACRDELMEVVRLLEQGGLDLDASLRLWERGEQLAKRCEEHLAGARQRVSDVLAGDEAQNG,"9,322",85,XseB family,DNA catabolic process [GO:0006308],exodeoxyribonuclease VII activity [GO:0008855],cytoplasm [GO:0005737]; exodeoxyribonuclease VII complex [GO:0009318],,MTV017.60c,1
P9WN93,FUMC_MYCTU,Rv1098c,fumC fum Rv1098c MTV017.51c,GO:0004333; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006099; GO:0006106; GO:0006108; GO:0040007; GO:0045239,IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; ,,fumC,,Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent fumarase),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; growth [GO:0040007]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609; 22561013; 27325754,X-ray crystallography (7),"FUNCTION: Involved in the TCA cycle. Catalyzes the stereospecific interconversion of fumarate to L-malate. {ECO:0000255|HAMAP-Rule:MF_00743, ECO:0000305|PubMed:27325754}.",MAVDADSANYRIEHDTMGEVRVPAKALWRAQTQRAVENFPISGRGLERTQIRALGLLKGACAQVNSDLGLLAPEKADAIIAAAAEIADGQHDDQFPIDVFQTGSGTSSNMNTNEVIASIAAKGGVTLHPNDDVNMSQSSNDTFPTATHIAATEAAVAHLIPALQQLHDALAAKALDWHTVVKSGRTHLMDAVPVTLGQEFSGYARQIEAGIERVRACLPRLGELAIGGTAVGTGLNAPDDFGVRVVAVLVAQTGLSELRTAANSFEAQAARDGLVEASGALRTIAVSLTKIANDIRWMGSGPLTGLAEIQLPDLQPGSSIMPGKVNPVLPEAVTQVAAQVIGNDAAIAWGGANGAFELNVYIPMMARNILESFKLLTNVSRLFAQRCIAGLTANVEHLRRLAESSPSIVTPLNSAIGYEEAAAVAKQALKERKTIRQTVIDRGLIGDRLSIEDLDRRLDVLAMAKAEQLDSDRL,"50,141",474,"Class-II fumarase/aspartase family, Fumarase subfamily",fumarate metabolic process [GO:0006106]; growth [GO:0040007]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],fumarate hydratase activity [GO:0004333],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; tricarboxylic acid cycle enzyme complex [GO:0045239],fum,MTV017.51c,1
P9WNS7,DUS_MYCTU,Rv0823c,dus Rv0823c MTV043.15c,GO:0000049; GO:0017150; GO:0019217; GO:0050660,IPR013785; IPR035587; IPR024036; IPR004652; IPR001269; IPR018517; ,,dus,,Probable tRNA-dihydrouridine synthase (EC 1.3.1.-),flavin adenine dinucleotide binding [GO:0050660]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150]; regulation of fatty acid metabolic process [GO:0019217],9634230; 21969609,,"FUNCTION: Catalyzes the synthesis of 5,6-dihydrouridine (D), a modified base found in the D-loop of most tRNAs, via the reduction of the C5-C6 double bond in target uridines. {ECO:0000250|UniProtKB:P33371}.",MSRRRAIQPSPALRIGPIELASPVVLAPMAGVTNVAFRALCRQLEQSKVGTVSGLYVCEMVTARALIERHPVTMHMTTFSADESPRSLQLYTVDPDTTYAAARMIAGEGLADHIDMNFGCPVPKVTKRGGGAALPFKRRLFGQIVAAAVRATEGTDIPVTVKFRIGIDDAHHTHLDAGRIAEAEGAAAVALHARTAAQRYSGTADWEQIARLKQHVRTIPVLGNGDIYDAGDALAMMSTTGCDGVVIGRGCLGRPWLFAELSAAFTGSPAPTPPTLGEVADIIRRHGTLLAAHFGEDKGMRDIRKHIAWYLHGFPAGSALRRALAMVKTFDELDCLLDRLDGTVPFPDSATGARGRQGSPARVALPDGWLTDPDDCRVPEGADAMGSGG,"41,388",389,Dus family,regulation of fatty acid metabolic process [GO:0019217],flavin adenine dinucleotide binding [GO:0050660]; tRNA binding [GO:0000049]; tRNA dihydrouridine synthase activity [GO:0017150],,,MTV043.15c,1
L0T864,FPG2_MYCTU,Rv0944,fpg2 Rv0944,GO:0003684; GO:0003906; GO:0006289; GO:0008270; GO:0016799,IPR015886; IPR010979; IPR000214; IPR010663; ,,fpg2,,Uncharacterized formamidopyrimidine-DNA glycosylase-like protein,"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; zinc ion binding [GO:0008270]; nucleotide-excision repair [GO:0006289]",9634230; 18457574; 20031487; 21764637,,,MAGTPQPRALGPDALDVSTDDLAGLLAGNTGRIKTVITDQKVIAGIGNAYSDEILHVAKISPFATAGKLSGAQLTCLHEAMASVLSDAVRRSVGQGAAMLKGEKRSGLRVHARTGLPCPVCGDTVREVSFADKSFQYCPTCQTGGKALADRRMSRLLK,"16,495",158,,nucleotide-excision repair [GO:0006289],"damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; zinc ion binding [GO:0008270]",,,,1
P9WN69,G6PI_MYCTU,Rv0946c,pgi Rv0946c MTCY10D7.28,GO:0004347; GO:0005737; GO:0005886; GO:0006094; GO:0006096; GO:0040007,IPR001672; IPR023096; IPR018189; IPR035476; IPR035482; ,,pgi,,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glucose-6-phosphate isomerase activity [GO:0004347]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (1),,MTSAPIPDITATPAWDALRRHHDQIGNTHLRQFFADDPGRGRELTVSVGDLYIDYSKHRVTRETLALLIDLARTAHLEERRDQMFAGVHINTSEDRAVLHTALRLPRDAELVVDGQDVVTDVHAVLDAMGAFTDRLRSGEWTGATGKRISTVVNIGIGGSDLGPVMVYQALRHYADAGISARFVSNVDPADLIATLADLDPATTLFIVASKTFSTLETLTNATAARRWLTDALGDAAVSRHFVAVSTNKRLVDDFGINTDNMFGFWDWVGGRYSVDSAIGLSLMTVIGRDAFADFLAGFHIIDRHFATAPLESNAPVLLGLIGLWYSNFFGAQSRTVLPYSNDLSRFPAYLQQLTMESNGKSTRADGSPVSADTGEIFWGEPGTNGQHAFYQLLHQGTRLVPADFIGFAQPLDDLPTAEGTGSMHDLLMSNFFAQTQVLAFGKTAEEIAADGTPAHVVAHKVMPGNRPSTSILASRLTPSVLGQLIALYEHQVFTEGVVWGIDSFDQWGVELGKTQAKALLPVITGAGSPPPQSDSSTDGLVRRYRTERGRAG,"59,974",553,GPI family,gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; growth [GO:0040007],glucose-6-phosphate isomerase activity [GO:0004347],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY10D7.28,1
P9WJI1,FPRB_MYCTU,Rv0886,fprB Rv0886 MTCY31.14,GO:0004324; GO:0005737; GO:0005886; GO:0016491; GO:0046872; GO:0051539,IPR017896; IPR017900; IPR036188; IPR023753; IPR021163; ,,fprB,DOMAIN 2 29 4Fe-4S ferredoxin-type 1. {ECO:0000255|PROSITE-ProRule:PRU00711}.; DOMAIN 37 66 4Fe-4S ferredoxin-type 2. {ECO:0000255|PROSITE-ProRule:PRU00711}.,Probable ferredoxin/ferredoxin--NADP reductase (FNR) (EC 1.18.1.2),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferredoxin-NADP+ reductase activity [GO:0004324]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",9634230; 21969609,,,MPHVITQSCCNDASCVFACPVNCIHPTPDEPGFATSEMLYIDPVACVDCGACVTACPVSAIAPNTRLDFEQLPFVEINASYYPKRPAGVKLAPTSKLAPVTPAAEVRVRRQPLTVAVVGSGPAAMYAADELLVQQGVQVNVFEKLPTPYGLVRSGVAPDHQNTKRVTRLFDRIAGHRRFRFYLNVEIGKHLGHAELLAHHHAVLYAVGAPDDRRLTIDGMGLPGTGTATELVAWLNGHPDFNDLPVDLSHERVVIIGNGNVALDVARVLAADPHELAATDIADHALSALRNSAVREVVVAARRGPAHSAFTLPELIGLTAGADVVLDPGDHQRVLDDLAIVADPLTRNKLEILSTLGDGSAPARRVGRPRIRLAYRLTPRRVLGQRRAGGVQFSVTGTDELRQLDAGLVLTSIGYRGKPIPDLPFDEQAALVPNDGGRVIDPGTGEPVPGAYVAGWIKRGPTGFIGTNKSCSMQTVQALVADFNDGRLTDPVATPTALDQLVQARQPQAIGCAGWRAIDAAEIARGSADGRVRNKFTDVAEMLAAATSAPKEPLRRRVLARLRDLGQPIVLTVPL,"61,337",575,Ferredoxin--NADP reductase family,,"4 iron, 4 sulfur cluster binding [GO:0051539]; ferredoxin-NADP+ reductase activity [GO:0004324]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY31.14,1
Q79FV4,CYSK2_MYCTU,Rv0848,cysK2 Rv0848,GO:0004124; GO:0005618; GO:0005737; GO:0005829; GO:0006535; GO:0016740; GO:0019344; GO:0030170; GO:0033847; GO:0042803; GO:0080146,IPR001926; IPR036052; ,,cysK2,,S-sulfocysteine synthase (EC 2.5.1.-) (O-phospho-L-serine-dependent S-sulfocysteine synthase) (OPS-dependent S-sulfocysteine synthase) (O-phosphoserine sulfhydrylase) (EC 2.5.1.65),cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; O-phosphoserine sulfhydrylase activity [GO:0033847]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transferase activity [GO:0016740]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],9634230; 12368430; 19099550; 25022854,,"FUNCTION: Catalyzes the synthesis of S-sulfocysteine, utilizing O-phosphoserine (OPS) and thiosulfate as substrates. To a lesser extent, can also use sulfide as donor substrate, producing L-cysteine. CysK2 thus provides a third metabolic route to cysteine, either directly using sulfide as donor or indirectly via S-sulfocysteine. S-sulfocysteine might also act as a signaling molecule triggering additional responses in redox defense in the pathogen upon exposure to reactive oxygen species during intracellular survival or dormancy. Cannot utilize thiocarboxylated CysO as a sulfur donor and O-acetylserine (OAS) as acceptor substrate. {ECO:0000269|PubMed:25022854}.",MRSRQTRDRYRLLPEGYQVTPGRNRHPGTMVGNTPVLWIPELSGTSDPDRGFWAKLEGFNPGGMKDRPALYMVECARARGDIAPGAAIVESTGGTLGLGLALAGKVYRHPVTLVTDPGLEPIIARMLTAYGAGVDMVTQPHPVGGWQQARKDRVAQLMAEYPGAWNPNQYGNPDNVGAYRSLALELVAQLGRIDVLVCSVGTGGHSAGVARVLREFNPDMRLIGVDTIGSTIFGQPASNRLMRGLGSSIYPRNVDYRAFDEVHWVAPPEAVWACRSLAATHYASGGWSVGAVALVAGWAARNLPADTTIAAVFPDGPQRYFDTIYNDAYCNEHELLGGQPPTEPDEIASPLDAVVTRWTRSTTVIDPTQVVS,"40,118",372,Cysteine synthase/cystathionine beta-synthase family,cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; O-phosphoserine sulfhydrylase activity [GO:0033847]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transferase activity [GO:0016740],cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829],,,1
P9WPZ5,DAPC_MYCTU,Rv0858c,dapC Rv0858c,GO:0005618; GO:0005737; GO:0009016; GO:0009089; GO:0030170,IPR004839; IPR015424; IPR015422; IPR015421; ,,dapC,,Probable N-succinyldiaminopimelate aminotransferase DapC (DAP-AT) (EC 2.6.1.17),cell wall [GO:0005618]; cytoplasm [GO:0005737]; pyridoxal phosphate binding [GO:0030170]; succinyldiaminopimelate transaminase activity [GO:0009016]; lysine biosynthetic process via diaminopimelate [GO:0009089],9634230; 16880560; 21969609; 17292400,X-ray crystallography (1),"FUNCTION: Involved in the lysine biosynthetic pathways. It catalyzes the transfer of an amino group from L-glutamate to N-succinyl-2-l-amino-6-oxoheptanedioate (N-succinyl-2-l-amino-6-ketopimelate) in a PLP-dependent reaction, yielding as products N-succinyl-l-2,6-diaminoheptanedioate (N-succinyl-diaminopimelate) and 2-oxoglutarate (Probable). {ECO:0000305|PubMed:17292400}.",MTVSRLRPYATTVFAEMSALATRIGAVNLGQGFPDEDGPPKMLQAAQDAIAGGVNQYPPGPGSAPLRRAIAAQRRRHFGVDYDPETEVLVTVGATEAIAAAVLGLVEPGSEVLLIEPFYDSYSPVVAMAGAHRVTVPLVPDGRGFALDADALRRAVTPRTRALIINSPHNPTGAVLSATELAAIAEIAVAANLVVITDEVYEHLVFDHARHLPLAGFDGMAERTITISSAAKMFNCTGWKIGWACGPAELIAGVRAAKQYLSYVGGAPFQPAVALALDTEDAWVAALRNSLRARRDRLAAGLTEIGFAVHDSYGTYFLCADPRPLGYDDSTEFCAALPEKVGVAAIPMSAFCDPAAGQASQQADVWNHLVRFTFCKRDDTLDEAIRRLSVLAERPAT,"42,209",397,Class-III pyridoxal-phosphate-dependent aminotransferase family,lysine biosynthetic process via diaminopimelate [GO:0009089],pyridoxal phosphate binding [GO:0030170]; succinyldiaminopimelate transaminase activity [GO:0009016],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
P9WNZ5,DESA2_MYCTU,Rv1094,desA2 Rv1094,GO:0005618; GO:0005829; GO:0005886; GO:0006633; GO:0040007; GO:0045300; GO:0046872,IPR005067; IPR009078; IPR012348; ,,desA2,,Putative acyl-[acyl-carrier-protein] desaturase DesA2 (Putative acyl-ACP desaturase DesA2) (EC 1.14.19.-),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; acyl-[acyl-carrier-protein] desaturase activity [GO:0045300]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007],9634230; 14559907; 19099550; 20066036; 21969609; 15929999,X-ray crystallography (1),FUNCTION: May be a desaturase involved in mycobacterial fatty acid biosynthesis. {ECO:0000305|PubMed:14559907}.,MAQKPVADALTLELEPVVEANMTRHLDTEDIWFAHDYVPFDQGENFAFLGGRDWDPSQSTLPRTITDACEILLILKDNLAGHHRELVEHFILEDWWGRWLGRWTAEEHLHAIALREYLVVTREVDPVANEDVRVQHVMKGYRAEKYTQVETLVYMAFYERCGAVFCRNLAAQIEEPILAGLIDRIARDEVRHEEFFANLVTHCLDYTRDETIAAIAARAADLDVLGADIEAYRDKLQNVADAGIFGKPQLRQLISDRITAWGLAGEPSLKQFVTG,"31,359",275,Fatty acid desaturase type 2 family,fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007],acyl-[acyl-carrier-protein] desaturase activity [GO:0045300]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WMN3,GLMU_MYCTU,Rv1018c,glmU Rv1018c,GO:0000287; GO:0000902; GO:0003977; GO:0005737; GO:0006048; GO:0008360; GO:0009103; GO:0009245; GO:0009252; GO:0019134; GO:0035635; GO:0040007; GO:0044650; GO:0070569; GO:0071555,IPR005882; IPR038009; IPR001451; IPR025877; IPR029044; IPR011004; ,P10145,glmU,,Bifunctional protein GlmU [Includes: UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase); Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157)],cytoplasm [GO:0005737]; glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; uridylyltransferase activity [GO:0070569]; adhesion of symbiont to host cell [GO:0044650]; cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; entry of bacterium into host cell [GO:0035635]; growth [GO:0040007]; lipid A biosynthetic process [GO:0009245]; lipopolysaccharide biosynthetic process [GO:0009103]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],9634230; 20066036; 21969609; 19237750; 19407371; 19121323; 23485416,X-ray crystallography (11),"FUNCTION: Catalyzes the last two sequential reactions in the de novo biosynthetic pathway for UDP-N-acetylglucosamine (UDP-GlcNAc). The C-terminal domain catalyzes the transfer of acetyl group from acetyl coenzyme A to glucosamine-1-phosphate (GlcN-1-P) to produce N-acetylglucosamine-1-phosphate (GlcNAc-1-P), which is converted into UDP-GlcNAc by the transfer of uridine 5-monophosphate (from uridine 5-triphosphate), a reaction catalyzed by the N-terminal domain. {ECO:0000255|HAMAP-Rule:MF_01631, ECO:0000269|PubMed:19121323, ECO:0000269|PubMed:19237750}.",MTFPGDTAVLVLAAGPGTRMRSDTPKVLHTLAGRSMLSHVLHAIAKLAPQRLIVVLGHDHQRIAPLVGELADTLGRTIDVALQDRPLGTGHAVLCGLSALPDDYAGNVVVTSGDTPLLDADTLADLIATHRAVSAAVTVLTTTLDDPFGYGRILRTQDHEVMAIVEQTDATPSQREIREVNAGVYAFDIAALRSALSRLSSNNAQQELYLTDVIAILRSDGQTVHASHVDDSALVAGVNNRVQLAELASELNRRVVAAHQLAGVTVVDPATTWIDVDVTIGRDTVIHPGTQLLGRTQIGGRCVVGPDTTLTDVAVGDGASVVRTHGSSSSIGDGAAVGPFTYLRPGTALGADGKLGAFVEVKNSTIGTGTKVPHLTYVGDADIGEYSNIGASSVFVNYDGTSKRRTTVGSHVRTGSDTMFVAPVTIGDGAYTGAGTVVREDVPPGALAVSAGPQRNIENWVQRKRPGSPAAQASKRASEMACQQPTQPPDADQTP,"51,584",495,N-acetylglucosamine-1-phosphate uridyltransferase family; Transferase hexapeptide repeat family,adhesion of symbiont to host cell [GO:0044650]; cell morphogenesis [GO:0000902]; cell wall organization [GO:0071555]; entry of bacterium into host cell [GO:0035635]; growth [GO:0040007]; lipid A biosynthetic process [GO:0009245]; lipopolysaccharide biosynthetic process [GO:0009103]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],glucosamine-1-phosphate N-acetyltransferase activity [GO:0019134]; magnesium ion binding [GO:0000287]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; uridylyltransferase activity [GO:0070569],cytoplasm [GO:0005737],,,1
P9WGI9,GLYA1_MYCTU,Rv1093,glyA1 glyA Rv1093 MTV017.46,GO:0004372; GO:0005618; GO:0005737; GO:0005886; GO:0006544; GO:0006563; GO:0019264; GO:0030170; GO:0035999; GO:0042783; GO:0042803,IPR015424; IPR015422; IPR015421; IPR001085; IPR019798; ,,glyA1,,Serine hydroxymethyltransferase 1 (SHM1) (SHMT 1) (Serine methylase 1) (EC 2.1.2.1),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; glycine hydroxymethyltransferase activity [GO:0004372]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; active evasion of host immune response [GO:0042783]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; tetrahydrofolate interconversion [GO:0035999],9634230; 12913008; 21969609; ,Model (1); X-ray crystallography (1),"FUNCTION: Catalyzes the reversible interconversion of serine and glycine with tetrahydrofolate (THF) serving as the one-carbon carrier. This reaction serves as the major source of one-carbon groups required for the biosynthesis of purines, thymidylate, methionine, and other important biomolecules. Also exhibits THF-independent aldolase activity toward beta-hydroxyamino acids, producing glycine and aldehydes, via a retro-aldol mechanism. Thus, is able to catalyze the cleavage of L-allo-threonine. {ECO:0000269|PubMed:12913008}.",MTAAPDARTTAVMSAPLAEVDPDIAELLAKELGRQRDTLEMIASENFVPRAVLQAQGSVLTNKYAEGLPGRRYYGGCEHVDVVENLARDRAKALFGAEFANVQPHSGAQANAAVLHALMSPGERLLGLDLANGGHLTHGMRLNFSGKLYENGFYGVDPATHLIDMDAVRATALEFRPKVIIAGWSAYPRVLDFAAFRSIADEVGAKLLVDMAHFAGLVAAGLHPSPVPHADVVSTTVHKTLGGGRSGLIVGKQQYAKAINSAVFPGQQGGPLMHVIAGKAVALKIAATPEFADRQRRTLSGARIIADRLMAPDVAKAGVSVVSGGTDVHLVLVDLRDSPLDGQAAEDLLHEVGITVNRNAVPNDPRPPMVTSGLRIGTPALATRGFGDTEFTEVADIIATALATGSSVDVSALKDRATRLARAFPLYDGLEEWSLVGR,"46,216",438,SHMT family,active evasion of host immune response [GO:0042783]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; tetrahydrofolate interconversion [GO:0035999],glycine hydroxymethyltransferase activity [GO:0004372]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],glyA,MTV017.46,2
P9WIR9,34KD_MYCTU,Rv0954,Rv0954 MTCY10D7.20c,GO:0005618; GO:0005887,IPR035166; ,,,,34 kDa antigenic protein homolog,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MTYSPGNPGYPQAQPAGSYGGVTPSFAHADEGASKLPMYLNIAVAVLGLAAYFASFGPMFTLSTELGGGDGAVSGDTGLPVGVALLAALLAGVALVPKAKSHVTVVAVLGVLGVFLMVSATFNKPSAYSTGWALWVVLAFIVFQAVAAVLALLVETGAITAPAPRPKFDPYGQYGRYGQYGQYGVQPGGYYGQQGAQQAAGLQSPGPQQSPQPPGYGSQYGGYSSSPSQSGSGYTAQPPAQPPAQSGSQQSHQGPSTPPTGFPSFSPPPPVSAGTGSQAGSAPVNYSNPSGGEQSSSPGGAPV,"30,204",303,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,MTCY10D7.20c,1
P9WQH9,ACCD_MYCTU,Rv0904c,accD3 Rv0904c MTCY31.32c,GO:0003989; GO:0005524; GO:0005886; GO:0009317; GO:0071768,IPR034733; IPR000438; IPR029045; IPR011763; IPR011762; ,,accD3,DOMAIN 1 236 CoA carboxyltransferase N-terminal. {ECO:0000255|PROSITE-ProRule:PRU01136}.; DOMAIN 242 470 CoA carboxyltransferase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU01137}.,Putative acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (ACCase beta chain) (EC 6.4.1.2),acetyl-CoA carboxylase complex [GO:0009317]; plasma membrane [GO:0005886]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; mycolic acid biosynthetic process [GO:0071768],9634230; 12657046; 19099550; 21969609,,"FUNCTION: This protein is a component of the acetyl coenzyme A carboxylase complex; first, biotin carboxylase catalyzes the carboxylation of the carrier protein and then the transcarboxylase transfers the carboxyl group to form malonyl-CoA. {ECO:0000250}.",MSRITTDQLRHAVLDRGSFVSWDSEPLAVPVADSYARELAAARAATGADESVQTGEGRVFGRRVAVVACEFDFLGGSIGVAAAERITAAVERATAERLPLLASPSSGGTRMQEGTVAFLQMVKIAAAIQLHNQARLPYLVYLRHPTTGGVFASWGSLGHLTVAEPGALIGFLGPRVYELLYGDPFPSGVQTAENLRRHGIIDGVVALDRLRPMLDRALTVLIDAPEPLPAPQTPAPVPDVPTWDSVVASRRPDRPGVRQLLRHGATDRVLLSGTDQGEAATTLLALARFGGQPTVVLGQQRAVGGGGSTVGPAALREARRGMALAAELCLPLVLVIDAAGPALSAAAEQGGLAGQIAHCLAELVTLDTPTVSILLGQGSGGPALAMLPADRVLAALHGWLAPLPPEGASAIVFRDTAHAAELAAAQGIRSADLLKSGIVDTIVPEYPDAADEPIEFALRLSNAIAAEVHALRKIPAPERLATRLQRYRRIGLPRD,"51,772",495,AccD/PCCB family,mycolic acid biosynthetic process [GO:0071768],acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524],acetyl-CoA carboxylase complex [GO:0009317]; plasma membrane [GO:0005886],,MTCY31.32c,1
P9WQG3,ACDC_MYCTU,Rv0972c,fadE12 Rv0972c MTCY10D7.02,GO:0003995; GO:0005886; GO:0050660; GO:0055114,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE12,,Acyl-CoA dehydrogenase fadE12 (EC 1.3.99.-),plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; oxidation-reduction process [GO:0055114],9634230; 9535763; 21969609,,,MTDTSFIESEERQALRKAVASWVANYGHEYYLDKARKHEHTSELWAEAGKLGFLGVNLPEEYGGGGAGMYELSLVMEEMAAAGSALLLMVVSPAINGTIIAKFGTDDQKKRWLPGIADGSLTMAFAITEPDAGSNSHKITTTARRDGSDWIIKGQKVFISGIDQAQAVLVVGRSEEAKTGKLRPALFVVPTDAPGFSYTPIEMELVSPERQFQVFLDDVRLPADALVGAEDAAIAQLFAGLNPERIMGAASAVGMGRFALGRAVDYVKTRKVWSTPIGAHQGLAHPLAQCHIEVELAKLMTQKAATLYDHGDDFGAAEAANMAKYAAAEASSRAVDQAVQSMGGNGLTKEYGVAAMMTSARLARIAPISREMVLNFVAQTSLGLPRSY,"41,515",388,Acyl-CoA dehydrogenase family,oxidation-reduction process [GO:0055114],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],plasma membrane [GO:0005886],,MTCY10D7.02,1
P9WP49,CSOR_MYCTU,Rv0967,csoR croR Rv0967,GO:0000976; GO:0001217; GO:0003677; GO:0005507; GO:0005737; GO:0005886; GO:0006351; GO:0010272; GO:0032993; GO:0045892; GO:0046688; GO:0097077,IPR003735; IPR038390; ,,csoR,,Copper-sensing transcriptional repressor CsoR (Copper-sensitive operon repressor),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; copper ion binding [GO:0005507]; copper ion sensor activity [GO:0097077]; DNA binding [GO:0003677]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription, DNA-templated [GO:0045892]; response to copper ion [GO:0046688]; response to silver ion [GO:0010272]; transcription, DNA-templated [GO:0006351]",9634230; 16586367; 21969609; 17143269,X-ray crystallography (1),"FUNCTION: Copper-sensitive repressor that has a key role in copper homeostasis. It is part of the cso operon involved in the cellular response to increasing concentrations of copper inside the bacterium, which can be highly toxic. In the presence of copper, CsoR fully dissociates from the promoter in the cso operon, leading to the transcription of its genes. Binds to a GC-rich pseudopallindromic sequence, 5'-GTAGCCCACCCCCAGTGGGGTGGGA-3', in the cso promoter region. {ECO:0000269|PubMed:17143269}.",MSKELTAKKRAALNRLKTVRGHLDGIVRMLESDAYCVDVMKQISAVQSSLERANRVMLHNHLETCFSTAVLDGHGQAAIEELIDAVKFTPALTGPHARLGGAAVGESATEEPMPDASNM,"12,800",119,CsoR family,"negative regulation of transcription, DNA-templated [GO:0045892]; response to copper ion [GO:0046688]; response to silver ion [GO:0010272]; transcription, DNA-templated [GO:0006351]","bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; copper ion binding [GO:0005507]; copper ion sensor activity [GO:0097077]; DNA binding [GO:0003677]; transcription regulatory region sequence-specific DNA binding [GO:0000976]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993],croR,,1
P9WPT1,CTPE_MYCTU,Rv0908,ctpE Rv0908 MTCY21C12.02,GO:0005388; GO:0005524; GO:0005887; GO:0043231; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR001757; ,,ctpE,,Calcium-transporting ATPase CtpE (EC 3.6.3.8),integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],9634230; 21969609,,FUNCTION: P-type ATPase involved in specific uptake of calcium. {ECO:0000250|UniProtKB:A0R3Y2}.,MTRSASATAGLTDAEVAQRVAEGKSNDIPERVTRTVGQIVRANVFTRINAILGVLLLIVLATGSLINGMFGLLIIANSVIGMVQEIRAKQTLDKLAIIGQAKPLVRRQSGTRTRSTNEVVLDDIIELGPGDQVVVDGEVVEEENLEIDESLLTGEADPIAKDAGDTVMSGSFVVSGAGAYRATKVGSEAYAAKLAAEASKFTLVKSELRNGINRILQFITYLLVPAGLLTIYTQLFTTHVGWRESVLRMVGALVPMVPEGLVLMTSIAFAVGVVRLGQRQCLVQELPAIEGLARVDVVCADKTGTLTESGMRVCEVEELDGAGRQESVADVLAALAAADARPNASMQAIAEAFHSPPGWVVAANAPFKSATKWSGVSFRDHGNWVIGAPDVLLDPASVAARQAERIGAQGLRVLLLAAGSVAVDHAQAPGQVTPVALVVLEQKVRPDARETLDYFAVQNVSVKVISGDNAVSVGAVADRLGLHGEAMDARALPTGREELADTLDSYTSFGRVRPDQKRAIVHALQSHGHTVAMTGDGVNDVLALKDADIGVAMGSGSPASRAVAQIVLLNNRFATLPHVVGEGRRVIGNIERVANLFLTKTVYSVLLALLVGIECLIAIPLRRDPLLFPFQPIHVTIAAWFTIGIPAFILSLAPNNERAYPGFVRRVMTSAVPFGLVIGVATFVTYLAAYQGRYASWQEQEQASTAALITLLMTALWVLAVIARPYQWWRLALVLASGLAYVVIFSLPLAREKFLLDASNLATTSIALAVGVVGAATIEAMWWIRSRMLGVKPRVWR,"84,973",797,Cation transport ATPase (P-type) (TC 3.A.3) family,,ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231],,MTCY21C12.02,1
P9WPS3,CTPV_MYCTU,Rv0969,ctpV Rv0969 MTCY10D7.05c,GO:0005524; GO:0005618; GO:0005886; GO:0005887; GO:0006825; GO:0009405; GO:0019829; GO:0046688; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR027256; IPR001757; ,,ctpV,,Probable copper-exporting P-type ATPase V (EC 3.6.3.54) (Cu(+)-exporting ATPase),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872]; copper ion transport [GO:0006825]; pathogenesis [GO:0009405]; response to copper ion [GO:0046688],9634230; 15952732; 17143269; 20624225; 21969609,,FUNCTION: Necessary for copper homeostasis and likely functions as a copper exporter. Also required for full virulence. {ECO:0000269|PubMed:20624225}.,MRVCVTGFNVDAVRAVAIEETVSQVTGVHAVHAYPRTASVVIWYSPELGDTAAVLSAITKAQHVPAELVPARAPHSAGVRGVGVVRKITGGIRRMLSRPPGVDKPLKASRCGGRPRGPVRGSASWPGEQNRRERRTWLPRVWLALPLGLLALGSSMFFGAYPWAGWLAFAATLPVQFVAGWPILRGAVQQARALTSNMDTLIALGTLTAFVYSTYQLFAGGPLFFDTSALIIAFVVLGRHLEARATGKASEAISKLLELGAKEATLLVDGQELLVPVDQVQVGDLVRVRPGEKIPVDGEVTDGRAAVDESMLTGESVPVEKTAGDRVAGATVNLDGLLTVRATAVGADTALAQIVRLVEQAQGDKAPVQRLADRVSAVFVPAVIGVAVATFAGWTLIAANPVAGMTAAVAVLIIACPCALGLATPTAIMVGTGRGAELGILVKGGEVLEASKKIDTVVFDKTGTLTRARMRVTDVIAGQRRQPDQVLRLAAAVESGSEHPIGAAIVAAAHERGLAIPAANAFTAVAGHGVRAQVNGGPVVVGRRKLVDEQHLVLPDHLAAAAVEQEERGRTAVFVGQDGQVVGVLAVADTVKDDAADVVGRLHAMGLQVAMITGDNARTAAAIAKQVGIEKVLAEVLPQDKVAEVRRLQDQGRVVAMVGDGVNDAPALVQADLGIAIGTGTDVAIEASDITLMSGRLDGVVRAIELSRQTLRTIYQNLGWAFGYNTAAIPLAALGALNPVVAGAAMGFSSVSVVTNSLRLRRFGRDGRTA,"80,103",770,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",copper ion transport [GO:0006825]; pathogenesis [GO:0009405]; response to copper ion [GO:0046688],ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY10D7.05c,1
P9WGD1,CPSY_MYCTU,Rv0806c,cpsY Rv0806c,GO:0000271; GO:0005618; GO:0016772,IPR031358; IPR021520; IPR031357; IPR031356; ,,cpsY,,Exopolysaccharide phosphotransferase CpsY (EC 2.7.-.-) (Stealth protein CpsY),"cell wall [GO:0005618]; transferase activity, transferring phosphorus-containing groups [GO:0016772]; polysaccharide biosynthetic process [GO:0000271]",9634230; 16299590; 21969609,,,MPKISSRDGGRPAQRTVNPIIVTRRGKIARLESGLTPQEAQIEDLVFLRKVLNRADIPYLLIRNHKNRPVLAINIELRAGLERALAAACATEPMYAKTIDEPGLSPVLVATDGLSQLVDPRVVRLYRRRIAPGGFRYGPAFGVELQFWVYEETVIRCPVENSLSRKVLPRNEITPTNVKLYGYKWPTLDGMFAPHASDVVFDIDMVFSWVDGSDPEFRARRMAQMSQYVVGEGDDAEARIRQIDELKYALRSVNMFAPWIRRIFIATDSTPPPWLAEHPKITIVRAEDHFSDRSALPTYNSHAVESQLHHIPGLSEHFLYSNDDMFFGRPLKASMFFSPGGVTRFIEAKTRIGLGANNPARSGFENAARVNRQLLFDRFGQVITRHLEHTAVPLRKSVLIEMEREFPEEFARTAASPFRSDTDISVTNSFYHYYALMTGRAVPQEKAKVLYVDTTSYAGLRLLPKLRKHRGYDFFCLNDGSFPEVPAAQRAERVVSFLERYFPIPAPWEKIAADVSRRDFAVPRTSAPSEGA,"60,268",532,Stealth family,polysaccharide biosynthetic process [GO:0000271],"transferase activity, transferring phosphorus-containing groups [GO:0016772]",cell wall [GO:0005618],,,1
P9WPN9,CP126_MYCTU,Rv0778,cyp126 Rv0778 MTCY369.22,GO:0005506; GO:0006707; GO:0008395; GO:0020037; GO:0036199,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp126,,Putative cytochrome P450 126 (EC 1.14.-.-),cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; cholesterol catabolic process [GO:0006707],9634230; 21969609,X-ray crystallography (4),,MTTAAGLSGIDLTDLDNFADGFPHHLFAIHRREAPVYWHRPTEHTPDGEGFWSVATYAETLEVLRDPVTYSSVTGGQRRFGGTVLQDLPVAGQVLNMMDDPRHTRIRRLVSSGLTPRMIRRVEDDLRRRARGLLDGVEPGAPFDFVVEIAAELPMQMICILLGVPETDRHWLFEAVEPGFDFRGSRRATMPRLNVEDAGSRLYTYALELIAGKRAEPADDMLSVVANATIDDPDAPALSDAELYLFFHLLFSAGAETTRNSIAGGLLALAENPDQLQTLRSDFELLPTAIEEIVRWTSPSPSKRRTASRAVSLGGQPIEAGQKVVVWEGSANRDPSVFDRADEFDITRKPNPHLGFGQGVHYCLGANLARLELRVLFEELLSRFGSVRVVEPAEWTRSNRHTGIRHLVVELRGG,"45,954",414,Cytochrome P450 family,cholesterol catabolic process [GO:0006707],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],,,MTCY369.22,1
P9WN71,G6PD1_MYCTU,Rv1121,zwf1 zwf Rv1121 MTCY22G8.10,GO:0004345; GO:0005886; GO:0006006; GO:0006098; GO:0050661,IPR001282; IPR019796; IPR022675; IPR022674; IPR036291; ,,zwf1,,Glucose-6-phosphate 1-dehydrogenase 1 (G6PD 1) (EC 1.1.1.49),plasma membrane [GO:0005886]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098],9634230; 21969609,,FUNCTION: Catalyzes the oxidation of glucose 6-phosphate to 6-phosphogluconolactone. {ECO:0000255|HAMAP-Rule:MF_00966}.,MVDGGGGASDLLVIFGITGDLARKMTFRALYRLERHQLLDCPILGVASDDMSVGQLVKWARESIGRTEKIDDAVFDRLAGRLSYLHGDVTDSQLYDSLAELIGSACRPLYYLEMPPALFAPIVENLANVRLLERARVAVEKPFGHDLASALELNARLRAVLGEDQILRVDHFLGKQPVVELEYLRFANQALAELWDRNSISEIHITMAEDFGVEDRGKFYDAVGALRDVVQNHLLQVLALVTMEPPVGSSADDLNDKKAEVFRAMAPLDPDRCVRGQYLGYTEVAGVASDSATETYVALRTEIDNWRWAGVPIFVRAGKELPAKVTEVRLFLRRVPALAFLPNRRPAEPNQIVLRIDPDPGMRLQISAHTDDSWRDIHLDSSFAVDLGEPIRPYERLLYAGLVGDHQLFAREDSIEQTWRIVQPLLDNPGEIHRYDRGSWGPEAAQSLLRGHRGWQSPWLPRGTDA,"52,173",466,Glucose-6-phosphate dehydrogenase family,glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098],glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661],plasma membrane [GO:0005886],zwf,MTCY22G8.10,1
P9WN21,GLPX_MYCTU,Rv1099c,glpX Rv1099c,GO:0005829; GO:0006071; GO:0006094; GO:0030388; GO:0042132; GO:0046872,IPR004464; ,,glpX,,"Fructose-1,6-bisphosphatase class 2 (FBPase class 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase class 2) (Fructose 1,6-bisphosphatase II)","cytosol [GO:0005829]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycerol metabolic process [GO:0006071]",9634230; 14569030; 15470127; 17259624; 21451980; 21636919; 21969609; 26258286; 26397812,,"FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate (PubMed:15470127, PubMed:21451980). Seems to be the major FBPase of M.tuberculosis and to play a key role in gluconeogenesis for conversion of lipid carbon into cell wall glycans. Does not display activity against inositol 1-phosphate (PubMed:15470127). {ECO:0000269|PubMed:15470127, ECO:0000269|PubMed:21451980}.",MTAEGSGSSTAAVASHDPSHTRPSRREAPDRNLAMELVRVTEAGAMAAGRWVGRGDKEGGDGAAVDAMRELVNSVSMRGVVVIGEGEKDHAPMLYNGEEVGNGDGPECDFAVDPIDGTTLMSKGMTNAISVLAVADRGTMFDPSAVFYMNKIAVGPDAAHVLDITAPISENIRAVAKVKDLSVRDMTVCILDRPRHAQLIHDVRATGARIRLITDGDVAGAISACRPHSGTDLLAGIGGTPEGIIAAAAIRCMGGAIQAQLAPRDDAERRKALEAGYDLNQVLTTEDLVSGENVFFCATGVTDGDLLKGVRYYPGGCTTHSIVMRSKSGTVRMIEAYHRLSKLNEYSAIDFTGDSSAVYPLP,"38,084",362,FBPase class 2 family,"fructose 1,6-bisphosphate metabolic process [GO:0030388]; gluconeogenesis [GO:0006094]; glycerol metabolic process [GO:0006071]","fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; metal ion binding [GO:0046872]",cytosol [GO:0005829],,,1
P9WMT9,GREA_MYCTU,Rv1080c,greA Rv1080c MTV017.33c,GO:0003677; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0032784; GO:0046677; GO:0070063,IPR036953; IPR018151; IPR006359; IPR028624; IPR001437; IPR023459; IPR022691; IPR036805; ,,greA,,Transcription elongation factor GreA (Transcript cleavage factor GreA),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; regulation of DNA-templated transcription, elongation [GO:0032784]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",9634230; 17259624; 21969609,,"FUNCTION: Necessary for efficient RNA polymerase transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by cleavage factors such as GreA or GreB allows the resumption of elongation from the new 3'terminus. GreA releases sequences of 2 to 3 nucleotides. {ECO:0000255|HAMAP-Rule:MF_00105}.",MTDTQVTWLTQESHDRLKAELDQLIANRPVIAAEINDRREEGDLRENGGYHAAREEQGQQEARIRQLQDLLSNAKVGEAPKQSGVALPGSVVKVYYNGDKSDSETFLIATRQEGVSDGKLEVYSPNSPLGGALIDAKVGETRSYTVPNGSTVSVTLVSAEPYHS,"17,855",164,GreA/GreB family,"regulation of DNA-templated transcription, elongation [GO:0032784]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV017.33c,1
P9WNP1,ECHA6_MYCTU,Rv0905,echA6 Rv0905 MTCY31.33,GO:0004300; GO:0005618; GO:0005886; GO:0006635,IPR029045; IPR018376; IPR001753; ,,echA6,,Probable enoyl-CoA hydratase echA6 (EC 4.2.1.17),cell wall [GO:0005618]; plasma membrane [GO:0005886]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,X-ray crystallography (8),FUNCTION: Could possibly oxidize fatty acids using specific components. {ECO:0000250}.,MIGITQAEAVLTIELQRPERRNALNSQLVEELTQAIRKAGDGSARAIVLTGQGTAFCAGADLSGDAFAADYPDRLIELHKAMDASPMPVVGAINGPAIGAGLQLAMQCDLRVVAPDAFFQFPTSKYGLALDNWSIRRLSSLVGHGRARAMLLSAEKLTAEIALHTGMANRIGTLADAQAWAAEIARLAPLAIQHAKRVLNDDGAIEEAWPAHKELFDKAWGSQDVIEAQVARMEKRPPKFQGA,"26,029",243,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY31.33,1
P9WNN9,ECHA8_MYCTU,Rv1070c,echA8 Rv1070c MTV017.23c,GO:0004300; GO:0005618; GO:0005886; GO:0006635,IPR029045; IPR018376; IPR001753; IPR014748; ,,echA8,,Probable enoyl-CoA hydratase echA8 (EC 4.2.1.17),cell wall [GO:0005618]; plasma membrane [GO:0005886]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,X-ray crystallography (5),FUNCTION: Could possibly oxidize fatty acids using specific components. {ECO:0000250}.,MTYETILVERDQRVGIITLNRPQALNALNSQVMNEVTSAATELDDDPDIGAIIITGSAKAFAAGADIKEMADLTFADAFTADFFATWGKLAAVRTPTIAAVAGYALGGGCELAMMCDVLIAADTAKFGQPEIKLGVLPGMGGSQRLTRAIGKAKAMDLILTGRTMDAAEAERSGLVSRVVPADDLLTEARATATTISQMSASAARMAKEAVNRAFESSLSEGLLYERRLFHSAFATEDQSEGMAAFIEKRAPQFTHR,"27,273",257,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV017.23c,1
P9WNZ7,DESA1_MYCTU,Rv0824c,desA1 des Rv0824c,GO:0005618; GO:0005829; GO:0005886; GO:0006633; GO:0009986; GO:0040007; GO:0045300; GO:0046872; GO:0052572,IPR005067; IPR009078; IPR012348; ,,desA1,,Putative acyl-[acyl-carrier-protein] desaturase DesA1 (Putative acyl-ACP desaturase DesA1) (EC 1.14.19.-),cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; acyl-[acyl-carrier-protein] desaturase activity [GO:0045300]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; response to host immune response [GO:0052572],9199463; 9634230; 12368430; 14559907; 19099550; 21969609,,FUNCTION: May be a desaturase involved in mycobacterial fatty acid biosynthesis. {ECO:0000305|PubMed:14559907}.,MSAKLTDLQLLHELEPVVEKYLNRHLSMHKPWNPHDYIPWSDGKNYYALGGQDWDPDQSKLSDVAQVAMVQNLVTEDNLPSYHREIAMNMGMDGAWGQWVNRWTAEENRHGIALRDYLVVTRSVDPVELEKLRLEVVNRGFSPGQNHQGHYFAESLTDSVLYVSFQELATRISHRNTGKACNDPVADQLMAKISADENLHMIFYRDVSEAAFDLVPNQAMKSLHLILSHFQMPGFQVPEFRRKAVVIAVGGVYDPRIHLDEVVMPVLKKWRIFEREDFTGEGAKLRDELALVIKDLELACDKFEVSKQRQLDREARTGKKVSAHELHKTAGKLAMSRR,"38,770",338,Fatty acid desaturase type 2 family,fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; response to host immune response [GO:0052572],acyl-[acyl-carrier-protein] desaturase activity [GO:0045300]; metal ion binding [GO:0046872],cell surface [GO:0009986]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],des,,1
P9WG89,EMRB_MYCTU,Rv0783c,emrB Rv0783c,GO:0005576; GO:0005887; GO:0022857,IPR004638; IPR011701; IPR020846; IPR036259; ,,emrB,,Multidrug resistance protein B homolog,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857],9634230,,,MLGNAMVEACPAEGDAPVPITPAGRPRSGQRSYPDRLDVGLLRTAGVCVLASVMAHVDVTVVSVAQRTFVADFGSTQAVVAWTMTGYMLALATVIPTAGWAADRFGTRRLFMGSVLAFTLGSLLCAVAPNILLLIIFRVVQGFGGGMLTPVSFAILAREAGPKRLGRVMAVVGIPMLLGPVGGPILGGWLIGAYGWRWIFLVNLPVGLSALVLAAIVFPRDRPAASENFDYMGLLLLSPGLATFLFGVSSSPARGTMADRHVLIPAITGLALIAAFVAHSWYRTEHPLIDMRLFQNRAVAQANMTMTVLSLGLFGSFLLLPSYLQQVLHQSPMQSGVHIIPQGLGAMLAMPIAGAMMDRRGPAKIVLVGIMLIAAGLGTFAFGVARQADYLPILPTGLAIMGMGMGCSMMPLSGAAVQTLAPHQIARGSTLISVNQQVGGSIGTALMSVLLTYQFNHSEIIATAKKVALTPESGAGRGAAVDPSSLPRQTNFAAQLLHDLSHAYAVVFVIATALVVSTLIPAAFLPKQQASHRRAPLLSA,"56,587",540,"Major facilitator superfamily, EmrB family",,transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
P9WNJ9,ESXJ_MYCTU,Rv1038c,esxJ Rv1038c MTCY10G2.11,GO:0005576; GO:0005618; GO:0005886,IPR036689; IPR010310; ,,esxJ,,ESAT-6-like protein EsxJ,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 12919853; 19876390; 22291682,,,MASRFMTDPHAMRDMAGRFEVHAQTVEDEARRMWASAQNISGAGWSGMAEATSLDTMTQMNQAFRNIVNMLHGVRDGLVRDANNYEQQEQASQQILSS,"10,993",98,"WXG100 family, CFP-10 subfamily",,,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY10G2.11,1
O06553,F420R_MYCTU,Rv1155,Rv1155,GO:0010181; GO:0016491; GO:0030170; GO:0042803; GO:0042816; GO:0070967,IPR019920; IPR011576; IPR012349; ,,,,F420H(2)-dependent reductase Rv1155 (EC 1.-.-.-),coenzyme F420 binding [GO:0070967]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; vitamin B6 metabolic process [GO:0042816],9634230; 21969609; 27364382; 16239726; 15620716; 25644473,X-ray crystallography (5),"FUNCTION: F420H(2)-dependent reductase able to catalyze the reduction of biliverdin-IXalpha to bilirubin-IXalpha in vitro. However, kinetic parameters show that it is less efficient than the biliverdin reductase Rv2074 and suggest biliverdin-IXalpha is unlikely to be the native substrate of Rv1155, which probably catalyzes the reduction of an alternative molecule in vivo (PubMed:27364382). Binds coenzyme F420, but does not bind FMN or other flavins (PubMed:25644473). Cannot use pyridoxine 5'-phosphate, pyridoxamine 5'-phosphate, pyridoxal 5'-phosphate (PLP), the anti-tuberculosis drug PA-824 or aflatoxin analogs as substrates (PubMed:25644473). {ECO:0000269|PubMed:25644473, ECO:0000269|PubMed:27364382}.",MARQVFDDKLLAVISGNSIGVLATIKHDGRPQLSNVQYHFDPRKLLIQVSIAEPRAKTRNLRRDPRASILVDADDGWSYAVAEGTAQLTPPAAAPDDDTVEALIALYRNIAGEHSDWDDYRQAMVTDRRVLLTLPISHVYGLPPGMR,"16,301",147,F420H(2)-dependent biliverdin reductase family,vitamin B6 metabolic process [GO:0042816],coenzyme F420 binding [GO:0070967]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],,,,1
P9WHT1,APEB_MYCTU,Rv0800,apeB pepC Rv0800 MTCY07H7A.09c,GO:0005829; GO:0005886; GO:0006518; GO:0008270; GO:0070006,IPR022984; IPR001948; IPR023358; ,,apeB,,Probable M18 family aminopeptidase 2 (EC 3.4.11.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518],9634230; 21969609,,,MAATAHGLCEFIDASPSPFHVCATVAGRLLGAGYRELREADRWPDKPGRYFTVRAGSLVAWNAEQSGHTQVPFRIVGAHTDSPNLRVKQHPDRLVAGWHVVALQPYGGVWLHSWLDRDLGISGRLSVRDGTGVSHRLVLIDDPILRVPQLAIHLAEDRKSLTLDPQRHINAVWGVGERVESFVGYVAQRAGVAAADVLAADLMTHDLTPSALIGASVNGTASLLSAPRLDNQASCYAGMEALLAVDVDSASSGFVPVLAIFDHEEVGSASGHGAQSDLLSSVLERIVLAAGGTREDFLRRLTTSMLASADMAHATHPNYPDRHEPSHPIEVNAGPVLKVHPNLRYATDGRTAAAFALACQRAGVPMQRYEHRADLPCGSTIGPLAAARTGIPTVDVGAAQLAMHSARELMGAHDVAAYSAALQAFLSAELSEA,"46,013",433,Peptidase M18 family,peptide metabolic process [GO:0006518],metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; plasma membrane [GO:0005886],pepC,MTCY07H7A.09c,1
P9WIU5,ARFA_MYCTU,Rv0899,arfA ompA Rv0899 MTCY31.27,GO:0005576; GO:0005618; GO:0005829; GO:0005887; GO:0009279; GO:0010447; GO:0015288; GO:0042834; GO:0044121; GO:0046872; GO:0072488,IPR007055; IPR006664; IPR006665; IPR006690; IPR036737; ,,arfA,DOMAIN 127 196 BON.; DOMAIN 212 326 OmpA-like. {ECO:0000255|PROSITE-ProRule:PRU00473}.,Peptidoglycan-binding protein ArfA (Outer membrane porin A) (Outer membrane protein A) (OmpATb) (Outer membrane protein ArfA),cell outer membrane [GO:0009279]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; metal ion binding [GO:0046872]; peptidoglycan binding [GO:0042834]; porin activity [GO:0015288]; ammonium transmembrane transport [GO:0072488]; growth of symbiont in host organelle [GO:0044121]; response to acidic pH [GO:0010447],9634230; 12366842; 17573469; 18439872; 21969609; 21410778; 20199110; 22108166; 22206986; 21117233,NMR spectroscopy (6),"FUNCTION: Probably plays a role in ammonia secretion that neutralizes the medium at pH 5.5, although it does not play a direct role in ammonia transport. The OmpA-like domain (196-326) binds M.tuberculosis peptidoglycan. Overexpression in M.bovis or M.smegmatis gives channels with average conductance value of 1,600 +/- 100 pS, but this may not be physiologically relevant. {ECO:0000269|PubMed:12366842, ECO:0000269|PubMed:17573469, ECO:0000269|PubMed:21410778}.",MASKAGLGQTPATTDARRTQKFYRGSPGRPWLIGAVVIPLLIAAIGYGAFERPQSVTGPTGVLPTLTPTSTRGASALSLSLLSISRSGNTVTLIGDFPDEAAKAALMTALNGLLAPGVNVIDQIHVDPVVRSLDFSSAEPVFTASVPIPDFGLKVERDTVTLTGTAPSSEHKDAVKRAATSTWPDMKIVNNIEVTGQAPPGPPASGPCADLQSAINAVTGGPIAFGNDGASLIPADYEILNRVADKLKACPDARVTINGYTDNTGSEGINIPLSAQRAKIVADYLVARGVAGDHIATVGLGSVNPIASNATPEGRAKNRRVEIVVN,"33,574",326,"OmpA family, ArfA(Rv0899) subfamily",ammonium transmembrane transport [GO:0072488]; growth of symbiont in host organelle [GO:0044121]; response to acidic pH [GO:0010447],metal ion binding [GO:0046872]; peptidoglycan binding [GO:0042834]; porin activity [GO:0015288],cell outer membrane [GO:0009279]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],ompA,MTCY31.27,1
P9WQ05,ARCA_MYCTU,Rv1001,arcA Rv1001 MTCI237.16,GO:0005737; GO:0005886; GO:0016990; GO:0019547,IPR003876; IPR033199; ,,arcA,,Arginine deiminase (ADI) (EC 3.5.3.6) (Arginine dihydrolase) (AD),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; arginine deiminase activity [GO:0016990]; arginine catabolic process to ornithine [GO:0019547],9634230; 19099550; 21969609,,,MGVELGSNSEVGALRVVILHRPGAELRRLTPRNTDQLLFDGLPWVSRAQDEHDEFAELLASRGAEVLLLSDLLTEALHHSGAARMQGIAAAVDAPRLGLPLAQELSAYLRSLDPGRLAHVLTAGMTFNELPSDTRTDVSLVLRMHHGGDFVIEPLPNLVFTRDSSIWIGPRVVIPSLALRARVREASLTDLIYAHHPRFTGVRRAYESRTAPVEGGDVLLLAPGVVAVGVGERTTPAGAEALARSLFDDDLAHTVLAVPIAQQRAQMHLDTVCTMVDTDTMVMYANVVDTLEAFTIQRTPDGVTIGDAAPFAEAAAKAMGIDKLRVIHTGMDPVVAEREQWDDGNNTLALAPGVVVAYERNVQTNARLQDAGIEVLTIAGSELGTGRGGPRCMSCPAARDPL,"43,089",402,Arginine deiminase family,arginine catabolic process to ornithine [GO:0019547],arginine deiminase activity [GO:0016990],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCI237.16,1
P9WJG7,ARFB_MYCTU,Rv0900,arfB Rv0900 MTCY31.28,GO:0005886; GO:0016021; GO:0040007; GO:0044119,,,arfB,,Uncharacterized membrane protein ArfB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],9634230; 21410778,,"FUNCTION: Required for wild-type expression of ArfA and ammonia secretion, not however part of an ammonia transporter. {ECO:0000269|PubMed:21410778}.",MDFVIQWSCYLLAFLGGSAVAWVVVTLSIKRASRDEGAAEAPSAAETGAQ,"5,245",50,ArfB membrane protein family,growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.28,1
P9WJG5,ARFC_MYCTU,Rv0901,arfC Rv0901 MTCY31.29,GO:0005618; GO:0005886; GO:0016021,,,arfC,,Uncharacterized membrane protein ArfC,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609; 21410778,,"FUNCTION: Required for wild-type expression of ArfA and ammonia secretion, not however part of an ammonia transporter. {ECO:0000269|PubMed:21410778}.",MEHVHWWLAGLAFTLGMVLTSTLMVRPVEHQVLVKKSVRGSSAKSKPPTARKPAVKSGTKREESPTAKTKVATESAAEQIPVAGEPAAEPIPVAGEPAARIPVVPYAPYGPGSARAGADGSGPQGWLVKGRSDTRLYYTPEDPTYDPTVAQVWFQDEESAARAFFTPWRKSTRRT,"18,909",175,ArfC membrane protein family,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.29,1
P9WQP7,3BHS_MYCTU,Rv1106c,Rv1106c,GO:0003854; GO:0004769; GO:0005829; GO:0005886; GO:0006694; GO:0008202; GO:0016042; GO:0030283; GO:0070403; GO:0102294,IPR002225; IPR036291; ,,,,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase (Cholesterol dehydrogenase) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (3-beta-HSD) (3BHSD) (EC 1.1.1.145) (3-beta hydroxysterol dehydrogenase) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)],cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholesterol dehydrogenase activity [GO:0102294]; NAD+ binding [GO:0070403]; steroid delta-isomerase activity [GO:0004769]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202],9634230; 17630785; 21969609,,"FUNCTION: 3-beta-HSD is a bifunctional enzyme, that catalyzes the oxidation and isomerization of cholesterol, pregnenolone, and dehydroepiandrosterone (DHEA) into cholest-4-en-3-one, progesterone, and androsterone, respectively. {ECO:0000269|PubMed:17630785}.",MLRRMGDASLTTELGRVLVTGGAGFVGANLVTTLLDRGHWVRSFDRAPSLLPAHPQLEVLQGDITDADVCAAAVDGIDTIFHTAAIIELMGGASVTDEYRQRSFAVNVGGTENLLHAGQRAGVQRFVYTSSNSVVMGGQNIAGGDETLPYTDRFNDLYTETKVVAERFVLAQNGVDGMLTCAIRPSGIWGNGDQTMFRKLFESVLKGHVKVLVGRKSARLDNSYVHNLIHGFILAAAHLVPDGTAPGQAYFINDAEPINMFEFARPVLEACGQRWPKMRISGPAVRWVMTGWQRLHFRFGFPAPLLEPLAVERLYLDNYFSIAKARRDLGYEPLFTTQQALTECLPYYVSLFEQMKNEARAEKTAATVKP,"40,742",370,3-beta-HSD family,lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202],3-beta-hydroxy-delta5-steroid dehydrogenase activity [GO:0003854]; cholesterol dehydrogenase activity [GO:0102294]; NAD+ binding [GO:0070403]; steroid delta-isomerase activity [GO:0004769]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WQG7,Y802_MYCTU,Rv0802c,Rv0802c,GO:0005737; GO:0006104; GO:0008080,IPR016181; IPR000182; ,,,DOMAIN 32 188 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,Putative succinyl-CoA transferase Rv0802c (EC 2.8.3.-),cytoplasm [GO:0005737]; N-acetyltransferase activity [GO:0008080]; succinyl-CoA metabolic process [GO:0006104],9634230; 16400876; 21969609; 18997321,X-ray crystallography (2),FUNCTION: May function as a succinyl-CoA transferase. {ECO:0000305|PubMed:18997321}.,MSRHWPLFDLRITTPRLQLQLPTEELCDQLIDTILEGVHDPDRMPFSVPWTRASREDLPFNTLSHLWQQLAGFKRDDWSLPLAVLVDGRAVGVQALSSKDFPITRQVDSGSWLGLRYQGHGYGTEMRAAVLYFAFAELEAQVATSRSFVDNPASIAVSRRNGYRDNGLDRVAREGAMAEALLFRLTRDDWQRHRTVEVRVDGFDRCRPLFGPLEPPRY,"24,983",218,,succinyl-CoA metabolic process [GO:0006104],N-acetyltransferase activity [GO:0008080],cytoplasm [GO:0005737],,,1
P9WQF7,Y873_MYCTU,Rv0873,fadE10 Rv0873 MTCY31.01 MTV043.66,GO:0005618; GO:0005829; GO:0005886; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE10,,Probable acyl-CoA dehydrogenase FadE10 (EC 1.3.-.-),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MAQQTQVTEEQARALAEESRESGWDKPSFAKELFLGRFPLGLIHPFPKPSDAEEARTEAFLVKLREFLDTVDGSVIERAAQIPDEYVKGLAELGCFGLKIPSEYGGLNMSQVAYNRVLMMVTTVHSSLGALLSAHQSIGVPEPLKLAGTAEQKRRFLPRCAAGAISAFLLTEPDVGSDPARMASTATPIDDGQAYELEGVKLWTTNGVVADLLVVMARVPRSEGHRGGISAFVVEADSPGITVERRNKFMGLRGIENGVTRLHRVRVPKDNLIGREGDGLKIALTTLNAGRLSLPAIATGVAKQALKIAREWSVERVQWGKPVGQHEAVASKISFIAATNYALDAVVELSSQMADEGRNDIRIEAALAKLWSSEMACLVGDELLQIRGGRGYETAESLAARGERAVPVEQMVRDLRINRIFEGSSEIMRLLIAREAVDAHLTAAGDLANPKADLRQKAAAAAGASGFYAKWLPKLVFGEGQLPTTYREFGALATHLRFVERSSRKLARNTFYGMARWQASLEKKQGFLGRIVDIGAELFAISAACVRAEAQRTADPVEGEQAYELAEAFCQQATLRVEALFDALWSNTDSIDVRLANDVLEGRYTWLEQGILDQSEGTGPWIASWEPGPSTEANLARRFLTVSPSSEAKL,"70,745",650,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY31.01 MTV043.66,1
P9WKR9,Y874_MYCTU,Rv0874c,Rv0874c MTCY31.02c,GO:0005886; GO:0016021,IPR019494; IPR013702; IPR016741; ,,,,Uncharacterized protein Rv0874c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MRIGVGVCTTPDARQAAVEAAGQARDELAGEAPSLAVLLGSRAHTDRAADVLSAVLQMIDPPALVGCIAQAIVAGRHEIEDEPAVVVWLASGLAAETFQLDFVRTGSGALITGYRFDRTARDLHLLLPDPYTFPSNLLIEHPNTDLPGTAVVGGVVSGGRRRGDTRLFRDHDVLTSGVVGVRLPGMRGVPVVSQGCRPIGYPYIVTGADGILITELGGRPPLQRLREIVEGLSPDERALVSHGLQIGIVVDEHLAAPGQGDFVIRGLLGADPSTGSIEIDEVVQVGATMQFQVRDAAGADKDLRLTVERAAARLPGRAAGALLFTCNGRGRRMFGVADHDASTIEELLGGIPLAGFFAAGEIGPIAGRNALHGFTASMALFVDDME,"40,402",386,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.02c,1
P9WKR7,Y875_MYCTU,Rv0875c,Rv0875c MTCY31.03c,GO:0005886; GO:0040007,IPR024495; ,,,,Uncharacterized protein Rv0875c,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MKRGVATLPVILVILLSVAAGAGAWLLVRGHGPQQPEISAYSHGHLTRVGPYLYCNVVDLDDCQTPQAQGELPVSERYPVQLSVPEVISRAPWRLLQVYQDPANTTSTLFRPDTRLAVTIPTVDPQRGRLTGIVVQLLTLVVDHSGELRDVPHAEWSVRLIF,"17,833",162,,growth [GO:0040007],,plasma membrane [GO:0005886],,MTCY31.03c,1
P9WNG1,Y892_MYCTU,Rv0892,Rv0892 MTCY31.20,GO:0004499; GO:0005618; GO:0050660; GO:0050661,IPR036188; IPR020946; ,,,,Uncharacterized monooxygenase Rv0892 (EC 1.14.13.-),"cell wall [GO:0005618]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",9634230; 21969609,,,MTGRCPTVAVVGAGMSGMCVAITLLSAGITDVCIYEKADDVGGTWRDNTYPGLTCDVPSRLYQYSFAKNPNWTQMFSRGGEIQDYLRGIAERYGLRHRIRFGATVVSARFDDGRWVLRTDSGTESTVDFLISATGVLHHPRIPPIAGLDDFRGTVFHSARWDHTVPLLGRRIAVIGTGSTGVQLVCGLAGVAGKVTMFQRTAQWVLPWPNPRYSKLARVFHRAFPCLGSLAYKAYSLSFETFAVALSNPGLHRKLVGAVCRASLRRVRDPRLRRALTPDYEPMCKRLVMSGGFYRAIQRDDVELVTAGIDHVEHRGIVTDDGVLHEVDVIVLATGFDSHAFFRPMQLTGRDGIRIDDVWQDGPHAHQTVAIPGFPNFFMMLGPHSPVGNFPLTAVAESQAEHIVQWIKRWRHGEFDTMEPKSAATEAYNTVLRAAMPNTVWTTGCDSWYLNKDGIPEVWPFAPAKHRAMLANLHPEEYDLRRYAAVRATSRPQSA,"55,039",495,FAD-binding monooxygenase family,,"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",cell wall [GO:0005618],,MTCY31.20,1
P9WFI1,Y893_MYCTU,Rv0893c,Rv0893c MTCY31.21c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv0893c (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MRTEDDSWDVTTSVGSTGLLVAAARALETQKADPLAIDPYAEVFCRAAGGEWADVLDGKLPDHYLTTGDFGEHFVNFQGARTRYFDEYFSRATAAGMKQVVILAAGLDSRAFRLQWPIGTTIFELDRPQVLDFKNAVLADYHIRPRAQRRSVAVDLRDEWQIALCNNGFDANRPSAWIAEGLLVYLSAEAQQRLFIGIDTLASPGSHVAVEEATPLDPCEFAAKLERERAANAQGDPRRFFQMVYNERWARATEWFDERGWRATATPLAEYLRRVGRAVPEADTEAAPMVTAITFVSAVRTGLVADPARTSPSSTSIGFKRFEAD,"36,073",325,UPF0677 family,,methyltransferase activity [GO:0008168],,,MTCY31.21c,1
P9WKA3,Y895_MYCTU,Rv0895,Rv0895 MTCY31.23,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR023213; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv0895 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv0895),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions very weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity.",MRQQQEADVVALGRKPGLLCVPERFRAMDLPMAAADALFLWAETPTRPLHVGALAVLSQPDNGTGRYLRKVFSAAVARQQVAPWWRRRPHRSLTSLGQWSWRTETEVDLDYHVRLSALPPRAGTAELWALVSELHAGMLDRSRPLWQVDLIEGLPGGRCAVYVKVHHALADGVSVMRLLQRIVTADPHQRQMPTLWEVPAQASVAKHTAPRGSSRPLTLAKGVLGQARGVPGMVRVVADTTWRAAQCRSGPLTLAAPHTPLNEPIAGARSVAGCSFPIERLRQVAEHADATINDVVLAMCGGALRAYLISRGALPGAPLIAMVPVSLRDTAVIDVFGQGPGNKIGTLMCSLATHLASPVERLSAIRASMRDGKAAIAGRSRNQALAMSALGAAPLALAMALGRVPAPLRPPNVTISNVPGPQGALYWNGARLDALYLLSAPVDGAALNITCSGTNEQITFGLTGCRRAVPALSILTDQLAHELELLVGVSEAGPGTRLRRIAGRR,"53,873",505,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY31.23,1
P9WKP7,Y897_MYCTU,Rv0897c,Rv0897c MTCY31.25c,GO:0005829; GO:0005886; GO:0016021,IPR036188; ,,,,Uncharacterized protein Rv0897c,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSDHDRDFDVVVVGGGHNGLVAAAYLARAGLRVRLLERLAQTGGAAVSIQAFDGVEVALSRYSYLVSLLPSRIVADLGAPVRLARRPFSSYTPAPATAGRSGLLIGPTGEPRAAHLAAIGAAPDAHGFAAFYRRCRLVTARLWPTLIEPLRTREQARRDIVEYGGHEAAAAWQAMVDEPIGHAIAGAVANDLLRGVIATDALIGTFARMHEPSLMQNICFLYHLVGGGTGVWHVPIGGMGSVTSALATAAARHGAEIVTGADVFALDPDGTVRYHSDGSDGAEHLVRGRFVLVGVTPAVLASLLGEPVAALAPGAQVKVNMVVRRLPRLRDDSVTPQQAFAGTFHVNETWSQLDAAYSQAASGRLPDPLPCEAYCHSLTDPSILSARLRDAGAQTLTVFGLHTPHSVFGDTEGLAERLTAAVLASLNSVLAEPIQDVLWTDAQSKPCIETTTTLDLQRTLGMTGGNIFHGALSWPFADNDDPLDTPARQWGVATDHERIMLCGSGARRGGAVSGIGGHNAAMAVLACLASRRKSP,"56,234",535,,,,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY31.25c,1
P9WKP5,Y898_MYCTU,Rv0898c,Rv0898c MTCY31.26c,,IPR020311; ,,,,Uncharacterized protein Rv0898c,,9634230; 21969609,,,MGKGRKPTDSETLAHIRDLVAEEKALRAQLRHGGISESEEQQQLRRIEIELDQCWDLLRQRRALRQTGGDPREAVVRPADQVEGYTG,"9,920",87,,,,,,MTCY31.26c,1
P9WKP3,Y906_MYCTU,Rv0906,Rv0906 MTCY31.34,GO:0008270; GO:0070290,IPR001279; IPR024884; IPR036866; ,,,,Uncharacterized protein Rv0906,N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],9634230; 21969609,,,MVRRALRLAAGTASLAAGTWLLRALHGTPAALGADAASIRAVSEQSPNYRDGAFVNLDPASMFTLDREELRLIVWELVARHSASRPAAPIPLASPNIYRGDASRLAVSWFGHSTALLEIDGYRVLTDPVWSDRCSPSDVVGPQRLHPPPVQLAALPAVDAVVISHDHYDHLDIDTVVALVGMQRAPFLVPLGVGAHLRSWGVPQDRIVELDWNQSAQVDELTVVCVPARHFSGRFLSRNTTLWASWAFVGPNHRAYFGGDTGYTKSFTQIGADHGPFDLTLLPIGAYNTAWPDIHMNPEEAVRAHLDVTDSGSGMLVPVHWGTFRLAPHPWGEPVERLLAAAEPEHVTVAVPLPGQRVDPTGPMRLHPWWRL,"40,641",372,,,N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270],,,MTCY31.34,1
P9WQK1,Y986_MYCTU,Rv0986,Rv0986 MTV044.14,GO:0005524; GO:0009405; GO:0016887; GO:0052572,IPR003593; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 7 246 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv0986,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; pathogenesis [GO:0009405]; response to host immune response [GO:0052572],9634230; 16586367; 21969609,,,MNRQPIVQLSNLSWTFREGETRRQVLDHITFDFEPGEFVALLGQSGSGKSTLLNLISGIEKPTTGDVTINGFAITQKTERDRTLFRRDQIGIVFQFFNLIPTLTVLENITLPQELAGVSQRKAAVVARDLLEKVGMADRERTFPDKLSGGEQQRVAISRALAHNPMLVLADEPTGNLDSDTGDKVLDVLLDLTRQAGKTLIMATHSPSMTQHADRVVNLQGGRLIPAVNRENQTDQPASTILLPTSYE,"27,373",248,ABC transporter superfamily,pathogenesis [GO:0009405]; response to host immune response [GO:0052572],ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,MTV044.14,1
P9WFF5,ZFPP_MYCTU,Rv1086,Rv1086 MTV017.39,GO:0000287; GO:0002094; GO:0005829; GO:0005886; GO:0016094; GO:0030145; GO:0033850,IPR001441; IPR018520; IPR036424; ,,,,"(2Z,6E)-farnesyl diphosphate synthase (EC 2.5.1.68) (Short-chain Z-isoprenyl diphosphate synthase) (Z-FPP synthase) (Z-FPPS) (Z-Polyprenyl diphosphate synthase) (Z-isoprenyl diphosphate synthase)",cytosol [GO:0005829]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polyprenyltransferase activity [GO:0002094]; Z-farnesyl diphosphate synthase activity [GO:0033850]; polyprenol biosynthetic process [GO:0016094],9634230; 11004176; 10816587; 11152452; 18790692; 21969609; 18597781,X-ray crystallography (3),"FUNCTION: Catalyzes the condensation of only one isopentenyl pyrophosphate (IPP) unit in the cis configuration to E-geranyl diphosphate (E-GPP) generating the 15 carbon product (2Z,6E)-farnesyl diphosphate (Z-FPP or EZ-FPP). Z-FPP is the precursor of decaprenyl diphosphate, which has a central role in the biosynthesis of the mycobacterial cell wall. {ECO:0000269|PubMed:10816587, ECO:0000269|PubMed:11004176, ECO:0000269|PubMed:11152452}.",MEIIPPRLKEPLYRLYELRLRQGLAASKSDLPRHIAVLCDGNRRWARSAGYDDVSYGYRMGAAKIAEMLRWCHEAGIELATVYLLSTENLQRDPDELAALIEIITDVVEEICAPANHWSVRTVGDLGLIGEEPARRLRGAVESTPEVASFHVNVAVGYGGRREIVDAVRALLSKELANGATAEELVDAVTVEGISENLYTSGQPDPDLVIRTSGEQRLSGFLLWQSAYSEMWFTEAHWPAFRHVDFLRALRDYSARHRSYGR,"29,410",262,"UPP synthase family, Z-FPP synthase subfamily",polyprenol biosynthetic process [GO:0016094],magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polyprenyltransferase activity [GO:0002094]; Z-farnesyl diphosphate synthase activity [GO:0033850],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV017.39,1
P9WJ55,VAPB9_MYCTU,Rv0959A,vapB9 Rv0959A,GO:0006355,IPR010985; ,,vapB9,,Putative antitoxin VapB9,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC9. {ECO:0000305|PubMed:15718296}.,MKTLYLRNVPDDVVERLERLAELAKTSVSAVAVRELTEASRRADNPALLGDLPDIGIDTTELIGGIDAERAGR,"7,918",73,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WHM7,PUR9_MYCTU,Rv0957,purH Rv0957 MTCY10D7.17c,GO:0003937; GO:0004643; GO:0005886; GO:0006189; GO:0040007,IPR024051; IPR016193; IPR011607; IPR036914; IPR002695; ,,purH,DOMAIN 1 152 MGS-like. {ECO:0000255|PROSITE-ProRule:PRU01202}.,Bifunctional purine biosynthesis protein PurH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)],plasma membrane [GO:0005886]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; 'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (2),,MSTDDGRRPIRRALISVYDKTGLVDLAQGLSAAGVEIISTGSTAKTIADTGIPVTPVEQLTGFPEVLDGRVKTLHPRVHAGLLADLRKSEHAAALEQLGIEAFELVVVNLYPFSQTVESGASVDDCVEQIDIGGPAMVRAAAKNHPSAAVVTDPLGYHGVLAALRAGGFTLAERKRLASLAFQHIAEYDIAVASWMQQTLAPEHPVAAFPQWFGRSWRRVAMLRYGENPHQQAALYGDPTAWPGLAQAEQLHGKDMSYNNFTDADAAWRAAFDHEQTCVAIIKHANPCGIAISSVSVADAHRKAHECDPLSAYGGVIAANTEVSVEMAEYVSTIFTEVIVAPGYAPGALDVLARKKNIRVLVAAEPLAGGSELRPISGGLLIQQSDQLDAHGDNPANWTLATGSPADPATLTDLVFAWRACRAVKSNAIVIAADGATVGVGMGQVNRVDAARLAVERGGERVRGAVAASDAFFPFPDGLETLAAAGVTAVVHPGGSVRDEEVTEAAAKAGVTLYLTGARHFAH,"55,026",523,PurH family,'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007],IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643],plasma membrane [GO:0005886],,MTCY10D7.17c,1
P9WHL5,PURQ_MYCTU,Rv0788,purQ Rv0788 MTCY369.32,GO:0004359; GO:0004642; GO:0005524; GO:0005737; GO:0005886; GO:0006189; GO:0006541; GO:0040007,IPR029062; IPR017926; IPR010075; ,,purQ,DOMAIN 4 224 Glutamine amidotransferase type-1. {ECO:0000255|HAMAP-Rule:MF_00421}.,Phosphoribosylformylglycinamidine synthase subunit PurQ (FGAM synthase) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase subunit I) (FGAR amidotransferase I) (FGAR-AT I) (Glutaminase PurQ) (EC 3.5.1.2) (Phosphoribosylformylglycinamidine synthase subunit I),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; growth [GO:0040007],9634230; 21969609,,FUNCTION: Part of the phosphoribosylformylglycinamidine synthase complex involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate. The FGAM synthase complex is composed of three subunits. PurQ produces an ammonia molecule by converting glutamine to glutamate. PurL transfers the ammonia molecule to FGAR to form FGAM in an ATP-dependent manner. PurS interacts with PurQ and PurL and is thought to assist in the transfer of the ammonia molecule from PurQ to PurL. {ECO:0000255|HAMAP-Rule:MF_00421}.,MTARIGVVTFPGTLDDVDAARAARQVGAEVVSLWHADADLKGVDAVVVPGGFSYGDYLRAGAIARFAPVMDEVVAAADRGMPVLGICNGFQVLCEAGLLPGALTRNVGLHFICRDVWLRVASTSTAWTSRFEPDADLLVPLKSGEGRYVAPEKVLDELEGEGRVVFRYHDNVNGSLRDIAGICSANGRVVGLMPHPEHAIEALTGPSDDGLGLFYSALDAVLTG,"23,633",224,,'de novo' IMP biosynthetic process [GO:0006189]; glutamine metabolic process [GO:0006541]; growth [GO:0040007],ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY369.32,1
P9WGN1,KDPE_MYCTU,Rv1027c,kdpE Rv1027c,GO:0000160; GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0040007,IPR011006; IPR001867; IPR001789; IPR036388; ,,kdpE,DOMAIN 3 116 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Transcriptional regulatory protein KdpE,"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; growth [GO:0040007]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 12595424; 19099550; 21969609,,FUNCTION: Member of the two-component regulatory system KdpD/KdpE involved in the regulation of the kdp operon. {ECO:0000250}.,MTLVLVIDDEPQILRALRINLTVRGYQVITASTGAGALRAAAEHPPDVVILDLGLPDMSGIDVLGGLRGWLTAPVIVLSARTDSSDKVQALDAGADDYVTKPFGMDEFLARLRAAVRRNTAAAELEQPVIETDSFTVDLAGKKVIKDGAEVHLTPTEWGMLEMLARNRGKLVGRGELLKEVWGPAYATETHYLRVYLAQLRRKLEDDPSHPKHLLTESGMGYRFEA,"24,741",226,,"growth [GO:0040007]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytoplasm [GO:0005737],,,1
O53838,KMTR_MYCTU,Rv0827c,kmtR Rv0827c,GO:0003677; GO:0003700; GO:0006351; GO:0010045; GO:0032025,IPR011991; IPR001845; IPR036388; IPR036390; ,,kmtR,DOMAIN 10 104 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,HTH-type transcriptional regulator KmtR,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; response to cobalt ion [GO:0032025]; response to nickel cation [GO:0010045]; transcription, DNA-templated [GO:0006351]",9634230; 17726022,,FUNCTION: Represses expression of Rv2025c and its own expression. Acts by binding to the promoter regions. {ECO:0000269|PubMed:17726022}.,MYADSGPDPLPDDQVCLVVEVFRMLADATRVQVLWSLADREMSVNELAEQVGKPAPSVSQHLAKLRMARLVRTRRDGTTIFYRLENEHVRQLVIDAVFNAEHAGPGIPRHHRAAGGLQSVAKASATKDVG,"14,296",130,,"response to cobalt ion [GO:0032025]; response to nickel cation [GO:0010045]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,3
O08343,TATD_MYCTU,Rv1008,tatD Rv1008,GO:0004536; GO:0005886; GO:0006308; GO:0016888; GO:0046872,IPR018228; IPR015991; IPR032466; IPR001130; ,,tatD,,Uncharacterized metal-dependent hydrolase TatD (EC 3.1.-.-),"plasma membrane [GO:0005886]; deoxyribonuclease activity [GO:0004536]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]; DNA catabolic process [GO:0006308]",9634230; 16952959; 21969609,,,MVDAHTHLDACGARDADTVRSLVERAAAAGVTAVVTVADDLESARWVTRAAEWDRRVYAAVALHPTRADALTDAARAELERLVAHPRVVAVGETGIDMYWPGRLDGCAEPHVQREAFAWHIDLAKRTGKPLMIHNRQADRDVLDVLRAEGAPDTVILHCFSSDAAMARTCVDAGWLLSLSGTVSFRTARELREAVPLMPVEQLLVETDAPYLTPHPHRGLANEPYCLPYTVRALAELVNRRPEEVALITTSNARRAYGLGWMRQ,"29,083",264,"Metallo-dependent hydrolases superfamily, TatD-type hydrolase family",DNA catabolic process [GO:0006308],"deoxyribonuclease activity [GO:0004536]; endodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872]",plasma membrane [GO:0005886],,,1
P9WHF9,THTR_MYCTU,Rv3117; Rv0815c,cysA1 cysA Rv3117 MTCY164.27; cysA2 Rv0815c MTV043.07c,GO:0004792; GO:0005618; GO:0005829; GO:0005886,IPR001763; IPR036873; IPR001307; ,,cysA1; cysA2,DOMAIN 18 125 Rhodanese 1. {ECO:0000255|PROSITE-ProRule:PRU00173}.; DOMAIN 154 274 Rhodanese 2. {ECO:0000255|PROSITE-ProRule:PRU00173}.,Putative thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese-like protein),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; thiosulfate sulfurtransferase activity [GO:0004792],9634230; 21969609,X-ray crystallography (3),FUNCTION: May be a sulfotransferase involved in the formation of thiosulfate. {ECO:0000250}.,MARCDVLVSADWAESNLHAPKVVFVEVDEDTSAYDRDHIAGAIKLDWRTDLQDPVKRDFVDAQQFSKLLSERGIANEDTVILYGGNNNWFAAYAYWYFKLYGHEKVKLLDGGRKKWELDGRPLSSDPVSRPVTSYTASPPDNTIRAFRDEVLAAINVKNLIDVRSPDEFSGKILAPAHLPQEQSQRPGHIPGAINVPWSRAANEDGTFKSDEELAKLYADAGLDNSKETIAYCRIGERSSHTWFVLRELLGHQNVKNYDGSWTEYGSLVGAPIELGS,"31,015",277,,,thiosulfate sulfurtransferase activity [GO:0004792],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],cysA; ,MTCY164.27; MTV043.07c,1
O05576,O05576_MYCTU,Rv0993,galU Rv0993,GO:0003983; GO:0005886; GO:0006011; GO:0009058; GO:0040007,IPR005771; IPR005835; IPR029044; ,,galU,,UTP--glucose-1-phosphate uridylyltransferase GalU (UDP-glucose pyrophosphorylase) (UDPGP) (Alpha-D-glucosyl-1-phosphate uridylyltransferase) (Uridine diphosphoglucose pyrophosphorylase),plasma membrane [GO:0005886]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; biosynthetic process [GO:0009058]; growth [GO:0040007]; UDP-glucose metabolic process [GO:0006011],9634230; 21969609,,,MSRPEVLTPFTAIVPAAGLGTRFLPATKTVPKELLPVVDTPGIELVAAEAAAAGAERLVIVTSEGKDGVVAHFVEDLVLEGTLEARGKIAMLAKVRRAPALIKVESVVQAEPLGLGHAIGCVEPTLSPDEDAVAVLLPDDLVLPTGVLETMSKVRASRGGTVLCAIEVAREEISAYGVFDVEPVPDGDYTDDPNVLKVRGMVEKPKAETAPSRYAAAGRYVLDRAIFDALRRIDQGAGGEVQLTDAIALLIAEGHPVHVVVHQGSRHDLGNPGGYLKAAVDFALDRDDYGPDLRRWLVARLGLTEQ,"32,378",306,,biosynthetic process [GO:0009058]; growth [GO:0040007]; UDP-glucose metabolic process [GO:0006011],UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983],plasma membrane [GO:0005886],,,1
O53892,O53892_MYCTU,Rv0979c,Rv0979c,,,,,,Uncharacterized protein,,9634230,,,MGFRTQVGAATIASTMTWRIPVEDGPAQFRAGVGPGRDRQFTVVAPMVVGLWDRNRRPGWQWPS,"7,127",64,,,,,,,2
O53431,O53431_MYCTU,Rv1083,Rv1083,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MNQILLSVIAEGGPGNTGPDFGKASPVGLLVIVLLVIATLFLVRSMNQQLKKVPKSFDRDHPELDQAADEGTDRDGPARPPGPPHESG,"9,296",88,,,,integral component of membrane [GO:0016021],,,1
I6Y560,I6Y560_MYCTU,Rv0922,Rv0922,,IPR001959; ,,,,Possible transposase,,9634230,,,MIVRMRSCAQAAKVAEATGGVQLAGKPKPDGTPTFSRYVEIGVDFEAHRPVVESVSVLFELYDGDANSYAATGGPGAQLPSGWMVTAAKFEVEWPADPQRAGLVRSHFGARRKAFNWGLAQVKADLDAKAADPAHESVDWDLKSLRWAWNRAKDDVAPWWAENSKECYSSGLADLAQGLANWKAGKNGTRKGRRVGFPRFKSGRRDPGRVRFTTGTMRIEDDRRTITVPVIGPLRAKENTRRVQRHLVSGRAQILNMTLSQRWGRLFVAVCYALRTPTTRSPLTQPTVRAGMDLGVRTLATVATLDTATGEQTIIEYPNPAPLKATLVARRRAGRELSRRIPGSHGHRAVKAKLARLDRRCVHLRREAAHQLTTELAGTYGQVVIEDLDVAAMKRSMRRRAFRRSVSDAAMGLVAPQLAYKTAKCSGVLTVADRWFASSQIHHGCTSPDGTPCRLQGKGRIDKHLLCPVTGEVVDRDRNAALNLRDWPDNASRGPVGTTAPSAPGPTTTVGTGHGADTGSSGAGGASVRPRPRRAGRGEAKTQTPQGDAA,"59,630",550,,,,,,,1
O53420,O53420_MYCTU,Rv1072,Rv1072,GO:0005576; GO:0016021,IPR010539; ,,,,Probable conserved transmembrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MRETSNPVFRSLPKQRGGYAQFGTGTAQQGFPADPYLAPYREAKATRPLTIDDVVTKTGLTLAMLAGTAVVSYFLVASNVALAMPLTLVGALGGLALVLVATFGRKQDNPAIVLSYAALEGLFLGAISFVLANFTVASANAGVLIGEAILGTMGVFFGMLVVYKTGAIRVTPKFTRMVVAALFGVLVLMLGNLVLAMFNVGGGEGLGLRSPGPLGIIFSLVCIGIAAFSFLIDFDAADQMIRAGAPEKAAWGVALGLTVTLVWLYIEILRLLSYLQNE,"29,144",278,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
P96378,P96378_MYCTU,Rv1022,lpqU Rv1022,GO:0005576,IPR023346; IPR031304; ,,lpqU,,Probable conserved lipoprotein LpqU,extracellular region [GO:0005576],9634230; 21969609,,,MSPRRWLRAVAVIGATAMLLASSCTWQLSLFITDGVPPPPGDPVPPVDTHAGGRPADQLREWAEKRAAALGIPVIALEAYAYAARVAEVENPKCHLAWTTLAGIGRVESHHGTYRGATIAPNGDVSPPIRGVRLDGTGGTLRIVDRDGGGLDGDAAVERAMGPMQFISETWRLYGVAARNDGIANVDNIDDAALSAAGYLCWRGKDLATPRGWITALRAYNNSVIYARAVRDWATAYAAGHPL,"25,832",243,,,,extracellular region [GO:0005576],,,4
O53863,O53863_MYCTU,Rv0851c,Rv0851c,GO:0005576; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,extracellular region [GO:0005576]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MDGFPGRGAVITGGASGIGLATGTEFARRGARVVLGDVDKPGLRQAVNHLRAEGFDVHSVMCDVRHREEVTHLADEAFRLLGHVDVVFSNAGIVVGGPIVEMTHDDWRWVIDVDLWGSIHTVEAFLPRLLEQGTGGHVVFTASFAGLVPNAGLGAYGVAKYGVVGLAETLAREVTADGIGVSVLCPMVVETNLVANSERIRGAACAQSSTTGSPGPLPLQDDNLGVDDIAQLTADAILANRLYVLPHAASRASIRRRFERIDRTFDEQAAEGWRH,"29,249",275,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],extracellular region [GO:0005576],,,3
O05592,O05592_MYCTU,Rv1006,Rv1006,GO:0005576; GO:0005618; GO:0005886,IPR017853; ,,,,Uncharacterized protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MVLRSRKSTLGVVVCLALVLGGPLNGCSSSASHRGPLNAMGSPAIPSTAQEIPNPLRGQYEDLMEPLFPQGNPAQQRYPPWPASYDASLRVSWRQLQPTDPRTLPPDAPDDRKYDFSVIDNALTRLADRGMRLTLRVYAYSSCCKASYPDGTNIAIPDWERAIASTNTSYPGPATDPSTGVVQVVPNFNDSTYLNDFAQLLAALGRRYDGDERLSVFEFSGYGDFSENHVAYLRDTLGAPGPGPDESVATLGYYSQFRDQNITTASIKQLIAANVSAFPHTQLVTSPANPEIVRELFADEVTNKLAAPVGVRSDCLGVDAPLPAWAESSTSHYVQTKDPVVAALRQRLATAPVITEWCELPTGSSPRAYYEKGLRDVIRYHVSMTSSVNFPDQTATSPMDPALYLVWAQANAAAGYRYSVEAQPGSQALAGKVATISVTWTNYGAAAATEKWVPGYRLVDSTGQVVRTLPAAVDLKTLVSDQRGDRSSDQPTPASVAETVRVDLSGLPAGHYTLRAAIDWQQHKPNGSHVVNYPPMLLSRDGRDDSGFYPVATLDIPRDAQTAVNAS,"61,298",567,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
I6Y8U3,I6Y8U3_MYCTU,Rv0807,Rv0807,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSARDRVDPAKTRQVVLALADWLRDETLPAPDTDVLAAAVRLTARTLAALAPGASVEVRIPPFAAVQCISGPRHTRGTPPNVVQTDPRTWLLVATGLSGVAQARGSGALQLSGSRAGEIEAWLPLVDLG,"13,480",129,,,,,,,1
L0T8G6,L0T8G6_MYCTU,Rv1046c,Rv1046c,,,,,,Uncharacterized protein,,9634230,,,MKVQARVGWNRRQLSAVGGRGQQLFANAPGHIPSTSHRRGTGDINRKIDESLAGAARPQANANYGATSDPPLTHQPKPGSPTQVGPRSPSPPGLRGLVKQLPEVHQSSLHLDTVASLPSSRPSPHHTPLALRSRSGHFSPDEIRNRRSRKRSQSHMPPRTPPRGRCLRAPEALA,"18,833",174,,,,,,,1
I6Y4Y1,I6Y4Y1_MYCTU,Rv0837c,Rv0837c,,IPR019238; IPR016600; ,,,,Uncharacterized protein,,9634230; 21969609,,,MDQIGADLAEAVERHLTEYGVRVLGGLSALNSAHPESLDLEIDAHPLTITALYLPHLSATAALQAWDTAGAGSPLLVVGPRLHPSSAETLRARGLWYIDGAGNAYLRHQGGLLIDVRGRRSAVSAQPGTLGDGLHSDGPRNPFTPKRAQVVCVLLDAPQLVDAPLRAIAASAGVSVGMAKETMDTLRTTGFFEHLGSRRRLVRTDELLDLWAAAYPGGLGRANKLLVASGDIHTWSAPDGLAVAVSGEQALPDEIRNPESLMLYVDTPAPGLPADLLIHNRWHRDPHGSIVIRKLFWRNLPDEQPGLAPTALIYADLLASREPRQVEVAHLMRRQDERLARL,"36,896",342,,,,,,,1
O53874,O53874_MYCTU,Rv0862c,Rv0862c,GO:0005618,IPR032830; ,,,,Conserved protein,cell wall [GO:0005618],9634230; 21969609,,,MTEHTPDIPLGSWLAALPDERLTQLLELRPDLAQPPPGSIAALAARAQARQSVKAATDELDFLRLAVFDALLVLQADTAPVPIVRLLAVIGDRAAQADVLGALADLKQRALAWGETAVRVATDAGTALPWHPGQVTLEGSSRSGDQLADLIAGLDPAQRDVLDKLLQGSPVGRTRDAAPGAPSDRPVPRLLAMGLLRRIDAETVILPRHVGQVLRGEQPGPMELTAPDPVVSTTTPDDADAAAAGAVIDLLREVDVLLENLGATPVAELRSGGLGVREFKRLAKATGIDEPRLGLILEIAAAAGLIASGMPDPEPPHSDGPFWAPTVAADRFATMSPAERWHLLASAWLDLPGRPALIGTRGPDAKPYGALSDSLFSTAAPLDRRLLLGMLAELPAGAGVDASRASATLIWRRPRWARRLQPAPIADLLTEGHALGLVGRGAISTPARALLDEALEPATAPAAAVGVMARALPKPIDHFLVQADLTVVVPGPLQRELADDLTTVATVESAGTAMVYRVSEQSIRHALDVGKSRDWLQEFFANRSKTPVPQGLTYLIDDVARRHGQLRIGMAASFVRCEDPTLLAQVVAAPEADGLALRALAPTVAVSPAPISEVLVTLRGAGFAPAAEDSTGAVVDVRTRGARVPTPQRRRPYRPPPRPNSEALKAVVAVLREVTAAPFANVRVDPAVTMSLLQRAAKDQATLVISYLDAAGVATQRVVAPITLRGGQLVAFDSSSGRLRDFAIHRITLVVSAHDR,"79,667",756,,,,cell wall [GO:0005618],,,1
O06562,O06562_MYCTU,Rv1164,narI Rv1164,GO:0005576; GO:0008940; GO:0009055; GO:0009325; GO:0016021; GO:0019645; GO:0020037,IPR023234; IPR036197; IPR003816; ,,narI,,Probable respiratory nitrate reductase (Gamma chain) NarI,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nitrate reductase complex [GO:0009325]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; nitrate reductase activity [GO:0008940]; anaerobic electron transport chain [GO:0019645],9634230; 21969609,,,MAVLDLVEIFWDAAPYVVVAIAVVGTWWRYRYDKFGWTTRSSQLYESRLLSIGSPMFHFGSLLVIMGHVMGLFIPDSWTRAFGMSDHLYHLQALLLGAPAGFATLLGIGLLIYRRRIQTPVWLATTRNDKLMYLVLVCAIVAGLACTLMGATHEGDMHDYRRSVSVWFRSIWMLAPRGDLMAQATLYYQVHVLIALALFALWPFTRLVHAFSAPIAYLFRPYIVYRSREVAAKHELIGSAPRRRGW,"28,058",246,,anaerobic electron transport chain [GO:0019645],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; nitrate reductase activity [GO:0008940],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nitrate reductase complex [GO:0009325],,,1
O53846,O53846_MYCTU,Rv0835,lpqQ Rv0835,GO:0005576,IPR026954; ,,lpqQ,,Possible lipoprotein LpqQ,extracellular region [GO:0005576],9634230; 21969609,,,MCCSTAAKSAVIVCCAAIATTACSFQATSTQPSTAPPTSRVDSLIVSIEDVRRIANYEELAAHFQTDLREPPEADTNVPGPCRVVGSSDRTFGTDWSEFRSAGYHGVTDDLRPGGPVMVETVSQAIALYPDPSTARGVFHRLESSLAECAGLHDPYFDFILDRPDASTVRIGAAGWSHVYRLKSSVFISVGVLGIEPAEPIANVILQTISDRIQ,"22,903",214,,,,extracellular region [GO:0005576],,,3
O53409,O53409_MYCTU,Rv1061,Rv1061,,IPR017932; IPR029055; IPR026869; ,,,,Conserved protein,,9634230; 21969609,,,MCRLFGLHSGTDAVTATFWLLNASDSLAEQSRRNPDGTGLGVFDEHHQPRLHKQPIAAWQDADFATEAHELTGTTFVAHVRYATTGSLDIRNTHPFLQDGRIFAHNGVVEGLDVLDERLREVGADDLVLGQTDSERVFALITASIRARDGNESAGLIDALRWLAANVPIYAVNVLLSTATDVWALRYPESHELYILDRRGDGAPEFHLRSKRIRAHSTHLRERSSVVFATEPMDDNPRWRLLDAGELVHVDAALRVNRSLVLPDPPRHPIRREDLSEPVLHAQHTSA,"32,038",287,,,,,,,1
O53453,O53453_MYCTU,Rv1105,Rv1105,,IPR029058; IPR002018; ,,,,Possible para-nitrobenzyl esterase,,9634230,,,MFTQIAAEQPDLQVPTEEQIGSAYSRWRRKARSLSMATDVGFRMPSVWLAEGHSGVAPVYLYRFDYSTPLLKLLLVRAAHATELPYVWGNLGGSQDPALKLGDAKAAIAVSRRVRTRWINFATRGKPTGPDGEPDWPCYEEAHRACLIIGRRDAVVHDVDAHIRATWGSKW,"19,145",171,,,,,,,2
O06572,O06572_MYCTU,Rv1120c,Rv1120c,GO:0005622; GO:0009190; GO:0016849; GO:0035556,IPR001054; IPR029787; ,,,,Uncharacterized protein,intracellular [GO:0005622]; phosphorus-oxygen lyase activity [GO:0016849]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],9634230,,,MLSGGREAVKTVWQTANLVRKEGFGAAVRSSIEDPADWAEVERPDLARVTPDGRVVILFSDIEESTALDERIGDRTWVKLIGAHDKLVHELVRRWSGHMVTSQGDGFMIAFARAEQAVRCGIDIQDALRNSAKRKRNQGIRVRIGTTWGARCGTVTICSAATSQ,"18,061",164,,cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],phosphorus-oxygen lyase activity [GO:0016849],intracellular [GO:0005622],,,1
I6XWJ8,I6XWJ8_MYCTU,Rv0914c,Rv0914c,GO:0003988; GO:0006635,IPR002155; IPR016039; IPR020617; IPR020616; ,,,,Possible lipid carrier protein or keto acyl-CoA thiolase,acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MDDGVWILGGYQSDFARNLSKENRDFADLTREVVDGTLTAAKVDAADLAAAGVVHVANAFGEMFARQGHLGAMPATVCDDLWDTPATRHEAACASGSVATLAAMADLRSGAYRVALVVGLELEKTVPGDTAAEHLSAAAWTGHEGAEARYLWPSMFAQVADEYDRRYGLDDTHLRAIAQLNFANARRNPNAQTRGWTIPDPITDDDATNPLTEGRLRRFDCSQMTDGGAGLVLVSDAYLRDHRDARPIGRIDGWGHRTVGLGLRQKLDRVAQGDSAPYLLPHVRATVLDALRRARVTLDDLDGIEVHDCFTPSEYLAIDHIGLTGPGESWKAIENGEIEIGGRLPINPSGGLIGGGHPVGASGVRMLLDAAKQVSGIAGDYQVENAEAFGTLNFGGSTATTVSFVVSTTRGS,"43,875",412,Thiolase family,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],,,,1
P96368,P96368_MYCTU,Rv1032c,trcS Rv1032c,GO:0000155; GO:0004672; GO:0005509; GO:0005524; GO:0005622; GO:0016021; GO:0030145; GO:0046777,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,trcS,,Two component sensor histidine kinase TrcS,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672]; protein autophosphorylation [GO:0046777],9634230,,,MIPDRNTRSRKAPCWRPRSLRQQLLLGVLAVVTVVLVAVGVVSVLSLSGYVTAMNDAELVESLHALNHSYTRYRDSAQTSTPTGNLPMSQAVLEFTGQTPGNLIAVLHDGVVIGSAVFSEDGARPAPPDVIRAIEAQVWDGGPPRVESLGSLGAYQVDSSAAGADRLFVGVSLSLANQIIARKKVTTVALVGAALVVTAALTVWVVGYALRPLRRVAATAAEVATMPLTDDDHQISVRVRPGDTDPDNEVGIVGHTLNRLLDNVDGALAHRVDSDLRMRQFITDASHELRTPLAAIQGYAELTRQDSSDLPPTTEYALARIESEARRMTLLVDELLLLSRLSEGEDLETEDLDLTDLVINAVNDAAVAAPTHRWVKNLPDEPVWVNGDHARLHQLVSNLLTNAWVHTQPGVTVTIGITCHRTGPNAPCVELSVTDDGPDIDPEILPHLFDRFVRASKSRSNGSGHGLGLAIVSSIVKAHRGSVTAESGNGQTVFRVRLPMIEQQIATTA,"54,591",509,,protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; manganese ion binding [GO:0030145]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672],integral component of membrane [GO:0016021]; intracellular [GO:0005622],,,1
I6Y936,I6Y936_MYCTU,Rv0916c,PE7 Rv0916c,,IPR000084; ,,PE7,,PE family protein PE7,,9634230,,,MSFVTIQPVVLAAATGDLPTIGTAVSARNTAVCAPTTGVLPPAANDVSVLTAARFTAHTKHYRVVSKPAALVHGMFVALPAATADAYATTEAVNVVATG,"9,917",99,,,,,,,1
O53452,O53452_MYCTU,Rv1104,Rv1104,,IPR029058; IPR002018; ,,,,Possible para-nitrobenzyl esterase,,9634230,,,MVVDSCVAESRYGPVRGADDGRVKVWKGIRYAAPPLGDLRFRTPEPPERWTEVADATTFGPACPQPAIPNMPLDLGASQSEDCWSLNIWAPADTEPGDGKPVMVWLHGGAYILGSGSQPLYNGRRLAASGDVVVVTVNYRLGALGFLDLSSFNTSRRRFDSNIGLRDVLAVLRWVADNIAVFGGDPEKVTLFGESARESSRPCSPPRRPRVCSRRRSPRAHRRHRSTTR,"25,170",229,,,,,,,1
Q79FV6,Q79FV6_MYCTU,Rv0834c,PE_PGRS14 Rv0834c,,IPR000084; ,,PE_PGRS14,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS14,,9634230,,,MSFVIAAPDLVAMATEDLAGIGASLTAANAAAAVPTSGLLAAAGDEVSAAIAALFSSHGQQYQAMSAQAAAFHARFVQALAGAMGAYAAAEAANASPLQTLEQGLLGAINAPAAALSGRPFIGNGTNGAPGTGEAGGPGGWLLGNGGNGGSGAPGQTGGAGGAAGLLGHGGTGGAGGTGASGGKGGTGGWLWGSGGAGGAGGSGGGSGGAGGNALMFGIGGNGGAGGAASGVGNGGVGGAGGAGGALVAIGGAGGAGGAATTGTGGAGGAGSNALGLFLGLGGSGGQGGDSAMGSGGAGGAGGSGGAASPFGIDIGIGGAGGHGGAGTNGGAGGAGGAGGSSGTVFALDLSWGGAGGNGGAATTGTGGAGGTGGFAVAPDFIGFGAAYGGAGGLGGAATGAGGTGGTGGVGAGGFAALGVGVGGAGGAGGAATETGGIGGAGGLGVGLLGGAGGAGGPGGAASAGSGGHGGTGGDALGLIGAGIGGVGGVGGAATDTGGNGGAGGSGTGLLGGVGGAGGHGGGASVGTGGSGGAGGDGFGFVGAGGNGGNAGTGVGVNGANGGNGGSATGALAAVGGAGAAGGDATSGTGGFGGAGGSARGLIFALGGAGAAGGDASTGVGGPGGPGGTGTASSPFGIAIAIGGAGAQGGAGTSGATGGAGGDGVFEGIAVLGLGFGGAAGAGGAATGDGATGGAGGFGGAGAGIANFLGFSVLHGGAGGAGGTATGTGGNGGAGGGGGLSSPVILGIGIGGAGGDGGGALGVLGGMGGDGGDGGEAVAVGIAVGGAGGAGGAAPTGNGGAGGNGGDALGLVGVGGNGGNAGTGFGANTGGNGGDTTIVVNGMLAPSTLGYGGNGGNGVNGGAGGTGGKAGVFGAPGQNGLP,"71,699",882,,,,,,,1
L7N682,L7N682_MYCTU,Rv1135A,Rv1135A,GO:0008152; GO:0016747,IPR016039; IPR020617; ,,,,Possible acetyl-CoA acetyltransferase (Acetoacetyl-CoA thiolase),"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; metabolic process [GO:0008152]",9634230,,,MQLGNQNTMRFAGRPQRFRQSAYPLFNPNSAIALGHPFGGSGARLMTTVLHHMPDKGIRYGLQTMCEGRGQANATIVELL,"8,801",80,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
Q79FT7,Q79FT7_MYCTU,Rv1028A,kdpF Rv1028A,GO:0005886; GO:0008556; GO:0043462; GO:0051365,IPR011726; ,,kdpF,,Probable membrane protein KdpF,plasma membrane [GO:0005886]; potassium-transporting ATPase activity [GO:0008556]; cellular response to potassium ion starvation [GO:0051365]; regulation of ATPase activity [GO:0043462],9634230,,,MTTVDNIVGLVIAVALMAFLFAALLFPEKF,"3,256",30,,cellular response to potassium ion starvation [GO:0051365]; regulation of ATPase activity [GO:0043462],potassium-transporting ATPase activity [GO:0008556],plasma membrane [GO:0005886],,,1
O06543,O06543_MYCTU,Rv1143,mcr Rv1143,GO:0006637; GO:0008111; GO:0042803,IPR003673; IPR023606; ,,mcr,,Probable alpha-methylacyl-CoA racemase Mcr (2-methylacyl-CoA racemase) (2-arylpropionyl-CoA epimerase ),alpha-methylacyl-CoA racemase activity [GO:0008111]; protein homodimerization activity [GO:0042803]; acyl-CoA metabolic process [GO:0006637],9634230; 15632186; 17320106; 21969609; 22360758,X-ray crystallography (7),,MAGPLSGLRVVELAGIGPGPHAAMILGDLGADVVRIDRPSSVDGISRDAMLRNRRIVTADLKSDQGLELALKLIAKADVLIEGYRPGVTERLGLGPEECAKVNDRLIYARMTGWGQTGPRSQQAGHDINYISLNGILHAIGRGDERPVPPLNLVGDFGGGSMFLLVGILAALWERQSSGKGQVVDAAMVDGSSVLIQMMWAMRATGMWTDTRGANMLDGGAPYYDTYECADGRYVAVGAIEPQFYAAMLAGLGLDAAELPPQNDRARWPELRALLTEAFASHDRDHWGAVFANSDACVTPVLAFGEVHNEPHIIERNTFYEANGGWQPMPAPRFSRTASSQPRPPAATIDIEAVLTDWDG,"38,685",360,,acyl-CoA metabolic process [GO:0006637],alpha-methylacyl-CoA racemase activity [GO:0008111]; protein homodimerization activity [GO:0042803],,,,3
O05572,O05572_MYCTU,Rv0989c,grcC2 Rv0989c,GO:0008299; GO:0016740,IPR008949; IPR000092; ,,grcC2,,Probable polyprenyl-diphosphate synthase GrcC2 (Polyprenyl pyrophosphate synthetase),transferase activity [GO:0016740]; isoprenoid biosynthetic process [GO:0008299],9634230; 21969609,,,MIPAVSLGDPQFTANVHDGIARITELINSELSQADEVMRDTVAHLVDAGGTPFRPLFTVLAAQLGSDPDGWEVTVAGAAIELMHLGTLCHDRVVDESDMSRKTPSDNTRWTNNFAILAGDYRFATASQLASRLDPEAFAVVAEAFAELITGQMRATRGPASHIDTIEHYLRVVHEKTGSLIAASGQLGAALSGAAEEQIRRVARLGRMIGAAFEISRDIIAISGDSATLSGADLGQAVHTLPMLYALREQTPDTSRLRELLAGPIHDDHVAEALTLLRCSPGIGKAKNVVAAYAAQAREELPYLPDRQPRRALATLIDHAISACD,"34,757",325,FPP/GGPP synthase family,isoprenoid biosynthetic process [GO:0008299],transferase activity [GO:0016740],,,,1
O06633,O06633_MYCTU,Rv0801,Rv0801,,IPR029068; IPR037523; ,,,DOMAIN 4 115 VOC. {ECO:0000259|PROSITE:PS51819}.,Conserved protein,,9634230; 21969609,,,MALKVEMVTFDCSDPAKLAGWWAEQFDGTTRELLPGEFVVVARTDGPRLGFQKVPDPAPGKNRVHLDFTTKDLDAEVLRLVAAGASEVGRHQVGESFRWVVLADPEGNAFCVAGQ,"12,512",115,,,,,,,1
O06568,O06568_MYCTU,Rv1116,Rv1116,,,,,,Uncharacterized protein,,9634230,,,MCSRMADEPRLEAGAHPFEEGRDKAPELRATQMDHVRFTEGRRERNRDRLERSQQFRQPGR,"7,296",61,,,,,,,3
P96375,P96375_MYCTU,Rv1025,Rv1025,GO:0040007,IPR007511; ,,,,Conserved protein,growth [GO:0040007],9634230; 21969609,,,MVTRQLGRAPRGVLAIAYRCPNGEPGVVKTAPRLPDGTPFPTLYYLTHPVLTAAASRLETTGLMREMNRRLGQDAELAAAYRRAHESYLSERDALEPLGTTVSAGGMPDRVKCLHVLIAHSLAKGPGLNPFGDEALALLAAEPRTAATLVAGQWR,"16,625",155,,growth [GO:0040007],,,,,4
O05574,O05574_MYCTU,Rv0991c,Rv0991c,,IPR013429; ,,,,Conserved serine rich protein,,9634230; 21969609,,,MPTYSYECTQCANRFDVVQAFTDDALTTCERCSGRLRKLFNAVGVVFKGTGFYRTDSRESGKKSKSQTNGSSTSESTKSSGSSGSSGSSESKASGSTEKSTSSTTAAAAV,"11,458",110,,,,,,,3
I6XWG2,I6XWG2_MYCTU,Rv0868c,moaD2 Rv0868c,,IPR012675; IPR016155; IPR003749; ,,moaD2,,"Probable molybdenum cofactor biosynthesis protein D 2 MoaD2 (Molybdopterin converting factor small subunit) (Molybdopterin [MPT] converting factor, subunit 1)",,9634230; 21969609,,,MTQVSDESAGIQVTVRYFAAARAAAGAGSEKVTLRSGATVAELIDGLSVRDVRLATVLSRCSYLRDGIVVRDDAVALSAGDTIDVLPPFAGG,"9,440",92,,,,,,,1
O06560,O06560_MYCTU,Rv1162,narH Rv1162,GO:0005618; GO:0005886; GO:0008940; GO:0009325; GO:0010447; GO:0036294; GO:0042126; GO:0071249; GO:0071732,IPR017896; IPR029263; IPR038262; IPR006547; ,,narH,,Probable respiratory nitrate reductase (Beta chain) NarH,cell wall [GO:0005618]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886]; nitrate reductase activity [GO:0008940]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to nitrate [GO:0071249]; cellular response to nitric oxide [GO:0071732]; nitrate metabolic process [GO:0042126]; response to acidic pH [GO:0010447],9634230; 21969609,,,MKVMAQMAMVMNLDKCIGCHTCSVTCKQAWTNRSGTEYVWFNNVETRPGVGYPRTYEDQERWRGGWVRDKKGRLRLRDGGRIHKLLRIFANPKLPTIGDYYEPWTYDYENLTSAPAGDTFPTAAPRSLISGNPMKVSWGSNWDDNLAGSPEIVPNDPVLKKVNQVNQEVKLKLEETFMFYLPRICEHCLNPSCVASCPSGAMYKRTEDGIVLVDQDRCRGWRMCVSGCPYKKVYFNHKTGKAEKCTLCYPRIEVGLPTVCSETCVGRLRYLGLVLYDVDQVLQAASVESDTDLYEAQRRILLDPHDPRVIAGARAEGIADEWIEAAQRSPVYALINTYRVALPLHPEYRTMPMVWYIPPLSPVVDAVSRDGHDGEDLGNLFGALDALRIPIAYLAELFTAGDTEVVAGVLRRLAAMRCYMRDINLGRETQPHIPESVGMTEEQIYQMYRLLAVAKYEERYVIPTSYAGELPAAAMTDDMGCSLSVDGGPGMYESGPFGQGSPTPVPIAVESFHALQHAGSAATGGAGRSRVNLLNWDPNGAAAGLFPEPQPSKDVVQR,"62,038",558,,cellular response to decreased oxygen levels [GO:0036294]; cellular response to nitrate [GO:0071249]; cellular response to nitric oxide [GO:0071732]; nitrate metabolic process [GO:0042126]; response to acidic pH [GO:0010447],nitrate reductase activity [GO:0008940],cell wall [GO:0005618]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886],,,1
I6Y941,I6Y941_MYCTU,Rv0920c,Rv0920c,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MDAAQVIEPAHAGQDVDEAAVAARELSGAERALVGDLVRQARAEGVALTGPDGLLKALTKTVLEAALQEEMTEHLGYDRHAAAGRGSGNSRNGSRNKKVITDACGQVEIAVPRDRNGTFEPVIVGKRKRRVTDVDRVVLSLYAKGLTTGEIAAHFADVYGVSVSKDTISRITDRVIEEMQAWWSRPLEKVYAAVFIDAIMVKIRDGQVRNRPVYAAIGVDLDGHKDILGMWAGEGDGESAKFWLAVLTDLRNRGVKDIFFLVCDGLKGLPDSVSAAFPLATVQTCIIHLIRNTFRYASRKYWDKISVDLKPIYTAASAAEARLRYEEFAEKWGKPYPAITRLWDSAWEEFIPFLDYDVEIRRVPCSTNAIESLNARYRRAVRARGHFPNEQSALKTLYLVTRSLDPKGTGQTKWAVRWKPALNALAITFADRMPAAEER,"48,672",439,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
O53839,O53839_MYCTU,Rv0828c,Rv0828c,GO:0002100; GO:0008270; GO:0016787,IPR016192; IPR002125; IPR016193; ,,,,Possible deaminase,hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; tRNA wobble adenosine to inosine editing [GO:0002100],9634230,,,MPAGMAGFRRWAQTNDPTAHAESLAIRAACTKLGTEHLVGTTLNVLAHPCPMCYGSLYYCSPDEVVFLTSRDAYEPHYVDDRRYFEPATFYDEFAKEWQDRRLPMRQEHRPDIRAGAVDVYRFRQEPNGGERSAIAAPTG,"15,901",140,,tRNA wobble adenosine to inosine editing [GO:0002100],hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270],,,,1
O53900,O53900_MYCTU,Rv0987,Rv0987,GO:0005886; GO:0016021,IPR003838; IPR025857; ,,,DOMAIN 28 234 MacB_PCD. {ECO:0000259|Pfam:PF12704}.; DOMAIN 290 386 FtsX. {ECO:0000259|Pfam:PF02687}.; DOMAIN 755 847 FtsX. {ECO:0000259|Pfam:PF02687}.,Probable adhesion component transport transmembrane protein ABC transporter,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MNDQAPVAYAPLWRTAWRRLRQRPFQYILLVLGIALGVAMIVAIDVSSNSAQRAFDLSAAAITGKSTHRLVSGPAGVDQQLYVDLRRHGYDFSAPVIEGYVLARGLGNRAMQFMGTDPFAESAFRSPLWSNQNIAELGGFLTRPNGVVLSRQVAQKYGLAVGDRIALQVKGAPTTVTLVGLLTPADEVSNQKLSDLIIADISTAQELFHMPGRLSHIDLIIKDEATATRIQQRLPAGVRMETSDTQRDTVKQMTDAFTVNLTALSLIALLVGIFLIYNTVTFNVVQRRPFFAILRCLGVTREQLFWLIMTESLVAGLIGTGLGLLIGIWLGEGLIGLVTQTINDFYFVINVRNVSVSAESLLKGLIIGIFAAMLATLPPAIEAMRTVPASTLRRSSLESKITKLMPWLWVAWFGLGSFGVLMLWLPGNNLVVAFVGLFSVLIALALIAPPLTRFVMLRLAPGLGRLLGPIGRMAPRNIVRSLSRTSIAIAALMMAVSLMVGVSISVGSFRQTLANWLEVTLKSDVYVSPPTLTSGRPSGNLPVDAVRNISKWPGVRDAVMARYSSVFAPDWGREVELMAVSGDISDGKRPYRWIDGNKDTLWPRFLAGKGVMLSEPMVSRQHLQMPPRPITLMTDSGPQTFPVLAVFSDYTSDQGVILMDRASYRAHWQDDDVTTMFLFLASGANSGALIDQLQAAFAGREDIVIQSTHSVREASMFIFDRSFTITIALQLVATVVAFIGVLSALMSLELDRAHELGVFRAIGMTTRQLWKLMFIETGLMGGMAGLMALPTGCILAWILVRIINVRSFGWTLQMHFESAHFLRALLVAVVAALAAGMYPAWRLGRMTIRTAIREE,"93,606",855,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
O05904,O05904_MYCTU,Rv0912,Rv0912,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MTRRLRPGWLVALSAAVIAASTWMPWLTTTVGGGGWVNAIGGTHGSLELPHGFGPGQLIVLLSSTLLVVGAMAGRGLSVKLSSIAALVVSLLIVALTVWYYKLNVNPPVSAEYGLYFGAAGGVCAVGCSLWAAVSAASPGRRRHREVVR,"15,438",149,,,,integral component of membrane [GO:0016021],,,1
O06579,O06579_MYCTU,Rv1127c,ppdK Rv1127c,GO:0005524; GO:0006090; GO:0016301; GO:0050242,IPR008279; IPR036637; IPR002192; IPR010121; ,,ppdK,DOMAIN 79 259 PPDK_N. {ECO:0000259|Pfam:PF01326}.; DOMAIN 269 320 PPDK_N. {ECO:0000259|Pfam:PF01326}.; DOMAIN 389 458 PEP-utilizers. {ECO:0000259|Pfam:PF00391}.,"Probable pyruvate, phosphate dikinase PpdK","ATP binding [GO:0005524]; kinase activity [GO:0016301]; pyruvate, phosphate dikinase activity [GO:0050242]; pyruvate metabolic process [GO:0006090]",9634230; 21969609,,,MTRITRANGCPDGTLENAVVALDGGANYPREILGNKGHGIDMMRRHHLPVPPAFCITTEVGVRYLAAPGSTIAAIWDDVLDRMSWLETETSCTFGRGPNPLLVSVRSGATQSMPGMMDTILDVGMTDAVERVLARPGAADFAHDTRRRFTSMYRRIVGSAGPITDDPYAQLRASIEAVFASWNSPRAVAYRDHHGLDDQGGTAVVVQAMVFGNLTANSGAGVLSSRNPITGANEPFGEWLPGGQGDDVVSGLVAVAPITALRDQQPAVYDQLMAAARSLERMAGDVQEIEFTVEDSQLWLLQTRGAERSAQAAVRLALQLHHEGLIDDTETLRRVTPTHIETLLRPSLQTETRLAAPLLAKGLPACPGVVSGTAYTEVDEALDAADRGEPVILVRDHTRPEDVMGMLAAQGIVTEVGGAASHAAVVSRELGRVAVVGCGPGVAAALAGKEITVDGYEGEVRQGVLALSAWSESDTPELRELADIAQRISS,"52,005",490,,pyruvate metabolic process [GO:0006090],"ATP binding [GO:0005524]; kinase activity [GO:0016301]; pyruvate, phosphate dikinase activity [GO:0050242]",,,,1
O06578,O06578_MYCTU,Rv1126c,Rv1126c,GO:0005886; GO:0040007,IPR036388; IPR036390; ,,,,Conserved protein,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MSELTVLQAVRLKGRVITTDLAQTLGEDLADVAATVDRLTAAGLLVDATPLRISPSGRMRLDDLLAEERNRADSTVLAAAYRDFRSVNADFKRLVTDWQLKGEKPNTHDDAEYDAAVLSRLDGVHRRVGPIIGTVAMQLPRLSRYPVKLRAALDKVKAGDIAWLTRPLIDSYHTVWFELHEELIQAVGLTRDEAAKSGDAQ,"22,197",201,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
P96357,P96357_MYCTU,Rv1044,Rv1044,,IPR025159; ,,,,Uncharacterized protein,,9634230; 21969609,,,MCAKPYLIDTIAHMAIWDRLVEVAAEQHGYVTTRDARDIGVDPVQLRLLAGRGRLERVGRGVYRVPVLPRGEHDDLAAAVSWTLGRGVISHESALALHALADVNPSRIHLTVPRNNHPRAAGGELYRVHRRDLQAAHVTSVDGIPVTTVARTIKDCVKTGTDPYQLRAAIERAEAEGTLRRGSAAELRAALDETTAGLRARPKRASA,"22,532",207,,,,,,,1
I6Y551,I6Y551_MYCTU,Rv0913c,Rv0913c,GO:0016702; GO:0046872,IPR004294; ,,,,Dioxygenase (EC 1.13.11.-),"metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",9634230; 21969609,,,MDITIVGKYLSTLPEDDDHPYRTGPWRPQTTEWDADDLTTVTGEVPADLDGIYLRNTENPLHPAFATYHPFDGDGMIHVVGFRDGKAFYRNRFIRTDGFLAENEAGGPLWPGLAEPVQLAKREHGWGARGLMKDASSTDVIVHRGIALTSFYQCGDLYRIDPYSANTLGKESWHGRFPFDWGVSAHPKVDNKTGELLFFNYSKQEPYMRYGVVDQNNELVHYVDVPLPGPRLPHDMAFTENYVILNDFPLFWDPRLLERDVHLPRFYPEIPSRFAVVARRGNDIRWFEADPTFVLHFTNAYEQGDEIVLDGFYEGDPQPLDTGGTKWEKLFRFLALDRLQSRLHRWRLNMVTGAVHEEQLSESITEFGTINADYAASSYRYTYAATGKPSWFLFDGLVKHDLLTGNHECYSFGDGVYGSETAMAPRVGSSAEDDGYLVTLTTDMNDDASYCLVFDAARPGDGPICKLALPERISSGTHSAWVPGAELRRWDHAESPAAAVGL,"56,639",502,Carotenoid oxygenase family,,"metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",,,,1
I6XWF9,I6XWF9_MYCTU,Rv0863,Rv0863,,,,,,Uncharacterized protein,,9634230; 21969609,,,MCSVIADQRRPDQPCGVGGCKTCQNGFVADIAEGKARKTRYVDHGWPTTDPDDHAVSELVTDRTGALSPFGELTFPVPSDDLPYIHPVTVINR,"10,111",93,,,,,,,1
O06538,O06538_MYCTU,Rv1138c,Rv1138c,GO:0005618; GO:0005829; GO:0071949,IPR002938; IPR003953; IPR036188; ,,,,Possible oxidoreductase,cell wall [GO:0005618]; cytosol [GO:0005829]; FAD binding [GO:0071949],9634230; 21969609,,,MTSYDTDLLVVGGGPGGLATALHARARGLSVIVAEPRENPIDKACGEGLMPGGLAELTSLGVDPVGLPFHGIAYVGEHRRVQARFRTGPGRGVRRTTLHAALAARAKEQDTEWIRSRVATIQQDAHGVTAAGVRAKWLVAADGLHSAVRRAVGIKATAGTPRRYGVRWHYRLPVWSDFVEVHWSRWGEAYVTPVEPDLVGVAILSRQRPELAWFPSLAHHLQDASRGHARGCGPLRQVVSRRVAGRVLLVGDAAGYEDALTGEGISLAVKQAAAAVSAIVDDTPASYEAAWHRITRDYRLVTRGLVLASTPRAARRAIVPLCALLPTAFRYGVNILAY,"36,346",338,,,FAD binding [GO:0071949],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
I6Y4S9,I6Y4S9_MYCTU,Rv0776c,Rv0776c,,IPR007362; IPR008306; ,,,,Uncharacterized protein,,9634230,,,MYFVGVDLAWAGRNPTGVAAVDADGCLVGVGAARDDASVLAALRPYVVGDCLVAFDAPLVVANRTGQRPAEAALNRDFRQFEAGAYPANTEKPEFADVPRAARLARQLALDMDPLSSATRRAIEVYPHPATVALFRLPRALKYKAKPGRSVDLLKSELLRLMDGVEGLAQAGVRMQVAGQPDWVSLRRQVTVAQRKSDLRAAEDPIDAVVCAYVALYAQRRPADVTIYGDFTTGYIVTPSLPTDFRTAPDAGRRARARR,"28,037",259,,,,,,,1
O53424,O53424_MYCTU,Rv1076,lipU Rv1076,GO:0008152; GO:0016787,IPR029058; IPR013094; IPR033140; ,,lipU,DOMAIN 66 272 Abhydrolase_3. {ECO:0000259|Pfam:PF07859}.,Possible lipase LipU,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230,,,MAVRPVLAVGSYLPHAPWPWGVIDQAARVLLPASTTVRAAVSLPNASAQLVRASGVLPADGTRRAVLYLHGGAFLTCGANSHGRLVELLSKFADSPVLVVDYRLIPKHSIGMALDDCHDGYRWLRLLGYEPEQIVLAGDSAGGYLALALAQRLQEVGEEPAALVAISPLLQLAKEHKQAHPNIKTDAMFPARAFDALDALVASAAARNQVDGEPEELYEPLEHITPGLPRTLIHVSGSEVLLHDAQLAAAKLAAAGVPAEVRVWPGQVHDFQVAASMLPEAIRSLRQIGEYIREATG,"31,681",297,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,3
O06555,O06555_MYCTU,Rv1157c,Rv1157c,GO:0005199; GO:0005576,IPR003882; ,,,,"Conserved ala-, pro-rich protein",extracellular region [GO:0005576]; structural constituent of cell wall [GO:0005199],9634230; 21969609,,,MRRLTNTEHRENTTVASTWSVCKGLAAVVITSAAAFALCPNAAADPATPQPNPTQQLPGLPALAQLSPIIQQAAMNPAQATQLLMAAASAFAGNPAVPTESKNVASSVNQFVAEPTNPDSAALGVPAPHGVALPEAIPVPHVPPLGAEPGVQAHLPTGIDPSHAAGPAPAVAPTVTPPVAAPPASAPAPAPDAAQPVAVPGPPPAPPAPRAAAPAPASAAPAPAAAPAPASGFGADAPPTQDFMYPSIGPNCVADGSNSIATALSVAGPAKIPLPGPGPGQTAYVFTAVGTPGPADVQRLPLNVTWVNLTTGKSGSATLRPRSDINPDGPTTLTVIADTGSGSIMSTIFGQVTTKDRQCQFMPTIGSTVVP,"36,480",371,,,structural constituent of cell wall [GO:0005199],extracellular region [GO:0005576],,,1
O53419,O53419_MYCTU,Rv1071c,echA9 Rv1071c,GO:0003860; GO:0005829,IPR029045; IPR032259; ,,echA9,,Possible enoyl-CoA hydratase EchA9 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),cytosol [GO:0005829]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860],9634230; 21969609,,,MTGESHEVLTNVEGGVGFVTLNRPKAINSLNQTMVDLLATVLMSWEHEDAVHAVVLSGAGERGLCAGGDVVAVYHSARKDGVEARRFWRHEYLLNALIGRFAKPYVALMDGIVMGGGVGVSAHANTRVVTDTSKVAMPEVGIGFIPDVGGVYLLSRAPGALGLHAALTGAPFSGADAIALGFADHFVPHGDLDAFTQKIVTGGVESALAAHAVEPPPSTLAAQRDWIDECYAGDSVADIVAALRKQGGEPAVNASDLIASRSPIALSVTLQAVRRAAKLDTLEDVLIQDYRVSSASLRSHDLVEGIRAQLIDKDRNPNWSPATLDAITAADIEAYFEPVDDDLSF,"36,354",345,,,3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860],cytosol [GO:0005829],,,1
O53836,O53836_MYCTU,Rv0825c,Rv0825c,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; ,,,DOMAIN 20 80 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Conserved protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MQTGQNRGRWSGVPLESRHALRRDNLVAAGVQLLGGAGGPALTVRAVCRHAGLTERYFYESFADREHFVRAVYDDVCTRAMATLTSAQTPREAVEQFVELMVDDPVRGRVLLLAPAVEPALTRSGAEWMPNFIELLQRKLSRIVDPVLQKLVATSLIGALTGLFTAYLNGRLGATRKQFIDYCVNMLLSTAATYAPHRERGESEHSIPAGPHN,"23,442",213,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
O05579,O05579_MYCTU,Rv0996,Rv0996,GO:0005576; GO:0016021,,,,,Probable conserved transmembrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MPSIPQSLLWISLVVLWLFVLVPMLISKRDAVRRTSDVALATRVLNGGAGARLLKRGGPAAGHRWGYLPPEGQGDDPDWKPEEDWRDDPVEDGFADVEHDIDEDQEADDARRRGAVVMKVAAPQTAGADEPDYLDVDVVEEDSEALPVGAGAAVGESADEADAEAADGVAGHADPEADPVEYEYEYEYVEDTCGLELEEDDQEAPPTVASGTSRRRRFDTKTAAAVSARKYTFRKRALIVMAVILVGSAAAAFELTPVAWWICGSATGVTVLYLAYLRRQTRIEEKVRRRRMQRIARARLGVENTRDREYDVVPSRLRRPGAVVLEIDDEDPIFTHLESAAPIRNYGWPRDLPRAVGQ,"39,519",358,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
I6WZH9,I6WZH9_MYCTU,Rv0817c,Rv0817c,,IPR021373; ,,,,Probable conserved exported protein,,9634230; 21969609,,,MPMRKVLVGVTGAAIVVAVLIVGAVGADFGASIYAEYRLSTTVRKAANLRSDPFVAILRFPFIPQAMREHYAELEIKAFAVEHAGSGTATLEATMHSIDLSYASWLIRPDAKLPVGELESRIIIDSMHLGRYLGISDLMVAAPRQESNDATGGTTESGISGSRGLVFSGTPISANFAHRVSVLVDLSVASDDRATLVITPTAVVTGPDTADQPVPDDKRDAVLHAFASKLPNQKLPFGVVPNTVGARGSDVIIEGITRGVTISLDEFKQS,"28,568",270,,,,,,,1
P71538,P71538_MYCTU,Rv0973c,accA2 Rv0973c,GO:0005524; GO:0005886; GO:0040007; GO:0046872,IPR011761; IPR005481; IPR001882; IPR011764; IPR005482; IPR000089; IPR005479; IPR016185; IPR011054; IPR011053; ,,accA2,,Probable acetyl-/propionyl-coenzyme A carboxylase alpha chain (Alpha subunit) AccA2: biotin carboxylase + biotin carboxyl carrier protein (BCCP),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; growth [GO:0040007],9634230; 21969609,,,MGITRVLVANRGEIARRVFATCRRLGLGTVAVYTDPDAAAPHVAEADARVRLPQTTDYLNAEAIIAAAQAAGADAVHPGYGFLSENAEFAAAVQEAGLTWVGPPVDAVRAMGSKIESKKLMAAAGVPVLEELDPDAVTTAQLPVLVKASAGGGGRGMRVVHELSALPAEVEAARREAQSAFGDPTVFCERYLPTGHHVEVQVMADTHGTVWAVGERECSIQRRHQKIIEEAPSPLVERVPGMRAKLFDAARLAASAIGYTGAGTVEFLADDSPGREGEFYFLEMNTRLQVEHPVTEETTGLDLVELQLMIADCGRLDTEPPPAQGYSIEARLYAEDPAHGWQPQAGVMHTIEVPGVRAQFDSLGQRTGIRLDSGIVDGSTVSIHYDPMLAKVVSYGATRRQAALVLADALVRARLHGLRTNRELLVNVLRHPAFLDGATDTGFFDTHGMAELSTPLADTATLRLSAIAAALADAEHNRASAGVFSSIPSGWRNLASGYQVKTYRDDADTEHRVEYRFTRTGLALPGDPVVQLVSADVDQVVLAQDGVAHGFTVARHGPDVYVDSARGPVHLVALSRFPEPSSAVEQGSLVAPMPGNVIRIGAEVGDTVTAGQPLIWLEAMKMEHTIAAPADGVLTHVSVNTGQQVEVGAILARVEAPQNGPAEGDSP,"70,745",667,,growth [GO:0040007],ATP binding [GO:0005524]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,,2
I6Y8X8,I6Y8X8_MYCTU,Rv0850,Rv0850,,,,,,Putative transposase,,9634230,,,MTRDPHSPDCGREGSYRDTITRPLTDLPVAGYPLVPRVASPRYRCTTPQCGRAVFNQDLANVDQYLVVNQLAHQLIDGSSLIPDADKRWDARRHADMTHHLTSSLKENQS,"12,384",110,,,,,,,1
O53445,O53445_MYCTU,Rv1097c,Rv1097c,GO:0005618; GO:0005886; GO:0005887,,,,,Probable membrane glycine and proline rich protein,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MTVPPAGPYGNYPYGPNTYGQDPYWGGQPQGGSYPPAYPPQQYPPGWPAGPYPPGPPPPGPGSKTPWLILAGLAVLGVILLVVILVIGLRGDNKSTTATSPATSAPTSQPFSQQTATGCTPNVSGGVQPIGDSISAGKLSFPTSAAPGWSAFSDDQNPNLIDAVGVGHEVAGADQWMMQAEVAITNFVTTMDVAAQASKLMQCVADGPGYAGSSPTLGPTKTSSITVDGVRAARVDADITIADSSRNVKGDSVTIIAVDTKPVTVFLGATPIGDATSRATVERVIEALKVNKS,"29,874",293,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
I6Y8S6,I6Y8S6_MYCTU,Rv0787A,purS Rv0787A,GO:0004642; GO:0005524; GO:0005737; GO:0006189,IPR003850; IPR036604; ,,purS,,Phosphoribosylformylglycinamidine synthase subunit PurS (FGAM synthase) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase subunit III) (FGAR amidotransferase III) (FGAR-AT III) (Phosphoribosylformylglycinamidine synthase subunit III),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189],9634230; 21969609,,FUNCTION: Part of the phosphoribosylformylglycinamidine synthase complex involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate. The FGAM synthase complex is composed of three subunits. PurQ produces an ammonia molecule by converting glutamine to glutamate. PurL transfers the ammonia molecule to FGAR to form FGAM in an ATP-dependent manner. PurS interacts with PurQ and PurL and is thought to assist in the transfer of the ammonia molecule from PurQ to PurL. {ECO:0000256|HAMAP-Rule:MF_01926}.,MARVVVHVMPKAEILDPQGQAIVGALGRLGHLGISDVRQGKRFELEVDDTVDDTTLAEIAESLLANTVIEDWTISRDPQ,"8,622",79,PurS family,'de novo' IMP biosynthetic process [GO:0006189],ATP binding [GO:0005524]; phosphoribosylformylglycinamidine synthase activity [GO:0004642],cytoplasm [GO:0005737],,,1
O53432,O53432_MYCTU,Rv1084,Rv1084,GO:0003824,IPR008928; IPR012341; IPR004879; IPR024705; IPR036249; ,,,,Conserved protein,catalytic activity [GO:0003824],9634230; 21969609,,,MSPANPSGTNTLALATSPYLRQHADNPVHWQQWTPQALAEAAARAVPILLSVGYAACHWCHVMAHESFDDDEVAAAMNAGFVCIKVDREERPDIDAVYMNATVALTGQGGWPMTCFLTPNGRPFFCGTYYPKAAFLQLLSAISETWRERRAEVEQASDHIAAELRSMASGLPGGGPEVAPELCDDAVAGVLREQDTAHGGFGGAPKFPPSALLEALMRHYERTRSPAALEAVARTGNAMARGGIYDQLGGGFARYSVDGAWVVPHFEKMLYDNALLLRAYAHWARRTGDPLARRVAAQTARFLLDELGSKAPADMFTSSLDADADGREGSTYVWTPVQLTEVLGGDDGRWAAEVFGVTEAGTFEHGTSVLQLPADPDDAARLDRVRAALLVARLARAQPARDDKVVTSWNGLAITALAEASVALDDPALAHAARRCATRLLDLHVVDGRLRRASLGGVVGDSAAILEDHAMLATGLLALYQLTSEGAWLTAATGLLDTAVAHFGDPQRPGRWFDTADDAERLMLRPSDPLDGATPSGASSIAEALLTAGHVVDGARAERYWQLAADTLRAHAVLLARAPRSAGHWLAVAEAVVRGPLQIAVACDLPRSSLLADARRLAPGGAIVVGGAAGSSALLVGRDRVAGADAAYVCRGRVCDLPVTSAAELATALGVPG,"71,050",673,,,catalytic activity [GO:0003824],,,,1
I6XWA9,I6XWA9_MYCTU,Rv0790c,Rv0790c,,IPR002931; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTLANNGTGMDHFLTPTEYLDAGHPLVRTTAATLIRDAVSDTERVRRIYYYVRDVPYDVLASFRYLAQGHHRASDVIGHGVAFCMGKASSFVALCRAAGVPARIAFQTIDAPDKEFLSPQVRALWGGRTGRPFPWHSLGEAYLGRRWVKLDATIDAPTAARLGKPYRQEFDGATPIPTVEGTILRENGSYADYPSAVAQWYERIAQSVLKALQSTEVHALVAADEELWTGPPVELADATHRL,"26,684",242,,,,,,,1
P71560,P71560_MYCTU,Rv0950c,Rv0950c,,IPR011055; IPR016047; ,,,,Uncharacterized protein,,9634230,,,MAAIRTPRDRWPHHHRNEVTEIIPLDGFLDGLALYDELDFAELDDLDLGDDCVFDYEAQLLAAPELDDLDDADDLAPEWLVAPTVVLTPEVTPVSRRVGQHRKQPIGAARGRLLISAMAAGAAAAAAHTAIQQSETPRTETVLTAHASALNEGSGSNPPRGVQVIAAQPAASAAVHNAEFARGVAFAEERAEREARLQRPLYVMPTKGIFTSSFGYRWGVLHAGIDLANAIGTPIYAVSDGVVIDAGPTAGYGMWVKLLHADGTVTLYGHVNTTLVSVGERVMAGDQIATMGSRGFSTGPHLHFEVLLGGTERVDPVPWLAKRGLSVGNYTG,"35,380",332,,,,,,,1
O86346,O86346_MYCTU,Rv0939,Rv0939,GO:0005829; GO:0005886; GO:0008152; GO:0016853,IPR011234; IPR036663; IPR001279; IPR036866; ,,,,"Possible bifunctional enzyme: 2-hydroxyhepta-2,4-diene-1,7-dioate isomerase (HHDD isomerase) + cyclase/dehydrase",cytosol [GO:0005829]; plasma membrane [GO:0005886]; isomerase activity [GO:0016853]; metabolic process [GO:0008152],9634230; 21969609,,,MKWVTYRSDHGERTGVLSGDAIYAMPPDVSLLDLVGRGADGLRTAGERAVRSPAAVVALDEVTLAAPIPRPPSIRDSLCFLDHMRNCQEAMGGGRVLMDTWYRIPAFYFACPSTVLGPYDDAPTAPGSAWQDFELEIAAVIGTSGKDLTVEQAERSIIGYTIFNDWSARDLQMLEGQLRIGQAKGKDSGITLGPYLVTPDELEPYCRGGKLSLRVIALVNGTVIGSGSTAQMDWSFGEVIAYASRGVTLTPGDVFGSGTVPTCTLVEHLRPPESFPGWLHDGDVVTLQVEGLGETRQTVRTSGTPFPLALRPNPDAEPDRRGVNPAPTRVPFTRGLHEVADRVWAWTLPDGGYGFSNAGLVAGDGASLLVDTLFDLALTREMLAAMKPVTERAPITDALITHSNGDHTHGTQLLDRSVRIIAAKGTSEEIEHGPAPEMLARIQTADLGPVATRYLRDRFGHFDFSGIKLRNADLTFDRDLAIELGGRRVDLLNLGPAHTTADSVVHVADAGVLFAGDLLFIGCTPIVWAGPIANWVAACDAMIALDAPTVVPGHGPVTGPDGIRAVRGYLAHIAEQAEAAYRKGLSLPEAVETIDLGEYASWLDSERVVVNVYQRYRELDPDTPRQDLLALLVMQAEWAARHCT,"69,354",644,,metabolic process [GO:0008152],isomerase activity [GO:0016853],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q79FV7,Q79FV7_MYCTU,Rv0833,PE_PGRS13 Rv0833,,,,PE_PGRS13,,PE-PGRS family protein PE_PGRS13,,9634230,,,MIGNGGAGGSGAPGAIGGAGGPAGLIGVGGAGGAGGDSAVAGVIGGAGGAGGAALLFGAGGAGGAGGSGGSGAAGGAGGAGGAGGLFASGGSGGFGGFASTGTGGAGGTGGAGGLFASGGVGGTGGGAGSGGTGGVGGTGGAGGLFASGGAGGAGGSGGTGGAGGTGGAGGLFGAGGAGGLGGQGNHTGGHGGAGGSAGLLALGDGGAGGAGGAATTGTGGAGGAGGKAGLLFGSGGAGGSGGAAGTFGDTGNSGGAGGAGGKAGLLFGSGGAGGSGGAGGFANGSTGGAGGAGGGAGLIGNGGNGGSGGTSVATGGAGNGGAGGAGGGAGLIGNGGNGGSGGMGDAPGGTGVGGIGGLLLGLDGANAPASTNPLHTAQQQALAAVNAPIQAVTGRPLIGNGANGAPGSGAPGGHGGWLFGGGGTGGSGVSGGAGGDGGAGGILFGAGGAGGAGGAVTGTGATGGSGGAGGGALLFGAGGAGGAGGSSGIGGFAAGGAGGPGGAGGLFNGGGAGGAGGSGVSGGAGGEGGAGGAGGLFAGGGAGGAGGSGNNVGGAGGAGGVGGLFGAGGAGGSGGGGSVAGDSGAGGNAGLLAPGLAGGAGGGGGQGFDTGGAGGPGGDAGLLVGSGGVGGAGGFGLTTGGPGAAGGDAGLLFGSGGAGGAGGSGRTDLGGAGGAGGKAGLIGNGGNGGAGGAGGNGGGDGGPGGAAFGLGNGGNGGNGGTGTSAGSPGAGGAGGSLIGAEGLPGLLP,"57,447",749,,,,,,,1
O53897,O53897_MYCTU,Rv0984,moaB2 Rv0984,GO:0005886,IPR036425; IPR001453; ,,moaB2,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MKVAAQCSKLGYTVAPMEQRAELVVGRALVVVVDDRTAHGDEDHSGPLVTELLTEAGFVVDGVVAVSADEVEIRNALNTAVIGGVDLVVSVGGTGVTPRDVTPEATRDILDREILGIAEAIRASGLSAGIVDAGLSRGLAGVSGSTLVVNLAGSRYAVRDGMATLNPLAAQIIGQLSSLEI,"18,441",181,,,,plasma membrane [GO:0005886],,,3
P71835,P71835_MYCTU,Rv0781,ptrBa Rv0781,GO:0004252; GO:0040007; GO:0070008,IPR029058; IPR023302; ,,ptrBa,,Probable protease II PtrBa [first part] (Oligopeptidase B),serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; growth [GO:0040007],9634230,,,MMHRTALPSPPVAKRVQTRREHHGDVFVDPYEWLRDKDSPEVIAYLEAENDYTERTTAHLEPLRQKIFHEIKARTKETDLSVPTRRGNWWYYARTFEGKQYGVHCRCPVTDPDDWNPPEFDERTEIPGEQLLLDENVEADGHDFFALGAASVSLDDNLLAYSVDVVGDERYTLRFKDLRTGEQYPDEIAGIGAGVTWAADNHCLLHHRGRGLASGHSVAIPTRVRRIVGAGLPRSR,"26,916",236,,growth [GO:0040007],serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],,,,3
Q79FS6,Q79FS6_MYCTU,Rv1089A,celA2a Rv1089A,,,,celA2a,,"Probable cellulase CelA2a (Endo-1,4-beta-glucanase) (Endoglucanase) (Carboxymethyl cellulase)",,9634230,,,MNGAAPTNGAPLSYPSICEGVHWGHLVGGHQPAY,"3,490",34,,,,,,,1
O06575,O06575_MYCTU,Rv1123c,bpoB Rv1123c,GO:0004601,IPR029058; IPR000073; ,,bpoB,DOMAIN 50 150 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Possible peroxidase BpoB (Non-haem peroxidase),peroxidase activity [GO:0004601],9634230,,,MTIWRVPSKVTSGPVSAVSSSPQAVAFSGARGITLVADEWNRGAAAADRPTILMLHGGGQNRFSWKNTGQILADEGHHVVALDTRGPGDSDRAPGADYAVETPTTDVLHVVEAIGRRVVVVEASMGGLTGILVAERAGPQTVNGLVLVDVVPRYEKEGNARIRDFMLGNIDGFGSLEEAADAVAEYLPHRDKPRSPEGLKRNLRLRDGRWHWHWDPAMMTAPGHDPQLRTENFERAAMGLTIPVLLIRGKLSDVVSSDGARDFLAKVPNAEFVELSNAGRTAAGDDNDAFTDVVVDFVRRLS,"32,544",302,,,peroxidase activity [GO:0004601],,,,3
P71834,P71834_MYCTU,Rv0782,ptrBb Rv0782,GO:0004252; GO:0070008,IPR029058; IPR023302; IPR001375; IPR002470; ,,ptrBb,DOMAIN 35 261 Peptidase_S9_N. {ECO:0000259|Pfam:PF02897}.; DOMAIN 317 533 Peptidase_S9. {ECO:0000259|Pfam:PF00326}.,Probable protease II PtrBb [second part] (Oligopeptidase B),serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],9634230,,,MTNDIPCGSRIYAPENSTRTRSPGSERESPGQLTTTVYYTTVDAAWRPDTVWRYRLGSGESSERVYHEADDRFWLAVGRTRSNAYLLIAAGSSITSEVRYAHAADPTAQFSVVLPRRDGVEYSVEHAVIAGQDRFLILHNDGAVNFTLVEAPVEDPARQRTLIAHRDDVRLDAVDALAGHLVVSYRREALPRVQLWPIGPDGNYGEPEEISFDSELMSAGLGPNPNWDSPKLRVGAGSFVTPVRIYDIDLVTGERTLLKEQPVLGGYRREDYVERRDWAYGDDGTRIPVSIVHRADIEFPAPALIYGYGAYEICEDPRFSIARLSLLDRGMVFVVAHVRGGGEMGRLWYENGKLLDKKNTFTDFIAVARHLVDTGLTSQQQLVALGGSAGGLLMGAVANMAPDLFAGILAQVPFVDPLTTILDPSLPLTVTEWDEWGNPLNDSDVYAYVKSYSPYENVTAQKYPAILAMTSLNDTRVYYVEPAKWVAALRHAKTDGNSVLLKTQMHAGHGGISGRYERWKETAFQYGWLLATADSDRYGGGQGNDLDGAAPA,"60,896",552,,,serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],,,,2
O06546,O06546_MYCTU,Rv1146,mmpL13b Rv1146,GO:0016021; GO:0052556,IPR004869; ,,mmpL13b,DOMAIN 203 422 MMPL. {ECO:0000259|Pfam:PF03176}.,Probable conserved transmembrane transport protein MmpL13b,integral component of membrane [GO:0016021]; positive regulation by symbiont of host immune response [GO:0052556],9634230,,,MATVAFVATASIVITPAAIVLLGPRLDALDVRRLVRRLLGRPDPVHKPVKQLFWYRSSKFVMRRWLPVGTAVVALLVLLGLPFLSVKWGFPDDRVLPRSASARQVGDILRDDFGHDPATQIPIVVPDARGLGPVELDSYAAELSRVPDVSAVAAPTGTFVDGSWVGTPRGATGLAEGSAFLTVSSTAPLFSRASDIQLKRLHQVAGPAGRSVVMAGVAQVNRDSVDAVTDRLPMVLGLIAAITYVLLFLLTGSVVLPAKALVCNVLSLTAAFGALVWIFQEGHFGALGTTPSGTLVANMPVLLFCIAFGLSMDYEVFLVSRIREYWLESGAARPARRSVAEVHAANDESVALGVARTGRVITAAALVMSMSFAALIAAHVSFMRMFGLGLTLAVAADATLVRMVVVPAFMHVTGRWNWWAPRPLAWLHERFGVSEAAEPVSRRRSHAGGLGKIAGRSDGQTIPASLTRNG,"50,059",470,,positive regulation by symbiont of host immune response [GO:0052556],,integral component of membrane [GO:0016021],,,1
O53848,O53848_MYCTU,Rv0836c,Rv0836c,,IPR014513; ,,,,Uncharacterized protein,,9634230,,,MLVGAQCRDLLHWRFCRGVPPRATNDTDIAGTLNNWDHFEAIRATFRALGSTGHRFLIADRAVDALPFGEVESPTGTTRHPPGNQLMNVHGCTDAYLRADVLPLPGGLTVHLPQPPNYAVLKLHAWLDRSADHDYKDGPDLALVVHWYAGDLDRLYAKPDQWALRRHDFDLRTAAAALLGHDMRASVSAPEAAVLATRATQADHDLLAQHFAVGRPG,"23,870",217,,,,,,,3
P71837,P71837_MYCTU,Rv0784,Rv0784,GO:0003824; GO:0005975,IPR018763; IPR011330; ,,,,Uncharacterized protein,catalytic activity [GO:0003824]; carbohydrate metabolic process [GO:0005975],9634230,,,MSVSGIGESTLADVDAFCAEMDARSVPVSLLVAPRMRDDYRLDRDPRTVDWLTGRRAAGDALVLHGYDEAATKRRRGEFAMLRAHEANLRLMAADRVLEHLGLRTRLFAAPGWLVSPGVRTALPANGFRLLADLHGITDLVRLTTVRARVLGIGEGFLAEPWWCRMVVMSAERIARRGGVVRIAVAARHLRKSGPLQAMLDAVDLAMLQGCTPMVYRWRADAAVLDAA,"25,052",228,,carbohydrate metabolic process [GO:0005975],catalytic activity [GO:0003824],,,,2
I6WZI4,I6WZI4_MYCTU,Rv0822c,Rv0822c,,IPR027381; IPR004474; ,,,,Conserved protein,,9634230; 21969609,,,MSDGESAAPWARLSESAFPDGVDRWITVPPATWVAAQGPRDTQNVGCHATGAVSVADLIARLGPAFPDLPTHRHVAPEPEPSGRGPKVHDDADDQQDTEAIAIPAHSLEFLSELPDLRAANYPRADHARREPELPGKQLTGSARVRPLRIRRTSPAPAKPAPNSGRRPMVLAARSLAALFAALALALTGGAWQWSASKNSRLNMVSALDPHSGDIVNPSGQHGDENFLLVGMDSRAGANANIGAGDAEDAGGARSDTVMLVNIPASRERVVAVSFPRDLAITPIQCEAWNPETGKYGPIYDEKTGTMGPRLVYTETKLNSAFSFGGPKCLVKVIQKLSGLSINRFIAIDFVGFARMVEALGGVEVCSTTPLRDYELGTVLEHAGRQVIDGPTALNYVRARQVTTESNGDYGRIKRQQLFLSSLLRSMISTDTLFNLSRLNNVVNMFIGNSYVDNVKTKDLVELGRSLQHMAAGHVTFVTVPTGITDQNGDEPPRTSDMKALFTAIIDDDPLPLENDHNAQRLGNTPSTPPTTTKKAPQAGLTNEIQHQQVTTTSPKEVTVQVSNSTGQAGLATTATDQLKRNGFNVMAPDDYPSSLLATTVFFSPGNEQAAATVAAVFGQSKIERVTGIGQLVQVVLGQDFSAVRAPLPSGSTVSVQISRNSSSPPTKLPEDLTVTNAADTTCE,"72,905",684,,,,,,,1
O53403,O53403_MYCTU,Rv1055,Rv1055,,,,,,Possible integrase,,9634230,,,MTLDRHGHLLNDDLAVWPMRCAKSSRTLRYHCGMRRRNRVGLRA,"5,221",44,,,,,,,2
O06571,O06571_MYCTU,Rv1119c,Rv1119c,,IPR029787; ,,,,Uncharacterized protein,,9634230,,,MTARVAGQAVGGQILVGEPVHDAVSDCADIRFGSYRLFSLDAAPGPDLD,"5,060",49,,,,,,,3
I6X9V3,I6X9V3_MYCTU,Rv0811c,Rv0811c,GO:0016740,IPR028896; IPR013977; IPR006222; IPR027266; IPR017703; ,,,,Conserved protein,transferase activity [GO:0016740],9634230; 21969609,,,MAAVPAPDPGPDAGAIWHYGDPLGEQRAGQADAVLVDRSHRAVLTLDGGDRQTWLHSISTQHVSDLPEGASTQNLSLDGQGRVEDHWIQTELGGTTYLDTEPWRGEPLLAYLRKMVFWSMVTPRAADMAVLSLLGPRLAEERVLDALGLDVLPAEWLAVPLAGGGIVRRMPDGLAGQIELDVVVKRGDRADWQRRLTQAGVRPAGIWAYEAHRVAHRVPARRPRLGVDTDERTIPHEVGWIGGPGAGAVHLNKGCYRGQETVARVHNLGRPPRMLVLLHLDESVQRPSTGDAVLAGGRTVGRLGTVVEHVELGPVALALLKRGLPGDTALVTGPEAEVAAVIDVDSLPPADDVGAGRRAVERLRGGIR,"39,447",368,GcvT family,,transferase activity [GO:0016740],,,,1
O53421,O53421_MYCTU,Rv1073,Rv1073,GO:0005618; GO:0005886,,,,,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230,,,MGAQPFIGSEALAAGLISWHELGKYYTAIMPNVYLDKRLKPSLRQRVIAAWLWSGRKGVIAGASASALHGAKWVDDHALVELIWRNARAPNGVRTKDELLLDGEVQRLCGLTVTTVERTAFDLGRRPPLGQAITRLDALANATDFKINDVRELARKHPHTRGLRQLDKALDLVDPGAQSPKETWLRLLLINAGFPRPSTQIPLLGVYGHPKYFLDMGWEDIMLAVEYDGEQHRLSRDQFVKDVERLEYIRRAGWTHIRVLADHKGPDVVRRVRQAWDTLTSRR,"32,043",283,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
O06567,O06567_MYCTU,Rv1115,Rv1115,GO:0016021,,,,,Possible exported protein,integral component of membrane [GO:0016021],9634230,,,MISTTRIDFLWILSVAFASMIALATLLTLINQVVGTPYIPGGDSPAGTDCSELASWVSNAATARPVFGDRFNTGNEEAALAARGFQQGTAPNALVIGWNGHHTAVTLPDGTPVSSGEGGGVRVGGGGAYQPKFTHHMYLPMDVDAGEDQPPAPDEPVTAVDDVEPEMPAPCPTQRPPVTPRHNLCNKLRTMPGALSAALAAAAPVWPAPISGCRGFSTSLLAKRNHPVIVGK,"24,082",232,,,,integral component of membrane [GO:0016021],,,1
O53404,O53404_MYCTU,Rv1056,Rv1056,GO:0005886,IPR007361; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MSVDYPQMAATRGRIEPAPRRVRGYLGHVLVFDTSAARYVWEVPYYPQYYIPLADVRMEFLRDENHPQRVQLGPSRLHSLVSAGQTHRSAARVFDVDGDSPVAGTVRFNWDPLRWFEEDEPIYGHPRNPYQRADALRSHRHVRVELDGIVLADTRSPVLLFETGIPTRYYIDPADIAFEHLEPTSTQTLCPYKGTTSGYWSVRVGDAVHRDLAWTYHYPLPAVAPIAGLVAFYNEKVDLTVDGVALPRPHTQFS,"28,946",254,,,,plasma membrane [GO:0005886],,,1
I6Y4U4,I6Y4U4_MYCTU,Rv0794c,Rv0794c,GO:0005623; GO:0009055; GO:0045454; GO:0050660,IPR036188; IPR023753; IPR016156; IPR001100; IPR004099; ,,,,Probable oxidoreductase,cell [GO:0005623]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454],9634230; 21969609,,,MTAAQQDQAPMATPGCREGETYDVVVLGAGPVGQNVADRARAGGLRVAVVERELVGGECSYWACVPSKALLRPVIAISDARRVDGAREAVDGSINTAGVFGRRNRYVAHWDDTGQADWVSGIGATLIRGDGRLDGPRRVVVTKSSGESVALTARHAVVICTGSRPALPDLPGITEARPWTNRQATDNSTVPDRLAIVGAGGVGVEMATAWQGLGASVTLLARGSGLLPRMEPFVGELIGRGLADAGVDVRVGVSVRALGRPNPTGPVVLELDDGTELRVDEVLFATGRAPRTDDIGLETIGLTPGSWLDVDDTCRVRAVDDGWLYAAGDVNHRALLTHQGKYQARIAGTAIGARAAGRPLDTTSWGMHATTADHHAVPQAFFTDPEAAAVGLTADQAAQAGHRIKAIDVEIGDVVMGAKLFADGYTGRARMVVDVDRGHLLGVTMVGPGAAELLHSATVAVAGQVPIDRLWHAVPCFPTISELWLRLLESYRDSFYLLV,"52,476",499,,cell redox homeostasis [GO:0045454],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660],cell [GO:0005623],,,1
O53406,O53406_MYCTU,Rv1058,fadD14 Rv1058,GO:0005886; GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD14,,Probable medium chain fatty-acid-CoA ligase FadD14 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),plasma membrane [GO:0005886]; ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MYGTMQDFPLTITAIMRHGCGVHGRRTVTTATGEGYRHSSYRDVGQRAGQLANALRRLGVTGDQRVATFMWNNTEHLVTYFAVPSMGAVLHTLNIRLFPEQIAYVTNEAEDRVILVDLSLARLLAPVLPKLDTVHTVIAVGEGDTTPLREAGKTVLRFAELIDAESPDFGWPQIDENSAAAMCYTSGTTGNPKGVVYSHRSSFLHTMAACTTNGIGVGSSDKVLPIVPMFHANGWGLPYAALMAGADLVLPDRHLDARSLIHMVETLKPTLAGAVPTIWNDVMHYLEKDPDHDMSSLRLVACGGSAVPESLMRTFEDKHDVQIRQLWGMTETSPLATMAWPPPGTPDDQHWAFRITQGQPVCGVETRIVDDDGQVLPNDGNAVGEVEVRGPWIAGSYYGGRDESKFDSGWLRTGDVGRIDEQGFITLTDRAKDVIKSGGEWISSVELENCLIAHPDVLEAAVVGVPDERWQERPLAVVVVREGATVSAGDLRAFLADKVVRWWLPERWAFVDEIPRTSVGKYDKKAIRSRYAEGAYQITEVHT,"59,625",543,,metabolic process [GO:0008152],ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
O06541,O06541_MYCTU,Rv1141c,echA11 Rv1141c,GO:0003824; GO:0008152,IPR029045; IPR001753; IPR014748; ,,echA11,,Probable enoyl-CoA hydratase EchA11 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MPDSGIAALTPVTGLNVTLTDRVLSVRINRPSSLNSLTVPILTGIADTLERAAADPVVKVVRLGGVGRGFSSGVSMSVDDVWGGGPPTAIVEEANRAVRAVAALPHPVVAVVQGPAVGVAVSLALACDFILASDSAFFMLANTKVALMPDGGASALVAAATGRIRAMRLALLAEQLPAREALAWGLISAVYPDSDFEAEVDKVISRLLAGPALAFAQAKNAINAAALTELEPTFARELDGQEVLLRTHDFAEGAAAFLQRRTPNFTGS,"27,616",268,,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
I6X9T8,I6X9T8_MYCTU,Rv0791c,Rv0791c,GO:0016705,IPR019921; IPR011251; IPR036661; ,,,,Conserved protein,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MNAKDDPHFGLMLAATVNGLAVGSYREMVVVSQTAEEYGFDSVWLCDHFLTISPGEYAKVAGIAADTGSATGTETGGAGQCAPSRSLPLLECWTALAALSRDTTKLRLGTSVLCNSYRHPSVLAKMAATLDVISQGRLDLGLGAGWFRRESQAYGIPFPPVGDRVSALAESLQVIKAVWTEPNPTYAGRFYTLDGATCDPPPVQRPHPPLWIGGEGDRVQRIAAKHAQGLNVRWWSPQQVTQRRGFLTQASEAAGRDPDTLRLSVTLLLAPTQSGEEEVRIREEFASIPEPGLIVGTPDRCVERIREYQDRGVGHFLFTIPHVVKSDYLHIIGSDIIPRVKTEVTIP,"37,715",347,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
O53402,O53402_MYCTU,Rv1054,Rv1054,GO:0003677,IPR011010; IPR014417; ,,,,Probable integrase,DNA binding [GO:0003677],9634230,,,MTGKGIVESTTKTKRDRHVPVPEPVWRRLHAELPTDPNALVFPGRKGGFLPLGEYRWAFDNAGDQVGIEGWYRTVWGTPRPRWRSAQALTSRSCNGSLDTQQRR,"11,830",104,,,DNA binding [GO:0003677],,,,2
P96358,P96358_MYCTU,Rv1043c,Rv1043c,,IPR009003; ,,,,Uncharacterized protein,,9634230,,,MCAHQFFGLVHNPVVAAAIGKPEPPPVDSDIGLPTTVPFEPWSVADFSRYLSTLGLPAAGDAVTLHRILSSMERAGLLLPLGWDPRLPVMGQKYISQGAISKGQRGGNLWLSEVFGAELIIPSYNAVTVQLAGHDDAGNPVDSWGTGLVVDHNHVITNKHVVTGLAGTSAGLSVYPSSNHAEAELVNFSGTAHPHPTLDVAVIKFEMPEGKYIPRLGGMAFRDPDWADEVYVFGYPRVPMTAEMAITVQRGEVVNPAATTIPGRQKIFLYSAIARPGNSGGPIVAQDGRVIGLVVEDSAEAPSTGTGPNAAPFYRGIPSSEVIRALDELDFGGIVEMDTLP,"36,089",341,,,,,,,1
O05910,O05910_MYCTU,Rv0918,Rv0918,GO:0006355; GO:0052572,IPR010985; IPR016547; IPR014795; ,,,,Conserved protein,"regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]",9634230,,,MHRAGAAVTANVWCRAGGIRMAPRPVIPVATQQRLRRQADRQSLGSSGLPALNCTPIRHTIDVMATKPERKTERLAARLTPEQDALIRRAAEAEGTDLTNFTVTAALAHARDVLADRRLFVLTDAAWTEFLAALDRPVSHKPRLEKLFAARSIFDTEG,"17,388",158,,"regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]",,,,,3
O05597,O05597_MYCTU,Rv1012,Rv1012,,,,,,Uncharacterized protein,,9634230,,,MPRAARGIRACRGRWVDRLAHQHASGRAAGIRPREVGGAHQSQAQKPYHDATEPLGESLRYRPAHGDSCINGHRDNPSARESSQFTAGSTAKAVTKL,"10,509",97,,,,,,,1
O53842,O53842_MYCTU,Rv0831c,Rv0831c,GO:0005618; GO:0005829; GO:0005886,IPR026349; ,,,,Conserved protein,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MLPETNQDEVQPNAPVALVTVEIRHPTTDSLTESANRELKHLLINDLPIERQAQDVSWGMTAPGGAPTPVADRFVRYVNRDNTTAASLKNQAIVVETTAYRSFEAFTDVVMRVVDARAQVSSIVGLERIGLRFVLEIRVPAGVDGRITWSNWIDEQLLGPQRFTPGGLVLTEWQGAAVYRELQPGKSLIVRYGPGMGQALDPNYHLRRITPAQTGPFFLLDIDSFWTPSGGSIPEYNRDALVSTFQDLYGPAQVVFQEMITSRLKDELLRQ,"30,189",271,,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
I6X9X6,I6X9X6_MYCTU,Rv0839,Rv0839,,IPR025714; IPR029063; ,,,,Uncharacterized protein,,9634230; 21969609,,,MNDKRRAIYTHGYHESVLRSHRRRTAENSAGYLLPYLVPGLSVLDVGCGPGTITVDLAARVVPGSVTGVEPTDDALSLARAEAQLHRLSNISFTTSDVHKLDFPDDAFDVVHAHQVLQHVADPVRALQEMRRVCTPGGIVAARDADYSGFIWFPKLPALDRWLDLYERAARANGGEPDAGRRLLSWARAAGFDDVTPTASVWCFATASAREWWGLVWADRILQSDLAHQLVDSGLATAAQLEEISTAWREWAAAPDGWLAIPHGEILCRA,"29,640",270,,,,,,,1
I6XWA1,I6XWA1_MYCTU,Rv0777,purB Rv0777,GO:0004018; GO:0006189; GO:0044208; GO:0070626,IPR019468; IPR020557; IPR000362; IPR022761; IPR008948; IPR004769; ,,purB,,Adenylosuccinate lyase (ASL) (EC 4.3.2.2) (Adenylosuccinase),"(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]",9634230; 21969609,,,MSIPNVLATRYASAEMVAIWSPEAKVVSERRLWLAVLRAQAELGVAVADSVLADYERVVDDVDLASISARERVLRHDVKARIEEFNALAGHEHVHKGMTSRDLTENVEQLQIRRSLEVIFAHGVAAVARLAERAVSYRDLIMAGRSHNVAAQATTLGKRFASAAQEMMIALRRLRELIDRYPLRGIKGPMGTGQDMLDLLGGDRAALADLERRVADFLGFATVFNSVGQVYPRSLDHDVVSALVQLGAGPSSLAHTIRLMAGHELATEGFAPGQVGSSAMPHKMNTRSCERVNGLQVVLRGYASMVAELAGAQWNEGDVFCSVVRRVALPDSFFAVDGQIETFLTVLDEFGAYPAVIGRELDRYLPFLATTKVLMAAVRAGMGRESAHRLISEHAVATALAMREHGAEPDLLDRLAADPRLTLGRDALEAALADKKAFAGAAGDQVDDVVAMVDALVSRYPDAAKYTPGAIL,"51,040",472,"Lyase 1 family, Adenylosuccinate lyase subfamily",'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189],"(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]",,,,1
Q79FW0,Q79FW0_MYCTU,Rv0812,Rv0812,GO:0005886; GO:0008483; GO:0008696; GO:0030170; GO:0046656,IPR017824; IPR001544; IPR036038; ,,,,Probable amino acid aminotransferase,plasma membrane [GO:0005886]; 4-amino-4-deoxychorismate lyase activity [GO:0008696]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; folic acid biosynthetic process [GO:0046656],9634230; 21969609,,,MVVTLDGEILQPGMPLLHADDLAAVRGDGVFETLLVRDGRACLVEAHLQRLTQSARLMDLPEPDLPRWRRAVEVATQRWVASTADEGALRLIYSRGREGGSAPTAYVMVSPVPARVIGARRDGVSAITLDRGLPADGGDAMPWLIASAKTLSYAVNMAVLRHAARQGAGDVIFVSTDGYVLEGPRSTVVIATDGDQGGGNPCLLTPPPWYPILRGTTQQALFEVARAKGYDCDYRALRVADLFDSQGIWLVSSMTLAARVHTLDGRRLPRTPIAEVFAELVDAAIVSDR,"31,123",289,,folic acid biosynthetic process [GO:0046656],4-amino-4-deoxychorismate lyase activity [GO:0008696]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],plasma membrane [GO:0005886],,,1
I6Y4U9,I6Y4U9_MYCTU,Rv0799c,Rv0799c,GO:0004601; GO:0020037,IPR011008; IPR006314; ,,,,Conserved protein,heme binding [GO:0020037]; peroxidase activity [GO:0004601],9634230; 21969609,,,MAVPAVSPQPILAPLTPAAIFLVATIGADGEATVHDALSKISGLVRAIGFRDPTKHLSVVVSIGSDAWDRLFAGPRPTELHPFVELTGPRHTAPATPGDLLFHIRAETMDVCFELAGRILKSMGDAVTVVDEVHGFRFFDNRDLLGFVDGTENPSGPIAIKATTIGDEDRNFAGSCYVHVQKYVHDMASWESLSVTEQERVIGRTKLDDIELDDNAKPANSHVALNVITDDDGTERKIVRHNMPFGEVGKGEYGTYFIGYSRTPTVTEQMLRNMFLGDPAGNTDRVLDFSTAVTGGLFFSPTIDFLDHPPPLPQAATPTLAAGSLSIGSLKGSPR,"36,048",335,,,heme binding [GO:0020037]; peroxidase activity [GO:0004601],,,,1
O06577,O06577_MYCTU,Rv1125,Rv1125,GO:0004144; GO:0005886,IPR009721; ,,,DOMAIN 270 413 DUF1298. {ECO:0000259|Pfam:PF06974}.,Uncharacterized protein,plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144],9634230; 21969609,,,MAGHRMAAVDAQFYWMSAKVPNDQFLLYAFDGEPTDLERAVAQVYRRARGCPGLGMRVQDRGALAYPQWVPTPVQRDQLVCHDLADRSWQGCLAAVVGLASKQLDMRRMPWRLHVFTPVHDVPGVSGLGTVAVMQFAHALGDGARASAMAAWLFGRPAAVPEIARSRAGFLPWRAAHAARAHLRLVRDTNAGLVAPGVGSRPPLSTNARPEGVRAVRTLLRRRSQLAGPTVTVTVLAAVSTGLLGLLGGDVDTLGAEVPMAKPGVPRSYNHFGNVVVGLYPRLEPDERVRRIATDLANARRRFEHPAMLSADRAFAAVPAALLRWGVSQFDAEVRPVRVAGNTVVSSVYRGAADLSFGDAPVVLTAGYPALSPAMGLTHGVHGIGDTVAISVHAAESAVSDIDAYMRLLDAALQ,"44,238",414,,,diacylglycerol O-acyltransferase activity [GO:0004144],plasma membrane [GO:0005886],,,1
I6WZS4,I6WZS4_MYCTU,Rv0921,Rv0921,GO:0000150; GO:0003677,IPR006119; IPR036162; ,,,,Possible resolvase,DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230,,,MNLADWAESVGVNRHTAYRWFREGTLPVPAERVGRLILVKTAASASAAAAGVVLYARVSSHDRRSDLDRQVARLTAWATERDLGVGQVVCEVGSGLNGKRPKLRRILSDPDARVIVVEHRDRLARFGVEHLEAALSAQGRRIVVADPGETTDDLVCDMIEVLTGMCARLYGRRGARNRAMRAVTEAKREPGAG,"21,080",193,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],,,,1
O53837,O53837_MYCTU,Rv0826,Rv0826,GO:0005886,IPR018713; ,,,DOMAIN 59 294 DUF2236. {ECO:0000259|Pfam:PF09995}.,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MTQDTSATCPLTSTVQDSSPVAGQLGRPIGFRGLAGGCPVSPLGYESPPLPLGPDSLTWRYFGDWRGMLQGPWAGSMQNMHPQLGAAVEDHSTFFRERWPRLLRSLYPIGGVVFDGDRAPVTGVQVRDYHITIKGVDGAGRRYHALNPDVFYWAHATFFVGTLHVAERFCGGLTEAQRRQLFDEHVQWYRMYGMSMRPVPATWEEFQDYWDHMCRNVLENNFAARAVLDLTELPKPPFAQRVPDWLWAAPRKLLARFFVWLTVGLYDPPVRELMGYRWLRRDEWLHRRFGDIVRLVFALVPFRFRKHPRARAGWDRATGRIPADAPLVQTPARNLPPPDERDNPTHYCPKV,"40,281",351,,,,plasma membrane [GO:0005886],,,3
O05582,O05582_MYCTU,Rv0999,Rv0999,GO:0005576; GO:0005886,,,,,Uncharacterized protein,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MRPPLAPQFAADLLVKTVSTLRSSGAALGRLTTMRKAVLAVGSVCWLVGCSSGASSTTASTGDIAKVAEVKSGFGPEYTVTDVTPRAIDPGFFSARKLPDGLSFDPANCAQVAAGPQLPTGLQGNMAAVSAEGNGNRFVVIAVETSQPLPAPSPGKDCSKVTFSGTQLRGGIEVVDVPHIDGTQTLGVHRVLQAVVGGSARTGELYDYSARFGDYQVIVIANPLVIPGRPVARVDTQRARDLLVQAVAAVRG,"25,970",252,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O06561,O06561_MYCTU,Rv1163,narJ Rv1163,GO:0005886; GO:0051082; GO:0051131,IPR020945; IPR003765; IPR036411; ,,narJ,,Probable respiratory nitrate reductase (Delta chain) NarJ,plasma membrane [GO:0005886]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131],9634230; 21969609,,,MWQSASLLLAYPDDGLAERLHMVDALRAHQTGPAAALLGRTVAELRALAPMAAAAQYVETFDMRRRSTMYLTYWTAGDTRNRGREMLAFATAYRDAGVKPPRTEAPDYLPVVLEFAATVDPEAGRRLLTEHRVPIDVLRGALADAKSPYEYTVAAICETLPAATNQEVRRAQRLAQSGPPAEAVGLQPFTLTVPPKRAEGA,"21,918",201,,chaperone-mediated protein complex assembly [GO:0051131],unfolded protein binding [GO:0051082],plasma membrane [GO:0005886],,,3
O53459,O53459_MYCTU,Rv1112,ychF Rv1112,GO:0005524; GO:0005525; GO:0005737; GO:0005886; GO:0016887; GO:0043022; GO:0043023,IPR004396; IPR012675; IPR031167; IPR006073; IPR027417; IPR012676; IPR023192; IPR013029; ,,ychF,DOMAIN 3 250 OBG-type G. {ECO:0000259|PROSITE:PS51710}.,Ribosome-binding ATPase YchF,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; GTP binding [GO:0005525]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022],9634230; 21969609,,FUNCTION: ATPase that binds to both the 70S ribosome and the 50S ribosomal subunit in a nucleotide-independent manner. {ECO:0000256|HAMAP-Rule:MF_00944}.,MSLSLGIVGLPNVGKSTLFNALTRNNVVAANYPFATIEPNEGVVSLPDPRLDKLAELFGSQRVVPAPVTFVDIAGLVKGASEGAGLGNKFLAHIRECDAICQVVRVFVDDDVTHVTGRVDPQSDIEVVETELILADLQTLERATGRLEKEARTNKARKPVYDAALRAQQVLDAGKTLFAAGVDAAALRELNLLTTKPFLYVFNADEAVLTDPARVGELRALVAPADAVFLDAAIESELTELDDESAAELLESIGQSERGLDALARAGFHTLKLQTFLTAGPKEARAWTIHQGDTAPKAAGVIHSDFEKGFIKAEIVSYDDLVAAGSMAAAKAAGKVRIEGKDYVMADGDVVEFRFNV,"38,097",357,"TRAFAC class OBG-HflX-like GTPase superfamily, OBG GTPase family, YchF/OLA1 subfamily",,ATPase activity [GO:0016887]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,2
O53407,O53407_MYCTU,Rv1059,Rv1059,GO:0008839; GO:0009089,IPR000846; IPR036291; ,,,DOMAIN 11 97 DapB_N. {ECO:0000259|Pfam:PF01113}.,Conserved protein,4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839]; lysine biosynthetic process via diaminopimelate [GO:0009089],9634230; 21969609,,,MTMSLRVIQWATGSVGVAAIKGVLQHPELELVGCWVHSAAKSGKDVGEIIGSPPLGVIATNSIDDVLALDADAVIYAPLLPSVDEVAALLRSGKNVVTPLGWFYPSEKEAAPLEVAAQAGNATLHGAGIGPGAVTELFPLLLSVMSTGVTFVRSEEFSDLRSYGAPDVLRYVMGFGGTPDSALTGPMQKILDGGFLQSVRLCVDRLGFAADPQIRTSQEVAVATAPIDSPIGVIEPGQVAGRRFHWEALVEDTVVVQIAVNWLMGSENLDPPWSFGPAGERYEIEVRGSPDTCVTIKGWQPQTVAAGLKSNPGIVATAAHCVNAIPATCAAPAGIQSFFDLPLITGRAAPGLAR,"36,910",354,,lysine biosynthetic process via diaminopimelate [GO:0009089],4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839],,,,3
O53830,O53830_MYCTU,Rv0818,Rv0818,GO:0000160; GO:0003677; GO:0005622; GO:0005886; GO:0006351; GO:0010468; GO:0019217; GO:0042128; GO:0045893,IPR011006; IPR001867; IPR016032; IPR036388; ,,,DOMAIN 124 221 OmpR/PhoB-type. {ECO:0000259|PROSITE:PS51755}.,Transcriptional regulatory protein,"intracellular [GO:0005622]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; nitrate assimilation [GO:0042128]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; 24733389,X-ray crystallography (1),,MLELLLLTSELYPDPVLPALSLLPHTVRTAPAEASSLLEAGNADAVLVDARNDLSSGRGLCRLLSSTGRSIPVLAVVSEGGLVAVSADWGLDEILLLSTGPAEIDARLRLVVGRRGDLADQESLGKVSLGELVIDEGTYTARLRGRPLDLTYKEFELLKYLAQHAGRVFTRAQLLHEVWGYDFFGGTRTVDVHVRRLRAKLGPEHEALIGTVRNVGYKAVRPARGRPPAADPDDEDADPGRDGMQEPLVDPLRSQ,"27,597",255,,"nitrate assimilation [GO:0042128]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],intracellular [GO:0005622]; plasma membrane [GO:0005886],,,3
O53868,O53868_MYCTU,Rv0856,Rv0856,,IPR005031; IPR023393; ,,,,Uncharacterized protein,,9634230,,,MEALADVGVLASWSPLHKQVEVIDYYPDGRPHHVRATVKILGLVDKEVLEYHWGPDWVCWDADQTFQQHGQHIEYTVKPEGVDRARVRFDITVEPAGPIPGFIVKRASEHVLDAAAKGLQKLIAGAGDQGNAKS,"14,831",134,,,,,,,3
Q79FS5,Q79FS5_MYCTU,Rv1091,PE_PGRS22 Rv1091,,IPR000084; ,,PE_PGRS22,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS22,,9634230,,,MSFVIAAPEALVAVASDLAGIGSALAEANAAALAPTTALLAAGADEVSAAIAALFGAHGQAYQTVSAQASAFHAQFVQALTGGGGAYAAAEAANVSAAQSTDQRLLDLINGPTQALLGRPLIGDGANGGPGQDGGPGGLLYGNGGNGGTSTTAGVAGGNGGAAGLIGNGGAGGGGGAGAAGGNGGAGGWLYGNGGAGGAGGTSVIPGVAGGNGGAGGSAGLWGTGGAGGDGGNGRSGPVNVAGSAGGNGGAGGAAGLFGDAGAGGNGGKGGAGGAAFSINFTAGDGGAGGAGGSGGHALLWGAGGAGGNGGSGGTGGAGGSTAGAGGNGGAGGGGGTGGLLFGNGGAGGHGAAAGNGLAAGNGVSSSGGGGAGGTGGAGGDGGAGGAGGNARLWGVGGAGGAGGDGGAGGAGGKGGSGLSGNANGGAGGDSGRGGTGGAGGEGGAAGLLVGTGGHGGDGGAGGAAVKGGDGGAAAGTGIAGAGGRGGAGGSGGSGGDGGGGAAGPAGWLFGDGGAGGNGGAAAAGGAGGQAGGGGGNGGNGGNGGNGGNGGNGATGGWLYGNGGAGGQGATAGAGGAGANGVSSTNGGGTGGNGGIGGTGGSGGAGGNAGLLGVGGAGGHGASGGAGDRGGAGGTGFISSDGGAGGDGGDGGNGGAGGTGGLLFGAGGNGGPGGSGGAADIGGNGGAGNGGGTDGNGGNGGSGGGAGSGGDGGGAGGNGAWLFGNGGAGGGGGKGGNGAGGGLGGGSFGLPGLNGSGGDGGDGGNGAPGGVLYGNGGAGGQGSSGGIGGPGATGGAGGKGGDGGDAQLIGDGGNGGNGGAGGTGGTPGPGGPGGSGGLGGLLFGQTGTAGVSP,"68,317",853,,,,,,,1
P71840,P71840_MYCTU,Rv0787,Rv0787,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 21969609,,,MHRPPWLAQLRRRLRIGVQLGSRVVLEQGRQPRDVYVIGVLVGDQDRGQTGDSLEAVRESTGIEEQAGLTELSEEAGMAEMRELHVYDCALMGAFPMRLILATMLVAGRLLATLMAAPSAQAEPETCPPICDQIPATAWISTHAVPLNSQYRWPAMAGAAVAVTRATPRFGFEQVCATPAFPHDSRDWAVAGRVTVVHPDGQWQLQAQVLHWRGDTARGGQIAASVFGTAVAALRACQLGAPLQSPSVTDDEPTRMAAVISGPVIMYTYLVAHVSSSTISELTLWSSGPPQVPWPTVADSAVLDALTAPLCEAYIGSCP,"34,182",319,,,,extracellular region [GO:0005576],,,2
O53873,O53873_MYCTU,Rv0861c,ercc3 Rv0861c,GO:0003677; GO:0004386; GO:0005524; GO:0005618; GO:0005886,IPR032438; IPR006935; IPR014001; IPR001650; IPR027417; IPR032830; ,,ercc3,DOMAIN 183 337 Helicase ATP-binding. {ECO:0000259|PROSITE:PS51192}.; DOMAIN 392 538 Helicase C-terminal. {ECO:0000259|PROSITE:PS51194}.,DNA helicase Ercc3,cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],9634230; 21969609,,,MQSDKTVLLEVDHELAGAARAAIAPFAELERAPEHVHTYRITPLALWNARAAGHDAEQVVDALVSYSRYAVPQPLLVDIVDTMARYGRLQLVKNPAHGLTLVSLDRAVLEEVLRNKKIAPMLGARIDDDTVVVHPSERGRVKQLLLKIGWPAEDLAGYVDGEAHPISLHQEGWQLRDYQRLAADSFWAGGSGVVVLPCGAGKTLVGAAAMAKAGATTLILVTNIVAARQWKRELVARTSLTENEIGEFSGERKEIRPVTISTYQMITRRTKGEYRHLELFDSRDWGLIIYDEVHLLPAPVFRMTADLQSKRRLGLTATLIREDGREGDVFSLIGPKRYDAPWKDIEAQGWIAPAECVEVRVTMTDSERMMYATAEPEERYRICSTVHTKIAVVKSILAKHPDEQTLVIGAYLDQLDELGAELGAPVIQGSTRTSEREALFDAFRRGEVATLVVSKVANFSIDLPEAAVAVQVSGTFGSRQEEAQRLGRILRPKADGGGAIFYSVVARDSLDAEYAAHRQRFLAEQGYGYIIRDADDLLGPAI,"59,804",542,,,ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53410,O53410_MYCTU,Rv1062,Rv1062,GO:0016042; GO:0016787,IPR016035; IPR002641; ,,,DOMAIN 7 206 PNPLA. {ECO:0000259|PROSITE:PS51635}.,Uncharacterized protein,hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],9634230; 21969609,,,MTTRRALVLAGGGLAGIAWETGVLRGIADESPAAARLLLDSDVLVGTSAGATVAAQISSGCPLDTLYERQLAETSAEIDPGVDIDAITDLFLTAVTEPHISTRRRLQRIGAVALAVDTVPESVRRQVIAQRLPSHDWPDRVLRVTAIDIATGELVVFHRESNVALVDAVAASCSVPGAWPPVTIAGRRYMDGGVASSVNLGVADDCDAAVVLVPAGADAPSPFGGGAAAEIAAATGMVFAVFADDDSLAAFGPNPLDPLCRVNSAMAGRQQGRREAQAVARLLGV,"29,279",285,,lipid catabolic process [GO:0016042],hydrolase activity [GO:0016787],,,,3
O53448,O53448_MYCTU,Rv1100,Rv1100,GO:0005618; GO:0016021,IPR025339; ,,,,Conserved protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230; 21969609,,,MVGDCPRSRTVRWSWDTGHVTAEPQPTPRPAKPRLLQDGRDMFWSLAPLVVGCILLAGLVGMCSFQLGGTKRGPIPSYDAAQALRADAKTLGFPIRLPQLPGGWTPNSGGRGGIENGRADPATGQRRNAATSIVGFISPTGRYLSLTQSNADEDKLVGSIHPSMYPTGTVDVGGTRWVVYEGSDENGAVEPVWTTRLTGPGGATQLAITGAGSIDQFRTLASATQSQPPLPAR,"24,563",233,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,1
O05589,O05589_MYCTU,Rv1004c,Rv1004c,GO:0005576,,,,,Probable membrane protein,extracellular region [GO:0005576],9634230,,,MSISCRVREGFVMRLAIVGTAAAAAIGGTLAVAPLTLSTPERVAGGTCSAGQQCDRLAAVLMPDTATPSGPAAAEHAVPAPFEPVADTIAPGLVPRPGVPAAAAVPRVGPPAVPGLPNIPGAAGPALPPPPALPNLAAPSVPGVGIPGIGIPGIGIPGIGIPGVPDPITGVNTAAAVVNGVLGVGGTAAGVVTASAVAVTYLVLAVNALESSGILPTARGTASTVASLLLPGAQSAAAALPAVGLPALPGVTPASLLAMAAAAGLPGVGFPSLPGVSPTDLMAMAAAAGLPTSLPGLAGMSPAELTALVAGGLPMLAAAGLPAGLAGVDPATLAAALPALAAGGLPPGLPALPGVDPAALAAALPALAAGLPALPAGLPPLPAVPALPAPPPLPGPPPLPALPSRLCTPGFGPIGVCIP,"38,786",419,,,,extracellular region [GO:0005576],,,2
I6WZG6,I6WZG6_MYCTU,Rv0798c,cfp29 Rv0798c,GO:0008233; GO:0042742,IPR007544; ,,cfp29,,29 kDa antigen CFP29,peptidase activity [GO:0008233]; defense response to bacterium [GO:0042742],9634230; 21969609,,,MNNLYRDLAPVTEAAWAEIELEAARTFKRHIAGRRVVDVSDPGGPVTAAVSTGRLIDVKAPTNGVIAHLRASKPLVRLRVPFTLSRNEIDDVERGSKDSDWEPVKEAAKKLAFVEDRTIFEGYSAASIEGIRSASSNPALTLPEDPREIPDVISQALSELRLAGVDGPYSVLLSADVYTKVSETSDHGYPIREHLNRLVDGDIIWAPAIDGAFVLTTRGGDFDLQLGTDVAIGYASHDTDTVRLYLQETLTFLCYTAEASVALSH,"28,830",265,,defense response to bacterium [GO:0042742],peptidase activity [GO:0008233],,,,1
O53413,O53413_MYCTU,Rv1065,Rv1065,GO:0005506; GO:0016702,IPR010300; IPR014710; IPR011051; ,,,,Uncharacterized protein,"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",9634230; 21969609,,,MVMPLVTPTTAVPSPGPTRLRVADLLRATDQAADDVLGGRCDHLLPDGGVPQTQRWYTRIHGDEELDIWLISWVPGQPTELHDHGGSLGALTVLSGSLNEYRWDGRRLRRRRLDAGDQAGFPLGWVHDVVWAPRPIGGPDAAGMAVAPTLSVHAYSPPLTAMSYYEITERNTLRRQRTELTDQPEGSG,"20,634",188,,,"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",,,,1
O53850,O53850_MYCTU,Rv0838,lpqR Rv0838,GO:0005576; GO:0005618; GO:0008237; GO:0008270; GO:0016805; GO:0071555,IPR000755; IPR009045; ,,lpqR,,D-alanyl-D-alanine dipeptidase (D-Ala-D-Ala dipeptidase) (EC 3.4.13.22),cell wall [GO:0005618]; extracellular region [GO:0005576]; dipeptidase activity [GO:0016805]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; cell wall organization [GO:0071555],9634230; 21969609,,"FUNCTION: Catalyzes hydrolysis of the D-alanyl-D-alanine dipeptide. {ECO:0000256|HAMAP-Rule:MF_01924, ECO:0000256|PIRNR:PIRNR026671}.",MRLIGRLRLLMVGLVVICGACACDRVSAGRWSESPSATSWPVRPVNTTTPSGPVPPVSEAARAAGLVDVRGVVPDAAIDLRYATANNFTGTQLYPPGARCLVHESMAEGLAAAAAVLRPHGQVLVFWDCYRPHDVQVRMFDVVPNPAWVARPGKYAHSHEAGRSVDVTFASAQRQCPSVRRSGELCLADMGTDFDDFSSRATAFATQGVSAEAQANRAHLRAAMQAGGLTVYSGEWWHFDGPGAGVDRPILEVPVD,"27,321",256,Peptidase M15D family,cell wall organization [GO:0071555],dipeptidase activity [GO:0016805]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
O53840,O53840_MYCTU,Rv0829,Rv0829,,IPR010095; ,,,,Possible transposase,,9634230,,,MGPSSKTCHACRHVQDIGWDEKWQCDGCSITHQRDDNAAINLARYEEPPSVVGPVGAAVKRGADRKTGPGPAGGREARKATGHPAGEQPRDGVLVA,"10,112",96,,,,,,,1
L7N6A4,L7N6A4_MYCTU,Rv1000c,Rv1000c,GO:0006307; GO:0035552; GO:0051213,IPR027450; IPR037151; IPR032854; IPR005123; ,,,,Uncharacterized protein,dioxygenase activity [GO:0051213]; DNA dealkylation involved in DNA repair [GO:0006307]; oxidative single-stranded DNA demethylation [GO:0035552],9634230,,,MCDKLGGVAIAVQGALFEHNERRQLGDGAFIDIRSGWLTGGEELLDALLSTVPWRAERRQMYDRVVDVPRLVSFHDLTIEDPPHPQLARMRRRLNDIYGGELGEPFTTAGLCYYRDGSDSVAWHGDTIGRGSTEDTMVAIVSLGATRVFALRPRGRGPSLRLPLAHGDLLVMGGSCQRTFEHAVPKTSAPTGPRVSIQFRPRDVR,"22,648",205,,DNA dealkylation involved in DNA repair [GO:0006307]; oxidative single-stranded DNA demethylation [GO:0035552],dioxygenase activity [GO:0051213],,,,1
O53854,O53854_MYCTU,Rv0842,Rv0842,GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,DOMAIN 1 409 MFS. {ECO:0000259|PROSITE:PS50850}.,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],9634230,,,MRYTGPERCSGDGQVRAAGDRYSTVIWLLGGNLLVRSAGFGYPFLAYHVAGRGHGAGAVGAVVAAYGLGWAVGQLLCGWLVDRVGARVTLVSTMLVAAAVLVLMAGLHTVPGLLVGAMIAGLVCDAPRPVLGAVIAELVADPQRRAQLDGWRYGWVLNIGAAITGGVGGVVAGWLDTPVLYWINGIGCAIFAGLAGRCIPADVCRRTESGLRACTAMSKVGYRQALSDKRLVLLAVSGLATLTTLMGFFAAVPMLMSASGLGVGAYGWVQLINALAVVAVTPLLTPWLSKQLALGPRPDILAGAGVWVTLCMAAAGLARTTVGFSVAAAACSPGEIAWFVVAAGIVHRIAPPAHGGRYHGIWSMAVAASSVAAPILAAFNLANGGRLVLAATTVTVGFFGAALCLPLARVLAAASCGPLSSKEPSRDSYQ,"43,855",430,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021],,,3
P96356,P96356_MYCTU,Rv1045,Rv1045,,IPR014942; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTKPYSSPPTNLRSLRDRLTQVAERQGVVFGRLQRHVAMIVVAQFAATLTDDTGAPLLLVKGGSSLELRRGIPDSRTSKDFDTVARRDIELIHEQLADAGETGWEGFTAIFTAPEEIDVPGMPVKPRRFTAKLSYRGRAFATVPIEVSSVEAGNADQFDTLTSDALGLVGVPAAVAVPCMTIPWQIAQKLHAVTAVLEEPKVNDRAHDLVDLQLLEGLLLDADLMPTRSACIAIFEARAQHPWPPRVATLPHWPLIYAGALEGLDHLELARTVDAAAQAVQRFVARIDRATKR,"31,991",293,,,,,,,2
L7N654,L7N654_MYCTU,Rv1087A,Rv1087A,GO:0002094; GO:0016094,IPR001441; IPR036424; ,,,,Uncharacterized protein,polyprenyltransferase activity [GO:0002094]; polyprenol biosynthetic process [GO:0016094],9634230,,,MPCVGYGDRREFVDAVAVEAICENLNTSGQPDPDLVIRTSGEQRLSGHRGPTGGVSRRRLLRALRDYSTPHASIPYVPPPYRSDGIHASRLAVESVFDALAGRVEL,"11,544",106,,polyprenol biosynthetic process [GO:0016094],polyprenyltransferase activity [GO:0002094],,,,1
O06542,O06542_MYCTU,Rv1142c,echA10 Rv1142c,GO:0003824; GO:0005829; GO:0005886; GO:0008152,IPR029045; IPR001753; IPR014748; ,,echA10,,Probable enoyl-CoA hydratase EchA10 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MSNYRIDTRTIVPGLAVTLADGVLSVTIDRPESLNSLTKPVLAGMADAIEGAATDPRVKVVRLGGAGRGFSSGGAISVDDVWASGPPTDTVAEANRTVRAIVALPQPVVAVVQGPTVGCGVSLALACDLVLASDNAFFMLAHTNVGLMPDGGASALVQAAIGRIRAMHMALLPDRVPAAEALSWGLVSAVYPAADFDAEVDKLISRLLAGPALAIAKTKNAINAATLTELAPTLLRELDGQALLLRTDDFAEGATAFQQRRTPMFTGR,"27,649",268,,metabolic process [GO:0008152],catalytic activity [GO:0003824],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P71833,P71833_MYCTU,Rv0779c,Rv0779c,GO:0016021,,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MRSRFLPYATTPGRLLAQLISDITVAVWTTLWMLVGLAVHDAISIIGEAGRQIEIGSHGIAGNLAAAGQDAQRIPVVGDALSNPITAASQAALDIAGAGHNLDTTAGWLAVVLALAVAATPILAVAMPWLFLRLRFCRRKWTVTTLAATPAGRQLLALRALANRPPGKLAAVSTDPVGAWRREDPATMRALAALELRAAGIPLRGD,"21,572",206,,,,integral component of membrane [GO:0016021],,,1
O86351,O86351_MYCTU,Rv1111c,Rv1111c,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSAQRARSAVQASHRSIHPHIPGVPWWAAILIAVTATAIGYAIDAGSGHKALTLVFTGCYIAGCVGAVLAVRQSDLFTALVQPPLILFCAVPGAYWLFHGGTIGKFKDLLINCGYSLIERFPLMLGTAAGVLLIGLVRWYLGTALFDSIARKLSSLMTGDSDDDGGRRSAQRPARTRSRHARPPSEDNREPIAERRSRRRPRPQNDPHPRRNAHERPAPRSSRFDSYRSYQPSEPSGPAEPVNRYERRGARYQPYARYEPTYEPQRRRARPSEPTNPTHHPISQVRYRGSATRDARRDNYREEQRFDRRDRSRAPRRPPAESWEYDV,"37,017",327,,,,integral component of membrane [GO:0016021],,,2
Q79FV8,Q79FV8_MYCTU,Rv0832,PE_PGRS12 Rv0832,,IPR000084; ,,PE_PGRS12,,PE-PGRS family protein PE_PGRS12,,9634230,,,MSYVSVLPATLATAATEVARIGSALSLASAVAAAQTSAVQAAAADEVSAAIAALFSAHGRDFQALSARAAAFHHEFVQALAAGAGSYAVAEIAAASPLQSLIDVFNAPIQAATGRPLIGNGANGQPGTGAPGGPAGG,"13,096",137,,,,,,,1
O53429,O53429_MYCTU,Rv1081c,Rv1081c,GO:0016021,IPR025443; ,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTHTPIPRPDARYGRPRLSRRARRRVAIALGVLVAAAGIVIAVIGYQRISTSAVTGSLVGYRLVDDETASVTISVTRSDPSRPVACIVRVRATNGSETGRRELLVPPSEATTVQVTTTVKSSQPPVMADVYGCGTEVPSYLRLP,"15,385",144,,,,integral component of membrane [GO:0016021],,,3
O06537,O06537_MYCTU,Rv1137c,Rv1137c,,,,,,Uncharacterized protein,,9634230,,,MLSARCHIRHIGSPGKDARCAHLSATLRPGIGISPTNVGNATVLADGTPAKPIQGAETMQRARHTGSCFSANARGPAISSGNPSRAGCGVPSSTTTPSSTPQAIRLLACTDSDALTVTRTAR,"12,376",122,,,,,,,1
I6WZS8,I6WZS8_MYCTU,Rv0926c,Rv0926c,,IPR036291; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAIPVVQLGTGNVGVHSLRALIADPEFELTGVWVSSDAKAGKDAAELAGLADSTGVRASTDLNAVLATGPRCAVYNAMADNRLPEALEDYRRILAAGINIVGSGPVFLQYPWQVIPDEIIKPLQDAARAGNSSLYVNGIDPGFANDLLPMALAGTCESIEQIRCMEIVDYATYDSAVVMFDVMGFGKPMDQIPMLLQPGVLSLAWGSVVRQLAAGLGISLDGVEEMYVREPAPEAFNIASGHIPKGSAAALRFEVLGLVDGVPAVVLEHVTRLRADLCPEWPQPAQPGGSYRIEISGEPCYAMDICLSSRHGDHNHAGLVATAMRIVNAIPAVVAAEPGIRTTLDLPLITGEGRYAAA,"37,751",358,,,,,,,1
P96353,P96353_MYCTU,Rv1048c,Rv1048c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MQASDRTWQSNFIRRWYFTETVEYRPLVKYDASMSWDERTVSALEGAFRSEVRARRVNGPHRDVIVSLDGAEFLVRWLTTGWPRQVAEALHATSRPDILAAPTMSPGARKAAHDAGVGWVDESGAADIHYRNTSTGTTLVIETKGAPPAPLDARIGWRRATLAVCEALLANIAGPTVASVVEATGLSMGSSAQALKFLEKNGHLASATARGPKSARLIVDRDALLDAYAEAADKLRSPISISTGVLWRDPTAGVVKAGQLWDAAGIEWAATSALSASLLAPMQTEIAPMEIYVPGRSWSDLRRAAMAAGLQEIAGGRLILRFFPTPACARLTEQNLQGFRSMLWPRVYADLRTAGVRGEDAAEHLREAMTK,"40,249",371,,,,,,,2
P71839,P71839_MYCTU,Rv0786c,Rv0786c,,IPR036866; ,,,,Conserved protein,,9634230; 21969609,,,MHVGDELPLAELTVRAVGGCHAVIHPEIPVIENISYLVGDSKHRARLMHPGDALFVPGEQVDVLATPAAAPWMKISEAVDYLRAVAPARAVPIHQAIVAPDARGIYYGRLTEMTTTDFQVLPEESAVTF,"13,949",129,,,,,,,2
O86319,O86319_MYCTU,Rv0975c,fadE13 Rv0975c,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE13,,Probable acyl-CoA dehydrogenase FadE13,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MNIWTTPERQQLRKTVRAFAEREILPHVDEWERIGELPRGLHRLAGAAGLLGAGFPEAVGGGGGDGADPVIICEEMHQAGAPGGVYASLFTCGIAVPHMVASGDERLIATYVRPTLAGEKIGALAITEPGGGSDVGHLRTSAVRDGDHYVINGAKTYITSGVRADYVVTAVRTGGPGAAGVSLLVVEKDTPGFEVTRKLDKMGWRSSDTAELCYTDVAVPATNLVGAENSGFTQIARAFVSERIGLAAQAYSSAQRCLDLTAQWCRDRETFGRPLISRQSVQNTLAEMARRIDVARVYAHHVVERQLAGETDLIAQVCFAKNTAVQAGEWVANQAVQLFGGMGYMAESEVERQYRDMRILGIGGGTTEILTALAAKTLGYQS,"40,747",382,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
I6Y4V6,I6Y4V6_MYCTU,Rv0809,purM Rv0809,GO:0004641; GO:0005524; GO:0005737; GO:0006189,IPR010918; IPR036676; IPR016188; IPR036921; IPR004733; ,,purM,,Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; 'de novo' IMP biosynthetic process [GO:0006189],9634230; 21969609,,,MTDLAKGPGKDPGSRGITYASAGVDIEAGDRAIDLFKPLASKATRPEVRGGLGGFAGLFTLRGDYREPVLAASSDGVGTKLAIAQAMDKHDTVGLDLVAMVVDDLVVCGAEPLFLLDYIAVGRIVPERLSAIVAGIADGCMRAGCALLGGETAEHPGLIEPDHYDISATGVGVVEADNVLGPDRVKPGDVIIAMGSSGLHSNGYSLVRKVLLEIDRMNLAGHVEEFGRTLGEELLEPTRIYAKDCLALAAETRVRTFCHVTGGGLAGNLQRVIPHGLIAEVDRGTWTPAPVFTMIAQRGRVRRTEMEKTFNMGVGMIAVVAPEDTTRALAVLTARHLDCWVLGTVCKGGKQGPRAKLVGQHPRF,"38,393",364,AIR synthase family,'de novo' IMP biosynthetic process [GO:0006189],ATP binding [GO:0005524]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641],cytoplasm [GO:0005737],,,1
I6XA34,I6XA34_MYCTU,Rv0911,Rv0911,,IPR029068; IPR004360; IPR037523; ,,,DOMAIN 11 125 VOC. {ECO:0000259|PROSITE:PS51819}.; DOMAIN 139 255 VOC. {ECO:0000259|PROSITE:PS51819}.,Conserved protein,,9634230; 21969609,,,MPTRSSAPLGAPCWIDLTTSDVDRAQDFYGTVFGWAFESAGPDYGGYINAAKGGHPVAGLMANRPEFQSPDGWATYFHTVDIGATVAKLAAAGGSSCLDPMEVPGKGFMSLAVDPSGAAFGLWQPLQHHGFEVIGEAGSPVWHQLTTRDYRSVIDFYRQVFGWRTEQISDTDEFCYTTAWFDDQQLLGVMDGSSCLPEGVPSNWTIFFGAEDVDETLRVICDNGGSVVRAAENTPYGRLAAAADPMGVVFNLSSLQA,"27,627",257,,,,,,,1
I6WZM9,I6WZM9_MYCTU,Rv0871,cspB Rv0871,GO:0003677; GO:0006355,IPR011129; IPR002059; IPR012340; ,,cspB,,Probable cold shock-like protein B CspB,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MPTGKVKWYDPDKGFGFLSQEGGEDVYVRSSALPTGVEALKAGQRVEFGIASGRRGPQALSLRLIEPPPSLSRPRREPAAEHKHSPDELHGMVEDMITLLESTVQPELRKGRYPDRKTARRVAEVVRAVAREFES,"15,021",135,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677],,,,1
I6Y5H3,I6Y5H3_MYCTU,Rv1049,Rv1049,GO:0003700; GO:0006355; GO:0044212,IPR000835; IPR036388; IPR036390; ,,,DOMAIN 8 148 HTH marR-type. {ECO:0000259|PROSITE:PS50995}.,Probable transcriptional repressor protein,"DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MGKGAAFDECACYTTRRAARQLGQAYDRALRPSGLTNTQFSTLAVISLSEGSAGIDLTMSELAARIGVERTTLTRNLEVMRRDGLVRVMAGADARCKRIELTAKGRAALQKAVPLWRGVQAEVTASVGDWPRVRRDIANLGQAAEACR,"15,980",148,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],,,,1
P71568,P71568_MYCTU,Rv0941c,Rv0941c,,IPR036890; IPR002645; IPR036513; ,,,DOMAIN 14 127 STAS. {ECO:0000259|PROSITE:PS50801}.,Uncharacterized protein,,9634230; 21969609,,,MVAVSTAAKSPTALAIAVRTQDSVVILTADGALDSSSSALLRDSLTRATLEQPSAVIVNVTELQVAEESAWSVFISARWQADFRADVPVLLVCGHRAGRAAVTRTGVARFMPVYPTEKAASKAIGRLARRNFKRSDAQLPANLNSLRESRQLVREWLTQWSRPGLIPVALVVVNVFVENVLKHTGSDPVMRIESDGPTATIAVSDGSSAPAVRLASPPKGIDVSGLAIVAALSRAWGSSPTSSGKTVWAIIGPENQL,"27,170",257,,,,,,,2
O06563,O06563_MYCTU,Rv1165,typA Rv1165,GO:0003746; GO:0003924; GO:0005525; GO:0005618; GO:0005886,IPR035651; IPR035647; IPR000640; IPR004161; IPR027417; IPR005225; IPR000795; IPR009000; IPR006298; ,,typA,DOMAIN 1 215 Tr-type G. {ECO:0000259|PROSITE:PS51722}.,Possible GTP-binding translation elongation factor TypA (Tyrosine phosphorylated protein A) (GTP-binding protein),cell wall [GO:0005618]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],9634230; 21969609,,,MPFRNVAIVAHVDHGKTTLVDAMLRQSGALRERGELQERVMDTGDLEREKGITILAKNTAVHRHHPDGTVTVINVIDTPGHADFGGEVERGLSMVDGVLLLVDASEGPLPQTRFVLRKALAAHLPVILVVNKTDRPDARIAEVVDASHDLLLDVASDLDDEAAAAAEHALGLPTLYASGRAGVASTTAPPDGQVPDGTNLDPLFEVLEKHVPPPKGEPDAPLQALVTNLDASTFLGRLALIRIYNGRIRKGQQVAWIRQVDGQQTVTTAKITELLATEGVERKPTDAAVAGDIVAVAGLPEIMIGDTLAASANPVALPRITVDEPAISVTIGTNTSPLAGKVGGHKLTARMVRSRLDAELVGNVSIRVVDIGAPDAWEVQGRGELALAVLVEQMRREGFELTVGKPQVVTKTIDGTLHEPFESMTVDCPEEYIGAVTQLMAARKGRMVEMANHTTGWVRMDFVVPSRGLIGWRTDFLTETRGSGVGHAVFDGYRPWAGEIRARHTGSLVSDRAGAITPFALLQLADRGQFFVEPGQQTYEGMVVGINPRPEDLDINVTREKKLTNMRSSTADVIETLAKPLQLDLERAMELCAPDECVEVTPEIVRIRKVELAAAARARSRARTKARG,"67,580",628,,,GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation elongation factor activity [GO:0003746],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
O53422,O53422_MYCTU,Rv1074c,fadA3 Rv1074c,GO:0003988; GO:0005576; GO:0005618; GO:0005886; GO:0006635,IPR002155; IPR016039; IPR020617; IPR020613; IPR020616; ,,fadA3,,Probable beta-ketoacyl CoA thiolase FadA3,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MPEAVIVSTARSPIGRAMKGSLVGMRPDDLAVQMVRAALDKVPALNPHQIDDLMMGCGLPGGESGFNIARVVAVALGYDFLPGTTVNRYCSSSLQTTRMAFHAIKAGEGDAFISAGVETVSRFAKGNSDSWPDTKNPLFDGAQERSAAAAAGADEWHDPRTDQKLPDIYIAMGQTAENVAIMTGISREEQDRWGVRSQNRAEEAIKNGFFEREITPVTLPDGTTVSTDDGPRPGTTYEKVSELKPAFRPNGTVTAGNACPLNDGAAAVVITSDTKAKELGLTPLARIVSTGVSGLSPEIMGLGPIEASKKALERAGMAITDIDLVEINEAFAVQVLGSARELGIDEDKLNISGGAIALGHPFGMTGARITTTLLNNLQTYDKTFGLETMCVGGGQGMAMVIERLA,"42,655",405,Thiolase family,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P71540,P71540_MYCTU,Rv0971c,echA7 Rv0971c,GO:0003824; GO:0005886; GO:0008152,IPR029045; IPR001753; IPR014748; ,,echA7,,Probable enoyl-CoA hydratase EchA7 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MDSPVDYAGPAACGGPFARLTLNSPHNRNALSSTLVSQLHQGLSAAEADPAVRLVVLGHTGGTFCAGADLSEAGGGGGDPYRMAVARAREMTALLRAIVESPLPVVGAINGHVRAGGFGLVGACDMVVAGPESTFALTEARIGVAPAIISLTLLPKLSPRAAARYYLTGEKFGAREAADIGLITMAADDVDAAVAALVADVGRGSPQGLAASKALTTAAVLEGFDRDAERLTEESARLFVSDEAREGMLAFLQKRPPRWVQPATMRAAD,"27,604",269,,metabolic process [GO:0008152],catalytic activity [GO:0003824],plasma membrane [GO:0005886],,,1
P71552,P71552_MYCTU,Rv0958,Rv0958,GO:0005524; GO:0005618; GO:0006355; GO:0008134,IPR027417; IPR002078; ,,,,Possible magnesium chelatase,"cell wall [GO:0005618]; ATP binding [GO:0005524]; transcription factor binding [GO:0008134]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MSPSNLPRTVGELRAAGHRERGVKQEIRENLLTALADGDNVWPGILGFDDTVIPQVERALIAGHDFVLLGERGQGKTRLLRALAGLLDEWTPVIAGAELGEHPYTPITPESIRRAAQLGDDLPVAWKHRSERYTEKLATPDTSVADLVGDVDPIKVAEGRSLGDPETIAYGLIPRAHRGIVAVNELPDLAERIQVSMLNVMEERDIQVRGYTLRLPLDVLVVASANPEDYTNRGRIITPIKDRFGAEIRTHYPLELEAEMGVIVQEAHLSAQVSDYLMQVLARFARYLRESRSIDQRSGVSARFAIAAAETVAAAARHRGAVLGETDPVARVVDLGTVIDVLRGKLEFESGEEGREQAVLEHLLRRATADTASRVLGGIDVGSLVTAVEGGSAVTTGERVSAKDVLAAVPGLPVVDRIARKLGAESEGERAAALELALEALYLAKRVDKVCGEGQTVYG,"49,581",459,,"regulation of transcription, DNA-templated [GO:0006355]",ATP binding [GO:0005524]; transcription factor binding [GO:0008134],cell wall [GO:0005618],,,1
O06583,O06583_MYCTU,Rv1132,Rv1132,GO:0005886,IPR021941; ,,,,Conserved membrane protein,plasma membrane [GO:0005886],9634230; 21969609,,,MGFLQPRLPDIDLAEWSQGSRSQKIRPMAQHWAEVGFGTPVLLHLFYVAKILLYVLVGWLIVLTTKGIDGFTDAAAWYAEPIVFEKVVLYTMLFEVIGLGCGFGPLNNRFFPPMGSILYWMRFGTIRLPPWPDRVPWTRGTKRKPVDVALYALLVMMLLSALFTDGAGPIPELGTTVGLLPAWQIVLILLLLGVLGLRDKVIFLAARGEVYATLTVTFLFGRLNGIDMIVAAKLVFLVIWIGAATSKLNRHFPFVISTMMSNNPLFRPRFIKRMFFKKFPGDLRPGLLSRIVAHVSTVIEMCVPVVLFVAHGGWPTVVAATIMVCFHLGILTAIPMGVPLEWNVFMIFGVLSLFVGHACLGLADVKNPVPLAILIAVVAGIVIAGNVFPRKISFLAAMRYYAGNWDTTLWCIKPSAEDKINRGIVAIASMPAAQLERFYGKDRAQIPMYLGYAFRAMNSHGRALFTLAHRAMAGHDEDDYVITDGERVCSTAVGWNFGDGHLHNEQLIAAMQQRCGFQPGEVRVVLLDAQPIHRQTQEYRLVDAATGEFERGYVRVADMVNRQPWDDDVPVHVLPG,"64,020",576,,,,plasma membrane [GO:0005886],,,3
P96366,P96366_MYCTU,Rv1035c,Rv1035c,GO:0005618; GO:0005829; GO:0005886,,,,,Probable transposase,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230,,,MPHPTTLMKLTTRCGSAAIDGLNEALLAKAAEAKLLGTNRIRADTTVARANVSYPTDLGLLAKAMRRIAATGKRIQAAGGAVRTRVGDRSRAAGRRAHAVAAKLRSRAELGRDEARAAVLRFTGELAELAQAAAQEAQQLLDNAKQAVLRAKAKAAALAARGERDAVAGRRCGGLVRAVNDLTELLNATRQIVAQTRQRVAGITSDGASRRVSLHDGDARPDHQGSAR,"23,975",228,,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O53398,O53398_MYCTU,Rv1050,Rv1050,GO:0005576; GO:0005886,IPR036291; IPR002347; ,,,,Probable oxidoreductase,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MARQRFRDQVVLITGASSGIGEATAKAFAREGAVVALAARREGALRRVAREIEAAGGRAMVAPLDVSSSESVRAMVADVVGEFGRIDVVFNNAGVSLVGPVDAETFLDDTREMLEIDYLGTVRVVREVLPIMKQQRSGRIMNMSSVVGRKAFARFAGYSSAMHAIAGFSDALRQELRGSGIAVSVIHPALTQTPLLANVDPADMPPPFRSLTPIPVHWVAAAVLDGVARRRARVVVPFQPRLLMVGDAFSPRYGDRVVRLLESKIFGRLIGSYRGSVYRHQPTESAKAQAAQPERGYSSAR,"32,497",301,Short-chain dehydrogenases/reductases (SDR) family,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,3
I6Y8X0,I6Y8X0_MYCTU,Rv0840c,pip Rv0840c,GO:0004177,IPR029058; IPR000073; IPR002410; IPR005945; ,,pip,DOMAIN 24 270 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Probable proline iminopeptidase Pip (Prolyl aminopeptidase) (Pap),aminopeptidase activity [GO:0004177],9634230; 21969609,,,MEGTIAVPGGRVWFQRIGGGPGRPLLVVHGGPGLPHNYLAPLRRLSDEREVIFWDQLGCGNSACPSDVDLWTMNRSVAEMATVAEALALTRFHIFSHSWGGMLAQQYVLDKAPDAVSLTIANSTASIPEFSASLVSLKSCLDVATRSAIDRHEAAGTTHSAEYQAAIRTWNETYLCRTRPWPRELTEAFANMGTEIFETMFGPSDFRIVGNVRDWDVVDRLADIAVPTLLVVGRFDECSPEHMREMQGRIAGSRLEFFESSSHMPFIEEPARFDRVMREFLRLHDI,"31,925",286,Peptidase S33 family,,aminopeptidase activity [GO:0004177],,,,1
O53443,O53443_MYCTU,Rv1095,phoH2 Rv1095,GO:0005524; GO:0005886,IPR027417; IPR003714; IPR029060; IPR002716; ,,phoH2,,Probable PHOH-like protein PhoH2 (Phosphate starvation-inducible protein PSIH),plasma membrane [GO:0005886]; ATP binding [GO:0005524],9634230; 21969609,,,MTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR,"46,914",433,,,ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
I6XWK6,I6XWK6_MYCTU,Rv0923c,Rv0923c,GO:0003839,IPR017939; IPR008585; IPR038128; IPR013024; IPR036568; ,,,,Uncharacterized protein,gamma-glutamylcyclotransferase activity [GO:0003839],9634230; 21969609,,,MPDRRHPYFAYGSNLCAHQMASRCPDAGAPRPAVLSDHNWLINQRGVATVEPFAGNKVHGVLWQLSERDLVRLDSAEGVPVRYRRERLTVHTDDTALPAWVYIDHRVMPGRPRPGYLPRVIDGARHHGLPQRWIDYLHRWDPARWPLPVLPSSRSGPAPQSLSELLSQPGVIETSQLRSRFGFLAIHGGGLEQVTDLIAERSAEAAGASVYLLRHPDNYPHHLPSARFDPAESARLAEFLDHVDVAVSLHGYDRIGRSTQLLAGGRNRALAAHLARHIQLPGYRVVTDLAAIPEELRGLHPDNPVNRVRDGGTQLELSIRVRGLGPRSTLPGVGGMSPVTATLVQGLVTAARSW,"39,059",354,,,gamma-glutamylcyclotransferase activity [GO:0003839],,,,1
O06574,O06574_MYCTU,Rv1122,gnd2 Rv1122,GO:0004616; GO:0005886; GO:0006098; GO:0040007,IPR008927; IPR004849; IPR013328; IPR006114; IPR006115; IPR036291; IPR006183; ,,gnd2,,"Probable 6-phosphogluconate dehydrogenase,decarboxylating Gnd2",plasma membrane [GO:0005886]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; growth [GO:0040007]; pentose-phosphate shunt [GO:0006098],9634230; 21969609,,,MQLGMIGLGRMGANIVRRLAKGGHDCVVYDHDPDAVKAMAGEDRTTGVASLRELSQRLSAPRVVWVMVPAGNITTAVIEELANTLEAGDIVIDGGNTYYRDDLRHEKLLFKKGIHLLDCGTSGGVWGRERGYCLMIGGDGDAFARAEPIFATVAPGVAAAPRTPGRDGEVAPSEQGYLHCGPCGSGHFVKMVHNGIEYGMMASLAEGLNILRNADVGTRVQHGDAETAPLPNPECYQYDFDIPEVAEVWRRGSVIGSWLLDLTAIALRESPDLAEFSGRVSDSGEGRWTAIAAIDEGVPAPVLTTALQSRFASRDLDDFANKALSAMRKQFGGHAEKPAN,"36,358",340,,growth [GO:0040007]; pentose-phosphate shunt [GO:0006098],phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],plasma membrane [GO:0005886],,,1
O53399,O53399_MYCTU,Rv1051c,Rv1051c,GO:0005618,IPR014942; IPR009061; ,,,,Uncharacterized protein,cell wall [GO:0005618],9634230,,,MRADVTAEHLTQVVRDIAVIDIDDGVAFNLDTSSVQEIRERADYPGLRVRVAMSVGPWQGIAAWDVSTGEPIAPWPTRVTIDRILGEPITLLGYAPETIIAEKGVTILERGITSTRWRDYVDIVQLDRRGIDDDELLRSARAVAQYRGATLEPVAPHLAGYGAVAQAKWATEHGRCQHCWRHWKPAHVGRRNMDLLDAKQVSEMIGVPVGTLRHWRHSDIGPASFTLGRRVVYRRDEVSRWISKRESATRR,"28,285",251,,,,cell wall [GO:0005618],,,1
O86318,O86318_MYCTU,Rv0974c,accD2 Rv0974c,GO:0016874; GO:0071768,IPR034733; IPR029045; IPR011763; IPR011762; ,,accD2,DOMAIN 20 271 CoA carboxyltransferase N-terminal. {ECO:0000259|PROSITE:PS50980}.; DOMAIN 270 520 CoA carboxyltransferase C-terminal. {ECO:0000259|PROSITE:PS50989}.,Probable acetyl-/propionyl-CoA carboxylase (Beta subunit) AccD2,ligase activity [GO:0016874]; mycolic acid biosynthetic process [GO:0071768],9634230; 21969609,,,MLQSTLDPNASAYDEAAATMSGKLDEINAELAKALAGGGPKYVDRHHARGNLTPRERIELLVDPDSPFLELSPLAAYGSNFQIGASLVTGIGAVCGVECMIVANDPTVKGGTSNPWTLRKILRANQIAFENRLPVISLVESGGADLPTQKEIFIPGGQMFRDLTRLSAAGIPTIALVFGNSTAGGAYVPGMSDHVVMIKERSKVFLAGPPLVKMATGEESDDESLGGAEMHARISGLADYFALDELDAIRIGRRIVARLNWIKQGPAPAPVTEPLFDAEELIGIVPPDLRIPFDPREVIARIVDGSEFDEFKPLYGSSLVTGWARLHGYPLGILANARGVLFSEESQKATQFIQLANRADTPLLFLHNTTGYMVGKDYEEGGMIKHGSMMINAVSNSTVPHISLLIGASYGAGHYGMCGRAYDPRFLFAWPSAKSAVMGGAQLSGVLSIVARAAAEARGQQVDEAADAAMRAAVEGQIEAESLPLVLSGMLYDDGVIDPRDTRTVLGMCLSAIANGPIKGTSNFGVFRM,"56,256",529,,mycolic acid biosynthetic process [GO:0071768],ligase activity [GO:0016874],,,,1
I6Y4U0,I6Y4U0_MYCTU,Rv0789c,Rv0789c,,,,,,Uncharacterized protein,,9634230,,,MSRRAIHSGRAAPRRSGNSHLVLRNRVPSSKDSPRRRPHHEFMTESIGEPLSTNLIERYLRARGRRYFRGHHDAEFFFVANAHLRLHVHLEISPAYRDVFTIRVSPAYFFPATDHTRLAEIVNAWNLQNHEVTAIVHGSSDPHRIGVAAERSLIRDRIRFDDFATFVDNAVSAATELFGQLTAAGLPPTATPPLLRDAG,"22,486",199,,,,,,,1
O06570,O06570_MYCTU,Rv1118c,Rv1118c,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MQSGPHLVGRVGTSFPLIARHQGATRDDAGDTGQPDPLPHVAHPDRLYPPMVHGVDPSTLALDRALNETRTGDLWLFRGRSRPDRAIQTLTNAPVNHVGMTVAIDDLPPLIWHAELGDKLLDVWTGTNHRGVQLNDARQVVQQWAGRYRQRCWLRQLTPHANRDQEDKLLRVIARMNGTPFPTTARLTGRWLRGRLPTLNDWLRGIPVLDRKVREQTQRRKQQQRTMGLATAYCAETVAITYEEMGLLVTDKDAHWFDPGKFWSGDSLPLAPGYRLGHEIAVDVGG,"32,190",286,,,,plasma membrane [GO:0005886],,,1
O05578,O05578_MYCTU,Rv0995,rimJ Rv0995,GO:0016740,IPR016181; IPR000182; ,,rimJ,,Ribosomal-protein-alanine acetyltransferase RimJ (Acetylating enzyme for N-terminal of ribosomal protein S5),transferase activity [GO:0016740],9634230; 21969609,,,MAVGPLRVSAGVIRLRPVRMRDGVHWSRIRLADRAHLEPWEPSADGEWTVRHTVAAWPAVCSGLRSEARNGRMLPYVIELDGQFCGQLTIGNVTHGALRSAWIGYWVPSAATGGGVATGALALGLDHCFGPVMLHRVEATVRPENAASRAVLAKVGFREEGLLRRYLEVDRAWRDHLLMAITVEEVYGSVASTLVRAGHASWP,"22,191",203,,,transferase activity [GO:0016740],,,,1
I6Y8Z3,I6Y8Z3_MYCTU,Rv0870c,Rv0870c,GO:0016021,IPR031308; IPR005185; ,,,,Possible conserved integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MRLILNVIWLVFGGLWLALGYLLASLVCFLLIITIPFGFAALRIASYALWPFGRTIVEKPTAGTGALIGNVIWVLLFGIWLALGHLVSAAAMAVTIIGIPLALANLKLIPVSLVPLGKDIVGVNSQVPT,"13,688",129,,,,integral component of membrane [GO:0016021],,,1
O06576,O06576_MYCTU,Rv1124,ephC Rv1124,GO:0005618; GO:0005829; GO:0005886; GO:0016787,IPR029058; IPR000073; IPR000639; ,,ephC,DOMAIN 45 306 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Probable epoxide hydrolase EphC (Epoxide hydratase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MRAGRGERESTWRTTMAEPHWIDVKGPNGDLKALTWGPAGAPVALCLHGFPDTAYGWRKVAPRLAESGWHVVAPFMRGYAPSSIPADGSYHVGALMHDALRVRSAAGGTERDVIIGHDWGAIAATGLAAMPDSPFAKAVIMSVPPSAAFRPLGRVPERGRLLRELPHQLLRSWYILYFQLPWLPERSASWVVPLLWRRWSPGYHAEEDLRHVDAAIGTPEGRRAALGPYRATMRNTRAPADYADLNRLWTEAPKLPVLYLHGHDDGCATSAFTHWTARVLPAGSEVAVVEHAGHFLQLEQPDKIAELIVAFIGSPG,"34,695",316,,,hydrolase activity [GO:0016787],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P96360,P96360_MYCTU,Rv1041c,Rv1041c,GO:0003677; GO:0004803; GO:0005618; GO:0005886; GO:0006313,IPR002559; ,,,DOMAIN 118 272 DDE_Tnp_1. {ECO:0000259|Pfam:PF01609}.,Probable is like-2 transposase,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MRASPADGLAITGLSWKGSRGGSVREVRGGTCPLSSGRGKRCGSAITVGRWMVPATRCSPTLPRCSGWTLRWPRISRSCCRWIPRTCGHTSIRRAPARTRSPQGALSDYKKSADEPDDHAIGRSRGGLTTKIHALTDQREAPVRIRLTAGQAGDNPQLLPLLDDYRHASTEYALGSTDFRLLADKAYSHPSTRAALRSKKIKHTIPERQDQIDRRKAKGSAGGRPPAFDAALYGLRNTVERGFHRLKQWRGIATRYDKYALTYLGGVLLACAVIHARVGTPKLGDTP,"31,403",287,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O06545,O06545_MYCTU,Rv1145,mmpL13a Rv1145,GO:0005886; GO:0016021,IPR004869; ,,mmpL13a,DOMAIN 44 276 MMPL. {ECO:0000259|Pfam:PF03176}.,Probable conserved transmembrane transport protein MmpL13a,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MLQRIARLAIAAPRRIIGFAVFVFIAAAVFGVPVADSLSPGGFQDPRSESARAIEVLTDKFGQSGQKMLIVVTAAAGADSPPAREVGTDIVEVLRRSPLVYNVTSPWTVPPTAAADLLSTDGKSGLIVVNVKGGENDAQNHAQTLSDEVAHDRDGVTVRAGGSAMEYAQINRQNKDDLLVMELIAIPLSFLVLIWVFGGLLAAGLPMAQAVLAVVGSMAVLRLVTFATEVSTFALNLSTALGLALAIDYTLLIVSRYRDELAEGSDRDEALIRTMALRGARCCFRRSPWRCRCRRLRCSRCTF,"32,546",303,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
Q79FT3,Q79FT3_MYCTU,Rv1067c,PE_PGRS19 Rv1067c,,IPR000084; ,,PE_PGRS19,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS19,,9634230,,,MSFVLVSPSQLMAAAADVAGIGSAISAANAAALAPTSVLAAAGADEVSAAVAALFSAHAGQYQQLGARAALFHEQFVQALTGAASAYASAEATNVEQQVLGLINAPTQALLGRPLIGNGADGTAANPNGGAGGLLYGNGGNGFSQTTAGLTGGTGGSAGLIGNGGNGGAGGAGANGGAGGNGGWLYGSGGNGGAGGAGPAGAIGAPGVAGGAGGAGGTAGLFGNGGVGGVGGDGGQGGNGAGAGASGTKGGDAGAGGAGGAGGWIHGHGGAGGDGGAGGAGGQASPGAPGPPSQPGGAGGAGGAGGRGGDGGSAGWLSGNGGDAGNGGGGGTAGGAGNGGQFGGDGGTGGTGGTAGAGGNGGRGAVLFGHGGNAGHGGAGGNGAAAGAGGEHVVATAGKGGTGGVGGDGGGGGAGGGGGLLYGNGGAGGAGNSGGDGGTGLNAALGGNGGGGGVGGNAGAGGTGGSAGWLSGNGGAGGSGGSAGAGGAGGKGGDTPNGLAINPGIGGNGGDTGNAGNGGNGGSAARLFGGGGAGGAGGTGSTAGSGGSGGTNPPTGLQAAGGNGGSGHAGGHGGNGGGAGLLGGGGTGGNGGGGGQGGLGAAAGGVDGNGGNGGNGGKGGDAQLVGDGGNGGNGGKGGAGLIAGLDGAGGAGGTRGLIFGNAGTPGQ,"54,724",667,,,,,,,1
L7N689,L7N689_MYCTU,Rv1033c,trcR Rv1033c,GO:0000160; GO:0003677; GO:0005622; GO:0006351; GO:0006355,IPR011006; IPR001867; IPR016032; IPR001789; IPR036388; ,,trcR,DOMAIN 33 147 Response regulatory. {ECO:0000259|PROSITE:PS50110}.; DOMAIN 158 255 OmpR/PhoB-type. {ECO:0000259|PROSITE:PS51755}.,Two component transcriptional regulator TrcR,"intracellular [GO:0005622]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,,MTTMSGYTRSQRPRQAILGQLPRIHRADGSPIRVLLVDDEPALTNLVKMALHYEGWDVEVAHDGQEAIAKFDKVGPDVLVLDIMLPDVDGLEILRRVRESDVYTPTLFLTARDSVMDRVTGLTSGADDYMTKPFSLEELVARLRGLLRRSSHLERPADEALRVGDLTLDGASREVTRDGTPISLSSTEFELLRFLMRNPRRALSRTEILDRVWNYDFAGRTSIVDLYISYLRKKIDSDREPMIHTVRGIGYMLRPPE,"29,209",257,,"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],intracellular [GO:0005622],,,1
O05900,O05900_MYCTU,Rv0907,Rv0907,GO:0005829; GO:0005886,IPR001466; IPR012338; IPR021860; ,,,DOMAIN 63 399 Beta-lactamase. {ECO:0000259|Pfam:PF00144}.; DOMAIN 439 512 DUF3471. {ECO:0000259|Pfam:PF11954}.,Conserved protein,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MATICGHDQTSGNGRHGDVADVNGCGSTHQALGPPSGLPDASPNERSAIQIPAGRIDDAVAKVDGLVGELMQNTGIPGMAVAIVHGGKTLYAKGFGVRDVGKGGGPDNKVDADTVFQLASVSKSVGATVVAHAVTDNVVTWDTPVVSKLPWFALRDPYVTGQVTIADLYSHRSGLPDHAGDLLEDLGYDRRQVLQRLKYLPLAPFRISYAYTNFGVTAAAEAVAAAAGQSWEDLSDEVLYRPLGMGSTSSRFTDFLARPNHAVNHVKVADRWEARYQRDPDAQSPAGGVSSSLNDMTHWLAMVLADGVYNGRRITSPEALLPVYTPQVISRHPVSPRARASFYGYGFNVGVTSSGRTEYSHSGAFGLGAAANFVVLPSEDLAIIALTNAGPIGVPETLTAEFMDLVQYGQVREDWAALYKKAFAPLNELAGSLVGKQSPANPAPSRPLNDYVGVYANDYWGPATVTYHDGQLRLSLGPKNQTFDLTHWDGDTFTFTLSTENALPGSISKATFAGDTLNLEYYDADKLGTFTR,"56,736",532,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O06551,O06551_MYCTU,Rv1153c,omt Rv1153c,GO:0005886; GO:0008168; GO:1901106,IPR007213; IPR029063; IPR016874; ,,omt,,Probable O-methyltransferase Omt,plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; tetracenomycin C biosynthetic process [GO:1901106],9634230; 21969609,,,MSAHKPAKQRVALTGVSETALLTLNARAAEARRRDAIIDDPMAVALVESIDFDFAKFGPTGQGFALRARAFDMAAQHYLDQHPAATVVALAEGLQTSFWRLDVAIPGGQFRWLTVDLPPIVDLRTRLLPSSPRVSVCAQSALDYSWMDSVDPAGGVFITAEGLLMYLQPEQALGLIAQCAQTFPGGQMLFDLPPRWFAGWSRLGLRTSLRYKVPRMPFSMSVAQAADLVNKVPGVVAVRDLRVPPGRGLWVNMALSTVYRLPVFDPLRPCLTLLEFSRPARG,"30,887",282,,tetracenomycin C biosynthetic process [GO:1901106],methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
I6Y4Z9,I6Y4Z9_MYCTU,Rv0857,Rv0857,,IPR019587; IPR023393; ,,,,Uncharacterized protein,,9634230,,,MIANLVAVAIRASREVVIEAPPEVIVEALADMDAVPSWSSVHKRVEVVDTYSDGRPHHVKVTIKVAGIVDTELLEYHWGPDWVVWDAAKTAQQHGQHGEYNLRREDNDKTRVRFTLTVEPSAPLPAFWVNIARKKILHAATEGLRKQVVGRRRFTSG,"17,649",157,,,,,,,1
O05580,O05580_MYCTU,Rv0997,Rv0997,,,,,,Uncharacterized protein,,9634230; 21969609,,,MAGIAGVDRDPPGWPQHSHLLAGDPERFRHQLQRAETTNSIECFVAEWHHAGVAADMTRPWPTVVQGGAGQRRRRDVEPDRKTPVRWMSGQRLSEITWPTTDIEHSVGAAEVQRHRGAVPLGSGGDAAGKVEGGRTPQPFVQP,"15,664",143,,,,,,,1
O53408,O53408_MYCTU,Rv1060,Rv1060,GO:0005886,IPR019587; IPR023393; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAKSVVVEQSRAIPVQSEDAFGGTLAAALPVICSHWYGLIPPIKEVRDQTGAWDSVGQARVITMVGGGRVREELTSVDPPRSFGYTLTDIKGPLAPLVALVEGKWSFAPADTGTTVTWQWTIHPRSALAAPVLPVFARMWRGYARGVLEKLSALLVG,"16,867",157,,,,plasma membrane [GO:0005886],,,1
Q79FV3,Q79FV3_MYCTU,Rv0872c,PE_PGRS15 Rv0872c,,IPR000084; ,,PE_PGRS15,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS15,,9634230; 21969609,,,MSYVLATPEMVAAAANNLAQIGSTLSAANAAALAPTTGVLAAGADEVSAAVASLFSGHAQAYQTLGTQAAAFHERFIQALSTAAGAYGSAEAANASPLQQALNVINAPTQTLLGRPLIGNGTNGAPGTGQAGGPGGLLYGNGGNGGSGGVGQAGGAGGSAGLIGIGGTGGAGGAGAVGGVGGNGGWLYGNGGAGGLGGTGVAGVNGGMGAAGGAGGNAYLFGSGGAGGQGGMGAAGADGVNPTPTGTADAGSTGTDQTLGGNAIGGNGGPGDAGDAMTSGGAGGSGGNAVSTVNGDAVGGEGGKGGEGAYGGAGGAGGSAASIGNAAIGGNGGAGGNAQAPGGVGGAGGEGGDAQVGTNSPSNAEAGNGGSGGNGFDSFASGGTGGAGGTGGAGGRGGLLIGDGGAGGAGGVGGTGGSGAPGGGGGAGGDGGAANTDSAGSSRKAFGGDGGVGGDGASALGTGGEGGIGGQGGNGGAGGLLIGNGGAGGVGGTAGAGGTGGSGGAGGAGGAGGGGTNSGPGAAFGGNGNTGGNGGNGGAPGALGGKGGSGGLIGRAGSDGGVGAGGAGGAGGAGGTGGEGGTGGDGKTTDGNPGMGGSPGSAGQPG,"50,268",606,,,,,,,1
O05575,O05575_MYCTU,Rv0992c,Rv0992c,GO:0005524; GO:0009396; GO:0030272; GO:0035999; GO:0046872,IPR002698; IPR024185; IPR037171; ,,,,5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2),5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999],9634230; 21969609,,,MAMASKSALRDQLLAARRRVADDVRAAEARMLRGHLERMVTSDSTVCAYVPVGGEPGSIEMLDVLLRRAGRVLLPVARTAGGDLPLPLRWGEYRAGGLARARWGLLEPPEPWLPEAALAQASLVLVPALAVDRQGVRLGRGRGFYDRSLRCRDPHARLVAVVRTVELVDVLPSEPHDVPMTHALTPERGLIALPCGE,"21,413",197,5-formyltetrahydrofolate cyclo-ligase family,folic acid-containing compound biosynthetic process [GO:0009396]; tetrahydrofolate interconversion [GO:0035999],5-formyltetrahydrofolate cyclo-ligase activity [GO:0030272]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],,,,1
P96376,P96376_MYCTU,Rv1024,Rv1024,GO:0007049; GO:0040007,IPR007060; ,,,,Possible conserved membrane protein,cell cycle [GO:0007049]; growth [GO:0040007],9634230,,,MPEAKRPESKRRSPASRPGKAGDSVRGGRATKPSAKPSTPAPHASRKTTRTPHEHIVEPIKRAITESVEKRSEQRLGFTARRAAILAAVVCVLTLTIARPVRTYFAQRAEMEQLAATEAMLRRQIADLEEQQVKLADPAYIAAQARERLGFVMPGDIPFQVQLPSTPLAPPQPGSDAATATNNEPWYTALWHTIADDPHLPPAAPPAPEPGRPGPLPPASPNPEQPGG,"24,570",228,,cell cycle [GO:0007049]; growth [GO:0040007],,,,,1
O06540,O06540_MYCTU,Rv1140,Rv1140,GO:0005886; GO:0016021,IPR003675; ,,,,Probable integral membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MPRDYTAPRWAHAWAGEPRPARWHPANQPAHPDHSNRESPACMSQSTTPYRSSVLAEFRRAITNVAVPHHEPPGIVRRRRVVVGVTLVIGAVMLGFSLRRTPGESSFYWLTLALAAVWIAGALMSGPLHLGGICWRGRNQRPVITGTTVGLLLAGIFGVGAMIVRAIPGAAEPIARVLQFAHQGTLLPILLITLINGIAEEMFFRGALYTALGRRYPVTISTVLYVGATMASANLMLGFAAIFVGTVCALERRASGGVLAPILTHFVWGLIMVFALPPLFAV,"30,426",282,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6XA42,I6XA42_MYCTU,Rv0919,Rv0919,GO:0016740,IPR016181; IPR000182; ,,,,GCN5-related N-acetyltransferase,transferase activity [GO:0016740],9634230; 21969609,,,MSGYSAPRRISDADDVTSFSSGEPSLDDYLRKRALANHVQGGSRCFVTCRDGRVVGFYALASGSVAHADAPGRVRRNMPDPVPVILLSRLAVDRKEQGRGLGSHLLRDAIGRCVQAADSIGLRAILVHALHDEARAFYVHFDFEISPTDPLHLMLLMKDARALIGD,"18,081",166,,,transferase activity [GO:0016740],,,,1
O05591,O05591_MYCTU,Rv1005c,pabB Rv1005c,GO:0005618; GO:0005737; GO:0005886; GO:0040007; GO:0046654; GO:0046820,IPR005801; IPR019999; IPR015890; IPR005802; ,,pabB,DOMAIN 188 435 Chorismate_bind. {ECO:0000259|Pfam:PF00425}.,Probable para-aminobenzoate synthase component I PABD,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 4-amino-4-deoxychorismate synthase activity [GO:0046820]; growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],9634230; 21969609,,,MNLAWELSTRTKSPRSHLRCENPQFCQARTVRIDRLGDLGGAPAVLRAVGRATSRLDLPPPAALTGEWFGALAVIAPSVSIQPVSGDDVFSGPPGTGGPDATGAVGGGWVGYLSYPDAGADGRPHRIPEAAGGWTDCVLRRDRDGQWWYESLSGAPIADWLASALATTRASVARPAPACRIDWEPADRAAHRDGVLACLEAIGAGEVYQACVCTQFAGTVTGSPLDFFIDGFGRTAPSRSAFVAGPWGAVASLSPELFLRRRGSVVTSSPIKGTLPLDAPPSALRASAKEVAENIMIVDLVRNDLGRVAVTGTVTVPELLVVRPAPGVWHLVSTVSARVPLEEPMSALLDAAFPPASVTGTPKLRARQLISQWERYRRGIYCGTVGLASPVAGCELNVAIRTVEFDTAGNAVLGVGGGITADSDPDAEWAECLHKAAPIVGLPAATRTTPARLASKVR,"47,899",458,,growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],4-amino-4-deoxychorismate synthase activity [GO:0046820],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
O53405,O53405_MYCTU,Rv1057,Rv1057,,IPR011048; IPR015943; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSVMNGREVARESRDAQVFEFGTAPGSAVVKIPVQGGPIGGIAISRDGSLLVVTNNGTDTVSVVGTDTCRVTQTVTSVNEPFAIAMGNAEANRAYVSTVSSAYDAIAVIDVATNTVLGTHPLALSVSDLTLSPDDKYLYVSRNGTRGADVAVLDTTTGALIDVVDVSQAPGTTTQCVRMSPDGSVLYVGANGPSGGLLVVITTRAQSDGGRIGSRSRSRQKSSKPRGNQAAAGLRVVATIDIGSSVRDVALSPDGAIAYVASCGSDFGAVVDVIDTRTHQITSSRAISEIGGLVTRVSVSGDADRAYLVSEDRVTVLCTRTHDVIGTIRTGQPSCVVESPDGKYLYIADYSGTITRTAVASTIVSGTEQLALQRRGSMQWFSPELQQYAPALA,"40,711",393,,,,,,,3
O06552,O06552_MYCTU,Rv1154c,Rv1154c,,IPR012545; ,,,,Uncharacterized protein,,9634230; 21969609,,,MEFPLITANSLSSKTWRAMPRAYVAVASFSGGLVQSGMAKFAAFLRGVNVGGVNLKMAEVATALTDAGFCNVRTILASGNVLLESTCGAAEVREKTEATLRERFGYDAWALIYDVDTVRTIVTAYPFECELEGYQSYVTFVADAAILDELSALADTAGPDENISRGPDPLGVLYWQVPKGSTLDSTIGQTMGKKRYKSSTTTRNLRTLAKVLR,"22,999",213,,,,,,,1
O06550,O06550_MYCTU,Rv1152,Rv1152,GO:0003677; GO:0003700; GO:0006351,IPR000524; IPR036388; IPR036390; ,,,DOMAIN 15 83 HTH gntR-type. {ECO:0000259|PROSITE:PS50949}.,Probable transcriptional regulatory protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MELRDWLRVDVKAGKPLFDQLRTQVIDGVRAGALPPGTRLPTVRDLAGQLGVAANTVARAYRELESAAIVETRGRFGTFISRFDPTDAAMAAAAKEYVGVARALGLTKSDAMRYLTHVPDD,"13,114",121,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
O06569,O06569_MYCTU,Rv1117,Rv1117,GO:0003824,IPR007138; IPR011008; ,,,,Conserved protein,catalytic activity [GO:0003824],9634230; 21969609,,,MIFIVVKFETKPEWTERWPDLVASFTAATRAEEGNLWFEWSRSLDDPAEYVLVESFRDGEAGGVHVNSDHFRQAMRELPKALASTPKIISQTIDATGWSAMGEMTVG,"12,050",107,,,catalytic activity [GO:0003824],,,,1
O06534,O06534_MYCTU,Rv1134,Rv1134,,,,,,Uncharacterized protein,,9634230,,,MAAYQKFGQEHAAAIRGGAVLHPTATATTVRVTGARGGDVVTGDGPYEAADLDEQGPFPMETVYLWEDGPNGTTRMTL,"8,195",78,,,,,,,1
O06539,O06539_MYCTU,Rv1139c,Rv1139c,GO:0004671; GO:0016021,IPR007269; ,,,,Conserved hypothetical membrane protein,integral component of membrane [GO:0016021]; protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671],9634230; 21969609,,,MYYLLILAVVFERLAELVVAQRNARWSFAQGGKEFGRPHYVVMVILHTALLLGCVVEPWALHRPFIPWLGWPMLAVVVASQGLRWWCVKSLGKRWNTRVIVLPHATLVRRGPYRWMRHPNYVAVVAEGFALPLVHTAWLTALVFTLANATLLTVRLRVENSVLGYI,"18,995",166,,,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity [GO:0004671],integral component of membrane [GO:0016021],,,1
P96365,P96365_MYCTU,Rv1036c,Rv1036c,,,,,,Probable IS1560 transposase,,9634230,,,MIPGRMVLNWEDGLNALVAEGIEAIVFRTLGDQCWLWESLLPDEVRRLPEELARVDALLDDPAFFAPFVPFFDPRRGRPSTPMEVYLQLMFVKFRYRLGYESLCREVADSIT,"12,996",112,,,,,,,1
O07182,O07182_MYCTU,Rv0797,Rv0797,GO:0003677; GO:0004803; GO:0006313,IPR003346; IPR002525; ,,,,Putative transposase for insertion sequence element IS1547,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MVVVGTDAHKYSHTFVATDEVGRQLGEKTVKATTAGHATAIMWAREQFGLELIWGIEDCRNMSARLERDLLAAGQQVVRVPTKLMAQTRKSARSRGKSDPIDALAVARAVMRETDLPLATHDETSRELKLLTDRRDVLVAQRTSAINRLRWLVHELDPERAPAARSLDAAKHQQALRTWLDTQPGLVAELARAELTDIIRLTGEINTLAQRISARVHQVAPALLEIPGCAELTAAKIVGEAAGVTRFKSEAAFACHAAVAPIPVWSGNTAGQMRLSRSGNRQLNAALHRIALTQIRMTDSRGQAYYQRLQDAGKTKRAALRCLKRRLARTVFQALRTVHQPSSEHTQPAAACHRSYCSRSCLSG,"40,046",364,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
Q79FT0,Q79FT0_MYCTU,Rv1087,PE_PGRS21 Rv1087,,IPR000084; ,,PE_PGRS21,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein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
I6Y4V2,I6Y4V2_MYCTU,Rv0804,Rv0804,GO:0016020,IPR003675; IPR015837; ,,,,Uncharacterized protein,membrane [GO:0016020],9634230; 21969609,,,MSRLRALSLAAGLVGWSLVSPRLPAPWRIPLQAGLGSVLVLVTRATMGLWPPRLWAGLRLGWAAGAAAATAIAATTPVPMVRLSMSARELPASVPVWLVWHIPGGTVWAEEAAFRGALATIGARAFGRSGGRILQAGAFGLSHIADARATGEPLVLTVLATGIAGWMFGWLADRSGSLAAPLLTHLAINEAGAVAAVLVQRRSGISTRL,"21,628",209,,,,membrane [GO:0016020],,,1
P96381,P96381_MYCTU,Rv1019,Rv1019,GO:0003677; GO:0003700; GO:0006355,IPR023772; IPR009057; IPR001647; IPR036271; ,,,DOMAIN 4 64 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MTGTERRHQLIGIARSLFAERGYDGTSIEEIAQRANVSKPVVYEHFGGKEGLYAVVVDREMSALLDGITSSLTNNRSRVRVERVALALLTYVEERTDGFRIMIRDSPASISSGTYSSLLNDAVSQVSSILAGDFARRGLDPDLAPLYAQALVGSVSMTAQWWLDAREPKKEVVAAHLVNLVWNGLTHLEADPRLQDE,"21,702",197,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,3
I6Y8V2,I6Y8V2_MYCTU,Rv0816c,thiX Rv0816c,GO:0004791; GO:0005829; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0047134,IPR005746; IPR036249; IPR013766; ,,thiX,,Probable thioredoxin ThiX,"cytosol [GO:0005829]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]",9634230,,,MTTMIVASVATGALATIARWLLTRRSVILREVGPETTPAAPARTAELGLSGAGPTVVHFRAPGCAPCDRVRRGVGDVCADLGDVAHIEVDLDSNPQAARRFSVLSLPTTLIFDVDGRQRYRTSGVPKAADLRSALKPLLA,"14,758",140,,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662],"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]",cytosol [GO:0005829],,,1
I6X043,I6X043_MYCTU,Rv1034c,Rv1034c,GO:0003677; GO:0004803; GO:0006313,IPR002559; ,,,DOMAIN 3 121 DDE_Tnp_1. {ECO:0000259|Pfam:PF01609}.,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MQQGNPPDAPQLAPAVAWVKKRAGRTPRTVTADRGYGEAAVDQQLTEVGVKNVLIPRKGKPSQDRRAEEHRKAFRRTIKWRTGCEGRISHLKRGYGWDRGRIGGLEGTRTWVGHGVFAHNLVTISALPA,"14,286",129,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
O53423,O53423_MYCTU,Rv1075c,Rv1075c,GO:0004622; GO:0005618; GO:0005886,IPR013830; IPR036514; ,,,,Conserved exported protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622],9634230,,,MPRRSTIALATAGALASTGTAYLGARNLLVGQATHARTVIPKSFDAPPRADGVYTRGGGPVQRWRREVPFDVHLMIFGDSTATGYGCASAEEVPGVLIARGLAEQTGKRIRLSTKAIVGATSKGVCGQVDAMFVVGPPPDAAVIMIGANDITALNGIGPSAQRLADCVRRLRTRGAVVVVGTCPDLGVITAIPQPLRALAHTRGVRLARAQTAAVKAAGGVPVPLGHLLAPKFRAMPELMFSADRYHPSAPAYALAADLLFLALRDALTEKLDIPIHETPSRPGTATLEPGHTRHSMMSRLRRPRPARAVPTGG,"32,879",314,,,lysophospholipase activity [GO:0004622],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
I6Y8Y8,I6Y8Y8_MYCTU,Rv0865,mog Rv0865,,IPR036425; IPR001453; ,,mog,,Probable molybdopterin biosynthesis Mog protein,,9634230; 21969609,,,MSTRSARIVVVSSRAAAGVYTDDCGPIIAGWLEQHGFSSVQPQVVADGNPVGEALHDAVNAGVDVIITSGGTGISPTDTTPEHTVAVLDYVIPGLADAIRRSGLPKVPTSVLSRGVCGVAGRTLIINLPGSPGGVRDGLGVLADVLDHALEQIAGGDHPR,"16,188",160,,,,,,,1
I6Y8Y0,I6Y8Y0_MYCTU,Rv0855,far Rv0855,GO:0003824,IPR003673; IPR023606; ,,far,,Probable fatty-acid-CoA racemase Far,catalytic activity [GO:0003824],9634230; 21969609,,,MTTGGPLAGVKVIELGGIGPGPHAGMVLADLGADVVRVRRPGGLTMPSEDRDLLHRGKRIVDLDVKTQPQAMLELAAKADVLLDCFRPGTCERLGIGPDDCASVNPRLIFARITGWGQDGPLASTAGHDINYLSQTGALAAFGYADRPPMPPLNLVADFGGGSMLVLLGIVVALYERERSGVGQVVDAAMVDGVSVLAQMMWTMKGIGSLRDQRESFLLDGGAPFYRCYETSDGKYMAVGAIEPQFFAALLSGLGLSAADVPTQLDVAGYPQMYDIFAERFASRTRDEWTRVFAGTDACVTPVLAWSEAANNDHLKARSTVITAHGVQQAAPAPRFSRTPAGPVRPPPAAATPIDEINW,"38,059",359,,,catalytic activity [GO:0003824],,,,1
O53401,O53401_MYCTU,Rv1053c,Rv1053c,,,,,,Uncharacterized protein,,9634230,,,MDSHKVCMNNNTQLPTGPIIGVHPAVRDGVERVAYLDGDLLRCNTDVEFTSSPPPGPVLYRTKHTRVEIADEMVTEKLIKRQRAFNSRRHQ,"10,326",91,,,,,,,1
I6XWB9,I6XWB9_MYCTU,Rv0810c,Rv0810c,,IPR021426; ,,,,Uncharacterized protein,,9634230,,,MGRGRAKAKQTKVARELKYSSPQTDFQRLQRELSGTGTDRLDGDGPSDDDSWNDEDDWRR,"6,900",60,,,,,,,1
O06536,O06536_MYCTU,Rv1136,Rv1136,GO:0004300; GO:0006635,IPR029045; IPR001753; ,,,,Possible enoyl-CoA hydratase,enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230,,,MVITINRPEARNAVNGAVSIVVGDALEEAHDNPDVRAVVITGAGDKSLCAGADLKAIARRENPYHPHHGEWGIAGYRHHFIDKPTSAAVSGTALDDGAEPALASDLVVADEHT,"11,825",113,,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],,,,1
O86331,O86331_MYCTU,Rv0792c,Rv0792c,GO:0003677; GO:0003700; GO:0006351; GO:0052572,IPR028978; IPR000524; IPR011663; IPR036388; IPR036390; ,,,DOMAIN 20 88 HTH gntR-type. {ECO:0000259|PROSITE:PS50949}.,Probable transcriptional regulatory protein (Probably GntR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MTSVKLDLDAADLRISRGSVPASTQLAEALKAQIIQQRLPRGGRLPSERELIDRSGLSRVTVRAAVGMLQRQGWLVRRQGLGTFVADPVEQELSCGVRTITEVLLSCGVTPQVDVLSHQTGPAPQRISETLGLVEVLCIRRRIRTGDQPLALVTAYLPPGVGPAVEPLLSGSADTETTYAMWERRLGVRIAQATHEIHAAGASPDVADALGLAVGSPVLVVDRTSYTNDGKPLEVVVFHHRPERYQFSVTLPRTLPGSGAGIIEKRDFA,"28,959",269,,"response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
O53414,O53414_MYCTU,Rv1066,Rv1066,,IPR001763; IPR036873; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSRIDRVLEAARRRYRRLAADQVPEAARRGAVLVDIRPQAQRAREGEVPGALVIERNVLEWRCDPTSDARLPQAVDDDVEWVILCSEGYTSSLAAASLLDLGLHRATDVVGGYRALAAGGVLAELGGAVGG,"14,033",131,,,,,,,1
O06547,O06547_MYCTU,Rv1147,Rv1147,,IPR029063; ,,,,Conserved protein,,9634230; 21969609,,,MTSGAAASASRVDHPLFARIWPVVAAHEAEAIRALRRENLAGLSGRVLEVGAGVGTNFAYYPVAVEQVIAMEPEPRLAAKARIAAADAPVPIVVTDKTVEEFRDTETFDAVVCSLVLCSVSDPGAVLAHLRSLLRRGGELRYLEHVASAGARGRVQRFVDATFWPRLAGNCHTHRHTERAILDAGFVVDSSRREWAFPAWVPLPVSELALGRAHRT,"23,405",216,,,,,,,1
O06556,O06556_MYCTU,Rv1158c,Rv1158c,GO:0005576,,,,,"Conserved hypothetical ala-, pro-rich protein",extracellular region [GO:0005576],9634230,,,MPTIWTFVRAAAVLVGSSAALLTGGIAHADPAPAPAPAPNIPQQLISSAANAPQILQNLATALGATPPLSAPKVAEPAPAAPGITATFPGLTPAAPAAAAAPALTPSIPGVNAPIPGITPAAPALPVTAPAAAPTIPGVNAPIPGITAPAPAAAAVPASVPGVPSAKVDLPQLPYLPLQVPQQLSLPADLPALASGVIPAAPIAPTPPAPGAPALPPGPPSLLAALP,"21,401",227,,,,extracellular region [GO:0005576],,,1
O05573,O05573_MYCTU,Rv0990c,Rv0990c,,IPR013974; ,,,,Uncharacterized protein,,9634230,,,MAESSLNPSLVSRISAFLRPDWTRTVRARRFAAAGLVMLAGVAALRSNPEDDRSEVVVAAHDLRPGTALTPGDVRLEKRSATTLPDGSQADLDAVVGSTLASPTRRGEVLTDVRLLGSRLAESTAGPDARIVPLHLADSALVDLVRVGDVVDVLAAPVTDSPAALRLLATDAIVVLVSAQQKAQAADSDRVVLVALPARLANTVAGAALGQTVTLTLH,"22,583",218,,,,,,,1
I6XWE5,I6XWE5_MYCTU,Rv0843,Rv0843,GO:0016624,IPR001017; IPR017596; IPR029061; ,,,,Probable dehydrogenase,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO:0016624]",9634230,,,MTRTSEGLAAFVVDQLEELYRRMWVLRLLDMALEQLRIEGLINGPLQGGFGQEAVSVGAAAALGEGDVIITTHRPHAQHVGTDAPLGPVIADMLGATAGDLEGADEDAHIADPRAGLPAAIRVVKQSPLLAIGHAYALWLRDTGRVTLCVTQDCDVDADAFNEAADLAAVWQLPVVILVENIRGALSVHLDRYTHEPRVYRRAVAYGMPGVSVDGNDVEAVRDCVANAVVRARAGGGPTLVQAITYRTTDFSGSDRGGYRDLAGSEQFLDPLIFARRRLIAAGTTRGRLDEQERAACQQVADAVAFAKARARPNGGGPISRPTSGWHQQPKTRF,"35,757",334,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO:0016624]",,,,1
L7N667,L7N667_MYCTU,Rv1040c,PE8 Rv1040c,,IPR000084; IPR022171; ,,PE8,,PE family protein PE8,,9634230; 28842489,X-ray crystallography (1),,MSFLKTVPEELTAAAAQLGTIGAAMAAQNAAAAAPTTAIAPAALDEVSALQAALFTAYGTFYQQVSAEAQAMHDMFVNTLGISAGTYGVTESLNSSAAASPLSGITGEASAIIQATTGLFPPELSGGIGNILNIGAGNWASATSTLIGLAGGGLLPAEEAAEAASALGGEAALGELGALGAAEAALGEAGIAAGLGSASAIGMLSVPPAWAGQATLVSTTSTLPGAGWTAAAPQAAAGTFIPGMPGVASAARNSAGFGAPRYGVKPIVMPKPATV,"26,225",275,,,,,,,1
I6WZK3,I6WZK3_MYCTU,Rv0841,Rv0841,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MVAASIVHHSAAPANRGRYHGIWSMTPVVASVVVPIMASYGPIHGAHLLAAVVVGSAGAALCLPLARALRRPTPSAMTTD,"8,151",80,,,,integral component of membrane [GO:0016021],,,1
L7N6A9,L7N6A9_MYCTU,Rv1116A,Rv1116A,,,,,,Uncharacterized protein,,9634230,,,MGALGTVRGLQDSNTAFVGALHSGNLLGATGAVLQAPGNAVNGFLFGQTSISQSIDVSPEYGYELVAVSDPVGGTAGSARAGHGYVHADLR,"9,044",91,,,,,,,1
O06554,O06554_MYCTU,Rv1156,Rv1156,GO:0003824; GO:0006284,IPR017658; IPR011257; IPR003265; ,,,,Conserved protein,catalytic activity [GO:0003824]; base-excision repair [GO:0006284],9634230; 21969609,,,MPNLQLVQEPAADALLNANPFALLVGMLLDQQVPMETAFAGPKKIADRMGSFDAGDIADYDPDKFVALCSERPAIHRFPGSMAKRIQALAQIIVDRYDGDAAALWTAGEPDGNELLRRLKGLPGFGEQKARIFLALLGKQYGVTPKGWQVAAGEFGQPGTYLSVADIVDAGSLGQVRSHKRQRKAAAKAEGKAPT,"20,872",195,,base-excision repair [GO:0006284],catalytic activity [GO:0003824],,,,1
O53444,O53444_MYCTU,Rv1096,Rv1096,GO:0005576; GO:0005618; GO:0005975; GO:0016020; GO:0016021; GO:0016810,IPR011330; IPR002509; ,,,,Possible glycosyl hydrolase,"cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MPKRPDNQTWRYWRTVTGVVVAGAVLVVGGLSGRVTRAENLSCSVIKCVALTFDDGPGPYTDRLLHILTDNDAKATFFLIGNKVAANPAGARRIADAGMEIGSHTWEHPNMTTIPPEDIPGQFSRANDVIAAATGRTPTLYRPAGGLSNDAVRQAAAKVGQAEILWDVIPFDWINDSNTAATRHMLMTQIKPGSVVLFHDTYSSTVDVVYQFIPVLKANGYRLVTVSELLGPRAPGSSYGSRENGPPVNELRDIPASEIPPLPNTSSPKPMPNFPITDIAGQNSGGPNNGA,"31,109",291,,carbohydrate metabolic process [GO:0005975],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020],,,1
I6Y4Z4,I6Y4Z4_MYCTU,Rv0852,fadD16 Rv0852,GO:0016874,,,fadD16,,Possible fatty-acid-CoA ligase FadD16 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874],9634230; 21969609,,,MFTIGYSCASRGADSWLIRRCSVVQGCLDDPGATVEAIDDDGWPHTGDPCSPNSAASGKYGERPASVSTGDIHSLVIASDYRVPDPGRVWPLLQRNKSALADIGAHHVLIYASTHDSGRVLVMIGVRSREPIVELLRSRVFFDWFDAMGVDDIPAVFAGEIVDRFVAAPTTTQSTPRVPGVVVAAFASVNNVSNLTAEVRSAIARFTAAGIRKTWVFQAFDDAHEVLILQEFADEAGARQWIEHPDAAAEWMSGAGVGAYPPLFVGRFFDMMRIEALQ,"30,108",278,,,ligase activity [GO:0016874],,,,1
O53896,O53896_MYCTU,Rv0983,pepD Rv0983,GO:0004252; GO:0005576; GO:0006508; GO:0008236; GO:0009405; GO:0016021; GO:0030163; GO:0071236,IPR001478; IPR036034; IPR009003; IPR001940; ,,pepD,DOMAIN 368 449 PDZ. {ECO:0000259|PROSITE:PS50106}.,Probable serine protease PepD (Serine proteinase) (MTB32B),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; cellular response to antibiotic [GO:0071236]; pathogenesis [GO:0009405]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],9634230; 18479146; 21969609,X-ray crystallography (2),,MAKLARVVGLVQEEQPSDMTNHPRYSPPPQQPGTPGYAQGQQQTYSQQFDWRYPPSPPPQPTQYRQPYEALGGTRPGLIPGVIPTMTPPPGMVRQRPRAGMLAIGAVTIAVVSAGIGGAAASLVGFNRAPAGPSGGPVAASAAPSIPAANMPPGSVEQVAAKVVPSVVMLETDLGRQSEEGSGIILSAEGLILTNNHVIAAAAKPPLGSPPPKTTVTFSDGRTAPFTVVGADPTSDIAVVRVQGVSGLTPISLGSSSDLRVGQPVLAIGSPLGLEGTVTTGIVSALNRPVSTTGEAGNQNTVLDAIQTDAAINPGNSGGALVNMNAQLVGVNSAIATLGADSADAQSGSIGLGFAIPVDQAKRIADELISTGKASHASLGVQVTNDKDTLGAKIVEVVAGGAAANAGVPKGVVVTKVDDRPINSADALVAAVRSKAPGATVALTFQDPSGGSRTVQVTLGKAEQ,"46,453",464,,cellular response to antibiotic [GO:0071236]; pathogenesis [GO:0009405]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508],serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
I6X9Y7,I6X9Y7_MYCTU,Rv0854,Rv0854,,IPR019587; IPR023393; ,,,,Conserved protein,,9634230; 21969609,,,MAIKESRDIVIEASPEEILDVIADFEAMTEWSPAHQSVEILETGDDGRPSKVKMKVKTAGITDEQVVAYSWTDRSVRWTLVSSTQQRSQDGKYELTPKGDNTLVQFEITVDPQVPLPGFVLKRAIKGTIDTATEALRSQVLKVKKGQ,"16,346",147,,,,,,,1
O86320,O86320_MYCTU,Rv0976c,Rv0976c,,IPR010839; ,,,,Uncharacterized protein,,9634230,,,MRIGNCSGFYGDRLSAMREMLTGGELDYLTGDYLAELTMLILGRDRMKNPDRGYAKTFLAQLEDCLGLAHDRGVRIVTNAGGLNPAGLANAVRALAARLGIPAQVAHVEGDDLQPRAAELGLGTPLTANAYLGAWGIVDCFERGADVVVTGRVTDASVVVGAAAAHFGWGRTDYHRLAGAVVAGHVIECGVQATGGNYAFFTEIGDLTHAGFPLAEIAADGSSVITKHHGTGGLVSVDTITAQLLYEITGARYANPDVTARMDSVELSPDGPDRVRISGVIGEPPPPTYKVSLNSIGGFRNAMTFVLTGLDIDAKADLVRRQLEAALTVKPAELQWTLARTDHPDADTEETASALLTCVARDPDPANVGRQFSSAAVELALASYPGFTATAPPGDGQVYGVFTPGYVDAGKVAHIAVHADGTRTEIPCATETLELAPAHPPALPDPLPAGPTRRVPLGLIAGARSGDKGGSANVGVWVRTDEQWRWLAHTLTVELLKELLPETAGLVVTRHVLPNLRALNFVIEAILGQGVAYQARFDPQAKGLGEWLRSRHVEIPETLL,"59,123",560,,,,,,,1
O86370,O86370_MYCTU,Rv0988,Rv0988,,IPR023374; IPR010791; ,,,DOMAIN 71 246 CrtC. {ECO:0000259|Pfam:PF07143}.,Possible conserved exported protein,,9634230; 21969609,,,MRKAGLTGVVLVLTLTLVAFWWWQRPRTNAVAADSLVGVLVDENNAGYSLATVPGAVRFPRDLGPHYDYQTEWWYYTGNLETADGRLFGYQLTFFRRALAPPGEGVAIADASSWRTTQVYMAHFAISDISNRGFYPAEKFSRQALGLAGASSEPYAVWLDDWYARESNNNSVQLFARTQNTVLDLTLTQTLPPILQGNAGLSVKGAQPGNASNYYSLVRQESRGTVSVNGDTFMVSGLSWKDHEYMTSALAPEDVGWDWFGLQFYNGTALMLFQIRQADGSVTRFSSGTFVAGDGGVIPLESSDFRIKTTDRWTSDQSGATYPIAWEIEIERIGLTLRGAALMANQELRLSRTYWEGAVALEGRYQGMPISGRGYVEMTGYVQRLS,"42,776",386,,,,,,,1
I6Y946,I6Y946_MYCTU,Rv0925c,Rv0925c,GO:0016491,IPR029039; IPR005025; ,,,,Conserved protein,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTTTSDQNAAAPPRFDGLRALFINATLKRSPELSHTDGLIERSSGIMREHGVQVDTLRAVDHDIATGVWPDMTEHGWATDEWPALYRRVLDAHILVLCGPIWLGDNSSVMKRVIERLYACSSLLNEDGQYAYYGRAGGCLITGNEDGVKHCAMNVLYSLQHLGYTIPPQADAGWIGEAGPGPSYLDPGSGGPENDFTNRNTTFMTFNLMHIAQMLRVAGGIPAYGNQRTKWDAGCRPDFANPDYR,"26,944",245,,,oxidoreductase activity [GO:0016491],,,,1
O53438,O53438_MYCTU,Rv1090,celA2b Rv1090,GO:0008810; GO:0051275,IPR013320; IPR013319; IPR002594; ,,celA2b,,"Probable cellulase CelA2b (Endo-1,4-beta-glucanase) (Endoglucanase) (Carboxymethyl cellulase)",cellulase activity [GO:0008810]; beta-glucan catabolic process [GO:0051275],9634230,,,MGTNLPTEVGQILSAPTSIDYNYPTTGVWDASYDICLDSTPKTTGVNQQEIMIWFNHQGSIQPVGSPVGNTTIEGKNFVVWDGSNGMNNAMAYVATEPIEVWSFDVMSFVDHTATMEPITDSWYLTSIRAGLEPWSDGVGLGVDSFSAKVN,"16,404",151,Glycosyl hydrolase 12 (cellulase H) family,beta-glucan catabolic process [GO:0051275],cellulase activity [GO:0008810],,,,1
O53400,O53400_MYCTU,Rv1052,Rv1052,,,,,,Uncharacterized protein,,9634230,,,MDCCEERGVARHKGLSQVGTPGCPRWSQAVSCRCSAYREAAVTAVQMPLTPGYGETPLPHDELAALLPEVVEVLDKPITRADVYDLEQGLQDQVFDLLMPTAVEGSLSLDELLSDHFVRDLHARMFGPV,"14,136",129,,,,,,,1
O53872,O53872_MYCTU,Rv0860,fadB Rv0860,GO:0000166; GO:0003857; GO:0005618; GO:0005829; GO:0005886; GO:0006635,IPR006176; IPR006108; IPR008927; IPR029045; IPR001753; IPR036291; ,,fadB,,Probable fatty oxidation protein FadB,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; nucleotide binding [GO:0000166]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609; 23496842,X-ray crystallography (3),,MPDNTIQWDKDADGIVTLTMDDPSGSTNVMNEAYIESMGKAVDRLVAEKDSITGVVVASAKKTFFAGGDVKTMIQARPEDAGDVFNTVETIKRQLRTLETLGKPVVAAINGAALGGGLEIALACHHRIAADVKGSQLGLPEVTLGLLPGGGGVTRTVRMFGIQNAFVSVLAQGTRFKPAKAKEIGLVDELVATVEELVPAAKAWIKEELKANPDGAGVQPWDKKGYKMPGGTPSSPGLAAILPSFPSNLRKQLKGAPMPAPRAILAAAVEGAQVDFDTASRIESRYFASLVTGQVAKNMMQAFFFDLQAINAGGSRPEGIGKTPIKRIGVLGAGMMGAGIAYVSAKAGYEVVLKDVSLEAAAKGKGYSEKLEAKALERGRTTQERSDALLARITPTADAADFKGVDFVIEAVFENQELKHKVFGEIEDIVEPNAILGSNTSTLPITGLATGVKRQEDFIGIHFFSPVDKMPLVEIIKGEKTSDEALARVFDYTLAIGKTPIVVNDSRGFFTSRVIGTFVNEALAMLGEGVEPASIEQAGSQAGYPAPPLQLSDELNLELMHKIAVATRKGVEDAGGTYQPHPAEAVVEKMIELGRSGRLKGAGFYEYADGKRSGLWPGLRETFKSGSSQPPLQDMIDRMLFAEALETQKCLDEGVLTSTADANIGSIMGIGFPPWTGGSAQFIVGYSGPAGTGKAAFVARARELAAAYGDRFLPPESLLS,"76,104",720,,fatty acid beta-oxidation [GO:0006635],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; nucleotide binding [GO:0000166],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53417,O53417_MYCTU,Rv1069c,Rv1069c,GO:0005829; GO:0005886; GO:0005887,IPR027787; IPR012037; IPR027788; ,,,,Conserved protein,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MTEPAAATTTNASDEPATGAEQAVDTAATPQTPEPQPIRSTWWIRHYTFTGTAMGLVFVWFSMTPSLLPRGPLFQGLVSGICGAFGYGLGVFAVWLVRYMRSHNSSPPPPRWAWPPLIAVGAVGMVGMAVQFHVWQDDVRDLMGVEHLRWYDYPLAAALSLVVLFTLVEIGQFIRWLFRFLVGQVDRIAPFRVSAAIVVVLLVVLTITLLNGVVLKFAMNSMNSTFAAVNNEMNPDSAPPKTPLRSGGPGSLVSWESLGHQGRIFVHSGPTIADLTAFNGTPAVEPIRTYAGLNSADGIMATAELAARELARTGGLRRAVVAVATSTGTGWINEAEASALEYMYNGDTAIVSMQYSFLPSWLSFLVDKENARHAGEALFEAVDKLIRQLPESQRPKLVVFGESLGSFGGEAPFMNLNNILARTDGALFSGPTFNNTVWNSLTANRDAGSPQWLPIYDDGRNVRFVARARDLQRPDAPWGRPRVVYLQHASDPIAWWTPRLLFREPDWLREQRGYDVLPQTRWIPVVTFVQVSADMAVATHVPDGHGHRYVATVADGWAAVLSPPGWTQQKTERLQPLLHANAKPFGS,"64,342",587,,,,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P96354,P96354_MYCTU,Rv1047 Rv3023c Rv3115,Rv1047 Rv3023c Rv3115,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTSSHLIDAEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANLMAATPKPSWPWVRTLLHSIYDQPDAESVVAQYDRVLDALTDKLPAVAEHLDTARTDLLAFTAFPKQIWRQIWSNNPQERLNREVRRRTDVVGIFPDRASIIRLVGAVLAEQHDEWIEGRRYLGLEVLTRARAALTSTEEPAKQQTTNTPALTT,"45,780",415,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
L0T897,L0T897_MYCTU,Rv1042c Rv1149,Rv1042c Rv1149,,IPR025161; ,,,,Possible transposase (Probable is like-2 transposase),,9634230,,,MTRVGVISDEFWAVVEPLMPSHEGKPGRRFSDHRLILEGIAWRFRTGSPWRDLPAEFGPWQTVWKRHHRWSLDGTCDEVFAHVAAVFGVDAEVAEDIEKLLSVDSTNVRAHQHSAGACSDTLATGGTVGLQEIRR,"15,117",135,,,,,,,1
P9WIT7,PYRB_MYCTU,Rv1380,pyrB Rv1380 MTCY02B12.14,GO:0004070; GO:0005618; GO:0005829; GO:0005886; GO:0006207; GO:0006520; GO:0009220; GO:0016597; GO:0040007; GO:0044205,IPR006132; IPR006130; IPR036901; IPR002082; IPR006131; ,,pyrB,,Aspartate carbamoyltransferase (EC 2.1.3.2) (Aspartate transcarbamylase) (ATCase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]; growth [GO:0040007]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],9634230; 19099550; 21969609,,,MTPRHLLTAADLSRDDATAILDDADRFAQALVGRDIKKLPTLRGRTVVTMFYENSTRTRVSFEVAGKWMSADVINVSAAGSSVGKGESLRDTALTLRAAGADALIIRHPASGAAHLLAQWTGAHNDGPAVINAGDGTHEHPTQALLDALTIRQRLGGIEGRRIVIVGDILHSRVARSNVMLLDTLGAEVVLVAPPTLLPVGVTGWPATVSHDFDAELPAADAVLMLRVQAERMNGGFFPSVREYSVRYGLTERRQAMLPGHAVVLHPGPMVRGMEITSSVADSSQSAVLQQVSNGVQVRMAVLFHVLVGAQDAGKEGAA,"33,819",319,ATCase/OTCase family,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; cellular amino acid metabolic process [GO:0006520]; growth [GO:0040007]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY02B12.14,1
P9WI51,RPE_MYCTU,Rv1408,rpe Rv1408 MTCY21B4.25,GO:0004750; GO:0005829; GO:0009052; GO:0019323; GO:0044262; GO:0046872,IPR013785; IPR026019; IPR000056; IPR011060; ,,rpe,,Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Pentose-5-phosphate 3-epimerase) (PPE) (R5P3E),"cytosol [GO:0005829]; metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",9634230; 21969609,,FUNCTION: Catalyzes the reversible epimerization of D-ribulose 5-phosphate to D-xylulose 5-phosphate. {ECO:0000250}.,MAGSTGGPLIAPSILAADFARLADEAAAVNGADWLHVDVMDGHFVPNLTIGLPVVESLLAVTDIPMDCHLMIDNPDRWAPPYAEAGAYNVTFHAEATDNPVGVARDIRAAGAKAGISVKPGTPLEPYLDILPHFDTLLVMSVEPGFGGQRFIPEVLSKVRAVRKMVDAGELTILVEIDGGINDDTIEQAAEAGVDCFVAGSAVYGADDPAAAVAALRRQAGAASLHLSL,"23,774",229,Ribulose-phosphate 3-epimerase family,"cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",metal ion binding [GO:0046872]; ribulose-phosphate 3-epimerase activity [GO:0004750],cytosol [GO:0005829],,MTCY21B4.25,1
P9WGY5,RPOZ_MYCTU,Rv1390,rpoZ Rv1390 MTCY21B4.07,GO:0003677; GO:0003899; GO:0005618; GO:0006351; GO:0040007,IPR003716; IPR006110; IPR012293; IPR036161; ,,rpoZ,,DNA-directed RNA polymerase subunit omega (RNAP omega subunit) (EC 2.7.7.6) (RNA polymerase omega subunit) (Transcriptase subunit omega),"cell wall [GO:0005618]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; growth [GO:0040007]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; 22570422,X-ray crystallography (11); Electron microscopy (1),FUNCTION: Promotes RNA polymerase assembly. Latches the N- and C-terminal regions of the beta' subunit thereby facilitating its interaction with the beta and alpha subunits. {ECO:0000269|PubMed:22570422}.,MSISQSDASLAAVPAVDQFDPSSGASGGYDTPLGITNPPIDELLDRVSSKYALVIYAAKRARQINDYYNQLGEGILEYVGPLVEPGLQEKPLSIALREIHADLLEHTEGE,"11,842",110,RNA polymerase subunit omega family,"growth [GO:0040007]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899],cell wall [GO:0005618],,MTCY21B4.07,1
P9WHA1,RL31_MYCTU,Rv1298,rpmE Rv1298 MTCY373.18,GO:0003735; GO:0005840; GO:0006412; GO:0019843; GO:0040007; GO:0046872,IPR034704; IPR002150; IPR027491; ,,rpmE,,50S ribosomal protein L31,ribosome [GO:0005840]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds the 23S rRNA. {ECO:0000255|HAMAP-Rule:MF_00501}.,MKSDIHPAYEETTVVCGCGNTFQTRSTKPGGRIVVEVCSQCHPFYTGKQKILDSGGRVARFEKRYGKRKVGADKAVSTGK,"8,753",80,"Bacterial ribosomal protein bL31 family, Type A subfamily",growth [GO:0040007]; translation [GO:0006412],metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],ribosome [GO:0005840],,MTCY373.18,1
P9WGZ7,RNPH_MYCTU,Rv1340,rph rphA Rv1340 MTCY02B10.04 MTCY130.25,GO:0000049; GO:0005886; GO:0006364; GO:0008033; GO:0009022; GO:0016075,IPR001247; IPR015847; IPR036345; IPR027408; IPR020568; IPR002381; IPR018336; ,,rph,,Ribonuclease PH (RNase PH) (EC 2.7.7.56) (tRNA nucleotidyltransferase),plasma membrane [GO:0005886]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033],9634230; 21969609; ,X-ray crystallography (1),"FUNCTION: Phosphorolytic 3'-5' exoribonuclease that plays an important role in tRNA 3'-end maturation. Removes nucleotide residues following the 3'-CCA terminus of tRNAs; can also add nucleotides to the ends of RNA molecules by using nucleoside diphosphates as substrates, but this may not be physiologically important. Probably plays a role in initiation of 16S rRNA degradation (leading to ribosome degradation) during starvation. {ECO:0000255|HAMAP-Rule:MF_00564}.",MSKREDGRLDHELRPVIITRGFTENPAGSVLIEFGHTKVLCTASVTEGVPRWRKATGLGWLTAEYAMLPSATHSRSDRESVRGRLSGRTQEISRLIGRSLRACIDLAALGENTIAIDCDVLQADGGTRTAAITGAYVALADAVTYLSAAGKLSDPRPLSCAIAAVSVGVVDGRIRVDLPYEEDSRAEVDMNVVATDTGTLVEIQGTGEGATFARSTLDKLLDMALGACDTLFAAQRDALALPYPGVLPQGPPPPKAFGT,"27,351",259,RNase PH family,rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033],tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022],plasma membrane [GO:0005886],rphA,MTCY02B10.04 MTCY130.25,1
P9WPU5,ATPB_MYCTU,Rv1310,atpD Rv1310 MTCY373.30,GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0015986; GO:0040007; GO:0045261; GO:0046933,IPR003593; IPR005722; IPR020003; IPR004100; IPR036121; IPR000194; IPR024034; IPR027417; ,,atpD,,ATP synthase subunit beta (EC 3.6.3.14) (ATP synthase F1 sector subunit beta) (F-ATPase subunit beta),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 21969609,,FUNCTION: Produces ATP from ADP in the presence of a proton gradient across the membrane. The catalytic sites are hosted primarily by the beta subunits. {ECO:0000255|HAMAP-Rule:MF_01347}.,MTTTAEKTDRPGKPGSSDTSGRVVRVTGPVVDVEFPRGSIPELFNALHAEITFESLAKTLTLEVAQHLGDNLVRTISLQPTDGLVRGVEVIDTGRSISVPVGEGVKGHVFNALGDCLDEPGYGEKFEHWSIHRKPPAFEELEPRTEMLETGLKVVDLLTPYVRGGKIALFGGAGVGKTVLIQEMINRIARNFGGTSVFAGVGERTREGNDLWVELAEANVLKDTALVFGQMDEPPGTRMRVALSALTMAEWFRDEQGQDVLLFIDNIFRFTQAGSEVSTLLGRMPSAVGYQPTLADEMGELQERITSTRGRSITSMQAVYVPADDYTDPAPATTFAHLDATTELSRAVFSKGIFPAVDPLASSSTILDPSVVGDEHYRVAQEVIRILQRYKDLQDIIAILGIDELSEEDKQLVNRARRIERFLSQNMMAAEQFTGQPGSTVPVKETIEAFDRLCKGDFDHVPEQAFFLIGGLDDLAKKAESLGAKL,"53,094",486,ATPase alpha/beta chains family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]",,MTCY373.30,1
P9WPV7,ATP6_MYCTU,Rv1304,atpB Rv1304 MTCY373.24,GO:0005886; GO:0005887; GO:0042777; GO:0045263; GO:0046933,IPR000568; IPR023011; IPR035908; ,,atpB,,ATP synthase subunit a (ATP synthase F0 sector subunit a) (F-ATPase subunit 6),"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; plasma membrane ATP synthesis coupled proton transport [GO:0042777]",9634230; 19099550; 21969609,,FUNCTION: Key component of the proton channel; it plays a direct role in the translocation of protons across the membrane. {ECO:0000255|HAMAP-Rule:MF_01393}.,MTETILAAQIEVGEHHTATWLGMTVNTDTVLSTAIAGLIVIALAFYLRAKVTSTDVPGGVQLFFEAITIQMRNQVESAIGMRIAPFVLPLAVTIFVFILISNWLAVLPVQYTDKHGHTTELLKSAAADINYVLALALFVFVCYHTAGIWRRGIVGHPIKLLKGHVTLLAPINLVEEVAKPISLSLRLFGNIFAGGILVALIALFPPYIMWAPNAIWKAFDLFVGAIQAFIFALLTILYFSQAMELEEEHH,"27,467",250,ATPase A chain family,plasma membrane ATP synthesis coupled proton transport [GO:0042777],"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]",,MTCY373.24,1
P9WPU9,ATPG_MYCTU,Rv1309,atpG Rv1309 MTCY373.29,GO:0005618; GO:0005886; GO:0015986; GO:0040007; GO:0045261; GO:0046933,IPR035968; IPR000131; IPR023632; ,,atpG,,ATP synthase gamma chain (ATP synthase F1 sector gamma subunit) (F-ATPase gamma subunit),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 21969609,,FUNCTION: Produces ATP from ADP in the presence of a proton gradient across the membrane. The gamma chain is believed to be important in regulating ATPase activity and the flow of protons through the CF(0) complex. {ECO:0000255|HAMAP-Rule:MF_00815}.,MAATLRELRGRIRSAGSIKKITKAQELIATSRIARAQARLESARPYAFEITRMLTTLAAEAALDHPLLVERPEPKRAGVLVVSSDRGLCGAYNANIFRRSEELFSLLREAGKQPVLYVVGRKAQNYYSFRNWNITESWMGFSEQPTYENAAEIASTLVDAFLLGTDNGEDQRSDSGEGVDELHIVYTEFKSMLSQSAEAHRIAPMVVEYVEEDIGPRTLYSFEPDATMLFESLLPRYLTTRVYAALLESAASELASRQRAMKSATDNADDLIKALTLMANRERQAQITQEISEIVGGANALAEAR,"33,890",305,ATPase gamma chain family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]",,MTCY373.29,1
P9WPX5,ASPG_MYCTU,Rv1538c,ansA Rv1538c MTCY48.27,GO:0004067; GO:0005829; GO:0006530,IPR036152; IPR006034; IPR020827; IPR027475; IPR027473; IPR027474; IPR037152; ,,ansA,DOMAIN 2 315 Asparaginase/glutaminase. {ECO:0000255|PROSITE-ProRule:PRU01068}.,Probable L-asparaginase (L-ASNase) (EC 3.5.1.1) (L-asparagine amidohydrolase),cytosol [GO:0005829]; asparaginase activity [GO:0004067]; asparagine catabolic process [GO:0006530],9634230; 21969609,,,MARLTVITTGGTISTTAGPDGVLRPTHCGATLIAGLDMDSDIEVVDLMALDSSKLTPADWDRIGAAVQEAFRGGADGVVITHGTDTLEETALWLDLTYAGSRPVVLTGAMLSADAPGADGPANLRDALAVAADPAARDLGVLVSFGGRVLQPLGLHKVANPDLCGFAGESLGFTSGGVRLTRTKTRPYLGDLGAAVAPRVDIVAVYPGSDAVAMDACVAAGARAVVLEALGSGNAGAAVIEGVRRHCRDGSDPVVIAVSTRVAGARVGAGYGPGHDLVEAGAVMVPRLPPSQARVLLMAALAANSPVADVIDRWG,"31,741",315,Asparaginase 1 family,asparagine catabolic process [GO:0006530],asparaginase activity [GO:0004067],cytosol [GO:0005829],,MTCY48.27,1
P9WPU7,ATPA_MYCTU,Rv1308,atpA Rv1308 MTCY373.28,GO:0005524; GO:0005618; GO:0005886; GO:0015986; GO:0040007; GO:0045261; GO:0046933,IPR023366; IPR000793; IPR038376; IPR033732; IPR005294; IPR020003; IPR004100; IPR036121; IPR000194; IPR027417; ,,atpA,,ATP synthase subunit alpha (EC 3.6.3.14) (ATP synthase F1 sector subunit alpha) (F-ATPase subunit alpha),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 20066036; 21969609,,FUNCTION: Produces ATP from ADP in the presence of a proton gradient across the membrane. The alpha chain is a regulatory subunit. {ECO:0000255|HAMAP-Rule:MF_01346}.,MAELTIPADDIQSAIEEYVSSFTADTSREEVGTVVDAGDGIAHVEGLPSVMTQELLEFPGGILGVALNLDEHSVGAVILGDFENIEEGQQVKRTGEVLSVPVGDGFLGRVVNPLGQPIDGRGDVDSDTRRALELQAPSVVHRQGVKEPLQTGIKAIDAMTPIGRGQRQLIIGDRKTGKTAVCVDTILNQRQNWESGDPKKQVRCVYVAIGQKGTTIAAVRRTLEEGGAMDYTTIVAAAASESAGFKWLAPYTGSAIAQHWMYEGKHVLIIFDDLTKQAEAYRAISLLLRRPPGREAYPGDVFYLHSRLLERCAKLSDDLGGGSLTGLPIIETKANDISAYIPTNVISITDGQCFLETDLFNQGVRPAINVGVSVSRVGGAAQIKAMKEVAGSLRLDLSQYRELEAFAAFASDLDAASKAQLERGARLVELLKQPQSQPMPVEEQVVSIFLGTGGHLDSVPVEDVRRFETELLDHMRASEEEILTEIRDSQKLTEEAADKLTEVIKNFKKGFAATGGGSVVPDEHVEALDEDKLAKEAVKVKKPAPKKKK,"59,288",549,ATPase alpha/beta chains family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"ATP binding [GO:0005524]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]",,MTCY373.28,1
P9WPV3,ATPFD_MYCTU,Rv1307,atpFH atpF atpH Rv1307 MTCY373.27,GO:0005618; GO:0005886; GO:0015986; GO:0016021; GO:0040007; GO:0045261; GO:0045263; GO:0046933,IPR028987; IPR002146; IPR005864; IPR000711; ,,atpFH,,ATP synthase subunit b-delta [Includes: ATP synthase subunit b (ATP synthase F(0) sector subunit b 2) (ATPase subunit I 2) (F-type ATPase subunit b 2) (F-ATPase subunit b 2); ATP synthase subunit delta (ATP synthase F(1) sector subunit delta) (F-type ATPase subunit delta) (F-ATPase subunit delta)],"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 19099550; 21969609,,"FUNCTION: F(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation (By similarity). {ECO:0000250}.; FUNCTION: This fusion protein includes a component of the F(0) channel (subunit b) and of the F(1) subunit (subunit delta). Two copies of subunit b and one of delta together form the peripheral ""stator"" stalk which links F(1) to F(0) (By similarity). {ECO:0000250}.",MSTFIGQLFGFAVIVYLVWRFIVPLVGRLMSARQDTVRQQLADAAAAADRLAEASQAHTKALEDAKSEAHRVVEEARTDAERIAEQLEAQADVEAERIKMQGARQVDLIRAQLTRQLRLELGHESVRQARELVRNHVADQAQQSATVDRFLDQLDAMAPATADVDYPLLAKMRSASRRALTSLVDWFGTMAQDLDHQGLTTLAGELVSVARLLDREAVVTRYLTVPAEDATPRIRLIERLVSGKVGAPTLEVLRTAVSKRWSANSDLIDAIEHVSRQALLELAERAGQVDEVEDQLFRFSRILDVQPRLAILLGDCAVPAEGRVRLLRKVLERADSTVNPVVVALLSHTVELLRGQAVEEAVLFLAEVAVARRGEIVAQVGAAAELSDAQRTRLTEVLSRIYGHPVTVQLHIDAALLGGLSIAVGDEVIDGTLSSRLAAAEARLPD,"48,806",446,ATPase B chain family; ATPase delta chain family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]",atpF atpH,MTCY373.27,1
P9WPV1,ATPE_MYCTU,Rv1311,atpC Rv1311 MTCY373.31,GO:0005618; GO:0005886; GO:0015986; GO:0040007; GO:0045261; GO:0046933,IPR001469; IPR020546; IPR036771; ,,atpC,,ATP synthase epsilon chain (ATP synthase F1 sector epsilon subunit) (F-ATPase epsilon subunit),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 19099550; 21969609,NMR spectroscopy (1),FUNCTION: Produces ATP from ADP in the presence of a proton gradient across the membrane. {ECO:0000250}.,MAELNVEIVAVDRNIWSGTAKFLFTRTTVGEIGILPRHIPLVAQLVDDAMVRVEREGEKDLRIAVDGGFLSVTEEGVSILAESAEFESEIDEAAAKQDSESDDPRIAARGRARLRAVGAID,"13,135",121,ATPase epsilon chain family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","cell wall [GO:0005618]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, catalytic core F(1) [GO:0045261]",,MTCY373.31,1
P9WPV5,ATPF_MYCTU,Rv1306,atpF Rv1306 MTCY373.26,GO:0005618; GO:0005886; GO:0005887; GO:0015078; GO:0015986; GO:0040007; GO:0045263,IPR028987; IPR002146; ,,atpF,,ATP synthase subunit b (ATP synthase F(0) sector subunit b) (ATPase subunit I) (F-type ATPase subunit b) (F-ATPase subunit b),"cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; proton transmembrane transporter activity [GO:0015078]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 21969609,,"FUNCTION: F(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. {ECO:0000255|HAMAP-Rule:MF_01398}.; FUNCTION: Component of the F(0) channel, it forms part of the peripheral stalk, linking F(1) to F(0). {ECO:0000255|HAMAP-Rule:MF_01398}.",MGEVSAIVLAASQAAEEGGESSNFLIPNGTFFVVLAIFLVVLAVIGTFVVPPILKVLRERDAMVAKTLADNKKSDEQFAAAQADYDEAMTEARVQASSLRDNARADGRKVIEDARVRAEQQVASTLQTAHEQLKRERDAVELDLRAHVGTMSATLASRILGVDLTASAATR,"18,325",171,ATPase B chain family,ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],proton transmembrane transporter activity [GO:0015078],"cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]",,MTCY373.26,1
L0T905,RSEA_MYCTU,Rv1222,rseA Rv1222,GO:0005737; GO:0006351; GO:0006355; GO:0046872,,,rseA,,Anti-sigma-E factor RseA (Regulator of SigE) (Sigma-E anti-sigma factor RseA),"cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9139909; 9634230; 18606740; 20025669; 21969609,,"FUNCTION: An anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigE. ECF sigma factors are held in an inactive form by an anti-sigma factor. {ECO:0000269|PubMed:18606740, ECO:0000269|PubMed:20025669}.",MADPGSVGHVFRRAFSWLPAQFASQSDAPVGAPRQFRSTEHLSIEAIAAFVDGELRMNAHLRAAHHLSLCAQCAAEVDDQSRARAALRDSHPIRIPSTLLGLLSEIPRCPPEGPSKGSSGGSSQGPPDGAAAGFGDRFADGDGGNRGRQSRVRR,"16,250",154,Zinc-associated anti-sigma factor (ZAS) superfamily,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",metal ion binding [GO:0046872],cytoplasm [GO:0005737],,,1
P9WGE3,RSFA_MYCTU,Rv1365c,rsfA Rv1365c MTCY02B10.29c,GO:0006351; GO:0006355; GO:0043856; GO:0045152,IPR003658; IPR002645; IPR036513; ,,rsfA,DOMAIN 17 128 STAS. {ECO:0000255|PROSITE-ProRule:PRU00198}.,Anti-sigma-F factor antagonist RsfA (Anti-anti-sigma F factor RsfA),"anti-sigma factor antagonist activity [GO:0043856]; antisigma factor binding [GO:0045152]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 12354223; 19130906,,"FUNCTION: Positive, redox-sensitive regulator of sigma-F (SigF) activity. When reduced binds to anti-sigma-F factor RsbW (UsfX) preventing its binding to SigF, thus activating transcription. {ECO:0000269|PubMed:12354223}.",MNPTQAGSFTTPVSNALKATIQHHDSAVIIHARGEIDAANEHTWQDLVTKAAAATTAPEPLVVNLNGLDFMGCCAVAVLAHEAERCRRRGVDVRLVSRDRAVARIIHACGYGDVLPVHPTTESALSAT,"13,589",128,Anti-sigma-factor antagonist family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",anti-sigma factor antagonist activity [GO:0043856]; antisigma factor binding [GO:0045152],,,MTCY02B10.29c,1
P9WHF3,RHO_MYCTU,Rv1297,rho Rv1297 MTCY373.17,GO:0003723; GO:0004386; GO:0005524; GO:0005618; GO:0005886; GO:0006355; GO:0006363; GO:0008186; GO:0040007,IPR003593; IPR000194; IPR011129; IPR012340; IPR027417; IPR011112; IPR036269; IPR011113; IPR004665; ,,rho,DOMAIN 223 301 Rho RNA-BD. {ECO:0000255|PROSITE-ProRule:PRU01203}.,Transcription termination factor Rho (EC 3.6.4.-) (ATP-dependent helicase Rho),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186]; growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; termination of RNA polymerase I transcription [GO:0006363]",9634230; 19099550; 20026069; 21969609,,"FUNCTION: Facilitates transcription termination by a mechanism that involves Rho binding to the nascent RNA, activation of Rho's RNA-dependent ATPase activity, and release of the mRNA from the DNA template. Shows poor RNA-dependent ATP hydrolysis and inefficient DNA-RNA unwinding activities, but exhibits robust and fast transcription termination, which suggests that the transcription termination function of M.tuberculosis Rho is not correlated with its helicase/translocase activities and that these functions may not be important for its RNA release process. {ECO:0000255|HAMAP-Rule:MF_01884, ECO:0000269|PubMed:20026069}.",MTDTDLITAGESTDGKPSDAAATDPPDLNADEPAGSLATMVLPELRALANRAGVKGTSGMRKNELIAAIEEIRRQANGAPAVDRSAQEHDKGDRPPSSEAPATQGEQTPTEQIDSQSQQVRPERRSATREAGPSGSGERAGTAADDTDNRQGGQQDAKTEERGTDAGGDQGGDQQASGGQQARGDEDGEARQGRRGRRFRDRRRRGERSGDGAEAELREDDVVQPVAGILDVLDNYAFVRTSGYLPGPHDVYVSMNMVRKNGMRRGDAVTGAVRVPKEGEQPNQRQKFNPLVRLDSINGGSVEDAKKRPEFGKLTPLYPNQRLRLETSTERLTTRVIDLIMPIGKGQRALIVSPPKAGKTTILQDIANAITRNNPECHLMVVLVDERPEEVTDMQRSVKGEVIASTFDRPPSDHTSVAELAIERAKRLVEQGKDVVVLLDSITRLGRAYNNASPASGRILSGGVDSTALYPPKRFLGAARNIEEGGSLTIIATAMVETGSTGDTVIFEEFKGTGNAELKLDRKIAERRVFPAVDVNPSGTRKDELLLSPDEFAIVHKLRRVLSGLDSHQAIDLLMSQLRKTKNNYEFLVQVSKTTPGSMDSD,"65,133",602,Rho family,"growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; termination of RNA polymerase I transcription [GO:0006363]",ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; RNA-dependent ATPase activity [GO:0008186],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY373.17,1
P9WPH1,RIBD_MYCTU,Rv1409,ribD ribG Rv1409 MTCY21B4.26,GO:0005829; GO:0005886; GO:0008270; GO:0008703; GO:0008835; GO:0009231; GO:0009451; GO:0040007,IPR016192; IPR002125; IPR016193; IPR024072; IPR004794; IPR002734; ,,ribD,DOMAIN 7 129 CMP/dCMP-type deaminase. {ECO:0000255|PROSITE-ProRule:PRU01083}.,Riboflavin biosynthesis protein RibD [Includes: Diaminohydroxyphosphoribosylaminopyrimidine deaminase (DRAP deaminase) (EC 3.5.4.26) (Riboflavin-specific deaminase); 5-amino-6-(5-phosphoribosylamino)uracil reductase (EC 1.1.1.193) (HTP reductase)],cytosol [GO:0005829]; plasma membrane [GO:0005886]; 5-amino-6-(5-phosphoribosylamino)uracil reductase activity [GO:0008703]; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity [GO:0008835]; zinc ion binding [GO:0008270]; growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231]; RNA modification [GO:0009451],9634230; 19099550; 21969609,,"FUNCTION: Converts 2,5-diamino-6-(ribosylamino)-4(3h)-pyrimidinone 5'-phosphate into 5-amino-6-(ribosylamino)-2,4(1h,3h)-pyrimidinedione 5'-phosphate. {ECO:0000250}.",MNVEQVKSIDEAMGLAIEHSYQVKGTTYPKPPVGAVIVDPNGRIVGAGGTEPAGGDHAEVVALRRAGGLAAGAIVVVTMEPCNHYGKTPPCVNALIEARVGTVVYAVADPNGIAGGGAGRLSAAGLQVRSGVLAEQVAAGPLREWLHKQRTGLPHVTWKYATSIDGRSAAADGSSQWISSEAARLDLHRRRAIADAILVGTGTVLADDPALTARLADGSLAPQQPLRVVVGKRDIPPEARVLNDEARTMMIRTHEPMEVLRALSDRTDVLLEGGPTLAGAFLRAGAINRILAYVAPILLGGPVTAVDDVGVSNITNALRWQFDSVEKVGPDLLLSLVAR,"35,367",339,Cytidine and deoxycytidylate deaminase family; HTP reductase family,growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231]; RNA modification [GO:0009451],5-amino-6-(5-phosphoribosylamino)uracil reductase activity [GO:0008703]; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity [GO:0008835]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; plasma membrane [GO:0005886],ribG,MTCY21B4.26,1
O53168,RIPA_MYCTU,Rv1477,ripA Rv1477,GO:0005576; GO:0005618; GO:0008234; GO:0008745; GO:0040007; GO:0071555,IPR000064; ,,ripA,,Peptidoglycan endopeptidase RipA (EC 3.4.-.-) (Macrophage invasion and intracellular persistence protein A) (Resuscitation-promoting factor interaction partner A) (Rpf-interacting protein A),cell wall [GO:0005618]; extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; cell wall organization [GO:0071555]; growth [GO:0040007],9634230; 16495549; 17919286; 19099550; 18463693; 20686708; 21969609; 20826344; 21864539,X-ray crystallography (7),"FUNCTION: Peptidoglycan endopeptidase that cleaves the bond between D-glutamate and meso-diaminopimelate. Binds and degrades high-molecular weight peptidoglycan from a number of Actinobacteria; activity is increased in the presence of RpfB and inhibited by PBP1A (ponA1). Required for normal separation of daughter cells after cell division and for cell wall integrity. Required for host cell invasion and intracellular survival in host macrophages. {ECO:0000269|PubMed:16495549, ECO:0000269|PubMed:17919286, ECO:0000269|PubMed:18463693, ECO:0000269|PubMed:20826344, ECO:0000269|PubMed:21864539}.",MRRNRRGSPARPAARFVRPAIPSALSVALLVCTPGLATADPQTDTIAALIADVAKANQRLQDLSDEVQAEQESVNKAMVDVETARDNAAAAEDDLEVSQRAVKDANAAIAAAQHRFDTFAAATYMNGPSVSYLSASSPDEIIATVTAAKTLSASSQAVMANLQRARTERVNTESAARLAKQKADKAAADAKASQDAAVAALTETRRKFDEQREEVQRLAAERDAAQARLQAARLVAWSSEGGQGAPPFRMWDPGSGPAGGRAWDGLWDPTLPMIPSANIPGDPIAVVNQVLGISATSAQVTANMGRKFLEQLGILQPTDTGITNAPAGSAQGRIPRVYGRQASEYVIRRGMSQIGVPYSWGGGNAAGPSKGIDSGAGTVGFDCSGLVLYSFAGVGIKLPHYSGSQYNLGRKIPSSQMRRGDVIFYGPNGSQHVTIYLGNGQMLEAPDVGLKVRVAPVRTAGMTPYVVRYIEY,"49,808",472,Peptidase C40 family,cell wall organization [GO:0071555]; growth [GO:0040007],cysteine-type peptidase activity [GO:0008234]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WHU5,RIPB_MYCTU,Rv1478,ripB Rv1478,GO:0005618; GO:0008234; GO:0071555,IPR000064; ,,ripB,,Peptidoglycan endopeptidase RipB (EC 3.4.-.-) (Macrophage invasion and intracellular persistence protein B) (Resuscitation-promoting factor interaction partner B) (Rpf-interacting protein B),cell wall [GO:0005618]; cysteine-type peptidase activity [GO:0008234]; cell wall organization [GO:0071555],9634230; 16495549; 21969609; 21864539,X-ray crystallography (1),"FUNCTION: Peptidoglycan endopeptidase that cleaves the bond between D-glutamate and meso-diaminopimelate. Binds high-molecular weight peptidoglycan, but does not degrade it. Required for normal separation of daughter cells after cell division and cell wall integrity. Required for host cell invasion. {ECO:0000269|PubMed:16495549}.",MRHTRFHPIKLAWITAVVAGLMVGVATPADAEPGQWDPTLPALVSAGAPGDPLAVANASLQATAQATQTTLDLGRQFLGGLGINLGGPAASAPSAATTGASRIPRANARQAVEYVIRRAGSQMGVPYSWGGGSLQGPSKGVDSGANTVGFDCSGLVRYAFAGVGVLIPRFSGDQYNAGRHVPPAEAKRGDLIFYGPGGGQHVTLYLGNGQMLEASGSAGKVTVSPVRKAGMTPFVTRIIEY,"24,624",241,Peptidase C40 family,cell wall organization [GO:0071555],cysteine-type peptidase activity [GO:0008234],cell wall [GO:0005618],,,1
P9WK35,RISA_MYCTU,Rv1412,ribE ribC Rv1412 MTCY21B4.29,GO:0004746; GO:0005829; GO:0009231,IPR023366; IPR001783; IPR026017; IPR017938; ,,ribE,,Riboflavin synthase (RS) (EC 2.5.1.9),cytosol [GO:0005829]; riboflavin synthase activity [GO:0004746]; riboflavin biosynthetic process [GO:0009231],9634230; 21969609,,"FUNCTION: Catalyzes the dismutation of two molecules of 6,7-dimethyl-8-ribityllumazine, resulting in the formation of riboflavin and 5-amino-6-(D-ribitylamino)uracil. {ECO:0000250}.",MFTGIVEERGEVTGREALVDAARLTIRGPMVTADAGHGDSIAVNGVCLTVVDVLPDGQFTADVMAETLNRSNLGELRPGSRVNLERAAALGSRLGGHIVQGHVDATGEIVARCPSEHWEVVRIEMPASVARYVVEKGSITVDGISLTVSGLGAEQRDWFEVSLIPTTRELTTLGSAAVGTRVNLEVDVVAKYVERLMRSAG,"21,320",201,,riboflavin biosynthetic process [GO:0009231],riboflavin synthase activity [GO:0004746],cytosol [GO:0005829],ribC,MTCY21B4.29,1
O50462,RELB_MYCTU,Rv1247c,relB relB1 Rv1247c,GO:0003677; GO:0006351; GO:0006355; GO:0045927; GO:0097351,IPR006442; IPR036165; ,,relB,,Antitoxin RelB,"DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 19114484; 20011113; 20498855; 21969609,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of toxin RelE. {ECO:0000269|PubMed:20498855}.; FUNCTION: Induces its own promoter, in combination with RelE represses its own promoter. Binds DNA in complex with toxin RelE but not alone. {ECO:0000269|PubMed:19114484}.",MAVVPLGEVRNRLSEYVAEVELTHERITITRHGHPAAVLISADDLASIEETLEVLRTPGASEAIREGLADVAAGRFVSNDEIRNRYTAR,"9,767",89,PhD/YefM antitoxin family,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351],,relB1,,1
O50461,RELE_MYCTU,Rv1246c,relE relE1 Rv1246c,GO:0003677; GO:0004519; GO:0006351; GO:0006355; GO:0006401; GO:0045926,IPR007712; IPR035093; ,,relE,,Toxin RelE (EC 3.1.-.-) (Putative endoribonuclease RelE),"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; negative regulation of growth [GO:0045926]; regulation of transcription, DNA-templated [GO:0006355]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",9634230; 15718296; 19114484; 20011113; 20061486; 20498855; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Has RNase activity (By similarity). Overexpression in M.tuberculosis or M.smegmatis inhibits colony formation in a bacteriostatic rather than bacteriocidal fashion. Its toxic effect is neutralized by coexpression with cognate antitoxin RelB (shown only for M.smegmatis). {ECO:0000250, ECO:0000269|PubMed:19114484, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20061486, ECO:0000269|PubMed:20498855}.; FUNCTION: In combination with RelB represses its own promoter. Has been seen to bind DNA in complex with cognate antitoxin RelB but not alone.",MSDDHPYHVAITATAARDLQRLPEKIAAACVEFVFGPLLNNPHRLGKPLRNDLEGLHSARRGDYRVVYAIDDGHHRVEIIHIARRSASYRMNPCRPR,"11,064",97,RelE toxin family,"negative regulation of growth [GO:0045926]; regulation of transcription, DNA-templated [GO:0006355]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,relE1,,1
P9WHG3,RF1_MYCTU,Rv1299,prfA Rv1299 MTCY373.19,GO:0005737; GO:0016149; GO:0040007,IPR005139; IPR000352; IPR004373; ,,prfA,,Peptide chain release factor 1 (RF-1),"cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]; growth [GO:0040007]",9634230; 21969609,,FUNCTION: Peptide chain release factor 1 directs the termination of translation in response to the peptide chain termination codons UAG and UAA. {ECO:0000250}.,MTQPVQTIDVLLAEHAELELALADPALHSNPAEARRVGRRFARLAPIVATHRKLTSARDDLETARELVASDESFAAEVAALEARVGELDAQLTDMLAPRDPHDADDIVLEVKSGEGGEESALFAADLARMYIRYAERHGWAVTVLDETTSDLGGYKDATLAIASKADTPDGVWSRMKFEGGVHRVQRVPVTESQGRVHTSAAGVLVYPEPEEVGQVQIDESDLRIDVFRSSGKGGQGVNTTDSAVRITHLPTGIVVTCQNERSQLQNKTRALQVLAARLQAMAEEQALADASADRASQIRTVDRSERIRTYNFPENRITDHRIGYKSHNLDQVLDGDLDALFDALSAADKQSRLRQS,"39,036",357,Prokaryotic/mitochondrial release factor family,growth [GO:0040007],"translation release factor activity, codon specific [GO:0016149]",cytoplasm [GO:0005737],,MTCY373.19,1
P9WHF1,RIBBA_MYCTU,Rv1415,ribBA ribA ribA2 Rv1415 MTCY21B4.33,GO:0003935; GO:0005525; GO:0005576; GO:0008686; GO:0009231; GO:0040007; GO:0046872,IPR017945; IPR000422; IPR032677; IPR000926; IPR036144; IPR016299; ,,ribBA,,"Riboflavin biosynthesis protein RibBA [Includes: 3,4-dihydroxy-2-butanone 4-phosphate synthase (DHBP synthase) (EC 4.1.99.12); GTP cyclohydrolase-2 (EC 3.5.4.25) (GTP cyclohydrolase II)]","extracellular region [GO:0005576]; 3,4-dihydroxy-2-butanone-4-phosphate synthase activity [GO:0008686]; GTP binding [GO:0005525]; GTP cyclohydrolase II activity [GO:0003935]; metal ion binding [GO:0046872]; growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231]",9634230; 21969609,,"FUNCTION: Catalyzes the conversion of D-ribulose 5-phosphate to formate and 3,4-dihydroxy-2-butanone 4-phosphate. {ECO:0000255|HAMAP-Rule:MF_01283}.; FUNCTION: Catalyzes the conversion of GTP to 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5'-phosphate (DARP), formate and pyrophosphate. {ECO:0000255|HAMAP-Rule:MF_01283}.",MTRLDSVERAVADIAAGKAVIVIDDEDRENEGDLIFAAEKATPEMVAFMVRYTSGYLCVPLDGAICDRLGLLPMYAVNQDKHGTAYTVTVDARNGIGTGISASDRATTMRLLADPTSVADDFTRPGHVVPLRAKDGGVLRRPGHTEAAVDLARMAGLQPAGAICEIVSQKDEGSMAHTDELRVFADEHGLALITIADLIEWRRKHEKHIERVAEARIPTRHGEFRAIGYTSIYEDVEHVALVRGEIAGPNADGDDVLVRVHSECLTGDVFGSRRCDCGPQLDAALAMVAREGRGVVLYMRGHEGRGIGLMHKLQAYQLQDAGADTVDANLKLGLPADARDYGIGAQILVDLGVRSMRLLTNNPAKRVGLDGYGLHIIERVPLPVRANAENIRYLMTKRDKLGHDLAGLDDFHESVHLPGEFGGAL,"46,017",425,DHBP synthase family; GTP cyclohydrolase II family,growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231],"3,4-dihydroxy-2-butanone-4-phosphate synthase activity [GO:0008686]; GTP binding [GO:0005525]; GTP cyclohydrolase II activity [GO:0003935]; metal ion binding [GO:0046872]",extracellular region [GO:0005576],ribA ribA2,MTCY21B4.33,1
P9WFV3,SYI_MYCTU,Rv1536,ileS Rv1536 MTCY48.29c,GO:0000049; GO:0002161; GO:0004822; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006428; GO:0046677; GO:0046872,IPR001412; IPR002300; IPR033709; IPR002301; IPR023586; IPR013155; IPR014729; IPR009080; IPR009008; ,,ileS,,Isoleucine--tRNA ligase (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; response to antibiotic [GO:0046677],9634230; 8756461; 21969609,,"FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS can inadvertently accommodate and process structurally similar amino acids such as valine, to avoid such errors it has two additional distinct tRNA(Ile)-dependent editing activities. One activity is designated as 'pretransfer' editing and involves the hydrolysis of activated Val-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Val-tRNA(Ile) (By similarity). {ECO:0000250}.; FUNCTION: Confers high-level resistance to the antibiotic mupirocin (pseudomonic acid A), an Ile-analog that competitively inhibits activation by Ile-tRNA synthetase, thus inhibiting protein biosynthesis.",MTDNAYPKLAGGAPDLPALELEVLDYWSRDDTFRASIARRDGAPEYVFYDGPPFANGLPHYGHLLTGYVKDIVPRYRTMRGYKVERRFGWDTHGLPAELEVERQLGITDKSQIEAMGIAAFNDACRASVLRYTDEWQAYVTRQARWVDFDNDYKTLDLAYMESVIWAFKQLWDKGLAYEGYRVLPYCWRDETPLSNHELRMDDDVYQSRQDPAVTVGFKVVGGQPDNGLDGAYLLVWTTTPWTLPSNLAVAVSPDITYVQVQAGDRRFVLAEARLAAYARELGEEPVVLGTYRGAELLGTRYLPPFAYFMDWPNAFQVLAGDFVTTDDGTGIVHMAPAYGEDDMVVAEAVGIAPVTPVDSKGRFDVTVADYQGQHVFDANAQIVRDLKTQSGPAAVNGPVLIRHETYEHPYPHCWRCRNPLIYRSVSSWFVRVTDFRDRMVELNQQITWYPEHVKDGQFGKWLQGARDWSISRNRYWGTPIPVWKSDDPAYPRIDVYGSLDELERDFGVRPANLHRPYIDELTRPNPDDPTGRSTMRRIPDVLDVWFDSGSMPYAQVHYPFENLDWFQGHYPGDFIVEYIGQTRGWFYTLHVLATALFDRPAFKTCVAHGIVLGFDGQKMSKSLRNYPDVTEVFDRDGSDAMRWFLMASPILRGGNLIVTEQGIRDGVRQVLLPLWNTYSFLALYAPKVGTWRVDSVHVLDRYILAKLAVLRDDLSESMEVYDIPGACEHLRQFTEALTNWYVRRSRSRFWAEDADAIDTLHTVLEVTTRLAAPLLPLITEIIWRGLTRERSVHLTDWPAPDLLPSDADLVAAMDQVRDVCSAASSLRKAKKLRVRLPLPKLIVAVENPQLLRPFVDLIGDELNVKQVELTDAIDTYGRFELTVNARVAGPRLGKDVQAAIKAVKAGDGVINPDGTLLAGPAVLTPDEYNSRLVAADPESTAALPDGAGLVVLDGTVTAELEAEGWAKDRIRELQELRKSTGLDVSDRIRVVMSVPAEREDWARTHRDLIAGEILATDFEFADLADGVAIGDGVRVSIEKT,"117,340",1041,"Class-I aminoacyl-tRNA synthetase family, IleS type 2 subfamily",isoleucyl-tRNA aminoacylation [GO:0006428]; response to antibiotic [GO:0046677],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; isoleucine-tRNA ligase activity [GO:0004822]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY48.29c,1
P9WG01,SUGB_MYCTU,Rv1237,sugB Rv1237,GO:0005886; GO:0008643; GO:0016021; GO:0044117; GO:0055085,IPR000515; IPR035906; ,,sugB,DOMAIN 66 259 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Trehalose transport system permease protein SugB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate transport [GO:0008643]; growth of symbiont in host [GO:0044117]; transmembrane transport [GO:0055085],9634230; 19099550; 21118978; 21969609,,"FUNCTION: Part of the ABC transporter complex LpqY-SugA-SugB-SugC, which is highly specific for uptake of trehalose. Involved in the recycling of extracellular trehalose released from trehalose-containing molecules synthesized by M.tuberculosis. Trehalose uptake is essential for virulence. Probably responsible for the translocation of the substrate across the membrane. {ECO:0000269|PubMed:21118978}.",MGARRATYWAVLDTLVVGYALLPVLWIFSLSLKPTSTVKDGKLIPSTVTFDNYRGIFRGDLFSSALINSIGIGLITTVIAVVLGAMAAYAVARLEFPGKRLLIGAALLITMFPSISLVTPLFNIERAIGLFDTWPGLILPYITFALPLAIYTLSAFFREIPWDLEKAAKMDGATPGQAFRKVIVPLAAPGLVTAAILVFIFAWNDLLLALSLTATKAAITAPVAIANFTGSSQFEEPTGSIAAGAIVITIPIIVFVLIFQRRIVAGLTSGAVKG,"29,158",274,Binding-protein-dependent transport system permease family,carbohydrate transport [GO:0008643]; growth of symbiont in host [GO:0044117]; transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WQI3,SUGC_MYCTU,Rv1238,sugC Rv1238,GO:0005524; GO:0005886; GO:0009405; GO:0015771; GO:0016887; GO:0044117,IPR003593; IPR003439; IPR017871; IPR008995; IPR027417; ,,sugC,DOMAIN 4 235 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Trehalose import ATP-binding protein SugC (EC 3.6.3.-),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; trehalose transport [GO:0015771],9634230; 21118978; 21969609,,"FUNCTION: Part of the ABC transporter complex LpqY-SugA-SugB-SugC, which is highly specific for uptake of trehalose. Involved in the recycling of extracellular trehalose released from trehalose-containing molecules synthesized by M.tuberculosis. Trehalose uptake is essential for virulence. Probably responsible for energy coupling to the transport system. {ECO:0000269|PubMed:21118978}.",MAEIVLDHVNKSYPDGHTAVRDLNLTIADGEFLILVGPSGCGKTTTLNMIAGLEDISSGELRIAGERVNEKAPKDRDIAMVFQSYALYPHMTVRQNIAFPLTLAKMRKADIAQKVSETAKILDLTNLLDRKPSQLSGGQRQRVAMGRAIVRHPKAFLMDEPLSNLDAKLRVQMRGEIAQLQRRLGTTTVYVTHDQTEAMTLGDRVVVMYGGIAQQIGTPEELYERPANLFVAGFIGSPAMNFFPARLTAIGLTLPFGEVTLAPEVQGVIAAHPKPENVIVGVRPEHIQDAALIDAYQRIRALTFQVKVNLVESLGADKYLYFTTESPAVHSVQLDELAEVEGESALHENQFVARVPAESKVAIGQSVELAFDTARLAVFDADSGANLTIPHRA,"42,915",393,ABC transporter superfamily,growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; trehalose transport [GO:0015771],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
P9WG03,SUGA_MYCTU,Rv1236,sugA Rv1236,GO:0005886; GO:0008643; GO:0016021; GO:0044117; GO:0055085,IPR000515; IPR035906; ,,sugA,DOMAIN 85 291 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Trehalose transport system permease protein SugA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbohydrate transport [GO:0008643]; growth of symbiont in host [GO:0044117]; transmembrane transport [GO:0055085],9634230; 21118978,,"FUNCTION: Part of the ABC transporter complex LpqY-SugA-SugB-SugC, which is highly specific for uptake of trehalose. Involved in the recycling of extracellular trehalose released from trehalose-containing molecules synthesized by M.tuberculosis. Trehalose uptake is essential for virulence. Probably responsible for the translocation of the substrate across the membrane. {ECO:0000269|PubMed:21118978}.",MTSVEQRTATAVFSRTGSRMAERRLAFMLVAPAAMLMVAVTAYPIGYALWLSLQRNNLATPNDTAFIGLGNYHTILIDRYWWTALAVTLAITAVSVTIEFVLGLALALVMHRTLIGKGLVRTAVLIPYGIVTVVASYSWYYAWTPGTGYLANLLPYDSAPLTQQIPSLGIVVIAEVWKTTPFMSLLLLAGLALVPEDLLRAAQVDGASAWRRLTKVILPMIKPAIVVALLFRTLDAFRIFDNIYVLTGGSNNTGSVSILGYDNLFKGFNVGLGSAISVLIFGCVAVIAFIFIKLFGAAAPGGEPSGR,"33,051",307,Binding-protein-dependent transport system permease family,carbohydrate transport [GO:0008643]; growth of symbiont in host [GO:0044117]; transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WN25,TRHBN_MYCTU,Rv1542c,glbN Rv1542c MTCY48.23,GO:0005344; GO:0005829; GO:0008941; GO:0019825; GO:0020037; GO:0046210; GO:0046872; GO:0051410; GO:0052060,IPR009050; IPR012292; IPR019795; IPR001486; IPR016339; ,,glbN,,Group 1 truncated hemoglobin GlbN (Truncated hemoglobin) (trHbN) (Hemoglobin-like protein HbN),cytosol [GO:0005829]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; detoxification of nitrogen compound [GO:0051410]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; nitric oxide catabolic process [GO:0046210],9634230; 10636862; 19099550; 21969609; 11483493; 15122887; 15016811; 16846220,X-ray crystallography (9),FUNCTION: Binds oxygen cooperatively with very high affinity (P(50) = 0.013 mmHg at 20 degrees Celsius) because of a fast combination (25 microM(-1).s(-1)) and a slow dissociation (0.2 s(-1)) rate.,MGLLSRLRKREPISIYDKIGGHEAIEVVVEDFYVRVLADDQLSAFFSGTNMSRLKGKQVEFFAAALGGPEPYTGAPMKQVHQGRGITMHHFSLVAGHLADALTAAGVPSETITEILGVIAPLAVDVTSGESTTAPV,"14,449",136,"Truncated hemoglobin family, Group I subfamily",detoxification of nitrogen compound [GO:0051410]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; nitric oxide catabolic process [GO:0046210],heme binding [GO:0020037]; metal ion binding [GO:0046872]; nitric oxide dioxygenase activity [GO:0008941]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],cytosol [GO:0005829],,MTCY48.23,1
P9WGC9,TSAC_MYCTU,Rv1301,Rv1301 MTCY373.21,GO:0000049; GO:0002949; GO:0003725; GO:0005524; GO:0005737; GO:0006450; GO:0016779; GO:0040007; GO:0061710,IPR017945; IPR006070; ,,,DOMAIN 14 199 YrdC-like. {ECO:0000255|PROSITE-ProRule:PRU00518}.,Putative threonylcarbamoyl-AMP synthase (TC-AMP synthase) (EC 2.7.7.87) (L-threonylcarbamoyladenylate synthase) (tRNA threonylcarbamoyladenosine biosynthesis protein Rv1301),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049]; growth [GO:0040007]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949],9634230; 21969609,,"FUNCTION: Required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. Catalyzes the conversion of L-threonine, HCO(3)(-)/CO(2) and ATP to give threonylcarbamoyl-AMP (TC-AMP) as the acyladenylate intermediate, with the release of diphosphate. {ECO:0000250}.",MTETFDCADPEQRSRGIVSAVGAIKAGQLVVMPTDTVYGIGADAFDSSAVAALLSAKGRGRDMPVGVLVGSWHTIEGLVYSMPDGARELIRAFWPGALSLVVVQAPSLQWDLGDAHGTVMLRMPLHPVAIELLREVGPMAVSSANISGHPPPVDAEQARSQLGDHVAVYLDAGPSEQQAGSTIVDLTGATPRVLRPGPVSTERIAEVLGVDAASLFG,"22,571",217,SUA5 family,growth [GO:0040007]; regulation of translational fidelity [GO:0006450]; tRNA threonylcarbamoyladenosine modification [GO:0002949],ATP binding [GO:0005524]; double-stranded RNA binding [GO:0003725]; L-threonylcarbamoyladenylate synthase [GO:0061710]; nucleotidyltransferase activity [GO:0016779]; tRNA binding [GO:0000049],cytoplasm [GO:0005737],,MTCY373.21,1
P9WFA7,VPC10_MYCTU,Rv1397c,vapC10 Rv1397c,GO:0004540; GO:0005886; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC10,DOMAIN 2 119 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC10 (RNase VapC10) (EC 3.1.-.-) (Toxin VapC10),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB10 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MILVDSDVLIAHLRGVVAARDWLVSARKDGPLAISVVSTAELIGGMRTAERREVWRLLASFRVQPATEVIARRAGDMMRRYRRSHNRIGLGDYLIAATADVQDLQLATLNVWHFPMFEQLKPPFAVPGHRPRA,"14,952",133,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],plasma membrane [GO:0005886],,,1
P9WF45,WHIA_MYCTU,Rv1423,whiA Rv1423,GO:0003677; GO:0005618; GO:0005886; GO:0006351; GO:0006355; GO:0043937,IPR027434; IPR018478; IPR003802; IPR023054; IPR036388; IPR033981; ,,whiA,,Putative sporulation transcription regulator WhiA,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; regulation of sporulation [GO:0043937]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,FUNCTION: May be required for sporulation. {ECO:0000255|HAMAP-Rule:MF_01420}.,MAMTTDVKDELSRLVVKSVSARRAEVTSLLRFAGGLHIVGGRVVVEAELDLGSIARRLRKEIFELYGYTAVVHVLSASGIRKSTRYVLRVANDGEALARQTGLLDMRGRPVRGLPAQVVGGSIDDAEAAWRGAFLAHGSLTEPGRSSALEVSCPGPEAALALVGAARRLGVGAKAREVRGADRVVVRDGEAIGALLTRMGAQDTRLVWEERRLRREVRATANRLANFDDANLRRSARAAVAAAARVERALEILGDTVPEHLASAGKLRVEHRQASLEELGRLADPPMTKDAVAGRIRRLLSMADRKAKVDGIPDTESVVTPDLLEDA,"35,135",327,WhiA transcriptional regulatory family,"regulation of sporulation [GO:0043937]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
P9WJZ7,Y1220_MYCTU,Rv1220c,Rv1220c,GO:0005618; GO:0005886; GO:0008171,IPR002935; IPR029063; ,,,,Putative O-methyltransferase Rv1220c (EC 2.1.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; O-methyltransferase activity [GO:0008171],9634230; 19099550; 21969609,X-ray crystallography (1),,MDGTPGHDDMPGQPAPSRGESLWAHAEGSISEDVILAGARERATDIGAGAVTPAVGALLCLLAKLSGGKAVAEVGTGAGVSGLWLLSGMRDDGVLTTIDIEPEHLRLARQAFAEAGIGPSRTRLISGRAQEVLTRLADASYDLVFIDADPIDQPDYVAEGVRLLRSGGVIVVHRAALGGRAGDPGARDAEVIAVREAARLIAEDERLTPALVPLGDGVLAAVRD,"23,033",224,"Class I-like SAM-binding methyltransferase superfamily, Cation-dependent O-methyltransferase family",,O-methyltransferase activity [GO:0008171],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
P9WM51,Y1260_MYCTU,Rv1260,Rv1260 MTCY50.22c,GO:0071949,IPR002938; IPR036188; ,,,,Uncharacterized protein Rv1260,FAD binding [GO:0071949],9634230; 21969609,,,MKTVVVSGASVAGTAAAYWLGRHGYSVTMVERHPGLRPGGQAIDVRGPALDVLERMGLLAAAQEHKTRIRGASFVDRDGNELFRDTESTPTGGPVNSPDIELLRDDLVELLYGATQPSVEYLFDDSISTLQDDGDSVRVTFERAAAREFDLVIGADGLHSNVRRLVFGPEEQFVKRLGTHAAIFTVPNFLELDYWQTWHYGDSTMAGVYSARNNTEARAALAFMDTELRIDYRDTEAQFAELQRRMAEDGWVRAQLLHYMRSAPDFYFDEMSQILMDRWSRGRVALVGDAGYCCSPLSGQGTSVALLGAYILAGELKAAGDDYQLGFANYHAEFHGFVERNQWLVSDNIPGGAPIPQEEFERIVHSITIKDY,"41,329",372,,,FAD binding [GO:0071949],,,MTCY50.22c,1
P9WMU9,Y1264_MYCTU,Rv1264,Rv1264 MTCY50.18c,GO:0004016; GO:0005524; GO:0005622; GO:0005886; GO:0006171; GO:0007165; GO:0008289; GO:0009268; GO:0030145; GO:0030818; GO:0035556; GO:0042803,IPR001054; IPR032026; IPR029787; ,,,DOMAIN 217 325 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,pH-sensitive adenylate cyclase Rv1264 (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Adenylyl cyclase),intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; negative regulation of cAMP biosynthetic process [GO:0030818]; response to pH [GO:0009268]; signal transduction [GO:0007165],9634230; 11416222; 11839758; 19099550; 17005450; 21969609; 15890882; 17482646,X-ray crystallography (6),FUNCTION: Catalyzes the formation of the second messenger cAMP.,MTDHVREADDANIDDLLGDLGGTARAERAKLVEWLLEQGITPDEIRATNPPLLLATRHLVGDDGTYVSAREISENYGVDLELLQRVQRAVGLARVDDPDAVVHMRADGEAAARAQRFVELGLNPDQVVLVVRVLAEGLSHAAEAMRYTALEAIMRPGATELDIAKGSQALVSQIVPLLGPMIQDMLFMQLRHMMETEAVNAGERAAGKPLPGARQVTVAFADLVGFTQLGEVVSAEELGHLAGRLAGLARDLTAPPVWFIKTIGDAVMLVCPDPAPLLDTVLKLVEVVDTDNNFPRLRAGVASGMAVSRAGDWFGSPVNVASRVTGVARPGAVLVADSVREALGDAPEADGFQWSFAGPRRLRGIRGDVRLFRVRRGATRTGSGGAAQDDDLAGSSP,"42,232",397,Adenylyl cyclase class-4/guanylyl cyclase family,cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; negative regulation of cAMP biosynthetic process [GO:0030818]; response to pH [GO:0009268]; signal transduction [GO:0007165],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; lipid binding [GO:0008289]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803],intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY50.18c,1
P9WFZ7,Y1283_MYCTU,Rv1283c,Rv1283c MTCY373.02c,GO:0005886; GO:0015031; GO:0016021; GO:0022857; GO:0055085,IPR000515; IPR035906; ,,,DOMAIN 102 310 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Putative peptide transport permease protein Rv1283c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],9634230; 21969609,,,MTRYLARRLLNYLVLLALASFLTYCLTSLAFSPLESLMQRSPRPPQAVIDAKAHDLGLDRPILARYANWVSHAVRGDFGTTITGQPVGTELGRRIGVSLRLLVVGSVFGTVAGVVIGAWGAIRQYRLSDRVMTTLALLVLSTPTFVVANLLILGALRVNWAVGIQLFDYTGETSPGVAGGVWDRLGDRLQHLILPSLTLALAAAAGFSRYQRNAMLDVLGQDFIRTARAKGLTRRRALLKHGLRTALIPMATLFAYGVAGLVTGAVFVEKIFGWHGMGEWMVRGISTQDTNIVAAITVFSGAVVLLAGLLSDVIYAALDPRVRVS,"35,083",325,"Binding-protein-dependent transport system permease family, OppBC subfamily",protein transport [GO:0015031]; transmembrane transport [GO:0055085],transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY373.02c,1
P9WME3,Y1287_MYCTU,Rv1287,Rv1287 MTCY373.06,GO:0003677,IPR030489; IPR000944; IPR036388; IPR036390; ,,,DOMAIN 2 132 HTH rrf2-type. {ECO:0000255|PROSITE-ProRule:PRU00540}.,Putative HTH-type transcriptional regulator Rv1287,DNA binding [GO:0003677],9634230; 19099550; 21969609,,,MRMSAKAEYAVRAMVQLATAASGTVVKTDDLAAAQGIPPQFLVDILTNLRTDRLVRSHRGREGGYELARPGTEISIADVLRCIDGPLASVRDIGLGDLPYSGPTTALTDVWRALRASMRSVLEETTLADVAGGALPEHVAQLADDYRAQESTRHGASRHGD,"17,209",161,,,DNA binding [GO:0003677],,,MTCY373.06,1
P9WM33,Y1291_MYCTU,Rv1291c,Rv1291c MTCY373.10c,,IPR007969; ,,,,Uncharacterized protein Rv1291c,,9634230,,,MFTRRFAASMVGTTLTAATLGLAALGFAGTASASSTDEAFLAQLQADGITPPSAARAIKDAHAVCDALDEGHSAKAVIKAVAKATGLSAKGAKTFAVDAASAYCPQYVTSS,"11,025",111,,,,,,MTCY373.10c,1
P9WQ33,Y1318_MYCTU,Rv1318c,Rv1318c MTCY130.03c,GO:0004016; GO:0004871; GO:0005829; GO:0005886; GO:0006171; GO:0016021; GO:0035556,IPR001054; IPR003660; IPR029787; ,,,DOMAIN 278 329 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 361 485 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Uncharacterized protein Rv1318c,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],9634230; 21969609,,,MSAKKSTAQRLGRVLETVTRQSGRLPETPAYGSWLLGRVSESQRRRRVRIQVMLTALVVTANLLGIGVALLLVTIAIPEPSIVRDTPRWLTFGVVPGYVLLALALGSYALTRQTVQALRWAIEGRKPTREEERRTFLAPWRVAVGHLMFWGVGTALLTTLYGLINNAFIPRFLFAVSFCGVLVATATYLHTEFALRPFAAQALEAGPPPRRLAPGILGRTMVVWLLGSGVPVVGIALMAMFEMVLLNLTRMQFATGVLIISMVTLVFGFILMWILAWLTATPVRVVRAALRRVERGELRTNLVVFDGTELGELQRGFNAMVAGLRERERVRDLFGRHVGREVAAAAERERSKLGGEERHVAVVFIDIVGSTQLVTSRPPADVVKLLNKFFAIVVDEVDRHHGLVNKFEGDASLTIFGAPNRLPCPEDKALAAARAIADRLVNEMPECQAGIGVAAGQVIAGNVGARERFEYTVIGEPVNEAARLCELAKSRPGKLLASAQAVDAASEEERARWSLGRHVKLRGHDQPVRLAKPVGLTKPRR,"59,332",541,Adenylyl cyclase class-3 family,cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY130.03c,1
P9WM23,Y1333_MYCTU,Rv1333,Rv1333 MTCY130.18,GO:0004177; GO:0005886; GO:0016021,IPR016117; IPR005321; ,,,,Uncharacterized aminopeptidase Rv1333 (EC 3.4.11.-),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177],9634230; 21969609,,FUNCTION: Aminopeptidase. {ECO:0000250|UniProtKB:Q52VH2}.,MNSITDVGGIRVGHYQRLDPDASLGAGWACGVTVVLPPPGTVGAVDCRGGAPGTRETDLLDPANSVRFVDALLLAGGSAYGLAAADGVMRWLEEHRRGVAMDSGVVPIVPGAVIFDLPVGGWNCRPTADFGYSACAAAGVDVAVGTVGVGVGARAGALKGGVGTASATLQSGVTVGVLAVVNAAGNVVDPATGLPWMADLVGEFALRAPPAEQIAALAQLSSPLGAFNTPFNTTIGVIACDAALSPAACRRIAIAAHDGLARTIRPAHTPLDGDTVFALATGAVAVPPEAGVPAALSPETQLVTAVGAAAADCLARAVLAGVLNAQPVAGIPTYRDMFPGAFGS,"33,953",344,Peptidase S58 family,,aminopeptidase activity [GO:0004177],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY130.18,1
P9WGC1,Y1339_MYCTU,Rv1339,Rv1339 MTCY02B10.03 MTCY130.24,GO:0005886; GO:0040007; GO:0042781,IPR001279; IPR036866; ,,,,Uncharacterized protein Rv1339,plasma membrane [GO:0005886]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; growth [GO:0040007],9634230; 19099550; 21969609,,,MRRCIPHRCIGHGTVVSVRITVLGCSGSVVGPDSPASGYLLRAPHTPPLVIDFGGGVLGALQRHADPASVHVLLSHLHADHCLDLPGLFVWRRYHPSRPSGKALLYGPSDTWSRLGAASSPYGGEIDDCSDIFDVHHWADSEPVTLGALTIVPRLVAHPTESFGLRITDPSGASLAYSGDTGICDQLVELARGVDVFLCEASWTHSPKHPPDLHLSGTEAGMVAAQAGVRELLLTHIPPWTSREDVISEAKAEFDGPVHAVVCDETFEVRRAG,"29,154",273,AtsA family,growth [GO:0040007],3'-tRNA processing endoribonuclease activity [GO:0042781],plasma membrane [GO:0005886],,MTCY02B10.03 MTCY130.24,1
P9WGR9,Y1350_MYCTU,Rv1350,fabG2 Rv1350 MTCY02B10.14,GO:0016491; GO:0040007,IPR036291; IPR020904; IPR002347; ,,fabG2,,Uncharacterized oxidoreductase Rv1350 (EC 1.-.-.-),oxidoreductase activity [GO:0016491]; growth [GO:0040007],9634230; 21969609,,,MASLLNARTAVITGGAQGLGLAIGQRFVAEGARVVLGDVNLEATEVAAKRLGGDDVALAVRCDVTQADDVDILIRTAVERFGGLDVMVNNAGITRDATMRTMTEEQFDQVIAVHLKGTWNGTRLAAAIMRERKRGAIVNMSSVSGKVGMVGQTNYSAAKAGIVGMTKAAAKELAHLGIRVNAIAPGLIRSAMTEAMPQRIWDQKLAEVPMGRAGEPSEVASVAVFLASDLSSYMTGTVLDVTGGRFI,"25,871",247,Short-chain dehydrogenases/reductases (SDR) family,growth [GO:0040007],oxidoreductase activity [GO:0016491],,,MTCY02B10.14,1
P9WM11,Y1355_MYCTU,Rv1355c,Rv1355c MTCY02B10.19c,GO:0005886; GO:0008641; GO:0016491; GO:0061503; GO:0061504,IPR000415; IPR000594; IPR035985; ,,,,Uncharacterized protein Rv1355c,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504],9634230,,,MTIPHEGGSTGILVLRDDDHDDVLVLDRLRSDPSIEFVDRFAEQLAGVRRLLPQPDPDLLEEAKRWAYYPWRRMVVAILGLRGFRAVRLDRNRHLITAEEQRALHALRVGVVGLSAGHAIAYTLAAEGACGTLRLADFDKIELSNLNRVPVGVFDIGLNKAMIAARRIAELDPYLAVDLVTSGLSPESVDEFLDGLDVVIEECDSLDIKVILRQAACARGVPVLMATSDRGLVDVERYDVEPGRPIFHGLLGDIDADKLCGLTTKDKVPHVLNILDCQELSARCAASMIEVDQTLWGWPQLAGDIWVGAATVAEAVRRIGLGEPLESGRVRVDVSAALDRLDQPPMPSRGNGWLLESVPPTAPAEPQPTSEIVAQAAIRAPSGGNVQPWHVVAKQHSLTIRLAPEHTSAMDIAFRGSAVAVGAAMFNARVAAAAHRVLGSVEFDESQPDSPLQATMHFGRGDDPSLAALYRPMLLRTTNRHHGMPGHVHPATVELLTNTAAAEGARLQLLLSRNEIDRAATILAAADRIRYLTPRLHEEMMSELRWPGDPSLDAGIDVRSLELDSGELRVLDILRRSDVVARLAQWDCGTALEDNTNERVSASSALAIVYVDGATLTDFARGGSAMQAVWIVAQQHGLAVQPMSPIFLYARGRHDLDQASPHFAAQLHRLQLDFRELVKPGKEGHEVLIFRLFHAPPPSVCSRRRVRHAIPEPHR,"78,181",715,,cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504],oxidoreductase activity [GO:0016491]; tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641],plasma membrane [GO:0005886],,MTCY02B10.19c,1
P9WM03,Y1360_MYCTU,Rv1360,Rv1360 MTCY02B10.24,GO:0016705,IPR019919; IPR011251; IPR036661; ,,,,Uncharacterized protein Rv1360,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 19099550; 21969609,,,MGGARRLKLDGSIPNQLARAADAAVALERNGFDGGWTAEASHDPFLPLLLAAEHTSRLELGTNIAVAFARNPMIVANVGWDLQTYSKGRLILGLGTQIRPHIEKRFSMPWGHPARRMREFVAALRAIWLAWQDGTKLCFEGEFYTHKIMTPMFTPEPQPYPVPRVFIAAVGEAMTEMCGEVADGHLGHPMVSKRYLTEVSVPALLRGLARSGRDRSAFEVSCEVMVATGADDAELAAACTATRKQIAFYGSTPAYRKVLEQHGWGDLHPELHRLSKLGEWEAMGGLIDDEMLGAFAVVGPVDTIAGALRNRCEGVVDRVLPIFMAASQECINAALQDFRR,"37,252",340,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCY02B10.24,1
P9WLZ3,Y1367_MYCTU,Rv1367c,Rv1367c MTCY02B10.31c MTCY02B12.01c,GO:0005886,IPR001466; IPR012338; ,,,,Uncharacterized protein Rv1367c,plasma membrane [GO:0005886],9634230; 21969609,,,MNLDGNQASIREVCDAGLLSGAVTMVWQREKLLQVNEIGYRDIDAGVPMQRDTLFRIASMTKPVTVAAAMSLVDEGKLALRDPITRWAPELCKVAVLDDAAGPLDRTHPARRAILIEDLLTHTSGLAYGFSVSGPISRAYQRLPFGQGPDVWLAALATLPLVHQPGDRVTYSHAIDVLGVIVSRIEDAPLYQIIDERVLGPAGMTDTGFYVSADAQRRAATMYRLDEQDRLRHDVMGPPHVTPPSFCNAGGGLWSTADDYLRFVRMLLGDGTVDGVRVLSPESVRLMRTDRLTDEQKRHSFLGAPFWVGRGFGLNLSVVTDPAKSRPLFGPGGLGTFSWPGAYGTWWQADPSADLILLYLIQHCPDLSVDAAAAVAGNPSLAKLRTAQPKFVRRTYRALGL,"43,742",401,,,,plasma membrane [GO:0005886],,MTCY02B10.31c MTCY02B12.01c,2
P9WF27,Y1375_MYCTU,Rv1375,Rv1375 MTCY02B12.09,,IPR003776; ,,,DOMAIN 116 439 YcaO. {ECO:0000255|PROSITE-ProRule:PRU00999}.,Uncharacterized protein Rv1375,,9634230,,,MTGRRLARFPAFRAGVAQDDDVGSTLSQGSTTGVLSGPNWSYWPSRVLGSADPTTIAHRHGTHRITSPDETWLALQPFLAPAGITGVADVTWLDCLGIPTVQAVRPASLTLSVSQGKAASYRAAQVSAVMESLEGWHAENVTADLWSATARDLEADLTYDPAQLRHRPGSLYHAGVKLDWMVATTLLTGRRTWVPWTAVLVNVATRDCWEPPMFEMDTTGLASGNCYDEATLHALYEVMERHSVAAAVAGETMFEVPTDDVAGSDSAHLVEMIRDAGDDVDLARIDVWDGYYCFAAELTSATLEVTFGGFGLHHDPNVALSRAITEAAQSRITAISGAREDLPSAIYHRFGRVHTYAKARKTSLRLNRARPTPWRVPDVDSLPELVASAATAVANRSGTEPLAVVCDFADACVPVVKVLAPGLVLSSASPMRTPLQEAE,"47,219",439,,,,,,MTCY02B12.09,1
P9WHQ3,Y1540_MYCTU,Rv1540,Rv1540 MTCY48.25c,GO:0000455; GO:0003723; GO:0005829; GO:0009982,IPR020103; IPR006225; IPR006224; IPR006145; IPR002942; IPR036986; ,,,DOMAIN 15 81 S4 RNA-binding. {ECO:0000255|PROSITE-ProRule:PRU00182}.,Uncharacterized RNA pseudouridine synthase Rv1540 (EC 5.4.99.-) (RNA pseudouridylate synthase) (RNA-uridine isomerase),cytosol [GO:0005829]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455],9634230; 21969609,,,MADRSMPVPDGLAGMRVDTGLARLLGLSRTAAAALAEEGAVELNGVPAGKSDRLVSGALLQVRLPEAPAPLQNTPIDIEGMTILYSDDDIVAVDKPAAVAAHASVGWTGPTVLGGLAAAGYRITTSGVHERQGIVHRLDVGTSGVMVVAISERAYTVLKRAFKYRTVDKRYHALVQGHPDPSSGTIDAPIGRHRGHEWKFAITKNGRHSLTHYDTLEAFVAASLLDVHLETGRTHQIRVHFAALHHPCCGDLVYGADPKLAKRLGLDRQWLHARSLAFAHPADGRRVEIVSPYPADLQHALKILRGEG,"33,017",308,Pseudouridine synthase RluA family,enzyme-directed rRNA pseudouridine synthesis [GO:0000455],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],cytosol [GO:0005829],,MTCY48.25c,1
P9WMD1,Y1556_MYCTU,Rv1556,Rv1556 MTCY48.09c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR023772; IPR009057; IPR001647; IPR011075; IPR036271; ,,,DOMAIN 19 79 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv1556,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MVGAVTQIADRPTDPSPWSPRETELLAVTLRLLQEHGYDRLTVDAVAASARASKATVYRRWPSKAELVLAAFIEGIRQVAVPPNTGNLRDDLLRLGELICREVGQHASTIRAVLVEVSRNPALNDVLQHQFVDHRKALIQYILQQAVDRGEISSAAISDELWDLLPGYLIFRSIIPNRPPTQDTVQALVDDVILPSLTRSTG,"22,330",202,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY48.09c,1
P9WMW5,WECA_MYCTU,Rv1302,wecA rfe Rv1302 MTCY373.22,GO:0000287; GO:0005886; GO:0008963; GO:0016021; GO:0016757; GO:0016780; GO:0030145; GO:0044038; GO:0045227; GO:0071555,IPR000715; ,,wecA,,Decaprenyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.35) (Decaprenyl-phosphate GlcNAc-1-phosphate transferase) (Decaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase) (UDP-GlcNAc:decaprenyl-phosphate GlcNAc-1-phosphate transferase),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity, transferring glycosyl groups [GO:0016757]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]",9634230; 20637039; 21969609,,"FUNCTION: Involved in the biosynthesis of the disaccharide D-N-acetylglucosamine-L-rhamnose which plays an important role in the mycobacterial cell wall as a linker connecting arabinogalactan and peptidoglycan via a phosphodiester linkage. Catalyzes the transfer of the N-acetylglucosamine-1-phosphate (GlcNAc-1P) moiety from UDP-GlcNAc onto the carrier lipid decaprenyl phosphate (C50-P), yielding GlcNAc-pyrophosphoryl-decaprenyl (GlcNAc-PP-C50). {ECO:0000269|PubMed:20637039}.",MQYGLEVSSDVAGVAGGLLALSYRGAGVPLRELALVGLTAAIITYFATGPVRMLASRLGAVAYPRERDVHVTPTPRMGGLAMFLGIVGAVFLASQLPALTRGFVYSTGMPAVLVAGAVIMGIGLIDDRWGLDALTKFAGQITAASVLVTMGVAWSVLYIPVGGVGTIVLDQASSILLTLALTVSIVNAMNFVDGLDGLAAGLGLITALAICMFSVGLLRDHGGDVLYYPPAVISVVLAGACLGFLPHNFHRAKIFMGDSGSMLIGLMLAAASTTAAGPISQNAYGARDVFALLSPFLLVVAVMFVPMLDLLLAIVRRTRAGRSAFSPDKMHLHHRLLQIGHSHRRVVLIIYLWVGIVAFGAASSIFFNPRDTAAVMLGAIVVAGVATLIPLLRRGDDYYDPDLD,"42,257",404,"Glycosyltransferase 4 family, WecA subfamily",capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555],"magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; transferase activity, transferring glycosyl groups [GO:0016757]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],rfe,MTCY373.22,1
P9WQJ3,Y1272_MYCTU,Rv1272c,Rv1272c MTCY50.10,GO:0005524; GO:0005886; GO:0016021; GO:0042626,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 41 365 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 397 631 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv1272c,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]",9634230; 21969609,,,MTAPPGARPRAASPPPNMRSRDFWGSAARLVKRLAPQRRLSIAVITLGIAGTTIGVIVPRILGHATDLLFNGVIGRGLPGGITKAQAVASARARGDNTFADLLSGMNVVPGQGVDFAAVERTLALALALYLAAALMIWAQARLLNLTVQKTMVRLRTDVEDKVHRLPLSYFDGQQRGELLSRVTNDIDNLQSSLSMTISQLVTSILTMVAVLAMMVSISGLLALITLLTVPLSLLVTRAITRRSQPLFVAHWTSTGRLNAHLEETYSGFTVVKTFGHQAAARERFHELNDDVYQAGFGAQFLSGLVQPATAFIGNLGYVAVAVAGGLQVATGQITLGSIQAFIQYIRQFNMPLSQLAGMYNALQSGVASAERVFDVLDEPEESPEPEPELPNLTGRVEFEHVNFAYLPGTPVIRDLSLVAEPGSTVAIVGPTGAGKTTLVNLLMRFYEIGSGRILIDGVDIASVSRQSLRSRIGMVLQDTWLYDGTIAENIAYGRPEATTDEIVEAARAAHVDRFVNTLPAGYQTRVSGDGGSISVGEKQLITIARAFLARPQLLILDEATSSVDTRTELLIQRAMRELRRDRTSFIIAHRLSTIRDADHILVVQTGQIVERGNHAELLARRGVYYQMTRA,"68,305",631,"ABC transporter superfamily, MsbA family",,"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY50.10,1
P9WQJ5,Y1281_MYCTU,Rv1281c,Rv1281c MTCY50.01,GO:0005524; GO:0005618; GO:0005886; GO:0015833; GO:0016887,IPR003593; IPR003439; IPR017871; IPR013563; IPR027417; ,,,DOMAIN 5 255 ABC transporter 1. {ECO:0000255|PROSITE-ProRule:PRU00434}.; DOMAIN 350 600 ABC transporter 2. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv1281c,cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptide transport [GO:0015833],9634230; 21969609,,,MSPLLEVTDLAVTFRTDGDPVTAVRGISYRVEPGEVVAMVGESGSGKSAAAMAVVGLLPEYAQVRGSVRLQGTELLGLADNAMSRFRGKAIGTVFQDPMSALTPVYTVGDQIAEAIEVHQPRVGKKAARRRAVELLDLVGISQPQRRSRAFPHELSGGERQRVVIAIAIANDPDLLICDEPTTALDVTVQAQILDVLKAARDVTGAGVLIITHDLGVVAEFADRALVMYAGRVVESAGVNDLYRDRRMPYTVGLLGSVPRLDAAQGTRLVPIPGAPPSLAGLAPGCPFAPRCPLVIDECLTAEPELLDVATDHRAACIRTELVTGRSAADIYRVKTEARPAALGDASVVVRVRHLVKTYRLAKGVVLRRAIGEVRAVDGISLELRQGRTLGIVGESGSGKSTTLHEILELAAPQSGSIEVLGTDVATLGTAERRSLRRDIQVVFQDPVASLDPRLPVFDLIAEPLQANGFGKNETHARVAELLDIVGLRHGDASRYPAEFSGGQKQRIGIARALALQPKILALDEPVSALDVSIQAGIINLLLDLQEQFGLSYLFVSHDLSVVKHLAHQVAVMLAGTVVEQGDSEEVFGNPKHEYTRRLLGAVPQPDPARRG,"65,293",612,ABC transporter superfamily,peptide transport [GO:0015833],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY50.01,1
P9WFZ9,Y1282_MYCTU,Rv1282c,Rv1282c MTCY373.01c MTCY3H3.01,GO:0005886; GO:0015031; GO:0016021; GO:0055085,IPR000515; IPR035906; IPR025966; ,,,DOMAIN 81 272 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Putative peptide transport permease protein Rv1282c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transport [GO:0015031]; transmembrane transport [GO:0055085],9634230; 21969609,,,MTEFASRRTLVVRRFLRNRAAVASLAALLLLFVSAYALPPLLPYSYDDLDFNALLQPPGTKHWLGTNALGQDLLAQTLRGMQKSMLIGVCVAVISTGIAATVGAISGYFGGWRDRTLMWVVDLLLVVPSFILIAIVTPRTKNSANIMFLVLLLAGFGWMISSRMVRGMTMSLREREFIRAARYMGVSSRRIIVGHVVPNVASILIIDAALNVAAAILAETGLSFLGFGIQPPDVSLGTLIADGTASATAFPWVFLFPASILVLILVCANLTGDGLRDALDPASRSLRRGVR,"31,374",291,"Binding-protein-dependent transport system permease family, OppBC subfamily",protein transport [GO:0015031]; transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY373.01c MTCY3H3.01,1
P9WM27,Y1322_MYCTU,Rv1322,Rv1322 MTCY130.07,,,,,,Uncharacterized protein Rv1322,,9634230; 21969609,,,MARRRKPLHRQRPEPPSWALRRVEAGPDGHEYEVRPVAAARAVKTYRCPGCDHEIRSGTAHVVVWPTDLPQAGVDDRRHWHTPCWANRATRGPTRKWT,"11,334",98,,,,,,MTCY130.07,1
P9WG61,Y1324_MYCTU,Rv1324,Rv1324 MTCY130.09,GO:0005618; GO:0005886; GO:0045454,IPR036249; IPR013766; IPR011990; ,,,DOMAIN 28 151 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Uncharacterized protein Rv1324,cell wall [GO:0005618]; plasma membrane [GO:0005886]; cell redox homeostasis [GO:0045454],9634230; 21969609,,,MTRPRPPLGPAMAGAVDLSGIKQRAQQNAAASTDADRALSTPSGVTEITEANFEDEVIVRSDEVPVVVLLWSPRSEVCVDLLDTLSGLAAAAKGKWSLASVNVDVAPRVAQIFGVQAVPTVVALAAGQPISSFQGLQPADQLSRWVDSLLSATAGKLKGAASSEESTEVDPAVAQARQQLEDGDFVAARKSYQAILDANPGSVEAKAAIRQIEFLIRATAQRPDAVSVADSLSDDIDAAFAAADVQVLNQDVSAAFERLIALVRRTSGEERTRVRTRLIELFELFDPADPEVVAGRRNLANALY,"32,170",304,,cell redox homeostasis [GO:0045454],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY130.09,1
P9WM21,Y1337_MYCTU,Rv1337,Rv1337 MTCY02B10.01 MTCY130.22,GO:0004252; GO:0005886; GO:0016021,IPR022764; IPR035952; ,,,,Uncharacterized protein Rv1337,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252],21029479; 9634230,,,MGMTPRRKRRGGAVQITRPTGRPRTPTTQTTKRPRWVVGGTTILTFVALLYLVELIDQLSGSRLDVNGIRPLKTDGLWGVIFAPLLHANWHHLMANTIPLLVLGFLMTLAGLSRFVWATAIIWILGGLGTWLIGNVGSSCGPTDHIGASGLIFGWLAFLLVFGLFVRKGWDIVIGLVVLFVYGGILLGAMPVLGQCGGVSWQGHLSGAVAGVVAAYLLSAPERKARALKRAGARSGHPKL,"25,703",240,,,serine-type endopeptidase activity [GO:0004252],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.01 MTCY130.22,1
P9WM17,Y1351_MYCTU,Rv1351,Rv1351 MTCY02B10.15,,,,,,Uncharacterized protein Rv1351,,9634230,,,MTPRSLPRYGNSSRRKSFPMHRPSNVATATRKKSSIGWVLLACSVAGCKGIDTTEFILGRAGAFELAVRAAQHRHRYLTMVNVGRAPPRRCRTVCMAATDTPRNIRLNG,"12,054",109,,,,,,MTCY02B10.15,1
P9WM13,Y1354_MYCTU,Rv1354c,Rv1354c MTCY02B10.18c,GO:0005886; GO:0009190; GO:0009214; GO:0052621; GO:0071111,IPR001633; IPR035919; IPR003018; IPR029016; IPR000160; IPR029787; ,,,DOMAIN 28 171 GAF.; DOMAIN 212 345 GGDEF. {ECO:0000255|PROSITE-ProRule:PRU00095}.; DOMAIN 354 609 EAL. {ECO:0000255|PROSITE-ProRule:PRU00074}.,Uncharacterized protein Rv1354c,plasma membrane [GO:0005886]; cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; diguanylate cyclase activity [GO:0052621]; cyclic nucleotide biosynthetic process [GO:0009190]; cyclic nucleotide catabolic process [GO:0009214],9634230,,,MCNDTATPQLEELVTTVANQLMTVDAATSAEVSQRVLAYLVEQLGVDVSFLRHNDRDRRATRLVAEWPPRLNIPDPDPLRLIYFADADPVFALCEHAKEPLVFRPEPATEDYQRLIEEARGVPVTSAAAVPLVSGEITTGLLGFIKFGDRKWHEAELNALMTIATLFAQVQARVAAEARLRYLADHDDLTGLHNRRALLQHLDQRLAPGQPGPVAALFLDLDRLKAINDYLGHAAGDQFIHVFAQRIGDALVGESLIARLGGDEFVLIPASPMSADAAQPLAERLRDQLKDHVAIGGEVLTRTVSIGVASGTPGQHTPSDLLRRADQAALAAKHAGGDSVAIFTADMSVSGELRNDIELHLRRGIESDALRLVYLPEVDLRTGDIVGTEALVRWQHPTRGLLAPGCFIPVAESINLAGELDRWVLRRACNEFSEWQSAGLGHDALLRINVSAGQLVTGGFVDFVADTIGQHGLDASSVCLEITENVVVQDLHTARATLARLKEVGVHIAIDDFGTGYSAISLLQTLPIDTLKIDKTFVRQLGTNTSDLVIVRGIMTLAEGFQLDVVAEGVETEAAARILLDQRCYRAQGFLFSRPVPGEAMRHMLSARRLPPTCIPATDPALS,"67,653",623,,cyclic nucleotide biosynthetic process [GO:0009190]; cyclic nucleotide catabolic process [GO:0009214],cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; diguanylate cyclase activity [GO:0052621],plasma membrane [GO:0005886],,MTCY02B10.18c,1
P9WM05,Y1359_MYCTU,Rv1359,Rv1359 MTCY02B10.23,GO:0010468; GO:0019217,IPR029787; ,,,,Uncharacterized protein Rv1359,regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468],9634230,,,MFMALRAPMLERMNGLHTDDAPVNWLERRGGRLTSRRRVTLLHAGVEHPMRLWGVQSEAITAAMVLSRKVSAIIAGHCGVRLVDQGVGDGFVAAFAHASDAVACALELHQAPLSPIVLRIGIHTGEAQLVDERIYAGATMNLAAELRDLAHGGQTVMSGATEDAVLGRLPMRAWLIGLRPMEGSPEGHNFPQSQRIAQLCHPNLRNTFPPLRMRIADASGIPYVGRILVNVQVVPHWEGGCAAAGMVLAG,"26,886",250,,regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468],,,,MTCY02B10.23,1
P9WMJ1,Y1395_MYCTU,Rv1395,Rv1395 MTCY21B4.12,GO:0003677; GO:0003700; GO:0006351; GO:0019172; GO:0019243; GO:0043565; GO:0044119,IPR032687; IPR009057; IPR018060; IPR020449; ,,,,Uncharacterized HTH-type transcriptional regulator Rv1395,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565]; growth of symbiont in host cell [GO:0044119]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; transcription, DNA-templated [GO:0006351]",9634230; 12368430; 21969609,,,MGHLPPPAEVRHPVYATRVLCEVANERGVPTADVLAGTAIEPADLDDPDAVVGALDEITAVRRLLARLPDDAGIGIDVGSRFALTHFGLFGFAVMSCGTLRELLTIAMRYFALTTMHVDITLFETADDCLVELDASHLPADVRGFFIERDIAGIIATTTSFALPLAAKYADQVSAELAVDAELLRPLLELVPVHDVAFGRAHNRVHFPRAMFDEPLPQADRHTLEMCIAQCDVLMQRNERRRGITALVRSKLFRDSGLFPTFTDVAGELDMHPRTLRRRLAEEGTSFRALLGEARSTVAVDLLRNVGLTVQQVSTRLGYTEVSTFSHAFKRWYGVAPSEYSRRG,"37,894",344,,"growth of symbiont in host cell [GO:0044119]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565],,,MTCY21B4.12,1
P9WLZ1,VPB10_MYCTU,Rv1398c,vapB10 Rv1398c MTCY21B4.15c,GO:0005886; GO:0006355,IPR013321; IPR002145; IPR010985; ,,vapB10,,Putative antitoxin VapB10,"plasma membrane [GO:0005886]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 21969609,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC10. {ECO:0000305|PubMed:15718296}.,MKRTNIYLDEEQTASLDKLAAQEGVSRAELIRLLLNRALTTAGDDLASDLQAINDSFGTLRHLDPPVRRSGGREQHLAQVWRATS,"9,444",85,,"regulation of transcription, DNA-templated [GO:0006355]",,plasma membrane [GO:0005886],,MTCY21B4.15c,1
P9WMD5,Y1255_MYCTU,Rv1255c,Rv1255c MTCY50.27,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR009057; IPR001647; ,,,DOMAIN 13 73 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv1255c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MAGTDWLSARRTELAADRILDAAERLFTQRDPASIGMNEIAKAAGCSRATLYRYFDSREALRTAYVHRETRRLGREIMVKIADVVEPAERLLVSITTTLRMVRDNPALAAWFTTTRPPIGGEMAGRSEVIAALAAAFLNSLGPDDPTTVERRARWVVRMLTSLLMFPGRDEADERAMIAEFVVPIVTPASAAARKAGHPGPE,"22,223",202,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY50.27,1
P9WM47,Y1268_MYCTU,Rv1268c,Rv1268c MTCY50.14,,IPR025660,,,,Uncharacterized protein Rv1268c,,9634230,,,MTTSKIATAFKTATFALAAGAVALGLASPADAAAGTMYGDPAAAAKYWRQQTYDDCVLMSAADVIGQVTGREPSERAIIKVAQSTPSVVHPGSIYTKPADAEHPNSGMGTSVADIPTLLAHYGVDAVITDEDHATATGVATGMAALEQYLGSGHAVIVSINAEMIWGQPVEETDSAGNPRSDHAVVVTGVDTENGIVHLNDSGTPTGRDEQIPMETFVEAWATSHDFMAVTT,"23,974",232,,,,,,MTCY50.14,1
P9WM25,Y1332_MYCTU,Rv1332,Rv1332 MTCY130.17,,IPR018561; ,,,,Uncharacterized protein Rv1332,,9634230; 21969609,,,MPPVCGRRCSRTGEIRGYSGSIVRRWKRVETRDGPRFRSSLAPHEAALLKNLAGAMIGLLDDRDSSSPSDELEEITGIKTGHAQRPGDPTLRRLLPDFYRPDDLDDDDPTAVDGSESFNAALRSLHEPEIIDAKRVAAQQLLDTVPDNGGRLELTESDANAWIAAVNDLRLALGVMLEIGPRGPERLPGNHPLAAHFNVYQWLTVLQEYLVLVLMGSR,"24,054",218,,,,,,MTCY130.17,1
P9WMD3,Y1353_MYCTU,Rv1353c,Rv1353c MTCY02B10.17c,GO:0000976; GO:0003700; GO:0005829; GO:0006351; GO:0045892,IPR023772; IPR009057; IPR001647; IPR036271; IPR004111; ,,,DOMAIN 15 75 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv1353c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230,,,MQTTPGKRQRRQRGSINPEDIISGAFELAQQVSIDNLSMPLLGKHLGVGVTSIYWYFRKKDDLLNAMTDRALSKYVFATPYIEAGDWRETLRNHARSMRKTFADNPVLCDLILIRAALSPKTARLGAQEMEKAIANLVTAGLSLEDAFDIYSAVSVHVRGSVVLDRLSRKSQSAGSGPSAIEHPVAIDPATTPLLAHATGRGHRIGAPDETNFEYGLECILDHAGRLIEQSSKAAGEVAVRRPTATADAPTPGARAKAVAR,"28,253",261,,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY02B10.17c,1
P9WLZ9,Y1363_MYCTU,Rv1363c,Rv1363c MTCY02B10.27c,GO:0016021,,,,,Uncharacterized protein Rv1363c,integral component of membrane [GO:0016021],9634230; 21969609,,,MAETTEPPSDAGTSQADAMALAAEAEAAEAEALAAAARARARAARLKREALAMAPAEDENVPEEYADWEDAEDYDDYDDYEAADQEAARSASWRRRLRVRLPRLSTIAMAAAVVIICGFTGLSGYIVWQHHEATERQQRAAAFAAGAKQGVINMTSLDFNKAKEDVARVIDSSTGEFRDDFQQRAADFTKVVEQSKVVTEGTVNATAVESMNEHSAVVLVAATSRVTNSAGAKDEPRAWRLKVTVTEEGGQYKMSKVEFVP,"28,308",261,,,,integral component of membrane [GO:0016021],,MTCY02B10.27c,1
P9WLZ7,Y1364_MYCTU,Rv1364c,Rv1364c MTCY02B10.28c,GO:0000155; GO:0000287; GO:0004035; GO:0005622; GO:0006355; GO:0016791; GO:0030145; GO:0042802,IPR003594; IPR036890; IPR000014; IPR000700; IPR035965; IPR013656; IPR036457; IPR001932; IPR002645; IPR036513; ,Itself,,DOMAIN 86 142 PAC. {ECO:0000255|PROSITE-ProRule:PRU00141}.; DOMAIN 177 396 PPM-type phosphatase. {ECO:0000255|PROSITE-ProRule:PRU01082}.; DOMAIN 546 653 STAS. {ECO:0000255|PROSITE-ProRule:PRU00198}.,Uncharacterized protein Rv1364c,"intracellular [GO:0005622]; alkaline phosphatase activity [GO:0004035]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,X-ray crystallography (4),,MAAEMDWDKTVGAAEDVRRIFEHIPAILVGLEGPDHRFVAVNAAYRGFSPLLDTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWRLQTDYDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAAEARVEELSERYRNVRDSATVMQQALLAASVPVVPGADIAAEYLVAAEDTAAGGDWFDALALGDRLVLVVGDVVGHGVEAAAVMSQLRTALRMQISAGYTVVEALEAVDRFHKQVPGSKSATMCVGSLDFTSGEFQYCTAGHPPPLLVTADASARYVEPTGAGPLGSGTGFPVRSEVLNIGDAILFYTDGLIERPGRPLEASTAEFADLAASIASGSGGFVLDAPARPIDRLCSDTLELLLRSTGYNDDVTLLAMQRRAPTPPLHITLDATINAARTVRAQLREWLAEIGADHSDIADIVHAISEFVENAVEHGYATDVSKGIVVAAALAGDGNVRASVIDRGQWKDHRDGARGRGRGLAMAEALVSEARIMHGAGGTTATLTHRLSRPARFVTDTMVRRAAFQQTIDSEFVSLVESGRIVVRGDVDSTTAATLDRQIAVESRSGIAPVTIDLSAVTHLGSAGVGALAAACDRARKQGTECVLVAPPGSPAHHVLSLVQLPVVGADTEDIFAQE,"69,524",653,,"regulation of transcription, DNA-templated [GO:0006355]",alkaline phosphatase activity [GO:0004035]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; phosphatase activity [GO:0016791]; phosphorelay sensor kinase activity [GO:0000155],intracellular [GO:0005622],,MTCY02B10.28c,1
P9WGX3,Y1407_MYCTU,Rv1407,Rv1407 MTCY21B4.24,GO:0003723; GO:0005618; GO:0005829; GO:0006355; GO:0009383; GO:0070475,IPR018314; IPR001678; IPR035926; IPR006027; IPR023267; IPR029063; ,,,,Putative methyltransferase Rv1407 (EC 2.1.1.-),"cell wall [GO:0005618]; cytosol [GO:0005829]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; regulation of transcription, DNA-templated [GO:0006355]; rRNA base methylation [GO:0070475]",9634230; 21969609,,FUNCTION: May act as RNA methyltransferase. {ECO:0000250}.,MTPRSRGPRRRPLDPARRAAFETLRAVSARDAYANLVLPALLAQRGIGGRDAAFATELTYGTCRARGLLDAVIGAAAERSPQAIDPVLLDLLRLGTYQLLRTRVDAHAAVSTTVEQAGIEFDSARAGFVNGVLRTIAGRDERSWVGELAPDAQNDPIGHAAFVHAHPRWIAQAFADALGAAVGELEAVLASDDERPAVHLAARPGVLTAGELARAVRGTVGRYSPFAVYLPRGDPGRLAPVRDGQALVQDEGSQLVARALTLAPVDGDTGRWLDLCAGPGGKTALLAGLGLQCAARVTAVEPSPHRADLVAQNTRGLPVELLRVDGRHTDLDPGFDRVLVDAPCTGLGALRRRPEARWRRQPADVAALAKLQRELLSAAIALTRPGGVVLYATCSPHLAETVGAVADALRRHPVHALDTRPLFEPVIAGLGEGPHVQLWPHRHGTDAMFAAALRRLT,"48,493",457,"Class I-like SAM-binding methyltransferase superfamily, RsmB/NOP family","regulation of transcription, DNA-templated [GO:0006355]; rRNA base methylation [GO:0070475]",RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY21B4.24,1
P9WLY5,Y1413_MYCTU,Rv1413,Rv1413 MTCY21B4.30,,IPR001608; IPR029066; ,,,,Uncharacterized protein Rv1413,,9634230,,,MATIGEVEVFVDHGADDVFITYPLWIGTRQADRLRQLADRARIAVGAGTAEGASNTGARLADAAGAIDVLIEIDSGHHRSGVRAEQVLEVAHAVGEAGLHLVGVFTFPGHSYAPGKPGEAGEQERRALNDAANALVAVGFPISCRSGGSTPTALLTAADGASETSRRLCAR,"17,640",171,,,,,,MTCY21B4.30,1
P9WFQ3,Y1421_MYCTU,Rv1421,Rv1421 MTCY21B4.39,GO:0005524; GO:0005525; GO:0005886,IPR027417; IPR005337; ,,,,Nucleotide-binding protein Rv1421,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525],9634230; 19099550; 21969609,,FUNCTION: Displays ATPase and GTPase activities. {ECO:0000255|HAMAP-Rule:MF_00636}.,MMNHARGVENRSEGGGIDVVLVTGLSGAGRGTAAKVLEDLGWYVADNLPPQLITRMVDFGLAAGSRITQLAVVMDVRSRGFTGDLDSVRNELATRAITPRVVFMEASDDTLVRRYEQNRRSHPLQGEQTLAEGIAAERRMLAPVRATADLIIDTSTLSVGGLRDSIERAFGGDGGATTSVTVESFGFKYGLPMDADMVMDVRFLPNPHWVDELRPLTGQHPAVRDYVLHRPGAAEFLESYHRLLSLVVDGYRREGKRYMTIAIGCTGGKHRSVAIAEALMGLLRSDQQLSVRALHRDLGRE,"32,912",301,RapZ-like family,,ATP binding [GO:0005524]; GTP binding [GO:0005525],plasma membrane [GO:0005886],,MTCY21B4.39,1
P9WLX7,Y1424_MYCTU,Rv1424c,Rv1424c MTCY21B4.42c MTCY493.30,GO:0005618; GO:0005886,,,,,Uncharacterized protein Rv1424c,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MTVVPGAPSRPASAVSRPSYRQCVQASAQTSARRYSFPSYRRPPAEKLVFPVLLGILTLLLSACQTASASGYNEPRGYDRATLKLVFSMDLGMCLNRFTYDSKLAPSRPQVVACDSREARIRNDGFHANAPSCMRIDYELITQNHRAYYCLKYLVRVGYCYPAVTTPGKPPSVLLYAPSACDESLPSPRVATALVPGTRSANREFSRFVVTEIKSLGAGGRCDSASVSLQPPEEIEGPAIPPASSQLVCVAPK,"27,427",253,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY21B4.42c MTCY493.30,1
P9WFP7,Y1461_MYCTU,Rv1461,Rv1461 MTV007.08,GO:0004519; GO:0005829; GO:0006314; GO:0016226; GO:0016539; GO:0040007,IPR003586; IPR003587; IPR036844; IPR027434; IPR006142; IPR030934; IPR004042; IPR006141; IPR010231; IPR000825; IPR037284; ,,,DOMAIN 388 528 DOD-type homing endonuclease. {ECO:0000255|PROSITE-ProRule:PRU00273}.,UPF0051 protein Rv1461 [Cleaved into: Endonuclease PI-MtuHIIP (EC 3.1.-.-) (Mtu pps1 intein)],cytosol [GO:0005829]; endonuclease activity [GO:0004519]; growth [GO:0040007]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]; iron-sulfur cluster assembly [GO:0016226],9634230; 19099550; 21969609,,,MTLTPEASKSVAQPPTQAPLTQEEAIASLGRYGYGWADSDVAGANAQRGLSEAVVRDISAKKNEPDWMLQSRLKALRIFDRKPIPKWGSNLDGIDFDNIKYFVRSTEKQAASWDDLPEDIRNTYDRLGIPEAEKQRLVAGVAAQYESEVVYHQIREDLEAQGVIFLDTDTGLREHPDIFKEYFGTVIPAGDNKFSALNTAVWSGGSFIYVPPGVHVDIPLQAYFRINTENMGQFERTLIIADEGSYVHYVEGCLPAGELITTADGDLRPIESIRVGDFVTGHDGRPHRVTAVQVRDLDGELFTFTPMSPANAFSVTAEHPLLAIPRDEVRVMRKERNGWKAEVNSTKLRSAEPRWIAAKDVAEGDFLIYPKPKPIPHRTVLPLEFARLAGYYLAEGHACLTNGCESLIFSFHSDEFEYVEDVRQACKSLYEKSGSVLIEEHKHSARVTVYTKAGYAAMRDNVGIGSSNKKLSDLLMRQDETFLRELVDAYVNGDGNVTRRNGAVWKRVHTTSRLWAFQLQSILARLGHYATVELRRPGGPGVIMGRNVVRKDIYQVQWTEGGRGPKQARDCGDYFAVPIKKRAVREAHEPVYNLDVENPDSYLAYGFAVHNCTAPIYKSDSLHSAVVEIIVKPHARVRYTTIQNWSNNVYNLVTKRARAEAGATMEWIDGNIGSKVTMKYPAVWMTGEHAKGEVLSVAFAGEDQHQDTGAKMLHLAPNTSSNIVSKSVARGGGRTSYRGLVQVNKGAHGSRSSVKCDALLVDTVSRSDTYPYVDIREDDVTMGHEATVSKVSENQLFYLMSRGLTEDEAMAMVVRGFVEPIAKELPMEYALELNRLIELQMEGAVG,"94,171",846,UPF0051 (ycf24) family,growth [GO:0040007]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]; iron-sulfur cluster assembly [GO:0016226],endonuclease activity [GO:0004519],cytosol [GO:0005829],,MTV007.08,1
P9WLX5,Y1480_MYCTU,Rv1480,Rv1480 MTCY277.01 MTV007.27,GO:0005829; GO:0005886; GO:0040007,IPR002881; IPR036465; ,,,,Uncharacterized protein Rv1480,cytosol [GO:0005829]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MTESKAPAVVHPPSMLRGDIDDPKLAAALRTLELTVKQKLDGVLHGDHLGLIPGPGSEPGESRLYQPGDDVRRMDWAVTARTTHPHVRQMIADRELETWLVVDMSASLDFGTACCEKRDLAVAAAAAITFLNSGGGNRLGALIANGAAMTRVPARTGRQHQHTMLRTIATMPQAPAGVRGDLAVAIDALRRPERRRGMAVIISDFLGPINWMRPLRAIAARHEVLAIEVLDPRDVELPDVGDVVLQDAESGVVREFSIDPALRDDFARAAAAHRADVARTIRGCGAPLLSLRTDRDWLADIVRFVASRRRGALAGHQ,"34,333",317,,growth [GO:0040007],,cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY277.01 MTV007.27,1
P9WLW5,Y1507_MYCTU,Rv1507c,Rv1507c MTCY277.29c,GO:0005886,IPR014985; ,,,,Uncharacterized protein Rv1507c,plasma membrane [GO:0005886],9634230; 21969609,,,MKKVAIVQSNYIPWRGYFDLIAFVDEFIIYDDMQYTKRDWRNRNRIKTSQGLQWITVPVQVKGRFHQKIRETLIDGTDWAKAHWRALEFNYSAAAHFAEIADWLAPIYLEEQHTNLSLLNRRLLNAICSYLGISTRLANSWDYELADGKTERLANLCQQAAATEYVSGPSARSYVDERVFDELSIRVTWFDYDGYRDYKQLWGGFEPAVSILDLLFNVGAEAPDYLRYCRQ,"27,091",231,,,,plasma membrane [GO:0005886],,MTCY277.29c,1
P9WLU7,Y1546_MYCTU,Rv1546,Rv1546 MTCY48.19c,GO:0005886,IPR019587; IPR023393; ,,,,Uncharacterized protein Rv1546,plasma membrane [GO:0005886],9634230; 21969609,,,MASVELSADVPISPQDTWDHVSELSELGEWLVIHEGWRSELPDQLGEGVQIVGVARAMGMRNRVTWRVTKWDPPHEVAMTGSGKGGTKYGVTLTVRPTKGGSALGLRLELGGRALFGPLGSAAARAVKGDVEKSLKQFAELYG,"15,324",143,,,,plasma membrane [GO:0005886],,MTCY48.19c,1
O50456,VPB33_MYCTU,Rv1241,vapB33 Rv1241,GO:0045927,,,vapB33,,Antitoxin VapB33,positive regulation of growth [GO:0045927],9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC33. {ECO:0000269|PubMed:20011113}.,MRTTLTLDDDVVRLVEDAVHRERRPMKQVINDALRRALAPPVKRQEQYRLEPHESAVRSGLDLAGFNKLADELEDEALLDATRRAR,"9,918",86,,positive regulation of growth [GO:0045927],,,,,3
P9WF69,VPC33_MYCTU,Rv1242,vapC33 Rv1242,GO:0004540; GO:0005886; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC33,,Ribonuclease VapC33 (RNase VapC33) (EC 3.1.-.-) (Toxin VapC33),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB33. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MIIPDINLLLYAVITGFPQHRRAHAWWQDTVNGHTRIGLTYPALFGFLRIATSARVLAAPLPTADAIAYVREWLSQPNVDLLTAGPRHLDIALGLLDKLGTASHLTTDVQLAAYGIEYDAEIHSSDTDFARFADLKWTDPLRE,"15,905",143,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],plasma membrane [GO:0005886],,,1
P9WGG7,SIGE_MYCTU,Rv1221,sigE Rv1221,GO:0003677; GO:0003700; GO:0006352; GO:0009405; GO:0009408; GO:0009410; GO:0016987; GO:0042542; GO:0044119; GO:0052572; GO:0090034,IPR014284; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigE,,ECF RNA polymerase sigma factor SigE (ECF sigma factor SigE) (Alternative RNA polymerase sigma factor SigE) (RNA polymerase sigma-E factor) (Sigma-E factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; response to heat [GO:0009408]; response to host immune response [GO:0052572]; response to hydrogen peroxide [GO:0042542]; response to xenobiotic stimulus [GO:0009410]",9139909; 9634230; 10027986; 11567012; 11489128; 11929527; 15102817; 16513743; 17379732; 18657035; 18606740; 20025669; 21969609,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor until released. Responds to heat shock and surface stress (detergent exposure). When combined with isolated core RNA polymerase from M.smegmatis is able to guide initiation from the sigB promoter. Required for full expression of sigB, and for sigB induction after detergent exposure but not after heat shock. Controls a regulon of about 38 genes in culture (PubMed:11489128) and about 16 genes during macrophage infection (PubMed:18657035), most of which have decreased expression in a disruption mutant. Probably down regulates the host immune response to mycobacterial infection. {ECO:0000269|PubMed:11489128, ECO:0000269|PubMed:18657035, ECO:0000269|PubMed:20025669, ECO:0000269|PubMed:9139909}.",MELLGGPRVGNTESQLCVADGDDLPTYCSANSEDLNITTITTLSPTSMSHPQQVRDDQWVEPSDQLQGTAVFDATGDKATMPSWDELVRQHADRVYRLAYRLSGNQHDAEDLTQETFIRVFRSVQNYQPGTFEGWLHRITTNLFLDMVRRRARIRMEALPEDYDRVPADEPNPEQIYHDARLGPDLQAALASLPPEFRAAVVLCDIEGLSYEEIGATLGVKLGTVRSRIHRGRQALRDYLAAHPEHGECAVHVNPVR,"28,877",257,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; response to heat [GO:0009408]; response to host immune response [GO:0052572]; response to hydrogen peroxide [GO:0042542]; response to xenobiotic stimulus [GO:0009410]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
P9WGH3,SIGI_MYCTU,Rv1189,sigI Rv1189,GO:0003677; GO:0003700; GO:0006352; GO:0016987,IPR032710; IPR014284; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigI,,Probable ECF RNA polymerase sigma factor SigI (ECF sigma factor SigI) (Alternative RNA polymerase sigma factor SigI) (RNA polymerase sigma-I factor) (Sigma-I factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]",9634230; 10027986; 18248429,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by a cognate anti-sigma factor until released, although no anti-sigma factor is known for this protein (By similarity). {ECO:0000250}.",MSQHDPVSAAWRAHRAYLVDLAFRMVGDIGVAEDMVQEAFSRLLRAPVGDIDDERGWLIVVTSRLCLDHIKSASTRRERPQDIAAWHDGDASVSSVDPADRVTLDDEVRLALLIMLERLGPAERVVFVLHEIFGLPYQQIATTIGSQASTCRQLAHRARRKINESRIAASVEPAQHRVVTRAFIEACSNGDLDTLLEVLDPGVAGEIDARKGVVVVGADRVGPTILRHWSHPATVLVAQPVCGQPAVLAFVNRALAGVLALSIEAGKITKIHVLVQPSTLDPLRAELGGG,"31,431",290,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
P9WGN5,SECG_MYCTU,Rv1440,secG Rv1440 MTCY493.14c,GO:0005886; GO:0009306; GO:0015450; GO:0016021,IPR004692; ,,secG,,Probable protein-export membrane protein SecG,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; protein secretion [GO:0009306],9634230; 21969609,,FUNCTION: Involved in protein export. Participates in an early event of protein translocation (By similarity). {ECO:0000250}.,MELALQITLIVTSVLVVLLVLLHRAKGGGLSTLFGGGVQSSLSGSTVVEKNLDRLTLFVTGIWLVSIIGVALLIKYR,"8,163",77,SecG family,protein secretion [GO:0009306],P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY493.14c,1
P9WHE9,RISB_MYCTU,Rv1416,ribH Rv1416 MTCY21B4.34,GO:0000906; GO:0005829; GO:0009231; GO:0009349; GO:0040007,IPR034964; IPR002180; IPR036467; ,,ribH,,"6,7-dimethyl-8-ribityllumazine synthase (DMRL synthase) (LS) (Lumazine synthase) (EC 2.5.1.78)","cytosol [GO:0005829]; riboflavin synthase complex [GO:0009349]; 6,7-dimethyl-8-ribityllumazine synthase activity [GO:0000906]; growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231]",9634230; 14750781; 17259624; 19099550; 21969609; 15723519; 16984393; 18331058,X-ray crystallography (8),"FUNCTION: Catalyzes the formation of 6,7-dimethyl-8-ribityllumazine by condensation of 5-amino-6-(D-ribitylamino)uracil with 3,4-dihydroxy-2-butanone 4-phosphate. This is the penultimate step in the biosynthesis of riboflavin. {ECO:0000269|PubMed:15723519}.",MKGGAGVPDLPSLDASGVRLAIVASSWHGKICDALLDGARKVAAGCGLDDPTVVRVLGAIEIPVVAQELARNHDAVVALGVVIRGQTPHFDYVCDAVTQGLTRVSLDSSTPIANGVLTTNTEEQALDRAGLPTSAEDKGAQATVAALATALTLRELRAHS,"16,371",160,DMRL synthase family,growth [GO:0040007]; riboflavin biosynthetic process [GO:0009231],"6,7-dimethyl-8-ribityllumazine synthase activity [GO:0000906]",cytosol [GO:0005829]; riboflavin synthase complex [GO:0009349],,MTCY21B4.34,1
P9WG43,TPIS_MYCTU,Rv1438,tpiA tpi Rv1438 MTCY493.16c,GO:0004807; GO:0005576; GO:0005829; GO:0005886; GO:0006094; GO:0006096; GO:0019563; GO:0040007; GO:0046166,IPR013785; IPR035990; IPR022896; IPR000652; IPR020861; ,,tpiA,,Triosephosphate isomerase (TIM) (TPI) (EC 5.3.1.1) (Triose-phosphate isomerase),cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 16978361; 21969609; 22120738; 25613812,X-ray crystallography (3),"FUNCTION: Involved in the gluconeogenesis. Catalyzes stereospecifically the conversion of dihydroxyacetone phosphate (DHAP) to D-glyceraldehyde-3-phosphate (G3P). {ECO:0000255|HAMAP-Rule:MF_00147, ECO:0000269|PubMed:16978361, ECO:0000269|PubMed:22120738}.",MSRKPLIAGNWKMNLNHYEAIALVQKIAFSLPDKYYDRVDVAVIPPFTDLRSVQTLVDGDKLRLTYGAQDLSPHDSGAYTGDVSGAFLAKLGCSYVVVGHSERRTYHNEDDALVAAKAATALKHGLTPIVCIGEHLDVREAGNHVAHNIEQLRGSLAGLLAEQIGSVVIAYEPVWAIGTGRVASAADAQEVCAAIRKELASLASPRIADTVRVLYGGSVNAKNVGDIVAQDDVDGGLVGGASLDGEHFATLAAIAAGGPLP,"27,403",261,Triosephosphate isomerase family,gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; growth [GO:0040007],triose-phosphate isomerase activity [GO:0004807],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],tpi,MTCY493.16c,1
P9WKH7,TS57_MYCTU,Rv1313c; Rv3798,Rv1313c MTCY373.33c; Rv3798 MTV026.03,GO:0003677; GO:0005618; GO:0005886; GO:0006310; GO:0032196,IPR002560; IPR032877; IPR029261; ,,; ,,Transposase for insertion sequence element IS1557,cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; transposition [GO:0032196],9634230,,,MRNVRLFRALLGVDKRTVIEDIEFEEDDAGDGARVIARVRPRSAVLRRCGRCGRKASWYDRGAGLRQWRSLDWGTVEVFLEAEAPRVNCPTHGPTVVAVPWARHHAGHTYAFDDTVAWLAVACSKTAVCELMRIAWRTVGAIVARVWADTEKRIDRFANLRRIGIDEISYKRHHRYLTVVVDHDSGRLVWAAPGHDKATLGLFFDALGAERAAQITHVSADAADWIADVVTERCPDAIQCADPFHVVAWATEALDVERRRAWNDARAIARTEPKWGRGRPGKNAAPRPGRERARRLKGARYALWKNPEDLTERQSAKLAWIAKTDPRLYRAYLLKESLRHVFSVKGEEGKQALDRWISWAQRCRIPVFVELAARIKRHRVAIDAALDHGLSQGLIESTNTKIRLLTRIAFGFRSPQALIALAMLTLAGHRPTLPGRHNHPQISQ,"50,186",444,Transposase 12 family,DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],cell wall [GO:0005618]; plasma membrane [GO:0005886],; ,MTCY373.33c; MTV026.03,1
P60230,TRA1_MYCTU,Rv1199c; Rv2512c,Rv1199c MTCI364.11c; Rv2512c MTCY07A7.18c,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,; ,,Transposase for insertion sequence element IS1081,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,FUNCTION: Required for the transposition of the insertion element.,MTSSHLIDTEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANLMAATPKPSWPWVRTLLHSIYDQPDAESVVAQYDRVLDALTDKLPAVAEHLDTARTDLLAFTAFPKQIWRQIWSNNPQERLNREVRRRTDVVGIFPDRASIIRLVGAVLAEQHDEWIEGRRYLGLEVLTRARAALTSTEEPAKQQTTNTPALTT,"45,810",415,Transposase mutator family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,; ,MTCI364.11c; MTCY07A7.18c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WG33,TAL_MYCTU,Rv1448c,tal Rv1448c MTCY493.06,GO:0004801; GO:0005576; GO:0005829; GO:0005975; GO:0006098; GO:0040007,IPR013785; IPR001585; IPR004732; IPR018225; ,,tal,,Transaldolase (EC 2.2.1.2),cytosol [GO:0005829]; extracellular region [GO:0005576]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; growth [GO:0040007]; pentose-phosphate shunt [GO:0006098],9634230; 21969609,,FUNCTION: Transaldolase is important for the balance of metabolites in the pentose-phosphate pathway. {ECO:0000250}.,MTAQNPNLAALSAAGVSVWLDDLSRDRLRSGNLQELIDTKSVVGVTTNPSIFQKALSEGHTYDAQIAELAARGADVDATIRTVTTDDVRSACDVLVPQWEDSDGVDGRVSIEVDPRLAHETEKTIQQAIELWKIVDRPNLFIKIPATKAGLPAISAVLAEGISVNVTLIFSVQRYREVMDAYLTGMEKARQAGHSLSKIHSVASFFVSRVDTEIDKRLDRIGSRQALELRGQAGVANARLAYATYREVFEDSDRYRSLKVDGARVQRPLWASTGVKNPDYSDTLYVTELVAPHTVNTMPEKTIDAVADHGVIQGDTVTGTASDAQAVFDQLGAIGIDLTDVFAVLEEEGVRKFEASWNELLQETRAHLDTAAQ,"40,721",373,"Transaldolase family, Type 2 subfamily",carbohydrate metabolic process [GO:0005975]; growth [GO:0040007]; pentose-phosphate shunt [GO:0006098],sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801],cytosol [GO:0005829]; extracellular region [GO:0005576],,MTCY493.06,1
P9WG99,TATB_MYCTU,Rv1224,tatB Rv1224 MTCI61.07,GO:0005886; GO:0008565; GO:0009306; GO:0016021; GO:0040007; GO:0043953,IPR003369; IPR018448; IPR003998; ,,tatB,,Sec-independent protein translocase protein TatB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; growth [GO:0040007]; protein secretion [GO:0009306]; protein transport by the Tat complex [GO:0043953],9634230; 16952959,,"FUNCTION: Part of the twin-arginine translocation (Tat) system that transports large folded proteins containing a characteristic twin-arginine motif in their signal peptide across membranes. Together with TatC, TatB is part of a receptor directly interacting with Tat signal peptides. TatB may form an oligomeric binding site that transiently accommodates folded Tat precursor proteins before their translocation. {ECO:0000255|HAMAP-Rule:MF_00237}.",MFANIGWWEMLVLVMVGLVVLGPERLPGAIRWAASALRQARDYLSGVTSQLREDIGPEFDDLRGHLGELQKLRGMTPRAALTKHLLDGDDSLFTGDFDRPTPKKPDAAGSAGPDATEQIGAGPIPFDSDAT,"14,114",131,TatB family,growth [GO:0040007]; protein secretion [GO:0009306]; protein transport by the Tat complex [GO:0043953],protein transporter activity [GO:0008565],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCI61.07,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WG51,Y1401_MYCTU,Rv1401,Rv1401 MTCY21B4.18,GO:0005886; GO:0016021,IPR012506; ,,,,Uncharacterized membrane protein Rv1401,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MGSIAGFSSAVLSKLGIPVPYAPRLLAGGWVVAGWAGLAYGVYLTVIALRLPPGSELTGHAMLQPAFKASMAVLLAAAAVAHPIGRERRWLVPALLLSATGDWLLAIPWWTWAFVFGLGAFLLAHLCFIGALLPLARQAAPSRGRVAAVVAMCVASAGLLVWFWPHLGKDNLTIPVTVYIVALSAMVCTALLARLPTIWTAVGAVCFAASDSMIGIGRFILGNEALAVPIWWSYAAAEILITAGFFFGREVPDNAAAPTDS,"27,391",261,TMEM86 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21B4.18,2
P9WLY9,Y1403_MYCTU,Rv1403c,Rv1403c MTCY21B4.20c,,IPR029063; ,,,,Uncharacterized protein Rv1403c,,9634230,,,MTVYTPTSERQAPATTHRQMWALGDYAAIAEELLAPLGPILVSTSGIRRGDRVLDVAAGSGNVSIPAAMAGAHVTASDLTPELLRRAQARAAAAGLELGWREANAEALPFSAGEFDAVLSTIGVMFAPRHQRTADELARVCRRGGKISTLNWTPEGFYGKLLSTIRPYRPTLPAGAPHEVWWGSEDYVSGLFRDHVSDIRTRRGSLTVDRFGCPDECRDYFKNFYGPAINAYRSIADSPECVATLDAEITELCREYLCDGVMQWEYLIFTARKC,"30,077",274,,,,,,MTCY21B4.20c,1
P9WLY7,Y1405_MYCTU,Rv1405c,Rv1405c MTCY21B4.22c,GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized protein Rv1405c,methyltransferase activity [GO:0008168],9634230; 21969609,,,MTIDTPAREDQTLAATHRAMWALGDYALMAEEVMAPLGPILVAAAGIGPGVRVLDVAAGSGNISLPAAKTGATVISTDLTPELLQRSQARAAQQGLTLQYQEANAQALPFADDEFDTVISAIGVMFAPDHQAAADELVRVCRPGGTIGVISWTCEGFFGRMLATIRPYRPSVSADLPPSALWGREAYVTGLLGDGVTGLKTARGLLEVKRFDTAQAVHDYFKNNYGPTIEAYAHIGDNAVLAAELDRQLVELAAQYLSDGVMEWEYLLLTAEKR,"29,262",274,,,methyltransferase activity [GO:0008168],,,MTCY21B4.22c,1
P9WLY3,Y1414_MYCTU,Rv1414,Rv1414 MTCY21B4.31,,IPR026956; ,,,,Uncharacterized protein Rv1414,,9634230,,,MLGDAQQLELGRCAPADIALTVAATVVSRQDCRSGLRRIVLDCGSKILGSDRPAWATGFGRLIDHADARIAALSEHHATVVWPDDAPLPPVGTRLRVIPNHVCLTTNLVDDVAVVRDATLIDRWKVAARGKNH,"14,330",133,,,,,,MTCY21B4.31,1
P9WLX9,Y1419_MYCTU,Rv1419,Rv1419 MTCY21B4.37,GO:0005576; GO:0016021; GO:0030246,IPR035992; IPR000772; ,,,DOMAIN 33 157 Ricin B-type lectin. {ECO:0000255|PROSITE-ProRule:PRU00174}.,Uncharacterized protein Rv1419,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246],9634230; 21969609,,,MGELRLVGGVLRVLVVVGAVFDVAVLNAGAASADGPVQLKSRLGDVCLDAPSGSWFSPLVINPCNGTDFQRWNLTDDRQVESVAFPGECVNIGNALWARLQPCVNWISQHWTVQPDGLVKSDLDACLTVLGGPDPGTWVSTRWCDPNAPDQQWDSVP,"16,853",157,,,carbohydrate binding [GO:0030246],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY21B4.37,1
P9WKC1,Y1425_MYCTU,Rv1425,Rv1425 MTCY21B4.43 MTCY493.29c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv1425 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv1425),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions very weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity.",MKRLSSVDAAFWSAETAGWHMHVGALAICDPSDAPEYSFQRLRELIIERLPEIPQLRWRVTGAPLGLDRPWFVEDEELDIDFHIRRIGVPAPGGRRELEELVGRLMSYKLDRSRPLWELWVIEGVEGGRIATLTKMHHAIVDGVSGAGLGEILLDITPEPRPPQQETVGFVGFQIPGLERRAIGALINVGIMTPFRIVRLLEQTVRQQIAALGVAGKPARYFEAPKTRFNAPVSPHRRVTGTRVELARAKAVKDAFGVKLNDVVLALVAGAARQYLQKRDELPAKPLIAQIPVSTRSEETKADVGNQVSSMTASLATHIEDPAKRLAAIHESTLSAKEMAKAPSAHQIMGLTETTPPGLLQLAARAYTASGLSHNLAPINLVVSNVPGPPFPLYMAGARLDSLVPLGPPVMDVALNITCFSYQDYLDFGLVTTPEVANDIDEMADAIEPALAELERAAE,"50,063",459,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY21B4.43 MTCY493.29c,1
P9WPR9,Y1488_MYCTU,Rv1488,Rv1488 MTCY277.09,GO:0005576; GO:0005618; GO:0005886; GO:0016021,IPR001107; IPR036013; IPR018080; IPR001972; ,,,,Uncharacterized protein Rv1488,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MQGAVAGLVFLAVLVIFAIIVVAKSVALIPQAEAAVIERLGRYSRTVSGQLTLLVPFIDRVRARVDLRERVVSFPPQPVITEDNLTLNIDTVVYFQVTVPQAAVYEISNYIVGVEQLTTTTLRNVVGGMTLEQTLTSRDQINAQLRGVLDEATGRWGLRVARVELRSIDPPPSIQASMEKQMKADREKRAMILTAEGTREAAIKQAEGQKQAQILAAEGAKQAAILAAEADRQSRMLRAQGERAAAYLQAQGQAKAIEKTFAAIKAGRPTPEMLAYQYLQTLPEMARGDANKVWVVPSDFNAALQGFTRLLGKPGEDGVFRFEPSPVEDQPKHAADGDDAEVAGWFSTDTDPSIARAVATAEAIARKPVEGSLGTPPRLTQ,"41,282",381,Band 7/mec-2 family,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY277.09,1
P9WLW3,Y1509_MYCTU,Rv1509,Rv1509 MTCY277.31,,IPR029063; ,,,,Uncharacterized protein Rv1509,,9634230,,,MFALSNNLNRVNACMDGFLARIRSHVDAHAPELRSLFDTMAAEARFARDWLSEDLARLPVGAALLEVGGGVLLLSCQLAAEGFDITAIEPTGEGFGKFRQLGDIVLELAAARPTIAPCKAEDFISEKRFDFAFSLNVMEHIDLPDEAVRRVSEVLKPGASYHFLCPNYVFPYEPHFNIPTFFTKELTCRVMRHRIEGNTGMDDPKGVWRSLNWITVPKVKRFAAKDATLTLRFHRAMLVWMLERALTDKEFAGRRAQWMVAAIRSAVKLRVHHLAGYVPATLQPIMDVRLTKR,"33,055",293,,,,,,MTCY277.31,1
P9WN07,Y1524_MYCTU,Rv1524,Rv1524 MTCY19G5.04c,GO:0005975; GO:0008194; GO:0016758; GO:0030259; GO:0043231,IPR004276; ,,,,Uncharacterized glycosyltransferase Rv1524 (EC 2.4.-.-),"intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]",9634230; 21969609,,,MKFVVASYGTRGDIEPCAAVGLELQRRGHDVCLAVPPNLIGFVETAGLSAVAYGSRDSQEQLDEQFLHNAWKLQNPIKLLREAMAPVTEGWAELSAMLTPVAAGADLLLTGQIYQEVVANVAEHHGIPLAALHFYPVRANGEIAFPARLPAPLVRSTITAIDWLYWRMTKGVEDAQRRELGLPKASTPAPRRMAVRGSLEIQAYDALCFPGLAAEWGGRRPFVGALTMESATDADDEVASWIAADTPPIYFGFGSMPIGSLADRVAMISAACAELGERALICSGPSDATGIPQFDHVKVVRVVSHAAVFPTCRAVVHHGGAGTTAAGLRAGIPTLILWVTSDQPIWAAQIKQLKVGRGRRFSSATKESLIADLRTILAPDYVTRAREIASRMTKPAASVTATADLLEDAARRAR,"44,362",414,Glycosyltransferase 28 family,carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259],"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]",intracellular membrane-bounded organelle [GO:0043231],,MTCY19G5.04c,1
P9WGS1,Y1543_MYCTU,Rv1543,Rv1543 MTCY48.22c,GO:0005618; GO:0005886; GO:0016491,IPR036291; IPR002347; ,,,,Uncharacterized oxidoreductase Rv1543 (EC 1.-.-.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MNLGDLTNFVEKPLAAVSNIVNTPNSAGRYRPFYLRNLLDAVQGRNLNDAVKGKVVLITGGSSGIGAAAAKKIAEAGGTVVLVARTLENLENVANDIRAIRGNGGTAHVYPCDLSDMDAIAVMADQVLGDLGGVDILINNAGRSIRRSLELSYDRIHDYQRTMQLNYLGAVQLILKFIPGMRERHFGHIVNVSSVGVQTRAPRFGAYIASKAALDSLCDALQAETVHDNVRFTTVHMALVRTPMISPTTIYDKFPTLTPDQAAGVITDAIVHRPRRASSPFGQFAAVADAVNPAVMDRVRNRAFNMFGDSSAAKGSESQTDTSELDKRSETFVRATRGIHW,"36,821",341,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY48.22c,1
P9WM43,Y1271_MYCTU,Rv1271c,Rv1271c MTCY50.11,,IPR007969; ,,,,Uncharacterized protein Rv1271c,,9634230,,,MLSPLSPRIIAAFTTAVGAAAIGLAVATAGTAGANTKDEAFIAQMESIGVTFSSPQVATQQAQLVCKKLASGETGTEIAEEVLSQTNLTTKQAAYFVVDATKAYCPQYASQLT,"11,589",113,,,,,,MTCY50.11,1
P9WM41,Y1278_MYCTU,Rv1278,Rv1278 MTCY50.04c,GO:0005618; GO:0005886; GO:0040007,IPR027417; ,,,,Uncharacterized protein Rv1278,cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MKLHRLALTNYRGIAHRDVEFPDHGVVVVCGANEIGKSSMVEALDLLLEYKDRSTKKEVKQVKPTNADVGSEVIAEISSGPYRFVYRKRFHKRCETELTVLAPRREQLTGDEAHERVRTMLAETVDTELWHAQRVLQAASTAAVDLSGCDALSRALDLAAGDDAALSGTESLLIERIEAEYARYFTPTGRPTGEWSAAVSRLAAAEAAVADCAAAVAEVDDGVRRHTELTEQVAELSQQLLAHQLRLEAARVAAEKIAAITDDAREAKLIATAAAATSGASTAAHAGRLGLLTEIDTRTAAVVAAEAKARQAADEQATARAEAEACDAALTEATQVLTAVRLRAESARRTLDQLADCEEADRLAARLARIDDIEGDRDRVCAELSAVTLTEELLSRIERAAAAVDRGGAQLASISAAVEFTAAVDIELGVGDQRVSLSAGQSWSVTATGPTEVKVPGVLTARIVPGATALDFQAKYAAAQQELADALAAGEVADLAAARSADLCRRELLSRRDQLTATLAGLCGDEQVDQLRSRLEQLCAGQPAELDLVSTDTATARAELDAVEAARIAAEKDCETRRQIAAGAARRLAETSTRATVLQNAAAAESAELGAAMTRLACERASVGDDELAAKAEADLRVLQTAEQRVIDLADELAATAPDAVAAELAEAADAVELLRERHDEAIRALHEVGVELSVFGTQGRKGKLDAAETEREHAASHHARVGRRARAARLLRSVMARHRDTTRLRYVEPYRAELHRLGRPVFGPSFEVEVDTDLRIRSRTLDDRTVPYECLSGGAKEQLGILARLAGAALVAKEDAVPVLIDDALGFTDPERLAKMGEVFDTIGADGQVIVLTCSPTRYGGVKGAHRIDLDAIQ,"93,351",875,,growth [GO:0040007],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY50.04c,1
P9WMV5,Y1279_MYCTU,Rv1279,Rv1279 MTCY50.03c,GO:0005618; GO:0005829; GO:0005886; GO:0016614; GO:0050660,IPR036188; IPR027424; IPR012132; IPR000172; IPR007867; ,,,,Uncharacterized GMC-type oxidoreductase Rv1279 (EC 1.1.-.-),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MDTQSDYVVVGTGSAGAVVASRLSTDPATTVVALEAGPRDKNRFIGVPAAFSKLFRSEIDWDYLTEPQPELDGREIYWPRGKVLGGSSSMNAMMWVRGFASDYDEWAARAGPRWSYADVLGYFRRIENVTAAWHFVSGDDSGVTGPLHISRQRSPRSVTAAWLAAARECGFAAARPNSPRPEGFCETVVTQRRGARFSTADAYLKPAMRRKNLRVLTGATATRVVIDGDRAVGVEYQSDGQTRIVYARREVVLCAGAVNSPQLLMLSGIGDRDHLAEHDIDTVYHAPEVGCNLLDHLVTVLGFDVEKDSLFAAEKPGQLISYLLRRRGMLTSNVGEAYGFVRSRPELKLPDLELIFAPAPFYDEALVPPAGHGVVFGPILVAPQSRGQITLRSADPHAKPVIEPRYLSDLGGVDRAAMMAGLRICARIAQARPLRDLLGSIARPRNSTELDEATLELALATCSHTLYHPMGTCRMGSDEASVVDPQLRVRGVDGLRVADASVMPSTVRGHTHAPSVLIGEKAADLIRS,"57,331",528,GMC oxidoreductase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY50.03c,1
P9WGU5,Y1280_MYCTU,Rv1280c,Rv1280c MTCY50.02,GO:0005886; GO:0005887; GO:0017038; GO:0030288; GO:0042277; GO:0042597; GO:0043190; GO:0043295; GO:1904680,IPR030678; IPR000914; ,,,,Uncharacterized protein Rv1280c,ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; glutathione binding [GO:0043295]; peptide binding [GO:0042277]; peptide transmembrane transporter activity [GO:1904680]; protein import [GO:0017038],9634230; 21969609,,,MADRGQRRGCAPGIASALRASFQGKSRPWTQTRYWAFALLTPLVVAMVLTGCSASGTQLELAPTADRRAAVGTTSDINQQDPATLQDGGNLRLSLTDFPPNFNILHIDGNNAEVAAMMKATLPRAFIIGPDGSTTVDTNYFTSIELTRTAPQVVTYTINPEAVWSDGTPITWRDIASQIHAISGADKAFEIASSSGAERVASVTRGVDDRQAVVTFAKPYAEWRGMFAGNGMLLPASMTATPEAFNKGQLDGPGPSAGPFVVSALDRTAQRIVLTRNPRWWGARPRLDSITYLVLDDAARLPALQNNTIDATGVGTLDQLTIAARTKGISIRRAPGPSWYHFTLNGAPGSILADKALRLAIAKGIDRYTIARVAQYGLTSDPVPLNNHVFVAGQDGYQDNSGVVAYNPEQAKRELDALGWRRSGAFREKDGRQLVIRDLFYDAQSTRQFAQIAQHTLAQIGVKLELQAKSGSGFFSDYVNVGAFDIAQFGWVGDAFPLSSLTQIYASDGESNFGKIGSPQIDAAIERTLAELDPGKARALANQVDELIWAEGFSLPLTQSPGTVAVRSTLANFGATGLADLDYTAIGFMRR,"63,477",591,Bacterial solute-binding protein 5 family,protein import [GO:0017038],glutathione binding [GO:0043295]; peptide binding [GO:0042277]; peptide transmembrane transporter activity [GO:1904680],ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; outer membrane-bounded periplasmic space [GO:0030288]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886],,MTCY50.02,1
P9WM39,Y1288_MYCTU,Rv1288,Rv1288 MTCY373.07,,IPR029058; IPR000801; IPR018392; IPR036779; ,,,DOMAIN 3 50 LysM 1. {ECO:0000255|PROSITE-ProRule:PRU01118}.; DOMAIN 54 101 LysM 2. {ECO:0000255|PROSITE-ProRule:PRU01118}.; DOMAIN 105 152 LysM 3. {ECO:0000255|PROSITE-ProRule:PRU01118}.,Uncharacterized protein Rv1288,,9634230; 21969609,,,MVSTHAVVAGETLSALALRFYGDAELYRLIAAASGIADPDVVNVGQRLIMPDFTRYTVVAGDTLSALALRFYGDAELNWLIAAASGIADPDVVNVGQRLIMPDFTRYTVVAGDTLSALAARFYGDASLYPLIAAVNGIADPGVIDVGQVLVIFIGRSDGFGLRIVDRNENDPRLWYYRFQTSAIGWNPGVNVLLPDDYRTSGRTYPVLYLFHGGGTDQDFRTFDFLGIRDLTAGKPIIIVMPDGGHAGWYSNPVSSFVGPRNWETFHIAQLLPWIEANFRTYAEYDGRAVAGFSMGGFGALKYAAKYYGHFASASSHSGPASLRRDFGLVVHWANLSSAVLDLGGGTVYGAPLWDQARVSADNPVERIDSYRNKRIFLVAGTSPDPANWFDSVNETQVLAGQREFRERLSNAGIPHESHEVPGGHVFRPDMFRLDLDGIVARLRPASIGAAAERAD,"49,619",456,,,,,,MTCY373.07,1
P9WM35,Y1290_MYCTU,Rv1290c,Rv1290c MTCY373.09c,GO:0005829; GO:0005886; GO:0009405; GO:0016021,IPR018723; ,,,,Uncharacterized protein Rv1290c,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 21969609,,,MLQRSLGVNGRKLAMSARSAKRERKNASTAASKCYVVPPSARGWVHAYSVTATSMLNRRKAILDYLQGAVWVLPTFGVAIGLGSGAVLSMIPVKSGTLIDKLMFQGTPGDARGVLIVVSATMITTIGIVFSLTVLSLQIASSQFSVRLLRTFLRDVPNQVVLAIFACTFAYSTGGLHTVGEHRDGGAFIPKVAVTGSLALAFVSIAALIYFLHHLMHSIQIDTIMDKVRLRTLGLVDQLYPESDTADRQVETPPSPPADAVPLLAPHSGYLQTVDVDDIAELAAASRYTALLVTFVGDYVTAGGLLGWCWRRGTAPGAPGSDFPQRCLRHVHIGFERTLQQDIRFGLRQMVDIALRALSPALNDPYTAIQVVHHLSAVESVLASRALPDDVRRDRAGELLFWLPYPSFATYLHVGCAQIRRYGSREPLVLTALLQLLSAVAQNCVDPSRRVAVQTQIALVVRAAQREFADESDRAMVLGAAARATEVVERPGTLAPPPSTFGQVAAAQAAASTIRSADRDG,"56,028",521,,pathogenesis [GO:0009405],,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY373.09c,1
P9WM31,Y1303_MYCTU,Rv1303,Rv1303 MTCY373.23,GO:0005886; GO:0016021; GO:0040007,IPR005598; ,,,,Uncharacterized protein Rv1303,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550; 21969609,,,MTTPAQDAPLVFPSVAFRPVRLFFINVGLAAVAMLVAGVFGHLTVGMFLGLGLLLGLLNALLVRRSAESITAKEHPLKRSMALNSASRLAIITILGLIIAYIFRPAGLGVVFGLAFFQVLLVATTALPVLKKLRTATEEPVATYSSNGQTGGSEGRSASDD,"16,895",161,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY373.23,1
P9WM29,Y1312_MYCTU,Rv1312,Rv1312 MTCY373.32,GO:0016021,IPR019675; ,,,,Uncharacterized protein Rv1312,integral component of membrane [GO:0016021],9634230; 21969609,,,MSAPMIGMVVLVVVLGLAVLALSYRLWKLRQGGTAGIMRDIPAVGGHGWRHGVIRYRGGEAAFYRLSSLRLWPDRRLSRRGVEIISRRAPRGDEFDIMTDEIVVVELCDSTQDRRVGYEIALDRGALTAFLSWLESRPSPRARRRSM,"16,594",147,,,,integral component of membrane [GO:0016021],,MTCY373.32,1
P9WQ31,Y1319_MYCTU,Rv1319c,Rv1319c MTCY130.04c,GO:0004016; GO:0004871; GO:0005576; GO:0005622; GO:0005886; GO:0006171; GO:0016021; GO:0035556,IPR001054; IPR003660; IPR029787; ,,,DOMAIN 279 330 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 362 486 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Uncharacterized protein Rv1319c,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],9634230; 21969609,,,MPAKKTMAQRLGQALETMTRQCGQLPETPAYGSWLLGRVSESPSRRWVRIKRIVTVYIMTANLTGIVVALLVVTFAFPVPSIYTDAPWWVTFGVAPAYATLALAIGTYWITTRIVRASIRWAIEERAPSQADGRNTLLLPFRVAAVHLILWDIGGALLATLYGLANRVFVTIILFSVTICGVLVATNCYLFTEFALRPVAAKALEAGRPPRRFAPGIMGRTMTVWSLGSGVPVTGIATTALYVLLVHNLTETQLASAVLILSITTLIFGFLVMWILAWLTAAPVRVVRAALKRVEQGDLRGDLVVFDGTELGELQRGFNAMVNGLRERERVRDLFGRHVGREVAAAAERERPQLGGEDRHAAVVFVDIVGSTQLVDNQPAAHVVKLLNRFFAIVVNEVDRHHGLINKFAGDAALAIFGAPNRLDRPEDAALAAARAIADRLANEMPEVQAGIGVAAGQIVAGNVGAKQRFEYTVVGKPVNQAARLCELAKSHPARLLASSDTLHAASETERAHWSLGETVTLRGHEQPTRLAVPT,"58,098",535,Adenylyl cyclase class-3 family,cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY130.04c,1
P9WQ29,Y1320_MYCTU,Rv1320c,Rv1320c MTCY130.05c,GO:0004016; GO:0004871; GO:0005618; GO:0005829; GO:0005886; GO:0016021; GO:0035556,IPR001054; IPR003660; IPR029787; ,,,DOMAIN 278 329 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 361 485 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Uncharacterized protein Rv1320c,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871]; intracellular signal transduction [GO:0035556],9634230; 21969609,,,MPSEKATTRHLPGAVETLSPRTGRRPETPAYGSWLLGRVSESPRMRRVRIQGMLTVAILVTNVIGLIVGAMLLTVAFPKPSVILDAPHWVSFGIVPGYCVLAFILGTYWLTRQTARALRWAIEERTPSHDEARSAFLVPLRVALAVLFLWGAAAALWTIIYGLANRLFIPRFLFSMGVIGVVAATSCYLLTEFALRPMAAQALEVGATPRSLVRGIVGRTMLVWLLCSGVPNVGVALTAIFDDTFWELSNDQFMITVLILWAPLLIFGFILMWILAWLTATPVRVVREALNRVEQGDLSGDLVVFDGTELGELQRGFNRMVEGLRERERVRDLFGRHVGREVAAAAERERPKLGGEERHVAVVFVDIVGSTQLVTSRPAAEVVMLLNRFFTVIVDEVNHHRGLVNKFQGDASLAVFGAPNRLSHPEDAALATARAIADRLASEMPECQAGIGVAAGQVVAGNVGAHERFEYTVIGEPVNEAARLCELAKSYPSRLLASSQTLRGASENECARWSLGETVTLRGHDQPIRLTSPVQQLQMPAQSADIVGGALGDHQTHTIYRGAHPTD,"61,965",567,Adenylyl cyclase class-3 family,intracellular signal transduction [GO:0035556],adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY130.05c,1
P9WM09,Y1356_MYCTU,Rv1356c,Rv1356c MTCY02B10.20c,,,,,,Uncharacterized protein Rv1356c,,9634230,,,MLIAGYLTDWRIMTTAQLRPIAPQKLHFSENLSVWVSDAQCRLVVSQPALDPTLWNTYLQGALRAYSKHGVECTLDLDAISDGSDTQLFFAAIDIGGDVVGGARVIGPLRSADDSHAVVEWAGNPGLSAVRKMINDRAPFGVVEVKSGWVNSDAQRSDAIAAALARALPLSMSLLGVQFVMGTAAAHALDRWRSSGGVIAARIPAAAYPDERYRTKMIWWDRRTLANHAEPKQLSRMLVESRKLLRDVEALSATTAATAGAEQ,"28,481",263,,,,,,MTCY02B10.20c,1
P9WM07,Y1357_MYCTU,Rv1357c,Rv1357c MTCY02B10.21c,GO:0005886; GO:0009214; GO:0016021; GO:0044119; GO:0071111,IPR001633; IPR035919; ,,,DOMAIN 54 307 EAL. {ECO:0000255|PROSITE-ProRule:PRU00074}.,Uncharacterized protein Rv1357c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cyclic-guanylate-specific phosphodiesterase activity [GO:0071111]; cyclic nucleotide catabolic process [GO:0009214]; growth of symbiont in host cell [GO:0044119],9634230,,,MDRCCQRATAFACALRPTKLIDYEEMFRGAMQARAMVANPDQWADSDRDQVNTRHYLSTSMRVALDRGEFFLVYQPIIRLADNRIIGAEALLRWEHPTLGTLLPGRFIDRAENNGLMVPLTAFVLEQACRHVRSWRDHSTDPQPFVSVNVSASTICDPGFLVLVEGVLGETGLPAHALQLELAEDARLSRDEKAVTRLQELSALGVGIAIDDFGIGFSSLAYLPRLPVDVVKLGGKFIECLDGDIQARLANEQITRAMIDLGDKLGITVTAKLVETPSQAARLRAFGCKAAQGWHFAKALPVDFFRE,"33,982",307,,cyclic nucleotide catabolic process [GO:0009214]; growth of symbiont in host cell [GO:0044119],cyclic-guanylate-specific phosphodiesterase activity [GO:0071111],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.21c,1
P9WM01,Y1362_MYCTU,Rv1362c,Rv1362c MTCY02B10.26c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv1362c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MTDDVRDVNTETTDATEVAEIDSAAGEAGDSATEAFDTDSATESTAQKGQRHRDLWRMQVTLKPVPVILILLMLISGGATGWLYLEQYRPDQQTDSGAARAAVAAASDGTIALLSYSPDTLDQDFATARSHLAGDFLSYYDQFTQQIVAPAAKQKSLKTTAKVVRAAVSELHPDSAVVLVFVDQSTTSKDSPNPSMAASSVMVTLAKVDGNWLITKFTPV,"23,503",220,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.26c,1
P9WLZ5,Y1366_MYCTU,Rv1366,Rv1366 MTCY02B10.30,GO:0015969,IPR007685; ,,,,Uncharacterized protein Rv1366,guanosine tetraphosphate metabolic process [GO:0015969],9634230; 21969609,,,MVVALVGSAIVDLHSRPPWSNNAVRRLGVALRDGVDPPVDCPSYAEVMLWHADLAAEVQDRIEGRSWSASELLVTSRAKSQDTLLAKLRRRPYLQLNTIQDIAGVRIDADLLLGEQTRLAREIADHFGADQPAIHDLRDHPHAGYRAVHVWLRLPAGRVEIQIRTILQSLWANFYELLADAYGRGIRYDERPEQLAAGVVPAQLQELVGVMQDASADLAMHEAEWQHCAEIEYPGQRAMALGEASKNKATVLATTKFRLERAINEAESAGGGG,"30,132",273,,guanosine tetraphosphate metabolic process [GO:0015969],,,,MTCY02B10.30,1
P9WLX3,Y1486_MYCTU,Rv1486c,Rv1486c MTCY277.07c,,,,,,Uncharacterized protein Rv1486c,,9634230; 21969609,,,MWCPSVSLSIWANAWLAGKAAPDDVLDALSLWAPTQSVAAYDAVAAGHTGLPWPDVHDAGTVSLLQTLRAAVGRRRLRGTINVVLPVPGDVRGLAAGTQFEHDALAAGEAVIVANPEDPGSAVGLVPEFSYGDVDEAAQSEPLTPELCALSWMVYSLPGAPVLEHYELGDAEYALRSAVRSAAEALSTIGLGSSDVAKPRGLVEQLLESSRQHRVPDHAPSRALRVLENAAHVDAIIAVSAGLSRLPIGTQSLSDAQRATDALRPLTAVVRSARMSAVTAILHSAWPD,"30,129",288,,,,,,MTCY277.07c,1
P9WLX1,Y1490_MYCTU,Rv1490,Rv1490 MTCY277.12,GO:0005886; GO:0016021; GO:0040007,,,,,Uncharacterized protein Rv1490,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230,,,MSQCFAVKGIGGADQATLGSAEILVKYAQLADKRARVYVLVSTWLVVWGIWHVYFVEAVFPNAILWLHYYAASYEFGFVRRGLGGELIRMLTGDHFFAGAYTVLWTSITVWLIALAVVVWLILSTGNRSERRIMLALLVPVLPFAFSYAIYNPHPELFGMTALVAFSIFLTRAHTSRTRVILSTLYGLTMAVLALIHEAIPLEFALGAVLAIIVLSKNATGATRRICTALAIGPGTVSVLLLAVVGRRDIADQLCAHIPHGMVENPWAVATTPQRVLDYIFGRVESHADYHDWVCEHVTPWFNLDWITSAKLVAVVGFRALFGAFLLGLLFFVATTSMIRYVSAVPVRTFFAELRGNLALPVLASALLVPLFITAVDWTRWWVMITLDVAIVYILYAIDRPEIEQPPSRRNVQVFVCVVLVLAVIPTGSANNIGR,"48,150",435,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY277.12,1
P9WLW7,Y1502_MYCTU,Rv1502,Rv1502 MTCY277.24,,IPR023296; ,,,,Uncharacterized protein Rv1502,,9634230; 21969609,,,MAWRKLGRIFAPSGELDWSRSHAALPVPEWIEGDIFRIYFSGRDGQNRSSIGSVIVDLAVGGKILDIPAEPILRPGARGMFDDCGVSIGSIVRAGDTRLLYYTGWNLAVTVPWKNTIGVAISEAGAPFERWSTFPVVALDERDPFSLSYPWVIQDGGTYRMWYGSNLGWGEGTDEIPHVIRYAQSRDGVHWEKQDRVHIDTSGSDNSAACRPYVVRDAGVYRMWFCARGAKYRIYCATSEDGLTWRQLGKDEGIDVSPDSWDSDMIEYPCVFDHRGQRFMLYSGDGYGRTGFGLAVLEN,"33,473",299,,,,,,MTCY277.24,1
P9WLW1,Y1510_MYCTU,Rv1510,Rv1510 MTCY277.32,GO:0005886; GO:0016021; GO:0046812,,,,,Uncharacterized protein Rv1510,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; host cell surface binding [GO:0046812],9634230; 21969609,,,MYERRHERGMCDRAVEMTDVGATAAPTGPIARGSVARVGAATALAVACVYTVIYLAARDLPPACFSIFAVFWGALGIATGATHGLLQETTREVRWVRSTQIVAGHRTHPLRVAGMIGTVAAVVIAGSSPLWSRQLFVEGRWLSVGLLSVGVAGFCAQATLLGALAGVDRWTQYGSLMVTDAVIRLAVAAAAVVIGWGLAGYLWAATAGAVAWLLMLMASPTARSAASLLTPGGIATFVRGAAHSITAAGASAILVMGFPVLLKVTSDQLGAKGGAVILAVTLTRAPLLVPLSAMQGNLIAHFVDRRTQRLRALIAPALVVGGIGAVGMLAAGLTGPWLLRVGFGPDYQTGGALLAWLTAAAVAIAMLTLTGAAAVAAALHRAYLLGWVSATVASTLLLLLPMPLETRTVIALLFGPTVGIAIHVAALARRPD,"44,293",432,,,host cell surface binding [GO:0046812],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY277.32,1
P9WLV7,Y1519_MYCTU,Rv1519,Rv1519 MTCY19G5.09c,GO:0003824,IPR000653; IPR015422; ,,,,Uncharacterized protein Rv1519,catalytic activity [GO:0003824],9634230,,,MRCGCLACDGVLCANGPGRPRRPALTCTAVATRTLHSLATNAELVESADLTVTEDICSRIVSLPVHDHMAIADVARVVAPFGEGLARGG,"9,200",89,,,catalytic activity [GO:0003824],,,MTCY19G5.09c,1
P9WLV3,Y1525_MYCTU,Rv1525,wbbL2 Rv1525 MTCY19G5.03c,,IPR029044; ,,wbbL2,,Uncharacterized protein Rv1525,,9634230; 21969609,,,MYAPLVSLMITVPVFGQHEYTHALVADLEREGADYLIVDNRGDYPRIGTERVSTPGENLGWAGGSELGFRLAFAEGYSHAMTLNNDTRVSKGFVAALLDSRLPADAGMVGPMFDVGFPFAVADEKPDAESYVPRARYRKVPAVEGTALVMSRDCWDAVGGMDLSTFGRYGWGLDLDLALRARKSGYGLYTTEMAYINHFGRKTANTHFGGHRYHWGASAAMIRGLRRTHGWPAAMGILREMGMAHHRKWHKSFPLTCPASC,"28,779",261,,,,,,MTCY19G5.03c,1
P9WLV1,Y1526_MYCTU,Rv1526c,Rv1526c MTCY19G5.02,GO:0005975; GO:0008194; GO:0016758; GO:0030259; GO:0043231,IPR004276; ,,,,Uncharacterized protein Rv1526c,"intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259]",9634230,,,MKFVLAVHGTRGDVEPCAAVGVELRRRGHAVHMAVPPNLIEFVESAGLTGVAYGPDSDEQINTVAAFVRNLTRAQNPLNLARAVKELFVEGWAEMGTTLTTLADGADLVMTGQTYHGVAANVAEYYDIPAAALHHFPMQVNGQIAIPSIPTPATLVRATMKVSWRLYAYVSKDADRAQRRELGLPPAPAPAVRRLAERGAPEIQAYDPVFFPGLAAEWSDRRPFVGPLTMELHSEPNEELESWIAAGTPPIYFGFGSTPVQTPVQTLAMISDVCAQLGERALIYSPAANSTRIRHADHVKRVGLVNYSTILPKCRAVVHHGGAGTTAAGLRAGMPTLILWDVADQPIWAGAVQRLKVGSAKRFTNITRGSLLKELRSILAPECAARAREISTRMTRPTAAVTAAADLLEATARQTPGSTPSSSPGR,"45,696",426,,carbohydrate metabolic process [GO:0005975]; lipid glycosylation [GO:0030259],"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]",intracellular membrane-bounded organelle [GO:0043231],,MTCY19G5.02,1
P9WIF7,PG24_MYCTU,Rv1325c,PE_PGRS24 Rv1325c MTCY130.10c,,IPR000084; ,,PE_PGRS24,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein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ycobacterial PE family, PGRS subfamily",,,,,MTCY130.10c,1
P9WI71,PKNH_MYCTU,Rv1266c,pknH Rv1266c MTCY50.16,GO:0004672; GO:0004674; GO:0005524; GO:0005618; GO:0005887; GO:0043085; GO:0043086; GO:0043388; GO:0045893; GO:0045926; GO:0046777; GO:0046890; GO:0052572,IPR011009; IPR026954; IPR038232; IPR000719; IPR017441; IPR008271; ,,pknH,DOMAIN 16 276 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknH (EC 2.7.11.1),"cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of catalytic activity [GO:0043086]; negative regulation of growth [GO:0045926]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; regulation of lipid biosynthetic process [GO:0046890]; response to host immune response [GO:0052572]",9634230; 14690440; 15043876; 16077122; 16817899; 16585755; 16739134; 17286964; 20630871; 21969609; 22727744,X-ray crystallography (1),"FUNCTION: May regulate bacterial growth in response to external signals to facilitate adaptation to the host environment. In vitro, phosphorylates several substrates such as EmbR, DevR (DosR), DacB1 and Rv0681. {ECO:0000269|PubMed:14690440, ECO:0000269|PubMed:15043876, ECO:0000269|PubMed:16077122, ECO:0000269|PubMed:16585755, ECO:0000269|PubMed:16817899, ECO:0000269|PubMed:17286964, ECO:0000269|PubMed:20630871}.",MSDAQDSRVGSMFGPYHLKRLLGRGGMGEVYEAEHTVKEWTVAVKLMTAEFSKDPVFRERMKREARIAGRLQEPHVVPIHDYGEVDGQMFLEMRLVEGTDLDSVLKRFGPLTPPRAVAIITQIASALDAAHADGVMHRDVKPQNILITRDDFAYLVDFGIASATTDEKLTQLGTAVGTWKYMAPERFSNDEVTYRADIYALACVLHECLTGAPPYRADSAGTLVSSHLMGPIPQPSAIRPGIPKAFDAVVARGMAKKPEDRYASAGDLALAAHEALSDPDQDHAADILRRSQESTLPAPPKPVPPPTMPATAMAPRQPPAPPVTPPGVQPAPKPSYTPPAQPGPAGQRPGPTGQPSWAPNSGPMPASGPTPTPQYYQGGGWGAPPSGGPSPWAQTPRKTNPWPLVAGAAAVVLVLVLGAIGIWIAIRPKPVQPPQPVAEERLSALLLNSSEVNAVMGSSSMQPGKPITSMDSSPVTVSLPDCQGALYTSQDPVYAGTGYTAINGLISSEPGDNYEHWVNQAVVAFPTADKARAFVQTSADKWKNCAGKTVTVTNKAKTYRWTFADVKGSPPTITVIDTQEGAEGWECQRAMSVANNVVVDVNACGYRITNQAGQIAAKIVDKVNKE,"66,754",626,"Protein kinase superfamily, Ser/Thr protein kinase family","negative regulation of catalytic activity [GO:0043086]; negative regulation of growth [GO:0045926]; positive regulation of catalytic activity [GO:0043085]; positive regulation of DNA binding [GO:0043388]; positive regulation of transcription, DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; regulation of lipid biosynthetic process [GO:0046890]; response to host immune response [GO:0052572]",ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,MTCY50.16,1
O53901,PKS5_MYCTU,Rv1527c LH57_08370,pks5 Rv1527c LH57_08370,GO:0005618; GO:0005829; GO:0005886; GO:0006633; GO:0009405; GO:0016491; GO:0016746; GO:0031177,IPR001227; IPR036736; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR016039; ,,pks5,DOMAIN 2025 2101 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Mycocerosic acid synthase-like polyketide synthase (MAS-like PKS) (EC 2.3.1.-) (Polyketide synthase Pks5),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; fatty acid biosynthetic process [GO:0006633]; pathogenesis [GO:0009405]",9634230; 12855735; 21969609,,"FUNCTION: Polyketide synthase likely involved in the biosynthesis of a polymethyl-branched fatty acid (PMB-FA) that might only be produced during host infection. Is required for the full virulence of M.tuberculosis during host infection. {ECO:0000269|PubMed:12855735, ECO:0000305}.",MGKERTKTVDRTRVTPVAVIGMGCRLPGGIDSPDRLWEALLRGDDLVTEIPADRWDIDEYYDPEPGVPGRTDCKWGAYLDNVGDFDPEFFGIGEKEAIAIDPQHRLLLETSWEAMEHGGLTPNQMASRTGVFVGLVHTDYILVHADNQTFEGPYGNTGTNACFASGRVAYAMGLQGPAITVDTACSSGLTAIHLACRSLHDGESDIALAGGVYVMLEPRRFASGSALGMLSATGRCHAFDVSADGFVSGEGCVMLALKRLPDALADGDRILAVIRGTAANQDGHTVNIATPSRSAQVAAYREALDVAGVDPATVGMVEAHGPGTPVGDPIEYASLAEVYGNDGPCALASVKTNFGHTQSAAGALGLMKAVLALQHGVVPQNLHFTALPDKLAAIETNLFVPQEITPWPGADQETPRRAAVSSYGMTGTNVHAIVEQAPVPAPESGAPGDTPATPGIDGALLFALSASSQDALRQTAARLADWVDAQGPELAPADLAYTLARRRGHRPVRTAVLAATTAELTEALREVATGEPPYPPAVGQDDRGPVWVFSGQGSQWAGMGADLLATEPVFAATIAAIEPLIAAESGFSVTEAMTAPEVVTGIDRVQPTLFAMQVALAATMKSYGVAPGAVIGHSLGESAAAVVAGALCLEDGVRVICRRSALMTRIAGAGAMASVELPAQQVLSELMARGVNDAVVAVVASPQSTVIGGATQTVRDLVAAWEQRDVLAREVAVDVASHSPQVDPILDELAEALAEISPLQPEIPYYSATSFDPREEPYCDAYYWVDNLRHTVRFAAAVQAALEDGYRVFTELTPHPLLTHAVDQTARSLDMSAAALAGMRREQPLPHGLRALAGDLYAAGAAVDFAVLYPTGRLINAPLPTWNHRRLLLDDTTRRIAHANTVAVHPLLGSHVRLPEEPERHVWQGEVGTVTQPWLADHQIHGAAALPGAAYCEMALAAARAVLGEASEVRDIRFEQMLLLDDETPIGVTATVEAPGVVPLTVETSHDGRYTRQLAAVLHVVREADDAPDQPPQKNIAELLASHPHKVDGAEVRQWLDKRGHRLGPAFAGLVDAYIAEGAGDTVLAEVNLPGPLRSQVKAYGVHPVLLDACFQSVAAHPAVQGMADGGLLLPLGVRRLRSYGSARHARYCCTTVTACGVGVEADLDVLDEHGAVVLAVRGLQLGTGASQASERARVLGERLLSIEWHERELPENSHAEPGAWLLISTCDATDLVAAQLTDALKVHDAQCTTMSWPQRADHAAQAARLRDQLGTGGFTGVFVLTAPQTGDPDAESPVRGGELVKHVVRIAREIPEITAQEPRLYVLTHNAQAVLSGDRPNLEQGGMRGLLRVIGAEHPHLKASYVDVDEQTGAESVARQLLAASGEDETAWRNDQWYTARLCPAPLRPEERQTTVVDHAEAGMRLQIRTPGDLQTLEFAAFDRVPPGPGEIEVAVTASSINFADVLVTFGRYQTLDGRQPQLGTDFAGVVSAVGPGVSELKVGDRVGGMSPNGCWATFVTCDARLATRLPEGLTDAQAAAVTTASATAWYGLQDLARIKAGDKVLIHSATGGVGQAAIAIARAAGAQIYATAGNEKRRDLLRDMGIEHVYDSRSVEFAEQIRRDTAGYGVDIVLNSVTGAAQLAGLKLLALGGRFIEIGKRDIYSNTRLELLPFRRNLAFYGLDLGLMSVSHPAAVRELLSTVYRLTVEGVLPMPQSTHYPLAEAATAIRVMGAAEHTGKLILDVPHAGRSSVVLPPEQARVFRSDGSYIITGGLGGLGLFLAEKMANAGAGRIVLSSRSQPSQKALETIELVRAIGSDVVVECGDIAQPDTADRLVTAATATGLPLRGVLHAAAVVEDATLANITDELIERDWAPKAYGAWQLHRATADQPLDWFCSFSSAAALVGSPGQGAYAAANSWLDTFTHWRRAQDLPATSIAWGAWGQIGRAIAFAEQTGDAIAPEEGAYAFETLLRHNRAYSGYAPVIGSPWLTAFAQHSPFAEKFQSLGQNRSGTSKFLAELVDLPREEWPDRLRRLLSKQVGLILRRTIDTDRLLSEYGLDSLSSQELRARVEAETGIRISATEINTTVRGLADLMCDKLAADRDAPAPA,"223,889",2108,,fatty acid biosynthetic process [GO:0006633]; pathogenesis [GO:0009405],"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
P9WI59,PLSB1_MYCTU,Rv1551,plsB1 Rv1551 MTCY48.14c,GO:0004366; GO:0005618; GO:0005886; GO:0008654,IPR022284; IPR028354; IPR002123; ,,plsB1,,Putative acyltransferase plsB1,cell wall [GO:0005618]; plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; phospholipid biosynthetic process [GO:0008654],9634230; 19099550; 21969609,,,MTAREVGRIGLRKLLQRIGIVAESMTPLATDPVEVTQLLDARWYDERLRALADELGRDPDSVRAEAAGYLREMAASLDERAVQAWRGFSRWLMRAYDVLVDEDQITQLRKLDRKATLAFAFSHRSYLDGMLLPEAILANRLSPALTFGGANLNFFPMGAWAKRTGAIFIRRQTKDIPVYRFVLRAYAAQLVQNHVNLTWSIEGGRTRTGKLRPPVFGILRYITDAVDEIDGPEVYLVPTSIVYDQLHEVEAMTTEAYGAVKRPEDLRFLVRLARQQGERLGRAYLDFGEPLPLRKRLQEMRADKSGTGSEIERIALDVEHRINRATPVTPTAVVSLALLGADRSLSISEVLATVRPLASYIAARNWAVAGAADLTNRSTIRWTLHQMVASGVVSVYDAGTEAVWGIGEDQHLVAAFYRNTAIHILVDRAVAELALLAAAETTTNGSVSPATVRDEALSLRDLLKFEFLFSGRAQFEKDLANEVLLIGSVVDTSKPAAAADVWRLLESADVLLAHLVLRPFLDAYHIVADRLAAHEDDSFDEEGFLAECLQVGKQWELQRNIASAESRSMELFKTALRLARHRELVDGADATDIAKRRQQFADEIATATRRVNTIAELARRQ,"69,224",621,GPAT/DAPAT family,phospholipid biosynthetic process [GO:0008654],glycerol-3-phosphate O-acyltransferase activity [GO:0004366],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY48.14c,1
P9WHV3,PRMC_MYCTU,Rv1300,prmC hemK Rv1300 MTCY373.20,GO:0003676; GO:0005829; GO:0008276; GO:0008757; GO:0040007; GO:0102559,IPR002052; IPR004556; IPR019874; IPR029063; ,,prmC,,Release factor glutamine methyltransferase (RF MTase) (EC 2.1.1.297) (M.MtuHHemKP) (N5-glutamine methyltransferase PrmC) (Protein-(glutamine-N5) MTase PrmC) (Protein-glutamine N-methyltransferase PrmC),cytosol [GO:0005829]; nucleic acid binding [GO:0003676]; protein methyltransferase activity [GO:0008276]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Methylates the class 1 translation termination release factors RF1/PrfA and RF2/PrfB on the glutamine residue of the universally conserved GGQ motif. {ECO:0000255|HAMAP-Rule:MF_02126}.,MTLRQAIDLAAALLAEAGVDSARCDAEQLAAHLAGTDRGRLPLFEPPGDEFFGRYRDIVTARARRVPLQHLIGTVSFGPVVLHVGPGVFVPRPETEAILAWATAQSLPARPLIVDACTGSGALAVALAQHRANLGLKARIIGIDDSDCALDYARRNAAGTPVELVRADVTTPRLLPELDGQVDLMVSNPPYIPDAAVLEPEVAQHDPHHALFGGPDGMTVISAVVGLAGRWLRPGGLFAVEHDDTTSSSTVDLVSSTKLFVDVQARKDLAGRPRFVTAMRWGHLPLAGENGAIDPRQRRCRAKR,"32,459",304,"Protein N5-glutamine methyltransferase family, PrmC subfamily",growth [GO:0040007],nucleic acid binding [GO:0003676]; protein-(glutamine-N5) methyltransferase activity [GO:0102559]; protein methyltransferase activity [GO:0008276]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytosol [GO:0005829],hemK,MTCY373.20,1
P9WI27,PPE17_MYCTU,Rv1168c,PPE17 Rv1168c,,IPR022171; IPR000030; IPR038332; ,,PPE17,,Uncharacterized PPE family protein PPE17,,9634230; 18400969; 21969609,,,MDFTIFPPEFNSLNIQGSARPFLVAANAWKNLSNELSYAASRFESEINGLITSWRGPSSTIMAAAVAPFRAWIVTTASLAELVADHISVVAGAYEAAHAAHVPLPVIETNRLTRLALATTNIFGIHTPAIFALDALYAQYWSQDGEAMNLYATMAAAAARLTPFSPPAPIANPGALARLYELIGSVSETVGSFAAPATKNLPSKLWTLLTKGTYPLTAARISSIPVEYVLAFVEGSNMGQMMGNLAMRSLTPTLKGPLELLPNAVRPAVSATLGNADTIGGLSVPPSWVADKSITPLAKAVPTSAPGGPSGTSWAQLGLASLAGGAVGAVAARTRSGVILRSPAAG,"35,821",346,Mycobacterial PPE family,,,,,,1
L7N675,PPE18_MYCTU,Rv1196,PPE18 Rv1196 LH57_06560,GO:0005576; GO:0005618; GO:0009405; GO:0009986,IPR022171; IPR000030; IPR038332; ,,PPE18,,PPE family protein PPE18,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 19651861; 19880448; 21451109; 21969609; 23300718,,"FUNCTION: Could be a crucial virulence factor for intracellular survival of M.tuberculosis (PubMed:23300718). Favors development of Th2-type response, and downregulates the proinflammatory and Th1-type response (PubMed:19880448, PubMed:21451109). Specifically interacts with the human Toll-like receptor 2 (TLR2), leading to an early and sustained activation of p38 MAPK, which induces IL-10 production and activates Th2-type immune response (PubMed:19880448). Also inhibits proinflammatory cytokines IL-12p40 and TNF-alpha production. Acts by upregulating the expression as well as tyrosine phosphorylation of suppressor of cytokine signaling 3 (SOCS-3), leading to the inhibition of phosphorylation of I-kappa-B-alpha, thereby preventing nuclear translocation of the NF-kappa-B/REL subunits and expression of NF-kappa-B regulated genes like IL-12 and TNF-alpha. Induction of SOCS-3 probably depends on the activation of p38 MAPK (PubMed:21451109). {ECO:0000269|PubMed:19880448, ECO:0000269|PubMed:21451109, ECO:0000269|PubMed:23300718}.",MVDFGALPPEINSARMYAGPGSASLVAAAQMWDSVASDLFSAASAFQSVVWGLTVGSWIGSSAGLMVAAASPYVAWMSVTAGQAELTAAQVRVAAAAYETAYGLTVPPPVIAENRAELMILIATNLLGQNTPAIAVNEAEYGEMWAQDAAAMFGYAAATATATATLLPFEEAPEMTSAGGLLEQAAAVEEASDTAAANQLMNNVPQALQQLAQPTQGTTPSSKLGGLWKTVSPHRSPISNMVSMANNHMSMTNSGVSMTNTLSSMLKGFAPAAAAQAVQTAAQNGVRAMSSLGSSLGSSGLGGGVAANLGRAASVGSLSVPQAWAAANQAVTPAARALPLTSLTSAAERGPGQMLGGLPVGQMGARAGGGLSGVLRVPPRPYVMPHSPAAG,"39,158",391,Mycobacterial PPE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,LH57_06560,1
P9WI23,PPE20_MYCTU,Rv1387,PPE20 Rv1387,GO:0005576,IPR000030; IPR038332; ,,PPE20,,Uncharacterized PPE family protein PPE20,extracellular region [GO:0005576],9634230; 21969609; 26729876,,,MTEPWIAFPPEVHSAMLNYGAGVGPMLISATQNGELSAQYAEAASEVEELLGVVASEGWQGQAAEAFVAAYMPFLAWLIQASADCVEMAAQQHVVIEAYTAAVELMPTQVELAANQIKLAVLVATNFFGINTIPIAINEAEYVEMWVRAATTMATYSTVSRSALSAMPHTSPPPLILKSDELLPDTGEDSDEDGHNHGGHSHGGHARMIDNFFAEILRGVSAGRIVWDPVNGTLNGLDYDDYVYPGHAIWWLARGLEFFQDGEQFGELLFTNPTGAFQFLLYVVVVDLPTHIAQIATWLGQYPQLLSAALTGVIAHLGAITGLAGLSGLSAIPSAAIPAVVPELTPVAAAPPMLAVAGVGPAVAAPGMLPASAPAPAAAAGATAAGPTPPATGFGGFPPYLVGGGGPGIGFGSGQSAHAKAAASDSAAAESAAQASARAQARAARRGRSAAKARGHRDEFVTMDMGFDAAAPAPEHQPGARASDCGAGPIGFAGTVRKEAVVKAAGLTTLAGDDFGGGPTMPMMPGTWTHDQGVFDEHR,"55,404",539,Mycobacterial PPE family,,,extracellular region [GO:0005576],,,1
P9WI25,PPE19_MYCTU,Rv1361c,PPE19 Rv1361c MTCY02B10.25c,GO:0005618; GO:0052572,IPR022171; IPR000030; IPR038332; ,,PPE19,,Uncharacterized PPE family protein PPE19,cell wall [GO:0005618]; response to host immune response [GO:0052572],9634230,,,MVDFGALPPEINSARMYAGPGSASLVAAAKMWDSVASDLFSAASAFQSVVWGLTTGSWIGSSAGLMVAAASPYVAWMSVTAGQAELTAAQVRVAAAAYETAYGLTVPPPVIAENRAELMILIATNLLGQNTPAIAVNEAEYGEMWAQDAAAMFGYAATAATATEALLPFEDAPLITNPGGLLEQAVAVEEAIDTAAANQLMNNVPQALQQLAQPTKSIWPFDQLSELWKAISPHLSPLSNIVSMLNNHVSMTNSGVSMASTLHSMLKGFAPAAAQAVETAAQNGVQAMSSLGSQLGSSLGSSGLGAGVAANLGRAASVGSLSVPQAWAAANQAVTPAARALPLTSLTSAAQTAPGHMLGGLPLGQLTNSGGGFGGVSNALRMPPRAYVMPRVPAAG,"40,016",396,Mycobacterial PPE family,response to host immune response [GO:0052572],,cell wall [GO:0005618],,MTCY02B10.25c,1
P9WI21,PPE21_MYCTU,Rv1548c,PPE21 Rv1548c MTCY48.17,GO:0005886; GO:0016021,IPR002989; IPR000030; IPR038332; ,,PPE21,,Uncharacterized PPE family protein PPE21,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MNFSVLPPEINSALMFAGAGPGPMLAAASAWTGLAGDLGSAAASFSAVTSQLATGSWQGPASAAMTGVAASYARWLTTAAAQAEQAAGQAQAAVSAFEAALAATVHPGAVSANRGRLRSLVASNLLGQNAPAIAAVEAVYEQMWAADVAAMLGYHGEASAVALSLTPFTPSPSAAATPGGAVIIAGFPFLDLGNVTIGGFNLASGNLGLGNLGSFNPGSANTGSVNLGNANIGDLNLGSGNIGSYNLGGGNTGDLNPDSGNTGTLNWGSGNIGSYNLGGGNLGSYNLGSGNTGDTNFGGGNTGNLNVGGGNTGNSNFGFGNTGNVNFGNGNTGDTNFGSGNLGSGNIGFGNKGSHNIGFGNSGNNNIGFGLTGDNQIGFGALNSGSGNLGFGNSGNGNIGFFNSGNNNIGMGNSGNGVGALSVEFGSSAERSSGFGNSGELSTGIGNSGQLSTGWFNSATTSTGWFNSGTTNTGWFNSGTTNTGIGNSGGNLVTGSMGLFNSGHTNTGSFNAGSMNTGDFNSGNVNTGYFNSGNINTGFFNSGDLNTGLFNSVNQPVQNSGWLHTGTNNSGYANAGTFNSGFDNNARDEHAEFVTGNSGLANVGNYNAGIINVGDHLSGFRNSVPTITGTANISGFVNAGTSISGFFNFGSLMSGFANFDDEVSGYLNGDSRASGWIH,"66,737",678,Mycobacterial PPE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.17,1
P9WMQ9,PRIA_MYCTU,Rv1402,priA Rv1402 MTCY21B4.19,GO:0003677; GO:0005524; GO:0005886; GO:0006268; GO:0006269; GO:0006270; GO:0006302; GO:0006310; GO:0043140; GO:0046872; GO:1990077,IPR005259,,priA,,Probable primosomal protein N' (EC 3.6.4.-) (ATP-dependent helicase PriA),"plasma membrane [GO:0005886]; primosome complex [GO:1990077]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA replication initiation [GO:0006270]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]",9634230; 21969609,,"FUNCTION: Involved in the restart of stalled replication forks. Recognizes and binds the arrested nascent DNA chain at stalled replication forks. It can open the DNA duplex, via its helicase activity, and promote assembly of the primosome and loading of the major replicative helicase DnaB onto DNA. {ECO:0000255|HAMAP-Rule:MF_00983}.",MLSVPHLDRDFDYLVPAEHSDDAQPGVRVRVRFHGRLVDGFVLERRSDSDHHGKLGWLDRVVSPEPVLTTEIRRLVDAVAARYAGTRQDVLRLAVPARHARVEREITTAPGRPVVAPVDPSGWAAYGRGRQFLAALADSRAARAVWQALPGELWADRFAEAAAQTVRAGRTVLAIVPDQRDLDTLWQAATALVDEHSVVALSAGLGPEARYRRWLAALRGSARLVIGTRSAVFAPLSELGLVMVWADADDSLAEPRAPYPHAREVAMLRAHQARCAALIGGYARTAEAHALVRSGWAHDVVAPRPEVRARSPRVVALDDSGYDDARDPAARTARLPSIALRAARSALQSGAPVLVQVPRRGYIPSLACGRCRAIARCRSCTGPLSLQGAGSPGAVCRWCGRVDPTLRCVRCGSDVVRAVVVGARRTAEELGRAFPGTAVITSAGDTLVPQLDAGPALVVATPGAEPRAPGGYGAALLLDSWALLGRQDLRAAEDALWRWMTAAALVRPRGAGGVVTVVAESSIPTVQSLIRWDPVGHAEAELAARTEVGLPPSVHIAALDGPAGTVTALLEAARLPDPDRLQADLLGPVDLPPGVRRPAGIPADAPVIRMLLRVCREQGLELAASLRRGIGVLSARQTRQTRSLVRVQIDPLHIG,"69,839",655,"Helicase family, PriA subfamily","DNA recombination [GO:0006310]; DNA replication, synthesis of RNA primer [GO:0006269]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair [GO:0006302]",ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],plasma membrane [GO:0005886]; primosome complex [GO:1990077],,MTCY21B4.19,1
P9WJI9,PNCB1_MYCTU,Rv1330c,pncB1 Rv1330c MTCY130.15c,GO:0004514; GO:0004516; GO:0005618; GO:0009435; GO:0019358; GO:0034355; GO:0047280,IPR013785; IPR007229; IPR006405; IPR036068; IPR002638; ,,pncB1,,Nicotinate phosphoribosyltransferase pncB1 (NAPRTase pncB1) (EC 6.3.4.21),cell wall [GO:0005618]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358],9634230; 18490451; 21969609,,"FUNCTION: Involved in the Preiss-Handler pathway, which is a recycling route that permits the salvage of free nicotinamide (NM) and nicotinic acid (Na) involved in the NAD biosynthesis. Catalyzes the synthesis of beta-nicotinate D-ribonucleotide from nicotinate and 5-phospho-D-ribose 1-phosphate at the expense of ATP. It is not able to use nicotinamide. PncB1 contributes to basal NAD level. {ECO:0000269|PubMed:18490451}.",MGPPPAARRREGEPDNQDPAGLLTDKYELTMLAAALRDGSANRPTTFEVFARRLPTGRRYGVVAGTGRLLEALPQFRFDADACELLAQFLDPATVRYLREFRFRGDIDGYAEGELYFPGSPVLSVRGSFAECVLLETLVLSIFNHDTAIASAAARMVSAAGGRPLIEMGSRRTHERAAVAAARAAYIAGFAASSNLAAQRRYGVPAHGTAAHAFTMLHAQHGGPTELAERAAFRAQVEALGPGTTLLVDTYDVTTGVANAVAAAGAELGAIRIDSGELGVLARQAREQLDRLGATRTRIVVSGDLDEFSIAALRGEPVDSYGVGTSLVTGSGAPTANMVYKLVEVDGVPVQKRSSYKESPGGRKEALRRSRATGTITEELVHPAGRPPVIVEPHRVLTLPLVRAGQPVADTSLAAARQLVASGLRSLPGDGLKLAPGEPAIPTRTIPA,"47,227",448,NAPRTase family,NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358],nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; nicotinate phosphoribosyltransferase activity [GO:0004516],cell wall [GO:0005618],,MTCY130.15c,1
P9WJM1,MURA_MYCTU,Rv1315,murA murZ Rv1315 MTCY149.01 MTCY373.35,GO:0005737; GO:0007049; GO:0008360; GO:0008760; GO:0009252; GO:0019277; GO:0040007; GO:0051301; GO:0071555,IPR001986; IPR036968; IPR013792; IPR005750; ,,murA,,UDP-N-acetylglucosamine 1-carboxyvinyltransferase (EC 2.5.1.7) (Enoylpyruvate transferase) (UDP-N-acetylglucosamine enolpyruvyl transferase) (EPT),cytoplasm [GO:0005737]; UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity [GO:0008760]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylgalactosamine biosynthetic process [GO:0019277],9634230; 8598279; 20066036; 21969609,,FUNCTION: Cell wall formation. Adds enolpyruvyl to UDP-N-acetylglucosamine. {ECO:0000255|HAMAP-Rule:MF_00111}.,MAERFVVTGGNRLSGEVAVGGAKNSVLKLMAATLLAEGTSTITNCPDILDVPLMAEVLRGLGATVELDGDVARITAPDEPKYDADFAAVRQFRASVCVLGPLVGRCKRARVALPGGDAIGSRPLDMHQAGLRQLGAHCNIEHGCVVARAETLRGAEIQLEFPSVGATENILMAAVVAEGVTTIHNAAREPDVVDLCTMLNQMGAQVEGAGSPTMTITGVPRLHPTEHRVIGDRIVAATWGIAAAMTRGDISVAGVDPAHLQLVLHKLHDAGATVTQTDASFRVTQYERPKAVNVATLPFPGFPTDLQPMAIALASIADGTSMITENVFEARFRFVEEMIRLGADARTDGHHAVVRGLPQLSSAPVWCSDIRAGAGLVLAGLVADGDTEVHDVFHIDRGYPLFVENLVSLGAEIERVCC,"44,064",418,"EPSP synthase family, MurA subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; UDP-N-acetylgalactosamine biosynthetic process [GO:0019277],UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity [GO:0008760],cytoplasm [GO:0005737],murZ,MTCY149.01 MTCY373.35,1
P9WPW9,MURI_MYCTU,Rv1338,murI Rv1338 MTCY02B10.02 MTCY130.23,GO:0005886; GO:0008360; GO:0008657; GO:0008881; GO:0009252; GO:0071555,IPR015942; IPR001920; IPR018187; IPR033134; IPR004391; ,,murI,,Glutamate racemase (EC 5.1.1.3),plasma membrane [GO:0005886]; DNA topoisomerase (ATP-hydrolyzing) inhibitor activity [GO:0008657]; glutamate racemase activity [GO:0008881]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 21969609,X-ray crystallography (1),FUNCTION: Provides the (R)-glutamate required for cell wall biosynthesis. {ECO:0000255|HAMAP-Rule:MF_00258}.,MNSPLAPVGVFDSGVGGLTVARAIIDQLPDEDIVYVGDTGNGPYGPLTIPEIRAHALAIGDDLVGRGVKALVIACNSASSACLRDARERYQVPVVEVILPAVRRAVAATRNGRIGVIGTRATITSHAYQDAFAAARDTEITAVACPRFVDFVERGVTSGRQVLGLAQGYLEPLQRAEVDTLVLGCTHYPLLSGLIQLAMGENVTLVSSAEETAKEVVRVLTEIDLLRPHDAPPATRIFEATGDPEAFTKLAARFLGPVLGGVQPVHPSRIH,"28,643",271,Aspartate/glutamate racemases family,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],DNA topoisomerase (ATP-hydrolyzing) inhibitor activity [GO:0008657]; glutamate racemase activity [GO:0008881],plasma membrane [GO:0005886],,MTCY02B10.02 MTCY130.23,1
P9WJK5,MUTB_MYCTU,Rv1493,mutB Rv1493 MTCY277.15,GO:0004494; GO:0005886; GO:0019678; GO:0031419; GO:0046872,IPR006159; IPR016176; IPR006158; IPR036724; IPR006099; IPR006098; ,,mutB,DOMAIN 616 748 B12-binding. {ECO:0000255|PROSITE-ProRule:PRU00666}.,Probable methylmalonyl-CoA mutase large subunit (MCM) (EC 5.4.99.2),"plasma membrane [GO:0005886]; cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; propionate metabolic process, methylmalonyl pathway [GO:0019678]",9634230; 21969609,Model (1),FUNCTION: Catalyzes the isomerization of succinyl-CoA to methylmalonyl-CoA during synthesis of propionate from tricarboxylic acid-cycle intermediates. {ECO:0000250}.,MTTKTPVIGSFAGVPLHSERAAQSPTEAAVHTHVAAAAAAHGYTPEQLVWHTPEGIDVTPVYIAADRAAAEAEGYPLHSFPGEPPFVRGPYPTMYVNQPWTIRQYAGFSTAADSNAFYRRNLAAGQKGLSVAFDLATHRGYDSDHPRVQGDVGMAGVAIDSILDMRQLFDGIDLSTVSVSMTMNGAVLPILALYVVAAEEQGVAPEQLAGTIQNDILKEFMVRNTYIYPPKPSMRIISDIFAYTSAKMPKFNSISISGYHIQEAGATADLELAYTLADGVDYIRAGLNAGLDIDSFAPRLSFFWGIGMNFFMEVAKLRAGRLLWSELVAQFAPKSAKSLSLRTHSQTSGWSLTAQDVFNNVARTCIEAMAATQGHTQSLHTNALDEALALPTDFSARIARNTQLVLQQESGTTRPIDPWGGSYYVEWLTHRLARRARAHIAEVAEHGGMAQAISDGIPKLRIEEAAARTQARIDSGQQPVVGVNKYQVPEDHEIEVLKVENSRVRAEQLAKLQRLRAGRDEPAVRAALAELTRAAAEQGRAGADGLGNNLLALAIDAARAQATVGEISEALEKVYGRHRAEIRTISGVYRDEVGKAPNIAAATELVEKFAEADGRRPRILIAKMGQDGHDRGQKVIATAFADIGFDVDVGSLFSTPEEVARQAADNDVHVIGVSSLAAGHLTLVPALRDALAQVGRPDIMIVVGGVIPPGDFDELYAAGATAIFPPGTVIADAAIDLLHRLAERLGYTLD,"80,604",750,Methylmalonyl-CoA mutase family,"propionate metabolic process, methylmalonyl pathway [GO:0019678]",cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494],plasma membrane [GO:0005886],,MTCY277.15,1
P9WJU1,MMPLA_MYCTU,Rv1183,mmpL10 Rv1183 MTV005.19,GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006869; GO:0016021,IPR004869; IPR004707; ,,mmpL10,,Acyltrehalose exporter MmpL10,cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid transport [GO:0006869],9634230; 21969609; 25124040; 25331437,,FUNCTION: Required for the biosynthesis of polyacyltrehalose (PAT) and the transport of diacyltrehalose (DAT) and possibly PAT to the cell surface. {ECO:0000269|PubMed:25124040}.,MVGCWVALALVLPMAVPSLAEMAQRHPVAVLPADAPSSVAVRQMAEAFHESGSENILVVLLTDEKGLGAADENVYHTLVDRLRNDAKDVVMLQDFLTTPPLREVLGSKDGKAWILPIGLAGDLGTPKSYHAYTDVERIVKRTVAGTTLTANVTGPAATVADLTDAGARDRASIELAIAVMLLVILMVIYRNPVTMLLPLVTIGASLMTAQALVAGVSLVGGLAVSNQAIVLLSAMIAGAGTDYAVFLISRYHEYVRLGEHPERAVQRAMMSVGKVIAASAATVGITFLGMRFAKLGVFSTVGPALAIGIAVSFLAAVTLLPAILVLASPRGWVAPRGERMATFWRRAGTRIVRRPKAYLGASLIGLVALASCASLAHFNYDDRKQLPPSDPSSVGYAAMEHHFSVNQTIPEYLIIHSAHDLRTPRGLADLEQLAQRVSQIPGVAMVRGVTRPNGETLEQARATYQAGQVGNRLGGASRMIDERTGDLNRLASGANLLADNLGDVRGQVSRAVAGVRSLVDALAYIQNQFGGNKTFNEIDNAARLVSNIHALGDALQVNFDGIANSFDWLDSVVAALDTSPVCDSNPMCGNARVQFHKLQTARDNGTLDKVVGLARQLQSTRSPQTVSAVVNDLGRSLNSVVRSLKSLGLDNPDAARARLISMQNGANDLASAGRQVADGVQMLVDQTKNMGIGLNQASAFLMAMGNDASQPSMAGFNVPPQVLKSEEFKKVAQAFISPDGHTVRYFIQTDLNPFSTAAMDQVNTIIDTAKGAQPNTSLADASISMSGYPVMLRDIRDYYERDMRLIVAVTVVVVILILMALLRAIVAPLYLVGSVVISYMSAIGLGVVVFQVFLGQELHWSVPGLAFVVLVAVGADYNMLLASRLRDESALGVRSSVIRTVRCTGGVITAAGLIFAASMSGLLFSSIGTVVQGGFIIGVGILIDTFVVRTITVPAMATLLGRASWWPGHPWQRCAPEEGQMSARMSARTKTVFQAVADGSKR,"106,415",1002,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",lipid transport [GO:0006869],,cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV005.19,1
P9WJK7,MUTA_MYCTU,Rv1492,mutA Rv1492 MTCY277.14,GO:0004494; GO:0005618; GO:0005829; GO:0005886; GO:0019652; GO:0019678; GO:0031419; GO:0046872,IPR016176; IPR036724; IPR006099; IPR004608; ,,mutA,,Probable methylmalonyl-CoA mutase small subunit (MCM) (EC 5.4.99.2),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; lactate fermentation to propionate and acetate [GO:0019652]; propionate metabolic process, methylmalonyl pathway [GO:0019678]",9634230; 19099550; 21969609,,FUNCTION: Catalyzes the isomerization of succinyl-CoA to methylmalonyl-CoA during synthesis of propionate from tricarboxylic acid-cycle intermediates. {ECO:0000250}.,MSIDVPERADLEQVRGRWRNAVAGVLSKSNRTDSAQLGDHPERLLDTQTADGFAIRALYTAFDELPEPPLPGQWPFVRGGDPLRDVHSGWKVAEAFPANGATADTNAAVLAALGEGVSALLIRVGESGVAPDRLTALLSGVYLNLAPVILDAGADYRPACDVMLALVAQLDPGQRDTLSIDLGADPLTASLRDRPAPPIEEVVAVASRAAGERGLRAITVDGPAFHNLGATAATELAATVAAAVAYLRVLTESGLVVSDALRQISFRLAADDDQFMTLAKMRALRQLWARVAEVVGDPGGGAAVVHAETSLPMMTQRDPWVNMLRCTLAAFGAGVGGADTVLVHPFDVAIPGGFPGTAAGFARRIARNTQLLLLEESHVGRVLDPAGGSWFVEELTDRLARRAWQRFQAIEARGGFVEAHDFLAGQIAECAARRADDIAHRRLAITGVNEYPNLGEPALPPGDPTSPVRRYAAGFEALRDRSDHHLARTGARPRVLLLPLGPLAEHNIRTTFATNLLASGGIEAIDPGTVDAGTVGNAVADAGSPSVAVICGTDARYRDEVADIVQAARAAGVSRVYLAGPEKALGDAAHRPDEFLTAKINVVQALSNLLTRLGA,"64,744",615,Methylmalonyl-CoA mutase family,"lactate fermentation to propionate and acetate [GO:0019652]; propionate metabolic process, methylmalonyl pathway [GO:0019678]",cobalamin binding [GO:0031419]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY277.14,1
P9WPJ7,MTCA1_MYCTU,Rv1284,mtcA1 canA Rv1284 MTCY373.03,GO:0004089; GO:0005886; GO:0008270; GO:0040007,IPR001765; IPR036874; ,,mtcA1,,Beta-carbonic anhydrase 1 (Beta-CA 1) (EC 4.2.1.1) (Carbonate dehydratase 1) (mtCA 1),plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; growth [GO:0040007],9634230; 19099550; 19317447; 19438226; 21969609; 15753099,X-ray crystallography (4),FUNCTION: Catalyzes the reversible hydration of carbon dioxide to form bicarbonate. {ECO:0000269|PubMed:19317447}.,MTVTDDYLANNVDYASGFKGPLPMPPSKHIAIVACMDARLDVYRMLGIKEGEAHVIRNAGCVVTDDVIRSLAISQRLLGTREIILLHHTDCGMLTFTDDDFKRAIQDETGIRPTWSPESYPDAVEDVRQSLRRIEVNPFVTKHTSLRGFVFDVATGKLNEVTP,"18,189",163,Beta-class carbonic anhydrase family,growth [GO:0040007],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],plasma membrane [GO:0005886],canA,MTCY373.03,1
P9WJN3,MSHB_MYCTU,Rv1170,mshB Rv1170,GO:0005886; GO:0008270; GO:0010125; GO:0016811; GO:0035595,IPR003737; IPR024078; IPR017810; ,,mshB,,1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside deacetylase (GlcNAc-Ins deacetylase) (EC 3.5.1.103) (N-acetyl-1-D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase),"plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylinositol deacetylase activity [GO:0035595]; zinc ion binding [GO:0008270]; mycothiol biosynthetic process [GO:0010125]",9634230; 11092856; 16630724; 18020307; 19099550; 21969609; 12958317; 14698305,X-ray crystallography (3),FUNCTION: Catalyzes the deacetylation of 1D-myo-inositol 2-acetamido-2-deoxy-alpha-D-glucopyranoside (GlcNAc-Ins) in the mycothiol (MSH) biosynthesis pathway. Shows some amidase activity toward S-conjugates of mycothiol. {ECO:0000269|PubMed:11092856}.,MSETPRLLFVHAHPDDESLSNGATIAHYTSRGAQVHVVTCTLGEEGEVIGDRWAQLTADHADQLGGYRIGELTAALRALGVSAPIYLGGAGRWRDSGMAGTDQRSQRRFVDADPRQTVGALVAIIRELRPHVVVTYDPNGGYGHPDHVHTHTVTTAAVAAAGVGSGTADHPGDPWTVPKFYWTVLGLSALISGARALVPDDLRPEWVLPRADEIAFGYSDDGIDAVVEADEQARAAKVAALAAHATQVVVGPTGRAAALSNNLALPILADEHYVLAGGSAGARDERGWETDLLAGLGFTASGT,"31,742",303,MshB deacetylase family,mycothiol biosynthetic process [GO:0010125],"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; N-acetylglucosaminylinositol deacetylase activity [GO:0035595]; zinc ion binding [GO:0008270]",plasma membrane [GO:0005886],,,1
P9WKE9,KGUA_MYCTU,Rv1389,gmk Rv1389 MTCY21B4.06,GO:0000287; GO:0004017; GO:0004385; GO:0005524; GO:0005829; GO:0019002; GO:0019003; GO:0040007,IPR008145; IPR008144; IPR017665; IPR020590; IPR027417; ,,gmk,DOMAIN 21 201 Guanylate kinase-like.,Guanylate kinase (EC 2.7.4.8) (GMP kinase),cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GMP binding [GO:0019002]; guanylate kinase activity [GO:0004385]; magnesium ion binding [GO:0000287]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (6),"FUNCTION: Essential for recycling GMP and indirectly, cGMP. {ECO:0000250}.",MSVGEGPDTKPTARGQPAAVGRVVVLSGPSAVGKSTVVRCLRERIPNLHFSVSATTRAPRPGEVDGVDYHFIDPTRFQQLIDQGELLEWAEIHGGLHRSGTLAQPVRAAAATGVPVLIEVDLAGARAIKKTMPEAVTVFLAPPSWQDLQARLIGRGTETADVIQRRLDTARIELAAQGDFDKVVVNRRLESACAELVSLLVGTAPGSP,"22,095",208,Guanylate kinase family,growth [GO:0040007],adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GDP binding [GO:0019003]; GMP binding [GO:0019002]; guanylate kinase activity [GO:0004385]; magnesium ion binding [GO:0000287],cytosol [GO:0005829],,MTCY21B4.06,1
P9WMR7,IXTPA_MYCTU,Rv1341,Rv1341 MTCY02B10.05 MTCY130.26,GO:0000166; GO:0005829; GO:0009117; GO:0009143; GO:0017111; GO:0046872; GO:0047429,IPR020922; IPR002637; IPR029001; ,,,,dITP/XTP pyrophosphatase (EC 3.6.1.66) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase),cytosol [GO:0005829]; metal ion binding [GO:0046872]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],9634230; 21969609,,"FUNCTION: Pyrophosphatase that catalyzes the hydrolysis of nucleoside triphosphates to their monophosphate derivatives, with a high preference for the non-canonical purine nucleotides XTP (xanthosine triphosphate), dITP (deoxyinosine triphosphate) and ITP. Seems to function as a house-cleaning enzyme that removes non-canonical purine nucleotides from the nucleotide pool, thus preventing their incorporation into DNA/RNA and avoiding chromosomal lesions. {ECO:0000255|HAMAP-Rule:MF_01405}.",MALVTKLLVASRNRKKLAELRRVLDGAGLSGLTLLSLGDVSPLPETPETGVTFEDNALAKARDAFSATGLASVADDSGLEVAALGGMPGVLSARWSGRYGDDAANTALLLAQLCDVPDERRGAAFVSACALVSGSGEVVVRGEWPGTIAREPRGDGGFGYDPVFVPYGDDRTAAQLSPAEKDAVSHRGRALALLLPALRSLATG,"21,016",204,HAM1 NTPase family,nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],metal ion binding [GO:0046872]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166],cytosol [GO:0005829],,MTCY02B10.05 MTCY130.26,1
P9WIS5,KGD_MYCTU,Rv1248c,kgd Rv1248c,GO:0000287; GO:0004149; GO:0005618; GO:0005829; GO:0005886; GO:0006099; GO:0006103; GO:0008683; GO:0009055; GO:0016624; GO:0030976; GO:0040007; GO:0045252; GO:0045254; GO:0050439; GO:0055114,IPR001078; IPR032106; IPR011603; IPR023213; IPR001017; IPR031717; IPR029061; IPR005475; ,P9WJA9,kgd,,Multifunctional 2-oxoglutarate metabolism enzyme (2-hydroxy-3-oxoadipate synthase) (HOA synthase) (HOAS) (EC 2.2.1.5) (2-oxoglutarate carboxy-lyase) (2-oxoglutarate decarboxylase) (Alpha-ketoglutarate decarboxylase) (KG decarboxylase) (KGD) (EC 4.1.1.71) (Alpha-ketoglutarate-glyoxylate carboligase) [Includes: 2-oxoglutarate dehydrogenase E1 component (ODH E1 component) (EC 1.2.4.2) (Alpha-ketoglutarate dehydrogenase E1 component) (KDH E1 component); Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex E2 component) (ODH E2 component) (OGDC-E2) (Dihydrolipoamide succinyltransferase)],"cell wall [GO:0005618]; cytosol [GO:0005829]; oxoglutarate dehydrogenase complex [GO:0045252]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]; 2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; electron transfer activity [GO:0009055]; magnesium ion binding [GO:0000287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO:0016624]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]; tricarboxylic acid cycle [GO:0006099]",9634230; 16045627; 16027371; 19019160; 19936047; 19318624; 20416504; 21867916; 21969609,,"FUNCTION: Shows three enzymatic activities that share a first common step, the attack of thiamine-PP on 2-oxoglutarate (alpha-ketoglutarate, KG), leading to the formation of an enamine-thiamine-PP intermediate upon decarboxylation. Thus, displays KGD activity, catalyzing the decarboxylation from five-carbon 2-oxoglutarate to four-carbon succinate semialdehyde (SSA). Also catalyzes C-C bond formation between the activated aldehyde formed after decarboxylation of alpha-ketoglutarate and the carbonyl of glyoxylate (GLX), to yield 2-hydroxy-3-oxoadipate (HOA), which spontaneously decarboxylates to form 5-hydroxylevulinate (HLA). And is also a component of the 2-oxoglutarate dehydrogenase (ODH) complex, that catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO(2). The KG decarboxylase and KG dehydrogenase reactions provide two alternative, tightly regulated, pathways connecting the oxidative and reductive branches of the TCA cycle, which can endow M.tuberculosis with the metabolic plasticity required for growth on diverse host-derived carbon sources. Appears to play a predominant role in growth on carbohydrates as the sole carbon source, and only a minimal role during growth on fatty acids. {ECO:0000269|PubMed:16027371, ECO:0000269|PubMed:19936047, ECO:0000269|PubMed:20416504, ECO:0000269|PubMed:21867916}.",MANISSPFGQNEWLVEEMYRKFRDDPSSVDPSWHEFLVDYSPEPTSQPAAEPTRVTSPLVAERAAAAAPQAPPKPADTAAAGNGVVAALAAKTAVPPPAEGDEVAVLRGAAAAVVKNMSASLEVPTATSVRAVPAKLLIDNRIVINNQLKRTRGGKISFTHLLGYALVQAVKKFPNMNRHYTEVDGKPTAVTPAHTNLGLAIDLQGKDGKRSLVVAGIKRCETMRFAQFVTAYEDIVRRARDGKLTTEDFAGVTISLTNPGTIGTVHSVPRLMPGQGAIIGVGAMEYPAEFQGASEERIAELGIGKLITLTSTYDHRIIQGAESGDFLRTIHELLLSDGFWDEVFRELSIPYLPVRWSTDNPDSIVDKNARVMNLIAAYRNRGHLMADTDPLRLDKARFRSHPDLEVLTHGLTLWDLDRVFKVDGFAGAQYKKLRDVLGLLRDAYCRHIGVEYAHILDPEQKEWLEQRVETKHVKPTVAQQKYILSKLNAAEAFETFLQTKYVGQKRFSLEGAESVIPMMDAAIDQCAEHGLDEVVIGMPHRGRLNVLANIVGKPYSQIFTEFEGNLNPSQAHGSGDVKYHLGATGLYLQMFGDNDIQVSLTANPSHLEAVDPVLEGLVRAKQDLLDHGSIDSDGQRAFSVVPLMLHGDAAFAGQGVVAETLNLANLPGYRVGGTIHIIVNNQIGFTTAPEYSRSSEYCTDVAKMIGAPIFHVNGDDPEACVWVARLAVDFRQRFKKDVVIDMLCYRRRGHNEGDDPSMTNPYVYDVVDTKRGARKSYTEALIGRGDISMKEAEDALRDYQGQLERVFNEVRELEKHGVQPSESVESDQMIPAGLATAVDKSLLARIGDAFLALPNGFTAHPRVQPVLEKRREMAYEGKIDWAFGELLALGSLVAEGKLVRLSGQDSRRGTFSQRHSVLIDRHTGEEFTPLQLLATNSDGSPTGGKFLVYDSPLSEYAAVGFEYGYTVGNPDAVVLWEAQFGDFVNGAQSIIDEFISSGEAKWGQLSNVVLLLPHGHEGQGPDHTSARIERFLQLWAEGSMTIAMPSTPSNYFHLLRRHALDGIQRPLIVFTPKSMLRHKAAVSEIKDFTEIKFRSVLEEPTYEDGIGDRNKVSRILLTSGKLYYELAARKAKDNRNDLAIVRLEQLAPLPRRRLRETLDRYENVKEFFWVQEEPANQGAWPRFGLELPELLPDKLAGIKRISRRAMSAPSSGSSKVHAVEQQEILDEAFG,"135,902",1231,"2-oxoacid dehydrogenase family, Kgd subfamily",2-oxoglutarate metabolic process [GO:0006103]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]; tricarboxylic acid cycle [GO:0006099],"2-hydroxy-3-oxoadipate synthase activity [GO:0050439]; 2-oxoglutarate decarboxylase activity [GO:0008683]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; electron transfer activity [GO:0009055]; magnesium ion binding [GO:0000287]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO:0016624]; thiamine pyrophosphate binding [GO:0030976]",cell wall [GO:0005618]; cytosol [GO:0005829]; oxoglutarate dehydrogenase complex [GO:0045252]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254],,,1
P9WGU9,LPQY_MYCTU,Rv1235,lpqY Rv1235,GO:0005886; GO:0009405; GO:0015771; GO:0044117,IPR006059; ,,lpqY,,Trehalose-binding lipoprotein LpqY,plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; trehalose transport [GO:0015771],9634230; 21118978; 21969609,,"FUNCTION: Part of the ABC transporter complex LpqY-SugA-SugB-SugC, which is highly specific for uptake of trehalose. Involved in the recycling of extracellular trehalose released from trehalose-containing molecules synthesized by M.tuberculosis. Trehalose uptake is essential for virulence. {ECO:0000269|PubMed:21118978}.",MVMSRGRIPRLGAAVLVALTTAAAACGADSQGLVVSFYTPATDGATFTAIAQRCNQQFGGRFTIAQVSLPRSPNEQRLQLARRLTGNDRTLDVMALDVVWTAEFAEAGWALPLSDDPAGLAENDAVADTLPGPLATAGWNHKLYAAPVTTNTQLLWYRPDLVNSPPTDWNAMIAEAARLHAAGEPSWIAVQANQGEGLVVWFNTLLVSAGGSVLSEDGRHVTLTDTPAHRAATVSALQILKSVATTPGADPSITRTEEGSARLAFEQGKAALEVNWPFVFASMLENAVKGGVPFLPLNRIPQLAGSINDIGTFTPSDEQFRIAYDASQQVFGFAPYPAVAPGQPAKVTIGGLNLAVAKTTRHRAEAFEAVRCLRDQHNQRYVSLEGGLPAVRASLYSDPQFQAKYPMHAIIRQQLTDAAVRPATPVYQALSIRLAAVLSPITEIDPESTADELAAQAQKAIDGMGLLP,"49,793",468,Bacterial solute-binding protein 1 family,growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; trehalose transport [GO:0015771],,plasma membrane [GO:0005886],,,1
P9WK49,LPRE_MYCTU,Rv1252c,lprE Rv1252c MTCY50.30,GO:0005576; GO:0005886,IPR025971; ,,lprE,,Putative lipoprotein LprE,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MPGVWSPPCPTTPRVGVVAALVAATLTGCGSGDSTVAKTPEATPSLSTAHPAPPSSEPSPPSATAAPPSNHSAAPVDPCAVNLASPTIAKVVSELPRDPRSEQPWNPEPLAGNYNECAQLSAVVIKANTNAGNPTTRAVMFHLGKYIPQGVPDTYGFTGIDTSQCTGDTVALTYASGIGLNNVVKFRWNGGGVELIGNTTGG,"20,442",202,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY50.30,1
P9WK43,LPRH_MYCTU,Rv1418,lprH Rv1418 MTCY21B4.36,GO:0005886; GO:0016021,,,lprH,,Putative lipoprotein LprH,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MACLGRPGCRGWAGASLVLVVVLALAACTESVAGRAMRATDRSSGLPTSAKPARARDLLLQDGDRAPFGQVTQSRVGDSYFTSAVPPECSAALLFKGSPLRPDGSSDHAEAAYNVTGPLPYAESVDVYTNVLNVHDVVWNGFRDVSHCRGDAVGVSRAGRSTPMRLRYFATLSDGVLVWTMSNPRWTCDYGLAVVPHAVLVLSACGFKPGFPMAEWASKRRAQLDSQV,"24,288",228,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21B4.36,1
P9WMW1,PHSG_MYCTU,Rv1328,glgP Rv1328 MTCY130.13,GO:0005829; GO:0005886; GO:0005977; GO:0008184; GO:0030170; GO:0102250; GO:0102499,IPR011834; IPR000811; IPR024517; IPR035090; ,,glgP,,Glycogen phosphorylase (EC 2.4.1.1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; glycogen metabolic process [GO:0005977],9634230; 19099550; 21969609,,"FUNCTION: Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties (By similarity). {ECO:0000250}.",MKALRRFTVRAHLPERLAALDQLSTNLRWSWDKPTQDLFAAIDPALWEQCGHDPVALLGAVNPARLDELALDAEFLGALDELAADLNDYLSRPLWYQEQQDAGVAAQALPTGIAYFSLEFGVAEVLPNYSGGLGILAGDHLKSASDLGVPLIAVGLYYRSGYFRQSLTADGWQHETYPSLDPQGLPLRLLTDANGDPVLVEVALGDNAVLRARIWVAQVGRVPLLLLDSDIPENEHDLRNVTDRLYGGDQEHRIKQEILAGIGGVRAIRAYTAVEKLTPPEVFHMNEGHAGFLGIERIRELVTDAGLDFDTALTVVRSSTVFTTHTPVPAGIDRFPLEMVQRYVNDQRGDGRSRLLPGLPADRIVALGAEDDPAKFNMAHMGLRLAQRANGVSLLHGRVSRAMFNELWAGFDPDEVPIGSVTNGVHAPTWAAPQWLQLGRELAGSDSLREPVVWQRLHQVDPAHLWWIRSQLRSMLVEDVRARLRQSWLERGATDAELGWIATAFDPNVLTVGFARRVPTYKRLTLMLRDPDRLEQLLLDEQRPIQLIVAGKSHPADDGGKALIQQVVRFADRPQVRHRIAFLPNYDMSMARLLYWGCDVWLNNPLRPLEACGTSGMKSALNGGLNLSIRDGWWDEWYDGENGWEIPSADGVADENRRDDLEAGALYDLLAQAVAPKFYERDERGVPQRWVEMVRHTLQTLGPKVLASRMVRDYVEHYYAPAAQSFRRTAGAQFDAARELADYRRRAEEAWPKIEIADVDSTGLPDTPLLGSQLTLTATVRLAGLRPNDVTVQGVLGRVDAGDVLMDPVTVEMAHTGTGDGGYEIFSTTTPLPLAGPVGYTVRVLPRHPMLAASNELGLVTLA,"95,515",863,Glycogen phosphorylase family,glycogen metabolic process [GO:0005977],glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY130.13,1
P9WPF1,PKS18_MYCTU,Rv1372,pks18 Rv1372,GO:0006633; GO:0009715; GO:0016747,IPR012328; IPR001099; IPR011141; IPR016039; ,,pks18,,Alpha-pyrone synthesis polyketide synthase-like Pks18 (EC 2.3.1.-) (Alpha-pyrone synthesis polyketide synthase type III Pks18) (Chalcone synthase-like protein) (CHS-like),"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; chalcone biosynthetic process [GO:0009715]; fatty acid biosynthetic process [GO:0006633]",9634230; 12941968; 15286723,X-ray crystallography (2),FUNCTION: Involved in the biosynthesis of tri- and tetraketide alpha-pyrones. Pks18 catalyzes the extension of medium- and long-chain aliphatic acyl-CoA substrates by using malonyl-CoA as an extender molecule to synthesize polyketide products. {ECO:0000269|PubMed:12941968}.,MNVSAESGAPRRAGQRHEVGLAQLPPAPPTTVAVIEGLATGTPRRVVNQSDAADRVAELFLDPGQRERIPRVYQKSRITTRRMAVDPLDAKFDVFRREPATIRDRMHLFYEHAVPLAVDVSKRALAGLPYRAAEIGLLVLATSTGFIAPGVDVAIVKELGLSPSISRVVVNFMGCAAAMNALGTATNYVRAHPAMKALVVCIELCSVNAVFADDINDVVIHSLFGDGCAALVIGASQVQEKLEPGKVVVRSSFSQLLDNTEDGIVLGVNHNGITCELSENLPGYIFSGVAPVVTEMLWDNGLQISDIDLWAIHPGGPKIIEQSVRSLGISAELAAQSWDVLARFGNMLSVSLIFVLETMVQQAESAKAISTGVAFAFGPGVTVEGMLFDIIRR,"42,032",393,Chalcone/stilbene synthases family,chalcone biosynthetic process [GO:0009715]; fatty acid biosynthetic process [GO:0006633],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
P9WJW5,OGT_MYCTU,Rv1316c,ogt Rv1316c MTCY130.01c,GO:0003908; GO:0005737; GO:0005886; GO:0006307; GO:0051409,IPR001497; IPR014048; IPR036217; IPR008332; IPR023546; IPR036631; IPR036388; ,,ogt,,Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908]; DNA dealkylation involved in DNA repair [GO:0006307]; response to nitrosative stress [GO:0051409],9634230; 21969609,X-ray crystallography (5),FUNCTION: Involved in the cellular defense against the biological effects of O6-methylguanine (O6-MeG) and O4-methylthymine (O4-MeT) in DNA. Repairs the methylated nucleobase in DNA by stoichiometrically transferring the methyl group to a cysteine residue in the enzyme. This is a suicide reaction: the enzyme is irreversibly inactivated. {ECO:0000255|HAMAP-Rule:MF_00772}.,MIHYRTIDSPIGPLTLAGHGSVLTNLRMLEQTYEPSRTHWTPDPGAFSGAVDQLNAYFAGELTEFDVELDLRGTDFQQRVWKALLTIPYGETRSYGEIADQIGAPGAARAVGLANGHNPIAIIVPCHRVIGASGKLTGYGGGINRKRALLELEKSRAPADLTLFD,"17,858",165,MGMT family,DNA dealkylation involved in DNA repair [GO:0006307]; response to nitrosative stress [GO:0051409],methylated-DNA-[protein]-cysteine S-methyltransferase activity [GO:0003908],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY130.01c,1
P9WIK5,PAPA3_MYCTU,Rv1182,papA3 Rv1182,GO:0005991; GO:0009247; GO:0016409; GO:0040007,IPR023213; IPR001242; ,,papA3,,Acyltransferase papA3 (EC 2.3.1.-) (Polyketide synthase-associated protein A3),palmitoyltransferase activity [GO:0016409]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; trehalose metabolic process [GO:0005991],9634230; 19276083; 21969609,,"FUNCTION: Involved in the biosynthesis of polyacyltrehalose (PAT) which could have a role in anchoring the bacterial capsule. In vitro catalyzes the sequential transfer of two palmitoyl groups onto a single glucose residue of trehalose generating the diacylated product 2,3-diacyltrehalose (trehalose dipalmitate). Although palmitoyl-CoA (PCoA) seems to be the physiological acyl donor, PapA3 can also use docosanoyl (22-carbon saturated fatty acid) coenzyme A as acyl donor. {ECO:0000269|PubMed:19276083}.",MLRVGPLTIGTLDDWAPSTGSTVSWRPSAVAHTKASQAPISDVPVSYMQAQHIRGYCEQKAKGLDYSRLMVVSCQQPGQCDIRAANYVINAHLRRHDTYRSWFQYNGNGQIIRRTIQDPADIEFVPVHHGELTLPQIREIVQNTPDPLQWGCFRFGIVQGCDHFTFFASVDHVHVDAMIVGVTLMEFHLMYAALVGGHAPLELPPAGSYDDFCRRQHTFSSTLTVESPQVRAWTKFAEGTNGSFPDFPLPLGDPSKPSDADIVTVMMLDEEQTAQFESVCTAAGARFIGGVLACCGLAEHELTGTTTYYGLTPRDTRRTPADAMTQGWFTGLIPITVPIAGSAFGDAARAAQTSFDSGVKLAEVPYDRVVELSSTLTMPRPNFPVVNFLDAGAAPLSVLLTAELTGTNIGVYSDGRYSYQLSIYVIRVEQGTAVAVMFPDNPIARESVARYLATLKSVFQRVAESGQQQNVA,"51,575",472,PapA acyltransferase family,glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; trehalose metabolic process [GO:0005991],palmitoyltransferase activity [GO:0016409],,,,1
P9WID1,PGK_MYCTU,Rv1437,pgk Rv1437 MTCY493.17c,GO:0004618; GO:0005524; GO:0005576; GO:0005737; GO:0005886; GO:0006096; GO:0040007,IPR001576; IPR015911; IPR015824; IPR036043; ,,pgk,,Phosphoglycerate kinase (EC 2.7.2.3),cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 21969609,,,MSVANLKDLLAEGVSGRGVLVRSDLNVPLDEDGTITDAGRIIASAPTLKALLDADAKVVVAAHLGRPKDGPDPTLSLAPVAVALGEQLGRHVQLAGDVVGADALARAEGLTGGDILLLENIRFDKRETSKNDDDRRALAKQLVELVGTGGVFVSDGFGVVHRKQASVYDIATLLPHYAGTLVADEMRVLEQLTSSTQRPYAVVLGGSKVSDKLGVIESLATKADSIVIGGGMCFTFLAAQGFSVGTSLLEDDMIEVCRGLLETYHDVLRLPVDLVVTEKFAADSPPQTVDVGAVPNGLMGLDIGPGSIKRFSTLLSNAGTIFWNGPMGVFEFPAYAAGTRGVAEAIVAATGKGAFSVVGGGDSAAAVRAMNIPEGAFSHISTGGGASLEYLEGKTLPGIEVLSREQPTGGVL,"42,512",412,Phosphoglycerate kinase family,glycolytic process [GO:0006096]; growth [GO:0040007],ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY493.17c,1
P9WP99,PDUO_MYCTU,Rv1314c,Rv1314c MTCY373.34c,GO:0005524; GO:0005737; GO:0006779; GO:0008817; GO:0009236,IPR016030; IPR036451; IPR029499; ,,,,"Cob(I)yrinic acid a,c-diamide adenosyltransferase (EC 2.5.1.17) (Cob(I)alamin adenosyltransferase)","cytoplasm [GO:0005737]; ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin biosynthetic process [GO:0009236]; porphyrin-containing compound biosynthetic process [GO:0006779]",9634230; 21969609; ,X-ray crystallography (1),,MAVHLTRIYTRTGDDGTTGLSDMSRVAKTDARLVAYADCDEANAAIGAALALGHPDTQITDVLRQIQNDLFDAGADLSTPIVENPKHPPLRIAQSYIDRLEGWCDAYNAGLPALKSFVLPGGSPLSALLHVARTVVRRAERSAWAAVDAHPEGVSVLPAKYLNRLSDLLFILSRVANPDGDVLWRPGGDRTAS,"20,694",193,Cob(I)alamin adenosyltransferase family,cobalamin biosynthetic process [GO:0009236]; porphyrin-containing compound biosynthetic process [GO:0006779],"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]",cytoplasm [GO:0005737],,MTCY373.34c,1
Q79FR3,PE13_MYCTU,Rv1195,PE13 Rv1195 LH57_06555,GO:0005576; GO:0005618; GO:0009405,IPR000084; ,,PE13,DOMAIN 1 93 PE. {ECO:0000255}.,PE family protein PE13,cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 19651861; 21969609; 27147522,,"FUNCTION: May play a pivotal role in the interaction between M.tuberculosis and host. Can enhance the survival within macrophages under stress conditions such as H(2)O(2), SDS and low pH. Increases the production of IL-6 and IL-1beta from macrophages, and decreases the secretion of suppressor of cytokine signaling 3 (SOCS-3). These changes probably involve the p38-ERK-NF-kappa-B signaling pathway. Also precipitates the macrophage death. {ECO:0000269|PubMed:27147522}.",MSFVMAYPEMLAAAADTLQSIGATTVASNAAAAAPTTGVVPPAADEVSALTAAHFAAHAAMYQSVSARAAAIHDQFVATLASSASSYAATEVANAAAAS,"9,616",99,Mycobacterial PE family,pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576],,LH57_06555,1
P9WIH1,PE15_MYCTU,Rv1386,PE15 Rv1386 MTCY21B4.03,GO:0005576; GO:0009405; GO:0009986; GO:0031975,IPR000084; ,,PE15,DOMAIN 3 91 PE. {ECO:0000255}.,PE family immunomodulator PE15,cell surface [GO:0009986]; envelope [GO:0031975]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 21969609; 23284742; 26729876,,FUNCTION: May play a pivotal role in the evasion of host immune response by M.tuberculosis. Mediates production of IL-10 via activation of the p38 and ERK1/2 mitogen-activated protein kinase (MAPK) signaling pathways. {ECO:0000269|PubMed:23284742}.,MTLRVVPESLAGASAAIEAVTARLAAAHAAAAPFIAAVIPPGSDSVSVCNAVEFSVHGSQHVAMAAQGVEELGRSGVGVAESGASYAARDALAAASYLSGGL,"9,862",102,Mycobacterial PE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; envelope [GO:0031975]; extracellular region [GO:0005576],,MTCY21B4.03,1
Q79FP3,PG26_MYCTU,Rv1441c,PE_PGRS26 Rv1441c,GO:0009986,IPR000084; ,,PE_PGRS26,DOMAIN 1 93 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS26,cell surface [GO:0009986],9634230; 16672626; 18957600; 22050772,,,MSNVMVVPGMLSAAAADVASIGAALSAANGAAAPTTAGVLAAGADEVSAAIASLFSGYARDYQALSAQMARFHQQFVQALTASVGSYAAAEAANASPLQALEQQVLAAINAPTQTLLGRPLIGNGADGLPGQNGGAGGLLWGNGGNGGAGDAAHPNGGNGGDAGMFGNGGAGGAGYSPAAGTGAAGGAGGAGGAGGWLSGNGGAGGNGGTGASGADGGGGLPPVPASPGGNGGGGDAGGAAGMFGTGGAGGTGGDGGAGGAGDSPNSGANGARGGDGGNGAAGGAGGRLFGNGGAGGNGGTAGQGGDGGTALGAGGIGGDGGTGGAGGTGGTAGIGGSSAGAGGAGGDGGAGGTGGGSSMIGGKGGTGGNGGVGGTGGASALTIGNGSSAGAGGAGGAGGTGGTGGYIESLDGKGQAGNGGNGGNGAAGGAGGGGTGAGGNGGAGGNGGDGGPSQGGGNPGFGGDGGTGGPGGVGVPDGIGGANGAQGKHG,"40,810",491,"Mycobacterial PE family, PGRS subfamily",,,cell surface [GO:0009986],,,1
O06825,LDT3_MYCTU,Rv1433 RVBD_1433,Rv1433 RVBD_1433 P425_01489,GO:0008360; GO:0009252; GO:0016746; GO:0071555,IPR005490; IPR038063; ,,,DOMAIN 167 269 YkuD.,"Probable L,D-transpeptidase 3 (LDT 3) (EC 2.3.2.-) (Ldt(Mt3))","transferase activity, transferring acyl groups [GO:0016746]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 24041897; ,X-ray crystallography (1),"FUNCTION: Probable L,D-transpeptidase that may perform as-yet-unknown cross-linking reactions in M.tuberculosis. Is not able to generate 3->3 cross-links in peptidoglycan, using tetrapeptide stems as acyl donor substrates. May function in the anchoring of proteins to peptidoglycan. {ECO:0000269|PubMed:24041897}.",MRAVFGCAIAVVGIAGSVVAGPADIHLVAAKQSYGFAVASVLPTRGQVVGVAHPVVVTFSAPITNPANRHAAERAVEVKSTPAMTGKFEWLDNDVVQWVPDRFWPAHSTVELSVGSLSSDFKTGPAVVGVASISQHTFTVSIDGVEEGPPPPLPAPHHRVHFGEDGVMPASMGRPEYPTPVGSYTVLSKERSVIMDSSSVGIPVDDPDGYRLSVDYAVRITSRGLYVHSAPWALPALGLENVSHGCISLSREDAEWYYNAVDIGDPVIVQE,"28,701",271,,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"transferase activity, transferring acyl groups [GO:0016746]",,,P425_01489,1
P9WJY3,MFS55_MYCTU,Rv1410c,Rv1410c,GO:0005887; GO:0008144; GO:0009405; GO:0015562; GO:0046677; GO:0055085,IPR011701; IPR020846; IPR036259; IPR005829; ,,,,Probable triacylglyceride transporter Rv1410c (MFS-type drug efflux transporter P55),integral component of plasma membrane [GO:0005887]; drug binding [GO:0008144]; efflux transmembrane transporter activity [GO:0015562]; pathogenesis [GO:0009405]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 14998516; 18156250; 21762531; 21969609; 25232742; 25356793; 26751071,,"FUNCTION: In association with lipoprotein LprG probably transports triacylglycerides (TAG) across the inner cell membrane into the periplasm; TAG probably regulates lipid metabolism and growth regulation (PubMed:26751071). Confers resistance to ethidium bromide, possibly acting as an efflux pump, requires LprG lipoprotein for normal function (PubMed:18156250). With LprG maintains cell wall permeability (PubMed:21762531). Probably required with LprG for normal surface localization of LAM (PubMed:25232742, PubMed:25356793). Overexpression of LprG and Rv1410c leads to increased levels of TAG in the culture medium (PubMed:26751071). {ECO:0000269|PubMed:18156250, ECO:0000269|PubMed:21762531, ECO:0000269|PubMed:26751071, ECO:0000305|PubMed:25232742, ECO:0000305|PubMed:25356793}.",MRAGRRVAISAGSLAVLLGALDTYVVVTIMRDIMNSVGIPINQLHRITWIVTMYLLGYIAAMPLLGRASDRFGRKLMLQVSLAGFIIGSVVTALAGHFGDFHMLIAGRTIQGVASGALLPITLALGADLWSQRNRAGVLGGIGAAQELGSVLGPLYGIFIVWLLHDWRDVFWINVPLTAIAMVMIHFSLPSHDRSTEPERVDLVGGLLLALALGLAVIGLYNPNPDGKHVLPDYGAPLLVGALVAAVAFFGWERFARTRLIDPAGVHFRPFLSALGASVAAGAALMVTLVDVELFGQGVLQMDQAQAAGMLLWFLIALPIGAVTGGWIATRAGDRAVAFAGLLIAAYGYWLISHWPVDLLADRHNILGLFTVPAMHTDLVVAGLGLGLVIGPLSSATLRVVPSAQHGIASAAVVVARMTGMLIGVAALSAWGLYRFNQILAGLSAAIPPNASLLERAAAIGARYQQAFALMYGEIFTITAIVCVFGAVLGLLISGRKEHADEPEVQEQPTLAPQVEPL,"54,689",518,Major facilitator superfamily,pathogenesis [GO:0009405]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],drug binding [GO:0008144]; efflux transmembrane transporter activity [GO:0015562],integral component of plasma membrane [GO:0005887],,,1
P9WK15,MBTK_MYCTU,Rv1347c,mbtK Rv1347c MTCY02B10.11c,GO:0016410; GO:0016747; GO:0019540; GO:0040007; GO:0047617,IPR016181; IPR019432; ,,mbtK,,Lysine N-acyltransferase MbtK (N-acyltransferase MbtK) (EC 2.3.1.-) (Mycobactin synthase protein K),"acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; growth [GO:0040007]; siderophore biosynthetic process from catechol [GO:0019540]",9634230; 12065475; 16461464; 21969609; 15695811,X-ray crystallography (1),FUNCTION: Acyltransferase required for the direct transfer of medium- to long-chain fatty acyl moieties from a carrier protein (MbtL) on to the epsilon-amino group of lysine residue in the mycobactin core. {ECO:0000269|PubMed:16461464}.,MTKPTSAGQADDALVRLARERFDLPDQVRRLARPPVPSLEPPYGLRVAQLTDAEMLAEWMNRPHLAAAWEYDWPASRWRQHLNAQLEGTYSLPLIGSWHGTDGGYLELYWAAKDLISHYYDADPYDLGLHAAIADLSKVNRGFGPLLLPRIVASVFANEPRCRRIMFDPDHRNTATRRLCEWAGCKFLGEHDTTNRRMALYALEAPTTAA,"23,799",210,Lysine N-acyltransferase MbtK family,growth [GO:0040007]; siderophore biosynthetic process from catechol [GO:0019540],"acyl-CoA hydrolase activity [GO:0047617]; N-acyltransferase activity [GO:0016410]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,MTCY02B10.11c,1
P9WGV1,METK_MYCTU,Rv1392,metK Rv1392 MTCY21B4.09,GO:0004478; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006556; GO:0006730; GO:0035375; GO:0040007; GO:0046872,IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; ,,metK,,S-adenosylmethionine synthase (AdoMet synthase) (EC 2.5.1.6) (MAT) (Methionine adenosyltransferase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; zymogen binding [GO:0035375]; growth [GO:0040007]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],9634230; 20066036; 21969609; 25613812,X-ray crystallography (1),"FUNCTION: Catalyzes the formation of S-adenosylmethionine (AdoMet) from methionine and ATP. The overall synthetic reaction is composed of two sequential steps, AdoMet formation and the subsequent tripolyphosphate hydrolysis which occurs prior to release of AdoMet from the enzyme. {ECO:0000255|HAMAP-Rule:MF_00086}.",MSEKGRLFTSESVTEGHPDKICDAISDSVLDALLAADPRSRVAVETLVTTGQVHVVGEVTTSAKEAFADITNTVRARILEIGYDSSDKGFDGATCGVNIGIGAQSPDIAQGVDTAHEARVEGAADPLDSQGAGDQGLMFGYAINATPELMPLPIALAHRLSRRLTEVRKNGVLPYLRPDGKTQVTIAYEDNVPVRLDTVVISTQHAADIDLEKTLDPDIREKVLNTVLDDLAHETLDASTVRVLVNPTGKFVLGGPMGDAGLTGRKIIVDTYGGWARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLAERVEVQVAYAIGKAAPVGLFVETFGTETEDPVKIEKAIGEVFDLRPGAIIRDLNLLRPIYAPTAAYGHFGRTDVELPWEQLDKVDDLKRAI,"43,047",403,AdoMet synthase family,growth [GO:0040007]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY21B4.09,1
P9WJT7,MMPLC_MYCTU,Rv1522c,mmpL12 Rv1522c MTCY19G5.06,GO:0005618; GO:0005829; GO:0005886; GO:0016021; GO:0052572,IPR004869; IPR004707; IPR000731; ,,mmpL12,,Probable transport protein MmpL12,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to host immune response [GO:0052572],9634230,,,MARHDEAKAGGLFDRIGNFVVRWPLIVIGCWIAVAAALTLLLPTLQAQAAKREQAPLPPGAPSMVLQKEMSAAFQEKIETSALLLVLLTNENGLGPADEAVYRKLIENLRADTQDKISVQDFLAVPEMKELLASKDNKAWNLPITFAGDAASPETQAAFKRVAAIVKQTVAGTSLTVHLSGPIATVADLTELGEKDVRIIEIGTAVSVLIILILVYRNLVTMLVPLATIGASVVTAQGTLSGLAEFGLAVNMQAIVFMSAVMIGAGTDYAVFLISRYHDYVRHGEKSDMAVKKALMSIGKVITASAATVAVTFLAMVFTKLEVFSAVGPAIAVAITVSLLGAVTLLPAILTLTGRRGWIKPRRDLTSRMWRRSGVRIVRRSTIHLVGSLIVLVALAGCTLLIRFNYDDLKTVPQHVESVKGYEAMNRHFPMNAMTPMVLFIKSPRDLRTPGALADIEMMSREIAELPNIVMVRGLTRPNGEPLKETKVSFQAGEVGGKLDEATTLLEEHGGELDQLTGGAHQLADALAQIRNEINGAVASSSGIVNTLQAMMDLMGGDKTIRQLENASQYVGRMRALGDNLSGTVTDAEQIATWASPMVNALNSSPVCNSDPACRTSRAQLAAIVQAQDDGLLRSIRALAVTLQQTQEYQTLARTVSTLDGQLKQVVSTLKAVDGLPTKLAQMQQGANALADGSAALAAGVQELVDQVKKMGSGLNEAADFLLGIKRDADKPSMAGFNIPPQIFSRDEFKKGAQIFLSADGHAARYFVQSALNPATTEAMDQVNDILRVADSARPNTELEDATIGLAGVPTALRDIRDYYNSDMKFIVIATIVIVFLILVILLRALVAPIYLIGSVLISYLSALGIGTLVFQLILGQEMHWSLPGLSFILLVAIGADYNMLLISRIRDESPHGIRIGVIRTVGSTGGVITSAGLIFAASMFGLVGASINTMAQAGFTIGIGIVLDTFLVRTVTVPALTTMIGRANWWPSELGRDPSTPPTKADRWLRRVKGHRRKAPIPAPKPPHTKVVRNTNGHASKAATKSVPNGKPADLAEGNGEYLIDHLRRHSLPLFGYAAMPAYDVVDGVSKPNGDGAHIGKEPVDHLLGHSLPLFGLAGLPSYDRWDDTSIGEPAVGHAGSKPDAKLST,"122,430",1146,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",response to host immune response [GO:0052572],,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY19G5.06,1
P9WQF9,MBTN_MYCTU,Rv1346,mbtN fadE14 Rv1346 MTCY02B10.10,GO:0016631; GO:0019540; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,mbtN,,Acyl-[acyl-carrier-protein] dehydrogenase MbtN (Acyl-ACP dehydrogenase MbtN) (EC 1.3.99.-) (Mycobactin synthase protein N),enoyl-[acyl-carrier-protein] reductase activity [GO:0016631]; flavin adenine dinucleotide binding [GO:0050660]; siderophore biosynthetic process from catechol [GO:0019540],9634230; 12065475; 16461464; 21969609,X-ray crystallography (1),"FUNCTION: Catalyzes the dehydrogenation at the alpha-beta position of ACP-bound acyl chains. This results in the introduction of a double bond in the lipidic chain, which is further transferred to the epsilon-amino group of lysine residue in the mycobactin core by MbtK. {ECO:0000269|PubMed:16461464}.",MTAGSDLDDFRGLLAKAFDERVVAWTAEAEAQERFPRQLIEHLGVCGVFDAKWATDARPDVGKLVELAFALGQLASAGIGVGVSLHDSAIAILRRFGKSDYLRDICDQAIRGAAVLCIGASEESGGSDLQIVETEIRSRDGGFEVRGVKKFVSLSPIADHIMVVARSVDHDPTSRHGNVAVVAVPAAQVSVQTPYRKVGAGPLDTAAVCIDTWVPADALVARAGTGLAAISWGLAHERMSIAGQIAASCQRAIGITLARMMSRRQFGQTLFEHQALRLRMADLQARVDLLRYALHGIAEQGRLELRTAAAVKVTAARLGEEVISECMHIFGGAGYLVDETTLGKWWRDMKLARVGGGTDEVLWELVAAGMTPDHDGYAAVVGASKA,"41,180",386,Acyl-CoA dehydrogenase family,siderophore biosynthetic process from catechol [GO:0019540],enoyl-[acyl-carrier-protein] reductase activity [GO:0016631]; flavin adenine dinucleotide binding [GO:0050660],,fadE14,MTCY02B10.10,1
P9WHS1,MEC_MYCTU,Rv1334,mec mec+ Rv1334 MTCY130.19,GO:0005829; GO:0006535; GO:0008235; GO:0008270; GO:0019344,IPR028090; IPR000555; IPR037518; ,,mec,DOMAIN 11 134 MPN. {ECO:0000255|PROSITE-ProRule:PRU01182}.,CysO-cysteine peptidase (EC 3.13.1.6) (Metallocarboxypeptidase Mec),cytosol [GO:0005829]; metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],9634230; 12123450; 16104727; 15928073; 21969609,,FUNCTION: Protease that hydrolyzes the covalent CysO-cysteine adduct synthesized by CysM to release L-cysteine and regenerate CysO. {ECO:0000269|PubMed:16104727}.,MLLRKGTVYVLVIRADLVNAMVAHARRDHPDEACGVLAGPEGSDRPERHIPMTNAERSPTFYRLDSGEQLKVWRAMEDADEVPVVIYHSHTATEAYPSRTDVKLATEPDAHYVLVSTRDPHRHELRSYRIVDGAVTEEPVNVVEQY,"16,530",146,Peptidase M67A family,cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],metalloexopeptidase activity [GO:0008235]; zinc ion binding [GO:0008270],cytosol [GO:0005829],mec+,MTCY130.19,1
P9WJU9,MMPL6_MYCTU,Rv1557,mmpL6 Rv1557 MTCY48.08c,GO:0005886; GO:0010033; GO:0016021,IPR004869; ,,mmpL6,,Probable transport protein MmpL6,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; response to organic substance [GO:0010033],9634230,,,MQGISVTGLVKRGWMVRSVFDTIDGIDQLGEQLASVTVTLDKLAAIQPQLVALLPDEIASQQINRELALANYATMSGIYAQTAALIENAAAMGQAFDAAKNDDSFYLPPEAFDNPDFQRGLKLFLSADGKAARMIISHEGDPATPEGISHIDAIKQAAHEAVKGTPMAGAGIYLAGTAATFKDIQDGATYDLLIAGIAALSLILLIMMIITRSLVAALVIVGTVALSLGASFGLSVLVWQHLLGIQLYWIVLALAVILLLAVGSDYNLLLISRFKEEIGAGLNTGIIRAMAGTGGVVTAAGLVFAATMSSFVFSDLRVLGQIGTTIGLGLLFDTLVVRAFMTPSIAVLLGRWFWWPQRVRPRPASRMLRPYGPRPVVRELLLREGNDDPRTQVATHR,"42,422",397,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",response to organic substance [GO:0010033],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.08c,1
P9WK87,NLHH_MYCTU,Rv1399c,nlhH lipH Rv1399c,GO:0009056; GO:0034338,IPR029058; IPR013094; ,,nlhH,,Carboxylesterase NlhH (EC 3.1.1.1),short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],9634230; 15373841; 21969609,,"FUNCTION: Hydrolyzes various short-chain esters, such as triacylglycerols and vinyl esters. Has no activity against emulsified substrates. {ECO:0000269|PubMed:15373841}.",MTEPTVARPDIDPVLKMLLDTFPVTFTAADGVEVARARLRQLKTPPELLPELRIEERTVGYDGLTDIPVRVYWPPVVRDNLPVVVYYHGGGWSLGGLDTHDPVARAHAVGAQAIVVSVDYRLAPEHPYPAGIDDSWAALRWVGENAAELGGDPSRIAVAGDSAGGNISAVMAQLARDVGGPPLVFQLLWYPTTMADLSLPSFTENADAPILDRDVIDAFLAWYVPGLDISDHTMLPTTLAPGNADLSGLPPAFIGTAEHDPLRDDGACYAELLTAAGVSVELSNEPTMVHGYVNFALVVPAAAEATGRGLAALKRALHA,"33,906",319,'GDXG' lipolytic enzyme family,catabolic process [GO:0009056],short-chain carboxylesterase activity [GO:0034338],,lipH,,1
P9WIY5,NUCS_MYCTU,Rv1321,nucS Rv1321 MTCY130.06,GO:0003677; GO:0004519; GO:0005737,IPR002793; IPR011856; ,,nucS,,Endonuclease NucS (EC 3.1.-.-),cytoplasm [GO:0005737]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519],9634230; 21969609,,FUNCTION: Cleaves both 3' and 5' ssDNA extremities of branched DNA structures. {ECO:0000255|HAMAP-Rule:MF_00722}.,MSRVRLVIAQCTVDYIGRLTAHLPSARRLLLFKADGSVSVHADDRAYKPLNWMSPPCWLTEESGGQAPVWVVENKAGEQLRITIEGIEHDSSHELGVDPGLVKDGVEAHLQALLAEHIQLLGEGYTLVRREYMTAIGPVDLLCSDERGGSVAVEIKRRGEIDGVEQLTRYLELLNRDSVLAPVKGVFAAQQIKPQARILATDRGIRCLTLDYDTMRGMDSGEYRLF,"25,094",226,NucS endonuclease family,,DNA binding [GO:0003677]; endonuclease activity [GO:0004519],cytoplasm [GO:0005737],,MTCY130.06,1
A0A089QRB9,MSL3_MYCTU,Rv1180/Rv1181,msl3 pks3 pks4 Rv1180/Rv1181 LH57_06485,GO:0005886; GO:0016491; GO:0016746; GO:0031177; GO:0034081; GO:1902321,IPR036736; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR016039; ,,msl3,DOMAIN 2005 2081 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Mycolipanoate synthase (EC 2.3.1.252) (Mycocerosic acid synthase-like polyketide synthase) (MAS-like PKS) (Mycolipanoic/mycolipenic acids synthase-like polyketide synthase),"plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; methyl-branched fatty acid biosynthetic process [GO:1902321]",9634230; 12207710; 21969609,,"FUNCTION: Polyketide synthase involved in the biosynthesis of methyl-branched fatty acids such as mycolipanoic, mycolipenic (phthienoic) and mycolipodienoic acids required for the synthesis of a major class of polyacylated trehaloses. Catalyzes the elongation of CoA esters of long-chain fatty acids by incorporation of three methylmalonyl (but not malonyl) residues, to form trimethyl-branched fatty-acids. {ECO:0000269|PubMed:12207710}.",MRTATATSVAVIGMACRLPGGIDSPQRLWEALLRGDDLVGEIPADRWDANVYYDPEPGVPGRSVSRWGAFLDDVGGFDCDFFGLTEREATAIDPQHRLLLEVSWEAIEHAGVDPATLAESQTGVFVGLTHGDYELLSADCGAAEGPYGFTGTSNSFASGRVAYTLGLHGPAVTVDTACSSGLTAVHQACRSLDDGESDLALAGGVVVTLEPRKSVSGSLQGMLSPTGRCHAFDEAADGFVSGEGCVVLLLKRLPDAVRDGDRVLAIVRGTAANQDGRTVNIAAPSAQAQIAVYQQALAAAGVEASTVGMVEAHGTGTPVGDPVEYASLAAVYGTEGPCALTSVKTNFGHLQSASGPLGLMKTILALRHGVVPQNLHFCRLPDQLAEIDTELFVPQANTSWPDNTGQPRRAAVSSYGMSGTNVHAILEQAPVSEPAASGPELTPEAGGLALFPVSATSAEQLHVTAARLADWVDQNGNAGSRVSMRDLGYTLSCRRAHRPVRTVVTASSFDELSAALRDVAGDQIPYQPAVGHDDRGPVWVFSGQGSQWPGMGTELLVAEPVFAATVAAMEPVIARESGFSVTEAMSAPQTVSGIDRVQPTIFAVQVALAAALKSYGVRPGAIIGHSLGEAAAAVVAGALSLHDGLRVICRRSRLMSRIAGSGAMASVELPGQQVLSELAIRGISDVVLSVVASPTSTVVGGATQSIRDLVAAWEQQDVLAREVAVDVASHTPQVDPILDELLEVLAEVDPTAPEIPYYSATLWDPRERPSFTGEYWVENLRYTVRFAAAVQAALKDGYRVFGELAPHPLLTYAVEQNAASLDMPIATLAAMRRGEQLPFGLRGFVADVHNAGAKVDFSVQYPDGRLVDAPLPSWTHRTLMLSREDSHRSHTGAVQAVHPLLGAHVHLLEEPERHVWQAGVGTGAHPWLGDHRIHNVAAFPGAAYCEMALAAARTTLGELSEVRDIKFEQTLLLDEQTVVSSAATIAAPGILQFAVESHQEGEPARRASAMLHALEEMPQPPGYDTNALTAAHESSMSGEELRKMFNSLGIQYGPAFSGLVAVHTARGDVTTVLAEVALPGAIRSQQSAYASHPALLDACFQSVLVHPEVQKATVGGLMLPVGVRRLRNYHSTRSAHYCLARVTSSSRAGECEADLDVFDQAGTVLLTVEGLRLAAGISEHERANRVFDERLLTIEWERGELPEVPQIDAGSWLLLSASEADPLTAQLADALNAVGAQSTSVASASDVAQLRSLLGGRLTGVVVVTGPPTGGLTQCGRDYVSQLVGIARELAELPGEPPRLFVVTRSAASVLPSDLANLEQAGLRGLMRVIDSEHPHLGATAIDVDNDETVAALVASQLQSGSQEDETAWRNGIWYTARLRPGPLRPAERRTAVVEYRRDGMRLQIRTPGDLESLEFVTFDRVAPGPGEIEVAVTASSVNFADVLVAFGRYPTFEGYRQQLGIDFAGVVTAVGPDVTEHRIGDHVGGMSANGCWSTFVRCDARLAVTLPPELPVAAAAAVPTASATAWYALHDLARICSDDKVLIHSGTGGVGQAAIAIARAAGCEIFATAGSAQRRQLLHDMGVEHVYDSRSTEFAEQIRGDTDGYGVDVVLNSLPGAAQRAGIELLAFGGRFVEIGKRDIYGDTRLGLFPFRRNLSLYAVDLALLTHSHPHTVRRLLKTVYQHTVEGTLPVPQTTHYPIHDAAVAIRLVGGAGHTGKVVLDVPRTGEGVAVVPPEQVRTSRPDGAYLVTGGLGGLGLFLAGELAAAGCGRIVLNSRSTPSPHATRVIERLRAAGADIQVECGDIADAATAHRVVAVATASGLPVRGVLHAAAVVEDATLANVTDELIDRCWAPKVHGAWNIHRATAAQPLEWFCLFSSAAALVGSPGQGAYAAANSWLDAFAHWRRAQGLPATSIAWGAWAEIGRATALAEGTGAAIAPAEGARAFQTLLRYGRAYSGYAPIMGTPWLTAFAQRSRFAEAFHATGQNQPATGKFLAELGSLPREEWPRTVRRLVSDQISLLLRRTIDPDRPLSDYGLDSLGNLELRTRIETETGIRVSPTKITTVRGLAEHVCDELAAAQSAPV,"220,462",2085,,methyl-branched fatty acid biosynthetic process [GO:1902321],"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081],pks3 pks4,LH57_06485,2
P9WQJ7,IRTB_MYCTU,Rv1349,irtB Rv1349 MTCY02B10.13,GO:0005524; GO:0005829; GO:0005886; GO:0009405; GO:0010106; GO:0015343; GO:0015891; GO:0016021; GO:0033216; GO:0040007; GO:0042626; GO:0052099; GO:0055072; GO:0075139,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR027417; ,,irtB,DOMAIN 17 299 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 332 567 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Iron import ATP-binding/permease protein IrtB (EC 3.6.3.-) (Iron-regulated transporter B),"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; siderophore transmembrane transporter activity [GO:0015343]; acquisition by symbiont of nutrients from host via siderophores [GO:0052099]; cellular response to iron ion starvation [GO:0010106]; ferric iron import [GO:0033216]; growth [GO:0040007]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]; response to host iron concentration [GO:0075139]; siderophore transport [GO:0015891]",9634230; 12065475; 16385031; 18461140; 19948799; 21969609,,"FUNCTION: Part of the ABC transporter complex IrtAB involved in iron import. Transmembrane domains (TMD) form a pore in the membrane and the ATP-binding domain (NBD) is responsible for energy generation. Required for replication in human macrophages and in mouse lungs. {ECO:0000269|PubMed:16385031, ECO:0000269|PubMed:19948799}.",MIRTWIALVPNDHRARLIGFALLAFCSVVARAVGTVLLVPLMAALFGEAPQRAWLWLGWLSAATVAGWVLDAVTARIGIELGFAVLNHTQHDVADRLPVVRLDWFTAENTATARQAIAATGPELVGLVVNLVTPLTSAILLPAVIALALLPISWQLGVAALAGVPLLLGALWASAAFARRADTAADKANTALTERIIEFARTQQALRAARRVEPARSLVGNALASQHTATMRLLGMQIPGQLLFSIASQLALIVLAGTTAALTITGTLTVPEAIALIVVMVRYLEPFTAVSELAPALESTRATLGRIGSVLTAPVMVAGSGTWRDGAVVPRIEFDDVAFGYDGGSGPVLDGVSFCLQPGTTTAIVGPSGCGKSTILALIAGLHQPTRGRVLIDGTDVATLDARAQQAVCSVVFQHPYLFHGTIRDNVFAADPGASDDQFAQAVRLARVDELIARLPDGANTIVGEAGSALSGGERQRVSIARALLKAAPVLLVDEATSALDAENEAAVVDALAADPRSRTRVIVAHRLASIRHADRVLFVDDGRVVEDGSISELLTAGGRFSQFWRQQHEAAEWQILAE,"60,954",579,"ABC transporter superfamily, Siderophore-Fe(3+) uptake transporter (SIUT) (TC 3.A.1.21) family",acquisition by symbiont of nutrients from host via siderophores [GO:0052099]; cellular response to iron ion starvation [GO:0010106]; ferric iron import [GO:0033216]; growth [GO:0040007]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]; response to host iron concentration [GO:0075139]; siderophore transport [GO:0015891],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]; siderophore transmembrane transporter activity [GO:0015343]",cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.13,1
P9WII5,MAZF4_MYCTU,Rv1495,mazF4 mazF-mt7 Rv1495 MTCY277.17,GO:0003677; GO:0004519; GO:2000372,IPR003477; IPR011067; ,,mazF4,,Endoribonuclease MazF4 (EC 3.1.-.-) (Toxin MazF4) (mRNA interferase MazF-mt7),DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000372],9634230; 18485066; 16611633; 20724443; 21969609,X-ray crystallography (2),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Acts as an endoribonuclease (mRNA interferase) on single-strand mRNA, cleaving between the first and second bases in the sequence UCGCU. Overexpression in M.smegmatis but not E.coli inhibits growth, this effect is neutralized by coexpression with cognate toxin MazE4. {ECO:0000269|PubMed:18485066}.; FUNCTION: Residues 29-56 inhibit ssDNA cleavage by DNA topoisomerase. This fragment does not have mRNA cleavage activity but it inhibits growth upon overexpression in M.smegmatis. {ECO:0000269|PubMed:20724443}.",MNAPLRGQVYRCDLGYGAKPWLIVSNNARNRHTADVVAVRLTTTRRTIPTWVAMGPSDPLTGYVNADNIETLGKDELGDYLGEVTPATMNKINTALATALGLPWP,"11,410",105,PemK/MazF family,negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000372],DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,mazF-mt7,MTCY277.17,1
P9WK13,MDH_MYCTU,Rv1240,mdh Rv1240 MTV006.12,GO:0005618; GO:0005829; GO:0005886; GO:0005975; GO:0006099; GO:0006107; GO:0006108; GO:0006734; GO:0030060,IPR001557; IPR022383; IPR001236; IPR015955; IPR001252; IPR010945; IPR036291; ,,mdh,,Malate dehydrogenase (EC 1.1.1.37),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,X-ray crystallography (2),FUNCTION: Catalyzes the reversible oxidation of malate to oxaloacetate. {ECO:0000255|HAMAP-Rule:MF_01517}.,MSASPLKVAVTGAAGQIGYSLLFRLASGSLLGPDRPIELRLLEIEPALQALEGVVMELDDCAFPLLSGVEIGSDPQKIFDGVSLALLVGARPRGAGMERSDLLEANGAIFTAQGKALNAVAADDVRVGVTGNPANTNALIAMTNAPDIPRERFSALTRLDHNRAISQLAAKTGAAVTDIKKMTIWGNHSATQYPDLFHAEVAGKNAAEVVNDQAWIEDEFIPTVAKRGAAIIDARGASSAASAASATIDAARDWLLGTPADDWVSMAVVSDGSYGVPEGLISSFPVTTKGGNWTIVSGLEIDEFSRGRIDKSTAELADERSAVTELGLI,"34,322",329,"LDH/MDH superfamily, MDH type 2 family",carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],L-malate dehydrogenase activity [GO:0030060],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV006.12,1
P9WK55,LPRA_MYCTU,Rv1270c,lprA Rv1270c MTCY50.12,GO:0005576; GO:0005615; GO:0005618; GO:0005886; GO:0008289; GO:0042785; GO:0048018,IPR029046; IPR009830; ,,lprA,,Lipoprotein LprA,cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; receptor ligand activity [GO:0048018]; active evasion of host immune response via regulation of host cytokine network [GO:0042785],9634230; 15294983; 16785538; 19362712; 20694006; 20234378; 21969609,,"FUNCTION: Constitutes a host TLR2 agonist (toll-like receptor), shown experimentally for human and mouse (PubMed:19362712). In host cells full-length (acylated) protein acts as a TLR2 agonist, inducing human and murine macrophages to produce cytokines, inducing murine dendritic cell maturation and cytokine production and inhibiting antibody processing in murine macrophages (PubMed:16785538). Binds diacylated phosphatidyl-myo-inositol mannosides (PIMs) (PubMed:20694006). Does not induce murine macrophage apoptosis or necrosis (PubMed:16785538). Non-acylated protein does not act as a TLR2 agonist (PubMed:20694006). Requires only host TLR2 as receptors to elicit host response in mouse, although TLR6 may play a redundant role, also requires CD14 and CD16 as accessory receptors (PubMed:19362712). {ECO:0000269|PubMed:16785538, ECO:0000269|PubMed:19362712, ECO:0000269|PubMed:20694006}.",MKHPPCSVVAAATAILAVVLAIGGCSTEGDAGKASDTAATASNGDAAMLLKQATDAMRKVTGMHVRLAVTGDVPNLRVTKLEGDISNTPQTVATGSATLLVGNKSEDAKFVYVDGHLYSDLGQPGTYTDFGNGASIYNVSVLLDPNKGLANLLANLKDASVAGSQQADGVATTKITGNSSADDIATLAGSRLTSEDVKTVPTTVWIASDGSSHLVQIQIAPTKDTSVTLTMSDWGKQVTATKPV,"24,874",244,LppX/LprAFG lipoprotein family,active evasion of host immune response via regulation of host cytokine network [GO:0042785],lipid binding [GO:0008289]; receptor ligand activity [GO:0048018],cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],,MTCY50.12,1
P9WK53,LPRB_MYCTU,Rv1274,lprB Rv1274 MTCY50.08c,GO:0005886; GO:0040007,IPR024520; ,,lprB,,Putative lipoprotein LprB,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MRRKVRRLTLAVSALVALFPAVAGCSDSGDNKPGATIPSTPANAEGRHGPFFPQCGGVSDQTVTELTRVTGLVNTAKNSVGCQWLAGGGILGPHFSFSWYRGSPIGRERKTEELSRASVEDINIDGHSGFIAIGNEPSLGDSLCEVGIQFSDDFIEWSVSFSQKPFPLPCDIAKELTRQSIANSK,"19,739",185,,growth [GO:0040007],,plasma membrane [GO:0005886],,MTCY50.08c,1
P9WK51,LPRD_MYCTU,Rv1343c,lprD Rv1343c MTCY02B10.07c,GO:0005886; GO:0016021,,,lprD,,Putative lipoprotein LprD,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MSTTRRRRPALIALVIIATCGCLALGWWQWTRFQSTSGTFQNLGYALQWPLFAWFCVYAYRNFVRYEETPPQPPTGGAAAEIPAGLLPERPKPAQQPPDDPVLREYNAYLAELAKDDARKQNRTTA,"14,273",126,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.07c,1
P9WK47,LPRF_MYCTU,Rv1368,lprF Rv1368 MTCY02B12.02,GO:0005576; GO:0005618; GO:0005886; GO:0006869; GO:0008289,IPR029046; IPR009830; ,,lprF,,Putative diacylated glycolipid transporter LprF (Lipoprotein LprF),cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; lipid transport [GO:0006869],9634230; 12581360; 19944079; 21969609; 24093492,,"FUNCTION: Might be involved in transporting short diacylated glycolipids to the cell outer membrane (By similarity). Overexpression induces expression of sensor protein kdpD gene at low K(+) concentrations (0 and 250 uM, tested in M.smegatis). {ECO:0000250|UniProtKB:P65315, ECO:0000269|PubMed:12581360}.",MNGLISQACGSHRPRRPSSLGAVAILIAATLFATVVAGCGKKPTTASSPSPGSPSPEAQQILQDSSKATKGLHSVHVVVTVNNLSTLPFESVDADVTNQPQGNGQAVGNAKVRMKPNTPVVATEFLVTNKTMYTKRGGDYVSVGPAEKIYDPGIILDKDRGLGAVVGQVQNPTIQGRDAIDGLATVKVSGTIDAAVIDPIVPQLGKGGGRLPITLWIVDTNASTPAPAANLVRMVIDKDQGNVDITLSNWGAPVTIPNPAG,"26,852",261,LppX/LprAFG lipoprotein family,lipid transport [GO:0006869],lipid binding [GO:0008289],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY02B12.02,1
P9WK45,LPRG_MYCTU,Rv1411c,lprG lpp-27 Rv1411c MTCY21B4.28c,GO:0005618; GO:0005886; GO:0006869; GO:0009405; GO:0009986; GO:0035091; GO:0046677; GO:0051861; GO:0097691,IPR029046; IPR009830; ,,lprG,,Lipoarabinomannan carrier protein LprG (27 kDa lipoprotein) (Antigen P27) (Lipoprotein LprG) (Triacylated glycolipid carrier LprG) (Triacylglyceride transfer protein LprG),bacterial extracellular vesicle [GO:0097691]; cell surface [GO:0009986]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; glycolipid binding [GO:0051861]; phosphatidylinositol binding [GO:0035091]; lipid transport [GO:0006869]; pathogenesis [GO:0009405]; response to antibiotic [GO:0046677],9634230; 14998516; 15294983; 18156250; 18424702; 19362712; 21078852; 21364279; 21762531; 21969609; 25041568; 25232742; 25356793; 20234378; 20694006; 26751071,X-ray crystallography (4),"FUNCTION: Probably helps membrane protein Rv1410c (P55) transport triacylglycerides (TAG) across the inner cell membrane into the periplasm; TAG probably regulates lipid metabolism and growth regulation (PubMed:26751071). Binds TAG and transfers it between lipid bilayers, probably to the outer membrane in vivo (PubMed:26751071). Binds di- and triacylated phosphatidyl-myo-inositol mannosides (PIMs), and glycolipid lipoglycan modulins lipoarabinomannan (LAM) and lipomannan (LM), facilitating their recognition by TLR2 (PubMed:20694006, PubMed:25356793). Binds LM > PIM6 > ManLAM > PI-LAM > PIM2 (mannose-capped LAM and phospho-myo-inositol-capped LAM, E.coli expressed without acyl-groups); deacylated LM and LAM also bind to this protein via their mannose moieties, showing LprG has at least 2 different ways to bind glycolipids (PubMed:25356793). Binds triacylglycerides (TAG) in the same cavity, is able to transfer TAG between lipid bilayers (PubMed:26751071). Overexpression of LprG and Rv1410c leads to increased levels of TAG in the culture medium (PubMed:26751071). Required for Rv1410c-mediated export of drugs (PubMed:18156250, PubMed:21762531). Required, probably with Rv1410c, for normal surface localization of LAM (PubMed:25232742). {ECO:0000269|PubMed:18156250, ECO:0000269|PubMed:20694006, ECO:0000269|PubMed:21762531, ECO:0000269|PubMed:25232742, ECO:0000269|PubMed:25356793, ECO:0000269|PubMed:26751071}.; FUNCTION: A host TLR2 agonist (toll-like receptor), shown experimentally for human and mouse (PubMed:19362712). Inhibits primary human macrophage MHC-II Ag processing via TLR2 (PubMed:15294983). Both lipidated and nonlipidated protein act as TLR2 agonists in antigen-presenting cells, although lipidated protein is more efficient (PubMed:20694006). In resting human CD4+ T-cells lipidated but not nonlipidated protein is a costimulatory ligand (with anti-CD3 and anti-CD28) for T-cell proliferation and IFN-gamma and IL-2 production, leading to increased expression of early T-cell activation markers, TLR2 and NFKB3 phosphorylation (PubMed:21078852). Human CD4+ T-cells use TLR1/TLR2 heterodimers to respond to this and probably other mycobacterial lipoproteins (PubMed:21078852). Able to stimulate proliferation of CD4+ T-cells derived from a human leprosy patient following protein processing/presentation by MHC class II molecules in peripheral blood mononuclear cells (PubMed:18424702). Requires both host TLR1 and TLR2 as coreceptors to elicit host response in mouse, although TLR6 may play a redundant role, has a partial requirement for CD14 as an accessory receptor (PubMed:19362712). {ECO:0000269|PubMed:15294983, ECO:0000269|PubMed:18424702, ECO:0000269|PubMed:19362712, ECO:0000269|PubMed:20694006, ECO:0000269|PubMed:21078852}.",MRTPRRHCRRIAVLAAVSIAATVVAGCSSGSKPSGGPLPDAKPLVEEATAQTKALKSAHMVLTVNGKIPGLSLKTLSGDLTTNPTAATGNVKLTLGGSDIDADFVVFDGILYATLTPNQWSDFGPAADIYDPAQVLNPDTGLANVLANFADAKAEGRDTINGQNTIRISGKVSAQAVNQIAPPFNATQPVPATVWIQETGDHQLAQAQLDRGSGNSVQMTLSKWGEKVQVTKPPVS,"24,548",236,LppX/LprAFG lipoprotein family,lipid transport [GO:0006869]; pathogenesis [GO:0009405]; response to antibiotic [GO:0046677],glycolipid binding [GO:0051861]; phosphatidylinositol binding [GO:0035091],bacterial extracellular vesicle [GO:0097691]; cell surface [GO:0009986]; cell wall [GO:0005618]; plasma membrane [GO:0005886],lpp-27,MTCY21B4.28c,1
P9WK41,LPRI_MYCTU,Rv1541c,lprI Rv1541c MTCY48.24,GO:0005576; GO:0005618; GO:0005886; GO:0009986,IPR009739; IPR018660; IPR036328; ,,lprI,,Lipoprotein LprI (Glycolipoprotein LprI) (Lysozyme inhibitor LprI),cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 26589796,,"FUNCTION: Strongly binds and inhibits lysozyme, may help bacteria survive in lysozyme-producing host cells. When overexpressed in M.tuberculosis or M.smegmatis increases resistance to hen egg white lysozyme. M.smegmatis overexpressing LprI survive better during intracellular infection of peritoneal and monocyte-derived macrophages, both of which produce lysozyme during infection; M.smegmatis does not encode this protein. Somewhat better survival is seen in human cell lines when M.smegmatis cells express both proteins from this operon, i.e. GlbN (HbN) and LprI. {ECO:0000269|PubMed:26589796}.",MRWIGVLVTALVLSACAANPPANTTSPTAGQSLDCTKPATIVQQLVCHDRQLTSLDHRLSTAYQQALAHRRSAALEAAQSSWTMLRDACAQDTDPRTCVQEAYQTRLVQLAIADPATATPPVLTYRCPTQDGPLTAQFYNQFDPKTAVLNWKGDQVIVFVELSGSGARYGRQGIEYWEHQGEVRLDFHGATFVCRTS,"21,624",197,MliC family,,,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY48.24,1
P9WK99,LSPA_MYCTU,Rv1539,lspA Rv1539 MTCY48.26c,GO:0004190; GO:0005886; GO:0006497; GO:0009405; GO:0016021; GO:0040007,IPR001872; ,,lspA,,Lipoprotein signal peptidase (EC 3.4.23.36) (Prolipoprotein signal peptidase) (Signal peptidase II) (SPase II),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aspartic-type endopeptidase activity [GO:0004190]; growth [GO:0040007]; pathogenesis [GO:0009405]; protein lipidation [GO:0006497],9634230; 21969609,,FUNCTION: This protein specifically catalyzes the removal of signal peptides from prolipoproteins. {ECO:0000250}.,MPDEPTGSADPLTSTEEAGGAGEPNAPAPPRRLRMLLSVAVVVLTLDIVTKVVAVQLLPPGQPVSIIGDTVTWTLVRNSGAAFSMATGYTWVLTLIATGVVVGIFWMGRRLVSPWWALGLGMILGGAMGNLVDRFFRAPGPLRGHVVDFLSVGWWPVFNVADPSVVGGAILLVILSIFGFDFDTVGRRHADGDTVGRRKADG,"21,345",202,Peptidase A8 family,growth [GO:0040007]; pathogenesis [GO:0009405]; protein lipidation [GO:0006497],aspartic-type endopeptidase activity [GO:0004190],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.26c,1
P9WJ91,MAZE4_MYCTU,Rv1494,mazE4 mazE-mt7 Rv1494 MTCY277.16,,,,mazE4,,Probable antitoxin MazE4,,9634230; 16611633; 20724443,X-ray crystallography (1),"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. In M.smegmatis neutralizes the toxic effect of mRNA interferase MazF4, its cognate toxin, on growth. {ECO:0000269|PubMed:20724443}.",MPFLVALSGIISGVRDHSMTVRLDQQTRQRLQDIVKGGYRSANAAIVDAINKRWEALHDEQLDAAYAAAIHDNPAYPYESEAERSAARARRNARQQRSAQ,"11,205",100,,,,,mazE-mt7,MTCY277.16,1
P9WQF1,MBTL_MYCTU,Rv1344,mbtL Rv1344 MTCY02B10.08,GO:0000035; GO:0000036; GO:0005829; GO:0009245; GO:0019540; GO:0031177,IPR036736; IPR009081; ,,mbtL,DOMAIN 6 81 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Acyl carrier protein MbtL (ACP) (Mycobactin synthase protein L),cytosol [GO:0005829]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; lipid A biosynthetic process [GO:0009245]; siderophore biosynthetic process from catechol [GO:0019540],9634230; 12065475; 16461464,,FUNCTION: Acyl carrier protein involved in the formation of acyl-S-ACP intermediates within the mycobactin biosynthesis process. The aliphatic chains carried by ACP are subsequently transferred on to the mycobactin core by MbtK. {ECO:0000269|PubMed:16461464}.,MTSSPSTVSTTLLSILRDDLNIDLTRVTPDARLVDDVGLDSVAFAVGMVAIEERLGVALSEEELLTCDTVGELEAAIAAKYRDE,"8,969",84,,lipid A biosynthetic process [GO:0009245]; siderophore biosynthetic process from catechol [GO:0019540],acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177],cytosol [GO:0005829],,MTCY02B10.08,1
P9WQ41,MBTM_MYCTU,Rv1345,mbtM fadD33 Rv1345 MTCY02B10.09,GO:0005524; GO:0005886; GO:0006633; GO:0008922; GO:0044119; GO:0070566,IPR020845; IPR000873; ,,mbtM,,Long-chain-fatty-acid--[acyl-carrier-protein] ligase MbtM (EC 6.2.1.20) (Fatty acyl-[acyl-carrier-protein] synthetase) (Fatty acyl-ACP synthetase) (Mycobactin synthetase protein M),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; long-chain fatty acid [acyl-carrier-protein] ligase activity [GO:0008922]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119],9634230; 12065475; 12480891; 16461464; 21969609,,"FUNCTION: Activates lipidic moieties required for mycobactin biosynthesis. Converts medium- to long-chain aliphatic fatty acids into acyl adenylate, which is further transferred on to the phosphopantetheine arm of the carrier protein MbtL. {ECO:0000269|PubMed:16461464}.",MSELAAVLTRSMQASAGDLMVLDRETSLWCRHPWPEVHGLAESVAAWLLDHDRPAAVGLVGEPTVELVAAIQGAWLAGAAVSILPGPVRGANDQRWADATLTRFLGIGVRTVLSQGSYLARLRSVDTAGVTIGDLSTAAHTNRSATPVASEGPAVLQGTAGSTGAPRTAILSPGAVLSNLRGLNQRVGTDAATDVGCSWLPLYHDMGLAFVLSAALAGAPLWLAPTTAFTASPFRWLSWLSDSGATMTAAPNFAYNLIGKYARRVSEVDLGALRVTLNGGEPVDCDGLTRFAEAMAPFGFDAGAVLPSYGLAESTCAVTVPVPGIGLLADRVIDGSGAHKHAVLGNPIPGMEVRISCGDQAAGNASREIGEIEIRGASMMAGYLGQQPIDPDDWFATGDLGYLGAGGLVVCGRAKEVISIAGRNIFPTEVELVAAQVRGVREGAVVALGTGDRSTRPGLVVAAEFRGPDEANARAELIQRVASECGIVPSDVVFVSPGSLPRTSSGKLRRLAVRRSLEMAD,"53,957",521,ATP-dependent AMP-binding enzyme family,fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119],adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; long-chain fatty acid [acyl-carrier-protein] ligase activity [GO:0008922],plasma membrane [GO:0005886],fadD33,MTCY02B10.09,1
P9WGR1,INHA_MYCTU,Rv1484,inhA Rv1484 MTCY277.05,GO:0004318; GO:0005504; GO:0005618; GO:0005886; GO:0030497; GO:0046677; GO:0070403; GO:0071768,IPR014358; IPR036291; ,,inhA,,Enoyl-[acyl-carrier-protein] reductase [NADH] (ENR) (Enoyl-ACP reductase) (EC 1.3.1.9) (FAS-II enoyl-ACP reductase) (NADH-dependent 2-trans-enoyl-ACP reductase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; fatty acid binding [GO:0005504]; NAD+ binding [GO:0070403]; fatty acid elongation [GO:0030497]; mycolic acid biosynthetic process [GO:0071768]; response to antibiotic [GO:0046677],8284673; 9634230; 7599116; 10521269; 12406221; 14623976; 19099550; 20864541; 21969609; 22283812; 25227413; 7886450; 9417034; 10336454; 12606558; 17163639; 17034137; 16647717; 16906155; 17723305; 17636923; 17227913; 17588773; 19130456; 20200152; 21143326; 22987724; 24107081; 24527857; 24616444; 24292073; 26147157; 25891098; 25568071; 26934341; 27428438,X-ray crystallography (85),"FUNCTION: Enoyl-ACP reductase of the type II fatty acid syntase (FAS-II) system, which is involved in the biosynthesis of mycolic acids, a major component of mycobacterial cell walls (PubMed:25227413). Catalyzes the NADH-dependent reduction of the double bond of 2-trans-enoyl-[acyl-carrier protein], an essential step in the fatty acid elongation cycle of the FAS-II pathway (PubMed:7599116). Shows preference for long-chain fatty acyl thioester substrates (>C16), and can also use 2-trans-enoyl-CoAs as alternative substrates (PubMed:7599116). The mycobacterial FAS-II system utilizes the products of the FAS-I system as primers to extend fatty acyl chain lengths up to C56, forming the meromycolate chain that serves as the precursor for final mycolic acids (PubMed:25227413). {ECO:0000269|PubMed:7599116, ECO:0000303|PubMed:25227413}.; FUNCTION: Is the primary target of the first-line antitubercular drug isoniazid (INH) and of the second-line drug ethionamide (ETH) (PubMed:8284673, PubMed:12406221, PubMed:16906155, PubMed:17227913). Overexpressed inhA confers INH and ETH resistance to M.tuberculosis (PubMed:12406221). The mechanism of isoniazid action against InhA is covalent attachment of the activated form of the drug to the nicotinamide ring of NAD and binding of the INH-NAD adduct to the active site of InhA (PubMed:9417034, PubMed:16906155). Similarly, the ETH-NAD adduct binds InhA (PubMed:17227913). {ECO:0000269|PubMed:12406221, ECO:0000269|PubMed:16906155, ECO:0000269|PubMed:17227913, ECO:0000269|PubMed:9417034, ECO:0000305|PubMed:8284673}.",MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL,"28,528",269,"Short-chain dehydrogenases/reductases (SDR) family, FabI subfamily",fatty acid elongation [GO:0030497]; mycolic acid biosynthetic process [GO:0071768]; response to antibiotic [GO:0046677],enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; fatty acid binding [GO:0005504]; NAD+ binding [GO:0070403],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY277.05,1
P9WQJ9,IRTA_MYCTU,Rv1348,irtA Rv1348 MTCY02B10.12,GO:0005524; GO:0005886; GO:0009405; GO:0010106; GO:0015343; GO:0015891; GO:0016021; GO:0016491; GO:0033216; GO:0040007; GO:0042626; GO:0052099; GO:0055072; GO:0071949; GO:0075139,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR013113; IPR017927; IPR027417; IPR017938; IPR007037; ,,irtA,DOMAIN 15 122 FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.; DOMAIN 293 575 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 610 843 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Iron import ATP-binding/permease protein IrtA (EC 3.6.3.-) (Iron-regulated transporter A),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; siderophore transmembrane transporter activity [GO:0015343]; acquisition by symbiont of nutrients from host via siderophores [GO:0052099]; cellular response to iron ion starvation [GO:0010106]; ferric iron import [GO:0033216]; growth [GO:0040007]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]; response to host iron concentration [GO:0075139]; siderophore transport [GO:0015891]",9634230; 12065475; 16385031; 18461140; 19948799; 21969609,,"FUNCTION: Part of the ABC transporter complex IrtAB involved in iron import. Transmembrane domains (TMD) form a pore in the membrane and the ATP-binding domain (NBD) is responsible for energy generation. Required for replication in human macrophages and in mouse lungs. {ECO:0000269|PubMed:16385031, ECO:0000269|PubMed:19948799}.",MARGLQGVMLRSFGARDHTATVIETISIAPHFVRVRMVSPTLFQDAEAEPAAWLRFWFPDPNGSNTEFQRAYTISEADPAAGRFAVDVVLHDPAGPASSWARTVKPGATIAVMSLMGSSRFDVPEEQPAGYLLIGDSASIPGMNGIIETVPNDVPIEMYLEQHDDNDTLIPLAKHPRLRVRWVMRRDEKSLAEAIENRDWSDWYAWATPEAAALKCVRVRLRDEFGFPKSEIHAQAYWNAGRAMGTHRATEPAATEPEVGAAPQPESAVPAPARGSWRAQAASRLLAPLKLPLVLSGVLAALVTLAQLAPFVLLVELSRLLVSGAGAHRLFTVGFAAVGLLGTGALLAAALTLWLHVIDARFARALRLRLLSKLSRLPLGWFTSRGSGSIKKLVTDDTLALHYLVTHAVPDAVAAVVAPVGVLVYLFVVDWRVALVLFGPVLVYLTITSSLTIQSGPRIVQAQRWAEKMNGEAGSYLEGQPVIRVFGAASSSFRRRLDEYIGFLVAWQRPLAGKKTLMDLATRPATFLWLIAATGTLLVATHRMDPVNLLPFMFLGTTFGARLLGIAYGLGGLRTGLLAARHLQVTLDETELAVREHPREPLDGEAPATVVFDHVTFGYRPGVPVIQDVSLTLRPGTVTALVGPSGSGKSTLATLLARFHDVERGAIRVGGQDIRSLAADELYTRVGFVLQEAQLVHGTAAENIALAVPDAPAEQVQVAAREAQIHDRVLRLPDGYDTVLGANSGLSGGERQRLTIARAILGDTPVLILDEATAFADPESEYLVQQALNRLTRDRTVLVIAHRLHTITRADQIVVLDHGRIVERGTHEELLAAGGRYCRLWDTGQGSRVAVAAAQDGTR,"92,966",859,"ABC transporter superfamily, Siderophore-Fe(3+) uptake transporter (SIUT) (TC 3.A.1.21) family",acquisition by symbiont of nutrients from host via siderophores [GO:0052099]; cellular response to iron ion starvation [GO:0010106]; ferric iron import [GO:0033216]; growth [GO:0040007]; iron ion homeostasis [GO:0055072]; pathogenesis [GO:0009405]; response to host iron concentration [GO:0075139]; siderophore transport [GO:0015891],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; siderophore transmembrane transporter activity [GO:0015343]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY02B10.12,1
O05306,LOGH_MYCTU,Rv1205 RVBD_1205 LH57_06605,log Rv1205 RVBD_1205 LH57_06605 P425_01253,GO:0009691; GO:0016799,IPR005269; IPR031100; ,,log,,Cytokinin riboside 5'-monophosphate phosphoribohydrolase (EC 3.2.2.n1) (Protein LONELY GUY homolog) (LOG homolog),"hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]; cytokinin biosynthetic process [GO:0009691]",9634230; 21969609; 25728768,,"FUNCTION: Catalyzes the hydrolytic removal of ribose 5'-monophosphate from nitrogen N6-modified adenosines, the final step of bioactive cytokinin synthesis. Is involved in the synthesis of isopentenyladenine (iP) and 2-methylthio-iP (2MeS-iP), the most abundant cytokinins detected in M.tuberculosis lysates and supernatants. Is also able to convert trans-zeatin-riboside monophosphate (tZRMP) to trans-zeatin (tZ) in vitro; however, it may not be involved in the biosynthesis of this minor cytokinin in vivo. Accumulation of Rv1205 sensitizes M.tuberculosis to nitric oxide since cytokinin breakdown products synergize with NO to kill M.tuberculosis. Shows a slow AMP hydrolase activity, but is not able to hydrolyze ATP. Displays no lysine decarboxylase (LDC) activity (L-lysine conversion to cadaverine). {ECO:0000269|PubMed:25728768}.",MSAKIDITGDWTVAVYCAASPTHAELLELAAEVGAAIAGRGWTLVWGGGHVSAMGAVASAARACGGWTVGVIPKMLVYRELADHDADELIVTDTMWERKQIMEDRSDAFIVLPGGVGTLDELFDAWTDGYLGTHDKPIVMVDPWGHFDGLRAWLNGLLDTGYVSPTAMERLVVVDNVKDALRACAPS,"20,014",187,LOG family,cytokinin biosynthetic process [GO:0009691],"hydrolase activity, hydrolyzing N-glycosyl compounds [GO:0016799]",,,P425_01253,1
P9WFR7,COXX_MYCTU,Rv1451,ctaB Rv1451,GO:0004311; GO:0005618; GO:0005886; GO:0006783; GO:0008495; GO:0016021; GO:0045333; GO:0048034,IPR006369; IPR000537; ,,ctaB,,Protoheme IX farnesyltransferase (EC 2.5.1.-) (Heme B farnesyltransferase) (Heme O synthase),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495]; cellular respiration [GO:0045333]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034],9634230,,FUNCTION: Converts heme B (protoheme IX) to heme O by substitution of the vinyl group on carbon 2 of heme B porphyrin ring with a hydroxyethyl farnesyl side group. {ECO:0000255|HAMAP-Rule:MF_00154}.,MNVRGRVAPRRVTGRAMSTLLAYLALTKPRVIELLLVTAIPAMLLADRGAIHPLLMLNTLVGGMMAAAGANTLNCVADADIDKVMKRTARRPLAREAVPTRNALALGLTLTVISFFWLWCATNLLAGVLALVTVAFYVFVYTLWLKRRTSQNVVWGGAAGCMPVMIGWSAITGTIAWPALAMFAIIFFWTPPHTWALAMRYKQDYQVAGVPMLPAVATERQVTKQILIYTWLTVAATLVLALATSWLYGAVALVAGGWFLTMAHQLYAGVRAGEPVRPLRLFLQSNNYLAVVFCALAVDSVIALPTLH,"33,538",308,"UbiA prenyltransferase family, Protoheme IX farnesyltransferase subfamily",cellular respiration [GO:0045333]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034],farnesyltranstransferase activity [GO:0004311]; protoheme IX farnesyltransferase activity [GO:0008495],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNZ1,COABC_MYCTU,Rv1391,coaBC dfp Rv1391 MTCY21B4.08,GO:0004632; GO:0004633; GO:0005886; GO:0010181; GO:0015937; GO:0015941; GO:0040007,IPR035929; IPR005252; IPR007085; IPR036551; IPR003382; ,,coaBC,,Coenzyme A biosynthesis bifunctional protein CoaBC (DNA/pantothenate metabolism flavoprotein) [Includes: Phosphopantothenoylcysteine decarboxylase (PPCDC) (EC 4.1.1.36) (CoaC); Phosphopantothenate--cysteine ligase (EC 6.3.2.5) (CoaB) (PPC synthetase) (PPCS) (Phosphopantothenoylcysteine synthase)],plasma membrane [GO:0005886]; FMN binding [GO:0010181]; phosphopantothenate--cysteine ligase activity [GO:0004632]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633]; coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007]; pantothenate catabolic process [GO:0015941],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes two steps in the biosynthesis of coenzyme A. In the first step cysteine is conjugated to 4'-phosphopantothenate to form 4-phosphopantothenoylcysteine, in the latter compound is decarboxylated to form 4'-phosphopantotheine (By similarity). {ECO:0000250}.",MVDHKRIPKQVIVGVSGGIAAYKACTVVRQLTEASHRVRVIPTESALRFVGAATFEALSGEPVCTDVFADVPAVPHVHLGQQADLVVVAPATADLLARAAAGRADDLLTATLLTARCPVLFAPAMHTEMWLHPATVDNVATLRRRGAVVLEPATGRLTGADSGAGRLPEAEEITTLAQLLLERHDALPYDLAGRKLLVTAGGTREPIDPVRFIGNRSSGKQGYAVARVAAQRGADVTLIAGHTAGLVDPAGVEVVHVSSAQQLADAVSKHAPTADVLVMAAAVADFRPAQVATAKIKKGVEGPPTIELLRNDDVLAGVVRARAHGQLPNMRAIVGFAAETGDANGDVLFHARAKLRRKGCDLLVVNAVGEGRAFEVDSNDGWLLASDGTESALQHGSKTLMASRIVDAIVTFLAGCSS,"43,577",418,HFCD (homo-oligomeric flavin containing Cys decarboxylase) superfamily; PPC synthetase family,coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007]; pantothenate catabolic process [GO:0015941],FMN binding [GO:0010181]; phosphopantothenate--cysteine ligase activity [GO:0004632]; phosphopantothenoylcysteine decarboxylase activity [GO:0004633],plasma membrane [GO:0005886],dfp,MTCY21B4.08,1
P9WPK3,CARB_MYCTU,Rv1384,carB Rv1384 MTCY02B12.18 MTCY21B4.01,GO:0000050; GO:0004087; GO:0004088; GO:0005524; GO:0005737; GO:0005886; GO:0006526; GO:0044205; GO:0046872,IPR011761; IPR006275; IPR005480; IPR036897; IPR005479; IPR005483; IPR011607; IPR036914; IPR033937; IPR016185; ,,carB,DOMAIN 138 333 ATP-grasp 1. {ECO:0000255|HAMAP-Rule:MF_01210}.; DOMAIN 693 884 ATP-grasp 2. {ECO:0000255|HAMAP-Rule:MF_01210}.; DOMAIN 966 1113 MGS-like. {ECO:0000255|PROSITE-ProRule:PRU01202}.,Carbamoyl-phosphate synthase large chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase ammonia chain),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],9634230; 21969609,,,MPRRTDLHHVLVIGSGPIVIGQACEFDYSGTQACRVLRAEGLQVSLVNSNPATIMTDPEFADHTYVEPITPAFVERVIAQQAERGNKIDALLATLGGQTALNTAVALYESGVLEKYGVELIGADFDAIQRGEDRQRFKDIVAKAGGESARSRVCFTMAEVRETVAELGLPVVVRPSFTMGGLGSGIAYSTDEVDRMAGAGLAASPSANVLIEESIYGWKEFELELMRDGHDNVVVVCSIENVDPMGVHTGDSVTVAPAMTLTDREYQRMRDLGIAILREVGVDTGGCNIQFAVNPRDGRLIVIEMNPRVSRSSALASKATGFPIAKIAAKLAIGYTLDEIVNDITGETPACFEPTLDYVVVKAPRFAFEKFPGADPTLTTTMKSVGEAMSLGRNFVEALGKVMRSLETTRAGFWTAPDPDGGIEEALTRLRTPAEGRLYDIELALRLGATVERVAEASGVDPWFIAQINELVNLRNELVAAPVLNAELLRRAKHSGLSDHQIASLRPELAGEAGVRSLRVRLGIHPVYKTVDTCAAEFEAQTPYHYSSYELDPAAETEVAPQTERPKVLILGSGPNRIGQGIEFDYSCVHAATTLSQAGFETVMVNCNPETVSTDYDTADRLYFEPLTFEDVLEVYHAEMESGSGGPGVAGVIVQLGGQTPLGLAHRLADAGVPIVGTPPEAIDLAEDRGAFGDLLSAAGLPAPKYGTATTFAQARRIAEEIGYPVLVRPSYVLGGRGMEIVYDEETLQGYITRATQLSPEHPVLVDRFLEDAVEIDVDALCDGAEVYIGGIMEHIEEAGIHSGDSACALPPVTLGRSDIAKVRKATEAIAHGIGVVGLLNVQYALKDDVLYVLEANPRASRTVPFVSKATAVPLAKACARIMLGATIAQLRAEGLLAVTGDGAHAARNAPIAVKEAVLPFHRFRRADGAAIDSLLGPEMKSTGEVMGIDRDFGSAFAKSQTAAYGSLPAQGTVFVSVANRDKRSLVFPVKRLADLGFRVLATEGTAEMLRRNGIPCDDVRKHFEPAQPGRPTMSAVDAIRAGEVNMVINTPYGNSGPRIDGYEIRSAAVAGNIPCITTVQGASAAVQGIEAGIRGDIGVRSLQELHRVIGGVER,"118,961",1115,CarB family,'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; urea cycle [GO:0000050],ATP binding [GO:0005524]; carbamoyl-phosphate synthase (ammonia) activity [GO:0004087]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; metal ion binding [GO:0046872],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY02B12.18 MTCY21B4.01,1
P9WPC1,CLPS_MYCTU,Rv1331,clpS Rv1331 MTCY130.16,GO:0030163,IPR022935; IPR003769; IPR014719; ,,clpS,,ATP-dependent Clp protease adapter protein ClpS,protein catabolic process [GO:0030163],9634230; 21969609,,FUNCTION: Involved in the modulation of the specificity of the ClpAP-mediated ATP-dependent protein degradation. {ECO:0000255|HAMAP-Rule:MF_00302}.,MAVVSAPAKPGTTWQRESAPVDVTDRAWVTIVWDDPVNLMSYVTYVFQKLFGYSEPHATKLMLQVHNEGKAVVSAGSRESMEVDVSKLHAAGLWATMQQDR,"11,222",101,ClpS family,protein catabolic process [GO:0030163],,,,MTCY130.16,1
P9WN83,G3P_MYCTU,Rv1436,gap Rv1436 MTCY493.18c,GO:0004365; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006006; GO:0006096; GO:0040007; GO:0050661; GO:0051287,IPR020831; IPR020830; IPR020829; IPR020828; IPR006424; IPR036291; ,,gap,,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (NAD-dependent glyceraldehyde-3-phosphate dehydrogenase),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 21969609; 24161676,,"FUNCTION: Catalyzes the oxidative phosphorylation of glyceraldehyde 3-phosphate (G3P) to 1,3-bisphosphoglycerate (BPG) using the cofactor NAD. The first reaction step involves the formation of a hemiacetal intermediate between G3P and a cysteine residue, and this hemiacetal intermediate is then oxidized to a thioester, with concomitant reduction of NAD to NADH. The reduced NADH is then exchanged with the second NAD, and the thioester is attacked by a nucleophilic inorganic phosphate to produce BPG. {ECO:0000269|PubMed:24161676}.",MTVRVGINGFGRIGRNFYRALLAQQEQGTADVEVVAANDITDNSTLAHLLKFDSILGRLPCDVGLEGDDTIVVGRAKIKALAVREGPAALPWGDLGVDVVVESTGLFTNAAKAKGHLDAGAKKVIISAPATDEDITIVLGVNDDKYDGSQNIISNASCTTNCLAPLAKVLDDEFGIVKGLMTTIHAYTQDQNLQDGPHKDLRRARAAALNIVPTSTGAAKAIGLVMPQLKGKLDGYALRVPIPTGSVTDLTVDLSTRASVDEINAAFKAAAEGRLKGILKYYDAPIVSSDIVTDPHSSIFDSGLTKVIDDQAKVVSWYDNEWGYSNRLVDLVTLVGKSL,"35,956",339,Glyceraldehyde-3-phosphate dehydrogenase family,glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; growth [GO:0040007],glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; NAD binding [GO:0051287]; NADP binding [GO:0050661],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY493.18c,1
P9WQ17,GLGE_MYCTU,Rv1327c,glgE Rv1327c MTCY130.12c,GO:0004553; GO:0005829; GO:0005886; GO:0005978; GO:0016758; GO:0040007,IPR026585; IPR021828; IPR006047; IPR013780; IPR017853; IPR013783; ,,glgE,,"Alpha-1,4-glucan:maltose-1-phosphate maltosyltransferase (GMPMT) (EC 2.4.99.16) ((1->4)-alpha-D-glucan:maltose-1-phosphate alpha-D-maltosyltransferase) ((1->4)-alpha-D-glucan:phosphate alpha-D-maltosyltransferase)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; transferase activity, transferring hexosyl groups [GO:0016758]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]",9634230; 21180647; 20305657; 21914799; 21969609,,"FUNCTION: Essential maltosyltransferase that uses maltose 1-phosphate (M1P) as the sugar donor to elongate linear or branched alpha-(1->4)-glucans. Maltooligosaccharides with a degree of polymerization (DP) superior or equal to 4 are efficient acceptors, with DP5 being optimal in the GlgE-catalyzed polymerization with M1P. Is specific for the alpha-anomer of M1P as substrate, since the beta-anomer of M1P gives no activity. Exhibits an alpha-retaining catalytic mechanism. Is also able to catalyze the reverse reaction in vitro, releasing M1P from glycogen in the presence of inorganic phosphate. Also catalyzes disproportionation reactions through maltosyl transfer between maltooligosaccharides. Is involved in a branched alpha-glucan biosynthetic pathway from trehalose, together with TreS, Mak and GlgB. {ECO:0000269|PubMed:20305657}.",MSGRAIGTETEWWVPGRVEIDDVAPVVSCGVYPAKAVVGEVVPVSAAVWREGHEAVAATLVVRYLGVRYPHLTDRPRARVLPTPSEPQQRVKPLLIPMTSGQEPFVFHGQFTPDRVGLWTFRVDGWGDPIHTWRHGLIAKLDAGQGETELSNDLLVGAVLLERAATGVPRGLRDPLLAAAAALRTPGDPVTRTALALTPEIEELLADYPLRDLVTRGEQFGVWVDRPLARFGAWYEMFPRSTGGWDDDGNPVHGTFATAAAELPRIAGMGFDVVYLPPIHPIGKVHRKGRNNSPTAAPTDVGSPWAIGSDEGGHDTVHPSLGTIDDFDDFVSAARDLGMEVALDLALQCAPDHPWAREHRQWFTELPDGTIAYAENPPKKYQDIYPLNFDNDPEGLYDEVLRVVQHWVNHGVKFFRVDNPHTKPPNFWAWLIAQVKTVDPDVLFLSEAFTPPARQYGLAKLGFTQSYSYFTWRTTKWELTEFGNQIAELADYRRPNLFVNTPDILHAVLQHNGPGMFAIRAVLAATMSPAWGMYCGYELFEHRAVREGSEEYLDSEKYELRPRDFASALDQGRSLQPFITRLNIIRRLHPAFQQLRTIHFHHVDNDALLAYSKFDPATGDCVLVVVTLNAFGPEEATLWLDMAALGMEDYDRFWVRDEITGEEYQWGQANYIRIDPARAVAHIINMPAVPYESRNTLLRRR,"78,640",701,"Glycosyl hydrolase 13 family, GlgE subfamily",glycogen biosynthetic process [GO:0005978]; growth [GO:0040007],"hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; transferase activity, transferring hexosyl groups [GO:0016758]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY130.12c,1
P9WP13,FQR61_MYCTU,Rv1261c,Rv1261c MTCY50.21,GO:0005618; GO:0005886; GO:0016491; GO:0055114; GO:0070967,IPR004378; IPR012349; ,,,,F420H(2)-dependent quinone reductase Rv1261c (Fqr) (EC 1.1.98.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230; 16000731; 21969609; 23240649,,"FUNCTION: Involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents. Catalyzes the F420H(2)-dependent two-electron reduction of quinones to dihydroquinones, thereby preventing the formation of cytotoxic semiquinones obtained by the one-electron reduction pathway. In vitro, catalyzes the reduction of menadione to menadiol; since menaquinone is the sole quinone electron carrier in the respiratory chain in M.tuberculosis, the physiological electron acceptor for Fqr-mediated F420H(2) oxidation is therefore likely to be the endogenous menaquinone found in the membrane fraction of M.tuberculosis. {ECO:0000269|PubMed:23240649}.",MDISRWLERHVGVQLLRLHDAIYRGTNGRIGHRIPGAPPSLLLHTTGAKTSQPRTTSLTYARDGDAYLIVASKGGDPRSPGWYHNLKANPDVEINVGPKRFGVTAKPVQPHDPDYARLWQIVNENNANRYTNYQSRTSRPIPVVVLTRR,"16,756",149,F420H(2)-dependent quinone reductase family,oxidation-reduction process [GO:0055114],coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY50.21,1
P9WN91,FRDA_MYCTU,Rv1552,frdA Rv1552 MTCY48.13c,GO:0000104; GO:0005886; GO:0006113; GO:0009055; GO:0009061; GO:0045284; GO:0050660; GO:0102040,IPR003953; IPR036188; IPR003952; IPR037099; IPR015939; IPR005884; IPR027477; IPR014006; ,,frdA,,Fumarate reductase flavoprotein subunit (EC 1.3.5.4),plasma membrane [GO:0005886]; plasma membrane fumarate reductase complex [GO:0045284]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fumarate reductase (menaquinone) [GO:0102040]; succinate dehydrogenase activity [GO:0000104]; anaerobic respiration [GO:0009061]; fermentation [GO:0006113],9634230; 21969609,,,MTAQHNIVVIGGGGAGLRAAIAIAETNPHLDVAIVSKVYPMRSHTVSAEGGAAAVTGDDDSLDEHAHDTVSGGDWLCDQDAVEAFVAEAPKELVQLEHWGCPWSRKPDGRVAVRPFGGMKKLRTWFAADKTGFHLLHTLFQRLLTYSDVMRYDEWFATTLLVDDGRVCGLVAIELATGRIETILADAVILCTGGCGRVFPFTTNANIKTGDGMALAFRAGAPLKDMEFVQYHPTGLPFTGILITEAARAEGGWLLNKDGYRYLQDYDLGKPTPEPRLRSMELGPRDRLSQAFVHEHNKGRTVDTPYGPVVYLDLRHLGADLIDAKLPFVRELCRDYQHIDPVVELVPVRPVVHYMMGGVHTDINGATTLPGLYAAGETACVSINGANRLGSNSLPELLVFGARAGRAAADYAARHQKSDRGPSSAVRAQARTEALRLERELSRHGQGGERIADIRADMQATLESAAGIYRDGPTLTKAVEEIRVLQERFATAGIDDHSRTFNTELTALLELSGMLDVALAIVESGLRREESRGAHQRTDFPNRDDEHFLAHTLVHRESDGTLRVGYLPVTITRWPPGERVYGR,"63,763",583,"FAD-dependent oxidoreductase 2 family, FRD/SDH subfamily",anaerobic respiration [GO:0009061]; fermentation [GO:0006113],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; fumarate reductase (menaquinone) [GO:0102040]; succinate dehydrogenase activity [GO:0000104],plasma membrane [GO:0005886]; plasma membrane fumarate reductase complex [GO:0045284],,MTCY48.13c,1
P9WN89,FRDB_MYCTU,Rv1553,frdB Rv1553 MTCY48.12c,GO:0006099; GO:0008177; GO:0009055; GO:0046872; GO:0051537; GO:0051538; GO:0051539,IPR036010; IPR017896; IPR017900; IPR012675; IPR009051; IPR004489; IPR025192; ,,frdB,DOMAIN 14 94 2Fe-2S ferredoxin-type.; DOMAIN 140 169 4Fe-4S ferredoxin-type. {ECO:0000255|PROSITE-ProRule:PRU00711}.,Fumarate reductase iron-sulfur subunit (EC 1.3.5.1),"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; tricarboxylic acid cycle [GO:0006099]",9634230; 21969609,,,MMDRIVMEVSRYRPEIESAPTFQAYEVPLTREWAVLDGLTYIKDHLDGTLSFRWSCRMGICGSSGMTINGDPKLACATFLADYLPGPVRVEPMRNFPVIRDLVVDISDFMAKLPSVKPWLVRHDEPPVEDGEYRQTPAELDAFKQFSMCINCMLCYSACPVYALDPDFLGPAAIALGQRYNLDSRDQGAADRRDVLAAADGAWACTLVGECSTACPKGVDPAGAIQRYKLTAATHALKKLLFPWGGG,"27,234",247,Succinate dehydrogenase/fumarate reductase iron-sulfur protein family,tricarboxylic acid cycle [GO:0006099],"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]",,,MTCY48.12c,1
P9WNB7,FRDC_MYCTU,Rv1554,frdC Rv1554 MTCY48.11c,GO:0005886; GO:0016021,IPR003510; IPR034804; ,,frdC,,Fumarate reductase subunit C,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,FUNCTION: Seems to be involved in the anchoring of the catalytic components of the fumarate reductase complex to the cytoplasmic membrane. {ECO:0000255|HAMAP-Rule:MF_00708}.,MSAYRQPVERYWWARRRSYLRFMLREISCIFVAWFVLYLMLVLRAVGAGGNSYQRFLDFSANPVVVVLNVVALSFLLLHAVTWFGSAPRAMVIQVRGRRVPARAVLAGHYAAWLVVSVIVAWMVLS,"14,449",126,FrdC family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.11c,1
P9WN73,G6PD2_MYCTU,Rv1447c,zwf2 zwf Rv1447c MTCY493.07,GO:0004345; GO:0005886; GO:0006006; GO:0006098; GO:0050661,IPR001282; IPR019796; IPR022675; IPR022674; IPR036291; ,,zwf2,,Glucose-6-phosphate 1-dehydrogenase 2 (G6PD 2) (EC 1.1.1.49),plasma membrane [GO:0005886]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098],9634230; 21969609,,FUNCTION: Catalyzes the oxidation of glucose 6-phosphate to 6-phosphogluconolactone. {ECO:0000255|HAMAP-Rule:MF_00966}.,MKPAHAAASWRNPLRDKRDKRLPRIAGPCGMVIFGVTGDLARKKVMPAVYDLANRGLLPPTFSLVGFARRDWSTQDFGQVVYNAVQEHCRTPFRQQNWDRLAEGFRFVPGTFDDDDAFAQLAETLEKLDAERGTGGNHAFYLAIPPKSFPVVCEQLHKSGLARPQGDRWSRVVIEKPFGHDLASARELNKAVNAVFPEEAVFRIDHYLGKETVQNILALRFANQLFDPIWNAHYVDHVQITMAEDIGLGGRAGYYDGIGAARDVIQNHLMQLLALTAMEEPVSFHPAALQAEKIKVLSATRLAEPLDQTTSRGQYAAGWQGGEKVVGLLDEEGFAEDSTTETFAAITLEVDTRRWAGVPFYLRTGKRLGRRVTEIALVFRRAPHLPFDATMTDELGTNAMVIRVQPDEGVTLRFGSKVPGTAMEVRDVNMDFSYGSAFAEDSPEAYERLILDVLLGEPSLFPVNAEVELAWEILDPALEHWAAHGTPDAYEAGTWGPESSLEMLRRTGREWRRP,"57,343",514,Glucose-6-phosphate dehydrogenase family,glucose metabolic process [GO:0006006]; pentose-phosphate shunt [GO:0006098],glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661],plasma membrane [GO:0005886],zwf,MTCY493.07,1
P9WND3,FMT_MYCTU,Rv1406,fmt Rv1406 MTCY21B4.23,GO:0004479; GO:0040007,IPR005794; IPR005793; IPR037022; IPR002376; IPR036477; IPR011034; ,,fmt,,Methionyl-tRNA formyltransferase (EC 2.1.2.9),methionyl-tRNA formyltransferase activity [GO:0004479]; growth [GO:0040007],9634230; 21969609,,FUNCTION: Attaches a formyl group to the free amino group of methionyl-tRNA(fMet). The formyl group appears to play a dual role in the initiator identity of N-formylmethionyl-tRNA by promoting its recognition by IF2 and preventing the misappropriation of this tRNA by the elongation apparatus. {ECO:0000255|HAMAP-Rule:MF_00182}.,MRLVFAGTPEPALASLRRLIESPSHDVIAVLTRPDAASGRRGKPQPSPVAREAAERGIPVLRPSRPNSAEFVAELSDLAPECCAVVAYGALLGGPLLAVPPHGWVNLHFSLLPAWRGAAPVQAAIAAGDTITGATTFQIEPSLDSGPIYGVVTEVIQPTDTAGDLLKRLAVSGAALLSTTLDGIADQRLTPRPQPADGVSVAPKITVANARVRWDLPAAVVERRIRAVTPNPGAWTLIGDLRVKLGPVHLDAAHRPSKPLPPGGIHVERTSVWIGTGSEPVRLGQIQPPGKKLMNAADWARGARLDLAARAT,"32,692",312,Fmt family,growth [GO:0040007],methionyl-tRNA formyltransferase activity [GO:0004479],,,MTCY21B4.23,1
P9WP11,FQR58_MYCTU,Rv1558,Rv1558 MTCY48.07c,GO:0005618; GO:0005886; GO:0016491; GO:0055114; GO:0070967,IPR004378; IPR012349; ,,,,F420H(2)-dependent quinone reductase Rv1558 (Fqr) (EC 1.1.98.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230; 17259624; 19099550; 21969609; 23240649,,"FUNCTION: Involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents. Catalyzes the F420H(2)-dependent two-electron reduction of quinones to dihydroquinones, thereby preventing the formation of cytotoxic semiquinones obtained by the one-electron reduction pathway. In vitro, catalyzes the reduction of menadione to menadiol; since menaquinone is the sole quinone electron carrier in the respiratory chain in M.tuberculosis, the physiological electron acceptor for Fqr-mediated F420H(2) oxidation is therefore likely to be the endogenous menaquinone found in the membrane fraction of M.tuberculosis. {ECO:0000269|PubMed:23240649}.",MPLSGEYAPSPLDWSREQADTYMKSGGTEGTQLQGKPVILLTTVGAKTGKLRKTPLMRVEHDGQYAIVASLGGAPKNPVWYHNVVKNPRVELQDGTVTGDYDAREVFGDEKAIWWQRAVAVWPDYASYQTKTDRQIPVFVLTPVRAGG,"16,348",148,F420H(2)-dependent quinone reductase family,oxidation-reduction process [GO:0055114],coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY48.07c,1
P9WIK1,CYSD_MYCTU,Rv1285,cysD Rv1285 MTCY373.04,GO:0004781; GO:0005524; GO:0005829; GO:0009336; GO:0010134; GO:0010438; GO:0034599; GO:0040007; GO:0070814,IPR002500; IPR014729; IPR011784; ,,cysD,,Sulfate adenylyltransferase subunit 2 (EC 2.7.7.4) (ATP-sulfurylase small subunit) (Sulfate adenylate transferase) (SAT),cytosol [GO:0005829]; sulfate adenylyltransferase complex (ATP) [GO:0009336]; ATP binding [GO:0005524]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; cellular response to oxidative stress [GO:0034599]; cellular response to sulfur starvation [GO:0010438]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation via adenylyl sulfate reduction [GO:0010134],9634230; 15184554; 19099550; 21969609,,,MTSDVTVGPAPGQYQLSHLRLLEAEAIHVIREVAAEFERPVLLFSGGKDSIVMLHLALKAFRPGRLPFPVMHVDTGHNFDEVIATRDELVAAAGVRLVVASVQDDIDAGRVVETIPSRNPIQTVTLLRAIRENQFDAAFGGARRDEEKARAKERVFSFRDEFGQWDPKAQRPELWNLYNGRHHKGEHIRVFPLSNWTEFDIWSYIGAEQVRLPSIYFAHRRKVFQRDGMLLAVHRHMQPRADEPVFEATVRFRTVGDVTCTGCVESSASTVAEVIAETAVARLTERGATRADDRISEAGMEDRKRQGYF,"34,889",309,"PAPS reductase family, CysD subfamily",cellular response to oxidative stress [GO:0034599]; cellular response to sulfur starvation [GO:0010438]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation via adenylyl sulfate reduction [GO:0010134],ATP binding [GO:0005524]; sulfate adenylyltransferase (ATP) activity [GO:0004781],cytosol [GO:0005829]; sulfate adenylyltransferase complex (ATP) [GO:0009336],,MTCY373.04,1
P9WMR5,DING_MYCTU,Rv1329c,dinG Rv1329c MTCY130.14c,GO:0003677; GO:0005524; GO:0005886; GO:0006281; GO:0006310; GO:0008026,IPR006555; IPR014013; IPR014001; IPR027417; ,,dinG,DOMAIN 14 290 Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.,Probable ATP-dependent helicase DinG homolog (EC 3.6.4.12),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],9634230; 21969609,,FUNCTION: Probable helicase involved in DNA repair and perhaps also replication. {ECO:0000250}.,MSESVSMSVPELLAIAVAALGGTRRRGQQEMAAAVAHAFETGEHLVVQAGTGTGKSLAYLVPAIIRALCDDAPVVVSTATIALQRQLVDRDLPQLVDSLTNALPRRPKFALLKGRRNYLCLNKIHNSVTASDHDDERPQEELFDPVAVTALGRDVQRLTAWASTTVSGDRDDLKPGVGDRSWSQVSVSARECLGVARCPFGSECFSERARGAAGLADVVVTNHALLAIDAVAESAVLPEHRLLVVDEAHELADRVTSVAAAELTSATLGMAARRITRLVDPKVTQRLQAASATFSSAIHDARPGRIDCLDDEMATYLSALRDAASAARSAIDTGSDTTTASVRAEAGAVLTEISDTASRILASFAPAIPDRSDVVWLEHEDNHESARAVLRVAPLSVAELLATQVFARATTVLTSATLTIGGSFDAMATAWGLTADTPWRGLDVGSPFQHAKSGILYVAAHLPPPGRDGSGSAEQLTEIAELITAAGGRTLGLFSSMRAARAATEAMRERLSTPVLCQGDDSTSTLVEKFTADAATSLFGTLSLWQGVDVPGPSLSLVLIDRIPFPRPDDPLLSARQRAVAARGGNGFMTVAASHAALLLAQGSGRLLRRVTDRGVVAVLDSRMATARYGEFLRASLPPFWQTTNATQVRAALRRLARADAKAH,"70,168",664,"Helicase family, DinG subfamily",DNA recombination [GO:0006310]; DNA repair [GO:0006281],ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; DNA binding [GO:0003677],plasma membrane [GO:0005886],,MTCY130.14c,1
P9WP53,CYSM_MYCTU,Rv1336,cysM Rv1336 MTCY130.21,GO:0004124; GO:0005737; GO:0005829; GO:0006535; GO:0030170; GO:0032991; GO:0033847,IPR005856; IPR001216; IPR001926; IPR036052; ,,cysM,,O-phosphoserine sulfhydrylase (OPS sulfhydrylase) (EC 2.5.1.113) (CysO-thiocarboxylate-dependent cysteine synthase) (Cysteine synthase B) (CSase B) (O-phosphoserine-specific cysteine synthase) ([CysO sulfur-carrier protein]-thiocarboxylate-dependent cysteine synthase),cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; cysteine synthase activity [GO:0004124]; O-phosphoserine sulfhydrylase activity [GO:0033847]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535],9634230; 12123450; 15928073; 18842002; 21969609; 18771296; 18799456; 19101553,X-ray crystallography (11),"FUNCTION: Catalyzes the formation of a covalent CysO-cysteine adduct via a sulfur transfer, using the thiocarboxylated sulfur carrier protein CysO-COSH as sulfur donor and O-phospho-L-serine (OPS) as sulfur acceptor. Can also use sodium sulfide as sulfur donor in vitro, albeit with less efficiency, but not thiosulfate or thio-nitro-benzoate. O-acetylserine (OAS) is a very poor substrate in comparison with OPS. May be of particular importance for cysteine biosynthesis in the persistent phase of M.tuberculosis. {ECO:0000269|PubMed:18799456, ECO:0000269|PubMed:18842002}.",MTRYDSLLQALGNTPLVGLQRLSPRWDDGRDGPHVRLWAKLEDRNPTGSIKDRPAVRMIEQAEADGLLRPGATILEPTSGNTGISLAMAARLKGYRLICVMPENTSVERRQLLELYGAQIIFSAAEGGSNTAVATAKELAATNPSWVMLYQYGNPANTDSHYCGTGPELLADLPEITHFVAGLGTTGTLMGTGRFLREHVANVKIVAAEPRYGEGVYALRNMDEGFVPELYDPEILTARYSVGAVDAVRRTRELVHTEGIFAGISTGAVLHAALGVGAGALAAGERADIALVVADAGWKYLSTGAYAGSLDDAETALEGQLWA,"34,438",323,Cysteine synthase/cystathionine beta-synthase family,cysteine biosynthetic process from serine [GO:0006535],cysteine synthase activity [GO:0004124]; O-phosphoserine sulfhydrylase activity [GO:0033847]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991],,MTCY130.21,1
P9WP33,CYSO_MYCTU,Rv1335,cysO cfp10A Rv1335 MTCY130.20,GO:0005829; GO:0019344; GO:0032991,IPR012675; IPR016155; IPR003749; ,,cysO,,Sulfur carrier protein CysO (9.5 kDa culture filtrate antigen cfp10A),cytosol [GO:0005829]; protein-containing complex [GO:0032991]; cysteine biosynthetic process [GO:0019344],9634230; 11681203; 12123450; 16104727; 18842002; 18799456; 21969609; 18771296,X-ray crystallography (2),"FUNCTION: In its thiocarboxylated form (CysO-COSH), is the sulfur donor in the CysM-dependent cysteine biosynthetic pathway. May be of particular importance for cysteine biosynthesis in the persistent phase of M.tuberculosis. {ECO:0000269|PubMed:16104727, ECO:0000269|PubMed:18799456, ECO:0000269|PubMed:18842002}.",MNVTVSIPTILRPHTGGQKSVSASGDTLGAVISDLEANYSGISERLMDPSSPGKLHRFVNIYVNDEDVRFSGGLATAIADGDSVTILPAVAGG,"9,557",93,Sulfur carrier protein CysO family,cysteine biosynthetic process [GO:0019344],,cytosol [GO:0005829]; protein-containing complex [GO:0032991],cfp10A,MTCY130.20,1
P9WHS9,DAPE_MYCTU,Rv1202,dapE Rv1202,GO:0008237; GO:0009014; GO:0009089; GO:0019877; GO:0040007; GO:0046872,IPR001261; IPR036264; IPR002933; IPR011650; IPR010174; ,,dapE,,Putative succinyl-diaminopimelate desuccinylase DapE (SDAP desuccinylase) (EC 3.5.1.18),metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; succinyl-diaminopimelate desuccinylase activity [GO:0009014]; diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],9634230; 21969609,,"FUNCTION: Catalyzes the hydrolysis of N-succinyl-L,L-diaminopimelic acid (SDAP), forming succinate and LL-2,6-diaminoheptanedioate (DAP), an intermediate involved in the bacterial biosynthesis of lysine and meso-diaminopimelic acid. {ECO:0000250}.",MLDLRGDPIELTAALIDIPSESRKEARIADEVEAALRAQASGFEIIRNGNAVLARTKLNRSSRVLLAGHLDTVPVAGNLPSRRENDQLHGCGAADMKSGDAVFLHLAATLAEPTHDLTLVFYDCEEIDSAANGLGRIQRELPDWLSADVAILGEPTAGCIEAGCQGTLRVVLSVTGTRAHSARSWLGDNAIHKLGAVLDRLAVYRARSVDIDGCTYREGLSAVRVAGGVAGNVIPDAASVTINYRFAPDRSVAAALQHVHDVFDGLDVQIEQTDAAAGALPGLSEPAAKALVEAAGGQVRAKYGWTDVSRFAALGIPAVNYGPGDPNLAHCRDERVPVGNITAAVDLLRRYLGG,"37,273",354,Peptidase M20A family,diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; succinyl-diaminopimelate desuccinylase activity [GO:0009014],,,,1
P9WPX1,DHOM_MYCTU,Rv1294,hom thrA Rv1294 MTCY373.14,GO:0004412; GO:0005618; GO:0005886; GO:0009086; GO:0009088; GO:0009097; GO:0040007; GO:0050661,IPR002912; IPR005106; IPR016204; IPR001342; IPR019811; IPR036291; ,,hom,DOMAIN 356 435 ACT. {ECO:0000255|PROSITE-ProRule:PRU01007}.,Homoserine dehydrogenase (HDH) (EC 1.1.1.3),cell wall [GO:0005618]; plasma membrane [GO:0005886]; homoserine dehydrogenase activity [GO:0004412]; NADP binding [GO:0050661]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088],9634230; 19099550; 21969609,,,MPGDEKPVGVAVLGLGNVGSEVVRIIENSAEDLAARVGAPLVLRGIGVRRVTTDRGVPIELLTDDIEELVAREDVDIVVEVMGPVEPSRKAILGALERGKSVVTANKALLATSTGELAQAAESAHVDLYFEAAVAGAIPVIRPLTQSLAGDTVLRVAGIVNGTTNYILSAMDSTGADYASALADASALGYAEADPTADVEGYDAAAKAAILASIAFHTRVTADDVYREGITKVTPADFGSAHALGCTIKLLSICERITTDEGSQRVSARVYPALVPLSHPLAAVNGAFNAVVVEAEAAGRLMFYGQGAGGAPTASAVTGDLVMAARNRVLGSRGPRESKYAQLPVAPMGFIETRYYVSMNVADKPGVLSAVAAEFAKREVSIAEVRQEGVVDEGGRRVGARIVVVTHLATDAALSETVDALDDLDVVQGVSSVIRLEGTGL,"45,553",441,Homoserine dehydrogenase family,growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088],homoserine dehydrogenase activity [GO:0004412]; NADP binding [GO:0050661],cell wall [GO:0005618]; plasma membrane [GO:0005886],thrA,MTCY373.14,1
P9WH05,DEAD_MYCTU,Rv1253,deaD csdA Rv1253 MTCY50.29c,GO:0000027; GO:0003723; GO:0004004; GO:0005524; GO:0005618; GO:0005829; GO:0010501; GO:0070417,IPR034415; IPR005580; IPR011545; IPR028618; IPR014001; IPR001650; IPR012677; IPR027417; IPR000629; IPR014014; ,,deaD,DOMAIN 44 215 Helicase ATP-binding. {ECO:0000255|HAMAP-Rule:MF_00964}.; DOMAIN 226 385 Helicase C-terminal. {ECO:0000255|HAMAP-Rule:MF_00964}.,ATP-dependent RNA helicase DeaD (EC 3.6.4.13) (Cold-shock DEAD box protein A),cell wall [GO:0005618]; cytosol [GO:0005829]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to cold [GO:0070417]; ribosomal large subunit assembly [GO:0000027]; RNA secondary structure unwinding [GO:0010501],9634230; 21969609,,"FUNCTION: DEAD-box RNA helicase involved in various cellular processes at low temperature, including ribosome biogenesis, mRNA degradation and translation initiation. {ECO:0000255|HAMAP-Rule:MF_00964}.",MAFPEYSPAASAATFADLQIHPRVLRAIGDVGYESPTAIQAATIPALMAGSDVVGLAQTGTGKTAAFAIPMLSKIDITSKVPQALVLVPTRELALQVAEAFGRYGAYLSQLNVLPIYGGSSYAVQLAGLRRGAQVVVGTPGRMIDHLERATLDLSRVDFLVLDEADEMLTMGFADDVERILSETPEYKQVALFSATMPPAIRKLSAKYLHDPFEVTCKAKTAVAENISQSYIQVARKMDALTRVLEVEPFEAMIVFVRTKQATEEIAEKLRARGFSAAAISGDVPQAQRERTITALRDGDIDILVATDVAARGLDVERISHVLNYDIPHDTESYVHRIGRTGRAGRSGAALIFVSPRELHLLKAIEKATRQTLTEAQLPTVEDVNTQRVAKFADSITNALGGPGIELFRRLVEEYEREHDVPMADIAAALAVQCRGGEAFLMAPDPPLSRRNRDQRRDRPQRPKRRPDLTTYRVAVGKRHKIGPGAIVGAIANEGGLHRSDFGQIRIGPDFSLVELPAKLPRATLKKLAQTRISGVLIDLRPYRPPDAARRHNGGKPRRKHVG,"61,453",563,"DEAD box helicase family, DeaD subfamily",cellular response to cold [GO:0070417]; ribosomal large subunit assembly [GO:0000027]; RNA secondary structure unwinding [GO:0010501],ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723],cell wall [GO:0005618]; cytosol [GO:0005829],csdA,MTCY50.29c,1
P9WNE3,HEMH_MYCTU,Rv1485,hemH hemZ Rv1485 MTCY277.06,GO:0004325; GO:0005737; GO:0005886; GO:0006783; GO:0040007; GO:0046872; GO:0051537,IPR001015; IPR019772; IPR033644; IPR033659; ,,hemH,,Ferrochelatase (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; growth [GO:0040007]; heme biosynthetic process [GO:0006783]",9634230; 11948160; 15850757; 19099550; 21969609,,"FUNCTION: Involved in the biosynthesis of heme. Catalyzes the ferrous insertion into protoporphyrin IX to form protoheme. {ECO:0000269|PubMed:11948160, ECO:0000269|PubMed:15850757}.",MQFDAVLLLSFGGPEGPEQVRPFLENVTRGRGVPAERLDAVAEHYLHFGGVSPINGINRTLIAELEAQQELPVYFGNRNWEPYVEDAVTAMRDNGVRRAAVFATSAWSGYSSCTQYVEDIARARRAAGRDAPELVKLRPYFDHPLFVEMFADAITAAAATVRGDARLVFTAHSIPTAADRRCGPNLYSRQVAYATRLVAAAAGYCDFDLAWQSRSGPPQVPWLEPDVTDQLTGLAGAGINAVIVCPIGFVADHIEVVWDLDHELRLQAEAAGIAYARASTPNADPRFARLARGLIDELRYGRIPARVSGPDPVPGCLSSINGQPCRPPHCVASVSPARPSAGSP,"37,144",344,Ferrochelatase family,growth [GO:0040007]; heme biosynthetic process [GO:0006783],"2 iron, 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886],hemZ,MTCY277.06,1
P9WPK5,CARA_MYCTU,Rv1383,carA Rv1383 MTCY02B12.17,GO:0000050; GO:0004088; GO:0005524; GO:0005951; GO:0006207; GO:0006526; GO:0006541; GO:0040007; GO:0044205,IPR006274; IPR002474; IPR036480; IPR029062; IPR035686; IPR017926; ,,carA,DOMAIN 184 376 Glutamine amidotransferase type-1.,Carbamoyl-phosphate synthase small chain (EC 6.3.5.5) (Carbamoyl-phosphate synthetase glutamine chain),carbamoyl-phosphate synthase complex [GO:0005951]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; urea cycle [GO:0000050],9634230; 21969609,,,MSKAVLVLEDGRVFTGRPFGATGQALGEAVFSTGMSGYQETLTDPSYHRQIVVATAPQIGNTGWNGEDSESRGERIWVAGYAVRDPSPRASNWRATGTLEDELIRQRIVGIAGIDTRAVVRHLRSRGSMKAGVFSDGALAEPADLIARVRAQQSMLGADLAGEVSTAEPYVVEPDGPPGVSRFTVAALDLGIKTNTPRNFARRGIRCHVLPASTTFEQIAELNPHGVFLSNGPGDPATADHVVALTREVLGAGIPLFGICFGNQILGRALGLSTYKMVFGHRGINIPVVDHATGRVAVTAQNHGFALQGEAGQSFATPFGPAVVSHTCANDGVVEGVKLVDGRAFSVQYHPEAAAGPHDAEYLFDQFVELMAGEGR,"39,767",376,CarA family,'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; arginine biosynthetic process [GO:0006526]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; urea cycle [GO:0000050],ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088],carbamoyl-phosphate synthase complex [GO:0005951],,MTCY02B12.17,1
P9WPS1,ATPL_MYCTU,Rv1305,atpE Rv1305 MTCY373.25,GO:0005886; GO:0008289; GO:0015986; GO:0015991; GO:0016021; GO:0040007; GO:0045263; GO:0046933,IPR005953; IPR000454; IPR020537; IPR038662; IPR002379; IPR035921; ,,atpE,,ATP synthase subunit c (ATP synthase F(0) sector subunit c) (F-type ATPase subunit c) (F-ATPase subunit c) (Lipid-binding protein),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]; lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007]",9634230; 19099550,,"FUNCTION: F(1)F(0) ATP synthase produces ATP from ADP in the presence of a proton or sodium gradient. F-type ATPases consist of two structural domains, F(1) containing the extramembraneous catalytic core and F(0) containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. {ECO:0000255|HAMAP-Rule:MF_01396}.; FUNCTION: Key component of the F(0) channel; it plays a direct role in translocation across the membrane. A homomeric c-ring of between 10-14 subunits forms the central stalk rotor element with the F(1) delta and epsilon subunits. {ECO:0000255|HAMAP-Rule:MF_01396}.",MDPTIAAGALIGGGLIMAGGAIGAGIGDGVAGNALISGVARQPEAQGRLFTPFFITVGLVEAAYFINLAFMALFVFATPVK,"8,055",81,ATPase C chain family,ATP hydrolysis coupled proton transport [GO:0015991]; ATP synthesis coupled proton transport [GO:0015986]; growth [GO:0040007],"lipid binding [GO:0008289]; proton-transporting ATP synthase activity, rotational mechanism [GO:0046933]","integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex, coupling factor F(o) [GO:0045263]",,MTCY373.25,1
P9WQP5,6PGL_MYCTU,Rv1445c,pgl devB Rv1445c MTCY493.09,GO:0005737; GO:0005886; GO:0005975; GO:0009051; GO:0017057,IPR005900; IPR006148; IPR037171; ,,pgl,,6-phosphogluconolactonase (6PGL) (EC 3.1.1.31),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 6-phosphogluconolactonase activity [GO:0017057]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, oxidative branch [GO:0009051]",9634230; 21969609,X-ray crystallography (1),FUNCTION: Hydrolysis of 6-phosphogluconolactone to 6-phosphogluconate. {ECO:0000250}.,MSSSIEIFPDSDILVAAAGKRLVGAIGAAVAARGQALIVLTGGGNGIALLRYLSAQAQQIEWSKVHLFWGDERYVPEDDDERNLKQARRALLNHVDIPSNQVHPMAASDGDFGGDLDAAALAYEQVLAASAAPGDPAPNFDVHLLGMGPEGHINSLFPHSPAVLESTRMVVAVDDSPKPPPRRITLTLPAIQRSREVWLLVSGPGKADAVAAAIGGADPVSVPAAGAVGRQNTLWLLDRDAAAKLPS,"25,804",247,"Glucosamine/galactosamine-6-phosphate isomerase family, 6-phosphogluconolactonase subfamily","carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, oxidative branch [GO:0009051]",6-phosphogluconolactonase activity [GO:0017057],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],devB,MTCY493.09,1
P9WQC3,ADH_MYCTU,Rv1530,adh Rv1530,GO:0004022; GO:0008270,IPR013149; IPR013154; IPR002328; IPR011032; IPR036291; ,,adh,,Probable alcohol dehydrogenase adh (EC 1.1.1.1),alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],9634230; 19099550; 21969609,,,MSDGAVVRALVLEAPRRLVVRQYRLPRIGDDDALVRVEACGLCGTDHEQYTGELAGGFAFVPGHETVGTIAAIGPRAEQRWGVSAGDRVAVEVFQSCRQCANCRGGEYRRCVRHGLADMYGFIPVDREPGLWGGYAEYQYLAPDSMVLRVAGDLSPEVATLFNPLGAGIRWGVTIPETKPGDVVAVLGPGIRGLCAAAAAKGAGAGFVMVTGLGPRDADRLALAAQFGADLAVDVAIDDPVAALTEQTGGLADVVVDVTAKAPAAFAQAIALARPAGTVVVAGTRGVGSGAPGFSPDVVVFKELRVLGALGVDATAYRAALDLLVSGRYPFASLPRRCVRLEGAEDLLATMAGERDGVPPIHGVLTP,"37,997",367,Zinc-containing alcohol dehydrogenase family,,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],,,,1
P9WQ97,AMIB2_MYCTU,Rv1263,amiB2 Rv1263 MTCY50.19c,GO:0004040,IPR000120; IPR020556; IPR023631; IPR036928; ,,amiB2,,Putative amidase AmiB2 (EC 3.5.1.4),amidase activity [GO:0004040],9634230; 19099550; 21969609,,,MDPTDLAFAGAAAQARMLADGALTAPMLLEVYLQRIERLDSHLRAYRVVQFDRARAEAEAAQQRLDAGERLPLLGVPIAIKDDVDIAGEVTTYGSAGHGPAATSDAEVVRRLRAAGAVIIGKTNVPELMIMPFTESLAFGATRNPWCLNRTPGGSSGGSAAAVAAGLAPVALGSDGGGSIRIPCTWCGLFGLKPQRDRISLEPHDGAWQGLSVNGPIARSVMDAALLLDATTTVPGPEGEFVAAAARQPGRLRIALSTRVPTPLPVRCGKQELAAVHQAGALLRDLGHDVVVRDPDYPASTYANYLPRFFRGISDDADAQAHPDRLEARTRAIARLGSFFSDRRMAALRAAEVVLSSRIQSIFDDVDVVVTPGAATGPSRIGAYQRRGAVSTLLLVVQRVPYFQVWNLTGQPAAVVPWDFDGDGLPMSVQLVGRPYDEATLLALAAQIESARPWAHRRPSVS,"49,081",462,Amidase family,,amidase activity [GO:0004040],,,MTCY50.19c,1
O53166,ACNA_MYCTU,Rv1475c RVBD_1475c,acn Rv1475c RVBD_1475c P425_01532,GO:0003729; GO:0003730; GO:0003994; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006099; GO:0010039; GO:0019679; GO:0030350; GO:0040007; GO:0046872; GO:0047456; GO:0051539,IPR001030; IPR015928; IPR006249; IPR018136; IPR036008; IPR000573; ,,acn,,"Aconitate hydratase A (ACN) (Aconitase) (EC 4.2.1.3) ((2R,3S)-2-methylisocitrate dehydratase) ((2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate dehydratase) (Iron-responsive protein-like) (IRP-like) (Probable 2-methyl-cis-aconitate hydratase) (EC 4.2.1.99) (RNA-binding protein)","cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; 2-methylisocitrate dehydratase activity [GO:0047456]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; growth [GO:0040007]; propionate metabolic process, methylcitrate cycle [GO:0019679]; response to iron ion [GO:0010039]; tricarboxylic acid cycle [GO:0006099]",9634230; 17384188; 21969609,,"FUNCTION: Involved in the catabolism of short chain fatty acids (SCFA) via the tricarboxylic acid (TCA)(acetyl degradation route) and probably via the 2-methylcitrate cycle I (propionate degradation route). Catalyzes the reversible isomerization of citrate to isocitrate via cis-aconitate. The apo form of AcnA functions as a RNA-binding regulatory protein which binds to selected IRE-like sequences present within the UTRs (untranslated regions) of 3' trxC and 5' IdeR mRNA (PubMed:17384188). Could catalyze the hydration of 2-methyl-cis-aconitate to yield (2R,3S)-2-methylisocitrate (By similarity). {ECO:0000250|UniProtKB:Q8ZP52, ECO:0000269|PubMed:17384188}.",MTSKSVNSFGAHDTLKVGEKSYQIYRLDAVPNTAKLPYSLKVLAENLLRNEDGSNITKDHIEAIANWDPKAEPSIEIQYTPARVVMQDFTGVPCIVDLATMREAIADLGGNPDKVNPLAPADLVIDHSVIADLFGRADAFERNVEIEYQRNGERYQFLRWGQGAFDDFKVVPPGTGIVHQVNIEYLASVVMTRDGVAYPDTCVGTDSHTTMVNGLGVLGWGVGGIEAEAAMLGQPVSMLIPRVVGFRLTGEIQPGVTATDVVLTVTEMLRQHGVVGKFVEFYGEGVAEVPLANRATLGNMSPEFGSTAAIFPIDEETIKYLRFTGRTPEQVALVEAYAKAQGMWHDPKHEPEFSEYLELNLSDVVPSIAGPKRPQDRIALAQAKSTFREQIYHYVGNGSPDSPHDPHSKLDEVVEETFPASDPGQLTFANDDVATDETVHSAAAHADGRVSNPVRVKSDELGEFVLDHGAVVIAAITSCTNTSNPEVMLGAALLARNAVEKGLTSKPWVKTTIAPGSQVVNDYYDRSGLWPYLEKLGFYLVGYGCTTCIGNSGPLPEEISKAVNDNDLSVTAVLSGNRNFEGRINPDVKMNYLASPPLVIAYALAGTMDFDFQTQPLGQDKDGKNVFLRDIWPSQQDVSDTIAAAINQEMFTRNYADVFKGDDRWRNLPTPSGNTFEWDPNSTYVRKPPYFEGMTAKPEPVGNISGARVLALLGDSVTTDHISPAGAIKPGTPAARYLDEHGVDRKDYNSFGSRRGNHEVMIRGTFANIRLRNQLLDDVSGGYTRDFTQPGGPQAFIYDAAQNYAAQHIPLVVFGGKEYGSGSSRDWAAKGTLLLGVRAVIAESFERIHRSNLIGMGVIPLQFPEGKSASSLGLDGTEVFDITGIDVLNDGKTPKTVCVQATKGDGATIEFDAVVRIDTPGEADYYRNGGILQYVLRNILKSG,"102,449",943,Aconitase/IPM isomerase family,"growth [GO:0040007]; propionate metabolic process, methylcitrate cycle [GO:0019679]; response to iron ion [GO:0010039]; tricarboxylic acid cycle [GO:0006099]","2-methylisocitrate dehydratase activity [GO:0047456]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,P425_01532,1
P9WJW3,ALKA_MYCTU,Rv1317c,alkA ada Rv1317c MTCY130.02c,GO:0003700; GO:0005618; GO:0005737; GO:0005886; GO:0006285; GO:0006307; GO:0006351; GO:0008168; GO:0008270; GO:0008725; GO:0032131; GO:0032993; GO:0043565; GO:0043916; GO:0051409; GO:0052821; GO:0052822,IPR035451; IPR004026; IPR010316; IPR037046; IPR011257; IPR003265; IPR009057; IPR018060; IPR018062; IPR023170; ,,alkA,DOMAIN 87 185 HTH araC/xylS-type. {ECO:0000255|PROSITE-ProRule:PRU00593}.,Probable bifunctional transcriptional activator/DNA repair enzyme AlkA (Regulatory protein AlkA) [Includes: Methylphosphotriester-DNA--protein-cysteine S-methyltransferase (EC 2.1.1.n11) (Methylphosphotriester-DNA methyltransferase); DNA-3-methyladenine glycosylase (EC 3.2.2.21) (DNA-3-methyladenine glycosidase)],"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; alkylated DNA binding [GO:0032131]; DNA binding transcription factor activity [GO:0003700]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; methyltransferase activity [GO:0008168]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; base-excision repair, AP site formation [GO:0006285]; DNA dealkylation involved in DNA repair [GO:0006307]; response to nitrosative stress [GO:0051409]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,"FUNCTION: Is involved in the adaptive response to alkylation damage in DNA caused by alkylating agents. Repairs the Sp diastereomer of DNA methylphosphotriester lesions by a direct and irreversible transfer of the methyl group to one of its own cysteine residues. Also catalyzes the hydrolysis of the deoxyribose N-glycosidic bond to excise 3-methyladenine, 3-methylguanine, 7-methylguanine, O2-methylthymine, and O2-methylcytosine from the damaged DNA polymer formed by alkylation lesions (By similarity). {ECO:0000250}.; FUNCTION: The methylation of Alka by methylphosphotriesters in DNA leads to its activation as a transcriptional regulator that activates the transcription of its own gene and other alkylation resistance genes. {ECO:0000250}.",MHDDFERCYRAIQSKDARFDGWFVVAVLTTGVYCRPSCPVRPPFARNVRFLPTAAAAQGEGFRACKRCRPDASPGSPEWNVRSDVVARAMRLIADGTVDRDGVSGLAAQLGYTIRQLERLLQAVVGAGPLALARAQRMQTARVLIETTNLPFGDVAFAAGFSSIRQFNDTVRLACDGTPTALRARAAARFESATASAGTVSLRLPVRAPFAFEGVFGHLAATAVPGCEEVRDGAYRRTLRLPWGNGIVSLTPAPDHVRCLLVLDDFRDLMTATARCRRLLDLDADPEAIVEALGADPDLRAVVGKAPGQRIPRTVDEAEFAVRAVLAQQVSTKAASTHAGRLVAAYGRPVHDRHGALTHTFPSIEQLAEIDPGHLAVPKARQRTINALVASLADKSLVLDAGCDWQRARGQLLALPGVGPWTAEVIAMRGLGDPDAFPASDLGLRLAAKKLGLPAQRRALTVHSARWRPWRSYATQHLWTTLEHPVNQWPPQEKIA,"53,743",496,Alkylbase DNA glycosidase AlkA family,"base-excision repair, AP site formation [GO:0006285]; DNA dealkylation involved in DNA repair [GO:0006307]; response to nitrosative stress [GO:0051409]; transcription, DNA-templated [GO:0006351]",alkylated DNA binding [GO:0032131]; DNA-3-methyladenine glycosylase activity [GO:0008725]; DNA-3-methylguanine glycosylase activity [GO:0052822]; DNA-7-methyladenine glycosylase activity [GO:0052821]; DNA-7-methylguanine glycosylase activity [GO:0043916]; DNA binding transcription factor activity [GO:0003700]; methyltransferase activity [GO:0008168]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993],ada,MTCY130.02c,1
O50440,CHP2_MYCTU,Rv1184c RVBD_1184c,chp2 Rv1184c RVBD_1184c LH57_06500 P425_01234,GO:0005618; GO:0005886; GO:0006629; GO:0016021; GO:0016746,IPR013228; ,,chp2,,Diacyltrehalose acyltransferase Chp2 (EC 2.3.1.-),"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; lipid metabolic process [GO:0006629]",9634230; 21969609; 25124040; 25331437,,"FUNCTION: Involved in the final steps of polyacyltrehalose (PAT) biosynthesis. Catalyzes the transfer of three mycolipenoyl groups onto diacyltrehalose (DAT) to form PAT. {ECO:0000269|PubMed:25124040, ECO:0000269|PubMed:25331437}.",MKRVIAGAFAVWLVGWAGGFGTAIAASEPAYPWAPGPPPSPSPVGDASTAKVVYALGGARMPGIPWYEYTNQAGSQYFPNAKHDLIDYPAGAAFSWWPTMLLPPGSHQDNMTVGVAVKDGTNSLDNAIHHGTDPAAAVGLSQGSLVLDQEQARLANDPTAPAPDKLQFTTFGDPTGRHAFGASFLARIFPPGSHIPIPFIEYTMPQQVDSQYDTNHVVTAYDGFSDFPDRPDNLLAVANAAIGAAIAHTPIGFTGPGDVPPQNIRTTVNSRGATTTTYLVPVNHLPLTLPLRYLGMSDAEVDQIDSVLQPQIDAAYARNDNWFTRPVSVDPVRGLDPLTAPGSIVEGARGLLGSPAFGG,"37,818",359,Mycobacterial PPE family,lipid metabolic process [GO:0006629],"transferase activity, transferring acyl groups [GO:0016746]",cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_06500 P425_01234,3
P9WNM5,CYSNC_MYCTU,Rv1286,cysNC cysN Rv1286 MTCY373.05,GO:0003924; GO:0004020; GO:0004781; GO:0005524; GO:0005525; GO:0005829; GO:0005886; GO:0009336; GO:0010134; GO:0010438; GO:0034599; GO:0040007; GO:0070814,IPR002891; IPR031157; IPR027417; IPR011779; IPR000795; IPR009000; IPR009001; ,,cysNC,DOMAIN 2 217 tr-type G.,Bifunctional enzyme CysN/CysC [Includes: Sulfate adenylyltransferase subunit 1 (EC 2.7.7.4) (ATP-sulfurylase large subunit) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (APS kinase) (ATP adenosine-5'-phosphosulfate 3'-phosphotransferase)],cytosol [GO:0005829]; plasma membrane [GO:0005886]; sulfate adenylyltransferase complex (ATP) [GO:0009336]; adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; cellular response to oxidative stress [GO:0034599]; cellular response to sulfur starvation [GO:0010438]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation via adenylyl sulfate reduction [GO:0010134],9634230; 15184554; 21969609,X-ray crystallography (3),"FUNCTION: ATP sulfurylase may be the GTPase, regulating ATP sulfurylase activity. {ECO:0000250}.; FUNCTION: APS kinase catalyzes the synthesis of activated sulfate. {ECO:0000250}.",MTTLLRLATAGSVDDGKSTLIGRLLYDSKAVMEDQWASVEQTSKDRGHDYTDLALVTDGLRAEREQGITIDVAYRYFATPKRKFIIADTPGHIQYTRNMVTGASTAQLVIVLVDARHGLLEQSRRHAFLASLLGIRHLVLAVNKMDLLGWDQEKFDAIRDEFHAFAARLDVQDVTSIPISALHGDNVVTKSDQTPWYEGPSLLSHLEDVYIAGDRNMVDVRFPVQYVIRPHTLEHQDHRSYAGTVASGVMRSGDEVVVLPIGKTTRITAIDGPNGPVAEAFPPMAVSVRLADDIDISRGDMIARTHNQPRITQEFDATVCWMADNAVLEPGRDYVVKHTTRTVRARIAGLDYRLDVNTLHRDKTATALKLNELGRVSLRTQVPLLLDEYTRNASTGSFILIDPDTNGTVAAGMVLRDVSARTPSPNTVRHRSLVTAQDRPPRGKTVWFTGLSGSGKSSVAMLVERKLLEKGISAYVLDGDNLRHGLNADLGFSMADRAENLRRLSHVATLLADCGHLVLVPAISPLAEHRALARKVHADAGIDFFEVFCDTPLQDCERRDPKGLYAKARAGEITHFTGIDSPYQRPKNPDLRLTPDRSIDEQAQEVIDLLESSS,"67,839",614,"APS kinase family; TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, CysN/NodQ subfamily",cellular response to oxidative stress [GO:0034599]; cellular response to sulfur starvation [GO:0010438]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation via adenylyl sulfate reduction [GO:0010134],adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525]; sulfate adenylyltransferase (ATP) activity [GO:0004781],cytosol [GO:0005829]; plasma membrane [GO:0005886]; sulfate adenylyltransferase complex (ATP) [GO:0009336],cysN,MTCY373.05,1
P9WPT3,CTPD_MYCTU,Rv1469,ctpD Rv1469 MTV007.16,GO:0005524; GO:0005886; GO:0016021; GO:0019829; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR027256; IPR001757; ,,ctpD,,Probable cobalt/nickel-exporting P-type ATPase (EC 3.6.3.-) (Cation-transporting P-type ATPase CtpD),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],9634230,,FUNCTION: Involved in heavy metal homeostasis. Probably exports nickel and cobalt ions out of the cell (By similarity). {ECO:0000250}.,MTLTACEVTAAEAPFDRVSKTIPHPLSWGAALWSVVSVRWATVALLLFLAGLVAQLNGAPEAMWWTLYLACYLAGGWGSAWAGAQALRNKALDVDLLMIAAAVGAVAIGQIFDGALLIVIFATSGALDDIATRHTAESVKGLLDLAPDQAVVVQGDGSERVVAASELVVGDRVVVRPGDRIPADGAVLSGASDVDQRSITGESMPVAKARGDEVFAGTVNGSGVLHLVVTRDPSQTVVARIVELVADASATKAKTQLFIEKIEQRYSLGMVAATLALIVIPLMFGADLRPVLLRAMTFMIVASPCAVVLATMPPLLSAIANAGRHGVLVKSAVVVERLADTSIVALDKTGTLTRGIPRLASVAPLDPNVVDARRLLQLAAAAEQSSEHPLGRAIVAEARRRGIAIPPAKDFRAVPGCGVHALVGNDFVEIASPQSYRGAPLAELAPLLSAGATAAIVLLDGVAIGVLGLTDQLRPDAVESVAAMAALTAAPPVLLTGDNGRAAWRVARNAGITDVRAALLPEQKVEVVRNLQAGGHQVLLVGDGVNDAPAMAAARAAVAMGAGADLTLQTADGVTIRDELHTIPTIIGLARQARRVVTVNLAIAATFIAVLVLWDLFGQLPLPLGVVGHEGSTVLVALNGMRLLTNRSWRAAASAAR,"67,885",657,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",,ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV007.16,1
P9WPN3,CP132_MYCTU,Rv1394c,cyp132 Rv1394c MTCY21B4.11c,GO:0004497; GO:0005506; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002401; IPR036396; ,,cyp132,,Putative cytochrome P450 132 (EC 1.14.-.-),"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MATATTQRPLKGPAKRMSTWTMTREAITIGFDAGDGFLGRLRGSDITRFRCAGRRFVSISHPDYVDHVLHEARLKYVKSDEYGPIRATAGLNLLTDEGDSWARHRGALNSTFARRHLRGLVGLMIDPIADVTAARVPGAQFDMHQSMVETTLRVVANALFSQDFGPLVQSMHDLATRGLRRAEKLERLGLWGLMPRTVYDTLIWCIYSGVHLPPPLREMQEITLTLDRAINSVIDRRLAEPTNSADLLNVLLSADGGIWPRQRVRDEALTFMLAGHETTANAMSWFWYLMALNPQARDHMLTELDDVLGMRRPTADDLGKLAWTTACLQESQRYFSSVWIIAREAVDDDIIDGHRIRRGTTVVIPIHHIHHDPRWWPDPDRFDPGRFLRCPTDRPRCAYLPFGGGRRICIGQSFALMEMVLMAAIMSQHFTFDLAPGYHVELEATLTLRPKHGVHVIGRRR,"52,229",461,Cytochrome P450 family,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCY21B4.11c,1
P9WQ69,CSD_MYCTU,Rv1464,csd Rv1464 MTV007.11,GO:0005886; GO:0006534; GO:0030170; GO:0031071; GO:0040007,IPR000192; IPR020578; IPR010970; IPR015424; IPR015422; IPR015421; ,,csd,,Probable cysteine desulfurase (EC 2.8.1.7),plasma membrane [GO:0005886]; cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170]; cysteine metabolic process [GO:0006534]; growth [GO:0040007],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the removal of elemental sulfur and selenium atoms from L-cysteine, L-cystine, L-selenocysteine, and L-selenocystine to produce L-alanine. {ECO:0000250}.",MTASVNSLDLAAIRADFPILKRIMRGGNPLAYLDSGATSQRPLQVLDAEREFLTASNGAVHRGAHQLMEEATDAYEQGRADIALFVGADTDELVFTKNATEALNLVSYVLGDSRFERAVGPGDVIVTTELEHHANLIPWQELARRTGATLRWYGVTDDGRIDLDSLYLDDRVKVVAFTHHSNVTGVLTPVSELVSRAHQSGALTVLDACQSVPHQPVDLHELGVDFAAFSGHKMLGPNGIGVLYGRRELLAQMPPFLTGGSMIETVTMEGATYAPAPQRFEAGTPMTSQVVGLAAAARYLGAIGMAAVEAHERELVAAAIEGLSGIDGVRILGPTSMRDRGSPVAFVVEGVHAHDVGQVLDDGGVAVRVGHHCALPLHRRFGLAATARASFAVYNTADEVDRLVAGVRRSRHFFGRA,"44,596",417,"Class-V pyridoxal-phosphate-dependent aminotransferase family, Csd subfamily",cysteine metabolic process [GO:0006534]; growth [GO:0040007],cysteine desulfurase activity [GO:0031071]; pyridoxal phosphate binding [GO:0030170],plasma membrane [GO:0005886],,MTV007.11,1
P9WPN5,CP130_MYCTU,Rv1256c,cyp130 Rv1256c MTCY50.26,GO:0004497; GO:0005506; GO:0005618; GO:0016705; GO:0020037,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp130,,Cytochrome P450 130 (EC 1.14.-.-),"cell wall [GO:0005618]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609; 18089574; 19605350,X-ray crystallography (5),,MTSVMSHEFQLATAETWPNPWPMYRALRDHDPVHHVVPPQRPEYDYYVLSRHADVWSAARDHQTFSSAQGLTVNYGELEMIGLHDTPPMVMQDPPVHTEFRKLVSRGFTPRQVETVEPTVRKFVVERLEKLRANGGGDIVTELFKPLPSMVVAHYLGVPEEDWTQFDGWTQAIVAANAVDGATTGALDAVGSMMAYFTGLIERRRTEPADDAISHLVAAGVGADGDTAGTLSILAFTFTMVTGGNDTVTGMLGGSMPLLHRRPDQRRLLLDDPEGIPDAVEELLRLTSPVQGLARTTTRDVTIGDTTIPAGRRVLLLYGSANRDERQYGPDAAELDVTRCPRNILTFSHGAHHCLGAAAARMQCRVALTELLARCPDFEVAESRIVWSGGSYVRRPLSVPFRVTS,"44,581",405,Cytochrome P450 family,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618],,MTCY50.26,1
P9WMZ1,GLGM_MYCTU,Rv1212c,glgM glgA Rv1212c,GO:0005978; GO:0009250; GO:0016757; GO:0045227,IPR001296; IPR028098; IPR011875; ,,glgM,,Alpha-maltose-1-phosphate synthase (M1P synthase) (EC 2.4.1.342) (ADP-alpha-D-glucose:alpha-D-glucose-1-phosphate 4-alpha-D-glucosyltransferase) (M1P-producing glucosyltransferase),"transferase activity, transferring glycosyl groups [GO:0016757]; capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978]",9634230; 18808383; 21969609; 27513637,,"FUNCTION: Involved in the biosynthesis of the maltose-1-phosphate (M1P) building block required for alpha-glucan production by the key enzyme GlgE (PubMed:18808383, PubMed:27513637). Catalyzes the formation of an alpha-1,4 linkage between glucose from ADP-glucose and glucose 1-phosphate (G1P) to yield maltose-1-phosphate (M1P) (PubMed:27513637). Also able to catalyze the elongation of the non-reducing ends of glycogen, maltodextrin and maltoheptaose using ADP-glucose as sugar donor, however the rate of the reaction appears to be too low to be physiologically relevant (PubMed:27513637). GlgM is also able to use UDP-glucose as sugar donor with G1P, however, it is less efficient than with ADP-glucose (PubMed:27513637). UDP-glucose is not used as sugar donor when glycogen is used as acceptor (PubMed:27513637). {ECO:0000269|PubMed:18808383, ECO:0000269|PubMed:27513637}.",MRVAMLTREYPPEVYGGAGVHVTELVAYLRRLCAVDVHCMGAPRPGAFAYRPDPRLGSANAALSTLSADLVMANAASAATVVHSHTWYTALAGHLAAILYDIPHVLTAHSLEPLRPWKKEQLGGGYQVSTWVEQTAVLAANAVIAVSSAMRNDMLRVYPSLDPNLVHVIRNGIDTETWYPAGPARTGSVLAELGVDPNRPMAVFVGRITRQKGVVHLVTAAHRFRSDVQLVLCAGAADTPEVADEVRVAVAELARNRTGVFWIQDRLTIGQLREILSAATVFVCPSVYEPLGIVNLEAMACATAVVASDVGGIPEVVADGITGSLVHYDADDATGYQARLAEAVNALVADPATAERYGHAGRQRCIQEFSWAYIAEQTLDIYRKVCA,"41,533",387,Glycosyltransferase group 1 family,capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978],"transferase activity, transferring glycosyl groups [GO:0016757]",,glgA,,1
P9WGB9,GLST_MYCTU,Rv1373,Rv1373,GO:0008146; GO:0046506,IPR027417; IPR000863; ,,,,Glycolipid sulfotransferase Rv1373 (EC 2.8.2.-),sulfotransferase activity [GO:0008146]; sulfolipid biosynthetic process [GO:0046506],11882713; 9634230; 21969609,,FUNCTION: Involved in the synthesis of cell wall sulfolipids with activity towards mycobacterial trehalose glycolipids and eukaryotic glycolipids such as glucosylceramide and galactosylceramide (type I and II) but not towards eukaryotic 3'-sulfate galactosylceramide. {ECO:0000269|PubMed:11882713}.,MNSEHPMTDRVVYRSLMADNLRWDALQLRDGDIIISAPSKSGLTWTQRLVSLLVFDGPDLPGPLSTVSPWLDQTIRPIEEVVATLDAQQHRRFIKTHTPLDGLVLDDRVSYICVGRDPRDAAVSMLYQSANMNEDRMRILHEAVVPFHERIAPPFAELGHARSPTEEFRDWMEGPNQPPPGIGFTHLKGIGTLANILHQLGTVWVRRHLPNVALFHYADYQADLAGELLRPARVLGIAATRDRARDLAQYATLDAMRSRASEIAPNTTDGIWHSDERFFRRGGSGDWQQFFTEAEHLRYYHRINQLAPPDLLAWAHEGRRGYDPAN,"37,006",326,Sulfotransferase 1 family,sulfolipid biosynthetic process [GO:0046506],sulfotransferase activity [GO:0008146],,,,1
P9WN45,GLGB_MYCTU,Rv1326c,glgB Rv1326c MTCY130.11c,GO:0003844; GO:0004553; GO:0005886; GO:0005978; GO:0009250; GO:0040007; GO:0043169; GO:0045227; GO:0102752,IPR006048; IPR037439; IPR006407; IPR006047; IPR004193; IPR013780; IPR017853; IPR013783; IPR014756; ,,glgB,,"1,4-alpha-glucan branching enzyme GlgB (EC 2.4.1.18) (1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-glucosyl-transferase) (Alpha-(1->4)-glucan branching enzyme) (Glycogen-branching enzyme) (BE)","plasma membrane [GO:0005886]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]",9634230; 17005418; 18808383; 19121228; 21969609; 20444687,X-ray crystallography (1),"FUNCTION: Essential enzyme that catalyzes the formation of the alpha-1,6-glucosidic linkages in glucan chains by scission of a 1,4-alpha-linked oligosaccharide from growing alpha-1,4-glucan chains and the subsequent attachment of the oligosaccharide to the alpha-1,6 position. Is involved in the biosynthesis of both glycogen and capsular alpha-D-glucan. {ECO:0000269|PubMed:17005418, ECO:0000269|PubMed:18808383}.",MSRSEKLTGEHLAPEPAEMARLVAGTHHNPHGILGAHEYDDHTVIRAFRPHAVEVVALVGKDRFSLQHLDSGLFAVALPFVDLIDYRLQVTYEGCEPHTVADAYRFLPTLGEVDLHLFAEGRHERLWEVLGAHPRSFTTADGVVSGVSFAVWAPNAKGVSLIGEFNGWNGHEAPMRVLGPSGVWELFWPDFPCDGLYKFRVHGADGVVTDRADPFAFGTEVPPQTASRVTSSDYTWGDDDWMAGRALRNPVNEAMSTYEVHLGSWRPGLSYRQLARELTDYIVDQGFTHVELLPVAEHPFAGSWGYQVTSYYAPTSRFGTPDDFRALVDALHQAGIGVIVDWVPAHFPKDAWALGRFDGTPLYEHSDPKRGEQLDWGTYVFDFGRPEVRNFLVANALYWLQEFHIDGLRVDAVASMLYLDYSRPEGGWTPNVHGGRENLEAVQFLQEMNATAHKVAPGIVTIAEESTPWSGVTRPTNIGGLGFSMKWNMGWMHDTLDYVSRDPVYRSYHHHEMTFSMLYAFSENYVLPLSHDEVVHGKGTLWGRMPGNNHVKAAGLRSLLAYQWAHPGKQLLFMGQEFGQRAEWSEQRGLDWFQLDENGFSNGIQRLVRDINDIYRCHPALWSLDTTPEGYSWIDANDSANNVLSFMRYGSDGSVLACVFNFAGAEHRDYRLGLPRAGRWREVLNTDATIYHGSGIGNLGGVDATDDPWHGRPASAVLVLPPTSALWLTPA,"81,729",731,"Glycosyl hydrolase 13 family, GlgB subfamily",capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007],"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",plasma membrane [GO:0005886],,MTCY130.11c,1
P9WMW9,GPGS_MYCTU,Rv1208,gpgS Rv1208,GO:0000287; GO:0006011; GO:0016758; GO:0040007; GO:0042803,IPR001173; IPR029044; ,,gpgS,,Glucosyl-3-phosphoglycerate synthase (GpgS) (EC 2.4.1.266) (Retaining glucosyltransferase),"magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; transferase activity, transferring hexosyl groups [GO:0016758]; growth [GO:0040007]; UDP-glucose metabolic process [GO:0006011]",9634230; 19099550; 19015727; 22637481; 26136334; 28625787,X-ray crystallography (14),FUNCTION: Involved in the biosynthesis of 6-O-methylglucose lipopolysaccarides (MGLPs). Catalyzes the transfer of a glucose (Glc) moiety from uridine diphosphate (UDP-Glc) to the position 2 of 3-phospho-D-glycerate (3-PGA) to form glucosyl-3-phosphoglycerate (GPG). {ECO:0000269|PubMed:22637481}.,MTASELVAGDLAGGRAPGALPLDTTWHRPGWTIGELEAAKAGRTISVVLPALNEEATIESVIDSISPLVDGLVDELIVLDSGSTDDTEIRAIASGARVVSREQALPEVPVRPGKGEALWRSLAATSGDIVVFIDSDLINPHPLFVPWLVGPLLTGEGIQLVKSFYRRPLQVSDVTSGVCATGGGRVTELVARPLLAALRPELGCVLQPLSGEYAASRELLTSLPFAPGYGVEIGLLIDTFDRLGLDAIAQVNLGVRAHRNRPLDELGAMSRQVIATLLSRCGIPDSGVGLTQFLPGGPDDSDYTRHTWPVSLVDRPPMKVMRPR,"34,379",324,Glycosyltransferase 2 family,growth [GO:0040007]; UDP-glucose metabolic process [GO:0006011],"magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; transferase activity, transferring hexosyl groups [GO:0016758]",,,,1
P9WMU5,GNGF_MYCTU,Rv1422,Rv1422 MTCY21B4.40,GO:0005737,IPR002882; IPR010119; IPR038136; ,,,,Putative gluconeogenesis factor,cytoplasm [GO:0005737],9634230; 15985609; 21969609,,FUNCTION: Required for morphogenesis under gluconeogenic growth conditions. {ECO:0000255|HAMAP-Rule:MF_00973}.,MTDGIVALGGGHGLYATLSAARRLTPYVTAVVTVADDGGSSGRLRSELDVVPPGDLRMALAALASDSPHGRLWATILQHRFGGSGALAGHPIGNLMLAGLSEVLADPVAALDELGRILGVKGRVLPMCPVALQIEADVSGLEADPRMFRLIRGQVAIATTPGKVRRVRLLPTDPPATRQAVDAIMAADLVVLGPGSWFTSVIPHVLVPGLAAALRATSARRALVLNLVAEPGETAGFSVERHLHVLAQHAPGFTVHDIIIDAERVPSEREREQLRRTATMLQAEVHFADVARPGTPLHDPGKLAAVLDGVCARDVGASEPPVAATQEIPIDGGRPRGDDAWR,"35,823",342,Gluconeogenesis factor family,,,cytoplasm [GO:0005737],,MTCY21B4.40,1
P9WN43,GLGC_MYCTU,Rv1213,glgC Rv1213 MTCI364.25,GO:0005524; GO:0005829; GO:0005978; GO:0008878; GO:0009250; GO:0045227,IPR011831; IPR005836; IPR023049; IPR005835; IPR029044; IPR011004; ,,glgC,,Glucose-1-phosphate adenylyltransferase (EC 2.7.7.27) (ADP-glucose pyrophosphorylase) (ADPGlc PPase) (ADP-glucose synthase),cytosol [GO:0005829]; ATP binding [GO:0005524]; glucose-1-phosphate adenylyltransferase activity [GO:0008878]; capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978],9634230; 18808383; 21969609; 27513637,,"FUNCTION: Involved in the biosynthesis of ADP-glucose building block required in the biosynthesis of maltose-1-phosphate (M1P) and in the elongation reactions to produce linear alpha-1,4-glucans. Catalyzes the reaction between ATP and alpha-D-glucose 1-phosphate (G1P) to produce pyrophosphate and ADP-Glc. {ECO:0000269|PubMed:18808383, ECO:0000269|PubMed:27513637}.",MREVPHVLGIVLAGGEGKRLYPLTADRAKPAVPFGGAYRLIDFVLSNLVNARYLRICVLTQYKSHSLDRHISQNWRLSGLAGEYITPVPAQQRLGPRWYTGSADAIYQSLNLIYDEDPDYIVVFGADHVYRMDPEQMVRFHIDSGAGATVAGIRVPRENATAFGCIDADDSGRIRSFVEKPLEPPGTPDDPDTTFVSMGNYIFTTKVLIDAIRADADDDHSDHDMGGDIVPRLVADGMAAVYDFSDNEVPGATDRDRAYWRDVGTLDAFYDAHMDLVSVHPVFNLYNKRWPIRGESENLAPAKFVNGGSAQESVVGAGSIISAASVRNSVLSSNVVVDDGAIVEGSVIMPGTRVGRGAVVRHAILDKNVVVGPGEMVGVDLEKDRERFAISAGGVVAVGKGVWI,"43,800",404,Bacterial/plant glucose-1-phosphate adenylyltransferase family,capsule polysaccharide biosynthetic process [GO:0045227]; glucan biosynthetic process [GO:0009250]; glycogen biosynthetic process [GO:0005978],ATP binding [GO:0005524]; glucose-1-phosphate adenylyltransferase activity [GO:0008878],cytosol [GO:0005829],,MTCI364.25,1
P9WMX5,GLYTR_MYCTU,Rv1500,pimF Rv1500,GO:0005886; GO:0016021; GO:0016757,IPR001173; IPR029044; ,,pimF,,Putative glycosyltransferases (EC 2.4.-.-),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 14960574; 19099550; 18585090; 21969609,,FUNCTION: May play only a redundant role in maintaining cell wall viability and bacterial virulence. {ECO:0000269|PubMed:18585090}.,MRLSIVTTMYMSEPYVLEFYRRARAAADKITPDVEIIFVDDGSPDAALQQAVSLLDSDPCVRVIQLSRNFGHHKAMMTGLAHATGDLVFLIDSDLEEDPALLEPFYEKLISTGADVVFGCHARRPGGWLRNFGPKIHYRASALLCDPPLHENTLTVRLMTADYVRSLVQHQERELSIAGLWQITGFYQVPMSVNKAWKGTTTYTFRRKVATLVDNVTSFSNKPLVFIFYLGAAIFIISSSAAGYLIIDRIFFRALQAGWASVIVSIWMLGGVTIFCIGLVGIYVSKVFIETKQRPYTIIRRIYGSDLTTREPSSLKTAFPAAHLSNGKRVTSEPEGLATGNR,"38,095",342,Glycosyltransferase 2 family,,"transferase activity, transferring glycosyl groups [GO:0016757]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNB5,FRDD_MYCTU,Rv1555,frdD Rv1555 MTCY48.10c,GO:0005886; GO:0006106; GO:0016021,IPR003418; IPR034804; ,,frdD,,Fumarate reductase subunit D,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; fumarate metabolic process [GO:0006106],9634230,,FUNCTION: Seems to be involved in the anchoring of the catalytic components of the fumarate reductase complex to the cytoplasmic membrane. {ECO:0000255|HAMAP-Rule:MF_00709}.,MTPSTSDARSRRRSAEPFLWLLFSAGGMVTALVAPVLLLLFGLAFPLGWLDAPDHGHLLAMVRNPITKLVVLVLVVLALFHAAHRFRFVLDHGLQLGRFDRVIALWCYGMAVLGSATAGWMLLTM,"13,754",125,FrdD family,fumarate metabolic process [GO:0006106],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.10c,1
P9WNN7,ECH12_MYCTU,Rv1472,echA12 fadB2 Rv1472 MTV007.19,GO:0004300; GO:0005886; GO:0006635,IPR029045; IPR018376; IPR001753; IPR014748; ,,echA12,,Probable enoyl-CoA hydratase echA12 (EC 4.2.1.17),plasma membrane [GO:0005886]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,FUNCTION: Could possibly oxidize fatty acids using specific components. {ECO:0000250}.,MPHRCAAQVVAGYRSTVSLVLVEHPRPEIAQITLNRPERMNSMAFDVMVPLKEALAQVSYDNSVRVVVLTGAGRGFSPGADHKSAGVVPHVENLTRPTYALRSMELLDDVILMLRRLHQPVIAAVNGPAIGGGLCLALAADIRVASSSAYFRAAGINNGLTASELGLSYLLPRAIGSSRAFEIMLTGRDVSAEEAERIGLVSRQVPDEQLLDACYAIAARMAGFSRPGIELTKRTLWSGLDAASLEAHMQAEGLGQLFVRLLTANFEEAVAARAEQRAPVFTDDT,"30,575",285,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],plasma membrane [GO:0005886],fadB2,MTV007.19,1
P9WNC9,DHPS2_MYCTU,Rv1207,folP2 Rv1207 MTCI364.19,GO:0005829; GO:0009396,IPR006390; IPR011005; IPR000489; ,,folP2,DOMAIN 42 299 Pterin-binding. {ECO:0000255|PROSITE-ProRule:PRU00334}.,Inactive dihydropteroate synthase 2 (DHPS 2) (Dihydropteroate pyrophosphorylase 2),cytosol [GO:0005829]; folic acid-containing compound biosynthetic process [GO:0009396],9634230; 21969609; 18680522,X-ray crystallography (1),"FUNCTION: Has very low affinity for the DHPS substrate 6-hydroxymethyl-7,8-dihydropterin-pyrophosphate, but can bind the inhibitor dapsone. Seems to lack dihydropteroate synthase activity, and does probably not function in folate metabolism. {ECO:0000269|PubMed:18680522}.",MRSTPPASAGRSTPPALAGHSTPPALAGHSTLCGRPVAGDRALIMAIVNRTPDSFYDKGATFSDAAARDAVHRAVADGADVIDVGGVKAGPGERVDVDTEITRLVPFIEWLRGAYPDQLISVDTWRAQVAKAACAAGADLINDTWGGVDPAMPEVAAEFGAGLVCAHTGGALPRTRPFRVSYGTTTRGVVDAVISQVTAAAERAVAAGVAREKVLIDPAHDFGKNTFHGLLLLRHVADLVMTGWPVLMALSNKDVVGETLGVDLTERLEGTLAATALAAAAGARMFRVHEVAATRRVLEMVASIQGVRPPTRTVRGLA,"33,046",318,DHPS family,folic acid-containing compound biosynthetic process [GO:0009396],,cytosol [GO:0005829],,MTCI364.19,1
P9WNT7,DPO3A_MYCTU,Rv1547,dnaE1 dnaE Rv1547 MTCY48.18c,GO:0003887; GO:0005618; GO:0005737; GO:0005886; GO:0006260; GO:0008408; GO:0040007,IPR011708; IPR029460; IPR004013; IPR003141; IPR016195; IPR004805; ,,dnaE1,,DNA polymerase III subunit alpha (EC 2.7.7.7),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (1),"FUNCTION: DNA polymerase III is a complex, multichain enzyme responsible for most of the replicative synthesis in bacteria. This DNA polymerase also exhibits 3' to 5' exonuclease activity. The alpha chain is the DNA polymerase (By similarity). {ECO:0000250}.",MSGSSAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGVEAYIAPGSRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQLSKWSRMDAELIAEHAEGIIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIERRVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQIWDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGLRRRFPAGPPDGYRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGLLFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFAIADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACAVIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLESVPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNRQAIKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKKREVLEKEFEGFSDGMQANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDKAAVYLADCRKLGITVLPPDVNESGLNFASVGQDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDYLNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFGSNDDGTGTADPVFTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVRVGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIANDLTVPDFSNAEVERPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTPSPALMGDLKELLGPGCLGS,"129,323",1184,"DNA polymerase type-C family, DnaE subfamily",DNA replication [GO:0006260]; growth [GO:0040007],3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],dnaE,MTCY48.18c,1
P9WP21,DAPD_MYCTU,Rv1201c,dapD Rv1201c,GO:0000287; GO:0005618; GO:0005737; GO:0005886; GO:0008666; GO:0009089; GO:0019877; GO:0031402; GO:0040007; GO:0050662,IPR019875; IPR001451; IPR032784; IPR038361; IPR011004; IPR026586; ,,dapD,,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase (EC 2.3.1.117) (Tetrahydrodipicolinate N-succinyltransferase) (THDP succinyltransferase) (THP succinyltransferase) (Tetrahydropicolinate succinylase)","cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity [GO:0008666]; coenzyme binding [GO:0050662]; magnesium ion binding [GO:0000287]; sodium ion binding [GO:0031402]; diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089]",9634230; 18765924; 19099550; 21969609; 19394346,X-ray crystallography (2),FUNCTION: Catalyzes the conversion of the cyclic tetrahydrodipicolinate (THDP) into the acyclic N-succinyl-L-2-amino-6-oxopimelate using succinyl-CoA. {ECO:0000269|PubMed:19394346}.,MSTVTGAAGIGLATLAADGSVLDTWFPAPELTESGTSATSRLAVSDVPVELAALIGRDDDRRTETIAVRTVIGSLDDVAADPYDAYLRLHLLSHRLVAPHGLNAGGLFGVLTNVVWTNHGPCAIDGFEAVRARLRRRGPVTVYGVDKFPRMVDYVVPTGVRIADADRVRLGAHLAPGTTVMHEGFVNYNAGTLGASMVEGRISAGVVVGDGSDVGGGASIMGTLSGGGTHVISIGKRCLLGANSGLGISLGDDCVVEAGLYVTAGTRVTMPDSNSVKARELSGSSNLLFRRNSVSGAVEVLARDGQGIALNEDLHAN,"32,642",317,Type 2 tetrahydrodipicolinate N-succinyltransferase family,diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase activity [GO:0008666]; coenzyme binding [GO:0050662]; magnesium ion binding [GO:0000287]; sodium ion binding [GO:0031402]",cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WIU7,DCDA_MYCTU,Rv1293,lysA Rv1293 MTCY373.13,GO:0005618; GO:0008836; GO:0009089; GO:0030170; GO:0040007,IPR009006; IPR002986; IPR022643; IPR022657; IPR022644; IPR022653; IPR000183; IPR029066; ,,lysA,,Diaminopimelate decarboxylase (DAP decarboxylase) (DAPDC) (EC 4.1.1.20),cell wall [GO:0005618]; diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],8440471; 9634230; 19099550; 16511157; 21969609; 12637582; 19543810,X-ray crystallography (3),"FUNCTION: Specifically catalyzes the decarboxylation of meso-diaminopimelate (meso-DAP) to L-lysine (Probable). Is essential for the viability of M.tuberculosis in the host (PubMed:12637582). {ECO:0000255|HAMAP-Rule:MF_02120, ECO:0000269|PubMed:12637582, ECO:0000305}.",MNELLHLAPNVWPRNTTRDEVGVVCIAGIPLTQLAQEYGTPLFVIDEDDFRSRCRETAAAFGSGANVHYAAKAFLCSEVARWISEEGLCLDVCTGGELAVALHASFPPERITLHGNNKSVSELTAAVKAGVGHIVVDSMTEIERLDAIAGEAGIVQDVLVRLTVGVEAHTHEFISTAHEDQKFGLSVASGAAMAAVRRVFATDHLRLVGLHSHIGSQIFDVDGFELAAHRVIGLLRDVVGEFGPEKTAQIATVDLGGGLGISYLPSDDPPPIAELAAKLGTIVSDESTAVGLPTPKLVVEPGRAIAGPGTITLYEVGTVKDVDVSATAHRRYVSVDGGMSDNIRTALYGAQYDVRLVSRVSDAPPVPARLVGKHCESGDIIVRDTWVPDDIRPGDLVAVAATGAYCYSLSSRYNMVGRPAVVAVHAGNARLVLRRETVDDLLSLEVR,"47,458",447,"Orn/Lys/Arg decarboxylase class-II family, LysA subfamily",growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],diaminopimelate decarboxylase activity [GO:0008836]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618],,MTCY373.13,1
P9WNT3,DPO41_MYCTU,Rv1537,dinB1 dinX Rv1537 MTCY48.28c,GO:0003684; GO:0003887; GO:0005829; GO:0005886; GO:0006260; GO:0006281; GO:0046872,IPR036775; IPR017961; IPR022880; IPR024728; IPR001126; ,,dinB1,DOMAIN 6 188 UmuC.,DNA polymerase IV 1 (Pol IV 1) (EC 2.7.7.7),cytosol [GO:0005829]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260],9634230; 21969609,,"FUNCTION: Poorly processive, error-prone DNA polymerase involved in untargeted mutagenesis. Copies undamaged DNA at stalled replication forks, which arise in vivo from mismatched or misaligned primer ends. These misaligned primers can be extended by PolIV. Exhibits no 3'-5' exonuclease (proofreading) activity. May be involved in translesional synthesis, in conjunction with the beta clamp from PolIII (By similarity). {ECO:0000250}.",MESRWVLHLDMDAFFASVEQLTRPTLRGRPVLVGGLGGRGVVAGASYEARAYGARSAMPMHQARRLIGVTAVVLPPRGVVYGIASRRVFDTVRGLVPVVEQLSFDEAFAEPPQLAGAVAEDVETFCERLRRRVRDETGLIASVGAGSGKQIAKIASGLAKPDGIRVVRHAEEQALLSGLPVRRLWGIGPVAEEKLHRLGIETIGQLAALSDAEAANILGATIGPALHRLARGIDDRPVVERAEAKQISAESTFAVDLTTMEQLHEAIDSIAEHAHQRLLRDGRGARTITVKLKKSDMSTLTRSATMPYPTTDAGALFTVARRLLPDPLQIGPIRLLGVGFSGLSDIRQESLFADSDLTQETAAAHYVETPGAVVPAAHDATMWRVGDDVAHPELGHGWVQGAGHGVVTVRFETRGSGPGSARTFPVDTGDISNASPLDSLDWPDYIGQLSVEGSAGASAPTVDDVGDR,"49,765",468,DNA polymerase type-Y family,DNA repair [GO:0006281]; DNA replication [GO:0006260],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],cytosol [GO:0005829]; plasma membrane [GO:0005886],dinX,MTCY48.28c,1
P9WNJ5,ESXL_MYCTU,Rv1198,esxL Rv1198 MTCI364.10,GO:0005576; GO:0005618; GO:0005886; GO:0009405,IPR009416; IPR036689; IPR010310; ,,esxL,,ESAT-6-like protein EsxL,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 17443846; 19876390; 22291682; 21969609; 25242740,,FUNCTION: Induces apoptosis of host cells. {ECO:0000269|PubMed:25242740}.,MTINYQFGDVDAHGAMIRAQAGLLEAEHQAIIRDVLTASDFWGGAGSAACQGFITQLGRNFQVIYEQANAHGQKVQAAGNNMAQTDSAVGSSWA,"9,928",94,"WXG100 family, ESAT-6 subfamily",pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCI364.10,1
P9WGJ9,EMBR_MYCTU,Rv1267c,embR Rv1267c MTCY50.15,GO:0000160; GO:0003677; GO:0003924; GO:0005618; GO:0005622; GO:0005886; GO:0006351; GO:0006355; GO:0016887,IPR005158; IPR000253; IPR001867; IPR016032; IPR008984; IPR011990; IPR036388; ,,embR,DOMAIN 308 357 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.,Transcriptional regulatory protein EmbR,"cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; GTPase activity [GO:0003924]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 14690440; 16817899; 16585755; 17286964; 21969609; 16477027,X-ray crystallography (2),"FUNCTION: Positively regulates the transcription of the embCAB operon. Exhibits ATPase and GTPase activities. {ECO:0000269|PubMed:16585755, ECO:0000269|PubMed:16817899}.",MAGSATVEKRLDFGLLGPLQMTIDGTPVPSGTPKQRAVLAMLVINRNRPVGVDALITALWEEWPPSGARASIHSYVSNLRKLLGGAGIDPRVVLAAAPPGYRLSIPDNTCDLGRFVAEKTAGVHAAAAGRFEQASRHLSAALREWRGPVLDDLRDFQFVEPFATALVEDKVLAHTAKAEAEIACGRASAVIAELEALTFEHPYREPLWTQLITAYYLSDRQSDALGAYRRVKTTLADDLGIDPGPTLRALNERILRQQPLDAKKSAKTTAAGTVTVLDQRTMASGQQAVAYLHDIASGRGYPLQAAATRIGRLHDNDIVLDSANVSRHHAVIVDTGTNYVINDLRSSNGVHVQHERIRSAVTLNDGDHIRICDHEFTFQISAGTHGGT,"41,933",388,AfsR/DnrI/RedD regulatory family,"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",ATPase activity [GO:0016887]; DNA binding [GO:0003677]; GTPase activity [GO:0003924],cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY50.15,1
P9WNJ7,ESXK_MYCTU,Rv1197,esxK Rv1197 MTCI364.09,GO:0005576,IPR036689; IPR010310; ,,esxK,,ESAT-6-like protein EsxK,extracellular region [GO:0005576],9634230; 12919853; 19876390; 22291682,,,MASRFMTDPHAMRDMAGRFEVHAQTVEDEARRMWASAQNISGAGWSGMAEATSLDTMAQMNQAFRNIVNMLHGVRDGLVRDANNYEQQEQASQQILSS,"10,963",98,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,MTCI364.09,1
P9WQ45,FAD25_MYCTU,Rv1521,fadD25 Rv1521 MTCY19G5.07,GO:0005886; GO:0006633; GO:0016021; GO:0016874; GO:0070566,IPR000873; ,,fadD25,,Putative fatty-acid--CoA ligase fadD25 (EC 6.2.1.-) (Acyl-CoA synthetase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MSVVESSLPGVLRERASFQPNDKALTFIDYERSWDGVEETLTWSQLYRRTLNLAAQLREHGSTGDRALILAPQSLDYVVSFIASLQAGIVAVPLSIPQGGAHDERTVSVFADTAPAIVLTASSVVDNVVEYVQPQPGQNAPAVIEVDRLDLDARPSSGSRSAAHGHPDILYLQYTSGSTRTPAGVMVSNKNLFANFEQIMTSYYGVYGKVAPPGSTVVSWLPFYHDMGFVLGLILPILAGIPAVLTSPIGFLQRPARWIQMLASNTLAFTAAPNFAFDLASRKTKDEDMEGLDLGGVHGILNGSERVQPVTLKRFIDRFAPFNLDPKAIRPSYGMAEATVYVATRKAGQPPKIVQFDPQKLPDGQAERTESDGGTPLVSYGIVDTQLVRIVDPDTGIERPAGTIGEIWVHGDNVAIGYWQKPEATERTFSATIVNPSEGTPAGPWLRTGDSGFLSEGELFIMGRIKDLLIVYGRNHSPDDIEATIQTISPGRCAAIAVSEHGAEKLVAIIELKKKDESDDEAAERLGFVKREVTSAISKSHGLSVADLVLVSPGSIPITTSGKIRRAQCVELYRQDEFTRLDA,"63,142",583,ATP-dependent AMP-binding enzyme family,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY19G5.07,1
P9WP77,FBIC_MYCTU,Rv1173,fbiC Rv1173,GO:0005886; GO:0009108; GO:0044689; GO:0046872; GO:0051409; GO:0051539,IPR013785; IPR019939; IPR019940; IPR006638; IPR034405; IPR020050; IPR007197; ,,fbiC,,"FO synthase (EC 2.5.1.77) (7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase)","plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase activity [GO:0044689]; metal ion binding [GO:0046872]; coenzyme biosynthetic process [GO:0009108]; response to nitrosative stress [GO:0051409]",9634230; 21969609,,"FUNCTION: Catalyzes the radical-mediated transfer of the hydroxybenzyl group from 4-hydroxyphenylpyruvate (HPP) to 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione to form 7,8-didemethyl-8-hydroxy-5-deazariboflavin (FO). {ECO:0000250}.",MPQPVGRKSTALPSPVVPPQANASALRRVLRRARDGVTLNVDEAAIAMTARGDELADLCASAARVRDAGLVSAGRHGPSGRLAISYSRKVFIPVTRLCRDNCHYCTFVTVPGKLRAQGSSTYMEPDEILDVARRGAEFGCKEALFTLGDRPEARWRQAREWLGERGYDSTLSYVRAMAIRVLEQTGLLPHLNPGVMSWSEMSRLKPVAPSMGMMLETTSRRLFETKGLAHYGSPDKDPAVRLRVLTDAGRLSIPFTTGLLVGIGETLSERADTLHAIRKSHKEFGHIQEVIVQNFRAKEHTAMAAFPDAGIEDYLATVAVARLVLGPGMRIQAPPNLVSGDECRALVGAGVDDWGGVSPLTPDHVNPERPWPALDELAAVTAEAGYDMVQRLTAQPKYVQAGAAWIDPRVRGHVVALADPATGLARDVNPVGMPWQEPDDVASWGRVDLGAAIDTQGRNTAVRSDLASAFGDWESIREQVHELAVRAPERIDTDVLAALRSAERAPAGCTDGEYLALATADGPALEAVAALADSLRRDVVGDEVTFVVNRNINFTNICYTGCRFCAFAQRKGDADAYSLSVGEVADRAWEAHVAGATEVCMQGGIDPELPVTGYADLVRAVKARVPSMHVHAFSPMEIANGVTKSGLSIREWLIGLREAGLDTIPGTAAEILDDEVRWVLTKGKLPTSLWIEIVTTAHEVGLRSSSTMMYGHVDSPRHWVAHLNVLRDIQDRTGGFTEFVPLPFVHQNSPLYLAGAARPGPSHRDNRAVHALARIMLHGRISHIQTSWVKLGVRRTQVMLEGGANDLGGTLMEETISRMAGSEHGSAKTVAELVAIAEGIGRPARQRTTTYALLAA,"92,506",856,"Radical SAM superfamily, CofG family; Radical SAM superfamily, CofH family",coenzyme biosynthetic process [GO:0009108]; response to nitrosative stress [GO:0051409],"4 iron, 4 sulfur cluster binding [GO:0051539]; 7,8-didemethyl-8-hydroxy-5-deazariboflavin synthase activity [GO:0044689]; metal ion binding [GO:0046872]",plasma membrane [GO:0005886],,,1
P9WG69,FADA4_MYCTU,Rv1323,fadA4 Rv1323 MTCY130.08,GO:0003985; GO:0003988; GO:0005576; GO:0005886; GO:0006635; GO:0052572,IPR002155; IPR016039; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; ,,fadA4,,Probable acetyl-CoA acetyltransferase (EC 2.3.1.9) (Acetoacetyl-CoA thiolase),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635]; response to host immune response [GO:0052572],9634230; 21969609,,,MIVAGARTPIGKLMGSLKDFSASELGAIAIKGALEKANVPASLVEYVIMGQVLTAGAGQMPARQAAVAAGIGWDVPALTINKMCLSGIDAIALADQLIRAREFDVVVAGGQESMTKAPHLLMNSRSGYKYGDVTVLDHMAYDGLHDVFTDQPMGALTEQRNDVDMFTRSEQDEYAAASHQKAAAAWKDGVFADEVIPVNIPQRTGDPLQFTEDEGIRANTTAAALAGLKPAFRGDGTITAGSASQISDGAAAVVVMNQEKAQELGLTWLAEIGAHGVVAGPDSTLQSQPANAINKALDREGISVDQLDVVEINEAFAAVALASIRELGLNPQIVNVNGGAIAVGHPLGMSGTRITLHAALQLARRGSGVGVAALCGAGGQGDALILRAG,"40,081",389,Thiolase family,fatty acid beta-oxidation [GO:0006635]; response to host immune response [GO:0052572],acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY130.08,1
P9WGT3,FABG_MYCTU,Rv1483,fabG1 mabA Rv1483 MTCY277.04,GO:0004316; GO:0005886; GO:0018454; GO:0046459; GO:0055114; GO:0070402; GO:0071768; GO:0102131; GO:0102132,IPR036291; IPR020904; IPR002347; ,,fabG1,,3-oxoacyl-[acyl-carrier-protein] reductase FabG1 (EC 1.1.1.100) (3-ketoacyl-acyl carrier protein reductase) (Beta-ketoacyl-ACP reductase) (Beta-ketoacyl-acyl carrier protein reductase),plasma membrane [GO:0005886]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; acetoacetyl-CoA reductase activity [GO:0018454]; NADPH binding [GO:0070402]; mycolic acid biosynthetic process [GO:0071768]; oxidation-reduction process [GO:0055114]; short-chain fatty acid metabolic process [GO:0046459],9802011; 9634230; 11932442; 19685079; 21969609; 12079383; 17642518,X-ray crystallography (4),"FUNCTION: Catalyzes the NADPH-dependent reduction of beta-ketoacyl-ACP substrates to beta-hydroxyacyl-ACP products, the first reductive step in the elongation cycle of fatty acid biosynthesis. MabA preferentially metabolizes long-chain substrates (C8-C20) and has a poor affinity for the C4 substrate. {ECO:0000269|PubMed:11932442, ECO:0000269|PubMed:19685079, ECO:0000269|PubMed:9802011}.",MTATATEGAKPPFVSRSVLVTGGNRGIGLAIAQRLAADGHKVAVTHRGSGAPKGLFGVECDVTDSDAVDRAFTAVEEHQGPVEVLVSNAGLSADAFLMRMTEEKFEKVINANLTGAFRVAQRASRSMQRNKFGRMIFIGSVSGSWGIGNQANYAASKAGVIGMARSIARELSKANVTANVVAPGYIDTDMTRALDERIQQGALQFIPAKRVGTPAEVAGVVSFLASEDASYISGAVIPVDGGMGMGH,"25,697",247,Short-chain dehydrogenases/reductases (SDR) family,mycolic acid biosynthetic process [GO:0071768]; oxidation-reduction process [GO:0055114]; short-chain fatty acid metabolic process [GO:0046459],3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; acetoacetyl-CoA reductase activity [GO:0018454]; NADPH binding [GO:0070402],plasma membrane [GO:0005886],mabA,MTCY277.04,1
P9WQ49,FAD21_MYCTU,Rv1185c,fadD21 Rv1185c MTV005.21c,GO:0005886; GO:0006633; GO:0016874; GO:0070566,IPR000873; ,,fadD21,,Putative fatty-acid--CoA ligase FadD21 (EC 6.2.1.-) (Acyl-CoA synthetase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 20066036; 21969609; 25124040,,,MSDSSVLSLLRERAGLQPDDAAFTYIDYEQDWAGITETLTWSEVFRRTRIVAHEVRRHCTTGDRAVILAPQGLAYIAAFLGSMQAGAIAVPLSVPQIGSHDERVSAVLADASPSVILTTSAVAEAVAEHIHRPNTNNVGPIIEIDSLDLTGNSPSFRVKDLPSAAYLQYTSGSTRAPAGVMISHRNLQANFQQLMSNYFGDRNGVAPPDTTIVSWLPFYHDMGLVLGIIAPILGGYRSELTSPLAFLQRPARWLHSLANGSPSWSAAPNFAFELAVRKTTDADIEGLDLGNVLGITSGAERVHPNTLSRFCNRFAPYNFREDMIRPSYGLAEATLYVASRNSGDKPEVVYFEPDKLSTGSANRCEPKTGTPLLSYGMPTSPTVRIVDPDTCIECPAGTIGEIWVKGDNVAEGYWNKPDETRHTFGAMLVHPSAGTPDGSWLRTGDLGFLSEDEMFIVGRMKDMLIVYGRNHYPEDIESTVQEITGGRVAAISVPVDHTEKLVTVIELKLLGDSAGEAMDELDVIKNNVTAAISRSHGLNVADLVLVPPGSIPTTTSGKIRRAACVEQYRLQQFTRLDG,"62,757",578,ATP-dependent AMP-binding enzyme family,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,MTV005.21c,1
P9WQ53,FAD11_MYCTU,Rv1550,fadD11 Rv1550 MTCY48.15c,GO:0005618; GO:0005886; GO:0006631; GO:0016021; GO:0016874,IPR020845; IPR000873; ,,fadD11,,Putative fatty-acid--CoA ligase fadD11 (EC 6.2.1.-) (Acyl-CoA synthetase),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],9634230; 19099550,,,MARLRGAGAAGRCRPGRFGSSARRHGLADDGEPDRVLPARRRCSARRRHLVFGVQHPARRAADLRVRQRGDQGGHLRATVRRSRSRQRCAHRTHRLRRWRAPGTLSLTDLYAAASGDFFDFESTWRAVQPEDIVTLIYTSGTTGNPKGVEMTHANLLFEGYAIDEVLGIRFGDRVTSFLPSAHIADRMTGLYLQEMFGTQVTAVADARTIAAALPDVRPTVWGAVPRVWEKLKAGIEFTVARETDEMKRQALAWAMSVAGKRANALLAGESMSDQLVAEWAKADELVLSKLRERLGFGELRWALSGAAPIPKETLAFFAGIGIPIAEIWGMSELSCVATASHPRDGRLGTVGKLLPGLQGKIAEDGEYLVRGPLVMKGYRKEPAKTAEAIDSDGWLHTGDVFDIDSDGYLRVVDRKKELIINAAGKNMSPANIENTILAACPMVGVMMAIGDGRTYNTALLVFDADSLGPYAAQRGLDASPAALAADPEVIARIAAGVAEGNAKLSRVEQIKRFRILPTLWEPGGDEITLTMKLKRRRIAAKYSAEIEELYASELRPQVYEPAAVPSTQPA,"62,309",571,ATP-dependent AMP-binding enzyme family,fatty acid metabolic process [GO:0006631],ligase activity [GO:0016874],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY48.15c,1
P9WJN7,APBC_MYCTU,Rv1229c,mrp Rv1229c MTCI61.12c MTV006.01c,GO:0005524; GO:0016787; GO:0040007; GO:0046872; GO:0051536,IPR034904; IPR002744; IPR019591; IPR000808; IPR027417; IPR033756; ,,mrp,,Iron-sulfur cluster carrier protein,ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Binds and transfers iron-sulfur (Fe-S) clusters to target apoproteins. Can hydrolyze ATP. {ECO:0000255|HAMAP-Rule:MF_02040}.,MSGTRDGDLNAAIRTALGKVIDPELRRPITELGMVKSIDTGPDGSVHVEIYLTIAGCPKKSEITERVTRAVADVPGTSAVRVSLDVMSDEQRTELRKQLRGDTREPVIPFAQPDSLTRVYAVASGKGGVGKSTVTVNLAAAMAVRGLSIGVLDADIHGHSIPRMMGTTDRPTQVESMILPPIAHQVKVISIAQFTQGNTPVVWRGPMLHRALQQFLADVYWGDLDVLLLDLPPGTGDVAISVAQLIPNAELLVVTTPQLAAAEVAERAGSIALQTRQRIVGVVENMSGLTLPDGTTMQVFGEGGGRLVAERLSRAVGADVPLLGQIPLDPALVAAGDSGVPLVLSSPDSAIGKELHSIADGLSTRRRGLAGMSLGLDPTRR,"40,084",381,MIP18 family; Mrp/NBP35 ATP-binding proteins family,growth [GO:0040007],ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872],,,MTCI61.12c MTV006.01c,1
P9WG87,Y1250_MYCTU,Rv1250,Rv1250,GO:0005886; GO:0016021; GO:0022857,IPR004638; IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv1250,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857],9634230,,,MTTAIRRAAGSSYFRNPWPALWAMMVGFFMIMLDSTVVAIANPTIMAQLRIGYATVVWVTSAYLLAYAVPMLVAGRLGDRFGPKNLYLIGLGVFTVASLGCGLSSGAGMLIAARVVQGVGAGLLTPQTLSTITRIFPAHRRGVALGAWGTVASVASLVGPLAGGALVDSMGWEWIFFVNVPVGVIGLILAAYLIPALPHHPHRFDWFGVGLSGAGMFLIVFGLQQGQSANWQPWIWAVIVGGIGFMSLFVYWQARNAREPLIPLEVFNDRNFSLSNLRIAIIAFAGTGMMLPVTFYAQAVCGLSPTHTAVLFAPTAIVGGVLAPFVGMIIDRSHPLCVLGFGFSVLAIAMTWLLCEMAPGTPIWRLVLPFIALGVAGAFVWSPLTVTATRNLRPHLAGASSGVFNAVRQLGAVLGSASMAAFMTSRIAAEMPGGVDALTGPAGQDATVLQLPEFVREPFAAAMSQSMLLPAFVALFGIVAALFLVDFTGAAVAKEPLPESDGDADDDDYVEYILRREPEEDCDTQPLRASRPAAAAASRSGAGGPLAVSWSTSAQGMPPGPPGRRAWQADTESTAPSAL,"60,908",579,"Major facilitator superfamily, EmrB family",,transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJX9,Y1258_MYCTU,Rv1258c,Rv1258c MTCY50.24,GO:0005886; GO:0015562; GO:0016021; GO:0046677,IPR011701; IPR020846; IPR036259; ,,,,Probable multidrug-efflux transporter Rv1258c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; response to antibiotic [GO:0046677],9634230; 12520088; 15057575,,FUNCTION: Could be involved in tetracycline efflux. {ECO:0000269|PubMed:12520088}.,MRNSNRGPAFLILFATLMAAAGDGVSIVAFPWLVLQREGSAGQASIVASATMLPLLFATLVAGTAVDYFGRRRVSMVADALSGAAVAGVPLVAWGYGGDAVNVLVLAVLAALAAAFGPAGMTARDSMLPEAAARAGWSLDRINGAYEAILNLAFIVGPAIGGLMIATVGGITTMWITATAFGLSILAIAALQLEGAGKPHHTSRPQGLVSGIAEGLRFVWNLRVLRTLGMIDLTVTALYLPMESVLFPKYFTDHQQPVQLGWALMAIAGGGLVGALGYAVLAIRVPRRVTMSTAVLTLGLASMVIAFLPPLPVIMVLCAVVGLVYGPIQPIYNYVIQTRAAQHLRGRVVGVMTSLAYAAGPLGLLLAGPLTDAAGLHATFLALALPIVCTGLVAIRLPALRELDLAPQADIDRPVGSAQ,"43,287",419,Major facilitator superfamily,response to antibiotic [GO:0046677],efflux transmembrane transporter activity [GO:0015562],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY50.24,1
P9WM49,Y1265_MYCTU,Rv1265,Rv1265 MTCY50.17c,GO:0005618; GO:0005886,,,,,Uncharacterized protein Rv1265,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MVLARPDAVFAPARNRCHVSLPVNAMSLKMKVCNHVIMRHHHMHGRRYGRPGGWQQAQQPDASGAAEWFAGRLPEDWFDGDPTVIVDREEITVIGKLPGLESPEEESAARASGRVSRFRDETRPERMTIADEAQNRYGRKVSWGVEVGGERILFTHIAVPVMTRLKQPERQVLDTLVDAGVARSRSDALAWSVKLVGEHTEEWLAKLRTAMSAVDDLRAQGPDLPA,"25,230",226,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY50.17c,1
P9WM45,Y1269_MYCTU,Rv1269c,Rv1269c MTCY50.13,GO:0005576; GO:0005618,IPR025240; IPR006311; ,,,,Protein Rv1269c,cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 11681203; 21969609,,,MTTMITLRRRFAVAVAGVATAAATTVTLAPAPANAADVYGAIAYSGNGSWGRSWDYPTRAAAEATAVKSCGYSDCKVLTSFTACGAVAANDRAYQGGVGPTLAAAMKDALTKLGGGYIDTWACN,"12,550",124,,,,cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY50.13,1
P9WQJ1,Y1273_MYCTU,Rv1273c,Rv1273c MTCY50.09,GO:0005524; GO:0005618; GO:0005886; GO:0016021; GO:0042626,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 17 300 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 335 571 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv1273c,"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]",9634230; 21969609,,,MLLALLRQHIRPYRRLVAMLMMLQLVSTLASLYLPTVNAAIVDDGVAKGDTATIVRLGAVMLGVTGLQVLCAIGAVYLGSRTGAGFGRDLRSAMFEHIITFSERETARFGAPTLLTRSTNDVRQILFLVQMTATVLVTAPIMCVGGIIMAIHQEAALTWLLLVSVPILAVANYWIISHMLPLFRRMQSLIDGINRVMRDQLSGVRVVRAFTREGYERDKFAQANTALSNAALSAGNWQALMLPVTTLTINASSVALIWFGGLRIDSGQMQVGSLIAFLSYFAQILMAVLMATMTLAVLPRASVCAERITEVLSTPAALGNPDNPKFPTDGVTGVVRLAGATFTYPGADCPVLQDISLTARPGTTTAIVGSTGSGKSTLVSLICRLYDVTAGAVLVDGIDVREYHTERLWSAIGLVPQRSYLFSGTVADNLRYGGGPDQVVTEQEMWEALRVAAADGFVQTDGLQTRVAQGGVNFSGGQRQRLAIARAVIRRPAIYVFDDAFSALDVHTDAKVHASLRQVSGDATIIVVTQRISNAAQADQVIVVDNGKIVGTGTHETLLADCPTYAEFAASQSLSATVGGVG,"62,116",582,ABC transporter superfamily,,"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]",cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY50.09,1
P9WGF9,Y1276_MYCTU,Rv1276c,Rv1276c MTCY50.06,GO:0016787,IPR013078; IPR029033; ,,,,Uncharacterized protein Rv1276c (EC 3.1.3.-),hydrolase activity [GO:0016787],9634230; 21969609,,,MRHAKSAYPDGIADHDRPLAPRGIREAGLAGGWLRANLPAVDAVLCSTATRARQTLAHTGIDAPARYAERLYGAAPGTVIEEINRVGDNVTTLLVVGHEPTTSALAIVLASISGTDAAVAERISEKFPTSGIAVLRVAGHWADVEPGCAALVGFHVPR,"16,462",158,SixA phosphatase family,,hydrolase activity [GO:0016787],,,MTCY50.06,1
P9WM37,Y1289_MYCTU,Rv1289,Rv1289 MTCY373.08,GO:0005618,,,,,Uncharacterized protein Rv1289,cell wall [GO:0005618],9634230; 21969609,,,MCVSVGESVAQSLQQWDRKLWDVAMLHACNAVDETGRKRYPTLGVGTRFRTALRDSLDIYGVMATPGVDLEKTRFPVGVRSDLLPDKRPDIADVLYGIHRWLHGHADESSVEFEVSPYVNASAALRIANDGKIQLPKSAILGLLAVAVFAPENKGEVIPPDYQLSWYDHVFFISVWWGWQDHFREIVNVDRASLVALDFGDLWNGWTPVG,"23,550",210,,,,cell wall [GO:0005618],,MTCY373.08,1
P9WM19,Y1342_MYCTU,Rv1342c,Rv1342c MTCY02B10.06c,GO:0005887; GO:0040007,IPR023845; ,,,,Uncharacterized protein Rv1342c,integral component of plasma membrane [GO:0005887]; growth [GO:0040007],9634230; 21969609,,,MTAPETPAAQHAEPAIAVERIRTALLGYRIMAWTTGLWLIALCYEIVVRYVVKVDNPPTWIGVVHGWVYFTYLLLTLNLAVKVRWPLGKTAGVLLAGTIPLLGIVVEHFQTKEIKARFGL,"13,382",120,,growth [GO:0040007],,integral component of plasma membrane [GO:0005887],,MTCY02B10.06c,1
P9WM15,Y1352_MYCTU,Rv1352,Rv1352 MTCY02B10.16,GO:0005576,,,,,Uncharacterized protein Rv1352,extracellular region [GO:0005576],9634230; 21969609,,,MARTLALRASAGLVAGMAMAAITLAPGARAETGEQFPGDGVFLVGTDIAPGTYRTEGPSNPLILVFGRVSELSTCSWSTHSAPEVSNENIVDTNTSMGPMSVVIPPTVAAFQTHNCKLWMRIS,"12,850",123,,,,extracellular region [GO:0005576],,MTCY02B10.16,1
P9WLY1,Y1417_MYCTU,Rv1417,Rv1417 MTCY21B4.35,GO:0005886; GO:0009231; GO:0016021,IPR019692; ,,,,Uncharacterized protein Rv1417,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; riboflavin biosynthetic process [GO:0009231],9634230; 21969609,,,MTAAPNDWDVVLRPHWTPLFAYAAAFLIAVAHVAGGLLLKVGSSGVVFQTADQVAMGALGLVLAGAVLLFARPRLRVGSAGLSVRNLLGDRIVGWSEVIGVSFPGGSRWARIDLADDEYIPVMAIQAVDKDRAVAAMDTVRSLLARYRPDLCAR,"16,383",154,,riboflavin biosynthetic process [GO:0009231],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY21B4.35,1
O53150,Y1459_MYCTU,Rv1459c,Rv1459c,GO:0016021; GO:0016757; GO:0040007,,,,,Alpha-(1->6)-mannopyranosyltransferase Rv1459c (EC 2.4.1.-),"integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]; growth [GO:0040007]",9634230; 18452585; 21969609,,FUNCTION: Catalyzes the addition of alpha-(1->6)-mannose residue. {ECO:0000269|PubMed:18452585}.,MAARHHTLSWSIASLHGDEQAVGAPLTTTELTALARTRLFGATGTVLMAIGALGAGARPVVQDPTFGVRLLNLPSRIQTVSLTMTTTGAVMMALAWLMLGRFTLGRRRMSRGKLDRTLLLWMLPLLIAPPMYSKDVYSYLAQSEIGRDGLDPYRVGPASGLGLGHVFTLSVPSLWRETPAPYGPLFLWIGRGISSLTGENIVAAVLCHRLVVLIGVTLIVWATPRLAQRCGVAEVSALWLGAANPLLIMHLVAGIHNEALMLGLMLTGVEFALRGLDMANTPRPSPETWRLGPATIRASRRPELGASPRAGASRAVKPRPEWGPLAMLLAGSILITLSSQVKLPSLLAMGFVTTVLAYRWGGNLRALLLAAAVMASLTLAIMAILGWASGLGFGWINTLGTANVVRSWMSPPTLLALGTGHVGILLGLGDHTTAVLSLTRAIGVLIITVMVCWLLLAVLRGRLHPIGGLGVALAVTVLLFPVVQPWYLLWAIIPLAAWATRPGFRVAAILATLIVGIFGPTANGDRFALFQIVDATAASAIIVILLIALTYTRLPWRPLAAEQVVTAAESASKTPATRRPTAAPDAYADST,"62,693",591,MptA/B family,growth [GO:0040007],"transferase activity, transferring glycosyl groups [GO:0016757]",integral component of membrane [GO:0016021],,,1
P9WFP5,Y1462_MYCTU,Rv1462,Rv1462 MTV007.09,GO:0016226; GO:0040007; GO:0052572,IPR000825; IPR037284; IPR011542; ,,,,UPF0051 protein Rv1462,growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226]; response to host immune response [GO:0052572],9634230; 19099550; 21969609,,,MTAPGLTAAVEGIAHNKGELFASFDVDAFEVPHGRDEIWRFTPLRRLRGLHDGSARATGSATITVSERPGVYTQTVRRGDPRLGEGGVPTDRVAAQAFSSFNSATLVTVERDTQVVEPVGITVTGPGEGAVAYGHLQVRIEELGEAVVVIDHRGGGTYADNVEFVVDDAARLTAVWIADWADNTVHLSAHHARIGKDAVLRHVTVMLGGDVVRMSAGVRFCGAGGDAELLGLYFADDGQHLESRLLVDHAHPDCKSNVLYKGALQGDPASSLPDAHTVWVGDVLIRAQATGTDTFEVNRNLVLTDGARADSVPNLEIETGEIVGAGHASATGRFDDEQLFYLRSRGIPEAQARRLVVRGFFGEIIAKIAVPEVRERLTAAIEHELEITESTEKTTVS,"42,523",397,UPF0051 (ycf24) family,growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226]; response to host immune response [GO:0052572],,,,MTV007.09,1
P9WFJ7,Y1481_MYCTU,Rv1481,Rv1481 MTCY277.02,GO:0005886; GO:0005887,IPR024163; IPR022933; IPR002035; IPR036465; ,,,DOMAIN 98 294 VWFA. {ECO:0000255|HAMAP-Rule:MF_01340}.,UPF0353 protein Rv1481,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MTLPLLGPMTLSGFAHSWFFLFLFVVAGLVALYILMQLARQRRMLRFANMELLESVAPKRPSRWRHVPAILLVLSLLLFTIAMAGPTHDVRIPRNRAVVMLVIDVSQSMRATDVEPSRMVAAQEAAKQFADELTPGINLGLIAYAGTATVLVSPTTNREATKNALDKLQFADRTATGEAIFTALQAIATVGAVIGGGDTPPPARIVLFSDGKETMPTNPDNPKGAYTAARTAKDQGVPISTISFGTPYGFVEINDQRQPVPVDDETMKKVAQLSGGNSYNAATLAELRAVYSSLQQQIGYETIKGDASVGWLRLGALALALAALAALLINRRLPT,"36,030",335,UPF0353 family,,,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY277.02,1
P9WFS3,Y1491_MYCTU,Rv1491c,Rv1491c MTCY277.13c,GO:0005886; GO:0016021,IPR032816; IPR015414; ,,,,TVP38/TMEM64 family membrane protein Rv1491c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MTAPAICNTTETVHGIATSLGAVARQASLPRIVGTVVGITVLVVVALLVPVPTAVELRDWAKSLGAWFPLAFLLVHTVVTVPPFPRTAFTLAAGLLFGSVVGVFIAVVGSTASAVIAMLLVRATGWQLNSLVRRRAINRLDERLRERGWLAILSLRLIPVVPFAAINYAAGASGVRILSFAWATLAGLLPGTAAVVILGDAFAGSGSPLLILVSVCTGALGLTGLVYEIRNYRRQHRRMPGYDDPVREPALI,"26,576",252,TVP38/TMEM64 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY277.13c,1
P9WPZ1,Y1496_MYCTU,Rv1496,Rv1496 MTCY277.18,GO:0003924; GO:0005524; GO:0005525,IPR005129; IPR027417; ,,,,Probable GTPase Rv1496 (EC 3.6.-.-),ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],9634230; 21969609; ,X-ray crystallography (3),FUNCTION: Probable GTPase. May also bind and hydrolyze ATP. May function as chaperone (Probable). {ECO:0000305}.,MMAASHDDDTVDGLATAVRGGDRAALPRAITLVESTRPDHREQAQQLLLRLLPDSGNAHRVGITGVPGVGKSTAIEALGMHLIERGHRVAVLAVDPSSTRTGGSILGDKTRMARLAVHPNAYIRPSPTSGTLGGVTRATRETVVLLEAAGFDVILIETVGVGQSEVAVANMVDTFVLLTLARTGDQLQGIKKGVLELADIVVVNKADGEHHKEARLAARELSAAIRLIYPREALWRPPVLTMSAVEGRGLAELWDTVERHRQVLTGAGEFDARRRDQQVDWTWQLVRDAVLDRVWSNPTVRKVRSELERRVRAGELTPALAAQQILEIANLTDR,"36,256",334,"SIMIBI class G3E GTPase family, ArgK/MeaB subfamily",,ATP binding [GO:0005524]; GTPase activity [GO:0003924]; GTP binding [GO:0005525],,,MTCY277.18,1
P9WLW9,Y1498_MYCTU,Rv1498c,Rv1498c MTCY277.20c,GO:0005737; GO:0008757; GO:0032259,IPR013216; IPR029063; ,,,,Uncharacterized protein Rv1498c,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MRCIIKRLFQNILTRSKRGSADGGSAEALPPKSLRQFVGGAYKEVGAEFVGYLVDLCGLQPDEAVLDVGCGSGRMALPLTGYLNSEGRYAGFDISQKAIAWCQEHITSAHPNFQFEVSDIYNSLYNPKGKYQSLDFRFPYPDASFDVVFLTSVFTHMFPPDVEHYLDEISRVLKPGGRCLCTYFLLNDESLAHIAEGKSAHNFQHEGPGYRTIHKKRPEEAIGLPETFVRDVYGKFGLAVHEPLHYGSWSGREPRLSFQDIVIATKTAS,"30,021",269,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,MTCY277.20c,2
P9WI91,Y1501_MYCTU,Rv1501,Rv1501 MTCY277.23,,IPR008775; ,,,,Uncharacterized protein Rv1501,,9634230; 21969609,,,MIPVKVENNTSLDQVQDALNCVGYAVVEDVLDEASLAATRDRMYRVQERILTEIGKERLARAGELGVLRLMMKYDPHFFTFLEIPEVLSIVDRVLSETAILHLQNGFILPSFPPFSTPDVFQNAFHQDFPRVLSGYIASVNIMFAIDPFTRDTGATLVVPGSHQRIEKPDHTYLARNAVPVQCAAGSLFVFDSTLWHAAGRNTSGKDRLAINHQFTRSFFKQQIDYVRALGDAVVLEQPARTQQLLGWYSRVVTNLDEYYQPPDKRLYRKGQG,"30,906",273,PhyH family,,,,,MTCY277.23,1
P71785,Y1506_MYCTU,Rv1506c,Rv1506c,GO:0008168; GO:0009247; GO:0052170,IPR029063; ,,,,Putative methyltransferase Rv1506c (EC 2.1.1.-),methyltransferase activity [GO:0008168]; glycolipid biosynthetic process [GO:0009247]; negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 20844580,,"FUNCTION: Probably plays a role in host phagosome maturation arrest, as well as a role in the synthesis of acyltrehalose-containing glycolipids (PubMed:20844580). {ECO:0000305|PubMed:20844580}.",MRIVNAADPFSINDLGCGYGALLDYLDARGFKTDYTGIDVSPEMVRAAALRFEGRANADFICAARIDREADYSVASGIFNVRLKSLDTEWCAHIEATLDMLNAASRRGFSFNCLTSYSDASKMRDDLYYADPCALFDLCKRRYSKSVALLHDYGLYEFTILVRKAS,"18,580",166,Methyltransferase superfamily,glycolipid biosynthetic process [GO:0009247]; negative regulation by symbiont of host innate immune response [GO:0052170],methyltransferase activity [GO:0008168],,,,2
P9WMX9,Y1514_MYCTU,Rv1514c,Rv1514c MTCY277.36c,GO:0016757,IPR001173; IPR029044; ,,,,Uncharacterized glycosyltransferase Rv1514c (EC 2.4.-.-),"transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 21969609,,,MTSAPTVSVITISFNDLDGLQRTVKSVRAQRYRGRIEHIVIDGGSGDDVVAYLSGCEPGFAYWQSEPDGGRYDAMNQGIAHASGDLLWFLHSADRFSGPDVVAQAVEALSGKGPVSELWGFGMDRLVGLDRVRGPIPFSLRKFLAGKQVVPHQASFFGSSLVAKIGGYDLDFGIAADQEFILRAALVCEPVTIRCVLCEFDTTGVGSHREPSAVFGDLRRMGDLHRRYPFGGRRISHAYLRGREFYAYNSRFWENVFTRMSK,"28,965",262,Glycosyltransferase 2 family,,"transferase activity, transferring glycosyl groups [GO:0016757]",,,MTCY277.36c,1
P9WLV9,Y1518_MYCTU,Rv1518,Rv1518 MTCY19G5.11c MTCY277.40,GO:0005886; GO:0016021,IPR001173; IPR029044; ,,,,Uncharacterized protein Rv1518,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MVPGDASSVVSVNPAKPLISVCIPMYNNGATIERCLRSILEQEGVEFEIVVVDDDSSDDCAAIAATMLRPGDRLLRNEPRLGLNRNHNKCLEVARGGLIQFVHGDDRLLPGALQTLSRRFEDPSVGMAFAPRRVESDDIKWQQRYGRVHTRFRKLRDRNHGPSLVLQMVLHGAKENWIGEPTAVMFRRQLALDAGGFRTDIYQLVDVDFWLRLMLRSAVCFVPHELSVRRHTAATETTRVMATRRNVLDRQRILTWLIVDPLSPNSVRSAAALWWIPAWLAMIVEVAVLGPQRRTHLKALAPAPFREFAHARRQLPMAD,"36,089",319,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY19G5.11c MTCY277.40,1
P9WLV5,Y1520_MYCTU,Rv1520,Rv1520 MTCY19G5.08c,GO:0005618; GO:0005886; GO:0016757,IPR001173; IPR029044; ,,,,Uncharacterized protein Rv1520,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 21969609,,,MSIVSISYNQEEYIREALDGFAAQRTEFPVEVIIADDASTDATPRIIGEYAARYPQLFRPILRQTNIGVHANFKDVLSAARGEYLALCEGDDYWTDPLKLSKQVKYLDRHPETTVCFHPVRVIYEDGAKDSEFPPLSWRRDLSVDALLARNFIQTNSVVYRRQPSYDDIPANVMPIDWYLHVRHAVGGEIAMLPETMAVYRRHAHGIWHSAYTDRRKFWETRGHGMAATLEAMLDLVHGHREREAIVGEVSAWVLREIGKTPGRQGRALLLKSIADHPRMTMLSLQHRWAQTPWRRFKRRLSTELSSLAALAYATRRRALEGRDGGYRETTSPPTGRGRNVRGSHA,"39,578",346,,,"transferase activity, transferring glycosyl groups [GO:0016757]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY19G5.08c,1
O06179,Y1533_MYCTU,Rv1533,Rv1533,GO:0018580,IPR013785; IPR004136; ,,,,Putative monooxygenase Rv1533 (EC 1.13.12.-),nitronate monooxygenase activity [GO:0018580],9634230; 21969609,,,MRTRVAELLGAEFPICAFSHCRDVVAAVSNAGGFGILGAVAHSPKRLESELTWIEEHTGGKPYGVDVLLPPKYIGAEQGGIDAQQARELIPEGHRTFVDDLLVRYGIPAVTDRQRSSSAGGLHISPKGYQPLLDVAFAHDIRLIASALGPPPPDLVERAHNHDVLVAALAGTAQHARRHAAAGVDLIVAQGTEAGGHTGEVATMVLVPEVVDAVSPTPVLAAGGIARGRQIAAALALGAEGVWCGSVWLTTEEAETPPVVKDKFLAATSSDTVRSRSLTGKPARMLRTAWTDEWDRPDSPDPLGMPLQSALVSDPQLRINQAAGQPGAKARELATYFVGQVVGSLDRVRSARSVVLDMVEEFIDTVGQLQGLVQR,"39,620",375,Nitronate monooxygenase family,,nitronate monooxygenase activity [GO:0018580],,,,1
P9WLU9,Y1545_MYCTU,Rv1545,Rv1545 MTCY48.20,,,,,,Uncharacterized protein Rv1545,,9634230,,,MPNGVLGLGNPSRLAALYGLQLAHESQCCQMHNLPSAARQVTVACREEVGITTILAGRDECGVCDKTAGLDGAAP,"7,722",75,,,,,,MTCY48.20,1
P9WLU5,Y1549_MYCTU,Rv1549,Rv1549 MTCY48.16c,GO:0003824; GO:0008152,IPR000873; ,,,,Uncharacterized protein Rv1549,catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230,,,MVAAPCFRVLRLWTYAHRCDLGHTDPLSRRTEMTTTERPTTMCEAFQRTAVMDPDAVALRTPGGNQTMTWRDYAAQVRRVAAGLAGLGVRRGDTVSLMMANRIEFYPLDVGAQHVGATSFSVYNTLPAEQLTYVFDNAGTKVVICEQQYVDRVRASGVPIEHIVCVDGAPPARSR,"19,335",175,,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,MTCY48.16c,1
P9WML1,YHI2_MYCTU,Rv1262c,Rv1262c MTCY50.20,GO:0003824,IPR019808; IPR001310; IPR011146; IPR036265; ,,,DOMAIN 4 111 HIT. {ECO:0000255|PROSITE-ProRule:PRU00464}.,Uncharacterized HIT-like protein Rv1262c,catalytic activity [GO:0003824],9634230,,,MPCVFCAIIAGEAPAIRIYEDGGYLAILDIRPFTRGHTLVLPKRHTVDLTDTPPEALADMVAIGQRIARAARATKLADATHIAINDGRAAFQTVFHVHLHVLPPRNGDKLSVAKGMMLRRDPDREATGRILREALAQQDAAAQD,"15,681",144,,,catalytic activity [GO:0003824],,,MTCY50.20,1
P9WM53,UDGB_MYCTU,Rv1259,udgB Rv1259 MTCY50.23c,GO:0004844; GO:0006284; GO:0033958; GO:0046872; GO:0051536; GO:0051539,IPR005122; IPR036895; ,,udgB,,Type-5 uracil-DNA glycosylase (EC 3.2.2.-),"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA-deoxyinosine glycosylase activity [GO:0033958]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]",9634230; 17588829; 21969609,,"FUNCTION: DNA glycosylase with broad substrate specificity. Can remove uracil from double-stranded DNA containing either a U/G, U/A, U/C or U/T base pair. Can also excise ethenocytosine and hypoxanthine from double-stranded DNA. {ECO:0000269|PubMed:17588829}.",MHPKTGRAFRSPVEPGSGWPGDPATPQTPVAADAAQVSALAGGAGSICELNALISVCRACPRLVSWREEVAVVKRRAFADQPYWGRPVPGWGSKRPRLLILGLAPAAHGANRTGRMFTGDRSGDQLYAALHRAGLVNSPVSVDAADGLRANRIRITAPVRCAPPGNSPTPAERLTCSPWLNAEWRLVSDHIRAIVALGGFAWQVALRLAGASGTPKPRFGHGVVTELGAGVRLLGCYHPSQQNMFTGRLTPTMLDDIFREAKKLAGIE,"28,500",268,"Uracil-DNA glycosylase (UDG) superfamily, Type 5 (UDGb) family",base-excision repair [GO:0006284],"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA-deoxyinosine glycosylase activity [GO:0033958]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; uracil DNA N-glycosylase activity [GO:0004844]",,,MTCY50.23c,1
P9WFC5,UVRC_MYCTU,Rv1420,uvrC Rv1420 MTCY21B4.38,GO:0003677; GO:0005618; GO:0005737; GO:0005886; GO:0006289; GO:0006974; GO:0009380; GO:0009381; GO:0009432; GO:0040007,IPR000305; IPR035901; IPR003583; IPR010994; IPR001943; IPR036876; IPR004791; IPR001162; IPR038476; ,,uvrC,DOMAIN 16 95 GIY-YIG. {ECO:0000255|HAMAP-Rule:MF_00203}.; DOMAIN 208 243 UVR. {ECO:0000255|HAMAP-Rule:MF_00203}.,UvrABC system protein C (Protein UvrC) (Excinuclease ABC subunit C),cell wall [GO:0005618]; cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381]; cellular response to DNA damage stimulus [GO:0006974]; growth [GO:0040007]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432],9634230; 21969609,,FUNCTION: The UvrABC repair system catalyzes the recognition and processing of DNA lesions. UvrC both incises the 5' and 3' sides of the lesion. The N-terminal half is responsible for the 3' incision and the C-terminal half is responsible for the 5' incision. {ECO:0000255|HAMAP-Rule:MF_00203}.,MPDPATYRPAPGSIPVEPGVYRFRDQHGRVIYVGKAKSLRSRLTSYFADVASLAPRTRQLVTTAAKVEWTVVGTEVEALQLEYTWIKEFDPRFNVRYRDDKSYPVLAVTLGEEFPRLMVYRGPRRKGVRYFGPYSHAWAIRETLDLLTRVFPARTCSAGVFKRHRQIDRPCLLGYIDKCSAPCIGRVDAAQHRQIVADFCDFLSGKTDRFARALEQQMNAAAEQLDFERAARLRDDLSALKRAMEKQAVVLGDGTDADVVAFADDELEAAVQVFHVRGGRVRGQRGWIVEKPGEPGDSGIQLVEQFLTQFYGDQAALDDAADESANPVPREVLVPCLPSNAEELASWLSGLRGSRVVLRVPRRGDKRALAETVHRNAEDALQQHKLKRASDFNARSAALQSIQDSLGLADAPLRIECVDVSHVQGTDVVGSLVVFEDGLPRKSDYRHFGIREAAGQGRSDDVACIAEVTRRRFLRHLRDQSDPDLLSPERKSRRFAYPPNLYVVDGGAPQVNAASAVIDELGVTDVAVIGLAKRLEEVWVPSEPDPIIMPRNSEGLYLLQRVRDEAHRFAITYHRSKRSTRMTASALDSVPGLGEHRRKALVTHFGSIARLKEATVDEITAVPGIGVATATAVHDALRPDSSGAAR,"71,614",646,UvrC family,cellular response to DNA damage stimulus [GO:0006974]; growth [GO:0040007]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432],DNA binding [GO:0003677]; excinuclease ABC activity [GO:0009381],cell wall [GO:0005618]; cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886],,MTCY21B4.38,1
P9WHK3,PYRR_MYCTU,Rv1379,pyrR Rv1379 MTCY02B12.13,GO:0004845; GO:0005618; GO:0006351; GO:0006355; GO:0009116,IPR000836; IPR029057; IPR023050; ,,pyrR,,Bifunctional protein PyrR [Includes: Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase (UPRTase) (EC 2.4.2.9)],"cell wall [GO:0005618]; uracil phosphoribosyltransferase activity [GO:0004845]; nucleoside metabolic process [GO:0009116]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (2),FUNCTION: Regulates the transcription of the pyrimidine nucleotide (pyr) operon in response to exogenous pyrimidines. {ECO:0000255|HAMAP-Rule:MF_01219}.; FUNCTION: Also displays a weak uracil phosphoribosyltransferase activity which is not physiologically significant. {ECO:0000255|HAMAP-Rule:MF_01219}.,MGAAGDAAIGRESRELMSAADVGRTISRIAHQIIEKTALDDPVGPDAPRVVLLGIPTRGVTLANRLAGNITEYSGIHVGHGALDITLYRDDLMIKPPRPLASTSIPAGGIDDALVILVDDVLYSGRSVRSALDALRDVGRPRAVQLAVLVDRGHRELPLRADYVGKNVPTSRSESVHVRLREHDGRDGVVISR,"20,627",193,"Purine/pyrimidine phosphoribosyltransferase family, PyrR subfamily","nucleoside metabolic process [GO:0009116]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",uracil phosphoribosyltransferase activity [GO:0004845],cell wall [GO:0005618],,MTCY02B12.13,1
P9WHL3,PYRC_MYCTU,Rv1381,pyrC Rv1381 MTCY02B12.15,GO:0004038; GO:0004151; GO:0005737; GO:0006145; GO:0040007; GO:0044205; GO:0046872,IPR006680; IPR004722; IPR002195; IPR011059; IPR032466; ,,pyrC,,Dihydroorotase (DHOase) (EC 3.5.2.3),cytoplasm [GO:0005737]; allantoinase activity [GO:0004038]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872]; 'de novo' UMP biosynthetic process [GO:0044205]; growth [GO:0040007]; purine nucleobase catabolic process [GO:0006145],9634230; 21969609,,FUNCTION: Catalyzes the reversible cyclization of carbamoyl aspartate to dihydroorotate. {ECO:0000255|HAMAP-Rule:MF_00220}.,MSVLIRGVRPYGEGERVDVLVDDGQIAQIGPDLAIPDTADVIDATGHVLLPGFVDLHTHLREPGREYAEDIETGSAAAALGGYTAVFAMANTNPVADSPVVTDHVWHRGQQVGLVDVHPVGAVTVGLAGAELTEMGMMNAGAAQVRMFSDDGVCVHDPLIMRRALEYATGLGVLIAQHAEEPRLTVGAVAHEGPMAARLGLAGWPRAAEESIVARDALLARDAGARVHICHASAAGTVEILKWAKDQGISITAEVTPHHLLLDDARLASYDGVNRVNPPLREASDAVALRQALADGIIDCVATDHAPHAEHEKCVEFAAARPGMLGLQTALSVVVQTMVAPGLLSWRDIARVMSENPACIARLPDQGRPLEVGEPANLTVVDPDATWTVTGADLASRSANTPFESMSLPATVTATLLRGKVTARDGKIRA,"45,192",430,"Metallo-dependent hydrolases superfamily, DHOase family, Class I DHOase subfamily",'de novo' UMP biosynthetic process [GO:0044205]; growth [GO:0040007]; purine nucleobase catabolic process [GO:0006145],allantoinase activity [GO:0004038]; dihydroorotase activity [GO:0004151]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY02B12.15,1
P9WIU3,PYRF_MYCTU,Rv1385,pyrF uraA Rv1385 MTCY21B4.02,GO:0004590; GO:0006207; GO:0044205,IPR013785; IPR018089; IPR011995; IPR001754; IPR011060; ,,pyrF,,Orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) (OMP decarboxylase) (OMPDCase) (OMPdecase),orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],9634230; 19099550; 21969609,,,MTGFGLRLAEAKARRGPLCLGIDPHPELLRGWDLATTADGLAAFCDICVRAFADFAVVKPQVAFFESYGAAGFAVLERTIAELRAADVLVLADAKRGDIGATMSAYATAWVGDSPLAADAVTASPYLGFGSLRPLLEVAAAHGRGVFVLAATSNPEGAAVQNAAADGRSVAQLVVDQVGAANEAAGPGPGSIGVVVGATAPQAPDLSAFTGPVLVPGVGVQGGRPEALGGLGGAASSQLLPAVAREVLRAGPGVPELRAAGERMRDAVAYLAAV,"27,377",274,"OMP decarboxylase family, Type 2 subfamily",'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],orotidine-5'-phosphate decarboxylase activity [GO:0004590],,uraA,MTCY21B4.02,1
P9WKE7,KHSE_MYCTU,Rv1296,thrB Rv1296 MTCY373.16,GO:0004413; GO:0005524; GO:0005829; GO:0009086; GO:0009088; GO:0009092; GO:0040007,IPR036554; IPR006204; IPR006203; IPR000870; IPR020568; IPR014721; ,,thrB,,Homoserine kinase (HK) (HSK) (EC 2.7.1.39),cytosol [GO:0005829]; ATP binding [GO:0005524]; homoserine kinase activity [GO:0004413]; growth [GO:0040007]; homoserine metabolic process [GO:0009092]; methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the ATP-dependent phosphorylation of L-homoserine to L-homoserine phosphate. {ECO:0000255|HAMAP-Rule:MF_00384}.,MVTQALLPSGLVASAVVAASSANLGPGFDSVGLALSLYDEIIVETTDSGLTVTVDGEGGDQVPLGPEHLVVRAVQHGLQAAGVSAAGLAVRCRNAIPHSRGLGSSAAAVVGGLAAVNGLVVQTDSSPSSDAELIQLASEFEGHPDNAAAAVLGGAVVSWTDHSGDRPNYSAVSLRLHPDIRLFTAIPEQRSSTAETRVLLPAQVSHDDARFNVSRAALLVVALTERPDLLMAATEDLLHQPQRAAAMTASAEYLRLLRRHNVAAALSGAGPSLIALSTDSELPTDAVEFGAAKGFAVTELTVGEAVRWSPTVRVPG,"32,346",316,"GHMP kinase family, Homoserine kinase subfamily",growth [GO:0040007]; homoserine metabolic process [GO:0009092]; methionine biosynthetic process [GO:0009086]; threonine biosynthetic process [GO:0009088],ATP binding [GO:0005524]; homoserine kinase activity [GO:0004413],cytosol [GO:0005829],,MTCY373.16,1
P9WFW5,SYR_MYCTU,Rv1292,argS Rv1292 MTCY373.12,GO:0004814; GO:0005524; GO:0005829; GO:0005886; GO:0006420; GO:0040007,IPR001412; IPR001278; IPR005148; IPR036695; IPR035684; IPR008909; IPR014729; IPR009080; ,,argS,,Arginine--tRNA ligase (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS),cytosol [GO:0005829]; plasma membrane [GO:0005886]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420]; growth [GO:0040007],9634230; 21969609,,,MTPADLAELLKATAAAVLAERGLDASALPQMVTVERPRIPEHGDYASNLAMQLAKKVGTNPRELAGWLAEALTKVDGIASAEVAGPGFINMRLETAAQAKVVTSVIDAGHSYGHSLLLAGRKVNLEFVSANPTGPIHIGGTRWAAVGDALGRLLTTQGADVVREYYFNDHGAQIDRFANSLIAAAKGEPTPQDGYAGSYITNIAEQVLQKAPDALSLPDAELRETFRAIGVDLMFDHIKQSLHEFGTDFDVYTHEDSMHTGGRVENAIARLRETGNIYEKDGATWLRTSAFGDDKDRVVIKSDGKPAYIAGDLAYYLDKRQRGFDLCIYMLGADHHGYIARLKAAAAAFGDDPATVEVLIGQMVNLVRDGQPVRMSKRAGTVLTLDDLVEAIGVDAARYSLIRSSVDTAIDIDLALWSSASNENPVYYVQYAHARLSALARNAAELALIPDTNHLELLNHDKEGTLLRTLGEFPRVLETAASLREPHRVCRYLEDLAGDYHRFYDSCRVLPQGDEQPTDLHTARLALCQATRQVIANGLAIIGVTAPERM,"59,709",550,Class-I aminoacyl-tRNA synthetase family,arginyl-tRNA aminoacylation [GO:0006420]; growth [GO:0040007],arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY373.12,1
P9WG25,TKT_MYCTU,Rv1449c,tkt Rv1449c MTCY493.05,GO:0004802; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0008152; GO:0040007; GO:0046872,IPR029061; IPR009014; IPR005475; IPR005478; IPR020826; IPR033248; IPR033247; IPR005474; ,,tkt,,Transketolase (TK) (EC 2.2.1.1),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; growth [GO:0040007]; metabolic process [GO:0008152],9634230; 21969609; 22645655,X-ray crystallography (1),"FUNCTION: Catalyzes the reversible transfer of a two-carbon ketol group from sedoheptulose-7-phosphate to glyceraldehyde-3-phosphate, producing xylulose-5-phosphate and ribose-5-phosphate. Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. {ECO:0000269|PubMed:22645655}.",MTTLEEISALTRPRHPDYWTEIDSAAVDTIRVLAADAVQKVGNGHPGTAMSLAPLAYTLFQRTMRHDPSDTHWLGRDRFVLSAGHSSLTLYIQLYLGGFGLELSDIESLRTWGSKTPGHPEFRHTPGVEITTGPLGQGLASAVGMAMASRYERGLFDPDAEPGASPFDHYIYVIASDGDIEEGVTSEASSLAAVQQLGNLIVFYDRNQISIEDDTNIALCEDTAARYRAYGWHVQEVEGGENVVGIEEAIANAQAVTDRPSFIALRTVIGYPAPNLMDTGKAHGAALGDDEVAAVKKIVGFDPDKTFQVREDVLTHTRGLVARGKQAHERWQLEFDAWARREPERKALLDRLLAQKLPDGWDADLPHWEPGSKALATRAASGAVLSALGPKLPELWGGSADLAGSNNTTIKGADSFGPPSISTKEYTAHWYGRTLHFGVREHAMGAILSGIVLHGPTRAYGGTFLQFSDYMRPAVRLAALMDIDTIYVWTHDSIGLGEDGPTHQPIEHLSALRAIPRLSVVRPADANETAYAWRTILARRNGSGPVGLILTRQGVPVLDGTDAEGVARGGYVLSDAGGLQPGEEPDVILIATGSEVQLAVAAQTLLADNDILARVVSMPCLEWFEAQPYEYRDAVLPPTVSARVAVEAGVAQCWHQLVGDTGEIVSIEHYGESADHKTLFREYGFTAEAVAAAAERALDN,"75,589",700,Transketolase family,growth [GO:0040007]; metabolic process [GO:0008152],metal ion binding [GO:0046872]; transketolase activity [GO:0004802],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY493.05,1
P9WG59,THRC_MYCTU,Rv1295,thrC Rv1295 MTCY373.15,GO:0004795; GO:0005829; GO:0005886; GO:0009088; GO:0030170; GO:0040007,IPR001926; IPR000634; IPR004450; IPR026260; IPR036052; ,,thrC,,Threonine synthase (TS) (EC 4.2.3.1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; pyridoxal phosphate binding [GO:0030170]; threonine synthase activity [GO:0004795]; growth [GO:0040007]; threonine biosynthetic process [GO:0009088],9634230; 19099550; 20066036; 21969609; 18621388,X-ray crystallography (1),FUNCTION: Catalyzes the gamma-elimination of phosphate from L-phosphohomoserine and the beta-addition of water to produce L-threonine. {ECO:0000269|PubMed:18621388}.,MTVPPTATHQPWPGVIAAYRDRLPVGDDWTPVTLLEGGTPLIAATNLSKQTGCTIHLKVEGLNPTGSFKDRGMTMAVTDALAHGQRAVLCASTGNTSASAAAYAARAGITCAVLIPQGKIAMGKLAQAVMHGAKIIQIDGNFDDCLELARKMAADFPTISLVNSVNPVRIEGQKTAAFEIVDVLGTAPDVHALPVGNAGNITAYWKGYTEYHQLGLIDKLPRMLGTQAAGAAPLVLGEPVSHPETIATAIRIGSPASWTSAVEAQQQSKGRFLAASDEEILAAYHLVARVEGVFVEPASAASIAGLLKAIDDGWVARGSTVVCTVTGNGLKDPDTALKDMPSVSPVPVDPVAVVEKLGLA,"37,322",360,Threonine synthase family,growth [GO:0040007]; threonine biosynthetic process [GO:0009088],pyridoxal phosphate binding [GO:0030170]; threonine synthase activity [GO:0004795],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY373.15,1
O53905,O53905_MYCTU,Rv1531,Rv1531,GO:0051920,IPR029032; IPR003779; ,,,,Conserved protein,peroxiredoxin activity [GO:0051920],9634230; 21969609,,,MTTSRVPLLPVDEAKAAADEAGVPDYMAELSIFQVLLNHPRLARTFNDLLATMLWHGTLDSRLRELVIMRIGWLTDCDYEWTQHWRVASGLGVSADDLLGVRDWQGYNGFGPAEQAVLAATDDVVREGAVSAQSWSACERELHCDKVVLIELVTVISAWRMVASILHSLEVPLEDGVSSWPPDGLSPR,"20,796",188,,,peroxiredoxin activity [GO:0051920],,,,1
O50431,O50431_MYCTU,Rv1175c,fadH Rv1175c,GO:0005618; GO:0005886; GO:0010181; GO:0016491,IPR013785; IPR036188; IPR023753; IPR001155; ,,fadH,,"Probable NADPH dependent 2,4-dienoyl-CoA reductase FadH (2,4-dienoyl coenzyme A reductase) (4-enoyl-CoA reductase)",cell wall [GO:0005618]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTNPYPNLLSPLDLGFTTLRNRVVMGSMHTGLEDRARHIDRLADYFAERARGGVGLIITGGYAPNRTGWLLPFASELVTSAQARRHRRITRAVHDSGAKILLQILHAGRYAYHPLAVSASPIKAPITPFRPRALSARGVEATIADFARCAQLARDAGYDGVEIMGSEGYLLNQFLAPRTNKRTDSWGGTPANRRRFPVEIIRRSRAAVGCDFIICYRLSMADYVAEGQSWDEIVALATEVEGAGATIINSGFGWHEARVPTIVTSVPGGAFVDISSAVAEHVTIPVVASNRINMPQAAERILAETQVRLISMARPMLSDPDWVLKAQSNRVDEINTCISCNQACLDHAFARKTVSCLLNPRAGRETQLVLSPTRRARSVAVVGAGPAGLATAANAAQRGHRVTLFEANDFIGGQFDMARRIPGKEEFSETIRYFSTILAKHGVEVRLGTRVAAQELTGYDEVVLATGVAPRIPAIPGIDHPMVLTYAEAITGVRPVGRTVAVVGAGGIGFDVTELLVTDSSPTLNLKEWKAEWGVADPREARGALTTPLPAPPAREVYLLQRTKGPQGKRLGKTTGWVHRASLKAKGVHQLSGVNYEQINDDGLHISFGPKRRRPQLLAVDNVVVCAGQEPVRDLESELRRHGINPHIIGGAAVAAELDAKRAIKQGTELAARL,"72,901",674,,,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O86314,O86314_MYCTU,Rv1231c,Rv1231c,GO:0005618; GO:0005886; GO:0016021,IPR010406; ,,,,Probable membrane protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSKPFAPRRLYTPRTSRTLAPRLDPEAVGRTTESIARFFGTGRYLLVQTLLVLTWIVLNLFAVGLRWDPYPFILLNLAFSTQASYAAPLILLAQNRQEKRDRAVFEEDRRRAAQTKADTEYNARELAALRLAIGEVPTRDYLRHELDSLRALLAELQPTDPDVAQPRVADEAEQHAKKSG,"20,445",180,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O86315,O86315_MYCTU,Rv1232c,Rv1232c,GO:0003938; GO:0005737; GO:0005886; GO:0006183; GO:0040007,IPR000644; IPR006668; IPR038076; IPR011033; ,,,,Conserved protein,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; IMP dehydrogenase activity [GO:0003938]; growth [GO:0040007]; GTP biosynthetic process [GO:0006183],9634230; 21969609,,,MGSVNRVYLARLSRMSVLGPLGESFGRVRDVVISISIVRQQPRVLGLVVDLATRRKIFIPILRVAAIEPHAVTLSTGNVSLHRFEQRPGEALALGQVLDTLVKVNDPALPELAGVDVVVTDLGVEQTRSRDWMVTRVAVRTQRRLRRRCPVHVVDWHNVAGLTPSALAMPGQDVAQLLDQFEGWKAVDVADAIRGLPPKRRHEVFKALHDKRLADVLQELPELDQAEVLSQLGTERAADVLEEMDPDDAADLLAVLNPTEAELLLTRMDPGDSGQVRRLLTHSPDTAGGLMTSDPVVLTPDTSIAEALARVRDPDLTPALASMVFVARPPTATPTGHYLGCVHLQRLLRDPPAELVGGVVDTDLLTLTPETPLAAVTRYFAAYNLVCGPVVDDENHLLGAVTVDDLLDHLLPHDWRVDMPELDPSGAPDRPGGPR,"47,374",435,,growth [GO:0040007]; GTP biosynthetic process [GO:0006183],IMP dehydrogenase activity [GO:0003938],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
O06817,O06817_MYCTU,Rv1442,bisC Rv1442,GO:0005618; GO:0016491; GO:0043546; GO:0046872,IPR009010; IPR006658; IPR006657; IPR006656; ,,bisC,,Probable biotin sulfoxide reductase BisC (BDS reductase) (BSO reductase),cell wall [GO:0005618]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MQVYTSATHWGVFTARVHGGDIAAVAALASDTNPAPQLQNLPGAVRHRSRIANPAVRRGWLQHGPGPSSARGAEEFVEVSWDELIELLASELRRTVDRYGNEAIYGSSYGWASAGRFHHAQSQVHRFLNMLGGYTASRHSYSAGASEVIFPHIVGAALFEALAETTTWDVIVDHTALLVAFGGLPVKNTAVMPGGTTAHPDRDYVGRYRARGGRLVSVSPLRDDIAAIAGPLDDRCRWLAPVPGTDVAIMLGLAYVLATESLADRAFLGRYCTGYERFERYLLGLDDGIPKTPEWAAALSGLAAGDLRDLARRMAEHRTLITTSLSLQRIEHGEQTVWMAATLAAMLGQIGLPGGGFGHGYSSNGVGNPPLACGLPALPQGNNPVSTFIPVAAISELLQRPGQRLAYNGRLLELPDIKCVYWAGGNPFHHHQNLPRLRRALSRVDTIVVHEQYWTAMAKHADIVVPTTTSFERDDFAASKTNPTLIAMPAMVPPYANARDDYHTFSALAHRLGFGKQFTEGRSAREWLEHMYDKWSAELDFPVPSFAEFWRTGRLELPTRTGLTWLADFRADPAAHPLGTPSGRIEIFSDTVDAFALPDCAGHPTWYEPSEWLGGPRAARYPLHLIANQPRTRLHSQLDHGGASMASKIRGREPIRIHPDDAAARELTDGDIVRVFNDRGACLAGVVIDDGLRPKVVQLSTGAWFDPADPRDPDSMCVHGNPNALSNDSGTSSLAHGSTGQHVLVQIERFTGELPPVRAHEPPRLA,"83,390",766,Prokaryotic molybdopterin-containing oxidoreductase family,,metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618],,,1
L7N691,L7N691_MYCTU,Rv1473A,Rv1473A,,,,,,Possible transcriptional regulatory protein,,9634230,,,MRKSKKTRDQLLRELRNAYEGGASIRNLAATTGRSYGSIHSMLRESGTTMRGRGGPNRRSRPR,"7,105",63,,,,,,,1
L0T6V0,L0T6V0_MYCTU,Rv1504c,Rv1504c,GO:0003824,IPR000653; IPR015424; IPR015421; ,,,,Uncharacterized protein,catalytic activity [GO:0003824],9634230,,,MSDHKVPFNRPYMTGRELAYIAEAHSCGHLAGDGPFTRRSHAWLEQQTGCRKALLTPSCTAALEMMALLLDIEEGDEVILPSYTFVSTANAFVLRGGVPVFVDIRPDTLNIDETRIVDAITPRTKAIVPVHYAGVACEMDAIMKIATHHNLAVVEDAAQGAMASYRGRALGSIGDLGALSFHETKNVISGEGGALLVNS,"21,349",199,,,catalytic activity [GO:0003824],,,,1
P71804,P71804_MYCTU,Rv1376,Rv1376,,IPR012924; IPR016845; ,,,,Uncharacterized protein,,9634230,,,MTACGRIVVTAGPTISAADIRSVVPDAEVAPPIAFGQALSYDLRSGDTLLIVDGLFFQQPSVRHKELLTLMADGVRVVGSSSMGALRAAELHPFGMEGYGWVFESYRDGVLEADDEVGVVHGDADDGYPVFVDALVNMRHTLARAVATGVVCSELAERIIETARATPFTMRTWARLLSEVGAPDQRGLAAQLRSLRVDVKHADALLALRQLGQRPRVEPLRPGPPPTVWSRRWRQRWAPPTSVAASADHGESFVDVTDLEVLSFLSVSSVDYWAYRPALQQVAAWYWTLKHPEQSGSVGERAARAVAEVASEGYGRALEFIAYRYALATGIIDETGFPEAVAAHWLTTEERHGLGNDPISISARVITRTLFVVRLLPAIDHFLDLLRKDSRLPRWRAMAAHALCKRDDLARQKPHLNLGRPDPTQLKRLFGARWGTQVNRIELARRGLMTEDAFYAAATPFAVAAVDDQLPRIEVGTLGPAPLSADVPERHFDFGSV,"54,517",497,,,,,,,1
Q10782,Q10782_MYCTU,Rv1544,Rv1544,GO:0005618; GO:0005886; GO:0016491; GO:0042783,IPR036291; IPR020904; IPR002347; ,,,,Possible ketoacyl reductase,cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MSLPKPNNQTTVVITGASSGIGVELARGLAGRGFPLMLVARRRERLDELADQLRQEHCVGVEVLPLDLADTQARAQLADRLRSDAIAGLCNSAGFGTSGRFWELPFARESEEVVLNALALMELTHAALPGMVKRGAGAVLNIASIAGFQPIPYMAVYSATKAFVLTFSEAVQEELHGTGVSVTALCPGPVPTEWAEIASAERFSIPLAQVSPHDVAEAAIAGMLSGKRTVVPGIVPKFVSTSGRFAPRSLLLPAIRIGNRLRGGPSR,"28,200",267,Short-chain dehydrogenases/reductases (SDR) family,active evasion of host immune response [GO:0042783],oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
Q11061,Q11061_MYCTU,Rv1257c,Rv1257c,GO:0005886; GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016164; IPR004113; IPR006094; IPR016171; ,,,,Probable oxidoreductase,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MNTDVLAGLMAELPEGMVVTDPAVTDGYRQDRAFDPSAGKPLAIIRPRRTEEVQTVLRWASANQVPVVTRGAGSGLSGGATALDGGIVLSTEKMRDITVDPVTRTAVCQPGLYNAEVKEAAAEHGLWYPPDPSSFEICSIGGNIATNAGGLCCVKYGVTGDYVLGMQVVLANGTAVRLGGPRLKDVAGLSLTKLFVGSEGTLGVITEVTLRLLPAQNASSIVVASFGSVQAAVDAVLGVTGRLRPAMLEFMDSVAINAVEDTLRMDLDRDAAAMLVAGSDERGRAATEDAAVMAAVFAENGAIDVFSTDDPDEGEAFIAARRFAIPAVESKGALLLEDVGVPLPALGELVTGIARIAEERNLMISVIAHAGDGNTHPLLVYDPADAAMLERAHLAYGEIMDLAVGLGGTITGEHGVGRLKRPWLAGYLGPDVLALNQRIKQALDPQGILNPGSAI,"47,270",455,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",plasma membrane [GO:0005886],,,1
O53146,O53146_MYCTU,Rv1454c,qor Rv1454c,GO:0000166; GO:0003960; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0017091; GO:0034599,IPR013149; IPR013154; IPR011032; IPR036291; IPR020843; ,,qor,,Probable quinone reductase Qor (NADPH:quinone reductase) (Zeta-crystallin homolog protein),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; AU-rich element binding [GO:0017091]; NADPH:quinone reductase activity [GO:0003960]; nucleotide binding [GO:0000166]; cellular response to oxidative stress [GO:0034599],9634230; 21969609; 25924579,X-ray crystallography (2),,MHAIEVTETGGPGVLRHVDQPQPQPGHGELLIKAEAIGVNFIDTYFRSGQYPRELPFVIGSEVCGTVEAVGPGVTAADTAISVGDRVVSASANGAYAEFCTAPASLTAKVPDDVTSEVAASALLKGLTAHYLLKSVYPVKRGDTVLVHAGAGGVGLILTQWATHLGVRVITTVSTAEKAKLSKDAGADVVLDYPEDAWQFAGRVRELTGGTGVQAVYDGVGATTFDASLASLAVRGTLALFGAASGPVPPVDPQRLNAAGSVYLTRPSLFHFTRTGEEFSWRAAELFDAIGSEAITVAVGGRYPLADALRAHQDLEARKTVGSVVLLP,"34,047",328,,cellular response to oxidative stress [GO:0034599],AU-rich element binding [GO:0017091]; NADPH:quinone reductase activity [GO:0003960]; nucleotide binding [GO:0000166],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,3
O06813,O06813_MYCTU,Rv1446c,opcA Rv1446c,GO:0005886; GO:0040007,IPR004555; ,,opcA,,Putative OXPP cycle protein OpcA,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MIVDLPDTTTTAVNKKLDELREKIGAVAMGRVLTLIIAPDSEAMLEESIEAANDASHEHPSRIIVTMRGDPYADRPRLDAQLRVGADAGAGEFVVLRLSGPLAGHADSVVIPFLLPDIPVVAWWPDIAPAVPAQDALGKLAIRRITDATNAIDPLSAIKSRLAGYGAGDTDLAWSRITYWRALLTSAVDQPRHEPIESALVSGLKTEPALDVLAGWLASRIEGPVRRAVGELKVELVRNSETIVLSRPQEGITATLTRTGKPDALVPLARRVTGECLAEDLRRLDPDEIYCAALEGIKKVQYR,"32,718",303,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
O50459,O50459_MYCTU,Rv1244,lpqZ Rv1244,GO:0005215; GO:0005618; GO:0005829; GO:0005886; GO:0022857; GO:0031460; GO:0043190,IPR007210; ,,lpqZ,,Probable lipoprotein LpqZ,ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215]; glycine betaine transport [GO:0031460],9634230; 21969609,,,MRITRILALLLAVLLAVSGVAGCSADTGDRHPELVVGSTPDSEAMLLAAIYVAALRSYGFAAHAETAADPVAKLDSGAFTVVPAFTGQMLQTLQPDASVRSDAQVYRAIVSALPEGIAAGDYTTAAEDKPALVVTQSTAKAWGGGDLSELPSHCRGLLVGRVAGAHTPAAVGPCRLPAPREFRNDATMFAALRAGQLVAAWTTTADPDIPADLIMLTDGKPALIRAENIVPLYRRNALTERQLLAVNEVAGVLDTTALIGMRRQVAAGADPAAVAAGWLAEHPLGR,"29,602",286,,glycine betaine transport [GO:0031460],transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O05318,O05318_MYCTU,Rv1217c,Rv1217c,GO:0016021,,,,,Probable tetronasin-transport integral membrane protein ABC transporter,integral component of membrane [GO:0016021],9634230; 21969609,,,MSSTVIDRARPAGHRAPHRGSGFTGTLGLLRLYLRRDRVSLPLWVLLLSVPLATVYIASVETVYPDRSARAAAAAAIMASPAQRALYGPVYNDSLGAVGIWKAGMFHTLIAVAVILTVIRHTRADEESGRAELIDSTVVGRYANLTGALLLSFGASIATGAIGALGLLATDVAPAGSVAFGVALAASGMVFTAVAAVAAQLSPSARFTRAVAFAVLGTAFALRAIGDAGSGTLSWCSPLGWSLQVRPYAGERWWVLLLSLATAAVLTVLAYRLRAGRDVGAGLIAERPGAGTAGPMLSEPFGLAWRLNRGSLLLWTVGLCLYGLVMGSVVHGIGDQLGDNTAVRDIVTRMGGTGALEQAFLALAFTMIGMVAAAFAVSLTLRLHQEETGLRAETLLAGAVSRTHWLASHLAMALAGSAVATLISGVAAGLAYGMTVGDVGGKLPTVVGTAAVQLPAVWLLSAVTVGLFGLAPRFTPVAWGVLVGFIALYLLGSLAGFPQMLLNLEPFAHIPRVGGGDFTAVPLLWLLAIDAALITLGAMAFRRRDVRC,"56,650",548,,,,integral component of membrane [GO:0016021],,,1
O50466,O50466_MYCTU,Rv1251c,Rv1251c,,IPR027417; IPR019993; IPR038720; ,,,DOMAIN 312 501 RNase_H_2. {ECO:0000259|Pfam:PF13482}.,Uncharacterized protein,,9634230; 21969609,,,MFVTGDSIVYSASDLAAAARCQYALLREFDAKLGRGPAVAVDDELMARAAVLGSAHEGRRLDQLRHEFGDAVAIIGRPAYTPAGLAAAADATRRAIANHAPVVYQAAMFDGRFVGFADFLIRDGHRYRVADTKLARSPTVTALLQLAAYADALVHSGVPVAADAELELGDGTIVRYRVGELIPVYRSQRALLQRLLDGHYTAGTAVRWDDERVQACFRCPQCTERLRASDDLLLVGGMRVRQRDKLLEAGITTIAELADHTAPVPGLTTNALGKLTAQAKLQIRQRDTGAPQFEIVDPRPLTLLPEPNPGDLFFDFEGDPLWTADGKQWGLEYLFGVLEAGRAGVFRPLWAHDRTAERQALTDFLAIVARRRRRHPNMHIYHYAPYEKTALLRLVGRYGIGEDDVDDLLRNGVLVDLYPLVRKSIRVGTDSFSLKALEPLYLGTQPRSGDVTTAADSINSYARYCELRAAGRIDEAATVLKEIEGYNHYDCRSTRALRDWLLMRAWEAGVTPIGAQPVPDADPIDDGDSLASVLSKFTGDAAAGERTPEQTAVALLAAARGYHRREDKPFWWAHFDRLNYPVDEWSDSTDVFLASEASVTVDWHMPPRARKPQRRVRLTGELARGDLNGNVFALYEPPAPPGMTDNPDRRAAGPAAVVETDDPTVPTEVVIVERTGSDGNTFQQLPFALAPGPPVPTTALRESIESTAAAVASGSPQLPSTALMDVLLRRPPRTRSGAALPRSSDPVTDIAAAALDLDSSYLAVHGPPGTGKTYTAARVIAELVTEHAWRIGVVAQSHATVENLLEGVISAGLDPGQVAKKPHDHTAGRWQSIDGSQYTEFIRDTAGCVIGGTAWDFANGNRVPKASLDLLVIDEAGQFCLANTIAVAPAATNLLLLGDPQQLPQVSQGTHPEPVDTSALSWLVDGQHTLPDERGYFLDRSYRMHPAVCAAVSALSYEGRLCSHTERTAVRRLDGYPPGVHTRGVHHKGNSIESPEEAEAILAELRQLLGSPWTDEHGTRPLAASDVLVLAPYNAQVALVRRRLASAGLGGADGVRVGTVDKFQGGQAPVVFISMTASSADDVPRGISFLLNRNRLNVAVSRAQYAAVIVRSELLTQYLPATPDGLVDLGAFLGLTSTS,"123,149",1139,,,,,,,3
O50433,O50433_MYCTU,Rv1177,fdxC Rv1177,GO:0009055; GO:0040007,IPR017896; IPR017900; IPR000813; ,,fdxC,,Probable ferredoxin FdxC,electron transfer activity [GO:0009055]; growth [GO:0040007],9634230; 21969609,,,MTYTIAEPCVDIKDKACIEECPVDCIYEGARMLYIHPDECVDCGACEPVCPVEAIFYEDDVPEQWSHYTQINADFFAELGSPGGAAKVGMTENDPQAVKDLAPQSEDA,"11,839",108,,growth [GO:0040007],electron transfer activity [GO:0009055],,,,1
O05310,O05310_MYCTU,Rv1209,Rv1209,GO:0005618; GO:0016021,IPR019933; ,,,,Conserved protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230; 21969609,,,MALVLVYLVVLVLVAIVLFAAASLLFGRGEQLPPLPRATTATTLPAFGVTRADVDAVKFTQVLRGYKTSEVDWVLERLGRELEALRSQLGAIHASSEDAEAESDASNPSRGETVVHYRSDPA,"13,121",122,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,1
P71784,P71784_MYCTU,Rv1505c,Rv1505c,,IPR001451; IPR020019; IPR011004; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTKPLVIFGSGDIAQLAHYYFTRDSEYEVVAFTVDRDYASVSEFCGLPLVAFDEVAQRFPPESHAMFVALAYAKLNGVRKEKYLAAKALGYELASYVSSHATVLNDGRIGENVFLLEDNTIQPFVSIGNNVTLWSGNHIGHHSTIHDHCFLASHIVVSGGVVIEEQSFIGVNATLRDHITIGSRCVVGAGALLLGDADADGVYIGTKTERRPVPSTELRKI,"24,056",221,,,,,,,1
O06180,O06180_MYCTU,Rv1535,Rv1535,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTAALHNDVVTVASAPKLRVVRDVPPAPASKKVARRLDAQPFGTGGDPLVDGAARLLSIPLRHLYAALWRVGLLEVQA,"8,276",78,,,,,,,1
O50432,O50432_MYCTU,Rv1176c,Rv1176c,GO:0005618,IPR018309; IPR005149; IPR036388; IPR036390; ,,,,Uncharacterized protein,cell wall [GO:0005618],9634230; 21969609,,,MALPHAILVSLCEQASSGYELARRFDRSIGYFWTATHQQIYRTLRVMENNNWVRATTVLQHGRPDKKVYAISDSGRAELARWIAEPLSPTRPGRGSALTDSSTRDIAVKLRGAGYGDVAALYTQVTALRAERVKSLDTYRGIEKRTFADPSALDGAALHQYLVLRGGIRAEESAIDWLDEVAEALQEKR,"21,077",189,,,,cell wall [GO:0005618],,,3
O53151,O53151_MYCTU,Rv1460,Rv1460,GO:0005886,IPR011991; IPR036388; IPR036390; ,,,,Probable transcriptional regulatory protein,plasma membrane [GO:0005886],9634230; 21969609,,,MTSTTLPHRASLVDRSTEFCHTDVVKIPAVSTTVPAAVSDGHTRRAIVRLLLESGSITAGEIGDRLGLSAAGVRRHLDALIEAGDAEASAAAPWQQVGRGRPAKRYRLTAAGRAKLDHSYDDLASAAMRQLREIGGEEAVRTFARRRIDAILADVAPADGPDDAALEAAAERIATALSKAGYVATTTRVGGPIHGVQICQHHCPVSHVAEEFPELCETEQQAMAEVLGTHVQRLATIVNGDCACTTHVPLSPAPSPRPPATSTEGASR,"28,180",268,,,,plasma membrane [GO:0005886],,,2
L7N664,L7N664_MYCTU,Rv1471,trxB1 Rv1471,GO:0004791; GO:0005829; GO:0006662; GO:0015035; GO:0016671; GO:0034599; GO:0045454; GO:0047134,IPR005746; IPR036249; IPR017937; IPR013766; ,,trxB1,,Thioredoxin,"cytosol [GO:0005829]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]",9634230; 21969609,,,MTTRDLTAAQFNETIQSSDMVLVDYWASWCGPCRAFAPTFAESSEKHPDVVHAKVDTEAERELAAAAQIRSIPTIMAFKNGKLLFNQAGALPPAALESLVQQLKAYEVEAGEATTQNGRAQQA,"13,341",123,Thioredoxin family,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662],"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]",cytosol [GO:0005829],,,1
P71668,P71668_MYCTU,Rv1400c,lipI Rv1400c,GO:0009056; GO:0034338,IPR029058; IPR013094; IPR002168; IPR033140; ,,lipI,,Probable lipase LipH,short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],9634230; 21969609,,,MPSLDNTADEKPAIDPILLKVLDAVPFRLSIDDGIEAVRQRLRDLPRQPVHPELRVVDLAIDGPAGPIGTRIYWPPTCPDQAEAPVVLYFHGGGFVMGDLDTHDGTCRQHAVGADAIVVSVDYRLAPEHPYPAAIEDAWAATRWVAEHGRQVGADLGRIAVAGDSAGGTIAAVIAQRARDMGGPPIVFQLLWYPSTLWDQSLPSLAENADAPILDVKAIAAFSRWYAGEIDLHNPPAPMAPGRAENLADLPPAYIAVAGYDPLRDDGIRYGELLAAAGVPVEVHNAQTLVHGYVGYAGVVPAATEATNRGLVALRVVLHG,"34,053",320,,catabolic process [GO:0009056],short-chain carboxylesterase activity [GO:0034338],,,,1
L7N693,L7N693_MYCTU,Rv1172c,PE12 Rv1172c,,IPR000084; ,,PE12,,PE family protein PE12,,9634230; 21969609,,,MSFVFAAPEALAAAAADMAGIGSTLNAANVVAAVPTTGVLAAAADEVSTQVAALLSAHAQGYQQLSRQMMTAFHDQFVQALRASADAYATAEASAAQTMVNAVNAPARALLGHPLISADASTGGGSNALSRVQSMFLGTGGSSALGGSAAANAAASGALQLQPTGGASGLSAVGALLPRAGAAAAAALPALAAESIGNAIKNLYNAVEPWVQYGFNLTAWAVGWLPYIGILAPQINFFYYLGEPIVQAVLFNAIDFVDGTVTFSQALTNIETATAASINQFINTEINWIRGFLPPLPPISPPGFPSLP,"31,002",308,,,,,,,1
O50434,O50434_MYCTU,Rv1178,Rv1178,GO:0005886; GO:0008483; GO:0009058; GO:0030170,IPR004839; IPR004838; IPR019880; IPR015424; IPR015422; IPR015421; ,,,,Aminotransferase (EC 2.6.1.-),plasma membrane [GO:0005886]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058],9634230; 21969609,,,MSASLPVFPWDTLADAKALAGAHPDGIVDLSVGTPVDPVAPLIQEALAAASAAPGYPATAGTARLRESVVAALARRYGITRLTEAAVLPVIGTKELIAWLPTLLGLGGADLVVVPELAYPTYDVGARLAGTRVLRADALTQLGPQSPALLYLNSPSNPTGRVLGVDHLRKVVEWARGRGVLVVSDECYLGLGWDAEPVSVLHPSVCDGDHTGLLAVHSLSKSSSLAGYRAGFVVGDLEIVAELLAVRKHAGMMVPAPVQAAMVAALDDDAHERQQRERYAQRRAALLPALGSAGFAVDYSDAGLYLWATRGEPCRDSAAWLAQRGILVAPGDFYGPGGAQHVRVALTATDERVAAAVGRLTC,"37,734",362,Class-I pyridoxal-phosphate-dependent aminotransferase family,biosynthetic process [GO:0009058],pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],plasma membrane [GO:0005886],,,1
Q50584,Q50584_MYCTU,Rv1523,Rv1523,GO:0008168,IPR013216; IPR029063; ,,,,Probable methyltransferase,methyltransferase activity [GO:0008168],9634230; 21969609,,,MTITALTVTLPLLWRRLTTAGVKYADQGHFVGSAGVPAADAGGRDAASEQIARWTQTCTVVLVCGHGPAKWAFRSWCTSRSCDTLPVALRYRLQSNPLVGKLTTKYFLPLGTRQVGDHVVFFNFGYEEDPPMALPLSESDEPNRYCIQLYHQTASQVDLTGKEVLEVSCGAGGGASYIARNLGPASYTGLDLNPASIDLCRAKHRLPGLQFVQGDAQNLPFPDESFDAVVNVEASHQYPDFRGFLAEVARVLRPGGHFLYTDSRRNPVVAEWEAALADAPLRTISQRDIGAQAKRGLDANTARSQEAIGRRAPVLLAGLTRCAVRVLDWDLRRGGGFSYRIYLFAKD,"37,915",347,,,methyltransferase activity [GO:0008168],,,,2
O86348,O86348_MYCTU,Rv1190,Rv1190,,IPR029058; IPR000073; ,,,DOMAIN 45 281 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Uncharacterized protein,,9634230; 21969609,,,MTMKSLAALDRPSWLSSSAWPWQPYLLSHHQGGIAVTDIGDGPAVLFVHVGSWSFVWRDVLLRLANDFRCVAIDAPGCGLSDRLSTPPTLAQAADAITSVIDALQLRDLTLVAHDLGGPAGFLAAARRGDRVAALAAVNCFAWRPTGPLFRGMLAAMGSAPVRELDAAINALARATSTRFGAGRHWSRADRAAFRAGIDAPARRAWHAYFRDARRAHALYTDVDAALRGGLADRPLLTIFGQFNDPLRFQPRWKELFPTARQLQVRRGNHFPMCDDPDLVAGALTSFVQRST,"31,804",292,,,,,,,1
I6XY36,I6XY36_MYCTU,Rv1498A,Rv1498A,,IPR009923; IPR025543; IPR036694; ,,,,Conserved protein,,9634230; 21969609,,,MSNHTYRVIEIVGTSPDGVDAAIQGGLARAAQTMRALDWFEVQSIRGHLVDGAVAHFQVTMKVGFRLEDS,"7,629",70,,,,,,,1
O33224,O33224_MYCTU,Rv1228,lpqX Rv1228,,,,lpqX,,Probable lipoprotein LpqX,,9634230; 21969609,,,MSRQWHWLAATLLLITTAACSRPGTEEPDCPTKITLPPGATPTTTLDPRCIVRATTTGTADGDAASRWTGTVRIAGFYASICNAVWDGNVSLAGKDELTGKATLILVETSCPGKVVAGELVLKGNVGSDSLAITWAHPELPQRAFDLGAGQGTIRRSGDRAEGTFNSDMGGGTEFFLTWSLTMRN,"19,513",185,,,,,,,1
O53156,O53156_MYCTU,Rv1465,Rv1465,GO:0005737; GO:0006879; GO:0008198; GO:0016226; GO:0036455; GO:0040007; GO:0051537; GO:0051539; GO:0097428,IPR002871; ,,,,Possible nitrogen fixation related protein,"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]; cellular iron ion homeostasis [GO:0006879]; growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428]",9634230; 21969609,,,MTLRLEQIYQDVILDHYKHPQHRGLREPFGAQVYHVNPICGDEVTLRVALSEDGTRVTDVSYDGQGCSISQAATSVLTEQVIGQRVPRALNIVDAFTEMVSSRGTVPGDEDVLGDGVAFAGVAKYPARVKCALLGWMAFKDALAQASEAFEEVTDERNQRTG,"17,711",162,,cellular iron ion homeostasis [GO:0006879]; growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]",cytoplasm [GO:0005737],,,1
L7N6B1,L7N6B1_MYCTU,Rv1322A,Rv1322A,,IPR029068; IPR017515; IPR037523; ,,,DOMAIN 20 150 VOC. {ECO:0000259|PROSITE:PS51819}.,Conserved protein,,9634230; 21969609,,,MMTTDQVHARHMLATSLVTGLDHVGIAVADLDVAIEWYHDHLGMILVHEEINDDQGIREALLAVPGSAAQIQLMAPLDESSVIAKFLDKRGPGIQQLACRVSDLDAMCRRLRSQGVRLVYETARRGTANSRINFIHPKDAGGVLIELVEPAP,"16,626",152,,,,,,,1
P71763,P71763_MYCTU,Rv1482c,Rv1482c,,,,,,Uncharacterized protein,,9634230,,,MTDPFLGSEALAAGVLTPYELRSRYVALHKDVYVPQGVELTAQLRAKALWLRSRRRGVLAGYSASAFHGAKWIDADLPAAIIDTNRRRAPGLQVWEERIEPDEICVIEGMRVTTPERTALDLTSRFPLDPAVAAVDALIQATDLKVADVEPLIERYRGRRGMKAARAALDLVDGGAQSPKETWLRLLLIRAGFPRPQTQIAVRNEWGWAEAHLDMGWQDIKVAAEYDGDHHLTSRYHYRKDILRHEKVQHRYGWIVVRVVAEDHPADIIRRVGEARAFRA,"31,664",280,,,,,,,2
O05294,O05294_MYCTU,Rv1192,Rv1192,GO:0005886; GO:0016787,IPR029058; ,,,,Uncharacterized protein,plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MLLPVLEPADRPCDAPGWFLYLTDIPRAGVEYGQLLAVLPLQRMLPAGDGHPVLVLPGLLAGDGSTWILRRILRRLGYAAYGWGLGRNIGPTAKAVSGMRDLLDKLHSRYHTPVSLIGWSLGGIFARGLARDHPSAVRQVITLGSPFGMRDTCETRSAWSFNRYAHLHTERHELPLEMESEPLPVPTTAIYSRCDGMVAWQTCMNSPSERAENIAVRSSHIGYGHNPPVVWAIADRLAQPQGAWAPFRPPKVLSPLFPRPDTPAEAVSTPQTRPA,"30,213",275,,,hydrolase activity [GO:0016787],plasma membrane [GO:0005886],,,1
P71778,P71778_MYCTU,Rv1497,lipL Rv1497,GO:0004806; GO:0046503,IPR001466; IPR012338; ,,lipL,,Probable esterase LipL,triglyceride lipase activity [GO:0004806]; glycerolipid catabolic process [GO:0046503],9634230,,,MMVDTGVDHRAVSSHDGPDAGRRVFGAADPRFACVVRAFASMFPGRRFGGGALAVYLDGQPVVDVWKGWADRAGWVPWSADSAPMVFSATKGMTATVIHRLADRGLIDYEAPVAEYWPAFGANGKATLTVRDVMRHQAGLSGLRGATQQDLLDHVVMEERLAAAVPGRLLGKSAYHALTFGWLMSGLARAVTGKDMRLLFREELAEPLDTDGLHLGRPPADAPTRVAEIIMPQDIAANAVLTCAMRRLAHRFSGGFRSMYFPGAIAAVQGEAPLLDAEIPAANGVATARALARMYGAIANGGEIDGIRFLSRELVTGLTRNRRQVLPDRNLLVPLNFHLGYHGMPIGNVMPGFGHVGLGGSIGWTDPETGVAFALVHNRLLSPLVMTDHAGFVGIYHLIRQAAAQARKRGYQPVTPFGAPYSEPGAAAG,"45,816",429,,glycerolipid catabolic process [GO:0046503],triglyceride lipase activity [GO:0004806],,,,2
O05296,O05296_MYCTU,Rv1194c,Rv1194c,GO:0005886; GO:0040007,IPR025736; ,,,,Conserved protein,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MAWQQPSPRIRELIREGARIALNPSPEWIEELDRATIAANPAIANDPVLAKVVQTANRANLVYWAAANLRDPGARVPANLGTEPLRMARDLVRRGLDTVAFNIYRTGEHIGWRFWMGIAFELTSDPQELRELLDVSARSVNDFIEATLTGIAAQVQSEHDELTRSTHAERLEVVGLILDGAPISPERAEAKLGYPLSRAHTAAIIWSDELDGDHSYLDRAADLFCHAVGSTRPLTVVAGAASRWAWVTDADGLDIDTVQAAVDNAPGARIAIGTTANGVEGFRRSHLEALITQRTLSRLRSTQRVAFFADVKMVALISQNPDAASEFITSTLGDLESASPDLQTALLTFINEQCNASRAAKRLHTHRNTFLRRLESAQRLLPRPLDHTSVHVAVALEALQWRGNKAHALSSPGRRSNSVPA,"46,098",421,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
O86337,O86337_MYCTU,Rv1275,lprC Rv1275,GO:0005618; GO:0005829; GO:0005886,IPR024520; ,,lprC,,Possible lipoprotein LprC,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MRRVLVGAAALITALLVLTGCTKSISGTAVKAGGAGVPRNNNSQERYPNLLKECEVLTTDILAKTVGADPLDIQSTFVGAICRWQAANPAGLIDITRFWFEQGSLSNERKVAEGLKYQVETRAIQGVDSIVMRTGDPNGACGVASDAAGVVGWWVNPQAPGIDACGQAIKLMELTLATNA,"18,871",180,,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
O50444,O50444_MYCTU,Rv1188,Rv1188,GO:0000166; GO:0004657; GO:0005618; GO:0010133; GO:0040007,IPR029041; IPR008219; IPR002872; ,,,,Probable proline dehydrogenase,cell wall [GO:0005618]; nucleotide binding [GO:0000166]; proline dehydrogenase activity [GO:0004657]; growth [GO:0040007]; proline catabolic process to glutamate [GO:0010133],9634230; 21969609,,,MAGWFAHTLRPAMLAAGRSDRLGRIVERSPLTRGVVRRFVPGDTLDDVVDIVTALRDSGRYLSIDYLGENVTDADDAAAAVRAYLGLLDVLGRRGDIACDGVRPLEVSLKLSALGQALDRDGQKIALDNARAICERAERVGAWVTVDAEDHTTTDSTLSISGDLRVDFPWLGTVVQAYLRRTLADCAELAAVGARVRLCKGAYDEPASVAYRDAAQVTDSYLRCLRVLTAGRGYPMVATHDPVIIAAVPGITRESGRSQGDFEYQMLYGVRDDEQRRLTGAGNHVRVYVPFGTRWYGYFLRRLAERPANLAFFLRALTDRRRARGCAER,"36,237",329,,growth [GO:0040007]; proline catabolic process to glutamate [GO:0010133],nucleotide binding [GO:0000166]; proline dehydrogenase activity [GO:0004657],cell wall [GO:0005618],,,1
P71790,P71790_MYCTU,Rv1511,gmdA gmd Rv1511,GO:0005886; GO:0008446; GO:0019673; GO:0070401; GO:0071456,IPR006368; IPR016040; IPR036291; ,,gmdA,,"GDP-mannose 4,6-dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase)","plasma membrane [GO:0005886]; GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]; cellular response to hypoxia [GO:0071456]; GDP-mannose metabolic process [GO:0019673]",9634230; 21969609,,FUNCTION: Catalyzes the conversion of GDP-D-mannose to GDP-4-dehydro-6-deoxy-D-mannose. {ECO:0000256|HAMAP-Rule:MF_00955}.,MKRALITGITGQDGSYLAELLLAKGYEVHGLIRRASTFNTSRIDHLYVDPHQPGARLFLHYGDLIDGTRLVTLLSTIEPDEVYNLAAQSHVRVSFDEPVHTGDTTGMGSMRLLEAVRLSRVHCRFYQASSSEMFGASPPPQNELTPFYPRSPYGAAKVYSYWATRNYREAYGLFAVNGILFNHESPRRGETFVTRKITRAVARIKAGIQSEVYMGNLDAVRDWGYAPEYVEGMWRMLQTDEPDDFVLATGRGFTVREFARAAFEHAGLDWQQYVKFDQRYLRPTEVDSLIGDATKAAELLGWRASVHTDELARIMVDADMAALECEGKPWIDKPMIAGRT,"38,342",340,"NAD(P)-dependent epimerase/dehydratase family, GDP-mannose 4,6-dehydratase subfamily",cellular response to hypoxia [GO:0071456]; GDP-mannose metabolic process [GO:0019673],"GDP-mannose 4,6-dehydratase activity [GO:0008446]; NADP+ binding [GO:0070401]",plasma membrane [GO:0005886],gmd,,2
Q79FP1,Q79FP1_MYCTU,Rv1452c,PE_PGRS28 Rv1452c,,IPR000084; ,,PE_PGRS28,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein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
O53165,O53165_MYCTU,Rv1474c,Rv1474c,GO:0000976; GO:0003700; GO:0005618; GO:0005829,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 10 70 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein,cell wall [GO:0005618]; cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230,,,MPKVSEDHLAARRRQILDGARRCFAEYGYDKATVRRLEQAIGMSRGAIFHHFRDKDALFFALAREDTERMAAVASREGLIGVMRDMLAAPDQFDWLATRLEIARKLRNDPDFSRGWAERSAELAAATTDRLRRQKQANRVRDDVPSDVLRCYLDLVLDGLLARLASGEDPQRLAAVLDLVENSVRRS,"21,269",187,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
P71810,P71810_MYCTU,Rv1382,Rv1382,GO:0005576; GO:0016021; GO:0040007,,,,,Probable export or membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; growth [GO:0040007],9634230; 21969609,,,MNSGTLAGSLIFAAVLVMLIAVLARLMMRGWRRRSERQAELLGDLPDVPEHVSSATVTTRGLYVGATLSPAWNERVTVGDLGYRSKAVLTRYPSGIMVERARAQPIWIPTESIAAIRMERGVAGKVVAGIGILAIRWRLPSGTEIDVGFRADNRDEYQEWLEEPV,"18,189",165,,growth [GO:0040007],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O50460,O50460_MYCTU,Rv1245c,Rv1245c,GO:0005618; GO:0005886; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MEGFAGKVAVVTGAGSGIGQALAIELARSGAKVAISDVDTDGLADTEHRLKAISTPVKTDRLDVTEREAFLAYADAVNEHFGTVNQIYNNAGIAFTGDIEVSQFKDIERVMDVDFWGVVNGTKAFLPHLIASGDGHVINISSVFGLFSAPGQAAYNSAKFAVRGFTEALRQEMALAGHPVKVTTVHPGGVKTAIARNATAAEGLDQAELAETFDKRVAHLSPQRAAQIILTGVAKNKARVLVGVDAKVLDLVVRLTGSGYQRIFPIITGRLIPRPR,"29,215",276,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53902,O53902_MYCTU,Rv1528c,papA4 Rv1528c,,,,papA4,,Probable conserved polyketide synthase associated protein PapA4,,9634230,,,MTQLPQPTWRWWQQRETEQVQSSHIDGEIVGALIPDLAVLHSEDASRAAVGREKHRCSLDPLGGGFRSRRASMPAGALLLSAVIAIQLDRMNARVFGDGWIGAQACMWVNKFHEESTVTALSPSSPIAQGSIARHPETMQSAYVRIAEGGSRDVAPAAQLQRRRP,"18,076",165,,,,,,,1
O86311,O86311_MYCTU,Rv1218c,Rv1218c,GO:0005524; GO:0005886; GO:0016887; GO:0046677,IPR003593; IPR003439; IPR017871; IPR025302; IPR027417; ,,,,Probable tetronasin-transport ATP-binding protein ABC transporter,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to antibiotic [GO:0046677],9634230; 21969609,,,MSADNHQVPIEIRGLTKHFGSVRALDGLDLTVREGEVHGFLGPNGAGKSTTLRILLGLVKADGGSVRLLGGDPWTDAVDLHRHIAYVPGDVTLWPSLTGGETIDLLARMRGGIDNARRAELIERFGLDPTKKARTYSKGNRQKVSLISALSSHATLLLLDEPSSGLDPLMENVFQQCIGEARQRGVTVLLSSHILAETEALCEKVTIIRAGKTVESGSLDALRHLSRTSIKAEMIGDPGDLSQIKGVEDISIEGTTVRAQVDSESLRELIQVLGHAGVRSLVSQPPTLEELFLRHYSLGPEVAAEQQVATP,"33,448",311,,response to antibiotic [GO:0046677],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
O50430,O50430_MYCTU,Rv1174c,TB8.4 Rv1174c,GO:0005576; GO:0005618; GO:0020037; GO:0085016,IPR032407; IPR016572; ,,TB8.4,,Low molecular weight T-cell antigen TB8.4,cell wall [GO:0005618]; extracellular region [GO:0005576]; heme binding [GO:0020037]; dormancy exit of symbiont in host [GO:0085016],9634230; 21969609,,,MRLSLTALSAGVGAVAMSLTVGAGVASADPVDAVINTTCNYGQVVAALNATDPGAAAQFNASPVAQSYLRNFLAAPPPQRAAMAAQLQAVPGAAQYIGLVESVAGSCNNY,"10,881",110,,dormancy exit of symbiont in host [GO:0085016],heme binding [GO:0020037],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P71794,P71794_MYCTU,Rv1515c,Rv1515c,GO:0005618; GO:0005737; GO:0008757; GO:0032259,IPR025714; IPR029063; ,,,,Uncharacterized protein,cell wall [GO:0005618]; cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MSTNPGPAEGANQVMAQEHSAGAVQFTAHNVRLDDGTLTIPESSRTLDESSWFISARGILETVFPGDKSHLRLADVGCLEGGYAVGFARMGFQVLGIEVRELNMAACNYIKSKTNLPNLRFVHDNALNIANHGLFDTVFCCGLFYHLENPKQYLETLSSVTNKLLILQTHFSIINRSDKWLRLPTTARQLTDRLLRRPAPVKFMLSAPTEHEGLPGRWFTEFSDDRSFGQRDTAKWASWDNRRSFWIQREHLLQAIKDVGVDLVMEEYDNLEPSIAESLLGGSYAANLRGTFIGIKTR,"33,461",298,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
O53148,O53148_MYCTU,Rv1456c,Rv1456c,GO:0005886; GO:0006784; GO:0016021; GO:0016627; GO:0040007,IPR003780; ,,,,Probable unidentified antibiotic-transport integral membrane ABC transporter,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; growth [GO:0040007]; heme a biosynthetic process [GO:0006784]",9634230,,,MPYDRAVSPSLRVQRVIAAIVILTQGGIAVTGAIVRVTASGLGCPTWPQCFPGSFTPVVVAEVPRVHQAVEFGNRMVTFAVVIAAALAVLVVTRARRRTEVLAYAWLMPVSTVVQAMIGGITVRTGLLWWTVAIHLLASMTMVWLAVLLYVKIGQPDDGVVHELVVSPLRALTALSALNLAAVLVTGTLVTAAGPHAGDRSPSRTVPRLKVEITTLVHMHSSLLVAYLALLIGLGFGLLAVGATRAILVRLAVLLALVATQAAVGTTQYFTGVPAALVAIHVAGAAAVTAATAALWASMGERAQPQPLQR,"32,369",310,,growth [GO:0040007]; heme a biosynthetic process [GO:0006784],"oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,3
Q79FP2,Q79FP2_MYCTU,Rv1450c,PE_PGRS27 Rv1450c,GO:0005618,IPR000084; ,,PE_PGRS27,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS27,cell wall [GO:0005618],9634230; 21969609,,,MSLVIVAPETVAAAALDVARIGSSIGAANAAAAGSTTSVLAAGADEVSAAIATLFGSHAREYQAISTQVAAFHDRFAQTLSAAVGSYVSAEATNAAPLATLEHNVLNALNAPTQALLGRPLIGDGAAGAPGTGQAGGAGGILWGNGGAGGSGAPGQVGGAGGAAGLFGTGGAGGAGGAGAAGGAGGSGGWLLGNGGVGGAGGQSLLGGATGGAGGNAGLFGVGGTGGPGGPGGPGGVGGTGGAGGLGGTLYGAGGHGGAGGPGPIGGVGGHGGVGGAAGLLGVGGHGGAGGHGAEGVAGAAGEDLSPHGTSGGVGGDAGDGGTGGRGGWLAGAGGAGGAGGVGGTGGAGGAGFSRALIVAGDNGGDPGAGGAGGTGGAGSTIGAHGAAGASPTSGGNGGAGGNGAHFSSGGKAGGNGGAGGAGGLVGNGGAGGAGGNGAPGAPPSGGDPNGGGGGAGGAGGKGGDGGAQAGDGGAGGAGGKGGNGGNGATGATGLNGLGAGADGTDGGKGGNGGAGGGGGAGGQGGKALAATHQDGSMGAGGAGGNGGAGGMGGDGGNGAKGTFDNGGDGVGGNGGNGGSRGIGGAGGIGGAGSTAGADGARGATPTSGGNGGTGGNGANATVAGGAGGAGGKGGNGGLVGNGGAGGKGGDGMAGVAGSSPTTAGESGTSGQNGGAGGAGGAGGRGGDFGGDGGTGGAGGNGANGANATTPGAKGGDGGHGGPGAQGGNGGQGGPGGLAGNLFGQNGIQGVGGSGGKGGAGGLAGDGGNGANGNFAFGDGNGGHGGNGGNPGAGGQGGSGGAGSTPGAKGAHGFTPTSGGDGGDGGNGGNSQVVGGNGGDGGNGGNGGSAGTGGNGGRGGDGAFGGMSANATNPGENGPNGNPGGNGGAGGAGGAGLNGGNGGAGGNGGLGGFGGNGAAGANGVAVGAPGQPGGAGGHGGAGGNGGAGGNGGQGVVSDGAGGAGGAGGDGGAPGDGANGGNGQGAGAFAGGGGGRGGDGGNAGNAGAGGPGGTGSTAGKAGPAGSILHDGGNGGHGGHGAASGGNGGPGGHGGNGGNGGTGANGGNGGIGGTGGAGSTGAKGVLGTNEGDGGDGGRGGNGGRGGNGGQGLTGAGGNGGTGGTPGNGGNGGNGASGDLVTSPGDGGGGGRGGDAGRGGDAGLGGSSGPGGTPGDWGTGGTGGTGGTGGQGANGGLTGGRGGTGGNGGNGNTGGTGGAGGTGGTGHNGSQPGMGGNGGAGGFGGNGFAGVGGRGGMGGSGGTGGTGDAGPFGTGTGGTGGHGGQGGGGGFSILLGLGGLGGLGSPGSIATGTAGGAGGGGGFGGLGGGEFV,"107,409",1329,,,,cell wall [GO:0005618],,,1
Q79FP0,Q79FP0_MYCTU,Rv1468c,PE_PGRS29 Rv1468c,,IPR000084; ,,PE_PGRS29,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS29,,9634230,,,MSFVVANTEFVSGAAGNLARLGSMISAANSAAAAQTTAVAAAGADEVSAAVAALFGAHGQTYQVLSAQAAAFHSQFVQALSGGAQAYAAAEATNFGPLQPLFDVINAPTLALLNRPLIGNGADGTAANPNGQAGGLLIGNGGNGFSPAAGPGGNGGAAGLLGHGGNGGVGALGANGGAGGTGGWLFGNGGAGGNSGGGGGAGGIGGSAVLFGAGGAGGISPNGMGAGGSGGNGGLFFGNGGAGASSFLGGGGAGGRAFLFGDGGAGGAALSAGSAGRGGDAGFFYGNGGAGGSGAGGASSAHGGAGGQAGLFGNGGEGGDGGALGGNGGNGGNAQLIGNGGDGGDGGGAGAPGLGGRGGLLLGLPGANGT,"32,216",370,,,,,,,1
P71658,P71658_MYCTU,Rv1388,mihF Rv1388,GO:0005618; GO:0005829; GO:0005886; GO:0040007,,,mihF,,Putative integration host factor MihF,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MLGNTIHVPCQPCRHGHGAPSRGLRGRPADRWPVARATPTLHVCPQNQGVGLDFVRKPEYGRLRWPAYPAGTNNDRLISMRDGGIVALPQLTDEQRAAALEKAAAARRARAELKDRLKRGGTNLTQVLKDAESDEVLGKMKVSALLEALPKVGKVKAQEIMTELEIAPTRRLRGLGDRQRKALLEKFGSA,"20,835",190,,growth [GO:0040007],,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P71662,P71662_MYCTU,Rv1393c,Rv1393c,GO:0005618,IPR036188; ,,,,Probable monoxygenase,cell wall [GO:0005618],9634230; 21969609,,,MMPDYHALIVGAGFSGIGAAIKLDRAGFSDYLVVEAGDGVGGTWHWNTYPGIAVDIPSFSYQFSFEQSRHWSRTYAPGHELKAYAEHCVDKYGIRSRIRLNTKVLAAEFDDEHSLWRVQTDPGGEITARFLISACGILTVPKLPDIDGVDSFEGVTMHTARWDHTQDLTGKRVGIIGTGASAVQVIPEMAPIVSHLTVFQRTPIWCFPKFDVPLPTAVRWAMRIPGGKAVHRLLSQAFVEATFPIAAHYFAVFPLAKHMESAGRRYLRQQVHDPVVREQLTPRYAVGCKRPGFHNTYLSTFNRDNVRLVTEPIDKITPTAVATTDGASHEIDVLVLATGFKVLDTDSIPTYAVTGTGGASLSRFWDEHRLQAYEGVSVPGYPNFFTVFGPYGYVGSSYFALIETQAHHIIRCLKRARRTGATRIEVTEEANARYFAEVMRRRHRQVFWQDSCRLANSYYFDKNGDVPLRPTTTVEAYWRSRRFDLGDYRISS,"55,252",492,,,,cell wall [GO:0005618],,,1
Q50699,Q50699_MYCTU,Rv1277,Rv1277,GO:0016787,IPR004843; IPR029052; IPR014577; ,,,DOMAIN 35 203 Metallophos. {ECO:0000259|Pfam:PF00149}.,Uncharacterized protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MSPRPGPAGRGPAPCRCADLHSLCVDSHALRRDGMRFLHTADWQLGMTRHFLAGDAQPRYSAARRDAVAGLKALAADVGAEFVVVAGDVFEHNQLAPQIVGQSLEAMRVIGLPVYLLPGNHDPLDASSVYTSTLFRAERPDNVVVLDRAGVHEVRPGVQIVAAPWRSKAPTTDPVAEVLAGLPTDAAIRLLVAHGGVDALDPDHDKPSLIRLAALDDALTRQAIHYVALGDKHSLTQVGSSGRVWYSGAPEVTNFDDVEPDPGHVLVVDIDESDPRHPVTVDARRIGRWRFVTLHHQVDTSRDIADLDLNLDLMTDKDRTVVRLALTGSLTVTDRAALDTCLDKYARLFAWLGLWERHTDLAVIPVDAEFTDLGIGGFAAAAVDELVATARGGDDESAVDAQAALALLLRLADRGAA,"44,791",417,,,hydrolase activity [GO:0016787],,,,2
O53164,O53164_MYCTU,Rv1473,Rv1473,GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0016887; GO:0046677,IPR003593; IPR032781; IPR003439; IPR017871; IPR027417; ,,,,Probable macrolide-transport ATP-binding protein ABC transporter,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to antibiotic [GO:0046677],9634230; 21969609,,,MITATDLEVRAGARILLAPDGPDLRVQPGDRIGLVGRNGAGKTTTLRILAGEVEPYAGSVTRAGEIGYLPQDPKVGDLDVLARDRVLSARGLDVLLTDLEKQQALMAEVADEDERDRAIRRYGQLEERFVALGGYGAESEAGRICASLGLPERVLTQRLRTLSGGQRRRVELARILFAASESGAGNSTTLLLDEPTNHLDADSLGWLRDFLRLHTGGLVVISHNVDLVADVVNKVWFLDAVRGQVDVYNMGWQRYVDARATDEQRRIRERANAERKAAALRAQAAKLGAKATKAVAAQNMLRRADRMMAALDEERVADKVARIKFPTPAACGRTPLVANGLGKTYGSLEVFTGVDLAIDRGSRVVILGLNGAGKTTLLRLLAGVEQPDTGVLEPGYGLRIGYFAQEHDTLDNDATVWENVRHAAPDAGEQDLRGLLGAFMFTGPQLEQPAGTLSGGEKTRLALAGLVASTANVLLLDEPTNNLDPASREQVLDALRSYRGAVVLVTHDPGAAAALGPQRVVLLPDGTEDYWSDEYRDLIELA,"58,424",542,,response to antibiotic [GO:0046677],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
L7N6A8,L7N6A8_MYCTU,Rv1489A,Rv1489A,GO:0008152; GO:0016866; GO:0031419,IPR006099; ,,,,Conserved protein,cobalamin binding [GO:0031419]; intramolecular transferase activity [GO:0016866]; metabolic process [GO:0008152],9634230,,,MSVGEVEVLKVENSRVRAEQLAKLYELRSSRDRVRVDAALAELSRAAAARGCAGTSGLGNNLMAPGPPHSLLGRDR,"8,101",76,,metabolic process [GO:0008152],cobalamin binding [GO:0031419]; intramolecular transferase activity [GO:0016866],,,,1
L7N697,L7N697_MYCTU,Rv1430,PE16 Rv1430,GO:0016021,IPR029058; IPR000084; IPR013228; ,,PE16,,PE family protein PE16,integral component of membrane [GO:0016021],9634230,,,MSFVFAVPEMVAATASDLASLGAALSEATAAAAIPTTQVLAAAADEVSAAIAELFGAHGQEFQALSAQASAFHDRFVRALSAAAGWYVDAEAANAALVDTAATGASELGSGGRTALILGSTGTPRPPFDYMQQVYDRYIAPHYLGYAFSGLYTPAQFQPWTGIPSLTYDQSVAEGAGYLHTAIMQQVAAGNDVVVLGFSQGASVATLEMRHLASLPAGVAPSPDQLSFVLLGNPNNPNGGILARFPGLYLQSLGLTFNGATPDTDYATTIYTTQYDGFADFPKYPLNILADVNALLGIYYSHSLYYGLTPEQVASGIVLPVSSPDTNTTYILLPNEDLPLLQPLRGIVPEPLLDLIEPDLRAIIELGYDRTGYADVPTPAALFPVHIDPIAVPPQIGAAIGGPLTALDGLLDTVINDQLNPVVTSGIYQAGAELSVAAAGYGAPAGVTNAIFIGQQVLPILVEGPGALVTADTHYLVDAIQDLAAGDLSGFNQNLQLIPATNIALLVFAAGIPAVAAVAILTGQDFPV,"54,584",528,,,,integral component of membrane [GO:0016021],,,1
O06815,O06815_MYCTU,Rv1444c,Rv1444c,,IPR022788; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTVMADRSGRPAPVRRRMKTLTQAALNADKTVEQVEDVLDGLGKTMAELNSSLSQLNSTVERLEDGLDHLEGTLHSLDDLAKRLIVLVEPVEAIVDRIDYIVSLGETVMSPLSVTEHAVRGVLDRLRNRTVHEPTN,"15,023",136,,,,,,,1
O53149,O53149_MYCTU,Rv1458c,Rv1458c,GO:0005524; GO:0005886; GO:0016887,IPR003593; IPR003439; IPR017871; IPR027417; ,,,,Probable unidentified antibiotic-transport ATP-binding protein ABC transporter,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MNRAPDTPEVVLRLRGVCKRYGSITAVSNLDLDVHDAEVMALLGPNGAGKTTTVEMCEGFVRPDAGSIEVLGLDPITDNARLRARIGVMLQGGGGYPAARAGEMLDLVASYAANPLDPHWLLDTLGLTEAARTTYRRLSGGQQQRLALACALVGRPQLVFLDEPTAGMDAHARVLVWELIDALRRDGVTVVLTTHHLKEAEELADRLVIIDHGVTVAAGTPAELMRSGAKDQLRFTAPPRLDLSLLASALPEGYQATELTPGEYLVEGPVDPQVLATVTAWCAQIDVLATDMRVEQRSLEDVFLDLTGRKLRQ,"33,759",313,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
O05301,O05301_MYCTU,Rv1200,Rv1200,GO:0016021; GO:0022857,IPR020846; IPR005828; IPR036259; IPR004736; IPR005829; ,,,,Probable conserved integral membrane transport protein,integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857],9634230,,,MKRVALACLVGSAIEFYDFLIYGTAAALVFPTVFFPHLDPTVAAVASMGTFAVAFLSRPFGAAVFGYFGDRLGRKKTLVATLLIMGLATVTVGLVPTTVAIGAAAPLILTTMRLLQGFAVGGEWAGSALLSAEYAPASKRGWYGMFTVVGGGIALVLTSLTFLGVNYTIGESSPTFMQWGWRIPFLVSAALIAVALYVRFNIDETPVFARERADEKTRLGPAETPIAQVLRRQRREIVLAAGSAVCCFGFVYLASTYLASYAQTRLGYSRGSILFDSVLGGLLCIVFTALSSALCDQLGRRRVLLAGWAVALPWSLLVMPLIDSGSPSLFAVAVVGMYAIGGFGFGPTASFIPELFATSYRYTGSALAANLAGVAGGALPPVIAGALVATYGSWAIGVMLAILALISLVCTYRLPETAGSALVSR,"44,575",425,,,transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021],,,1
O05316,O05316_MYCTU,Rv1215c,Rv1215c,GO:0005829; GO:0005886; GO:0008239; GO:0040007,IPR029058; IPR005674; IPR008979; IPR000383; IPR013736; ,,,,Conserved protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; growth [GO:0040007],9634230; 21969609,,,MARNPSPALDRPWRRPGALRYALERVRGVAKPPITVTDPPADVVIERDVEVPTRDGTLLRINVFRSAEGGARPVIASIHPYGKDALPRRRGNRWTFSPQYRMLRQPKPLTFSALTGWEAPDPAWWTAQGFVVVNADSRGCGRSDGTGDLLSHQEAEDTYDLVGWLADQAWSDGRVVMLGVSYLAISQYAVAALQPPALRAICPWEGFTDAYRDLAFPGGIRESGFTRLWSRGVRRRTRQTYDMEQMQEAHPLRDDFWRSRVPDLSAIKVPMLVCGSFSDNNLHSRGSIRAFTRSGCGHARLYTHRGGKWETFYSATALSEQLKFLRDALAGSSGSRSVRLEVREDRDTITAVREETQWPLAGTRWRPMYLAGPGLLATEPPPTAGSIRFQTRSRAAAFNWTIPEDIELTGPMAARLWVQLDGCDDANLFVGVEKWRDGQFVAFEGSYGWGRDRVTTGWQRVSLRELDPELSQPWEPVPACARPRPVTAGEVVAVDVALGPSATLFRAGEQLRLVVGGRWLSPRNPLTGQFPAAYPRPPRGRVTLHWGPRYDAHLLIPEVPG,"62,611",561,,growth [GO:0040007],dipeptidyl-peptidase activity [GO:0008239],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O05311,O05311_MYCTU,Rv1210,tagA Rv1210,GO:0006284; GO:0008725,IPR005019; IPR011257; IPR004597; ,,tagA,,"Probable DNA-3-methyladenine glycosylase I TagA (Tag I) (3-methyladenine-DNA glycosylase I, constitutive) (DNA-3-methyladenine glycosidase I)",DNA-3-methyladenine glycosylase activity [GO:0008725]; base-excision repair [GO:0006284],9634230; 21969609,,,MSGDGLVRCPWAEVRPGPDAQLYRDYHDNEWGRPLYGRVALFERMSLEAFQSGLSWLIILRKRENFRRAFSGFDIDKIARYTDTDVRRLLADDGIVRNRAKIEATIANARAAADLGSSEDLSELLWSFAPPPRPRPVDGSEIPSVSTESKAMSRELKRRGFRFVGPTTAYALMQATGMVDDHIQACWVPTERPFDQPGCPMAAR,"23,005",204,,base-excision repair [GO:0006284],DNA-3-methyladenine glycosylase activity [GO:0008725],,,,1
P71791,P71791_MYCTU,Rv1512,epiA fcl Rv1512,GO:0016853; GO:0042351; GO:0050577; GO:0070401,IPR001509; IPR028614; IPR036291; ,,epiA,,"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase)",GDP-L-fucose synthase activity [GO:0050577]; isomerase activity [GO:0016853]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351],9634230; 21969609,,"FUNCTION: Catalyzes the two-step NADP-dependent conversion of GDP-4-dehydro-6-deoxy-D-mannose to GDP-fucose, involving an epimerase and a reductase reaction. {ECO:0000256|HAMAP-Rule:MF_00956}.",MNAHTSVGPLDRAARVYIAGHRGLVGSALLRTFAGAGFTNLLVRSRAELDLTDRAATFDFVLESRPQVVIDAAARVGGILANDTYPADFLSENLQIQVNLLDAAVAARVPRLLFLGSSCIYPKLAPQPIPESALLTGPLEPTNDAYAIAKIAGILAVQAVRRQHGLPWISAMPTNLYGPGDNFSPSGSHLLPALIRRYDEAKASGAPNVTNWGTGTPRRELLHVDDLASACLYLLEHFDGPTHVNVGTGIDHTIGEIAEMVASAVGYSGETRWDPSKPDGTPRKLLDVSVLREAGWRPSIALRDGIEATVAWYREHAGTVRQ,"34,537",322,"NAD(P)-dependent epimerase/dehydratase family, Fucose synthase subfamily",'de novo' GDP-L-fucose biosynthetic process [GO:0042351],GDP-L-fucose synthase activity [GO:0050577]; isomerase activity [GO:0016853]; NADP+ binding [GO:0070401],,fcl,,1
O53157,O53157_MYCTU,Rv1466,Rv1466,GO:0005618; GO:0040007,IPR034904; IPR002744; ,,,DOMAIN 13 87 FeS_assembly_P. {ECO:0000259|Pfam:PF01883}.,Conserved protein,cell wall [GO:0005618]; growth [GO:0040007],9634230; 21969609,,,MSETSAPAEELLADVEEAMRDVVDPELGINVVDLGLVYGLDVQDGDEGTVALIDMTLTSAACPLTDVIEDQSRSALVGSGLVDDIRINWVWNPPWGPDKITEDGREQLRALGFTV,"12,384",115,,growth [GO:0040007],,cell wall [GO:0005618],,,2
O50423,O50423_MYCTU,Rv1167c,Rv1167c,GO:0000976; GO:0003700; GO:0005829,IPR009057; IPR001647; IPR011075; IPR036271; ,,,DOMAIN 17 77 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein,cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MTVSAPAKANPYRRRGEVLERALYDATLAELESAGYGGLTMEGIAARAQTGKAALYRRWAGKRELVLAAVQYALPPVPEPRADRSARENLLAVFTANCEILAGKTALPSMEIVSQLLHEPELRAIFINSVWAPRLRIVESILQAGVRSGEIDPATLTPMTARIGPALIHQHVLFTGSPPDREQLTRIIDAMILTTGERRES,"21,962",201,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
P71796,P71796_MYCTU,Rv1517,Rv1517,GO:0016021,IPR021315; ,,,,Conserved hypothetical transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MWTMVLLLGLGMAIDPARLGLAVVMLSRRRPMLNLFAFWVGGMVAGVGIALAVLVFMRDVALAAIQGVVSAANEFREAVGILAGGRLHIVIGVIMLLLAARMVARARAQVGVPVGPVGVADGGMSALALAQRPPGLVARLEVRTQQMLQGDVVWPAFVVGVASSAPPFESVVALTVIMASGAEIGTQLGAFVVFTLLVLAVIEIPLVAYLAIPQQTQQVMLRFQDWVRSNRRQISLTILIGVGFLFLYQGVTSL,"26,864",254,,,,integral component of membrane [GO:0016021],,,1
Q79FQ7,Q79FQ7_MYCTU,Rv1243c,PE_PGRS23 Rv1243c,,IPR000084; ,,PE_PGRS23,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS23,,9634230,,,MEYLIAAQDVLVAAAADLEGIGSALAAANRAAEAPTTGLLAAGADEVSAAIASLFSGNAQAYQALSAQAAAFHQQFVRALSSAAGSYAAAEAANASPMQAVLDVVNGPTQLLLGRPLIGDGANGGPGQNGGDGGLLYGNGGNGGSSSTPGQPGGRGGAAGLIGNGGAGGAGGPGANGGAGGNGGWLYGNGGLGGNGGAATQIGGNGGNGGHGGNAGLWGNGGAGGAGAAGAAGANGQNPVSHQVTHATDGADGTTGPDGNGTDAGSGSNAVNPGVGGGAGGIGGDGTNLGQTDVSGGAGGDGGDGANFASGGAGGNGGAAQSGFGDAVGGNGGAGGNGGAGGGGGLGGAGGSANVANAGNSIGGNGGAGGNGGIGAPGGAGGAGGNANQDNPPGGNSTGGNGGAGGDGGVGASADVGGAGGFGGSGGRGGLLLGTGGAGGDGGVGGDGGIGAQGGSGGNGGNGGIGADGMANQDGDGGDGGNGGDGGAGGAGGVGGNGGTGGAGGLFGQSGSPGSGAAGGLGGAGGNGGAGGGGGTGFNPGAPGDPGTQGATGANGQHGLNG,"47,285",562,,,,,,,1
P71780,P71780_MYCTU,Rv1499,Rv1499,,,,,,Uncharacterized protein,,9634230,,,MPSGEPSTAGHFEHLPRGSFGRILSVLNAAADHHPRELLVVGIATFDQKRPAVGVDEHDPGGAATPAVVINYESRSSAGGTIGHSTTSQVACCLYQQPKRPALRPTKAAATTAATTWIERVQNRRGRHSALV,"13,971",132,,,,,,,3
O05295,O05295_MYCTU,Rv1193,fadD36 Rv1193,GO:0008152; GO:0016874; GO:0040007,IPR025110; IPR020845; IPR000873; ,,fadD36,,Probable fatty-acid-CoA ligase FadD36 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; growth [GO:0040007]; metabolic process [GO:0008152],9634230; 21969609,,,MLLASLNPAVVSAADIADAVRIDGDVLSRSDLVGAATSVAERVAGAHRVAVLATPTASTVLAITGCLIAGVPVVPVPADVGVTERRHMLTDSGVQAWLGPLPDDPAGLPHIPVRTHARSWHRYPEPSPGAIAMVVYTSGTTGPPKGVQLSRRAIAADLDALAEAWQWTAEDVLVHGLPLYHVHGLVLGLLGSLRFGNRFVHTGKPTPAGYAQACYEAHGTLFFGVPTVWSRVAADQAAAGALKPARLLVSGSAALPVPVFDKLVQLTGHRPVERYGASESLITLSTRADGERRPGWVGLPLAGVQTRLVDDDGGEVPHDGETVGKLQVRGPTLFDGYLNQPDATAAAFDADSWYRTGDVAVVDGSGMHRIVGRESVDLIKSGGYRVGAGEIETVLLGHPDVAEAAVVGVPDDDLGQRIVAYVVGSANVDADGLINFVAQQLSVHKRPREVRIVDALPRNALGKVLKKQLLSEG,"49,520",473,,growth [GO:0040007]; metabolic process [GO:0008152],ligase activity [GO:0016874],,,,1
P71787,P71787_MYCTU,Rv1508c,Rv1508c,GO:0005886; GO:0016021; GO:0016758,IPR018584; ,,,,Probable membrane protein,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity, transferring hexosyl groups [GO:0016758]",9634230; 21969609,,,MIPVMSARFTGFPLLPVALRHGITSGRGCGFILDVGAQRPFGNDVLLSVATRKIRSRLPGDRVGNHGALLPFRAEPRRIQMKRPPEVLRGAVTASRERLWAIGSQSERTLMLGTILLASVISAATAYALSQWYAVDVFSTLLVVPGDCWLDWGMNIGRHCFSDYAMVAAAGIQPNPADYLISLPADYQPTAVAAWAPARIPYAIFGLPSHWLGAPRLGLICYLVALTMAVISPAIWAARGARGLERVVIFVTLGAAAIPAWGVIDRGNSTGFVVPIALAYFVALSRQRWGLATITVILAVLVKPQFVVLGVVLLAARQWRWAGIGITGVVVSNIAAFLLWPRGFPGTIAQSIHGIIKFNSSFGGLRDPRNVSFGKALLLIPDSIKNYQSGKIPEGFLTGPRTQIGFAVLVIVVVAVLALGRRIPPVMVGIVLLATATFSPADVAFYYLVFVLPIAALVARDPNGPPGAGIFDQLAAHGDRRRAVGVCVSLAVALSIVNVAVPGQPFYVPLYGQLGAKGVVGTTPLVFTTVTWAPFLWLVTCVVIIVSYARKPARPHDSHNGPTRESDQDTAASTTSCLPNPVEESSPRGPGPICQNYTP,"63,889",599,,,"transferase activity, transferring hexosyl groups [GO:0016758]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
Q11064,Q11064_MYCTU,Rv1254,Rv1254,GO:0009103; GO:0016020; GO:0016021; GO:0016747; GO:0040007,IPR002656; ,,,,Probable acyltransferase,"integral component of membrane [GO:0016021]; membrane [GO:0016020]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103]",9634230,,,MTLPKERAAQGGLERIAHVDRVASLTGIRAVAALLVVGTHAAYTTGKYTHGYWGLMSSRMEIGVPIFFVLSGFLLFRPWVKSAATGGPPPSLSRYAWHRVRRIMPAYTVTVLLAYLVYHFRTAGPNPGHTWVGLFRNLTLTQIYTDGYLGAFLHQGLTQMWSLAVEVAFYLALPALAYLLLVLVCRRRWQPRLLLATMAGLTMISPAWLILVHNTHWMPDGARLWLPTYLAWFVGGMMLAVLAAMGVRCYAFVAIPLAVICYFIVSTPIAGAPTTSPTALAEALVKTAFYAVIAVLAVAPLALGDQGWYAQLLASRPMVFLGEISYEIFLIHLVTMEIAMVDVLGYRVYTSSMVNLCLVTLVLTIPLAWLLHRFTRVQGDRPS,"42,314",383,,growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",integral component of membrane [GO:0016021]; membrane [GO:0016020],,,1
O53167,O53167_MYCTU,Rv1476,Rv1476,GO:0005886; GO:0040007,,,,,Possible membrane protein,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MTGPYFPQTIPFLPSYIPQDVDMTAVKAEVAALGVSAPPAATPGLLEVVQHARDEGIDLKIVLLDHNPPNDTPLRDIATVVGADYSDATVLVLSPNYVGSYSTQYPRVTLEAGEDHSKTGNPVQSAQNFVHELSTPEFPWSALTIVLLIGVLAAAVGARLMQLRGRRSATSTDAAPGAGDDLNQGV,"19,601",186,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
L7N692,L7N692_MYCTU,Rv1489,Rv1489,GO:0016021,IPR032808; ,,,,Conserved protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSGLTSPKTYAVLAALQAGDAVACAIPLPPIARLLDDLDVPVSVRPVLPVVKAASAVGLLSVTRFPALARLTTAMLTLYFILAVGAHVRVRDRVVNAIPAASFLTLFALMTAKGPERT,"12,306",118,,,,integral component of membrane [GO:0016021],,,1
Q79FQ6,Q79FQ6_MYCTU,Rv1290A,Rv1290A,,,,,,Uncharacterized protein,,9634230,,,MLALHGLSEGVSGSGGSGGRWGAGEVLEGARIGVIADGVSCFPTKADCRRIRGVPVFDGYTRMVARLMGSLAVLRSVSIPKGYRDFGFGSLRAVAPKNCPDVSG,"10,713",104,,,,,,,1
P71672,P71672_MYCTU,Rv1404,Rv1404,GO:0003700; GO:0005886; GO:0006351; GO:0006355; GO:0044212,IPR000835; IPR023187; IPR036388; IPR036390; ,,,DOMAIN 14 148 HTH marR-type. {ECO:0000259|PROSITE:PS50995}.,Probable transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (1),,MMPTEYPATAEESVDVITDALLTASRLLVAISAHSIAQVDENITIPQFRTLVILSNHGPINLATLATLLGVQPSATGRMVDRLVGAELIDRLPHPTSRRELLAALTKRGRDVVRQVTEHRRTEIARIVEQMAPAERHGLVRALTAFTEAGGEPDARYEIE,"17,521",160,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],plasma membrane [GO:0005886],,,1
O53161,O53161_MYCTU,Rv1470,trxA Rv1470,GO:0005886; GO:0015035; GO:0045454,IPR036249; IPR013766; ,,trxA,,Probable thioredoxin TrxA,plasma membrane [GO:0005886]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],9634230; 21969609,,,MTTRDLTAAYFQQTISANSNVLVYFWAPLCAPCDLFTPTYEASSRKHFDVVHGKVNIETEKDLASIAGVKLLPTLMAFKKGKLVFKQAGIANPAIMDNLVQQLRAYTFKSPAGEGIGPGTKTSS,"13,472",124,,cell redox homeostasis [GO:0045454],protein disulfide oxidoreductase activity [GO:0015035],plasma membrane [GO:0005886],,,2
O06830,O06830_MYCTU,Rv1428c,Rv1428c,GO:0005886; GO:0008152; GO:0016746,IPR016676; IPR002123; ,,,,Uncharacterized protein,"plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; metabolic process [GO:0008152]",9634230; 21969609,,,MSETDSPGNGDDAGIGDIGKFDPGLTQRLISVLRPVLKTYHRSQVHGLDSFPPGGALVVANHSGGMFPMDVPVFSVDFYDKFGYDRPVYTLSHDILFMGLTGDLFRRTGYIRATRENAAKALRSGGVVVVFPGGDYDAYRPTFAENVIDFNGRKGYVSTAVEAGVPIVPAVSIGGQESQLYLSRGTWLARRLGLKRLLRSDILPISFGFPFGFSAAIPPNLPLPAKIVMQVLDPINLTKQFGEDPDVDAVDEHVRSVMQQALNDLAAKRRFPILG,"29,912",275,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886],,,1
O06824,O06824_MYCTU,Rv1434,Rv1434,,,,,,Uncharacterized protein,,9634230,,,MRASPAERVDGAYAGAGPHTQSVLEEDQRQRAPAGAEAEGPGRTG,"4,606",45,,,,,,,1
O50451,O50451_MYCTU,Rv1234,Rv1234,GO:0005886; GO:0005887,,,,,Probable transmembrane protein,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MTSPFQPRQVPGSTPAAAGAGRRGVPALPTPPKGWPVGSYPTYAEAQRAVDYLSEQQFPVQQVTIVGVDLMQVERVTGRLTWPKVLGGGVLSGAWLGLFIGLVLGFFSPNPWSALVTGLVAGVFFGLITSAVPYAMARGTRDFSSTMQLVAGRYDVLCDPQNAEKARDLLARLAI,"18,605",175,,,,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O86312,O86312_MYCTU,Rv1219c,Rv1219c,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 6 65 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609; 24424575,X-ray crystallography (1),,MRSADLTAHARIREAAIEQFGRHGFGVGLRAIAEAAGVSAALVIHHFGSKEGLRKACDDFVAEEIRSSKAAALKSNDPTTWLAQMAEIESYAPLMAYLVRSMQSGGELAKMLWQKMIDNAEEYLDEGVRAGTVKPSRDPRARARFLAITGGGGFLLYLQMHENPTDLRAALRDYAHDMVLPSLEVYTEGLLADRAMYEAFLAEAQQGEAHVG,"23,181",212,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
O06831,O06831_MYCTU,Rv1427c,fadD12 Rv1427c,GO:0008152; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD12,DOMAIN 48 439 AMP-binding. {ECO:0000259|Pfam:PF00501}.; DOMAIN 448 523 AMP-binding_C. {ECO:0000259|Pfam:PF13193}.,Possible long-chain-fatty-acid--CoA ligase FadD12 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MRIRQAFGLIATMRRAGLIAPLRPDRYLRIVAAMRREGMGFTAGFAGAARRCPDRPGLIDELGTLTWRQLDERGNALAAALQALPAGPPRVVGIMCRNHRGFVDALLAVNRIGAHILLLNTSFAGPALAEVVTREGVDTVVYDEEFSATVDRALAEKPQATRIVAWTDEDHDLTVEKLVAAHAGRRPEHTGSHGKVILLTSGTTGTPKGARHSGGGIGTLKAILDRTPWRAEEVTVIVAPMFHAWGFSQLVLASSLACTIVTRRRFDPEATLDLIDRHHATGLVVVPVMFDRIMDLPAEIRNRYDGRSLRFAAASGSRMRPDVVIAFMDQFGDVIYNNYNATEAGMIATATPADLRTAPDTAGRPAEGTEIRILDQQFTEVPTGEVGTIYVRNDSQFDGYTSGAAKDFHAGFMSSGDVGYLDENGRLFVVGRDDEMIVSGGENIYPIEVEKTLATHPDVAEAAVIGVDDQQYGQRLAAFVVLKPGVSATPETLKQHVRDNLANYKVPRDIAVLDELPRGITGKILRTELQSRVGS,"58,064",535,,metabolic process [GO:0008152],ligase activity [GO:0016874],,,,1
O06832,O06832_MYCTU,Rv1426c,lipO Rv1426c,GO:0005886; GO:0008152; GO:0016021; GO:0016787; GO:0052572,IPR029058; IPR013094; ,,lipO,DOMAIN 182 390 Abhydrolase_3. {ECO:0000259|Pfam:PF07859}.,Probable esterase LipO,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metabolic process [GO:0008152]; response to host immune response [GO:0052572],9634230; 21969609,,,MRFRRMARPRPLTRAAVELLNAANGLRPLSGSGYSTVLAFWLGWPTSEVPGVYLGASVLDALRRGRRGDFGGLKGKAALALTAAAWVILAVIRYRGATTPGPVLEAGLTEQLGPDYAKELATLPTEPMRSRGRNLPLRTAMARRRYVETTNVVCYGPYGRANLADIWRRRDLPRDAKAPVLVQVPGGAWVLGWRRPQAYPLMSHLAARGWVCVSLNYRVSPRHTWPDHIVDVKRALAWVKENIAAYGGDPNFVAISGGSAGGHLCALAALTPNDPRFQPGFEQVDTSVAAAVPVYGRYDWFTTDAPGRREFVGLLETFVVKRKFSTHRDIFVDASPIHHVRADAPPFFVLHGRHDSLIPVAEAHAFVEELRAVSKSPVAYADLPHAQHAFDVFGSPRAHHTAEAVARFLSWVYATNPPAT,"46,097",420,,metabolic process [GO:0008152]; response to host immune response [GO:0052572],hydrolase activity [GO:0016787],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O05312,O05312_MYCTU,Rv1211,Rv1211,GO:0005509; GO:0033670; GO:0051336,IPR021465; ,,,,Conserved protein,calcium ion binding [GO:0005509]; regulation of hydrolase activity [GO:0051336]; regulation of NAD+ kinase activity [GO:0033670],9634230; 21969609,,,MLGADQARAGGPARIWREHSMAAMKPRTGDGPLEATKEGRGIVMRVPLEGGGRLVVELTPDEAAALGDELKGVTS,"7,810",75,,regulation of hydrolase activity [GO:0051336]; regulation of NAD+ kinase activity [GO:0033670],calcium ion binding [GO:0005509],,,,3
O06291,O06291_MYCTU,Rv1223,htrA Rv1223,GO:0004252; GO:0005618; GO:0005886; GO:0005887; GO:0040007,IPR001478; IPR036034; IPR009003; IPR001940; ,,htrA,DOMAIN 440 514 PDZ. {ECO:0000259|SMART:SM00228}.,Probable serine protease HtrA (DEGP protein),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; growth [GO:0040007],9634230; 21969609,,,MDTRVDTDNAMPARFSAQIQNEDEVTSDQGNNGGPNGGGRLAPRPVFRPPVDPASRQAFGRPSGVQGSFVAERVRPQKYQDQSDFTPNDQLADPVLQEAFGRPFAGAESLQRHPIDAGALAAEKDGAGPDEPDDPWRDPAAAAALGTPALAAPAPHGALAGSGKLGVRDVLFGGKVSYLALGILVAIALVIGGIGGVIGRKTAEVVDAFTTSKVTLSTTGNAQEPAGRFTKVAAAVADSVVTIESVSDQEGMQGSGVIVDGRGYIVTNNHVISEAANNPSQFKTTVVFNDGKEVPANLVGRDPKTDLAVLKVDNVDNLTVARLGDSSKVRVGDEVLAVGAPLGLRSTVTQGIVSALHRPVPLSGEGSDTDTVIDAIQTDASINHGNSGGPLIDMDAQVIGINTAGKSLSDSASGLGFAIPVNEMKLVANSLIKDGKIVHPTLGISTRSVSNAIASGAQVANVKAGSPAQKGGILENDVIVKVGNRAVADSDEFVVAVRQLAIGQDAPIEVVREGRHVTLTVKPDPDST,"54,190",528,,growth [GO:0040007],serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,3
O86349,O86349_MYCTU,Rv1457c,Rv1457c,GO:0040007; GO:0043190; GO:0043215; GO:0046677; GO:0055085; GO:1900753,IPR013525; IPR000412; IPR004377; ,,,,Probable unidentified antibiotic-transport integral membrane ABC transporter,ATP-binding cassette (ABC) transporter complex [GO:0043190]; daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth [GO:0040007]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 21969609,,,MTQTNRPAFPAGTFSPDPRPNAVPLMLAAQFSLELKLLLRNGEQLLLTMFIPITLLVGLTLLPMGSFGHNRAATFVPVIMALAVISTAFTGQAIAVAFDRRYGALKRLGATPLPVWGIIAGKSLAVVAVVFLQAIILGAIGFALGWRPALTALTLGAGIIALGTAGFAALGLLLGGTLRAEIVLAVANLMWFVFAGFGALTLESNVIPTAFKWVARVTPSGALTEALSQAMTVSVDWFGIVVLAVWGALAALAALRWFRFT,"27,371",261,,daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth [GO:0040007]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
P71806,P71806_MYCTU,Rv1378c,Rv1378c,GO:0005618; GO:0005886,IPR003870; IPR003615; ,,,DOMAIN 362 412 HNHc. {ECO:0000259|SMART:SM00507}.,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230,,,MGNLDLLLRLSGRIVKGCRPLGSVALARCGPAVRWPRWPRPAILEHMFDLVSLAGVDSRDDEASLTARIAELERVKSAAAAGQARAAAALDKLRRCNEADAGVPARRRGRGVASEVALARRDSPARGGRHLGFAKALVYEMPHTLAALEVGRLSEWRATLIVRESACLDVEDRRALDAELCADMSALDGMGDARIAAAARAIAYRLDAQAVVERAARAETERTVTIRPAPDTMTWVTALLPVARGVSVYAALKRAADTTFDDRTRGQVMADTLVERVTGQPAEAAQPVAVNLVLSDETLLAGDRAPAVVDGYGPIPAAVARNLVRDAVADTRSRATLRRLYRHPRSGALVAMESRARRFPKGLAAFIGLRDQRCRMPYCDAPIRHRDHAQPHHRGGPTTATNGLGSCERCNYVKEAPGWRVSTDTDETGRHTAEFTTPTGMYYHCTAPPLPGPLEIDVSQVEARIGVALTHLHAA,"51,256",475,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O06816,O06816_MYCTU,Rv1443c,Rv1443c,GO:0005886,IPR023393,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MVGYAEPVLIERQSVVAAPAEQVWQRVVTPEGINDELRPWMTMSVPRGAKGMTVDTVPIGAPIGRAWLRLFGVLPFDYDRLSIAELEPGRRFREDSTMLSMRQWQHERTVTPEGDTKTIVRDRITFQTRAGLRFAAPLIAAGLRALFGHRHRRLQRHFAQG,"18,316",161,,,,plasma membrane [GO:0005886],,,1
P71799,P71799_MYCTU,Rv1371,Rv1371,GO:0005576; GO:0005886; GO:0006629; GO:0016021,IPR001199; IPR036400; IPR005804; ,,,DOMAIN 31 89 Cytochrome b5 heme-binding. {ECO:0000259|PROSITE:PS50255}.,Probable conserved membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lipid metabolic process [GO:0006629],9634230,,,MTNDLPDVRERDGGPRPAPPAGGPRLSDVWVYNGRAYDLSEWISKHPGGAFFIGRTKNRDITAIVKSYHRDPAIVERILQRRYALGRDATPRDIHPKHNAPAFLFKDDFNSWRDTPKYRFDDPNDLLHRVKARLAEPALAARIKRMDTLFNAIVAVLAVGYFAVQGVRLVEPSWMPLWAFVIAMVLLRSSLAGFGHYALHRAQRGLNRVFNNAFDLNYVALSLVTADGHTLLHHPYTQSEVDIKKNVFTMMMRLPWLYRVPVHTIHKFGHMLSGMAIRIVDVFRITRKVGVEESYGSWRAALPHFLGSAGVRLLLVSELVVFAIAGDFWPWALQFVATLWVSTFLVVASHEFEDDTQGGAVNGEDWGIDQLEHANDLTVIGNRYVDCFLSAGLSSHRVHHVLPFQRSGFANIVTEDVLREEAAKFGVEWLPAKGFITDRLPRLCRKYLLTPSRQAKERHWGFVREHCSPAALKASASYVVAGFVGIGSV,"55,124",489,,lipid metabolic process [GO:0006629],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
O06823,O06823_MYCTU,Rv1435c,Rv1435c,GO:0005576,,,,,"Probable conserved proline, glycine, valine-rich secreted protein",extracellular region [GO:0005576],9634230; 21969609,,,MTLMAIVNRFNIKVIAGAGLFAAAIALSPDAAADPLMTGGYACIQGMAGDAPVAAGDPVAAGGPAAAGACSAALTDMAGVPFVAPGPVPAAAPVPIGAPVPIPGAPVPIPGAPVPIPGGPVPIPGAPVPVPAVPAPVIPVGTPLIALGPVLAGAPGDGVVSAPIIGMSGVKDALTDPAPAGGPVPGQPVLPGPSASAPAGAR,"18,506",202,,,,extracellular region [GO:0005576],,,1
O50442,O50442_MYCTU,Rv1186c,Rv1186c,GO:0005576; GO:0005618; GO:0040007,IPR025736; ,,,DOMAIN 475 533 HTH_30. {ECO:0000259|Pfam:PF13556}.,Conserved protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; growth [GO:0040007],9634230; 21969609,,,MRIAGVGLGQLLLALDATVVSLVDAPRGLDLPVASTALIDSDDVRLGLAAAAGSADVFFLIGVTDDEAVRWVDDQARQRAPVAIFVKHPSDSVVAGAVRAGSAVVAVEPRARWERLYHLVNHVLEHHGDRADPTDDSGTDLFGLAQSLADRIHGMISIEDAQSHVLAYSASNDEADELRRLSILGRAGPPEHLQWIGQWGIFDALRPGREVVRVAERPELGLRPRLAIGIHQPGVGALRPPVFAGTIWVQQGSQPLADDAEEMLRGAAVLAARIMSRLATQPNTHALRVQQLLGLAELNATTAPVDVSTIARELGVAAEGNATLIGFDTAENRDTAVRHVRLVDVMALSASAFRHDAQVAANGSRIYVLLPQTTTGRAVTSWVRGTISALRAELGVALRAAIAGPVAGLAEVNPARVEVDRVLESAERHPILGQVTSLAEARTTVLLDEIVTLVGTDQRLVDPRIRDLGAQDPVLAQTLRAYLDAFGDIGAAARSLQVHPNTVRYRIRRIEQLLSTSLGDPDVRLLFSLGLRAMERTA,"57,530",538,,growth [GO:0040007],,cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
L7N6A7,L7N6A7_MYCTU,Rv1214c,PE14 Rv1214c,,IPR000084; ,,PE14,,PE family protein PE14,,9634230,,,MLASAATDLAGIGSALSAANAAAAAPTTAMLAACADEVSAVVASLFARHAQAYQALSLQATAFHQQFVQALTGAGGAYAAAEAVNAAVAQSVQQDVLNVINAPTQALFDR,"10,846",110,,,,,,,1
O06829,O06829_MYCTU,Rv1429,Rv1429,GO:0005886,IPR025736; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAEAGGGPISVIARHMQLIRDDFISELFDKMKAEIRGLDYDARMADLWRASITENFVTAVHYLDRDTPQSLVEAPAAALAYARAAAQRDIPLSGLVRAHRLGHARFLEVAMQYVSLLEPADRVSTIIELVNRSARLVDLVADQLIVAYEHEHDRWLSRRSGLQQQWVSELLADTPVDVPRAERALGYRLDGVHIAAVVWVDSAVPIGDVVAQFDQVRCLLAGELGPELGPVANSLMVPTDEREARLWFSPAPTRAFAPSRIRAAFESAGIRARLACGRVGDGLRGFRASLKQAERVKALALAGGARPGGRVMFYDDVAPVALLADDLEELRRFVTDVLGDLSVDDERNSWLRETLREFLLRNRSYVATADAMILHRNTIQYRVIQAMELCGQNLDDPDAAFRVQMALEVCRWMAPAVLRAKQ,"46,899",422,,,,plasma membrane [GO:0005886],,,1
O08377,O08377_MYCTU,Rv1534,Rv1534,GO:0000976; GO:0003700; GO:0005829,IPR023772; IPR009057; IPR001647; IPR036271; ,,,DOMAIN 18 78 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulator,cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MSRASARRRRAVSDEDKSQRRDEILAAAKIVFAHKGFHATTVADIAKQAGLAYGLIYWYFDSKDDLFHALMAGEEEALRAHVAAELARVGGSTEAPLRALLQAAVQATFEFFETDKATVKLLFRDAYALGGRFEEHLGGIYERFIDDIEAVVVAAQRRGEVVEAPSRMAAYTLAALVGQLAHRRLNTDDNVTAAQVADFVVSLVLDGLRPRALAVGARGGRAART,"24,501",225,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O53154,O53154_MYCTU,Rv1463,Rv1463,GO:0005524; GO:0005886; GO:0016887; GO:0040007,IPR003593; IPR003439; IPR010230; IPR027417; ,,,,Probable conserved ATP-binding protein ABC transporter,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth [GO:0040007],9634230; 21969609,,,MTILEIKDLHVSVENPAEADHEIPILRGVDLTVKSGETHALMGPNGSGKSTLSYAIAGHPKYHVTSGTITLDGADVLAMSIDERARAGLFLAMQYPVEVPGVSMSNFLRSAATAIRGEPPKLRHWVKEVKAAMAALDIDPAFAERSVNEGFSGGEKKRHEILQLELLKPKIAILDETDSGLDVDALRVVSEGVNRYAESQHGGILLITHYTRILRYIHPEYVHVFVGGRIVESGGSELADELDQNGYVRFSPASGRYPHQPAPTGA,"28,823",266,,growth [GO:0040007],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
O05293,O05293_MYCTU,Rv1191,Rv1191,,IPR029058; IPR000073; ,,,DOMAIN 37 133 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Conserved protein,,9634230; 21969609,,,MAVAIARPKLEGNIAVGEDRRIGFAEFGAPQGRAVFWLHGTPGARRQIPTEARVYAEHHNIRLIGVDRPGIGASTPHQYETILAFADDLRTIADTLGIDKMAVVGLSGGGPYTLACAAGLPDRVVAAGVLGGVAPTRGPDAISGGLMRLGSAVAPLLQVGGTPLRLGASLLIRAARPVASPALDLYGLLSPRADRHLLARPEFKAMFLDDLLNGSRKQLAAPFADVIAFARDWGFRLDEVKVPVRWWHGDHDHIVPFSHGEHVVSRLPDAKLLHLPGESHLAGLGRGEEILSTLMQIWDRDLRK,"32,612",304,,,,,,,3
P71805,P71805_MYCTU,Rv1377c,Rv1377c,GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Putative transferase,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MPGIDFDALYRGESPGEGLPPITTPPWDTKAPKDNVIGWHTGGWVHGDVLDIGCGLGDNAIYLARNGYQVTGLDISPTALTTAKRRASDAGVDVKFAVGDATKLTGYTGAFDTVIDCGMFHCLDDDGKRSYAASVHRATRPGATLLLSCFSNAMPPDEEWPRSTVSEQTLRDVLGGAGWDIESLEPATVRRELDGTEVEMAFWNVRAQRRGS,"22,815",212,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,3
O06826,O06826_MYCTU,Rv1432,Rv1432,,IPR036188; ,,,,Probable dehydrogenase,,9634230; 21969609,,,MTTAVVVGAGPNGLAAAIHLARHGVDVQVLEARDTIGGGARSGELTVPGVIHDHCSAFHPLGVGSPFWAAIDLQRYGLTWKWPDVDCAHPLDDGTAGVLYRSIEATAAGLGPDGKRWQRAVGDLAAGFDELAEDLLRPVLNMPRHPIRLARFGPRAALPATAMARRFHTERARALFGGAAAHVYTRLDRPLTASLGLMILASGHRHGWPVARGGSGSITKALAAALDAYGGTVATGVTVTSRRDIPDADIVMLDLSPAAVLGIYGDVMPTRINRSYRRYRAGSSAFKVDFAIEGDVGWTNPDCRRAGTVHLGGTFAEIADTERQRAQGTMVQRPFVLVGQQYLADPSRSVGNINPIWAYAHVPFGYTGDATAAVIDQIERFAPGFRDRIVATVSTSTTELQTYNRNFIGGDIIGGANDRLQVIFRPRVAVDPYAIGVPGVYLCSQSAPPGAGIHGLCGYHAAESALRWLRKRR,"50,476",473,,,,,,,1
O05305,O05305_MYCTU,Rv1204c,Rv1204c,,IPR003593; IPR027417; ,,,,Uncharacterized protein,,9634230; 21969609,,,MRVWKHVEAAVDSPDRCGVVLVGPHGVGKTLLAQLAAEQVMSEDGRSGRARWVVGTAPGRAIPFGAFRHLISLPASGADIGRPAALLRAARSSLTGDAGDLLLVVDDAHNLDPLSATLVYQLARAGAARLVVTVASEAEPPDAIAALWSDDLLTRVAIEPLDRAQTAAFVESALDATLDVADADELFRRSLGNPLYLRHLIDGGGLEHVDGRWRCRDEDRRPLSGVIDEYLCALPEPARAVVDYLAIAEPLARTDLVALVGGEQLDTLGQAEAAGAVRVGPDSDTSEIFVGHPLYADRARAVLTAEHAHALRVSLVAQLAKHPSDHVSDQLRLSSLAIDVPASATPAAVTDAATAAGQALRLGDVRLAERLARAALDRSDALAARLPLAYALGWQGRGREADAVLAAVNPAELTETELMAWAIPRAANRFWMLNEPERATAFLQTTRSRVTEPTARSTLDALAATFAMNSGNLPRAITLATEVLSGPAADDMAVAWAASAAALSSARMGRFGDVDRLAERASAAEHPGLLRFTVGLAQITSLLLAGDVAPAQELAKRFTDFA,"59,219",562,,,,,,,1
O50443,O50443_MYCTU,Rv1187,rocA Rv1187,GO:0000166; GO:0003842; GO:0010133; GO:0016620; GO:0040007; GO:0046872,IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR005931; ,,rocA,,Probable pyrroline-5-carboxylate dehydrogenase RocA,"1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; growth [GO:0040007]; proline catabolic process to glutamate [GO:0010133]",9634230; 21969609; 24699642; 25557497,X-ray crystallography (6),,MDAITQVPVPANEPVHDYAPKSPERTRLRTELASLADHPIDLPHVIGGRHRMGDGERIDVVQPHRHAARLGTLTNATHADAAAAVEAAMSAKSDWAALPFDERAAVFLRAADLLAGPWREKIAAATMLGQSKSVYQAEIDAVCELIDFWRFNVAFARQILEQQPISGPGEWNRIDYRPLDGFVYAITPFNFTSIAGNLPTAPALMGNTVIWKPSITQTLAAYLTMQLLEAAGLPPGVINLVTGDGFAVSDVALADPRLAGIHFTGSTATFGHLWQWVGTNIGRYHSYPRLVGETGGKDFVVAHASARPDVLRTALIRGAFDYQGQKCSAVSRAFIAHSVWQRMGDELLAKAAELRYGDITDLSNYGGALIDQRAFVKNVDAIERAKGAAAVTVAVGGEYDDSEGYFVRPTVLLSDDPTDESFVIEYFGPLLSVHVYPDERYEQILDVIDTGSRYALTGAVIADDRQAVLTALDRLRFAAGNFYVNDKPTGAVVGRQPFGGARGSGTNDKAGSPLNLLRWTSARSIKETFVAATDHIYPHMAVD,"58,841",543,,growth [GO:0040007]; proline catabolic process to glutamate [GO:0010133],"1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,1
L7N6B6,L7N6B6_MYCTU,Rv1507A,Rv1507A,,,,,,Uncharacterized protein,,9634230,,,MQSGQNILAKVCNLIEQSRLSSTRCLQFRITNTSRPRQLRWSEFKRFCDIFNMVLGKARMGRDPGRPVRDERRIVSCEIIASDHIGLAAARLLAKRYRGRSVSGFVLMIKSASVHEIDSWSSPSVAMSIGVALCSYPHYAAARTSPPNRDWGEDTTRSRPVTGLLAG,"18,653",167,,,,,,,1
O50427,O50427_MYCTU,Rv1171,Rv1171,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MGHRVDTLSDRQRANLTTGATDRAIRLVVLALLTVDGVVSALAGALLMPWYIGSAPFPISALISGLVNAALVWAAARWTTSSRVAALPLWAWLLTVAAMSFGGPGDDVILGGQGLLVYGALVFVVAGAVPPAWVLWRRRVQADGSG,"15,218",146,,,,integral component of membrane [GO:0016021],,,3
O06178,O06178_MYCTU,Rv1532c,Rv1532c,,IPR029069; IPR003736; IPR006683; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSDPLTAQEQHKRRQAVRELMPRTPFIGGLGIVFERYEPDDVVIRLPFRTDLTNDGTYFHGGVIASVMDTAGAAAAWSNHDFDRGTRAATVAMSIQYTGAAKRCDLLCHARTARRRKELTFTEITATDPDGNIVAHAVQTYRIV,"16,007",144,,,,,,,1
L0T8G4,L0T8G4_MYCTU,Rv1503c,Rv1503c,GO:0003824,IPR000653; IPR015424; IPR015422; ,,,,Uncharacterized protein (Fragment),catalytic activity [GO:0003824],9634230,,,DFLLRAEILREKGTNRSRFLRNEVDKYTWQDKGSSYLPSELVAAFLWAQFEEAERITRIRLDLWNRYHESFESLEQRGLLRRPIIPQGCSHNAHMYYVLLAPSADREEVLARLTSEGIGAVFHYVPLHDSPAGRRYGRTNGNLTVTNDVASRLIRLPMWVGLQEVDQSRVVEALTRILTLRA,"21,096",182,,,catalytic activity [GO:0003824],,,,1
O53158,O53158_MYCTU,Rv1467c,fadE15 Rv1467c,GO:0005618; GO:0005886; GO:0016627; GO:0050660,IPR025878; IPR020953; IPR006091; IPR036250; IPR009075; IPR037069; IPR009100; ,,fadE15,,Probable acyl-CoA dehydrogenase FadE15,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MGHYIANVRDLEFNLLEVLDIGAVLGTGRYSDLDVDTVRTILAEAARLAEGPIAESFGYADRNPPVFDPNTHSISVPDELAKTVQAIKEAGWWRLGLAEEIGGMPAPPPLAWAVNEMIYCANPSACFFNLGPVLAQSLYIEGNDEQRRWAAEGVQRGWQATMVLTEPDAGSDVGAGRTKAFEQPDGTWHIEGVKRFISGGDVGNTAENIFHLVLARPEGAGPGTKGLSLFYVPNYLFDPDTFELGARNGVYVTGLEHKMGLKSSPTCELTFGGADVPAVGYLVGGVHNGIAQMFTVIEHARMTIGVKSAGTLSTGYLNALAFAKERVQGADLTQMTDKTAPRVTIMHHPDVRRSLMTQKAYAEGLRALYLYAAAHQDDAVAQRVSGADHDMAHRVDDLLLPIVKGVGSERAYEILTESLQTLGGSGFLVDYPLEQYIRDAKIDSLYEGTTAIQALDFFFRKIVRDHGKALQFVLAQVTHTVENIDPSLKPQAELLRTALDDITAMTGALTGYLMSAAQHSSDIYKVGLGSVRYLLAVGDLLIGWRLLVLAGVAHAALADGPSQNDEAFYRGKIAVAAFFAKNMLPKLTGVRSVIENIDDDIMRVPEDAF,"65,924",609,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
Q79FN7,Q79FN7_MYCTU,Rv1479,moxR1 Rv1479,GO:0005524; GO:0005618; GO:0005886; GO:0016887; GO:0040007,IPR011703; IPR027417; ,,moxR1,,Probable transcriptional regulatory protein MoxR1,cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth [GO:0040007],9634230; 21969609,,,MTSAGGFPAGAGGYQTPGGHSASPAHEAPPGGAEGLAAEVHTLERAIFEVKRIIVGQDQLVERMLVGLLSKGHVLLEGVPGVAKTLAVETFARVVGGTFSRIQFTPDLVPTDIIGTRIYRQGREEFDTELGPVVANFLLADEINRAPAKVQSALLEVMQERHVSIGGRTFPMPSPFLVMATQNPIEHEGVYPLPEAQRDRFLFKINVGYPSPEEEREIIYRMGVTPPQAKQILSTGDLLRLQEIAANNFVHHALVDYVVRVVFATRKPEQLGMNDVKSWVAFGASPRASLGIIAAARSLALVRGRDYVIPQDVIEVIPDVLRHRLVLTYDALADEISPEIVINRVLQTVALPQVNAVPQQGHSVPPVMQAAAAASGR,"40,763",377,,growth [GO:0040007],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O05304,O05304_MYCTU,Rv1203c,Rv1203c,,,,,,Uncharacterized protein,,9634230,,,MLLAYVLITKGEFGAAASMLEPAAATLERTGYSWGPLSLMLLATAIAQQGHIAESAKTLQRAEARHGTKSALFAPELGLARAWTRAAAQDMTGAIAAAREAARTAERAGQAAVALCAWHNAVRLGDIRAVDPVTRLAAEIDCTVGNILVKHARGLADGDAAELTAVAEELAGIGMAAAAADATKAAARLGPQQR,"19,906",194,,,,,,,1
O05307,O05307_MYCTU,Rv1206,fadD6 Rv1206,GO:0004467; GO:0006633,IPR025110; IPR020845; IPR000873; IPR030310; ,,fadD6,,Probable fatty-acid-CoA ligase FadD6 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MSDYYGGAHTTVRLIDLATRMPRVLADTPVIVRGAMTGLLARPNSKASIGTVFQDRAARYGDRVFLKFGDQQLTYRDANATANRYAAVLAARGVGPGDVVGIMLRNSPSTVLAMLATVKCGAIAGMLNYHQRGEVLAHSLGLLDAKVLIAESDLVSAVAECGASRGRVAGDVLTVEDVERFATTAPATNPASASAVQAKDTAFYIFTSGTTGFPKASVMTHHRWLRALAVFGGMGLRLKGSDTLYSCLPLYHNNALTVAVSSVINSGATLALGKSFSASRFWDEVIANRATAFVYIGEICRYLLNQPAKPTDRAHQVRVICGNGLRPEIWDEFTTRFGVARVCEFYAASEGNSAFINIFNVPRTAGVSPMPLAFVEYDLDTGDPLRDASGRVRRVPDGEPGLLLSRVNRLQPFDGYTDPVASEKKLVRNAFRDGDCWFNTGDVMSPQGMGHAAFVDRLGDTFRWKGENVATTQVEAALASDQTVEECTVYGVQIPRTGGRAGMAAITLRAGAEFDGQALARTVYGHLPGYALPLFVRVVGSLAHTTTFKSRKVELRNQAYGADIEDPLYVLAGPDEGYVPYYAEYPEEVSLGRRPQG,"64,337",597,,fatty acid biosynthetic process [GO:0006633],long-chain fatty acid-CoA ligase activity [GO:0004467],,,,1
Q11028,Q11028_MYCTU,Rv1358,Rv1358,GO:0003677; GO:0005886; GO:0006351; GO:0006355,IPR029787; IPR027417; IPR016032; IPR011990; IPR000792; IPR036388; ,,,DOMAIN 1093 1158 HTH luxR-type. {ECO:0000259|PROSITE:PS50043}.,Probable transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,,MFLSAPAFRVEPTRSRHSALRWARHRRFADGPRWQMLRSLQIADQIARTGHMPVRRLDLIWISARNAARRELDLGVAALVEAVTLLTADVEGSTRLSQTRLNELAADYPTLDQNISEAVAAHGGVTRPVDQEVGSGLVVAFLRAGDAIACALELQLSTLAPMRPRVGVHTGDVRLRGDGTITGSAINESACLRDLAHEGQTLLSAATGDLVIDQLPANTWLTDVGKYPLRGLHRQERVIQLCHRDLRNEFPPLRMSVGNRSSLPAQFTTFVGRDAQINEVQEVLTNYRLVTLRGEGGVGKTRLAIQIAAASEFRDGLCFVDLAPIADPGMVSTTAAHALGLIDRPGSSTFDTLSHAIGNCHMLMVLDNCEHVLDACAELVVELLGACPELSILATSRESIGVTGEVTWVVPSLSPANEAIQLFTERARLVQPNFEIVADNFDAVSEICRRLDGMPLAIELAAARLRSLSPNEIANSLDDRFRLLTGGARSTVQRQQTLRASMDWSYALLTDTERILFRRLAVFVGGFDLTAASEVAAAGGDDFVERYSVLDQLTLLVDKSLVVAEESRGSTRYRLLETVRQYALEKLNESEEIDGVRARHRTHYATMAAGLNVPASTDYEQRLLQAEAEIDNLRAAFTWSRGNGDIAAALQLASALQPLWSQGRMREGLAWLESILEREGDNHLVPAGVWARALAEKVILKAWPATSPMGAPDIVAQAHHALALARDAGDCAVLARALVACGCGSGCDTEAAQPYFAEAIELARAINDEWTLSQIDYWQVVGIFISGQPIPLRAAAEQARELADSIGNRFVSRQCRLFACLAQIWEGDANGALALSRDVTAEAEVANDVVTKVLGLYVEAMALSYIGDSAARTIAGAALEAATELGGIYQDLGYGAITRAALAAGDVAAIEASEASWDLRNQHNVVTAHHELMAQAALVRGDVTTARRFADEAVLASTGWHLMMALIARARVAIAQDELGKARDDAHAAVACGVGVQTYLAMPDALELLAGLAGEAGNHGQAVRLFGAAAAQRQRTGEVRHKIWDAGYEAATAALRDAMGDEDFTAAWAEGAAAPLDEAIAYAQRGRGERKRPSNGWDALTPAEHKIVKLVTEGLVTKDIAARLFVSPRTVQTHLTHIYTKLDVTSRVQLVQEAAQHST,"125,056",1159,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],plasma membrane [GO:0005886],,,1
O50435,O50435_MYCTU,Rv1179c,Rv1179c,GO:0003677; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0016787,IPR006935; IPR014001; IPR027417; ,,,,Uncharacterized protein,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],9634230; 21969609,,,MDPHRDLESRAFAGNWRVYQQQALDAFDADVAAGDNRAYLVLPPGAGKTMIGLEAARRLGRRSLVLVPNTAVQAQWAAAWDNSFPSSDRSASKCGTERGLASAMNVLTYQSLAVIDAETDSTVRREVLRNRDQQALLDLLHPNGRAVIERAATLGPWTLVLDECHHLLATWGALVSALASVLGAQTALIGLTATPATELTAWQHTLHDELFGTADFVIPTPALVREGDLAPYQELVYLTQPTPEEQAWIGTHRARFADLMLALIDQKVGSMSLAAWLHTRIVDRATREGNQIAWSTFERAEPDLACSGLRFAYDGLIPLPDGVRLREQHRIAPDAQDWVNVLTDFSVGHLQQSADPRDAHALTAIKRVLPGLGYRLTSRGVRVATSPVDRLCALSESKIAATAHILDTEDAVLGARLRALVLCDFESMTGALPTSLKGAPVSEQSGSAQLVAAMLAASDHRRRTPLHALLVTGQTFACPAAIEDDLIAFCAERGALVTAEPLDAHPSLRVMRGTGGFTPRTWVALATEYFLAGRARVLVGTRSLLGEGWDCAAVNVNIDLTSATTQAAITQMRGRAIRNDPSDGHKVADNWSVCCIATEHPRGDADYLRLVRKHDGYYAATPQGLIESGVTHCDPSLSPYGPPVTDTHAITARALQRVAERAQARSWWRIGEPYEGVDVATIRVRSRQPLGVAAPRIPASALTPPVPGQFSPVRLARGAVAAVSVVGASTATAVASANLGMLAGAGTAGAIVAAGVGLVATAAAAESRRLDHAPNALEQLAAVVADALYAAGGAQRGSAALRLASDPEGWIRCQLDGVPTEQSLRFTAALDELLAPLAEPRYLIGRKILTPPARPVARRLFAVRAVVGLSLPGTVAWHAVPRWFARNKDRRQHLAQAWRKHIGPPRQLPADSPQGQAILDLFRGDNPLSVTTQLRTTWR,"100,674",939,,,ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q79FN0,Q79FN0_MYCTU,Rv1508A,Rv1508A,GO:0008446; GO:0019673,IPR006368; IPR016040; ,,,,Uncharacterized protein,"GDP-mannose 4,6-dehydratase activity [GO:0008446]; GDP-mannose metabolic process [GO:0019673]",9634230,,,MKRALITGITGPDGSYLAKLPLKGYVAAGSPAEVYFCWATRNYRELYGLLAVNSIWFNHESPRHGETFMTRNPAPYRGRQRGADRCADADAPAHPDRYQYWGVPASVRGVIDRAMGVCVE,"13,349",120,,GDP-mannose metabolic process [GO:0019673],"GDP-mannose 4,6-dehydratase activity [GO:0008446]",,,,1
O33222,O33222_MYCTU,Rv1226c,Rv1226c,GO:0005886; GO:0016021,IPR005182; IPR014529; ,,,,Probable transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MTDRPHDWHRLSPRMLLVHPVHEMLRQLPVLIGSVVLGSATGNPVWPLAALGVTVVFGVLRWFFTTYRIDDENVSLRTGILSRRAVSVPRNRIRSVQTEARLLHRLLGLTVLRVGTGQEARGEAAFELDAVDSARVPRLRALLLAESLAPVEPTGRVLARWQSSWLRYAPLSFSGLVMIGAVIGLGYQTGLAVRLPESGFARSAVDAAQRAGVVLVVAVTVLLVVGVSALLAVLFSWLTYGNLLLRRGGSGQEGVLHLRHGLLRVREHTYDMRRLRGATLREPLLVRLLRGARLDAVMTGVHGEGQSSMLLPPCPFETATAVLTDLIDNTDAAAGPLRRHGPAAARRRWTRALLVPTLAGVALIAAAPILGVPGWAWTLWAVLTAGCAGLAVDRVRSLGHRVADGWLVARAGSLQRRRDCIACTGIIGWTVRQTLFQRRAGVATLVAATVAGRKGYQVLDVPAELAWSVAGAASPWVADSVWLRHGS,"52,598",487,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O50464,O50464_MYCTU,Rv1249c,Rv1249c,GO:0005886; GO:0042783,,,,,Possible membrane protein,plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MSARRIRSWKRFDNRSANAAEPDPQLAGTGGRPKVSTRALAQVIERSSRIQGPAAQAYVARLRRAHPGASPAKIVAKLEKRFLSVVTASGAAVGAAATLPGIGTLAAWFAAAGEVVVFLEATALFVLALASVHAIPLDHRERRRALVLAVLVGDNTTAVADLLGPGRTSGGWVSETMASLPLPAISSLNSRMLKYVVKRFALKRGALMFGKLVPMGIGAIIGAIGNRLVGKKLVRNARSAFGTPPARWPVTLHVLPTVRDAS,"27,571",262,,active evasion of host immune response [GO:0042783],,plasma membrane [GO:0005886],,,1
Q79FR5,Q79FR5_MYCTU,Rv1169c,lipX Rv1169c,GO:0004806; GO:0040007; GO:0052572,IPR000084; ,,lipX,,PE family protein. Possible lipase LipX,triglyceride lipase activity [GO:0004806]; growth [GO:0040007]; response to host immune response [GO:0052572],9634230; 21969609,,,MSFVTTRPDSIGETAANLHEIGVTMSAHDDGVTPLITNVESPAHDLVSIVTSMLFSMHGELYKAIARQAHVIHESFVQTLQTSKTSYWLTELANRAGTST,"10,872",100,,growth [GO:0040007]; response to host immune response [GO:0052572],triglyceride lipase activity [GO:0004806],,,,1
V5QQR7,V5QQR7_MYCTU,Rv1366A,Rv1366A,,,,,,Conserved protein,,9634230; 21969609,,,MRPSRQGEVGEVAGYVVEYNRRTHVRRITEFATPQEAMEHRLKLEAERTDSNIEIVALVSKSLGTLKQTHSRYFTGEELNVGNGAR,"9,773",86,,,,,,,1
P71664,P71664_MYCTU,Rv1396c,PE_PGRS25 Rv1396c,,IPR000084; ,,PE_PGRS25,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS25,,9634230,,,MSFLFAQPEMLGAAATDLASIGSAISTANAAAAAATTRVLAAGADEVSAAVAALFSGHAQTYQALRTQAAAFHQQIVQTLTSTAGAYASAEAANVEQQLLGAINAPTMALLGRPLIGHGADGAPGTGQAGGAGGILYGNGGNGGSGATGQAGGAGGAAGLIGHGGAGGLGGTGASGGAGGAGGWLWGNGGAGGNGGVGVAGDPGGVGGAGGAGGAAGLWGSGGSGGTGGQGGVGGGKSGDGGTGGIGGAGGGGGWLHGDGGAGGHGGQGGTGVSSGGNGGAGGTGGDGRGLSGSGGAGGRGGQTGVGGKVGENNFGGAGGAGGTGGLIGNGGAGGNGGQGAISGAGGAGGNAWLIGDGGAGGNGGDIRGQGGGAGGAGGAGGQLIGNGGTGGAGGTVTSPNGLGGAGGAGGSAGLIGHGGTGGAGGHSAQGPDGNGGIGGAGGAGGNGGQLYGTGGTGGTGGKGGDGFGVFGKGGAGGTGGRGGAAGLIGDAGTGGTGGKGGTAGEDGTGGNGGTGGNGGAAVLIGNGGGGGAGGNGGAGNDGTPGNGGGGGVGGTGGTLFGQPGQPGPPGQPGPA,"47,900",576,,,,,,,1
O33221,O33221_MYCTU,Rv1225c,Rv1225c,,IPR036412; IPR006357; IPR023214; IPR006355; ,,,,Uncharacterized protein,,9634230; 21969609,,,MDVAHLMAAAVLFDIDGVLVLSWRAIPGAAETVRQLTHRGIACAYLTNTTTRTRRQIAEALGAAGIPVAADDVITAGVLTAEYLHGAYPGARCFLVNNGDITEDLPGIDVVLSTEIGPEDCPEAPDVVVLGSAGPQFDHRTLSRVYGWMLDGVPVVAMHRNMTWNTTDGLRIDTGMYLTGMEQACGKTATAIGKPAAEGFLAAADRVGVDPQQMVMIGDDLHNDVLAAQAVGMTGVLVRTGKFRQQTLDRWLAGASATRPHHVIDSVAGLPPLLGC,"29,121",276,,,,,,,2
O06807,O06807_MYCTU,Rv1453,Rv1453,GO:0005618; GO:0005886,IPR025736; ,,,,Possible transcriptional activator protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MALRETSPRIHELIREAARIALNPTQEWLDEFDRAILAANPSIAADPALATVVKRSNRAHLIHFAAANLRNPGAPVPANLGPEPLRMARDLVRVGLDALALDIYRIGQNVAWRRWTDIAFGLTSDPDELHELLDVPFRTANEFVDTTLAGITTEMQLERDKLTRDVPAERRKIVQLLIDGAPISREHAEARLGYPLDRSHTAAVIWGDQAQGDHSHLDRVADAFGHAGGCPHPLVVVAGAATRWVWVKDAPGFDIDLIHEVLHDIPDARIAIGATAPGIEGFRRSHRDALTTARMIIRLESPHRVAFFTDVEMVALLTENAEGADDFIQRTLGNLESASPALKTTLLTFINQQCNASRAARLLFTHRNTLMNRLETAQRLLPRPLADTTIHVAVALEAQQWREKPTSDPPAKKESNGTKMR,"46,593",421,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
O86316,O86316_MYCTU,Rv1233c,Rv1233c,GO:0016021,IPR025241; ,,,,Conserved hypothetical membrane protein,integral component of membrane [GO:0016021],9634230,,,MTAPSGSSGESAHDAAGGPPPVGERPPEQPIADAPWAPPASSPMANHPPPAYPPSGYPPAYQPGYPTGYPPPMPPGGYAPPGYPPPGTSSAGYGDIPYPPMPPPYGGSPGGYYPEPGYLDGYGPSQPGMNTMALVSLISALVGVLCCIGSIVGIVFGAIAINQIKQTREEGYGLAVAGIVIGIATLLVYMIAGIFAIP,"19,899",198,,,,integral component of membrane [GO:0016021],,,3
O86313,O86313_MYCTU,Rv1230c,Rv1230c,GO:0003677; GO:0003700; GO:0005576; GO:0005618; GO:0016021,IPR001827; IPR023346; IPR031304; ,,,DOMAIN 194 248 SLT_2. {ECO:0000259|Pfam:PF13406}.,Possible membrane protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],9634230,,,MHIGGRWGARPAVAAVRRGACRLTRAPAFGVAAIAPLVFASAVGSAAPVFPGRTAPVHAVITPVAAVAASGIDLSGPVVIAMKRPPTSFRVAVATISAPPPPMIVNSPGALGIPAMALSAYRNAELKMAAAAPGCGVSWNLLAGIGRIESMHANGGATDARGTAIQPIYGPTLDGTLPGNEIIIQSSVGNRVTYARAMGPMQFLPGTWARYATDGDDDGVADPQNLFDSTLAAARYLCSGGLNLRDPAQVMAALLRYNNSMPYAQNVLGWAAGYATGVFPVDLPPITGPPPPLGDAHLENPEGLGPGLPINVNGLTADGPMAHLPLIDLTPRQAALNPPPMFPWMAPDPSAPMPGCTLICIGSHGPPVGAPPFPPTAPPPPFLPAAPPPPDPLAGPPGDAGLAPPAPAPAG,"41,417",411,,,DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O06820,O06820_MYCTU,Rv1439c,Rv1439c,,IPR032710; IPR037401; ,,,DOMAIN 10 109 SnoaL-like. {ECO:0000259|Pfam:PF12680}.,Uncharacterized protein,,9634230; 21969609,,,MQMSASNAFVEGFADFWKAPSPDRLTDHLHPDVVLVRPLSPPRHGLGAAQREFTRILGLLPDLHGEVDRWSQAGDVVFIEFRLIARLGSEVVEWPVVDRFLLRGDKAVERVSYFDSLPLLIKVVKHPSAWRGWLTTMRSRA,"16,027",141,,,,,,,1
O53147,O53147_MYCTU,Rv1455,Rv1455,,,,,,Conserved protein,,9634230; 21969609,,,MKLARPDVFHPRVVLAGWPQQPAGDGDDAGLVAALRHRGLHAGWLSWDDPEIVHADLVILRATRDYPARLDEFLAWTTRVANLLNSRPVVAWNVERRYLRDLMDRGVPTVPGEVYVPGEPVRLPRKGQVFVGPTIGTGTRRCSARFAAEFVAQLHAAGQAVLVQPGGSGDETVLVFLGGEPSHAFTKQADTWRQTEPDFEIWDVGAAAVAGAAAQVGVDPGELLYARAHITGGSRDPRLLELQLVDPSLGWQWLDPDIRNLAQRDFALCVQSALERLGLGPFSHRRP,"31,427",287,,,,,,,3
P71802,P71802_MYCTU,Rv1374c,Rv1374c,,,,,,Uncharacterized protein,,9634230,,,MVTSVADENVASRIASWGTGPAPDPRLDYAHAHLKGRRGRSPARPNAPIGARSFAVGRKICRVERFTLLEHGFVGHALHRVPCAGLVALVMSACSLAVCREVGNYAQRRVGRFAFFEQTFVRHALTPRCSRTDSKTSYTQLNRICKFPPHWV,"16,855",152,,,,,,,4
O53903,O53903_MYCTU,Rv1529,fadD24 Rv1529,GO:0005886; GO:0006633; GO:0016874; GO:0070566,IPR000873; ,,fadD24,,Probable fatty-acid-AMP ligase FadD24 (Fatty-acid-AMP synthetase) (Fatty-acid-AMP synthase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MVASSIPTALRERASVHPNGAAITYIDYEQDWAGVAETLTWSQLYRRMLNVAEPLRHVGATGDRAVILAPQGIEYVVGFLGALQAGRIAVPLPVPHAGAHDERTISVLSDTSPAVILTTSGAVDDVRECAQPQPGQSAPSIVELDLLDLDSRQRSRSPGARPTGRDTPETAYLQYTSGSTRTPAGVMVSNKNVFANFEQIVADFFAPEGGVVPPDLTVVSWLPLYHDMGLLLGAIMPILAGVPTVLTSPVGFLQRPARWIQLLARNGRTISAGPNFAFELAVRKTSDDDMDGLDLAGVHTILNGSERVHPATLKRFAERFGRFNFAAAALRPAYGMAEATVYIATRNVNEPPEIVDFESEKLPAGQAIRCPSGSGTPLVSYGVPRSQLVRIVDPDTCIECPQGSVGEIWVQGGNVASGYWHKPEESKRTFGARIVTPSAGTPEAPWLRTGDSGFVSGGELFIIGRIKDLLIVYGRNHAPDDIEATIQEITSGRCAAIAVPDHGTEKLVAIIELKKRGDSDEDVADRLRIVKRDVAAAIFDSHGLSVADLVLVSPGSIPITTSGKIRRAQCVQLYRRREFTRLDA,"62,829",584,,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
P71795,P71795_MYCTU,Rv1516c,Rv1516c,GO:0016757,IPR001173; IPR029044; ,,,,Probable sugar transferase,"transferase activity, transferring glycosyl groups [GO:0016757]",9634230; 21969609,,,MSPQLCPKVSIVSTTHNQAGYARQAFDSFLDQQTDFPVEIIVADDASTDATPAIIREYAERYPHVFRPIFRTENLGLNGNLTGALSAARGEYVALCEADDYWIDPLKLSKQVAFLDRHPKTTVCFHPVRVIWEDGHAKDSKFPPVRVRGNLSLDALILMNFIQTNSAVYRRLERYDDIPADVMPLDWYLHVRHAVHGDIAMLPDTMAVYRRHAQGMWHNQVVDPPKFWLTQGPGHAATFDAMLDLFPGDPAREELIAVMADWILRQIANVPGPEGRAALQETIARHPRIAMLALQHRGATPARRLKTQWRKLAAATPSRRGLVDVWPSRLRRGCRA,"37,965",336,,,"transferase activity, transferring glycosyl groups [GO:0016757]",,,,3
P71792,P71792_MYCTU,Rv1513,Rv1513,GO:0005886,IPR006342; IPR029063; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MRLARRARNILRRNGIEVSRYFAELDWERNFLRQLQSHRVSAVLDVGANSGQYARGLRGAGFAGRIVSFEPLPGPFAVLQRSASTDPLWECRRCALGDVDGTISINVAGNEGASSSVLPMLKRHQDAFPPANYVGAQRVPIHRLDSVAADVLRPNDIAFLKIDVQGFEKQVIAGGDSTVHDRCVGMQLELSFQPLYEGGMLIREALDLVDSLGFTLSGLQPGFTDPRNGRMLQADGIFFRGSD,"26,684",243,,,,plasma membrane [GO:0005886],,,1
O06827,O06827_MYCTU,Rv1431,Rv1431,GO:0016021,IPR021941; ,,,,Conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGFLKPDLPDVDHDTWLTQPRRTRLQVVTRDWVEHGFGTPYAVYLLYLTKIAVYVAAGAAIISLNPGLGGLSRIGDWWTQPIVYQKVIVFTLLFEVLGFGCGSGPLTGRFWPPIGGFLYWLRPNTIRLPAWPDKVPFTQGDTRTVVDVALYAIVLIGGVWALLSPGSPGPGGTPVTAAGDVGLINPVLVVPTIVALGVLGLRDKTIFLAARGEHYWLKLFVFFFPFTDQIAAFKIIMLCLWWGAATSKLNHHFPYVVAVMTSNNALLRSRVFNPIKHLLYRDHANDLRPSWLPKLMAHGGGTTAEFLVPGILVLVADGHPWRWFLIGFMVLFHLNILSNLPMGVPLEWNVFFIFSLCYLFGHYGAITATDLRSPLLLAIVIAVVAVVIMGNLLPEKISFLPAMRYYAGNWATSIWCFRGDAEATMETSVVKSSALVVNQLAKLYDGATAEIMTDKVAAFRAMHTHGRALNGLLPRALDDEAHYRIREGEIVAGPLVGWNFGEGHLHNEQLVAAVQRRCNFADGDLRVIILEGQPIHVQKQWYRIVDAKTGLFEAGYVTVEDMLSRQPWPEPGDEFPVHVTTQRGTPSKP,"65,322",589,,,,integral component of membrane [GO:0016021],,,1
O33223,O33223_MYCTU,Rv1227c,Rv1227c,GO:0016021,IPR005182; ,,,DOMAIN 87 165 bPH_2. {ECO:0000259|Pfam:PF03703}.,Probable transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MDHARNVPSATGPQRNHLALAEPAHRPSSQAPVMWALSASLGWILPVIAQLVWWAVHPQPPWPHLAAAALTAVAMVVHIGVVPLWRYRVHRWEISPQAVFTRTGWLVQERRITPISRVQTVDTYRGPMDRLFGLANVTVTTASSAGAVHIEALDTDVADRVVAQLTDIAALRGEDAT,"19,388",177,,,,integral component of membrane [GO:0016021],,,1
O50455,O50455_MYCTU,Rv1239c,corA Rv1239c,GO:0000287; GO:0005576; GO:0005887; GO:0015087; GO:0015095; GO:0050897; GO:0051260,IPR004488; IPR002523; ,,corA,,Magnesium transport protein CorA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; magnesium ion binding [GO:0000287]; magnesium ion transmembrane transporter activity [GO:0015095]; protein homooligomerization [GO:0051260],9634230; 21969609,,FUNCTION: Mediates influx of magnesium ions. {ECO:0000256|RuleBase:RU362010}.,MFPGFDALPEVLRPVARPQPPNAHPVAQPPAQALVDCGVYVCGQRLPGKYTYAAALREVREIELTGQEAFVWIGLHEPDENQMQDVADVFGLHPLAVEDAVHAHQRPKLERYDETLFLVLKTVNYVPHESVVLAREIVKTGEIMIFVGKDFVVTVRHGEHGGLSEVRKRMDADPEHLRLGPYAVMHAIADYVVDHYLEVTNLMETDIDSIEEVAFAPGRKLDIEPIYLLKREVVELRRCVNPLSTAFQRMQTESKDLISKEVRRYLRDVADHQTEAADQIASYDDMLNSLVQAALARVGMQQNMDMRKISAWAGIIAVPTMIAGIYGMNFHFMPELDSRWGYPTVIGGMVLICLFLYHVFRNRNWL,"41,501",366,CorA metal ion transporter (MIT) (TC 1.A.35) family,protein homooligomerization [GO:0051260],cobalt ion binding [GO:0050897]; cobalt ion transmembrane transporter activity [GO:0015087]; magnesium ion binding [GO:0000287]; magnesium ion transmembrane transporter activity [GO:0015095],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
O05317,O05317_MYCTU,Rv1216c,Rv1216c,,IPR007318; ,,,,Probable conserved integral membrane protein,,9634230; 21969609,,,MHIGLKIFIWGVLGLVVFGALLFGPAGTFDYWQAWVFLAAFVSTTIGPTIYLARNDPAALQRRMRSGPLAEGRTIQKFIVIGAFLGFFAMMVLSACDHRYGWSSVPAAVCVIGDVLVMTGLGIAMLVVIQNRYAASTVRVEAGQILASDGLYKIVRHPMYAGNVVMMTGIPLALGSYWAMFILVPGTLVLVFRILDEEKLLTQELSGYREYRQLVRYRLVPYVW,"24,862",224,,,,,,,1
P71767,P71767_MYCTU,Rv1487,Rv1487,,IPR002810; ,,,,Conserved membrane protein,,9634230; 21969609,,,MPVALIWLIAALVLVGAEALTGDMFLLMLGGGALAASVSSWLLAWPMWADGAVFLLVSVLLLVLVRPAVRRRLTQTKGVQLGIEALEGKKAVVLGRVARDGGQVKLDGQVWTARPLNDGDVFEPGDSVTVVQIDGATAVVFKDV,"15,159",144,,,,,,,1
O07747,RPFC_MYCTU,Rv1884c,rpfC Rv1884c MTCY180.34,GO:0005576; GO:0009405; GO:0010628; GO:0010629; GO:0016787; GO:0040010,IPR023346; IPR010618; ,,rpfC,,Resuscitation-promoting factor RpfC (EC 3.-.-.-),extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],9634230; 12410821; 15375142; 15207486; 15723078; 18186793; 21969609,NMR spectroscopy (1); X-ray crystallography (1),"FUNCTION: Factor that stimulates resuscitation of dormant cells. Has peptidoglycan (PG) hydrolytic activity. Active in the pM concentration range. Has little to no effect on actively-growing cells. PG fragments could either directly activate the resuscitation pathway of dormant bacteria or serve as a substrate for endogenous Rpf, resulting in low molecular weight products with resuscitation activity. {ECO:0000269|PubMed:12410821}.; FUNCTION: Stimulates growth of stationary phase M.bovis (a slow-growing Mycobacterium), reduces the lag phase of diluted fast-growers M.smegmatis and Micrococcus luteus. Sequential gene disruption indicates RpfB and RpfE are higher than RpfD and RpfC in functional hierarchy. {ECO:0000269|PubMed:12410821}.",MHPLPADHGRSRCNRHPISPLSLIGNASATSGDMSSMTRIAKPLIKSAMAAGLVTASMSLSTAVAHAGPSPNWDAVAQCESGGNWAANTGNGKYGGLQFKPATWAAFGGVGNPAAASREQQIAVANRVLAEQGLDAWPTCGAASGLPIALWSKPAQGIKQIINEIIWAGIQASIPR,"18,047",176,"Transglycosylase family, Rpf subfamily",negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],hydrolase activity [GO:0016787],extracellular region [GO:0005576],,MTCY180.34,3
P9WQI9,BACA_MYCTU,Rv1819c,bacA Rv1819c MTCY1A11.24c,GO:0005524; GO:0005576; GO:0005886; GO:0005887; GO:0042626; GO:0052572,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR027417; ,,bacA,DOMAIN 67 393 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.; DOMAIN 427 639 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Vitamin B12 transport ATP-binding protein BacA,"extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; response to host immune response [GO:0052572]",9634230; 18996991; 21969609; 23407640,,"FUNCTION: ABC transporter involved in uptake of vitamin B12 and related corrinoids. Transmembrane domains (TMD) form a pore in the membrane and the ATP-binding domain (NBD) is responsible for energy generation. Contributes to maintenance of chronic infections. {ECO:0000269|PubMed:18996991, ECO:0000269|PubMed:23407640}.",MGPKLFKPSIDWSRAFPDSVYWVGKAWTISAICVLAILVLLRYLTPWGRQFWRITRAYFVGPNSVRVWLMLGVLLLSVVLAVRLNVLFSYQGNDMYTALQKAFEGIASGDGTVKRSGVRGFWMSIGVFSVMAVLHVTRVMADIYLTQRFIIAWRVWLTHHLTQDWLDGRAYYRDLFIDETIDNPDQRIQQDVDIFTAGAGGTPNAPSNGTASTLLFGAVQSIISVISFTAILWNLSGTLNIFGVSIPRAMFWTVLVYVFVATVISFIIGRPLIWLSFRNEKLNAAFRYALVRLRDAAEAVGFYRGERVEGTQLQRRFTPVIDNYRRYVRRSIAFNGWNLSVSQTIVPLPWVIQAPRLFAGQIDFGDVGQTATSFGNIHDSLSFFRNNYDAFASFRAAIIRLHGLVDANEKGRALPAVLTRPSDDESVELNDIEVRTPAGDRLIDPLDVRLDRGGSLVITGRSGAGKTTLLRSLAELWPYASGTLHRPGGENETMFLSQLPYVPLGTLRDVVCYPNSAAAIPDATLRDTLTKVALAPLCDRLDEERDWAKVLSPGEQQRVAFARILLTKPKAVFLDESTSALDTGLEFALYQLLRSELPDCIVISVSHRPALERLHENQLELLGGGQWRLAPVEAAPAEV,"71,317",639,ABC transporter superfamily,response to host immune response [GO:0052572],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]",extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY1A11.24c,1
P9WPW7,ASSY_MYCTU,Rv1658,argG Rv1658 MTCY06H11.23,GO:0000050; GO:0000053; GO:0004055; GO:0005524; GO:0005829; GO:0005886; GO:0006526; GO:0040007,IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; ,,argG,,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; growth [GO:0040007]; urea cycle [GO:0000050],9634230; 21969609,,,MSERVILAYSGGLDTSVAISWIGKETGREVVAVAIDLGQGGEHMDVIRQRALDCGAVEAVVVDARDEFAEGYCLPTVLNNALYMDRYPLVSAISRPLIVKHLVAAAREHGGGIVAHGCTGKGNDQVRFEVGFASLAPDLEVLAPVRDYAWTREKAIAFAEENAIPINVTKRSPFSIDQNVWGRAVETGFLEHLWNAPTKDIYAYTEDPTINWGVPDEVIVGFERGVPVSVDGKPVSMLAAIEELNRRAGAQGVGRLDVVEDRLVGIKSREIYEAPGAMVLITAHTELEHVTLERELGRFKRQTDQRWAELVYDGLWYSPLKAALEAFVAKTQEHVSGEVRLVLHGGHIAVNGRRSAESLYDFNLATYDEGDSFDQSAARGFVYVHGLSSKLAARRDLR,"43,682",398,"Argininosuccinate synthase family, Type 1 subfamily",arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; growth [GO:0040007]; urea cycle [GO:0000050],argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY06H11.23,1
P9WQ87,BIOF1_MYCTU,Rv1569,bioF1 Rv1569 MTCY336.34c,GO:0005618; GO:0005886; GO:0008710; GO:0009102; GO:0030170,IPR001917; IPR004839; IPR015424; IPR015422; IPR015421; ,,bioF1,,8-amino-7-oxononanoate synthase 1 (AONS) (EC 2.3.1.47) (7-keto-8-amino-pelargonic acid synthase) (7-KAP synthase) (KAPA synthase) (8-amino-7-ketopelargonate synthase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; 8-amino-7-oxononanoate synthase activity [GO:0008710]; pyridoxal phosphate binding [GO:0030170]; biotin biosynthetic process [GO:0009102],9634230; 16769720; 21969609,,"FUNCTION: Catalyzes the decarboxylative condensation of pimeloyl-[acyl-carrier protein] and L-alanine to produce 8-amino-7-oxononanoate (AON), [acyl-carrier protein], and carbon dioxide (By similarity). Can also use pimeloyl-CoA instead of pimeloyl-ACP as substrate. To a lesser extent, can also utilize D-alanine instead of L-alanine as substrate. {ECO:0000250, ECO:0000269|PubMed:16769720}.",MKAATQARIDDSPLAWLDAVQRQRHEAGLRRCLRPRPAVATELDLASNDYLGLSRHPAVIDGGVQALRIWGAGATGSRLVTGDTKLHQQFEAELAEFVGAAAGLLFSSGYTANLGAVVGLSGPGSLLVSDARSHASLVDACRLSRARVVVTPHRDVDAVDAALRSRDEQRAVVVTDSVFSADGSLAPVRELLEVCRRHGALLLVDEAHGLGVRGGGRGLLYELGLAGAPDVVMTTTLSKALGSQGGVVLGPTPVRAHLIDAARPFIFDTGLAPAAVGAARAALRVLQAEPWRPQAVLNHAGELARMCGVAAVPDSAMVSVILGEPESAVAAAAACLDAGVKVGCFRPPTVPAGTSRLRLTARASLNAGELELARRVLTDVLAVARR,"40,028",386,"Class-II pyridoxal-phosphate-dependent aminotransferase family, BioF subfamily",biotin biosynthetic process [GO:0009102],8-amino-7-oxononanoate synthase activity [GO:0008710]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY336.34c,1
P9WQ81,BIOA_MYCTU,Rv1568,bioA Rv1568 MTCY336.35c,GO:0004015; GO:0005737; GO:0009102; GO:0030170,IPR005814; IPR005815; IPR015424; IPR015422; IPR015421; ,,bioA,,"Adenosylmethionine-8-amino-7-oxononanoate aminotransferase (EC 2.6.1.62) (7,8-diamino-pelargonic acid aminotransferase) (DAPA AT) (DAPA aminotransferase) (7,8-diaminononanoate synthase) (DANS) (Diaminopelargonic acid synthase)",cytoplasm [GO:0005737]; adenosylmethionine-8-amino-7-oxononanoate transaminase activity [GO:0004015]; pyridoxal phosphate binding [GO:0030170]; biotin biosynthetic process [GO:0009102],9634230; 16984394; 21969609; 20565114,X-ray crystallography (23),"FUNCTION: Catalyzes the reversible transfer of the alpha-amino group from S-adenosyl-L-methionine (SAM) to 7-keto-8-aminopelargonic acid (KAPA) to form 7,8-diaminopelargonic acid (DAPA). It is the only animotransferase known to utilize SAM as an amino donor. Can also use sinefungin as substrate. {ECO:0000269|PubMed:16984394}.",MAAATGGLTPEQIIAVDGAHLWHPYSSIGREAVSPVVAVAAHGAWLTLIRDGQPIEVLDAMSSWWTAIHGHGHPALDQALTTQLRVMNHVMFGGLTHEPAARLAKLLVDITPAGLDTVFFSDSGSVSVEVAAKMALQYWRGRGLPGKRRLMTWRGGYHGDTFLAMSICDPHGGMHSLWTDVLAAQVFAPQVPRDYDPAYSAAFEAQLAQHAGELAAVVVEPVVQGAGGMRFHDPRYLHDLRDICRRYEVLLIFDEIATGFGRTGALFAADHAGVSPDIMCVGKALTGGYLSLAATLCTADVAHTISAGAAGALMHGPTFMANPLACAVSVASVELLLGQDWRTRITELAAGLTAGLDTARALPAVTDVRVCGAIGVIECDRPVDLAVATPAALDRGVWLRPFRNLVYAMPPYICTPAEITQITSAMVEVARLVGSLP,"46,319",437,"Class-III pyridoxal-phosphate-dependent aminotransferase family, BioA subfamily",biotin biosynthetic process [GO:0009102],adenosylmethionine-8-amino-7-oxononanoate transaminase activity [GO:0004015]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737],,MTCY336.35c,1
P9WPZ3,ARGJ_MYCTU,Rv1653,argJ Rv1653 MTCY06H11.18,GO:0004042; GO:0004358; GO:0005737; GO:0006526; GO:0006592; GO:0040007; GO:0103045,IPR002813; IPR016117; ,,argJ,,Arginine biosynthesis bifunctional protein ArgJ [Cleaved into: Arginine biosynthesis bifunctional protein ArgJ alpha chain; Arginine biosynthesis bifunctional protein ArgJ beta chain] [Includes: Glutamate N-acetyltransferase (EC 2.3.1.35) (Ornithine acetyltransferase) (OATase) (Ornithine transacetylase); Amino-acid acetyltransferase (EC 2.3.1.1) (N-acetylglutamate synthase) (AGSase)],cytoplasm [GO:0005737]; acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; glutamate N-acetyltransferase activity [GO:0004358]; methione N-acyltransferase activity [GO:0103045]; arginine biosynthetic process [GO:0006526]; growth [GO:0040007]; ornithine biosynthetic process [GO:0006592],9634230; 19099550; 21969609; 20184895,X-ray crystallography (2),"FUNCTION: Catalyzes two activities which are involved in the cyclic version of arginine biosynthesis: the synthesis of N-acetylglutamate from glutamate and acetyl-CoA as the acetyl donor, and of ornithine by transacetylation between N(2)-acetylornithine and glutamate. {ECO:0000250}.",MTDLAGTTRLLRAQGVTAPAGFRAAGVAAGIKASGALDLALVFNEGPDYAAAGVFTRNQVKAAPVLWTQQVLTTGRLRAVILNSGGANACTGPAGFADTHATAEAVAAALSDWGTETGAIEVAVCSTGLIGDRLPMDKLLAGVAHVVHEMHGGLVGGDEAAHAIMTTDNVPKQVALHHHDNWTVGGMAKGAGMLAPSLATMLCVLTTDAAAEPAALERALRRAAAATFDRLDIDGSCSTNDTVLLLSSGASEIPPAQADLDEAVLRVCDDLCAQLQADAEGVTKRVTVTVTGAATEDDALVAARQIARDSLVKTALFGSDPNWGRVLAAVGMAPITLDPDRISVSFNGAAVCVHGVGAPGAREVDLSDADIDITVDLGVGDGQARIRTTDLSHAYVEENSAYSS,"41,147",404,ArgJ family,arginine biosynthetic process [GO:0006526]; growth [GO:0040007]; ornithine biosynthetic process [GO:0006592],acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; glutamate N-acetyltransferase activity [GO:0004358]; methione N-acyltransferase activity [GO:0103045],cytoplasm [GO:0005737],,MTCY06H11.18,1
P9WPY9,ARGR_MYCTU,Rv1657,argR ahrC Rv1657 MTCY06H11.22,GO:0003677; GO:0003700; GO:0005737; GO:0006351; GO:0006526; GO:0034618; GO:0051259,IPR001669; IPR020899; IPR036251; IPR020900; IPR036388; IPR036390; ,,argR,,Arginine repressor,"cytoplasm [GO:0005737]; arginine binding [GO:0034618]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; arginine biosynthetic process [GO:0006526]; protein complex oligomerization [GO:0051259]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (7),FUNCTION: Regulates arginine biosynthesis genes. {ECO:0000250}.,MSRAKAAPVAGPEVAANRAGRQARIVAILSSAQVRSQNELAALLAAEGIEVTQATLSRDLEELGAVKLRGADGGTGIYVVPEDGSPVRGVSGGTDRMARLLGELLVSTDDSGNLAVLRTPPGAAHYLASAIDRAALPQVVGTIAGDDTILVVAREPTTGAQLAGMFENLR,"17,350",170,ArgR family,"arginine biosynthetic process [GO:0006526]; protein complex oligomerization [GO:0051259]; transcription, DNA-templated [GO:0006351]",arginine binding [GO:0034618]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cytoplasm [GO:0005737],ahrC,MTCY06H11.22,1
P9WID9,BCPB_MYCTU,Rv1608c,bcpB bcp1 Rv1608c,GO:0004601; GO:0005623; GO:0045454; GO:0051920,IPR000866; IPR024706; IPR036249; IPR013766; ,,bcpB,DOMAIN 1 153 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Putative peroxiredoxin Rv1608c (EC 1.11.1.15) (Bacterioferritin comigratory protein) (Thioredoxin peroxidase),cell [GO:0005623]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],9634230; 21969609; ,X-ray crystallography (1),"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. {ECO:0000250|UniProtKB:P0AE52}.",MKTGDTVADFELPDQTGTPRRLSVLLSDGPVVLFFYPAAMTPGCTKEACHFRDLAKEFAEVRASRVGISTDPVRKQAKFAEVRRFDYPLLSDAQGTVAAQFGVKRGLLGKLMPVKRTTFVIDTDRKVLDVISSEFSMDAHADKALATLRAIRSG,"16,894",154,"Peroxiredoxin family, BCP/PrxQ subfamily",cell redox homeostasis [GO:0045454],peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cell [GO:0005623],bcp1,,1
P9WPQ9,BFR_MYCTU,Rv1876,bfr bfrA Rv1876 MTCY180.42c,GO:0004322; GO:0005576; GO:0005829; GO:0005886; GO:0006826; GO:0008199; GO:0010039; GO:0033214,IPR002024; IPR012347; IPR009040; IPR009078; IPR008331; ,,bfr,DOMAIN 1 145 Ferritin-like diiron. {ECO:0000255|PROSITE-ProRule:PRU00085}.,Bacterioferritin (BFR) (EC 1.16.3.1),cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; iron assimilation by chelation and transport [GO:0033214]; iron ion transport [GO:0006826]; response to iron ion [GO:0010039],9634230; 18453710; 21969609; 19946376,X-ray crystallography (4),"FUNCTION: Iron-storage protein, whose ferroxidase center binds Fe(2+) ions, oxidizes them by dioxygen to Fe(3+), and participates in the subsequent Fe(3+) oxide mineral core formation within the central cavity of the protein complex. {ECO:0000250}.",MQGDPDVLRLLNEQLTSELTAINQYFLHSKMQDNWGFTELAAHTRAESFDEMRHAEEITDRILLLDGLPNYQRIGSLRIGQTLREQFEADLAIEYDVLNRLKPGIVMCREKQDTTSAVLLEKIVADEEEHIDYLETQLELMDKLGEELYSAQCVSRPPT,"18,341",159,Bacterioferritin family,iron assimilation by chelation and transport [GO:0033214]; iron ion transport [GO:0006826]; response to iron ion [GO:0010039],ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],bfrA,MTCY180.42c,1
P9WIB9,SCMU_MYCTU,Rv1885c,Rv1885c,GO:0004106; GO:0005576; GO:0046417,IPR036263; IPR008240; IPR002701; ,,,DOMAIN 34 113 Chorismate mutase. {ECO:0000255|PROSITE-ProRule:PRU00515}.,Secreted chorismate mutase (*MtCM) (CM) (EC 5.4.99.5),extracellular region [GO:0005576]; chorismate mutase activity [GO:0004106]; chorismate metabolic process [GO:0046417],9634230; 15654876; 15737998; 21969609; 16499927; 16752890; 17146044; 19099550,X-ray crystallography (4),"FUNCTION: Catalyzes the Claisen rearrangement of chorismate to prephenate. May play some role in the pathogenicity. {ECO:0000269|PubMed:15654876, ECO:0000269|PubMed:15737998}.",MLTRPREIYLATAVSIGILLSLIAPLGPPLARADGTSQLAELVDAAAERLEVADPVAAFKWRAQLPIEDSGRVEQQLAKLGEDARSQHIDPDYVTRVFDDQIRATEAIEYSRFSDWKLNPASAPPEPPDLSASRSAIDSLNNRMLSQIWSHWSLLSAPSCAAQLDRAKRDIVRSRHLDSLYQRALTTATQSYCQALPPA,"21,945",199,,chorismate metabolic process [GO:0046417],chorismate mutase activity [GO:0004106],extracellular region [GO:0005576],,,1
P9WH43,RS1_MYCTU,Rv1630,rpsA Rv1630 MTCY01B2.22,GO:0003723; GO:0005618; GO:0005829; GO:0005840; GO:0005886; GO:0040007,IPR012340; IPR022967; IPR003029; ,,rpsA,DOMAIN 36 105 S1 motif 1. {ECO:0000255|PROSITE-ProRule:PRU00180}.; DOMAIN 123 188 S1 motif 2. {ECO:0000255|PROSITE-ProRule:PRU00180}.; DOMAIN 209 277 S1 motif 3. {ECO:0000255|PROSITE-ProRule:PRU00180}.; DOMAIN 294 363 S1 motif 4. {ECO:0000255|PROSITE-ProRule:PRU00180}.,30S ribosomal protein S1,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; RNA binding [GO:0003723]; growth [GO:0040007],9634230; 21969609; 21835980; 25430994,X-ray crystallography (3),"FUNCTION: Binds mRNA, facilitating recognition of most mRNAs by the 30S ribosomal subunit during translation initiation (By similarity). Probably plays a role in trans-translation; binds tmRNA (the product of the ssrA gene) (PubMed:21835980). In trans-translation Ala-aminoacylated transfer-messenger RNA (tmRNA, product of the ssrA gene; the 2 termini fold to resemble tRNA(Ala) while it encodes a short internal open reading frame (the tag peptide)) acts like a tRNA, entering the A-site of the ribosome and displacing the stalled mRNA (which is subsequently degraded). The ribosome then switches to translate the ORF on the tmRNA, the nascent peptide is terminated with the ""tag peptide"" encoded by the tmRNA and thus targeted for degradation (By similarity). {ECO:0000250|UniProtKB:P0AG67, ECO:0000269|PubMed:21835980}.; FUNCTION: Binds pyrazinoic acid (POA), the active form of the prodrug pyrazinamide (PZA); POA disrupts tmRNA binding (at 50 ug/ml in vitro) and also trans-translation (at 25 ug/ml in vitro using purified H37Ra ribosomes). {ECO:0000269|PubMed:21835980}.",MPSPTVTSPQVAVNDIGSSEDFLAAIDKTIKYFNDGDIVEGTIVKVDRDEVLLDIGYKTEGVIPARELSIKHDVDPNEVVSVGDEVEALVLTKEDKEGRLILSKKRAQYERAWGTIEALKEKDEAVKGTVIEVVKGGLILDIGLRGFLPASLVEMRRVRDLQPYIGKEIEAKIIELDKNRNNVVLSRRAWLEQTQSEVRSEFLNNLQKGTIRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVQVGDEVTVEVLDVDMDRERVSLSLKATQEDPWRHFARTHAIGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAERHVEVPDQVVAVGDDAMVKVIDIDLERRRISLSLKQANEDYTEEFDPAKYGMADSYDEQGNYIFPEGFDAETNEWLEGFEKQRAEWEARYAEAERRHKMHTAQMEKFAAAEAAGRGADDQSSASSAPSEKTAGGSLASDAQLAALREKLAGSA,"53,202",481,Bacterial ribosomal protein bS1 family,growth [GO:0040007],RNA binding [GO:0003723],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome [GO:0005840],,MTCY01B2.22,1
P9WFU1,SYFB_MYCTU,Rv1650,pheT Rv1650 MTCY06H11.15,GO:0000049; GO:0000287; GO:0004826; GO:0005524; GO:0005618; GO:0005886; GO:0006432; GO:0009328; GO:0040007,IPR005146; IPR009061; IPR005121; IPR036690; IPR012340; IPR004532; IPR020825; IPR002547; IPR033714; IPR005147; ,,pheT,DOMAIN 44 155 tRNA-binding.; DOMAIN 414 489 B5.; DOMAIN 737 830 FDX-ACB.,Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS),cell wall [GO:0005618]; phenylalanine-tRNA ligase complex [GO:0009328]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; growth [GO:0040007]; phenylalanyl-tRNA aminoacylation [GO:0006432],9634230; 19099550; 21969609,,,MRLPYSWLREVVAVGASGWDVTPGELEQTLLRIGHEVEEVIPLGPVDGPVTVGRVADIEELTGYKKPIRACAVDIGDRQYREIICGATNFAVGDLVVVALPGATLPGGFTISARKAYGRNSDGMICSAAELNLGADHSGILVLPPGAAEPGADGAGVLGLDDVVFHLAITPDRGYCMSVRGLARELACAYDLDFVDPASNSRVPPLPIEGPAWPLTVQPETGVRRFALRPVIGIDPAAVSPWWLQRRLLLCGIRATCPAVDVTNYVMLELGHPMHAHDRNRISGTLGVRFARSGETAVTLDGIERKLDTADVLIVDDAATAAIGGVMGAASTEVRADSTDVLLEAAIWDPAAVSRTQRRLHLPSEAARRYERTVDPAISVAALDRCARLLADIAGGEVSPTLTDWRGDPPCDDWSPPPIRMGVDVPDRIAGVAYPQGTTARRLAQIGAVVTHDGDTLTVTPPSWRPDLRQPADLVEEVLRLEGLEVIPSVLPPAPAGRGLTAGQQRRRTIGRSLALSGYVEILPTPFLPAGVFDLWGLEADDSRRMTTRVLNPLEADRPQLATTLLPALLEALVRNVSRGLVDVALFAIAQVVQPTEQTRGVGLIPVDRRPTDDEIAMLDASLPRQPQHVAAVLAGLREPRGPWGPGRPVEAADAFEAVRIIARASRVDVTLRPAQYLPWHPGRCAQVFVGESSVGHAGQLHPAVIERSGLPKGTCAVELNLDAIPCSAPLPAPRVSPYPAVFQDVSLVVAADIPAQAVADAVRAGAGDLLEDIALFDVFTGPQIGEHRKSLTFALRFRAPDRTLTEDDASAARDAAVQSAAERVGAVLRG,"88,374",831,"Phenylalanyl-tRNA synthetase beta subunit family, Type 1 subfamily",growth [GO:0040007]; phenylalanyl-tRNA aminoacylation [GO:0006432],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049],cell wall [GO:0005618]; phenylalanine-tRNA ligase complex [GO:0009328]; plasma membrane [GO:0005886],,MTCY06H11.15,1
E2FZM4,SOCA_MYCTU,Rv1706c.1,socA Rv1706c.1,,,,socA,,Uncharacterized protein SocA (Small ORF induced by copper A),,21166899; 9634230; 24549843,,,MHRRARRMPMRPRRSKRVRNRYTMGTFALHGLTHRLPSASLQTTAARHPDVTQFSMPGHYR,"7,242",61,,,,,,,1
P9WFU3,SYFA_MYCTU,Rv1649,pheS Rv1649 MTCY06H11.14,GO:0000049; GO:0004826; GO:0005524; GO:0005737; GO:0005886; GO:0006432; GO:0040007; GO:0046872,IPR006195; IPR004529; IPR004188; IPR022911; IPR002319; IPR010978; ,,pheS,,Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; growth [GO:0040007]; phenylalanyl-tRNA aminoacylation [GO:0006432],9634230; 21969609,,,MLSPEALTTAVDAAQQAIALADTLDVLARVKTEHLGDRSPLALARQALAVLPKEQRAEAGKRVNAARNAAQRSYDERLATLRAERDAAVLVAEGIDVTLPSTRVPAGARHPIIMLAEHVADTFIAMGWELAEGPEVETEQFNFDALNFPADHPARGEQDTFYIAPEDSRQLLRTHTSPVQIRTLLARELPVYIISIGRTFRTDELDATHTPIFHQVEGLAVDRGLSMAHLRGTLDAFARAEFGPSARTRIRPHFFPFTEPSAEVDVWFANKIGGAAWVEWGGCGMVHPNVLRATGIDPDLYSGFAFGMGLERTLQFRNGIPDMRDMVEGDVRFSLPFGVGA,"37,371",341,"Class-II aminoacyl-tRNA synthetase family, Phe-tRNA synthetase alpha subunit type 1 subfamily",growth [GO:0040007]; phenylalanyl-tRNA aminoacylation [GO:0006432],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY06H11.14,1
P9WQ21,TREY_MYCTU,Rv1563c,treY Rv1563c MTCY48.02,GO:0005829; GO:0005992; GO:0030980; GO:0047470,IPR006047; IPR017853; IPR012767; ,,treY,,"Putative maltooligosyl trehalose synthase (EC 5.4.99.15) ((1,4)-alpha-D-glucan 1-alpha-D-glucosylmutase)","cytosol [GO:0005829]; (1,4)-alpha-D-glucan 1-alpha-D-glucosylmutase activity [GO:0047470]; alpha-glucan catabolic process [GO:0030980]; trehalose biosynthetic process [GO:0005992]",9634230; 21969609,,"FUNCTION: Catalyzes the conversion of maltooligosaccharide into the non-reducing saccharide, maltooligosyl trehalose (alpha-maltooligosyl alpha-D-glucoside) by intramolecular transglycosylation. {ECO:0000250}.",MAFPVISTYRVQMRGRSNGFGFTFADAENLLDYLDDLGVSHLYLSPILTAVGGSTHGYDVTDPTTVSPELGGSDGLARLSAAARSRGMGLIVDIVPSHVGVGKPEQNAWWWDVLKFGRSSAYAEFFDIDWELGDGRIILPLLGSDSDVANLRVDGDLLRLGDLALPVAPGSGDGTGPAVHDRQHYRLVGWRHGLCGYRRFFSITSLAGLRQEDRAVFDASHAEVARWFTEGLVDGVRVDHLDGLSDPSGYLAQLRELLGPNAWIVVEKILAVDEALEPTLPVDGSTGYDVLREIGGVLVDPQGESPLTALVESAGVDYQEMPAMLADLKVHAAVHTLASELRRLRRCIAAAAGADHPLLPAAVAALLRHIGRYRCDYPGQAAVLPCALAETHSTTPQLAPGLQLIAAAVARGGEPAVRLQQLCGAVSAKAVEDCMFYRDARLVSLNEVGGEPRRFGVGAAEFHHRAATRARLWPRSMTTLSTHDTKRGEDVRARIGVLSQVPWLWAKFIGHAQAIAPAPDAVTGQFLWQNVFGVWPVSGEVSAALRGRLHTYAEKAIREAAWHTSWHNPNRAFEDDVHGWLDLVLDGPLASELTGLVAHLNSHAESDALAAKLLALTVPGVPDVYQGSELWDDSLVDPDNRRPVDYGTRRVALKALQHPKIRVLAAALRLRRTHPESFLGGAYHPVFAAGPAADHVVAFRRGDDILVAVTRWTVRLQQTGWDHTVLPLPDGSWTDALTGFTASGHTPAVELFADLPVVLLVRDNA,"82,707",765,Glycosyl hydrolase 13 family,alpha-glucan catabolic process [GO:0030980]; trehalose biosynthetic process [GO:0005992],"(1,4)-alpha-D-glucan 1-alpha-D-glucosylmutase activity [GO:0047470]",cytosol [GO:0005829],,MTCY48.02,1
P9WQ23,TREZ_MYCTU,Rv1562c,treZ Rv1562c MTCY48.03,GO:0005829; GO:0005992; GO:0030980; GO:0033942,IPR022567; IPR006047; IPR017853; IPR013783; IPR014756; IPR012768; ,,treZ,,Malto-oligosyltrehalose trehalohydrolase (MTHase) (EC 3.2.1.141) (4-alpha-D-((1->4)-alpha-D-glucano)trehalose trehalohydrolase) (Maltooligosyl trehalose trehalohydrolase),cytosol [GO:0005829]; 4-alpha-D-(1->4)-alpha-D-glucanotrehalose trehalohydrolase activity [GO:0033942]; alpha-glucan catabolic process [GO:0030980]; trehalose biosynthetic process [GO:0005992],9634230; 10658666; 18808383; 21969609,,FUNCTION: Is involved in the biosynthesis of trehalose but not in that of capsular glucan and glycogen. {ECO:0000269|PubMed:10658666}.,MPEFRVWAPKPALVRLDVNGAVHAMTRSADGWWHTTVAAPADARYGYLLDDDPTVLPDPRSARQPDGVHARSQRWEPPGQFGAARTDTGWPGRSVEGAVIYELHIGTFTTAGTFDAAIEKLDYLVDLGIDFVELMPVNSFAGTRGWGYDGVLWYSVHEPYGGPDGLVRFIDACHARRLGVLIDAVFNHLGPSGNYLPRFGPYLSSASNPWGDGINIAGADSDEVRHYIIDCALRWMRDFHADGLRLDAVHALVDTTAVHVLEELANATRWLSGQLGRPLSLIAETDRNDPRLITRPSHGGYGITAQWNDDIHHAIHTAVSGERQGYYADFGSLATLAYTLRNGYFHAGTYSSFRRRRHGRALDTSAIPATRLLAYTCTHDQVGNRALGDRPSQYLTGGQLAIKAALTLGSPYTAMLFMGEEWGASSPFQFFCSHPEPELAHSTVAGRKEEFAEHGWAADDIPDPQDPQTFQRCKLNWAEAGSGEHARLHRFYRDLIALRHNEADLADPWLDHLMVDYDEQQRWVVMRRGQLMIACNLGAEPTCVPVSGELVLAWESPIIGDNSTELAAYSLAILRAAEPA,"64,077",580,Glycosyl hydrolase 13 family,alpha-glucan catabolic process [GO:0030980]; trehalose biosynthetic process [GO:0005992],4-alpha-D-(1->4)-alpha-D-glucanotrehalose trehalohydrolase activity [GO:0033942],cytosol [GO:0005829],,MTCY48.03,1
P9WFY1,TRPA_MYCTU,Rv1613,trpA Rv1613 MTCY01B2.05,GO:0004834; GO:0005886; GO:0040007,IPR013785; IPR011060; IPR018204; IPR002028; ,,trpA,,Tryptophan synthase alpha chain (EC 4.2.1.20),plasma membrane [GO:0005886]; tryptophan synthase activity [GO:0004834]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (6),FUNCTION: The alpha subunit is responsible for the aldol cleavage of indoleglycerol phosphate to indole and glyceraldehyde 3-phosphate. {ECO:0000255|HAMAP-Rule:MF_00131}.,MVAVEQSEASRLGPVFDSCRANNRAALIGYLPTGYPDVPASVAAMTALVESGCDIIEVGVPYSDPGMDGPTIARATEAALRGGVRVRDTLAAVEAISIAGGRAVVMTYWNPVLRYGVDAFARDLAAAGGLGLITPDLIPDEAQQWLAASEEHRLDRIFLVAPSSTPERLAATVEASRGFVYAASTMGVTGARDAVSQAAPELVGRVKAVSDIPVGVGLGVRSRAQAAQIAQYADGVIVGSALVTALTEGLPRLRALTGELAAGVRLGMSA,"27,728",270,TrpA family,growth [GO:0040007],tryptophan synthase activity [GO:0004834],plasma membrane [GO:0005886],,MTCY01B2.05,1
P9WFX9,TRPB_MYCTU,Rv1612,trpB Rv1612 MTCY01B2.04,GO:0000162; GO:0004834; GO:0005737; GO:0040007,IPR001926; IPR006653; IPR006654; IPR023026; IPR036052; ,,trpB,,Tryptophan synthase beta chain (EC 4.2.1.20),cytoplasm [GO:0005737]; tryptophan synthase activity [GO:0004834]; growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],9634230; 21969609,X-ray crystallography (8),FUNCTION: The beta subunit is responsible for the synthesis of L-tryptophan from indole and L-serine. {ECO:0000250}.,MMTDLSTPDLPRMSAAIAEPTSHDPDSGGHFGGPSGWGGRYVPEALMAVIEEVTAAYQKERVSQDFLDDLDRLQANYAGRPSPLYEATRLSQHAGSARIFLKREDLNHTGSHKINNVLGQALLARRMGKTRVIAETGAGQHGVATATACALLGLDCVIYMGGIDTARQALNVARMRLLGAEVVAVQTGSKTLKDAINEAFRDWVANADNTYYCFGTAAGPHPFPTMVRDFQRIIGMEARVQIQGQAGRLPDAVVACVGGGSNAIGIFHAFLDDPGVRLVGFEAAGDGVETGRHAATFTAGSPGAFHGSFSYLLQDEDGQTIESHSISAGLDYPGVGPEHAWLKEAGRVDYRPITDSEAMDAFGLLCRMEGIIPAIESAHAVAGALKLGVELGRGAVIVVNLSGRGDKDVETAAKWFGLLGND,"44,645",422,TrpB family,growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],tryptophan synthase activity [GO:0004834],cytoplasm [GO:0005737],,MTCY01B2.04,1
P9WIG5,WA22_MYCTU,Rv1759c,wag22 wag22b Rv1759c MTCY28.25c,GO:0005576,IPR000084; ,,wag22,DOMAIN 1 93 PE. {ECO:0000255}.,WAG22 antigen,extracellular region [GO:0005576],9634230,,,MSFVIAVPETIAAAATDLADLGSTIAGANAAAAANTTSLLAAGADEISAAIAALFGAHGRAYQAASAEAAAFHGRFVQALTTGGGAYAAAEAAAVTPLLNSINAPVLAATGRPLIGNGANGAPGTGANGGDAGWLIGNGGAGGSGAKGANGGAGGPGGAAGLFGNGGAGGAGGTATANNGIGGAGGAGGSAMLFGAGGAGGAGGAATSLVGGIGGTGGTGGNAGMLAGAAGAGGAGGFSFSTAGGAGGAGGAGGLFTTGGVGGAGGQGHTGGAGGAGGAGGLFGAGGMGGAGGFGDHGTLGTGGAGGDGGGGGLFGAGGDGGAGGSGLTTGGAAGNGGNAGTLSLGAAGGAGGTGGAGGTVFGGGKGGAGGAGGNAGMLFGSGGGGGTGGFGFAAGGQGGVGGSAGMLSGSGGSGGAGGSGGPAGTAAGGAGGAGGAPGLIGNGGNGGNGGESGGTGGVGGAGGNAVLIGNGGEGGIGALAGKSGFGGFGGLLLGADGYNAPESTSPWHNLQQDILSFINEPTEALTGRPLIGNGDSGTPGTGDDGGAGGWLFGNGGNGGAGAAGTNGSAGGAGGAGGILFGTGGAGGAGGVGTAGAGGAGGAGGSAFLIGSGGTGGVGGAATTTGGVGGAGGNAGLLIGAAGLGGCGGGAFTAGVTTGGAGGTGGAAGLFANGGAGGAGGTGSTAGGAGGAGGAGGLYAHGGTGGPGGNGGSTGAGGTGGAGGPGGLYGAGGSGGAGGHGGMAGGGGGVGGNAGSLTLNASGGAGGSGGSSLSGKAGAGGAGGSAGLFYGSGGAGGNGGYSLNGTGGDGGTGGAGQITGLRSGFGGAGGAGGASDTGAGGNGGAGGKAGLYGNGGDGGAGGDGATSGKGGAGGNAVVIGNGGNGGNAGKAGGTAGAGGAGGLVLGRDGQHGLT,"74,354",914,"Mycobacterial PE family, PGRS subfamily",,,extracellular region [GO:0005576],wag22b,MTCY28.25c,1
P9WGF7,Y1739_MYCTU,Rv1739c,Rv1739c,GO:0000103; GO:0005886; GO:0005887; GO:0008271; GO:0015116; GO:0015138; GO:0015141; GO:0015183; GO:0015741; GO:0019001,IPR011547; IPR001902; IPR002645; IPR036513; ,,,DOMAIN 442 557 STAS. {ECO:0000255|PROSITE-ProRule:PRU00198}.,Probable sulfate transporter Rv1739c,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; fumarate transmembrane transporter activity [GO:0015138]; guanyl nucleotide binding [GO:0019001]; L-aspartate transmembrane transporter activity [GO:0015183]; secondary active sulfate transmembrane transporter activity [GO:0008271]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; fumarate transport [GO:0015741]; sulfate assimilation [GO:0000103],9634230; 11416222; 18255326; 19636956,,"FUNCTION: Expression in E.coli induces sulfate uptake during early-to mid-log phase growth. Uptake is maximal at pH 6.0, is sulfate-specific, requires E.coli CysA and the transmembrane segment but not the STAS domain of the protein. {ECO:0000269|PubMed:18255326}.",MIPTMTSAGWAPGVVQFREYQRRWLRGDVLAGLTVAAYLIPQAMAYATVAGLPPAAGLWASIAPLAIYALLGSSRQLSIGPESATALMTAAVLAPMAAGDLRRYAVLAATLGLLVGLICLLAGTARLGFLASLRSRPVLVGYMAGIALVMISSQLGTITGTSVEGNEFFSEVHSFATSVTRVHWPTFVLAMSVLALLTMLTRWAPRAPGPIIAVLAATMLVAVMSLDAKGIAIVGRIPSGLPTPGVPPVSVEDLRALIIPAAGIAIVTFTDGVLTARAFAARRGQEVNANAELRAVGACNIAAGLTHGFPVSSSSSRTALADVVGGRTQLYSLIALGLVVIVMVFASGLLAMFPIAALGALVVYAALRLIDLSEFRRLARFRRSELMLALATTAAVLGLGVFYGVLAAVALSILELLRRVAHPHDSVLGFVPGIAGMHDIDDYPQAKRVPGLVVYRYDAPLCFANAEDFRRRALTVVDQDPGQVEWFVLNAESNVEVDLTALDALDQLRTELLRRGIVFAMARVKQDLRESLRAASLLDKIGEDHIFMTLPTAVQAFRRR,"59,367",560,SLC26A/SulP transporter (TC 2.A.53) family,fumarate transport [GO:0015741]; sulfate assimilation [GO:0000103],fumarate transmembrane transporter activity [GO:0015138]; guanyl nucleotide binding [GO:0019001]; L-aspartate transmembrane transporter activity [GO:0015183]; secondary active sulfate transmembrane transporter activity [GO:0008271]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WJJ1,Y1812_MYCTU,Rv1812c,Rv1812c,GO:0005576; GO:0005886; GO:0016491,IPR036188; IPR023753; IPR000103; ,,,,NADH dehydrogenase-like protein Rv1812c (EC 1.6.-.-),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 12953092; 18400743; 21969609,,,MTRVVVIGSGFAGLWAALGAARRLDELAVLAGTVDVMVVSNKPFHDIRVRNYEADLSACRIPLGDVLGPAGVAHVTAEVTAIDADGRRVTTSTGASYSYDRLVLASGSHVVKPALPGLAEFGFDVDTYDGAVRLQQHLQGLAGGPLTSAAATVVVVGAGLTGIETACELPGRLHALFARGDGVTPRVVLIDHNPFVGSDMGLSARPVIEQALLDNGVETRTGVSVAAVSPGGVTLSSGERLAAATVVWCAGMRASRLTEQLPVARDRLGRLQVDDYLRVIGVPAMFAAGDVAAARMDDEHLSVMSCQHGRPMGRYAGCNVINDLFDQPLLALRIPWYVTVLDLGSAGAVYTEGWERKVVSQGAPAKTTKQSINTRRIYPPLNGSRADLLAAAAPRVQPRP,"41,956",400,NADH dehydrogenase family,,oxidoreductase activity [GO:0016491],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WLS1,Y1813_MYCTU,Rv1813c,Rv1813c MTCY1A11.30 MTY16F9.01,,IPR025240; ,,,,Uncharacterized protein Rv1813c,,9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,,MITNLRRRTAMAAAGLGAALGLGILLVPTVDAHLANGSMSEVMMSEIAGLPIPPIIHYGAIAYAPSGASGKAWHQRTPARAEQVALEKCGDKTCKVVSRFTRCGAVAYNGSKYQGGTGLTRRAAEDDAVNRLEGGRIVNWACN,"14,981",143,,,,,,MTCY1A11.30 MTY16F9.01,1
P9WFG1,Y1823_MYCTU,Rv1823,Rv1823 MTCY1A11.20c,GO:0005886; GO:0005887,IPR010273; ,,,,UPF0749 protein Rv1823,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MAESDRLLGGYDPNAGYSAHAGAQPQRIPVPSLLRALLSEHLDAGYAAVAAERERAAAPRCWQARAVSWMWQALAATLVAAVFAAAVAQARSVAPGVRAAQQLLVASVRSTQAAATTLAQRRSTLSAKVDDVRRIVLADDAEGQRLLARLDVLSLAAASAPVVGPGLTVTVTDPGASPNLSDVSKQRVSGSQQIILDRDLQLVVNSLWESGAEAISIDGVRIGPNVTIRQAGGAILVDNNPTSSPYTILAVGPPHAMQDVFDRSAGLYRLRLLETSYGVGVSVNVGDGLALPAGATRDVKFAKQIGP,"31,935",307,UPF0749 family,,,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY1A11.20c,1
P9WFG3,Y1825_MYCTU,Rv1825,Rv1825 MTCY1A11.18c,GO:0005576; GO:0005887,IPR010273; ,,,,UPF0749 protein Rv1825,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],9634230; 21969609,X-ray crystallography (1),,MSENRPEPVAAETSAATTARHSQADAGAHDAVRRGRHELPADHPRSKVGPLRRTRLTEILRGGRSRLVFGTLAILLCLVLGVAIVTQVRQTDSGDSLETARPADLLVLLDSLRQREATLNAEVIDLQNTLNALQASGNTDQAALESAQARLAALSILVGAVGATGPGVMITIDDPGPGVAPEVMIDVINELRAAGAEAIQINDAHRSVRVGVDTWVVGVPGSLTVDTKVLSPPYSILAIGDPPTLAAAMNIPGGAQDGVKRVGGRMVVQQADRVDVTALRQPKQHQYAQPVK,"30,645",292,UPF0749 family,,,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTCY1A11.18c,1
P9WFP3,Y1842_MYCTU,Rv1842c,Rv1842c MTCY1A11.02 MTCY359.31,GO:0005886; GO:0016021; GO:0016614; GO:0050660,IPR000644; IPR002550; IPR036318; IPR005170; ,,,DOMAIN 2 205 CNNM transmembrane. {ECO:0000255|PROSITE-ProRule:PRU01193}.; DOMAIN 224 285 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 286 346 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,UPF0053 protein Rv1842c,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MNLTDTVATILAILALTAGTGVFVAAEFSLTALDRSTVEANARGGTSRDRFIQRAHHRLSFQLSGAQLGISITTLATGYLTEPLVAELPHPGLVAVGMSDRVADGLITFFALVIVTSLSMVFGELVPKYLAVARPLRTARSVVAGQVLFSLLLTPAIRLTNGAANWIVRRLGIEPAEELRSARTPQELVSLVRSSARSGALDDATAWLMRRSLQFGALTAEELMTPRSKIVALQTDDTIADLVAAAAASGFSRFPVVEGDLDATVGIVHVKQVFEVPPGDRAHTLLTTVAEPVAVVPSTLDGDAVMAQVRASALQTAMVVDEYGGTAGMVTLEDLIEEIVGDVRDEHDDATPDVVAAGNGWRVSGLLRIDEVASATGYRAPDGPYETIGGLVLRELGHIPVAGETVELTALDQDGLPDDSMRWLATVIQMDGRRIDLLELIKMGGHADPGSGRGR,"48,124",455,UPF0053 family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY1A11.02 MTCY359.31,1
P9WIM3,Y1847_MYCTU,Rv1847,Rv1847 MTCY359.26c,GO:0016787,IPR029069; IPR003736; IPR006683; ,,,,Putative esterase Rv1847 (EC 3.1.2.-),hydrolase activity [GO:0016787],9634230; 19099550; 21969609,X-ray crystallography (1),,MQPSPDSPAPLNVTVPFDSELGLQFTELGPDGARAQLDVRPKLLQLTGVVHGGVYCAMIESIASMAAFAWLNSHGEGGSVVGVNNNTDFVRSISSGMVYGTAEPLHRGRRQQLWLVTITDDTDRVVARGQVRLQNLEARP,"15,098",140,Thioesterase PaaI family,,hydrolase activity [GO:0016787],,,MTCY359.26c,1
P9WLU3,VPB11_MYCTU,Rv1560,vapB11 Rv1560 MTCY48.05c,GO:0045727; GO:0045927; GO:0075136,IPR019239; ,,vapB11,,Antitoxin VapB11,positive regulation of growth [GO:0045927]; positive regulation of translation [GO:0045727]; response to host [GO:0075136],9634230; 15718296; 19016878; 20011113,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and M.smegmatis neutralizes the effect of cognate toxin VapC11. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000305|PubMed:15718296}.",MYRWCMSRTNIDIDDELAAEVMRRFGLTTKRAAVDLALRRLVGSPLSREFLLGLEGVGWEGDLDDLRSDRPD,"8,241",72,,positive regulation of growth [GO:0045927]; positive regulation of translation [GO:0045727]; response to host [GO:0075136],,,,MTCY48.05c,1
P9WFA5,VPC11_MYCTU,Rv1561,vapC11 Rv1561 MTCY48.04c,GO:0004540; GO:0017148; GO:0045926; GO:0046872; GO:0075136,IPR029060; IPR002716; IPR022907; ,,vapC11,DOMAIN 2 126 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC11 (RNase VapC11) (EC 3.1.-.-) (Toxin VapC11),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148]; response to host [GO:0075136],9634230; 15718296; 19016878; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Acts as an RNase. Upon expression in E.coli and M.smegmatis inhibits translation, cell growth and colony formation. Its toxic effects on cell growth and colony formation are neutralized by coexpression with cognate antitoxin VapB11; the effect on translation has not been tested but is probably also neutralized. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113}.",MILIDTSAWVEYFRATGSIAAVEVRRLLSEEAARIAMCEPIAMEILSGALDDNTHTTLERLVNGLPSLNVDDAIDFRAAAGIYRAARRAGETVRSINDCLIAALAIRHGARIVHRDADFDVIARITNLQAASFR,"14,651",134,PINc/VapC protein family,negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148]; response to host [GO:0075136],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY48.04c,1
P9WF99,VPC14_MYCTU,Rv1953,vapC14 Rv1953,GO:0004518; GO:0046872,IPR029060; ,,vapC14,DOMAIN 3 74 PINc.,Ribonuclease VapC14 (RNase VapC14) (EC 3.1.-.-) (Toxin VapC14),metal ion binding [GO:0046872]; nuclease activity [GO:0004518],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB14 (By similarity). {ECO:0000250}.,MTYVLDTNVVSALRVPGRHPAVAAWADSVQVAEQFVVAITLAEIERGVIAKERTDPTQSEHLRRWFDDKVLRIFVFARRGTNLIMQPLAGHIGYSLYSGISWF,"11,628",103,PINc/VapC protein family,,metal ion binding [GO:0046872]; nuclease activity [GO:0004518],,,,1
P9WF33,XERD_MYCTU,Rv1701,xerD Rv1701 MTCI125.23,GO:0003677; GO:0005737; GO:0007049; GO:0007059; GO:0009009; GO:0015074; GO:0040007; GO:0051301,IPR011010; IPR013762; IPR002104; IPR010998; IPR004107; IPR011932; IPR023009; ,,xerD,,Tyrosine recombinase XerD,cytoplasm [GO:0005737]; DNA binding [GO:0003677]; site-specific recombinase activity [GO:0009009]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; growth [GO:0040007],9634230; 19099550; 21969609,,"FUNCTION: Site-specific tyrosine recombinase, which acts by catalyzing the cutting and rejoining of the recombining DNA molecules. The XerC-XerD complex is essential to convert dimers of the bacterial chromosome into monomers to permit their segregation at cell division. It also contributes to the segregational stability of plasmids. {ECO:0000255|HAMAP-Rule:MF_01807}.",MKTLALQLQGYLDHLTIERGVAANTLSSYRRDLRRYSKHLEERGITDLAKVGEHDVSEFLVALRRGDPDSGTAALSAVSAARALIAVRGLHRFAAAEGLAELDVARAVRPPTPSRRLPKSLTIDEVLSLLEGAGGDKPSDGPLTLRNRAVLELLYSTGARISEAVGLDLDDIDTHARSVLLRGKGGKQRLVPVGRPAVHALDAYLVRGRPDLARRGRGTAAIFLNARGGRLSRQSAWQVLQDAAERAGITAGVSPHMLRHSFATHLLEGGADVRVVQELLGHASVTTTQIYTLVTVHALREVWAGAHPRAR,"33,517",311,"'phage' integrase family, XerD subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; growth [GO:0040007],DNA binding [GO:0003677]; site-specific recombinase activity [GO:0009009],cytoplasm [GO:0005737],,MTCI125.23,1
P95262,VPB14_MYCTU,Rv1952,vapB14 Rv1952,GO:0006355,IPR013321; IPR010985; ,,vapB14,,Putative antitoxin VapB14,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapB14. {ECO:0000305|PubMed:15718296}.,MIRNLPEGTKAALRVRAARHHHSVEAEARAILTAGLLGEEVPMPVLLAADSGHDIDFEPERLGLIARTPQL,"7,700",71,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,2
P9WJ31,VPB34_MYCTU,Rv1740,vapB34 Rv1740,,IPR011660; ,,vapB34,,Putative antitoxin VapB34,,9634230; 20011113,,FUNCTION: Antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC34. {ECO:0000305|PubMed:20011113}.,MELAARMGETLTQAVVVAVREQLARRTGRTRSISLREELAAIGRRCAALPVLDTRAADTILGYDERGLPA,"7,608",70,,,,,,,1
P9WLT9,Y1588_MYCTU,Rv1588c,Rv1588c MTCY336.16,GO:0005886,IPR003870; ,,,,Uncharacterized protein Rv1588c,plasma membrane [GO:0005886],9634230,,,MLANSREELVEVFDALDAELDRLDEVSFEVLTTPERLRSLERLECLVRRLPAVGHALINQLDAQASEEELGGTLCCALANRLRITKPDAARRIADAADLGPRRALTGEPLAPQLTATATAQRQGLIGEAHVKVIRALFRPPARRGGCVHPPGRRSRPGRQSRSISSRRAGPLRPAGHGLATPRRRPHRHRTRPQTRHHPEQPAIRRHVTAKWLPDPPSAGHL,"24,560",222,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,plasma membrane [GO:0005886],,MTCY336.16,1
P9WLR9,Y1815_MYCTU,Rv1815,Rv1815 MTCY1A11.28c,GO:0005576; GO:0005618,IPR009003; ,,,,Uncharacterized protein Rv1815,cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 15375142; 21969609,,,MVRLVPRAFAATVALLAAGFSPATASADPVLVFPGMEIRQDNHVCTLGYVDPALKIAFTAGHCRGGGAVTSRDYKVIGHLRAIRDNTPSGSTVATHELIADYEAIVLADDVTASNILPSGRALESRPGVVLHPGQAVCHFGVSTGETCGTVESVNNGWFTMSHGVLSEKGDSGGPVYLAPDGGPAQIVGIFNSVWGGFPAAVSWRSTSEQVHADLGVTPLA,"22,819",221,,,,cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY1A11.28c,1
P9WMC9,Y1816_MYCTU,Rv1816,Rv1816 MTCY1A11.27c,GO:0003677; GO:0003700; GO:0006351; GO:0006355; GO:0016021,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 15 75 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv1816,"integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 15375142; 21969609,X-ray crystallography (1),,MCQTCRVGKRRDAREQIEAKIVELGRRQLLDHGAAGLSLRAIARNLGMVSSAVYRYVSSRDELLTLLLVDAYSDLADTVDRARDDTVADSWSDDVIAIARAVRGWAVTNPARWALLYGSPVPGYHAPPDRTAGVATRVVGAFFDAIAAGIATGDIRLTDDVAPQPMSSDFEKIRQEFGFPGDDRVVTKCFLLWAGVVGAISLEVFGQYGADMLTDPGVVFDAQTRLLVAVLAEH,"25,353",234,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],integral component of membrane [GO:0016021],,MTCY1A11.27c,1
P9WME5,Y1830_MYCTU,Rv1830,Rv1830 MTCY1A11.13c,GO:0003677; GO:0006351; GO:0006355,IPR009061; IPR000551; ,,,DOMAIN 64 136 HTH merR-type. {ECO:0000255|PROSITE-ProRule:PRU00254}.,Uncharacterized HTH-type transcriptional regulator Rv1830,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MTQLVTRARSARGSTLGEQPRQDQLDFADHTGTAGDGNDGAAAASGPVQPGLFPDDSVPDELVGYRGPSACQIAGITYRQLDYWARTSLVVPSIRSAAGSGSQRLYSFKDILVLKIVKRLLDTGISLHNIRVAVDHLRQRGVQDLANITLFSDGTTVYECTSAEEVVDLLQGGQGVFGIAVSGAMRELTGVIADFHGERADGGESIAAPEDELASRRKHRDRKIG,"24,020",225,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,MTCY1A11.13c,1
P9WIQ9,Y1835_MYCTU,Rv1835c,Rv1835c MTCY1A11.08,GO:0005886; GO:0008239; GO:0052689,IPR029058; IPR005674; IPR008979; IPR000383; IPR013736; ,,,,Putative serine esterase Rv1835c (EC 3.1.1.-),plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; dipeptidyl-peptidase activity [GO:0008239],9634230; 21969609,,,MTRRGGSDAAWYSAPDQRSAYPRYRGMRYSSCYVTMRDGVRIAIDLYLPAGLTSAARLPAILHQTRYYRSLQLRWPLRMLLGGKPLQHIAADKRRRRRFVASGYAWVDVDVRGSGASFGARVCEWSSDEIRDGAEIVDWIVRQPWCNGTVAALGNSYDGTSAELLLVNQHPAVRVIAPCFSLFDVYTDIAFPGGIHAAWFTDTWGRYNEALDRNALHEVVGWWAKLPVTGMQPVQEDRDRSLRDGAIAAHRGNYDVHQIAGSLTFRDDVSASDPYRGQPDARLEPIGTPIESGSINLISPHNYWRDVQASGAAIYSYSGWFDGGYAHAAIKRFLTVSTPGSHLILGPWNHTGGWRVDPLRGLSRPDFDHDGELLRFIDHHVKGADTGIGSEPPVHYFTMVENRWKSADTWPPPATTQSYYLSADRQLRPDAPDCDSGADEYVVDQTAGTGERSRWRSQVGIGGHVCYPDRKAQDAKLLTYTSAPLDHPLEVTGHVVVTLFITSTSSDGTFFVYLEDVDPRGRVAYITEGQLRAIHRRLSDGPPPYRQVVPYRTFASGDAWPLVPGEIARLTFDLLPTSYLFQPGHRIRIAIAGADASHFAILPGCAPTVRVYRSRMHASRIDLPVIQP,"69,932",628,CocE/NonD hydrolase family,,carboxylic ester hydrolase activity [GO:0052689]; dipeptidyl-peptidase activity [GO:0008239],plasma membrane [GO:0005886],,MTCY1A11.08,1
P95149,Y1866_MYCTU,Rv1866 RVBD_1866,Rv1866 RVBD_1866 P425_01930,GO:0005618; GO:0005886; GO:0008152; GO:0033608,IPR003673; IPR023606; ,,,,Probable CoA-transferase Rv1866 (EC 2.8.3.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; formyl-CoA transferase activity [GO:0033608]; metabolic process [GO:0008152],9634230; 21969609,,FUNCTION: Probable CoA-transferase. {ECO:0000305}.,MPERLLDAVRVLDLSDGCSAGGTDMVTRLLADLGADVLKVEPPGGSPGRHVRPTLAGTSIGFAMHNANKRSAVLNPLDESDRRRFLDLAASADIVVDCGLPGQAAAYGASCAELADRYRHLVALSITDFGAAGPRSSWRATDPVLYAMSGALSRSGPTAGTPVLPPDGIASATAAVQAAWAVLVAYFNRLRCGTGDYIDFSRFDAVVMALDPPFGAHGQVAAGIRSTGRWRGRPKNQDAYPIYPCRDGYVRFCVMAPRQWRGLRRWLGEPEDFQDPKYDVIGARLAAWPQISVLVAKLCAEKTMKELVAAGQALGVPITAVLTPSRILASEHFQAVGAITDAELVPGVRTGVPTGYFVVDGKRAGFRTPAPAAGQDEPRWLADPAPVPPPSGRVGGYPFEGLRILDLGIIVAGGELSRLFGDLGAEVIKVESADHPDGLRQTRVGDAMSESFAWTHRNHLALGLDLRNSEGKAIFGRLVAESDAVFANFKPGTLTSLGFSYDVLHAFNPRIVLAGSSAFGNRGPWSTRMGYGPLVRAATGVTRVWTSDEAQPDNSRHPFYDATTIFPDHVVGRVGALLALAALIHRDRTGGGAHVHISQAEVVVNQLDTMFVAEAARATDVAEIHPDTSVHAVYPCAGDDEWCVISIRSDDEWRRATSVFGQPELANDPRFGASRSRVANRSELVAAVSAWTSTRTPVQAAGALQAAGVAAGPMNRPSDILEDPQLIERNLFRDMVHPLIARPLPAETGPAPFRHIPQAPQRPAPLPGQDSVQICRKLLGMTADETERLINERVMFGPAVTA,"85,655",802,CaiB/BaiF CoA-transferase family,metabolic process [GO:0008152],formyl-CoA transferase activity [GO:0033608],cell wall [GO:0005618]; plasma membrane [GO:0005886],,P425_01930,2
P9WFA3,VPC12_MYCTU,Rv1720c,vapC12 Rv1720c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC12,,Ribonuclease VapC12 (RNase VapC12) (EC 3.1.-.-) (Toxin VapC12),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB12 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIVLDASAAVELMLTTPAGAAVARRLRGETVHAPAHFDVEVIGAIRQAVVRQLISDHEGLVVVVNFLSLPVRRWPLKPFTQRAYQLRSTHTVADGAYVALAEGLGVPLITCDGRLAQSHGHNAEIELVA,"13,850",129,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WFA1,VPC13_MYCTU,Rv1838c,vapC13 Rv1838c MTCY1A11.05 MTCY359.35,GO:0004540; GO:0005576; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC13,DOMAIN 2 128 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC13 (RNase VapC13) (EC 3.1.-.-) (Toxin VapC13),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296; 21969609; 23345537,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB13 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MILVDSNIPMYLVGASHPHKLDAQRLLESALSGGERLVTDAEVLQEICHRYVAIKRREAIQPAFDAIIGVVDEVLPIERTDVEHARDALLRYQTLSARDALHIAVMAHHDITRLMSFDRGFDSYPGIKRLA,"14,726",131,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,MTCY1A11.05 MTCY359.35,1
P9WF71,VPC34_MYCTU,Rv1741,vapC34 Rv1741,GO:0004518; GO:0046872,IPR029060; ,,vapC34,,Putative ribonuclease VapC34 (Putative RNase VapC34) (EC 3.1.-.-) (Toxin VapC34),metal ion binding [GO:0046872]; nuclease activity [GO:0004518],9634230; 20011113,,FUNCTION: Toxic component of a possible type II toxin-antitoxin (TA) system. A putative RNase. Its cognate antitoxin is VapB34 (By similarity). {ECO:0000250}.,MVIDTSALVAMLNDEPEAQRFEIAVAADHVWLMSTASYPEMATVIETRFGEPGGREPKVSGQPLLYKGDDFACIDIRAVLAG,"8,884",82,PINc/VapC protein family,,metal ion binding [GO:0046872]; nuclease activity [GO:0004518],,,,1
E2FZM5,SOCB_MYCTU,Rv1706c.2,socB Rv1706c.2,,,,socB,,Uncharacterized protein SocB (Small ORF induced by copper B),,21166899; 9634230,,,MWTLKARKEHTGISGKPTARTDRHGSTRSGDSELQASARRFSRLPDRCGAQGVT,"5,927",54,,,,,,,1
P9WGP3,SECA2_MYCTU,Rv1821,secA2 Rv1821 MTCY1A11.22c,GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0006605; GO:0009405; GO:0015462; GO:0016887; GO:0017038; GO:0031522; GO:0043952; GO:0044119; GO:0052553,IPR027417; IPR000185; IPR026389; IPR020937; IPR011115; IPR014018; IPR011130; IPR011116; IPR036266; IPR036670; ,,secA2,,Protein translocase subunit SecA 2,cell envelope Sec protein transport complex [GO:0031522]; cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled protein transmembrane transporter activity [GO:0015462]; growth of symbiont in host cell [GO:0044119]; modulation by symbiont of host immune response [GO:0052553]; pathogenesis [GO:0009405]; protein import [GO:0017038]; protein targeting [GO:0006605]; protein transport by the Sec complex [GO:0043952],9634230; 21969609,X-ray crystallography (1),"FUNCTION: Part of the Sec protein translocase complex. Interacts with the SecYEG preprotein conducting channel. Has a central role in coupling the hydrolysis of ATP to the transfer of proteins into and across the cell membrane, serving as an ATP-driven molecular motor driving the stepwise translocation of polypeptide chains across the membrane. {ECO:0000255|HAMAP-Rule:MF_01382}.",MNVHGCPRIAACRCTDTHPRGRPAFAYRWFVPKTTRAQPGRLSSRFWRLLGASTEKNRSRSLADVTASAEYDKEAADLSDEKLRKAAGLLNLDDLAESADIPQFLAIAREAAERRTGLRPFDVQLLGALRMLAGDVIEMATGEGKTLAGAIAAAGYALAGRHVHVVTINDYLARRDAEWMGPLLDAMGLTVGWITADSTPDERRTAYDRDVTYASVNEIGFDVLRDQLVTDVNDLVSPNPDVALIDEADSVLVDEALVPLVLAGTTHRETPRLEIIRLVAELVGDKDADEYFATDSDNRNVHLTEHGARKVEKALGGIDLYSEEHVGTTLTEVNVALHAHVLLQRDVHYIVRDDAVHLINASRGRIAQLQRWPDGLQAAVEAKEGIETTETGEVLDTITVQALINRYATVCGMTGTALAAGEQLRQFYQLGVSPIPPNKPNIREDEADRVYITTAAKNDGIVEHITEVHQRGQPVLVGTRDVAESEELHERLVRRGVPAVVLNAKNDAEEARVIAEAGKYGAVTVSTQMAGRGTDIRLGGSDEADHDRVAELGGLHVVGTGRHHTERLDNQLRGRAGRQGDPGSSVFFSSWEDDVVAANLDHNKLPMATDENGRIVSPRTGSLLDHAQRVAEGRLLDVHANTWRYNQLIAQQRAIIVERRNTLLRTVTAREELAELAPKRYEELSDKVSEERLETICRQIMLYHLDRGWADHLAYLADIRESIHLRALGRQNPLDEFHRMAVDAFASLAADAIEAAQQTFETANVLDHEPGLDLSKLARPTSTWTYMVNDNPLSDDTLSALSLPGVFR,"88,952",808,SecA family,growth of symbiont in host cell [GO:0044119]; modulation by symbiont of host immune response [GO:0052553]; pathogenesis [GO:0009405]; protein import [GO:0017038]; protein targeting [GO:0006605]; protein transport by the Sec complex [GO:0043952],ATPase activity [GO:0016887]; ATPase-coupled protein transmembrane transporter activity [GO:0015462]; ATP binding [GO:0005524],cell envelope Sec protein transport complex [GO:0031522]; cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY1A11.22c,1
P9WHC5,RL20_MYCTU,Rv1643,rplT Rv1643 MTCY06H11.07,GO:0000027; GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022625,IPR005813; IPR035566; ,,rplT,,50S ribosomal protein L20,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: Binds directly to 23S ribosomal RNA and is necessary for the in vitro assembly process of the 50S ribosomal subunit. It is not involved in the protein synthesizing functions of that subunit (By similarity). {ECO:0000250}.,MARVKRAVNAHKKRRSILKASRGYRGQRSRLYRKAKEQQLHSLNYAYRDRRARKGEFRKLWIARINAAARLNDITYNRLIQGLKAAGVEVDRKNLADIAISDPAAFTALVDVARAALPEDVNAPSGEAA,"14,527",129,Bacterial ribosomal protein bL20 family,ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY06H11.07,1
P9WH91,RL35_MYCTU,Rv1642,rpmI Rv1642 MTCY06H11.06,GO:0003735; GO:0006412; GO:0022625,IPR021137; IPR018265; IPR001706; IPR037229; ,,rpmI,,50S ribosomal protein L35,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),,MPKAKTHSGASKRFRRTGTGKIVRQKANRRHLLEHKPSTRTRRLDGRTVVAANDTKRVTSLLNG,"7,220",64,Bacterial ribosomal protein bL35 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],,MTCY06H11.06,1
P9WHI7,RECN_MYCTU,Rv1696,recN Rv1696 MTCI125.18,GO:0005524; GO:0005618; GO:0006281; GO:0006310,IPR004604; IPR027417; IPR003395; ,,recN,,DNA repair protein RecN (Recombination protein N),cell wall [GO:0005618]; ATP binding [GO:0005524]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],9634230; 21969609,,FUNCTION: May be involved in recombinational repair of damaged DNA. {ECO:0000250}.,MLTELRIESLGAISVATAEFDRGFTVLTGETGTGKTMVVTGLHLLGGARADATRVRSGADRAVVEGRFTTTDLDDATVAGLQAVLDSSGAERDEDGSVIALRSISRDGPSRAYLGGRGVPAKSLSGFTNELLTLHGQNDQLRLMRPDEQRGALDRFAAAGEAVQRYRKLRDAWLTARRDLVDRRNRARELAQEADRLKFALNEIDTVDPQPGEDVALVADIARLSELDTLREAATTARATLCGTPDADAFDRGAVDSLGRARAALQSSDDAALRGLAEQVGEALTVVVDAVAELGAYLDELPADASALDAKLARQAQLRTLTRKYAADIDGVLRWADEARARLAQLDVSEEGLAALERRTGELAHELGQAAVDLSTIRRKAAKRLAKEVSAELSALAMADAEFTIGVTTELADHGDPVALALASGELARAGADGVDAVEFGFVAHRGMTVLPLAKSASGGELSRVMLSLEVVLATSRKQAAGTTMVFDEIDAGVGGWAAVQIGRRLARLARTHQVIVVTHLPQVAAYADVHLMVQRTGRDGASGVRRLTSEDRVAELARMLAGLGDSDSGRAHARELLETAQNDELT,"62,229",587,RecN family,DNA recombination [GO:0006310]; DNA repair [GO:0006281],ATP binding [GO:0005524],cell wall [GO:0005618],,MTCI125.18,1
P9WFX3,TRPE_MYCTU,Rv1609,trpE Rv1609 MTCY01B2.01 MTV046.07,GO:0000162; GO:0000287; GO:0004049; GO:0005886; GO:0005950; GO:0040007,IPR005801; IPR019999; IPR006805; IPR005256; IPR015890; ,,trpE,,Anthranilate synthase component 1 (AS) (ASI) (EC 4.1.3.27),anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886]; anthranilate synthase activity [GO:0004049]; magnesium ion binding [GO:0000287]; growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],9634230; 21969609,,"FUNCTION: Part of a heterotetrameric complex that catalyzes the two-step biosynthesis of anthranilate, an intermediate in the biosynthesis of L-tryptophan. In the first step, the glutamine-binding beta subunit (TrpG) of anthranilate synthase (AS) provides the glutamine amidotransferase activity which generates ammonia as a substrate that, along with chorismate, is used in the second step, catalyzed by the large alpha subunit of AS (TrpE) to produce anthranilate. In the absence of TrpG, TrpE can synthesize anthranilate directly from chorismate and high concentrations of ammonia (By similarity). {ECO:0000250}.",MHADLAATTSREDFRLLAAEHRVVPVTRKVLADSETPLSAYRKLAANRPGTFLLESAENGRSWSRWSFIGAGAPTALTVREGQAVWLGAVPKDAPTGGDPLRALQVTLELLATADRQSEPGLPPLSGGMVGFFAYDMVRRLERLPERAVDDLCLPDMLLLLATDVAAVDHHEGTITLIANAVNWNGTDERVDWAYDDAVARLDVMTAALGQPLPSTVATFSRPEPRHRAQRTVEEYGAIVEYLVDQIAAGEAFQVVPSQRFEMDTDVDPIDVYRILRVTNPSPYMYLLQVPNSDGAVDFSIVGSSPEALVTVHEGWATTHPIAGTRWRGRTDDEDVLLEKELLADDKERAEHLMLVDLGRNDLGRVCTPGTVRVEDYSHIERYSHVMHLVSTVTGKLGEGRTALDAVTACFPAGTLSGAPKVRAMELIEEVEKTRRGLYGGVVGYLDFAGNADFAIAIRTALMRNGTAYVQAGGGVVADSNGSYEYNEARNKARAVLNAIAAAETLAAPGANRSGC,"55,849",516,Anthranilate synthase component I family,growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],anthranilate synthase activity [GO:0004049]; magnesium ion binding [GO:0000287],anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886],,MTCY01B2.01 MTV046.07,1
P9WG35,TPX_MYCTU,Rv1932,tpx Rv1932 MTCY09F9.32c,GO:0004601; GO:0005576; GO:0005618; GO:0005829; GO:0006979; GO:0008379; GO:0009405; GO:0015036; GO:0045454; GO:0051409; GO:0051920; GO:0052060; GO:0055114,IPR013740; IPR036249; IPR013766; IPR002065; IPR018219; ,,tpx,DOMAIN 18 165 Thioredoxin. {ECO:0000255|HAMAP-Rule:MF_00269}.,Thiol peroxidase (Tpx) (EC 1.11.1.15) (Peroxiredoxin tpx) (Prx) (Thioredoxin peroxidase),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979],9634230; 14871480; 21969609; 16627951; 16884737,X-ray crystallography (2),"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides. {ECO:0000255|HAMAP-Rule:MF_00269, ECO:0000269|PubMed:14871480}.",MAQITLRGNAINTVGELPAVGSPAPAFTLTGGDLGVISSDQFRGKSVLLNIFPSVDTPVCATSVRTFDERAAASGATVLCVSKDLPFAQKRFCGAEGTENVMPASAFRDSFGEDYGVTIADGPMAGLLARAIVVIGADGNVAYTELVPEIAQEPNYEAALAALGA,"16,896",165,"Peroxiredoxin family, Tpx subfamily",cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979],disulfide oxidoreductase activity [GO:0015036]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; thioredoxin peroxidase activity [GO:0008379],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576],,MTCY09F9.32c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WFX7,TRPC_MYCTU,Rv1611,trpC Rv1611 MTCY01B2.03,GO:0000162; GO:0000287; GO:0004425; GO:0005618; GO:0005886; GO:0040007; GO:0046391,IPR013785; IPR013798; IPR001468; IPR011060; ,,trpC,,Indole-3-glycerol phosphate synthase (IGPS) (EC 4.1.1.48),cell wall [GO:0005618]; plasma membrane [GO:0005886]; indole-3-glycerol-phosphate synthase activity [GO:0004425]; magnesium ion binding [GO:0000287]; 5-phosphoribose 1-diphosphate metabolic process [GO:0046391]; growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],9634230; 19099550; 21969609,X-ray crystallography (6),,MSPATVLDSILEGVRADVAAREASVSLSEIKAAAAAAPPPLDVMAALREPGIGVIAEVKRASPSAGALATIADPAKLAQAYQDGGARIVSVVTEQRRFQGSLDDLDAVRASVSIPVLRKDFVVQPYQIHEARAHGADMLLLIVAALEQSVLVSMLDRTESLGMTALVEVHTEQEADRALKAGAKVIGVNARDLMTLDVDRDCFARIAPGLPSSVIRIAESGVRGTADLLAYAGAGADAVLVGEGLVTSGDPRAAVADLVTAGTHPSCPKPAR,"28,023",272,TrpC family,5-phosphoribose 1-diphosphate metabolic process [GO:0046391]; growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],indole-3-glycerol-phosphate synthase activity [GO:0004425]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY01B2.03,1
P0CV86,Y954A_MYCTU,Rv1954A,Rv1954A,,,,,,Uncharacterized protein Rv1954A,,9634230; 19118359; 20585061,,,MARGRVVCIGDAGCDCTPGVFRATAGGMPVLVVIESGTGGDQMARKATSPGKPAPTSGQYRPVGGGNEVTVPKGHRLPPSPKPGQKWVNVDPTKNKSGRG,"10,167",100,,,,,,,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WHQ1,Y1711_MYCTU,Rv1711,Rv1711 MTCI125.33,GO:0000455; GO:0003723; GO:0005829; GO:0009982; GO:0040007,IPR020103; IPR000748; IPR018496; IPR006145; IPR002942; IPR036986; ,,,DOMAIN 14 81 S4 RNA-binding. {ECO:0000255|PROSITE-ProRule:PRU00182}.,Uncharacterized RNA pseudouridine synthase Rv1711 (EC 5.4.99.-) (RNA pseudouridylate synthase) (RNA-uridine isomerase),cytosol [GO:0005829]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; growth [GO:0040007],9634230; 19099550; 21969609,,,MMAEPEESREPRGIRLQKVLSQAGIASRRAAEKMIVDGRVEVDGHVVTELGTRVDPQVAVVRVDGARVVLDDSLVYLALNKPRGMHSTMSDDRGRPCIGDLIERKVRGTKKLFHVGRLDADTEGLMLLTNDGELAHRLMHPSHEVPKTYLATVTGSVPRGLGRTLRAGIELDDGPAFVDDFAVVDAIPGKTLVRVTLHEGRNRIVRRLLAAAGFPVEALVRTDIGAVSLGKQRPGSVRALRSNEIGQLYQAVGL,"27,597",254,Pseudouridine synthase RsuA family,enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; growth [GO:0040007],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],cytosol [GO:0005829],,MTCI125.33,1
P9WLS9,Y1733_MYCTU,Rv1733c,Rv1733c,GO:0005886; GO:0016021,,,,,Probable membrane protein Rv1733c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 11416222; 12953092; 16931093; 18474359; 18400743; 19553548,,,MIATTRDREGATMITFRLRLPCRTILRVFSRNPLVRGTDRLEAVVMLLAVTVSLLTIPFAAAAGTAVQDSRSHVYAHQAQTRHPATATVIDHEGVIDSNTTATSAPPRTKITVPARWVVNGIERSGEVNAKPGTKSGDRVGIWVDSAGQLVDEPAPPARAIADAALAALGLWLSVAAVAGALLALTRAILIRVRNASWQHDIDSLFCTQR,"22,458",210,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WLS7,Y1734_MYCTU,Rv1734c,Rv1734c,GO:0008152; GO:0016746,IPR001078; IPR023213; ,,,,Uncharacterized protein Rv1734c,"transferase activity, transferring acyl groups [GO:0016746]; metabolic process [GO:0008152]",9634230; 11416222; 12953092; 18400743,,,MTNVGDQGVDAVFGVIYPPQVALVSFGKPAQRVCAVDGAIHVMTTVLATLPADHGCSDDHRGALFFLSINELTRCAAVTG,"8,315",80,2-oxoacid dehydrogenase family,metabolic process [GO:0008152],"transferase activity, transferring acyl groups [GO:0016746]",,,,1
P9WLR5,Y1829_MYCTU,Rv1829,Rv1829 MTCY1A11.14c,GO:0004518; GO:0005618; GO:0005886,IPR036104; IPR003729; ,,,DOMAIN 1 129 BFN.,Uncharacterized protein Rv1829,cell wall [GO:0005618]; plasma membrane [GO:0005886]; nuclease activity [GO:0004518],9634230; 21969609,,,MGEVRVVGIRVEQPQNQPVLLLREANGDRYLPIWIGQSEAAAIALEQQGVEPPRPLTHDLIRDLIAALGHSLKEVRIVDLQEGTFYADLIFDRNIKVSARPSDSVAIALRVGVPIYVEEAVLAQAGLLIPDESDEEATTAVREDEVEKFKEFLDSVSPDDFKAT,"18,115",164,,,nuclease activity [GO:0004518],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY1A11.14c,1
P9WGQ1,Y1856_MYCTU,Rv1856c,Rv1856c,GO:0005886; GO:0016491,IPR036291; ,,,,Putative oxidoreductase Rv1856c (EC 1.-.-.-),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 19099550; 21969609,,,MEVLVTGGDTDLGRTMAEGFRNDGHKVTLVGARRGDLEVAAKELDVDAVVCDTTDPTSLTEARGLFPRHLDTIVNVPAPSWDAGDPRAYSVSDTANAWRNALDATVLSVVLTVQSVGDHLRSGGSIVSVVAENPPAGGAESAIKAALSNWIAGQAAVFGTRGITINTVACGRSVQTGYEGLSRTPAPVAAEIARLALFLTTPAARHITGQTLHVSHGALAHFG,"23,058",223,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,2
O07737,Y1895_MYCTU,Rv1895,Rv1895,GO:0004022; GO:0008270,IPR013149; IPR013154; IPR002328; IPR011032; IPR036291; IPR020843; ,,,,Probable zinc-binding alcohol dehydrogenase Rv1895 (EC 1.1.1.1),alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],9634230; 21969609,,,MRAVVIDGAGSVRVNTQPDPALPGPDGVVVAVTAAGICGSDLHFYEGEYPFTEPVALGHEAVGTIVEAGPQVRTVGVGDLVMVSSVAGCGVCPGCETHDPVMCFSGPMIFGAGVLGGAQADLLAVPAADFQVLKIPEGITTEQALLLTDNLATGWAAAQRADISFGSAVAVIGLGAVGLCALRSAFIHGAATVFAVDRVKGRLQRAATWGATPIPSPAAETILAATRGRGADSVIDAVGTDASMSDALNAVRPGGTVSVVGVHDLQPFPVPALTCLLRSITLRMTMAPVQRTWPELIPLLQSGRLDVDGIFTTTLPLDEAAKGYATARARSGEELRFCLRPDSRDVLGAHETVDLYVHVRRCQSVADLQLEGAADGVDGPSMLN,"39,479",384,Zinc-containing alcohol dehydrogenase family,,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],,,,1
P9WFQ1,Y1898_MYCTU,Rv1898,Rv1898 MTCY180.20c,GO:0005829,IPR029756; IPR002767; ,,,,UPF0045 protein Rv1898,cytosol [GO:0005829],9634230; 21969609,,,MSVLVAFSVTPLGVGEGVGEIVTEAIRVVRDSGLPNQTDAMFTVIEGDTWAEVMAVVQRAVEAVAARAPRVSAVIKVDWRPGVTDAMTQKVATVERYLLRPE,"10,953",102,UPF0045 family,,,cytosol [GO:0005829],,MTCY180.20c,1
P9WK29,Y1899_MYCTU,Rv1899c,Rv1899c MTCY180.19,GO:0005576; GO:0005886,IPR002589; ,,,DOMAIN 179 354 Macro. {ECO:0000255|PROSITE-ProRule:PRU00490}.,Uncharacterized protein Rv1899c,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MAAMRAHARRRHPHALMSRAAGLPRLSWFAGLTWFAGGSTGAGCAAHPALAGLTAGARCPAYAAISASTARPAATAGTTPATGASGSARPTDAAGMADLARPGVVATHAVRTLGTTGSRAIGLCPCQPLDCPRSPQATLNLGSMGRSLDGPQWRRARVRLCGRWWRRSNTTRGASPRPPSTCRGDNVSMIELEVHQADVTKLELDAITNAANTRLRHAGGVAAAIARAGGPELQRESTEKAPIGLGEAVETTAGDMPARYVIHAATMELGGPTSGEIITAATAATLRKADELGCRSLALVAFGTGVGGFPLDDAARLMVGAVRRHRPGSLQRVVFAVHGDAAERAFSAAIQAGEDTARR,"36,936",359,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY180.19,1
P9WFN5,Y1910_MYCTU,Rv1910c,Rv1910c MTCY180.08,GO:0005576,IPR008914; IPR036610; IPR005247; ,,,,UPF0098 protein Rv1910c,extracellular region [GO:0005576],9634230; 21969609,,,MESTVAHAFHRFALAILGLALPVALVAYGGNGDSRKAAPLAPKAAALGRSMPETPTGDVLTISSPAFADGAPIPEQYTCKGANIAPPLTWSAPFGGALVVDDPDAPREPYVHWIVIGIAPGAGSTADGETPGGGISLPNSSGQPAYTGPCPPAGTGTHHYRFTLYHLPAVPPLAGLAGTQAARVIAQAATMQARLIGTYEG,"20,298",201,UPF0098 family,,,extracellular region [GO:0005576],,MTCY180.08,1
P95283,Y1931_MYCTU,Rv1931c,Rv1931c LH57_10510,GO:0003700; GO:0005886; GO:0006351; GO:0009405; GO:0010468; GO:0019217; GO:0043565,IPR029062; IPR002818; IPR009057; IPR018060; ,,,DOMAIN 174 257 HTH araC/xylS-type. {ECO:0000255|PROSITE-ProRule:PRU00593}.,HTH-type transcriptional regulator Rv1931c,"plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; pathogenesis [GO:0009405]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]",9634230; 15322050; 19389781,,FUNCTION: Controls the expression of genes important for virulence. {ECO:0000269|PubMed:15322050}.,MVIVGFPGDPVDTVILPGGAGVDAARSEPALIDWVKAVSGTARRVVTVCTGAFLAAEAGLLGRTPSDDALGLCRTFRPRISGRSGRCRPDLHAQFAEGVDRGWSHRRHRPRAGTGRRRPRHRDCPDGCPLARPVSAPTRWADPVRGSGVDATRQTDLDPPGAGGHRGRAGGAHRIGELAQRAAMSPRHFTRVFSDEVGEAPGRYVERIRTEAARRQLEETHDTVVAIAARCGFGTAETMRRSFIRRVGISPDQYRKAFA,"27,996",259,,"pathogenesis [GO:0009405]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],plasma membrane [GO:0005886],,LH57_10510,4
P9WLT5,Y1591_MYCTU,Rv1591,Rv1591 MTCY336.13c,GO:0005576; GO:0005886; GO:0005887,IPR021213; ,,,,Uncharacterized protein Rv1591,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MLGLSATGVLVGGLWAWIAPPIHAVVAITRAGERVHEYLGSESQNFFIAPFMLLGLLSVLAVVASALMWQWREHRGPQMVAGLSIGLTTAAAIAAGVGALVVRLRYGALDFDTVPLSRGDHALTYVTQAPPVFFARRPLQIALTLMWPAGIASLVYALLAAGTARDDLGGYPAVDPSSNARTEALETPQAPVS,"20,299",193,,,,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY336.13c,1
P9WJX3,Y1634_MYCTU,Rv1634,Rv1634,GO:0005887; GO:0015562; GO:0042891; GO:0046677,IPR011701; IPR020846; IPR036259; ,,,,Probable multidrug-efflux transporter Rv1634,integral component of plasma membrane [GO:0005887]; efflux transmembrane transporter activity [GO:0015562]; antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],9634230; 12520088; 21969609,,FUNCTION: Could be involved in fluoroquinolones efflux. {ECO:0000269|PubMed:12520088}.,MTETASETGSWRELLSRYLGTSIVLAGGVALYATNEFLTISLLPSTIADIGGSRLYAWVTTLYLVGSVVAATTVNTMLLRVGARSSYLMGLAVFGLASLVCAAAPSMQILVAGRTLQGIAGGLLAGLGYALINSTLPKSLWTRGSALVSAMWGVATLIGPATGGLFAQLGLWRWAFGVMTLLTALMAMLVPVALGAGGVGPGGETPVGSTHKVPVWSLLLMGAAALAISVAALPNYLVQTAGLLAAAALLVAVFVVVDWRIHAAVLPPSVFGSGPLKWIYLTMSVQMIAAMVDTYVPLFGQRLGHLTPVAAGFLGAALAVGWTVGEVASASLNSARVIGHVVAAAPLVMASGLALGAVTQRADAPVGIIALWALALLIIGTGIGIAWPHLTVRAMDSVADPAESSAAAAAINVVQLISGAFGAGLAGVVVNTAKGGEVAAARGLYMAFTVLAAAGVIASYQATHRDRRLPR,"47,713",471,Major facilitator superfamily,antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],efflux transmembrane transporter activity [GO:0015562],integral component of plasma membrane [GO:0005887],,,1
P9WG85,Y1877_MYCTU,Rv1877,Rv1877,GO:0005887; GO:0022857,IPR011701; IPR020846; IPR036259; IPR005829; IPR001958; IPR036388; IPR036390; ,,,,Uncharacterized MFS-type transporter Rv1877,integral component of plasma membrane [GO:0005887]; transmembrane transporter activity [GO:0022857],9634230,,,MAGPTAPTTAPTAIRAGGPLLSPVRRNIIFTALVFGVLVAATGQTIVVPALPTIVAELGSTVDQSWAVTSYLLGGTVVVVVAGKLGDLLGRNRVLLGSVVVFVVGSVLCGLSQTMTMLAISRALQGVGAGAISVTAYALAAEVVPLRDRGRYQGVLGAVFGVNTVTGPLLGGWLTDYLSWRWAFWINVPVSIAVLTVAATAVPALARPPKPVIDYLGILVIAVATTALIMATSWGGTTYAWGSATIVGLLIGAAVALGFFVWLEGRAAAAILPPRLFGSPVFAVCCVLSFVVGFAMLGALTFVPIYLGYVDGASATASGLRTLPMVIGLLIASTGTGVLVGRTGRYKIFPVAGMALMAVAFLLMSQMDEWTPPLLQSLYLVVLGAGIGLSMQVLVLIVQNTSSFEDLGVATSGVTFFRVVGASFGTATFGALFVNFLDRRLGSALTSGAVPVPAVPSPAVLHQLPQSMAAPIVRAYAESLTQVFLCAVSVTVVGFILALLLREVPLTDIHDDADDLGDGFGVPRAESPEDVLEIAVRRMLPNGVRLRDIATQPGCGLGVAELWALLRIYQYQRLFEAVRLTDIGRHLHVPYQVFEPVFDRLVQTGYAARDGDILTLTPSGHRQVDSLAVLIRQWLLDHLAVAPGLKRQPDHQFEAALQHVTDAVLVQRDWYEDLGDLSESRQLAATT,"72,354",687,"Major facilitator superfamily, TCR/Tet family",,transmembrane transporter activity [GO:0022857],integral component of plasma membrane [GO:0005887],,,1
P9WLQ5,Y1945_MYCTU,Rv1945,Rv1945 MTCY09F9.19c,,IPR003870; IPR003615; ,,,DOMAIN 364 405 HNH.,Uncharacterized protein Rv1945,,9634230; 21969609,,,MRSDTREEISAALDAYHASLSRVLDLKCDALTTPELLACLQRLEVERRRQGAAEHALINQLAGQACEEELGGTLRTALANRLHITPGEASRRIAEAEDLGERRALTGEPLPAQLTATAAAQREGKIGREHIKEIQAFFKELSAAVDLGIREAAEAQLAELATSRRPDHLHGLATQLMDWLHPDGNFSDQERARKRGITMGKQEFDGMSRISGLLTPELRATIEAVLAKLAAPGACNPDDQTPVVDDTPDADAVRRDTRSQAQRHHDGLLAGLRGLLASGELGQHRGLPVTVVVSTTLKELEAATGKGVTGGGSRVPMSDLIRMASNAHHYLALFDGAKPLALYHTKRLASPAQRIMLYAKDRGCSRPGCDAPAYHSEVHHVTPWTTTHRTDINDLTLACGPDNRLVEKGWKTRKNAKGDTEWLPPAHLDHGQPRINRYHHPEKILCEPDDDEPH,"49,671",454,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,,,MTCY09F9.19c,1
P9WFH7,Y1947_MYCTU,Rv1896c,Rv1896c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv1896c (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MTTPEYGSLRSDDDHWDIVSNVGYTALLVAGWRALHTTGPKPLVQDEYAKHFITASADPYLEGLLANPRTSEDGTAFPRLYGVQTRFFDDFFNCADEAGIRQAVIVAAGLDCRAYRLDWQPGTTVFEIDVPKVLEFKARVLSERGAVPKAHRVAVPADLRTDWPTPLTAAGFDPQRPSAWSVEGLLPYLTGDAQYALFARIDELCAPGSRVALGALGSRLDHEQLAALETAHPGVNMSGDVNFSALTYDDKTDPVEWLVEHGWAVDPVRSTLELQVGYGLTPPDVDVKIDSFMRSQYITAVRA,"33,267",303,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
P9WLQ3,Y1954_MYCTU,Rv1954c,Rv1954c MTCY09F9.10,,,,,,Uncharacterized protein Rv1954c,,9634230; 20585061,,,MAAGSGGGTVGLVLPRVASLSGLDGAPTVPEGSDKALMHLGDPPRRCDTHPDGTSSAAAALVLRRIDVHPLLTGLGRGRQTVSLRNGHLVATANRAILSRRRSRLTRGRSFTSHLITSCPRLDDHQHRHPTRCRAEHAGCTVATCIPNAHDPAPGHQTPRWGPFRLKPAYTRI,"18,481",173,,,,,,MTCY09F9.10,1
P9WLT3,Y1702_MYCTU,Rv1702c,Rv1702c MTCI125.24c,,IPR003870; IPR003615; ,,,,Uncharacterized protein Rv1702cMb1728c,,9634230,,,MYSSSREEAVAAFDNLDTALNRVLKVSPDDLTIPECLAMLQRCEKIRRRLPAAEHPFINKLADQTDQTELGGKLPFALAERLHISRGEASRRIHEAADLGPRRTLTGQPLPPLLTATAAAQRAGHLGPAHVQVIRCFLHQLPHHVDLPTREKAEAELATLGGRFRPDQLHKLATKLADCLNPDGNYNDTDRARRRSIILGNQGPDGMSAISGYLTPEARATVDAVLAKLAAPGMANPADDTPCLAGTPSQAAIEADTRSAGQRHHDGLLAALRALLCSGELGQHNGLPAAIIVSTSLTELQSRAGHALTGGGTLLPMSDVIRLASHANHYLRIFDHGRELALYHTKRLASPGQRIVLYAKDRGCSFPNCDVPGYLTEVHHVTDFAQCQETDINELTQGCGPHHQLATTGGWITRKRKDGTTEWLPPAHLDHGQPRTNSYFHPEKLLHDSDEDDP,"49,396",454,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,,,MTCI125.24c,1
P9WLT1,Y1708_MYCTU,Rv1708,Rv1708,GO:0005524; GO:0005886; GO:0040007; GO:0043590,IPR025669; IPR027417; ,,,,Uncharacterized protein Rv1708,bacterial nucleoid [GO:0043590]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; growth [GO:0040007],9634230; 12657046; 16735741; 21969609,,FUNCTION: May play a role in septum formation. {ECO:0000269|PubMed:16735741}.,MPAGLPGQASVAVRLSCDVPPDARHHEPRPGMTDHPDTGNGIGLTGRPPRAIPDPAPRSSHGPAKVIAMCNQKGGVGKTTSTINLGAALGEYGRRVLLVDMDPQGALSAGLGVPHYELDKTIHNVLVEPRVSIDDVLIHSRVKNMDLVPSNIDLSAAEIQLVNEVGREQTLARALYPVLDRYDYVLIDCQPSLGLLTVNGLACTDGVIIPTECEFFSLRGLALLTDTVDKVRDRLNPKLDISGILITRYDPRTVNSREVMARVVERFGDLVFDTVITRTVRFPETSVAGEPITTWAPKSAGALAYRALARELIDRFGM,"34,380",318,ParA family,growth [GO:0040007],ATP binding [GO:0005524],bacterial nucleoid [GO:0043590]; plasma membrane [GO:0005886],,,1
P9WKB9,Y1760_MYCTU,Rv1760,Rv1760 MTCY28.26,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv1760 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv1760),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has very weak wax synthase activity, incorporating palmityl alcohol into wax esters in the presence of palmitoyl-CoA.",MPRGCAGARFACNACLNFLAGLGISEPISPGWAAMERLSGLDAFFLYMETPSQPLNVCCVLELDTSTMPGGYTYGRFHAALEKYVKAAPEFRMKLADTELNLDHPVWVDDDNFQIRHHLRRVAMPAPGGRRELAEICGYIAGLPLDRDRPLWEMWVIEGGARSDTVAVMLKVHHAVVDGVAGANLLSHLCSLQPDAPAPQPVRGTGGGNVLQIAASGLEGFASRPVRLATVVPATVLTLVRTLLRAREGRTMAAPFSAPPTPFNGPLGRLRNIAYTQLDMRDVKRVKDRFGVTINDVVVALCAGALRRFLLEHGVLPEAPLVATVPVSVHDKSDRPGRNQATWMFCRVPSQISDPAQRIRTIAAGNTVAKDHAAAIGPTLLHDWIQFGGSTMFGAAMRILPHISITHSPAYNLILSNVPGPQAQLYFLGCRMDSMFPLGPLLGNAGLNITVMSLNGELGVGIVSCPDLLPDLWGVADGFPEALKELLECSDDQPEGSNHQDS,"54,092",502,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY28.26,1
P9WFH9,Y1770_MYCTU,Rv1729c,Rv1729c,GO:0005886; GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv1729c (EC 2.1.1.-),plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MARTDDDNWDLTSSVGVTATIVAVGRALATKDPRGLINDPFAEPLVRAVGLDLFTKMMDGELDMSTIADVSPAVAQAMVYGNAVRTKYFDDYLLNATAGGIRQVAILASGLDSRAYRLPWPTRTVVYEIDQPKVMEFKTTTLADLGAEPSAIRRAVPIDLRADWPTALQAAGFDSAAPTAWLAEGLLIYLKPQTQDRLFDNITALSAPGSMVATEFVTGIADFSAERARTISNPFRCHGVDVDLASLVYTGPRNHVLDYLAAKGWQPEGVSLAELFRRSGLDVRAADDDTIFISGCLTDHSSISPPTAAGWR,"33,654",312,UPF0677 family,,methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
P9WLR7,Y1824_MYCTU,Rv1824,Rv1824 MTCY1A11.19c,GO:0005886; GO:0016021,IPR009709; ,,,,Uncharacterized protein Rv1824,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MGSDTAWSPARMIGIAALAVGIVLGLVFHPGVPEVIQPYLPIAVVAALDAVFGGLRAYLERIFDPKVFVVSFVFNVLVAALIVYVGDQLGVGTQLSTAIIVVLGIRIFGNTAALRRRLFGA,"12,750",121,Sbp family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY1A11.19c,1
P9WME7,Y1828_MYCTU,Rv1828,Rv1828 MTCY1A11.15c,GO:0003677; GO:0005829; GO:0006351; GO:0006355; GO:0040007,IPR009061; IPR000551; ,,,DOMAIN 11 85 HTH merR-type. {ECO:0000255|PROSITE-ProRule:PRU00254}.,Uncharacterized HTH-type transcriptional regulator Rv1828,"cytosol [GO:0005829]; DNA binding [GO:0003677]; growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,,MSAPDSPALAGMSIGAVLDLLRPDFPDVTISKIRFLEAEGLVTPRRASSGYRRFTAYDCARLRFILTAQRDHYLPLKVIRAQLDAQPDGELPPFGSPYVLPRLVPVAGDSAGGVGSDTASVSLTGIRLSREDLLERSEVADELLTALLKAGVITTGPGGFFDEHAVVILQCARALAEYGVEPRHLRAFRSAADRQSDLIAQIAGPLVKAGKAGARDRADDLAREVAALAITLHTSLIKSAVRDVLHR,"26,443",247,,"growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytosol [GO:0005829],,MTCY1A11.15c,1
P9WLR3,Y1831_MYCTU,Rv1831,Rv1831 MTCY1A11.12c,,,,,,Uncharacterized protein Rv1831,,9634230,,,MRLCVCSAVDWTTHRSSAGEFCGCQLRTPKEQYLSVNLSGTRTARDYDASGKRWRPLAVLTRRWGKAIHLTVDRVAESLRRLACR,"9,696",85,,,,,,MTCY1A11.12c,1
P9WLQ7,Y1841_MYCTU,Rv1841c,Rv1841c MTCY1A11.03 MTCY359.32,GO:0005886; GO:0016021,IPR000644; IPR002550; ,,,DOMAIN 1 198 CNNM transmembrane. {ECO:0000255|PROSITE-ProRule:PRU01193}.; DOMAIN 217 280 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 285 342 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,Uncharacterized protein Rv1841c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MDVLSAVLLALLLIGANAFFVGAEFALISARRDRLEALAEQGKATAVTVIRAGEQLPAMLTGAQLGVTVSSILLGRVGEPAVVKLLQLSFGLSGVPPALLHTLSLAIVVALHVLLGEMVPKNIALAGPERTAMLLVPPYLVYVRLARPFIAFYNNCANAILRLVGVQPKDELDIAVSTAELSEMIAESLSEGLLDHEEHTRLTRALRIRTRLVADVAVPLVNIRAVQVSAVGSGPTIGGVEQALAQTGYSRFPVVDRGGRFIGYLHIKDVLTLGDNPQTVIDLAVVRPLPRVPQSLPLADALSRMRRINSHLALVTADNGSVVGMVALEDVVEDLVGTMRDGTHR,"36,685",345,TerC family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY1A11.03 MTCY359.32,1
P9WLU1,Y1583_MYCTU,Rv1583c,Rv1583c MTCY336.21,,IPR024384; ,,,,Uncharacterized protein Rv1583c,,9634230,,,MTAGAGGSPPTRRCPATEDRAPATVATPSSADPTASRAVSWWSVHEHVAPVLDAAGSWPMAGTPAWRQLDDADPRKWAAICDAARHWALRVETCQEAMAQASRDVSAAADWPGIAREIVRRRGVYIPRAGVA,"14,039",132,,,,,,MTCY336.21,1
P9WLT7,Y1590_MYCTU,Rv1590,Rv1590 MTCY336.14c,GO:0052556,,,,,Uncharacterized protein Rv1590,positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,,MVEIVAGKQRAPVAAGVYNVYTGELADTATPTAARMGLEPPRFCAQCGRRMVVQVRPDGWWARCSRHGQVDSADLATQR,"8,603",79,,positive regulation by symbiont of host immune response [GO:0052556],,,,MTCY336.14c,1
P9WK89,Y1592_MYCTU,Rv1592c,Rv1592c,GO:0004806; GO:0016042,IPR029058; IPR005152; ,,,,Probable inactive lipase Rv1592c,triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042],9634230; 11416222; 19099550; 21969609,,,MVEPGNLAGATGAEWIGRPPHEELQRKVRPLLPSDDPFYFPPAGYQHAVPGTVLRSRDVELAFMGLIPQPVTATQLLYRTTNMYGNPEATVTTVIVPAELAPGQTCPLLSYQCAIDAMSSRCFPSYALRRRAKALGSLTQMELLMISAALAEGWAVSVPDHEGPKGLWGSPYEPGYRVLDGIRAALNSERVGLSPATPIGLWGYSGGGLASAWAAEACGEYAPDLDIVGAVLGSPVGDLGHTFRRLNGTLLAGLPALVVAALQHSYPGLARVIKEHANDEGRQLLEQLTEMTTVDAVIRMAGRDMGDFLDEPLEDILSTPEISHVFGDTKLGSAVPTPPVLIVQAVHDYLIDVSDIDALADSYTAGGANVTYHRDLFSEHVSLHPLSAPMTLRWLTDRFAGKPLTDHRVRTTWPTIFNPMTYAGMARLAVIAAKVITGRKLSRRPL,"48,043",446,"AB hydrolase superfamily, Lipase family",lipid catabolic process [GO:0016042],triglyceride lipase activity [GO:0004806],,,,1
P9WLS5,Y1735_MYCTU,Rv1735c,Rv1735c,GO:0005886; GO:0016021; GO:0055085,IPR004695; ,,,,Uncharacterized membrane protein Rv1735c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 12953092; 18400743; 19553548,,,MFLYVAVGSLVVARLLLYPLRPADLTPPYWVAMGATAITVLAGAHIVEMADAPMAIVTSGLVAGASVVFWAFGPWLIPPLVAASIWKHVVHRVPLRYEATLWSVVFPLGMYGVGAYRLGLAAHLPIVESIGEFEGWVALAVWTITFVAMLHHLAATIGRSGRSSHAIGAADDTHAIICRPPRSFDHQVRAFRRNQPM,"21,357",197,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WLS3,Y1738_MYCTU,Rv1738,Rv1738 MTCY04C12.23,GO:0005829; GO:0005886; GO:0040007; GO:0052572,IPR015057; IPR038070; ,,,,Uncharacterized protein Rv1738,cytosol [GO:0005829]; plasma membrane [GO:0005886]; growth [GO:0040007]; response to host immune response [GO:0052572],9634230; 11416222; 12953092; 19099550; 18474359; 18400743; 21969609,X-ray crystallography (2),,MCGDQSDHVLQHWTVDISIDEHEGLTRAKARLRWREKELVGVGLARLNPADRNVPEIGDELSVARALSDLGKRMLKVSTHDIEAVTHQPARLLY,"10,606",94,,growth [GO:0040007]; response to host immune response [GO:0052572],,cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY04C12.23,1
P9WLQ9,Y1836_MYCTU,Rv1836c,Rv1836c MTCY1A11.07,GO:0005576; GO:0005618; GO:0005887,IPR002035; IPR036465; ,,,,Uncharacterized protein Rv1836c,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],9634230; 19099550; 21969609,,,MGRHSKPDPEDSVDDLSDGHAAEQQHWEDISGSYDYPGVDQPDDGPLSSEGHYSAVGGYSASGSEDYPDIPPRPDWEPTGAEPIAAAPPPLFRFGHRGPGDWQAGHRSADGRRGVSIGVIVALVAVVVMVAGVILWRFFGDALSNRSHTAAARCVGGKDTVAVIADPSIADQVKESADSYNASAGPVGDRCVAVAVTSAGSDAVINGFIGKWPTELGGQPGLWIPSSSISAARLTGAAGSQAISDSRSLVISPVLLAVRPELQQALANQNWAALPGLQTNPNSLSGLDLPAWGSLRLAMPSSGNGDAAYLAGEAVAAASAPAGAPATAGIGAVRTLMGARPKLADDSLTAAMDTLLKPGDVATAPVHAVVTTEQQLFQRGQSLSDAENTLGSWLPPGPAAVADYPTVLLSGAWLSQEQTSAASAFARYLHKPEQLAKLARAGFRVSDVKPPSSPVTSFPALPSTLSVGDDSMRATLADTMVTASAGVAATIMLDQSMPNDEGGNSRLSNVVAALENRIKAMPPSSVVGLWTFDGREGRTEVPAGPLADPVNGQPRPAALTAALGKQYSSGGGAVSFTTLRLIYQEMLANYRVGQANSVLVITAGPHTDQTLDGPGLQDFIRKSADPAKPIAVNIIDFGADPDRATWEAVAQLSGGSYQNLETSASPDLATAVNIFLS,"69,677",677,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTCY1A11.07,1
P9WKI3,Y1843_MYCTU,Rv1843c,guaB1 Rv1843c MTCY1A11.01 MTCY359.30,GO:0005829; GO:0005886; GO:0006164; GO:0016491,IPR013785; IPR000644; IPR005990; IPR005991; IPR001093; ,,guaB1,DOMAIN 96 153 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 154 212 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,Uncharacterized oxidoreductase Rv1843c (EC 1.-.-.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; purine nucleotide biosynthetic process [GO:0006164],9634230; 19099550; 21081761; 21969609,,FUNCTION: Has no inosine-5'-monophosphate dehydrogenase activity. {ECO:0000269|PubMed:21081761}.,MMRFLDGHPPGYDLTYNDVFIVPNRSEVASRFDVDLSTADGSGTTIPVVVANMTAVAGRRMAETVARRGGIVILPQDLPIPAVKQTVAFVKSRDLVLDTPVTLAPDDSVSDAMALIHKRAHGVAVVILEGRPIGLVRESSCLGVDRFTRVRDIAVTDYVTAPAGTEPRKIFDLLEHAPVDVAVLTDADGTLAGVLSRTGAIRAGIYTPATDSAGRLRIGAAVGINGDVGAKARALAEAGVDVLVIDTAHGHQVKTLDAIKAVSALDLGLPLAAGNVVSAEGTRDLLKAGANVVKVGVGPGAMCTTRMMTGVGRPQFSAVLECASAARQLGGHIWADGGIRHPRDVALALAAGASNVMIGSWFAGTYESPGDLMRDRDDQPYKESYGMASKRAVVARTGADNPFDRARKALFEEGISTSRMGLDPDRGGVEDLIDHITSGVRSTCTYVGASNLAELHERAVVGVQSGAGFAEGHPLPAGW,"49,965",479,IMPDH/GMPR family,purine nucleotide biosynthetic process [GO:0006164],oxidoreductase activity [GO:0016491],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY1A11.01 MTCY359.30,1
P9WJ53,VPB12_MYCTU,Rv1721c,vapB12 Rv1721c,GO:0006355,IPR010985; ,,vapB12,,Putative antitoxin VapB12,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 21969609,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC12. {ECO:0000305|PubMed:15718296}.,MSAMVQIRNVPDELLHELKARAAAQRMSLSDFLLARLAEIAEEPALDDVLDRLAALPRRDLGASAAELVDEARSE,"8,226",75,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WJ51,VPB13_MYCTU,Rv1839c,vapB13 Rv1839c,,,,vapB13,,Putative antitoxin VapB13,,9634230; 15718296,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC13. {ECO:0000305|PubMed:15718296}.,MSKRLQVLLDPDEWEELREIARRHRTTVSEWVRRTLREAREREPRGDLDMKLRSVRAAARHEFPTADVEQMLEEIERGRGAEREGSR,"10,439",87,,,,,,,1
P9WQK7,UVRA_MYCTU,Rv1638,uvrA Rv1638 MTCY06H11.02,GO:0003677; GO:0004518; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006289; GO:0006974; GO:0009380; GO:0009432; GO:0016887; GO:0046872; GO:0060543,IPR003439; IPR017871; IPR027417; IPR004602; ,,uvrA,DOMAIN 315 601 ABC transporter 1. {ECO:0000255|HAMAP-Rule:MF_00205}.; DOMAIN 621 950 ABC transporter 2. {ECO:0000255|HAMAP-Rule:MF_00205}.,UvrABC system protein A (UvrA protein) (Excinuclease ABC subunit A),cell wall [GO:0005618]; cytosol [GO:0005829]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of strand invasion [GO:0060543]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432],9634230; 20455546; 21969609; 22467787,X-ray crystallography (1),"FUNCTION: The UvrABC repair system catalyzes the recognition and processing of DNA lesions. UvrA is an ATPase and a DNA-binding protein. A damage recognition complex composed of 2 UvrA and 2 UvrB subunits scans DNA for abnormalities. When the presence of a lesion has been verified by UvrB, the UvrA molecules dissociate. Alone it slightly inhibits RecA-mediated DNA strand exchange, in concert with UvrD1 greatly inhibits RecA-mediated DNA strand exchange. {ECO:0000255|HAMAP-Rule:MF_00205, ECO:0000269|PubMed:20455546, ECO:0000269|PubMed:22467787}.",MADRLIVKGAREHNLRSVDLDLPRDALIVFTGLSGSGKSSLAFDTIFAEGQRRYVESLSAYARQFLGQMDKPDVDFIEGLSPAVSIDQKSTNRNPRSTVGTITEVYDYLRLLYARAGTPHCPTCGERVARQTPQQIVDQVLAMPEGTRFLVLAPVVRTRKGEFADLFDKLNAQGYSRVRVDGVVHPLTDPPKLKKQEKHDIEVVVDRLTVKAAAKRRLTDSVETALNLADGIVVLEFVDHELGAPHREQRFSEKLACPNGHALAVDDLEPRSFSFNSPYGACPECSGLGIRKEVDPELVVPDPDRTLAQGAVAPWSNGHTAEYFTRMMAGLGEALGFDVDTPWRKLPAKARKAILEGADEQVHVRYRNRYGRTRSYYADFEGVLAFLQRKMSQTESEQMKERYEGFMRDVPCPVCAGTRLKPEILAVTLAGESKGEHGAKSIAEVCELSIADCADFLNALTLGPREQAIAGQVLKEIRSRLGFLLDVGLEYLSLSRAAATLSGGEAQRIRLATQIGSGLVGVLYVLDEPSIGLHQRDNRRLIETLTRLRDLGNTLIVVEHDEDTIEHADWIVDIGPGAGEHGGRIVHSGPYDELLRNKDSITGAYLSGRESIEIPAIRRSVDPRRQLTVVGAREHNLRGIDVSFPLGVLTSVTGVSGSGKSTLVNDILAAVLANRLNGARQVPGRHTRVTGLDYLDKLVRVDQSPIGRTPRSNPATYTGVFDKIRTLFAATTEAKVRGYQPGRFSFNVKGGRCEACTGDGTIKIEMNFLPDVYVPCEVCQGARYNRETLEVHYKGKTVSEVLDMSIEEAAEFFEPIAGVHRYLRTLVDVGLGYVRLGQPAPTLSGGEAQRVKLASELQKRSTGRTVYILDEPTTGLHFDDIRKLLNVINGLVDKGNTVIVIEHNLDVIKTSDWIIDLGPEGGAGGGTVVAQGTPEDVAAVPASYTGKFLAEVVGGGASAATSRSNRRRNVSA,"106,132",972,"ABC transporter superfamily, UvrA family",cellular response to DNA damage stimulus [GO:0006974]; negative regulation of strand invasion [GO:0060543]; nucleotide-excision repair [GO:0006289]; SOS response [GO:0009432],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518],cell wall [GO:0005618]; cytosol [GO:0005829]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886],,MTCY06H11.02,1
Q79FL8,PG30_MYCTU,Rv1651c,PE_PGRS30 Rv1651c,GO:0005576; GO:0005618; GO:0009405; GO:0009986,IPR000084; ,,PE_PGRS30,"DOMAIN 1 93 PE. {ECO:0000255, ECO:0000305|PubMed:25390359}.",PE-PGRS family protein PE_PGRS30,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 21732963; 22050772; 24530527; 25390359; 27129781,,"FUNCTION: Mediates suppression of proinflammatory immune response in macrophages via modulation of host cytokine response (PubMed:27129781). Required for full virulence. Involved in inhibition of phago-lysosome fusion (PubMed:22050772). {ECO:0000269|PubMed:22050772, ECO:0000269|PubMed:27129781}.",MSFLLVEPDLVTAAAANLAGIRSALSEAAAAASTPTTALASAGADEVSAAVSRLFGAYGQQFQALNARAATFHAEFVSLLNGGAAAYTGAEAASVSSMQALLDAVNAPTQTLLGRPLIGNGADGVAGTGSNAGGNGGPGGILYGNGGNGGAGGNGGAAGLIGNGGAGGAGGAGGAGGAGGAGGTGGLLYGNGGAGGNGGSAAAAGGAGGNALLFGNGGNGGSGASGGAAGHAGTIFGNGGNAGAGSGLAGADGGLFGNGGDGGSSTSKAGGAGGNALFGNGGDGGSSTVAAGGAGGNTLVGNGGAGGAGGTSGLTGSGVAGGAGGSVGLWGSGGAGGDGGAATSLLGVGMNAGAGGAGGNAGLLYGNGGAGGAGGNGGDTTVPLFDSGVGGAGGAGGNASLFGNGGTGGVGGKGGTSSDLASATSGAGGAGGAGGVGGLLYGNGGNGGAGGIGGAAINILANAGAGGAGGAAGSSFIGNGGNGGAGGAGGAAALFSSGVGGAGGSGGTALLLGSGGAGGNGGTGGANSGSLFASPGGTGGAGGHGGAGGLIWGNGGAGGNGGNGGTTADGALEGGTGGIGGTGGSAIAFGNGGQGGAGGTGGDHSGGNGIGGKGGASGNGGNAGQVFGDGGTGGTGGAGGAGSGTKAGGTGSDGGHGGNATLIGNGGDGGAGGAGGAGSPAGAPGNGGTGGTGGVLFGQSGSSGPPGAAALAFPSLSSSVPILGPYEDLIANTVANLASIGNTWLADPAPFLQQYLANQFGYGQLTLTALTDATRDFAIGLAGIPPSLQSALQALAAGDVSGAVTDVLGAVVKVFVSGVDASDLSNILLLGPVGDLFPILSIPGAMSQNFTNVVMTVTDTTIAFSIDTTNLTGVMTFGLPLAMTLNAVGSPITTAIAFAESTTAFVSAVQAGNLQAAAAALVGAPANVANGFLNGEARLPLALPTSATGGIPVTVEVPVGGILAPLQPFQATAVIPVIGPVTVTLEGTPAGGIVPALVNYAPTQLAQAIAP,"88,455",1011,"Mycobacterial PE family, PGRS subfamily",pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WIF5,PG33_MYCTU,Rv1818c,PE_PGRS33 Rv1818c MTCY1A11.25c,GO:0005576; GO:0005618; GO:0009279; GO:0009405; GO:0009986; GO:0042594; GO:0046789; GO:0052167; GO:0070482,IPR000084; ,,PE_PGRS33,DOMAIN 1 93 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS33,cell outer membrane [GO:0009279]; cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell surface receptor binding [GO:0046789]; modulation by symbiont of host innate immune response [GO:0052167]; pathogenesis [GO:0009405]; response to oxygen levels [GO:0070482]; response to starvation [GO:0042594],9634230; 11500435; 11967065; 15101979; 16672626; 17687113; 17095513; 17223373; 18028308; 18957600; 19068228; 21081760; 22110736; 24106104; 24904584; 25693607; 27483162; 26978522,,"FUNCTION: Induces TNF-alpha release through human Toll-like receptor 2 (TLR2) signaling pathway, leading to macrophage apoptosis (PubMed:17095513, PubMed:17223373, PubMed:24106104). The signaling pathway involves TLR2-dependent activation of the mitogen-activated protein kinase kinase kinase 5 (ASK1), which activates the p38 and JNK MAPKs, leading to enhanced expression of TNF-alpha and tumor necrosis factor receptor superfamily member 1A (TNFRI) genes. Signals are amplified through classical caspase 8-dependent mitochondrial release of cytochrome c, leading to the activation of caspases 9 and 3 (PubMed:17095513). Mediates Ca(2+)-dependent up-regulation of the anti-inflammatory cytokine IL-10 (PubMed:27483162). Mediates entry into macrophages in a TLR2-dependent mechanism and activates the TLR2-dependent pro-adhesive pathway (PubMed:26978522). {ECO:0000269|PubMed:17095513, ECO:0000269|PubMed:17223373, ECO:0000269|PubMed:24106104, ECO:0000269|PubMed:26978522, ECO:0000269|PubMed:27483162}.",MSFVVTIPEALAAVATDLAGIGSTIGTANAAAAVPTTTVLAAAADEVSAAMAALFSGHAQAYQALSAQAALFHEQFVRALTAGAGSYAAAEAASAAPLEGVLDVINAPALALLGRPLIGNGANGAPGTGANGGDGGILIGNGGAGGSGAAGMPGGNGGAAGLFGNGGAGGAGGNVASGTAGFGGAGGAGGLLYGAGGAGGAGGRAGGGVGGIGGAGGAGGNGGLLFGAGGAGGVGGLAADAGDGGAGGDGGLFFGVGGAGGAGGTGTNVTGGAGGAGGNGGLLFGAGGVGGVGGDGVAFLGTAPGGPGGAGGAGGLFGVGGAGGAGGIGLVGNGGAGGSGGSALLWGDGGAGGAGGVGSTTGGAGGAGGNAGLLVGAGGAGGAGALGGGATGVGGAGGNGGTAGLLFGAGGAGGFGFGGAGGAGGLGGKAGLIGDGGDGGAGGNGTGAKGGDGGAGGGAILVGNGGNGGNAGSGTPNGSAGTGGAGGLLGKNGMNGLP,"40,755",498,"Mycobacterial PE family, PGRS subfamily",modulation by symbiont of host innate immune response [GO:0052167]; pathogenesis [GO:0009405]; response to oxygen levels [GO:0070482]; response to starvation [GO:0042594],host cell surface receptor binding [GO:0046789],cell outer membrane [GO:0009279]; cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY1A11.25c,1
P9WPF3,PKS11_MYCTU,Rv1665,pks11 Rv1665,GO:0006633; GO:0008610; GO:0009715; GO:0016747; GO:0034081; GO:0071770,IPR012328; IPR001099; IPR011141; IPR016039; ,,pks11,,Alpha-pyrone synthesis polyketide synthase-like Pks11 (EC 2.3.1.-) (Alpha-pyrone synthesis polyketide synthase type III Pks11) (Chalcone synthase-like protein) (CHS-like),"polyketide synthase complex [GO:0034081]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; chalcone biosynthetic process [GO:0009715]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]",9634230; 12941968; 21969609,X-ray crystallography (6),FUNCTION: Involved in the biosynthesis of tri- and tetraketide alpha-pyrones. Pks11 catalyzes the extension of medium- and long-chain aliphatic acyl-CoA substrates by using malonyl-CoA as an extender molecule to synthesize polyketide products. {ECO:0000269|PubMed:12941968}.,MSVIAGVFGALPPHRYSQSEITDSFVEFPGLKEHEEIIRRLHAAAKVNGRHLVLPLQQYPSLTDFGDANEIFIEKAVDLGVEALLGALDDANLRPSDIDMIATATVTGVAVPSLDARIAGRLGLRPDVRRMPLFGLGCVAGAAGVARLRDYLRGAPDDVAVLVSVELCSLTYPAVKPTVSSLVGTALFGDGAAAVVAVGDRRAEQVRAGGPDILDSRSSLYPDSLHIMGWDVGSHGLRLRLSPDLTNLIERYLANDVTTFLDAHRLTKDDIGAWVSHPGGPKVIDAVATSLALPPEALELTWRSLGEIGNLSSASILHILRDTIEKRPPSGSAGLMLAMGPGFCTELVLLRWR,"37,639",353,Chalcone/stilbene synthases family,chalcone biosynthetic process [GO:0009715]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",polyketide synthase complex [GO:0034081],,,1
P9WI07,PPE30_MYCTU,Rv1802,PPE30 Rv1802 MTV049.24,,IPR022171; IPR000030; IPR038332; ,,PPE30,,Uncharacterized PPE family protein PPE30,,9634230,,,MDFGVLPPEINSGRMYAGPGSGPMLAAAAAWDGLATELQSTAADYGSVISVLTGVWSGQSSGTMAAAAAPYVAWMSATAALAREAAAQASAAAAAYEAAFAATVPPPVVAANRAELAVLAATNIFGQNTGAIAAAEARYAEMWAQDAAAMYGYAGSSSVATQVTPFAAPPPTTNAAGLATQGVAVAQAVGASAGNARSLVSEVLEFLATAGTNYNKTVASLMNAVTGVPYASSVYNSMLGLGFAESKMVLPANDTVISTIFGMVQFQKFFNPVTPFNPDLIPKSALGAGLGLRSAISSGLGSTAPAISAGASQAGSVGGMSVPPSWAAATPAIRTVAAVFSSTGLQAVPAAAISEGSLLSQMALASVAGGALGGAAARATGGFLGGGRVTAVKKSLKDSDSPDKLRRVVAHMMEKPESVQHWHTDEDGLDDLLAELKKKPGIHAVHMAGGNKAEIAPTISESG,"46,021",463,Mycobacterial PPE family,,,,,MTV049.24,1
P9WI03,PPE33_MYCTU,Rv1809,PPE33 Rv1809,,IPR022171; IPR000030; IPR038332; ,,PPE33,,Uncharacterized PPE family protein PPE33,,9634230; 21969609,,,MDFGLQPPEITSGEMYLGPGAGPMLAAAVAWDGLAAELQSMAASYASIVEGMASESWLGPSSAGMAAAAAPYVTWMSGTSAQAKAAADQARAAVVAYETAFAAVVPPPQIAANRSQLISLVATNIFGQNTAAIAATEAEYGEMWAQDTMAMFGYASSSATASRLTPFTAPPQTTNPSGLAGQAAATGQATALASGTNAVTTALSSAAAQFPFDIIPTLLQGLATLSTQYTQLMGQLINAIFGPTGATTYQNVFVTAANVTKFSTWANDAMSAPNLGMTEFKVFWQPPPAPEIPKSSLGAGLGLRSGLSAGLAHAASAGLGQANLVGDLSVPPSWASATPAVRLVANTLPATSLAAAPATQIPANLLGQMALGSMTGGALGAAAPAIYTGSGARARANGGTPSAEPVKLEAVIAQLQKQPDAVRHWNVDKADLDGLLDRLSKQPGIHAVHVSNGDKPKVALPDTQLGSH,"47,156",468,Mycobacterial PPE family,,,,,,1
Q79FI9,PPE34_MYCTU,Rv1917c,PPE34 Rv1917c,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0009986; GO:0052553,IPR002989; IPR000030; IPR038332; ,,PPE34,,PPE family protein PPE34,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; modulation by symbiont of host immune response [GO:0052553]; pathogenesis [GO:0009405],9634230; 11800581; 20837474,,"FUNCTION: Facilitates a shift in the ensuing immunity toward the Th2 phenotype and could aid in immune evasion by mycobacteria. Interacts with human Toll-like receptor 2 (TLR2) and triggers functional maturation of human dendritic cells (DCs), leading to secretion of IL-4, IL-5 and IL-10 from CD4(+) T cells and induction of Th2 immune response. Maturation of DCs involves PI3K, ERK1/2, p38 MAPK and NF-kappa-B signaling pathways. {ECO:0000269|PubMed:20837474}.",MNFSTLPPEINSALIFGGAGSEPMSAAAVAWDQLAMELASAAASFNSVTSGLVGESWLGPSSAAMAAAVAPYLGWLAAAAAQAQRSATQAAALVAEFEAVRAAMVQPALVAANRSDLVSLVFSNFFGQNAPAIAAIEAAYEQMWAIDVSVMSAYHAGASAVASALTPFTAPPQNLTDLPAQLAAAPAAVVTAAITSSKGVLANLSLGLANSGFGQMGAANLGILNLGSLNPGGNNFGLGNVGSNNVGLGNTGNGNIGFGNTGNGNIGFGLTGDNQQGFGGWNSGTGNIGLFNSGTGNIGIGNTGTGNFGIGNSGTSYNTGIGNTGQANTGFFNAGIANTGIGNTGNYNTGSFNLGSFNTGDFNTGSSNTGFFNPGNLNTGVGNTGNVNTGGFNSGNYSNGFFWRGDYQGLIGFSGTLTIPAAGLDLNGLGSVGPITIPSITIPEIGLGINSSGALVGPINVPPITVPAIGLGINSTGALVGPINIPPITLNSIGLELSAFQVINVGSISIPASPLAIGLFGVNPTVGSIGPGSISIQLGTPEIPAIPPFFPGFPPDYVTVSGQIGPITFLSGGYSLPAIPLGIDVGGGLGPFTVFPDGYSLPAIPLGIDVGGGLGPFTVFPDGYSLPAIPLGIDVGGGLGPFTVFPDGYSLPAIPLGIDVGGAIGPLTTPPITIPSIPLGIDVSGSLGPINIPIEIAGTPGFGNSTTTPSSGFFNSGTGGTSGFGNVGSGGSGFWNIAGNLGNSGFLNVGPLTSGILNFGNTVSGLYNTSTLGLATSAFHSGVGNTDSQLAGFMRNAAGGTLFNFGFANDGTLNLGNANLGDYNVGSGNVGSYNFGSGNIGNGSFGFGNIGSNNFGFGNVGSNNLGFANTGPGLTEALHNIGFGNIGGNNYGFANIGNGNIGFGNTGTGNIGIGLTGDNQVGFGALNSGSGNIGFFNSGNGNIGFFNSGNGNVGIGNSGNYNTGLGNVGNANTGLFNTGNVNTGIGNAGSYNTGSYNAGDTNTGDLNPGNANTGYLNLGDLNTGWGNIGDLNTGALISGSYSNGILWRGDYQGLIGYSDTLSIPAIPLSVEVNGGIGPIVVPDITIPGIPLSLNALGGVGPIVVPDITIPGIPLSLNALGGVGPIVVPDITIPGIPLSLNALGGVGPIVVPDITIPGIPLSLNALGGVGPIVVPDITIPGIPLSLNALGGVGPITVPGVPISRIPLTINIRIPVNITLNELPFNVAGIFTGYIGPIPLSTFVLGVTLAGGTLESGIQGFSVNPFGLNIPLSGATNAVTIPGFAINPFGLNVPLSGGTSPVTIPGFAINPFGLNVPLSGGTSPVTIPGFTIPGSPLNLTANGGLGPINIPINITSAPGFGNSTTTPSSGFFNSGDGSASGFGNVGPGISGLWNQVPNALQGGVSGIYNVGQLASGVANLGNTVSGFNNTSTVGHLTAAFNSGVNNIGQMLLGFFSPGAGP,"142,944",1459,Mycobacterial PPE family,modulation by symbiont of host immune response [GO:0052553]; pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WI17,PPE23_MYCTU,Rv1706c,PPE23 Rv1706c,,IPR022171; IPR000030; IPR038332; ,,PPE23,,Uncharacterized PPE family protein PPE23,,9634230; 19099550,,,MTLDVPVNQGHVPPGSVACCLVGVTAVADGIAGHSLSNFGALPPEINSGRMYSGPGSGPLMAAAAAWDGLAAELSSAATGYGAAISELTNMRWWSGPASDSMVAAVLPFVGWLSTTATLAEQAAMQARAAAAAFEAAFAMTVPPPAIAANRTLLMTLVDTNWFGQNTPAIATTESQYAEMWAQDAAAMYGYASAAAPATVLTPFAPPPQTTNATGLVGHATAVAALRGQHSWAAAIPWSDIQKYWMMFLGALATAEGFIYDSGGLTLNALQFVGGMLWSTALAEAGAAEAAAGAGGAAGWSAWSQLGAGPVAASATLAAKIGPMSVPPGWSAPPATPQAQTVARSIPGIRSAAEAAETSVLLRGAPTPGRSRAAHMGRRYGRRLTVMADRPNVG,"39,778",394,Mycobacterial PPE family,,,,,,1
P9WI13,PPE25_MYCTU,Rv1787,PPE25 Rv1787,,IPR022171; IPR000030; IPR038332; ,,PPE25,,Uncharacterized PPE family protein PPE25,,9634230,,,MDFGALPPEINSGRMYCGPGSGPMLAAAAAWDGVAVELGLAATGYASVIAELTGAPWVGAASLSMVAAATPYVAWLSQAAARAEQAGMQAAAAAAAYEAAFVMTVPPPVITANRVLVMTLIATNFFGQNSAAIAVAEAQYAEMWAQDAVAMYGYAAASASASRLIPFAAPPKTTNSAGVVAQVAAVAAMPGLLQRLSSAASVSWSNPNDWWLVRLLGSITPTERTTIVRLLGQSYFATGMAQFFASIAQQLTFGPGGTTAGSGGAWYPTPQFAGLGASRAVSASLARANKIGALSVPPSWVKTTALTESPVAHAVSANPTVGSSHGPHGLLRGLPLGSRITRRSGAFAHRYGFRHSVVARPPSAG,"37,090",365,Mycobacterial PPE family,,,,,,1
P9WI19,PPE22_MYCTU,Rv1705c,PPE22 Rv1705c,,IPR022171; IPR000030; IPR038332; ,,PPE22,,Uncharacterized PPE family protein PPE22,,9634230; 19099550,,,MDFGALPPEVNSGRMYCGPGSAPMVAAASAWNGLAAELSVAAVGYERVITTLQTEEWLGPASTLMVEAVAPYVAWMRATAIQAEQAASQARAAAAAYETAFAAIVPPPLIAANRARLTSLVTHNVFGQNTASIAATEAQYAEMWAQDAMAMYGYAGSSATATKVTPFAPPPNTTSPSAAATQLSAVAKAAGTSAGAAQSAIAELIAHLPNTLLGLTSPLSSALTAAATPGWLEWFINWYLPISQLFYNTVGLPYFAIGIGNSLITSWRALGWIGPEAAEAAAAAPAAVGAAVGGTGPVSAGLGNAATIGKLSLPPNWAGASPSLAPTVGSASAPLVSDIVEQPEAGAAGNLLGGMPLAGSGTGTGGAGPRYGFRVTVMSRPPFAG,"38,444",385,Mycobacterial PPE family,,,,,,1
P9WI15,PPE24_MYCTU,Rv1753c,PPE24 Rv1753c,GO:0040007,IPR002989; IPR000030; IPR038332; ,,PPE24,,Uncharacterized PPE family protein PPE24,growth [GO:0040007],9634230; 19099550,,,MNFSVLPPEINSALIFAGAGPEPMAAAATAWDGLAMELASAAASFGSVTSGLVGGAWQGASSSAMAAAAAPYAAWLAAAAVQAEQTAAQAAAMIAEFEAVKTAVVQPMLVAANRADLVSLVMSNLFGQNAPAIAAIEATYEQMWAADVSAMSAYHAGASAIASALSPFSKPLQNLAGLPAWLASGAPAAAMTAAAGIPALAGGPTAINLGIANVGGGNVGNANNGLANIGNANLGNYNFGSGNFGNSNIGSASLGNNNIGFGNLGSNNVGVGNLGNLNTGFANTGLGNFGFGNTGNNNIGIGLTGNNQIGIGGLNSGTGNFGLFNSGSGNVGFFNSGNGNFGIGNSGNFNTGGWNSGHGNTGFFNAGSFNTGMLDVGNANTGSLNTGSYNMGDFNPGSSNTGTFNTGNANTGFLNAGNINTGVFNIGHMNNGLFNTGDMNNGVFYRGVGQGSLQFSITTPDLTLPPLQIPGISVPAFSLPAITLPSLNIPAATTPANITVGAFSLPGLTLPSLNIPAATTPANITVGAFSLPGLTLPSLNIPAATTPANITVGAFSLPGLTLPSLNIPAATTPANITVGAFSLPGLTLPSLNIPAATTPANITVGAFSLPGLTLPSLNIPAATTPANITVSGFQLPPLSIPSVAIPPVTVPPITVGAFNLPPLQIPEVTIPQLTIPAGITIGGFSLPAIHTQPITVGQIGVGQFGLPSIGWDVFLSTPRITVPAFGIPFTLQFQTNVPALQPPGGGLSTFTNGALIFGEFDLPQLVVHPYTLTGPIVIGSFFLPAFNIPGIDVPAINVDGFTLPQITTPAITTPEFAIPPIGVGGFTLPQITTQEIITPELTINSIGVGGFTLPQITTPPITTPPLTIDPINLTGFTLPQITTPPITTPPLTIDPINLTGFTLPQITTPPITTPPLTIEPIGVGGFTTPPLTVPGIHLPSTTIGAFAIPGGPGYFNSSTAPSSGFFNSGAGGNSGFGNNGSGLSGWFNTNPAGLLGGSGYQNFGGLSSGFSNLGSGVSGFANRGILPFSVASVVSGFANIGTNLAGFFQGTTS,"104,650",1053,Mycobacterial PPE family,growth [GO:0040007],,,,,1
Q79FK6,PPE26_MYCTU,Rv1789,PPE26 Rv1789 LH57_09780,GO:0009405,IPR022171; IPR000030; IPR038332; ,,PPE26,,PPE family protein PPE26,pathogenesis [GO:0009405],9634230; 21969609; 26439698,,"FUNCTION: Probably plays a key role in regulating innate and adaptive immune responses through human Toll-like receptor 2 (TLR2). Interacts with TLR2, leading to the subsequent activation of the mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kappa-B) signaling pathways. Stimulates macrophage activation by augmenting pro-inflammatory cytokine production (TNF-alpha, IL-6 and IL-12p40) and the expression of cell surface molecules (CD80, CD86, MHC class I and II). Also participates in adaptive immunity by directing Th1-polarised immune responses. {ECO:0000269|PubMed:26439698}.",MDFGALPPEVNSVRMYAGPGSAPMVAAASAWNGLAAELSSAATGYETVITQLSSEGWLGPASAAMAEAVAPYVAWMSAAAAQAEQAATQARAAAAAFEAAFAATVPPPLIAANRASLMQLISTNVFGQNTSAIAAAEAQYGEMWAQDSAAMYAYAGSSASASAVTPFSTPPQIANPTAQGTQAAAVATAAGTAQSTLTEMITGLPNALQSLTSPLLQSSNGPLSWLWQILFGTPNFPTSISALLTDLQPYASFFYNTEGLPYFSIGMGNNFIQSAKTLGLIGSAAPAAVAAAGDAAKGLPGLGGMLGGGPVAAGLGNAASVGKLSVPPVWSGPLPGSVTPGAAPLPVSTVSAAPEAAPGSLLGGLPLAGAGGAGAGPRYGFRPTVMARPPFAG,"38,589",393,Mycobacterial PPE family,pathogenesis [GO:0009405],,,,LH57_09780,1
P9WI09,PPE29_MYCTU,Rv1801,PPE29 Rv1801,GO:0005618,IPR022171; IPR000030; IPR038332; ,,PPE29,,Uncharacterized PPE family protein PPE29,cell wall [GO:0005618],9634230; 16586367,,FUNCTION: Could be required for host endothelial-cell invasion and/or intracellular survival. {ECO:0000269|PubMed:16586367}.,MDFGLLPPEINSGRMYTGPGPGPMLAAATAWDGLAVELHATAAGYASELSALTGAWSGPSSTSMASAAAPYVAWMSATAVHAELAGAQARLAIAAYEAAFAATVPPPVIAANRAQLMVLIATNIFGQNTPAIMMTEAQYMEMWAQDAAAMYGYAGSSATASRMTAFTEPPQTTNHGQLGAQSSAVAQTAATAAGGNLQSAFPQLLSAVPRALQGLALPTASQSASATPQWVTDLGNLSTFLGGAVTGPYTFPGVLPPSGVPYLLGIQSVLVTQNGQGVSALLGKIGGKPITGALAPLAEFALHTPILGSEGLGGGSVSAGIGRAGLVGKLSVPQGWTVAAPEIPSPAAALQATRLAAAPIAATDGAGALLGGMALSGLAGRAAAGSTGHPIGSAAAPAVGAAAAAVEDLATEANIFVIPAMDD,"41,477",423,Mycobacterial PPE family,,,cell wall [GO:0005618],,,1
P9WI11,PPE28_MYCTU,Rv1800,PPE28 Rv1800,,IPR029058; IPR013228; IPR000030; IPR038332; ,,PPE28,,Uncharacterized PPE family protein PPE28,,9634230,,,MLPNFAVLPPEVNSARVFAGAGSAPMLAAAAAWDDLASELHCAAMSFGSVTSGLVVGWWQGSASAAMVDAAASYIGWLSTSAAHAEGAAGLARAAVSVFEEALAATVHPAMVAANRAQVASLVASNLFGQNAPAIAALESLYECMWAQDAAAMAGYYVGASAVATQLASWLQRLQSIPGAASLDARLPSSAEAPMGVVRAVNSAIAANAAAAQTVGLVMGGSGTPIPSARYVELANALYMSGSVPGVIAQALFTPQGLYPVVVIKNLTFDSSVAQGAVILESAIRQQIAAGNNVTVFGYSQSATISSLVMANLAASADPPSPDELSFTLIGNPNNPNGGVATRFPGISFPSLGVTATGATPHNLYPTKIYTIEYDGVADFPRYPLNFVSTLNAIAGTYYVHSNYFILTPEQIDAAVPLTNTVGPTMTQYYIIRTENLPLLEPLRSVPIVGNPLANLVQPNLKVIVNLGYGDPAYGYSTSPPNVATPFGLFPEVSPVVIADALVAGTQQGIGDFAYDVSHLELPLPADGSTMPSTAPGSGTPVPPLSIDSLIDDLQVANRNLANTISKVAATSYATVLPTADIANAALTIVPSYNIHLFLEGIQQALKGDPMGLVNAVGYPLAADVALFTAAGGLQLLIIISAGRTIANDISAIVP,"67,067",655,Mycobacterial PPE family,,,,,,1
P9WIF3,PG34_MYCTU,Rv1840c,PE_PGRS34 Rv1840c MTCY1A11.04 MTCY359.33,GO:0005886; GO:0016021,IPR000084; ,,PE_PGRS34,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS34,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MSFVVAAPEVVVAAASDLAGIGSAIGAANAAAAVPTMGVLAAGADEVSAAVADLFGAHAQAYQALSAQAALFHEQFVHAMTAGAGAYAGAEAADAAALDVLNGPFQALFGRPLIGDGANGAPGQPGGPGGLLYGNGGNGGNGGIGQPGGAGGDAGLIGNGGNGGIGGPGATGLAGGAGGVGGLLFGDGGNGGAGGLGTGPVGATGGIGGPGGAAVGLFGHGGAGGAGGLGKAGFAGGAGGTGGTGGLLYGNGGNGGNVPSGAADGGAGGDARLIGNGGDGGSVGAAPTGIGNGGNGGNGGWLYGDGGSGGSTLQGFSDGGTGGNAGMFGDGGNGGFSFFDGNGGDGGTGGTLIGNGGDGGNSVQTDGFLRGHGGDGGNAVGLIGNGGAGGAGSAGTGVFAPGGGSGGNGGNGALLVGNGGAGGSGGPTQIPSVAVPVTGAGGTGGNGGTAGLIGNGGNGGAAGVSGDGTPGTGGNGGYAQLIGDGGDGGPGDSGGPGGSGGTGGTLAGQNGSPGG,"43,916",515,"Mycobacterial PE family, PGRS subfamily",,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY1A11.04 MTCY359.33,1
P9WI05,PPE32_MYCTU,Rv1808,PPE32 Rv1808,,IPR022171; IPR000030; IPR038332; ,,PPE32,,Uncharacterized PPE family protein PPE32,,9634230; 21969609,,,MDFGALPPEINSGRMYAGPGSGPLLAAAAAWDALAAELYSAAASYGSTIEGLTVAPWMGPSSITMAAAVAPYVAWISVTAGQAEQAGAQAKIAAGVYETAFAATVPPPVIEANRALLMSLVATNIFGQNTPAIAATEAHYAEMWAQDAAAMYGYAGSSATASQLAPFSEPPQTTNPSATAAQSAVVAQAAGAAASSDITAQLSQLISLLPSTLQSLATTATATSASAGWDTVLQSITTILANLTGPYSIIGLGAIPGGWWLTFGQILGLAQNAPGVAALLGPKAAAGALSPLAPLRGGYIGDITPLGGGATGGIARAIYVGSLSVPQGWAEAAPVMRAVASVLPGTGAAPALAAEAPGALFGEMALSSLAGRALAGTAVRSGAGAARVAGGSVTEDVASTTTIIVIPAD,"39,917",409,Mycobacterial PPE family,,,,,,1
P9WJY7,NARK2_MYCTU,Rv1737c,narK2 narK-3 Rv1737c,GO:0001666; GO:0005886; GO:0016021; GO:0042128; GO:0055085; GO:0090352,IPR011701; IPR020846; IPR036259; ,,narK2,,Probable nitrate/nitrite transporter NarK2,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; nitrate assimilation [GO:0042128]; regulation of nitrate assimilation [GO:0090352]; response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085],9634230; 11416222; 14645286; 12953092; 18474359; 18400743; 19553548,,FUNCTION: Permits nitrate and nitrate transport into E.coli. {ECO:0000269|PubMed:14645286}.; FUNCTION: Involved in excretion of nitrite produced by the dissimilatory reduction of nitrate. {ECO:0000269|PubMed:14645286}.,MRGQAANLVLATWISVVNFWAWNLIGPLSTSYARDMSLSSAEASLLVATPILVGALGRIVTGPLTDRFGGRAMLIAVTLASILPVLAVGVAATMGSYALLVFFGLFLGVAGTIFAVGIPFANNWYQPARRGFSTGVFGMGMVGTALSAFFTPRFVRWFGLFTTHAIVAAALASTAVVAMVVLRDAPYFRPNADPVLPRLKAAARLPVTWEMSFLYAIVFGGFVAFSNYLPTYITTIYGFSTVDAGARTAGFALAAVLARPVGGWLSDRIAPRHVVLASLAGTALLAFAAALQPPPEVWSAATFITLAVCLGVGTGGVFAWVARRAPAASVGSVTGIVAAAGGLGGYFPPLVMGATYDPVDNDYTVGLLLLVATALVACTYTALHAREPVSEEASR,"41,109",395,"Major facilitator superfamily, Nitrate/nitrite porter (TC 2.A.1.8) family",nitrate assimilation [GO:0042128]; regulation of nitrate assimilation [GO:0090352]; response to hypoxia [GO:0001666]; transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],narK-3,,1
P9WG13,MODB_MYCTU,Rv1858,modB Rv1858 MTCY359.15c,GO:0005886; GO:0015098; GO:0016021,IPR000515; IPR035906; IPR011867; IPR006469; ,,modB,DOMAIN 51 253 ABC transmembrane type-1. {ECO:0000255|PROSITE-ProRule:PRU00441}.,Molybdenum transport system permease protein ModB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; molybdate ion transmembrane transporter activity [GO:0015098],9634230,,FUNCTION: Part of the binding-protein-dependent transport system ModABCD for molybdenum; probably responsible for the translocation of the substrate across the membrane. {ECO:0000250}.,MHPPTDLPRWVYLPAIAGIVFVAMPLVAIAIRVDWPRFWALITTPSSQTALLLSVKTAAASTVLCVLLGVPMALVLARSRGRLVRSLRPLILLPLVLPPVVGGIALLYAFGRLGLIGRYLEAAGISIAFSTAAVVLAQTFVSLPYLVISLEGAARTAGADYEVVAATLGARPGTVWWRVTLPLLLPGVVSGSVLAFARSLGEFGATLTFAGSRQGVTRTLPLEIYLQRVTDPDAAVALSLLLVVVAALVVLGVGARTPIGTDTR,"27,676",264,"Binding-protein-dependent transport system permease family, CysTW subfamily",,molybdate ion transmembrane transporter activity [GO:0015098],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY359.15c,1
P9WJJ7,NADC_MYCTU,Rv1596,nadC Rv1596 MTCY336.08c,GO:0004514; GO:0005618; GO:0005737; GO:0005886; GO:0009435; GO:0034213,IPR013785; IPR004393; IPR027277; IPR036068; IPR037128; IPR002638; IPR022412; ,,nadC,,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],9634230; 21969609; 9862811,X-ray crystallography (4),FUNCTION: Involved in the catabolism of quinolinic acid (QA). {ECO:0000250}.,MGLSDWELAAARAAIARGLDEDLRYGPDVTTLATVPASATTTASLVTREAGVVAGLDVALLTLNEVLGTNGYRVLDRVEDGARVPPGEALMTLEAQTRGLLTAERTMLNLVGHLSGIATATAAWVDAVRGTKAKIRDTRKTLPGLRALQKYAVRTGGGVNHRLGLGDAALIKDNHVAAAGSVVDALRAVRNAAPDLPCEVEVDSLEQLDAVLPEKPELILLDNFAVWQTQTAVQRRDSRAPTVMLESSGGLSLQTAATYAETGVDYLAVGALTHSVRVLDIGLDM,"29,951",285,NadC/ModD family,NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY336.08c,1
P9WHV7,NADK_MYCTU,Rv1695,ppnK Rv1695 MTCI125.17,GO:0003951; GO:0005524; GO:0005737; GO:0006741; GO:0006797; GO:0016310; GO:0019674; GO:0040007; GO:0051287,IPR017438; IPR017437; IPR016064; IPR002504; ,,ppnK,,NAD kinase (EC 2.7.1.23) (ATP-dependent NAD kinase) (Poly(P)-dependent NAD kinase) (PPNK),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; NAD binding [GO:0051287]; NAD+ kinase activity [GO:0003951]; growth [GO:0040007]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; polyphosphate metabolic process [GO:0006797],11006082; 9634230; 11526331; 16233726; 19099550; 15182203; 21969609; 15269221; 15629142,X-ray crystallography (4),"FUNCTION: Involved in the regulation of the intracellular balance of NAD and NADP, and is a key enzyme in the biosynthesis of NADP. Catalyzes specifically the phosphorylation on 2'-hydroxyl of the adenosine moiety of NAD to yield NADP. It can use ATP and other nucleoside triphosphates as well as inorganic polyphosphate (poly(P)) as a source of phosphorus. {ECO:0000255|HAMAP-Rule:MF_00361, ECO:0000269|PubMed:11006082, ECO:0000269|PubMed:15182203}.",MTAHRSVLLVVHTGRDEATETARRVEKVLGDNKIALRVLSAEAVDRGSLHLAPDDMRAMGVEIEVVDADQHAADGCELVLVLGGDGTFLRAAELARNASIPVLGVNLGRIGFLAEAEAEAIDAVLEHVVAQDYRVEDRLTLDVVVRQGGRIVNRGWALNEVSLEKGPRLGVLGVVVEIDGRPVSAFGCDGVLVSTPTGSTAYAFSAGGPVLWPDLEAILVVPNNAHALFGRPMVTSPEATIAIEIEADGHDALVFCDGRREMLIPAGSRLEVTRCVTSVKWARLDSAPFTDRLVRKFRLPVTGWRGK,"32,904",307,NAD kinase family,growth [GO:0040007]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741]; phosphorylation [GO:0016310]; polyphosphate metabolic process [GO:0006797],ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; NAD binding [GO:0051287],cytoplasm [GO:0005737],,MTCI125.17,1
O53945,MYCP5_MYCTU,Rv1796,mycP5 Rv1796 LH57_09820,GO:0004252; GO:0005886; GO:0016021,IPR000209; IPR036852; IPR023827; IPR015500; IPR023834; ,,mycP5,DOMAIN 268 513 Peptidase S8. {ECO:0000255}.,Mycosin-5 (EC 3.4.21.-) (MycP5 protease),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252],9634230; 10974545; 21969609,,,MQRFGTGSSRSWCGRAGTATIAAVLLASGALTGLPPAYAISPPTIDPGALPPDGPPGPLAPMKQNAYCTEVGVLPGTDFQLQPKYMEMLNLNEAWQFGRGDGVKVAVIDTGVTPHPRLPRLIPGGDYVMAGGDGLSDCDAHGTLVASMIAAVPANGAVPLPSVPRRPVTIPTTETPPPPQTVTLSPVPPQTVTVIPAPPPEEGVPPGAPVPGPEPPPAPGPQPPAVDRGGGTVTVPSYSGGRKIAPIDNPRNPHPSAPSPALGPPPDAFSGIAPGVEIISIRQSSQAFGLKDPYTGDEDPQTAQKIDNVETMARAIVHAANMGASVINISDVMCMSARNVIDQRALGAAVHYAAVDKDAVIVAAAGDGSKKDCKQNPIFDPLQPDDPRAWNAVTTVVTPSWFHDYVLTVGAVDANGQPLSKMSIAGPWVSISAPGTDVVGLSPRDDGLINAIDGPDNSLLVPAGTSFSAAIVSGVAALVRAKFPELSAYQIINRLIHTARPPARGVDNQVGYGVVDPVAALTWDVPKGPAEPPKQLSAPLVVPQPPAPRDMVPIWVAAGGLAGALLIGGAVFGTATLMRRSRKQQ,"60,028",585,Peptidase S8 family,,serine-type endopeptidase activity [GO:0004252],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_09820,1
P9WJJ9,NADB_MYCTU,Rv1595,nadB Rv1595 MTCY336.09c,GO:0005737; GO:0008734; GO:0009435; GO:0040007; GO:0044318,IPR003953; IPR036188; IPR037099; IPR015939; IPR005288; IPR027477; ,,nadB,,L-aspartate oxidase (LASPO) (EC 1.4.3.16) (Quinolinate synthase B),cytoplasm [GO:0005737]; L-aspartate oxidase activity [GO:0008734]; L-aspartate:fumarate oxidoreductase activity [GO:0044318]; growth [GO:0040007]; NAD biosynthetic process [GO:0009435],9634230; 21969609,,FUNCTION: Catalyzes the oxidation of L-aspartate to iminoaspartate. {ECO:0000250}.,MAGPAWRDAADVVVIGTGVAGLAAALAADRAGRSVVVLSKAAQTHVTATHYAQGGIAVVLPDNDDSVDAHVADTLAAGAGLCDPDAVYSIVADGYRAVTDLVGAGARLDESVPGRWALTREGGHSRRRIVHAGGDATGAEVQRALQDAAGMLDIRTGHVALRVLHDGTAVTGLLVVRPDGCGIISAPSVILATGGLGHLYSATTNPAGSTGDGIALGLWAGVAVSDLEFIQFHPTMLFAGRAGGRRPLITEAIRGEGAILVDRQGNSITAGVHPMGDLAPRDVVAAAIDARLKATGDPCVYLDARGIEGFASRFPTVTASCRAAGIDPVRQPIPVVPGAHYSCGGIVTDVYGQTELLGLYAAGEVARTGLHGANRLASNSLLEGLVVGGRAGKAAAAHAAAAGRSRATSSATWPEPISYTALDRGDLQRAMSRDASMYRAAAGLHRLCDSLSGAQVRDVACRRDFEDVALTLVAQSVTAAALARTESRGCHHRAEYPCTVPEQARSIVVRGADDANAVCVQALVAVC,"53,785",527,"FAD-dependent oxidoreductase 2 family, NadB subfamily",growth [GO:0040007]; NAD biosynthetic process [GO:0009435],L-aspartate:fumarate oxidoreductase activity [GO:0044318]; L-aspartate oxidase activity [GO:0008734],cytoplasm [GO:0005737],,MTCY336.09c,1
P9WJQ1,NARX_MYCTU,Rv1736c,narX Rv1736c,GO:0001666; GO:0005886; GO:0008940; GO:0009325; GO:0016021; GO:0042128; GO:0046872; GO:0051082; GO:0051131; GO:0051539,IPR020945; IPR006656; IPR006963; IPR027467; IPR023234; IPR036197; IPR003816; IPR003765; IPR036411; ,,narX,DOMAIN 53 117 4Fe-4S Mo/W bis-MGD-type. {ECO:0000255|PROSITE-ProRule:PRU01004}.,Nitrate reductase-like protein NarX,"integral component of membrane [GO:0016021]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; nitrate reductase activity [GO:0008940]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; nitrate assimilation [GO:0042128]; response to hypoxia [GO:0001666]",9634230; 11416222; 14645286; 12953092; 18474359; 18400743; 19553548; 21969609,,FUNCTION: Does not seem to have nitrate reductase activity. {ECO:0000269|PubMed:14645286}.,MTVTPRTGSRIEELLARSGRFFIPGEISADLRTVTRRGGRDGDVFYRDRWSHDKVVRSTHGVNCTGSCSWKIYVKDDIITWETQETDYPSVGPDRPEYEPRGCPRGAAFSWYTYSPTRVRHPYARGVLVEMYREAKARLGDPVAAWADIQADPRRRRRYQRARGKGGLVRVSWAEATEMIAAAHVHTISTYGPDRVAGFSPIPAMSMVSHAAGSRFVELIGGVMTSFYDWYADLPVASPQVFGDQTDVPESGDWWDVVWQCASVLLTYPNSRQLGTAEELLAHIDGPAADLLGRTVSELRRADPLTAATRYVDTFDLRGRATLYLTYWTAGDTRNRGREMLAFAQTYRSTDVAPPRGETPDFLPVVLEFAATVDPEAGRRLLSGYRVPIAALCNALTEAALPYAHTVAAVCRTGDMMGELFWTVVPYVTMTIVAVGSWWRYRYDKFGWTTRSSQLYESRLLRIASPMFHFGILVVIVGHGIGLVIPQSWTQAAGLSEGAYHVQAVVLGSIAGITTLAGVTLLIYRRRTRGPVFMATTVNDKVMYLVLVAAIVAGLGATALGSGVVGEAYNYRETVSVWFRSVWVLQPRGDLMAEAPLYYQIHVLIGLALFALWPFTRLVHAFSAPIGYLFRPYIIYRSREELVLTRPRRRGW,"72,825",652,Nitrate reductase alpha subunit family; NarJ/NarW family; Nitrate reductase gamma subunit family,chaperone-mediated protein complex assembly [GO:0051131]; nitrate assimilation [GO:0042128]; response to hypoxia [GO:0001666],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; nitrate reductase activity [GO:0008940]; unfolded protein binding [GO:0051082]",integral component of membrane [GO:0016021]; nitrate reductase complex [GO:0009325]; plasma membrane [GO:0005886],,,1
P9WGU3,MODA_MYCTU,Rv1857,modA Rv1857 MTCY359.16c,GO:0005886; GO:0015689; GO:0030288; GO:0030973; GO:0044119; GO:0046872,IPR005950; ,,modA,,Molybdate-binding protein ModA (Molybdate/tungstate-binding protein ModA),outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; molybdate ion binding [GO:0030973]; growth of symbiont in host cell [GO:0044119]; molybdate ion transport [GO:0015689],9634230; 19099550; 21969609,,FUNCTION: Involved in the transport of molybdenum into the cell. Part of the binding-protein-dependent transport system ModABCD (By similarity). {ECO:0000250}.,MRWIGLSTGLVSAMLVAGLVACGSNSPASSPAGPTQGARSIVVFAAASLQSAFTQIGEQFKAGNPGVNVNFAFAGSSELATQLTQGATADVFASADTAQMDSVAKAGLLAGHPTNFATNTMVIVAAAGNPKKIRSFADLTRPGLNVVVCQPSVPCGSATRRIEDATGIHLNPVSEELSVTDVLNKVITGQADAGLVYVSDALSVATKVTCVRFPEAAGVVNVYAIAVLKRTSQPALARQFVAMVTAAAGRRILDQSGFAKP,"26,576",261,Bacterial solute-binding protein ModA family,growth of symbiont in host cell [GO:0044119]; molybdate ion transport [GO:0015689],metal ion binding [GO:0046872]; molybdate ion binding [GO:0030973],outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,MTCY359.16c,1
P9WIP1,MP63_MYCTU,Rv1926c,mpt63 Rv1926c MTCY09F9.38,GO:0005576; GO:0005615; GO:0005618,IPR029050; IPR015250; ,,mpt63,,Immunogenic protein MPT63 (16 kDa immunoprotective extracellular protein) (Antigen MPT63),cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615],8975887; 9169770; 9634230; 7878014; 1898899; 21969609,X-ray crystallography (1),,MKLTTMIKTAVAVVAMAAIATFAAPVALAAYPITGKLGSELTMTDTVGQVVLGWKVSDLKSSTAVIPGYPVAGQVWEATATVNAIRGSVTPAVSQFNARTADGINYRVLWQAAGPDTISGATIPQGEQSTGKIYFDVTGPSPTIVAMNNGMEDLLIWEP,"16,514",159,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615],,MTCY09F9.38,1
P9WND5,LLDD_MYCTU,Rv1872c,lldD lldD2 Rv1872c,GO:0005618; GO:0005886; GO:0010181; GO:0016491,IPR013785; IPR012133; IPR000262; IPR037396; IPR008259; ,,lldD,DOMAIN 29 406 FMN hydroxy acid dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00683}.,Putative L-lactate dehydrogenase (EC 1.1.-.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],9634230; 19099550; 21969609,,,MAVNRRVPRVRDLAPLLQFNRPQFDTSKRRLGAALTIQDLRRIAKRRTPRAAFDYADGGAEDELSIARARQGFRDIEFHPTILRDVTTVCAGWNVLGQPTVLPFGIAPTGFTRLMHTEGEIAGARAAAAAGIPFSLSTLATCAIEDLVIAVPQGRKWFQLYMWRDRDRSMALVRRVAAAGFDTMLVTVDVPVAGARLRDVRNGMSIPPALTLRTVLDAMGHPRWWFDLLTTEPLAFASLDRWPGTVGEYLNTVFDPSLTFDDLAWIKSQWPGKLVVKGIQTLDDARAVVDRGVDGIVLSNHGGRQLDRAPVPFHLLPHVARELGKHTEILVDTGIMSGADIVAAIALGARCTLIGRAYLYGLMAGGEAGVNRAIEILQTGVIRTMRLLGVTCLEELSPRHVTQLRRLGPIGAPT,"45,342",414,FMN-dependent alpha-hydroxy acid dehydrogenase family,,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],lldD2,,1
P9WPA9,KCY_MYCTU,Rv1712,cmk Rv1712 MTCI125.34,GO:0004127; GO:0004592; GO:0005524; GO:0005829; GO:0033317; GO:0040007,IPR003136; IPR011994; IPR027417; ,,cmk,,Cytidylate kinase (CK) (EC 2.7.4.25) (Cytidine monophosphate kinase) (CMP kinase),cytosol [GO:0005829]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; pantoate-beta-alanine ligase activity [GO:0004592]; growth [GO:0040007]; pantothenate biosynthetic process from valine [GO:0033317],9634230; 19181797; 21969609,,,MSRLSAAVVAIDGPAGTGKSSVSRRLARELGARFLDTGAMYRIVTLAVLRAGADPSDIAAVETIASTVQMSLGYDPDGDSCYLAGEDVSVEIRGDAVTRAVSAVSSVPAVRTRLVELQRTMAEGPGSIVVEGRDIGTVVFPDAPVKIFLTASAETRARRRNAQNVAAGLADDYDGVLADVRRRDHLDSTRAVSPLQAAGDAVIVDTSDMTEAEVVAHLLELVTRRSEAVR,"24,177",230,"Cytidylate kinase family, Type 1 subfamily",growth [GO:0040007]; pantothenate biosynthetic process from valine [GO:0033317],ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; pantoate-beta-alanine ligase activity [GO:0004592],cytosol [GO:0005829],,MTCI125.34,1
P9WML9,HIS7_MYCTU,Rv1601,hisB Rv1601 MTCY336.03c,GO:0000105; GO:0004424; GO:0005737; GO:0040007,IPR038494; IPR000807; IPR020565; IPR020568; ,,hisB,,Imidazoleglycerol-phosphate dehydratase (IGPD) (EC 4.2.1.19),cytoplasm [GO:0005737]; imidazoleglycerol-phosphate dehydratase activity [GO:0004424]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 21969609,X-ray crystallography (2),,MTTTQTAKASRRARIERRTRESDIVIELDLDGTGQVAVDTGVPFYDHMLTALGSHASFDLTVRATGDVEIEAHHTIEDTAIALGTALGQALGDKRGIRRFGDAFIPMDETLAHAAVDLSGRPYCVHTGEPDHLQHTTIAGSSVPYHTVINRHVFESLAANARIALHVRVLYGRDPHHITEAQYKAVARALRQAVEPDPRVSGVPSTKGAL,"22,770",210,Imidazoleglycerol-phosphate dehydratase family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105],imidazoleglycerol-phosphate dehydratase activity [GO:0004424],cytoplasm [GO:0005737],,MTCY336.03c,1
P9WML7,HIS8_MYCTU,Rv1600,hisC hisC1 Rv1600 MTCY336.04c,GO:0000105; GO:0004400; GO:0005618; GO:0005886; GO:0030170; GO:0040007,IPR001917; IPR004839; IPR005861; IPR015424; IPR015422; IPR015421; ,,hisC,,Histidinol-phosphate aminotransferase (EC 2.6.1.9) (Imidazole acetol-phosphate transaminase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; histidinol-phosphate transaminase activity [GO:0004400]; pyridoxal phosphate binding [GO:0030170]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 19099550; 21969609,X-ray crystallography (2),,MTRSGHPVTLDDLPLRADLRGKAPYGAPQLAVPVRLNTNENPHPPTRALVDDVVRSVREAAIDLHRYPDRDAVALRADLAGYLTAQTGIQLGVENIWAANGSNEILQQLLQAFGGPGRSAIGFVPSYSMHPIISDGTHTEWIEASRANDFGLDVDVAVAAVVDRKPDVVFIASPNNPSGQSVSLPDLCKLLDVAPGIAIVDEAYGEFSSQPSAVSLVEEYPSKLVVTRTMSKAFAFAGGRLGYLIATPAVIDAMLLVRLPYHLSSVTQAAARAALRHSDDTLSSVAALIAERERVTTSLNDMGFRVIPSDANFVLFGEFADAPAAWRRYLEAGILIRDVGIPGYLRATTGLAEENDAFLRASARIATDLVPVTRSPVGAP,"40,581",380,"Class-II pyridoxal-phosphate-dependent aminotransferase family, Histidinol-phosphate aminotransferase subfamily",growth [GO:0040007]; histidine biosynthetic process [GO:0000105],histidinol-phosphate transaminase activity [GO:0004400]; pyridoxal phosphate binding [GO:0030170],cell wall [GO:0005618]; plasma membrane [GO:0005886],hisC1,MTCY336.04c,1
P9WKE5,KPYK_MYCTU,Rv1617,pyk pykA Rv1617 MTCY01B2.09,GO:0000287; GO:0004743; GO:0005524; GO:0005829; GO:0005886; GO:0006096; GO:0016301; GO:0030955; GO:0040007,IPR001697; IPR015813; IPR011037; IPR018209; IPR015793; IPR015795; IPR036918; IPR015806; ,,pyk,,Pyruvate kinase (PK) (EC 2.7.1.40),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; glycolytic process [GO:0006096]; growth [GO:0040007],9634230; 20520732; 21969609,X-ray crystallography (6),,MTRRGKIVCTLGPATQRDDLVRALVEAGMDVARMNFSHGDYDDHKVAYERVRVASDATGRAVGVLADLQGPKIRLGRFASGATHWAEGETVRITVGACEGSHDRVSTTYKRLAQDAVAGDRVLVDDGKVALVVDAVEGDDVVCTVVEGGPVSDNKGISLPGMNVTAPALSEKDIEDLTFALNLGVDMVALSFVRSPADVELVHEVMDRIGRRVPVIAKLEKPEAIDNLEAIVLAFDAVMVARGDLGVELPLEEVPLVQKRAIQMARENAKPVIVATQMLDSMIENSRPTRAEASDVANAVLDGADALMLSGETSVGKYPLAAVRTMSRIICAVEENSTAAPPLTHIPRTKRGVISYAARDIGERLDAKALVAFTQSGDTVRRLARLHTPLPLLAFTAWPEVRSQLAMTWGTETFIVPKMQSTDGMIRQVDKSLLELARYKRGDLVVIVAGAPPGTVGSTNLIHVHRIGEDDV,"50,699",472,Pyruvate kinase family,glycolytic process [GO:0006096]; growth [GO:0040007],ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743],cytosol [GO:0005829]; plasma membrane [GO:0005886],pykA,MTCY01B2.09,1
P9WFN3,LPPC_MYCTU,Rv1911c,lppC Rv1911c MTCY180.07,GO:0005576; GO:0005618; GO:0005886; GO:0009986,IPR008914; IPR036610; IPR005247; ,,lppC,,Putative lipoprotein LppC (UPF0098 protein Rv1911c),cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609; 25041568,,FUNCTION: Probably involved in bacterial recognition and uptake by its host (human) (PubMed:25041568). {ECO:0000269|PubMed:25041568}.,MTSTLHRTPLATAGLALVVALGGCGGGGGDSRETPPYVPKATTVDATTPAPAAEPLTIASPMFADGAPIPVQFSCKGANVAPPLTWSSPAGAAELALVVDDPDAVGGLYVHWIVTGIAPGSGSTADGQTPAGGHSVPNSGGRQGYFGPCPPAGTGTHHYRFTLYHLPVALQLPPGATGVQAAQAIAQAASGQARLVGTFEG,"19,798",201,UPF0098 family,,,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY180.07,2
O33192,LPRJ_MYCTU,Rv1690,lprJ Rv1690 LH57_09210,GO:0005886; GO:0016021,IPR007969; ,,lprJ,,Putative lipoprotein LprJ,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 12581360,,"FUNCTION: Overexpression induces expression of sensor protein kdpD gene at low K(+) concentrations (0 and 250 uM, tested in M.smegatis). {ECO:0000269|PubMed:12581360}.",MTAHTHDGTRTWRTGRQATTLLALLAGVFGGAASCAAPIQADMMGNAFLTALTNAGIAYDQPATTVALGRSVCPMVVAPGGTFESITSRMAEINGMSRDMASTFTIVAIGTYCPAVIAPLMPNRLQA,"13,106",127,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_09210,1
P9WI77,PKNE_MYCTU,Rv1743,pknE Rv1743 MTCY28.05,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005886; GO:0006468; GO:0009405; GO:0016021; GO:0043085; GO:0043086; GO:0045717; GO:0046777; GO:0051409,IPR011009; IPR000719; IPR017441; IPR012336; IPR036249; ,,pknE,DOMAIN 16 275 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknE (EC 2.7.11.1),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to nitrosative stress [GO:0051409],9634230; 12927792; 15967413; 15987910; 16739134; 17892498; 21969609; 23108860; 21945589; 16762364,X-ray crystallography (1),"FUNCTION: Important for survival of the bacterium in the host during infection. Promotes the survival of infected macrophages by activating multiple signaling responses and suppressing apoptosis of macrophages during nitrate stress. May contribute to the adaptation of M.tuberculosis during stress conditions by maintaining the cellular integrity. Can phosphorylate the FHA domain of Rv1747. {ECO:0000269|PubMed:15987910, ECO:0000269|PubMed:17892498, ECO:0000269|PubMed:21945589, ECO:0000269|PubMed:23108860}.",MDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILRRSQVAKLPVPSTHPVSPGTRWPQPTPWAGGAPPWGPPSSPLPRSARQPWLWVGVAVAVVVALAGGLGIALAHPWRSSGPRTSAPPPPPPADAVELRVLNDGVFVGSSVAPTTIDIFNEPICPPCGSFIRSYASDIDTAVADKQLAVRYHLLNFLDDQSHSKNYSTRAVAASYCVAGQNDPKLYASFYSALFGSDFQPQENAASDRTDAELAHLAQTVGAEPTAISCIKSGADLGTAQTKATNASETLAGFNASGTPFVWDGSMVVNYQDPSWLARLIG,"60,512",566,"Protein kinase superfamily, Ser/Thr protein kinase family",negative regulation of catalytic activity [GO:0043086]; negative regulation of fatty acid biosynthetic process [GO:0045717]; pathogenesis [GO:0009405]; positive regulation of catalytic activity [GO:0043085]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to nitrosative stress [GO:0051409],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY28.05,1
P9WI75,PKNF_MYCTU,Rv1746,pknF Rv1746 MTCY28.09,GO:0000921; GO:0001558; GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0005887; GO:0010827; GO:0043085; GO:0043086; GO:0051055,IPR011009; IPR000719; IPR008271; ,P9WPE7; P9WMK1,pknF,DOMAIN 12 279 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknF (EC 2.7.11.1),cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of catalytic activity [GO:0043086]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of catalytic activity [GO:0043085]; regulation of cell growth [GO:0001558]; regulation of glucose transmembrane transport [GO:0010827]; septin ring assembly [GO:0000921],9634230; 11496007; 15135525; 15967413; 16040957; 15866927; 15987910; 19201798; 21622570; 21969609,,"FUNCTION: Phosphorylates the FHA domains of the ABC transporter Rv1747, the heat-shock protein GroEL 1, and Rv0020c. May play a role in the regulation of glucose transport, cell growth and septum formation. {ECO:0000269|PubMed:15135525, ECO:0000269|PubMed:15866927, ECO:0000269|PubMed:15987910, ECO:0000269|PubMed:19201798, ECO:0000269|PubMed:21622570}.",MPLAEGSTFAGFTIVRQLGSGGMGEVYLARHPRLPRQDALKVLRADVSADGEYRARFNREADAAASLWHPHIVAVHDRGEFDGQLWIDMDFVDGTDTVSLLRDRYPNGMPGPEVTEIITAVAEALDYAHERRLLHRDVKPANILIANPDSPDRRIMLADFGIAGWVDDPSGLTATNMTVGTVSYAAPEQLMGNELDGRADQYALAATAFHLLTGSPPFQHANPAVVISQHLSASPPAIGDRVPELTPLDPVFAKALAKQPKDRYQRCVDFARALGHRLGGAGDPDDTRVSQPVAVAAPAKRSLLRTAVIVPAVLAMLLVMAVAVAVREFQRADDERAAQPARTRTTTSAGTTTSVAPASTTRPAPTTPTTTGAADTATASPTAAVVAIGALCFPLGSTGTTKTGATAYCSTLQGTNTTIWSLTEDTVASPTVTATADPTEAPLPIEQESPIRVCMQQTGQTRRECREEIRRSNGWP,"50,668",476,"Protein kinase superfamily, Ser/Thr protein kinase family",negative regulation of catalytic activity [GO:0043086]; negative regulation of lipid biosynthetic process [GO:0051055]; positive regulation of catalytic activity [GO:0043085]; regulation of cell growth [GO:0001558]; regulation of glucose transmembrane transport [GO:0010827]; septin ring assembly [GO:0000921],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887],,MTCY28.09,1
P9WPF5,PKS10_MYCTU,Rv1660,pks10 Rv1660,GO:0005886; GO:0006633; GO:0008610; GO:0016747; GO:0034081; GO:0071770,IPR012328; IPR001099; IPR011141; IPR016039; ,,pks10,,Polyketide synthase-like Pks10 (EC 2.3.1.-) (Chalcone synthase-like protein) (CHS-like) (Polyketide synthase type III Pks10),"plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]",9634230; 12730158; 21969609,,FUNCTION: Could catalyze the elongation of hydroxybenzoyl-CoA as well as elongation of the aliphatic precursor involved in the synthesis of phthiocerol dimycocerosate (DIM). {ECO:0000269|PubMed:12730158}.,MSVIAGVFGALPPYRYSQRELTDSFVSIPDFEGYEDIVRQLHASAKVNSRHLVLPLEKYPKLTDFGEANKIFIEKAVDLGVQALAGALDESGLRPEDLDVLITATVTGLAVPSLDARIAGRLGLRADVRRVPLFGLGCVAGAAGVARLHDYLRGAPDGVAALVSVELCSLTYPGYKPTLPGLVGSALFADGAAAVVAAGVKRAQDIGADGPDILDSRSHLYPDSLRTMGYDVGSAGFELVLSRDLAAVVEQYLGNDVTTFLASHGLSTTDVGAWVTHPGGPKIINAITETLDLSPQALELTWRSLGEIGNLSSASVLHVLRDTIAKPPPSGSPGLMIAMGPGFCSELVLLRWH,"37,146",353,Chalcone/stilbene synthases family,DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081],,,1
P9WIT9,OTC_MYCTU,Rv1656,argF Rv1656 MTCY06H11.21,GO:0000050; GO:0004585; GO:0005737; GO:0006526; GO:0016597; GO:0040007; GO:0042450,IPR006132; IPR006130; IPR036901; IPR006131; IPR002292; IPR024904; ,,argF,,Ornithine carbamoyltransferase (OTCase) (EC 2.1.3.3),cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; ornithine carbamoyltransferase activity [GO:0004585]; arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007]; urea cycle [GO:0000050],9634230; 17012791; 21969609; 18062991,X-ray crystallography (2),"FUNCTION: Reversibly catalyzes the transfer of the carbamoyl group from carbamoyl phosphate (CP) to the N(epsilon) atom of ornithine (ORN) to produce L-citrulline, which is a substrate for argininosuccinate synthetase, the enzyme involved in the final step in arginine biosynthesis. {ECO:0000305|PubMed:18062991}.",MIRHFLRDDDLSPAEQAEVLELAAELKKDPVSRRPLQGPRGVAVIFDKNSTRTRFSFELGIAQLGGHAVVVDSGSTQLGRDETLQDTAKVLSRYVDAIVWRTFGQERLDAMASVATVPVINALSDEFHPCQVLADLQTIAERKGALRGLRLSYFGDGANNMAHSLLLGGVTAGIHVTVAAPEGFLPDPSVRAAAERRAQDTGASVTVTADAHAAAAGADVLVTDTWTSMGQENDGLDRVKPFRPFQLNSRLLALADSDAIVLHCLPAHRGDEITDAVMDGPASAVWDEAENRLHAQKALLVWLLERS,"33,057",307,ATCase/OTCase family,arginine biosynthetic process [GO:0006526]; arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007]; urea cycle [GO:0000050],amino acid binding [GO:0016597]; ornithine carbamoyltransferase activity [GO:0004585],cytoplasm [GO:0005737],,MTCY06H11.21,1
P9WGM3,PDTAR_MYCTU,Rv1626,pdtaR Rv1626,GO:0000160; GO:0003723; GO:0005618; GO:0005622; GO:0005886; GO:0006351; GO:0031564; GO:0040007; GO:0043168,IPR005561; IPR011006; IPR008327; IPR001789; IPR036388; ,,pdtaR,DOMAIN 15 129 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.; DOMAIN 135 196 ANTAR. {ECO:0000255|PROSITE-ProRule:PRU00308}.,Probable transcriptional regulatory protein pdtaR,"cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; anion binding [GO:0043168]; RNA binding [GO:0003723]; growth [GO:0040007]; phosphorelay signal transduction system [GO:0000160]; transcription antitermination [GO:0031564]; transcription, DNA-templated [GO:0006351]",9634230; 16026786; 21969609; 15341725,X-ray crystallography (2),FUNCTION: Member of the two-component regulatory system pdtaR/pdtaS. {ECO:0000269|PubMed:16026786}.,MTGPTTDADAAVPRRVLIAEDEALIRMDLAEMLREEGYEIVGEAGDGQEAVELAELHKPDLVIMDVKMPRRDGIDAASEIASKRIAPIVVLTAFSQRDLVERARDAGAMAYLVKPFSISDLIPAIELAVSRFREITALEGEVATLSERLETRKLVERAKGLLQTKHGMTEPDAFKWIQRAAMDRRTTMKRVAEVVLETLGTPKDT,"22,669",205,,"growth [GO:0040007]; phosphorelay signal transduction system [GO:0000160]; transcription, DNA-templated [GO:0006351]; transcription antitermination [GO:0031564]",anion binding [GO:0043168]; RNA binding [GO:0003723],cell wall [GO:0005618]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
P9WIA9,PHLD_MYCTU,Rv1755c,plcD Rv1755c MTCY28.21c,GO:0009405; GO:0016042; GO:0034480; GO:0052008,IPR017849; IPR007312; IPR006311; ,,plcD,,Phospholipase C 4 (EC 3.1.4.3),phosphatidylcholine phospholipase C activity [GO:0034480]; disruption by symbiont of host cellular component [GO:0052008]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405],9634230,,,MSQSHIGGVSRREFLAKVAAGGAGALMSFAGPVIEKAYGAGPCSGHLTDIEHFVFFMQENRSFDHYFGTLSGTDGFNTVSPLFQQKGWNPMTQALDATGVTMPYRFDTTRGPFLDGACVNDPDHSWVAMHESWNGGVNDNWLPAQAKTRSAAHTPTVMGYYTRQDIPIHYLLADAFTVCDRYFCSVLGPTLPNRLYWLSATIDPDGQNGGPELQSPTFQPVRRFGWRIMPQNLSDAGVSWKVYRNKTLGPISSVLTYGSLVTSFKQSADPRSDLVRFGVAPSYPASFAADVLANRLPRVSWVIPNVLESEHPAVPAAAGAFAIVNILRILLANPAVWEKTALIVSYDENGGFFDHVVPATAPAGTPGEYVTVPDIDQVPGSGGIRGPIGLGFRVPCFVISPYSRGPQMVHDTFDHTSQLRLLETRFGVPVPNLTAWRRSVTGDMTSTFNFAVPPNSSWPNLDYPGLHALSTVPQCVPNAALGTINRGIPYRVPDPQIMPTQETTPTRGIPSGPC,"55,770",514,Bacterial phospholipase C family,disruption by symbiont of host cellular component [GO:0052008]; lipid catabolic process [GO:0016042]; pathogenesis [GO:0009405],phosphatidylcholine phospholipase C activity [GO:0034480],,,MTCY28.21c,1
P9WPG5,PGSA1_MYCTU,Rv1822,pgsA1 pgsA pgsA2 Rv1822 MTCY1A11.21c,GO:0005886; GO:0006655; GO:0008444; GO:0008654; GO:0016021; GO:0046474,IPR000462; IPR004570; ,,pgsA1,,Putative CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyl-transferase 1 (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase) (PGP synthase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; glycerophospholipid biosynthetic process [GO:0046474]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,FUNCTION: This protein catalyzes the committed step to the synthesis of the acidic phospholipids. {ECO:0000250}.,MEPVLTQNRVLTVPNMLSVIRLALIPAFVYVVLSAHANGWGVAILVFSGVSDWADGKIARLLNQSSRLGALLDPAVDRLYMVTVPIVFGLSGIVPWWFVLTLLTRDALLAGTLPLLWSRGLSALPVTYVGKAATFGFMVGFPTILLGQCDPLWSHVLLACGWAFLIWGMYAYLWAFVLYAVQMTMVVRQMPKLKGRAHRPAAQNAGERG,"22,911",209,CDP-alcohol phosphatidyltransferase class-I family,glycerophospholipid biosynthetic process [GO:0046474]; phosphatidylglycerol biosynthetic process [GO:0006655]; phospholipid biosynthetic process [GO:0008654],CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],pgsA pgsA2,MTCY1A11.21c,1
P9WQL3,MODC_MYCTU,Rv1859,modC Rv1859 MTCY359.14,GO:0005524; GO:0005886; GO:0015412; GO:0042888,IPR003593; IPR003439; IPR017871; IPR015852; IPR008995; IPR027417; IPR005116; ,,modC,DOMAIN 4 239 ABC transporter. {ECO:0000255|HAMAP-Rule:MF_01705}.,Molybdenum import ATP-binding protein ModC (EC 3.6.3.29),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled molybdate transmembrane transporter activity [GO:0015412]; molybdenum ion transmembrane transporter activity [GO:0042888],9634230; 21969609,,FUNCTION: Part of the ABC transporter complex ModABC involved in molybdenum import. Responsible for energy coupling to the transport system. {ECO:0000255|HAMAP-Rule:MF_01705}.,MSKLQLRAVVADRRLDVEFSVSAGEVLAVLGPNGAGKSTALHVIAGLLRPDAGLVRLGDRVLTDTEAGVNVATHDRRVGLLLQDPLLFPHLSVAKNVAFGPQCRRGMFGSGRARTRASALRWLREVNAEQFADRKPRQLSGGQAQRVAIARALAAEPDVLLLDEPLTGLDVAAAAGIRSVLRSVVARSGCAVVLTTHDLLDVFTLADRVLVLESGTIAEIGPVADVLTAPRSRFGARIAGVNLVNGTIGPDGSLRTQSGAHWYGTPVQDLPTGHEAIAVFPPTAVAVYPEPPHGSPRNIVGLTVAEVDTRGPTVLVRGHDQPGGAPGLAACITVDAATELRVAPGSRVWFSVKAQEVALHPAPHQHASS,"38,610",369,"ABC transporter superfamily, Molybdate importer (TC 3.A.1.8) family",,ATPase-coupled molybdate transmembrane transporter activity [GO:0015412]; ATP binding [GO:0005524]; molybdenum ion transmembrane transporter activity [GO:0042888],plasma membrane [GO:0005886],,MTCY359.14,1
P9WK93,LGT_MYCTU,Rv1614,lgt Rv1614 MTCY01B2.06,GO:0005887; GO:0016757; GO:0040007; GO:0042158,IPR001640; ,,lgt,,Prolipoprotein diacylglyceryl transferase (EC 2.4.99.-),"integral component of plasma membrane [GO:0005887]; transferase activity, transferring glycosyl groups [GO:0016757]; growth [GO:0040007]; lipoprotein biosynthetic process [GO:0042158]",9634230; 21969609,,FUNCTION: Transfers the N-acyl diglyceride group on what will become the N-terminal cysteine of membrane lipoproteins. {ECO:0000255|HAMAP-Rule:MF_01147}.,MRMLPSYIPSPPRGVWYLGPLPVRAYAVCVITGIIVALLIGDRRLTARGGERGMTYDIALWAVPFGLIGGRLYHLATDWRTYFGDGGAGLAAALRIWDGGLGIWGAVTLGVMGAWIGCRRCGIPLPVLLDAVAPGVVLAQAIGRLGNYFNQELYGRETTMPWGLEIFYRRDPSGFDVPNSLDGVSTGQVAFVVQPTFLYELIWNVLVFVALIYIDRRFIIGHGRLFGFYVAFYCAGRFCVELLRDDPATLIAGIRINSFTSTFVFIGAVVYIILAPKGREAPGALRGSEYVVDEALEREPAELAAAAVASAASAVGPVGPGEPNQPDDVAEAVKAEVAEVTDEVAAESVVQVADRDGESTPAVEETSEADIEREQPGDLAGQAPAAHQVDAEAASAAPEEPAALASEAHDETEPEVPEKAAPIPDPAKPDELAVAGPGDDPAEPDGIRRQDDFSSRRRRWWRLRRRRQ,"50,392",468,Lgt family,growth [GO:0040007]; lipoprotein biosynthetic process [GO:0042158],"transferase activity, transferring glycosyl groups [GO:0016757]",integral component of plasma membrane [GO:0005887],,MTCY01B2.06,1
P9WLR1,LIPZ_MYCTU,Rv1834,lipZ Rv1834 MTCY1A11.09c,GO:0016787,IPR029058; IPR000073; IPR000639; ,,lipZ,,Putative hydrolase LipZ (EC 3.-.-.-),hydrolase activity [GO:0016787],9634230; 16354661,,,MTSPSVREWRDGGRWLPTAVGKVFVRSGPGDTPTMLLLHGYPSSSFDFRAVIPHLTGQAWVTMDFLGFGLSDKPRPHRYSLLEQAHLVETVVAHTVTGAVVVLAHDMGTSVTTELLARDLDGRLPFDLRRAVLSNGSVILERASLRPIQKVLRSPLGPVAARLVSRGGFTRGFGRIFSPAHPLSAQEAQAQWELLCYNDGNRIPHLLISYLDERIRHAQRWHGAVRDWPKPLGFVWGLDDPVATTNVLNGLRELRPSAAVVELPGLGHYPQVEAPKAYAEAALSLLVD,"31,676",288,AB hydrolase superfamily,,hydrolase activity [GO:0016787],,,MTCY1A11.09c,1
P9WFU7,LYSX_MYCTU,Rv1640c,lysX lysS2 lysU mprF Rv1640c MTCY06H11.04c,GO:0003677; GO:0004824; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006430; GO:0008654; GO:0009405; GO:0016021; GO:0030322; GO:0046471; GO:0046677; GO:0046872; GO:0050071,IPR004364; IPR006195; IPR024320; IPR002313; IPR018149; IPR012340; IPR004365; IPR031553; ,,lysX,,Lysylphosphatidylglycerol biosynthesis bifunctional protein LysX [Includes: Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS); Phosphatidylglycerol lysyltransferase (EC 2.3.2.3) (Lysylphosphatidylglycerol synthetase) (LPG synthetase)],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; lysine-tRNA ligase activity [GO:0004824]; lysyltransferase activity [GO:0050071]; metal ion binding [GO:0046872]; lysyl-tRNA aminoacylation [GO:0006430]; pathogenesis [GO:0009405]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid biosynthetic process [GO:0008654]; response to antibiotic [GO:0046677]; stabilization of membrane potential [GO:0030322],9634230; 19649276; 21969609,,"FUNCTION: Catalyzes the production of L-lysyl-tRNA(Lys)transfer and the transfer of a lysyl group from L-lysyl-tRNA(Lys) to membrane-bound phosphatidylglycerol (PG), which produces lysylphosphatidylglycerol (LPG), one of the components of the bacterial membrane with a positive net charge. LPG synthesis contributes to the resistance to cationic antimicrobial peptides (CAMPs) and likely protects M.tuberculosis against the CAMPs produced by competiting microorganisms (bacteriocins). In fact, the modification of anionic phosphatidylglycerol with positively charged L-lysine results in repulsion of the peptides. {ECO:0000269|PubMed:19649276}.",MGLHLTVPGLRRDGRGVQSNSHDTSSKTTADISRCPQHTDAGLQRAATPGISRLLGISSRSVTLTKPRSATRGNSRYHWVPAAAGWTVGVIATLSLLASVSPLIRWIIKVPREFINDYLFNFPDTNFAWSFVLALLAAALTARKRIAWLVLLANMVLAAVVNAAEIAAGGNTAAESFGENLGFAVHVVAIVVLVLGYREFWAKVRRGALFRAAAVWLAGAVVGIVASWGLVELFPGSLAPDERLGYAANRVVGFALADPDLFTGRPHVFLNAIFGLFGAFALIGAAIVLFLSQRADNALTGEDESAIRGLLDLYGKDDSLGYFATRRDKSVVFASSGRACITYRVEVGVCLASGDPVGDHRAWPQAVDAWLRLCQTYGWAPGVMGASSQGAQTYREAGLTALELGDEAILRPADFKLSGPEMRGVRQAVTRARRAGLTVRIRRHRDIAEDEMAQTITRADSWRDTETERGFSMALGRLGDPADSDCLLVEAIDPHNQVLAMLSLVPWGTTGVSLDLMRRSPQSPNGTIELMVSELALHAESLGITRISLNFAVFRAAFEQGAQLGAGPVARLWRGLLVFFSRWWQLETLYRSNMKYQPEWVPRYACYEDARVIPRVGVASVIAEGFLVLPFSRRNRVHTGHHPAVPERLAATGLLHHDGSAPDVSGLRQVGLTNGDGVERRLPEQVRVRFDKLEKLRSSGIDAFPVGRPPSHTVAQALAADHQASVSVSGRIMRIRNYGGVLFAQLRDWSGEMQVLLDNSRLDQGCAADFNAATDLGDLVEMTGHMGASKTGTPSLIVSGWRLIGKCLRPLPNKWKGLLDPEARVRTRYLDLAVNAESRALITARSSVLRAVRETLFAKGFVEVETPILQQLHGGATARPFVTHINTYSMDLFLRIAPELYLKRLCVGGVERVFELGRAFRNEGVDFSHNPEFTLLEAYQAHADYLEWIDGCRELIQNAAQAANGAPIAMRPRTDKGSDGTRHHLEPVDISGIWPVRTVHDAISEALGERIDADTGLTTLRKLCDAAGVPYRTQWDAGAVVLELYEHLVECRTEQPTFYIDFPTSVSPLTRPHRSKRGVAERWDLVAWGIELGTAYSELTDPVEQRRRLQEQSLLAAGGDPEAMELDEDFLQAMEYAMPPTGGLGMGIDRVVMLITGRSIRETLPFPLAKPH,"128,240",1172,LPG synthetase family; Class-II aminoacyl-tRNA synthetase family,lysyl-tRNA aminoacylation [GO:0006430]; pathogenesis [GO:0009405]; phosphatidylglycerol metabolic process [GO:0046471]; phospholipid biosynthetic process [GO:0008654]; response to antibiotic [GO:0046677]; stabilization of membrane potential [GO:0030322],ATP binding [GO:0005524]; DNA binding [GO:0003677]; lysine-tRNA ligase activity [GO:0004824]; lysyltransferase activity [GO:0050071]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],lysS2 lysU mprF,MTCY06H11.04c,1
P9WJK1,NADA_MYCTU,Rv1594,nadA Rv1594 MTCY336.10c,GO:0005618; GO:0005829; GO:0008987; GO:0016765; GO:0034628; GO:0040007; GO:0046872; GO:0051539,IPR003473; IPR036094; IPR023066; ,,nadA,,Quinolinate synthase A (EC 2.5.1.72),"cell wall [GO:0005618]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; quinolinate synthetase A activity [GO:0008987]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; 'de novo' NAD biosynthetic process from aspartate [GO:0034628]; growth [GO:0040007]",9634230; 19099550; 21969609,,FUNCTION: Catalyzes the condensation of iminoaspartate with dihydroxyacetone phosphate to form quinolinate. {ECO:0000255|HAMAP-Rule:MF_00568}.,MTVLNRTDTLVDELTADITNTPLGYGGVDGDERWAAEIRRLAHLRGATVLAHNYQLPAIQDVADHVGDSLALSRVAAEAPEDTIVFCGVHFMAETAKILSPHKTVLIPDQRAGCSLADSITPDELRAWKDEHPGAVVVSYVNTTAAVKALTDICCTSSNAVDVVASIDPDREVLFCPDQFLGAHVRRVTGRKNLHVWAGECHVHAGINGDELADQARAHPDAELFVHPECGCATSALYLAGEGAFPAERVKILSTGGMLEAAHTTRARQVLVATEVGMLHQLRRAAPEVDFRAVNDRASCKYMKMITPAALLRCLVEGADEVHVDPGIAASGRRSVQRMIEIGHPGGGE,"37,408",349,"Quinolinate synthase A family, Type 2 subfamily",'de novo' NAD biosynthetic process from aspartate [GO:0034628]; growth [GO:0040007],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; quinolinate synthetase A activity [GO:0008987]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]",cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY336.10c,1
P9WNW9,HISX_MYCTU,Rv1599,hisD Rv1599 MTCY336.05c,GO:0000105; GO:0004399; GO:0005618; GO:0005829; GO:0008270; GO:0040007; GO:0051287,IPR016161; IPR001692; IPR022695; IPR012131; ,,hisD,,Histidinol dehydrogenase (HDH) (EC 1.1.1.23),cell wall [GO:0005618]; cytosol [GO:0005829]; histidinol dehydrogenase activity [GO:0004399]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 21672513; 21969609,,FUNCTION: Catalyzes the sequential NAD-dependent oxidations of L-histidinol to L-histidinaldehyde and then to L-histidine. {ECO:0000269|PubMed:21672513}.,MVYVTAPPPVLTRIDLRGAELTAAELRAALPRGGADVEAVLPTVRPIVAAVAERGAEAALDFGASFDGVRPHAIRVPDAALDAALAGLDCDVCEALQVMVERTRAVHSGQRRTDVTTTLGPGATVTERWVPVERVGLYVPGGNAVYPSSVVMNVVPAQAAGVDSLVVASPPQAQWDGMPHPTILAAARLLGVDEVWAVGGAQAVALLAYGGTDTDGAALTPVDMITGPGNIYVTAAKRLCRSRVGIDAEAGPTEIAILADHTADPVHVAADLISQAEHDELAASVLVTPSEDLADATDAELAGQLQTTVHRERVTAALTGRQSAIVLVDDVDAAVLVVNAYAAEHLEIQTADAPQVASRIRSAGAIFVGPWSPVSLGDYCAGSNHVLPTAGCARHSSGLSVQTFLRGIHVVEYTEAALKDVSGHVITLATAEDLPAHGEAVRRRFER,"46,302",447,Histidinol dehydrogenase family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105],histidinol dehydrogenase activity [GO:0004399]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY336.05c,2
P9WMM3,HIS6_MYCTU,Rv1605,hisF Rv1605 MTV046.03,GO:0000105; GO:0000107; GO:0005737; GO:0016829; GO:0040007,IPR013785; IPR006062; IPR004651; IPR011060; ,,hisF,,Imidazole glycerol phosphate synthase subunit HisF (EC 4.1.3.-) (IGP synthase cyclase subunit) (IGP synthase subunit HisF) (ImGP synthase subunit HisF) (IGPS subunit HisF),cytoplasm [GO:0005737]; imidazoleglycerol-phosphate synthase activity [GO:0000107]; lyase activity [GO:0016829]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 21969609,,"FUNCTION: IGPS catalyzes the conversion of PRFAR and glutamine to IGP, AICAR and glutamate. The HisF subunit catalyzes the cyclization activity that produces IGP and AICAR from PRFAR using the ammonia provided by the HisH subunit (By similarity). {ECO:0000250}.",MYADRDLPGAGGLAVRVIPCLDVDDGRVVKGVNFENLRDAGDPVELAAVYDAEGADELTFLDVTASSSGRATMLEVVRRTAEQVFIPLTVGGGVRTVADVDSLLRAGADKVAVNTAAIACPDLLADMARQFGSQCIVLSVDARTVPVGSAPTPSGWEVTTHGGRRGTGMDAVQWAARGADLGVGEILLNSMDADGTKAGFDLALLRAVRAAVTVPVIASGGAGAVEHFAPAVAAGADAVLAASVFHFRELTIGQVKAALAAEGITVR,"27,221",267,HisA/HisF family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105],imidazoleglycerol-phosphate synthase activity [GO:0000107]; lyase activity [GO:0016829],cytoplasm [GO:0005737],,MTV046.03,1
P9WIE5,KATG_MYCTU,Rv1908c,katG Rv1908c MTCY180.10,GO:0004096; GO:0004601; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006979; GO:0009405; GO:0016677; GO:0020037; GO:0042744; GO:0045739; GO:0046872; GO:0052059; GO:0070301; GO:0070402; GO:0070404,IPR000763; IPR010255; IPR002016; IPR019794; IPR019793; ,,katG,,Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor [GO:0016677]; peroxidase activity [GO:0004601]; cellular response to hydrogen peroxide [GO:0070301]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; hydrogen peroxide catabolic process [GO:0042744]; pathogenesis [GO:0009405]; positive regulation of DNA repair [GO:0045739]; response to oxidative stress [GO:0006979]",8320241; 7798673; 22972833; 9634230; 1501713; 10463167; 8658136; 9006925; 10080924; 11401695; 15165233; 15840564; 17260948; 18052167; 18178143; 19099550; 21969609; 21244531; 15231843; 16566587; 24185282,Model (1); X-ray crystallography (5),"FUNCTION: Bifunctional enzyme with both catalase and broad-spectrum peroxidase activity, oxidizing various electron donors including NADP(H) (PubMed:9006925, PubMed:18178143). Protects M.tuberculosis against toxic reactive oxygen species (ROS) including hydrogen peroxide as well as organic peroxides and thus contributes to its survival within host macrophages by countering the phagocyte oxidative burst (PubMed:8658136, PubMed:15165233). Also displays efficient peroxynitritase activity, which may help the bacterium to persist in macrophages (PubMed:10080924). {ECO:0000255|HAMAP-Rule:MF_01961, ECO:0000269|PubMed:10080924, ECO:0000269|PubMed:15165233, ECO:0000269|PubMed:18178143, ECO:0000269|PubMed:8658136, ECO:0000269|PubMed:9006925}.; FUNCTION: Might be involved in DNA repair. Partly complements recA-deficient E.coli cells exposed to UV radiation, mitomycin C or hydrogen peroxide. Increases resistance to mitomycin C in E.coli cells deficient for either uvrA, uvrB or uvrC. {ECO:0000269|PubMed:10463167}.; FUNCTION: Catalyzes the oxidative activation of the antitubercular pro-drug isoniazid (INH) to generate an isonicotinoyl radical that then reacts nonenzymatically with NAD to form an isonicotinoyl-NAD adduct which inhibits InhA. {ECO:0000269|PubMed:16566587, ECO:0000269|PubMed:18178143, ECO:0000269|PubMed:24185282, ECO:0000269|PubMed:9006925, ECO:0000269|PubMed:9634230}.",MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR,"80,605",740,"Peroxidase family, Peroxidase/catalase subfamily",cellular response to hydrogen peroxide [GO:0070301]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; hydrogen peroxide catabolic process [GO:0042744]; pathogenesis [GO:0009405]; positive regulation of DNA repair [GO:0045739]; response to oxidative stress [GO:0006979],"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor [GO:0016677]; peroxidase activity [GO:0004601]",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY180.10,1
P9WKJ9,IF3_MYCTU,Rv1641,infC Rv1641 MTCY06H11.05,GO:0003743; GO:0005829; GO:0005886; GO:0032790; GO:0040007; GO:0043022,IPR036788; IPR036787; IPR019813; IPR001288; IPR019815; IPR019814; ,,infC,,Translation initiation factor IF-3,cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; growth [GO:0040007]; ribosome disassembly [GO:0032790],9634230; 21969609,,"FUNCTION: IF-3 binds to the 30S ribosomal subunit and shifts the equilibrum between 70S ribosomes and their 50S and 30S subunits in favor of the free subunits, thus enhancing the availability of 30S subunits on which protein synthesis initiation begins. {ECO:0000255|HAMAP-Rule:MF_00080}.",MSTETRVNERIRVPEVRLIGPGGEQVGIVRIEDALRVAADADLDLVEVAPNARPPVCKIMDYGKYKYEAAQKARESRRNQQQTVVKEQKLRPKIDDHDYETKKGHVVRFLEAGSKVKVTIMFRGREQSRPELGYRLLQRLGADVADYGFIETSAKQDGRNMTMVLAPHRGAKTRARARHPGEPAGGPPPKPTAGDSKAAPN,"22,333",201,IF-3 family,growth [GO:0040007]; ribosome disassembly [GO:0032790],ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY06H11.05,1
P9WG39,ILVG_MYCTU,Rv1820,ilvG Rv1820 MTCY1A11.23c,GO:0000287; GO:0003984; GO:0009082; GO:0009097; GO:0009099; GO:0030976,IPR029035; IPR029061; IPR012000; IPR012001; IPR000399; IPR011766; ,,ilvG,,Acetolactate synthase large subunit IlvG (ALS) (EC 2.2.1.6) (Acetohydroxy-acid synthase large subunit) (AHAS),acetolactate synthase activity [GO:0003984]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; branched-chain amino acid biosynthetic process [GO:0009082]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 20884690; 21969609,,"FUNCTION: Catalyzes the conversion of 2 pyruvate molecules into acetolactate in the first common step of the biosynthetic pathway of the branched-amino acids such as leucine, isoleucine, and valine. {ECO:0000269|PubMed:20884690}.",MSTDTAPAQTMHAGRLIARRLKASGIDTVFTLSGGHLFSIYDGCREEGIRLIDTRHEQTAAFAAEGWSKVTRVPGVAALTAGPGITNGMSAMAAAQQNQSPLVVLGGRAPALRWGMGSLQEIDHVPFVAPVARFAATAQSAENAGLLVDQALQAAVSAPSGVAFVDFPMDHAFSMSSDNGRPGALTELPAGPTPAGDALDRAAGLLSTAQRPVIMAGTNVWWGHAEAALLRLVEERHIPVLMNGMARGVVPADHRLAFSRARSKALGEADVALIVGVPMDFRLGFGGVFGSTTQLIVADRVEPAREHPRPVAAGLYGDLTATLSALAGSGGTDHQGWIEELATAETMARDLEKAELVDDRIPLHPMRVYAELAALLERDALVVIDAGDFGSYAGRMIDSYLPGCWLDSGPFGCLGSGPGYALAAKLARPQRQVVLLQGDGAFGFSGMEWDTLVRHNVAVVSVIGNNGIWGLEKHPMEALYGYSVVAELRPGTRYDEVVRALGGHGELVSVPAELRPALERAFASGLPAVVNVLTDPSVAYPRRSNLA,"57,521",547,TPP enzyme family,branched-chain amino acid biosynthetic process [GO:0009082]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase activity [GO:0003984]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],,,MTCY1A11.23c,1
O07750,LPPE_MYCTU,Rv1881c,lppE Rv1881c LH57_10245,GO:0005618; GO:0005886,IPR008691; ,,lppE,,Probable lipoprotein LppE,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21920479; 21969609,,,MCNRLVTVTGVAMVVAAGLSACGQAQTVPRKAARLTIDGVTHTTRPATCSQEHSYRTIDIRNHDSTVQAVVLLSGDRVIPQWVKIRNVDGFNGSFWHGGVGNARADRARNTYTVAGSAYGISSKKPNTVVSTDFNILAEC,"14,975",140,Mycobacterial 19 kDa antigen family,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,LH57_10245,2
P9WK23,MALQ_MYCTU,Rv1781c,malQ Rv1781c MTV049.03c,GO:0004134; GO:0005829; GO:0102500,IPR003385; IPR017853; ,,malQ,,4-alpha-glucanotransferase (EC 2.4.1.25) (Amylomaltase) (Disproportionating enzyme) (D-enzyme),cytosol [GO:0005829]; 4-alpha-glucanotransferase activity [GO:0004134]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500],9634230; 21969609,,,MTELAPSLVELARRFGIATEYTDWTGRQVLVSEATLVAALAALGVPAQTEQQRNDALAAQLRSYWARPLPATIVMRAGEQTQFRVHVTDGAPADVWLQLEDGTTRAEVVQVDNFTPPFDLDGRWIGEASFVLPADLPLGYHRVNLRSGDSQASAAVVVTPDWLGLPDKLAGRRAWGLAVQLYSVRSRQSWGIGDLTDLANLALWSASAHGAGYVLVNPLHAATLPGPAGRSKPIEPSPYLPTSRRFVNPLYLRVEAIPELVDLPKRGRVQRLRTNVQQHADQLDTIDRDSAWAAKRAALKLVHRVPRSAGRELAYAAFRTREGRALDDFATWCALAETYGDDWHRWPKSLRHPDASGVADFVDKHADAVDFHRWLQWQLDEQLASAQSQALRAGMSLGIMADLAVGVHPNGADAWALQDVLAQGVTAGAPPDEFNQLGQDWSQPPWRPDRLAEQEYRPFRALIQAALRHAGAVRIDHIIGLFRLWWIPDGAPPTQGTYVRYDHDAMIGIVALEAHRAGAVVVGEDLGTVEPWVRDYLLLRGLLGTSILWFEQDRDCGPAGTPLPAERWREYCLSSVTTHDLPPTAGYLAGDQVRLRESLGLLTNPVEAELESARADRAAWMAELRRVGLLADGAEPDSEEAVLALYRYLGRTPSRLLAVALTDAVGDRRTQNQPGTTDEYPNWRVPLTGPDGQPMLLEDIFTDRRAATLAEAVRAATTSPMSCW,"79,745",724,Disproportionating enzyme family,,4-alpha-glucanotransferase activity [GO:0004134]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500],cytosol [GO:0005829],,MTV049.03c,1
P9WK17,MASZ_MYCTU,Rv1837c,glcB Rv1837c MTCY1A11.06,GO:0000287; GO:0001968; GO:0004474; GO:0005576; GO:0005618; GO:0005737; GO:0005829; GO:0005886; GO:0006097; GO:0006099; GO:0009436; GO:0009986; GO:0015936; GO:0042603; GO:0042803; GO:0043236; GO:0044406; GO:0046810; GO:0050662,IPR011076; IPR023310; IPR001465; IPR006253; ,,glcB,,Malate synthase G (EC 2.3.3.9),capsule [GO:0042603]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; coenzyme binding [GO:0050662]; fibronectin binding [GO:0001968]; host cell extracellular matrix binding [GO:0046810]; laminin binding [GO:0043236]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homodimerization activity [GO:0042803]; adhesion of symbiont to host [GO:0044406]; coenzyme A metabolic process [GO:0015936]; glyoxylate catabolic process [GO:0009436]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609; 16877713; 23261599,X-ray crystallography (33),FUNCTION: Involved in the glycolate utilization. Catalyzes the condensation and subsequent hydrolysis of acetyl-coenzyme A (acetyl-CoA) and glyoxylate to form malate and CoA. {ECO:0000255|HAMAP-Rule:MF_00641}.,MTDRVSVGNLRIARVLYDFVNNEALPGTDIDPDSFWAGVDKVVADLTPQNQALLNARDELQAQIDKWHRRRVIEPIDMDAYRQFLTEIGYLLPEPDDFTITTSGVDAEITTTAGPQLVVPVLNARFALNAANARWGSLYDALYGTDVIPETDGAEKGPTYNKVRGDKVIAYARKFLDDSVPLSSGSFGDATGFTVQDGQLVVALPDKSTGLANPGQFAGYTGAAESPTSVLLINHGLHIEILIDPESQVGTTDRAGVKDVILESAITTIMDFEDSVAAVDAADKVLGYRNWLGLNKGDLAAAVDKDGTAFLRVLNRDRNYTAPGGGQFTLPGRSLMFVRNVGHLMTNDAIVDTDGSEVFEGIMDALFTGLIAIHGLKASDVNGPLINSRTGSIYIVKPKMHGPAEVAFTCELFSRVEDVLGLPQNTMKIGIMDEERRTTVNLKACIKAAADRVVFINTGFLDRTGDEIHTSMEAGPMVRKGTMKSQPWILAYEDHNVDAGLAAGFSGRAQVGKGMWTMTELMADMVETKIAQPRAGASTAWVPSPTAATLHALHYHQVDVAAVQQGLAGKRRATIEQLLTIPLAKELAWAPDEIREEVDNNCQSILGYVVRWVDQGVGCSKVPDIHDVALMEDRATLRISSQLLANWLRHGVITSADVRASLERMAPLVDRQNAGDVAYRPMAPNFDDSIAFLAAQELILSGAQQPNGYTEPILHRRRREFKARAAEKPAPSDRAGDDAAR,"80,403",741,"Malate synthase family, GlcB subfamily",adhesion of symbiont to host [GO:0044406]; coenzyme A metabolic process [GO:0015936]; glyoxylate catabolic process [GO:0009436]; glyoxylate cycle [GO:0006097]; tricarboxylic acid cycle [GO:0006099],coenzyme binding [GO:0050662]; fibronectin binding [GO:0001968]; host cell extracellular matrix binding [GO:0046810]; laminin binding [GO:0043236]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homodimerization activity [GO:0042803],capsule [GO:0042603]; cell surface [GO:0009986]; cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY1A11.06,1
O53907,IMPA_MYCTU,Rv1604,impA Rv1604,GO:0005886; GO:0006020; GO:0006021; GO:0007165; GO:0008934; GO:0046854; GO:0046855; GO:0046872; GO:0052832; GO:0052833,IPR000760; IPR020550; ,,impA,,Probable inositol 1-monophosphatase ImpA (I-1-Pase) (IMPase) (Inositol-1-phosphatase) (EC 3.1.3.25),plasma membrane [GO:0005886]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],9634230; 20167072,,"FUNCTION: Catalyzes the dephosphorylation of inositol 1-phosphate (I-1-P) to yield free myo-inositol, a key metabolite in mycobacteria. {ECO:0000250}.",MHLDSLVAPLVEQASAILDAATALFLVGHRADSAVRKKGNDFATEVDLAIERQVVAALVAATGIEVHGEEFGGPAVDSRWVWVLDPIDGTINYAAGSPLAAILLGLLHDGVPVAGLTWMPFTDPRYTAVAGGPLIKNGVPQPPLADAELANVLVGVGTFSADSRGQFPGRYRLAVLEKLSRVSSRLRMHGSTGIDLVFVADGILGGAISFGGHVWDHAAGVALVRAAGGVVTDLAGQPWTPASRSALAGPPRVHAQILEILGSIGEPEDY,"27,979",270,Inositol monophosphatase superfamily,inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,,1
P9WKK5,IDI_MYCTU,Rv1745c,idi Rv1745c MTCY04C12.29c MTCY28.08c,GO:0004452; GO:0005737; GO:0009240; GO:0016787; GO:0046872; GO:0050992,IPR011876; IPR015797; IPR000086; ,,idi,DOMAIN 38 172 Nudix hydrolase.,Isopentenyl-diphosphate Delta-isomerase (IPP isomerase) (EC 5.3.3.2) (IPP:DMAPP isomerase) (Isopentenyl pyrophosphate isomerase),cytoplasm [GO:0005737]; hydrolase activity [GO:0016787]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240],9634230; 21969609,,"FUNCTION: Catalyzes the 1,3-allylic rearrangement of the homoallylic substrate isopentenyl (IPP) to its highly electrophilic allylic isomer, dimethylallyl diphosphate (DMAPP). {ECO:0000255|HAMAP-Rule:MF_00202}.",MTRSYRPAPPIERVVLLNDRGDATGVADKATVHTGDTPLHLAFSSYVFDLHDQLLITRRAATKRTWPAVWTNSCCGHPLPGESLPGAIRRRLAAELGLTPDRVDLILPGFRYRAAMADGTVENEICPVYRVQVDQQPRPNSDEVDAIRWLSWEQFVRDVTAGVIAPVSPWCRSQLGYLTKLGPCPAQWPVADDCRLPKAAHGN,"22,490",203,IPP isomerase type 1 family,dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process [GO:0009240],hydrolase activity [GO:0016787]; isopentenyl-diphosphate delta-isomerase activity [GO:0004452]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY04C12.29c MTCY28.08c,1
P9WG95,ILVA_MYCTU,Rv1559,ilvA Rv1559 MTCY48.06c,GO:0004794; GO:0005886; GO:0006566; GO:0009097; GO:0030170,IPR011820; IPR001926; IPR000634; IPR001721; IPR038110; IPR036052; ,,ilvA,DOMAIN 346 420 ACT-like. {ECO:0000255|PROSITE-ProRule:PRU01008}.,L-threonine dehydratase biosynthetic IlvA (EC 4.3.1.19) (Threonine deaminase),plasma membrane [GO:0005886]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; threonine metabolic process [GO:0006566],9634230; 21969609,,"FUNCTION: Catalyzes the anaerobic formation of alpha-ketobutyrate and ammonia from threonine in a two-step reaction. The first step involved a dehydration of threonine and a production of enamine intermediates (aminocrotonate), which tautomerizes to its imine form (iminobutyrate). Both intermediates are unstable and short-lived. The second step is the nonenzymatic hydrolysis of the enamine/imine intermediates to form 2-ketobutyrate and free ammonia. In the low water environment of the cell, the second step is accelerated by RidA (By similarity). {ECO:0000250}.",MSAELSQSPSSSPLFSLSGADIDRAAKRIAPVVTPTPLQPSDRLSAITGATVYLKREDLQTVRSYKLRGAYNLLVQLSDEELAAGVVCSSAGNHAQGFAYACRCLGVHGRVYVPAKTPKQKRDRIRYHGGEFIDLIVGGSTYDLAAAAALEDVERTGATLVPPFDDLRTIAGQGTIAVEVLGQLEDEPDLVVVPVGGGGCIAGITTYLAERTTNTAVLGVEPAGAAAMMAALAAGEPVTLDHVDQFVDGAAVNRAGTLTYAALAAAGDMVSLTTVDEGAVCTAMLDLYQNEGIIAEPAGALSVAGLLEADIEPGSTVVCLISGGNNDVSRYGEVLERSLVHLGLKHYFLVDFPQEPGALRRFLDDVLGPNDDITLFEYVKRNNRETGEALVGIELGSAADLDGLLARMRATDIHVEALEPGSPAYRYLL,"45,041",429,Serine/threonine dehydratase family,isoleucine biosynthetic process [GO:0009097]; threonine metabolic process [GO:0006566],L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170],plasma membrane [GO:0005886],,MTCY48.06c,1
P9WJ89,MAZE5_MYCTU,Rv1943c,mazE5 mazE-mt5 Rv1943c,GO:0045927,,,mazE5,,Antitoxin MazE5,positive regulation of growth [GO:0045927],9634230; 15718296; 16611633; 19389781; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin MazF5. {ECO:0000269|PubMed:20011113}.,MKTARLQVTLRCAVDLINSSSDQCFARIEHVASDQADPRPGVWHSSGMNRIRLSTTVDAALLTSARDMRAGITDAALIDEALAALLARHRSAEVDASYAAYDKHPVDEPDEWGDLASWRRAAGDS,"13,592",125,,positive regulation of growth [GO:0045927],,,mazE-mt5,,1
P95272,MAZF5_MYCTU,Rv1942c,mazF5 mazF-mt5 Rv1942c,GO:0003677; GO:0004519; GO:0045926,IPR003477; IPR011067; ,,mazF5,,Probable endoribonuclease MazF5 (EC 3.1.-.-) (Toxin MazF5),DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; negative regulation of growth [GO:0045926],9634230; 16611633; 19389781; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin MazE5 (PubMed:20011113). Probably an endoribonuclease (By similarity). {ECO:0000250|UniProtKB:P9WIH9, ECO:0000269|PubMed:20011113}.",MTALPARGEVWWCEMAEIGRRPVVVLSRDAAIPRLRRALVAPCTTTIRGLASEVVLEPGSDPIPRRSAVNLDSVESVSVAVLVNRLGRLADIRMRAICTALEVAVDCSR,"11,820",109,PemK/MazF family,negative regulation of growth [GO:0045926],DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,mazF-mt5,,4
P9WJ83,MCTB_MYCTU,Rv1698,mctB Rv1698 MTCI125.20,GO:0006811; GO:0009279; GO:0015288; GO:0046930; GO:0055070,IPR021522; ,,mctB,,Copper transporter MctB (Mycobacterial copper transport protein B),cell outer membrane [GO:0009279]; pore complex [GO:0046930]; porin activity [GO:0015288]; copper ion homeostasis [GO:0055070]; ion transport [GO:0006811],9634230; 18434314; 18439872; 21969609; 21205886; 21045312,,"FUNCTION: Pore-forming protein, which is involved in efflux of copper across the outer membrane. Essential for copper resistance and maintenance of a low intracellular copper concentration. Required for virulence. {ECO:0000269|PubMed:18434314, ECO:0000269|PubMed:21205886}.",MISLRQHAVSLAAVFLALAMGVVLGSGFFSDTLLSSLRSEKRDLYTQIDRLTDQRDALREKLSAADNFDIQVGSRIVHDALVGKSVVIFRTPDAHDDDIAAVSKIVGQAGGAVTATVSLTQEFVEANSAEKLRSVVNSSILPAGSQLSTKLVDQGSQAGDLLGIALLSNADPAAPTVEQAQRDTVLAALRETGFITYQPRDRIGTANATVVVTGGALSTDAGNQGVSVARFAAALAPRGSGTLLAGRDGSANRPAAVAVTRADADMAAEISTVDDIDAEPGRITVILALHDLINGGHVGHYGTGHGAMSVTVSQ,"32,391",314,MctB (TC 1.B.50) family,copper ion homeostasis [GO:0055070]; ion transport [GO:0006811],porin activity [GO:0015288],cell outer membrane [GO:0009279]; pore complex [GO:0046930],,MTCI125.20,1
P9WMH5,CMR_MYCTU,Rv1675c,cmr Rv1675c,GO:0003677; GO:0006351; GO:0006355,IPR018490; IPR000595; IPR012318; IPR014710; IPR036388; IPR036390; ,,cmr,DOMAIN 174 237 HTH crp-type. {ECO:0000255|PROSITE-ProRule:PRU00387}.,HTH-type transcriptional regulator Cmr,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; 22464736,,FUNCTION: Positively regulates the expression of at least groEL2. Cyclic AMP does not affect transcription in vitro. {ECO:0000269|PubMed:22464736}.,MADRSVRPLRHLVHAVTGGQPPSEAQVRQAAWIARCVGRGGSAPLHRDDVSALAETLQVKEFAPGAVVFHADQTADGVWIVRHGLIELAVGSRRRRAVVNILHPGDVDGDIPLLLEMPMVYTGRALTQATCLFLDRQAFERLLATHPAIARRWLSSVAQRVSTAQIRLMGMLGRPLPAQVAQLLLDEAIDARIELAQRTLAAMLGAQRPSINKILKEFERDRLITVGYAVIEITDQHGLRARAQ,"26,793",244,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,,1
P9WPA3,COAE_MYCTU,Rv1631,coaE Rv1631 MTCY01B2.23,GO:0002135; GO:0004140; GO:0005524; GO:0005829; GO:0015937; GO:0032564; GO:0040007,IPR001977; IPR007344; IPR027417; ,,coaE,DOMAIN 3 204 DPCK.,Dephospho-CoA kinase (EC 2.7.1.24) (Dephosphocoenzyme A kinase),cytosol [GO:0005829]; ATP binding [GO:0005524]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; dephospho-CoA kinase activity [GO:0004140]; coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the phosphorylation of the 3'-hydroxyl group of dephosphocoenzyme A to form coenzyme A. {ECO:0000250}.,MLRIGLTGGIGAGKSLLSTTFSQCGGIVVDGDVLAREVVQPGTEGLASLVDAFGRDILLADGALDRQALAAKAFRDDESRGVLNGIVHPLVARRRSEIIAAVSGDAVVVEDIPLLVESGMAPLFPLVVVVHADVELRVRRLVEQRGMAEADARARIAAQASDQQRRAVADVWLDNSGSPEDLVRRARDVWNTRVQPFAHNLAQRQIARAPARLVPADPSWPDQARRIVNRLKIACGHKALRVDHIGSTAVSGFPDFLAKDVIDIQVTVESLDVADELAEPLLAAGYPRLEHITQDTEKTDARSTVGRYDHTDSAALWHKRVHASADPGRPTNVHLRVHGWPNQQFALLFVDWLAANPGAREDYLTVKCDADRRADGELARYVTAKEPWFLDAYQRAWEWADAVHWRP,"44,669",407,CoaE family; UPF0157 (GrpB) family,coenzyme A biosynthetic process [GO:0015937]; growth [GO:0040007],ATP binding [GO:0005524]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; dephospho-CoA kinase activity [GO:0004140],cytosol [GO:0005829],,MTCY01B2.23,1
P9WQP1,A85B_MYCTU,Rv1886c,fbpB Rv1886c MTCY180.32,GO:0001968; GO:0004144; GO:0005576; GO:0005618; GO:0005886; GO:0010756; GO:0016747; GO:0035375; GO:0040007; GO:0044044; GO:0044119; GO:0046677; GO:0050348; GO:0052572,IPR029058; IPR000801; ,,fbpB,,Diacylglycerol acyltransferase/mycolyltransferase Ag85B (DGAT) (EC 2.3.1.122) (EC 2.3.1.20) (30 kDa extracellular protein) (Acyl-CoA:diacylglycerol acyltransferase) (Antigen 85 complex B) (85B) (Ag85B) (Extracellular alpha-antigen) (Fibronectin-binding protein B) (Fbps B),"cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; fibronectin binding [GO:0001968]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]; growth [GO:0040007]; growth of symbiont in host cell [GO:0044119]; interaction with host via substance in symbiont surface [GO:0044044]; positive regulation of plasminogen activation [GO:0010756]; response to antibiotic [GO:0046677]; response to host immune response [GO:0052572]",7987013; 8757831; 20223296; 9634230; 2403534; 3141278; 9162010; 12010501; 19099550; 21969609; 11254389,X-ray crystallography (2),"FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria for fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. {ECO:0000269|PubMed:12010501, ECO:0000269|PubMed:3141278, ECO:0000269|PubMed:9162010}.",MTDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGAFSRPGLPVEYLQVPSPSMGRDIKVQFQSGGNNSPAVYLLDGLRAQDDYNGWDINTPAFEWYYQSGLSIVMPVGGQSSFYSDWYSPACGKAGCQTYKWETFLTSELPQWLSANRAVKPTGSAAIGLSMAGSSAMILAAYHPQQFIYAGSLSALLDPSQGMGPSLIGLAMGDAGGYKAADMWGPSSDPAWERNDPTQQIPKLVANNTRLWVYCGNGTPNELGGANIPAEFLENFVRSSNLKFQDAYNAAGGHNAVFNFPPNGTHSWEYWGAQLNAMKGDLQSSLGAG,"34,581",325,Mycobacterial A85 antigen family,growth [GO:0040007]; growth of symbiont in host cell [GO:0044119]; interaction with host via substance in symbiont surface [GO:0044044]; positive regulation of plasminogen activation [GO:0010756]; response to antibiotic [GO:0046677]; response to host immune response [GO:0052572],"diacylglycerol O-acyltransferase activity [GO:0004144]; fibronectin binding [GO:0001968]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]",cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY180.32,1
I6YC03,EPHB_MYCTU,Rv1938,ephB Rv1938 LH57_10545,GO:0009636; GO:0018742; GO:0042803,IPR029058; IPR000073; IPR000639; ,,ephB,DOMAIN 28 129 AB hydrolase-1. {ECO:0000255}.,Epoxide hydrolase B (EHB) (EC 3.3.2.10) (Epoxide hydrolase EphB),epoxide hydrolase B activity [GO:0018742]; protein homodimerization activity [GO:0042803]; response to toxic substance [GO:0009636],9634230; 16511284; 19389781; 21969609,,FUNCTION: Could be involved in detoxification of extraneous host-cell epoxides. Catalyzes the hydrolysis of epoxide-containing substrates. {ECO:0000305|PubMed:16511284}.,MSQVHRILNCRGTRIHAVADSPPDQQGPLVVLLHGFPESWYSWRHQIPALAGAGYRVVAIDQRGYGRSSKYRVQKAYRIKELVGDVVGVLDSYGAEQAFVVGHDWGAPVAWTFAWLHPDRCAGVVGISVPFAGRGVIGLPGSPFGERRPSDYHLELAGPGRVWYQDYFAVQDGIITEIEEDLRGWLLGLTYTVSGEGMMAATKAAVDAGVDLESMDPIDVIRAGPLCMAEGARLKDAFVYPETMPAWFTEADLDFYTGEFERSGFGGPLSFYHNIDNDWHDLADQQGKPLTPPALFIGGQYDVGTIWGAQAIERAHEVMPNYRGTHMIADVGHWIQQEAPEETNRLLLDFLGGLRP,"39,297",356,"AB hydrolase superfamily, Epoxide hydrolase family",response to toxic substance [GO:0009636],epoxide hydrolase B activity [GO:0018742]; protein homodimerization activity [GO:0042803],,,LH57_10545,1
P9WNZ9,ERG3_MYCTU,Rv1814,erg3 Rv1814 MTCY1A11.29c,GO:0005506; GO:0005886; GO:0006643; GO:0016021; GO:0016126; GO:0050479,IPR006694; ,,erg3,,C-5 sterol desaturase (EC 1.3.-.-) (Sterol-C5-desaturase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506]; membrane lipid metabolic process [GO:0006643]; sterol biosynthetic process [GO:0016126],9634230,,,MRDPVLFAIPCFLLLLILEWTAARKLESIETAATGQPRPASGAYLTRDSVASISMGLVSIATTAGWKSLALLGYAAIYAYLAPWQLSAHRWYTWVIAIVGVDLLYYSYHRIAHRVRLIWATHQAHHSSEYFNFATALRQKWNNSGEILMWVPLPLMGLPPWMVFCSWSLNLIYQFWVHTERIDRLPRWFEFVFNTPSHHRVHHGMDPVYLDKNYGGILIIWDRLFGSFQPELFRPHYGLTKRVDTFNIWKLQTREYVAIVRDWRSATRLRDRLGYVFGPPGWEPRTIDKSNAAASLVTSR,"34,882",300,Sterol desaturase family,membrane lipid metabolic process [GO:0006643]; sterol biosynthetic process [GO:0016126],glyceryl-ether monooxygenase activity [GO:0050479]; iron ion binding [GO:0005506],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY1A11.29c,1
P9WNA5,ECCC5_MYCTU,Rv1783,eccC5 Rv1783,GO:0003677; GO:0005524; GO:0005618; GO:0005886; GO:0016021,IPR003593; IPR023836; IPR023837; IPR002543; IPR027417; ,,eccC5,DOMAIN 476 678 FtsK 1. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 858 1052 FtsK 2. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 1161 1354 FtsK 3. {ECO:0000255|PROSITE-ProRule:PRU00289}.,ESX-5 secretion system protein EccC5 (ESX conserved component C5) (Type VII secretion system protein EccC5) (T7SS protein EccC5),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677],9634230; 19876390; 21969609; 22340629; 22925462; 23284869,,"FUNCTION: Part of the ESX-5 specialized secretion system, which is responsible for the secretion of EsxN and a number of PE_PGRS and PPE proteins, including PPE41. {ECO:0000269|PubMed:22340629, ECO:0000269|PubMed:22925462, ECO:0000269|PubMed:23284869}.",MKRGFARPTPEKPPVIKPENIVLSTPLSIPPPEGKPWWLIVVGVVVVGLLGGMVAMVFASGSHVFGGIGSIFPLFMMVGIMMMMFRGMGGGQQQMSRPKLDAMRAQFMLMLDMLRETAQESADSMDANYRWFHPAPNTLAAAVGSPRMWERKPDGKDLNFGVVRVGVGMTRPEVTWGEPQNMPTDIELEPVTGKALQEFGRYQSVVYNLPKMVSLLVEPWYALVGEREQVLGLMRAIICQLAFSHGPDHVQMIVVSSDLDQWDWVKWLPHFGDSRRHDAAGNARMVYTSVREFAAEQAELFAGRGSFTPRHASSSAQTPTPHTVIIADVDDPQWEYVISAEGVDGVTFFDLTGSSMWTDIPERKLQFDKTGVIEALPRDRDTWMVIDDKAWFFALTDQVSIAEAEEFAQKLAQWRLAEAYEEIGQRVAHIGARDILSYYGIDDPGNIDFDSLWASRTDTMGRSRLRAPFGNRSDNGELLFLDMKSLDEGGDGPHGVMSGTTGSGKSTLVRTVIESLMLSHPPEELQFVLADLKGGSAVKPFAGVPHVSRIITDLEEDQALMERFLDALWGEIARRKAICDSAGVDDAKEYNSVRARMRARGQDMAPLPMLVVVIDEFYEWFRIMPTAVDVLDSIGRQGRAYWIHLMMASQTIESRAEKLMENMGYRLVLKARTAGAAQAAGVPNAVNLPAQAGLGYFRKSLEDIIRFQAEFLWRDYFQPGVSIDGEEAPALVHSIDYIRPQLFTNSFTPLEVSVGGPDIEPVVAQPNGEVLESDDIEGGEDEDEEGVRTPKVGTVIIDQLRKIKFEPYRLWQPPLTQPVAIDDLVNRFLGRPWHKEYGSACNLVFPIGIIDRPYKHDQPPWTVDTSGPGANVLILGAGGSGKTTALQTLICSAALTHTPQQVQFYCLAYSSTALTTVSRIPHVGEVAGPTDPYGVRRTVAELLALVRERKRSFLECGIASMEMFRRRKFGGEAGPVPDDGFGDVYLVIDNYRALAEENEVLIEQVNVIINQGPSFGVHVVVTADRESELRPPVRSGFGSRIELRLAAVEDAKLVRSRFAKDVPVKPGRGMVAVNYVRLDSDPQAGLHTLVARPALGSTPDNVFECDSVVAAVSRLTSAQAPPVRRLPARFGVEQVRELASRDTRQGVGAGGIAWAISELDLAPVYLNFAENSHLMVTGRRECGRTTTLATIMSEIGRLYAPGASSAPPPAPGRPSAQVWLVDPRRQLLTALGSDYVERFAYNLDGVVAMMGELAAALAGREPPPGLSAEELLSRSWWSGPEIFLIVDDIQQLPPGFDSPLHKAVPFVNRAADVGLHVIVTRTFGGWSSAGSDPMLRALHQANAPLLVMDADPDEGFIRGKMKGGPLPRGRGLLMAEDTGVFVQVAATEVRR,"152,740",1391,,,ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNP9,ECCD5_MYCTU,Rv1795,eccD5 Rv1795,GO:0005886; GO:0016021,IPR006707; IPR024962; ,,eccD5,,ESX-5 secretion system protein EccD5 (ESX conserved component D5) (Type VII secretion system protein EccD5) (T7SS protein EccD5),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 19099550; 19876390; 21969609; 22340629; 22925462,,"FUNCTION: Part of the ESX-5 specialized secretion system, which is responsible for the secretion of EsxN and a number of PE_PGRS and PPE proteins, including PPE41. {ECO:0000269|PubMed:22340629, ECO:0000269|PubMed:22925462}.",MTAVADAPQADIEGVASPQAVVVGVMAGEGVQIGVLLDANAPVSVMTDPLLKVVNSRLRELGEAPLEATGRGRWALCLVDGAPLRATQSLTEQDVYDGDRLWIRFIADTERRSQVIEHISTAVASDLSKRFARIDPIVAVQVGASMVATGVVLATGVLGWWRWHHNTWLTTIYTAVIGVLVLAVAMLLLMRAKTDADRRVADIMLMSAIMPVTVAAAAAPPGPVGSPQAVLGFGVLTVAAALALRFTGRRLGIYTTIVIIGALTMLAALARMVAATSAVTLLSSLLLICVVAYHAAPALSRRLAGIRLPVFPSATSRWVFEARPDLPTTVVVSGGSAPVLEGPSSVRDVLLQAERARSFLSGLLTGLGVMVVVCMTSLCDPHTGQRWLPLILAGFTSGFLLLRGRSYVDRWQSITLAGTAVIIAAAVCVRYALELSSPLAVSIVAAILVLLPAAGMAAAAHVPHTIYSPLFRKFVEWIEYLCLMPIFPLALWLMNVYAAIRYR,"53,435",503,EccD/Snm4 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WN55,GCSH_MYCTU,Rv1826,gcvH Rv1826 MTCY1A11.17c,GO:0005960; GO:0019464,IPR003016; IPR000089; IPR002930; IPR033753; IPR017453; IPR011053; ,,gcvH,DOMAIN 24 106 Lipoyl-binding. {ECO:0000255|PROSITE-ProRule:PRU01066}.,Glycine cleavage system H protein,glycine cleavage complex [GO:0005960]; glycine decarboxylation via glycine cleavage system [GO:0019464],9634230; 21969609,X-ray crystallography (3),FUNCTION: The glycine cleavage system catalyzes the degradation of glycine. The H protein shuttles the methylamine group of glycine from the P protein to the T protein. {ECO:0000255|HAMAP-Rule:MF_00272}.,MSDIPSDLHYTAEHEWIRRSGDDTVRVGITDYAQSALGDVVFVQLPVIGTAVTAGETFGEVESTKSVSDLYAPISGKVSEVNSDLDGTPQLVNSDPYGAGWLLDIQVDSSDVAALESALTTLLDAEAYRGTLTE,"14,238",134,GcvH family,glycine decarboxylation via glycine cleavage system [GO:0019464],,glycine cleavage complex [GO:0005960],,MTCY1A11.17c,1
P9WJA9,GARA_MYCTU,Rv1827,garA Rv1827 MTCY1A11.16c,GO:0005576; GO:0005618; GO:0005886; GO:0042802; GO:0043457; GO:0045820; GO:0046777,IPR000253; IPR008984; ,Itself; O53203; P9WIS5; P9WI81; P9WI73,garA,DOMAIN 77 126 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.,Glycogen accumulation regulator GarA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; negative regulation of glycolytic process [GO:0045820]; protein autophosphorylation [GO:0046777]; regulation of cellular respiration [GO:0043457],9634230; 15978616; 19019160; 19114043; 19638631; 21969609; 19318624,NMR spectroscopy (1),"FUNCTION: Involved in regulation of glutamate metabolism. Acts as a phosphorylation-dependent molecular switch that modulates the activities of Kgd, Gdh and GltB. {ECO:0000269|PubMed:19019160, ECO:0000269|PubMed:19114043, ECO:0000269|PubMed:19318624}.",MTDMNPDIEKDQTSDEVTVETTSVFRADFLSELDAPAQAGTESAVSGVEGLPPGSALLVVKRGPNAGSRFLLDQAITSAGRHPDSDIFLDDVTVSRRHAEFRLENNEFNVVDVGSLNGTYVNREPVDSAVLANGDEVQIGKFRLVFLTGPKQGEDDGSTGGP,"17,251",162,,negative regulation of glycolytic process [GO:0045820]; protein autophosphorylation [GO:0046777]; regulation of cellular respiration [GO:0043457],identical protein binding [GO:0042802],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY1A11.16c,1
P9WN87,FURA_MYCTU,Rv1909c,furA fur Rv1909c MTCY180.09,GO:0003677; GO:0003700; GO:0005737; GO:0006351; GO:0006355; GO:0006979; GO:0010039; GO:0046872,IPR002481; IPR036388; IPR036390; ,,furA,,Transcriptional regulator FurA,"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to iron ion [GO:0010039]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",9634230; 11401695; 12949087; 21969609,,"FUNCTION: Represses transcription of the catalase-peroxidase gene katG and its own transcription by binding to the promoter region in a redox-dependent manner. {ECO:0000269|PubMed:11401695, ECO:0000269|PubMed:12949087}.",MSSIPDYAEQLRTADLRVTRPRVAVLEAVNAHPHADTETIFGAVRFALPDVSRQAVYDVLHALTAAGLVRKIQPSGSVARYESRVGDNHHHIVCRSCGVIADVDCAVGEAPCLTASDHNGFLLDEAEVIYWGLCPDCSISDTSRSHP,"15,892",147,Fur family,"regulation of transcription, DNA-templated [GO:0006355]; response to iron ion [GO:0010039]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],fur,MTCY180.09,1
P9WN53,GCSP_MYCTU,Rv1832,gcvP gcvB Rv1832 MTCY1A11.11c,GO:0004375; GO:0005618; GO:0005886; GO:0006546; GO:0040007,IPR003437; IPR020581; IPR015424; IPR015422; IPR015421; ,,gcvP,,Probable glycine dehydrogenase (decarboxylating) (EC 1.4.4.2) (Glycine cleavage system P-protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring)),cell wall [GO:0005618]; plasma membrane [GO:0005886]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; glycine catabolic process [GO:0006546]; growth [GO:0040007],9634230; 21969609,,FUNCTION: The glycine cleavage system catalyzes the degradation of glycine. The P protein binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein (By similarity). {ECO:0000250}.,MSDHSTFADRHIGLDSQAVATMLAVIGVDSLDDLAVKAVPAGILDTLTDTGAAPGLDSLPPAASEAEALAELRALADANTVAVSMIGQGYYDTHTPPVLLRNIIENPAWYTAYTPYQPEISQGRLEALLNFQTLVTDLTGLEIANASMLDEGTAAAEAMTLMHRAARGPVKRVVVDADVFTQTAAVLATRAKPLGIEIVTADLRAGLPDGEFFGVIAQLPGASGRITDWSALVQQAHDRGALVAVGADLLALTLIAPPGEIGADVAFGTTQRFGVPMGFGGPHAGYLAVHAKHARQLPGRLVGVSVDSDGTPAYRLALQTREQHIRRDKATSNICTAQVLLAVLAAMYASYHGAGGLTAIARRVHAHAEAIAGALGDALVHDKYFDTVLARVPGRADEVLARAKANGINLWRVDADHVSVACDEATTDTHVAVVLDAFGVAAAAPAHTDIATRTSEFLTHPAFTQYRTETSMMRYLRALADKDIALDRSMIPLGSCTMKLNAAAEMESITWPEFGRQHPFAPASDTAGLRQLVADLQSWLVLITGYDAVSLQPNAGSQGEYAGLLAIHEYHASRGEPHRDICLIPSSAHGTNAASAALAGMRVVVVDCHDNGDVDLDDLRAKVGEHAERLSALMITYPSTHGVYEHDIAEICAAVHDAGGQVYVDGANLNALVGLARPGKFGGDVSHLNLHKTFCIPHGGGGPGVGPVAVRAHLAPFLPGHPFAPELPKGYPVSSAPYGSASILPITWAYIRMMGAEGLRAASLTAITSANYIARRLDEYYPVLYTGENGMVAHECILDLRGITKLTGITVDDVAKRLADYGFHAPTMSFPVAGTLMVEPTESESLAEVDAFCEAMIGIRAEIDKVGAGEWPVDDNPLRGAPHTAQCLLASDWDHPYTREQAAYPLGTAFRPKVWPAVRRIDGAYGDRNLVCSCPPVEAFA,"99,511",941,GcvP family,glycine catabolic process [GO:0006546]; growth [GO:0040007],glycine dehydrogenase (decarboxylating) activity [GO:0004375],cell wall [GO:0005618]; plasma membrane [GO:0005886],gcvB,MTCY1A11.11c,1
P9WNX7,GABD2_MYCTU,Rv1731,gabD2 Rv1731,GO:0005886; GO:0006099; GO:0009013,IPR016161; IPR016163; IPR029510; IPR016162; IPR015590; ,,gabD2,,Putative succinate-semialdehyde dehydrogenase [NADP(+)] 2 (SSADH 2) (SSDH 2) (EC 1.2.1.79),plasma membrane [GO:0005886]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; tricarboxylic acid cycle [GO:0006099],9634230; 16027371; 21969609,,"FUNCTION: Catalyzes the NADP(+)-dependent oxidation of succinate semialdehyde to succinate. Although it has succinate semialdehyde dehydrogenase activity, is likely to act physiologically on a different aldehyde(s). NAD(+) can substitute for NADP(+), but enzymatic activity is three times reduced. {ECO:0000269|PubMed:16027371}.",MPAPSAEVFDRLRNLAAIKDVAARPTRTIDEVFTGKPLTTIPVGTAADVEAAFAEARAAQTDWAKRPVIERAAVIRRYRDLVIENREFLMDLLQAEAGKARWAAQEEIVDLIANANYYARVCVDLLKPRKAQPLLPGIGKTTVCYQPKGVVGVISPWNYPMTLTVSDSVPALVAGNAVVLKPDSQTPYCALACAELLYRAGLPRALYAIVPGPGSVVGTAITDNCDYLMFTGSSATGSRLAEHAGRRLIGFSAELGGKNPMIVARGANLDKVAKAATRACFSNAGQLCISIERIYVEKDIAEEFTRKFGDAVRNMKLGTAYDFSVDMGSLISEAQLKTVSGHVDDATAKGAKVIAGGKARPDIGPLFYEPTVLTNVAPEMECAANETFGPVVSIYPVADVDEAVEKANDTDYGLNASVWAGSTAEGQRIAARLRSGTVNVDEGYAFAWGSLSAPMGGMGLSGVGRRHGPEGLLKYTESQTIATARVFNLDPPFGIPATVWQKSLLPIVRTVMKLPGRR,"55,324",518,Aldehyde dehydrogenase family,tricarboxylic acid cycle [GO:0006099],succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013],plasma membrane [GO:0005886],,,1
P9WNL3,DER_MYCTU,Rv1713,der engA Rv1713 MTCI125.35,GO:0005525; GO:0005618; GO:0005886; GO:0040007; GO:0042254,IPR003593; IPR031166; IPR016484; IPR006073; IPR032859; IPR015946; IPR027417; IPR005225; ,,der,DOMAIN 27 190 EngA-type G 1.; DOMAIN 200 373 EngA-type G 2.; DOMAIN 374 456 KH-like. {ECO:0000255|HAMAP-Rule:MF_00195}.,GTPase Der (GTP-binding protein EngA),cell wall [GO:0005618]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; growth [GO:0040007]; ribosome biogenesis [GO:0042254],9634230; 21969609,,FUNCTION: GTPase that plays an essential role in the late steps of ribosome biogenesis. {ECO:0000255|HAMAP-Rule:MF_00195}.,MTQDGTWVDESDWQLDDSEIAESGAAPVVAVVGRPNVGKSTLVNRILGRREAVVQDIPGVTRDRVCYDALWTGRRFVVQDTGGWEPNAKGLQRLVAEQASVAMRTADAVILVVDAGVGATAADEAAARILLRSGKPVFLAANKVDSEKGESDAAALWSLGLGEPHAISAMHGRGVADLLDGVLAALPEVGESASASGGPRRVALVGKPNVGKSSLLNKLAGDQRSVVHEAAGTTVDPVDSLIELGGDVWRFVDTAGLRRKVGQASGHEFYASVRTHAAIDSAEVAIVLIDASQPLTEQDLRVISMVIEAGRALVLAYNKWDLVDEDRRELLQREIDRELVQVRWAQRVNISAKTGRAVHKLVPAMEDALASWDTRIATGPLNTWLTEVTAATPPPVRGGKQPRILFATQATARPPTFVLFTTGFLEAGYRRFLERRLRETFGFDGSPIRVNVRVREKRAGKRR,"49,958",463,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, EngA (Der) GTPase family",growth [GO:0040007]; ribosome biogenesis [GO:0042254],GTP binding [GO:0005525],cell wall [GO:0005618]; plasma membrane [GO:0005886],engA,MTCI125.35,1
P9WQ35,CYA1_MYCTU,Rv1625c,cya Rv1625c MTCY01B2.17c,GO:0000287; GO:0004016; GO:0005524; GO:0005622; GO:0005886; GO:0006171; GO:0007165; GO:0016021; GO:0030145; GO:0035556,IPR001054; IPR018297; IPR029787; ,,cya,DOMAIN 251 378 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Adenylate cyclase (EC 4.6.1.1) (ATP pyrophosphate-lyase) (Adenylyl cyclase),integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],11431477; 9634230; 11447108; 21969609; 16403515; 25295175,X-ray crystallography (4),,MAARKCGAPPIAADGSTRRPDCVTAVRTQARAPTQHYAESVARRQRVLTITAWLAVVVTGSFALMQLATGAGGWYIALINVFTAVTFAIVPLLHRFGGLVAPLTFIGTAYVAIFAIGWDVGTDAGAQFFFLVAAALVVLLVGIEHTALAVGLAAVAAGLVIALEFLVPPDTGLQPPWAMSVSFVLTTVSACGVAVATVWFALRDTARAEAVMEAEHDRSEALLANMLPASIAERLKEPERNIIADKYDEASVLFADIVGFTERASSTAPADLVRFLDRLYSAFDELVDQHGLEKIKVSGDSYMVVSGVPRPRPDHTQALADFALDMTNVAAQLKDPRGNPVPLRVGLATGPVVAGVVGSRRFFYDVWGDAVNVASRMESTDSVGQIQVPDEVYERLKDDFVLRERGHINVKGKGVMRTWYLIGRKVAADPGEVRGAEPRTAGV,"47,370",443,Adenylyl cyclase class-4/guanylyl cyclase family,cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY01B2.17c,1
P9WMM1,HIS5_MYCTU,Rv1602,hisH Rv1602 MTCY336.02c,GO:0000105; GO:0005618; GO:0005737; GO:0006541; GO:0016763; GO:0040007,IPR029062; IPR017926; IPR010139; ,,hisH,DOMAIN 5 206 Glutamine amidotransferase type-1.,Imidazole glycerol phosphate synthase subunit HisH (EC 2.4.2.-) (IGP synthase glutamine amidotransferase subunit) (IGP synthase subunit HisH) (ImGP synthase subunit HisH) (IGPS subunit HisH),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; transferase activity, transferring pentosyl groups [GO:0016763]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105]",9634230; 21969609,,"FUNCTION: IGPS catalyzes the conversion of PRFAR and glutamine to IGP, AICAR and glutamate. The HisH subunit provides the glutamine amidotransferase activity that produces the ammonia necessary to HisF for the synthesis of IGP and AICAR (By similarity). {ECO:0000250}.",MTAKSVVVLDYGSGNLRSAQRALQRVGAEVEVTADTDAAMTADGLVVPGVGAFAACMAGLRKISGERIIAERVAAGRPVLGVCVGMQILFACGVEFGVQTPGCGHWPGAVIRLEAPVIPHMGWNVVDSAAGSALFKGLDVDARFYFVHSYAAQRWEGSPDALLTWATYRAPFLAAVEDGALAATQFHPEKSGDAGAAVLSSWVDGL,"21,418",206,,glutamine metabolic process [GO:0006541]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],"transferase activity, transferring pentosyl groups [GO:0016763]",cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY336.02c,1
P9WMM7,HIS3_MYCTU,Rv1606,hisI Rv1606 MTV046.04,GO:0000105; GO:0004635; GO:0005737; GO:0040007; GO:0046872,IPR026660; IPR002496; IPR038019; ,,hisI,,Phosphoribosyl-AMP cyclohydrolase (PRA-CH) (EC 3.5.4.19),cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; phosphoribosyl-AMP cyclohydrolase activity [GO:0004635]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 21969609,,FUNCTION: Catalyzes the hydrolysis of the adenine ring of phosphoribosyl-AMP. {ECO:0000255|HAMAP-Rule:MF_01021}.,MTLDPKIAARLKRNADGLVTAVVQERGSGDVLMVAWMNDEALARTLQTREATYYSRSRAEQWVKGATSGHTQHVHSVRLDCDGDAVLLTVDQVGGACHTGDHSCFDAAVLLEPDD,"12,465",115,PRA-CH family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105],metal ion binding [GO:0046872]; phosphoribosyl-AMP cyclohydrolase activity [GO:0004635],cytoplasm [GO:0005737],,MTV046.04,1
P9WMM5,HIS4_MYCTU,Rv1603,priA hisA Rv1603 MTCY336.01c MTV046.01,GO:0000105; GO:0000162; GO:0003949; GO:0004640; GO:0005737; GO:0040007,IPR013785; IPR006062; IPR010188; IPR023016; IPR011060; ,,priA,,Phosphoribosyl isomerase A (1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase) (EC 5.3.1.16) (N-(5'-phosphoribosyl)anthranilate isomerase) (PRAI) (EC 5.3.1.24) (Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase),cytoplasm [GO:0005737]; 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase activity [GO:0003949]; phosphoribosylanthranilate isomerase activity [GO:0004640]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; tryptophan biosynthetic process [GO:0000162],9634230; 12634849; 21969609,X-ray crystallography (4),FUNCTION: Involved in both the histidine and tryptophan biosynthetic pathways.,MPLILLPAVDVVEGRAVRLVQGKAGSQTEYGSAVDAALGWQRDGAEWIHLVDLDAAFGRGSNHELLAEVVGKLDVQVELSGGIRDDESLAAALATGCARVNVGTAALENPQWCARVIGEHGDQVAVGLDVQIIDGEHRLRGRGWETDGGDLWDVLERLDSEGCSRFVVTDITKDGTLGGPNLDLLAGVADRTDAPVIASGGVSSLDDLRAIATLTHRGVEGAIVGKALYARRFTLPQALAAVRD,"25,632",244,HisA/HisF family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; tryptophan biosynthetic process [GO:0000162],1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino]imidazole-4-carboxamide isomerase activity [GO:0003949]; phosphoribosylanthranilate isomerase activity [GO:0004640],cytoplasm [GO:0005737],hisA,MTCY336.01c MTV046.01,1
P9WPQ5,BIOD_MYCTU,Rv1570,bioD Rv1570 MTCY336.33c,GO:0000287; GO:0004141; GO:0005524; GO:0005829; GO:0009102,IPR004472; IPR027417; ,,bioD,,ATP-dependent dethiobiotin synthetase BioD (EC 6.3.3.3) (DTB synthetase) (DTBS) (Dethiobiotin synthase),cytosol [GO:0005829]; ATP binding [GO:0005524]; dethiobiotin synthase activity [GO:0004141]; magnesium ion binding [GO:0000287]; biotin biosynthetic process [GO:0009102],9634230; 21969609; 20565114,X-ray crystallography (5),"FUNCTION: Catalyzes a mechanistically unusual reaction, the ATP-dependent insertion of CO2 between the N7 and N8 nitrogen atoms of 7,8-diaminopelargonic acid (DAPA) to form an ureido ring. {ECO:0000255|HAMAP-Rule:MF_00336, ECO:0000269|PubMed:20565114}.",MTILVVTGTGTGVGKTVVCAALASAARQAGIDVAVCKPVQTGTARGDDDLAEVGRLAGVTQLAGLARYPQPMAPAAAAEHAGMALPARDQIVRLIADLDRPGRLTLVEGAGGLLVELAEPGVTLRDVAVDVAAAALVVVTADLGTLNHTKLTLEALAAQQVSCAGLVIGSWPDPPGLVAASNRSALARIAMVRAALPAGAASLDAGDFAAMSAAAFDRNWVAGLVG,"22,456",226,Dethiobiotin synthetase family,biotin biosynthetic process [GO:0009102],ATP binding [GO:0005524]; dethiobiotin synthase activity [GO:0004141]; magnesium ion binding [GO:0000287],cytosol [GO:0005829],,MTCY336.33c,1
P9WPQ7,BIOB_MYCTU,Rv1589,bioB Rv1589 MTCY336.15c,GO:0004076; GO:0005618; GO:0005886; GO:0009102; GO:0046872; GO:0051537; GO:0051539,IPR013785; IPR010722; IPR034416; IPR002684; IPR024177; IPR006638; IPR007197; ,,bioB,,Biotin synthase (EC 2.8.1.6),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; biotin synthase activity [GO:0004076]; metal ion binding [GO:0046872]; biotin biosynthetic process [GO:0009102]",9634230; 19099550; 21969609,,FUNCTION: Catalyzes the conversion of dethiobiotin (DTB) to biotin by the insertion of a sulfur atom into dethiobiotin via a radical-based mechanism. {ECO:0000255|HAMAP-Rule:MF_01694}.,MTQAATRPTNDAGQDGGNNSDILVVARQQVLQRGEGLNQDQVLAVLQLPDDRLEELLALAHEVRMRWCGPEVEVEGIISLKTGGCPEDCHFCSQSGLFASPVRSAWLDIPSLVEAAKQTAKSGATEFCIVAAVRGPDERLMAQVAAGIEAIRNEVEINIACSLGMLTAEQVDQLAARGVHRYNHNLETARSFFANVVTTHTWEERWQTLSMVRDAGMEVCCGGILGMGETLQQRAEFAAELAELGPDEVPLNFLNPRPGTPFADLEVMPVGDALKAVAAFRLALPRTMLRFAGGREITLGDLGAKRGILGGINAVIVGNYLTTLGRPAEADLELLDELQMPLKALNASL,"37,550",349,"Radical SAM superfamily, Biotin synthase family",biotin biosynthetic process [GO:0009102],"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; biotin synthase activity [GO:0004076]; metal ion binding [GO:0046872]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY336.15c,1
P9WMJ5,BLAI_MYCTU,Rv1846c,blaI Rv1846c,GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0045892; GO:0046677,IPR005650; IPR036388; IPR036390; ,,blaI,,Transcriptional regulator BlaI,"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609; 19154333,X-ray crystallography (1),"FUNCTION: Transcription regulator that binds to an inverted DNA repeat with the consensus sequence 5'-TAC[GT]AC-NNNNN-GT[AC]GTA-3' and regulates genes involved in antibiotic transport, detoxification and cell wall function. Also regulates its own transcription. Binds DNA as a dimer. {ECO:0000269|PubMed:19154333}.",MAKLTRLGDLERAVMDHLWSRTEPQTVRQVHEALSARRDLAYTTVMTVLQRLAKKNLVLQIRDDRAHRYAPVHGRDELVAGLMVDALAQAEDSGSRQAALVHFVERVGADEADALRRALAELEAGHGNRPPAGAATET,"15,211",138,BlaI transcriptional regulatory family,"negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytoplasm [GO:0005737],,,1
O07717,ACEAB_MYCTU,Rv1916 RVBD_1916,aceAb Rv1916 RVBD_1916 LH57_10435 P425_01981,GO:0004451; GO:0019752,IPR006254; IPR015813; ,,aceAb,,Putative isocitrate lyase subunit B (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase),isocitrate lyase activity [GO:0004451]; carboxylic acid metabolic process [GO:0019752],9634230; ,,"FUNCTION: Together with AceAa, they could catalyze the formation of succinate and glyoxylate from isocitrate. {ECO:0000305}.",MTYGEAVADVLEFGQSEGEPIGMAPEEWRAFAARASLHAARAKAKELGADPPWDCELAKTPEGYYQIRGGIPYAIAKSLAAAPFADILWMETKTADLADARQFAEAIHAEFPDQMLAYNLSPSFNWDTTGMTDEEMRRFPEELGKMGFVFNFITYGGHQIDGVAAEEFATALRQDGMLALARLQRKMRLVESPYRTPQTLVGGPRSDAALAASSGRTATTKAMGKGSTQHQHLVQTEVPRKLLEEWLAMWSGHYQLKDKLRVQLRPQRAGSEVLELGIHGESDDKLANVIFQPIQDRRGRTILLVRDQNTFGAELRQKRLMTLIHLWLVHRFKAQAVHYVTPTDDNLYQTSKMKSHGIFTEVNQEVGEIIVAEVNHPRIAELLTPDRVALRKLITKEA,"44,582",398,"Isocitrate lyase/PEP mutase superfamily, Isocitrate lyase family",carboxylic acid metabolic process [GO:0019752],isocitrate lyase activity [GO:0004451],,,LH57_10435 P425_01981,1
P95280,ACD17_MYCTU,Rv1934c,fadE17 Rv1934c LH57_10525,GO:0005618; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE17,,Putative acyl-CoA dehydrogenase FadE17 (EC 1.3.99.-),"cell wall [GO:0005618]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 19389781,,,MDVSYPPEAEAFRDRIREFVAEHLPPGWPGPGALPPHEREEFARHWRRALAGAGLVAVSWPTEYGGGGLSPMEQVVLAEEFARAGAPERAENDLLGIDLLGNTLIALGSEAQKRHFLPRILSGEHRWCQGFSEPEAGSDLASVRTRGVLDGDEWVINGHKIWTSAGTTANWIFLLARTDPSAAKHRGLSFLLVPMDQPGVVVRPIVNAAGHSSFSEVFLTDARTSAGNVVGRVGDGWSTAMTLLGFERGSHIATAAIDFERDLQRLCELARDRGLHTDPRVRDGLAWCYARVQIMRYRGYRDLTLALTGRPPGAEAAITKVIWSEYFRRYTDLAVEILGLEALGPRGPGNGGARLVPEAGTPNSPACWMDELLYARAATIYAGSSQIQRNVIGERLLGLPKEPRPEVLC,"44,684",409,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cell wall [GO:0005618],,LH57_10525,2
P9WQC1,ADHA_MYCTU,Rv1862,adhA Rv1862,GO:0004022; GO:0008270,IPR013154; IPR002328; IPR014187; IPR011032; IPR036291; ,,adhA,,Probable alcohol dehydrogenase AdhA (EC 1.1.1.1),alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],9634230; 19099550; 21969609,,,MVSPATTATMSAWQVRRPGPMDTGPLERVTTRVPRPAPSELLVAVHACGVCRTDLHVTEGDLPVHRERVIPGHEVVGEVIEVGSAVGAAAGGEFDRGDRVGIAWLRHTCGVCKYCRRGSENLCPQSRYTGWDADGGYAEFTTVPAAFAHHLPSGYSDSELAPLLCAGIIGYRSLLRTELPPGGRLGLYGFGGSAHITAQVALAQGAEIHVMTRGARARKLALQLGAASAQDAADRPPVPLDAAILFAPVGDLVLPALEALDRGGILAIAGIHLTDIPDLNYQQHLFQERQIRSVTSNTRADARAFFDFAAQHHIEVTTPEYPLGQADRALGDLSAGRIAGAAVLLI,"36,632",346,Zinc-containing alcohol dehydrogenase family,,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],,,,1
O65934,ABC1_MYCTU,Rv1747,Rv1747,GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0016021; GO:0042626,IPR003593; IPR013525; IPR003439; IPR017871; IPR000253; IPR027417; IPR008984; ,,,DOMAIN 29 78 FHA 1. {ECO:0000255|PROSITE-ProRule:PRU00086}.; DOMAIN 230 279 FHA 2. {ECO:0000255|PROSITE-ProRule:PRU00086}.; DOMAIN 319 552 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.; DOMAIN 596 810 ABC transmembrane type-2.,ABC transporter ATP-binding/permease protein Rv1747 (EC 3.6.3.-),"cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]",9634230; 15135525; 16040957; 15987910; 21622570; 21969609,,"FUNCTION: Involved in the translocation of an unknown substrate across the membrane. Transmembrane domains (TMD) form a pore in the membrane and the ATP-binding domain (NBD) is responsible for energy generation. Required for virulence. {ECO:0000269|PubMed:15135525, ECO:0000269|PubMed:16040957}.",MPMSQPAAPPVLTVRYEGSERTFAAGHDVVVGRDLRADVRVAHPLISRAHLLLRFDQGRWVAIDNGSLNGLYLNNRRVPVVDIYDAQRVHIGNPDGPALDFEVGRHRGSAGRPPQTTSIRLPNLSAGAWPTDGPPQTGTLGSGQLQQLPPATTRIPAAPPSGPQPRYPTGGQQLWPPSGPQRAPQIYRPPTAAPPPAGARGGTEAGNLATSMMKILRPGRLTGELPPGAVRIGRANDNDIVIPEVLASRHHATLVPTPGGTEIRDNRSINGTFVNGARVDAALLHDGDVVTIGNIDLVFADGTLARREENLLETRVGGLDVRGVTWTIDGDKTLLDGISLTARPGMLTAVIGPSGAGKSTLARLVAGYTHPTDGTVTFEGHNVHAEYASLRSRIGMVPQDDVVHGQLTVKHALMYAAELRLPPDTTKDDRTQVVARVLEELEMSKHIDTRVDKLSGGQRKRASVALELLTGPSLLILDEPTSGLDPALDRQVMTMLRQLADAGRVVLVVTHSLTYLDVCDQVLLLAPGGKTAFCGPPTQIGPVMGTTNWADIFSTVADDPDAAKARYLARTGPTPPPPPVEQPAELGDPAHTSLFRQFSTIARRQLRLIVSDRGYFVFLALLPFIMGALSMSVPGDVGFGFPNPMGDAPNEPGQILVLLNVGAVFMGTALTIRDLIGERAIFRREQAVGLSTTAYLIAKVCVYTVLAVVQSAIVTVIVLVGKGGPTQGAVALSKPDLELFVDVAVTCVASAMLGLALSAIAKSNEQIMPLLVVAVMSQLVFSGGMIPVTGRVPLDQMSWVTPARWGFAASAATVDLIKLVPGPLTPKDSHWHHTASAWWFDMAMLVALSVIYVGFVRWKIRLKAC,"92,153",865,ABC transporter superfamily; ABC-2 integral membrane protein family,,"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]",cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WPE3,CINAL_MYCTU,Rv1901,cinA Rv1901 MTCY180.17c,GO:0005886,IPR036653; IPR008136; IPR008135; IPR036425; IPR001453; ,,cinA,,CinA-like protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAVSARAGIVITGTEVLTGRVQDRNGPWIADRLLELGVELAHITICGDRPADIEAQLRFMAEQGVDLIVTSGGLGPTADDMTVEVVARYCGRELVLDDELENRIANILKKLMGRNPAIEPANFDSIRAANRKQAMIPAGSQVIDPVGTAPGLVVPGRPAVMVLPGPPRELQPIWSKAIQTAPVQDAIAGRTTYRQETIRIFGLPESSLADTLRDAEAAIPGFDLVEITTCLRRGEIEMVTRFEPNAAQVYTQLARLLRDRHGHQVYSEDGASVDELVAKLLTGRRIATAESCTAGLLAARLTDRPGSSKYVAGAVVAYSNEAKAQLLGVDPALIEAHGAVSEPVAQAMAAGALQGFGADTATAITGIAGPSGGTPEKPVGTVCFTVLLDDGRTTTRTVRLPGNRSDIRERSTTVAMHLLRRTLSGIPGSP,"45,512",430,CinA family,,,plasma membrane [GO:0005886],,MTCY180.17c,1
P9WPM1,CP139_MYCTU,Rv1666c,cyp139 Rv1666c MTV047.02c,GO:0004497; GO:0005506; GO:0005618; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002403; IPR036396; ,,cyp139,,Putative cytochrome P450 139 (EC 1.14.-.-),"cell wall [GO:0005618]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MRYPLGEALLALYRWRGPLINAGVGGHGYTYLLGAEANRFVFANADAFSWSQTFESLVPVDGPTALIVSDGADHRRRRSVVAPGLRHHHVQRYVATMVSNIDTVIDGWQPGQRLDIYQELRSAVRRSTAESLFGQRLAVHSDFLGEQLQPLLDLTRRPPQVMRLQQRVNSPGWRRAMAARKRIDDLIDAQIADARTAPRPDDHMLTTLISGCSEEGTTLSDNEIRDSIVSLITAGYETTSGALAWAIYALLTVPGTWESAASEVARVLGGRVPAADDLSALTYLNGVVHETLRLYSPGVISARRVLRDLWFDGHRIRAGRLLIFSAYVTHRLPEIWPEPTEFRPLRWDPNAADYRKPAPHEFIPFSGGLHRCIGAVMATTEMTVILARLVARAMLQLPAQRTHRIRAANFAALRPWPGLTVEIRKSAPAQ,"47,865",430,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618],,MTV047.02c,1
P9WPL1,CP144_MYCTU,Rv1777,cyp144 Rv1777 MTCY25C11.04,GO:0004497; GO:0005506; GO:0005618; GO:0016705; GO:0020037,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp144,,Cytochrome P450 144 (EC 1.14.-.-),"cell wall [GO:0005618]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 20621636,X-ray crystallography (1),,MRRSPKGSPGAVLDLQRRVDQAVSADHAELMTIAKDANTFFGAESVQDPYPLYERMRAAGSVHRIANSDFYAVCGWDAVNEAIGRPEDFSSNLTATMTYTAEGTAKPFEMDPLGGPTHVLATADDPAHAVHRKLVLRHLAAKRIRVMEQFTVQAADRLWVDGMQDGCIEWMGAMANRLPMMVVAELIGLPDPDIAQLVKWGYAATQLLEGLVENDQLVAAGVALMELSGYIFEQFDRAAADPRDNLLGELATACASGELDTLTAQVMMVTLFAAGGESTAALLGSAVWILATRPDIQQQVRANPELLGAFIEETLRYEPPFRGHYRHVRNATTLDGTELPADSHLLLLWGAANRDPAQFEAPGEFRLDRAGGKGHISFGKGAHFCVGAALARLEARIVLRLLLDRTSVIEAADVGGWLPSILVRRIERLELAVQ,"47,219",434,Cytochrome P450 family,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618],,MTCY25C11.04,1
P9WPL3,CP143_MYCTU,Rv1785c,cyp143 Rv1785c MTV049.07c,GO:0004497; GO:0005506; GO:0016705; GO:0020037,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp143,,Putative cytochrome P450 143 (EC 1.14.-.-),"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTTPGEDHAGSFYLPRLEYSTLPMAVDRGVGWKTLRDAGPVVFMNGWYYLTRREDVLAALRNPKVFSSRKALQPPGNPLPVVPLAFDPPEHTRYRRILQPYFSPAALSKALPSLRRHTVAMIDAIAGRGECEAMADLANLFPFQLFLVLYGLPLEDRDRLIGWKDAVIAMSDRPHPTEADVAAARELLEYLTAMVAERRRNPGPDVLSQVQIGEDPLSEIEVLGLSHLLILAGLDTVTAAVGFSLLELARRPQLRAMLRDNPKQIRVFIEEIVRLEPSAPVAPRVTTEPVTVGGMTLPAGSPVRLCMAAVNRDGSDAMSTDELVMDGKVHRHWGFGGGPHRCLGSHLARLELTLLVGEWLNQIPDFELAPDYAPEIRFPSKSFALKNLPLRWS,"43,541",393,Cytochrome P450 family,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTV049.07c,1
P9WPL9,CP140_MYCTU,Rv1880c,cyp140 Rv1880c MTCY180.38,GO:0004497; GO:0005506; GO:0016705; GO:0020037,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp140,,Putative cytochrome P450 140 (EC 1.14.-.-),"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MKDKLHWLAMHGVIRGIAAIGIRRGDLQARLIADPAVATDPVPFYDEVRSHGALVRNRANYLTVDHRLAHDLLRSDDFRVVSFGENLPPPLRWLERRTRGDQLHPLREPSLLAVEPPDHTRYRKTVSAVFTSRAVSALRDLVEQTAINLLDRFAEQPGIVDVVGRYCSQLPIVVISEILGVPEHDRPRVLEFGELAAPSLDIGIPWRQYLRVQQGIRGFDCWLEGHLQQLRHAPGDDLMSQLIQIAESGDNETQLDETELRAIAGLVLVAGFETTVNLLGNGIRMLLDTPEHLATLRQHPELWPNTVEEILRLDSPVQLTARVACRDVEVAGVRIKRGEVVVIYLAAANRDPAVFPDPHRFDIERPNAGRHLAFSTGRHFCLGAALARAEGEVGLRTFFDRFPDVRAAGAGSRRDTRVLRGWSTLPVTLGPARSMVSP,"48,872",438,Cytochrome P450 family,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCY180.38,1
O33194,G3PP_MYCTU,Rv1692 LH57_09220,Rv1692 LH57_09220,GO:0000121; GO:0000287; GO:0006071; GO:0030145; GO:0042803; GO:0046475; GO:0050897,IPR036412; IPR006357; IPR023214; ,,,,"D,L-glycerol 3-phosphate phosphatase (G3P phosphatase) (EC 3.1.3.21)",cobalt ion binding [GO:0050897]; glycerol-1-phosphatase activity [GO:0000121]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475],9634230; 21969609; 23801751,X-ray crystallography (1),"FUNCTION: Glycerol-phosphate phosphatase with a preference for D-glycerol 3-phosphate (sn-glycerol 1-phosphate) over L-glycerol 3-phosphate (sn-glycerol 3-phosphate). Is the final enzyme involved in the recycling/catabolism of glycerophospholipid polar heads. To a lesser extent, is also able to act on glycerol 2-phosphate and D-ribulose 5-phosphate, but cannot use D-glyceraldehyde 3-phosphate, dihydroxyacetone-phosphate, UMP or GMP as substrates. {ECO:0000269|PubMed:23801751}.",MKSIAQEHDCLLIDLDGTVFCGRQPTGGAVQSLSQVRSRKLFVTNNASRSADEVAAHLCELGFTATGEDVVTSAQSAAHLLAGQLAPGARVLIVGTEALANEVAAVGLRPVRRFEDRPDAVVQGLSMTTGWSDLAEAALAIRAGALWVAANVDPTLPTERGLLPGNGSMVAALRTATGMDPRVAGKPAPALMTEAVARGDFRAALVVGDRLDTDIEGANAAGLPSLMVLTGVNSAWDAVYAEPVRRPTYIGHDLRSLHQDSKLLAVAPQPGWQIDVGGGAVTVCANGDVDDLEFIDDGLSIVRAVASAVWEARAADLHQRPLRIEAGDERARAALQRWSLMRSDHPVTSVGTQ,"37,011",353,HAD-like hydrolase superfamily,glycerol metabolic process [GO:0006071]; glycerophospholipid catabolic process [GO:0046475],cobalt ion binding [GO:0050897]; glycerol-1-phosphatase activity [GO:0000121]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803],,,,1
P9WIT3,GULDH_MYCTU,Rv1771,Rv1771,GO:0003885; GO:0005618; GO:0005886; GO:0019853; GO:0050660; GO:0080049,IPR007173; IPR016166; IPR036318; IPR016167; IPR010031; IPR006094; IPR006093; IPR016171; ,,,DOMAIN 12 179 FAD-binding PCMH-type. {ECO:0000255|PROSITE-ProRule:PRU00718}.,"L-gulono-1,4-lactone dehydrogenase (EC 1.1.2.-)","cell wall [GO:0005618]; plasma membrane [GO:0005886]; D-arabinono-1,4-lactone oxidase activity [GO:0003885]; flavin adenine dinucleotide binding [GO:0050660]; L-gulono-1,4-lactone dehydrogenase activity [GO:0080049]; L-ascorbic acid biosynthetic process [GO:0019853]",9634230; 16956367; 21969609,,"FUNCTION: Oxidizes L-gulono-1,4-lactone to L-xylo-hexulonolactone which spontaneously isomerizes to L-ascorbate. Can use both cytochrome c and phenazine methosulfate as exogenous electron acceptors, but molecular oxygen does not serve as a substrate. Is very specific for the L-gulono-1,4-lactone substrate, since it can not oxidize L-galactono-1,4-lactone, D-glucurono-3,6-lactone, D-glucuronate, D-arabinose, or D-xylose. {ECO:0000269|PubMed:16956367}.",MSPIWSNWPGEQVCAPSAIVRPTSEAELADVIAQAAKRGERVRAVGSGHSFTDIACTDGVMIDMTGLQRVLDVDQPTGLVTVEGGAKLRALGPQLAQRRLGLENQGDVDPQSITGATATATHGTGVRFQNLSARIVSLRLVTAGGEVLSLSEGDDYLAARVSLGALGVISQVTLQTVPLFTLHRHDQRRSLAQTLERLDEFVDGNDHFEFFVFPYADKALTRTMHRSDEQPKPTPGWQRMVGENFENGGLSLICQTGRRFPSVAPRLNRLMTNMMSSSTVQDRAYKVFATQRKVRFTEMEYAIPRENGREALQRVIDLVRRRSLPIMFPIEVRFSAPDDSFLSTAYGRDTCYIAVHQYAGMEFESYFRAVEEIMDDYAGRPHWGKRHYQTAATLRERYPQWDRFAAVRDRLDPDRVFLNDYTRRVLGP,"48,045",428,Oxygen-dependent FAD-linked oxidoreductase family,L-ascorbic acid biosynthetic process [GO:0019853],"D-arabinono-1,4-lactone oxidase activity [GO:0003885]; flavin adenine dinucleotide binding [GO:0050660]; L-gulono-1,4-lactone dehydrogenase activity [GO:0080049]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WQ25,GLGX_MYCTU,Rv1564c,glgX treX Rv1564c MTCY48.01,GO:0004133; GO:0004553; GO:0005980,IPR006047; IPR004193; IPR013780; IPR011837; IPR017853; IPR013783; IPR014756; ,,glgX,,Glycogen operon protein GlgX homolog (EC 3.2.1.-),"glycogen debranching enzyme activity [GO:0004133]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; glycogen catabolic process [GO:0005980]",9634230; 21969609,,,MSSNNAGESDGTGPALPTVWPGNAYPLGATYDGAGTNFSLFSEIAEKVELCLIDEDGVESRIPLDEVDGYVWHAYLPNITPGQRYGFRVHGPFDPAAGHRCDPSKLLLDPYGKSFHGDFTFGQALYSYDVNAVDPDSTPPMVDSLGHTMTSVVINPFFDWAYDRSPRTPYHETVIYEAHVKGMTQTHPSIPPELRGTYAGLAHPVIIDHLNELNVTAVELMPVHQFLHDSRLLDLGLRNYWGYNTFGFFAPHHQYASTRQAGSAVAEFKTMVRSLHEAGIEVILDVVYNHTAEGNHLGPTINFRGIDNTAYYRLMDHDLRFYKDFTGTGNSLNARHPHTLQLIMDSLRYWVIEMHVDGFRFDLASTLARELHDVDRLSAFFDLVQQDPVVSQVKLIAEPWDVGEGGYQVGNFPGLWTEWNGKYRDTVRDYWRGEPATLGEFASRLTGSSDLYEATGRRPSASINFVTAHDGFTLNDLVSYNDKHNEANGENNRDGESYNRSWNCGVEGPTDDPDILALRARQMRNMWATLMVSQGTPMIAHGDEIGRTQYGNNNVYCQDSELSWMDWSLVDKNADLLAFARKATTLRKNHKVFRRRRFFEGEPIRSGDEVRDIAWLTPSGREMTHEDWGRGFDRCVAVFLNGEAITAPDARGERVVDDSFLLCFNAHDHDVEFVMPHDGYAQQWTGELDTNDPVGDIDLTVTATDTFSVPARSLLVLRKTL,"81,081",721,Glycosyl hydrolase 13 family,glycogen catabolic process [GO:0005980],"glycogen debranching enzyme activity [GO:0004133]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",,treX,MTCY48.01,1
P9WNS9,DTD_MYCTU,Rv1897c,dtd Rv1897c MTCY180.21,GO:0000049; GO:0002161; GO:0005737; GO:0006399; GO:0051500,IPR003732; IPR023509; ,,dtd,,D-aminoacyl-tRNA deacylase (DTD) (EC 3.1.1.96) (Gly-tRNA(Ala) deacylase) (EC 3.1.1.-),cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; tRNA metabolic process [GO:0006399],9634230; 19099550; 21969609,,"FUNCTION: An aminoacyl-tRNA editing enzyme that deacylates mischarged D-aminoacyl-tRNAs. Also deacylates mischarged glycyl-tRNA(Ala), protecting cells against glycine mischarging by AlaRS. Acts via tRNA-based rather than protein-based catalysis; rejects L-amino acids rather than detecting D-amino acids in the active site. By recycling D-aminoacyl-tRNA to D-amino acids and free tRNA molecules, this enzyme counteracts the toxicity associated with the formation of D-aminoacyl-tRNA entities in vivo and helps enforce protein L-homochirality. {ECO:0000255|HAMAP-Rule:MF_00518}.",MRVLVQRVSSAAVRVDGRVVGAIRPDGQGLVAFVGVTHGDDLDKARRLAEKLWNLRVLADEKSASDMHAPILVISQFTLYADTAKGRRPSWNAAAPGAVAQPLIAAFAAALRQLGAHVEAGVFGAHMQVELVNDGPVTVMLEG,"15,116",143,DTD family,tRNA metabolic process [GO:0006399],aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049],cytoplasm [GO:0005737],,MTCY180.21,1
P9WPI1,ECCA5_MYCTU,Rv1798,eccA5 Rv1798 MTV049.20,GO:0005524; GO:0005737; GO:0005886,IPR003593; IPR003959; IPR000641; IPR027417; IPR023835; IPR011990; ,,eccA5,,ESX-5 secretion system protein EccA5 (ESX conserved component A5) (Type VII secretion system protein EccA5) (T7SS protein EccA5),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524],9634230; 19876390; 21969609; 22340629; 22925462,,"FUNCTION: Part of the ESX-5 specialized secretion system, which is responsible for the secretion of EsxN and a number of PE_PGRS and PPE proteins, including PPE41 (PubMed:22340629, PubMed:22925462). EccA5 exhibits ATPase activity and may provide energy for the export of ESX-5 substrates (By similarity). {ECO:0000250|UniProtKB:P9WPH9, ECO:0000269|PubMed:22340629, ECO:0000269|PubMed:22925462}.",MTRPQAAAEDARNAMVAGLLASGISVNGLQPSHNPQVAAQMFTTATRLDPKMCDAWLARLLAGDQSIEVLAGAWAAVRTFGWETRRLGVTDLQFRPEVSDGLFLRLAITSVDSLACAYAAVLAEAKRYQEAAELLDATDPRHPFDAELVSYVRGVLYFRTKRWPDVLAQFPEATQWRHPELKAAGAAMATTALASLGVFEEAFRRAQEAIEGDRVPGAANIALYTQGMCLRHVGREEEAVELLRRVYSRDAKFTPAREALDNPNFRLILTDPETIEARTDPWDPDSAPTRAQTEAARHAEMAAKYLAEGDAELNAMLGMEQAKKEIKLIKSTTKVNLARAKMGLPVPVTSRHTLLLGPPGTGKTSVARAFTKQLCGLTVLRKPLVVETSRTKLLGRYMADAEKNTEEMLEGALGGAVFFDEMHTLHEKGYSQGDPYGNAIINTLLLYMENHRDELVVFGAGYAKAMEKMLEVNQGLRRRFSTVIEFFSYTPQELIALTQLMGRENEDVITEEESQVLLPSYTKFYMEQSYSEDGDLIRGIDLLGNAGFVRNVVEKARDHRSFRLDDEDLDAVLASDLTEFSEDQLRRFKELTREDLAEGLRAAVAEKKTK,"67,756",610,CbxX/CfxQ family,,ATP binding [GO:0005524],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV049.20,1
P9WMS1,DHMA2_MYCTU,Rv1833c,dhmA2 Rv1833c MTCY1A11.10,GO:0005576; GO:0005886; GO:0018786,IPR029058; IPR000073; IPR000639; IPR023489; ,,dhmA2,DOMAIN 35 134 AB hydrolase-1. {ECO:0000255}.,Haloalkane dehalogenase 2 (EC 3.8.1.5),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; haloalkane dehalogenase activity [GO:0018786],9634230; 21969609,,"FUNCTION: Catalyzes hydrolytic cleavage of carbon-halogen bonds in halogenated aliphatic compounds, leading to the formation of the corresponding primary alcohols, halide ions and protons. {ECO:0000250}.",MSIDFTPDPQLYPFESRWFDSSRGRIHYVDEGTGPPILLCHGNPTWSFLYRDIIVALRDRFRCVAPDYLGFGLSERPSGFGYQIDEHARVIGEFVDHLGLDRYLSMGQDWGGPISMAVAVERADRVRGVVLGNTWFWPADTLAMKAFSRVMSSPPVQYAILRRNFFVERLIPAGTEHRPSSAVMAHYRAVQPNAAARRGVAEMPKQILAARPLLARLAREVPATLGTKPTLLIWGMKDVAFRPKTIIPRLSATFPDHVLVELPNAKHFIQEDAPDRIAAAIIERFG,"32,151",286,"Haloalkane dehalogenase family, Type 1 subfamily",,haloalkane dehalogenase activity [GO:0018786],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY1A11.10,1
P9WNQ9,ECCB5_MYCTU,Rv1782,eccB5 Rv1782,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0016787,IPR007795; ,,eccB5,,ESX-5 secretion system ATPase EccB5 (EC 3.6.-.-) (ESX conserved component B5) (Type VII secretion system protein EccB5) (T7SS protein EccB5),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],9634230; 19876390; 21969609; 22340629; 22925462; 23284869; 26396239,,"FUNCTION: An ATPase (shown for residues 80-506) (PubMed:26396239). Part of the ESX-5 specialized secretion system, which is responsible for the secretion of EsxN and a number of PE_PGRS and PPE proteins, including PPE41. {ECO:0000269|PubMed:22340629, ECO:0000269|PubMed:22925462, ECO:0000269|PubMed:23284869}.",MAEESRGQRGSGYGLGLSTRTQVTGYQFLARRTAMALTRWRVRMEIEPGRRQTLAVVASVSAALVICLGALLWSFISPSGQLNESPIIADRDSGALYVRVGDRLYPALNLASARLITGRPDNPHLVRSSQIATMPRGPLVGIPGAPSSFSPKSPPASSWLVCDTVATSSSIGSLQGVTVTVIDGTPDLTGHRQILSGSDAVVLRYGGDAWVIREGRRSRIEPTNRAVLLPLGLTPEQVSQARPMSRALFDALPVGPELLVPEVPNAGGPATFPGAPGPIGTVIVTPQISGPQQYSLVLGDGVQTLPPLVAQILQNAGSAGNTKPLTVEPSTLAKMPVVNRLDLSAYPDNPLEVVDIREHPSTCWWWERTAGENRARVRVVSGPTIPVAATEMNKVVSLVKADTSGRQADQVYFGPDHANFVAVTGNNPGAQTSESLWWVTDAGARFGVEDSKEARDALGLTLTPSLAPWVALRLLPQGPTLSRADALVEHDTLPMDMTPAELVVPK,"53,721",506,EccB family,,ATP binding [GO:0005524]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJE3,ECCE5_MYCTU,Rv1797,eccE5 Rv1797,GO:0005829; GO:0005886; GO:0016021,IPR021368; ,,eccE5,,ESX-5 secretion system protein EccE5 (ESX conserved component E5) (Type VII secretion system protein EccE5) (T7SS protein EccE5),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 19876390; 21969609; 22340629; 22925462,,"FUNCTION: Part of the ESX-5 specialized secretion system, which is responsible for the secretion of EsxN and a number of PE_PGRS and PPE proteins, including PPE41. {ECO:0000269|PubMed:22340629, ECO:0000269|PubMed:22925462}.",MKAQRSFGLALSWPRVTAVFLVDVLILAVASHCPDSWQADHHVAWWVGVGVAAVVTLLSVVSYHGITVISGLATWVRDWSADPGTTLGAGCTPAIDHQRRFGRDTVGVREYNGRLVSVIEVTCGESGPSGRHWHRKSPVPMLPVVAVADGLRQFDIHLDGIDIVSVLVRGGVDAAKASASLQEWEPQGWKSEERAGDRTVADRRRTWLVLRMNPQRNVAAVACRDSLASTLVAATERLVQDLDGQSCAARPVTADELTEVDSAVLADLEPTWSRPGWRHLKHFNGYATSFWVTPSDITSETLDELCLPDSPEVGTTVVTVRLTTRVGSPALSAWVRYHSDTRLPKEVAAGLNRLTGRQLAAVRASLPAPTHRPLLVIPSRNLRDHDELVLPVGQELEHATSSFVGQ,"44,178",406,EccE family,,,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P95279,ECH13_MYCTU,Rv1935c,echA13 Rv1935c LH57_10530,GO:0006631; GO:0016829,IPR029045; IPR001753; ,,echA13,,Putative enoyl-CoA hydratase EchA13,lyase activity [GO:0016829]; fatty acid metabolic process [GO:0006631],9634230; 19389781,,,MFVGRVGPVDRRSDGERSRRPREFEYIRYETIDDGRIAAITLDRPKQRNAQTRGMLVELGAAFELAEADDTVRVVILRAAGPAFSAGHDLGSADDIRERSPGPDQHPSYRCNGATFGGVESRNRQEWHYYFENTKRWRNLRKITIAQVHGAVLSAGLMLAWCCDLIVASEDTVFADVVGTRLGMCGVEYFGHPWEFGPRKTKELLLTGDCIGADEAHALGMVSKVFPADELATSTIEFARRIAKVPTMAALLIKESVNQTVDAMGFSAALDGCFKIHQLNHAHWGEVTGGKLSYGTVEYGLEDWRAAPQIRPAIKQRP,"35,250",318,Enoyl-CoA hydratase/isomerase family,fatty acid metabolic process [GO:0006631],lyase activity [GO:0016829],,,LH57_10530,1
P9WP27,DAO_MYCTU,Rv1905c,aao Rv1905c,GO:0003884; GO:0046416; GO:0071949,IPR023209; IPR006076; ,,aao,,Probable D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3),D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949]; D-amino acid metabolic process [GO:0046416],9634230; 19099550; 21969609,,,MAIGEQQVIVIGAGVSGLTSAICLAEAGWPVRVWAAALPQQTTSAVAGAVWGPRPKEPVAKVRGWIEQSLHVFRDLAKDPATGVRMTPALSVGDRIETGAMPPGLELIPDVRPADPADVPGGFRAGFHATLPMIDMPQYLDCLTQRLAATGCEIETRPLRSLAEAAEAAPIVINCAGLGARELAGDATVWPRFGQHVVLTNPGLEQLFIERTGGSEWICYFAHPQRVVCGGISIPGRWDPTPEPEITERILQRCRRIQPRLAEAAVIETITGLRPDRPSVRVEAEPIGRALCIHNYGHGGDGVTLSWGCAREVVNLVGGG,"34,108",320,DAMOX/DASOX family,D-amino acid metabolic process [GO:0046416],D-amino-acid oxidase activity [GO:0003884]; FAD binding [GO:0071949],,,,1
P9WNU5,DPO1_MYCTU,Rv1629,polA Rv1629 MTCY01B2.21,GO:0003677; GO:0003887; GO:0005618; GO:0005737; GO:0005886; GO:0006261; GO:0006281; GO:0008408; GO:0008409; GO:0040007,IPR002562; IPR020046; IPR036279; IPR002421; IPR019760; IPR001098; IPR020045; IPR018320; IPR002298; IPR008918; IPR029060; IPR012337; IPR036397; ,,polA,DOMAIN 186 279 5'-3' exonuclease. {ECO:0000255}.; DOMAIN 317 493 3'-5' exonuclease. {ECO:0000255}.,DNA polymerase I (POL I) (EC 2.7.7.7),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; growth [GO:0040007],8294019; 9634230; 19099550; 21969609,,"FUNCTION: In addition to polymerase activity, this DNA polymerase exhibits 3'-5' and 5'-3' exonuclease activity.",MVTTASAPSEDRAKPTLMLLDGNSLAFRAFYALPAENFKTRGGLTTNAVYGFTAMLINLLRDEAPTHIAAAFDVSRQTFRLQRYPEYKANRSSTPDEFAGQIDITKEVLGALGITVLSEPGFEADDLIATLATQAENEGYRVLVVTGDRDALQLVSDDVTVLYPRKGVSELTRFTPEAVVEKYGLTPRQYPDFAALRGDPSDNLPGIPGVGEKTAAKWIAEYGSLRSLVDNVDAVRGKVGDALRANLASVVRNRELTDLVRDVPLAQTPDTLRLQPWDRDHIHRLFDDLEFRVLRDRLFDTLAAAGGPEVDEGFDVRGGALAPGTVRQWLAEHAGDGRRAGLTVVGTHLPHGGDATAMAVAAADGEGAYLDTATLTPDDDAALAAWLADPAKPKALHEAKAAVHDLAGRGWTLEGVTSDTALAAYLVRPGQRSFTLDDLSLRYLRRELRAETPQQQQLSLLDDDDTDAETIQTTILRARAVIDLADALDAELARIDSTALLGEMELPVQRVLAKMESAGIAVDLPMLTELQSQFGDQIRDAAEAAYGVIGKQINLGSPKQLQVVLFDELGMPKTKRTKTGYTTDADALQSLFDKTGHPFLQHLLAHRDVTRLKVTVDGLLQAVAADGRIHTTFNQTIAATGRLSSTEPNLQNIPIRTDAGRRIRDAFVVGDGYAELMTADYSQIEMRIMAHLSGDEGLIEAFNTGEDLHSFVASRAFGVPIDEVTGELRRRVKAMSYGLAYGLSAYGLSQQLKISTEEANEQMDAYFARFGGVRDYLRAVVERARKDGYTSTVLGRRRYLPELDSSNRQVREAAERAALNAPIQGSAADIIKVAMIQVDKALNEAQLASRMLLQVHDELLFEIAPGERERVEALVRDKMGGAYPLDVPLEVSVGYGRSWDAAAH,"98,472",904,DNA polymerase type-A family,DNA-dependent DNA replication [GO:0006261]; DNA repair [GO:0006281]; growth [GO:0040007],3'-5' exonuclease activity [GO:0008408]; 5'-3' exonuclease activity [GO:0008409]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY01B2.21,1
P9WNJ3,ESXN_MYCTU,Rv1793,esxN Rv1793 MTV049.15,GO:0005576; GO:0005886,IPR009416; IPR036689; IPR010310; ,,esxN,,ESAT-6-like protein EsxN,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 19876390; 21969609; 22925462; 22340629,,,MTINYQFGDVDAHGAMIRAQAASLEAEHQAIVRDVLAAGDFWGGAGSVACQEFITQLGRNFQVIYEQANAHGQKVQAAGNNMAQTDSAVGSSWA,"9,942",94,"WXG100 family, ESAT-6 subfamily",,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV049.15,1
O53943,ESPG5_MYCTU,Rv1794,espG5 Rv1794 LH57_09810,GO:0005618; GO:0005737; GO:0005886,IPR025734; ,,espG5,,ESX-5 secretion-associated protein EspG5,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],9634230; 21969609; 22340629; 25155747; 25275011,X-ray crystallography (3),FUNCTION: Specific chaperone for cognate PE/PPE proteins. Plays an important role in preventing aggregation of PE/PPE dimers. {ECO:0000269|PubMed:25155747}.,MDQQSTRTDITVNVDGFWMLQALLDIRHVAPELRCRPYVSTDSNDWLNEHPGMAVMREQGIVVNDAVNEQVAARMKVLAAPDLEVVALLSRGKLLYGVIDDENQPPGSRDIPDNEFRVVLARRGQHWVSAVRVGNDITVDDVTVSDSASIAALVMDGLESIHHADPAAINAVNVPMEEMLEATKSWQESGFNVFSGGDLRRMGISAATVAALGQALSDPAAEVAVYARQYRDDAKGPSASVLSLKDGSGGRIALYQQARTAGSGEAWLAICPATPQLVQVGVKTVLDTLPYGEWKTHSRV,"32,400",300,EspG family,,,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,LH57_09810,1
P9WIR7,APA_MYCTU,Rv1860,apa modD Rv1860 MTCY359.13,GO:0005576; GO:0009267; GO:0009986; GO:0050840; GO:0052559,IPR010801; ,,apa,,Alanine and proline-rich secreted protein Apa (45 kDa glycoprotein) (45/47 kDa antigen) (Antigen MPT-32) (FAP-B) (Fibronectin attachment protein) (Immunogenic protein MPT32),cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular matrix binding [GO:0050840]; cellular response to starvation [GO:0009267]; induction by symbiont of host immune response [GO:0052559],7558311; 9634230; 1898899; 7622204; 8626314; 10542234; 10531201; 12654810; 16092920; 21969609; 25359607,,"FUNCTION: A potent antigen in animals immunized with live bacteria, it induces a strong delayed-type hypersensitivity (DTH) in immunized animals (PubMed:10531201). Elicits a mostly Th1 type of T-cell response in healthy humans; induces IFN-gamma production from CD4(+) and CD8(+) cells (PubMed:12654810). Functions as an adhesin, binds to mouse macrophages via mannose residues (PubMed:10531201, PubMed:25359607). Might interact via host CD209 (PubMed:16092920). {ECO:0000269|PubMed:10531201, ECO:0000269|PubMed:12654810, ECO:0000269|PubMed:16092920, ECO:0000269|PubMed:25359607}.",MHQVDPNLTRRKGRLAALAIAAMASASLVTVAVPATANADPEPAPPVPTTAASPPSTAAAPPAPATPVAPPPPAAANTPNAQPGDPNAAPPPADPNAPPPPVIAPNAPQPVRIDNPVGGFSFALPAGWVESDAAHFDYGSALLSKTTGDPPFPGQPPPVANDTRIVLGRLDQKLYASAEATDSKAAARLGSDMGEFYMPYPGTRINQETVSLDANGVSGSASYYEVKFSDPSKPNGQIWTGVIGSPAANAPDAGPPQRWFVVWLGTANNPVDKGAAKALAESIRPLVAPPPAPAPAPAEPAPAPAPAGEVAPTPTTPTPQRTLPA,"32,721",325,Apa family,cellular response to starvation [GO:0009267]; induction by symbiont of host immune response [GO:0052559],extracellular matrix binding [GO:0050840],cell surface [GO:0009986]; extracellular region [GO:0005576],modD,MTCY359.13,1
P9WPY7,ARLY_MYCTU,Rv1659,argH Rv1659 MTCY06H11.24,GO:0004056; GO:0005618; GO:0005737; GO:0040007; GO:0042450,IPR029419; IPR009049; IPR024083; IPR020557; IPR000362; IPR022761; IPR008948; ,,argH,,Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007],9634230; 21969609,,,MSTNEGSLWGGRFAGGPSDALAALSKSTHFDWVLAPYDLTASRAHTMVLFRAGLLTEEQRDGLLAGLDSLAQDVADGSFGPLVTDEDVHAALERGLIDRVGPDLGGRLRAGRSRNDQVAALFRMWLRDAVRRVATGVLDVVGALAEQAAAHPSAIMPGKTHLQSAQPILLAHHLLAHAHPLLRDLDRIVDFDKRAAVSPYGSGALAGSSLGLDPDAIAADLGFSAAADNSVDATAARDFAAEAAFVFAMIAVDLSRLAEDIIVWSSTEFGYVTLHDSWSTGSSIMPQKKNPDIAELARGKSGRLIGNLAGLLATLKAQPLAYNRDLQEDKEPVFDSVAQLELLLPAMAGLVASLTFNVQRMAELAPAGYTLATDLAEWLVRQGVPFRSAHEAAGAAVRAAEQRGVGLQELTDDELAAISPELTPQVREVLTIEGSVSARDCRGGTAPGRVAEQLNAIGEAAERLRRQLVR,"49,774",470,"Lyase 1 family, Argininosuccinate lyase subfamily",arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007],argininosuccinate lyase activity [GO:0004056],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY06H11.24,1
P9WQ01,ARGB_MYCTU,Rv1654,argB Rv1654 MTCY06H11.19,GO:0003991; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006526; GO:0034618; GO:0040007,IPR036393; IPR004662; IPR037528; IPR001048; IPR001057; ,,argB,,Acetylglutamate kinase (EC 2.7.2.8) (N-acetyl-L-glutamate 5-phosphotransferase) (NAG kinase) (NAGK),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; acetylglutamate kinase activity [GO:0003991]; arginine binding [GO:0034618]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; growth [GO:0040007],9634230; 21969609; ,X-ray crystallography (1),FUNCTION: Catalyzes the ATP-dependent phosphorylation of N-acetyl-L-glutamate. {ECO:0000255|HAMAP-Rule:MF_00082}.,MSRIEALPTHIKAQVLAEALPWLKQLHGKVVVVKYGGNAMTDDTLRRAFAADMAFLRNCGIHPVVVHGGGPQITAMLRRLGIEGDFKGGFRVTTPEVLDVARMVLFGQVGRELVNLINAHGPYAVGITGEDAQLFTAVRRSVTVDGVATDIGLVGDVDQVNTAAMLDLVAAGRIPVVSTLAPDADGVVHNINADTAAAAVAEALGAEKLLMLTDIDGLYTRWPDRDSLVSEIDTGTLAQLLPTLESGMVPKVEACLRAVIGGVPSAHIIDGRVTHCVLVELFTDAGTGTKVVRG,"30,937",294,"Acetylglutamate kinase family, ArgB subfamily",arginine biosynthetic process [GO:0006526]; growth [GO:0040007],acetylglutamate kinase activity [GO:0003991]; arginine binding [GO:0034618]; ATP binding [GO:0005524],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY06H11.19,1
P9WPZ9,ARGC_MYCTU,Rv1652,argC Rv1652 MTCY06H11.17,GO:0003942; GO:0005737; GO:0006526; GO:0040007; GO:0046983; GO:0051287; GO:0070401,IPR023013; IPR000706; IPR036291; IPR000534; IPR012280; ,,argC,,N-acetyl-gamma-glutamyl-phosphate reductase (AGPR) (EC 1.2.1.38) (N-acetyl-glutamate semialdehyde dehydrogenase) (NAGSA dehydrogenase),cytoplasm [GO:0005737]; N-acetyl-gamma-glutamyl-phosphate reductase activity [GO:0003942]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; protein dimerization activity [GO:0046983]; arginine biosynthetic process [GO:0006526]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (3),FUNCTION: Catalyzes the NADPH-dependent reduction of N-acetyl-5-glutamyl phosphate to yield N-acetyl-L-glutamate 5-semialdehyde. {ECO:0000255|HAMAP-Rule:MF_00150}.,MQNRQVANATKVAVAGASGYAGGEILRLLLGHPAYADGRLRIGALTAATSAGSTLGEHHPHLTPLAHRVVEPTEAAVLGGHDAVFLALPHGHSAVLAQQLSPETLIIDCGADFRLTDAAVWERFYGSSHAGSWPYGLPELPGARDQLRGTRRIAVPGCYPTAALLALFPALAADLIEPAVTVVAVSGTSGAGRAATTDLLGAEVIGSARAYNIAGVHRHTPEIAQGLRAVTDRDVSVSFTPVLIPASRGILATCTARTRSPLSQLRAAYEKAYHAEPFIYLMPEGQLPRTGAVIGSNAAHIAVAVDEDAQTFVAIAAIDNLVKGTAGAAVQSMNLALGWPETDGLSVVGVAP,"36,304",352,"NAGSA dehydrogenase family, Type 1 subfamily",arginine biosynthetic process [GO:0006526]; growth [GO:0040007],N-acetyl-gamma-glutamyl-phosphate reductase activity [GO:0003942]; NAD binding [GO:0051287]; NADP+ binding [GO:0070401]; protein dimerization activity [GO:0046983],cytoplasm [GO:0005737],,MTCY06H11.17,1
P9WPZ7,ARGD_MYCTU,Rv1655,argD Rv1655 MTCY06H11.20,GO:0003992; GO:0005737; GO:0006526; GO:0030170; GO:0040007; GO:0042802,IPR004636; IPR005814; IPR015424; IPR015422; IPR015421; ,,argD,,Acetylornithine aminotransferase (ACOAT) (EC 2.6.1.11),cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity [GO:0003992]; pyridoxal phosphate binding [GO:0030170]; arginine biosynthetic process [GO:0006526]; growth [GO:0040007],9634230; 17259624; 19099550; 20066036; 21969609,,,MTGASTTTATMRQRWQAVMMNNYGTPPIALASGDGAVVTDVDGRTYIDLLGGIAVNVLGHRHPAVIEAVTRQMSTLGHTSNLYATEPGIALAEELVALLGADQRTRVFFCNSGAEANEAAFKLSRLTGRTKLVAAHDAFHGRTMGSLALTGQPAKQTPFAPLPGDVTHVGYGDVDALAAAVDDHTAAVFLEPIMGESGVVVPPAGYLAAARDITARRGALLVLDEVQTGMGRTGAFFAHQHDGITPDVVTLAKGLGGGLPIGACLAVGPAAELLTPGLHGSTFGGNPVCAAAALAVLRVLASDGLVRRAEVLGKSLRHGIEALGHPLIDHVRGRGLLLGIALTAPHAKDAEATARDAGYLVNAAAPDVIRLAPPLIIAEAQLDGFVAALPAILDRAVGAP,"40,910",400,"Class-III pyridoxal-phosphate-dependent aminotransferase family, ArgD subfamily",arginine biosynthetic process [GO:0006526]; growth [GO:0040007],identical protein binding [GO:0042802]; N2-acetyl-L-ornithine:2-oxoglutarate 5-aminotransferase activity [GO:0003992]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737],,MTCY06H11.20,1
P9WJP7,3MGH_MYCTU,Rv1688,Rv1688 MTCI125.10,GO:0003677; GO:0003905; GO:0006284,IPR011034; IPR003180; IPR036995; ,,,,Putative 3-methyladenine DNA glycosylase (EC 3.2.2.-),alkylbase DNA N-glycosylase activity [GO:0003905]; DNA binding [GO:0003677]; base-excision repair [GO:0006284],9634230; 21969609,,,MNAEELAIDPVAAAHRLLGATIAGRGVRAMVVEVEAYGGVPDGPWPDAAAHSYRGRNGRNDVMFGPPGRLYTYRSHGIHVCANVACGPDGTAAAVLLRAAAIEDGAELATSRRGQTVRAVALARGPGNLCAALGITMADNGIDLFDPSSPVRLRLNDTHRARSGPRVGVSQAADRPWRLWLTGRPEVSAYRRSSRAPARGASD,"21,340",203,DNA glycosylase MPG family,base-excision repair [GO:0006284],alkylbase DNA N-glycosylase activity [GO:0003905]; DNA binding [GO:0003677],,,MTCI125.10,1
O07718,ACEAA_MYCTU,Rv1915 RVBD_1915 LH57_10430,aceAa Rv1915 RVBD_1915 LH57_10430 P425_01980,GO:0004451; GO:0006097; GO:0006102; GO:0046421,IPR006254; IPR018523; IPR015813; ,,aceAa,,Putative isocitrate lyase subunit A (ICL) (EC 4.1.3.1) (Isocitrase) (Isocitratase),isocitrate lyase activity [GO:0004451]; methylisocitrate lyase activity [GO:0046421]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102],9634230; 21969609,,"FUNCTION: Together with AceAb, they could catalyze the formation of succinate and glyoxylate from isocitrate. {ECO:0000305}.",MAIAETDTEVHTPFEQDFEKDVAATQRYFDSSRFAGIIRLYTARQVVEQRGTIPVDHIVAREAAGAFYERLRELFAARKSITTFGPYSPGQAVSMKRMGIEAIYLGGWATSAKGSSTEDPGPDLASYPLSQVPDDAAVLVRALLTADRNQHYLRLQMSERQRAATPAYDFRPFIIADAGTGHGGDPHVRNLIRRFVEVGVPGYHIEDQRPGTKKCGHQGGKVLVPSDEQIKRLNAARFQLDIMRVPGIIVARTDAEAANLIDSRADERDQPFLLGATKLDVPSYKSCFLAMVRRFTNWASRSSMVIFSMRLATASTRRPAVGLSAKAFSAWSPTRSTRGGRTASSRSTAFSTRSSRGSWRPGRTTRA,"40,490",367,"Isocitrate lyase/PEP mutase superfamily, Isocitrate lyase family",glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102],isocitrate lyase activity [GO:0004451]; methylisocitrate lyase activity [GO:0046421],,,P425_01980,1
P9WFC9,Y1636_MYCTU,Rv1636,Rv1636 TB15.3,GO:0005618; GO:0005886; GO:0006950; GO:0046677,IPR014729; IPR006015; IPR006016; ,,,,Universal stress protein Rv1636 (USP Rv1636),cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to antibiotic [GO:0046677]; response to stress [GO:0006950],9634230; 21969609; ,X-ray crystallography (1),,MSAYKTVVVGTDGSDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAKVDVLIVHTT,"15,312",146,Universal stress protein A family,response to antibiotic [GO:0046677]; response to stress [GO:0006950],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,TB15.3,1
P9WGQ3,Y1714_MYCTU,Rv1714,Rv1714,GO:0005829; GO:0016491; GO:0040007,IPR036291; IPR002347; ,,,,Uncharacterized oxidoreductase Rv1714 (EC 1.-.-.-),cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; growth [GO:0040007],9634230; 19099550,,,MEEMALAQQVPNLGLARFSVQDKSILITGATGSLGRVAARALADAGARLTLAGGNSAGLAELVNGAGIDDAAVVTCRPDSLADAQQMVEAALGRYGRLDGVLVASGSNHVAPITEMAVEDFDAVMDANVRGAWLVCRAAGRVLLEQGQGGSVVLVSSVRGGLGNAAGYSAYCPSKAGTDLLAKTLAAEWGGHGIRVNALAPTVFRSAVTEWMFTDDPKGRATREAMLARIPLRRFAEPEDFVGALIYLLSDASSFYTGQVMYLDGGYTAC,"27,986",270,Short-chain dehydrogenases/reductases (SDR) family,growth [GO:0040007],oxidoreductase activity [GO:0016491],cytosol [GO:0005829],,,1
P9WFE5,UREF_MYCTU,Rv1851,ureF Rv1851 MTCY359.22c,GO:0005737; GO:0006807; GO:0016151,IPR002639; IPR038277; ,,ureF,,Urease accessory protein UreF,cytoplasm [GO:0005737]; nickel cation binding [GO:0016151]; nitrogen compound metabolic process [GO:0006807],7559354; 9634230,,FUNCTION: Required for maturation of urease via the functional incorporation of the urease nickel metallocenter. {ECO:0000255|HAMAP-Rule:MF_01385}.,MTSLAVLLTLADSRLPTGAHVHSGGIEEAIAAGMVTGLATLEAFLKRRVRTHGLLTASIAAAVHRGELAVDDADRETDARTPAPAARHASRSQGRGLIRLARRVWPDSGWEELGPRPHLAVVAGRVGALSGLAPEHNALHLVYITMTGSAIAAQRLLALDPAEVTVVTFQLSELCEQIAQEATAGLADLSDPLLDTLAQRHDERVRPLFVS,"22,356",211,UreF family,nitrogen compound metabolic process [GO:0006807],nickel cation binding [GO:0016151],cytoplasm [GO:0005737],,MTCY359.22c,1
P9WFE3,UREG_MYCTU,Rv1852,ureG Rv1852 MTCY359.21c,GO:0003924; GO:0005525; GO:0005737; GO:0006807; GO:0016151,IPR003495; IPR012202; IPR027417; IPR004400; ,,ureG,,Urease accessory protein UreG,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nickel cation binding [GO:0016151]; nitrogen compound metabolic process [GO:0006807],7559354; 9634230; 17309280; 21969609,,"FUNCTION: Facilitates the functional incorporation of the urease nickel metallocenter. This process requires GTP hydrolysis, probably effectuated by UreG. {ECO:0000255|HAMAP-Rule:MF_01389}.",MATHSHPHSHTVPARPRRVRKPGEPLRIGVGGPVGSGKTALVAALCRQLRGELSLAVLTNDIYTTEDADFLRTHAVLPDDRIAAVQTGGCPHTAIRDDITANLDAIDELMAAHDALDLILVESGGDNLTATFSSGLVDAQIFVIDVAGGDKVPRKGGPGVTYSDLLVVNKTDLAALVGADLAVMARDADAVRDGRPTVLQSLTEDPAASDVVAWVRSQLAADGV,"23,348",224,"SIMIBI class G3E GTPase family, UreG subfamily",nitrogen compound metabolic process [GO:0006807],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; nickel cation binding [GO:0016151],cytoplasm [GO:0005737],,MTCY359.21c,1
P9WFC7,UVRB_MYCTU,Rv1633,uvrB Rv1633 MTCY01B2.25,GO:0003677; GO:0004518; GO:0005524; GO:0005737; GO:0005886; GO:0006289; GO:0009380; GO:0009432; GO:0016887; GO:0051409; GO:0052556,IPR006935; IPR014001; IPR001650; IPR027417; IPR001943; IPR036876; IPR004807; IPR024759; ,,uvrB,DOMAIN 49 435 Helicase ATP-binding. {ECO:0000255|HAMAP-Rule:MF_00204}.; DOMAIN 453 606 Helicase C-terminal. {ECO:0000255|HAMAP-Rule:MF_00204}.; DOMAIN 674 709 UVR. {ECO:0000255|HAMAP-Rule:MF_00204}.,UvrABC system protein B (Protein UvrB) (Excinuclease ABC subunit B),cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; nucleotide-excision repair [GO:0006289]; positive regulation by symbiont of host immune response [GO:0052556]; response to nitrosative stress [GO:0051409]; SOS response [GO:0009432],9634230; 21969609,,"FUNCTION: The UvrABC repair system catalyzes the recognition and processing of DNA lesions. A damage recognition complex composed of 2 UvrA and 2 UvrB subunits scans DNA for abnormalities. Upon binding of the UvrA(2)B(2) complex to a putative damaged site, the DNA wraps around one UvrB monomer. DNA wrap is dependent on ATP binding by UvrB and probably causes local melting of the DNA helix, facilitating insertion of UvrB beta-hairpin between the DNA strands. Then UvrB probes one DNA strand for the presence of a lesion. If a lesion is found the UvrA subunits dissociate and the UvrB-DNA preincision complex is formed. This complex is subsequently bound by UvrC and the second UvrB is released. If no lesion is found, the DNA wraps around the other UvrB subunit that will check the other stand for damage. {ECO:0000255|HAMAP-Rule:MF_00204}.",MAFATEHPVVAHSEYRAVEEIVRAGGHFEVVSPHAPAGDQPAAIDELERRINAGERDVVLLGATGTGKSATTAWLIERLQRPTLVMAPNKTLAAQLANELREMLPHNAVEYFVSYYDYYQPEAYIAQTDTYIEKDSSINDDVERLRHSATSALLSRRDVVVVASVSCIYGLGTPQSYLDRSVELKVGEEVPRDGLLRLLVDVQYTRNDMSFTRGSFRVRGDTVEIIPSYEELAVRIEFFGDEIEALYYLHPLTGEVIRQVDSLRIFPATHYVAGPERMAHAVSAIEEELAERLAELESQGKLLEAQRLRMRTNYDIEMMRQVGFCSGIENYSRHIDGRGPGTPPATLLDYFPEDFLLVIDESHVTVPQIGGMYEGDISRKRNLVEYGFRLPSACDNRPLTWEEFADRIGQTVYLSATPGPYELSQTGGEFVEQVIRPTGLVDPKVVVKPTKGQIDDLIGEIRTRADADQRVLVTTLTKKMAEDLTDYLLEMGIRVRYLHSEVDTLRRVELLRQLRLGDYDVLVGINLLREGLDLPEVSLVAILDADKEGFLRSSRSLIQTIGRAARNVSGEVHMYADKITDSMREAIDETERRRAKQIAYNEANGIDPQPLRKKIADILDQVYREADDTAVVEVGGSGRNASRGRRAQGEPGRAVSAGVFEGRDTSAMPRAELADLIKDLTAQMMAAARDLQFELAARFRDEIADLKRELRGMDAAGLK,"80,407",719,UvrB family,nucleotide-excision repair [GO:0006289]; positive regulation by symbiont of host immune response [GO:0052556]; response to nitrosative stress [GO:0051409]; SOS response [GO:0009432],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; nuclease activity [GO:0004518],cytoplasm [GO:0005737]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886],,MTCY01B2.25,2
P9WFF1,URE1_MYCTU,Rv1850,ureC Rv1850 MTCY359.23c,GO:0005737; GO:0009039; GO:0016151; GO:0040007; GO:0043419,IPR006680; IPR011059; IPR032466; IPR011612; IPR017950; IPR005848; IPR017951; IPR029754; ,,ureC,DOMAIN 136 577 Urease. {ECO:0000255|HAMAP-Rule:MF_01953}.,Urease subunit alpha (EC 3.5.1.5) (Urea amidohydrolase subunit alpha),cytoplasm [GO:0005737]; nickel cation binding [GO:0016151]; urease activity [GO:0009039]; growth [GO:0040007]; urea catabolic process [GO:0043419],7559354; 7568014; 9634230; 19099550; 21969609,,,MARLSRERYAQLYGPTTGDRIRLADTNLLVEVTEDRCGGPGLAGDEAVFGGGKVLRESMGQGRASRADGAPDTVITGAVIIDYWGIIKADIGIRDGRIVGIGKAGNPDIMTGVHRDLVVGPSTEIISGNRRIVTAGTVDCHVHLICPQIIVEALAAGTTTIIGGGTGPAEGTKATTVTPGEWHLARMLESLDGWPVNFALLGKGNTVNPDALWEQLRGGASGFKLHEDWGSTPAAIDTCLAVADVAGVQVALHSDTLNETGFVEDTIGAIAGRSIHAYHTEGAGGGHAPDIITVAAQPNVLPSSTNPTRPHTVNTLDEHLDMLMVCHHLNPRIPEDLAFAESRIRPSTIAAEDVLHDMGAISMIGSDSQAMGRVGEVVLRTWQTAHVMKARRGALEGDPSGSQAADNNRVRRYIAKYTICPAIAHGMDHLIGSVEVGKLADLVLWEPAFFGVRPHVVLKGGAIAWAAMGDANASIPTPQPVLPRPMFGAAAATAAATSVHFVAPQSIDARLADRLAVNRGLAPVADVRAVGKTDLPLNDALPSIEVDPDTFTVRIDGQVWQPQPAAELPMTQRYFLF,"60,825",577,"Metallo-dependent hydrolases superfamily, Urease alpha subunit family",growth [GO:0040007]; urea catabolic process [GO:0043419],nickel cation binding [GO:0016151]; urease activity [GO:0009039],cytoplasm [GO:0005737],,MTCY359.23c,1
P9WFE9,URE2_MYCTU,Rv1849,ureB Rv1849 MTCY359.24c,GO:0005737; GO:0009039; GO:0043419,IPR002019; IPR036461; ,,ureB,,Urease subunit beta (EC 3.5.1.5) (Urea amidohydrolase subunit beta),cytoplasm [GO:0005737]; urease activity [GO:0009039]; urea catabolic process [GO:0043419],7559354; 7568014; 9634230; 21969609,,,MIPGEIFYGSGDIEMNAAALSRLQMRIINAGDRPVQVGSHVHLPQANRALSFDRATAHGYRLDIPAATAVRFEPGIPQIVGLVPLGGRREVPGLTLNPPGRLDR,"11,190",104,Urease beta subunit family,urea catabolic process [GO:0043419],urease activity [GO:0009039],cytoplasm [GO:0005737],,MTCY359.24c,1
P9WFE7,URE3_MYCTU,Rv1848,ureA Rv1848 MTCY359.25c,GO:0005737; GO:0009039; GO:0016151; GO:0043419,IPR012010; IPR002026; IPR036463; ,,ureA,,Urease subunit gamma (EC 3.5.1.5) (Urea amidohydrolase subunit gamma),cytoplasm [GO:0005737]; nickel cation binding [GO:0016151]; urease activity [GO:0009039]; urea catabolic process [GO:0043419],7559354; 7568014; 9634230; 21969609,X-ray crystallography (1),,MRLTPHEQERLLLSYAAELARRRRARGLRLNHPEAIAVIADHILEGARDGRTVAELMASGREVLGRDDVMEGVPEMLAEVQVEATFPDGTKLVTVHQPIA,"11,090",100,Urease gamma subunit family,urea catabolic process [GO:0043419],nickel cation binding [GO:0016151]; urease activity [GO:0009039],cytoplasm [GO:0005737],,MTCY359.25c,1
P9WHK7,PYRG_MYCTU,Rv1699,pyrG Rv1699 MTCI125.21,GO:0003883; GO:0005524; GO:0005886; GO:0006541; GO:0040007; GO:0044210; GO:0046872,IPR029062; IPR004468; IPR017456; IPR017926; IPR033828; IPR027417; ,,pyrG,DOMAIN 303 551 Glutamine amidotransferase type-1. {ECO:0000255|HAMAP-Rule:MF_01227}.,CTP synthase (EC 6.3.4.2) (Cytidine 5'-triphosphate synthase) (Cytidine triphosphate synthetase) (CTP synthetase) (CTPS) (UTP--ammonia ligase),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872]; 'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]; growth [GO:0040007],9634230; 21969609; 26097035,X-ray crystallography (3),"FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with either L-glutamine or ammonia as the source of nitrogen. Is essential for M.tuberculosis growth in vitro and ex vivo (PubMed:26097035). Regulates intracellular CTP levels through interactions with the four ribonucleotide triphosphates (By similarity). {ECO:0000255|HAMAP-Rule:MF_01227, ECO:0000269|PubMed:26097035}.",MRKHPQTATKHLFVSGGVASSLGKGLTASSLGQLLTARGLHVTMQKLDPYLNVDPGTMNPFQHGEVFVTEDGAETDLDVGHYERFLDRNLPGSANVTTGQVYSTVIAKERRGEYLGDTVQVIPHITDEIKRRILAMAQPDADGNRPDVVITEIGGTVGDIESQPFLEAARQVRHYLGREDVFFLHVSLVPYLAPSGELKTKPTQHSVAALRSIGITPDALILRCDRDVPEALKNKIALMCDVDIDGVISTPDAPSIYDIPKVLHREELDAFVVRRLNLPFRDVDWTEWDDLLRRVHEPHETVRIALVGKYVELSDAYLSVAEALRAGGFKHRAKVEICWVASDGCETTSGAAAALGDVHGVLIPGGFGIRGIEGKIGAIAYARARGLPVLGLCLGLQCIVIEAARSVGLTNANSAEFDPDTPDPVIATMPDQEEIVAGEADLGGTMRLGSYPAVLEPDSVVAQAYQTTQVSERHRHRYEVNNAYRDKIAESGLRFSGTSPDGHLVEFVEYPPDRHPFVVGTQAHPELKSRPTRPHPLFVAFVGAAIDYKAGELLPVEIPEIPEHTPNGSSHRDGVGQPLPEPASRG,"63,635",586,CTP synthase family,'de novo' CTP biosynthetic process [GO:0044210]; glutamine metabolic process [GO:0006541]; growth [GO:0040007],ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,MTCI125.21,1
P9WJ63,TLYA_MYCTU,Rv1694,tlyA Rv1694,GO:0003723; GO:0005576; GO:0005618; GO:0005737; GO:0008649; GO:0016020; GO:0019836; GO:0020002; GO:0031167; GO:0090729,IPR004538; IPR002877; IPR002942; IPR036986; IPR029063; ,,tlyA,DOMAIN 5 67 S4 RNA-binding. {ECO:0000255|PROSITE-ProRule:PRU00182}.,16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyA (EC 2.1.1.226) (EC 2.1.1.227) (16S rRNA (cytidine1409-2'-O)-methyltransferase) (23S rRNA (cytidine1920-2'-O)-methyltransferase) (Hemolysin TlyA),cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; toxin activity [GO:0090729]; hemolysis by symbiont of host erythrocytes [GO:0019836]; rRNA methylation [GO:0031167],9611795; 9634230; 15673735; 16857584; 20854656; 21969609; 21443791; 26347855; 25847237,X-ray crystallography (2),"FUNCTION: Acts as a host evasion factor, that significantly contributes to the pathogenesis of M.tuberculosis by modulating adaptive immune responses by inhibiting host-protective Th1 and Th17 cytokine responses as well as autophagy (PubMed:25847237). Catalyzes the 2'-O-methylation at nucleotides C1409 in 16S rRNA and C1920 in 23S rRNA (PubMed:16857584, PubMed:20854656). Is likely involved in ribosomal biogenesis (PubMed:21443791). Also exhibits hemolytic activity in vitro, by binding with and oligomerizing into host cell membranes (PubMed:20854656, PubMed:9611795). {ECO:0000269|PubMed:16857584, ECO:0000269|PubMed:20854656, ECO:0000269|PubMed:21443791, ECO:0000269|PubMed:25847237, ECO:0000269|PubMed:9611795}.",MARRARVDAELVRRGLARSRQQAAELIGAGKVRIDGLPAVKPATAVSDTTALTVVTDSERAWVSRGAHKLVGALEAFAIAVAGRRCLDAGASTGGFTEVLLDRGAAHVVAADVGYGQLAWSLRNDPRVVVLERTNARGLTPEAIGGRVDLVVADLSFISLATVLPALVGCASRDADIVPLVKPQFEVGKGQVGPGGVVHDPQLRARSVLAVARRAQELGWHSVGVKASPLPGPSGNVEYFLWLRTQTDRALSAKGLEDAVHRAISEGP,"28,074",268,TlyA family,hemolysis by symbiont of host erythrocytes [GO:0019836]; rRNA methylation [GO:0031167],RNA binding [GO:0003723]; rRNA methyltransferase activity [GO:0008649]; toxin activity [GO:0090729],cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell plasma membrane [GO:0020002]; membrane [GO:0016020],,,1
P9WFT1,SYY_MYCTU,Rv1689,tyrS Rv1689 MTCI125.11,GO:0003723; GO:0004831; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006437; GO:0040007; GO:0043039,IPR001412; IPR002305; IPR014729; IPR002942; IPR036986; IPR002307; IPR024088; IPR024107; ,,tyrS,DOMAIN 356 413 S4 RNA-binding. {ECO:0000255|HAMAP-Rule:MF_02006}.,Tyrosine--tRNA ligase (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831]; growth [GO:0040007]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr). {ECO:0000255|HAMAP-Rule:MF_02006}.,MSGMILDELSWRGLIAQSTDLDTLAAEAQRGPMTVYAGFDPTAPSLHAGHLVPLLTLRRFQRAGHRPIVLAGGATGMIGDPRDVGERSLNEADTVAEWTERIRGQLERFVDFDDSPMGAIVENNLEWTGSLSAIEFLRDIGKHFSVNVMLARDTIRRRLAGEGISYTEFSYLLLQANDYVELHRRHGCTLQIGGADQWGNIIAGVRLVRQKLGATVHALTVPLVTAADGTKFGKSTGGGSLWLDPQMTSPYAWYQYFVNTADADVIRYLRWFTFLSADELAELEQATAQRPQQRAAQRRLASELTVLVHGEAATAAVEHASRALFGRGELARLDEATLAAALRETTVAELKPGSPDGIVDLLVASGLSASKGAARRTIHEGGVSVNNIRVDNEEWVPQSSDFLHGRWLVLRRGKRSIAGVERIG,"46,330",424,"Class-I aminoacyl-tRNA synthetase family, TyrS type 1 subfamily",growth [GO:0040007]; tRNA aminoacylation [GO:0043039]; tyrosyl-tRNA aminoacylation [GO:0006437],ATP binding [GO:0005524]; RNA binding [GO:0003723]; tyrosine-tRNA ligase activity [GO:0004831],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCI125.11,1
O07751,O07751_MYCTU,Rv1879,Rv1879,GO:0016787,IPR006680; IPR032466; ,,,,Uncharacterized protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MADSAGSDLTRHTAEVPLIDQHVHGCWLTEGNRRRFENALNEANTEPLADFDSGFDSQLGFAVRNHCAPILGLPRHVDPQTYWDRRSQFSEAELARRFLQAAGVTDWLVETGIGYDVSGMASVAGLGELSGSHAHEVVRLEQVAEQAVQASGDYASAFNEILRRRAATAVATKSILAYRGGFDGDLTEPPAAQVAEAAKRWRDRGGVRLQDRVLLRFGLHQALRLGKPLQFHVGFGDRDADLHKANPLYLLDFLRQSGNTPIVLLHCYPYEREAGYLAQAFNNVYLDGGLSVHYLGARSPAFIGRLLELAPFRKIVYSSDGFGPAELHFLGATLWRSGIQRVLRGFVERDDWCETDALRVVDLIAHGTAARIYRLGDR,"41,865",378,,,hydrolase activity [GO:0016787],,,,1
P94983,P94983_MYCTU,Rv1648,Rv1648,GO:0005576; GO:0016021,,,,,Probable transmembrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MIYRVACLLARIRFTVGYVAALASVSTTILMHGPQVHAQVIRHASTNLHNLAHGHLGTLWNSAFVIDEGPLYFWLPCLACLLAVAELQLRSLRLTVAFVVGHIGATLLVAAVLAGAIEIGWLPWSISRVSDVGMSYGALAALGALTAAIPGRWRPAWIGWWVSLGLATATIGGGFTDAGHTVALLLGMLVTACFTRPARWTLGRCALLAVASGFCLVLLAHSWWSLVSGSALGLLGALGAAGFARWTRARATSLPPGALAIPQPALSR,"28,142",268,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O06793,O06793_MYCTU,Rv1758,cut1 Rv1758,GO:0008152; GO:0016787,IPR029058; IPR000675; ,,cut1,DOMAIN 2 173 Cutinase. {ECO:0000259|SMART:SM01110}.,Probable cutinase Cut1,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230,,,MPGRFREDFIDALRSKIGEKSMGVYGVDYPATTDFPTAMAGIYDAGTHVEQTAANCPQSKLVLGGFSQGAAVMGFVTAAAIPDGAPLDAPRPMPPEVADHVAAVTLFGMPSVAFMHSIGAPPIVIGPLYAEKTIQLCAPGDPVCSSGGNWAAHNGYADDGMVEQAAVFAAGRLG,"17,868",174,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
O06132,O06132_MYCTU,Rv1615,Rv1615,GO:0016021,IPR007829; ,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGLRPARVVRPARSGMLKGVTDPLQHGAFEPGWQSAPPGYPPPYPQYPGPGSYFDPFAPYGRHPVTGQPFSDKSKTVAGLLQLLGLFGIAGIGRIYLGHTGLGIAQLLVGWVTCGLGAVIWGVIDALLILTDKVGDPWGRPLRDGS,"15,442",146,,,,integral component of membrane [GO:0016021],,,1
O53953,O53953_MYCTU,Rv1804c,Rv1804c,GO:0005576,IPR007969; ,,,,Conserved protein,extracellular region [GO:0005576],9634230,,,MRVVSTLLSIPLMIGLAVPAHAGPSGDDAVFLASLERAGITYSHPDQAIASGKAVCALVESGESGLQVVNELRTRNPGFSMDGCCKFAAISAHVYCPHQITKTSVSAK,"11,198",108,,,,extracellular region [GO:0005576],,,3
I6XYM2,I6XYM2_MYCTU,Rv1677,dsbF Rv1677,GO:0005623; GO:0016209; GO:0016491; GO:0045454,IPR000866; IPR036249; IPR017937; IPR013766; ,,dsbF,,Probable conserved lipoprotein DsbF,cell [GO:0005623]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; cell redox homeostasis [GO:0045454],9634230; 21969609,,,MTHSRLIGALTVVAIIVTACGSQPKSQPAVAPTGDAAAATQVPAGQTVPAQLQFSAKTLDGHDFHGESLLGKPAVLWFWAPWCPTCQGEAPVVGQVAASHPEVTFVGVAGLDQVPAMQEFVNKYPVKTFTQLADTDGSVWANFGVTQQPAYAFVDPHGNVDVVRGRMSQDELTRRVTALTSR,"19,238",182,,cell redox homeostasis [GO:0045454],antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],cell [GO:0005623],,,1
O07743,O07743_MYCTU,Rv1889c,Rv1889c,GO:0008168,IPR007213; IPR029063; ,,,,Uncharacterized protein,methyltransferase activity [GO:0008168],9634230,,,MPRTNNDAWDLATSVGATATMVAAARAVATRADNPLIDDPFAEPLVRAVGIDFFTRWAAGNIKATDVDDPDGTWGLQRLADLLAARTRYFDAFFRDATSAGIRQAVILASGLDARAYR,"12,716",118,,,methyltransferase activity [GO:0008168],,,,1
O06623,O06623_MYCTU,Rv1567c,Rv1567c,GO:0005576; GO:0016021,,,,,Probable hypothetical membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MVTMTSWPSRLFAFTDNVCPPDACPLVPFGVNYYIYPVMWGGIGAAIATAVIGPFVSMLKGWYMSFWPIISIAVITVTSIAGYAIAGFSERYWH,"10,362",94,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O06605,O06605_MYCTU,Rv1585c,Rv1585c,,,,,,Possible phage PhiRv1 protein,,9634230; 21969609,,,MSRHHNIVIVCDHGRKGDGRIEHERCDLVAPIIWVDETQGWLPQAPAVATLLDDDNQPRAVIGLPPNESRLRPEMRRDGWVRLHWEFACLRYGAAGVRTCEQRPVRVRNGDLQTLCENVPRLLTGLAGNPDYAPGFAVQSDAVVVAMWLWRTLCESDTPNKLRATPTRGSC,"19,213",171,,,,,,,1
L7N669,L7N669_MYCTU,Rv1940,ribA1 Rv1940,GO:0008686; GO:0009231; GO:0016787; GO:0046872,IPR017945; IPR000422; IPR032677; IPR036144; ,,ribA1,,Probable riboflavin biosynthesis protein RibA1 (GTP cyclohydrolase II),"3,4-dihydroxy-2-butanone-4-phosphate synthase activity [GO:0008686]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; riboflavin biosynthetic process [GO:0009231]",9634230,,,MKTTDVRVRRAITAMAGGHAVVLTGDPNGDGYLVFAAQAATPRLVAFAVRHTSGYLRVALPGAECERLHLPPMCDRDTTHCVSVDVRGTGTGISASDRAWTIAALASATSVAADFQRPGHVVPVQAQADGVLGRRGPAEAAVDLARLAERRPAAALCEIVSPDNPVQMAHHAESVEFAVEHGLAMVSIGELVAYRRRIEPQVVRFTAATLPTWAGASRVIGFRDVYDLGEHLAVIVGAVGAGVPVPLHVHIECLTGDVFGSTACRCGEELNGALARMSAQGSGVVLYLRPPGPAQACGLFARGDAATDVMPETVTWILRDLGVYAIRLSDDVPGFGLVMFGAIREASTLAAAG,"36,869",353,DHBP synthase family,riboflavin biosynthetic process [GO:0009231],"3,4-dihydroxy-2-butanone-4-phosphate synthase activity [GO:0008686]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]",,,,1
O07749,O07749_MYCTU,Rv1882c,Rv1882c,GO:0005886; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MKAIFITGAGSGMGREGATLFHANGWRVGAIDRNEDGLAALRVQLGAERLWARAVDVTDKAALEGALADFCAGNVGGGLDMMWNNAGIGEGGWFEDVPYEAAVRVVDVNFKAVLTGAYAALPYLKKAPGSLMFSTSSSSGTYGMPRIAVYSATKHAVKGLTEALSVEWQRHGVRVADVLPGLIDTAILTSTRQHSDEGPYTISAEQIRAAAPKKGMFRLMPSSSVAEAAWRAYQHPTRLHWYVPRSIRWIDRLKGVSPEFVRRHIAKSLATLEPKRK,"30,010",277,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
O06139,O06139_MYCTU,Rv1622c,cydB Rv1622c,GO:0016021; GO:0040007; GO:0055114,IPR003317; ,,cydB,,Probable integral membrane cytochrome D ubiquinol oxidase (Subunit II) CydB (Cytochrome BD-I oxidase subunit II),integral component of membrane [GO:0016021]; growth [GO:0040007]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MVLQELWFGVIAALFLGFFILEGFDFGVGMLMAPFAHVGMGDPETHRRTALNTIGPVWDGNEVWLITAGAAIFAAFPGWYATVFSALYLPLLAILFGMILRAVAIEWRGKIDDPKWRTGADFGIAAGSWLPALLWGVAFAILVRGLPVDANGHVALSIPDVLNAYTLLGGLATAGLFSLYGAVFIALKTSGPIRDDAYRFAVWLSLPVAGLVAGFGLWTQLAYGKDWTWLVLAVAGCAQAAATVLVWRRVSDGWAFMCTLIVVAAVVVLLFGALYPNLVPSTLNPQWSLTIHNASSTPYTLKIMTWVTAFFAPLTVAYQTWTYWVFRQRISAERIPPPTGLARRAP,"37,627",346,,growth [GO:0040007]; oxidation-reduction process [GO:0055114],,integral component of membrane [GO:0016021],,,1
O33198,O33198_MYCTU,Rv1697,Rv1697,GO:0004788; GO:0005524; GO:0009229; GO:0016021; GO:0040007,IPR036759; IPR022215; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; thiamine diphosphokinase activity [GO:0004788]; growth [GO:0040007]; thiamine diphosphate biosynthetic process [GO:0009229],9634230; 21969609,,,MRMSALLSRNTSRPGLIGIARVDRNIDRLLRRVCPGDIVVLDVLDLDRITADALVEAEIAAVVNASSSVSGRYPNLGPEVLVTNGVTLIDETGPEIFKKVKDGAKVRLYEGGVYAGDRRLIRGTERTDHDIADLMREAKSGLVAHLEAFAGNTIEFIRSESPLLIDGIGIPDVDVDLRRRHVVIVADEPSGPDDLKSLKPFIKEYQPVLVGVGTGADVLRKAGYRPQLIVGDPDQISTEVLKCGAQVVLPADADGHAPGLERIQDLGVGAMTFPAAGSATDLALLLADHHGAALLVTAGHAANIETFFDRTRVQSNPSTFLTRLRVGEKLVDAKAVATLYRNHISGGAIALLALTMLIAIIVALWVSRTDGVVLHWIIDYWNRFSLWVQHLVS,"42,423",393,,growth [GO:0040007]; thiamine diphosphate biosynthetic process [GO:0009229],ATP binding [GO:0005524]; thiamine diphosphokinase activity [GO:0004788],integral component of membrane [GO:0016021],,,1
P95278,P95278_MYCTU,Rv1936,Rv1936,GO:0004497; GO:0016705,IPR011251; IPR036661; ,,,,Possible monooxygenase,"monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MEIGIFLMPAHPPERTLYDATRWDLDVIELADQLGYVEAWVGEHFTVPWEPICAPDLLLAQALLRTQQIKLAPGAHLLPYHHPVELAHRVAYFDHLAQGRFMLGVGASGIPGDWALYDVDGKNGEHREMTREALEIMLRIWTEDEPWEHRGKYWNANGIAPMFEGLMRRHIKPYQKPHPPIGVTGFSAGSETLKLAGERGYIPMSLDLNTEYVATHWDAVEEGALRSGRTPDRRDWRLVREVLVAETDEQAFRYAVDGTMGRAMREYVLPTFRMFGMTKFYKHNPSVPDDEVTPEYLAENTFVVGSVQTVVDKLEATYDQVGGFGHLLILGFDYSDNPGPWKESLRLLAHEVMPRLNARLATKPATAVV,"41,830",369,,,"monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
P71982,P71982_MYCTU,Rv1724c,Rv1724c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MVGNEENELQDLRNLRRPCFSRAEAPIGVYNGEQAIIVYDLRPVPHWPKYWIQALAKHFQRQLKPSPKIDISLLDDRIRFSVFVSTDVSAKDLCKLDDAVYNAVRNAGRAIENEQAALDHKLAEVRKRRMDTWDESYFR,"16,229",139,,,,,,,1
L0T7Y7,L0T7Y7_MYCTU,Rv1807,PPE31 Rv1807,,IPR022171; IPR000030; IPR038332; ,,PPE31,DOMAIN 317 395 PE_PPE_C. {ECO:0000259|Pfam:PF12484}.,PPE family protein PPE31 (Fragment),,9634230; 21969609,,,LDFATLPPEINSARMYSGAGSAPMLAAASAWHGLSAELRASALSYSSVLSTLTGEEWHGPASASMTAAAAPYVAWMSVTAVRAEQAGAQAEAAAAAYEAAFAATVPPPVIEANRAQLMALIATNVLGQNAPAIAATEAQYAEMWSQDAMAMYGYAGASAAATQLTPFTEPVQTTNASGLAAQSAAIAHATGASAGAQQTTLSQLIAAIPSVLQGLSSSTAATFASGPSGLLGIVGSGSSWLDKLWALLDPNSNFWNTIASSGLFLPSNTIAPFLGLLGGVAAADAAGDVLGEATSGGLGGALVAPLGSAGGLGGTVAAGLGNAATVGTLSVPPSWTAAAPLASPLGSALGGTPMVAPPPAVAAGMPGMPFGTMGGQGFGRAVPQYGFRPNFVARPPAAG,"38,869",399,Mycobacterial PPE family,,,,,,1
O53919,O53919_MYCTU,Rv1672c,Rv1672c,GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Probable conserved integral membrane transport protein,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],9634230; 21969609,,,MATIAASPTHNALGKAARRLLPLLFVLYVINFVDRANISVAALAMNADLRLSATAYGTAAGVFFLGYVLFQVPANAALARFGAGRTLTAVVLAWGVCSAATALVTSAHTLYLARFALGVAEGGFFPGVIAYLTVWFPCAQRARAVATFLLAIPVANTVGLPLSGLIVGHVHMAGLPGWRAMFVIEALPALLLAPLLRRLLPDNPQRASWLTPEERAELSARLTEDTPAPTGRSSGAGWDLVLFAVVYGGLYFALYALQFFLPQLVASLAHGTATLTAATLAALPYGVAALAMLAWSHRSIDRSGAQAGHITLPTTAAGSAALGAALSPMSPIVTLSWLTIAVAGILAAMPAFWSRCTAALAGPRVAVAIATVNAVASLASFAGPYATGHLKDATGTYHLALLTVAAVLAAAAACSLLLRHAGRTVCANDSEIMLHPSPATPFV,"45,666",443,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021],,,1
L7N649,L7N649_MYCTU,Rv1788,PE18 Rv1788,,IPR000084; ,,PE18,,PE family protein PE18,,9634230,,,MSFVTTQPEALAAAAGSLQGIGSALNAQNAAAATPTTGVVPAAADEVSALTAAQFAAHAQIYQAVSAQAAAIHEMFVNTLQMSSGSYAATEAANAAAAG,"9,552",99,,,,,,,1
O07740,O07740_MYCTU,Rv1892,Rv1892,GO:0016021,,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230,,,MIMCEGRPTESPIPRWLRFVLTSDRAGSAWYIGAGFFFAPVLAVLSPWPTITAVLWWIIGLAGLWLGLLGIAMAVGLARVLRSGAEIPEAYWRTLVDYRSANE,"11,408",103,,,,integral component of membrane [GO:0016021],,,1
L7N681,L7N681_MYCTU,Rv1646,PE17 Rv1646,,IPR000084; ,,PE17,,PE family protein PE17,,9634230; 21969609,,,MSFLTVAPDMVTAAAGNLESVGSALNEAAAAAAPATVGLAAPAADRVSAVVAAMLGAYARDFQGISAQIAGFHNQFVGALRGGAAAYASAEAANVQQTVVNAVNAPAQALLGHPLIGPETVGSSAAAVSFGFGPLLLAGSDPLLAVPFSYPASLPTPFGPVTMTLNGSFDPLTQQVVFDSGSLTAPAPFVYGLGAVGPALTTMTALQNSGTAFSGAVQSGNLLGAAGALLQAPGNAVTGFLFGQTAISQSIPGPSNLGYESVGISVPVGGLLAPLQPVTVTLTPTSGMPTAIQLSGTQFGGLLPALLNGF,"30,219",310,,,,,,,1
O53937,O53937_MYCTU,Rv1786,Rv1786,,,,,,Probable ferredoxin,,9634230,,,MKVRLDPSRCVGHAQCYAVDPDLFPIDDSGNSILAEHEVRPEDMQLTRDGVAACPEMALILEEDDAD,"7,385",67,,,,,,,1
O07739,O07739_MYCTU,Rv1893,Rv1893,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSFNPKDAVDAVRDIAANAVEKASDIVENAGHIIRGDIAGGASGIVKDSIDIATHAVDRTKEVFTGKTDDEG,"7,467",72,,,,,,,1
O06145,O06145_MYCTU,Rv1628c,Rv1628c,,IPR002878; IPR022002; IPR012340; ,,,,Conserved protein,,9634230; 21969609,,,MPEVTREEPAIDGWFTTDKAGNPHLLGGKCPQCGTYVFPPRADNCPNPACGSDTLESVGLSTRGKLWSYTENRYAPPPPYPAPDPFEPFAVAAVELADEGLIVLGKVVDGTLAADLKVGMEMELTTMPLFADDDGVQRIVYAWRIPSRAGDDAERSDAEERRR,"17,754",163,,,,,,,1
O06138,O06138_MYCTU,Rv1621c,cydD Rv1621c,GO:0005524; GO:0005886; GO:0016021; GO:0034040; GO:0042883,IPR003593; IPR011527; IPR036640; IPR003439; IPR017871; IPR014216; IPR027417; ,,cydD,,Probable 'component linked with the assembly of cytochrome' transport transmembrane ATP-binding protein ABC transporter CydD,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; lipid-transporting ATPase activity [GO:0034040]; cysteine transport [GO:0042883],9634230; 21969609,,,MACGVGISGCAIGSAIVLASIVAGVIDPANPGMAGLRRWLGPLSILLVLWGLRASIQWLQARLAQRGASAVIADLSGQVLTAVTARRPSQLAAQRDAAAVLITRGLDGLRPYFTGYLPTLLLAAILTPATVAVIGLYDLKSMAIVVITLPLIPIFMVLIGLATTNPSAAALAAMTAVQARLLDLIAGIPTLRALGRASGPEQRIAELSADHRRSAMATLRIAFLSALVLELLATLGVALVAVGIGLRLVFGEMSLTAGLTVLLLAPEVYWPLRRVGVQFHAAADGRTAADKAFALLGESPSPTPGRRTVTARGGVIRLERLSVRGRDGRAPYDLTADIEPGRVTVLTGRNGAGKSTTLQAIAGLTAPSSGRITVAGVDVTNLAPAAWWRQLSWLPQRPVLVPGTVRHNLVLLGPVDDLERACAAAGFDAVLDELPRGLDTVLGRGGVGLSLGQRQRLGLARALGSPAAVLLLDEPTAHLDARTEQHVLGAIVERARAGATVLVVAHRQQVAAAGDRVVEVNSDGFRR,"54,798",527,,cysteine transport [GO:0042883],ATP binding [GO:0005524]; lipid-transporting ATPase activity [GO:0034040],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O06141,O06141_MYCTU,Rv1624c,Rv1624c,GO:0016021,IPR005325; ,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MCHTAPMEPSPVVSPLPRLLPHLWKSTLASGILSLILGVLVLAWPGISILVAAMAFGVYLLITGVAQVAFAFSLHVSAGGRILLFISGAASLILAVLAFRHFGDAVLLLAIWIGIGFIFRGVATTVSAISDPMLPGRGWSIFVGVISLIAGIVVMASPFESIWILALVVGIWLVVIGTCEIASSFAIRKASQTLG,"20,372",195,,,,integral component of membrane [GO:0016021],,,1
O33186,O33186_MYCTU,Rv1684,Rv1684,,IPR005651; ,,,,Uncharacterized protein,,9634230; 21969609,,,MLDEALLAILVCPADRGPLVLVEDGDIQVLYNPRLRRAYRIEDGIPVLLVDEAREVDEDEHARLMARGRPAAPQ,"8,290",74,,,,,,,1
P95266,P95266_MYCTU,Rv1948c,Rv1948c,,,,,,Uncharacterized protein,,9634230,,,MTVFGIKPDNYFGDVVLAAADRDGLRIFQYAVRSAHESGQATFDIDGVQQRIVRESGTADMELGSQTVVWRFDDTKLVEILDKLSPLIDGEGPGHQYIDDLNSPAPTLMISVDEYA,"12,792",116,,,,,,,1
O06592,O06592_MYCTU,Rv1598c,Rv1598c,GO:0016491; GO:0048037,IPR004378; IPR012349; ,,,,Conserved protein,cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MSAKDHPNNAPGVPMVFPLWLERLQVKYINRALKPIARYLPGTATIEHRGRKSGKPYQTIVTAYRKDGVLAIALAHGKTDWVKNVLAAGEADVHFARGVVHVINPRIVPAGSDGQGLPRMARLQLRRIGVFVGDIA,"14,892",136,,,cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],,,,1
P95263,P95263_MYCTU,Rv1951c,Rv1951c,,,,,,Uncharacterized protein,,9634230,,,MKAGELRVNIQQVAATASQWSGRSTELSVLAPPPLGQPFQPTTAAVGGAHAAVGLAVAAFTARTHATASAVEAAAAEYANNEAAAAAEMAAVPQTRLV,"9,752",98,,,,,,,3
P95286,P95286_MYCTU,Rv1928c,Rv1928c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MSVLDLFDLHGKRALITGASTGIGKRVALAYVEAGAQVAIAARHLDALEKLADEIGTSGGKVVPVCCDVSQHQQVTSMLDQVTAELGGIDIAVCNAGIITVTPMLDMPLEEFQRLQNTNVTGVFLTAQAAAKAMVKQGQGGVIINTASMSGHIINVPQQVSHYCASKAAVIHLTKAMAVELAPHKIRVNSVSPGYILTELVEPYTEYQPLWEPKIPLGRLGRPEELAGLYLYLASEASSYMTGSDIVIDGGYTCP,"27,031",255,,,oxidoreductase activity [GO:0016491],,,,1
I6Y7V6,I6Y7V6_MYCTU,Rv1925,fadD31 Rv1925,GO:0005886; GO:0006633; GO:0016874; GO:0070566,IPR000873; ,,fadD31,,Probable acyl-CoA ligase FadD31 (Acyl-CoA synthetase) (Acyl-CoA synthase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MNDGSRQELRVRSGLLQIEDCLDADGGIALPAGTTLISLIERNIKYVGDLVAYRYLDHARSAAGCALEVTWTQFGMRLAAIGAHVQRFAGPGDRVAILAPQGIDYVCGFYAAIKAGTVAVPLFAPELPGHAERLDTALRDSEPAVILTTAAAKNAVEGFLNNVPRLRKPTVLVIDQIPDREGELFVPVELDIDAVSHLQYTSGSTRPPVGVEITHRAVGTNLVQMILSIDLLNRNTHGVSWLPLYHDMGLSMIGFPAVYGGHSTLMSPTAFVRRPLRWIQALSEGSRTGRVVTAAPNFAYEWAAQRGLPAQGDDVDLSNVVLIIGSEPVSIDAVTTFNKAFAPYGLPRTAFKPSYGIAEATLLVATIDHAAEPTVVYLDPEQLGAGHATRVAPDAPNAVVHVSCGHVARSLWAVIVDPDTGPEAGAELPDGEIGEVWLQGDNVARGYWGRPEETRMTFGARLQSPLAEGSHADGSAIDDTWLRTGDLGVYLDGELYITGRIADLLTIDGRNHYPQDIEATAAEASPMVRRGYITAFTVPASDGDDRNQRLVIIAERAAGTSRSDPRPALDAIRAAVCNRHGLSVADLSFLPAGAIPRTTSGKLARQACRAQYLSGRLGVH,"66,310",620,,fatty acid biosynthetic process [GO:0006633],adenylyltransferase activity [GO:0070566]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
O53910,O53910_MYCTU,Rv1607,chaA Rv1607,GO:0016021; GO:0055085,IPR004837; ,,chaA,,Probable ionic transporter integral membrane protein ChaA,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],9634230; 21969609,,,MLKRVPWTVVLPSLAFVALVLTWGKQIGPVVGLLAAVLLAGAVLAAVNHAEVVAARVGEPFGSLVLAVAVTTIEVALIVALMVSGGDDAATLARDTVFAAVMITTNGIAGLSLLLGSLRYGVTLFNPHGSGAALATVTTLATLSLVLPTFTTSQSGPELSPGQLIFAGAASLGLYVLFLFTQTVRHRDFFLPVAQKGAVEDDSHADPPSTRAALLSLGLLLVALVAVVGLAKVESPVIEEVVSAAGFPQSFVGVVIATLVLLPETLAAARAARQGRLQTSLNLAYGSAMASIGLTIPTIALASLWLSGPLQLGLGAIQLVLLVLTVVVSVLTVVPGRATRLQGEVHLVLLAAYLFLAVVP,"36,772",360,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021],,,1
O07730,O07730_MYCTU,Rv1902c,nanT Rv1902c,GO:0005886; GO:0015136; GO:0016021; GO:0046942; GO:0046943,IPR011701; IPR020846; IPR005828; IPR036259; IPR004742; IPR005829; ,,nanT,,Probable sialic acid-transport integral membrane protein NanT,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxylic acid transmembrane transporter activity [GO:0046943]; sialic acid transmembrane transporter activity [GO:0015136]; carboxylic acid transport [GO:0046942],9634230,,,MAAPRLTGDQRNAFMASFLGWTMDAFDYFLVVLVYADIATTFHHTKTDVAFLTTATLAMRPVGALLFGLWADRVGRRVPLMVDVSFYSVIGFLCAFAPNFTVLVILRLLYGIGMGGEWGLGAALSMEKVPAERRGVFSGLLQEGYAFGYLLASVAALVVMNWLGLSWRWLFGLSIIPALISLIIRYRVKESEVWEAAQDRMRLTKTRIRDVLGNPAIVRRFVYLVLLMTAFNWMSHGTQDVYPTFLTATTDHGAGLSSLTARWIVVIYNIGAIIGGLAFGTLSQRFSRRYTIVFCAALGLPIVPLFAYSRTAAMLCLGSFLMQVFVQGAWGVIPAHLTEMSPDAIRGVYPGVTYQLGNLLAAFNLPIQERLAESHGYPFALAATIVPVLLVVAVLTAIGKDATGIRFGTTETAFLVRHRNRH,"46,453",422,,carboxylic acid transport [GO:0046942],carboxylic acid transmembrane transporter activity [GO:0046943]; sialic acid transmembrane transporter activity [GO:0015136],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53926,O53926_MYCTU,Rv1679,fadE16 Rv1679,GO:0005886; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE16,,Possible acyl-CoA dehydrogenase FadE16,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MATPGVVQEVVSVAAEHAERVDTDCAFPAEAVDALRKTGLLGLVLPREIGGMGSGPVEFTEVVAQLSAACGSTAMIYLMHMAAAVTVAASPPPGLPDLLADMASGKQLGTLAFSEPGSRSHFWAPVSTASADGDGIAVRADKSWVTSAGFADVYVVSVGSADGAAGDVDLYAVPADTPGLRVAGTFTGMGLRGNASAPMAVDIRIPDSYRLGEAGGGFGIMMQTVLPWFNLGNAAVSLGLATAATGAAVKHVGTARLEHLGGSLAELPTIRAQIARMGTTLAAQKAYLEVAANSVSSPDDTTLTHVLGVKASVNDAALTITESAMRVCGGAAFSKHLPIERAFRDARAGSVMAPTADALYDFYGRAVTGLPLF,"37,876",373,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,,2
O06610,O06610_MYCTU,Rv1580c,Rv1580c,,,,,,Probable PhiRv1 phage protein,,9634230,,,MAETPDHAELRRRIADMAFNADVGMATCKRCGDAVPYIILPNLQTGEPVMGVADNKWKRANCPVDVGKPCPFLIAEGVADSTDDTIEVDQ,"9,747",90,,,,,,,1
P71976,P71976_MYCTU,Rv1718,Rv1718,GO:0016740; GO:0019475,IPR013785; IPR008567; ,,,,Uncharacterized protein,transferase activity [GO:0016740]; L-lysine catabolic process to acetate [GO:0019475],9634230,,,MSIVITVAPTGPIATKADNPALPTSPEEIATAVEQAYHAGAAVAHIHLRDENERPTADPNIARRAMDLIGERCPILIQLSTGVGLTVPFEQREQLVELRPRMATLNPCSMSFGAGEFRNPPQAVRRLAARMRELDIKPELEIYDTGHLEACLRLWAEDLLAEPLQFSIVLGVRGGMAATADNLLTMVRRLPPGAIWQVIAIGKANMELTAMGLALGGNARVGLEDTLYLRKGELAPSNLALVSRTIRLAEALDLPIASVEEAEAALQLPGTS,"29,244",272,,L-lysine catabolic process to acetate [GO:0019475],transferase activity [GO:0016740],,,,1
O06787,O06787_MYCTU,Rv1744c,Rv1744c,,,,,,Probable membrane protein,,9634230,,,MVINRSIASIDSIAVAGSAATTGAVAVAGSVATAGSVAVAGSVATAGSVAIAGAAATAGSVGIIGSLLTVLCVAVRQCVACLACITCTRCVACIGCVRCTDCVGCLWCVNCSGLRNVVGARNLRVGNLGRVSN,"12,718",133,,,,,,,3
O06137,O06137_MYCTU,Rv1620c,cydC Rv1620c,GO:0005524; GO:0005618; GO:0016021; GO:0034775; GO:0042626; GO:0045454,IPR003593; IPR011527; IPR036640; IPR014223; IPR003439; IPR017871; IPR027417; ,,cydC,,Probable 'component linked with the assembly of cytochrome' transport transmembrane ATP-binding protein ABC transporter CydC,"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; cell redox homeostasis [GO:0045454]; glutathione transmembrane transport [GO:0034775]",9634230; 21969609,,,MNRPSAVSRRQRDLLAASGLLGPRLPRILAAVALGVLSLGSALALAGVSAWLITRAWQMPPVLDLSVAVVAVRAFAISRGVLHYCERLATHDTALRAAGRARTLIYHRLAHGPAAAAVGLHSGDLAARVGADVDELANMLVRALVPIAVAAVLAVAATAVVAAVSVPAAVVLAVCLLVAGVVAPWLAGRTAAAQEAIARQHRGMRDTSAMIALEHAPELRVAGALRNVIADSQRRQHAWADALDAAARTGAIAEAMPTAAIGASLLGAVVAGIGMAPTVAPTTLAILMLLPLSAFEATVALPAAAVQLTRSRIAAARLLDLTGSNRVRETESTVSARLPVGTGVLAADVCCGHQEAQSIRVTIDLPPGARLAVTGASGAGKTTLLMTLAGLLPPVHGRVLLDGTNLSDFDEDELRSAVSFFAEDAHIFATTVRDNLLTARGDCPDDELIEALDRVGLCGWLAGLPEGLSTVLIGGAQAVSAGQRRRLLLARAVLSPARIVLLDEPVEHLDAANADLLRDLLAPNSGIMSAMRTVVVATHHLPNDIQCAELSIATDQRCRRRGTNSSDNNTNASAKT,"59,497",576,,cell redox homeostasis [GO:0045454]; glutathione transmembrane transport [GO:0034775],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; ATP binding [GO:0005524]",cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,1
O06597,O06597_MYCTU,Rv1593c,Rv1593c,GO:0005618; GO:0005886; GO:0016787,IPR015797; IPR000086; IPR036388; IPR036390; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MAHGSTAHEVLAVVFQVRGVGMSRGAAKPQLNVLLWQRAKEPQRGAWSLPGGRLRNDEDMTSSVRRQLAEKVDLRELAHLEQLAVFSDPHRLPGIRMIASTYLGVVPSPATPELPADTRWHPVSSLPPMAFDHGPMVTHARTRLIAKMSYTNIGFALAPKEFALSTLRDIYGAALGYQVDATNLQRVLARRRVITQTGTIAQSGRSGGRPAALYRFTDSQLRVTDEFAALRPPGQL,"25,908",236,,,hydrolase activity [GO:0016787],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O07741,O07741_MYCTU,Rv1891,Rv1891,GO:0005576; GO:0009405,,,,,Conserved protein,extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 21969609,,,MIRELVTTAAITGAAIGGAPVAGADPQRYDGDVPGMNYDASLGAPCSSWERFIFGRGPSGQAEACHFPPPNQFPPAETGYWVISYPLYGVQQVGAPCPKPQAAAQSPDGLPMLCLGARGWQPGWFTGAGFFPPEP,"14,109",135,,pathogenesis [GO:0009405],,extracellular region [GO:0005576],,,1
P95267,P95267_MYCTU,Rv1947,Rv1947,,,,,,Uncharacterized protein,,9634230,,,MDRYNDQASGRALIEIRLCNERATPMPIPIGLWMFQTKLHVNAGGADVFLPVCDVLEQDLAERDEEVRQLNLQYRNRLEYAIGRTCSAAWSVNGSRRPSAVWTTWLPVAETPHTRARSVENALLSMDSRGGVT,"14,971",133,,,,,,,2
P71983,P71983_MYCTU,Rv1725c,Rv1725c,GO:0006351; GO:0006355,IPR011991; IPR002577; IPR036527; IPR036388; IPR036390; ,,,DOMAIN 8 103 HTH hxlR-type. {ECO:0000259|PROSITE:PS51118}.,Uncharacterized protein,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,,MQPYGQYCPVARAAELLGDRWTLLIVRELLFGPLRFTEIERGLPGISRSVLAQRLRRLQHDRIIEAVPEHTGGGYRFTVAGEELRPVLQTLGDWVSRWLMADPTPAECDPELLTLWISRRVNTEALPGRRVVVEFRYHGERPLWAWLVLEPGDISVCLHDPCLPVDLTVRGHPRDLYRVYSGRSTLAAEISAERIELDGLPAMRRAFPSWMAWSPFAPAMRQAVVSVDQMPEAHGG,"26,754",236,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",,,,,2
O07738,O07738_MYCTU,Rv1894c,Rv1894c,GO:0018580,IPR013785; IPR004136; ,,,,Uncharacterized protein,nitronate monooxygenase activity [GO:0018580],9634230; 21969609,,,MHTAICDELGIEFPIFAFTHCRDVVVAVSKAGGFGVLGAVGFTPEQLEIELNWIDEHIGDHPYGVDIVIPNKYEGMDSQLSADELAKTLRSMVPQEHLDFARKILADHGVPVEDADEDSLQLLGWTEATATPQVDAALKHPKMTMVANALGTPPADMIKHIHDSGRKVAALCGSPSQARKHADAGVDIIIAQGGEAGGHCGEVGSIVLWPQVVKEVAPVPVLAAGGIGSGQQIAAALALGTQGAWTGSQWLMVEEAANTAVQQAAYVKATSRDTVRSRSFTGKPARMLRNDWTEAWEQPESPKPLGMPLQYMVSGMAVKATHKYPNETVDVAFNPVGQVVGQFTKVEKTATVIERWVQEYLEATARLDALNAAASV,"40,186",376,,,nitronate monooxygenase activity [GO:0018580],,,,1
P71988,P71988_MYCTU,Rv1730c,Rv1730c,GO:0040007,IPR001466; IPR012338; ,,,,Possible penicillin-binding protein,growth [GO:0040007],9634230; 21969609,,,MCPPIILSSATPTGTRCGTRHGRAVVTEYVRALDRLPHEIATAVVETVNCADPGAAFDELDAKINAGMKAYAIPGVAVAVWAGGQEYVKGYGVTNVDHPMPVDGDTVFRIGSTTKTFTGTVMMRLVERGKVDLDSPVRRYIPDFAVADESASATVTVRQLLNHTAGWDGRNGQDFGRGDDAVALYVKAMTRLPQLTPPGTAFAYNNSGLVVAGRIIELVAGTTYESTVQRLLLDPLQLAHTRYFSDQIIGLNVAASHSVVDGKPIAVTDFWTFPRSCNPTGGLMSTARDQLRYAQFHLGDGRAPNGEQILSRQSLKAMRSNPGAGGTLWVELTGMGVTWMLRPSAENVTIVEHGGTWKGQRSGFVMVPDRNFAMTVLTNSDGGFHMINDLFASDWALQRFAGLSNLPATPQRLGAVDLAPYEGRYIAKQVAQNGDLETTVIDFRARDGQLAGSMSTDDANPDGQNSANLGLAFYRPDYGLDLGPDNKPTGSRSNFVRGPDGNIAWFCSQHGRLFRRQ,"55,801",517,,growth [GO:0040007],,,,,1
O53916,O53916_MYCTU,Rv1668c,Rv1668c,GO:0005524; GO:0016887,IPR003593; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 5 223 ABC transporter. {ECO:0000259|PROSITE:PS50893}.,Probable first part of macrolide-transport ATP-binding protein ABC transporter,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230,,,MAHLLGAEAVHLAYPTQVVFEAVTLGVNDGARIGIVGRNGDGKSSLLGLLTGQLRPDSGRVTRRSGLRVNALSQTDTLDPNRTVGWTLIGDQPEHQWAGNPRIRDVVAGLVSDIAWDTPVSTLSGGQRRRVQLASLLVGEWDVIALDEPTNHLDIQGITWLADHLRRRWARNTGGLLVVTHDRWFLDEVATTTWEVHDGIVEPFEGGYAAYVLQRVERDRLTAAAEAKRQNLLRKELAWLRRGAPARTCKPKFRIEAANQLIADVPPPRNTVELAKLAAARLGKDVVDLLGVSVSYQPSGGRPVLRDIEWRIGPGERIGIVGANGAGKSTLLGLIAGTVQPGVGRVKPSGWQCSISTGTIWHRLPTTGSPMC,"40,339",372,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
Q79FK4,Q79FK4_MYCTU,Rv1791,PE19 Rv1791,,IPR000084; ,,PE19,,PE family protein PE19,,9634230,,,MSFVTTQPEALAAAAANLQGIGTTMNAQNAAAAAPTTGVVPAAADEVSALTAAQFAAHAQMYQTVSAQAAAIHEMFVNTLVASSGSYAATEAANAAAAG,"9,584",99,,,,,,,1
O06796,O06796_MYCTU,Rv1761c,Rv1761c,GO:0016021,IPR031816; ,,,,Possible exported protein,integral component of membrane [GO:0016021],9634230; 19177358,NMR spectroscopy (1),,MSDFDTERVSRAVAAALVGPGGVALVVKVFAGLPGVIHTPARRGFFRSNPERIQIGDWRYEVAHDGRLLAAHMVNGIVIAEDALIAEAVGPHLARALGQIVSRYGATVIPNINAAIEVLGTGTDYRF,"13,488",127,,,,integral component of membrane [GO:0016021],,,1
Q79FL4,Q79FL4_MYCTU,Rv1706A,Rv1706A,,,,,,Uncharacterized protein,,9634230,,,MGSLAAFKLGWLLSAMAPNVVLLTAFRVPQGLTMLTVFATGQAGQHRCRTFHVTP,"5,915",55,,,,,,,1
O33183,O33183_MYCTU,Rv1681,moeX Rv1681,GO:0003824; GO:0051536,IPR013785; IPR007197; IPR034395; ,,moeX,DOMAIN 87 217 Radical_SAM. {ECO:0000259|Pfam:PF04055}.,Possible molybdopterin biosynthesis protein MoeX,catalytic activity [GO:0003824]; iron-sulfur cluster binding [GO:0051536],9634230,,,MIIELMRRVVGLAQGATAEVAVYGDRDRDLAERWCANTGNTLVRADVDQTGVGTLVVRRGHPPDPASVLGPDRLPGVRLWLYTNFHCNLCCDYCCVSSSPSTPHRELGAERIGRIVGEAARWGVRELFLTGGEPFLLPDIDTIIATCVKQLPTTVLTNGMVFKGRGRRALESLPRGLALQISLDSATPELHDAHRGAGTWVKAVAGIRLALSLGFRVRVAATVASPAPGELTAFHDFLDGLGIAPGDQLVRPIALEGAASQGVALTRESLVPEVTVTADGVYWHPVAATDERALVTRTVEPLTPALDMVSRLFAEQWTRAAEEAALFPCA,"35,371",330,,,catalytic activity [GO:0003824]; iron-sulfur cluster binding [GO:0051536],,,,3
Q79FJ9,Q79FJ9_MYCTU,Rv1803c,PE_PGRS32 Rv1803c,,IPR000084; ,,PE_PGRS32,DOMAIN 4 95 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS32,,9634230,,,MWTSQMIVAPAFVDAAAKDLATIGSAISRANAEALVPITALLPAGADDVSAAIAALFATHGQAYQELSAHAVAFHEQFVQLMSAGAAQYASAEAANSSPLQIVGQTALDAINSPVQTLTGRPLIGNGANGVAGTGQNGGDGGWLYGNGGNGGSGGTGQNGGNGGSAGLWGSGGNGGQGGAGANGAAGQPGKAGGSGGNGGAGGWIYGHGGHGGAGGNGGNATAPGGASAGFDGGAGGNGGSGGRGGLLFGNGGNGSVGGMGGQGTNDTAGDSAGSGGLGGNGGNGAQGGWLIGNGGQGGDSGAGGGTDSTQTGVMNGASGGSAGIAGNGGDAGLVGNGGAGGNGGNGAAGSALGTTIFGGSGGVGGSGGDGGNGGWLFGSGASGGNGGQGGDAGTNGFAGFGGSAGGGGWVGAVNFGPISVQGFGLFGHGGDGGNGGDVGAGSLSIQFGASGGDGGQGGVLYGNGGNGGNAGSGGGTGFEGSAGQGGAAILIGNGGAGGNGATGGTGVGNIIQEAGGDGSDGGAGGSGGLLFGSGGAGGIGGAGGVGGSGNDGGNGGDGGQGGASGLGIGNGGPGGSGGTGGAGGTGGSAGTGGAGGDGGNAALLIGTGGDGGDGVPPAPGGQGGKGGLIGLPGQNGQP,"54,882",639,,,,,,,1
O53962,O53962_MYCTU,Rv1920,Rv1920,GO:0005886; GO:0008152; GO:0016746,IPR016676; IPR002123; ,,,,Probable membrane protein,"plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; metabolic process [GO:0008152]",9634230; 21969609,,,MFPRWPQQAHNHEVSRADTVSVPRAPTQAEVAAVLRIMTPLRKVIKPKVYGIENVPTERALLVGNHNTLGLVDAPLLAAELWERGRIVRSLGDHAHFKIPGWRDALTRTGVVEGTREITSELMRRGELVMVFPGGAREVNKRKNERYKLVWKNRLGFARLAIQHGYPIVPFASVGAEHGIDIVLDNESPLLAPVQFLAEKLLGTKDGPALVRGVGLTPVPRPERQYYWFGEPIDTTEFMGQQADDNAARRVRERAAAAIEHGIELMLAERAADPNRSLVGRLLRSDA,"31,981",287,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886],,,1
O53930,O53930_MYCTU,Rv1779c,Rv1779c,GO:0005576; GO:0005829; GO:0016021,IPR025519; ,,,,Possible integral membrane protein,cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MCAHEYAEQRSAVSGIEGLLTWLGGGHWRELGERHERSTHAVAGVIVAVGAALAGLLASLAVSEAAQGPISSPIGAASLALVLGLLVGAVTRGTASGPARGRAGVTGRASVAVAVGFVVGELAALVMFSGAIDRRLDEQAMHSADATPAAVQASASLQQARNARTALDSAVERARGRLDDALVVARCEYHPTPACPQTRITGVPGRGPETRTANQLLADAQRELDNALAARDHQAPALDAKMAHDEQALAEVRQAVVADAGRGLGSRWVAMNDLTLASAGALTARMLAIAFFALLYLLPLILRLWRGDTTHDRHAAARAERERAELEADTAIAIKRAEVRRAAEIMWAEHQLTQTRLAIEAQAEIDREQQRRRVVEALEGPVRASSERTLQPVEDEVYLPIAAETEAASRTVAQLPAGAAHHRPGIAKNLPAQVQPEGAVEPREKRATPVIRSIPDATKAAARWIRPLVPPFVARMLDNTTAPLRTARQVFEEVEEIAFSFKRTHKVTVNAEGSDPNDQPPLESHSPAAPAESNPIASSDSARRSRLATNDDHPPLAQVPPRDLASLSVGSTGELTQREGPHELRSPDGPRQLPPPR,"63,512",597,,,,cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O07754,O07754_MYCTU,Rv1875,Rv1875,GO:0005618; GO:0005829; GO:0010106; GO:0048037,IPR019920; IPR011576; IPR012349; ,,,DOMAIN 6 91 Putative_PNPOx. {ECO:0000259|Pfam:PF01243}.,Conserved protein,cell wall [GO:0005618]; cytosol [GO:0005829]; cofactor binding [GO:0048037]; cellular response to iron ion starvation [GO:0010106],9634230; 21969609,,,MTTLNEAAALAAAERGLAVVSTVRADGTVQASLVNVGLLPHPVSGEPSLGFTTYGKVKLGNLRARPQLAVTFRNGWQWATVEGRAQLVGPDDPRPWLVDGERLRLLLREVFTAAGGTHDDWDEYDRVMAQEQRAVVLITPTRIYSNG,"15,979",147,,cellular response to iron ion starvation [GO:0010106],cofactor binding [GO:0048037],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
O07222,O07222_MYCTU,Rv1810,Rv1810,GO:0005576,IPR007969; ,,,DOMAIN 19 113 DUF732. {ECO:0000259|Pfam:PF05305}.,Conserved protein,extracellular region [GO:0005576],9634230; 21969609,,,MQLQRTMGQCRPMRMLVALLLSAATMIGLAAPGKADPTGDDAAFLAALDQAGITYADPGHAITAAKAMCGLCANGVTGLQLVADLRDYNPGLTMDSAAKFAAIASGAYCPEHLEHHPS,"12,142",118,,,,extracellular region [GO:0005576],,,4
P95159,P95159_MYCTU,Rv1855c,Rv1855c,GO:0005886; GO:0016705,IPR019952; IPR011251; IPR036661; ,,,,Possible oxidoreductase,"plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTIRLGLQIPNFSYGTGVEKLFPSVIAQAREAEAAGYDSLFVMDHFYQLPMLGTPDQPMLEAYTALGALATATERLQLGALVTGNTYRSPTLLAKIITTLDVVSAGRAILGIGAGWFELEHRQLGFEFGTFSDRFNRLEEALQILEPMVKGERPTFFGDWYTTESAMAEPRYRDRIPILIGGGGEKKTFAIAARFADHLNIVAAVDELPRKMRALAARCDEAGRDRSTLQTSLLLTVMIDETLSPDAIPAEMSGRVVVGSPAQIADQIQAKVLDAGVDGLIINLAPHGYLPGVITTAAEALRPLLGV,"33,220",307,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",plasma membrane [GO:0005886],,,2
P95268,P95268_MYCTU,Rv1946c,lppG Rv1946c,,,,lppG,,Possible lipoprotein,,9634230,,,MIRGSAVSGLLMPSVNGGTAGSVACVQCLFLPKVAVDLINLSGIQCFARIEHVAHAQAHPFVVLVGKPAQHGARIGAVAGAILTGDVIVSHDGELYRAVTALRQNGPRPHASRRLHAPALCSARSRRGHLRPSCWLPPPRFAGRQSLVAR,"15,799",150,,,,,,,1
O06802,O06802_MYCTU,Rv1769,Rv1769,GO:0005886,IPR001608; IPR029066; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MHEVAAREQRSDGPMRLDAQGRLQRYEEAFADYDAPFAFVDLDAMWGNADQLLARAGDKPIRVASKSLRCRPLQREILDASERFDGLLTFTLTETLWLAGQGFSNLLLAYPPTDRAALRALGELTAKDPDGAPIVMVDSVEHLDLIERTTDKPVRLCLDFDAGYWRAGGRIKIGSKRSPLHTPEQARALAVEIARRPALTLAALMCYEAHIAGLGDNVAGKRVHNAIIRRMQRMSFEELRERRARAVELVREVADIKIVNAGGTGDLQLVAQEPLITEATAGSGFYAPTLFDSYSTFTLQPAAMFALPVCRRPGAKTVTALGGGYLASGVGAKDRMPTPYLPVGLKLNALEGTGEVQTPLSGDAARRLKLGDKVYFRHTKAGELCERFDHLHLVRGAEVVDTVPTYRGEGRTFL,"45,413",414,,,,plasma membrane [GO:0005886],,,1
O33177,O33177_MYCTU,Rv1774,Rv1774,GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016167; IPR006094; IPR006093; ,,,,Probable oxidoreductase,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MRALPAGRHFFRGSDGYEAARRGTVWHRRVPDRYPEVIVQAVSADDIVSAIRYATVNGHKVSVVSGGHSFAASHLRDGAVLLDVSRIDHASIDADKGRAVVGPGKGGSVLMAELEAQGLFFPGGHCRGVCLGGYLLQGGYGWNSRIYGPACESVIGLDVITADGAQIHCDADNHADLYWAARGAGPGFFGVVTSFYLKLYPRPATCGTSVYVYPFDLADEVFTWARAVSAEVDPRVELQALASRGEPSMGIDVPVISLASPAFADSPEEAEQALALFGTCPVVEQALVKVPYMPTDLPAWYDVAMTHYLSDHHYAVDNMWTSASAEDLLPGIRSILDTLPPHPAHFLWLNWGPCPPRQDMAYSIEADIYLALYGSWKDPADEAKYADWARSHMAAMSHLAVGIQLADENLGARPARFASDAAMAKLDRVRAEYDPDGLFNSWMGRI,"48,341",446,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,1
O53920,O53920_MYCTU,Rv1673c,Rv1673c,,IPR002931; ,,,,Uncharacterized protein,,9634230,,,MTITDPAVSAHADATIGLFEITDHITIDSTQGAHTVEMWCPVIGDGAFQRVLDVEVTSEDPYDLTREPEFGNLMLYSRLRLATAASWSIRYVVERRAIGHAPDPARARPLATAQLFSRALIPEAHVDVDERTRTLAQDVVGPETNPLEQARRIYDYVTGAMDYDATKQSFLGSTEHALTCSVGNCNDIHALFVSLCRSVDIPARFVLGQALELPQPGAQDCEVCGYHCWAEFFVAGLGWLPADASCATKYGTHGLFANLQANHIAWSIGRDILLAPPQRAGRSLFFAGPYAEIDGETHPAQRQIRFTAMT,"33,989",310,,,,,,,1
Q79FJ2,Q79FJ2_MYCTU,Rv1844c,gnd1 Rv1844c,GO:0004616; GO:0006098; GO:0019521,IPR008927; IPR013328; IPR006114; IPR006113; IPR006115; IPR006184; IPR036291; IPR006183; ,,gnd1,,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098],9634230; 21969609,,"FUNCTION: Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. {ECO:0000256|PIRNR:PIRNR000109}.",MSSSESPAGIAQIGVTGLAVMGSNIARNFARHGYTVAVHNRSVAKTDALLKEHSSDGKFVRSETIPEFLAALEKPRRVLIMVKAGEATDADAVINELADAMEPGDIIIDGGNALYTDTMRREKAMRERGLHFVGAGISGGEEGALNGPSIMPGGPAESYQSLGPLLEEISAHVDGVPCCTHIGPDGSGHFVKMVHNGIEYSDMQLIGEAYQLMRDGLGLTAPAIADVFTEWNNGDLDSYLVEITAEVLRQTDAKTGKPLVDVIVDRAEQKGTGRWTVKSALDLGVPVTGIAEAVFARALSGSVGQRSAASGLASGKLGEQPADPATFTEDVRQALYASKIVAYAQGFNQIQAGSAEFGWDITPGDLATIWRGGCIIRAKFLNHIKEAFDASPNLASLIVAPYFRGAVESAIDSWRRVVSTAAQLGIPTPGFSSALSYYDALRTARLPAALTQAQRDFFGAHTYGRIDEPGKFHTLWSSDRTEVPV,"51,547",485,6-phosphogluconate dehydrogenase family,D-gluconate metabolic process [GO:0019521]; pentose-phosphate shunt [GO:0006098],phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616],,,,1
O06149,O06149_MYCTU,Rv1632c,Rv1632c,,IPR007295; IPR035930; IPR014465; ,,,,Uncharacterized protein,,9634230; 21969609,,,MRAVDEYTVHPWGLYLARPTPGRAQFHYLESWLLPSLGLRATVFHFNPSHKRDHDYYLDVGEYTPGPSVWRSEDHYLDIEVRTGGGAELADVDELLDAVRHGLLTPTVAEQAVRHAVDAVEGLARNGYDLTRWLATKGMELTWRSGS,"16,631",147,,,,,,,1
O06799,O06799_MYCTU,Rv1766,Rv1766,GO:0003677; GO:0006355; GO:0046872,IPR003735; IPR038390; ,,,,Conserved protein,"DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MIGDQDSIAAVLNRLRRAQGQLAGVISMIEQGRDCRDVVTQLAAVSRALDRAGFKIVAAGLKECVSGATASGAAPLSAAELEKLFLALA,"9,168",89,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],,,,2
O07728,O07728_MYCTU,Rv1904,Rv1904,GO:0006355; GO:0045152,IPR003658; IPR002645; IPR036513; ,,,,Anti-sigma factor antagonist,"antisigma factor binding [GO:0045152]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MRTVAIGPGAGPSSTRPSSQPSDLHSGLRAVTECTGSAVVVHVGGDIDASNEVAWQRLVSKSAAIAIAPGPFVIDIRDLDFMGSCAYAVLAQESVRCRRRGVNMRLVSNQPIVARTIAACGLRRLIPLYATVETALAPPPSAH,"14,944",143,Anti-sigma-factor antagonist family,"regulation of transcription, DNA-templated [GO:0006355]",antisigma factor binding [GO:0045152],,,,3
P95150,P95150_MYCTU,Rv1865c,Rv1865c,GO:0005886; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MPGRTSIGVKIRDKVQDKVIAITGGARGIGLATAAALHNLGAKVAIGDIDEAMAKESGADLDLDMYGKLDVTDPDSFSGFLDAVERQLGPIDVLVNNAGIMPVGRIVDEPDPVTRRILDINVYGVILGSKLAAQRMVPRGRGHVINVASLAGEIYAVGVATYCASKHAVVAFTDSARLEYRSAGVKFSMVLPSFVNTELIAGTGGIKGFKNAEPADIADAIVGLIVHPKPRVRVTKAAGSMIVAQRFMPRQVSEGLNRLLGGEHVFTDDVDMEKRRTYEARARGEE,"30,405",286,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,2
Q50616,Q50616_MYCTU,Rv1817,Rv1817,GO:0005618,IPR003953; IPR036188; IPR027477; ,,,,Possible flavoprotein,cell wall [GO:0005618],9634230; 21969609,,,MSTDIPATVSAETVTSWSDDVDVTVIGFGIAGGCAAVSAAAAGARVLVLERAAAAGGTTALAGGHFYLGGGTTVQLATGHPDSPEEMYKYLVAVSREPDHDKIRAYCDGSVEHFNWLEGLGFQFERSYFPGKAVIQPNTEGLMFTGNEKVWPFLELAVPAPRGHKVPVPGDTGGAAMVIDLLLKRAASLGIQIRYETGATELIVDGTGKVTGVMWKRFSETGAIKAKSVIIAAGGFVMNPDMVAKYTPKLAEKPFVLGNTYDDGLGIRLGVSAGGATQHMDQMFITAPPYPPSILLTGIIVNKLGQRFVAEDSYHSRTAGFIMEQPDSAAYLIVDEAHLEHPKMPLVPLIDGWETVVEMEAALGIPPGNLAATLDRYNAYAARGADPDFHKQPEFLAAQDNGPWGAFDMSLGKAMYAGFTLGGLATSVDGQVLRDDGAVVAGLYAVGACASNIAQDGKGYASGTQLGEGSFFGRRAGAHAAARAQGM,"51,035",487,,,,cell wall [GO:0005618],,,1
O86371,O86371_MYCTU,Rv1669,Rv1669,,,,,,Uncharacterized protein,,9634230,,,MSRRPGYSNGRAGASRQAARGGSAGASSVAFSSQPNCGLTESVLGHQVTGICLGTIHLDAMQWPWSSAYRLEPAVATTLIGISAWWANGSVKQYAGDLTDRVATMTVCRRTPAPRVHYRQ,"12,779",120,,,,,,,1
O06618,O06618_MYCTU,Rv1572c,Rv1572c,,,,,,Uncharacterized protein,,9634230,,,MECSSAVHGQPRTNTFHHHEKLLRHNDEDNHDDP,"4,005",34,,,,,,,2
O33206,O33206_MYCTU,Rv1707,Rv1707,GO:0005576; GO:0005887; GO:0008271; GO:0015116,IPR011547; IPR001902; IPR002645; IPR036513; ,,,,Probable conserved transmembrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116],9634230; 21969609,,,MLQRIARELLSGVAVAIVALPLAIAFGITATGTSQGALIGLYGAIFAGFFAAVFGGTPGQVTGPTGPITVVATATIAEHGLEGAFFAFILAGVFQILFGACRLGSLIRYVPHPVISGFMGGIAILIIMTQLDQVRSSSLLVLVTVVLLLASGRFIKAIPPSLLVLVLVSSVLPLAAPWLRDLRAGPVSINRTVDYIGEIPQAMPSFDFPQVANSTMLQVLLSAVAIALLGSLDSLLTSLVMDNIRGTRHRSNKELIGQGIGNIAAGLFGGLSGAGATVRSVVNVRNGGQTALSAATHSVVLFVFVAGLGAVVQYIPLAVLSGILILVAVGMFDWHAMRKAHVSPRGDVIVMFTTMIITVVVDLTIAVMVGIALSLLVHRLRSRQRKAKVTQDDTGTYRIDGPLSFLSVDGVFGSLRDGREDVSLDLQHVTYLDTSGARALLYFIDHSEKDGVAVSIKRIPPRLESQLTALADNEQRDKLRTVLESA,"51,203",486,,,secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
O06619,O06619_MYCTU,Rv1571,Rv1571,,IPR009097; ,,,,Conserved protein,,9634230; 21969609,,,MVHSIELVFDSDTEAAIRRIWAGLAAAGIPSQAPASRPHVSLAVAERIAPEVDEPLGAVARRLPLDCVIGAPVLFGRANVVFTRLVVPTSELLALHAEVHRLCGPHLAPAPMANSLPGQWTAHVTLARRVGGHQLGRALRIAGRPSRIDGRFAGLRRWDGNTRAEYLLG,"18,100",169,,,,,,,1
O53961,O53961_MYCTU,Rv1919c,Rv1919c,GO:0005618; GO:0005886,IPR019587; IPR023393; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MSGRKFSFEVTKTSSAPAATLFRLVTDGGNWATWAKPIVAQSSWARRGDPAPGGIGAIRKLGMWPVFVQEETVEYEQDRRHVYKLVGARTPVQDYFGEVVLTPNASGGTDLRWSGSFTEKVRGTGPVMRAALGGAVRFFAGQLVKAAEREAVRR,"16,803",154,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
O07748,O07748_MYCTU,Rv1883c,Rv1883c,,IPR019587; IPR023393; ,,,,Uncharacterized protein,,9634230; 21969609,,,MCLDQVMEGSATVHMAAPPDKIWTLIADVRNTGRFSPETFEAEWLDGATGPALGARFRGHVRRNGIGPVYWTVCEPGREFGFAVLLGDRPVNNWHYRLTPTADGTEVTESFRLPPSVLTTVYYRVFGGWLRQRRNIRDMTKTLQRIKDLVEAG,"17,281",153,,,,,,,1
O53925,O53925_MYCTU,Rv1678,Rv1678,GO:0016021,,,,,Probable integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MARVRRGTELLLSPQSPPATGGLIVLTGLRLLAGLIWLYNVVWKVPPDFGERGRRDLYHFTHLAVEHPVFTPFSWVIEHAVLPYFTAFGWGVLFAESALAVLLLTGTAVRLAALIGIGQSVAIGLSVAESPGEWPWAYAMLLGIHVVLLFTCSTRYAAVDAVRAAATGSAARTAAQRLLAGWGIVLGLIGLVAVWRGLGDDRPAYVGIRALEFSLGEYNLRGALALIAIALAMLAAAKRGWRTVALVAAVVAVAAAAAIYLQVGRTAVWLGGTNTTAAVFVCAAVVSLATEFRIGRVEGA,"31,637",300,,,,integral component of membrane [GO:0016021],,,3
O07755,O07755_MYCTU,Rv1874,Rv1874,GO:0005886,IPR011008; IPR009799; ,,,DOMAIN 121 193 EthD. {ECO:0000259|Pfam:PF07110}.,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MLMRPEPDDDWCARQRAQVADALLGLGVAGLSINVRDSTVRDSLMTLTTLYPPVAAVVSLWTQQCYGEQVAAALRLLAQECDELGAYLVTESVPLTFPSLVESGSRTPGLANIALLRRPDGLDQATWLTRWQRDHTQVAIEAQATFGYTQNWVVRALTPEAPGIAGIVEELFPVAATTDLKAFFGAADDNDLRNRISRMVASTSAFGANQNIDTVPTSRYVFRTPFKD,"24,931",228,,,,plasma membrane [GO:0005886],,,1
P71980,P71980_MYCTU,Rv1722,Rv1722,GO:0005524; GO:0046872,IPR011761; ,,,DOMAIN 147 349 ATP-grasp. {ECO:0000259|PROSITE:PS50975}.,Possible carboxylase,ATP binding [GO:0005524]; metal ion binding [GO:0046872],9634230; 21969609,,,MIVPAREPEPQPRRVLNGLSDVRAFFHNNTVPLYFISPTPFNLLGIYRWIRNFFYLTYYDSFEGEHSRVFVPRRRDRRDFDGMGDVCNHLLRDPETLEFIKNRGPGGKACFVMLDEETQALARQAGLEVMHPPAELRHRLESKIVMTRLADEAGVPSVPHVIGRVSSYDELSALAHGAGLGDDLVVEAAYGNAGSATFFVRGLRDWDQCAGGIVGQPEIKVMKRIRNVEVCIEATVTRHGTVIGPAMTSLVGYPELTPYRGAWCGNDVWRGALPPAQTRAAREMVAKLGDVLSREGYRGYFEVDLLHDLDADELYLGEVNPRLSGASPMTNLTTEAYADMPLFLFHLLEYMDVDYELDIEAINSRWERGYGEDEVWGQLIMSETSPDLELFTATPRTGMWRLNHDGRVSFARQGNDWATMLDESEAFYMRVAAPGDLRCEGAQLGVLVTRGHLQTDDYQLTERGRRWIDGLKAQFASTPLTPAAPIVSRLVARA,"55,461",494,,,ATP binding [GO:0005524]; metal ion binding [GO:0046872],,,,2
O06154,O06154_MYCTU,Rv1637c,Rv1637c,,IPR001279; IPR036866; ,,,DOMAIN 75 243 Lactamase_B. {ECO:0000259|SMART:SM00849}.,Conserved protein,,9634230; 21969609,,,MLCARTDNHQGTGNVVTSAHMTRANDDDAGAAGIGAVAHMTTVDDNYTGHVERGKAARRFLPGATILKASVGPMDNNAYLVTCSATGETLLIDAANDAEVLIDLVRRYAPKLALIVTSHQHFDHWQALQAVAAATGAPTAAHPIDADPLPVKPDRLLTHGDSVRIGELTFDVIHLRGHTPGSIALALGGPVTGGVTQLFTGDCLFPGGVGKTWQPADFTQLLDDVTTRVFDVYADSTVIYPGHGDDTELGAERPSLSEWRARGW,"27,936",264,,,,,,,2
O06585,O06585_MYCTU,Rv1663,pks17 Rv1663,GO:0005886; GO:0006636; GO:0031177; GO:0040007,IPR036736; IPR036291; IPR013968; IPR020806; IPR009081; IPR006162; ,,pks17,DOMAIN 340 414 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable polyketide synthase Pks17,plasma membrane [GO:0005886]; phosphopantetheine binding [GO:0031177]; growth [GO:0040007]; unsaturated fatty acid biosynthetic process [GO:0006636],9634230,,,MEAGPQRIAQMLAELVELFKTEALHRLPVKSWDVRHAREAYRFLSQARHVGKVVLTMPDAWAAGTVLITGGTGMAGSAVARHLVSRYGVRQVVLASRAGEHTESVAALVDELGSAGARVQVVSCDVADRDAVAGLVASQPDLTAVFHAAGVLDDAVITGLTPERVDKVLRAKVDGAWNLHELTRHLDVSAFVLFSSMAGIVGAPGQANYAAANAFLDGLAAYRRSRGLAALSVAWGLWEQASAMTEHLGERDRVRMSRVGLAPLPTNQAMGFLDAALLADRPVVVAARLDRAALAGAELPALFSQLVAGPIRRIIDGADEVSGSGLASRLHGLTPEQRHRELTELVCSNAAIVLGHSGTEIDAHKAFQDLGFDSLTAVELRNRLKTATGLTLPPTLIFDYPTAAELAEHLDIQLANAPAVTVDQPNPSTRFNEVTRELQALLDQPNWNPDDKTRLIKRLQAILTDCTAPPASSGPSTTHDDEDITTATESQLFAILDDELGP,"53,525",502,,growth [GO:0040007]; unsaturated fatty acid biosynthetic process [GO:0006636],phosphopantetheine binding [GO:0031177],plasma membrane [GO:0005886],,,1
P72005,P72005_MYCTU,Rv1748,Rv1748,GO:0005618; GO:0016021,,,,,Uncharacterized protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230; 21969609,,,MPGGVCSGRPWGRPWWHPGLVGLLIRLAELLVVMLPLIGVLYVGIKALSSFTRRLGEASGDLASDSPAMPRPTTVENDAARWRAITRAVEAHERTDARWLEYELDAAKLLDFPVMTDMRDPLTTAFHKAKLQADFHKPLRAEDLLDDPDAAGHYLDAVRDYVTAFDTAEAEAMRRRRTGFSREEQQRLARAQSLLRVASDAGATAQERERAYRLARTELDGLIVLPDRTRAGIERGIAGELDD,"27,085",243,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,1
O06790,O06790_MYCTU,Rv1754c,Rv1754c,GO:0005886; GO:0016021,IPR025442; ,,,DOMAIN 234 559 DUF4185. {ECO:0000259|Pfam:PF13810}.,Conserved protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MYRYQVRVQQRRSEMNRWVATRSRRHTYQWITDHKSPRDHYRHISELRTSIATSSPGRCDMSPIPRIVSVSLAWAAAIGLMVPIGLAPPAMAAPCSGDAANAPPPPSAIVTDPGATALGPVRPGHGPIPTGRKPRGANDRAPLPKLGPLISALLNPGARNAAPLQQQALVPRANPGPNPAPNPPATGPQPPNATQLTPNPAPAPDPAPAAAPDPGATLAGATTSLAEWVTGPDSPNKTLERFGISGTDLGIPWDNGDPANRQVLMIFGDTFGYCAVDGHQWRYNTLFRSQDRDLGNGVHVTSGDASNRYSGSPVRQPGFSKQLINSIKWARDETGIIPTAGIAVGKTQYVNFMSIRNWGRDGEWTTNYSGIAVSKDNGQTWGVFPGTIRASGPDSGGKARFVPGNENFQMGAYLKSNDGYLYSFGTPPGRGGSAYLARVPQRFVPDLTKYQYWNGDSNSWVPNKPDAATPVIPGPVGEMSVQYNTYLKQYLALYTNGMNDVVARTAPAPQGPWSAEQMLVSSWQMPGGIYAPMMHPWSTGKDVYFNLSLWSAYNVMLMHTVLP,"60,608",563,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O33193,O33193_MYCTU,Rv1691,Rv1691,GO:0005618,IPR011990; ,,,,Uncharacterized protein,cell wall [GO:0005618],9634230; 21969609,,,MVDDRQGRRGGRRPRSAAADNRPAFRDGPAIPPGIHARQLAPEIRRELSTLDRATADAVACHLVAAGELIDDDPEAALRHARAARVRASRIAAVREAVGIAAYRCGDWAQALAELRAARRMGSKSPLLALIADCERGLGRPQRAIELARGSEAVELSGDAADELRIVAAGARADLGQLEQALTVLSTPQLDPGRTGSTAARLFYAYAEILLALGRGDEALQWFLRSAAADIDGVTDAEDRVDELGAREQK,"26,682",250,,,,cell wall [GO:0005618],,,1
O06586,O06586_MYCTU,Rv1664,pks9 Rv1664,GO:0008152; GO:0016740; GO:0031177,IPR001227; IPR036736; IPR014043; IPR016035; IPR032821; IPR014031; IPR014030; IPR016036; IPR020801; IPR020841; IPR020806; IPR009081; IPR006162; IPR016039; ,,pks9,DOMAIN 864 942 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable polyketide synthase Pks9,phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; metabolic process [GO:0008152],9634230; 21969609,,,MQPTGIAIIGLACRFPTVVSPGDLWDLLRDGREAAGSIDNVADFDADFFNLSPREASAMDPRQRLALELTWELLEDAFVVPETLRGQPIAVYLGAMNDDYAVLTLAADRVDHHAFAGTSRAIIANRVSFAFGLRGPSVTIDSGQSSSLVAVHLACESVRTGEAPLAIAGGVHLNLARETAMLEQEFGAVSPSGHTYAFDERADGYVPGDGGGLVLLKPVQAALDDGDRIHAIIRGSAVGNAGHSATGLTVPSVAGQVDVIRRAMSGAGVDCHQVHYVEAHGTGTKIGDPIEARALGEIFAARQRRPVSVGSVKTNIGHTGGAAGIAGLLKAVLAIENAVIPPSLNYVGAAIDLDSLGLRVDTALTPWPVADEPRRAGVSSFGMGGTNAHVILEQGPTQSPEIVESVAAAGSNAPVAVPWVLAARSPQALTNQAGRLLAHLTADDGLTALDVGWSLVSTRSVFDHRAVVVGADRGRLMAGLAGLAAGEPGAGVVVGRARSVGKTVFVFPGQGSQWLGMGRQLYGRYSVFARAFDEVVAVLDGQLRLSVRQVMWGADAGLLESTEFAQPALFVVQVALAALLQDWGVLPDLVMGHSVGEIAAAYVAGALSLVDAARVVAARGRLMQALPAGGVMVAVAASEDEVAPLLTEGVCIAAVNAPESVVISGEQAAVGVVVDRLVGLGRRVRRLAVSHAFHSVLMDPMVEEFSKVLADVCVRAPRIGLVSNVTGQLAGAGYGSPAYWVEHVRKPVRFFDGVGLAESLGARVFVEVGPGAGLEASVALLARDRPEVESVLAGVGRLFAEGVAVDWSSVFAGLGGRRVELPTYGFARQRFWLGDNGELSVDQTGKDAGAIARLQSLAPPELQRQLVELVCFHAAIVLGRKSSHDIDPECAFQDLGFDSMSGVELRNRLQMAIGLPGLSLPRTLIFDYPTASALAECLGQLLGGQHESSDDESIWQLLKNIPIHQLRRTGLLDKLLLLAGQPEESLAGRTVSDEVIDSLSPEALIGLALDEDENDIR,"106,403",1017,,metabolic process [GO:0008152],phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],,,,1
P94982,P94982_MYCTU,Rv1647,Rv1647,GO:0000287; GO:0004016; GO:0005622; GO:0005886; GO:0006171; GO:0007165; GO:0009190; GO:0030145; GO:0035556; GO:0042803,IPR001054; IPR029787; ,,,DOMAIN 130 242 Guanylate cyclase. {ECO:0000259|PROSITE:PS50125}.,Adenylate cyclase (ATP pyrophosphate-lyase) (Adenylyl cyclase),intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; cAMP biosynthetic process [GO:0006171]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],9634230; 21969609,,,MAGSARTTYPCHVEVGPQDSESGAPDETATAMASPVPRQRSALRWLRTVNRSPGLVSFIHRARRLLPGDPEFGDPLSTAGEGGPRAAARAADRLLRDRDAASREVGLSVLQVWQALTEAVSRRPANPEVTLVFTDLVGFSTWSLHAGDDATLTLLRQVARAVESPLLDAGGHIVKRLGDGIMAVFRNPTVALRAVLVAQDAVKSLEVQGYTPRMRIGIHTGRPQRLAADWLGVDVNIAARVMERATKGGIMISQPTLDLIPQSELDALGVVARRVRKPVFASKPTGIPPDLAIYRIKTVSESTAADNFDEMSPDAQ,"33,957",316,,cAMP biosynthetic process [GO:0006171]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],adenylate cyclase activity [GO:0004016]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803],intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
O53923,O53923_MYCTU,Rv1676,Rv1676,GO:0005886; GO:0016209; GO:0016491,IPR000866; IPR036249; ,,,DOMAIN 51 205 AhpC-TSA. {ECO:0000259|Pfam:PF00578}.,Uncharacterized protein,plasma membrane [GO:0005886]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MACPEWEISRSKRTRKPVLRPRHSVSTLTNRFLAEFCHRYGIGVPTRLARGATVPTRRLQDINDQPVDVPAATGRTHLQFRRFAACPICHLHLRSFANRHQEVADSGITEVVFFHSAADALRGYQSLLPFAVIADPDRVQYREFGVEKSLGAITHPRALWAAVRGSAAMLHRNDPERAGVGFGDGTTHLGLPADFLLDADGTVAAVHYGRHADDQWSVDQLIDINRSLGGKGTQ,"25,877",234,,,antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
L0TAY1,L0TAY1_MYCTU,Rv1907c,Rv1907c,,IPR025358; ,,,,Uncharacterized protein,,9634230,,,MIGPARRSTTTRRSTPRADRLAGCWCLPGAICQTPRAWWSQARRDGDDETGMRRKGAEMCWMCDHPEATAEEYLDEVYGIMLMHGWAVQHVECERRPFAYTVGLTRRGLPELVVTGLSPRRGQRLLNIAARRALVGDLLTPGMQTTLPAGPLVETVQVTHPDAHLYCAIAIFGDKVTALQLVWADRRGRWPWAADFDEGRGTQPVLGMRATRRSA,"24,053",215,,,,,,,1
O06128,O06128_MYCTU,Rv1610,Rv1610,GO:0016021; GO:0040007,IPR019051; IPR011746; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230,,,MAANAGSVRPNRRARPMIGIAQLLLVVAAGALWMAARLPWVVIGSFDELGPPKEVTLTGASWSTALLPLALLMLAAAVAALAVRGWPLRALAVLLAAASFAVGYLGISLWVVPDVAARGADLAHVPVVTLVGSARHYWGAVAAVLAAVCALLAAVFLMSSAAIRGSAGEDMARYAAPRARRSIARRQHSNAAGRAAPQDDGPDMGPRMSERMIWEALDEGRDPTDREQESDTEGR,"24,619",235,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,1
O33203,O33203_MYCTU,Rv1704c,cycA Rv1704c,GO:0005829; GO:0005886; GO:0006865; GO:0016021; GO:0022857,IPR004841; IPR002293; IPR004840; ,,cycA,DOMAIN 25 433 AA_permease. {ECO:0000259|Pfam:PF00324}.,Probable D-serine/alanine/glycine transporter protein CycA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865],9634230,,,MPDDIAAADPTDTQPHLRRDLANRHIQLIAIGGAIGTGLFMGSGRTISLAGPAVMVVYGIIGFFVFFVLRAMGELLLSNLNYKSFVDFAADLRGPAAGFFVGWSYWFAWVVTGIADLVAITGYARFWWPGLPIWVPALVTVALILAVNLFSVRHFGELEFWFALIKVAAIVCLIAVGAILVATNFVSPHGVHATIENLWNDNGFFPTGFLGVVSGFQIAFFAYIGVELVGTAAAETADPRRTLPRAINAVPLRVAVFYIGALLAILAVVPWRQFASGESPFVTMFSLAGLAAAASVVNFVVVTAAASSANSGFFSTGRMLFGLADEGHAPAAFHQLNRGGVPAPALLLTAPLLLTSIPLLYAGRSVIGAFTLVTTVSSLLFMFVWAMIIISYLVYRRRHPQRHTDSVYKMPGGVVMCWAVLVFFAFVIWTLTTETETATALAWFPLWFVLLAVGWLVTQRRQSRRSFGFHCQVVGVRQQLGRGMARLAMKIHARPKLRSAVVVEPVSAGEPGARRSAKSVRKLASDDSQSAHCPVAVVGLADGGRDPQYHHDGPDR,"60,047",556,,amino acid transport [GO:0006865],transmembrane transporter activity [GO:0022857],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O33188,O33188_MYCTU,Rv1686c,Rv1686c,GO:0010033; GO:0043190; GO:0043215; GO:0046677; GO:0055085; GO:1900753,IPR013525; IPR000412; IPR004377; ,,,,Transport permease protein,ATP-binding cassette (ABC) transporter complex [GO:0043190]; daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; response to antibiotic [GO:0046677]; response to organic substance [GO:0010033]; transmembrane transport [GO:0055085],9634230,,,MILLVPILIITLMYFMFENVPHRPGTPSGFNTACLVLLGLFPLFVMFVITAITMQRERASGTLERILTTPLRRLDLLAGYGTAFSIAAAAQATLACIVAFWFLGFDTAGSPVWVFAIAIVNAVLGVGLGLLCSAFARTEFQAVQFIPLVMVPQLLLAGIIVPRALMPTWLEWISNVMPASYALEALQQVGAHPELTGIAVRDVVVVLSFAVASLCLAAVTLRRRTS,"24,392",226,ABC-2 integral membrane protein family,daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; response to antibiotic [GO:0046677]; response to organic substance [GO:0010033]; transmembrane transport [GO:0055085],,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
O06604,O06604_MYCTU,Rv1586c,Rv1586c,GO:0000150; GO:0003677; GO:0005618; GO:0008979,IPR011109; IPR006119; IPR036162; ,,,DOMAIN 8 154 Resolvase/invertase-type recombinase catalytic. {ECO:0000259|PROSITE:PS51736}.; DOMAIN 161 275 Recombinase. {ECO:0000259|PROSITE:PS51737}.,Probable PhiRv1 integrase,cell wall [GO:0005618]; DNA binding [GO:0003677]; prophage integrase activity [GO:0008979]; recombinase activity [GO:0000150],9634230; 21969609,,,MRYTTPVRAAVYLRISEDRSGEQLGVARQREDCLKLCGQRKWVPVEYLDNDVSASTGKRRPAYEQMLADITAGKIAAVVAWDLDRLHRRPIELEAFMSLADEKRLALATVAGDVDLATPQGRLVARLKGSVAAHETEHKKARQRRAARQKAERGHPNWSKAFGYLPGPNGPEPDPRTAPLVKQAYADILAGASLGDVCRQWNDAGAFTITGRPWTTTTLSKFLRKPRNAGLRAYKGARYGPVDRDAIVGKAQWSPLVDEATFWAAQAVLDAPGRAPGRKSVRRHLLTGLAGCGKCGNHLAGSYRTDGQVVYVCKACHGVAILADNIEPILYHIVAERLAMPDAVDLLRREIHDAAEAETIRLELETLYGELDRLAVERAEGLLTARQVKISTDIVNAKITKLQARQQDQERLRVFDGIPLGTPQVAGMIAELSPDRFRAVLDVLAEVVVQPVGKSGRIFNPERVQVNWR,"51,742",469,,,DNA binding [GO:0003677]; prophage integrase activity [GO:0008979]; recombinase activity [GO:0000150],cell wall [GO:0005618],,,1
P95281,P95281_MYCTU,Rv1933c,fadE18 Rv1933c,GO:0016627; GO:0050660,IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE18,,Probable acyl-CoA dehydrogenase FadE18,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230,,,MDFRYSTEQDDFRASLRGFLGRGAPVREMAAADGSDRRLWQRLCTELELPALHVPPEHGGLGATLVETAIAFAELGRALTPIPFAATVFAIEAILRMGDDEQRKRLLAGLLTGARIGTIAVSGHDVASATTVRAVRRDGRPALTGECTPVLHGHVADLFVVPAVADGSIVLHVVAADAPGVTVTPLPSFDITRPVATLRLAGSPAEPLTAGTPDDMERVLDVARVLLAAEMLGGAEACLDLAVQYAGRRTQFDRPIGSFQAVKHACADMMIEIDATRATVMFAAMSAANGDELQTVAPLAKAQTAETFVLCAGSALQIHGAIAFTWEHDLHLYYRRAKTTEALFGSSARNRALLAERAGLVKA,"38,509",363,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,2
O06606,O06606_MYCTU,Rv1584c,Rv1584c,,,,,,Possible PhiRv1 phage protein,,9634230,,,MSTIYHHRGRVAALSRSRASDDPEFIAAKTDLVAANIADYLIRTLAAAPPLTDEQRTRLAELLRPVRRSGGAR,"8,028",73,,,,,,,1
O53918,O53918_MYCTU,Rv1671,Rv1671,GO:0016021,,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230,,,MPTVGPADHAAGLDRRATPDQLPIWRIGIISGLVGMLCCVGPTILALVGIISAATAFAWANDLYDNYAWWFRVSGLAVLAILVWWALRHRNRCSVNAIRRLRWRLMAVLAIAVGTYGVLSAVTTWFGTFV,"14,267",130,,,,integral component of membrane [GO:0016021],,,3
L7N688,L7N688_MYCTU,Rv1715,fadB3 Rv1715,GO:0003857; GO:0006631; GO:0070403,IPR022694; IPR006176; IPR006108; IPR008927; IPR013328; IPR036291; ,,fadB3,,Probable 3-hydroxybutyryl-CoA dehydrogenase FadB3 (Beta-hydroxybutyryl-CoA dehydrogenase) (BHBD),3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid metabolic process [GO:0006631],9634230,,,MLTSHGFSRAAVVGAGLMGRRIAGVLASAGLDVAITDTNAEILHAAAVEAARVAGAGRGSVAAAADLAAAIPDADLVIEAVVENLAVKQELFERLATLAPDAVLATNTSVLPIGAVTERVEDGSRVIGTHFWNPPDLIPVVEVVPSARTAPDTADRVVALLTQVGKLPVRVGRDVPGFIGNRLQHALWREAIALVAEGVCDPKTVDLVVRNTIGLRLATLGPLENADYIGLDLTLAIHDAVIPSLNHDPHPSPLLRELVAAGQLGARTGHGFLDWPAGAREATTARLAQHIAAQLQANEKGRGT,"31,506",304,,fatty acid metabolic process [GO:0006631],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403],,,,1
O33179,O33179_MYCTU,Rv1776c,Rv1776c,GO:0003677; GO:0003700; GO:0005886; GO:0006355,IPR009057; IPR001647; ,,,DOMAIN 14 74 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MPGNDWIVGGNRRTIAAERIYAAATDLITRYGLNALDIDKLAREVHCSRATIYRRAGGKAQIRDVVLTRAAARIADGVRSDVETLRGRERVVAAILLSLQRIRSDPLGKLMFGSIHGGAGELAWLTESPLLADFATELTGIAGGDPQGAKWVVRVVLSLMYWPAENDEAERRLVEKYVAPAFAEQS,"20,314",186,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,1
O33189,O33189_MYCTU,Rv1687c,Rv1687c,GO:0005524; GO:0010033; GO:0016887,IPR003593; IPR003439; IPR017871; IPR027417; ,,,,Probable conserved ATP-binding protein ABC transporter,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; response to organic substance [GO:0010033],9634230; 21969609,,,MMISSSDELLRDGADPAVIIDQLRVIRGKRLALQDVSVRVACGTITGLLGPSGSGKTTLIRCIVGSQIIASGSVSVLGQPAGSAELRHRVGYMPQDPTIYNDLRVIDNIRYFAELCGVDRQAADEVIEAVDLRDHRTARCANLSGGQRARVSLACALVGRPDLLVLDEPTIGLDPVLRVELWDRFTALARRGTTLLVSSHVMDEADRCGDLLLLRQGQLLAHTTPHRLRKETGCTSLEEAFLSIVRRTTTVPAAG,"27,558",255,,response to organic substance [GO:0010033],ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
O06133,O06133_MYCTU,Rv1616,Rv1616,,IPR021215; ,,,,Conserved membrane protein,,9634230,,,MEASGRQRRYAAAGSVVLLAGALGYIGLVDPHNSNSLYPPCLFKLLTGWNCPACGGLRMIHDLLHGELAASINDNVFLLVGVPVLASWVLLRRRHGDLALPIPVMIAVAVAVIAWTVLRNLPGFPLVPTISG,"14,030",132,,,,,,,1
P95154,P95154_MYCTU,Rv1861,Rv1861,GO:0016021,IPR007341; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MDITATTEFSAMNLDGKTGIGWLGYIVIGGIAGWLASKIVKGGGSGILMNVVIGVVGAFGAGLVLNALGVDVNHGGYWFTFFVALGGAVVLLWIVGMVRKT,"10,330",101,,,,integral component of membrane [GO:0016021],,,1
O53921,O53921_MYCTU,Rv1674c,Rv1674c,GO:0003700; GO:0004792; GO:0005886,IPR011991; IPR001845; IPR001763; IPR036873; IPR001307; IPR036388; IPR036390; ,,,DOMAIN 4 98 HTH arsR-type. {ECO:0000259|PROSITE:PS50987}.; DOMAIN 128 217 Rhodanese. {ECO:0000259|PROSITE:PS50206}.,Probable transcriptional regulatory protein,plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; thiosulfate sulfurtransferase activity [GO:0004792],9634230; 21969609,,,MSGAKKLIFEQFALVGQALSSGHRLELLDLLVQGERSVDALARASGLTFANASQHLLQLRRAGLVTSRRDGKRVIYALSDPQVWDVVRAVRAVAERNLASVGSLVRQYYTDRDSLEPISRDELQARVAAGSVLVLDVRPAMEYAAGHLPGAVSIPLDELAERLDELPSGIDIVACCRGPYCVYAYDALELLRPNGFSARRLDGGFSEWLAADLPVVRT,"23,759",218,,,DNA binding transcription factor activity [GO:0003700]; thiosulfate sulfurtransferase activity [GO:0004792],plasma membrane [GO:0005886],,,1
I6YBN6,I6YBN6_MYCTU,Rv1811,mgtC Rv1811,GO:0016021,IPR003416; ,,mgtC,,Possible Mg2+ transport P-type ATPase C MgtC,integral component of membrane [GO:0016021],9634230,,,MQTLTVADFALRLAVGVGCGAIIGLERQWRARMAGLRTNALVATGATLFVLYAVATEDSSPTRVASYVVSGIGFLGGGVILREGFNVRGLNTAATLWCSAAVGVLAASGHLVFTLIGTGTIVAVHLLGRPLGRLVDRDNAVEDEGLQPYQVRVICRPKAETYVRAHIVQRTSSNDITLRGIRTGPAGDDNITLTAHLLMVGHTPAKLERLVAELSLQPGVYAVHWYAGEHAQAE,"24,807",234,,,,integral component of membrane [GO:0016021],,,1
O53954,O53954_MYCTU,Rv1805c,Rv1805c,GO:0005829,,,,,Uncharacterized protein,cytosol [GO:0005829],9634230,,,MTASVVATSRERHSHKAAKQRACEITDFEPEGRFRVRKRRRGRIGTKRSSISDTDYRRDSFRSHLLTAGAHGDADAQHKGMTAQQTTELGTPLVRALAPHGVSGRSSRKPLGLNP,"12,703",115,,,,cytosol [GO:0005829],,,3
P95291,P95291_MYCTU,Rv1922,Rv1922,,IPR001466; IPR012338; ,,,,Probable conserved lipoprotein,,9634230; 21969609,,,MDSTVTASIRRMLGLLAATLLLGGCTGQHTTRTAASTTYTPHIKASSQDVLDGAINADEPGCSAAVGVEGKVIWSGVRGIADLASGAKITTDTVFDIASVSKQFTATAILLLVEAGKLTLDDPISQYVPELPDWAQTVTVEQLMHQTSGIPDYVALLAARGYQVSDRTIEAEARQALAAAPELQFKPGTRFDYSNSNYLLLGEIVHRASGQPLPEFLSAEIFQPLGLAMVVDPVGKVPNKAVSYEKGTGGNRSEYRVGNPAWEQIGDGGIQTTPSQLARWADNYRTGSVGGLKLLEAQLAGAVETEPGGGDRYGAGIVSRADGTLDHAGAWAGFVTAFHISSDRRTSVAISCNTDKPDPVAMADALGRLWM,"39,062",371,,,,,,,1
O33184,O33184_MYCTU,Rv1682,Rv1682,,IPR007793; ,,,,Probable coiled-coil structural protein,,9634230; 21969609,,,MLPQRPNCTKLFRPRRGVSERYRVTTAHNGSAPRFQRTRSGYDPVAVNHYIAELVLRQQAQHCEIETLKAEIASLKDENAALKDTSPSAQAVTDRMAKMLRLAVDEVFQMQSEARAEAATLVSAARDEAEAVRTQKREMLADMNARQRALESEHADVMRRAREEAEQLVAQATAEVERMRVIDARRREKAEQELDAEIIRLRTDAQFQIDDQLQATQQECEKRLGEAKIEADRRLHVADEQIEHGLSEARRTLEEISQRRVGILEQLARIHAQLENIPALLESARHSETEPLQSINGAVAELRAI,"34,666",305,,,,,,,1
O06612,O06612_MYCTU,Rv1578c,Rv1578c,,IPR022357; IPR006448; ,,,,Probable PhiRv1 phage protein,,9634230,,,MPRPPKPARLKLVEGRSPGRDSGGRKVPESPKFIRQAPDAPDWLDAEALAEWRRVAPTLERLDLLKPEDRALLSAYCETWSVYVAAVQRVRAEGLTITSPKSGVVHRNPAVTVAETARMHLLRLASEFGLTPAAEQRLAVAPGDDGDGLNPFAPDR,"17,050",156,,,,,,,1
O53929,O53929_MYCTU,Rv1716,Rv1716,GO:0004061; GO:0019441,IPR007325; IPR037175; ,,,,Uncharacterized protein,arylformamidase activity [GO:0004061]; tryptophan catabolic process to kynurenine [GO:0019441],9634230,,,MTFAWPLGAAESTLEFYDLSHPWGHGAPAWPYFEDVQIERLHGMAKSRVLTQKITTVMHSGTHIDAPAHVVEGTPFLDEIPLSAFFGTGVVVSIPKGKWGMVTAEDLQNATPDIRPGDIVVVNTGWHHKYADSAEYYAYSPGFDKKAGEWFAAKGVKAVGTDTQALDHPLATAIAPHSPAEAQGGLLPWAVREYEAQTGRKVLDDFPDWEPCHRAILSQGIYGFENVGGDLDKVTGKRVTFAAFPWRWVGGDGCIVRLVAIVDPTGSYRIETGKAV,"30,073",276,,tryptophan catabolic process to kynurenine [GO:0019441],arylformamidase activity [GO:0004061],,,,2
O33187,O33187_MYCTU,Rv1685c,Rv1685c,GO:0000976; GO:0003700; GO:0005829; GO:0010033,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 18 78 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Uncharacterized protein,cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; response to organic substance [GO:0010033],9634230; 21969609,,,MAAPDNSRRRPGRPAGSSDTRERILSSARELFAHNGIDRTSIRAVAAKAGVDAALVHHYFGTKQQLFAAAIHIPIDPMVIIGPIREAPVEELGYKLPSLLLPIWDSELGAGLIATLRSLISGSDVGLARSFLEEVVTVELGSRVDNPPGTGKIRTQFVASQLMGVVMARYIVRIEPFASLPAEQIVQTIAPNLQRYLTGELPDDLAP,"22,324",207,,response to organic substance [GO:0010033],DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O33195,O33195_MYCTU,Rv1693,Rv1693,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTIDPDQIRAEIDALLASLPDPADAENGPSLAELEGIARRLSEAHEVLLAALESAEKG,"6,095",58,,,,,,,1
O53915,O53915_MYCTU,Rv1667c,Rv1667c,GO:0005524; GO:0016887,IPR003439; IPR027417; ,,,DOMAIN 20 67 ABC transporter. {ECO:0000259|Pfam:PF00005}.,Probable second part of macrolide-transport ATP-binding protein ABC transporter,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MLGRLRGGYQVEGREVTPTQLLERLGFRRDQLSARVDDLSGGQRRRLQLMLTLLSEPNVLLLDEPTNDVDTEMLTATEDLLDSWAGTLIVVSHDRYLLERVTDQQYAILDDRLRHLPGGIDEYLQLAARVSAPAPAERPAPPAMSGAQRRATEKELAAVDRQLARLADRVAAKHTELAEHDQSDHVGITRLTQQLRVLQDHVAAMENRWLELSEMLE,"24,472",217,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
O33271,O33271_MYCTU,Rv1742,Rv1742,GO:0005618,,,,,Uncharacterized protein,cell wall [GO:0005618],9634230; 21969609,,,MSALLDGVLDAHGGLQRWRAAETVHGRVRTGGLLLRTRVPGNRFADYRITVHVQQARTVLDPFPRDGYRGVFESGQVRIESHDGAVISSRAHPRAAFFGRSGLRRNIRWDPLDSVYFAGYAMWNYLTTPYLLTREGVAVEEGAPWQQEGETWRRLIVSFPPDIDTHSPRQTFYVDASGLLRRHDYVPEVVGHWARAAHYCADPVDVDGFVFPTCRWVHPIGPGNRSLPFPTLVSILLTDIRVETD,"27,702",245,,,,cell wall [GO:0005618],,,1
P95146,P95146_MYCTU,Rv1869c,Rv1869c,GO:0005576; GO:0005886; GO:0016491; GO:0050660,IPR036188; IPR023753; IPR016156; IPR028202; ,,,,Probable reductase,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MASSTTFVIVGGGLAGAKAVEALRRSDFGGRIILFGDEEHLPYDRPPLSKEFLAGKKSLSDFTIQTSDWYRDHDVDVRLGVRVSSLDRSAHTVELPDGAAVRYDKLLLATGSAPRRPPIPGSDAAGVHYLRSYNDAVALNSVLVQGSSLAVVGAGWIGLEVAASARQRGVDVTVVETAIQPLLAALGEAVGKVFADLHRDQGVDLRLQTQLEEITAADGKATGLKMRDGSTVAADAVLVAVGAKPNVELAQQAGLAMGEGGVLVDASLRTSDPDIYAVGDIAAAEHPLLGTRVRTEHWANALKQPAVAAAGMLGRPGEYAELPYLFTDQYDLGMEYVGHAPSCDRVVFRGNVAGREFLSFWLDGDSRVLAGMNVNVWDVVDDVKGLIRSGNPVDVDRLVDPQWPLADLTTN,"43,629",411,,,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
L7N673,L7N673_MYCTU,Rv1638A,Rv1638A,,,,,,Uncharacterized protein,,9634230; 21969609,,,MPDEPTPPEATTPNSESDPRYDSAGVPTFESVREKIETRYGTALGATELDAESPQGRRLEDQYAQRQRAAAERLAQIRESMHTDE,"9,507",85,,,,,,,1
P95160,P95160_MYCTU,Rv1854c,ndh Rv1854c,GO:0003955; GO:0005886; GO:0005887; GO:0019646,IPR036188; IPR023753; ,,ndh,,Probable NADH dehydrogenase Ndh,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; aerobic electron transport chain [GO:0019646],9634230; 21969609,,,MSPQQEPTAQPPRRHRVVIIGSGFGGLNAAKKLKRADVDIKLIARTTHHLFQPLLYQVATGIISEGEIAPPTRVVLRKQRNVQVLLGNVTHIDLAGQCVVSELLGHTYQTPYDSLIVAAGAGQSYFGNDHFAEFAPGMKSIDDALELRGRILSAFEQAERSSDPERRAKLLTFTVVGAGPTGVEMAGQIAELAEHTLKGAFRHIDSTKARVILLDAAPAVLPPMGAKLGQRAAARLQKLGVEIQLGAMVTDVDRNGITVKDSDGTVRRIESACKVWSAGVSASRLGRDLAEQSRVELDRAGRVQVLPDLSIPGYPNVFVVGDMAAVEGVPGVAQGAIQGAKYVASTIKAELAGANPAEREPFQYFDKGSMATVSRFSAVAKIGPVEFSGFIAWLIWLVLHLAYLIGFKTKITTLLSWTVTFLSTRRGQLTITDQQAFARTRLEQLAELAAEAQGSAASAKVAS,"49,619",463,,aerobic electron transport chain [GO:0019646],NAD(P)H dehydrogenase (quinone) activity [GO:0003955],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O06798,O06798_MYCTU,Rv1765c,Rv1765c,GO:0003676; GO:0004519; GO:0005829,IPR003870; IPR002711; IPR003615; ,,,DOMAIN 297 348 HNHc. {ECO:0000259|SMART:SM00507}.,Uncharacterized protein,cytosol [GO:0005829]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676],9634230,,,MSSTATSGAAVVSPAERVEVLFEELAELAGQRNAIDGRIVEIVAELDRDGLWGVTGARSVAGLVAWKMGCSSGNAHTIATVARRLPEFPRCARGMREGRLSLDQVGVIAGRAGEGSDAHYAQLAGVATVNQLRTALKLEPRPEPEPDFRPEPRPSITRSADEQFSCWRIKLPHVEAAKFDAALQSHLDALIAEYKRDHDNSDGVSDQRPPLPGNVEAFLRLVEAGWDAEVARRPHGQHTTVVMHLDVQERAAGLHLGPLLSESERRYLLCDATFEAWFERDGQVIGCGRTTRQINRRLRRALEHRDRTCVVPGCGATRGLHAHHIRHWQDGGATELANLVLVCPYHHRAHHRGLNRPGESGDSLI,"40,091",365,,,endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676],cytosol [GO:0005829],,,2
P95161,P95161_MYCTU,Rv1853,ureD Rv1853,GO:0006807; GO:0016151,IPR002669; ,,ureD,,Probable urease accessory protein UreD,nickel cation binding [GO:0016151]; nitrogen compound metabolic process [GO:0006807],9634230; 21969609,,,MVASPNRLPRIDCRGGVQARRTAPDTVHLVSAAATPLGGDTMRIRVIVERGAQLRLRSAAATVALPGVDTLTSHAHWEIDVTGTLDVDLEPTVVAASARHLSHATLRLHDDGRVRLRERVQIGRCNEREGFWSSSLQADRHGRPLLRHRVELGAGSLADDVIAAPRATISELRYPATAFTDAIDARSTVLALAGGGTLSTWQADRLPG,"22,335",208,,nitrogen compound metabolic process [GO:0006807],nickel cation binding [GO:0016151],,,,4
O06144,O06144_MYCTU,Rv1627c,Rv1627c,GO:0003988; GO:0005618; GO:0005886; GO:0006635,IPR002155; IPR016039; IPR020616; ,,,DOMAIN 9 227 Thiolase_N. {ECO:0000259|Pfam:PF00108}.,Probable nonspecific lipid-transfer protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MRMSAPEPVYILGAGMHPWGKWGNDFTEYGVVAARAALRDAGVDWRHVQLVAGADTIRNGYPGFVAGATFAQKLGWTGVPVSSSYAACASGSQALQSARAQILAGFCDVALVIGADTTPKGFFAPVGGERKGDPDWQRFHLIGATNTVYFALLARRRMDLYGATVEDFAQVKVKNSRHGLDNPNARYRKENSIDDVLASPVVSDPLRLLDICATSDGAAALIVASKSFTEKHLGSVAGVPSVRAISTVTPKYPQHLPELPDIATDSTAAVPAPERVFKDQILDAAYAEAGIGPEDLSLAEVYDLSTALELDWYEHLGLCPKGEAEALLRSGATTLGGRVPVNPSGGLACFGEAIPAQAIAQVCELTWQLRGQATGRQVADAKVGVTANQGLFGHGSSVIVAR,"42,386",402,,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O06603,O06603_MYCTU,Rv1587c,Rv1587c,,IPR003870; IPR003615; ,,,DOMAIN 136 188 HNHc. {ECO:0000259|SMART:SM00507}.,Partial REP13E12 repeat protein,,9634230,,,MLAKLAAPGATNPDDHTPVIDTTPDAAAIDRDTRSQAQRNHDGLLAGLRALIASGKLGQHNGLPVSIVVTTTLTDLQTGAGKGFTGGGTLLPMADVIRMTSHAHHYSPASGRYPQAIFDHGTPLALYHTKRLASPAQRIMLFANDRGCTKPGCDAPAYHSQAHHVTAWTSTGRTDITELTLACGPDNRLAEKGWTTHNNTHGHTEWLPPPHLDHGQPWTCEIHYTCACCCLPPNLRRPLRRTARRGPPTRGLPKAVRAAKMGARRVPRQRRQRINRQAPPRLRADVGRHHRRQDRRRGGLGPGPAPSPSHRAGSLHVISRREAAGPGHRRRRR,"36,377",333,,,,,,,2
O86372,O86372_MYCTU,Rv1717,Rv1717,,IPR013096; IPR014710; IPR011051; ,,,,Uncharacterized protein,,9634230,,,MKLTRASQAPRYVAPAHHEVSTMRLQGREAGRTERFWVGLSVYRPGGTAEPAPTREETVYVVLDGELVVTVDGAETVLGWLDSVHLAKGELRSIHNRTDRQALLLVTVAHPVAEVA,"12,723",116,,,,,,,1
P94979,P94979_MYCTU,Rv1645c,Rv1645c,,IPR018713; ,,,DOMAIN 19 250 DUF2236. {ECO:0000259|Pfam:PF09995}.,Uncharacterized protein,,9634230,,,MTVASRTSADPLGPDSLTWKYFGDLRTGMMGVWIGAIQNMYPELGAGVEEHSILLREPLQRVARSVYPIMGVVYDGDRAAQTGQQIKGYHRTIKGVDAEGRRYHALNPDTFYWAHATFFMLVIKVAEYFCGGLTEAEKHQLFEEHVRWYRMYGMSMRPVPKSWEDFQDYWDRVCRDKLEINQATVDILQMRIPKPRFVLMPTPIWDQLFKPLIAGQRWIAAGLFDPAVREKAGMHWTPGDEVLLRVFGKVVELAFLAVPDEIRLHPRALAAYRRAAGRTRHDAPLVQAPGFMAPPRDRQGLPMHYFPPRSHRFTRSALDPAKALMERAGALVHSTLSLAGVRPARGPSRAA,"39,864",351,,,,,,,1
O07720,O07720_MYCTU,Rv1913,Rv1913,,IPR001279; IPR036866; ,,,,Uncharacterized protein,,9634230; 21969609,,,MHFDWERLTDSVHRCRLPFCDVTVGLVRGRTGILLVDTGTTLGEATAIAADVKQIAGCQVTHVVLTHKHFDHVLGSSVFDQAEVFCAPEVVEYLRSATDRLREDALSYGADTAEVDRAIAALKPPQHGIYDAAVDLGDRTVTITHPGSGHTTADLVVVAPATGHADGPTVVFTGDLVEESADPDIDADSDLAAWPATLDRVLAIGGPDASYVPGHGKVVDAQFVRRQRAWLRTRASRQPRETPATLPCKR,"26,876",250,,,,,,,1
Q79FI8,Q79FI8_MYCTU,Rv1918c,PPE35 Rv1918c,,IPR002989; IPR000030; IPR038332; ,,PPE35,,PPE family protein PPE35,,9634230,,,MHYSVLPPEINSALIFAGAGSGPMLAAASAWDGLATELASAAVSFGSVTAGLVGGSWQGRSSVAMAAAAAPYAGWLAAAATQAEQAATQAQVMVAEFEAVRLAMVQPALVAANRSGLISLVISNLFGQNAPAIAAAEAAYEEMWALDVSAMAAYHSGASAVAVALPAFALPLRLPAGLAAGPAAVVTALTTAVGMPTFAGRAIAASLGLANVGGGNLGNANNGLGNIGNANLGNNNLGSGNFGSFNIGSANLGGNNIGIGNAGANNFGLANLGNLNTGFANAGIGNFGIANTGNNNIGNGLTGNNQIGIGGLNSGNGNVGLFNAGSANIGFFNSGNGNFGIGNSGNFSTGLFNPGHGNTGFLNAGSFNTGMFDVGNANTGSFNVGHYNFGAFNPGPSNTGTFNTGGANTGWFNTGSINTGAFNIGDMNNGLFNTGDMNNGVFYRGVGQGSLQFAITSPDLTLPSLEIPGISVPAFSLPAITLPSLTIPAVTTPANVTVGAFDLPGLTVPSLTIPAAMTPANITVGAFDLPGLTVPSLTIPATTTPANITVGAFNLPQLSIPSVTVPPITIPAGTALGAFNLPTLSIPSVTVPPITIPAGTTVGGFTLPTIHTPLISTPQISIGGFSTPGIATQANSGVINLPTFSLNGITITNLVVFIPNNITALQTNMPGVFPQIGGFANTPPAFINTGTITVGGGQINGVGFSIGAINVTPFTLPNVVIQPWSLGGISVDGFTLPEISTQEFTTPALTISPIGVGALSLPDITTQQFTTPELTIDPITLGGFTLPQLSIPAITTPAFTIDPIALGGFTLPQIMTPEITTPPFAIDPIGLSGFTLPQVNIPEITTPEFTIQPVGLAAFTTPALTIASIHLPSTTMGGFAIPAGPGYFNSSATPSLGFFNAGIGGNSGFGNSGSGLSGWFNTSPVGLLAGSGYQNYGGLISGFSNLGSGISGFANTGTLPFAVTSLVSGLANIGNNLSGLFFQSTTP,"97,951",987,Mycobacterial PPE family,,,,,,1
O65936,O65936_MYCTU,Rv1751,Rv1751,GO:0005829; GO:0005886; GO:0071949,IPR002938; IPR036188; ,,,,Probable oxidoreductase,cytosol [GO:0005829]; plasma membrane [GO:0005886]; FAD binding [GO:0071949],9634230; 21969609,,,MIATMPSMARRSRHDNKITTPAVDCLTIERLDSPASGAPQVTPYARALMGETTTCAIIGGGPAGMVLGLLLARAGVQVTLLEKHGDFLRDFRGDTVHPTTMRLLDELGLWERFAALPYSEVRTATLHSNGRAVTYIDFERLHQPYPYVAMVPQWDLLNLLAEAAQAEPSFTLRMKTEVTGLLREGGKVTGVRYQGAEGPGELRAELTVACDGRWSIARHEAGLKAREFPVNFDVWWFKLPREGDAEFSFLPRFSPGKGLGVIPREGYFQIAYLGPKGTDAQLRERGIEEFRRDVSELLPEATASVAALASMDEVKHLNVKVNRLRRWHIDGLLCIGDAAHAMSPVAGVGINLAVQDAVAAATILAEPLREHRVSSRHLAAVRRRRAFPTAVTQAVQRVLHRRLLGPLLQGRDPTPPAALLGLVERLPWLSAVPAYFVGVGVRPEHAPAFARRGPGNRKGP,"50,412",460,,,FAD binding [GO:0071949],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P71985,P71985_MYCTU,Rv1727,Rv1727,GO:0046872,IPR017517; IPR017520; IPR034660; IPR024344; ,,,,Uncharacterized protein,metal ion binding [GO:0046872],9634230,,,MDLYSNLVEAEQRLVALVSSIEADSYSSPTPCDRWDVRALLSHALASIDAFAAAVDGAPGPDMAQVFSGADIVGDDPLGATQRITRRSQAAWSTVRDLNAELSTFIGVMPAGQALAIITFSTVVHGWDLAVATGQAGELPEHLAEAAQQVAAELVPVLRPRGLFAHDVDLAGEATPTQRLVALTGRKPR,"19,910",189,,,metal ion binding [GO:0046872],,,,1
O06805,O06805_MYCTU,Rv1772,Rv1772,GO:0003723; GO:0006351; GO:0031564,IPR005561; IPR024189; ,,,DOMAIN 9 70 ANTAR. {ECO:0000259|PROSITE:PS50921}.,Uncharacterized protein,"RNA binding [GO:0003723]; transcription antitermination [GO:0031564]; transcription, DNA-templated [GO:0006351]",9634230,,,MGSTGGSQPMTANRGPAAISSGSNSGRVLDTARGILIALRRCPAETAFDELHNAAQRHRLPVFEIAWALVHLAVEGSTPCRSFVDAQSAARREWGQLFAHAAA,"10,896",103,,"transcription, DNA-templated [GO:0006351]; transcription antitermination [GO:0031564]",RNA binding [GO:0003723],,,,1
I6X235,I6X235_MYCTU,Rv1700,Rv1700,GO:0016787,IPR015797; IPR000086; ,,,,NUDIX hydrolase,hydrolase activity [GO:0016787],9634230; 21969609; 27683242,X-ray crystallography (1),,MAEHDFETISSETLHTGAIFALRRDQVRMPGGGIVTREVVEHFGAVAIVAMDDNGNIPMVYQYRHTYGRRLWELPAGLLDVAGEPPHLTAARELREEVGLQASTWQVLVDLDTAPGFSDESVRVYLATGLREVGRPEAHHEEADMTMGWYPIAEAARRVLRGEIVNSIAIAGVLAVHAVTTGFAQPRPLDTEWIDRPTAFAARRAER,"22,893",207,,,hydrolase activity [GO:0016787],,,,1
P95275,P95275_MYCTU,Rv1939,Rv1939,GO:0010181; GO:0042602,IPR002563; IPR012349; ,,,,Probable oxidoreductase,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],9634230,,,MSCTFDMVPETVDHLDEVGLRRVFGCFPCGVIAVCAMVDDQPVGMAASSFTSVSVDPPLVSICVQNCSTTWPKLRDRPRLGVSVLAEGHDAACMSLSRKEGNRFAGVFWSELSSGGVVIAGAGAWLDCRPYAEIPAGDHLIALLEICAVRADPETPPLVFHGSRFRRLESR,"18,410",171,,,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],,,,2
O33178,O33178_MYCTU,Rv1775,Rv1775,,,,,,Uncharacterized protein,,9634230,,,MASDLYLGYRNDDADTPFGKFFKPEMAPLPQHVVVALQHGPQAGMALLAFDDAASIVDEGYQQTENGYGILGDGSMQVSVRTDMPGVTPAMWAWWFGWHGSDTRRYKLWHPRAHLSARWKDGDQDSGAGRRGAQRYVGRWSMISEYIGSTKLGAAIQFVEPAAMGLPDDSDDTVSICARLGSADAPVDAGWFVHQVRSTPGGSEMRSRFWMGGPHIAVRKAPEVASKAVRPIASKLIGVSESTARNLLVYCAQEMNHLAGFLADLWESFGDE,"29,751",272,,,,,,,1
L7N662,L7N662_MYCTU,Rv1623c,cydA Rv1623c,GO:0009055; GO:0016021; GO:0019646; GO:0070069,IPR002585; ,,cydA,,Probable integral membrane cytochrome D ubiquinol oxidase (Subunit I) CydA (Cytochrome BD-I oxidase subunit I),cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021]; electron transfer activity [GO:0009055]; aerobic electron transport chain [GO:0019646],9634230; 21969609,,,MNVVDISRWQFGITTVYHFIFVPLTIGLAPLIAVMQTLWVVTDNPAWYRLTKFFGKLFLINFAIGVATGIVQEFQFGMNWSEYSRFVGDVFGAPLAMEGLAAFFFESTFIGLWIFGWNRLPRLVHLACIWIVAIAVNVSAFFIIAANSFMQHPVGAHYNPTTGRAELSSIVVLLTNNTAQAAFTHTVSGALLTAGTFVAAVSAWWLVRSSTTHADSDTQAMYRPATILGCWVALAATAGLLFTGDHQGKLMFQQQPMKMASAESLCDTQTDPNFSVLTVGRQNNCDSLTRVIEVPYVLPFLAEGRISGVTLQGIRDLQQEYQQRFGPNDYRPNLFVTYWSFRMMIGLMAIPVLFALIALWLTRGGQIPNQRWFSWLALLTMPAPFLANSAGWVFTEMGRQPWVVVPNPTGDQLVRLTVKAGVSDHSATVVATSLLMFTLVYAVLAVIWCWLLKRYIVEGPLEHDAEPAAHGAPRDDEVAPLSFAY,"53,827",485,,aerobic electron transport chain [GO:0019646],electron transfer activity [GO:0009055],cytochrome complex [GO:0070069]; integral component of membrane [GO:0016021],,,1
O06608,O06608_MYCTU,Rv1582c,Rv1582c,GO:0005886,IPR006500; IPR014015; IPR027417; IPR014818; ,,,,Probable PhiRv1 phage protein,plasma membrane [GO:0005886],9634230,,,MADIPYGTDYPDAPWIDRDGHVLIDDGGKPTQVHRGQARIAYRLAERYQDKLLHVAGIGWHSWDGRRWAADDRGEAKRAVLAELRQALSDSLNDKELRADVRKCESASGVAGVLDLAAALVPFAATVADLDSDPHLLNVANGTLDLHTLKLRPHAPADRITKICRGAYQSDTESPLWQAFLTRVLPDEGVRGFVQRLAGVGLLGTVREHVLAILIGVGANGKSVFDKAIRYALGDYACTAEPDLFMHRENAHPTGEMDLRGVRWVAVSESEKDRRLAESTIKRLTGGDTIRARKMRQDFVEFTPSHTPLLITNHLPRVPGDDTAIWRRIRVVPFEVVIPADEQDRELDARLQLEADSILSWAVAGWSDYQRIGLSQPDAVLAATSNYREDSDTIKRFIDDECVTSSPVLKATTTHLFEAWQRWRVQEGVPEISRKAFGQSLDTHGYPVTDKARDGRWRAGIAVRGADDFDD,"52,401",471,,,,plasma membrane [GO:0005886],,,3
P95284,P95284_MYCTU,Rv1930c,Rv1930c,GO:0003700; GO:0006355,IPR029062; ,,,,Uncharacterized protein,"DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MTQIAFVAYPGVTALDVVGPYEVLRNLPHAQVRFVWLRGRRATSHWLTLPALKAFGAIPVADERIVHQDNIVTSAGVSAGLDLALWLAGQLGGEARAKAIQLAIEYDPQPPFDSGHMSKASPTTKAAATALLSKDSAKPANLTAATLLAWERALAAVQSRRRKRQPVGAQARRP,"18,663",174,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding transcription factor activity [GO:0003700],,,,1
O06624,O06624_MYCTU,Rv1566c,Rv1566c,GO:0005576,IPR000064; ,,,,Possible Inv protein,extracellular region [GO:0005576],9634230; 21969609; 24107184,X-ray crystallography (2),,MKRSMKSGSFAIGLAMMLAPMVAAPGLAAADPATRPVDYQQITDVVIARGLSQRGVPFSWAGGGISGPTRGTGTGINTVGFDASGLIQYAYAGAGLKLPRSSGQMYKVGQKVLPQQARKGDLIFYGPEGTQSVALYLGKGQMLEVGDVVQVSPVRTNGMTPYLVRVLGTQPTPVQQAPVQPAPVQQAPVQQAPVQQAPVQQAPVQQAPVQQAPVQQAPVQPPPFGTARSR,"23,965",230,,,,extracellular region [GO:0005576],,,3
O06797,O06797_MYCTU,Rv1762c,Rv1762c,GO:0005886,IPR002765; IPR035439; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MQSSSLDPVASERLSHAEKSFTSDLSINEFALLHGAGFEPIELVMGVSVYHVGFQFSGMRQQQELGVLTEATYRARWNAMARMQAEADALKADGIVGVRLNWRHHGEGGEHLEFMAVGTAVRYTAKPGAFRRPNGQAFSSHLSGQDMVTLLRSGFAPVAFVMGNCVFHIAVQGFMQTLRQIGRNMEMPQWTQGNYQARELAMSRMQSEAERDGATGVVGVHFAISNYAWGVHTVEFYTAGTAVRRTGSGETITPSFVLPMDS,"28,755",262,UPF0145 family,,,plasma membrane [GO:0005886],,,1
O06593,O06593_MYCTU,Rv1597,Rv1597,GO:0005829; GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized protein,cytosol [GO:0005829]; methyltransferase activity [GO:0008168],9634230; 21969609,,,MARTFEDLVAEAASASVGGWGFSWLDGRATEERPSWGYQRQLSQRLANATAALDLETGGGEVLAGAGNFPPTMVATEAWPPNAAMATRRLHPLGAVVVITGDKPPLPFADAAFDLVTSRHPSTRWWTEIARVLRAGGSYFAQHVGPATLWDLREHFLGPREHNGADQYAQVVRTCITDAGLEIVDLQMERLRVEFFDVGAVIYFLRKVIWFLPDFTVEGYHDRLRALHERIQAEGPFVTYSTRALIEARKPS,"27,963",252,,,methyltransferase activity [GO:0008168],cytosol [GO:0005829],,,1
P95285,P95285_MYCTU,Rv1929c,Rv1929c,,IPR017517; IPR017519; IPR034660; ,,,,Uncharacterized protein,,9634230; 21969609,,,MADVPLDAQERLELCDLLEELGPAVATLIEGWTAHDLAAHIVLRERDLVAGLCIVLPGPFQRFAERRRARLAQSKDFTWLVARIRSGPPMGFFRIGWVRTLANLNEFFVHHEDVRRASGRGPRSLTPEMDAALWRNVRRGSHFLSRRLHGCGLEIEWVGTGKRVRVRSGEPTARLTGPPGELLLYVFGRRAVARVEVSGPLEAIAAVHRTHFGM,"24,010",214,,,,,,,2
O07732,O07732_MYCTU,Rv1900c,lipJ Rv1900c,GO:0004016; GO:0004383; GO:0004601; GO:0005622; GO:0006171; GO:0006182; GO:0016787; GO:0030145; GO:0035556; GO:0042803,IPR001054; IPR029058; IPR000073; IPR029787; ,,lipJ,,Probable lignin peroxidase LipJ,intracellular [GO:0005622]; adenylate cyclase activity [GO:0004016]; guanylate cyclase activity [GO:0004383]; hydrolase activity [GO:0016787]; manganese ion binding [GO:0030145]; peroxidase activity [GO:0004601]; protein homodimerization activity [GO:0042803]; cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556],9634230; 15678099; 21969609,X-ray crystallography (2),,MAQAPHIHRTRYAKCGDMDIAYQVLGDGPTDLLVLPGPFVPIDSIDDEPSLYRFHRRLASFSRVIRLDHRGVGLSSRLAAITTLGPKFWAQDAIAVMDAVGCEQATIFAPSFHAMNGLVLAADYPERVRSLIVVNGSARPLWAPDYPVGAQVRRADPFLTVALEPDAVERGFDVLSIVAPTVAGDDVFRAWWDLAGNRAGPPSIARAVSKVIAEADVRDVLGHIEAPTLILHRVGSTYIPVGHGRYLAEHIAGSRLVELPGTDTLYWVGDTGPMLDEIEEFITGVRGGADAERMLATIMFTDIVGSTQHAAALGDDRWRDLLDNHDTIVCHEIQRFGGREVNTAGDGFVATFTSPSAAIACADDIVDAVAALGIEVRIGIHAGEVEVRDASHGTDVAGVAVHIGARVCALAGPSEVLVSSTVRDIVAGSRHRFAERGEQELKGVPGRWRLCVLMRDDATRTR,"49,716",462,,cAMP biosynthetic process [GO:0006171]; cGMP biosynthetic process [GO:0006182]; intracellular signal transduction [GO:0035556],adenylate cyclase activity [GO:0004016]; guanylate cyclase activity [GO:0004383]; hydrolase activity [GO:0016787]; manganese ion binding [GO:0030145]; peroxidase activity [GO:0004601]; protein homodimerization activity [GO:0042803],intracellular [GO:0005622],,,1
P95152,P95152_MYCTU,Rv1863c,Rv1863c,GO:0016020,IPR003675; IPR015837; ,,,,Probable conserved integral membrane protein,membrane [GO:0016020],9634230,,,MSDHLTACAAVHPGPLVSHLSVMHRFRIYVDIAVVVLVLVLTNLIAHFTTPWASIATVPAAAVGLVILVRSRGLGWAELGLSRQHWKSGLVYALAAVALVVAVISVGVLLPITRPMFMNHHYATISGAVIASMVMIPLQTVIPEELAFRGVLHGALNRAWGFRGVAVAGSVLFGLWHIATSLGLTSSNVGFTRLFGGGIIGLVAGVMLAVLATGVAGFVFSWLRRRSGSLIAPIALHWSLNGMGALAAALVWHLST,"26,939",256,,,,membrane [GO:0016020],,,1
P95151,P95151_MYCTU,Rv1864c,Rv1864c,GO:0003824; GO:0030151; GO:0030170,IPR005302; IPR011037; ,,,,Conserved protein,catalytic activity [GO:0003824]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170],9634230; 21969609,,,MTVAPRRLAWTNARQSYPVRVAHVLSVNLARVRANPDPRAQSKLTGIDKVAASEAVMVRAPGSMHAGVGSGLVGDTVGNPKLHGGDDQAVYAYAREDLDAWETQLHRTLHNGMFGENLTTSGVDVTYARIGERWRIGSDGLVLEVSAPRIPCRTFAAFLDLRYWIKTFTRAAKPGAYLRVIAPGTVRAGDTITVDYRPEHNVTVGLVFRARTSESELLPQLLAADALAAELKAYARERTPSPPPVDSADDV,"27,240",251,,,catalytic activity [GO:0003824]; molybdenum ion binding [GO:0030151]; pyridoxal phosphate binding [GO:0030170],,,,2
O07719,O07719_MYCTU,Rv1914c,Rv1914c,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MVLSRTSTGRVILVPTQLRFDRWFLPLAVPLGLGPKNSELWVGAGSLHVKMGWAFAADIPLTSITKAEATNARVYAAGVHFGFGRWLVNGSRKGLVALTIDPPEQAKMWKKSMTVRELWVSVTDPDALVTACTAK,"14,719",135,,,,plasma membrane [GO:0005886],,,1
O65935,O65935_MYCTU,Rv1749c,Rv1749c,GO:0016021,,,,,Possible integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLRAVNEIRQHDGTLKLGKGVGMFTIVGVIVALIGAFVQSRRHRHRPAADIHMLWWMVLIVGVVSIIGAGYHVFDGERTAELIGYTRGDGGFQWENAMGDLAIGVVGLMAYRFRGHFWLATIVVLTIQYVGDAAGHIYYWVVENNTNPYNIGVPLWTDILLPIVMWALYAWSWHSNGDAVPKGQP,"20,629",185,,,,integral component of membrane [GO:0016021],,,1
P95290,P95290_MYCTU,Rv1923,lipD Rv1923,,IPR001466; IPR012338; ,,lipD,DOMAIN 59 394 Beta-lactamase. {ECO:0000259|Pfam:PF00144}.,Probable lipase LipD,,9634230; 21969609,,,MDVAGLPRLAAGTQAAIIHGMAQPPSLLTTDNGLPFGVQGACDSRFTGVIRAFAGLYPGRKFGGGALSVYIDGRQVVDVWTGWSDRQGKVPWTADTGAMVFSATKGLAATVIHRLVDRGLLSYDAPVAEYWPEFGANGKSEVTVSDVLRHRSGLAHLKGVDKDEVMDHLLMEQKLAAAPLDRQHGKLAYHAVTYGWLLSGLARAVTGKGMRELFREELARPLNTDGIHLGRPPADSPTKAAQTLLPQAKVPTPLLDFIAPKVAGLSFSGLLGAVYFPGILSLLQDDMPFLDGEVPAVNGVVTARALAKTYGALANDGVIDGTRLLSSQAVRGLTGKSELWPDLNLGLPFTYHQGYQSSPVPGLLEGYGHIGLGGTIGWADPETGSAFGYVHNRLLTLLLFDIGSFAGLAALLNSAVVAARRDDPLEVPHFGAPYSEPRHEQAASGA,"47,170",446,,,,,,,1
O65933,O65933_MYCTU,Rv1662,pks8 Rv1662,GO:0006636; GO:0008270; GO:0016491; GO:0016740; GO:0040007; GO:0048037,IPR001227; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR015083; IPR002364; IPR016039; ,,pks8,DOMAIN 36 457 PKS_KS. {ECO:0000259|SMART:SM00825}.; DOMAIN 563 854 PKS_AT. {ECO:0000259|SMART:SM00827}.; DOMAIN 921 1081 PKS_DH. {ECO:0000259|SMART:SM00826}.; DOMAIN 1356 1594 PKS_ER. {ECO:0000259|SMART:SM00829}.,Probable polyketide synthase Pks8,cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; growth [GO:0040007]; unsaturated fatty acid biosynthetic process [GO:0006636],9634230,,,MSGTTTHVDYLKRLTADLRRTRRRLSDLEAKLSEPVAVVGMGCRYPGGVDSPETLWELVAQGRDAVSDFPADRGWDVDGLFDPDPDACGKMYTRRGTFLEHAGDFDAGFFGIGPSEALAMDPQQRLLLEVSWEALERTGIDPTKLRGSATGVFAGVIHAGYGGQLSGELEGYGLTGSTLSVASGRVAYVLGLEGPAVSVDTACSSSLVALHLAVQSLRSGECDLALAGGVTVMATPAAFVEFSRQRALARDGRCKVYAGAADGTAWSEGAGVLVVERLVDARRLGHPVLALVRGSAVNQDGASNGLTAPNGPSQQRVIRAALASARLRAVEVDVVEGHGTGTMLGDPIEAQALLATYGQDRVEPLWLGSIKSNIGHTSAAAGVAGVIKMVQAMRHGVMPKTLHVDVPTPHVDWSVGAVSLLTQPRAWSVHGRPRRAGVSSFGISGTNAHVILEQAPVVESVVPEVASPTAASAVPWVLSARSEQALAGQAQRLLAFVAANPDLDPIDVGWSLVKTRAMFEHRAVVVGADRGALLAGLAALAAGESGAGVAVGRARSVGKTVFVFPGQGAQWVGMGAQLYAELPLFALAFDAVAEELDRHLRLPLRNVLWEGDEALLTSTEFAQPALFAIEVALATLLQHWGISPDFLIGHSVGEIAAAHLAGVLSLTDAAGLVAARGRLMAELPAGGVMVVVAASEEEVLPVLVDGANLAAVNAPHSVVVSGCEAAVSDIADHFARRGRRVHRLAVSHAFHSLLMEPMLAEFTRIAAGISVSKPRIPLVSNVTGQMAGAGYGDGQYWVEHARRPVRFAEGVQLLNAVGATRFVEVGPGGGLTALVEQSLPLGEALSVAMMRREHPEVSSVLGAVATLFTAGAQMDWPAVFGSPGRRIELPTYAFQRQRYWLPPTSAGSADISGVGLLAARHGLLGAVVEQPDSDVVVLTGRLSVGEQRWLADHVIAGVVLLAGAAFVELALRAADQVDCGVVEELTVVTPLVLPTVGGVQLQVVVGVGEMGQRPVSIYSRNAESDSGWVLHARGVLGAKAVAPAADLSVWPPLGAAPVDVDGAYQRFAELGYEYGRAFQGLTAMWRRESELFADVAVPDDVDVTLSGFGIHPLVLDAALHAMGMVGEQAATMLPFSWQGVSLHAAGASRVRARIAPAGDGTVSVELADQAGLPVLSVQALVMRSVSSQLLSAAVAAADAAGRGLLEVAWLPVELAHNDISADLVVWELESFQDGVGPVYSATHRVLVALQSWLAQERAGRLVVLTQGSVGQDATNLAGAAVWGLVRSAQAEHPGRVMLVDSDGSMDVGDVIGCGEEQLMIRNGTAYAARLAQLRPQPILQLPDTNSGWRLVAGGAGALEDLTLASCPAKELAPGQVRIEVRALGVNFRDVLVALGIYPGAAELGAEGAGVVTEVGPGVTGLAVGDPVMGLLGVAGSEAVVDARLVVKLPNRWPLTDAAGVPVVFLTAYYALRVLAQVQPGESVLVHAAAGGVGMAAVQLARLWGLEVFATASRGKWDTLHTMGCDNTHVADSRTLAFEETFWLTTEGRGVDVVLNSLAGEFTDASLRLLPRGGRFIEMGKTEFGTPRSLPRTILGWPTGLST,"167,096",1602,,growth [GO:0040007]; unsaturated fatty acid biosynthetic process [GO:0006636],cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],,,,1
Q79FK9,Q79FK9_MYCTU,Rv1768,PE_PGRS31 Rv1768,,IPR000084; ,,PE_PGRS31,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS31,,9634230; 21969609,,,MSYLVVVPELVAAAATDLANIGSSISAANAAAAAPTTALVAAGGDEVSAAIAALFGAHARAYQALSAQAAMFHEQFVRALAAGGNSYAVAEAATAQSVQQDLLNLINAPTQALLGRPLIGNGANGLPGTGQNGGDGGILYGNGGNGGSGGVNQAGGNGGNAGLWGNGGSGGAGGNATTAGRNGFNGGAGGSGGLLWGNGGAGGAGGNGGPAPLVGGVGTTGGAGGNGGGAGLFYGFGGAGGNGGMGGVAPSTGPSMGILPAGGVGGPGGSGGASALAFGSGGVGGAGGLGGPTDGTVQGVGGFGGQGGNGGQSGLLFGNAGAGGAGAAGGAGTGDTESFGGHGGAGGDGGAVGLIGNGGAGGTGSPGAVVGGNGGVGGLGGAGSPGGLLYGTGGAGGNGGPGGDGGTGATVGFAGSGGFGGAGGIAQLFGTGGMGGSGGGIGAGTTTVVPPDVAPVGGTGGNGGRAGLLLGVGGMGGNGGATSVGGTLYAAGGNGGDGGLVWGNGGTGGSGGAGGAGSVGNGGAGGNAALLFGNGGAGGAGGAGGIGAGGAGGFGAVLFGNGGAGGSGAPGGIGAGGNGGNALLVGNGGNGGAGTGGAAGGAGGSGGLLFGQNGMPGP,"51,963",618,,,,,,,1
P94996,P94996_MYCTU,Rv1661,pks7 Rv1661,GO:0005618; GO:0005829; GO:0005886; GO:0009405; GO:0016491; GO:0016740; GO:0031177; GO:0040007; GO:0071770,IPR001227; IPR036736; IPR014043; IPR016035; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,pks7,DOMAIN 1976 2051 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable polyketide synthase Pks7,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; DIM/DIP cell wall layer assembly [GO:0071770]; growth [GO:0040007]; pathogenesis [GO:0009405],9634230; 21969609,,,MNSTPEDLVKALRRSLKQNERLKRENRDLLARTTEPVAVVGMGCRYPGGVDSPETLWELVAHGRDAVSEFPADRGWDVAGLFDPDPDAVGKSYTRCGGFLTDVAGFDAEFFGIAPSEALAMDPQQRLLLEVSWEALERAGIDPITLRGSQTGVFAGVFHGSYGGQGRVPGDLERYGLRGSTLSVASGRVAYVLGLQGPAVSVDTACSSSLVALHLAVQSLRLGECDLALVGGVTVMATPAMFIEFSRQRALSADGRCKAYAGAADGTAFAEGAGVLVLARLADARRLGHPVLALVRGSAVNQDGASNGLATPNGPAQQRVITAALASARLGVADVDVVEGHGTGTTLGDPIEAQAILATYGQRPADRPLWLGSIKSNIGHTSAAAGVAGVIKMVQAMRHGVLPKTLHVDVPTPHVDWSAGAVSLLTEPRPWHVPGRPRRAGVSSFGISGTNAHVILEEAPAVEPVGAAHGNDPVAVPWVLSARSAQALTNQARRLLAWVGADENVRPLDVGWSLVNTRSLFDHRAVVVGADRTQLMEGLTGLAAGVPGADVVAGRAQTVGKTAFVFPGQGAQWLGMGAQLCATAPVFAEHIHRCERALREHVEWSLLDVLRGAPGAPGLDRVDVVQPALWAVMVSLAELWRSVGVVPDAVIGHSQGEIAAAYVAGALSLRDAAAVVALRSRLLVRLGGAGGMVSLACGQPQAEKLASQWGDRLNIAAVNGVSSVVLAGETDAVTELMQRCEAEGIRARRIDVDYASHSAQVDAIREELIAALRGIEPRTSTVAFFSTVTGELMDTAGVNAEYWYRSIRQPVQFERAVRNAFDGGYRVFVESSPHPVLIAGIEETLVDCDRGATGEPIVIPTLGRDDGGVGRFWLSAGQAHVAGVGVDWRAAFADLGGRRVELPTYAFARQRFWLDGLGAVGGDLGGVGLVGAEHGLLAAVVQRPDSGGVVLTGRISVVAAPWLADHAVGPVVLFPGTGFVELALRAGDEVGCSVLQELTLQAPLVLPADGVRVQVVVGGVEQSGTRNVWVYSAAGQADSSPGWTLHAQGVLGVGSVQPAAELSVWPPVGARAMDVADGYQVLAARGYGYGPAFRGLQALWRRGAEVFADVTLPEGVPIRGFGIHPAVLDAALHAWGIVEGEQQTMLPFSWQGVCLHASGAARVRVRLAPVGRGAVSVELADPQGLPVLSVRQLMVRPVSAAALSRSTAGDRGLLEMIWTPVPLEGGDIGDDAVVWELPPHAGAQAGGDVLAAVYRGVHEVLEVLQSWLASDATGLGVVVTRGAVGPVDDDVTDLAGAAVWGLVRSAQAEHPGRVVLVDTDGSVAVEDAVGFGARSGEPQLVVRRGRVYAARLAPVAAGLTLPSASAGGWRLVAGGGGTLADVVVAPVAPVELATGQVRVAVGAVGVNFRDVLVALGMYPGGGELGVDGAGVVVEVGPGVTGLAVGDRVMGLLGLVGSEAVVDARLVTMVPAGWSLVEAAAVPVAFLTAFYGLSVLAEVAAGQKVLVHAGTGGVGMAAVSLARYWGAEVFVTASRAKWDTLRAMGFDDIHISDSRSLEFEEAFLRATEGSGVDVVLNSLAGEFTDASLRLLPSGGRFIELGKTDIRDGQTVAERHRGVRYRAFDLVEAGPDRIAAMLSEVVGLLAAGVLARLPVKTFDARCAPAAYRFVSQARHIGKVVLTIPDGPGGQSGLAGGTVVVTGGTGMAGSAVATHLVRRHGVANLVLVSRSGEQADRAAEVAALLREGGAQVAVVSCDVADRDALAALLAGLDPRYPLKGVFHAAGVLDDAVITGLTPDRVDTVLRAKVDGAWNLHELTEDMDLSAFVVFSSMAGIVGTPAQGNYAAANAFLDGLVAYRRSRGLAGLSVAWGLWEQASAMTRHLGERDRARMTQAGLAPLTTEQALGFLDTALQADRAVVVAARLDRAALAGAGAALPALFSQLAAGPTRRRIDAADTAVSMSGLVSRLHALTPERRQRELTDLVISNAAAVLGRSSSVDINAHKAFQDLGFDSLTAVELRNRLKTATGLTLSPTLIFDYPTPATLAEHLDSRLVTASGSDQQSLSDRVDDITRELVVLLDQPDLSANVKAHLRTRLQTMLTSLTTEDDDIAAATESQLFAILDEELGS,"221,047",2126,,DIM/DIP cell wall layer assembly [GO:0071770]; growth [GO:0040007]; pathogenesis [GO:0009405],oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
L0T9U5,L0T9U5_MYCTU,Rv1575,Rv1575,,,,,,Probable PhiRv1 phage protein,,9634230,,,MEPKPSQRHTDKEVGAALGISAGTYKRLKRIDNATRSDDKEIRLFAEKQMAPLAAGSPSWNGRKPSSGNRKAATMAARLDILAWGPWAPSQNRSVVRRKQTLLSAQPSASPPAPTGGSNESTTQPAASWRVGGPAPLSRGRPRLALSYLRGSLHLQNSKRVAHQHI,"17,917",166,,,,,,,1
O06152,O06152_MYCTU,Rv1635c,Rv1635c,GO:0005576; GO:0016021; GO:0016757,IPR038731; ,,,DOMAIN 114 265 PMT_2. {ECO:0000259|Pfam:PF13231}.,Probable mannosyltransferase. Probable conserved transmembrane protein,"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]",9634230,,,MHASRPGAPPHAGLPSRRTAGDQDHRADPKVTRIMSASTLEQPAAAHVDELVARMRGRLLDPLAIAVLAAVISGAWASRPSLWFDEGATISASASRTLPELWSLLGHIDAVHGLYYLLMHGWFAIFPPTELWSRLPSCLAIGAAAAGVVVFAKQFSGRTTAVCAGAVFAILPRVTWAGIEARSSALSVAAAVWLTVLLVAAVRCNTQRRWLLYALVLMLSILVSINLALLVPAYATMVPLLASGKSRKSPVIWWTVVTAAALGAMTPFILFAHGQVWQVGWIAGLNRNIILDVIHRQYFDHSVPFAILAGLIVAAGIAAHLAGARGPGGDTHRLVLVSAAWIVVPTAVVLIYSATVEPIYYPRYLILTAPAAAVILAVCVVTIARKPWLIAGVVFLLAAAAFPNYFFTQRGPYAKEGWDYSQVADVISAHAKPGDCLLVDNTAGWRPGPIRALLATRPAAFRSLIDVERGTYGPKVGTLWDGHVAVWLTTAKIDKCPTLWTIANRDKSLPDHQVGEMLSPGTGFGRTPVYRFPSYLGFRIVERWQFHYSQVVKSTR,"60,035",556,,,"transferase activity, transferring glycosyl groups [GO:0016757]",extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
P95144,P95144_MYCTU,Rv1871c,Rv1871c,GO:0005618; GO:0005886; GO:0016491; GO:0048037,IPR004378; IPR012349; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MNAAMNLKREFVHRVQRFVVNPIGRQLPMTMLETIGRKTGQPRRTAVGGRVVDNQFWMVSEHGEHSDYVYNIKANPAVRVRIGGRWRSGTAYLLPDDDPRQRLRGLPRLNSAGVRAMGTDLLTIRVDLD,"14,681",129,,,cofactor binding [GO:0048037]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O06803,O06803_MYCTU,Rv1770,Rv1770,GO:0005886,IPR007484; ,,,DOMAIN 248 418 Peptidase_M28. {ECO:0000259|Pfam:PF04389}.,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MDEAHPAHPADAGRPGGPIQGARRGAAMTPITALPTELAAMREVVETLAPIERAAGEPGEHKAAEWIVERLRTAGAQDARIEEEQYLDGYPRLHLKLSVIGVAAGVAGLLSRRLRIPAALAGVGAGLAIADDCANGPRIVRKRTETPRTTWNAVAEAGDPAGQLTVVVCAHHDAAHSGKFFEAHIEEVMVELFPGIVERIDTQLPNWWGPILAPALAGVGALRGSRPMMIAGTVGSALAAALFADIARSPVVPGANDNLSAVALLVALAERLRERPVKGVRVLLVSLGAEETLQGGIYGFLARHKPELDRDRTYFLNFDTIGSPELIMLEGEGPTVMEDYFYRPFRDLVIRAAERADAPLRRGIRSRNSTDAVLMSRAGYPTACFVSINRHKSVANYHLMSDTPENLCYETVSHAVTVAESVIRELAR,"45,973",428,,,,plasma membrane [GO:0005886],,,1
O53931,O53931_MYCTU,Rv1780,Rv1780,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MQNHDYVTYEEFGRRFFEVAVTPDRVAAAFADIAGSEFAMEPISQGPGGIAKVSANVKIREPRVTRKLGDLITFVIHIPLSIDLLLDLRLDKQRFMVAGDIALRATARAAEPLLLIVDVAKPRPSDITVNVSSKSIRGEVLRILAGVDGEIRRFIAQYVSAEIDSPKSQAAQVINVAEQLDSTWSGP,"20,457",187,,,,plasma membrane [GO:0005886],,,1
O06135,O06135_MYCTU,Rv1618,tesB1 Rv1618,GO:0005829; GO:0006637; GO:0009062; GO:0047617,IPR003703; IPR025652; IPR029069; ,,tesB1,DOMAIN 23 111 Acyl_CoA_thio. {ECO:0000259|Pfam:PF02551}.; DOMAIN 154 285 Acyl_CoA_thio. {ECO:0000259|Pfam:PF02551}.,Probable acyl-CoA thioesterase II TesB1,cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; acyl-CoA metabolic process [GO:0006637]; fatty acid catabolic process [GO:0009062],9634230; 21969609,,,MPDGKPMSDFDELLAVLDLNAVASDLFTGSHPSKNPLRTFGGQLMAQSFVASSRTLTRHHLPPSAFSVHFINGGDTAKDIEFQVIRLRDERRFANRRVDAVQDGTLLSSAMVSYMAGGRGHEHALDPPQVAEPHTRPPIGELLRGYEETVPHFVNALQPIEWRYANDPAWIMRDKGDRLAYNRVWVKALGEMPDDPVLHTATLLYSSDTTVLDSVITTHGLSWGFDRIFAASANHSVWFHRQVNFDDWVLYSTSSPVAADSRGLGSGHFFDRSGKLIATVVQEGVLKYFPATPDSAAGRS,"33,172",300,,acyl-CoA metabolic process [GO:0006637]; fatty acid catabolic process [GO:0009062],acyl-CoA hydrolase activity [GO:0047617],cytosol [GO:0005829],,,1
P71984,P71984_MYCTU,Rv1726,Rv1726,GO:0016614; GO:0050660,IPR012951; IPR016166; IPR036318; IPR016167; IPR006094; ,,,DOMAIN 38 208 FAD-binding PCMH-type. {ECO:0000259|PROSITE:PS51387}.,Probable oxidoreductase,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230,,,MTATLTKTLGSLDDFRGTLCVPGDPDYPRVRAIWNGQVAREPALIATCHDACDVRTVLRRAVDAGMVTAVRGGGHNVAGTALCDGGVVIDLSAMRAVSLDPATGRVRVQGGATLADLDHATVPFARVAPAGIVTTTGVGGLTLGGGVGWTTRRFGLSCDNLVAVRLVTAAGDYLSVDDERDPELMWGLRGGGGNFGIVTEFEFATHPFGPVAVAGFVVYRLDDGPAVLRGYRQFAAAAPEEVTTIVVLRHAPPAPWIPVDQRGKPVVMIGAVHTGSIQTGIEALRPVKSLARPVADTVWPTPFLAHQAVLDASNPAGHRYYWKSDHLAELNDEAIDLLVEQTAQLSSPDSLIGIFQLGGAAARGGERSCFPSRHARFMVNYATHWTEAREDDLHRQWTRDAIEALAPYGLGTAYVNFTADDAPMHVETLYSTTEFSRLVTLKNRLDPDNVFRNNHNIRPSA,"49,373",461,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,1
O07742,O07742_MYCTU,Rv1890c,Rv1890c,GO:0005829,IPR007372; IPR036761; ,,,DOMAIN 25 200 YceI. {ECO:0000259|SMART:SM00867}.,Uncharacterized protein,cytosol [GO:0005829],9634230; 21969609,,,MAHKTRREGRAGRSSEYSRGVSDAVWTLDASDGELVLRTGVVGRAARLGHRLTIAMTRWQALVNWSGTDPVAGELVAEVDSFEVMRGEGGVKGLSEPEKALVRANALKTLNASRFPHIRFTTEAIAQTGNGYRLTGKLHIRGKSREHVIDLHTEDLGAAWRISADTTVRQSNYGVKPYSLLMGSIRVADEVSVAFTAVRAKDD,"22,143",203,UPF0312 family,,,cytosol [GO:0005829],,,1
O33185,O33185_MYCTU,Rv1683,Rv1683,GO:0003824; GO:0005886; GO:0008152; GO:0040007,IPR029058; IPR000073; IPR000873; ,,,DOMAIN 125 340 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.; DOMAIN 455 861 AMP-binding. {ECO:0000259|Pfam:PF00501}.,Possible bifunctional enzyme long-chain acyl-CoA synthase and lipase,plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; growth [GO:0040007]; metabolic process [GO:0008152],9634230; 21969609,,,MVDLNFSMVTRPIERLVATAQNGLEVLRLGGLETGSVPSPSQIVESVPMYKLRRYFPPDNRPGQPPVGPPVLMVHPMMMSADMWDVTREDGAVGILHASGLDPWVIDFGSPDEVEGGMRRNLADHIVALSEAVDTVKDATGHDVHFVGYSQGGMFCYQAAAYRRSKDIASVVAFGSPVDTLAALPMGIPANMGAAVADFMADHVFNRLDIPSWMARMGFQMMDPLKTAKARVDFVRQLHDREALLPREQQRRFLESEGWIAWSGPAISELLKQFIAHNRMMTGGFAISGQMVTLTDITCPILAFVGEVDDIGQPASVRGIRRAAPNSEVYECLIRAGHFGLVVGSRAAQQSWPTVADWVRWISGDGTKPENIHLMADQPAEHTDSGVAFSSRVAHGIGEVSEAALALARGAADAVVAANRSVRTLAVETVRTLPRLARLGQLNDHTRISLGRIIDEQAHDAPKGEFLLFDGRVHTYEAVNRRINNVVRGLIAVGVRQGDRVGVLMETRPSALVAIAALSRLGAVAVVMRPDTDLSASVRLGRVTEILTDPTNLDAARQLPGQVLVLGGGESRDLDLPADALEQGQVIDMEKIDPDAVELPAWYRPNPGLARDLAFIAFSSADGDLVAKQITNYRWAVSAFGTASTAALGRRDTVYCLTPLHHESALLVSLGGAVVGGTRIALSRGLRPDRFVAEVRQYGVTVVSYTWAMLRDVVDDPAFVLHGNHPVRLFIGSGMPTGLWERVVEAFAPAHVVEFFATTDGQAVLANVAGAKIGSKGRPLPGAGRVELGAYDAEHDLILENDRGFVQVAGVNQVGVLLAQSRGPIDPTASVKRGVFAPADTWISTDYLFWRDDDGDYWLAGGRGSVVRTARGMVYTEPVTNALGLITGVDLAVTYGVLVRGRHVAVSAVTLLPGATITAADLTEAVASMPVGLGPDIVHVVPQLTLSGTYRPTVSALRANGIPKAGRQAWYFNSGGNEYRRLTPAVRTELTGQHRRGNA,"107,395",999,,growth [GO:0040007]; metabolic process [GO:0008152],catalytic activity [GO:0003824],plasma membrane [GO:0005886],,,3
Q79FL0,Q79FL0_MYCTU,Rv1765A,Rv1765A,GO:0015074,IPR038965; IPR001584; IPR012337; ,,,,Putative transposase,DNA integration [GO:0015074],9634230,,,MWVADITFVRTWQGFCYTAFVTDVCTRKIVVWAVSATMRTEDLPVQVFNHAVWQSNSDLSELVHHSDPGSQ,"8,116",71,,DNA integration [GO:0015074],,,,,1
P71986,P71986_MYCTU,Rv1728c,Rv1728c,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 21969609,,,MSVNGLPGAHNAGLQPIDSKGCHTRRTRHTKVLFVSKGVLANGRGRWLAIAASLVVSAAILYAQGAEHTCCRETPAAIPTGPDSAPANAPRIASPTEADLLAASAPVAAQQFQFALPAGVASEEGLQVKTIWVARAVSVLFPQITNIFGYRQDPLKWHPNGLAIDVMIPNHHSDEGIQLGNQVAGLALANAKRWGVLHVIWRQGYYPGIGAPSWTADYGSETLNHYDHVHIATDGGGYPTGRETYYVGSMSPTPPE,"27,198",256,,,,extracellular region [GO:0005576],,,3
P95145,P95145_MYCTU,Rv1870c,Rv1870c,GO:0003824; GO:0006281,IPR011257; ,,,,Uncharacterized protein,catalytic activity [GO:0003824]; DNA repair [GO:0006281],9634230,,,MPPRIAGMRLLVIKPEPLARRLLKLAGTTYAAEAGIRIRDKPMPLFQLLVLCMLASKPIGAATAARAARELFCSGLRTPKAVLSAERQTMISAFGRAHYVRYDESSATRLTAIAHRVRDEYSGDLRELAQRTRPDVSAAKRMLKTFNGIGDTGADIFLREVQDVWIWVRPYFDDRATAAAKQLGLPTDPKKLASVAPSSNALLAAALVRVA,"23,098",211,,DNA repair [GO:0006281],catalytic activity [GO:0003824],,,,1
P71977,P71977_MYCTU,Rv1719,Rv1719,GO:0003677; GO:0003700; GO:0006351; GO:0045892,IPR029016; IPR012318; IPR014757; IPR005471; IPR036388; IPR036390; ,,,DOMAIN 13 75 HTH iclR-type. {ECO:0000259|PROSITE:PS51077}.; DOMAIN 76 259 IclR-ED. {ECO:0000259|PROSITE:PS51078}.,Probable transcriptional regulatory protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSAEEQDTRSGGIQVIARAAELLRVLQAHPGGLSQAEIGERVGMARSTVSRILNALEDEGLVASRGARGPYRLGPEITRMATTVRLGVVTEMHPFLTELSRELDETVDLSILDGDRADVVDQVVPPQRLRAVSAVGESFPLYCCANGKALLAALPPERQARALPSRLAPLTANTITDRAALRDELNRIRVDGVAYDREEQTEGICAVGAVLRGVSVELVAVSVPVPAQRFYGREAELAGALLAWVSKVDAWFNGTEDRK,"27,905",259,,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,2
L0TA08,L0TA08_MYCTU,Rv1574,Rv1574,,,,,,Probable PhiRv1 phage related protein,,9634230,,,MGYKPESERHSTKTDTAIGAALGISAGTYRRLKRIDNATHSDDKEIRRFAEKQMAPLVAGSPSWNARKPRSANARVVASVHRSPMPALVPWNQSRLSATLTRR,"11,411",103,,,,,,,1
O06611,O06611_MYCTU,Rv1579c,Rv1579c,,,,,,Probable PhiRv1 phage protein,,9634230,,,MTPINRPLTNDERQLMHELAVQVVCSQTGCSPDAAVEALESFAKDGTLILRGDTENAYLEAGGNVLVHADRDWLAFHASYPGNDPLRDARPIEQDDDQGAGSPS,"11,234",104,,,,,,,1
P95264,P95264_MYCTU,Rv1950c,Rv1950c,,,,,,Uncharacterized protein,,9634230,,,MLPTLSHIHAWDTEHLIEAAYYWTKVADQWEDVFLEMRNRSHFIAWEGAGGDGCDSEPALTYR,"7,339",63,,,,,,,1
P95289,P95289_MYCTU,Rv1924c,Rv1924c,GO:0005887,,,,,Uncharacterized protein,integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MDPADVINPTSTRDAALARVLAYRQRVRARPLLIRATLAVVGGGLFVVSLPMIVLLPELGIPALLVAFRLLAVEAQWAVRAYAWTDWRFTQLREWFHRQVLVTRAAILVGLFLAAVALVWLLVYEF,"14,166",126,,,,integral component of plasma membrane [GO:0005887],,,3
P95270,P95270_MYCTU,Rv1944c,Rv1944c,,IPR004027; ,,,,Conserved protein,,9634230; 21969609,,,MISDTEDFAHGDKAAPPRLRASYAACGGDAAGCWTMSDNGASRVPPVDETPAAESAEPITAVSLAWLPAGDYERALDLWPDFAGSDLVTGPDGPVAHPLYCRRMQQKLVEFAEAGFPGLAVAAIRVAPFAAWCAEQGQEPDSPEARAEYAAYLTAHGDHDVMAWPPGRNQQCWCGSGHKYKKCCAAASFIDTEPAP,"20,795",196,,,,,,,1
O06625,O06625_MYCTU,Rv1565c,Rv1565c,GO:0005829; GO:0005886; GO:0009103; GO:0016020; GO:0016021; GO:0016747,IPR002656; ,,,,Conserved hypothetical membrane protein,"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; lipopolysaccharide biosynthetic process [GO:0009103]",9634230,,,MLTLSPPRPPALTPEPALPPVTMGTRTTGFYRHDLDGLRGVAIALVAVFHVWFGRVSGGVDVFLALSGFFFGGKILRAALNPDLSLSPIAEVIRLIRRLLPALVVVLAGCALLTIAIQPQTRWEAFANQSLASLGYYQNWELASTVSNYLRAGEAVSPLQHIWSMSVQGQFYLAFLLLVAGCAYLLRRLFRGPRAPYLRTMFVVLLSTLTLASFIYAIVAHHAYQATAYYNTFARAWELLAGALVGAVVPHVRWPMWLRTAVATAALAAILSCGALIDGVKEFPGPWALVPVGATMLMILAGANRQGHPGTRDRLPLPNRLLATAPLVALGAMAYSWYLWHWPLLIFWLSYTGHRHANFVEGAAVLLVSGLLAYLTTRLVEDPLRYRAPAGVRSPAAVPPIPWRLRLRRPTIVLGSVVALLGVALTATSFTWREHVIVQRAAGKELSGLSSRDYPGARALIDHVRVPKLRMRPTVLEVRHDLPTSTKDGCISDFVNPAIINCTYGDVDAPRTIALAGGSHAEHWLTALDLLGRMHHFKVVTYLKMGCPLSTEEVPLIMGNNAPYPQCHQWVQAAMAKLVADHPDYVFTTSTRPWNIKPGDVMPATYVGIWQTFADNNIPVLAMRDTPWLVKDGQPFIPADCLAKGGNPQSCGIARSKVLVDRNPTLDFVARFPLLKPLDMSDAICRTDTCRAVEGNVLVYRDSHHLTPTYMRTMTSELGRQIAANTDWW,"80,163",729,,lipopolysaccharide biosynthetic process [GO:0009103],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",cytosol [GO:0005829]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886],,,1
O06617,O06617_MYCTU,Rv1573,Rv1573,,,,,,Probable PhiRv1 phage protein,,9634230,,,MTTTPARFNHLVTVTDLETGDRAVCDRDQVAETIRAWFPDAPLEVREALVRLQAALNRHEHTGELEAFLRISVEHADAAGGDECGPAILAGRSGPEQAAINRQLGLAGDDEPDGDDTPPWSRMIGLGGGSPAEDER,"14,581",136,,,,,,,1
O07744,O07744_MYCTU,Rv1888c,Rv1888c,GO:0016021,IPR025498; ,,,,Possible transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MQPDAYPVRVRGDLDPALSRWQWLVKWFLAIPHYIVLFFLHVAAVVVTVIAFFAILFTGRYPRTLFDFNVGVMRWRWRVAFYALSALGTDRYPPFSLQTKAEYPADLEVDYPERLSRGLVLIKWWLLAIPHYLILAVFLSSGWRVFLIDPHDRVGIMWPSLLVILLLVAVVALLFTGRYPIGLYNL,"21,639",186,,,,integral component of membrane [GO:0016021],,,1
P95164,P95164_MYCTU,Rv1845c,blaR Rv1845c,GO:0004222; GO:0005576; GO:0005886; GO:0016021,IPR001915; ,,blaR,,Possible sensor-transducer protein BlaR,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222],9634230,,,MSALAFTILAVLLAGPTPALLARATWPLRAPRAAMVLWQAIALAAVLSSFSAGIAIASRLLMPGPDGRPTTSFVGAAGRLGWPLWAAYITVFALTVLVGARLAVAVVRVATATRRRRAHHRMVVDLVGVGHNGALAQPCARARDLRVLDVAQPLAYCLPGVRSRVVVSEGTLTALADAEVAAILTHERAHLRARHDLVLEAFTAVHAAFPRLVRSANALGAVQLLVELLADDAAVRAAGRTPLARALVACASGRAPSGALAVGGPSTVLRVRRLSGRGNSAVLSAAAYLAAAAVLVVPTVALAVPWLTQLQRLFIA,"32,737",316,Peptidase M48B family,,metalloendopeptidase activity [GO:0004222],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
O07726,O07726_MYCTU,Rv1906c,Rv1906c,GO:0005576,,,,,Conserved protein,extracellular region [GO:0005576],9634230; 21969609,,,MRLKPAPSPAAAFAVAGLILAGWAGSVGLAGADPEPAPTPKTAIDSDGTYAVGIDIAPGTYSSAGPVGDGTCYWKRMGNPDGALIDNALSKKPQVVTIEPTDKAFKTHGCQPWQNTGSEGAAPAGVPGPEAGAQLQNQLGILNGLLGPTGGRVPQP,"15,537",156,,,,extracellular region [GO:0005576],,,3
O06614,O06614_MYCTU,Rv1576c,Rv1576c,GO:0005829,IPR024455; ,,,,Probable PhiRv1 phage protein,cytosol [GO:0005829],9634230; 21969609,,,MTEFDDIKNLSLPETRDAAKQLLDSVAGDLTGEAAQRFQALTRHAEELRAEQRRRGREAEEALRRYRAGELRVVPGAPTGGDDGDAPPGNSLRDTAFRTLDSCVRDGLMSSRAAETAETLCRTGPPQSTSWAQRWLAATGSRDYLGAFVKRVSNPVAGHTVWTDREAAAWREAAAVAAEQRAMGLVDTQGGFLIPAALDPAILLSGDGSTNPIRQVARVVQTTSEIWRGVTSEGAEARWYSEAQEVSDDSPALAQPAVPNYRGSCWIPFSIELEGDAASFVGEIGKILADSVEQLQAAAFVNGSGNGEPTGFVSALTGTSDQVVVGAGSEAIVAADVYALQSALPPRFQASAAFAANLSTINTLRQAETSNGALKFPSLHDSPPMLAGKSVLEVSHMDTVDSAVTATNHPLVLGDWKQFLIGDRVGSMVELVPHLFGPNRRPTGQRGFFAWFRVGSDVLVRNAFRVLKVETTA,"50,474",473,,,,cytosol [GO:0005829],,,1
O53948,O53948_MYCTU,Rv1799,lppT Rv1799,,,,lppT,,Probable lipoprotein LppT,,9634230,,,MSVKSKNGRLAARVLVALAALFAMIALTGSACLAEGPPLGRNPQGAPAPVGGTVIVAPMHSGV,"6,164",63,,,,,,,1
O06136,O06136_MYCTU,Rv1619,Rv1619,GO:0005886; GO:0016021,IPR024320; ,,,,Conserved membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MVAAAGEPLNCQRANPEVTVKLPSADVVPRLRGRQRVVVHVDSRTARCVGALALVCAACWLIALLAGDYRHAQWAVAGRLGWSLTVLAAVAFIARGIFLGRPVTAMHATAAGLFLLAGLAAHVLVADLLGEILIAGSGWALMWPTSAHPRPEDLPRVWALINATRADSLAPFAMQAGKSHHFSAAGTAALAYRTRIGYAVVSGDPIGDEAQFPQLVADFAAMCHMHGWRIVVVGCSERRLGLWSDPMVVGQSLRPIPIGRDVVIDVSNFEMTGRRFRNLRQAVKRTHNFGVTTEIVAEQQLDDQRQAELAEVLAASPSGARTDRGFCMNLDGVLEGRYPGIQLIIARDASGRVQGFHRYATAGGGSDMSLDVPWRRRGAPNGIDERLSADMIAAAKDAGVQRLSLAFAAFPDLFGANQLGRLQRVCRALIHILDPLIALESLYRYLRKFHALDERRYVLISMTQVFALALVLLSLEFVPRRRHL,"52,642",484,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O07752,O07752_MYCTU,Rv1878,glnA3 Rv1878,GO:0004356; GO:0006807; GO:0051260,IPR014746; IPR008146; ,,glnA3,,Probable glutamine synthetase GlnA3 (Glutamine synthase) (GS-I),glutamate-ammonia ligase activity [GO:0004356]; nitrogen compound metabolic process [GO:0006807]; protein homooligomerization [GO:0051260],9634230; 21969609,,,MTATPLAAAAIAQLEAEGVDTVIGTVVNPAGLTQAKTVPIRRTNTFANPGLGASPVWHTFCIDQCSIAFTADISVVGDQRLRIDLSALRIIGDGLAWAPAGFFEQDGTPVPACSRGTLSRIEAALADAGIDAVIGHEVEFLLVDADGQRLPSTLWAQYGVAGVLEHEAFVRDVNAAATAAGIAIEQFHPEYGANQFEISLAPQPPVAAADQLVLTRLIIGRTARRHGLRVSLSPAPFAGSIGSGAHQHFSLTMSEGMLFSGGTGAAGMTSAGEAAVAGVLRGLPDAQGILCGSIVSGLRMRPGNWAGIYACWGTENREAAVRFVKGGAGSAYGGNVEVKVVDPSANPYLASAAILGLALDGMKTKAVLPSETTVDPTQLSDVDRDRAGILRLAADQADAIAVLDSSKLLRCILGDPVVDAVVAVRQLEHERYGDLDPAQLADKFRMAWSV,"46,720",450,Glutamine synthetase family,nitrogen compound metabolic process [GO:0006807]; protein homooligomerization [GO:0051260],glutamate-ammonia ligase activity [GO:0004356],,,,1
L0T9Q6,L0T9Q6_MYCTU,Rv1949c,Rv1949c,,,,,,Uncharacterized protein (Fragment),,9634230,,,WLRQRTGADLQIVSGIAEHLRQASGLAREGAGTIGAAQRRVIYAVQDAHNAGFNVEEDLSVTDTRTSRTFAEQAARQAQAQALAGDIRQRATQLIGVEHEVAAKIATATAPLNTVGFHEPPIAPSLPTPVPHNEKPQIHAVDRSWKQDPPSPMPGDPKDMTAVQARAAWDAVNADIARYNARCGRTFVLPNEQAAYDACIADKGSLFERQAAIRARLGELGVPVEGEPPPAPDPAGPQPNEGLPPPGVSPPAESNLTVGPPSRPIQQARGGESLWDENGGEWRYFPGDNYRYPHWDYNPHDSPTARWQNIPIGDLPTHK,"34,487",319,,,,,,,1
O07745,O07745_MYCTU,Rv1887,Rv1887,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 21969609,,,MDTVLGLSITPTTLGWVLAEGHGADGAILDRNELELHSGRNAQAIHTAEQLAAEVLLAHEVAAAGDHRLRVIGVTWNAEASAQAALLVESLTGAGFDNVVPVRRLRAIETLAQAIAPVIGYEQIAVCVLEHESATVVMVDTHDGKTQIAVKHVCRGLSGLTSWLTGMFGRDAWRPAGVVVVGSDSEVSEFSWQLERVLPVPVFAQTMAQVTVARGAALAAAQSTEFTDAQLVADSVSQPTVAPRRSRHYAGAAAALAAAAVTFVASLSLAVGIQLAPHNDTGTAKHGAHKPTPRIAKAVAPAVPPPPTVTPPVPARAPRPAAQHEPPARVTSGEALTEPNPPEEQPNASAPQQDRNDSQPITRVLEHIPGAYGDSAPPAE,"39,552",380,,,,extracellular region [GO:0005576],,,3
O07756,O07756_MYCTU,Rv1873,Rv1873,,IPR014937; IPR036287; ,,,,Uncharacterized protein,,9634230; 17142896,X-ray crystallography (1),,MKSASDPFDLKRFVYAQAPVYRSVVEELRAGRKRGHWMWFVFPQLRGLGSSPLAVRYGISSLEEAQAYLQHDLLGPRLHECTGLVNQVQGRSIEEIFGPPDDLKLCSSMTLFARATDANQDFVALLAKYYGGGEDRRTVALLAVT,"16,208",145,,,,,,,3
P95287,P95287_MYCTU,Rv1927,Rv1927,,IPR018644; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTAIPGPSGAEPGESRALAGYPVTPPALPRPVIFDQRWTDLTFIHWPVLPESVAGSYPPGTRPDVFADGMTYVGLVPFRMSSTKLGTALPIPYVGTFPETNVRLYSIDNAGRHGVLFRSLETARLTVVPLTRIGLGIPYAWSRMRMMRSGKHITYHSVRRWPRRGLRSLLTITIGDLVEPTPLEVWLTARWGAHTRKAGRTWWVPNEHKPWPLRAAEIAELNDELIDASGVQPTGDRLRALFSPGVHARFGRPCVVQ,"28,586",257,,,,,,,4
P95147,P95147_MYCTU,Rv1868,Rv1868,GO:0005886,IPR016040; IPR036291; ,,,DOMAIN 8 105 NAD(P)-bd_dom. {ECO:0000259|Pfam:PF13460}.,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MQILVTDATGAVGRSVTRQLIAAGHTVSGIAQHPHDALDPRVDYVCASLRNPVLQELAGEADAVIHLAPVDTSAPGGVGITGLAHVANAAARAGARLLFVSQAAGRPELYRQAETLVSTGWAPSLVIRIAPPVGRQLDWMVCRTVATLLRSKVSARPIRVLHLDDLVRFLVLALNTDRNGVVDLATPDTTNVVTAWRLLRSVDPHLRTRRVRSWEQLIPEVDIAAVQEDWNFEFGWQATEAIVDTGRGLVGRRLHPAGATNGSGQLALPVEAPPRSVPSHGEPLGSAAPEGLEGEFDDRIDERFPVFSSASLAEALPGPLTPMTLDVQLSGLRAAGRAMGRVLALGGVVADEWERRAIAVFGHRPYIGVSANIVAAAQLPGWDAQAVARRALGEQPQVTELLPFGRPQLAGGPLGSVAKVVVTARSLALLRHLRSDTHHYVAAADAEHLAAGQLASLPDAGLEVRIRLLRDRIHQGWILTVLWVIDTGVTAATLEHTRAGSAVSGGGMIMESGRIGAEIAPLAAVLRADPPLCALANDGNLASIRALSAPAAAAVDAVIARIGHRGLGEAELANLTFADDPALLLKTAAEIAARPAGPAHPATLIQRLAAGTRSARELAHDTTIRFTHELRMTLRELGSRRVAADVIDVVDDVFYLTCDELITTPADARLRIKRRRAERERLQAQRPPDVIDHAWVPVE,"74,397",699,,,,plasma membrane [GO:0005886],,,2
Q79FJ0,Q79FJ0_MYCTU,Rv1888A,Rv1888A,GO:0008168,IPR007213; IPR029063; ,,,,Uncharacterized protein,methyltransferase activity [GO:0008168],9634230,,,MVPVDLRRDWPTPLRQAGFDPNQPSAWLAEGLLAFLPPDAQDRLLDNITALSAPGSR,"6,268",57,,,methyltransferase activity [GO:0008168],,,,1
Q79FK5,Q79FK5_MYCTU,Rv1790,PPE27 Rv1790,,IPR022171; IPR000030; IPR038332; ,,PPE27,,PPE family protein PPE27,,9634230,,,MDFGALPPEINSGRMYCGPGSGPMLAAAAAWDGVAVELGLAATGYASVIAELTGAPWVGAASLSMVAAATPYVAWLSQAAARAEQAGMQAAAAAAAYEAAFVMTVPPPVITANRVLVMTLIATNFFGQNSAAIAVAEAQYAEMWAQDAVAMYGYAAASASASRLIPFAAPPKTTNSAGVVAQAVASVSWPNPNDWWLVRLLGSITPTERTTIVRLLGQSYLATGMARFLTSIAQQLTFGPGGTTAGSGGAWYPTPQFAGLGAGPAVSASLARAEPVGRLSVPPSWAVAAPAFAEKPEAGTPMSVIGEASSCGQGGLLRGIPLARAGRRTGAFAHRYGFRHSVITRSPSAG,"35,460",350,Mycobacterial PPE family,,,,,,1
O06789,O06789_MYCTU,Rv1752,Rv1752,,,,,,Uncharacterized protein,,9634230,,,MDAGCYAVHMAHTFGGATPEVVSAQAKLRDPAVDRAMTAELKFPGGHTGGIRCSMRSSDLLNVSARVVGDRGELRVLNPVVPQLFHRLPPLACVSARRFRCRSAARASGQDDAQGRGREHERDPRDLSGRRAPIAQPELNMVAASGSAA,"15,898",149,,,,,,,1
O06609,O06609_MYCTU,Rv1581c,Rv1581c,,IPR036869; ,,,,Probable PhiRv1 phage protein,,9634230,,,MTAVAITPASGGRHSVRFAYDSAIVSLIKSTIPAYARSWSAHTRCWFIDADWTPLLAAELRYHGHTVTGPADPAQQQCTDWAKALFRAVGPQRTPAVYRALSKVLHPDAPTGCPILQQQLNAARTALTNPA,"14,178",131,,,,,,,3
O06806,O06806_MYCTU,Rv1773c,Rv1773c,GO:0003677; GO:0003700; GO:0006351; GO:0045892,IPR029016; IPR014757; IPR005471; IPR036388; IPR036390; ,,,DOMAIN 16 77 HTH iclR-type. {ECO:0000259|PROSITE:PS51077}.; DOMAIN 78 248 IclR-ED. {ECO:0000259|PROSITE:PS51078}.,Probable transcriptional regulatory protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPPTEGKSTTNRDEGIQVLRRAVAALDEIAAEPGHLRLVDLCERLGLAKSTTRRLLVGLVEVGLVSVDSHGRFALGERLLGFGSVTGAHIAAAFRPTVERVARATDGETVDLSVLRGQRMWFVDQIESSYRLRAVSAVGLRFPLNGTANGKAALAALDDADAEAALCRLDPMVAEGLRREIVEIRRTGIAFDRNEHTPGISAAAIARRALGDNVIAISVPAPTARFLEKEQRIIAALRAAADSPDWTR,"26,632",248,,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
O07721,O07721_MYCTU,Rv1912c,fadB5 Rv1912c,GO:0008270; GO:0016491,IPR013149; IPR013154; IPR011032; IPR036291; IPR020843; IPR002364; ,,fadB5,,Possible oxidoreductase FadB5,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],9634230; 21969609,,,MRAVVITKHGDPSVLQVRQRPDPPPPGPGQLRVAVRAAGVNFADHLARVGLYPDAPKLPAVVGYEVAGTVEAVGDGVDPNRVGERVLAGTRFGGYCEIVNVAATDSVVLPDALSFEQGAAVPVNYATAWAALHGYGSLRAGERVLIHAAAGGVGIAAVQFAKAAKAEVHGTASPQKHQKLAEFGVDRAIDYRRDGWWQGLGPYDVVLDALGGTSLRRSYTLLRPGGRLVGYGISNMQHGEKRSMRRVAPHALSMLRGFNLMKQLEESKTVIGLNMLRLWDDRRTLEPWIAPLTKALNDGTILPIVHAIVPFAEAPEAHRILAARENVDKVVLVP,"35,813",334,,,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],,,,1
O33182,O33182_MYCTU,Rv1680,Rv1680,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSTEPLVVGAVAYTPNVVPIWEGIRGYFQDSESPDTQMDFVLYSNYARLVDSLIAGHIDIAWNTNLAYVRTVLQTGGRCTPLAQRDTDVDYTTVFVAHAGSDLHGAKDIAGKRLALGSADSAHAAILPLYYLRRAGIAESDLQVIRFDTDIGKHGDTGRSELDAVDAVLAGEADVAAIGSSTWAAMGAAELMGESLTEVWRTDGYCHCMFTALDTLPAERYQPWLDRLLAMSWDDSEHRKILELEGLRRWVPPHLDGYKPLFEAVQEQGIDPRW,"30,214",274,,,,,,,1
P95148,P95148_MYCTU,Rv1867,Rv1867,GO:0003988; GO:0005618; GO:0006635,IPR016039; ,,,,Conserved protein,cell wall [GO:0005618]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MPVDPRTPVLIGYGQVNHRGDIDAEKQSIEPVDLMAAAARKAADSTVLEAVDSIRVVHMLSAHYRNPGQLLGERIKARTFTTGYSGVGGNMPQSLVNRACLDIQRGRAGVVLLAGAETWRTRTGLRAKGSKLEWTVQDESVPLPDMAGDDVPMAGAAELRINLDRPAYVYPIFEQALRIAYGESIENHRKRIGELWARFSAVAADNPHAWIRNPVTADEIWQPGPQNRMVSWPYTKLMNSNNMVDQGAALLLTSVERATRLRIPAERWVYPQAGTDAHDTPAVADRHRLHRSTAIRIAGARALELAGLGLDDIEYVDLYSCFPSAVQVAAIELGLDTDDPARPLTVTGGLTFAGGPWSNYVTHSIATMAELLAANPGRRGLITANGGYLTKHSFGVYGTEPPSEFRWEDMQPAVDREPTGDGLVEWEGIGTVEAWTTPVNRDGQPEKAFLAVRTPDGSRSLAVITDPASVQATVREDIAGVKVAVAPDGTATLR,"53,560",494,,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],cell wall [GO:0005618],,,1
I6XCB2,I6XCB2_MYCTU,Rv1710,scpB Rv1710,GO:0005737; GO:0051301; GO:0051304,IPR005234; IPR036388; IPR036390; ,,scpB,,Segregation and condensation protein B,cytoplasm [GO:0005737]; cell division [GO:0051301]; chromosome separation [GO:0051304],9634230; 21969609,,FUNCTION: Participates in chromosomal partition during cell division. May act via the formation of a condensin-like complex containing Smc and ScpA that pull DNA away from mid-cell into both cell halves. {ECO:0000256|SAAS:SAAS00383137}.,MTEHMPEHDPSYGIPDIAEPAELDADELKRVLEALLLVIDTPVTADALAAATEQPVYRVAAKLQLMADELTGRDSGIDLRHTSEGWRMYTRARFAPYVEKLLLDGARTKLTRAALETLAVVAYRQPVTRARVSAVRGVNVDAVMRTLLARGLITEVGTDADTGAVTFATTELFLERLGLTSLSELPDIAPLLPDVDTIDDLSESLDSEPRFIKLTGELASEQTLSFDVDRD,"25,277",231,ScpB family,cell division [GO:0051301]; chromosome separation [GO:0051304],,cytoplasm [GO:0005737],,,1
L0TAD5,L0TAD5_MYCTU,Rv1703c,Rv1703c,GO:0008171,IPR002935; IPR029063; ,,,,Probable catechol-O-methyltransferase,O-methyltransferase activity [GO:0008171],9634230; 21969609,,,MLATIDKFAYEKSMLINVGDEKGTLLDAAVRRADPALALELGTYLGYGALRIARAAPEARVYSVELAEANASNARRIWAHAGVDDRVVCVVGTIGDGGRTLDALTEHGFATGTLDFVFLDHDKKAYLPDLQSILDRGWLHPGSIVVADNVRVPGAPKYRAYMRRQQGMSWNTIEHKTHLEYQTLVPDLVLESEYLG,"21,570",196,,,O-methyltransferase activity [GO:0008171],,,,1
P94978,P94978_MYCTU,Rv1644,tsnR Rv1644,GO:0003723; GO:0005886; GO:0006396; GO:0008173,IPR029028; IPR029064; IPR001537; IPR013123; IPR029026; ,,tsnR,,Possible 23S rRNA methyltransferase TsnR,plasma membrane [GO:0005886]; RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],9634230; 21969609,,,MLTERSARVATAVKLHRHVGRRRAGRFLAEGPNLVAAALARGLVREVFVTEVAARRHELLLAAHEASVHLVTERAAKALSDTVTPAGLVAVCDLPATRLEDVLAGSPQLIAVTVEIREPGNAGTVIRIADAMGAAAVILAGRSVDPYNGKCLRASTGSIFAIPVVVAPDVGAAIADLRAAGLQVLATAVDGEMALDDADRLLAEPTAWLFGPEAHGLSAEIAALADHRVHILMSGGAESLNVAAAAAICLYESARALGRR,"26,880",260,"Class IV-like SAM-binding methyltransferase superfamily, RNA methyltransferase TrmH family",RNA processing [GO:0006396],RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173],plasma membrane [GO:0005886],,,2
L7N656,L7N656_MYCTU,Rv1806,PE20 Rv1806,,IPR000084; ,,PE20,,PE family protein PE20,,9634230,,,MAFVLVCPDALAIAAGQLRHVGSVIAARNAVAAPATAELAPAAADEVSALTATQFNFHAAMYQAVGAQAIAMNEAFVAMLGASADSYAATEAANIIAVS,"9,820",99,,,,,,,1
I6XZC4,I6XZC4_MYCTU,Rv1941,Rv1941,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609; 25613812,X-ray crystallography (1),,MNHPDLAGKVAIVTGAGAGIGLAVARRLADEGCHVLCADIDGDAADAAATKIGCGAAACRVDVSDEQQIIAMVDACVAAFGGVDKLVANAGVVHLASLIDTTVEDFDRVIAINLRGAWLCTKHAAPRMIERGGGAIVNLSSLAGQVAVGGTGAYGMSKAGIIQLSRITAAELRSSGIRSNTLLPAFVDTPMQQTAMAMFDGALGAGGARSMIARLQGRMAAPEEMAGIVVFLLSDDASMITGTTQIADGGTIAALW,"25,835",256,,,oxidoreductase activity [GO:0016491],,,,1
O33181,O33181_MYCTU,Rv1778c,Rv1778c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MRVSLFLSDAAQADAQSGKVHALGLGWRQCQTPTPPFALVLFLDIDWDETNKQHQLKCQLLTADGDPVVVPGPHGPQRILFEAAAEAGRAPGAIHGTSVRMPLTLNIPAGIPLEPGIYEWRVEVEGYERATAVEAFIVAGGGHPPASCG,"15,828",149,,,,,,,3
O53917,O53917_MYCTU,Rv1670,Rv1670,,IPR007361; ,,,,Uncharacterized protein,,9634230,,,MIRAVWNGTVLAEAPRTVRVEGNHYFPPESLHREHLIESPTTSICPWKGLAHYYNVVVDGPYGPVNPDAAWYYRRPSPLARRIKNHVAFWHGVTVEGESESRHGLARRVVAWLGK,"13,110",115,,,,,,,1
P94973,P94973_MYCTU,Rv1639c,Rv1639c,GO:0016021,IPR029058; IPR000801; ,,,,Conserved hypothetical membrane protein,integral component of membrane [GO:0016021],9634230,,,MAQNELVTASTPPAATQPLAVGHTSLMHGWVPLAVQVVTAVVLVLAAGWRSRHWQRRWLPTAAAIGATLAWGTRWYVTGNGLANERPPSTLWIWVALTGAAATVLILGWRSARWWRRGASLLAVPLCLLSATLTLNLWVGYFPTVQTAWNQLTSGPLPDQADQAAVAALAHSGVRPSHGTLLPVVIPSDASHFKHRGELVYLPPAWFDREHRSENPPPPQLPTVMMIGGQFNTPADWARAGNAVKTLDDFAAAHSGNAPVVVFVDSGGAFNNDTECVNGRRGNAADHLTKDVVPYMVSKFGVSPEQTSWGIVGWSMGGTCAVDLTVMHPTLFSAFVDIAGDFYPNAGNKTQTIVRLFGGNEDAWSAFDPTTVITRHGSYTGLSGWFAISSPGPPSPDNAVADTTTMRLAGRDAAANPGNQAAAANALCALGRANGIYCAVVPQPGKHDWPFADRVFAAALPWLAGQLATPGVPKIPLPGTTQQIAGTGR,"51,792",489,,,,integral component of membrane [GO:0016021],,,1
O53963,O53963_MYCTU,Rv1921c,lppF Rv1921c,,IPR036412; IPR023214; ,,lppF,,Probable conserved lipoprotein LppF,,9634230,,,MVRLIPSLLAMATVLGGVIGCSAHQPPTPASGCRQLDAFLKWHHGVREFLQSAIDANSRCTGTADGSARKVAIFDWDNTVVKNDIGYATNYYMLQHSLVLQPANQDWHAASRYLTDAAANALSVACGKVVPAGKPLPTGSNALCANEILSLLDGETTTGQPAFVGNNVRRLAGPYAWSNALSAGYTAEELAGFADQAKKQNLAADVGATQQVGTQQVDGYIRVYPQMKDLIGTLQAHGIDTWVVSASPEPIVKVWAGEVGLDDQHVVGVRSVADQSGKLTAHLVGCGGVRDGDDSVMTYLDGKRCWANQVIFGVTGPQAFNQLAADRRQVLAAGDSNSDATFVGDATVVSLVINRNQDDLMCRAYDGLFTRGGKWAINPMFIDPLPQHAPYVCGEAFINPDGSKQPVLRNDGTPIPDQVDSVF,"44,996",423,,,,,,,2
O33208,O33208_MYCTU,Rv1709,scpA Rv1709,GO:0005737; GO:0007049; GO:0007059; GO:0051301,IPR003768; ,,scpA,,Segregation and condensation protein A,cytoplasm [GO:0005737]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],9634230; 21969609,,FUNCTION: Participates in chromosomal partition during cell division. May act via the formation of a condensin-like complex containing Smc and ScpB that pull DNA away from mid-cell into both cell halves. {ECO:0000256|SAAS:SAAS00952070}.,MNGLQNSLANGGTAPENGYSAGFRVRLTNFEGPFDLLLQLIFAHQLDVTEVALHQVTDDFIAYTKAIGARLELEETTAFLVIAATLLDLKAARLLPAGQVDDEEDLALLEVRDLLFARLLQYRAFKHVAEMFAELEATALRSYPRAVSLEDGFVGLLPEVMLGVDAHRFAEIAAIALTPRPAPTVATEHLHELMVSVPEQAEHLLAMLKARGSGQWASFSELVADCTAPIEIVGRFLALLELYRTRAVAFEQSEPLGALQVSWTGDDAERSDEKERRL,"30,569",278,ScpA family,cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],,cytoplasm [GO:0005737],,,1
O06800,O06800_MYCTU,Rv1767,Rv1767,GO:0004601; GO:0051920,IPR029032; IPR004675; IPR003779; ,,,,Alkyl hydroperoxide reductase AhpD (EC 1.11.1.15),peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],9634230; 21969609,,FUNCTION: Antioxidant protein with alkyl hydroperoxidase activity. Required for the reduction of the AhpC active site cysteine residues and for the regeneration of the AhpC enzyme activity. {ECO:0000256|SAAS:SAAS00384272}.,MSDQPRHHQVLDDLLPQHRALRHQIPQVYQRFVALGDAALTDGALSRKVKELVALAIAVVQGCDGCVASHAQAAVRAGATAQEAAEAIGVTILMHGGPATIHGARAYAAFCEFADTTPS,"12,491",119,AhpD family,,peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],,,,1
O07729,O07729_MYCTU,Rv1903,Rv1903,GO:0016021,IPR007165; ,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MVPFLMRAAVTGFALWVVTLFVPGMRFAGGDTTLQRVAIIFVVAVIFGLVNAFIKPIVQILSIPLYILTLGLFHVVVNASMLWLTAWITEHTTHWGLQIDHFWWTAIWAAILLSIVSWILSLLARDFRRVTRAH,"15,199",134,,,,integral component of membrane [GO:0016021],,,3
P71981,P71981_MYCTU,Rv1723,Rv1723,GO:0016787,IPR001466; IPR012338; ,,,,Probable hydrolase,hydrolase activity [GO:0016787],9634230; 21969609,,,MSGGVPAGLALDNWLSSPYSHWAFQHVEDFMPTTVIARGTEPVVTLPADNAPIADIGLTSTDGIATTVGAVMAATATDGWAVAHRGALVAEQYLDGLGPRTRHLLFSVSKSLVAAVVGALHGAGAIELDAPVTAYVPALADCGYAGATVRHLLDMRSGVAFSENYDDPAAEIHVREQVIGWAPKRGPDLPATLRDYLLTLRRKSAHGGPFEYRSCETDVLGWICEAAAGQPMPELMSELLWSRIGAQCDATIALDVAGAAGTGIFDGGISACLTDMIRFGSLYLRDGVSLAGQQVVPAAWIADTFDGGPDSRQAFAASPDDNPMPGGMYRNQVWFPYPGSNVALCVGMCGQLIYVNRAAEVVAAKLSTQPHSHEPHMLDTLRAFDAVAHELSGIRSSSTNDPQRPSPPAQEASPG,"43,630",415,,,hydrolase activity [GO:0016787],,,,2
O06613,O06613_MYCTU,Rv1577c,Rv1577c,,IPR006433; ,,,,Probable PhiRv1 phage protein,,9634230,,,MAELRSGEGRTVHGTIVPYNEATTVRDFDGEFQEMFAPGAFRRSIAERGHKLKLLVSHDARTRYPVGRAVELREEPHGLFGAFEIADTPDGDEALANVKAGVVDSFSVGFRPIRDRREGDVLVRVEAALLEVSLTGVPAYSGAQIAGVRAESLTVVSRSTAEAWLSLLDW,"18,539",170,,,,,,,1
P71990,P71990_MYCTU,Rv1732c,Rv1732c,GO:0005623; GO:0016209; GO:0016491; GO:0045454,IPR000866; IPR036249; IPR013766; ,,,,Conserved protein,cell [GO:0005623]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; cell redox homeostasis [GO:0045454],9634230; 21969609,,,MAVESSMLALGTPAPSFTLPQPATGATVSLDELTGPALVVTFICNHCPYVQHVAAGLATLGRDLADQGVPMVGISSNDVVTYPQDGPDQMVAEARRHGWTFPYLYDETQDVARAFSAACTPDTFVFDGQRRLVYRGQLDDSRPGNGRPVTAADVRAAVDALLAGRPVNPDQRPSIGCGIKWR,"19,399",182,,cell redox homeostasis [GO:0045454],antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],cell [GO:0005623],,,1
P95277,P95277_MYCTU,Rv1937,Rv1937,GO:0005618; GO:0005829; GO:0005886; GO:0009055; GO:0042602; GO:0046872; GO:0051537; GO:0052875,IPR036010; IPR001041; IPR006058; IPR012675; IPR036188; IPR017927; IPR008333; IPR001433; IPR001221; IPR017938; ,,,,Possible oxygenase,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; riboflavin reductase (NADH) activity [GO:0052875]; riboflavin reductase (NADPH) activity [GO:0042602]",9634230,,,MAVRQVTVGYSDGTHKTMPVRCDQTVLDAAEEHGVAIVNECQSGICGTCVATCTAGRYQMGRTEGLSDVERAARKILTCQTFVTSDCRIELQYPVDDNAALLVTGDGVVTAVELVSPSTAILRVDTSGMAGALRYRAGQFAQLQVPGTNVWRNYSYAHPADGRGECEFIIRLLPDGVMSNYLRDRAQPGDHIALRCSKGSFYLRPIVRPVILVAGGTGLSAILAMAQSLDADVAHPVYLLYGVERTEDLCKLDELTELRRRVGRLEVHVVVARPDPDWDGRTGLVTDLLDERMLASGDADVYLCGPVAMVDAARTWLDHNGFHRVGLYYEKFVASGAARRRTPARLDYAGVDIAEVCRRGRGTAVVIGGSIAGIAAAKMLSETFDRVIVLEKDGPHRRREGRPGAAQGWHLHHLLTAGQIELERIFPGIVDDMVREGAFKVDMAAQYRIRLGGTWKKPGTSDIEIVCAGRPLLEWCVRRRLDDEPRIDFRYESEVADLAFDRANNAIVGVAVDNGDADGGDGLQVVPAEFVVDASGKNTRVPEFLERLGVGAPEAEQDIINCFYSTMQHRVPPERRWQDKVMVICYAYRPFEDTYAAQYYTDSSRTILSTSLVAYNCYSPPRTAREFRAFADLMPSPVIGENIDGLEPASPIYNFRYPNMLRLRYEKKRNLPRALLAVGDAYTSADPVSGLGMSLALKEVREMQALLAKYGAGHRDLPRRYYRAIAKMADTAWFVIREQNLRFDWMKDVDKKRPFYFGVLTWYMDRVLELVHDDLDAYREFLAVVHLVKPPSALMRPRIASRVLGKWARTRLSGQKTLIARNYENHPIPAEPADQLVNA,"93,429",839,,,"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; riboflavin reductase (NADH) activity [GO:0052875]; riboflavin reductase (NADPH) activity [GO:0042602]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P72007,P72007_MYCTU,Rv1750c,fadD1 Rv1750c,GO:0004467; GO:0005829; GO:0005886; GO:0006633,IPR025110; IPR020845; IPR000873; IPR030310; ,,fadD1,,Possible fatty-acid-CoA ligase FadD1 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MTDTIQSLLRQHVSDPTIAVKYGGLQWTWSQYLAESAARAAALITIADPQRPTHIGSLLGNTPEMLAQLAAAGLGGYVLCGLNTTRRGDALAADVRRADCQIVVTDADHRALLDGLDLAGARILDTSTPRWAELVAGDGAFVPYREVDTMDPFMMIFTSGTSGNPKAVPVSHLMATFAGRSLTERFGLTEQDTCYVSMPLFHSNAVVAGWAPAVVSGAAIAPATFSATGFLDDVRRYHATYMNYVGKPLAYILATPERDDDADNPLRVAFGNEANDKDIEEFSRRFGVQVEDGFGSTENAVIVIREPGTPPGSIGRGAHGVAVYNGETVTECAVARFDAHGALTNADEAIGELVNTTGSGFFTGYYNDPEANAERMRHGMYWSGDLAYRDSEGWIYLAGRTADWMRVDGENLTAAPIERILLRYKAINRVAVYAVPDEYVGDQVMAALVLRAGDTFDPDAFEAFLDAQPDLSTKARPRYIRIAADLPSTATHKVLKRQLIDEGTAVGKADTLWVREPRGSAYHHASGPAKAI,"57,413",532,,fatty acid biosynthetic process [GO:0006633],long-chain fatty acid-CoA ligase activity [GO:0004467],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WH47,RS182_MYCTU,Rv2055c,rpsR2 Rv2055c MTCY63A.05,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0019843; GO:0022627,IPR001648; IPR018275; IPR036870; ,,rpsR2,,30S ribosomal protein S18 2,cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230,,"FUNCTION: Binds as a heterodimer with protein S6 to the central domain of the 16S rRNA, where it helps stabilize the platform of the 30S subunit. {ECO:0000255|HAMAP-Rule:MF_00270}.",MAAKSARKGPTKAKKNLLDSLGVESVDYKDTATLRVFISDRGKIRSRGVTGLTVQQQRQVAQAIKNAREMALLPYPGQDRQRRAALCP,"9,696",88,Bacterial ribosomal protein bS18 family,translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY63A.05,1
P9WLH5,RNHPH_MYCTU,Rv2228c,Rv2228c MTCY427.09c,GO:0004523; GO:0006401; GO:0009236; GO:0032296; GO:0043755; GO:0046872; GO:0071667,IPR013078; IPR029033; IPR012337; IPR014636; IPR002156; IPR036397; ,,,DOMAIN 1 139 RNase H. {ECO:0000255|PROSITE-ProRule:PRU00408}.,Bifunctional protein Rv2228c [Includes: Ribonuclease H (EC 3.1.26.4); Adenosylcobalamin/alpha-ribazole phosphatase (EC 3.1.3.73)],alpha-ribazole phosphatase activity [GO:0043755]; DNA/RNA hybrid binding [GO:0071667]; double-stranded RNA-specific ribonuclease activity [GO:0032296]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; cobalamin biosynthetic process [GO:0009236]; RNA catabolic process [GO:0006401],9634230; 18678948; 21969609; 20363939,X-ray crystallography (1),"FUNCTION: Endonuclease that displays both RNase H activity with a hybrid RNA/DNA substrate as well as double-stranded RNase activity. As the only authenticated RNase HI in M.tuberculosis, probably plays an important role in the physiology of this organism, being likely involved in bacterial replication. {ECO:0000269|PubMed:20363939}.; FUNCTION: Catalyzes the hydrolysis of the phospho group from alpha-ribazole 5'-phosphate to form alpha-ribazole (PubMed:20363939). May also catalyze the conversion of adenosylcobalamin 5'-phosphate to adenosylcobalamin (vitamin B12) (By similarity). Has a possible role in B12 recycling, but the primary role of the C-terminal domain of this phosphatase enzyme could be phosphate generation to help bacterial survival within the macrophage, which is a phosphate-deprived environment (PubMed:20363939). {ECO:0000250|UniProtKB:P39701, ECO:0000269|PubMed:20363939}.",MKVVIEADGGSRGNPGPAGYGAVVWTADHSTVLAESKQAIGRATNNVAEYRGLIAGLDDAVKLGATEAAVLMDSKLVVEQMSGRWKVKHPDLLKLYVQAQALASQFRRINYEWVPRARNTYADRLANDAMDAAAQSAAADADPAKIVATESPTSPGWTGARGTPTRLLLLRHGQTELSEQRRYSGRGNPGLNEVGWRQVGAAAGYLARRGGIAAVVSSPLQRAYDTAVTAARALALDVVVDDDLVETDFGAWEGLTFAEAAERDPELHRRWLQDTSITPPGGESFDDVLRRVRRGRDRIIVGYEGATVLVVSHVTPIKMLLRLALDAGSGVLYRLHLDLASLSIAEFYADGASSVRLVNQTGYL,"39,145",364,RNase H family; Histidine phosphatase superfamily,cobalamin biosynthetic process [GO:0009236]; RNA catabolic process [GO:0006401],alpha-ribazole phosphatase activity [GO:0043755]; DNA/RNA hybrid binding [GO:0071667]; double-stranded RNA-specific ribonuclease activity [GO:0032296]; metal ion binding [GO:0046872]; RNA-DNA hybrid ribonuclease activity [GO:0004523],,,MTCY427.09c,1
P9WGH1,RPSC_MYCTU,Rv2069,sigC Rv2069 MTCY49.08,GO:0001666; GO:0003677; GO:0003700; GO:0006352; GO:0006355; GO:0009405; GO:0009408; GO:0009410; GO:0009415; GO:0016987,IPR014284; IPR000838; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigC,,ECF RNA polymerase sigma factor SigC (ECF sigma factor SigC) (Alternative RNA polymerase sigma factor SigC) (RNA polymerase sigma-C factor) (Sigma-C factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to water [GO:0009415]; response to xenobiotic stimulus [GO:0009410]",9634230; 10027986; 16735723; 19099550; 19118359; 22015173; 17145760,X-ray crystallography (2),FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are usually held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis; this sigma factor does not seem to have a cognate anti-sigma factor however. It has been suggested that the sigma domains 2 and 4 may interact via polar residues in this protein to autoregulate. Positively regulates expression of a small regulon of genes.,MTATASDDEAVTALALSAAKGNGRALEAFIKATQQDVWRFVAYLSDVGSADDLTQETFLRAIGAIPRFSARSSARTWLLAIARHVVADHIRHVRSRPRTTRGARPEHLIDGDRHARGFEDLVEVTTMIADLTTDQREALLLTQLLGLSYADAAAVCGCPVGTIRSRVARARDALLADAEPDDLTG,"19,966",185,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to water [GO:0009415]; response to xenobiotic stimulus [GO:0009410]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTCY49.08,1
P9WN33,ASNH_MYCTU,Rv2201,asnB Rv2201 MTCY190.12,GO:0004066; GO:0005524; GO:0005576; GO:0005829; GO:0005886; GO:0006541; GO:0040007; GO:0070981,IPR006426; IPR001962; IPR033738; IPR017932; IPR029055; ,,asnB,DOMAIN 2 231 Glutamine amidotransferase type-2. {ECO:0000255|PROSITE-ProRule:PRU00609}.,Putative asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4),cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; L-asparagine biosynthetic process [GO:0070981],9634230; 21969609,,,MCGLLAFVAAPAGAAGPEGADAASAIARASHLMRHRGPDESGTWHAVDGASGGVVFGFNRLSIIDIAHSHQPLRWGPPEAPDRYVLVFNGEIYNYLELRDELRTQHGAVFATDGDGEAILAGYHHWGTEVLQRLRGMFAFALWDTVTRELFCARDPFGIKPLFIATGAGGTAVASEKKCLLDLVELVGFDTEIDHRALQHYTVLQYVPEPETLHRGVRRLESGCFARIRADQLAPVITRYFVPRFAASPITNDNDQARYDEITAVLEDSVAKHMRADVTVGAFLSGGIDSTAIAALAIRHNPRLITFTTGFEREGFSEIDVAVASAEAIGARHIAKVVSADEFVAALPEIVWYLDEPVADPALVPLFFVAREARKHVKVVLSGEGADELFGGYTIYREPLSLRPFDYLPKPLRRSMGKVSKPLPEGMRGKSLLHRGSLTLEERYYGNARSFSGAQLREVLPGFRPDWTHTDVTAPVYAESAGWDPVARMQHIDLFTWLRGDILVKADKITMANSLELRVPFLDPEVFAVASRLPAGAKITRTTTKYALRRALEPIVPAHVLHRPKLGFPVPIRHWLRAGELLEWAYATVGSSQAGHLVDIAAVYRMLDEHRCGSSDHSRRLWTMLIFMLWHAIFVEHSVVPQISEPQYPVQL,"72,150",652,Asparagine synthetase family,glutamine metabolic process [GO:0006541]; growth [GO:0040007]; L-asparagine biosynthetic process [GO:0070981],asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY190.12,1
O53512,AROG_MYCTU,Rv2178c,aroG Rv2178c,GO:0003849; GO:0005618; GO:0005829; GO:0005886; GO:0009073; GO:0009423; GO:0030145; GO:0040007; GO:0051260,IPR013785; IPR002480; ,P9WIC1,aroG,,Phospho-2-dehydro-3-deoxyheptonate aldolase AroG (EC 2.5.1.54) (3-deoxy-D-arabino-heptulosonate 7-phosphate synthase) (DAHP synthase) (Phospho-2-keto-3-deoxyheptonate aldolase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-deoxy-7-phosphoheptulonate synthase activity [GO:0003849]; manganese ion binding [GO:0030145]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007]; protein homooligomerization [GO:0051260],9634230; 21969609; 16288916; 19556970; ,X-ray crystallography (20),FUNCTION: Catalyzes an aldol-like condensation reaction between phosphoenolpyruvate (PEP) and D-erythrose 4-phosphate (E4P) to generate 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAH7P) and inorganic phosphate. {ECO:0000269|PubMed:16288916}.,MNWTVDIPIDQLPSLPPLPTDLRTRLDAALAKPAAQQPTWPADQALAMRTVLESVPPVTVPSEIVRLQEQLAQVAKGEAFLLQGGDCAETFMDNTEPHIRGNVRALLQMAVVLTYGASMPVVKVARIAGQYAKPRSADIDALGLRSYRGDMINGFAPDAAAREHDPSRLVRAYANASAAMNLVRALTSSGLASLHLVHDWNREFVRTSPAGARYEALATEIDRGLRFMSACGVADRNLQTAEIYASHEALVLDYERAMLRLSDGDDGEPQLFDLSAHTVWIGERTRQIDGAHIAFAQVIANPVGVKLGPNMTPELAVEYVERLDPHNKPGRLTLVSRMGNHKVRDLLPPIVEKVQATGHQVIWQCDPMHGNTHESSTGFKTRHFDRIVDEVQGFFEVHRALGTHPGGIHVEITGENVTECLGGAQDISETDLAGRYETACDPRLNTQQSLELAFLVAEMLRD,"50,641",462,Class-II DAHP synthase family,aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007]; protein homooligomerization [GO:0051260],3-deoxy-7-phosphoheptulonate synthase activity [GO:0003849]; manganese ion binding [GO:0030145],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WKD3,BLAC_MYCTU,Rv2068c,blaC blaA Rv2068c MTCY49.07c,GO:0005576; GO:0005886; GO:0008800; GO:0030655; GO:0033250; GO:0033251; GO:0042597; GO:0046677,IPR012338; IPR000871; IPR023650; ,,blaC,,Beta-lactamase (EC 3.5.2.6) (Ambler class A beta-lactamase),extracellular region [GO:0005576]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; beta-lactamase activity [GO:0008800]; cephalosporinase activity [GO:0033251]; penicillinase activity [GO:0033250]; beta-lactam antibiotic catabolic process [GO:0030655]; response to antibiotic [GO:0046677],9634230; 16267291; 15699201; 17915954; 21969609; 23000993; 24989449; 16870770; 18422342; 19251630; 20353175; 20961112; 22587688; 24060876; 24023821,X-ray crystallography (31),"FUNCTION: Extended spectrum beta-lactamase (ESBL) that inactivates beta-lactam antibiotics by hydrolyzing the amide group of the beta-lactam ring. Displays high levels of penicillinase and cephalosporinase activity as well as measurable activity with carbapenems, including imipenem and meropenem. Plays a primary role in the intrinsic resistance of M.tuberculosis to beta-lactam antibiotics. {ECO:0000269|PubMed:15699201, ECO:0000269|PubMed:16870770, ECO:0000269|PubMed:17915954, ECO:0000269|PubMed:19251630, ECO:0000269|PubMed:20353175}.",MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA,"32,568",307,Class-A beta-lactamase family,beta-lactam antibiotic catabolic process [GO:0030655]; response to antibiotic [GO:0046677],beta-lactamase activity [GO:0008800]; cephalosporinase activity [GO:0033251]; penicillinase activity [GO:0033250],extracellular region [GO:0005576]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886],blaA,MTCY49.07c,1
P9WJP1,RSMH_MYCTU,Rv2165c,rsmH mraW Rv2165c MTCY270.03,GO:0005737; GO:0005886; GO:0040007; GO:0070475; GO:0071424,IPR002903; IPR023397; IPR029063; ,,rsmH,,Ribosomal RNA small subunit methyltransferase H (EC 2.1.1.199) (16S rRNA m(4)C1402 methyltransferase) (rRNA (cytosine-N(4)-)-methyltransferase RsmH),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; growth [GO:0040007]; rRNA base methylation [GO:0070475],9634230; 19099550; 21969609,,FUNCTION: Specifically methylates the N4 position of cytidine in position 1402 (C1402) of 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_01007}.,MQTRAPWSLPEATLAYFPNARFVSSDRDLGAGAAPGIAASRSTACQTWGGITVADPGSGPTGFGHVPVLAQRCFELLTPALTRYYPDGSQAVLLDATIGAGGHAERFLEGLPGLRLIGLDRDPTALDVARSRLVRFADRLTLVHTRYDCLGAALAESGYAAVGSVDGILFDLGVSSMQLDRAERGFAYATDAPLDMRMDPTTPLTAADIVNTYDEAALADILRRYGEERFARRIAAGIVRRRAKTPFTSTAELVALLYQAIPAPARRVGGHPAKRTFQALRIAVNDELESLRTAVPAALDALAIGGRIAVLAYQSLEDRIVKRVFAEAVASATPAGLPVELPGHEPRFRSLTHGAERASVAEIERNPRSTPVRLRALQRVEHRAQSQQWATEKGDS,"42,529",396,"Methyltransferase superfamily, RsmH family",growth [GO:0040007]; rRNA base methylation [GO:0070475],rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],mraW,MTCY270.03,2
P95257,SECBL_MYCTU,Rv1957,secBL Rv1957,GO:0005618,IPR035958; ,,secBL,,SecB-like chaperone Rv1957,cell wall [GO:0005618],9634230; 19118359; 12657046; 20585061; 21969609; 21536872,,"FUNCTION: Chaperone component of an atypical, type II toxin-antitoxin chaperone (TAC) system. Prevents antitoxin HigA1 aggregation in vitro at a 1:3 chaperone:antitoxin ratio, probably also protects antitoxin HigA1 from protease. Required for neutralization of toxin HigB1 upon ectopic expression in Mycobacterium marinum or E.coli. When expressed in E.coli complements a secB deletion, restores export of OmpA and MBP and inhibits aggregation of proOmpC although it is less efficient than endogenous SecB. Complements the general chaperone function of E.coli SecB less well. {ECO:0000269|PubMed:21536872}.",MTDRTDADDLDLQRVGARLAARAQIRDIRLLRTQAAVHRAPKPAQGLTYDLEFEPAVDADPATISAFVVRISCHLRIQNQAADDDVKEGDTKDETQDVATADFEFAALFDYHLQEGEDDPTEEELTAYAATTGRFALYPYIREYVYDLTGRLALPPLTLEILSRPMPVSPGAQWPATRGTP,"20,106",181,SecB-like family,,,cell wall [GO:0005618],,,1
P9WH59,RS14_MYCTU,Rv2056c,rpsN rpsN2 Rv2056c MTCY63A.04,GO:0003735; GO:0005618; GO:0006412; GO:0015935; GO:0019843,IPR001209; IPR023036; ,,rpsN,,30S ribosomal protein S14,cell wall [GO:0005618]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230,,"FUNCTION: Binds 16S rRNA, required for the assembly of 30S particles and may also be responsible for determining the conformation of the 16S rRNA at the A site. {ECO:0000255|HAMAP-Rule:MF_00537}.",MAKKSKIVKNQRRAATVARYASRRTALKDIIRSPSSAPEQRSTAQRALARQPRDASPVRLRNRDAIDGRPRGHLRKFGLSRVRVRQLAHDGHLPGVRKASW,"11,441",101,Universal ribosomal protein uS14 family,translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; small ribosomal subunit [GO:0015935],rpsN2,MTCY63A.04,1
P9WHN5,PUP_MYCTU,Rv2111c,pup Rv2111c,GO:0010498; GO:0019941; GO:0031386; GO:0040007; GO:0070490; GO:0070628,IPR008515; ,P9WQN5,pup,,Prokaryotic ubiquitin-like protein Pup (Bacterial ubiquitin-like modifier),proteasome binding [GO:0070628]; protein tag [GO:0031386]; growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490],18832610; 9634230; 17082771; 19580545; 19761766; 19607839; 19448618; 20203624; 20355727; 20233925; 21969609,X-ray crystallography (2),"FUNCTION: Protein modifier that is covalently attached to lysine residues of substrate proteins, thereby targeting them for proteasomal degradation. The tagging system is termed pupylation. Among the identified substrates are the FabD, PanB and Mpa proteins. {ECO:0000269|PubMed:18832610, ECO:0000269|PubMed:19448618, ECO:0000269|PubMed:20233925}.",MAQEQTKRGGGGGDDDDIAGSTAAGQERREKLTEETDDLLDEIDDVLEENAEDFVRAYVQKGGQ,"6,944",64,Prokaryotic ubiquitin-like protein family,growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490],proteasome binding [GO:0070628]; protein tag [GO:0031386],,,,1
P9WH73,RIR2A_MYCTU,Rv1981c,nrdF1 Rv1981c MTCY39.38,GO:0004748; GO:0005971; GO:0006260; GO:0009263; GO:0046872,IPR009078; IPR012348; IPR026494; IPR033909; IPR030475; IPR000358; ,,nrdF1,,Ribonucleoside-diphosphate reductase subunit beta nrdF1 (EC 1.17.4.1) (Ribonucleotide reductase R2-1 small subunit) (Ribonucleotide reductase small subunit 1),"ribonucleoside-diphosphate reductase complex [GO:0005971]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]",9335290; 9634230; 14573627; 21969609,,"FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides (By similarity). Two genes for this protein are present in M.tuberculosis; this is thought to not be the active form. When coexpressed in E.coli with nrdE the 2 proteins do not complement a temperature-sensitive E.coli mutant, whereas the other gene (nrdF2) does complement. {ECO:0000250}.",MTGKLVERVHAINWNRLLDAKDLQVWERLTGNFWLPEKIPLSNDLASWQTLSSTEQQTTIRVFTGLTLLDTAQATVGAVAMIDDAVTPHEEAVLTNMAFMESVHAKSYSSIFSTLCSTKQIDDAFDWSEQNPYLQRKAQIIVDYYRGDDALKRKASSVMLESFLFYSGFYLPMYWSSRGKLTNTADLIRLIIRDEAVHGYYIGYKCQRGLADLTDAERADHREYTCELLHTLYANEIDYAHDLYDELGWTDDVLPYMRYNANKALANLGYQPAFDRDTCQVNPAVRAALDPGAGENHDFFSGSGSSYVMGTHQPTTDTDWDF,"36,590",322,Ribonucleoside diphosphate reductase small chain family,deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",ribonucleoside-diphosphate reductase complex [GO:0005971],,MTCY39.38,1
P9WIA1,PTPA_MYCTU,Rv2234,ptpA Rv2234 MTCY427.15,GO:0004725; GO:0005576; GO:0005886; GO:0006470; GO:0009405; GO:0044174; GO:0052046; GO:0052083,IPR023485; IPR036196; IPR017867; ,,ptpA,,Probable low molecular weight protein-tyrosine-phosphatase (PTPase) (EC 3.1.3.48),extracellular region [GO:0005576]; host cell endosome [GO:0044174]; plasma membrane [GO:0005886]; protein tyrosine phosphatase activity [GO:0004725]; modification by symbiont of host morphology or physiology via secreted substance [GO:0052046]; negative regulation by symbiont of host cell-mediated immune response [GO:0052083]; pathogenesis [GO:0009405]; protein dephosphorylation [GO:0006470],9634230; 18474358; 21969609,NMR spectroscopy (1); Model (1); X-ray crystallography (2),"FUNCTION: Mediates host-pathogen interaction and interferes with vesicular trafficking in the infected macrophage. Inhibits host phagolysosomal fusion in M.tuberculosis-infected macrophages to promote bacteria survival. Dephosphorylates host VPS33B protein, which induces a block of the host phagosome maturation within macrophage cells. Acts on tyrosine phosphorylated proteins, low-MW aryl phosphates and natural and synthetic acyl phosphates. {ECO:0000269|PubMed:18474358}.",MSDPLHVTFVCTGNICRSPMAEKMFAQQLRHRGLGDAVRVTSAGTGNWHVGSCADERAAGVLRAHGYPTDHRAAQVGTEHLAADLLVALDRNHARLLRQLGVEAARVRMLRSFDPRSGTHALDVEDPYYGDHSDFEEVFAVIESALPGLHDWVDERLARNGPS,"17,892",163,Low molecular weight phosphotyrosine protein phosphatase family,modification by symbiont of host morphology or physiology via secreted substance [GO:0052046]; negative regulation by symbiont of host cell-mediated immune response [GO:0052083]; pathogenesis [GO:0009405]; protein dephosphorylation [GO:0006470],protein tyrosine phosphatase activity [GO:0004725],extracellular region [GO:0005576]; host cell endosome [GO:0044174]; plasma membrane [GO:0005886],,MTCY427.15,1
P9WHU1,PSA_MYCTU,Rv2109c,prcA Rv2109c,GO:0004298; GO:0005618; GO:0005737; GO:0005886; GO:0009405; GO:0010498; GO:0019773; GO:0019941; GO:0040007; GO:0051603,IPR029055; IPR023332; IPR022296; IPR001353; ,P9WHT9,prcA,,Proteasome subunit alpha (EC 3.4.25.1) (20S proteasome alpha subunit) (Proteasome core protein PrcA),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome core complex, alpha-subunit complex [GO:0019773]; threonine-type endopeptidase activity [GO:0004298]; growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteolysis involved in cellular protein catabolic process [GO:0051603]",9634230; 16468985; 17082771; 17259624; 18059281; 19099550; 21969609; 20085764; 20711362; 25224505; 25469515; 16468986; 19759536; 20558127; 20461058,Electron microscopy (3); X-ray crystallography (16),"FUNCTION: Component of the proteasome core, a large protease complex with broad specificity involved in protein degradation. The M.tuberculosis proteasome is able to cleave oligopeptides not only after hydrophobic but also after basic, acidic and small neutral residues (PubMed:16468985). In complex with the ATPase Mpa, degrades protein targets conjugated to a prokaryotic ubiquitin-like protein (Pup). Among the identified substrates of the M.tuberculosis proteasome are the pupylated FabD, PanB and Mpa proteins (PubMed:17082771). One function of the proteasome is to contribute to M.tuberculosis ability to resist killing by host macrophages, since the core proteasome is essential for persistence of the pathogen during the chronic phase of infection in mice (PubMed:18059281). Likely functions to recycle amino acids under nutrient starvation, thereby enabling the cell to maintain basal metabolic activities (PubMed:20711362) (By similarity). The mechanism of protection against bactericidal chemistries of the host's immune response probably involves the degradation of proteins that are irreversibly oxidized, nitrated, or nitrosated. A proteolysis-independent activity of the proteasome core is required for optimal growth of M.tuberculosis in mouse lungs and for RNI resistance; in contrast, long-term survival of M.tuberculosis in stationary phase and during starvation in vitro and in the chronic phase of mouse infection required a proteolytically active proteasome (PubMed:20711362). {ECO:0000250|UniProtKB:A0QZ46, ECO:0000255|HAMAP-Rule:MF_00289, ECO:0000269|PubMed:16468985, ECO:0000269|PubMed:17082771, ECO:0000269|PubMed:18059281, ECO:0000269|PubMed:20711362}.",MSFPYFISPEQAMRERSELARKGIARAKSVVALAYAGGVLFVAENPSRSLQKISELYDRVGFAAAGKFNEFDNLRRGGIQFADTRGYAYDRRDVTGRQLANVYAQTLGTIFTEQAKPYEVELCVAEVAHYGETKRPELYRITYDGSIADEPHFVVMGGTTEPIANALKESYAENASLTDALRIAVAALRAGSADTSGGDQPTLGVASLEVAVLDANRPRRAFRRITGSALQALLVDQESPQSDGESSG,"26,881",248,Peptidase T1A family,growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteolysis involved in cellular protein catabolic process [GO:0051603],threonine-type endopeptidase activity [GO:0004298],"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome core complex, alpha-subunit complex [GO:0019773]",,,1
P9WHT9,PSB_MYCTU,Rv2110c,prcB Rv2110c,GO:0004298; GO:0005576; GO:0005737; GO:0005886; GO:0009405; GO:0010498; GO:0019774; GO:0019941; GO:0035375; GO:0040007; GO:0051603,IPR029055; IPR022483; IPR001353; IPR023333; ,P9WHU1,prcB,,Proteasome subunit beta (EC 3.4.25.1) (20S proteasome beta subunit) (Proteasome core protein PrcB),"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; proteasome core complex, beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; zymogen binding [GO:0035375]; growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteolysis involved in cellular protein catabolic process [GO:0051603]",9634230; 16468985; 17082771; 18059281; 21969609; 20085764; 20711362; 25224505; 16468986; 19759536; 20558127; 20461058,Electron microscopy (3); X-ray crystallography (17),"FUNCTION: Component of the proteasome core, a large protease complex with broad specificity involved in protein degradation. The M.tuberculosis proteasome is able to cleave oligopeptides not only after hydrophobic but also after basic, acidic and small neutral residues (PubMed:16468985). In complex with the ATPase Mpa, degrades protein targets conjugated to a prokaryotic ubiquitin-like protein (Pup). Among the identified substrates of the M.tuberculosis proteasome are the pupylated FabD, PanB and Mpa proteins (PubMed:17082771). One function of the proteasome is to contribute to M.tuberculosis ability to resist killing by host macrophages, since the core proteasome is essential for persistence of the pathogen during the chronic phase of infection in mice (PubMed:18059281). Likely functions to recycle amino acids under nutrient starvation, thereby enabling the cell to maintain basal metabolic activities (PubMed:20711362) (By similarity). The mechanism of protection against bactericidal chemistries of the host's immune response probably involves the degradation of proteins that are irreversibly oxidized, nitrated, or nitrosated. A proteolysis-independent activity of the proteasome core is required for optimal growth of M.tuberculosis in mouse lungs and for RNI resistance; in contrast, long-term survival of M.tuberculosis in stationary phase and during starvation in vitro and in the chronic phase of mouse infection required a proteolytically active proteasome (PubMed:20711362). {ECO:0000250|UniProtKB:A0QZ47, ECO:0000255|HAMAP-Rule:MF_02113, ECO:0000269|PubMed:16468985, ECO:0000269|PubMed:17082771, ECO:0000269|PubMed:18059281, ECO:0000269|PubMed:20711362}.",MTWPLPDRLSINSLSGTPAVDLSSFTDFLRRQAPELLPASISGGAPLAGGDAQLPHGTTIVALKYPGGVVMAGDRRSTQGNMISGRDVRKVYITDDYTATGIAGTAAVAVEFARLYAVELEHYEKLEGVPLTFAGKINRLAIMVRGNLAAAMQGLLALPLLAGYDIHASDPQSAGRIVSFDAAGGWNIEEEGYQAVGSGSLFAKSSMKKLYSQVTDGDSGLRVAVEALYDAADDDSATGGPDLVRGIFPTAVIIDADGAVDVPESRIAELARAIIESRSGADTFGSDGGEK,"30,305",291,Peptidase T1B family,growth [GO:0040007]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteolysis involved in cellular protein catabolic process [GO:0051603],threonine-type endopeptidase activity [GO:0004298]; zymogen binding [GO:0035375],"cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; proteasome core complex, beta-subunit complex [GO:0019774]",,,1
P9WLG1,STF3_MYCTU,Rv2267c,stf3 Rv2267c MTCY339.43,GO:0008146; GO:0016021; GO:0046506,IPR027417; ,,stf3,,PAPS-dependent sulfotransferase Stf3 (EC 2.8.2.-),integral component of membrane [GO:0016021]; sulfotransferase activity [GO:0008146]; sulfolipid biosynthetic process [GO:0046506],9634230; 12144918; 16537518; 18928249,,"FUNCTION: Required for the sulfation of S881. S881 is a sulfated menaquinone, which is localized in the outer envelope of M.tuberculosis and negatively regulates its virulence. 3'-phosphoadenosine-5'-phosphosulfate (PAPS) is the sulfate donor. {ECO:0000269|PubMed:16537518, ECO:0000269|PubMed:18928249}.",MKALRSSSRLSRWREWAAPLWVGCNFSAWMRLLIRNRFAVHHSRWHFAVLYTFLSMVNSCLGLWQKIVFGRRVAETVIADPPIFIVGHWRTGTTLLHELLVVDDRHTGPTGYECLAPHHFLLTEWFAPYVEFLVSKHRAMDNMDLSLHHPQEDEFVWCMQGLPSPYLTIAFPNRPPQYEEYLDLEQVAPRELEIWKRTLFRFVQQVYFRRRKTVILKNPTHSFRIKVLLEVFPQAKFIHIVRDPYVVYPSTIHLHKALYRIHGLQQPTFDGLDDKVVSTYVDLYRKLDEGRELVDPTRFYELRYEDLIGDPEGQLRRLYQHLGLGDFECYLPRLRQYLADHADYKTNSYQLTVEQRAIVDEHWGEIIDRYGYDRHTPEPARLRPAVGG,"46,062",388,Stf3 family,sulfolipid biosynthetic process [GO:0046506],sulfotransferase activity [GO:0008146],integral component of membrane [GO:0016021],,MTCY339.43,1
P9WG91,STP_MYCTU,Rv2333c,stp Rv2333c,GO:0005886; GO:0016021; GO:0022857; GO:0046677,IPR004638; IPR011701; IPR020846; IPR036259; ,,stp,,Multidrug resistance protein Stp (Spectinomycin tetracycline efflux pump),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; response to antibiotic [GO:0046677],9634230; 17242035,,FUNCTION: Contributes to spectinomycin and tetracycline resistance. {ECO:0000269|PubMed:17242035}.,MNRTQLLTLIATGLGLFMIFLDALIVNVALPDIQRSFAVGEDGLQWVVASYSLGMAVFIMSAATLADLDGRRRWYLIGVSLFTLGSIACGLAPSIAVLTTARGAQGLGAAAVSVTSLALVSAAFPEAKEKARAIGIWTAIASIGTTTGPTLGGLLVDQWGWRSIFYVNLPMGALVLFLTLCYVEESCNERARRFDLSGQLLFIVAVGALVYAVIEGPQIGWTSVQTIVMLWTAAVGCALFVWLERRSSNPMMDLTLFRDTSYALAIATICTVFFAVYGMLLLTTQFLQNVRGYTPSVTGLMILPFSAAVAIVSPLVGHLVGRIGARVPILAGLCMLMLGLLMLIFSEHRSSALVLVGLGLCGSGVALCLTPITTVAMTAVPAERAGMASGIMSAQRAIGSTIGFAVLGSVLAAWLSATLEPHLERAVPDPVQRHVLAEIIIDSANPRAHVGGIVPRRHIEHRDPVAIAEEDFIEGIRVALLVATATLAVVFLAGWRWFPRDVHTAGSDLSERLPTAMTVECAVSHMPGATWCRLWPA,"57,115",537,"Major facilitator superfamily, EmrB family",response to antibiotic [GO:0046677],transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJ29,VPB36_MYCTU,Rv1982A,vapB36 Rv1982A,,IPR011660; ,,vapB36,,Putative antitoxin VapB36,,9634230; 20011113; 21969609,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC36. {ECO:0000305|PubMed:20011113}.,MALNIKDPEVDRLAAELADRLHTSKTAAIRHALSAQLAFLESRAGDREAQLLDILRTEIWPLLADRSPITKLEREQILGYDPATGV,"9,561",86,,,,,,,1
P9WF97,VPC15_MYCTU,Rv2010,vapC15 Rv2010 MTCY39.07c,GO:0001666; GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC15,DOMAIN 1 121 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC15 (RNase VapC15) (EC 3.1.-.-) (Toxin VapC15),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926]; response to hypoxia [GO:0001666],9634230; 15718296; 20011113; 21969609; 25450593,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Degrades total E.coli RNA, which is partially inhibited by cognate antitoxin VapB15 (PubMed:25450593). Upon expression in M.smegmatis inhibits colony formation, which is neutralized by coexpression with VapB15 (PubMed:20011113). {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:25450593}.",MIVDTSVWIAYLSTSESLASRWLADRIAADSTVIVPEVVMMELLIGKTDEDTAALRRRLLQRFAIEPLAPVRDAEDAAAIHRRCRRGGDTVRSLIDCQVAAMALRIGVAVAHRDRDYEAIRTHCGLRTEPLF,"14,731",132,PINc/VapC protein family,negative regulation of growth [GO:0045926]; response to hypoxia [GO:0001666],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY39.07c,1
P9WLM7,VPB15_MYCTU,Rv2009,vapB15 Rv2009 MTCY39.08c,GO:0001666; GO:0045927; GO:0046872,IPR019239; ,,vapB15,,Antitoxin VapB15,metal ion binding [GO:0046872]; positive regulation of growth [GO:0045927]; response to hypoxia [GO:0001666],9634230; 15718296; 20011113; 25450593,X-ray crystallography (1),"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC15 (PubMed:20011113). Partially inhibits the RNase activity of VapC15 (PubMed:25450593). {ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:25450593, ECO:0000305|PubMed:15718296}.",MYSGVVSRTNIEIDDELVAAAQRMYRLDSKRSAVDLALRRLVGEPLGRDEALALQGSGFDFSNDEIESFSDTDRKLADES,"8,884",80,,positive regulation of growth [GO:0045927]; response to hypoxia [GO:0001666],metal ion binding [GO:0046872],,,MTCY39.08c,1
P9WJ27,VPB37_MYCTU,Rv2104c,vapB37 Rv2104c,,,,vapB37,,Putative antitoxin VapB37,,9634230; 20011113,,FUNCTION: Probable antitoxin component of a type II toxin-antitoxin (TA) system. Its putative cognate toxin is VapC37. {ECO:0000305|PubMed:20011113}.,MRTTVTLDDDVEQLVRRRMAERQVSFKKALNDAIRDGASGRPAPSHFSTRTADLGVPAVNLDRALQLAADLEDEELVRRQRRGS,"9,418",84,,,,,,,1
O53464,VPB45_MYCTU,Rv2018 RVBD_2018,vapB45 Rv2018 RVBD_2018 LH57_10995 P425_02089,GO:0003677,IPR007367; IPR009057; IPR017277; ,,vapB45,,Putative antitoxin VapB45,DNA binding [GO:0003677],9634230; 21969609; 24662523,X-ray crystallography (1),FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC45. {ECO:0000305|PubMed:24662523}.,MAGDQELELRFDVPLYTLAEASRYLVVPRATLATWADGYERRPANAPAVQGQPIITALPHPTGSHARLPFVGIAEAYVLNAFRRAGVPMQRIRPSLDWLIKNVGPHALASQDLCTDGAEVLWRFAERSGEGSPDDLVVRGLIVPRSGQYVFKEIVEHYLQQISFADDNLASMIRLPQYGDANVVLDPRRGYGQPVFDGSGVRVADVLGPLRAGATFQAVADDYGVTPDQLRDALDAIAA,"26,034",239,,,DNA binding [GO:0003677],,,LH57_10995 P425_02089,3
O53501,VPC37_MYCTU,Rv2103c,vapC37 Rv2103c,GO:0004540; GO:0005576; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC37,DOMAIN 3 137 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC37 (RNase VapC37) (EC 3.1.-.-) (Toxin VapC37),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609; 23345537,,FUNCTION: Probable toxic component of a type II toxin-antitoxin (TA) system. An RNase. Upon expression in M.smegmatis inhibits colony formation. The putative cognate antitoxin is VapB37. {ECO:0000269|PubMed:20011113}.,MKIVDANVLLYAVNTTSEHHKPSLRWLDGALSGADRVGFAWVPLLAFVRLATKVGLFPRPLPREAAITQVADWLAAPSAVLVNPTVRHADILARMLTYVGTGANLVNDAHLAALAVEHRASIVSYDSDFGRFEGVRWDQPPALL,"15,662",144,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,3
P9WMU1,WAG31_MYCTU,Rv2145c,wag31 ag84 Rv2145c MTCY270.23,GO:0005618; GO:0005737; GO:0005886; GO:0007049; GO:0008360; GO:0009273; GO:0040007; GO:0050821; GO:0051301; GO:0060187,IPR019933; IPR007793; ,,wag31,,Cell wall synthesis protein Wag31 (Antigen 84),cell pole [GO:0060187]; cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007]; peptidoglycan-based cell wall biogenesis [GO:0009273]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360],7868268; 9634230; 15985609; 19099550; 18310019; 19496931; 21190553; 21470298; 21969609; 23002219,,"FUNCTION: Important for maintaining cell shape and cell wall integrity by localizing peptidoglycan synthesis to the cell poles. Protects PbpB (PBP3, FtsI) from oxidative stress-induced cleavage. {ECO:0000269|PubMed:18310019, ECO:0000269|PubMed:19496931, ECO:0000269|PubMed:21190553}.",MPLTPADVHNVAFSKPPIGKRGYNEDEVDAFLDLVENELTRLIEENSDLRQRINELDQELAAGGGAGVTPQATQAIPAYEPEPGKPAPAAVSAGMNEEQALKAARVLSLAQDTADRLTNTAKAESDKMLADARANAEQILGEARHTADATVAEARQRADAMLADAQSRSEAQLRQAQEKADALQADAERKHSEIMGTINQQRAVLEGRLEQLRTFEREYRTRLKTYLESQLEELGQRGSAAPVDSNADAGGFDQFNRGKN,"28,277",260,DivIVA family,cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007]; peptidoglycan-based cell wall biogenesis [GO:0009273]; protein stabilization [GO:0050821]; regulation of cell shape [GO:0008360],,cell pole [GO:0060187]; cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],ag84,MTCY270.23,1
P9WQM5,Y1979_MYCTU,Rv1979c,Rv1979c MTCY39.40 MTV051.17c,GO:0005886; GO:0016021; GO:0022857,IPR002293; ,,,,Uncharacterized transporter Rv1979c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857],9634230; 21969609,,FUNCTION: Probable amino-acid or metabolite transport protein. {ECO:0000250}.,MVGPRTRGYAIHKLGFCSVVMLGINSIIGAGIFLTPGEVIGLAGPFAPMAYVLAGIFAGVVAIVFATAARYVRTNGASYAYTTAAFGRRIGIYVGVTHAITASIAWGVLASFFVSTLLRVAFPDKAWADAEQLFSVKTLTFLGFIGVLLAINLFGNRAIKWANGTSTVGKAFALSAFIVGGLWIITTQHVNNYATAWSAYSATPYSLLGVAEIGKGTFSSMALATIVALYAFTGFESIANAAEEMDAPDRNLPRAIPIAIFSVGAIYLLTLTVAMLLGSNKIAASDDTVKLAAAIGNATFRTIIVVGALISMFGINVAASFGAPRLWTALADSGVLPTRLSRKNQYDVPMVSFAITASLALAFPLALRFDNLHLTGLAVIARFVQFIIVPIALIALARSQAVEHAAVRRNAFTDKVLPLVAIVVSVGLAVSYDYRCIFLVRGGPNYFSIALIVITFIVVPAMAYLHYYRIIRRVGDRPSTR,"51,116",481,Amino acid-polyamine-organocation (APC) superfamily,,transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY39.40 MTV051.17c,1
P9WMF5,Y1985_MYCTU,Rv1985c,Rv1985c MTCY39.34,GO:0001130; GO:0003677; GO:0003688; GO:0006351; GO:0006355; GO:0008156,IPR017685; IPR005119; IPR000847; IPR036388; IPR036390; ,,,DOMAIN 6 62 HTH lysR-type. {ECO:0000255|PROSITE-ProRule:PRU00253}.,Uncharacterized HTH-type transcriptional regulator Rv1985c,"bacterial-type RNA polymerase transcription factor activity, sequence-specific DNA binding [GO:0001130]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; negative regulation of DNA replication [GO:0008156]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (1),,MVDPQLDGPQLAALAAVVELGSFDAAAERLHVTPSAVSQRIKSLEQQVGQVLVVREKPCRATTAGIPLLRLAAQTALLESEALAEMGGNASLKRTRITIAVNADSMATWFSAVFDGLGDVLLDVRIEDQDHSARLLREGVAMGAVTTERNPVPGCRVHPLGEMRYLPVASRPFVQRHLSDGFTAAAAAKAPSLAWNRDDGLQDMLVRKAFRRAITRPTHFVPTTEGFTAAARAGLGWGMFPEKLAASPLADGSFVRVCDIHLDVPLYWQCWKLDSPIIARITDTVRAAASGLYRGQQRRRRPG,"32,837",303,,"negative regulation of DNA replication [GO:0008156]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","bacterial-type RNA polymerase transcription factor activity, sequence-specific DNA binding [GO:0001130]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]",,,MTCY39.34,1
P9WK31,Y1986_MYCTU,Rv1986,Rv1986 MTCY39.33c,GO:0005886; GO:0015181; GO:0016021; GO:1902023,IPR001123; IPR004777; ,,,,Putative amino-acid transporter Rv1986,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arginine transmembrane transporter activity [GO:0015181]; L-arginine transport [GO:1902023],9634230,,,MNSPLVVGFLACFTLIAAIGAQNAFVLRQGIQREHVLPVVALCTVSDIVLIAAGIAGFGALIGAHPRALNVVKFGGAAFLIGYGLLAARRAWRPVALIPSGATPVRLAEVLVTCAAFTFLNPHVYLDTVVLLGALANEHSDQRWLFGLGAVTASAVWFATLGFGAGRLRGLFTNPGSWRILDGLIAVMMVALGISLTVT,"20,776",199,LysE/ArgO transporter (TC 2.A.75) family,L-arginine transport [GO:1902023],arginine transmembrane transporter activity [GO:0015181],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY39.33c,1
P9WLP9,Y1989_MYCTU,Rv1989c,Rv1989c MTCY39.30,GO:0005886; GO:0016021,IPR014914; ,,,,Uncharacterized protein Rv1989c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSDALDEGLVQRIDARGTIEWSETCYRYTGAHRDALSGEGARRFGGRWNPPLLFPAIYLADSAQACMVEVERAAQAASTTAEKMLEAAYRLHTIDVTDLAVLDLTTPQAREAVGLENDDIYGDDWSGCQAVGHAAWFLHMQGVLVPAAGGVGLVVTAYEQRTRPGQLQLRQSVDLTPALYQELRAT,"20,281",186,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY39.30,1
P9WLN9,Y1998_MYCTU,Rv1998c,Rv1998c MTCY39.20,GO:0003824,IPR015813; ,,,,Uncharacterized protein Rv1998c,catalytic activity [GO:0003824],9634230; 11416222; 12953092; 21969609,,,MSFHDLHHQGVPFVLPNAWDVPSALAYLAEGFTAIGTTSFGVSSSGGHPDGHRATRGANIALAAALAPLQCYVSVDIEDGYSDEPDAIADYVAQLSTAGINIEDSSAEKLIDPALAAAKIVAIKQRNPEVFVNARVDTYWLRQHADTTSTIQRALRYVDAGADGVFVPLANDPDELAELTRNIPCPVNTLPVPGLTIADLGELGVARVSTGSVPYSAGLYAAAHAARAVSDGEQLPRSVPYAELQARLVDYENRTSTT,"27,253",258,,,catalytic activity [GO:0003824],,,MTCY39.20,1
P9WLN1,Y2005_MYCTU,Rv2005c,Rv2005c MTCY39.12,GO:0001666; GO:0005618; GO:0005886,IPR006015; IPR006016; ,,,,Universal stress protein Rv2005c (USP Rv2005c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to hypoxia [GO:0001666],9634230; 11416222; 12953092; 15528667; 18474359; 18400743; 20541977; 21969609,,,MSKPRKQHGVVVGVDGSLESDAAACWGATDAAMRNIPLTVVHVVNADVATWPPMPYPETWGVWQEDEGRQIVANAVKLAKEAVGADRKLSVKSELVFSTPVPTMVEISNEAEMVVLGSSGRGALARGLLGSVSSSLVRRAGCPVAVIHSDDAVIPDPQHAPVLVGIDGSPVSELATAVAFDEASRRGVELIAVHAWSDVEVVELPGLDFSAVQQEAELSLAERLAGWQERYPDVPVSRVVVCDRPARKLVQKSASAQLVVVGSHGRGGLTGMLLGSVSNAVLHAARVPVIVARQS,"30,985",295,Universal stress protein A family,response to hypoxia [GO:0001666],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY39.12,1
P9WLM3,Y2012_MYCTU,Rv2012,Rv2012 MTCY39.05c,,IPR009833; IPR036696; ,,,,Uncharacterized protein Rv2012,,9634230,,,MLSKSKRSCRRRETLRIGEKMSAPITNLQAAQRDAIMNRPAVNGFPHLAETLRRAGVRTNTWWLPAMQSLYETDYGPVLDQGVPLIDGVAEVPAFDRTALVTALRADQAGQTSFREFAAAAWRAGVLRYVVDLENRTCTYFGLHDQTYMEHYAAVEPSGGAPTS,"18,203",164,,,,,,MTCY39.05c,1
P9WLL5,Y2075_MYCTU,Rv2075c,Rv2075c MTCY49.14c,GO:0005886; GO:0006629; GO:0008081; GO:0016021,IPR016187; IPR017946; IPR000909; ,,,,Uncharacterized protein Rv2075c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phosphoric diester hydrolase activity [GO:0008081]; lipid metabolic process [GO:0006629],9634230,,,MPRARWLQSAALMGALAVVLITAAPVAADAYQVPAPPSPTASCDVISPVAIPCVALGKFADAVAAECRRVGVPDARCVLPLAHRVTQAARDAYLQSWVHRTARFQDALQDPVPLRETQWLGTHNSFNSLSDSFTVSHADSNQQLSLAQQLDIDVRALELDLHYLPRLEGHGAPGVTVCHGLGPKNANLGCTVEPLLATVLPQIANWLNAPGHTEEVILLYLEDQLKNASAYESVVATLDQVLRRADGTSLIYRPNPARRATNGCVPLPLDVSREEIRASGARAVLVGSCAPGWSAAVFDWSGVELESGSNSGYRPYPACDATYGRGVYAWRLVRYYEDSTLATALANPTRPPANPQALTPPKVPAMTDCGVNLFGFDQLLPEDGRIQASLWSWAPDEPRAGAGACALQGADGRWVAASCGDPHPAACRDAAGRWTVTPAPVVFAGAALACTAIGADFTLPRTGNQNARLHAVAGPAGGAWVHYLLPP,"51,580",487,,lipid metabolic process [GO:0006629],phosphoric diester hydrolase activity [GO:0008081],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.14c,1
P9WLJ9,Y2085_MYCTU,Rv2085,Rv2085 MTCY49.24,,,,,,Uncharacterized protein Rv2085,,9634230,,,MSDMCDVVSFVGAAERVLRARFRPSPESGPPVHARRCGWSLGISAETLRRWAGQAEVDSGVVAGVSASRSGSVKTSELEQTIEILKVATSFFARKCDPRHR,"10,960",101,,,,,,MTCY49.24,1
P64937,Y2086_MYCTU,Rv2086,Rv2086 MTCY49.27,,IPR025948; ,,,,Uncharacterized protein Rv2086,,9634230,,,MRPATPLICAFGDKHKHTYGVTPICRALAVHGVQIASRTYFADRAAAPSKRALWDTTITEILAGYYEPDAEGKRPPECLYGSLKMWAHLQRQGFRWPSATVKTIMRANGWRGVPLAAHITHHRTRPGRGPGPRPGGSAMAGFSNEPAGSGRLHLRADDVEFRLHRVRGRRLRRCDRGLGMLADQRRSVRRTRITPRPSRLT,"22,518",201,,,,,,MTCY49.27,1
P9WLJ3,Y2100_MYCTU,Rv2100,Rv2100 MTCY49.40,GO:0005618; GO:0005886,IPR003870; IPR003615; ,,,,Uncharacterized protein Rv2100,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230,,,MAGALFEPSFAAAHPAGLLRRPVTRTVVLSVAATSIAHMFEISLPDPTELCRSDDGALVAAIEDCARVEAAASARRLSAIAELTGRRTGADQRADWACDFWDCAAAEVAAALTISHGKASGQMHLSLALNRLPQVAALFLAGHLGARLFSIIAWRTYLVRDPHALSLLDAALAEHAGAWGPLSAPKLEKAIDSWIDRYDPGALRRSRISARTRDLCIGDPDEDAGTAALWGRLYATDAAMLDRRLTEMAHGVCEDDPRTLAQRRADALGALAAGADHLACGCGKPDCPSGAGNDERAAGVVIHVVADASALDAQPDPHLSGDEPPSRPLTPETTLFEALTPDPEPDPPATHAPAELITTGGGVVPAPLLAELIRGGATISQVRHPGDLAAEPHYRPSAKLAEFVRMRDLTCRFPGCDVPAEFCDIDHSAPWPLGPTHPSNLKCACRKHHLLKTFWTGWRDVQLPDGTVIWTAPNGHTYTTHPGSRIFFPTWHTTTAELPQTSTAAVNVDARGLMMPRRRRTRAAELAHRINAERALNDAYMAERNKPPSF,"58,935",550,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY49.40,1
P9WFN1,Y2140_MYCTU,Rv2140c,Rv2140c MTCY270.28,GO:0005576; GO:0005886; GO:0042802,IPR008914; IPR036610; IPR005247; ,Itself,,,UPF0098 protein Rv2140c,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802],9634230; 19099550; 21969609,X-ray crystallography (1),,MTTSPDPYAALPKLPSFSLTSTSITDGQPLATPQVSGIMGAGGADASPQLRWSGFPSETRSFAVTVYDPDAPTLSGFWHWAVANLPANVTELPEGVGDGRELPGGALTLVNDAGMRRYVGAAPPPGHGVHRYYVAVHAVKVEKLDLPEDASPAYLGFNLFQHAIARAVIFGTYEQR,"18,634",176,UPF0098 family,,identical protein binding [GO:0042802],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY270.28,1
P9WHU3,Y2190_MYCTU,Rv2190c,Rv2190c MTCY190.01c MTV021.23c,GO:0005576; GO:0008234,IPR000064; ,,,,Probable endopeptidase Rv2190c (EC 3.4.-.-),extracellular region [GO:0005576]; cysteine-type peptidase activity [GO:0008234],9634230,,,MRLDQRWLIARVIMRSAIGFFASFTVSSGVLAANVLADPADDALAKLNELSRQAEQTTEALHSAQLDLNEKLAAQRAADQKLADNRTALDAARARLATFQTAVNKVAAATYMGGRTHGMDAILTAESPQLLIDRLSVQRVMAHQMSTQMARFKAAGEQAVKAEQAAAKSAADARSAAEQAAAVRANLQHKQSQLQVQIAVVKSQYVALTPEERTALADPGPVPAVAAIAPGAPPAALPPGAPPGDGPAPGVAPPPGGMPGLPFVQPDGAGGDRTAVVQAALTQVGAPYAWGGAAPGGFDCSGLVMWAFQQAGIALPHSSQALAHGGQPVALSDLQPGDVLTFYSDASHAGIYIGDGLMVHSSTYGVPVRVVPMDSSGPIYDARRY,"39,756",385,Peptidase C40 family,,cysteine-type peptidase activity [GO:0008234],extracellular region [GO:0005576],,MTCY190.01c MTV021.23c,1
P9WLI9,Y2197_MYCTU,Rv2197c,Rv2197c MTCY190.08c,GO:0005886; GO:0016021,IPR024381; ,,,,Uncharacterized protein Rv2197c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MVSRYSAYRRGPDVISPDVIDRILVGACAAVWLVFTGVSVAAAVALMDLGRGFHEMAGNPHTTWVLYAVIVVSALVIVGAIPVLLRARRMAEAEPATRPTGASVRGGRSIGSGHPAKRAVAESAPVQHADAFEVAAEWSSEAVDRIWLRGTVVLTSAIGIALIAVAAATYLMAVGHDGPSWISYGLAGVVTAGMPVIEWLYARQLRRVVAPQSS,"22,480",214,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.08c,1
P9WMN5,Y2204_MYCTU,Rv2204c,Rv2204c MTCY190.15c,GO:0005198; GO:0005506; GO:0005829; GO:0005886; GO:0016226; GO:0051537; GO:0051539; GO:0051604; GO:0097428,IPR000361; IPR016092; IPR017870; IPR035903; ,,,,Protein Rv2204c,"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]; iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by iron-sulfur cluster transfer [GO:0097428]",9634230; 11681203; 21969609,,,MTVQNEPSAKTHGVILTEAAAAKAKSLLDQEGRDDLALRIAVQPGGCAGLRYNLFFDDRTLDGDQTAEFGGVRLIVDRMSAPYVEGASIDFVDTIEKQGFTIDNPNATGSCACGDSFN,"12,544",118,HesB/IscA family,iron-sulfur cluster assembly [GO:0016226]; protein maturation [GO:0051604]; protein maturation by iron-sulfur cluster transfer [GO:0097428],"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]; structural molecule activity [GO:0005198]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY190.15c,1
P9WMT7,Y2205_MYCTU,Rv2205c,Rv2205c MTCY190.16c,GO:0005618; GO:0008887; GO:0031388,IPR018193; IPR004381; IPR018197; IPR036129; ,,,,Uncharacterized protein Rv2205c,cell wall [GO:0005618]; glycerate kinase activity [GO:0008887]; organic acid phosphorylation [GO:0031388],9634230; 21969609,,,MKGSQASDDATGSLGPGRLQLPAMRVLVAPDCYGDSLSAVEAAAAIATGWTRSRPGDSFIVAPQSDGGPGFVEVLGSRLGETRRLRVCGPLNTVVNAAWVFDPGSATAYLECAQACGLGLLGGPPTPETALAAHSKGVGQLIAAALRAGAARIVVGLGGSACTDGGKGMIAELGGLDAARRQLADVEVIAASDVEYPLLGPWGTARVFAPQKGADMATVAVLEGRLAAWAIELDAAAGRGVSAEPGAGAAGGIGAGLLAVGGRYQSGAAIIAEHTHFADDLADAELIVTGEGRFDEQSLHGKVVGAIAAAARPLAIPVIVLAGQVSLDKSALRSAGIMAALSIAEYAGSVRLALADAANQLMGLASQVAARLGNSGPSGYR,"37,832",381,Glycerate kinase type-1 family,organic acid phosphorylation [GO:0031388],glycerate kinase activity [GO:0008887],cell wall [GO:0005618],,MTCY190.16c,2
P9WLI5,Y2206_MYCTU,Rv2206,Rv2206 MTCY190.17,GO:0005886; GO:0016021; GO:0042783,IPR021403; ,,,,Uncharacterized protein Rv2206,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MKLLGHRKSHGHQRADASPDAGSKDGCRPDSGRTSGSDTSRGSQTTGPKGRPTPKRNQSRRHTKKGPVAPAPMTAAQARARRKSLAGPKLSREERRAEKAANRARMTERRERMMAGEEAYLLPRDRGPVRRYVRDVVDSRRNLLGLFMPSALTLLFVMFAVPQVQFYLSPAMLILLALMTIDAIILGRKVGRLVDTKFPSNTESRWRLGLYAAGRASQIRRLRAPRPQVERGGDVG,"26,216",236,,active evasion of host immune response [GO:0042783],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.17,1
P9WLI3,Y2209_MYCTU,Rv2209,Rv2209 MTCY190.20,GO:0005886; GO:0016021,IPR036259; ,,,,Uncharacterized protein Rv2209,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MPASRLVRQVSAPRNLFGRLVAQGGFYTAGLQLGSGAVVLPVICAHQGLTWAAGLLYPAFCIGAILGNSLSPLILQRAGQLRHLLMAAISATAAALVVCNAAVPWTGVGVAAVFLATTGAGGVVTGVSSVAYTDMISSMLPAVRRGELLLTQGAAGSVLATGVTLVIVPMLAHGNEMARYHDLLWLGAAGLVCSGIAALFVGPMRSVSVTTATRMPLREIYWMGFAIARSQPWFRRYMTTYLLFVPISLGTTFFSLRAAQSNGSLHVLVILSSIGLVVGSMLWRQINRLFGVRGLLLGSALLNAAAALLCMVAESCGQWVHAWAYGTAFLLATVAAQTVVAASISWISVLAPERYRATLICVGSTLAAVEATVLGVALGGIAQKHATIWPVVVVLTLAVIAAVASLRAPTRIGVTADTSPQAATLQAYRPATPNPIHSDERSTPPDHLSVRRGQLRHVWDSRRPAPPLNRPSCRRAARRPAPGKPAAALPQPRHPAVGVREGAPLDAGQRIA,"53,579",512,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.20,1
P9WGA7,Y2235_MYCTU,Rv2235,Rv2235 MTCY427.16,GO:0005618; GO:0005886; GO:0016021; GO:0040007; GO:0044119,IPR002994; ,,,,Uncharacterized SURF1-like protein Rv2235,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],9634230; 21969609,,,MPRLAFLLRPGWLALALVVVAFTYLCFTVLAPWQLGKNAKTSRENQQIRYSLDTPPVPLKTLLPQQDSSAPDAQWRRVTATGQYLPDVQVLARLRVVEGDQAFEVLAPFVVDGGPTVLVDRGYVRPQVGSHVPPIPRLPVQTVTITARLRDSEPSVAGKDPFVRDGFQQVYSINTGQVAALTGVQLAGSYLQLIEDQPGGLGVLGVPHLDPGPFLSYGIQWISFGILAPIGLGYFAYAEIRARRREKAGSPPPDKPMTVEQKLADRYGRRR,"29,762",271,SURF1 family,growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY427.16,1
P9WLG9,Y2239_MYCTU,Rv2239c,Rv2239c MTCY427.20c,,IPR021412; ,,,,Uncharacterized protein Rv2239c,,9634230; 21969609,,,MPIATVCTWPAETEGGSTVVAADHASNYARKLGIQRDQLIQEWGWDEDTDDDIRAAIEEACGGELLDEDTDEVIDVVLLWWRDGDGDLVDTLMDAIGPLAEDGVIWVVTPKTGQPGHVLPAEIAEAAPTAGLMPTSSVNLGNWSASRLVQPKSRAGKR,"16,963",158,,,,,,MTCY427.20c,1
P9WLG3,Y2265_MYCTU,Rv2265,Rv2265 MTCY339.45c,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR036259; ,,,,Uncharacterized protein Rv2265,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MGANGDVALSRIGATRPALSAWRFVTVFGVVGLLADVVYEGARSITGPLLASLGATGLVVGVVTGVGEAAALGLRLVSGPLADRSRRFWAWTIAGYTLTVVTVPLLGIAGALWVACALVIAERVGKAVRGPAKDTLLSHAASVTGRGRGFAVHEALDQVGAMIGPLTVAGMLAITGNAYAPALGVLTLPGGAALALLLWLQRRVPRPESYEDCPVVLGNPSAPRPWALPAQFWLYCGFTAITMLGFGTFGLLSFHMVSHGVLAAAMVPVVYAAAMAADALTALASGFSYDRYGAKTLAVLPILSILVVLFAFTDNVTMVVIGTLVWGAAVGIQESTLRGVVADLVASPRRASAYGVFAAGLGAATAGGGALIGWLYDISIGTLVVVVIALELMALVMMFAIRLPRVAPS,"41,890",409,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.45c,1
P9WLF5,Y2272_MYCTU,Rv2272,Rv2272 MTCY339.38c,GO:0005886; GO:0016021,IPR003807; ,,,,Uncharacterized protein Rv2272,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MADDSNDTATDVEPDYRFTLANERTFLAWQRTALGLLAAAVALVQLVPELTIPGARQVLGVVLAILAILTSGMGLLRWQQADRAMRRHLPLPRHPTPGYLAVGLCVVGVVALALVVAKAITG,"12,994",122,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.38c,1
P9WLE3,Y2292_MYCTU,Rv2292c,Rv2292c MTCY339.18,GO:0003824; GO:0009116,IPR000845; IPR035994; ,,,,Uncharacterized protein Rv2292c,catalytic activity [GO:0003824]; nucleoside metabolic process [GO:0009116],9634230,,,MNPGFDAVDQETAAAQAVADAHGVPFLGIRGMSDGPGDPLHLPGFPVQFFVYKQIAANNAARVTEAFLQNWAGV,"7,784",74,,nucleoside metabolic process [GO:0009116],catalytic activity [GO:0003824],,,MTCY339.18,1
P9WLE1,Y2293_MYCTU,Rv2293c,Rv2293c MTCY339.17,GO:0003824; GO:0005886; GO:0009116; GO:0016021,IPR000845; IPR035994; ,,,,Uncharacterized protein Rv2293c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; nucleoside metabolic process [GO:0009116],9634230,,,MGAPLRHCLLVAAALSLGCGVAAADPGYVANVIPCEQRTLVLSAFPAEADAVLAHTALDANPVVVADRRRYYLGSISGKKVIVAMTGIGLVNATNTTETAFARFTCASSIAIAAVMFSGVAGGAGRTSIGDVAIPARWTLDNGATFRGVDPGMLATAQTLSVVLDNINTLGNPVCLCRNVPVVRLNHLGRQPQLFVGGDGSSSDKNNGQAFPCIPNGGSVFAANPVVHPIAHLAIPVTFSRRRDPG,"25,255",246,,nucleoside metabolic process [GO:0009116],catalytic activity [GO:0003824],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.17,1
P9WFL7,Y2295_MYCTU,Rv2295,Rv2295 MTCY339.15c,GO:0052170,IPR005363; ,,,,UPF0167 protein Rv2295,negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 20844580; 21969609,,FUNCTION: Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000305|PubMed:20844580}.,MPVEETSTPQKLPQFRYHPDPVGTGSIVADEVSCVSCEQRRPYTYTGPVYAEEELNEAICPWCIADGSAASRFDATFTDAMWAVPDDVPEDVTEEVLCRTPGFTGWLQEEWLHHCGDAAAFLGPVGASEVADLPDALDALRNEYRGYDWPADKIEEFILTLDRNGLATAYLFRCLSCGVHLAYADFA,"20,691",187,UPF0167 family,negative regulation by symbiont of host innate immune response [GO:0052170],,,,MTCY339.15c,1
P9WLD9,Y2297_MYCTU,Rv2297,Rv2297 MTCY339.13c,GO:0005829,,,,,Uncharacterized protein Rv2297,cytosol [GO:0005829],9634230; 21969609,,,MAMEMAMMGLLGTVVGASAMGIGGIAKSIAEAYVPGVAAAKDRRQQMNVDLQARRYEAVRVWRSGLCSASNAYRQWEAGSRDTHAPNVVGDEWFEGLRPHLPTTGEAAKFRTAYEVRCDNPTLMVLSLEIGRIEKEWMVEASGRTPKHRG,"16,468",150,,,,cytosol [GO:0005829],,MTCY339.13c,1
P9WLD7,Y2300_MYCTU,Rv2300c,Rv2300c MTCY339.09,GO:0005886; GO:0016787; GO:0046872,IPR001279; IPR036866; ,,,,Probable metallo-hydrolase Rv2300c (EC 3.-.-.-),plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 21969609,,,MVATRGRPCPTNFSRPQRPRVAGNGTKSQRCRGRLTTSMLGVAPEAKGPPVKVHHLNCGTMNAFGIALLCHVLLVETDDGLVLVDTGFGIQDCLDPGRVGLFRHVLRPAFLQAETAARQIEQLGYRTSDVRHIVLTHFDFDHIGGIADFPEAHLHVTAAEARGAIHAPSLRERLRYRRGQWAHGPKLVEHGPDGEPWRGFASAKPLDSIGTGVVLVPMPGHTRGHAAVAVDAGHRWVLHCGDAFYHRGTLDGRFRVPFVMRAEEKLLSYNRNQLRDNQARIVELHRRHDPDLLIVCAHDPDLYQLARDTA,"34,352",310,Metallo-beta-lactamase superfamily,,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,MTCY339.09,1
P9WLD3,Y2304_MYCTU,Rv2304c,Rv2304c MTCY339.05,,,,,,Uncharacterized protein Rv2304c,,9634230,,,MSHDIATEEADDGALDRCVLCDLTGKRVDVKEATCTGRPATTFEQAFAVERDAGFDDFLHGPVGPRSTP,"7,411",69,,,,,,MTCY339.05,1
P9WLC3,Y2310_MYCTU,Rv2310,Rv2310 MTCY3G12.24c,GO:0003677,IPR009061; IPR010093; ,,,,Uncharacterized protein Rv2310,DNA binding [GO:0003677],9634230,,,MVAALHAGKAVTIAPQSMTLTTQQAADLLGVSRPTVVRLIKSGELAAERIGNRHRLVLDDVLAYREARRQRQYDALAESAMDIDADEDPEVICEQLREARRVVAARRRTERRRA,"12,776",114,,,DNA binding [GO:0003677],,,MTCY3G12.24c,1
P9WQI7,Y2326_MYCTU,Rv2326c,Rv2326c MTCY3G12.08,GO:0005524; GO:0005618; GO:0005886; GO:0005887; GO:0016887,IPR003593; IPR003439; IPR017871; IPR027417; ,,,DOMAIN 251 473 ABC transporter 1. {ECO:0000255|PROSITE-ProRule:PRU00434}.; DOMAIN 477 696 ABC transporter 2. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv2326c,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MCCAVCGPEPGRIGEVTPLGPCPAQHRGGPLRPSELAQASVMAALCAVTAIISVVVPFAAGLALLGTVPTGLLAYRYRLRVLAAATVAAGMIAFLIAGLGGFMGVVHSAYIGGLTGIVKRRGRGTPTVVVSSLIGGFVFGAAMVGMLAAMVRLRHLIFKVMTANVDGIAATLARMHMQGAAADVKRYFAEGLQYWPWVLLGYFNIGIMIVSLIGWWALSRLLERMRGIPDVHKLDPPPGDDVDALIGPVPVRLDKVRFRYPRAGQDALREVSLDVRAGEHLAIIGANGSGKTTLMLILAGRAPTSGTVDRPGTVGLGKLGGTAVVLQHPESQVLGTRVADDVVWGLPLGTTADVGRLLSEVGLEALAERDTGSLSGGELQRLALAAALAREPAMLIADEVTTMVDQQGRDALLAVLSGLTQRHRTALVHITHYDNEADSADRTLSLSDSPDNTDMVHTAAMPAPVIGVDQPQHAPALELVGVGHEYASGTPWAKTALRDINFVVEQGDGVLIHGGNGSGKSTLAWIMAGLTIPTTGACLLDGRPTHEQVGAVALSFQAARLQLMRSRVDLEVASAAGFSASEQDRVAAALTVVGLDPALGARRIDQLSGGQMRRVVLAGLLARAPRALILDEPLAGLDAASQRGLLRLLEDLRRARGLTVVVVSHDFAGMEELCPRTLHLRDGVLESAAASEAGGMS,"72,835",697,ABC transporter superfamily,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY3G12.08,1
P9WLB3,Y2331_MYCTU,Rv2331,Rv2331 MTCY3G12.03c,,,,,,Uncharacterized protein Rv2331,,9634230,,,MPPVFLPQIGRLTPDAVGEAIGIAADDIPMAARWIGSRPCSLIGQPNTMGDEMGYLGPGLAGQRCVDRLVMGASRSTCSRLPVIASVDERLSVLKPVRPRLHSISFIFKGRPGEVYLTVTGYNFRGVP,"13,736",128,,,,,,MTCY3G12.03c,1
P0CV93,VPC16_MYCTU,Rv2231A,vapC16 Rv2231A,GO:0004540; GO:0046872,IPR022907,,vapC16,,Ribonuclease VapC16 (RNase VapC16) (EC 3.1.-.-) (Toxin VapC16),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB16 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MTMACTACPTIWTLRCQTTCSNAFTGEALPHRHPRLAADAVNETRAIVQDVRNSILLSAASAWEIAINYRLGKLPPPEPSASYVPDRMRRCGTSPLSVDHAHTAHRRASGSPSTSIRPCAHRPGTAAWPDDHHRRRPVSCL,"15,443",141,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WF67,VPC35_MYCTU,Rv1962c,vapC35 Rv1962c,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC35,DOMAIN 2 123 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC35 (RNase VapC35) (EC 3.1.-.-) (Toxin VapC35),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB35. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MIYLETSALVKLIRIEVESDALADWLDDRTELRWITSALTEVELSRAIRAVSPEGLPAVPSVLARLDRFEIDAVIRSTAAAYPNPALRSLDAIHLATAQTAGSVAPLTALVTYDNRLKEAAEALSLAVVAPGQAR,"14,521",135,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WF65,VPC36_MYCTU,Rv1982c,vapC36 Rv1982c MTCY39.37,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC36,DOMAIN 1 127 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC36 (RNase VapC36) (EC 3.1.-.-) (Toxin VapC36),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB36 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIVDTSAVVALVQGERPHATLVAAALAGAHSPVMSAPTVAECLIVLTARHGPVARTIFERLRSEIGLSVSSFTAEHAAATQRAFLRYGKGRHRAALNFGDCMTYATAQLGHQPLLAVGNDFPQTDLEFRGVVGYWPGVA,"14,725",139,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY39.37,1
O53465,VPC45_MYCTU,Rv2019 RVBD_2019,vapC45 Rv2019 RVBD_2019 LH57_11000 P425_02090,GO:0004518,,,vapC45,,Putative ribonuclease VapC45 (RNase VapC45) (EC 3.1.-.-) (Toxin VapC45),nuclease activity [GO:0004518],9634230; 21969609; 24662523,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB45. {ECO:0000305|PubMed:24662523}.,MQPDRNLLADLDHIFVDRSLGAVQVPQLLRDAGFRLTTMREHYGETQAQSVSDHKWIAMTAECGWIGFHKDANIRRNAVERRTVLDTGARLFCVPRADILAEQVAARYIASLAAIARAARFPGPFIYTVHPSKIVRVL,"15,511",138,,,nuclease activity [GO:0004518],,,LH57_11000 P425_02090,1
P9WGJ5,SEPF_MYCTU,Rv2147c,sepF Rv2147c,GO:0005737; GO:0005886; GO:0090529,IPR023052; IPR007561; IPR038594; ,,sepF,,Cell division protein SepF,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cell septum assembly [GO:0090529],9634230; 21969609,,"FUNCTION: Cell division protein that is part of the divisome complex and is recruited early to the Z-ring. Probably stimulates Z-ring formation, perhaps through the cross-linking of FtsZ protofilaments. Its function overlaps with FtsA. {ECO:0000255|HAMAP-Rule:MF_01197}.",MSTLHKVKAYFGMAPMEDYDDEYYDDRAPSRGYARPRFDDDYGRYDGRDYDDARSDSRGDLRGEPADYPPPGYRGGYADEPRFRPREFDRAEMTRPRFGSWLRNSTRGALAMDPRRMAMMFEDGHPLSKITTLRPKDYSEARTIGERFRDGSPVIMDLVSMDNADAKRLVDFAAGLAFALRGSFDKVATKVFLLSPADVDVSPEERRRIAETGFYAYQ,"25,028",218,SepF family,cell septum assembly [GO:0090529],,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WH97,RL331_MYCTU,Rv2057c,rpmG1 rpmG Rv2057c MTCY63A.03,GO:0003735; GO:0006412; GO:0022625,IPR038584; IPR001705; IPR018264; IPR011332; ,,rpmG1,,50S ribosomal protein L33 1,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230,,,MARTDIRPIVKLRSTAGTGYTYTTRKNRRNDPDRLILRKYDPILRRHVDFREER,"6,589",54,Bacterial ribosomal protein bL33 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],rpmG,MTCY63A.03,1
P9WHA9,RL28B_MYCTU,Rv2058c,rpmB2 Rv2058c MTCY63A.02,GO:0003735; GO:0006412; GO:0022625,IPR034704; IPR026569; IPR037147; IPR001383; ,,rpmB2,,50S ribosomal protein L28-2,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230,,,MSAHCQVTGRKPGFGNTVSHSHRRSRRRWSPNIQQRTYYLPSEGRRIRLRVSTKGIKVIDRDGIEAVVARLRRQGQRI,"9,095",78,Bacterial ribosomal protein bL28 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625],,MTCY63A.02,1
P9WHJ5,RBPA_MYCTU,Rv2050,rbpA Rv2050,GO:0001000; GO:0001108; GO:0006351; GO:0045893,IPR038638; IPR025182; ,,rbpA,,RNA polymerase-binding protein RbpA,"bacterial-type RNA polymerase core enzyme binding [GO:0001000]; bacterial-type RNA polymerase holo enzyme binding [GO:0001108]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; 21840262; 22570422; 23548911; 23605043,NMR spectroscopy (2); X-ray crystallography (1),"FUNCTION: Binds to RNA polymerase (RNAP), stimulating and stabilizing the formation of stable RNAP promoter complexes up to 2-fold from principal sigma factor SigA-dependent but not alternative sigma factor SigF-dependent promoters. Increases the affinity of core RNAP for SigA, increasing the transcriptional activity of RNAP. Unlike the case in M.smegmatis or S.coelicolor, has no effect on rifampicin inhibition of transcription. Has no effect on E.coli RNAP. {ECO:0000269|PubMed:22570422}.",MADRVLRGSRLGAVSYETDRNHDLAPRQIARYRTDNGEEFEVPFADDAEIPGTWLCRNGMEGTLIEGDLPEPKKVKPPRTHWDMLLERRSIEELEELLKERLELIRSRRRG,"12,972",111,RNA polymerase-binding protein RbpA family,"positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",bacterial-type RNA polymerase core enzyme binding [GO:0001000]; bacterial-type RNA polymerase holo enzyme binding [GO:0001108],,,,1
P9WFZ1,TRMI_MYCTU,Rv2118c,trmI Rv2118c,GO:0005886; GO:0008757; GO:0016429; GO:0030488; GO:0031515,IPR029063; IPR014816; ,,trmI,,tRNA (adenine(58)-N(1))-methyltransferase TrmI (EC 2.1.1.220) (tRNA(m1A58)-methyltransferase) (tRNA(m1A58)MTase),plasma membrane [GO:0005886]; tRNA (m1A) methyltransferase complex [GO:0031515]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; tRNA methylation [GO:0030488],9634230; 14960715; 21969609; 11554794,X-ray crystallography (1),FUNCTION: Catalyzes the S-adenosyl-L-methionine-dependent formation of N(1)-methyladenine at position 58 (m1A58) in tRNA. {ECO:0000269|PubMed:14960715}.,MSATGPFSIGERVQLTDAKGRRYTMSLTPGAEFHTHRGSIAHDAVIGLEQGSVVKSSNGALFLVLRPLLVDYVMSMPRGPQVIYPKDAAQIVHEGDIFPGARVLEAGAGSGALTLSLLRAVGPAGQVISYEQRADHAEHARRNVSGCYGQPPDNWRLVVSDLADSELPDGSVDRAVLDMLAPWEVLDAVSRLLVAGGVLMVYVATVTQLSRIVEALRAKQCWTEPRAWETLQRGWNVVGLAVRPQHSMRGHTAFLVATRRLAPGAVAPAPLGRKREGRDG,"30,123",280,"Class I-like SAM-binding methyltransferase superfamily, TRM61 family",tRNA methylation [GO:0030488],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429],plasma membrane [GO:0005886]; tRNA (m1A) methyltransferase complex [GO:0031515],,,1
P9WFX5,TRPD_MYCTU,Rv2192c,trpD Rv2192c MTCY190.03c,GO:0000162; GO:0004048; GO:0005576; GO:0005886; GO:0040007; GO:0046872,IPR005940; IPR000312; IPR017459; IPR036320; IPR035902; ,,trpD,,Anthranilate phosphoribosyltransferase (EC 2.4.2.18),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; anthranilate phosphoribosyltransferase activity [GO:0004048]; metal ion binding [GO:0046872]; growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],9634230; 21969609; 16337227; 23363292,X-ray crystallography (36),FUNCTION: Catalyzes the transfer of the phosphoribosyl group of 5-phosphorylribose-1-pyrophosphate (PRPP) to anthranilate to yield N-(5'-phosphoribosyl)-anthranilate (PRA).,MALSAEGSSGGSRGGSPKAEAASVPSWPQILGRLTDNRDLARGQAAWAMDQIMTGNARPAQIAAFAVAMTMKAPTADEVGELAGVMLSHAHPLPADTVPDDAVDVVGTGGDGVNTVNLSTMAAIVVAAAGVPVVKHGNRAASSLSGGADTLEALGVRIDLGPDLVARSLAEVGIGFCFAPRFHPSYRHAAAVRREIGVPTVFNLLGPLTNPARPRAGLIGCAFADLAEVMAGVFAARRSSVLVVHGDDGLDELTTTTTSTIWRVAAGSVDKLTFDPAGFGFARAQLDQLAGGDAQANAAAVRAVLGGARGPVRDAVVLNAAGAIVAHAGLSSRAEWLPAWEEGLRRASAAIDTGAAEQLLARWVRFGRQI,"37,740",370,Anthranilate phosphoribosyltransferase family,growth [GO:0040007]; tryptophan biosynthetic process [GO:0000162],anthranilate phosphoribosyltransferase activity [GO:0004048]; metal ion binding [GO:0046872],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY190.03c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WG97,TATC_MYCTU,Rv2093c,tatC Rv2093c MTCY49.33c,GO:0005829; GO:0009977; GO:0016021; GO:0033281; GO:0040007; GO:0043953; GO:0065002,IPR019820; IPR002033; ,,tatC,,Sec-independent protein translocase protein TatC,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; TAT protein transport complex [GO:0033281]; proton motive force dependent protein transmembrane transporter activity [GO:0009977]; growth [GO:0040007]; intracellular protein transmembrane transport [GO:0065002]; protein transport by the Tat complex [GO:0043953],9634230; 16952959; 21969609,,"FUNCTION: Part of the twin-arginine translocation (Tat) system that transports large folded proteins containing a characteristic twin-arginine motif in their signal peptide across membranes. Together with TatB, TatC is part of a receptor directly interacting with Tat signal peptides. {ECO:0000255|HAMAP-Rule:MF_00902}.",MRAAGLLKRLNPRNRRSRVNPDATMSLVDHLTELRTRLLISLAAILVTTIFGFVWYSHSIFGLDSLGEWLRHPYCALPQSARADISADGECRLLATAPFDQFMLRLKVGMAAGIVLACPVWFYQLWAFITPGLYQRERRFAVAFVIPAAVLFVAGAVLAYLVLSKALGFLLTVGSDVQVTALSGDRYFGFLLNLLVVFGVSFEFPLLIVMLNLAGLLTYERLKSWRRGLIFAMFVFAAIFTPGSDPFSMTALGAALTVLLELAIQIARVHDKRKAKREAAIPDDEASVIDPPSPVPAPSVIGSHDDVT,"33,855",308,TatC family,growth [GO:0040007]; intracellular protein transmembrane transport [GO:0065002]; protein transport by the Tat complex [GO:0043953],proton motive force dependent protein transmembrane transporter activity [GO:0009977],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; TAT protein transport complex [GO:0033281],,MTCY49.33c,1
P9WGA1,TATA_MYCTU,Rv2094c,tatA Rv2094c MTCY49.34c,GO:0005886; GO:0008565; GO:0009306; GO:0016021; GO:0040007,IPR003369; IPR006312; ,,tatA,,Sec-independent protein translocase protein TatA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; growth [GO:0040007]; protein secretion [GO:0009306],9634230; 16952959; 21969609,,FUNCTION: Part of the twin-arginine translocation (Tat) system that transports large folded proteins containing a characteristic twin-arginine motif in their signal peptide across membranes. TatA could form the protein-conducting channel of the Tat system. {ECO:0000255|HAMAP-Rule:MF_00236}.,MGSLSPWHWAILAVVVIVLFGAKKLPDAARSLGKSLRIFKSEVRELQNENKAEASIETPTPVQSQRVDPSAASGQDSTEARPA,"8,941",83,TatA/E family,growth [GO:0040007]; protein secretion [GO:0009306],protein transporter activity [GO:0008565],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.34c,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WLP7,Y1990_MYCTU,Rv1990c,Rv1990c MTCY39.29,,IPR024467; ,,,,Uncharacterized protein Rv1990c,,9634230; 21969609,,,MGVNVLASTVSGAIERLGLTYEEVGDIVDASPRSVARWTAGQVVPQRLNKQRLIELAYVADALAEVLPRDQANVWMFSPNRLLEHRKPADLVRDGEYQRVLALIDAMAEGVFV,"12,488",113,,,,,,MTCY39.29,1
P9WLP5,Y1993_MYCTU,Rv1993c,Rv1993c MTCY39.26,GO:0005886,IPR009963; ,,,,Uncharacterized protein Rv1993c,plasma membrane [GO:0005886],9634230; 21969609,,,MVTHELLVKAAGAVLTGLVGVSAYETLRKALGTAPIRRASVTVMEWGLRGTRRAEAAAESARLTVADVVAEARGRIGEEAPLPAGARVDE,"9,366",90,,,,plasma membrane [GO:0005886],,MTCY39.26,1
P9WLP1,Y1996_MYCTU,Rv1996,Rv1996 MTCY39.23c,GO:0005618; GO:0005886; GO:0006950,IPR006015; IPR006016; ,,,,Universal stress protein Rv1996 (USP Rv1996),cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to stress [GO:0006950],9634230; 12953092; 18474359; 18400743; 20066036; 20541977; 21969609,,,MSAQQTNLGIVVGVDGSPCSHTAVEWAARDAQMRNVALRVVQVVPPVITAPEGWAFEYSRFQEAQKREIVEHSYLVAQAHQIVEQAHKVALEASSSGRAAQITGEVLHGQIVPTLANISRQVAMVVLGYRGQGAVAGALLGSVSSSLVRHAHGPVAVIPEEPRPARPPHAPVVVGIDGSPTSGLAAEIAFDEASRRGVDLVALHAWSDMGPLDFPRLNWAPIEWRNLEDEQEKMLARRLSGWQDRYPDVVVHKVVVCDRPAPRLLELAQTAQLVVVGSHGRGGFPGMHLGSVSRAVVNSGQAPVIVARIPQDPAVPA,"33,880",317,Universal stress protein A family,response to stress [GO:0006950],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY39.23c,1
P9WQM3,Y1999_MYCTU,Rv1999c,Rv1999c MTCY39.19,GO:0005886; GO:0016021; GO:0022857,IPR002293; ,,,,Uncharacterized transporter Rv1999c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857],9634230; 21969609,,FUNCTION: Probable amino-acid or metabolite transport protein. {ECO:0000250}.,MRRPLDPRDIPDELRRRLGLLDAVVIGLGSMIGAGIFAALAPAAYAAGSGLLLGLAVAAVVAYCNAISSARLAARYPASGGTYVYGRMRLGDFWGYLAGWGFVVGKTASCAAMALTVGFYVWPAQAHAVAVAVVVALTAVNYAGIQKSAWLTRSIVAVVLVVLTAVVVAAYGSGAADPARLDIGVDAHVWGMLQAAGLLFFAFAGYARIATLGEEVRDPARTIPRAIPLALGITLAVYALVAVAVIAVLGPQRLARAAAPLSEAMRVAGVNWLIPVVQIGAAVAALGSLLALILGVSRTTLAMARDRHLPRWLAAVHPRFKVPFRAELVVGAVVAALAATADIRGAIGFSSFGVLVYYAIANASALTLGLDEGRPRRLIPLVGLIGCVVLAFALPLSSVAAGAAVLGVGVAAYGVRRIITRRARQTDSGDTQRSGHPSAT,"45,267",440,Amino acid-polyamine-organocation (APC) superfamily,,transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY39.19,1
P9WGF5,Y2025_MYCTU,Rv2025c,Rv2025c,GO:0005886; GO:0008324; GO:0016021,IPR002524; IPR027470; IPR036837; IPR027469; ,,,,Probable cation efflux system protein Rv2025c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324],9634230; 17726022; 21969609,,,MTHDHAHSRGVPAMIKEIFAPHSHDAADSVDDTLESTAAGIRTVKISLLVLGLTALIQIVIVVMSGSVALAADTIHNFADALTAVPLWIAFALGAKPATRRYTYGFGRVEDLAGSFVVAMITMSAIIAGYEAIARLIHPQQIEHVGWVALAGLVGFIGNEWVALYRIRVGHRIGSAALIADGLHARTDGFTSLAVLCSAGGVALGFPLADPIVGLLITAAILAVLRTAARDVFRRLLDGVDPAMVDAAEQALAARPGVQAVRSVRMRWIGHRLHADAELDVDPALDLAQAHRIAHDAEHELTHTVPKLTTALIHAYPAEHGSSIPDRGRTVE,"35,207",332,Cation diffusion facilitator (CDF) transporter (TC 2.A.4) family,,cation transmembrane transporter activity [GO:0008324],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WFD1,Y2026_MYCTU,Rv2026c,Rv2026c,GO:0006950; GO:0040007,IPR006015; IPR006016; ,,,,Universal stress protein Rv2026c (USP Rv2026c),growth [GO:0040007]; response to stress [GO:0006950],9634230; 19099550; 20541977; 21969609,,,MSAATAKYGILVGVDGSAQSNAAVAWAAREAVMRQLPITLLHIVAPVVVGWPVGQLYANMTEWQKDNAQQVIEQAREALTNSLGESKPPQVHTELVFSNVVPTLIDASQQAWLMVVGSQGMGALGRLLLGSISTALLHHARCPVAIIHSGNGATPDSDAPVLVGIDGSPASEAATALAFDEASRRRVDLVALHAWTDLGMFPVLGMDWREREKREAEVLAERLAGWQEQYPDVRVHRSLVCDKPARWLLEHSEQAQLVVVGSHGRGGFSGMLLGSVSSAVAHSVRIPVIVVRPS,"31,456",294,Universal stress protein A family,growth [GO:0040007]; response to stress [GO:0006950],,,,,1
P9WLM1,Y2030_MYCTU,Rv2030c,Rv2030c,GO:0005618; GO:0005829; GO:0005886; GO:0009116; GO:0016740; GO:0046677,IPR007815; IPR000836; IPR029057; IPR014622; ,,,,Uncharacterized protein Rv2030c,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; transferase activity [GO:0016740]; nucleoside metabolic process [GO:0009116]; response to antibiotic [GO:0046677],9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,,MLMTAAADVTRRSPRRVFRDRREAGRVLAELLAAYRDQPDVIVLGLARGGLPVAWEVAAALHAPLDAFVVRKLGAPGHDEFAVGALASGGRVVVNDDVVRGLRITPQQLRDIAEREGRELLRRESAYRGERPPTDITGKTVIVVDDGLATGASMFAAVQALRDAQPAQIVIAVPAAPESTCREFAGLVDDVVCATMPTPFLAVGESFWDFRQVTDEEVRRLLATPTAGPSLRRPAASTAADVLRRVAIDAPGGVPTHEVLAELVGDARIVLIGESSHGTHEFYQARAAMTQWLIEEKGFGAVAAEADWPDAYRVNRYVRGLGEDTNADEALSGFERFPAWMWRNTVVRDFVEWLRTRNQRYESGALRQAGFYGLDLYSLHRSIQEVISYLDKVDPRAAARARARYACFDHACADDGQAYGFAAAFGAGPSCEREAVEQLVDVQRNALAYARQDGLLAEDELFYAQQNAQTVRDAEVYYRAMFSGRVTSWNLRDQHMAQTLGSLLTHLDRHLDAPPARIVVWAHNSHVGDARATEVWADGQLTLGQIVRERYGDESRSIGFSTYTGTVTAASEWGGIAQRKAVRPALHGSVEELFHQTADSFLVSARLSRDAEAPLDVVRLGRAIGVVYLPATERQSHYLHVRPADQFDAMIHIDQTRALEPLEVTSRWIAGENPETYPTGL,"74,930",681,Purine/pyrimidine phosphoribosyltransferase family,nucleoside metabolic process [GO:0009116]; response to antibiotic [GO:0046677],transferase activity [GO:0016740],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WIH5,Y2047_MYCTU,Rv2047c,Rv2047c,GO:0005618; GO:0016310; GO:0016772; GO:0050662,IPR001509; IPR036291; IPR008279; IPR036637; ,,,,Uncharacterized protein Rv2047c,"cell wall [GO:0005618]; coenzyme binding [GO:0050662]; transferase activity, transferring phosphorus-containing groups [GO:0016772]; phosphorylation [GO:0016310]",9634230; 21969609,,,MRIAVTGASGVLGRGLTARLLSQGHEVVGIARHRPDSWPSSADFIAADIRDATAVESAMTGADVVAHCAWVRGRNDHINIDGTANVLKAMAETGTGRIVFTSSGHQPRVEQMLADCGLEWVAVRCALIFGRNVDNWVQRLFALPVLPAGYADRVVQVVHSDDAQRLLVRALLDTVIDSGPVNLAAPGELTFRRIAAALGRPMVPIGSPVLRRVTSFAELELLHSAPLMDVTLLRDRWGFQPAWNAEECLEDFTLAVRGRIGLGKRTFSLPWRLANIQDLPAVDSPADDGVAPRLAGPEGANGEFDTPIDPRFPTYLATNLSEALPGPFSPSSASVTVRGLRAGGVGIAERLRPSGVIQREIAMRTVAVFAHRLYGAITSAHFMAATVPFAKPATIVSNSGFFGPSMASLPIFGAQRPPSESSRARRWLRTLRNIGVFGVNLVGLSAGSPRDTDAYVADVDRLERLAFDNLATHDDRRLLSLILLARDHVVHGWVLASGSFMLCAAFNVLLRGLCGRDTAPAAGPELVSARSVEAVQRLVAAARRDPVVIRLLAEPGERLDKLAVEAPEFHSAVLAELTLIGHRGPAEVEMAATSYADNPELLVRMVAKTLRAVPAPQPPTPVIPLRAKPVALLAARQLRDREVRRDRMVRAIWVLRALLREYGRRLTEAGVFDTPDDVFYLLVDEIDALPADVSGLVARRRAEQRRLAGIVPPTVFSGSWEPSPSSAAALAAGDTLRGVGVCGGRVRGRVRIVRPETIDDLQPGEILVAEVTDVGYTAAFCYAAAVVTELGGPMSHAAVVAREFGFPCVVDAQGATRFLPPGALVEVDGATGEIHVVELASEDGPALPGSDLSR,"91,385",854,PEP-utilizing enzyme family,phosphorylation [GO:0016310],"coenzyme binding [GO:0050662]; transferase activity, transferring phosphorus-containing groups [GO:0016772]",cell wall [GO:0005618],,,1
P9WLK7,Y2079_MYCTU,Rv2079,Rv2079 MTCY49.18,,IPR010427; ,,,,Uncharacterized protein Rv2079,,9634230,,,MQLRHINIRALIAEAGGDPWAIEHSLHAGRPAQIAELAEAFHAAGRYTAEANAAFEEARRRFEASWNRENGEHPINDSAEVQRVTAALGVQSLQLPKIGVDLENIAADLAEAQRAAAGRIATLESQLQRIDDQLDQALELEHDPRLAAAERSELDALITCLEQDAIDDTASALGQLQSIRAGYSDHLQQSLAMLRADGYDGAGLQGLDAPQSPVKPEEPIQIPPPGTGAPEVHRWWTSLTSEERQRLIAEHPEQIGNLNGVPVSARSDANIAVMTRDLNRVRDIATRYRTSVDDVLGDPAKYGLSAGDITRYRNADETKKGLDHNARNDPRNPSPVYLFAYDPMAFGGKGRAAIAIGNPDTAKHTAVIVPGTSSSVKGGWLHDNHDDALNLFNQAKAADPNNPTAVIAWMGYDAPNDFTDPRIATPMLARIGGAALAEDVNGLWVTHLGVGQNVTVLGHSYGSTTVADAFALGGMHANDAVLLGCPGTDLAHSAASFHLDGGRVYVGAASTDPISMLGQLDSLSQYVNRGNLAGQLQGLAVGLGTDPAGDGFGSVRFRAEVPNSDGINPHDHSYYYHRGSEALRSMADIASGHGDALASDGMLAQPRHQPGVEIDIPGLGSVEIDIPGTPASIDPEWSRPPGSITDDHVFDAPLHR,"69,823",656,,,,,,MTCY49.18,1
P9WLK5,Y2081_MYCTU,Rv2081c,Rv2081c MTCY49.20c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2081c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MFANAGLSPFVAIWTARAASLYTSHNFWCAAAVSAAVYVGSAVVPAAVAGPLFVGRVSATIKAAAPSTTAAIATLATAANGQLRERGGAGGWVGVHCPVVGGGGVGHPRKAIAAAVSVHSTCMPAAFGGHLGLGDRSRSVSLSGTP,"14,238",146,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.20c,1
P9WLK3,Y2083_MYCTU,Rv2083,Rv2083 MTCY49.22,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2083,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MTSIESHPEQYWAAAGRPGPVPLALGPVHPGGPTLIDLLMALFGLSTNADLGGANADIEGDDTDRRAHAADAARKFSANEANAAEQMQGVGAQGMAQMASGIGGALSGALGGVMGPLTQLPQQAMQAGQGAMQPLMSAMQQAQGADGLAAVDGARLLDSIGGEPGLGSGAGGGDVGGGGAGGTTPTGYLGPPPVPTSSPPTTPAGAPTKSATMPPPGGASPASAHMGAAGMPMVPPGAMGARGEGSGQEKPVEKRLTAPAVPNGQPVKGRLTVPPSAPTTKPTDGKPVVRRRILLPEHKDFGRIAPDEKTDAGE,"30,774",314,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.22,1
P9WLJ7,Y2087_MYCTU,Rv2087,Rv2087 MTCY49.27,,,,,,Uncharacterized protein Rv2087,,9634230,,,MLAGLRPSIGIVGDALDNALCETTTGPHRTECSHGSPFRSGPIRTLADLEDIASAWVEHTCHTQQGVRIPGRLQPA,"8,088",76,,,,,,MTCY49.27,1
P9WLJ5,Y2091_MYCTU,Rv2091c,Rv2091c MTCY49.31c,GO:0005618; GO:0005887,IPR025637; ,,,,Uncharacterized protein Rv2091c,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MSGPQGSDPRQPWQPPGQGADHSSDPTVAAGYPWQQQPTQEATWQAPAYTPQYQQPADPAYPQQYPQPTPGYAQPEQFGAQPTQLGVPGQYGQYQQPGQYGQPGQYGQPGQYAPPGQYPGQYGPYGQSGQGSKRSVAVIGGVIAVMAVLFIGAVLILGFWAPGFFVTTKLDVIKAQAGVQQVLTDETTGYGAKNVKDVKCNNGSDPTVKKGATFECTVSIDGTSKRVTVTFQDNKGTYEVGRPQ,"26,020",244,,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,MTCY49.31c,1
P9WPI9,Y2232_MYCTU,Rv2232,Rv2232 MTCY427.13/MTCY427.14,GO:0004713; GO:0005829; GO:0046777,IPR036412; IPR023214; IPR023198; ,,,,Uncharacterized protein Rv2232,cytosol [GO:0005829]; protein tyrosine kinase activity [GO:0004713]; protein autophosphorylation [GO:0046777],9634230; 12368430; 21969609,,,MSSPRERRPASQAPRLSRRPPAHQTSRSSPDTTAPTGSGLSNRFVNDNGIVTDTTASGTNCPPPPRAAARRASSPGESPQLVIFDLDGTLTDSARGIVSSFRHALNHIGAPVPEGDLATHIVGPPMHETLRAMGLGESAEEAIVAYRADYSARGWAMNSLFDGIGPLLADLRTAGVRLAVATSKAEPTARRILRHFGIEQHFEVIAGASTDGSRGSKVDVLAHALAQLRPLPERLVMVGDRSHDVDGAAAHGIDTVVVGWGYGRADFIDKTSTTVVTHAATIDELREALGV,"30,694",291,"HAD-like hydrolase superfamily, CbbY/CbbZ/Gph/YieH family",protein autophosphorylation [GO:0046777],protein tyrosine kinase activity [GO:0004713],cytosol [GO:0005829],,MTCY427.13/MTCY427.14,1
P9WLH1,Y2237_MYCTU,Rv2237,Rv2237 MTCY427.18,GO:0005886; GO:0016021,IPR018713; ,,,,Uncharacterized protein Rv2237,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MLLPAANVIMQLAVPGVGYGVLESPVDSGNVYKHPFKRARTTGTYLAVATIGTESDRALIRGAVDVAHRQVRSTASSPVSYNAFDPKLQLWVAACLYRYFVDQHEFLYGPLEDATADAVYQDAKRLGTTLQVPEGMWPPDRVAFDEYWKRSLDGLQIDAPVREHLRGVASVAFLPWPLRAVAGPFNLFATTGFLAPEFRAMMQLEWSQAQQRRFEWLLSVLRLADRLIPHRAWIFVYQLYLWDMRFRARHGRRIV,"29,067",255,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY427.18,1
P9WPH5,Y2242_MYCTU,Rv2242,Rv2242 MTCY427.23,GO:0040007,IPR025736; ,,,,Uncharacterized protein Rv2242,growth [GO:0040007],9634230; 21969609,,,MNDNQLAPVARPRSPLELLDTVPDSLLRRLKQYSGRLATEAVSAMQERLPFFADLEASQRASVALVVQTAVVNFVEWMHDPHSDVGYTAQAFELVPQDLTRRIALRQTVDMVRVTMEFFEEVVPLLARSEEQLTALTVGILKYSRDLAFTAATAYADAAEARGTWDSRMEASVVDAVVRGDTGPELLSRAAALNWDTTAPATVLVGTPAPGPNGSNSDGDSERASQDVRDTAARHGRAALTDVHGTWLVAIVSGQLSPTEKFLKDLLAAFADAPVVIGPTAPMLTAAHRSASEAISGMNAVAGWRGAPRPVLARELLPERALMGDASAIVALHTDVMRPLADAGPTLIETLDAYLDCGGAIEACARKLFVHPNTVRYRLKRITDFTGRDPTQPRDAYVLRVAATVGQLNYPTPH,"44,638",414,CdaR family,growth [GO:0040007],,,,MTCY427.23,1
P9WLG5,Y2248_MYCTU,Rv2248,Rv2248 MTCY427.29,GO:0005886,IPR011335; ,,,,Uncharacterized protein Rv2248,plasma membrane [GO:0005886],9634230,,,MTRQQLDVQVKNGGLVRVWYGVYAAQEPDLLGRLAALDVFMGGHAVACLGTAAALYGFDTENTVAIHMLDPGVRMRPTVGLMVHQRVGARLQRVSGRLATAPAWTAVEVARQLRRPRALATLDAALRSMRCARSEIENAVAEQRGRRGIVAARELLPFADGRAESAMESEARLVMIDHGLPLPELQYPIHGHGGEMWRVDFAWPDMRLAAEYESIEWHAGPAEMLRDKTRWAKLQELGWTIVPIVVDDVRREPGRLAARIARHLDRARMAG,"30,120",271,,,,plasma membrane [GO:0005886],,MTCY427.29,1
P9WLF1,Y2277_MYCTU,Rv2277c,Rv2277c MTCY339.33,GO:0006629; GO:0008889,IPR004129; IPR030395; IPR017946; ,,,DOMAIN 31 300 GP-PDE.,Uncharacterized protein Rv2277c,glycerophosphodiester phosphodiesterase activity [GO:0008889]; lipid metabolic process [GO:0006629],9634230; 21969609,X-ray crystallography (1),,MPGRFTVALVIALGGTCGVADALPLGQTDDPMIVAHRAGTRDFPENTVLAITNAVAAGVDGMWLTVQVSSDGVPVLYRPSDLATLTDGAGPVNSKTVQQLQQLNAGWNFTTPGVEGHPYRQRATPIPTLEQAIGATPPDMTLFLDLKQTPPQPLVSAVAQVLTRTGAAGRSIVYSTNADITAAASRQEGLQVAESRDVTRQRLFNMALNHHCDPQPDPGKWAGFELHRDVTVTEEFTLGSGISAVNAELWDEASVDCFRSQSGMKVMGFAVKTVDDYRLAHKIGLDAVLVDSPLAAQQWRH,"32,163",301,,lipid metabolic process [GO:0006629],glycerophosphodiester phosphodiesterase activity [GO:0008889],,,MTCY339.33,1
P9WLQ1,Y1987_MYCTU,Rv1987,Rv1987 MTCY39.32c,GO:0004553; GO:0005975; GO:0030248,IPR001919; IPR008965; IPR012291; ,,,DOMAIN 38 142 CBM2. {ECO:0000255|PROSITE-ProRule:PRU01135}.,Uncharacterized protein Rv1987,"cellulose binding [GO:0030248]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MAGLNIYVRRWRTALHATVSALIVAILGLAITPVASAATARATLSVTSTWQTGFIARFTITNSSTAPLTDWKLEFDLPAGESVLHTWNSTVARSGTHYVLSPANWNRIIAPGGSATGGLRGGLTGSYSPPSSCLLNGQYPCT,"14,919",142,,carbohydrate metabolic process [GO:0005975],"cellulose binding [GO:0030248]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]",,,MTCY39.32c,1
P9WLN3,Y2004_MYCTU,Rv2004c,Rv2004c MTCY39.13,GO:0005524; GO:0005576; GO:0005618; GO:0046812,IPR011009; IPR027417; ,,,,Uncharacterized protein Rv2004c,cell wall [GO:0005618]; extracellular region [GO:0005576]; ATP binding [GO:0005524]; host cell surface binding [GO:0046812],9634230; 12953092; 16199660; 18474359; 18400743; 21969609,,FUNCTION: Some isolated peptides of this protein are able to bind to human U937 monocytoblastic and A549 epithelial cell lines.,MDSPTNDGTCDAHPVTDEPFIDVRETHTAVVVLAGDRAFKAKKPVVTDFCDFRTAEQRERACIREFELNSRLAAQSYLGIAHLSDPSGGHAEPVVVMRRYRDKQRLASMVTAGLPVEGALDAIAEVLARFHQRAQRNRCIDTQGEVGAVARRWHENLAELRHHADKVVSGDVIRRIEHMVDEFVSGREVLFAGRIKEGCIVDGHADLLADDIFLVDGEPALLDCLEFEDELRYLDRIDDAAFLAMDLEFLGRKDLGDYFLAGYAVRSGDTAPASLRDFYIAYRAVVRAKVECVRFSQGKPEAAADAVRHLIIATQHLQHATVRLALVGGNPGTGKSTLARGVAELVGAQVISTDDVRRRLRDCGVITGEPGVLDSGLYSRANVVAVYQEALRKARLLLGSGHSVILDGTWGDPQMRACARRLAADTHSAIVEFRCSATVDVMADRIVARAGGNSDATAEIAAALAARQADWDTGHRIDTAGPRERSVGQAYHIWRSAI,"54,423",498,,,ATP binding [GO:0005524]; host cell surface binding [GO:0046812],cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY39.13,1
P9WN15,Y2006_MYCTU,Rv2006,Rv2006 MTCY39.11c,GO:0005576; GO:0005618; GO:0005886; GO:0005992; GO:0016787; GO:0016798; GO:0030246,IPR008928; IPR012341; IPR011013; IPR005194; IPR005195; IPR005196; IPR037018; IPR036412; IPR006379; IPR023214; IPR023198; IPR003337; ,,,,Uncharacterized glycosyl hydrolase Rv2006 (EC 3.2.1.-),"cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; trehalose biosynthetic process [GO:0005992]",9634230; 15703182; 12953092; 18474359; 18400743; 19553548; 21969609,,,MRCGIVVNVTGPPPTIDRRYHDAVIVGLDNVVDKATRVHAAAWTKFLDDYLTRRPQRTGEDHCPLTHDDYRRFLAGKPDGVADFLAARGIRLPPGSPTDLTDDTVYGLQNLERQTFLQLLNTGVPEGKSIASFARRLQVAGVRVAAHTSHRNYGHTLDATGLAEVFAVFVDGAVTAELGLPAEPNPAGLIETAKRLGANPGRCVVIDSCQTGLRAGRNGGFALVIAVDAHGDAENLLSSGADAVVADLAAVTVGSGDAAISTIPDALQVYSQLKRLLTGRRPAVFLDFDGTLSDIVERPEAATLVDGAAEALRALAAQCPVAVISGRDLADVRNRVKVDGLWLAGSHGFELVAPDGSHHQNAAATAAIDGLAEAAAQLADALREIAGAVVEHKRFAVAVHYRNVADDSVDNLIAAVRRLGHAAGLRVTTGRKVVELRPDIAWDKGKALDWIGERLGPAEVGPDLRLPIYIGDDLTDEDAFDAVRFTGVGIVVRHNEHGDRRSAATFRLECPYTVCQFLSQLACDLQEAVQHDDPWTLVFHGYDPGQERLREALCAVGNGYLGSRGCAPESAESEAHYPGTYVAGVYNQLTDHIEGCTVDNESLVNLPNWLSLTFRIDGGAWFNVDTVELLSYRQTFDLRRATLTRSLRFRDAGGRVTTMTQERFASMNRPNLVALQTRIESENWSGTVDFRSLVDGGVHNTLVDRYRQLSSQHLTTAEIEVLADSVLLRTQTSQSGIAIAVAARSTLWRDGQRVDAQYRVARDTNRGGHDIQVTLSAGQSVTLEKVATIFTSRDAATLTAAISAQRCLGEAGRYAELCQQHVRAWARLWERCAIDLTGNTEELRLVRLHLLHLLQTISPHTAELDAGVPARGLNGEAYRGHVFWDALFVAPVLSLRMPKVARSLLDYRYRRLPAARRAAHRAGHLGAMYPWQSGSDGSEVSQQLHLNPRSGRWTPDPSDRAHHVGLAVAYNAWHYYQVTGDRQYLVDCGAELLVEIARFWVGLAKLDDSRGRYLIRGVIGPDEFHSGYPGNEYDGIDNNAYTNVMAVWVILRAMEALDLLPLTDRRHLIEKLGLTTQERDQWDDVSRRMFVPFHDGVISQFEGYSELAELDWDHYRHRYGNIQRLDRILEAEGDSVNNYQASKQADALMLLYLLSSDELIGLLARLGYRFAPTQIPGTVDYYLARTSDGSTLSAVVHAWVLARANRSNAMEYFRQVLRSDIADVQGGTTQEGIHLAAMAGSIDLLQRCYSGLELRDDRLVLSPQWPEALGPLEFPFVYRRHQLSLRISGRSATLTAESGDAEPIEVECRGHVQRLRCGHTIEVGCSR,"145,784",1327,Trehalose phosphatase family; Glycosyl hydrolase 65 family,trehalose biosynthetic process [GO:0005992],"carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, acting on glycosyl bonds [GO:0016798]",cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY39.11c,1
P9WLL9,Y2067_MYCTU,Rv2067c,Rv2067c MTCY49.06c,GO:0005618; GO:0005737; GO:0005886; GO:0008757; GO:0032259,IPR025714; IPR029063; ,,,,Uncharacterized protein Rv2067c,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MTDDHPRADIVSRQYHRWLYPHPIADLEAWTTANWEWFDPVHSHRILWPDREYRPDLDILIAGCGTNQAAIFAFTNRAAKVVAIDISRPALDHQQYLKDKHGLANLELHLLPIEELATLGRDFDLVVSTGVLHHLADPRAGMKELAHCLRRDGVVAAMLYGKYGRIGVELLGSVFRDLGLGQDDASIKLAKEAISLLPTYHPLRNYLTKARDLLSDSALVDTFLHGRQRSYTVEECVDLVTSAGLVFQGWFHKAPYYPHDFFVPNSEFYAAVNTLPEVKAWSVMERLETLNATHLFMACRRDRPKEQYTIDFSTVAALDYVPLMRTRCGVSGTDMFWPGWRMAPSPAQLAFLQQVDGRRTIREIAGCVARTGEPSGGSLADLEEFGRKLFQSLWRLDFVAVALPASG,"45,930",407,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY49.06c,1
P9WGR3,Y2073_MYCTU,Rv2073c,Rv2073c MTCY49.12c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Uncharacterized oxidoreductase Rv2073c (EC 1.-.-.-),oxidoreductase activity [GO:0016491],9634230; 21969609,,,MDDTGAAPVVIFGGRSQIGGELARRLAAGATMVLAARNADQLADQAAALRAAGAIAVHTREFDADDLAAHGPLVASLVAEHGPIGTAVLAFGILGDQARAETDAAHAVAIVHTDYVAQVSLLTHLAAAMRTAGRGSLVVFSSVAGIRVRRANYVYGSAKAGLDGFASGLADALHGTGVRLLIARPGFVIGRMTEGMTPAPLSVTPERVAAATARALVNGKRVVWIPWALRPMFVALRLLPRFVWRRMPR,"25,922",249,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,MTCY49.12c,1
P9WLL3,Y2076_MYCTU,Rv2076c,Rv2076c MTCY49.15c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2076c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MVVCLIGGVAGSLWPRPAGRLRGGCYFAFMGVAWVLLAISAIANAVKGSLWWDIWSLGLLVLIPAVVYGKMRRSRRISSDQDR,"9,077",83,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.15c,1
P9WLL1,Y2077_MYCTU,Rv2077c,Rv2077c MTCY49.16c,GO:0005829; GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2077c,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MLATLSQIRAWSTEHLIDAAGYWTETADRWEDVFLQMRNQAHAIAWNGAGGDGLRQRTRADFSTVSGIADQLRRAATIARNGAGTIDAAQRRVMYAVEDAQDAGFNVGEDLSVTDTKTTQPAAVQAARLAQAQALAGDIRLRVGQLVAAENEVSGQLAATTGDVGNVRFAGAPVVAHSAVQLVDFFKQDGPTPPPPGAPHPSGGADGPYSDPITSMMLPPAGTEAPVSDATKRWVDNMVNELAARPPDDPIAVEARRLAFQALHRPCNSAEWTAAVAGFAGSSAGVVGTALAIPAGPADWALLGAALLGVGGSGAAVVNCATK,"33,321",323,,,,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.16c,1
P9WLK9,Y2078_MYCTU,Rv2078,Rv2078 MTCY49.17,,IPR022534; ,,,,Uncharacterized protein Rv2078,,9634230,,,MFVDVELLHSGANESHYAGEHAHGGADQLSRGPLLSGMFGTFPVAQTFHDAVGAAHAQQMRNLHAHRQALITVGEKARHAATGFTDMDDGNAAELKAVVCSCAT,"10,938",104,,,,,,MTCY49.17,1
Q10690,Y2082_MYCTU,Rv2082,Rv2082 MTCY49.21,GO:0052556,,,,,Uncharacterized protein Rv2082,positive regulation by symbiont of host immune response [GO:0052556],9634230; 21969609,,,MAGDLPPGRWSALLVGAWWPARPDAPMAGVTYWRKAAQLKRNEANDLRNERSLLAVNQGRTADDLLERYWRGEQRLATIAHQCEVKSDQSEQVADAVNYLRDRLTEIAQSGNQQINQILAGKGPIEAKVAAVNAVIEQSNAMADHVGATAMSNIIDATQRVFDETIGGDAHTWLRDHGVSLDTPARPRPVTAEDMTSMTANSPAGSPFGAAPSAPSHSTTTSGPPTAPTPTSPFGTAPMVLSSSSTSSGPPTAPTPTSPFGTAPMPPGPPPPGTVSPPLPPSAPAVGVGGPSVPAAGMPPAAAAATAPLSPQSLGQSFTTGMTTGTPAAAGAQALSAGALHAATEPLPPPAPPPTTPTVTTPTVATATTAGIPHIPDSAPTPSPAPIAPPTTDNASAMTPIAPMVANGPPASPAPPAAAPAGPLPAYGADLRPPVTTPPATPPTPTGPISGAAVTPSSPAAGGSLMSPVVNKSTAPATTQAQPSNPTPPLASATAAATTGAAAGDTSRRAAEQQRLRRILDTVARQEPGLSWAAGLRDNGQTTLLVTDLASGWIPPHIRLPAHITLLEPAPRRRHATVTDLLGTTTVAAAHHPHGYLSQPDPDTPALTGDRTARIAPTIDELGPTLVETVRRHDTLPPIAQAVVVAATRNYGVPDNETDLLHHKTTEIHQAVLTTYPNHDIATVVDWMLLAAINALIAGDQSGANYHLAWAIAAISTRRSR,"73,565",721,,positive regulation by symbiont of host immune response [GO:0052556],,,,MTCY49.21,1
P9WLK1,Y2084_MYCTU,Rv2084,Rv2084 MTCY49.23,GO:0005886,,,,,Uncharacterized protein Rv2084,plasma membrane [GO:0005886],9634230; 21969609,,,MPVSDDSSSAFDLICAEIERQLRGGELLMDAAAASELLLTVRYQLDTQPRPLVIVHGPLFQAVKAARAQVYGRLIQLRHARCEVLDERWQLRPTGQRDVRALLIDVLNVLLAAITAAGVERAYACAERRAMAAAVVAKNYRDALGVELQCNSVCRAAAEAIHALAHRTGATEDADCLPPVDVIHADVTRRMHGEVATDVVAAGELVIAARHLLDPMPRGELSYGPLHEGGNAARKSVYRRLVQLWQARRAVTDGDVDLRDARTLLTDLDSILREMRTAATIQQSGTAGDGGGGRRQDSRRRNGPRRPARRGTSRGRRCAPRVAIGWHTPIGDPLAVEGVEEIGASLPGRESTPSDDGGSLHPSGRPRRVHRRRWCGLGLC,"41,314",380,,,,plasma membrane [GO:0005886],,MTCY49.23,1
O53509,Y2175_MYCTU,Rv2175c,Rv2175c,GO:0003677; GO:0018107; GO:0019217,,,,,DNA-binding protein Rv2175c,DNA binding [GO:0003677]; peptidyl-threonine phosphorylation [GO:0018107]; regulation of fatty acid metabolic process [GO:0019217],9634230; 18175374; 21969609; 19457863,NMR spectroscopy (1),FUNCTION: Binds DNA at low salt concentrations. {ECO:0000269|PubMed:19457863}.,MPGRAPGSTLARVGSIPAGDDVLDPDEPTYDLPRVAELLGVPVSKVAQQLREGHLVAVRRAGGVVIPQVFFTNSGQVVKSLPGLLTILHDGGYRDTEIMRWLFTPDPSLTITRDGSRDAVSNARPVDALHAHQAREVVRRAQAMAY,"15,743",146,,peptidyl-threonine phosphorylation [GO:0018107]; regulation of fatty acid metabolic process [GO:0019217],DNA binding [GO:0003677],,,,3
P9WLI7,Y2203_MYCTU,Rv2203,Rv2203 MTCY190.14,GO:0005576; GO:0016021,,,,,Uncharacterized protein Rv2203,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MPGPHSPNPGVGTNGPAPYPEPSSHEPQALDYPHDLGAAEPAFAPGPADDAALPPAAYPGVPPQVSYPKRRHKRLLIGIVVALALVSAMTAAIIYGVRTNGANTAGTFSEGPAKTAIQGYLNALENRDVDTIVRNALCGIHDGVRDKRSDQALAKLSSDAFRKQFSQVEVTSIDKIVYWSQYQAQVLFTMQVTPAAGGPPRGQVQGIAQLLFQRGQVLVCSYVLRTAGSY,"24,372",230,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY190.14,1
P9WGP7,Y2216_MYCTU,Rv2216,Rv2216 MTCY190.27,GO:0005618; GO:0005886; GO:0006707; GO:0020037; GO:0031073; GO:0036199; GO:0050662,IPR013549; IPR001509; IPR036291; IPR010099; ,,,,Epimerase family protein Rv2216,cell wall [GO:0005618]; plasma membrane [GO:0005886]; cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; coenzyme binding [GO:0050662]; heme binding [GO:0020037]; cholesterol catabolic process [GO:0006707],9634230; 21969609,,,MANAVVAIAGSSGLIGSALTAALRAADHTVLRIVRRAPANSEELHWNPESGEFDPHALTDVDAVVNLCGVNIAQRRWSGAFKQSLRDSRITPTEVLSAAVADAGVATLINASAVGYYGNTKDRVVDENDSAGTGFLAQLCVDWETATRPAQQSGARVVLARTGVVLSPAGGMLRRMRPLFSVGLGARLGSGRQYMSWISLEDEVRALQFAIAQPNLSGPVNLTGPAPVTNAEFTTAFGRAVNRPTPLMLPSVAVRAAFGEFADEGLLIGQRAIPSALERAGFQFHHNTIGEALGYATTRPG,"31,672",301,"NAD(P)-dependent epimerase/dehydratase family, SDR39U1 subfamily",cholesterol catabolic process [GO:0006707],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; coenzyme binding [GO:0050662]; heme binding [GO:0020037],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY190.27,1
P9WLH3,Y2229_MYCTU,Rv2229c,Rv2229c MTCY427.10c,GO:0005618; GO:0005886; GO:0040007,IPR003743; ,,,,Uncharacterized protein Rv2229c,cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MKAGVAQQRSLLELAKLDAELTRIAHRATHLPQRAAYQQVQAEHNAANDRMAALRIAAEDLDGQVSRFESEIDAVRKRGDRDRSLLTSGATDAKQLADLQHELDSLQRRQASLEDALLEVLERREELQAQQTAESRALQALRADLAAAQQALDEALAEIDQARHQHSSQRDMLTATLDPELAGLYERQRAGGGPGAGRLQGHRCGACRIEIGRGELAQISAAAEDEVVRCPECGAILLRLEGFEE,"26,851",245,,growth [GO:0040007],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY427.10c,1
P9WLG7,Y2240_MYCTU,Rv2240c,Rv2240c MTCY427.21c,GO:0005576; GO:0016021,,,,,Uncharacterized protein Rv2240c,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MLIGWRAVPRRHGGELPRRGALALGCIALLLMGIVGCTTVTDGTAMPDTNVAPAYRSSVSASVSASAATSSIRESQRQQSLTTKAIRTSCDALAATSKDAIDKVNAYVAAFNQGRNTGPTEGPAIDALNNSASTVSGSLSAALSAQLGDALNAYVDAARAVANAIGAHASTAEFNRRVDRLNDTKTKALTMCVAAF,"20,084",196,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY427.21c,1
P9WLF9,Y2269_MYCTU,Rv2269c,Rv2269c MTCY339.41,GO:0042783,,,,,Uncharacterized protein Rv2269c,active evasion of host immune response [GO:0042783],9634230,,,MANDARPLARLANCRVGDQSSATHAYTVGPVLGVPPTGGVDLRYGGRAGIGRSETVTDHGAVGRRYHQPCAGQIRLSELRVTILLRCETLCETAQLLRCPPLPCDCSTPL,"11,697",110,,active evasion of host immune response [GO:0042783],,,,MTCY339.41,1
P9WLF7,Y2271_MYCTU,Rv2271,Rv2271 MTCY339.39c,,IPR024248; ,,,,Uncharacterized protein Rv2271,,9634230; 21969609,,,MTTPPDKARRRFLRDAYKNAERVARTALLTIDQDQLEQLLDYVDERLGEQPCDHTARHAQRWAQSHRIEWETLAEGLQEFGGYCDCEIVMNVEPEAIFG,"11,535",99,,,,,,MTCY339.39c,1
P9WLF3,Y2273_MYCTU,Rv2273,Rv2273 MTCY339.37c,GO:0005886; GO:0016021,IPR003807; IPR020264; ,,,,Uncharacterized protein Rv2273,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MNRHSTAASDRGLQAERTTLAWTRTAFALLVNGVLLTLKDTQGADGPAGLIPAGLAGAAASCCYVIALQRQRALSHRPLPARITPRGQVHILATAVLVLMVVTAFAQLL,"11,439",109,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.37c,1
P9WIT1,Y2280_MYCTU,Rv2280,Rv2280,GO:0005618; GO:0005886; GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016164; IPR004113; IPR006094; IPR016171; ,,,DOMAIN 35 214 FAD-binding PCMH-type. {ECO:0000255|PROSITE-ProRule:PRU00718}.,Uncharacterized FAD-linked oxidoreductase Rv2280 (EC 1.-.-.-),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 20066036; 21969609,,,MSEMTARFSEIVGNANLLTGDAIPEDYAHDEELTGPPQKPAYAAKPATPEEVAQLLKAASENGVPVTARGSGCGLSGAARPVEGGLLISFDRMNKVLEVDTANQVAVVQPGVALTDLDAATADTGLRYTVYPGELSSSVGGNVGTNAGGMRAVKYGVARHNVLGLQAVLPTGEIIRTGGRMAKVSTGYDLTQLIIGSEGTLALVTEVIVKLHPRLDHNASVLAPFADFDQVMAAVPKILASGLAPDILEYIDNTSMAALISTQNLELGIPDQIRDSCEAYLLVALENRIADRLFEDIQTVGEMLMELGAVDAYVLEGGSARKLIEAREKAFWAAKALGADDIIDTVVPRASMPKFLSTARGLAAAADGAAVGCGHAGDGNVHMAIACKDPEKKKKLMTDIFALAMELGGAISGEHGVGRAKTGYFLELEDPVKISLMRRIKQSFDPAGILNPGVVFGDT,"48,052",459,Oxygen-dependent FAD-linked oxidoreductase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WLE7,Y2286_MYCTU,Rv2286c,Rv2286c MTCY339.24,GO:0015035,IPR001853; IPR036249; ,,,,Uncharacterized protein Rv2286c,protein disulfide oxidoreductase activity [GO:0015035],9634230; 21969609,,,MTTVDFHFDPLCPFAYQTSVWIRDVRAQLGITINWRFFSLEEINLVAGKKHPWERDWSYGWSLMRIGALLRRTNMSLLDRWYAAIGHELHTLGGKPHDPAVARRLLCDVGVNAAILDAALDDPTTHDDVRADHQRVVAAGGYGVPTLFLDGQCLFGPVLVDPPAGPAALNLWSVVTGMAGLPHVYELQRPKSPADVELIAQQLRPYLDGRDWVSINRGEIVDIDRLAGRS,"25,642",230,,,protein disulfide oxidoreductase activity [GO:0015035],,,MTCY339.24,1
P9WJI3,Y2287_MYCTU,Rv2287,Rv2287 MTCY339.23c,GO:0005886; GO:0015385; GO:0015386; GO:0016021; GO:0051453; GO:0071805; GO:0098719,IPR006153; IPR018422; IPR004705; ,,,,Uncharacterized Na(+)/H(+) exchanger Rv2287,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],9634230; 21969609,,,MNGRRTIGEDGLVFGLVVIVALVAAVVVGTVLGHRYRVGPPVLLILSGSLLGLIPRFGDVQIDGEVVLLLFLPAILYWESMNTSFREIRWNLRVIVMFSIGLVIATAVAVSWTARALGMESHAAAVLGAVLSPTDAAAVAGLAKRLPRRALTVLRGESLINDGTALVLFAVTVAVAEGAAGIGPAALVGRFVVSYLGGIMAGLLVGGLVTLLRRRIDAPLEEGALSLLTPFAAFLLAQSLKCSGVVAVLVSALVLTYVGPTVIRARSRLQAHAFWDIATFLINGSLWVFVGVQIPGAIDHIAGEDGGLPRATVLALAVTGVVIATRIAWVQATTVLGHTVDRVLKKPTRHVGFRQRCVTSWAGFRGAVSLAAALAVPMTTNSGAPFPDRNLIIFVVSVVILVTVLVQGTSLPTVVRWARMPEDVAHANELQLARTRSAQAALDALPTVADELGVAPDLVKHLEKEYEERAVLVMADGADSATSDLAERNDLVRRVRLGVLQHQRQAVTTLRNQNLIDDIVLRELQAAMDLEEVQLLDPADAE,"57,491",542,Monovalent cation:proton antiporter 1 (CPA1) transporter (TC 2.A.36) family,potassium ion transmembrane transport [GO:0071805]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.23c,1
P9WLE5,Y2288_MYCTU,Rv2288,Rv2288 MTCY339.22c,GO:0005618,,,,,Uncharacterized protein Rv2288,cell wall [GO:0005618],9634230,,,MSRRRPLIEPATVQVLAIAFTDSFSVSLHWPQREQGCRTAILAPMRRWCDGDVDGRKLLPPARRTGTQQRRIRPAAPRVYTTGDILRDRKGIAPWQEQREPGWAPFGWLHEPSGARCPKADGQSV,"14,167",125,,,,cell wall [GO:0005618],,MTCY339.22c,1
P9WLD5,Y2302_MYCTU,Rv2302,Rv2302 MTCY339.07c,GO:0005618,IPR015035; ,,,,Uncharacterized protein Rv2302,cell wall [GO:0005618],9634230; 21969609,NMR spectroscopy (1),,MHAKVGDYLVVKGTTTERHDQHAEIIEVRSADGSPPYVVRWLVNGHETTVYPGSDAVVVTATEHAEAEKRAAARAGHAAT,"8,591",80,,,,cell wall [GO:0005618],,MTCY339.07c,1
P9WLC5,Y2308_MYCTU,Rv2308,Rv2308 MTCY339.01c,GO:0003677,IPR007367; IPR009057; IPR017277; ,,,,Uncharacterized protein Rv2308,DNA binding [GO:0003677],9634230,,,MRADMSVTSMLDREVYVYAEVDKLIGLPAGTAKRWINGYERGGKDHPPILRVTPGATPWVTWGEFVETRMLAEYRDRRKVPIVRQRAAIEELRARFNLRYPLAHLRPFLSTHERDLTMGGEEIGLPDAEVTIRTGQALLGDARWLASIATPGRDEVGEAVIVELPVDKAFPEIVINPSRYSGQPTFVGRRVSPVTIAQMVDGGEEREDLAADYGLSLKQIQDAIDYTKKYRLARLVAA,"26,689",238,,,DNA binding [GO:0003677],,,MTCY339.01c,1
P9WLC1,Y2311_MYCTU,Rv2311,Rv2311 MTCY3G12.23c,,IPR027417; ,,,,Uncharacterized protein Rv2311,,9634230,,,MAPTGQAVDVAVREGAGDVGYSVERENLPADDPVRNGNRWRVIAVDTEHHRIAARRLGDGARAAFSGDYLHEHITHGYAITVHASQGTTAHSTHAVLGDNTSRATLYVAMTPARESNTAYLCERTAGEGARVDLAGWDLWVSGKAEAMSDEKSASPVWCRVGARCDHRGKRSCW,"18,811",174,,,,,,MTCY3G12.23c,1
P9WPI7,Y2325_MYCTU,Rv2325c,Rv2325c MTCY3G12.09,GO:0005886; GO:0016021; GO:0040007,IPR003339; ,,,,Uncharacterized protein Rv2325c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MTTTSAPARNGTRRPSRPIVLLIPVPGSSVIHDLWAGTKLLVVFGISVLLTFYPGWVTIGMMAALVLAAARIAHIPRGALPSVPRWLWIVLAIGFLTAALAGGTPVVAVGGVQLGLGGALHFLRITALSVVLLALGAMVSWTTNVAEISPAVATLGRPFRVLRIPVDEWAVALALALRAFPMLIDEFQVLYAARRLRPKRMPPSRKARRQRHARELIDLLAAAITVTLRRADEMGDAITARGGTGQLSAHPGRPKLADWVTLAITAMASGTAVAIESLILHS,"29,956",282,CbiQ family,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY3G12.09,1
P9WLI1,Y2219_MYCTU,Rv2219,Rv2219 MTCY190.30,GO:0005886; GO:0005887; GO:0040007,IPR025445; ,,,,Uncharacterized protein Rv2219,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MAKPRNAAESKAAKAQANAARKAAARQRRAQLWQAFTLQRKEDKRLLPYMIGAFLLIVGASVGVGVWAGGFTMFTMIPLGVLLGALVAFVIFGRRAQRTVYRKAEGQTGAAAWALDNLRGKWRVTPGVAATGNLDAVHRVIGRPGVIFVGEGSAARVKPLLAQEKKRTARLVGDVPIYDIIVGNGDGEVPLAKLERHLTRLPANITVKQMDTVESRLAALGSRAGAGVMPKGPLPTTAKMRSVQRTVRRK,"26,864",250,,growth [GO:0040007],,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY190.30,1
P9WLH9,Y2226_MYCTU,Rv2226,Rv2226 MTCY427.07,GO:0005829; GO:0005886,IPR007899; IPR038186; IPR033469; IPR023577; ,,,,Uncharacterized protein Rv2226,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MPVEAPRPARHLEVERKFDVIESTVSPSFEGIAAVVRVEQSPTQQLDAVYFDTPSHDLARNQITLRRRTGGADAGWHLKLPAGPDKRTEMRAPLSASGDAVPAELLDVVLAIVRDQPVQPVARISTHRESQILYGAGGDALAEFCNDDVTAWSAGAFHAAGAADNGPAEQQWREWELELVTTDGTADTKLLDRLANRLLDAGAAPAGHGSKLARVLGATSPGELPNGPQPPADPVHRAVSEQVEQLLLWDRAVRADAYDAVHQMRVTTRKIRSLLTDSQESFGLKESAWVIDELRELADVLGVARDAEVLGDRYQRELDALAPELVRGRVRERLVDGARRRYQTGLRRSLIALRSQRYFRLLDALDALVSERAHATSGEESAPVTIDAAYRRVRKAAKAAKTAGDQAGDHHRDEALHLIRKRAKRLRYTAAATGADNVSQEAKVIQTLLGDHQDSVVSREHLIQQAIAANTAGEDTFTYGLLYQQEADLAERCREQLEAALRKLDKAVRKARD,"56,333",513,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY427.07,1
P9WLH7,Y2227_MYCTU,Rv2227,Rv2227 MTCY427.08,,IPR018655; ,,,,Uncharacterized protein Rv2227,,9634230,,,MGQTRRLRRLGRHRCRGQRVRWRTATSADHPRRGRPAAQAVRRRRPVSLDGRYGIQAVRRRAVSIFPCPLSRVIERLKQALYPKLLPIARNWWAKLGREAPWPDSLDDWLASCHAAGQTRSTALMLKYGTNDWNALHQDLYGELVFPLQVVINLSDPETDYTGGEFLLVEQRPRAQSRGTAMQLPQGHGYVFTTRDRPVRTSRGWSASPVRHGLSTIRSGERYAMGLIFHDAA,"26,614",233,,,,,,MTCY427.08,1
P9WQ89,Y2231_MYCTU,Rv2231c,Rv2231c MTCY427.12c,GO:0005737; GO:0008483; GO:0009058; GO:0030170; GO:0040007,IPR004839; IPR004838; IPR015424; IPR015422; IPR015421; ,,,,Uncharacterized aminotransferase Rv2231c (EC 2.6.1.-),cytoplasm [GO:0005737]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058]; growth [GO:0040007],9634230; 19099550; 21969609,,,MLWILGPHTGPLLFDAVASLDTSPLAAARYHGDQDVAPGVLDFAVNVRHDRPPEWLVRQLAALLPELARYPSTDDVHRAQDAVAERHGRTRDEVLPLVGAAEGFALLHNLSPVRAAIVVPAFTEPAIALSAAGITAHHVVLKPPFVLDTAHVPDDADLVVVGNPTNPTSVLHLREQLLELRRPGRILVVDEAFADWVPGEPQSLADDSLPDVLVLRSLTKTWSLAGLRVGYALGSPDVLARLTVQRAHWPLGTLQLTAIAACCAPRAVAAAAADAVRLTALRAEMVAGLRSVGAEVVDGAAPFVLFNIADADGLRNYLQSKGIAVRRGDTFVGLDARYLRAAVRPEWPVLVAAIAEWAKRGGRR,"38,937",364,Class-I pyridoxal-phosphate-dependent aminotransferase family,biosynthetic process [GO:0009058]; growth [GO:0040007],pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],cytoplasm [GO:0005737],,MTCY427.12c,1
P9WMC5,Y2250_MYCTU,Rv2250c,Rv2250c MTCY427.32c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR023772; IPR009057; IPR001647; IPR036271; ,,,DOMAIN 9 69 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv2250c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MLSMSNDRADTGGRILRAAASCVVDYGVDRVTLAEIARRAGVSRPTVYRRWPDTRSIMASMLTSHIADVLREVPLDGDDREALVKQIVAVADRLRGDDLIMSVMHSELARVYITERLGTSQQVLIEGLAARLTVAQRSGSVRSGDARRLATMVLLIAQSTIQSADIVDSILDSAALATELTHALNGYLC,"20,494",189,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY427.32c,1
P9WIA5,Y2281_MYCTU,Rv2281,Rv2281 MTCY339.29c,GO:0005315; GO:0005887; GO:0035435,IPR001204; ,,,,Putative phosphate permease Rv2281,integral component of plasma membrane [GO:0005887]; inorganic phosphate transmembrane transporter activity [GO:0005315]; phosphate ion transmembrane transport [GO:0035435],9634230; 19099550,,FUNCTION: Potential transporter for phosphate. {ECO:0000250}.,MSDNAKHHRDGHLVASGLQDRAARTPQHEGFLGPDRPWHLSFSLLLAGSFVLFSWWAFDYAGSGANKVILVLATVVGMFMAFNVGGNDVANSFGTSVGAGTLTMKQALLVAAIFEVSGAVIAGGDVTETIRSGIVDLSGVSVDPRDFMNIMLSALSAAALWLLFANRMGYPVSTTHSIIGGIVGAAIALGMVSGQGGAALRMVQWDQIGQIVVSWVLSPVLGGLVSYLLYGVIKRHILLYNEQAERRLTEIKKERIAHRERHKAAFDRLTEIQQIAYTGALARDAVAANRKDFDPDELESDYYRELHEIDAKTSSVDAFRALQNWVPLVAAAGSMIIVAMLLFKGFKHMHLGLTTMNNYFIIAMVGAAVWMATFIFAKTLRGESLSRSTFLMFSWMQVFTASGFAFSHGSNDIANAIGPFAAILDVLRTGAIEGNAAVPAAAMVTFGVALCAGLWFIGRRVIATVGHNLTTMHPASGFAAELSAAGVVMGATVLGLPVSSTHILIGAVLGVGIVNRSTNWGLMKPIVLAWVITLPSAAILASVGLVALRAIF,"58,789",552,Inorganic phosphate transporter (PiT) (TC 2.A.20) family,phosphate ion transmembrane transport [GO:0035435],inorganic phosphate transmembrane transporter activity [GO:0005315],integral component of plasma membrane [GO:0005887],,MTCY339.29c,1
P9WMF3,Y2282_MYCTU,Rv2282c,Rv2282c MTCY339.28,GO:0003677; GO:0003700; GO:0005829; GO:0006351,IPR005119; IPR000847; IPR036388; IPR036390; ,,,DOMAIN 8 65 HTH lysR-type. {ECO:0000255|PROSITE-ProRule:PRU00253}.,Uncharacterized HTH-type transcriptional regulator Rv2282c,"cytosol [GO:0005829]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPLSSRMPGLTCFEIFLAIAEAGSLGGAARELGLTQQAVSRRLASMEAQIGVRLAIRTTRGSQLTPAGIVVAEWAARLLEVADEIDAGLGSLRTEGRQRIRVVASQTIAEQLMPHWMLSLRAADMRRGGTVPEVILTATNSEHAIAAVRDGIADLGFIENPCPPTGLGSVVVARDELVVVVPPGHKWARRSRVVSARELAQTPLVTREPNSGIRDSLTAALRDTLGEDMQQAPPVLELSSAAAVRAAVLAGAGPAAMSRLAIADDLAFGRLLAVDIPALNLRRQLRAIWVGGRTPPAGAIRDLLSHITSRST,"32,989",312,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cytosol [GO:0005829],,MTCY339.28,1
P9WQA7,Y2298_MYCTU,Rv2298,Rv2298 MTCY339.12c,GO:0005618; GO:0005886; GO:0016491,IPR023210; IPR036812; ,,,,Uncharacterized oxidoreductase Rv2298 (EC 1.-.-.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MKYLDVDGIGQVSRIGLGTWQFGSREWGYGDRYATGAARDIVKRARALGVTLFDTAEIYGLGKSERILGEALGDDRTEVVVASKVFPVAPFPAVIKNRERASARRLQLNRIPLYQIHQPNPVVPDSVIMPGMRDLLDSGDIGAAGVSNYSLARWRKADAALGRPVVSNQVHFSLAHPDALEDLVPFAELENRIVIAYSPLAQGLLGGKYGLENRPGGVRALNPLFGTENLRRIEPLLATLRAIAVDVDAKPAQVALAWLISLPGVVAIPGASSVEQLEFNVAAADIELSAQSRDALTDAARAFRPVSTGRFLTDMVREKVSRR,"34,986",323,"Aldo/keto reductase family, Aldo/keto reductase 2 subfamily",,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY339.12c,1
P9WLD1,Y2305_MYCTU,Rv2305,Rv2305 MTCY339.04c,GO:0005886,IPR023213; IPR001242; ,,,,Uncharacterized protein Rv2305,plasma membrane [GO:0005886],9634230; 21969609,,,MTQTLRLTALDEMFITDDIDIVPSVQIEARVSGRFDLDRLAAALRAAVAKHALARARLGRASLTARTLYWEVPDRADHLAVEITDEPVGEVRSRFYARAPELHRSPVFAVAVVRETVGDRLLLNFHHAAFDGMGGLRLLLSLARAYAGEPDEVGGPPIEEARNLKGVAGSRDLFDVLIRARGLAKPAIDRKRTTRVAPDGGSPDGPRFVFAPLTIESDEMATAVARRPEGATVNDLAMAALALTILQWNRTHDVPAADSVSVNMPVNFRPTAWSTEVISNFASYLAIVLRVDEVTDLEKATAIVAGITGPLKQSGAAGWVVDLLEGGKVLPAMLKRQLQLLLPLVEDRFVESVCLSNLGRVDVPAFGGEAGDTTEVWFSPTAAMSVMPIGVGLVGFGGTLRAMFRGDGRTIGGEALGRFAALYRDTLLT,"46,124",429,,,,plasma membrane [GO:0005886],,MTCY339.04c,1
P9WLB9,Y2312_MYCTU,Rv2312,Rv2312 MTCY3G12.22c,,,,,,Uncharacterized protein Rv2312,,9634230,,,MMKEIELHLVDAAAPSGEIAIKDLAALATALQELTTRISRDPINTPGPGRTKQFMEELSQLASAPGPDIDGGIDLTDDEFQAFLQAARS,"9,493",89,,,,,,MTCY3G12.22c,1
P9WLB7,Y2313_MYCTU,Rv2313c,Rv2313c MTCY3G12.21,,IPR029032; ,,,,Uncharacterized protein Rv2313c,,9634230; 21969609,,,MPAPVSVRDDLCRLVALSPGDGRIAGLVRQVCARALSLPSLPCEVAVNEPESPAEAVVAEFAEQFSVDVSAITGEQRSLLWTHLGEDAFGAVVAMYIADFVPRVRAGLEALGVGKEYLGWVTGPISWDHNTDLSAAVFNGFLPAVARMRALDPVTSELVRLRGAAQHNCRVCKSLREVSALDAGGSETLYGEIERFDTSVLLDVRAKAALRYADALIWTPAHLAVDVAVEVRSRFSDDEAVELTFDIMRNASNKVAVSLGADAPRVQQGTERYRIGLDGQTVFG,"30,523",284,,,,,,MTCY3G12.21,1
P9WLB5,Y2319_MYCTU,Rv2319c,Rv2319c MTCY3G12.15,GO:0006950; GO:0040007,IPR006015; IPR006016; ,,,,Universal stress protein Rv2319c (USP Rv2319c),growth [GO:0040007]; response to stress [GO:0006950],9634230; 19099550; 21969609,,,MTIVVGYLAGKVGPSALHLAVRVARMHKTSLTVATIVRRHWPTPSLARVDAEYELWSEQLAAASAREAQRYLRRLADGIEVSYHHRAHRSVSAGLLDVVEELEAEVLVLGSFPSGRRARVLIGSTADRLLHSSPVPVAITPRRYRCYTDRLTRLSCGYSATSGSVDVVRRCGHLASRYGVPMRVITFAVRGRTMYPPEVGLHAEASVLEAWAAQARELLEKLRINGVVSEDVVLQVVTGNGWAQALDAADWQDGEILALGTSPFGDVARVFLGSWSGKIIRYSPVPVLVLPG,"31,867",292,Universal stress protein A family,growth [GO:0040007]; response to stress [GO:0006950],,,,MTCY3G12.15,1
P9WLP3,Y1995_MYCTU,Rv1995,Rv1995 MTCY39.24c,GO:0005886,IPR012312; ,,,,Uncharacterized protein Rv1995,plasma membrane [GO:0005886],9634230; 21969609,,,MVASGAATKGVTVMKQTPPAAVGRRHLLEISASAAGVIALSACSGSPPEPGKGRPDTTPEQEVPVTAPEDLMREHGVLKRILLIYREGIRRLQADDQSPAPALNESAQIIRRFIEDYHGQLEEQYVFPKLEQAGKLTDITSVLRTQHQRGRVLTDRVLAATTAAAAFDQPARDTLAQDMAAYIRMFEPHEAREDTVVFPALRDVMSAVEFRDMAETFEDEEHRRFGEAGFQSVVDKVADIEKSLGIYDLSQFTPS,"28,073",255,,,,plasma membrane [GO:0005886],,MTCY39.24c,1
P9WLN7,Y2000_MYCTU,Rv2000,Rv2000 MTCY39.18c,GO:0005618; GO:0005829; GO:0005886,IPR036188,,,,Uncharacterized protein Rv2000,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MRPGFVGLGFGQWPVYVVRWPKLHLTPRQRKRVLHRRRLLTDRPISLSQIPIRTGGPMNDPWPRPTQGPAKTIETDYLVIGAGAMGMAFTDTLITESGARVVMIDRACQPGGHWTTAYPFVRLHQPSAYYGVNSRALGNNTIDLVGWNQGLNELAPVGEICAYFDAVLQQQLLPTGRVDYFPMSEYLGDGRFRTLAGTEYVVTVNRRIVDATYLRAVVPSMRPAPYSVAPGVDCVAPNELPKLGTRDRYVVVGAGKTGMDVCLWLLRNDVCPDKLTWIMPRDSWLIDRATLQPGPTFVRQFRESYGATLEAIGAATSTDDLFDRLETAGTLLRIDPSVRPSMYRCATVSHLELEQLRRIRDIVRMGHVQRIEPTTIVLDGGSVPATPTALYIDCTADGAPQRPAKPVFDADHLTLQAVRGCQQVFSAAFIAHVEFAYEDDAVKNELCTPIPHPDCDLDWMRLMHSDLGNFQRWLNDPDLTDWLSSARLNLLADLLPPLSHKPRVRERVVSMFQKRLGTAGDQLAKLLDAATATTEQR,"59,895",537,,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY39.18c,1
P9WLN5,Y2001_MYCTU,Rv2001,Rv2001 MTCY39.17c,GO:0006633; GO:0016790,IPR002864; IPR029069; ,,,,Uncharacterized protein Rv2001,thiolester hydrolase activity [GO:0016790]; fatty acid biosynthetic process [GO:0006633],9634230; 21969609,,,MHHNRDVDLALVERPSSGYVYTTGWRLATTDIDEHQQLRLDGVARYIQEVGAEHLADAQLAEVHPHWIVLRTVIDVINPIELPSDITFHRWCAALSTRWCSMRVQLQGSAGGRIETEGFWICVNKDTLTPSRLTDDCIARFGSTTENHRLKWRPWLTGPNIDGTETPFPLRRTDIDPFEHVNNTIYWHGVHEILCQIPTLTAPYRAVLEYRSPIKSGEPLTIRYEQHDDVVRMHFVVGDDVRAAALLRRL,"28,734",250,,fatty acid biosynthetic process [GO:0006633],thiolester hydrolase activity [GO:0016790],,,MTCY39.17c,1
P9WJZ5,Y2003_MYCTU,Rv2003c,Rv2003c MTCY39.14,GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized protein Rv2003c,methyltransferase activity [GO:0008168],9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,,MVKRSRATRLSPSIWSGWESPQCRSIRARLLLPRGRSRPPNADCCWNQLAVTPDTRMPASSAAGRDAAAYDAWYDSPTGRPILATEVAALRPLIEVFAQPRLEIGVGTGRFADLLGVRFGLDPSRDALMFARRRGVLVANAVGEAVPFVSRHFGAVLMAFTLCFVTDPAAIFRETRRLLADGGGLVIGFLPRGTPWADLYALRAARGQPGYRDARFYTAAELEQLLADSGFRVIARRCTLHQPPGLARYDIEAAHDGIQAGAGFVAISAVDQAHEPKDDHPLESE,"31,049",285,Methyltransferase superfamily,,methyltransferase activity [GO:0008168],,,MTCY39.14,1
P9WLM9,Y2008_MYCTU,Rv2008c,Rv2008c MTCY39.09,GO:0005524,IPR025420; IPR027417; ,,,,Uncharacterized protein Rv2008c,ATP binding [GO:0005524],9634230; 21969609,,,MDEIESLIGLRPTPLTWPVVIAGDFLGVWDPPPSLPGAANHEISAPTARISCMLIERRDAAARLRRALHRAPVVLLTGPRQAGKTTLSRLVGKSAPECTFDAENPVDATRLADPMLALSGLSGLITIDEAQRIPDLFPVLRVLVDRPVMPARFLILGSASPDLVGLASESLAGRVELVELSGLTVRDVGSSAADRLWLRGGLPPSFTARSNEDSAAWRDGYITTFLERDLAQLGVRIPAATMRRAWTMLAHYHGQLFSGAELARSLDVAQTTARRYLDALTDALVVRQLTPWFANIGKRQRRSPKIYIRDTGLLHRLLGIDDRLALERNPKLGASWEGFVLEQLAALLAPNPLYYWRTQQDAELDLYVELSGRPYGFEIKRTSTPSISRSMRSALVDLQLARLAIVYPGEHRFPLSDTVVAVPADQILTTGSVDELLALLK,"48,393",441,,,ATP binding [GO:0005524],,,MTCY39.09,1
P9WLM5,Y2011_MYCTU,Rv2011c,Rv2011c MTCY39.06,,IPR036388; IPR036390; ,,,,Uncharacterized protein Rv2011c,,9634230,,,MSDEIARLVADVFELAGLLRRSGEVVAAREGHTQARWQLLSVVSDRALTVPQAARRLGVTRQGVQRVANDLVVCGLAELRHNPDHRTSPLLVLTENGRRVLQAITERAIVVNNRLADAVDPAALQATRDSLRRMIVALKAERP,"15,725",143,,,,,,MTCY39.06,1
P9WFD9,Y2028_MYCTU,Rv2028c,Rv2028c,GO:0005618; GO:0005886; GO:0006950,IPR006015; IPR006016; ,,,,Universal stress protein Rv2028c (USP Rv2028c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to stress [GO:0006950],9634230; 11416222; 12953092; 18400743; 20541977; 21969609,,,MNQSHKPPSIVVGIDGSKPAVQAALWAVDEAASRDIPLRLLYAIEPDDPGYAAHGAAARKLAAAENAVRYAFTAVEAADRPVKVEVEITQERPVTSLIRASAAAALVCVGAIGVHHFRPERVGSTAAALALSAQCPVAIVRPHRVPIGRDAAWIVVEADGSSDIGVLLGAVMAEARLRDSPVRVVTCRQSGVGDTGDDVRASLDRWLARWQPRYPDVRVQSAAVHGELLDYLAGLGRSVHMVVLSASDQEHVEQLVGAPGNAVLQEAGCTLLVVGQQYL,"29,442",279,Universal stress protein A family,response to stress [GO:0006950],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53500,Y2102_MYCTU,Rv2102 RVBD_2102,Rv2102 RVBD_2102 P425_02177,GO:0008270,IPR007527; ,,,,Uncharacterized protein Rv2102,zinc ion binding [GO:0008270],9634230; 21969609,,,MSSTWYPPPSRPRPVEGGIKARSTRGAIAQTWWSERFIAVLEDIGLGNRLQRGRSYARKGQVISLQVDAGLVTALVQGSRARPYRIRIGIPAFGKSQWAHVERTLAENAWYAAKLLSGEMPEDIEDVFAGLGLSLFPGTARELSLDCSCPDYAVPCKHLAATFYLLAESFDEDPFAILAWRGREREDLLANLAAARADGAAPAADHAEQVAQPLTDCLDRYYARQADINVPSPPATPSTALLDQLPDTGLSARGRPLTELLRPAYHALTHHHNSAGG,"30,165",277,,,zinc ion binding [GO:0008270],,,P425_02177,4
P9WLJ1,Y2191_MYCTU,Rv2191,Rv2191 MTCY190.02,GO:0003677; GO:0003887; GO:0004519; GO:0004527; GO:0005618; GO:0005829; GO:0005886; GO:0006260; GO:0006974; GO:0009380,IPR006054; IPR013520; IPR000305; IPR035901; IPR012337; IPR036397; ,,,DOMAIN 44 207 Exonuclease. {ECO:0000255}.; DOMAIN 248 326 GIY-YIG. {ECO:0000255|PROSITE-ProRule:PRU00977}.,Putative bifunctional exonuclease/endonuclease protein Rv2191 (EC 3.1.-.-),cell wall [GO:0005618]; cytosol [GO:0005829]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],9634230; 21969609,,,MQGPNVAAMGATGGTQLSFADLAHAQGAAWTPADEMSLRETTFVVVDLETTGGRTTGNDATPPDAITEIGAVKVCGGAVLGEFATLVNPQHSIPPQIVRLTGITTAMVGNAPTIDAVLPMFFEFAGDSVLVAHNAGFDIGFLRAAARRCDITWPQPQVLCTMRLARRVLSRDEAPSVRLAALARLFAVASNPTHRALDDARATVDVLHALIERVGNQGVHTYAELRSYLPNVTQAQRCKRVLAETLPHRPGVYLFRGPSGEVLYVGTAADLRRRVSQYFNGTDRRKRMTEMVMLASSIDHVECAHPLEAGVRELRMLSTHAPPYNRRSKFPYRWWWVALTDEAFPRLSVIRAPRHDRVVGPFRSRSKAAETAALLARCTGLRTCTTRLTRSARHGPACPELEVSACPAARDVTAAQYAEAVLRAAALIGGLDNAALAAAVQQVTELAERRRYESAARLRDHLATAIEALWHGQRLRALAALPELIAAKPDGPREGGYQLAVIRHGQLAAAGRAPRGVPPMPVVDAIRRGAQAILPTPAPLGGALVEEIALIARWLAEPGVRIVGVSNDAAGLASPVRSAGPWAAWAATARSAQLAGEQLSRGWQSDLPTEPHPSREQLFGRTGVDCRTGPPQPLLPGRQPFSTAG,"69,180",645,,cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; endonuclease activity [GO:0004519]; exonuclease activity [GO:0004527],cell wall [GO:0005618]; cytosol [GO:0005829]; excinuclease repair complex [GO:0009380]; plasma membrane [GO:0005886],,MTCY190.02,1
P9WMU7,Y2212_MYCTU,Rv2212,Rv2212 MTCY190.23,GO:0004016; GO:0005504; GO:0005622; GO:0006171; GO:0035556,IPR001054; IPR032026; IPR029787; ,,,DOMAIN 208 317 Guanylate cyclase. {ECO:0000255|PROSITE-ProRule:PRU00099}.,Uncharacterized protein Rv2212,intracellular [GO:0005622]; adenylate cyclase activity [GO:0004016]; fatty acid binding [GO:0005504]; cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],9634230; 21969609,,,MYDSLDFDALEAAGIANPRERAGLLTYLDELGFTVEEMVQAERRGRLFGLAGDVLLWSGPPIYTLATAADELGLSADDVARAWSLLGLTVAGPDVPTLSQADVDALATWVALKALVGEDGAFGLLRVLGTAMARLAEAESTMIRAGSPNIQMTHTHDELATARAYRAAAEFVPRIGALIDTVHRHHLASARTYFEGVIGDTSASVTCGIGFADLSSFTALTQALTPAQLQDLLTEFDAAVTDVVHADGGRLVKFIGDAVMWVSSSPERLVRAAVDLVDHPGARAAELQVRAGLAYGTVLALNGDYFGNPVNLAARLVAAAAPGQILAAAQLRDMLPDWPALAHGPLTLKGFDAPVMAFELHDNPRARDADTPSPAASD,"39,775",378,Adenylyl cyclase class-4/guanylyl cyclase family,cAMP biosynthetic process [GO:0006171]; intracellular signal transduction [GO:0035556],adenylate cyclase activity [GO:0004016]; fatty acid binding [GO:0005504],intracellular [GO:0005622],,MTCY190.23,1
P9WLE9,Y2283_MYCTU,Rv2283,Rv2283 MTCY339.27c,GO:0040007,,,,,Uncharacterized protein Rv2283,growth [GO:0040007],9634230,,,MLEKCPHASVDCGASKIGITDNDPATATNRRLASTIRKPPIEHAAGPLGSTSRAGHRSYGGVAS,"6,557",64,,growth [GO:0040007],,,,MTCY339.27c,1
P9WKB5,Y2285_MYCTU,Rv2285,Rv2285 MTCY339.25c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv2285 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv2285),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has very weak wax synthase activity, incorporating palmityl alcohol into wax esters in the presence of palmitoyl-CoA.",MKLLSPLDQMFARMEAPRTPMHIGAFAVFDLPKGAPRRFIRDLYEAISQLAFLPFPFDSVIAGGASMAYWRQVQPDPSYHVRLSALPYPGTGRDLGALVERLHSTPLDMAKPLWELHLIEGLTGRQFAMYFKAHHCAVDGLGGVNLIKSWLTTDPEAPPGSGKPEPFGDDYDLASVLAAATTKRAVEGVSAVSELAGRLSSMVLGANSSVRAALTTPRTPFNTRVNRHRRLAVQVLKLPRLKAVAHATDCTVNDVILASVGGACRRYLQELGDLPTNTLTASVPVGFERDADTVNAASGFVAPLGTSIEDPVARLTTISASTTRGKAELLAMSPNALQHYSVFGLLPIAVGQKTGALGVIPPLFNFTVSNVVLSKDPLYLSGAKLDVIVPMSFLCDGYGLNVTLVGYTDKVVLGFLGCRDTLPHLQRLAQYTGAAFEELETAALP,"47,707",445,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY339.25c,1
P9WLC7,Y2307_MYCTU,Rv2307c,Rv2307c MTCY339.02,GO:0005618; GO:0005886; GO:0016021; GO:0052562,IPR029058; IPR022742; ,,,,Uncharacterized protein Rv2307c,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; negative regulation by symbiont of host immune response [GO:0052562],9634230; 21969609,,,MSLKRCRALPVVAIVALVASGVIMFIWSQQRRLIYFPSAGPVPSASSVLPAGRDVVVETQDGMRLGGWYFPHTSGGSGPAVLVCNGNAGDRSMRAELAVALHGLGLSVLLFDYRGYGGNPGRPSEQGLAADARAAQEWLSGQSDVDPARIAYFGESLGAAVAVGLAVQRPPAALVLRSPFTSLAEVGAVHYPWLPLRRLLLDHYPSIERIASVHAPVLVIAGGSDDIVPATLSERLVAAAAEPKRYVVVPGVGHNDPELLDGRVMLDAIRRFLTETAVLGQ,"29,671",281,,negative regulation by symbiont of host immune response [GO:0052562],,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.02,1
P0CW31,VPB16_MYCTU,Rv2231B,vapB16 Rv2231B,,,,vapB16,,Putative antitoxin VapB16,,9634230; 15718296,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC16. {ECO:0000305|PubMed:15718296}.,MALWYQAMIAKFGEQVVDAKVWAPAKRVGVHEAKTRLSELLRLVYGGQRLRLPAAASR,"6,509",58,,,,,,,1
P9WF17,VPB35_MYCTU,Rv1962A,vapB35 Rv1962A,GO:0045927,IPR006442; IPR036165; ,,vapB35,,Antitoxin VapB35,positive regulation of growth [GO:0045927],9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC35. {ECO:0000269|PubMed:20011113}.,MNEVSIRTLNQETSKVLARVKRGEEINLTERGKVIARIIPASAGPLDSLISTGSVQPARVHGPAPRPTIPMRGGLDSGTLLERMRAEERY,"9,818",90,PhD/YefM antitoxin family,positive regulation of growth [GO:0045927],,,,,1
P9WID3,PFKB_MYCTU,Rv2029c,pfkB Rv2029c,GO:0003872; GO:0005524; GO:0005829; GO:0019200; GO:0046835; GO:0046872,IPR002173; IPR011611; IPR029056; IPR017583; ,,pfkB,,Putative ATP-dependent 6-phosphofructokinase isozyme 2 (ATP-PFK 2) (Phosphofructokinase 2) (EC 2.7.1.11) (Phosphohexokinase 2),cytosol [GO:0005829]; 6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872]; carbohydrate phosphorylation [GO:0046835],9634230; 11416222; 12953092; 16931093; 19099550; 18474359; 18400743; 20066036; 21969609,,"FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. {ECO:0000250}.",MTEPAAWDEGKPRIITLTMNPALDITTSVDVVRPTEKMRCGAPRYDPGGGGINVARIVHVLGGCSTALFPAGGSTGSLLMALLGDAGVPFRVIPIAASTRESFTVNESRTAKQYRFVLPGPSLTVAEQEQCLDELRGAAASAAFVVASGSLPPGVAADYYQRVADICRRSSTPLILDTSGGGLQHISSGVFLLKASVRELRECVGSELLTEPEQLAAAHELIDRGRAEVVVVSLGSQGALLATRHASHRFSSIPMTAVSGVGAGDAMVAAITVGLSRGWSLIKSVRLGNAAGAAMLLTPGTAACNRDDVERFFELAAEPTEVGQDQYVWHPIVNPEASP,"35,401",339,Carbohydrate kinase PfkB family,carbohydrate phosphorylation [GO:0046835],6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872],cytosol [GO:0005829],,,1
P9WMZ3,PIMB_MYCTU,Rv2188c,pimB Rv2188c,GO:0000030; GO:0005886; GO:0008654; GO:0009247; GO:0009405; GO:0033164; GO:0040007; GO:0043750; GO:0046488,IPR001296; IPR028098; ,,pimB,,GDP-mannose-dependent alpha-(1-6)-phosphatidylinositol monomannoside mannosyltransferase (EC 2.4.1.346) (Alpha-D-mannose-alpha-(1-6)-phosphatidylmyo-inositol-mannosyltransferase) (Alpha-mannosyltransferase) (Alpha-ManT) (Guanosine diphosphomannose-phosphatidyl-inositol alpha-mannosyltransferase) (Phosphatidylinositol alpha-mannosyltransferase) (PI alpha-mannosyltransferase),plasma membrane [GO:0005886]; glycolipid 6-alpha-mannosyltransferase activity [GO:0033164]; mannosyltransferase activity [GO:0000030]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],9634230; 19395496; 21969609,,"FUNCTION: Involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIM) which are early precursors in the biosynthesis of lipomannans (LM) and lipoarabinomannans (LAM) (PubMed:19395496). Catalyzes the addition of a mannosyl residue from GDP-D-mannose (GDP-Man) to the position 6 of a phosphatidyl-myo-inositol bearing an alpha-1,2-linked mannose residue (PIM1) to generate phosphatidyl-myo-inositol bearing alpha-1,2- and alpha-1,6-linked mannose residues (Ac1PIM2) (PubMed:19395496). PimB also catalyzes the addition of a mannosyl residue from GDP-Man to the position 6 of phosphatidyl-myo-inositol bearing an acylated alpha-1,2-linked mannose residue (Ac1PIM1) to generate monoacylated phosphatidyl-myo-inositol bearing alpha-1,2- and alpha-1,6-linked mannose residues (Ac1PIM2) (By similarity). The addition of the second mannosyl residue by PimB preferentially occurs before the acylation of the mannosyl residue transferred by PimA (By similarity). Also able to transfer a mannosyl residue from GDP-Man to the position 6 of a phosphatidyl-myo-inositol (PI), but this reaction is very slow (By similarity). {ECO:0000250|UniProtKB:A0R043, ECO:0000269|PubMed:19395496}.",MSRVLLVTNDFPPRRGGIQSYLGEFVGRLVGSRAHAMTVYAPQWKGADAFDDAARAAGYRVVRHPSTVMLPGPTVDVRMRRLIAEHDIETVWFGAAAPLALLAPRARLAGASRVLASTHGHEVGWSMLPVARSVLRRIGDGTDVVTFVSSYTRSRFASAFGPAASLEYLPPGVDTDRFRPDPAARAELRKRYRLGERPTVVCLSRLVPRKGQDTLVTALPSIRRRVDGAALVIVGGGPYLETLRKLAHDCGVADHVTFTGGVATDELPAHHALADVFAMPCRTRGAGMDVEGLGIVFLEASAAGVPVIAGNSGGAPETVQHNKTGLVVDGRSVDRVADAVAELLIDRDRAVAMGAAGREWVTAQWRWDTLAAKLADFLRGDDAAR,"41,220",385,"Glycosyltransferase group 1 family, Glycosyltransferase 4 subfamily",glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],glycolipid 6-alpha-mannosyltransferase activity [GO:0033164]; mannosyltransferase activity [GO:0000030]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750],plasma membrane [GO:0005886],,,1
P9WMZ9,PIMG_MYCTU,Rv2181,Rv2181,GO:0000026; GO:0005886; GO:0008654; GO:0009247; GO:0009405; GO:0016021; GO:0046488,IPR018584; ,,,,Polyprenol-phosphate-mannose-dependent alpha-(1-2)-phosphatidylinositol mannoside mannosyltransferase (EC 2.4.1.-) (Alpha-D-mannose-alpha-(1-2)-mannosyltransferase) (Alpha-mannosyltransferase) (Alpha-ManT) (PPM-dependent mannosyltransferase) (Polyprenol-phosphate-mannose alpha-mannosyltransferase) (PPM alpha-mannosyltransferase),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; alpha-1,2-mannosyltransferase activity [GO:0000026]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]",9634230; 16945913; 21969609,,FUNCTION: Responsible for the addition of alpha-(1-2) mannose branches to the linear mannan core on the biosynthetic pathway to mature lipoarabinomannan (LAM). {ECO:0000269|PubMed:16945913}.,MSAWRAPEVGSRLGRRVLWCLLWLLAGVALGYVAWRLFGHTPYRIDIDIYQMGARAWLDGRPLYGGGVLFHTPIGLNLPFTYPPLAAVLFSPFAWLQMPAASVAITVLTLVLLIASTAIVLTGLDAWPTSRLVPAPARLRRLWLAVLIVAPATIWLEPISSNFAFGQINVVLMTLVIVDCFPRRTPWPRGLMLGLGIALKLTPAVFLLYFLLRRDGRAALTALASFAVATLLGFVLAWRDSWEYWTHTLHHTDRIGAAALNTDQNIAGALARLTIGDDERFALWVAGSLLVLAATIWAMRRVLRAGEPTLAVICVALFGLVVSPVSWSHHWVWMLPAVLVIGLLGWRRRNVALAMLSLAGVVLMRWTPIDLLPQHRETTAVWWRQLAGMSYVWWALAVIVVAGLTVTARMTPQRSLTRGLTPAPTAS,"47,143",427,Glycosyltransferase 87 family,glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],"alpha-1,2-mannosyltransferase activity [GO:0000026]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WI67,PKNJ_MYCTU,Rv2088,pknJ Rv2088 MTCY49.28,GO:0004674; GO:0005524; GO:0005886; GO:0016021; GO:0016151; GO:0046777; GO:0050897; GO:0097009,IPR011009; IPR026954; IPR038232; IPR000719; IPR008271; ,,pknJ,DOMAIN 14 276 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknJ (EC 2.7.11.1),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; nickel cation binding [GO:0016151]; protein serine/threonine kinase activity [GO:0004674]; energy homeostasis [GO:0097009]; protein autophosphorylation [GO:0046777],9634230; 20185505; 20520732; 21969609,,"FUNCTION: In vitro, phosphorylates various substrates such as EmbR, PepE, MmaA4, Pyk, LldD and GroEL2. {ECO:0000269|PubMed:20185505, ECO:0000269|PubMed:20520732}.",MAHELSAGSVFAGYRIERMLGAGGMGTVYLARNPDLPRSEALKVLAAELSRDLDFRARFVREADVAAGLDHPNIVAVHQRGQFEGRLWIAMQFVDGGNAEDALRAATMTTARAVYVIGEVAKALDYAHQQGVIHRDIKPANFLLSRAAGGDERVLLSDFGIARALGDTGLTSTGSVLATLAYAAPEVLAGQGFDGRADLYSLGCALFRLLTGEAPFAAGAGAAVAVVAGHLHQPPPTVSDRVPGLSAAMDAVIATAMAKDPMRRFTSAGEFAHAAAAALYGGATDGWVPPSPAPHVISQGAVPGSPWWQHPVGSVTALATPPGHGWPPGLPPLPRRPRRYRRGVAAVAAVMVVAAAAVTAVTMTSHQPRTATPPSAAALSPTSSSTTPPQPPIVTRSRLPGLLPPLDDVKNFVGIQNLVAHEPMLQPQTPNGSINPAECWPAVGGGVPSAYDLGTVIGFYGLTIDEPPTGTAPNQVGQLIVAFRDAATAQRHLADLASIWRRCGGRTVTLFRSEWRRPVELSTSVPEVVDGITTMVLTAQGPVLRVREDHAIAAKNNVLVDVDIMTPDTSRGQQAVIGITNYILAKIPG,"61,595",589,"Protein kinase superfamily, Ser/Thr protein kinase family",energy homeostasis [GO:0097009]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; cobalt ion binding [GO:0050897]; nickel cation binding [GO:0016151]; protein serine/threonine kinase activity [GO:0004674],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.28,1
P9WFQ7,PLPHP_MYCTU,Rv2148c,Rv2148c MTCY270.20,GO:0005622; GO:0030170,IPR001608; IPR029066; IPR011078; ,,,,Pyridoxal phosphate homeostasis protein (PLP homeostasis protein),intracellular [GO:0005622]; pyridoxal phosphate binding [GO:0030170],9634230; 21969609,,"FUNCTION: Pyridoxal 5'-phosphate (PLP)-binding protein, which is involved in PLP homeostasis. {ECO:0000255|HAMAP-Rule:MF_02087}.",MAADLSAYPDRESELTHALAAMRSRLAAAAEAAGRNVGEIELLPITKFFPATDVAILFRLGCRSVGESREQEASAKMAELNRLLAAAELGHSGGVHWHMVGRIQRNKAGSLARWAHTAHSVDSSRLVTALDRAVVAALAEHRRGERLRVYVQVSLDGDGSRGGVDSTTPGAVDRICAQVQESEGLELVGLMGIPPLDWDPDEAFDRLQSEHNRVRAMFPHAIGLSAGMSNDLEVAVKHGSTCVRVGTALLGPRRLRSP,"27,693",258,Pyridoxal phosphate-binding protein YggS/PROSC family,,pyridoxal phosphate binding [GO:0030170],intracellular [GO:0005622],,MTCY270.20,1
I6XD65,PNCA_MYCTU,Rv2043c LH57_11125,pncA Rv2043c LH57_11125,GO:0005737; GO:0006769; GO:0008198; GO:0008936; GO:0017144; GO:0019363; GO:0030145; GO:0046677,IPR000868; IPR036380; ,,pncA,,Nicotinamidase/pyrazinamidase (Nicotinamidase) (EC 3.5.1.19) (Nicotinamide deamidase) (NAMase) (Pyrazinamidase) (PZAase) (EC 3.5.1.-),cytoplasm [GO:0005737]; ferrous iron binding [GO:0008198]; manganese ion binding [GO:0030145]; nicotinamidase activity [GO:0008936]; drug metabolic process [GO:0017144]; nicotinamide metabolic process [GO:0006769]; pyridine nucleotide biosynthetic process [GO:0019363]; response to antibiotic [GO:0046677],9634230; 18201201; 21969609; 21283666,X-ray crystallography (1),"FUNCTION: Catalyzes the deamidation of nicotinamide (NAM) into nicotinate (PubMed:18201201). Likely functions in the cyclical salvage pathway for production of NAD from nicotinamide (By similarity). {ECO:0000250|UniProtKB:P21369, ECO:0000269|PubMed:18201201}.; FUNCTION: Is involved in the activation of the first-line antituberculous drug pyrazinamide (PZA) by converting it into the active form, pyrazinoic acid. {ECO:0000269|PubMed:18201201}.",MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSGTPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWLRQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASVELVCSS,"19,605",186,Isochorismatase family,drug metabolic process [GO:0017144]; nicotinamide metabolic process [GO:0006769]; pyridine nucleotide biosynthetic process [GO:0019363]; response to antibiotic [GO:0046677],ferrous iron binding [GO:0008198]; manganese ion binding [GO:0030145]; nicotinamidase activity [GO:0008936],cytoplasm [GO:0005737],,,1
P9WI63,PKNL_MYCTU,Rv2176,pknL Rv2176 MTV021.09,GO:0004672; GO:0004674; GO:0005524; GO:0005886; GO:0016021; GO:0018107; GO:0045717; GO:0046777,IPR011009; IPR000719; IPR008271; ,,pknL,DOMAIN 19 278 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknL (EC 2.7.11.1),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; negative regulation of fatty acid biosynthetic process [GO:0045717]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777],9634230; 18276158; 18175374; 19457863,,"FUNCTION: Phosphorylates the DNA-binding protein Rv2175c. May be involved in the regulation of cell division and cell envelope biosynthesis. {ECO:0000269|PubMed:18175374, ECO:0000269|PubMed:19457863}.",MVEAGTRDPLESALLDSRYLVQAKIASGGTSTVYRGLDVRLDRPVALKVMDSRYAGDEQFLTRFRLEARAVARLNNRALVAVYDQGKDGRHPFLVMELIEGGTLRELLIERGPMPPHAVVAVLRPVLGGLAAAHRAGLVHRDVKPENILISDDGDVKLADFGLVRAVAAASITSTGVILGTAAYLSPEQVRDGNADPRSDVYSVGVLVYELLTGHTPFTGDSALSIAYQRLDADVPRASAVIDGVPPQFDELVACATARNPADRYADAIAMGADLEAIAEELALPEFRVPAPRNSAQHRSAALYRSRITQQGQLGAKPVHHPTRQLTRQPGDCSEPASGSEPEHEPITGQFAGIAIEEFIWARQHARRMVLVWVSVVLAITGLVASAAWTIGSNLSGLL,"42,834",399,"Protein kinase superfamily, Ser/Thr protein kinase family",negative regulation of fatty acid biosynthetic process [GO:0045717]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV021.09,1
P9WKD5,POLOX_MYCTU,Rv2149c,Rv2149c MTCY270.19,GO:0005507; GO:0005618; GO:0016491,IPR003730; IPR038371; IPR011324; ,,,,Polyphenol oxidase (EC 1.10.3.-) (Multicopper oxidase Rv2149c),cell wall [GO:0005618]; copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],9634230; 21969609,,FUNCTION: Multicopper oxidase with polyphenol oxidase activity. {ECO:0000250|UniProtKB:Q1EIR0}.,MLASTRHIARGDTGNVSVRIRRVTTTRAGGVSAPPFDTFNLGDHVGDDPAAVAANRARLAAAIGLPGNRVVWMNQVHGDRVELVDQPRNTALDDTDGLVTATPRLALAVVTADCVPVLMADARAGIAAAVHAGRAGAQRGVVVRALEVMLSLGAQVRDISALLGPAVSGRNYEVPAAMADEVEAALPGSRTTTAAGTPGVDLRAGIACQLRDLGVESIDVDPRCTVADPTLFSHRRDAPTGRFASLVWME,"25,965",250,Multicopper oxidase YfiH/RL5 family,,copper ion binding [GO:0005507]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618],,MTCY270.19,1
P9WI01,PPE36_MYCTU,Rv2108,PPE36 p27 Rv2108,GO:0005886,IPR000030; IPR038332; ,,PPE36,,Uncharacterized PPE family protein PPE36,plasma membrane [GO:0005886],10970728; 9634230; 15958258; 18289677,,,MPNFWALPPEINSTRIYLGPGSGPILAAAQGWNALASELEKTKVGLQSALDTLLESYRGQSSQALIQQTLPYVQWLTTTAEHAHKTAIQLTAAANAYEQARAAMVPPAMVRANRVQTTVLKAINWFGQFSTRIADKEADYEQMWFQDALVMENYWEAVQEAIQSTSHFEDPPEMADDYDEAWMLNTVFDYHNENAKEEVIHLVPDVNKERGPIELVTKVDKEGTIRLVYDGEPTFSYKEHPKF,"27,480",243,Mycobacterial PPE family,,,plasma membrane [GO:0005886],p27,,1
Q79FH3,PPE37_MYCTU,Rv2123,PPE37 Rv2123,GO:0052572; GO:0075139,IPR000030; IPR038332; ,,PPE37,,Uncharacterized PPE family protein PPE37,response to host immune response [GO:0052572]; response to host iron concentration [GO:0075139],9634230; 16113319; 21969609,,,MTFPMWFAVPPEVPSAWLSTGMGPGPLLAAARAWHALAAQYTEIATELASVLAAVQASSWQGPSADRFVVAHQPFRYWLTHAATVATAAAAAHETAAAGYTSALGGMPTLAELAANHAMHGALVTTNFFGVNTIPIALNEADYLRMWIQAATVMSHYQAVAHESVAATPSTPPAPQIVTSAASSAASSSFPDPTKLILQLLKDFLELLRYLAVELLPGPLGDLIAQVLDWFISFVSGPVFTFLAYLVLDPLIYFGPFAPLTSPVLLPAGLTGLAGLGAVSGPAGPMVERVHSDGPSRQSWPAATGVTLVGTNPAALVTTPAPAPTTSAAPTAPSTPGSSAAQGLYAVGGPDGEGFNPIAKTTALAGVTTDAAAPAAKLPGDQAQSSASKATRLRRRLRQHRFEFLADDGRLTMPNTPEMADVAAGNRGLDALGFAGTIPKSAPGSATGLTHLGGGFADVLSQPMLPHTWDGSD,"48,563",473,Mycobacterial PPE family,response to host immune response [GO:0052572]; response to host iron concentration [GO:0075139],,,,,1
O53493,PPMNT_MYCTU,Rv2051c,ppm1 lnt Rv2051c,GO:0004582; GO:0005618; GO:0005829; GO:0005886; GO:0009247; GO:0016021; GO:0016410; GO:0016787; GO:0042158; GO:0052553,IPR004563; IPR003010; IPR036526; IPR001173; IPR029044; ,,ppm1,DOMAIN 241 497 CN hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00054}.,Bifunctional apolipoprotein N-acyltransferase/polyprenol monophosphomannose synthase [Includes: Apolipoprotein N-acyltransferase (EC 2.3.1.-); Polyprenol monophosphomannose synthase (PPM synthase) (Polyprenol-P-Man synthase) (Ppm1) (EC 2.4.1.-) (Dolichol-phosphate mannose synthase) (EC 2.4.1.83)],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; hydrolase activity [GO:0016787]; N-acyltransferase activity [GO:0016410]; glycolipid biosynthetic process [GO:0009247]; lipoprotein biosynthetic process [GO:0042158]; modulation by symbiont of host immune response [GO:0052553],9634230; 11931640; 12427759; 19661058; 21969609,,"FUNCTION: Transfers a fatty acyl group to the free alpha-amino group (N-acylation) on the N-terminus of membrane apolipoproteins. {ECO:0000269|PubMed:19661058}.; FUNCTION: Transfers mannose from GDP-mannose to lipid acceptors (works best on C20-C95 lipid monophosphate substrates in which the lipid can be modified, tested with the C-terminal domain expressed in M.smegmatis) to form polyprenol monophosphomannose (PPM). PMM is an alkai-stable sugar donor which adds mannose-phosphate residues to triacylated-phosphatidyl-myo-inositol mannosides (PIM2), eventually leading to generation of the cell wall glycolipid lipoglycan modulins lipoarabinomannan (LAM) and lipomannan (LM). {ECO:0000269|PubMed:11931640}.",MKLGAWVAAQLPTTRTAVRTRLTRLVVSIVAGLLLYASFPPRNCWWAAVVALALLAWVLTHRATTPVGGLGYGLLFGLVFYVSLLPWIGELVGPGPWLALATTCALFPGIFGLFAVVVRLLPGWPIWFAVGWAAQEWLKSILPFGGFPWGSVAFGQAEGPLLPLVQLGGVALLSTGVALVGCGLTAIALEIEKWWRTGGQGDAPPAVVLPAACICLVLFAAIVVWPQVRHAGSGSGGEPTVTVAVVQGNVPRLGLDFNAQRRAVLDNHVEETLRLAADVHAGLAQQPQFVIWPENSSDIDPFVNPDAGQRISAAAEAIGAPILIGTLMDVPGRPRENPEWTNTAIVWNPGTGPADRHDKAIVQPFGEYLPMPWLFRHLSGYADRAGHFVPGNGTGVVRIAGVPVGVATCWEVIFDRAPRKSILGGAQLLTVPSNNATFNKTMSEQQLAFAKVRAVEHDRYVVVAGTTGISAVIAPDGGELIRTDFFQPAYLDSQVRLKTRLTPATRWGPILQWILVGAAAAVVLVAMRQNGWFPRPRRSEPKGENDDSDAPPGRSEASGPPALSESDDELIQPEQGGRHSSGFGRHRATSRSYMTTGQPAPPAPGNRPSQRVLVIIPTFNERENLPVIHRRLTQACPAVHVLVVDDSSPDGTGQLADELAQADPGRTHVMHRTAKNGLGAAYLAGFAWGLSREYSVLVEMDADGSHAPEQLQRLLDAVDAGADLAIGSRYVAGGTVRNWPWRRLVLSKTANTYSRLALGIGIHDITAGYRAYRREALEAIDLDGVDSKGYCFQIDLTWRTVSNGFVVTEVPITFTERELGVSKMSGSNIREALVKVARWGIEGRLSRSDHARARPDIARPGAGGSRVSRADVTE,"93,824",874,"CN hydrolase family, Apolipoprotein N-acyltransferase subfamily; Glycosyltransferase 2 family",glycolipid biosynthetic process [GO:0009247]; lipoprotein biosynthetic process [GO:0042158]; modulation by symbiont of host immune response [GO:0052553],dolichyl-phosphate beta-D-mannosyltransferase activity [GO:0004582]; hydrolase activity [GO:0016787]; N-acyltransferase activity [GO:0016410],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],lnt,,1
P9WJM9,MSHC_MYCTU,Rv2130c,mshC cysS2 Rv2130c MTCY261.29c,GO:0005524; GO:0005829; GO:0005886; GO:0006423; GO:0010125; GO:0035446; GO:0040007; GO:0046872,IPR024909; IPR017812; IPR014729; IPR032678; ,,mshC,,L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase (L-Cys:GlcN-Ins ligase) (EC 6.3.1.13) (Mycothiol ligase) (MSH ligase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cysteine-glucosaminylinositol ligase activity [GO:0035446]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]; growth [GO:0040007]; mycothiol biosynthetic process [GO:0010125],9634230; 12033919; 21969609,,FUNCTION: Catalyzes the ATP-dependent condensation of GlcN-Ins and L-cysteine to form L-Cys-GlcN-Ins.,MQSWYCPPVPVLPGRGPQLRLYDSADRQVRPVAPGSKATMYVCGITPYDATHLGHAATYVTFDLIHRLWLDLGHELHYVQNITDIDDPLFERADRDGVDWRDLAQAEVALFCEDMAALRVLPPQDYVGATEAIAEMVELIEKMLACGAAYVIDREMGEYQDIYFRADATLQFGYESGYDRDTMLRLCEERGGDPRRPGKSDELDALLWRAARPGEPSWPSPFGPGRPGWHVECAAIALSRIGSGLDIQGGGSDLIFPHHEFTAAHAECVSGERRFARHYVHAGMIGWDGHKMSKSRGNLVLVSALRAQDVEPSAVRLGLLAGHYRADRFWSQQVLDEATARLHRWRTATALPAGPAAVDVVARVRRYLADDLDTPKAIAALDGWVTDAVEYGGHDAGAPKLVATAIDALLGVDL,"45,595",414,"Class-I aminoacyl-tRNA synthetase family, MshC subfamily",cysteinyl-tRNA aminoacylation [GO:0006423]; growth [GO:0040007]; mycothiol biosynthetic process [GO:0010125],ATP binding [GO:0005524]; cysteine-glucosaminylinositol ligase activity [GO:0035446]; metal ion binding [GO:0046872],cytosol [GO:0005829]; plasma membrane [GO:0005886],cysS2,MTCY261.29c,1
P9WJL5,MURD_MYCTU,Rv2155c,murD Rv2155c MTCY270.13,GO:0005524; GO:0005829; GO:0007049; GO:0008360; GO:0008764; GO:0009252; GO:0040007; GO:0051301; GO:0071555,IPR036565; IPR004101; IPR036615; IPR013221; IPR005762; ,,murD,,UDP-N-acetylmuramoylalanine--D-glutamate ligase (EC 6.3.2.9) (D-glutamic acid-adding enzyme) (UDP-N-acetylmuramoyl-L-alanyl-D-glutamate synthetase),cytosol [GO:0005829]; ATP binding [GO:0005524]; UDP-N-acetylmuramoylalanine-D-glutamate ligase activity [GO:0008764]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 21969609,,FUNCTION: Cell wall formation. Catalyzes the addition of glutamate to the nucleotide precursor UDP-N-acetylmuramoyl-L-alanine (UMA). {ECO:0000250}.,MSGLPRSVPDVLDPLGPGAPVLVAGGRVTGQAVAAVLTRFGATPTVCDDDPVMLRPHAERGLPTVSSSDAVQQITGYALVVASPGFSPATPLLAAAAAAGVPIWGDVELAWRLDAAGCYGPPRSWLVVTGTNGKTTTTSMLHAMLIAGGRRAVLCGNIGSAVLDVLDEPAELLAVELSSFQLHWAPSLRPEAGAVLNIAEDHLDWHATMAEYTAAKARVLTGGVAVAGLDDSRAAALLDGSPAQVRVGFRLGEPAARELGVRDAHLVDRAFSDDLTLLPVASIPVPGPVGVLDALAAAALARSVGVPAGAIADAVTSFRVGRHRAEVVAVADGITYVDDSKATNPHAARASVLAYPRVVWIAGGLLKGASLHAEVAAMASRLVGAVLIGRDRAAVAEALSRHAPDVPVVQVVAGEDTGMPATVEVPVACVLDVAKDDKAGETVGAAVMTAAVAAARRMAQPGDTVLLAPAGASFDQFTGYADRGEAFATAVRAVIR,"50,354",496,MurCDEF family,cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],ATP binding [GO:0005524]; UDP-N-acetylmuramoylalanine-D-glutamate ligase activity [GO:0008764],cytosol [GO:0005829],,MTCY270.13,2
P9WJL3,MURE_MYCTU,Rv2158c,murE Rv2158c MTCY270.10,GO:0005524; GO:0005829; GO:0005886; GO:0007049; GO:0008360; GO:0008765; GO:0009252; GO:0051301; GO:0071555,IPR036565; IPR004101; IPR036615; IPR013221; IPR000713; IPR035911; IPR005761; ,,murE,,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase (EC 6.3.2.13) (Meso-A2pm-adding enzyme) (Meso-diaminopimelate-adding enzyme) (UDP-MurNAc-L-Ala-D-Glu:meso-diaminopimelate ligase) (UDP-MurNAc-tripeptide synthetase) (UDP-N-acetylmuramyl-tripeptide synthetase)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity [GO:0008765]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 19099550; 21969609,X-ray crystallography (2),FUNCTION: Catalyzes the addition of meso-diaminopimelic acid to the nucleotide precursor UDP-N-acetylmuramoyl-L-alanyl-D-glutamate (UMAG) in the biosynthesis of bacterial cell-wall peptidoglycan. {ECO:0000255|HAMAP-Rule:MF_00208}.,MSSLARGISRRRTEVATQVEAAPTGLRPNAVVGVRLAALADQVGAALAEGPAQRAVTEDRTVTGVTLRAQDVSPGDLFAALTGSTTHGARHVGDAIARGAVAVLTDPAGVAEIAGRAAVPVLVHPAPRGVLGGLAATVYGHPSERLTVIGITGTSGKTTTTYLVEAGLRAAGRVAGLIGTIGIRVGGADLPSALTTPEAPTLQAMLAAMVERGVDTVVMEVSSHALALGRVDGTRFAVGAFTNLSRDHLDFHPSMADYFEAKASLFDPDSALRARTAVVCIDDDAGRAMAARAADAITVSAADRPAHWRATDVAPTDAGGQQFTAIDPAGVGHHIGIRLPGRYNVANCLVALAILDTVGVSPEQAVPGLREIRVPGRLEQIDRGQGFLALVDYAHKPEALRSVLTTLAHPDRRLAVVFGAGGDRDPGKRAPMGRIAAQLADLVVVTDDNPRDEDPTAIRREILAGAAEVGGDAQVVEIADRRDAIRHAVAWARPGDVVLIAGKGHETGQRGGGRVRPFDDRVELAAALEALERRA,"55,341",535,"MurCDEF family, MurE subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"ATP binding [GO:0005524]; UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase activity [GO:0008765]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY270.10,1
P9WJL7,MURC_MYCTU,Rv2152c,murC Rv2152c MTCY270.16,GO:0005524; GO:0005737; GO:0007049; GO:0008360; GO:0008763; GO:0009252; GO:0040007; GO:0051301; GO:0071555,IPR036565; IPR004101; IPR036615; IPR013221; IPR000713; IPR005758; ,,murC,,UDP-N-acetylmuramate--L-alanine ligase (EC 6.3.2.8) (UDP-N-acetylmuramoyl-L-alanine synthetase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; UDP-N-acetylmuramate-L-alanine ligase activity [GO:0008763]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 21969609,,FUNCTION: Cell wall formation. {ECO:0000255|HAMAP-Rule:MF_00046}.,MSTEQLPPDLRRVHMVGIGGAGMSGIARILLDRGGLVSGSDAKESRGVHALRARGALIRIGHDASSLDLLPGGATAVVTTHAAIPKTNPELVEARRRGIPVVLRPAVLAKLMAGRTTLMVTGTHGKTTTTSMLIVALQHCGLDPSFAVGGELGEAGTNAHHGSGDCFVAEADESDGSLLQYTPHVAVITNIESDHLDFYGSVEAYVAVFDSFVERIVPGGALVVCTDDPGGAALAQRATELGIRVLRYGSVPGETMAATLVSWQQQGVGAVAHIRLASELATAQGPRVMRLSVPGRHMALNALGALLAAVQIGAPADEVLDGLAGFEGVRRRFELVGTCGVGKASVRVFDDYAHHPTEISATLAAARMVLEQGDGGRCMVVFQPHLYSRTKAFAAEFGRALNAADEVFVLDVYGAREQPLAGVSGASVAEHVTVPMRYVPDFSAVAQQVAAAASPGDVIVTMGAGDVTLLGPEILTALRVRANRSAPGRPGVLG,"51,177",494,MurCDEF family,cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],ATP binding [GO:0005524]; UDP-N-acetylmuramate-L-alanine ligase activity [GO:0008763],cytoplasm [GO:0005737],,MTCY270.16,1
P9WJT1,MMPS3_MYCTU,Rv2198c,mmpS3 Rv2198c MTCY190.09c,GO:0005618; GO:0005887,IPR008693; IPR038468; ,,mmpS3,,Probable transport accessory protein MmpS3,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MSGPNPPGREPDEPESEPVSDTGDERASGNHLPPVAGGGDKLPSDQTGETDAYSRAYSAPESEHVTGGPYVPADLRLYDYDDYEESSDLDDELAAPRWPWVVGVAAIIAAVALVVSVSLLVTRPHTSKLATGDTTSSAPPVQDEITTTKPAPPPPPPAPPPTTEIPTATETQTVTVTPPPPPPPATTTAPPPATTTTAAAPPPTTTTPTGPRQVTYSVTGTKAPGDIISVTYVDAAGRRRTQHNVYIPWSMTVTPISQSDVGSVEASSLFRVSKLNCSITTSDGTVLSSNSNDGPQTSC,"30,955",299,MmpS family,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,MTCY190.09c,1
P9WJL1,MURF_MYCTU,Rv2157c,murF Rv2157c MTCY270.11,GO:0005524; GO:0005737; GO:0007049; GO:0008360; GO:0009252; GO:0040007; GO:0047480; GO:0051301; GO:0071555,IPR036565; IPR004101; IPR036615; IPR013221; IPR000713; IPR035911; IPR005863; ,,murF,,UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (EC 6.3.2.10) (D-alanyl-D-alanine-adding enzyme) (UDP-MurNAc-pentapeptide synthetase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase activity [GO:0047480]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 19099550; 21969609,,"FUNCTION: Involved in cell wall formation. Catalyzes the final step in the synthesis of UDP-N-acetylmuramoyl-pentapeptide, the precursor of murein. {ECO:0000255|HAMAP-Rule:MF_02019}.",MIELTVAQIAEIVGGAVADISPQDAAHRRVTGTVEFDSRAIGPGGLFLALPGARADGHDHAASAVAAGAAVVLAARPVGVPAIVVPPVAAPNVLAGVLEHDNDGSGAAVLAALAKLATAVAAQLVAGGLTIIGITGSSGKTSTKDLMAAVLAPLGEVVAPPGSFNNELGHPWTVLRATRRTDYLILEMAARHHGNIAALAEIAPPSIGVVLNVGTAHLGEFGSREVIAQTKAELPQAVPHSGAVVLNADDPAVAAMAKLTAARVVRVSRDNTGDVWAGPVSLDELARPRFTLHAHDAQAEVRLGVCGDHQVTNALCAAAVALECGASVEQVAAALTAAPPVSRHRMQVTTRGDGVTVIDDAYNANPDSMRAGLQALAWIAHQPEATRRSWAVLGEMAELGEDAIAEHDRIGRLAVRLDVSRLVVVGTGRSISAMHHGAVLEGAWGSGEATADHGADRTAVNVADGDAALALLRAELRPGDVVLVKASNAAGLGAVADALVADDTCGSVRP,"51,633",510,"MurCDEF family, MurF subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],ATP binding [GO:0005524]; UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase activity [GO:0047480],cytoplasm [GO:0005737],,MTCY270.11,1
P9WJK9,MURG_MYCTU,Rv2153c,murG Rv2153c MTCY270.15,GO:0005886; GO:0005975; GO:0007049; GO:0008360; GO:0009252; GO:0030259; GO:0040007; GO:0050511; GO:0051301; GO:0051991; GO:0071555,IPR006009; IPR007235; IPR004276; ,,murG,,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (EC 2.4.1.227) (Undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase),"plasma membrane [GO:0005886]; UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity [GO:0051991]; undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity [GO:0050511]; carbohydrate metabolic process [GO:0005975]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; lipid glycosylation [GO:0030259]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 19099550; 21969609,,FUNCTION: Cell wall formation. Catalyzes the transfer of a GlcNAc subunit on undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (lipid intermediate I) to form undecaprenyl-pyrophosphoryl-MurNAc-(pentapeptide)GlcNAc (lipid intermediate II). {ECO:0000255|HAMAP-Rule:MF_00033}.,MKDTVSQPAGGRGATAPRPADAASPSCGSSPSADSVSVVLAGGGTAGHVEPAMAVADALVALDPRVRITALGTLRGLETRLVPQRGYHLELITAVPMPRKPGGDLARLPSRVWRAVREARDVLDDVDADVVVGFGGYVALPAYLAARGLPLPPRRRRRIPVVIHEANARAGLANRVGAHTADRVLSAVPDSGLRRAEVVGVPVRASIAALDRAVLRAEARAHFGFPDDARVLLVFGGSQGAVSLNRAVSGAAADLAAAGVCVLHAHGPQNVLELRRRAQGDPPYVAVPYLDRMELAYAAADLVICRAGAMTVAEVSAVGLPAIYVPLPIGNGEQRLNALPVVNAGGGMVVADAALTPELVARQVAGLLTDPARLAAMTAAAARVGHRDAAGQVARAALAVATGAGARTTT,"41,860",410,"Glycosyltransferase 28 family, MurG subfamily",carbohydrate metabolic process [GO:0005975]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; lipid glycosylation [GO:0030259]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"UDP-N-acetyl-D-glucosamine:N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine-diphosphoundecaprenol 4-beta-N-acetylglucosaminlytransferase activity [GO:0051991]; undecaprenyldiphospho-muramoylpentapeptide beta-N-acetylglucosaminyltransferase activity [GO:0050511]",plasma membrane [GO:0005886],,MTCY270.15,1
P9WJ77,OMP2_MYCTU,Rv1973,Rv1973,GO:0009279,,,,,Outer membrane protein Rv1973,cell outer membrane [GO:0009279],9634230; 18439872,,,MSWSRVIAYGLLPGLALALTCGAGLLKWQDGAVRDAAVARAESVRAATDGTTALLSYRPDTVQHDLESARSRLTGTFLDAYTQLTHDVVIPGAQQKQISAVATVAAAASVSTSADRAVVLLFVNQTITVGKDAPTTAASSVRVTLDNINGRWLISQFEPI,"16,824",160,,,,cell outer membrane [GO:0009279],,,1
P9WIS7,ODP2_MYCTU,Rv2215,dlaT sucB Rv2215 MTCY190.26,GO:0004148; GO:0004742; GO:0005618; GO:0005829; GO:0005886; GO:0006096; GO:0009405; GO:0015036; GO:0016209; GO:0031405; GO:0040007; GO:0045254; GO:0045454,IPR003016; IPR001078; IPR014276; IPR000089; IPR023213; IPR036625; IPR004167; IPR011053; ,,dlaT,DOMAIN 2 77 Lipoyl-binding 1. {ECO:0000255|PROSITE-ProRule:PRU01066}.; DOMAIN 121 196 Lipoyl-binding 2. {ECO:0000255|PROSITE-ProRule:PRU01066}.; DOMAIN 243 280 Peripheral subunit-binding (PSBD). {ECO:0000255|PROSITE-ProRule:PRU01170}.,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (EC 2.3.1.12) (Component of peroxynitrite reductase/peroxidase complex) (Component of PNR/P) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDH component E2),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]; antioxidant activity [GO:0016209]; dihydrolipoyl dehydrogenase activity [GO:0004148]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; disulfide oxidoreductase activity [GO:0015036]; lipoic acid binding [GO:0031405]; cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]; growth [GO:0040007]; pathogenesis [GO:0009405],9634230; 11799204; 16045627; 16368957; 18329613; 21238944; 21969609,,"FUNCTION: Component of the pyruvate dehydrogenase (PDH) complex, that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2).; FUNCTION: Together with AhpC, AhpD and Lpd, constitutes an NADH-dependent peroxidase active against hydrogen and alkyl peroxides as well as serving as a peroxynitrite reductase, thus protecting the bacterium against reactive nitrogen intermediates and oxidative stress generated by the host immune system.; FUNCTION: Appears to be essential for Mtb pathogenesis.",MAFSVQMPALGESVTEGTVTRWLKQEGDTVELDEPLVEVSTDKVDTEIPSPAAGVLTKIIAQEDDTVEVGGELAVIGDAKDAGEAAAPAPEKVPAAQPESKPAPEPPPVQPTSGAPAGGDAKPVLMPELGESVTEGTVIRWLKKIGDSVQVDEPLVEVSTDKVDTEIPSPVAGVLVSISADEDATVPVGGELARIGVAADIGAAPAPKPAPKPVPEPAPTPKAEPAPSPPAAQPAGAAEGAPYVTPLVRKLASENNIDLAGVTGTGVGGRIRKQDVLAAAEQKKRAKAPAPAAQAAAAPAPKAPPAPAPALAHLRGTTQKASRIRQITANKTRESLQATAQLTQTHEVDMTKIVGLRARAKAAFAEREGVNLTFLPFFAKAVIDALKIHPNINASYNEDTKEITYYDAEHLGFAVDTEQGLLSPVIHDAGDLSLAGLARAIADIAARARSGNLKPDELSGGTFTITNIGSQGALFDTPILVPPQAAMLGTGAIVKRPRVVVDASGNESIGVRSVCYLPLTYDHRLIDGADAGRFLTTIKHRLEEGAFEADLGL,"57,088",553,2-oxoacid dehydrogenase family,cell redox homeostasis [GO:0045454]; glycolytic process [GO:0006096]; growth [GO:0040007]; pathogenesis [GO:0009405],antioxidant activity [GO:0016209]; dihydrolipoyl dehydrogenase activity [GO:0004148]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; disulfide oxidoreductase activity [GO:0015036]; lipoic acid binding [GO:0031405],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254],sucB,MTCY190.26,1
P9WIS9,ODP1_MYCTU,Rv2241,aceE Rv2241 MTCY427.22,GO:0000287; GO:0004739; GO:0005576; GO:0005618; GO:0005886; GO:0006096; GO:0045254; GO:0055114,IPR004660; IPR035807; IPR029061; IPR009014; IPR005474; ,,aceE,,Pyruvate dehydrogenase E1 component (PDH E1 component) (EC 1.2.4.1),cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254]; magnesium ion binding [GO:0000287]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; glycolytic process [GO:0006096]; oxidation-reduction process [GO:0055114],9634230; 16045627; 20066036; 21969609,,"FUNCTION: Component of the pyruvate dehydrogenase (PDH) complex, that catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2). AceE has reductase activity with pyruvate but does not react with 2-oxoglutarate. {ECO:0000269|PubMed:16045627}.",MTTDFARHDLAQNSNSASEPDRVRVIREGVASYLPDIDPEETSEWLESFDTLLQRCGPSRARYLMLRLLERAGEQRVAIPALTSTDYVNTIPTELEPWFPGDEDVERRYRAWIRWNAAIMVHRAQRPGVGVGGHISTYASSAALYEVGFNHFFRGKSHPGGGDQVFIQGHASPGIYARAFLEGRLTAEQLDGFRQEHSHVGGGLPSYPHPRLMPDFWEFPTVSMGLGPLNAIYQARFNHYLHDRGIKDTSDQHVWCFLGDGEMDEPESRGLAHVGALEGLDNLTFVINCNLQRLDGPVRGNGKIIQELESFFRGAGWNVIKVVWGREWDALLHADRDGALVNLMNTTPDGDYQTYKANDGGYVRDHFFGRDPRTKALVENMSDQDIWNLKRGGHDYRKVYAAYRAAVDHKGQPTVILAKTIKGYALGKHFEGRNATHQMKKLTLEDLKEFRDTQRIPVSDAQLEENPYLPPYYHPGLNAPEIRYMLDRRRALGGFVPERRTKSKALTLPGRDIYAPLKKGSGHQEVATTMATVRTFKEVLRDKQIGPRIVPIIPDEARTFGMDSWFPSLKIYNRNGQLYTAVDADLMLAYKESEVGQILHEGINEAGSVGSFIAAGTSYATHNEPMIPIYIFYSMFGFQRTGDSFWAAADQMARGFVLGATAGRTTLTGEGLQHADGHSLLLAATNPAVVAYDPAFAYEIAYIVESGLARMCGENPENIFFYITVYNEPYVQPPEPENFDPEGVLRGIYRYHAATEQRTNKAQILASGVAMPAALRAAQMLAAEWDVAADVWSVTSWGELNRDGVAIETEKLRHPDRPAGVPYVTRALENARGPVIAVSDWMRAVPEQIRPWVPGTYLTLGTDGFGFSDTRPAARRYFNTDAESQVVAVLEALAGDGEIDPSVPVAAARQYRIDDVAAAPEQTTDPGPGA,"103,440",930,,glycolytic process [GO:0006096]; oxidation-reduction process [GO:0055114],magnesium ion binding [GO:0000287]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pyruvate dehydrogenase complex [GO:0045254],,MTCY427.22,2
O53478,HTHAR_MYCTU,Rv2034,Rv2034,GO:0003677; GO:0003700; GO:0006351; GO:0006355; GO:0019217; GO:0044212; GO:0090034,IPR011991; IPR001845; IPR036388; IPR036390; ,,,DOMAIN 1 93 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,HTH-type transcriptional regulator Rv2034,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of fatty acid metabolic process [GO:0019217]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21782791; 22558408,,"FUNCTION: Involved in the regulation of lipid metabolism and hypoxic response. Positively regulates transcription of various genes, such as phoP, groEL2 and dosR. Negatively regulates its own transcription. Acts by binding to a specific palindromic sequence motif in promoter regions. {ECO:0000269|PubMed:21782791, ECO:0000269|PubMed:22558408}.",MSTYRSPDRAWQALADGTRRAIVERLAHGPLAVGELARDLPVSRPAVSQHLKVLKTARLVCDRPAGTRRVYQLDPTGLAALRTDLDRFWTRALTGYAQLIDSEGDDT,"11,856",107,,"regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of fatty acid metabolic process [GO:0019217]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],,,,3
P9WMJ7,HTPG_MYCTU,Rv2299c,htpG Rv2299c MTCY339.11,GO:0005524; GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0006457; GO:0051082; GO:0071451,IPR003594; IPR036890; IPR019805; IPR037196; IPR001404; IPR020575; IPR020568; ,,htpG,,Chaperone protein HtpG (Heat shock protein HtpG) (High temperature protein G),cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to superoxide [GO:0071451]; protein folding [GO:0006457],9634230; 21969609,,FUNCTION: Molecular chaperone. Has ATPase activity. {ECO:0000255|HAMAP-Rule:MF_00505}.,MNAHVEQLEFQAEARQLLDLMVHSVYSNKDAFLRELISNASDALDKLRIEALRNKDLEVDTSDLHIEIDADKAARTLTVRDNGIGMAREEVVDLIGTLAKSGTAELRAQLREAKNAAASEELIGQFGIGFYSSFMVADKVQLLTRKAGESAATRWESSGEGTYTIESVEDAPQGTSVTLHLKPEDAEDDLHDYTSEWKIRNLVKKYSDFIAWPIRMDVERRTPASQEEGGEGGEETVTIETETLNSMKALWARPKEEVSEQEYKEFYKHVAHAWDDPLEIIAMKAEGTFEYQALLFIPSHAPFDLFDRDAHVGIQLYVKRVFIMGDCDQLMPEYLRFVKGVVDAQDMSLNVSREILQQDRQIKAIRRRLTKKVLSTIKDVQSSRPEDYRTFWTQFGRVLKEGLLSDIDNRETLLGISSFVSTYSEEEPTTLAEYVERMKDGQQQIFYATGETRQQLLKSPHLEAFKAKGYEVLLLTDPVDEVWVGMVPEFDGKPLQSVAKGEVDLSSEEDTSEAEREERQKEFADLLTWLQETLSDHVKEVRLSTRLTESPACLITDAFGMTPALARIYRASGQEVPVGKRILELNPSHPLVTGLRQAHQDRADDAEKSLAETAELLYGTALLAEGGALEDPARFAELLAERLARTL,"72,961",647,Heat shock protein 90 family,cellular response to superoxide [GO:0071451]; protein folding [GO:0006457],ATP binding [GO:0005524]; unfolded protein binding [GO:0051082],cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY339.11,1
P9WK77,LPPJ_MYCTU,Rv2080,lppJ Rv2080 MTCY49.19,GO:0005576; GO:0005886,,,lppJ,,Putative lipoprotein LppJ,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MPHSTADRRLRLTRQALLAAAVVPLLAGCALVMHKPHSAGSSNPWDDSAHPLTDDQAMAQVVEPAKQIVAAADLQAVRAGFSFTSCNDQGDPPYQGTVRMAFLLQGDHDAYFQHVRAAMLSHGWIDGPPPGQYFHGITLHKNGVTANMSLALDHSYGEMILDGECRNTTDHHHDDETTNITNQLVQP,"20,324",187,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY49.19,1
P9WK75,LPPK_MYCTU,Rv2116,lppK Rv2116 MTCY261.12,GO:0005886,IPR020235; ,,lppK,,Putative lipoprotein LppK,plasma membrane [GO:0005886],9634230; 21969609,,,MRRNIRVTLGAATIVAALGLSGCSHPEFKRSSPPAPSLPPVTSSPLEAAPITPLPAPEALIDVLSRLADPAVPGTNKVQLIEGATPENAAALDRFTTALRDGSYLPMTFAANDIAWSDNKPSDVMATVVVTTAHPDNREFTFPMEFVSFKGGWQLSRQTAEMLLAMGNSPDSTPSATSPAPAPSPTPPG,"19,728",189,MTB12 family,,,plasma membrane [GO:0005886],,MTCY261.12,1
P9WK69,LPPP_MYCTU,Rv2330c,lppP Rv2330c MTCY3G12.04,GO:0005886,IPR025971; IPR020217; ,,lppP,,Putative lipoprotein LppP,plasma membrane [GO:0005886],9634230; 21969609,,,MRRQRSAVPILALLALLALLALIVGLGASGCAWKPPTTRPSPPNTCKDSDGPTADTVRQAIAAVPIVVPGSKWVEITRGHTRNCRLHWVQIIPTIASQSTPQQLLFFDRNIPLGSPTRNPKPYITVLPAGDDTVTVQYQWQIGSDQECCPTGIGTVRFHIGSDGKLEALGSIPHQ,"18,860",175,,,,plasma membrane [GO:0005886],,MTCY3G12.04,1
P9WK83,LIPB_MYCTU,Rv2217,lipB Rv2217 MTCY190.28,GO:0005737; GO:0005886; GO:0009107; GO:0009249; GO:0033819; GO:0040007; GO:0102555,IPR004143; IPR000544; IPR020605; ,,lipB,DOMAIN 38 215 BPL/LPL catalytic. {ECO:0000255|PROSITE-ProRule:PRU01067}.,Octanoyltransferase (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555]; growth [GO:0040007]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249],9634230; 21969609; 16735476,X-ray crystallography (1),"FUNCTION: Catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of lipoate-dependent enzymes. Lipoyl-ACP can also act as a substrate although octanoyl-ACP is likely to be the physiological substrate. {ECO:0000255|HAMAP-Rule:MF_00013, ECO:0000269|PubMed:16735476}.",MTGSIRSKLSAIDVRQLGTVDYRTAWQLQRELADARVAGGADTLLLLEHPAVYTAGRRTETHERPIDGTPVVDTDRGGKITWHGPGQLVGYPIIGLAEPLDVVNYVRRLEESLIQVCADLGLHAGRVDGRSGVWLPGRPARKVAAIGVRVSRATTLHGFALNCDCDLAAFTAIVPCGISDAAVTSLSAELGRTVTVDEVRATVAAAVCAALDGVLPVGDRVPSHAVPSPL,"24,211",230,LipB family,growth [GO:0040007]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249],lipoyl(octanoyl) transferase activity [GO:0033819]; octanoyl transferase activity (acting on glycine-cleavage complex H protein) [GO:0102555],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY190.28,1
P9WIM1,PAFB_MYCTU,Rv2096c,pafB Rv2096c MTCY49.36c,GO:0005618; GO:0005886,IPR026881; ,,pafB,,Protein PafB (Proteasome accessory factor B),cell wall [GO:0005618]; plasma membrane [GO:0005886],17277063; 9634230; 21969609,,"FUNCTION: Part of the pafABC operon, however PafB does not seem to be involved in pupylation or substrate degradation. Appears to play at least a small role in resistance to reactive nitrogen intermediates (RNI) in vitro. {ECO:0000269|PubMed:17277063}.",MATSKVERLVNLVIALLSTRGYITAEKIRSSVAGYSDSPSVEAFSRMFERDKNELRDLGIPLEVGRVSALEPTEGYRINRDAYALSPVELTPDEAAAVAVATQLWESPELITATQGALLKLRAAGVDVDPLDTGAPVAIASAAAVSGLRGSEDVLGILLSAIDSGQVVQFSHRSSRAEPYTVRTVEPWGVVTEKGRWYLVGHDRDRDATRVFRLSRIGAQVTPIGPAGATTVPAGVDLRSIVAQKVTEVPTGEQATVWVAEGRATALRRAGRSAGPRQLGGRDGEVIELEIRSSDRLAREITGYGADAIVLQPGSLRDDVLARLRAQAGALA,"35,300",332,PafB family,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY49.36c,1
P9WIL9,PAFC_MYCTU,Rv2095c,pafC Rv2095c MTCY49.35c,GO:0005618,IPR028349; IPR026881; ,,pafC,,Protein PafC (Proteasome accessory factor C),cell wall [GO:0005618],17277063; 9634230; 21969609,,"FUNCTION: Part of the pafABC operon, but PafC does not seem to be involved in pupylation or substrate degradation. Appears to play at least a small role in resistance to reactive nitrogen intermediates (RNI) in vitro. {ECO:0000269|PubMed:17277063}.",MSALSTRLVRLLNMVPYFQANPRITRAEAAAELGVTAKQLEEDLNQLWMCGLPGYSPGDLIDFEFCGDTIEVTFSAGIDRPLKLTSPEATGLLVALRALADIPGVVDPQAARSAIAKIAAAAGAVAAVAEQAPTESPAAAAVRAAVRNSRALTIDYYAASHDTLTTRIVDPIRVLLIGGHSYLEAWSREAEGVRLFRFDRIVDAAELGEPAVPPESARQAPPDTSLFDGDLSLPSATLRVAPSASWMLEYYPIRELRQLPDGSCEVAMTYASEDWMTRLLLGFGSDVRVLAPESLAQRVRDAATAALDAYQAAAPP,"33,764",316,PafC family,,,cell wall [GO:0005618],,MTCY49.35c,1
P9WIJ7,PARD1_MYCTU,Rv1960c,parD1 Rv1960c MTCY09F9.04,GO:0006355; GO:0045927,IPR022789; IPR038296; IPR010985; ,,parD1,,Antitoxin ParD1,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 19016878,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli neutralizes the effect of cognate toxin ParE1. {ECO:0000269|PubMed:19016878}.,MGKNTSFVLDEHYSAFIDGEIAAGRYRSASEVIRSALRLLEDRETQLRALREALEAGERSGSSTPFDFDGFLGRKRADASRGR,"9,239",83,ParD antitoxin family,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,MTCY09F9.04,1
P9WHG7,PARE1_MYCTU,Rv1959c,parE1 Rv1959c,GO:0045926,IPR028344; IPR007712; IPR035093; ,,parE1,,Toxin ParE1,negative regulation of growth [GO:0045926],9634230; 15718296; 19016878; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli inhibits cell growth and colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin ParD1. {ECO:0000269|PubMed:19016878}.,MSSRYLLSPAAQAHLEEIWDCTYDRWGVDQAEQYLRELQHAIDRAAANPRIGRACDEIRPGYRKLSAGSHTLFYRVTGEGTIDVVRVLHQRMDVDRNL,"11,301",98,RelE toxin family,negative regulation of growth [GO:0045926],,,,,1
P9WIL7,PANB_MYCTU,Rv2225,panB Rv2225 MTCY427.06,GO:0000287; GO:0003864; GO:0005737; GO:0005886; GO:0015940; GO:0040007,IPR003700; IPR015813; ,,panB,,3-methyl-2-oxobutanoate hydroxymethyltransferase (EC 2.1.2.11) (Ketopantoate hydroxymethyltransferase) (KPHMT),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 3-methyl-2-oxobutanoate hydroxymethyltransferase activity [GO:0003864]; magnesium ion binding [GO:0000287]; growth [GO:0040007]; pantothenate biosynthetic process [GO:0015940],9634230; 12515554; 17082771; 19099550; 20355727; 21969609; 12842039,X-ray crystallography (1),"FUNCTION: Catalyzes the reversible reaction in which hydroxymethyl group from 5,10-methylenetetrahydrofolate is transferred onto alpha-ketoisovalerate to form ketopantoate. {ECO:0000269|PubMed:12515554}.",MSEQTIYGANTPGGSGPRTKIRTHHLQRWKADGHKWAMLTAYDYSTARIFDEAGIPVLLVGDSAANVVYGYDTTVPISIDELIPLVRGVVRGAPHALVVADLPFGSYEAGPTAALAAATRFLKDGGAHAVKLEGGERVAEQIACLTAAGIPVMAHIGFTPQSVNTLGGFRVQGRGDAAEQTIADAIAVAEAGAFAVVMEMVPAELATQITGKLTIPTVGIGAGPNCDGQVLVWQDMAGFSGAKTARFVKRYADVGGELRRAAMQYAQEVAGGVFPADEHSF,"29,336",281,PanB family,growth [GO:0040007]; pantothenate biosynthetic process [GO:0015940],3-methyl-2-oxobutanoate hydroxymethyltransferase activity [GO:0003864]; magnesium ion binding [GO:0000287],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY427.06,1
P9WNU7,PAFA_MYCTU,Rv2097c,pafA paf Rv2097c MTCY49.37c,GO:0005524; GO:0005618; GO:0005886; GO:0009405; GO:0010498; GO:0016881; GO:0019787; GO:0019941; GO:0046872; GO:0051409; GO:0070490; GO:0071732,IPR022279; IPR004347; ,,pafA,,Pup--protein ligase (EC 6.3.1.19) (Proteasome accessory factor A) (Pup-conjugating enzyme),cell wall [GO:0005618]; plasma membrane [GO:0005886]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ubiquitin-like protein transferase activity [GO:0019787]; cellular response to nitric oxide [GO:0071732]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490]; response to nitrosative stress [GO:0051409],17277063; 9634230; 14671303; 17082771; 18832610; 19448618; 20355727; 20636328; 21969609,,"FUNCTION: Catalyzes the covalent attachment of the prokaryotic ubiquitin-like protein modifier Pup to the proteasomal substrate proteins, thereby targeting them for proteasomal degradation. This tagging system is termed pupylation. The ligation reaction involves the side-chain carboxylate of the C-terminal glutamate of Pup and the side-chain amino group of a substrate lysine. PafA is required to confer resistance against the lethal effects of reactive nitrogen intermediates (RNI), antimicrobial molecules produced by activated macrophages and other cell types. {ECO:0000269|PubMed:14671303, ECO:0000269|PubMed:17082771, ECO:0000269|PubMed:19448618, ECO:0000269|PubMed:20355727}.",MQRRIMGIETEFGVTCTFHGHRRLSPDEVARYLFRRVVSWGRSSNVFLRNGARLYLDVGSHPEYATAECDSLVQLVTHDRAGEWVLEDLLVDAEQRLADEGIGGDIYLFKNNTDSAGNSYGCHENYLIVRAGEFSRISDVLLPFLVTRQLICGAGKVLQTPKAATYCLSQRAEHIWEGVSSATTRSRPIINTRDEPHADAEKYRRLHVIVGDSNMSETTTMLKVGTAALVLEMIESGVAFRDFSLDNPIRAIREVSHDVTGRRPVRLAGGRQASALDIQREYYTRAVEHLQTREPNAQIEQVVDLWGRQLDAVESQDFAKVDTEIDWVIKRKLFQRYQDRYDMELSHPKIAQLDLAYHDIKRGRGIFDLLQRKGLAARVTTDEEIAEAVDQPPQTTRARLRGEFISAAQEAGRDFTVDWVHLKLNDQAQRTVLCKDPFRAVDERVKRLIASM,"51,384",452,"Pup ligase/Pup deamidase family, Pup-conjugating enzyme subfamily",cellular response to nitric oxide [GO:0071732]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490]; response to nitrosative stress [GO:0051409],acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ubiquitin-like protein transferase activity [GO:0019787],cell wall [GO:0005618]; plasma membrane [GO:0005886],paf,MTCY49.37c,1
P9WHG5,PARE2_MYCTU,Rv2142c,parE2 Rv2142c,GO:0045926,IPR007712; IPR035093; ,,parE2,,Toxin ParE2,negative regulation of growth [GO:0045926],9634230; 15718296; 19016878; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli inhibits cell growth and colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin ParD2. {ECO:0000269|PubMed:19016878}.,MTRRLRVHNGVEDDLFEAFSYYADAAPDQIDRLYNLFVDAVTKRIPQAPNAFAPLFKHYRHIYLRPFRYYVAYRTTDEAIDILAVRHGMENPNAVEAEISGRTFE,"12,313",105,RelE toxin family,negative regulation of growth [GO:0045926],,,,,1
L0T911,PBPB_MYCTU,Rv2163c,pbpB ftsI pbp3 Rv2163c,GO:0005886; GO:0008360; GO:0008658; GO:0009252; GO:0016021; GO:0071555,IPR012338; IPR005311; IPR036138; IPR001460; ,,pbpB,,Penicillin-binding protein PbpB (Penicillin-binding protein 3) (PBP3),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; penicillin binding [GO:0008658]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 19496931,,"FUNCTION: Synthesis of cross-linked peptidoglycan from the lipid intermediates. {ECO:0000250, ECO:0000269|PubMed:19496931}.",MSRAAPRRASQSQSTRPARGLRRPPGAQEVGQRKRPGKTQKARQAQEATKSRPATRSDVAPAGRSTRARRTRQVVDVGTRGASFVFRHRTGNAVILVLMLVAATQLFFLQVSHAAGLRAQAAGQLKVTDVQPAARGSIVDRNNDRLAFTIEARALTFQPKRIRRQLEEARKKTSAAPDPQQRLRDIAQEVAGKLNNKPDAAAVLKKLQSDETFVYLARAVDPAVASAICAKYPEVGAERQDLRQYPGGSLAANVVGGIDWDGHGLLGLEDSLDAVLAGTDGSVTYDRGSDGVVIPGSYRNRHKAVHGSTVVLTLDNDIQFYVQQQVQQAKNLSGAHNVSAVVLDAKTGEVLAMANDNTFDPSQDIGRQGDKQLGNPAVSSPFEPGSVNKIVAASAVIEHGLSSPDEVLQVPGSIQMGGVTVHDAWEHGVMPYTTTGVFGKSSNVGTLMLSQRVGPERYYDMLRKFGLGQRTGVGLPGESAGLVPPIDQWSGSTFANLPIGQGLSMTLLQMTGMYQAIANDGVRVPPRIIKATVAPDGSRTEEPRPDDIRVVSAQTAQTVRQMLRAVVQRDPMGYQQGTGPTAGVPGYQMAGKTGTAQQINPGCGCYFDDVYWITFAGIATADNPRYVIGIMLDNPARNSDGAPGHSAAPLFHNIAGWLMQRENVPLSPDPGPPLVLQAT,"72,537",679,Transpeptidase family,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],penicillin binding [GO:0008658],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],ftsI pbp3,,1
P9WHS7,PEPE_MYCTU,Rv2089c,pepE Rv2089c MTCY49.29c,GO:0005886; GO:0016021; GO:0016787; GO:0046872,IPR029149; IPR036005; IPR000587; IPR000994; IPR001131; ,,pepE,,Probable dipeptidase PepE (EC 3.4.13.-),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 21969609,,,MGSRRFDAEVYARRLALAAAATADAGLAGLVITPGYDLCYLIGSRAETFERLTALVLPAAGAPAVVLPRLELAALKQSAAAELGLRVCDWVDGDDPYGLVSAVLGGAPVATAVTDSMPALHMLPLADALGVLPVLATDVLRRLRMVKEETEIDALRKAGAAIDRVHARVPEFLVPGRTEADVAADIAEAIVAEGHSEVAFVIVGSGPHGADPHHGYSDRELREGDIVVVDIGGTYGPGYHSDSTRTYSIGEPDSDVAQSYSMLQRAQRAAFEAIRPGVTAEQVDAAARDVLAEAGLAEYFVHRTGHGIGLCVHEEPYIVAGNDLVLVPGMAFSIEPGIYFPGRWGARIEDIVIVTEDGAVSVNNCPHELIVVPVS,"39,440",375,Peptidase M24B family,,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY49.29c,1
P9WIF1,PG35_MYCTU,Rv1983,PE_PGRS35 Rv1983 MTCY39.36c,GO:0005886; GO:0016021,IPR000084; IPR021109; ,,PE_PGRS35,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS35,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MSFLVVVPEFLTSAAADVENIGSTLRAANAAAAASTTALAAAGADEVSAAVAALFARFGQEYQAVSAQASAFHQQFVQTLNSASGSYAAAEATIASQLQTAQHDLLGAVNAPTETLLGRPLIGDGAPGTATSPNGGAGGLLYGNGGNGYSATASGVGGGAGGSAGLIGNGGAGGAGGPNAPGGAGGNGGWLLGNGGIGGPGGASSIPGMSGGAGGTGGAAGLLGWGANGGAGGLGDGVGVDRGTGGAGGRGGLLYGGYGVSGPGGDGRTVPLEIIHVTEPTVHANVNGGPTSTILVDTGSAGLVVSPEDVGGILGVLHMGLPTGLSISGYSGGLYYIFATYTTTVDFGNGIVTAPTAVNVVLLSIPTSPFAISTYFSALLADPTTTPFEAYFGAVGVDGVLGVGPNAVGPGPSIPTMALPGDLNQGVLIDAPAGELVFGPNPLPAPNVEVVGSPITTLYVKIDGGTPIPVPSIIDSGGVTGTIPSYVIGSGTLPANTNIEVYTSPGGDRLYAFNTNDYRPTVISSGLMNTGFLPFRFQPVYIDYSPSGIGTTVFDHPA,"53,738",558,"Mycobacterial PE family, PGRS subfamily",,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY39.36c,1
P9WQH5,PCC6_MYCTU,Rv2247,accD6 Rv2247 MTCY427.28,GO:0003989; GO:0004658; GO:0005524; GO:0005618; GO:0009062; GO:0009317; GO:0019367; GO:0040007,IPR034733; IPR029045; IPR011763; IPR011762; ,,accD6,DOMAIN 2 224 CoA carboxyltransferase N-terminal. {ECO:0000255|PROSITE-ProRule:PRU01136}.; DOMAIN 225 473 CoA carboxyltransferase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU01137}.,Probable propionyl-CoA carboxylase beta chain 6 (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase),"acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; fatty acid catabolic process [GO:0009062]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",9634230; 21969609,X-ray crystallography (1),,MTIMAPEAVGESLDPRDPLLRLSNFFDDGSVELLHERDRSGVLAAAGTVNGVRTIAFCTDGTVMGGAMGVEGCTHIVNAYDTAIEDQSPIVGIWHSGGARLAEGVRALHAVGQVFEAMIRASGYIPQISVVVGFAAGGAAYGPALTDVVVMAPESRVFVTGPDVVRSVTGEDVDMASLGGPETHHKKSGVCHIVADDELDAYDRGRRLVGLFCQQGHFDRSKAEAGDTDIHALLPESSRRAYDVRPIVTAILDADTPFDEFQANWAPSMVVGLGRLSGRTVGVLANNPLRLGGCLNSESAEKAARFVRLCDAFGIPLVVVVDVPGYLPGVDQEWGGVVRRGAKLLHAFGECTVPRVTLVTRKTYGGAYIAMNSRSLNATKVFAWPDAEVAVMGAKAAVGILHKKKLAAAPEHEREALHDQLAAEHERIAGGVDSALDIGVVDEKIDPAHTRSKLTEALAQAPARRGRHKNIPL,"50,136",473,AccD/PCCB family,"fatty acid catabolic process [GO:0009062]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658],acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618],,MTCY427.28,1
P9WIG9,PE23_MYCTU,Rv2328,PE23 Rv2328 MTCY3G12.06,GO:0005886; GO:0016021,IPR000084; ,,PE23,DOMAIN 1 92 PE. {ECO:0000255}.,Uncharacterized PE family protein PE23,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MQFLSVIPEQVESAAQDLAGIRSALSASYAAAAGPTTAVVSAAEDEVSTAIASIFGAYGRQCQVLSAQASAFHDEFVNLLKTGATAYRNTEFANAQSNVLNAVNAPARSLLGHPSAAESVQNSAPTLGGGHSTVTAGLAAQAGRAVATVEQQAAAAVAPLPSAGAGLAQVVNGVVTAGQGSAAKLATALQSAAPWLAKSGGEFIVAGQSALTGVALLQPAVVGVVQAGGTFLTAGTSAATGLGLLTLAGVEFSQGVGNLALASGTAATGLGLLGSAGVQLFSPAFLLAVPTALGGVGSLAIAVVQLVQGVQHLSLVVPNVVAGIAALQTAGAQFAQGVNHTMLAAQLGAPGIAVLQTAGGHFAQGIGHLTTAGNAAVTVLIS,"36,833",382,Mycobacterial PE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY3G12.06,1
P9WJ75,PARD2_MYCTU,Rv2142A,parD2 Rv2142A,GO:0045927,IPR013406; ,,parD2,,Antitoxin ParD2,positive regulation of growth [GO:0045927],9634230; 15718296; 19016878,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli neutralizes the effect of cognate toxin ParE2. {ECO:0000269|PubMed:19016878}.,MVVNRALLASVDALSRDEQIELVEHINGNLAEGMHISEANQALIEARANDTDDAHWSTIDDFDKRIRARLG,"7,913",71,,positive regulation of growth [GO:0045927],,,,,1
P9WK91,LIPA_MYCTU,Rv2218,lipA Rv2218 MTCY190.29,GO:0005737; GO:0009107; GO:0009249; GO:0016992; GO:0040007; GO:0046872; GO:0051539,IPR013785; IPR006638; IPR031691; IPR003698; IPR007197; ,,lipA,,Lipoyl synthase (EC 2.8.1.8) (Lip-syn) (LS) (Lipoate synthase) (Lipoic acid synthase) (Sulfur insertion protein LipA),"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; growth [GO:0040007]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249]",9634230; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes the radical-mediated insertion of two sulfur atoms into the C-6 and C-8 positions of the octanoyl moiety bound to the lipoyl domains of lipoate-dependent enzymes, thereby converting the octanoylated domains into lipoylated derivatives. {ECO:0000255|HAMAP-Rule:MF_00206}.",MSVAAEGRRLLRLEVRNAQTPIERKPPWIKTRARIGPEYTELKNLVRREGLHTVCEEAGCPNIFECWEDREATFLIGGDQCTRRCDFCQIDTGKPAELDRDEPRRVADSVRTMGLRYATVTGVARDDLPDGGAWLYAATVRAIKELNPSTGVELLIPDFNGEPTRLAEVFESGPEVLAHNVETVPRIFKRIRPAFTYRRSLGVLTAARDAGLVTKSNLILGLGETSDEVRTALGDLRDAGCDIVTITQYLRPSARHHPVERWVKPEEFVQFARFAEGLGFAGVLAGPLVRSSYRAGRLYEQARNSRALASR,"34,719",311,"Radical SAM superfamily, Lipoyl synthase family",growth [GO:0040007]; lipoate biosynthetic process [GO:0009107]; protein lipoylation [GO:0009249],"4 iron, 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737],,MTCY190.29,1
P0CL60,MAZE8_MYCTU,Rv2274A,mazE8 Rv2274A,,,,mazE8,,Antitoxin MazE8,,9634230; 15718296,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is MazF8.,MAEPETLPGRWLPECACLAETVSWEQSRLWSRLLCRPHFRHALPGLTGGSASRPSARSARLVRQPRMTLFSLDHRDGVDARC,"9,256",82,,,,,,,1
P9WII3,MAZF6_MYCTU,Rv1991c,mazF6 mazF-mt3 Rv1991c MTCY39.28,GO:0003677; GO:0004519; GO:0004540; GO:0005576; GO:0006402; GO:0016075; GO:0045926; GO:0045927,IPR003477; IPR011067; ,,mazF6,,Endoribonuclease MazF6 (EC 3.1.27.-) (Toxin MazF6) (mRNA interferase MazF-mt3),extracellular region [GO:0005576]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; ribonuclease activity [GO:0004540]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; rRNA catabolic process [GO:0016075],9634230; 16611633; 17623030; 18258191; 18485066; 19016878; 20011113; 20876537; 21969609; 23345537; 24709835; 25608501,X-ray crystallography (3),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and in M.smegmatis partially inhibits cell growth and colony formation; its toxic effect is neutralized by coexpression with cognate antitoxin MazE6. Acts as an mRNA interferase on ssRNA, cleaving between the second and third bases in the sequences CUCCU and UUCCU (PubMed:18485066). Further experiments demonstrate that it digests between the first and second bases of UCCUU, yielding a 5'-hydroxyl end; digests M.tuberculosis mRNA (in coding as well as the 5'- and 3'-UTR regions) and 23S rRNA, digests E.coli 16S rRNA both alone and in the 70S ribosome but no data for M.tuberculosis 16S rRNA cleavage was presented. 23S and 16S rRNA digestion occurs in predicted single-stranded regions, the 16S rRNA UCCUU site is in the anti-Shine-Dalgarno site and would cleave off the last 7 nucleotides (PubMed:24709835). Non-cognate antitoxins VapB27 and VapB40 partially neutralize toxicity in vivo (PubMed:20876537). {ECO:0000269|PubMed:17623030, ECO:0000269|PubMed:18258191, ECO:0000269|PubMed:18485066, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20876537, ECO:0000269|PubMed:24709835, ECO:0000269|PubMed:25608501}.",MVISRAEIYWADLGPPSGSQPAKRRPVLVIQSDPYNASRLATVIAAVITSNTALAAMPGNVFLPATTTRLPRDSVVNVTAIVTLNKTDLTDRVGEVPASLMHEVDRGLRRVLDL,"12,262",114,PemK/MazF family,mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; rRNA catabolic process [GO:0016075],DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],mazF-mt3,MTCY39.28,1
O33259,METH_MYCTU,Rv2124c,metH Rv2124c MTCY261.20c,GO:0005618; GO:0005829; GO:0005886; GO:0008270; GO:0008705; GO:0031419; GO:0042558,IPR003759; IPR006158; IPR036724; IPR011005; IPR003726; IPR036589; IPR033706; IPR011822; IPR036594; IPR000489; IPR004223; IPR037010; ,,metH,DOMAIN 1 312 Hcy-binding. {ECO:0000255|PROSITE-ProRule:PRU00333}.; DOMAIN 343 601 Pterin-binding. {ECO:0000255|PROSITE-ProRule:PRU00334}.; DOMAIN 635 728 B12-binding N-terminal. {ECO:0000255|PROSITE-ProRule:PRU00667}.; DOMAIN 729 866 B12-binding. {ECO:0000255|PROSITE-ProRule:PRU00666}.; DOMAIN 893 1192 AdoMet activation. {ECO:0000255|PROSITE-ProRule:PRU00346}.,"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine, yielding enzyme-bound cob(I)alamin and methionine. Subsequently, remethylates the cofactor using methyltetrahydrofolate (By similarity). {ECO:0000250}.",MTAADKHLYDTDLLDVLSQRVMVGDGAMGTQLQAADLTLDDFRGLEGCNEILNETRPDVLETIHRNYFEAGADAVETNTFGCNLSNLGDYDIADRIRDLSQKGTAIARRVADELGSPDRKRYVLGSMGPGTKLPTLGHTEYAVIRDAYTEAALGMLDGGADAILVETCQDLLQLKAAVLGSRRAMTRAGRHIPVFAHVTVETTGTMLLGSEIGAALTAVEPLGVDMIGLNCATGPAEMSEHLRHLSRHARIPVSVMPNAGLPVLGAKGAEYPLLPDELAEALAGFIAEFGLSLVGGCCGTTPAHIREVAAAVANIKRPERQVSYEPSVSSLYTAIPFAQDASVLVIGERTNANGSKGFREAMIAEDYQKCLDIAKDQTRDGAHLLDLCVDYVGRDGVADMKALASRLATSSTLPIMLDSTETAVLQAGLEHLGGRCAINSVNYEDGDGPESRFAKTMALVAEHGAAVVALTIDEEGQARTAQKKVEIAERLINDITGNWGVDESSILIDTLTFTIATGQEESRRDGIETIEAIRELKKRHPDVQTTLGLSNISFGLNPAARQVLNSVFLHECQEAGLDSAIVHASKILPMNRIPEEQRNVALDLVYDRRREDYDPLQELMRLFEGVSAASSKEDRLAELAGLPLFERLAQRIVDGERNGLDADLDEAMTQKPPLQIINEHLLAGMKTVGELFGSGQMQLPFVLQSAEVMKAAVAYLEPHMERSDDDSGKGRIVLATVKGDVHDIGKNLVDIILSNNGYEVVNIGIKQPIATILEVAEDKSADVVGMSGLLVKSTVVMKENLEEMNTRGVAEKFPVLLGGAALTRSYVENDLAEIYQGEVHYARDAFEGLKLMDTIMSAKRGEAPDENSPEAIKAREKEAERKARHQRSKRIAAQRKAAEEPVEVPERSDVAADIEVPAPPFWGSRIVKGLAVADYTGLLDERALFLGQWGLRGQRGGEGPSYEDLVETEGRPRLRYWLDRLSTDGILAHAAVVYGYFPAVSEGNDIVVLTEPKPDAPVRYRFHFPRQQRGRFLCIADFIRSRELAAERGEVDVLPFQLVTMGQPIADFANELFASNAYRDYLEVHGIGVQLTEALAEYWHRRIREELKFSGDRAMAAEDPEAKEDYFKLGYRGARFAFGYGACPDLEDRAKMMALLEPERIGVTLSEELQLHPEQSTDAFVLHHPEAKYFNV,"130,323",1192,Vitamin-B12 dependent methionine synthase family,pteridine-containing compound metabolic process [GO:0042558],cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY261.20c,1
P9WIN9,MP64_MYCTU,Rv1980c,mpt64 Rv1980c MTCY39.39,GO:0005576; GO:0005618; GO:0009267; GO:0035375,IPR021729; IPR037126; ,,mpt64,,Immunogenic protein MPT64 (Antigen MPT64),cell wall [GO:0005618]; extracellular region [GO:0005576]; zymogen binding [GO:0035375]; cellular response to starvation [GO:0009267],7513311; 9169770; 9634230; 1502498; 21969609,NMR spectroscopy (1),,MRIKIFMLVTAVVLLCCSGVATAAPKTYCEELKGTDTGQACQIQMSDPAYNINISLPSYYPDQKSLENYIAQTRDKFLSAATSSTPREAPYELNITSATYQSAIPPRGTQAVVLKVYQNAGGTHPTTTYKAFDWDQAYRKPITYDTLWQADTDPLPVVFPIVQGELSKQTGQQVSIAPNAGLDPVNYQNFAVTNDGVIFFFNPGELLPEAAGPTQVLVPRSAIDSMLA,"24,855",228,,cellular response to starvation [GO:0009267],zymogen binding [GO:0035375],cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY39.39,1
O53508,MPTA_MYCTU,Rv2174,mptA Rv2174,GO:0000030; GO:0009247; GO:0016021; GO:0040007,IPR017822; ,,mptA,,Alpha-(1->6)-mannopyranosyltransferase A (MptA) (EC 2.4.1.-) (Polyprenyl-1-monophosphorylmannose dependent alpha-(1->6)-mannopyranosyltransferase) (PPM-dependent alpha-(1->6)-mannopyranosyltransferase),integral component of membrane [GO:0016021]; mannosyltransferase activity [GO:0000030]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007],9634230; 17714444; 21969609,,FUNCTION: Involved in the latter stages of the biosynthesis of the alpha-(1->6) mannan core of lipomannan (LM). Catalyzes the addition of alpha-(1->6)-mannose residue. {ECO:0000269|PubMed:17714444}.,MTTPSHAPAVDLATAKDAVVQHLSRLFEFTTGPQGGPARLGFAGAVLITAGGLGAGSVRQHDPLLESIHMSWLRFGHGLVLSSILLWTGVGVMLLAWLGLGRRVLAGEATEFTMRATTVIWLAPLLLSVPVFSRDTYSYLAQGALLRDGLDPYAVGPVGNPNALLDDVSPIWTITTAPYGPAFILVAKFVTVIVGNNVVAGTMLLRLCMLPGLALLVWATPRLASHLGTHGPTALWICVLNPLVLIHLMGGVHNEMLMVGLMTAGIALTVQGRNVAGIILITVAIAVKATAGIALPFLVWVWLRHLRERRGYRPVQAFLAAAAISLLIFVAVFAVLSAVAGVGLGWLTALAGSVKIINWLTVPTGAANVIHALGRGLFTVDFYTLLRITRLIGIVIIAVSLPLLWWRFRRDDRAALTGVAWSMLIVVLFVPAALPWYYSWPLAVAAPLAQARRAIAAIAGLSTWVMVIFKPDGSHGMYSWLHFWIATACALTAWYVLYRSPDRRGVQAATPVVNTP,"55,294",516,MptA/B family,glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007],mannosyltransferase activity [GO:0000030],integral component of membrane [GO:0016021],,,1
P9WMW7,MRAY_MYCTU,Rv2156c,mraY murX Rv2156c MTCY270.12,GO:0005886; GO:0007049; GO:0008360; GO:0008963; GO:0009252; GO:0016021; GO:0040007; GO:0051301; GO:0051992; GO:0071555,IPR000715; IPR003524; IPR018480; ,,mraY,,Phospho-N-acetylmuramoyl-pentapeptide-transferase (EC 2.7.8.13) (UDP-MurNAc-pentapeptide phosphotransferase),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine:undecaprenyl-phosphate transferase activity [GO:0051992]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 19099550; 21969609,,FUNCTION: First step of the lipid cycle reactions in the biosynthesis of the cell wall peptidoglycan. {ECO:0000255|HAMAP-Rule:MF_00038}.,MRQILIAVAVAVTVSILLTPVLIRLFTKQGFGHQIREDGPPSHHTKRGTPSMGGVAILAGIWAGYLGAHLAGLAFDGEGIGASGLLVLGLATALGGVGFIDDLIKIRRSRNLGLNKTAKTVGQITSAVLFGVLVLQFRNAAGLTPGSADLSYVREIATVTLAPVLFVLFCVVIVSAWSNAVNFTDGLDGLAAGTMAMVTAAYVLITFWQYRNACVTAPGLGCYNVRDPLDLALIAAATAGACIGFLWWNAAPAKIFMGDTGSLALGGVIAGLSVTSRTEILAVVLGALFVAEITSVVLQILTFRTTGRRMFRMAPFHHHFELVGWAETTVIIRFWLLTAITCGLGVALFYGEWLAAVGA,"37,713",359,"Glycosyltransferase 4 family, MraY subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"phospho-N-acetylmuramoyl-pentapeptide-transferase activity [GO:0008963]; UDP-N-acetylmuramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminopimelyl-D-alanyl-D-alanine:undecaprenyl-phosphate transferase activity [GO:0051992]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],murX,MTCY270.12,1
P9WJN9,MRAZ_MYCTU,Rv2166c,mraZ Rv2166c MTCY270.02,GO:0000976; GO:0003700; GO:0005737; GO:0006351; GO:0009295; GO:0040007; GO:2000143,IPR003444; IPR035644; IPR020603; IPR035642; IPR038619; IPR007159; IPR037914; ,,mraZ,DOMAIN 5 47 SpoVT-AbrB 1. {ECO:0000255|PROSITE-ProRule:PRU01076}.; DOMAIN 76 119 SpoVT-AbrB 2. {ECO:0000255|PROSITE-ProRule:PRU01076}.,Transcriptional regulator MraZ,"cytoplasm [GO:0005737]; nucleoid [GO:0009295]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; growth [GO:0040007]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,,MFLGTYTPKLDDKGRLTLPAKFRDALAGGLMVTKSQDHSLAVYPRAAFEQLARRASKAPRSNPEARAFLRNLAAGTDEQHPDSQGRITLSADHRRYASLSKDCVVIGAVDYLEIWDAQAWQNYQQIHEENFSAASDEALGDIF,"15,912",143,MraZ family,"growth [GO:0040007]; negative regulation of DNA-templated transcription, initiation [GO:2000143]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytoplasm [GO:0005737]; nucleoid [GO:0009295],,MTCY270.02,1
P9WJA5,HIGB1_MYCTU,Rv1955,higB1 higB Rv1955,GO:0001666; GO:0004521; GO:0045926; GO:0045927,IPR009241; ,,higB1,,Probable endoribonuclease HigB1 (EC 3.1.-.-) (Toxin HigB1),endoribonuclease activity [GO:0004521]; negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; response to hypoxia [GO:0001666],9634230; 15718296; 19016878; 19118359; 20011113; 20585061; 21673191; 21536872; 23927792; 24662523,,"FUNCTION: Toxic component of an atypical, type II toxin-antitoxin chaperone (TAC) system. Upon expression in M.smegmatis inhibits colony formation and cell growth (PubMed:20011113, PubMed:23927792). Ectopic expression in wild-type M.tuberculosis has no effect on cell growth; ectopic expression in a triple higB1-higA1-Rv1957 (delta TAC) disruption mutant causes growth arrest, killing a considerable proportion of the cells. Increased ectopic expression leads to decreased levels of IdeR- and Zur-regulated genes as well as cleavage within the mRNA region of tmRNA (transfer-mRNA), strongly suggesting it is an endoribonuclease; also degrades E.coli and M-smegmatis tmRNA (PubMed:23927792). Its toxic effect is neutralized by coexpression with antitoxin HigA. Neutralization of HigB1 toxin in E.coli or M.marinum also requires SecB-like chaperone Rv1957, making this the first toxin-antitoxin chaperone (TAC) system (PubMed:21536872). {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:21536872, ECO:0000269|PubMed:23927792}.",MPPPDPAAMGTWKFFRASVDGRPVFKKEFDKLPDQARAALIVLMQRYLVGDLAAGSIKPIRGDILELRWHEANNHFRVLFFRWGQHPVALTAFYKNQQKTPKTKIETALDRQKIWKRAFGDTPPI,"14,430",125,Mycobacterial HigB family,negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; response to hypoxia [GO:0001666],endoribonuclease activity [GO:0004521],,higB,,1
P9WGT1,HSD_MYCTU,Rv2002,fabG3 Rv2002 MTCY39.16c,GO:0005886; GO:0008202; GO:0008207; GO:0047044,IPR036291; IPR020904; IPR002347; ,,fabG3,,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase (EC 1.1.1.53),"plasma membrane [GO:0005886]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; C21-steroid hormone metabolic process [GO:0008207]; steroid metabolic process [GO:0008202]",9634230; 21969609; 12524453,X-ray crystallography (3),,MSGRLIGKVALVSGGARGMGASHVRAMVAEGAKVVFGDILDEEGKAVAAELADAARYVHLDVTQPAQWTAAVDTAVTAFGGLHVLVNNAGILNIGTIEDYALTEWQRILDVNLTGVFLGIRAVVKPMKEAGRGSIINISSIEGLAGTVACHGYTATKFAVRGLTKSTALELGPSGIRVNSIHPGLVKTPMTDWVPEDIFQTALGRAAEPVEVSNLVVYLASDESSYSTGAEFVVDGGTVAGLAHNDFGAVEVSSQPEWVT,"27,030",260,Short-chain dehydrogenases/reductases (SDR) family,C21-steroid hormone metabolic process [GO:0008207]; steroid metabolic process [GO:0008202],"androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]",plasma membrane [GO:0005886],,MTCY39.16c,1
P9WK73,LPPN_MYCTU,Rv2270,lppN Rv2270 MTCY339.40c,GO:0005886; GO:0009986,,,lppN,,Putative lipoprotein LppN,cell surface [GO:0009986]; plasma membrane [GO:0005886],9634230; 25041568,,FUNCTION: Probably involved in bacterial recognition and uptake by its host (human) (PubMed:25041568). {ECO:0000269|PubMed:25041568}.,MRLPGRHVLYALSAVTMLAACSSNGARGGIASTNMNPTNPPATAETATVSPTPAPQSARTETWINLQVGDCLADLPPADLSRITVTIVDCATAHSAEVYLRAPVAVDAAVVSMANRDCAAGFAPYTGQSVDTSPYSVAYLIDSHQDRTGADPTPSTVICLLQPANGQLLTGSARR,"18,081",175,,,,cell surface [GO:0009986]; plasma membrane [GO:0005886],,MTCY339.40c,1
P9WJ85,MAZE7_MYCTU,Rv2063,mazE7 Rv2063,GO:0003677; GO:0045927; GO:0097351,,,mazE7,,Antitoxin MazE7,DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927],9634230; 15718296; 19016878; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli but not in M.smegmatis neutralizes the effect of cognate toxin MazF7. {ECO:0000269|PubMed:19016878}.,MSTSTTIRVSTQTRDRLAAQARERGISMSALLTELAAQAERQAIFRAEREASHAETTTQAVRDEDREWEGTVGDGLG,"8,450",77,,positive regulation of growth [GO:0045927],DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351],,,,1
P9WIH7,MAZF8_MYCTU,Rv2274c,mazF8 Rv2274c MTCY339.36,GO:0004519,,,mazF8,,Putative toxin MazF8 (EC 3.1.-.-),endonuclease activity [GO:0004519],9634230,,"FUNCTION: Putative toxic component of a type II toxin-antitoxin (TA) system, its cognate toxin is MaZE8. Probably an endoribonuclease (By similarity). {ECO:0000250|UniProtKB:P9WIH9, ECO:0000305}.",MSIARSAQPIGWISCPPKGGSSCCRCGGGYTHIFCVSAWTGLVVDLQAEQVRSVVTERLRRRIGRGAPILAGTLAPGVGLAAQNREFRQFTGRSAPPSATIAFGE,"11,046",105,,,endonuclease activity [GO:0004519],,,MTCY339.36,1
P9WK25,MAOX_MYCTU,Rv2332,mez Rv2332 MTCY3G12.02c MTCY98.01,GO:0004470; GO:0004471; GO:0005829; GO:0006090; GO:0006108; GO:0008948; GO:0046872; GO:0051287,IPR015884; IPR012301; IPR037062; IPR012302; IPR001891; IPR036291; ,,mez,,Putative malate oxidoreductase [NAD] (EC 1.1.1.38) (Malic enzyme),cytosol [GO:0005829]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090],9634230; 21969609,,,MSDARVPRIPAALSAPSLNRGVGFTHAQRRRLGLTGRLPSAVLTLDQQAERVWHQLQSLATELGRNLLLEQLHYRHEVLYFKVLADHLPELMPVVYTPTVGEAIQRFSDEYRGQRGLFLSIDEPDEIEEAFNTLGLGPEDVDLIVCTDAEAILGIGDWGVGGIQIAVGKLALYTAGGGVDPRRCLAVSLDVGTDNEQLLADPFYLGNRHARRRGREYDEFVSRYIETAQRLFPRAILHFEDFGPANARKILDTYGTDYCVFNDDMQGTGAVVLAAVYSGLKVTGIPLRDQTIVVFGAGTAGMGIADQIRDAMVADGATLEQAVSQIWPIDRPGLLFDDMDDLRDFQVPYAKNRHQLGVAVGDRVGLSDAIKIASPTILLGCSTVYGAFTKEVVEAMTASCKHPMIFPLSNPTSRMEAIPADVLAWSNGRALLATGSPVAPVEFDETTYVIGQANNVLAFPGIGLGVIVAGARLITRRMLHAAAKAIAHQANPTNPGDSLLPDVQNLRAISTTVAEAVYRAAVQDGVASRTHDDVRQAIVDTMWLPAYD,"59,423",548,Malic enzymes family,malate metabolic process [GO:0006108]; pyruvate metabolic process [GO:0006090],malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948],cytosol [GO:0005829],,MTCY3G12.02c MTCY98.01,1
P9WJ87,MAZE6_MYCTU,Rv1991A,mazE6 mazE-mt3 Rv1991A,GO:0003677; GO:0006355; GO:0045926; GO:0045927,IPR002145; IPR010985; ,,mazE6,,Antitoxin MazE6,"DNA binding [GO:0003677]; negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 16611633; 17623030; 18258191; 19016878; 20011113; 20876537; 21969609; 25608501,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and in M.smegmatis counteracts the ribonuclease activity of cognate toxin MazF6. {ECO:0000269|PubMed:17623030, ECO:0000269|PubMed:18258191, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20876537}.",MKTAISLPDETFDRVSRRASELGMSRSEFFTKAAQRYLHELDAQLLTGQIDRALESIHGTDEAEALAVANAYRVLETMDDEW,"9,290",82,,"negative regulation of growth [GO:0045926]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677],,mazE-mt3,,1
P0CL62,MAZF7_MYCTU,Rv2063A,mazF7 Rv2063A,GO:0003677; GO:0004521; GO:0017148; GO:0045926,IPR003477; IPR011067; ,,mazF7,,Probable endoribonuclease MazF7 (EC 3.1.-.-) (Toxin MazF7),DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148],9634230; 15718296; 19016878; 20011113,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and M.smegmatis inhibits cell growth and colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin MazE7 (PubMed:19016878, PubMed:20011113). Probably an endoribonuclease (By similarity). {ECO:0000250|UniProtKB:P9WIH9, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113}.",MAEPRRGDLWLVSLGAARAGEPGKHRPAVVVSVDELLTGIDDELVVVVPVSSSRSRTPLRPPVAPSEGVAADSVAVCRGVRAVARARLVERLGALKPATMRAIENALTLILGLPTGPERGEAATHSPVRWTGGRDP,"14,235",136,PemK/MazF family,negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148],DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521],,,,1
O53505,LPPM_MYCTU,Rv2171,lppM Rv2171,GO:0005576; GO:0005618; GO:0008289; GO:0016021; GO:0052170,,,lppM,,Protein LppM (Putative lipoprotein LppM),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; lipid binding [GO:0008289]; negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 20844580; 21969609; 27220037; 27568926,NMR spectroscopy (1),"FUNCTION: A putative lipoprotein that seems to be specialized for the initial steps of macrophage infection (PubMed:27220037). A non-acylated fragment (residues 26-185) binds phosphatidyl-myo-inositol mannosides (PIMs) (PubMed:27568926). Limits, in a TLR2-dependent fashion, bacterial uptake by host (mouse); this effect may be mediated by nonacylated fragment 26-185 (PubMed:27220037). Plays a TLR2-dependent role in host phagosome maturation arrest (PubMed:20844580, PubMed:27220037). Plays a TLR2-independent role in chemokine production during the first 24 hours of mouse infection (PubMed:27220037). {ECO:0000269|PubMed:27568926, ECO:0000305|PubMed:20844580, ECO:0000305|PubMed:27220037}.",MARTRRRGMLAIAMLLMLVPLATGCLRVRASITISPDDLVSGEIIAAAKPKNSKDTGPALDGDVPFSQKVAVSNYDSDGYVGSQAVFSDLTFAELPQLANMNSDAAGVNLSLRRNGNIVILEGRADLTSVSDPDADVELTVAFPAAVTSTNGDRIEPEVVQWKLKPGVVSTMSAQARYTDPNTRSFTGAGIWLGIAAFAAAGVVAVLAWIDRDRSPRLTASGDPPTS,"23,846",227,,negative regulation by symbiont of host innate immune response [GO:0052170],lipid binding [GO:0008289],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
P9WK71,LPPO_MYCTU,Rv2290,lppO Rv2290 MTCY339.20c,GO:0005576; GO:0005886,IPR008691; ,,lppO,,Putative lipoprotein LppO,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MTDPRHTVRIAVGATALGVSALGATLPACSAHSGPGSPPSAPSAPAAATVMVEGHTHTISGVVECRTSPAVRTATPSESGTQTTRVNAHDDSASVTLSLSDSTPPDVNGFGISLKIGSVDYQMPYQPVQSPTQVEATRQGKSYTLTGTGHAVIPGQTGMRELPFGVHVTCP,"17,342",171,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY339.20c,1
P95251,MCE3R_MYCTU,Rv1963c,mce3R Rv1963c LH57_10685,GO:0000976; GO:0003677; GO:0003700; GO:0005829; GO:0006351; GO:0016042; GO:0019216; GO:0040007; GO:0045892,IPR009057; IPR001647; ,,mce3R,DOMAIN 13 73 HTH tetR-type 1. {ECO:0000255|PROSITE-ProRule:PRU00335}.; DOMAIN 217 277 HTH tetR-type 2. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Transcriptional repressor Mce3R (TetR family transcriptional regulator),"cytosol [GO:0005829]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; growth [GO:0040007]; lipid catabolic process [GO:0016042]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of lipid metabolic process [GO:0019216]; transcription, DNA-templated [GO:0006351]",9634230; 12368433; 18304349; 19389781; 21969609,,"FUNCTION: Mce3R represses the transcription of mce3 operon and downregulates its own expression, but does not affect the transcription of mce1, mce2 and mce4 operons. {ECO:0000269|PubMed:12368433, ECO:0000269|PubMed:18304349, ECO:0000269|PubMed:19389781}.",MASVAQPVRRRPKDRKKQILDQAVGLFIERGFHSVKLEDIAEAAGVTARALYRHYDNKQALLAEAIRTGQDQYQSARRLTEGETEPTPRPLNADLEDLIAAAVASRALTVLWQREARYLNEDDRTAVRRRINAIVAGMRDSVLLEVPDLSPQHSELRAWAVSSTLTSLGRHSLSLPGEELKKLLYQACMAAARTPPVCELPPLPAGDAARDEADVLFSRYETLLAAGARLFRAQGYPAVNTSEIGKGAGIAGPGLYRSFSSKQAILDALIRRLDEWRCLECIRALRANQQAAQRLRGLVQGHVRISLDAPDLVAVSVTELSHASVEVRDGYLRNQGDREAVWIDLIGKLVPATSVAQGRLLVAAAISFIEDVARTWHLTRYAGVADEISGLALAILTSGAGNLLRA,"44,342",406,,"growth [GO:0040007]; lipid catabolic process [GO:0016042]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of lipid metabolic process [GO:0019216]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,LH57_10685,2
P9WQ75,ILVE_MYCTU,Rv2210c,ilvE Rv2210c MTCY190.21c,GO:0004084; GO:0009081; GO:0009082; GO:0009097; GO:0009098; GO:0009099; GO:0018272; GO:0030170; GO:0040007; GO:0052654; GO:0052655; GO:0052656; GO:0071267,IPR001544; IPR018300; IPR036038; IPR005786; IPR033939; ,,ilvE,,Branched-chain-amino-acid aminotransferase (BCAT) (EC 2.6.1.42),branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; pyridoxal phosphate binding [GO:0030170]; branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid metabolic process [GO:0009081]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; L-methionine salvage [GO:0071267]; leucine biosynthetic process [GO:0009098]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; valine biosynthetic process [GO:0009099],9634230; 20445230; 21969609; 19923721,X-ray crystallography (2),FUNCTION: Catalyzes the reversible transfers of an amino group from glutamate to the alpha-ketoacid of the respective amino acid in the final step in the biosynthesis of branchedchain amino acids. The amino acids can be ranked in the following order with respect to their efficiency as amino donor: Leu > Ile > Val. {ECO:0000269|PubMed:20445230}.,MTSGSLQFTVLRAVNPATDAQRESMLREPGFGKYHTDHMVSIDYAEGRGWHNARVIPYGPIELDPSAIVLHYAQEVFEGLKAYRWADGSIVSFRADANAARLRSSARRLAIPELPDAVFIESLRQLIAVDKAWVPGAGGEEALYLRPFIFATEPGLGVRPATQYRYLLIASPAGAYFKGGIAPVSVWVSTEYVRACPGGTGAAKFGGNYAASLLAQAEAAENGCDQVVWLDAVERRYIEEMGGMNIFFVLGSGGSARLVTPELSGSLLPGITRDSLLQLAIDAGFAVEERRIDIDEWQKKAAAGEITEVFACGTAAVITPVARVRHGASEFRIADGQPGEVTMALRDTLTGIQRGTFADTHGWMARLG,"39,666",368,Class-IV pyridoxal-phosphate-dependent aminotransferase family,branched-chain amino acid biosynthetic process [GO:0009082]; branched-chain amino acid metabolic process [GO:0009081]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; leucine biosynthetic process [GO:0009098]; L-methionine salvage [GO:0071267]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272]; valine biosynthetic process [GO:0009099],branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; pyridoxal phosphate binding [GO:0030170],,,MTCY190.21c,1
P9WP93,COBD_MYCTU,Rv2236c,cobD Rv2236c MTCY427.17c,GO:0005576; GO:0005886; GO:0009236; GO:0016021; GO:0048472,IPR004485; ,,cobD,,Cobalamin biosynthesis protein CobD,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; threonine-phosphate decarboxylase activity [GO:0048472]; cobalamin biosynthetic process [GO:0009236],9634230; 21969609,,FUNCTION: Converts cobyric acid to cobinamide by the addition of aminopropanol on the F carboxylic group. {ECO:0000250}.,MFASTWQTRAVGVLIGCLLDVVFGDPKRGHPVALFGRAAAKLEQITYRDGRVAGAVHVGLLVGAVGLLGAALQRLPGRSWPVAATATATWAALGGTSLARTGRQISDLLERDDVEAARRLLPSLCGRDPAQLGGPGLTRAALESVAENTADAQVVPLLWAASSGVPAVLGYRAINTLDSMIGYRSPRYLRFGWAAARLDDWANYVGARATAVLVVICAPVVGGSPRGAVRAWRRDAARHPSPNAGVVEAAFAGALDVRLGGPTRYHHELQIRPTLGDGRSPKVADLRRAVVLSRVVQAGAAVLAVMLVYRRRP,"32,976",313,CobD/CbiB family,cobalamin biosynthetic process [GO:0009236],threonine-phosphate decarboxylase activity [GO:0048472],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY427.17c,1
P9WP87,COBH_MYCTU,Rv2065,cobH Rv2065 MTCY49.04,GO:0009236; GO:0016993,IPR003722; IPR036588; ,,cobH,,Precorrin-8X methylmutase (EC 5.4.99.61) (HBA synthase) (Precorrin isomerase),precorrin-8X methylmutase activity [GO:0016993]; cobalamin biosynthetic process [GO:0009236],9634230; 21969609,,FUNCTION: Catalyzes the conversion of precorrin-8X to hydrogenobyrinate. {ECO:0000250}.,MLDYLRDAAEIYRRSFAVIRAEADLARFPADVARVVVRLIHTCGQVDVAEHVAYTDDVVARAGAALAAGAPVLCDSSMVAAGITTSRLPADNQIVSLVADPRATELAARRQTTRSAAGVELCAERLPGAVLAIGNAPTALFRLLELVDEGAPPPAAVLGGPVGFVGSAQAKEELIERPRGMSYLVVRGRRGGSAMAAAAVNAIASDRE,"21,614",208,CobH/CbiC family,cobalamin biosynthetic process [GO:0009236],precorrin-8X methylmutase activity [GO:0016993],,,MTCY49.04,1
P9WGB3,COBIJ_MYCTU,Rv2066,cobIJ cobI Rv2066 MTCY49.05,GO:0005886; GO:0009236; GO:0030788; GO:0030789; GO:0055114,IPR000878; IPR035996; IPR014777; IPR014776; IPR006363; IPR012382; IPR006364; IPR003043; ,,cobIJ,,Cobalamin biosynthesis protein CobIJ [Includes: Precorrin-2 C(20)-methyltransferase (EC 2.1.1.130) (S-adenosyl-L-methionine--precorrin-2 methyltransferase) (SP2MT); Precorrin-3B C17-methyltransferase (EC 2.1.1.131) (S-adenosyl-L-methionine--precorrin-3B methyltransferase)],plasma membrane [GO:0005886]; precorrin-2 C20-methyltransferase activity [GO:0030788]; precorrin-3B C17-methyltransferase activity [GO:0030789]; cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114],9634230; 21969609,,FUNCTION: Methylates precorrin-2 at the C-20 position to produce precorrin-3A. {ECO:0000250}.,MSARGTLWGVGLGPGDPELVTVKAARVIGEADVVAYHSAPHGHSIARGIAEPYLRPGQLEEHLVYPVTTEATNHPGGYAGALEDFYADATERIATHLDAGRNVALLAEGDPLFYSSYMHLHTRLTRRFNAVIVPGVTSVSAASAAVATPLVAGDQVLSVLPGTLPVGELTRRLADADAAVVVKLGRSYHNVREALSASGLLGDAFYVERASTAGQRVLPAADVDETSVPYFSLAMLPGGRRRALLTGTVAVVGLGPGDSDWMTPQSRRELAAATDLIGYRGYLDRVEVRDGQRRHPSDNTDEPARARLACSLADQGRAVAVVSSGDPGVFAMATAVLEEAEQWPGVRVRVIPAMTAAQAVASRVGAPLGHDYAVISLSDRLKPWDVIAARLTAAAAADLVLAIYNPASVTRTWQVGAMRELLLAHRDPGIPVVIGRNVSGPVSGPNEDVRVVKLADLNPAEIDMRCLLIVGSSQTRWYSVDSQDRVFTPRRYPEAGRATATKSSRHSD,"53,911",508,Precorrin methyltransferase family,cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114],precorrin-2 C20-methyltransferase activity [GO:0030788]; precorrin-3B C17-methyltransferase activity [GO:0030789],plasma membrane [GO:0005886],cobI,MTCY49.05,1
P9WP67,COX3_MYCTU,Rv2193,ctaE Rv2193 MTCY190.04,GO:0004129; GO:0005886; GO:0016021; GO:0019646; GO:0040007,IPR024791; IPR000298; IPR035973; IPR013833; ,,ctaE,,Probable cytochrome c oxidase subunit 3 (EC 1.9.3.1) (Cytochrome aa3 subunit 3) (Cytochrome c oxidase polypeptide III),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytochrome-c oxidase activity [GO:0004129]; aerobic electron transport chain [GO:0019646]; growth [GO:0040007],9634230; 21969609,,,MTSAVGTSGTAITSRVHSLNRPNMVSVGTIVWLSSELMFFAGLFAFYFSARAQAGGNWPPPPTELNLYQAVPVTLVLIASSFTCQMGVFAAERGDIFGLRRWYVITFLMGLFFVLGQAYEYRNLMSHGTSIPSSAYGSVFYLATGFHGLHVTGGLIAFIFLLVRTGMSKFTPAQATASIVVSYYWHFVDIVWIALFTVIYFIR,"22,420",203,Cytochrome c oxidase subunit 3 family,aerobic electron transport chain [GO:0019646]; growth [GO:0040007],cytochrome-c oxidase activity [GO:0004129],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.04,1
P9WGB1,COBM_MYCTU,Rv2071c,cobM Rv2071c MTCY49.10c,GO:0009236; GO:0046026; GO:0055114,IPR000878; IPR035996; IPR014777; IPR014776; IPR006362; IPR003043; ,,cobM,,Precorrin-4 C(11)-methyltransferase (EC 2.1.1.133) (Precorrin-3 methylase),precorrin-4 C11-methyltransferase activity [GO:0046026]; cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114],9634230; 21969609,,FUNCTION: Catalyzes the methylation of C-11 in precorrin-4 to form precorrin-5. {ECO:0000250}.,MTVYFIGAGPGAADLITVRGQRLLQRCPVCLYAGSIMPDDLLAQCPPGATIVDTGPLTLEQIVRKLADADADGRDVARLHSGDPSLYSALAEQCRELDALGIGYEIVPGVPAFAAAAAALKRELTVPGVAQTVTLTRVATLSTPIPPGEDLAALARSRATLVLHLAAAQIDAIVPRLLDGGYRPETPVAVVAFASWPQQRTLRGTLADIAARMHDAKITRTAVIVVGDVLTAEGFTDSYLYSVARHGRYAQ,"26,420",251,Precorrin methyltransferase family,cobalamin biosynthetic process [GO:0009236]; oxidation-reduction process [GO:0055114],precorrin-4 C11-methyltransferase activity [GO:0046026],,,MTCY49.10c,1
P9WP85,COBT_MYCTU,Rv2207,cobT Rv2207 MTCY190.18,GO:0008939; GO:0009163; GO:0009236,IPR003200; IPR023195; IPR017846; IPR036087; ,,cobT,,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (NN:DBI PRT) (EC 2.4.2.21) (N(1)-alpha-phosphoribosyltransferase),nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity [GO:0008939]; cobalamin biosynthetic process [GO:0009236]; nucleoside biosynthetic process [GO:0009163],9634230; 21969609,,"FUNCTION: Catalyzes the synthesis of alpha-ribazole-5'-phosphate from nicotinate mononucleotide (NAMN) and 5,6-dimethylbenzimidazole (DMB). {ECO:0000250}.",MIGFAPVSTPDAAAEAAARARQDSLTKPRGALGSLEDLSVWVASCQQRCPPRQFERARVVVFAGDHGVARSGVSAYPPEVTAQMVANIDAGGAAINALADVAGATVRVADLAVDADPLSERIGAHKVRRGSGNIATEDALTNDETAAAITAGQQIADEEVDAGADLLIAGDMGIGNTTAAAVLVAALTDAEPVAVVGFGTGIDDAGWARKTAAVRDALFRVRPVLPDPVGLLRCAGGADLAAIAGFCAQAAVRRTPLLLDGVAVTAAALVAERLAPGAHRWWQAGHRSSEPGHGLALAALGLDPIVDLHMRLGEGTGAAVALMVLRAAVAALSSMATFTEAGVSTRSVDGVDRTAPPAVSP,"36,411",361,CobT family,cobalamin biosynthetic process [GO:0009236]; nucleoside biosynthetic process [GO:0009163],nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity [GO:0008939],,,MTCY190.18,1
P9WJ73,EXRBN_MYCTU,Rv2179c RVBD_2179c,Rv2179c RVBD_2179c,GO:0000287; GO:0003676; GO:0008408; GO:0040007; GO:0042802,IPR030853; IPR012337; IPR036397; IPR033390; ,Itself,,,3'-5' exoribonuclease Rv2179c (EC 3.1.13.-),3'-5' exonuclease activity [GO:0008408]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676]; growth [GO:0040007],9634230; 21969609; 24311791,X-ray crystallography (2),"FUNCTION: Exonuclease that cleaves single-stranded 3' overhangs of double-stranded RNA. Has no activity with 5' overhangs. Has negligible endonuclease activity. Can bind ATP, dATP and AMP (in vitro); the nucleotide occupies the predicted substrate binding site. {ECO:0000255|HAMAP-Rule:MF_00977, ECO:0000269|PubMed:24311791}.",MRYFYDTEFIEDGHTIELISIGVVAEDGREYYAVSTEFDPERAGSWVRTHVLPKLPPPASQLWRSRQQIRLDLEEFLRIDGTDSIELWAWVGAYDHVALCQLWGPMTALPPTVPRFTRELRQLWEDRGCPRMPPRPRDVHDALVDARDQLRRFRLITSTDDAGRGAAR,"19,520",168,,growth [GO:0040007],3'-5' exonuclease activity [GO:0008408]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleic acid binding [GO:0003676],,,,1
P9WQD7,FAB2_MYCTU,Rv2246,kasB Rv2246 MTCY427.27,GO:0001666; GO:0004315; GO:0005618; GO:0005737; GO:0005886; GO:0030497; GO:0040007; GO:0071768,IPR014031; IPR014030; IPR020841; IPR016039; ,,kasB,,3-oxoacyl-[acyl-carrier-protein] synthase 2 (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase 2) (KAS 2),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; fatty acid elongation [GO:0030497]; growth [GO:0040007]; mycolic acid biosynthetic process [GO:0071768]; response to hypoxia [GO:0001666],9634230; 21969609; 17174327,X-ray crystallography (1),FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. {ECO:0000250}.,MTELVTGKAFPYVVVTGIAMTTALATDAETTWKLLLDRQSGIRTLDDPFVEEFDLPVRIGGHLLEEFDHQLTRIELRRMGYLQRMSTVLSRRLWENAGSPEVDTNRLMVSIGTGLGSAEELVFSYDDMRARGMKAVSPLTVQKYMPNGAAAAVGLERHAKAGVMTPVSACASGAEAIARAWQQIVLGEADAAICGGVETRIEAVPIAGFAQMRIVMSTNNDDPAGACRPFDRDRDGFVFGEGGALLLIETEEHAKARGANILARIMGASITSDGFHMVAPDPNGERAGHAITRAIQLAGLAPGDIDHVNAHATGTQVGDLAEGRAINNALGGNRPAVYAPKSALGHSVGAVGAVESILTVLALRDQVIPPTLNLVNLDPEIDLDVVAGEPRPGNYRYAINNSFGFGGHNVAIAFGRY,"44,277",417,Beta-ketoacyl-ACP synthases family,fatty acid elongation [GO:0030497]; growth [GO:0040007]; mycolic acid biosynthetic process [GO:0071768]; response to hypoxia [GO:0001666],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY427.27,1
P9WN97,FTSW_MYCTU,Rv2154c,ftsW Rv2154c MTCY270.14,GO:0005886; GO:0007049; GO:0008360; GO:0008955; GO:0009252; GO:0016021; GO:0040007; GO:0051301; GO:0071555,IPR018365; IPR013437; IPR001182; ,,ftsW,,Probable peptidoglycan glycosyltransferase FtsW (PGT) (EC 2.4.1.129) (Cell division protein FtsW) (Cell wall polymerase) (Peptidoglycan polymerase) (PG polymerase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; peptidoglycan glycosyltransferase activity [GO:0008955]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 12101218; 17427288,,FUNCTION: Peptidoglycan polymerase that is essential for cell division. {ECO:0000250|UniProtKB:P39604}.,MLTRLLRRGTSDTDGSQTRGAEPVEGQRTGPEEASNPGSARPRTRFGAWLGRPMTSFHLIIAVAALLTTLGLIMVLSASAVRSYDDDGSAWVIFGKQVLWTLVGLIGGYVCLRMSVRFMRRIAFSGFAITIVMLVLVLVPGIGKEANGSRGWFVVAGFSMQPSELAKMAFAIWGAHLLAARRMERASLREMLIPLVPAAVVALALIVAQPDLGQTVSMGIILLGLLWYAGLPLRVFLSSLAAVVVSAAILAVSAGYRSDRVRSWLNPENDPQDSGYQARQAKFALAQGGIFGDGLGQGVAKWNYLPNAHNDFIFAIIGEELGLVGALGLLGLFGLFAYTGMRIASRSADPFLRLLTATTTLWVLGQAFINIGYVIGLLPVTGLQLPLISAGGTSTAATLSLIGIIANAARHEPEAVAALRAGRDDKVNRLLRLPLPEPYLPPRLEAFRDRKRANPQPAQTQPARKTPRTAPGQPARQMGLPPRPGSPRTADPPVRRSVHHGAGQRYAGQRRTRRVRALEGQRYG,"56,337",524,"SEDS family, FtsW subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],peptidoglycan glycosyltransferase activity [GO:0008955],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY270.14,1
P9WFM1,GCH1L_MYCTU,Rv2230c,Rv2230c MTCY427.11c,GO:0005737; GO:0046872,IPR002678; IPR036069; IPR017221; IPR015867; ,,,,GTP cyclohydrolase 1 type 2 homolog,cytoplasm [GO:0005737]; metal ion binding [GO:0046872],9634230; 21969609,,,MSVRLADVIDVLDQAYPPRLAQSWDSVGLVCGDPDDVVDSVTVAVDATPAVVDQVPQAGLLLVHHPLLLRGVDTVAANTPKGVLVHRLIRTGRSLFTAHTNADSASPGVSDALAHAVGLTVDAVLDPVPGAADLDKWVIYVPRENSEAVRAAVFEAGAGHIGDYSHCSWSVAGTGQFLAHDGASPAIGSVGTVERVAEDRVEVVAPARARAEVLAAMRAAHPYEEPAFDIFALVPPPVGSGLGRIGRLPKPEPLRTFVARLEAALPPTATGVRAAGDPDLLVSRVAVCGGAGDSLLATVAAADVQAYVTADLRHHPADEHCRASQVALIDVAHWASEFPWCGQAAEVLRSHFGASLPVRVCTICTDPWNLDHETGRDQA,"39,598",379,GTP cyclohydrolase I type 2/NIF3 family,,metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY427.11c,1
P9WPF9,CDTS_MYCTU,Rv2275,Rv2275,GO:0016755; GO:0016875,IPR030903; IPR038622; ,,,,Cyclo(L-tyrosyl-L-tyrosyl) synthase (EC 2.3.2.21) (Cyclodipeptide synthase) (CDPS) (Cyclodityrosine synthase),"ligase activity, forming carbon-oxygen bonds [GO:0016875]; transferase activity, transferring amino-acyl groups [GO:0016755]",9634230; 19430487; 20852636,X-ray crystallography (1),"FUNCTION: Involved in the biosynthesis of mycocyclosin. It uses activated amino acids in the form of aminoacyl-tRNAs (aa-tRNAs) as substrates to catalyze the ATP-independent formation of cyclodipeptides which are intermediates in diketopiperazine (DKP) biosynthetic pathways. Catalyzes the formation of cyclo(L-Tyr-L-Tyr) (cYY) from L-tyrosyl-tRNA(Tyr). Can incorporate various nonpolar residues, such as L-phenylalanine, L-leucine, L-tyrosine and L-methionine, and to a much lesser extent L-alanine, into cyclodipeptides. Cyclodipeptides synthesized by Rv2275 always contain L-tyrosine. {ECO:0000269|PubMed:19430487}.",MSYVAAEPGVLISPTDDLQSPRSAPAAHDENADGITGGTRDDSAPNSRFQLGRRIPEATAQEGFLVRPFTQQCQIIHTEGDHAVIGVSPGNSYFSRQRLRDLGLWGLTNFDRVDFVYTDVHVAESYEALGDSAIEARRKAVKNIRGVRAKITTTVNELDPAGARLCVRPMSEFQSNEAYRELHADLLTRLKDDEDLRAVCQDLVRRFLSTKVGPRQGATATQEQVCMDYICAEAPLFLDTPAILGVPSSLNCYHQSLPLAEMLYARGSGLRASRNQGHAIVTPDGSPAE,"31,612",289,CDPS family,,"ligase activity, forming carbon-oxygen bonds [GO:0016875]; transferase activity, transferring amino-acyl groups [GO:0016755]",,,,1
P9WKJ1,CYSQ_MYCTU,Rv2131c,cysQ Rv2131c MTCY270.37,GO:0000103; GO:0000287; GO:0005886; GO:0008441; GO:0008934; GO:0030145; GO:0040007; GO:0042132; GO:0046854; GO:0050427; GO:0050897; GO:0052832; GO:0052833,IPR020583; IPR000760; ,,cysQ,,"3'-phosphoadenosine 5'-phosphate phosphatase (PAP phosphatase) (EC 3.1.3.7) (3'(2'),5'-bisphosphate nucleotidase) (3'(2'),5-bisphosphonucleoside 3'(2')-phosphohydrolase) (D-fructose-1,6-bisphosphate 1-phosphohydrolase) (DPNPase) (Fructose-1,6-bisphosphatase) (FBPase) (EC 3.1.3.11) (Inositol-1-monophosphatase) (I-1-Pase) (IMPase) (EC 3.1.3.25) (Inositol-1-phosphatase)","plasma membrane [GO:0005886]; 3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; cobalt ion binding [GO:0050897]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; growth [GO:0040007]; phosphatidylinositol phosphorylation [GO:0046854]; sulfate assimilation [GO:0000103]",9634230; 16325768; 18454554; 20167072; 21969609,X-ray crystallography (6),"FUNCTION: Phosphatase with a broad specificity. Its primary physiological function is to dephosphorylate 3'-phosphoadenosine 5'-phosphate (PAP) and 3'-phosphoadenosine 5'-phosphosulfate (PAPS). Thus, plays a role in mycobacterial sulfur metabolism, since it can serve as a key regulator of the sulfate assimilation pathway by controlling the pools of PAP and PAPS in the cell. To a lesser extent, is also able to hydrolyze inositol 1-phosphate (I-1-P), fructose 1,6-bisphosphate (FBP) (to fructose 6-phosphate (F-6-P)) and AMP in vitro, but this might has no significance in vivo. Glucose-1-phosphate (G-1-P), p-nitrophenyl phosphate (pNPP), and beta-glycerol phosphate (beta-GP) are also good substrates, compared to I-1-P. With much lower efficiency, can also hydrolyze inositol 2-phosphate (I-2-P) and glucose-6-phosphate (G-6-P) in vitro, but not fructose-6-phosphate (F-6-P) and trehalose-6-phosphate (T-6-P). {ECO:0000269|PubMed:16325768, ECO:0000269|PubMed:18454554}.",MVSPAAPDLTDDLTDAELAADLAADAGKLLLQVRAEIGFDQPWTLGEAGDRQANSLLLRRLQAERPGDAVLSEEAHDDLARLKSDRVWIIDPLDGTREFSTPGRDDWAVHIALWRRSSNGQPEITDAAVALPARGNVVYRTDTVTSGAAPAGVPGTLRIAVSATRPPAVLHRIRQTLAIQPVSIGSAGAKAMAVIDGYVDAYLHAGGQWEWDSAAPAGVMLAAGMHASRLDGSPLRYNQLDPYLPDLLMCRAEVAPILLGAIADAWR,"28,447",267,Inositol monophosphatase superfamily,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; growth [GO:0040007]; phosphatidylinositol phosphorylation [GO:0046854]; sulfate assimilation [GO:0000103],"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; cobalt ion binding [GO:0050897]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]",plasma membrane [GO:0005886],,MTCY270.37,1
P9WMS3,DHMA1_MYCTU,Rv2296,dhmA1 Rv2296 MTCY339.14c,GO:0005618; GO:0005886; GO:0018786,IPR029058; IPR000073; IPR000639; IPR023489; ,,dhmA1,DOMAIN 47 176 AB hydrolase-1. {ECO:0000255}.,Haloalkane dehalogenase 1 (EC 3.8.1.5),cell wall [GO:0005618]; plasma membrane [GO:0005886]; haloalkane dehalogenase activity [GO:0018786],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes hydrolytic cleavage of carbon-halogen bonds in halogenated aliphatic compounds, leading to the formation of the corresponding primary alcohols, halide ions and protons. {ECO:0000250}.",MDVLRTPDSRFEHLVGYPFAPHYVDVTAGDTQPLRMHYVDEGPGDGPPIVLLHGEPTWSYLYRTMIPPLSAAGHRVLAPDLIGFGRSDKPTRIEDYTYLRHVEWVTSWFENLDLHDVTLFVQDWGSLIGLRIAAEHGDRIARLVVANGFLPAAQGRTPLPFYVWRAFARYSPVLPAGRLVNFGTVHRVPAGVRAGYDAPFPDKTYQAGARAFPRLVPTSPDDPAVPANRAAWEALGRWDKPFLAIFGYRDPILGQADGPLIKHIPGAAGQPHARIKASHFIQEDSGTELAERMLSWQQAT,"33,358",300,"Haloalkane dehalogenase family, Type 1 subfamily",,haloalkane dehalogenase activity [GO:0018786],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY339.14c,1
P9WP41,CUT2_MYCTU,Rv2301,cut2 Rv2301 MTCY339.08c,GO:0005576; GO:0008152; GO:0042783; GO:0052689,IPR029058; IPR000675; IPR011150; IPR006311; ,,cut2,,Probable cutinase cut2 (EC 3.1.1.74),extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; active evasion of host immune response [GO:0042783]; metabolic process [GO:0008152],9634230; 21969609,,,MNDLLTRRLLTMGAAAAMLAAVLLLTPITVPAGYPGAVAPATAACPDAEVVFARGRFEPPGIGTVGNAFVSALRSKVNKNVGVYAVKYPADNQIDVGANDMSAHIQSMANSCPNTRLVPGGYSLGAAVTDVVLAVPTQMWGFTNPLPPGSDEHIAAVALFGNGSQWVGPITNFSPAYNDRTIELCHGDDPVCHPADPNTWEANWPQHLAGAYVSSGMVNQAADFVAGKLQ,"23,926",230,Cutinase family,active evasion of host immune response [GO:0042783]; metabolic process [GO:0008152],carboxylic ester hydrolase activity [GO:0052689],extracellular region [GO:0005576],,MTCY339.08c,1
P9WP55,CYSK_MYCTU,Rv2334,cysK1 cysK Rv2334 MTCY98.03,GO:0004124; GO:0005576; GO:0005737; GO:0005829; GO:0006535; GO:0030170; GO:0080146,IPR005856; IPR005859; IPR001216; IPR001926; IPR036052; ,,cysK1,,O-acetylserine sulfhydrylase (OAS sulfhydrylase) (OASS) (EC 2.5.1.47) (Cysteine synthase A) (CSase A) (O-acetylserine (thiol)-lyase A) (OAS-TL A) (O-acetylserine-specific cysteine synthase) (Sulfide-dependent cysteine synthase),cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process from serine [GO:0006535],9634230; 21969609; 17567578,X-ray crystallography (4),FUNCTION: Catalyzes the conversion of O-acetylserine (OAS) to cysteine through the elimination of acetate and addition of hydrogen sulfide. {ECO:0000269|PubMed:17567578}.,MSIAEDITQLIGRTPLVRLRRVTDGAVADIVAKLEFFNPANSVKDRIGVAMLQAAEQAGLIKPDTIILEPTSGNTGIALAMVCAARGYRCVLTMPETMSLERRMLLRAYGAELILTPGADGMSGAIAKAEELAKTDQRYFVPQQFENPANPAIHRVTTAEEVWRDTDGKVDIVVAGVGTGGTITGVAQVIKERKPSARFVAVEPAASPVLSGGQKGPHPIQGIGAGFVPPVLDQDLVDEIITVGNEDALNVARRLAREEGLLVGISSGAATVAALQVARRPENAGKLIVVVLPDFGERYLSTPLFADVAD,"32,753",310,Cysteine synthase/cystathionine beta-synthase family,cysteine biosynthetic process from serine [GO:0006535],cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576],cysK,MTCY98.03,1
P71889,DDAH_MYCTU,Rv2323c,Rv2323c,GO:0016403,,,,,"N(G),N(G)-dimethylarginine dimethylaminohydrolase (DDAH) (Dimethylarginine dimethylaminohydrolase) (EC 3.5.3.18) (Dimethylargininase)",dimethylargininase activity [GO:0016403],9634230; 10510241,,"FUNCTION: Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA). {ECO:0000269|PubMed:10510241}.",MENTQRPSFDCEIRAKYRWFMTDSYVAAARLGSPARRTPRTRRYAMTPPAFFAVAYAINPWMDVTAPVDVQVAQAQWEHLHQTYLRLGHSVDLIEPISGLPDMVYTANGGFIAHDIAVVARFRFPERAGESRAYASWMSSVGYRPVTTRHVNEGQGDLLMVGERVLAGYGFRTDQRAHAEIAAVLGLPVVSLELVDPRFYHLDTALAVLDDHTIAYYPPAFSTAAQEQLSALFPDAIVVGSADAFVFGLNAVSDGLNVVLPVAAMGFAAQLRAAGFEPVGVDLSELLKGGGSVKCCTLEIHP,"32,960",302,DDAH family,,dimethylargininase activity [GO:0016403],,,,1
P9WN39,GLN1B_MYCTU,Rv2220,glnA1 glnA Rv2220 MTCY190.31 MTCY427.01,GO:0001968; GO:0004356; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006542; GO:0009399; GO:0009405; GO:0010756; GO:0020012; GO:0035375; GO:0040007; GO:0044044; GO:0046872,IPR008147; IPR036651; IPR014746; IPR008146; IPR027303; IPR004809; IPR001637; IPR027302; ,,glnA1,,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Glutamine synthetase I beta) (GSI beta),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; zymogen binding [GO:0035375]; evasion or tolerance of host immune response [GO:0020012]; glutamine biosynthetic process [GO:0006542]; growth [GO:0040007]; interaction with host via substance in symbiont surface [GO:0044044]; nitrogen fixation [GO:0009399]; pathogenesis [GO:0009405]; positive regulation of plasminogen activation [GO:0010756],9278431; 9634230; 7937767; 10618433; 12496196; 12819079; 15037612; 21969609; 12146952; 16027359; 19695264; 22369127; ,X-ray crystallography (9),"FUNCTION: Involved in nitrogen metabolism via ammonium assimilation. Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia (PubMed:7937767, PubMed:12819079). Also able to use GTP (PubMed:7937767). D-glutamate is a poor substrate, and DL-glutamate shows about 50% of the standard specific activity (PubMed:7937767). Also plays a key role in controlling the ammonia levels within infected host cells and so contributes to the pathogens capacity to inhibit phagosome acidification and phagosome-lysosome fusion (PubMed:7937767, PubMed:12819079). Involved in cell wall biosynthesis via the production of the major component poly-L-glutamine (PLG) (PubMed:7937767, PubMed:10618433). PLG synthesis in the cell wall occurs only in nitrogen limiting conditions and on the contrary high nitrogen conditions inhibit PLG synthesis (Probable). {ECO:0000269|PubMed:10618433, ECO:0000269|PubMed:12819079, ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:9278431}.",MTEKTPDDVFKLAKDEKVEYVDVRFCDLPGIMQHFTIPASAFDKSVFDDGLAFDGSSIRGFQSIHESDMLLLPDPETARIDPFRAAKTLNINFFVHDPFTLEPYSRDPRNIARKAENYLISTGIADTAYFGAEAEFYIFDSVSFDSRANGSFYEVDAISGWWNTGAATEADGSPNRGYKVRHKGGYFPVAPNDQYVDLRDKMLTNLINSGFILEKGHHEVGSGGQAEINYQFNSLLHAADDMQLYKYIIKNTAWQNGKTVTFMPKPLFGDNGSGMHCHQSLWKDGAPLMYDETGYAGLSDTARHYIGGLLHHAPSLLAFTNPTVNSYKRLVPGYEAPINLVYSQRNRSACVRIPITGSNPKAKRLEFRSPDSSGNPYLAFSAMLMAGLDGIKNKIEPQAPVDKDLYELPPEEAASIPQTPTQLSDVIDRLEADHEYLTEGGVFTNDLIETWISFKRENEIEPVNIRPHPYEFALYYDV,"53,570",478,Glutamine synthetase family,evasion or tolerance of host immune response [GO:0020012]; glutamine biosynthetic process [GO:0006542]; growth [GO:0040007]; interaction with host via substance in symbiont surface [GO:0044044]; nitrogen fixation [GO:0009399]; pathogenesis [GO:0009405]; positive regulation of plasminogen activation [GO:0010756],ATP binding [GO:0005524]; fibronectin binding [GO:0001968]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],glnA,MTCY190.31 MTCY427.01,1
P9WN81,GLPD1_MYCTU,Rv2249c,glpD1 glpD Rv2249c MTCY427.31c,GO:0005618; GO:0005886; GO:0006071; GO:0006072; GO:0009331; GO:0052591,IPR031656; IPR038299; IPR006076; IPR036188; IPR000447; ,,glpD1,,Glycerol-3-phosphate dehydrogenase 1 (EC 1.1.5.3),cell wall [GO:0005618]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072],9634230; 21969609,,,MLMPHSAALNAARRSADLTALADGGALDVIVIGGGITGVGIALDAATRGLTVALVEKHDLAFGTSRWSSKLVHGGLRYLASGNVGIARRSAVERGILMTRNAPHLVHAMPQLVPLLPSMGHTKRALVRAGFLAGDALRVLAGTPAATLPRSRRIPASRVVEIAPTVRRDGLDGGLLAYDGQLIDDARLVMAVARTAAQHGARILTYVGASNVTGTSVELTDRRTRQSFALSARAVINAAGVWAGEIDPSLRLRPSRGTHLVFDAKSFANPTAALTIPIPGELNRFVFAMPEQLGRIYLGLTDEDAPGPIPDVPQPSSEEITFLLDTVNTALGTAVGTKDVIGAYAGLRPLIDTGGAGVQGRTADVSRDHAVFESPSGVISVVGGKLTEYRYMAEDVLNRAITLRHLRAAKCRTRNLPLIGAPANPGPAPGSGAGLPESLVARYGAEAANVAAAATCERPTEPVADGIDVTRAEFEYAVTHEGALDVDDILDRRTRIGLVPRDRERVVAVAKEFLSR,"54,176",516,FAD-dependent glycerol-3-phosphate dehydrogenase family,glycerol-3-phosphate metabolic process [GO:0006072]; glycerol metabolic process [GO:0006071],sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591],cell wall [GO:0005618]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886],glpD,MTCY427.31c,1
P9WMR1,HELY_MYCTU,Rv2092c,helY Rv2092c MTCY49.32c,GO:0003676; GO:0004004; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006401,IPR011545; IPR014001; IPR001650; IPR027417; IPR012961; ,,helY,DOMAIN 26 184 Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.; DOMAIN 259 463 Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.,Probable helicase HelY (EC 3.6.4.-),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; RNA catabolic process [GO:0006401],9634230; 21969609,,,MTELAELDRFTAELPFSLDDFQQRACSALERGHGVLVCAPTGAGKTVVGEFAVHLALAAGSKCFYTTPLKALSNQKHTDLTARYGRDQIGLLTGDLSVNGNAPVVVMTTEVLRNMLYADSPALQGLSYVVMDEVHFLADRMRGPVWEEVILQLPDDVRVVSLSATVSNAEEFGGWIQTVRGDTTVVVDEHRPVPLWQHVLVGKRMFDLFDYRIGEAEGQPQVNRELLRHIAHRREADRMADWQPRRRGSGRPGFYRPPGRPEVIAKLDAEGLLPAITFVFSRAGCDAAVTQCLRSPLRLTSEEERARIAEVIDHRCGDLADSDLAVLGYYEWREGLLRGLAAHHAGMLPAFRHTVEELFTAGLVKAVFATETLALGINMPARTVVLERLVKFNGEQHMPLTPGEYTQLTGRAGRRGIDVEGHAVVIWHPEIEPSEVAGLASTRTFPLRSSFAPSYNMTINLVHRMGPQQAHRLLEQSFAQYQADRSVVGLVRGIERGNRILGEIAAELGGSDAPILEYARLRARVSELERAQARASRLQRRQAATDALAALRRGDIITITHGRRGGLAVVLESARDRDDPRPLVLTEHRWAGRISSADYSGTTPVGSMTLPKRVEHRQPRVRRDLASALRSAAAGLVIPAARRVSEAGGFHDPELESSREQLRRHPVHTSPGLEDQIRQAERYLRIERDNAQLERKVAAATNSLARTFDRFVGLLTEREFIDGPATDPVVTDDGRLLARIYSESDLLVAECLRTGAWEGLKPAELAGVVSAVVYETRGGDGQGAPFGADVPTPRLRQALTQTSRLSTTLRADEQAHRITPSREPDDGFVRVIYRWSRTGDLAAALAAADVNGSGSPLLAGDFVRWCRQVLDLLDQVRNAAPNPELRATAKRAIGDIRRGVVAVDAG,"99,606",906,"Helicase family, SKI2 subfamily",RNA catabolic process [GO:0006401],ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY49.32c,1
P9WMN1,HIS1_MYCTU,Rv2121c,hisG Rv2121c MTCY261.17c,GO:0000105; GO:0000287; GO:0003879; GO:0005524; GO:0005737; GO:0005886; GO:0016208; GO:0040007,IPR013820; IPR018198; IPR001348; IPR020621; IPR013115; IPR011322; IPR015867; ,,hisG,,ATP phosphoribosyltransferase (ATP-PRT) (ATP-PRTase) (EC 2.4.2.17),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]; magnesium ion binding [GO:0000287]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105],9634230; 21969609; 12511575,X-ray crystallography (5),FUNCTION: Catalyzes the condensation of ATP and 5-phosphoribose 1-diphosphate to form N'-(5'-phosphoribosyl)-ATP (PR-ATP). Has a crucial role in the pathway because the rate of histidine biosynthesis seems to be controlled primarily by regulation of HisG enzymatic activity (By similarity). {ECO:0000250}.,MLRVAVPNKGALSEPATEILAEAGYRRRTDSKDLTVIDPVNNVEFFFLRPKDIAIYVGSGELDFGITGRDLVCDSGAQVRERLALGFGSSSFRYAAPAGRNWTTADLAGMRIATAYPNLVRKDLATKGIEATVIRLDGAVEISVQLGVADAIADVVGSGRTLSQHDLVAFGEPLCDSEAVLIERAGTDGQDQTEARDQLVARVQGVVFGQQYLMLDYDCPRSALKKATAITPGLESPTIAPLADPDWVAIRALVPRRDVNGIMDELAAIGAKAILASDIRFCRF,"30,481",284,"ATP phosphoribosyltransferase family, Long subfamily",growth [GO:0040007]; histidine biosynthetic process [GO:0000105],AMP binding [GO:0016208]; ATP binding [GO:0005524]; ATP phosphoribosyltransferase activity [GO:0003879]; magnesium ion binding [GO:0000287],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY261.17c,1
O53467,HIGA2_MYCTU,Rv2021c RVBD_2021c,higA2 Rv2021c RVBD_2021c LH57_11010 P425_02092,GO:0003677; GO:0019217; GO:0043565; GO:0050708,IPR001387; IPR010982; ,,higA2,DOMAIN 35 90 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Putative antitoxin HigA2,DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565]; regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708],9634230; 21673191; 21969609; 24662523,,FUNCTION: Putative antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin would be HigB2. {ECO:0000305|PubMed:24662523}.,MAMTLRDMDAVRPVNREAVDRHKARMRDEVRAFRLRELRAAQSLTQVQVAALAHIRQSRVSSIENGDIGSAQVNTLRKYVSALGGELDITVRLGDETFTLA,"11,292",101,,regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708],DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565],,,LH57_11010 P425_02092,1
O53468,HIGB2_MYCTU,Rv2022c RVBD_2022c,higB2 Rv2022c RVBD_2022c LH57_11015 P425_02093,,IPR009241; ,,higB2,,Putative toxin HigB2,,9634230; 21673191; 21969609; 24662523,,FUNCTION: Putative toxic component of a type II toxin-antitoxin (TA) system. Its cognate antitoxin would be HigA2. {ECO:0000305|PubMed:24662523}.,MNVPWENAHGGALYCLIRGDEFSAWHRLLFQRPGCAESVLACRHFLDGSPVARCSYPEEYHPCVISRIALLCDSVGWTADVERISAWLNGLDRETYELVFAAIEVLEEEGPALGCPLVDTVRGSRHKNMKELRPGSQGRSEVRILFAFDPARQAIMLAAGNKAGRWTQWYDEKIKAADEMFAEHLAQFEDTKPKRRKRKKG,"22,777",201,Mycobacterial HigB family,,,,,LH57_11015 P425_02093,1
P9WJA7,HIGA1_MYCTU,Rv1956,higA1 higA Rv1956,GO:0001666; GO:0006351; GO:0019217; GO:0043565; GO:0045892; GO:0045926; GO:0045927,IPR001387; IPR010982; ,,higA1,DOMAIN 42 96 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Antitoxin HigA1,"sequence-specific DNA binding [GO:0043565]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of growth [GO:0045927]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",9634230; 15718296; 19016878; 19118359; 20011113; 20585061; 21673191; 21536872; 24662523,,"FUNCTION: Antitoxin component of an atypical, type II toxin-antitoxin chaperone (TAC) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin HigB1. Neutralization of HigB1 toxin in E.coli or M.marinum also requires SecB-like chaperone Rv1957, making this the first toxin-antitoxin chaperone (TAC) system. Antitoxin aggregation and degradation are prevented by the chaperone. {ECO:0000269|PubMed:21536872}.; FUNCTION: In M.tuberculosis represses expression of the Rv1954A-higB1-higA1-Rv1957 operon promoter but not that of the higB1-higA1-Rv1957 operon. {ECO:0000269|PubMed:20585061}.",MSIDFPLGDDLAGYIAEAIAADPSFKGTLEDAEEARRLVDALIALRKHCQLSQVEVAKRMGVRQPTVSGFEKEPSDPKLSTLQRYARALDARLRLVLEVPTLREVPTWHRLSSYRGSARDHQVRVGADKEILMQTNWARHISVRQVEVA,"16,760",149,,"negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of growth [GO:0045927]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",sequence-specific DNA binding [GO:0043565],,higA,,1
P9WMM9,HIS2_MYCTU,Rv2122c,hisE Rv2122c MTCY261.18,GO:0000105; GO:0000287; GO:0004636; GO:0005524; GO:0005618; GO:0005737; GO:0040007; GO:0075139,IPR008179; IPR021130; ,,hisE,,Phosphoribosyl-ATP pyrophosphatase (PRA-PH) (EC 3.6.1.31),cell wall [GO:0005618]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphoribosyl-ATP diphosphatase activity [GO:0004636]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; response to host iron concentration [GO:0075139],9634230; 21969609,X-ray crystallography (2),,MQQSLAVKTFEDLFAELGDRARTRPADSTTVAALDGGVHALGKKLLEEAGEVWLAAEHESNDALAEEISQLLYWTQVLMISRGLSLDDVYRKL,"10,275",93,PRA-PH family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; response to host iron concentration [GO:0075139],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phosphoribosyl-ATP diphosphatase activity [GO:0004636],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY261.18,1
P9WHR5,CAEB_MYCTU,Rv2223c,caeB Rv2223c MTCY427.04c,GO:0005576; GO:0005618; GO:0016787,IPR029058; IPR000073; IPR013595; ,,caeB,DOMAIN 105 403 AB hydrolase-1. {ECO:0000255}.,Carboxylesterase B (EC 3.1.1.-),cell wall [GO:0005618]; extracellular region [GO:0005576]; hydrolase activity [GO:0016787],9634230; 17428787; 21969609,,FUNCTION: Catalyzes the cleavage of ester bonds. Esterase activity increases with increasing carbon chain length of the substrate (Potential). {ECO:0000305}.,MAAMWRRRPLSSALLSFGLLLGGLPLAAPPLAGATEEPGAGQTPGAPVVAPQQSWNSCREFIADTSEIRTARCATVSVPVDYDQPGGTQAKLAVIRVPATGQRFGALLVNPGGPGASAVDMVAAMAPAIADTDILRHFDLVGFDPRGVGHSTPALRCRTDAEFDAYRRDPMADYSPAGVTHVEQVYRQLAQDCVDRMGFSFLANIGTASVARDMDMVRQALGDDQINYLGYSYGTELGTAYLERFGTHVRAMVLDGAIDPAVSPIEESISQMAGFQTAFNDYAADCARSPACPLGTDSAQWVNRYHALVDPLVQKPGKTSDPRGLSYADATTGTINALYSPQRWKYLTSGLLGLQRGSDAGDLLVLADDYDGRDADGHYSNDQDAFNAVRCVDAPTPADPAAWVAADQRIRQVAPFLSYGQFTGSAPRDLCALWPVPATSTPHPAAPAGAGKVVVVSTTHDPATPYQSGVDLARQLGAPLITFDGTQHTAVFDGNQCVDSAVMHYFLDGTLPPTSLRCAP,"55,078",520,Peptidase S33 family,,hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY427.04c,1
P9WHR3,CAEA_MYCTU,Rv2224c,caeA Rv2224c MTCY427.05c,GO:0005576; GO:0005829; GO:0005886; GO:0009405; GO:0043687; GO:0052572; GO:0052689,IPR029058; IPR000073; ,,caeA,DOMAIN 102 497 AB hydrolase-1. {ECO:0000255}.,Carboxylesterase A (EC 3.1.1.-),cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; carboxylic ester hydrolase activity [GO:0052689]; pathogenesis [GO:0009405]; post-translational protein modification [GO:0043687]; response to host immune response [GO:0052572],9634230; 17428787; 21969609,X-ray crystallography (3),FUNCTION: Involved in virulence. Catalyzes the cleavage of ester bonds. Esterase activity increases with increasing carbon chain length of the substrate. {ECO:0000269|PubMed:17428787}.,MGMRLSRRDKIARMLLIWAALAAVALVLVGCIRVVGGRARMAEPKLGQPVEWTPCRSSNPQVKIPGGALCGKLAVPVDYDRPDGDVAALALIRFPATGDKIGSLVINPGGPGESGIEAALGVFQTLPKRVHERFDLVGFDPRGVASSRPAIWCNSDADNDRLRAEPQVDYSREGVAHIENETKQFVGRCVDKMGKNFLAHVGTVNVAKDLDAIRAALGDDKLTYLGYSYGTRIGSAYAEEFPQRVRAMILDGAVDPNADPIEAELRQAKGFQDAFNNYAADCAKNAGCPLGADPAKAVEVYHSLVDPLVDPDNPRISRPARTKDPRGLSYSDAIVGTIMALYSPNLWQHLTDGLSELVDNRGDTLLALADMYMRRDSHGRYNNSGDARVAINCVDQPPVTDRDKVIDEDRRAREIAPFMSYGKFTGDAPLGTCAFWPVPPTSQPHAVSAPGLVPTVVVSTTHDPATPYKAGVDLANQLRGSLLTFDGTQHTVVFQGDSCIDEYVTAYLIGGTTPPSGAKC,"55,924",520,Peptidase S33 family,pathogenesis [GO:0009405]; post-translational protein modification [GO:0043687]; response to host immune response [GO:0052572],carboxylic ester hydrolase activity [GO:0052689],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY427.05c,1
P9WQ83,CBL_MYCTU,Rv2294,Rv2294 MTCY339.16c,GO:0004121; GO:0005886; GO:0009086; GO:0030170,IPR004839; IPR015424; IPR015422; IPR015421; ,,,,Putative cystathionine beta-lyase (CBL) (EC 4.4.1.8) (Beta-cystathionase) (Cysteine lyase),plasma membrane [GO:0005886]; cystathionine beta-lyase activity [GO:0004121]; pyridoxal phosphate binding [GO:0030170]; methionine biosynthetic process [GO:0009086],9634230; 21969609,,,MIPNPLEELTLEQLRSQRTSMKWRAHPADVLPLWVAEMDVKLPPTVADALRRAIDDGDTGYPYGTEYAEAVREFACQRWQWHDLEVSRTAIVPDVMLGIVEVLRLITDRGDPVIVNSPVYAPFYAFVSHDGRRVIPAPLRGDGRIDLDALQEAFSSARASSGSSGNVAYLLCNPHNPTGSVHTADELRGIAERAQRFGVRVVSDEIHAPLIPSGARFTPYLSVPGAENAFALMSASKAWNLGGLKAALAIAGREAAADLARMPEEVGHGPSHLGVIAHTAAFRTGGNWLDALLRGLDHNRTLLGALVDEHLPGVQYRWPQGTYLAWLDCRELGFDDAASDEMTEGLAVVSDLSGPARWFLDHARVALSSGHVFGIGGAGHVRINFATSRAILIEAVSRMSRSLLERR,"44,283",407,"Class-II pyridoxal-phosphate-dependent aminotransferase family, MalY/PatB cystathionine beta-lyase subfamily",methionine biosynthetic process [GO:0009086],cystathionine beta-lyase activity [GO:0004121]; pyridoxal phosphate binding [GO:0030170],plasma membrane [GO:0005886],,MTCY339.16c,1
P9WIZ9,ACG_MYCTU,Rv2032,acg Rv2032,GO:0001666; GO:0005618; GO:0005829; GO:0005886; GO:0016491; GO:0052572,IPR000415; ,,acg,,Putative NAD(P)H nitroreductase acg (EC 1.-.-.-),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666],9634230; 11416222; 11854240; 12953092; 18474359; 18400743; 21969609,,,MPDTMVTTDVIKSAVQLACRAPSLHNSQPWRWIAEDHTVALFLDKDRVLYATDHSGREALLGCGAVLDHFRVAMAAAGTTANVERFPNPNDPLHLASIDFSPADFVTEGHRLRADAILLRRTDRLPFAEPPDWDLVESQLRTTVTADTVRIDVIADDMRPELAAASKLTESLRLYDSSYHAELFWWTGAFETSEGIPHSSLVSAAESDRVTFGRDFPVVANTDRRPEFGHDRSKVLVLSTYDNERASLLRCGEMLSAVLLDATMAGLATCTLTHITELHASRDLVAALIGQPATPQALVRVGLAPEMEEPPPATPRRPIDEVFHVRAKDHR,"36,559",331,Nitroreductase family,response to host immune response [GO:0052572]; response to hypoxia [GO:0001666],oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WMK1,ACR_MYCTU,Rv2031c,hspX acr Rv2031c MTV018.18c,GO:0001666; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006457; GO:0009267; GO:0009408; GO:0010039; GO:0044121; GO:0044183; GO:0045926; GO:0046777; GO:0051409; GO:0052572; GO:0071456; GO:0075136,IPR002068; IPR008978; ,P9WI75,hspX,DOMAIN 33 143 sHSP. {ECO:0000255|PROSITE-ProRule:PRU00285}.,Alpha-crystallin (Acr) (14 kDa antigen) (16 kDa antigen) (HSP 16.3) (Nox16),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein binding involved in protein folding [GO:0044183]; cellular response to hypoxia [GO:0071456]; cellular response to starvation [GO:0009267]; growth of symbiont in host organelle [GO:0044121]; negative regulation of growth [GO:0045926]; protein autophosphorylation [GO:0046777]; protein folding [GO:0006457]; response to heat [GO:0009408]; response to host [GO:0075136]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nitrosative stress [GO:0051409],1370952; 9634230; 1563797; 9864257; 8755875; 11416222; 12057942; 12953092; 12506197; 15528667; 16428728; 17145953; 17609369; 18474359; 18400743; 20066036; 21969609,,"FUNCTION: Acts as a chaperone, as it has a significant ability to suppress the thermal denaturation of alcohol dehydrogenase. Cells overexpressing this gene grow more slowly than wild-type cells, and are less susceptible to autolysis following saturation of the culture in vitro, suggesting this protein may slow down the growth rate of M.tuberculosis in culture and by extension during macrophage infection. {ECO:0000269|PubMed:8755875}.",MATTLPVQRHPRSLFPEFSELFAAFPSFAGLRPTFDTRLMRLEDEMKEGRYEVRAELPGVDPDKDVDIMVRDGQLTIKAERTEQKDFDGRSEFAYGSFVRTVSLPVGADEDDIKATYDKGILTVSVAVSEGKPTEKHIQIRSTN,"16,227",144,Small heat shock protein (HSP20) family,cellular response to hypoxia [GO:0071456]; cellular response to starvation [GO:0009267]; growth of symbiont in host organelle [GO:0044121]; negative regulation of growth [GO:0045926]; protein autophosphorylation [GO:0046777]; protein folding [GO:0006457]; response to heat [GO:0009408]; response to host [GO:0075136]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nitrosative stress [GO:0051409],protein binding involved in protein folding [GO:0044183],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],acr,MTV018.18c,1
P9WHT3,AMPA_MYCTU,Rv2213,pepA pepB Rv2213 MTCY190.24,GO:0004177; GO:0005618; GO:0005737; GO:0005886; GO:0008235; GO:0030145,IPR011356; IPR000819; IPR023042; IPR008283; ,,pepA,,Probable cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase) (LAP) (EC 3.4.11.10) (Leucyl aminopeptidase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],9634230; 21969609,,FUNCTION: Presumably involved in the processing and regular turnover of intracellular proteins. Catalyzes the removal of unsubstituted N-terminal amino acids from various peptides (By similarity). {ECO:0000250}.,MTTEPGYLSPSVAVATSMPKRGVGAAVLIVPVVSTGEEDRPGAVVASAEPFLRADTVAEIEAGLRALDATGASDQVHRLAVPSLPVGSVLTVGLGKPRREWPADTIRCAAGVAARALNSSEAVITTLAELPGDGICSATVEGLILGSYRFSAFRSDKTAPKDAGLRKITVLCCAKDAKKRALHGAAVATAVATARDLVNTPPSHLFPAEFAKRAKTLSESVGLDVEVIDEKALKKAGYGGVIGVGQGSSRPPRLVRLIHRGSRLAKNPQKAKKVALVGKGITFDTGGISIKPAASMHHMTSDMGGAAAVIATVTLAARLRLPIDVIATVPMAENMPSATAQRPGDVLTQYGGTTVEVLNTDAEGRLILADAIVRACEDKPDYLIETSTLTGAQTVALGTRIPGVMGSDEFRDRVAAISQRVGENGWPMPLPDDLKDDLKSTVADLANVSGQRFAGMLVAGVFLREFVAESVDWAHIDVAGPAYNTGSAWGYTPKGATGVPTRTMFAVLEDIAKNG,"53,481",515,Peptidase M17 family,,aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],pepB,MTCY190.24,1
P9WQF3,ACPM_MYCTU,Rv2244,acpM Rv2244 MTCY427.25,GO:0000035; GO:0000036; GO:0005618; GO:0005829; GO:0005886; GO:0006637; GO:0009245; GO:0031177; GO:0040007,IPR036736; IPR003231; IPR009081; ,,acpM,DOMAIN 3 81 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Meromycolate extension acyl carrier protein (ACP),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; acyl-CoA metabolic process [GO:0006637]; growth [GO:0040007]; lipid A biosynthetic process [GO:0009245],9634230; 19099550; 21969609,NMR spectroscopy (1),FUNCTION: Acyl carrier protein involved in meromycolate extension. {ECO:0000250}.,MPVTQEEIIAGIAEIIEEVTGIEPSEITPEKSFVDDLDIDSLSMVEIAVQTEDKYGVKIPDEDLAGLRTVGDVVAYIQKLEEENPEAAQALRAKIESENPDAVANVQARLEAESK,"12,524",115,Acyl carrier protein (ACP) family,acyl-CoA metabolic process [GO:0006637]; growth [GO:0040007]; lipid A biosynthetic process [GO:0009245],acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY427.25,1
P9WID5,ADOK_MYCTU,Rv2202c,adoK cbhK Rv2202c MTCY190.13c,GO:0000287; GO:0004001; GO:0005524; GO:0005525; GO:0005737; GO:0005886; GO:0006166; GO:0019200; GO:0032567; GO:0044209; GO:0046835,IPR002173; IPR011611; IPR029056; ,,adoK,,Adenosine kinase (ADK) (AK) (EC 2.7.1.20),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; AMP salvage [GO:0044209]; carbohydrate phosphorylation [GO:0046835]; purine ribonucleoside salvage [GO:0006166],9634230; 14594827; 19099550; 16511094; 21969609; 17597075; 25259627,X-ray crystallography (6),"FUNCTION: Catalyzes the phosphorylation of adenosine to adenosine monophosphate (AMP) (PubMed:14594827, PubMed:16511094). Can also catalyze the phosphorylation of the adenosine analog 2-methyladenosine (methyl-Ado) to methyl-AMP, the first step in the metabolism of this compound to an active form that displays antitubercular activity. Is not active on guanosine, inosine, deoxyadenosine, cytidine, uridine, or thymidine. Prefers dGTP and GTP to ATP as phosphate donors in vitro (PubMed:14594827). {ECO:0000269|PubMed:14594827, ECO:0000269|PubMed:16511094}.",MTIAVTGSIATDHLMRFPGRFSEQLLPEHLHKVSLSFLVDDLVMHRGGVAGNMAFAIGVLGGEVALVGAAGADFADYRDWLKARGVNCDHVLISETAHTARFTCTTDVDMAQIASFYPGAMSEARNIKLADVVSAIGKPELVIIGANDPEAMFLHTEECRKLGLAFAADPSQQLARLSGEEIRRLVNGAAYLFTNDYEWDLLLSKTGWSEADVMAQIDLRVTTLGPKGVDLVEPDGTTIHVGVVPETSQTDPTGVGDAFRAGFLTGRSAGLGLERSAQLGSLVAVLVLESTGTQEWQWDYEAAASRLAGAYGEHAAAEIVAVLA,"34,472",324,Carbohydrate kinase PfkB family,AMP salvage [GO:0044209]; carbohydrate phosphorylation [GO:0046835]; purine ribonucleoside salvage [GO:0006166],adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; dGTP binding [GO:0032567]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cbhK,MTCY190.13c,1
P9WQM9,ANSP1_MYCTU,Rv2127,ansP1 ansP Rv2127 MTCY261.26,GO:0005576; GO:0005886; GO:0006865; GO:0016021; GO:0022857,IPR004841; IPR002293; IPR004840; ,,ansP1,,L-asparagine permease 1 (L-asparagine transport protein 1),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; amino acid transport [GO:0006865],9634230; 21969609,,,MSAASQRVGAFGEEAGYHKGLKPRQLQMIGIGGAIGTGLFLGAGGRLAKAGPGLFLVYGVCGVFVFLILRALGELVLHRPSSGSFVSYAREFFGEKAAYAVGWMYFLHWAMTSIVDTTAIATYLQRWTIFTVVPQWILALIALTVVLSMNLISVEWFGELEFWAALIKVLALMAFLVVGTVFLAGRYPVDGHSTGLSLWNNHGGLFPTSWLPLLIVTSGVVFAYSAVELVGTAAGETAEPEKIMPRAINSVVARIAIFYVGSVALLALLLPYTAYKAGESPFVTFFSKIGFHGAGDLMNIVVLTAALSSLNAGLYSTGRVMHSIAMSGSAPRFTARMSKSGVPYGGIVLTAVITLFGVALNAFKPGEAFEIVLNMSALGIIAGWATIVLCQLRLHKLANAGIMQRPRFRMPFSPYSGYLTLLFLLVVLVTMASDKPIGTWTVATLIIVIPALTAGWYLVRKRVMAVARERLGHTGPFPAVANPPVRSRD,"52,447",489,"Amino acid-polyamine-organocation (APC) superfamily, Amino acid transporter (AAT) (TC 2.A.3.1) family",amino acid transport [GO:0006865],transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],ansP,MTCY261.26,1
P9WPG9,CDH_MYCTU,Rv2289,cdh Rv2289 MTCY339.21c,GO:0005576; GO:0005886; GO:0008654; GO:0008715; GO:0016021; GO:0046342,IPR003763; IPR038433; IPR036265; ,,cdh,,Probable CDP-diacylglycerol pyrophosphatase (EC 3.6.1.26) (CDP-diacylglycerol phosphatidylhydrolase) (CDP-diglyceride hydrolase),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CDP-diacylglycerol diphosphatase activity [GO:0008715]; CDP-diacylglycerol catabolic process [GO:0046342]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,,MPKSRRAVSLSVLIGAVIAALAGALIAVTVPARPNRPEADREALWKIVHDRCEFGYRRTGAYAPCTFVDEQSGTALYKADFDPYQFLLIPLARITGIEDPALRESAGRNYLYDAWAARFLVTARLNNSLPESDVVLTINPKNARTQDQLHIHISCSSPTTSAALRNVDTSEYVGWKQLPIDLGGRRFQGLAVDTKAFESRNLFRDIYLKVTADGKKMENASIAVANVAQDQFLLLLAEGTEDQPVAAETLQDHDCSITKS,"28,608",260,Cdh family,CDP-diacylglycerol catabolic process [GO:0046342]; phospholipid biosynthetic process [GO:0008654],CDP-diacylglycerol diphosphatase activity [GO:0008715],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.21c,1
P9WP29,DAGK_MYCTU,Rv2252,dagK Rv2252,GO:0003951; GO:0004143; GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0008654; GO:0009247; GO:0046872,IPR017438; IPR005218; IPR001206; IPR016064; ,,dagK,DOMAIN 9 140 DAGKc. {ECO:0000255|PROSITE-ProRule:PRU00783}.,Diacylglycerol kinase (DAG kinase) (DAGK) (EC 2.7.1.107),cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; glycolipid biosynthetic process [GO:0009247]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,"FUNCTION: Catalyzes the phosphorylation of diacylglycerol (DAG) into phosphatidic acid. Is involved in the biosynthesis of phosphatidylinositol mannosides (PIMs), probably via a role in the biosynthesis of phosphatidylinositol (PI), a PIM precursor, which is derived from phosphatidic acid (By similarity). {ECO:0000250}.",MSAGQLRRHEIGKVTALTNPLSGHGAAVKAAHGAIARLKHRGVDVVEIVGGDAHDARHLLAAAVAKGTDAVMVTGGDGVVSNALQVLAGTDIPLGIIPAGTGNDHAREFGLPTKNPKAAADIVVDGWTETIDLGRIQDDNGIEKWFGTVAATGFDSLVNDRANRMRWPHGRMRYYIAMLAELSRLRPLPFRLVLDGTEEIVADLTLADFGNTRSYGGGLLICPNADHSDGLLDITMAQSDSRTKLLRLFPTIFKGAHVELDEVSTTRAKTVHVECPGINVYADGDFACPLPAEISAVPAALQVLRPRHG,"32,805",309,Diacylglycerol/lipid kinase family,glycolipid biosynthetic process [GO:0009247]; phospholipid biosynthetic process [GO:0008654],ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WPS9,CTPF_MYCTU,Rv1997,ctpF Rv1997 MTCY39.21c MTCY39.22c,GO:0005388; GO:0005524; GO:0005618; GO:0005886; GO:0005887; GO:0043231; GO:0046872,IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR001757; ,,ctpF,,Probable cation-transporting ATPase F (EC 3.6.3.-),cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],9634230; 11416222; 12953092; 18474359; 18400743; 19553548; 21969609,,,MSASVSATTAHHGLPAHEVVLLLESDPYHGLSDGEAAQRLERFGPNTLAVVTRASLLARILRQFHHPLIYVLLVAGTITAGLKEFVDAAVIFGVVVINAIVGFIQESKAEAALQGLRSMVHTHAKVVREGHEHTMPSEELVPGDLVLLAAGDKVPADLRLVRQTGLSVNESALTGESTPVHKDEVALPEGTPVADRRNIAYSGTLVTAGHGAGIVVATGAETELGEIHRLVGAAEVVATPLTAKLAWFSKFLTIAILGLAALTFGVGLLRRQDAVETFTAAIALAVGAIPEGLPTAVTITLAIGMARMAKRRAVIRRLPAVETLGSTTVICADKTGTLTENQMTVQSIWTPHGEIRATGTGYAPDVLLCDTDDAPVPVNANAALRWSLLAGACSNDAALVRDGTRWQIVGDPTEGAMLVVAAKAGFNPERLATTLPQVAAIPFSSERQYMATLHRDGTDHVVLAKGAVERMLDLCGTEMGADGALRPLDRATVLRATEMLTSRGLRVLATGMGAGAGTPDDFDENVIPGSLALTGLQAMSDPPRAAAASAVAACHSAGIAVKMITGDHAGTATAIATEVGLLDNTEPAAGSVLTGAELAALSADQYPEAVDTASVFARVSPEQKLRLVQALQARGHVVAMTGDGVNDAPALRQANIGVAMGRGGTEVAKDAADMVLTDDDFATIEAAVEEGRGVFDNLTKFITWTLPTNLGEGLVILAAIAVGVALPILPTQILWINMTTAIALGLMLAFEPKEAGIMTRPPRDPDQPLLTGWLVRRTLLVSTLLVASAWWLFAWELDNGAGLHEARTAALNLFVVVEAFYLFSCRSLTRSAWRLGMFANRWIILGVSAQAIAQFAITYLPAMNMVFDTAPIDIGVWVRIFAVATAITIVVATDTLLPRIRAQPP,"95,033",905,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IIA subfamily",,ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],,MTCY39.21c MTCY39.22c,1
P9WPS7,CTPG_MYCTU,Rv1992c,ctpG Rv1992c MTCY39.27,GO:0005524; GO:0005886; GO:0005887; GO:0019829; GO:0046688; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR027256; IPR001757; ,,ctpG,,Probable cation-transporting ATPase G (EC 3.6.3.-),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872]; response to copper ion [GO:0046688],9634230; 21969609,,,MTTVVDAEVQLTVVSDAAGRMRVQATGFQFDAGRAVAIEDTVGKVAGVQAVHAYPRTASIVIWYSRAICDTAAILSAIIDAETVPAAAVPAYASRSASNRKAGVVQKIIDWSTRTLSGVRRDVAAQPSGETSDACCDGEDNEDREPEQLWQVAKLRRAAFSGVLLTASLVAAWAYPLWPVVLGLKALALAVGASTFVPSSLKRLAEGRVGVGTLMTIAALGAVALGELGEAATLAFLFSISEGLEEYATARTRRGLRALLSLVPDQATVLREGTETIVASTELHVGDQMIVKPGERLATDGIIRAGRTALDVSAITGESVPVEVGPGDEVFAGSINGLGVLQVGVTATAANNSLARIVHIVEAEQVRKGASQRLADCIARPLVPSIMIAAALIAGTGSVLGNPLVWIERALVVLVAAAPCALAIAVPVTVVASIGAASRLGVLIKGGAALETLGTIRAVALDKTGTLTANRPVVIDVATTNGATREEVLAVAAALEARSEHPLAVAVLAATQATTAASDVQAVPGAGLIGRLDGRVVRLGRPGWLDAAELADHVACMQQAGATAVLVERDQQLLGAIAVRDELRPEAAEVVAGLRTGGYQVTMLTGDNHATAAALAAQAGIEQVHAELRPEDKAHLVAQLRARQPTAMVGDGVNDAPALAAADLGIAMGAMGTDVAIETADVALMGQDLRHLPQALDHARRSRQIMVQNVGLSLSIITVLMPLALFGILGLAAVVLVHEFTEVIVIANGVRAGRIKPLAGPPKTPDRTIPG,"79,309",771,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",response to copper ion [GO:0046688],ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY39.27,1
P9WP69,COX2_MYCTU,Rv2200c,ctaC Rv2200c MTCY190.11c,GO:0004129; GO:0005507; GO:0005576; GO:0005886; GO:0005887; GO:0009319; GO:0040007; GO:0042773; GO:0044121; GO:0070469,IPR002429; IPR001505; IPR008972; IPR036257; ,,ctaC,,Cytochrome c oxidase subunit 2 (EC 1.9.3.1) (Cytochrome aa3 subunit 2) (Cytochrome c oxidase polypeptide II) (Mtb92),cytochrome o ubiquinol oxidase complex [GO:0009319]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469]; copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129]; ATP synthesis coupled electron transport [GO:0042773]; growth [GO:0040007]; growth of symbiont in host organelle [GO:0044121],10436930; 9634230; 19099550; 21969609,,FUNCTION: Subunits I and II form the functional core of the enzyme complex. Electrons originating in cytochrome c are transferred via heme a and Cu(A) to the binuclear center formed by heme a3 and Cu(B) (By similarity). {ECO:0000250}.,MTPRGPGRLQRLSQCRPQRGSGGPARGLRQLALAAMLGALAVTVSGCSWSEALGIGWPEGITPEAHLNRELWIGAVIASLAVGVIVWGLIFWSAVFHRKKNTDTELPRQFGYNMPLELVLTVIPFLIISVLFYFTVVVQEKMLQIAKDPEVVIDITSFQWNWKFGYQRVNFKDGTLTYDGADPERKRAMVSKPEGKDKYGEELVGPVRGLNTEDRTYLNFDKVETLGTSTEIPVLVLPSGKRIEFQMASADVIHAFWVPEFLFKRDVMPNPVANNSVNVFQIEEITKTGAFVGHCAEMCGTYHSMMNFEVRVVTPNDFKAYLQQRIDGKTNAEALRAINQPPLAVTTHPFDTRRGELAPQPVG,"40,480",363,Cytochrome c oxidase subunit 2 family,ATP synthesis coupled electron transport [GO:0042773]; growth [GO:0040007]; growth of symbiont in host organelle [GO:0044121],copper ion binding [GO:0005507]; cytochrome-c oxidase activity [GO:0004129],cytochrome o ubiquinol oxidase complex [GO:0009319]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469],,MTCY190.11c,1
P9WGA9,COBL_MYCTU,Rv2072c,cobL Rv2072c MTCY49.11c,GO:0005618; GO:0008276; GO:0009236; GO:0046025,IPR000878; IPR035996; IPR014777; IPR012818; IPR006365; IPR014008; IPR029063; ,,cobL,,"Precorrin-6Y C(5,15)-methyltransferase [decarboxylating] (Precorrin-6 methyltransferase) (Precorrin-6Y methylase) (EC 2.1.1.132)","cell wall [GO:0005618]; precorrin-6Y C5,15-methyltransferase (decarboxylating) activity [GO:0046025]; protein methyltransferase activity [GO:0008276]; cobalamin biosynthetic process [GO:0009236]",9634230; 21969609,,FUNCTION: Catalyzes the methylation of both C-5 and C-15 in precorrin-6Y to form precorrin-8X. {ECO:0000250}.,MIIVVGIGADGMTGLSEHSRSELRRATVIYGSKRQLALLDDTVTAERWEWPTPMLPAVQGLSPDGADLHVVASGDPLLHGIGSTLIRLFGHDNVTVLPHVSAVTLACARMGWNVYDTEVISLVTAQPHTAVRRGGRAIVLSGDRSTPQALAVLLTEHGRGDSKFSVLEQLGGPAERRRDGTARAWACDPPLDVDELNVIAVRYLLDERTSWAPDEAFAHDGQITKHPIRVLTLAALAPRPGQRLWDVGAGSGAIAVQWCRSWPGCTAVAFERDERRRRNIGFNAAAFGVSVDVRGDAPDAFDDAARPSVIFLGGGVTQPGLLEACLDSLPAGGNLVANAVTVESEAALAHAYSRLGGELRRFQHYLGEPLGGFTGWRPQLPVTQWSVTKR,"41,854",390,Precorrin methyltransferase family,cobalamin biosynthetic process [GO:0009236],"precorrin-6Y C5,15-methyltransferase (decarboxylating) activity [GO:0046025]; protein methyltransferase activity [GO:0008276]",cell wall [GO:0005618],,MTCY49.11c,1
P9WPP7,CP121_MYCTU,Rv2276,cyp121 Rv2276 MTCY339.34c,GO:0004497; GO:0005506; GO:0005737; GO:0009975; GO:0016125; GO:0016491; GO:0020037; GO:0040007; GO:0046996; GO:0055114; GO:0070025,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp121,,Mycocyclosin synthase (EC 1.14.21.9) (Cytochrome P450 121) (Cytochrome P450 MT2),"cytoplasm [GO:0005737]; carbon monoxide binding [GO:0070025]; cyclase activity [GO:0009975]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated [GO:0046996]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]; sterol metabolic process [GO:0016125]",9634230; 12237220; 11914502; 19099550; 21969609; 12435731; 17028183; 18818197; 19416919; 22890978; 23620594,X-ray crystallography (31),"FUNCTION: Catalyzes C-C bond formation between the carbons ortho to the phenolic hydroxyl of cyclo(L-tyr-L-tyr) (cYY) producing mycocyclosin. Can also use cyclo(L-Tyr-L-Phe) (cYF), cyclo(L-Tyr-L-Trp) (cYW) and cyclo(L-Tyr-L-3,4-dihydroxyphenylalanine) (cY-DOPA) as substrate. {ECO:0000269|PubMed:12237220, ECO:0000269|PubMed:19416919, ECO:0000269|Ref.2}.",MTATVLLEVPFSARGDRIPDAVAELRTREPIRKVRTITGAEAWLVSSYALCTQVLEDRRFSMKETAAAGAPRLNALTVPPEVVNNMGNIADAGLRKAVMKAITPKAPGLEQFLRDTANSLLDNLITEGAPADLRNDFADPLATALHCKVLGIPQEDGPKLFRSLSIAFMSSADPIPAAKINWDRDIEYMAGILENPNITTGLMGELSRLRKDPAYSHVSDELFATIGVTFFGAGVISTGSFLTTALISLIQRPQLRNLLHEKPELIPAGVEELLRINLSFADGLPRLATADIQVGDVLVRKGELVLVLLEGANFDPEHFPNPGSIELDRPNPTSHLAFGRGQHFCPGSALGRRHAQIGIEALLKKMPGVDLAVPIDQLVWRTRFQRRIPERLPVLW,"43,256",396,Cytochrome P450 family,growth [GO:0040007]; oxidation-reduction process [GO:0055114]; sterol metabolic process [GO:0016125],"carbon monoxide binding [GO:0070025]; cyclase activity [GO:0009975]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated [GO:0046996]",cytoplasm [GO:0005737],,MTCY339.34c,1
P9WPN7,CP128_MYCTU,Rv2268c,cyp128 Rv2268c MTCY339.42,GO:0004497; GO:0005506; GO:0005886; GO:0016021; GO:0016125; GO:0016491; GO:0016705; GO:0020037; GO:0040007,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp128,,Putative cytochrome P450 128 (EC 1.14.-.-),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; growth [GO:0040007]; sterol metabolic process [GO:0016125]",9634230,,,MTATQSPPEPAPDRVRLAGCPLAGTPDVGLTAQDATTALGVPTRRRASSGGIPVATSMWRDAQTVRTYGPAVAKALALRVAGKARSRLTGRHCRKFMQLTDFDPFDPAIAADPYPHYRELLAGERVQYNPKRDVYILSRYADVREAARNHDTLSSARGVTFSRGWLPFLPTSDPPAHTRMRKQLAPGMARGALETWRPMVDQLARELVGGLLTQTPADVVSTVAAPMPMRAITSVLGVDGPDEAAFCRLSNQAVRITDVALSASGLISLVQGFAGFRRLRALFTHRRDNGLLRECTVLGKLATHAEQGRLSDDELFFFAVLLLVAGYESTAHMISTLFLTLADYPDQLTLLAQQPDLIPSAIEEHLRFISPIQNICRTTRVDYSVGQAVIPAGSLVLLAWGAANRDPRQYEDPDVFRADRNPVGHLAFGSGIHLCPGTQLARMEGQAILREIVANIDRIEVVEPPTWTTNANLRGLTRLRVAVTPRVAP,"53,313",489,Cytochrome P450 family,growth [GO:0040007]; sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY339.42,1
P9WP89,COBK_MYCTU,Rv2070c,cobK Rv2070c MTCY49.09c,GO:0009236; GO:0016994,IPR003723; ,,cobK,,Precorrin-6A reductase (EC 1.3.1.54) (Precorrin-6X reductase),precorrin-6A reductase activity [GO:0016994]; cobalamin biosynthetic process [GO:0009236],9634230; 21969609,,FUNCTION: Catalyzes the reduction of the macrocycle of precorrin-6X into precorrin-6Y. {ECO:0000250}.,MTRVLLLGGTAEGRALAKELHPHVEIVSSLAGRVPNPALPIGPVRIGGFGGVEGLRGWLREERIDAVVDATHPFAVTITAHAAQVCGELGLPYLVLARPPWDPGTAIIAVSDIEAADVVAEQGYSRVFLTTGRSGIAAFANSDAWFLIRVVTAPDGTALPRRHKLVLSRGPYGYHDEFALLREQRIDALVTKNSGGKMTRAKLDAAAALGISVVMIARPLLPAGVAAVDSVHRAAMWVAGLPSR,"25,737",244,Precorrin-6x reductase family,cobalamin biosynthetic process [GO:0009236],precorrin-6A reductase activity [GO:0016994],,,MTCY49.09c,1
P9WP91,COBS_MYCTU,Rv2208,cobS Rv2208 MTCY190.19,GO:0005886; GO:0008818; GO:0009236; GO:0016021; GO:0051073,IPR003805; ,,cobS,,Adenosylcobinamide-GDP ribazoletransferase (EC 2.7.8.26) (Cobalamin synthase) (Cobalamin-5'-phosphate synthase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenosylcobinamide-GDP ribazoletransferase activity [GO:0051073]; cobalamin 5'-phosphate synthase activity [GO:0008818]; cobalamin biosynthetic process [GO:0009236],9634230,,FUNCTION: Joins adenosylcobinamide-GDP and alpha-ribazole to generate adenosylcobalamin (Ado-cobalamin). Also synthesizes adenosylcobalamin 5'-phosphate from adenosylcobinamide-GDP and alpha-ribazole 5'-phosphate (By similarity). {ECO:0000250}.,MMRSLATAFAFATVIPTPGSATTPMGRGPMTALPVVGAALGALAAAIAWAGAQVFGPSSPLSGMLTVAVLLVVTRGLHIDGVADTADGLGCYGPPQRALAVMRDGSTGPFGVAAVVLVIALQGLAFATLTTVGIAGITLAVLSGRVTAVLVCRRLVPAAHGSTLGSRVAGTQPAPVVAAWLAVLLAVSVPAGPRPWQGPIAVLVAVTAGAALAAHCVHRFGGVTGDVLGSAIELSTTVSAVTLAGLARL,"24,346",249,CobS family,cobalamin biosynthetic process [GO:0009236],adenosylcobinamide-GDP ribazoletransferase activity [GO:0051073]; cobalamin 5'-phosphate synthase activity [GO:0008818],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.19,1
P9WP43,CUT1_MYCTU,Rv1984c,Rv1984c MTCY39.35,GO:0005576; GO:0005618; GO:0019626; GO:0034338; GO:0047372; GO:0051793; GO:0052651; GO:0052689,IPR029058; IPR000675; IPR011150; ,,,,Probable cutinase Rv1984c (EC 3.1.1.74),cell wall [GO:0005618]; extracellular region [GO:0005576]; acylglycerol lipase activity [GO:0047372]; carboxylic ester hydrolase activity [GO:0052689]; short-chain carboxylesterase activity [GO:0034338]; medium-chain fatty acid catabolic process [GO:0051793]; monoacylglycerol catabolic process [GO:0052651]; short-chain fatty acid catabolic process [GO:0019626],9634230; 21969609,,,MTPRSLVRIVGVVVATTLALVSAPAGGRAAHADPCSDIAVVFARGTHQASGLGDVGEAFVDSLTSQVGGRSIGVYAVNYPASDDYRASASNGSDDASAHIQRTVASCPNTRIVLGGYSQGATVIDLSTSAMPPAVADHVAAVALFGEPSSGFSSMLWGGGSLPTIGPLYSSKTINLCAPDDPICTGGGNIMAHVSYVQSGMTSQAATFAANRLDHAG,"21,782",217,Cutinase family,medium-chain fatty acid catabolic process [GO:0051793]; monoacylglycerol catabolic process [GO:0052651]; short-chain fatty acid catabolic process [GO:0019626],acylglycerol lipase activity [GO:0047372]; carboxylic ester hydrolase activity [GO:0052689]; short-chain carboxylesterase activity [GO:0034338],cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY39.35,1
P9WMI9,CMTR_MYCTU,Rv1994c,cmtR Rv1994c MTCY39.25,GO:0003677; GO:0003700; GO:0006351; GO:0010288; GO:0010468; GO:0032791; GO:0046686; GO:0046870; GO:0097063,IPR011991; IPR001845; IPR036388; IPR036390; ,,cmtR,DOMAIN 3 97 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,HTH-type transcriptional regulator CmtR,"cadmium ion binding [GO:0046870]; cadmium ion sensor activity [GO:0097063]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; lead ion binding [GO:0032791]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; transcription, DNA-templated [GO:0006351]",9634230; 12939264; 15966722; 21969609; 17599915,NMR spectroscopy (1),"FUNCTION: Metal-responsive transcriptional repressor for the cmt operon. Binding of cadmium or lead causes the repressor to dissociate from the DNA. {ECO:0000269|PubMed:12939264, ECO:0000269|PubMed:15966722}.",MLTCEMRESALARLGRALADPTRCRILVALLDGVCYPGQLAAHLGLTRSNVSNHLSCLRGCGLVVATYEGRQVRYALADSHLARALGELVQVVLAVDTDQPCVAERAASGEAVEMTGS,"12,495",118,,"regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to lead ion [GO:0010288]; transcription, DNA-templated [GO:0006351]",cadmium ion binding [GO:0046870]; cadmium ion sensor activity [GO:0097063]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; lead ion binding [GO:0032791],,,MTCY39.25,1
P9WP45,COX4_MYCTU,Rv2199c,ctaF Rv2199c MTCY190.10c,GO:0004129; GO:0005886; GO:0016021,IPR021050; ,,ctaF,,Probable cytochrome c oxidase polypeptide 4 (EC 1.9.3.1) (Cytochrome aa3 subunit 4) (Cytochrome c oxidase polypeptide IV),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytochrome-c oxidase activity [GO:0004129],9634230,,"FUNCTION: Part of cytochrome c oxidase, its function is unknown. {ECO:0000250}.",MHIEARLFEFVAAFFVVTAVLYGVLTSMFATGGVEWAGTTALALTGGMALIVATFFRFVARRLDSRPEDYEGAEISDGAGELGFFSPHSWWPIMVALSGSVAAVGIALWLPWLIAAGVAFILASAAGLVFEYYVGPEKH,"14,865",139,Cytochrome c oxidase bacterial subunit CtaF family,,cytochrome-c oxidase activity [GO:0004129],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY190.10c,1
P9WPP3,CP124_MYCTU,Rv2266,cyp124 Rv2266 MTCY339.44c,GO:0005506; GO:0006707; GO:0010430; GO:0020037; GO:0031073; GO:0036199; GO:0070402; GO:0097089,IPR001128; IPR002397; IPR036396; ,,cyp124,,Methyl-branched lipid omega-hydroxylase (EC 1.14.15.14) (Cholest-4-en-3-one C26-monooxygenase) (Cholest-4-en-3-one C26-monooxygenase [(25R)-3-oxocholest-4-en-26-oate forming]) (Cholesterol C26-monooxygenase) (Cholesterol C26-monooxygenase [(25R)-3beta-hydroxycholest-5-en-26-oate forming]) (Cytochrome P450 124) (Steroid C26-monooxygenase) (EC 1.14.13.221) (Steroid C27-monooxygenase),cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; NADPH binding [GO:0070402]; cholesterol catabolic process [GO:0006707]; fatty acid omega-oxidation [GO:0010430]; methyl-branched fatty acid metabolic process [GO:0097089],9634230; 20843794; 19933331,X-ray crystallography (2),"FUNCTION: Primarily hydroxylates the omega-carbon of a number of methyl-branched lipids, including (2E,6E)-farnesol, phytanate, geranylgeraniol, 15-methylpalmitate and (2E,6E)-farnesyl diphosphate (PubMed:19933331). Also catalyzes the sequential oxidation of the terminal methyl of cholest-4-en-3-one into (25R)-26-hydroxycholest-4-en-3-one (alcohol), (25R)-26-oxocholest-4-en-3-one (aldehyde), to finally yield the carboxylic acid (25R)-3-oxocholest-4-en-26-oate (PubMed:20843794). Cyp124 catalyzes preferencially the oxidation of (25R)-26-hydroxycholest-4-en-3-one diastereomer (PubMed:20843794). Also able to sequentially oxidize cholesterol itself, not only cholest-4-en-3-one (PubMed:20843794). {ECO:0000269|PubMed:19933331, ECO:0000269|PubMed:20843794}.",MGLNTAIATRVNGTPPPEVPIADIELGSLDFWALDDDVRDGAFATLRREAPISFWPTIELPGFVAGNGHWALTKYDDVFYASRHPDIFSSYPNITINDQTPELAEYFGSMIVLDDPRHQRLRSIVSRAFTPKVVARIEAAVRDRAHRLVSSMIANNPDRQADLVSELAGPLPLQIICDMMGIPKADHQRIFHWTNVILGFGDPDLATDFDEFMQVSADIGAYATALAEDRRVNHHDDLTSSLVEAEVDGERLSSREIASFFILLVVAGNETTRNAITHGVLALSRYPEQRDRWWSDFDGLAPTAVEEIVRWASPVVYMRRTLTQDIELRGTKMAAGDKVSLWYCSANRDESKFADPWTFDLARNPNPHLGFGGGGAHFCLGANLARREIRVAFDELRRQMPDVVATEEPARLLSQFIHGIKTLPVTWS,"47,825",428,Cytochrome P450 family,cholesterol catabolic process [GO:0006707]; fatty acid omega-oxidation [GO:0010430]; methyl-branched fatty acid metabolic process [GO:0097089],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; NADPH binding [GO:0070402],,,MTCY339.44c,1
P9WN51,GCST_MYCTU,Rv2211c,gcvT Rv2211c MTCY190.22,GO:0004047; GO:0005618; GO:0006546; GO:0008483; GO:0040007,IPR006223; IPR022903; IPR028896; IPR013977; IPR006222; IPR029043; IPR027266; ,,gcvT,,Aminomethyltransferase (EC 2.1.2.10) (Glycine cleavage system T protein),cell wall [GO:0005618]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: The glycine cleavage system catalyzes the degradation of glycine. {ECO:0000255|HAMAP-Rule:MF_00259}.,MSDVPELIHGPLEDRHRELGASFAEFGGWLMPVSYAGTVSEHNATRTAVGLFDVSHLGKALVRGPGAAQFVNSALTNDLGRIGPGKAQYTLCCTESGGVIDDLIAYYVSDDEIFLVPNAANTAAVVGALQAAAPGGLSITNLHRSYAVLAVQGPCSTDVLTALGLPTEMDYMGYADASYSGVPVRVCRTGYTGEHGYELLPPWESAGVVFDALLAAVSAAGGEPAGLGARDTLRTEMGYPLHGHELSLDISPLQARCGWAVGWRKDAFFGRAALLAEKAAGPRRLLRGLRMVGRGVLRPGLAVLVGDETVGVTTSGTFSPTLQVGIGLALIDSDAGIEDGQQINVDVRGRAVECQVVCPPFVAVKTR,"38,318",367,GcvT family,glycine catabolic process [GO:0006546]; growth [GO:0040007],aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483],cell wall [GO:0005618],,MTCY190.22,1
P9WN37,GLN1A_MYCTU,Rv2222c,glnA2 Rv2222c MTCY190.33c MTCY427.03c,GO:0004356; GO:0005524; GO:0005737; GO:0005886; GO:0006542; GO:0046872; GO:0050001,IPR008147; IPR036651; IPR014746; IPR008146; IPR027303; ,,glnA2,,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate--ammonia ligase) (Glutamine synthetase I alpha) (GSI alpha),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; D-glutaminase activity [GO:0050001]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; glutamine biosynthetic process [GO:0006542],9634230; 20066036; 21969609,,"FUNCTION: Glutamine synthetase (GS) is an unusual multitasking protein that functions as an enzyme, a transcription coregulator, and a chaperone in ammonium assimilation and in the regulation of genes involved in nitrogen metabolism. It catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia. Feedback-inhibited GlnA also interacts with and regulates the activity of the transcriptional regulator TnrA. During nitrogen limitation, TnrA is in its DNA-binding active state and turns on the transcription of genes required for nitrogen assimilation. Under conditions of nitrogen excess, feedback-inhibited GlnA forms a stable complex with TnrA, which inhibits its DNA-binding activity. In contrast, feedback-inhibited GlnA acts as a chaperone to stabilize the DNA-binding activity of GlnR, which represses the transcription of nitrogen assimilation genes. {ECO:0000250|UniProtKB:P12425}.",MDRQKEFVLRTLEERDIRFVRLWFTDVLGFLKSVAIAPAELEGAFEEGIGFDGSSIEGFARVSESDTVAHPDPSTFQVLPWATSSGHHHSARMFCDITMPDGSPSWADPRHVLRRQLTKAGELGFSCYVHPEIEFFLLKPGPEDGSVPVPVDNAGYFDQAVHDSALNFRRHAIDALEFMGISVEFSHHEGAPGQQEIDLRFADALSMADNVMTFRYVIKEVALEEGARASFMPKPFGQHPGSAMHTHMSLFEGDVNAFHSADDPLQLSEVGKSFIAGILEHACEISAVTNQWVNSYKRLVQGGEAPTAASWGAANRSALVRVPMYTPHKTSSRRVEVRSPDSACNPYLTFAVLLAAGLRGVEKGYVLGPQAEDNVWDLTPEERRAMGYRELPSSLDSALRAMEASELVAEALGEHVFDFFLRNKRTEWANYRSHVTPYELRTYLSL,"49,608",446,Glutamine synthetase family,glutamine biosynthetic process [GO:0006542],ATP binding [GO:0005524]; D-glutaminase activity [GO:0050001]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY190.33c MTCY427.03c,1
P9WN27,GLNE_MYCTU,Rv2221c,glnE Rv2221c MTCY190.32c MTCY427.02c,GO:0000820; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0008152; GO:0008882; GO:0040007; GO:0047388; GO:0060359,IPR023057; IPR005190; IPR013546; ,,glnE,,Bifunctional glutamine synthetase adenylyltransferase/adenylyl-removing enzyme (ATP:glutamine synthetase adenylyltransferase) (ATase) [Includes: Glutamine synthetase adenylyl-L-tyrosine phosphorylase (EC 2.7.7.89) (Adenylyl removase) (AR) (AT-N); Glutamine synthetase adenylyl transferase (EC 2.7.7.42) (Adenylyl transferase) (AT) (AT-C)],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; [glutamate-ammonia-ligase] adenylyltransferase activity [GO:0008882]; [glutamine synthetase]-adenylyl-L-tyrosine phosphorylase [GO:0047388]; ATP binding [GO:0005524]; growth [GO:0040007]; metabolic process [GO:0008152]; regulation of glutamine family amino acid metabolic process [GO:0000820]; response to ammonium ion [GO:0060359],9634230; 19099550; 21969609,,"FUNCTION: Involved in the regulation of glutamine synthetase GlnA, a key enzyme in the process to assimilate ammonia. When cellular nitrogen levels are high, the C-terminal adenylyl transferase (AT) inactivates GlnA by covalent transfer of an adenylyl group from ATP to specific tyrosine residue of GlnA, thus reducing its activity. Conversely, when nitrogen levels are low, the N-terminal adenylyl removase (AR) activates GlnA by removing the adenylyl group by phosphorolysis, increasing its activity. The regulatory region of GlnE binds the signal transduction protein PII (GlnB) which indicates the nitrogen status of the cell. {ECO:0000255|HAMAP-Rule:MF_00802}.",MVVTKLATQRPKLPSVGRLGLVDPPAGERLAQLGWDRHEDQAHVDLLWSLSRAPDADAALRALIRLSENPDTGWDELNAALLRERSLRGRLFSVLGSSLALGDHLVAHPQSWKLLRGKVTLPSHDQLQRSFVECVEESEGMPGSLVHRLRTQYRDYVLMLAALDLAATVEDEPVLPFTVVAARLADAADAALAAALRVAEASVCGEHPPPRLAVIAMGKCGARELNYVSDVDVIFVAERSDPRNARVASEMMRVASAAFFEVDAALRPEGRNGELVRTLESHIAYYQRWAKTWEFQALLKARPVVGDAELGERYLTALMPMVWRACEREDFVVEVQAMRRRVEQLVPADVRGRELKLGSGGLRDVEFAVQLLQLVHARSDESLRVASTVDALAALGEGGYIGREDAANMTASYEFLRLLEHRLQLQRLKRTHLLPDPEDEEAVRWLARAAHIRPDGRNDAAGVLREELKKQNVRVSKLHTKLFYQPLLESIGPTGLEIAHGMTLEAAGRRLAALGYEGPQTALKHMSALVNQSGRRGRVQSVLLPRLLDWMSYAPDPDGGLLAYRRLSEALATESWYLATLRDKPAVAKRLMHVLGTSAYVPDLLMRAPRVIQQYEDGPAGPKLLETEPAAVARALIASASRYPDPERAIAGARTLRRRELARIGSADLLGLLEVTEVCRALTSVWVAVLQAALDVMIRASLPDDDRAPAAIAVIGMGRLGGAELGYGSDADVMFVCEPATGVDDARAVKWSTSIAERVRALLGTPSVDPPLELDANLRPEGRNGPLVRTLGSYAAYYEQWAQPWEIQALLRAHAVAGDAELGQRFLRMVDKTRYPPDGVSADSVREIRRIKARIESERLPRGADPNTHTKLGRGGLADIEWTVQLLQLQHAHQVPALHNTSTLQSLDVIAAADLVPAADVELLRQAWLTATRARNALVLVRGKPTDQLPGPGRQLNAVAVAAGWRNDDGGEFLDNYLRVTRRAKAVVRKVFGS,"109,138",994,GlnE family,growth [GO:0040007]; metabolic process [GO:0008152]; regulation of glutamine family amino acid metabolic process [GO:0000820]; response to ammonium ion [GO:0060359],[glutamate-ammonia-ligase] adenylyltransferase activity [GO:0008882]; [glutamine synthetase]-adenylyl-L-tyrosine phosphorylase [GO:0047388]; ATP binding [GO:0005524],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY190.32c MTCY427.02c,1
P9WN95,FTSZ_MYCTU,Rv2150c,ftsZ Rv2150c MTCY270.18,GO:0000287; GO:0000921; GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0007049; GO:0032153; GO:0040007; GO:0045787; GO:0051258; GO:0051301,IPR000158; IPR020805; IPR024757; IPR008280; IPR018316; IPR037103; IPR036525; IPR003008; ,P9WP57,ftsZ,,Cell division protein FtsZ,cell division site [GO:0032153]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007]; positive regulation of cell cycle [GO:0045787]; protein polymerization [GO:0051258]; septin ring assembly [GO:0000921],9634230; 20066037; 21969609; 15342249; 18479968; 23888039,X-ray crystallography (7),FUNCTION: Essential cell division protein that forms a contractile ring structure (Z ring) at the future cell division site. The regulation of the ring assembly controls the timing and the location of cell division. One of the functions of the FtsZ ring is to recruit other cell division proteins to the septum to produce a new cell wall between the dividing cells. Binds GTP and shows GTPase activity. {ECO:0000255|HAMAP-Rule:MF_00909}.,MTPPHNYLAVIKVVGIGGGGVNAVNRMIEQGLKGVEFIAINTDAQALLMSDADVKLDVGRDSTRGLGAGADPEVGRKAAEDAKDEIEELLRGADMVFVTAGEGGGTGTGGAPVVASIARKLGALTVGVVTRPFSFEGKRRSNQAENGIAALRESCDTLIVIPNDRLLQMGDAAVSLMDAFRSADEVLLNGVQGITDLITTPGLINVDFADVKGIMSGAGTALMGIGSARGEGRSLKAAEIAINSPLLEASMEGAQGVLMSIAGGSDLGLFEINEAASLVQDAAHPDANIIFGTVIDDSLGDEVRVTVIAAGFDVSGPGRKPVMGETGGAHRIESAKAGKLTSTLFEPVDAVSVPLHTNGATLSIGGDDDDVDVPPFMRR,"38,756",379,FtsZ family,cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007]; positive regulation of cell cycle [GO:0045787]; protein polymerization [GO:0051258]; septin ring assembly [GO:0000921],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287],cell division site [GO:0032153]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY270.18,1
P9WNA1,FTSQ_MYCTU,Rv2151c,ftsQ Rv2151c MTCY270.17,GO:0005829; GO:0005887; GO:0040007; GO:0090529,IPR005548; IPR026579; IPR034746; IPR013685; ,,ftsQ,DOMAIN 124 192 POTRA. {ECO:0000255|PROSITE-ProRule:PRU01115}.,Cell division protein FtsQ,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; cell septum assembly [GO:0090529]; growth [GO:0040007],9634230; 20066037; 21969609,,FUNCTION: Essential cell division protein. {ECO:0000255|HAMAP-Rule:MF_00911}.,MTEHNEDPQIERVADDAADEEAVTEPLATESKDEPAEHPEFEGPRRRARRERAERRAAQARATAIEQARRAAKRRARGQIVSEQNPAKPAARGVVRGLKALLATVVLAVVGIGLGLALYFTPAMSAREIVIIGIGAVSREEVLDAARVRPATPLLQIDTQQVADRVATIRRVASARVQRQYPSALRITIVERVPVVVKDFSDGPHLFDRDGVDFATDPPPPALPYFDVDNPGPSDPTTKAALQVLTALHPEVASQVGRIAAPSVASITLTLADGRVVIWGTTDRCEEKAEKLAALLTQPGRTYDVSSPDLPTVK,"33,934",314,"FtsQ/DivIB family, FtsQ subfamily",cell septum assembly [GO:0090529]; growth [GO:0040007],,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887],,MTCY270.17,1
P9WNU9,DOP_MYCTU,Rv2112c,dop pafD Rv2112c,GO:0005524; GO:0008233; GO:0009405; GO:0010498; GO:0016811; GO:0019941; GO:0046872; GO:0070490,IPR022366; IPR004347; ,,dop,,Pup deamidase/depupylase (EC 3.4.-.-) (EC 3.5.1.119) (Deamidase of protein Pup),"ATP binding [GO:0005524]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490]",9634230; 19448618; 20705495; 20636328; 21969609,,"FUNCTION: Specifically catalyzes the deamidation of the C-terminal glutamine of the prokaryotic ubiquitin-like protein Pup to glutamate, thereby rendering Pup competent for conjugation. Also displays depupylase (DPUP) activity, removing conjugated Pup from target proteins; is thus involved in the recycling of Pup and may function similarly to deubiquitinases (DUBs) in eukaryotes to prevent or promote proteasomal degradation of certain proteins. {ECO:0000269|PubMed:19448618, ECO:0000269|PubMed:20636328, ECO:0000269|PubMed:20705495}.",MQRIIGTEVEYGISSPSDPTANPILTSTQAVLAYAAAAGIQRAKRTRWDYEVESPLRDARGFDLSRSAGPPPVVDADEVGAANMILTNGARLYVDHAHPEYSAPECTDPLDAVIWDKAGERVMEAAARHVASVPGAAKLQLYKNNVDGKGASYGSHENYLMSRQTPFSAIITGLTPFLVSRQVVTGSGRVGIGPSGDEPGFQLSQRSDYIEVEVGLETTLKRGIINTRDEPHADADRYRRLHVIIGDANLAETSTYLKLGTTALVLDLIEEGPAHAIDLTDLALARPVHAVHAISRDPSLRATVALADGRELTGLALQRIYLDRVAKLVDSRDPDPRAADIVETWAHVLDQLERDPMDCAELLDWPAKLRLLDGFRQRENLSWSAPRLHLVDLQYSDVRLDKGLYNRLVARGSMKRLVTEHQVLSAVENPPTDTRAYFRGECLRRFGADIAAASWDSVIFDLGGDSLVRIPTLEPLRGSKAHVGALLDSVDSAVELVEQLTAEPR,"55,179",505,"Pup ligase/Pup deamidase family, Pup deamidase subfamily",modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; protein pupylation [GO:0070490],"ATP binding [GO:0005524]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]",,pafD,,1
P9WGK1,DOST_MYCTU,Rv2027c,dosT Rv2027c,GO:0000155; GO:0000287; GO:0004672; GO:0004673; GO:0005509; GO:0005524; GO:0005737; GO:0016021; GO:0019825; GO:0019826; GO:0020037; GO:0046777; GO:0046983; GO:0070025; GO:0070026; GO:0070483,IPR027035; IPR003018; IPR029016; IPR003594; IPR036890; IPR011712; ,,dosT,DOMAIN 61 198 GAF 1.; DOMAIN 229 366 GAF 2.; DOMAIN 380 573 Histidine kinase. {ECO:0000305}.,Oxygen sensor histidine kinase response regulator DosT (EC 2.7.13.3),cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbon monoxide binding [GO:0070025]; heme binding [GO:0020037]; magnesium ion binding [GO:0000287]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; phosphorelay sensor kinase activity [GO:0000155]; protein dimerization activity [GO:0046983]; protein histidine kinase activity [GO:0004673]; protein kinase activity [GO:0004672]; detection of hypoxia [GO:0070483]; protein autophosphorylation [GO:0046777],9634230; 15135056; 15033981; 17609369; 17600145; 18474359; 18400743; 19487478; 21536032; 21969609; 28977726; 25002970; 18980385; 23486471,X-ray crystallography (2),"FUNCTION: Interacts with the two-component regulatory system DevR/DevS (DosR/DosS) involved in onset of the dormancy response. Required for full induction of the DevR (DosR) regulon; required during early adaptation to anaerobiosis, to start induction of the DevR regulon (PubMed:19487478). May act as a direct hypoxia/oxygen sensor (PubMed:17609369, PubMed:17600145, PubMed:28977726). O(2) acts as a switch, with the Fe(2+)-O(2)-bound protein inactive in autophosphorylation (PubMed:17600145). Autophosphorylates under anaerobic but not aerobic conditions, binding of NO or CO has no effect on autophosphorylation (PubMed:17600145). Binds a number of gases; O(2), NO, CO (PubMed:17609369, PubMed:17600145). May be a secondary sensor for CO (PubMed:18400743). Donates a phosphate group to transcriptional regulator DevR (DosR) (PubMed:15135056, PubMed:15033981, PubMed:28977726). {ECO:0000269|PubMed:15033981, ECO:0000269|PubMed:15135056, ECO:0000269|PubMed:17600145, ECO:0000269|PubMed:17609369, ECO:0000269|PubMed:18400743, ECO:0000269|PubMed:18474359, ECO:0000269|PubMed:19487478, ECO:0000269|PubMed:28977726}.",MTHPDRANVNPGSPPLRETLSQLRLRELLLEVQDRIEQIVEGRDRLDGLIDAILAITSGLKLDATLRAIVHTAAELVDARYGALGVRGYDHRLVEFVYEGIDEETRHLIGSLPEGRGVLGALIEEPKPIRLDDISRHPASVGFPLHHPPMRTFLGVPVRIRDEVFGNLYLTEKADGQPFSDDDEVLVQALAAAAGIAVDNARLFEESRTREAWIEATRDIGTQMLAGADPAMVFRLIAEEALTLMAGAATLVAVPLDDEAPACEVDDLVIVEVAGEISPAVKQMTVAVSGTSIGGVFHDRTPRRFDRLDLAVDGPVEPGPALVLPLRAADTVAGVLVALRSADEQPFSDKQLDMMAAFADQAALAWRLATAQRQMREVEILTDRDRIARDLHDHVIQRLFAVGLTLQGAAPRARVPAVRESIYSSIDDLQEIIQEIRSAIFDLHAGPSRATGLRHRLDKVIDQLAIPALHTTVQYTGPLSVVDTVLANHAEAVLREAVSNAVRHANATSLAINVSVEDDVRVEVVDDGVGISGDITESGLRNLRQRADDAGGEFTVENMPTGGTLLRWSAPLR,"62,169",573,,detection of hypoxia [GO:0070483]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; carbon monoxide binding [GO:0070025]; heme binding [GO:0020037]; magnesium ion binding [GO:0000287]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; phosphorelay sensor kinase activity [GO:0000155]; protein dimerization activity [GO:0046983]; protein histidine kinase activity [GO:0004673]; protein kinase activity [GO:0004672],cytoplasm [GO:0005737]; integral component of membrane [GO:0016021],,,1
P9WGS3,EPHD_MYCTU,Rv2214c,ephD Rv2214c MTCY190.25c,GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0016491,IPR029058; IPR000073; IPR036291; IPR020904; IPR002347; ,,ephD,DOMAIN 30 286 AB hydrolase-1. {ECO:0000255}.,Probable oxidoreductase EphD (EC 1.-.-.-),cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MPATQQMSRLVDSPDGVRIAVYHEGNPDGPTVVLVHGFPDSHVLWDGVVPLLAERFRIVRYDNRGVGRSSVPKPISAYTMAHFADDFDAVIGELSPGEPVHVLAHDWGSVGVWEYLRRPGASDRVASFTSVSGPSQDHLVNYVYGGLRRPWRPRTFLRAISQTLRLSYMALFSVPVVAPLLLRVALSSAAVRRNMVGDIPVDQIHHSETLARDAAHSVKTYPANYFRSFSSSRRGRAIPIVDVPVQLIVNSQDPYVRPYGYDQTARWVPRLWRRDIKAGHFSPMSHPQVMAAAVHDFADLADGKQPSRALLRAQVGRPRGYFGDTLVSVTGAGSGIGRETALAFAREGAEIVISDIDEATVKDTAAEIAARGGIAYPYVLDVSDAEAVEAFAERVSAEHGVPDIVVNNAGIGQAGRFLDTPAEQFDRVLAVNLGGVVNGCRAFGQRLVERGTGGHIVNVSSMAAYAPLQSLSAYCTSKAATYMFSDCLRAELDAAGVGLTTICPGVIDTNIVATTGFHAPGTDEEKIDGRRGQIDKMFALRSYGPDKVADAIVSAVKKKKPIRPVAPEAYALYGISRVLPQALRSTARLRVI,"64,030",592,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY190.25c,1
P9WNG5,FABD_MYCTU,Rv2243,fabD Rv2243 MTCY427.24,GO:0004314; GO:0005835; GO:0006633,IPR001227; IPR014043; IPR016035; IPR016036; IPR020801; ,,fabD,,Malonyl CoA-acyl carrier protein transacylase (MCT) (EC 2.3.1.39),fatty acid synthase complex [GO:0005835]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; fatty acid biosynthetic process [GO:0006633],9634230; 17082771; 18832610; 19099550; 20066036; 21969609,X-ray crystallography (2),,MIALLAPGQGSQTEGMLSPWLQLPGAADQIAAWSKAADLDLARLGTTASTEEITDTAVAQPLIVAATLLAHQELARRCVLAGKDVIVAGHSVGEIAAYAIAGVIAADDAVALAATRGAEMAKACATEPTGMSAVLGGDETEVLSRLEQLDLVPANRNAAGQIVAAGRLTALEKLAEDPPAKARVRALGVAGAFHTEFMAPALDGFAAAAANIATADPTATLLSNRDGKPVTSAAAAMDTLVSQLTQPVRWDLCTATLREHTVTAIVEFPPAGTLSGIAKRELRGVPARAVKSPADLDELANL,"30,788",302,FabD family,fatty acid biosynthetic process [GO:0006633],[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314],fatty acid synthase complex [GO:0005835],,MTCY427.24,1
P9WQD9,FAB1_MYCTU,Rv2245,kasA Rv2245 MTCY427.26,GO:0004315; GO:0005618; GO:0005829; GO:0005886; GO:0019367; GO:0030497; GO:0040007; GO:0042802,IPR014031; IPR014030; IPR020841; IPR016039; ,Itself,kasA,,3-oxoacyl-[acyl-carrier-protein] synthase 1 (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase 1) (KAS 1),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; identical protein binding [GO:0042802]; fatty acid elongation [GO:0030497]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",9634230; 21969609; 19604480,X-ray crystallography (5),FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. {ECO:0000250}.,MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY,"43,316",416,Beta-ketoacyl-ACP synthases family,"fatty acid elongation [GO:0030497]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; identical protein binding [GO:0042802],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY427.26,1
P9WNU3,EX53_MYCTU,Rv2090,Rv2090 MTCY49.30,GO:0003677; GO:0004527; GO:0005618,IPR020046; IPR036279; IPR002421; IPR020045; IPR008918; IPR029060; ,,,DOMAIN 194 278 5'-3' exonuclease. {ECO:0000255}.,5'-3' exonuclease (EC 3.1.11.-),cell wall [GO:0005618]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527],9634230; 21969609,,FUNCTION: 5'-3' exonuclease acting preferentially on double-stranded DNA. {ECO:0000250}.,MRSPLVLLDGASMWFRSFFGVPSSITAPDGRPVNAVRGFIDSMAVVITQQRPNRLAVCLDLDWRPQFRVDLIPSYKAHRVAEPEPNGQPDVEEVPDELTPQVDMIMELLDAFGIAMAGAPGFEADDVLGTLATRERRDPVIVVSGDRDLLQVVADDPVPVRVLYLGRGLAKATLFGPAEVAERYGLPAHRAGAAYAELALLRGDPSDGLPGVPGVGEKTAATLLARHGSLDQIMAAADDRKTTMAKGLRTKLLAASAYIKAADRVVRVATDAPVTLSTPTDRFPLVAADPERTAELATRFGVESSIARLQKALDTLPG,"34,023",318,,,DNA binding [GO:0003677]; exonuclease activity [GO:0004527],cell wall [GO:0005618],,MTCY49.30,1
P9WLL7,FBVR_MYCTU,Rv2074,Rv2074 MTCY49.13,GO:0005576; GO:0005618; GO:0009986; GO:0016627; GO:0042803; GO:0055114; GO:0070967,IPR019920; IPR011576; IPR012349; ,,,,F420H(2)-dependent biliverdin reductase (F-BVR) (EC 1.3.98.-),"cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; coenzyme F420 binding [GO:0070967]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; protein homodimerization activity [GO:0042803]; oxidation-reduction process [GO:0055114]",9634230; 20066036; 21969609; 16880544; 27364382,X-ray crystallography (2),"FUNCTION: Catalyzes the F420H(2)-dependent reduction of biliverdin-IXalpha at C10 position, leading to bilirubin-IXalpha, a potent antioxidant. As biliverdin-IXalpha is produced in high amounts in macrophages infected with M.tuberculosis, its reduction by Rv2074 may play a role in protecting mycobacteria against oxidative stress, aiding the persistence of M.tuberculosis infection. {ECO:0000269|PubMed:27364382}.",MAMVNTTTRLSDDALAFLSERHLAMLTTLRADNSPHVVAVGFTFDPKTHIARVITTGGSQKAVNADRSGLAVLSQVDGARWLSLEGRAAVNSDIDAVRDAELRYAQRYRTPRPNPRRVVIEVQIERVLGSADLLDRA,"15,024",137,F420H(2)-dependent biliverdin reductase family,oxidation-reduction process [GO:0055114],"coenzyme F420 binding [GO:0070967]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; protein homodimerization activity [GO:0042803]",cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY49.13,1
P9WNE7,FER_MYCTU,Rv2007c,fdxA Rv2007c MTCY39.10,GO:0001666; GO:0005829; GO:0009055; GO:0046872; GO:0051538; GO:0051539; GO:0052572; GO:0075136,IPR017896; IPR000813; ,,fdxA,DOMAIN 31 60 4Fe-4S ferredoxin-type. {ECO:0000255|PROSITE-ProRule:PRU00711}.,Ferredoxin,"cytosol [GO:0005829]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; response to host [GO:0075136]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666]",9634230; 11416222; 12953092; 17609369; 18474359; 18400743; 21969609,,FUNCTION: Ferredoxins are iron-sulfur proteins that transfer electrons in a wide variety of metabolic reactions. {ECO:0000250}.,MTYVIGSECVDVMDKSCVQECPVDCIYEGARMLYINPDECVDCGACKPACRVEAIYWEGDLPDDQHQHLGDNAAFFHQVLPGRVAPLGSPGGAAAVGPIGVDTPLVAAIPVECP,"12,064",114,,response to host [GO:0075136]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]",cytosol [GO:0005829],,MTCY39.10,1
O53521,FAC15_MYCTU,Rv2187,fadD15 Rv2187,GO:0001676; GO:0004467; GO:0005524; GO:0005618; GO:0005886; GO:0006633; GO:0008610; GO:0071766; GO:0102391,IPR020845; IPR000873; ,,fadD15,,Long-chain-fatty-acid--CoA ligase FadD15 (FACL) (EC 6.2.1.3) (Acyl-CoA synthetase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676],9634230; 15042094; 21969609,,"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-coenzyme A (acyl-CoA), which are then transferred to the multifunctional polyketide synthase (PKS) type III for further chain extension. {ECO:0000269|PubMed:15042094}.",MREISVPAPFTVGEHDNVAAMVFEHERDDPDYVIYQRLIDGVWTDVTCAEAANQIRAAALGLISLGVQAGDRVVIFSATRYEWAILDFAILAVGAVTVPTYETSSAEQVRWVLQDSEAVVLFAETDSHATMVAELSGSVPALREVLQIAGSGPNALDRLTEAGASVDPAELTARLAALRSTDPATLIYTSGTTGRPKGCQLTQSNLVHEIKGARAYHPTLLRKGERLLVFLPLAHVLARAISMAAFHSKVTVGFTSDIKNLLPMLAVFKPTVVVSVPRVFEKVYNTAEQNAANAGKGRIFAIAAQTAVDWSEACDRGGPGLLLRAKHAVFDRLVYRKLRAALGGNCRAAVSGGAPLGARLGHFYRGAGLTIYEGYGLSGTSGGVAISQFNDLKIGTVGKPVPGNSLRIADDGELLVRGGVVFSGYWRNEQATTEAFTDGWFKTGDLGAVDEDGFLTITGRKKEIIVTAGGKNVAPAVLEDQLRAHPLISQAVVVGDAKPFIGALITIDPEAFEGWKQRNSKTAGASVGDLATDPDLIAEIDAAVKQANLAVSHAESIRKFRILPVDFTEDTGELTPTMKVKRKVVAEKFASDIEAIYNKE,"64,035",600,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid metabolic process [GO:0001676],ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
P9WIE3,AHPE_MYCTU,Rv2238c,ahpE Rv2238c MTCY427.19c,GO:0004601; GO:0005829; GO:0045454; GO:0051409; GO:0051920; GO:0052060,IPR000866; IPR024706; IPR036249; IPR013766; ,,ahpE,DOMAIN 2 153 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Alkyl hydroperoxide reductase E (EC 1.11.1.15) (Peroxiredoxin AhpE) (Prx) (Thioredoxin peroxidase) (TPx),cytosol [GO:0005829]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; response to nitrosative stress [GO:0051409],9634230; 19737009; 21969609; 24379404; 15701515; 27471753; 27417938; 27468924,X-ray crystallography (7),"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides. May represent an important antioxidant defense against cytotoxic peroxides, especially peroxynitrite, which can be formed by activated macrophages during infection. {ECO:0000269|PubMed:19737009, ECO:0000269|PubMed:24379404}.",MLNVGATAPDFTLRDQNQQLVTLRGYRGAKNVLLVFFPLAFTGICQGELDQLRDHLPEFENDDSAALAISVGPPPTHKIWATQSGFTFPLLSDFWPHGAVSQAYGVFNEQAGIANRGTFVVDRSGIIRFAEMKQPGEVRDQRLWTDALAALTA,"16,819",153,"Peroxiredoxin family, AhpE subfamily",cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; response to nitrosative stress [GO:0051409],peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cytosol [GO:0005829],,MTCY427.19c,1
P9WQN5,ARC_MYCTU,Rv2115c,mpa Rv2115c MTCY261.11c,GO:0005524; GO:0005618; GO:0005886; GO:0009405; GO:0010498; GO:0010499; GO:0016887; GO:0019941; GO:0022623; GO:0042802; GO:0043335; GO:0051409; GO:0070628; GO:0071732; GO:0140035,IPR003593; IPR003959; IPR003960; IPR027417; IPR032501; IPR022482; ,Itself; P9WHN5,mpa,,Proteasome-associated ATPase (AAA ATPase forming ring-shaped complexes) (ARC) (Mycobacterial proteasome ATPase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; proteasome-activating nucleotidase complex [GO:0022623]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; ubiquitination-like modification-dependent protein binding [GO:0140035]; cellular response to nitric oxide [GO:0071732]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein unfolding [GO:0043335]; response to nitrosative stress [GO:0051409],15659170; 9634230; 14671303; 15626759; 17082771; 18832610; 19580545; 19761766; 19607839; 19448618; 20203624; 20066036; 21969609; 19836337,X-ray crystallography (7),"FUNCTION: ATPase which is responsible for recognizing, binding, unfolding and translocation of pupylated proteins into the bacterial 20S proteasome core particle. May be essential for opening the gate of the 20S proteasome via an interaction with its C-terminus, thereby allowing substrate entry and access to the site of proteolysis. Thus, the C-termini of the proteasomal ATPase may function like a 'key in a lock' to induce gate opening and therefore regulate proteolysis. Is required but not sufficient to confer resistance against the lethal effects of reactive nitrogen intermediates (RNI), antimicrobial molecules produced by activated macrophages and other cell types. {ECO:0000255|HAMAP-Rule:MF_02112, ECO:0000269|PubMed:14671303, ECO:0000269|PubMed:15659170, ECO:0000269|PubMed:17082771, ECO:0000269|PubMed:19836337, ECO:0000269|PubMed:20203624}.",MGESERSEAFGIPRDSPLSSGDAAELEQLRREAAVLREQLENAVGSHAPTRSARDIHQLEARIDSLAARNSKLMETLKEARQQLLALREEVDRLGQPPSGYGVLLATHDDDTVDVFTSGRKMRLTCSPNIDAASLKKGQTVRLNEALTVVEAGTFEAVGEISTLREILADGHRALVVGHADEERVVWLADPLIAEDLPDGLPEALNDDTRPRKLRPGDSLLVDTKAGYAFERIPKAEVEDLVLEEVPDVSYADIGGLSRQIEQIRDAVELPFLHKELYREYSLRPPKGVLLYGPPGCGKTLIAKAVANSLAKKMAEVRGDDAHEAKSYFLNIKGPELLNKFVGETERHIRLIFQRAREKASEGTPVIVFFDEMDSIFRTRGTGVSSDVETTVVPQLLSEIDGVEGLENVIVIGASNREDMIDPAILRPGRLDVKIKIERPDAEAAQDIYSKYLTEFLPVHADDLAEFDGDRSACIKAMIEKVVDRMYAEIDDNRFLEVTYANGDKEVMYFKDFNSGAMIQNVVDRAKKNAIKSVLETGQPGLRIQHLLDSIVDEFAENEDLPNTTNPDDWARISGKKGERIVYIRTLVTGKSSSASRAIDTESNLGQYL,"67,401",609,AAA ATPase family,cellular response to nitric oxide [GO:0071732]; modification-dependent protein catabolic process [GO:0019941]; pathogenesis [GO:0009405]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; protein unfolding [GO:0043335]; response to nitrosative stress [GO:0051409],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome binding [GO:0070628]; ubiquitination-like modification-dependent protein binding [GO:0140035],cell wall [GO:0005618]; plasma membrane [GO:0005886]; proteasome-activating nucleotidase complex [GO:0022623],,MTCY261.11c,1
P9WFF9,UPPP_MYCTU,Rv2136c,uppP bacA upk Rv2136c MTCY270.32,GO:0005886; GO:0008360; GO:0009252; GO:0016021; GO:0016311; GO:0046677; GO:0050380; GO:0051409; GO:0071555,IPR003824; ,,uppP,,Undecaprenyl-diphosphatase (EC 3.6.1.27) (Bacitracin resistance protein) (Undecaprenyl pyrophosphate phosphatase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; undecaprenyl-diphosphatase activity [GO:0050380]; cell wall organization [GO:0071555]; dephosphorylation [GO:0016311]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]; response to nitrosative stress [GO:0051409],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the dephosphorylation of undecaprenyl diphosphate (UPP). Confers resistance to bacitracin. {ECO:0000255|HAMAP-Rule:MF_01006}.,MTAAPAMSWWQVIVLAAAQGLTEFLPVSSSGHLAIVSRIFFSGDAGASFTAVSQLGTEAAVVIYFARDIVRILSAWLHGLVVKAHRNTDYRLGWYVIIGTIPICILGLFFKDDIRSGVRNLWVVVTALVVFSGVIALAEYVGRQSRHIERLTWRDAVVVGIAQTLALVPGVSRSGSTISAGLFLGLDRELAARFGFLLAIPAVFASGLFSLPDAFHPVTEGMSATGPQLLVATLIAFVLGLTAVAWLLRFLVRHNMYWFVGYRVLVGTGMLVLLATGTVAAT,"30,276",282,UppP family,cell wall organization [GO:0071555]; dephosphorylation [GO:0016311]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677]; response to nitrosative stress [GO:0051409],undecaprenyl-diphosphatase activity [GO:0050380],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],bacA upk,MTCY270.32,1
P9WH23,QCRA_MYCTU,Rv2195,qcrA Rv2195 MTCY190.06,GO:0005618; GO:0005886; GO:0005887; GO:0016679; GO:0040007; GO:0046872; GO:0051537; GO:0070469,IPR017941; IPR036922; IPR014349; ,,qcrA,DOMAIN 316 410 Rieske. {ECO:0000255|PROSITE-ProRule:PRU00628}.,Cytochrome bc1 complex Rieske iron-sulfur subunit (Cytochrome bc1 reductase complex subunit QcrA) (Rieske iron-sulfur protein) (Ubiquinol--cytochrome c reductase iron-sulfur subunit),"cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; growth [GO:0040007]",9634230; 19099550; 21969609,,"FUNCTION: Iron-sulfur subunit of the cytochrome bc1 complex, an essential component of the respiratory electron transport chain required for ATP synthesis. The bc1 complex catalyzes the oxidation of menaquinol and the reduction of cytochrome c in the respiratory chain. The bc1 complex operates through a Q-cycle mechanism that couples electron transfer to generation of the proton gradient that drives ATP synthesis. {ECO:0000305}.",MSRADDDAVGVPPTCGGRSDEEERRIVPGPNPQDGAKDGAKATAVPREPDEAALAAMSNQELLALGGKLDGVRIAYKEPRWPVEGTKAEKRAERSVAVWLLLGGVFGLALLLIFLFWPWEFKAADGESDFIYSLTTPLYGLTFGLSILSIAIGAVLYQKRFIPEEISIQERHDGASREIDRKTVVANLTDAFEGSTIRRRKLIGLSFGVGMGAFGLGTLVAFAGGLIKNPWKPVVPTAEGKKAVLWTSGWTPRYQGETIYLARATGTEDGPPFIKMRPEDMDAGGMETVFPWRESDGDGTTVESHHKLQEIAMGIRNPVMLIRIKPSDLGRVVKRKGQESFNFGEFFAFTKVCSHLGCPSSLYEQQSYRILCPCHQSQFDALHFAKPIFGPAARALAQLPITIDTDGYLVANGDFVEPVGPAFWERTTT,"46,923",429,,growth [GO:0040007],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]",cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469],,MTCY190.06,1
P9WP37,QCRB_MYCTU,Rv2196,qcrB Rv2196 MTCY190.07,GO:0005886; GO:0005887; GO:0008121; GO:0022904; GO:0040007; GO:0046872; GO:0070469,IPR005797; IPR027387; IPR016174; ,,qcrB,,Cytochrome bc1 complex cytochrome b subunit (EC 1.10.2.2) (Cytochrome bc1 reductase complex subunit QcrB) (Ubiquinol--cytochrome c reductase cytochrome b subunit),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; growth [GO:0040007]; respiratory electron transport chain [GO:0022904],9634230; 19099550; 21969609; 23913123; 26158909,,"FUNCTION: Cytochrome b subunit of the cytochrome bc1 complex, an essential component of the respiratory electron transport chain required for ATP synthesis. The bc1 complex catalyzes the oxidation of ubiquinol and the reduction of cytochrome c in the respiratory chain. The bc1 complex operates through a Q-cycle mechanism that couples electron transfer to generation of the proton gradient that drives ATP synthesis. The cytochrome b subunit contains two ubiquinol reactive sites: the oxidation (QP) site and the reduction (QN) site. {ECO:0000305, ECO:0000305|PubMed:23913123, ECO:0000305|PubMed:26158909}.",MSPKLSPPNIGEVLARQAEDIDTRYHPSAALRRQLNKVFPTHWSFLLGEIALYSFVVLLITGVYLTLFFDPSMVDVTYNGVYQPLRGVEMSRAYQSALDISFEVRGGLFVRQIHHWAALMFAAAIMVHLARIFFTGAFRRPRETNWVIGSLLLILAMFEGYFGYSLPDDLLSGLGLRAALSSITLGMPVIGTWLHWALFGGDFPGTILIPRLYALHILLLPGIILALIGLHLALVWFQKHTQFPGPGRTEHNVVGVRVMPVFAFKSGAFFAAIVGVLGLMGGLLQINPIWNLGPYKPSQVSAGSQPDFYMMWTEGLARIWPPWEFYFWHHTIPAPVWVAVIMGLVFVLLPAYPFLEKRFTGDYAHHNLLQRPRDVPVRTAIGAMAIAFYMVLTLAAMNDIIALKFHISLNATTWIGRIGMVILPPFVYFITYRWCIGLQRSDRSVLEHGVETGIIKRLPHGAYIELHQPLGPVDEHGHPIPLQYQGAPLPKRMNKLGSAGSPGSGSFLFADSAAEDAALREAGHAAEQRALAALREHQDSIMGSPDGEH,"61,014",549,Cytochrome b family,growth [GO:0040007]; respiratory electron transport chain [GO:0022904],metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; respiratory chain [GO:0070469],,MTCY190.07,1
P9WHL1,PYRD_MYCTU,Rv2139,pyrD Rv2139 MTCY270.29c,GO:0004152; GO:0005737; GO:0005886; GO:0006207; GO:0044205,IPR013785; IPR005720; IPR005719; IPR001295; ,,pyrD,,Dihydroorotate dehydrogenase (quinone) (EC 1.3.5.2) (DHOdehase) (DHOD) (DHODase) (Dihydroorotate oxidase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; dihydroorotate dehydrogenase activity [GO:0004152]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. {ECO:0000250}.,MYPLVRRLLFLIPPEHAHKLVFAVLRGVAAVAPVRRLLRRLLGPTDPVLASTVFGVRFPAPLGLAAGFDKDGTALSSWGAMGFGYAEIGTVTAHPQPGNPAPRLFRLADDRALLNRMGFNNHGARALAIRLARHRPEIPIGVNIGKTKKTPAGDAVNDYRASARMVGPLASYLVVNVSSPNTPGLRDLQAVESLRPILSAVRAETSTPVLVKIAPDLSDSDLDDIADLAVELDLAGIVATNTTVSRDGLTTPGVDRLGPGGISGPPLAQRAVQVLRRLYDRVGDRLALISVGGIETADDAWERITAGASLLQGYTGFIYGGERWAKDIHEGIARRLHDGGFGSLHEAVGSARRRQPS,"37,999",357,"Dihydroorotate dehydrogenase family, Type 2 subfamily",'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],dihydroorotate dehydrogenase activity [GO:0004152],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY270.29c,1
P9WP35,QCRC_MYCTU,Rv2194,qcrC Rv2194 MTCY190.05,GO:0005506; GO:0005887; GO:0008121; GO:0020037; GO:0040007; GO:0070469,IPR009152; IPR009056; IPR036909; ,,qcrC,DOMAIN 60 140 Cytochrome c 1. {ECO:0000255|PROSITE-ProRule:PRU00433}.; DOMAIN 161 239 Cytochrome c 2. {ECO:0000255|PROSITE-ProRule:PRU00433}.,Cytochrome bc1 complex cytochrome c subunit (EC 1.10.2.2) (Cytochrome bc1 reductase complex subunit QcrC) (Ubiquinol--cytochrome c reductase cytochrome c subunit),integral component of plasma membrane [GO:0005887]; respiratory chain [GO:0070469]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; growth [GO:0040007],9634230; 19099550; 21969609,,"FUNCTION: Cytochrome b subunit of the cytochrome bc1 complex, an essential component of the respiratory electron transport chain required for ATP synthesis. The bc1 complex catalyzes the oxidation of ubiquinol and the reduction of cytochrome c in the respiratory chain. The bc1 complex operates through a Q-cycle mechanism that couples electron transfer to generation of the proton gradient that drives ATP synthesis. {ECO:0000305}.",MTKLGFTRSGGSKSGRTRRRLRRRLSGGVLLLIALTIAGGLAAVLTPTPQVAVADESSSALLRTGKQLFDTSCVSCHGANLQGVPDHGPSLIGVGEAAVYFQVSTGRMPAMRGEAQAPRKDPIFDEAQIDAIGAYVQANGGGPTVVRNPDGSIATQSLRGNDLGRGGDLFRLNCASCHNFTGKGGALSSGKYAPDLAPANEQQILTAMLTGPQNMPKFSNRQLSFEAKKDIIAYVKVATEARQPGGYLLGGFGPAPEGMAMWIIGMVAAIGLALWIGARS,"29,138",280,,growth [GO:0040007],heme binding [GO:0020037]; iron ion binding [GO:0005506]; ubiquinol-cytochrome-c reductase activity [GO:0008121],integral component of plasma membrane [GO:0005887]; respiratory chain [GO:0070469],,MTCY190.05,1
P9WHF5,THT3_MYCTU,Rv2291,sseB Rv2291 MTCY339.19c,GO:0004792,IPR001763; IPR036873; IPR001307; ,,sseB,DOMAIN 20 138 Rhodanese 1. {ECO:0000255|PROSITE-ProRule:PRU00173}.; DOMAIN 169 280 Rhodanese 2. {ECO:0000255|PROSITE-ProRule:PRU00173}.,Putative thiosulfate sulfurtransferase SseB (EC 2.8.1.1),thiosulfate sulfurtransferase activity [GO:0004792],9634230; 19099550; 21969609,,,MQARGQVLITAAELAGMIQAGDPVSILDVRWRLDEPDGHAAYLQGHLPGAVFVSLEDELSDHTIAGRGRHPLPSGASLQATVRRCGIRHDVPVVVYDDWNRAGSARAWWVLTAAGIANVRILDGGLPAWRSAGGSIETGQVSPQLGNVTVLHDDLYAGQRLTLTAQQAGAGGVTLLDARVPERFRGDVEPVDAVAGHIPGAINVPSGSVLADDGTFLGNGALNALLSDHGIDHGGRVGVYCGSGVSAAVIVAALAVIGQDAELFPGSWSEWSSDPTRPVGRGTA,"29,400",284,,,thiosulfate sulfurtransferase activity [GO:0004792],,,MTCY339.19c,1
O33262,O33262_MYCTU,Rv2128,Rv2128,GO:0016021,,,,,Conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLRRGESIIRNRYASKPPLYGMAMVFLAMAVVAVTAYFRMGWWSIIGYAAAAIIGVIGFALAFRDLS,"7,404",67,,,,integral component of membrane [GO:0016021],,,1
Q50681,Q50681_MYCTU,Rv2284,lipM Rv2284,GO:0005576; GO:0005886; GO:0005887; GO:0008152; GO:0016787; GO:0052562,IPR029058; IPR013094; ,,lipM,,Probable esterase LipM,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metabolic process [GO:0008152]; negative regulation by symbiont of host immune response [GO:0052562],9634230; 21969609,,,MGAPRLIHVIRQIGALVVAAVTAAATINAYRPLARNGFASLWSWFIGLVVTEFPLPTLASQLGGLVLTAQRLTRPVRAVSWLVAAFSALGLLNLSRAGRQADAQLTAALDSGLGPDRRTASAGLWRRPAGGGTAKTPGPLRMLRIYRDYAHDGDISYGEYGRANHLDIWRRPDLDLTGTAPVLFQIPGGAWTTGNKRGQAHPLMSHLAELGWICVAINYRHSPRNTWPDHIIDVKRALAWVKAHISEYGGDPDFIAITGGSAGGHLSSLAALTPNDPRFQPGFEEADTRVQAAVPFYGVYDFTRLQDAMHPMMLPLLERMVVKQPRTANMQSYLDASPVTHISADAPPFFVLHGRNDSLVPVQQARGFVDQLRQVSKQPVVYAELPFTQHAFDLLGSARAAHTAIAVEQFLAEVYATQHAGSEPGPAVAIP,"46,681",431,,metabolic process [GO:0008152]; negative regulation by symbiont of host immune response [GO:0052562],hydrolase activity [GO:0016787],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O86340,O86340_MYCTU,Rv2061c,Rv2061c,GO:0005618; GO:0005829; GO:0005886; GO:0048037,IPR019965; IPR011576; IPR012349; ,,,DOMAIN 7 88 Putative_PNPOx. {ECO:0000259|Pfam:PF01243}.,Conserved protein,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; cofactor binding [GO:0048037],9634230; 21969609,,,MTPTFSDLAEAQYLLLTTFTKDGRPKPVPIWAALDTDRGDRLLVITEKKSWKVKRIRNTPRVTLATCTLRGRPTSEAVEATAAILDESQTGAVYDAIVKRYGIQGKLFTFVSKLRGGMRNNIGLELKVAESETG,"14,814",134,,,cofactor binding [GO:0048037],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
O53516,O53516_MYCTU,Rv2182c,Rv2182c,GO:0005886; GO:0008152; GO:0016411; GO:0040007; GO:0042171,IPR002123; ,,,,1-acylglycerol-3-phosphate O-acyltransferase,plasma membrane [GO:0005886]; acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; growth [GO:0040007]; metabolic process [GO:0008152],9634230; 21969609,,,MWYYLFKYIFMGPLFTLLGRPKVEGLEYIPSSGPAILASNHLAVADSFYLPLVVRRRIWFLAKSEYFTGTGLKGWINRWFYSVSGQVPIDRTNADSAQGALQTAVVLLGQGKLLGMYPEGTRSPDGRLYKGKTGLARLALHTGVPVIPVAMIGTNVVNPPGRKMLRFGRVTVRFGKPMDFSRFEGLAGNHFIERAVTDEVIYELMGLSGQEYVDIYAASVKDGRNAGGAGANPNSTDAARIPETAAG,"26,955",247,,growth [GO:0040007]; metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],plasma membrane [GO:0005886],,,1
O53511,O53511_MYCTU,Rv2177c,Rv2177c,GO:0003677; GO:0004803; GO:0006313,IPR003346; ,,,,Possible transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MRSKIPDLQRALEGRFDDHHALMCRLHLAHLDQLDAMIGALDEQIEQLMHPFCARRELIASIPGIGVGASATVISEIGADPAAWFPSAEHLASWVRLCPGNHESAGKRHHGARRTGNQHLQPVLVECAWAAVRTDGYLREYYRRQVRKFGGFRSPAANKKAIIAVAHKLIVIIWHVLATGRPYQDLGADYFTTRMDPDKERRRLVAKLEAQGLGVTLEPAA,"24,632",221,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
O06241,O06241_MYCTU,Rv2134c,Rv2134c,,IPR021441; ,,,,Conserved protein,,9634230; 21969609,,,MARAIHVFRTPDRFVAGTVGQPGNRTFYLQAVHDSRVVSVVLEKQQVAVLAERIGALLFEVNRRFGTPVPPEPTEIDDLSPLIMPVDAEFRVGTMGLGWDSEAQSVVVELLAVTDAEFDASVVLDDTEEGPDAVRVFLTPESARQFATRSYRVISAGRPPCPLCDEPLDPEGHICARTNGYRRDVLLGSGDDPAG,"21,217",195,,,,,,,1
O53537,O53537_MYCTU,Rv2263,Rv2263,GO:0000253,IPR036291; IPR002347; ,,,,Possible oxidoreductase,3-keto sterol reductase activity [GO:0000253],9634230; 21969609,,,MAKDLVATVPDLSGKLAIITGANSGLGFGLARRLSAAGADVIMAIRNRAKGEAAVEEIRTAVPDAKLTIKALDLSSLASVAALGEQLMADGRPIDLLINNAGVMTPPERVTTADGFELQFGSNHLGHFALTAHLLPLLRAAQRARVVSLSSLAARRGRIHFDDLQFERSYAPMTAYGQSKLAVLMFARELDRRSRAAGWGIISNAAHPGLTKTNLQIAGPSHGRDKPALMERLYKTSWRFAPFLWQEIEEGILPALYAAATPQADGGAFYGPRGRYEVAGGGVREAKVPAAARNDADSKRLWEVSEQLTGVSYPKSR,"33,966",317,Short-chain dehydrogenases/reductases (SDR) family,,3-keto sterol reductase activity [GO:0000253],,,,1
O53536,O53536_MYCTU,Rv2262c,Rv2262c,GO:0005886; GO:0016021; GO:0016410; GO:0042158,IPR004563; IPR003010; IPR036526; ,,,DOMAIN 221 360 CN hydrolase. {ECO:0000259|PROSITE:PS50263}.,Uncharacterized protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; N-acyltransferase activity [GO:0016410]; lipoprotein biosynthetic process [GO:0042158],9634230,,,MALRAGARRQPVIGCAAALVFGGLPALAFPAPSWWWLAWFGLVPLLLVVRAAPTSWEGALRAWTGMGGFVLATQYWLVTSAGPMLVLLAAGLGVLWLPAGWLAHRLLSVPVTTCRVGAALVVVPSAWVAAEAVRSWQSLGGPWALLGASQWSQPVTLASASLGGVWLTSFLLVATNTAIASVLVCRATGGRLVALGCVIGCAGLGPASYLLGSVPVGGPTVRVALVQAGDIADAAARLAAGEEFTAAVADQRPDLVVWGESSVGQDLTRHPDVLARLAELSQRVGADLLVNVDAPAPDGGIYKSAVLVGAHEAVGSYRKTRLVPFGEYVLRCARFSAGSPATARPPQRIGSAAPGRWCWR,"37,258",360,,lipoprotein biosynthetic process [GO:0042158],N-acyltransferase activity [GO:0016410],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P71898,P71898_MYCTU,Rv2314c,Rv2314c,GO:0005576; GO:0005618; GO:0008237,IPR002510; IPR036059; ,,,,Conserved protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; metallopeptidase activity [GO:0008237],9634230; 21969609,,,MIEPQHAVNIVLKEAARSGRADETMVLVTEKVEATLRWAGNSMTTNGVSHSRNVTVISIVRRGDSAFVGSVVSAEVDPSVLPGLVVSSQDAARSAPEAGDAAPLLADTGEPDDWDAPVPGTGAGVFTGIAGSLSRGFRGADRLYGYAHRSVSTTFLASSTGLRRRYTQPTGAIEINAKRGDASAWVGIGTPDFVEVPIDLMLERLSTRLRWAQRTVELPAGRYQTIMPPSTVADMMIYLGWSMAGRGAQEGRTAFSAPGGGTRVGERLTELPLTLFTDPAAPGLACTPFVAVSNSSETQSVFDNGMEISQVDWIRSGVINALAYPRATAAKFDAPVAVAADNLIMTGGSADLADMIAGTERGLLLTTLWYIREVDPTTLLLTGLTRDGVYLVEDGEVSAAVNNFRFNESPLDLLRRATEAGVSEPTLPREWSDWVTRTAMPPLRIPDFHMSSVSQAQ,"48,712",457,,,metallopeptidase activity [GO:0008237],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
O53976,O53976_MYCTU,Rv1975,Rv1975,,IPR014044; IPR035940; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSRRASATCALSATTAVAIMAAPAARADDKRLNDGVVANVYTVQRQAGCTNDVTINPQLQLAAQWHTLDLLNNRHLNDDTGSDGSTPQDRAHAAGFRGKVAETVAINPAVAISGIELINQWYYNPAFFAIMSDCANTQIGVWSENSPDRTVVVAVYGQPDRPSAMPPRGAVTGPPSPVAAQENVPIDPSPDYDASDEIEYGINWLPWILRGVYPPPAMPPQ,"23,649",221,,,,,,,1
O53972,O53972_MYCTU,Rv1971,mce3F Rv1971,GO:0016021,IPR005693; IPR003399; ,,mce3F,,Mce-family protein Mce3F,integral component of membrane [GO:0016021],9634230,,,MLHLPRRVIVQLAVFTVIAVGVLAITFLHFVRLPAMLFGVGRYTVTMELVEAGGLYRTGNVTYRGFEVGRVAAVRLTDTGVQAVLALKSGIDIPSDLKAEVHSHTAIGETYVELLPRNAASPPLKNGDVIALADTSVPPDINDLLSAANTALEAIPHENLQTVIDESYTAVAGLGLELSRLIKGSAELAIDARANLDPLVALIDRAGPVLDSQTHTSDAIAAWAAQLAAVTGQLQTHDSAVGDLIDRGGPALGETRQLLERLQPTVPILLANLVSVGQVALTYHNDIEQLLVVFPMAIAAEQAGILANLNTKQAYRGQYLSFNLNLNLPPPCTTGFLPAQQRRIPTFEDYPDRPAGDLYCRVPQDSPFNVRGARNIPCETVPGKRAPTVKLCESDAPYLPLNDGYNWKGDPNATVPGLGSGQDIPQTWQTMLLPPGS,"46,725",437,,,,integral component of membrane [GO:0016021],,,1
O53517,O53517_MYCTU,Rv2183c,Rv2183c,,,,,,Conserved protein,,9634230; 21969609,,,MSGAHTDVRPELRKLAQAILDGIDPAVRVAAAMASGGGPGTGKCQQVWCPLCALAALVTGEQHPLLTVIADHSLALLEVIRAIVDDIDRSAKPPPEGPPGGGQTGASGGENTNGEGSMKSHYQAIPVTIEE,"13,354",131,,,,,,,3
O53480,O53480_MYCTU,Rv2036,Rv2036,GO:0046872,IPR017517; IPR034660; IPR024344; ,,,,Uncharacterized protein,metal ion binding [GO:0046872],9634230; 21969609,,,MIAADDDTEKSMMDMARAERAELAAFLTTLTLQQWETPSLCAGWSVKEVVAHMISYEDLGVFGLLKRFAKGRIVRANEVGVDEFAGLSPQELADYVGRHLQPRGLTAGFGGMIALVDGMIHHQDIRRPLGQPRTIPAQRLDRVLRLMPKNPRLRARPRIKGLRLRATDLDWTIGTGPEVTGPGEALLMAMAGRPAAVSDLSGPGKPTLAGRLG,"23,172",213,,,metal ion binding [GO:0046872],,,,3
P71883,P71883_MYCTU,Rv2329c,narK1 Rv2329c,GO:0005887; GO:0015112; GO:0015514; GO:0015707,IPR011701; IPR020846; IPR036259; ,,narK1,,Probable nitrite extrusion protein 1 NarK1 (Nitrite facilitator 1),integral component of plasma membrane [GO:0005887]; nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514]; nitrite transport [GO:0015707],9634230,,,MEQHTLLQREESPRSPAAPSLRRLGGSRHITHWDPEDLGAWEAGNKGIARRNLLWSVVTVHLGYSVWTLWPVLELLMPQDVYGFSTSDKFLLGTIATLFGAFLRMPYALASAIFGGRNWATFSAIVLLIPAIGTTVLLTHPGLPLWPYLVCAALTGLGGGNFASSMSNANAFYPHRLKGSALGIAGGVGNLGVPAIQLVGLLAIATVGERKPYLVCALYVVLVAIAVIGVSLFMNNVEQHRVQVNRLRPIVSAVLSTRDTWLLSLLYLGTFGSFIGFSFVFGQVLQTNFLACGQSPARATLHAVELAFVGPLLAAVARIYGGRLADRVGGSRLTLIVFVAMTLAAGLLISASTLEGRHVGQHRGATMVGYFVCFVALFVLSGLGNGSVYKMIPTIFEACSRSLDLSEAERRDWSRIISGVVIGFVAAFGALGGVGINMALRESYLSTGSGTDAFWIFMMCYAAAAVLTWKVYDRRTVTDMGMLQAALVRQPASTPAELIGPRTQSDRFSGCSISA,"55,136",515,,nitrite transport [GO:0015707],nitrate transmembrane transporter activity [GO:0015112]; nitrite efflux transmembrane transporter activity [GO:0015514],integral component of plasma membrane [GO:0005887],,,1
P71903,P71903_MYCTU,Rv2309c,Rv2309c,GO:0003677; GO:0006310; GO:0015074,IPR011010; IPR013762; IPR002104; IPR014417; ,,,,Possible integrase,DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310],9634230,,,MTGAGIVETTTNRVRHVPVPEPVSERLRDELPTEPNALVFPSYRGGHLPIEEYRRAFDKGCKAVGIADLVPHGLRHTTASLAISAGANVKVVQRLLGHATAAMTLDRHGHLLSDDLAGVAGLLVQAIKSAAASLRYSDPDSVAVENISAAS,"15,920",151,,DNA integration [GO:0015074]; DNA recombination [GO:0006310],DNA binding [GO:0003677],,,,2
O53469,O53469_MYCTU,Rv2023c,Rv2023c,,,,,,Uncharacterized protein,,9634230,,,MAARHARAGRWAAQPRPMLGSGAVRYEVGANIDATGFGGIAAVHRLVTRLGLVTRLGLVERVDAHSRFSSSNLPKSSRRISGRVSLSGMSNSAAKVVASTSSSPWGQPLSVGLRRRWRS,"12,665",119,,,,,,,1
O53965,O53965_MYCTU,Rv1964,yrbE3A Rv1964,GO:0043190,IPR030802; ,,yrbE3A,,Conserved hypothetical integral membrane protein YrbE3A,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230,,,MVIVADKAAGRVADPVLRPVGALGDFFAMTLDTSVCMFKPPFAWREYLLQCWFVARVSTLPGVLMTIPWAVISGFLFNVLLTDIGAADFSGTGCAIFTVNQSAPIVTVLVVAGAGATAMCADLGARTIREELDALRVMGINPIQALAAPRVLAATTVSLALNSVVTATGLIGAFFCSVFLMHVSAGAWVTGLTTLTHTVDVVISMIKATLFGLMAGLIACYKGMSVGGGPAGVGRAVNETVVFAFIVLFVINIVVTAVGIPFMVS,"27,494",265,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
O53975,O53975_MYCTU,Rv1974,Rv1974,,IPR007969; ,,,,Probable conserved membrane protein,,9634230,,,MQRQSLMPQQTLAAGVFVGALLCGVVTAAVPPHARADVVAYLVNVTVRPGYNFANADAALSYGHGLCEKVSRGRPYAQIIADVKADFDTRDQYQASYLLSQAVNELCPALIWQLRNSAVDNRRSG,"13,523",125,,,,,,,1
L0TBP1,L0TBP1_MYCTU,Rv2160A,Rv2160A,GO:0003677; GO:0003700; GO:0006351; GO:0006355,IPR009057; IPR001647; ,,,DOMAIN 8 68 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Uncharacterized protein,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,,MPSADVGRQTRAQILRAAMDIASVKGLSGLSIGELAGRLGMSKSGLFRHFGAKEQLQLATVEAAVSVFEAEVVAPAMAAPPGVDRVRALMHAWVGYLERDVPAAAFSRPRPPTWTHSLARCATASPRPGGPESPPSRPTSKRRNAGARSGRISKCANSRSSCTPTRWRPTGRCCCSTTTAPESGRERRSTRPWPESAPPRRESNHEICQPY,"22,713",211,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
I6YCF3,I6YCF3_MYCTU,Rv2101,helZ Rv2101,GO:0004386; GO:0005524,IPR014001; IPR001650; IPR022138; IPR027417; IPR038718; IPR000330; ,,helZ,,Probable helicase HelZ,ATP binding [GO:0005524]; helicase activity [GO:0004386],9634230; 21969609,,,MLVLHGFWSNSGGMRLWAEDSDLLVKSPSQALRSARPHPFAAPADLIAGIHPGKPATAVLLLPSLRSAPLDSPELIRLAPRPAARTDPMLLAWTVPVVDLDPTAALAAFDQPAPDVRYGASVDYLAELAVFARELVERGRVLPQLRRDTHGAAACWRPVLQGRDVVAMTSLVSAMPPVCRAEVGGHDPHELATSALDAMVDAAVRAALSPMDLLPPRRGRSKRHRAVEAWLTALTCPDGRFDAEPDELDALAEALRPWDDVGIGTVGPARATFRLSEVETENEETPAGSLWRLEFLLQSTQDPSLLVPAEQAWNDDGSLRRWLDRPQELLLTELGRASRIFPELVPALRTACPSGLELDADGAYRFLSGTAAVLDEAGFGVLLPSWWDRRRKLGLVLSAYTPVDGVVGKASKFGREQLVEFRWELAVGDDPLSEEEIAALTETKSPLIRLRGQWVALDTEQLRRGLEFLERKPTGRKTTAEILALAASHPDDVDTPLEVTAVRADGWLGDLLAGAAAASLQPLDPPDGFTATLRPYQQRGLAWLAFLSSLGLGSCLADDMGLGKTVQLLALETLESVQRHQDRGVGPTLLLCPMSLVGNWPQEAARFAPNLRVYAHHGGARLHGEALRDHLERTDLVVSTYTTATRDIDELAEYEWNRVVLDEAQAVKNSLSRAAKAVRRLRAAHRVALTGTPMENRLAELWSIMDFLNPGLLGSSERFRTRYAIPIERHGHTEPAERLRASTRPYILRRLKTDPAIIDDLPEKIEIKQYCQLTTEQASLYQAVVADMMEKIENTEGIERRGNVLAAMAKLKQVCNHPAQLLHDRSPVGRRSGKVIRLEEILEEILAEGDRVLCFTQFTEFAELLVPHLAARFGRAARDIAYLHGGTPRKRRDEMVARFQSGDGPPIFLLSLKAGGTGLNLTAANHVVHLDRWWNPAVENQATDRAFRIGQRRTVQVRKFICTGTLEEKIDEMIEEKKALADLVVTDGEGWLTELSTRDLREVFALSEGAVGE,"111,612",1013,,,ATP binding [GO:0005524]; helicase activity [GO:0004386],,,,1
O06243,O06243_MYCTU,Rv2132,Rv2132,GO:0006355,IPR002145; ,,,,Uncharacterized protein,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MRTTVSLADDVAAAVQRLRKERSIGLSEAVNELIRAGLTKRQVANRFQQQTYDMGEGIDYSNIGDAIETLDGPASG,"8,240",76,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,3
O53538,O53538_MYCTU,Rv2264c,Rv2264c,GO:0005576,IPR013126; ,,,,Conserved hypothetical proline rich protein,extracellular region [GO:0005576],9634230; 21969609,,,MATGARPALGLSIGVTNLAAVAADHSITRKPVLTLYRQRPPEVGVPSENPRLDEPGLVITDFVDRVGDSVGIVAADGSVYRSEALVADALLALAYTATGGRALPGSVTVTYPAHWGPAAVAALDSALRRASEWSHGTSSTAQPLSLLPDAAAALYAIRADPGIPARGIVAVCDFGGSGTGITLVDAADEYRPVAATVRHQAFSGDLIDQSLLSYVMSELPGTGAFDPAGTSAIGSLTKLRIECRKAKERLSSSTVTTLTDALGGDIRLTRNELEDTIRDSLDSVGRALEQTLARSGIRTAELVAIVSVGGGANIPAVTTTLSGRFCVPVVRTPRPQLTAAFGGALWAARRPGDTSATVLTAVTSATATAPADAPASVLQPALAWSEADEDSHIGPAPGYTAARPSLSFDHDAHAEPEPKSPPIPWYRLPAVIITGTTVAVLLVGAAVAIGLSTGDQPTAPGTPQRPGVTTTAAPPPSPAPASDGPTTEPAPPVQAPATGGPAPPLQQPLPPPPTTTNTQPAVTTDVITPAPTTPASAPPATTQPPATTQPPATTSPSPPPIPPIPPIPEIPQLPPGIPQVPGIGQFSAISGS,"59,848",592,,,,extracellular region [GO:0005576],,,1
O53482,O53482_MYCTU,Rv2038c,Rv2038c,GO:0005524; GO:0005829; GO:0005886; GO:0016887; GO:0022857; GO:0043190,IPR003593; IPR003439; IPR017871; IPR008995; IPR027417; IPR013611; ,,,,Probable sugar-transport ATP-binding protein ABC transporter,ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; transmembrane transporter activity [GO:0022857],9634230,,,MASVSFEQATRRYPGTDRPALDRLDLIVGDGEFVVLVGPSGCGKTTSLRMVAGLETLDCGRIRIGERDVTEVDPKDRDVAMVFQNYALYPHMTVAQNMGFALKVAKIGKAEIRERVLAAAKLLDLQSYLDRKPKDLSGGQRQRVAMGRAIVRRPQVFLMDEPLSNLDAKLRGQTRNQIAALQRQLGTTTVYVTHDQVEAMTMGDRVAVLSDGVLQQCASPRELYRNPGNVFVAGFIGSPAMNLFRLSIADSTVSLGDWQILLPRAVVGTAAEVIIGVRPEHLELGGAGIEMDVDMVEELGADAYLYGRIVSGGCEMDQSIVARVDGRGPPERGSRVRLCPTPGHLHFFAVDGRRIPG,"38,887",357,ABC transporter superfamily,,ATPase activity [GO:0016887]; ATP binding [GO:0005524]; transmembrane transporter activity [GO:0022857],ATP-binding cassette (ABC) transporter complex [GO:0043190]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53498,O53498_MYCTU,Rv2062c,cobN Rv2062c,GO:0005829; GO:0005886; GO:0009236; GO:0051116,IPR011953; IPR003672; ,,cobN,,Cobalamin biosynthesis protein CobN,cytosol [GO:0005829]; plasma membrane [GO:0005886]; cobaltochelatase activity [GO:0051116]; cobalamin biosynthetic process [GO:0009236],9634230; 21969609,,,MPEPTVLLLSTSDTDLISARSSGKNYRWANPSRLSDLELTDLLAEASIVVIRILGGYRAWQSGIDTVIAGGVPAVLVSGEQAADAELTDRSTVAAGTALQAHIYLAHGGVDNLRELHAFLCDTVLMTGFGFTPPVATPTWGVLERPDAGKTGPTIAVLYYRAQHLAGNTGYVEALCRAIEDAGGRPLPLYCASLRTAEPRLLERLGGADAMVVTVLAAGGVKPAAASAGGDDDSWNVEHLAALDIPILQGLCLTSPRDQWCANDDGLSPLDVASQVAVPEFDGRIITVPFSFKEIDDDGLISYVADPERCARVAGLAVRHARLRQVAPADKRVALVFSAYPTKHARIGNAVGLDTPASAVALLQAMRQRGYRVGDLPGVESNDGDALIHALIECGGHDPDWLTEGQLAGNPIRVSAKEYRDWFATLPAELTDVVTAYWGPPPGELFVDRSHDPDGEIVIAALRAGNLVLMVQPPRGFGENPVAIYHDPDLPPSHHYLAAYRWLDTGFSNGFGAHAVVHLGKHGNLEWLPGKTLGMSASCGPDAALGDLPLIYPFLVNDPGEGTQAKRRAHAVLVDHLIPPMARAETYGDIARLEQLLDEHASVAALDPGKLPAIRQQIWTLIRAAKMDHDLGLTERPEEDSFDDMLLHVDGWLCEIKDVQIRDGLHILGQNPTGEQELDLVLAILRARQLFGGAHAIPGLRQALGLAEDGTDERATVDQTEAKARELVAALQATGWDPSAADRLTGNADAAAVLRFAATEVIPRLAGTATEIEQVLRALDGRFIPAGPSGSPLRGLVNVLPTGRNFYSVDPKAVPSRLAWEAGVALADSLLARYRDEHGRWPRSVGLSVWGTSAMRTAGDDIAEVLALLGVRPVWDDASRRVIDLAPMQPAELGRPRIDVTVRISGFFRDAFPHVVTMLDDAVRLVADLDEAAEDNYVRAHAQADLAHHGDQRRATTRIFGSKPGTYGAGLLQLIDSRSWRDDADLAQVYTAWGGFAYGRDLDGREAIDDMNRQYRRIAVAAKNTDTREHDIADSDDYFQYHGGMVATVRALTGQAPAAYIGDNTRPDAIRTRTLSEETTRVFRARVVNPRWMAAMRRHGYKGAFEMAATVDYLFGYDATAGVMADWMYEQLTQRYVLDAQNRTFMTESNPWALHGMAERLLEAAGRGLWAQPAPETLDGLRQVLLETEGDLEA,"129,210",1194,,cobalamin biosynthetic process [GO:0009236],cobaltochelatase activity [GO:0051116],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,4
O53971,O53971_MYCTU,Rv1970,lprM Rv1970,,IPR005693; IPR003399; ,,lprM,,Possible Mce-family lipoprotein LprM (Mce-family lipoprotein Mce3E),,9634230,,,MRIGLTLVMIAAVVASCGWRGLNSLPLPGTQGNGPGSFAVQAQLPDVNNIQPNSRVRVADVTVGHVTKIERQGWHALVTMRLDGDVDLPANATAKIGTTSLLGSYHIELAPPKGEARQGKLRDGSLIALSHGSAYPSTEQTLAALSLVLNGGGLGQVQDITEALSTAFAGREHDLRGLIGQLDTFTAYLNNQSGDIIAATDSLNRLVGKFADQQPVFDRALATIPDALAVLADERDTLVEAAEQLSKFSALTVDSVNKTTANLVTELRQLGPVLESLANSGPALTRSLSLLATFPFPNETFQNFQRGEYANLTAIVDLTLSRIDQGLLTGTRWECHLTQLELQWGRTIGQFPSPCTAGYRGTPGNPLTIAYRWDQGP,"40,216",377,,,,,,,1
O53486,O53486_MYCTU,Rv2042c,Rv2042c,GO:0005886,IPR002075; IPR032710; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAPPNRDELLAAVERSPQAAAAHDRAGWVGLFTGDARVEDPVGSQPQVGHEAIGRFYDTFIGPRDITFHRDLDIVSGTVVLRDLELEVAMDSAVTVFIPAFLRYDLRPVTGEWQIAALRAYWELPAMMLQFLRTGSGATRPALQLSRALLGNQGLGGTAGFLTGFRRAGRRHKKLVETFLNAASRADKSAAYHALSRTATMTLGEDELLDIVELFEQLRGASWTKVTGAGSTVAVSLASDHRRGIMFADVPWRGNRINRIRYFPA,"29,091",265,,,,plasma membrane [GO:0005886],,,1
O53531,O53531_MYCTU,Rv2257c,Rv2257c,GO:0071456,IPR001466; IPR012338; ,,,,Conserved protein,cellular response to hypoxia [GO:0071456],9634230; 21969609,,,MTALEVLGGWPVPAAAAAVIGPAGVLATHGDTARVFALASVTKPLVARAAQVAVEEGVVNLDTPAGPPGSTVRHLLAHTSGLAMHSDQALARPGTRRMYSNYGFTVLAESVQRESGIEFGRYLTEAVCEPLGMVTTRLDGGPAAAGFGATSTVADLAVFAGDLLRPSTVSAQMHADATTVQFPGLDGVLPGYGVQRPNDWGLGFEIRNSKSPHWTGECNSTRTFGHFGQSGGFIWVDPKADLALVVLTARDFGDWALDLWPAISDAVLAEYT,"28,385",272,,cellular response to hypoxia [GO:0071456],,,,,1
O53529,O53529_MYCTU,Rv2255c,Rv2255c,,,,,,Uncharacterized protein,,9634230,,,MDGIVDRGVRARPCQKVVAVLRRSKSHIDKRLDAATGNAFLGKQVLSAAGVVEYRPPRRSPLST,"6,972",64,,,,,,,1
O53534,O53534_MYCTU,Rv2260,Rv2260,GO:0005618; GO:0040007,IPR001279; IPR036866; ,,,,Uncharacterized protein,cell wall [GO:0005618]; growth [GO:0040007],9634230; 21969609,,,MAAIERVITHGTFELDGGSWEVDNNIWLVGDDSEVVVFDAAHHAAPIIDAVGGRKVVAVICTHGHNDHVTVAPELGTALDAPVLMHPGDAVLWRMTHPDKSFRAVSDGDAVRVGGTELRALHTPGHSPGSVCWYAPELGPGTGTVFSGDTLFAGGPGATGRSYSDFPTILRSISGRLGALPGDTVVHTGHGDSTTIGDEIVHYEEWVARGH,"22,138",211,,growth [GO:0040007],,cell wall [GO:0005618],,,3
P95253,P95253_MYCTU,Rv1961,Rv1961,,,,,,Uncharacterized protein,,9634230,,,MFLPTNAQYQLLVVGVSPWDTPSPSGRISWGSAWPHQARRAQTCQRVRRHWMIDTTEAAYRLTYQPDGTSITVRENLVDILARELLGPIRGPQEVLPFSPRSQYLVGHLAPVKLTGAALIDDNAVQARANAEALAEGGGVPAYAADETTPTPTTTPKTAHPSRA,"17,822",164,,,,,,,2
L7N678,L7N678_MYCTU,Rv2307A,Rv2307A,,,,,,Hypothetical glycine rich protein,,9634230,,,MAFVDLRYPWCRGDGWISPPVVAVALGWAMRRKPFSRFNEYVGSASNTCWFARALELRTLLIR,"7,307",63,,,,,,,1
O53495,O53495_MYCTU,Rv2053c,fxsA Rv2053c,GO:0016021,IPR007313; ,,fxsA,,Probable transmembrane protein FxsA,integral component of membrane [GO:0016021],9634230,,,MSRLLLSYAVVELAVVFALAATIGFGWTLLVLLATFVLGFGLLAPLGGWQLGRRLLWLRSGLAEPRSALSDGALVTVASVLVLVPGLVTTTMGLLLLVPPIRALARPGLTAIAVRGFLRNVPLTADAAANMAGAFGESGTDPDFIDGEVIDVIDVEPLTLQPPRVAAEPPSPGSN,"18,118",175,,,,integral component of membrane [GO:0016021],,,2
O53969,O53969_MYCTU,Rv1968,mce3C Rv1968,,IPR005693; IPR003399; ,,mce3C,,Mce-family protein Mce3C,,9634230,,,MKSFAERNRLAIGTVGIVVVAAVALAALQYQRLPFFNQGTRVSAYFADAGGLRTGNTVEVSGYPVGKVSSISLDGPGVLVEFKVDTDVRLGNRTEVAIKTKGLLGSKFLDVTPRGDGRLDSPIPIERTTSPYQLPDALGDLAATISGLHTERLSESLATLAQTFADTPAHFRNAIHGVARLAQTLDERDNQLRSLLANAAKATGVLANRTDQIVGLVRDTNVVLAQLRTQSAALDRIWANISAVAEQLRGFIAENRQQLRPALDKLNGVLAIVENRKERVRQAIPLINTYVMSLGESLSSGPFFKAYVVNLLPGQFVQPFISAAFSDLGLDPATLLPSQLTDPPTGQPGTPPLPMPYPRTGQGGEPRLTLPDAITGNPGDPRYPYRPEPPAPPPGGPPPGPPAQQPGDQP,"43,672",410,,,,,,,3
O53484,O53484_MYCTU,Rv2040c,Rv2040c,GO:0005576; GO:0005887; GO:0055085,IPR000515; IPR035906; ,,,,Probable sugar-transport integral membrane protein ABC transporter,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085],9634230,,,MTRRRGRRAWAGRMFVAPNLAAVVVFMLFPLGFSLYMSFQKWDLFTHATFVRLDNFRNLFTSDPLFLIAVVNTAVYTVGTVVPTVIVSLVVAAFLNRKIKGISLFRTVVFLPLAISSVVMAVVWQFVFNTDNGLLNIMLGWLGIGPIPWLIEPRWAMVSLCLVSVWRSVPFATVVLLAAMQGVPETVYEAARIDGAGEIRQFVSITVPLIRGALSFVVVISIIHAFQAFDLVYVLTGANGGPETATYVLGIMLFQHAFSFLEFGYASALAWVMFAILLVLTVLQLRITHRRSWEASRGLG,"33,327",300,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
O53978,O53978_MYCTU,Rv1977,Rv1977,GO:0004222; GO:0005886,IPR001915; ,,,,Conserved protein,plasma membrane [GO:0005886]; metalloendopeptidase activity [GO:0004222],9634230; 21969609,,,MSQTPATTRKTFPEISSRAWEHPADRTALSALRRLKGFDQILKLMSGMLRERQHRLLYLASAARVGPRQFADLDALLDECVDVLDASAKPELYVMQSPIADAFTIGMGKPFTVITSGLYDLVTHDEMRFVMGHELGHALSGHAVYRTMMMHLLRLARSFGVLPVGGWALRAIVAALLEWQRKSELSGDRAGLLCAQDLDTALRVEMKLAGGCRLDKLDSEAFLAQAREYETSGDMRDGVLKLLNLELQTHPFSVLRAAALTHWVDTGGYAKVIAGEYPRRADDGNAKFADDLGAAARYYRDGFDQSNDPLIKGIRDGFGGIVEGVGRAASNAADSLGRKITEWRQPSK,"38,308",348,Peptidase M48B family,,metalloendopeptidase activity [GO:0004222],plasma membrane [GO:0005886],,,1
O06213,O06213_MYCTU,Rv2164c,Rv2164c,GO:0016021; GO:0040007,,,,,Probable conserved proline rich membrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230; 21969609,,,MRAKREAPKSRSSDRRRRADSPAAATRRTTTNSAPSRRIRSRAGKTSAPGRQARVSRPGPQTSPMLSPFDRPAPAKNTSQAKARAKARKAKAPKLVRPTPMERLAARLTSIDLRPRTLANKVPFVVLVIGSLGVGLGLTLWLSTDAAERSYQLSNARERTRMLQQHKEALERDVREAASAPALAEAARRQGMIPTRDTAHLVQDPDGNWVVVGTPKPADGVPPPPLNTKLPEDPPPPPKPAAVPLEVPVRVTPGPDDPAPPARSGPEVLVRTPDGTATLGGATHLPTQAGPQLPGPVPIPGAPGPMPAPPLGAVPSPAPAENPVPLQVGAAPPAGLPGPAPVAATPGLSGGSQPMVAPPAPVPANGEQFGPVTAPVPTAPGAPR,"39,648",384,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,1
O53970,O53970_MYCTU,Rv1969,mce3D Rv1969,GO:0005618,IPR005693; IPR003399; ,,mce3D,,Mce-family protein Mce3D,cell wall [GO:0005618],9634230,,,MTTKLRRARSVLATALVLVAGVILAMRTADAAARTTVVAYFDNSNGVFAGDDVLIRGVPVGKIVKIEPQPLRAKISFWFDRKYRVPADAAAAILSPQLVTGRAIQLTPPYAGGPTMADGTVIPQERTVVPVEWDDLRAQLQRLTALLQPTRPGGVSTLGALINTAADNLRGQGATIRDTIIKLSQAISALGDHSKDIFSTVTNLSTLVTALHDSADLLERLNHNLAAVTSLLADGPDKIGQAAEDLNAVVADVGSFAAEHREAIGTASDKLASITTALVDSLDDIKQTLHISPTVLQNFNNIFEPANGALTGALAGNNMANPIAFLCGAIQAASRLGGEQAAKLCVQYLAPIVKNRQYNYPPLGANLFVGAQARPNEVTYSEDWLRPDYVAPVADTPPDPAAAVTVDPATGLRGMMMPPGGGS,"44,420",423,,,,cell wall [GO:0005618],,,1
Q79FG5,Q79FG5_MYCTU,Rv2306A,Rv2306A,GO:0016021,IPR015414; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MTDNECPADSRRRHVLRLALFAGILLGLFYLVAVARVIHVDGVRSAIVVATGPIAPLAYVVVSAALGALFVPGPILAAGSGVLFGPLLDTFVTLPAFSAGAQAGMTPRRCWVSIAPIASMHRSNGADCGRWSVSASSPASRMRWPRTPSGRSEFRCGRWSLGRSSGRRHGCSSTPRWARRSPTCRRRWFTRRSRCGA,"21,233",197,,,,integral component of membrane [GO:0016021],,,1
Q79FG2,Q79FG2_MYCTU,Rv2307B,Rv2307B,,,,,,Hypothetical glycine rich protein,,9634230; 21969609,,,MEEVPTGPPAMGHRACGGQKAAFPTRMNSGVEKMYKNSIAIAIGTLTMAVEFSMVSANAEPAPPPGQDPHMPNSAMGYCPGGGFGGITGWGYCDGIRYPDGSYWHQVRVPAPFVGTTLTLSCVIDDGSPVPPLAAPGSCGGGA,"14,586",143,,,,,,,1
O53520,O53520_MYCTU,Rv2186c,Rv2186c,,,,,,Uncharacterized protein,,9634230,,,MNSIQIADETYVAADAARVSAAVADRCSWRRWWPDLRLQVTEDRADKGIRWTVTGALTGTMEIWLEPSMDGVLLHYFLHAEPTGVAAWQLARMNLARMTHHRRVAGKKMAFEVKTVLERSRPIGVSPVT,"14,574",129,,,,,,,1
L7N6B5,L7N6B5_MYCTU,Rv2107,PE22 Rv2107,,IPR000084; ,,PE22,,PE family protein PE22,,9634230,,,MSFVNVDPFGMLAAAATLESLGSHMAVSNAAVASVTTKVPPPAADYVSKKLSLFFSSHGQQYQVQAARGTAFHRKLVRTLANGALAYEEVEIANNEGF,"10,374",98,,,,,,,1
O33260,O33260_MYCTU,Rv2125,Rv2125,,IPR008492; IPR019151; IPR038389; ,,,,Uncharacterized protein,,9634230; 21969609; 28193903,X-ray crystallography (1),,MTPSEGNAPLPELHNTVVVAAFEGWNDAGDAAGDAVAHLAASWQALPIVEIDDEAYYDYQVNRPVIRQVDGVTRELQWPAMRISHCRPPGSDRDVVLMCGVEPNMRWRTFCDELLAVIDKLNVDTVVILGALLADTPHTRPVPVSGAAYSAASARQFGLQETRYEGPTGIAGVFQSACVGAGIPAVTFWAAVPHYVSHPPNPKATIALLRRVEDVLDVEVPLADLPAQAEAWEREITETIAEDHELAEYVQTLEQHGDAAVDMNEALGNIDGDALAAEFERYLRRRRPGFGR,"31,841",292,,,,,,,1
O53487,O53487_MYCTU,Rv2044c,Rv2044c,GO:0016021,IPR021218; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MHFAFIAYVLAGGFLALRWRRTMWLHVPAVIWGIGIAAKRVDCPLTWVERWARTKAAMTPLSPDGFVAHYITGVIYPAGWVAAAQLVMFAIVAASWTLYLWLPRR,"11,886",105,,,,integral component of membrane [GO:0016021],,,3
O53523,O53523_MYCTU,Rv2189c,Rv2189c,,,,,,Uncharacterized protein,,9634230,,,MRDGPAAPAQVVAPADGFVALRVADDRTVRLLSLGGAATDRLLSRIAAGIDAAVDEVVAFWGTDWSHDIFVVAAGSDEQFHAAAGGGLASQWADIAAITVVDRVDPARRTVVGQRIVFAPGAAHMSPAALRIVLGHELFHYAARADTALDAPRWLAEGVADFVARPKTPPPADAVSVALSLPSDTDLDTPGPQRSLAYDRAWWFARFVAAAYGTAKLRELYLATCGVGHFDLATAAHDVLGIDAAGLLARWQRWLMG,"27,126",257,,,,,,,1
P71891,P71891_MYCTU,Rv2321c,rocD2 Rv2321c,GO:0004587; GO:0030170,IPR005814; IPR034757; IPR015424; IPR015422; IPR015421; ,,rocD2,,Probable ornithine aminotransferase (C-terminus part) RocD2 (Ornithine--oxo-acid aminotransferase),ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170],9634230,,,MIADEIQSGLACTGYPFACDHGGVLPDIYLLGKTLGGGAVPLSAMVADREIFGVVHPGEHGSTFGGNPLAAAIGTPVVSMVVWGECQARSAKLGAHLHQRLADLIGDGAVALRGLGWWADVDIERALAIGTDMSMRLADRGVLLKDTYGAALRFAPPLVITAQEIDCAVRRFADALWEAGS,"18,881",181,,,ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170],,,,1
O53504,O53504_MYCTU,Rv2170,Rv2170,GO:0016747,IPR016181; IPR013653; IPR000182; ,,,,GCN5-related N-acetyltransferase,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",9634230; 21969609,,,MAIFLIDLPPSDMERRLGDALTVYVDAMRYPRGTETLRAPMWLEHIRRRGWQAVAAVEVTAAEQAEAADTTALPSAAELSNAPMLGVAYGYPGAPGQWWQQQVVLGLQRSGFPRLAIARLMTSYFELTELHILPRAQGRGLGEALARRLLAGRDEDNVLLSTPETNGEDNRAWRLYRRLGFTDIIRGYHFAGDPRAFAILGRTLPL,"22,944",206,,,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
L0TB61,L0TB61_MYCTU,Rv2037c,Rv2037c,GO:0016021; GO:0016042; GO:0016787,IPR016035; IPR002641; ,,,DOMAIN 11 210 PNPLA. {ECO:0000259|PROSITE:PS51635}.,Conserved transmembrane protein,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],9634230; 21969609,,,MALVSTARVDLVCEGGGVRGIGLVGAVDALADAGYRFPRVAGSSAGAIVASLVAALQTAGEPVTRLAEMMRSIDYPKFLDRNLIGHVPLIGGGLSLLLSDGVYRGAYLEQLLGGLLADLGVHTFGDLRTGEAPEQFAWSLVVTASDLSRRRLVRIPWDLDSYGIHPDDFSVARAVHASSAIPFVFEPVRVRGATWVDGGLLSNFPVALFDRTDAEPRWPTFGIRLSARPGIPPTRPVQGPVSLGIAAIETLVSNQDNAYIDDPCTVRRTIFVPAHDVSPIDFDITAEQREALYQRGFQAGQKFLANWNYADCLADCGGPFTPSL,"34,689",324,,lipid catabolic process [GO:0016042],hydrolase activity [GO:0016787],integral component of membrane [GO:0016021],,,1
L0TBR2,L0TBR2_MYCTU,Rv2251,Rv2251,GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016164; IPR004113; IPR006094; IPR016171; ,,,DOMAIN 41 223 FAD-binding PCMH-type. {ECO:0000259|PROSITE:PS51387}.,Possible flavoprotein,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MRWRASSAPSISAPPIATGCCTPAASPPQTCCGAKTPVSRMRPTRCCCPAAPTGEDAVADILHYCSDHGIAVVPFGGGTSVVGGLDPVRNDFRAVISLDMRRFDRLHRIDEVSGEAELEAGVTGPEAERLLGEHGFSLGHFPQSFEFATIGGFAATRSSGQDSAGYGRFNDMILGLRMITPVGVLDLGRVPASAAGPDLRQLAIGSEGVFGVITRVRLRVHRIPESTRYEAWSFPDFATGVAALRTITQTGTGPTVVRLSDEAETGVNLATTEAIGETQITGGCLGITVFEGTQEHTESRHAETRALLAARGGTSLGEGPARAWERGRFAAPYLRDSLLAAGALCETLETATVWSNTPVLKAAVTEALTTSLAASGTPALVMCHVSHVYPTGASLYFTVVAGQRGDPIEQWLAAKKAASDAIMATGGTITHHHAVGSDHRPWMRAEVGDLGVTLLRTIKATLDPAGILNPGKLIP,"49,782",475,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,1
O06218,O06218_MYCTU,Rv2159c,Rv2159c,GO:0004601; GO:0005618; GO:0005886; GO:0051920,IPR029032; IPR004675; IPR003779; ,,,DOMAIN 49 121 CMD. {ECO:0000259|Pfam:PF02627}.,Alkyl hydroperoxide reductase AhpD (EC 1.11.1.15),cell wall [GO:0005618]; plasma membrane [GO:0005886]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],9634230; 21969609,,FUNCTION: Antioxidant protein with alkyl hydroperoxidase activity. Required for the reduction of the AhpC active site cysteine residues and for the regeneration of the AhpC enzyme activity. {ECO:0000256|SAAS:SAAS00384272}.,MKFVNHIEPVAPRRAGGAVAEVYAEARREFGRLPEPLAMLSPDEGLLTAGWATLRETLLVGQVPRGRKEAVAAAVAASLRCPWCVDAHTTMLYAAGQTDTAAAILAGTAPAAGDPNAPYVAWAAGTGTPAGPPAPFGPDVAAEYLGTAVQFHFIARLVLVLLDETFLPGGPRAQQLMRRAGGLVFARKVRAEHRPGRSTRRLEPRTLPDDLAWATPSEPIATAFAALSHHLDTAPHLPPPTRQVVRRVVGSWHGEPMPMSSRWTNEHTAELPADLHAPTRLALLTGLAPHQVTDDDVAAARSLLDTDAALVGALAWAAFTAARRIGTWIGAAAEGQVSRQNPTG,"36,376",344,AhpD family,,peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P71892,P71892_MYCTU,Rv2320c,rocE Rv2320c,GO:0005576; GO:0016021; GO:0022857,IPR002293; ,,rocE,,Probable cationic amino acid transport integral membrane protein RocE,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857],9634230,,,MPTTSMSLRELMLRRRPVSGAPVASGASGNLKRSFGTFQLTMFGVGATIGTGIFFVLAQAVPEAGPGVIVSFIIAGIAAGLAAICYAELASAVPISGSAYSYAYTTLGEAVAMVVAACLLLEYGVATAAVAVGWSGYVNKLLSNLFGFQMPHVLSAAPWDTHPGWVNLPAVILIGLCALLLIRGASESARVNAIMVLIKLGVLGMFMIIAFSAYSADHLKDFVPFGVAGIGSAAGTIFFSYIGLDAVSTAGDEVKDPQKTMPRALIAALVVVTGVYVLVALAALGTQPWQDFAEQETAGLAIILDNVTHGEWASTILAAGAVVSIFTVTLVTMYGQTRILFAMGRDGLLPARFAKVNPRTMTPVHNTVIVAIFASTLAAFIPLDSLADMVSIGTLTAFSVVAVGVIVLRVREPDLPRGFKVPGYPVTPVLSVLACGYILASLHWYTWLAFSGWVAVAVIFYLMWGRHHSALNEEVP,"49,947",476,,,transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O53519,O53519_MYCTU,Rv2185c,TB16.3 Rv2185c,GO:0001666; GO:0005618; GO:0005886,IPR019587; IPR023393; ,,TB16.3,,Conserved protein TB16.3,cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to hypoxia [GO:0001666],9634230; 21969609,,,MADKTTQTIYIDADPGEVMKAIADIEAYPQWISEYKEVEILEADDEGYPKRARMLMDAAIFKDTLIMSYEWPEDRQSLSWTLESSSLLKSLEGTYRLAPKGSGTEVTYELAVDLAVPMIGMLKRKAERRLIDGALKDLKKRVEG,"16,325",144,,response to hypoxia [GO:0001666],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P71894,P71894_MYCTU,Rv2318,uspC Rv2318,,IPR006059; ,,uspC,,Probable periplasmic sugar-binding lipoprotein UspC,,9634230; 27335320,X-ray crystallography (2),,MTRPRQSTLVATALVLVAILLGVTAVLLGLSAEPRGGKIVVTVRLWDEPIAAAYRQSFAAFTRSHPDIEVRTNLVAYSTYFETLRTDVAGGSADDIFWLSNAYFAAYADSGRLMKIQTDAADWEPAVVDQFTRSGVLWGVPQLTDAGIAVFYNADLLAAAGVDPTQVDNLRWSRGDDDTLRPMLARLTVDADGRTANTPGFDARRVRQWGYNAANDPQAIYLNYIGSAGGVFQRDGKFAFDNPGAIEAFRYLVGLINDDHVAPPASDTNDNGDFSRNQFLAGKMALFQSGTYSLAPVARDALFHWGVAMLPAGPAGRVSVTNGIAAAGNSASKHPDAVRQVLAWMGSTEGNSYLGRHGAAIPAVLSAQPVYFDYWSARGVDVTPFFAVLNGPRIAAPGGAGFAAGQQALEPYFDEMFLGRGDVTTTLRQAQAAANAATQR,"47,023",440,,,,,,,2
I6XD69,I6XD69_MYCTU,Rv2048c,pks12 Rv2048c,GO:0016491; GO:0016740; GO:0031177; GO:0042802,IPR001227; IPR036736; IPR014043; IPR016035; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,Itself,pks12,DOMAIN 1963 2038 Carrier. {ECO:0000259|PROSITE:PS50075}.; DOMAIN 3995 4070 Carrier. {ECO:0000259|PROSITE:PS50075}.,Polyketide synthase Pks12,identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],9634230; 21969609,,,MVDQLQHATEALRKALVQVERLKRTNRALLERSSEPIAIVGMSCRFPGGVDSPEGLWQMVADARDVMSEFPTDRGWDLAGLFDPDPDVRHKSYARTGGFVDGVADFDPAFFGISPSEALAMDPQHRMLLELSWEALERAGIDPTGLRGSATGVFAGLIVGGYGMLAEEIEGYRLTGMTSSVASGRVAYVLGLEGPAVSVDTACSSSLVALHMAVGSLRSGECDLALAGGVTVNATPTVFVEFSRHRGLAPDGRCKPYAGRADGVGWSEGGGMLVLQRLSDARRLGHPVLAVVVGSAVNQDGASNGLTAPNGPSQQRVVRAALANAGLSAAEVDVVEGHGTGTTLGDPIEAQALLATYGQDRGEPGEPLWLGSVKSNMGHTQAAAGVAGVIKMVLAMRHELLPATLHVDVPSPHVDWSAGAVELLTAPRVWPAGARTRRAGVSSFGISGTNAHVIIEAVPVVPRREAGWAGPVVPWVVSAKSESALRGQAARLAAYVRGDDGLDVADVGWSLAGRSVFEHRAVVVGGDRDRLLAGLDELAGDQLGGSVVRGTATAAGKTVFVFPGQGSQWLGMGIELLDTAPAFAQQIDACAEAFAEFVDWSLVDVLRGAPGAPGLDRVDVVQPVLFAVMVSLAELWKSVAVHPDAVIGHSQGEIAAAYVAGALSLRDAARVVTLRSKLLAGLAGPGGMVSIACGADQARDLLAPFGDRVSIAVVNGPSAVVVSGEVGALEELIAVCSTKELRTRRIEVDYASHSVEVEAIRGPLAEALSGIEPRSTRTVFFSTVTGNRLDTAGLDADYWYRNVRQTVLFDQAVRNACEQGYRTFIESSPHPALITGVEETFAACTDGDSEAIVVPTLGRGDGGLHRFLLSAASAFVAGVAVNWRGTLDGAGYVELPTYAFDKRRFWLSAEGSGADVSGLGLGASEHPLLGAVVDLPASGGVVLTGRLSPNVQPWLADHAVSDVVLFPGTGFVELAIRAGDEVGCSVLDELTLAAPLLLPATGSVAVQVVVDAGRDSNSRGVSIFSRADAQAGWLLHAEGILRPGSVEPGADLSVWPPAGAVTVDVADGYERLATRGYRYGPAFRGLTAMWARGEEIFAEVRLPEAAGGVGGFGVHPALLDAVLHAVVIAGDPDELALPFAWQGVSLHATGASAVRARIAPAGPSAVSVELADGLGLPVLSVASMVARPVTERQLLAAVSGSGPDRLFEVIWSPASAATSPGPTPAYQIFESVAADQDPVAGSYVRSHQALAAVQSWLTDHESGVLVVATRGAMALPREDVADLAGAAVWGLVRSAQTEHPGRIVLVDSDAATDDAAIAMALATGEPQVVLRGGQVYTARVRGSRAADAILVPPGDGPWRLGLGSAGTFENLRLEPVPNADAPLGPGQVRVAMRAIAANFRDIMITLGMFTHDALLGGEGAGVVVEVGPGVTEFSVGDSVFGFFPDGSGTLVAGDVRLLLPMPADWSYAEAAAISAVFTTAYYAFIHLADVQPGQRVLIHAGTGGVGMAAVQLARHLGLEVFATASKGKWDTLRAMGFDDDHISDSRSLEFEDKFRAATGGRGFDVVLDSLAGEFVDASLRLVAPGGVFLEMGKTDIRDPGVIAQQYPGVRYRAFDLFEPGRPRMHQYMLELATLFGDGVLRPLPVTTFDVRRAPAALRYLSQARHTGKVVMLMPGSWAAGTVLITGGTGMAGSAVARHVVARHGVRNLVLVSRRGPDAPGAAELVAELAAAGAQVQVVACDAADRAALAKVIADIPVQHPLSGVIHTAGALDDAVVMSLTPDRVDVVLRSKVDAAWHLHELTRDLDVSAFVMFSSMAGLVGSSGQANYAAANSFLDALAAHRRAHGLPAISLGWGLWDQASAMTGGLDAADLARLGREGVLALSTAEALELFDTAMIVDEPFLAPARIDLTALRAHAVAVPPMFSDLASAPTRRQVDDSVAAAKSKSALAHRLHGLPEAEQHAVLLGLVRLHIATVLGNITPEAIDPDKAFQDLGFDSLTAVEMRNRLKSATGLSLSPTLIFDYPTPNRLASYIRTELAGLPQEIKHTPAVRTTSEDPIAIVGMACRYPGGVNSPDDMWDMLIQGRDVLSEFPADRGWDLAGLYNPDPDAAGACYTRTGGFVDGVGDFDPAFFGVGPSEALAMDPQHRMLLELSWEALERAGIDPTGLRGSATGVFAGVMTQGYGMFAAEPVEGFRLTGQLSSVASGRVAYVLGLEGPAVSVDTACSSSLVALHMAVGSLRSGECDLALAGGVTVNATPDIFVEFSRWRGLSPDGRCKAFAAAADGTGFSEGGGMLVLQRLSDARRLGHPVLAVVVGSAVNQDGASNGLTAPNGPSQQRVVRAALANAGLSAAEVDVVEGHGTGTTLGDPIEAQALLATYGQDRGEPGEPLWLGSVKSNMGHTQAAAGVAGVIKMVLAMRHELLPATLHVDVPSPHVDWSAGAVELLTAPRVWPAGARTRRAGVSSFGISGTNAHVIIEAVPVVPRREAGWAGPVVPWVVSAKSESALRGQAARLAAYVRGDDGLDVADVGWSLAGRSVFEHRAVVVGGDRDRLLAGLDELAGDQLGGSVVRGTATAAGKTVFVFPGQGSQWLGMGMGLHAGYPVFAEAFNTVVGELDRHLLRPLREVMWGHDENLLNSTEFAQPALFAVEVALFRLLGSWGVRPDFVMGHSIGELSAAHVAGVLSLENAAVLVAARGRLMQALPAGGAMVAVQAAEEEVRPLLSAEVDIAAVNGPASLVISGAQNAVAAVADQLRADGRRVHQLAVSHAFHSPLMDPMIDEFAAVAAGIAIGRPTIGVISNVTGQLAGDDFGSAAYWRRHIRQAVRFADSVRFAQAAGGSRFLEVGPSGGLVASIEESLPDVAVTTMSALRKDRPEPATLTNAVAQGFVTGMDLDWRAVVGEAQFVELPTYAFQRRRFWLSGDGVAADAAGLGLAASEHALLGAVIDLPASGGVVLTGRLSPSVQGWLADHSVAGVTIFPGAGFVELAIRAGDEVGCGVVDELTLAAPLVLPASGSVAVQVVVNGPDESGVRGVSVYSRGDVGTGWVLHAEGALRAGSAEPTADLAMWPPAGAVPVEVADGYQQLAERGYGYGPAFRGLTAMWRRGDEVFAEVALPADAGVSVTGFGVHPVLLDAALHAVVLSAESAERGQGSVLVPFSWQGVSLHAAGASAVRARIAPVGPSAVSIELADGLGLPVLSVASMLARPVTDQQLRAAVSSSGPDRLFEVTWSPQPSAAVEPLPVCAWGTTEDSAAVVFESVPLAGDVVAGVYAATSSVLDVLQSWLTRDGAGVLVVMTRGAVALPGEDVTDLAGAAVWGLVRSAQTEHPGRIVLVDSDAPLDDSALAAVVTTGEPQVLWRRGEVYTARVHGSRAVGGLLVPPSDRPWRLAMSTAGTFENLRLELIPDADAPLGPGQVRVAVSAIAANFRDVMIALGLYPDPDAVMGVEACGVVIETSLNKGSFAVGDRVMGLFPEGTGTVASTDQRLLVKVPAGWSHTAAATTSVVFATAHYALVDLAAARSGQRVLIHAGTGGVGMAAVQLARHLGLEVFATASKGKWDTLRAMGFDDDHISDSRSLEFEDKFRAATGGRGFDVVLDSLAGEFVDASLRLVAPGGVFLEMGKTDIRDPGVIAQQYPGVRYRAFDLFEPGPDRIAQILAELATLFGDGVLRPLPVTTFDVRCAPAALRYLSQARHTGKVVMLMPGSWAAGTVLITGGTGMAGSAVARHVVARHGVRNLVLVSRRGPDAPGAAELVAELAAAGAQVQVVACDAADRAALAKVIADIPVQHPLSGVIHTAGALDDAVVMSLTPDRVDVVLRSKVDAAWHLHELTRDLDVSAFVMFSSMAGLVGSSGQANYAAANSFLDALAAHRRAHGLPAISLGWGLWDQASAMTGGLATVDFKRFARDGIVAMSSADALQLFDTAMIVDEPFMLPAHIDFAALKVKFDGGTLPPMFVDLINAPTRRQVDDSLAAAKSKSALLQRLEGLPEDEQHAVLLDLVRSHIATVLGSASPEAIDPDRAFQELGFDSLTAVEMRNRLKSATGLALSPTLIFDYPNSAALAGYMRRELLGSSPQDTSAVAAGEAELQRIVASIPVKRLRQAGVLDLLLALANETETSGQDPALAPTAEQEIADMDLDDLVNAAFRNDDE,"431,607",4151,,,identical protein binding [GO:0042802]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],,,,1
I6XDU8,I6XDU8_MYCTU,Rv2237A,Rv2237A,,,,,,Conserved protein,,9634230; 21969609,,,MLRCRRGAGYGSVVVVGERPGFQSDSAARQTAPPVRPMTSDQLPATKADLYAAVDAMRADMRELLEQISTLIREATQK,"8,508",78,,,,,,,1
Q79FF7,Q79FF7_MYCTU,Rv2331A,Rv2331A,,,,,,Uncharacterized protein,,9634230,,,MKGHLATFGHPALPTYRGSWLSREPGSPYRLPAGAGRDRGDACRRIPRRTGSGTLLRPGQRCTFAANADPMAKGVDRALCEIVAERRQLDLDLAKAQVRSALANQRYHRDVH,"12,361",112,,,,,,,1
O06237,O06237_MYCTU,Rv2138,lppL Rv2138,GO:0040007,IPR015943,,lppL,,Probable conserved lipoprotein LppL,growth [GO:0040007],9634230; 21969609,,,MLTGNKPAVQRRFIGLLMLSVLVAGCSSNPLANFAPGYPPTIEPAQPAVSPPTSQDPAGAVRPLSGHPRAALFDNGTRQLVALRPGADSAAPASIMVFDDVHVAPRVIFLPGPAAALTSDDHGTAFLAARGGYFVADLSSGHTARVNVADAAHTDFTAIARRSDGKLVLGSADGAVYTLAKNPAVDPASGAATVASRTKIFARVDALVTQGNTTVVLDRGQTSVTTIGADGHAQQALRAGQGATTMAADPLGRVLIADTRGGQLLVYGVDPLILRQAYPVRQAPYGLAGSRELAWVSQTASNTVIGYDLTTGIPVEKVRYPTVQQPNSLAFDETSDTLYVVSGSGAGVQVIEHAAGTR,"36,837",358,,growth [GO:0040007],,,,,1
Q10843,Q10843_MYCTU,Rv2014,Rv2014,GO:0003677; GO:0004803; GO:0006313,IPR003346; ,,,,Transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MLHDRLTGAPRGATGDEGAANAHITRAMVAALTSVATQIKTLDAQIAEQLSLHADAHIFTSLPRSGTVRAARLLAEIGDCRARFPTPESLACLAGVAPSTRQSGKVKHVGFRWAADKQLRDAVCDFAGDSRRANLWAADRYNRAIARGHDHPHAVRILARAWLYAIWHCWQDGAAYHPANHRALQALLNQDQDRAA,"21,349",196,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,3
O33254,O33254_MYCTU,Rv2119,Rv2119,GO:0005886,IPR011604; IPR038726; IPR011335; ,,,DOMAIN 14 260 PDDEXK_1. {ECO:0000259|Pfam:PF12705}.,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MADQPDPPTPRPALSPSRATDFKQCPLLYRFRAIDRLPEATSAAQLRGSVVHAALEQLYGLPAGLRSPDTARSLVQRAWDQMVAAEPELAGELDPGQPTQLLEDARALVSGYYRLEDPTRFDPQCCEQRVEVELADGTLLRGYIDRIDVAATGELRVVDYKTGKAPPAARALAEFKAMFQMKFYAVALFRSRGVPPTRLRLIYLADGQLLDYSPDRDELLRFEKTLMAIWRAIQSAGETGDFRPNPSRLCDWCPHQQRCPAFGGTPPPYPGWPTEPAA,"30,926",278,,,,plasma membrane [GO:0005886],,,1
O86339,O86339_MYCTU,Rv2060,Rv2060,GO:0005576; GO:0005886; GO:0005887; GO:0010043; GO:0042626; GO:0043190,IPR037294; IPR001626; ,,,,Possible conserved integral membrane protein,"ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATPase activity, coupled to transmembrane movement of substances [GO:0042626]; response to zinc ion [GO:0010043]",9634230,,,MLTVVCLLVVTVLAICYRPLLFATVDPEVAAARGVPVRALGIVFAALMGVVAAQAVQIVGALLVMSLLITPAAAAARVVVAPVAAIATSVVFAEVSAVGGILLSLAPGVPVSVFVATISFVIYLICWLLRRRR,"13,665",133,ABC-3 integral membrane protein family,response to zinc ion [GO:0010043],"ATPase activity, coupled to transmembrane movement of substances [GO:0042626]",ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
Q79FG7,Q79FG7_MYCTU,Rv2219A,Rv2219A,GO:0016021,IPR010432; IPR016795; ,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MTAKSPPDYPGKTLGLPDTGPGSLAPMGRRLAALLIDWLIAYGLALLGVEFGVWSTPMLSTVVLVIWLLLGVAAVRLFGFTPGQLMLGLVVVAVGGRRPVGIGRLVVRGLLIGLVVPPLFTDSDGRGLHDRLTATAVVRR,"14,705",140,,,,integral component of membrane [GO:0016021],,,1
Q79FG9,Q79FG9_MYCTU,Rv2160c,Rv2160c,,IPR036271; ,,,,Uncharacterized protein,,9634230,,,MGRIPGTRRAGGCFFAAAAADVDSQPGPVRDRIAATGRAGIAAITADVETAQRRGEIRADIEVRQLAFELHAYAMEANWALLLLDDDGAGERARTAIDAALARVGTTQEGVES,"11,851",113,,,,,,,2
L7N6B8,L7N6B8_MYCTU,Rv2077A,Rv2077A,,,,,,Uncharacterized protein,,9634230,,,MGSNELQVVLGQLEVAASQSQGLGAQFAASATPPESGQPFQATTVAVSGINAAICCAAAEFATRTQATATGVAAAAAAYAHQEATAASEMAAVTQVTVV,"9,641",99,,,,,,,1
O53973,O53973_MYCTU,Rv1972,Rv1972,,,,,,Probable conserved Mce associated membrane protein,,9634230,,,MSVAVDSDAEDDAVSEIAEAAGVSPAPAKPSMSAPRRMLLFGLVVVVALAVLLCCWGFRVQRARHAQDQRGHFLQAARQCALNLTTIDWRNAEADVRRILDGATGEFYNDFAQRSQPFVEVLRHAKASTVGTITEAGLQTQTADTAQALVAVSVQTSNAGEADPVPRAWRMRITVQRVGDRVKVSDVGFVP,"20,601",191,,,,,,,1
P71896,P71896_MYCTU,Rv2316,uspA Rv2316,GO:0005887; GO:0055085,IPR000515; IPR035906; ,,uspA,,Probable sugar-transport integral membrane protein ABC transporter UspA,integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085],9634230,,,MRDAPRRRTALAYALLAPSLVGVVAFLLLPILVVVWLSLHRWDLLGPLRYVGLTNWRSVLTDSGFADSLVVTAVFVAIVVPAQTVLGLLAASLLARRLPGTGLFRTLYVLPWICAPLAIAVMWRWIVAPTDGAISTVLGHRIEWLTDPGLALPVVSAVVVWTNVGYVSLFFLAGLMAIPQDIHNAARTDGASAWQRFWRITLPMLRPTMFFVLVTGIISAAQVFDTVYALTGGGPQGSTDLVAHRIYAEAFGAAAIGRASVMAVVLFVILVGATVVQHLYFRRRISYELT,"31,531",290,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of plasma membrane [GO:0005887],,,1
O53491,O53491_MYCTU,Rv2049c,Rv2049c,,,,,,Uncharacterized protein,,9634230,,,MLTRGEVRALPADAVVLSADDAADLSDRVYQVRCAAEDVVTALDEGAAATELRDLCDELIRAARAADGWRRAGA,"7,830",74,,,,,,,1
O06216,O06216_MYCTU,Rv2161c,Rv2161c,GO:0005886; GO:0016705,IPR019921; IPR011251; IPR036661; ,,,,Conserved protein,"plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MLVSLMQFVTDLTPPPQLVAVWAEERGFAGLYVPEKTHVPISRSTPWPGGELPDWYRRCYDPVVALAAAAAVTTRLRVGTGACLVAVHDPILLAKQIASLCAMSGERFVLGVGFGWNVEELADHGVPFADRIAVTVDKLAAMRALWAAEPVHYEGTHASVPPSWAWPKPAVAPPVLFGCRPSARAFEVIARHGDGWQPIEGYGELLGALPMLHAAFERAGRDPATAQVCVYSSAGDPATLHEYRRAGVAEVALALPSAGRDQVLAALDRSAPLVDAFAGDDREVKSHA,"30,768",288,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",plasma membrane [GO:0005886],,,1
O33249,O33249_MYCTU,Rv2114,Rv2114,GO:0005829,IPR016792; ,,,,Conserved protein,cytosol [GO:0005829],9634230; 21969609,,,MSAPERVTGLSGQRYGEVLLVTPGEAGPQATVYNSFPLNDCPAELWSALDPQALATEHKAATALLNGPRYWLMNAIEKAPQGPPVTKTFGGIEMLQQATVLLSSMNPAPYTVSQVSRNTVFVFNAGEEVYELQDPKGQRWVMQTWSQVVDPNLSRADLPKLGERLNLPAGWSYHTRVLTSELRVDTTNREARVLQDDLTNSYSLVTA,"22,775",207,,,,cytosol [GO:0005829],,,3
O53485,O53485_MYCTU,Rv2041c,Rv2041c,GO:0005886; GO:0040007,IPR006059; IPR006311; ,,,,Probable sugar-binding lipoprotein,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MVNKPFERRSLLRGAGALTAASLAPWAAGCAADDDDALTFFFAANPDELRPRMRVVNEFQRRYPDIKVRALLSGPGVMQQLATFCAGGKCPDVLMAWELTYAELADRGVLLDLNTLLARDQAFAAELKSDSIGALYETFTFNGGQYAFPEQWSGNFLFYNKQLFDDAGVPPPPGSWERPWSFAEFLDAAQALTKQGRSGRDRQWGFVNAWVSFYAAGLFAMNNGVPWSVPRMNPTHLNFDHDGFLEAVQFYADLTNKHKVAPSAAEQQSMSTADLFSVGKAGIALAGHWRYQTFDRADGLDFDVAPLPIGPRGRAACSDIGVTGLAIAATSRRKDQAWEFVKFATGPVGQALIGESRLFVPVLRSAINSHGFANAHRRVGNLAVLSEGPAYSEGLPVTPAWEKIAALMDRYFGPVLRGSRPATSLTGLSQAVDEVLRNP,"47,876",439,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
O53518,O53518_MYCTU,Rv2184c,Rv2184c,GO:0005524; GO:0016887,IPR025723; IPR016300; IPR008978; IPR027417; ,,,DOMAIN 1 279 ArsA_ATPase. {ECO:0000259|Pfam:PF02374}.,Uncharacterized protein,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MVVSTDQAHSLGDVLGIAVPPTGQGDPVRVLAYDPEAGGGFLDALALDTLALLEGRWLHVVETLDRRFPGSELSSIAPEELCALPGIQEVLGLHAVGELAAARRWDRIVVDCASTADALRMLTLPATFGLYVERAWPRHRRLSIGADDGRSAVLAELLERIRASVERLSTLLTDGALVSAHLVLTPERVVAAEAVRTLGSLALMGVRVEELLVNQLLVQDENYEYRSLPDHPAFHWYAERIGEQRAVLDDLDATIGDVALVLVPHLAGEPIGPKALGGLLDSARRRQGSAPPGPLQPIVDLESGSGLASIYRLRLALPQLDPGTLTLGRADDDLIVSAGGMRRRVRLASVLRRCTVLDAHLRGGELTVRFRPNPEVWPT,"40,857",379,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,3
Q10675,Q10675_MYCTU,Rv2064,cobG Rv2064,GO:0016491; GO:0046872; GO:0051539,IPR012798; IPR005117; IPR036136; ,,cobG,,Precorrin-3B synthase CobG,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",9634230; 21969609,,,MAGTRDADACPGALRPHQAADGALARIRLPGGMITAAQLATLASVASDFGSATLELTARGNVQLRGIRDVAAVADAVAKAGLLPSATHERVRNIVASPLSGRAGGLADVRAWVGELDAAIRAEPRLAELGGRFWFGLDDGRADVSGLGADVGVQVFPDGPRLLLTGRDTGVRVADVAETLIEVALRFVKIRETAWRVTELADIGELQSGVELGPSVRPVTKTPVGWIPQDDSRVTLGAAVPLGVLPARVAECLAAIEAPLVITPWRSVLICDLDDATADAALRVLAPLGLVFDENSPWLNISACTGSPGCAHSAADVRADAARSLNVESAGHRHFVGCERACGSPPAGEVLVATGGGYRRLRP,"37,529",363,,,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",,,,1
L7N666,L7N666_MYCTU,Rv2309A,Rv2309A,,,,,,Uncharacterized protein,,9634230,,,MATSSDDITINRHPPLNCAVNRHDESRRSPLRRGLLANGLRERQAGALFERYESQFDSFGYIEKVRYRGSGYRVEDVYARADSGPSAGAELPVGP,"10,599",95,,,,,,,1
L7N684,L7N684_MYCTU,Rv2141c,Rv2141c,GO:0008237,IPR001261; IPR036264; IPR002933; IPR011650; ,,,,Conserved protein,metallopeptidase activity [GO:0008237],9634230; 21969609,,,MTDETGASSDHSDDVAQVVSRLIRFDTTNSGEPGTTKGEAECARWVAEQLAEVGYQPEYVESGAPGRGNVFARLAGADSSRGALLIHGHLDVVPAEPAEWSVHPFSGAIEDGYVWGRGAVDMKDMVGMMIVVARHLRQAAIVPPRDLVFAFVADEEHGGKYGSHWLVDNRPDLFDGITEAIGEVGGFSLTVPRHDGGERRLYLIETAEKGIQWMRLTARGRAGHGSMVHDQNAVTAVCEAVARLGRHQFPLVCTDTVAQFLAVVGEETGLAFDLDSPDLAGTIDKLGPMARMLKAVLHDTANPTMLKAGYKANVVPATAEAVVDCRVLPGRRAAFEAEVDALIGPDVTREWVSDLPSYETTFDGDLVAAMNAAVLAVDPDGRTVPYMLSGGTDAKAFARLGIRCFGFSPLRLPPDLDFTSLFHGVDERVPIDGLRFGTEVLTHLLTHC,"48,142",448,,,metallopeptidase activity [GO:0008237],,,,1
O53483,O53483_MYCTU,Rv2039c,Rv2039c,GO:0005886; GO:0016021; GO:0055085,IPR000515; IPR035906; ,,,,Probable sugar-transport integral membrane protein ABC transporter,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MGWADRIVHRHFIRGLALYAGLIGIAWCALFPIIWALSGSLKADGEVTEPTLFPSHPQWSNYREVFALMPFWRMFFNTVLYAGCVTAGQVFFCSLAGYAFARLQFRGRDTLFVLYLSTLMVPLTVTVIPQVILMRIVGWVDTPWAMIVPGLFGSAFGTYLMRQFFRTLPTDLEEAAILDGCSPWQIYWRILLPHSRPAVLVLGVLTWVNVWNDFLWPLLMIQRNSLATLTLGLVRLRGEYVARWPVLMAASMLMLVPLVILYAVAQRSFVRGIAVTGLGG,"31,608",280,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P71890,P71890_MYCTU,Rv2322c,rocD1 Rv2322c,GO:0004587; GO:0009447; GO:0030170; GO:0033094; GO:0042802,IPR005814; IPR034757; IPR015424; IPR015422; IPR015421; ,,rocD1,,Probable ornithine aminotransferase (N-terminus part) RocD1 (Ornithine--oxo-acid aminotransferase),"butane-1,4-diamine:2-oxoglutarate aminotransferase activity [GO:0033094]; identical protein binding [GO:0042802]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; putrescine catabolic process [GO:0009447]",9634230,,,MTNLADATQATMALVERHAAHNYSPLPVVAASAEGAWIADIDGLRYLDWLAAYSAVNLGHRNPASTATAHAQVDTVTLLNRALHADRLGPLGAALAQLCGKDVVLPMNSDAEAVESGLRVARKWGADVNGLPAGRHDIILANNNFHGHTSSVVSFSSDPAAGSGVEPSTPGLRSVPFGDAAAPAQTIDDNTVADLLEPIPGQAGIIVPADDYLPAASSTTC,"22,714",221,,putrescine catabolic process [GO:0009447],"butane-1,4-diamine:2-oxoglutarate aminotransferase activity [GO:0033094]; identical protein binding [GO:0042802]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]",,,,1
O33255,O33255_MYCTU,Rv2120c,Rv2120c,GO:0016021; GO:0019867,IPR008816; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; outer membrane [GO:0019867],9634230; 21969609,,,MTHVLVLLLALLIGVVAGLRSLTAPAVVSWAAFLGWINLHGTWASWMGNFVTVVIVSVLAVAELVNDKRPKTPPRTVTPVFAVRIILGAFAGAVIGTAWGYRWGGLGAGVIGAVLGTMGGYQARTRLVAARGGHDLPIALLEDSVAVLGGFAIVAAAAAL,"16,404",160,,,,integral component of membrane [GO:0016021]; outer membrane [GO:0019867],,,1
O53463,O53463_MYCTU,Rv2017,Rv2017,GO:0019217; GO:0043565; GO:1902882,IPR001387; IPR010359; IPR010982; ,,,DOMAIN 8 61 HTH cro/C1-type. {ECO:0000259|PROSITE:PS50943}.,Transcriptional regulatory protein,sequence-specific DNA binding [GO:0043565]; regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882],9634230; 21969609,,,MNGLGDVLAVARKARGLTQIELAELVGLTQPAINRYESGDRDPDQHIVAKLAEILGVTDDLLIHGNRFRGALAVDAHMRRHKTTKASAWRQLEARLNLLRVHASFLFEEVAINSEQHVPAFDPEFTAAEDAARLVRAQWRMPMGPVVNLTRWMEAAGCLVFEEDFATQRIDGLSQWVDDYPVMLINANAAPDRKRLTLAHELGHLVLHSTNPTENMETEATAFAAEFLMPESEIRPELRRLDLGKLLELKREWGVSMQALLARAYRMGLVSAEARTKLYKAMNARGWKTKEPGIESIVREKPSLPAHIGMTLRSRGFTDQQAAAIAGYANPADNPFRPEGGRLHAI,"38,605",346,,regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882],sequence-specific DNA binding [GO:0043565],,,,1
O53494,O53494_MYCTU,Rv2052c,Rv2052c,GO:0005618; GO:0005829; GO:0005886; GO:0016810,IPR013108; IPR011059; IPR032466; IPR033932; ,,,,Conserved protein,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",9634230; 21969609,,,MSQIPVKLLVNGRVYSPTHPEATAMAVRGDVVAWLGSDDVGRDQFPDADVQDLDGRFVAPGFVDSHIHLTATGLMLSGLDLRPATSRAQCLRMVADYAADHPGQPLWGHGWDESAWPENAAPSTADLDAVLGDCPAYLARIDSHSALVSSGLRRLVPELAAATGYTAQRPLTGDAHHLARAAARYLLTDVQLADARAVALQAIAAAGVVAVHECAGPEIGGLDDWLRLRALEHGVEVIGYWGEAVATPAQARDLVTETGARGLAGDLFVDGALGSRTAWLHEPYADAPDCIGTCHLDVDGIEAHVRACTKAEVTAGFHVIGDAAVSAAVAAFERVVADLGVVAVARCGHRLEHVEMVTADQAAKLGAWGVIASVQPNFDELWGGGDGMYARRLGAQRGSELNPLALLASQGVPLALGSDAPVTGFDPWASVRAAVNHRTPGSGVSARAAFAAATRGGWRAGGVRDGRIGTLVPGAPASYAIWDAGDFDVDAPRDAVQRWSTDPRSRVPALPRLGPTDALPRCRQTVHRGAVIYG,"55,854",534,,,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q50662,Q50662_MYCTU,Rv2303c,Rv2303c,GO:0016787; GO:0016831,IPR032465; IPR006680; IPR032466; ,,,,Probable antibiotic-resistance protein,carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787],9634230; 21969609,,,MTAPEPRVPVIDMWAPFVPSAEVIDDLREGFPVELLSYFEVFTKTTISAEQFGAYAESLRRTDDQILDSLDDAGITRSLITGFDERSTCGVTFVHNASVAAVAARYPDRFLPFAGADILAGDSAVDEFERWVVEHGFRGLSLRPFMIGRPASDPAYFPCYAKCVELGVPVSIHTSADWTRTRLSDLGHPRHIDDVACRFPELTILMSHGGYPWVLQACLIAWKHPNVYLELAAHRPKYFASPGAGWEPLMRFGQTTIRNKIVYGTGGFLINRPYLQLCDEMRALPVPREVLEDWLWRNATRVLRLDT,"34,550",307,,,carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787],,,,1
O53506,O53506_MYCTU,Rv2172c,Rv2172c,,,,,,Conserved protein,,9634230; 21969609,,,MTLNTIALELVPPNLEGGKERAIEDARKVVQYSAASGLDGRIRHVMMPGMIAEDDDRPIPMQPKLDVLDFWSIIKPELAGVHGLCTQVTAFMDEPSLHRRLVDLSDAGMEGIVFVGVPRTMQDGEGSGVAPTDALSLYRQLVANRGVIVIPTRDGEQGRLNFKCSRGATYGMTQLLYSDAIVGFLREFARTTEHRPEILLSFGFVPKVETRIGLINWLIQDPGNAAVADEQAFVQKLAGSEPARRRRLMVDLYKRVLDGVADLGFPLSIHLEATYGVSAAAFETFAEMLAYWSPAEPGKPD,"33,039",301,,,,,,,3
L7N698,L7N698_MYCTU,Rv1966,mce3A Rv1966,GO:0016021,IPR005693; IPR003399; IPR024516; ,,mce3A,,Mce-family protein Mce3A,integral component of membrane [GO:0016021],9634230,,,MRRGPGRHRLHDAWWTLILFAVIGVAVLVTAVSFTGSLRSTVPVTLAADRSGLVMDSGAKVMMRGVQVGRVAQIGRIEWAQNGASLRLEIDPDQIRYIPANVEAQISATTAFGAKFVDLVMPQNPSRARLSAGAVLHSKNVSTEINTVFENVVDLLNMIDPLKLNAVLTAVADAVRGQGERIGQATTDLNEVLEALNARGDTIGGNWRSLKNFTDTYDAAAQDILTILNAASTTSATVVNHSTQLDALLLNAIGLSNAGTNLLGSSRDNLVGAADILAPTTSLLFKYNPEYTCFLQGAKWYLDNGGYAAWGGADGRTLQLDVALLFGNDPYVYPDNLPVVAAKGGPGGRPGCGPLPDATHNFPVRQLVTNTGWGTGLDIRPNPGIGHPCWANYFPVTRAVPEPPSIRQCIPGPAIGPNPAAGEQP,"45,000",425,,,,integral component of membrane [GO:0016021],,,1
O06231,O06231_MYCTU,Rv2144c,Rv2144c,GO:0016021,,,,,Probable transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MLIIALVLALIGLLALVFAVVTSNQLVAWVCIGASVLGVALLIVDALRERQQGGADEADGAGETGVAEEADVDYPEEAPEESQAVDAGVIGSEEPSEEASEATEESAVSADRSDDSAK,"12,027",118,,,,integral component of membrane [GO:0016021],,,1
P71888,P71888_MYCTU,Rv2324,Rv2324,GO:0003700; GO:0005829; GO:0006351; GO:0043200; GO:0043565,IPR011991; IPR000485; IPR011008; IPR019888; IPR019887; IPR036388; IPR036390; ,,,DOMAIN 4 65 HTH asnC-type. {ECO:0000259|PROSITE:PS50956}.,Probable transcriptional regulatory protein (Probably AsnC-family),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MDRLDDTDERILAELAEHARATFAEIGHKVSLSAPAVKRRVDRMLESGVIKGFTTVVDRNALGWNTEAYVQIFCHGRIAPDQLRAAWVNIPEVVSAATVTGTSDAILHVLAHDMRHLEAALERIRSSADVERSESTVVLSNLIDRMPP,"16,352",148,,"response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],cytosol [GO:0005829],,,1
L7N683,L7N683_MYCTU,,Rv2307D,,,,,,Uncharacterized protein,,9634230,,,MWRHLWLMQPQRRYPRGSGTTRTARRDAGVAPLYGVSRVTVLASTTATTAPPVKSFPDLL,"6,697",60,,,,,,Rv2307D,1
Q10844,Q10844_MYCTU,Rv2013,Rv2013,GO:0003677; GO:0004803; GO:0006313; GO:0040007,IPR002525; ,,,,Transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; growth [GO:0040007]; transposition, DNA-mediated [GO:0006313]",9634230,,,MDTLLEAGITVVVISPNQLKNLRGRYGSAGNKDDRFDAFVLADTLRTDRSRLRPLLPDTPATATLRRTCRPRKDLVAHRVALANQLRAHLRVVFPGVVGLFADLDSPISLAFLTFLPRFDCQDRADWLSVKRLAGWLAAAGYCGRAPRPAHRCPARRHR,"17,766",159,,"growth [GO:0040007]; transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
O53528,O53528_MYCTU,Rv2254c,Rv2254c,GO:0006865; GO:0016021,IPR001123; ,,,,Probable integral membrane protein,integral component of membrane [GO:0016021]; amino acid transport [GO:0006865],9634230,,,MRYRDLETVAAPTINVLRVWPEIVGAIVLLVIAAMGIGHGLRPSPEPVPAPQKQLGCVRFALIFGLTAINPATFVYFTAVAVTLARALRATTAIAVVVGVALASLLWQLLLVSAGAFLRSRATARVRRMTVLAGNAVIAAFGAVLVVHAFA,"15,867",151,,amino acid transport [GO:0006865],,integral component of membrane [GO:0016021],,,1
Q79FG4,Q79FG4_MYCTU,Rv2306B,Rv2306B,GO:0016021,IPR032816; IPR015414; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MWAVVGQRFVPGISDALASYTFGAFGVPLWQMVVGSFIGSAPRVFVYTALGASITNLSSPLVYSAIAVWCVTAIIGAFAARRWYRKWRARPRRRCGLAQLTTGSQQRHTSHRTPAGVVMPGSLSEHRRLRQEAPDRIEHHPPIE,"15,957",144,,,,integral component of membrane [GO:0016021],,,1
P95256,P95256_MYCTU,Rv1958c,Rv1958c,,,,,,Uncharacterized protein,,9634230,,,MIPTPSIGAVINAKISHRACRTFPRPTDIHPRRYLPRKHGGTNPRRLSMNPGGMRIRCRRGDKSRKLLSRSQVQPLVGRPAKIPSPAANAPPSRARTASPVFENLELRAAAGLAFGFRLRPFGGTAADSPPVAAQDLDPCRWADSPALHLAVGVETMVVGQLDSPSFGQGVPLVAGHWAPGETGIGRDNISRVNGGSARRPVRS,"21,792",204,,,,,,,1
L7N6A1,L7N6A1_MYCTU,Rv2162c,PE_PGRS38 Rv2162c,,IPR000084; ,,PE_PGRS38,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS38,,9634230; 21969609,,,MSFVIAAPEVMAAAATDLANIGSSISAASAAAAGPTMGILAAGADEVSVAISALFGSHAQGYQTLSAQLAAYHNQFVRALNAGAGSYASAEAANVQQTLLNAINAPTQTLLGRPLIGNGADGGPGQNGGPGGLLYGNGGNGGAGDTANPNGGNGGSAGLIGNGGAGGAGAATGAGGAGGNGGWLYGNGGPGGAAGLGTAGGVSPAGGAGGAAGLWGHGGAGGAGGSASGAPGAGGAGGDGGRGGLLYGDGGAGGAGGNGSNGVTGVHGGNGGAGGAAGLIGNGGAGGDGGNGGLSNTGASGGAGGAGGAALIGNGGDGGHGGNGGHGNSGGAGGAGGAGGAGGAGGHVGLIGNGGNGGAGGNGGNDNSSTLADAGSGGAGAAGGNGGLFYGNGGVGGRGGNGGFSSAGTSGGDGGIGGAGGIGGLIGSGGGGGDGGNGGQAPTPGNAGDGGAGGNARLIGDGGRGGNGGEGGDGPPGVKGDGGNGGNGGNAVVIGNGGNGGAGGFGIPVGSGGAGGSRGVLFGTPGANGADG,"44,479",532,,,,,,,1
O06242,O06242_MYCTU,Rv2133c,Rv2133c,,IPR022292; ,,,,Uncharacterized protein,,9634230; 21969609,,,MLADGELTVLGRIRSASNATFLCESTLGLRSLHCVYKPVSGERPLWDFPDGTLAGRELSAYLVSTQLGWNLVPHTIIRDGPAGIGMLQLWVQQPGDAVDSDPLPGPDLVDLFPAHRPRPGYLPVLRAYDYAGDEVVLMHADDIRLRRMAVFDVLINNADRKGGHILCGIDGQVYGVDHGLCLHVENKLRTVLWGWAGKPIDDQILQAVAGLADALGGPLAEALAGRIAAAEIGALRRRAQSLLDQPVMPGPNGHRPIPWPAF,"28,317",262,,,,,,,1
O53470,O53470_MYCTU,Rv2024c,Rv2024c,GO:0003677; GO:0005524; GO:0016787,IPR006935; IPR014001; IPR027417; IPR011335; ,,,DOMAIN 181 380 Helicase ATP-binding. {ECO:0000259|PROSITE:PS51192}.,Uncharacterized protein,ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],9634230,,,MGSVHDVIEAFRKAPSNAERGTKFEQLMVRYFELDPTMAQQYDAVWWWIDWPERRGRTDTGIDLVARERDTGNYTAIQCKFYEPTHTLAKGDIDSFFTASGKTGFTNRVIISTTDRWGRNAEDALADQLVPVQRIGMAEIAESPIDWDIAWPADDLQVNLTPAKRHELRPHQQQAIDAVFRGFAVGNDRGKLIMACGTGKTFTALKIAERIAADNGGSARILLLVPSISLLSQTLREWTAQSELDVRAFAVCSDTKVSRSAEDYHVHDVPIPVTTDARVLLHEMAHRRRAQGLTVVFCTYQSLPTVAKAQRLGVDEFDLVMCDEAHRTTGVTLAGDDESNFVRVHDGQYLKAARRLYMTATPRIFTESIKDRADQHSAELVSMDDELTFGPEFHRLSFGEAVERGLLTDYKVMVLTVDQGVIAPRLQQELSGVSGELMLDDASKIVGCWNGLAKRSGTGIVAGEPPMRRAVAFAKDIKTSKQVAELFPKVVEAYRELVDDGPGLACLNSSRRIQA,"57,274",515,,,ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],,,,1
O53507,O53507_MYCTU,Rv2173,idsA2 Rv2173,GO:0008299; GO:0016740,IPR008949; IPR000092; IPR033749; ,,idsA2,,Probable geranylgeranyl pyrophosphate synthetase IdsA2 (Ggppsase) (GGPP synthetase) (Geranylgeranyl diphosphate synthase),transferase activity [GO:0016740]; isoprenoid biosynthetic process [GO:0008299],9634230; 21969609,,,MAGAITDQLRRYLHGRRRAAAHMGSDYDGLIADLEDFVLGGGKRLRPLFAYWGWHAVASREPDPDVLLLFSALELLHAWALVHDDLIDRSATRRGRPTAQLRYAALHRDRDWRGSPDQFGMSAAILLGDLAQVWADDIVSKVCQSALAPDAQRRVHRVWADIRNEVLGGQYLDIVAEASAAESIESAMNVATLKTACYTVSRPLQLGTAAAADRSDVAAIFEHFGADLGVAFQLRDDVLGVFGDPAVTGKPSGDDLKSGKRTVLVAEAVELADRSDPLAAKLLRTSIGTRLTDAQVRELRTVIEAVGARAAAESRIAALTQRALATLASAPINATAKAGLSELAMMAANRSA,"37,781",352,FPP/GGPP synthase family,isoprenoid biosynthetic process [GO:0008299],transferase activity [GO:0016740],,,,1
O53488,O53488_MYCTU,Rv2045c,lipT Rv2045c,GO:0008152; GO:0016787,IPR029058; IPR002018; IPR019826; IPR019819; IPR002168; ,,lipT,DOMAIN 19 495 COesterase. {ECO:0000259|Pfam:PF00135}.,Carboxylic ester hydrolase (EC 3.1.1.-),hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230; 21969609,,,MALESATVGSMHERTVRARTATGIVEGFTRDGVHRWRSIPYARAPVGSLRFRAPQPAQPWPGVRHCHTFANCAPQQRRYTVMGIGRYQTRSEDCLTLNVVTPEEPATQPLPVMVFIHGGGYILGSSATPIYDGAALARRGCVYVSVNYRLGALGCLDLSSLSTPQITLDSNVYLRDLVLALRWVHDNIAEFGGDPGNVTIFGESAGAHITATLLAVPAAKGLFARAISESPAAGMVRSREVAAEFAARFANLIGARTQDAANALMQASPAQLVEAQHHLIRQGMRKRLGAFPIGPVFGDDYLPMDPVEAMRSGRVHAVPLIVGTNAEEGRLFTRFLGMLPTNEPMVEELLSGMKPADRERITAAYPNYPAPSACIQLGGDFAFSSAAWQIAEAHGANAPTYLYRYDYAPRTLRWSGFGATHATELFAVFDIYRTRFGALLTAAADRRAALRVSNEVQRRWRCFSQIGVPGDDWPAYTQDDRAVLVFDRRCRIEFDPHQHRRIAWDGFSLAN,"56,088",511,Type-B carboxylesterase/lipase family,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
O53514,O53514_MYCTU,Rv2180c,Rv2180c,GO:0016021,,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MEVFHWLQHDIVDRGRLPLLCCLVAFVLTFLVTRSFVRFIHRRAADGRPARWWQPRNVHIGSVHIHHVAFGVVLVMISGLTLVTLSVDGREPEFTIAASIFGVGAALVLDEYALILHLSDVYWEEDGRTSVDAVFAAVAVAGLLIMGLHPLIFFLPVRQGANWVVLQTTLIAGLVLTLPLAVVVLLKGKVWTGLLGMFVVVLLVVGAVRLSRPHAPWARWRYTRHPEKMRRALQRERTWRRPVVRIKLWLQYVIAGTPRMPDERAVDAQLDQDVRPAPPPERTAPILISGSVWSD,"33,213",295,,,,integral component of membrane [GO:0016021],,,3
O07257,O07257_MYCTU,Rv2059,Rv2059,GO:0005618; GO:0005886; GO:0030001; GO:0046872,IPR006127; ,,,,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metal ion transport [GO:0030001],9634230,,,MATPVILVTGHEGTAAVTADLLGLLTDHGTATLRSVAPGSVRRADPRPRCHRREQRRRHRASMKSAIHPDHHPRRLPRCPVLRRDQVVLEMIVITMVGRPSGPGERKWDVWGSVARAVTGGHVPVKSILTGAHADPHSYQASPADAAAIVDAELVIYNGGGYDPWVDQVLAGHPGVQAVDAYSLLGAVGDDDAPNEHVFYDPNVAKAVAATIADRLADLDPSNSGNYRANAAEFSRGADAIAISEHAIATTYPDAAVIATEPVVHYLLAAAGLKNRTPATFIAANENGNDPTPADMAAVLDMIAGREVAALLVNPQTPTAATDELQVAARRAGVPITELTETLPSGTDRDQFCAADRPDRRGRSLRADHADRGLSARGHRVGDLLPTALVCHRRSGGRGRPRRASARPGNCVRRTDGRGSRPGCPDRRGTPRDVFADHPRRGGRPGRGCPGRRDRDLGGLRRGFRRRRHPAVAGAWSPGVGVRGHHLVCDLPDLLVAPAAPLTSRSRFRPL,"54,558",511,,metal ion transport [GO:0030001],metal ion binding [GO:0046872],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
O53530,O53530_MYCTU,Rv2256c,Rv2256c,,IPR021491; ,,,,Uncharacterized protein,,9634230; 21969609,,,MEPKEQQMRASNQFADVTSGVVYIHASPAAVCPHVEWALSSTLQAKANLVWTPQPALPPQLRAVTNWVGPVGTGARLANALRSWSVLRFEVTEDPSPGVDGQRFSHTPQLGLWSGAMSANGDIMVGEMRLRAMMAQGADTLAAELDSVLGTAWDQALEVYRDGGDAGEVTWLSRGVG,"18,928",177,,,,,,,1
O06232,O06232_MYCTU,Rv2143,Rv2143,GO:0009116,IPR032466; IPR000836; IPR029057; ,,,DOMAIN 144 331 Pribosyltran. {ECO:0000259|Pfam:PF00156}.,Uncharacterized protein,nucleoside metabolic process [GO:0009116],9634230,,,MEAPPYAGDPTFERLRRSFQPADLLPELQAAGVHYTIAVEAADDPAENESLLATARHHDWIARVIGWVPLADPDEVTESSTHGRHRPDASWRRDLRCPGLLPPGCHQPVLVVGLVGQQPEMRPMNPPSGFLRRTPTRRFRDRRDAGRVLADELASYRGRDRLLVLGLARGGVPVGWEVASALGAELDVFLVRKLGVPQWRELAMGALASGGGVVMNDDVVSSLRITDQQVRAAIDSETAELQRRELAYRGGRPVVDPRARIVILVDDGIATGASMLAAVRTIRATGPESIVVAVPVGPATACRELAAEADDVVCATMPAAFEAVGQVYNDFHQVTDDEVRELLATPTTGAAT,"37,983",352,,nucleoside metabolic process [GO:0009116],,,,,1
O06238,O06238_MYCTU,Rv2137c,Rv2137c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MRNMKSTSHESESGKLLSISSCRPREMVLQRYSLGMTVTADRHLADKREEFAVEDISTGIFASGYGQVGDGRSFSFHIEHRSLVVEIYRPRVAGPVPQAEDVVAMAVRGLVDIDLTDERSLAAAVRDSVASAAPVSR,"14,965",137,,,,,,,1
O53461,O53461_MYCTU,Rv2015c,Rv2015c,GO:0003676; GO:0004519,IPR003870; IPR002711; IPR003615; ,,,DOMAIN 297 348 HNHc. {ECO:0000259|SMART:SM00507}.,Uncharacterized protein,endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676],9634230,,,MSSTATSGAAVVSPAERVEVLFEELAELAGQRNAIDGRIVEIVAELDRDGLWGVTGARSVAGLVAWKMGCSSGNAHTIATVARRLPEFPRCARGMREGRLSLDQVGVIAGRAGEGSDAHYAQLAGVATVNQLRTALKLEPRPEPEPDFRPEPRPSITRSADEQFSCWRIKLPHVEAAKFDAALQSHLDALIAEYKRDHDNSDGVSDQRPPLPGNVEAFLRLVEAGWDAEVARRPHGQHTTVVMHLDVQERAAGLHLGPLLSESERRYLLCDATFEAWFERDGQVIGCGRTTRQINRRLRRALEHRDRTCVVPGCGATRGLHAHHIRHWQDGGATELANLVLVCPYHHRAHHRGLITITGPADNLTVADSAGRPLSAGSLARASTKPPPAVAPWPGPTGERADWWWYEPFQPQPPPISN,"45,711",418,,,endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676],,,,3
L7N6A3,L7N6A3_MYCTU,Rv1990A,Rv1990A,,IPR036291; ,,,,Possible dehydrogenase,,9634230,,,MGRLEGKVAFITGVARGQGRSHAVRLADGQARALGKVDVEACGALVGEVEVWGRDVRDDRRVFVESPADEFGACRRVARQGIRVVGLPVSQRELVEPEAGCAARRSAAGSQ,"11,784",111,,,,,,,1
O53503,O53503_MYCTU,Rv2169c,Rv2169c,GO:0016021,IPR021401; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MPLSDHEQRMLDQIESALYAEDPKFASSVRGGGFRAPTARRRLQGAALFIIGLGMLVSGVAFKETMIGSFPILSVFGFVVMFGGVVYAITGPRLSGRMDRGGSAAGASRQRRTKGAGGSFTSRMEDRFRRRFDE,"14,571",134,,,,integral component of membrane [GO:0016021],,,1
O53477,O53477_MYCTU,Rv2033c,Rv2033c,GO:0005886,IPR021447; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MLDRYGTDVLAAGGRRRPRSVEHPVELGMVVEDAETGYVGAVVRVEYGRIDLEDRYGKTRGFPLGPGYLLDGLPVILTAPRCAAAAGPRRTASGSVAVPGARARVARASRIYVEGRHDAELIAAVWGADLRIEGVVVEHLGGVDDLVEIVAKFRPGPRRRLGVLVDHLVAGSKEARIAEVVRRGPGGSDTLVVGHPYVDIWQAVKPQRVGLAAWPRVPRHIEWKHGVCDALGWPHADQADIAAAWRRIRSQVRDWTDLEPALIGRVEELIDFVTQPAGDE,"30,471",280,,,,plasma membrane [GO:0005886],,,1
O53462,O53462_MYCTU,Rv2016,Rv2016,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTELGDKFLAALVGTIRDTRFDIADMRNWRPGWFPTMHSRCLSNLIHDRIWAHLVTLIASNPGTSIKDKGATREIVVGAHLRLRIKRHHAGDEISTYPTRTAIEFWQQGSQPAFPGLEEVRIAVGYRWDPDTREIGAPLLSLRDGKDHVIWVVELDEPAAGVKITWTPIEPTLPSIDFGDLGEDSGASGER,"21,358",191,,,,,,,1
O53479,O53479_MYCTU,Rv2035,Rv2035,GO:0006950,IPR013538; IPR023393; ,,,,Uncharacterized protein,response to stress [GO:0006950],9634230; 21969609,,,MTRPRTDAIHHHVVVNAPIERAFAVFTTRFGDFKPREHNLLAIPITETVFECHAGGHIYDRGVDGSVCKWARVLVYEPPSRVLFTWDIGPTWRPETDLAKTSEVEVRFTAQSAETTRVDLEHRHLDRHGPGWESVADGVDSEAGWPLYLRRYTDLLCIQVQP,"18,515",162,,response to stress [GO:0006950],,,,,1
O53966,O53966_MYCTU,Rv1965,yrbE3B Rv1965,GO:0043190,IPR030802; ,,yrbE3B,,Conserved hypothetical integral membrane protein YrbE3B,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230,,,MTAAKALVSEWNRMGSQMRFFVGTLAGIPDALMHYRGELLRVIAQMGLGTGVLAVIGGTVAIVGFLAMTTGAIVAVQGYNQFASVGVEALTGFASAFFNTREIQPGTVMVALAATVGAGTTAALGAMRINEEIDALEVIGIRSISYLASTRVLAGVVVAVPLFCVGLMTAYLAARVGTTAIYGQGSGVYDHYFNTFLRPTDVLWSSVEVVVVALMIMLVCTYYGYAAHGGPAGVGEAVGRAVRASMVVASIAILVMTLAIYGQSPNFHLAT,"28,144",271,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
Q10838,Q10838_MYCTU,Rv1988,erm(37) Rv1988,GO:0000179; GO:0003723; GO:0005737; GO:0005886; GO:0046677,IPR001737; IPR020598; IPR029063; ,,erm(37),,Probable 23S rRNA methyltransferase Erm(37),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]; response to antibiotic [GO:0046677]",9634230,,,MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR,"19,606",179,"Class I-like SAM-binding methyltransferase superfamily, rRNA adenine N(6)-methyltransferase family",response to antibiotic [GO:0046677],"RNA binding [GO:0003723]; rRNA (adenine-N6,N6-)-dimethyltransferase activity [GO:0000179]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
L7N652,L7N652_MYCTU,Rv2317,uspB Rv2317,GO:0005886; GO:0016021; GO:0055085,IPR000515; IPR035906; ,,uspB,DOMAIN 70 260 ABC transmembrane type-1. {ECO:0000259|PROSITE:PS50928}.,Probable sugar-transport integral membrane protein ABC transporter UspB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MSSPSRVSNTAVYAVLTIGAVITLSPFLLGLLTSFTSAHQFATGTPLQLPRPPTLANYADIADAGFRRAAVVTALMTAVILLGQLTFSVLAAYAFARLQFRGRDALFWVYVATLMVPGTVTVVPLYLMMAQLGLRNTFWALVLPFMFGSPYAIFLLREHFRLIPDDLINAARLDGANTLDVIVHVVIPSSRPVLAALAMITVVSQWNNFMWPLVITSGHKWRVLTVATADLQSRFNDQWTLVMAATTVAIVPLIALFVTFQRHIVASIVVSGLK,"29,931",274,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53466,O53466_MYCTU,Rv2020c,Rv2020c,,,,,,Uncharacterized protein,,9634230,,,MAPGMKWAAKTDHLAIVLLPRHHRRHSRRGRALPARSRSALGWIIERYRVTTDKASGIVNDPNDWCDEHDDPTYIVDLIKKVTTVSVETMKIVDGLAGG,"11,113",99,,,,,,,1
O53979,O53979_MYCTU,Rv1978,Rv1978,GO:0005886,IPR029063; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MGEANIREQAIATMPRGGPDASWLDRRFQTDALEYLDRDDVPDEVKQKIIGVLDRVGTLTNLHEKYARIALKLVSDIPNPRILELGAGHGKLSAKILELHPTATVTISDLDPTSVANIAAGELGTHPRARTQVIDATAIDGHDHSYDLAVFALAFHHLPPTVACKAIAEATRVGKRFLIIDLKRQKPLSFTLSSVLLLPLHLLLLPWSSMRSSMHDGFISALRAYSPSALQTLARAADPGMQVEILPAPTRLFPPSLAVVFSRSSSAPTESSECSADRQPGE,"30,584",282,,,,plasma membrane [GO:0005886],,,3
O86353,O86353_MYCTU,Rv2054,Rv2054,GO:0005829; GO:0005886; GO:0016787,IPR029058; IPR002925; ,,,,Conserved protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MTTIEIDAPAGPIDALLGLPPGQGPWPGVVVVHDAVGYVPDNKLISERIARAGYVVLTPNMYARGGRARCITRVFRELLTKRGRALDDILAARDHLLAMPECSGRVGIVGFCMGGQFALVLSPRGFGATAPFYGTPLPRHLSETLNGACPIVASFGTRDPLGIGAANRLRKVTAAKNIPADIKSYPGAGHSFANKLPGQPLVRIAGFGYNEAATEDAWRRVFEFFGQHLRAGSPGEP,"25,183",237,,,hydrolase activity [GO:0016787],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O33252,O33252_MYCTU,Rv2117,Rv2117,,IPR007546; IPR036746; ,,,,Uncharacterized protein,,9634230; 21969609,,,MWIGWLEFDVLLGDVRSLKQKRSVTRPLVAELQRKFSVSAAETGSHDLYRRAGIGVAVVSGDRSHAVDVLDNAERLVAAHPEFELLSVRRGLHRTDD,"10,850",97,,,,,,,1
O53977,O53977_MYCTU,Rv1976c,Rv1976c,,IPR010298; ,,,,Uncharacterized protein,,9634230; 21969609,,,MRWIVDGMNVIGSRPDGWWRDRHRAMVMLVERLEGWAITKARGDDVTVVFERPPSTAIPSSVVEVAHAPKAAANSADDEIVRLVRSGAQPQEIRVVTSDKALTDRVRDLGAAVYPAERFRDLIDPRGSNAARRTQ,"15,029",135,,,,,,,1
L0TBY6,L0TBY6_MYCTU,Rv2250A,Rv2250A,GO:0003824; GO:0050660; GO:0055114,IPR016167,,,,Possible flavoprotein,catalytic activity [GO:0003824]; flavin adenine dinucleotide binding [GO:0050660]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MKWDAWGDPAAAKPLSDGVRSLLKQVVGLADSEQPELDPAQVQLRPSALSGADHDALARIVGTEYFRTADRDRLLHAGGKSTPDLLRRKDTGVQDAPDAVLLPGGPNGGGRRRRHLALLLRPRHCRGPVWWRHQRRWWA,"15,459",139,,oxidation-reduction process [GO:0055114],catalytic activity [GO:0003824]; flavin adenine dinucleotide binding [GO:0050660],,,,1
P71897,P71897_MYCTU,Rv2315c,Rv2315c,GO:0005829; GO:0008237,IPR002510; IPR035068; IPR036059; ,,,,Conserved protein,cytosol [GO:0005829]; metallopeptidase activity [GO:0008237],9634230; 21969609,,,MTPNRGIDEDFLDLPRQQLADAALSAAATAGASHADLRVHRISTEIIQLRDGELETAVISRELGLAVRVIVAGTWGFASHAELAPDVAAATARHAVHVATVLAALNTERVRLAPEPVYTDAEWVSNYRIDPFGVPASEKIAVLRDYSGRLLDADGIDHVSASLNAVKEQTFYADTFGSSITQQRVRLLPCLDAVAVDSAAGNFESMRTLAPPTARGWEVVAGDEIWNWTDELAQLPSLLAEKVRAPSVMPGPTDLVIDPTNLWLTIHESIGHATEYDRAIGYEAAYAGTSFATPDKLGTLRYGSPVMNVTADRTAEFGLATVGYDDEGVAAQSWDLVRDGVFVGYQLDRAFAPRLGEPRSNGCSYADSPHHVPIQRMANISLQPGIEDLSTADLIGRVDDGIYIVGDKSWSIDMQRYNFQFTGQRFFRIRGGQLYGQLRDVAYQSSTTDFWNAMEAVGGPSTWRMGGAINCGKAQPGQVAAVSHGCPSALFRGVNVLNTRTEGGR,"54,578",505,,,metallopeptidase activity [GO:0008237],cytosol [GO:0005829],,,2
P71885,P71885_MYCTU,Rv2327,Rv2327,GO:0003700,IPR000835; IPR036388; IPR036390; ,,,DOMAIN 21 151 HTH marR-type. {ECO:0000259|PROSITE:PS50995}.,Conserved protein,DNA binding transcription factor activity [GO:0003700],9634230; 21969609,,,MSPSPAAANRSEVGGPLPGLGADLLAVVARLNRLATQRIQMPLPAAQARLLATIEAQGEARIGDLAAVDHCSQPTMTTQVRRLEDAGLVTRTADPGDARAVRIRITPEGIRTLTAVRADRAAAIEPQLALLPPADRRVLADAVDVLRRLLDHAATTPGRATRQ,"17,208",163,,,DNA binding transcription factor activity [GO:0003700],,,,1
O53968,O53968_MYCTU,Rv1967,mce3B Rv1967,GO:0005886; GO:0016021,IPR005693; IPR003399; ,,mce3B,,Mce-family protein Mce3B,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MRENLGGVVVRLGVFLAVCLLTAFLLIAVFGEVRFGDGKTYYAEFANVSNLRTGKLVRIAGVEVGKVTRISINPDATVRVQFTADNSVTLTRGTRAVIRYDNLFGDRYLALEEGAGGLAVLRPGHTIPLARTQPALDLDALIGGFKPLFRALNPEQVNALSEQLLHAFAGQGPTIGSLLAQSAAVTNTLADRDRLIGQVITNLNVVLGSLGAHTDRLDQAVTSLSALIHRLAQRKTDISNAVAYTNAAAGSVADLLSQARAPLAKVVRETDRVAGIAAADHDYLDNLLNTLPDKYQALVRQGMYGDFFAFYLCDVVLKVNGKGGQPVYIKLAGQDSGRCAPK,"36,515",342,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O33263,O33263_MYCTU,Rv2129c,Rv2129c,GO:0005618; GO:0005829; GO:0005886,IPR036291; IPR002347; ,,,,Probable oxidoreductase,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MTSLQGKVVFITGAARGIGAEVARRLHNKGAKLVLTDLSKSELAVMGAELGGDDRLLTVVADVRDLPAMQAAAETAVERFGGIDVVVANAGIASYGSVLKVDPQAFRRVLDVNLLGNFHTVRATLPALIDRRGYVLIVSSLAAFAAPPGMAPYNMSKAGNEHFANALRLEVAHLGVSVGSAHMSWIDTALVRDTKADLPAFAELLARLPWPLNKTTSVNKCAAAFVNGIEGRKDRVYCPGWVALFRWLKPLLSTRVGQRPIRNTVAKLMPQMDAEVAALGRFASAYTESLENS,"31,331",293,Short-chain dehydrogenases/reductases (SDR) family,,,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
L0TBL4,L0TBL4_MYCTU,Rv2126c,PE_PGRS37 Rv2126c,,,,PE_PGRS37,,PE-PGRS family protein PE_PGRS37,,9634230,,,MIGDGANGGPGQPGGPGGLLYGNGGHGGAGAAGQDRGAGNSAGLIGNGGAGGAGGNGGIGGAGAPGGLGGDGGKGGFADEFTGGFAQGGRGGFGGNGNTGASGGMGGAGGAGGAGGAGGLLIGDGGAGGAGGIGGAGGVGGGGGAGGTGGGGVASAFGGGNAFGGRGGDGGDGGDGGTGGAGGARGAGGAGGAGGWLSGHSGAHGAMGSGGEGGAGGGGGARGEAGAGGGTSTGTNPGKAGAPGTQGDSGDPGPPG,"20,324",256,,,,,,,1
I6XDW5,I6XDW5_MYCTU,Rv2261c,Rv2261c,GO:0006807; GO:0016021,IPR003010; IPR036526; ,,,DOMAIN 1 97 CN hydrolase. {ECO:0000259|PROSITE:PS50263}.,Uncharacterized protein,integral component of membrane [GO:0016021]; nitrogen compound metabolic process [GO:0006807],9634230,,,MHIAPLISYEMTFSDLTRHAARLGAALLVYQSSTSTFQGSWAQPQLAAQPAVRAVEAGIPAVHASLSGDSSAFDTRGRRLAWCSAEFNGAIVVNVPLASNVTLYLRLGDWVPVTAFVVMGAGFAVFLRRSLARVSDCADK,"14,941",140,,nitrogen compound metabolic process [GO:0006807],,integral component of membrane [GO:0016021],,,1
O53533,O53533_MYCTU,Rv2259,mscR Rv2259,GO:0005829; GO:0008270; GO:0010127; GO:0016491; GO:0016620; GO:0050607; GO:0052060; GO:0055114,IPR013149; IPR013154; IPR002328; IPR011032; IPR017816; IPR036291; IPR020843; ,,mscR,,S-nitrosomycothiol reductase MscR,"cytosol [GO:0005829]; mycothiol-dependent formaldehyde dehydrogenase activity [GO:0050607]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; zinc ion binding [GO:0008270]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; mycothiol-dependent detoxification [GO:0010127]; oxidation-reduction process [GO:0055114]",9634230; 21969609,,,MSQTVRGVIARQKGEPVELVNIVVPDPGPGEAVVDVTACGVCHTDLTYREGGINDEYPFLLGHEAAGIIEAVGPGVTAVEPGDFVILNWRAVCGQCRACKRGRPRYCFDTFNAEQKMTLTDGTELTAALGIGAFADKTLVHSGQCTKVDPAADPAVAGLLGCGVMAGLGAAINTGGVTRDDTVAVIGCGGVGDAAIAGAALVGAKRIIAVDTDDTKLDWARTFGATHTVNAREVDVVQAIGGLTDGFGADVVIDAVGRPETYQQAFYARDLAGTVVLVGVPTPDMRLDMPLVDFFSHGGALKSSWYGDCLPESDFPTLIDLYLQGRLPLQRFVSERIGLEDVEEAFHKMHGGKVLRSVVML,"37,888",361,Zinc-containing alcohol dehydrogenase family,evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; mycothiol-dependent detoxification [GO:0010127]; oxidation-reduction process [GO:0055114],"mycothiol-dependent formaldehyde dehydrogenase activity [GO:0050607]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; zinc ion binding [GO:0008270]",cytosol [GO:0005829],,,1
O53489,O53489_MYCTU,Rv2046,lppI Rv2046,GO:0005886,,,lppI,,Probable lipoprotein LppI,plasma membrane [GO:0005886],9634230; 21969609,,,MRIAALVAVSLLIAGCSREVGGDVGQSQTIAPPAPAPSAAPSTPPAAGAPITTIVSWIEAGHPVDPAAYHVATRDGVTTQLGDDVAFSASSGTVACMTDARHTSGTLACLVRLANPPPRPETAYGEWKGGWVDFDGIHLQVGSARADPGPFVYGNGPELANGDTLSIGDYRCRSYQAGLFCVNYAHQSAVRFASAGIEPFGCLKPAPPPDGVGVAFGC,"22,202",218,,,,plasma membrane [GO:0005886],,,1
O06240,O06240_MYCTU,Rv2135c,Rv2135c,,IPR013078; IPR029033; IPR022492; ,,,,Conserved protein,,9634230; 21969609,,,MTVILLRHARSTSNTAGVLAGRSGVDLDEKGREQATGLIDRIGDLPIRAVASSPMLRCQRTVEPLAEALCLEPLIDDRFSEVDYGEWTGRKIGDLVDEPLWRVVQAHPSAAVFPGGEGLAQVQTRAVAAVREHDRRLADQHGHDVLWLACTHGDVIKAVIADAFGMHLDSFQRITADPGSVSVVRYTQLRPFVLHVNHTGARLAPALQAAASAQGASPEPNAAVPPGDAVIGGSTD,"25,122",236,,,,,,,1
O33248,O33248_MYCTU,Rv2113,Rv2113,GO:0005576; GO:0005887,,,,,Probable integral membrane protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MSLSVRRPPAARAAAIVEAESWFLKRGLPSVLTMRGRCRRLWPRSAPMLAAWAVVEGCLMAVFFVTDGGEVFISATPTTAQWVILALLAVALPLASLVGWLVSQISSGRGQAAVATMAVAFAAASDVIESGPIQLLRTAVVVGLVLLQTGCGVGSVLGWAVRMTLEHLATVGTLAVRALPIVLLTALVFFNTYVWLMAANINGERLTLAMVFLLAIAGAFVVSKTVERVRPLLRSTTVMPQGSQSLAGTPFATMGDPSPGFPLTRAERLNVVFLLAASQLVEILVVASVGAAIYLVLGMIILTPPLLREWTHYDSMTTTVLGMTFPAPDSLIRMCLFLGALTFMYISARAVDDAEYRAMFLDPLIDDLHTALLARNRYRNNVVTAPCAGVDAGHVDD,"42,394",397,,,,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,,1
O53532,O53532_MYCTU,Rv2258c,Rv2258c,GO:0005618; GO:0005737; GO:0005886; GO:0008757; GO:0032259; GO:0071456,IPR025714; IPR029063; ,,,,Possible transcriptional regulatory protein,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cellular response to hypoxia [GO:0071456]; methylation [GO:0032259],9634230; 21969609; 26772148,X-ray crystallography (3),,MSGALETTEEFGNRFVAAIDSAGLAILVSVGHQTGLLDTMAGLPPATSMEIAEAAGLEERYVREWLGGMTTGQIVEYDAGSSTYSLPAHRAGMLTRAAGPDNLAVIAQFVSLLGEVEQKVIRCFREGGGVPYSEYPRFHKLMAEMSGMVFDAALIDVVLPLVDGLPDRLRSGADVADFGCGSGRAVKLMAQAFGASRFTGIDFSDEAVAAGTEEAARLGLANATFERHDLAELDKVGAYDVITVFDAIHDQAQPARVLQNIYRALRPGGVLLMVDIKASSQLEDNVGVPLSTYLYTTSLMHCMTVSLALDGAGLGTVWGRQLATSMLADAGFTDVTVAEIESDVLNNYYIARK,"37,514",353,,cellular response to hypoxia [GO:0071456]; methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
O06230,O06230_MYCTU,Rv2146c,Rv2146c,GO:0005576; GO:0016021,IPR003425; ,,,,Possible conserved transmembrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MVVFFQILGFALFIFWLLLIARVVVEFIRSFSRDWRPTGVTVVILEIIMSITDPPVKVLRRLIPQLTIGAVRFDLSIMVLLLVAFIGMQLAFGAAA,"10,822",96,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
O53527,O53527_MYCTU,Rv2253,Rv2253,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 21969609,,,MSGHRKKAMLALAAASLAATLAPNAVAAAEPSWNGQYLVTLSANAKTGTSMAANRPEYPHKANYTFSSRCASDVCIATVVDAPPPKNEFIPRPIEYTWNGTQWVREISWQWDCLLPDGTIEYAPAKSITAYTPGQYGILTGVFHTDIASGTCKGNVDMPVSAKPIVG,"17,831",167,,,,extracellular region [GO:0005576],,,1
O53177,RPFE_MYCTU,Rv2450c,rpfE Rv2450c MTV008.06c,GO:0005576; GO:0009405; GO:0010628; GO:0010629; GO:0016787; GO:0040010,IPR023346; IPR010618; ,,rpfE,,Resuscitation-promoting factor RpfE (EC 3.-.-.-),extracellular region [GO:0005576]; hydrolase activity [GO:0016787]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],9634230; 12410821; 12874362; 15207486; 17919286; 18186793,X-ray crystallography (1),"FUNCTION: Factor that stimulates resuscitation of dormant cells. Has peptidoglycan (PG) hydrolytic activity. Active in the pM concentration range. Has little to no effect on actively-growing cells. PG fragments could either directly activate the resuscitation pathway of dormant bacteria or serve as a substrate for endogenous Rpf, resulting in low molecular weight products with resuscitation activity. {ECO:0000269|PubMed:12410821}.; FUNCTION: Stimulates growth of stationary phase M.bovis (a slow-growing Mycobacterium), reduces the lag phase of diluted fast-growers M.smegmatis and Micrococcus luteus. Sequential gene disruption indicates RpfB and RpfE are higher than RpfD and RpfC in functional hierarchy. {ECO:0000269|PubMed:12410821}.",MKNARTTLIAAAIAGTLVTTSPAGIANADDAGLDPNAAAGPDAVGFDPNLPPAPDAAPVDTPPAPEDAGFDPNLPPPLAPDFLSPPAEEAPPVPVAYSVNWDAIAQCESGGNWSINTGNGYYGGLRFTAGTWRANGGSGSAANASREEQIRVAENVLRSQGIRAWPVCGRRG,"17,456",172,"Transglycosylase family, Rpf subfamily",negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],hydrolase activity [GO:0016787],extracellular region [GO:0005576],,MTV008.06c,1
P9WGZ5,RNZ_MYCTU,Rv2407,rnz Rv2407 MTCY253.13c,GO:0016891; GO:0042779; GO:0046872,IPR001279; IPR036866; IPR013471; ,,rnz,,Ribonuclease Z (RNase Z) (EC 3.1.26.11) (tRNA 3 endonuclease) (tRNase Z),"endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]; tRNA 3'-trailer cleavage [GO:0042779]",9634230,,"FUNCTION: Zinc phosphodiesterase, which displays some tRNA 3'-processing endonuclease activity. Probably involved in tRNA maturation, by removing a 3'-trailer from precursor tRNA. {ECO:0000255|HAMAP-Rule:MF_01818}.",MLEITLLGTGSPIPDPDRAGPSTLVRAGAQAFLVDCGRGVLQRAAAVGVGAAGLSAVLLTHLHGDVLITSWVTNFAADPAPLPIIGPPGTAEVVEATLKAFGHDIGYRIAHHADLTTPPPIEVHEYTAGPAWDRDGVTIRVAPTDHRPVTPTIGFRIESDGASVVLAGDTVPCDSLDQLAAGADALVHTVIRKDIVTQIPQQRVKDICDYHSSVQEAAATANRAGVGTLVMTHYVPAIGPGQEEQWRALAATEFSGRIEVGNDLHRVEVHPRR,"28,707",273,RNase Z family,tRNA 3'-trailer cleavage [GO:0042779],"endoribonuclease activity, producing 5'-phosphomonoesters [GO:0016891]; metal ion binding [GO:0046872]",,,MTCY253.13c,1
P9WG27,RPFD_MYCTU,Rv2389c,rpfD Rv2389c MTCY253.32,GO:0005576; GO:0005886; GO:0009405; GO:0010628; GO:0010629; GO:0016021; GO:0016787; GO:0040010; GO:0085016,IPR023346; IPR010618; ,,rpfD,,Resuscitation-promoting factor RpfD (EC 3.-.-.-),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; dormancy exit of symbiont in host [GO:0085016]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],9634230; 12410821; 12874362; 15207486; 18186793,,"FUNCTION: Factor that stimulates resuscitation of dormant cells. Has peptidoglycan (PG) hydrolytic activity. Active in the pM concentration range. Has little to no effect on actively-growing cells. PG fragments could either directly activate the resuscitation pathway of dormant bacteria or serve as a substrate for endogenous Rpf, resulting in low molecular weight products with resuscitation activity. {ECO:0000269|PubMed:12410821}.; FUNCTION: Stimulates growth of stationary phase M.bovis (a slow-growing Mycobacterium), reduces the lag phase of diluted fast-growers M.smegmatis and Micrococcus luteus. Sequential gene disruption indicates RpfB and RpfE are higher than RpfD and RpfC in functional hierarchy. {ECO:0000269|PubMed:12410821}.",MTPGLLTTAGAGRPRDRCARIVCTVFIETAVVATMFVALLGLSTISSKADDIDWDAIAQCESGGNWAANTGNGLYGGLQISQATWDSNGGVGSPAAASPQQQIEVADNIMKTQGPGAWPKCSSCSQGDAPLGSLTHILTFLAAETGGCSGSRDD,"15,679",154,"Transglycosylase family, Rpf subfamily",dormancy exit of symbiont in host [GO:0085016]; negative regulation of gene expression [GO:0010629]; pathogenesis [GO:0009405]; positive regulation of gene expression [GO:0010628]; positive regulation of growth rate [GO:0040010],hydrolase activity [GO:0016787],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY253.32,1
P9WKD7,RPIB_MYCTU,Rv2465c,rpiB Rv2465c MTV008.21c,GO:0004751; GO:0005576; GO:0005975; GO:0009052,IPR011860; IPR003500; IPR036569; ,,rpiB,,Ribose-5-phosphate isomerase B (EC 5.3.1.6) (Phosphoriboisomerase B),"extracellular region [GO:0005576]; ribose-5-phosphate isomerase activity [GO:0004751]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",9634230; 21969609; 14687575; 15590681; 18640127,X-ray crystallography (6),"FUNCTION: Catalyzes the interconversion of ribulose-5-P and ribose-5-P. It has not isomerase activity towards D-allose 6-phosphate. {ECO:0000269|PubMed:14687575, ECO:0000269|PubMed:18640127}.",MSGMRVYLGADHAGYELKQRIIEHLKQTGHEPIDCGALRYDADDDYPAFCIAAATRTVADPGSLGIVLGGSGNGEQIAANKVPGARCALAWSVQTAALAREHNNAQLIGIGGRMHTVAEALAIVDAFVTTPWSKAQRHQRRIDILAEYERTHEAPPVPGAPA,"17,278",162,LacAB/RpiB family,"carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt, non-oxidative branch [GO:0009052]",ribose-5-phosphate isomerase activity [GO:0004751],extracellular region [GO:0005576],,MTV008.21c,1
P9WIS1,BKDB_MYCTU,Rv2496c,bkdB pdhB Rv2496c,GO:0003863; GO:0005618; GO:0005886,IPR029061; IPR009014; IPR005475; IPR033248; ,,bkdB,,3-methyl-2-oxobutanoate dehydrogenase subunit beta (EC 1.2.4.4) (Branched-chain alpha-ketoacid dehydrogenase E1 component subunit beta) (BCKADH E1-beta),cell wall [GO:0005618]; plasma membrane [GO:0005886]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863],9634230; 11929527; 16045627; 21238944; 21969609,,"FUNCTION: Component of the branched-chain alpha-ketoacid dehydrogenase (BCKADH) complex, that catalyzes the overall conversion of branched-chain alpha-ketoacids to acyl-CoA and CO(2). {ECO:0000269|PubMed:21238944}.",MTQIADRPARPDETLAVAVSDITQSLTMVQAINRALYDAMAADERVLVFGEDVAVEGGVFRVTEGLADTFGADRCFDTPLAESAIIGIAVGLALRGFVPVPEIQFDGFSYPAFDQVVSHLAKYRTRTRGEVDMPVTVRIPSFGGIGAAEHHSDSTESYWVHTAGLKVVVPSTPGDAYWLLRHAIACPDPVMYLEPKRRYHGRGMVDTSRPEPPIGHAMVRRSGTDVTVVTYGNLVSTALSSADTAEQQHDWSLEVIDLRSLAPLDFDTIAASIQRTGRCVVMHEGPRSLGYGAGLAARIQEEMFYQLEAPVLRACGFDTPYPPARLEKLWLPGPDRLLDCVERVLRQP,"38,064",348,,,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863],cell wall [GO:0005618]; plasma membrane [GO:0005886],pdhB,,1
O06159,BKDC_MYCTU,Rv2495c,bkdC pdhC Rv2495c,GO:0005618; GO:0005886; GO:0008152; GO:0043754,IPR001078; IPR015761; IPR000089; IPR023213; IPR036625; IPR004167; IPR011053; ,,bkdC,DOMAIN 7 82 Lipoyl-binding. {ECO:0000255|PROSITE-ProRule:PRU01066}.; DOMAIN 119 157 Peripheral subunit-binding (PSBD). {ECO:0000255|PROSITE-ProRule:PRU01170}.,Dihydrolipoyllysine-residue acyltransferase component of branched-chain alpha-ketoacid dehydrogenase complex (EC 2.3.1.168) (Branched-chain alpha-ketoacid dehydrogenase complex component E2) (BCKADH E2) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; metabolic process [GO:0008152],9634230; 11929527; 16045627; 21238944; 21969609; ,X-ray crystallography (1),"FUNCTION: Component of the branched-chain alpha-ketoacid dehydrogenase (BCKADH) complex, that catalyzes the overall conversion of branched-chain alpha-ketoacids to acyl-CoA and CO(2). {ECO:0000269|PubMed:21238944}.",MSGEDSIRSFPVPDLGEGLQEVTVTCWSVAVGDDVEINQTLCSVETAKAEVEIPSPYAGRIVELGGAEGDVLKVGAELVRIDTGPTAVAQPNGEGAVPTLVGYGADTAIETSRRTSRPLAAPVVRKLAKELAVDLAALQRGSGAGGVITRADVLAAARGGVGAGPDVRPVHGVHARMAEKMTLSHKEIPTAKASVEVICAELLRLRDRFVSAAPEITPFALTLRLLVIALKHNVILNSTWVDSGEGPQVHVHRGVHLGFGAATERGLLVPVVTDAQDKNTRELASRVAELITGAREGTLTPAELRGSTFTVSNFGALGVDDGVPVINHPEAAILGLGAIKPRPVVVGGEVVARPTMTLTCVFDHRVVDGAQVAQFMCELRDLIESPETALLDL,"41,061",393,2-oxoacid dehydrogenase family,metabolic process [GO:0008152],dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754],cell wall [GO:0005618]; plasma membrane [GO:0005886],pdhC,,2
P9WPX7,AROQ_MYCTU,Rv2537c,aroQ aroD Rv2537c MTCY159.19,GO:0003855; GO:0005829; GO:0009073; GO:0009423; GO:0040007,IPR001874; IPR018509; IPR036441; ,,aroQ,,3-dehydroquinate dehydratase (3-dehydroquinase) (EC 4.2.1.10) (Type II DHQase),cytosol [GO:0005829]; 3-dehydroquinate dehydratase activity [GO:0003855]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007],1910148; 9634230; 19099550; 21969609; 10360352; 12387860; ,X-ray crystallography (32),FUNCTION: Catalyzes a trans-dehydration via an enolate intermediate. {ECO:0000250}.,MSELIVNVINGPNLGRLGRREPAVYGGTTHDELVALIEREAAELGLKAVVRQSDSEAQLLDWIHQAADAAEPVILNAGGLTHTSVALRDACAELSAPLIEVHISNVHAREEFRRHSYLSPIATGVIVGLGIQGYLLALRYLAEHVGT,"15,790",147,Type-II 3-dehydroquinase family,aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007],3-dehydroquinate dehydratase activity [GO:0003855],cytosol [GO:0005829],aroD,MTCY159.19,1
P9WGW5,RTCB_MYCTU,Rv2631,rtcB Rv2631 MTCY441.01,GO:0005576; GO:0005618; GO:0006396; GO:0008452; GO:0046872,IPR001233; IPR036025; ,,rtcB,,RNA-splicing ligase RtcB (EC 6.5.1.-),cell wall [GO:0005618]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; RNA ligase activity [GO:0008452]; RNA processing [GO:0006396],9634230; 12368430; 12953092; 18474359; 18400743,,FUNCTION: RNA ligase that mediates the joining of broken tRNA-like stem-loop structures. {ECO:0000250}.,MQVVNVATLPGIVRASYAMPDVHWGYGFPIGGVAATDVDNDGVVSPGGVGFDISCGVRLLVGEGLDREELQPRLPAVMDRLDRAIPRGVGTAGVWRLPDRNTLQEVLTGGARFAVEQGHGVALDLERCEDGGVMTGADAAKISDRALQRGLGQIGSLGSGNHFLEVQAVDRVYDPVAAAPMGLAEGTVCVMIHTGSRGLGHQICTDHVRQMEQAMGRYGIAVPDRQLACVPVHSPDGQAYLAAMAAAANYGRANRQLLTEATRRVFADATGTPLDLLYDVSHNLAKIETHPIDGQLRSVCVHRKGATRSLPPHHHELPAELAAVGQPVLIPGTMGTASYVLAGVTGNPAFFSTAHGAGRVLSRHQAARHTSGEAIRASLAKRGIIVRGTSRRGIAEEKPEAYKDVDEVIEASHQSGLARKVARLVPLGCVKG,"45,528",432,RtcB family,RNA processing [GO:0006396],metal ion binding [GO:0046872]; RNA ligase activity [GO:0008452],cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY441.01,1
P9WPW5,SCOA_MYCTU,Rv2504c,scoA Rv2504c MTCY07A7.10c,GO:0008152; GO:0008260,IPR012792; IPR004165; IPR004163; IPR037171; ,,scoA,,Probable succinyl-CoA:3-ketoacid coenzyme A transferase subunit A (EC 2.8.3.5) (Succinyl-CoA:3-oxoacid CoA-transferase) (OXCT A),3-oxoacid CoA-transferase activity [GO:0008260]; metabolic process [GO:0008152],9634230; 21969609,,,MDKVVATAAEAVADIANGSSLAVGGFGLCGIPEALIAALVDSGVTDLETVSNNCGIDGVGLGLLLQHKRIRRTVSSYVGENKEFARQFLAGELEVELTPQGTLAERLRAGGMGIPAFYTPAGVGTQVADGGLPWRYDASGGVAVVSPAKETREFDGVTYVLERGIRTDFALVHAWQGDRHGNLMYRHAAANFNPECASAGRITIAEVEHLVEPGEIDPATVHTPGVFVHRVVHVPNPAKKIERETVRQ,"26,276",248,3-oxoacid CoA-transferase subunit A family,metabolic process [GO:0008152],3-oxoacid CoA-transferase activity [GO:0008260],,,MTCY07A7.10c,1
P9WGW1,RUVB_MYCTU,Rv2592c,ruvB Rv2592c MTCY227.09,GO:0003677; GO:0005524; GO:0006281; GO:0006310; GO:0009378; GO:0009432,IPR003593; IPR004605; IPR008823; IPR027417; IPR008824; IPR036388; IPR036390; ,,ruvB,,Holliday junction ATP-dependent DNA helicase RuvB (EC 3.6.4.12),ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432],9634230; 21969609,,"FUNCTION: The RuvA-RuvB complex in the presence of ATP renatures cruciform structure in supercoiled DNA with palindromic sequence, indicating that it may promote strand exchange reactions in homologous recombination. RuvAB is a helicase that mediates the Holliday junction migration by localized denaturation and reannealing. {ECO:0000255|HAMAP-Rule:MF_00016}.",MTERSDRDVSPALTVGEGDIDVSLRPRSLREFIGQPRVREQLQLVIEGAKNRGGTPDHILLSGPPGLGKTSLAMIIAAELGSSLRVTSGPALERAGDLAAMLSNLVEHDVLFIDEIHRIARPAEEMLYLAMEDFRVDVVVGKGPGATSIPLEVAPFTLVGATTRSGALTGPLRDRFGFTAHMDFYEPAELERVLARSAGILGIELGADAGAEIARRSRGTPRIANRLLRRVRDFAEVRADGVITRDVAKAALEVYDVDELGLDRLDRAVLSALTRSFGGGPVGVSTLAVAVGEEAATVEEVCEPFLVRAGMVARTPRGRVATALAWTHLGMTPPVGASQPGLFE,"36,627",344,RuvB family,DNA recombination [GO:0006310]; DNA repair [GO:0006281]; SOS response [GO:0009432],ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378],,,MTCY227.09,1
P9WGW3,RUVA_MYCTU,Rv2593c,ruvA Rv2593c MTCY227.08,GO:0000724; GO:0003677; GO:0005524; GO:0005886; GO:0006974; GO:0009378; GO:0009379; GO:0009432,IPR013849; IPR003583; IPR012340; IPR000085; IPR010994; IPR011114; IPR036267; ,,ruvA,,Holliday junction ATP-dependent DNA helicase RuvA (EC 3.6.4.12),Holliday junction helicase complex [GO:0009379]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; SOS response [GO:0009432],9634230; 21969609,X-ray crystallography (4),"FUNCTION: The RuvA-RuvB complex in the presence of ATP renatures cruciform structure in supercoiled DNA with palindromic sequence, indicating that it may promote strand exchange reactions in homologous recombination. RuvAB is a helicase that mediates the Holliday junction migration by localized denaturation and reannealing. RuvA stimulates, in the presence of DNA, the weak ATPase activity of RuvB. {ECO:0000255|HAMAP-Rule:MF_00031}.",MIASVRGEVLEVALDHVVIEAAGVGYRVNATPATLATLRQGTEARLITAMIVREDSMTLYGFPDGETRDLFLTLLSVSGVGPRLAMAALAVHDAPALRQVLADGNVAALTRVPGIGKRGAERMVLELRDKVGVAATGGALSTNGHAVRSPVVEALVGLGFAAKQAEEATDTVLAANHDATTSSALRSALSLLGKAR,"20,189",196,RuvA family,cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via homologous recombination [GO:0000724]; SOS response [GO:0009432],ATP binding [GO:0005524]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378],Holliday junction helicase complex [GO:0009379]; plasma membrane [GO:0005886],,MTCY227.08,1
P9WGV9,RUVC_MYCTU,Rv2594c,ruvC Rv2594c MTCY227.07,GO:0000725; GO:0003676; GO:0006974; GO:0008821; GO:0046872; GO:0048476; GO:0071932,IPR012337; IPR036397; IPR020563; IPR002176; ,,ruvC,,Crossover junction endodeoxyribonuclease RuvC (EC 3.1.22.4) (Holliday junction nuclease RuvC) (Holliday junction resolvase RuvC),Holliday junction resolvase complex [GO:0048476]; crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cellular response to DNA damage stimulus [GO:0006974]; recombinational repair [GO:0000725]; replication fork reversal [GO:0071932],9634230,,FUNCTION: Nuclease that resolves Holliday junction intermediates in genetic recombination. Cleaves the cruciform structure in supercoiled DNA by nicking to strands with the same polarity at sites symmetrically opposed at the junction in the homologous arms and leaves a 5'-terminal phosphate and a 3'-terminal hydroxyl group (By similarity). {ECO:0000250}.,MRVMGVDPGLTRCGLSLIESGRGRQLTALDVDVVRTPSDAALAQRLLAISDAVEHWLDTHHPEVVAIERVFSQLNVTTVMGTAQAGGVIALAAAKRGVDVHFHTPSEVKAAVTGNGSADKAQVTAMVTKILALQAKPTPADAADALALAICHCWRAPTIARMAEATSRAEARAAQQRHAYLAKLKAAR,"19,786",188,RuvC family,cellular response to DNA damage stimulus [GO:0006974]; recombinational repair [GO:0000725]; replication fork reversal [GO:0071932],crossover junction endodeoxyribonuclease activity [GO:0008821]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],Holliday junction resolvase complex [GO:0048476],,MTCY227.07,1
P9WPW3,SCOB_MYCTU,Rv2503c,scoB Rv2503c MTCY07A7.09c,GO:0001666; GO:0008152; GO:0008260,IPR012791; IPR004165; IPR004164; IPR037171; ,,scoB,,Probable succinyl-CoA:3-ketoacid coenzyme A transferase subunit B (EC 2.8.3.5) (OXCT B) (Succinyl-CoA:3-oxoacid CoA-transferase),3-oxoacid CoA-transferase activity [GO:0008260]; metabolic process [GO:0008152]; response to hypoxia [GO:0001666],9634230; 21969609,,,MSAPGWSRDEMAARVAAEFEDGQYVNLGIGMPTLIPNHIPDGVHVVLHSENGILGVGPYPRREDVDADLINAGKETVTTLPGAAFFSSSTSFGIIRGGHLDVAVLGAMQVSVTGDLANWMIPGKMVKGMGGAMDLVHGARKVIVMMEHTAKDGSPKILERCTLPLTGVGCVDRIVTELAVIDVCADGLHLVQTAPGVSVDEVVAKTQPPLVLRDLATQ,"22,898",218,3-oxoacid CoA-transferase subunit B family,metabolic process [GO:0008152]; response to hypoxia [GO:0001666],3-oxoacid CoA-transferase activity [GO:0008260],,,MTCY07A7.09c,1
P9WGP1,SECD_MYCTU,Rv2587c,secD Rv2587c MTCY227.14,GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0006886; GO:0015031; GO:0015450,IPR005791; IPR022813; IPR022645; IPR022646; ,,secD,,Protein translocase subunit SecD,cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031],9634230; 21969609,,FUNCTION: Part of the Sec protein translocase complex. Interacts with the SecYEG preprotein conducting channel. SecDF uses the proton motive force (PMF) to complete protein translocation after the ATP-dependent function of SecA. {ECO:0000255|HAMAP-Rule:MF_01463}.,MASSSAPVHPARYLSVFLVMLIGIYLLVFFTGDKHTAPKLGIDLQGGTRVTLTARTPDGSAPSREALAQAQQIISARVNGLGVSGSEVVVDGDNLVITVPGNDGSEARNLGQTARLYIRPVLNSMPAQPAAEEPQPAPSAEPQPPGQPAAPPPAQSGAPASPQPGAQPRPYPQDPAPSPNPTSPASPPPAPPAEAPATDPRKDLAERIAQEKKLRQSTNQYMQMVALQFQATRCESDDILAGNDDPKLPLVTCSTDHKTAYLLAPSIISGDQIQNATSGMDQRGIGYVVDLQFKGPAANIWADYTAAHIGTQTAFTLDSQVVSAPQIQEAIPGGRTQISGGDPPFTAATARQLANVLKYGSLPLSFEPSEAQTVSATLGLSSLRAGMIAGAIGLLLVLVYSLLYYRVLGLLTALSLVASGSMVFAILVLLGRYINYTLDLAGIAGLIIGIGTTADSFVVFFERIKDEIREGRSFRSAVPRGWARARKTIVSGNAVTFLAAAVLYFLAIGQVKGFAFTLGLTTILDLVVVFLVTWPLVYLASKSSLLAKPAYNGLGAVQQVARERRAMARTGRG,"60,267",573,"SecD/SecF family, SecD subfamily",intracellular protein transport [GO:0006886]; protein transport [GO:0015031],P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY227.14,1
P9WGX1,RSME_MYCTU,Rv2372c,rsmE Rv2372c MTCY27.08,GO:0005737; GO:0070042; GO:0070475,IPR029028; IPR015947; IPR006700; IPR029026; ,,rsmE,,Ribosomal RNA small subunit methyltransferase E (EC 2.1.1.193) (16S rRNA m3U1498 methyltransferase),cytoplasm [GO:0005737]; rRNA (uridine-N3-)-methyltransferase activity [GO:0070042]; rRNA base methylation [GO:0070475],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Specifically methylates the N3 position of the uracil ring of uridine 1498 (m3U1498) in 16S rRNA. Acts on the fully assembled 30S ribosomal subunit (By similarity). {ECO:0000250}.,MVAMLFYVDTLPDTGAVAVVDGDEGFHAATVRRIRPGEQLVLGDGVGRLARCVVEQAGRGGLRARVLRRWSVPPVRPPVTVVQALPKSERSELAIELATEAGADAFLAWQAARCVANWDGARVDKGLRRWRAVVRSAARQSRRARIPPVDGVLSTPMLVQRVREEVAAGAAVLVLHEEATERIVDIAAAQAGSLMLVVGPEGGIAPDELAALTDAGAVAVRLGPTVLRTSTAAAVALGAVGVLTSRWDASASDCEYCDVTRR,"27,653",262,RNA methyltransferase RsmE family,rRNA base methylation [GO:0070475],rRNA (uridine-N3-)-methyltransferase activity [GO:0070042],cytoplasm [GO:0005737],,MTCY27.08,1
P9WH41,RS20_MYCTU,Rv2412,rpsT Rv2412 MTCY253.08c,GO:0003735; GO:0005829; GO:0005840; GO:0006412; GO:0019843; GO:0040007,IPR002583; IPR036510; ,,rpsT,,30S ribosomal protein S20,cytosol [GO:0005829]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 19099550; 21969609,,FUNCTION: Binds directly to 16S ribosomal RNA. {ECO:0000255|HAMAP-Rule:MF_00500}.,MANIKSQQKRNRTNERARLRNKAVKSSLRTAVRAFREAAHAGDKAKAAELLASTNRKLDKAASKGVIHKNQAANKKSALAQALNKL,"9,405",86,Bacterial ribosomal protein bS20 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosol [GO:0005829]; ribosome [GO:0005840],,MTCY253.08c,1
P9WHG9,RELA_MYCTU,Rv2583c,relA Rv2583c MTCY227.18,GO:0005524; GO:0005525; GO:0005618; GO:0005886; GO:0008728; GO:0008893; GO:0009405; GO:0015968; GO:0015969; GO:0015970; GO:0016301; GO:0030145,IPR002912; IPR012675; IPR003607; IPR004811; IPR007685; IPR004095; IPR012676; IPR033655; ,,relA,DOMAIN 53 150 HD. {ECO:0000255|PROSITE-ProRule:PRU01175}.; DOMAIN 662 736 ACT. {ECO:0000255|PROSITE-ProRule:PRU01007}.,"Bifunctional (p)ppGpp synthase/hydrolase RelA [Includes: GTP pyrophosphokinase (EC 2.7.6.5) ((p)ppGpp synthase) (ATP:GTP 3'-pyrophosphotransferase) (Stringent response-like protein) (ppGpp synthase II); Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase (EC 3.1.7.2) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)]","cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTP diphosphokinase activity [GO:0008728]; guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; kinase activity [GO:0016301]; manganese ion binding [GO:0030145]; guanosine tetraphosphate biosynthetic process [GO:0015970]; guanosine tetraphosphate metabolic process [GO:0015969]; pathogenesis [GO:0009405]; stringent response [GO:0015968]",9634230; 10375643; 10995231; 10940033; 16026164; 20529853; 21969609,X-ray crystallography (1),"FUNCTION: In eubacteria ppGpp (guanosine 3'-diphosphate 5-' diphosphate) is a mediator of the stringent response that coordinates a variety of cellular activities in response to changes in nutritional abundance. This enzyme catalyzes both the formation of pppGpp, which is then hydrolyzed to form ppGpp, as well as the hydrolysis of ppGpp. RelA is probably a key factor in the pathogenesis of M.tuberculosis as it regulates the intracellular concentrations of (p)ppGpp. {ECO:0000269|PubMed:10375643, ECO:0000269|PubMed:10940033}.",MTAQRSTTNPVLEPLVAVHREIYPKADLSILQRAYEVADQRHASQLRQSGDPYITHPLAVANILAELGMDTTTLVAALLHDTVEDTGYTLEALTEEFGEEVGHLVDGVTKLDRVVLGSAAEGETIRKMITAMARDPRVLVIKVADRLHNMRTMRFLPPEKQARKARETLEVIAPLAHRLGMASVKWELEDLSFAILHPKKYEEIVRLVAGRAPSRDTYLAKVRAEIVNTLTASKIKATVEGRPKHYWSIYQKMIVKGRDFDDIHDLVGVRILCDEIRDCYAAVGVVHSLWQPMAGRFKDYIAQPRYGVYQSLHTTVVGPEGKPLEVQIRTRDMHRTAEYGIAAHWRYKEAKGRNGVLHPHAAAEIDDMAWMRQLLDWQREAADPGEFLESLRYDLAVQEIFVFTPKGDVITLPTGSTPVDFAYAVHTEVGHRCIGARVNGRLVALERKLENGEVVEVFTSKAPNAGPSRDWQQFVVSPRAKTKIRQWFAKERREEALETGKDAMAREVRRGGLPLQRLVNGESMAAVARELHYADVSALYTAIGEGHVSAKHVVQRLLAELGGIDQAEEELAERSTPATMPRRPRSTDDVGVSVPGAPGVLTKLAKCCTPVPGDVIMGFVTRGGGVSVHRTDCTNAASLQQQAERIIEVLWAPSPSSVFLVAIQVEALDRHRLLSDVTRALADEKVNILSASVTTSGDRVAISRFTFEMGDPKHLGHLLNAVRNVEGVYDVYRVTSAA,"81,827",738,RelA/SpoT family,guanosine tetraphosphate biosynthetic process [GO:0015970]; guanosine tetraphosphate metabolic process [GO:0015969]; pathogenesis [GO:0009405]; stringent response [GO:0015968],"ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTP diphosphokinase activity [GO:0008728]; guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; kinase activity [GO:0016301]; manganese ion binding [GO:0030145]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY227.18,1
P9WKI9,SUHB_MYCTU,Rv2701c,suhB Rv2701c MTCY05A6.22c,GO:0000287; GO:0006020; GO:0006021; GO:0007165; GO:0008934; GO:0046854; GO:0046855; GO:0052832; GO:0052833,IPR033942; IPR020583; IPR000760; IPR020550; ,,suhB,,Inositol-1-monophosphatase SuhB (I-1-Pase) (IMPase) (Inositol-1-phosphatase) (EC 3.1.3.25),inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; magnesium ion binding [GO:0000287]; inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],9634230; 11914086; 20167072; 21969609; 17725819,X-ray crystallography (1),"FUNCTION: Catalyzes the dephosphorylation of inositol 1-phosphate (I-1-P) to yield free myo-inositol, a key metabolite in mycobacteria. Is also able to hydrolyze a variety of polyol phosphates such as glucitol-6-phosphate, inositol 2-phosphate (I-2-P), glycerol-2-phosphate, and 2'-AMP, albeit with reduced efficiency. {ECO:0000269|PubMed:11914086}.",MTRPDNEPARLRSVAENLAAEAAAFVRGRRAEVFGISRAGDGDGAVRAKSSPTDPVTVVDTDTERLLRDRLAQLRPGDPILGEEGGGPADVTATPSDRVTWVLDPIDGTVNFVYGIPAYAVSIGAQVGGITVAGAVADVAARTVYSAATGLGAHLTDERGRHVLRCTGVDELSMALLGTGFGYSVRCREKQAELLAHVVPLVRDVRRIGSAALDLCMVAAGRLDAYYEHGVQVWDCAAGALIAAEAGARVLLSTPRAGGAGLVVVAAAPGIADELLAALQRFNGLEPIPD,"30,027",290,Inositol monophosphatase superfamily,inositol biosynthetic process [GO:0006021]; inositol metabolic process [GO:0006020]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; magnesium ion binding [GO:0000287],,,MTCY05A6.22c,1
P9WFT5,SYT_MYCTU,Rv2614c,thrS Rv2614c MTCY1A10.20,GO:0000049; GO:0004829; GO:0005524; GO:0005737; GO:0005886; GO:0006435; GO:0040007; GO:0046872,IPR002314; IPR006195; IPR004154; IPR036621; IPR002320; IPR018163; IPR033728; IPR012947; ,,thrS,,Threonine--tRNA ligase (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; growth [GO:0040007]; threonyl-tRNA aminoacylation [GO:0006435],9634230; 21969609,,FUNCTION: Catalyzes the attachment of threonine to tRNA(Thr) in a two-step reaction: L-threonine is first activated by ATP to form Thr-AMP and then transferred to the acceptor end of tRNA(Thr). Also edits incorrectly charged L-seryl-tRNA(Thr). {ECO:0000255|HAMAP-Rule:MF_00184}.,MSAPAQPAPGVDGGDPSQARIRVPAGTTAATAVGEAGLPRRGTPDAIVVVRDADGNLRDLSWVPDVDTDITPVAANTDDGRSVIRHSTAHVLAQAVQELFPQAKLGIGPPITDGFYYDFDVPEPFTPEDLAALEKRMRQIVKEGQLFDRRVYESTEQARAELANEPYKLELVDDKSGDAEIMEVGGDELTAYDNLNPRTRERVWGDLCRGPHIPTTKHIPAFKLTRSSAAYWRGDQKNASLQRIYGTAWESQEALDRHLEFIEEAQRRDHRKLGVELDLFSFPDEIGSGLAVFHPKGGIVRRELEDYSRRKHTEAGYQFVNSPHITKAQLFHTSGHLDWYADGMFPPMHIDAEYNADGSLRKPGQDYYLKPMNCPMHCLIFRARGRSYRELPLRLFEFGTVYRYEKSGVVHGLTRVRGLTMDDAHIFCTRDQMRDELRSLLRFVLDLLADYGLTDFYLELSTKDPEKFVGAEEVWEEATTVLAEVGAESGLELVPDPGGAAFYGPKISVQVKDALGRTWQMSTIQLDFNFPERFGLEYTAADGTRHRPVMIHRALFGSIERFFGILTEHYAGAFPAWLAPVQVVGIPVADEHVAYLEEVATQLKSHGVRAEVDASDDRMAKKIVHHTNHKVPFMVLAGDRDVAAGAVSFRFGDRTQINGVARDDAVAAIVAWIADRENAVPTAELVKVAGRE,"77,122",692,Class-II aminoacyl-tRNA synthetase family,growth [GO:0040007]; threonyl-tRNA aminoacylation [GO:0006435],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY1A10.20,1
P9WFW7,SYA_MYCTU,Rv2555c,alaS Rv2555c MTCY159.01 MTCYW318.01c,GO:0000049; GO:0004813; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006400; GO:0006419; GO:0016597; GO:0040007; GO:0046872,IPR002318; IPR018162; IPR018165; IPR018164; IPR023033; IPR003156; IPR018163; IPR009000; IPR012947; ,,alaS,,Alanine--tRNA ligase (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049]; alanyl-tRNA aminoacylation [GO:0006419]; growth [GO:0040007]; tRNA modification [GO:0006400],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the attachment of alanine to tRNA(Ala) in a two-step reaction: alanine is first activated by ATP to form Ala-AMP and then transferred to the acceptor end of tRNA(Ala). Also edits incorrectly charged Ser-tRNA(Ala) and Gly-tRNA(Ala) via its editing domain. {ECO:0000255|HAMAP-Rule:MF_00036}.,MQTHEIRKRFLDHFVKAGHTEVPSASVILDDPNLLFVNAGMVQFVPFFLGQRTPPYPTATSIQKCIRTPDIDEVGITTRHNTFFQMAGNFSFGDYFKRGAIELAWALLTNSLAAGGYGLDPERIWTTVYFDDDEAVRLWQEVAGLPAERIQRRGMADNYWSMGIPGPCGPSSEIYYDRGPEFGPAGGPIVSEDRYLEVWNLVFMQNERGEGTTKEDYQILGPLPRKNIDTGMGVERIALVLQDVHNVYETDLLRPVIDTVARVAARAYDVGNHEDDVRYRIIADHSRTAAILIGDGVSPGNDGRGYVLRRLLRRVIRSAKLLGIDAAIVGDLMATVRNAMGPSYPELVADFERISRIAVAEETAFNRTLASGSRLFEEVASSTKKSGATVLSGSDAFTLHDTYGFPIELTLEMAAETGLQVDEIGFRELMAEQRRRAKADAAARKHAHADLSAYRELVDAGATEFTGFDELRSQARILGIFVDGKRVPVVAHGVAGGAGEGQRVELVLDRTPLYAESGGQIADEGTISGTGSSEAARAAVTDVQKIAKTLWVHRVNVESGEFVEGDTVIAAVDPGWRRGATQGHSGTHMVHAALRQVLGPNAVQAGSLNRPGYLRFDFNWQGPLTDDQRTQVEEVTNEAVQADFEVRTFTEQLDKAKAMGAIALFGESYPDEVRVVEMGGPFSLELCGGTHVSNTAQIGPVTILGESSIGSGVRRVEAYVGLDSFRHLAKERALMAGLASSLKVPSEEVPARVANLVERLRAAEKELERVRMASARAAATNAAAGAQRIGNVRLVAQRMSGGMTAADLRSLIGDIRGKLGSEPAVVALIAEGESQTVPYAVAANPAAQDLGIRANDLVKQLAVAVEGRGGGKADLAQGSGKNPTGIDAALDAVRSEIAVIARVG,"97,357",904,Class-II aminoacyl-tRNA synthetase family,alanyl-tRNA aminoacylation [GO:0006419]; growth [GO:0040007]; tRNA modification [GO:0006400],alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tRNA binding [GO:0000049],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY159.01 MTCYW318.01c,1
P9WFV7,SYG_MYCTU,Rv2357c,glyQS glyS Rv2357c MTCY27.23 MTCY98.26,GO:0004081; GO:0004820; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0006418; GO:0006426; GO:0015966; GO:0040007; GO:0046983; GO:0070062; GO:0070150; GO:1903561; GO:1990742,IPR002314; IPR006195; IPR004154; IPR036621; IPR027031; IPR022961; IPR033731; IPR002315; ,,glyQS,,Glycine--tRNA ligase (EC 6.1.1.14) (Glycyl-tRNA synthetase) (GlyRS),cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; microvesicle [GO:1990742]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; growth [GO:0040007]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],9634230; 21969609,,FUNCTION: Catalyzes the attachment of glycine to tRNA(Gly). {ECO:0000255|HAMAP-Rule:MF_00253}.,MHHPVAPVIDTVVNLAKRRGFVYPSGEIYGGTKSAWDYGPLGVELKENIKRQWWRSVVTGRDDVVGIDSSIILPREVWVASGHVDVFHDPLVESLITHKRYRADHLIEAYEAKHGHPPPNGLADIRDPETGEPGQWTQPREFNMMLKTYLGPIETEEGLHYLRPETAQGIFVNFANVVTTARKKPPFGIGQIGKSFRNEITPGNFIFRTREFEQMEMEFFVEPATAKEWHQYWIDNRLQWYIDLGIRRENLRLWEHPKDKLSHYSDRTVDIEYKFGFMGNPWGELEGVANRTDFDLSTHARHSGVDLSFYDQINDVRYTPYVIEPAAGLTRSFMAFLIDAYTEDEAPNTKGGMDKRTVLRLDPRLAPVKAAVLPLSRHADLSPKARDLGAELRKCWNIDFDDAGAIGRRYRRQDEVGTPFCVTVDFDSLQDNAVTVRERDAMTQDRVAMSSVADYLAVRLKGS,"52,938",463,Class-II aminoacyl-tRNA synthetase family,diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; growth [GO:0040007]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; microvesicle [GO:1990742]; plasma membrane [GO:0005886],glyS,MTCY27.23 MTCY98.26,1
P9WHH5,STHA_MYCTU,Rv2713,sthA Rv2713 MTCY05A6.34,GO:0003957; GO:0005618; GO:0005829; GO:0005886; GO:0009055; GO:0045454; GO:0050660,IPR036188; IPR023753; IPR016156; IPR001100; IPR004099; IPR022962; ,,sthA,,Probable soluble pyridine nucleotide transhydrogenase (STH) (EC 1.6.1.1) (NAD(P)(+) transhydrogenase [B-specific]),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; cell redox homeostasis [GO:0045454],9634230; 21969609,,"FUNCTION: Conversion of NADPH, generated by peripheral catabolic pathways, to NADH, which can enter the respiratory chain for energy generation. {ECO:0000250}.",MREYDIVVIGSGPGGQKAAIASAKLGKSVAIVERGRMLGGVCVNTGTIPSKTLREAVLYLTGMNQRELYGASYRVKDRITPADLLARTQHVIGKEVDVVRNQLMRNRVDLIVGHGRFIDPHTILVEDQARREKTTVTGDYIIIATGTRPARPSGVEFDEERVLDSDGILDLKSLPSSMVVVGAGVIGIEYASMFAALGTKVTVVEKRDNMLDFCDPEVVEALKFHLRDLAVTFRFGEEVTAVDVGSAGTVTTLASGKQIPAETVMYSAGRQGQTDHLDLHNAGLEVQGRGRIFVDDRFQTKVDHIYAVGDVIGFPALAATSMEQGRLAAYHAFGEPTDGITELQPIGIYSIPEVSYVGATEVELTKSSIPYEVGVARYRELARGQIAGDSYGMLKLLVSTEDLKLLGVHIFGTSATEMVHIGQAVMGCGGSVEYLVDAVFNYPTFSEAYKNAALDVMNKMRALNQFRR,"50,754",468,Class-I pyridine nucleotide-disulfide oxidoreductase family,cell redox homeostasis [GO:0045454],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY05A6.34,1
P9WFW3,SYDND_MYCTU,Rv2572c,aspS Rv2572c MTCY227.29,GO:0003676; GO:0005524; GO:0005618; GO:0005737; GO:0006418; GO:0050560,IPR004364; IPR006195; IPR004524; IPR002312; IPR004115; IPR029351; IPR012340; IPR004365; ,,aspS,,Aspartate--tRNA(Asp/Asn) ligase (EC 6.1.1.23) (Aspartyl-tRNA synthetase) (AspRS) (Non-discriminating aspartyl-tRNA synthetase) (ND-AspRS),cell wall [GO:0005618]; cytoplasm [GO:0005737]; aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; tRNA aminoacylation for protein translation [GO:0006418],9634230; 21969609,X-ray crystallography (1),FUNCTION: Aspartyl-tRNA synthetase with relaxed tRNA specificity since it is able to aspartylate not only its cognate tRNA(Asp) but also tRNA(Asn). Reaction proceeds in two steps: L-aspartate is first activated by ATP to form Asp-AMP and then transferred to the acceptor end of tRNA(Asp/Asn). {ECO:0000255|HAMAP-Rule:MF_00044}.,MLRSHAAGLLREGDAGQQVTLAGWVARRRDHGGVIFIDLRDASGIAQVVFRDPQDTEVLAQAHRLRAEFCVSVAGVVEIRPEGNANPEIATGEIEVNATSLTVLGECAPLPFQLDEPAGEELRLKYRYLDLRRDDPAAAIRLRSRVNAAARAVLARHDFVEIETPTITRSTPEGARDFLVPARLHPGSFYALPQSPQLFKQLLMVAGMERYYQIARCYRDEDFRADRQPEFTQLDMEMSFVDAEDIIAISEEVLTELWALIGYRIPTPIPRIGYAEAMRRFGTDKPDLRFGLELVECTDFFSDTTFRVFQAPYVGAVVMPGGASQPRRTLDGWQDWAKQRGHRGLAYVLVAEDGTLGGPVAKNLTEAERTGLADHVGAKPGDCIFFSAGPVKSSRALLGAARVEIANRLGLIDPDAWAFVWVVDPPLFEPADEATAAGEVAVGSGAWTAVHHAFTAPKPEWEDRIESDTGSVLADAYDIVCNGHEIGGGSVRIHRRDIQERVFAVMGLDKAEAEEKFGFLLEAFMFGAPPHGGIAFGWDRTTALLAGMDSIREVIAFPKTGGGVDPLTDAPAPITAQQRKESGIDAQPKRVQQA,"64,981",594,"Class-II aminoacyl-tRNA synthetase family, Type 1 subfamily",tRNA aminoacylation for protein translation [GO:0006418],aspartate-tRNA(Asn) ligase activity [GO:0050560]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY227.29,1
P9WFV5,SYH_MYCTU,Rv2580c,hisS Rv2580c MTCY227.21,GO:0004821; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006427; GO:0040007,IPR006195; IPR004154; IPR036621; IPR015807; IPR004516; IPR033656; ,,hisS,,Histidine--tRNA ligase (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; growth [GO:0040007]; histidyl-tRNA aminoacylation [GO:0006427],9634230; 21969609,,,MTEFSSFSAPKGVPDYVPPDSAQFVAVRDGLLAAARQAGYSHIELPIFEDTALFARGVGESTDVVSKEMYTFADRGDRSVTLRPEGTAGVVRAVIEHGLDRGALPVKLCYAGPFFRYERPQAGRYRQLQQVGVEAIGVDDPALDAEVIAIADAGFRSLGLDGFRLEITSLGDESCRPQYRELLQEFLFGLDLDEDTRRRAGINPLRVLDDKRPELRAMTASAPVLLDHLSDVAKQHFDTVLAHLDALGVPYVINPRMVRGLDYYTKTAFEFVHDGLGAQSGIGGGGRYDGLMHQLGGQDLSGIGFGLGVDRTVLALRAEGKTAGDSARCDVFGVPLGEAAKLRLAVLAGRLRAAGVRVDLAYGDRGLKGAMRAAARSGARVALVAGDRDIEAGTVAVKDLTTGEQVSVSMDSVVAEVISRLAG,"45,149",423,Class-II aminoacyl-tRNA synthetase family,growth [GO:0040007]; histidyl-tRNA aminoacylation [GO:0006427],ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY227.21,1
P9WIZ1,NRDR_MYCTU,Rv2718c,nrdR Rv2718c MTCY05A6.39c,GO:0003677; GO:0005524; GO:0005829; GO:0006351; GO:0008270; GO:0045892,IPR005144; IPR003796; ,,nrdR,DOMAIN 46 136 ATP-cone. {ECO:0000255|HAMAP-Rule:MF_00440}.,Transcriptional repressor NrdR,"cytosol [GO:0005829]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,FUNCTION: Negatively regulates transcription of bacterial ribonucleotide reductase nrd genes and operons by binding to NrdR-boxes. {ECO:0000255|HAMAP-Rule:MF_00440}.,MHCPFCRHPDSRVIDSRETDEGQAIRRRRSCPECGRRFTTVETAVLAVVKRSGVTEPFSREKVISGVRRACQGRQVDDDALNLLAQQVEDSVRAAGSPEIPSHDVGLAILGPLRELDEVAYLRFASVYRSFSSADDFAREIEALRAHRNLSAHS,"17,177",154,NrdR family,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],cytosol [GO:0005829],,MTCY05A6.39c,1
P95006,VPB19_MYCTU,Rv2547,vapB19 Rv2547,GO:0006355; GO:0045927,IPR002145; IPR010985; ,,vapB19,,Putative antitoxin VapB19,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 20011113,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC19. {ECO:0000269|PubMed:20011113, ECO:0000305|PubMed:15718296}.",MRTQVTLGKEELELLDRAAKASGASRSELIRRAIHRAYGTGSKQERLAALDHSRGSWRGRDFTGTEYVDAIRGDLNERLARLGLA,"9,454",85,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,,3
P9WJ21,VPB41_MYCTU,Rv2601A,vapB41 Rv2601A,GO:0006355; GO:0045927,IPR013321; IPR010985; ,,vapB41,,Antitoxin VapB41,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",12368430; 9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC41. {ECO:0000269|PubMed:20011113}.,MKTTLDLPDELMRAIKVRAAQQGRKMKDVVTELLRSGLSQTHSGAPIPTPRRVQLPLVHCGGAATREQEMTPERVAAALLDQEAQWWSGHDDAAL,"10,454",95,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,,,,1
P9WF93,VPC19_MYCTU,Rv2548,vapC19 Rv2548,GO:0004540; GO:0005576; GO:0044119; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC19,DOMAIN 3 122 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC19 (RNase VapC19) (EC 3.1.-.-) (Toxin VapC19),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; growth of symbiont in host cell [GO:0044119]; negative regulation of growth [GO:0045926],9634230; 15718296; 16483748; 20011113; 21969609; 23345537,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB19. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MKLIDTTIAVDHLRGEPAAAVLLAELINNGEEIAASELVRFELLAGVRESELAALEAFFSAVVWTLVTEDIARIGGRLARRYRSSHRGIDDVDYLIAATAIVVDADLLTTNVRHFPMFPDLQPPY,"13,761",125,PINc/VapC protein family,growth of symbiont in host cell [GO:0044119]; negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
P9WJ45,VPB20_MYCTU,Rv2550c,vapB20 Rv2550c,GO:0003677; GO:0006355; GO:0045927; GO:0097351,IPR002145; ,,vapB20,,Antitoxin VapB20,"DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 15718296; 19016878; 24225902,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli neutralizes the toxic effect of cognate toxin VapC20. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:24225902}.",MKRLQIYIDEDVDRALAVEARRRRTSKAALIREYVAEHLRQPGPDPVDAFVGSFVGEADLSASVDDVVYGKHE,"8,199",73,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351],,,,2
P9WF63,VPC39_MYCTU,Rv2530c,vapC39 Rv2530c,GO:0004540; GO:0005576; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC39,DOMAIN 4 133 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC39 (RNase VapC39) (EC 3.1.-.-) (Toxin VapC39),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609; 23345537,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB39. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MTALLDVNVLIALGWPNHVHHAAAQRWFTQFSSNGWATTPITEAGYVRISSNRSVMQVSTTPAIAIAQLAAMTSLAGHTFWPDDVPLIVGSAGDRDAVSNHRRVTDCHLIALAARYGGRLVTFDAALADSASAGLVEVL,"14,765",139,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
P9WF59,VPC41_MYCTU,Rv2602,vapC41 Rv2602,GO:0004540; GO:0005576; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC41,DOMAIN 3 142 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC41 (RNase VapC41) (EC 3.1.-.-) (Toxin VapC41),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609; 23345537,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB41. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MLLCDTNIWLALALSGHVHHRASRAWLDTINAPGVIHFCRATQQSLLRLLTNRTVLGAYGSPPLTNREAWAAYAAFLDDDRIVLAGAEPDGLEAQWRAFAVRQSPAPKVWMDAYLAAFALTGGFELVTTDTAFTQYGGIELRLLAK,"16,026",146,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
P9WJ23,VPB39_MYCTU,Rv2530A,vapB39 Rv2530A,GO:0045927,,,vapB39,,Antitoxin VapB39,positive regulation of growth [GO:0045927],12368430; 9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC39. {ECO:0000269|PubMed:20011113}.,MRTTLQIDDDVLEDARSIARSEGKSVGAVISELARRSLRPVGIVEVDGFPVFDVPPDAPTVTSEDVVRALEDDV,"7,994",74,,positive regulation of growth [GO:0045927],,,,,1
P9WFC3,VPB40_MYCTU,Rv2595,vapB40 vapB-mt25 Rv2595 MTCY227.06c,GO:0003677,IPR007159; IPR037914; ,,vapB40,DOMAIN 1 45 SpoVT-AbrB. {ECO:0000255|PROSITE-ProRule:PRU01076}.,Antitoxin VapB40,DNA binding [GO:0003677],9634230; 20876537; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC40. Upon expression in E.coli partially counteracts the ribonuclease activity of non-cognate toxins MazF6 and MazF9. {ECO:0000269|PubMed:20876537}.,MRTTIDVAGRLVIPKRIRERLGLRGNDQVEITERDGRIEIEPAPTGVELVREGSVLVARPERPLPPLTDEIVRETLDRTRR,"9,250",81,VapB family,,DNA binding [GO:0003677],,vapB-mt25,MTCY227.06c,1
P95007,VPC18_MYCTU,Rv2546,vapC18 Rv2546,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC18,DOMAIN 4 126 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC18 (RNase VapC18) (EC 3.1.-.-) (Toxin VapC18),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB18 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MVFCVDTSAWHHAARPEVARRWLAALSADQIGICDHVRLEILYSANSATDYDALADELDGLARIPVGAETFTRACQVQRELAHVAGLHHRSVKIADLVIAAAAELSGTIVWHYDENYDRVAAITGQPTEWIVPRGTL,"15,045",137,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,3
P95004,VPC20_MYCTU,Rv2549c,vapC20 Rv2549c,GO:0004521; GO:0016075; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC20,DOMAIN 2 130 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,23S rRNA-specific endonuclease VapC20 (EC 3.1.-.-) (Ribonuclease VapC20) (RNase VapC20) (Toxin VapC20),endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; negative regulation of growth [GO:0045926]; rRNA catabolic process [GO:0016075],9634230; 15718296; 19016878; 21969609; 24225902,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system (PubMed:19016878, PubMed:24225902). An endoribonuclease that cleaves both E.coli and M.smegmatis 23S rRNA between G2661 and A2662 in the sarcin-ricin loop (SRL, E.coli 23S rRNA numbering). The SRL sequence is highly conserved and is implicated in GTP hydrolysis by EF-Tu and EF-G. Acts on purified ribosomes but not on isolated RNA in E.coli, nor on a shortened artificial substrate (PubMed:24225902). Upon expression in E.coli inhibits cell growth, colony formation and translation. Its toxic effect is neutralized by coexpression, or subsequent expression (tested over 2 hours) with cognate antitoxin VapB20 (PubMed:19016878, PubMed:24225902). {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:24225902}.",MIFVDTSFWAALGNAGDARHGTAKRLWASKPPVVMTSNHVLGETWTLLNRRCGHRAAVAAAAIRLSTVVRVEHVTADLEEQAWEWLVRHDEREYSFVDATSFAVMRKKGIQNAYAFDGDFSAAGFVEVRPE,"14,620",131,PINc/VapC protein family,negative regulation of growth [GO:0045926]; rRNA catabolic process [GO:0016075],endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872],,,,1
P9WFP1,Y2366_MYCTU,Rv2366c,Rv2366c MTCY27.14,GO:0005886; GO:0016021; GO:0016614; GO:0050660,IPR000644; IPR002550; IPR036318; IPR005170; ,,,DOMAIN 1 185 CNNM transmembrane. {ECO:0000255|PROSITE-ProRule:PRU01193}.; DOMAIN 204 267 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 272 329 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,UPF0053 protein Rv2366c,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MTGYYQLLGSIVLIGLGGLFAAIDAAISTVSPARVDELVRDQRPGAGSLRKVMADRPRYVNLVVLLRTSCEITATALLVVFIRYHFSMVWGLYLAAGIMVLASFVVVGVGPRTLGRQNAYSISLATALPLRLISWLLMPISRLLVLLGNALTPGRGFRNGPFASEIELREVVDLAQQRGVVAADERRMIESVFELGDTPAREVMVPRTEMIWIESDKTAGQAMTLAVRSGHSRIPVIGENVDDIVGVVYLKDLVEQTFCSTNGGRETTVARVMRPAVFVPDSKPLDALLREMQRDRNHMALLVDEYGAIAGLVSIEDVLEEIVGEIADEYDQAETAPVEDLGDKRFRVSARLPIEDVGELYGVEFDDDLDVDTVGGLLALELGRVPLPGAEVISHGLRLHAEGGTDHRGRVRIGTVLLSPAEPDGADDEEADHPG,"47,213",435,UPF0053 family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY27.14,1
P9WJ47,VPB18_MYCTU,Rv2545,vapB18 Rv2545,,IPR019239; ,,vapB18,,Putative antitoxin VapB18,,9634230; 15718296,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC18. {ECO:0000305|PubMed:15718296}.,MSTTIVAGVIQGHLPVILPTRRRARDLGHTTALFRAQTLQCIYLSIEYLYVCSMSRRTTIDIDDILLARAQAALGTTGLKDRVDAALRAAVR,"10,126",92,,,,,,,1
P9WF95,VPC17_MYCTU,Rv2527,vapC17 Rv2527,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC17,DOMAIN 30 118 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC17 (RNase VapC17) (EC 3.1.-.-) (Toxin VapC17),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB17 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MTTWILDKSAHVRLVAGATPPAGIDLTDLAICDIGELEWLYSARSATDYDSQQTSLRAYQILRAPSDIFDRVRHLQRDLAHHRGMWHRTPLPDLFIAETALHHRAGVLHHDRDYKRIAVVRPGFQACELSRGR,"15,175",133,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
O53219,VPC38_MYCTU,Rv2494,vapC38 Rv2494,GO:0004540; GO:0005576; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC38,,Ribonuclease VapC38 (RNase VapC38) (EC 3.1.-.-) (Toxin VapC38),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609; 23345537,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB38 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MALLDVNALVALAWDSHIHHARIREWFTANATLGWATCPLTEAGFVRVSTNPKVLPSAIGIADARRVLVALRAVGGHRFLADDVSLVDDDVPLIVGYRQVTDAHLLTLARRRGVRLVTFDAGVFTLAQQRPKTPVELLTIL,"15,425",141,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
P9WF61,VPC40_MYCTU,Rv2596,vapC40 vapC-mt25 Rv2596 MTCY227.05c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC40,DOMAIN 3 126 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC40 (RNase VapC40) (EC 3.1.-.-) (Toxin VapC40),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20876537; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Its cognate antitoxin is VapB40. {ECO:0000255|HAMAP-Rule:MF_00265}.,MIAPDTSVLVAGFATWHEGHEAAVRALNRGVHLIAHAAVETYSVLTRLPPPHRIAPVAVHAYLADITSSNYLALDACSYRGLTDHLAEHDVTGGATYDALVGFTAKAAGAKLLTRDLRAVETYERLRVEVELVT,"14,414",134,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,vapC-mt25,MTCY227.05c,1
P9WJ03,SIR_MYCTU,Rv2391,sir nirA Rv2391,GO:0000103; GO:0005618; GO:0005829; GO:0006535; GO:0016002; GO:0020037; GO:0040007; GO:0046872; GO:0050311; GO:0051539,IPR005117; IPR036136; IPR006067; IPR006066; ,,sir,,Sulfite reductase [ferredoxin] (EC 1.8.7.1),"cell wall [GO:0005618]; cytosol [GO:0005829]; 4 iron, 4 sulfur cluster binding [GO:0051539]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; sulfite reductase (ferredoxin) activity [GO:0050311]; sulfite reductase activity [GO:0016002]; cysteine biosynthetic process from serine [GO:0006535]; growth [GO:0040007]; sulfate assimilation [GO:0000103]",9634230; 19099550; 21969609; 15917234,X-ray crystallography (2),"FUNCTION: Catalyzes the reduction of sulfite to sulfide, a step in the biosynthesis of sulfur-containing amino acids and cofactors. {ECO:0000269|PubMed:15917234}.",MTTARPAKARNEGQWALGHREPLNANEELKKAGNPLDVRERIENIYAKQGFDSIDKTDLRGRFRWWGLYTQREQGYDGTWTGDDNIDKLEAKYFMMRVRCDGGALSAAALRTLGQISTEFARDTADISDRQNVQYHWIEVENVPEIWRRLDDVGLQTTEACGDCPRVVLGSPLAGESLDEVLDPTWAIEEIVRRYIGKPDFADLPRKYKTAISGLQDVAHEINDVAFIGVNHPEHGPGLDLWVGGGLSTNPMLAQRVGAWVPLGEVPEVWAAVTSVFRDYGYRRLRAKARLKFLIKDWGIAKFREVLETEYLKRPLIDGPAPEPVKHPIDHVGVQRLKNGLNAVGVAPIAGRVSGTILTAVADLMARAGSDRIRFTPYQKLVILDIPDALLDDLIAGLDALGLQSRPSHWRRNLMACSGIEFCKLSFAETRVRAQHLVPELERRLEDINSQLDVPITVNINGCPNSCARIQIADIGFKGQMIDDGHGGSVEGFQVHLGGHLGLDAGFGRKLRQHKVTSDELGDYIDRVVRNFVKHRSEGERFAQWVIRAEEDDLR,"62,112",555,Nitrite and sulfite reductase 4Fe-4S domain family,cysteine biosynthetic process from serine [GO:0006535]; growth [GO:0040007]; sulfate assimilation [GO:0000103],"4 iron, 4 sulfur cluster binding [GO:0051539]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; sulfite reductase (ferredoxin) activity [GO:0050311]; sulfite reductase activity [GO:0016002]",cell wall [GO:0005618]; cytosol [GO:0005829],nirA,,1
P9WGI1,SIGA_MYCTU,Rv2703,sigA mysA rpoD rpoV Rv2703 MTCY05A6.24,GO:0003677; GO:0003700; GO:0005618; GO:0005737; GO:0005886; GO:0006352; GO:0009405; GO:0009415; GO:0016987; GO:0040007,IPR014284; IPR000943; IPR009042; IPR007627; IPR007624; IPR007630; IPR013325; IPR013324; IPR012760; IPR028630; IPR036388; ,P9WF41,sigA,,RNA polymerase sigma factor SigA (Sigma-A),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; growth [GO:0040007]; pathogenesis [GO:0009405]; response to water [GO:0009415]",7489918; 7644534; 9634230; 9882660; 10027986; 11929527; 12354223; 11880648; 19099550; 20729364; 21969609; 22570422; 23548911; 23605043,Electron microscopy (1); X-ray crystallography (12),"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. This sigma factor is the primary sigma factor during exponential growth (Probable). {ECO:0000305|PubMed:12354223, ECO:0000305|PubMed:20729364, ECO:0000305|PubMed:22570422}.",MAATKASTATDEPVKRTATKSPAASASGAKTGAKRTAAKSASGSPPAKRATKPAARSVKPASAPQDTTTSTIPKRKTRAAAKSAAAKAPSARGHATKPRAPKDAQHEAATDPEDALDSVEELDAEPDLDVEPGEDLDLDAADLNLDDLEDDVAPDADDDLDSGDDEDHEDLEAEAAVAPGQTADDDEEIAEPTEKDKASGDFVWDEDESEALRQARKDAELTASADSVRAYLKQIGKVALLNAEEEVELAKRIEAGLYATQLMTELSERGEKLPAAQRRDMMWICRDGDRAKNHLLEANLRLVVSLAKRYTGRGMAFLDLIQEGNLGLIRAVEKFDYTKGYKFSTYATWWIRQAITRAMADQARTIRIPVHMVEVINKLGRIQRELLQDLGREPTPEELAKEMDITPEKVLEIQQYAREPISLDQTIGDEGDSQLGDFIEDSEAVVAVDAVSFTLLQDQLQSVLDTLSEREAGVVRLRFGLTDGQPRTLDEIGQVYGVTRERIRQIESKTMSKLRHPSRSQVLRDYLD,"57,800",528,"Sigma-70 factor family, RpoD/SigA subfamily","DNA-templated transcription, initiation [GO:0006352]; growth [GO:0040007]; pathogenesis [GO:0009405]; response to water [GO:0009415]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],mysA rpoD rpoV,MTCY05A6.24,1
P9WGI5,SIGB_MYCTU,Rv2710,sigB mysB Rv2710,GO:0001666; GO:0003677; GO:0003700; GO:0005829; GO:0005886; GO:0006352; GO:0009408; GO:0009410; GO:0016987; GO:0019217; GO:0040007; GO:0043175; GO:0045893; GO:0050708,IPR014284; IPR000943; IPR009042; IPR007627; IPR007624; IPR007630; IPR013325; IPR013324; IPR036388; ,,sigB,,RNA polymerase sigma factor SigB,"cytosol [GO:0005829]; plasma membrane [GO:0005886]; bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase core enzyme binding [GO:0043175]; DNA-templated transcription, initiation [GO:0006352]; growth [GO:0040007]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]",7489918; 9634230; 9882660; 10027986; 11567012; 11489128; 12123450; 11929527; 16513743; 17379732; 19592585; 21969609; 23605043; 23548911,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. A non-essential principal sigma factor that responds to cell envelope stress and hypoxia. Controls a regulon of about 40 genes, with another 100 genes expression being altered during SDS stress and about 50 gene being altered during diamide (oxidative) stress. {ECO:0000269|PubMed:19592585}.",MADAPTRATTSRVDSDLDAQSPAADLVRVYLNGIGKTALLNAAGEVELAKRIEAGLYAEHLLETRKRLGENRKRDLAAVVRDGEAARRHLLEANLRLVVSLAKRYTGRGMPLLDLIQEGNLGLIRAMEKFDYTKGFKFSTYATWWIRQAITRGMADQSRTIRLPVHLVEQVNKLARIKREMHQHLGREATDEELAAESGIPIDKINDLLEHSRDPVSLDMPVGSEEEAPLGDFIEDAEAMSAENAVIAELLHTDIRSVLATLDEREHQVIRLRFGLDDGQPRTLDQIGKLFGLSRERVRQIERDVMSKLRHGERADRLRSYAS,"36,343",323,Sigma-70 factor family,"DNA-templated transcription, initiation [GO:0006352]; growth [GO:0040007]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase core enzyme binding [GO:0043175],cytosol [GO:0005829]; plasma membrane [GO:0005886],mysB,,1
P9WMI5,SMTB_MYCTU,Rv2358,smtB Rv2358,GO:0003700; GO:0006351; GO:0006355; GO:0010043; GO:0044212; GO:0046872,IPR011991; IPR001845; IPR036388; IPR036390; ,,smtB,DOMAIN 40 134 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,HTH-type transcriptional repressor SmtB,"DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; response to zinc ion [GO:0010043]; transcription, DNA-templated [GO:0006351]",9634230; 15059632; 16077132; 21969609,,FUNCTION: Transcriptional regulator involved in zinc homeostasis. Represses the expression of the smtB-zur operon in the absence of zinc. Could act as the metal sensor that controls the expression of zur in response to zinc availability. {ECO:0000269|PubMed:16077132}.,MVTSPSTPTAAHEDVGADEVGGHQHPADRFAECPTFPAPPPREILDAAGELLRALAAPVRIAIVLQLRESQRCVHELVDALHVPQPLVSQHLKILKAAGVVTGERSGREVLYRLADHHLAHIVLDAVAHAGEDAI,"14,421",135,,"regulation of transcription, DNA-templated [GO:0006355]; response to zinc ion [GO:0010043]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212],,,,1
P9WGE5,SPEE_MYCTU,Rv2601,speE Rv2601 MTCI270.04c MTV001.02,GO:0004766; GO:0005618; GO:0005886; GO:0008295; GO:0016021,IPR030374; IPR030373; IPR029063; IPR001045; ,,speE,DOMAIN 231 465 PABS. {ECO:0000255|HAMAP-Rule:MF_00198}.,Polyamine aminopropyltransferase (Putrescine aminopropyltransferase) (PAPT) (Spermidine synthase) (SPDS) (SPDSY) (EC 2.5.1.16),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; spermidine synthase activity [GO:0004766]; spermidine biosynthetic process [GO:0008295],9634230; 19099550,,"FUNCTION: Catalyzes the irreversible transfer of a propylamine group from the amino donor S-adenosylmethioninamine (decarboxy-AdoMet) to putrescine (1,4-diaminobutane) to yield spermidine. {ECO:0000255|HAMAP-Rule:MF_00198}.",MTSTRQAGEATEASVRWRAVLLAAVAACAACGLVYELALLTLAASLNGGGIVATSLIVAGYIAALGAGALLIKPLLAHAAIAFIAVEAVLGIIGGLSAAALYAAFAFLDELDGSTLVLAVGTALIGGLVGAEVPLLMTLLQRGRVAGAADAGRTLANLNAADYLGALVGGLAWPFLLLPQLGMIRGAAVTGIVNLAAAGVVSIFLLRHVVSGRQLVTALCALAAALGLIATLLVHSHDIETTGRQQLYADPIIAYRHSAYQEIVVTRRGDDLRLYLDGGLQFCTRDEYRYTESLVYPAVSDGARSVLVLGGGDGLAARELLRQPGIEQIVQVELDPAVIELARTTLRDVNAGSLDNPRVHVVIDDAMSWLRGAAVPPAGFDAVIVDLRDPDTPVLGRLYSTEFYALAARALAPGGLMVVQAGSPYSTPTAFWRIISTIRSAGYAVTPYHVHVPTFGDWGFALARLTDIAPTPAVPSTAPALRFLDQQVLEAATVFSGDIRPRTLDPSTLDNPHIVEDMRHGWD,"54,683",523,Spermidine/spermine synthase family,spermidine biosynthetic process [GO:0008295],spermidine synthase activity [GO:0004766],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCI270.04c MTV001.02,1
P9WHI5,RECO_MYCTU,Rv2362c,recO Rv2362c MTCY27.18,GO:0005618; GO:0006281; GO:0006310,IPR037278; IPR022572; IPR012340; IPR003717; ,,recO,,DNA repair protein RecO (Recombination protein O),cell wall [GO:0005618]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],9634230,,FUNCTION: Involved in DNA repair and RecF pathway recombination. {ECO:0000250}.,MRLYRDRAVVLRQHKLGEADRIVTLLTRDHGLVRAVAKGVRRTRSKFGARLEPFAHIEVQLHPGRNLDIVTQVVSVDAFATDIVADYGRYTCGCAILETAERLAGEERAPAPALHRLTVGALRAVADGQRPRDLLLDAYLLRAMGIAGWAPALTECARCATPGPHRAFHIATGGSVCAHCRPAGSTTPPLGVVDLMSALYDGDWEAAEAAPQSARSHVSGLVAAHLQWHLERQLKTLPLVERFYQADRSVAERRAALIGQDIAGG,"28,724",265,RecO family,DNA recombination [GO:0006310]; DNA repair [GO:0006281],,cell wall [GO:0005618],,MTCY27.18,1
P9WGN9,SECF_MYCTU,Rv2586c,secF Rv2586c MTCY227.15,GO:0005618; GO:0005622; GO:0005886; GO:0005887; GO:0006886; GO:0015031; GO:0015450,IPR022813; IPR022645; IPR022646; IPR005665; ,,secF,,Protein translocase subunit SecF,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; intracellular protein transport [GO:0006886]; protein transport [GO:0015031],9634230; 21969609,,FUNCTION: Part of the Sec protein translocase complex. Interacts with the SecYEG preprotein conducting channel. SecDF uses the proton motive force (PMF) to complete protein translocation after the ATP-dependent function of SecA. {ECO:0000255|HAMAP-Rule:MF_01464}.,MASKAKTGRDDEATSAVELTEATESAVARTDGDSTTDTASKLGHHSFLSRLYTGTGAFEVVGRRRLWFGVSGAIVAVAIASIVFRGFTFGIDFKGGTTVSFPRGSTQVAQVEDVYYRALGSEPQSVVIVGAGASATVQIRSETLTSDQTAKLRDALFEAFGPKGTDGQPSKQAISDSAVSETWGGQITKKAVIALVVFLVLVALYITVRYERYMTISAITAMLFDLTVTAGVYSLVGFEVTPATVIGLLTILGFSLYDTVIVFDKVEENTHGFQHTTRRTFAEQANLAINQTFMRSINTSLIGVLPVLALMVVAVWLLGVGTLKDLALVQLIGIIIGTYSSIFFATPLLVTLRERTELVRNHTRRVLKRRNSGSPAGSEDASTDGGEQPAAADEQSLVGITQASSQSAPRAAQGSSKPAPGARPVRPVGTRRPTGKRNAGRR,"47,014",442,"SecD/SecF family, SecF subfamily",intracellular protein transport [GO:0006886]; protein transport [GO:0015031],P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,MTCY227.15,1
P9WHR1,RIP3_MYCTU,Rv2625c,rip3 Rv2625c,GO:0004222; GO:0005618; GO:0005886; GO:0005887; GO:0046872,IPR000644; IPR008915; IPR016483; ,,rip3,DOMAIN 251 308 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 315 376 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,Putative zinc metalloprotease Rip3,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],9634230; 11416222; 12953092; 18400743; 21969609,,,MRDAIPLGRIAGFVVNVHWSVLVILWLFTWSLATMLPGTVGGYPAVVYWLLGAGGAVMLLASLLAHELAHAVVARRAGVSVESVTLWLFGGVTALGGEAKTPKAAFRIAFAGPATSLALSATFGALAITLAGVRTPAIVISVAWWLATVNLLLGLFNLLPGAPLDGGRLVRAYLWRRHGDSVRAGIGAARAGRVVALVLIALGLAEFVAGGLVGGVWLAFIGWFIFAAAREEETRISTQQLFAGVRVADAMTAQPHTAPGWINVEDFIQRYVLGERHSAYPVADRDGSITGLVALRQLRDVAPSRRSTTSVGDIALPLHSVPTARPQEPLTALLERMAPLGPRSRALVTEGSAVVGIVTPSDVARLIDVYRLAQPEPTFTTSPQDADRFSDAG,"41,480",393,Peptidase M50B family,,metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WHB3,RL27_MYCTU,Rv2441c,rpmA Rv2441c MTCY428.05,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0022625; GO:0040007,IPR001684; IPR018261; ,,rpmA,,50S ribosomal protein L27,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),,MAHKKGASSSRNGRDSAAQRLGVKRYGGQVVKAGEILVRQRGTKFHPGVNVGRGGDDTLFAKTAGAVEFGIKRGRKTVSIVGSTTA,"8,968",86,Bacterial ribosomal protein bL27 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY428.05,1
P9WHC3,RL21_MYCTU,Rv2442c,rplU Rv2442c MTCY428.04,GO:0003735; GO:0005840; GO:0005886; GO:0006412; GO:0019843; GO:0040007,IPR036164; IPR028909; IPR001787; IPR018258; ,,rplU,,50S ribosomal protein L21,plasma membrane [GO:0005886]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: This protein binds to 23S rRNA in the presence of protein L20. {ECO:0000255|HAMAP-Rule:MF_01363}.,MATYAIVKTGGKQYKVAVGDVVKVEKLESEQGEKVSLPVALVVDGATVTTDAKALAKVAVTGEVLGHTKGPKIRIHKFKNKTGYHKRQGHRQQLTVLKVTGIA,"11,020",103,Bacterial ribosomal protein bL21 family,growth [GO:0040007]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],plasma membrane [GO:0005886]; ribosome [GO:0005840],,MTCY428.04,1
P60230,TRA1_MYCTU,Rv1199c; Rv2512c,Rv1199c MTCI364.11c; Rv2512c MTCY07A7.18c,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,; ,,Transposase for insertion sequence element IS1081,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,FUNCTION: Required for the transposition of the insertion element.,MTSSHLIDTEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANLMAATPKPSWPWVRTLLHSIYDQPDAESVVAQYDRVLDALTDKLPAVAEHLDTARTDLLAFTAFPKQIWRQIWSNNPQERLNREVRRRTDVVGIFPDRASIIRLVGAVLAEQHDEWIEGRRYLGLEVLTRARAALTSTEEPAKQQTTNTPALTT,"45,810",415,Transposase mutator family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,; ,MTCI364.11c; MTCY07A7.18c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WFZ3,TRKA_MYCTU,Rv2692,trkA ceoC Rv2692 MTCY05A6.13,GO:0005886; GO:0015079,IPR006036; IPR036291; IPR006037; IPR036721; IPR003148; ,,trkA,DOMAIN 2 125 RCK N-terminal. {ECO:0000255|PROSITE-ProRule:PRU00543}.; DOMAIN 137 218 RCK C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00544}.,Trk system potassium uptake protein TrkA (K(+)-uptake protein TrkA),plasma membrane [GO:0005886]; potassium ion transmembrane transporter activity [GO:0015079],9634230; 9784509; 21969609,,FUNCTION: Part of a potassium transport system. {ECO:0000250}.,MKVAVAGAGAVGRSVTRELVENGHDITLIERNPDHLDAAAIPEAHWRLGDACELSLLESIHLEEFDVVVAATGDDKVNVVLSLLAKTEFAVPRVVARVNDPRNEWLFNDAWGVDVAVSTPRMLASLIEEAVTIGDLVRLMEFRTGQANLVEITLPDNTPWGGKPVRKLQLPRDAALVTILRGPRVIVPEADEPLEGGDELLFVAVTEAEEELSRLLLPSM,"23,947",220,,,potassium ion transmembrane transporter activity [GO:0015079],plasma membrane [GO:0005886],ceoC,MTCY05A6.13,1
P71741,TREH_MYCTU,Rv2402,Rv2402,GO:0004555; GO:0005886; GO:0005993; GO:0015927,IPR008928; IPR012341; IPR011613; ,,,,"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)","plasma membrane [GO:0005886]; alpha,alpha-trehalase activity [GO:0004555]; trehalase activity [GO:0015927]; trehalose catabolic process [GO:0005993]",9634230; 17319935; 21969609,,"FUNCTION: Catalyzes the hydrolysis of alpha,alpha-trehalose into two molecules of D-glucose. {ECO:0000269|PubMed:17319935}.",MVLHAQPPDQSTETAREAKALAGATDGATATSADLHAPMALSSSSPLRNPFPPIADYAFLSDWETTCLISPAGSVEWLCVPRPDSPSVFGAILDRSAGHFRLGPYGVSVPSARRYLPGSLIMETTWQTHTGWLIVRDALVMGKWHDIERRSRTHRRTPMDWDAEHILLRTVRCVSGTVELMMSCEPAFDYHRLGATWEYSAEAYGEAIARANTEPDAHPTLRLTTNLRIGLEGREARARTRMKEGDDVFVALSWTKHPPPQTYDEAADKMWQTTECWRQWINIGNFPDHPWRAYLQRSALTLKGLTYSPTGALLAASTTSLPETPRGERNWDYRYAWIRDSTFALWGLYTLGLDREADDFFAFIADVSGANNNERHPLQVMYGVGGERSLVEAELHHLSGYDHARPVRIGNGAYNQRQHDIWGSILDSFYLHAKSREQVPENLWPVLKRQVEEAIKHWREPDRGIWEVRGEPQHFTSSKVMCWVALDRGAKLAERQGEKSYAQQWRAIADEIKADILEHGVDSRGVFTQRYGDEALDASLLLVVLTRFLPPDDPRVRNTVLAIADELTEDGLVLRYRVHETDDGLSGEEGTFTICSFWLVSALVEIGEVGRAKRLCERLLSFASPLLLYAEEIEPRSGRHLGNFPQAFTHLALINAVVHVIRAEEEADSSGMFQPANAPM,"76,518",680,Glycosyl hydrolase 15 family,trehalose catabolic process [GO:0005993],"alpha,alpha-trehalase activity [GO:0004555]; trehalase activity [GO:0015927]",plasma membrane [GO:0005886],,,2
P9WN23,TRHBO_MYCTU,Rv2470,glbO Rv2470 MTV008.26,GO:0005344; GO:0005886; GO:0015671; GO:0019825; GO:0020037; GO:0046872,IPR009050; IPR012292; IPR019795; IPR001486; ,,glbO,,Group 2 truncated hemoglobin GlbO (Hemoglobin-like protein HbO) (Truncated hemoglobin) (trHbO),plasma membrane [GO:0005886]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344]; oxygen transport [GO:0015671],9634230; 11796724; 21969609; 12719529,X-ray crystallography (2),"FUNCTION: When expressed in E.coli and M.smegmatis, HbO increases oxygen uptake. Membrane vesicles of E.coli carrying HbO show a respiration activity about twice that of membranes without HbO. HbO seems to interact with a terminal oxidase. Therefore, HbO could participate in oxygen/electron-transfer process, suggesting a function related to the facilitation of oxygen transfer during aerobic metabolism of M.tuberculosis.",MPKSFYDAVGGAKTFDAIVSRFYAQVAEDEVLRRVYPEDDLAGAEERLRMFLEQYWGGPRTYSEQRGHPRLRMRHAPFRISLIERDAWLRCMHTAVASIDSETLDDEHRRELLDYLEMAAHSLVNSPF,"14,950",128,"Truncated hemoglobin family, Group II subfamily",oxygen transport [GO:0015671],heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],plasma membrane [GO:0005886],,MTV008.26,1
O53193,TRLR_MYCTU,Rv2466c RVBD_2466c,Rv2466c RVBD_2466c LH57_13485 P425_02568,GO:0005618; GO:0005737; GO:0015035,IPR001853; IPR036249; ,,,,Thioredoxin-like reductase Rv2466c,cell wall [GO:0005618]; cytoplasm [GO:0005737]; protein disulfide oxidoreductase activity [GO:0015035],9634230; 21969609; 24877756,X-ray crystallography (3),"FUNCTION: In vitro, the reduced form of Rv2466c catalyzes the reduction and activation of TP053, which is a thienopyrimidine derivative drug that can kill both replicating and non-replicating M.tuberculosis. {ECO:0000269|PubMed:24877756}.",MLEKAPQKSVADFWFDPLCPWCWITSRWILEVAKVRDIEVNFHVMSLAILNENRDDLPEQYREGMARAWGPVRVAIAAEQAHGAKVLDPLYTAMGNRIHNQGNHELDEVITQSLADAGLPAELAKAATSDAYDNALRKSHHAGMDAVGEDVGTPTIHVNGVAFFGPVLSKIPRGEEAGKLWDASVTFASYPHFFELKRTRTEPPQFD,"23,035",207,,,protein disulfide oxidoreductase activity [GO:0015035],cell wall [GO:0005618]; cytoplasm [GO:0005737],,LH57_13485 P425_02568,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WLA1,Y2560_MYCTU,Rv2560,Rv2560 MTCY9C4.08c,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2560,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSQPPEHPGNPADPQGGNQGAGSYPPPGYGAPPPPPGYGPPPGTYLPPGYNAPPPPPGYGPPPGPPPPGYPTHLQSSGFSVGDAISWSWNRFTQNAVTLVVPVLAYAVALAAVIGATAGLVVALSDRATTAYTNTSGVSSESVDITMTPAAGIVMFLGYIALFALVLYMHAGILTGCLDIADGKPVTIATFFRPRNLGLVLVTGLLIVAVTFIGGLLCVIPGLIFGFVAQFAVAFAVDRSTSPIDSVKASIETVGSNIGGSVLSWLAQLTAVLVGELLCFVGMLIGIPVAALIHVYTYRKLSGGQVVEAVRPAPPVGWPPGPQLA,"33,124",325,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY9C4.08c,1
P9WL99,Y2561_MYCTU,Rv2561/Rv2562,Rv2561/Rv2562 MTCY9C4.07c/MTCY9C4.06c,,IPR020503; ,,,,Uncharacterized protein Rv2561/Rv2562,,9634230,,,MAQLLESVIDAAKGMKLAKLEGDAAFFWAPGGNTSVLVCDRPPQMRQRFRTRREQIKKDHPCDCKSCEQRDNLSIKFVAHEGEVAEQKVKRNVELAGVDVILVHRMLKNEVPVSEYLFMTDVVAQCLDESVRKLATPLTHDFEGIGETSTHYIDLATSDMPPAVPDHSFFGLLWADVKFEWHALPYLLGFKKACAGFRSLGRGATEEPAEMG,"23,707",212,,,,,,MTCY9C4.07c/MTCY9C4.06c,1
P9WG15,Y2563_MYCTU,Rv2563,Rv2563 MTCY9C4.05c,GO:0005576; GO:0005886; GO:0005887,,,,,Uncharacterized ABC transporter permease Rv2563,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MLFAALRDVQWRKRRLVIAIVSTGLVFAMTLVLTGLVNGFRVEAERTVDSMGVDAFVVKAGAAGPFLGSTPFAQIDLPQVARAPGVLAAAPLATAPSTIRQGTSARNVTAFGAPEHGPGMPRVSDGRAPSTPDEVAVSSTLGRNLGDDLQVGARTLRIVGIVPESTALAKIPNIFLTTEGLQQLAYNGQPTISSIGIDGMPRQLPDGYQTVNRADAVSDLMRPLKVAVDAITVVAVLLWIVAALIVGSVVYLSALERLRDFAVFKAIGVPTRSILAGLALQAVVVALLAAVVGGILSLLLAPLFPMTVVVPLSAFVALPAIATVIGLLASVAGLRRVVAIDPALAFGGP,"36,025",349,ABC-4 integral membrane protein family,,,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY9C4.05c,1
P9WL71,Y2598_MYCTU,Rv2598,Rv2598 MTCY227.03c,,IPR024486; ,,,,Uncharacterized protein Rv2598,,9634230,,,MPLHQLAIAPVDVSGALLGLVLNAPAPRPLATHRLAHTDGSALQLGVLGASHVVTVEGRFCEEVSCVARSRGGDLPESTHAPGYHLQSHTETHDEAAFRRLARHLRERCTRATGWLGGVFPGDDAALTALAAEPDGTGWRWRTWHLYPSASGGTVVHTTSRWRP,"17,616",164,,,,,,MTCY227.03c,1
P9WFG5,Y2600_MYCTU,Rv2600,Rv2600 MTCY227.01c,GO:0005886; GO:0016021,IPR007140; ,,,,UPF0719 transmembrane protein Rv2600,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MYQAGVDFGTISLTPILHGVVATVLYFLVGAAVLVAGFLMVNLLTPGDLRRLVFIDRRPNAVVLAATMYVALAIVTIAAIYASSNQLAQGLIGVAVYGIVGVALQGVALVILEIAVPGRFREHIDAPALHPAVFATAVMLLAVAGVIAAALS,"15,648",152,UPF0719 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY227.01c,1
P9WGA5,Y2603_MYCTU,Rv2603c,Rv2603c MTCI270A.02,GO:0003677; GO:0005829; GO:0006351; GO:0006355,IPR017856; IPR002876; IPR026564; IPR029072; ,,,,Probable transcriptional regulatory protein Rv2603c,"cytosol [GO:0005829]; DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSGHSKWATTKHKKAVVDARRGKMFARLIKNIEVAARVGGGDPAGNPTLYDAIQKAKKSSVPNENIERARKRGAGEEAGGADWQTIMYEGYAPNGVAVLIECLTDNRNRAASEVRVAMTRNGGTMADPGSVSYLFSRKGVVTLEKNGLTEDDVLAAVLEAGAEDVNDLGDSFEVISEPAELVAVRSALQDAGIDYESAEASFQPSVSVPVDLDGARKVFKLVDALEDSDDVQNVWTNVDVSDEVLAALDDE,"26,799",251,TACO1 family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytosol [GO:0005829],,MTCI270A.02,1
P9WL61,Y2632_MYCTU,Rv2632c,Rv2632c MTCY441.02c,,IPR015057; IPR038070; ,,,,Uncharacterized protein Rv2632c,,9634230; 21969609,X-ray crystallography (1),,MTDSEHVGKTCQIDVLIEEHDERTRAKARLSWAGRQMVGVGLARLDPADEPVAQIGDELAIARALSDLANQLFALTSSDIEASTHQPVTGLHH,"10,083",93,,,,,,MTCY441.02c,1
P9WL55,Y2636_MYCTU,Rv2636,Rv2636 MTCY441.06,GO:0005524; GO:0016740,IPR012853; IPR027417; ,,,,Putative O-phosphotransferase Rv2636 (EC 2.7.1.-),ATP binding [GO:0005524]; transferase activity [GO:0016740],9634230; 21969609,,,MINPTRARRMRYRLAAMAGMPEGKLILLNGGSSAGKTSLALAFQDLAAECWMHIGIDLFWFALPPEQLDLARVRPEYYTWDSAVEADGLEWFTVHPGPILDLAMHSRYRAIRAYLDNGMNVIADDVIWTREWLVDALRVFEGCRVWMVGVHVSDEEGARRELERGDRHPGWNRGSARAAHADAEYDFELDTTATPVHELARELHESYQACPYPMAFNRLRKRFLS,"25,749",225,,,ATP binding [GO:0005524]; transferase activity [GO:0016740],,,MTCY441.06,1
P9WP07,Y2637_MYCTU,Rv2637,Rv2637 MTCY441.07,GO:0005886; GO:0016021,IPR032818; IPR032816; ,,,,Uncharacterized membrane protein Rv2637,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MDVEALLQSIPPLMVYLVVGAVVGIESLGIPLPGEIVLVSAAVLSSHPELAVNPIGVGGAAVIGAVVGDSIGYSIGRRFGLPLFDRLGRRFPKHFGPGHVALAERLFNRWGVRAVFLGRFIALLRIFAGPLAGALKMPYPRFLAANVTGGICWAGGTTALVYFAGMAAQHWLERFSWIALVIAVIAGITAAILLRERTSRAIAELEAEHCRKAGTTAA,"23,003",218,DedA family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY441.07,1
P9WFN9,Y2639_MYCTU,Rv2639c,Rv2639c MTCY441.09c,GO:0005576; GO:0005886; GO:0016021,IPR003844; ,,,,UPF0060 membrane protein Rv2639c,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MVVRSILLFVLAAVAEIGGAWLVWQGVREQRGWLWAGLGVIALGVYGFFATLQPDAHFGRVLAAYGGVFVAGSLAWGMALDGFRPDRWDVIGALGCMAGVAVIMYAPRGH,"11,720",110,UPF0060 family,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY441.09c,1
P9WL51,Y2645_MYCTU,Rv2645,Rv2645 MTCY441.15,,,,,,Uncharacterized protein Rv2645,,9634230; 21969609,,,MTTTPRQPLFCAHADTNGDPGRCACGQQLADVGPATPPPPWCEPGTEPIWEQLTERYGGVTICQWTRYFPAGDPVAADVWIAADDRVVDGRVLRTQPAIHYTEPPVLGIGPAAARRLAAELLNAADTLDDGRRQLDDLGEHRR,"15,552",143,,,,,,MTCY441.15,1
P9WJ11,Y2654_MYCTU,Rv2654c,Rv2654c,GO:0045927,,,,,Antitoxin Rv2654c,positive regulation of growth [GO:0045927],9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin Rv2653c. {ECO:0000269|PubMed:20011113}.,MSGHALAARTLLAAADELVGGPPVEASAAALAGDAAGAWRTAAVELARALVRAVAESHGVAAVLFAATAAAAAAVDRGDPP,"7,698",81,,positive regulation of growth [GO:0045927],,,,,1
P9WL47,Y2658_MYCTU,Rv2658c,Rv2658c MTCY441.27c,,,,,,Uncharacterized protein Rv2658c,,9634230; 21969609,,,MADAVKYVVMCNCDDEPGALIIAWIDDERPAGGHIQMRSNTRFTETQWGRHIEWKLECRACRKYAPISEMTAAAILDGFGAKLHELRTSTIPDADDPSIAEARHVIPFSALCLRLSQLGG,"13,314",120,,,,,,MTCY441.27c,1
P9WL45,Y2676_MYCTU,Rv2676c,Rv2676c,GO:0005886,IPR011008; IPR010644; ,,,,Uncharacterized protein Rv2676c,plasma membrane [GO:0005886],9634230; 20066036; 21969609,,,MARLDYDALNATLRYLMFSVFSVSPGALGDQRDAIIDDASTFFKQQEERGVVVRGLYDVAGLRADADFMVWTHAERVEALQATYADFRRTTTLGRACTPVWSGVGLHRPAEFNKSHIPAFLAGEEPGAYICVYPFVRSYEWYLLPDEERRRMLAEHGMAARGYKDVRANTVPAFALGDYEWILAFEAPELDRIVDLMRELRATDARRHTRAETPFFTGPRVPVEQLVHSLP,"26,250",231,,,,plasma membrane [GO:0005886],,,1
P9WPD9,Y2684_MYCTU,Rv2684,Rv2684 MTCY05A6.05,GO:0005886; GO:0015105; GO:0016021,IPR000802; IPR004680; ,,,,Uncharacterized transporter Rv2684,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arsenite transmembrane transporter activity [GO:0015105],9634230,,,MSVVAVTIFVAAYVLIASDRVNKTMVALTGAAAVVVLPVITSHDIFYSHDTGIDWDVIFLLVGMMIIVGVLRQTGVFEYTAIWAAKRARGSPLRIMILLVLVSALASALLDNVTTVLLIAPVTLLVCDRLNINTTSFLMAEVFASNIGGAATLVGDPPNIIVASRAGLTFNDFMLHLTPLVVIVLIALIAVLPRLFGSITVEADRIADVMALDEGEAIRDRGLLVKCGAVLVLVFAAFVAHPVLHIQPSLVALLGAGMLIVVSGLTRSEYLSSVEWDTLLFFAGLFIMVGALVKTGVVNDLARAATQLTGGNIVATAFLILGVSAPISGIIDNIPYVATMTPLVAELVAVMGGQPSTDTPWWALALGADFGGNLTAIGASANVVMLGIARRAGAPISFWEFTRKGAVVTAVSIALAAIYLWLRYFVLLH,"45,188",429,CitM (TC 2.A.11) transporter family,,arsenite transmembrane transporter activity [GO:0015105],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY05A6.05,1
P9WL75,YAJC_MYCTU,Rv2588c,yajC Rv2588c MTCY227.13,GO:0005886; GO:0015031; GO:0016021,IPR003849; ,,yajC,,Sec translocon accessory complex subunit YajC,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein transport [GO:0015031],9634230; 21969609,,"FUNCTION: The SecYEG-SecDF-YajC-YidC holo-translocon (HTL) protein secretase/insertase is a supercomplex required for protein secretion, insertion of proteins into membranes, and assembly of membrane protein complexes. While the SecYEG complex is essential for assembly of a number of proteins and complexes, the SecDF-YajC-YidC subcomplex facilitates these functions. {ECO:0000250|UniProtKB:P0ADZ7}.",MESFVLFLPFLLIMGGFMYFASRRQRRAMQATIDLHDSLQPGERVHTTSGLEATIVAIADDTIDLEIAPGVVTTWMKLAIRDRILPDDDIDEELNEDLDKDVDDVAGERRVTNDS,"12,967",115,YajC family,protein transport [GO:0015031],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY227.13,1
P9WQN1,Y2559_MYCTU,Rv2559c,Rv2559c MTCY9C4.09,GO:0003677; GO:0005524; GO:0006260,IPR003593; IPR032423; IPR003959; IPR008921; IPR021886; IPR027417; ,,,,Uncharacterized AAA domain-containing protein Rv2559c,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA replication [GO:0006260],9634230; 21969609,,,MPEAVSDGLFDVPGVPMTSGHDLGASAGAPLAVRMRPASLDEVVGQDHLLAPGSPLRRLVEGSGVASVILYGPPGSGKTTLAALISQATGRRFEALSALSAGVKEVRAVIENSRKALLHGEQTVLFIDEVHRFSKTQQDALLSAVEHRVVLLVAATTENPSFSVVAPLLSRSLILQLRPLTAEDTRAVVQRAIDDPRGLGRAVAVAPEAVDLLVQLAAGDARRALTALEVAAEAAQAAGELVSVQTIERSVDKAAVRYDRDGDQHYDVVSAFIKSVRGSDVDAALHYLARMLVAGEDPRFIARRLMILASEDIGMAGPSALQVAVAAAQTVALIGMPEAQLTLAHATIHLATAPKSNAVTTALAAAMNDIKAGKAGLVPAHLRDGHYSGAAALGNAQGYKYSHDDPDGVVAQQYPPDELVDVDYYRPTGRGGEREIAGRLDRLRAIIRKKRG,"47,499",452,"AAA ATPase family, RarA/MGS1/WRNIP1 subfamily",DNA replication [GO:0006260],ATP binding [GO:0005524]; DNA binding [GO:0003677],,,MTCY9C4.09,1
P9WQI5,Y2564_MYCTU,Rv2564,Rv2564 MTCY9C4.04c,GO:0005524; GO:0016887,IPR003593; IPR003439; IPR017871; IPR018490; IPR018488; IPR000595; IPR027417; IPR014710; ,,,DOMAIN 4 242 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Uncharacterized ABC transporter ATP-binding protein Rv2564,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MGGLTISDLVVEYSSGGYAVRPIDGLSLDVAPGSLVILLGPSGCGKTTLLSCLGGILRPKSGSIKFDDVDITTLEGAALAKYRRDKVGIVFQAFNLVSSLTALENVMVPLRAAGVSRAAARKRAEDLLIRVNLGERMKHRPGDMSGGQQQRVAVARAIALDPQLILADEPTAHLDFIQVEEVLRLIRSLAQGDRVVVVATHDSRMLPLADRVLELMPAQVSPNQPPETVHVKAGEVLFEQSTMGDLIYVVSEGEFEIVRELADGGEELVKTAAPGDYFGEIGVLFHLPRSATVRARSDATAVGYTAQAFRERLGVTRVADLIEHRELASE,"35,429",330,ABC transporter superfamily,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,MTCY9C4.04c,1
P9WL97,Y2567_MYCTU,Rv2567,Rv2567 MTCY227.34c MTCY9C4.01c,GO:0005886,IPR025841; IPR007296; ,,,,Uncharacterized protein Rv2567,plasma membrane [GO:0005886],9634230; 21969609,,,MAPSASAATNGYDVDRLLAGYRTARAQETLFDLRDGPGAGYDEFVDDDGNVRPTWTELADAVAERGKAGLDRLRSVVHSLIDHDGITYTAIDAHRDALTGDHDLEPGPWRLDPLPLVISAADWEVLEAGLVQRSRLLDAILADLYGPRSMLTEGVLPPEMLFAHPGYVRAANGIQMPGRHQLFMHACDLSRLPDGTFQVNADWTQAPSGSGYAMADRRVVAHAVPDLYEELAPRPTTPFAQALRLALIDAAPDVAQDPVVVVLSPGIYSETAFDQAYLATLLGFPLVESADLVVRDGKLWMRSLGTLKRVDVVLRRVDAHYADPLDLRADSRLGVVGLVEAQHRGTVTVVNTLGSGILENPGLLRFLPQLSERLLDESPLLHTAPVYWGGIASERSHLLANVSSLLIKSTVSGETLVGPTLSSAQLADLAVRIEAMPWQWVGQELPQFSSAPTNHAGVLSSAGVGMRLFTVAQRSGYAPMIGGLGYVLAPGPAAYTLKTVAAKDIWVRPTERAHAEVITVPVLAPPAKTGAGTWAVSSPRVLSDLFWMGRYGERAENMARLLIVTRERYHVFRHQQDTDESECVPVLMAALGKITGYDTATGAGSAYDRADMIAVAPSTLWSLTVDPDRPGSLVQSVEGLALAAQAVRDQLSNDTWMVLANVERAVEHKSDPPQSLAEADAVLASAQAETLAGMLTLSGVAGESMVHDVGWTMMDIGKRIERGLWLTALLQATLSTVRHPAAEQAIIEATLVACESSVIYRRRTVGKFSVAAVTELMLFDAQNPRSLVYQLERLRADLKDLPGSSGSSRPERMVDEMNTRLRRSHPEELEEVSADGLRAELAELLAGIHASLRDVADVLTATQLALPGGMQPLWGPDQRRVMPA,"95,449",884,,,,plasma membrane [GO:0005886],,MTCY227.34c MTCY9C4.01c,1
P9WL95,Y2568_MYCTU,Rv2568c,Rv2568c MTCY227.33,,IPR031321; IPR011201; ,,,,Uncharacterized protein Rv2568c,,9634230; 21969609,,,MRDFHCPNCGQRLAFENSACLSCGSALGFSLGRMALLVIADDADVQLCANLHLAQCNWLVPSDQLGGLCSSCVLTIERPSDTNTAGLAEFARAEGAKRRLIAELHELKLPIVGRDQDPDHGLAFRLLSSAHENVTTGHQNGVITLDLAEGDDVHREQLRVEMDEPYRTLLGHFRHEIGHYYFYRLIASSSDYLSRFNELFGDPDADYSQALDRHYRGGPPEGWQDSFVSSYATMHASEDWAETFAHYLHIRDALDTAAWCGLAPASATFDRPALGPSAFNTIIDKWLPLSWSLNMVNRSMGHDDLYPFVLPAAVLEKMRFIHTVVDEVAPDFEPAHSRRTV,"38,003",341,,,,,,MTCY227.33,1
P9WL89,Y2571_MYCTU,Rv2571c,Rv2571c MTCY227.30,GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv2571c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSASLLVRTACGGRAVAQRLRTVLWPITQTSVVAGLAWYLTHDVFNHPQAFFAPISAVVCMSATNVLRARRAQQMIVGVALGIVLGAGVHALLGSGPIAMGVVVFIALSVAVLCARGLVAQGLMFINQAAVSAVLVLVFASNGSVVFERLFDALVGGGLAIVFSILLFPPDPVVMLCSARADVLAAVRDILAELVNTVSDPTSAPPDWPMAAADRLHQQLNGLIEVRANAAMVARRAPRRWGVRSTVRDLDQQAVYLALLVSSVLHLARTIAGPGGDKLPTPVHAVLTDLAAGTGLADADPTAANEHAAAARATASTLQSAACGSNEVVRADIVQACVTDLQRVIERPGPSGMSA,"36,790",355,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY227.30,1
P9WL69,Y2599_MYCTU,Rv2599,Rv2599 MTCY227.02c,GO:0005576; GO:0016021,IPR025341; ,,,,Uncharacterized protein Rv2599,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MSRNRLFLVAGSLAVAAAVSLISGITLLNRDVGSYIASHYRQESRDVNGTRYLCTGSPKQVATTLVKYQTPAARASHTDTEYLRYRNNIVTVGPDGTYPCIIRVENLSAGYNHGAYVFLGPGFTPGSPSGGSGGSPGGPGGSK,"14,955",143,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY227.02c,1
P9WFD7,Y2623_MYCTU,Rv2623,Rv2623 TB31.7,GO:0001666; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0009405; GO:0040007; GO:0040008; GO:0085014,IPR006015; IPR006016; ,,,,Universal stress protein Rv2623 (USP Rv2623),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; dormancy entry of symbiont in host [GO:0085014]; growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of growth [GO:0040008]; response to hypoxia [GO:0001666],9634230; 11416222; 12057942; 12953092; 12506197; 19099550; 18474359; 18400743; 21969609; 19478878; ,X-ray crystallography (2),"FUNCTION: May play a role in the establishment of a persistent infection (latency) in the host, as strains without this gene are hypervirulent. Overexpression of the protein retards growth in culture; Glu-15 and Ala-117 mutant proteins which bind less ATP do not show this retardation, suggesting growth may be regulated through an ATP-dependent function.",MSSGNSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLRAGPPTVHSEIVPAAAVPTLVDMSKDAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAHCPVVIIHDEDSVMPHPQQAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPGIDWPATQSMAEQVLAERLAGWQERYPNVAITRVVVRDQPARQLVQRSEEAQLVVVGSRGRGGYAGMLVGSVGETVAQLARTPVIVARESLT,"31,652",297,Universal stress protein A family,dormancy entry of symbiont in host [GO:0085014]; growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of growth [GO:0040008]; response to hypoxia [GO:0001666],ATP binding [GO:0005524],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,TB31.7,1
P9WL53,Y2644_MYCTU,Rv2644c,Rv2644c MTCY441.14c,GO:0005886,,,,,Uncharacterized protein Rv2644c,plasma membrane [GO:0005886],9634230,,,MSPRRTSGGVVPVDRYRIDEGLIVVLVFAGRDERRRTVCFADKFGCVHIGNPDLYRPQTSLPQPLPISSHAISGSRFVETTNRADQQEPIGPNRAELFDQALHAG,"11,629",105,,,,plasma membrane [GO:0005886],,MTCY441.14c,1
P9WL49,Y2656_MYCTU,Rv2656c,Rv2656c MTCY441.25c,,IPR024384; ,,,,Uncharacterized protein Rv2656c,,9634230,,,MTAVGGSPPTRRCPATEDRAPATVATPSSTDPTASRAVSWWSVHEYVAPTLAAAVEWPMAGTPAWCDLDDTDPVKWAAICDAARHWALRVETCQAASAEASRDVSAAADWPAVSREIQRRRDAYIRRVVV,"14,047",130,,,,,,MTCY441.25c,1
P9WPD7,Y2685_MYCTU,Rv2685,Rv2685 MTCY05A6.06,GO:0005886; GO:0015105; GO:0016021,IPR000802; IPR004680; ,,,,Uncharacterized transporter Rv2685,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arsenite transmembrane transporter activity [GO:0015105],9634230; 21969609,,,MSIIAITVFVAGYALIASDRVSKTRVALTCAAIMVGAGIVGSDDVFYSHEAGIDWDVIFLLLGMMIIVSVLRHTGVFEYVAIWAVKRANAAPLRIMILLVLVTALGSALLDNVTTVLLIAPVTLLVCDRLGVNSTPFLVAEVFASNVGGAATLVGDPPNIIIASRAGLTFNDFLIHMAPAVLVVMIALIGLLPWLLGSVTAEPDRVADVLSLNEREAIHDRGLLIKCGVVLVLVFAAFIAHPVLHIQPSLVALLGAGVLVRFSGLERSDYLSSVEWDTLLFFAGLFVMVGALVKTGVVEQLARAATELTGGNELLTVGLILGISAPVSGIIDNIPYVATMTPIVTELVAAMPGHVHPDTFWWALALSADFGGNLTAVAASANVVMLGIARRSGTPISFWKFTRKGAVVTAVSLVLSAVYLWLRYFVFG,"45,238",428,CitM (TC 2.A.11) transporter family,,arsenite transmembrane transporter activity [GO:0015105],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY05A6.06,1
P9WP73,Y2388_MYCTU,Rv2388c,hemN Rv2388c MTCY253.33,GO:0004109; GO:0005737; GO:0006779; GO:0006782; GO:0046872; GO:0051539,IPR034505; IPR006638; IPR004559; IPR007197; IPR023404; ,,hemN,,Oxygen-independent coproporphyrinogen-III oxidase-like protein Rv2388c (EC 1.3.99.-),"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]; porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782]",9634230; 19099550; 21969609,,FUNCTION: Involved in the biosynthesis of porphyrin-containing compound. {ECO:0000250}.,MPGQPFGVYLHVPFCLTRCGYCDFNTYTPAQLGGVSPDRWLLALRAELELAAAKLDAPTVHTVYVGGGTPSLLGGERLATLLDMVRDHFVLAPDAEVSTEANPESTWPEFFATIRAAGYTRVSLGMQSVAPRVLATLDRVHSPGRAAAAATEAIAEGFTHVNLDLIYGTPGESDDDLVRSVDAAVQAGVDHVSAYALVVEHGTALARRVRRGELAAPDDDVLAHRYELVDARLSAAGFAWYEVSNWCRPGGECRHNLGYWDGGQWWGAGPGAHGYIGVTRWWNVKHPNTYAEILAGATLPVAGFEQLGADALHTEDVLLKVRLRQGLPLARLGAAERERAEAVLADGLLDYHGDRLVLTGRGRLLADAVVRTLLG,"40,334",375,"Anaerobic coproporphyrinogen-III oxidase family, HemN-like subfamily",porphyrin-containing compound biosynthetic process [GO:0006779]; protoporphyrinogen IX biosynthetic process [GO:0006782],"4 iron, 4 sulfur cluster binding [GO:0051539]; coproporphyrinogen oxidase activity [GO:0004109]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737],,MTCY253.33,1
P9WLA9,Y2411_MYCTU,Rv2411c,Rv2411c MTCY253.09,,IPR007302; IPR016450; ,,,,Uncharacterized protein Rv2411c,,9634230; 21969609,,,MRRVSLPNQLNETRRRSPTRGERIFGGYNTSDVYAMAFDEMFDAQGIVRGPYKGIYAELAPSDASELKARADALGRAFIDQGITFSLSGQERPFPLDLVPRVISAPEWTRLERGITQRVKALECYLDDIYGDQEILRDGVIPRRLVTSCEHFHRQAVGIVPPNGVRIHVAGIDLIRDHRGDFRVLEDNLRSPSGVSYVMENRRTMARVFPNLFATHRVRAVDDYASHLLRALRNSAATNEADPTVVVLTPGVYNSAYFEHSLLARQMGVELVEGRDLFCRDNQVYMRTTEGERQVDVIYRRIDDAFLDPLQFRADSVLGVAGLVNAARAGNVVLSSAIGNGVGDDKLVYTYVPTMIEYYLHEKPLLANVETLRCWLDDEREEVLDRIRELVLKPVEGSGGYGIVFGPEASQAELAAVSQKIRDDPRSWIAQPMMELSTVPTRIEGTLAPRYVDLRPFAVNDGNEVWVLPGGLTRVALVEGSRVVNSSQGGGSKDTWVLAPRASAAARELGAAQIVRSLPQPLCDPTVDASGYEPHDQQPQQQQQQQQQAFH,"61,383",551,,,,,,MTCY253.09,1
P9WLA7,Y2468_MYCTU,Rv2468c,Rv2468c,GO:0005886,IPR033437; ,,,,Uncharacterized protein Rv2468c,plasma membrane [GO:0005886],9634230; 21969609,,,MTHRSSRLEVGPVARGDVATIEHAELPPGWVLTTSGRISGVTEPGELSVHYPFPIADLVALDDALTYSSRACQVRFAIYLGDLGRDTAARAREILGKVPTPDNAVLLAVSPNQCAIEVVYGSQVRGRGAESAAPLGVAAASSAFEQGELVDGLISAIRVLSAGIAPG,"17,289",167,,,,plasma membrane [GO:0005886],,,1
P9WLA5,Y2557_MYCTU,Rv2557,Rv2557 MTCY9C4.11c,GO:0009267,IPR007138; IPR011008; ,,,,Uncharacterized protein Rv2557,cellular response to starvation [GO:0009267],9634230; 21969609,,,MTGGATGALPRTMKEGWIVYARSTTIQAQSECIDTGIAHVRDVVMPALQGMDGCIGVSLLVDRQSGRCIATSAWETAEAMHASREQVTPIRDRCAEMFGGTPAVEEWEIAAMHRDHRSAEGACVRATWVKVPADQVDQGIEYYKSSVLPQIEGLDGFCSASLLVDRTSGRAVSSATFDSFDAMERNRDQSNALKATSLREAGGEELDECEFELALAHLRVPELV,"24,295",224,,cellular response to starvation [GO:0009267],,,,MTCY9C4.11c,1
P9WLA3,Y2558_MYCTU,Rv2558,Rv2558 MTCY9C4.10c,GO:0009267,IPR011008; ,,,,Uncharacterized protein Rv2558,cellular response to starvation [GO:0009267],9634230; 21969609,,,MPGSAGWRKVFGGTGGATGALPRHGRGSIVYARSTTIEAQPLSVDIGIAHVRDVVMPALQEIDGCVGVSLLVDRQSGRCIATSAWETLEAMRASVERVAPIRDRAALMFAGSARVEEWDIALLHRDHPSHEGACVRATWLKVVPDQLGRSLEFYRTSVLPELESLDGFCSASLMVDHPACRRAVSCSTFDSMDAMARNRDRASELRSRRVRELGAEVLDVAEFELAIAHLRVPELV,"25,718",236,,cellular response to starvation [GO:0009267],,,,MTCY9C4.10c,1
P9WL87,Y2574_MYCTU,Rv2574,Rv2574 MTCY227.27c,GO:0005886,IPR019587; IPR023393; ,,,,Uncharacterized protein Rv2574,plasma membrane [GO:0005886],9634230; 21969609,,,MYPCERVGLSFTETAPYLFRNTVDLAITPEQLFEVLADPQAWPRWATVITKVTWTSPEPFGAGTTRIVEMRGGIVGDEEFISWEPFTRMAFRFNECSTRAVGAFAEDYRVQAIPGGCRLTWTMAQKLAGPARPALFVFRPLLNLALRRFLRNLRRYTDARFAAAQQS,"19,002",167,,,,plasma membrane [GO:0005886],,MTCY227.27c,1
P9WL83,Y2576_MYCTU,Rv2576c,Rv2576c MTCY227.25,GO:0005576; GO:0005618; GO:0016021,IPR016793; ,,,,Uncharacterized protein Rv2576c,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MPAGVGNASGSVLDMTSVRTVPSAVALVTFAGAALSGVIPAIARADPVGHQVTYTVTTTSDLMANIRYMSADPPSMAAFNADSSKYMITLHTPIAGGQPLVYTATLANPSQWAIVTASGGLRVNPEFHCEIVVDGQVVVSQDGGSGVQCSTRPW,"15,793",154,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY227.25,1
P9WL81,Y2577_MYCTU,Rv2577,Rv2577 MTCY227.24c,GO:0003993; GO:0005886; GO:0046872,IPR004843; IPR029052; IPR008963; IPR015914; IPR006311; ,,,,Uncharacterized protein Rv2577,plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],9634230,,,MGADLKQPQDADSPPKGVSRRRFLTTGAAAVVGTGVGAGGTALLSSHPRGPAVWYQRGRSGAPPVGGLHLQFGRNASTEMVVSWHTTDTVGNPRVMLGTPTSGFGSVVVAETRSYRDAKSNTEVRVNHAHLTNLTPDTDYVYAAVHDGTTPELGTARTAPSGRKPLRFTSFGDQSTPALGRLADGRYVSDNIGSPFAGDITIAIERIAPLFNLINGDLCYANLAQDRIRTWSDWFDNNTRSARYRPWMPAAGNHENEVGNGPIGYDAYQTYFAVPDSGSSPQLRGLWYSFTAGSVRVISLHNDDVCYQDGGNSYVRGYSGGEQRRWLQAELANARRDSEIDWVVVCMHQTAISTADDNNGADLGIRQEWLPLFDQYQVDLVVCGHEHHYERSHPLRGALGTDTRTPIPVDTRSDLIDSTRGTVHLVIGGGGTSKPTNALLFPQPRCQVITGVGDFDPAIRRKPSIFVLEDAPWSAFRDRDNPYGFVAFDVDPGQPGGTTSIKATYYAVTGPFGGLTVIDQFTLTKPRGG,"57,272",529,,,acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,MTCY227.24c,1
P9WL79,Y2578_MYCTU,Rv2578c,Rv2578c MTCY227.23,GO:0003824; GO:0005886; GO:0016021; GO:0046872; GO:0051539,IPR013785; IPR006638; IPR007197; ,,,,Uncharacterized protein Rv2578c,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]",9634230,,,MRWARQAVAVNGMPVDDGALPGLQRIGLVRSVRAPQFDGITFHEVLCKSALNKVPNAAALPFRYTVNGYRGCSHACRYCFARPTHEYLDFNPGTDFDTQVVVKTNVAAVLRHELRRPSWRRETVALGTNTDPYQRAEGRYALMPGIIGALAASGTPLSILTKGTLLRRDLPLIAEAAQQVPVSVAVSLAVGDPELHRDVESGTPTPQARLALITAIRAAGLDCHVMVAPVLPQLTDSGEHLDQLLGQIAAAGATGVTVFGLHLRGSTRGWFMCWLARAHPELVSRYRELYRRGPYLPPSYREMLRERVAPLIAKYRLAGDHRPAPPETEAALVPVQATLF,"37,176",340,,,"4 iron, 4 sulfur cluster binding [GO:0051539]; catalytic activity [GO:0003824]; metal ion binding [GO:0046872]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY227.23,1
P9WL73,Y2597_MYCTU,Rv2597,Rv2597 MTCY227.04c,GO:0005886; GO:0016021,IPR025235; ,,,,Uncharacterized protein Rv2597,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MGNLLVVIAVALFIAAIVVLVVAIRRPKTPATPGGRRDPLAFDAMPQFGPRQLGPGAIVSHGGIDYVVRGSVTFREGPFVWWEHLLEGGDTPTWLSVQEDDGRLELAMWVKRTDLGLQPGGQHVIDGVTFQETERGHAGYTTEGTTGLPAGGEMDYVDCASAGQGADESMLLSFERWAPDMGWEIATGKSVLAGELTVYPAPPVSA,"21,943",206,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY227.04c,1
P9WL67,Y2627_MYCTU,Rv2627c,Rv2627c,GO:0005886,IPR029058; ,,,,Uncharacterized protein Rv2627c,plasma membrane [GO:0005886],9634230; 11416222; 12953092; 16931093; 18474359; 18400743; 21969609,,,MASSASDGTHERSAFRLSPPVLSGAMGPFMHTGLYVAQSWRDYLGQQPDKLPIARPTIALAAQAFRDEIVLLGLKARRPVSNHRVFERISQEVAAGLEFYGNRRWLEKPSGFFAQPPPLTEVAVRKVKDRRRSFYRIFFDSGFTPHPGEPGSQRWLSYTANNREYALLLRHPEPRPWLVCVHGTEMGRAPLDLAVFRAWKLHDELGLNIVMPVLPMHGPRGQGLPKGAVFPGEDVLDDVHGTAQAVWDIRRLLSWIRSQEEESLIGLNGLSLGGYIASLVASLEEGLACAILGVPVADLIELLGRHCGLRHKDPRRHTVKMAEPIGRMISPLSLTPLVPMPGRFIYAGIADRLVHPREQVTRLWEHWGKPEIVWYPGGHTGFFQSRPVRRFVQAALEQSGLLDAPRTQRDRSA,"46,252",413,,,,plasma membrane [GO:0005886],,,1
P9WL65,Y2628_MYCTU,Rv2628,Rv2628,GO:0040007,,,,,Putative uncharacterized protein Rv2628,growth [GO:0040007],9634230; 11416222; 12953092; 16931093; 18474359; 18400743; 19926735,,,MSTQRPRHSGIRAVGPYAWAGRCGRIGRWGVHQEAMMNLAIWHPRKVQSATIYQVTDRSHDGRTARVPGDEITSTVSGWLSELGTQSPLADELARAVRIGDWPAAYAIGEHLSVEIAVAV,"13,129",120,,growth [GO:0040007],,,,,1
P9WFJ5,Y2345_MYCTU,Rv2345,Rv2345,GO:0005618; GO:0005886; GO:0005887,IPR007621; ,,,,UPF0603 protein Rv2345,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 12657046; 16735741; 21969609,,FUNCTION: May play a role in septum formation. {ECO:0000269|PubMed:16735741}.,MRLVRLLGMVLTILAAGLLLGPPAGAQPPFRLSNYVTDNAGVLTSSGRTAVTAAVDRLYADRRIRLWVVYVENFSGQSALNWAQRTTRTSELGNYDALLAVATTGREYAFLVPSAMPGVSEGQVDNVRRYQIEPALHDGDYSGAAVAAANGLNRSPSSSSRVVLLVTVGIIVIVVAVLLVVMRHRNRRRRADELAAARRVDPTNVMALAAVPLQALDDLSRSMVVDVDNAVRTSTNELALAIEEFGERRTAPFTQAVNNAKAALSQAFTVRQQLDDNTPETPAQRRELLTRVIVSAAHADRELASQTEAFEKLRDLVINAPARLDLLTQQYVELTTRIGPTQQRLAELHTEFDAAAMTSIAGNVTTATERLAFADRNISAARDLADQAVSGRQAGLVDAVRAAESALGQARALLDAVDSAATDIRHAVASLPAVVADIQTGIKRANQHLQQAQQPQTGRTGDLIAARDAAARALDRARGAADPLTAFDQLTKVDADLDRLLATLAEEQATADRLNRSLEQALFTAESRVRAVSEYIDTRRGSIGPEARTRLAEAKRQLEAAHDRKSSNPTEAIAYANAASTLAAHAQSLANADVQSAQRAYTRRGGNNAGAILGGIIIGDLLSGGTRGGLGGWIPTSFGGSSNAPGSSPDGGFLGGGGRF,"70,030",660,UPF0603 family,,,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O53176,Y2449_MYCTU,Rv2449c,Rv2449c,GO:0005886; GO:0016021; GO:0016491,IPR036291; IPR005097; ,,,,Putative trans-acting enoyl reductase Rv2449c (EC 1.3.1.-),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 20066036; 21969609,,,MTATPREFDIVLYGATGFVGKLTAEYLARAGGDARIALAGRSTQRVLAVREALGESAQTWPILTADASLPSTLQAMAARAQVVVTTVGPYTRYGLPLVAACAAAGTDYADLTGEPMFMRNSIDLYHKQAADTGARIVHACGFDSVPSDLSVYALYHAAREDGAGELTDTNCVVRSFKGGFSGGTIASMLEVLSTASNDPDARRQLSDPYMLSPDRGAEPELGPQPDLPSRRGRRLAPELAGVWTAGFIMAPTNTRIVRRSNALLDWAYGRRFRYSETMSVGSTVLAPVVSVVGGGVGNAMFGLASRYIRLLPRGLVKRVVPKPGTGPSAAARERGYYRIETYTTTTTGARYLARMAQDGDPGYKATSVLLGECGLALALDRDKLSDMRGVLTPAAAMGDALLERLPAAGVSLQTTRLAS,"44,379",419,"Saccharopine dehydrogenase family, Enoyl reductase subfamily",,oxidoreductase activity [GO:0016491],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,3
P9WIY7,Y2565_MYCTU,Rv2565,Rv2565 MTCY9C4.03c,GO:0004622; GO:0005829; GO:0016042; GO:0016787; GO:0046470,IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; ,,,DOMAIN 309 469 PNPLA. {ECO:0000255|PROSITE-ProRule:PRU01161}.,Uncharacterized NTE family protein Rv2565,cytosol [GO:0005829]; hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],9634230; 21969609,,,MTTARRRPKRRGTDARTALRNVPILADIDDEQLERLATTVERRHVPANQWLFHAGEPADSIYIVDSGRFVAVAPEGHVFAEMASGDSIGDLGVIAGAARSAGVRALRDGVVWRIAAETFTDMLEATPLLQSAMLRAMARMLRQSRPAKTARRPRVIGVVSNGDTAAAPMVDAIATSLDSHGRTAVIAPPVETTSAVQEYDELVEAFSETLDRAERSNDWVLVVADRGAGDLWRHYVSAQSDRLVVLVDQRYPPDAVDSLATQRPVHLITCLAEPDPSWWDRLAPVSHHPANSDGFGALARRIAGRSLGLVMAGGGARGLAHFGVYQELTEAGVVIDRFGGTSSGAIASAAFALGMDAGDAIAAAREFIAGSDPLGDYTIPISALTRGGRVDRLVQGFFGNTLIEHLPRGFFSVSADMITGDQIIHRRGSVSGAVRASISIPGLIPPVHNGEQLLVDGGLLNNLPANVMCADTDGEVICVDLRRTFVPSKGFGLLPPIVTPPGLLRRLLTGTDNALPPLQETLLRAFDLAASTANLRELPRVAAIIEPDVSKIGVLNFKQIDAALEAGRMAARAALQAQPDLVR,"62,124",583,NTE family,lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],hydrolase activity [GO:0016787]; lysophospholipase activity [GO:0004622],cytosol [GO:0005829],,MTCY9C4.03c,1
P9WL93,Y2569_MYCTU,Rv2569c,Rv2569c MTCY227.32,GO:0005886,IPR013589; IPR002931; ,,,,Uncharacterized protein Rv2569c,plasma membrane [GO:0005886],9634230; 21969609,,,MSADSSLSLPLSGTHRYRVTHRTEYRYSDVVTSSYGRGFLTPRNSLRQRCVAHRLTIDPAPADRSTSRDGYGNISSYFHVTEPHRTLTITSDSIVDVSPPPPGLYTSGPALQPWEAARPAGLPGSLATEFTLDLNPPEITDAVREYAAPSFLPKRPLVEVLRDLASRIYTDFTYRSGSTTISTGVNEVLLAREGVCQDFARLAIACLRANGLAACYVSGYLATDPPPGKDRMIGIDATHAWASVWTPQQPGRFEWLGLDPTNDQLVDQRYIVVGRGRDYADVPPLRGIIYTNSENSVIDVSVDVVPFEGDALHA,"34,397",314,,,,plasma membrane [GO:0005886],,MTCY227.32,1
P9WL63,Y2629_MYCTU,Rv2629,Rv2629,GO:0001666; GO:0005618; GO:0005829; GO:0005886,IPR029064; ,,,,Uncharacterized protein Rv2629,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; response to hypoxia [GO:0001666],9634230; 17970586; 11416222; 12953092; 15528667; 18400743; 18550732; 21969609,,,MRSERLRWLVAAEGPFASVYFDDSHDTLDAVERREATWRDVRKHLESRDAKQELIDSLEEAVRDSRPAVGQRGRALIATGEQVLVNEHLIGPPPATVIRLSDYPYVVPLIDLEMRRPTYVFAAVDHTGADVKLYQGATISSTKIDGVGYPVHKPVTAGWNGYGDFQHTTEEAIRMNCRAVADHLTRLVDAADPEVVFVSGEVRSRTDLLSTLPQRVAVRVSQLHAGPRKSALDEEEIWDLTSAEFTRRRYAEITNVAQQFEAEIGRGSGLAAQGLAEVCAALRDGDVDTLIVGELGEATVVTGKARTTVARDADMLSELGEPVDRVARADEALPFAAIAVGAALVRDDNRIAPLDGVGALLRYAATNRLGSHRS,"40,840",374,,response to hypoxia [GO:0001666],,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WL57,Y2635_MYCTU,Rv2635,Rv2635 MTCY441.05,,,,,,Uncharacterized protein Rv2635,,9634230,,,MVAADHRALGSNKSYPASQTAEAIWPPARTLRYDRQSPWLATGFDRRMSQTVTGVGVQNCAVSKRRCSAVDHSSRTPYRR,"8,937",80,,,,,,MTCY441.05,1
P9WPC7,Y2667_MYCTU,Rv2667,Rv2667 MTCY441.36,GO:0005829; GO:0019538,IPR004176; IPR036628; ,,,,Uncharacterized protein Rv2667,cytosol [GO:0005829]; protein metabolic process [GO:0019538],9634230,,,MPEPTPTAYPVRLDELINAIKRVHSDVLDQLSDAVLAAEHLGEIADHLIGHFVDQARRSGASWSDIGKSMGVTKQAAQKRFVPRAEATTLDSNQGFRRFTPRARNAVVAAQNAAHGAASSEITPDHLLLGVLTDPAALATALLQQQEIDIATLRTAVTLPPAVTEPPQPIPFSGPARKVLELTFREALRLGHNYIGTEHLLLALLELEDGDGPLHRSGVDKSRAEADLITTLASLTGANAAGATDAGATDAG,"26,627",252,"ClpA/ClpB family, ClpC subfamily",protein metabolic process [GO:0019538],,cytosol [GO:0005829],,MTCY441.36,1
P9WQG5,Y2669_MYCTU,Rv2669,Rv2669 MTCY441.38,GO:0005737; GO:0008080; GO:1902882,IPR016181; IPR000182; ,,,DOMAIN 10 156 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,Uncharacterized N-acetyltransferase Rv2669 (EC 2.3.1.-),cytoplasm [GO:0005737]; N-acetyltransferase activity [GO:0008080]; regulation of response to oxidative stress [GO:1902882],9634230; 21969609,,,MTDADELAAVAARTFPLACPPAVAPEHIASFVDANLSSARFAEYLTDPRRAILTARHDGRIVGYAMLIRGDDRDVELSKLYLLPGYHGTGAAAALMHKVLATAADWGALRVWLGVNQKNQRAQRFYAKTGFKINGTRTFRLGAHHENDYVMVRELV,"17,195",156,Acetyltransferase family,regulation of response to oxidative stress [GO:1902882],N-acetyltransferase activity [GO:0008080],cytoplasm [GO:0005737],,MTCY441.38,1
P9WNH3,Y2715_MYCTU,Rv2715,Rv2715 MTCY05A6.36,GO:0005886; GO:0016787,IPR029058; IPR000073; IPR000639; ,,,,Uncharacterized protein Rv2715,plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 19099550; 21969609,,,MTERKRNLRPVRDVAPPTLQFRTVHGYRRAFRIAGSGPAILLIHGIGDNSTTWNGVHAKLAQRFTVIAPDLLGHGQSDKPRADYSVAAYANGMRDLLSVLDIERVTIVGHSLGGGVAMQFAYQFPQLVDRLILVSAGGVTKDVNIVFRLASLPMGSEAMALLRLPLVLPAVQIAGRIVGKAIGTTSLGHDLPNVLRILDDLPEPTASAAFGRTLRAVVDWRGQMVTMLDRCYLTEAIPVQIIWGTKDVVLPVRHAHMAHAAMPGSQLEIFEGSGHFPFHDDPARFIDIVERFMDTTEPAEYDQAALRALLRRGGGEATVTGSADTRVAVLNAIGSNERSAT,"36,933",341,DmpD/TodF/XylF esterase family,,hydrolase activity [GO:0016787],plasma membrane [GO:0005886],,MTCY05A6.36,1
P9WL43,Y2716_MYCTU,Rv2716,Rv2716 MTCY05A6.37,GO:0003824; GO:0009058,IPR003719; ,,,,Uncharacterized protein Rv2716,catalytic activity [GO:0003824]; biosynthetic process [GO:0009058],9634230; 21969609,,,MAIEVSVLRVFTDSDGNFGNPLGVINASKVEHRDRQQLAAQSGYSETIFVDLPSPGSTTAHATIHTPRTEIPFAGHPTVGASWWLRERGTPINTLQVPAGIVQVSYHGDLTAISARSEWAPEFAIHDLDSLDALAAADPADFPDDIAHYLWTWTDRSAGSLRARMFAANLGVTEDEATGAAAIRITDYLSRDLTITQGKGSLIHTTWSPEGWVRVAGRVVSDGVAQLD,"24,574",228,,biosynthetic process [GO:0009058],catalytic activity [GO:0003824],,,MTCY05A6.37,1
P9WFG7,Y2717_MYCTU,Rv2717c,Rv2717c,,IPR012674; IPR014878; IPR022939; ,,,,UPF0678 fatty acid-binding protein-like protein Rv2717c,,9634230; 12368430; 21969609; ,X-ray crystallography (1),FUNCTION: May play a role in the intracellular transport of hydrophobic ligands. {ECO:0000305}.,MTRDLAPALQALSPLLGSWAGRGAGKYPTIRPFEYLEEVVFAHVGKPFLTYTQQTRAVADGKPLHSETGYLRVCRPGCVELVLAHPSGITEIEVGTYSVTGDVIELELSTRADGSIGLAPTAKEVTALDRSYRIDGDELSYSLQMRAVGQPLQDHLAAVLHRQR,"17,846",164,UPF0678 family,,,,,,1
P9WG93,Y2723_MYCTU,Rv2723,Rv2723 MTCY154.03,GO:0005886; GO:0016021,IPR005496; IPR022369; ,,,,Uncharacterized membrane protein Rv2723,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MGASGLVWTLTIVLIAGLMLVDYVLHVRKTHVPTLRQAVIQSATFVGIAILFGIAVVVFGGSELAVEYFACYLTDEALSVDNLFVFLVIISSFGVPRLAQQKVLLFGIAFALVTRTGFIFVGAALIENFNSAFYLFGLVLLVMAGNLARPTGLESRDAETLKRSVIIRLADRFLRTSQDYNGDRLFTVSNNKRMMTPLLLVMIAVGGTDILFAFDSIPALFGLTQNVYLVFAATAFSLLGLRQLYFLIDGLLDRLVYLSYGLAVILGFIGVKLMLEALHDNKIPFINGGKPVPTVEVSTTQSLTVIIIVLLITTAASFWSARGRAQNAMARARRYATAYLDLHYETESAERDKIFTALLAAERQINTLPTKYRMQPGQDDDLMTLLCRAHAARDAHM,"43,679",397,TerC family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY154.03,1
P9WP05,Y2417_MYCTU,Rv2417c,Rv2417c MTCY253.03,GO:0005886; GO:0008289,IPR003797; ,,,DOMAIN 3 274 DegV. {ECO:0000255|PROSITE-ProRule:PRU00815}.,DegV domain-containing protein Rv2417c,plasma membrane [GO:0005886]; lipid binding [GO:0008289],9634230; 21969609,,"FUNCTION: May bind long-chain fatty acids, such as palmitate, and may play a role in lipid transport or fatty acid metabolism. {ECO:0000250}.",MTVVVVTDTSCRLPADLREQWSIRQVPLHILLDGLDLRDGVDEIPDDIHKRHATTAGATPVELSAAYQRALADSGGDGVVAVHISSALSGTFRAAELTAAELGPAVRVIDSRSAAMGVGFAALAAGRAAAAGDELDTVARAAAAAVSRIHAFVAVARLDNLRRSGRISGAKAWLGTALALKPLLSVDDGKLVLVQRVRTVSNATAVMIDRVCQLVGDRPAALAVHHVADPAAANDVAAALAERLPACEPAMVTAMGPVLALHVGAGAVGVCVDVGASPPA,"28,488",280,,,lipid binding [GO:0008289],plasma membrane [GO:0005886],,MTCY253.03,1
P9WJX1,Y2456_MYCTU,Rv2456c,Rv2456c,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv2456c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 21969609,,,MSGTVVAVPPRVARALDLLNFSLADVRDGLGPYLSIYLLLIHDWDQASIGFVMAVGGIAAIVAQTPIGALVDRTTAKRALVVAGAVLVTAAAVAMPLFAGLYSISVLQAVTGIASSVFAPALAAITLGAVGPQFFARRIGRNEAFNHAGNASAAGATGALAYFFGPVVVFWVLAGMALISVLATLRIPPDAVDHDLARGMDHAPGEPHPQPSRFTVLAHNRELVIFGAAVVAFHFANAAMLPLVGELLALHNRDEGTALMSSCIVAAQVVMVPVAYVVGTRADAWGRKPIFLVGFAVLTARGFLYTLSDNSYWLVGVQLLDGIGAGIFGALFPLVVQDVTHGTGHFNISLGAVTTATGIGAALSNLVAGWIVVVAGYDAAFMSLGALAGAGFLLYLVAMPETVDSDVRVRSRPTLGGK,"43,133",418,Major facilitator superfamily,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WKB3,Y2484_MYCTU,Rv2484c,Rv2484c MTV008.40c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR023213; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv2484c (EC 2.3.1.20) (Putative triacylglycerol synthase Rv2484c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Upon expression in E.coli functions very weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity.",MAESGESPRLSDELGPVDYLMHRGEANPRTRSGIMALELLDGTPDWDRFRTRFENASRRVLRLRQKVVVPTLPTAAPRWVVDPDFNLDFHVRRVRVSGPATLREVLDLAEVILQSPLDISRPLWTATLVEGMADGRAAMLLHVSHAVTDGVGGVEMFAQIYDLERDPPPRSTPPQPIPEDLSPNDLMRRGINHLPIAVVGGVLDALSGAVSMAGRAVLEPVSTVSGILGYARSGIRVLNRAAEPSPLLRRRSLTTRTEAIDIRLADLHKAAKAGGGSINDAYLAGLCGALRRYHEALGVPISTLPMAVPVNLRAEGDAAGGNQFTGVNLAAPVGTIDPVARMKKIRAQMTQRRDEPAMNIIGSIAPVLSVLPTAVLEGITGSVIGSDVQASNVPVYPGDTYLAGAKILRQYGIGPLPGVAMMVVLISRGGWCTVTVRYDRASVRNDELFAQCLQAGFDEILALAGGPAPRVLPASFDTQGAGSVPRSVSGS,"52,309",491,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV008.40c,1
P9WJ49,VPB17_MYCTU,Rv2526,vapB17 Rv2526,,IPR019239; ,,vapB17,,Putative antitoxin VapB17,,9634230; 15718296; 21969609,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC17. {ECO:0000305|PubMed:15718296}.,MTVKRTTIELDEDLVRAAQAVTGETLRATVERALQQLVAAAAEQAAARRRRIVDHLAHAGTHVDADVLLSEQAWR,"8,242",75,,,,,,,1
P9WJ25,VPB38_MYCTU,Rv2493,vapB38 Rv2493,,,,vapB38,,Putative antitoxin VapB38,,9634230; 20011113; 21969609,,FUNCTION: Probable antitoxin component of a type II toxin-antitoxin (TA) system. Its putative cognate toxin is VapC38. {ECO:0000305|PubMed:20011113}.,MRTTLDLDDDVIAAARELASSQRRSLGSVISELARRGLMPGRVEADDGLPVIRVPAGTPPITPEMVRRALDED,"7,897",73,,,,,,,1
P9WFK7,EIS_MYCTU,Rv2416c,eis Rv2416c MTCY253.04,GO:0030649; GO:0034069; GO:0042802; GO:0043655; GO:0044119; GO:0044121; GO:0044161; GO:0046677; GO:0052035; GO:0052040; GO:0052164; GO:0052167; GO:0097691,IPR016181; IPR025559; IPR000182; IPR022902; IPR036527; ,Itself,eis,DOMAIN 3 154 N-acetyltransferase.,N-acetyltransferase Eis (EC 2.3.1.-) (Aminoglycoside N-acetyltransferase) (Enhanced intracellular survival protein) (Protein-lysine N-acetyltransferase),bacterial extracellular vesicle [GO:0097691]; extracellular space of host [GO:0043655]; host cell cytoplasmic vesicle [GO:0044161]; aminoglycoside N-acetyltransferase activity [GO:0034069]; identical protein binding [GO:0042802]; aminoglycoside antibiotic catabolic process [GO:0030649]; growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121]; modulation by symbiont of defense-related host reactive oxygen species production [GO:0052164]; modulation by symbiont of host innate immune response [GO:0052167]; modulation by symbiont of host programmed cell death [GO:0052040]; positive regulation by symbiont of host inflammatory response [GO:0052035]; response to antibiotic [GO:0046677],9634230; 10629183; 11401966; 17449476; 17259625; 19906990; 21187903; 21969609; 23233486; 21628583; 22547814; 24106131; 27010218,X-ray crystallography (11),"FUNCTION: Effector that is released into the host cell and affects host immune responses; it negatively modulates inflammation, macrophage autophagy, and cell death through redox-dependent signaling (PubMed:17259625, PubMed:21187903). Acts as an acetyltransferase. Acetylates 'Lys-55' of dual-specificity protein phosphatase 16 (DUSP16)/mitogen-activated protein kinase phosphatase-7 (MKP-7), a JNK-specific phosphatase; this leads to the inhibition of JNK-dependent autophagy, phagosome maturation, and ROS (reactive oxygen species) generation for enhanced intracellular survival of M.tuberculosis (PubMed:22547814). Inhibits Con A-mediated T-cell proliferation in vitro (PubMed:17449476). Treatment of T-cells with Eis inhibits ERK1/2, JAK pathway, and subsequent production of tumor necrosis factor-alpha (TNF-alpha) and interleukin-4 (IL-4); on the contrary, there is increased production of interferon-gamma (IFN-gamma) and interleukin-10 (IL-10), which indicates that immunity in response to Eis treatment is skewed away from a protective T(H)1 response and Eis disturbs the cross regulation of T-cells (PubMed:17449476). When expressed in M.smegmatis, enhances intracellular survival of the bacteria in host macrophages during infection (PubMed:10629183). {ECO:0000269|PubMed:10629183, ECO:0000269|PubMed:17259625, ECO:0000269|PubMed:17449476, ECO:0000269|PubMed:21187903, ECO:0000269|PubMed:22547814}.; FUNCTION: Can also acetylate multiple amine groups of many aminoglycoside (AG) antibiotics, leading to their inactivation, and thus contributes to drug resistance (PubMed:19906990, PubMed:21628583, PubMed:24106131). Is also able to acetylate and deactivate the cyclic peptide antibiotic capreomycin, but not the other anti-tuberculous drugs isoniazid and pyrazinamide (PubMed:23233486). Acetylates kanamycin (KAN) more efficiently than amikacin (AMK), even though Eis seems to bind AMK with higher affinity (PubMed:19906990). Does not acetylate and inactivate streptomycin, apramycin and spectinomycin (PubMed:19906990, PubMed:21628583). {ECO:0000269|PubMed:19906990, ECO:0000269|PubMed:21628583, ECO:0000269|PubMed:23233486, ECO:0000269|PubMed:24106131}.",MTVTLCSPTEDDWPGMFLLAAASFTDFIGPESATAWRTLVPTDGAVVVRDGAGPGSEVVGMALYMDLRLTVPGEVVLPTAGLSFVAVAPTHRRRGLLRAMCAELHRRIADSGYPVAALHASEGGIYGRFGYGPATTLHELTVDRRFARFHADAPGGGLGGSSVRLVRPTEHRGEFEAIYERWRQQVPGGLLRPQVLWDELLAECKAAPGGDRESFALLHPDGYALYRVDRTDLKLARVSELRAVTADAHCALWRALIGLDSMERISIITHPQDPLPHLLTDTRLARTTWRQDGLWLRIMNVPAALEARGYAHEVGEFSTVLEVSDGGRFALKIGDGRARCTPTDAAAEIEMDRDVLGSLYLGAHRASTLAAANRLRTKDSQLLRRLDAAFASDVPVQTAFEF,"43,804",402,Acetyltransferase Eis family,aminoglycoside antibiotic catabolic process [GO:0030649]; growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121]; modulation by symbiont of defense-related host reactive oxygen species production [GO:0052164]; modulation by symbiont of host innate immune response [GO:0052167]; modulation by symbiont of host programmed cell death [GO:0052040]; positive regulation by symbiont of host inflammatory response [GO:0052035]; response to antibiotic [GO:0046677],aminoglycoside N-acetyltransferase activity [GO:0034069]; identical protein binding [GO:0042802],bacterial extracellular vesicle [GO:0097691]; extracellular space of host [GO:0043655]; host cell cytoplasmic vesicle [GO:0044161],,MTCY253.04,2
P9WIB1,PHLC_MYCTU,Rv2349c,plcC Rv2349c MTCY98.18c,GO:0008152; GO:0009405; GO:0034480; GO:0052008,IPR017849; IPR007312; IPR006311; ,,plcC,,Phospholipase C 3 (EC 3.1.4.3),phosphatidylcholine phospholipase C activity [GO:0034480]; disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],9634230; 21969609,,,MVSQGAFAGMSRRAFLAKAAGAGAAAVLTDWAAPVIEKAYGAGPCSGHLTDIEHIVLCLQENRSFDHYFGTLSAVDGFDTPTPLFQQKGWNPETQALDPTGITLPYRINTTGGPNGVGECVNDPDHQWIAAHLSWNGGANDGWLPAQARTRSVANTPVVMGYYARPDIPIHYLLADTFTICDQYFSSLLGGTMPNRLYWISATVNPDGDQGGPQIVEPAIQPKLTFTWRIMPQNLSDAGISWKVYNSKLLGGLNDTSLSRNGYVGSFKQAADPRSDLARYGIAPAYPWDFIRDVINNTLPQVSWVVPLTVESEHPSFPVAVGAVTIVNLIRVLLRNPAVWEKTALIIAYDEHGGFFDHVTPLTAPEGTPGEWIPNSVDIDKVDGSGGIRGPIGLGFRVPCFVISPYSRGGLMVHDRFDHTSQLQLIGKRFGVPVPNLTPWRASVTGDMTSAFNFAAPPDPSPPNLDHPVRQLPKVAKCVPNVVLGFLNEGLPYRVPYPQTTPVQESGPARPIPSGIC,"55,896",517,Bacterial phospholipase C family,disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],phosphatidylcholine phospholipase C activity [GO:0034480],,,MTCY98.18c,1
P9WHZ7,PPE40_MYCTU,Rv2356c,PPE40 Rv2356c,,IPR002989; IPR000030; IPR038332; ,,PPE40,,Uncharacterized PPE family protein PPE40,,9634230; 21969609,,,MVNFSVLPPEINSGRMFFGAGSGPMLAAAAAWDGLAAELGLAAESFGLVTSGLAGGSGQAWQGAAAAAMVVAAAPYAGWLAAAAARAGGAAVQAKAVAGAFEAARAAMVDPVVVAANRSAFVQLVLSNVFGQNAPAIAAAEATYEQMWAADVAAMVGYHGGASAAAAALAPWQQAVPGLSGLLGGAANAPAAAAQGAAQGLAELTLNLGVGNIGSLNLGSGNIGGTNVGSGNVGGTNLGSGNYGSLNWGSGNTGTGNAGSGNTGDYNPGSGNFGSGNFGSGNIGSLNVGSGNFGTLNLANGNNGDVNFGGGNTGDFNFGGGNNGTLNFGFGNTGSGNFGFGNTGNNNIGIGLTGDGQIGIGGLNSGTGNIGFGNSGNNNIGFFNSGDGNIGFFNSGDGNTGFGNAGNINTGFWNAGNLNTGFGSAGNGNVGIFDGGNSNSGSFNVGFQNTGFGNSGAGNTGFFNAGDSNTGFANAGNVNTGFFNGGDINTGGFNGGNVNTGFGSALTQAGANSGFGNLGTGNSGWGNSDPSGTGNSGFFNTGNGNSGFSNAGPAMLPGFNSGFANIGSFNAGIANSGNNLAGISNSGDDSSGAVNSGSQNSGAFNAGVGLSGFFR,"58,390",615,Mycobacterial PPE family,,,,,,1
Q79FE1,PPE41_MYCTU,Rv2430c,PPE41 Rv2430c LH57_13290,GO:0005576; GO:0009405; GO:0009986,IPR000030; IPR038332; ,Q7D756; I6X486,PPE41,,PPE family protein PPE41,cell surface [GO:0009986]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 17076665; 18974870; 21969609; 22340629; 25379378; 26318856; 16690741; 25155747; 25275011,X-ray crystallography (4),"FUNCTION: The PE25/PPE41 dimer induces both a strong humoral and cellular immune response (PubMed:18974870). The dimer induces necrosis, but not apoptosis, in mouse macrophage cells (PubMed:25379378). It also induces activation and maturation of mouse dendritic cells and drives Th2-biased immune responses (PubMed:26318856). {ECO:0000269|PubMed:18974870, ECO:0000269|PubMed:25379378, ECO:0000269|PubMed:26318856}.",MHFEAYPPEVNSANIYAGPGPDSMLAAARAWRSLDVEMTAVQRSFNRTLLSLMDAWAGPVVMQLMEAAKPFVRWLTDLCVQLSEVERQIHEIVRAYEWAHHDMVPLAQIYNNRAERQILIDNNALGQFTAQIADLDQEYDDFWDEDGEVMRDYRLRVSDALSKLTPWKAPPPIAHSTVLVAPVSPSTASSRTDT,"21,943",194,Mycobacterial PPE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; extracellular region [GO:0005576],,LH57_13290,1
P9WMP1,PPOX_MYCTU,Rv2677c,hemY Rv2677c MTV010.01c,GO:0004729; GO:0005737; GO:0006782; GO:0016020,IPR002937; IPR036188; IPR004572; ,,hemY,,Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4),cytoplasm [GO:0005737]; membrane [GO:0016020]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; protoporphyrinogen IX biosynthetic process [GO:0006782],9634230; 12368430; 21969609,,FUNCTION: Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX. {ECO:0000250}.,MTPRSYCVVGGGISGLTSAYRLRQAVGDDATITLFEPADRLGGVLRTEHIGGQPMDLGAEAFVLRRPEMPALLAELGLSDRQLASTGARPLIYSQQRLHPLPPQTVVGIPSSAGSMAGLVDDATLARIDAEAARPFTWQVGSDPAVADLVADRFGDQVVARSVDPLLSGVYAGSAATIGLRAAAPSVAAALDRGATSVTDAVRQALPPGSGGPVFGALDGGYQVLLDGLVRRSRVHWVRARVVQLERGWVLRDETGGRWQADAVILAVPAPRLARLVDGIAPRTHAAARQIVSASSAVVALAVPGGTAFPHCSGVLVAGDESPHAKAITLSSRKWGQRGDVALLRLSFGRFGDEPALTASDDQLLAWAADDLVTVFGVAVDPVDVRVRRWIEAMPQYGPGHADVVAELRAGLPPTLAVAGSYLDGIGVPACVGAAGRAVTSVIEALDAQVAR,"46,846",452,Protoporphyrinogen oxidase family,protoporphyrinogen IX biosynthetic process [GO:0006782],oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729],cytoplasm [GO:0005737]; membrane [GO:0016020],,MTV010.01c,1
P9WHV1,PROA_MYCTU,Rv2427c,proA Rv2427c MTCY428.20,GO:0004350; GO:0005829; GO:0005886; GO:0050661; GO:0055129,IPR016161; IPR016163; IPR016162; IPR015590; IPR020593; IPR012134; IPR000965; ,,proA,,Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase) (GSA dehydrogenase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; NADP binding [GO:0050661]; L-proline biosynthetic process [GO:0055129],9634230; 21969609,,FUNCTION: Catalyzes the NADPH-dependent reduction of L-glutamate 5-phosphate into L-glutamate 5-semialdehyde and phosphate. The product spontaneously undergoes cyclization to form 1-pyrroline-5-carboxylate. {ECO:0000255|HAMAP-Rule:MF_00412}.,MTVPAPSQLDLRQEVHDAARRARVAARRLASLPTTVKDRALHAAADELLAHRDQILAANAEDLNAAREADTPAAMLDRLSLNPQRVDGIAAGLRQVAGLRDPVGEVLRGYTLPNGLQLRQQRVPLGVVGMIYEGRPNVTVDAFGLTLKSGNAALLRGSSSAAKSNEALVAVLRTALVGLELPADAVQLLSAADRATVTHLIQARGLVDVVIPRGGAGLIEAVVRDAQVPTIETGVGNCHVYVHQAADLDVAERILLNSKTRRPSVCNAAETLLVDAAIAETALPRLLAALQHAGVTVHLDPDEADLRREYLSLDIAVAVVDGVDAAIAHINEYGTGHTEAIVTTNLDAAQRFTEQIDAAAVMVNASTAFTDGEQFGFGAEIGISTQKLHARGPMGLPELTSTKWIAWGAGHTRPA,"43,745",415,Gamma-glutamyl phosphate reductase family,L-proline biosynthetic process [GO:0055129],glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; NADP binding [GO:0050661],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY428.20,1
P9WHU9,PROB_MYCTU,Rv2439c,proB Rv2439c MTCY428.07,GO:0003723; GO:0004349; GO:0005524; GO:0005829; GO:0006561; GO:0040007; GO:0055129,IPR036393; IPR001048; IPR001057; IPR011529; IPR005715; IPR019797; IPR002478; IPR015947; IPR036974; ,,proB,DOMAIN 280 358 PUA. {ECO:0000255|HAMAP-Rule:MF_00456}.,Glutamate 5-kinase (EC 2.7.2.11) (Gamma-glutamyl kinase) (GK),cytosol [GO:0005829]; ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; RNA binding [GO:0003723]; growth [GO:0040007]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the transfer of a phosphate group to glutamate to form L-glutamate 5-phosphate. {ECO:0000255|HAMAP-Rule:MF_00456}.,MRSPHRDAIRTARGLVVKVGTTALTTPSGMFDAGRLAGLAEAVERRMKAGSDVVIVSSGAIAAGIEPLGLSRRPKDLATKQAAASVGQVALVNSWSAAFARYGRTVGQVLLTAHDISMRVQHTNAQRTLDRLRALHAVAIVNENDTVATNEIRFGDNDRLSALVAHLVGADALVLLSDIDGLYDCDPRKTADATFIPEVSGPADLDGVVAGRSSHLGTGGMASKVAAALLAADAGVPVLLAPAADAATALADASVGTVFAARPARLSARRFWVRYAAEATGALTLDAGAVRAVVRQRRSLLAAGITAVSGRFCGGDVVELRAPDAAMVARGVVAYDASELATMVGRSTSELPGELRRPVVHADDLVAVSAKQAKQV,"38,788",376,Glutamate 5-kinase family,growth [GO:0040007]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; RNA binding [GO:0003723],cytosol [GO:0005829],,MTCY428.07,1
P9WHZ9,PPE38_MYCTU,Rv2352c,PPE38 Rv2352c,,IPR022171; IPR000030; IPR038332; ,,PPE38,,Uncharacterized PPE family protein PPE38,,9634230; 21969609,,,MILDFSWLPPEINSARIYAGAGSGPLFMAAAAWEGLAADLRASASSFDAVIAGLAAGPWSGPASVAMAGAAAPYVGWLSAAAGQAELSAGQATAAATAFEAALAATVHPAAVTANRVLLGALVATNILGQNTPAIAATEFDYVEMWAQDVGAMVGYHAGAAAVAETLTPFSVPPLDLAGLASQAGAQLTGMATSVSAALSPIAEGAVEGVPAVVAAAQSVAAGLPVDAALQVGQAAAYPASMLIGPMMQLAQMGTTANTAGLAGAEAAGLAAADVPTFAGDIASGTGLGGAGGLGAGMSAELGKARLVGAMSVPPTWEGSVPARMASSAMAGLGAMPAEVPAAGGPMGMMPMPMGMGGAGAGMPAGMMGRGGANPHVVQARPSVVPRVGIG,"37,355",391,Mycobacterial PPE family,,,,,,1
P9WIN1,PPGK_MYCTU,Rv2702,ppgK Rv2702 MTCY05A6.23,GO:0004340; GO:0005524; GO:0040007; GO:0047330,IPR000600; ,,ppgK,,Polyphosphate glucokinase (Poly(P) glucokinase) (EC 2.7.1.63) (ATP-dependent glucokinase) (EC 2.7.1.2) (Polyphosphate--glucose phosphotransferase),ATP binding [GO:0005524]; glucokinase activity [GO:0004340]; polyphosphate-glucose phosphotransferase activity [GO:0047330]; growth [GO:0040007],8617763; 9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the phosphorylation of glucose using polyphosphate or ATP as the phosphoryl donor (PubMed:8617763). Polyphosphate, rather than ATP, seems to be the major phosphate donor for the enzyme in M.tuberculosis (By similarity). {ECO:0000250|UniProtKB:A5U654, ECO:0000269|PubMed:8617763}.",MTSTGPETSETPGATTQRHGFGIDVGGSGIKGGIVDLDTGQLIGDRIKLLTPQPATPLAVAKTIAEVVNGFGWRGPLGVTYPGVVTHGVVRTAANVDKSWIGTNARDTIGAELGGQQVTILNDADAAGLAETRYGAGKNNPGLVVLLTFGTGIGSAVIHNGTLIPNTEFGHLEVGGKEAEERAASSVKEKNDWTYPKWAKQVIRVLIAIENAIWPDLFIAGGGISRKADKWVPLLENRTPVVPAALQNTAGIVGAAMASVADTTH,"27,429",265,ROK (NagC/XylR) family,growth [GO:0040007],ATP binding [GO:0005524]; glucokinase activity [GO:0004340]; polyphosphate-glucose phosphotransferase activity [GO:0047330],,,MTCY05A6.23,1
P9WI61,PLSB_MYCTU,Rv2482c,plsB plsB2 Rv2482c MTV008.38c,GO:0004366; GO:0005886; GO:0016024; GO:0102420,IPR022284; IPR028354; IPR002123; ,,plsB,,Glycerol-3-phosphate acyltransferase (GPAT) (EC 2.3.1.15),plasma membrane [GO:0005886]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; CDP-diacylglycerol biosynthetic process [GO:0016024],9634230; 19099550; 21969609,,,MTKPAADASAVLTAEDTLVLASTATPVEMELIMGWLGQQRARHPDSKFDILKLPPRNAPPAALTALVEQLEPGFASSPQSGEDRSIVPVRVIWLPPADRSRAGKVAALLPGRDPYHPSQRQQRRILRTDPRRARVVAGESAKVSELRQQWRDTTVAEHKRDFAQFVSRRALLALARAEYRILGPQYKSPRLVKPEMLASARFRAGLDRIPGATVEDAGKMLDELSTGWSQVSVDLVSVLGRLASRGFDPEFDYDEYQVAAMRAALEAHPAVLLFSHRSYIDGVVVPVAMQDNRLPPVHMFGGINLSFGLMGPLMRRSGMIFIRRNIGNDPLYKYVLKEYVGYVVEKRFNLSWSIEGTRSRTGKMLPPKLGLMSYVADAYLDGRSDDILLQGVSICFDQLHEITEYAAYARGAEKTPEGLRWLYNFIKAQGERNFGKIYVRFPEAVSMRQYLGAPHGELTQDPAAKRLALQKMSFEVAWRILQATPVTATGLVSALLLTTRGTALTLDQLHHTLQDSLDYLERKQSPVSTSALRLRSREGVRAAADALSNGHPVTRVDSGREPVWYIAPDDEHAAAFYRNSVIHAFLETSIVELALAHAKHAEGDRVAAFWAQAMRLRDLLKFDFYFADSTAFRANIAQEMAWHQDWEDHLGVGGNEIDAMLYAKRPLMSDAMLRVFFEAYEIVADVLRDAPPDIGPEELTELALGLGRQFVAQGRVRSSEPVSTLLFATARQVAVDQELIAPAADLAERRVAFRRELRNILRDFDYVEQIARNQFVACEFKARQGRDRI,"88,315",789,GPAT/DAPAT family,CDP-diacylglycerol biosynthetic process [GO:0016024],glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420],plasma membrane [GO:0005886],plsB2,MTV008.38c,1
P9WHW1,PPIB_MYCTU,Rv2582,ppiB ppi Rv2582 MTCY227.19c,GO:0003755; GO:0005886; GO:0005887; GO:0040007,IPR029000; IPR024936; IPR002130; ,,ppiB,DOMAIN 139 307 PPIase cyclophilin-type. {ECO:0000255|PROSITE-ProRule:PRU00156}.,Probable peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (Rotamase B),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides (By similarity). {ECO:0000250}.,MGHLTPVAAPRLACAFVPTNAQRRATAKRKLERQLERRAKQAKRRRILTIVGGSLAAVAVIVAVVVTVVVNKDDHQSTTSATPTDSASTSPPQAATAPPLPPFKPSANLGANCQYPPSPDKAVKPVKLPRTGKVPTDPAQVSVSMVTNQGNIGLMLANNESPCTVNSFVSLAQQGFFKGTTCHRLTTSPMLAVLQCGDPKGDGTGGPGYQFANEYPTDQYSANDPKLNEPVIYPRGTLAMANAGPNTNSSQFFMVYRDSKLPPQYTVFGTIQADGLTTLDKIAKAGVAGGGEDGKPATEVTITSVLLD,"32,371",308,Cyclophilin-type PPIase family,growth [GO:0040007],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],ppi,MTCY227.19c,1
P9WHZ5,PPE42_MYCTU,Rv2608,PPE42 Rv2608,GO:0052556,IPR029058; IPR013228; IPR000030; IPR038332; ,,PPE42,,Uncharacterized PPE family protein PPE42,positive regulation by symbiont of host immune response [GO:0052556],9634230; 15346333; 21969609,,FUNCTION: Elicits a high humoral and a low T-cell response. Could be involved in directing the host toward development of a more humoral type of immune response. {ECO:0000269|PubMed:15346333}.,MNFAVLPPEVNSARIFAGAGLGPMLAAASAWDGLAEELHAAAGSFASVTTGLAGDAWHGPASLAMTRAASPYVGWLNTAAGQAAQAAGQARLAASAFEATLAATVSPAMVAANRTRLASLVAANLLGQNAPAIAAAEAEYEQIWAQDVAAMFGYHSAASAVATQLAPIQEGLQQQLQNVLAQLASGNLGSGNVGVGNIGNDNIGNANIGFGNRGDANIGIGNIGDRNLGIGNTGNWNIGIGITGNGQIGFGKPANPDVLVVGNGGPGVTALVMGGTDSLLPLPNIPLLEYAARFITPVHPGYTATFLETPSQFFPFTGLNSLTYDVSVAQGVTNLHTAIMAQLAAGNEVVVFGTSQSATIATFEMRYLQSLPAHLRPGLDELSFTLTGNPNRPDGGILTRFGFSIPQLGFTLSGATPADAYPTVDYAFQYDGVNDFPKYPLNVFATANAIAGILFLHSGLIALPPDLASGVVQPVSSPDVLTTYILLPSQDLPLLVPLRAIPLLGNPLADLIQPDLRVLVELGYDRTAHQDVPSPFGLFPDVDWAEVAADLQQGAVQGVNDALSGLGLPPPWQPALPRLF,"59,675",580,Mycobacterial PPE family,positive regulation by symbiont of host immune response [GO:0052556],,,,,1
P9WPG7,PISA_MYCTU,Rv2612c,pgsA1 Rv2612c,GO:0003881; GO:0003882; GO:0005618; GO:0005737; GO:0005886; GO:0008654; GO:0016021; GO:0040007; GO:0046474; GO:0046488,IPR000462; ,,pgsA1,,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882]; glycerophospholipid biosynthetic process [GO:0046474]; growth [GO:0040007]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],9634230; 12368430; 10889206; 21969609,,,MSKLPFLSRAAFARITTPIARGLLRVGLTPDVVTILGTTASVAGALTLFPMGKLFAGACVVWFFVLFDMLDGAMARERGGGTRFGAVLDATCDRISDGAVFCGLLWWIAFHMRDRPLVIATLICLVTSQVISYIKARAEASGLRGDGGFIERPERLIIVLTGAGVSDFPFVPWPPALSVGMWLLAVASVITCVQRLHTVWTSPGAIDRMAIPGKGDR,"23,252",217,CDP-alcohol phosphatidyltransferase class-I family,glycerophospholipid biosynthetic process [GO:0046474]; growth [GO:0040007]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity [GO:0003881]; CDP-diacylglycerol-serine O-phosphatidyltransferase activity [GO:0003882],cell wall [GO:0005618]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJJ5,NADD_MYCTU,Rv2421c,nadD Rv2421c MTCY428.26,GO:0000309; GO:0004515; GO:0005524; GO:0034628; GO:0040007,IPR004821; IPR005248; IPR014729; ,,nadD,,Probable nicotinate-nucleotide adenylyltransferase (EC 2.7.7.18) (Deamido-NAD(+) diphosphorylase) (Deamido-NAD(+) pyrophosphorylase) (Nicotinate mononucleotide adenylyltransferase) (NaMN adenylyltransferase),ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; 'de novo' NAD biosynthetic process from aspartate [GO:0034628]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (5),FUNCTION: Catalyzes the reversible adenylation of nicotinate mononucleotide (NaMN) to nicotinic acid adenine dinucleotide (NaAD). {ECO:0000250}.,MGGTFDPIHYGHLVAASEVADLFDLDEVVFVPSGQPWQKGRQVSAAEHRYLMTVIATASNPRFSVSRVDIDRGGPTYTKDTLADLHALHPDSELYFTTGADALASIMSWQGWEELFELARFVGVSRPGYELRNEHITSLLGQLAKDALTLVEIPALAISSTDCRQRAEQSRPLWYLMPDGVVQYVSKCRLYCGACDAGARSTTSLAAGNGL,"23,053",211,NadD family,'de novo' NAD biosynthetic process from aspartate [GO:0034628]; growth [GO:0040007],ATP binding [GO:0005524]; nicotinamide-nucleotide adenylyltransferase activity [GO:0000309]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515],,,MTCY428.26,1
P9WIN7,MTB12_MYCTU,Rv2376c,mtb12 cfp2 Rv2376c MTCY27.04,GO:0005576; GO:0005618,IPR020235; ,,mtb12,,Low molecular weight antigen MTB12 (CFP-2) (Low molecular weight protein antigen 2),cell wall [GO:0005618]; extracellular region [GO:0005576],9712769; 9634230; 10812229; 21969609,,FUNCTION: May play a role in the development of protective immune responses.,MKMVKSIAAGLTAAAAIGAAAAGVTSIMAGGPVVYQMQPVVFGAPLPLDPASAPDVPTAAQLTSLLNSLADPNVSFANKGSLVEGGIGGTEARIADHKLKKAAEHGDLPLSFSVTNIQPAAAGSATADVSVSGPKLSSPVTQNVTFVNQGGWMLSRASAMELLQAAGN,"16,635",168,MTB12 family,,,cell wall [GO:0005618]; extracellular region [GO:0005576],cfp2,MTCY27.04,1
P9WJQ9,MOBA_MYCTU,Rv2453c,mobA Rv2453c MTV008.09c,GO:0005525; GO:0005737; GO:0005886; GO:0006777; GO:0046872; GO:0061603,IPR025877; IPR013482; IPR029044; ,,mobA,,Probable molybdenum cofactor guanylyltransferase (MoCo guanylyltransferase) (EC 2.7.7.77) (GTP:molybdopterin guanylyltransferase) (Mo-MPT guanylyltransferase) (Molybdopterin guanylyltransferase) (Molybdopterin-guanine dinucleotide synthase) (MGD synthase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; molybdenum cofactor guanylyltransferase activity [GO:0061603]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],9634230; 21969609,,FUNCTION: Transfers a GMP moiety from GTP to Mo-molybdopterin (Mo-MPT) cofactor (Moco or molybdenum cofactor) to form Mo-molybdopterin guanine dinucleotide (Mo-MGD) cofactor. {ECO:0000255|HAMAP-Rule:MF_00316}.,MAELAPDTVPLAGVVLAGGESRRMGRDKATLPLPGGTTTLVEHMVGILGQRCAPVFVMAAPGQPLPTLPVPVLRDELPGLGPLPATGRGLRAAAEAGVRLAFVCAVDMPYLTVELIEDLARRAVQTDAEVVLPWDGRNHYLAAVYRTDLADRVDTLVGAGERKMSALVDASDALRIVMADSRPLTNVNSAAGLHAPMQPGR,"21,084",201,MobA family,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],GTP binding [GO:0005525]; metal ion binding [GO:0046872]; molybdenum cofactor guanylyltransferase activity [GO:0061603],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV008.09c,1
P9WK97,LEPA_MYCTU,Rv2404c,lepA Rv2404c MTCY253.16,GO:0003924; GO:0005525; GO:0005618; GO:0005829; GO:0005886; GO:0006412,IPR006297; IPR035647; IPR000640; IPR031157; IPR038363; IPR013842; IPR035654; IPR027417; IPR005225; IPR000795; IPR009000; ,,lepA,DOMAIN 50 231 tr-type G.,Elongation factor 4 (EF-4) (EC 3.6.5.n1) (Ribosomal back-translocase LepA),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation [GO:0006412],9634230; 22578863; 21969609,,"FUNCTION: Required for accurate and efficient protein synthesis under certain stress conditions. May act as a fidelity factor of the translation reaction, by catalyzing a one-codon backward translocation of tRNAs on improperly translocated ribosomes. Back-translocation proceeds from a post-translocation (POST) complex to a pre-translocation (PRE) complex, thus giving elongation factor G a second chance to translocate the tRNAs correctly. Binds to ribosomes in a GTP-dependent manner. {ECO:0000255|HAMAP-Rule:MF_00071, ECO:0000269|PubMed:22578863}.",MRTPCSQHRRDRPSAIGSQLPDADTLDTRQPPLQEIPISSFADKTFTAPAQIRNFCIIAHIDHGKSTLADRMLQLTGVVDERSMRAQYLDRMDIERERGITIKAQNVRLPWRVDKTDYVLHLIDTPGHVDFTYEVSRALEACEGAVLLVDAAQGIEAQTLANLYLALDRDLHIIPVLNKIDLPAADPDRYAAEMAHIIGCEPAEVLRVSGKTGEGVSDLLDEVVRQVPPPQGDAEAPTRAMIFDSVYDIYRGVVTYVRVVDGKISPRERIMMMSTGATHELLEVGIVSPEPKPCEGLGVGEVGYLITGVKDVRQSKVGDTVTSLSRARGAAAEALTGYREPKPMVYSGLYPVDGSDYPNLRDALDKLQLNDAALTYEPETSVALGFGFRCGFLGLLHMEITRERLEREFGLDLISTSPNVVYRVHKDDGTEIRVTNPSDWPEGKIRTVYEPVVKTTIIAPSEFIGTIMELCQSRRGELGGMDYLSPERVELRYTMPLGEIIFDFFDALKSRTRGYASLDYEEAGEQEAALVKVDILLQGEAVDAFSAIVHKDTAYAYGNKMTTKLKELIPRQQFEVPVQAAIGSKIIARENIRAIRKDVLSKCYGGDITRKRKLLEKQKEGKKRMKTIGRVEVPQEAFVAALSTDAAGDKGKK,"72,396",653,"TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, LepA subfamily",translation [GO:0006412],GTPase activity [GO:0003924]; GTP binding [GO:0005525],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY253.16,1
P9WMT1,OBG_MYCTU,Rv2440c,obg Rv2440c,GO:0000287; GO:0003924; GO:0005525; GO:0005840; GO:0005886; GO:0040007; GO:0046777,IPR031167; IPR014100; IPR015349; IPR036346; IPR006074; IPR006169; IPR036726; IPR006073; IPR027417; ,,obg,DOMAIN 160 340 OBG-type G. {ECO:0000255|HAMAP-Rule:MF_01454}.,GTPase Obg (EC 3.6.5.-) (GTP-binding protein Obg),plasma membrane [GO:0005886]; ribosome [GO:0005840]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; growth [GO:0040007]; protein autophosphorylation [GO:0046777],9634230; 22578863; 21352546; 21969609,,"FUNCTION: An essential GTPase which binds GTP, GDP and possibly (p)ppGpp with moderate affinity, with high nucleotide exchange rates and a fairly low GTP hydrolysis rate. Plays a role in control of the cell cycle, stress response, ribosome biogenesis and in those bacteria that undergo differentiation, in morphogenesis control (By similarity). GTPase activity is not inhibited by ATP or GDP. Overexpression decreases cell growth starting in late log phase and continuing into stationary phase (PubMed:21352546). {ECO:0000255|HAMAP-Rule:MF_01454, ECO:0000269|PubMed:21352546}.",MPRFVDRVVIHTRAGSGGNGCASVHREKFKPLGGPDGGNGGRGGSIVFVVDPQVHTLLDFHFRPHLTAASGKHGMGNNRDGAAGADLEVKVPEGTVVLDENGRLLADLVGAGTRFEAAAGGRGGLGNAALASRVRKAPGFALLGEKGQSRDLTLELKTVADVGLVGFPSAGKSSLVSAISAAKPKIADYPFTTLVPNLGVVSAGEHAFTVADVPGLIPGASRGRGLGLDFLRHIERCAVLVHVVDCATAEPGRDPISDIDALETELACYTPTLQGDAALGDLAARPRAVVLNKIDVPEARELAEFVRDDIAQRGWPVFCVSTATRENLQPLIFGLSQMISDYNAARPVAVPRRPVIRPIPVDDSGFTVEPDGHGGFVVSGARPERWIDQTNFDNDEAVGYLADRLARLGVEEELLRLGARSGCAVTIGEMTFDWEPQTPAGEPVAMSGRGTDPRLDSNKRVGAAERKAARSRRREHGDG,"50,461",479,"TRAFAC class OBG-HflX-like GTPase superfamily, OBG GTPase family",growth [GO:0040007]; protein autophosphorylation [GO:0046777],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287],plasma membrane [GO:0005886]; ribosome [GO:0005840],,,1
P9WIU1,ORN_MYCTU,Rv2511,orn Rv2511 MTCY07A7.17,GO:0000175; GO:0003676; GO:0005737; GO:0040007; GO:0090305,IPR013520; IPR022894; IPR012337; IPR036397; ,,orn,DOMAIN 5 170 Exonuclease. {ECO:0000255|HAMAP-Rule:MF_00045}.,Oligoribonuclease (EC 3.1.-.-),cytoplasm [GO:0005737]; 3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676]; growth [GO:0040007]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],9634230; 21969609,,FUNCTION: 3'-to-5' exoribonuclease specific for small oligoribonucleotides. {ECO:0000255|HAMAP-Rule:MF_00045}.,MQDELVWIDCEMTGLDLGSDKLIEIAALVTDADLNILGDGVDVVMHADDAALSGMIDVVAEMHSRSGLIDEVKASTVDLATAEAMVLDYINEHVKQPKTAPLAGNSIATDRAFIARDMPTLDSFLHYRMIDVSSIKELCRRWYPRIYFGQPPKGLTHRALADIHESIRELRFYRRTAFVPQPGPSTSEIAAVVAELSDGAGAQEETDSAEAPQSG,"23,442",215,Oligoribonuclease family,growth [GO:0040007]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],3'-5'-exoribonuclease activity [GO:0000175]; nucleic acid binding [GO:0003676],cytoplasm [GO:0005737],,MTCY07A7.17,1
P71725,OCTT_MYCTU,Rv2418c,octT Rv2418c LH57_13210,GO:0005886; GO:0016414; GO:0040007; GO:0051262,IPR013830; ,,octT,,Diglucosylglycerate octanoyltransferase (DGG octanoyltransferase) (EC 2.3.1.-),plasma membrane [GO:0005886]; O-octanoyltransferase activity [GO:0016414]; growth [GO:0040007]; protein tetramerization [GO:0051262],9634230; 21969609; 26324178,,"FUNCTION: Sugar octanoyltransferase likely involved in the biosynthesis of mycobacterial methylglucose lipopolysaccharide (MGLP). Catalyzes the transfer of an octanoyl group from octanoyl-CoA to the C6 OH of the second glucose in diglucosylglycerate (DGG). DGG is the preferred acceptor, but to a lesser extent, GG (glucosylglycerate) can also be used as substrate. DGG and GG are the two earliest intermediates in MGLP biosynthesis. {ECO:0000250|UniProtKB:K5BJH8, ECO:0000305|PubMed:26324178}.",MSSRRGRRPALLVFADSLAYYGPTGGLPADDPRIWPNIVASQLDWDLELIGRIGWTCRDVWWAATQDPRAWAALPRAGAVIFATGGMDSLPSVLPTALRELIRYVRPSWLRRWVRDGYAWVQPRLSPVARAALPPHLTAEYLEKTRGAIDFNRPGIPIIASLPSVHIAETYGKAHHGRAGTVAAITEWAQHHDIPLVDLKAAVAEQILSGYGNRDGIHWNFEAHQAVAELMLKALAEAGVPNEKSRG,"27,225",247,OctT acyltransferase family,growth [GO:0040007]; protein tetramerization [GO:0051262],O-octanoyltransferase activity [GO:0016414],plasma membrane [GO:0005886],,LH57_13210,1
P9WIV1,NUSB_MYCTU,Rv2533c,nusB Rv2533c MTCY159.23,GO:0003723; GO:0006353; GO:0031564; GO:0040007,IPR035926; IPR011605; IPR006027; ,,nusB,,Transcription antitermination protein NusB (Antitermination factor NusB),"RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; growth [GO:0040007]; transcription antitermination [GO:0031564]",9634230; 19099550; 21969609; 10881194,X-ray crystallography (1),FUNCTION: Involved in transcription antitermination. Required for transcription of ribosomal RNA (rRNA) genes. Binds specifically to the boxA antiterminator sequence of the ribosomal RNA (rrn) operons. {ECO:0000255|HAMAP-Rule:MF_00073}.,MSDRKPVRGRHQARKRAVALLFEAEVRGISAAEVVDTRAALAEAKPDIARLHPYTAAVARGVSEHAAHIDDLITAHLRGWTLDRLPAVDRAILRVSVWELLHAADVPEPVVVDEAVQLAKELSTDDSPGFVNGVLGQVMLVTPQLRAAAQAVRGGA,"16,740",156,NusB family,"DNA-templated transcription, termination [GO:0006353]; growth [GO:0040007]; transcription antitermination [GO:0031564]",RNA binding [GO:0003723],,,MTCY159.23,1
P9WHR7,LEXA_MYCTU,Rv2720,lexA Rv2720 MTCY05A6.41,GO:0003677; GO:0004252; GO:0005618; GO:0006260; GO:0006281; GO:0006351; GO:0006974; GO:0009432; GO:0045892; GO:0046677,IPR006200; IPR036286; IPR006199; IPR006197; IPR015927; IPR036388; IPR036390; ,,lexA,,LexA repressor (EC 3.4.21.88),"cell wall [GO:0005618]; DNA binding [GO:0003677]; serine-type endopeptidase activity [GO:0004252]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription, DNA-templated [GO:0045892]; response to antibiotic [GO:0046677]; SOS response [GO:0009432]; transcription, DNA-templated [GO:0006351]",9084177; 9634230; 19118359; 21969609,,"FUNCTION: Represses a number of genes involved in the response to DNA damage (SOS response), including recA and lexA. Has been shown to bind to the 14 bp palindromic sequence 5'-CGAACNNNNGTTCG-3'. In the presence of single-stranded DNA, RecA interacts with LexA causing an autocatalytic cleavage which disrupts the DNA-binding part of LexA, leading to derepression of the SOS regulon and eventually DNA repair.",MNDSNDTSVAGGAAGADSRVLSADSALTERQRTILDVIRASVTSRGYPPSIREIGDAVGLTSTSSVAHQLRTLERKGYLRRDPNRPRAVNVRGADDAALPPVTEVAGSDALPEPTFVPVLGRIAAGGPILAEEAVEDVFPLPRELVGEGTLFLLKVIGDSMVEAAICDGDWVVVRQQNVADNGDIVAAMIDGEATVKTFKRAGGQVWLMPHNPAFDPIPGNDATVLGKVVTVIRKV,"24,841",236,Peptidase S24 family,"cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; negative regulation of transcription, DNA-templated [GO:0045892]; response to antibiotic [GO:0046677]; SOS response [GO:0009432]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618],,MTCY05A6.41,1
O53181,KORB_MYCTU,Rv2454c,korB Rv2454c,GO:0000287; GO:0005618; GO:0005829; GO:0006099; GO:0030976; GO:0047553,IPR029061; IPR011766; ,,korB,,2-oxoglutarate oxidoreductase subunit KorB (EC 1.2.7.3) (Alpha-ketoglutarate oxidoreductase subunit beta) (KG oxidoreductase subunit beta) (KGO subunit beta) (KOR subunit beta),cell wall [GO:0005618]; cytosol [GO:0005829]; 2-oxoglutarate synthase activity [GO:0047553]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; tricarboxylic acid cycle [GO:0006099],9634230; 19936047; 21969609,,"FUNCTION: Component of KG oxidoreductase (KOR) that catalyzes the CoA-dependent oxidative decarboxylation of 2-oxoglutarate (alpha-ketoglutarate, KG) to succinyl-CoA. Methyl viologen can act as electron acceptor in vitro; the physiologic electron acceptor is unknown. Is involved in the alternative TCA pathway that functions concurrently with fatty acid beta-oxidation. Since a growing body of evidence indicates that lipids (for example cholesterol and fatty acids) are a predominant growth substrate for M.tuberculosis during infection, flux through KOR likely represents an important step in intermediary metabolism in vivo. KOR-dependent decarboxylation of KG also appears to be an important source of CO(2) in M.tuberculosis metabolism. {ECO:0000269|PubMed:19936047}.",MTRSGDEAQLMTGVTGDLAGTELGLTPSLTKNAGVPTTDQPQKGKDFTSDQEVRWCPGCGDYVILNTIRNFLPELGLRRENIVFISGIGCSSRFPYYLETYGFHSIHGRAPAIATGLALAREDLSVWVVTGDGDALSIGGNHLIHALRRNINVTILLFNNRIYGLTKGQYSPTSEVGKVTKSTPMGSLDHPFNPVSLALGAEATFVGRALDSDRNGLTEVLRAAAQHRGAALVEILQDCPIFNDGSFDALRKEGAEERVIKVRHGEPIVFGANGEYCVVKSGFGLEVAKTADVAIDEIIVHDAQVDDPAYAFALSRLSDQNLDHTVLGIFRHISRPTYDDAARSQVVAARNAAPSGTAALQSLLHGRDTWTVD,"40,143",373,,tricarboxylic acid cycle [GO:0006099],2-oxoglutarate synthase activity [GO:0047553]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],cell wall [GO:0005618]; cytosol [GO:0005829],,,1
P9WMK3,HRCA_MYCTU,Rv2374c,hrcA Rv2374c MTCY27.06,GO:0003677; GO:0005886; GO:0006351; GO:0045892,IPR029016; IPR002571; IPR021153; IPR036388; IPR036390; IPR023120; ,,hrcA,,Heat-inducible transcription repressor HrcA,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609,,FUNCTION: Negative regulator of class I heat shock genes (grpE-dnaK-dnaJ and groELS operons). Prevents heat-shock induction of these operons. {ECO:0000255|HAMAP-Rule:MF_00081}.,MGSADERRFEVLRAIVADFVATQEPIGSKSLVERHNLGVSSATVRNDMAVLEAEGYITQPHTSSGRVPTEKGYREFVDRLEDVKPLSSAERRAIQSFLESGVDLDDVLRRAVRLLAQLTRQVAVVQYPTLSTSTVRHLEVIALTPARLLMVVITDSGRVDQRIVELGDVIDDHQLAQLREILGQALEGKKLSAASVAVADLASQLGGAGGLGDAVGRAATVLLESLVEHTEERLLLGGTANLTRNAADFGGSLRSILEALEEQVVVLRLLAAQQEAGKVTVRIGHETASEQMVGTSMVSTAYGTAHTVYGGMGVVGPTRMDYPGTIASVAAVALYIGDVLGAR,"36,475",343,HrcA family,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],plasma membrane [GO:0005886],,MTCY27.06,1
P9WJA3,HRP1_MYCTU,Rv2626c,hrp1 Rv2626c,GO:0001666; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0046872; GO:0052553; GO:0052572,IPR000644; ,,hrp1,DOMAIN 8 65 CBS 1. {ECO:0000255|PROSITE-ProRule:PRU00703}.; DOMAIN 73 131 CBS 2. {ECO:0000255|PROSITE-ProRule:PRU00703}.,Hypoxic response protein 1 (HRP1),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; modulation by symbiont of host immune response [GO:0052553]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666],9634230; 11416222; 12057942; 12953092; 12506197; 15528667; 16511097; 17145953; 18474359; 18400743; 21969609; 18640126,X-ray crystallography (2),FUNCTION: Unlike some other CBS-domain containing proteins does not seem to bind AMP.,MTTARDIMNAGVTCVGEHETLTAAAQYMREHDIGALPICGDDDRLHGMLTDRDIVIKGLAAGLDPNTATAGELARDSIYYVDANASIQEMLNVMEEHQVRRVPVISEHRLVGIVTEADIARHLPEHAIVQFVKAICSPMALAS,"15,518",143,,modulation by symbiont of host immune response [GO:0052553]; response to host immune response [GO:0052572]; response to hypoxia [GO:0001666],metal ion binding [GO:0046872],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
I6Y9J2,LDT2_MYCTU,Rv2518c RVBD_2518c,ldtB lppS Rv2518c RVBD_2518c P425_02624,GO:0005886; GO:0008360; GO:0009252; GO:0016746; GO:0046872; GO:0071555,IPR005490; IPR038063; ,,ldtB,DOMAIN 259 377 YkuD.,"L,D-transpeptidase 2 (LDT 2) (EC 2.3.2.-) (Ldt(Mt2))","plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; transferase activity, transferring acyl groups [GO:0016746]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]",9634230; 21969609; 24041897; 23519417; 23519418; 23588382,X-ray crystallography (25),"FUNCTION: Generates 3->3 cross-links in peptidoglycan, catalyzing the cleavage of the mDap(3)-D-Ala(4) bond of a tetrapeptide donor stem and the formation of a bond between the carbonyl of mDap(3) of the donor stem and the side chain of mDap(3) of the acceptor stem. Is specific for donor substrates containing a stem tetrapeptide since it cannot use pentapeptide stems. {ECO:0000269|PubMed:24041897}.",MPKVGIAAQAGRTRVRRAWLTALMMTAVMIGAVACGSGRGPAPIKVIADKGTPFADLLVPKLTASVTDGAVGVTVDAPVSVTAADGVLAAVTMVNDNGRPVAGRLSPDGLRWSTTEQLGYNRRYTLNATALGLGGAATRQLTFQTSSPAHLTMPYVMPGDGEVVGVGEPVAIRFDENIADRGAAEKAIKITTNPPVEGAFYWLNNREVRWRPEHFWKPGTAVDVAVNTYGVDLGEGMFGEDNVQTHFTIGDEVIATADDNTKILTVRVNGEVVKSMPTSMGKDSTPTANGIYIVGSRYKHIIMDSSTYGVPVNSPNGYRTDVDWATQISYSGVFVHSAPWSVGAQGHTNTSHGCLNVSPSNAQWFYDHVKRGDIVEVVNTVGGTLPGIDGLGDWNIPWDQWRAGNAKA,"43,366",408,,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],"metal ion binding [GO:0046872]; transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886],lppS,P425_02624,1
P9WK81,LPPA_MYCTU,Rv2543,lppA Rv2543,GO:0005886,IPR032018; ,,lppA,,Putative lipoprotein LppA,plasma membrane [GO:0005886],9634230; 21969609; ,X-ray crystallography (1),,MIAPQPISRTLPRWQRIVALTMIGISTALIGGCTMDHNPDTSRRLTGEQKIQLIDSMRNKGSYEAARERLTATARIIADRVSAAIPGQTWKFDDDPNIQQSDRNGALCDKLTADIARRPIANSVMFGATFSAEDFKIAANIVREEAAKYGATTESSLFNESAKRDYDVQGNGYEFRLLQIKFATLNITGDCFLLQKVLDLPAGQLPPEPPIWPTTSTPH,"24,180",219,Mycobacteriales LppA/LppB family,,,plasma membrane [GO:0005886],,,1
P9WIB5,PHLA_MYCTU,Rv2351c,plcA mpcA mtp40 Rv2351c MTCY98.20c,GO:0004629; GO:0005886; GO:0008152; GO:0009405; GO:0034480; GO:0052008,IPR017849; IPR007312; IPR006311; ,,plcA,,Phospholipase C 1 (EC 3.1.4.3) (MTP40 antigen),plasma membrane [GO:0005886]; phosphatidylcholine phospholipase C activity [GO:0034480]; phospholipase C activity [GO:0004629]; disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],7591062; 8757862; 9634230; 1909999; 8298518; 9114405; 21969609,,"FUNCTION: Hydrolyzes sphingomyelin in addition to phosphatidylcholine. Probable virulence factor implicated in the pathogenesis of M.tuberculosis at the level of intracellular survival, by the alteration of cell signaling events or by direct cytotoxicity.",MSASPLLGMSRREFLTKLTGAGAAAFLMDWAAPVIEKAYGAGPCPGHLTDIEHIVLLMQENRSFDHYFGTLSSTNGFNAASPAFQQMGWNPMTQALDPAGVTIPFRLDTTRGPFLDGECVNDPEHQWVGMHLAWNGGANDNWLPAQATTRAGPYVPLTMGYYTRQDIPIHYLLADTFTICDGYHCSLLTGTLPNRLYWLSANIDPAGTDGGPQLVEPGFLPLQQFSWRIMPENLEDAGVSWKVYQNKGLGRFINTPISNNGLVQAFRQAADPRSNLARYGIAPTYPGDFAADVRANRLPKVSWLVPNILQSEHPALPVALGAVSMVTALRILLSNPAVWEKTALIVSYDENGGFFDHVTPPTAPPGTPGEFVTVPNIDAVPGSGGIRGPLGLGFRVPCIVISPYSRGPLMVSDTFDHTSQLKLIRARFGVPVPNMTAWRDGVVGDMTSAFNFATPPNSTRPNLSHPLLGALPKLPQCIPNVVLGTTDGALPSIPYRVPYPQVMPTQETTPVRGTPSGLCS,"56,138",520,Bacterial phospholipase C family,disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],phosphatidylcholine phospholipase C activity [GO:0034480]; phospholipase C activity [GO:0004629],plasma membrane [GO:0005886],mpcA mtp40,MTCY98.20c,1
P9WMZ5,PIMA_MYCTU,Rv2610c,pimA Rv2610c MTCY01A10.23,GO:0000030; GO:0000287; GO:0004377; GO:0005886; GO:0008654; GO:0009247; GO:0009405; GO:0043750; GO:0046488,IPR028098; ,,pimA,,Phosphatidyl-myo-inositol mannosyltransferase (EC 2.4.1.345) (Alpha-mannosyltransferase) (GDP-mannose-dependent alpha-(1-2)-phosphatidylinositol mannosyltransferase) (Guanosine diphosphomannose-phosphatidyl-inositol alpha-mannosyltransferase) (Phosphatidylinositol alpha-mannosyltransferase) (PI alpha-mannosyltransferase),"plasma membrane [GO:0005886]; GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; magnesium ion binding [GO:0000287]; mannosyltransferase activity [GO:0000030]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654]",9634230; 15939292; 19099550; 21969609; 25049093,,"FUNCTION: Involved in the biosynthesis of phosphatidyl-myo-inositol mannosides (PIM) which are early precursors in the biosynthesis of lipomannans (LM) and lipoarabinomannans (LAM). Catalyzes the addition of a mannosyl residue from GDP-D-mannose (GDP-Man) to the position 2 of the carrier lipid phosphatidyl-myo-inositol (PI) to generate a phosphatidyl-myo-inositol bearing an alpha-1,2-linked mannose residue (PIM1) (PubMed:15939292). PimA plays an essential role for growth in macrophages and during both the acute and chronic phases of infection (PubMed:25049093). {ECO:0000269|PubMed:15939292, ECO:0000269|PubMed:25049093}.",MRIGMICPYSFDVPGGVQSHVLQLAEVMRTRGHLVSVLAPASPHAALPDYFVSGGRAVPIPYNGSVARLRFGPATHRKVKKWLAHGDFDVLHLHEPNAPSLSMLALNIAEGPIVATFHTSTTKSLTLTVFQGILRPMHEKIVGRIAVSDLARRWQMEALGSDAVEIPNGVDVDSFASAARLDGYPRQGKTVLFLGRYDEPRKGMAVLLDALPKVVQRFPDVQLLIVGHGDADQLRGQAGRLAAHLRFLGQVDDAGKASAMRSADVYCAPNTGGESFGIVLVEAMAAGTAVVASDLDAFRRVLRDGEVGHLVPVDPPDLQAAALADGLIAVLENDVLRERYVAAGNAAVRRYDWSVVASQIMRVYETVAGSGAKVQVAS,"40,445",378,"Glycosyltransferase group 1 family, Glycosyltransferase 4 subfamily",glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; phosphatidylinositol metabolic process [GO:0046488]; phospholipid biosynthetic process [GO:0008654],"GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO:0004377]; magnesium ion binding [GO:0000287]; mannosyltransferase activity [GO:0000030]; phosphatidylinositol alpha-mannosyltransferase activity [GO:0043750]",plasma membrane [GO:0005886],,MTCY01A10.23,1
P9WIL1,PANE_MYCTU,Rv2573,Rv2573 MTCY227.28c,GO:0005829; GO:0008677; GO:0033317,IPR008927; IPR013328; IPR003710; IPR013752; IPR013332; IPR036291; ,,,,Putative 2-dehydropantoate 2-reductase (EC 1.1.1.169) (Ketopantoate reductase) (KPA reductase) (KPR),cytosol [GO:0005829]; 2-dehydropantoate 2-reductase activity [GO:0008677]; pantothenate biosynthetic process from valine [GO:0033317],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the NADPH-dependent reduction of ketopantoate into pantoic acid. {ECO:0000250}.,MATGIALVGPGAVGTTVAALLHKAGYSPLLCGHTPRAGIELRRDGADPIVVPGPVHTSPREVAGPVDVLILAVKATQNDAARPWLTRLCDERTVVAVLQNGVEQVEQVQPHCPSSAVVPAIVWCSAETQPQGWVRLRGEAALVVPTGPAAEQFAGLLRGAGATVDCDPDFTTAAWRKLLVNALAGFMVLSGRRSAMFRRDDVAALSRRYVAECLAVARAEGARLDDDVVDEVVRLVRSAPQDMGTSMLADRAAHRPLEWDLRNGVIVRKARAHGLATPISDVLVPLLAAASDGPG,"31,033",295,Ketopantoate reductase family,pantothenate biosynthetic process from valine [GO:0033317],2-dehydropantoate 2-reductase activity [GO:0008677],cytosol [GO:0005829],,MTCY227.28c,1
I6X486,PE25_MYCTU,Rv2431c,PE25 Rv2431c LH57_13295,GO:0005576; GO:0009405,IPR000084; ,Q79FE1,PE25,DOMAIN 1 92 PE. {ECO:0000255}.,PE-PGRS family protein PE25,extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 18974870; 21969609; 25379378; 26318856; 16690741; 25155747; 25275011,X-ray crystallography (4),"FUNCTION: The PE25/PPE41 dimer induces both a strong humoral and cellular immune response. PE25 protein alone induces low response (PubMed:18974870). The dimer induces necrosis, but not apoptosis, in mouse macrophage cells (PubMed:25379378). It also induces activation and maturation of mouse dendritic cells and drives Th2-biased immune responses (PubMed:26318856). {ECO:0000269|PubMed:18974870, ECO:0000269|PubMed:25379378, ECO:0000269|PubMed:26318856}.",MSFVITNPEALTVAATEVRRIRDRAIQSDAQVAPMTTAVRPPAADLVSEKAATFLVEYARKYRQTIAAAAVVLEEFAHALTTGADKYATAEADNIKTFS,"10,687",99,Mycobacterial PE family,pathogenesis [GO:0009405],,extracellular region [GO:0005576],,LH57_13295,1
P9WIB3,PHLB_MYCTU,Rv2350c,plcB mpcB Rv2350c MTCY98.19c,GO:0004629; GO:0005576; GO:0005886; GO:0008152; GO:0009405; GO:0034480; GO:0052008,IPR017849; IPR007312; IPR006311; ,,plcB,,Phospholipase C 2 (EC 3.1.4.3),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; phosphatidylcholine phospholipase C activity [GO:0034480]; phospholipase C activity [GO:0004629]; disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],8757862; 9634230; 21969609,,"FUNCTION: Hydrolyzes sphingomyelin in addition to phosphatidylcholine. Probable virulence factor implicated in the pathogenesis of M.tuberculosis at the level of intracellular survival, by the alteration of cell signaling events or by direct cytotoxicity.",MGSEHPVDGMTRRQFFAKAAAATTAGAFMSLAGPIIEKAYGAGPCPGHLTDIEHIVLLMQENRSFDHYFGTLSDTRGFDDTTPPVVFAQSGWNPMTQAVDPAGVTLPYRFDTTRGPLVAGECVNDPDHSWIGMHNSWNGGANDNWLPAQVPFSPLQGNVPVTMGFYTRRDLPIHYLLADTFTVCDGYFCSLLGGTTPNRLYWMSAWIDPDGTDGGPVLIEPNIQPLQHYSWRIMPENLEDAGVSWKVYQNKLLGALNNTVVGYNGLVNDFKQAADPRSNLARFGISPTYPLDFAADVRNNRLPKVSWVLPGFLLSEHPAFPVNVGAVAIVDALRILLSNPAVWEKTALIVNYDENGGFFDHVVPPTPPPGTPGEFVTVPDIDSVPGSGGIRGPIGLGFRVPCLVISPYSRGPLMVHDTFDHTSTLKLIRARFGVPVPNLTAWRDATVGDMTSTFNFAAPPNPSKPNLDHPRLNALPKLPQCVPNAVLGTVTKTAIPYRVPFPQSMPTQETAPTRGIPSGLC,"56,533",521,Bacterial phospholipase C family,disruption by symbiont of host cellular component [GO:0052008]; metabolic process [GO:0008152]; pathogenesis [GO:0009405],phosphatidylcholine phospholipase C activity [GO:0034480]; phospholipase C activity [GO:0004629],extracellular region [GO:0005576]; plasma membrane [GO:0005886],mpcB,MTCY98.19c,1
P9WIJ1,PDXH_MYCTU,Rv2607,pdxH Rv2607 MTCY1A10.26c,GO:0008615; GO:0010181; GO:0016638; GO:0016899; GO:0042803; GO:0042823,IPR000659; IPR019740; IPR011576; IPR019576; IPR012349; ,,pdxH,,Pyridoxine 5'-phosphate oxidase (PNP oxidase) (PNPOx) (EC 1.4.3.5) (Pyridoxal 5'-phosphate synthase),"FMN binding [GO:0010181]; oxidoreductase activity, acting on the CH-NH2 group of donors [GO:0016638]; oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor [GO:0016899]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615]",9634230; 21969609; 22110704; 16374842,X-ray crystallography (1),"FUNCTION: Catalyzes the oxidation of pyridoxine 5'-phosphate (PNP) into pyridoxal 5'-phosphate (PLP). Unlike many PNPOx enzymes, Rv2607 does not recognize pyridoxamine 5'-phosphate (PMP) as a substrate. {ECO:0000269|PubMed:22110704}.",MDDDAQMVAIDKDQLARMRGEYGPEKDGCGDLDFDWLDDGWLTLLRRWLNDAQRAGVSEPNAMVLATVADGKPVTRSVLCKILDESGVAFFTSYTSAKGEQLAVTPYASATFPWYQLGRQAHVQGPVSKVSTEEIFTYWSMRPRGAQLGAWASQQSRPVGSRAQLDNQLAEVTRRFADQDQIPVPPGWGGYRIAPEIVEFWQGRENRMHNRIRVANGRLERLQP,"25,186",224,Pyridoxamine 5'-phosphate oxidase family,pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],"FMN binding [GO:0010181]; oxidoreductase activity, acting on the CH-NH2 group of donors [GO:0016638]; oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor [GO:0016899]; protein homodimerization activity [GO:0042803]",,,MTCY1A10.26c,1
P9WII9,PDXS_MYCTU,Rv2606c,pdxS Rv2606c MTCY1A10.27,GO:0005886; GO:0016843; GO:0036381; GO:0040007; GO:0042823,IPR013785; IPR001852; IPR033755; IPR011060; ,,pdxS,,Pyridoxal 5'-phosphate synthase subunit PdxS (PLP synthase subunit PdxS) (EC 4.3.3.6) (Pdx1),plasma membrane [GO:0005886]; amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; growth [GO:0040007]; pyridoxal phosphate biosynthetic process [GO:0042823],9634230; 20066036; 21969609,X-ray crystallography (1),"FUNCTION: Catalyzes the formation of pyridoxal 5'-phosphate from ribose 5-phosphate (RBP), glyceraldehyde 3-phosphate (G3P) and ammonia. The ammonia is provided by the PdxT subunit. Can also use ribulose 5-phosphate and dihydroxyacetone phosphate as substrates, resulting from enzyme-catalyzed isomerization of RBP and G3P, respectively. {ECO:0000255|HAMAP-Rule:MF_01824}.",MDPAGNPATGTARVKRGMAEMLKGGVIMDVVTPEQARIAEGAGAVAVMALERVPADIRAQGGVSRMSDPDMIEGIIAAVTIPVMAKVRIGHFVEAQILQTLGVDYIDESEVLTPADYAHHIDKWNFTVPFVCGATNLGEALRRISEGAAMIRSKGEAGTGDVSNATTHMRAIGGEIRRLTSMSEDELFVAAKELQAPYELVAEVARAGKLPVTLFTAGGIATPADAAMMMQLGAEGVFVGSGIFKSGAPEHRAAAIVKATTFFDDPDVLAKVSRGLGEAMVGINVDEIAVGHRLAQRGW,"31,365",299,PdxS/SNZ family,growth [GO:0040007]; pyridoxal phosphate biosynthetic process [GO:0042823],amine-lyase activity [GO:0016843]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381],plasma membrane [GO:0005886],,MTCY1A10.27,1
P9WII7,PDXT_MYCTU,Rv2604c,pdxT Rv2604c,GO:0004359; GO:0005829; GO:0006541; GO:0008614; GO:0016843; GO:0036381; GO:0040007; GO:0042823; GO:1903600,IPR029062; IPR002161; IPR021196; ,,pdxT,,Pyridoxal 5'-phosphate synthase subunit PdxT (EC 4.3.3.6) (Pdx2) (Pyridoxal 5'-phosphate synthase glutaminase subunit) (EC 3.5.1.2),cytosol [GO:0005829]; glutaminase complex [GO:1903600]; amine-lyase activity [GO:0016843]; glutaminase activity [GO:0004359]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine metabolic process [GO:0008614],9634230; 21969609,,FUNCTION: Catalyzes the hydrolysis of glutamine to glutamate and ammonia as part of the biosynthesis of pyridoxal 5'-phosphate. The resulting ammonia molecule is channeled to the active site of PdxS. {ECO:0000255|HAMAP-Rule:MF_01615}.,MSVPRVGVLALQGDTREHLAALRECGAEPMTVRRRDELDAVDALVIPGGESTTMSHLLLDLDLLGPLRARLADGLPAYGSCAGMILLASEILDAGAAGRQALPLRAMNMTVRRNAFGSQVDSFEGDIEFAGLDDPVRAVFIRAPWVERVGDGVQVLARAAGHIVAVRQGAVLATAFHPEMTGDRRIHQLFVDIVTSAA,"21,072",198,Glutaminase PdxT/SNO family,glutamine metabolic process [GO:0006541]; growth [GO:0040007]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine metabolic process [GO:0008614],amine-lyase activity [GO:0016843]; glutaminase activity [GO:0004359]; pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381],cytosol [GO:0005829]; glutaminase complex [GO:1903600],,,1
P9WIE9,PG44_MYCTU,Rv2591,PE_PGRS44 Rv2591 MTCY227.10c,,IPR000084; ,,PE_PGRS44,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS44,,9634230,,,MSFVTAAPEMLATAAQNVANIGTSLSAANATAAASTTSVLAAGADEVSQAIARLFSDYATHYQSLNAQAAAFHHSFVQTLNAAGGAYSSAEAANASAQALEQNLLAVINAPAQALFGRPLIGNGANGTAASPNGGDGGILYGNGGNGFSQTTAGVAGGAGGSAGLIGNGGNGGAGGAGAAGGAGGAGGWLLGNGGAGGPGGPTDVPAGTGGAGGAGGDAPLIGWGGNGGPGGFAAFGNGGAGGNGGASGSLFGVGGAGGVGGSSEDVGGTGGAGGAGRGLFLGLGGDGGAGGTSNNNGGDGGAGGTAGGRLFSLGGDGGNGGAGTAIGSNAGDGGAGGDSSALIGYAQGGSGGLGGFGESTGGDGGLGGAGAVLIGTGVGGFGGLGGGSNGTGGAGGAGGTGATLIGLGAGGGGGIGGFAVNVGNGVGGLGGQGGQGAALIGLGAGGAGGAGGATVVGLGGNGGDGGDGGGLFSIGVGGDGGNAGNGAMPANGGNGGNAGVIANGSFAPSFVGFGGNGGNGVNGGTGGSGGILFGANGANGPS,"46,287",543,"Mycobacterial PE family, PGRS subfamily",,,,,MTCY227.10c,1
P9WIE7,PG46_MYCTU,Rv2634c,PE_PGRS46 Rv2634c MTCY441.04c,,IPR000084; ,,PE_PGRS46,DOMAIN 1 92 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS46,,9634230,,,MSFVIAVPEALTMAASDLANIGSTINAANAAAALPTTGVVAAAADEVSAAVAALFGSYAQSYQAFGAQLSAFHAQFVQSLTNGARSYVVAEATSAAPLQDLLGVVNAPAQALLGRPLIGNGANGADGTGAPGGPGGLLLGNGGNGGSGAPGQPGGAGGDAGLIGNGGTGGKGGDGLVGSGAAGGVGGRGGWLLGNGGTGGAGGAAGATLVGGTGGVGGATGLIGSGGFGGAGGAAAGVGTTGGVGGSGGVGGVFGNGGFGGAGGLGAAGGVGGAASYFGTGGGGGVGGDGAPGGDGGAGPLLIGNGGVGGLGGAGAAGGNGGAGGMLLGDGGAGGQGGPAVAGVLGGMPGAGGNGGNANWFGSGGAGGQGGTGLAGTNGVNPGSIANPNTGANGTDNSGNGNQTGGNGGPGPAGGVGEAGGVGGQGGLGESLDGNDGTGGKGGAGGTAGTDGGAGGAGGAGGIGETDGSAGGVATGGEGGDGATGGVDGGVGGAGGKGGQGHNTGVGDAFGGDGGIGGDGNGALGAAGGNGGTGGAGGNGGRGGMLIGNGGAGGAGGTGGTGGGGAAGFAGGVGGAGGEGLTDGAGTAEGGTGGLGGLGGVGGTGGMGGSGGVGGNGGAAGSLIGLGGGGGAGGVGGTGGIGGIGGAGGNGGAGGAGTTTGGGATIGGGGGTGGVGGAGGTGGTGGAGGTTGGSGGAGGLIGWAGAAGGTGAGGTGGQGGLGGQGGNGGNGGTGATGGQGGDFALGGNGGAGGAGGSPGGSSGIQGNMGPPGTQGADG,"63,131",778,"Mycobacterial PE family, PGRS subfamily",,,,,MTCY441.04c,1
P9WIA3,PHOL_MYCTU,Rv2368c,Rv2368c MTCY27.12,GO:0003723; GO:0005524; GO:0005737; GO:0005886,IPR004087; IPR036612; IPR027417; IPR003714; ,,,,PhoH-like protein,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; RNA binding [GO:0003723],9634230; 21969609,,,MTSRETRAADAAGARQADAQVRSSIDVPPDLVVGLLGSADENLRALERTLSADLHVRGNAVTLCGEPADVALAERVISELIAIVASGQSLTPEVVRHSVAMLVGTGNESPAEVLTLDILSRRGKTIRPKTLNQKRYVDAIDANTIVFGIGPAGTGKTYLAMAKAVHALQTKQVTRIILTRPAVEAGERLGFLPGTLSEKIDPYLRPLYDALYDMMDPELIPKLMSAGVIEVAPLAYMRGRTLNDAFIVLDEAQNTTAEQMKMFLTRLGFGSKVVVTGDVTQIDLPGGARSGLRAAVDILEDIDDIHIAELTSVDVVRHRLVSEIVDAYARYEEPGSGLNRAARRASGARGRR,"37,799",352,PhoH family,,ATP binding [GO:0005524]; RNA binding [GO:0003723],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY27.12,1
P9WJU3,MMPL9_MYCTU,Rv2339,mmpL9 Rv2339 MTCY98.08,GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0042783,IPR004869; IPR004707; ,,mmpL9,,Probable transport protein MmpL9,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MVPGEVHMSDTPSGPHPIIPRTIRLAAIPILLCWLGFTVFVSVAVPPLEAIGETRAVAVAPDDAQSMRAMRRAGKVFNEFDSNSIAMVVLESDQPLGEKAHRYYDHLVDTLVLDQSHIQHIQDFWRDPLTAAGAVSADGKAAYVQLYLAGNMGEALANESVEAVRKIVANSTPPEGIRTYVTGPAALFADQIAAGDRSMKLITGLTFAVITVLLLLVYRSIATTLLILPMVFIGLGATRGTIAFLGYHGMVGLSTFVVNILTALAIAAGTDYAIFLVGRYQEARHIGQNREASFYTMYRGTANVILGSGLTIAGATYCLSFARLTLFHTMGPPLAIGMLVSVAAALTLAPAIIAIAGRFGLLDPKRRLKTRGWRRVGTAVVRWPGPILATSVALALVGLLALPGYRPGYNDRYYLRAGTPVNRGYAAADRHFGPARMNPEMLLVESDQDMRNPAGMLVIDKIAKEVLHVSGVERVQAITRPQGVPLEHASIPFQISMMGATQTMSLPYMRERMADMLTMSDEMLVAINSMEQMLDLVQQLNDVTHEMAATTREIKATTSELRDHLADIDDFVRPLRSYFYWEHHCFDIPLCSATRSLFDTLDGVDTLTDQLRALTDDMNKMEALTPQFLALLPPMITTMKTMRTMMLTMRSTISGVQDQMADMQDHATAMGQAFDTAKSGDSFYLPPEAFDNAEFQQGMKLFLSPNGKAVRFVISHESDPASTEGIDRIEAIRAATKDAIKATPLQGAKIYIGGTAATYQDIRDGTKYDILIVGIAAVCLVFIVMLMITQSLIASLVIVGTVLLSLGTAFGLSVLIWQHFVGLQVHWTIVAMSVIVLLAVGSDYNLLLVSRFKEEVGAGLKTGIIRAMAGTGAVVTSAGLVFAFTMASMAVSELRVIGQVGTTIGLGLLFDTLVVRSFMTPSIAALLGRWFWWPNMIHSRPTVPEAHTRQGARRIQPHLHRG,"104,613",962,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",active evasion of host immune response [GO:0042783],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY98.08,1
I6XEI5,LYS25_MYCTU,Rv2525c LH57_13835,Rv2525c LH57_13835,GO:0003796; GO:0005576; GO:0016998; GO:0071555,IPR015020; IPR017853; IPR006311; IPR019546; ,,,,Putative peptidoglycan hydrolase Rv2525c (EC 3.2.1.17),extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555],9634230; 16952959; 21969609; 25869294; 25260828,X-ray crystallography (4),"FUNCTION: May function as a peptidoglycan hydrolase with glycosidase activity (PubMed:25260828). In vitro, displays esterase activity toward p-nitrophenyl esters of various acyl chain length (C4 to C16), with a preference for p-nitrophenyl butyrate (C4) (PubMed:25869294). {ECO:0000269|PubMed:25869294, ECO:0000305|PubMed:25260828}.",MSVSRRDVLKFAAATPGVLGLGVVASSLRAAPASAGSLGTLLDYAAGVIPASQIRAAGAVGAIRYVSDRRPGGAWMLGKPIQLSEARDLSGNGLKIVSCYQYGKGSTADWLGGASAGVQHARRGSELHAAAGGPTSAPIYASIDDNPSYEQYKNQIVPYLRSWESVIGHQRTGVYANSKTIDWAVNDGLGSYFWQHNWGSPKGYTHPAAHLHQVEIDKRKVGGVGVDVNQILKPQFGQWA,"25,370",240,,cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555],lysozyme activity [GO:0003796],extracellular region [GO:0005576],,,1
P9WJJ3,NADE_MYCTU,Rv2438c,nadE Rv2438c MTCY428.08,GO:0003952; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0008795; GO:0009435; GO:0040007; GO:0042802,IPR003010; IPR036526; IPR014445; IPR022310; IPR003694; IPR014729; ,Itself,nadE,DOMAIN 12 276 CN hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00054}.,Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; growth [GO:0040007]; NAD biosynthetic process [GO:0009435],9634230; 9620974; 15748981; 21969609; 19270703; 22280445,X-ray crystallography (6),"FUNCTION: Catalyzes the ATP-dependent amidation of deamido-NAD to form NAD. Uses L-glutamine as a nitrogen source. In vitro, can also use ammonia with comparable specific activity. {ECO:0000269|PubMed:15748981, ECO:0000269|PubMed:19270703, ECO:0000269|PubMed:9620974}.",MNFYSAYQHGFVRVAACTHHTTIGDPAANAASVLDMARACHDDGAALAVFPELTLSGYSIEDVLLQDSLLDAVEDALLDLVTESADLLPVLVVGAPLRHRHRIYNTAVVIHRGAVLGVVPKSYLPTYREFYERRQMAPGDGERGTIRIGGADVAFGTDLLFAASDLPGFVLHVEICEDMFVPMPPSAEAALAGATVLANLSGSPITIGRAEDRRLLARSASARCLAAYVYAAAGEGESTTDLAWDGQTMIWENGALLAESERFPKGVRRSVADVDTELLRSERLRMGTFDDNRRHHRELTESFRRIDFALDPPAGDIGLLREVERFPFVPADPQRLQQDCYEAYNIQVSGLEQRLRALDYPKVVIGVSGGLDSTHALIVATHAMDREGRPRSDILAFALPGFATGEHTKNNAIKLARALGVTFSEIDIGDTARLMLHTIGHPYSVGEKVYDVTFENVQAGLRTDYLFRIANQRGGIVLGTGDLSELALGWSTYGVGDQMSHYNVNAGVPKTLIQHLIRWVISAGEFGEKVGEVLQSVLDTEITPELIPTGEEELQSSEAKVGPFALQDFSLFQVLRYGFRPSKIAFLAWHAWNDAERGNWPPGFPKSERPSYSLAEIRHWLQIFVQRFYSFSQFKRSALPNGPKVSHGGALSPRGDWRAPSDMSARIWLDQIDREVPKG,"74,683",679,NAD synthetase family,growth [GO:0040007]; NAD biosynthetic process [GO:0009435],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY428.08,1
P9WJH7,NDK_MYCTU,Rv2445c,ndkA ndk Rv2445c MTCY428.01 MTV008.01c,GO:0004518; GO:0004550; GO:0005524; GO:0005576; GO:0005622; GO:0005737; GO:0005886; GO:0006163; GO:0006183; GO:0006220; GO:0006228; GO:0006241; GO:0042025; GO:0046777; GO:0046872; GO:0090305,IPR034907; IPR036850; IPR001564; ,,ndkA,,Nucleoside diphosphate kinase (NDK) (NDKA) (NDP kinase) (EC 2.7.4.6) (Nucleoside-2-P kinase),cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell nucleus [GO:0042025]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; protein autophosphorylation [GO:0046777]; purine nucleotide metabolic process [GO:0006163]; pyrimidine nucleotide metabolic process [GO:0006220]; UTP biosynthetic process [GO:0006228],9634230; 21969609; 12001234,X-ray crystallography (4),"FUNCTION: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. {ECO:0000255|HAMAP-Rule:MF_00451}.",MTERTLVLIKPDGIERQLIGEIISRIERKGLTIAALQLRTVSAELASQHYAEHEGKPFFGSLLEFITSGPVVAAIVEGTRAIAAVRQLAGGTDPVQAAAPGTIRGDFALETQFNLVHGSDSAESAQREIALWFPGA,"14,508",136,NDK family,CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; protein autophosphorylation [GO:0046777]; purine nucleotide metabolic process [GO:0006163]; pyrimidine nucleotide metabolic process [GO:0006220]; UTP biosynthetic process [GO:0006228],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nuclease activity [GO:0004518]; nucleoside diphosphate kinase activity [GO:0004550],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell nucleus [GO:0042025]; intracellular [GO:0005622]; plasma membrane [GO:0005886],ndk,MTCY428.01 MTV008.01c,1
P9WMB3,INT2_MYCTU,Rv2659c,Rv2659c,GO:0003677; GO:0006310; GO:0015074; GO:0044826; GO:0046718; GO:0075713,IPR011010; IPR013762; IPR002104; IPR010998; IPR004107; ,,,,Putative prophage phiRv2 integrase,DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826],9634230; 11416222; 21969609,,"FUNCTION: Integrase is necessary for integration of the phage into the host genome by site-specific recombination. In conjunction with excisionase, integrase is also necessary for excision of the prophage from the host genome (By similarity). {ECO:0000250}.",MTQTGKRQRRKFGRIRQFNSGRWQASYTGPDGRVYIAPKTFNAKIDAEAWLTDRRREIDRQLWSPASGQEDRPGAPFGEYAEGWLKQRGIKDRTRAHYRKLLDNHILATFADTDLRDITPAAVRRWYATTAVGTPTMRAHSYSLLRAIMQTALADDLIDSNPCRISGASTARRVHKIRPATLDELETITKAMPDPYQAFVLMAAWLAMRYGELTELRRKDIDLHGEVARVRRAVVRVGEGFKVTTPKSDAGVRDISIPPHLIPAIEDHLHKHVNPGRESLLFPSVNDPNRHLAPSALYRMFYKARKAAGRPDLRVHDLRHSGAVLAASTGATLAELMQRLGHSTAGAALRYQHAAKGRDREIAALLSKLAENQEM,"42,176",375,'phage' integrase family,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; establishment of integrated proviral latency [GO:0075713]; viral entry into host cell [GO:0046718]; viral genome integration into host DNA [GO:0044826],DNA binding [GO:0003677],,,,1
P9WK79,LPPB_MYCTU,Rv2544,lppB Rv2544,GO:0005576; GO:0005886,IPR032018; ,,lppB,,Putative lipoprotein LppB,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230,,,MIAPQPIPRTLPRWQRIVALTMIGISTALIGGCTMGQNPDKSPHLTGEQKIQLIDSMRHKGSYEAARERLTATAQIIADRVSAAIPGQTWKFNDDSYGQDFYRNGSLCKELSADIARRPMAKPVDFGSTFSAEDFKIAANIVREEAAKYGVTTESSLFNESAKRDYDVQGNGYEFNLGQIKFATLNITGDCFLLQKVLDLPAGQLPPEPPIWPTTSTPTP,"24,193",220,Mycobacteriales LppA/LppB family,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WMH1,IDER_MYCTU,Rv2711,ideR dtxR Rv2711 MTCY05A6.32,GO:0003677; GO:0003700; GO:0005506; GO:0005618; GO:0005737; GO:0005886; GO:0006351; GO:0006355; GO:0006979; GO:0008198; GO:0008270; GO:0016151; GO:0019540; GO:0030145; GO:0040007; GO:0045892; GO:0046870; GO:0046983; GO:0050897,IPR007167; IPR001367; IPR036421; IPR038157; IPR022687; IPR022689; IPR008988; IPR036388; IPR036390; ,,ideR,DOMAIN 4 65 HTH dtxR-type. {ECO:0000255|PROSITE-ProRule:PRU00296}.,Iron-dependent repressor IdeR,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cadmium ion binding [GO:0046870]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; nickel cation binding [GO:0016151]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270]; growth [GO:0040007]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; siderophore biosynthetic process from catechol [GO:0019540]; transcription, DNA-templated [GO:0006351]",7489918; 9634230; 11722747; 12065475; 21969609; 9887269,X-ray crystallography (6),"FUNCTION: Metal-dependent DNA-binding protein that controls transcription of many genes involved in iron metabolism. Acts as a repressor of siderophore biosynthesis and as a positive modulator of iron storage. Also regulates expression of transporters, proteins involved in siderophore synthesis, iron storage and transcriptional regulators. {ECO:0000269|PubMed:11722747, ECO:0000269|PubMed:12065475}.",MNELVDTTEMYLRTIYDLEEEGVTPLRARIAERLDQSGPTVSQTVSRMERDGLLRVAGDRHLELTEKGRALAIAVMRKHRLAERLLVDVIGLPWEEVHAEACRWEHVMSEDVERRLVKVLNNPTTSPFGNPIPGLVELGVGPEPGADDANLVRLTELPAGSPVAVVVRQLTEHVQGDIDLITRLKDAGVVPNARVTVETTPGGGVTIVIPGHENVTLPHEMAHAVKVEKV,"25,233",230,,"growth [GO:0040007]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transcription, DNA-templated [GO:0006355]; response to oxidative stress [GO:0006979]; siderophore biosynthetic process from catechol [GO:0019540]; transcription, DNA-templated [GO:0006351]",cadmium ion binding [GO:0046870]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; nickel cation binding [GO:0016151]; protein dimerization activity [GO:0046983]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],dtxR,MTCY05A6.32,1
P9WQ63,MBTB_MYCTU,Rv2383c,mbtB Rv2383c,GO:0000036; GO:0005618; GO:0005886; GO:0009405; GO:0010106; GO:0016788; GO:0016874; GO:0019540; GO:0031177; GO:0052572,IPR010071; IPR029058; IPR036736; IPR025110; IPR020845; IPR000873; IPR023213; IPR001242; IPR020806; IPR009081; IPR006162; IPR001031; ,,mbtB,DOMAIN 5 78 Carrier 1. {ECO:0000255|PROSITE-ProRule:PRU00258}.; DOMAIN 1057 1135 Carrier 2. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phenyloxazoline synthase MbtB (EC 6.3.2.-) (Mycobactin synthetase protein B),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; acyl carrier activity [GO:0000036]; hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; cellular response to iron ion starvation [GO:0010106]; pathogenesis [GO:0009405]; response to host immune response [GO:0052572]; siderophore biosynthetic process from catechol [GO:0019540]",9634230; 10655517; 11722747; 21969609,,FUNCTION: Involved in the initial steps of the mycobactin biosynthetic pathway. Putatively couples activated salicylic acid with serine or threonine and cyclizes this precursor to the hydroxyphenyloxazoline ring system present in this class of siderophores. Essential for growth in macrophages. {ECO:0000269|PubMed:10655517}.,MVHATACSEIIRAEVAELLGVRADALHPGANLVGQGLDSIRMMSLVGRWRRKGIAVDFATLAATPTIEAWSQLVSAGTGVAPTAVAAPGDAGLSQEGEPFPLAPMQHAMWVGRHDHQQLGGVAGHLYVEFDGARVDPDRLRAAATRLALRHPMLRVQFLPDGTQRIPPAAGSRDFPISVADLRHVAPDVVDQRLAGIRDAKSHQQLDGAVFELALTLLPGERTRLHVDLDMQAADAMSYRILLADLAALYDGREPPALGYTYREYRQAIEAEETLPQPVRDADRDWWAQRIPQLPDPPALPTRAGGERDRRRSTRRWHWLDPQTRDALFARARARGITPAMTLAAAFANVLARWSASSRFLLNLPLFSRQALHPDVDLLVGDFTSSLLLDVDLTGARTAAARAQAVQEALRSAAGHSAYPGLSVLRDLSRHRGTQVLAPVVFTSALGLGDLFCPDVTEQFGTPGWIISQGPQVLLDAQVTEFDGGVLVNWDVREGVFAPGVIDAMFTHQVDELLRLAAGDDAWDAPSPSALPAAQRAVRAALNGRTAAPSTEALHDGFFRQAQQQPDAPAVFASSGDLSYAQLRDQASAVAAALRAAGLRVGDTVAVLGPKTGEQVAAVLGILAAGGVYLPIGVDQPRDRAERILATGSVNLALVCGPPCQVRVPVPTLLLADVLAAAPAEFVPGPSDPTALAYVLFTSGSTGEPKGVEVAHDAAMNTVETFIRHFELGAADRWLALATLECDMSVLDIFAALRSGGAIVVVDEAQRRDPDAWARLIDTYEVTALNFMPGWLDMLLEVGGGRLSSLRAVAVGGDWVRPDLARRLQVQAPSARFAGLGGATETAVHATIFEVQDAANLPPDWASVPYGVPFPNNACRVVADSGDDCPDWVAGELWVSGRGIARGYRGRPELTAERFVEHDGRTWYRTGDLARYWHDGTLEFVGRADHRVKISGYRVELGEIEAALQRLPGVHAAAATVLPGGSDVLAAAVCVDDAGVTAESIRQQLADLVPAHMIPRHVTLLDRIPFTDSGKIDRAEVGALLAAEVERSGDRSAPYAAPRTVLQRALRRIVADILGRANDAVGVHDDFFALGGDSVLATQVVAGIRRWLDSPSLMVADMFAARTIAALAQLLTGREANADRLELVAEVYLEIANMTSADVMAALDPIEQPAQPAFKPWVKRFTGTDKPGAVLVFPHAGGAAAAYRWLAKSLVANDVDTFVVQYPQRADRRSHPAADSIEALALELFEAGDWHLTAPLTLFGHCMGAIVAFEFARLAERNGVPVRALWASSGQAPSTVAASGPLPTADRDVLADMVDLGGTDPVLLEDEEFVELLVPAVKADYRALSGYSCPPDVRIRANIHAVGGNRDHRISREMLTSWETHTSGRFTLSHFDGGHFYLNDHLDAVARMVSADVR,"151,634",1414,"ATP-dependent AMP-binding enzyme family, MbtB subfamily",cellular response to iron ion starvation [GO:0010106]; pathogenesis [GO:0009405]; response to host immune response [GO:0052572]; siderophore biosynthetic process from catechol [GO:0019540],"acyl carrier activity [GO:0000036]; hydrolase activity, acting on ester bonds [GO:0016788]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WKF7,MBTG_MYCTU,Rv2378c,mbtG Rv2378c,GO:0019540; GO:0040007; GO:0047091,IPR036188; IPR025700; ,,mbtG,,L-lysine N6-monooxygenase MbtG (EC 1.14.13.59) (Lysine 6-N-hydroxylase) (Lysine N6-hydroxylase) (Lysine-N-oxygenase) (Mycobactin synthase protein G),L-lysine 6-monooxygenase (NADPH) activity [GO:0047091]; growth [GO:0040007]; siderophore biosynthetic process from catechol [GO:0019540],9634230; 16461464; 21969609,,"FUNCTION: Flavoprotein monooxygenase required for N-hydroxylation of the two acylated lysine residues during mycobactin assembly, thus producing the hydroxamate groups necessary for iron sequestration. Is also able, but less efficiently, to hydroxylate L-lysine (non acylated) in vitro. {ECO:0000269|PubMed:16461464}.",MNPTLAVLGAGAKAVAVAAKASVLRDMGVDVPDVIAVERIGVGANWQASGGWTDGAHRLGTSPEKDVGFPYRSALVPRRNAELDERMTRYSWQSYLIATASFAEWIDRGRPAPTHRRWSQYLAWVADHIGLKVIHGEVERLAVTGDRWALCTHETTVQADALMITGPGQAEKSLLPGNPRVLSIAQFWDRAAGHDRINAERVAVIGGGETAASMLNELFRHRVSTITVISPQVTLFTRGEGFFENSLFSDPTDWAALTFDERRDALARTDRGVFSATVQEALLADDRIHHLRGRVAHAVGRQGQIRLTLSTNRGSENFETVHGFDLVIDGSGADPLWFTSLFSQHTLDLLELGLGGPLTADRLQEAIGYDLAVTDVTPKLFLPTLSGLTQGPGFPNLSCLGLLSDRVLGAGIFTPTKHNDTRRSGEHQSFR,"46,944",431,Lysine N(6)-hydroxylase/L-ornithine N(5)-oxygenase family,growth [GO:0040007]; siderophore biosynthetic process from catechol [GO:0019540],L-lysine 6-monooxygenase (NADPH) activity [GO:0047091],,,,1
P9WIP5,MBTH_MYCTU,Rv2377c,mbtH Rv2377c MTCY27.03,,IPR005153; IPR038020; IPR037407; ,,mbtH,,Protein MbtH,,9634230; 21969609,NMR spectroscopy (1),FUNCTION: Could be involved in mycobactin synthesis. {ECO:0000250}.,MSTNPFDDDNGAFFVLVNDEDQHSLWPVFADIPAGWRVVHGEASRAACLDYVEKNWTDLRPKSLRDAMVED,"8,082",71,,,,,,MTCY27.03,1
P9WFX1,MBTI_MYCTU,Rv2386c,mbtI trpE2 Rv2386c,GO:0000162; GO:0000287; GO:0004049; GO:0004106; GO:0005886; GO:0005950; GO:0008909; GO:0009697; GO:0010106; GO:0019540; GO:0040007; GO:0043904; GO:0052572,IPR005801; IPR019999; IPR015890; IPR019996; ,,mbtI,,Salicylate synthase (Chorismate mutase) (CM) (EC 5.4.99.5) (Isochorismate synthase/isochorismate lyase) (EC 4.2.99.21) (EC 5.4.4.2) (Mycobactin synthase protein),anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886]; anthranilate synthase activity [GO:0004049]; chorismate mutase activity [GO:0004106]; isochorismate pyruvate lyase activity [GO:0043904]; isochorismate synthase activity [GO:0008909]; magnesium ion binding [GO:0000287]; cellular response to iron ion starvation [GO:0010106]; growth [GO:0040007]; response to host immune response [GO:0052572]; salicylic acid biosynthetic process [GO:0009697]; siderophore biosynthetic process from catechol [GO:0019540]; tryptophan biosynthetic process [GO:0000162],9634230; 9831524; 11722747; 16508110; 20487026; 21969609; 16923875; 17240979; 20512795; 22607697,X-ray crystallography (9),"FUNCTION: Involved in the incorporation of salicylate into the virulence-conferring salicylate-based siderophore mycobactin. Catalyzes the initial conversion of chorismate to yield the intermediate isochorismate (isochorismate synthase activity), and the subsequent elimination of the enolpyruvyl side chain to give salicylate (isochorismate pyruvate-lyase activity). In the absence of magnesium, MbtI displays a chorismate mutase activity and converts chorismate to prephenate. {ECO:0000269|PubMed:16923875, ECO:0000269|PubMed:17240979, ECO:0000269|PubMed:20487026, ECO:0000269|PubMed:20512795, ECO:0000269|PubMed:9831524}.",MSELSVATGAVSTASSSIPMPAGVNPADLAAELAAVVTESVDEDYLLYECDGQWVLAAGVQAMVELDSDELRVIRDGVTRRQQWSGRPGAALGEAVDRLLLETDQAFGWVAFEFGVHRYGLQQRLAPHTPLARVFSPRTRIMVSEKEIRLFDAGIRHREAIDRLLATGVREVPQSRSVDVSDDPSGFRRRVAVAVDEIAAGRYHKVILSRCVEVPFAIDFPLTYRLGRRHNTPVRSFLLQLGGIRALGYSPELVTAVRADGVVITEPLAGTRALGRGPAIDRLARDDLESNSKEIVEHAISVRSSLEEITDIAEPGSAAVIDFMTVRERGSVQHLGSTIRARLDPSSDRMAALEALFPAVTASGIPKAAGVEAIFRLDECPRGLYSGAVVMLSADGGLDAALTLRAAYQVGGRTWLRAGAGIIEESEPEREFEETCEKLSTLTPYLVARQ,"48,754",450,"Anthranilate synthase component I family, Salicylate synthase subfamily",cellular response to iron ion starvation [GO:0010106]; growth [GO:0040007]; response to host immune response [GO:0052572]; salicylic acid biosynthetic process [GO:0009697]; siderophore biosynthetic process from catechol [GO:0019540]; tryptophan biosynthetic process [GO:0000162],anthranilate synthase activity [GO:0004049]; chorismate mutase activity [GO:0004106]; isochorismate pyruvate lyase activity [GO:0043904]; isochorismate synthase activity [GO:0008909]; magnesium ion binding [GO:0000287],anthranilate synthase complex [GO:0005950]; plasma membrane [GO:0005886],trpE2,,1
P9WPE1,CITEL_MYCTU,Rv2498c,citE Rv2498c,GO:0000287; GO:0006107; GO:0016829,IPR005000; IPR011206; IPR015813; ,,citE,,Citrate lyase subunit beta-like protein (EC 4.1.-.-),lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; oxaloacetate metabolic process [GO:0006107],9634230; 21969609; 17064730,X-ray crystallography (3),FUNCTION: May play a role in fatty acid biosynthesis. {ECO:0000305}.,MNLRAAGPGWLFCPADRPERFAKAAAAADVVILDLEDGVAEAQKPAARNALRDTPLDPERTVVRINAGGTADQARDLEALAGTAYTTVMLPKAESAAQVIELAPRDVIALVETARGAVCAAEIAAADPTVGMMWGAEDLIATLGGSSSRRADGAYRDVARHVRSTILLAASAFGRLALDAVHLDILDVEGLQEEARDAAAVGFDVTVCIHPSQIPVVRKAYRPSHEKLAWARRVLAASRSERGAFAFEGQMVDSPVLTHAETMLRRAGEATSE,"28,886",273,"HpcH/HpaI aldolase family, Citrate lyase beta subunit-like subfamily",oxaloacetate metabolic process [GO:0006107],lyase activity [GO:0016829]; magnesium ion binding [GO:0000287],,,,1
P9WPC5,CLPP1_MYCTU,Rv2461c,clpP1 clpP Rv2461c MTV008.17c,GO:0004252; GO:0005829; GO:0005886,IPR001907; IPR029045; IPR023562; IPR033135; ,,clpP1,,ATP-dependent Clp protease proteolytic subunit 1 (EC 3.4.21.92) (Endopeptidase Clp 1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252],9634230; 21969609; 23314154; 17242518,X-ray crystallography (7),"FUNCTION: Cleaves peptides in various proteins in a process that requires ATP hydrolysis. Has a chymotrypsin-like activity. Plays a major role in the degradation of misfolded proteins (By similarity). Degrades anti-sigma-D factor (rsdA) when present in a complex with ClpP2 and ClpX. Does not seem to act on anti-sigma-L factor (rslA). {ECO:0000255|HAMAP-Rule:MF_00444, ECO:0000269|PubMed:23314154}.",MSQVTDMRSNSQGLSLTDSVYERLLSERIIFLGSEVNDEIANRLCAQILLLAAEDASKDISLYINSPGGSISAGMAIYDTMVLAPCDIATYAMGMAASMGEFLLAAGTKGKRYALPHARILMHQPLGGVTGSAADIAIQAEQFAVIKKEMFRLNAEFTGQPIERIEADSDRDRWFTAAEALEYGFVDHIITRAHVNGEAQ,"21,708",200,Peptidase S14 family,,serine-type endopeptidase activity [GO:0004252],cytosol [GO:0005829]; plasma membrane [GO:0005886],clpP,MTV008.17c,1
P9WPC3,CLPP2_MYCTU,Rv2460c,clpP2 Rv2460c MTV008.16c,GO:0004252; GO:0005618; GO:0005829; GO:0005886; GO:0040007,IPR001907; IPR029045; IPR023562; IPR033135; IPR018215; ,,clpP2,,ATP-dependent Clp protease proteolytic subunit 2 (EC 3.4.21.92) (Endopeptidase Clp 2),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; growth [GO:0040007],9634230; 20025669; 21969609; 23314154,X-ray crystallography (3),"FUNCTION: Cleaves peptides in various proteins in a process that requires ATP hydrolysis. Has a chymotrypsin-like activity. Plays a major role in the degradation of misfolded proteins (By similarity). Degrades anti-sigma-D factor RsdA when present in a complex with ClpP1 and ClpX. Degrades anti-sigma-E factor RseA in the presence of ClpC1. Does not seem to act on anti-sigma-L factor RslA. {ECO:0000255|HAMAP-Rule:MF_00444, ECO:0000269|PubMed:20025669, ECO:0000269|PubMed:23314154}.",MNSQNSQIQPQARYILPSFIEHSSFGVKESNPYNKLFEERIIFLGVQVDDASANDIMAQLLVLESLDPDRDITMYINSPGGGFTSLMAIYDTMQYVRADIQTVCLGQAASAAAVLLAAGTPGKRMALPNARVLIHQPSLSGVIQGQFSDLEIQAAEIERMRTLMETTLARHTGKDAGVIRKDTDRDKILTAEEAKDYGIIDTVLEYRKLSAQTA,"23,540",214,Peptidase S14 family,growth [GO:0040007],serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV008.16c,1
P9WNB9,END8A_MYCTU,Rv2464c,nei1 nei2 Rv2464c MTV008.20c,GO:0000703; GO:0003684; GO:0003690; GO:0003697; GO:0003906; GO:0004844; GO:0006281; GO:0006284; GO:0006289; GO:0006979; GO:0008270; GO:0008534; GO:0034599; GO:0140078,IPR015886; IPR015887; IPR012319; IPR035937; IPR010979; IPR000214; IPR010663; ,,nei1,,Endonuclease 8 1 (DNA glycosylase/AP lyase Nei 1) (EC 3.2.2.-) (DNA-(apurinic or apyrimidinic site) lyase Nei 1) (EC 4.2.99.18) (Endonuclease VIII 1),class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-stranded DNA binding [GO:0003697]; uracil DNA N-glycosylase activity [GO:0004844]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979],9634230; 18457574; 19496823; 20031487; 21969609; 21764637,,"FUNCTION: Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. DNA glycosylase that recognizes and removes damaged pyrimidines. Excises Tg:A (thymine glycol, prefers 5R isomers), Tg:G, 5,6-dihydrouracil:G base pairs and urea:A, also excises oxidized purine derivatives guanidinohydantoin:C and spiroiminodihydantoin:C. Poorly cleaves dsDNA with uracil substitutions, thus also acting as a weak uracil-DNA glycosylase. Acts on DNA bubble and 3'-fork structures, suggesting a role in replication-associated DNA repair. Activity on 7,8-dihydro-8-oxoguanine (8-oxoG) is debated; a report shows weak activity (PubMed:18457574), whereas another shows none (PubMed:20031487). Has AP (apurinic/apyrimidinic) activity and introduces nicks in dsDNA strand, inefficiently cleaves ssDNA with AP sites and uracil. Probably cleaves the DNA backbone by beta-delta elimination to generate a single-strand break at the site of the removed base with both 3'- and 5'-phosphates. Cleaves ssDNA containing an AP site. Complements an E.coli fpg mutY but not nei nth double mutant (PubMed:18457574). {ECO:0000269|PubMed:18457574, ECO:0000269|PubMed:20031487}.",MPEGHTLHRLARLHQRRFAGAPVSVSSPQGRFADSASALNGRVLRRASAWGKHLFHHYVGGPVVHVHLGLYGTFTEWARPTDGWLPEPAGQVRMRMVGAEFGTDLRGPTVCESIDDGEVADVVARLGPDPLRSDANPSSAWSRITKSRRPIGALLMDQTVIAGVGNVYRNELLFRHRIDPQRPGRGIGEPEFDAAWNDLVSLMKVGLRRGKIIVVRPEHDHGLPSYLPDRPRTYVYRRAGEPCRVCGGVIRTALLEGRNVFWCPVCQT,"29,714",268,FPG family,base-excision repair [GO:0006284]; cellular response to oxidative stress [GO:0034599]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA binding [GO:0003690]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity [GO:0000703]; single-stranded DNA binding [GO:0003697]; uracil DNA N-glycosylase activity [GO:0004844]; zinc ion binding [GO:0008270],,nei2,MTV008.20c,1
P9WQ79,GABT_MYCTU,Rv2589,gabT Rv2589 MTCY227.12c,GO:0005886; GO:0009450; GO:0030170; GO:0034386; GO:0047298,IPR004632; IPR005814; IPR015424; IPR015422; IPR015421; ,,gabT,,4-aminobutyrate aminotransferase (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (Glutamate:succinic semialdehyde transaminase) (L-AIBAT),plasma membrane [GO:0005886]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; pyridoxal phosphate binding [GO:0030170]; gamma-aminobutyric acid catabolic process [GO:0009450],9634230; 21969609,,,MASLQQSRRLVTEIPGPASQALTHRRAAAVSSGVGVTLPVFVARAGGGIVEDVDGNRLIDLGSGIAVTTIGNSSPRVVDAVRTQVAEFTHTCFMVTPYEGYVAVAEQLNRITPGSGPKRSVLFNSGAEAVENAVKIARSYTGKPAVVAFDHAYHGRTNLTMALTAKSMPYKSGFGPFAPEIYRAPLSYPYRDGLLDKQLATNGELAAARAIGVIDKQVGANNLAALVIEPIQGEGGFIVPAEGFLPALLDWCRKNHVVFIADEVQTGFARTGAMFACEHEGPDGLEPDLICTAKGIADGLPLSAVTGRAEIMNAPHVGGLGGTFGGNPVACAAALATIATIESDGLIERARQIERLVTDRLTTLQAVDDRIGDVRGRGAMIAVELVKSGTTEPDAGLTERLATAAHAAGVIILTCGMFGNIIRLLPPLTIGDELLSEGLDIVCAILADL,"46,813",449,Class-III pyridoxal-phosphate-dependent aminotransferase family,gamma-aminobutyric acid catabolic process [GO:0009450],(S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; pyridoxal phosphate binding [GO:0030170],plasma membrane [GO:0005886],,MTCY227.12c,1
P9WPB9,CLPX_MYCTU,Rv2457c,clpX Rv2457c MTV008.13c,GO:0004176; GO:0005524; GO:0005618; GO:0006457; GO:0006508; GO:0008270; GO:0030163; GO:0032272; GO:0040007; GO:0046983; GO:0051082; GO:0051301,IPR003593; IPR003959; IPR019489; IPR004487; IPR027417; IPR010603; IPR038366; ,,clpX,,ATP-dependent Clp protease ATP-binding subunit ClpX,cell wall [GO:0005618]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; growth [GO:0040007]; negative regulation of protein polymerization [GO:0032272]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508],9634230; 20025669; 21969609; 23314154,,"FUNCTION: ATP-dependent specificity component of the Clp protease. It directs the protease to specific substrates. Can perform chaperone functions in the absence of ClpP (By similarity). Degrades anti-sigma-D factor RsdA when present in a complex with ClpP1 and ClpP2. Does not seem to act on anti-sigma-L factor RslA. {ECO:0000255|HAMAP-Rule:MF_00175, ECO:0000269|PubMed:23314154}.",MARIGDGGDLLKCSFCGKSQKQVKKLIAGPGVYICDECIDLCNEIIEEELADADDVKLDELPKPAEIREFLEGYVIGQDTAKRTLAVAVYNHYKRIQAGEKGRDSRCEPVELTKSNILMLGPTGCGKTYLAQTLAKMLNVPFAIADATALTEAGYVGEDVENILLKLIQAADYDVKRAETGIIYIDEVDKIARKSENPSITRDVSGEGVQQALLKILEGTQASVPPQGGRKHPHQEFIQIDTTNVLFIVAGAFAGLEKIIYERVGKRGLGFGAEVRSKAEIDTTDHFADVMPEDLIKFGLIPEFIGRLPVVASVTNLDKESLVKILSEPKNALVKQYIRLFEMDGVELEFTDDALEAIADQAIHRGTGARGLRAIMEEVLLPVMYDIPSRDDVAKVVVTKETVQDNVLPTIVPRKPSRSERRDKSA,"46,783",426,ClpX chaperone family,cell division [GO:0051301]; growth [GO:0040007]; negative regulation of protein polymerization [GO:0032272]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis [GO:0006508],ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; protein dimerization activity [GO:0046983]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],cell wall [GO:0005618],,MTV008.13c,1
P9WIK3,CYSH_MYCTU,Rv2392,cysH Rv2392 MTCY253.29c,GO:0004604; GO:0005737; GO:0005829; GO:0005886; GO:0006535; GO:0019379; GO:0040007; GO:0043866; GO:0051539; GO:0070814,IPR011798; IPR004511; IPR002500; IPR014729; ,,cysH,,"Probable phosphoadenosine phosphosulfate reductase (EC 1.8.4.8) (3'-phosphoadenylylsulfate reductase) (PAPS reductase, thioredoxin dependent) (PAPS sulfotransferase) (PAdoPS reductase)","cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; adenylyl-sulfate reductase (thioredoxin) activity [GO:0043866]; phosphoadenylyl-sulfate reductase (thioredoxin) activity [GO:0004604]; cysteine biosynthetic process from serine [GO:0006535]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]",9634230; 19099550; 21969609,,FUNCTION: Reduction of activated sulfate into sulfite. {ECO:0000250}.,MSGETTRLTEPQLRELAARGAAELDGATATDMLRWTDETFGDIGGAGGGVSGHRGWTTCNYVVASNMADAVLVDLAAKVRPGVPVIFLDTGYHFVETIGTRDAIESVYDVRVLNVTPEHTVAEQDELLGKDLFARNPHECCRLRKVVPLGKTLRGYSAWVTGLRRVDAPTRANAPLVSFDETFKLVKVNPLAAWTDQDVQEYIADNDVLVNPLVREGYPSIGCAPCTAKPAEGADPRSGRWQGLAKTECGLHAS,"27,423",254,"PAPS reductase family, CysH subfamily","cysteine biosynthetic process from serine [GO:0006535]; growth [GO:0040007]; hydrogen sulfide biosynthetic process [GO:0070814]; sulfate assimilation, phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379]","4 iron, 4 sulfur cluster binding [GO:0051539]; adenylyl-sulfate reductase (thioredoxin) activity [GO:0043866]; phosphoadenylyl-sulfate reductase (thioredoxin) activity [GO:0004604]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY253.29c,1
P9WNW1,DNAG_MYCTU,Rv2343c,dnaG Rv2343c MTCY98.12c,GO:0003677; GO:0003896; GO:0005886; GO:0008270; GO:0040007; GO:1990077,IPR013264; IPR037068; IPR019475; IPR006295; IPR013173; IPR036977; IPR030846; IPR034151; IPR006171; IPR002694; ,,dnaG,DOMAIN 262 348 Toprim. {ECO:0000255|HAMAP-Rule:MF_00974}.,DNA primase (EC 2.7.7.-),plasma membrane [GO:0005886]; primosome complex [GO:1990077]; DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; zinc ion binding [GO:0008270]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (4),FUNCTION: RNA polymerase that catalyzes the synthesis of short RNA molecules used as primers for DNA polymerase during DNA replication. {ECO:0000255|HAMAP-Rule:MF_00974}.,MSGRISDRDIAAIREGARIEDVVGDYVQLRRAGADSLKGLCPFHNEKSPSFHVRPNHGHFHCFGCGEGGDVYAFIQKIEHVSFVEAVELLADRIGHTISYTGAATSVQRDRGSRSRLLAANAAAAAFYAQALQSDEAAPARQYLTERSFDAAAARKFGCGFAPSGWDSLTKHLQRKGFEFEELEAAGLSRQGRHGPMDRFHRRLLWPIRTSAGEVVGFGARRLFDDDAMEAKYVNTPETLLYKKSSVMFGIDLAKRDIAKGHQAVVVEGYTDVMAMHLAGVTTAVASCGTAFGGEHLAMLRRLMMDDSFFRGELIYVFDGDEAGRAAALKAFDGEQKLAGQSFVAVAPDGMDPCDLRLKCGDAALRDLVARRTPLFEFAIRAAIAEMDLDSAEGRVAALRRCVPMVGQIKDPTLRDEYARQLAGWVGWADVAQVIGRVRGEAKRTKHPRLGRLGSTTIARAAQRPTAGPPTELAVRPDPRDPTLWPQREALKSALQYPALAGPVFDALTVEGFTHPEYAAVRAAIDTAGGTSAGLSGAQWLDMVRQQTTSTVTSALISELGVEAIQVDDDKLPRYIAGVLARLQEVWLGRQIAEVKSKLQRMSPIEQGDEYHALFGDLVAMEAYRRSLLEQASGDDLTA,"69,593",639,DnaG primase family,growth [GO:0040007],DNA binding [GO:0003677]; DNA primase activity [GO:0003896]; zinc ion binding [GO:0008270],plasma membrane [GO:0005886]; primosome complex [GO:1990077],,MTCY98.12c,1
P9WFE1,DCUP_MYCTU,Rv2678c,hemE Rv2678c MTV010.02c,GO:0004853; GO:0005829; GO:0006782; GO:0006783,IPR038071; IPR006361; IPR000257; ,,hemE,,Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37),cytosol [GO:0005829]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the decarboxylation of four acetate groups of uroporphyrinogen-III to yield coproporphyrinogen-III. {ECO:0000255|HAMAP-Rule:MF_00218}.,MSTRRDLPQSPYLAAVTGRKPSRVPVWFMRQAGRSLPEYRALRERYSMLAACFEPDVACEITLQPIRRYDVDAAILFSDIVVPLRAAGVDLDIVADVGPVIADPVRTAADVAAMKPLDPQAIQPVLVAASLLVAELGDVPLIGFAGAPFTLASYLVEGGPSRHHAHVKAMMLAEPASWHALMAKLTDLTIAFLVGQIDAGVDAIQVFDSWAGALSPIDYRQYVLPHSARVFAALGEHGVPMTHFGVGTAELLGAMSEAVTAGERPGRGAVVGVDWRTPLTDAAARVVPGTALQGNLDPAVVLAGWPAVERAARAVVDDGRRAVDAGAAGHIFNLGHGVLPESDPAVLADLVSLVHSL,"37,606",357,Uroporphyrinogen decarboxylase family,heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],uroporphyrinogen decarboxylase activity [GO:0004853],cytosol [GO:0005829],,MTV010.02c,1
P9WMR9,DHAA_MYCTU,Rv2579,dhaA Rv2579 MTCY227.22c,GO:0005618; GO:0005886; GO:0018786; GO:0042206,IPR029058; IPR000073; IPR000639; IPR023594; ,,dhaA,DOMAIN 32 155 AB hydrolase-1. {ECO:0000255}.,Haloalkane dehalogenase 3 (EC 3.8.1.5),cell wall [GO:0005618]; plasma membrane [GO:0005886]; haloalkane dehalogenase activity [GO:0018786]; halogenated hydrocarbon catabolic process [GO:0042206],9634230; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes hydrolytic cleavage of carbon-halogen bonds in halogenated aliphatic compounds, leading to the formation of the corresponding primary alcohols, halide ions and protons. {ECO:0000250}.",MTAFGVEPYGQPKYLEIAGKRMAYIDEGKGDAIVFQHGNPTSSYLWRNIMPHLEGLGRLVACDLIGMGASDKLSPSGPDRYSYGEQRDFLFALWDALDLGDHVVLVLHDWGSALGFDWANQHRDRVQGIAFMEAIVTPMTWADWPPAVRGVFQGFRSPQGEPMALEHNIFVERVLPGAILRQLSDEEMNHYRRPFVNGGEDRRPTLSWPRNLPIDGEPAEVVALVNEYRSWLEETDMPKLFINAEPGAIITGRIRDYVRSWPNQTEITVPGVHFVQEDSPEEIGAAIAQFVRRLRSAAGV,"33,728",300,"Haloalkane dehalogenase family, Type 2 subfamily",halogenated hydrocarbon catabolic process [GO:0042206],haloalkane dehalogenase activity [GO:0018786],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY227.22c,1
O53203,DHE2_MYCTU,Rv2476c,gdh Rv2476c,GO:0004352; GO:0005618; GO:0005829; GO:0005886; GO:0019551,IPR036291; IPR028971; IPR007780; ,P9WJA9,gdh,,NAD-specific glutamate dehydrogenase (NAD-GDH) (EC 1.4.1.2) (NAD(+)-dependent glutamate dehydrogenase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate catabolic process to 2-oxoglutarate [GO:0019551],9634230; 19019160; 19318624; 21969609,,FUNCTION: Catalyzes the reversible conversion of L-glutamate to 2-oxoglutarate. {ECO:0000250}.,MTIDPGAKQDVEAWTTFTASADIPDWISKAYIDSYRGPRDDSSEATKAAEASWLPASLLTPAMLGAHYRLGRHRAAGESCVAVYRADDPAGFGPALQVVAEHGGMLMDSVTVLLHRLGIAYAAILTPVFDVHRSPTGELLRIEPKAEGTSPHLGEAWMHVALSPAVDHKGLAEVERLLPKVLADVQRVATDATALIATLSELAGEVESNAGGRFSAPDRQDVGELLRWLGDGNFLLLGYQRCRVADGMVYGEGSSGMGVLRGRTGSRPRLTDDDKLLVLAQARVGSYLRYGAYPYAIAVREYVDGSVVEHRFVGLFSVAAMNADVLEIPTISRRVREALAMAESDPSHPGQLLLDVIQTVPRPELFTLSAQRLLTMARAVVDLGSQRQALLFLRADRLQYFVSCLVYMPRDRYTTAVRMQFEDILVREFGGTRLEFTARVSESPWALMHFMVRLPEVGVAGEGAAAPPVDVSEANRIRIQGLLTEAARTWADRLIGAAAAAGSVGQADAMHYAAAFSEAYKQAVTPADAIGDIAVITELTDDSVKLVFSERDEQGVAQLTWFLGGRTASLSQLLPMLQSMGVVVLEERPFSVTRPDGLPVWIYQFKISPHPTIPLAPTVAERAATAHRFAEAVTAIWHGRVEIDRFNELVMRAGLTWQQVVLLRAYAKYLRQAGFPYSQSYIESVLNEHPATVRSLVDLFEALFVPVPSGSASNRDAQAAAAAVAADIDALVSLDTDRILRAFASLVQATLRTNYFVTRQGSARCRDVLALKLNAQLIDELPLPRPRYEIFVYSPRVEGVHLRFGPVARGGLRWSDRRDDFRTEILGLVKAQAVKNAVIVPVGAKGGFVVKRPPLPTGDPAADRDATRAEGVACYQLFISGLLDVTDNVDHATASVNPPPEVVRRDGDDAYLVVAADKGTATFSDIANDVAKSYGFWLGDAFASGGSVGYDHKAMGITARGAWEAVKRHFREIGIDTQTQDFTVVGIGDMSGDVFGNGMLLSKHIRLIAAFDHRHIFLDPNPDAAVSWAERRRMFELPRSSWSDYDRSLISEGGGVYSREQKAIPLSAQVRAVLGIDGSVDGGAAEMAPPNLIRAILRAPVDLLFNGGIGTYIKAESESDADVGDRANDPVRVNANQVRAKVIGEGGNLGVTALGRVEFDLSGGRINTDALDNSAGVDCSDHEVNIKILIDSLVSAGTVKADERTQLLESMTDEVAQLVLADNEDQNDLMGTSRANAASLLPVHAMQIKYLVAERGVNRELEALPSEKEIARRSEAGIGLTSPELATLMAHVKLGLKEEVLATELPDQDVFASRLPRYFPTALRERFTPEIRSHQLRREIVTTMLINDLVDTAGITYAFRIAEDVGVTPIDAVRTYVATDAIFGVGHIWRRIRAANLPIALSDRLTLDTRRLIDRAGRWLLNYRPQPLAVGAEINRFAAMVKALTPRMSEWLRGDDKAIVEKTAAEFASQGVPEDLAYRVSTGLYRYSLLDIIDIADIADIDAAEVADTYFALMDRLGTDGLLTAVSQLPRHDRWHSLARLAIRDDIYGALRSLCFDVLAVGEPGESSEQKIAEWEHLSASRVARARRTLDDIRASGQKDLATLSVAARQIRRMTRTSGRGISG,"176,900",1624,Glu/Leu/Phe/Val dehydrogenases family,glutamate catabolic process to 2-oxoglutarate [GO:0019551],glutamate dehydrogenase (NAD+) activity [GO:0004352],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WNY7,DGTL1_MYCTU,Rv2344c,dgt Rv2344c MTCY98.13c,GO:0005886; GO:0006203; GO:0008832,IPR006261; IPR023023; IPR003607; IPR006674; IPR026875; ,,dgt,DOMAIN 72 222 HD. {ECO:0000255|PROSITE-ProRule:PRU01175}.,Deoxyguanosinetriphosphate triphosphohydrolase-like protein,plasma membrane [GO:0005886]; dGTPase activity [GO:0008832]; dGTP catabolic process [GO:0006203],9634230; 21969609,,,MSASEHDPYDDFDRQRRVAEAPKTAGLPGTEGQYRSDFARDRARVLHSAALRRLADKTQVVGPREGDTPRTRLTHSLEVAQIGRGMAIGLGCDLDLVELAGLAHDIGHPPYGHNGERALDEVAASHGGFEGNAQNFRILTSLEPKVVDAQGLSAGLNLTRASLDAVTKYPWMRGDGLGSQRRKFGFYDDDRESAVWVRQGAPPERACLEAQVMDWADDVAYSVHDVEDGVVSERIDLRVLAAEEDAAALARLGEREFSRVSADELMAAARRLSRLPVVAAVGKYDATLSASVALKRLTSELVGRFASAAIATTRAAAGPGPLVRFRADLQVPDLVRAEVAVLKILALQFIMSDPRHLETQARQRERIHRVAHRLYSGAPQTLDPVYAAAFNTAADDAARLRVVVDQIASYTEGRLERIDADQLGVSRNALD,"46,912",431,"DGTPase family, Type 2 subfamily",dGTP catabolic process [GO:0006203],dGTPase activity [GO:0008832],plasma membrane [GO:0005886],,MTCY98.13c,1
P9WQM1,CYSA_MYCTU,Rv2397c,cysA Rv2397c MTCY253.24,GO:0005524; GO:0005886; GO:0008272; GO:0015419; GO:0040007; GO:0043190; GO:0102025,IPR003593; IPR014769; IPR003439; IPR017871; IPR008995; IPR027417; IPR005666; IPR024765; ,,cysA,DOMAIN 5 235 ABC transporter. {ECO:0000255|HAMAP-Rule:MF_01701}.,Sulfate/thiosulfate import ATP-binding protein CysA (EC 3.6.3.25) (Sulfate-transporting ATPase),ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase-coupled sulfate transmembrane transporter activity [GO:0015419]; ATPase-coupled thiosulfate transmembrane transporter activity [GO:0102025]; growth [GO:0040007]; sulfate transport [GO:0008272],9634230; 11929522; 21969609,,FUNCTION: Part of the ABC transporter complex CysAWTP involved in sulfate/thiosulfate import. Responsible for energy coupling to the transport system.,MTYAIVVADATKRYGDFVALDHVDFVVPTGSLTALLGPSGSGKSTLLRTIAGLDQPDTGTITINGRDVTRVPPQRRGIGFVFQHYAAFKHLTVRDNVAFGLKIRKRPKAEIKAKVDNLLQVVGLSGFQSRYPNQLSGGQRQRMALARALAVDPEVLLLDEPFGALDAKVREELRAWLRRLHDEVHVTTVLVTHDQAEALDVADRIAVLHKGRIEQVGSPTDVYDAPANAFVMSFLGAVSTLNGSLVRPHDIRVGRTPNMAVAAADGTAGSTGVLRAVVDRVVVLGFEVRVELTSAATGGAFTAQITRGDAEALALREGDTVYVRATRVPPIAGGVSGVDDAGVERVKVTST,"37,444",351,"ABC transporter superfamily, Sulfate/tungstate importer (TC 3.A.1.6) family",growth [GO:0040007]; sulfate transport [GO:0008272],ATPase-coupled sulfate transmembrane transporter activity [GO:0015419]; ATPase-coupled thiosulfate transmembrane transporter activity [GO:0102025]; ATP binding [GO:0005524],ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886],,MTCY253.24,2
P95231,CYSE_MYCTU,Rv2335,cysE Rv2335,GO:0005829; GO:0006535; GO:0009001; GO:0019344,IPR001451; IPR018357; IPR005881; IPR011004; ,,cysE,,Serine acetyltransferase (SAT) (EC 2.3.1.30),cytosol [GO:0005829]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],9634230; 14569030; 19099550; 21969609,,FUNCTION: Catalyzes the acetylation of serine by acetyl-CoA to produce O-acetylserine (OAS). {ECO:0000250}.,MLTAMRGDIRAARERDPAAPTALEVIFCYPGVHAVWGHRLAHWLWQRGARLLARAAAEFTRILTGVDIHPGAVIGARVFIDHATGVVIGETAEVGDDVTIYHGVTLGGSGMVGGKRHPTVGDRVIIGAGAKVLGPIKIGEDSRIGANAVVVKPVPPSAVVVGVPGQVIGQSQPSPGGPFDWRLPDLVGASLDSLLTRVARLEALGGGPQAAGVIRPPEAGIWHGEDFSI,"23,770",229,Transferase hexapeptide repeat family,cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],serine O-acetyltransferase activity [GO:0009001],cytosol [GO:0005829],,,1
P9WIC7,GPGP_MYCTU,Rv2419c,gpgP Rv2419c,GO:0016311; GO:0016791; GO:0050531,IPR013078; IPR029033; IPR001345; ,,gpgP,,Glucosyl-3-phosphoglycerate phosphatase (EC 3.1.3.85) (Mannosyl-3-phosphoglycerate phosphatase) (EC 3.1.3.70),mannosyl-3-phosphoglycerate phosphatase activity [GO:0050531]; phosphatase activity [GO:0016791]; dephosphorylation [GO:0016311],9634230; 20066036; 21969609; 22355692; 24914210,X-ray crystallography (3),"FUNCTION: Involved in the biosynthesis of mycobacterial methylglucose lipopolysaccharides (MGLPs). Catalyzes the dephosphorylation of glucosyl-3-phosphoglycerate (GPG) to glucosylglycerate (GG). GPG is the preferred substrate, but GpgP also exhibits low dephosphorylation activity on mannosyl-3-phosphoglycerate (MPG) and mannosylglucosyl-3-phosphoglycerate (MGPG) in vitro. Shows only trace of phosphoglycerate mutase (PGM) activity. {ECO:0000269|PubMed:22355692}.",MRARRLVMLRHGQTDYNVGSRMQGQLDTELSELGRTQAVAAAEVLGKRQPLLIVSSDLRRAYDTAVKLGERTGLVVRVDTRLRETHLGDWQGLTHAQIDADAPGARLAWREDATWAPHGGESRVDVAARSRPLVAELVASEPEWGGADEPDRPVVLVAHGGLIAALSAALLKLPVANWPALGGMGNASWTQLSGHWAPGSDFESIRWRLDVWNASAQVSSDVL,"24,174",223,Phosphoglycerate mutase family,dephosphorylation [GO:0016311],mannosyl-3-phosphoglycerate phosphatase activity [GO:0050531]; phosphatase activity [GO:0016791],,,,1
P9WIS3,BKDA_MYCTU,Rv2497c,bkdA pdhA Rv2497c,GO:0003863; GO:0046872,IPR001017; IPR017596; IPR029061; ,,bkdA,,3-methyl-2-oxobutanoate dehydrogenase subunit alpha (EC 1.2.4.4) (Branched-chain alpha-ketoacid dehydrogenase E1 component subunit alpha) (BCKADH E1-alpha),3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; metal ion binding [GO:0046872],9634230; 11929527; 16045627; 21238944; 21969609,,"FUNCTION: Component of the branched-chain alpha-ketoacid dehydrogenase (BCKADH) complex, that catalyzes the overall conversion of branched-chain alpha-ketoacids to acyl-CoA and CO(2). {ECO:0000269|PubMed:21238944}.",MGEGSRRPSGMLMSVDLEPVQLVGPDGTPTAERRYHRDLPEETLRWLYEMMVVTRELDTEFVNLQRQGELALYTPCRGQEAAQVGAAACLRKTDWLFPQYRELGVYLVRGIPPGHVGVAWRGTWHGGLQFTTKCCAPMSVPIGTQTLHAVGAAMAAQRLDEDSVTVAFLGDGATSEGDVHEALNFAAVFTTPCVFYVQNNQWAISMPVSRQTAAPSIAHKAIGYGMPGIRVDGNDVLACYAVMAEAAARARAGDGPTLIEAVTYRLGPHTTADDPTRYRSQEEVDRWATLDPIPRYRTYLQDQGLWSQRLEEQVTARAKHVRSELRDAVFDAPDFDVDEVFTTVYAEITPGLQAQREQLRAELARTD,"40,616",367,,,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; metal ion binding [GO:0046872],,pdhA,,1
P9WIR5,CADI_MYCTU,Rv2641,cadI Rv2641 MTCY441.11,GO:0046686,IPR029068; IPR004360; IPR037523; ,,cadI,DOMAIN 2 117 VOC. {ECO:0000255|PROSITE-ProRule:PRU01163}.,Cadmium-induced protein CadI,response to cadmium ion [GO:0046686],9634230; 11425467; 21969609,,,MSRVQLALNVDDLEAAITFYSRLFNAEPAKRKPGYANFAIADPPLKLVLLENPGTGGTLNHLGVEVGSSNTVHAEIARLTEAGLVTEKEIGTTCCFATQDKVWVTGPGGERWEVYTVLADSETFGSGPRHNDTSDGEASMCCDGQVAVGASG,"16,031",152,,response to cadmium ion [GO:0046686],,,,MTCY441.11,1
P9WPQ3,BCCA_MYCTU,Rv2501c,accA1 bccA Rv2501c MTCY07A7.07c,GO:0004075; GO:0005524; GO:0005886; GO:0006633; GO:0046872,IPR011761; IPR005481; IPR001882; IPR011764; IPR005482; IPR000089; IPR005479; IPR016185; IPR011054; IPR011053; ,,accA1,DOMAIN 1 448 Biotin carboxylation.; DOMAIN 120 319 ATP-grasp. {ECO:0000255|PROSITE-ProRule:PRU00409}.; DOMAIN 578 653 Biotinyl-binding. {ECO:0000255|PROSITE-ProRule:PRU01066}.,Acetyl-/propionyl-coenzyme A carboxylase alpha chain [Includes: Biotin carboxylase (EC 6.3.4.14); Biotin carboxyl carrier protein (BCCP)],plasma membrane [GO:0005886]; ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; fatty acid biosynthetic process [GO:0006633],7909542; 9634230; 20066036; 21969609,,FUNCTION: This protein carries two functions: biotin carboxyl carrier protein and biotin carboxyltransferase. {ECO:0000250}.,MFDTVLVANRGEIAVRVIRTLRRLGIRSVAVYSDPDVDARHVLEADAAVRLGPAPARESYLDIGKVLDAAARTGAQAIHPGYGFLAENADFAAACERARVVFLGPPARAIEVMGDKIAAKNAVAAFDVPVVPGVARAGLTDDALVTAAAEVGYPVLIKPSAGGGGKGMRLVQDPARLPEALVSARREAMSSFGDDTLFLERFVLRPRHIEVQVLADAHGNVVHLGERECSLQRRHQKVIEEAPSPLLDPQTRERIGVAACNTARCVDYVGAGTVEFIVSAQRPDEFFFMEMNTRLQVEHPVTEAITGLDLVEWQLRVGAGEKLGFAQNDIELRGHAIEARVYAEDPAREFLPTGGRVLAVFEPAGPGVRVDSSLLGGTVVGSDYDPLLTKVIAHGADREEALDRLDQALARTAVLGVQTNVEFLRFLLADERVRVGDLDTAVLDERSADFTARPAPDDVLAAGGLYRQWALARRAQGDLWAAPSGWRGGGHMAPVRTAMRTPLRSETVSVWGPPESAQVQVGDGEIDCASVQVTREQMSVTISGLRRDYRWAEADRHLWIADERGTWHLREAEEHKIHRAVGARPAEVVSPMPGSVIAVQVESGSQISAGDVVVVVEAMKMEHSLEAPVSGRVQVLVSVGDQVKVEQVLARIKD,"70,592",654,,fatty acid biosynthetic process [GO:0006633],ATP binding [GO:0005524]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],bccA,MTCY07A7.07c,1
P9WIE1,BCP_MYCTU,Rv2521,bcp bcp2 Rv2521,GO:0004601; GO:0005829; GO:0005886; GO:0045454; GO:0051920,IPR000866; IPR024706; IPR036249; IPR013766; ,,bcp,DOMAIN 7 157 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Putative peroxiredoxin Rv2521 (EC 1.11.1.15) (Bacterioferritin comigratory protein) (Thioredoxin peroxidase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],9634230; 20066036; 21969609,,"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. {ECO:0000250|UniProtKB:P0AE52}.",MTKTTRLTPGDKAPAFTLPDADGNNVSLADYRGRRVIVYFYPAASTPGCTKQACDFRDNLGDFTTAGLNVVGISPDKPEKLATFRDAQGLTFPLLSDPDREVLTAWGAYGEKQMYGKTVQGVIRSTFVVDEDGKIVVAQYNVKATGHVAKLRRDLSV,"17,077",157,"Peroxiredoxin family, BCP/PrxQ subfamily",cell redox homeostasis [GO:0045454],peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cytosol [GO:0005829]; plasma membrane [GO:0005886],bcp2,,1
P9WMZ7,AFTC_MYCTU,Rv2673,aftC Rv2673,GO:0016021; GO:0016758; GO:0040007; GO:0045227; GO:0071555,IPR018584; ,,aftC,,Alpha-(1->3)-arabinofuranosyltransferase (EC 2.4.2.47) (Arabinofuranan 3-O-arabinosyltransferase) (Arabinofuranosyltransferase C),"integral component of membrane [GO:0016021]; transferase activity, transferring hexosyl groups [GO:0016758]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007]",9634230; 18627460; 21595486; 21969609,,"FUNCTION: Involved in the biosynthesis of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the addition of an arabinofuranosyl (Araf) residue from the sugar donor decaprenyl-phospho-arabinose (DPA) on the C-3 of an alpha-(1->5)-linked Araf from the arabinan backbone of AG. It can also use (Z,Z)-farnesylphosphoryl D-arabinose (Z-FPA), and to a lesser extent (E,E,Z,Z,Z,Z)-heptaprenylphosphoryl D-arabinose (Z-HPA) and (Z)-nerylphosphoryl D-arabinose (Z-NPA) as sugar donors. {ECO:0000269|PubMed:18627460, ECO:0000269|PubMed:21595486}.",MYGALVTAADSIRTGLGASLLAGFRPRTGAPSTATILRSALWPAAVLSVLHRSIVLTTNGNITDDFKPVYRAVLNFRRGWDIYNEHFDYVDPHYLYPPGGTLLMAPFGYLPFAPSRYLFISINTAAILVAAYLLLRMFNFTLTSVAAPALILAMFATETVTNTLVFTNINGCILLLEVLFLRWLLDGRASRQWCGGLAIGLTLVLKPLLGPLLLLPLLNRQWRALVAAVVVPVVVNVAALPLVSDPMSFFTRTLPYILGTRDYFNSSILGNGVYFGLPTWLILFLRILFTAITFGALWLLYRYYRTGDPLFWFTTSSGVLLLWSWLVMSLAQGYYSMMLFPFLMTVVLPNSVIRNWPAWLGVYGFMTLDRWLLFNWMRWGRALEYLKITYGWSLLLIVTFTVLYFRYLDAKADNRLDGGIDPAWLTPEREGQR,"48,915",433,,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007],"transferase activity, transferring hexosyl groups [GO:0016758]",integral component of membrane [GO:0016021],,,1
P9WMB5,ACYLT_MYCTU,Rv2611c,Rv2611c,GO:0005886; GO:0009247; GO:0016020; GO:0016021; GO:0016746; GO:0040007; GO:0046488,IPR004960; ,,,,Phosphatidylinositol mannoside acyltransferase (PIM acyltransferase) (EC 2.3.1.265),"integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; phosphatidylinositol metabolic process [GO:0046488]",9634230; 12368430; 12851411; 21969609,,"FUNCTION: Catalyzes the acylation to the position 6 of the alpha-1,2-linked mannose residue of the phosphatidyl-myo-inositol dimannoside (PIM2) or monomannoside (PIM1). {ECO:0000269|PubMed:12851411}.",MIAGLKGLKLPKDPRSSVTRTATDWAYAAGWMAVRALPEFAVRNAFDTGARYFARHGGPEQLRKNLARVLGVPPAAVPDPLMCASLESYGRYWREVFRLPTINHRKLARQLDRVIGGLDHLDAALAAGLGAVLALPHSGNWDMAGMWLVQRHGTFTTVAERLKPESLYQRFIDYRESLGFEVLPLSGGERPPFEVLSERLRNNRVVCLMAERDLTRTGVEVDFFGEPTRMPVGPAKLAVETGAALLPTHCWFEGRGWGFQVYPALDCTSGDVAAITQALADRFAQNIAAHPADWHMLQPQWLADLSESRRAQLRSR,"35,126",316,LpxL/LpxM/LpxP family,glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; phosphatidylinositol metabolic process [GO:0046488],"transferase activity, transferring acyl groups [GO:0016746]",integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886],,,1
P9WQD3,ACPS_MYCTU,Rv2523c,acpS Rv2523c MTV009.08c,GO:0000287; GO:0005737; GO:0006633; GO:0008897,IPR008278; IPR037143; IPR002582; IPR004568; ,,acpS,,Holo-[acyl-carrier-protein] synthase (Holo-ACP synthase) (EC 2.7.8.7) (4'-phosphopantetheinyl transferase AcpS),cytoplasm [GO:0005737]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; fatty acid biosynthetic process [GO:0006633],9634230; 19099550; 21969609,X-ray crystallography (5),FUNCTION: Transfers the 4'-phosphopantetheine moiety from coenzyme A to a Ser of acyl-carrier-protein. {ECO:0000255|HAMAP-Rule:MF_00101}.,MGIVGVGIDLVSIPDFAEQVDQPGTVFAETFTPGERRDASDKSSSAARHLAARWAAKEAVIKAWSGSRFAQRPVLPEDIHRDIEVVTDMWGRPRVRLTGAIAEYLADVTIHVSLTHEGDTAAAVAILEAP,"14,003",130,"P-Pant transferase superfamily, AcpS family",fatty acid biosynthetic process [GO:0006633],holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287],cytoplasm [GO:0005737],,MTV009.08c,1
P9WQB7,AHPC_MYCTU,Rv2428,ahpC Rv2428,GO:0004601; GO:0005618; GO:0005829; GO:0005886; GO:0008785; GO:0016491; GO:0032843; GO:0045454; GO:0051409; GO:0051920; GO:0052059; GO:0052060; GO:0055114,IPR000866; IPR024706; IPR036249; IPR013766; ,,ahpC,DOMAIN 4 170 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Alkyl hydroperoxide reductase C (MtAhpC) (EC 1.11.1.15) (Peroxiredoxin) (Thioredoxin peroxidase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; alkyl hydroperoxide reductase activity [GO:0008785]; hydroperoxide reductase activity [GO:0032843]; oxidoreductase activity [GO:0016491]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; oxidation-reduction process [GO:0055114]; response to nitrosative stress [GO:0051409],7604044; 8596438; 9634230; 8658136; 10766746; 11171096; 11416222; 12084012; 11799204; 14871480; 15178486; 21969609; 15886207,X-ray crystallography (1),"FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides. Together with AhpD, DlaT and Lpd, constitutes an NADH-dependent peroxidase active against hydrogen and alkyl peroxides as well as serving as a peroxynitrite reductase, thus protecting the bacterium against reactive nitrogen intermediates and oxidative stress generated by the host immune system. Does not however seem to play a role in detoxification of isoniazid. {ECO:0000269|PubMed:10766746, ECO:0000269|PubMed:11799204, ECO:0000269|PubMed:12084012}.",MPLLTIGDQFPAYQLTALIGGDLSKVDAKQPGDYFTTITSDEHPGKWRVVFFWPKDFTFVCPTEIAAFSKLNDEFEDRDAQILGVSIDSEFAHFQWRAQHNDLKTLPFPMLSDIKRELSQAAGVLNADGVADRVTFIVDPNNEIQFVSATAGSVGRNVDEVLRVLDALQSDELCACNWRKGDPTLDAGELLKASA,"21,566",195,"Peroxiredoxin family, AhpC/Prx1 subfamily",cell redox homeostasis [GO:0045454]; evasion or tolerance by symbiont of host-produced nitric oxide [GO:0052060]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; oxidation-reduction process [GO:0055114]; response to nitrosative stress [GO:0051409],alkyl hydroperoxide reductase activity [GO:0008785]; hydroperoxide reductase activity [GO:0032843]; oxidoreductase activity [GO:0016491]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WQ99,AMIA2_MYCTU,Rv2363,amiA2 Rv2363 MTCY27.17c,GO:0004040,IPR000120; IPR020556; IPR023631; IPR036928; ,,amiA2,,Putative amidase AmiA2 (EC 3.5.1.4),amidase activity [GO:0004040],9634230; 21969609,,,MVGASGSDAGAISGSGNQRLPTLTDLLYQLATRAVTSEELVRRSLRAIDVSQPTLNAFRVVLTESALADAAAADKRRAAGDTAPLLGIPIAVKDDVDVAGVPTAFGTQGYVAPATDDCEVVRRLKAAGAVIVGKTNTCELGQWPFTSGPGFGHTRNPWSRRHTPGGSSGGSAAAVAAGLVTAAIGSDGAGSIRIPAAWTHLVGIKPQRGRISTWPLPEAFNGVTVNGVLARTVEDAALVLDAASGNVEGDRHQPPPVTVSDFVGIAPGPLKIALSTHFPYTGFRAKLHPEILAATQRVGDQLELLGHTVVKGNPDYGLRLSWNFLARSTAGLWEWAERLGDEVTLDRRTVSNLRMGHVLSQAILRSARRHEAADQRRVGSIFDIVDVVLAPTTAQPPPMARAFDRLGSFGTDRAIIAACPSTWPWNLLGWPSINVPAGFTSDGLPIGVQLMGPANSEGMLISLAAELEAVSGWATKQPQVWWTS,"50,884",484,Amidase family,,amidase activity [GO:0004040],,,MTCY27.17c,1
P9WQB5,AHPD_MYCTU,Rv2429,ahpD Rv2429 MTCY428.17c,GO:0004601; GO:0005829; GO:0005886; GO:0006979; GO:0015036; GO:0032843; GO:0045454; GO:0051920,IPR004674; IPR029032; IPR004675; IPR003779; ,,ahpD,,Alkyl hydroperoxide reductase AhpD (EC 1.11.1.15) (Alkylhydroperoxidase AhpD),cytosol [GO:0005829]; plasma membrane [GO:0005886]; disulfide oxidoreductase activity [GO:0015036]; hydroperoxide reductase activity [GO:0032843]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],9634230; 10766746; 15178486; 21969609; 11914371; 11799204; 12761216,X-ray crystallography (4),"FUNCTION: Antioxidant protein with alkyl hydroperoxidase activity. Required for the reduction of the AhpC active site cysteine residues and for the regeneration of the AhpC enzyme activity.; FUNCTION: Together with AhpC, DlaT and Lpd, constitutes an NADH-dependent peroxidase active against hydrogen and alkyl peroxides as well as serving as a peroxynitrite reductase, thus protecting the bacterium against reactive nitrogen intermediates and oxidative stress generated by the host immune system.",MSIEKLKAALPEYAKDIKLNLSSITRSSVLDQEQLWGTLLASAAATRNPQVLADIGAEATDHLSAAARHAALGAAAIMGMNNVFYRGRGFLEGRYDDLRPGLRMNIIANPGIPKANFELWSFAVSAINGCSHCLVAHEHTLRTVGVDREAIFEALKAAAIVSGVAQALATIEALSPS,"18,781",177,AhpD family,cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],disulfide oxidoreductase activity [GO:0015036]; hydroperoxide reductase activity [GO:0032843]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY428.17c,1
P9WQL7,FLQE1_MYCTU,Rv2688c,Rv2688c,GO:0005524; GO:0005886; GO:0015562; GO:0016887; GO:0042891; GO:0046677,IPR003593; IPR003439; IPR027417; ,,,DOMAIN 18 246 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Fluoroquinolones export ATP-binding protein Rv2688c (EC 3.6.3.-),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; efflux transmembrane transporter activity [GO:0015562]; antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],9634230; 15273144,,"FUNCTION: Part of the ABC transporter complex Rv2686c/Rv2687c/Rv2688c involved in fluoroquinolones export. Confers resistance to ciprofloxacin and, to a lesser extent, norfloxacin, moxifloxacin and sparfloxacin. Probably responsible for energy coupling to the transport system. {ECO:0000269|PubMed:15273144}.",MTALNRAVASARVGTEVIRVRGLTFRYPKAAEPAVRGMEFTVGRGEIFGLLGPSGAGKSTTQKLLIGLLRDHGGQATVWDKEPAEWGPDYYERIGVSFELPNHYQKLTGYENLRFFASLYAGATADPMQLLAAVGLADDAHTLVGKYSKGMQMRLPFARSLINDPELLFLDEPTSGLDPVNARKIKDIIVDLKARGRTIFLTTHDMATADELCDRVAFVVDGRIVALDSPTELKIARSRRRVRVEYRGDGGGLETAEFGMDGLADDPAFHSVLRNHHVETIHSREASLDDVFVEVTGRQLT,"33,100",301,ABC transporter superfamily,antibiotic transport [GO:0042891]; response to antibiotic [GO:0046677],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; efflux transmembrane transporter activity [GO:0015562],plasma membrane [GO:0005886],,,1
P9WJB3,FLQE2_MYCTU,Rv2686c,Rv2686c,GO:0005886; GO:0015562; GO:0016021; GO:0046677; GO:0055085,,,,,Fluoroquinolones export permease protein Rv2686c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],21653760; 9634230; 15273144,,"FUNCTION: Part of the ABC transporter complex Rv2686c/Rv2687c/Rv2688c involved in fluoroquinolones export. Confers resistance to ciprofloxacin and, to a lesser extent, norfloxacin, moxifloxacin and sparfloxacin. Probably responsible for the translocation of the substrate across the membrane. {ECO:0000269|PubMed:15273144}.",MRAISSLAGPRALAAFGRNDIRGTYRDPLLVMLVIAPVIWTTGVALLTPLFTEMLARRYGFDLVGYYPLILTAFLLLTSIIVAGALAAFLVLDDVDAGTMTALRVTPVPLSVFFGYRAATVMVVTTIYVVATMSCSGILEPGLVSSLIPIGLVAGLSAVVTLLLILAVANNKIQGLAMVRALGMLIAGLPCLPWFISSNWNLAFGVLPPYWAAKAFWVASDHGTWWPYLVGGAVYNLAIVWVLFRRFRAKHA,"27,144",252,,response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],efflux transmembrane transporter activity [GO:0015562],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNV7,DNAJ2_MYCTU,Rv2373c,dnaJ2 Rv2373c MTCY27.07,GO:0005524; GO:0005618; GO:0005737; GO:0006260; GO:0006457; GO:0009408; GO:0031072; GO:0040007; GO:0046872; GO:0051082,IPR012724; IPR002939; IPR001623; IPR008971; IPR001305; IPR036410; IPR036869; ,,dnaJ2,DOMAIN 4 68 J. {ECO:0000255|HAMAP-Rule:MF_01152}.,Chaperone protein DnaJ 2,cell wall [GO:0005618]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; DNA replication [GO:0006260]; growth [GO:0040007]; protein folding [GO:0006457]; response to heat [GO:0009408],9634230; 19099550; 21568871; 21969609,,"FUNCTION: Participates actively in the response to hyperosmotic and heat shock by preventing the aggregation of stress-denatured proteins and by disaggregating proteins, also in an autonomous, DnaK-independent fashion. Unfolded proteins bind initially to DnaJ; upon interaction with the DnaJ-bound protein, DnaK hydrolyzes its bound ATP, resulting in the formation of a stable complex. GrpE releases ADP from DnaK; ATP binding to DnaK triggers the release of the substrate protein, thus completing the reaction cycle. Several rounds of ATP-dependent interactions between DnaJ, DnaK and GrpE are required for fully efficient folding. Also involved, together with DnaK and GrpE, in the DNA replication of plasmids through activation of initiation proteins (By similarity). Inhibits the beta-lactamase and RNase activity of RNase J. {ECO:0000255|HAMAP-Rule:MF_01152, ECO:0000269|PubMed:21568871}.",MARDYYGLLGVSKNASDADIKRAYRKLARELHPDVNPDEAAQAKFKEISVAYEVLSDPDKRRIVDLGGDPLESAAAGGNGFGGFGGLGDVFEAFFGGGFGGGAASRGPIGRVRPGSDSLLRMRLDLEECATGVTKQVTVDTAVLCDRCQGKGTNGDSVPIPCDTCGGRGEVQTVQRSLLGQMLTSRPCPTCRGVGVVIPDPCQQCMGDGRIRARREISVKIPAGVGDGMRVRLAAQGEVGPGGGPAGDLYVEVHEQAHDVFVREGDHLHCTVSVPMVDAALGVTVTVDAILDGLSEITIPPGTQPGSVITLRGRGMPHLRSNTRGDLHVHVEVVVPTRLDHQDIELLRELKGRRDREVAEVRSTHAAAGGLFSRLRETFTGR,"40,489",382,DnaJ family,DNA replication [GO:0006260]; growth [GO:0040007]; protein folding [GO:0006457]; response to heat [GO:0009408],ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY27.07,1
P9WNM3,EFP_MYCTU,Rv2534c,efp Rv2534c MTCY159.22,GO:0003746; GO:0005737; GO:0040007,IPR015365; IPR012340; IPR014722; IPR020599; IPR013185; IPR001059; IPR013852; IPR011768; IPR008991; ,,efp,,Elongation factor P (EF-P),cytoplasm [GO:0005737]; translation elongation factor activity [GO:0003746]; growth [GO:0040007],9634230; 21969609,,"FUNCTION: Involved in peptide bond synthesis. Stimulates efficient translation and peptide-bond synthesis on native or reconstituted 70S ribosomes in vitro. Probably functions indirectly by altering the affinity of the ribosome for aminoacyl-tRNA, thus increasing their reactivity as acceptors for peptidyl transferase (By similarity). {ECO:0000250}.",MATTADFKNGLVLVIDGQLWTITEFQHVKPGKGPAFVRTKLKNVLSGKVVDKTFNAGVKVDTATVDRRDTTYLYRDGSDFVFMDSQDYEQHPLPEALVGDAARFLLEGMPVQVAFHNGVPLYIELPVTVELEVTHTEPGLQGDRSSAGTKPATLQTGAQINVPLFINTGDKLKVDSRDGSYLGRVNA,"20,407",187,Elongation factor P family,growth [GO:0040007],translation elongation factor activity [GO:0003746],cytoplasm [GO:0005737],,MTCY159.22,1
P9WNN5,ECH14_MYCTU,Rv2486,echA14 Rv2486 MTV008.42,GO:0004300; GO:0006635,IPR029045; IPR018376; IPR001753; ,,echA14,,Probable enoyl-CoA hydratase echA14 (EC 4.2.1.17),enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,FUNCTION: Could possibly oxidize fatty acids using specific components. {ECO:0000250}.,MAQYDPVLLSVDKHVALITVNDPDRRNAVTDEMSAQLRAAIQRAEGDPDVHAVVVTGAGKAFCAGADLSALGAGVGDPAEPRLLRLYDGFMAVSSCNLPTIAAVNGAAVGAGLNLALAADVRIAGPAALFDARFQKLGLHPGGGATWMLQRAVGPQVARAALLFGMCFDAESAVRHGLALMVADDPVTAALELAAGPAAAPREVVLASKATMRATASPGSLDLEQHELAKRLELGPQAKSVQSPEFAARLAAAQHR,"26,280",256,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],,,MTV008.42,1
P9WFF7,DPDS_MYCTU,Rv2361c,uppS Rv2361c MTCY27.19,GO:0000287; GO:0002094; GO:0005829; GO:0005886; GO:0008834; GO:0016094; GO:0030145; GO:0033850; GO:0040007; GO:0050347,IPR001441; IPR018520; IPR036424; ,,uppS,,"Decaprenyl diphosphate synthase (DecaPP) (EC 2.5.1.86) (EC 2.5.1.87) (Decaprenyl pyrophosphate synthase) (Long-chain isoprenyl diphosphate synthase) (Trans,polycis-decaprenyl diphosphate synthase)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; di-trans,poly-cis-decaprenylcistransferase activity [GO:0008834]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polyprenyltransferase activity [GO:0002094]; trans-octaprenyltranstransferase activity [GO:0050347]; Z-farnesyl diphosphate synthase activity [GO:0033850]; growth [GO:0040007]; polyprenol biosynthetic process [GO:0016094]",9634230; 11004176; 10816587; 15516568; 21969609; 18597781,X-ray crystallography (4),"FUNCTION: Catalyzes the sequential condensation of isopentenyl diphosphate (IPP) in the cis configuration with (2Z,6E)-farnesyl diphosphate (Z-FPP or EZ-FPP) generating the 50 carbon product trans,polycis-decaprenyl diphosphate. When (2E,6E)-farnesyl diphosphate (E-FPP or EE-FPP) is used in vitro, both primary products decaprenyl diphosphate and (2E,6E,10E)-geranylgeranyl diphosphate (EEE-GGPP) are synthesized. M.tuberculosis does not synthesize (2E,6E,10Z)-geranylgeranyl diphosphate (EEZ-GGPP) and heptaprenyl diphosphate. Can also accept many different allylic substrates, including E-geranyl diphosphate (E-GPP), neryl diphosphate (NPP), and all-trans-geranyl-geranyl diphosphate. {ECO:0000269|PubMed:10816587, ECO:0000269|PubMed:11004176, ECO:0000269|PubMed:15516568}.",MARDARKRTSSNFPQLPPAPDDYPTFPDTSTWPVVFPELPAAPYGGPCRPPQHTSKAAAPRIPADRLPNHVAIVMDGNGRWATQRGLARTEGHKMGEAVVIDIACGAIELGIKWLSLYAFSTENWKRSPEEVRFLMGFNRDVVRRRRDTLKKLGVRIRWVGSRPRLWRSVINELAVAEEMTKSNDVITINYCVNYGGRTEITEATREIAREVAAGRLNPERITESTIARHLQRPDIPDVDLFLRTSGEQRSSNFMLWQAAYAEYIFQDKLWPDYDRRDLWAACEEYASRTRRFGSA,"33,791",296,UPP synthase family,growth [GO:0040007]; polyprenol biosynthetic process [GO:0016094],"di-trans,poly-cis-decaprenylcistransferase activity [GO:0008834]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; polyprenyltransferase activity [GO:0002094]; trans-octaprenyltranstransferase activity [GO:0050347]; Z-farnesyl diphosphate synthase activity [GO:0033850]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY27.19,1
P9WNS3,DXS_MYCTU,Rv2682c,dxs Rv2682c MTCY05A6.03c,GO:0000287; GO:0008661; GO:0009228; GO:0016114; GO:0019288; GO:0030145; GO:0030975; GO:0040007; GO:0052865,IPR005477; IPR029061; IPR009014; IPR005475; IPR020826; IPR033248; IPR005474; ,,dxs,,1-deoxy-D-xylulose-5-phosphate synthase (EC 2.2.1.7) (1-deoxyxylulose-5-phosphate synthase) (DXP synthase) (DXPS),"1-deoxy-D-xylulose-5-phosphate synthase activity [GO:0008661]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; thiamine binding [GO:0030975]; 1-deoxy-D-xylulose 5-phosphate biosynthetic process [GO:0052865]; growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]; thiamine biosynthetic process [GO:0009228]",9634230; 21969609,,FUNCTION: Catalyzes the acyloin condensation reaction between C atoms 2 and 3 of pyruvate and glyceraldehyde 3-phosphate to yield 1-deoxy-D-xylulose-5-phosphate (DXP). {ECO:0000255|HAMAP-Rule:MF_00315}.,MLQQIRGPADLQHLSQAQLRELAAEIREFLIHKVAATGGHLGPNLGVVELTLALHRVFDSPHDPIIFDTGHQAYVHKMLTGRSQDFATLRKKGGLSGYPSRAESEHDWVESSHASAALSYADGLAKAFELTGHRNRHVVAVVGDGALTGGMCWEALNNIAASRRPVIIVVNDNGRSYAPTIGGVADHLATLRLQPAYEQALETGRDLVRAVPLVGGLWFRFLHSVKAGIKDSLSPQLLFTDLGLKYVGPVDGHDERAVEVALRSARRFGAPVIVHVVTRKGMGYPPAEADQAEQMHSTVPIDPATGQATKVAGPGWTATFSDALIGYAQKRRDIVAITAAMPGPTGLTAFGQRFPDRLFDVGIAEQHAMTSAAGLAMGGLHPVVAIYSTFLNRAFDQIMMDVALHKLPVTMVLDRAGITGSDGASHNGMWDLSMLGIVPGIRVAAPRDATRLREELGEALDVDDGPTALRFPKGDVGEDISALERRGGVDVLAAPADGLNHDVLLVAIGAFAPMALAVAKRLHNQGIGVTVIDPRWVLPVSDGVRELAVQHKLLVTLEDNGVNGGAGSAVSAALRRAEIDVPCRDVGLPQEFYEHASRSEVLADLGLTDQDVARRITGWVAALGTGVCASDAIPEHLD,"67,885",638,"Transketolase family, DXPS subfamily","1-deoxy-D-xylulose 5-phosphate biosynthetic process [GO:0052865]; growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]; thiamine biosynthetic process [GO:0009228]",1-deoxy-D-xylulose-5-phosphate synthase activity [GO:0008661]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; thiamine binding [GO:0030975],,,MTCY05A6.03c,1
P9WNS5,DUT_MYCTU,Rv2697c,dut Rv2697c MTCY05A6.18c,GO:0000287; GO:0004170; GO:0006226; GO:0040007; GO:0046080; GO:0046081,IPR029054; IPR036157; IPR008181; IPR033704; ,,dut,,Deoxyuridine 5'-triphosphate nucleotidohydrolase (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase),dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; dUTP metabolic process [GO:0046080]; growth [GO:0040007],9634230; 21969609; 15276840,X-ray crystallography (15),"FUNCTION: This enzyme is involved in nucleotide metabolism: it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot be incorporated into DNA.",MSTTLAIVRLDPGLPLPSRAHDGDAGVDLYSAEDVELAPGRRALVRTGVAVAVPFGMVGLVHPRSGLATRVGLSIVNSPGTIDAGYRGEIKVALINLDPAAPIVVHRGDRIAQLLVQRVELVELVEVSSFDEAGLASTSRGDGGHGSSGGHASL,"15,803",154,DUTPase family,dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; dUTP metabolic process [GO:0046080]; growth [GO:0040007],dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287],,,MTCY05A6.18c,1
P9WNI7,ESXO_MYCTU,Rv2346c,esxO Rv2346c MTCY98.15c,GO:0005576; GO:0005618; GO:0005886; GO:0009405,IPR009416; IPR036689; IPR010310; ,,esxO,,ESAT-6-like protein EsxO,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 12919853; 17443846; 19876390; 21969609; 26786654; 24312350,X-ray crystallography (2),"FUNCTION: Plays an important role in mycobacterial pathogenesis in the context of innate immunity. Aids host cell invasion and intracellular bacillary persistence. Increases host oxidative stress response, leading to genomic instability and decrease in macrophage viability. Also induces autophagy and modulates the immune function of macrophages. {ECO:0000269|PubMed:26786654}.",MTINYQFGDVDAHGAMIRAQAGLLEAEHQAIVRDVLAAGDFWGGAGSVACQEFITQLGRNFQVIYEQANAHGQKVQAAGNNMAQTDSAVGSSWA,"9,954",94,"WXG100 family, ESAT-6 subfamily",pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY98.15c,1
P9WNK9,ERA_MYCTU,Rv2364c,era Rv2364c MTCY27.16,GO:0005525; GO:0005829; GO:0005886; GO:0016787; GO:0019843; GO:0040007; GO:0042254,IPR030388; IPR005662; IPR006073; IPR015946; IPR004044; IPR009019; IPR027417; IPR005225; ,,era,DOMAIN 5 176 Era-type G.; DOMAIN 207 286 KH type-2.,GTPase Era,cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; rRNA binding [GO:0019843]; growth [GO:0040007]; ribosome biogenesis [GO:0042254],9634230; 22578863; 20705052; 21969609,,"FUNCTION: An essential GTPase that binds both GDP and GTP, with rapid nucleotide exchange. Plays a role in 16S rRNA processing and 30S ribosomal subunit biogenesis and possibly also in cell cycle regulation and energy metabolism (By similarity). {ECO:0000250, ECO:0000269|PubMed:22578863}.",MTEFHSGFVCLVGRPNTGKSTLTNALVGAKVAITSTRPQTTRHAIRGIVHSDDFQIILVDTPGLHRPRTLLGKRLNDLVRETYAAVDVIGLCIPADEAIGPGDRWIVEQLRSTGPANTTLVVIVTKIDKVPKEKVVAQLVAVSELVTNAAEIVPVSAMTGDRVDLLIDVLAAALPAGPAYYPDGELTDEPEEVLMAELIREAALQGVRDELPHSLAVVIDEVSPREGRDDLIDVHAALYVERDSQKGIVIGKGGARLREVGTAARSQIENLLGTKVYLDLRVKVAKNWQRDPKQLGRLGF,"32,460",300,"TRAFAC class TrmE-Era-EngA-EngB-Septin-like GTPase superfamily, Era GTPase family",growth [GO:0040007]; ribosome biogenesis [GO:0042254],GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; rRNA binding [GO:0019843],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY27.16,1
P9WNI5,ESXP_MYCTU,Rv2347c,esxP Rv2347c MTCY98.16c,GO:0005576,IPR036689; IPR010310; ,,esxP,,ESAT-6-like protein EsxP,extracellular region [GO:0005576],9634230; 12919853; 19876390; 24312350,X-ray crystallography (2),,MATRFMTDPHAMRDMAGRFEVHAQTVEDEARRMWASAQNISGAGWSGMAEATSLDTMAQMNQAFRNIVNMLHGVRDGLVRDANNYEQQEQASQQILSS,"10,977",98,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,MTCY98.16c,1
P9WQK3,ETTA_MYCTU,Rv2477c,ettA Rv2477c,GO:0000049; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0016887; GO:0019843; GO:0040007; GO:0045900,IPR003593; IPR032781; IPR003439; IPR017871; IPR022374; IPR027417; ,,ettA,DOMAIN 6 256 ABC transporter 1. {ECO:0000255|PROSITE-ProRule:PRU00434}.; DOMAIN 322 539 ABC transporter 2. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Energy-dependent translational throttle protein EttA (Translational regulatory factor EttA),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; growth [GO:0040007]; negative regulation of translational elongation [GO:0045900]; translation [GO:0006412],9634230; 20001742; 20066036; 21969609,,"FUNCTION: A translation factor that gates the progression of the 70S ribosomal initiation complex (IC, containing tRNA(fMet) in the P site) into the translation elongation cycle by using a mechanism sensitive to the ATP/ADP ratio. Binds to the 70S ribosome E site where it modulates the state of the translating ribosome during subunit translocation (By similarity). {ECO:0000250}.",MAEFIYTMKKVRKAHGDKVILDDVTLSFYPGAKIGVVGPNGAGKSSVLRIMAGLDKPNNGDAFLATGATVGILQQEPPLNEDKTVRGNVEEGMGDIKIKLDRFNEVAELMATDYTDELMEEMGRLQEELDHADAWDLDAQLEQAMDALRCPPADEPVTNLSGGERRRVALCKLLLSKPDLLLLDEPTNHLDAESVQWLEQHLASYPGAILAVTHDRYFLDNVAEWILELDRGRAYPYEGNYSTYLEKKAERLAVQGRKDAKLQKRLTEELAWVRSGAKARQAKSKARLQRYEEMAAEAEKTRKLDFEEIQIPVGPRLGNVVVEVDHLDKGYDGRALIKDLSFSLPRNGIVGVIGPNGVGKTTLFKTIVGLETPDSGSVKVGETVKLSYVDQARAGIDPRKTVWEVVSDGLDYIQVGQTEVPSRAYVSAFGFKGPDQQKPAGVLSGGERNRLNLALTLKQGGNLILLDEPTNDLDVETLGSLENALLNFPGCAVVISHDRWFLDRTCTHILAWEGDDDNEAKWFWFEGNFGAYEENKVERLGVDAARPHRVTHRKLTRG,"61,893",558,"ABC transporter superfamily, ABCF family, Translational throttle EttA subfamily",growth [GO:0040007]; negative regulation of translational elongation [GO:0045900]; translation [GO:0006412],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WJB1,FLQE3_MYCTU,Rv2687c,Rv2687c,GO:0005886; GO:0015562; GO:0016021; GO:0046677; GO:0055085,,,,,Fluoroquinolones export permease protein Rv2687c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; efflux transmembrane transporter activity [GO:0015562]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 15273144,,"FUNCTION: Part of the ABC transporter complex Rv2686c/Rv2687c/Rv2688c involved in fluoroquinolones export. Confers resistance to ciprofloxacin and, to a lesser extent, norfloxacin, moxifloxacin and sparfloxacin. Probably responsible for the translocation of the substrate across the membrane. {ECO:0000269|PubMed:15273144}.",MTRLVPALRLELTLQVRQKFLHAAVFSGLIWLAVLLPMPVSLRPVAEPYVLVGDIAIIGFFFVGGTVFFEKQERTIGAIVSTPLRFWEYLAAKLTVLLAISLFVAVVVATIVHGLGYHLLPLVAGIVLGTLLMLLVGFSSSLPFASVTDWFLAAVIPLAIMLAPPVVHYSGLWPNPVLYLIPTQGPLLLLGAAFDQVSLAPWQVGYAVVYPIVCAAGLCRAAKALFGRYVVQRSGVL,"25,576",237,,response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],efflux transmembrane transporter activity [GO:0015562],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6Y0R5,FOLC_MYCTU,Rv2447c LH57_13380,folC Rv2447c LH57_13380,GO:0004326; GO:0005524; GO:0005737; GO:0008841; GO:0046654; GO:0046656; GO:0046677; GO:0046872,IPR001645; IPR018109; IPR036565; IPR004101; IPR036615; IPR013221; ,,folC,,Dihydrofolate synthase/folylpolyglutamate synthase (DHFS / FPGS) (EC 6.3.2.12) (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (Tetrahydrofolylpolyglutamate synthase),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; dihydrofolate synthase activity [GO:0008841]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; folic acid biosynthetic process [GO:0046656]; response to antibiotic [GO:0046677]; tetrahydrofolate biosynthetic process [GO:0046654],9634230; 12657046; 16754987; 21969609; 23779105; 23118010; 24366731; 18566510,X-ray crystallography (2),"FUNCTION: Catalyzes the addition of a glutamate residue to dihydropteroate (7,8-dihydropteroate or H2Pte) to form dihydrofolate (7,8-dihydrofolate monoglutamate or H2Pte-Glu) (PubMed:23118010). Also catalyzes successive additions of L-glutamate to tetrahydrofolate, leading to folylpolyglutamate derivatives (By similarity). {ECO:0000250|UniProtKB:P08192, ECO:0000269|PubMed:23118010}.; FUNCTION: Is involved in the bioactivation of the antituberculous drug para-aminosalicylic acid (PAS). Is able to use hydroxy-dihydropteroate (H2PtePAS) as substrate, which is the product formed by the action of DHPS (FolP1) on PAS, leading to hydroxy-dihydrofolate (H2PtePAS-Glu). This compound inhibits dihydrofolate reductase DHFR (DfrA), the next enzyme in the folate pathway, and thus disrupts the folate-dependent metabolic pathways. {ECO:0000269|PubMed:23118010, ECO:0000305|PubMed:23779105}.",MNSTNSGPPDSGSATGVVPTPDEIASLLQVEHLLDQRWPETRIDPSLTRISALMDLLGSPQRSYPSIHIAGTNGKTSVARMVDALVTALHRRTGRTTSPHLQSPVERISIDGKPISPAQYVATYREIEPLVALIDQQSQASAGKGGPAMSKFEVLTAMAFAAFADAPVDVAVVEVGMGGRWDATNVINAPVAVITPISIDHVDYLGADIAGIAGEKAGIITRAPDGSPDTVAVIGRQVPKVMEVLLAESVRADASVAREDSEFAVLRRQIAVGGQVLQLQGLGGVYSDIYLPLHGEHQAHNAVLALASVEAFFGAGAQRQLDGDAVRAGFAAVTSPGRLERMRSAPTVFIDAAHNPAGASALAQTLAHEFDFRFLVGVLSVLGDKDVDGILAALEPVFDSVVVTHNGSPRALDVEALALAAGERFGPDRVRTAENLRDAIDVATSLVDDAAADPDVAGDAFSRTGIVITGSVVTAGAARTLFGRDPQ,"50,779",487,Folylpolyglutamate synthase family,folic acid biosynthetic process [GO:0046656]; response to antibiotic [GO:0046677]; tetrahydrofolate biosynthetic process [GO:0046654],ATP binding [GO:0005524]; dihydrofolate synthase activity [GO:0008841]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326],cytoplasm [GO:0005737],,,1
P9WPX9,AROB_MYCTU,Rv2538c,aroB Rv2538c MTCY159.18,GO:0000166; GO:0003856; GO:0005507; GO:0005618; GO:0005829; GO:0005886; GO:0008270; GO:0009073; GO:0009423; GO:0040007,IPR016037; IPR030963; IPR030960; ,,aroB,,3-dehydroquinate synthase (DHQS) (EC 4.2.3.4),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-dehydroquinate synthase activity [GO:0003856]; copper ion binding [GO:0005507]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007],1910148; 9634230; 19099550; 21969609; ,X-ray crystallography (2),FUNCTION: Catalyzes the conversion of 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) to dehydroquinate (DHQ). {ECO:0000255|HAMAP-Rule:MF_00110}.,MTDIGAPVTVQVAVDPPYPVVIGTGLLDELEDLLADRHKVAVVHQPGLAETAEEIRKRLAGKGVDAHRIEIPDAEAGKDLPVVGFIWEVLGRIGIGRKDALVSLGGGAATDVAGFAAATWLRGVSIVHLPTTLLGMVDAAVGGKTGINTDAGKNLVGAFHQPLAVLVDLATLQTLPRDEMICGMAEVVKAGFIADPVILDLIEADPQAALDPAGDVLPELIRRAITVKAEVVAADEKESELREILNYGHTLGHAIERRERYRWRHGAAVSVGLVFAAELARLAGRLDDATAQRHRTILSSLGLPVSYDPDALPQLLEIMAGDKKTRAGVLRFVVLDGLAKPGRMVGPDPGLLVTAYAGVCAP,"38,119",362,"Sugar phosphate cyclases superfamily, Dehydroquinate synthase family",aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007],3-dehydroquinate synthase activity [GO:0003856]; copper ion binding [GO:0005507]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY159.18,1
P9WPY1,AROC_MYCTU,Rv2540c,aroC aroF Rv2540c MTCY159.16,GO:0004107; GO:0005829; GO:0009073; GO:0009423; GO:0010181; GO:0016651; GO:0040007; GO:0051287,IPR000453; IPR035904; IPR020541; ,,aroC,,Chorismate synthase (CS) (EC 4.2.3.5) (5-enolpyruvylshikimate-3-phosphate phospholyase),"cytosol [GO:0005829]; chorismate synthase activity [GO:0004107]; FMN binding [GO:0010181]; NAD binding [GO:0051287]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007]",9634230; 19099550; 21969609; 16459102; 23178456,X-ray crystallography (7),"FUNCTION: Catalyzes the anti-1,4-elimination of the C-3 phosphate and the C-6 proR hydrogen from 5-enolpyruvylshikimate-3-phosphate (EPSP) to yield chorismate, which is the branch point compound that serves as the starting substrate for the three terminal pathways of aromatic amino acid biosynthesis. This reaction introduces a second double bond into the aromatic ring system. {ECO:0000255|HAMAP-Rule:MF_00300}.",MLRWITAGESHGRALVAVVEGMVAGVHVTSADIADQLARRRLGYGRGARMTFERDAVTVLSGIRHGSTLGGPIAIEIGNTEWPKWETVMAADPVDPAELADVARNAPLTRPRPGHADYAGMLKYGFDDARPVLERASARETAARVAAGTVARAFLRQALGVEVLSHVISIGASAPYEGPPPRAEDLPAIDASPVRAYDKAAEADMIAQIEAAKKDGDTLGGVVEAVALGLPVGLGSFTSGDHRLDSQLAAAVMGIQAIKGVEIGDGFQTARRRGSRAHDEMYPGPDGVVRSTNRAGGLEGGMTNGQPLRVRAAMKPISTVPRALATVDLATGDEAVAIHQRSDVCAVPAAGVVVETMVALVLARAALEKFGGDSLAETQRNIAAYQRSVADREAPAARVSG,"41,792",401,Chorismate synthase family,aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007],"chorismate synthase activity [GO:0004107]; FMN binding [GO:0010181]; NAD binding [GO:0051287]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]",cytosol [GO:0005829],aroF,MTCY159.16,1
P9WQ07,APT_MYCTU,Rv2584c,apt Rv2584c MTCY227.17,GO:0003999; GO:0005737; GO:0005886; GO:0006166; GO:0006168; GO:0044209,IPR005764; IPR000836; IPR029057; ,,apt,,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; adenine phosphoribosyltransferase activity [GO:0003999]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],9634230; 21969609,,"FUNCTION: Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis. {ECO:0000255|HAMAP-Rule:MF_00004}.",MLNVIATGLSLKARGKRRRQRWVDDGRVLALGESRRSSAISVADVVASLTRDVADFPVPGVEFKDLTPLFADRRGLAAVTEALADRASGADLVAGVDARGFLVAAAVATRLEVGVLAVRKGGKLPRPVLSEEYYRAYGAATLEILAEGIEVAGRRVVIIDDVLATGGTIGATRRLLERGGANVAGAAVVVELAGLSGRAALAPLPVHSLSRL,"22,040",212,Purine/pyrimidine phosphoribosyltransferase family,adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],adenine phosphoribosyltransferase activity [GO:0003999],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY227.17,2
P9WPY3,AROK_MYCTU,Rv2539c,aroK Rv2539c MTCY159.17,GO:0000287; GO:0004765; GO:0005524; GO:0005829; GO:0009073; GO:0009423; GO:0019632; GO:0040007,IPR027417; IPR031322; IPR000623; IPR023000; ,,aroK,,Shikimate kinase (SK) (EC 2.7.1.71),cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; shikimate kinase activity [GO:0004765]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007]; shikimate metabolic process [GO:0019632],11483005; 9634230; 11717501; 19099550; 21969609; 12054870; 15583379; 15358538; 16834327; 17020768; 17183161,X-ray crystallography (21),"FUNCTION: Catalyzes the specific phosphorylation of the 3-hydroxyl group of shikimic acid using ATP as a cosubstrate. {ECO:0000269|PubMed:11483005, ECO:0000269|PubMed:17020768}.",MAPKAVLVGLPGSGKSTIGRRLAKALGVGLLDTDVAIEQRTGRSIADIFATDGEQEFRRIEEDVVRAALADHDGVLSLGGGAVTSPGVRAALAGHTVVYLEISAAEGVRRTGGNTVRPLLAGPDRAEKYRALMAKRAPLYRRVATMRVDTNRRNPGAVVRHILSRLQVPSPSEAAT,"18,583",176,Shikimate kinase family,aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423]; growth [GO:0040007]; shikimate metabolic process [GO:0019632],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; shikimate kinase activity [GO:0004765],cytosol [GO:0005829],,MTCY159.17,1
P9WMK9,AP4A_MYCTU,Rv2613c,Rv2613c,GO:0003877; GO:0005524; GO:0005886; GO:0008796; GO:0015967; GO:0040007,IPR001310; IPR011146; IPR036265; ,,,DOMAIN 57 166 HIT. {ECO:0000255|PROSITE-ProRule:PRU00464}.,"AP-4-A phosphorylase (EC 2.7.7.53) (ATP adenylyltransferase) (Diadenosine 5',5'''-P1,P4-tetraphosphate phosphorylase) (AP,A phosphorylase)",plasma membrane [GO:0005886]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase activity [GO:0008796]; diadenosine tetraphosphate catabolic process [GO:0015967]; growth [GO:0040007],9634230; 12368430; 19778616; 19099550; 21969609; 21565198,X-ray crystallography (2),"FUNCTION: Catabolizes diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) into ADP and ATP. It does not catalyze the reverse phosphorolysis reaction. The optimum substrates are dinucleoside polyphosphates containing four or five phosphate residues. {ECO:0000269|PubMed:19778616, ECO:0000269|PubMed:21565198}.",MSDEDRTDRATEDHTIFDRGVGQRDQLQRLWTPYRMNYLAEAPVKRDPNSSASPAQPFTEIPQLSDEEGLVVARGKLVYAVLNLYPYNPGHLMVVPYRRVSELEDLTDLESAELMAFTQKAIRVIKNVSRPHGFNVGLNLGTSAGGSLAEHLHVHVVPRWGGDANFITIIGGSKVIPQLLRDTRRLLATEWARQP,"21,869",195,,diadenosine tetraphosphate catabolic process [GO:0015967]; growth [GO:0040007],ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase activity [GO:0008796],plasma membrane [GO:0005886],,,1
P9WQ03,ARCH_MYCTU,Rv2630,Rv2630,GO:0008033; GO:0046872,IPR023572; IPR036820; ,,,,Probable protein archease,metal ion binding [GO:0046872]; tRNA processing [GO:0008033],9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,"FUNCTION: Activates the tRNA-splicing ligase complex by facilitating the enzymatic turnover of catalytic subunit RtcB. Acts by promoting the guanylylation of RtcB, a key intermediate step in tRNA ligation. Can also alter the NTP specificity of RtcB such that ATP, dGTP or ITP is used efficiently (By similarity). {ECO:0000250}.",MLHRDDHINPPRPRGLDVPCARLRATNPLRALARCVQAGKPGTSSGHRSVPHTADLRIEAWAPTRDGCIRQAVLGTVESFLDLESAHAVHTRLRRLTADRDDDLLVAVLEEVIYLLDTVGETPVDLRLRDVDGGVDVTFATTDASTLVQVGAVPKAVSLNELRFSQGRHGWRCAVTLDV,"19,566",179,Archease family,tRNA processing [GO:0008033],metal ion binding [GO:0046872],,,,1
P9WJW9,Y2459_MYCTU,Rv2459,Rv2459,GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv2459,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MTPRQRLTVLATGLGIFMVFVDVNIVNVALPSIQKVFHTGEQGLQWAVAGYSLGMAAVLMSCALLGDRYGRRRSFVFGVTLFVVSSIVCVLPVSLAVFTVARVIQGLGAAFISVLSLALLSHSFPNPRMKARAISNWMAIGMVGAASAPALGGLMVDGLGWRSVFLVNVPLGAIVWLLTLVGVDESQDPEPTQLDWVGQLTLIPAVALIAYTIIEAPRFDRQSAGFVAALLLAAGVLLWLFVRHEHRAAFPLVDLKLFAEPLYRSVLIVYFVVMSCFFGTLMVITQHFQNVRDLSPLHAGLMMLPVPAGFGVASLLAGRAVNKWGPQLPVLTCLAAMFIGLAIFAISMDHAHPVALVGLTIFGAGAGGCATPLLHLGMTKVDDGRAGMAAGMLNLQRSLGGIFGVAFLGTIVAAWLGAALPNTMADEIPDPIARAIVVDVIVDSANPHAHAAFIGPGHRITAAQEDEIVLAADAVFVSGIKLALGGAAVLLTGAFVLGWTRFPRTPAS,"53,479",508,Major facilitator superfamily,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WFP9,Y2556_MYCTU,Rv2556c,Rv2556c MTCY9C4.12,GO:0005618,IPR001602; IPR035917; ,,,,UPF0047 protein Rv2556c,cell wall [GO:0005618],9634230; 21969609,,,MDTDVLDVDTARRRIVDLTDAVRAFCTAHDDGLCNVFVPHATAGVAIIETGAGSDEDLVDTLVRLLPRDDRYRHAHGSYGHGADHLLPAFVAPSVTVPVSGGQPLLGTWQSIVLVDLNQDNPRRSVRLSFVEG,"14,355",133,UPF0047 family,,,cell wall [GO:0005618],,MTCY9C4.12,2
P9WL91,Y2570_MYCTU,Rv2570,Rv2570 MTCY227.31c,,,,,,Uncharacterized protein Rv2570,,9634230,,,MATWDDVARIVGGLPLTAEQAPHDWRVGRKLLAWERPLRKSDREALTRAGSEPPSGDIVGVRVSDEGVKFALIADEPGVYFTTPHFDGYPAVLVRLAEIEVRDLEELITEAWLMQAPKQLVQAFLANSG,"14,264",129,,,,,,MTCY227.31c,1
P9WL85,Y2575_MYCTU,Rv2575,Rv2575 MTCY227.26c,GO:0005576; GO:0016021,IPR007343; ,,,,Uncharacterized protein Rv2575,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MTFNEGVQIDTSTTSTSGSGGGRRLAIGGGLGGLLVVVVAMLLGVDPGGVLSQQPLDTRDHVAPGFDLSQCRTGADANRFVQCRVVATGNSVDAVWKPLLPGYTRPHMRLFSGQVGTGCGPASSEVGPFYCPVDKTAYFDTDFFQVLVTQFGSSGGPFAEEYVVAHEYGHHVQNLLGVLGRAQQGAQGAAGSGVRTELQADCYAGVWAYYASTVKQESTGVPYLEPLSDKDIQDALAAAAAVGDDRIQQQTTGRTNPETWTHGSAAQRQKWFTVGYQTGDPNICDTFSAADLG,"30,806",293,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,MTCY227.26c,1
P9WMW3,Y2581_MYCTU,Rv2581c,Rv2581c MTCY227.20,GO:0016787; GO:0046872,IPR001279; IPR036866; ,,,,Uncharacterized protein Rv2581c (EC 3.-.-.-),hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 21969609,,,MLITGFPAGLLACNCYVLAERPGTDAVIVDPGQGAMGTLRRILDKNRLTPAAVLLTHGHIDHIWSAQKVSDTFGCPTYVHPADRFMLTDPIYGLGPRIAQLVAGAFFREPKQVVELDRDGDKIDLGGISVNIDHTPGHTRGSVVFRVLQATNNDKDIVFTGDTLFERAIGRTDLAGGSGRDLLRSIVDKLLVLDDSTVVLPGHGNSTTIGAERRFNPFLEGLSR,"24,198",224,"Metallo-beta-lactamase superfamily, Glyoxalase II family",,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,MTCY227.20,1
P9WL77,Y2585_MYCTU,Rv2585c,Rv2585c MTCY227.16,GO:0005576; GO:0005829; GO:0005886; GO:0030288,IPR000914; ,,,,Uncharacterized lipoprotein Rv2585c,cytosol [GO:0005829]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],9634230; 21969609,,,MAPRRRRHTRIAGLRVVGTATLVAATTLTACSGSAAAQIDYVVDGALVTYNTNTVIGAASAGAQAFARTLTGFGYHGPDGQVVADRDFGTVSVVEGSPLILDYQISDDAVYSDGRPVTCDDLVLAWAAQSGRFPGFDAATQAGYVDIANIECTAGQKKARVSFIPDRSVVDHSQLFTATSLMPSHVIADQLHIDVTAALLSNNVSAVEQIARLWNSTWDLKPGRSHDEVRSRFPSSGPYKIESVLDDGAVVLVANDRWWGTKAITKRITVWPQGADIQDRVNNRSVDVVDVAAGSSGSLVTPDSYQRTDYPSAGIEQLIFAPQGSLAQSRTRRALALCVPRDAIARDAGVPIANSRLSPATDDALTDADGAAEARQFGRVDPAAARDALGGTPLTVRIGYGRPNARLAATIGTIADACAPAGITVSDVTVDTPGPQALRDGKIDVLLASTGGATGSGSSGSCAMDAYDLHSGNGNNLSGYANAQIDGIISALAVSADPAERARLLAEAAPVLWDEMPTLPLYRQQRTLLMSTKMYAVSRNPTRWGAGWNMDRWALAR,"58,635",557,,,,cytosol [GO:0005829]; extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,MTCY227.16,1
P9WFD5,Y2624_MYCTU,Rv2624c,Rv2624c,GO:0005886; GO:0006950,IPR006015; IPR006016; ,,,,Universal stress protein Rv2624c (USP Rv2624c),plasma membrane [GO:0005886]; response to stress [GO:0006950],9634230; 11416222; 12953092; 18474359; 18400743; 20066036; 21969609,,,MSGRGEPTMKTIIVGIDGSHAAITAALWGVDEAISRAVPLRLVSVIKPTHPSPDDYDRDLAHAERSLREAQSAVEAAGKLVKIETDIPRGPAGPVLVEASRDAEMICVGSVGIGRYASSILGSTATELAEKAHCPVAVMRSKVDQPASDINWIVVRMTDAPDNEAVLEYAAREAKLRQAPILALGGRPEELREIPDGEFERRVQDWHHRHPDVRVYPITTHTGIARFLADHDERVQLAVIGGGEAGQLARLVGPSGHPVFRHAECSVLVVRR,"29,400",272,Universal stress protein A family,response to stress [GO:0006950],,plasma membrane [GO:0005886],,,1
P9WL59,Y2633_MYCTU,Rv2633c,Rv2633c MTCY441.03c,,IPR012312; ,,,,Uncharacterized protein Rv2633c,,9634230; 21969609,,,MNAYDVLKRHHTVLKGLGRKVGEAPVNSEERHVLFDEMLIELDIHFRIEDDLYYPALSAAGKPITGTHAEHRQVVDQLATLLRTPQRAPGYEEEWNVFRTVLEAHADVEERDMIPAPTPVHITDAELEELGDKMAARIEQLRGSPLYTLRTKGKADLLKAI,"18,242",161,,,,,,MTCY441.03c,1
P9WJ13,Y2653_MYCTU,Rv2653c,Rv2653c,GO:0045926,,,,,Toxin Rv2653c,negative regulation of growth [GO:0045926],9634230; 20011113,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin Rv2654c. {ECO:0000269|PubMed:20011113}.,MTHKRTKRQPAIAAGLNAPRRNRVGRQHGWPADVPSAEQRRAQRQRDLEAIRRAYAEMVATSHEIDDDTAELALLSMHLDDEQRRLEAGMKLGWHPYHFPDEPDSKQ,"12,360",107,,negative regulation of growth [GO:0045926],,,,,1
P9WGV7,YQGF_MYCTU,Rv2554c,Rv2554c MTCY159.02,GO:0000967; GO:0004518; GO:0005829; GO:0040007,IPR012337; IPR005227; IPR006641; IPR037027; ,,,,Putative pre-16S rRNA nuclease (EC 3.1.-.-),cytosol [GO:0005829]; nuclease activity [GO:0004518]; growth [GO:0040007]; rRNA 5'-end processing [GO:0000967],9634230; 19099550; 21969609,,FUNCTION: Could be a nuclease involved in processing of the 5'-end of pre-16S rRNA. {ECO:0000255|HAMAP-Rule:MF_00651}.,MVPAQHRPPDRPGDPAHDPGRGRRLGIDVGAARIGVACSDPDAILATPVETVRRDRSGKHLRRLAALAAELEAVEVIVGLPRTLADRIGRSAQDAIELAEALARRVSPTPVRLADERLTTVSAQRSLRQAGVRASEQRAVIDQAAAVAILQSWLDERLAAMAGTQEGSDA,"18,065",170,YqgF nuclease family,growth [GO:0040007]; rRNA 5'-end processing [GO:0000967],nuclease activity [GO:0004518],cytosol [GO:0005829],,MTCY159.02,1
P9WN85,ZUR_MYCTU,Rv2359,zur fur-2 furB Rv2359,GO:0000976; GO:0001217; GO:0005737; GO:0005886; GO:0006351; GO:0008270; GO:0010043; GO:0032993; GO:0042803; GO:0045892; GO:0045893,IPR002481; IPR036388; IPR036390; ,,zur,,Zinc uptake regulation protein (Zinc uptake regulator),"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; response to zinc ion [GO:0010043]; transcription, DNA-templated [GO:0006351]",9634230; 15059632; 16077132; 17098899; 21969609; 17213192,X-ray crystallography (1),"FUNCTION: Global transcriptional regulator involved in zinc homeostasis. Represses the transcription of at least 32 genes, including genes involved in zinc homeostasis, by binding to promoter sequences that contain a conserved 26 bp palindrome, in the presence of zinc. {ECO:0000269|PubMed:17098899}.",MSAAGVRSTRQRAAISTLLETLDDFRSAQELHDELRRRGENIGLTTVYRTLQSMASSGLVDTLHTDTGESVYRRCSEHHHHHLVCRSCGSTIEVGDHEVEAWAAEVATKHGFSDVSHTIEIFGTCSDCRS,"14,398",130,Fur family,"negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; response to zinc ion [GO:0010043]; transcription, DNA-templated [GO:0006351]","bacterial-type RNA polymerase transcriptional repressor activity, sequence-specific DNA binding [GO:0001217]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]",cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993],fur-2 furB,,1
P9WGX9,YBEY_MYCTU,Rv2367c,ybeY Rv2367c MTCY27.13,GO:0004222; GO:0004519; GO:0005737; GO:0006364; GO:0046872,IPR023091; IPR002036; IPR020549; ,,ybeY,,Endoribonuclease YbeY (EC 3.1.-.-),cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; rRNA processing [GO:0006364],9634230; 21969609,,FUNCTION: Single strand-specific metallo-endoribonuclease involved in late-stage 70S ribosome quality control and in maturation of the 3' terminus of the 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_00009}.,MSIEVANESGIDVSEAELVSVARFVIAKMDVNPCAELSMLLLDTAAMADLHMRWMDLPGPTDVMSFPMDELEPGGRPDAPEPGPSMLGDIVLCPEFAAEQAAAAGHSLGHELALLTIHGVLHLLGYDHAEPDEEKEMFALQDRLLEEWVADQVEAYQHDRQDEKDRRLLDKSRYFDL,"19,656",177,Endoribonuclease YbeY family,rRNA processing [GO:0006364],endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],cytoplasm [GO:0005737],,MTCY27.13,1
P9WG55,TIG_MYCTU,Rv2462c,tig Rv2462c MTV008.18c,GO:0003755; GO:0005618; GO:0005829; GO:0005886; GO:0006457; GO:0007049; GO:0009267; GO:0015031; GO:0046677; GO:0051301,IPR005215; IPR008880; IPR037041; IPR008881; IPR036611; IPR027304; ,,tig,DOMAIN 162 243 PPIase FKBP-type.,Trigger factor (TF) (EC 5.2.1.8) (PPIase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to starvation [GO:0009267]; protein folding [GO:0006457]; protein transport [GO:0015031]; response to antibiotic [GO:0046677],9634230; 21969609,,FUNCTION: Involved in protein export. Acts as a chaperone by maintaining the newly synthesized protein in an open conformation. Functions as a peptidyl-prolyl cis-trans isomerase (By similarity). {ECO:0000250}.,MKSTVEQLSPTRVRINVEVPFAELEPDFQRAYKELAKQVRLPGFRPGKAPAKLLEARIGREAMLDQIVNDALPSRYGQAVAESDVQPLGRPNIEVTKKEYGQDLQFTAEVDIRPKISPPDLSALTVSVDPIEIGEDDVDAELQSLRTRFGTLTAVDRPVAVGDVVSIDLSATVDGEDIPNAAAEGLSHEVGSGRLIAGLDDAVVGLSADESRVFTAKLAAGEHAGQEAQVTVTVRSVKERELPEPDDEFAQLASEFDSIDELRASLSDQVRQAKRAQQAEQIRNATIDALLEQVDVPLPESYVQAQFDSVLHSALSGLNHDEARFNELLVEQGSSRAAFDAEARTASEKDVKRQLLLDALADELQVQVGQDDLTERLVTTSRQYGIEPQQLFGYLQERNQLPTMFADVRRELAIRAAVEAATVTDSDGNTIDTSEFFGKRVSAGEAEEAEPADEGAARAASDEATT,"50,616",466,"FKBP-type PPIase family, Tig subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to starvation [GO:0009267]; protein folding [GO:0006457]; protein transport [GO:0015031]; response to antibiotic [GO:0046677],peptidyl-prolyl cis-trans isomerase activity [GO:0003755],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV008.18c,1
O53182,KORA_MYCTU,Rv2455c,korA Rv2455c,GO:0005618; GO:0005886; GO:0006099; GO:0006979; GO:0016491; GO:0047553,IPR022367; IPR033412; IPR019752; IPR002880; IPR002869; IPR029061; IPR009014; ,,korA,,2-oxoglutarate oxidoreductase subunit KorA (EC 1.2.7.3) (Alpha-ketoglutarate oxidoreductase subunit alpha/gamma) (KG oxidoreductase subunit alpha/gamma) (KGO subunit alpha/gamma) (KOR subunit alpha/gamma),cell wall [GO:0005618]; plasma membrane [GO:0005886]; 2-oxoglutarate synthase activity [GO:0047553]; oxidoreductase activity [GO:0016491]; response to oxidative stress [GO:0006979]; tricarboxylic acid cycle [GO:0006099],9634230; 19936047; 21969609,,"FUNCTION: Component of KG oxidoreductase (KOR) that catalyzes the CoA-dependent oxidative decarboxylation of 2-oxoglutarate (alpha-ketoglutarate, KG) to succinyl-CoA. Methyl viologen can act as electron acceptor in vitro; the physiologic electron acceptor is unknown. Is involved in the alternative TCA pathway that functions concurrently with fatty acid beta-oxidation. Since a growing body of evidence indicates that lipids (for example cholesterol and fatty acids) are a predominant growth substrate for M.tuberculosis during infection, flux through KOR likely represents an important step in intermediary metabolism in vivo. KOR-dependent decarboxylation of KG also appears to be an important source of CO(2) in M.tuberculosis metabolism. {ECO:0000269|PubMed:19936047}.",MDPNGSGAGPESHDAAFHAAPDRQRLENVVIRFAGDSGDGMQLTGDRFTSEAALFGNDLATQPNYPAEIRAPAGTLPGVSSFQIQIADYDILTAGDRPDVLVAMNPAALKANIGDLPLGGMVIVNSDEFTKRNLTKVGYVTNPLESGELSDYVVHTVAMTTLTLGAVEAIGASKKDGQRAKNMFALGLLSWMYGRELEHSEAFIREKFARKPEIAEANVLALKAGWNYGETTEAFGTTYEIPPATLPPGEYRQISGNTALAYGIVVAGQLAGLPVVLGSYPITPASDILHELSKHKNFNVVTFQAEDEIGGICAALGAAYGGALGVTSTSGPGISLKSEALGLGVMTELPLLVIDVQRGGPSTGLPTKTEQADLLQALYGRNGESPVAVLAPRSPADCFETALEAVRIAVSYHTPVILLSDGAIANGSEPWRIPDVNALPPIKHTFAKPGEPFQPYARDRETLARQFAIPGTPGLEHRIGGLEAANGSGDISYEPTNHDLMVRLRQAKIDGIHVPDLEVDDPTGDAELLLIGWGSSYGPIGEACRRARRRGTKVAHAHLRYLNPFPANLGEVLRRYPKVVAPELNLGQLAQVLRGKYLVDVQSVTKVKGVSFLADEIGRFIRAALAGRLAELEQDKTLVARLSAATAGAGANG,"69,182",653,,response to oxidative stress [GO:0006979]; tricarboxylic acid cycle [GO:0006099],2-oxoglutarate synthase activity [GO:0047553]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
P9WFS9,SYV_MYCTU,Rv2448c,valS Rv2448c MTV008.04c,GO:0002161; GO:0004832; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006438; GO:0040007,IPR001412; IPR002300; IPR033705; IPR013155; IPR014729; IPR010978; IPR009080; IPR037118; IPR019499; IPR009008; IPR002303; ,,valS,,Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; growth [GO:0040007]; valyl-tRNA aminoacylation [GO:0006438],9634230; 21969609,,"FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As ValRS can inadvertently accommodate and process structurally similar amino acids such as threonine, to avoid such errors, it has a ""posttransfer"" editing activity that hydrolyzes mischarged Thr-tRNA(Val) in a tRNA-dependent manner. {ECO:0000255|HAMAP-Rule:MF_02004}.",MTASPHPAADMLPKSWDPAAMESAIYQKWLDAGYFTADPTSTKPAYSIVLPPPNVTGSLHMGHALEHTMMDALTRRKRMQGYEVLWQPGTDHAGIATQSVVEQQLAVDGKTKEDLGRELFVDKVWDWKRESGGAIGGQMRRLGDGVDWSRDRFTMDEGLSRAVRTIFKRLYDAGLIYRAERLVNWSPVLQTAISDLEVNYRDVEGELVSFRYGSLDDSQPHIVVATTRVETMLGDTAIAVHPDDERYRHLVGTSLAHPFVDRELAIVADEHVDPEFGTGAVKVTPAHDPNDFEIGVRHQLPMPSILDTKGRIVDTGTRFDGMDRFEARVAVRQALAAQGRVVEEKRPYLHSVGHSERSGEPIEPRLSLQWWVRVESLAKAAGDAVRNGDTVIHPASMEPRWFSWVDDMHDWCISRQLWWGHRIPIWYGPDGEQVCVGPDETPPQGWEQDPDVLDTWFSSALWPFSTLGWPDKTAELEKFYPTSVLVTGYDILFFWVARMMMFGTFVGDDAAITLDGRRGPQVPFTDVFLHGLIRDESGRKMSKSKGNVIDPLDWVEMFGADALRFTLARGASPGGDLAVSEDAVRASRNFGTKLFNATRYALLNGAAPAPLPSPNELTDADRWILGRLEEVRAEVDSAFDGYEFSRACESLYHFAWDEFCDWYLELAKTQLAQGLTHTTAVLAAGLDTLLRLLHPVIPFLTEALWLALTGRESLVSADWPEPSGISVDLVAAQRINDMQKLVTEVRRFRSDQGLADRQKVPARMHGVRDSDLSNQVAAVTSLAWLTEPGPDFEPSVSLEVRLGPEMNRTVVVELDTSGTIDVAAERRRLEKELAGAQKELASTAAKLANADFLAKAPDAVIAKIRDRQRVAQQETERITTRLAALQ,"98,800",886,"Class-I aminoacyl-tRNA synthetase family, ValS type 1 subfamily",growth [GO:0040007]; valyl-tRNA aminoacylation [GO:0006438],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV008.04c,2
I6XF25,I6XF25_MYCTU,Rv2691,ceoB Rv2691,GO:0005886; GO:0015079,IPR006036; IPR036291; IPR006037; IPR036721; IPR003148; ,,ceoB,,TRK system potassium uptake protein CeoB,plasma membrane [GO:0005886]; potassium ion transmembrane transporter activity [GO:0015079],9634230; 21969609,,,MRVVVMGCGRVGASVADGLSRIGHEVAIIDRDSAAFNRLSPQFAGERVLGQGFDRDVLLRAGIQGADAFAAVSSGDNSNIISARLARETFGVPRVVARIYDAKRAEVYERLGIPTITTVPWTTDRLLNALMQDTETAKWRDPTGTVAVAEVVLHEDWVGHRATDLEQATGARIAFLIRFGTGVLPEPKTVLQAGDKVYIAAISGRAAEAAAIAALPPSEDFESGARR,"24,240",227,,,potassium ion transmembrane transporter activity [GO:0015079],plasma membrane [GO:0005886],,,1
O53214,O53214_MYCTU,Rv2489c,Rv2489c,,,,,,Hypothetical alanine rich protein,,9634230,,,MGVTAKAAEAAAPSSSFPSLRKPHRAGDSADRSAGDFDGTAHDAVVSVLAGDAASTGGLTIASGQHGHCRSAAMARRSPNASTKARRTHGPAAKRFRAI,"9,952",99,,,,,,,3
I6Y0X0,I6Y0X0_MYCTU,Rv2505c,fadD35 Rv2505c,GO:0008152; GO:0016874,IPR025110; IPR000873; ,,fadD35,,Probable fatty-acid-CoA ligase FadD35 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874]; metabolic process [GO:0008152],9634230; 21969609,,,MAAAEVVDPNRLSYDRGPSAPSLLESTIGANLAATAARYGHREALVDMVARRRFNYSELLTDVHRLATGLVRAGIGPGDRVGIWAPNRWEWVLVQYATAEIGAILVTINPAYRVREVEYALRQSGVAMVIAVASFKDADYAAMLAEVGPRCPDLADVILLESDRWDALAGAEPDLPALQQTAARLDGSDPVNIQYTSGTTAYPKGVTLSHRNILNNGYLVGELLGYTAQDRICIPVPFYHCFGMVMGNLAATSHGAAMVIPAPGFDPAATLRAVQDERCTSLYGVPTMFIAELGLPDFTDYELGSLRTGIMAGAACPVEVMRKVISRMHMPGVSICYGMTETSPVSTQTRADDSVDRRVGTVGRVGPHLEIKVVDPATGETVPRGVVGEFCTRGYSVMAGYWNDPQKTAEVIDADGWMHTGDLAEMDPSGYVRIAGRIKDLVVRGGENISPREIEELLHTHPDIVDGHVIGVPDAKYGEELMAVVKLRNDAPELTIERLREYCMGRIARFKIPRYLWIVDEFPMTVTGKVRKVEMRQQALEYLRGQQ,"59,778",547,,metabolic process [GO:0008152],ligase activity [GO:0016874],,,,1
P71906,P71906_MYCTU,Rv2443,dctA Rv2443,GO:0005576; GO:0015293; GO:0016021,IPR001991; IPR036458; ,,dctA,,Probable C4-dicarboxylate-transport transmembrane protein DctA,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; symporter activity [GO:0015293],9634230,,,MTAPLDRAPVTDLPANNKGRDRTHWLYLAVIFAVIAGVIVGLTAPSTGKSLTVLGTVFVNLIKMMIAPVIFCTIVLGIGSVRKAAAVGKVGGLALAYFLTMSSVALGIGLIVGNLLSPGRDLHLRPGAVGSGAALAGQAAESHGIAGFIQQIIPRSLPSALTEGNVLQVLLVALLVGFAVQGLGPAGESILRAVENLQKLVFKVLVMVLWLAPIGAFGAIANIVATTGFNAVTNLLLLMAGFYLTCVVFVFGVLGVLLRIVSGLSIFRLLRYLAREYLLIFATSSSEVVLPRLITKMKHLGVQSSTVGVVVPTGYSFNLDGTAIYLTMASLFIADAMGHRLTWGEQIALLAFMIIASKGAAGVSGAGLATLAGGLQAHRPELLDGVGLIVGIDRFMSEARSLTNFSGNAVATILVASWTKTIDLSKADEVLRGRDPFDESTMVDPHDEEPPAATPHGGGVPTNPALCDFEQVSLGGLVGRPAGPQRADVDG,"50,988",491,Dicarboxylate/amino acid:cation symporter (DAACS) (TC 2.A.23) family,,symporter activity [GO:0015293],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
I6YA32,I6YA32_MYCTU,Rv2719c,Rv2719c,GO:0016021,IPR018392; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MTPVRPPHTPDPLNLRGPLDGPRWRRAEPAQSRRPGRSRPGGAPLRYHRTGVGMSRTGHGSRPVPPATTVGLALLAAAITLWLGLVAQFGQMITGGSADGSADSTGRVPDRLAVVRVETGESLYDVAVRVAPNAPTRQVADRIRELNGLQTPALAVGQTLIAPVG,"17,324",165,,,,integral component of membrane [GO:0016021],,,1
I6YA29,I6YA29_MYCTU,Rv2714,Rv2714,,IPR008492; IPR019151; IPR038389; ,,,,Conserved alanine and leucine rich protein,,9634230; 21969609,,,MARDQGADEAREYEPGQPGMYELEFPAPQLSSSDGRGPVLVHALEGFSDAGHAIRLAAAHLKAALDTELVASFAIDELLDYRSRRPLMTFKTDHFTHSDDPELSLYALRDSIGTPFLLLAGLEPDLKWERFITAVRLLAERLGVRQTIGLGTVPMAVPHTRPITMTAHSNNRELISDFQPSISEIQVPGSASNLLEYRMAQHGHEVVGFTVHVPHYLTQTDYPAAAQALLEQVAKTGSLQLPLAVLAEAAAEVQAKIDEQVQASAEVAQVVAALERQYDAFIDAQENRSLLTRDEDLPSGDELGAEFERFLAQQAEKKSDDDPT,"35,520",324,,,,,,,1
O86327,O86327_MYCTU,Rv2420c,rsfS Rv2420c,GO:0005737; GO:0017148; GO:0042256; GO:0042802; GO:0043023; GO:0090071,IPR004394; ,Itself,rsfS,,Ribosomal silencing factor RsfS,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; ribosomal large subunit binding [GO:0043023]; mature ribosome assembly [GO:0042256]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148],9634230; 21969609; 26299947,X-ray crystallography (1),"FUNCTION: Functions as a ribosomal silencing factor. Interacts with ribosomal protein L14 (rplN), blocking formation of intersubunit bridge B8. Prevents association of the 30S and 50S ribosomal subunits and the formation of functional ribosomes, thus repressing translation. {ECO:0000256|HAMAP-Rule:MF_01477}.",MTANREAIDMARVAAGAAAAKLADDVVVIDVSGQLVITDCFVIASGSNERQVNAIVDEVEEKMRQAGYRPARREGAREGRWTLLDYRDIVVHIQHQDDRNFYALDRLWGDCPVVPVDLSANSAGAQ,"13,827",126,Iojap/RsfS family,mature ribosome assembly [GO:0042256]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of translation [GO:0017148],identical protein binding [GO:0042802]; ribosomal large subunit binding [GO:0043023],cytoplasm [GO:0005737],,,1
P71905,P71905_MYCTU,Rv2444c,rne Rv2444c,GO:0003723; GO:0004540; GO:0005618; GO:0005737; GO:0005829; GO:0005886; GO:0006364; GO:0040007,IPR012340; IPR019307; IPR004659; IPR022967; IPR003029; ,,rne,,Possible ribonuclease E Rne,cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; growth [GO:0040007]; rRNA processing [GO:0006364],9634230; 21969609,,,MIDGAPPSDPPEPSQHEELPDRLRVHSLARTLGTTSRRVLDALTALDGRVRSAHSTVDRVDAVRVRDLLATHLETAGVLAASVHAPEASEEPESRLMLETQETRNADVERPHYMPLFVAPQPIPEPLADDEDVDDGPDYVADDSDADDEGQLDRPANRRRRRGRRGRGRGRGEQGGSDGDPVDQQSEPRAQQFTSADAAETDDGDDRDSEDTEAGDNGEDENGSLEAGNRRRRRRRRRKSASGDDNDAALEGPLPDDPPNTVVHERVPRAGDKAGNSQDGGSGSTEIKGIDGSTRLEAKRQRRRDGRDAGRRRPPVLSEAEFLARREAVERVMVVRDRVRTEPPLPGTRYTQIAVLEDGIVVEHFVTSAASASLVGNIYLGIVQNVLPSMEAAFVDIGRGRNGVLYAGEVNWDAAGLGGADRKIEQALKPGDYVVVQVSKDPVGHKGARLTTQVSLAGRFLVYVPGASSTGISRKLPDTERQRLKEILREVVPSDAGVIIRTASEGVKEDDIRADVARLRERWEQIEAKAQETKEKAAGAAVALYEEPDVLVKVIRDLFNEDFVGLIVSGDEAWNTINEYVNSVAPELVSKLTKYESADGPDGQSAPDVFTVHRIDEQLAKAMDRKVWLPSGGTLVIDRTEAMTVIDVNTGKFTGAGGNLEQTVTKNNLEAAEEIVRQLRLRDIGGIVVIDFIDMVLESNRDLVLRRLTESLARDRTRHQVSEVTSLGLVQLTRKRLGTGLIEAFSTSCPNCSGRGILLHADPVDSAAATGRKSEPGARRGKRSKKSRSEESSDRSMVAKVPVHAPGEHPMFKAMAAGLSSLAGRGDEESGEPAAELAEQAGDQPPTDLDDTAQADFEDTEDTDEDEDELDADEDLEDLDDEDLDEDLDVEDSDSDDEDSDEDAADADVDEEDAAGLDGSPGEVDVPGVTELAPTRPRRRVAGRPAGPPIRLD,"103,390",953,,growth [GO:0040007]; rRNA processing [GO:0006364],ribonuclease activity [GO:0004540]; RNA binding [GO:0003723],cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
P71926,P71926_MYCTU,Rv2422,Rv2422,,,,,,Uncharacterized protein,,9634230,,,MPASVSTVLVDTSVAVAPVVADHDHHEDTFQALRGRTLGLAGHAAFERRTLATVAKLLAHTFPATRFLGAGAAMSLLPELAPAEIAGGAV,"9,212",90,,,,,,,1
I6YDI9,I6YDI9_MYCTU,Rv2483c,plsC Rv2483c,GO:0008152; GO:0016411; GO:0042171,IPR036412; IPR006385; IPR023214; IPR002123; ,,plsC,,Uncharacterized protein,acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; metabolic process [GO:0008152],9634230; 21969609,,,MSAADEQGEERATRKSAPDLRLPGSVAEILASPAGPKVGAFFDLDGTLVAGFTAVILTQERLRRRDMGVGELLGMVQAGLNHTLGRIEFEDLIGKAAAALAGRLLTDLEEIGERLFAQRIESRIYPEMRELVRAHVARGHTVVLSSSALTIQVGPVARFLGINNMLTNKFETNEDGILTGGVLKPILWCPGKATAVQRFAAEHDIDLKDSYFYADGDEDVALMYLVGNPRPTNPEGKMAAVAKRRGWPILKFNSRGGVGIRRQLRTLAGLSTIVPVAAGAVGIGVLTGSRRRGVNFFTSTFSQLLLATSGVHLNVIGKENLTAQRPAVFIFNHRNQVDPVIAGALVRDNWVGVGKKELASDPIMGTLGKLLDGVFIDRDDPVAAVETLHTVEERARNGLSIVIAPEGTRLDTTEVGSFKKGPFRIAMAAKIPIVPIVIRNAEIVASRNSTTINPGTVDVAVFPPIPVDDWTLDALPDRIAEVRQLYLDTLADWPVDGLPAVDLYAEQKAARKARAQVAKATAKRVPAKKAPAKSAANKGAAATKAATKKASPKAKPSESKIAGKDGEASASPSSSAKGRS,"61,788",580,,metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],,,,1
I6X4K0,I6X4K0_MYCTU,Rv2531c,Rv2531c,GO:0003824,IPR000310; IPR008286; IPR036633; IPR015424; ,,,,Probable amino acid decarboxylase,catalytic activity [GO:0003824],9634230; 21969609,,,MNPNSVRPRRLHVSALAAVANPSYTRLDTWNLLDDACRHLAEVDLAGLDTTHDVARAKRLMDRIGAYERYWLYPGAQNLATFRAHLDSHSTVRLTEEVSLAVRLLSEYGDRTALFDTSASLAEQELVAQAKQQQFYTVLLADDSPATAPDSLAECLRQLRNPADEVQFELLVVASIEDAITAVALNGEIQAAIIRHDLPLRSRDRVPLMTTLLGTDGDEAVANETHDWVECAEWIRELRPHIDLYLLTDESIAAETQDEPDVYDRTFYRLNDVTDLHSTVLAGLRNRYATPFFDALRAYAAAPVGQFHALPVARGASIFNSKSLHDMGEFYGRNIFMAETSTTSGGLDSLLDPHGNIKTAMDKAAVTWNANQTYFVTNGTSTANKIVVQALTRPGDIVLIDRNCHKSHHYGLVLAGAYPMYLDAYPLPQYAIYGAVPLRTIKQALLDLEAAGQLHRVRMLLLTNCTFDGVVYNPRRVMEEVLAIKPDICFLWDEAWYAFATAVPWARQRTAMIAAERLEQMLSTAEYAEEYRNWCASMDGVDRSEWVDHRLLPDPNRARVRVYATHSTHKSLSALRQASMIHVRDQDFKALTRDAFGEAFLTHTSTSPNQQLLASLDLARRQVDIEGFELVRHVYNMALVFRHRVRKDRLISKWFRILDESDLVPDAFRSSTVSSYRQVRQGALADWNEAWRSDQFVLDPTRLTLFIGATGMNGYDFREKILMERFGIQINKTSINSVLLIFTIGVTWSSVHYLLDVLRRVAIDLDRSQKAASGADLALHRRHVEEITQDLPHLPDFSEFDLAFRPDDASSFGDMRSAFYAGYEEADREYVQIGLAGRRLAEGKTLVSTTFVVPYPPGFPVLVPGQLVSKEIIYFLAQLDVKEIHGYNPDLGLSVFTQAALARMEAARNAVATVGAALPAFEVPRDASALNGTVNGDSVLQGVAEDA,"106,029",947,,,catalytic activity [GO:0003824],,,,1
O53178,O53178_MYCTU,Rv2451,Rv2451,GO:0005829,,,,,Hypothetical proline and serine rich protein,cytosol [GO:0005829],9634230,,,MGRAVSVRHGSGALDLPGAAASRRLRVGQPIQPSPAPLARGSVDSIVEISCCPSAGPRGPYDNDLDSSSPANRDISSITSRSRRGGTIVVAGQKCGFGSAVSLRPRRYREPNHANIVTPDTDLSPSWPWSGI,"13,816",132,,,,cytosol [GO:0005829],,,1
L0TC46,L0TC46_MYCTU,Rv2369c,Rv2369c,,,,,,Uncharacterized protein,,9634230,,,MIVGLADRHGHGRDVAAHRQAQLAGPRVAAVRRHRTGGHRQASSRIKVSAHGLGVVRCAPTPSLTGVRMKLQHSSVRQVPVDRPESRHQKPGDVPRDPRC,"10,893",100,,,,,,,1
V5QPR9,V5QPR9_MYCTU,Rv2395A,aprA Rv2395A,,,,aprA,,Acid and phagosome regulated protein A AprA,,9634230,,,MTMTASVAKVTAARPEPSAAWAEARRRVRQRREDMLRHPAFLSKQLPAEPADDDGVAAVYDIAIARRRRPA,"7,927",71,,,,,,,1
P71733,P71733_MYCTU,Rv2410c,Rv2410c,,IPR007296; ,,,,Conserved protein,,9634230; 21969609,,,MLARNAEALYWIGRYVERADDTARILDVAVHQLLEDSSVDPDQASRLLLRVLGIEPPDHELDVWSLTDLVAFSTNSQGGSSIVDAISAARENAKSAREVTSSETWECLNTTYNALPERERAAKRLGPHEFLSFIEGRAAMFAGLADSTLLRDDGYRFMLLGRAIERVDMTVRLLLSRVGDSASSPAWVTLLRSAGAHDTYLRTYRGVLDAGRVVEFMMLDRLFPRSVFHSLKLAEHNLAELMHNPHSRIGATTEAQRLLGQARSELEFVQPGVLLETLESRLAGLQTTCRDVGDALALQYFHAAPWVAWSDAGQRGQLVGSQEES,"36,021",325,,,,,,,1
I6X4W0,I6X4W0_MYCTU,Rv2638,Rv2638,GO:0006355; GO:0045152,IPR003658; IPR002645; IPR036513; ,,,,Anti-sigma factor antagonist,"antisigma factor binding [GO:0045152]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MGLITTEPRSSPHPLSPRLVHELGDPHSTLRATTDGSGAALLIHAGGEIDGRNEHLWRQLVTEAAAGVTAPGPLIVDVTGLDFMGCCAFAALADEAQRCRCRGIDLRLVSHQPIVARIAEAGGLSRVLPIYPTVDTALGKGTAGPARC,"15,420",148,Anti-sigma-factor antagonist family,"regulation of transcription, DNA-templated [GO:0006355]",antisigma factor binding [GO:0045152],,,,1
I6Y0Y0,I6Y0Y0_MYCTU,Rv2514c,Rv2514c,,IPR029060; IPR016541; ,,,,Uncharacterized protein,,9634230,,,MLYSFDTSAILNGRRDLFRPAVFRSLWGRVEDAISAGQIRSVDEVQRELARRDDDAKRWADGQTGLFCPLDEQIQQAARHILRLHPNMVRQGGRRSAADPFVIALAMVNNATVVTQETASGNIEKPRIPDVCDALGVPWLTLMGYIEAQGWTF,"17,155",153,,,,,,,1
I6Y0X6,I6Y0X6_MYCTU,Rv2510c,Rv2510c,,IPR033186; IPR027417; ,,,,Conserved protein,,9634230; 21969609,,,MGTESAAGGPGGPAQRIAAGYTVEGQALQLGTVVVDGEPDPSAQIRIPLATVNRHGLVAGATGTGKTKTLQLIAEQLSAAGVAVLMADVKGDLSGLARPGEAADKTAARAKDTGDDWVPTAFPVEFLSLGASGVGVPVRATISSFGPILLAKVLGLNATQESTLGLIFHWADQRGLPLLDLKDLRAVITHLTSDEGKVELKSLGAVSPTTAGVILRALVNLEAEGADTFFGEPELRPEDLLRVDSQGRGIISLLEFGSQALRPAMFSTFLMWVLADLFTFLPEVGDLDKPKLVFFFDEAHLLFTDASKAFLEQVEQTVKLIRSKGVGVFFCTQLPTDLPNDVLSQLGARIQHALRAFTPDDHKALRKTVRTYPKTDVYDLESALTSLGTGEAVVTVLSEKGAPTPVAWTRMRAPRSLMAAIGAEAIGAAAQASSLQAVYGQTIDRPSAHEILSAKLAPAQEAPAQEAPAPRGQYDPLPWPDDFEVPPMPAPVEPQGPAVWEEILKNPTVKSVLNTTAREITRSIFGTGRRRRK,"56,547",533,,,,,,,1
I6XF31,I6XF31_MYCTU,Rv2696c,Rv2696c,,IPR022183; ,,,,Conserved alanine and glycine and valine rich protein,,9634230; 21969609,,,MAFGRRTGKDGGKRKAGHAPVQPADEHVRPEDTVVASAAAASGVEDQEELQGPFDIDDFDDPSVAVLARLDLGSVLIPMPAAGQVQVELTESGVPSAVWVITPNGRYSIAAYAAPKTGGLWREVAGELADSLRKDSAKVSIKDGPWGREVIGIAAGVVRFIGVDGYRWMIRCVVNGPQETVDALTEEAREALADTVVRRGDTPLPVRTPLPVHLPEPMAAQLREAAAAQADTQRQAAAGVARRGAQGSAMQQLRSTTGG,"27,217",259,,,,,,,1
I6YDM0,I6YDM0_MYCTU,Rv2516c,Rv2516c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTADWVVTFTFDADPSMETMDAWETQLEGFDALVSRVPGHGIDVTVYAPGDWSVFDALAKMAGEVMPVVQAKSPIAVQIISEPEHRLRAEAFTTPELMSAAEIADELGVSRQRVHQLRSTAGFPAPLADLRGGAVWDAAAVRRFAETWERKPGRPHTGTAKFAYSWAVGPAVGRSGKAPNVRWRVENPDKIRFVLRNIGDDIAEDVEIDLSRIDAITRNVPKKTVIRPGEGLNMVLIAAWGHPLPNQLYVRWAGQDEWAAVPLHPAH,"29,387",267,,,,,,,1
I6Y1I1,I6Y1I1_MYCTU,Rv2695,Rv2695,,IPR029058; IPR000073; ,,,DOMAIN 11 196 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Conserved hypothetical alanine rich protein,,9634230; 21969609,,,MAVDLDGVTTVLLPGTGSDNDYVRRAFSAPLRRAGAVLVTPVPHPGRLIDGYRAALDDAARDGPVVVGGVSLGAAVAAAWALEHPDRAVAVLAALPAWTGEPELAPAAQAARYTAARLRCDGLAATTTRMRASSPVWLAEELTRSWRVQWPELPDAMEEAAAYVAPSRAELARLVAPLAVAAAVDDPIHPLQVAADWVSVAPHAALRTVTLDEIGADAAALGSACLAALAEVSGA,"24,155",235,,,,,,,1
P71740,P71740_MYCTU,Rv2403c,lppR Rv2403c,,IPR026954; IPR038232; ,,lppR,,Probable conserved lipoprotein LppR,,9634230; 21969609,,,MTNRWRWVVPLFAVFLAAGCTTTTTGKAGLAPNAVPRPLMGSLIQRVPLDGAALSTLLNQPFQALPPFPPVFGGSDSLGDSDVSARPADCVGVGYLTQRNVYRSVEVKSVARVSWRHDGSSVKVDDVDEGVVALPSAAAADDLFARFSAQWKECDGTTLTVPASAFGQRSITDVRVADSVVAATVSLRRGTHSILASVPQARAVGVRGNCVVEVAVTFFGITHPSDQGSADISTSAVDIAHAMMDRISELS,"26,339",251,,,,,,,2
O53200,O53200_MYCTU,Rv2473,Rv2473,GO:0016021,,,,,Possible alanine and proline rich membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MAPTSSSVASELLMPWPSAAASGVVGWRTTATASQRYHRPMSDTPFAEPYPEQRPPWGVPPPGWDGSSRPAPSTTPRSPGRWSLVAALALAVVSLGVGIVGWFHRQPHDKPSPAPSAPTFTSQQISDAKENVCAAHRIVRQAAVLNTNQANPVPGDPTGDLAVAANARLALYSGGDYLLRRLTAEPATPAELRDAVRSLANALQELAVNYLAGAPDSVVTPLRLALERDTRAVDPLCV,"25,133",238,,,,integral component of membrane [GO:0016021],,,1
I6YA21,I6YA21_MYCTU,Rv2704,Rv2704,,IPR035959; IPR006175; ,,,,Conserved protein,,9634230; 21969609,,,MSASRTMVSSGSEFESAVGYSRAVRIGPLVVVAGTTGSGDDIAAQTRDALRRIEIALGQAGATLADVVRTRIYVTDISRWREVGEVHAQAFGKIRPVTSMVEVTALIAPGLLVEIEADAYVGSAVADRNSGAGPKDPSPAGG,"14,628",142,,,,,,,1
O53185,O53185_MYCTU,Rv2458,mmuM Rv2458,GO:0005737; GO:0008270; GO:0009086; GO:0047150,IPR017226; IPR003726; IPR036589; ,,mmuM,,Probable homocysteine S-methyltransferase MmuM (S-methylmethionine:homocysteine methyltransferase) (Cysteine methyltransferase),cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],9634230; 21969609,,,MELVSDSVLISDGGLATELEARGHDLSDPLWSARLLVDAPHAITAVHTAYFRAGAQIATTASYQASFEGFAARGIGHDDATVLLRRSVELAQAARDEVGVGGLSVAASVGPYGAALADGSEYRGYYGLSVAALMKWHLPRLEVLVDAGADMLALETIPDIDEAEALVNLVRRLATPAWLSYTINGTRTRAGQPLTDAFAVAAGVPEIVAVGVNCCAPDDVLPAIAFAVAHTGKPVIVYPNSGEGWDGRRRAWVGPRRFSGSSGQLAREWVAAGARIVGGCCRVRPIDIAEIGRALTTAPPRG,"31,593",302,,methionine biosynthetic process [GO:0009086],betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737],,,1
L7N659,L7N659_MYCTU,Rv2340c,PE_PGRS39 Rv2340c,,IPR000084; ,,PE_PGRS39,,PE-PGRS family protein PE_PGRS39,,9634230,,,MSHVTAAPNVLAASAGELAAIGSTMRAANAAAAAPTAGVLAAGGDDVSAGIAALFGARAQAYQAISAQAALFHDRFVQILQEGAAAYAMAEAANALPLQKAQGVVSELAQDRTGGTGTGQSRGAGGFGGVGQAGGKGWDGGPIGNGQVGEQHGAGQLGSTDGNPGVAGAAHGSGVSASHGSGATGAAGVADPGGSGAGVGSAAGNGTGAGSADAVGGAGTGRDIVGSVRGDGGVGMASGDGGLSTGAAGASAEGGLMPGFGGAPWVGGHWGLGGEGHSGAIGGVGEQVAPAVATAPAVSPATTSAVAAESGSTPATKAQAMHATTNPGNAAHQGNPADPGNSARRADGGRDEQLLLLPLTSLRGLRHTLKKLSGLRARNGLLTASGDNASGSGRPWDRDQLLRALGLRPPGHE,"38,722",413,,,,,,,1
P71917,P71917_MYCTU,Rv2432c,Rv2432c,,,,,,Uncharacterized protein,,9634230,,,MTVRAEHCRGAGGCDECPSVMPEHPTALFHDVAAIALAQPGAEPGAMMGFPCRPALLPHLSRAVMRCVRTRSASTSLGVSVIAGQLPAAGSRHRLGAPCRHVRWWLASDGHWGMVSYIPTALNVSMGGIVGWRCVP,"14,378",136,,,,,,,1
I6XF17,I6XF17_MYCTU,Rv2681,Rv2681,GO:0000166; GO:0003676; GO:0005622; GO:0008408,IPR002562; IPR010997; IPR002121; IPR012337; IPR036397; ,,,,Conserved hypothetical alanine rich protein,intracellular [GO:0005622]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166],9634230; 21969609,,,MCPEPSHAGAAESEGTESEPTPLLRPAGGIPDLCVTVGEIAAAAELLDRGRGPFAVDAERASGFRYSGRAYLIQIRRAEAGTVLIDPVSHGGDPLTVLAPVAEVLSTNEWILHSADQDLPCLAEVGMRPPALYDTELAGRLAGFDRVNLAAMVERLLGLGLTKGHGAADWSKRPLPSAWLNYAALDVELLIELRAAISRVLAEQGKTDWAAQEFEHLRSFESRPPPAAARQDRWRRTSGIHKVHDRRGLAAVRELWTARDRIAQRRDIAPRRILPDSAIIDAAIADPKSVDDLVALPVFGGRNQRRSAAVWWAALAAARESPDPPEIAEPANGPPPPGRWVRRKPAAAARLDAARAALTEVSQRVRVPTENLVSPDLVRRLCWEWEDISQSSPDPIAAVEAYLRTGQARAWQLELVVPILTAALTGAPDAGAQGDDGS,"47,224",438,,,3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]; nucleotide binding [GO:0000166],intracellular [GO:0005622],,,1
O53190,O53190_MYCTU,Rv2463,lipP Rv2463,GO:0005886,IPR001466; IPR012338; ,,lipP,,Probable esterase/lipase LipP,plasma membrane [GO:0005886],9634230; 21969609,,,MNQPDIKGSCASEFTKVRDAFERNFVLRNEVGAAVAVWVDGDLVVNLWGGSADAGGTRPWQHDTLATVLSGTKALTATCVHQLVDRGELDLHAPVARYWPEFGQAGKQAITLAMVMSHRSGAIGPRGRLGWEQVADWDFVCEQLAAAEPWWQPGAAQGYHMTTFGFILGEVFRRVTGRTVGQYLRTEIAEPLGADVHIGLHPGEQLRCADLVDKPHIRQLLADVQAPGYPTSLNEHPKAALSVSMGFAPDDELGSNDLQLWRQIEFPGTNGQVSALGLATFYNGLAQEKLLSREHMELVRVSQGGFDTDLVLGPRVADHGWGLGYMLNQRGVNGPNPRIFGHGGLGGSFGFVDLEHRIGYAYVMNRFDATKANADPRSVVLSNEVYAALGVNRS,"42,839",394,,,,plasma membrane [GO:0005886],,,1
O53173,O53173_MYCTU,Rv2446c,Rv2446c,GO:0016021,IPR025327; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MTDRSREPADPWKGFSAVMAATLILEAIVVLLAIPVVDAVGGGLRPASLGYLVGLAVLLILLTGLQRRPWAIWVNLGAQPVLVAGFAVYPGVGFIGVLFAALWVLIAYLRAEVRRRRDYRVSQ,"13,311",123,,,,integral component of membrane [GO:0016021],,,1
Q79FD9,Q79FD9_MYCTU,Rv2438A,Rv2438A,,,,,,Uncharacterized protein,,9634230,,,MARTGHVQYRRGVGRRVTDGGVVSAGGNAHEPVLVGGVKVHRPFIVAQRRQNARITRRVSTLDTVESPALLADGGIDRRGDATDWAAADPGP,"9,751",92,,,,,,,1
Q79FE4,Q79FE4_MYCTU,Rv2401A,Rv2401A,GO:0016021,,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGPMNGFLSWWDGVELWLSGLPFALQALAVMPVVLALAYFTAALLDALLGRVIQLIRRARRPDQAPR,"7,435",67,,,,integral component of membrane [GO:0016021],,,1
O33227,O33227_MYCTU,Rv2722,Rv2722,,,,,,Uncharacterized protein,,9634230,,,MPCLARQPVDLPPWAGPRCGPYCPRARITLLQRTTIAKSNRKYYENGYPADVKLMPGHAAVVSNRAAARAGFALPCRKRQPD,"9,078",82,,,,,,,3
I6Y1G3,I6Y1G3_MYCTU,Rv2670c,Rv2670c,GO:0005524,IPR005654; IPR027417; ,,,,Uncharacterized protein,ATP binding [GO:0005524],9634230; 21969609,,,MTLIAARRYSATMHGSASEACGSVDHLVDRHPTVSPVRLIAQLRPPPTFAEVSFATYRPDPVEPTQAAAVVACQDFCRQAVERRAGRKKWFGKRDVLPGVGLYLDGGFGVGKTHLLASAYYQLPGTGPDAPTCPKAFATFGELTQLAGVFGFADCIDLLANYTALCIDEFELDDPGNTTLISRLLSALVERGVSVAATSNTLPEQLGEGRFAAQDFLREINTLASIFTTVRIEGPDYRHRDLPPAPAPLSDEEVAARAARVEGATLDDFDALCAHLATMHPSRYLTLIEGVTAVFLTGVHGIDDQNVALRLVALVDRLYDAGIPVVASGAKLDTIFSEEMLAGGYRKKYLRATSRLLALTAGVIQAREP,"39,659",369,,,ATP binding [GO:0005524],,,,1
O05828,O05828_MYCTU,Rv2370c,Rv2370c,,IPR025736; ,,,,Uncharacterized protein,,9634230,,,MVLPKPTPRGRELIRQAAKVALHPTPEWLDELDRATLAAHPSIAADPALATVVSRANRSHLIHFATANLRKPGQPVPANLGPDPLRMARDLVRRGLDASALDVYRVGQNVAWQRWTEIAFGLTTDPQELHELLTLPFRSASEFIDATLAGLAAQMQLEYDELTRDVHAEHRRIVELILDGAPISRQSAEAKLGYPLDRSHTAAIIWYDDPDDNQNHLDHTARAFGRALGCPQPLIAVASAATRWVWVSDAATLDTDRIHQVLDHAPHARIAVGTTARGIDGFRRSHRDALATQRMLARLRSQQRLAFFADIHMIAVLTENPDSAADFITSTLGDLESASPQLLTTVLTYINEQCNASRAAHVLHTHRNTLLRRLETAQRLLPRPLDHTIIQVAVAISALQWRGSQTSDPVETPVEGITSPPPESLGRRRSRLAQLER,"48,382",437,,,,,,,1
P95024,P95024_MYCTU,Rv2529,Rv2529,GO:0003677; GO:0004518; GO:0005829; GO:0005886,IPR006166; IPR024412; IPR011335; ,,,,Uncharacterized protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; nuclease activity [GO:0004518],9634230; 21969609,,,MHLAHRVASSRDTPSSSATPNAVSGSASNAADRPCLVRPPTAPPWAHGPRLRRDPTGGGSTPSIVLSRSTDRSKDGHRIVPAGARKSGVRASTGRLPSTRKTTRSPDCRPSASRTAFGTVTCPFDVTMGSSECLLHRCRTPPVPSHSVELLVAANPAEDSRLPYLIRLPVGAGLVFATSDVWPRTKALYCHRLDIADWPADPVVVDRVELRSCSRRGAAIDVVAARARENRSQLVHTMARGRQVVFWQSPKTRKQSRPGVRTPTARAAGIPELHIVVDAHERYPYTFADKPAKTTREALPCGDYGLKVAGQLVAAVERKALADLTSGVLNGNLKYQLTELAALPRAAVVVEDRYSEIFAHSFARPTAIADGLAELQIGFPNVPIVFCQTRKLAQEYTYRYLAAALTWFVDDADATTVFEPAAAEPEPSSAELRAWAKSVGLPVSDRGRLRPQILQAWRAAHPR,"50,192",463,,,DNA binding [GO:0003677]; nuclease activity [GO:0004518],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
I6XER9,I6XER9_MYCTU,Rv2617c,Rv2617c,GO:0016021,IPR032808; ,,,,Probable transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSIRPTTSPALADQLKDPAYSAYVLLRTLFTVAPILFGLDKFFNLLTHPQHWNMYLAGWINDLVPGTADQCMYLVGAIEIVAGVLVAVAPRIGAWVVAAWLAGIILNLVTGPGFYDIALRDFGLLVGAIALARLAQGVHSGGIGRP,"15,584",146,,,,integral component of membrane [GO:0016021],,,1
P95017,P95017_MYCTU,Rv2536,Rv2536,GO:0005618; GO:0005887; GO:0046812,,,,,Probable conserved transmembrane protein,cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887]; host cell surface binding [GO:0046812],9634230; 21969609,,,MTNWMLRGLAFAAAMVVLRLFQGALINAWQMLSGLISLVLLLLFAIGGVVWGVMDGRADAKASPDPDRRQDLAMTWLLAGLVAGALSGAVAWLISLFYKAIYTGGPINELTTFAAFTALIVFLVGIVGVAVGRWLVDRQLAKAPVRHHGLAAEHERAADTDVFSAVRADDSPTGEMQVAQPEAQTAAVATVEREAPTEVIRTTESDTPTEVIRTDTEADQTKPGDEPKKD,"24,626",230,,,host cell surface binding [GO:0046812],cell wall [GO:0005618]; integral component of plasma membrane [GO:0005887],,,3
I6Y9U6,I6Y9U6_MYCTU,Rv2620c,Rv2620c,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSAGPAIEVAVAFVWLGMVVAISFLEAPLKFRAAGVTLQIGLGIGRLVFRALNTVEVGFALVILAIVVVGSTPARIAAAFSVALAALAVQLIAVRPRLTRRSNQVLAGLQAPRSRGHHIYVGLEIVKVVALLVAGILLLNG,"14,639",141,,,,integral component of membrane [GO:0016021],,,1
P71916,P71916_MYCTU,Rv2433c,Rv2433c,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MGLRDADERWDTVGQAIGLFLRGHTLRTAAPTALIVGTVLCAVNQGATLAEGAATIGTWVRMVINYLVPFLVASVGYLGARRGVRRASGRSDPSAQ,"10,111",96,,,,integral component of membrane [GO:0016021],,,2
P95021,P95021_MYCTU,Rv2532c,Rv2532c,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MTRLELRVVVAAVLAATVVLGAVVCAAYGLTIVASAMSIYALGVGAWLYHAIERLILARRISTVRTAAKPLQPLLPVMAAIMGLTQAVVRSLGDVTDLPARRRELSQLPVLRWVDNSGNRANRRIADSDDLAD,"14,273",133,,,,integral component of membrane [GO:0016021],,,1
Q79FE6,Q79FE6_MYCTU,Rv2396,PE_PGRS41 Rv2396,,IPR000084; ,,PE_PGRS41,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS41,,9634230,,,MSFLIASPEALAATATYLTGIGSAISAANAVAAAPTTEILAAGTDEVSTAISALFGAHAQAYQALSAHVAAFHDQFVHTLTAGAGSYMAAEAAAASPLQALQLELLNAINAPTLALLGRPLIGDGTDAAPGSGGAGGAGGILIGNGGTGGASDLAGTGRGGVGGAGGAGGLFGIGGAGGGCGSAVAIGGDGGAGGAGGVFSGGGAGGAGDAIGGSGGAGGTGGLLGGGGGAGGAGGAGGNGGGASNSASIGGDGGSGGAGGMLYGAGGVGGNGGAAVAIGGDGGAGGRAGAIGNGGDGGNGGTSNTPGGSGGDGGNGGNAGLIGNGGNGGNAEIVISGGSVAGTGGNGGLLLGFNGTNGLP,"30,724",361,,,,,,,1
O06169,O06169_MYCTU,Rv2506,Rv2506,GO:0000976; GO:0003700; GO:0005829; GO:0042783; GO:0042802,IPR009057; IPR001647; IPR036271; ,Itself,,DOMAIN 24 84 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MTASAPDGRPGQPEATNRRSQLKSDRRFQLLAAAERLFAERGFLAVRLEDIGAAAGVSGPAIYRHFPNKESLLVELLVGVSARLLAGARDVTTRSANLAAALDGLIEFHLDFALGEADLIRIQDRDLAHLPAVAERQVRKAQRQYVEVWVGVLRELNPGLAEADARLMAHAVFGLLNSTPHSMKAADSKPARTVRARAVLRAMTVAALSAADRCL,"23,220",215,,active evasion of host immune response [GO:0042783],DNA binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,3
I6YDJ7,I6YDJ7_MYCTU,Rv2492,Rv2492,,IPR036926; ,,,,Uncharacterized protein,,9634230,,,MSRRIINEFGVQIYGATIGDTWAGLVRAVLDLGSQCFDEDRERIALSNVRIKSSVQNYPDLTIEEHCNSAQLKAMLDFMFNTDTMEDIDVVKSFSRGAKSYHRRIKEGRMIEFVIERLSLIPESKKAVVVFPTYEDYAAVMRNHRDDYLPCLVSIQFRLLPDGKDYVFHTTFYSRSMDAWQKGHGNLLSIAKLSDWVRENVSARIGRKIMLGPLDGMICDVHIYKETYAEACKRLANLDLRRTQFDAVRN,"28,818",250,,,,,,,1
I6YDK7,I6YDK7_MYCTU,Rv2502c,accD1 Rv2502c,GO:0016874,IPR034733; IPR029045; IPR011763; IPR011762; ,,accD1,,Probable acetyl-/propionyl-CoA carboxylase (Beta subunit) AccD1,ligase activity [GO:0016874],9634230; 21969609; ,X-ray crystallography (1),,MTTPSIAIAPSFADEHRRLVAELNNKLAAAALGGNERARKRHVSRGKLLPRERVDRLLDPGSPFLELAPLAAGGMYGDESPGAGIITGIGRVSGRQCVIVANDATVKGGTYYPMTVKKHLRAQEVALQNMLPCIYLVDSGGAFLPRQDEVFPDREHFGRIFYNQATMSAKGIPQVAAVLGSCTAGGAYVPAMSDEAVIVREQGTIFLGGPPLVKAATGEIVSAEELGGGDLHSRTSGVTDHLADDDEDALRIVRAIADTFGPCEPAQWDVRRSVEPKYPQAELYDVVPPDPRVPYDVHEVVVRIVDGSEFSEFKAKYGKTLVTAFARVHGHPVGIVANNGVLFSESALKGAHFIELCDKRKIPLLFLQNIAGFMVGRDYEAGGIAKHGAKMVTAVACARVPKLTVVIGGSYGAGNYSMCGRAYSPRFLWMWPNARISVMGGEQAASVLATVRGEQLSAAGTPWSPDEEEAFKAPIRAQYEDQGNPYYSTARLWDDGIIDPADTRTVVGLALSLCAHAPLDQVGYGVFRM,"56,778",529,,,ligase activity [GO:0016874],,,,1
P71754,P71754_MYCTU,Rv2390c,Rv2390c,GO:0005829; GO:0016021,,,,,Uncharacterized protein,cytosol [GO:0005829]; integral component of membrane [GO:0016021],9634230,,,MAIFGRGHGASEPGGTGEPAETPGRGRLTRSVIGWVGAVAVVVSLAGSGWCGWVLFEKHQTDVAAGQALQAARSYVVKLATMDCERIDHNMRDILEGSTGEFKDKYGKSSAHLRQLLADNRVATHGTVVAASVKSATTNKVVVLMFIDQSVSNRNSPTPQIDRSRIKVIMDKVNGRWLASKVELL,"19,857",185,,,,cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
I6XEU5,I6XEU5_MYCTU,Rv2646,Rv2646,GO:0003677; GO:0006310; GO:0015074,IPR011010; IPR013762; IPR002104; ,,,,Probable integrase,DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310],9634230,,,MNTATRVRLARKRADRLNLKLIKNGHHFRLRDADEITLAVGHLGVVEAFLAAAKSQNKPPGPPPSLHAPPSWRRDIDDYLLNLNAAGQRPATIRLRKTVLCAAAHGLGRPPADVTAEHLLDWLGKQQHLSPEGRKTYRSTLRGFFVWAYEMDRVRDYVADSLPKVRCPKQPPRPAGDDVWQAALAKADRRIELMIRLAGEAGLRRAEAAQAHTGDLMDGGLLLVHGKGGKRRIVPISDYLAALIRDTPHGYLFPNGTGGHLTAEHVGKLVSRALPGDATMHTLRHRYATRAYRGSHNLRAVQQLLGHASIVTTERYTALCDDEVRAAAAAAW,"36,590",332,,DNA integration [GO:0015074]; DNA recombination [GO:0006310],DNA binding [GO:0003677],,,,1
I6Y0W5,I6Y0W5_MYCTU,Rv2500c,fadE19 Rv2500c,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE19,,Possible acyl-CoA dehydrogenase FadE19 (MMGC),acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MTTTTTTISGGILPKEYQDLRDTVADFARTVVAPVSAKHDAEHSFPYEIVAKMGEMGLFGLPFPEEYGGMGGDYFALSLVLEELGKVDQSVAITLEAAVGLGAMPIYRFGTEEQKQKWLPDLTSGRALAGFGLTEPGAGSDAGSTRTTARLEGDEWIINGSKQFITNSGTDITSLVTVTAVTGTTGTAADAKKEISTIIVPSGTPGFTVEPVYNKVGWNASDTHPLTFADARVPRENLLGARGSGYANFLSILDEGRIAIAALATGAAQGCVDESVKYANQRQSFGQPIGAYQAIGFKIARMEARAHVARTAYYDAAAKMLAGKPFKKEAAIAKMISSEAAMDNSRDATQIHGGYGFMNEYPVARHYRDSKVLEIGEGTTEVQLMLIARSLGLQ,"41,916",394,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
I6X520,I6X520_MYCTU,Rv2663,Rv2663,,,,,,Uncharacterized protein,,9634230,,,MEVRASARKHGINDDAMLHAYRNALRYVELEYHGEVQLLVIGPDQTGRLLELVIPADEPPRIIHANVLRPKFYDYLR,"8,938",77,,,,,,,1
P71963,P71963_MYCTU,Rv2666,Rv2666,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Probable transposase for insertion sequence element IS1081,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTSSHLIDTEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANHGRHNA,"28,975",267,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
P71744,P71744_MYCTU,Rv2400c,subI Rv2400c,GO:0000103; GO:0005886; GO:0015419; GO:0040007,IPR005669; ,,subI,,Probable sulfate-binding lipoprotein SubI,plasma membrane [GO:0005886]; ATPase-coupled sulfate transmembrane transporter activity [GO:0015419]; growth [GO:0040007]; sulfate assimilation [GO:0000103],9634230; 21969609,,,MLSLTLSEASCIASASRWRHIIPAGVVCALIAGIGVGCHGGPSDVVGRAGPDRAHTSITLVAYAVPEPGWSAVIPAFNASEQGRGVQVITSYGASADQSRGVADGKPADLVNFSVEPDIARLVKAGKVDKDWDADATKGIPFGSVVTFVVRAGNPKNIRDWDDLLRPGIEVITPSPLSSGSAKWNLLAPYAAKSDGGRNNQAGIDFVNTLVNEHVKLRPGSGREATDVFVQGSGDVLISYENEAIATERAGKPVQHVTPPQTFKIENPLAVVATSTHLGAATAFRNFQYTVQAQKLWAQAGFRPVDPAVAADFADLFPVPAKLWTIADLGGWGSVDPQLFDKATGSITKIYLRATG,"37,418",356,,growth [GO:0040007]; sulfate assimilation [GO:0000103],ATPase-coupled sulfate transmembrane transporter activity [GO:0015419],plasma membrane [GO:0005886],,,1
I6Y1A7,I6Y1A7_MYCTU,Rv2640c,Rv2640c,GO:0003700; GO:0006355; GO:0044212,IPR011991; IPR001845; IPR036388; IPR036390; ,,,DOMAIN 24 119 HTH arsR-type. {ECO:0000259|PROSITE:PS50987}.,Possible transcriptional regulatory protein (Probably ArsR-family),"DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MPKSLPVIDISAPVCCAPVAAGPMSDGDALAVALRLKALADPARVKIMSYLFSSPAGEQVSGQLAAALSLSDGTVSHHLAQLRKAGLVISDRRGMHVFHRVHPEALQALCTVLNPNCCA,"12,365",119,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],,,,1
I6YA17,I6YA17_MYCTU,Rv2699c,Rv2699c,,IPR025242; ,,,,Uncharacterized protein,,9634230; 21969609,,,MPTDYDAPRRTETDDVSEDSLEELKARRNEAASAVVDVDESESAESFELPGADLSGEELSVRVVPKQADEFTCSSCFLVQHRSRLASEKNGVMICTDCAA,"10,916",100,,,,,,,1
P71969,P71969_MYCTU,Rv2672,Rv2672,GO:0005576; GO:0008233,IPR029058; IPR013595; ,,,DOMAIN 425 526 Abhydrolase_4. {ECO:0000259|Pfam:PF08386}.,Possible secreted protease,extracellular region [GO:0005576]; peptidase activity [GO:0008233],9634230; 21969609,,,MATVVGMSRPMTSTAMLVALTCSATVLAACVPAFGADPRFATYSGAGPQGAATTTPPPAGPPPLAAPKNDLSWHDCTSRVYSNAGIPAAPGVKLECASYDTDLDPLVGGSTAVSIGVVRARSNQTPSDAGPLVFTTGSDLPSSTQLPVWLAHAGIDVLRSHPIVAVDRRGMGMSSPIDCRDHFDRDEMRDQAQFQAGDDPVANLSDISNTATTDCTDAIAPGESAYDNTHAASDIERLRKLWDVPALAFVGIGNGTQVALAYAASRPDNVARLILDSPIALGVSAEAAAEQQVQGQQAALDAFAAQCVAVNCALGSHPKGAVSALLSAARSGDGPGGASVAAVANAVATALGFPDSGRVDSTTKLADALAAARSGDMNLLSALINRADTTRDTDGQFISSCSDAVNRPTPDRVRELVVAWGKLYPQFGAVAALNLVKCVHWPSSSPPQPPKDLKVDVLLLGVQNDPIVGNEGVAATAATAINANAASKRVMWQGIGHGASIYSSCAVPPLVAYLDTGKLPDTDTYCPA,"54,016",528,,,peptidase activity [GO:0008233],extracellular region [GO:0005576],,,1
O06171,O06171_MYCTU,Rv2508c,Rv2508c,GO:0016021,IPR024671; IPR036259; ,,,,Probable conserved integral membrane leucine and alanine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MNNPGSRAGTLLHFRVVAWAMWDCGSTGLNAIVTTFVFSVYLTSAVGQGLPGGTSPASWLGRAGAVAGLTIGVLAPVVGVWVESPHRRRVALSVLTGTAVALTCAMFLIRDDPRYLWAGLVLLAATAASSDLSSVPYNAMLRQLSTPSTAGRISGFGWASGYVGSVALLLVIYLGFMSGSGSQRGLLQLPVANGLNVRMAMLVAAAWLALLGLPLLLVAHRLPDSGAASHPSTGLLGGYRKLWTEISAEWRRDRNLVYFLVASAIFRDGLAAIFAFGAVLGVNAYGLTQADVLIFGAAASVVAAVGAVLGGFVDHRIGSKPVIVGSLAAIIAAALTLLTLSGPTAFWACGLLLCVFIGPAQSSARALLLHMAQHGKEGVAFGLYTMTGRAVSFLGPWLFSVFVDVFHTVRAGLGGVCLVLTTGLLLMLRVQVSRHGGALTTAQSS,"46,074",445,,,,integral component of membrane [GO:0016021],,,3
P71915,P71915_MYCTU,Rv2434c,Rv2434c,GO:0016021; GO:0055085,IPR018490; IPR000595; IPR016846; IPR010920; IPR006685; IPR014710; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],9634230,,,MNLLDSTWFYWAVGIAIGLPAGLIVLTELHNILVRRNSHLARQASLLRNYLLPLGAVLLLLVKASEVPAEDPTVRVLTTAFGFLVLVLLLSLLNATLFQGAPQQSWRKRLPAIFVDVARFALIGIGLAVILSYIWGVRVGGLFAALGVTSVVIGLMLQNSVGQIVSGLFMLFEQPFRIDDWLETPTARGRVVEVNWRAVHIDTGSGLQIMPNSMLATTAFTNLSRPAGAHECSITTTFSTSDPPDKVCAMLNRAASALPHVKPGVVPATIARGAAEYRTTVRLTSPADEGPTQATFLRWVWYAARREGLHLDEADDEFSTAERVESALRTVVGPELRLSSSDQQSLARYARLVRYGTDEIVQHAGVVPMGITFVIAGSVRLTVTTDDGSVVAIATLKKGTFLGLTALTRQPDPAGAVALEEVTALQIGREHLEQVVMNKPMLLQELGRVIDERQRKAQQAIRRDLHQSPAAAGEHRGPARR,"52,273",481,,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021],,,1
I6YE70,I6YE70_MYCTU,Rv2712c,Rv2712c,,IPR025447; ,,,,Uncharacterized protein,,9634230,,,MTKYRGQFELNRPATLIAALPAILGFVPEKSLVLVSLAAGELGSVMRADLCDELADRVGHLAELVAAANPAAAIAVIVDANGAQCPRCNEEYRQLCAALAAALSQRDIVLWAAHVVDRVAAGGRWHCVDGCGCSGVIDDPSASPLAMAAVLDGRQLYPRRSDLQAVIAVDDPVRSAELAVALGHQAADREIAHRADSVGCSRQDVENALAAAARVADGQSLSDTELARLGCALGDARVRDMLYALAVGENAGAAESLWALLARVLPEPWRVEALVLLAFSAYARGDGPLAGVSLQAALCCEPGHRMAGMLDTALQSGLRPEHIRDIAVTGYQRAEQLGIRLPPRRAFGQRAG,"36,957",352,,,,,,,1
O53196,O53196_MYCTU,Rv2469c,Rv2469c,GO:0005576,IPR029471; IPR003615; ,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230,,,MAHGKKRRGHRSSGVAAGVTGPASCLHSVHSHRLASGVETHPPNRHESASIWNRRRVLLLNSTYEPLTALSMRRAIVMVICGKADVVHEDPSGPVIHSATRSILVPSVIQLRSYVRVPYRARVPMTRAALMHRDRFCCAYCGGKADTVDHVVPRSRGGAHSWENCVACCSPCNHRKGDRLLTELGWALRRAPLPPTGPHWRLLSAVKELDPSWARYLGEGAA,"24,405",222,,,,extracellular region [GO:0005576],,,1
I6XEK2,I6XEK2_MYCTU,Rv2548A,Rv2548A,,,,,,Conserved protein,,9634230; 21969609,,,MLPENLEQRVTALESQVRELADRVRASEQDAAAARVLAGAADRDVTEFVGEFRDFRRATIGSFNALREDFTALREEMTERFSHVEERFSRVDDGFTEMRGKLDGAAAGQQRIVELIEQLIADQG,"13,975",124,,,,,,,1
O07196,O07196_MYCTU,Rv2694c,Rv2694c,,IPR016499; ,,,,Conserved protein,,9634230; 21969609,,,MGAQGYLRRLTRRLTEDLEQRDVEELSDEVLNAGAQRAIDCQRGQEVTVVGTLRSVETNGKGCSGGVRAELFDGSDTVTLVWLGQRRIPGIDTGRTLRVRGRLGKLENGTKAIYNPHYEIQR,"13,570",122,,,,,,,3
I6XEH5,I6XEH5_MYCTU,Rv2515c,Rv2515c,GO:0043565,IPR001387; IPR010359; IPR010982; ,,,DOMAIN 29 83 HTH cro/C1-type. {ECO:0000259|PROSITE:PS50943}.,Uncharacterized protein,sequence-specific DNA binding [GO:0043565],9634230,,,MGIGHPMWVGWCIIIAMRSIPASVESSVLRWARESCGLTEVAAARKLGLPDDRVAAWEVGEVVPTIAQLRKAAEVYKRSLAVFFLSEPPEGFDTLRDFRRLDGAASGQWTPGLHEEFRRAHTQRDFALELADAEDREIPGAWRLPLSGDEADADIAARIRKALIEVSPLPIPVASVDPYEHLNAWVSAIETSGVLVLATRGGKVAIDEMRGMCLYFDELPVIVLNGSDHPRPRLFSLLHEFVHVVLHTEGLCDVIADAHPSTQDRSLEARCNAIAAAVLMPADVVRARPEVIVRSETPSSWDYESLRPVAAHFGVSAEAFLRRLSTLGIVPVEVYRQRRAEFIAAHEDEAERARSAGGGNWYRNTVRDLGKGYVRAVTDAHRRRVIDSNTAAIYLDAKVSQIPKLAESAELRSVV,"45,799",415,,,sequence-specific DNA binding [GO:0043565],,,,1
P95011,P95011_MYCTU,Rv2542,Rv2542,GO:0005886,IPR029058; IPR010427; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MLDAVSDARRDGFAVGEDYTVTDRSTGGSRQQRAARLGQAQGHADFIRHRVGALLATDRDIATRVSAATQGLDELAFEDVPGVDTPAEDGVQAVDFRQAPPPGAPGGMSSGDIDAIDAANRALLQDMLAEYSRLPDGQVKTDRLADIAAIQEALRVPDSHLIYVARPDDPADMIPAVTAVGDPFTADHVSVTVPGVSGTTRQTIATMTQETRGLREEARVIAHSVGESENVATIAWVGYQPPPVLASWNTVDDDLAQAGAPKLEAFLRDLQAGSHNPGHTTALFGHSYGSLLSGIALKDGASSLVDNAVLYGSPGFDATSPAKLGMNDHNFFVMTTPDDPIRYPARLAPLHGWGSDGADTIGTVGRQGTPARVGIRPQRDHRRIPGPLPLHPSADRRGIHSAG,"42,480",403,,,,plasma membrane [GO:0005886],,,2
O06194,O06194_MYCTU,Rv2619c,Rv2619c,,IPR014710; IPR011051; ,,,,Conserved protein,,9634230; 21969609,,,MESISLTSLAAEKLAEAQQTHSGRAAHTIHGGHTHELRQTVLALLAGHDLSEHDSPGEATLQVLQGHVCLTAGEDAWNGRAGDYVAIPPTRHALHAVEDSVIMLTVLKSLPDAHSGS,"12,322",117,,,,,,,1
I6YE30,I6YE30_MYCTU,Rv2657c,Rv2657c,GO:0003677,IPR009061; IPR010093; ,,,,Probable PhiRv2 prophage protein,DNA binding [GO:0003677],9634230,,,MCAFPSPSLGWTVSHETERPGMADAPPLSRRYITISEAAEYLAVTDRTVRQMIADGRLRGYRSGTRLVRLRRDEVDGAMHPFGGAA,"9,507",86,,,DNA binding [GO:0003677],,,,1
O05819,O05819_MYCTU,Rv2379c,mbtF Rv2379c,GO:0005618; GO:0005829; GO:0005886; GO:0008152; GO:0016874; GO:0031177,IPR010071; IPR036736; IPR025110; IPR020845; IPR000873; IPR023213; IPR001242; IPR020806; IPR009081; ,,mbtF,DOMAIN 961 1035 Carrier. {ECO:0000259|PROSITE:PS50075}.,Peptide synthetase MbtF (Peptide synthase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; metabolic process [GO:0008152],9634230; 21969609,,,MGPVAVTRADARGAIDDVMALSPLQQGLFSRATLVAAESGSEAAEADPYVIAMAADAAGPLDIALLRDCAAAMLTRHPNLRASFLHGNLSRPVQVIPSSAEVLWRHVRAHPSEVGALAAEERRRRFDVGRGPLIRFLLIELPDECWHLVIVAHHIVIDGWSLPLFVSELLALYRAGGHVAALPAAPRPYRDYIGWLAGRDQTASRAMWADHLNGLDGPTLLSPALADTPVQPGIPGRTEVRLDREATAELADAARTRGVTISTLVQMAWATTLSAFTGRGDVTFGVTVSGRPSELSGVETMIGLFINTVPLRVRLDARATVGGQCAVLQRQFAMLRDHSYLGFNEFRAIAGIGEMFDTLLVYENFPPGEVVGTAEFVANGVTFRPVALESLSHFPVTVAAHRSTGELTLLVEVLDGALGTMAPESLGRRVLAVLQRLVSRWDRPLRDVDILLDGEHDPTAPGLPDVTTSAPAVHTRFAEIAAAQPDSVAVSWADGQLTYRELDALADRLATGLRRADVSRETPVAVALSRGPRYVAAMLAVLKAGGMIVPLDPAMPGERVAEILRQTSAPVVIDEGVFAASVGADILEEDRAITVPVDQAAYVIFTSGTTGTPKGVIGTHRALSAYADDHIERVLRPAAQRLGRPLRIAHAWSFTFDAAWQPLVALLDGHAVHIVDDHRQRDAGALVEAIDRFGLDMIDTTPSMFAQLHNAGLLDRAPLAVLALGGEALGAATWRMIQQNCARTAMTAFNCYGPTETTVEAVVAAVAEHARPVIGRPTCTTRAYVMDSWLRPVPDGVAGELYLAGAQLTRGYLGRPAETAARFVAEPNGRGSRMYRTGDVVRRLPDGGLEFLGRSDDQVKIRGFRVEPGEIAAVLNGHHAVHGCHVTARGHASGPRLTAYVAGGPQPPPVAELRAMLLERLPRYLVPHHIVVLDELPLTPHGKIDENALAAINVTEGPATPPQTPTELVLAEAFADVMETSNVDVTAGFLQMGLDSIVALSVVQAARRRGIALRARLMVECDTIRELAAAIDSDAAWQAPANDAGEPIPVLPNTHWLYEYGDPRRLAQTEVIRLPDRITRERLDAVLAAVVDGHEVLRCRFDRDAMALVAQPKTDILSEVWVSGELVTAVAEQTLGALASLDPQAGRLLSAVWLREPDGPGVLVLTAHVLAMDPASWRIVLGELDAGLHALAAGRAPSPARENTSYRQWSRLLAQRAKALDSVDFWVAELEGADPPLGARRVAPQTDRVGELAITMSISDADLTARLLSTGRSMTDLLATAAARMVTAWRRQRGQQTPAPLLALETHGRADVHVDKTADTSDTVGLLSAIYPLRIHCDGATDFARIPGSGIDYGLLRYLRADTAERLRAHREPQLLLNYLGSLHVGVGDLAVDRALLADVGQLPEPEQPVRHELTVLAALLGPADAPVLATRWRTLPDILSADDVATLQSLWQGALAEITA,"156,748",1461,,metabolic process [GO:0008152],ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P71738,P71738_MYCTU,Rv2405,Rv2405,GO:0003677; GO:0005886,IPR003477; ,,,,Conserved protein,plasma membrane [GO:0005886]; DNA binding [GO:0003677],9634230; 21969609,,,MQRFAENLVFTEAPKLVRHLQNTQETLRTIRQAVKITANIMTTAVPSPPAEIAAGRPVTSTSCPTAARARRLVYAPDLDGRADPGEIVWTWVAYEQDPTRGKDRPVLVVGRDRSVLLGLLVSSQERHAADRDWVGIGSGAWDYEGRESWVRLDRVLDVPEESIRREGAILEREVFDVVAARLRADYAWR,"21,259",189,,,DNA binding [GO:0003677],plasma membrane [GO:0005886],,,1
I6X4D6,I6X4D6_MYCTU,Rv2474c,Rv2474c,,IPR016601; ,,,,Uncharacterized protein,,9634230; 21969609,,,MVERGLWLPDPAHRADLATFVDHALRLDDAAVIRIRARSTGLLSAWVATGFDVLASRVVAGKVRPDDLSVAARSLAHGLATTDASGYVDPGYSMDSAWRGGLPPESGFTYLDDVPARVMLDLAHRGARLAKEHGSSAGPPVSLLDQEVIQVSSADVVVGLPMRCVFALTAMGFLPQSAETISADELIRVRISPAWLRLDARFGSVYRHRGHAALVLR,"23,302",217,,,,,,,1
P71719,P71719_MYCTU,Rv2381c,mbtD Rv2381c,GO:0005886; GO:0008152; GO:0016740; GO:0031177,IPR001227; IPR036736; IPR014043; IPR016035; IPR016036; IPR036291; IPR020801; IPR013968; IPR020806; IPR009081; IPR006162; ,,mbtD,DOMAIN 912 990 Carrier. {ECO:0000259|PROSITE:PS50075}.,Polyketide synthetase MbtD (Polyketide synthase),plasma membrane [GO:0005886]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740]; metabolic process [GO:0008152],9634230; 21969609,,,MAPKQLPDGRVAVLLSAHAEELIGPDARAIADYLERFPATTVTEVARQLRKTRRVRRHRAVLRAADRLELAEGLRALAAGREHPLIARSSLGSAPRQAFVFPGQGGHWPGMGAVAYRELPTYRTATDTCAAAFAAAGVDSPLPYLIAPPGTDERQAFCEIEIEGAQFVHAVALAEVWRSCGVLPDLTVGHSLGEVAAAYLAGSITLSDAVAVVAARANVVGRLPGRYAVAALGIGEQDASALIATTGGWLELSVVNASSTVAVSGERQAVAAIVDTVRSSGHFARGITVGFPVHTSVLESLRDELCEQLPDSEFMEAPVQFIGGTTGDVVAPGTTFGDYWYANLRHTVRFDRAVESAIRCGARAFIEISAHPALLFAIGQNCEGAANLPDGPAVLVGSARRGERFVDALSANIVSAAVADPGYPWGDLGGDPLDGDVDLSGFPNAPMRAVPMWAHPEPLPPVSGLTIAVERWERMVPSTPVAGRHRHLAVLDLGAHRALAQTLCAAIDSHPDTELSAARDAELILVIAPDFEHTDAVRAAGALADLVGAGLLDYPMHIGARCQSVCLVTVGAEQVDAADAVPSAGQAALAAMHRSIGFEHPEQTFSHLDLPSWDLDPVLGVSVITAVLRGFGETALRGSVNGYTLFERTLADAPAVPNWSLDSGVLDDVVVTGGAGAIGMHYARYLAEHGARRIVLLSRRAADQATVAMLRKQHGTVIVSPPCDITDPTQLSAIAAEYGGVGASLIVHAAGSVISGTAPGVTSAAVVDNFAAKVLGLAQMIELWPLRPDVRTLLCSSVMGVWGGHGVVAYSAANRLLDVMAAQLRAQGRHCVAVKWGLWQAPKAGEPARGIADAVTIARVERSGLRQMAPQQAIEASLHEFTVDPLVFAADAARLQMLLDSRQFERYEGPTDPNLTIVDAVRTQLAAVLGIPQAGEVNLQESLFDLGVDSMLALDLRNRLKRSIGATVSLATLMGDITGDGLVAKLEDADERSHTAQKVDISRD,"105,592",1004,,metabolic process [GO:0008152],phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],plasma membrane [GO:0005886],,,3
P71949,P71949_MYCTU,Rv2652c,Rv2652c,,IPR006448; ,,,,Probable PhiRv2 prophage protein,,9634230,,,MPSPATARPDTATVGERVRAQVLWGVFWHHGIRDPKPGKRRVVLKMGRRGPAPAPAQLKLLGGRSPGRDSGGRRVTPPAAFERVAPECPDWLPPGAKDMWGRVVPELAALNLLKESDLGVLTSFCVAWDQLMQAVTAYREQGFIATNARSRRVTVHPAVAAARAATRDVLVLARELGCTPSAEANLAAVLAAAGDPDDDEFNPFAPDR,"22,324",208,,,,,,,1
Q79FE8,Q79FE8_MYCTU,Rv2385,mbtJ Rv2385,GO:0004806; GO:0008152,IPR029058; IPR013094; ,,mbtJ,DOMAIN 77 277 Abhydrolase_3. {ECO:0000259|Pfam:PF07859}.,Putative acetyl hydrolase MbtJ,triglyceride lipase activity [GO:0004806]; metabolic process [GO:0008152],9634230; 21969609,,,MVLRPITGAIPPDGPWGIWASRRIIAGLMGTFGPSLAGTRVEQVNSVLPDGRRVVGEWVYGPHNNAINAGPGGGAIYYVHGSGYTMCSPRTHRRLTSWLSSLTGLPVFSVDYRLAPRYRFPTAATDVRAAWDWLAHVCGLAAEHMVIAADSAGGHLTVDMLLQPEVAARPPAAVVLFSPLIDLTFRLGASRELQRPDPVVRADRAARSVALYYTGVDPAHHRLALDVAGGPPLPPTLIQVGGAEILEADARQLDADIRAAGGICELQVWPDQMHVFQALPRMTPEAAKAMTYVAQFIRSTTARGDL,"32,877",306,,metabolic process [GO:0008152],triglyceride lipase activity [GO:0004806],,,,1
I6Y9H2,I6Y9H2_MYCTU,Rv2499c,Rv2499c,,IPR029069; IPR002539; ,,,DOMAIN 39 159 MaoC-like. {ECO:0000259|Pfam:PF01575}.,Possible oxidase regulatory-related protein,,9634230; 21969609,,,MTKHAGDRESDDAVSACRVAGSTVGRRILQRGLWFEEFQIGTTYLHRPGRTVTEADNVLFTTLTMNTQSLHLDAAWAGQQPGFRGERLVNSMFTLSTMVGLSVAQLTLGTIVANLGFSEVSFPKPVFHGDTLYAETVCTGKRESKSRPGEGIVTLEHIARNQHGEVVARAVRTTLVQKQSIKEAQ,"20,259",185,,,,,,,1
P71730,P71730_MYCTU,Rv2413c,Rv2413c,GO:0003677; GO:0003887; GO:0006260; GO:0009360,IPR008921; IPR010372; IPR027417; ,,,DOMAIN 2 164 DNA_pol3_delta. {ECO:0000259|Pfam:PF06144}.,Uncharacterized protein,DNA polymerase III complex [GO:0009360]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260],9634230; 21969609,,,MHLVLGDEELLVERAVADVLRSARQRAGTADVPVSRMRAGDVGAYELAELLSPSLFAEERIVVLGAAAEAGKDAAAVIESAAADLPAGTVLVVVHSGGGRAKSLANQLRSMGAQVHPCARITKVSERADFIRSEFASLRVKVDDETVTALLDAVGSDVRELASACSQLVADTGGAVDAAAVRRYHSGKAEVRGFDIADKAVAGDVAGAAEALRWAMMRGEPLVVLADALAEAVHTIGRVGPQSGDPYRLAAQLGMPPWRVQKAQKQARRWSRDTVATAMRLVAELNANVKGAVADADYALESAVRQVAELVADRGR,"33,132",316,,DNA replication [GO:0006260],DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],DNA polymerase III complex [GO:0009360],,,3
O86317,O86317_MYCTU,Rv2680,Rv2680,,IPR021555; ,,,,Conserved protein,,9634230; 21969609,,,MTSAGDDAERSDEEERRLTSAEPALFREAVAAMNAVTVRPEIELGPIRPPQRLAPYSYALGAEIKHPELDVIPERSEGDAFGRLIMLYDPDGSDAWDGTIRLVAYVQADLDSSEAVDPLLPEVAWSWLVDALTARTDQVRALGGTVTATTSVRYGDISGPPRAHQLELRASWTATTPDLGAHVQAFCDVLEHAAGLPPAGVTDLGSRSRA,"22,573",210,,,,,,,1
P71746,P71746_MYCTU,Rv2398c,cysW Rv2398c,GO:0005886; GO:0015419; GO:0016021; GO:0040007,IPR011866; IPR000515; IPR035906; IPR005667; ,,cysW,,Probable sulfate-transport integral membrane protein ABC transporter CysW,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATPase-coupled sulfate transmembrane transporter activity [GO:0015419]; growth [GO:0040007],9634230,,,MTSLPAARYLVRSVALGYVFVLLIVPVALILWRTFEPGFGQFYAWISTPAAISALNLSLLVVAIVVPLNVIFGVTTALVLARNRFRGKGVLQAIIDLPFAVSPVIVGVSLILLWGSAGALGFVEQDLGFKIIFGLPGIVLGSMFVTCPFVVREVEPVLHELGTDQEQAAATLGSGWWQTFWRITLPSIRWGLTYGIVLTVARTLGEYGAVIIVSSNLPGTSQTLTLLVSDRYHRGAEYGAYALSTLLMAVSVVVLIVQMVLDARRARAVSEG,"29,289",272,,growth [GO:0040007],ATPase-coupled sulfate transmembrane transporter activity [GO:0015419],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P71745,P71745_MYCTU,Rv2399c,cysT Rv2399c,GO:0005886; GO:0015419; GO:0016021; GO:0040007,IPR011865; IPR000515; IPR035906; IPR005667; ,,cysT,,Probable sulfate-transport integral membrane protein ABC transporter CysT,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATPase-coupled sulfate transmembrane transporter activity [GO:0015419]; growth [GO:0040007],9634230,,,MTESLVGERRAPQFRARLSGPAGPPSVRVGMAVVWLSVIVLLPLAAIVWQAAGGGWRAFWLAVSSHAAMESFRVTLTISTAVTVINLVFGLLIAWVLVRDDFAGKRIVDAIIDLPFALPTIVASLVMLALYGNNSPVGLHFQHTATGVGVALAFVTLPFVVRAVQPVLLEIDRETEEAAASLGANGAKIFTSVVLPSLTPALLSGAGLAFSRAIGEFGSVVLIGGAVPGKTEVSSQWIRTLIENDDRTGAAAISVVLLSISFIVLLILRVVGARAAKREEMAA,"29,683",283,,growth [GO:0040007],ATPase-coupled sulfate transmembrane transporter activity [GO:0015419],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O07191,O07191_MYCTU,Rv2689c,Rv2689c,GO:0006396; GO:0008173,IPR012340; IPR029063; IPR002792; IPR010280; ,,,,Conserved alanine and valine and glycine rich protein,RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],9634230; 21969609,,,MTRAGDDAVNLTLVTGAPANGGSCVAHHEGRVVFVRYALPGERVRARVTAQRGSYWHAEAFEVIDPSPDRIGSLCSIAGADGAGCCDLAFAAPEAARTLKAQVVANQLERLGRHSWQGEAQPLSDAGPTGWRIRVRLDVGADRRPGFHRYHSGELVTDLDCGQLPVGMLDGLVAADWPPEAQLYVALDDDGERHVVCSVRQGPRNRTRTVTNVVEGAYHAHQRVHRRSWRVPVTAFWQAHRDAAAVYSDLIADWAQPAPGMTAWDLYGGAGVFAAVLGEAVGESGRVLTVDTSRLASGAARAALVDLPQVEVVTGSVRRVLAVQPAGADLAVLDPPRSGAGREVVDLLAGAGVPRLIHIGCEAASFARDIGLYRGHGYAVEKIKVFDAFPLTHYVECVALLTRKV,"43,242",405,"Class I-like SAM-binding methyltransferase superfamily, RNA M5U methyltransferase family",RNA processing [GO:0006396],RNA methyltransferase activity [GO:0008173],,,,3
Q79FF3,Q79FF3_MYCTU,Rv2353c,PPE39 Rv2353c,,IPR002989; ,,PPE39,,PPE family protein PPE39,,9634230,,,MPGRFRNFGSQNLGSGNIGSTNVGSGNIGSTNVGSGNIGDTNFGNGNNGNFNFGSGNTGSNNIGFGNTGSGNFGFGNTGNNNIGIGLTGDGQIGIGGLNSGSGNIGFGNSGTGNVGLFNSGTGNVGFGNSGTANTGFGNAGNVNTGFWNGGSTNTGLANAGAGNTGFFDAGNYNFGSLNAGNINSSFGNSGDGNSGFLNAGDVNSGVGNAGDVNTGLGNSGNINTGGFNPGTLNTGFFSAMTQAGPNSGFFNAGTGNSGFGHNDPAGSGNSGIQNSGFGNSGYVNTSTTSMFGGNSGVLNTGYGNSGFYNAAVNNTGIFVTGVMSSGFFNFGTGNSGLLVSGNGLSGFFKNLFG,"34,069",354,,,,,,,1
I6YA03,I6YA03_MYCTU,Rv2679,echA15 Rv2679,GO:0003824; GO:0008152,IPR029045; IPR018376; IPR001753; IPR014748; ,,echA15,,Probable enoyl-CoA hydratase EchA15 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MPVTYDDFPSLRCEIHDQPGHEGVLELVLDSPGLNSVGPHMHRDLADIWPVIDRDPAVRVVLVRGEGKAFSSGGSFDLIAETIGDYQGRLRIMREARDLVLNLVNFDKPVVSAIRGPAVGAGLVVALLADISVAGRAAKIIDGHTKLGVAAGDHAAICWPLLVGMAKAKYYLLTCEPLSGEEAERIGLVSICVDDDDVLPTATRLAERLAAGAQNAIRWTKRSLNHWYRMFGPAFETSLGLEFIGFGGPDVREGLAAHREKRPARFGADPDPGAGS,"29,635",276,Enoyl-CoA hydratase/isomerase family,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
I6Y1G8,I6Y1G8_MYCTU,Rv2675c,Rv2675c,GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Uncharacterized protein,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MTAQFDPADPTRFEEMYRDDRVAHGLPAATPWDIGGPQPVVQQLVALGAIRGEVLDPGTGPGHHAIYYAAKGYAATGIDGSVAAIERARDNARKAGVSVNFQVGDATTLDGLDGRFDTVVDCAFYHTFSTAPELQRCYVRALRRASKPGARLYMFEFGEHNVNGFSMPRSLSEDDFRQVLPVGGWEITYLGTTTYQVNLSVEALELMAARNPDMADQVRCVLERFRAIKPWLVGGRVHAPFWEVHATRVD,"27,545",250,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
O53222,O53222_MYCTU,Rv2517c,Rv2517c,,,,,,Uncharacterized protein,,9634230,,,MNSAIIKIAKWAQSQQWTVEDDASGYTRFYNPQGVYIARFPATPSNEYRRMRDLLGALKKAGLTWPPPSKKERRAQHRKEGAQ,"9,565",83,,,,,,,3
P71914,P71914_MYCTU,Rv2435c,Rv2435c,GO:0004016; GO:0004871; GO:0005622; GO:0005886; GO:0007165; GO:0009190; GO:0016021; GO:0035556,IPR001054; IPR003660; IPR029787; ,,,,Probable cyclase (Adenylyl-or guanylyl-)(Adenylate-or guanylate-),integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],9634230; 21969609,,,MTSGEALDSVAESESTPAKKRHKNVLRRRPRFRASIQSKLMVLLLLTSIVSVAAIAAIVYQSGRTSLRAAAYERLTQLRESQKRAVETLFSDLTNSLVIYERGLTVVDAVVRFTAGFDQLADATISPAQQQAIVNYYNNEFITPVERTTGDKLDITALLPTSPAQRYLQAYYTAPFTSDQDAMRLDDAGDGSAWSAANAQFNSYFREIVTRFDYDDAVLLDTRGNIVYTLSKDPDLGTNILTGPYRESNLRDAYLKALGANAVDFTWITDFKPYQPQLGVPTAWLVAPVEAGGKTQGVLALPLPIDKINKIMTADRQWQAAGMGSGTETYLAGPDSLMRSDSRLFLQDPEEYRKQVVAAGTSLDVVNRAIQFGGTTLLQPVATEGLRAAQRGQTGTVTSTDYTGSRELEAYAPLNVPDSDLHWSILATRNDSEAFAAVASFSRALVLVTVGIIVVICVASMLIAHAMVRPIRRLEVGTQKISAGDYEVNIPVKSRDEIGDLTAAFNEMSRNLQTKEELLNEQRKENDRLLLSMMPEPVVERYRLGEQTIAQEHQDVTVLFADILGVDEISSGLSGNELVKIVDELVRQFDSAAEHLGVERIRTLHNGYLAGCGVTTPRLDNIPRTVDFALEMRRIVDRFNCQTGNDLHLRVGINTGDVISGLVGRSSVVYDMWGAAVSLAYQMHSGSPQPGIYVTSQVYEAMRDVWQFTAAGTISVGGLEEPIYRLSERS,"80,264",730,,cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; signal transduction [GO:0007165],adenylate cyclase activity [GO:0004016]; signal transducer activity [GO:0004871],integral component of membrane [GO:0016021]; intracellular [GO:0005622]; plasma membrane [GO:0005886],,,1
P95232,P95232_MYCTU,Rv2336,Rv2336,GO:0005886; GO:0052572,,,,,Uncharacterized protein,plasma membrane [GO:0005886]; response to host immune response [GO:0052572],9634230; 21969609,,,MDVPHEQPALSSSKSNRFTSQRQTTGVGTTTVERLEPRLSPASRHITEAKAFGTECHVSSFTREQDPDRAVRVEQIHGEAYVAAGHVYESALDELGRLDNSNAEFILDKARGSTRETEVIYLHAVPAEPLSGSQGEGGLRIVGISAVGSIDDLSAFKAAKPSMGLAHQRKLYDAIEDLGHGGVKEIAALSVTADAPPTVSYSLIREVLRLYHRTGEKLIITFAMPAYAKMVMNFGRFAMPQVGEPFYAHRNNDPRTSNDLLLVPSIVEPSNFLENISRGVVTADDGPTARRRFATLCYMTDGLDDYFMPLTRQVLSEGIQDI,"35,264",322,,response to host immune response [GO:0052572],,plasma membrane [GO:0005886],,,1
P71968,P71968_MYCTU,Rv2671,ribD Rv2671,GO:0000166; GO:0005829; GO:0008703; GO:0009231,IPR024072; IPR002734; ,,ribD,,Possible bifunctional enzyme riboflavin biosynthesis protein RibD: diaminohydroxyphosphoribosylaminopyrimidine deaminase (Riboflavin-specific deaminase) + 5-amino-6-(5-phosphoribosylamino)uracil reduc...,cytosol [GO:0005829]; 5-amino-6-(5-phosphoribosylamino)uracil reductase activity [GO:0008703]; nucleotide binding [GO:0000166]; riboflavin biosynthetic process [GO:0009231],9634230; 21969609; 26848874,X-ray crystallography (6),,MPDSGQLGAADTPLRLLSSVHYLTDGELPQLYDYPDDGTWLRANFISSLDGGATVDGTSGAMAGPGDRFVFNLLRELADVIVVGVGTVRIEGYSGVRMGVVQRQHRQARGQSEVPQLAIVTRSGRLDRDMAVFTRTEMAPLVLTTTAVADDTRQRLAGLAEVIACSGDDPGTVDEAVLVSQLAARGLRRILTEGGPTLLGTFVERDVLDELCLTIAPYVVGGLARRIVTGPGQVLTRMRCAHVLTDDSGYLYTRYVKT,"27,694",258,,riboflavin biosynthetic process [GO:0009231],5-amino-6-(5-phosphoribosylamino)uracil reductase activity [GO:0008703]; nucleotide binding [GO:0000166],cytosol [GO:0005829],,,1
I6YDZ2,I6YDZ2_MYCTU,Rv2647,Rv2647,,,,,,Uncharacterized protein,,9634230,,,MHVCHTIADVVDRAKAERSENTLRKDFTPSELLAAGRRIAELERPKAKQRQREGGDHGRQARYSGLGSMEPKPESERDAHKADTAISEALGISRGHYQRLKRIDNATRSEAGYRDGLNGWSG,"13,610",122,,,,,,,2
O05838,O05838_MYCTU,Rv2360c,Rv2360c,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MPSLPDRLASILRDVLPAEEEPDGALTVRHDGTFASLRVVSIAEDLELVSLTQILAWDLPLTKRLAEQVAKQARDINFGSVSLREKVSEKAARRSSGRPASNTADVMLRYNFPGTGLTDDALRTLILLVLETGATIRSALVG,"15,380",142,,,,plasma membrane [GO:0005886],,,1
P71958,P71958_MYCTU,Rv2661c,Rv2661c,,,,,,Uncharacterized protein,,9634230,,,MRARSDAGGQSVKSRTSNRSRSSRRSRVRSSISALVDNPQARPRELPVLCGWPVVRVEPVCEFVPEPVCGQAEVLGEPAAAHRVTSARRSPSTTVCSRSQKASAVVISSVSSVARVRRASVSSVDATTA,"13,701",129,,,,,,,1
I6X4S7,I6X4S7_MYCTU,Rv2605c,tesB2 Rv2605c,GO:0005829; GO:0006637; GO:0009062; GO:0047617,IPR003703; IPR029069; ,,tesB2,,Probable acyl-CoA thioesterase II TesB2 (TEII),cytosol [GO:0005829]; acyl-CoA hydrolase activity [GO:0047617]; acyl-CoA metabolic process [GO:0006637]; fatty acid catabolic process [GO:0009062],9634230; 21969609,,,MSIEEILDLEQLEVNIYRGSVFSPESGFLQRTFGGHVAGQSLVSAVRTVDPRYMVHSLHGYFLRPGDAKERTVFLVERIRDGGSFCTRRVNAVQHGETIFSMAASFQTEQEGITHQDVMPAAPPPDGLPGLNSIKVFDDAGFRQFDEWDVCIVPRERLRLLPGKASQQQVWLRHRDPLPDDPVLHICALAYMSDLTLLGSAQVNHLDVRDQLQVASLDHAMWFMRPFRADEWLLYDQSSPSASGGRALTRGEIFTRSGEMVAAVMQEGLTRHRRGHRSVGQ,"31,569",281,,acyl-CoA metabolic process [GO:0006637]; fatty acid catabolic process [GO:0009062],acyl-CoA hydrolase activity [GO:0047617],cytosol [GO:0005829],,,1
I6Y1F5,I6Y1F5_MYCTU,Rv2660c,Rv2660c,,,,,,Uncharacterized protein,,9634230,,,MIAGVDQALAATGQASQRAAGASGGVTVGVGVGTEQRNLSVVAPSQFTFSSRSPDFVDETAGQSWCAILGLNQFH,"7,582",75,,,,,,,1
I6X552,I6X552_MYCTU,Rv2698,Rv2698,GO:0016021,IPR021443; ,,,,Probable conserved alanine rich transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSGTRLAPHSVRYRERLWVPWWWWPLAFALAALIAFEVNLGVAALPDWVPFATLFTVAAGTLLWLGRVEIRVTAGSADGAGVKLWAGPAHLPVAVIARSAEIPATAKSAALGRQLDPAAYVLHRAWVGPMVLVVLDDPNDPTPYWLVSCRHPERVLSALRS,"17,563",161,,,,integral component of membrane [GO:0016021],,,1
Q79FD3,Q79FD3_MYCTU,Rv2519,PE26 Rv2519,GO:0004190,IPR001969; IPR000084; IPR021109; ,,PE26,,PE family protein PE26,aspartic-type endopeptidase activity [GO:0004190],9634230,,,MSRLIVAPDWLASAAAEVQSIGSALSAANAAAAAPTTLLVAAAEDEVSAAAAALFANYGREYQTLSVRFASLDQQFAQALNSAAASYQTAEATGASLVQTATQGVLGVINAPTEFMFGRSLIGDGADGTAASPIGEPGGILYGDGGNGYSQTTPGAVGGAGGSAGFIGNGGAGGAGGPGAGGGTGGLGGWLWGNNGAAGTGDPVNVAVPLRVENNFPLVNLLVNRGPTVPILLDTGSSSLVIPFWKIGWQNLGLPTGFDVVHYGNGVSIVYADVPTTVDFGGGAATTPTSVHVGILPYPRNLDSLVLIASGGAFGPNGNGILGIGPNVGSYAVSGPGNVVTTDLPGQLNEGTLIDIPGGYMQFGPNTGTPITSVTGAPITVLNVQIGGYDPNGGYWSLPSIFDSGGNHGTLPAVILGTGQTTGYAPPGTVISISIHDNQTLLYQYTTTASNSPVVTADPRLNTGLTPFLLGPVYISNNPSGVGTVVFNYPPP,"48,784",492,,,aspartic-type endopeptidase activity [GO:0004190],,,,1
P95238,P95238_MYCTU,Rv2342,Rv2342,,,,,,Uncharacterized protein,,9634230; 21969609,,,MIGYVAVLGLGYVLGAKAGRRRYEQIASTYRALTGSPVARSMIEGGRRKIANRISPDAGFVTLAEIDNQTAVVQRGVERQPKTAR,"9,206",85,,,,,,,3
I6Y9I3,I6Y9I3_MYCTU,Rv2509,Rv2509,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MPIPAPSPDARAVVTGASQNIGAALATELAARGHHLIVTARREDVLTELAARLADKYRVTVDVRPADLADPQERSKLADELAARPISILCANAGTATFGPIASLDLAGEKTQVQLNAVAVHDLTLAVLPGMIERKAGGILISGSAAGNSPIPYNATYAATKAFVNTFSESLRGELRGSGVHVTVLAPGPVRTELPDASEASLVEKLVPDFLWISTEHTARVSLNALERNKMRVVPGLTSKAMSVASQYAPRAIVAPIVGAFYKRLGGS,"28,013",268,,,oxidoreductase activity [GO:0016491],,,,1
O53206,O53206_MYCTU,Rv2481c,Rv2481c,,,,,,Uncharacterized protein,,9634230,,,MALRRRHEPDGWPFSQRSEKPNAVRHAVRCSAVSAAASTANGTPVNWVSGRVTRAMGVHRQTRGGVASVHADSLRGAVLVHGQLRNSIPISANVPASGANTKSSIAH,"11,267",107,,,,,,,1
O86326,O86326_MYCTU,Rv2401,Rv2401,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230,,,MRDFGQRSRSGGKAIAEHCRTHELHIRPRTGGESATTVQVGRSAANERADIAPRKTRCCVHVAKPNRIRLADQLARSSMGEKPGHDHQRNQRDQNQRDVRPRHPGYLGA,"12,238",109,,,,extracellular region [GO:0005576],,,3
I6Y1F0,I6Y1F0_MYCTU,Rv2655c,Rv2655c,,IPR022081; ,,,,Possible PhiRv2 prophage protein,,9634230,,,MADIPYGRDYPDPIWCDEDGQPMPPVGAELLDDIRAFLRRFVVYPSDHELIAHTLWIAHCWFMEAWDSTPRIAFLSPEPGSGKSRALEVTEPLVPRPVHAINCTPAYLFRRVADPVGRPTVLYDECDTLFGPKAKEHEEIRGVINAGHRKGAVAGRCVIRGKIVETEELPAYCAVALAGLDDLPDTIMSRSIVVRMRRRAPTEPVEPWRPRVNGPEAEKLHDRLANWAAAINPLESGWPAMPDGVTDRRADVWESLVAVADTAGGHWPKTARATAETDATANRGAKPSIGVLLLRDIRRVFSDRDRMRTSDILTGLNRMEEGPWGSIRRGDPLDARGLATRLGRYGIGPKFQHSGGEPPYKGYSRTQFEDAWSRYLSADDETPEERDLSVSAVSAVSPPVGDPGDATGATDATDLPEAGDLPYEPPAPNGHPNGDAPLCSGPGCPNKLLSTEAKAAGKCRPCRGRAAASARDGAR,"51,718",475,,,,,,,1
O05823,O05823_MYCTU,Rv2375,Rv2375,,IPR014447; ,,,,Uncharacterized protein,,9634230; 21969609,,,MIFKGVREGKPYPEHGLSYRDWSQIPPQQIRLDELVTTTTVLALDRLLSEDSTFYGDLFPHAVKWRGTTYLEDGLHRAVRAALRNRTVLHARVFDMDASPGGRRS,"12,026",105,,,,,,,1
O05833,O05833_MYCTU,Rv2365c,Rv2365c,GO:0003824; GO:0040007,IPR016193; ,,,,Uncharacterized protein,catalytic activity [GO:0003824]; growth [GO:0040007],9634230,,,MMRRPITLAEQLDAEDAKLVVLARAAMARAEAGAGAAVRDVDGRTYAAAPVALSALELTGLQAAVAAAVSSGATGLQAAVLVAGSVDDPGIAAVRELAPTAAIIVTDRAGNPL,"11,131",113,,growth [GO:0040007],catalytic activity [GO:0003824],,,,1
I6XEK6,I6XEK6_MYCTU,Rv2553c,mltG Rv2553c,GO:0005887; GO:0008932; GO:0009252; GO:0016829; GO:0071555,IPR003770; ,,mltG,,Endolytic murein transglycosylase (EC 4.2.2.-) (Peptidoglycan polymerization terminase),integral component of plasma membrane [GO:0005887]; lyase activity [GO:0016829]; lytic endotransglycosylase activity [GO:0008932]; cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252],9634230; 21969609,,FUNCTION: Functions as a peptidoglycan terminase that cleaves nascent peptidoglycan strands endolytically to terminate their elongation. {ECO:0000256|HAMAP-Rule:MF_02065}.,MPDGGHRHRAQPVSVRPNRHRRTRVSRAQRRHAQQIRRRRRVAGGFALSLLVVVVVVAVVVGAKLWQTMLGFGNDYTGPGKRDIVIQIRAGDSTTAVGETLLKHGVVATVRAFVDAAHGNTAISSIQPGFYRMRTEISAASAVARLTDPHNRVGKLVIPEGRQLDDTTDMKTNVVNPGIFALISRATCVDLDGTQRCVSVADLRAAASRSTPTMLSVPRWAVGPVMELGTDHRRIEGLIAPGTFNIDPSASAETILATLISAGAVEYMKSGLVDTAKSLGLSPYDILVVASLVQQEANTQDFPKVARVIYNRLHEHRTLEFDSTVNYPLDRREVATSDTDRAQRTPWNTYMAQGLPATAICSPGVDALRAAEHPVPGDWLYFVTIDSQGTTLFTRDYQQHLANIELAKHNGVLDSAR,"45,474",417,Transglycosylase MltG family,cell wall organization [GO:0071555]; peptidoglycan biosynthetic process [GO:0009252],lyase activity [GO:0016829]; lytic endotransglycosylase activity [GO:0008932],integral component of plasma membrane [GO:0005887],,,1
I6X540,I6X540_MYCTU,Rv2683,Rv2683,,IPR000644; ,,,DOMAIN 24 84 CBS. {ECO:0000259|PROSITE:PS51371}.; DOMAIN 111 165 CBS. {ECO:0000259|PROSITE:PS51371}.,Conserved protein,,9634230; 21969609,,,MKVNIDPTAPTFATYRRDMRAEQMAEDYPVVSIDSDALDAARMLAEHRLPGLLVTAGAGKQYAVLPASQVVRFIVPRYVQDDPLLAGVLNESTADRCAERLSGKKVRDVLPDHLVEVPPANADDTIIEVAAVMARLRSPLLAVVKDGSLLGVVTASRLLAAALKT,"17,730",165,,,,,,,1
P71737,P71737_MYCTU,Rv2406c,Rv2406c,,IPR000644; ,,,,Conserved protein,,9634230; 21969609,,,MRIADVLRNKGAAVVTINPDATVGELLAGLAEQNIGAMVVVGAEGVVGIVSERDVVRQLHTYGASVLSRPVAKIMSTTVATCTKSDTVDKISVLMTENRVRHVPVLDGKKLIGIVSIGDVVKSRMGELEAEQQQLQSYITQG,"15,053",142,,,,,,,1
P95233,P95233_MYCTU,Rv2337c,Rv2337c,GO:0005886; GO:0016491,IPR000415,,,,Uncharacterized protein,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MRAGRWGPGMTGLDPAEFLSLVEAAALAPSADNRREVQLEHAGRRVRLWGDQTWRSAPEHRRIMSLVAIGAAVENVKLRAGRLGFETKVCWFPDSGNPGLVAEIDVDRLPQTRVDPIEGAIERRRTNRRVRFRGPPLSQGELGALSAEATGIDGIQLHWFDSPETRKQILRLVRLAETERFRSRELHEELFSAVRFDIGWTASSDDGLPPGSLEVEAWMRPMFRGLRHWRVLRLLRTVGMHHALGLRAAYLPCRLAPHVGALTTSLDLASGALTAGAVFERIWLRTTLLGAELQPFAASAVLSLPACEWVAPHVRAALVGGWNLLAPGHWPMMVFRIGHARAPSVRTMRQSVEAYCYAPAERSGSDSESRFA,"41,272",372,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
P71728,P71728_MYCTU,Rv2415c,Rv2415c,GO:0003677; GO:0005829; GO:0006281; GO:0016021,IPR004509; IPR003583; IPR010994; IPR019554; ,,,,Uncharacterized protein,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; DNA binding [GO:0003677]; DNA repair [GO:0006281],9634230,,,MRTELPAERLQRRLGAVPDIDSHAASAHLDPEPHDPTDDGPDHDEPRDDPNSLLPRWLPDTSRGQGWADRIRADPGRAGAVALAVIAALAVLVTVFTLIRDRTEPVMSAKLPPVEPVSPTNPRSSASPGSPDRSGLPVVVSVVGLVHTPGLVTLAPGARIADALQAAGGAVDGADTVGLNMARQLGDGEQIVVGLAPPSGQPRVLGSSVGAGTPGPAGTSGTATTGPKTAPKTAEVLDLNTATVEQLDALPGIGPVTAAAIVAWRQRNGRFTSVDQLADVDGIGPARLDKRRNLVRV,"30,501",297,,DNA repair [GO:0006281],DNA binding [GO:0003677],cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
I6XEF1,I6XEF1_MYCTU,Rv2487c,PE_PGRS42 Rv2487c,,IPR000084; ,,PE_PGRS42,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS42,,9634230,,,MSLVIATPQLLATAALDLASIGSQVSAANAAAAMPTTEVVAAAADEVSAAIAGLFGAHARQYQALSVQVAAFHEQFVQALTAAAGRYASTEAAVERSLLGAVNAPTEALLGRPLIGNGADGTAPGQPGAAGGLLFGNGGNGAAGGFGQTGGSGGAAGLIGNGGNGGAGGTGAAGGAGGNGGWLWGNGGNGGVGGTSVAAGIGGAGGNGGNAGLFGHGGAGGTGGAGLAGANGVNPTPGPAASTGDSPADVSGIGDQTGGDGGTGGHGTAGTPTGGTGGDGATATAGSGKATGGAGGDGGTAAAGGGGGNGGDGGVAQGDIASAFGGDGGNGSDGVAAGSGGGSGGAGGGAFVHIATATSTGGSGGFGGNGAASAASGADGGAGGAGGNGGAGGLLFGDGGNGGAGGAGGIGGDGATGGPGGSGGNAGIARFDSPDPEAEPDVVGGKGGDGGKGGSGLGVGGAGGTGGAGGNGGAGGLLFGNGGNGGNAGAGGDGGAGVAGGVGGNGGGGGTATFHEDPVAGVWAVGGVGGDGGSGGSSLGVGGVGGAGGVGGKGGASGMLIGNGGNGGSGGVGGAGGVGGAGGDGGNGGSGGNASTFGDENSIGGAGGTGGNGGNGANGGNGGAGGIAGGAGGSGGFLSGAAGVSGADGIGGAGGAGGAGGAGGSGGEAGAGGLTNGPGSPGVSGTEGMAGAPG,"57,218",694,,,,,,,1
O53179,O53179_MYCTU,Rv2452c,Rv2452c,GO:0044119,,,,,Uncharacterized protein,growth of symbiont in host cell [GO:0044119],9634230,,,MAFRDILVLFSMKTLLTLAMAAASSTALTTVGVSGARLITYCVGVEDI,"5,023",48,,growth of symbiont in host cell [GO:0044119],,,,,1
I6XEI0,I6XEI0_MYCTU,Rv2520c,Rv2520c,GO:0016021,IPR022062; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVDRDPNTIKQEIDQTRDQLAATIDSLAERANPRRLADDAKTRVIAFLRKPIVTVSLVGIGSVVVVVVIHKIRNR,"8,374",75,,,,integral component of membrane [GO:0016021],,,1
O06198,O06198_MYCTU,Rv2616,Rv2616,GO:0005886,IPR018960; IPR014457; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MDLNALADLPLTYPEVGATATGRLPAGYNHLDVSTQIGTGRQRFEQAADAVMHWGMQRNAGLRVRASSETAVVSAVVLVGIAFLRAPCRVVYVIDEPDVRGFGYGTLPGHPVSGEERFAVRCDPMTSVVFAEVLSFSRPATWASKAAGPLGAVTQRFIAQRYLRAV,"17,833",166,,,,plasma membrane [GO:0005886],,,1
P71913,P71913_MYCTU,Rv2436,rbsK Rv2436,GO:0004747; GO:0005524; GO:0005829; GO:0019200; GO:0019303; GO:0046835; GO:0046872,IPR011877; IPR011611; IPR002139; IPR029056; ,,rbsK,DOMAIN 15 288 PfkB. {ECO:0000259|Pfam:PF00294}.,Ribokinase (RK) (EC 2.7.1.15),cytosol [GO:0005829]; ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303],9634230; ,X-ray crystallography (2),"FUNCTION: Catalyzes the phosphorylation of ribose at O-5 in a reaction requiring ATP and magnesium. The resulting D-ribose-5-phosphate can then be used either for sythesis of nucleotides, histidine, and tryptophan, or as a component of the pentose phosphate pathway. {ECO:0000256|HAMAP-Rule:MF_01987}.",MANASETNVGPMAPRVCVVGSVNMDLTFVVDALPRPGETVLAASLTRTPGGKGANQAVAAARAGAQVQFSGAFGDDPAAAQLRAHLRANAVGLDRTVTVPGPSGTAIIVVDASAENTVLVAPGANAHLTPVPSAVANCDVLLTQLEIPVATALAAARAAQSADAVVMVNASPAGQDRSSLQDLAAIADVVIANEHEANDWPSPPTHFVITLGVRGARYVGADGVFEVPAPTVTPVDTAGAGDVFAGVLAANWPRNPGSPAERLRALRRACAAGALATLVSGVGDCAPAAAAIDAALRANRHNGS,"30,280",304,"Carbohydrate kinase PfkB family, Ribokinase subfamily",carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303],ATP binding [GO:0005524]; carbohydrate kinase activity [GO:0019200]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747],cytosol [GO:0005829],,,1
P95237,P95237_MYCTU,Rv2341,lppQ Rv2341,,,,lppQ,,Probable conserved lipoprotein LppQ,,9634230,,,MPVGGRQHVFEKLASILGLVAAPLMLLGLSACGRSAGKTSEPTCPTEPIDAADSSTTPDPSCVVRATEINGNGSRIQTWTGSYDAAATQSGGVCGGTCNFHATVRFTVDEGQISGSVDQVYQAAMVAIATRPTSPSLAP,"14,141",139,,,,,,,1
I6XEX3,I6XEX3_MYCTU,Rv2651c,Rv2651c,GO:0008233,IPR006433; ,,,,Possible PhiRv2 prophage protease,peptidase activity [GO:0008233],9634230,,,MSSILFRTAELRPGEGRTVYGVIVPYGEVTTVRDLDGEFREMFAPGAFRRSIAERGHKVKLLVSHDARTRYPVGRAVELREEPHGLFGAFELANTPDGDEALANVKAGVVDAFSVGFRPIRDRREGDVIVRVEAALLEVSLTGVPAYLGAQIAGVRAESLAVVSRSLAEARLALMDW,"19,292",177,,,peptidase activity [GO:0008233],,,,1
I6Y1H7,I6Y1H7_MYCTU,Rv2690c,Rv2690c,GO:0005887; GO:0015179; GO:0015297,IPR002293; ,,,,Probable conserved integral membrane alanine and valine and leucine rich protein,integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179],9634230; 21969609,,,MSKLSTAARRLLIGRPFRSDRLSHTLLPKRIALPVFASDAMSSIAYAPEEIFLVLSVAGLAAYSMAPLIGLAVAAVLLVVVSSYRQNVHAYPSGGGDYEVVTTNLGATGGLVVASALMVDYVLTVAVSISSAASNIGSVSPFVYEHKVLFAVGAIVLIMAMNLRGVRESGLAFAIPTYAFIAGIGTMLVWGLFRIFVLGNPVRAESAAFEMHAEHGQIVGFALVFLVARSFSSGCAALTGVEAISNGVPAFQKPKSRNAATTLLMLGIIAVSMFMGMIVLAVETGVQVVDDPDTQLTGAPPGYQQKTLVAQLAQAVFGGFYLGFLLIAAVTALILVLAANTAFNGFPVLGSVLAQHSYLPRQLHTRGDRLAFSNGILFLAAAAIGAVVAFRAELTALIQLYIVGVFISFTMSQVGMVRHWTRLLSAETDPRARRAMLRSRAVNTVGFVSTGTVLLIVLVTKFLAGAWIAIVAMGGFFMMMKLIHRHYDAVNRELAEQAEEAEITLPSRNHAVVLVSKLHLPTLRALTYARATRPDVLEAVTVNVDDAETRELVRQWQDSDVSVPLKVIASPYREITRPVLDYVKRVSKESPRTVVTVFIPEYVVGRWWEQLLHNQSALRLKGRLLFMPGVMVTSVPWQLTSSERIKTLQPHAAPGDT,"70,802",657,,,antiporter activity [GO:0015297]; L-amino acid transmembrane transporter activity [GO:0015179],integral component of plasma membrane [GO:0005887],,,1
I6YE67,I6YE67_MYCTU,Rv2707,Rv2707,GO:0005886; GO:0016021,IPR017039; ,,,,Probable conserved transmembrane alanine and leucine rich protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MSDQVPKPHRHHIWRITRRTLSKSWDDSIFSESAQAAFWSALSLPPLLLGMLGSLAYVAPLFGPDTLPAIEKSALSTAHSFFSPSVVNEIIEPTIGDITNNARGEVASLGFLISLWAGSSAISAFVDAVVEAHDQTPLRHPVRQRFFALFLYVVMLVFLVATAPVMVVGPRKVSEHIPESLANLLRYGYYPALILGLTVGVILLYRVALPVPLPTHRLVLGAVLAIAVFLIATLGLRVYLAWITRTGYTYGALATPIAFLLFAFFGGFAIMLGAELNAAVQEEWPAPATHAHRLGNWLKARIGVGTTTYSSTAQHSAVAAEPPS,"35,047",324,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P95234,P95234_MYCTU,Rv2338c,moeW Rv2338c,GO:0008641; GO:0040007; GO:0061503; GO:0061504,IPR000594; IPR035985; ,,moeW,,Possible molybdopterin biosynthesis protein MoeW,tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504]; growth [GO:0040007],9634230; 21969609,,,MRAGADAPDSGRVKESAPWSYDEAFCRNLGLISPTEQQRLRNSRVAIAGMGGVGGIDMVALARMGIGKFTIADPDVFEIRNSNRQYGAMRSTNGQAKAEVMRNIVHDINPEAEIRAFCEPIGKENAATFLEGADVLVDGIDAFEIDLRRLLYREAQQRGIYALGAGPLGFSTAWVVFDPKGMTFDRYFDLSDAMNTVDKFVAFIAGIAPSATHRRSIDLSYVDIENRTGPSVGLACHLASGVVAAEVLKILLGHGRVYAAPYFHQFDAYRSIYVRKRLRCGNRHPLQRVKRRLLARYINRRSAGVIPGLRYHRTEPSY,"35,271",318,,cyclic threonylcarbamoyladenosine biosynthetic process [GO:0061504]; growth [GO:0040007],tRNA threonylcarbamoyladenosine dehydratase [GO:0061503]; ubiquitin-like modifier activating enzyme activity [GO:0008641],,,,1
P95244,P95244_MYCTU,Rv2348c,Rv2348c,,,,,,Uncharacterized protein,,9634230,,,MLLPLGPPLPPDAVVAKRAESGMLGGLSVPLSWGVAVPPDDYDHWAPAPEDGADVDVQAAEGADAEAAAMDEWDEWQAWNEWVAENAEPRFEVPRSSSSVIPHSPAAG,"11,397",108,,,,,,,2
I6YA00,I6YA00_MYCTU,Rv2674,msrB Rv2674,GO:0006979; GO:0030091; GO:0033743; GO:0046872,IPR028427; IPR002579; IPR011057; ,,msrB,DOMAIN 10 134 MsrB. {ECO:0000259|PROSITE:PS51790}.,Peptide-methionine (R)-S-oxide reductase (EC 1.8.4.12),metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979],9634230; 21969609,,,MTRPKLELSDDEWRQKLTPQEFHVLRRAGTERPFTGEYTDTTTAGIYQCRACGAELFRSTEKFESHCGWPSFFDPKSSDAVTLRPDHSLGMTRTEVLCANCDSHLGHVFAGEGYPTPTDKRYCINSISLRLVPGSV,"15,318",136,,protein repair [GO:0030091]; response to oxidative stress [GO:0006979],metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743],,,,1
I6Y9F7,I6Y9F7_MYCTU,Rv2485c,lipQ Rv2485c,GO:0008152; GO:0016787,IPR029058; IPR013094; ,,lipQ,,Probable carboxylesterase LipQ,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230,,,MHIASVTSRCSRAGAEALRQGAQLAADARDTCRAGALLLRGSPCAIGWVAGWLSAEFPARVVTGHALSRISPRSIGRFGTSWAAQRADQILHAALVDAFGPDFRDLVWHPTGEQSEAARRSGLLNLPHIPGPHRRYAAQTSDIPYGPGGRENLLDIWRRPDLAPGRRAPVLIQVPGGAWTINGKRPQAYPLMSRMVELGWICVSINYSKSPRCTWPAHIVDVKRAIAWVRENIADYGGDPDFITITGGSAGAHLAALAALSANDPALQPGFESADTAVQAAAPYYGVYDLTNAENMHEMMMPFLEHFVMRSRYVDNPGLFKAASPISYVHSEAPPFFVLHGEKDPMVPSAQSRAFSAALRDAGAATVSYAELPNAHHAFDLAATVRSRMVAEAVSDFLGVIYGRRMGARKGSLALSSPPAS,"45,249",421,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
I6YDV4,I6YDV4_MYCTU,Rv2609c,Rv2609c,GO:0016787,IPR015797; IPR020084; IPR000086; ,,,,Probable conserved membrane protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MTWLVLAGAVLLVVLVAFGAWGYQTANRLNRLNVRYDLSWQSLDSALARRAVVARAVAIDAYGGAPQGSRLAALADAAEGAPRHARENAENELSAALAMVNPASLPAALIAELADAEARVLLARRFHNDAVRDTLALGERRLVRLLRLGGTAVLPTYFEIVERPHALVHGDQGASGRRTSARVVLLDDSGAVLLLCGSDPANPAFRDGAAPKWWFTVGGQVRPGERLAQAAARELAEETGLRVAPADMIGPIWRRDEVFEFNGSLIDSEEFYLVHRTRRFEPAVQGRTELERRYIRDARWCDANDIAQLVAAGERVYPLQLGELLPAANRLVDVALDNGAARDAGVPQPIR,"38,096",351,,,hydrolase activity [GO:0016787],,,,1
P71729,P71729_MYCTU,Rv2414c,Rv2414c,GO:0016021,IPR004477; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MGFGASRLDVRLVPAALVSWIVTAAGIVWPIGNVCALCCVVVALGGGALWWCVARRSWHAPRLGSISAGLVAVGMVGAGYGLAVALRSEAVDRHPITVAFGTSALVTVTPSESPVSLGRGRLMFRATVQRLRDDETSGRVVVFARALDFGELMVGQPVQFRARISRPARHDLTVAVFNATGRPTVGRAGPVHRAAHIVRHRFAAAVREVLPADQATMLPALVLGDTSTVTALTSREFRAAGLTHLTAVSGANVTIVCAAALVSARLIGPRAAVVCAAVALVAFVILVQPTASVLRAAVMGAIALVGMLSARRRQAIPALSGSVLVLLAAAPHLAVDIGFALSVAATGALVVIAPVWSRRLVDRGCPKVLADALAVAAAAQLVTAPLVAAISGRVSLVAVVANLAVAAVIAPITVLGSVAAVLVVPWPAGAQVLIRFTGPEVWWVLRVAHWASGVPAATVPVAAGLPGVLLVGGATVFTVAQWRWRWFRAAMCKTMAVAVICLLAWSLSGLVGPS,"52,813",514,,,,integral component of membrane [GO:0016021],,,3
O53198,O53198_MYCTU,Rv2471,aglA Rv2471,GO:0003824; GO:0005618; GO:0005829; GO:0005886; GO:0005975,IPR006047; IPR017853; ,,aglA,DOMAIN 39 424 Aamy. {ECO:0000259|SMART:SM00642}.,Probable alpha-glucosidase AglA (Maltase) (Glucoinvertase) (Glucosidosucrase) (Maltase-glucoamylase) (Lysosomal alpha-glucosidase) (Acid maltase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; carbohydrate metabolic process [GO:0005975],9634230; 21969609,,,MDQHQRPDPMGPGSPRASARRPEPDPMGEPWWSRAVFYQVYPRSFADSNGDGVGDLDGLASRLDHLQQLGVDAIWINPVTVSPMADHGYDVADPRDIDPLFGGMPAFERLVAAAHRQGIKVTMDVVPNHTSSAHPWFQAALADLPGSPARDRYFFRDGRGPDGSLPPNNWESVFGGPAWTRVREPDGNPGQWYLHLFDTEQPDLNWDNPEILDDFEKTLRFWLDRGVDGFRIDVAHGMAKPPGLPDSPDLGIEVLHHRDDDPRFNHPNVHAIHRDIRTVIDEYPGAVTVGEVWVHDNARWAEYLRPDELHLGFNFRLARTEFDAAEIRDAVANSLAAAALQNATPTWTLANHDVGREVSRYGGGEIGLRRAKAMAVVMLALPGVVFLYNGQELGLPDVDLPDEVLQDPTWERSGRTERGRDGCRVPIPWSGNIPPFGFSTCPDTWLPMPPEWAALTAEKQRADAGSTLSFFRLALRLRRERNEFDGDVDWLAAPDDALIFRRHGGGLVCALNAAERPLALPAGEPILASAPLTDATLPPNAAAWLV,"60,444",546,,carbohydrate metabolic process [GO:0005975],catalytic activity [GO:0003824],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P95012,P95012_MYCTU,Rv2541,Rv2541,,,,,,Hypothetical alanine rich protein,,9634230,,,MRRRRPPHVNAPTPCDRGDVRPPGCPASIPGVEVAGGTRARLRVTADGLQALAGRCATLAGELSAAVAPSGAVLSWQANAVAVNAAHARAGAAAAAVSARMRATAAALGQAARRYAGQDTAAAAALGAVRPWGTH,"13,403",135,,,,,,,1
O53213,O53213_MYCTU,Rv2488c,Rv2488c,GO:0003677; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0009190; GO:0016849; GO:0035556,IPR001054; IPR029787; IPR027417; IPR016032; IPR011990; IPR000792; IPR036388; ,,,DOMAIN 58 164 Guanylate cyclase. {ECO:0000259|PROSITE:PS50125}.; DOMAIN 1063 1128 HTH luxR-type. {ECO:0000259|PROSITE:PS50043}.,Probable transcriptional regulatory protein (LuxR-family),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; phosphorus-oxygen lyase activity [GO:0016849]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MDRRPRDFEQSRRRCRCNALRAGSMLASMSKIHPGVDVVPVDWSADGVSELVPTGTVTLLLADIEGATHLPGSQLDTTAIAKLDRTLTELVREHRGVCPVEQGEGDSFLVAFARASDAVACALGLQRAPLAPIRLRIGMHTGEVSSPDEGNCVGPTIDRTARLRELAHGGQTVLSGTTSDLVADLLPKDAWLNDLGTYRLDDLPRPERVVQLCHPDLHNAFPPLRTRKVVGAHCLPAQLTRLVGRVDEVAQVRGLLDVKRWVTLTGVGGVGKTRLATQVASAVADGYPDGVWYVNLAPITDPALVPIAAARVLGLPDQPGRSTVDTIVRRIGDRRMLVVLDNCEHLLDGCAALIVALLGACPALRVLATSREPIAVAGEQIWRVPPLGHGEAIELFTDRAREARPELEITADNLALVTEICHRLDGIPLAIELAASRVRALALTEIVDSLHDRFRLLTGGSRIAVRRQQTMRASVDWSHALLTGPEQVLFRRLAVFPSGFDLDGAQAAAAGGDVQRYEVVDLLSLLADKSLVVTDDSDGRTRYRLLETVRQYALEKLRESGDADAVRARHRDHYAAVAAGLDAPSVAGHERRLNQAELEIDNLRAAFAFSRENGDTGHALLLASCLQPLWRARGRLQEGLAWFAAALADHDAHPAGADPGLYARALADRALIDAVAGITDRLDDAQKALAIARDIEDPALLARALTACGGVAAYNADLARPWLAEAVGLARAVGDKWRLAEVLAWQAYVGFAGEGDPGATRAAGEEARSLADEIGDAFLSRSCRWALAAANLWQGNLEAAVGLSREVIGESDAAHDMVSSCAGQACLAHALAHRGDTEAAAAAQASIDTAVGLSPVLSGSACSALVFATLAAGDVAAAEHARESATRFFGASAAAIINDPTSSAQISCARGDLNAAHRLADGAASITRGVHRARALTTRCRIEIAQGDRHRAERDAHDALGVAASIGAYLWVPDILECLASVMADAGSNREAVRLFGAADAARGRMGAVRFGIYQAGCNSSLATLRKSMGDSEFDDAWAEGTALSIDEAIAYAQRGRGARKRPTSGWGALTPTELEVALLVGEGLSNKEIGVRLFISPRTVHSHLTHVYTKLGLSSRLQLAQQAARRGESERGPSRP,"120,818",1137,,"cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; phosphorus-oxygen lyase activity [GO:0016849],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q50631,Q50631_MYCTU,Rv2590,fadD9 Rv2590,GO:0005829; GO:0005886; GO:0008152; GO:0016874; GO:0031177,IPR036736; IPR020845; IPR000873; IPR013120; IPR036291; IPR020806; IPR009081; IPR010080; ,,fadD9,DOMAIN 645 720 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable fatty-acid-CoA ligase FadD9 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; metabolic process [GO:0008152],9634230; 21969609,,,MSINDQRLTRRVEDLYASDAQFAAASPNEAITQAIDQPGVALPQLIRMVMEGYADRPALGQRALRFVTDPDSGRTMVELLPRFETITYRELWARAGTLATALSAEPAIRPGDRVCVLGFNSVDYTTIDIALIRLGAVSVPLQTSAPVTGLRPIVTETEPTMIATSIDNLGDAVEVLAGHAPARLVVFDYHGKVDTHREAVEAARARLAGSVTIDTLAELIERGRALPATPIADSADDALALLIYTSGSTGAPKGAMYRESQVMSFWRKSSGWFEPSGYPSITLNFMPMSHVGGRQVLYGTLSNGGTAYFVAKSDLSTLFEDLALVRPTELCFVPRIWDMVFAEFHSEVDRRLVDGADRAALEAQVKAELRENVLGGRFVMALTGSAPISAEMTAWVESLLADVHLVEGYGSTEAGMVLNDGMVRRPAVIDYKLVDVPELGYFGTDQPYPRGELLVKTQTMFPGYYQRPDVTAEVFDPDGFYRTGDIMAKVGPDQFVYLDRRNNVLKLSQGEFIAVSKLEAVFGDSPLVRQIFIYGNSARAYPLAVVVPSGDALSRHGIENLKPVISESLQEVARAAGLQSYEIPRDFIIETTPFTLENGLLTGIRKLARPQLKKFYGERLERLYTELADSQSNELRELRQSGPDAPVLPTLCRAAAALLGSTAADVRPDAHFADLGGDSLSALSLANLLHEIFGVDVPVGVIVSPASDLRALADHIEAARTGVRRPSFASIHGRSATEVHASDLTLDKFIDAATLAAAPNLPAPSAQVRTVLLTGATGFLGRYLALEWLDRMDLVNGKLICLVRARSDEEAQARLDATFDSGDPYLVRHYRELGAGRLEVLAGDKGEADLGLDRVTWQRLADTVDLIVDPAALVNHVLPYSQLFGPNAAGTAELLRLALTGKRKPYIYTSTIAVGEQIPPEAFTEDADIRAISPTRRIDDSYANGYANSKWAGEVLLREAHEQCGLPVTVFRCDMILADTSYTGQLNLPDMFTRLMLSLAATGIAPGSFYELDAHGNRQRAHYDGLPVEFVAEAICTLGTHSPDRFVTYHVMNPYDDGIGLDEFVDWLNSPTSGSGCTIQRIADYGEWLQRFETSLRALPDRQRHASLLPLLHNYREPAKPICGSIAPTDQFRAAVQEAKIGPDKDIPHLTAAIIAKYISNLRLLGLL,"127,328",1168,,metabolic process [GO:0008152],ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O07206,O07206_MYCTU,Rv2705c,Rv2705c,,IPR009297; ,,,,Uncharacterized protein,,9634230; 21969609,,,MRMTPDPAMLVHLCGVQEWSHARERGGIYPESDKTGYIHLSTLEQVHLPANRLYRGRADLVLLYIDPAALDSPVRWEPGVPTDPRSMLFPHLYGPLPVRAVIGAAAYPPAGDGSFGPAPEFRSATADPT,"14,087",129,,,,,,,1
P71941,P71941_MYCTU,Rv2642,Rv2642,GO:0003700; GO:0005622; GO:0006355; GO:0044212; GO:0046688,IPR011991; IPR018334; IPR001845; IPR036388; IPR036390; ,,,DOMAIN 23 120 HTH arsR-type. {ECO:0000259|PROSITE:PS50987}.,Possible transcriptional regulatory protein (Probably ArsR-family),"intracellular [GO:0005622]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; response to copper ion [GO:0046688]",9634230,,,MSNLHPLPEVASCVVAPLVREPLNPPAAAEMAARFKALADPVRLQLLSSVASRAGGEACVCDISAGVEVSQPTISHHLKVLRDAGLLTSRRRASWVYYAVVPEALTVLSNLLSVHADAAPALGAPA,"13,111",126,,"regulation of transcription, DNA-templated [GO:0006355]; response to copper ion [GO:0046688]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],intracellular [GO:0005622],,,1
Q79FC3,Q79FC3_MYCTU,Rv2615c,PE_PGRS45 Rv2615c,,IPR000084; ,,PE_PGRS45,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS45,,9634230,,,MSFVNVAPQLVSTAAADAARIGSAINTANTAAAATTQVLAAAQDEVSTAIAALFGSHGQHYQAISAQVAAYQQRFVLALSQAGSTYAVAEAASATPLQNVLDAINAPVQSLTGRPLIGDGANGIDGTGQAGGNGGWLWGNGGNGGSGAPGQAGGAGGAAGLIGNGGAGGAGGQGLPFEAGANGGAGGAGGWLFGNGGAGGNGGIGGAGTNLAIGGHGGNGGNAGLIGAGGTGGAGGTGGGEPSAGASGGNGGNGGNGGLLIGNSGDGGAAGNGAGISQNGPASGFGGNGGHAGTTGLIGNGGNGGAGGAGGDVSADFGGVGFGGQGGNGGAGGLLYGNGGAGGNGGAAGSPGSVTAFGGNGGSGGSGGNGGNALIGNAGAGGSAGAGGNGASAGTAGGSGGDGGKGGNGGSVGLIGNGGNGGNGGAGSLFNGAPGFGGPGGSGGASLLGPPGLAGTNGADG,"39,311",461,,,,,,,1
Q50732,Q50732_MYCTU,Rv2566,Rv2566,GO:0005829,IPR013589; IPR018667; IPR002931; ,,,DOMAIN 210 286 TGc. {ECO:0000259|SMART:SM00460}.,Long conserved protein,cytosol [GO:0005829],9634230; 21969609,,,MPLRPTQVSGTGRTRCAGRSGVISSAAMSIKVALEHRTSYTFDRLVRVYPHIVRLRPAPHSRTSIEAYSLRIEPADHFINWQQDALGNFLARLVFPNPMRQLRITVGLIADLKVINPFDFFIEDWAEIWPCAGMAYPKALADDLRPYLRPVDEDGDGSGPGELTQAWVRNFTVPDGTRTIDFLVALNRAINADVGYCVRMEPGVQTPDFTLRTGVGSCRDSAWLLVSILRQFGLAARFVSGYLVQLASDIEALDGPSGPAADFTDLHAWAEAYIPGAGWIGLDPTSGLLAGEGHIPLAATPHPASAAPISGGTDVCDTVLEFSNTVTRVHEDPRVTLPYTDESWKTICEVGQRVDERLAAADVRLTVGGEPTFVSVDNQVAEEWRTAADGPHKRERASDLAARLKAVWAPQGLIHRGQGRWYPGEPLPRWQIALYWRTDGRPLWTNDALLADPWGAPPADPVDDDAAYRVLAGIADGLGLPISQVRPAYEDPLSRLAAAVRMPAGDPVESGDDLGCDTNPDTPTGRAALLARLDEAITSPAAYVLPLHRRDDGQGWASANWRLRRGRIVLLEGDSPAGLRLPLDSISWRPPRASFDADPVAVRSTLPAELHTDRAVVEDPETAPTTALVAEVRGGLVHIFLPPTDALEHFIDLVARVEAAATTANCPVVIEGYGPPPDPRLTSTTITPDPGVIEVNIAPTASFAEQRQQLETLYQQARLARLTTEAFDVDGTHGGTGGGNHITLGGVTPADSPLLRRPDLLVSLLTYWQRHPSLSYLFAGRFVGTTSQAPRVDEGRAEALYELEIAFAEILRLSPSSGGGRPQPWVTDRALRHLLTDITGNTHRAEFCIDKLYSPDSARGRLGLLELRGFEMPPHLHMAMVQSLLVRSLVAWFWDQPLRAPLIRHGANLHGRYLLPHFLIHDIADVAADLRAHGIAFETSWLDPFTEFRFPRIGTAVFDGIEIELRGAIEPWHTLGEEATAAGTARYVDSSVERIQVRIIGADRHRYVVTCNGYPMPLLATDNPDIHVGGVRFKAWQPPSALHPTITVDGPLRFELIDIATATSCGGCTYHVAHPGGRAYDEPPVNAVEAEARRARRFEATGFTPGKLDLSDIREKQARISTDIGAPGILDLRRVRTVQQ,"124,536",1140,,,,cytosol [GO:0005829],,,1
I6X562,I6X562_MYCTU,Rv2708c,Rv2708c,,IPR021400; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSGMQTQTIERTDADERVDDGTGSDTPKYFHYVKKDKIAESAVMGSHVVALCGEVFPVTRAPKPGSPVCPDCKRIYDTLKKG,"8,962",82,,,,,,,1
O07207,O07207_MYCTU,Rv2706c,Rv2706c,,,,,,Uncharacterized protein,,9634230,,,MLVGVMLAEKKLGSGGQLGAHPSCSATAVAAVCSSQLRTGQSCVHGSPFSGIFTFSDVRGSRRVPRPLSGVSFLTTFAPANRAGW,"8,724",85,,,,,,,1
I6Y120,I6Y120_MYCTU,Rv2552c,aroE Rv2552c,GO:0004764; GO:0005829; GO:0009423; GO:0019632; GO:0050661,IPR036291; IPR013708; IPR010110; ,,aroE,DOMAIN 10 92 Shikimate_dh_N. {ECO:0000259|Pfam:PF08501}.,Probable shikimate 5-dehydrogenase AroE (5-dehydroshikimate reductase),cytosol [GO:0005829]; NADP binding [GO:0050661]; shikimate 3-dehydrogenase (NADP+) activity [GO:0004764]; chorismate biosynthetic process [GO:0009423]; shikimate metabolic process [GO:0019632],9634230; 21969609; ,X-ray crystallography (3),,MSEGPKKAGVLGSPIAHSRSPQLHLAAYRALGLHDWTYERIECGAAELPVVVGGFGPEWVGVSVTMPGKFAALRFADERTARADLVGSANTLVRTPHGWRADNTDIDGVAGALGAAAGHALVLGSGGTAPAAVVGLAELGVTDITVVARNSDKAARLVDLGTRVGVATRFCAFDSGGLADAVAAAEVLVSTIPAEVAAGYAGTLAAIPVLLDAIYDPWPTPLAAAVGSAGGRVISGLQMLLHQAFAQVEQFTGLPAPREAMTCALAALD,"27,208",269,,chorismate biosynthetic process [GO:0009423]; shikimate metabolic process [GO:0019632],NADP binding [GO:0050661]; shikimate 3-dehydrogenase (NADP+) activity [GO:0004764],cytosol [GO:0005829],,,1
I6Y0L1,I6Y0L1_MYCTU,Rv2380c,mbtE Rv2380c,GO:0003824; GO:0008152; GO:0031177,IPR010071; IPR036736; IPR025110; IPR020845; IPR000873; IPR023213; IPR001242; IPR020806; IPR009081; IPR006162; ,,mbtE,DOMAIN 936 1011 Carrier. {ECO:0000259|PROSITE:PS50075}.; DOMAIN 1573 1647 Carrier. {ECO:0000259|PROSITE:PS50075}.,Peptide synthetase MbtE (Peptide synthase),catalytic activity [GO:0003824]; phosphopantetheine binding [GO:0031177]; metabolic process [GO:0008152],9634230; 21969609,,,MWFVQMADPSGALLNICVSYRITGDIDLARLRDAVNAVARRHRILRTTYPVGDDGVAQPTVHADLRPGWTQYDLTDLSQRAQRLRLEVLAQREFCAPFELSRDAPLRITVVRTAADEHVLLLVAHHIAWDDGSWRVFFTDLTQAYSRADLGADLGPEHRPSAASGPDTTEADLNYWRAIMADPPEPLELPGPAGTCVPTSWRAARATLRLPADTAARVATMAKNTGCTPYMVLLAAFGALVHRYTHSDDFLVAAPVLNRGAGTEDAIGYFGNTVAMRLRPQSAMSFRELLTATRDIASGAFAHQRINLDRVVRELNPDRRHGAERMTRVSFGFREPDGGGFNPPGIECERYDLRSNITQLPLGFMVEFDRAGVLVEAEHLVEILEPALAKQMLRHFGVLLDNALAAPDNTLSGLALMDERDAARLREVSRGERFDTPVKTLVDLVNEQTTRTPDATAVVYEGQHFTYHDLNEASNRLGHWLIEQGIGSEDRVAVLLDKSPDLIVTALGVVKSGAVYVPVDPSYPQDRLDFILADCDAKLVLRTPVRELAGYRSDDPTDADRIRPLRPDNTAYLIYTSGTTGLPKGVAVPHRPVAEYFVWFKGEYDVDDTDRLLQVASPSFDVSIAEIFGTLACGARMVIPRPGGLTDIGYLTALLRDEGITAMHFVPSLLGLFLSLPGVSQWRTLQRVPIGGEPLPGEVADKFHATFDALLHNFYGPTETVINASRFKVVGPQGTRIVPIGRPKINTTMHLLDDSLQPVPTGVIGEIYIGGTHVAYGYHRRAGLTAERFVADPFNPGSRMYRSGDLARRNADGDIEFVGRADEQVKIRGFRIELGDVAAAIAVDPTVGQAVVVVSDLPRLGKSLVGYVTPAAGGDGPADVGVDLDRIRARVAAALPEYMLPAAYVVLDEIPITAHGKIDRAALPEPQIASDTEFRAPQTATERRLAQLFGELLGRDRVGADDSFFDLGGHSLLATKLVAAVRNAFGVDVGVREIFEFATVTALAGHIDTLDSDSARPRLTRVDHDGPVRLSSSQMRSWFNYRFDGPNAVNNIPFAAALHGPCDTNAFAAAITDVVARHEILRTVYREIGGVPHQIIQPPAEVPVRCAAGSDAAWLRAELNNERGYVFDLETDWPIRAALLSTPEQTVLSLVVHHIAGDHWSAGVLFTDLLTAYRARSTGQRPSWAPLPVQYADYSVWQSALLDDGAGIVGPQRDYWIRQLGGLAGETGLRPDFPRPALLSGAGDAVEFRLGAAIRDKLAAVSRDLGVTEFMLLQAAVAVVLHKAGGGVDVPIGAPVAGRSEANLDQLIGFFINIVVLRNDLRGNPTLREVLQRTRQMALAAYAHQDLPFDQVVEAVNPQRSLSRNPLFDIVVHVREQMPQDHVIDTGPDGDTTLRVLEPTFDAAQADLSVNFFACGDEYRGHVIYRTELYERATAQRFADWLVRVVEAFADRPDQPLREVEMVSAQARRRILDRSNAGAGTARVYLLDDALKPVPVGVVGDVYYGGGPAVGARLARPSETATRFVADPFAAQPGSRLYRNGERGVWKADGQLELLAEIERLPTAQAAPVPAEPADTETERALAAILADVLEVGEVGRYDDFFNLGGDSILATQVAARARDGGIPLTARMVFEHPVLCELAAAVDAKPHVEAEPDDKHHAPMSTSGLSPDELSALTASWDQWP,"183,283",1682,,metabolic process [GO:0008152],catalytic activity [GO:0003824]; phosphopantetheine binding [GO:0031177],,,,2
I6X4J0,I6X4J0_MYCTU,Rv2522c,Rv2522c,GO:0008152; GO:0016787,IPR002933; IPR011650; ,,,DOMAIN 211 360 M20_dimer. {ECO:0000259|Pfam:PF07687}.,Uncharacterized protein,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230; 21969609,,,MSASRRRIASKSGFSCDSASARELVERVREVLPSVRCDLEELVRIESVWADPDRRDEVHRSARAVADLLSQAGFDDVRIVSERGAPAVIARYPAPPGAPTVLLYAHHDVQPEGDRGQWVSPPFEPTERGGRLYGRGTADDKAGIATHVAAFWAHGGRPPVGVTVFVEGEEESGSPSLGRLLAAHRDALAADVIVIADSDNWSTDIPALTVSLRGMADCVVEVATLDHGLHSGLWGGVVPDALTVLVRLLASLHDDDGNVAVAGMHESTAARVDYPAGRVRAESGLLDGVSEIGTGSVPQRLWAKPAITVIGIDTTSVAAASNTLIPRARAKISIRVAPGGDATAHLDAVEAHLRRHAPWGAQVTVTRGEVGQPYAIEASGPVYDAARSAFRQAWGADPIDMGMGGSIPFIAEFAAAFPQATILVTGVEDPGTQAHSVNESLHLGVLERAATAEALLLAKLAAIPTGRAEA,"49,325",470,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
I6X4W4,I6X4W4_MYCTU,Rv2643,arsC Rv2643,GO:0005886; GO:0015104; GO:0015105; GO:0015297; GO:0015699; GO:0015700; GO:0016021,IPR004706; IPR002657; IPR038770; IPR023485; IPR036196; ,,arsC,,Probable arsenic-transport integral membrane protein ArsC,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antimonite transmembrane transporter activity [GO:0015104]; antiporter activity [GO:0015297]; arsenite transmembrane transporter activity [GO:0015105]; antimonite transport [GO:0015699]; arsenite transport [GO:0015700],9634230; 21969609,,,MTETVTRTAAPAVVGKLSTLDRFLPVWIGSAMAAGLLLGRWIPGLHTALEGVQLDGISLPIALGLLIMMYPVLAKVRYDRLDTVTGDRKLLLSSLLLNWVLGPALMFALAWLLLADLPEYRTGLIIVGLARCIAMVIIWNDLACGDREAAAVLVALNSIFQVAMFAALGWFYLSVLPGWLGLEQTTIATSPWQIAKSVLIFLGIPLLAGYLSRRIGEKTKGRNWYESRFLPKVGPWALYGLLFTIVILFALQGDQITGRPLDVARIALPLLAYFAIMWVGGYLLGAALRLGYRRTTTLAFTAASNNFELAIAVAIATYGATSGQALAGVVGPLIEVPVLVGLVYVSLALRNRLAGPNATHDADKPSVLFVCVHNAGRSQMAAGLLTHLAGDRIEVRSAGTEPAGQVNPTAVAAMAEMGIDITANAPTLLTGGQVQSSDVVITMGCGDACPYFPGVSYRNWKLPDPAGQPLDVVRMIRDDIADRVQALIAELLATAKTR,"53,226",498,Low molecular weight phosphotyrosine protein phosphatase family,antimonite transport [GO:0015699]; arsenite transport [GO:0015700],antimonite transmembrane transporter activity [GO:0015104]; antiporter activity [GO:0015297]; arsenite transmembrane transporter activity [GO:0015105],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6YA25,I6YA25_MYCTU,Rv2709,Rv2709,GO:0016021,IPR021449; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MWDSRVMKHGLRLGFNGQFDDFDDFDDKGRPVLITAAAPSYEVEHRTRVRKYLTLMAFRVPALILAAIAYGAWHNGLISLLIVAASVPLPWMAVLIANDRPPRRADEPRRFDVARRRIPLFPTAERPALEPRRQPAERSAPRGFADHG,"16,810",148,,,,integral component of membrane [GO:0016021],,,1
O06195,O06195_MYCTU,Rv2618,Rv2618,,IPR036390; ,,,,Uncharacterized protein,,9634230; 21969609,,,MDPVRRQLYQFVCSQSMPVSRDQAADAVGIPRHQAKFHLDRLTAEGLLDTEYARLTGRSGPGAGRTAKLYRRAGRDIALSLPQREYELAGRLMAAAIVLSATTGEPTVEVLNRIAHDYGQAMGAAATTRPPADPAAALELTLDVLRKYGYEPRRPAGPGDDEVELVNCPFHALAREQTELACNMNHALITGVADALAPHSPAVRLAPGPARCCVVLKRCSAHDPE,"24,241",225,,,,,,,1
P71922,P71922_MYCTU,Rv2426c,Rv2426c,GO:0005524; GO:0005886; GO:0016887,IPR003593; IPR011704; IPR027417; ,,,,Uncharacterized protein,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MTVPARPTPLFADIADVSRRLAETGYLPDTATATAVFLADRLGKPLLVEGPAGVGKTELARAVAQATGSGLVRLQCYEGVDEARALYEWNHAKQILRIQAGSGDWEATKTDVFSEEFLLQRPLLTAIRRTEPTVLLIDETDKADIEIEGLLLEVLSDFAVTVPELGTLTATRAPFVLLTSNATRELSEALKRRCLYLHIDFPTPELERRILLSRVPELPEHFAEELVRIIGVLRGMQLKKVPSIAETIDWGRTVLALGLDTIDDAVVAATLGVVLKHQSDQQRATGELRLN,"31,951",291,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,2
P71947,P71947_MYCTU,Rv2650c,Rv2650c,GO:0005618; GO:0005829,IPR024455; ,,,,Possible PhiRv2 prophage protein,cell wall [GO:0005618]; cytosol [GO:0005829],9634230; 21969609,,,MTNEQHFADDGDIKQLSLDETRSAAKQLLDSVEGDLTGDVAQRFQALTRHAEELRAEQRRRGREAEEALRRCRAGELRVVPGAPTGGDDGDAPPGNSLRDIAFRTLDVCVRDGLMSSRAAEAAETLCRTGPPQSTSWAQRWLAATGNRDYLGAFVKRVSNPVAGHTTWTDREAAAWREAAAVAAEQRAMGLVDTAGGFLIPAALDPAILLSGDGSTNPIRQVARVVQTTSEVWRGVTSEGAEAHWYSEAQEVSDDSPTLAQPAVPSYRGSCWIPFSLEIEGDAAGFVAEVGRVLADSVEQLQAAAFVSGSGNGEPTGFVSALTGTADYTVTGAGTEAVVAADVYALQSALPPRFQSNSAFAANLSTINVLRQAETANGALKFPSLHASPPMLAGKHIWEVSNMDTVDAAVTATNYPLVLGDWKQFIITDRVGSTVELVPHVFGGNRRPTGQRGFFCWFRVGSDVLVDNAFRVLKVQTTA,"51,100",479,,,,cell wall [GO:0005618]; cytosol [GO:0005829],,,1
P71924,P71924_MYCTU,Rv2424c,Rv2424c,GO:0003677; GO:0004803; GO:0006313,IPR003346; ,,,,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MQCRAREERPGRKTDLLDAEWLVHLLECGLLRGWLIPPADIKAARDVIRYRRKLVEHRTSKLQRLGNVLQDAGIKADSVASSVTPKSVRAMVEALIDGERRPAVLADLARGSMRSKIPDLQRALEGRFDDHHALMCRLHLAHLDQLDAMIGALDEQIEQLMHPFCARRELIASIPGIGVGASATVISEIGADPAAWFPSAEHLASWVRLCPGNHESAGKRHHGARRTGNQHLQPVLVECAWAAVRTDGYLREYYRRQVRKFGGFRSPAANKKAITTVAHKLIVIIWHVLATGRPHQDLGADYFTTRMDPDKERRRLVAKLEAQGLGVTLEPAA,"37,128",333,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
Q79FD4,Q79FD4_MYCTU,Rv2490c,PE_PGRS43 Rv2490c,,IPR000084; ,,PE_PGRS43,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS43,,9634230,,,MSYVIATPEMMATAAFDLARIGSQVSAASAVAAMPTTEVVAAGADEVSAGIAALFSAHAQEYQALSAQAAAFHDQFVHTLTAAARWYTATEIANAAAMRVVLGAVNAPTQTLLGRPLIGDGAHGTAPGQPGGAGGLLFGNGGNGAAGAVGQVGGAGGAAGLFGIGGAGGAGGAGAPGGTGGTGGWLAGGGGVGGMGGAGGGAGGAGGNAGLFGNGGAGGAGGAGGGAGGAGGNAGWFGHGGAGGVGGVGAAGANGATPGQDGAAGVAGSDDGAGGDGLAGSDGGDGGAGGVGGNGGRGGWLLGNGGAGGVGGVGGAGGAGAAGGAGGAGATGINGPAGISAAGGDGGAGGNGGAGGNGGVGGAGGAGGSAGLLGYVGRAGDGGAGGGGGLGGAPGDGGAGGNGGSWLAAGDGGAGGHGGDPGLGGAGGAGGASGGAGARAGANGLAAGNDGPVSGGNGGKGGNGAHAPVAGGHGGNGGAGGNGGLVGDGGAGGHGGDGAAGAGYADMTAIFLGSSGTPGEDGGNGGAGGAGGAGGAHAGDGGAGGAGGNGGAGGAGGNGAHGFNAVLVSDGGNGGDGGAGGRGGDGGAGGAGGDAPAGRAGSQGVGGDGGAGGAGGAPGNGGSGGRGDMAFKDGDGGAGGDGGDPGAGGKGGAGGAGATEGVTGATGATVHSGGNGGKGGNGADATVAGANGGKGGAGGNGGLVGDGGAGGDGGSGAAGANGANVGEDGADGTLSGQPGEGSEANGGQGGVGGGGAGGAGGDGGAGSSALGSGGNGGRGDAGQAGGAGGAGGAGGAGGSVSGDGGPGGKGGAGGAGGAGASGGGGGKGASGADSAEAVGGAGGKGGDGGVGGVGGDGGPGGDGGAGGAAPAGQVGSHGVGGVGGDGGLGGAGGNGGDGGHGSDGGDGGDGGDPGAGGLGGLGGDSGNGTRAASGVDASDHGPGSGGNGGNGGNGAQASVAGGAGGNGGDGGNAGRVGDGGAGGNGGDGAAGANGANSGAPGSDALALGQPGGNGGQGDAGQAGGAGGAGGAGGAGGSVSGDGGAGGNGGAGGNGGVGASGGAGARGANGIDSIGGTGGAGGGGGDGGAGGVGGHGGDGGVGGAAPSGTVGSHGTGGVGGDGGLGGAGGVGGAGGNGGIGITVGGAGGAGGNGGDPGAGGRGGLGGDSGNGTSAANGVDASKHGPLTGGDGGVGGNGAKAAAAGGDGGQGGDGGNAGLFGDGGAGGDGADGTAAEALGGDGGAGGAGGKGGDAGDIGDGGDGGKGGDGAHGALGGLTVAGGNGGAGGAGGAGGAGGAFLGDGGNGGAGGQGGAGRGGSPGGGGGVGGHGGAGGDAGMNGGGGTGGQGGNGAAGGAGWSPDSDLKGFDGFDGGSGGAGGDGGAGGAGGTQTGDGGDGGAGGLGGAGGVGGNGVDGFDINETTGRDGGDGGDGGYGGWGGAGGNGGAGGSAPAGEVGNRGVGGDGGDGGSGGDAGNGGLGGDGFTYLADFDGEPGGDGGDGGDGGWGRPGGQGGFGSTSGAHGKAGFGAPGGDGGDGGNGGHGGDGNGSFADAGDGGPGGNGGNGGLGGAGRDGGAPGGDGGDGGTGGSGGFGAPPPRSIGGGDGGDGGRGGDGGRGAGGLTSGGVGSSGESGGSGNGRGDPGSGGSGGEGGEGGPSISVNVT,"133,124",1660,,,,,,,1
I6Y9E8,I6Y9E8_MYCTU,Rv2475c,Rv2475c,,IPR029069; ,,,,Conserved protein,,9634230; 21969609,,,MSVGFVTPVGVRWSDIDMYQHVNHATMVTILEEARVPFLKDAFGADITSTGLLIADVRVTYKGQLRLSDSPLQVTIWTKRLRAVDFTLGYEVRSVNAEPDSRPAVIAESQLAAFHIEEQRLVRLSPHHREYLQRWFRG,"15,765",138,,,,,,,1
P71749,P71749_MYCTU,Rv2395,Rv2395,GO:0016020; GO:0022857,IPR004814; IPR004813; ,,,,Probable conserved integral membrane protein,membrane [GO:0016020]; transmembrane transporter activity [GO:0022857],9634230,,,MSGATVGAREITIRGVVLGALITLVFTAANVYLGLRVGLTFATSIPAAVISMGVLRLFANHSVVENNIVQTIASAAGTLSSIIFVLPALLMIGWWSGFPYWTTAAVCALGGILGVMYSIPLRRALVTGSDLPYPEGVAGAEVLKIGDSAREMEHNRRGIGVIALGAAAAAGYALLASLRVINNSLSATFRVGSGATMIGASLSLALIGVGHLVGVTVGVAMIVGLAIAFGVMLPIRTAGQLPPDGDYAVAVARIFSTDVRFIGAGAIAVAAAWTFLKILGPILRGIADAAVSARTRRRGQAVGQTERDIPIHIVAMVVLLSLIPIGWLLADFTDGTPLDDRRPGAIAAGVLLVLVIGLMVAAVCGYMAGLIGSSNSPISGVGILVVVLAGLLIKTAYGPATGSQIPALVAYTVFTAALVFGVATISNDNLQDLKTGQLVGATPWKQQVALIIGVLVGSVVMAPILQLMQAGFGFQGAPGATANALAAPQAALMSALAKGVFGGSLNWSLVGVGALTGVIAVALDETLAKTTTNLRLPPLAVGMGMYLSAALTLMIPIGAFLGRIYDSWARWSGDDDERKKRLGVMLATGLIVGESLYGVLFAVIVATTGKEEPLAMVGDGFRFASQPLGAIVFAGLLAWLYQRTRVTASYRLAAPAGSSKPLPDLPG,"68,252",667,,,transmembrane transporter activity [GO:0022857],membrane [GO:0016020],,,1
L7N655,L7N655_MYCTU,Rv2467,pepN Rv2467,GO:0004177; GO:0008237; GO:0008270,IPR024571; IPR012778; IPR001930; IPR014782; ,,pepN,DOMAIN 211 444 Peptidase_M1. {ECO:0000259|Pfam:PF01433}.; DOMAIN 531 850 ERAP1_C. {ECO:0000259|Pfam:PF11838}.,Probable aminopeptidase N PepN (Lysyl aminopeptidase) (LYS-AP) (Alanine aminopeptidase),aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],9634230; 21969609,,,MALPNLTRDQAVERAALITVDSYQIILDVTDGNGAPGERTFRSTTTVVFDALPGADTVIDISAHTVRRASLNDQDLDVSGYDEAAGIPLRGLAQRNVVVVDADCHYSNTGEGLHRFVDPVDGETYLYSQFETADAKRMFACFDQPDLKATFDVRVTAPAHWKVISNGAPLAAANGVHTFATTPRMSTYLVALIAGPYAAWTDTYIDDHGEIPLGIYCRASLAEYMDAERLFTQTKQGFGFYHKHFGLPYAFGKYDQLFVPEFNAGAMENAGAVTFLEDYVFRSKVTRASYERRAETVLHEMAHMWFGDLVTMTWWDDLWLNESFATFASVLCQSEATEFTEAWTTFATVEKSWAYRQDQLPSTHPIAADIPDLAAVEVNFDGITYAKGASVLKQLVAYVGLERFLAGLRDYFRTHAFGNASFDDLLAALEKASGRDLSNWGEQWLKTTGLNTLRPDFEVDAEGRFTRFAVTQSGAAPGAGETRVHRLAVGIYDDDGSKSSGKLVRVHREELDVSGPITNVPALVGVSRGKLILVNDDDLTYCSLRLDERSLQTALDRIADIAEPLPRTLVWSAAWEMTREAELRARDFVSLVSGGVHAETEVGVAQRLLLQAQTALGCYAEPGWARERGWPQFADRLLELAREAEPGSDHQLAYINSLCSSVLSPRHVQTLGALLEGEPAACGLAGLAVDTDLRWRIVTALATAGAIDADGPETPRIDAEVQRDPTAAGKRHAAQARAARPQFVVKDEAFTTVVEDDTLANATGRAMIAGIAAPGQGELLKPFARRYFQAIPGVWARRSSEVAQSVVIGLYPHWDISEQGITAAEEFLSDPEVPPALRRLVLEGQAAVQRSLRARNFDADG,"94,285",861,,,aminopeptidase activity [GO:0004177]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],,,,1
I6Y9Z5,I6Y9Z5_MYCTU,Rv2664,Rv2664,,,,,,Uncharacterized protein,,9634230,,,MKHKTDIDEWLDTIEPNPADAHDASHLRRIIAAKEAVQTAESELRAAVNAARAAGDTWAAIGVALGITRQAAFQRFGPHSTASP,"8,986",84,,,,,,,1
P71718,P71718_MYCTU,Rv2382c,mbtC Rv2382c,GO:0008152; GO:0016740; GO:0040007,IPR032821; IPR014031; IPR014030; IPR020841; IPR016039; ,,mbtC,,Polyketide synthetase MbtC (Polyketide synthase),transferase activity [GO:0016740]; growth [GO:0040007]; metabolic process [GO:0008152],9634230; 21969609,,,MSDNDPVVIVGLAIEAPGGVETADDYWTLLSEQREGLGPFPTDRGWALRELFDGSRRNGFKPIHNLGGFLSSATTFDPEFFRISPREATAMDPQQRVGLRVAWRTLENSGINPDDLAGHDVGCYVGASALEYGPALTEFSHHSGHLITGTSLGVISGRIAYTLDLAGPALTVDTSCSSALAAFHTAVQAIRAGDCDLALAGGVCVMGTPGYFVEFSKQHALSDDGHCRPYSAHASGTAWAEGAAMFLLQRRSRATADRRRVLAEVRASCLNSDGLSDGLTAPSGDAQTRLLRRAIAQAAVVPADVGMVEGHGTATRLGDRTELRSLAASYGTAPAGRGPLLGSVKSNIGHAQAAAGGLGLVKVILAAQHAAIPPTLHVDEPSREIDWEKQGLRLADKLTPWRAVDGWRTAAVSAFGMSGTNSHVIVSMPDTVSAPERGPECGEV,"46,624",444,Beta-ketoacyl-ACP synthases family,growth [GO:0040007]; metabolic process [GO:0008152],transferase activity [GO:0016740],,,,3
P95029,P95029_MYCTU,Rv2524c,fas Rv2524c,GO:0004314; GO:0004318; GO:0005618; GO:0005737; GO:0005829; GO:0005835; GO:0005886; GO:0006633; GO:0040007; GO:0042802,IPR001227; IPR014043; IPR016035; IPR013785; IPR013565; IPR003965; IPR029069; IPR014031; IPR014030; IPR002539; IPR036291; IPR020801; IPR020841; IPR016039; ,Itself,fas,,Probable fatty acid synthase Fas (Fatty acid synthetase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fatty acid synthase complex [GO:0005835]; plasma membrane [GO:0005886]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; identical protein binding [GO:0042802]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007],9634230; 21969609,,,MTIHEHDRVSADRGGDSPHTTHALVDRLMAGEPYAVAFGGQGSAWLETLEELVSATGIETELATLVGEAELLLDPVTDELIVVRPIGFEPLQWVRALAAEDPVPSDKHLTSAAVSVPGVLLTQIAATRALARQGMDLVATPPVAMAGHSQGVLAVEALKAGGARDVELFALAQLIGAAGTLVARRRGISVLGDRPPMVSVTNADPERIGRLLDEFAQDVRTVLPPVLSIRNGRRAVVITGTPEQLSRFELYCRQISEKEEADRKNKVRGGDVFSPVFEPVQVEVGFHTPRLSDGIDIVAGWAEKAGLDVALARELADAILIRKVDWVDEITRVHAAGARWILDLGPGDILTRLTAPVIRGLGIGIVPAATRGGQRNLFTVGATPEVARAWSSYAPTVVRLPDGRVKLSTKFTRLTGRSPILLAGMTPTTVDAKIVAAAANAGHWAELAGGGQVTEEIFGNRIEQMAGLLEPGRTYQFNALFLDPYLWKLQVGGKRLVQKARQSGAAIDGVVISAGIPDLDEAVELIDELGDIGISHVVFKPGTIEQIRSVIRIATEVPTKPVIMHVEGGRAGGHHSWEDLDDLLLATYSELRSRANITVCVGGGIGTPRRAAEYLSGRWAQAYGFPLMPIDGILVGTAAMATKESTTSPSVKRMLVDTQGTDQWISAGKAQGGMASSRSQLGADIHEIDNSASRCGRLLDEVAGDAEAVAERRDEIIAAMAKTAKPYFGDVADMTYLQWLRRYVELAIGEGNSTADTASVGSPWLADTWRDRFEQMLQRAEARLHPQDFGPIQTLFTDAGLLDNPQQAIAALLARYPDAETVQLHPADVPFFVTLCKTLGKPVNFVPVIDQDVRRWWRSDSLWQAHDARYDADAVCIIPGTASVAGITRMDEPVGELLDRFEQAAIDEVLGAGVEPKDVASRRLGRADVAGPLAVVLDAPDVRWAGRTVTNPVHRIADPAEWQVHDGPENPRATHSSTGARLQTHGDDVALSVPVSGTWVDIRFTLPANTVDGGTPVIATEDATSAMRTVLAIAAGVDSPEFLPAVANGTATLTVDWHPERVADHTGVTATFGEPLAPSLTNVPDALVGPCWPAVFAAIGSAVTDTGEPVVEGLLSLVHLDHAARVVGQLPTVPAQLTVTATAANATDTDMGRVVPVSVVVTGADGAVIATLEERFAILGRTGSAELADPARAGGAVSANATDTPRRRRRDVTITAPVDMRPFAVVSGDHNPIHTDRAAALLAGLESPIVHGMWLSAAAQHAVTATDGQARPPARLVGWTARFLGMVRPGDEVDFRVERVGIDQGAEIVDVAARVGSDLVMSASARLAAPKTVYAFPGQGIQHKGMGMEVRARSKAARKVWDTADKFTRDTLGFSVLHVVRDNPTSIIASGVHYHHPDGVLYLTQFTQVAMATVAAAQVAEMREQGAFVEGAIACGHSVGEYTALACVTGIYQLEALLEMVFHRGSKMHDIVPRDELGRSNYRLAAIRPSQIDLDDADVPAFVAGIAESTGEFLEIVNFNLRGSQYAIAGTVRGLEALEAEVERRRELTGGRRSFILVPGIDVPFHSRVLRVGVAEFRRSLDRVMPRDADPDLIIGRYIPNLVPRLFTLDRDFIQEIRDLVPAEPLDEILADYDTWLRERPREMARTVFIELLAWQFASPVRWIETQDLLFIEEAAGGLGVERFVEIGVKSSPTVAGLATNTLKLPEYAHSTVEVLNAERDAAVLFATDTDPEPEPEEDEPVAESPAPDVVSEAAPVAPAASSAGPRPDDLVFDAADATLALIALSAKMRIDQIEELDSIESITDGASSRRNQLLVDLGSELNLGAIDGAAESDLAGLRSQVTKLARTYKPYGPVLSDAINDQLRTVLGPSGKRPGAIAERVKKTWELGEGWAKHVTVEVALGTREGSSVRGGAMGHLHEGALADAASVDKVIDAAVASVAARQGVSVALPSAGSGGGATIDAAALSEFTDQITGREGVLASAARLVLGQLGLDDPVNALPAAPDSELIDLVTAELGADWPRLVAPVFDPKKAVVFDDRWASAREDLVKLWLTDEGDIDADWPRLAERFEGAGHVVATQATWWQGKSLAAGRQIHASLYGRIAAGAENPEPGRYGGEVAVVTGASKGSIAASVVARLLDGGATVIATTSKLDEERLAFYRTLYRDHARYGAALWLVAANMASYSDVDALVEWIGTEQTESLGPQSIHIKDAQTPTLLFPFAAPRVVGDLSEAGSRAEMEMKVLLWAVQRLIGGLSTIGAERDIASRLHVVLPGSPNRGMFGGDGAYGEAKSALDAVVSRWHAESSWAARVSLAHALIGWTRGTGLMGHNDAIVAAVEEAGVTTYSTDEMAALLLDLCDAESKVAAARSPIKADLTGGLAEANLDMAELAAKAREQMSAAAAVDEDAEAPGAIAALPSPPRGFTPAPPPQWDDLDVDPADLVVIVGGAEIGPYGSSRTRFEMEVENELSAAGVLELAWTTGLIRWEDDPQPGWYDTESGEMVDESELVQRYHDAVVQRVGIREFVDDGAIDPDHASPLLVSVFLEKDFAFVVSSEADARAFVEFDPEHTVIRPVPDSTDWQVIRKAGTEIRVPRKTKLSRVVGGQIPTGFDPTVWGISADMAGSIDRLAVWNMVATVDAFLSSGFSPAEVMRYVHPSLVANTQGTGMGGGTSMQTMYHGNLLGRNKPNDIFQEVLPNIIAAHVVQSYVGSYGAMIHPVAACATAAVSVEEGVDKIRLGKAQLVVAGGLDDLTLEGIIGFGDMAATADTSMMCGRGIHDSKFSRPNDRRRLGFVEAQGGGTILLARGDLALRMGLPVLAVVAFAQSFGDGVHTSIPAPGLGALGAGRGGKDSPLARALAKLGVAADDVAVISKHDTSTLANDPNETELHERLADALGRSEGAPLFVVSQKSLTGHAKGGAAVFQMMGLCQILRDGVIPPNRSLDCVDDELAGSAHFVWVRDTLRLGGKFPLKAGMLTSLGFGHVSGLVALVHPQAFIASLDPAQRADYQRRADARLLAGQRRLASAIAGGAPMYQRPGDRRFDHHAPERPQEASMLLNPAARLGDGEAYIG,"326,255",3069,,fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007],[acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0004318]; identical protein binding [GO:0042802],cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fatty acid synthase complex [GO:0005835]; plasma membrane [GO:0005886],,,3
I6XEF6,I6XEF6_MYCTU,Rv2491,Rv2491,,IPR005268; IPR010787; ,,,,Uncharacterized protein,,9634230,,,MVDTSAPASRLDTDPRRAHVSLSKHPYQIGVFGSGTIGPRVYELAYQVGAEIAKQGHILISGGMTGTMEASSRGASDADGLVVGVLPGDKFTDGNAYSTIKILSGMQFARNYITGLSCHGAIVVGGSSGAYEEARRVWEGRGPVVVLANSGSPTGASAQMLSMQEIFGVAFPEDKPKPWRVFSAATPAESVSLVIGLIRKGYAQHEP,"21,668",207,,,,,,,1
I6Y1F9,I6Y1F9_MYCTU,Rv2665,Rv2665,,,,,,Hypothetical arginine rich protein,,9634230,,,MIVVRTAEAAEQALTEGQLVCPRRGCGDTLRRWRYGRRRHVRSLGSQVIDVRPQRVRCRRCESTHVLLPAALQPRLGRGGGGQLRPGVWCTGR,"10,458",93,,,,,,,1
O53205,O53205_MYCTU,Rv2478c,Rv2478c,GO:0003697; GO:0006260,IPR012340; IPR000424; IPR011344; ,,,,Uncharacterized protein,single-stranded DNA binding [GO:0003697]; DNA replication [GO:0006260],9634230,,,MVGHIVNDLQRRKVGDQEVVKFRVASNSRRRTSDGGWEPGNSLFITVNCWGRLVTGVGAALGKGAPVIVVGHVYTSEYEDRDGIRRSSLEMRATSVGPDLSRVIVRIEKPAYTGPSAGDLPAATGTGAAGAADAPASAADSVSDVVVDDAITGHNPLPISA,"16,708",161,,DNA replication [GO:0006260],single-stranded DNA binding [GO:0003697],,,,1
V5QRX2,V5QRX2_MYCTU,Rv2395B,aprB Rv2395B,,,,aprB,,Acid and phagosome regulated protein B AprB,,9634230,,,MPGLVPAMPLDALRPARQPTSGLGECATMRRPEAGNEKVAVIWESLDVVPPESL,"5,755",54,,,,,,,1
Q79FC4,Q79FC4_MYCTU,Rv2614A,Rv2614A,,,,,,Uncharacterized protein,,9634230,,,MGDRYRAGDRVLYGGSMSPKDVDDLATQQDVDDGQSIERRWTGSGQRRWRRSPPTGRYRSNSQIQVWISGAGRLR,"8,570",75,,,,,,,1
P71959,P71959_MYCTU,Rv2662,Rv2662,,,,,,Uncharacterized protein,,9634230,,,MDDLTRLRRELLDRFDVRDFTDWPPASLRALIATYDPWIDMTASPPQPVSPGGPRLRLVRLTTNPSARAAPIGNGGDSSVCAGEKQCRPP,"9,901",90,,,,,,,1
P71965,P71965_MYCTU,Rv2668,Rv2668,,,,,,Possible exported alanine and valine rich protein,,9634230; 21969609,,,MRHWLIVLATLLVAAAGVAAANDVPRAWAGDAPIGHIGDTLRVDTGTYVADVTVSSVVPVDPPPGFGYTRSGVPVKSFPDSSVTRADVTVRAVRVPNSFILATNFSFTGVTPFADAYKPRPCDASDWLDAALGNAPQGSIVRGGVYWDAYRDPVSVVVLLDEKTGQHLAQWNL,"18,346",173,,,,,,,1
I6Y9M6,I6Y9M6_MYCTU,Rv2551c,Rv2551c,GO:0004190; GO:0016021,IPR000045; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021]; aspartic-type endopeptidase activity [GO:0004190],9634230,,,MLAAAVLAWMGVLCVCDVRQRRLPNWLTLPGAGVILLFAGLAGRGVPALAGAAALAGVYLLVHLALPAAMGAGDVKLAIGLGGLTGCFGVEVWFLAALAAPLLTAVCGVMVTPWGVRTLPHGPSMCVASLGAVGLALLG,"13,794",139,,,aspartic-type endopeptidase activity [GO:0004190],integral component of membrane [GO:0016021],,,1
P71757,P71757_MYCTU,Rv2387,Rv2387,GO:0016021,IPR010293; ,,,,Conserved protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLHEFWVNFTHNLFKPLLLFFYFGFLIPIFKVRFEFPYVLYQGLTLYLLLAIGWHGGEELAKIKPSNVGAIVGFMVVGFALNFVIGTLAYFLLSKLTAMRRVDRATVAGYYGSDSAGTFATCVAVLTSVGMAFDAYMPVMLAVMEIPGCLVALYLVARLRHRGMNEAGYMADEPGYTTAAMIGAGPGTPARPAHSDSLTAQAERGIEEELELSLEKREHPNWDEDGVKDSGTNASIFSRELLQEVFLNPGLVLLFGGIVIGLISGLQGQKVLHDDDNFFVAAFQGVLCLFLLEMGMTASRKLKDLASAGSGFVFFGLLAPNLFATLGIIVAHGYAYVTNNDFAPGTYVLFAVLCGAASYIAVPAVQRLAIPEASPTLPLAASLGLTFSYNVTIGIPLYIEIARIVGQWFPATGASIG,"45,008",417,,,,integral component of membrane [GO:0016021],,,3
I6YDN6,I6YDN6_MYCTU,Rv2535c,pepQ Rv2535c,GO:0016787,IPR029149; IPR036005; IPR000587; IPR000994; IPR001714; IPR001131; ,,pepQ,,Probable cytoplasmic peptidase PepQ,hydrolase activity [GO:0016787],9634230; 21969609,,,MTHSQRRDKLKAQIAASGLDAMLISDLINVRYLSGFSGSNGALLVFADERDAVLATDGRYRTQAASQAPDLEVAIERAVGRYLAGRAGEAGVGKLGFESHVVTVDGLDALAGALEGKNTELVRASGTVESLREVKDAGELALLRLACEAADAALTDLVARGGLRPGRTERQVSRELEALMLDHGADAVSFETIVAAGANSAIPHHRPTDAVLQVGDFVKIDFGALVAGYHSDMTRTFVLGKAADWQLEIYQLVAEAQQAGRQALLPGAELRGVDAAARQLIADAGYGEHFGHGLGHGVGLQIHEAPGIGVTSAGTLLAGSVVTVEPGVYLPGRGGVRIEDTLVVAGGTPKMPETAGQTPELLTRFPKELAIL,"38,791",372,,,hydrolase activity [GO:0016787],,,,1
I6YDH3,I6YDH3_MYCTU,Rv2468A,Rv2468A,GO:0016021,,,,,Conserved protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MEIHLFFVGIPLLLVVVLSVLIWSRKGPHPATYKLSEPWTHPPILWAATDEVVGSAHGGHGHDASEFTVGGGASGTW,"8,239",77,,,,integral component of membrane [GO:0016021],,,1
I6Y9K2,I6Y9K2_MYCTU,Rv2528c,mrr Rv2528c,GO:0003677; GO:0004519; GO:0009307,IPR025745; IPR011335; IPR007560; ,,mrr,,Probable restriction system protein Mrr,DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; DNA restriction-modification system [GO:0009307],9634230; 21969609,,,MTIPDAQTLMRPILAYLADGQAKSAKDVIAAMSDEFGLSDDERAQMLPSGRQRTMYDRVHWSLTHMSQAGLLDRPTRGHVQVTDTGRQVLKAHPERVDMAVLREFPSYIAFRERTKAKQPVDATAKRPSGDDVQVSPEDLIDAALAENRAAVEGEILKKALTLSPTGFEDLVIRLLEAMGYGRAGAVERTSASGDAGIDGIISQDPLGLDRIYVQAKRYAVDQTIGRPKIHEFAGALLGKQGDRGVYITTSSFSRGAREEAERINARIELIDGARLAELLVRYRVGVQAVQTVELLRLDEDFFDGL,"33,648",306,,DNA restriction-modification system [GO:0009307],DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,,,1
P71734,P71734_MYCTU,Rv2409c,Rv2409c,GO:0005886,IPR013589; IPR002931; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MWRTRVVHTTGYVYQSPVTASYNEARLTPRSSSRQNLVLNRVETIPATRSYRYIDYWGTAVTAFDLHAPHTELTVTSSSVVETERPEPLAAKATWADLQSTAVIDRFDEVLRPTPHTPASARVDAVGRRIRKCHEPSEAVVAAARWARSELDYIPGTTSVHSSGLDALEQGKGVCQDFVHLSLMVLRSMGIPCRYVSGYLHPKRDAVVGKTVDGRSHAWVQAWTGGWWHYDPTNDNEITEQYISVGVGRDYTDVSPLKGIYSGEGVTDLDVVVEITRLA,"31,029",279,,,,plasma membrane [GO:0005886],,,1
O33229,O33229_MYCTU,Rv2724c,fadE20 Rv2724c,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE20,,Probable acyl-CoA dehydrogenase FadE20,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MGSATKYQRTLFEPEHELFRESYRAFLDRHVAPYHDEWEKTKIVDRGVWLEAGKQGFLGMAVPEEYGGGGNADFRYNTVITEETCAGRYSGIGFGLHNDIVAPYLLALATEEQKRRWFPNFCTGELITAIAMTEPGTGSDLQGITTRAVKHGDHYVLNGSKTFITNGINSDLVIVVAQTDPEKGAQGFSLLVVERGMAGFERGRQLDKIGLDAQDTAELSFTDVAVPAENLLGQEGMGFIYLMQNLPQERISIAIMAAAGMESVLEQTLQYAKERKAFGRSIGSFQNSRFLLAELATEATVVRIMVDEFIKLHLAGKLTAEQAAMAKWYATEKQVYLNDRCLQLHGGYGYMREYPVARAYLDSRVQTIYGGTTEIMKEIIGRGLGV,"42,845",386,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
P71912,P71912_MYCTU,Rv2437,Rv2437,GO:0016021; GO:0040007,IPR007318; ,,,,Conserved transmembrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230,,,MLQRTNVVQPLNTLRMVWIQVAGIIPATAGIAATVYAQLAMGDSWRIGVDEQENTTLVRTGPFKWVRHPIYTAMMAFGLGLLLVTPNLVALAGFILLVATLEVHVRRVEEPYLLRTHSAVYRGYTASVGRFVPGVGLIR,"15,315",139,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,4
I6X548,I6X548_MYCTU,Rv2693c,Rv2693c,GO:0016021,IPR016566; ,,,,Probable conserved integral membrane alanine and leucine rich protein,integral component of membrane [GO:0016021],9634230,,,MNANRTSAQRLLAQAGGVSGLVYSSLPVVTFVVASSAAGLLPAIGFALSMAGLILLWRLLRRESARPVVAGFCGVAVCALIAYLVGQSKGYFLLGIWMSLLWAVVFTLSILIRRPIVGYLWSWLSGRDRAWRDVSRAVFAFDVATLGWTLVFAARFIVQRHLYDADKTGWLGVARIGMGWPLTALAALATYAAIKAAQRAILASHDAAAVGGAAEFDADAGRE,"23,801",223,,,,integral component of membrane [GO:0016021],,,1
P71925,P71925_MYCTU,Rv2423,Rv2423,GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Uncharacterized protein,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MDNLPIESAESTRLAKAAMTRRFYTRSVVKGEITLPAVPSMIDEYVTMCAGLFAGVGRKFSDEELAHLRAVLQGQLAEAYAASQRSTIVISYNAPMGPTLHYQVRAQWRTVAQEYENWIATREPPLFGTEPDARVWALANEAADPTTHRVLEIGAGTGRNALALARRGHPVDVVEMTPKFADIIRSDAERDSLDVRVIMRDVFSTMDDLRQDYQLMVLSEVVPDFRTTQQLRNLFELAAQCLAPGARLVFNAFLANGDYAPDQAAREFGQQMYTGMCTRAEMSAAAAGLPLELVADDSVYDYEKTHLPPGAWPPTSWYADWIRGLDVFTTNVESCPIEMRWLVFQRRR,"38,990",348,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,2
I6Y1I5,I6Y1I5_MYCTU,Rv2700,Rv2700,GO:0016021,IPR027381; ,,,,Possible conserved secreted alanine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVAQITEGTAFDKHGRPFRRRNPRPAIVVVAFLVVVTCVMWTLALTRPPDVREAAVCNPPPQPAGSAPTNLGEQVSRTDMTDVAPAKLSDTKVHVLNASGRGGQAADIAGALQDLGFAQPTAANDPIYAGTRLDCQGQIRFGTAGQATAAALWLVAPCTELYHDSRADDSVDLALGTDFTTLAHNDDIDAVLANLRPGATEPSDPALLAKIHANSC,"22,660",216,,,,integral component of membrane [GO:0016021],,,1
I6XF52,I6XF52_MYCTU,Rv2721c,Rv2721c,GO:0016021,IPR013207; ,,,,Possible conserved transmembrane alanine and glycine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MNGQRGQLSTLIGRTLLGLAATAVTAVLLAPTVAASPMGDAEDAMMAAWEKAGGDTSTLGVRKGDVYPIGDGFALDFAGGKMFFTPATGAKYLYGPLLDKYESLGGAADSDLGFPTINEVPGLAGPDSRVSTFSAADNPVIFWTPEHGAFVVRGALNAAWDKLGSSGGVLGAPVGDETYDGEVTAQKFSGGEVSWNRATKEFTTVPAVLAEQLKGLQVAIDPSAAINMAWRAAGGAAGPLGAKKGGQYPIGGDGIAQDFVGGKVFFSPATGANAVEGEILAKYESLGGPVSSDLGFPIANETDGGFGPSSRIVRFSAADKPVIFWTPDHGAFVVRGAMVAAWDKLRGPNGKLGAPVGDQTVDGDVVSQKFTGGMISWNRAKNTFTTDPANLAPLLSGLQVSGQNQPSTSAMPPPGKKFTWHWWWLGAAALGVLLVVMVALVVFGLRRRRRGYDAAAYDDDRAGDVEYGTAADGDWPPDEDFGSEHFGFGDQFPPEPVAPDAGSTPRVSWPRGAGAAVGDAEHLPGEEGYGSDLLSGPSNVGVEEEDTDAVDTTPTPVVSQADLSEVGPDLIVPERVVPETFVPQAFVPEAVAPEAVPPDVHAADLADTGLPAAAVSAAEDRGGRHAAAEPPEPPSAGVRPAIHLPLEDPYQMPNGYPVKASVSFGLYYPPGSALYHDTLAELWFASEEVAQVNGFIRAD,"72,372",699,,,,integral component of membrane [GO:0016021],,,1
O06170,O06170_MYCTU,Rv2507,Rv2507,GO:0016021; GO:0040007,IPR008693; IPR038468; ,,,,Possible conserved proline rich membrane protein,integral component of membrane [GO:0016021]; growth [GO:0040007],9634230; 21969609,,,MNDPRRPQRFGPPLSGYGPTGPQVPPNPPTADPAYADQSPYASTYGGYVSPPWSPGGPPPRPPQWPPGPHEASPTQQLPQYWQYDQPPPGGFPPDGLTPPPPQGPRTPRWLWFAAGSAVLLVVALVIALVIANGSVKKQTAIEPLPPMPGPSPTRPTTTTPTPPSPSAAPAPTTTTGTPSETVAGAMQTVVYDVTGEGRAISITYMDSGNVIQTEFNVALPWRKEVSLSKSSLHPASVTIVNIGHNVTCSVTVAGVQVRQRTGAGLTICDAPS,"28,520",273,,growth [GO:0040007],,integral component of membrane [GO:0016021],,,3
P71923,P71923_MYCTU,Rv2425c,Rv2425c,,IPR011195; IPR008912; IPR036465; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAARRIRAARPLAPHGLPGHLVGFVEALRGSGISVGPSETVDAGRVMATLGLGDREVLREGIACAVLRRPDHRDTYDAMFDLWFPAALGARAVITTEDESAGSGGLPPDDVEAMRQLLLDLLANNQDLAGKDERLVEMIARIVEAYGKYSSSRGPSFSSYQALKAMALDELEGKLLAGLLAPYGDEPTATQEQIAKALAAQKIAQLRRMVDAETKRRTAEQLGREHVQMYGIPQLSENVEFLRASGEQLRQMRRVVAPLARTLATRLAARRRRARAGSIDLRKTLRKSMSTGGVPIDLVLHKPRPARPELVVLCDVSGSVAGFSHFTLLLVHALRQQFSRVRVFAFIDSTDEVTHMFGPESDLAIAIQRITREAGVYARDGHSDYGNAFVSFMQGFPNVLSPRSSLLVLGDGRTNYRNPATDVLADMVTASRHAHWLNPEPKHLWGSGDSAVPRYQEVITMHECRSAKQLATVIDQLLPV,"52,590",480,,,,,,,2
O53199,O53199_MYCTU,Rv2472,Rv2472,,,,,,Uncharacterized protein,,9634230,,,MMMRIAVRLPGEVITFVDSEVSQIRIPSRRAAVVLRASNASDAAILTATEPNHHLDALAGQAAKLAPTSIDAAHPARPARRDPCLYPRTGQALPRTG,"10,348",97,,,,,,,1
Q79FE9,Q79FE9_MYCTU,Rv2371,PE_PGRS40 Rv2371,,IPR000084; ,,PE_PGRS40,,PE-PGRS family protein PE_PGRS40,,9634230,,,MSLVSVAPELVVTAVPDVARIGSSIGAPDTAAAARPTTSVLAAGADEVSADVVALFGWVAR,"5,978",61,,,,,,,1
I6XES4,I6XES4_MYCTU,Rv2622,Rv2622,GO:0005737; GO:0008757; GO:0032259,IPR013216; IPR029063; ,,,,Possible methyltransferase (Methylase),cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MANKRGNAGQPLPLSDRDDDHMQGHWLLARLGKRVLRPGGVELTRTLLARAEVTDADVLELAPGLGRTAAEILARNPRSYVGAESDPNAANLVRHVLAGRGDVRVTDAADTGLSDASADVVIGEAMLTMQGNAAKHTIVAEAARVLRPGGRYAIHELALVPDDVAEQVRTDLRQSLARALKVNARPLTVAEWSHLLAGHGLVVEHVVTASMALLQPRRVIADEGLLGALRFAGNLLIHRAARRRVLLMRHTFRRHRERLTAVAIVAHKPHVDS,"29,542",273,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
P71750,P71750_MYCTU,Rv2394,ggtB Rv2394,GO:0005576; GO:0005886; GO:0016740,IPR029055; ,,ggtB,,Probable gamma-glutamyltranspeptidase GgtB (Gamma-glutamyltransferase) (Glutamyl transpeptidase),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; transferase activity [GO:0016740],9634230; 21969609,,,MSVWLRAGALVAAVMLSLSGCGGFHAGAPSTAGPCEIVPNGTPAPKTPPATVPSSRNLATNPEIATGYRRDMTVVRTAHYAAATANPLATQVACRVLRDGGTAADAVVAAQAVLGLVEPQSSGIGGGGYLVYFDARTGSVQAYDGREVAPAAATENYLRWVSDVDRSAPRPNARASGRSIGVPGILRMLEMVHNEHGRTPWRDLFGPAVTLADGGFDISARMGAAISDAAPQLRDDPEARKYFLNPDGSPKPAGTRLTNPAYSKTLSAIASAGANAFYSGDIAHDIVAAASDTSNGRTPGLLTIEDLAGYLAKRRQPLCTTYRGREICGMPSSGGVAVAATLGILEHFPMSDYAPSKVDLNGGRPTVMGVHLIAEAERLAYADRDQYIADVDFVRLPGGSLTTLVDPGYLAARAALISPQHSMGSARPGDFGAPTAVAPPVPEHGTSHLSVVDSYGNAATLTTTVESSFGSYHLVDGFILNNQLSDFSAEPHATDGSPVANRVEPGKRPRSSMAPTLVFDHSSAGRGALYAVLGSPGGSMIIQFVVKTLVAMLDWGLNPQQAVSLVDFGAANSPHTNLGGENPEINTSDDGDHDPLVQGLRALGHRVNLAEQSSGLSAITRSEAGWAGGADPRREGAVMGDDA,"66,560",643,,,transferase activity [GO:0016740],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,2
P71751,P71751_MYCTU,Rv2393,che1 Rv2393,GO:0009236; GO:0016852; GO:0019354; GO:0051266,IPR002762; ,,che1,,Ferrochelatase Che1,sirohydrochlorin cobaltochelatase activity [GO:0016852]; sirohydrochlorin ferrochelatase activity [GO:0051266]; cobalamin biosynthetic process [GO:0009236]; siroheme biosynthetic process [GO:0019354],9634230; 21969609,,,MTAPATMQSAAMLRSGAIEAPPATMQSAAMRWGHLPLAEESGTIAPQLVLTAHGSKDPRSAANARAIAGRLARMRPGLDVRVAFCELNSPNLVDVLNRCRGAAVVTPLLLADAYHARVDIPAQIASCRVGHRVRQASVLGEDIRLVSALHERLTELGVSPFDHTLGVVVLAIGSSHPAANARTSTVASRLAEGTQWAAVTTAFITRPEASLADATDRLRRHGARRMVIAPWLLAPGILSDRVRGYAREAGIAMAQPLGAHPMVAATMWDRYRQAVAGRIAA,"29,781",281,,cobalamin biosynthetic process [GO:0009236]; siroheme biosynthetic process [GO:0019354],sirohydrochlorin cobaltochelatase activity [GO:0016852]; sirohydrochlorin ferrochelatase activity [GO:0051266],,,,2
P71716,P71716_MYCTU,Rv2384,mbtA Rv2384,GO:0008668; GO:0010106; GO:0016881; GO:0019540,IPR025110; IPR000873; ,,mbtA,,Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase,"(2,3-dihydroxybenzoyl)adenylate synthase activity [GO:0008668]; acid-amino acid ligase activity [GO:0016881]; cellular response to iron ion starvation [GO:0010106]; siderophore biosynthetic process from catechol [GO:0019540]",9634230; 21969609,,,MPPKAADGRRPSPDGGLGGFVPFPADRAASYRAAGYWSGRTLDTVLSDAARRWPDRLAVADAGDRPGHGGLSYAELDQRADRAAAALHGLGITPGDRVLLQLPNGCQFAVALFALLRAGAIPVMCLPGHRAAELGHFAAVSAATGLVVADVASGFDYRPMARELVADHPTLRHVIVDGDPGPFVSWAQLCAQAGTGSPAPPADPGSPALLLVSGGTTGMPKLIPRTHDDYVFNATASAALCRLSADDVYLVVLAAGHNFPLACPGLLGAMTVGATAVFAPDPSPEAAFAAIERHGVTVTALVPALAKLWAQSCEWEPVTPKSLRLLQVGGSKLEPEDARRVRTALTPGLQQVFGMAEGLLNFTRIGDPPEVVEHTQGRPLCPADELRIVNADGEPVGPGEEGELLVRGPYTLNGYFAAERDNERCFDPDGFYRSGDLVRRRDDGNLVVTGRVKDVICRAGETIAASDLEEQLLSHPAIFSAAAVGLPDQYLGEKICAAVVFAGAPITLAELNGYLDRRGVAAHTRPDQLVAMPALPTTPIGKIDKRAIVRQLGIATGPVTTQRCH,"59,281",565,,cellular response to iron ion starvation [GO:0010106]; siderophore biosynthetic process from catechol [GO:0019540],"(2,3-dihydroxybenzoyl)adenylate synthase activity [GO:0008668]; acid-amino acid ligase activity [GO:0016881]",,,,2
I6Y187,I6Y187_MYCTU,Rv2621c,Rv2621c,,IPR036388; IPR036390; ,,,,Possible transcriptional regulatory protein,,9634230,,,MGVSVIIRSLQEPVGRRRAVLRALCASRVPMSIAAIAGKLGVHPNTVRFHLDNLVADGQVERVEPGRGRPGRPPLMFRAVRRTDSTGTRRYRLLAEILASGLAAERDSRAMALSAGRAWGRQLEAPPAGADTEETIDHLVAVLDDLGFAPERRASNGRQQVGLRHCPFLELAETQAGVVCPVHLGIMRGALQTWGAPVTVDRLDAFVEPDLCLAHFTPLEGAIR,"24,241",224,,,,,,,1
O06175,O06175_MYCTU,Rv2513,Rv2513,,,,,,Uncharacterized protein,,9634230,,,MDDIAAFKLDSLPDITFTVTRAISSGGENPAGFLNFAARREQPEILGGGGRPGPVGPEAVDTPRIRGGKVPFVFRTLPGYTFYASQIEPRVGDPEGPTLLAGFGNIPETSQRSPGWIRITCTGPDDDEELEFFGFAGPES,"14,930",140,,,,,,,1
Q79FE3,Q79FE3_MYCTU,Rv2408,PE24 Rv2408,,IPR000084; ,,PE24,DOMAIN 16 87 PE. {ECO:0000259|Pfam:PF00934}.,Possible PE family-related protein PE24,,9634230,,,MLIARPDILCSRGPEAMRAKAADLDLAAAAKTVGVQPAADQVAAAIAAILLSHAQIYQDISTQMAAFHDQLVENRTADSTSYASAEANAQQSLLNAMDAPSWQQRRETVGEVGLPADPAGSGTATAAVAAATTARAGSRSAAQATVAPIGGLKLRRESALSQPGDLHHHVEVGDALPRVDPFQRGNVGVVAAYTHTDVLLGDLIVIGGVVVPPSTGPGLNPGMAAPVYRLSHHGITLRV,"24,509",239,,,,,,,1
P9WN09,RNTF_MYCTU,Rv2962c,Rv2962c,GO:0005886; GO:0008194; GO:0009247; GO:0016758; GO:0020012; GO:0043231,IPR002213; ,,,,PGL/p-HBAD biosynthesis rhamnosyltransferase (EC 2.4.1.-),"intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; evasion or tolerance of host immune response [GO:0020012]; glycolipid biosynthetic process [GO:0009247]",9634230; 15292272; 19099550; 21969609,,"FUNCTION: Catalyzes the transfer of the first rhamnosyl residue on p-hydroxybenzoic acid or phenolphthiocerol derivatives to form, after O-methylation at position 2 of the sugar unit, mono-O-methyl-glycosyl-p-hydroxybenzoic acid derivative (p-HBAD I) and 2-O-methyl-rhamnosyl-phenolphthiocerol dimycocerosate (also called mycoside B) during p-hydroxybenzoic acid derivatives (p-HBAD) and glycosylated phenolphthiocerol dimycocerosates (PGL) biosynthesis. {ECO:0000269|PubMed:15292272}.",MRVSCVYATASRWGGPPVASEVRGDAAISTTPDAAPGLAARRRRILFVAEAVTLAHVVRPFALAQSLDPSRYEVHFACDPRYNQLLGPLPFRHHAIHTIPSERFFGNLTQGRFYAMRTLRKYVEADLRVLDEIAPDLVVGDLRISLSVSARLAGIPYIAIANAYWSPYAQRRFPLPDVIWTRLFGVRLVKLLYRLERPLLFALQCMPLNWVRRRHGLSSLGWNLCRIFTDGDHTLYADVPELMPTYDLPANHEYLGPVLWSPAGKPPTWWDSLPTDRPIVYATLGTSGGRNLLQLVLNALAELPVTVIAATAGRSDLKTVPANAFVADYLPGEAAAARSAVVVCNGGSLTTQQALVAGVPVIGVAGNLDQHLNMEAVERAGAGVLLRTERLKSQRVAGAVMQVISRSEYRQAAARLADAFGRDRVGFPQHVENALRLMPENRPRTWLAS,"49,433",449,Glycosyltransferase 28 family,evasion or tolerance of host immune response [GO:0020012]; glycolipid biosynthetic process [GO:0009247],"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]",intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],,,1
P9WH03,RNC_MYCTU,Rv2925c,rnc Rv2925c MTCY338.14c,GO:0003725; GO:0004525; GO:0005737; GO:0006364; GO:0006396; GO:0006397; GO:0008033; GO:0016075; GO:0040007; GO:0046872; GO:0090502,IPR014720; IPR011907; IPR000999; IPR036389; ,,rnc,DOMAIN 19 134 RNase III.; DOMAIN 161 229 DRBM.,Ribonuclease 3 (EC 3.1.26.3) (Ribonuclease III) (RNase III),"cytoplasm [GO:0005737]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525]; growth [GO:0040007]; mRNA processing [GO:0006397]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033]",9634230; 19099550; 21969609; 16155207,X-ray crystallography (1),"FUNCTION: Digests double-stranded RNA. Involved in the processing of primary rRNA transcript to yield the immediate precursors to the large and small rRNAs (23S and 16S). Processes some mRNAs, and tRNAs when they are encoded in the rRNA operon. Processes pre-crRNA and tracrRNA of type II CRISPR loci if present in the organism (By similarity). {ECO:0000250}.",MIRSRQPLLDALGVDLPDELLSLALTHRSYAYENGGLPTNERLEFLGDAVLGLTITDALFHRHPDRSEGDLAKLRASVVNTQALADVARRLCAEGLGVHVLLGRGEANTGGADKSSILADGMESLLGAIYLQHGMEKAREVILRLFGPLLDAAPTLGAGLDWKTSLQELTAARGLGAPSYLVTSTGPDHDKEFTAVVVVMDSEYGSGVGRSKKEAEQKAAAAAWKALEVLDNAMPGKTSA,"25,399",240,Ribonuclease III family,"growth [GO:0040007]; mRNA processing [GO:0006397]; RNA phosphodiester bond hydrolysis, endonucleolytic [GO:0090502]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; tRNA processing [GO:0008033]",double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; ribonuclease III activity [GO:0004525],cytoplasm [GO:0005737],,MTCY338.14c,1
P9WGZ9,RNJ_MYCTU,Rv2752c,rnj Rv2752c,GO:0003723; GO:0004521; GO:0004534; GO:0005737; GO:0006364; GO:0008270; GO:0008800,IPR001279; IPR036866; IPR011108; IPR004613; IPR030854; ,,rnj,,Ribonuclease J (RNase J) (EC 3.1.-.-) (Beta-lactamase) (EC 3.5.2.6) (Penicillinase),cytoplasm [GO:0005737]; 5'-3' exoribonuclease activity [GO:0004534]; beta-lactamase activity [GO:0008800]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; rRNA processing [GO:0006364],9634230; 20066036; 21568871; 21969609,,"FUNCTION: An RNase that has 5'-3' exonuclease and possible endonuclease activity. Involved in maturation of rRNA and in some organisms also mRNA maturation and/or decay (By similarity). Has both beta-lactamase and RNase activity, but the physiological relevance of the beta-lactamase activity, i.e. whether it confers antibiotic resistance, has not been shown (PubMed:21568871). {ECO:0000250, ECO:0000269|PubMed:21568871}.",MDVDLPPPGPLTSGGLRVTALGGINEIGRNMTVFEHLGRLLIIDCGVLFPGHDEPGVDLILPDMRHVEDRLDDIEALVLTHGHEDHIGAIPFLLKLRPDIPVVGSKFTLALVAEKCREYRITPVFVEVREGQSTRHGVFECEYFAVNHSTPDALAIAVYTGAGTILHTGDIKFDQLPPDGRPTDLPGMSRLGDTGVDLLLCDSTNAEIPGVGPSESEVGPTLHRLIRGADGRVIVACFASNVDRVQQIIDAAVALGRRVSFVGRSMVRNMRVARQLGFLRVADSDLIDIAAAETMAPDQVVLITTGTQGEPMSALSRMSRGEHRSITLTAGDLIVLSSSLIPGNEEAVFGVIDALSKIGARVVTNAQARVHVSGHAYAGELLFLYNGVRPRNVMPVHGTWRMLRANAKLAASTGVPQESILLAENGVSVDLVAGKASISGAVPVGKMFVDGLIAGDVGDITLGERLILSSGFVAVTVVVRRGTGQPLAAPHLHSRGFSEDPKALEPAVRKVEAELESLVAANVTDPIRIAQGVRRTVGKWVGETYRRQPMIVPTVIEV,"59,533",558,"Metallo-beta-lactamase superfamily, RNA-metabolizing metallo-beta-lactamase-like family, Bacterial RNase J subfamily",rRNA processing [GO:0006364],5'-3' exoribonuclease activity [GO:0004534]; beta-lactamase activity [GO:0008800]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737],,,1
P9WIM5,RNMT_MYCTU,Rv2959c,Rv2959c,GO:0005886; GO:0008168; GO:0008610; GO:0030206; GO:0071770,IPR007072; IPR029063; ,,,,Rhamnosyl O-methyltransferase (EC 2.1.1.-),plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; chondroitin sulfate biosynthetic process [GO:0030206]; DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610],9634230; 15292265; 19099550; 21969609,,FUNCTION: Catalyzes the O-methylation of the hydroxyl group located on C-2 of the first rhamnosyl residue linked to the phenolic group of glycosylated phenolphthiocerol dimycocerosates (PGL) and p-hydroxybenzoic acid derivatives (p-HBAD). {ECO:0000269|PubMed:15292265}.,MGLVWRSRTSLVGQLIGLVRLVASFAAQLFYRPSDAVAEEYHKWYYGNLVWTKTTYMGINCWKSVSDMWNYQEILSELQPSLVIEFGTRYGGSAVYFANIMRQIGQPFKVLTVDNSHKALDPRARREPDVLFVESSSTDPAIAEQIQRLKNEYPGKIFAILDSDHSMNHVLAEMKLLRPLLSAGDYLVVEDSNINGHPVLPGFGPGPYEAIEAYEDEFPNDYKHDAERENKFGWTSAPNGFLIRN,"27,845",245,Rhamnosyl O-methyltransferase family,chondroitin sulfate biosynthetic process [GO:0030206]; DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610],methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
P9WH55,RS15_MYCTU,Rv2785c,rpsO Rv2785c MTV002.50c,GO:0003735; GO:0005886; GO:0006412; GO:0019843; GO:0022627,IPR000589; IPR005290; IPR009068; ,,rpsO,,30S ribosomal protein S15,cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: One of the primary rRNA binding proteins, it binds directly to 16S rRNA where it helps nucleate assembly of the platform of the 30S subunit by binding and bridging several RNA helices of the 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_01343}.; FUNCTION: Forms an intersubunit bridge (bridge B4) with the 23S rRNA of the 50S subunit in the ribosome. {ECO:0000255|HAMAP-Rule:MF_01343}.",MALTAEQKKEILRSYGLHETDTGSPEAQIALLTKRIADLTEHLKVHKHDHHSRRGLLLLVGRRRRLIKYISQIDVERYRSLIERLGLRR,"10,475",89,Universal ribosomal protein uS15 family,translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTV002.50c,1
P9WH01,RNH2_MYCTU,Rv2902c,rnhB Rv2902c MTCY274.33c,GO:0003723; GO:0004523; GO:0005737; GO:0006298; GO:0032299; GO:0043137; GO:0046872,IPR022898; IPR001352; IPR024567; IPR012337; IPR036397; ,,rnhB,,Ribonuclease HII (RNase HII) (EC 3.1.26.4),"cytoplasm [GO:0005737]; ribonuclease H2 complex [GO:0032299]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]",9634230; 19099550; 21969609,,FUNCTION: Endonuclease that specifically degrades the RNA of RNA-DNA hybrids. {ECO:0000250}.,MTKTWPPRTVIRKSGGLRGMRTLESALHRGGLGPVAGVDEVGRGACAGPLVVAACVLGPGRIASLAALDDSKKLSEQAREKLFPLICRYAVAYHVVFIPSAEVDRRGVHVANIEGMRRAVAGLAVRPGYVLSDGFRVPGLPMPSLPVIGGDAAAACIAAASVLAKVSRDRVMVALDADHPGYGFAEHKGYSTPAHSRALARLGPCPQHRYSFINVRRVASGSNTAEVADGQPDPRDGTAQTGEGRWSKSSHPATMRATGRAQGT,"27,646",264,RNase HII family,"DNA replication, removal of RNA primer [GO:0043137]; mismatch repair [GO:0006298]",metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523],cytoplasm [GO:0005737]; ribonuclease H2 complex [GO:0032299],,MTCY274.33c,1
P9WQ27,BE_MYCTU,Rv3031,Rv3031,GO:0003844; GO:0005576; GO:0005886; GO:0005975; GO:0040007; GO:0102752,IPR037090; IPR015293; IPR011330; IPR027291; IPR028995; IPR004300; ,,,,"Probable 1,4-alpha-glucan branching enzyme Rv3031 (EC 2.4.1.18) (1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-glucosyl-transferase) (Alpha-(1->4)-glucan branching enzyme) (Branching enzyme) (BE)","extracellular region [GO:0005576]; plasma membrane [GO:0005886]; 1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; carbohydrate metabolic process [GO:0005975]; growth [GO:0040007]",9634230; 17640872; 21969609,,"FUNCTION: Catalyzes the formation of branch points in alpha-glucans by cleavage of an alpha-1,4 glycosidic bond and subsequent transfer of the cleaved-off oligosaccharide to a new alpha-1,6 position (Probable). Is probably involved in the biosynthesis of 6-O-methylglucosyl lipopolysaccharides (MGLP). {ECO:0000305}.",MNTSASPVPGLFTLVLHTHLPWLAHHGRWPVGEEWLYQSWAAAYLPLLQVLAALADENRHRLITLGMTPVVNAQLDDPYCLNGVHHWLANWQLRAEEAASVRYARQSKSADYPSCTPEALRAFGIRECADAARALDNFATRWRHGGSPLLRGLIDAGTVELLGGPLAHPFQPLLAPRLREFALREGLADAQLRLAHRPKGIWAPECAYAPGMEVDYATAGVSHFMVDGPSLHGDTALGRPVGKTDVVAFGRDLQVSYRVWSPKSGYPGHAAYRDFHTYDHLTGLKPARVTGRNVPSEQKAPYDPERADRAVDVHVADFVDVVRNRLLSESERIGRPAHVIAAFDTELFGHWWYEGPTWLQRVLRALPAAGVRVGTLSDAIADGFVGDPVELPPSSWGSGKDWQVWSGAKVADLVQLNSEVVDTALTTIDKALAQTASLDGPLPRDHVADQILRETLLTVSSDWPFMVSKDSAADYARYRAHLHAHATREIAGALAAGRRDTARRLAEGWNRADGLFGALDARRLPK,"57,815",526,Glycosyl hydrolase 57 family,carbohydrate metabolic process [GO:0005975]; growth [GO:0040007],"1,4-alpha-glucan branching enzyme activity [GO:0003844]; 1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]",extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WGP9,SADH_MYCTU,Rv3085,sadH Rv3085,GO:0010447; GO:0016491; GO:0044119,IPR036291; IPR020904; IPR002347; ,,sadH,,Putative oxidoreductase SadH (EC 1.-.-.-),oxidoreductase activity [GO:0016491]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],9634230; 14568148; 15937179; 16893682,,FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. {ECO:0000269|PubMed:15937179}.,MSSFEGKVAVITGAGSGIGRALALNLSEKRAKLALSDVDTDGLAKTVRLAQALGAQVKSDRLDVAEREAVLAHADAVVAHFGTVHQVYNNAGIAYNGNVDKSEFKDIERIIDVDFWGVVNGTKAFLPHVIASGDGHIVNISSLFGLIAVPGQSAYNAAKFAVRGFTEALRQEMLVARHPVKVTCVHPGGIKTAVARNATVADGEDQQTFAEFFDRRLALHSPEMAAKTIVNGVAKGQARVVVGLEAKAVDVLARIMGSSYQRLVAAGVAKFFPWAK,"29,217",276,Short-chain dehydrogenases/reductases (SDR) family,growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],oxidoreductase activity [GO:0016491],,,,1
P9WH53,RS16_MYCTU,Rv2909c,rpsP Rv2909c MTCY274.41c,GO:0003735; GO:0005886; GO:0006412; GO:0015935,IPR000307; IPR020592; IPR023803; ,,rpsP,,30S ribosomal protein S16,plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,,,MAVKIKLTRLGKIRNPQYRVAVADARTRRDGRAIEVIGRYHPKEEPSLIEINSERAQYWLSVGAQPTEPVLKLLKITGDWQKFKGLPGAQGRLKVAAPKPSKLEVFNAALAAADGGPTTEATKPKKKSPAKKAAKAAEPAPQPEQPDTPALGGEQAELTAES,"17,437",162,Bacterial ribosomal protein bS16 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935],,MTCY274.41c,1
P9WH39,RS2_MYCTU,Rv2890c,rpsB Rv2890c MTCY274.21c,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0022627; GO:0040007,IPR001865; IPR005706; IPR018130; IPR023591; ,,rpsB,,30S ribosomal protein S2,cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,,MAVVTMKQLLDSGTHFGHQTRRWNPKMKRFIFTDRNGIYIIDLQQTLTFIDKAYEFVKETVAHGGSVLFVGTKKQAQESVAAEATRVGMPYVNQRWLGGMLTNFSTVHKRLQRLKELEAMEQTGGFEGRTKKEILGLTREKNKLERSLGGIRDMAKVPSAIWVVDTNKEHIAVGEARKLGIPVIAILDTNCDPDEVDYPIPGNDDAIRSAALLTRVIASAVAEGLQARAGLGRADGKPEAEAAEPLAEWEQELLASATASATPSATASTTALTDAPAGATEPTTDAS,"31,089",287,Universal ribosomal protein uS2 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY274.21c,1
P9WGY1,RRF_MYCTU,Rv2882c,frr Rv2882c MTCY274.13c,GO:0002184; GO:0005618; GO:0005737; GO:0005829; GO:0005886; GO:0006415; GO:0008079; GO:0040007; GO:0043023,IPR002661; IPR023584; IPR036191; ,,frr,,Ribosome-recycling factor (RRF) (Ribosome-releasing factor),cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosomal large subunit binding [GO:0043023]; translation termination factor activity [GO:0008079]; cytoplasmic translational termination [GO:0002184]; growth [GO:0040007]; translational termination [GO:0006415],9634230; 21969609,X-ray crystallography (8),FUNCTION: Responsible for the release of ribosomes from messenger RNA at the termination of protein biosynthesis. May increase the efficiency of translation by recycling ribosomes from one round of translation to another. {ECO:0000255|HAMAP-Rule:MF_00040}.,MIDEALFDAEEKMEKAVAVARDDLSTIRTGRANPGMFSRITIDYYGAATPITQLASINVPEARLVVIKPYEANQLRAIETAIRNSDLGVNPTNDGALIRVAVPQLTEERRRELVKQAKHKGEEAKVSVRNIRRKAMEELHRIRKEGEAGEDEVGRAEKDLDKTTHQYVTQIDELVKHKEGELLEV,"20,828",185,RRF family,cytoplasmic translational termination [GO:0002184]; growth [GO:0040007]; translational termination [GO:0006415],ribosomal large subunit binding [GO:0043023]; translation termination factor activity [GO:0008079],cell wall [GO:0005618]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY274.13c,1
P9WH19,RIMM_MYCTU,Rv2907c,rimM Rv2907c MTCY274.38c,GO:0005840; GO:0006364; GO:0040007; GO:0043022,IPR011961; IPR027275; IPR011033; IPR002676; IPR036976; IPR009000; ,,rimM,DOMAIN 100 172 PRC barrel. {ECO:0000255|HAMAP-Rule:MF_00014}.,Ribosome maturation factor RimM,ribosome [GO:0005840]; ribosome binding [GO:0043022]; growth [GO:0040007]; rRNA processing [GO:0006364],9634230; 21969609,,"FUNCTION: An accessory protein needed during the final step in the assembly of 30S ribosomal subunit, possibly for assembly of the head region. Probably interacts with S19. Essential for efficient processing of 16S rRNA. May be needed both before and after RbfA during the maturation of 16S rRNA. It has affinity for free ribosomal 30S subunits but not for 70S ribosomes. {ECO:0000255|HAMAP-Rule:MF_00014}.",MELVVGRVVKSHGVTGEVVVEIRTDDPADRFAPGTRLRAKGPFDGGAEGSAVSYVIESVRQHGGRLLVRLAGVADRDAADALRGSLFVIDADDLPPIDEPDTYYDHQLVGLMVQTATGEGVGVVTEVVHTAAGELLAVKRDSDEVLVPFVRAIVTSVSLDDGIVEIDPPHGLLNLE,"18,616",176,RimM family,growth [GO:0040007]; rRNA processing [GO:0006364],ribosome binding [GO:0043022],ribosome [GO:0005840],,MTCY274.38c,1
P9WH71,RIR2B_MYCTU,Rv3048c,nrdF2 Rv3048c,GO:0004748; GO:0005971; GO:0006260; GO:0009263; GO:0040007; GO:0046872,IPR009078; IPR012348; IPR026494; IPR033909; IPR030475; IPR000358; ,,nrdF2,,Ribonucleoside-diphosphate reductase subunit beta nrdF2 (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase nrdF2) (Ribonucleotide reductase R2-2 small subunit),"ribonucleoside-diphosphate reductase complex [GO:0005971]; metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; growth [GO:0040007]",9335290; 9634230; 14573627; 21969609; 15225619,X-ray crystallography (1),FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Two genes for this protein are present in M.tuberculosis; this is the active form. When coexpressed in E.coli with nrdE the 2 proteins complement a temperature-sensitive E.coli mutant. {ECO:0000269|PubMed:9335290}.,MTGNAKLIDRVSAINWNRLQDEKDAEVWDRLTGNFWLPEKVPVSNDIPSWGTLTAGEKQLTMRVFTGLTMLDTIQGTVGAVSLIPDALTPHEEAVLTNIAFMESVHAKSYSQIFSTLCSTAEIDDAFRWSEENRNLQRKAEIVLQYYRGDEPLKRKVASTLLESFLFYSGFYLPMYWSSRAKLTNTADMIRLIIRDEAVHGYYIGYKFQRGLALVDDVTRAELKDYTYELLFELYDNEVEYTQDLYDEVGLTEDVKKFLRYNANKALMNLGYEALFPRDETDVNPAILSALSPNADENHDFFSGSGSSYVIGKAVVTEDDDWDF,"36,992",324,Ribonucleoside diphosphate reductase small chain family,deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; growth [GO:0040007],"metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",ribonucleoside-diphosphate reductase complex [GO:0005971],,,1
O33347,RELF_MYCTU,Rv2865,relF relB2 Rv2865,GO:0003677; GO:0006351; GO:0006355; GO:0045927; GO:0097351,IPR006442; IPR036165; ,,relF,,Antitoxin RelF,"DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19114484; 20011113; 20498855; ,X-ray crystallography (1),"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of toxin RelE2.; FUNCTION: Induces its own promoter, in combination with RelG represses its own promoter. Has been seen to bind DNA in complex with toxin RelG but not alone.",MRILPISTIKGKLNEFVDAVSSTQDQITITKNGAPAAVLVGADEWESLQETLYWLAQPGIRESIAEADADIASGRTYGEDEIRAEFGVPRRPH,"10,183",93,PhD/YefM antitoxin family,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; toxin-antitoxin pair type II binding [GO:0097351],,relB2,,1
P9WHI1,RECX_MYCTU,Rv2736c,recX Rv2736c MTV002.01c,GO:0005737; GO:0005886; GO:0006282,IPR003783; IPR036388; ,,recX,,Regulatory protein RecX,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; regulation of DNA repair [GO:0006282],9634230; 12218174,,FUNCTION: Binds to RecA inhibiting ATP hydrolysis and the generation of heteroduplex DNA. It might act as an anti-recombinase to quell inappropriate recombinational repair during normal DNA metabolism. It is essential for cell survival. {ECO:0000269|PubMed:12218174}.,MTVSCPPPSTSEREEQARALCLRLLTARSRTRAELAGQLAKRGYPEDIGNRVLDRLAAVGLVDDTDFAEQWVQSRRANAAKSKRALAAELHAKGVDDDVITTVLGGIDAGAERGRAEKLVRARLRREVLIDDGTDEARVSRRLVAMLARRGYGQTLACEVVIAELAAERERRRV,"19,146",174,RecX family,regulation of DNA repair [GO:0006282],,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV002.01c,1
P9WH17,RIMP_MYCTU,Rv2842c,rimP Rv2842c MTCY24A1.15,GO:0000028; GO:0005829; GO:0005886; GO:0006412,IPR003728; IPR028998; IPR036847; IPR028989; IPR035956; ,,rimP,,Ribosome maturation factor RimP,cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],9634230; 19099550; 21969609,,FUNCTION: Required for maturation of 30S ribosomal subunits. {ECO:0000255|HAMAP-Rule:MF_01077}.,MTTGLPSQRQVIELLGADFACAGYEIEDVVIDARARPPRIAVIADGDAPLDLDTIAALSRRASALLDGLDGANKIRGRYLLEVSSPGVERPLTSEKHFRRARGRKVELVLSDGSRLTGRVGEMRAGTVALVIREDRGWAVREIPLAEIVKAVVQVEFSPPAPAELELAQSSEMGLARGTEAGA,"19,565",183,RimP family,ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],,cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY24A1.15,1
P9WFV9,SYE_MYCTU,Rv2992c,gltX gltS Rv2992c MTV012.06c,GO:0000049; GO:0004818; GO:0005524; GO:0005737; GO:0005886; GO:0006424; GO:0008270; GO:0040007,IPR008925; IPR020752; IPR020751; IPR004527; IPR000924; IPR020058; IPR020061; IPR033910; IPR014729; ,,gltX,,Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; glutamyl-tRNA aminoacylation [GO:0006424]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (3),FUNCTION: Catalyzes the attachment of glutamate to tRNA(Glu) in a two-step reaction: glutamate is first activated by ATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu). {ECO:0000255|HAMAP-Rule:MF_00022}.,MTATETVRVRFCPSPTGTPHVGLVRTALFNWAYARHTGGTFVFRIEDTDAQRDSEESYLALLDALRWLGLDWDEGPEVGGPYGPYRQSQRAEIYRDVLARLLAAGEAYHAFSTPEEVEARHVAAGRNPKLGYDNFDRHLTDAQRAAYLAEGRQPVVRLRMPDDDLAWNDLVRGPVTFAAGSVPDFALTRASGDPLYTLVNPCDDALMKITHVLRGEDLLPSTPRQLALHQALIRIGVAERIPKFAHLPTVLGEGTKKLSKRDPQSNLFAHRDRGFIPEGLLNYLALLGWSIADDHDLFGLDEMVAAFDVADVNSSPARFDQKKADALNAEHIRMLDVGDFTVRLRDHLDTHGHHIALDEAAFAAAAELVQTRIVVLGDAWELLKFFNDDQYVIDPKAAAKELGPDGAAVLDAALAALTSVTDWTAPLIEAALKDALIEGLALKPRKAFSPIRVAATGTTVSPPLFESLELLGRDRSMQRLRAARQLVGHA,"53,864",490,"Class-I aminoacyl-tRNA synthetase family, Glutamate--tRNA ligase type 1 subfamily",glutamyl-tRNA aminoacylation [GO:0006424]; growth [GO:0040007],ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],gltS,MTV012.06c,1
P9WFT9,SYP_MYCTU,Rv2845c,proS Rv2845c MTCY24A1.12,GO:0002161; GO:0004827; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006433; GO:0040007,IPR002314; IPR006195; IPR004154; IPR036621; IPR002316; IPR004500; IPR023717; IPR033730; IPR036754; IPR007214; ,,proS,,Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827]; growth [GO:0040007]; prolyl-tRNA aminoacylation [GO:0006433],9634230; 20066036; 21969609,,"FUNCTION: Catalyzes the attachment of proline to tRNA(Pro) in a two-step reaction: proline is first activated by ATP to form Pro-AMP and then transferred to the acceptor end of tRNA(Pro). As ProRS can inadvertently accommodate and process non-cognate amino acids such as alanine and cysteine, to avoid such errors it has two additional distinct editing activities against alanine. One activity is designated as 'pretransfer' editing and involves the tRNA(Pro)-independent hydrolysis of activated Ala-AMP. The other activity is designated 'posttransfer' editing and involves deacylation of mischarged Ala-tRNA(Pro). The misacylated Cys-tRNA(Pro) is not edited by ProRS. {ECO:0000255|HAMAP-Rule:MF_01569}.",MITRMSELFLRTLRDDPADAEVASHKLLIRAGYIRPVAPGLYSWLPLGLRVLRNIERVIRDEMNAIGGQEILFPALLPRAPYETTNRWTQYGDSVFRLKDRRGNDYLLGPTHEELFTLTVKGEYSSYKDFPLTLYQIQTKYRDEARPRAGILRAREFVMKDSYSFDIDAAGLKAAYHAHREAYQRIFDRLQVRYVIVSAVSGAMGGSASEEFLAESPSGEDAFVRCLESGYAANVEAVVTARPDTLPIDGLPEAVVHDTGDTPTIASLVAWANEADLGRTVTAADTLKNVLIKVRQPGGDTELLAIGVPGDREVDDKRLGAALEPADYALLDDDDFAKHPFLVKGYIGPKALRENNVRYLVDPRIVDGTSWITGADQPGRHVVGLVAGRDFTADGTIEAAEVREGDPSPDGAGPLVMARGIEIGHIFQLGSKYTDAFTADVLGEDGKPVRLTMGSYGIGVSRLVAVVAEQHHDELGLRWPSTVAPFDVHLVIANKDAQARAGATALAADLDRLGVEVLLDDRQASPGVKFKDAELLGMPWIVVVGRGWADGVVELRDRFSGQTRELVAGASLATDIAAAVTG,"63,302",582,"Class-II aminoacyl-tRNA synthetase family, ProS type 1 subfamily",growth [GO:0040007]; prolyl-tRNA aminoacylation [GO:0006433],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; proline-tRNA ligase activity [GO:0004827],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY24A1.12,1
P9WGD7,SRP54_MYCTU,Rv2916c,ffh Rv2916c MTCY338.04c,GO:0003924; GO:0005525; GO:0005618; GO:0005886; GO:0006614; GO:0008312; GO:0040007; GO:0048500,IPR003593; IPR027417; IPR036891; IPR013822; IPR004125; IPR022941; IPR000897; IPR004780; ,,ffh,,Signal recognition particle protein (Fifty-four homolog),cell wall [GO:0005618]; plasma membrane [GO:0005886]; signal recognition particle [GO:0048500]; 7S RNA binding [GO:0008312]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; growth [GO:0040007]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],9634230; 21969609; 22534010,,"FUNCTION: Involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane. Binds to the hydrophobic signal sequence of the ribosome-nascent chain (RNC) as it emerges from the ribosomes. The SRP-RNC complex is then targeted to the cytoplasmic membrane where it interacts with the SRP receptor FtsY (By similarity). Shows GTPase activity. {ECO:0000255|HAMAP-Rule:MF_00306, ECO:0000269|PubMed:22534010}.",MFESLSDRLTAALQGLRGKGRLTDADIDATTREIRLALLEADVSLPVVRAFIHRIKERARGAEVSSALNPAQQVVKIVNEELISILGGETRELAFAKTPPTVVMLAGLQGSGKTTLAGKLAARLRGQGHTPLLVACDLQRPAAVNQLQVVGERAGVPVFAPHPGASPESGPGDPVAVAAAGLAEARAKHFDVVIVDTAGRLGIDEELMAQAAAIRDAINPDEVLFVLDAMIGQDAVTTAAAFGEGVGFTGVALTKLDGDARGGAALSVREVTGVPILFASTGEKLEDFDVFHPDRMASRILGMGDVLSLIEQAEQVFDAQQAEEAAAKIGAGELTLEDFLEQMLAVRKMGPIGNLLGMLPGAAQMKDALAEVDDKQLDRVQAIIRGMTPQERADPKIINASRRLRIANGSGVTVSEVNQLVERFFEARKMMSSMLGGMGIPGIGRKSATRKSKGAKGKSGKKSKKGTRGPTPPKVKSPFGVPGMPGLAGLPGGLPDLSQMPKGLDELPPGLADFDLSKLKFPGKK,"55,002",525,"GTP-binding SRP family, SRP54 subfamily",growth [GO:0040007]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],7S RNA binding [GO:0008312]; GTPase activity [GO:0003924]; GTP binding [GO:0005525],cell wall [GO:0005618]; plasma membrane [GO:0005886]; signal recognition particle [GO:0048500],,MTCY338.04c,1
P9WGD3,SSRP_MYCTU,Rv3100c,smpB Rv3100c MTCY164.11c,GO:0003723; GO:0005829,IPR023620; IPR000037; IPR020081; ,,smpB,,SsrA-binding protein (Small protein B),cytosol [GO:0005829]; RNA binding [GO:0003723],8921846; 9634230; 21969609; 24145139,,"FUNCTION: Required for rescue of stalled ribosomes mediated by trans-translation. Binds to transfer-messenger RNA (tmRNA), required for stable association of tmRNA with ribosomes. tmRNA and SmpB together mimic tRNA shape, replacing the anticodon stem-loop with SmpB. tmRNA is encoded by the ssrA gene; the 2 termini fold to resemble tRNA(Ala) and it encodes a 'tag peptide', a short internal open reading frame. During trans-translation Ala-aminoacylated tmRNA acts like a tRNA, entering the A-site of stalled ribosomes, displacing the stalled mRNA. The ribosome then switches to translate the ORF on the tmRNA; the nascent peptide is terminated with the 'tag peptide' encoded by the tmRNA and targeted for degradation. The ribosome is freed to recommence translation, which seems to be the essential function of trans-translation. {ECO:0000255|HAMAP-Rule:MF_00023}.",MSKSSRGGRQIVASNRKARHNYSIIEVFEAGVALQGTEVKSLREGQASLADSFATIDDGEVWLRNAHIPEYRHGSWTNHEPRRNRKLLLHRRQIDTLVGKIREGNFALVPLSLYFAEGKVKVELALARGKQARDKRQDMARRDAQREVLRELGRRAKGMT,"18,230",160,SmpB family,,RNA binding [GO:0003723],cytosol [GO:0005829],,MTCY164.11c,1
P0CW32,VPB23_MYCTU,Rv2862A,vapB23 Rv2862A,,,,vapB23,,Putative antitoxin VapB23,,9634230; 15718296,,FUNCTION: Putative antitoxin component of a possible type II toxin-antitoxin (TA) system. The cognate toxin is VapC23. {ECO:0000305|PubMed:15718296}.,MLSDEEREAFRQQAAAQQMSLSNWLRQAGLRQLEAQRQRPLRTAQELREFFASRPDETGAEPDWQAHLQVMAESRRRGLPAP,"9,533",82,,,,,,,1
P9WF35,XERC_MYCTU,Rv2894c,xerC Rv2894c MTCY274.25c,GO:0003677; GO:0005737; GO:0005886; GO:0006310; GO:0007049; GO:0007059; GO:0015074; GO:0051301,IPR011010; IPR013762; IPR002104; IPR010998; IPR004107; IPR023009; ,,xerC,,Tyrosine recombinase XerC,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; DNA recombination [GO:0006310],9634230; 21969609,,"FUNCTION: Site-specific tyrosine recombinase, which acts by catalyzing the cutting and rejoining of the recombining DNA molecules. The XerC-XerD complex is essential to convert dimers of the bacterial chromosome into monomers to permit their segregation at cell division. It also contributes to the segregational stability of plasmids (By similarity). {ECO:0000250}.",MQAILDEFDEYLALQCGRSVHTRRAYLGDLRSLFAFLADRGSSLDALTLSVLRSWLAATAGAGAARTTLARRTSAVKAFTAWAVRRGLLAGDPAARLQVPKARRTLPAVLRQDQALRAMAAAESGAEQGDPLALRDRLIVELLYATGIRVSELCGLDVDDIDTGHRLVRVLGKGNKQRTVPFGQPAADALHAWLVDGRRALVTAESGHALLLGARGRRLDVRQARTAVHQTVAAVDGAPDMGPHGLRHSAATHLLEGGADLRVVQELLGHSSLATTQLYTHVAVARLRAVHERAHPRA,"31,980",298,"'phage' integrase family, XerC subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; DNA integration [GO:0015074]; DNA recombination [GO:0006310],DNA binding [GO:0003677],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY274.25c,1
P9WMJ3,VIRS_MYCTU,Rv3082c,virS Rv3082c MTV013.03c,GO:0003700; GO:0005829; GO:0006351; GO:0009405; GO:0019172; GO:0019243; GO:0043565; GO:0045893; GO:0071468,IPR032687; IPR009057; IPR018060; ,,virS,DOMAIN 236 334 HTH araC/xylS-type. {ECO:0000255|PROSITE-ProRule:PRU00593}.,HTH-type transcriptional regulator VirS (Virulence-regulating protein VirS),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565]; cellular response to acidic pH [GO:0071468]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; pathogenesis [GO:0009405]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",8472958; 9634230; 14568148; 15937179; 19251699,,FUNCTION: Regulates the expression of the mymA operon (Rv3083-Rv3089). {ECO:0000269|PubMed:14568148}.,MELGSLIRATNLWGYTDLMRELGADPLPFLRRFDIPPGIEHQEDAFMSLAGFVRMLEASAAELDCPDFGLRLARWQGLGILGPVAVIARNAATLFGGLEAIGRYLYVHSPALTLTVSSTTARSNVRFGYEVTEPGIPYPLQGYELSMANAARMIRLLGGPQARARVFSFRHAQLGTDAAYREALGCTVRFGRTWCGFEVDHRLAGRPIDHADPETKRIATKYLESQYLPSDATLSERVVGLARRLLPTGQCSAEAIADQLDMHPRTLQRRLAAEGLRCHDLIERERRAQAARYLAQPGLYLSQIAVLLGYSEQSALNRSCRRWFGMTPRQYRAYGGVSGR,"37,789",340,,"cellular response to acidic pH [GO:0071468]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; pathogenesis [GO:0009405]; positive regulation of transcription, DNA-templated [GO:0045893]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565],cytosol [GO:0005829],,MTV013.03c,1
P9WF89,VPC23_MYCTU,Rv2863,vapC23 Rv2863,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC23,DOMAIN 2 118 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC23 (RNase VapC23) (EC 3.1.-.-) (Toxin VapC23),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 15718296,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB23 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIFVDTNVFMYAVGRDHPLRMPAREFLEHSLEHQDRLVTSAEAMQELLNAYVPVGRNSTLDSALTLVRALTEIWPVEAADVAHARTLHHRHPGLGARDLLHLACCQRRGVTRIKTFDHTLASAFRS,"14,237",126,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WF57,VPC42_MYCTU,Rv2759c,vapC42 Rv2759c MTV002.24c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC42,DOMAIN 1 125 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC42 (RNase VapC42) (EC 3.1.-.-) (Toxin VapC42),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB42 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MIVDTSAIVAIVSGESGAQVLKEALERSPNSRMSAPNYVELCAIMQRRDRPEISRLVDRLLDDYGIQVEAVDADQARVAAQAYRDYGRGSGHPARLNLGDTYSYALAQVTGEPLLFRGDDFTHTDIRPACT,"14,372",131,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTV002.24c,1
P9WJ19,VPB42_MYCTU,Rv2760c,vapB42 Rv2760c,,IPR011660; ,,vapB42,,Putative antitoxin VapB42,,9634230; 20011113,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC42. {ECO:0000305|PubMed:20011113}.,MSLNIKSQRTVALVRELAARTGTNQTAAVEDAVARRLSELDREDRARAEARRAAAEQTLRDLDKLLSDDDKRLIRRHEVDLYDDSGLPR,"10,115",89,,,,,,,1
P9WL41,VPB43_MYCTU,Rv2871,vapB43 Rv2871 MTCY274.02,GO:0005886; GO:0006355; GO:0045927,IPR002145; IPR010985; ,,vapB43,,Antitoxin VapB43,"plasma membrane [GO:0005886]; positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC43. {ECO:0000269|PubMed:20011113}.,MRTTIRIDDELYREVKAKAARSGRTVAAVLEDAVRRGLNPPKPQAAGRYRVQPSGKGGLRPGVDLSSNAALAEAMNDGVSVDAVR,"9,045",85,,"positive regulation of growth [GO:0045927]; regulation of transcription, DNA-templated [GO:0006355]",,plasma membrane [GO:0005886],,MTCY274.02,1
P9WF91,VPC21_MYCTU,Rv2757c,vapC21 Rv2757c,GO:0004540; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC21,DOMAIN 6 128 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC21 (RNase VapC21) (EC 3.1.-.-) (Toxin VapC21),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 15718296; 20011113,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB21. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MTTRYLLDKSAAYRAHLPAVRHRLEPLMERGLLARCGITDLEFGVSARSREDHRTLGTYRRDALEYVNTPDTVWVRAWEIQEALTDKGFHRSVKIPDLIIAAVAEHHGIPVMHYDQDFERIAAITRQPVEWVVAPGTA,"15,773",138,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WF55,VPC43_MYCTU,Rv2872,vapC43 Rv2872 MTCY274.03,GO:0004540; GO:0045926; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC43,DOMAIN 3 139 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC43 (RNase VapC43) (EC 3.1.-.-) (Toxin VapC43),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB43. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MLCVDVNVLVYAHRADLREHADYRGLLERLANDDEPLGLPDSVLAGFIRVVTNRRVFTEPTSPQDAWQAVDALLAAPAAMRLRPGERHWMAFRQLASDVDANGNDIADAHLAAYALENNATWLSADRGFARFRRLRWRHPLDGQTHL,"16,596",147,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY274.03,1
P9WFQ9,UNG_MYCTU,Rv2976c,ung Rv2976c MTCY349.11,GO:0004844; GO:0005737; GO:0006284; GO:0097510,IPR002043; IPR018085; IPR005122; IPR036895; ,,ung,,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),"cytoplasm [GO:0005737]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]",9634230; 21969609,X-ray crystallography (19),FUNCTION: Excises uracil residues from the DNA which can arise as a result of misincorporation of dUMP residues by DNA polymerase or due to deamination of cytosine. {ECO:0000250}.,MTARPLSELVERGWAAALEPVADQVAHMGQFLRAEIAAGRRYLPAGSNVLRAFTFPFDNVRVLIVGQDPYPTPGHAVGLSFSVAPDVRPWPRSLANIFDEYTADLGYPLPSNGDLTPWAQRGVLLLNRVLTVRPSNPASHRGKGWEAVTECAIRALAARAAPLVAILWGRDASTLKPMLAAGNCVAIESPHPSPLSASRGFFGSRPFSRANELLVGMGAEPIDWRLP,"24,481",227,"Uracil-DNA glycosylase (UDG) superfamily, UNG family","base-excision repair [GO:0006284]; base-excision repair, AP site formation via deaminated base removal [GO:0097510]",uracil DNA N-glycosylase activity [GO:0004844],cytoplasm [GO:0005737],,MTCY349.11,1
P9WJ43,VPB21_MYCTU,Rv2758c,vapB21 Rv2758c,GO:0045927,IPR019239; ,,vapB21,,Antitoxin VapB21,positive regulation of growth [GO:0045927],9634230; 15718296; 20011113,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC21. {ECO:0000269|PubMed:20011113, ECO:0000305|PubMed:15718296}.",MHRGYALVVCSPGVTRTMIDIDDDLLARAAKELGTTTKKDTVHAALRAALRASAARSLMNRMAENATGTQDEALVNAMWRDGHPENTA,"9,494",88,,positive regulation of growth [GO:0045927],,,,,1
P71622,VPB22_MYCTU,Rv2830c,vapB22 Rv2830c,GO:0040007; GO:0045727,IPR006442; IPR036165; ,,vapB22,,Antitoxin VapB22,growth [GO:0040007]; positive regulation of translation [GO:0045727],9634230; 15718296; 20011113,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC22. {ECO:0000269|PubMed:20011113, ECO:0000305|PubMed:15718296}.",MTATEVKAKILSLLDEVAQGEEIEITKHGRTVARLVAATGPHALKGRFSGVAMAAADDDELFTTGVSWNVS,"7,483",71,PhD/YefM antitoxin family,growth [GO:0040007]; positive regulation of translation [GO:0045727],,,,,1
P71623,VPC22_MYCTU,Rv2829c,vapC22 Rv2829c,GO:0004540; GO:0005576; GO:0017148; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC22,DOMAIN 4 119 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC22 (RNase VapC22) (EC 3.1.-.-) (Toxin VapC22),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of translation [GO:0017148],9634230; 15718296; 20011113; 21969609; 23345537,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits translation and colony formation. Its toxic effect on colony formation is neutralized by coexpression with cognate antitoxin VapB22; the effect on translation has not been tested but is probably neutralized also. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MTTVLLDSHVAYWWSAEPQRLSMAASQAIEHADELAVAAISWFELAWLAEQERIQLAIPVLSWLQQLAEHVRTVGITPSVAATAVALPSSFPGDPADRLIYATAIEHGWRLVTKDRRLRSHRHPRPVTVW,"14,611",130,PINc/VapC protein family,negative regulation of translation [GO:0017148],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
P9WGF3,SMC_MYCTU,Rv2922c,smc Rv2922c MTCY338.11c,GO:0003677; GO:0005524; GO:0005618; GO:0005694; GO:0005829; GO:0005886; GO:0007062; GO:0030261,IPR027417; IPR003395; IPR024704; IPR010935; IPR036277; IPR011890; ,,smc,,Chromosome partition protein Smc,cell wall [GO:0005618]; chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; chromosome condensation [GO:0030261]; sister chromatid cohesion [GO:0007062],14660695; 9634230; 21969609,,FUNCTION: Required for chromosome condensation and partitioning. {ECO:0000255|HAMAP-Rule:MF_01894}.,MYLKSLTLKGFKSFAAPTTLRFEPGITAVVGPNGSGKSNVVDALAWVMGEQGAKTLRGGKMEDVIFAGTSSRAPLGRAEVTVSIDNSDNALPIEYTEVSITRRMFRDGASEYEINGSSCRLMDVQELLSDSGIGREMHVIVGQGKLEEILQSRPEDRRAFIEEAAGVLKHRKRKEKALRKLDTMAANLARLTDLTTELRRQLKPLGRQAEAAQRAAAIQADLRDARLRLAADDLVSRRAEREAVFQAEAAMRREHDEAAARLAVASEELAAHESAVAELSTRAESIQHTWFGLSALAERVDATVRIASERAHHLDIEPVAVSDTDPRKPEELEAEAQQVAVAEQQLLAELDAARARLDAARAELADRERRAAEADRAHLAAVREEADRREGLARLAGQVETMRARVESIDESVARLSERIEDAAMRAQQTRAEFETVQGRIGELDQGEVGLDEHHERTVAALRLADERVAELQSAERAAERQVASLRARIDALAVGLQRKDGAAWLAHNRSGAGLFGSIAQLVKVRSGYEAALAAALGPAADALAVDGLTAAGSAVSALKQADGGRAVLVLSDWPAPQAPQSASGEMLPSGAQWALDLVESPPQLVGAMIAMLSGVAVVNDLTEAMGLVEIRPELRAVTVDGDLVGAGWVSGGSDRKLSTLEVTSEIDKARSELAAAEALAAQLNAALAGALTEQSARQDAAEQALAALNESDTAISAMYEQLGRLGQEARAAEEEWNRLLQQRTEQEAVRTQTLDDVIQLETQLRKAQETQRVQVAQPIDRQAISAAADRARGVEVEARLAVRTAEERANAVRGRADSLRRAAAAEREARVRAQQARAARLHAAAVAAAVADCGRLLAGRLHRAVDGASQLRDASAAQRQQRLAAMAAVRDEVNTLSARVGELTDSLHRDELANAQAALRIEQLEQMVLEQFGMAPADLITEYGPHVALPPTELEMAEFEQARERGEQVIAPAPMPFDRVTQERRAKRAERALAELGRVNPLALEEFAALEERYNFLSTQLEDVKAARKDLLGVVADVDARILQVFNDAFVDVEREFRGVFTALFPGGEGRLRLTEPDDMLTTGIEVEARPPGKKITRLSLLSGGEKALTAVAMLVAIFRARPSPFYIMDEVEAALDDVNLRRLLSLFEQLREQSQIIIITHQKPTMEVADALYGVTMQNDGITAVISQRMRGQQVDQLVTNSS,"130,637",1205,SMC family,chromosome condensation [GO:0030261]; sister chromatid cohesion [GO:0007062],ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; chromosome [GO:0005694]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY338.11c,1
O53289,SERB2_MYCTU,Rv3042c,serB2 Rv3042c,GO:0004647; GO:0004722; GO:0005576; GO:0006470; GO:0006564; GO:0016311; GO:0016597; GO:0040007; GO:0044164; GO:0046872,IPR002912; IPR036412; IPR023214; IPR023190; ,,serB2,DOMAIN 8 86 ACT 1. {ECO:0000255|PROSITE-ProRule:PRU01007}.; DOMAIN 102 174 ACT 2. {ECO:0000305|PubMed:25521849}.,Phosphoserine phosphatase SerB2 (PSP) (PSPase) (EC 3.1.3.3) (O-phosphoserine phosphohydrolase) (Protein-serine/threonine phosphatase) (EC 3.1.3.16),extracellular region [GO:0005576]; host cell cytosol [GO:0044164]; amino acid binding [GO:0016597]; metal ion binding [GO:0046872]; phosphoserine phosphatase activity [GO:0004647]; protein serine/threonine phosphatase activity [GO:0004722]; dephosphorylation [GO:0016311]; growth [GO:0040007]; L-serine biosynthetic process [GO:0006564]; protein dephosphorylation [GO:0006470],9634230; 12657046; 21969609; 25037224; 25521849; 26984196,,"FUNCTION: Catalyzes the dephosphorylation of O-phospho-L-serine into L-serine, a step in the L-serine biosynthetic pathway (PubMed:25037224, PubMed:25521849). Exhibits high specificity for L-phophoserine compared to substrates like L-phosphothreonine (5% relative activity) and L-phosphotyrosine (1.7% relative activity) (PubMed:25521849). {ECO:0000269|PubMed:25037224, ECO:0000269|PubMed:25521849}.; FUNCTION: In the host, induces significant cytoskeleton rearrangements through cofilin dephosphorylation and its subsequent activation, and affects the expression of genes that regulate actin dynamics. It specifically interacts with HSP90, HSP70 and HSP27 that block apoptotic pathways but not with other HSPs. Also interacts with GAPDH. It actively dephosphorylates MAP kinase p38 and NF-kappa B p65 (specifically at Ser-536) that play crucial roles in inflammatory and immune responses. This in turn leads to down-regulation of Interleukin 8, a chemotactic and inflammatory cytokine. Thus might help the pathogen to evade the host's immune response (PubMed:26984196). Exogenous addition of purified SerB2 protein to human THP-1 cells (that can be differentiated into macrophage-like cells) induces microtubule rearrangements; the phosphatase activity is co-related to the elicited rearrangements, while addition of the ACT-domains alone elicits no rearrangements (PubMed:25521849). {ECO:0000269|PubMed:25521849, ECO:0000269|PubMed:26984196}.",MPAKVSVLITVTGMDQPGVTSALFEVLAQHGVELLNVEQVVIRGRLTLGVLVSCPLDVADGTALRDDVAAAIHGVGLDVAIERSDDLPIIRQPSTHTIFVLGRPITAGAFSAVARGVAALGVNIDFIRGISDYPVTGLELRVSVPPGCVGPLQIALTKVAAEEHVDVAVEDYGLAWRTKRLIVFDVDSTLVQGEVIEMLAARAGAQGQVAAITEAAMRGELDFAESLQRRVATLAGLPATVIDDVAEQLELMPGARTTIRTLRRLGFRCGVVSGGFRRIIEPLARELMLDFVASNELEIVDGILTGRVVGPIVDRPGKAKALRDFASQYGVPMEQTVAVGDGANDIDMLGAAGLGIAFNAKPALREVADASLSHPYLDTVLFLLGVTRGEIEAADAGDCGVRRVEIPAD,"43,059",409,"HAD-like hydrolase superfamily, SerB family",dephosphorylation [GO:0016311]; growth [GO:0040007]; L-serine biosynthetic process [GO:0006564]; protein dephosphorylation [GO:0006470],amino acid binding [GO:0016597]; metal ion binding [GO:0046872]; phosphoserine phosphatase activity [GO:0004647]; protein serine/threonine phosphatase activity [GO:0004722],extracellular region [GO:0005576]; host cell cytosol [GO:0044164],,,1
P9WNX3,SERA_MYCTU,Rv2996c,serA Rv2996c MTV012.10,GO:0004617; GO:0005618; GO:0005886; GO:0006564; GO:0040007; GO:0051287,IPR002912; IPR029009; IPR006139; IPR029753; IPR029752; IPR006140; IPR036291; IPR006236; ,,serA,DOMAIN 455 527 ACT. {ECO:0000255|PROSITE-ProRule:PRU01007}.,D-3-phosphoglycerate dehydrogenase (PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399),cell wall [GO:0005618]; plasma membrane [GO:0005886]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; growth [GO:0040007]; L-serine biosynthetic process [GO:0006564],9634230; 19099550; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes the reversible oxidation of 3-phospho-D-glycerate to 3-phosphonooxypyruvate, the first step of the phosphorylated L-serine biosynthesis pathway. Also catalyzes the reversible oxidation of 2-hydroxyglutarate to 2-oxoglutarate. {ECO:0000250|UniProtKB:P0A9T0}.",MSLPVVLIADKLAPSTVAALGDQVEVRWVDGPDRDKLLAAVPEADALLVRSATTVDAEVLAAAPKLKIVARAGVGLDNVDVDAATARGVLVVNAPTSNIHSAAEHALALLLAASRQIPAADASLREHTWKRSSFSGTEIFGKTVGVVGLGRIGQLVAQRIAAFGAYVVAYDPYVSPARAAQLGIELLSLDDLLARADFISVHLPKTPETAGLIDKEALAKTKPGVIIVNAARGGLVDEAALADAITGGHVRAAGLDVFATEPCTDSPLFELAQVVVTPHLGASTAEAQDRAGTDVAESVRLALAGEFVPDAVNVGGGVVNEEVAPWLDLVRKLGVLAGVLSDELPVSLSVQVRGELAAEEVEVLRLSALRGLFSAVIEDAVTFVNAPALAAERGVTAEICKASESPNHRSVVDVRAVGADGSVVTVSGTLYGPQLSQKIVQINGRHFDLRAQGINLIIHYVDRPGALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDVPDDVRTAIAAAVDAYKLEVVDLS,"54,554",528,D-isomer specific 2-hydroxyacid dehydrogenase family,growth [GO:0040007]; L-serine biosynthetic process [GO:0006564],NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV012.10,1
O33348,RELG_MYCTU,Rv2866,relG relE2 Rv2866,GO:0003677; GO:0004519; GO:0006351; GO:0006401; GO:0045892; GO:0045926,IPR007712; IPR035093; ,,relG,,Toxin RelG (EC 3.1.-.-) (Putative endoribonuclease RelG),"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",9634230; 15718296; 19114484; 20011113; 20061486; 20498855; 21969609; ,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Has RNase activity and preferentially cleaves at the 3'-end of purine ribonucleotides (By similarity). Overexpression in M.tuberculosis or M.smegmatis inhibits colony formation in a bacteriostatic rather than bacteriocidal fashion. Its toxic effect is neutralized by coexpression with cognate antitoxin RelB2 (shown only for M.smegmatis). Overexpression also increases the number of gentamicin-tolerant and levofloxacin-tolerant persister cells. {ECO:0000250, ECO:0000269|PubMed:19114484, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20061486, ECO:0000269|PubMed:20498855}.; FUNCTION: In combination with cognate antitoxin RelF represses its own promoter. Has been seen to bind DNA in complex with antitoxin RelF but not alone.",MPYTVRFTTTARRDLHKLPPRILAAVVEFAFGDLSREPLRVGKPLRRELAGTFSARRGTYRLLYRIDDEHTTVVILRVDHRADIYRR,"10,237",87,RelE toxin family,"negative regulation of growth [GO:0045926]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,relE2,,1
P9WHS3,RIP1_MYCTU,Rv2869c,rip1 Rv2869c MTV003.15c,GO:0004222; GO:0005886; GO:0016021; GO:0040007; GO:0046872,IPR001478; IPR036034; IPR008915; ,,rip1,DOMAIN 121 203 PDZ. {ECO:0000255|PROSITE-ProRule:PRU00143}.,Zinc metalloprotease Rip1 (EC 3.4.24.-) (Regulator of sigma KLM proteases) (S2P endopeptidase) (Site-2 protease Rip1) (S2P protease Rip1) (Site-2-type intramembrane protease),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; growth [GO:0040007],9634230; 19099550; 19496931; 21969609,,"FUNCTION: A probable intramembrane site-2 protease (S2P) that cleaves type-2 transmembrane proteins within their membrane-spanning domains. Cleaves PbpB (PBP3, FtsI) near 'Ala-102' and 'Ala-103' in response to oxidative stress; cleavage is inhibited by Wag31-PbpB interaction. Probably also cleaves anti-sigma factors RskA, RslA and RsmA but not RsdA. {ECO:0000269|PubMed:19496931}.; FUNCTION: Regulated intramembrane proteolysis (RIP) occurs when an extracytoplasmic signal (possibly oxidative stress) triggers a concerted proteolytic cascade to transmit information and elicit cellular responses. The membrane-spanning regulatory substrate protein (includes anti-sigma factors RskA, RslA, RsmA, and PbpB in M.tuberculosis) is first cut extracytoplasmically (site-1 protease, S1P), then within the membrane itself (site-2 protease, S2P, this entry), while cytoplasmic proteases finish degrading the regulatory protein, liberating the effector protein (ECF sigma factors SigK, SigL and SigM). {ECO:0000269|PubMed:19496931}.",MMFVTGIVLFALAILISVALHECGHMWVARRTGMKVRRYFVGFGPTLWSTRRGETEYGVKAVPLGGFCDIAGMTPVEELDPDERDRAMYKQATWKRVAVLFAGPGMNLAICLVLIYAIALVWGLPNLHPPTRAVIGETGCVAQEVSQGKLEQCTGPGPAALAGIRSGDVVVKVGDTPVSSFDEMAAAVRKSHGSVPIVVERDGTAIVTYVDIESTQRWIPNGQGGELQPATVGAIGVGAARVGPVRYGVFSAMPATFAVTGDLTVEVGKALAALPTKVGALVRAIGGGQRDPQTPISVVGASIIGGDTVDHGLWVAFWFFLAQLNLILAAINLLPLLPFDGGHIAVAVFERIRNMVRSARGKVAAAPVNYLKLLPATYVVLVLVVGYMLLTVTADLVNPIRLFQ,"42,834",404,Peptidase M50B family,growth [GO:0040007],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV003.15c,1
P9WH75,RIR1_MYCTU,Rv3051c,nrdE Rv3051c MTV012.66c,GO:0004748; GO:0005524; GO:0005886; GO:0005971; GO:0006260; GO:0009263; GO:0040007; GO:0051063; GO:0055114,IPR013346; IPR026459; IPR000788; IPR013509; IPR013554; IPR008926; ,,nrdE,,Ribonucleoside-diphosphate reductase subunit alpha (EC 1.17.4.1) (Ribonucleotide reductase R1 subunit),"plasma membrane [GO:0005886]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; CDP reductase activity [GO:0051063]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; growth [GO:0040007]; oxidation-reduction process [GO:0055114]",9634230; 7961427; 9335290; 14573627; 21969609,,"FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. When coexpressed in E.coli with nrdF2 the 2 proteins complement a temperature-sensitive E.coli mutant, however coexpression with nrdF1 does not complement. {ECO:0000269|PubMed:9335290}.",MPPTVIAEPVASGAHASYSGGPGETDYHALNAMLNLYDADGKIQFDKDREAAHQYFLQHVNQNTVFFHNQDEKLDYLIRENYYEREVLDQYSRNFVKTLLDRAYAKKFRFPTFLGAFKYYTSYTLKTFDGKRYLERFEDRVVMVALTLAAGDTALAELLVDEIIDGRFQPATPTFLNSGKKQRGEPVSCFLLRVEDNMESIGRSINSALQLSKRGGGVALLLTNIREHGAPIKNIENQSSGVIPIMKLLEDAFSYANQLGARQGAGAVYLHAHHPDIYRFLDTKRENADEKIRIKTLSLGVVIPDITFELAKRNDDMYLFSPYDVERVYGVPFADISVTEKYYEMVDDARIRKTKIKAREFFQTLAELQFESGYPYIMFEDTVNRANPIDGKITHSNLCSEILQVSTPSLFNEDLSYAKVGKDISCNLGSLNIAKTMDSPDFAQTIEVAIRALTAVSDQTHIKSVPSIEQGNNDSHAIGLGQMNLHGYLARERIFYGSDEGIDFTNIYFYTVLYHALRASNRIAIERGTHFKGFERSKYASGEFFDKYTDQIWEPKTQKVRQLFADAGIRIPTQDDWRRLKESVQAHGIYNQNLQAVPPTGSISYINHSTSSIHPIVSKVEIRKEGKIGRVYYPAPYMTNDNLEYYEDAYEIGYEKIIDTYAAATQHVDQGLSLTLFFKDTATTRDVNKAQIYAWRKGIKTLYYIRLRQMALEGTEVEGCVSCML,"82,441",725,Ribonucleoside diphosphate reductase large chain family,deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; growth [GO:0040007]; oxidation-reduction process [GO:0055114],"ATP binding [GO:0005524]; CDP reductase activity [GO:0051063]; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor [GO:0004748]",plasma membrane [GO:0005886]; ribonucleoside-diphosphate reductase complex [GO:0005971],,MTV012.66c,1
P9WH15,RLMN_MYCTU,Rv2880c/Rv2879c,rlmN Rv2880c/Rv2879c MTCY274.11c/MTCY274.10c,GO:0005618; GO:0005737; GO:0005886; GO:0008175; GO:0008649; GO:0046872; GO:0051539; GO:0070040; GO:0070475,IPR013785; IPR027492; IPR004383; IPR007197; ,,rlmN,,Probable dual-specificity RNA methyltransferase RlmN (EC 2.1.1.192) (23S rRNA (adenine(2503)-C(2))-methyltransferase) (23S rRNA m2A2503 methyltransferase) (Ribosomal RNA large subunit methyltransferase N) (tRNA (adenine(37)-C(2))-methyltransferase) (tRNA m2A37 methyltransferase),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; rRNA (adenine-C2-)-methyltransferase activity [GO:0070040]; rRNA methyltransferase activity [GO:0008649]; tRNA methyltransferase activity [GO:0008175]; rRNA base methylation [GO:0070475]",9634230,,FUNCTION: Specifically methylates position 2 of adenine 2503 in 23S rRNA and position 2 of adenine 37 in tRNAs. {ECO:0000255|HAMAP-Rule:MF_01849}.,MVPELMFDEPRPGRPPRHLADLDAAGRASAVAELGLPAFRAKQLAHQYYGRLIADPRQMTDLPAAVRDRIAGAMFPNLLTASADITCDAGQTRKTLWRAVDGTMFESVLMRYPRRNTVCISSQAGCGMACPFCATGQGGLTRNLSTAEILEQVRAGAAALRDDFGDRLSNVVFMGMGEPLANYARVLAAVQRITARPPSGFGISARAVTVSTVGLAPAIRNLADARLGVTLALSLHAPDDGLRDTLVPVNNRWRISEALDAARYYANVTGRRVSIEYALIRDVNDQPWRADLLGKRLHRVLGPLAHVNLIPLNPTPGSDWDASPKPVEREFVKRVRAKGVSCTVRDTRGREISAACGQLAAVGG,"39,255",364,"Radical SAM superfamily, RlmN family",rRNA base methylation [GO:0070475],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; rRNA (adenine-C2-)-methyltransferase activity [GO:0070040]; rRNA methyltransferase activity [GO:0008649]; tRNA methyltransferase activity [GO:0008175]",cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY274.11c/MTCY274.10c,1
P9WHG1,RF2_MYCTU,Rv3105c,prfB Rv3105c MTCY164.15c,GO:0005618; GO:0005737; GO:0016149; GO:0040007,IPR005139; IPR000352; IPR004374; ,,prfB,,Peptide chain release factor 2 (RF-2),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; translation release factor activity, codon specific [GO:0016149]; growth [GO:0040007]",9634230; 19099550; 21969609,,FUNCTION: Peptide chain release factor 2 directs the termination of translation in response to the peptide chain termination codons UGA and UAA. {ECO:0000250}.,MDPDRQADIAALDCTLTTVERVLDVEGLRSRIEKLEHEASDPHLWDDQTRAQRVTSELSHTQGELRRVEELRRRLDDLPVLYELAAEEAGAAAADAVAEADAELKSLRADIEATEVRTLLSGEYDEREALVTIRSGAGGVDAADWAEMLMRMYIRWAEQHKYPVEVFDTSYAEEAGIKSATFAVHAPFAYGTLSVEQGTHRLVRISPFDNQSRRQTSFAEVEVLPVVETTDHIDIPEGDVRVDVYRSSGPGGQSVNTTDSAVRLTHIPSGIVVTCQNEKSQLQNKIAAMRVLQAKLLERKRLEERAELDALKADGGSSWGNQMRSYVLHPYQMVKDLRTEYEVGNPAAVLDGDLDGFLEAGIRWRNRRNDD,"41,473",371,Prokaryotic/mitochondrial release factor family,growth [GO:0040007],"translation release factor activity, codon specific [GO:0016149]",cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY164.15c,1
P9WHJ7,RBFA_MYCTU,Rv2838c,rbfA Rv2838c MTCY16B7.04,GO:0005737; GO:0006364,IPR015946; IPR000238; IPR023799; IPR020053; ,,rbfA,,Ribosome-binding factor A,cytoplasm [GO:0005737]; rRNA processing [GO:0006364],9634230; 21969609,,FUNCTION: One of several proteins that assist in the late maturation steps of the functional core of the 30S ribosomal subunit. Associates with free 30S ribosomal subunits (but not with 30S subunits that are part of 70S ribosomes or polysomes). Required for efficient processing of 16S rRNA. May interact with the 5'-terminal helix region of 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_00003}.,MADAARARRLAKRIAAIVASAIEYEIKDPGLAGVTITDAKVTADLHDATVYYTVMGRTLHDEPNCAGAAAALERAKGVLRTKVGAGTGVRFTPTLTFTLDTISDSVHRMDELLARARAADADLARVRVGAKPAGEADPYRDNGSVAQSPAPGGLGIRTSDGPEAVEAPLTCGGDTGDDDRPKE,"18,998",183,RbfA family,rRNA processing [GO:0006364],,cytoplasm [GO:0005737],,MTCY16B7.04,1
P9WMQ7,RECG_MYCTU,Rv2973c,recG Rv2973c MTCY349.14,GO:0003677; GO:0004003; GO:0004004; GO:0005524; GO:0005737; GO:0005886; GO:0006281; GO:0006310; GO:0010501,IPR004609; IPR011545; IPR014001; IPR001650; IPR012340; IPR027417; IPR033454; ,,recG,DOMAIN 302 477 Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.; DOMAIN 514 673 Helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00542}.,ATP-dependent DNA helicase RecG (EC 3.6.4.12),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; RNA secondary structure unwinding [GO:0010501],9634230,,FUNCTION: Critical role in recombination and DNA repair. Helps process Holliday junction intermediates to mature products by catalyzing branch migration. Has a DNA unwinding activity characteristic of a DNA helicase with a 3'- to 5'- polarity. Unwinds branched duplex DNA (Y-DNA) (By similarity). {ECO:0000250}.,MASLSDRLDRVLGATAADALDEQFGMRTVDDLLRHYPRSYVEGAARVGIGDARPEAGEHITIVDVITDTYSFPMKKKPNRKCLRITVGGGRNKVTATFFNADYIMRDLTKHTKVMLSGEVGYYKGAMQLTHPAFLILDSPDGKNHGTRSLKSIADASKAISGELVVEEFERRFFPIYPASTKVQSWDIFKCVRQVLDVLDRVDDPLPAELRAKHGLIPEDEALRAIHLAESQSLRERARERLTFDEAVGLQWALVARRHGELSESGPSAAWKSNGLAAELLRRLPFELTAGQREVLDVLSDGLAANRPLNRLLQGEVGSGKTIVAVLAMLQMVDAGYQCALLAPTEVLAAQHLRSIRDVLGPLAMGGQLGGAENATRVALLTGSMTAGQKKQVRAEIASGQVGIVIGTHALLQEAVDFHNLGMVVVDEQHRFGVEQRDQLRAKAPAGITPHLLVMTATPIPRTVALTVYGDLETSTLRELPLGRQPIATNVIFVKDKPAWLDRAWRRIIEEAAAGRQAYVVAPRIDESDDTDVQGGVRPSATAEGLFSRLRSAELAELRLALMHGRLSADDKDAAMAAFRAGEVDVLVCTTVIEVGVDVPNATVMLVMDADRFGISQLHQLRGRIGRGEHPSVCLLASWVPPDTPAGQRLRAVAGTMDGFALADLDLKERKEGDVLGRNQSGKAITLRLLSLAEHEEYIVAARDFCIEAYKNPTDPALALMAARFTSTDRIEYLDKS,"80,361",737,"Helicase family, RecG subfamily",DNA recombination [GO:0006310]; DNA repair [GO:0006281]; RNA secondary structure unwinding [GO:0010501],ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY349.14,1
P9WHC9,RL19_MYCTU,Rv2904c,rplS Rv2904c MTCY274.35c,GO:0003735; GO:0005886; GO:0006412; GO:0022625; GO:0040007,IPR038657; IPR001857; IPR018257; IPR008991; ,,rplS,,50S ribosomal protein L19,cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),FUNCTION: This protein is located at the 30S-50S ribosomal subunit interface and may play a role in the structure and function of the aminoacyl-tRNA binding site. {ECO:0000250}.,MNRLDFVDKPSLRDDIPAFNPGDTINVHVKVIEGAKERLQVFKGVVIRRQGGGIRETFTVRKESYGVGVERTFPVHSPNIDHIEVVTRGDVRRAKLYYLRELRGKKAKIKEKR,"13,013",113,Bacterial ribosomal protein bL19 family,growth [GO:0040007]; translation [GO:0006412],structural constituent of ribosome [GO:0003735],cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY274.35c,1
P9WHP7,TRUB_MYCTU,Rv2793c,truB Rv2793c MTV002.58c,GO:0003723; GO:0005618; GO:0006400; GO:0009982; GO:1990481,IPR020103; IPR002501; IPR015947; IPR036974; IPR015225; IPR014780; IPR032819; ,,truB,,tRNA pseudouridine synthase B (EC 5.4.99.25) (MTB-TRUB) (tRNA pseudouridine(55) synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),cell wall [GO:0005618]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400],9634230; 21969609; 15028724,X-ray crystallography (1),FUNCTION: Responsible for synthesis of pseudouridine from uracil-55 in the psi GC loop of transfer RNAs. {ECO:0000255|HAMAP-Rule:MF_01080}.,MSATGPGIVVIDKPAGMTSHDVVGRCRRIFATRRVGHAGTLDPMATGVLVIGIERATKILGLLTAAPKSYAATIRLGQTTSTEDAEGQVLQSVPAKHLTIEAIDAAMERLRGEIRQVPSSVSAIKVGGRRAYRLARQGRSVQLEARPIRIDRFELLAARRRDQLIDIDVEIDCSSGTYIRALARDLGDALGVGGHVTALRRTRVGRFELDQARSLDDLAERPALSLSLDEACLLMFARRDLTAAEASAAANGRSLPAVGIDGVYAACDADGRVIALLRDEGSRTRSVAVLRPATMHPG,"31,820",298,"Pseudouridine synthase TruB family, Type 1 subfamily",mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],cell wall [GO:0005618],,MTV002.58c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WFY7,TRMD_MYCTU,Rv2906c,trmD Rv2906c MTCY274.37c,GO:0005737; GO:0009019; GO:0040007; GO:0050518; GO:0052906,IPR029028; IPR002649; IPR023148; IPR029026; IPR016009; ,,trmD,,tRNA (guanine-N(1)-)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase),cytoplasm [GO:0005737]; 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity [GO:0050518]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Specifically methylates guanosine-37 in various tRNAs. {ECO:0000250}.,MRIDIVTIFPACLDPLRQSLPGKAIESGLVDLNVHDLRRWTHDVHHSVDDAPYGGGPGMVMKAPVWGEALDEICSSETLLIVPTPAGVLFTQATAQRWTTESHLVFACGRYEGIDQRVVQDAARRMRVEEVSIGDYVLPGGESAAVVMVEAVLRLLAGVLGNPASHQDDSHSTGLDGLLEGPSYTRPASWRGLDVPEVLLSGDHARIAAWRREVSLQRTRERRPDLSHPD,"25,166",230,RNA methyltransferase TrmD family,growth [GO:0040007],2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity [GO:0050518]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019],cytoplasm [GO:0005737],,MTCY274.37c,1
P9WFR9,TYSY_MYCTU,Rv2764c,thyA Rv2764c MTV002.29c,GO:0004799; GO:0005737; GO:0006231; GO:0006235; GO:0046079; GO:0046677,IPR023451; IPR036926; IPR000398; IPR020940; ,,thyA,,Thymidylate synthase ThyA (TS) (TSase) (EC 2.1.1.45),cytoplasm [GO:0005737]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP catabolic process [GO:0046079]; response to antibiotic [GO:0046677],9634230; 15225321; 18493582; 19237648; 21969609; 22034487; ,X-ray crystallography (5),"FUNCTION: Catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor and reductant in the reaction, yielding dihydrofolate (DHF) as a by-product. This enzymatic reaction provides an intracellular de novo source of dTMP, an essential precursor for DNA biosynthesis. {ECO:0000269|PubMed:18493582}.",MTPYEDLLRFVLETGTPKSDRTGTGTRSLFGQQMRYDLSAGFPLLTTKKVHFKSVAYELLWFLRGDSNIGWLHEHGVTIWDEWASDTGELGPIYGVQWRSWPAPSGEHIDQISAALDLLRTDPDSRRIIVSAWNVGEIERMALPPCHAFFQFYVADGRLSCQLYQRSADLFLGVPFNIASYALLTHMMAAQAGLSVGEFIWTGGDCHIYDNHVEQVRLQLSREPRPYPKLLLADRDSIFEYTYEDIVVKNYDPHPAIKAPVAV,"29,853",263,"Thymidylate synthase family, Bacterial-type ThyA subfamily",dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP catabolic process [GO:0046079]; response to antibiotic [GO:0046677],thymidylate synthase activity [GO:0004799],cytoplasm [GO:0005737],,MTV002.29c,1
P9WGV5,TAER_MYCTU,Rv2953,Rv2953,GO:0005618; GO:0005886; GO:0009247; GO:0016491; GO:0071770,IPR036291; IPR005097; ,,,,Trans-acting enoyl reductase (EC 1.3.1.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; DIM/DIP cell wall layer assembly [GO:0071770]; glycolipid biosynthetic process [GO:0009247],9634230; 17468241; 21969609,,FUNCTION: Involved in the reduction of the double bond between C-4 and C-5 during phthiocerol dimycocerosates (DIM A) and glycosylated phenolphthiocerol dimycocerosates (PGL) biosynthesis. {ECO:0000269|PubMed:17468241}.,MSPAEREFDIVLYGATGFSGKLTAEHLAHSGSTARIALAGRSSERLRGVRMMLGPNAADWPLILADASQPLTLEAMAARAQVVLTTVGPYTRYGLPLVAACAKAGTDYADLTGELMFCRNSIDLYHKQAADTGARIILACGFDSIPSDLNVYQLYRRSVEDGTGELCDTDLVLRSFSQRWVSGGSVATYSEAMRTASSDPEARRLVTDPYTLTTDRGAEPELGAQPDFLRRPGRDLAPELAGFWTGGFVQAPFNTRIVRRSNALQEWAYGRRFRYSETMSLGKSMAAPILAAAVTGTVAGTIGLGNKYFDRLPRRLVERVTPKPGTGPSRKTQERGHYTFETYTTTTTGARYRATFAHNVDAYKSTAVLLAQSGLALALDRDRLAELRGVLTPAAAMGDALLARLPGAGVVMGTTRLS,"45,104",418,"Saccharopine dehydrogenase family, Enoyl reductase subfamily",DIM/DIP cell wall layer assembly [GO:0071770]; glycolipid biosynthetic process [GO:0009247],oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WKC3,TGS4_MYCTU,Rv3088,tgs4 Rv3088 MTV013.09,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0010447; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,tgs4,,Probable diacyglycerol O-acyltransferase Tgs4 (TGS4) (EC 2.3.1.20) (Probable triacylglycerol synthase tgs4),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 14568148; 15262939; 15937179; 16893682; 21969609,,"FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. Upon expression in E.coli functions as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has very weak wax synthase activity, incorporating palmityl alcohol into wax esters in the presence of palmitoyl-CoA. {ECO:0000269|PubMed:15262939, ECO:0000269|PubMed:15937179}.",MTRINPIDLSFLLLERANRPNHMAAYTIFEKPKGQKSSFGPRLFDAYRHSQAAKPFNHKLKWLGTDVAAWETVEPDMGYHIRHLALPAPGSMQQFHETVSFLNTGLLDRGHPMWECYIIDGIERGRIAILLKVHHALIDGEGGLRAMRNFLSDSPDDTTLAGPWMSAQGADRPRRTPATVSRRAQLQGQLQGMIKGLTKLPSGLFGVSADAADLGAQALSLKARKASLPFTARRTLFNNTAKSAARAYGNVELPLADVKALAKATGTSVNDVVMTVIDDALHHYLAEHQASTDRPLVAFMPMSLREKSGEGGGNRVSAELVPMGAPKASPVERLKEINAATTRAKDKGRGMQTTSRQAYALLLLGSLTVADALPLLGKLPSANVVISNMKGPTEQLYLAGAPLVAFSGLPIVPPGAGLNVTFASINTALCIAIGAAPEAVHEPSRLAELMQRAFTELQTEAGTTSPTTSKSRTP,"50,887",474,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV013.09,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WL33,Y2891_MYCTU,Rv2891,Rv2891 MTCY274.22,,IPR011055; IPR016047; ,,,,Uncharacterized protein Rv2891,,9634230,,,MAKSPARRCTAKVRRVLSRSVLILCWSLLGAAPAHADDSRLGWPLRPPPAVVRQFDAASPNWNPGHRGVDLAGRPGQPVYAAGSATVVFAGLLAGRPVVSLAHPGGLRTSYEPVVAQVRVGQPVSAPTVIGALAAGHPGCQAAACLHWGAMWGPASGANYVDPLGLLKSTPIRLKPLSSEGRTLHYRQAEPVFVNEAAAGALAGAGHRKSPKQGVFRGAAQGGDIVARQPPGRWVCPSSAGGPIGWHRQ,"25,807",249,,,,,,MTCY274.22,1
P9WPR1,Y2897_MYCTU,Rv2897c,Rv2897c MTCY274.28c,GO:0005886; GO:0040007,IPR003593; IPR004482; IPR025158; IPR000523; IPR027417; IPR020568; IPR014721; ,,,,Uncharacterized protein Rv2897c,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 19099550,,,MALGRAFSVAVRGLDGEIVEIEADITSGLPGVHLVGLPDAALQESRDRVRAAVTNCGNSWPMARLTLALSPATLPKMGSVYDIALAAAVLSAQQKKPWERLENTLLLGELSLDGRVRPVRGVLPAVLAAKRDGWPAVVVPADNLPEASLVDGIDVRGVRTLGQLQSWLRGSTGLAGRITTADTTPESAADLADVVGQSQARFAVEVAAAGAHHLMLTGPPGVGKTMLAQRLPGLLPSLSGSESLEVTAIHSVAGLLSGDTPLITRPPFVAPHHSSSVAALVGGGSGMARPGAVSRAHRGVLFLDECAEISLSALEALRTPLEDGEIRLARRDGVACYPARFQLVLAANPCPCAPADPQDCICAAATKRRYLGKLSGPLLDRVDLRVQMHRLRAGAFSAADGESTSQVRQRVALAREAAAQRWRPHGFRTNAEVSGPLLRRKFRPSSAAMLPLRTALDRGLLSIRGVDRTLRVAWSLADLAGRTSPGIDEVAAALSFRQTGARR,"52,913",503,"Mg-chelatase subunits D/I family, ComM subfamily",growth [GO:0040007],,plasma membrane [GO:0005886],,MTCY274.28c,1
P9WFM9,Y2898_MYCTU,Rv2898c,Rv2898c MTCY274.29c,GO:0003676; GO:0004518,IPR011335; IPR011856; IPR003509; ,,,,UPF0102 protein Rv2898c,nuclease activity [GO:0004518]; nucleic acid binding [GO:0003676],9634230,,,MTTLKTMTRVQLGAMGEALAVDYLTSMGLRILNRNWRCRYGELDVIACDAATRTVVFVEVKTRTGDGYGGLAHAVTERKVRRLRRLAGLWLADQEERWAAVRIDVIGVRVGPKNSGRTPELTHLQGIG,"14,224",128,UPF0102 family,,nuclease activity [GO:0004518]; nucleic acid binding [GO:0003676],,,MTCY274.29c,1
P9WL39,Y2876_MYCTU,Rv2876,Rv2876 MTCY274.07,GO:0005886; GO:0016021,IPR024341; ,,,,Uncharacterized protein Rv2876,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MFGQWEFDVSPTGGIAVASTEVEHFAGSQHEVDTAEVPSAAWGWSRIDHRTWHIVGLCIFGFLLAMLRGNHVGHVEDWFLITFAAVVLFVLARDLWGRRRGWIR,"11,805",104,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY274.07,1
P9WL27,Y2901_MYCTU,Rv2901c,Rv2901c MTCY274.32c,GO:0005886,IPR019592; ,,,,Uncharacterized protein Rv2901c,plasma membrane [GO:0005886],9634230; 21969609,,,MSAEDLEKYETEMELSLYREYKDIVGQFSYVVETERRFYLANSVEMVPRNTDGEVYFELRLADAWVWDMYRPARFVKQVRVVTFKDVNIEEVEKPELRLPE,"12,226",101,,,,plasma membrane [GO:0005886],,MTCY274.32c,1
P9WFM7,Y2908_MYCTU,Rv2908c,Rv2908c MTCY274.40c,GO:0003723; GO:0040007,IPR015946; IPR009019; IPR020627; ,,,DOMAIN 33 80 KH.,UPF0109 protein Rv2908c,RNA binding [GO:0003723]; growth [GO:0040007],9634230; 17259624; 21969609,,,MSAVVVDAVEHLVRGIVDNPDDVRVDLITSRRGRTVEVHVHPDDLGKVIGRGGRTATALRTLVAGIGGRGIRVDVVDTDQ,"8,521",80,UPF0109 family,growth [GO:0040007],RNA binding [GO:0003723],,,MTCY274.40c,1
P9WJH9,Y2913_MYCTU,Rv2913c,Rv2913c MTCY274.45c MTCY338.01c,GO:0005829; GO:0016810,IPR013108; IPR011059; IPR032466; ,,,,Uncharacterized protein Rv2913c,"cytosol [GO:0005829]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",9634230; 21969609,,,MLAWRQLNDLEETVTYDVIIRDGLWFDGTGNAPLTRTLGIRDGVVATVAAGALDETGCPEVVDAAGKWVVPGFIDVHTHYDAEVLLDPGLRESVRHGVTTVLLGNCSLSTVYANSEDAADLFSRVEAVPREFVLGALRDNQTWSTPAEYIEAIDALPLGPNVSSLLGHSDLRTAVLGLDRATDDTVRPTEAELAKMAKLLDEALEAGMLGMSGMDAAIDKLDGDRFRSRALPSTFATWRERRKLISVLRHRGRILQSAPDVDNPVSALLFFLASSRIFNRRKGVRMSMLVSADAKSMPLAVHVFGLGTRVLNKLLGSQVRFQHLPVPFELYSDGIDLPVFEEFGAGTAALHLRDQLQRNELLADRSYRRSFRREFDRIKLGPSLWHRDFHDAVIVECPDKSLIGKSFGAIADERGLHPLDAFLDVLVDNGERNVRWTTIVANHRPNQLNKLAAEPSVHMGFSDAGAHLRNMAFYNFGLRLLKRARDADRAGQPFLSIERAVYRLTGELAEWFGIGAGTLRQGDRADFAVIDPTHLDESVDGYHEEAVPYYGGLRRMVNRNDATVVATGVGGTVVFRGGQFGGQFRDGYGQNVKSGRYLRAGELGAALSRSA,"67,205",611,"Metallo-dependent hydrolases superfamily, N-acyl-D-amino-acid deacylase family",,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]",cytosol [GO:0005829],,MTCY274.45c MTCY338.01c,1
P9WL23,Y2915_MYCTU,Rv2915c,Rv2915c MTCY338.03c,GO:0016787,IPR006680; IPR032466; ,,,,Uncharacterized protein Rv2915c,hydrolase activity [GO:0016787],9634230; 21969609,,,MKRVDTIRPRSRAVRLHVRGLGLPDETAIQLWIVDGRISTEPVAGADTVFDGGWILPGLVDAHCHVGLGKHGNVELDEAIAQAETERDVGALLLRDCGSPTDTRGLDDHEDLPRIIRAGRHLARPKRYIAGFAVELEDESQLPAAVAEQARRGDGWVKLVGDWIDRQIGDLAPLWSDDVLKAAIDTAHAQGARVTAHVFSEDALPGLINAGIDCIEHGTGLTDDTIALMLEHGTALVPTLINLENFPGIADAAGRYPTYAAHMRDLYARGYGRVAAAREAGVPVYAGTDAGSTIEHGRIADEVAALQRIGMTAHEALGAACWDARRWLGRPGLDDRASADLLCYAQDPRQGPGVLQHPDLVILRGRTFGP,"39,770",370,Metallo-dependent hydrolases superfamily,,hydrolase activity [GO:0016787],,,MTCY338.03c,1
P9WL19,Y2923_MYCTU,Rv2923c,Rv2923c MTCY338.12c,GO:0005886,IPR015946; IPR003718; IPR036102; ,,,,Uncharacterized protein Rv2923c,plasma membrane [GO:0005886],9634230; 21969609,,,MTQLWVERTGTRRYIGRSTRGAQVLVGSEDVDGVFTPGELLKIALAACSGMASDQPLARRLGDDYQAVVKVSGAADRDQERYPLIEETMELDLSGLTEDEKERLLVVINRAVELACTVGRTLKSGTTVNLEVVDVGA,"14,854",137,,,,plasma membrane [GO:0005886],,MTCY338.12c,1
O53281,Y3034_MYCTU,Rv3034c,Rv3034c,GO:0005618; GO:0005886; GO:0016746,IPR001451; IPR011004; ,,,,Putative acetyltransferase Rv3034c (EC 2.3.1.-),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]",9634230; 17640872; 21969609,,FUNCTION: Putative acetyltransferase that is probably involved in the biosynthesis of 6-O-methylglucosyl lipopolysaccharides (MGLP).,MNVLSLGSSSGVVWGRVPITAPAGAATGVTSRADAHSQMRRYAQTGPTAKLSSAPMTTMWGAPLHRRWRGSRLRDPRQAKFLTLASLKWVLANRAYTPWYLVRYWRLLRFKLANPHIITRGMVFLGKGVEIHATPELAQLEIGRWVHIGDKNTIRAHEGSLRFGDKVVLGRDNVINTYLDIEIGDSVLMADWCYICDFDHRMDDITLPIKDQGIIKSPVRIGPDTWIGVKVSVLRGTTIGRGCVLGSHAVVRGAIPDYSIAVGAPAKVVKNRQLSWEASAAQRAELAAALADIERKKAAR,"33,064",300,Transferase hexapeptide repeat family,,"transferase activity, transferring acyl groups [GO:0016746]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WJZ3,Y3037_MYCTU,Rv3037c,Rv3037c,GO:0036261; GO:0071164,IPR029063; ,,,,Uncharacterized S-adenosylmethionine-dependent methyltransferase Rv3037c (EC 2.1.1.-),RNA trimethylguanosine synthase activity [GO:0071164]; 7-methylguanosine cap hypermethylation [GO:0036261],9634230,,,MRARFGDRAPWLVETTLLRRRAAGKLGELCPNVGVSQWLFTDEALQQATAAPVARHRARRLAGRVVHDATCSIGTELAALRELAVRAVGSDIDPVRLAMARHNLAALGMEADLCRADVLHPVTRDAVVVIDPARRSNGRRRFHLADYQPGLGPLLDRYRGRDVVVKCAPGIDFEEVGRLGFEGEIEVISYRGGVREACLWSAGLAGSGIRRRASILDSGEQIGDDEPDDCGVRPAGKWIVDPDGAVVRAGLVRNYGARHGLWQLDPQIAYLSGDRLPPALRGFEVLEQLAFDERRLRQVLSALDCGAAEILVRGVAIDPDALRRRLRLRGSRPLAVVITRIGAGSLSHVTAYVCRPSR,"39,082",358,Methyltransferase superfamily,7-methylguanosine cap hypermethylation [GO:0036261],RNA trimethylguanosine synthase activity [GO:0071164],,,,1
P9WL11,Y3073_MYCTU,Rv3073c,Rv3073c MTCY22D7.08,,IPR007438; ,,,,Uncharacterized protein Rv3073c,,9634230,,,MVRETRVRVARVYEDIDPDDGQRVLVDRIWPHGIRKDDQRVGIWCKDVAPSKELREWYHHQPERFDEFASRYQEELHDSAALAELRKLTGRSVVTPVTATRHVARSHAAVLAQLLNGR,"13,751",118,,,,,,MTCY22D7.08,1
P9WMG3,Y3095_MYCTU,Rv3095,Rv3095 MTCY164.06,GO:0003677; GO:0006351; GO:0006355,IPR011991; IPR002577; IPR036388; IPR036390; ,,,DOMAIN 13 110 HTH hxlR-type. {ECO:0000255|PROSITE-ProRule:PRU00435}.,Uncharacterized HTH-type transcriptional regulator Rv3095,"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MAVSDLSHRFEGESVGRALELVGERWTLLILREAFFGVRRFGQLARNLGIPRPTLSSRLRMLVEVGLFDRVPYSSDPERHEYRLTEAGRDLFAAIVVLMQWGDEYLPRPEGPPIKLRHHTCGEHADPRLICTHCGEEITARNVTPEPGPGFKAKLASS,"17,801",158,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,MTCY164.06,1
P9WL25,Y2910_MYCTU,Rv2910c,Rv2910c MTCY274.42c,,IPR032710; IPR037401; ,,,,Uncharacterized protein Rv2910c,,9634230; 19099550; 21969609,,,MCAVLDRSMLSVAEISDRLEIQQLLVDYSSAIDQRRFDDLDRVFTPDAYIDYRALGGIDGRYPKIKQWLSQVLGNFPVYAHMLGNFSVRVDGDTASSRVICFNPMVFAGDRQQVLFCGLWYDDDFVRTPDGWRIIRRVETKCFQKMM,"17,049",147,,,,,,MTCY274.42c,1
P9WMC7,Y2912_MYCTU,Rv2912c,Rv2912c MTCY274.44c,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR023772; IPR009057; IPR001647; ,,,DOMAIN 10 70 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,Uncharacterized HTH-type transcriptional regulator Rv2912c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MARTQQQRREETVARLLQASIDTIIEVGYARASAAVITKRAGVSVGALFRHFETMGDFMAATAYEVLRRQLETFTKQVAEIPADRPALPAALTILRDITAGSTNAVLYELMVAARTDEKLKETLQNVLGQYSAKIHDAARALPGAESFPEETFPVIVALMTNVFDGAAIVRGVLPQPELEEQRIPMLTALLTAGL,"21,239",195,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY274.44c,1
P9WL21,Y2917_MYCTU,Rv2917,Rv2917 MTCY338.05,GO:0003677; GO:0005524; GO:0005886; GO:0016787,IPR006935; IPR014001; IPR027417; ,,,DOMAIN 51 210 Helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00541}.,Uncharacterized protein Rv2917,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],9634230,,,MLHFTAATSRFRLGRERANSVRSDGGWGVLQPVSATFNPPLRGWQRRALVQYLGTQPRDFLAVATPGSGKTSFALRIAAELLRYHTVEQVTVVVPTEHLKVQWAHAAAAHGLSLDPKFANSNPQTSPEYHGVMVTYAQVASHPTLHRVRTEARKTLVVFDEIHHGGDAKTWGDAIREAFGDATRRLALTGTPFRSDDSPIPFVSYQPDADGVLRSQADHTYGYAEALADGVVRPVVFLAYSGQARWRDSAGEEYEARLGEPLSAEQTARAWRTALDPEGEWMPAVITAADRRLRQLRAHVPDAGGMIIASDRTTARAYARLLTTMTAEEPTVVLSDDPGSSARITEFAQGTSRWLVAVRMVSEGVDVPRLSVGVYATNASTPLFFAQAIGRFVRSRRPGETASIFVPSVPNLLQLASALEVQRNHVLGRPHRESAHDPLDGDPATRTQTERGGAERGFTALGADAELDQVIFDGSSFGTATPTGSDEEADYLGIPGLLDAEQMRALLHRRQDEQLRKRAQLQKGATQPATSGASASVHGQLRDLRRELHTLVSIAHHRTGKPHGWIHDERRRRCGGPPIAAATRAQIKARIDALRQLNSERS,"65,825",602,,,ATP binding [GO:0005524]; DNA binding [GO:0003677]; hydrolase activity [GO:0016787],plasma membrane [GO:0005886],,MTCY338.05,1
P9WJW7,Y2994_MYCTU,Rv2994,Rv2994,GO:0005576; GO:0005886; GO:0016021; GO:0055085,IPR011701; IPR020846; IPR036259; ,,,,Uncharacterized MFS-type transporter Rv2994,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 21969609,,,MSRDPTGVGARWAIMIVSLGVTASSFLFINGVAFLIPRLENARGTPLSHAGLLASMPSWGLVVTMFAWGYLLDHVGERMVMAVGSALTAAAAYAAASVHSLLWIGVFLFLGGMAAGGCNSAGGRLVSGWFPPQQRGLAMGIRQTAQPLGIASGALVIPELAERGVHAGLMFPAVVCTLAAVASVLGIVDPPRKSRTKASEQELASPYRGSSILWRIHAASALLMMPQTVTVTFMLVWLINHHGWSVAQAGVLVTISQLLGALGRVAVGRWSDHVGSRMRPVRLIAAAAAATLFLLAAVDNEGSRYDVLLMIAISVIAVLDNGLEATAITEYAGPYWSGRALGIQNTTQRLMAAAGPPLFGSLITTAAYPTAWALCGVFPLAAVPLVPVRLLPPGLETRARRQSVRRHRWWQAVRCHAWPNGPRRPGPPGQPRRVRQGGTAITPPT,"47,046",445,Major facilitator superfamily,transmembrane transport [GO:0055085],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJZ1,Y3030_MYCTU,Rv3030,Rv3030,GO:0005829; GO:0005886; GO:0008757; GO:0032259; GO:0040007,IPR013216; IPR029063; ,,,,Probable S-adenosylmethionine-dependent methyltransferase Rv3030 (EC 2.1.1.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; growth [GO:0040007]; methylation [GO:0032259],9634230; 21969609,,FUNCTION: Probable S-adenosylmethionine-dependent methyltransferase required for the 6-O-methylation of the polysaccharide backbone of 6-O-methylglucosyl lipopolysaccharides (MGLP). {ECO:0000250}.,MCAFVPHVPRHSRGDNPPSASTASPAVLTLTGERTIPDLDIENYWFRRHQVVYQRLAPRCTARDVLEAGCGEGYGADLIACVARQVIAVDYDETAVAHVRSRYPRVEVMQANLAELPLPDASVDVVVNFQVIEHLWDQARFVRECARVLRGSGLLMVSTPNRITFSPGRDTPINPFHTRELNADELTSLLIDAGFVDVAMCGLFHGPRLRDMDARHGGSIIDAQIMRAVAGAPWPPELAADVAAVTTADFEMVAAGHDRDIDDSLDLIAIAVRP,"29,984",274,Methyltransferase superfamily,growth [GO:0040007]; methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WGS5,Y2750_MYCTU,Rv2750,Rv2750,GO:0016491,IPR036291; IPR020904; IPR002347; IPR023985; ,,,,Uncharacterized oxidoreductase Rv2750 (EC 1.-.-.-),oxidoreductase activity [GO:0016491],9634230; 21969609,,,MIDRPLEGKVAFITGAARGLGRAHAVRLAADGANIIAVDICEQIASVPYPLSTADDLAATVELVEDAGGGIVARQGDVRDRASLSVALQAGLDEFGRLDIVVANAGIAMMQAGDDGWRDVIDVNLTGVFHTVQVAIPTLIEQGTGGSIVLISSAAGLVGIGSSDPGSLGYAAAKHGVVGLMRAYANHLAPQNIRVNSVHPCGVDTPMINNEFFQQWLTTADMDAPHNLGNALPVELVQPTDIANAVAWLASEEARYVTGVTLPVDAGFVNKR,"28,223",272,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,,1
P9WHT5,Y2782_MYCTU,Rv2782c,Rv2782c MTV002.47c,GO:0004222; GO:0005886; GO:0046872,IPR011249; IPR011765; IPR001431; IPR007863; ,,,,Uncharacterized zinc protease Rv2782c (EC 3.4.24.-),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],9634230; 21969609,,,MPRRSPADPAAALAPRRTTLPGGLRVVTEFLPAVHSASVGVWVGVGSRDEGATVAGAAHFLEHLLFKSTPTRSAVDIAQAMDAVGGELNAFTAKEHTCYYAHVLGSDLPLAVDLVADVVLNGRCAADDVEVERDVVLEEIAMRDDDPEDALADMFLAALFGDHPVGRPVIGSAQSVSVMTRAQLQSFHLRRYTPERMVVAAAGNVDHDGLVALVREHFGSRLVRGRRPVAPRKGTGRVNGSPRLTLVSRDAEQTHVSLGIRTPGRGWEHRWALSVLHTALGGGLSSRLFQEVRETRGLAYSVYSALDLFADSGALSVYAACLPERFADVMRVTADVLESVARDGITEAECGIAKGSLRGGLVLGLEDSSSRMSRLGRSELNYGKHRSIEHTLRQIEQVTVEEVNAVARHLLSRRYGAAVLGPHGSKRSLPQQLRAMVG,"47,072",438,Peptidase M16 family,,metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],plasma membrane [GO:0005886],,MTV002.47c,1
O33341,Y2859_MYCTU,Rv2859c,Rv2859c,GO:0006541; GO:0016740; GO:0016787,IPR029062; IPR017926; IPR011697; ,,,DOMAIN 78 301 Glutamine amidotransferase type-1. {ECO:0000255|PROSITE-ProRule:PRU00605}.,Putative glutamine amidotransferase Rv2859c (EC 2.4.2.-),hydrolase activity [GO:0016787]; transferase activity [GO:0016740]; glutamine metabolic process [GO:0006541],9634230; 20066036; 21969609,,,MDLSASRSDGGDPLRPASPRLRSPVSDGGDPLRPASPRLRSPVSDGGDPLRPASPRLRSPLGASRPVVGLTAYLEQVRTGVWDIPAGYLPADYFEGITMAGGVAVLLPPQPVDPESVGCVLDSLHALVITGGYDLDPAAYGQEPHPATDHPRPGRDAWEFALLRGALQRGMPVLGICRGTQVLNVALGGTLHQHLPDILGHSGHRAGNGVFTRLPVHTASGTRLAELIGESADVPCYHHQAIDQVGEGLVVSAVDVDGVIEALELPGDTFVLAVQWHPEKSLDDLRLFKALVDAASGYAGRQSQAEPR,"32,442",308,,glutamine metabolic process [GO:0006541],hydrolase activity [GO:0016787]; transferase activity [GO:0016740],,,,1
P9WL17,Y2926_MYCTU,Rv2926c,Rv2926c MTCY338.15c,GO:0040007,IPR003772; ,,,,Uncharacterized protein Rv2926c,growth [GO:0040007],9634230; 21969609,,,MDLGGVRRRISLMARQHGPTAQRHVASPMTVDIARLGRRPGAMFELHDTVHSPARIGLELIAIDQGALLDLDLRVESVSEGVLVTGTVAAPTVGECARCLSPVRGRVQVALTELFAYPDSATDETTEEDEVGRVVDETIDLEQPIIDAVGLELPFSPVCRPDCPGLCPQCGVPLASEPGHRHEQIDPRWAKLVEMLGPESDTLRGER,"22,411",207,,growth [GO:0040007],,,,MTCY338.15c,1
I6XFZ8,Y3035_MYCTU,Rv3035 RVBD_3035,Rv3035 RVBD_3035 P425_03163,,IPR002372; IPR011047; IPR015943; ,,,,Uncharacterized protein Rv3035,,9634230; 21969609,,,MGGCGSADSWVEAAPAQGWPAQYGDAANSSYTTTNGATNLTLRWTRSVKGSLAAGPALSARGYLALNGQTPAGCSLMEWQNDNNGRQRWCVRLVQGGGFAGPLFDGFDNLYVGQPGAIISFPPTQWTRWRQPVIGMPSTPRFLGHGRLLVSTHLGQLLVFDTRRGMVVGSPVDLVDGIDPTDATRGLADCAPARPGCPVAAAPAFSSVNGTVVVSVWQPGEPAAKLVGLKYHAEQLVREWTSDAVSAGVLASPVLSADGSTVYVNGRDHRLWALNAADGKAKWSAPLGFLAQTPPALTPHGLIVSGGGPDTALAAFRDAGDHAEGAWRRDDVTALSTASLAGTGVGYTVISGPNHDGTPGLSLLVFDPANGHTVNSYPLPGATGYPVGVSVGNDRRVVTATSDGQVYSFAP,"42,539",411,,,,,,P425_03163,2
P9WJY5,EFPA_MYCTU,Rv2846c,efpA Rv2846c,GO:0005886; GO:0016021; GO:0040007; GO:0055085,IPR011701; IPR020846; IPR036259; ,,efpA,,Uncharacterized MFS-type transporter EfpA (Efflux protein A),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007]; transmembrane transport [GO:0055085],9008277; 9634230; 17590082; 21969609,,,MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL,"55,580",530,Major facilitator superfamily,growth [GO:0040007]; transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WIN3,PHMT_MYCTU,Rv2952,Rv2952,GO:0005886; GO:0006629; GO:0008171; GO:0071770,IPR013216; IPR029063; ,,,,Phthiotriol/phenolphthiotriol dimycocerosates methyltransferase (EC 2.1.1.-),plasma membrane [GO:0005886]; O-methyltransferase activity [GO:0008171]; DIM/DIP cell wall layer assembly [GO:0071770]; lipid metabolic process [GO:0006629],9634230; 15292265; 19099550; 21969609,,FUNCTION: Catalyzes the methylation of the lipid moiety of the intermediate compounds phthiotriol and glycosylated phenolphthiotriol dimycoserosates to form phthiocerol dimycocerosates (DIM A) and glycosylated phenolphthiocerol dimycocerosates (PGL). {ECO:0000269|PubMed:15292265}.,MAFSRTHSLLARAGSTSTYKRVWRYWYPLMTRGLGNDEIVFINWAYEEDPPMDLPLEASDEPNRAHINLYHRTATQVDLGGKQVLEVSCGHGGGASYLTRTLHPASYTGLDLNQAGIKLCKKRHRLPGLDFVRGDAENLPFDDESFDVVLNVEASHCYPHFRRFLAEVVRVLRPGGYFPYADLRPNNEIAAWEADLAATPLRQLSQRQINAEVLRGIGNNSQKSRDLVDRHLPAFLRFAGREFIGVQGTQLSRYLEGGELSYRMYCFTKD,"30,652",270,"Methyltransferase superfamily, Phthiotriol/phenolphthiotriol dimycocerosates methyltransferase family",DIM/DIP cell wall layer assembly [GO:0071770]; lipid metabolic process [GO:0006629],O-methyltransferase activity [GO:0008171],plasma membrane [GO:0005886],,,1
P9WI65,PKNK_MYCTU,Rv3080c,pknK Rv3080c MTCY22D7.01 MTV013.01c,GO:0004672; GO:0004674; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0009405; GO:0042802; GO:0046777; GO:0046872; GO:0051090,IPR011009; IPR027417; IPR000719; IPR017441; IPR016236; IPR011990; ,Itself,pknK,DOMAIN 26 283 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknK (EC 2.7.11.1) (Protein kinase K),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pathogenesis [GO:0009405]; protein autophosphorylation [GO:0046777]; regulation of DNA binding transcription factor activity [GO:0051090],9634230; 19251699; 20522497; 21969609; 22661693; 22740025,,"FUNCTION: Key microbial factor involved in regulation of early and late events in tuberculosis infection, and in host-pathogen interactions. Modulates host immunity during early infection. Slows mycobacterial growth during chronic infection in host and during a variety of stress conditions in vitro. Regulates the expression of a large subset of tRNA genes as a means to facilitate adaptation to changing growth environments. In vitro, directs the inhibition of transcription and translation processes in a phosphorylation-dependent manner. Phosphorylates the transcriptional regulator VirS, thereby increasing the affinity of VirS for the mycobacterial monooxygenase (mymA) promoter. In vitro, can also phosphorylate the mycobacterial monooxygenase operon products Rv3083 (MymA), Rv3084 (LipR), Rv3085 and Rv3088. {ECO:0000269|PubMed:19251699, ECO:0000269|PubMed:20522497, ECO:0000269|PubMed:22661693, ECO:0000269|PubMed:22740025}.",MTDVDPHATRRDLVPNIPAELLEAGFDNVEEIGRGGFGVVYRCVQPSLDRAVAVKVLSTDLDRDNLERFLREQRAMGRLSGHPHIVTVLQVGVLAGGRPFIVMPYHAKNSLETLIRRHGPLDWRETLSIGVKLAGALEAAHRVGTLHRDVKPGNILLTDYGEPQLTDFGIARIAGGFETATGVIAGSPAFTAPEVLEGASPTPASDVYSLGATLFCALTGHAAYERRSGERVIAQFLRITSQPIPDLRKQGLPADVAAAIERAMARHPADRPATAADVGEELRDVQRRNGVSVDEMPLPVELGVERRRSPEAHAAHRHTGGGTPTVPTPPTPATKYRPSVPTGSLVTRSRLTDILRAGGRRRLILIHAPSGFGKSTLAAQWREELSRDGAAVAWLTIDNDDNNEVWFLSHLLESIRRVRPTLAESLGHVLEEHGDDAGRYVLTSLIDEIHENDDRIAVVIDDWHRVSDSRTQAALGFLLDNGCHHLQLIVTSWSRAGLPVGRLRIGDELAEIDSAALRFDTDEAAALLNDAGGLRLPRADVQALTTSTDGWAAALRLAALSLRGGGDATQLLRGLSGASDVIHEFLSENVLDTLEPELREFLLVASVTERTCGGLASALAGITNGRAMLEEAEHRGLFLQRTEDDPNWFRFHQMFADFLHRRLERGGSHRVAELHRRASAWFAENGYLHEAVDHALAAGDPARAVDLVEQDETNLPEQSKMTTLLAIVQKLPTSMVVSRARLQLAIAWANILLQRPAPATGALNRFETALGRAELPEATQADLRAEADVLRAVAEVFADRVERVDDLLAEAMSRPDTLPPRVPGTAGNTAALAAICRFEFAEVYPLLDWAAPYQEMMGPFGTVYAQCLRGMAARNRLDIVAALQNFRTAFEVGTAVGAHSHAARLAGSLLAELLYETGDLAGAGRLMDESYLLGSEGGAVDYLAARYVIGARVKAAQGDHEGAADRLSTGGDTAVQLGLPRLAARINNERIRLGIALPAAVAADLLAPRTIPRDNGIATMTAELDEDSAVRLLSAGDSADRDQACQRAGALAAAIDGTRRPLAALQAQILHIETLAATGRESDARNELAPVATKCAELGLSRLLVDAGLA,"119,418",1110,"Protein kinase superfamily, Ser/Thr protein kinase family",pathogenesis [GO:0009405]; protein autophosphorylation [GO:0046777]; regulation of DNA binding transcription factor activity [GO:0051090],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY22D7.01 MTV013.01c,1
P96284,PKS15_MYCTU,Rv2947c,pks15 Rv2947c,GO:0005829; GO:0009247; GO:0016740; GO:0048037,IPR032821; IPR018201; IPR014031; IPR014030; IPR020841; IPR015083; IPR036299; IPR016039; ,,pks15,,Putative inactive phenolphthiocerol synthesis polyketide synthase type I Pks15,cytosol [GO:0005829]; cofactor binding [GO:0048037]; transferase activity [GO:0016740]; glycolipid biosynthetic process [GO:0009247],9634230; 12138124; 21969609,,,MIEEQRTMSVEGADQQSEKLFHYLKKVAVELDETRARLREYEQRATEPVAVVGIGCRFPGGVDGPDGLWDVVSAGRDVVSEFPTDRGWDVEGLYDPDPDAEGKTYTRWGAFLDDATGFDAGFFGIAPSEVLAMDPQQRLMLEVSWEALEHAGIDPLSLRGSATGVYTGIFAASYGNRDTGGLQGYGLTGTSISVASGRVSYVLGLQGPAVSVDTACSSSLVAIHWAMSSLRSGECDLALAGGVTVMGLPSIFVGFSRQRGLAADGRCKAFAAAADGTGWGEGAGVVVLERLSDARRLGHSVLAVVRGSAVNQDGASNGLTAPNGLAQQRVIQVALANAGLSAADVDVVEAHGTATTLGDPIEAQALLSTYGQGGPAEQPLWVGSIKSNMGHTQAAAGVAGVIKMVQAMRHGVMPATLHVDEPSPRVDWTSGAVSVLTEAREWSVDGRPRRAAVSSFGISGTNAHLILEEAPVPAPAEAPVEASESTGGRGRRWCRG,"51,702",496,,glycolipid biosynthetic process [GO:0009247],cofactor binding [GO:0048037]; transferase activity [GO:0016740],cytosol [GO:0005829],,,2
P9WQE5,PPSB_MYCTU,Rv2932,ppsB Rv2932 MTCY338.21 MTV011.01,GO:0004315; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071770; GO:0097040; GO:0097041,IPR036736; IPR014043; IPR016035; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR013968; IPR020806; IPR009081; IPR016039; ,,ppsB,DOMAIN 1423 1498 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthiocerol synthesis polyketide synthase type I PpsB (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41),polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],9634230; 21969609,,FUNCTION: Involved in the elongation of either C22-24 fatty acids by the addition of malonyl-CoA and methylmalonyl-CoA extender units to yield phthiocerol derivatives. {ECO:0000250}.,MMRTAFSRISGMTAQQRTSLADEFDRVSRIAVAEPVAVVGIGCRFPGDVDGPESFWDFLVAGRNAISTVPADRWDAEAFYHPDPLTPGRMTTKWGGFVPDVAGFDAEFFGITPREAAAMDPQQRMLLEVAWEALEHAGIPPDSLGGTRTAVMMGVYFNEYQSMLAASPQNVDAYSGTGNAHSITVGRISYLLGLRGPAVAVDTACSSSLVAVHLACQSLRLRETDLALAGGVSITLRPETQIAISAWGLLSPQGRCAAFDAAADGFVRGEGAGVVVLKRLTDAVRDGDQVLAVVRGSAVNQDGRSNGVTAPNTAAQCDVIADALRSGDVAPDSVNYVEAHGTGTVLGDPIEFEALAATYGHGGDACALGAVKTNIGHLEAAAGIAGFIKATLAVQRATIPPNLHFSQWNPAIDAASTRFFVPTQNSPWPTAEGPRRAAVSSFGLGGTNAHVIIEQGSELAPVSEGGEDTGVSTLVVTGKTAQRMAATAQVLADWMEGPGAEVAVADVAHTVNHHRARQATFGTVVARDRAQAIAGLRALAAGQHAPGVVSHQDGSPGPGTVFVYSGRGSQWAGMGRQLLADEPAFAAAVAELEPVFVEQAGFSLRDVIATGKELVGIEQIQLGLIGMQLTLTELWRSYGVQPDLVIGHSMGEVAAAVVAGALTPAEGLRVTATRARLMAPLSGQGGMALLGLDAAATEALIADYPQVTVGIYNSPRQTVIAGPTEQIDELIARVRAQNRFASRVNIEVAPHNPAMDALQPAMRSELADLTPRTPTIGIISTTYADLHTQPIFDAEHWATNMRNPVRFQQAIASAGSGADGAYHTFIEISAHPLLTQAIADTLEDAHRPTKSAAKYLSIGTLQRDADDTVTFRTNLYTADIAHPPHTCHPPEPHPTIPTTPWQHTHHWIATTHPSTAAPEDPGSNKVVVNGQSTSESRALEDWCHQLAWPIRPAVSADPPSTAAWLVVADNELCHELARAADSRVDSLSPPALAAGSDPAALLDALRGVDNVLYAPPVPGELLDIESAYQVFHATRRLAAAMVASSATAISPPKLFIMTRNAQPISEGDRANPGHAVLWGLGRSLALEHPEIWGGIIDLDDSMPAELAVRHVLTAAHGTDGEDQVVYRSGARHVPRLQRRTLPGKPVTLNADASQLVIGATGNIGPHLIRQLARMGAKTIVAMARKPGALDELTQCLAATGTDLIAVAADATDPAAMQTLFDRFGTELPPLEGIYLAAFAGRPALLSEMTDDDVTTMFRPKLDALALLHRRSLKSPVRHFVLFSSVSGLLGSRWLAHYTATSAFLDSFAGARRTMGLPATVVDWGLWKSLADVQKDATQISAESGLQPMADEVAIGALPLVMNPDAAVATVVVAADWPLLAAAYRTRGALRIVDDLLPAPEDVGKGESEFRTSLRSCPAEKRRDMLFDHVGALAATVMGMPPTEPLDPSAGFFQLGMDSLMSVTLQRALSESLGEFLPASVVFDYPTVYSLTDYLATVLPELLEIGATAVATQQATDSYHELTEAELLEQLSERLRGTQ,"162,528",1538,,DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],polyketide synthase complex [GO:0034081],,MTCY338.21 MTV011.01,1
P96202,PPSC_MYCTU,Rv2933,ppsC Rv2933,GO:0004315; GO:0005829; GO:0005886; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0071770; GO:0097040; GO:0097041,IPR036736; IPR014043; IPR016035; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,ppsC,DOMAIN 2069 2145 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthiocerol synthesis polyketide synthase type I PpsC (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41),cytosol [GO:0005829]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],9634230; 19099550; 21969609; ,X-ray crystallography (6),FUNCTION: Involved in the elongation of either C22-24 fatty acids by the addition of malonyl-CoA and methylmalonyl-CoA extender units to yield phthiocerol derivatives. {ECO:0000250}.,MTAATPDRRAIITEALHKIDDLTARLEIAEKSSSEPIAVIGMGCRFPGGVNNPEQFWDLLCAGRSGIVRVPAQRWDADAYYCDDHTVPGTICSTEGGFLTSWQPDEFDAEFFSISPREAAAMDPQQRLLIEVAWEALEDAGVPQHTIRGTQTSVFVGVTAYDYMLTLAGRLRPVDLDAYIPTGNSANFAAGRLAYILGARGPAVVIDTACSSSLVAVHLACQSLRGRESDMALVGGTNLLLSPGPSIACSRWGMLSPEGRCKTFDASADGYVRGEGAAVVVLKRLDDAVRDGNRILAVVRGSAVNQDGASSGVTVPNGPAQQALLAKALTSSKLTAADIDYVEAHGTGTPLGDPIELDSLSKVFSDRAGSDQLVIGSVKTNLGHLEAAAGVAGLMKAVLAVHNGYIPRHLNFHQLTPHASEAASRLRIAADGIDWPTTGRPRRAGVSSFGVSGTNAHVVIEQAPDPMAAAGTEPQRGPVPAVSTLVVFGKTAPRVAATASVLADWLDGPGAAVPLADVAHTLNHHRARQTRFGTVAAVDRRQAVIGLRALAAGQSAPGVVAPREGSIGGGTVFVYSGRGSQWAGMGRQLLADEPAFAAAIAELEPEFVAQGGFSLRDVIAGGKELVGIEQIQLGLIGMQLALTALWRSYGVTPDAVIGHSMGEVAAAVVAGALTPAQGLRVTAVRSRLMAPLSGQGTMALLELDAEATEALIADYPEVSLGIYASPRQTVISGPPLLIDELIDKVRQQNGFATRVNIEVAPHNPAMDALQPAMRSELADLTPQPPTIPIISTTYADLGISLGSGPRFDAEHWATNMRNPVRFHQAIAHAGADHHTFIEISAHPLLTHSISDTLRASYDVDNYLSIGTLQRDAHDTLEFHTNLNTTHTTHPPQTPHPPEPHPVLPTTPWQHTQHWITATSAAYHRPDTHPLLGVGVTDPTNGTRVWESELDPDLLWLADHVIDDLVVLPGAAYAEIALAAATDTFAVEQDQPWMISELDLRQMLHVTPGTVLVTTLTGDEQRCQVEIRTRSGSSGWTTHATATVARAEPLAPLDHEGQRREVTTADLEDQLDPDDLYQRLRGAGQQHGPAFQGIVGLAVTQAGVARAQVRLPASARTGSREFMLHPVMMDIALQTLGATRTATDLAGGQDARQGPSSNSALVVPVRFAGVHVYGDITRGVRAVGSLAAAGDRLVGEVVLTDANGQPLLVVDEVEMAVLGSGSGATELTNRLFMLEWEPAPLEKTAEATGALLLIGDPAAGDPLLPALQSSLRDRITDLELASAADEATLRAAISRTSWDGIVVVCPPRANDESMPDEAQLELARTRTLLVASVVETVTRMGARKSPRLWIVTRGAAQFDAGESVTLAQTGLRGIARVLTFEHSELNTTLVDIEPDGTGSLAALAEELLAGSEADEVALRDGQRYVNRLVPAPTTTSGDLAAEARHQVVNLDSSGASRAAVRLQIDQPGRLDALNVHEVKRGRPQGDQVEVRVVAAGLNFSDVLKAMGVYPGLDGAAPVIGGECVGYVTAIGDEVDGVEVGQRVIAFGPGTFGTHLGTIADLVVPIPDTLADNEAATFGVAYLTAWHSLCEVGRLSPGERVLIHSATGGVGMAAVSIAKMIGARIYTTAGSDAKREMLSRLGVEYVGDSRSVDFADEILELTDGYGVDVVLNSLAGEAIQRGVQILAPGGRFIELGKKDVYADASLGLAALAKSASFSVVDLDLNLKLQPARYRQLLQHILQHVADGKLEVLPVTAFSLHDAADAFRLMASGKHTGKIVISIPQHGSIEAIAAPPPLPLVSRDGGYLIVGGMGGLGFVVARWLAEQGAGLIVLNGRSAPSDEVAAAIAELNASGSRIEVITGDITEPDTAERLVRAVEDAGFRLAGVVHSAMVLADEIVLNMTDSAARRVFAPKVTGSWRLHVATAARDVDWWLTFSSAAALLGTPGQGAYAAANSWVDGLVAHRRSAGLPAVGINWGPWADVGRAQFFKDLGVEMINAEQGLAAMQAVLTADRGRTGVFSLDARQWFQSFPAVAGSSLFAKLHDSAARKSGQRRGGGAIRAQLDALDAAERPGHLASAIADEIRAVLRSGDPIDHHRPLETLGLDSLMGLELRNRLEASLGITLPVALVWAYPTISDLATALCERMDYATPAAAQEISDTEPELSDEEMDLLADLVDASELEAATRGES,"230,622",2188,,Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],cytosol [GO:0005829]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081],,,2
P9WHZ3,PPE44_MYCTU,Rv2770c,PPE44 Rv2770c,,IPR022171; IPR000030; IPR038332; ,,PPE44,,Uncharacterized PPE family protein PPE44,,9634230; 18822333,,,MDFGALPPEVNSARMYGGAGAADLLAAAAAWNGIAVEVSTAASSVGSVITRLSTEHWMGPASLSMAAAVQPYLVWLTCTAESSALAAAQAMASAAAFETAFALTVPPAEVVANRALLAELTATNILGQNVSAIAATEARYGEMWAQDASAMYGYAAASAVAARLNPLTRPSHITNPAGLAHQAAAVGQAGASAFARQVGLSHLISDVADAVLSFASPVMSAADTGLEAVRQFLNLDVPLFVESAFHGLGGVADFATAAIGNMTLLADAMGTVGGAAPGGGAAAAVAHAVAPAGVGGTALTADLGNASVVGRLSVPASWSTAAPATAAGAALDGTGWAVPEEDGPIAVMPPAPGMVVAANSVGADSGPRYGVKPIVMPKHGLF,"37,467",382,Mycobacterial PPE family,,,,,,1
P9WHY9,PPE46_MYCTU,Rv3018c,PPE46 Rv3018c MTV012.32c,GO:0040007; GO:0044119,IPR000030; IPR038332; ,,PPE46,,Uncharacterized PPE family protein PPE46,growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],9634230; 19099550,,,MTAPVWLASPPEVHSALLSAGPGPGSLQAAAAGWSALSAEYAAVAQELSVVVAAVGAGVWQGPSAELFVAAYVPYVAWLVQASADSAAAAGEHEAAAAGYVCALAEMPTLPELAANHLTHAVLVATNFFGINTIPIALNEADYVRMWVQAATVMSAYEAVVGAALVATPHTGPAPVIVKPGANEASNAVAAATITPFPWHEIVQFLEETFAAYDQYLSALLSELPAVAWVWFQLFVDILGFNIIGFIITLASNAQLLTEFAINASYVAVGLLYAIAGVIDIVVEWVIGNLFGVVPLLGGPLLGALAAAVVPGVAGLAGVAGLAALPAVGAAAGAPAALVGSVAPVSGGVVSPQARLVSAVEPAPASTSVSVLASDRGAGALGFVGTAGKESVGQPAGLTVLADEFGDGAPVPMLPGSWGPDLVGVAGDGGLVSV,"43,029",434,Mycobacterial PPE family,growth [GO:0040007]; growth of symbiont in host cell [GO:0044119],,,,MTV012.32c,1
P9WHV9,PPK1_MYCTU,Rv2984,ppk Rv2984 MTCY349.03c,GO:0000287; GO:0001666; GO:0005524; GO:0005886; GO:0006799; GO:0006979; GO:0008976; GO:0009358; GO:0009405; GO:0015968; GO:0016310; GO:0040007; GO:0046777,IPR003414; IPR024953; IPR036830; IPR025200; IPR025198; IPR036832; ,,ppk,,Polyphosphate kinase (EC 2.7.4.1) (ATP-polyphosphate phosphotransferase) (Polyphosphoric acid kinase),plasma membrane [GO:0005886]; polyphosphate kinase complex [GO:0009358]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; polyphosphate kinase activity [GO:0008976]; growth [GO:0040007]; pathogenesis [GO:0009405]; phosphorylation [GO:0016310]; polyphosphate biosynthetic process [GO:0006799]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; stringent response [GO:0015968],9634230; 21969609,,FUNCTION: Catalyzes the reversible transfer of the terminal phosphate of ATP to form a long-chain polyphosphate (polyP). {ECO:0000255|HAMAP-Rule:MF_00347}.,MMSNDRKVTEIENSPVTEVRPEEHAWYPDDSALAAPPAATPAAISDQLPSDRYLNRELSWLDFNARVLALAADKSMPLLERAKFLAIFASNLDEFYMVRVAGLKRRDEMGLSVRSADGLTPREQLGRIGEQTQQLASRHARVFLDSVLPALGEEGIYIVTWADLDQAERDRLSTYFNEQVFPVLTPLAVDPAHPFPFVSGLSLNLAVTVRQPEDGTQHFARVKVPDNVDRFVELAAREASEEAAGTEGRTALRFLPMEELIAAFLPVLFPGMEIVEHHAFRITRNADFEVEEDRDEDLLQALERELARRRFGSPVRLEIADDMTESMLELLLRELDVHPGDVIEVPGLLDLSSLWQIYAVDRPTLKDRTFVPATHPAFAERETPKSIFATLREGDVLVHHPYDSFSTSVQRFIEQAAADPNVLAIKQTLYRTSGDSPIVRALIDAAEAGKQVVALVEIKARFDEQANIAWARALEQAGVHVAYGLVGLKTHCKTALVVRREGPTIRRYCHVGTGNYNSKTARLYEDVGLLTAAPDIGADLTDLFNSLTGYSRKLSYRNLLVAPHGIRAGIIDRVEREVAAHRAEGAHNGKGRIRLKMNALVDEQVIDALYRASRAGVRIEVVVRGICALRPGAQGISENIIVRSILGRFLEHSRILHFRAIDEFWIGSADMMHRNLDRRVEVMAQVKNPRLTAQLDELFESALDPCTRCWELGPDGQWTASPQEGHSVRDHQESLMERHRSP,"83,039",742,Polyphosphate kinase 1 (PPK1) family,growth [GO:0040007]; pathogenesis [GO:0009405]; phosphorylation [GO:0016310]; polyphosphate biosynthetic process [GO:0006799]; protein autophosphorylation [GO:0046777]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; stringent response [GO:0015968],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; polyphosphate kinase activity [GO:0008976],plasma membrane [GO:0005886]; polyphosphate kinase complex [GO:0009358],,MTCY349.03c,1
P9WI69,PKNI_MYCTU,Rv2914c,pknI Rv2914c MTCY338.02c,GO:0004672; GO:0004674; GO:0005524; GO:0005829; GO:0005886; GO:0009405; GO:0016021; GO:0018105; GO:0018107; GO:0030145; GO:0040009; GO:0046777,IPR011009; IPR000719; ,,pknI,DOMAIN 12 252 Protein kinase. {ECO:0000255|PROSITE-ProRule:PRU00159}.,Serine/threonine-protein kinase PknI (EC 2.7.11.1),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; pathogenesis [GO:0009405]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of growth rate [GO:0040009],9634230; 15177288; 16256441; 19341393; 21969609,X-ray crystallography (4),FUNCTION: Plays an important role in slowing down the growth of mycobacteria within the infected host. {ECO:0000269|PubMed:19341393}.,MALASGVTFAGYTVVRMLGCSAMGEVYLVQHPGFPGWQALKVLSPAMAADDEFRRRFQRETEVAARLFHPHILEVHDRGEFDGQLWIAMDYVDGIDATQHMADRFPAVLPVGEVLAIVTAVAGALDYAHQRGLLHRDVNPANVVLTSQSAGDQRILLADFGIASQPSYPAPELSAGADVDGRADQYALALTAIHLFAGAPPVDRSHTGPLQPPKLSAFRPDLARLDGVLSRALATAPADRFGSCREFADAMNEQAGVAIADQSSGGVDASEVTAAAGEEAYVVDYPAYGWPEAVDCKEPSARAPAPAAPTPQRRGSMLQSAAGVLARRLDNFSTATKAPASPTRRRPRRILVGAVAVLLLAGLFAVGIVIGRKTNTTATEVARPPTSGSAVPSAPTTTVAVTAPVPLDGTYRIEIQRSKQTYDYTPTPQPPDVNTWWAFRTSCTPTECLAAATMLDDNDHTQAKTPPVRPFLMQFGEGQWKSRPETVQFPCVGPNGSPSTQATTQLLALRPQPQGDLVGEMVVTVHSNECGQQGAVIRIPAVASRSGDLPPAVTVPDPATIPDTPDTTSTATLTPPTTTAPGPGR,"61,805",585,"Protein kinase superfamily, Ser/Thr protein kinase family",pathogenesis [GO:0009405]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; regulation of growth rate [GO:0040009],ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY338.02c,1
P9WHZ1,PPE45_MYCTU,Rv2892c,PPE45 Rv2892c MTCY274.23c,GO:0005886; GO:0016021,IPR022171; IPR000030; IPR038332; ,,PPE45,,Uncharacterized PPE family protein PPE45,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MDFGVLPPEINSGRMYAGPGSGPMMAAAAAWDSLAAELGLAAGGYRLAISELTGAYWAGPAAASMVAAVTPYVAWLSATAGQAEQAGMQARAAAAAYELAFAMTVPPPVVVANRALLVALVATNFFGQNTPAIAATEAQYAEMWAQDAAAMYAYAGSAAIATELTPFTAAPVTTSPAALAGQAAATVSSTVPPLATTAAVPQLLQQLSSTSLIPWYSALQQWLAENLLGLTPDNRMTIVRLLGISYFDEGLLQFEASLAQQAIPGTPGGAGDSGSSVLDSWGPTIFAGPRASPSVAGGGAVGGVQTPQPYWYWALDRESIGGSVSAALGKGSSAGSLSVPPDWAARARWANPAAWRLPGDDVTALRGTAENALLRGFPMASAGQSTGGGFVHKYGFRLAVMQRPPFAG,"41,469",408,Mycobacterial PPE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY274.23c,1
P9WHY7,PPE47_MYCTU,Rv3021c/Rv3022c,PPE47/ppe48 Rv3021c/Rv3022c MTV012.35c/MTV012.36c,,IPR000030; IPR038332; ,,PPE47/ppe48,,Uncharacterized PPE family protein PPE47/PPE48,,9634230; 16586367,,,MTAPVWLASPPEVHSALLSAGPGPGSLQAAAAGWSALSAEYAAVAQELSVVVAAVGAGVWQGPSAELFVAAYVPYVAWLVQASADSAAAAGEHEAAAAGYVCALAEMPTLPELAANHLTHAVLVATNFFGINTIPIALNEADYVRMWVQAATVMSAYEAVVGAALVATPHTGPAPVIVKPGANEASNAVAAATITPFPFGELAKFLEMAAQAFTEVGELIMKSAEAWAVGFVELITGLVNFEPWLVLTGMIDMFFATVGFALGVFVLVPLLEFAVVLELAILSIGWIISNIFGAIPVLGGPLLGALAAAVVPGVAGLAGVAGLAALPAVGAAAGAPAALVGSVAPVSGGVVSPQARLVSAVEPAPASTSVSVLASDRGAGALGFVGTAGKESVGQPAGLTVLADEFGDGAPVPMLPGSWGPDLVGVAGDGGLVSV,"42,877",435,Mycobacterial PPE family,,,,,MTV012.35c/MTV012.36c,1
P96285,PKS1_MYCTU,Rv2946c,pks1 Rv2946c,GO:0005886; GO:0006633; GO:0008610; GO:0016491; GO:0016746; GO:0031177; GO:0071766; GO:0071770,IPR001227; IPR036736; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR016036; IPR036291; IPR020801; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; ,,pks1,DOMAIN 1514 1589 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Putative inactive phenolphthiocerol synthesis polyketide synthase type I Pks1,"plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]",9634230; 12138124; 12730158; 19099550; 21969609,,FUNCTION: May play a role in phthiocerol biosynthesis.,MISARSAEALTAQAGRLMAHVQANPGLDPIDVGCSLASRSVFEHRAVVVGASREQLIAGLAGLAAGEPGAGVAVGQPGSVGKTVVVFPGQGAQRIGMGRELYGELPVFAQAFDAVADELDRHLRLPLRDVIWGADADLLDSTEFAQPALFAVEVASFAVLRDWGVLPDFVMGHSVGELAAAHAAGVLTLADAAMLVVARGRLMQALPAGGAMVAVAASEDEVEPLLGEGVGIAAINAPESVVISGAQAAANAIADRFAAQGRRVHQLAVSHAFHSPLMEPMLEEFARVAARVQAREPQLGLVSNVTGELAGPDFGSAQYWVDHVRRPVRFADSARHLQTLGATHFIEAGPGSGLTGSIEQSLAPAEAMVVSMLGKDRPELASALGAAGQVFTTGVPVQWSAVFAGSGGRRVQLPTYAFQRRRFWETPGADGPADAAGLGLGATEHALLGAVVERPDSDEVVLTGRLSLADQPWLADHVVNGVVLFPGAGFVELVIRAGDEVGCALIEELVLAAPLVMHPGVGVQVQVVVGAADESGHRAVSVYSRGDQSQGWLLNAEGMLGVAAAETPMDLSVWPPEGAESVDISDGYAQLAERGYAYGPAFQGLVAIWRRGSELFAEVVAPGEAGVAVDRMGMHPAVLDAVLHALGLAVEKTQASTETRLPFCWRGVSLHAGGAGRVRARFASAGADAISVDVCDATGLPVLTVRSLVTRPITAEQLRAAVTAAGGASDQGPLEVVWSPISVVSGGANGSAPPAPVSWADFCAGSDGDASVVVWELESAGGQASSVVGSVYAATHTALEVLQSWLGADRAATLVVLTHGGVGLAGEDISDLAAAAVWGMARSAQAENPGRIVLIDTDAAVDASVLAGVGEPQLLVRGGTVHAPRLSPAPALLALPAAESAWRLAAGGGGTLEDLVIQPCPEVQAPLQAGQVRVAVAAVGVNFRDVVAALGMYPGQAPPLGAEGAGVVLETGPEVTDLAVGDAVMGFLGGAGPLAVVDQQLVTRVPQGWSFAQAAAVPVVFLTAWYGLADLAEIKAGESVLIHAGTGGVGMAAVQLARQWGVEVFVTASRGKWDTLRAMGFDDDHIGDSRTCEFEEKFLAVTEGRGVDVVLDSLAGEFVDASLRLLVRGGRFLEMGKTDIRDAQEIAANYPGVQYRAFDLSEAGPARMQEMLAEVRELFDTRELHRLPVTTWDVRCAPAAFRFMSQARHIGKVVLTMPSALADRLADGTVVITGATGAVGGVLARHLVGAYGVRHLVLASRRGDRAEGAAELAADLTEAGAKVQVVACDVADRAAVAGLFAQLSREYPPVRGVIHAAGVLDDAVITSLTPDRIDTVLRAKVDAAWNLHQATSDLDLSMFALCSSIAATVGSPGQGNYSAANAFLDGLAAHRQAAGLAGISLAWGLWEQPGGMTAHLSSRDLARMSRSGLAPMSPAEAVELFDAALAIDHPLAVATLLDRAALDARAQAGALPALFSGLARRPRRRQIDDTGDATSSKSALAQRLHGLAADEQLELLVGLVCLQAAAVLGRPSAEDVDPDTEFGDLGFDSLTAVELRNRLKTATGLTLPPTVIFDHPTPTAVAEYVAQQMSGSRPTESGDPTSQVVEPAAAEVSVHA,"166,672",1616,,Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]",plasma membrane [GO:0005886],,,4
P9WI57,PNP_MYCTU,Rv2783c,pnp Rv2783c,GO:0003723; GO:0004654; GO:0005618; GO:0005829; GO:0005886; GO:0006396; GO:0006402; GO:0046872,IPR001247; IPR036345; IPR014069; IPR004087; IPR004088; IPR036612; IPR012340; IPR012162; IPR027408; IPR015848; IPR036456; IPR020568; IPR022967; IPR003029; ,,pnp,DOMAIN 595 654 KH. {ECO:0000255|HAMAP-Rule:MF_01595}.; DOMAIN 666 735 S1 motif. {ECO:0000255|HAMAP-Rule:MF_01595}.,Polyribonucleotide nucleotidyltransferase (EC 2.7.7.8) (Polynucleotide phosphorylase) (PNPase),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396],9634230; 21969609,,FUNCTION: Involved in mRNA degradation. Catalyzes the phosphorolysis of single-stranded polyribonucleotides processively in the 3'- to 5'-direction. {ECO:0000255|HAMAP-Rule:MF_01595}.,MSAAEIDEGVFETTATIDNGSFGTRTIRFETGRLALQAAGAVVAYLDDDNMLLSATTASKNPKEHFDFFPLTVDVEERMYAAGRIPGSFFRREGRPSTDAILTCRLIDRPLRPSFVDGLRNEIQIVVTILSLDPGDLYDVLAINAASASTQLGGLPFSGPIGGVRVALIDGTWVGFPTVDQIERAVFDMVVAGRIVEGDVAIMMVEAEATENVVELVEGGAQAPTESVVAAGLEAAKPFIAALCTAQQELADAAGKSGKPTVDFPVFPDYGEDVYYSVSSVATDELAAALTIGGKAERDQRIDEIKTQVVQRLADTYEGREKEVGAALRALTKKLVRQRILTDHFRIDGRGITDIRALSAEVAVVPRAHGSALFERGETQILGVTTLDMIKMAQQIDSLGPETSKRYMHHYNFPPFSTGETGRVGSPKRREIGHGALAERALVPVLPSVEEFPYAIRQVSEALGSNGSTSMGSVCASTLALLNAGVPLKAPVAGIAMGLVSDDIQVEGAVDGVVERRFVTLTDILGAEDAFGDMDFKVAGTKDFVTALQLDTKLDGIPSQVLAGALEQAKDARLTILEVMAEAIDRPDEMSPYAPRVTTIKVPVDKIGEVIGPKGKVINAITEETGAQISIEDDGTVFVGATDGPSAQAAIDKINAIANPQLPTVGERFLGTVVKTTDFGAFVSLLPGRDGLVHISKLGKGKRIAKVEDVVNVGDKLRVEIADIDKRGKISLILVADEDSTAAATDAATVTS,"79,735",752,Polyribonucleotide nucleotidyltransferase family,mRNA catabolic process [GO:0006402]; RNA processing [GO:0006396],metal ion binding [GO:0046872]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WQE7,PPSA_MYCTU,Rv2931,ppsA Rv2931 MTCY338.20,GO:0000036; GO:0004315; GO:0004316; GO:0005618; GO:0006633; GO:0031177; GO:0034081; GO:0055114; GO:0071770; GO:0097040; GO:0097041,IPR036736; IPR014043; IPR016035; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,ppsA,DOMAIN 9 83 Carrier 1. {ECO:0000255|PROSITE-ProRule:PRU00258}.; DOMAIN 1759 1836 Carrier 2. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthiocerol synthesis polyketide synthase type I PpsA (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41),cell wall [GO:0005618]; polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],9634230; 19099550; 21969609,,FUNCTION: Involved in the elongation of either C22-24 fatty acids by the addition of malonyl-CoA and methylmalonyl-CoA extender units to yield phthiocerol derivatives. {ECO:0000250}.,MTGSISGEADLRHWLIDYLVTNIGCTPDEVDPDLSLADLGVSSRDAVVLSGELSELLGRTVSPIDFWEHPTINALAAYLAAPEPSPDSDAAVKRGARNSLDEPIAVVGMGCRFPGGISCPEALWDFLCERRSSISQVPPQRWQPFEGGPPEVAAALARTTRWGSFLPDIDAFDAEFFEISPSEADKMDPQQRLLLEVAWEALEHAGIPPGTLRRSATGVFAGACLSEYGAMASADLSQVDGWSNSGGAMSIIANRLSYFLDLRGPSVAVDTACSSSLVAIHLACQSLRTQDCHLAIAAGVNLLLSPAVFRGFDQVGALSPTGQCRAFDATADGFVRGEGAGVVVLKRLTDAQRDGDRVLAVICGSAVNQDGRSNGLMAPNPAAQMAVLRAAYTNAGMQPSEVDYVEAHGTGTLLGDPIEARALGTVLGRGRPEDSPLLIGSVKTNLGHTEAAAGIAGFIKTVLAVQHGQIPPNQHFETANPHIPFTDLRMKVVDTQTEWPATGHPRRAGVSSFGFGGTNAHVVIEQGQEVRPAPGQGLSPAVSTLVVAGKTMQRVSATAGMLADWMEGPGADVALADVAHTLNHHRSRQPKFGTVVARDRTQAIAGLRALAAGQHAPGVVNPADGSPGPGTVFVYSGRGSQWAGMGRQLLADEPAFAAAVAELEPVFVEQAGFSLHDVLANGEELVGIEQIQLGLIGMQLALTELWCSYGVRPDLVIGHSMGEVAAAVVAGALTPAEGLRVTATRSRLMAPLSGQGGMALLELDAPTTEALIADFPQVTLGIYNSPRQTVIAGPTEQIDELIARVRAQNRFASRVNIEVAPHNPAMDALQPAMRSELADLTPRTPTIGIISTTYADLHTQPVFDAEHWATNMRNPVRFQQAIASAGSGADGAYHTFIEISAHPLLTQAIIDTLHSAQPGARYTSLGTLQRDTDDVVTFRTNLNKAHTIHPPHTPHPPEPHPPIPTTPWQHTRHWITTKYPAGSVGSAPRAGTLLGQHTTVATVSASPPSHLWQARLAPDAKPYQGGHRFHQVEVVPASVVLHTILSAATELGYSALSEVRFEQPIFADRPRLIQVVADNRAISLASSPAAGTPSDRWTRHVTAQLSSSPSDSASSLNEHHRANGQPPERAHRDLIPDLAELLAMRGIDGLPFSWTVASWTQHSSNLTVAIDLPEALPEGSTGPLLDAAVHLAALSDVADSRLYVPASIEQISLGDVVTGPRSSVTLNRTAHDDDGITVDVTVAAHGEVPSLSMRSLRYRALDFGLDVGRAQPPASTGPVEAYCDATNFVHTIDWQPQTVPDATHPGAEQVTHPGPVAIIGDDGAALCETLEGAGYQPAVMSDGVSQARYVVYVADSDPAGADETDVDFAVRICTEITGLVRTLAERDADKPAALWILTRGVHESVAPSALRQSFLWGLAGVIAAEHPELWGGLVDLAINDDLGEFGPALAELLAKPSKSILVRRDGVVLAPALAPVRGEPARKSLQCRPDAAYLITGGLGALGLLMADWLADRGAHRLVLTGRTPLPPRRDWQLDTLDTELRRRIDAIRALEMRGVTVEAVAADVGCREDVQALLAARDRDGAAPIRGIIHAAGITNDQLVTSMTGDAVRQVMWPKIGGSQVLHDAFPPGSVDFFYLTASAAGIFGIPGQGSYAAANSYLDALARARRQQGCHTMSLDWVAWRGLGLAADAQLVSEELARMGSRDITPSEAFTAWEFVDGYDVAQAVVVPMPAPAGADGSGANAYLLPARNWSVMAATEVRSELEQGLRRIIAAELRVPEKELDTDRPFAELGLNSLMAMAIRREAEQFVGIELSATMLFNHPTVKSLASYLAKRVAPHDVSQDNQISALSSSAGSVLDSLFDRIESAPPEAERSV,"198,835",1876,,DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177],cell wall [GO:0005618]; polyketide synthase complex [GO:0034081],,MTCY338.20,1
P9WQE3,PPSD_MYCTU,Rv2934,ppsD Rv2934,GO:0004315; GO:0005886; GO:0006633; GO:0016491; GO:0031177; GO:0034081; GO:0071770; GO:0097040; GO:0097041,IPR036736; IPR014043; IPR016035; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,ppsD,DOMAIN 1706 1785 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthiocerol synthesis polyketide synthase type I PpsD (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41),plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],9634230; 21969609,,FUNCTION: Involved in the elongation of either C22-24 fatty acids by the addition of malonyl-CoA and methylmalonyl-CoA extender units to yield phthiocerol derivatives. {ECO:0000250}.,MTSLAERAAQLSPNARAALARELVRAGTTFPTDICEPVAVVGIGCRFPGNVTGPESFWQLLADGVDTIEQVPPDRWDADAFYDPDPSASGRMTTKWGGFVSDVDAFDADFFGITPREAVAMDPQHRMLLEVAWEALEHAGIPPDSLSGTRTGVMMGLSSWDYTIVNIERRADIDAYLSTGTPHCAAVGRIAYLLGLRGPAVAVDTACSSSLVAIHLACQSLRLRETDVALAGGVQLTLSPFTAIALSKWSALSPTGRCNSFDANADGFVRGEGCGVVVLKRLADAVRDQDRVLAVVRGSATNSDGRSNGMTAPNALAQRDVITSALKLADVTPDSVNYVETHGTGTVLGDPIEFESLAATYGLGKGQGESPCALGSVKTNIGHLEAAAGVAGFIKAVLAVQRGHIPRNLHFTRWNPAIDASATRLFVPTESAPWPAAAGPRRAAVSSFGLSGTNAHVVVEQAPDTAVAAAGGMPYVSALNVSGKTAARVASAAAVLADWMSGPGAAAPLADVAHTLNRHRARHAKFATVIARDRAEAIAGLRALAAGQPRVGVVDCDQHAGGPGRVFVYSGQGSQWASMGQQLLANEPAFAKAVAELDPIFVDQVGFSLQQTLIDGDEVVGIDRIQPVLVGMQLALTELWRSYGVIPDAVIGHSMGEVSAAVVAGALTPEQGLRVITTRSRLMARLSGQGAMALLELDADAAEALIAGYPQVTLAVHASPRQTVIAGPPEQVDTVIAAVATQNRLARRVEVDVASHHPIIDPILPELRSALADLTPQPPSIPIISTTYESAQPVADADYWSANLRNPVRFHQAVTAAGVDHNTFIEISPHPVLTHALTDTLDPDGSHTVMSTMNRELDQTLYFHAQLAAVGVAASEHTTGRLVDLPPTPWHHQRFWVTDRSAMSELAATHPLLGAHIEMPRNGDHVWQTDVGTEVCPWLADHKVFGQPIMPAAGFAEIALAAASEALGTAADAVAPNIVINQFEVEQMLPLDGHTPLTTQLIRGGDSQIRVEIYSRTRGGEFCRHATAKVEQSPRECAHAHPEAQGPATGTTVSPADFYALLRQTGQHHGPAFAALSRIVRLADGSAETEISIPDEAPRHPGYRLHPVVLDAALQSVGAAIPDGEIAGSAEASYLPVSFETIRVYRDIGRHVRCRAHLTNLDGGTGKMGRIVLINDAGHIAAEVDGIYLRRVERRAVPLPLEQKIFDAEWTESPIAAVPAPEPAAETTRGSWLVLADATVDAPGKAQAKSMADDFVQQWRSPMRRVHTADIHDESAVLAAFAETAGDPEHPPVGVVVFVGGASSRLDDELAAARDTVWSITTVVRAVVGTWHGRSPRLWLVTGGGLSVADDEPGTPAAASLKGLVRVLAFEHPDMRTTLVDLDITQDPLTALSAELRNAGSGSRHDDVIAWRGERRFVERLSRATIDVSKGHPVVRQGASYVVTGGLGGLGLVVARWLVDRGAGRVVLGGRSDPTDEQCNVLAELQTRAEIVVVRGDVASPGVAEKLIETARQSGGQLRGVVHAAAVIEDSLVFSMSRDNLERVWAPKATGALRMHEATADCELDWWLGFSSAASLLGSPGQAAYACASAWLDALVGWRRASGLPAAVINWGPWSEVGVAQALVGSVLDTISVAEGIEALDSLLAADRIRTGVARLRADRALVAFPEIRSISYFTQVVEELDSAGDLGDWGGPDALADLDPGEARRAVTERMCARIAAVMGYTDQSTVEPAVPLDKPLTELGLDSLMAVRIRNGARADFGVEPPVALILQGASLHDLTADLMRQLGLNDPDPALNNADTIRDRARQRAAARHGAAMRRRPKPEVQGG,"193,315",1827,,DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; phenolic phthiocerol biosynthetic process [GO:0097041]; phthiocerol biosynthetic process [GO:0097040],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081],,,1
P9WQE1,PPSE_MYCTU,Rv2935,ppsE Rv2935,GO:0004315; GO:0005618; GO:0005886; GO:0006633; GO:0008610; GO:0016491; GO:0031177; GO:0034081; GO:0071766; GO:0071770,IPR001227; IPR036736; IPR014043; IPR016035; IPR023213; IPR001242; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR020801; IPR020841; IPR020806; IPR009081; IPR016039; ,,ppsE,DOMAIN 930 1004 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthiocerol synthesis polyketide synthase type I PpsE (Beta-ketoacyl-acyl-carrier-protein synthase I) (EC 2.3.1.41),cell wall [GO:0005618]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],9634230; 19099550; 19197369; 21969609,,FUNCTION: Involved in the elongation of either C22-24 fatty acids by the addition of malonyl-CoA and methylmalonyl-CoA extender units to yield phthiocerol derivatives. {ECO:0000269|PubMed:19197369}.,MSIPENAIAVVGMAGRFPGAKDVSAFWSNLRRGKESIVTLSEQELRDAGVSDKTLADPAYVRRAPLLDGIDEFDAGFFGFPPLAAQVLDPQHRLFLQCAWHALEDAGADPARFDGSIGVYGTSSPSGYLLHNLLSHRDPNAVLAEGLNFDQFSLFLQNDKDFLATRISHAFNLRGPSIAVQTACSSSLVAVHLACLSLLSGECDMALAGGSSLCIPHRVGYFTSPGSMVSAVGHCRPFDVRADGTVFGSGVGLVVLKPLAAAIDAGDRIHAVIRGSAINNDGSAKMGYAAPNPAAQADVIAEAHAVSGIDSSTVSYVECHGTGTPLGDPIEIQGLRAAFEVSQTSRSAPCVLGSVKSNIGHLEVAAGIAGLIKTILCLKNKALPATLHYTSPNPELRLDQSPFVVQSKYGPWECDGVRRAGVSSFGVGGTNAHVVLEEAPAEASEVSAHAEPAGPQVILLSAQTAAALGESRTALAAALETQDGPRLSDVAYTLARRRKHNVTMAAVVHDREHAATVLRAAEHDNVFVGEAAHDGEHGDRADAAPTSDRVVFLFPGQGAQHVGMAKGLYDTEPVFAQHFDTCAAGFRDETGIDLHAEVFDGTATDLERIDRSQPALFTVEYALAKLVDTFGVRAGAYIGYSTGEYIAATLAGVFDLQTAIKTVSLRARLMHESPPGAMVAVALGPDDVTQYLPPEVELSAVNDPGNCVVAGPKDQIRALRQRLTEAGIPVRRVRATHAFHTSAMDPMLGQFQEFLSRQQLRPPRTPLLSNLTGSWMSDQQVVDPASWTRQISSPIRFADELDVVLAAPSRILVEVGPGGSLTGSAMRHPKWSTTHRTVRLMRHPLQDVDDRDTFLRALGELWSAGVEVDWTPRRPAVPHLVSLPGYPFARQRHWVEPNHTVWAQAPGANNGSPAGTADGSTAATVDAARNGESQTEVTLQRIWSQCLGVSSVDRNANFFDLGGDSLMAISIAMAAANEGLTITPQDLYEYPTLASLTAAVDASFASSGLAKPPEAQANPAVPPNVTYFLDRGLRDTGRCRVPLILRLDPKIGLPDIRAVLTAVVNHHDALRLHLVGNDGIWEQHIAAPAEFTGLSNRSVPNGVAAGSPEERAAVLGILAELLEDQTDPNAPLAAVHIAAAHGGPHYLCLAIHAMVTDDSSRQILATDIVTAFGQRLAGEEITLEPVSTGWREWSLRCAALATHPAALDTRSYWIENSTKATLWLADALPNAHTAHPPRADELTKLSSTLSVEQTSELDDGRRRFRRSIQTILLAALGRTIAQTVGEGVVAVELEGEGRSVLRPDVDLRRTVGWFTTYYPVPLACATGLGALAQLDAVHNTLKSVPHYGIGYGLLRYVYAPTGRVLGAQRTPDIHFRYAGVIPELPSGDAPVQFDSDMTLPVREPIPGMGHAIELRVYRFGGSLHLDWWYDTRRIPAATAEALERTFPLALSALIQEAIAAEHTEHDDSEIVGEPEAGALVDLSSMDAG,"158,745",1488,,Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610],3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177],cell wall [GO:0005618]; plasma membrane [GO:0005886]; polyketide synthase complex [GO:0034081],,,1
P9WHH3,MTR_MYCTU,Rv2855,mtr gorA Rv2855,GO:0005829; GO:0009055; GO:0010126; GO:0040007; GO:0045454; GO:0050627; GO:0050660; GO:0055114; GO:0070402,IPR036188; IPR023753; IPR016156; IPR017817; IPR001100; IPR004099; IPR012999; ,,mtr,,Mycothione reductase (EC 1.8.1.15) (Mycothiol-disulfide reductase) (NADPH-dependent mycothione reductase),cytosol [GO:0005829]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; mycothione reductase activity [GO:0050627]; NADPH binding [GO:0070402]; cell redox homeostasis [GO:0045454]; growth [GO:0040007]; mycothiol metabolic process [GO:0010126]; oxidation-reduction process [GO:0055114],9634230; 10512639; 11318633; 21969609,,FUNCTION: Catalyzes the NAD(P)H-dependent reduction of mycothione (the oxidized disulfide form of mycothiol) to mycothiol. {ECO:0000269|PubMed:10512639}.,METYDIAIIGTGSGNSILDERYASKRAAICEQGTFGGTCLNVGCIPTKMFVYAAEVAKTIRGASRYGIDAHIDRVRWDDVVSRVFGRIDPIALSGEDYRRCAPNIDVYRTHTRFGPVQADGRYLLRTDAGEEFTAEQVVIAAGSRPVIPPAILASGVDYHTSDTVMRIAELPEHIVIVGSGFIAAEFAHVFSALGVRVTLVIRGSCLLRHCDDTICERFTRIASTKWELRTHRNVVDGQQRGSGVALRLDDGCTINADLLLVATGRVSNADLLDAEQAGVDVEDGRVIVDEYQRTSARGVFALGDVSSPYLLKHVANHEARVVQHNLLCDWEDTQSMIVTDHRYVPAAVFTDPQIAAVGLTENQAVAKGLDISVKIQDYGDVAYGWAMEDTSGIVKLITERGSGRLLGAHIMGYQASSLIQPLIQAMSFGLTAAEMARGQYWIHPALPEVVENALLGLR,"49,946",459,Class-I pyridine nucleotide-disulfide oxidoreductase family,cell redox homeostasis [GO:0045454]; growth [GO:0040007]; mycothiol metabolic process [GO:0010126]; oxidation-reduction process [GO:0055114],electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; mycothione reductase activity [GO:0050627]; NADPH binding [GO:0070402],cytosol [GO:0005829],gorA,,1
L7N6B4,MOAD_MYCTU,Rv3112,moaD1 Rv3112 LH57_16990,GO:0000166; GO:0006777,IPR012675; IPR010034; IPR016155; IPR003749; ,,moaD1,,Molybdopterin synthase sulfur carrier subunit,nucleotide binding [GO:0000166]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],9634230; 20844580,,"FUNCTION: Involved in sulfur transfer in the conversion of molybdopterin precursor Z to molybdopterin (By similarity). Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000250|UniProtKB:Q6YVX4, ECO:0000255|RuleBase:RU362014, ECO:0000305|PubMed:20844580}.",MIKVNVLYFGAVREACDETPREEVEVQNGTDVGNLVDQLQQKYPRLRDHCQRVQMAVNQFIAPLSTVLGDGDEVAFIPQVAGG,"9,188",83,MoaD family,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],nucleotide binding [GO:0000166],,,LH57_16990,1
P9WNF5,MP70_MYCTU,Rv2875,mpt70 Rv2875 MTCY274.06,GO:0005576; GO:0005615; GO:0030288,IPR036378; IPR000782; ,,mpt70,DOMAIN 57 189 FAS1. {ECO:0000255|PROSITE-ProRule:PRU00082}.,Immunogenic protein MPT70,extracellular region [GO:0005576]; extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288],7871388; 9634230; 21969609,NMR spectroscopy (1),,MKVKNTIAATSFAAAGLAALAVAVSPPAAAGDLVGPGCAEYAAANPTGPASVQGMSQDPVAVAASNNPELTTLTAALSGQLNPQVNLVDTLNSGQYTVFAPTNAAFSKLPASTIDELKTNSSLLTSILTYHVVAGQTSPANVVGTRQTLQGASVTVTGQGNSLKVGNADVVCGGVSTANATVYMIDSVLMPPA,"19,073",193,,,,extracellular region [GO:0005576]; extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288],,MTCY274.06,1
P9WNF3,MP83_MYCTU,Rv2873,mpt83 Rv2873 MTCY274.04,GO:0005576; GO:0005615; GO:0005618; GO:0005886; GO:0030288; GO:0052572,IPR036378; IPR000782; ,,mpt83,DOMAIN 83 215 FAS1. {ECO:0000255|PROSITE-ProRule:PRU00082}.,Cell surface glycolipoprotein MPT83 (Lipoprotein p23),cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886]; response to host immune response [GO:0052572],8633206; 9634230; 21969609; 22174456; 22567094,,"FUNCTION: Recombinant, non-modified protein stimulates secretion of cytokines (TNF-alpha, IL-6 and IL-12p40) by mouse macrophage cell lines in a TLR2-dependent fashion, which leads to increased host innate immunity responses against the bacterium (PubMed:22174456). Serves as a strong human and mouse antigen T cell antigen during M.tuberculosis infection, inducing strong IFN-gamma expression (PubMed:22567094). {ECO:0000269|PubMed:22174456, ECO:0000269|PubMed:22567094}.",MINVQAKPAAAASLAAIAIAFLAGCSSTKPVSQDTSPKPATSPAAPVTTAAMADPAADLIGRGCAQYAAQNPTGPGSVAGMAQDPVATAASNNPMLSTLTSALSGKLNPDVNLVDTLNGGEYTVFAPTNAAFDKLPAATIDQLKTDAKLLSSILTYHVIAGQASPSRIDGTHQTLQGADLTVIGARDDLMVNNAGLVCGGVHTANATVYMIDTVLMPPAQ,"22,070",220,,response to host immune response [GO:0052572],,cell wall [GO:0005618]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,MTCY274.04,1
P9WIY3,MUTT1_MYCTU,Rv2985,mutT1 Rv2985,GO:0006260; GO:0006281; GO:0016787; GO:0046872,IPR013078; IPR029033; IPR020476; IPR015797; IPR020084; IPR000086; ,,mutT1,DOMAIN 15 148 Nudix hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00794}.,"Probable 8-oxo-dGTP diphosphatase 1 (8-oxo-dGTPase 1) (EC 3.6.1.55) (7,8-dihydro-8-oxoguanine-triphosphatase 1) (Mutator protein MutT1) (dGTP pyrophosphohydrolase 1)",hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260],9634230; 16585780; 21969609,,"FUNCTION: May be involved in the GO system responsible for removing an oxidatively damaged form of guanine (7,8-dihydro-8-oxoguanine, 8-oxo-dGTP) from DNA and the nucleotide pool. 8-oxo-dGTP is inserted opposite dA and dC residues of template DNA with almost equal efficiency thus leading to A.T to G.C transversions. MutT specifically degrades 8-oxo-dGTP to the monophosphate (By similarity). In vitro has 8-oxo-dGTPase activity. {ECO:0000250, ECO:0000269|PubMed:16585780}.",MSIQNSSARRRSAGRIVYAAGAVLWRPGSADSEGPVEIAVIHRPRYDDWSLPKGKVDPGETAPVGAVREILEETGHRANLGRRLLTVTYPTDSPFRGVKKVHYWAARSTGGEFTPGSEVDELIWLPVPDAMNKLDYAQDRKVLCRFAKHPADTQTVLVVRHGTAGSKAHFSGDDSKRPLDKRGRAQAEALVPQLLAFGATDVYAADRVRCHQTMEPLAAELNVTIHNEPTLTEESYANNPKRGRHRVLQIVEQVGTPVICTQGKVIPDLITWWCERDGVHPDKSRNRKGSTWVLSLSAGRLVTADHIGGALAANVRA,"34,780",317,Nudix hydrolase family,DNA repair [GO:0006281]; DNA replication [GO:0006260],hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,,1
P9WJP5,MQO_MYCTU,Rv2852c,mqo Rv2852c MTCY24A1.05,GO:0005737; GO:0005886; GO:0006099; GO:0008924; GO:0016491; GO:0052589,IPR036188; IPR006231; ,,mqo,,Probable malate:quinone oxidoreductase (EC 1.1.5.4) (MQO) (Malate dehydrogenase [quinone]),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; malate dehydrogenase (menaquinone) activity [GO:0052589]; malate dehydrogenase (quinone) activity [GO:0008924]; oxidoreductase activity [GO:0016491]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,,,MSDLARTDVVLIGAGIMSATLGVLLRRLEPNWSITLIERLDAVAAESSGPWNNAGTGHSALCEMNYTPEMPDGSIDITKAVRVNEQFQVTRQFWAYAAENGILTDVRSFLNPVPHVSFVHGSRGVEYLRRRQKALAGNPLFAGTEFIESPDEFARRLPFMAAKRAFSEPVALNWAADGTDVDFGALAKQLIGYCVQNGTTALFGHEVRNLSRQSDGSWTVTMCNRRTGEKRKLNTKFVFVGAGGDTLPVLQKSGIKEVKGFAGFPIGGRFLRAGNPALTASHRAKVYGFPAPGAPPLGALHLDLRFVNGKSWLVFGPYAGWSPKFLKHGQISDLPRSIRPDNLLSVLGVGLTERRLLNYLISQLRLSEPERVSALREFAPSAIDSDWELTIAGQRVQVIRRDERNGGVLEFGTTVIGDADGSIAGLLGGSPGASTAVAIMLDVLQKCFANRYQSWLPTLKEMVPSLGVQLSNEPALFDEVWSWSTKALKLGAA,"53,595",493,MQO family,tricarboxylic acid cycle [GO:0006099],malate dehydrogenase (menaquinone) activity [GO:0052589]; malate dehydrogenase (quinone) activity [GO:0008924]; oxidoreductase activity [GO:0016491],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY24A1.05,1
P9WG65,MPT53_MYCTU,Rv2878c,mpt53 mpb53 Rv2878c MTCY274.09c,GO:0005576; GO:0005623; GO:0016209; GO:0016491; GO:0045454; GO:0055114,IPR000866; IPR036249; IPR013766; ,,mpt53,,Soluble secreted antigen MPT53,cell [GO:0005623]; extracellular region [GO:0005576]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114],10089161; 9634230; 21969609; 14597624,X-ray crystallography (1),"FUNCTION: Disulfide oxidoreductase that catalyzes the oxidation of reduced, unfolded secreted proteins to form disulfide bonds. Despite a weak homology to thioredoxin this cannot serve as a substrate for thioredoxin reductase. {ECO:0000269|PubMed:14597624}.",MSLRLVSPIKAFADGIVAVAIAVVLMFGLANTPRAVAADERLQFTATTLSGAPFDGASLQGKPAVLWFWTPWCPFCNAEAPSLSQVAAANPAVTFVGIATRADVGAMQSFVSKYNLNFTNLNDADGVIWARYNVPWQPAFVFYRADGTSTFVNNPTAAMSQDELSGRVAALTS,"18,383",173,Thioredoxin family,cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114],antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],cell [GO:0005623]; extracellular region [GO:0005576],mpb53,MTCY274.09c,1
P9WJR9,MOAC1_MYCTU,Rv3111,moaC1 moaC Rv3111 MTCY164.21,GO:0005576; GO:0006777; GO:0040007; GO:0052170; GO:0061799,IPR023045; IPR036522; IPR002820; ,,moaC1,,Cyclic pyranopterin monophosphate synthase 1 (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C 1),extracellular region [GO:0005576]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; growth [GO:0040007]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 20378651; 20844580,,"FUNCTION: Catalyzes the conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cyclic pyranopterin monophosphate (cPMP) (By similarity). Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000255|HAMAP-Rule:MF_01224, ECO:0000305|PubMed:20844580}.",MIDHALALTHIDERGAARMVDVSEKPVTLRVAKASGLVIMKPSTLRMISDGAAAKGDVMAAARIAGIAAAKRTGDLIPLCHPLGLDAVSVTITPCEPDRVKILATTTTLGRTGVEMEALTAVSVAALTIYDMCKAVDRAMEISQIVLQEKSGGRSGVYRRSASDLACQSR,"17,845",170,MoaC family,growth [GO:0040007]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; negative regulation by symbiont of host innate immune response [GO:0052170],cyclic pyranopterin monophosphate synthase activity [GO:0061799],extracellular region [GO:0005576],moaC,MTCY164.21,1
P9WKK9,LEU3_MYCTU,Rv2995c,leuB Rv2995c MTV012.09,GO:0000287; GO:0003862; GO:0005737; GO:0009098; GO:0040007; GO:0051287,IPR023698; IPR019818; IPR024084; ,,leuB,,3-isopropylmalate dehydrogenase (EC 1.1.1.85) (3-IPM-DH) (Beta-IPM dehydrogenase) (IMDH),cytoplasm [GO:0005737]; 3-isopropylmalate dehydrogenase activity [GO:0003862]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; growth [GO:0040007]; leucine biosynthetic process [GO:0009098],9111927; 9634230; 21969609; 15663922,X-ray crystallography (2),FUNCTION: Catalyzes the oxidation of 3-carboxy-2-hydroxy-4-methylpentanoate (3-isopropylmalate) to 3-carboxy-4-methyl-2-oxopentanoate. The product decarboxylates to 4-methyl-2 oxopentanoate.,MKLAIIAGDGIGPEVTAEAVKVLDAVVPGVQKTSYDLGARRFHATGEVLPDSVVAELRNHDAILLGAIGDPSVPSGVLERGLLLRLRFELDHHINLRPARLYPGVASPLSGNPGIDFVVVREGTEGPYTGNGGAIRVGTPNEVATEVSVNTAFGVRRVVADAFERARRRRKHLTLVHKTNVLTFAGGLWLRTVDEVGECYPDVEVAYQHVDAATIHMITDPGRFDVIVTDNLFGDIITDLAAAVCGGIGLAASGNIDATRANPSMFEPVHGSAPDIAGQGIADPTAAIMSVALLLSHLGEHDAAARVDRAVEAHLATRGSERLATSDVGERIAAAL,"35,306",336,"Isocitrate and isopropylmalate dehydrogenases family, LeuB type 2 subfamily",growth [GO:0040007]; leucine biosynthetic process [GO:0009098],3-isopropylmalate dehydrogenase activity [GO:0003862]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287],cytoplasm [GO:0005737],,MTV012.09,1
P9WK95,LEUD_MYCTU,Rv2987c,leuD Rv2987c MTV012.01c,GO:0003861; GO:0005886; GO:0009098; GO:0009316; GO:0040007,IPR004431; IPR015928; IPR000573; IPR033940; ,,leuD,,3-isopropylmalate dehydratase small subunit (EC 4.2.1.33) (Alpha-IPM isomerase) (IPMI) (Isopropylmalate isomerase),3-isopropylmalate dehydratase complex [GO:0009316]; plasma membrane [GO:0005886]; 3-isopropylmalate dehydratase activity [GO:0003861]; growth [GO:0040007]; leucine biosynthetic process [GO:0009098],9634230; 20066036; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes the isomerization between 2-isopropylmalate and 3-isopropylmalate, via the formation of 2-isopropylmaleate. {ECO:0000250}.",MEAFHTHSGIGVPLRRSNVDTDQIIPAVFLKRVTRTGFEDGLFAGWRSDPAFVLNLSPFDRGSVLVAGPDFGTGSSREHAVWALMDYGFRVVISSRFGDIFRGNAGKAGLLAAEVAQDDVELLWKLIEQSPGLEITANLQDRIITAATVVLPFKIDDHSAWRLLEGLDDIALTLRKLDEIEAFEGACAYWKPRTLPAP,"21,780",198,"LeuD family, LeuD type 1 subfamily",growth [GO:0040007]; leucine biosynthetic process [GO:0009098],3-isopropylmalate dehydratase activity [GO:0003861],3-isopropylmalate dehydratase complex [GO:0009316]; plasma membrane [GO:0005886],,MTV012.01c,1
I6Y2J4,LIPY_MYCTU,Rv3097c,lipY PE-PGRS63 Rv3097c LH57_16905,GO:0004806; GO:0005576; GO:0016042,IPR029058; IPR013094; IPR000084; ,,lipY,"DOMAIN 1 100 PE. {ECO:0000255, ECO:0000305|PubMed:17938218}.",Triacylglycerol lipase (EC 3.1.1.3) (Esterase/lipase) (Triolein hydrolase),extracellular region [GO:0005576]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042],9634230; 16354661; 17938218; 21471225,,"FUNCTION: Responsible for the utilization of stored long-chain triacylglycerol (TG) during dormancy and reactivation stage of the infection cycle. Catalyzes the hydrolysis of long-chain triacylglycerol with high specific activity. {ECO:0000269|PubMed:16354661, ECO:0000269|PubMed:17938218, ECO:0000269|PubMed:21471225}.",MVSYVVALPEVMSAAATDVASIGSVVATASQGVAGATTTVLAAAEDEVSAAIAALFSGHGQDYQALSAQLAVFHERFVQALTGAAKGYAAAELANASLLQSEFASGIGNGFATIHQEIQRAPTALAAGFTQVPPFAAAQAGIFTGTPSGAAGFDIASLWPVKPLLSLSALETHFAIPNNPLLALIASDIPPLSWFLGNSPPPLLNSLLGQTVQYTTYDGMSVVQITPAHPTGEYVVAIHGGAFILPPSIFHWLNYSVTAYQTGATVQVPIYPLVQEGGTAGTVVPAMAGLISTQIAQHGVSNVSVVGDSAGGNLALAAAQYMVSQGNPVPSSMVLLSPWLDVGTWQISQAWAGNLAVNDPLVSPLYGSLNGLPPTYVYSGSLDPLAQQAVVLEHTAVVQGAPFSFVLAPWQIHDWILLTPWGLLSWPQINQQLGIAA,"45,023",437,"Mycobacterial PE family, PGRS subfamily; 'GDXG' lipolytic enzyme family",lipid catabolic process [GO:0016042],triglyceride lipase activity [GO:0004806],extracellular region [GO:0005576],PE-PGRS63,LH57_16905,1
P9WIV3,NUSA_MYCTU,Rv2841c,nusA Rv2841c MTCY16B7.01 MTCY24A1.16,GO:0003700; GO:0003723; GO:0005618; GO:0005829; GO:0005886; GO:0006353; GO:0031564; GO:0040007,IPR015946; IPR025249; IPR009019; IPR012340; IPR030842; IPR036555; IPR022967; IPR003029; IPR013735; IPR010213; ,,nusA,DOMAIN 112 184 S1 motif. {ECO:0000255|HAMAP-Rule:MF_00945}.; DOMAIN 220 286 KH 1. {ECO:0000255|HAMAP-Rule:MF_00945}.; DOMAIN 287 347 KH 2. {ECO:0000255|HAMAP-Rule:MF_00945}.,Transcription termination/antitermination protein NusA,"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; DNA-templated transcription, termination [GO:0006353]; growth [GO:0040007]; transcription antitermination [GO:0031564]",9634230; 21969609; 11743725; 16193062,X-ray crystallography (3),FUNCTION: Participates in both transcription termination and antitermination. {ECO:0000255|HAMAP-Rule:MF_00945}.,MNIDMAALHAIEVDRGISVNELLETIKSALLTAYRHTQGHQTDARIEIDRKTGVVRVIARETDEAGNLISEWDDTPEGFGRIAATTARQVMLQRFRDAENERTYGEFSTREGEIVAGVIQRDSRANARGLVVVRIGTETKASEGVIPAAEQVPGESYEHGNRLRCYVVGVTRGAREPLITLSRTHPNLVRKLFSLEVPEIADGSVEIVAVAREAGHRSKIAVRSNVAGLNAKGACIGPMGQRVRNVMSELSGEKIDIIDYDDDPARFVANALSPAKVVSVSVIDQTARAARVVVPDFQLSLAIGKEGQNARLAARLTGWRIDIRGDAPPPPPGQPEPGVSRGMAHDR,"37,642",347,NusA family,"DNA-templated transcription, termination [GO:0006353]; growth [GO:0040007]; transcription antitermination [GO:0031564]",DNA binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY16B7.01 MTCY24A1.16,1
P9WQF5,LEUC_MYCTU,Rv2988c,leuC Rv2988c MTV012.02c,GO:0003861; GO:0005618; GO:0009098; GO:0046872; GO:0051539,IPR004430; IPR015931; IPR001030; IPR018136; IPR036008; IPR033941; ,,leuC,,3-isopropylmalate dehydratase large subunit (EC 4.2.1.33) (Alpha-IPM isomerase) (IPMI) (Isopropylmalate isomerase),"cell wall [GO:0005618]; 3-isopropylmalate dehydratase activity [GO:0003861]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; leucine biosynthetic process [GO:0009098]",9634230; 21969609,,"FUNCTION: Catalyzes the isomerization between 2-isopropylmalate and 3-isopropylmalate, via the formation of 2-isopropylmaleate. {ECO:0000255|HAMAP-Rule:MF_01026}.",MALQTGEPRTLAEKIWDDHIVVSGGGCAPDLIYIDLHLVHEVTSPQAFDGLRLAGRRVRRPELTLATEDHNVPTVDIDQPIADPVSRTQVETLRRNCAEFGIRLHSMGDIEQGIVHVVGPQLGLTQPGMTIVCGDSHTSTHGAFGALAMGIGTSEVEHVLATQTLPLRPFKTMAVNVDGRLPDGVSAKDIILALIAKIGTGGGQGHVIEYRGSAIESLSMEGRMTICNMSIEAGARAGMVAPDETTYAFLRGRPHAPTGAQWDTALVYWQRLRTDVGAVFDTEVYLDAASLSPFVTWGTNPGQGVPLAAAVPDPQLMTDDAERQAAEKALAYMDLRPGTAMRDIAVDAVFVGSCTNGRIEDLRVVAEVLRGRKVADGVRMLIVPGSMRVRAQAEAEGLGEIFTDAGAQWRQAGCSMCLGMNPDQLASGERCAATSNRNFEGRQGAGGRTHLVSPAVAAATAVRGTLSSPADLN,"50,185",473,"Aconitase/IPM isomerase family, LeuC type 1 subfamily",leucine biosynthetic process [GO:0009098],"3-isopropylmalate dehydratase activity [GO:0003861]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",cell wall [GO:0005618],,MTV012.02c,1
P9WK67,LPPW_MYCTU,Rv2905,lppW Rv2905 MTCY274.36,GO:0005576; GO:0005886,IPR012338; ,,lppW,,Putative lipoprotein LppW,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MRARPLTLLTALAAVTLVVVAGCEARVEAEAYSAADRISSRPQARPQPQPVELLLRAITPPRAPAASPNVGFGELPTRVRQATDEAAAMGATLSVAVLDRATGQLVSNGNTQIIATASVAKLFIADDLLLAEAEGKVTLSPEDHHALDVMLQSSDDGAAERFWSQDGGNAVVTQVARRYGLRSTAPPSDGRWWNTISSAPDLIRYYDMLLDGSGGLPLDRAAVIIADLAQSTPTGIDGYPQRFGIPDGLYAEPVAVKQGWMCCIGSSWMHLSTGVIGPERRYIMVIESLQPADDATARATITQAVRTMFPNGRI,"33,402",314,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY274.36,1
P9WPG3,PGSA2_MYCTU,Rv2746c,pgsA2 pgsA-2 pgsA3 Rv2746c,GO:0005618; GO:0005886; GO:0008444; GO:0008654; GO:0016021; GO:0040007; GO:0046474,IPR000462; IPR004570; ,,pgsA2,,Putative CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyl-transferase 2 (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase) (PGP synthase),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; glycerophospholipid biosynthetic process [GO:0046474]; growth [GO:0040007]; phospholipid biosynthetic process [GO:0008654],9634230; 12368430; 10889206,,,MSRSTRYSVAVSAQPETGQIAGRARIANLANILTLLRLVMVPVFLLALFYGGGHHSAARVVAWAIFATACITDRFDGLLARNYGMATEFGAFVDPIADKTLIGSALIGLSMLGDLPWWVTVLILTRELGVTVLRLAVIRRGVIPASWGGKLKTFVQAVAIGLFVLPLSGPLHVAAVVVMAAAILLTVITGVDYVARALRDIGGIRQTAS,"22,136",209,CDP-alcohol phosphatidyltransferase class-I family,glycerophospholipid biosynthetic process [GO:0046474]; growth [GO:0040007]; phospholipid biosynthetic process [GO:0008654],CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],pgsA-2 pgsA3,,1
P9WIB7,PHKR_MYCTU,Rv2951c,Rv2951c,GO:0005829; GO:0005886; GO:0006629; GO:0016705,IPR011251; IPR036661; ,,,,Phthiodiolone/phenolphthiodiolone dimycocerosates ketoreductase (EC 1.2.-.-),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]",9634230; 17371506; 21969609,,FUNCTION: Catalyzes the reduction of the keto moiety of phthiodiolone dimycocerosates (DIM B) and glycosylated phenolphthiodiolone dimycocerosates to form the intermediate compounds phthiotriol and glycosylated phenolphthiotriol dimycocerosates during phthiocerol dimycocerosates (DIM A) and glycosylated phenolphthiocerol dimycocerosates (PGL) biosynthesis. {ECO:0000269|PubMed:17371506}.,MGGLRFGFVDALVHSRLPPTLPARSSMAAATVMGADSYWVGDHLNALVPRSIATSEYLGIAAKFVPKIDANYEPWTMLGNLAFGLPSRLRLGVCVTDAGRRNPAVTAQAAATLHLLTRGRAILGIGVGEREGNEPYGVEWTKPVARFEEALATIRALWNSNGELISRESPYFPLHNALFDLPPYRGKWPEIWVAAHGPRMLRATGRYADAWIPIVVVRPSDYSRALEAVRSAASDAGRDPMSITPAAVRGIITGRNRDDVEEALESVVVKMTALGVPGEAWARHGVEHPMGADFSGVQDIIPQTMDKQTVLSYAAKVPAALMKEVVFSGTPDEVIDQVAEWRDHGLRYVVLINGSLVNPSLRKTVTAVLPHAKVLRGLKKL,"41,348",381,"Mer family, Phthiodiolone/phenolphthiodiolone dimycocerosates ketoreductase subfamily",lipid metabolic process [GO:0006629],"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WIN5,PAPA5_MYCTU,Rv2939,papA5 Rv2939 MTCY19H9.07,GO:0008374; GO:0008610; GO:0016747; GO:0071770,IPR023213; IPR001242; IPR031641; ,,papA5,,Phthiocerol/phthiodiolone dimycocerosyl transferase (EC 2.3.1.-) (Acyltransferase PapA5) (Phthiocerol/phthiodiolone O-acyltransferase) (Polyketide synthase-associated protein A5),"O-acyltransferase activity [GO:0008374]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610]",9634230; 15070765; 15749014; 19099550; 19826007; 21969609; 15123643,X-ray crystallography (1),"FUNCTION: Catalyzes diesterification of phthiocerol and phthiodiolone with mycocerosic acids, the final step in the phthiocerol and phthiodiolone dimycocerosate esters (PDIM) synthesis. Can directly transfer the mycocerosate bound to the mycocerosic acid synthase (mas) onto the substrate alcohols. Is also able to catalyze acyl transfer using various nucleophiles as acceptors and several acyl-CoA thioesters as donors in vitro; preference is observed for saturated medium chain alcohols and long chain acyl-CoA thioesters. {ECO:0000269|PubMed:15070765, ECO:0000269|PubMed:15749014}.",MFPGSVIRKLSHSEEVFAQYEVFTSMTIQLRGVIDVDALSDAFDALLETHPVLASHLEQSSDGGWNLVADDLLHSGICVIDGTAATNGSPSGNAELRLDQSVSLLHLQLILREGGAELTLYLHHCMADGHHGAVLVDELFSRYTDAVTTGDPGPITPQPTPLSMEAVLAQRGIRKQGLSGAERFMSVMYAYEIPATETPAVLAHPGLPQAVPVTRLWLSKQQTSDLMAFGREHRLSLNAVVAAAILLTEWQLRNTPHVPIPYVYPVDLRFVLAPPVAPTEATNLLGAASYLAEIGPNTDIVDLASDIVATLRADLANGVIQQSGLHFGTAFEGTPPGLPPLVFCTDATSFPTMRTPPGLEIEDIKGQFYCSISVPLDLYSCAVYAGQLIIEHHGHIAEPGKSLEAIRSLLCTVPSEYGWIME,"45,429",422,Acyltransferase PapA5 family,DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610],"O-acyltransferase activity [GO:0008374]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,MTCY19H9.07,1
P9WIC5,PHBS_MYCTU,Rv2949c,Rv2949c,GO:0008813; GO:0046417; GO:0071770; GO:0072330,IPR028978; IPR002800; ,,,,Chorismate pyruvate-lyase (EC 4.1.3.40) (4-HB synthase) (p-hydroxybenzoic acid synthase),chorismate lyase activity [GO:0008813]; chorismate metabolic process [GO:0046417]; DIM/DIP cell wall layer assembly [GO:0071770]; monocarboxylic acid biosynthetic process [GO:0072330],9634230; 16210318; 19099550; 21969609,,FUNCTION: Removes the pyruvyl group from chorismate to provide 4-hydroxybenzoate (4HB). Involved in the synthesis of glycosylated p-hydroxybenzoic acid methyl esters (p-HBADs) and phenolic glycolipids (PGL) that play important roles in the pathogenesis of mycobacterial infections. {ECO:0000269|PubMed:16210318}.,MTECFLSDQEIRKLNRDLRILIAANGTLTRVLNIVADDEVIVQIVKQRIHDVSPKLSEFEQLGQVGVGRVLQRYIILKGRNSEHLFVAAESLIAIDRLPAAIITRLTQTNDPLGEVMAASHIETFKEEAKVWVGDLPGWLALHGYQNSRKRAVARRYRVISGGQPIMVVTEHFLRSVFRDAPHEEPDRWQFSNAITLAR,"22,587",199,Chorismate pyruvate-lyase type 2 family,chorismate metabolic process [GO:0046417]; DIM/DIP cell wall layer assembly [GO:0071770]; monocarboxylic acid biosynthetic process [GO:0072330],chorismate lyase activity [GO:0008813],,,,1
P9WID7,PFKA_MYCTU,Rv3010c,pfkA Rv3010c MTV012.24c,GO:0003872; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006002; GO:0046872; GO:0047334,IPR022953; IPR012003; IPR015912; IPR000023; IPR012829; IPR035966; ,,pfkA,,ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; diphosphate-fructose-6-phosphate 1-phosphotransferase activity [GO:0047334]; metal ion binding [GO:0046872]; fructose 6-phosphate metabolic process [GO:0006002],9634230; 21969609,,"FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate to fructose 1,6-bisphosphate by ATP, the first committing step of glycolysis. {ECO:0000255|HAMAP-Rule:MF_01976}.",MRIGVLTGGGDCPGLNAVIRAVVRTCHARYGSSVVGFQNGFRGLLENRRVQLHNDDRNDRLLAKGGTMLGTARVHPDKLRAGLPQIMQTLDDNGIDVLIPIGGEGTLTAASWLSEENVPVVGVPKTIDNDIDCTDVTFGHDTALTVATEAIDRLHSTAESHERVMLVEVMGRHAGWIALNAGLASGAHMTLIPEQPFDIEEVCRLVKGRFQRGDSHFICVVAEGAKPAPGTIMLREGGLDEFGHERFTGVAAQLAVEVEKRINKDVRVTVLGHIQRGGTPTAYDRVLATRFGVNAADAAHAGEYGQMVTLRGQDIGRVPLADAVRKLKLVPQSRYDDAAAFFG,"36,880",343,"Phosphofructokinase type A (PFKA) family, Mixed-substrate PFK group III subfamily",fructose 6-phosphate metabolic process [GO:0006002],6-phosphofructokinase activity [GO:0003872]; ATP binding [GO:0005524]; diphosphate-fructose-6-phosphate 1-phosphotransferase activity [GO:0047334]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV012.24c,1
Q79FB3,PG47_MYCTU,Rv2741,PE_PGRS47 Rv2741,GO:0005576; GO:0009405; GO:0009986; GO:0044164,IPR000084; ,,PE_PGRS47,DOMAIN 1 93 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS47,cell surface [GO:0009986]; extracellular region [GO:0005576]; host cell cytosol [GO:0044164]; pathogenesis [GO:0009405],9634230; 27562263,,"FUNCTION: Contributes to evasion of both innate and adaptive immunity. Inhibits autophagy in infected host phagocytes and inhibits major histocompatibility complex (MHC) class II antigen presentation by mycobacteria-infected dendritic cells. Has an important role in the growth and survival of M.tuberculosis, particularly during intracellular growth and in the later chronic phase of infection. {ECO:0000269|PubMed:27562263}.",MSFVIAAPEFLTAAAMDLASIGSTVSAASAAASAPTVAILAAGADEVSIAVAALFGMHGQAYQALSVQASAFHQQFVQALTAGAYSYASAEAAAVTPLQQLVDVINAPFRSALGRPLIGNGANGKPGTGQDGGAGGLLYGSGGNGGSGLAGSGQKGGNGGAAGLFGNGGAGGAGASNQAGNGGAGGNGGAGGLIWGTAGTGGNGGFTTFLDAAGGAGGAGGAGGLFGAGGAGGVGGAALGGGAQAAGGNGGAGGVGGLFGAGGAGGAGGFSDTGGTGGAGGAGGLFGPGGGSGGVGGFGDTGGTGGDGGSGGLFGVGGAGGHGGFGSAAGGDGGAGGAGGTVFGSGGAGGAGGVATVAGHGGHGGNAGLLYGTGGAGGAGGFGGFGGDGGDGGIGGLVGSGGAGGSGGTGTLSGGRGGAGGNAGTFYGSGGAGGAGGESDNGDGGNGGVGGKAGLVGEGGNGGDGGATIAGKGGSGGNGGNAWLTGQGGNGGNAAFGKAGTGSVGVGGAGGLLEGQNGENGLLPS,"44,210",525,"Mycobacterial PE family, PGRS subfamily",pathogenesis [GO:0009405],,cell surface [GO:0009986]; extracellular region [GO:0005576]; host cell cytosol [GO:0044164],,,1
P9WKA1,LEP_MYCTU,Rv2903c,lepB Rv2903c MTCY274.34c,GO:0005576; GO:0005887; GO:0008236; GO:0040007,IPR036286; IPR000223; IPR019758; IPR019756; IPR015927; IPR019533; ,,lepB,,Signal peptidase I (SPase I) (EC 3.4.21.89) (Leader peptidase I),extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; serine-type peptidase activity [GO:0008236]; growth [GO:0040007],9634230; 19099550; 21969609; 22427625,,,MTETTDSPSERQPGPAEPELSSRDPDIAGQVFDAAPFDAAPDADSEGDSKAAKTDEPRPAKRSTLREFAVLAVIAVVLYYVMLTFVARPYLIPSESMEPTLHGCSTCVGDRIMVDKLSYRFGSPQPGDVIVFRGPPSWNVGYKSIRSHNVAVRWVQNALSFIGFVPPDENDLVKRVIAVGGQTVQCRSDTGLTVNGRPLKEPYLDPATMMADPSIYPCLGSEFGPVTVPPGRVWVMGDNRTHSADSRAHCPLLCTDDPLPGTVPVANVIGKARLIVWPPSRWGVVRSVNPQQGR,"31,880",294,Peptidase S26 family,growth [GO:0040007],serine-type peptidase activity [GO:0008236],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTCY274.34c,1
P9WK85,LIPR_MYCTU,Rv3084,lipR bah Rv3084,GO:0005886; GO:0009056; GO:0010447; GO:0034338; GO:0044119,IPR029058; IPR013094; ,,lipR,,Putative acetyl-hydrolase LipR (EC 3.1.1.-),plasma membrane [GO:0005886]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],9634230; 14568148; 15937179; 16893682; 21969609,,FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. {ECO:0000269|PubMed:15937179}.,MNLRKNVIRSVLRGARPLFASRRLGIAGRRVLLATLTAGARAPKGTRFQRVSIAGVPVQRVQPPHAATSGTLIYLHGGAYALGSARGYRGLAAQLAAAAGMTALVPDYTRAPHAHYPVALEEMAAVYTRLLDDGLDPKTTVIAGDSAGGGLTLALAMALRDRGIQAPAALGLICPWADLAVDIEATRPALRDPLILPSMCTEWAPRYVGSSDPRLPGISPVYGDMSGLPPIVMQTAGDDPICVDADKIETACAASKTSIEHRRFAGMWHDFHLQVSLLPEARDAIADLGARLRGHLHQSQGQPRGVVK,"32,617",308,'GDXG' lipolytic enzyme family,catabolic process [GO:0009056]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],short-chain carboxylesterase activity [GO:0034338],plasma membrane [GO:0005886],bah,,1
P9WJW1,MIAA_MYCTU,Rv2727c,miaA Rv2727c MTCY154.07c,GO:0005524; GO:0006400; GO:0040007; GO:0052381,IPR018022; IPR027417; ,,miaA,,tRNA dimethylallyltransferase (EC 2.5.1.75) (Dimethylallyl diphosphate:tRNA dimethylallyltransferase) (DMAPP:tRNA dimethylallyltransferase) (DMATase) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (IPTase),ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381]; growth [GO:0040007]; tRNA modification [GO:0006400],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the transfer of a dimethylallyl group onto the adenine at position 37 in tRNAs that read codons beginning with uridine, leading to the formation of N6-(dimethylallyl)adenosine (i(6)A). {ECO:0000255|HAMAP-Rule:MF_00185}.",MRPLAIIGPTGAGKSQLALDVAARLGARVSVEIVNADAMQLYRGMDIGTAKLPVSERRGIPHHQLDVLDVTETATVARYQRAAAADIEAIAARGAVPVVVGGSMLYVQSLLDDWSFPATDPSVRARWERRLAEVGVDRLHAELARRDPAAAAAILPTDARRTVRALEVVELTGQPFAASAPRIGAPRWDTVIVGLDCQTTILDERLARRTDLMFDQGLVEEVRTLLRNGLREGVTASRALGYAQVIAALDAGAGADMMRAAREQTYLGTRRYVRRQRSWFRRDHRVHWLDAGVASSPDRARLVDDAVRLWRHVT,"34,446",314,IPP transferase family,growth [GO:0040007]; tRNA modification [GO:0006400],ATP binding [GO:0005524]; tRNA dimethylallyltransferase activity [GO:0052381],,,MTCY154.07c,1
P9WK05,MIAB_MYCTU,Rv2733c,miaB Rv2733c MTCY154.13c,GO:0005737; GO:0006400; GO:0016740; GO:0046872; GO:0051539,IPR006638; IPR005839; IPR020612; IPR013848; IPR038135; IPR006463; IPR007197; IPR023404; IPR002792; ,,miaB,DOMAIN 58 174 MTTase N-terminal. {ECO:0000255|HAMAP-Rule:MF_01864}.; DOMAIN 436 504 TRAM. {ECO:0000255|HAMAP-Rule:MF_01864}.,tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase (EC 2.8.4.3) ((Dimethylallyl)adenosine tRNA methylthiotransferase MiaB) (tRNA-i(6)A37 methylthiotransferase),"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; tRNA modification [GO:0006400]",9634230; 21969609,,"FUNCTION: Catalyzes the methylthiolation of N6-(dimethylallyl)adenosine (i(6)A), leading to the formation of 2-methylthio-N6-(dimethylallyl)adenosine (ms(2)i(6)A) at position 37 in tRNAs that read codons beginning with uridine. {ECO:0000255|HAMAP-Rule:MF_01864}.",MSSASPLARCCDEATPSAGPRAAQPPYHGPVTSMVAHDAAAGVTGEGAGPPVRRAPARTYQVRTYGCQMNVHDSERLAGLLEAAGYRRATDGSEADVVVFNTCAVRENADNRLYGNLSHLAPRKRANPDMQIAVGGCLAQKDRDAVLRRAPWVDVVFGTHNIGSLPTLLERARHNKVAQVEIAEALQQFPSSLPSSRESAYAAWVSISVGCNNSCTFCIVPSLRGREVDRSPADILAEVRSLVNDGVLEVTLLGQNVNAYGVSFADPALPRNRGAFAELLRACGDIDGLERVRFTSPHPAEFTDDVIEAMAQTRNVCPALHMPLQSGSDRILRAMRRSYRAERYLGIIERVRAAIPHAAITTDLIVGFPGETEEDFAATLDVVRRARFAAAFTFQYSKRPGTPAAQLDGQLPKAVVQERYERLIALQEQISLEANRALVGQAVEVLVATGEGRKDTVTARMSGRARDGRLVHFTAGQPRVRPGDVITTKVTEAAPHHLIADAGVLTHRRTRAGDAHTAGQPGRAVGLGMPGVGLPVSAAKPGGCR,"58,381",545,"Methylthiotransferase family, MiaB subfamily",tRNA modification [GO:0006400],"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]",cytoplasm [GO:0005737],,MTCY154.13c,2
P9WGF1,MMR_MYCTU,Rv3065,mmr Rv3065 MTCY22D7.17c,GO:0005887; GO:0015562; GO:0022857; GO:0046677; GO:0055085,IPR000390; ,,mmr,,Multidrug resistance protein Mmr,integral component of plasma membrane [GO:0005887]; efflux transmembrane transporter activity [GO:0015562]; transmembrane transporter activity [GO:0022857]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 9811672; 11574548,Model (1),"FUNCTION: Multidrug efflux pump. Confers resistance to tetraphenylphosphonium (TPP), erythromycin, ethidium bromide, acriflavine, safranin O, pyronin Y and methyl viologen. {ECO:0000269|PubMed:11574548, ECO:0000269|PubMed:9811672}.",MIYLYLLCAIFAEVVATSLLKSTEGFTRLWPTVGCLVGYGIAFALLALSISHGMQTDVAYALWSAIGTAAIVLVAVLFLGSPISVMKVVGVGLIVVGVVTLNLAGAH,"11,083",107,"Small multidrug resistance (SMR) protein family, Mmr (TC 2.A.7.1.2) subfamily",response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],efflux transmembrane transporter activity [GO:0015562]; transmembrane transporter activity [GO:0022857],integral component of plasma membrane [GO:0005887],,MTCY22D7.17c,1
P9WJS3,MOAA1_MYCTU,Rv3109,moaA1 moaA Rv3109 MTCY164.19,GO:0005525; GO:0005886; GO:0006777; GO:0019008; GO:0040007; GO:0046872; GO:0051539; GO:0061798,IPR013785; IPR006638; IPR034481; IPR013483; IPR000385; IPR010505; IPR007197; IPR034395; ,,moaA1,,"GTP 3',8-cyclase 1 (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A 1)","molybdopterin synthase complex [GO:0019008]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; growth [GO:0040007]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]",9634230; 20378651,,"FUNCTION: Catalyzes the cyclization of GTP to (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate. {ECO:0000255|HAMAP-Rule:MF_01225}.",MSTPTLPDMVAPSPRVRVKDRCRRMMGDLRLSVIDQCNLRCRYCMPEEHYTWLPRQDLLSVKEISAIVDVFLSVGVSKVRITGGEPLIRPDLPEIVRTLSAKVGEDSGLRDLAITTNGVLLADRVDGLKAAGMKRITVSLDTLQPERFKAISQRNSHDKVIAGIKAVAAAGFTDTKIDTTVMRGANHDELADLIEFARTVNAEVRFIEYMDVGGATHWAWEKVFTKANMLESLEKRYGRIEPLPKHDTAPANRYALPDGTTFGIIASTTEPFCATCDRSRLTADGLWLHCLYAISGINLREPLRAGATHDDLVETVTTGWRRRTDRGAEQRLAQRERGVFLPLSTLKADPHLEMHTRGG,"39,960",359,"Radical SAM superfamily, MoaA family",growth [GO:0040007]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],"4 iron, 4 sulfur cluster binding [GO:0051539]; GTP 3',8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]",molybdopterin synthase complex [GO:0019008]; plasma membrane [GO:0005886],moaA,MTCY164.19,1
P9WJU7,MMPL7_MYCTU,Rv2942,mmpL7 Rv2942 MTCY24G1.07c,GO:0005887; GO:0006855; GO:0006869; GO:0009405; GO:0044119; GO:0052572; GO:0071555,IPR004869; ,,mmpL7,,Phthiocerol dimycocerosate exporter MmpL7,integral component of plasma membrane [GO:0005887]; cell wall organization [GO:0071555]; drug transmembrane transport [GO:0006855]; growth of symbiont in host cell [GO:0044119]; lipid transport [GO:0006869]; pathogenesis [GO:0009405]; response to host immune response [GO:0052572],9634230; 10573420; 11279114; 16251328; 15908378; 16879801; 21969609,,"FUNCTION: Required for export of phthiocerol dimycocerosate (PDIM) to the cell wall (PubMed:10573420, PubMed:11279114). Essential for normal replication during the active-growth phase of the murine tuberculosis model (PubMed:15908378). {ECO:0000269|PubMed:10573420, ECO:0000269|PubMed:11279114, ECO:0000269|PubMed:15908378}.; FUNCTION: Confers a high level of resistance to isoniazid (INH) when overexpressed in M.smegmatis. {ECO:0000269|PubMed:16251328}.",MPSPAGRLHRIRYIRLKKSSPDCRATITSGSADGQRRSPRLTNLLVVAAWVAAAVIANLLLTFTQAEPHDTSPALLPQDAKTAAATSRIAQAFPGTGSNAIAYLVVEGGSTLEPQDQPYYDAAVGALRADTRHVGSVLDWWSDPVTAPLGTSPDGRSATAMVWLRGEAGTTQAAESLDAVRSVLRQLPPSEGLRASIVVPAITNDMPMQITAWQSATIVTVAAVIAVLLLLRARLSVRAAAIVLLTADLSLAVAWPLAAVVRGHDWGTDSVFSWTLAAVLTIGTITAATMLAARLGSDAGHSAAPTYRDSLPAFALPGACVAIFTGPLLLARTPALHGVGTAGLGVFVALAASLTVLPALIALAGASRQLPAPTTGAGWTGRLSLPVSSASALGTAAVLAICMLPIIGMRWGVAENPTRQGGAQVLPGNALPDVVVIKSARDLRDPAALIAINQVSHRLVEVPGVRKVESAAWPAGVPWTDASLSSAAGRLADQLGQQAGSFVPAVTAIKSMKSIIEQMSGAVDQLDSTVNVTLAGARQAQQYLDPMLAAARNLKNKTTELSEYLETIHTWIVGFTNCPDDVLCTAMRKVIEPYDIVVTGMNELSTGADRISAISTQTMSALSSAPRMVAQMRSALAQVRSFVPKLETTIQDAMPQIAQASAMLKNLSADFADTGEGGFHLSRKDLADPSYRHVRESMFSSDGTATRLFLYSDGQLDLAAAARAQQLEIAAGKAMKYGSLVDSQVTVGGAAQIAAAVRDALIHDAVLLAVILLTVVALASMWRGAVHGAAVGVGVLASYLAALGVSIALWQHLLDRELNALVPLVSFAVLASCGVPYLVAGIKAGRIADEATGARSKGAVSGRGAVAPLAALGGVFGAGLVLVSGGSFSVLSQIGTVVVLGLGVLITVQRAWLPTTPGRR,"95,122",920,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",cell wall organization [GO:0071555]; drug transmembrane transport [GO:0006855]; growth of symbiont in host cell [GO:0044119]; lipid transport [GO:0006869]; pathogenesis [GO:0009405]; response to host immune response [GO:0052572],,integral component of plasma membrane [GO:0005887],,MTCY24G1.07c,1
P9WJS5,MNMA_MYCTU,Rv3024c,mnmA trmU Rv3024c MTV012.39c,GO:0000049; GO:0005524; GO:0005737; GO:0008033; GO:0016783,IPR023382; IPR014729; IPR004506; ,,mnmA,,tRNA-specific 2-thiouridylase MnmA (EC 2.8.1.13),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; tRNA processing [GO:0008033],9634230; 21969609,,"FUNCTION: Catalyzes the 2-thiolation of uridine at the wobble position (U34) of tRNA, leading to the formation of s(2)U34. {ECO:0000255|HAMAP-Rule:MF_00144}.",MKVLAAMSGGVDSSVAAARMVDAGHEVVGVHMALSTAPGTLRTGSRGCCSKEDAADARRVADVLGIPFYVWDFAEKFKEDVINDFVSSYARGETPNPCVRCNQQIKFAALSARAVALGFDTVATGHYARLSGGRLRRAVDRDKDQSYVLAVLTAQQLRHAAFPIGDTPKRQIRAEAARRGLAVANKPDSHDICFIPSGNTKAFLGERIGVRRGVVVDADGVVLASHDGVHGFTIGQRRGLGIAGPGPNGRPRYVTAIDADTATVHVGDVTDLDVQTLTGRAPVFTAGAAPSGPVDCVVQVRAHGETVSAVAELIGDALFVQLHAPLRGVARGQTLVLYRPDPAGDEVLGSATIAGASGLSTGGNPGA,"38,120",367,MnmA/TRMU family,tRNA processing [GO:0008033],ATP binding [GO:0005524]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049],cytoplasm [GO:0005737],trmU,MTV012.39c,1
P9WNF7,MYMA_MYCTU,Rv3083,mymA Rv3083,GO:0004499; GO:0005618; GO:0010447; GO:0044119; GO:0050660; GO:0050661,IPR036188; IPR020946; ,,mymA,,Putative FAD-containing monooxygenase MymA (EC 1.14.13.-),"cell wall [GO:0005618]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447]",9634230; 14568148; 15937179; 16893682; 21969609,,FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. {ECO:0000269|PubMed:15937179}.,MNQHFDVLIIGAGLSGIGTACHVTAEFPDKTIALLERRERLGGTWDLFRYPGVRSDSDMFTFGYKFRPWRDVKVLADGASIRQYIADTATEFGVDEKIHYGLKVNTAEWSSRQCRWTVAGVHEATGETRTYTCDYLISCTGYYNYDAGYLPDFPGVHRFGGRCVHPQHWPEDLDYSGKKVVVIGSGATAVTLVPAMAGSNPGSAAHVTMLQRSPSYIFSLPAVDKISEVLGRFLPDRWVYEFGRRRNIAIQRKLYQACRRWPKLMRRLLLWEVRRRLGRSVDMSNFTPNYLPWDERLCAVPNGDLFKTLASGAASVVTDQIETFTEKGILCKSGREIEADIIVTATGLNIQMLGGMRLIVDGAEYQLPEKMTYKGVLLENAPNLAWIIGYTNASWTLKSDIAGAYLCRLLRHMADNGYTVATPRDAQDCALDVGMFDQLNSGYVKRGQDIMPRQGSKHPWRVLMHYEKDAKILLEDPIDDGVLHFAAAAQDHAAA,"55,482",495,FAD-binding monooxygenase family,growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",cell wall [GO:0005618],,,1
P71615,NRNA_MYCTU,Rv2837c,nrnA Rv2837c,GO:0003676; GO:0004527; GO:0008441; GO:0040007,IPR001667; IPR038763; IPR003156; ,,nrnA,,"Bifunctional oligoribonuclease and PAP phosphatase NrnA (EC 3.1.-.-) (3'(2'),5'-bisphosphate nucleotidase) (EC 3.1.3.7) (3'-phosphoadenosine 5'-phosphate phosphatase) (PAP phosphatase) (nanoRNase)","3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]; growth [GO:0040007]",9634230; 21969609; 22114320; 19099550,X-ray crystallography (2),"FUNCTION: Bifunctional enzyme which has both oligoribonuclease and pAp-phosphatase activities. Degrades RNA oligonucleotides with a length of 5 nucleotides and shorter, with a preference for 2-mers. Also degrades 24-mers. Converts 3'(2')-phosphoadenosine 5'-phosphate (PAP) to AMP. {ECO:0000269|PubMed:22114320}.",MTTIDPRSELVDGRRRAGARVDAVGAAALLSAAARVGVVCHVHPDADTIGAGLALALVLDGCGKRVEVSFAAPATLPESLRSLPGCHLLVRPEVMRRDVDLVVTVDIPSVDRLGALGDLTDSGRELLVIDHHASNDLFGTANFIDPSADSTTTMVAEILDAWGKPIDPRVAHCIYAGLATDTGSFRWASVRGYRLAARLVEIGVDNATVSRTLMDSHPFTWLPLLSRVLGSAQLVSEAVGGRGLVYVVVDNREWVAARSEEVESIVDIVRTTQQAEVAAVFKEVEPHRWSVSMRAKTVNLAAVASGFGGGGHRLAAGYTTTGSIDDAVASLRAALG,"35,415",336,NrnA oligoribonuclease family,growth [GO:0040007],"3'(2'),5'-bisphosphate nucleotidase activity [GO:0008441]; exonuclease activity [GO:0004527]; nucleic acid binding [GO:0003676]",,,,2
P9WIZ3,NRDI_MYCTU,Rv3052c,nrdI Rv3052c MTCY22D7.30,GO:0006464; GO:0010181,IPR029039; IPR020852; IPR004465; ,,nrdI,,Protein NrdI,FMN binding [GO:0010181]; cellular protein modification process [GO:0006464],9634230; 21969609,,FUNCTION: Probably involved in ribonucleotide reductase function. {ECO:0000250}.,MDIAGRSLVYFSSVSENTHRFVQKLGIPATRIPLHGRIEVDEPYVLILPTYGGGRANPGLDAGGYVPKQVIAFLNNDHNRAQLRGVIAAGNTNFGAEFCYAGDVVSRKCSVPYLYRFELMGTEDDVAAVRTGLAEFWKEQTCHQPSLQSL,"16,491",150,NrdI family,cellular protein modification process [GO:0006464],FMN binding [GO:0010181],,,MTCY22D7.30,1
P9WQ71,ISCSL_MYCTU,Rv3025c,iscS Rv3025c,GO:0008483; GO:0016226; GO:0031071; GO:0040007; GO:0046872; GO:0051536,IPR000192; IPR016454; IPR015424; IPR015422; IPR015421; ,,iscS,,IscS-like cysteine desulfurase (EC 2.8.1.7),cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; transaminase activity [GO:0008483]; growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226],9634230; 17609386; 21969609; 24548275,X-ray crystallography (1),"FUNCTION: Catalyzes the removal of elemental sulfur from cysteine to produce alanine (Probable). Participates in the biosynthesis of metalloclusters by providing the inorganic sulfur required for Fe-S core formation. One acceptor is Whib3, on which this enzyme assembles a 4Fe-4S cluster. It can use both L-cysteine and L-selenocysteine as substrates. {ECO:0000269|PubMed:17609386, ECO:0000269|PubMed:24548275}.",MAYLDHAATTPMHPAAIEAMAAVQRTIGNASSLHTSGRSARRRIEEARELIADKLGARPSEVIFTAGGTESDNLAVKGIYWARRDAEPHRRRIVTTEVEHHAVLDSVNWLVEHEGAHVTWLPTAADGSVSATALREALQSHDDVALVSVMWANNEVGTILPIAEMSVVAMEFGVPMHSDAIQAVGQLPLDFGASGLSAMSVAGHKFGGPPGVGALLLRRDVTCVPLMHGGGQERDIRSGTPDVASAVGMATAAQIAVDGLEENSARLRLLRDRLVEGVLAEIDDVCLNGADDPMRLAGNAHFTFRGCEGDALLMLLDANGIECSTGSACTAGVAQPSHVLIAMGVDAASARGSLRLSLGHTSVEADVDAALEVLPGAVARARRAALAAAGASR,"40,947",393,"Class-V pyridoxal-phosphate-dependent aminotransferase family, NifS/IscS subfamily",growth [GO:0040007]; iron-sulfur cluster assembly [GO:0016226],cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; transaminase activity [GO:0008483],,,,1
P9WG41,ILVB1_MYCTU,Rv3003c,ilvB1 Rv3003c MTV012.17c,GO:0000287; GO:0003984; GO:0005618; GO:0009082; GO:0009097; GO:0009099; GO:0030976; GO:0040007; GO:0050660,IPR012846; IPR029035; IPR029061; IPR012000; IPR012001; IPR000399; IPR011766; ,,ilvB1,,Acetolactate synthase large subunit IlvB1 (ALS) (EC 2.2.1.6) (Acetohydroxy-acid synthase large subunit) (AHAS),cell wall [GO:0005618]; acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; branched-chain amino acid biosynthetic process [GO:0009082]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 16111681; 18337064; 19542000; 20884690; 21969609,,"FUNCTION: Catalyzes the conversion of 2 pyruvate molecules into acetolactate in the first common step of the biosynthetic pathway of the branched-amino acids such as leucine, isoleucine, and valine. Also involved in condensing pyruvate and 2-ketobutyrate to form 2-aceto-2-hydroxybutyrate. {ECO:0000269|PubMed:16111681, ECO:0000269|PubMed:20884690}.",MSAPTKPHSPTFKPEPHSAANEPKHPAARPKHVALQQLTGAQAVIRSLEELGVDVIFGIPGGAVLPVYDPLFDSKKLRHVLVRHEQGAGHAASGYAHVTGRVGVCMATSGPGATNLVTPLADAQMDSIPVVAITGQVGRGLIGTDAFQEADISGITMPITKHNFLVRSGDDIPRVLAEAFHIAASGRPGAVLVDIPKDVLQGQCTFSWPPRMELPGYKPNTKPHSRQVREAAKLIAAARKPVLYVGGGVIRGEATEQLRELAELTGIPVVTTLMARGAFPDSHRQNLGMPGMHGTVAAVAALQRSDLLIALGTRFDDRVTGKLDSFAPEAKVIHADIDPAEIGKNRHADVPIVGDVKAVITELIAMLRHHHIPGTIEMADWWAYLNGVRKTYPLSYGPQSDGSLSPEYVIEKLGEIAGPDAVFVAGVGQHQMWAAQFIRYEKPRSWLNSGGLGTMGFAIPAAMGAKIALPGTEVWAIDGDGCFQMTNQELATCAVEGIPVKVALINNGNLGMVRQWQSLFYAERYSQTDLATHSHRIPDFVKLAEALGCVGLRCEREEDVVDVINQARAINDCPVVIDFIVGADAQVWPMVAAGTSNDEIQAARGIRPLFDDITEGHA,"66,123",618,TPP enzyme family,branched-chain amino acid biosynthetic process [GO:0009082]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase activity [GO:0003984]; flavin adenine dinucleotide binding [GO:0050660]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],cell wall [GO:0005618],,MTV012.17c,1
P9WKK1,IF2_MYCTU,Rv2839c,infB Rv2839c MTCY16B7.03,GO:0003743; GO:0003924; GO:0005525; GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0040007,IPR006847; IPR027417; IPR005225; IPR000795; IPR000178; IPR015760; IPR023115; IPR036925; IPR009000; ,,infB,DOMAIN 396 567 tr-type G.,Translation initiation factor IF-2,cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; growth [GO:0040007],9634230; 21969609,,FUNCTION: One of the essential components for the initiation of protein synthesis. Protects formylmethionyl-tRNA from spontaneous hydrolysis and promotes its binding to the 30S ribosomal subunits. Also involved in the hydrolysis of GTP during the formation of the 70S ribosomal complex (By similarity). {ECO:0000250}.,MAAGKARVHELAKELGVTSKEVLARLSEQGEFVKSASSTVEAPVARRLRESFGGSKPAPAKGTAKSPGKGPDKSLDKALDAAIDMAAGNGKATAAPAKAADSGGAAIVSPTTPAAPEPPTAVPPSPQAPHPGMAPGARPGPVPKPGIRTPRVGNNPFSSAQPADRPIPRPPAPRPGTARPGVPRPGASPGSMPPRPGGAVGGARPPRPGAPRPGGRPGAPGAGRSDAGGGNYRGGGVGAAPGTGFRGRPGGGGGGRPGQRGGAAGAFGRPGGAPRRGRKSKRQKRQEYDSMQAPVVGGVRLPHGNGETIRLARGASLSDFADKIDANPAALVQALFNLGEMVTATQSVGDETLELLGSEMNYNVQVVSPEDEDRELLESFDLSYGEDEGGEEDLQVRPPVVTVMGHVDHGKTRLLDTIRKANVREAEAGGITQHIGAYQVAVDLDGSQRLITFIDTPGHEAFTAMRARGAKATDIAILVVAADDGVMPQTVEAINHAQAADVPIVVAVNKIDKEGADPAKIRGQLTEYGLVPEEFGGDTMFVDISAKQGTNIEALEEAVLLTADAALDLRANPDMEAQGVAIEAHLDRGRGPVATVLVQRGTLRVGDSVVAGDAYGRVRRMVDEHGEDVEVALPSRPVQVIGFTSVPGAGDNFLVVDEDRIARQIADRRSARKRNALAARSRKRISLEDLDSALKETSQLNLILKGDNAGTVEALEEALMGIQVDDEVVLRVIDRGVGGITETNVNLASASDAVIIGFNVRAEGKATELASREGVEIRYYSVIYQAIDEIEQALRGLLKPIYEENQLGRAEIRALFRSSKVGLIAGCLVTSGVMRRNAKARLLRDNIVVAENLSIASLRREKDDVTEVRDGFECGLTLGYADIKEGDVIESYELVQKERA,"94,041",900,"TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, IF-2 subfamily",growth [GO:0040007],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743],cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY16B7.03,1
P9WKG3,ISPG_MYCTU,Rv2868c,ispG gcpE Rv2868c MTV003.14c,GO:0005506; GO:0005618; GO:0005886; GO:0016114; GO:0019288; GO:0046429; GO:0051539,IPR011005; IPR016425; IPR004588; ,,ispG,,4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (flavodoxin) (EC 1.17.7.3) (1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase activity [GO:0046429]; iron ion binding [GO:0005506]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]",9634230; 21969609,,"FUNCTION: Converts 2C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-2,4cPP) into 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate. {ECO:0000255|HAMAP-Rule:MF_00159}.",MTVGLGMPQPPAPTLAPRRATRQLMVGNVGVGSDHPVSVQSMCTTKTHDVNSTLQQIAELTAAGCDIVRVACPRQEDADALAEIARHSQIPVVADIHFQPRYIFAAIDAGCAAVRVNPGNIKEFDGRVGEVAKAAGAAGIPIRIGVNAGSLDKRFMEKYGKATPEALVESALWEASLFEEHGFGDIKISVKHNDPVVMVAAYELLAARCDYPLHLGVTEAGPAFQGTIKSAVAFGALLSRGIGDTIRVSLSAPPVEEVKVGNQVLESLNLRPRSLEIVSCPSCGRAQVDVYTLANEVTAGLDGLDVPLRVAVMGCVVNGPGEAREADLGVASGNGKGQIFVRGEVIKTVPEAQIVETLIEEAMRLAAEMGEQDPGATPSGSPIVTVS,"40,482",387,IspG family,"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process [GO:0016114]","4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase activity [GO:0046429]; 4 iron, 4 sulfur cluster binding [GO:0051539]; iron ion binding [GO:0005506]",cell wall [GO:0005618]; plasma membrane [GO:0005886],gcpE,MTV003.14c,1
P9WK65,LPPX_MYCTU,Rv2945c,lppX Rv2945c MTCY24G1.04,GO:0005319; GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0009986; GO:0044121; GO:0071770,IPR029046; IPR009830; ,,lppX,,Putative phthiocerol dimycocerosate transporter LppX (Lipoprotein LppX),cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid transporter activity [GO:0005319]; DIM/DIP cell wall layer assembly [GO:0071770]; growth of symbiont in host organelle [GO:0044121]; pathogenesis [GO:0009405],9634230; 10678905; 19661058; 21969609; 24093492; 16541102,X-ray crystallography (1),FUNCTION: Might be involved in translocating phthiocerol dimycocerosates (PDIM) from the cell membrane to the outer membrane; PDIM forms part of the cell wall. {ECO:0000305|PubMed:16541102}.,MNDGKRAVTSAVLVVLGACLALWLSGCSSPKPDAEEQGVPVSPTASDPALLAEIRQSLDATKGLTSVHVAVRTTGKVDSLLGITSADVDVRANPLAAKGVCTYNDEQGVPFRVQGDNISVKLFDDWSNLGSISELSTSRVLDPAAGVTQLLSGVTNLQAQGTEVIDGISTTKITGTIPASSVKMLDPGAKSARPATVWIAQDGSHHLVRASIDLGSGSIQLTQSKWNEPVNVD,"24,140",233,LppX/LprAFG lipoprotein family,DIM/DIP cell wall layer assembly [GO:0071770]; growth of symbiont in host organelle [GO:0044121]; pathogenesis [GO:0009405],lipid transporter activity [GO:0005319],cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY24G1.04,1
P9WK19,MAP12_MYCTU,Rv2861c,map mapB Rv2861c MTV003.07c,GO:0005506; GO:0006555; GO:0016151; GO:0030145; GO:0035551; GO:0050897; GO:0070006,IPR036005; IPR000994; IPR001714; IPR002467; ,,map,,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M),cobalt ion binding [GO:0050897]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; nickel cation binding [GO:0016151]; methionine metabolic process [GO:0006555]; protein initiator methionine removal involved in protein maturation [GO:0035551],9634230; 19688379; 21969609; 15882055; 20038112; 21465667,X-ray crystallography (15),"FUNCTION: Removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). Requires deformylation of the N(alpha)-formylated initiator methionine before it can be hydrolyzed. {ECO:0000255|HAMAP-Rule:MF_01974, ECO:0000269|PubMed:19688379, ECO:0000269|PubMed:20038112}.",MPSRTALSPGVLSPTRPVPNWIARPEYVGKPAAQEGSEPWVQTPEVIEKMRVAGRIAAGALAEAGKAVAPGVTTDELDRIAHEYLVDNGAYPSTLGYKGFPKSCCTSLNEVICHGIPDSTVITDGDIVNIDVTAYIGGVHGDTNATFPAGDVADEHRLLVDRTREATMRAINTVKPGRALSVIGRVIESYANRFGYNVVRDFTGHGIGTTFHNGLVVLHYDQPAVETIMQPGMTFTIEPMINLGALDYEIWDDGWTVVTKDRKWTAQFEHTLLVTDTGVEILTCL,"30,891",285,"Peptidase M24A family, Methionine aminopeptidase type 1 subfamily",methionine metabolic process [GO:0006555]; protein initiator methionine removal involved in protein maturation [GO:0035551],cobalt ion binding [GO:0050897]; iron ion binding [GO:0005506]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; nickel cation binding [GO:0016151],,mapB,MTV003.07c,1
P0CL61,MAZE9_MYCTU,Rv2801A,mazE9 mazE-mt1 Rv2801A,GO:0045927; GO:0097351,,,mazE9,,Antitoxin MazE9,toxin-antitoxin pair type II binding [GO:0097351]; positive regulation of growth [GO:0045927],9634230; 15718296; 16611633; 19016878; 20011113; 20876537; 25608501,,"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and M.smegmatis neutralizes the effect of cognate toxin MazF9. {ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20876537}.",MKLSVSLSDDDVAILDAYVKRAGLPSRSAGLQHAIRVLRYPTLEDDYANAWQEWSAAGDTDAWEQTVGDGVGDAPR,"8,263",76,,positive regulation of growth [GO:0045927],toxin-antitoxin pair type II binding [GO:0097351],,mazE-mt1,,1
P71650,MAZF9_MYCTU,Rv2801c,mazF9 mazF-mt1 Rv2801c,GO:0003677; GO:0004521; GO:0006402; GO:0045926,IPR003477; IPR011067; ,,mazF9,,Endoribonuclease MazF9 (EC 3.1.-.-) (Toxin MazF9) (mRNA interferase MazF-mt1),DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926],9634230; 16611633; 19016878; 20011113; 20876537; 21969609; 25608501,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Upon expression in E.coli and M.smegmatis inhibits cell growth and colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin MazE9. Acts as an mRNA interferase, specifically cleaving between U and C in UAC sequences. May cleave its cognate antitoxin's gene (PubMed:25608501). In E.coli expression with non-cognate antitoxins VapB27 and VapB40 partially neutralizes the toxin. {ECO:0000269|PubMed:16611633, ECO:0000269|PubMed:19016878, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20876537, ECO:0000269|PubMed:25608501}.",MMRRGEIWQVDLDPARGSEANNQRPAVVVSNDRANATATRLGRGVITVVPVTSNIAKVYPFQVLLSATTTGLQVDCKAQAEQIRSIATERLLRPIGRVSAAELAQLDEALKLHLDLWS,"12,891",118,PemK/MazF family,mRNA catabolic process [GO:0006402]; negative regulation of growth [GO:0045926],DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521],,mazF-mt1,,2
P9WKJ3,ILVH_MYCTU,Rv3002c,ilvH ilvN Rv3002c MTV012.16c,GO:0003984; GO:0005618; GO:0005829; GO:0005886; GO:0005948; GO:0009097; GO:0009099; GO:0040007,IPR004789; IPR027271; IPR019455; IPR002912; ,,ilvH,DOMAIN 7 82 ACT. {ECO:0000255|PROSITE-ProRule:PRU01007}.,Putative acetolactate synthase small subunit (EC 2.2.1.6) (Acetohydroxy-acid synthase small subunit) (AHAS) (ALS),acetolactate synthase complex [GO:0005948]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; acetolactate synthase activity [GO:0003984]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 20066036; 20884690; 21969609,,"FUNCTION: Catalyzes the conversion of 2 pyruvate molecules into acetolactate in the first common step of the biosynthetic pathway of the branched-amino acids such as leucine, isoleucine, and valine. {ECO:0000250}.",MSPKTHTLSVLVEDKPGVLARVAALFSRRGFNIESLAVGATECKDRSRMTIVVSAEDTPLEQITKQLNKLINVIKIVEQDDEHSVSRELALIKVQADAGSRSQVIEAVNLFRANVIDVSPESLTVEATGNRGKLEALLRVLEPFGIREIAQSGMVSLSRGPRGIGTAK,"18,187",168,Acetolactate synthase small subunit family,growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase activity [GO:0003984],acetolactate synthase complex [GO:0005948]; cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ilvN,MTV012.16c,1
P9WKJ7,ILVC_MYCTU,Rv3001c,ilvC Rv3001c MTV012.15c,GO:0004455; GO:0005829; GO:0005886; GO:0009097; GO:0009099; GO:0040007; GO:0046872; GO:0050661,IPR008927; IPR013023; IPR000506; IPR013116; IPR014359; IPR036291; ,,ilvC,DOMAIN 3 183 KARI N-terminal Rossmann. {ECO:0000255|PROSITE-ProRule:PRU01197}.; DOMAIN 184 329 KARI C-terminal knotted. {ECO:0000255|PROSITE-ProRule:PRU01198}.,Ketol-acid reductoisomerase (NADP(+)) (KARI) (EC 1.1.1.86) (Acetohydroxy-acid isomeroreductase) (AHIR) (Alpha-keto-beta-hydroxylacyl reductoisomerase) (Ketol-acid reductoisomerase type 1) (Ketol-acid reductoisomerase type I),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ketol-acid reductoisomerase activity [GO:0004455]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 21969609; 26876563,X-ray crystallography (1),"FUNCTION: Involved in the biosynthesis of branched-chain amino acids (BCAA). Catalyzes an alkyl-migration followed by a ketol-acid reduction of (S)-2-acetolactate (S2AL) to yield (R)-2,3-dihydroxy-isovalerate. In the isomerase reaction, S2AL is rearranged via a Mg-dependent methyl migration to produce 3-hydroxy-3-methyl-2-ketobutyrate (HMKB). In the reductase reaction, this 2-ketoacid undergoes a metal-dependent reduction by NADPH to yield (R)-2,3-dihydroxy-isovalerate. It is also able to use 3-hydroxypyruvate (HP). {ECO:0000269|PubMed:26876563}.",MALEMFYDDDADLSIIQGRKVGVIGYGSQGHAHSLSLRDSGVQVRVGLKQGSRSRPKVEEQGLDVDTPAEVAKWADVVMVLAPDTAQAEIFAGDIEPNLKPGDALFFGHGLNVHFGLIKPPADVAVAMVAPKGPGHLVRRQFVDGKGVPCLVAVEQDPRGDGLALALSYAKAIGGTRAGVIKTTFKDETETDLFGEQTVLCGGTEELVKAGFEVMVEAGYPAELAYFEVLHELKLIVDLMYEGGLARMYYSVSDTAEFGGYLSGPRVIDAGTKERMRDILREIQDGSFVHKLVADVEGGNKQLEELRRQNAEHPIEVVGKKLRDLMSWVDRPITETA,"36,535",337,Ketol-acid reductoisomerase family,growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],ketol-acid reductoisomerase activity [GO:0004455]; metal ion binding [GO:0046872]; NADP binding [GO:0050661],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV012.15c,2
P9WPA5,COAD_MYCTU,Rv2965c,coaD kdtB Rv2965c MTCY349.22 u0002e,GO:0004595; GO:0005524; GO:0005737; GO:0015937; GO:0034214,IPR004821; IPR001980; IPR014729; ,,coaD,,Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937]; protein hexamerization [GO:0034214],9634230; 21969609; 15322293; 20851704; 21543857; 23151631; ,X-ray crystallography (11),"FUNCTION: Reversibly transfers an adenylyl group from ATP to 4'-phosphopantetheine, yielding dephospho-CoA (dPCoA) and pyrophosphate. {ECO:0000255|HAMAP-Rule:MF_00151, ECO:0000269|PubMed:20851704, ECO:0000269|Ref.5}.",MTGAVCPGSFDPVTLGHVDIFERAAAQFDEVVVAILVNPAKTGMFDLDERIAMVKESTTHLPNLRVQVGHGLVVDFVRSCGMTAIVKGLRTGTDFEYELQMAQMNKHIAGVDTFFVATAPRYSFVSSSLAKEVAMLGGDVSELLPEPVNRRLRDRLNTERT,"17,628",161,Bacterial CoaD family,coenzyme A biosynthetic process [GO:0015937]; protein hexamerization [GO:0034214],ATP binding [GO:0005524]; pantetheine-phosphate adenylyltransferase activity [GO:0004595],cytoplasm [GO:0005737],kdtB,MTCY349.22 u0002e,1
P9WMH7,CLGR_MYCTU,Rv2745c,clgR Rv2745c,GO:0003677; GO:0006351; GO:0006979; GO:0009408; GO:0010447; GO:0019217; GO:0043565; GO:0043620; GO:0044119; GO:0045893; GO:0052170; GO:0061136; GO:0085016; GO:0090062; GO:1902882,IPR001387; IPR010982; ,,clgR,DOMAIN 13 67 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Transcriptional regulator ClgR,"DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565]; dormancy exit of symbiont in host [GO:0085016]; growth of symbiont in host cell [GO:0044119]; negative regulation by symbiont of host innate immune response [GO:0052170]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of fatty acid metabolic process [GO:0019217]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of response to oxidative stress [GO:1902882]; regulation of trehalose metabolic process [GO:0090062]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",9634230; 11489128; 21969609,,"FUNCTION: Overexpression leads to expression of the clp regulon (ClpP1, ClpP2 and ClpC1). {ECO:0000250}.",MAALVREVVGDVLRGARMSQGRTLREVSDSARVSLGYLSEIERGRKEPSSELLSAICTALQLPLSVVLIDAGERMARQERLARATPAGRATGATIDASTKVVIAPVVSLAVA,"11,786",112,,"dormancy exit of symbiont in host [GO:0085016]; growth of symbiont in host cell [GO:0044119]; negative regulation by symbiont of host innate immune response [GO:0052170]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of fatty acid metabolic process [GO:0019217]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of response to oxidative stress [GO:1902882]; regulation of trehalose metabolic process [GO:0090062]; response to acidic pH [GO:0010447]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; sequence-specific DNA binding [GO:0043565],,,,1
P9WP83,COFC_MYCTU,Rv2983,cofC Rv2983,GO:0005525; GO:0009108; GO:0043814,IPR002835; IPR029044; ,,cofC,,2-phospho-L-lactate guanylyltransferase (LP guanylyltransferase) (EC 2.7.7.68),GTP binding [GO:0005525]; phospholactate guanylyltransferase activity [GO:0043814]; coenzyme biosynthetic process [GO:0009108],9634230; 21969609,,"FUNCTION: Guanylyltransferase that catalyzes the activation of 2-phospho-L-lactate (LP) as (2S)-lactyl-2-diphospho-5'-guanosine (LPPG), via the condensation of LP with GTP. Is involved in the biosynthesis of coenzyme F420, a hydride carrier cofactor. {ECO:0000255|HAMAP-Rule:MF_02114}.",MSGTPDDGDIGLIIAVKRLAAAKTRLAPVFSAQTRENVVLAMLVDTLTAAAGVGSLRSITVITPDEAAAAAAAGLGADVLADPTPEDDPDPLNTAITAAERVVAEGASNIVVLQGDLPALQTQELAEAISAARHHRRSFVADRLGTGTAVLCAFGTALHPRFGPDSSARHRRSGAVELTGAWPGLRCDVDTPADLTAARQLGVGPATARAVAHR,"21,819",214,CofC family,coenzyme biosynthetic process [GO:0009108],GTP binding [GO:0005525]; phospholactate guanylyltransferase activity [GO:0043814],,,,1
P9WPJ1,CAS6_MYCTU,Rv2824c,cas6 Rv2824c,GO:0004519; GO:0051607,IPR019267; IPR010156; ,,cas6,,CRISPR-associated endoribonuclease Cas6 (EC 3.1.-.-),endonuclease activity [GO:0004519]; defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Processes pre-crRNA into individual crRNA units (By similarity). {ECO:0000250}.",MAARRGGIRRTDLLRRSGQPRGRHRASAAESGLTWISPTLILVGFSHRGDRRMTEHLSRLTLTLEVDAPLERARVATLGPHLHGVLMESIPADYVQTLHTVPVNPYSQYALARSTTSLEWKISTLTNEARQQIVGPINDAAFAGFRLRASGIATQVTSRSLEQNPLSQFARIFYARPETRKFRVEFLTPTAFKQSGEYVFWPDPRLVFQSLAQKYGAIVDGEEPDPGLIAEFGQSVRLSAFRVASAPFAVGAARVPGFTGSATFTVRGVDTFASYIAALLWFGEFSGCGIKASMGMGAIRVQPLAPREKCVPKP,"34,432",314,CRISPR-associated protein Cas6/Cse3/CasE family,defense response to virus [GO:0051607],endonuclease activity [GO:0004519],,,,1
O33283,EPHG_MYCTU,Rv2740,ephG Rv2740,GO:0004301; GO:0005886; GO:0033963; GO:0097176,IPR013100; IPR032710; ,,ephG,,"Epoxide hydrolase EphG (EH) (EC 3.3.2.10) (Cholesterol-5,6-oxide hydrolase) (EC 3.3.2.11)","plasma membrane [GO:0005886]; cholesterol-5,6-oxide hydrolase activity [GO:0033963]; epoxide hydrolase activity [GO:0004301]; epoxide metabolic process [GO:0097176]",9634230; 21969609; 16051262,X-ray crystallography (1),"FUNCTION: Epoxide hydrolase capable of hydrolyzing long or bulky lipophilic epoxides such as 9,10-epoxystearic acid and cholesterol 5,6-oxide in vitro. The physiological substrates have yet to be identified, but could be fatty acid or steroid derivatives. {ECO:0000269|PubMed:16051262}.",MAELTETSPETPETTEAIRAVEAFLNALQNEDFDTVDAALGDDLVYENVGFSRIRGGRRTATLLRRMQGRVGFEVKIHRIGADGAAVLTERTDALIIGPLRVQFWVCGVFEVDDGRITLWRDYFDVYDMFKGLLRGLVALVVPSLKATL,"16,593",149,"Limonene-1,2-epoxide hydrolase family",epoxide metabolic process [GO:0097176],"cholesterol-5,6-oxide hydrolase activity [GO:0033963]; epoxide hydrolase activity [GO:0004301]",plasma membrane [GO:0005886],,,1
P9WNJ1,ESXQ_MYCTU,Rv3017c,esxQ Rv3017c MTV012.31c,GO:0005576,IPR036689; ,,esxQ,,ESAT-6-like protein EsxQ,extracellular region [GO:0005576],9634230; 19876390,,,MSQSMYSYPAMTANVGDMAGYTGTTQSLGADIASERTAPSRACQGDLGMSHQDWQAQWNQAMEALARAYRRCRRALRQIGVLERPVGDSSDCGTIRVGSFRGRWLDPRHAGPATAADAGD,"12,954",120,"WXG100 family, ESAT-6 subfamily",,,extracellular region [GO:0005576],,MTV012.31c,1
P9WNI9,ESXR_MYCTU,Rv3019c,esxR Rv3019c MTV012.33c,GO:0005576; GO:0032991,IPR036689; IPR010310; ,,esxR,,ESAT-6-like protein EsxR (TB10.3),extracellular region [GO:0005576]; protein-containing complex [GO:0032991],9634230; 15336430; 19876390; 20629176,X-ray crystallography (1),,MSQIMYNYPAMMAHAGDMAGYAGTLQSLGADIASEQAVLSSAWQGDTGITYQGWQTQWNQALEDLVRAYQSMSGTHESNTMAMLARDGAEAAKWGG,"10,312",96,"WXG100 family, ESAT-6 subfamily",,,extracellular region [GO:0005576]; protein-containing complex [GO:0032991],,MTV012.33c,1
P9WN59,GATC_MYCTU,Rv3012c,gatC Rv3012c MTV012.26c,GO:0005524; GO:0005618; GO:0006412; GO:0006450; GO:0016874,IPR003837; IPR036113; ,,gatC,,Glutamyl-tRNA(Gln) amidotransferase subunit C (Glu-ADT subunit C) (EC 6.3.5.-),cell wall [GO:0005618]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Allows the formation of correctly charged Asn-tRNA(Asn) or Gln-tRNA(Gln) through the transamidation of misacylated Asp-tRNA(Asn) or Glu-tRNA(Gln) in organisms which lack either or both of asparaginyl-tRNA or glutaminyl-tRNA synthetases. The reaction takes place in the presence of glutamine and ATP through an activated phospho-Asp-tRNA(Asn) or phospho-Glu-tRNA(Gln) (By similarity). {ECO:0000250}.,MSQISRDEVAHLARLARLALTETELDSFAGQLDAILTHVSQIQAVDVTGVQATDNPLKDVNVTRPDETVPCLTQRQVLDQAPDAVDGRFAVPQILGDEQ,"10,748",99,GatC family,regulation of translational fidelity [GO:0006450]; translation [GO:0006412],ATP binding [GO:0005524]; ligase activity [GO:0016874],cell wall [GO:0005618],,MTV012.26c,1
P9WMY9,GLGSY_MYCTU,Rv3032,Rv3032,GO:0004373; GO:0005978; GO:0009103; GO:0016757; GO:0040007,IPR001296; IPR028098; ,,,,"Glycogen synthase (EC 2.4.1.11) (Alpha-1,4-glucosyltransferase Rv3032) (UDP-glucose--glycogen glucosyltransferase)","glycogen (starch) synthase activity [GO:0004373]; transferase activity, transferring glycosyl groups [GO:0016757]; glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103]",9634230; 17640872; 18808383; 20305657; 21969609,,"FUNCTION: Glucosyltransferase that uses UDP-glucose as the sugar donor to elongate alpha-(1->4)-glucans. Is involved in the biosynthesis of both 6-O-methylglucosyl lipopolysaccharides (MGLP) and glycogen. May also use ADP-glucose as substrate. {ECO:0000269|PubMed:17640872, ECO:0000269|PubMed:18808383}.",MRILMVSWEYPPVVIGGLGRHVHHLSTALAAAGHDVVVLSRCPSGTDPSTHPSSDEVTEGVRVIAAAQDPHEFTFGNDMMAWTLAMGHAMIRAGLRLKKLGTDRSWRPDVVHAHDWLVAHPAIALAQFYDVPMVSTIHATEAGRHSGWVSGALSRQVHAVESWLVRESDSLITCSASMNDEITELFGPGLAEITVIRNGIDAARWPFAARRPRTGPAELLYVGRLEYEKGVHDAIAALPRLRRTHPGTTLTIAGEGTQQDWLIDQARKHRVLRATRFVGHLDHTELLALLHRADAAVLPSHYEPFGLVALEAAAAGTPLVTSNIGGLGEAVINGQTGVSCAPRDVAGLAAAVRSVLDDPAAAQRRARAARQRLTSDFDWQTVATATAQVYLAAKRGERQPQPRLPIVEHALPDR,"44,805",414,Glycosyltransferase group 1 family,glycogen biosynthetic process [GO:0005978]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103],"glycogen (starch) synthase activity [GO:0004373]; transferase activity, transferring glycosyl groups [GO:0016757]",,,,1
P9WG19,FTSX_MYCTU,Rv3101c,ftsX Rv3101c MTCY164.12c,GO:0005576; GO:0005618; GO:0005886; GO:0005887; GO:0007049; GO:0040007; GO:0051301,IPR003838; IPR004513; ,,ftsX,,Cell division protein FtsX,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007],8921846; 9634230; 21969609,X-ray crystallography (2),FUNCTION: Part of the ABC transporter FtsEX involved in cellular division. {ECO:0000250}.,MRFGFLLNEVLTGFRRNVTMTIAMILTTAISVGLFGGGMLVVRLADSSRAIYLDRVESQVFLTEDVSANDSSCDTTACKALREKIETRSDVKAVRFLNRQQAYDDAIRKFPQFKDVAGKDSFPASFIVKLENPEQHKDFDTAMKGQPGVLDVLNQKELIDRLFAVLDGLSNAAFAVALVQAIGAILLIANMVQVAAYTRRTEIGIMRLVGASRWYTQLPFLVEAMLAATMGVGIAVAGLMVVRALFLENALNQFYQANLIAKVDYADILFITPWLLLLGVAMSGLTAYLTLRLYVRR,"32,819",297,"ABC-4 integral membrane protein family, FtsX subfamily",cell cycle [GO:0007049]; cell division [GO:0051301]; growth [GO:0040007],,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY164.12c,1
P9WIQ3,FPRA_MYCTU,Rv3106,fprA Rv3106 MTCY164.16,GO:0004324; GO:0005618; GO:0005737; GO:0008860; GO:0050660; GO:0055114; GO:0070401,IPR036188; IPR023753; IPR021163; ,,fprA,,NADPH-ferredoxin reductase FprA (NFR) (EC 1.18.1.2),cell wall [GO:0005618]; cytoplasm [GO:0005737]; ferredoxin-NAD+ reductase activity [GO:0008860]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP+ binding [GO:0070401]; oxidation-reduction process [GO:0055114],9634230; 12071965; 12614197; 21969609; 12102623; 16846214,X-ray crystallography (3),FUNCTION: May serve as electron transfer protein and supply electrons to P450 systems.,MRPYYIAIVGSGPSAFFAAASLLKAADTTEDLDMAVDMLEMLPTPWGLVRSGVAPDHPKIKSISKQFEKTAEDPRFRFFGNVVVGEHVQPGELSERYDAVIYAVGAQSDRMLNIPGEDLPGSIAAVDFVGWYNAHPHFEQVSPDLSGARAVVIGNGNVALDVARILLTDPDVLARTDIADHALESLRPRGIQEVVIVGRRGPLQAAFTTLELRELADLDGVDVVIDPAELDGITDEDAAAVGKVCKQNIKVLRGYADREPRPGHRRMVFRFLTSPIEIKGKRKVERIVLGRNELVSDGSGRVAAKDTGEREELPAQLVVRSVGYRGVPTPGLPFDDQSGTIPNVGGRINGSPNEYVVGWIKRGPTGVIGTNKKDAQDTVDTLIKNLGNAKEGAECKSFPEDHADQVADWLAARQPKLVTSAHWQVIDAFERAAGEPHGRPRVKLASLAELLRIGLG,"49,341",456,Ferredoxin--NADP reductase type 1 family,oxidation-reduction process [GO:0055114],ferredoxin-NAD+ reductase activity [GO:0008860]; ferredoxin-NADP+ reductase activity [GO:0004324]; flavin adenine dinucleotide binding [GO:0050660]; NADP+ binding [GO:0070401],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY164.16,1
P9WN61,GATB_MYCTU,Rv3009c,gatB Rv3009c MTV012.23c,GO:0005524; GO:0005886; GO:0006412; GO:0040007; GO:0050567; GO:0070681,IPR004413; IPR017959; IPR006075; IPR018027; IPR003789; IPR023168; IPR017958; IPR014746; ,,gatB,,Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B (Asp/Glu-ADT subunit B) (EC 6.3.5.-),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Allows the formation of correctly charged Asn-tRNA(Asn) or Gln-tRNA(Gln) through the transamidation of misacylated Asp-tRNA(Asn) or Glu-tRNA(Gln) in organisms which lack either or both of asparaginyl-tRNA or glutaminyl-tRNA synthetases. The reaction takes place in the presence of glutamine and ATP through an activated phospho-Asp-tRNA(Asn) or phospho-Glu-tRNA(Gln) (By similarity). {ECO:0000250}.,MTVAAGAAKAAGAELLDYDEVVARFQPVLGLEVHVELSTATKMFCGCTTTFGGEPNTQVCPVCLGLPGSLPVLNRAAVESAIRIGLALNCEIVPWCRFARKNYFYPDMPKNYQISQYDEPIAINGYLDAPLEDGTTWRVEIERAHMEEDTGKLTHIGSETGRIHGATGSLIDYNRAGVPLIEIVTKPIVGAGARAPQIARSYVTALRDLLRALDVSDVRMDQGSMRCDANVSLKPAGTTEFGTRTETKNVNSLKSVEVAVRYEMQRQGAILASGGRITQETRHFHEAGYTSAGRTKETAEDYRYFPEPDLEPVAPSRELVERLRQTIPELPWLSRRRIQQEWGVSDEVMRDLVNAGAVELVAATVEHGASSEAARAWWGNFLAQKANEAGIGLDELAITPAQVAAVVALVDEGKLSNSLARQVVEGVLAGEGEPEQVMTARGLALVRDDSLTQAAVDEALAANPDVADKIRGGKVAAAGAIVGAVMKATRGQADAARVRELVLEACGQG,"54,633",509,"GatB/GatE family, GatB subfamily",glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; growth [GO:0040007]; translation [GO:0006412],ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567],plasma membrane [GO:0005886],,MTV012.23c,1
P9WNC3,FPG1_MYCTU,Rv2924c,fpg1 mutM Rv2924c MTCY338.13c,GO:0003684; GO:0003690; GO:0005886; GO:0006281; GO:0006284; GO:0006289; GO:0006979; GO:0008270; GO:0008534; GO:0034039; GO:0140078,IPR015886; IPR015887; IPR020629; IPR012319; IPR035937; IPR010979; IPR000214; IPR010663; ,,fpg1,,Formamidopyrimidine-DNA glycosylase 1 (Fapy-DNA glycosylase 1) (EC 3.2.2.23) (DNA-(apurinic or apyrimidinic site) lyase MutM 1) (AP lyase MutM 1) (EC 4.2.99.18),"plasma membrane [GO:0005886]; 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979]",9634230; 17698424; 19496823; 20031487; 21969609; 21764637,,"FUNCTION: Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. Acts as DNA glycosylase that recognizes and removes damaged bases. Has a preference for oxidized purines, such as 7,8-dihydro-8-oxoguanine (8-oxoG) when paired with C, G or T, as well as methyl-faPy (formanidopyrimidine residues) in poly(dG-dC) and spiroiminodihydantoin:C base pairs. Unlike its E.coli ortholog has no activity on 8-oxoG:A. Has AP (apurinic/apyrimidinic) lyase activity and introduces nicks in the DNA strand. Cleaves the DNA backbone by beta-delta elimination to generate a single-strand break at the site of the removed base with both 3'- and 5'-phosphates. Cleaves ssDNA containing an AP site. Complements the H(2)O(2) sensitivity of an M.smegmatis fpg disruption mutant; upon expression in M.smegmatis excises 8-oxoG from dsDNA. {ECO:0000269|PubMed:17698424, ECO:0000269|PubMed:19496823, ECO:0000269|PubMed:20031487}.",MPELPEVEVVRRGLQAHVTGRTITEVRVHHPRAVRRHDAGPADLTARLRGARINGTDRRGKYLWLTLNTAGVHRPTDTALVVHLGMSGQMLLGAVPCAAHVRISALLDDGTVLSFADQRTFGGWLLADLVTVDGSVVPVPVAHLARDPLDPRFDCDAVVKVLRRKHSELKRQLLDQRVVSGIGNIYADEALWRAKVNGAHVAATLRCRRLGAVLHAAADVMREALAKGGTSFDSLYVNVNGESGYFERSLDAYGREGENCRRCGAVIRRERFMNRSSFYCPRCQPRPRK,"31,951",289,FPG family,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289]; response to oxidative stress [GO:0006979],"8-oxo-7,8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; zinc ion binding [GO:0008270]",plasma membrane [GO:0005886],mutM,MTCY338.13c,1
O05779,FTSE_MYCTU,Rv3102c RVBD_3102c LH57_16935,ftsE Rv3102c RVBD_3102c LH57_16935 P425_03233,GO:0000287; GO:0005524; GO:0005886; GO:0007049; GO:0016887; GO:0030145; GO:0051301,IPR003593; IPR003439; IPR017871; IPR005286; IPR027417; ,,ftsE,DOMAIN 3 228 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Cell division ATP-binding protein FtsE,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; cell cycle [GO:0007049]; cell division [GO:0051301],9634230; 8921846; 21969609,,"FUNCTION: Part of the ABC transporter FtsEX involved in cellular division. Has ATPase activity. {ECO:0000250|UniProtKB:A5U7B7, ECO:0000250|UniProtKB:P0A9R7}.",MMITLDHVTKQYKSSARPALDDINVKIDKGEFVFLIGPSGSGKSTFMRLLLAAETPTSGDVRVSKFHVNKLRGRHVPKLRQVIGCVFQDFRLLQQKTVYDNVAFALEVIGKRTDAINRVVPEVLETVGLSGKANRLPDELSGGEQQRVAIARAFVNRPLVLLADEPTGNLDPETSRDIMDLLERINRTGTTVLMATHDHHIVDSMRQRVVELSLGRLVRDEQRGVYGMDR,"25,728",230,ABC transporter superfamily,cell cycle [GO:0007049]; cell division [GO:0051301],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],plasma membrane [GO:0005886],,P425_03233,2
P9WP19,DAPF_MYCTU,Rv2726c,dapF Rv2726c MTCY154.06c,GO:0005829; GO:0005886; GO:0008837; GO:0009089; GO:0040007,IPR018510; IPR001653; ,,dapF,,Diaminopimelate epimerase (DAP epimerase) (EC 5.1.1.7) (PLP-independent amino acid racemase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; diaminopimelate epimerase activity [GO:0008837]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],9634230; 19099550; 16907737; 18269631; 21969609; 19307721,X-ray crystallography (1),"FUNCTION: Catalyzes the stereoinversion of LL-2,6-diaminoheptanedioate (L,L-DAP) to meso-diaminoheptanedioate (meso-DAP), a precursor of L-lysine and an essential component of the bacterial peptidoglycan. {ECO:0000269|PubMed:16907737, ECO:0000269|PubMed:18269631}.",MIFAKGHGTQNDFVLLPDVDAELVLTAARVAALCDRRKGLGADGVLRVTTAGAAQAVGVLDSLPEGVRVTDWYMDYRNADGSAAQMCGNGVRVFAHYLRASGLEVRDEFVVGSLAGPRPVTCHHVEAAYADVSVDMGKANRLGAGEAVVGGRRFHGLAVDVGNPHLACVDSQLTVDGLAALDVGAPVSFDGAQFPDGVNVEVLTAPVDGAVWMRVHERGVGETRSCGTGTVAAAVAALAAVGSPTGTLTVHVPGGEVVVTVTDATSFLRGPSVLVARGDLADDWWNAMG,"29,698",289,Diaminopimelate epimerase family,growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],diaminopimelate epimerase activity [GO:0008837],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY154.06c,1
P9WP25,DAPA_MYCTU,Rv2753c,dapA Rv2753c MTV002.18c,GO:0005737; GO:0005886; GO:0008840; GO:0009089; GO:0019877; GO:0040007,IPR013785; IPR005263; IPR002220; IPR020625; IPR020624; ,,dapA,,4-hydroxy-tetrahydrodipicolinate synthase (HTPA synthase) (EC 4.3.3.7),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 4-hydroxy-tetrahydrodipicolinate synthase [GO:0008840]; diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],9634230; 19099550; 17077492; 21969609; 18062777; 21672512,X-ray crystallography (3),FUNCTION: Catalyzes the condensation of (S)-aspartate-beta-semialdehyde [(S)-ASA] and pyruvate to 4-hydroxy-tetrahydrodipicolinate (HTPA). {ECO:0000305|PubMed:18062777}.,MTTVGFDVAARLGTLLTAMVTPFSGDGSLDTATAARLANHLVDQGCDGLVVSGTTGESPTTTDGEKIELLRAVLEAVGDRARVIAGAGTYDTAHSIRLAKACAAEGAHGLLVVTPYYSKPPQRGLQAHFTAVADATELPMLLYDIPGRSAVPIEPDTIRALASHPNIVGVKDAKADLHSGAQIMADTGLAYYSGDDALNLPWLAMGATGFISVIAHLAAGQLRELLSAFGSGDIATARKINIAVAPLCNAMSRLGGVTLSKAGLRLQGIDVGDPRLPQVAATPEQIDALAADMRAASVLR,"30,858",300,DapA family,diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089],4-hydroxy-tetrahydrodipicolinate synthase [GO:0008840],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV002.18c,1
P9WP23,DAPB_MYCTU,Rv2773c,dapB Rv2773c MTV002.38c,GO:0005618; GO:0005829; GO:0005886; GO:0008839; GO:0009089; GO:0019877; GO:0070402; GO:0070404,IPR022663; IPR000846; IPR022664; IPR023940; IPR036291; ,,dapB,,4-hydroxy-tetrahydrodipicolinate reductase (HTPA reductase) (EC 1.17.1.8),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089],9098082; 9634230; 16511139; 21969609; 12962488; 20057050,X-ray crystallography (9),"FUNCTION: Catalyzes the conversion of 4-hydroxy-tetrahydrodipicolinate (HTPA) to tetrahydrodipicolinate (Probable). Can use both NADH and NADPH as a reductant, with NADH being 6-fold as effective as NADPH. {ECO:0000255|HAMAP-Rule:MF_00102, ECO:0000269|PubMed:12962488, ECO:0000305}.",MRVGVLGAKGKVGATMVRAVAAADDLTLSAELDAGDPLSLLTDGNTEVVIDFTHPDVVMGNLEFLIDNGIHAVVGTTGFTAERFQQVESWLVAKPNTSVLIAPNFAIGAVLSMHFAKQAARFFDSAEVIELHHPHKADAPSGTAARTAKLIAEARKGLPPNPDATSTSLPGARGADVDGIPVHAVRLAGLVAHQEVLFGTEGETLTIRHDSLDRTSFVPGVLLAVRRIAERPGLTVGLEPLLDLH,"25,733",245,DapB family,diaminopimelate biosynthetic process [GO:0019877]; lysine biosynthetic process via diaminopimelate [GO:0009089],4-hydroxy-tetrahydrodipicolinate reductase [GO:0008839]; NADH binding [GO:0070404]; NADPH binding [GO:0070402],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV002.38c,1
P9WMK7,DBH_MYCTU,Rv2986c,hup hlp hupB lbp21 Rv2986c MTCY349.01,GO:0000976; GO:0001216; GO:0003684; GO:0003690; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0010106; GO:0030261; GO:0032993; GO:0040007; GO:0042262; GO:0045893; GO:0090143; GO:0097100,IPR000119; IPR020816; IPR010992; ,,hup,,DNA-binding protein HU homolog (21 kDa laminin-2-binding protein) (28 kDa iron-regulated protein) (Irep-28) (Histone-like protein) (Hlp),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding [GO:0001216]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; supercoiled DNA binding [GO:0097100]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to iron ion starvation [GO:0010106]; chromosome condensation [GO:0030261]; DNA protection [GO:0042262]; growth [GO:0040007]; nucleoid organization [GO:0090143]; positive regulation of transcription, DNA-templated [GO:0045893]",10569769; 9634230; 12438350; 17028216; 10645441; 19099550; 21969609,X-ray crystallography (2),"FUNCTION: Histone-like DNA-binding protein which is capable of wrapping DNA to stabilize it, and thus to prevent its denaturation under extreme environmental conditions. Binds DNA non-specifically. Induces lymphoproliferation, particularly in health tuberculin reactors, and is immunogenic. Maybe involved in pathogenesis of inflammatory bowel disease (IBD) in patients with ulcerative colitis and Crohn disease (CD). Bound by anti-neutrophil cytoplasmic antibodies (pANCA), which are a hallmark of IBD. The binding is due to pANCA directed against HIST1H1D cross-reacting with DBH epitopes. In CD, target of a strong IgA response. {ECO:0000269|PubMed:10569769, ECO:0000269|PubMed:10645441}.",MNKAELIDVLTQKLGSDRRQATAAVENVVDTIVRAVHKGDSVTITGFGVFEQRRRAARVARNPRTGETVKVKPTSVPAFRPGAQFKAVVSGAQRLPAEGPAVKRGVGASAAKKVAKKAPAKKATKAAKKAATKAPARKAATKAPAKKAATKAPAKKAVKATKSPAKKVTKAVKKTAVKASVRKAATKAPAKKAAAKRPATKAPAKKATARRGRK,"22,187",214,Bacterial histone-like protein family,"cellular response to iron ion starvation [GO:0010106]; chromosome condensation [GO:0030261]; DNA protection [GO:0042262]; growth [GO:0040007]; nucleoid organization [GO:0090143]; positive regulation of transcription, DNA-templated [GO:0045893]","bacterial-type RNA polymerase transcriptional activator activity, sequence-specific DNA binding [GO:0001216]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; supercoiled DNA binding [GO:0097100]; transcription regulatory region sequence-specific DNA binding [GO:0000976]",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993],hlp hupB lbp21,MTCY349.01,1
P9WP31,DDL_MYCTU,Rv2981c,ddl ddlA Rv2981c MTCY349.06,GO:0005524; GO:0005737; GO:0005886; GO:0008360; GO:0008716; GO:0009252; GO:0040007; GO:0046872; GO:0071555,IPR011761; IPR013815; IPR000291; IPR005905; IPR011095; IPR011127; IPR016185; ,,ddl,DOMAIN 156 363 ATP-grasp. {ECO:0000255|HAMAP-Rule:MF_00047}.,D-alanine--D-alanine ligase (EC 6.3.2.4) (D-Ala-D-Ala ligase) (D-alanine:D-alanine ligase) (D-alanylalanine synthetase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872]; cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],9634230; 21969609; 23286234; 20956591,X-ray crystallography (1),"FUNCTION: Catalyzes the ATP-driven ligation of two D-alanine molecules to form the D-alanyl-D-alanine dipeptide. This molecule is a key building block in peptidoglycan biosynthesis. {ECO:0000255|HAMAP-Rule:MF_00047, ECO:0000269|PubMed:20956591, ECO:0000269|PubMed:23286234}.",MSANDRRDRRVRVAVVFGGRSNEHAISCVSAGSILRNLDSRRFDVIAVGITPAGSWVLTDANPDALTITNRELPQVKSGSGTELALPADPRRGGQLVSLPPGAGEVLESVDVVFPVLHGPYGEDGTIQGLLELAGVPYVGAGVLASAVGMDKEFTKKLLAADGLPVGAYAVLRPPRSTLHRQECERLGLPVFVKPARGGSSIGVSRVSSWDQLPAAVARARRHDPKVIVEAAISGRELECGVLEMPDGTLEASTLGEIRVAGVRGREDSFYDFATKYLDDAAELDVPAKVDDQVAEAIRQLAIRAFAAIDCRGLARVDFFLTDDGPVINEINTMPGFTTISMYPRMWAASGVDYPTLLATMIETTLARGVGLH,"39,710",373,D-alanine--D-alanine ligase family,cell wall organization [GO:0071555]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360],ATP binding [GO:0005524]; D-alanine-D-alanine ligase activity [GO:0008716]; metal ion binding [GO:0046872],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],ddlA,MTCY349.06,1
P9WQB1,DHA_MYCTU,Rv2780,ald Rv2780 MTV002.45,GO:0000166; GO:0000286; GO:0001666; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006524; GO:0042853; GO:0046872,IPR008141; IPR008143; IPR008142; IPR007886; IPR007698; IPR036291; ,,ald,,Alanine dehydrogenase (EC 1.4.1.1) (40 kDa antigen) (TB43),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; alanine dehydrogenase activity [GO:0000286]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; alanine catabolic process [GO:0006524]; L-alanine catabolic process [GO:0042853]; response to hypoxia [GO:0001666],1587598; 9634230; 7822223; 10527947; 11929527; 21969609; 18304579; 18491387,X-ray crystallography (7),"FUNCTION: Catalyzes the reversible reductive amination of pyruvate to L-alanine. However, since the physiological environment of M.tuberculosis has a neutral pH, it can be assumed that the enzyme catalyzes exclusively the formation of L-alanine. May play a role in cell wall synthesis as L-alanine is an important constituent of the peptidoglycan layer. {ECO:0000269|PubMed:10527947}.",MRVGIPTETKNNEFRVAITPAGVAELTRRGHEVLIQAGAGEGSAITDADFKAAGAQLVGTADQVWADADLLLKVKEPIAAEYGRLRHGQILFTFLHLAASRACTDALLDSGTTSIAYETVQTADGALPLLAPMSEVAGRLAAQVGAYHLMRTQGGRGVLMGGVPGVEPADVVVIGAGTAGYNAARIANGMGATVTVLDINIDKLRQLDAEFCGRIHTRYSSAYELEGAVKRADLVIGAVLVPGAKAPKLVSNSLVAHMKPGAVLVDIAIDQGGCFEGSRPTTYDHPTFAVHDTLFYCVANMPASVPKTSTYALTNATMPYVLELADHGWRAACRSNPALAKGLSTHEGALLSERVATDLGVPFTEPASVLA,"38,713",371,AlaDH/PNT family,alanine catabolic process [GO:0006524]; L-alanine catabolic process [GO:0042853]; response to hypoxia [GO:0001666],alanine dehydrogenase activity [GO:0000286]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV002.45,1
P9WG63,DIPZ_MYCTU,Rv2874,dipZ Rv2874 MTCY274.05,GO:0005886; GO:0016021; GO:0016209; GO:0016491; GO:0017004; GO:0045454,IPR000866; IPR003834; IPR008979; IPR036249; IPR013766; ,,dipZ,DOMAIN 394 542 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Protein DipZ,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491]; cell redox homeostasis [GO:0045454]; cytochrome complex assembly [GO:0017004],9634230,X-ray crystallography (2),,MVESRRAAAAASAYASRCGIAPATSQRSLATPPTISVPSGEGRCRCHVARGAGRDPRRRLRRRRWCGRCGYHSHLTGGEFDVNRLCQQRSRERSCQLVAVPADPRPKRQRITDVLTLALVGFLGGLITGISPCILPVLPVIFFSGAQSVDAAQVAKPEGAVAVRRKRALSATLRPYRVIGGLVLSFGMVTLLGSALLSVLHLPQDAIRWAALVALVAIGAGLIFPRFEQLLEKPFSRIPQKQIVTRSNGFGLGLALGVLYVPCAGPILAAIVVAGATATIGLGTVVLTATFALGAALPLLFFALAGQRIAERVGAFRRRQREIRIATGSVTILLAVALVFDLPAALQRAIPDYTASLQQQISTGTEIREQLNLGGIVNAQNAQLSNCSDGAAQLESCGTAPDLKGITGWLNTPGNKPIDLKSLRGKVVLIDFWAYSCINCQRAIPHVVGWYQAYKDSGLAVIGVHTPEYAFEKVPGNVAKGAANLGISYPIALDNNYATWTNYRNRYWPAEYLIDATGTVRHIKFGEGDYNVTETLVRQLLNDAKPGVKLPQPSSTTTPDLTPRAALTPETYFGVGKVVNYGGGGAYDEGSAVFDYPPSLAANSFALRGRWALDYQGATSDGNDAAIKLNYHAKDVYIVVGGTGTLTVVRDGKPATLPISGPPTTHQVVAGYRLASETLEVRPSKGLQVFSFTYG,"74,168",695,,cell redox homeostasis [GO:0045454]; cytochrome complex assembly [GO:0017004],antioxidant activity [GO:0016209]; oxidoreductase activity [GO:0016491],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY274.05,1
P9WPJ5,CAS1_MYCTU,Rv2817c,cas1 Rv2817c,GO:0003677; GO:0004519; GO:0005618; GO:0040007; GO:0043571; GO:0046872; GO:0051607,IPR002729; ,,cas1,,CRISPR-associated endonuclease Cas1 (EC 3.1.-.-),cell wall [GO:0005618]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; growth [GO:0040007]; maintenance of CRISPR repeat elements [GO:0043571],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette (By similarity). {ECO:0000250}.",MVQLYVSDSVSRISFADGRVIVWSEELGESQYPIETLDGITLFGRPTMTTPFIVEMLKRERDIQLFTTDGHYQGRISTPDVSYAPRLRQQVHRTDDPAFCLSLSKRIVSRKILNQQALIRAHTSGQDVAESIRTMKHSLAWVDRSGSLAELNGFEGNAAKAYFTALGHLVPQEFAFQGRSTRPPLDAFNSMVSLGYSLLYKNIIGAIERHSLNAYIGFLHQDSRGHATLASDLMEVWRAPIIDDTVLRLIADGVVDTRAFSKNSDTGAVFATREATRSIARAFGNRIARTATYIKGDPHRYTFQYALDLQLQSLVRVIEAGHPSRLVDIDITSEPSGA,"37,664",338,CRISPR-associated endonuclease Cas1 family,defense response to virus [GO:0051607]; growth [GO:0040007]; maintenance of CRISPR repeat elements [GO:0043571],DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872],cell wall [GO:0005618],,,1
P9WPJ3,CAS2_MYCTU,Rv2816c,cas2 Rv2816c,GO:0004521; GO:0043571; GO:0046872; GO:0051607,IPR021127; IPR019199; ,,cas2,,CRISPR-associated endoribonuclease Cas2 (EC 3.1.-.-),endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; defense response to virus [GO:0051607]; maintenance of CRISPR repeat elements [GO:0043571],9634230,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain sequences complementary to antecedent mobile elements and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Functions as a ssRNA-specific endoribonuclease. Involved in the integration of spacer DNA into the CRISPR cassette (By similarity). {ECO:0000250}.",MPTRSREEYFNLPLKVDESSGTIGKMFVLVIYDISDNRRRASLAKILAGFGYRVQESAFEAMLTKGQLAKLVARIDRFAIDCDNIRIYKIRGVAAVTFYGRGRLVSAEEFVFF,"12,867",113,CRISPR-associated endoribonuclease Cas2 protein family,defense response to virus [GO:0051607]; maintenance of CRISPR repeat elements [GO:0043571],endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872],,,,1
P9WPF7,CDSA_MYCTU,Rv2881c,cdsA Rv2881c MTCY274.12c,GO:0004605; GO:0005618; GO:0005886; GO:0006655; GO:0016020; GO:0016021; GO:0016024; GO:0040007,IPR000374; ,,cdsA,,Phosphatidate cytidylyltransferase (EC 2.7.7.41) (CDP-DAG synthase) (CDP-DG synthase) (CDP-diacylglycerol synthase) (CDS) (CDP-diglyceride pyrophosphorylase) (CDP-diglyceride synthase) (CTP:phosphatidate cytidylyltransferase),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; phosphatidate cytidylyltransferase activity [GO:0004605]; CDP-diacylglycerol biosynthetic process [GO:0016024]; growth [GO:0040007]; phosphatidylglycerol biosynthetic process [GO:0006655],9634230; 21969609,,,MSWLNTKKASCWRSSGRSATKSVTTNDAGTGNPAEQPARGAKQQPATETSRAGRDLRAAIVVGLSIGLVLIAVLVFVPRVWVAIVAVATLVATHEVVRRLREAGYLIPVIPLLIGGQAAVWLTWPFGAVGALAGFGGMVVVCMIWRLFMQDSVTRPTTGGAPSPGNYLSDVSATVFLAVWVPLFCSFGAMLVYPENGSGWVFCMMIAVIASDVGGYAVGVLFGKHPMVPTISPKKSWEGFAGSLVCGITATIITATFLVGKTPWIGALLGVLFVLTTALGDLVESQVKRDLGIKDMGRLLPGHGGLMDRLDGILPSAVAAWIVLTLLP,"34,458",328,CDS family,CDP-diacylglycerol biosynthetic process [GO:0016024]; growth [GO:0040007]; phosphatidylglycerol biosynthetic process [GO:0006655],phosphatidate cytidylyltransferase activity [GO:0004605],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886],,MTCY274.12c,2
P71629,CAS10_MYCTU,Rv2823c,cas10 csm1 Rv2823c,GO:0005576; GO:0005886; GO:0051607,IPR013408; IPR000160; IPR003607; ,,cas10,DOMAIN 1 98 HD. {ECO:0000255|PROSITE-ProRule:PRU01175}.; DOMAIN 547 700 GGDEF. {ECO:0000255|PROSITE-ProRule:PRU00095}.,"CRISPR-associated protein Cas10/Csm1 (CRISPR-associated protein Cas10/Csm1, subtype III-A/Mtube)",extracellular region [GO:0005576]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MNPQLIEAIIGCLLHDIGKPVQRAALGYPGRHSAIGRAFMKKVWLRDSRNPSQFTDEVDEADIGVSDRRILDAISYHHSSALRTAAENGRLAADAPAYIAYNIAAGTDRRKADSDDGHGASTWDPDTPLYSMFNRFGSGTANLAFAPEMLDDRKPINIPSPRRIEFDKDRYAAIVNKLKAILVDLERSDTYLASLLNVLEATLSFVPSSTDASEVVDVSLFDHLKLTGALGACIWHYLQATGQSDFKSALFDKQDTFYNEKAFLLTTFDVSGIQDFIYTIHSSGAAKMLRARSFYLEMLTEHLIDELLARVGLSRANLNYSGGGHAYLLLPNTESARKSVEQFEREANDWLLENFATRLFIATGSVPLAANDLMRRPNESASQASNRALRYSGLYRELSEQLSAKKLARYSADQLRELNSRDHDGQKGDRECSVCHTVNRTVSADDEPKCSLCQALTAASSQIQSESRRFLLISDGATKGLPLPFGATLTFCSRADADKALQQPQTRRRYAKNKFFAGECLGTGLWVGDYVAQMEFGDYVKRASGIARLGVLRLDVDNLGQAFTHGFMEQGNGKFNTISRTAAFSRMLSLFFRQHINYVLARPKLRPITGDDPARPREATIIYSGGDDVFVVGAWDDVIEFGIELRERFHEFTQGKLTVSAGIGMFPDKYPISVMAREVGDLEDAAKSLPGKNGVALFDREFTFGWDELLSKVIEEKYRHIADYFSGNEERGMAFIYKLLELLAERDDRITKARWVYFLTRMRNPTGDTAPFQQFANRLHQWFQDPTDAKQLKTALHLYIYRTRKEESE,"90,747",809,CRISPR-associated Cas10/Csm1 family,defense response to virus [GO:0051607],,extracellular region [GO:0005576]; plasma membrane [GO:0005886],csm1,,1
P9WQC5,ADHC_MYCTU,Rv3045,adhC adh Rv3045 MTV012.60,GO:0005618; GO:0005829; GO:0005886; GO:0008106; GO:0008270,IPR013149; IPR013154; IPR002328; IPR011032; IPR036291; IPR020843; ,,adhC,,NADP-dependent alcohol dehydrogenase C (EC 1.1.1.2),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270],9634230; 20066036; 21969609,,,MSTVAAYAAMSATEPLTKTTITRRDPGPHDVAIDIKFAGICHSDIHTVKAEWGQPNYPVVPGHEIAGVVTAVGSEVTKYRQGDRVGVGCFVDSCRECNSCTRGIEQYCKPGANFTYNSIGKDGQPTQGGYSEAIVVDENYVLRIPDVLPLDVAAPLLCAGITLYSPLRHWNAGANTRVAIIGLGGLGHMGVKLGAAMGADVTVLSQSLKKMEDGLRLGAKSYYATADPDTFRKLRGGFDLILNTVSANLDLGQYLNLLDVDGTLVELGIPEHPMAVPAFALALMRRSLAGSNIGGIAETQEMLNFCAEHGVTPEIELIEPDYINDAYERVLASDVRYRFVIDISAL,"37,075",346,Zinc-containing alcohol dehydrogenase family,,alcohol dehydrogenase (NADP+) activity [GO:0008106]; zinc ion binding [GO:0008270],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],adh,MTV012.60,1
P9WQC9,ACYP_MYCTU,Rv2922.1c,acyP Rv2922.1c MTCY338.11Bc Rv2922A,GO:0003998,IPR020456; IPR001792; IPR036046; IPR017968; ,,acyP,DOMAIN 7 93 Acylphosphatase-like. {ECO:0000255|PROSITE-ProRule:PRU00520}.,Acylphosphatase (EC 3.6.1.7) (Acylphosphate phosphohydrolase),acylphosphatase activity [GO:0003998],9634230; 12368430; 21969609,,,MSAPDVRLTAWVHGWVQGVGFRWWTRCRALELGLTGYAANHADGRVLVVAQGPRAACQKLLQLLQGDTTPGRVAKVVADWSQSTEQITGFSER,"10,206",93,Acylphosphatase family,,acylphosphatase activity [GO:0003998],,,MTCY338.11Bc Rv2922A,1
P9WQB9,ADHD_MYCTU,Rv3086,adhD Rv3086,GO:0004022; GO:0005618; GO:0008270; GO:0010447; GO:0044119,IPR013149; IPR013154; IPR023921; IPR002328; IPR011032; IPR036291; IPR020843; ,,adhD,,Putative alcohol dehydrogenase D (EC 1.1.1.1),cell wall [GO:0005618]; alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],9634230; 14568148; 15937179; 16893682; 21969609,,FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. {ECO:0000269|PubMed:15937179}.,MKTTAAVLFEAGKPFELMELDLDGPGPGEVLVKYTAAGLCHSDLHLTDGDLPPRFPIVGGHEGSGVIEEVGAGVTRVKPGDHVVCSFIPNCGTCRYCCTGRQNLCDMGATILEGCMPDGSFRFHSQGTDFGAMCMLGTFAERATVSQHSVVKVDDWLPLETAVLVGCGVPSGWGTAVNAGNLRAGDTAVIYGVGGLGINAVQGATAAGCKYVVVVDPVAFKRETALKFGATHAFADAASAAAKVDELTWGQGADAALILVGTVDDEVVSAATAVIGKGGTVVITGLADPAKLTVHVSGTDLTLHEKTIKGSLFGSCNPQYDIVRLLRLYDAGQLMLDELVTTTYNLEQVNQGYQDLRDGKNIRGVIVH,"38,342",368,Zinc-containing alcohol dehydrogenase family,growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],cell wall [GO:0005618],,,1
P9WQ95,AMI3_MYCTU,Rv2888c,amiC Rv2888c MTCY274.19c,GO:0004040; GO:0005618; GO:0005886,IPR000120; IPR020556; IPR023631; IPR036928; ,,amiC,,Putative amidase AmiC (EC 3.5.1.4),cell wall [GO:0005618]; plasma membrane [GO:0005886]; amidase activity [GO:0004040],9634230; 21969609,,,MSRVHAFVDDALGDLDAVALADAIRSGRVGRADVVEAAIARAEAVNPALNALAYAAFDVARDAAAMGTGQEAFFSGVPTFIKDNVDVAGQPSMHGTDAWEPYAAVADSEITRVVLGTGLVSLGKTQLSEFGFSAVAEHPRLGPVRNPWNTDYTAGASSSGSGALVAAGVVPIAHANDGGGSIRIPAACNGLVGLKPSRGRLPLEPEYRRLPVGIVANGVLTRTVRDTAAFYREAERLWRNHQLPPVGDVTSPVKQRLRIAVVTRSVLREASPEVRQLTLKLAGLLEELGHRVEHVDHPPAPASFVDDFVLYWGFLALAQVRSGRRTFGRTFDPTRLDELTLGLARHTGRNLHRLPLAIMRLRMLRRRSVRFFGTYDVLLTPTVAEATPQVGYLAPTDYQTVLDRLSSWVVFTPVQNVTGVPAISLPLAQSADGMPVGMMLSADTGREALLLELAYELEEARPWARIHAPNIAE,"50,916",473,Amidase family,,amidase activity [GO:0004040],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY274.19c,1
V5QRX7,3098A_MYCTU,Rv3098A RVBD_3098A LH57_16915,Rv3098A RVBD_3098A LH57_16915 P425_03229,GO:0003677,IPR003477; IPR011067; ,,,,Putative toxin Rv3098A/RVBD_3098A,DNA binding [GO:0003677],9634230; 21969609,,FUNCTION: Putative toxic component of a possible type II toxin-antitoxin (TA) system. Its toxic effect may be neutralized by cognate antitoxin Rv3098B/RVBD_3098B. {ECO:0000305}.,MVIRGAVYRVDFGDAKRGHEQRGRRYAVVISPGSMPWSVVTVVPTSTSAQPAVFRPELEVMGTKTRFLVDQIRTIGIVYVHGDPVDYLDRDQMAKVEHAVARYLGL,"11,859",106,PemK/MazF family,,DNA binding [GO:0003677],,,P425_03229,1
P9WQ65,AMT_MYCTU,Rv2920c,amt Rv2920c MTCY338.09c,GO:0005886; GO:0008519; GO:0016021,IPR029020; IPR001905; IPR018047; IPR024041; ,,amt,,Probable ammonia channel (Ammonia transporter),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ammonium transmembrane transporter activity [GO:0008519],9634230,,FUNCTION: Involved in the uptake of ammonia. {ECO:0000250}.,MDQFPIMGVPDGGDTAWMLVSSALVLLMTPGLAFFYGGMVRSKSVLNMIMMSISAMGVVTVLWALYGYSIAFGDDVGNIAGNPSQYWGLKGLIGVNAVAADPSTQTAAVNIPLAGTLPATVFVAFQLMFAIITVALISGAVADRLKFGAWLLFAGLWATFVYFPVAHWVFAFDGFAAEHGGWIANKLHAIDFAGGTAVHINAGVAALMLAIVLGKRRGWPATLFRPHNLPFVMLGAALLWFGWYGFNAGSATTANGVAGATFVTTTIATAAAMLGWLLTERVRDGKATTLGAASGIVAGLVAITPSCSSVNVLGALAVGVSAGVLCALAVGLKFKLGFDDSLDVVGVHLVGGLVGTLLVGLLAAPEAPAINGVAGVSKGLFYGGGFAQLERQALGACSVLVYSGIITLILALILKFTIGLRLDAEQESTGIDEAEHAESGYDFAVASGSVLPPRVTVEDSRNGIQERIGQKVEAEPK,"49,241",477,Ammonia transporter channel (TC 1.A.11.2) family,,ammonium transmembrane transporter activity [GO:0008519],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY338.09c,1
P9WJG1,CSM2_MYCTU,Rv2822c,csm2 Rv2822c,GO:0051607,IPR010149; ,,csm2,,CRISPR type III-associated protein Csm2 (CRISPR type III-A/Mtube-associated protein Csm2),defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MSVIQDDYVKQAEVIRGLPKKKNGFELTTTQLRVLLSLTAQLFDEAQQSANPTLPRQLKEKVQYLRVRFVYQSGREDAVKTFVRNAKLLEALEGIGDSRDGLLRFCRYMEALAAYKKYLDPKDK,"14,287",124,CRISPR-associated Csm2 family,defense response to virus [GO:0051607],,,,,1
P9WJF9,CSM3_MYCTU,Rv2821c,csm3 Rv2821c,GO:0051607,IPR013412; IPR005537; ,,csm3,,CRISPR type III-associated RAMP protein Csm3 (CRISPR type III-A/Mtube-associated RAMP protein Csm3),defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MTTSYAKIEITGTLTVLTGLQIGAGDGFSAIGAVDKPVVRDPLSRLPMIPGTSLKGKVRTLLSRQYGADTETFYRKPNEDHAHIRRLFGDTEEYMTGRLVFRDTKLTNKDDLEARGAKTLTEVKFENAINRVTAKANLRQMERVIPGSEFAFSLVYEVSFGTPGEEQKASLPSSDEIIEDFNAIARGLKLLELDYLGGSGTRGYGQVKFSNLKARAAVGALDGSLLEKLNHELAAV,"25,773",236,CRISPR-associated Csm3 family,defense response to virus [GO:0051607],,,,,1
P9WJF5,CSM5_MYCTU,Rv2819c,csm5 Rv2819c,GO:0005829; GO:0005886; GO:0051607,IPR010173; IPR005537; ,,csm5,,CRISPR type III-associated RAMP protein Csm5 (CRISPR type III-A/Mtube-associated RAMP protein Csm5),cytosol [GO:0005829]; plasma membrane [GO:0005886]; defense response to virus [GO:0051607],9634230,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MNTYLKPFELTLRCLGPVFIGSGEKRTSKEYHVEGDRVYFPDMELLYADIPAHKRKSFEAFVMNTDGAQATAPLKEWVEPNAVKLDPAKHRGYEVKIGSIEPRRASRGRGGRMTRKKLTLNEIHAFIKDPLGRPYVPGSTVKGMLRSIYLQSLVHKRTAQPVRVPGHQTREHRQYGERFERKELRKSGRPNTRPQDAVNDLFQAIRVTDSPALRTSDLLICQKMDMNVHGKPDGLPLFRECLAPGTSISHRVVVDTSPTARGGWREGERFLETLAETAASVNQARYAEYRAMYPGVNAIVGPIVYLGGGAGYRSKTFVTDQDDMAKVLDAQFGKVVKHVDKTRELRVSPLVLKRTKIDNICYEMGQCELSIRRAE,"42,340",375,CRISPR-associated Csm5 family,defense response to virus [GO:0051607],,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WJF7,CSM4_MYCTU,Rv2820c,csm4 Rv2820c,GO:0051607,IPR005510; ,,csm4,,CRISPR type III-associated RAMP protein Csm4 (CRISPR type III-A/Mtube-associated RAMP protein Csm4),defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MNSRLFRFDFDRTHFGDHGLESSTISCPADTLYSALCVEALRMGGQQLLGELVACSTLRLTDLLPYVGPDYLVPKPLHSVRSDGSSMQKKLAKKIGFLPAAQLGSFLDGTADLKELAARQTKIGVHAVSAKAAIHNGKKDADPYRVGYFRFELDAGLWLLATGSESELGLLTRLLKGISALGGERTSGFGAFNLTESEAPAALTPTVDAASLMTLTTSLPTDDELEAALAGATYRLVKRSGFVASSTYADMPLRKRDIYKFAAGSVFSRPFQGGILDVSLGGNHPVYSYARPLFLALPESAA,"32,301",302,CRISPR-associated Csm4 family,defense response to virus [GO:0051607],,,,,1
P9WP63,CRCB1_MYCTU,Rv3069,crcB1 Rv3069 MTCY22D7.12c,GO:0005887; GO:1903424; GO:1903425,IPR003691; ,,crcB1,,Putative fluoride ion transporter CrcB 1,integral component of plasma membrane [GO:0005887]; fluoride transmembrane transporter activity [GO:1903425]; fluoride transmembrane transport [GO:1903424],9634230; 21969609,,"FUNCTION: Important for reducing fluoride concentration in the cell, thus reducing its toxicity. {ECO:0000255|HAMAP-Rule:MF_00454}.",MPNHDYRELAAVFAGGALGALARAALSALAIPDPARWPWPTFTVNVVGAFLVGYFTTRLLERLPLSSYRRPLLGTGLCGGLTTFSTMQVETISMIEHGHWGLAAAYSVVSITLGLLAVHLATVLVRRVRIRR,"14,301",132,CrcB (TC 9.B.71) family,fluoride transmembrane transport [GO:1903424],fluoride transmembrane transporter activity [GO:1903425],integral component of plasma membrane [GO:0005887],,MTCY22D7.12c,1
P9WP47,CSTA_MYCTU,Rv3063,cstA Rv3063 MTCY22D7.18c,GO:0005887; GO:0009267; GO:0015031; GO:0031669,IPR025299; IPR003706; ,,cstA,,Peptide transporter CstA (Carbon starvation protein A homolog),integral component of plasma membrane [GO:0005887]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; protein transport [GO:0015031],9634230,,FUNCTION: Involved in peptide utilization. {ECO:0000250|UniProtKB:P15078}.,MAAPTPSNRIEERSGHASCVRADADLPPVAILGRSPITLRHKIFFVAVAVIGALAWTVVAFFRNEPVNAVWIVVAAGCTYIIGFRFYARLIEMKVVRPRDDHATPAEILDDGTDYVPTDRRVVFGHHFAAIAGAGPLVGPVLATQMGYLPSSIWIVVGAVLAGCVQDYLVLWISVRRRGRSLGQMVRDELGATAGVAALVGIPVIITIVIAVLALVVVRALAKSPWGVFSIAMTIPIAIFMGCYLRFLRPGRVSEVSLIGIGLLLLAVVSGDWVAHTSWGAAWFSLSPVTLCWLLISYGFAASVLPVWLLLAPRDYLSTFMKVGTIALLAIGVCAAHPIIEAPAVSKFAGSGNGPVFAGSLFPFLFITIACGALSGFHALICSGTTPKMLEKEGQMRVIGYGGMMTESFVAVIALLTAAILDQHLYFTLNAPSLHTHDSAATAAKYVNGLGLTGSPVTPDHISQAAASVGEQTIVSRTGGAPTLAFGMAEMLHRVVGGVGLKAFWYHFAIMFEALFILTTVDAGTRAARFMISDALGNFGGVLRKLQNPSWRPGAWACRLVVVAAWGSILLLGVTDPLGGINTLFPLFGIANQLLAGIALTVITVVVIKKGRLKWAWIPGIPLLWDLAVTLTASWQKIFSADPSVGYWTQHAHYAAAQHAGETAFGSATNADEINDVVRNTFVQGTLSIVFVVVVVLVVVAGVIVALKTIRGRGIPLAEDDPAPSTLFAPAGLIPTAAERKLQRRLGAPASASVAAPD,"80,163",758,Peptide transporter carbon starvation (CstA) (TC 2.A.114) family,cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; protein transport [GO:0015031],,integral component of plasma membrane [GO:0005887],,MTCY22D7.18c,1
P9WIR1,CFP6_MYCTU,Rv3004,cfp6 Rv3004 MTV012.18,GO:0005576,IPR019692; IPR020535; ,,cfp6,,Low molecular weight protein antigen 6 (CFP-6),extracellular region [GO:0005576],9634230; 10812229,,,MAHFAVGFLTLGLLVPVLTWPVSAPLLVIPVALSASIIRLRTLADERGVTVRTLVGSRAVRWDDIDGLRFHRGSWARATLKDGTELRLPAVTFATLPHLTEASSGRVPNPYR,"12,223",112,,,,extracellular region [GO:0005576],,MTV012.18,1
P9WP97,COBB_MYCTU,Rv2848c,cobB Rv2848c MTCY24A1.09,GO:0005524; GO:0005886; GO:0006541; GO:0009236; GO:0042242; GO:0043802,IPR004484; IPR029062; IPR017929; IPR002586; IPR011698; IPR027417; ,,cobB,DOMAIN 255 441 GATase cobBQ-type. {ECO:0000255|HAMAP-Rule:MF_00027}.,"Hydrogenobyrinate a,c-diamide synthase (EC 6.3.5.9) (Hydrogenobyrinic acid a,c-diamide synthase)","plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cobyrinic acid a,c-diamide synthase activity [GO:0042242]; hydrogenobyrinic acid a,c-diamide synthase (glutamine-hydrolysing) activity [GO:0043802]; cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541]",9634230; 21969609,,"FUNCTION: Catalyzes the ATP-dependent amidation of the two carboxylate groups at positions a and c of hydrogenobyrinate, using either L-glutamine or ammonia as the nitrogen source. {ECO:0000255|HAMAP-Rule:MF_00027}.",MRVSAVAVAAPASGSGKTTIATGLIGALRQAGHTVAPFKVGPDFIDPGYHALAAGRPGRNLDPVLVGERLIGPLYAHGVAGADIAVIEGVLGLFDGRIGPAGGAPAAGSTAHVAALLGAPVILVVDARGQSHSVAALLHGFSTFDTATRIAGVILNRVGSARHEQVLRQACDQAGVAVLGAIPRTAELELPTRYLGLVTAVEYGRRARLAVQAMTAVVARHVDLAAVIACAGSQAAHPPWDPVIAVGNTARQPATVAIAAGRAFTFGYAEHAEMLRAAGAEVVEFDPLSETLPEGTDAVVLPGGFPEQFTAELSANDTVRRQINELAAAGAPVHAECAGLLYLVSELDGHPMCGVVAGSARFTQHLKLGYRDAVAVVDSALYSVGERVVGHEFHRTAVTFADSYQPAWVYQGQDVDDVRDGAVHSGVHASYLHTHPAATPGAVARFVAHAACNTPRA,"46,958",457,CobB/CbiA family,cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541],"ATP binding [GO:0005524]; cobyrinic acid a,c-diamide synthase activity [GO:0042242]; hydrogenobyrinic acid a,c-diamide synthase (glutamine-hydrolysing) activity [GO:0043802]",plasma membrane [GO:0005886],,MTCY24A1.09,1
P9WPM7,CP136_MYCTU,Rv3059,cyp136 Rv3059 MTCY22D7.22c,GO:0004497; GO:0005506; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002403; IPR036396; ,,cyp136,,Putative cytochrome P450 136 (EC 1.14.-.-),"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MATIHPPAYLLDQAKRRFTPSFNNFPGMSLVEHMLLNTKFPEKKLAEPPPGSGLKPVVGDAGLPILGHMIEMLRGGPDYLMFLYKTKGPVVFGDSAVLPGVAALGPDAAQVIYSNRNKDYSQQGWVPVIGPFFHRGLMLLDFEEHMFHRRIMQEAFVRSRLAGYLEQMDRVVSRVVADDWVVNDARFLVYPAMKALTLDIASMVFMGHEPGTDHELVTKVNKAFTITTRAGNAVIRTSVPPFTWWRGLRARELLENYFTARVKERREASGNDLLTVLCQTEDDDGNRFSDADIVNHMIFLMMAAHDTSTSTATTMAYQLAAHPEWQQRCRDESDRHGDGPLDIESLEQLESLDLVMNESIRLVTPVQWAMRQTVRDTELLGYYLPKGTNVIAYPGMNHRLPEIWTDPLTFDPERFTEPRNEHKRHRYAFTPFGGGVHKCIGMVFDQLEIKTILHRLLRRYRLELSRPDYQPRWDYSAMPIPMDGMPIVLRPR,"56,228",492,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,MTCY22D7.22c,1
P9WP61,CRCB2_MYCTU,Rv3070,crcB2 Rv3070 MTCY22D7.11c,GO:0005887; GO:1903424; GO:1903425,IPR003691; ,,crcB2,,Putative fluoride ion transporter CrcB 2,integral component of plasma membrane [GO:0005887]; fluoride transmembrane transporter activity [GO:1903425]; fluoride transmembrane transport [GO:1903424],9634230,,"FUNCTION: Important for reducing fluoride concentration in the cell, thus reducing its toxicity. {ECO:0000255|HAMAP-Rule:MF_00454}.",MTASTALTVAIWIGVMLIGGIGSVLRFLVDRSVARRLARTFPYGTLTVNITGAALLGFLAGLALPKDAALLAGTGFVGAYTTFSTWMLETQRLGEDRQMVSALANIVVSVVLGLAAALLGQWIAQI,"13,167",126,CrcB (TC 9.B.71) family,fluoride transmembrane transport [GO:1903424],fluoride transmembrane transporter activity [GO:1903425],integral component of plasma membrane [GO:0005887],,MTCY22D7.11c,1
P71635,CSM6_MYCTU,Rv2818c,csm6 Rv2818c,GO:0003677; GO:0051607,IPR013489; ,,csm6,,CRISPR-associated protein Csm6 (CRISPR type III-A/Mtube-associated protein Csm6),DNA binding [GO:0003677]; defense response to virus [GO:0051607],9634230; 21969609,,"FUNCTION: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA) (By similarity). {ECO:0000250}.",MILFSPIGTADPITALGDGPMLHIVRHYRPIVVVLFLSAEIAAFENADRRYSAAITRLAPETDVRIVTYTNPSVHRFDLFVPVFRNHLVELSAEFPDRTILLNTSSGTPAMQAALVAINVFGIPRTTAVQVSTPARALSKPGDRESPDAYDLELMWDANDDNQPGAPNRCFEATSAALGALLERANLKQLIVSYDYSAAVTIAADSRLPDQVSNLIRGAMHRSRLEHLVAPKFFKDTAFTYDPANKVAEYISALALLAKREQWAEFARSATPAITIVLRAAVAKHLPEDRYLDDMGRVDRRKLEREPEIRCALKHPPKSPNAEWYLYTKDWLALLRQFAPDRVGALEVLGRFESRVRNTAAHEIVSISEDRITKDGGLLPEQLLKILARETGADLTLYDRLNDEIIRQIDMAPLG,"46,232",415,CRISPR-associated Csm6 family,defense response to virus [GO:0051607],DNA binding [GO:0003677],,,,5
P9WP71,COX1_MYCTU,Rv3043c,ctaD Rv3043c MTV012.58c,GO:0004129; GO:0005887; GO:0006119; GO:0009060; GO:0015990; GO:0020037; GO:0022904; GO:0040007; GO:0046872; GO:0070469,IPR023616; IPR036927; IPR000883; IPR023615; IPR014241; ,,ctaD,,Probable cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Cytochrome aa3 subunit 1) (Cytochrome c oxidase polypeptide I),integral component of plasma membrane [GO:0005887]; respiratory chain [GO:0070469]; cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; growth [GO:0040007]; oxidative phosphorylation [GO:0006119]; respiratory electron transport chain [GO:0022904],9634230; 21969609,,FUNCTION: Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Subunits 1-3 form the functional core of the enzyme complex. CO I is the catalytic subunit of the enzyme. Electrons originating in cytochrome c are transferred via the copper A center of subunit 2 and heme A of subunit 1 to the bimetallic center formed by heme A3 and copper B (By similarity). {ECO:0000250}.,MTAEAPPLGELEAIRPYPARTGPKGSLVYKLITTTDHKMIGIMYCVACISFFFIGGLLALLMRTELAAPGLQFLSNEQFNQLFTMHGTIMLLFYATPIVFGFANLVLPLQIGAPDVAFPRLNAFSFWLFVFGATIGAAGFITPGGAADFGWTAYTPLTDAIHSPGAGGDLWIMGLIVAGLGTILGAVNMITTVVCMRAPGMTMFRMPIFTWNIMVTSILILIAFPLLTAALFGLAADRHLGAHIYDAANGGVLLWQHLFWFFGHPEVYIIALPFFGIVSEIFPVFSRKPIFGYTTLVYATLSIAALSVAVWAHHMFATGAVLLPFFSFMTYLIAVPTGIKFFNWIGTMWKGQLTFETPMLFSVGFMVTFLLGGLTGVLLASPPLDFHVTDSYFVVAHFHYVLFGTIVFATFAGIYFWFPKMTGRLLDERLGKLHFWLTFIGFHTTFLVQHWLGDEGMPRRYADYLPTDGFQGLNVVSTIGAFILGASMFPFVWNVFKSWRYGEVVTVDDPWGYGNSLEWATSCPPPRHNFTELPRIRSERPAFELHYPHMVERLRAEAHVGRHHDEPAMVTSS,"63,673",573,Heme-copper respiratory oxidase family,aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; growth [GO:0040007]; oxidative phosphorylation [GO:0006119]; respiratory electron transport chain [GO:0022904],cytochrome-c oxidase activity [GO:0004129]; heme binding [GO:0020037]; metal ion binding [GO:0046872],integral component of plasma membrane [GO:0005887]; respiratory chain [GO:0070469],,MTV012.58c,1
P9WQA1,GATA_MYCTU,Rv3011c,gatA Rv3011c MTV012.25c,GO:0004040; GO:0005524; GO:0006412; GO:0030956; GO:0040007; GO:0050567,IPR000120; IPR020556; IPR023631; IPR036928; IPR004412; ,,gatA,,Glutamyl-tRNA(Gln) amidotransferase subunit A (Glu-ADT subunit A) (EC 6.3.5.7),glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,,FUNCTION: Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in organisms which lack glutaminyl-tRNA synthetase. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln) (By similarity). {ECO:0000250}.,MTDIIRSDAATLAAKIAIKEVSSAEITRACLDQIEATDETYHAFLHVAADEALAAAAAIDKQVAAGEPLPSALAGVPLALKDVFTTSDMPTTCGSKILEGWRSPYDATLTARLRAAGIPILGKTNMDEFAMGSSTENSAYGPTRNPWNLDRVPGGSGGGSAAALAAFQAPLAIGSDTGGSIRQPAALTATVGVKPTYGTVSRYGLVACASSLDQGGPCARTVLDTALLHQVIAGHDPRDSTSVDAEVPDVVGAARAGAVGDLRGVRVGVVRQLHGGEGYQPGVLASFEAAVEQLTALGAEVSEVDCPHFDHALAAYYLILPSEVSSNLARFDAMRYGLRVGDDGTRSAEEVMAMTRAAGFGPEVKRRIMIGTYALSAGYYDAYYNQAQKVRTLIARDLDAAYRSVDVLVSPTTPTTAFRLGEKVDDPLAMYLFDLCTLPLNLAGHCGMSVPSGLSPDDGLPVGLQIMAPALADDRLYRVGAAYEAARGPLLSAI,"51,420",494,"Amidase family, GatA subfamily",growth [GO:0040007]; translation [GO:0006412],amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567],glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956],,MTV012.25c,1
P9WN31,GLNB_MYCTU,Rv2919c,glnB Rv2919c MTCY338.08c,GO:0005524; GO:0005886; GO:0006351; GO:0006355; GO:0006808; GO:0030234; GO:0043531; GO:0044119,IPR002187; IPR011322; IPR015867; IPR017918; IPR002332; ,,glnB,,Nitrogen regulatory protein P-II,"plasma membrane [GO:0005886]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme regulator activity [GO:0030234]; growth of symbiont in host cell [GO:0044119]; regulation of nitrogen utilization [GO:0006808]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (2),"FUNCTION: In nitrogen-limiting conditions, when the ratio of Gln to 2-ketoglutarate decreases, P-II is uridylylated to P-II-UMP. P-II-UMP allows the deadenylation of glutamine synthetase (GS), thus activating the enzyme. Conversely, in nitrogen excess P-II is deuridylated and promotes the adenylation of GS. P-II indirectly controls the transcription of the GS gene (glnA). P-II prevents NR-II-catalyzed conversion of NR-I to NR-I-phosphate, the transcriptional activator of glnA. When P-II is uridylylated to P-II-UMP, these events are reversed (By similarity). {ECO:0000250}.",MKLITAIVKPFTLDDVKTSLEDAGVLGMTVSEIQGYGRQKGHTEVYRGAEYSVDFVPKVRIEVVVDDSIVDKVVDSIVRAARTGKIGDGKVWVSPVDTIVRVRTGERGHDAL,"12,227",112,P(II) protein family,"growth of symbiont in host cell [GO:0044119]; regulation of nitrogen utilization [GO:0006808]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",ADP binding [GO:0043531]; ATP binding [GO:0005524]; enzyme regulator activity [GO:0030234],plasma membrane [GO:0005886],,MTCY338.08c,1
P9WN29,GLND_MYCTU,Rv2918c,glnD Rv2918c MTCY338.07c,GO:0005618; GO:0005886; GO:0006807; GO:0008773; GO:0016787; GO:0070566,IPR002912; IPR003607; IPR006674; IPR013546; IPR010043; ,,glnD,DOMAIN 430 544 HD. {ECO:0000255|PROSITE-ProRule:PRU01175}.; DOMAIN 610 686 ACT 1. {ECO:0000255|HAMAP-Rule:MF_00277}.; DOMAIN 730 805 ACT 2. {ECO:0000255|HAMAP-Rule:MF_00277}.,Bifunctional uridylyltransferase/uridylyl-removing enzyme (UTase/UR) (Bifunctional [protein-PII] modification enzyme) (Bifunctional nitrogen sensor protein) [Includes: [Protein-PII] uridylyltransferase (PII uridylyltransferase) (UTase) (EC 2.7.7.59); [Protein-PII]-UMP uridylyl-removing enzyme (UR) (EC 3.1.4.-)],cell wall [GO:0005618]; plasma membrane [GO:0005886]; [protein-PII] uridylyltransferase activity [GO:0008773]; adenylyltransferase activity [GO:0070566]; hydrolase activity [GO:0016787]; nitrogen compound metabolic process [GO:0006807],9634230; 17303474; 21969609,,"FUNCTION: Modifies, by uridylylation and deuridylylation, the PII regulatory protein (GlnB), in response to the nitrogen status of the cell that GlnD senses through the glutamine level. Under low glutamine levels, catalyzes the conversion of the PII protein and UTP to PII-UMP and PPi, while under higher glutamine levels, GlnD hydrolyzes PII-UMP to PII and UMP (deuridylylation). Thus, controls uridylylation state and activity of the PII protein, and plays an important role in the regulation of nitrogen assimilation and metabolism (Probable). {ECO:0000305|PubMed:17303474}.",MEAESPCAASDLAVARRELLSGNHRELDPVGLRQTWLDLHESWLIDKADEIGIADASGFAIVGVGGLGRRELLPYSDLDVLLLHDGKPADILRPVADRLWYPLWDANIRLDHSVRTVSEALTIANSDLMAALGMLEARHIAGDQQLSFALIDGVRRQWRNGIRSRMGELVEMTYARWRRCGRIAQRAEPDLKLGRGGLRDVQLLDALALAQLIDRHGIGHTDLPAGSLDGAYRTLLDVRTELHRVSGRGRDHLLAQFADEISAALGFGDRFDLARTLSSAGRTIGYHAEAGLRTAANALPRRGISALVRRPKRRPLDEGVVEYAGEIVLARDAEPEHDPGLVLRVAAASADTGLPIGAATLSRLAASVPDLPTPWPQEALDDLLVVLSAGPTTVATIEALDRTGLWGRLLPEWEPIRDLPPRDVAHKWTVDRHVVETAVHAAPLATRVARPDLLALGALLHDIGKGRGTDHSVLGAELVIPVCTRLGLSPPDVRTLSKLVRHHLLLPITATRRDLNDPKTIEAVSEALGGDPQLLEVLHALSEADSKATGPGVWSDWKASLVDDLVRRCRMVMAGESLPQAEPTAPHYLSLAADHGVHVEISPRDGERIDAVIVAPDERGLVSKAAAVLALNSLRVHSASVNVHQGVAITEFVVSPLFGSPPAAELVRQQFVGALNGDVDVLGMLQKRDSDAASLVSARAGDVQAGVPVTRTAAPPRILWLDTAAPAKLILEVRAMDRAGLLALLAGALEGAGAGIVWAKVNTFGSTAADVFCVTVPAELDARAAVEQHLLEVLGASVDVVVDEPVGD,"86,438",808,GlnD family,nitrogen compound metabolic process [GO:0006807],[protein-PII] uridylyltransferase activity [GO:0008773]; adenylyltransferase activity [GO:0070566]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY338.07c,1
P9WMX7,GLTR1_MYCTU,Rv2957,Rv2957 MTCY349.31c u0002kc,GO:0009247; GO:0016758,IPR001173; IPR029044; ,,,,PGL/p-HBAD biosynthesis glycosyltransferase Rv2957 (EC 2.4.1.-),"transferase activity, transferring hexosyl groups [GO:0016758]; glycolipid biosynthetic process [GO:0009247]",9634230; 15292272; 19099550; 21969609,,FUNCTION: Involved in glycosylation steps downstream of mono-O-methyl-glycosyl-p-hydroxybenzoic acid derivative (p-HBAD I) and 2-O-methyl-rhamnosyl-phenolphthiocerol dimycocerosate (mycoside B) during the p-hydroxybenzoic acid derivatives (p-HBAD) and glycosylated phenolphthiocerol dimycocerosates (PGL) biosynthesis. {ECO:0000269|PubMed:15292272}.,MAAPMFSIIIPTLNVAAVLPACLDSIARQTCGDFELVLVDGGSTDETLDIANIFAPNLGERLIIHRDTDQGVYDAMNRGVDLATGTWLLFLGADDSLYEADTLARVAAFIGEHEPSDLVYGDVIMRSTNFRWGGAFDLDRLLFKRNICHQAIFYRRGLFGTIGPYNLRYRVLADWDFNIRCFSNPALVTRYMHVVVASYNEFGGLSNTIVDKEFLKRLPMSTRLGIRLVIVLVRRWPKVISRAMVMRTVISWRRRR,"29,013",256,Glycosyltransferase 2 family,glycolipid biosynthetic process [GO:0009247],"transferase activity, transferring hexosyl groups [GO:0016758]",,,MTCY349.31c u0002kc,1
P9WFR1,GLTR2_MYCTU,Rv2958c,Rv2958c,GO:0005886; GO:0008194; GO:0009247; GO:0009405; GO:0016758; GO:0020012; GO:0043231,IPR002213; ,,,,PGL/p-HBAD biosynthesis glycosyltransferase Rv2958c (EC 2.4.1.-),"intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; evasion or tolerance of host immune response [GO:0020012]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]",9634230; 15292272; 21969609,,FUNCTION: Involved in glycosylation steps downstream of mono-O-methyl-glycosyl-p-hydroxybenzoic acid derivative (p-HBAD I) and 2-O-methyl-rhamnosyl-phenolphthiocerol dimycocerosate (mycoside B) during the p-hydroxybenzoic acid derivatives (p-HBAD) and glycosylated phenolphthiocerol dimycocerosates (PGL) biosynthesis. {ECO:0000269|PubMed:15292272}.,MEETSVAGDPGPDAGTSTAPNAAPEPVARRQRILFVGEAATLAHVVRPFVLARSLDPSRYEVHFACDPRFNKLLGPLPFPHHPIHTVPSEEVLLKIAQGRLFYNTRTLRKYIAADRKILNEIAPDVVVGDNRLSLSVSARLAGIPYIAIANAYWSPQARRRFPLPDVPWTRFFGVRPVSILYRLYRPLIFALYCLPLNWLRRKHGLSSLGWDLCRIFTDGDYTLYADVPELVPTYNLPANHRYLGPVLWSPDVKPPTWWHSLPTDRPIIYATLGSSGGKNLLQVVLNALADLPVTVIAATAGRNHLKNVPANAFVADYLPGEAAAARSAVVLCNGGSPTTQQALAAGVPVIGLPSNMDQHLNMEALERAGAGVLLRTERLNTEGVAAAVKQVLSGAEFRQAARRLAEAFGPDFAGFPQHIESALRLVC,"46,796",428,UDP-glycosyltransferase family,evasion or tolerance of host immune response [GO:0020012]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405],"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]",intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],,,1
P9WNA3,FTSK_MYCTU,Rv2748c,ftsK Rv2748c MTV002.13c,GO:0003677; GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0007049; GO:0007059; GO:0016021; GO:0040007; GO:0051301,IPR025199; IPR002543; IPR018541; IPR027417; IPR036388; IPR036390; ,,ftsK,DOMAIN 476 676 FtsK. {ECO:0000255|PROSITE-ProRule:PRU00289}.,DNA translocase FtsK,cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; growth [GO:0040007],9634230; 19099550; 21969609,,"FUNCTION: Essential cell division protein that coordinates cell division and chromosome segregation. The N-terminus is involved in assembly of the cell-division machinery. The C-terminus functions as a DNA motor that moves dsDNA in an ATP-dependent manner towards the dif recombination site, which is located within the replication terminus region. Required for activation of the Xer recombinase, allowing activation of chromosome unlinking by recombination (By similarity). {ECO:0000250}.",MSSKTVARSGTRTSRSKATSRGASRSARSAVPRKRSRPVKGVGRPSRRHHRSLLVSTGLACGRAMRAVWMMAAKGTGGAARSIGRARDIEPGHRRDGIALVLLGLAVVVAASSWFDAARPLGAWVDALLRTFIGSAVVMLPLVAAAVAVVLMRTSPNPDSRPRLILGASLIGLSFLGLCHLWAGSPEAPESRLRAAGFIGFAIGGPLSDGLTAWIAAPLLFIGALFGLLLLAGITIREVPDAMRAMFGTRLLPREYADDFEDFADFDGDDADTVEVARQDFSDGYYDEVPLCSDDGPPAWPSAEVPQDDTATIPEASAGRGSGRRGRRKDTQVLDRIVEGPYTLPSLDLLISGDPPKKRSAANTHMAGAIGEVLTQFKVDAAVTGCTRGPTVTRYEVELGPGVKVEKITALQRNIAYAVATESVRMLAPIPGKSAVGIEVPNTDREMVRLADVLTARETRRDHHPLVIGLGKDIEGDFISANLAKMPHLLVAGSTGSGKSSFVNSMLVSLLTRATPEEVRMILIDPKMVELTPYEGIPHLITPIITQPKKAAAALAWLVDEMEQRYQDMQASRVRHIDDFNDKVRSGAITAPLGSQREYRPYPYVVAIVDELADLMMTAPRDVEDAIVRITQKARAAGIHLVLATQRPSVDVVTGLIKTNVPSRLAFATSSLTDSRVILDQAGAEKLIGMGDGLFLPMGASKPLRLQGAYVSDEEIHAVVTACKEQAEPEYTEGVTTAKPTAERTDVDPDIGDDMDVFLQAVELVVSSQFGSTSMLQRKLRVGFAKAGRLMDLMETRGIVGPSEGSKAREVLVKPDELAGTLAAIRGDGGE,"88,887",831,FtsK/SpoIIIE/SftA family,cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; growth [GO:0040007],ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV002.13c,1
P9WGD9,FTSY_MYCTU,Rv2921c,ftsY Rv2921c MTCY338.10c,GO:0005525; GO:0005618; GO:0005737; GO:0005886; GO:0006614,IPR003593; IPR027417; IPR013822; IPR004390; IPR036225; IPR000897; ,,ftsY,,Signal recognition particle receptor FtsY (SRP receptor),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],9634230; 21969609,,FUNCTION: Involved in targeting and insertion of nascent membrane proteins into the cytoplasmic membrane. Acts as a receptor for the complex formed by the signal recognition particle (SRP) and the ribosome-nascent chain (RNC). {ECO:0000255|HAMAP-Rule:MF_00920}.,MWEGLWIATAVIAALVVIAALTLGLVLYRRRRISLSPRPERGVVDRSGGYTASSGITFSQTPTTQPAERIDTSGLPAVGDDATVPRDAPKRTIADVHLPEFEPEPQAPEVPEADAIAPPEGRLERLRGRLARSQNALGRGLLGLIGGGDLDEDSWQDVEDTLLVADLGPAATASVVSQLRSRLASGNVRTEADARAVLRDVLINELQPGMDRSIRALPHAGHPSVLLVVGVNGTGKTTTVGKLARVLVADGRRVVLGAADTFRAAAADQLQTWAARVGAAVVRGPEGADPASVAFDAVDKGIAAGADVVLIDTAGRLHTKVGLMDELDKVKRVVTRRASVDEVLLVLDATIGQNGLAQARVFAEVVDISGAVLTKLDGTAKGGIVFRVQQELGVPVKLVGLGEGPDDLAPFEPAAFVDALLG,"44,031",422,"GTP-binding SRP family, FtsY subfamily",SRP-dependent cotranslational protein targeting to membrane [GO:0006614],GTP binding [GO:0005525],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY338.10c,1
P9WN77,GPDA_MYCTU,Rv2982c,gpsA gpdA2 Rv2982c MTCY349.05,GO:0004367; GO:0005886; GO:0005975; GO:0006650; GO:0008654; GO:0009331; GO:0036439; GO:0046168; GO:0047952; GO:0051287,IPR008927; IPR013328; IPR006168; IPR006109; IPR011128; IPR036291; ,,gpsA,,Glycerol-3-phosphate dehydrogenase [NAD(P)+] (EC 1.1.1.94) (NAD(P)H-dependent glycerol-3-phosphate dehydrogenase),glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; glycerol-3-phosphate dehydrogenase [NADP+] activity [GO:0036439]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654],9634230; 21969609,,,MAGIASTVAVMGAGAWGTALAKVLADAGGEVTLWARRAEVADQINTTRYNPDYLPGALLPPSIHATADAEEALGGASTVLLGVPAQTMRANLERWAPLLPEGATLVSLAKGIELGTLMRMSQVIISVTGAEPPQVAVISGPNLASEIAECQPAATVVACSDSGRAVALQRALNSGYFRPYTNADVVGTEIGGACKNIIALACGMAVGIGLGENTAAAIITRGLAEIIRLGTALGANGATLAGLAGVGDLVATCTSPRSRNRSFGERLGRGETLQSAGKACHVVEGVTSCESVLALASSYDVEMPLTDAVHRVCHKGLSVDEAITLLLGRRTKPE,"33,992",334,NAD-dependent glycerol-3-phosphate dehydrogenase family,carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650]; phospholipid biosynthetic process [GO:0008654],glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; glycerol-3-phosphate dehydrogenase [NADP+] activity [GO:0036439]; NAD binding [GO:0051287],glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886],gpdA2,MTCY349.05,1
P9WNX1,DYR_MYCTU,Rv2763c,folA dfrA Rv2763c MTV002.28c,GO:0004146; GO:0006545; GO:0006730; GO:0046654; GO:0070401,IPR012259; IPR024072; IPR017925; IPR001796; ,,folA,DOMAIN 1 160 DHFR. {ECO:0000255|PROSITE-ProRule:PRU00660}.,Dihydrofolate reductase (EC 1.5.1.3),dihydrofolate reductase activity [GO:0004146]; NADP+ binding [GO:0070401]; glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654],9634230; 21969609; 10623528; 16648861,X-ray crystallography (15),"FUNCTION: Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis.",MTMVGLIWAQATSGVIGRGGDIPWRLPEDQAHFREITMGHTIVMGRRTWDSLPAKVRPLPGRRNVVLSRQADFMASGAEVVGSLEEALTSPETWVIGGGQVYALALPYATRCEVTEVDIGLPREAGDALAPVLDETWRGETGEWRFSRSGLRYRLYSYHRS,"17,872",161,Dihydrofolate reductase family,glycine biosynthetic process [GO:0006545]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654],dihydrofolate reductase activity [GO:0004146]; NADP+ binding [GO:0070401],,dfrA,MTV002.28c,2
P9WNN3,ECH17_MYCTU,Rv3039c,echA17 Rv3039c,GO:0004300; GO:0005886; GO:0006635,IPR029045; IPR001753; ,,echA17,,Probable enoyl-CoA hydratase echA17 (EC 4.2.1.17),plasma membrane [GO:0005886]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,FUNCTION: Could possibly oxidize fatty acids using specific components. {ECO:0000250}.,MPEFVNVVVSDGSQDAGLAMLLLSRPPTNAMTRQVYREVVAAANELGRRDDVAAVILYGGHEIFSAGDDMPELRTLSAQEADTAARIRQQAVDAVAAIPKPTVAAITGYALGAGLTLALAADWRVSGDNVKFGATEILAGLIPSGDGMARLTRAAGPSRAKELVFSGRFFDAEEALALGLIDDMVAPDDVYDAAAAWARRFLDGPPHALAAAKAGISDVYELAPAERIAAERRRYVEVFAAGQGGGSKGDRGGR,"26,538",254,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],plasma membrane [GO:0005886],,,1
P9WNV5,DNLI_MYCTU,Rv3062,ligB Rv3062,GO:0000287; GO:0003677; GO:0003910; GO:0005524; GO:0005618; GO:0005737; GO:0006266; GO:0006273; GO:0006310; GO:0007049; GO:0051103; GO:0051301; GO:0071897,IPR022865; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR036599; IPR012340; ,,ligB,,DNA ligase B (LigB) (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP]),cell wall [GO:0005618]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; magnesium ion binding [GO:0000287]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273],9634230; 14985346; 21969609,,"FUNCTION: DNA ligase that seals nicks in double-stranded DNA during DNA replication, DNA recombination and DNA repair. {ECO:0000255|HAMAP-Rule:MF_00407, ECO:0000269|PubMed:14985346}.",MLLHDVAITSMDVAATSSRLTKVARIAALLHRAAPDTQLVTIIVSWLSGELPQRHIGVGWAALRSLPPPAPQPALTVTGVDATLSKIGTLPGKGSQAQRAALVAELFSAATEAEQTFLLRLLGGELRQGAKGGIMADAVAQAAGLPAATVQRAAMLGGDLAAAAAAGLSGAALDTFTLRVGRPIGPMLAQTATSVHDALERHGGTTIFEAKLDGARVQIHRANDQVRIYTRSLDDVTARLPEVVEATLALPVRDLVADGEAIALCPDNRPQRFQVTASRFGRSVDVAAARATQPLSVFFFDILHRDGTDLLEAPTTERLAALDALVPARHRVDRLITSDPTDAANFLDATLAAGHEGVMAKAPAARYLAGRRGAGWLKVKPVHTLDLVVLAVEWGSGRRRGKLSNIHLGARDPATGGFVMVGKTFKGMTDAMLDWQTTRFHEIAVGPTDGYVVQLRPEQVVEVALDGVQRSSRYPGGLALRFARVVRYRADKDPAEADTIDAVRALY,"53,737",507,ATP-dependent DNA ligase family,cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
P9WNV1,DNLJ_MYCTU,Rv3014c,ligA lig Rv3014c MTV012.28c,GO:0000287; GO:0003911; GO:0005618; GO:0005829; GO:0005886; GO:0006260; GO:0006266; GO:0006288; GO:0040007,IPR001357; IPR036420; IPR018239; IPR033136; IPR001679; IPR013839; IPR013840; IPR012340; IPR004150; IPR010994; IPR004149; ,,ligA,DOMAIN 607 691 BRCT. {ECO:0000255|HAMAP-Rule:MF_01588}.,DNA ligase A (LigA) (EC 6.5.1.2) (Polydeoxyribonucleotide synthase [NAD(+)]),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA ligase (NAD+) activity [GO:0003911]; magnesium ion binding [GO:0000287]; base-excision repair, DNA ligation [GO:0006288]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; growth [GO:0040007]",9634230; 14985346; 21969609; 15901723,X-ray crystallography (2),"FUNCTION: DNA ligase that catalyzes the formation of phosphodiester linkages between 5'-phosphoryl and 3'-hydroxyl groups in double-stranded DNA using NAD as a coenzyme and as the energy source for the reaction. It is essential for DNA replication and repair of damaged DNA. {ECO:0000255|HAMAP-Rule:MF_01588, ECO:0000269|PubMed:14985346}.",MSSPDADQTAPEVLRQWQALAEEVREHQFRYYVRDAPIISDAEFDELLRRLEALEEQHPELRTPDSPTQLVGGAGFATDFEPVDHLERMLSLDNAFTADELAAWAGRIHAEVGDAAHYLCELKIDGVALSLVYREGRLTRASTRGDGRTGEDVTLNARTIADVPERLTPGDDYPVPEVLEVRGEVFFRLDDFQALNASLVEEGKAPFANPRNSAAGSLRQKDPAVTARRRLRMICHGLGHVEGFRPATLHQAYLALRAWGLPVSEHTTLATDLAGVRERIDYWGEHRHEVDHEIDGVVVKVDEVALQRRLGSTSRAPRWAIAYKYPPEEAQTKLLDIRVNVGRTGRITPFAFMTPVKVAGSTVGQATLHNASEIKRKGVLIGDTVVIRKAGDVIPEVLGPVVELRDGSEREFIMPTTCPECGSPLAPEKEGDADIRCPNARGCPGQLRERVFHVASRNGLDIEVLGYEAGVALLQAKVIADEGELFALTERDLLRTDLFRTKAGELSANGKRLLVNLDKAKAAPLWRVLVALSIRHVGPTAARALATEFGSLDAIAAASTDQLAAVEGVGPTIAAAVTEWFAVDWHREIVDKWRAAGVRMVDERDESVPRTLAGLTIVVTGSLTGFSRDDAKEAIVARGGKAAGSVSKKTNYVVAGDSPGSKYDKAVELGVPILDEDGFRRLLADGPASRT,"75,289",691,"NAD-dependent DNA ligase family, LigA subfamily","base-excision repair, DNA ligation [GO:0006288]; DNA ligation [GO:0006266]; DNA replication [GO:0006260]; growth [GO:0040007]",DNA ligase (NAD+) activity [GO:0003911]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],lig,MTV012.28c,1
P9WNM1,EFTS_MYCTU,Rv2889c,tsf Rv2889c MTCY274.20c,GO:0003746; GO:0005618; GO:0005829; GO:0005886; GO:0040007,IPR036402; IPR001816; IPR014039; IPR018101; IPR009060; ,,tsf,,Elongation factor Ts (EF-Ts),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; translation elongation factor activity [GO:0003746]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Associates with the EF-Tu.GDP complex and induces the exchange of GDP to GTP. It remains bound to the aminoacyl-tRNA.EF-Tu.GTP complex up to the GTP hydrolysis stage on the ribosome (By similarity). {ECO:0000250}.,MANFTAADVKRLRELTGAGMLACKNALAETDGDFDKAVEALRIKGAKDVGKRAERATAEGLVAAKDGALIELNCETDFVAKNAEFQTLADQVVAAAAAAKPADVDALKGASIGDKTVEQAIAELSAKIGEKLELRRVAIFDGTVEAYLHRRSADLPPAVGVLVEYRGDDAAAAHAVALQIAALRARYLSRDDVPEDIVASERRIAEETARAEGKPEQALPKIVEGRLNGFFKDAVLLEQASVSDNKKTVKALLDVAGVTVTRFVRFEVGQA,"28,755",271,EF-Ts family,growth [GO:0040007],translation elongation factor activity [GO:0003746],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY274.20c,1
P9WG21,DRRC_MYCTU,Rv2938,drrC Rv2938,GO:0005576; GO:0005618; GO:0043190; GO:0043215; GO:0044119; GO:0046677; GO:0052572; GO:0055085; GO:1900753,IPR013525; IPR000412; IPR004377; IPR005943; ,,drrC,DOMAIN 46 273 ABC transmembrane type-2. {ECO:0000255|PROSITE-ProRule:PRU00442}.,Probable doxorubicin resistance ABC transporter permease protein DrrC,ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; extracellular region [GO:0005576]; daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth of symbiont in host cell [GO:0044119]; response to antibiotic [GO:0046677]; response to host immune response [GO:0052572]; transmembrane transport [GO:0055085],9634230; 19099550; 21969609,,FUNCTION: Probably part of the ABC transporter complex DrrABC involved in doxorubicin resistance. Probably responsible for the translocation of the substrate across the membrane.,MITTTSQEIELAPTRLPGSQNAARLFVAQTLLQTNRLLTRWARDYITVIGAIVLPILFMVVLNIVLGNLAYVVTHDSGLYSIVPLIALGAAITGSTFVAIDLMRERSFGLLARLWVLPVHRASGLISRILANAIRTLVTTLVMLGTGVVLGFRFRQGLIPSLMWISVPVILGIAIAAMVTTVALYTAQTVVVEGVELVQAIAIFFSTGLVPLNSYPGWIQPFVAHQPVSYAIAAMRGFAMGGPVLSPMIGMLVWTAGICVVCAVPLAIGYRRASTH,"29,593",276,ABC-2 integral membrane protein family,daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth of symbiont in host cell [GO:0044119]; response to antibiotic [GO:0046677]; response to host immune response [GO:0052572]; transmembrane transport [GO:0055085],,ATP-binding cassette (ABC) transporter complex [GO:0043190]; cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WNS1,DXR_MYCTU,Rv2870c,dxr Rv2870c MTCY274.01c,GO:0000287; GO:0030145; GO:0030604; GO:0050897; GO:0051483; GO:0051484; GO:0070402,IPR003821; IPR013644; IPR013512; IPR026877; IPR036169; IPR036291; ,,dxr,,1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXP reductoisomerase) (EC 1.1.1.267) (1-deoxyxylulose-5-phosphate reductoisomerase) (2-C-methyl-D-erythritol 4-phosphate synthase),"1-deoxy-D-xylulose-5-phosphate reductoisomerase activity [GO:0030604]; cobalt ion binding [GO:0050897]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; NADPH binding [GO:0070402]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process [GO:0051484]; terpenoid biosynthetic process, mevalonate-independent [GO:0051483]",9634230; 21969609,X-ray crystallography (22),FUNCTION: Catalyzes the NADP-dependent rearrangement and reduction of 1-deoxy-D-xylulose-5-phosphate (DXP) to 2-C-methyl-D-erythritol 4-phosphate (MEP). {ECO:0000255|HAMAP-Rule:MF_00183}.,MTNSTDGRADGRLRVVVLGSTGSIGTQALQVIADNPDRFEVVGLAAGGAHLDTLLRQRAQTGVTNIAVADEHAAQRVGDIPYHGSDAATRLVEQTEADVVLNALVGALGLRPTLAALKTGARLALANKESLVAGGSLVLRAARPGQIVPVDSEHSALAQCLRGGTPDEVAKLVLTASGGPFRGWSAADLEHVTPEQAGAHPTWSMGPMNTLNSASLVNKGLEVIETHLLFGIPYDRIDVVVHPQSIIHSMVTFIDGSTIAQASPPDMKLPISLALGWPRRVSGAAAACDFHTASSWEFEPLDTDVFPAVELARQAGVAGGCMTAVYNAANEEAAAAFLAGRIGFPAIVGIIADVLHAADQWAVEPATVDDVLDAQRWARERAQRAVSGMASVAIASTAKPGAAGRHASTLERS,"42,853",413,DXR family,"isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process [GO:0051484]; terpenoid biosynthetic process, mevalonate-independent [GO:0051483]",1-deoxy-D-xylulose-5-phosphate reductoisomerase activity [GO:0030604]; cobalt ion binding [GO:0050897]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; NADPH binding [GO:0070402],,,MTCY274.01c,1
P9WQL9,DRRA_MYCTU,Rv2936,drrA Rv2936,GO:0005524; GO:0005618; GO:0005886; GO:0006869; GO:0016887; GO:0043215; GO:0044119; GO:0046677; GO:0055085; GO:1900753,IPR003593; IPR003439; IPR017871; IPR005894; IPR027417; ,,drrA,DOMAIN 8 240 ABC transporter. {ECO:0000255|PROSITE-ProRule:PRU00434}.,Doxorubicin resistance ATP-binding protein DrrA (EC 3.6.3.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth of symbiont in host cell [GO:0044119]; lipid transport [GO:0006869]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 12057006; 21969609,,FUNCTION: Part of the ABC transporter complex DrrABC involved in doxorubicin resistance. Responsible for energy coupling to the transport system. Binds ATP. {ECO:0000269|PubMed:12057006}.,MRNDDMAVVVNGVRKTYGKGKIVALDDVSFKVRRGEVIGLLGPNGAGKTTMVDILSTLTRPDAGSAIIAGYDVVSEPAGVRRSIMVTGQQVAVDDALSGEQNLVLFGRLWGLSKSAARKRAAELLEQFSLVHAGKRRVGTYSGGMRRRIDIACGLVVQPQVAFLDEPTTGLDPRSRQAIWDLVASFKKLGIATLLTTQYLEEADALSDRIILIDHGIIIAEGTANELKHRAGDTFCEIVPRDLKDLDAIVAALGSLLPEHHRAMLTPDSDRITMPAPDGIRMLVEAARRIDEARIELADIALRRPSLDHVFLAMTTDPTESLTHLVSGSAR,"35,818",331,"ABC transporter superfamily, Drug exporter-1 (DrugE1) (TC 3.A.1.105) family",daunorubicin transport [GO:0043215]; doxorubicin transport [GO:1900753]; growth of symbiont in host cell [GO:0044119]; lipid transport [GO:0006869]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WG23,DRRB_MYCTU,Rv2937,drrB Rv2937,GO:0005886; GO:0008610; GO:0043190; GO:0043215; GO:0046677; GO:0055085; GO:0071770; GO:1900753,IPR000412; IPR004377; ,,drrB,DOMAIN 47 282 ABC transmembrane type-2.,Doxorubicin resistance ABC transporter permease protein DrrB,ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886]; daunorubicin transport [GO:0043215]; DIM/DIP cell wall layer assembly [GO:0071770]; doxorubicin transport [GO:1900753]; lipid biosynthetic process [GO:0008610]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],9634230; 12057006; 19099550; 21969609,,FUNCTION: Part of the ABC transporter complex DrrABC involved in doxorubicin resistance. Probably responsible for the translocation of the substrate across the membrane. {ECO:0000269|PubMed:12057006}.,MSGPAIDASPALTFNQSSASIQQRRLSTGRQMWVLYRRFAAPSLLNGEVLTTVGAPIIFMVGFYIPFAIPWNQFVGGASSGVASNLGQYITPLVTLQAVSFAAIGSGFRAATDSLLGVNRRFQSMPMAPLTPLLARVWVAVDRCFTGLVISLVCGYVIGFRFHRGALYIVGFCLLVIAIGAVLSFAADLVGTVTRNPDAMLPLLSLPILIFGLLSIGLMPLKLFPHWIHPFVRNQPISQFVAALRALAGDTTKTASQVSWPVMAPTLTWLFAFVVILALSSTIVLARRP,"31,109",289,ABC-2 integral membrane protein family,daunorubicin transport [GO:0043215]; DIM/DIP cell wall layer assembly [GO:0071770]; doxorubicin transport [GO:1900753]; lipid biosynthetic process [GO:0008610]; response to antibiotic [GO:0046677]; transmembrane transport [GO:0055085],,ATP-binding cassette (ABC) transporter complex [GO:0043190]; plasma membrane [GO:0005886],,,1
P9WNT1,DPO42_MYCTU,Rv3056,dinB2 dinP Rv3056 MTCY22D7.25c,GO:0003684; GO:0003887; GO:0005829; GO:0005886; GO:0006260; GO:0006281; GO:0046872,IPR036775; IPR017961; IPR022880; IPR001126; ,,dinB2,DOMAIN 9 191 UmuC.,DNA polymerase IV 2 (Pol IV 2) (EC 2.7.7.7),cytosol [GO:0005829]; plasma membrane [GO:0005886]; damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; DNA repair [GO:0006281]; DNA replication [GO:0006260],9634230,,"FUNCTION: Poorly processive, error-prone DNA polymerase involved in untargeted mutagenesis. Copies undamaged DNA at stalled replication forks, which arise in vivo from mismatched or misaligned primer ends. These misaligned primers can be extended by PolIV. Exhibits no 3'-5' exonuclease (proofreading) activity. May be involved in translesional synthesis, in conjunction with the beta clamp from PolIII (By similarity). {ECO:0000250}.",MPTAAPRWILHVDLDQFLASVELLRHPELAGLPVIVGGNGDPTEPRKVVTCASYEARAYGVRAGMPLRTAARRCPEATFLPSNPAAYNAASEEVVALLRDLGYPVEVWGWDEAYLAVAPGTPDDPIEVAEEIRKVILSQTGLSCSIGISDNKQRAKIATGLAKPAGIYQLTDANWMAIMGDRTVEALWGVGPKTTKRLAKLGINTVYQLAHTDSGLLMSTFGPRTALWLLLAKGGGDTEVSAQAWVPRSRSHAVTFPRDLTCRSEMESAVTELAQRTLNEVVASSRTVTRVAVTVRTATFYTRTKIRKLQAPSTDPDVITAAARHVLDLFELDRPVRLLGVRLELA,"37,562",346,DNA polymerase type-Y family,DNA repair [GO:0006281]; DNA replication [GO:0006260],damaged DNA binding [GO:0003684]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872],cytosol [GO:0005829]; plasma membrane [GO:0005886],dinP,MTCY22D7.25c,1
P9WL29,DPRA_MYCTU,Rv2896c,dprA Rv2896c MTCY274.27c,GO:0009294,IPR003488; ,,dprA,,Putative DNA processing protein DprA,DNA mediated transformation [GO:0009294],9634230; 22375954,,FUNCTION: May help load RecA onto ssDNA (By similarity). {ECO:0000250|UniProtKB:Q8DPI7}.,MIDPTARAWAYLSRVAEPPCAQLAALVRCVGPVEAADRVRRGQVGNELAQHTGARREIDRAADDLELLMRRGGRLITPDDDEWPVLAFAAFSGAGARARPCGHSPLVLWALGPARLDEVAPRAAAVVGTRAATAYGEHVAADLAAGLAERDVAVVSGGAYGIDGAAHRAALDSEGITVAVLAGGFDIPYPAGHSALLHRIAQHGVLFTEYPPGVRPARHRFLTRNRLVAAVARAAVVVEAGLRSGAANTAAWARALGRVVAAVPGPVTSSASAGCHTLLRHGAELVTRADDIVEFVGHIGELAGDEPRPGAALDVLSEAERQVYEALPGRGAATIDEIAVGSGLLPAQVLGPLAILEVAGLAECRDGRWRILRAGAGQAAAKGAAARLV,"40,100",389,DprA/Smf family,DNA mediated transformation [GO:0009294],,,,MTCY274.27c,1
P9WNG9,ETFA_MYCTU,Rv3028c,etfA fixB Rv3028c MTV012.43c,GO:0005618; GO:0005829; GO:0005886; GO:0009055; GO:0050660,IPR029035; IPR014730; IPR001308; IPR033947; IPR014731; IPR018206; IPR014729; ,,etfA,,Electron transfer flavoprotein subunit alpha (Alpha-ETF) (Electron transfer flavoprotein large subunit) (ETFLS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,FUNCTION: The electron transfer flavoprotein serves as a specific electron acceptor for other dehydrogenases. It transfers the electrons to the main respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (By similarity). {ECO:0000250}.,MAEVLVLVEHAEGALKKVSAELITAARALGEPAAVVVGVPGTAAPLVDGLKAAGAAKIYVAESDLVDKYLITPAVDVLAGLAESSAPAGVLIAATADGKEIAGRLAARIGSGLLVDVVDVREGGVGVHSIFGGAFTVEAQANGDTPVITVRAGAVEAEPAAGAGEQVSVEVPAAAENAARITAREPAVAGDRPELTEATIVVAGGRGVGSAENFSVVEALADSLGAAVGASRAAVDSGYYPGQFQVGQTGKTVSPQLYIALGISGAIQHRAGMQTSKTIVAVNKDEEAPIFEIADYGVVGDLFKVAPQLTEAIKARKG,"31,691",318,ETF alpha-subunit/FixB family,,electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],fixB,MTV012.43c,1
Q6MX18,ESXS_MYCTU,Rv3020c,esxS Rv3020c LH57_16495,GO:0005576; GO:0032991,IPR036689; IPR010310; ,,esxS,,ESAT-6-like protein EsxS,extracellular region [GO:0005576]; protein-containing complex [GO:0032991],9634230; 15336430; 19876390; 20629176,X-ray crystallography (1),,MSLLDAHIPQLIASHTAFAAKAGLMRHTIGQAEQQAMSAQAFHQGESAAAFQGAHARFVAAAAKVNTLLDIAQANLGEAAGTYVAADAAAASSYTGF,"9,842",97,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576]; protein-containing complex [GO:0032991],,LH57_16495,1
P9WQ43,FAA26_MYCTU,Rv2930,fadD26 Rv2930 MTCY338.19,GO:0005524; GO:0005886; GO:0006633; GO:0008610; GO:0016874; GO:0016878; GO:0044119; GO:0052572; GO:0070566; GO:0071766; GO:0071770; GO:0097040,IPR000873; ,,fadD26,,Long-chain-fatty-acid--AMP ligase FadD26 (FAAL) (EC 6.2.1.-) (Acyl-AMP synthetase),plasma membrane [GO:0005886]; acid-thiol ligase activity [GO:0016878]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; phthiocerol biosynthetic process [GO:0097040]; response to host immune response [GO:0052572],9634230; 11279114; 15042094; 21969609,,"FUNCTION: Catalyzes the activation of long-chain fatty acids (C22-24 fatty acids) as acyl-adenylates (acyl-AMP), which are then transferred to the multifunctional polyketide synthase PpsA for further chain extension. Involved in the biosynthesis of phthiocerol dimycocerosate (DIM A) and phthiodiolone dimycocerosate (DIM B). {ECO:0000269|PubMed:11279114, ECO:0000269|PubMed:15042094}.",MPVTDRSVPSLLQERADQQPDSTAYTYIDYGSDPKGFADSLTWSQVYSRACIIAEELKLCGLPGDRVAVLAPQGLEYVLAFLGALQAGFIAVPLSTPQYGIHDDRVSAVLQDSKPVAILTTSSVVGDVTKYAASHDGQPAPVVVEVDLLDLDSPRQMPAFSRQHTGAAYLQYTSGSTRTPAGVIVSHTNVIANVTQSMYGYFGDPAKIPTGTVVSWLPLYHDMGLILGICAPLVARRRAMLMSPMSFLRRPARWMQLLATSGRCFSAAPNFAFELAVRRTSDQDMAGLDLRDVVGIVSGSERIHVATVRRFIERFAPYNLSPTAIRPSYGLAEATLYVAAPEAGAAPKTVRFDYEQLTAGQARPCGTDGSVGTELISYGSPDPSSVRIVNPETMVENPPGVVGEIWVHGDHVTMGYWQKPKQTAQVFDAKLVDPAPAAPEGPWLRTGDLGVISDGELFIMGRIKDLLIVDGRNHYPDDIEATIQEITGGRAAAIAVPDDITEQLVAIIEFKRRGSTAEEVMLKLRSVKREVTSAISKSHSLRVADLVLVSPGSIPITTSGKIRRSACVERYRSDGFKRLDVAV,"63,044",583,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; phthiocerol biosynthetic process [GO:0097040]; response to host immune response [GO:0052572],acid-thiol ligase activity [GO:0016878]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,MTCY338.19,1
P9WQ37,FAC13_MYCTU,Rv3089,fadD13 Rv3089,GO:0004321; GO:0004467; GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0006633; GO:0010447; GO:0044119; GO:0102391,IPR025110; IPR020845; IPR000873; ,,fadD13,,Long-chain-fatty-acid--CoA ligase FadD13 (EC 6.2.1.3) (Fatty acyl-CoA ligase) (FACL) (FACL13) (Fatty acyl-CoA synthetase) (ACS) (FACS) (Very-long-chain fatty-acyl-CoA synthetase) (ACSVL),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty-acyl-CoA synthase activity [GO:0004321]; long-chain fatty acid-CoA ligase activity [GO:0004467]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],9634230; 14568148; 15937179; 16893682; 20027301; 20454815; 21969609; 22206988; 22560731,X-ray crystallography (3),"FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. Catalyzes the activation of long-chain fatty acids as acyl-coenzyme A (acyl-CoA), which are then transferred to the multifunctional polyketide synthase (PKS) type III for further chain extension. It has preference for the fatty acid with long chain length in the following order: hexacosanoic acid (C26), tetracosanoic acid (C24) and palmitic acid (C16). {ECO:0000269|PubMed:15937179, ECO:0000269|PubMed:20027301, ECO:0000269|PubMed:22560731}.",MKNIGWMLRQRATVSPRLQAYVEPSTDVRMTYAQMNALANRCADVLTALGIAKGDRVALLMPNSVEFCCLFYGAAKLGAVAVPINTRLAAPEVSFILSDSGSKVVIYGAPSAPVIDAIRAQADPPGTVTDWIGADSLAERLRSAAADEPAVECGGDDNLFIMYTSGTTGHPKGVVHTHESVHSAASSWASTIDVRYRDRLLLPLPMFHVAALTTVIFSAMRGVTLISMPQFDATKVWSLIVEERVCIGGAVPAILNFMRQVPEFAELDAPDFRYFITGGAPMPEALIKIYAAKNIEVVQGYALTESCGGGTLLLSEDALRKAGSAGRATMFTDVAVRGDDGVIREHGEGEVVIKSDILLKEYWNRPEATRDAFDNGWFRTGDIGEIDDEGYLYIKDRLKDMIISGGENVYPAEIESVIIGVPGVSEVAVIGLPDEKWGEIAAAIVVADQNEVSEQQIVEYCGTRLARYKLPKKVIFAEAIPRNPTGKILKTVLREQYSATVPK,"54,459",503,ATP-dependent AMP-binding enzyme family,fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; response to acidic pH [GO:0010447],ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; fatty-acyl-CoA synthase activity [GO:0004321]; long-chain fatty acid-CoA ligase activity [GO:0004467],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WNF1,FDHD_MYCTU,Rv2899c,fdhD Rv2899c MTCY274.30c,GO:0005737; GO:0006777; GO:0016783,IPR016193; IPR003786; ,,fdhD,,Sulfur carrier protein FdhD,cytoplasm [GO:0005737]; sulfurtransferase activity [GO:0016783]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],9634230; 21969609,,FUNCTION: Required for formate dehydrogenase (FDH) activity. Acts as a sulfur carrier protein that transfers sulfur from IscS to the molybdenum cofactor prior to its insertion into FDH. {ECO:0000255|HAMAP-Rule:MF_00187}.,MGYATAHRRVRHLSADQVITRPETLAVEEPLEIRVNGTPVTVTMRTPGSDFELVQGFLLAEGVVAHREDVLTVSYCGRRVEGNATGASTYNVLDVALAPGVKPPDVDVTRTFYTTSSCGVCGKASLQAVSQVSRFAPGGDPATVAADTLKAMPDQLRRAQKVFARTGGLHAAALFGVDGAMLAVREDIGRHNAVDKVIGWAFERDRIPLGASVLLVSGRASFELTQKALMAGIPVLAAVSAPSSLAVSLADASGITLVAFLRGDSMNVYTRADRIT,"29,090",276,FdhD family,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],sulfurtransferase activity [GO:0016783],cytoplasm [GO:0005737],,MTCY274.30c,1
P9WQ61,FAA22_MYCTU,Rv2948c,fadD22 Rv2948c,GO:0006633; GO:0008610; GO:0009247; GO:0016874; GO:0016878; GO:0031177; GO:0044550; GO:0071766; GO:0097041,IPR036736; IPR025110; IPR000873; IPR020806; IPR009081; ,,fadD22,DOMAIN 541 619 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,p-hydroxybenzoic acid--AMP ligase FadD22 (p-HB--AMP ligase FadD22) (EC 6.2.1.50) (p-hydroxybenzoic acid-AMP synthetase) (p-HB-AMP synthetase),acid-thiol ligase activity [GO:0016878]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; glycolipid biosynthetic process [GO:0009247]; lipid biosynthetic process [GO:0008610]; phenolic phthiocerol biosynthetic process [GO:0097041]; secondary metabolite biosynthetic process [GO:0044550],9634230; 20553505; 21969609,,"FUNCTION: Catalyzes the adenylation of p-hydroxybenzoic acid (pHBA) to form p-hydroxybenzoic acid-AMP (pHBA-AMP), which is converted directly to p-hydroxybenzoyl-S-FadD22 (pHBA-S-FAdD22) thioester intermediate in a CoA-independent manner by attack of the phosphopantetheine thiol of FadD22. Usually, this intermediate primes the biosynthesis of the phenolphthiocerol (PPOL) by presenting the pHBA starter unit for elongation by Pks15/1, but M.tuberculosis lacks Pks15/1 due to a natural framshift and thus is unable to produce PPOL. {ECO:0000269|PubMed:20553505}.",MRNGNLAGLLAEQASEAGWYDRPAFYAADVVTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPELHRDDHALAARNTEPALVVTSDALRDRFQPSRVAEAAELMSEAARVAPGGYEPMGGDALAYATYTSGTTGPPKAAIHRHADPLTFVDAMCRKALRLTPEDTGLCSARMYFAYGLGNSVWFPLATGGSAVINSAPVTPEAAAILSARFGPSVLYGVPNFFARVIDSCSPDSFRSLRCVVSAGEALELGLAERLMEFFGGIPILDGIGSTEVGQTFVSNRVDEWRLGTLGRVLPPYEIRVVAPDGTTAGPGVEGDLWVRGPAIAKGYWNRPDSPVANEGWLDTRDRVCIDSDGWVTYRCRADDTEVIGGVNVDPREVERLIIEDEAVAEAAVVAVRESTGASTLQAFLVATSGATIDGSVMRDLHRGLLNRLSAFKVPHRFAVVDRLPRTPNGKLVRGALRKQSPTKPIWELSLTEPGSGVRAQRDDLSASNMTIAGGNDGGATLRERLVALRQERQRLVVDAVCAEAAKMLGEPDPWSVDQDLAFSELGFDSQMTVTLCKRLAAVTGLRLPETVGWDYGSISGLAQYLEAELAGGHGRLKSAGPVNSGATGLWAIEEQLNKVEELVAVIADGEKQRVADRLRALLGTIAGSEAGLGKLIQAASTPDEIFQLIDSELGK,"75,198",705,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; glycolipid biosynthetic process [GO:0009247]; lipid biosynthetic process [GO:0008610]; phenolic phthiocerol biosynthetic process [GO:0097041]; secondary metabolite biosynthetic process [GO:0044550],acid-thiol ligase activity [GO:0016878]; ligase activity [GO:0016874]; phosphopantetheine binding [GO:0031177],,,,1
P9WQ59,FAA28_MYCTU,Rv2941,fadD28 acoas Rv2941,GO:0004321; GO:0005524; GO:0005886; GO:0006633; GO:0008610; GO:0016874; GO:0044119; GO:0052170; GO:0052572; GO:0070566; GO:0071770,IPR000873; ,,fadD28,,Long-chain-fatty-acid--AMP ligase FadD28 (FAAL) (EC 6.2.1.-) (Acyl-AMP synthetase),plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; fatty-acyl-CoA synthase activity [GO:0004321]; ligase activity [GO:0016874]; DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; negative regulation by symbiont of host innate immune response [GO:0052170]; response to host immune response [GO:0052572],9634230; 19099550; 10573420; 11279114; 15042094; 20844580; 21969609; 19182784; 22206988,X-ray crystallography (2),"FUNCTION: Catalyzes the activation of long-chain fatty acids (C22-24 fatty acids) as acyl-adenylates (acyl-AMP), which are then transferred to the multifunctional polyketide synthase Mas for further chain extension. Involved in the biosynthesis of mycoserates. Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000269|PubMed:10573420, ECO:0000269|PubMed:11279114, ECO:0000269|PubMed:15042094, ECO:0000305|PubMed:20844580}.",MSVRSLPAALRACARLQPHDPAFTFMDYEQDWDGVAITLTWSQLYRRTLNVAQELSRCGSTGDRVVISAPQGLEYVVAFLGALQAGRIAVPLSVPQGGVTDERSDSVLSDSSPVAILTTSSAVDDVVQHVARRPGESPPSIIEVDLLDLDAPNGYTFKEDEYPSTAYLQYTSGSTRTPAGVVMSHQNVRVNFEQLMSGYFADTDGIPPPNSALVSWLPFYHDMGLVIGICAPILGGYPAVLTSPVSFLQRPARWMHLMASDFHAFSAAPNFAFELAARRTTDDDMAGRDLGNILTILSGSERVQAATIKRFADRFARFNLQERVIRPSYGLAEATVYVATSKPGQPPETVDFDTESLSAGHAKPCAGGGATSLISYMLPRSPIVRIVDSDTCIECPDGTVGEIWVHGDNVANGYWQKPDESERTFGGKIVTPSPGTPEGPWLRTGDSGFVTDGKMFIIGRIKDLLIVYGRNHSPDDIEATIQEITRGRCAAISVPGDRSTEKLVAIIELKKRGDSDQDAMARLGAIKREVTSALSSSHGLSVADLVLVAPGSIPITTSGKVRRGACVEQYRQDQFARLDA,"62,641",580,ATP-dependent AMP-binding enzyme family,DIM/DIP cell wall layer assembly [GO:0071770]; fatty acid biosynthetic process [GO:0006633]; growth of symbiont in host cell [GO:0044119]; lipid biosynthetic process [GO:0008610]; negative regulation by symbiont of host innate immune response [GO:0052170]; response to host immune response [GO:0052572],adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; fatty-acyl-CoA synthase activity [GO:0004321]; ligase activity [GO:0016874],plasma membrane [GO:0005886],acoas,,1
P9WNG7,ETFB_MYCTU,Rv3029c,etfB fixA Rv3029c MTV012.44c,GO:0005618; GO:0005829; GO:0005886; GO:0009055; GO:0040007; GO:0055114,IPR000049; IPR014730; IPR012255; IPR033948; IPR014729; ,,etfB,,Electron transfer flavoprotein subunit beta (Beta-ETF) (Electron transfer flavoprotein small subunit) (ETFSS),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; growth [GO:0040007]; oxidation-reduction process [GO:0055114],9634230; 21969609,,FUNCTION: The electron transfer flavoprotein serves as a specific electron acceptor for other dehydrogenases. It transfers the electrons to the main respiratory chain via ETF-ubiquinone oxidoreductase (ETF dehydrogenase) (By similarity). {ECO:0000250}.,MTNIVVLIKQVPDTWSERKLTDGDFTLDREAADAVLDEINERAVEEALQIREKEAADGIEGSVTVLTAGPERATEAIRKALSMGADKAVHLKDDGMHGSDVIQTGWALARALGTIEGTELVIAGNESTDGVGGAVPAIIAEYLGLPQLTHLRKVSIEGGKITGERETDEGVFTLEATLPAVISVNEKINEPRFPSFKGIMAAKKKEVTVLTLAEIGVESDEVGLANAGSTVLASTPKPAKTAGEKVTDEGEGGNQIVQYLVAQKII,"28,081",266,ETF beta-subunit/FixA family,growth [GO:0040007]; oxidation-reduction process [GO:0055114],electron transfer activity [GO:0009055],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],fixA,MTV012.44c,1
P95141,FAA29_MYCTU,Rv2950c,fadD29 Rv2950c,GO:0005524; GO:0005886; GO:0006633; GO:0008610; GO:0016874; GO:0016878; GO:0070566; GO:0071766; GO:0097040,IPR000873; ,,fadD29,,4-hydroxyphenylalkanoate adenylyltransferase (EC 6.2.1.51) (Acyl-AMP synthase) (Long-chain-fatty-acid--AMP ligase FadD29) (FAAL),plasma membrane [GO:0005886]; acid-thiol ligase activity [GO:0016878]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; phthiocerol biosynthetic process [GO:0097040],9634230; 15042094; 20553505; 21969609,,"FUNCTION: Catalyzes the activation of the long-chain fatty acids (C22-24 fatty acids) as acyl-adenylates (acyl-AMP), which are then transferred to the multifunctional polyketide synthase PpsA for further chain extension. Involved in the biosynthesis of phenolphthiocerol, which is an important intermediate in the biosynthesis of phenolic glycolipid (mycosid B). {ECO:0000269|PubMed:15042094, ECO:0000269|PubMed:20553505}.",MKTNSSFHAAGEVATQPAWGTGEQAAQPLNGSTSRFAMSESSLADLLQKAASQYPNRAAYKFIDYDTDPAGFTETVTWWQVHRRAMIVAEELWIYASSGDRVAILAPQGLEYIIAFMGVLQAGLIAVPLPVPQFGIHDERISSALRDSAPSIILTTSSVIDEVTTYAPHACAAQGQSAPIVVAVDALDLSSSRALDPTRFERPSTAYLQYTSGSTRAPAGVVLSHKNVITNCVQLMSDYIGDSEKVPSTPVSWLPFYHDMGLMLGIILPMINQDTAVLMSPMAFLQRPARWMQLLAKHRAQISSAPNFGFELAVRRTSDDDMAGLDLGHVRTIVTGAERVNVATLRRFTERFAPFNLSETAIRPSYGLAEATVYVATAGPGRAPKSVCFDYQQLSVGQAKRAENGSEGANLVSYGAPRASTVRIVDPETRMENPAGTVGEIWVQGDNVGLGYWRNPQQTEATFRARLVTPSPGTSEGPWLRTGDLGVIFEGELFITGRIKELLVVDGANHYPEDIEATIQEITGGRVVAIAVPDDRTEKLVTIIELMKRGRTDEEEKNRLRTVKREVASAISRSHRLRVADVVMVAPGSIPVTTSGKVRRSASVERYLHHEFSRLDAMA,"67,447",619,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; phthiocerol biosynthetic process [GO:0097040],acid-thiol ligase activity [GO:0016878]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874],plasma membrane [GO:0005886],,,1
O33289,ARGA_MYCTU,Rv2747,argA Rv2747,GO:0004042; GO:0040007; GO:0042450; GO:0042803; GO:0051289; GO:0103045,IPR016181; IPR000182; ,,argA,DOMAIN 10 148 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,Amino-acid acetyltransferase (EC 2.3.1.1) (N-acetylglutamate synthase) (AGS) (NAGS),acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; methione N-acyltransferase activity [GO:0103045]; protein homodimerization activity [GO:0042803]; arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007]; protein homotetramerization [GO:0051289],9634230; 15838030; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the conversion of L-glutamate to alpha-N-acetyl-L-glutamate. L-glutamine is a significantly better substrate compared to L-glutamate. {ECO:0000269|PubMed:15838030}.,MTERPRDCRPVVRRARTSDVPAIKQLVDTYAGKILLEKNLVTLYEAVQEFWVAEHPDLYGKVVGCGALHVLWSDLGEIRTVAVDPAMTGHGIGHAIVDRLLQVARDLQLQRVFVLTFETEFFARHGFTEIEGTPVTAEVFDEMCRSYDIGVAEFLDLSYVKPNILGNSRMLLVL,"19,589",174,Acetyltransferase family,arginine biosynthetic process via ornithine [GO:0042450]; growth [GO:0040007]; protein homotetramerization [GO:0051289],acetyl-CoA:L-glutamate N-acetyltransferase activity [GO:0004042]; methione N-acyltransferase activity [GO:0103045]; protein homodimerization activity [GO:0042803],,,,1
P9WHP5,35KD_MYCTU,Rv2744c,Rv2744c MTV002.09c,GO:0005618; GO:0005737; GO:0005886,IPR007157; ,,,,35 kDa protein,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],9634230; 21969609,,,MANPFVKAWKYLMALFSSKIDEHADPKVQIQQAIEEAQRTHQALTQQAAQVIGNQRQLEMRLNRQLADIEKLQVNVRQALTLADQATAAGDAAKATEYNNAAEAFAAQLVTAEQSVEDLKTLHDQALSAAAQAKKAVERNAMVLQQKIAERTKLLSQLEQAKMQEQVSASLRSMSELAAPGNTPSLDEVRDKIERRYANAIGSAELAESSVQGRMLEVEQAGIQMAGHSRLEQIRASMRGEALPAGGTTATPRPATETSGGAIAEQPYGQ,"29,258",270,PspA/IM30 family,,,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV002.09c,1
P9WPR3,Y2850_MYCTU,Rv2850c,Rv2850c MTCY24A1.07,GO:0005524; GO:0016887,IPR003593; IPR011704; IPR027417; IPR002035; IPR036465; ,,,DOMAIN 451 587 VWFA. {ECO:0000255|PROSITE-ProRule:PRU00219}.,Uncharacterized protein Rv2850c,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MKPYPFSAIVGHDRLRLALLLCAVRPEIGGALIRGEKGTAKSTAVRGLAALLSVATGSTETGLVELPLGATEDRVVGSLDLQRVMRDGEHAFSPGLLARAHGGVLYVDEVNLLHDHLVDILLDAAAMGRVHVERDGISHSHEARFVLIGTMNPEEGELRPQLLDRFGLTVDVQASRDIDVRVQVIRRRMAYEADPDAFVARYADADAELAHRIAAARATVDDVVLGDNELRRIAALCAAFDVDGMRADLVVARTAAAHAAWRGVRTVEEQDIRAAAELALPHRRRRDPFDDHGIDRDQLDEALALASVDPEPEPDPPGGGQSANEPASQPNSRSKSTEPGAPSSMGDDPPRPASPRLRSSPRPSAPPSKIFRTRALRVPGVGTGAPGRRSRARNASGSVVAAAEVSDPDAHGLHLFATLLAAGERAFGAGPLRPWPDDVRRAIREGREGNLVIFVVDASGSMAARDRMAAVSGATLSLLRDAYQRRDKVAVITFRQHEATLLLSPTSSAHIAGRRLARFSTGGKTPLAEGLLAARALIIREKVRDRARRPLVVVLTDGRATAGPDPLGRSRTAAAGLVAEGAAAVVVDCETSYVRLGLAAQLARQLGAPVVRLEQLHADYLVHAVRGVA,"66,987",629,Mg-chelatase subunits D/I family,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,MTCY24A1.07,1
P9WFQ5,Y2851_MYCTU,Rv2851c,Rv2851c MTCY24A1.06,GO:0006473; GO:0016747,IPR016181; IPR000182; ,,,DOMAIN 8 150 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,UPF0039 protein Rv2851c,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; protein acetylation [GO:0006473]",9634230; 21969609,,,MTEALRRVWAKDLDARALYELLKLRVEVFVVEQACPYPELDGRDLLAETRHFWLETPDGEVTCTLRLMEEHAGGEKVFRIGRLCTKRDARGQGHSNRLLCAALAEVGDYPCRIDAQAYLTAMYAQHGFVRDGDEFLDDGIPHVPMLRPGSGQVERP,"17,670",156,UPF0039 (ElaA) family,protein acetylation [GO:0006473],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,MTCY24A1.06,1
P9WL37,Y2885_MYCTU,Rv2885c,Rv2885c MTCY274.16c,GO:0003677; GO:0005886; GO:0006310; GO:0032196; GO:0046872,IPR001959; IPR010095; IPR021027; ,,,,Putative transposase Rv2885c,plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; transposition [GO:0032196],9634230,,,MMARLKVPEGWCVQAFRFTLNPTQTQAASLARHFGARRKAFNWTVTALKADIKAWRADGTESAKPSLRVLRKRWNTVKDQVCVNAQTGQVWWPECSKEAYADGIAGAVDAYWNWQSCRAGKRAGKTVGVPRFKKKGRDADRVCFTTGAMRVEPDRRHLTLPVIGTIRTYENTRRVERLIAKGRARVLAITVRRNGTRLDASVRVLVQRPQQRRVALPDSRVGVDVGVRRLATVADAEGTVLEQVPNPRPLDAALRGLRRVSRARSRCTKGSRRYCERTTELSRLHRRVNDVRTHHLHVLTTRLAKTHGRIVVEGLDAAGMLRQKGLPGARARRRALSDAALATPRRHLSYKTGWYGSSLVVADRWFPSSKTCHACRHVQDIGWDEKWQCDGCSITHQRDDNAAINLARYEEPPSVVGPVGAAVKRGADRKTGPGPAGGREARKATGHPAGEQPRDGVQVK,"51,284",460,Transposase 2 family; Transposase 35 family,DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,MTCY274.16c,1
P9WL35,Y2886_MYCTU,Rv2886c,Rv2886c MTCY274.17c,GO:0000150; GO:0003677; GO:0005829; GO:0005886,IPR006119; IPR036162; ,,,DOMAIN 151 290 Resolvase/invertase-type recombinase catalytic. {ECO:0000255|PROSITE-ProRule:PRU01072}.,Uncharacterized protein Rv2886c,cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230; 21969609,,,MSRILTHVPGRTVNRSYALPALVGSAAGRLSGNHSHGREAYIALPQWACSRQPSTPPLQTPGRINALWSLRPVLPMPGRGCQLLRLGGRWLSVVCCRNGSMNLVVWAEGNGVARVIAYRWLRVGRLPVPARRVGRVILVDEPAGQPGRWGRTAVCARLSSADQKVDLDRQVVGVTAWATAEQIPVGKVVTEVGSALYGRRRTFLTLLGDPTVRRIVMKRRDRLGRFGFECVQAVLAADGRELVVVDSADVDDDVVGDITEILTSICARLYGKRAAGNRAARAVAAAARAGGHEAR,"31,860",295,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY274.17c,1
P9WME9,Y2887_MYCTU,Rv2887,Rv2887 MTCY274.18,GO:0003700; GO:0006351; GO:0006355; GO:0044212,IPR000835; IPR023187; IPR036388; IPR036390; ,,,DOMAIN 6 138 HTH marR-type. {ECO:0000255|PROSITE-ProRule:PRU00345}.,Uncharacterized HTH-type transcriptional regulator Rv2887,"DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,X-ray crystallography (4),,MGLADDAPLGYLLYRVGAVLRPEVSAALSPLGLTLPEFVCLRMLSQSPGLSSAELARHASVTPQAMNTVLRKLEDAGAVARPASVSSGRSLPATLTARGRALAKRAEAVVRAADARVLARLTAPQQREFKRMLEKLGSD,"14,690",139,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212],,,MTCY274.18,1
P9WL31,Y2895_MYCTU,Rv2895c,Rv2895c MTCY274.26c,GO:0005886; GO:0010106; GO:0015891; GO:0033212; GO:0052851,IPR013113; IPR017927; IPR017938; IPR007037; ,,,DOMAIN 4 131 FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.,Uncharacterized protein Rv2895c,plasma membrane [GO:0005886]; ferric-chelate reductase (NADPH) activity [GO:0052851]; cellular response to iron ion starvation [GO:0010106]; iron assimilation [GO:0033212]; siderophore transport [GO:0015891],9634230; 21969609,,,MAGRPLHAFEVVATRHLAPHMVRVVLGGSGFDTFVPSDFTDSYIKLVFVDDDVDVGRLPRPLTLDSFADLPTAKRPPVRTMTVRHVDAAAREIAVDIVLHGEHGVAGPWAAGAQRGQPIYLMGPGGAYAPDPAADWHLLAGDESAIPAIAAALEALPPDAIGRAFIEVAGPDDEIGLTAPDAVEVNWVYRGGRADLVPEDRAGDHAPLIEAVTTTAWLPGQVHVFIHGEAQAVMHNLRPYVRNERGVDAKWASSISGYWRRGRTEEMFRKWKKELAEAEAGTH,"30,603",283,,cellular response to iron ion starvation [GO:0010106]; iron assimilation [GO:0033212]; siderophore transport [GO:0015891],ferric-chelate reductase (NADPH) activity [GO:0052851],plasma membrane [GO:0005886],,MTCY274.26c,1
P9WJP9,Y2900_MYCTU,Rv2900c,Rv2900c MTCY274.31c,GO:0005886; GO:0008863; GO:0030151; GO:0043546; GO:0051539,IPR009010; IPR037951; IPR006657; IPR006656; IPR010046; ,,,,Uncharacterized oxidoreductase Rv2900c (EC 1.-.-.-),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; formate dehydrogenase (NAD+) activity [GO:0008863]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]",9634230; 19099550; 21969609,,,MYVEAVRWQRSAASRDVLADYDEQAVTVAPRKREAAGVRAVMVSLQRGMQQMGALRTAAALARLNQRNGFDCPGCAWPEEPGGRKLAEFCENGAKAVAEEATKRTVTAEFFARHSVAELSAKPEYWLSQQGRLAHPMVLRPGDDHYRPISWDAAYQLIAEQLNGLDSPDRAVFYTSGRTSNEAAFCYQLLVRSFGTNNLPDCSNMCHESSGAALTDSIGIGKGSVTIGDVEHADLIVIAGQNPGTNHPRMLSVLGKAKANGAKIIAVNPLPEAGLIRFKDPQKVNGVVGHGIPIADEFVQIRLGGDMALFAGLGRLLLEAEERVPGSVVDRSFVDNHCAGFDGYRRRTLQVGLDTVMDATGIELAQLQRVAAMLMASQRTVICWAMGLTQHAHAVATIGEVTNVLLLRGMIGKPGAGVCPVRGHSNVQGDRTMGIWEKMPEQFLAALDREFGITSPRAHGFDTVAAIRAMRDGRVSVFMGMGGNFASATPDTAVTEAALRRCALTVQVSTKLNRSHLVHGATALILPTLGRTDRDTRNGRKQLVSVEDSMSMVHLSRGSLHPPSDQVRSEVQIICQLARALFGPGHPVPWERFADDYDTIRDAIAAVVPGCDDYNHKVRVPDGFQLPHPPRDAREFRTSTGKANFAVNPLQWVPVPPGRLVLQTLRSHDQYNTTIYGLDDRYRGVKGGRRVVFINPADIETFGLTAGDRVDLVSEWTDGQGGLQERRAKDFLVVAYSTPVGNAAAYYPETNPLVPLDHTAAQSNTPVSKAIIVRLEPTA,"84,566",779,Prokaryotic molybdopterin-containing oxidoreductase family,,"4 iron, 4 sulfur cluster binding [GO:0051539]; formate dehydrogenase (NAD+) activity [GO:0008863]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]",plasma membrane [GO:0005886],,MTCY274.31c,1
P9WL15,Y2927_MYCTU,Rv2927c,Rv2927c MTCY338.16c,GO:0040007,,,,,Uncharacterized protein Rv2927c,growth [GO:0040007],9634230; 21969609,,,MYRVFEALDELSAIVEEARGVPMTAGCVVPRGDVLELIDDIKDAIPGELDDAQDVLDARDSMLQDAKTHADSMVSSATTEAESILNHARTEADRILSDAKAQADRMVSEARQHSERMVADAREEAIRIATAAKREYEASVSRAQAECDRLIENGNISYEKAVQEGIKEQQRLVSQNEVVAAANAESTRLVDTAHAEADRLRGECDIYVDNKLAEFEEFLNGTLRSVGRGRHQLRTAAGTHDYAVR,"26,986",245,,growth [GO:0040007],,,,MTCY338.16c,1
P9WL13,Y2929_MYCTU,Rv2929,Rv2929 MTCY338.18,GO:0044119,,,,,Uncharacterized protein Rv2929,growth of symbiont in host cell [GO:0044119],9634230,,,MIELSYAPDVAGRRSNWPKGSGVNTWTAIRWTFAEDSPYVGTGLERMASDTHGGGGGRPVTPPPPGMHHLGCSRGVLLISSQRDAGHKTCDPAAGGTLTSVLT,"10,744",103,,growth of symbiont in host cell [GO:0044119],,,,MTCY338.18,1
I6YET7,Y2963_MYCTU,Rv2963 RVBD_2963,Rv2963 RVBD_2963 P425_03084,GO:0005886; GO:0016021,IPR005524; ,,,,Putative permease Rv2963,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609; 21166899; 24549843,,,MTSTKVEDRVTAAVLGAIGHALALTASMTWEILWALILGFALSAVVQAVVRRSTIVTLLGDDRPRTLVIATGLGAASSSCSYAAVALARSLFRKGANFTAAMAFEIGSTNLVVELGIILALLMGWQFTAAEFVGGPIMILVLAVLFRLFVGARLIDAAREQAERGLAGSMEGHAAMDMSIKREGSFWRRLLSPPGFTSIAHVFVMEWLAILRDLILGLLIAGAIAAWVPESFWQSFFLANHPAWSAVWGPIIGPIVAIVSFVCSIGNVPLAAVLWNGGISFGGVIAFIFADLLILPILNIYRKYYGARMMLVLLGTFYASMVVAGYLIELLFGTTNLIPSQRSATVMTAEISWNYTTWLNVIFLVIAAALVVRFITSGGLPMLRMMGGSPDAPHDHHDRHDDHLGH,"43,729",406,UPF0718 family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,P425_03084,1
P9WQA5,Y2971_MYCTU,Rv2971,Rv2971,GO:0005618; GO:0005886; GO:0016491; GO:0040007,IPR018170; IPR020471; IPR023210; IPR036812; ,,,,Uncharacterized oxidoreductase Rv2971 (EC 1.-.-.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; growth [GO:0040007],9634230; 21969609,X-ray crystallography (1),,MTGESGAAAAPSITLNDEHTMPVLGLGVAELSDDETERAVSAALEIGCRLIDTAYAYGNEAAVGRAIAASGVAREELFVTTKLATPDQGFTRSQEACRASLDRLGLDYVDLYLIHWPAPPVGKYVDAWGGMIQSRGEGHARSIGVSNFTAENIENLIDLTFVTPAVNQIELHPLLNQDELRKANAQHTVVTQSYCPLALGRLLDNPTVTSIASEYVKTPAQVLLRWNLQLGNAVVVRSARPERIASNFDVFDFELAAEHMDALGGLNDGTRVREDPLTYAGT,"30,364",282,Aldo/keto reductase family,growth [GO:0040007],oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
I6YB21,Y3067_MYCTU,Rv3067 RVBD_3067 LH57_16745,Rv3067 RVBD_3067 LH57_16745 P425_03195,GO:0005886; GO:0016021,IPR007969; ,,,,Uncharacterized protein Rv3067,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MRDEPPTDTAAAPTTGAAPEIDTAREYEVTAEYQSWRVVWGSAAALLTVGVGIGAAILLGWFTLAHRHPDQPGAAATPPPAGLTTRSAPTAAPPSTLQSPDLDSVFLGNLHDRGISFTNPDAAVYNGKMVCTNLGGGMTVQQVVEALQSSSPALGDRTTAYVAVSIRTYCPKYDAVLPPGS,"18,749",181,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,P425_03195,2
P9WKB1,Y3087_MYCTU,Rv3087,Rv3087 MTV013.08,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0010447; GO:0019432; GO:0044119; GO:0047196; GO:0052562; GO:0071731,IPR014292; IPR023213; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv3087 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv3087),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; negative regulation by symbiont of host immune response [GO:0052562]; response to acidic pH [GO:0010447]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 14568148; 15262939; 15937179; 16893682; 21969609,,"FUNCTION: Required for maintaining the appropriate mycolic acid composition and permeability of the envelope on its exposure to acidic pH. Upon expression in E.coli functions weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity. {ECO:0000269|PubMed:15262939, ECO:0000269|PubMed:15937179}.",MRRLNGVDALMLYLDGGSAYNHTLKISVLDPSTDPDGWSWPKARQMFEERAHLLPVFRLRYLPTPLGLHHPIWVEDPEFDLDAHVRRVVCPAPGGMAEFCALVEQIYAHPLDRDRPLWQTWVVEGLDGGRVALVTLLHHAYSDGVGVLDMLAAFYNDTPDEAPVVAPPWEPPPLPSTRQRLGWALRDLPSRLGKIAPTVRAVRDRVRIEREFAKDGDRRVPPTFDRSAPPGPFQRGLSRSRRFSCESFPLAEVREVSKTLGVTINDVFLACVAGAVRRYLERCGSPPTDAMVATMPLAVTPAAERAHPGNYSSVDYVWLRADIADPLERLHATHLAAEATKQHFAQTKDADVGAVVELLPERLISGLARANARTKGRFDTFKNVVVSNVPGPREPRYLGRWRVDQWFSTGQISHGATLNMTVWSYCDQFNLCVMADAVAVRNTWELLGGFRASHEELLAAARAQATPKEMAT,"52,597",472,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; negative regulation by symbiont of host immune response [GO:0052562]; response to acidic pH [GO:0010447]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV013.08,1
P9WHM3,PURU_MYCTU,Rv2964,purU Rv2964 MTCY349.23c,GO:0006189; GO:0006730; GO:0008864; GO:0016742,IPR002912; IPR002376; IPR036477; IPR004810; ,,purU,DOMAIN 32 108 ACT. {ECO:0000255|HAMAP-Rule:MF_01927}.,Formyltetrahydrofolate deformylase (EC 3.5.1.10) (Formyl-FH(4) hydrolase),"formyltetrahydrofolate deformylase activity [GO:0008864]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; 'de novo' IMP biosynthetic process [GO:0006189]; one-carbon metabolic process [GO:0006730]",9634230; 21969609,,FUNCTION: Catalyzes the hydrolysis of 10-formyltetrahydrofolate (formyl-FH4) to formate and tetrahydrofolate (FH4). {ECO:0000255|HAMAP-Rule:MF_01927}.,MGKGSMTAHATPNEPDYPPPPGGPPPPADIGRLLLRCHDRPGIIAAVSTFLARAGANIISLDQHSTAPEGGTFLQRAIFHLPGLTAAVDELQRDFGSTVADKFGIDYRFAEAAKPKRVAIMASTEDHCLLDLLWRNRRGELEMSVVMVIANHPDLAAHVRPFGVPFIHIPATRDTRTEAEQRQLQLLSGNVDLVVLARYMQILSPGFLEAIGCPLINIHHSFLPAFTGAAPYQRARERGVKLIGATAHYVTEVLDEGPIIEQDVVRVDHTHTVDDLVRVGADVERAVLSRAVLWHCQDRVIVHHNQTIVF,"34,006",310,PurU family,'de novo' IMP biosynthetic process [GO:0006189]; one-carbon metabolic process [GO:0006730],"formyltetrahydrofolate deformylase activity [GO:0008864]; hydroxymethyl-, formyl- and related transferase activity [GO:0016742]",,,MTCY349.23c,1
P9WHJ3,RECA_MYCTU,Rv2737c,recA Rv2737c MTV002.02c,GO:0000150; GO:0000287; GO:0000725; GO:0003697; GO:0004520; GO:0005524; GO:0005829; GO:0006314; GO:0006974; GO:0008094; GO:0009432; GO:0009650; GO:0016539; GO:0016887; GO:0030145; GO:0042148; GO:0046677,IPR003593; IPR013765; IPR020584; IPR003586; IPR003587; IPR036844; IPR027434; IPR006142; IPR030934; IPR004042; IPR006141; IPR004860; IPR027417; IPR020588; IPR023400; IPR020587; ,,recA,DOMAIN 366 508 DOD-type homing endonuclease.,Protein RecA (Recombinase A) [Cleaved into: Endonuclease PI-MtuI (EC 3.1.-.-) (Mtu RecA intein)],cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]; recombinational repair [GO:0000725]; response to antibiotic [GO:0046677]; SOS response [GO:0009432]; strand invasion [GO:0042148]; UV protection [GO:0009650],1909321; 9634230; 1423588; 8639660; 20455546; 20066036; 21969609; 11121488,X-ray crystallography (31); NMR spectroscopy (1),"FUNCTION: Can catalyze the hydrolysis of ATP in the presence of single-stranded DNA, the ATP-dependent uptake of single-stranded DNA by duplex DNA, and the ATP-dependent hybridization of homologous single-stranded DNAs. It interacts with LexA causing its activation and leading to its autocatalytic cleavage.; FUNCTION: PI-MtuI is an endonuclease.",MTQTPDREKALELAVAQIEKSYGKGSVMRLGDEARQPISVIPTGSIALDVALGIGGLPRGRVIEIYGPESSGKTTVALHAVANAQAAGGVAAFIDAEHALDPDYAKKLGVDTDSLLVSQPDTGEQALEIADMLIRSGALDIVVIDSVAALVPRAELEGEMGDSHVGLQARLMSQALRKMTGALNNSGTTAIFINQLRDKIGVMFGSPETTTGGKALKFYASVRMDVRRVETLKDGTNAVGNRTRVKVVKNKCLAEGTRIFDPVTGTTHRIEDVVDGRKPIHVVAAAKDGTLHARPVVSWFDQGTRDVIGLRIAGGAIVWATPDHKVLTEYGWRAAGELRKGDRVAQPRRFDGFGDSAPIPADHARLLGYLIGDGRDGWVGGKTPINFINVQRALIDDVTRIAATLGCAAHPQGRISLAIAHRPGERNGVADLCQQAGIYGKLAWEKTIPNWFFEPDIAADIVGNLLFGLFESDGWVSREQTGALRVGYTTTSEQLAHQIHWLLLRFGVGSTVRDYDPTQKRPSIVNGRRIQSKRQVFEVRISGMDNVTAFAESVPMWGPRGAALIQAIPEATQGRRRGSQATYLAAEMTDAVLNYLDERGVTAQEAAAMIGVASGDPRGGMKQVLGASRLRRDRVQALADALDDKFLHDMLAEELRYSVIREVLPTRRARTFDLEVEELHTLVAEGVVVHNCSPPFKQAEFDILYGKGISREGSLIDMGVDQGLIRKSGAWFTYEGEQLGQGKENARNFLVENADVADEIEKKIKEKLGIGAVVTDDPSNDGVLPAPVDF,"85,389",790,RecA family,cellular response to DNA damage stimulus [GO:0006974]; intein-mediated protein splicing [GO:0016539]; intron homing [GO:0006314]; recombinational repair [GO:0000725]; response to antibiotic [GO:0046677]; SOS response [GO:0009432]; strand invasion [GO:0042148]; UV protection [GO:0009650],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA-dependent ATPase activity [GO:0008094]; endodeoxyribonuclease activity [GO:0004520]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; recombinase activity [GO:0000150]; single-stranded DNA binding [GO:0003697],cytosol [GO:0005829],,MTV002.02c,1
P9WHK5,PYRH_MYCTU,Rv2883c,pyrH Rv2883c MTCY274.14c,GO:0000287; GO:0005524; GO:0005737; GO:0005886; GO:0006225; GO:0033862; GO:0040007; GO:0044210,IPR036393; IPR001048; IPR011817; IPR015963; ,,pyrH,,Uridylate kinase (UK) (EC 2.7.4.22) (Uridine monophosphate kinase) (UMP kinase) (UMPK),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; UMP kinase activity [GO:0033862]; 'de novo' CTP biosynthetic process [GO:0044210]; growth [GO:0040007]; UDP biosynthetic process [GO:0006225],9634230; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the reversible phosphorylation of UMP to UDP. {ECO:0000255|HAMAP-Rule:MF_01220}.,MTEPDVAGAPASKPEPASTGAASAAQLSGYSRVLLKLGGEMFGGGQVGLDPDVVAQVARQIADVVRGGVQIAVVIGGGNFFRGAQLQQLGMERTRSDYMGMLGTVMNSLALQDFLEKEGIVTRVQTAITMGQVAEPYLPLRAVRHLEKGRVVIFGAGMGLPYFSTDTTAAQRALEIGADVVLMAKAVDGVFAEDPRVNPEAELLTAVSHREVLDRGLRVADATAFSLCMDNGMPILVFNLLTDGNIARAVRGEKIGTLVTT,"27,430",261,UMP kinase family,'de novo' CTP biosynthetic process [GO:0044210]; growth [GO:0040007]; UDP biosynthetic process [GO:0006225],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; UMP kinase activity [GO:0033862],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY274.14c,1
P9WG71,THIL_MYCTU,Rv2977c,thiL Rv2977c,GO:0005524; GO:0009030; GO:0009228; GO:0009229; GO:0040007; GO:0046872,IPR010918; IPR036676; IPR016188; IPR036921; IPR006283; ,,thiL,,Thiamine-monophosphate kinase (TMP kinase) (Thiamine-phosphate kinase) (EC 2.7.4.16),ATP binding [GO:0005524]; metal ion binding [GO:0046872]; thiamine-phosphate kinase activity [GO:0009030]; growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the ATP-dependent phosphorylation of thiamine-monophosphate (TMP) to form thiamine-pyrophosphate (TPP), the active form of vitamin B1. {ECO:0000255|HAMAP-Rule:MF_02128}.",MTTKDHSLATESPTLQQLGEFAVIDRLVRGRRQPATVLLGPGDDAALVSAGDGRTVVSTDMLVQDSHFRLDWSTPQDVGRKAIAQNAADIEAMGARATAFVVGFGAPAETPAAQASALVDGMWEEAGRIGAGIVGGDLVSCRQWVVSVTAIGDLDGRAPVLRSGAKAGSVLAVVGELGRSAAGYALWCNGIEDFAELRRRHLVPQPPYGHGAAAAAVGAQAMIDVSDGLLADLRHIAEASGVRIDLSAAALAADRDALTAAATALGTDPWPWVLSGGEDHALVACFVGPVPAGWRTIGRVLDGPARVLVDGEEWTGYAGWQSFGEPDNQGSLG,"34,331",333,Thiamine-monophosphate kinase family,growth [GO:0040007]; thiamine biosynthetic process [GO:0009228]; thiamine diphosphate biosynthetic process [GO:0009229],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; thiamine-phosphate kinase activity [GO:0009030],,,,1
P9WQD5,TESA_MYCTU,Rv2928,tesA Rv2928 MTCY338.17,GO:0005886; GO:0008610; GO:0016788; GO:0052562; GO:0071770,IPR029058; IPR020802; IPR012223; IPR001031; ,,tesA,,Probable thioesterase TesA (EC 3.1.2.-),"plasma membrane [GO:0005886]; hydrolase activity, acting on ester bonds [GO:0016788]; DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610]; negative regulation by symbiont of host immune response [GO:0052562]",9634230; 21969609,,,MLARHGPRYGGSVNGHSDDSSGDAKQAAPTLYIFPHAGGTAKDYVAFSREFSADVKRIAVQYPGQHDRSGLPPLESIPTLADEIFAMMKPSARIDDPVAFFGHSMGGMLAFEVALRYQSAGHRVLAFFVSACSAPGHIRYKQLQDLSDREMLDLFTRMTGMNPDFFTDDEFFVGALPTLRAVRAIAGYSCPPETKLSCPIYAFIGDKDWIATQDDMDPWRDRTTEEFSIRVFPGDHFYLNDNLPELVSDIEDKTLQWHDRA,"29,152",261,Thioesterase family,DIM/DIP cell wall layer assembly [GO:0071770]; lipid biosynthetic process [GO:0008610]; negative regulation by symbiont of host immune response [GO:0052562],"hydrolase activity, acting on ester bonds [GO:0016788]",plasma membrane [GO:0005886],,MTCY338.17,1
P9WG57,THYX_MYCTU,Rv2754c,thyX Rv2754c MTV002.19c,GO:0004799; GO:0006231; GO:0006235; GO:0040007; GO:0050660; GO:0050797; GO:0070402,IPR003669; IPR036098; ,,thyX,DOMAIN 7 233 ThyX. {ECO:0000255|PROSITE-ProRule:PRU00661}.,Flavin-dependent thymidylate synthase (FDTS) (EC 2.1.1.148) (FAD-dependent thymidylate synthase) (Thymidylate synthase ThyX) (TS) (TSase),flavin adenine dinucleotide binding [GO:0050660]; NADPH binding [GO:0070402]; thymidylate synthase (FAD) activity [GO:0050797]; thymidylate synthase activity [GO:0004799]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; growth [GO:0040007],9634230; 12657046; 19099550; 18192395; 18493582; 21657202; 21969609; 22034487; 16139296; 16730023; 25613812,X-ray crystallography (4),"FUNCTION: Catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) while utilizing 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor, and NADPH and FADH(2) as the reductant (PubMed:18493582). Is essential for growth of the pathogen on solid media in vitro; the essential function is something other than dTMP synthase (PubMed:12657046) (PubMed:22034487). {ECO:0000269|PubMed:12657046, ECO:0000269|PubMed:16139296, ECO:0000269|PubMed:18493582, ECO:0000269|PubMed:22034487}.",MAETAPLRVQLIAKTDFLAPPDVPWTTDADGGPALVEFAGRACYQSWSKPNPKTATNAGYLRHIIDVGHFSVLEHASVSFYITGISRSCTHELIRHRHFSYSQLSQRYVPEKDSRVVVPPGMEDDADLRHILTEAADAARATYSELLAKLEAKFADQPNAILRRKQARQAARAVLPNATETRIVVTGNYRAWRHFIAMRASEHADVEIRRLAIECLRQLAAVAPAVFADFEVTTLADGTEVATSPLATEA,"27,591",250,Thymidylate synthase ThyX family,dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; growth [GO:0040007],flavin adenine dinucleotide binding [GO:0050660]; NADPH binding [GO:0070402]; thymidylate synthase (FAD) activity [GO:0050797]; thymidylate synthase activity [GO:0004799],,,MTV002.19c,1
I6YAZ1,I6YAZ1_MYCTU,Rv3038c,Rv3038c,GO:0005737; GO:0008757; GO:0032259,IPR013216; IPR029063; ,,,,Conserved protein,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MTRSSNIPADATPNPHATAEQVAAARHDSKLAQVLYHDWEAENYDEKWSISYDQRCVDYARGRFDAIVPDEVIAQLPYDRALELGCGTGFFLLNLIQAGVARRGSVTDLSPGMVKVATRNGQALGLDIDGRVADAEGIPYDDDAFDLVVGHAVLHHIPDVELSLREVVRVLKPGGRFVFAGEPTTVGDGYARTLSTLTWRVVTNATKLPGLRGWRRPQGELDESSRAAALEALVDLHTFTPQDLQRIAHNAGAVEVQTATEEFTAAMLGWPLRTFECTVPPGRLGWGWARFAFTSWKTLGWVDANVWRHVVPKGWFYNVMITGVKPS,"36,050",327,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
I6YAY5,I6YAY5_MYCTU,Rv3033,Rv3033,,IPR025637; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAHSIVRTLLASGAATALIAIPTACSFSIGTSHSHSVSKAEVARQITAKMTDAAGNKPESVTCPSDLPAEVGAELNCEMKIKDRTFNVNVTVTSVDGSDVKFDMVETVDKNQVANIISDKLFQRVGARPDSVTCPDNLKGVEGAKLRCRLTDGSKTYGISVIVTSVDAGDVNFDFKVDDHPE,"19,272",182,,,,,,,1
I6XG43,I6XG43_MYCTU,Rv3079c,Rv3079c,GO:0016705,IPR019921; IPR011251; IPR036661; ,,,,Conserved protein,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MQFGVLTFVTDEGIGPAELGAALEHRGFESLFLAEHTHIPVNTQSPYPGGGPIPEKYYRTLDPFVALAAAAATTQSLVLGTGIALIPERDPIVTAKEVASLDLVSQGRFRFGVGVGWLREEVANHGVDPAVRGRVIDERLRAIIEIWTQEQAEFHGTYVDFDPIYCWPKPVTKPYPPLYVGGGPANFPRIARLNAGWIAISPSPQRLSGPLQRLRAMAGGDVPVTVCQWGEAAAKDLEGYRHLGVERVLLELPTEPRDPTLRYLDKLQAELARLA,"30,064",275,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
I6Y259,I6Y259_MYCTU,Rv2974c,Rv2974c,GO:0004371; GO:0006071,IPR019986; IPR004007; IPR036117; IPR033470; ,,,,Conserved hypothetical alanine rich protein,glycerone kinase activity [GO:0004371]; glycerol metabolic process [GO:0006071],9634230; 21969609,,,MNGARGNSGVILSQILRGIAEVTATAAAASGAVLRAVDANALGAALWRGVELVVASMGGVEVPGTIVSVLRAAAGAVDQCAHEGLAGAVTAAGDAAVIALEKTPEQLDVLADAGAVDAGGRGLLVLLDALRSTICGQAPARAVYEPSPRALPTDTATQRPAPQFEVMYLLAVCDAAAADQLRDRLKELGESVAIAAAPPDSYSVHVHTDDAGAAVEAGLAVGRVSRIVISALGSGTSGLPAGGWTRGRAVLAVVDGDGAAELFAGEGACVLRPGPDAVTPAADISAHQLVRAVVDTGAAHVMVLPNGYVAAEELVAGCTAAIGWGVDVVPVPTGSMVQGLAALAVHDAARQAVDDGYSMARAAGASRHGSVRIATQKALTWAGTCKPGDGLGIAGDEVLIVADDVAAAAIGLVDLLLASGGDLVTVLIGAGVTEDVAVVLERHVHDHHPGTELVSYRTGHRGDALLIGVE,"46,703",470,,glycerol metabolic process [GO:0006071],glycerone kinase activity [GO:0004371],,,,1
I6YEF3,I6YEF3_MYCTU,Rv2809,Rv2809,,,,,,Uncharacterized protein,,9634230,,,MTYAARDDTTLPKLLAQMRWVVLVDKRQLAVLLLENEGPVASATDTLDTRGDSDYENQPVDAVERLCRRLADQAVRQWGFMQGLKQKLGPGVDVRMKLVEWNR,"11,742",103,,,,,,,1
I6X5B0,I6X5B0_MYCTU,Rv2762c,Rv2762c,,,,,,Uncharacterized protein,,9634230,,,MSAATAAWDRRAAVVVGGVAEPGSAGPIAGADRKRLISRIQVRQLDSAAVAAKRRHLYYVRPLDGHPVARVDRKTDRAADSLPVAGVLGELDIPPVTVAEGLAGELASMASWLGLGGIAVSTRGDLAGELCAATKRTNG,"14,276",139,,,,,,,1
I6YEE1,I6YEE1_MYCTU,Rv2795c,Rv2795c,GO:0016787,IPR004843; ,,,,Uncharacterized protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MTWKGSGQETVGAEPTLWAISDLHTGHLGNKPVAESLYPSSPDDWLIVAGDVAERTDEIRWSLDLLRRRFAKVIWVPGNHELWTTNRDPMQIFGRARYDYLVNMCDEMGVVTPEHPFPVWTERGGPATIVPMFLLYDYSFLPEGANSKAEGVAIAKERNVVATDEFLLSPEPYPTRDAWCHERVAATRARLEQLDWMQPTVLVNHFPLLRQPCDALFYPEFSLWCGTTKTADWHTRYNAVCSVYGHLHIPRTTWYDGVRFEEVSVGYPREWRRRKPYSWLRQVLPDPQYAPGYLNDFGGHFVITPEMRTQAAQFRERLRQRQSR,"37,601",324,,,hydrolase activity [GO:0016787],,,,1
I6Y1V6,I6Y1V6_MYCTU,Rv2849c,cobO Rv2849c,GO:0005524; GO:0008817; GO:0009236,IPR003724; IPR027417; ,,cobO,,Probable cob(I)alamin adenosyltransferase CobO (Corrinoid adenosyltransferase) (Corrinoid adotransferase activity),"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]; cobalamin biosynthetic process [GO:0009236]",9634230; 21969609,,,MPQGNPLAVPNDGLTTRARRNMPILAVHTGEGKGKSTAAFGMALRAWNAGLDIAVFQFVKSAKWKVGEEAAFRQLGRLHDQHGIGGAVEWHKMGAGWSWTRTSRKAGTDVDRAAAAADGWAEIALRLATQRHDFYLLDEFTYPLKWGWLDVDEVVDVLRARPGHQHVVITGRDAPQRLVAAADLVTEMTKVKHPMDAGRKGQKGIEW,"22,810",207,,cobalamin biosynthetic process [GO:0009236],"ATP binding [GO:0005524]; cob(I)yrinic acid a,c-diamide adenosyltransferase activity [GO:0008817]",,,,1
I6XF60,I6XF60_MYCTU,Rv2731,Rv2731,,IPR007139; ,,,,Conserved alanine and arginine rich protein,,9634230; 21969609,,,MTADEPRSDDSSGSAPQPAATPVPRPGPRPGPRPVPRPTSYPVGAHPPSDPHRFGRIDDDGTVWLVSASGERIVGSWQAGDPEAAFAHFGRRFDDLSTEIMLMDERLASGTGDARKIKAHAIALAETLPTACVLGDVDALADRLTSIRDRAEVIAAADRSRREEHRAAQTARKEALAAEAEELAANATQWKVAGDRLRAILDEWKTISGVDRKVDDALWKRYSTARDTFNRRRGSHFAELDRERSGVRQSKERLCERAEELSESTDWTATSAEFRKLLADWKAAGRASKDVDDALWRRFKAAQDSFFTARNAATAEKEAELRANADAKEALLAEAERLDTTNHEAARAALRSIAEKWDAIGKVSRERAAELERRLRAVEKKVREAGEADWSDPQARARAEQFRARAEQFEHQAEKAAAAGRTKEADEAKANAEQWRQWAEAAADALTRRP,"49,796",450,,,,,,,1
I6X654,I6X654_MYCTU,Rv3061c,fadE22 Rv3061c,GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE22,,Probable acyl-CoA dehydrogenase FadE22,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MGIALTDDHRELSGVARAFLTSQKVRWAARASLDAAGDARPPFWQNLAELGWLGLHIDERHGGSGYGLSELVVVIEELGRAVAPGLFVPTVIASAVVAKEGTDDQRARLLPALIDGTLTAGVGLDSQVQVTDGVADGEAGIVLGAGLAELLLVAAGDDVLVLERGRKGVSVDVPENFDPTRRSGRVRLDNVRVTTDDILLGAYESALARARTLLAAEAVGGAADCVDSAVAYAKVRQQFGRTIATFQAVKHHCANMLVAAESAIAAVWDAARAAAEDEEQFRLAAAVAAALAFPAYARNAELNIQVHGGIGFTWEHDAHLHLRRALVTVGLFGGDAPVRDVFERTAAGVTRAISLDLPAQAEELRARIRSDAAEIAALEKDAQRDKLIETGYVMPHWPRPWGRAAGAVEQLVIEEEFSAAGIERPDYSITGWVILTLIQHGTPWQIERFVEKALRQQEIWCQLFSEPDAGSDAASVKTRATRVEGGWKINGQKVWTSGAQYCARGLATVRTDPDAPKHAGITTVIIDMLAPGVEVRPLRQITGDSEFNEVFFNDVFVPDEDVVGAPNSGWTVARATLGNERVSIGGSGSYYEAMAAKLVQLVQRRSDAFAGAPIRVGAFLAEDHALRLLNLRRAARSVEGAGPGPEGNITKLKVAEHMIEGAAIAAALWGPEIALLDGPGRVIGRTVMGARGMAIAGGTSEVTRNQIAERILGMPRDPLIS,"76,741",721,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,1
P95086,P95086_MYCTU,Rv3072c,Rv3072c,GO:0016705,IPR011251; IPR036661; ,,,,Uncharacterized protein,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230,,,MACVRRSCDVTGTARAGIGAGADPAVVDAVAVAADDCGFATLWVGEHVVMVDRPASRYPYSRDGVIAVPAQADWLDPMIALSFAAAASSRVDVATGVLLLPEHNPVIVAKEAASLDRLSGRRLTLGVASDGPRRSSTRSECHSSGAQSAPPNTSLQCAHYGATTSHRSTATVGS,"17,844",174,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
P71653,P71653_MYCTU,Rv2798c,Rv2798c,,IPR036689; ,,,,Uncharacterized protein,,9634230,,,MFQISPEQWMHSAAQVTTQGEGLAVGHLSSDYRMQAAQFGWQGASAMALNAKMDDWLDASRALLTRIGDHAFGLQEAAIQHAAAEAERAQALAQVGVSADVVAGPRGV,"11,406",108,,,,,,,2
P95120,P95120_MYCTU,Rv2975c,Rv2975c,GO:0004371; GO:0006071,IPR004007; IPR036117; ,,,,Uncharacterized protein,glycerone kinase activity [GO:0004371]; glycerol metabolic process [GO:0006071],9634230,,,MGTADRPLDASALRDWAHAVVSDLILHIDEINRLNVFPVADSDTGVNMLFTMRAAVVEADLHANSQADAEDVARVAAALAAGAR,"8,868",84,,glycerol metabolic process [GO:0006071],glycerone kinase activity [GO:0004371],,,,4
P95125,P95125_MYCTU,Rv2970c,lipN Rv2970c,GO:0005886; GO:0009056; GO:0034338,IPR029058; IPR013094; ,,lipN,,Probable lipase/esterase LipN,plasma membrane [GO:0005886]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],9634230; 21969609,,,MTKSLPGVADLRLGANHPRMWTRRVQGTVVNVGVKVLPWIPTPAKRILSAGRSVIIDGNTLDPTLQLMLSTSRIFGVDGLAVDDDIVASRAHMRAICEAMPGPQIHVDVTDLSIPGPAGEIPARHYRPSGGGATPLLVFYHGGGWTLGDLDTHDALCRLTCRDADIQVLSIDYRLAPEHPAPAAVEDAYAAFVWAHEHASDEFGALPGRVAVGGDSAGGNLSAVVCQLARDKARYEGGPTPVLQWLLYPRTDFTAQTRSMGLFGNGFLLTKRDIDWFHTQYLRDSDVDPADPRLSPLLAESLSGLAPALIAVAGFDPLRDEGESYAKALRAAGTAVDLRYLGSLTHGFLNLFQLGGGSAAGTNELISALRAHLSRV,"40,135",376,,catabolic process [GO:0009056],short-chain carboxylesterase activity [GO:0034338],plasma membrane [GO:0005886],,,1
I6XFF3,I6XFF3_MYCTU,Rv2835c,ugpA Rv2835c,GO:0005887; GO:0055085,IPR000515; IPR035906; ,,ugpA,,Probable Sn-glycerol-3-phosphate transport integral membrane protein ABC transporter UgpA,integral component of plasma membrane [GO:0005887]; transmembrane transport [GO:0055085],9634230,,,MAAPQRARLRSSKERVRDYALFVVLVGPNVALLLLFVYRPLADNIRLSFFDWNVSDPSARFVGLSNYTEWFTRSDTRQIVFNTAVFTGAAVVGSMVLGLALAMLLDRPLRGRNLVRSTVFAPFVISGAAVGLAAQFVFDPHFGLIQDLLRRIGVGVPDFYQDARWALFMVTITYVWKNLGYTFVIYLAALQGVRRDLLEAAEIDGASRWAVFRRVLLPQLRPTTFFLSITVLINSLQVFDVINVMTRGGPEGTGTTTMVYQVYVETFRNFRAGYGATVATIMFLVLLAVTYYQVRVMDRGQRQ,"34,111",303,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of plasma membrane [GO:0005887],,,1
I6Y1V1,I6Y1V1_MYCTU,Rv2844,Rv2844,,IPR029447; IPR012347; IPR009078; ,,,,Conserved alanine rich protein,,9634230; 21969609,,,MTSSEPAHGATPKRSPSEGSADNAALCDALAVEHATIYGYGIVSALSPPGVNFLVADALKQHRHRRDDVIVMLSARGVTAPIAAAGYQLPMQVSSAADAARLAVRMENDGATAWRAVVEHAETADDRVFASTALTESAVMATRWNRVLGAWPITAAFPGGDE,"16,940",162,,,,,,,1
I6Y204,I6Y204_MYCTU,Rv2911,dacB2 Rv2911,GO:0004175; GO:0009002,IPR012338; IPR018044; IPR001967; ,,dacB2,,Probable penicillin-binding protein DacB2 (D-alanyl-D-alanine carboxypeptidase) (DD-peptidase) (DD-carboxypeptidase) (PBP) (DD-transpeptidase) (Serine-type D-ala-D-ala carboxypeptidase) (D-amino acid...,endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002],9634230; 21969609; ,X-ray crystallography (1),,MRKLMTATAALCACAVTVSAGAAWADADVQPAGSVPIPDGPAQTWIVADLDSGQVLAGRDQNVAHPPASTIKVLLALVALDELDLNSTVVADVADTQAECNCVGVKPGRSYTARQLLDGLLLVSGNDAANTLAHMLGGQDVTVAKMNAKAATLGATSTHATTPSGLDGPGGSGASTAHDLVVIFRAAMANPVFAQITAEPSAMFPSDNGEQLIVNQDELLQRYPGAIGGKTGYTNAARKTFVGAAARGGRRLVIAMMYGLVKEGGPTYWDQAATLFDWGFALNPQASVGSL,"29,747",291,Peptidase S11 family,,endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002],,,,1
O05777,O05777_MYCTU,Rv3099c,Rv3099c,GO:0005618; GO:0005886; GO:0046872,IPR017517; IPR034660; IPR010872; IPR024344; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872],9634230; 21969609,,,MTTPGRPLTTLDKSDVLAGLFAVWHSLDALLDGLLETDWQATSPLPGWDVKAVVSHIIGTESFLLGIAAPEPDTDVSALAHVRNPIGVMNECWVRHLGTESGVGLLERFRAVTSQRRKVLASLSDDEWNAPTTTPSGPDSYGRFMRIRIFDCWMHEQDIRAAVQRPSSDDELGGPASPLVLDEIAATMGFVVGKLAKAPDGSRVLLELTGPLSRSIRVSVDGRARVVDDFGGPAPTATIRLDGLQFTRLAGGRPMSPARSQDVELGGDKELAGHILERLNFVI,"30,508",283,,,metal ion binding [GO:0046872],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P71641,P71641_MYCTU,Rv2810c,Rv2810c,,IPR002560; ,,,DOMAIN 61 118 DDE_Tnp_ISL3. {ECO:0000259|Pfam:PF01610}.,Probable transposase (Fragment),,9634230,,,PLRLQAHTGGPPVALRQETTGGPSPTNDLITEPPRHYKQQTRVRQAPALLTVSAGTGVPVVLEELAKLGRTLWRCRHDVLAYFDHHASNGPTEAINGRLEALCRNALGFRNLTHYRIRSLLHCGNLAQLIHAL,"14,648",133,,,,,,,1
I6X5W1,I6X5W1_MYCTU,Rv2968c,Rv2968c,GO:0016021,IPR012932; IPR038354; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MVAARPAERSGDPAAVRVPVPSAWWVLIGGVIGLFASMTLTVEKVRILLDPIYVPSCNVNPIVSCGSVMTTPQASLLGFPNPLLGIAGFTVVVVTGVLAVAKVPLPRWYWIGLAVGILVGVAFVHWLIFQSLYRIGALCPYCMVVWAVIATLLVVVASIVFGPMRENRGSQERVGARLLYQWRWSLATLWFTTVFLLIMVRFWDYWSTLI,"23,133",210,,,,integral component of membrane [GO:0016021],,,1
O05784,O05784_MYCTU,Rv3107c,agpS Rv3107c,GO:0005618; GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016164; IPR004113; IPR006094; ,,agpS,,Possible alkyldihydroxyacetonephosphate synthase AgpS (Alkyl-DHAP synthase) (Alkylglycerone-phosphate synthase),"cell wall [GO:0005618]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MRSWWGWGTVEDALSDQETQALQSRVAALVSGHDLSDHPPPDLTALGLAAPRVSPPASLAALCSSDLVDRAGHARGKAYRDIARNLQGQLDHLPDLIARPRSEQDVIDVLDWCAREGIAVIPYGGGSSVVGGVEPRFDEPVVTVDVTAMSAVLEIDRVSRAARIQAGAFGPSIEHQLRPHDLTLRHFPQSFGFSTLGGWLATRSGGHFATLYTHIDDLTESLRIVTPVGISESRRLPGSGAGPSPDRLFLGSEGTLGIITEAWMRLQHRPRWQVTVSVVFDDWAAAVAATRTIAQAGLYPANCRLLDPAEALLNAGTSVGGGLLVLAFESADHPIDPWLHRAVAITAEHGGTVTAQRSRGTTSDATEHNAAANWRSAFLRMPYQRDALVRRGVIAETFETACTWDGFDTLHAAVTDAARTAIWKVCGTGVVTCRFTHVYPDGPAPYYGIYAGGRWGSLDAQWDEIKAAVSEAISASGGTITHHHAVGRDHRAWYDRQRPDPFAAALRAAKSALDPAGILNPGVLLGR,"56,521",527,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",cell wall [GO:0005618],,,1
P71625,P71625_MYCTU,Rv2827c,Rv2827c,GO:0040007,IPR025159; IPR018547; IPR036390; ,,,,Uncharacterized protein,growth [GO:0040007],9634230; 21969609,,,MVSPAGADRRIPTWASRVVSGLARDRPVVVTKEDLTQRLTEAGCGRDPDSAIRELRRIGWLVQLPVKGTWAFIPPGEAAISDPYLPLRSWLARDQNAGFMLAGASAAWHLGYLDRQPDGRIPIWLPPAKRLPDGLASYVSVVRIPWNAADTALLAPRPALLVRRRLDLVAWATGLPALGPEALLVQIATRPASFGPWADLVPHLDDLVADCSDERLERLLSGRPTSAWQRASYLLDSGGEPARGQALLAKRHTEVMPVTRFTTAHSRDRGESVWAPEYQLVDELVVPLLRVIGKA,"32,347",295,,growth [GO:0040007],,,,,4
I6YEE6,I6YEE6_MYCTU,Rv2800,Rv2800,GO:0008239,IPR029058; IPR005674; IPR008979; IPR000383; IPR013736; ,,,,Possible hydrolase,dipeptidyl-peptidase activity [GO:0008239],9634230,,,MSTTSARPERPKLRALTGRVGGQALGGLLGLPRATTRYTVGHVRVPMRDGVQLVADHYAPATSQPVGTLLVRGPYGRRFPFSLVFARIYAARGYHVVLQSVRGTFGSGGVFEPMVNEAADGADTVAWLREQPWFTGRFGTIGLPYLGFTQWALLHDPPPELAAAVITVGPHDFRASVWGTGSFTVNDFLGWSDLVSHQEDPGRIRAGIRQLTAPRRVARTAATLPLGESARTLLGTGAPWFESWVEHTDRDDPFWDRLRFPAALDRVQVPVLLVGGWQDIFLRQTLQQYRHLRDRGVHVALTVGPWTHTQMLTKGLATGARESLDWLDAHLGRAPALRPSPVRVFVTGQGWRHLPDWPPATTERAWYLQPGGRLGESAPASGTPPATFRYHPADPTPTTGGPLLSSNGGYRDDSRLATRADVLCFTGAPLTHDLCVHGNPVVELVHSSDNPYVDVFVRVSEVDAKGRSRNVSDGYRRLGDAPELVRVELDAIAHRFRADSRIRVLIAGSWFPRYARNLGTPEPILTGRQLKPATHAVHFGRSRLLLPVG,"60,284",549,,,dipeptidyl-peptidase activity [GO:0008239],,,,1
O33340,O33340_MYCTU,Rv2858c,aldC Rv2858c,GO:0005886; GO:0016620; GO:0040007,IPR016161; IPR016163; IPR016160; IPR029510; IPR016162; IPR015590; ,,aldC,,Probable aldehyde dehydrogenase AldC,"plasma membrane [GO:0005886]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; growth [GO:0040007]",9634230; 21969609,,,MSTTQLINPATEEVLASVDHTDANAVDDAVQRARAAQRRWARLAPAQRAAGLRAFAAAVQAHLDELAALEVANSGHPIVSAEWEAGHVRDVLAFYAASPERLSGRQIPVAGGVDVTFNEPMGVVGVITPWNFPMVIASWAIAPALAAGNAVLVKPAELTPLTTMRLGELAVEAGLDEDLLQVLPGKGTVVGERFVTHPDIRKIVFTGSTEVGKRVMAGAAAQVKRVTLELGGKSANIVFHDCDLERAATTAPAGVFDNAGQDCCARSRILVQRSVYDRFMELLEPAVHSIVVGDPGSRATEMGPLVSRAHRDKVAGYVPDDAPVAFRGTAPAGRGFWFPPTVLTPKRGDRTVTDEIFGPVVVVLTFDDEADAISLANDTAYGLSGSIWTDDLSRALRVARAVESGNLSVNSHSSVRFNTPFGGFKQSGVGRELGPDAPLQFTETKNVFIAVGEEM,"48,259",455,Aldehyde dehydrogenase family,growth [GO:0040007],"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",plasma membrane [GO:0005886],,,1
I6Y263,I6Y263_MYCTU,Rv2978c,Rv2978c,,IPR001959; IPR010095; IPR021027; ,,,,Probable transposase,,9634230,,,MPKFEVPDGWTVQAFRFTLDPTEDQAKALARHFGARRKAYNWTVATLKADIQAWHASGTVTAKPSLRVLRKRWNTVKDDVCVNTETGVAWWPECSKEAYADGIAGAVEAYWNWQTSRAGKRAGKRVGFPRFKRKGRDQDRVSFTTGAMRVEPDRRHLTLPVIGTVRTHENTRRIERLIKAGRARVLAISVRRNGTRLDASVRVLVQRPQQPKVVHPGSRVGVDVGVRRLATVATADGTAIEQVENPRPLGAALRELRHVCRARSRCTKGSRRYRERTTQISRLHRRVNDVRTHHLHVLTTRLAQTHGRIVVEGLDATEMLRQKGLPGARARRRGLSDAALGTPRRHLSYKTVWYGSALVVADRWFPSSKTCHACRHVQDIGWDEQWQCDRCSVVHQRDDCAAINLARYEETSSIVGPVGAAVKRGADRKTGPRPAGGCEARKGSSPKAAEQPRDGVQVA,"51,407",459,,,,,,,1
I6XFY8,I6XFY8_MYCTU,Rv3026c,Rv3026c,GO:0008152; GO:0016021; GO:0016411; GO:0042171,IPR002123; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021]; acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; metabolic process [GO:0008152],9634230,,,MSAPAVTEHSWLPRATCGVSCVSVGDAAQVRRPLVVLRVALRVMLALLLVPGVPLVVMPLPGRTRVQRIYCRLVLRLFGVRITVSGSPVRNLRGVLVVSGHVSWLDVFCIGSVLPGSFVARADMFTGRTIGIVARILKIIPIERASLRRLPGVVDTIARRLRAGQTVVAFPEGTTWCGRPGDDAGRPAARAGAGCSHRGCGAFYPAMFQAAIDAGRPVQPLRLTYHHVDGTVSTAPAFVGDDTLVRSVCRLLTVRRTLAWVRVESLQLPGTDRRNLARRCQSAVLAGALGQSGQRPGRRHVPAT,"32,632",304,,metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],integral component of membrane [GO:0016021],,,1
O05769,O05769_MYCTU,Rv3090,Rv3090,GO:0005576; GO:0005886; GO:0005887,IPR001107; ,,,,Uncharacterized protein,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MTWQIVFVVICVIVAGVAALFWRLPSDDTTRSRAKTVTIAAVAAAAVFFFLGCFTIVGTRQFAIMTTFGRPTGVSLNNGFHGKWPWQMTHPMDGAVQIDKYVKEGNTDQRITVRLGNQSTALADVSIRWQLKQAAAPELFQQYKTFDNVRVNLIERNLSVALNEVFAGFNPLDPRNLDVSPLPSLAKRAADILRQDVGGQVDIFDVNVPTIQYDQSTEDKINQLNQQRAQTSIALEAQRTAEAQAKANEILSRSISDDPNVVVQNCITAAINKGISPLGCWPGSSALPTIAVPGR,"32,271",295,,,,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
I6Y2I9,I6Y2I9_MYCTU,Rv3092c,Rv3092c,GO:0016021,IPR008526; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSGGLFGLLDHVAVLARLAAASIDDIGAAAGRATAKAAGVVIDDTAVTPQYVHRITAERELPIIKRIAIGSVRNKLLLILPGALLLSQLVPWLLTPLLMLGATYLCYEGAEKVCGVIGGRGHDAAPQVAERELVAGAIRTDFILSAEIMVIALNEVADQPFVPRLIVLVIVALVITAAVYGVVAVIVQMDDVGLRLTQTASRFGQRIGGGLVAGMPKLLSALSAVGMGAMLWVGGHIVLVGSDHLGWHAPYRLVHHLDDHLVGSAGGALTWLVSTAACAATGLVIGIVVVALVHLVCFRPPRSRSL,"31,853",306,,,,integral component of membrane [GO:0016021],,,1
I6YA42,I6YA42_MYCTU,Rv2734,Rv2734,,IPR011101; ,,,,Uncharacterized protein,,9634230; 21969609,,,MSDRSAIEWTGATWNPVTGCDRVSPGCDHCYAMTLAKRLKAMGSDKYQTDGDPRTSGPGFGVTIHPRSLDEPFRWRSPRTVFVNSMADLFHARVALWFIREVFEVMRATPQHTYQILTKRSLRLRRLAHKLEWPSNVWMGVSVENVDAFRRIEDLRQVPAAVRFLSCEPLLGPLDGINLGSIDWVIAGGESGPNFRPIDPQWVRHIRDTCTAADVPFFFKQWGGRTPKAFGRELDGRCWDEMPLIEIRNPDPRTTSRVHADPMLATAPTESAQRSNPGQLVRQR,"32,254",284,,,,,,,1
P71639,P71639_MYCTU,Rv2812,Rv2812,GO:0003677; GO:0005618; GO:0005829; GO:0005886; GO:0015074; GO:0040007,IPR009057; IPR001584; IPR012337; IPR036397; IPR015378; ,,,,Probable transposase,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; growth [GO:0040007],9634230,,,MAVGDDEEKVRAERARAIGLFRYQLIWEAADAAHSTKQRGKMVRELASREHTDPFGRRVRISRQTIDRWIRGWRAGGFDALVPNPRQCTPRTPAEVLELAVALRRENPQRTAAAIRRILRTQLGWAPDERTLQRNFHRLGLTGATTGSAPAVFGRFEAEHPNALWTGDVLHGIRIDLRKTYLFAFLDDHSRLVPGYRWGHAEDTVRLAAALRPALASRGVPNAVYVDNGSPYVDAWLLRACAKLGVRLVHSTPGRPQGRGKIERFFRTVREQFLVEITGEPDVVGRHYVADLAELNRLFTAWVETVYHRSVHSETGQTPLARWSAGGPIPLPAPETLTEAFLWEEHRRVTKTATVSLHGNRYEIDPALVGRKVELVFDPFDLTRIEVRLAGAPMRRAIPYHIGRHSHPKAKPETPTAPPKPSGIDYAQLIETAHAAELARGVNYTALTGAADQIPGQLDLLTGQEAQPK,"52,437",469,,DNA integration [GO:0015074]; growth [GO:0040007],DNA binding [GO:0003677],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
I6X5C5,I6X5C5_MYCTU,Rv2781c,Rv2781c,GO:0018580,IPR013785; IPR004136; ,,,,Possible alanine rich oxidoreductase,nitronate monooxygenase activity [GO:0018580],9634230; 21969609,,,MVLGFWDIAVPIVGAPMAGGPSTPALAAAVSNAGGLGFVAGGYLSADRLADDIAAARAATTGPIGANLFVPQPSVADWAQLEYYADELEEVAEYYHTEVGQPVYGDDDDWVRKLEVVADVRPEVVSFTFGAPPPDVVQRLSALGLLVSITVTSVYEAGVAIAAGADSLVVQGPAAGGHRGTFAPDMEPGTESLHQLLDRIGSAHDVPLVAAGGLGTAEDVAAVLRRGAIAAQVGTALLLADEAGTNAAHRAALKNPEFDATLVTRAFSGRYARGLANNFTRLLDHVAPLGYPEVHQMTKPIRAAAVQADDPHGTNLWAGSAHRKTRPGPAADIIASLTPDVCSA,"35,393",344,,,nitronate monooxygenase activity [GO:0018580],,,,1
O05781,O05781_MYCTU,Rv3104c,Rv3104c,GO:0008381; GO:0016021; GO:0071470,IPR010920; IPR011066; IPR006685; IPR011014; IPR023408; ,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021]; mechanosensitive ion channel activity [GO:0008381]; cellular response to osmotic stress [GO:0071470],9634230; 21969609,,,MTTSGTVLATSIAQHWHNFWRGEIGDWILNRGLRIVMLLIAAVLAARFVTWLANRVTRRLDLGFTESDALVRSEATKHRQAVASVISWVSIVLIYVVVVYEVIDVLPVPVGALVGPAAVLGAALGFGAQRLVQDLLAGFFIIVEKQYGFGDLVELSMVGSPENAAGTVEDVTLRVTKLRSSEGEVFTVPNGNIVKSVNLSKDWARAVVDIPVPTSADLGRVNEVLHQECEHARHDSLLGELLLDEPTVMGVERIEVDTVTLRLVARTLPGKQFEAGRQLRVLVIRALTRAGIVTAADARAAVAESPEQ,"33,381",308,,cellular response to osmotic stress [GO:0071470],mechanosensitive ion channel activity [GO:0008381],integral component of membrane [GO:0016021],,,1
P95115,P95115_MYCTU,Rv2980,Rv2980,GO:0016021,IPR021903; ,,,,Possible conserved secreted protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTGESDGPPRAVLIAAAALAAAVIGVILVVAANRQPPERPVVIPAVPAPQATGPGCKALLAALPQRLGEYRRAPVAEPTTAGATAWRTGPNSTPVILRCGLDRPAEFVVGSAIQVVDRVQWFQVAAQNPDEPGRSTWYTVDRPVYVALTLPSGSGPTAIQELSDVIDHTIPAVPIDPAPAR,"18,785",181,,,,integral component of membrane [GO:0016021],,,4
I6Y1U3,I6Y1U3_MYCTU,Rv2834c,ugpE Rv2834c,GO:0005886; GO:0016021; GO:0055085,IPR000515; IPR035906; ,,ugpE,,Probable Sn-glycerol-3-phosphate transport integral membrane protein ABC transporter UgpE,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MTPDRLRSSVGYAAMLLVVTLIAGPLLFVFFTSFKDQPDIYAQPTSWWPLRWYPQNYRTATEQIPFWTFLRNSLIITSVLAVVKFTLGVLSAFGLVFVRFPGRTAVFLVIIAALMVPNQITVISNYALISHLGLRNTFAGIILPLAGVAFGTFLMRNHFLSLPAEIIEAARMDGARWWQLLLRVVLPMSRPTMVAVGVITVVNEWNEYLWPFLMSDDESVAPLPIGLTFLQQAEGVTNWGPVMAVTLLAMLPILLVFIALQRQMIKGLTSGAVKG,"30,615",275,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6YEL8,I6YEL8_MYCTU,Rv2877c,Rv2877c,GO:0016021; GO:0017004; GO:0055114,IPR003834; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; cytochrome complex assembly [GO:0017004]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MNEALIGLAFAAGLVAALNPCGFAMLPAYLLLVVYGQDSAGRTGPLSAVGRAAAATVGMALGFLTVFGIFGALTISAATAVQRYLPYATVLIGLALIALGGWLLLGRGLTALTPRSLGVRWAPTVRLGSMYGYGISYAVASLSCTIGPFLAVTGAGLRGGSVVGSVAIYLAYVAGLTLVVGVLAVAAATASSALADRLRRILPFVNRISGALLVVVGLYVGYYGLYELRLIAGVGANPQDAVIAAAGRLQGALAGWVNQHGAWPWAVLLVVLVVGAFAGTWFRRVRR,"29,322",287,,cytochrome complex assembly [GO:0017004]; oxidation-reduction process [GO:0055114],,integral component of membrane [GO:0016021],,,1
O33332,O33332_MYCTU,Rv2790c,ltp1 Rv2790c,GO:0003988; GO:0005618; GO:0006635,IPR002155; IPR016039; IPR020615; IPR020617; IPR020613; IPR020616; ,,ltp1,,Probable lipid-transfer protein Ltp1,cell wall [GO:0005618]; acetyl-CoA C-acyltransferase activity [GO:0003988]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MPNQGSSNKVYVIGVGMTKFEKPGRREGWDYPDMARESGTKALRDAGIDYREVEQGYVGYVYGESTSGQRALYELGMTGIPIVNVNNNCSTGSTALYLGAQAIRGGLADCVLALGFEKMQPGALGGGADDRESPLGRHVKALAEIDEFGFPVAPWMFGAAGREHMKKYGTTAEHFAKIGYKNHKHSVNNPYAQFQDEYTLDDILASKMISDPLTKLQCSPTSDGSAAVVLASEDYLANHNLAGRAVEIVGQAMTTDFASTFDGSARNIIGYDMTVQAAQRVYQQSGLGPKDFGVIELHDCFSANELLLYEALGLCGPGEAPELIDDNQTTYGGRWVVNPSGGLISKGHPLGATGLAQCAELTWQLRGTAEARQVDNVTAALQHNIGLGGAAVVTAYQRAER,"42,904",401,Thiolase family,fatty acid beta-oxidation [GO:0006635],acetyl-CoA C-acyltransferase activity [GO:0003988],cell wall [GO:0005618],,,1
I6X5G8,I6X5G8_MYCTU,Rv2828c,Rv2828c,,IPR014923; IPR008307; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTPALKEWSAAVHALLDGRQTVLLRKGGIGEKRFEVAAHEFLLFPTVAHSHAERVRPEHRDLLGPAAADSTDECVLLRAAAKVVAALPVNRPEGLDAIEDLHIWTAESVRADRLDFRPKHRLAVLVVSAIPLAEPVRLARTPEYGGCTSWVQLPVTPTLAAPVHDEAALAEVAARVREAVG,"19,583",181,,,,,,,1
P71644,P71644_MYCTU,Rv2807,Rv2807,GO:0003676; GO:0005886; GO:0015074,IPR001584; IPR012337; IPR036397; ,,,,Uncharacterized protein,plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; DNA integration [GO:0015074],9634230,,,MVSTTGMGRSTARRMLTGPGLPEPAEQVDGRRLRARGFSDDARALLEHVWALMGMPCGKYLVVMLELWLPLEAAAGDLDKPFATEAAVAELKAMSAATVDRYLKPARERMRIKGISTTKPSPLLRNSITIHTCSDEAPKVPGVIEADTVAHCGPSLIGEFARTLTMTDLVTGWTENASIRNNAAKWILEGIKECQQRFPFPMTVFDSDCGGEFINHDVAGWLQARDIAQTRSRPYQKNDQAHVESKNNHVVRKHAFYWRYDTGEELELLNRLWPLVSLRCNFFTPTKKPVGYTSTVNGRRKRIYDKPATPWQRLQASGVLDAQQLSTVAARIEGFNPADLTRQINAIQMQLLDLAKTKTEALATARHIDLQSLQPSINRLAKAK,"42,820",384,,DNA integration [GO:0015074],nucleic acid binding [GO:0003676],plasma membrane [GO:0005886],,,2
O33346,O33346_MYCTU,Rv2864c,Rv2864c,GO:0005618; GO:0008658; GO:0046677,IPR012338; IPR007887; IPR001460; ,,,,Possible penicillin-binding lipoprotein,cell wall [GO:0005618]; penicillin binding [GO:0008658]; response to antibiotic [GO:0046677],9634230,,,MVTKTTLASATSGLLLLAVVAMSGCTPRPQGPGPAAEKFFAALAIGDTASAAQLSDNPNEAREALNAAWAGLQAAHLDAQVLSAKYAEDTGTVAYRFSWHLPKDRIWTYDGQLKMARDEGRWHVRWTTSGLHPKLGEHQTFALRADPPRRASVNEVGGTDVLVPGYLYHYSLDAGQAGRELFGTAHAVVGALHPFDDTLNDPQLLAEQASSSTQPLDLVTLHADDSNRVAAAIGQLPGVVITPQAELLPTDKHFAPAVLNDVKKAVVDELDGKAGWRVVSVNQNGVDVSVLHEVAPSPASSVSITLDRVVQNAAQHAVNTRGGKAMIVVIKPSTGEILAIAQNAGADADGPVATTGLYPPGSTFKMITAGAAVERDLATPETLLGCPGEIDIGHRTIPNYGGFDLGVVPMSRAFASSCNTTFAELSSRLPPRGLTQAARRYGIGLDYQVDGITTVTGSVPPTVDLAERTEDGFGQGKVLASPFGMALVAATVAAGKTPVPQLIAGRPTAVEGDATPISQKMIDALRPMMRLVVTNGTAKEIAGCGEVFGKTGEAEFPGGSHSWFAGYRGDLAFASLIVGGGSSEYAVRMTKVMFESLPPGYLA,"63,014",603,,response to antibiotic [GO:0046677],penicillin binding [GO:0008658],cell wall [GO:0005618],,,3
I6YAC9,I6YAC9_MYCTU,Rv2828A,Rv2828A,,IPR018735; ,,,,Uncharacterized protein,,9634230,,,MCRNITELRGLQPPATPVEIAAAARQYVRKVSGITHPSAATAEAFEAAVAEVTATTTRLLDALPPRRQPPKTVPPLRRPDVAARLAGSR,"9,493",89,,,,,,,1
I6X579,I6X579_MYCTU,Rv2728c,Rv2728c,,,,,,Conserved alanine rich protein,,9634230; 21969609,,,MLSAIGIVPSAPVLVPELAGAAAAELADLGAAVIAAASLLPKSWIAVGTGRADDVVRPTDVGTFAGFGADVRVGLAPQDGDGVAVPVELPLCALLTAWVRGQARPEARAQVHVYASDHGSDAAVARGRQLRADIDREPDPIGVLVVADGLNTLTPRAPGGYDPDGAGMQRALDDALASGDLAVLTRLPAQVLGRVAFQVLAGLAEPGPRSAKEFYRGAPHGVGYFAGVWQP,"23,488",231,,,,,,,1
I6Y2H3,I6Y2H3_MYCTU,Rv3078,hab Rv3078,GO:0016021,,,hab,,Probable hydroxylaminobenzene mutase Hab,integral component of membrane [GO:0016021],9634230,,,MQKLLFTIGLALFLIGLLTGLVIPALKNPRMALSSHLEGVLNGMFLVVLGLLWPHIDLPEAWQVIAVALIVYSAYANWLATLLAAAWGAGRKFAPIATGDHKAPAAKEGFVSFLLLSLSVAIVIGVVIVIIGL,"14,080",133,,,,integral component of membrane [GO:0016021],,,1
I6XG31,I6XG31_MYCTU,Rv3064c,Rv3064c,GO:0016021,IPR032808; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MVKDLDRRLAGCLPAVLSLFRLVYGLLFAGYGSMILFGWPVTSAQPVEFGSWPGWYAGVIELVAGLLIATGLFTRAVAFVASGEMAVAYFWMHQPYALWPIGGPPDGNGGTPAILFCFGFFLLVFTGGGIYSIDARRTVTA,"15,134",141,,,,integral component of membrane [GO:0016021],,,1
O53254,O53254_MYCTU,Rv3007c,Rv3007c,GO:0010181; GO:0042602,IPR002563; IPR012349; ,,,,Possible oxidoreductase,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],9634230,,,MSEDVARIHDGDVIDESFDELMGMLDHPVFVVTTQADGHPAGCLVSFATQTSVQPPSFMVGLPRSTGTSEVASRSEHLAVHVLSQRQHVLAELFGSQTEEEVNKFARCSWRAGPCGMPILDDAAAWFIGRTASRSDVGDYVAYLLEPVSVWAPECSEDLLYLSDLDFDVDDIDPGKEASPRFYERERGDETRRYGVVRFTLDVP,"22,587",204,,,FMN binding [GO:0010181]; riboflavin reductase (NADPH) activity [GO:0042602],,,,3
I6YEJ7,I6YEJ7_MYCTU,Rv2856,nicT Rv2856,GO:0005886; GO:0015099; GO:0016021; GO:0046872,IPR004688; IPR011541; ,,nicT,,Nickel/cobalt efflux system,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; nickel cation transmembrane transporter activity [GO:0015099],9634230,,,MASSQLDRQRSRSAKMNRALTAAEWWRLGLMFAVIVALHLVGWLTVTLLVEPARLSLGGKAFGIGVGLTAYTLGLRHAFDADHIAAIDNTTRKLMSDGHRPLAVGFFFSLGHSTVVFGLAVMLVTGLKAIVGPVENDSSTLHHYTGLIGTSISGAFLYLIGILNVIVLVGIVRVFAHLRRGDYDEAELEQQLDNRGLLIRFLGRFTKSLTKSWHMYPVGFLFGLGFDTATEIALLVLAGTSAAAGLPWYAILCLPVLFAAGMCLLDTIDGSFMNFAYGWAFSSPVRKIYYNITVTGLSVAVALLIGSVELLGLIANQLGWQGPFWDWLGGLDLNTVGFVVVAMFALTWAIALLVWHYGRVEERWTPAPDRTT,"40,534",372,NiCoT transporter (TC 2.A.52) family,,metal ion binding [GO:0046872]; nickel cation transmembrane transporter activity [GO:0015099],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6YB54,I6YB54_MYCTU,Rv3096,Rv3096,,IPR017853; ,,,,Uncharacterized protein,,9634230; 21969609,,,MHRRTALKLPLLLAAGTVLGQAPRAAAEEPGRWSADRAHRWYQAHGWLVGANYITSNAINQLEMFQPGTYDPRRIDNELGLARFHGFNTVRVFLHDLLWAQDAPGFQTRLAQFVAIAARYHIKPLFVLFDSCWDPLPRPGRQRAPRAGVHNSGWVQSPGAERLDDRRYASTLYNYVTGVLGQFRNDDRVLGWDLWNEPDNPARVYRKVERKDKLERVAELLPQVFRWARTVDPVQPLTSGVWQGNWGDPGRRSTISAIQLDNADVITFHSYAAPAEFEGRIAELAPLQRPILCTEYLARSQGSTVEGILPIAKRHNVGAFNWGLVAGKTQTYLPWDSWDHPYRAPPKVWFHDLLHPNGRPYRDGEVQTIRKLNGMPSQD,"43,162",379,,,,,,,1
P71640,P71640_MYCTU,Rv2811,Rv2811,,,,,,Uncharacterized protein,,9634230,,,MVTVEADVDQVERRLAAGELSCPSCGGVLAGWGRARSRQLRGPAGPVELCPRRSRCTGCGVTHVLLPVSALLRRADTAAVIVSALAAKATSRVGFRRIATDVARPAETVRGWLRRFAERVEAVRSVFTVWLCAVDADPVMPDAGGGGFVDAVVAIGALAAAIGRRFSLPTVSLAETAVAVSGGRLLAPGWPGEWVQHESTLP,"21,118",202,,,,,,,2
I6YF08,I6YF08_MYCTU,Rv3036c,TB22.2 Rv3036c,,IPR021729; IPR037126; ,,TB22.2,,Probable conserved secreted protein TB22.2,,9634230; 21969609,,,MRYLIATAVLVAVVLVGWPAAGAPPSCAGLGGTVQAGQICHVHASGPKYMLDMTFPVDYPDQQALTDYITQNRDGFVNVAQGSPLRDQPYQMDATSEQHSSGQPPQATRSVVLKFFQDLGGAHPSTWYKAFNYNLATSQPITFDTLFVPGTTPLDSIYPIVQRELARQTGFGAAILPSTGLDPAHYQNFAITDDSLIFYFAQGELLPSFVGACQAQVPRSAIPPLAI,"24,407",227,,,,,,,1
P95098,P95098_MYCTU,Rv3060c,Rv3060c,GO:0003677; GO:0003700; GO:0005618; GO:0005886; GO:0006351,IPR011711; IPR008920; IPR000524; IPR036388; IPR036390; ,,,DOMAIN 11 81 HTH gntR-type. {ECO:0000259|PROSITE:PS50949}.; DOMAIN 265 335 HTH gntR-type. {ECO:0000259|PROSITE:PS50949}.,Probable transcriptional regulatory protein (Probably GntR-family),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSTEPDAVWTDKRASKIARRIEADIVRRGWPIGASLGSESALQQRFCVSRSVLREAVRLVEHHQVARMRRGPNGGLFICEPNAGPATRAVVIYLEYLGTTIGDLLGARLVLEPLAASLAAEHIDEPGIERLRAVLRAEERWRPGLPPPPEQFYRVLAEQSKNPVLQLFIDILMRLTKRYVQKSGTQSAGEAVEAAGQVHNEHSDIVAAVTAGDSAWAKTLSERHVEAVAGWLQQHQRGNDAAVRNGGRAREPRRAQQLILGAPRGKLAEVLAATIGDDIAASGWQVGSVFGTETALLERYQVSRAVLREAVRLLEYHAIAHMRRGPGGGLVVTTPQPQASIDTIALYLQYRKPSREDLRCVRDAIEIDNVAKVVKRRSEPEVASFLDTLGRPRLDNPTDDVRAAAVEEFRFHVGLARAAGNTMLDLFLLILVELFRRHLSSTEQALPTWSDVVAVGHAHVRILEAIGSGDDSLARCRTRRHLDAAASWWL,"54,008",490,,"transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
I6X5M3,I6X5M3_MYCTU,Rv2884,Rv2884,GO:0000160; GO:0003677; GO:0005622; GO:0006355,IPR001867; IPR016032; IPR036388; ,,,DOMAIN 138 235 OmpR/PhoB-type. {ECO:0000259|PROSITE:PS51755}.,Probable transcriptional regulatory protein,"intracellular [GO:0005622]; DNA binding [GO:0003677]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MPTGPTTGKWHPHEVWRYLLEVLLLTDEADLESALPELESFAQSVQRAPLDDPGAAKGADADVAIIDARADLAAARRVCRRLTTSAPALAVVAVVAPANFVAVDGDWIFDDVLLNAAGGAELQARLRLAITRRRSTLAGTLQFGDLVLHPASYTASLGDRDLGLTLTEFKLMNFLVQHAGRAFTRTRLMREVWGYECHGRIRTVDVHVRRLRAKLGAEHESMIDTVRGVGYMAVTPPQPRWIISESILNRCK,"27,713",252,,"phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677],intracellular [GO:0005622],,,1
I6XFT2,I6XFT2_MYCTU,Rv2970A,Rv2970A,GO:0016491,IPR018170; IPR036812; ,,,,Uncharacterized protein,oxidoreductase activity [GO:0016491],9634230,,,MLIRWHIQLGNIVIPKSVNPMRIASNFDAFDFPRSMTEPGLVRIRKPSISQAGEMT,"6,369",56,,,oxidoreductase activity [GO:0016491],,,,1
I6YEA3,I6YEA3_MYCTU,Rv2751,Rv2751,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,S-adenosyl-L-methionine-dependent methyltransferase (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,"FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000256|RuleBase:RU362030, ECO:0000256|SAAS:SAAS00276433}.",MARNPAAQTAFGPMVLAAVEQNEPPGRRLVDDDLADLFLPRPLRWLAGATRSAVLRRLLISASEWSGRGLWANLACRKRFIGDKLDEALGDIDAVVILGAGLDTRAYRLTRRVRMPVFEVDLPVNIARKAKTVRRVLGELPLSVRLVALDFEHDDLLTALAEHGYRTEYRVFFVCEGVTQYLTERAVRRTLEGLRAAAPGSRMVFTYVRRDFIDGTNRYGTRTLYHTVRQRRQLWHFGLDPEEVAGFLADYGWRLTEQAGPEELVQRYVEPTGRNLNASQIEWSAYAEKSEPVTPR,"33,610",296,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
O53260,O53260_MYCTU,Rv3013,Rv3013,,IPR002912; ,,,DOMAIN 5 84 ACT. {ECO:0000259|PROSITE:PS51671}.,Conserved protein,,9634230; 21969609,,,MRSYLLRIELADRPGSLGSLAVALGSVGADILSLDVVERGNGYAIDDLVVELPPGAMPDTLITAAEALNGVRVDSVRPHTGLLEAHRELELLDHVAAAEGATARLQVLVNEAPRVLRVSWCTVLRSSGGELHRLAGSPGAPETRANSAPWLPIERAAALDGGADWVPQAWRDMDTTMVAAPLGDTHTAVVLGRPGPEFRPSEVARLGYLAGIVATMLR,"22,999",218,,,,,,,3
I6X5U4,I6X5U4_MYCTU,Rv2954c,Rv2954c,GO:0008171,IPR029063; ,,,,Uncharacterized protein,O-methyltransferase activity [GO:0008171],9634230; 21969609,,,MRLPGMLRPTAERHFHSIFYLRHNARRQEHLATLGLDLGNKSVLEVGAGIGDHTQFFLDRGCKVLCTEPRGENLDVIRQRFGSNPNVTVDHLDLDGDLPAEAHQYDVVYCYGVLYHLSRPAEALAWMCDRAVDLLLLETCVSYSGEDEPFLVSERASSPSQAITGTGCRPSRVWVMNRLREKMPHVYVTATQPRHRQFPLDWRANGPIASTGLARAVFVASRAPLNLPTLVEELPMVQRRC,"27,144",241,,,O-methyltransferase activity [GO:0008171],,,,1
O05776,O05776_MYCTU,Rv3098c,Rv3098c,,,,,,Uncharacterized protein,,9634230,,,MASLRIAEVDPVDRSPNHHASGSVETSSSRSRSASVRACLIHTSRSSSCSARRMTSLLRSPLRIAALMICSSFSVGRKPMVAVMSTTIADVAQSYSNCSTHSGTPTPAFAASFLLDAINAPRVIAGRFASESVRFPAAAPHGSVPSRLPV,"15,728",150,,,,,,,4
I6X658,I6X658_MYCTU,Rv3066,Rv3066,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 13 73 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably DeoR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; ,X-ray crystallography (1),,MTAGSDRRPRDPAGRRQAIVEAAERVIARQGLGGLSHRRVAAEANVPVGSTTYYFNDLDALREAALAHAANASADLLAQWRSDLDKDRDLAATLARLTTVYLADQDRYRTLNELYMAAAHRPELQRLARLWPDGLLALLEPRIGRRAANAVTVFFDGATLHALITGTPLSTDELTDAIARLVADGPEQREVGQSAHAGRTPD,"21,958",202,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
Q6MX19,Q6MX19_MYCTU,Rv3018A,PE27A Rv3018A,,,,PE27A,,PE family protein PE27A,,9634230,,,MTLSVVPEGLAAASAAVEALTARLAAAH,"2,692",28,,,,,,,1
O33329,O33329_MYCTU,Rv2787,Rv2787,GO:0005618,IPR002586; IPR027417; IPR011990; ,,,,Conserved hypothetical alanine rich protein,cell wall [GO:0005618],9634230,,,MSTFRECRSMFDAAVKSYQSGDLANARAAFGRLTVENPDMSDGWLGLLACGDHHLDTLAGAHQHSEALYSETRRVGLTDGELSAVVMAPMYLGLRVWSRATIGLAYASALIIADRHDEAAATLDDPVITEDTGAAQYRQFVMATLFHKTRSWSNLLKVTEISPPSGATDVRDEVADAVAALASTAAASLGQFQFALELAEQVSTTNPRVTADVTLTRAWCLRELGDDDAARVALSATTTGDAPRTNTTAEQAGSPQPKFRHPYDDGRDLLVARRRPPAGDGWRKAVTKMTFGRVNPEPSAKREQTDELIQRICAPLADVHKLAFVSAKGGVGKTTMTVLVGNAVARLRGDRVMAVDVDADLGDLSARFSERGGPQTNIEHFVSSQHTKRYADVRVHTVMNKDRLEMLGAQNDPRSTYKFGPEDYGAAMQILETHCNVILLDCGTPVNGPLFSNILNDVTGLVVVASEDVRGVEGALVTLDWLGAHGFGRLLQHTVVVLNAIQKTRSLVDCGAAENQFRKRVPDFFRIPYDPHLATGLAVDFSSLKRRTRNAVLDLAGGLAQHYPASRVRPRGEDSWKTWIETMRQVG,"63,849",587,,,,cell wall [GO:0005618],,,3
I6Y1W7,I6Y1W7_MYCTU,Rv2862c,Rv2862c,,IPR012551; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTETGGDMVALRVSDADRNGTMRRLHNAVALGLINIDEFEQRSSRVSFACTRSELDGLVGDLPRPGAIVTSAADRVELRGWAGSLKRHGEWIVPTRLALVRRLGSIELDLVKARFAGPVVVIELDMMFGSLEVRLPNGASASIDDVEVYVGSASDRRKDAPAEGTPHVVLTGRMVCGSVVIKGPRRALLRRHRG,"21,021",194,,,,,,,1
P95103,P95103_MYCTU,Rv3055,Rv3055,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; ,,,DOMAIN 26 86 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230,,,MSGAERLGDLPVFARQEPVPERGDAARNRALLLEAARRLIARSGADAITMDDVAAAAGVGKGTLFRRFGSRAGLMMVLLDEDERASQQAFLFGPPPLGPDAPPLDRLIAFGRERMRFVHAHHQLLSEANRDPQTRHSAALSVLRTHLRVLLASAPTTGDLDAQTDALLALLDVDYVEHQLNAGGHTLQTLGDAWESLARKLCGR,"22,083",204,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,4
I6XFA6,I6XFA6_MYCTU,Rv2784c,lppU Rv2784c,,,,lppU,,Probable lipoprotein LppU,,9634230; 21969609,,,MRAWLAAATTALFVVATGCSSATNVAELKVGDCVKLAGTPDRPQATKAECGSPASNFKVVAVVQEDHAECPADVDSTYSMRNAFNGSTNTICLDIDWVIGGCMSVDPTHNTDPFRVDCDDASVPHRQRATQILKDLDSPVSVDQCASGVGYVYTQRRFAVCVEDVTGGPRS,"18,133",171,,,,,,,1
I6YEW1,I6YEW1_MYCTU,Rv2990c,Rv2990c,,IPR029063; ,,,,Uncharacterized protein,,9634230; 21969609,,,MCVTWAEMPKIAALIRHIEDLHARHGRSYILRAGISSLFRYIEGVHGERPWGTVLDAGTGVKSLQWIQTLPTERWTAVTAARSLADKTRAALGSAMRPQDRLLVGNWVDDSLLAGETFDTILVDYLVGAIEGFAPYWQDRVFERLRPHLADHGRLYLVGLEPYVQFEPETESGKIIWEIGRVRDACLLLAGERPYREFPLDWMLGRLGLAGFRILEARRFPIRYRARYVNGQLNMCLARIERFSSNGLGMAMRAYVEELRARALQLNERQDGLWHGNDYVIAVEPM,"32,697",286,,,,,,,1
P95131,P95131_MYCTU,Rv2961,Rv2961,GO:0003677; GO:0004803; GO:0005829; GO:0005886; GO:0006313,IPR002559; ,,,,Probable transposase,"cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MEHGNPHDAPQLAPAVERITTRAGRPPGTVTADRGYGEKRVEDDLHDLGVRTVAIPRKGRPSQARRAEEQRPSFRRTVKWRTGSEGRISTLKRNYGWNRSCIDGTEGTRIWTRHGILTHNLIKISSLAA,"14,487",129,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
O53240,O53240_MYCTU,Rv2991,Rv2991,GO:0048037,IPR019920; IPR014419; IPR011576; IPR012349; ,,,DOMAIN 14 100 Putative_PNPOx. {ECO:0000259|Pfam:PF01243}.,Conserved protein,cofactor binding [GO:0048037],9634230; 21969609,X-ray crystallography (1),,MGTKQRADIVMSEAEIADFVNSSRTGTLATIGPDGQPHLTAMWYAVIDGEIWLETKAKSQKAVNLRRDPRVSFLLEDGDTYDTLRGVSFEGVAEIVEEPEALHRVGVSVWERYTGPYTDECKPMVDQMMNKRVGVRIVARRTRSWDHRKLGLPHMSVGGSTAP,"18,204",163,,,cofactor binding [GO:0048037],,,,1
I6Y242,I6Y242_MYCTU,Rv2956,Rv2956,GO:0008171,IPR006342; IPR029063; ,,,,Conserved protein,O-methyltransferase activity [GO:0008171],9634230; 21969609,,,MKSLKLARFIARSAAFEVSRRYSERDLKHQFVKQLKSRRVDVVFDVGANSGQYAAGLRRAAYKGRIVSFEPLSGPFTILESKASTDPLWDCRQHALGDSDGTVTINIAGNAGQSSSVLPMLKSHQNAFPPANYVGTQEASIHRLDSVAPEFLGMNGVAFLKVDVQGFEKQVLAGGKSTIDDHCVGMQLELSFLPLYEGGMLIPEALDLVYSLGFTLTGLLPCFIDANNGRMLQADGIFFREDD,"26,566",243,,,O-methyltransferase activity [GO:0008171],,,,1
Q6MX22,Q6MX22_MYCTU,Rv2943A,Rv2943A,GO:0005524; GO:0005737; GO:0006271,IPR002611; ,,,DOMAIN 69 118 IstB_IS21. {ECO:0000259|Pfam:PF01695}.,Possible transposase,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA strand elongation involved in DNA replication [GO:0006271],9634230,,,MPTTKATQRRDVSTEIAYLTRALKAPTLRESVSRLADRARAENWSHEEYLAACLQREVSARESHGGEGRIRAARFPARKSLEEFDFEHARGLKRDTIAHLGTLDFITARDNVVFLGPAWHREDSSCGRPGDTRVSGRSSGAVRHRRRMGSTARRGSPRRAHLRRTHPALPLSAPGG,"19,658",176,,DNA strand elongation involved in DNA replication [GO:0006271],ATP binding [GO:0005524],cytoplasm [GO:0005737],,,1
O86347,O86347_MYCTU,Rv2776c,Rv2776c,GO:0009055; GO:0046872; GO:0051537,IPR036010; IPR001041; IPR006058; IPR012675; IPR017927; IPR008333; IPR001433; IPR000951; IPR017938; ,,,DOMAIN 2 104 FAD-binding FR-type. {ECO:0000259|PROSITE:PS51384}.; DOMAIN 229 309 2Fe-2S ferredoxin-type. {ECO:0000259|PROSITE:PS51085}.,Probable oxidoreductase,"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]",9634230,,,MRRTNPAVVTKRELVAPDVVALTLADPGGGLLPAWSPGGHIDVQLPSGRRRQYSLCGVPGRRTDYRIAIRRIADGGGGSIEMHEAFDVGDTCEFEGPRNAFHLGLAERDVLFVIGGIGVTPILPMIRAAEQRGIDWRAIYAGRGREYMPFLDEVVAVAPGRVTVWADDEHGRFASVDELLAGAGPTTAVYVCGPPGMLEAVRVARNQHADAPLHYERFSPPPVVDGVPFELELARSRRVLRVPANRSALDVMLDWDPTTAYSCQQGFCGTCKVRVLAGQVDRRGRIIEGDNEMLVCVSRAVSGRVVIDA,"33,517",309,,,"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]",,,,3
O05785,O05785_MYCTU,Rv3108,Rv3108,,,,,,Uncharacterized protein,,9634230,,,MTPNAASTGDSAKNTITGCCLITARALVARTRSISLPGMPFRMPADYHNASSDEPTNRHPWPAPARCCRHEWRTMRRTNACDRRRFGLSLTIHEDACRIISVVPVVLEVRRAEPAHPATPYPEPLARCSRSPGLNESSHMSGRIPP,"16,138",146,,,,,,,3
P95087,P95087_MYCTU,Rv3071,Rv3071,GO:0005618; GO:0005829,IPR003793; IPR011322; IPR015867; ,,,DOMAIN 7 103 DUF190. {ECO:0000259|Pfam:PF02641}.; DOMAIN 127 220 DUF190. {ECO:0000259|Pfam:PF02641}.; DOMAIN 248 343 DUF190. {ECO:0000259|Pfam:PF02641}.,Uncharacterized protein,cell wall [GO:0005618]; cytosol [GO:0005829],9634230; 21969609,,,MNEQCLKLTAYFGERQRAVGGAGRFLADAMLDLFGSHNVATSVMLRGTTSFGPKHEFRCDQSLSLSEDPPVTVAAVDIESKIRSLVDDVTAMTDRGLVTLERARLVTRHSGAEEFGDIDSRNGDAAKLTIYAGRQVRVAGAPAYYTICELLHRHGFAGATVLLGVDGTAHGRRRRARFFGRNVNVPLMIIAVGTPAQVAVAAMELTAALPNPLLTIERVRLCKRDGELFARPQQLPQTDDQGRTLWQKLMVHTAEATHHEGLPIHRALVHRLMQSETARGATALRGIWGFYGDHKPHGDKLFQLVRRVPVTTIIVDTPQAIARSFDIVDELTNWHGLVTSEMVPAAVSLTGSRDGTQKTGETPLARYDY,"40,466",369,,,,cell wall [GO:0005618]; cytosol [GO:0005829],,,3
P71626,P71626_MYCTU,Rv2826c,Rv2826c,GO:0005886,IPR014942; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MAGLTRALVARHALGRAEAYDAALLDVAQDHLLYLLSQTVQFGDNRLVFKGGTSLRKCRLGNVGRFSTDLDFSAPDDEVVLEVCELIDGARVGGFEFGVQSTRGDGRHWQLRVRHTELGEPRIVASVEFARRPLALPSELLAFIQLPIHKAYGFGLPTLPVVAEAEACAEKLARYRRVALARDLYDLNHFASRTIDEPLVRRLWVLKVWGDVVDDRRGTRPLRVEDVLAARSEHDFQPDSIGVLTRPVAMAAWEARVRKRFAFLTDLDADEQRWAACDERHRREVENALAVLRS,"33,089",294,,,,plasma membrane [GO:0005886],,,4
I6YAE2,I6YAE2_MYCTU,Rv2843,Rv2843,GO:0016021,IPR006311; ,,,,Probable conserved transmembrane alanine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLRAAPVINRLTNRPISRRGVLAGGAALAALGVVSACGESAPKAPAVEELRSPLDQARHDGALAAAAATAIGIPPQVAAALTVVATQRTSHARALATEIARAAGKLVSATSETSSSSPSPTDPAAPPPAVSDVIDSLRTSAGEASRLVATTSGYRAGLLASIAASCTASYTVALVPSGPSI,"17,767",181,,,,integral component of membrane [GO:0016021],,,1
P95105,P95105_MYCTU,Rv3054c,Rv3054c,GO:0005829; GO:0010181; GO:0052873,IPR029039; IPR005025; ,,,DOMAIN 9 155 FMN_red. {ECO:0000259|Pfam:PF03358}.,Uncharacterized protein,cytosol [GO:0005829]; FMN binding [GO:0010181]; FMN reductase (NADPH) activity [GO:0052873],9634230; 21969609,,,MSDTKSDIKILALVGSLRAASFNRQIAELAAKVAPDGVTVTMFEGLGDLPFYNEDIDTATEVPAPVSALREAASDAHAALVVTPEYNGSIPAVIKNAIDWLSRPFGDGALKDKPLAVIGGSMGRYGGVWAHDETRKSFSIAGTRVVDAIKLSVPFQTLGKSVADDAGLAANVRDAVGNLAAEVG,"19,095",184,,,FMN binding [GO:0010181]; FMN reductase (NADPH) activity [GO:0052873],cytosol [GO:0005829],,,4
I6YB49,I6YB49_MYCTU,Rv3091,Rv3091,GO:0016042; GO:0016787,IPR016035; IPR002641; ,,,DOMAIN 181 420 PNPLA. {ECO:0000259|PROSITE:PS51635}.,Conserved protein,hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],9634230; 21969609,,,MPIPFADGMLSRLGRRGAALDLIEEFEDESGEPPASLSPADLLAAEPALLLQKMENRLVRHHLANPDVLSGEQLRKLRYILNFARLADFEPGAAGPGGSRGRGDISVGGQVAPWRSRVVDALYAPLREEPDPVTALEGAKDVLATLVDDQDDQRRVLIERHGSDFSATELDAEVGYKKLVTVLGGGGGAGFVYIGGMQRLLAAGQVPDYMIGSSFGSIIGSLVARELPVPIDEYAEWAKTVSYRAILGPERRRSRHGLAGMFTLRFDQFAHTLLSRADGERMRMSDLAIPFDVVVAGVRRQPYAALPSRFRHRERSTLTLRSLPFLPIGIGPWVAARMWQVAAFIDLRVVKPIVISADGATRDVNVVDAASFSSAIPGVLHHETSDPRMLPILDELCADQDVAAMVDGGAASNVPVELAWERVRDGRLGTRNACYLAFDCFHPHWDPRHLWLVPITQAVQLQMVRNLPYADHLVRFEPTLSPVNLAPSAAAIDRACRWGRDSVEPAIAVTSALLEPTWWEGDRPPAAEPKERTKSAASSMSAVMAAIQAPTGRFRRWRSRHLT,"61,645",563,,lipid catabolic process [GO:0016042],hydrolase activity [GO:0016787],,,,1
I6Y2G3,I6Y2G3_MYCTU,Rv3068c,pgmA Rv3068c,GO:0000287; GO:0004614; GO:0005829; GO:0005978; GO:0006006; GO:0019388,IPR005844; IPR016055; IPR005845; IPR005846; IPR005843; IPR036900; IPR016066; IPR005852; ,,pgmA,DOMAIN 40 181 PGM_PMM_I. {ECO:0000259|Pfam:PF02878}.; DOMAIN 209 318 PGM_PMM_II. {ECO:0000259|Pfam:PF02879}.; DOMAIN 323 442 PGM_PMM_III. {ECO:0000259|Pfam:PF02880}.; DOMAIN 493 540 PGM_PMM_IV. {ECO:0000259|Pfam:PF00408}.,Probable phosphoglucomutase PgmA (Glucose phosphomutase) (PGM),cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978],9634230; 21969609,,,MVANPRAGQPAQPEDLVDLPHLVTAYYSIEPDPDDLAQQVAFGTSGHRGSALTGTFNELHILAITQAIVEYRAAQGTTGPLFIGRDTHGLSEPAWVSALEVLAANQVVAVVDSRDRYTPTPAISHAILTYNRGRTEALADGIVVTPSHNPPSDGGIKYNPPNGGPADTAATTAIAKRANEILLARSMVKRLPLARALRTAQRHDYLGHYVDDLPNVVDIAAIREAGVRIGADPLGGASVDYWGEIAHRHGLDLTVVNPLVDATWRFMTLDTDGKIRMDCSSPDAMAGLIRTMFGNRERYQIATGNDADADRHGIVTPDEGLLNPNHYLAVAIEYLYTHRPSWPAGIAVGKTVVSSSIIDRVVAGIGRQLVEVPVGFKWFVDGLIGATLGFGGEESAGASFLRRDGSVWTTDKDGIIMALLAAEILAVTGATPSQRYHALAGEYGGPCYARIDAPADREQKARLARLSADQVSATELAGEPITAKLTTAPGNGAALGGLKVTTANAWFAARPSGTEDVYKIYAESFRGPQHLVEVQQTAREVVDRVIG,"58,266",547,Phosphohexose mutase family,galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978],magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614],cytosol [GO:0005829],,,1
P71654,P71654_MYCTU,Rv2797c,Rv2797c,,IPR029058; IPR010427; ,,,,Uncharacterized protein,,9634230,,,MPLTVADIDRWNAQAVREVFHAASARAEVTFEASRQLAALSIFANSGGKTAEAAAHHNAGIRRDLDAHGNEALAVARAADRAADGIVKVQSELAALRHAAAAAELTIDALINRVVPIPGLRSTEAQWARTLAKQTELQAELDAIMAEANAVDEELASAVNMADGDAPIPADSGPPVGPEGLTPTQLASDANEERLREERARLQAHLERLQAEYDQLSVRAARDYHNGILDGDAVGRLAALTDELSAARGRLGELDAVDEALSRAPETYLTQLQIPEDPNQQVLAAVAVGNPDTAANVSVTVPGVGSTTRGALPGMVTEARDLRSEVIRQLNAAGKPASVATIAWMGYHPPPNPLDTGSAGDLWQTMTDGQAHAGAADLSRYLQQVRANNPSGHLTVLGHSYGSLTASLALQDLDAQSAHPVNDVVFYGSPGLELYSPAQLGLDHGHAYVMQAPHDLITNLVAPLAPLHGWGLDPYLTPGFTELSSQAGFDPGGIWRDGVYAHGDYPRSFLDAAGQPQLRMSGYNLAAIAAGLPDNTVGPPLLPPILGGGMPAAPGPALRGGR,"58,792",562,,,,,,,2
O33317,O33317_MYCTU,Rv2775,Rv2775,GO:0006473; GO:0016747,IPR016181; IPR000182; ,,,DOMAIN 1 151 N-acetyltransferase. {ECO:0000259|PROSITE:PS51186}.,GCN5-related N-acetyltransferase,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; protein acetylation [GO:0006473]",9634230,,,MHYPVWRQSWTGILDPYLLDMIGSPKLWVEESYPQSLKRGGWSMWIAESGGQPIGMTMFGPDIAHPDRIQIDALYVAENSQRHGIGGRLLNRALHSHPSADMILWCAEKNSKARGFYEKKDFHIDGRTFTWKPLSGVNVPHVGYRLYRSAPPG,"17,406",153,,protein acetylation [GO:0006473],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,3
I6YEE9,I6YEE9_MYCTU,Rv2804c,Rv2804c,,,,,,Uncharacterized protein,,9634230,,,MHDHQVLAARHAHQGPHVLQQRPGFVAEAPRPKATPVDLLGRARQPRAGQHLPRRRAAHPRGGHHRIQNLAVAPPHHRRQQQRGHSRRSIGSTSPSDDSASYSQRPRDVADPPVEASTLEGQEAVVTVELGGAVVDGVDDQGAGAVVPGTGHGSDEGIEEKIATETGALLLPVERQASEDEHWDRVGSGWPRPGRDGTRIRSMLPMASA,"22,473",209,,,,,,,1
I6X5C9,I6X5C9_MYCTU,Rv2786c,ribF Rv2786c,GO:0003919; GO:0005524; GO:0006747; GO:0008531; GO:0009231; GO:0009398,IPR015864; IPR023468; IPR002606; IPR015865; IPR023465; IPR014729; ,,ribF,DOMAIN 194 329 Flavokinase. {ECO:0000259|SMART:SM00904}.,Riboflavin biosynthesis protein [Includes: Riboflavin kinase (EC 2.7.1.26) (Flavokinase); FMN adenylyltransferase (EC 2.7.7.2) (FAD pyrophosphorylase) (FAD synthase)],ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; riboflavin kinase activity [GO:0008531]; FAD biosynthetic process [GO:0006747]; FMN biosynthetic process [GO:0009398]; riboflavin biosynthetic process [GO:0009231],9634230; 21969609,,,MRRRLAIVQRWRGQDEIPTDWGRCVLTIGVFDGVHRGHAELIAHAVKAGRARGVPAVLMTFDPHPMEVVYPGSHPAQLTTLTRRAELVQDLGIEVFLVMPFTTDFMKLTPDRFIHELLVEHLHVVEVVVGENFTFGKKAAGNVDTLRRAGERFGFAVESMSLVSEHHSNETVTFSSTYIRSCVDAGDMVAAMEALGRPHRVEGVVVRGEGRGAELGFPTANVAPPMYSAIPADGVYAAWFTVLGHGPVTGTVVPGERYQAAVSVGTNPTFSGRTRTVEAFVLDTTADLYGQHVALDFVGRIRGQKKFESVRQLVAAMGADTERARDLLSTG,"36,090",331,RibF family,FAD biosynthetic process [GO:0006747]; FMN biosynthetic process [GO:0009398]; riboflavin biosynthetic process [GO:0009231],ATP binding [GO:0005524]; FMN adenylyltransferase activity [GO:0003919]; riboflavin kinase activity [GO:0008531],,,,1
O05805,O05805_MYCTU,Rv2854,Rv2854,GO:0005618; GO:0005829; GO:0006629; GO:0016020; GO:0016298,IPR029058; IPR022742; ,,,DOMAIN 51 201 Hydrolase_4. {ECO:0000259|Pfam:PF12146}.,Uncharacterized protein,cell wall [GO:0005618]; cytosol [GO:0005829]; membrane [GO:0016020]; lipase activity [GO:0016298]; lipid metabolic process [GO:0006629],9634230; 21969609,,,MTGWVPDVLPGYWQCTIPLGPDPDDEGDIVATLVGRGPQTGKARGDTTGAHHTVLAVHGYTDYFFHTELADHFANRGFAFYALDLRKCGRSRAPGQTPHFITDLARYDTELEHSLSIINEQNRSAKVLVYGHSAGGLIVSLWLDRLRQRGEITRAGVTGLVLNSPFLDLQGPAILRLPLTSAFFAAMARMRPKWVARPPKEGGYGCTLHRDYDGEFDYNLQWKPVGGFPVTFGWIHASRRGHARLHRGIDVGVPNLILCSDHTVREKADPATLHRGDAVLDVTHITRWAGCIGNRSTVIAVADAKHDVFLSLPQPRQMAYRRLDLWLDDYLGTHNDTDASASSGKG,"38,223",346,,lipid metabolic process [GO:0006629],lipase activity [GO:0016298],cell wall [GO:0005618]; cytosol [GO:0005829]; membrane [GO:0016020],,,1
I6Y231,I6Y231_MYCTU,Rv2940c,mas Rv2940c,GO:0016491; GO:0016740; GO:0031177,IPR001227; IPR036736; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,mas,DOMAIN 2025 2100 Carrier. {ECO:0000259|PROSITE:PS50075}.,Probable multifunctional mycocerosic acid synthase membrane-associated Mas,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],9634230; 21969609,,,MESRVTPVAVIGMGCRLPGGINSPDKLWESLLRGDDLVTEIPPDRWDADDYYDPEPGVPGRSVSRWGGFLDDVAGFDAEFFGISEREATSIDPQQRLLLETSWEAIEHAGLDPASLAGSSTAVFTGLTHEDYLVLTTTAGGLASPYVVTGLNNSVASGRIAHTLGLHGPAMTFDTACSSGLMAVHLACRSLHDGEADLALAGGCAVLLEPHASVAASAQGMLSSTGRCHSFDADADGFVRSEGCAMVLLKRLPDALRDGNRIFAVVRGTATNQDGRTETLTMPSEDAQVAVYRAALAAAGVQPETVGVVEAHGTGTPIGDPIEYRSLARVYGAGTPCALGSAKSNMGHSTASAGTVGLIKAILSLRHGVVPPLLHFNRLPDELSDVETGLFVPQAVTPWPNGNDHTPKRVAVSSFGMSGTNVHAIVEEAPAEASAPESSPGDAEVGPRLFMLSSTSSDALRQTARQLATWVEEHQDCVAASDLAYTLARGRAHRPVRTAVVAANLPELVEGLREVADGDALYDAAVGHGDRGPVWVFSGQGSQWAAMGTQLLASEPVFAATIAKLEPVIAAESGFSVTEAITAQQTVTGIDKVQPAVFAVQVALAATMEQTYGVRPGAVVGHSMGESAAAVVAGALSLEDAARVICRRSKLMTRIAGAGAMGSVELPAKQVNSELMARGIDDVVVSVVASPQSTVIGGTSDTVRDLIARWEQRDVMAREVAVDVASHSPQVDPILDDLAAALADIAPMTPKVPYYSATLFDPREQPVCDGAYWVDNLRNTVQFAAAVQAAMEDGYRVFAELSPHPLLTHAVEQTGRSLDMSVAALAGMRREQPLPHGLRGLLTELHRAGAALDYSALYPAGRLVDAPLPAWTHARLFIDDDGQEQRAQGACTITVHPLLGSHVRLTEEPERHVWQGDVGTSVLSWLSDHQVHNVAALPGAAYCEMALAAAAEVFGEAAEVRDITFEQMLLLDEQTPIDAVASIDAPGVVNFTVETNRDGETTRHATAALRAAEDDCPPPGYDITALLQAHPHAVNGTAMRESFAERGVTLGAAFGGLTTAHTAEAGAATVLAEVALPASIRFQQGAYRIHPALLDACFQSVGAGVQAGTATGGLLLPLGVRSLRAYGPTRNARYCYTRLTKAFNDGTRGGEADLDVLDEHGTVLLAVRGLRMGTGTSERDERDRLVSERLLTLGWQQRALPEVGDGEAGSWLLIDTSNAVDTPDMLASTLTDALKSHGPQGTECASLSWSVQDTPPNDQAGLEKLGSQLRGRDGVVIVYGPRVGDPDEHSLLAGREQVRHLVRITRELAEFEGELPRLFVVTRQAQIVKPHDSGERANLEQAGLRGLLRVISSEHPMLRTTLIDVDEHTDVERVAQQLLSGSEEDETAWRNGDWYVARLTPSPLGHEERRTAVLDPDHDGMRVQVRRPGDLQTLEFVASDRVPPGPGQIEVAVSMSSINFADVLIAFGRFPIIDDREPQLGMDFVGVVTAVGEGVTGHQVGDRVGGFSEGGCWRTFLTCDANLAVTLPPGLTDEQAITAATAHATAWYGLNDLAQIKAGDKVLIHSATGGVGQAAISIARAKGAEIFATAGNPAKRAMLRDMGVEHVYDSRSVEFAEQIRRDTDGYGVDIVLNSLTGAAQRAGLELLAFGGRFVEIGKADVYGNTRLGLFPFRRGLTFYYLDLALMSVTQPDRVRELLATVFKLTADGVLTAPQCTHYPLAEAADAIRAMSNAEHTGKLVLDVPRSGRRSVAVTPEQAPLYRRDGSYIITGGLGGLGLFFASKLAAAGCGRIVLTARSQPNPKARQTIEGLRAAGADIVVECGNIAEPDTADRLVSAATATGLPLRGVLHSAAVVEDATLTNITDELIDRDWSPKVFGSWNLHRATLGQPLDWFCLFSSGAALLGSPGQGAYAAANSWVDVFAHWRRAQGLPVSAIAWGAWGEVGRATFLAEGGEIMITPEEGAYAFETLVRHDRAYSGYIPILGAPWLADLVRRSPWGEMFASTGQRSRGPSKFRMELLSLPQDEWAGRLRRLLVEQASVILRRTIDADRSFIEYGLDSLGMLEMRTHVETETGIRLTPKVIATNNTARALAQYLADTLAEEQAAAPAAS,"224,380",2111,,,oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity [GO:0016740],,,,1
P71643,P71643_MYCTU,Rv2808,Rv2808,,,,,,Uncharacterized protein,,9634230,,,MSNVLDAISTEHRPVIEQELENRNPALFDELRRTEKPTNEQSDAVIDVLSDALMKTFGPDWVPNDYGLKIERAIDAYLETWPIYR,"9,862",85,,,,,,,4
I6YF40,I6YF40_MYCTU,Rv3075c,Rv3075c,GO:0000287; GO:0003824; GO:0006107,IPR005000; IPR011206; IPR015813; ,,,DOMAIN 27 228 HpcH_HpaI. {ECO:0000259|Pfam:PF03328}.,Conserved protein,catalytic activity [GO:0003824]; magnesium ion binding [GO:0000287]; oxaloacetate metabolic process [GO:0006107],9634230; 21969609,,,MTSMYEQVDTNTADPVAGSRIDPVLARSWLLVNGAHGDRFESAAHSRADIVVLDIEDAVAPKDKHAARDNAVRWFGDGNADWVRINGFGTPWWADDLAMLADSPVGGVMLAMVESVDHVTETAKRLPNVPIVALVETARGLERINEIAAAKGTFRLAFGIGDFRRDTGFGEDPATLAYARSRFTIAARAAGLPSAIDGPTIGSNALKLIEATAVSAEFGMTGKICLSPDQCPVVNEGLSPSQDEIVWAKEFFAEFARDGGEIRNGSDLPRIARATKILDLARAYGIEVSDFEDEPVHMPAPTDTYHY,"33,100",307,HpcH/HpaI aldolase family,oxaloacetate metabolic process [GO:0006107],catalytic activity [GO:0003824]; magnesium ion binding [GO:0000287],,,,1
P71655,P71655_MYCTU,Rv2796c,lppV Rv2796c,,IPR032018; ,,lppV,,Probable conserved lipoprotein LppV,,9634230,,,MRWPTAWLLALVCVMATGCGPSGHGTRAGEEGPLSPEKVAELENPLRAKPPLEDAKDQYRAAVTQLANAITALVPGLTWRTDMDTWTGCGGEYEWTRAKAAYFMIVFSGPIPDDKWLQAVQIVKDGVEQFGATGFGVMKNKPADHDVYFAGHGGVEFKCSTQKAAVLTAQSDCRISRTDTPKPSPTP,"20,197",187,,,,,,,4
P95137,P95137_MYCTU,Rv2955c,Rv2955c,GO:0005618; GO:0005829; GO:0005886; GO:0008171,IPR006342; IPR029063; ,,,,Conserved protein,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; O-methyltransferase activity [GO:0008171],9634230; 21969609,,,MQFQDVRLMRVVVCRRLGPAKGQRRWRPLDLGTTGCFENLGAQRPTYRMRAIRMLECAMPNRLVRSLQRWRPFGLPPHRWRLAPWYWRGLQVTLEPGSAIAWIVRLTGGFEETEIDIAAALYSALYPDRCILDVGANVGIHSLAWARLAPVVALEPAPGTHSRLEANVAANGLQDRIRTLRTAAGDAVGEVDFFVAADSAFSSLNDTGRIRIRERTRVPCTTLDALAAELPLPVGLLKIDVEGLERAVIAGAAELLRRDRPVLLVEIYGGAASNPDPERTIADIRAYGYEPFVYADDAGLQPYQRHRDDRYCYFFIPSRKG,"35,950",321,,,O-methyltransferase activity [GO:0008171],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,4
I6Y1P2,I6Y1P2_MYCTU,Rv2778c,Rv2778c,,IPR019587; IPR023393; ,,,,Conserved protein,,9634230; 21969609,,,MPDPDGPSVTVTVEIDANPDLVYGLITDLPTLASLAEEVVAMQLRKGDDVRKGAVFVGRNENGGRRWTTTCTVTDADPGRVFAFDVRSGIIPISRWQYGIVATEHGCRVTESTWDRRPSWFRAVARMATGVKDRASVNTEHIRRTLQRLKDRAEAG,"17,268",156,,,,,,,1
I6YA47,I6YA47_MYCTU,Rv2738c,Rv2738c,,IPR021408; ,,,,Uncharacterized protein,,9634230; 21969609,,,MLAGVRLTEFHERVALHFGAAYGSSVLLDHVLTGFDGRSAAQAIEDGVEPRDVWRALCADFDVPHDRW,"7,551",68,,,,,,,1
P71616,P71616_MYCTU,Rv2836c,dinF Rv2836c,GO:0015238; GO:0015297; GO:0016021,IPR002528; ,,dinF,,Possible DNA-damage-inducible protein F DinF,integral component of membrane [GO:0016021]; antiporter activity [GO:0015297]; drug transmembrane transporter activity [GO:0015238],9634230,,,MSQVGHRAGGRQIAQLALPALGVLAAEPLYLLFDIAVVGRLGAISLAGLAIGSLVLGLVGSQATFLSYGTTARAARRYGAGNRVAAVTEGVQATWLALGLGALVVVVVEATATPLVSAIASGDGITAAALPWLRIAILGTPAILVSLAGNGWLRGVQDTVRPLRYVVAGFGSSALLCPLLVYGWLGLPRWGLTGSAVANLVGQWLAALLFAGALLAERVSLRPDRAVLGAQLMMARDLIVRTLAFQVCYVSAAAVAARFGAAALAAHQVVLQLWGLLALVLDSLAIAAQSLVGAALGAGDAGHAKAVAWRVTAFSLLAAGILAAALGLGSSVLPGLFTDDRSVLAAIGVPWWFMVVQLPFAGIVFAVDGVLLGAGDAAFMRTATVASALVGFLPLVWLSLAYGWGLAGIWSGLGTFIVLRLIFVGWRAYSGRWAVTGAA,"44,756",439,,,antiporter activity [GO:0015297]; drug transmembrane transporter activity [GO:0015238],integral component of membrane [GO:0016021],,,1
P71619,P71619_MYCTU,Rv2833c,ugpB Rv2833c,GO:0005886; GO:0040007,IPR006059; IPR006311; ,,ugpB,,Probable Sn-glycerol-3-phosphate-binding lipoprotein UgpB,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MDPLNRRQFLALAAAAAGVTAGCAGMGGGGSVKSGSGPIDFWSSHPGQSSAAERELIGRFQDRFPTLSVKLIDAGKDYDEVAQKFNAALIGTDVPDVVLLDDRWWFHFALSGVLTALDDLFGQVGVDTTDYVDSLLADYEFNGRHYAVPYARSTPLFYYNKAAWQQAGLPDRGPQSWSEFDEWGPELQRVVGAGRSAHGWANADLISWTFQGPNWAFGGAYSDKWTLTLTEPATIAAGNFYRNSIHGKGYAAVANDIANEFATGILASAVASTGSLAGITASARFDFGAAPLPTGPDAAPACPTGGAGLAIPAKLSEERKVNALKFIAFVTNPTNTAYFSQQTGYLPVRKSAVDDASERHYLADNPRARVALDQLPHTRTQDYARVFLPGGDRIISAGLESIGLRGADVTKTFTNIQKRLQVILDRQIMRKLAGHG,"46,725",436,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
I6XG13,I6XG13_MYCTU,Rv3050c,Rv3050c,GO:0000976; GO:0003700; GO:0005829; GO:0016021,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 29 88 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably AsnC-family),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MVRIPRPHPSAKPGVKVDARSERWREHRKKVRNEIVDAAFRAIDRLGPELSVRQIAEEAGTAKPKIYRHFTDKSDLLEAIGMRLRDMLWAAIFPSLDLATDSAREVIRRSVEEYVNLVDQHPNVLRVFIQGRSAKQSEATVRTLNEGREITLAMAEMFNNELREMELNRAALELAAFAAFGSAASATEWWLGPEPDSPRRMPREQFVAHLTTIMMGVIVGTAEALGIAVDPDQPIHDAVPNNPAVR,"27,619",246,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
P95133,P95133_MYCTU,Rv2960c,Rv2960c,,,,,,Uncharacterized protein,,9634230,,,MGRNATAVVSLPVVALSPRAGQAGYLWQSITRGLRVTPICCYHPPCGGGVQKMLSRKLGRVCPAPSPKDAARGAHNVGANAV,"8,465",82,,,,,,,4
I6Y1W3,I6Y1W3_MYCTU,Rv2857c,Rv2857c,,IPR036291; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,,9634230; 21969609,,,MMDLSQRLAGRVAVITGGGSGIGLAAGRRMRAEGATIVVGDVDVEAGGAAADELSGLFVPTDVCDEDAVNGLFDGAAETYGRIDIAFNNAGISPPEDNLIENTELAAWQRVQDVNLKSVYLCCRAALRHMVLAGKGSIVNTASFVAVMGSATSQISYTASKGGVLAMSRELGVQFARQGIRVNALCPGPVNTPLLQELFAKNPERAARRMVHVPLGRFAEPDEIAAAVAFLASDDASFITASTFLVDGGISSAYVTPL,"26,804",258,,,,,,,1
I6X5W6,I6X5W6_MYCTU,Rv2972c,Rv2972c,GO:0005576,IPR011089; ,,,,Possible conserved membrane or exported protein,extracellular region [GO:0005576],9634230; 21969609,,,MNRRTLLWLSAIAALALVVAYQTLGSSAGRHADEFAARAGVPTVQPGADVLAGIAVLPKRIHRYDYRRSAFGHPWDDRNDAPGGHNGCDTRDDILDRDLVDKTYVSIKRCPNAVATGTLRDPYTNTTVAFQRGASVGQSVQIDHIVPLSYAWDMGAYRWPNSERMRFANDPANLLAVQGQANQDKGDSPPAQWMPPNKAFACQYAMQFIAVLRGYSLPVDQPSSDVLRQAAATCPTG,"25,856",237,,,,extracellular region [GO:0005576],,,1
I6YAV3,I6YAV3_MYCTU,Rv3005c,Rv3005c,GO:0016021,IPR032808; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTSSNDSHWQRPDDSPGPMPGRPVSASLVDPEDDLTPARYAGDFGSGTTTVIPPYDAASSGVGNSGYSLIEAAEPLPYVQPQPGRQVPAGSAGIDMDDDERVRAAGRRGTQNLGLLILRVGLGAVLIAHGLQKLFGWWDGQGLAGFQNSLSDIGYQHAEILAYVSAGGEIVAGVLLVLGLFTPLAAAGALAFLINGLLAGISAQHSRPVAYFLQDGHEYQITLVVMAVAVILSGPGRYGLDAARGWAHRPFIGSFVALLGGIAAGIAVWVLLNGANPLA,"28,860",279,,,,integral component of membrane [GO:0016021],,,1
I6YEB1,I6YEB1_MYCTU,Rv2761c,hsdS Rv2761c,GO:0003677; GO:0006304,IPR000055; ,,hsdS,,Possible type I restriction/modification system specificity determinant HsdS (S protein),DNA binding [GO:0003677]; DNA modification [GO:0006304],9634230; 21969609,,,MSRVEKVEKVRLGDHLDFSNGHTSGHTSPASEPGGRYPVYGANGVIGYSAQHNARGPLIVVGRVGSYCGSLRYCDSDVWVTDNALACRAKKPEETRYWYYALLGFGLNRYRAGSGQPLLSQGVLRNVSVSAVAAPDRPRIGEILGAFDDKIAANDRVIEAAEALMLAIVGRLSAYVPLSSLASRSTACLDAQHFDSTVAHYSFAAFDGGAQPSRVGGRTIRSAKLVVSQPCVLFPKLNPRIPRIWNITSLPSEMALASTEFVVLRPVGVDTSALWAALRQPDVLAELRQLVGGMTGSRQRIQPTQLLRVWVRDVRRLTPGHAAAIANLGALCNERRIESARLASCRDALLPLLMSGIDGLPAGR,"39,212",364,,DNA modification [GO:0006304],DNA binding [GO:0003677],,,,1
I6XFA9,I6XFA9_MYCTU,Rv2789c,fadE21 Rv2789c,GO:0003995; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE21,,Probable acyl-CoA dehydrogenase FadE21,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MFEWSDTDLMVRDAVRQFIDKEIRPHQDALETGELSPYPIARKLFSQFGLDVLLAESVNQMLDGERAKREKRDSSGSFGLADQASMVAVLVSELAGVSIGLLSTVAVSLGLGAATIMSRGTLAQQERWVPTLVTLEKIAAWAITEPDSGSDAFGGMKTHVTRDGEDYILNGHKTFITNGPYADVLVVYAKLADGEPASDWRNRPVLVFVLDAGMPGLTQGKPFKKMGMMSSPTGELFFDNVRLTPDRLLCAEGDGRDSARANFAVERLGVALMSLGIINECHRLCVDYAKTRTLWGRNIGQFQLIQLKLAKMEVARINVQNMVFQAIERLKAGKQLTLAEASAIKLYSSEAATDVAMEAVQLFGGNGYMAEYRVEQLARDAKSLMIYAGSNEVQVTHIAKGLLGEPASRA,"44,743",410,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],,,,1
I6Y2A3,I6Y2A3_MYCTU,Rv3016,lpqA Rv3016,,IPR026954; IPR038232; ,,lpqA,,Probable lipoprotein LpqA,,9634230; 21969609,,,MVGLTRPLLLCGATLLIAACTRVVGGTASATFGGDRQGMLDVATILLDQSRMQAITGSGDDLTIIPTMDTTYPVDVDDFAQPIPRECRFIYAETAVFGSEIEAFHKTTFQDRPDGSLISEAAAAYRDAGTARRAFDTLAVTVHDCAASPAGWLFVSRWTAGGNSLHIRAGDCGRDYRVLSAALLEVTFCGFPESVSDIVMTNIAANVPG,"22,143",209,,,,,,,1
O33291,O33291_MYCTU,Rv2749,Rv2749,GO:0003824,IPR007138; IPR011008; ,,,,Conserved protein,catalytic activity [GO:0003824],9634230; 21969609,,,MPVVVVATLTAKPESVDTVRDILTRAVDDVHREPGCQLYALHETGETFIFVEQWADAEALKAHSGAPAVATMFTAAGEHLVGAPDIKLLQPVPAGDPSKGQLRR,"11,099",104,,,catalytic activity [GO:0003824],,,,1
I6YEN3,I6YEN3_MYCTU,Rv2893,Rv2893,GO:0016705,IPR019923; IPR011251; IPR036661; ,,,,Possible oxidoreductase,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTVASTAHHTRRLRFGLAAPLPRAGTQMRAFAQAVEAAGFDVLAFPDHLVPSVSPFAGATAAAMATQRLHTGTLVLNNDFRHPVDTAREAAGVATLAEGRFELGLGAGHRRSEYDAAGITFDSGATRVARLIESAHLIRALLDAEPVDFDGQHYRVHAEAGSLVAPPKVRVPLLVGGNGTEVLRLGGRIADIVGLAGISHNRDATQVRFTHFDADGLADRIAVVRHAAGDRFEAIELNALIQAVVCTNDRNAAAAELAATLGGITPEQVLESPFLLLGTHEQMAEALAARQRRFGVSYWTVFDEWAGRASAMRDIAEVIALLRYG,"34,617",325,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
I6YEY1,I6YEY1_MYCTU,Rv3008,Rv3008,,,,,,Uncharacterized protein,,9634230,,,MLTVVAVIGILECGLVLHMPDNDLWYCGPWTLWVMAGRGVASGAGVWRGDRVATPLAVAITAAGLVSGARIGPGAAAKRDPQLAQWNEIRSHYQEIAEWIDHDTATAHPAVAATQISAAGSFGRANMVDYLGLLDSRADETVRRDEFSRWLSAKPDYLVTTEQSVDAATIALPEFRHAYDRAATIGTLNVYRRNSPDGDEPLPADGN,"22,283",207,,,,,,,1
O53246,O53246_MYCTU,Rv2999,lppY Rv2999,GO:0005618; GO:0005886; GO:0040007,IPR011094; ,,lppY,,Probable conserved lipoprotein LppY,cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MAGAKHAGRIVAITTAAAVILAACSSGSKGGAGSGHAGKARSAVTTTDADWKPVADALGRSGKLGDNNTAYRINLPRNDLHITSYGVDIKPGLSLGGYAAFARYDNNETLLMGDLVITEEELPKVTDALQAHGIAQTALHKHLLQQDPPVWWTHIHGMGDAARLAQGLKAALDATTIGPPTPPPARQPPVDIDVAGVDQALGRKGTQDGGLMKYSIPRKDTIIEDGHVLPAVSLNLTTVINFQPVGRGRAAINGDFILIAPEVQEVIRAMRAGNITIVELHNHGLTEEPRLFYMHYWAVDDAVTLARALRPAMDATNLQSS,"33,950",321,,growth [GO:0040007],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O05772,O05772_MYCTU,Rv3093c,Rv3093c,GO:0016705,IPR022526; IPR011251; IPR036661; ,,,,Hypothetical oxidoreductase,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTDIEVALPFWLDRPDHEATDVALAAADTGFAALWIGEMATYDAFALATSIGLRTPNMTLKVGPLAVGVRGPVGLALGVSSVASLTGCRVDLALGASSPAIVAGWHGRPWAHHVPVMRETIECLRSIFTGARVEYSGRHVNSRGFRLRGAAPDTRIALGAFGPGMIRLAAQHADEVVLNLASPFRVGRVRAAIDSAAAAAGRAAPRLTVCVPVAVNPGAAAHSQLAAQLAVYLAPPGYGEMFSALGFDGLVRSARSRATRRELAVAVPSELLDRVCALGSPDRVAARLRAYADAGADCVAVVPATAEDPGGRVALRALRPGGLYGTAGDNDGRR,"34,566",334,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,1
I6X5I7,I6X5I7_MYCTU,Rv2847c,cysG Rv2847c,GO:0004851; GO:0009236; GO:0019354; GO:0043115; GO:0051266; GO:0051287,IPR000878; IPR035996; IPR014777; IPR014776; IPR006366; IPR036291; IPR012409; ,,cysG,DOMAIN 162 372 TP_methylase. {ECO:0000259|Pfam:PF00590}.,Possible multifunctional enzyme siroheme synthase CysG: uroporphyrin-III C-methyltransferase (Urogen III methylase) (SUMT) (Uroporphyrinogen III methylase) (UROM) + precorrin-2 oxidase + ferrochelatas...,NAD binding [GO:0051287]; precorrin-2 dehydrogenase activity [GO:0043115]; sirohydrochlorin ferrochelatase activity [GO:0051266]; uroporphyrin-III C-methyltransferase activity [GO:0004851]; cobalamin biosynthetic process [GO:0009236]; siroheme biosynthetic process [GO:0019354],9634230; 21969609,,,MTENPYLVGLRLAGKKVVVVGGGTVAQRRLPLLIASGADVHVIAPSVTPAVEAMDQITLSVRDYRDGDLDGAWYAIAATDDARVNVAVVAEAERRRIFCVRADIAVEGTAVTPASFSYAGLSVGVLAGGEHRRSAAIRSAIREALQQGVITAQSSDVLSGGVALVGGGPGDPELITVRGRRLLAQADVVVADRLAPPELLAELPPHVEVIDAAKIPYGRAMAQDAINAVLIERARSGNFVVRLKGGDPFVFARGYEEVLACAHAGIPVTVVPGVTSAIAVPAMAGVPVTHRAMTHEFVVVSGHLAPGHPESLVNWDALAALTGTIVLLMAVERIELFVDVLLKGGRTADTPVLVVQHGTTAAQQTLRATLADTPEKVRAAGIRPPAIIVIGAVVGLSGVRGLNNS,"41,970",405,,cobalamin biosynthetic process [GO:0009236]; siroheme biosynthetic process [GO:0019354],NAD binding [GO:0051287]; precorrin-2 dehydrogenase activity [GO:0043115]; sirohydrochlorin ferrochelatase activity [GO:0051266]; uroporphyrin-III C-methyltransferase activity [GO:0004851],,,,1
O33313,O33313_MYCTU,Rv2771c,Rv2771c,GO:0016491; GO:0055114,IPR029039; ,,,,Uncharacterized protein,oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MRRLLIVHHTPSPHMQEMFEAVVSGATDPEIEGVEVVRRPALTVSPIEMLEADGYLLGTPANLGYISGALKHAFDVCYYLCLDTTRGRSFGAYIHGNEGTEGAERAVDAITTGLGWVQAAETVVVMGKPSKADIEACWNLGATVAAQLMG,"16,032",150,,oxidation-reduction process [GO:0055114],oxidoreductase activity [GO:0016491],,,,1
O53291,O53291_MYCTU,Rv3044,fecB Rv3044,GO:0005576; GO:0005886; GO:0030288,IPR002491; ,,fecB,,Probable FEIII-dicitrate-binding periplasmic lipoprotein FecB,extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],9634230; 21969609,,,MRSTVAVAVAAAVIAASSGCGSDQPAHKASQSMITPTTQIAGAGVLGNDRKPDESCARAAAAADPGPPTRPAHNAAGVSPEMVQVPAEAQRIVVLSGDQLDALCALGLQSRIVAAALPNSSSSQPSYLGTTVHDLPGVGTRSAPDLRAIAAAHPDLILGSQGLTPQLYPQLAAIAPTVFTAAPGADWENNLRGVGAATARIAAVDALITGFAEHATQVGTKHDATHFQASIVQLTANTMRVYGANNFPASVLSAVGVDRPPSQRFTDKAYIEIGTTAADLAKSPDFSAADADIVYLSCASEAAAERAAVILDSDPWRKLSANRDNRVFVVNDQVWQTGEGMVAARGIVDDLRWVDAPIN,"36,910",359,,,,extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288]; plasma membrane [GO:0005886],,,1
O53238,O53238_MYCTU,Rv2989,Rv2989,GO:0003677; GO:0003700; GO:0005886; GO:0006351; GO:0045892,IPR029016; IPR014757; IPR005471; IPR036388; IPR036390; ,,,DOMAIN 7 66 HTH iclR-type. {ECO:0000259|PROSITE:PS51077}.; DOMAIN 67 233 IclR-ED. {ECO:0000259|PROSITE:PS51078}.,Probable transcriptional regulatory protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MRQHSGIGVLDKAVGVLHAVAESPCGLAELCDRTDLPRATAYRLAAALEVHRLLGRGQDGHWRLGPAITELATHVDDPLLVACAAVLPQLRDATGESVQVYRREGTSRVCVAALEPAAGLRDTVPVGARLPMTAGSGAKVLLAHTDAATQAAVLPKAVFSARALAEVCRRGWAQSVAEREPGVASVSAPVRDGRGVVIAAISVSGPIDRMGRRPGVRWAADLLSAADALTRRL,"24,316",233,,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,3
I6YEH6,I6YEH6_MYCTU,Rv2831,echA16 Rv2831,GO:0003824; GO:0008152,IPR029045; IPR001753; ,,echA16,,Probable enoyl-CoA hydratase EchA16 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609; ,X-ray crystallography (1),,MTDDILLIDTDERVRTLTLNRPQSRNALSAALRDRFFAALADAEADDDIDVVILTGADPVFCAGLDLKELAGQTALPDISPRWPAMTKPVIGAINGAAVTGGLELALYCDILIASEHARFADTHARVGLLPTWGLSVRLPQKVGIGLARRMSLTGDYLSATDALRAGLVTEVVAHDQLLPTARRVAASIVGNNQNAVRALLASYHRIDESQTAAGLWLEACAAKQFRTSGDTIAANREAVLQRGRAQVR,"26,630",249,,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
P96287,P96287_MYCTU,Rv2944,Rv2944,GO:0005524; GO:0005737; GO:0006271,IPR003593; IPR002611; IPR027417; ,,,,Possible transposase for insertion sequence element IS1533,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA strand elongation involved in DNA replication [GO:0006271],9634230,,,MSQCPGWPIAPAPRTGATKNTWPPACSGKCQPGSPMVVRAASAPPASRLGSRWKSSTLSMLVASNATPSHIWAPWISSPPAITSCFWAPPGTGKTHLAVGLAIRACQAGHRVLFATAAEWVARLAEAHHAGRIYAELTRLCRYPLLVVDEVGYIPFEPEAANLFFQLVSSRYERASLIVTSNKAFGRWGEVFGGDDVVAAAMIDRLVHHAEVVALKGDSYRLKDRDLGRVPPAGTTEE,"25,567",238,,DNA strand elongation involved in DNA replication [GO:0006271],ATP binding [GO:0005524],cytoplasm [GO:0005737],,,2
I6XFD1,I6XFD1_MYCTU,Rv2813,Rv2813,,IPR003593; IPR027417; ,,,,Uncharacterized protein,,9634230,,,MMHKLISYYGFSRMPFGRDLAPGMLHRHSAHNEAVARIGWCIADRRIGVITGEVGAGKTVAVRAALASLDRSRHTIIYLPDPTVGVQGIHHRIVASLGGQPLTHHATLAPQAADALAAEQAERGRTPVVVVEEAHLLGYDQLEALRLLTNHDLDSSSPFACLLIGQPTLRRRMKLGVLAALDQRIGLRYAMPPMTDTNTGSYLRHHLKLAGRDDALFSDDAIGLIHQTSRGYPRAVNNLALQALVAAFAADKAIVDESTTRTAIAEVTAD,"29,192",270,,,,,,,1
I6XFS7,I6XFS7_MYCTU,Rv2966c,Rv2966c,GO:0003676; GO:0008168; GO:0031167,IPR002052; IPR004398; IPR029063; ,,,,Possible methyltransferase (Methylase),methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; rRNA methylation [GO:0031167],9634230; 21969609,,,MTRIIGGVAGGRRIAVPPRGTRPTTDRVRESLFNIVTARRDLTGLAVLDLYAGSGALGLEALSRGAASVLFVESDQRSAAVIARNIEALGLSGATLRRGAVAAVVAAGTTSPVDLVLADPPYNVDSADVDAILAALGTNGWTREGTVAVVERATTCAPLTWPEGWRRWPQRVYGDTRLELAERLFANV,"19,807",188,,rRNA methylation [GO:0031167],methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676],,,,1
I6X5Z8,I6X5Z8_MYCTU,Rv3000,Rv3000,GO:0005524; GO:0005887; GO:0006879; GO:0015075; GO:0016887,IPR003439; IPR027417; IPR005226; ,,,,Possible conserved transmembrane protein,integral component of plasma membrane [GO:0005887]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ion transmembrane transporter activity [GO:0015075]; cellular iron ion homeostasis [GO:0006879],9634230,,,MAVHGFLLERVSVVRDEATVLRQVSAHFPAGRCSAVRGASGSGKTTLLRLLNRLIDPTSGKVWLDGVPLTDLDVLVLRRRVGLVAQAPVVLTDAVLNEVRVGRPDLPEGRVTELLARLCLGQSAREAFLPHQRSALRTALIPAIDSTKVVGLISLPGAMSGLILAGVDPLTAIRYQIVVMYLLLAATAVAALTCARLAERALFDRAHRLVSLPAATRRA,"23,400",219,,cellular iron ion homeostasis [GO:0006879],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; ion transmembrane transporter activity [GO:0015075],integral component of plasma membrane [GO:0005887],,,1
O05780,O05780_MYCTU,Rv3103c,Rv3103c,GO:0005576; GO:0016021,,,,,Hypothetical proline-rich protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MKLSNQKRHWPGYLFGRIRTSTLVLIAAFLAVWWIYETYRPQAPGPGDSPPTQVVPPGFVPDPDYTWVPRTRVQPPTVKATPTTTSSTPPVSPPETTTDSAVPPPFELPPPFGPGTTTPTPPAPLPQPGPGPTAGTYPKSEPPTR,"15,600",145,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
O33319,O33319_MYCTU,Rv2777c,Rv2777c,,IPR016516; ,,,,Uncharacterized protein,,9634230; 21969609,,,MNVEVHSAPGWRAGSSPLGYAQLYLPTRDVYWGDMSGIYVNAVATFSEGAAMVSVDDRATGPHSSESRAADHERLVLEPRDVEFDWTNLPFHYVPNEPMATHVLNVLHMLLPAGEEFFVRVFKKTLPLIKDDQLRLDVQGFIGQEAMHSQAHSGVVDHFDAQGVDVTAFTNQIRWLFEKLLGESPRRSPRRQYSWLLEQVSFIAAIEHYTAVMGEWILNSPQLDAVGADPVMLDMLRWHGAEEVEHKAVAFDTMKHLRAGYWRQVRAQLTVTPVMLLLWIRGVRFMYSVDPYLPPGTKPRWRDYFKAARRGLVPGLPRLLRVVGHYYKPGFHPSQLGGLGAAVDYLAVSPAARASH,"40,181",356,,,,,,,3
O33298,O33298_MYCTU,Rv2756c,hsdM Rv2756c,GO:0003677; GO:0005618; GO:0005886; GO:0006306; GO:0008170,IPR022749; IPR038333; IPR003356; IPR029063; ,,hsdM,,Possible type I restriction/modification system DNA methylase HsdM (M protein) (DNA methyltransferase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; N-methyltransferase activity [GO:0008170]; DNA methylation [GO:0006306],9634230; 21969609,,,MPPRKKQAPQAPSTMKELKDTLWKAADKLRGSLSASQYKDVILGLVFLKYVSDAYDERREAIRAELAAEGMEESQIEDLIDDPEQYQGYGVFVVPVSARWKFLAENTKGKPAVGGEPAKNIGQLIDEAMDAVMKANPTLGGTLPRLYNKDNIDQRRLGELIDLFNSARFSRQGEHRARDLMGEVYEYFLGNFARAEGKRGGEFFTPPSVVKVIVEVLEPSSGRVYDPCCGSGGMFVQTEKFIYEHDGDPKDVSIYGQESIEETWRMAKMNLAIHGIDNKGLGARWSDTFARDQHPDVQMDYVMANLPFNIKDWARNEEDPRWRFGVPPANNANYAWIQHILYKLAPGGRAGVVMANGSMSSNSNGEGDIRAQIVEADLVSCMVALPTQLFRSTGIPVCLWFFAKDKAAGKQGSIDRCGQVLFIDARELGDLVDRAERALTNEEIVRIGDTFHAWRGSKSAAVKGIMYEDVPGFCKSATLAEIKATDYALTPGRYVGTPAVEDDGEPIDEKMARLSKALLEAFDESARLERVVREQLGRLR,"60,084",540,,DNA methylation [GO:0006306],DNA binding [GO:0003677]; N-methyltransferase activity [GO:0008170],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
I6X666,I6X666_MYCTU,Rv3076,Rv3076,,IPR019587; IPR023393; ,,,,Uncharacterized protein,,9634230; 21969609,,,MVLDGVVSDTRRSRTIAARQQTIWDVLADFGSLSSWVEGVDHSCVLNHGPDGGALGSTRRVQVGRNTLVERVIEFDPPTTLAYRIEGLPARLRKVTNRWTLRPADPVGAVTVVTLTSTIEIGGNPLARLAELVVGRAMAKRSNTMLAGLAQRLEDKHG,"17,122",158,,,,,,,1
I6YAW3,I6YAW3_MYCTU,Rv3015c,Rv3015c,GO:0003871; GO:0008270; GO:0009086,IPR002629; IPR038071; ,,,,Uncharacterized protein,5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],9634230; 21969609,,,MSVFATATGIGSWPGTAAREAAQVVVGELAGALAYLTELPARGVGADMLGRAGGLLVDVAIDTVPRGYRIAARPGAVTRRAASLLDEDMDALEEAWETAGLRGCGRAVKVQAPGPVTLVAGLELANGHRAITDPGAVRDLAASLAEGVAAHRAALARRLDTPVVVQFDEPSLPAALGGRLTGVTALSPVAPLDETVAEALLDTCIAAVDADVALHSCSPDLPWDLLQRSRISAVSVDASTLQAADLDAVAAFVESGRTVVLGLVPVTAPERAPSMEEVAAAAVAVTDRLGVPRSALRDRLGVSPACGLANATGQWARTAVGLARDVAEAFARDPEAI,"34,244",337,Vitamin-B12 independent methionine synthase family,methionine biosynthetic process [GO:0009086],5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase activity [GO:0003871]; zinc ion binding [GO:0008270],,,,1
O33316,O33316_MYCTU,Rv2774c,Rv2774c,,,,,,Uncharacterized protein,,9634230,,,MGTAVEVGWRDPCGLAVGELRCAPAVSDQPVVGCAGCPLVDMVDFAPVTGCVAVGSTMGAVPALLRVRFPWPPFEPDVRLSPYLALHGICRWGGSDSCDRTTVQVFHLHSINKRLTAHAGFGAAAVVGLEDGPV,"13,953",134,,,,,,,3
O05773,O05773_MYCTU,Rv3094c,Rv3094c,GO:0016627; GO:0050660,IPR013107; IPR036250; IPR013786; IPR037069; IPR009100; ,,,,Uncharacterized protein,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MNQSETEIEILAEKIARWARARSAEIERDRRLPDELVTRLREAGLLRATMPREVAAPELAPGRALRCAEAVARGDASAGWCVSIAITSALLVAYLPARSREEMFGGGRGVAAGVWAPRGTARSVDGGVVVSGRWPFCSGINHADIMFAGCFVDDRQVPSVVALNKDELQVLDTWHTLGLRGTGSHDCVADDVFVPADRVFSVFDGPIVDRPLYRFPVFGFFALSIGAAALGNARAAIDDLVELAGGKKGLGSTRTLAERSATQAAAATAESALGAARALFYEVIEAAWQVSHDAEAVPVTMRNRLRLAATHAVRTSADVVRSMYDLAGGTAIYDNAPLQRRFRDAFTATAHFQVNEASRELPGRVLLDQPADVSML,"40,329",376,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,3
I6X642,I6X642_MYCTU,Rv3047c,Rv3047c,,,,,,Uncharacterized protein,,9634230,,,MGGPFDADAEAHFDEVAEAFAKLTNVDRDVGVDLEKELCMTVEADDRSDALVTRRLLPRVPRCIPLAARLAPGTIGCPSFWNPIATGGASRQAL,"10,067",94,,,,,,,1
O53245,O53245_MYCTU,Rv2998,Rv2998,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MDVIWSATIATTVATGMRKPRMHGMPPITSGSMVTRVTRMSIRLAGDSTLGRFSTSRLGLSSAKSKPEGDFGTACGAVSGGDAGVVALAEGVDDGQSKPGAAGGARGVGGFRESRADCGEQFGVASWTPQGEFEFGGQEAKGVRSSWPASLTN,"15,572",153,,,,plasma membrane [GO:0005886],,,1
O53287,O53287_MYCTU,Rv3040c,Rv3040c,GO:0005886; GO:0016787,IPR015797; IPR000086; ,,,,Conserved protein,plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],9634230; 21969609,,,MNSPREPLVPPPTPRPAATVMLVRDPDAGSASGLAVFLMRRHAAMDFAAGVMVFPGGGVDDRDRDADLGRLGAWAGPPPQWWAQRFGIEPDLAEALVCAAARETFEESGVLFAGPVDQDHSAPNSIVSDASVYGDARRALADRTLSFADFLQREKLVLRSDLLRPWANWVTPEAELTRRYDTYFFVGALPEGQRADGENTESDRAGWVLPADAIADFAAGRNFLLPPTWTQLDSLAGHTVADVLAVERQIVPVQPQLARNGDNWEIEFFDSDRYNQARRSGGSTGWPL,"31,485",288,,,hydrolase activity [GO:0016787],plasma membrane [GO:0005886],,,1
I6XF84,I6XF84_MYCTU,Rv2755c,hsdS.1 Rv2755c,,,,hsdS.1,,Possible type I restriction/modification system specificity determinant HsdS.1 (S protein),,9634230,,,MSDGWKTLRFGEVLELQRGHDLPAASRGSGTVPVIGSFGVTGMHDTAAYDGPGVAIGRSGAAIGTATFVAGPIWPLDTCLFVRDFKGNDPR,"9,476",91,,,,,,,1
Q79FB4,Q79FB4_MYCTU,Rv2737A,Rv2737A,GO:0051537,IPR024726; ,,,,Conserved hypothetical cysteine rich protein,"2 iron, 2 sulfur cluster binding [GO:0051537]",9634230,,,MRPDLRARLVRITDDLLNTASLAGSGVLTGPDLTFRRRSCCLFYRVPAGGKCGDCPL,"6,196",57,,,"2 iron, 2 sulfur cluster binding [GO:0051537]",,,,1
I6YA93,I6YA93_MYCTU,Rv2792c,Rv2792c,GO:0000150; GO:0003677,IPR006118; IPR006119; IPR036162; ,,,,Possible resolvase,DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230,,,MNLAVWAERNGVARVTAYRWFHAGLLPVPARKAGRLILVDDQPADRSRRARTAVYARVSSADQKPDLDRQVARVTAWATTEQIAVDKVVTEVGSALNGHRRKFLALLRDPSVKRIVVEHRDRFCRFGSEYVEAALAAQGRELVVVDSAEVDDDLVRDMTEILTSMCARLYGKRAAQNRAKRALAAAAEESEAA,"21,412",193,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],,,,1
I6XFB7,I6XFB7_MYCTU,Rv2799,Rv2799,GO:0016021,IPR024520; ,,,,Probable membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MYTPGKGPPRAGGVVFTRVRLIGGLGALTAAVVVVGTVGWQGIPPAPTGGDAVQLRSTAAPMSTTMKSPIVATTDPSPFDPCRDIPFDVIQRLGLAYTPPEAEEGLRCHFDAGNYQMAVEPIIWRTYAQTLPPDAIETTIAGHRAAQYWVRKPTYHNSFWYSSCMVTFKTSYGVIQQSLFYSTVYSEPDVDCPSTNLQRANDLVPYYRF,"22,888",209,,,,integral component of membrane [GO:0016021],,,1
I6XFF7,I6XFF7_MYCTU,Rv2840c,Rv2840c,,IPR007393; IPR037465; IPR035931; ,,,DOMAIN 2 82 DUF448. {ECO:0000259|Pfam:PF04296}.,Uncharacterized protein,,9634230,,,MRTCVGCRKRGLAVELLRVVAVSTGNGNYAVIVDTATSLPGRGAWLHPLRQCAQQAIRRRAFARALRIAGSPDTSAVVEYLESLGELEPPGNRTGSNRT,"10,633",99,,,,,,,1
Q6MX26,Q6MX26_MYCTU,Rv2853,PE_PGRS48 Rv2853,,IPR000084; ,,PE_PGRS48,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS48,,9634230,,,MLYVVASPDLMTAAATNLAEIGSAISTANGAAALPTVEVVAAAADEVSTQIAALFGAHARSYQTLSTQAAAFHSRFVQALTTAAASYASVEAANASPLQVALDVINAPAQTLLGRPLIGNGADGSTPGQAGGPGGLLYGNGGNGAAGGPNQAGGAGGNAGLIGNGGAGGAGGVGAVGGKRGTGGLLFGNGGAGGQGGLGLAGINGGSGGQGGHGGNAILFGQGGAGGPGGTGAMGVAGTNPTPIGTAAPGSDGVNQIGNGGNTDLTGGAGGDGNAGSTTVNGGNGGTGGAARNSSGGTGNSFGGAGGAGGDGANGGDGGAGGEALTEGGATAVSGAGGKGGNAEASGGAGGNGGKGGFAQATTSVTGGNGGNGGNGHDSNAPGGAGGSGGVGGDGGRGGLLAGNGGTGGAGGNGGTGGAGAPGGAGGAGGKADIANSLGDNATVTGGNGGTGGDGGSALGTGGAGGAGGLGGHGGAGGLLIGNGGAGGAGGLGGAGGAGGAGGEGGAGGAGGEAIPGGASTNSAGGDGGAGGTGGNGGDGGAGGAPGLGGAGGAGGWLIGQSGSTGGGGAGGAGGAGGAGGAGGSGGAGGHGDTTSGKNGSSGTAGFDGNPGQPG,"51,257",615,,,,,,,1
P71646,P71646_MYCTU,Rv2805,Rv2805,,,,,,Uncharacterized protein,,9634230,,,MGRGNGKILDPVVATTGMGRSTARQMLTGPRLPGPAEQVDGRSLRPRGFSDEARALLEHVWALMGMPCGKYLVVMHDLWLPLLTAAGDLDKPLVTEASVAELKATALPGANRMPHWAAGTLPDGFPARAVRTRT,"14,308",134,,,,,,,1
P71627,P71627_MYCTU,Rv2825c,Rv2825c,,IPR014923; IPR008307; ,,,,Uncharacterized protein,,9634230,,,MKLPGAKRLGDDRRPLGTLRCWRHSDIGPARGIVVTPALKEWSAAVHALLDGRQTVLLRKGGIGEKRFEVAAHEFLLFPTVAHSHAERVRPEHRDLLGPAAADSTDECVLLRAAAKVVAALPVNRPEGLDAIEDLHIWTAESVRADRLDFRPKHKLAVLVVSAIPLAEPVRLARRPEYGGCTSWVQLPVTPTLAAPVHDEAALAEVAARVREAVG,"23,359",215,,,,,,,1
I6YF11,I6YF11_MYCTU,Rv3041c,Rv3041c,GO:0005524; GO:0016887,IPR003593; IPR003439; IPR027417; ,,,DOMAIN 22 262 ABC transporter. {ECO:0000259|PROSITE:PS50893}.,Probable conserved ATP-binding protein ABC transporter,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MRHDSRVLDNGGPDAADPDLLIDFRNVSLRRNGRTLVGPLDWAVELDERWVIVGPNGAGKTSLLRIAAAAEHPSSGVAFVLGERLGRVDVSELRARVGLSSSALAERVPGDERVRDLVVSAGYAVLGRWRERYEAVDYHRAIDMLESLGAEHLANRTYGTLSEGERKRVLIARALMTDPELLLLDEPAAGLDLGGREELVARLADLAADPDAPALVLVTHHVEEIPPGFSHCLLLSEARVVAAGLLPDALTAENLSTAFGQEITLEVADGRYFARRRRSRAAHRRQS,"31,249",287,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
I6Y276,I6Y276_MYCTU,Rv2993c,Rv2993c,GO:0008152; GO:0016853,IPR018833; IPR011234; IPR036663; ,,,DOMAIN 2 31 DUF2437. {ECO:0000259|Pfam:PF10370}.; DOMAIN 36 234 FAA_hydrolase. {ECO:0000259|Pfam:PF01557}.,"Possible 2-hydroxyhepta-2,4-diene-1,7-dioate isomerase (HHDD isomerase)",isomerase activity [GO:0016853]; metabolic process [GO:0008152],9634230; 21969609,,,MTAREIAEHPFGTPTFTGRSWPLADVRLLAPILASKVVCVGKNYADHIAEMGGRPPADPVIFLKPNTAIIGPNTPIRLPANASPVHFEGELAIVIGRACKDVPAAQAVDNILGYTIGNDVSARDQQQSDGQWTRAKGHDTFCPVGPWIVTDLAPFDPADLELRTVVNGDVKQHARTSLMIHDIGAIVEWISAIMTLLPGDLILTGTPAGVGPIEDGDTVSITIEGIGTLTNPVVRKGKP,"25,341",239,,metabolic process [GO:0008152],isomerase activity [GO:0016853],,,,2
O53298,O53298_MYCTU,Rv3081,Rv3081,GO:0005886,IPR018700; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MTPHYRQAAASRLDTHRTQKLRSQTNGGKDRHQLTYEQFARMLTLMGPSDLWTVERAARHWGVSASRARAILSSRHIHRVSGYPAQAIKAVTLRQGARTDLKTANHLVPAAQAFTMAETGAAIGETEDERARLRIFFEFLRGADETGTSALDLIVDEPALIGEHRFDALLAAAAEYISARWGRPGPLWSVSIERFLDTAWWVSDLPSARAFAAVWTPAPFRRRGIYLDRHDLTSDGVCVMPEPVFNRTELQRAFTALAAKLERRGVVGQVHVVGGAAMLLAYNSRVTTRDIDALFSTDGPMLEAIREVADEMGWPRTWLNNQASGYVSRTPGEGAPVFDHPFLHVVATPAQHLLAMKVVAARGVRDGEDIRLLLDRLRITSAAGVWEIVARYFPAETITDRSRLLVEDLLNQ,"45,820",412,,,,plasma membrane [GO:0005886],,,3
O33309,O33309_MYCTU,Rv2767c,Rv2767c,GO:0016021,,,,,Possible membrane protein,integral component of membrane [GO:0016021],9634230,,,MVGYEGARGRAGREMSESATAGARSSRIPFGIIRNHEAVRPRRSRHLNHARDTPQMVAVAQVWREVVQATAIAIAPPLPVVSWGLISLAFLSHTVRGRYRRSPPAESGHHSNRRQAK,"12,938",117,,,,integral component of membrane [GO:0016021],,,1
I6XF92,I6XF92_MYCTU,Rv2765,Rv2765,GO:0016787,IPR029058; IPR002925; ,,,DOMAIN 17 242 DLH. {ECO:0000259|Pfam:PF01738}.,Probable alanine rich hydrolase,hydrolase activity [GO:0016787],9634230; 21969609,,,MPKTTDTAATPDGTCAVRLFTPDGPGRWPGVVMFPDAGGVRDTFDRMAAKLAGFGYVVLLPDVYYREGDWAPFDMKTAFGDPQERARIMFMIGTLTPDRVTRDADALLNYLASRPEVIGDRFGVCGYCMGGRMSVVVAGRLPDRVAAAAAFHPGGLVANSPDSPHLLADRISATVYIGGAENDPSFTADHAEKLDKAFSAAGVPHRIECYPAAHGFAVPDNPSYDAAADERHWAAMTETFGAALN,"26,160",245,,,hydrolase activity [GO:0016787],,,,1
I6XFI7,I6XFI7_MYCTU,Rv2867c,Rv2867c,GO:0016747,IPR016181; IPR025289; IPR013653; IPR000182; IPR016794; ,,,,GCN5-related N-acetyltransferase,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",9634230; 21969609,,,MSAPPISRLVGERQVSVVRDAAAVWRVLDDDPIESCMVAARVADHGIDPNAIGGELWTRRGAHESLCFAGANLIPLRGGPIDLNAFADVAMSTPRRCSSLVGRADLVLPMWQRLEPVWGPARDVRDNQPLMALATHPSCAIDTGVRQVRPEELDSYLVAAVDMFIGEVGVDPRLGDGGRGYRRRVAGLIAAGRAWARFEHGQVIFKAEVGSQSPAVGQIQGVWVHPEWRGIGLGTAGTATLAAVIVGSGRIASLYVNSFNTVARAAYARVGFKEIGTFATVLLD,"30,327",284,,,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
I6Y1K7,I6Y1K7_MYCTU,Rv2735c,Rv2735c,,IPR031009; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAREWSYWTRNKLEILAGYLPAFNRASQTSRERIYLDLMAGQPENIDRDMGEKFDGSSLIAMKADPPFTRLRFCELNPLASELDVALRTRFPGDGRYRVVAGDSNVTIDETLAELGPWRWAPTFAFIDQQAAEVHWETINKVAAFRQNPRNLKTELWMLMSPTMIARGVKGTNAELFIEQVTRMYGDADWKRIQAARWRHHLTAPAYRAEMVNLMRVKLEYELGYKYSHRIPMQMHNKVTIFDMVFATDHWAGDAIMCHLYNRAAQKEPEMMRQAKSAKQQKESEDRGEMGLFSVGELAVQDSNAGQILWAPSPTWDPRARGWWSEDPGF,"38,129",330,,,,,,,1
I6Y293,I6Y293_MYCTU,Rv3006,lppZ Rv3006,GO:0003824,IPR011042; IPR012938; IPR011041; ,,lppZ,DOMAIN 86 249 GSDH. {ECO:0000259|Pfam:PF07995}.,Probable conserved lipoprotein LppZ,catalytic activity [GO:0003824],9634230; 21969609,,,MWTTRLVRSGLAALCAAVLVSSGCARFNDAQSQPFTTEPELRPQPSSTPPPPPPLPPVPFPKECPAPGVMQGCLESTSGLIMGIDSKTALVAERITGAVEEISISAEPKVKTVIPVDPAGDGGLMDIVLSPTYSQDRLMYAYISTPTDNRVVRVADGDIPKDILTGIPKGAAGNTGALIFTSPTTLVVMTGDAGDPALAADPQSLAGKVLRIEQPTTIGQTPPTTALSGIGSGGGLCIDPVDGSLYVADRTPTADRLQRITKNSEVSTVWTWPDKPGVAGCAAMDGTVLVNLINTKLTVAVRLAPSTGAVTGEPDVVRKDTHAHAWALRMSPDGNVWGATVNKTAGDAEKLDDVVFPLFPQGGGFPRNNDDKT,"38,752",373,,,catalytic activity [GO:0003824],,,,1
O33230,O33230_MYCTU,Rv2725c,hflX Rv2725c,GO:0003924; GO:0005525; GO:0005737; GO:0005886; GO:0043022,IPR030394; IPR032305; IPR006073; IPR016496; IPR025121; IPR027417; ,,hflX,DOMAIN 271 440 Hflx-type G. {ECO:0000259|PROSITE:PS51705}.,GTPase HflX (GTP-binding protein HflX),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022],9634230; 21969609,,FUNCTION: GTPase that associates with the 50S ribosomal subunit and may have a role during protein synthesis or ribosome biogenesis. {ECO:0000256|HAMAP-Rule:MF_00900}.,MPANSDARPAATCHHRVLAMTYPDPPQTGLSDFTPSLGELALEDRSALRRVAGLSTELADVSEVEYRQLRLERVVLVGVWTEGSAADNRASLAELAALAETAGSQVLEGLIQRRDKPDPSTYIGSGKAAELREVIVATGADTVICDGELSPAQLTALEKAVQVKVIDRTALILDIFAQHATSREGKAQVSLAQMEYMLPRLRGWGESMSRQAGGRAGGSGGGVGLRGPGETKIETDRRRIRERMAKLRRDIRAMKQVRDTQRSRRRHSDVPSIAIVGYTNAGKSSLLNALTGAGVLVQDALFATLEPTTRRAEFGDGRPVVLTDTVGFVRHLPTQLVEAFRSTLEEVVHADLLVHVVDGSDGHPLAQIDAVRQVISEVIADHDGDPPPELLVVNKVDVASDLMLAKLRHGLPGAVFVSARTGDGIDALRRRMAELVVPADTAVDVVIPYDRGDLVARVHADGRIQQAEHKPEGTRIKARVPEALAATLREFAPRA,"53,328",495,"TRAFAC class OBG-HflX-like GTPase superfamily, HflX GTPase family",,GTPase activity [GO:0003924]; GTP binding [GO:0005525]; ribosome binding [GO:0043022],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
Q6MX15,Q6MX15_MYCTU,Rv3077,Rv3077,GO:0008152; GO:0008484,IPR017850; IPR000917; ,,,,Possible hydrolase,sulfuric ester hydrolase activity [GO:0008484]; metabolic process [GO:0008152],9634230; 21969609,,,MANRPDIIIVMTDEERAVPPYESAEVLAWRQRSLTGRRWFDEHGISFTRHYTGSLACVPSRPTIFTGQYPDLHGVTQTDGIGKRFDDSRLRWLRAGEVPTLGNWFRAAGYDTHYDGKWHISHADLEDPATGAPLATNDNEGVVDSAAVRRYLDADPLGPYGFSGWVGPEPHGAGLANSGFRRDPLVADRVVAWLTERYARRRAGDTAAMRPFLLVASFVNPHDIVLFPAWVWRSPLKPSPLDPPHVPAAPTADEDLSTKPAAQVAYREAYYSGYGLTRMVSRNYARNAQRYRDLYYRLHAEVDGPIDRVGRAVTEGGSEDAMLVRTSDHGDLLGAHGGLHQKWFNLYDEATRVPFVIARIGEKATQPRTVSAPTSHVDLVPTLLSAAGVDVDVVAAALAESFSEVHPLPGRDLMPVVDGASADEGRAIYLMTRDNVLEGDTGASLLSRQLGRIVNPPAPLRIKVPAHVAANFEGLVVRVDDTDAAGGAGHLWKLVRTFDDPATWTEPGVRHLATNGMGGDAYRTDPLDDQWELYDLTADPIEAYNRWTDPQLHELRQHLRMLLKQQRAVSVPERNQPWPYAHRLPPSGASNGLVRRVLGRFVR,"66,741",603,,metabolic process [GO:0008152],sulfuric ester hydrolase activity [GO:0008484],,,,1
Q79FA9,Q79FA9_MYCTU,Rv2768c,PPE43 Rv2768c,,IPR022171; IPR000030; IPR038332; ,,PPE43,,PPE family protein PPE43,,9634230,,,MDFGALPPEINSTRMYAGAGAAPLMAAGATWNGLAVELSTTASSVESVIMQLTTEQWLGPASMSMVVAAQPYLAWLTYTAESAAHAAAQAMASAAAFEAAFAMTVPPAEVAANRALLAALVATNVLGQNTPAIMATEAHYGEMWAQDALAMYGYAASSAAAGRLNPLITPSQTANMAGLAGQAAAVSHAAAASTVQQVGLGSLISNLPNAVMGFASPLTSAADAAGLGGIIQDIEELLGITFVQNAINGAVNTTAWFVMATIPNAVFLGHAFAALNPATVTAAADAVPAAAAAAGLAHTVTPVGVGGASLTASLGEASSVGGLSVPAGWSTAAPAMTSGTTALEGSGWAVPEEAGPVAAMPGMAGISGAAKGAGAYAGPRYGFKPIVMPKQVVV,"38,627",394,Mycobacterial PPE family,,,,,,1
O33333,O33333_MYCTU,Rv2791c,Rv2791c,GO:0005618; GO:0005886,IPR001959; IPR010095; IPR021027; ,,,,Probable transposase,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230,,,MAKFEIPEGWMVQAFRFTLDPTAEQARALARHFGARRKAYNWTVATLKADIDAWQATGIQTAKPSLRVLRKRWNTVKNDVCVNIETGVVWWPECSKEAYADGIDGAVDAYWNWQNSRSGKRDGKRMGFPRFKKKGRDPDRVTFTTGAMRVEPDRRHLTLPVIGTVRTHENTRRVERLIAKGRSRVLAITVRRNGTRIDASVRVLVQRPQQPKVTDPGSRVGVDVGVRRLATVATADGAVLERVPNPRPLDAALNELRHVCRARSRCTKGSRRYRERTTEISRLHRRVNDVRTHHLHCLTTHLAKTHGRIVVEGLDAAGMLRQQGLSGARARRRGLSDAALGTPRRHLSYKTGWYGSQLVVADRWFPSSKTCHVCGHVQEIGWAEHWQCDSCSASHQRDDCAAINLARYEDTSSVVGPVGAAVKRGADRKTRPGRAGGREARKGSSRKAAEQPRDGVQVA,"51,422",459,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
Q79FA8,Q79FA8_MYCTU,Rv2769c,PE27 Rv2769c,,IPR000084; IPR022171; ,,PE27,,PE family protein PE27,,9634230,,,MSFLTTQPEELAAAAGKLETIGSAMVAQNAAAAAPTTTGVIPAAADEISVLQAPLFTAYGTLYQQVSAEAAAVYDLFVKTLGVSAGTYAATEAANSSAAASPLSGIASILGSTPGKVPSWISDIANIFNIGAGNWASAASDLLGLASGGLLPAAEEAALEEGLEGAGLSELGAAEAAVGEAPIAAGLGAAPLAAGLSRASSIGALSVPPSWAGQANLVSSTSTLQGAGWTTAAPHGAAGTVIPGMPGLASATRSSAGFGAPRYGAKPIVVPKPAV,"26,382",275,,,,,,,1
I6XFU1,I6XFU1_MYCTU,Rv2979c,Rv2979c,GO:0000150; GO:0003677,IPR006118; IPR006119; IPR036162; ,,,,Probable resolvase,DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230,,,MNLATWAERNGVAPGTAYRWFRAGLLSVMARRVGRLILVDEPAGDAGMRSPTAVYARVSSADQKADLDRQVARVTAWATAQQMPVDKVVTEVGSAFNEHRRKFLSLLRDPSVHRIVVEHRDRFCRLGSKYVQAAFAAQGRELVVVDSAEVDDDLVRDMTEILTSMCARLYGKRAAENRTKRALAAAAGEDHEAA,"21,412",194,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],,,,1
P71649,P71649_MYCTU,Rv2802c,Rv2802c,,IPR018744; ,,,,Hypothetical arginine and alanine rich protein,,9634230; 21969609,,,MARQPLEQRVARAAQAALARQRFVSAIDVLLGLGWLAPSHVDQWRQGRVDSLEQVVQANLSKITAVMAALRRWARDRGLNPSETDYVARTRDRRRLRFSVTGEDAIERAYRTHWVSPELSERAVARQSRRPDLVVIMPVNDWSCASCGGSGDLMFLEDAGPLCLDCADLGHLVFLPSGDAALTRRAKRASRLSAVVVRWSRARKRYERQGILVEAEALERAENECLADAEVRARRRERDEARRANEDLRLQAEFGAAIRTLFPNCPAGRAEAIARHAATRGSGRIGRSAAGRALDPEAVRLAVAASVRHIDTSFDELLMSGVDRETARHRVGEHVEEVLRDWRATSR,"38,794",347,,,,,,,4
O33282,O33282_MYCTU,Rv2739c,Rv2739c,GO:0008194; GO:0016758; GO:0040007; GO:0043231,IPR007235; ,,,,Possible alanine rich transferase,"intracellular membrane-bounded organelle [GO:0043231]; transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; growth [GO:0040007]",9634230; 21969609,,,MRVAVVAGPDPGHSFPAIALCQRFRAAADTPTLFTGVEWLEAARAAGIDAVELDGLAATDRDLDAGARIHRRAAQMAVLNVPRLRALEPELVVSDVITACGGMAAELLGIPWVELNPHPLYLPSKGLPPIGSGLAAGTGIRGRLRDATMRALTGRSWRAGLRQRAAVRVEIGLPARDPGPLRRLIATLPALEVPRPDWPAEAVVVGPLHFEPTDRVLAIPAGTGPVVVVAPSTALTGTAGLTEVALQSLTPGETVPSGSRLVVSRLSGADLTVPPWAVAGLGSQAELLTRADLVICGGGHGMVAKTLLAGVPMVVVPGGGDQWEIANRVVRQGSAVLIRPLTADALVAAVNEVLSSPRFREAARRAAASVAGAADPVRVCHDALALAG,"39,962",388,,growth [GO:0040007],"transferase activity, transferring hexosyl groups [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]",intracellular membrane-bounded organelle [GO:0043231],,,3
O33336,O33336_MYCTU,Rv2794c,pptT Rv2794c,GO:0000287; GO:0005886; GO:0008897; GO:0009239; GO:0009366; GO:0019540,IPR008278; IPR037143; IPR003542; ,,pptT,,Phosphopantetheinyl transferase PptT (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrier protein]pantetheinephosphotransferase),enterobactin synthetase complex [GO:0009366]; plasma membrane [GO:0005886]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; enterobactin biosynthetic process [GO:0009239]; siderophore biosynthetic process from catechol [GO:0019540],9634230; 21969609; 24963544; 25450595; ,X-ray crystallography (3),,MTVGTLVASVLPATVFEDLAYAELYSDPPGLTPLPEEAPLIARSVAKRRNEFITVRHCARIALDQLGVPPAPILKGDKGEPCWPDGMVGSLTHCAGYRGAVVGRRDAVRSVGIDAEPHDVLPNGVLDAISLPAERADMPRTMPAALHWDRILFCAKEATYKAWFPLTKRWLGFEDAHITFETDSTGWTGRFVSRILIDGSTLSGPPLTTLRGRWSVERGLVLTAIVL,"24,709",227,P-Pant transferase superfamily,enterobactin biosynthetic process [GO:0009239]; siderophore biosynthetic process from catechol [GO:0019540],holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287],enterobactin synthetase complex [GO:0009366]; plasma membrane [GO:0005886],,,1
O33321,O33321_MYCTU,Rv2779c,Rv2779c,GO:0003700; GO:0005829; GO:0006351; GO:0043200; GO:0043565,IPR011991; IPR000485; IPR011008; IPR019888; IPR019887; IPR036388; IPR036390; ,,,DOMAIN 32 93 HTH asnC-type. {ECO:0000259|PROSITE:PS50956}.,Possible transcriptional regulatory protein (Probably Lrp/AsnC-family),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",9634230; 21969609; ,X-ray crystallography (1),,MIILFRGHMRDNSTEHKTRRAASSKDVRPAELDEVDRRILSLLHGDARMPNNALADTVGIAPSTCHGRVRRLVDLGVIRGFYTDIDPVAVGLPLQAMISVNLQSSARGKIRSFIQQIRRKRQVMDVYFLAGADDFILHVAARDTEDLRSFVVENLNADADVAGTQTSLIFEHLRGAAPI,"19,872",179,,"response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],cytosol [GO:0005829],,,3
I6YAA5,I6YAA5_MYCTU,Rv2806,Rv2806,GO:0016021,,,,,Possible membrane protein,integral component of membrane [GO:0016021],9634230,,,MKTNPRYGPAFYSVMTVLFLALFVLNVCTHGSTLGLISTGGLAVLMGYIGYRGWSGKRHINRQ,"6,936",63,,,,integral component of membrane [GO:0016021],,,1
Q6MX13,Q6MX13_MYCTU,Rv3110,moaB1 Rv3110,GO:0006729; GO:0008124,IPR036428; IPR001533; ,,moaB1,,4a-hydroxytetrahydrobiopterin dehydratase (EC 4.2.1.96),4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; tetrahydrobiopterin biosynthetic process [GO:0006729],9634230,,,MTVSTPEQHEQRASHDASEGKHNVCQGRLAALADAAVSEKLGALPGWQLLDMRLSRAFQCTNFDQSIDFMNRVASIANDINHHPDIAVLDKRSVRVTAWTRKLGYLTDIDFDLAASVEAMYATEFADRPAR,"14,558",131,Pterin-4-alpha-carbinolamine dehydratase family,tetrahydrobiopterin biosynthetic process [GO:0006729],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124],,,,1
I6Y1K4,I6Y1K4_MYCTU,Rv2730,Rv2730,,,,,,Uncharacterized protein,,9634230,,,MMMNWRQTNITTKRCAQTRASSSASEFCGIFAAPGLMRNCHHGGSAPSAVGGSAVQLTVAYGPQRFHGRCASNSSVRPLTTGGSWTPTSISSTDGGKAQGHDTHDRQISRRTVCQAASILASILLETVAGPGEGIGPTTSVPLRAADARHTREGLQGR,"16,476",158,,,,,,,1
O33272,O33272_MYCTU,Rv2969c,Rv2969c,GO:0005618; GO:0005886; GO:0009986; GO:0040007,IPR012336; IPR036249; ,,,,Possible conserved membrane or secreted protein,cell surface [GO:0009986]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609; 24100317; 24134223; 23828196,X-ray crystallography (4),,MADKSKRPPRFDLKSADGSFGRLVQIGGTTIVVVFAVVLVFYIVTSRDDKKDGVAGPGDAVRVTSSKLVTQPGTSNPKAVVSFYEDFLCPACGIFERGFGPTVSKLVDIGAVAADYTMVAILDSASNQHYSSRAAAAAYCVADESIEAFRRFHAALFSKDIQPAELGKDFPDNARLIELAREAGVVGKVPDCINSGKYIEKVDGLAAAVNVHATPTVRVNGTEYEWSTPAALVAKIKEIVGDVPGIDSAAATATS,"26,862",255,,growth [GO:0040007],,cell surface [GO:0009986]; cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
I6X630,I6X630_MYCTU,Rv3032A,Rv3032A,,,,,,Conserved protein,,9634230; 21969609,,,MKPQDQGLHFPYRYDLRLAPMWLPFRWPGSQGVTVTEDGRFVARYGPFRVEAPLSSVRDAHITGPYRWWTAVGPRLSMVDDGLTFGTNAAAGVCIHFEPRIHRVIGLRDHSALTVTVADPEGLVAALSS,"14,330",129,,,,,,,1
P95100,P95100_MYCTU,Rv3058c,Rv3058c,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 20 80 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MTSHAADEKQAAPPMRRRGDRHRQAILRAARELLEETPFAELSVRAISLRAGVARSGFYFYFDSKYSVLAQILAEATEELEEASQHFSARQPGESPEQFVNRMIGSVAAVYANNDPVLRACNAARQSDMEIRDILERQFQVLLRETIGVFEAEVKAGTAHPISEDLPTLVRTLAATTALMLTGDALLVGPDSDAARRVRVLEQMWLNALWGGGKAP,"23,835",216,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,4
I6X5H3,I6X5H3_MYCTU,Rv2832c,ugpC Rv2832c,GO:0005524; GO:0016887,IPR003593; IPR003439; IPR017871; IPR008995; IPR027417; ,,ugpC,,Probable Sn-glycerol-3-phosphate transport ATP-binding protein ABC transporter UgpC,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MANVQYSAVTQRYPGADAPTVDNLDLDIADGEFLVLVGPSGCGKSTTLRVLAGLEPIESGRISIGDVDVTHLPPRARDVAMVFQNYALYPNMTVAANMGFALRNAGMSRADTRRRVLEVADMLELTDLLDRKPAKLSGGQRQRVAMGRAIVRRPRVFCMDEPLSNLDAKLRVSTRSQISGLQRRLGTTTVYVTHDQVEAMTMGDRVAVLKDGVLQQVDTPRALYDDPVNTFVATFIGAPAMNLIDAAVAHGVVRAPDLAIPVPDPAAERVLVGVRPESWDVASIGTPGSLTVHVELVEELGFESFVYATPVDQRGWSSRAPRIVFRTDRRTAVRVGESLAIVPHSQEVRLFNSRTETRLR,"39,311",360,ABC transporter superfamily,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
O33237,O33237_MYCTU,Rv2732c,Rv2732c,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MMSHEHDAGDLDALRAEIEAAERRVAREIEPGARALVVAILVFVLLGSFILPHTGSVRGWDVLFSSHGAGRAAVALPSRVFAWLALVFGVGFSMLALLTRRWALAWVALAGSAMASGTGLLAVWSRQTVAAGHPGPGIGLIVAWITAIVLTFHWAQVVWSRTIVQLAAEERRRRVVAQQQCKTLLDHVQTDSEAGTTPDRGTDR,"21,989",204,,,,integral component of membrane [GO:0016021],,,1
I6YEU0,I6YEU0_MYCTU,Rv2967c,pca Rv2967c,GO:0004736; GO:0005524; GO:0006090; GO:0006094; GO:0009374; GO:0046872,IPR013785; IPR011761; IPR005481; IPR001882; IPR011764; IPR005482; IPR000089; IPR003379; IPR005479; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; ,,pca,,Pyruvate carboxylase (EC 6.4.1.1),ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090],9634230; 21969609,,"FUNCTION: Catalyzes a 2-step reaction, involving the ATP-dependent carboxylation of the covalently attached biotin in the first step and the transfer of the carboxyl group to pyruvate in the second. {ECO:0000256|PIRNR:PIRNR001594}.",MFSKVLVANRGEIAIRAFRAAYELGVGTVAVYPYEDRNSQHRLKADESYQIGDIGHPVHAYLSVDEIVATARRAGADAIYPGYGFLSENPDLAAACAAAGISFVGPSAEVLELAGNKSRAIAAAREAGLPVLMSSAPSASVDELLSVAAGMPFPLFVKAVAGGGGRGMRRVGDIAALPEAIEAASREAESAFGDPTVYLEQAVINPRHIEVQILADNLGDVIHLYERDCSVQRRHQKVIELAPAPHLDAELRYKMCVDAVAFARHIGYSCAGTVEFLLDERGEYVFIEMNPRVQVEHTVTEEITDVDLVASQLRIAAGETLEQLGLRQEDIAPHGAALQCRITTEDPANGFRPDTGRISALRTAGGAGVRLDGSTNLGAEISPYFDSMLVKLTCRGRDLPTAVSRARRAIAEFRIRGVSTNIPFLQAVLDDPDFRAGRVTTSFIDERPQLLTARASADRGTKILNFLADVTVNNPYGSRPSTIYPDDKLPDLDLRAAPPAGSKQRLVKLGPEGFARWLRESAAVGVTDTTFRDAHQSLLATRVRTSGLSRVAPYLARTMPQLLSVECWGGATYDVALRFLKEDPWERLATLRAAMPNICLQMLLRGRNTVGYTPYPEIVTSAFVQEATATGIDIFRIFDALNNIESMRPAIDAVRETGSAIAEVAMCYTGDLTDPGEQLYTLDYYLKLAEQIVDAGAHVLAIKDMAGLLRPPAAQRLVSALRSRFDLPVHLHTHDTPGGQLASYVAAWHAGADAVDGAAAPLAGTTSQPALSSIVAAAAHTEYDTGLSLSAVCALEPYWEALRKVYAPFESGLPGPTGRVYHHEIPGGQLSNLRQQAIALGLGDRFEEIEEAYAGADRVLGRLVKVTPTSKVVGDLALALVGAGVSADEFASDPARFGIPESVLGFLRGELGDPPGGWPEPLRTAALAGRGAARPTAQLAADDEIALSSVGAKRQATLNRLLFPSPTKEFNEHREAYGDTSQLSANQFFYGLRQGEEHRVKLERGVELLIGLEAISEPDERGMRTVMCILNGQLRPVLVRDRSIASAVPAAEKADRGNPGHIAAPFAGVVTVGVCVGERVGAGQTIATIEAMKMEAPITAPVAGTVERVAVSDTAQVEGGDLLVVVS,"120,424",1127,,gluconeogenesis [GO:0006094]; pyruvate metabolic process [GO:0006090],ATP binding [GO:0005524]; biotin binding [GO:0009374]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736],,,,1
I6YEB6,I6YEB6_MYCTU,Rv2766c,Rv2766c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTSLDLTGRTAIITGASRGIGLAIAQQLAAAGAHVVLTARRQEAADEAAAQVGDRALGVGAHAVDEDAARRCVDLTLERFGSVDILINNAGTNPAYGPLLEQDHARFAKIFDVNLWAPLMWTSLVVTAWMGEHGGAVVNTASIGGMHQSPAMGMYNATKAALIHVTKQLALELSPRIRVNAICPGVVRTRLAEALWKDHEDPLAATIALGRIGEPADIASAVAFLVSDAASWITGETMIIDGGLLLGNALGFRAAPSTEH,"27,140",260,,,oxidoreductase activity [GO:0016491],,,,1
I6Y2E2,I6Y2E2_MYCTU,Rv3049c,Rv3049c,GO:0004499; GO:0050660; GO:0050661,IPR036188; IPR020946; ,,,,Probable monooxygenase,"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",9634230; 21969609,,,MSIADTAAKPSTPSPANQPPVRTRAVIIGTGFSGLGMAIALQKQGVDFVILEKADDVGGTWRDNTYPGCACDIPSHLYSFSFEPKADWKHLFSYWDEILGYLKGVTDKYGLRRYIEFNSLVDRGYWDDDECRWHVFTADGREYVAQFLISGAGALHIPSFPEIAGRDEFAGPAFHSAQWDHSIDLTGKRVAIVGTGASAIQIVPEIVGQVAELQLYQRTPPWVVPRTNEELPVSLRRALRTVPGLRALLRLGIYWAQEALAYGMTKRPNTLKIIEAYAKYNIRRSVKDRELRRKLTPRYRIGCKRILNSSTYYPAVADPKTELITDRIDRITHDGIVTADGTGREVFREADVIVYATGFHVTDSYTYVQIKGRHGEDLVDRWNREGIGAHRGITVANMPNLFFLLGPNTGLGHNSVVFMIESQIHYVADAIAKCDRMGVQALAPTREAQDRFNQELQRRLAGSVWNSGGCRSWYLDEHGKNTVLWCGYTWQYWLTTRSVNPAEYRFFGIGNGLSSDRATVAAAN,"58,777",524,,,"flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,1
I6YEZ8,I6YEZ8_MYCTU,Rv3027c,Rv3027c,GO:0016740,IPR016181; ,,,,GCN5-related N-acetyltransferase,transferase activity [GO:0016740],9634230,,,MSIASVLIPSDKPHGVATGSSTGPRYSLLLSTDPSMVEAAQRLRYDVFSTTPGFALPAAADTRRDGDRFDEYCDHLLVRDDDTGELVGCYRMLAPAGAIAAGGLYTATEFDVCAFDPLRPSLVEMGRAVVREGHRNGGVVLLMWAGILAYLDRYGYDYVTGCVSVPIGGDGETPGSRLRGVRDFILNRHAAPPQCQVYPYRPVRVDGRSLDDILPPPRPAVPPLMRGYLRLGARACGEPAHDPDFGVGDFCLLLDKDHADTRYLRRLRSVAAASEMVNDAR,"30,514",281,,,transferase activity [GO:0016740],,,,1
I6YB06,I6YB06_MYCTU,Rv3053c,nrdH Rv3053c,GO:0005623; GO:0009055; GO:0015035; GO:0045454,IPR011909; IPR002109; IPR036249; ,,nrdH,,Probable glutaredoxin electron transport component of NRDEF (Glutaredoxin-like protein) NrdH,cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],9634230; 21969609; 23675692,X-ray crystallography (2),,MTVTVYTKPACVQCSATSKALDKQGIAYQKVDISLDSEARDYVMALGYLQAPVVVAGNDHWSGFRPDRIKALAGAALTA,"8,419",79,,cell redox homeostasis [GO:0045454],electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035],cell [GO:0005623],,,1
Q6MX20,Q6MX20_MYCTU,Rv2998A,Rv2998A,GO:0000155; GO:0005622,IPR003661; IPR036097; ,,,,Uncharacterized protein,intracellular [GO:0005622]; phosphorelay sensor kinase activity [GO:0000155],9634230,,,MERMRIRAAGISATDPHARLPLPLARDEIRYLGTTFNDLLQRLQDALERERQFVSDAGHELRTPLAS,"7,658",67,,,phosphorelay sensor kinase activity [GO:0000155],intracellular [GO:0005622],,,1
I6Y1Q2,I6Y1Q2_MYCTU,Rv2788,sirR Rv2788,GO:0003700; GO:0006351; GO:0043565; GO:0046914; GO:0046983,IPR011991; IPR000485; IPR007167; IPR001367; IPR036421; IPR022687; IPR022689; IPR008988; IPR036388; IPR036390; ,P9WF25; P9WF09,sirR,DOMAIN 10 72 HTH dtxR-type. {ECO:0000259|PROSITE:PS50944}.,Probable transcriptional repressor SirR,"DNA binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; transition metal ion binding [GO:0046914]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MRADEEPGDLSAVAQDYLKVIWTAQEWSQDKVSTKMLAERIGVSASTASESIRKLAEQGLVDHEKYGAVTLTDSGRRAALAMVRRHRLLETFLVNELGYRWDEVHDEAEVLEHAVSDRLMARIDAKLGFPQRDPHGDPIPGADGQVPTPPARQLWACRDGDTGTVARISDADPQMLRYFASIGISLDSRLRVLARREFAGMISVAIDSADGATVDLGSPAAQAIWVVS,"24,951",228,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; transition metal ion binding [GO:0046914],,,,1
I6YAU3,I6YAU3_MYCTU,Rv2997,Rv2997,GO:0005829,IPR036188; ,,,,Possible alanine rich dehydrogenase,cytosol [GO:0005829],9634230,,,MDVTVVGSGPNGLATAVICARAGLNVQVVEAQATFGGGARSAADFEFPEVLHDVCSAVHPLALASPFFAEFDLPARGVTLTVPDIAYANPLPGRPAAIAYHDLAHTCAKLDDGASWRRLLGPLVAHSETVVEFMLSDKRSLPTALGSVLRLGLRMLAQGTPAWRSLAGEDARALFTGVAAHAISPLPSLVSAGAGLMLATLAHSVGWPIPVGGTQAIADALIADLRAHGGRLAAGVEITEPQRSVVVFDTAPTALLRVYRDKLPHRYAKALRRYRFRAGIAKVDFVLSDEIPWSDPRLRRAATLHLGGTRDQMARAEADVAAGRHADWPMVLAACPHVADPGRIDETGRRPFWTYAHVPSGSTLDATETVTSVLERFAPGFRDIVVAARAVPAARMADHNANYVGGDITVGANSTWRAIAGPTPRLNPWRTPIPKVYLCSAATPPGAGVHGMCGWYAARTLLRTEFGITRMPPLGHELRP,"50,937",480,,,,cytosol [GO:0005829],,,1
I6YF16,I6YF16_MYCTU,Rv3046c,Rv3046c,,IPR021784; ,,,,Conserved protein,,9634230; 21969609,,,MTKTFSHPHFFRSVLRWLQVGYPEGVPGPDRVALLSLLRSTPLTEEQIGEVVRHFTENGSPAVADRVIDRDEIAEFISEVTHHDAGPENIQRVAGILAAAGWPLAGVDVGESESGSDRAPASQG,"13,383",124,,,,,,,1
I6XG38,I6XG38_MYCTU,Rv3074,Rv3074,,IPR003870; IPR003615; ,,,,Uncharacterized protein,,9634230,,,MFETLTAIDPDAEEAALIERIAELERLKSAAAAGQARAAAAVDAARRAAEGAAGVPAARRGRGLASEIALARRDSPARGSRHLGFAKALVYEMPHTLAALDCGALSEWRATLIVRESACLDVADRRALDAELCGDPGDLEGMGDARVVAAARAIAYRLDPQAVVDRAANAENDRTVTIRPAPDTMTYLTALLPVAQGVSVYAALTRAADTRCDGRSRGQVMADTLVERVTGRDAAVPTPIAVNLVMSDETLLGAANTPAQLCGYGPIPAAVARTMVASAVTDQRSRATLRRLYAHPQAGALVSMESRARLFPRGLAAFIELRDQRCRTPYCDAPIRHRDHAHPWADGGPTSAHNGLGTCERCNYAKQAPGWRVSTSVDENHTHTAEFITPTGSRHRSGAPPHLPAVTVSELEVRIGIALARYAA,"44,950",424,,,,,,,1
Q6MX17,Q6MX17_MYCTU,Rv3022A,PE29 Rv3022A,,IPR000084; ,,PE29,,PE family protein PE29,,9634230,,,MTLRVVPEGLAAASAAVEALTARLAAAHAGAAPAITAVVAPAADPVSLQSAVGFSALGSEHAAIAGEGVEELGRSGVAVGESGIGYAAGDAVAAATYLVSGGSL,"9,683",104,,,,,,,1
I6YB11,I6YB11_MYCTU,Rv3057c,Rv3057c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short chain alcohol dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MLQRGAGQYFAGKRCFVTGAASGIGRATALRLAAQGAELYLTDRDRDGLAQTVCDARALGAQVPEHRVLDVSDYQDVAAFAADIHARHPSMDVVLNIAGVSAWGTVDQLTHDQWSRMVAINLMGPIHVIETLVPPMVAAGRGGHLVNVSSAAGLVGLPWHAAYSASKYGLRGLSEVLRFDLARHGIGVSVVVPGAVKTPLVNTVEIAGVDRDDPRVNRWVERFSGHAVTPEKAADKILAGVTRNRYLVYTSADIRALYAFKRYAWWPYTLVMRRVNVFFTRALRPGP,"31,154",287,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,,1
I6X5T4,I6X5T4_MYCTU,Rv2943,Rv2943,GO:0015074,IPR001584; IPR012337; ,,,,Probable transposase for insertion sequence element IS1533,DNA integration [GO:0015074],9634230,,,MLTVEDWAEIRRLHRAEGLPIKMIARVLGISKNTVKSALESNQQPKYERAPQGSIVDAVEPRIRELLQAYPTMPATVIAERIGWERSIRVLSARVAELRPVYLPPDPASRTTYVAGEIAQCDFWFPPIELPVGFGQTRTAKQLPVLTMVCAYSRWLLAMLLPSRCAEDLFAGWWRLIEALGAVPRVLVWDGEGAIGRWRGGRSELTTECQAFRGTLAAKVLICRPADPEAKGLIERAHDYLERSFLPGRVFASPADFNAQLGAWLALVNTRTRRALGCAPTDRIGADRAAMLSLPPVAPATGWCTSLRLPRDHYVRCDSNDYSVHPGVIGHRVLVRADLERVHVFCDGELVADHERIWAVHQTVSDPAHVEAAKVLRRRHFSAASPVVEPQVQVRSLSDYDDALGVDIDGGVA,"45,778",413,,DNA integration [GO:0015074],,,,,1
I6YA75,I6YA75_MYCTU,Rv2772c,Rv2772c,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MTRRTLYVQLIIAFMCVAMVAYLVMLGRVAVAMIGSGRAAAAGLGLALLILPVIGLWAMIATLRAGFAYQRLARLIAEDGLDIDASALPRRASGRIQRDAADALFAAVRTELEDDADDWRRWYRLARAYDYAGDRRRAREAMKTALQLEGRARPGAR,"17,326",157,,,,integral component of membrane [GO:0016021],,,1
I6XFC2,I6XFC2_MYCTU,Rv2803,Rv2803,GO:0006355,IPR010985; IPR016547; IPR014795; ,,,,Uncharacterized protein,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MTCPSLVGLRTEAAELSYSDQPDALGVAMRERREQQNLVRPPRRNASRRINTDQTSTKYVYITYMPETLTGRLNFRLSPEQEQALRHAAALTGQSLSGFVLSAAVDHAHDLLARANRIELSEAAFRRFVAALDEPDEAAPELVRLARRKSRIPPH,"17,407",155,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
O33234,O33234_MYCTU,Rv2729c,Rv2729c,GO:0016021,,,,,Probable conserved integral membrane alanine valine and leucine rich protein,integral component of membrane [GO:0016021],9634230,,,MASVEFATILALGAALLAGIGYVTLQRSARQVTAEEYVGHFTLFHLSLRHALWWLGSLAAVASFTLQAIALTMGSVVLVQSLQATALLFALLIDARLTHHRCTPREWMWAVLLAGAVAVIVMSGNPAAGTTRAPFSTWAVVAVVVVPAVVLCVVGARIASGSLSAVLLAVASSATLAVFTVLTKGVVTELGEGFATLIRTPALYAWILVLPIGLMLQQSSLRVGALTASLPTITVARPVIASVLGITVLDEVLHTGRVALVALVAAVVVVVVATVALARDEVAMMTVSAGELGAAGQLAVR,"31,028",301,,,,integral component of membrane [GO:0016021],,,1
I6X5K1,I6X5K1_MYCTU,Rv2860c,glnA4 Rv2860c,GO:0004356; GO:0006542,IPR036651; IPR014746; IPR008146; ,,glnA4,,Probable glutamine synthetase GlnA4 (Glutamine synthase) (GS-II),glutamate-ammonia ligase activity [GO:0004356]; glutamine biosynthetic process [GO:0006542],9634230; 21969609,,,MTGPGSPPLAWTELERLVAAGDVDTVIVAFTDMQGRLAGKRISGRHFVDDIATRGVECCSYLLAVDVDLNTVPGYAMASWDTGYGDMVMTPDLSTLRLIPWLPGTALVIADLVWADGSEVAVSPRSILRRQLDRLKARGLVADVATELEFIVFDQPYRQAWASGYRGLTPASDYNIDYAILASSRMEPLLRDIRLGMAGAGLRFEAVKGECNMGQQEIGFRYDEALVTCDNHAIYKNGAKEIADQHGKSLTFMAKYDEREGNSCHIHVSLRGTDGSAVFADSNGPHGMSSMFRSFVAGQLATLREFTLCYAPTINSYKRFADSSFAPTALAWGLDNRTCALRVVGHGQNIRVECRVPGGDVNQYLAVAALIAGGLYGIERGLQLPEPCVGNAYQGADVERLPVTLADAAVLFEDSALVREAFGEDVVAHYLNNARVELAAFNAAVTDWERIRGFERL,"49,747",457,Glutamine synthetase family,glutamine biosynthetic process [GO:0006542],glutamate-ammonia ligase activity [GO:0004356],,,,1
I6YA50,I6YA50_MYCTU,Rv2743c,Rv2743c,GO:0016021,,,,,Possible conserved transmembrane alanine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MAVKAGQRRPWRSLLQRGVDTAGDLADLVAQKISVAIDPRARLLRRRRRALRWGLVFTAGCLLWGLVTALLAAWGWFTSLLVITGTIAVTQAIPATLLLLRYRWLRSEPLPVRRPASVRRLPPPGSAARPAMSALGASERGFFSLLGVMERGAMLPADEIRDLTAAANQTSAAMVATAAEVVSMERAVQCSAASRSYLVPTINAFTAQLSTGVRQYNEMVTAAAQLVSSANGAGGAGPGQQRYREELAGATDRLVAWAQAFDELGGLPRR,"28,962",270,,,,integral component of membrane [GO:0016021],,,1
O33285,O33285_MYCTU,Rv2742c,Rv2742c,GO:0005886,IPR021408; ,,,,Conserved hypothetical arginine rich protein,plasma membrane [GO:0005886],9634230,,,MLVDELGVKIVHAQHVPAPYLVQRMREIHERDENRQRHAQVDVQRRRDQPERGQHQHRRNRDADHHPDGRTLAGQIVAHPVSHRVRQPRPVAIADVLPRVGPRADCVVAHSLQGSPRRRERRRGQTAHQRLGRRSGNAIACPLYLENAAGPEPDTKRAEGRRFGAFGGGDLRWMADRVPRQGSGRRGLGSRSGAGVPQGADARGWRHTADGVPRVGQPAIRRGVPGFWCWLDHVLTGFGGRNAICAIEDGVEPRVAWWALCTDFDVPRSMGRRTPGG,"30,883",277,,,,plasma membrane [GO:0005886],,,3
P96354,P96354_MYCTU,Rv1047 Rv3023c Rv3115,Rv1047 Rv3023c Rv3115,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTSSHLIDAEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANLMAATPKPSWPWVRTLLHSIYDQPDAESVVAQYDRVLDALTDKLPAVAEHLDTARTDLLAFTAFPKQIWRQIWSNNPQERLNREVRRRTDVVGIFPDRASIIRLVGAVLAEQHDEWIEGRRYLGLEVLTRARAALTSTEEPAKQQTTNTPALTT,"45,780",415,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
P9WN65,RMLB_MYCTU,Rv3464,rmlB rfbB Rv3464,GO:0005618; GO:0008460; GO:0019305; GO:0040007; GO:0045226; GO:0070404,IPR005888; IPR016040; IPR036291; ,,rmlB,,"dTDP-glucose 4,6-dehydratase (EC 4.2.1.46)","cell wall [GO:0005618]; dTDP-glucose 4,6-dehydratase activity [GO:0008460]; NADH binding [GO:0070404]; dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007]",9634230; 16472764; 21969609,,"FUNCTION: Catalyzes the dehydration of dTDP-D-glucose to form dTDP-6-deoxy-D-xylo-4-hexulose via a three-step process involving oxidation, dehydration and reduction (By similarity). Involved in the biosynthesis of the dTDP-L-rhamnose which is a component of the critical linker, D-N-acetylglucosamine-L-rhamnose disaccharide, which connects the galactan region of arabinogalactan to peptidoglycan via a phosphodiester linkage (PubMed:16472764). {ECO:0000250|UniProtKB:P27830, ECO:0000269|PubMed:16472764}.",MRLLVTGGAGFIGTNFVHSAVREHPDDAVTVLDALTYAGRRESLADVEDAIRLVQGDITDAELVSQLVAESDAVVHFAAESHVDNALDNPEPFLHTNVIGTFTILEAVRRHGVRLHHISTDEVYGDLELDDRARFTESTPYNPSSPYSATKAGADMLVRAWVRSYGVRATISNCSNNYGPYQHVEKFIPRQITNVLTGRRPKLYGAGANVRDWIHVDDHNSAVRRILDRGRIGRTYLISSEGERDNLTVLRTLLRLMDRDPDDFDHVTDRVGHDLRYAIDPSTLYDELCWAPKHTDFEEGLRTTIDWYRDNESWWRPLKDATEARYQERGQ,"37,558",331,"NAD(P)-dependent epimerase/dehydratase family, dTDP-glucose dehydratase subfamily",dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007],"dTDP-glucose 4,6-dehydratase activity [GO:0008460]; NADH binding [GO:0070404]",cell wall [GO:0005618],rfbB,,1
P9WH09,RMLD_MYCTU,Rv3266c,rmlD strL Rv3266c,GO:0008831; GO:0019305; GO:0045226,IPR005913; IPR036291; IPR029903; ,,rmlD,,dTDP-4-dehydrorhamnose reductase (EC 1.1.1.133) (dTDP-4-keto-L-rhamnose reductase) (dTDP-6-deoxy-L-lyxo-4-hexulose reductase) (dTDP-6-deoxy-L-mannose dehydrogenase) (dTDP-L-rhamnose synthase),dTDP-4-dehydrorhamnose reductase activity [GO:0008831]; dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226],9634230; 12029057; 19099550; 21969609,,"FUNCTION: Catalyzes the reduction of dTDP-6-deoxy-L-lyxo-4-hexulose to yield dTDP-L-rhamnose. Involved in the biosynthesis of the dTDP-L-rhamnose which is a component of the critical linker, D-N-acetylglucosamine-L-rhamnose disaccharide, which connects the galactan region of arabinogalactan to peptidoglycan via a phosphodiester linkage. {ECO:0000269|PubMed:12029057}.",MAGRSERLVITGAGGQLGSHLTAQAAREGRDMLALTSSQWDITDPAAAERIIRHGDVVINCAAYTDVDGAESNEAVAYAVNATGPQHLARACARVGARLIHVSTDYVFDGDFGGAEPRPYEPTDETAPQGVYARSKLAGEQAVLAAFPEAAVVRTAWVYTGGTGKDFVAVMRRLAAGHGRVDVVDDQTGSPTYVADLAEALLALADAGVRGRVLHAANEGVVSRFGQARAVFEECGADPQRVRPVSSAQFPRPAPRSSYSALSSRQWALAGLTPLRHWRSALATALAAPANSTSIDRRLPSTRD,"32,045",304,DTDP-4-dehydrorhamnose reductase family,dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226],dTDP-4-dehydrorhamnose reductase activity [GO:0008831],,strL,,1
P9WHM1,PURE_MYCTU,Rv3275c,purE Rv3275c MTCY71.15c,GO:0006189; GO:0034023; GO:0040007,IPR033747; IPR000031; IPR024694; IPR035893; ,,purE,,N5-carboxyaminoimidazole ribonucleotide mutase (N5-CAIR mutase) (EC 5.4.99.18) (5-(carboxyamino)imidazole ribonucleotide mutase),5-(carboxyamino)imidazole ribonucleotide mutase activity [GO:0034023]; 'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007],9634230; 19099550; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the conversion of N5-carboxyaminoimidazole ribonucleotide (N5-CAIR) to 4-carboxy-5-aminoimidazole ribonucleotide (CAIR). {ECO:0000255|HAMAP-Rule:MF_01929}.,MTPAGERPRVGVIMGSDSDWPVMADAAAALAEFDIPAEVRVVSAHRTPEAMFSYARGAAERGLEVIIAGAGGAAHLPGMVAAATPLPVIGVPVPLGRLDGLDSLLSIVQMPAGVPVATVSIGGAGNAGLLAVRMLGAANPQLRARIVAFQDRLADVVAAKDAELQRLAGKLTRD,"17,675",174,"AIR carboxylase family, Class I subfamily",'de novo' IMP biosynthetic process [GO:0006189]; growth [GO:0040007],5-(carboxyamino)imidazole ribonucleotide mutase activity [GO:0034023],,,MTCY71.15c,1
P9WHL9,PURK_MYCTU,Rv3276c,purK Rv3276c MTCY71.16c,GO:0004638; GO:0005524; GO:0005829; GO:0005886; GO:0006189; GO:0034028; GO:0046872,IPR011761; IPR003135; IPR013815; IPR016185; IPR005875; IPR011054; ,,purK,DOMAIN 121 310 ATP-grasp. {ECO:0000255|HAMAP-Rule:MF_01928}.,N5-carboxyaminoimidazole ribonucleotide synthase (N5-CAIR synthase) (EC 6.3.4.18) (5-(carboxyamino)imidazole ribonucleotide synthetase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; 5-(carboxyamino)imidazole ribonucleotide synthase activity [GO:0034028]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; 'de novo' IMP biosynthetic process [GO:0006189],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the ATP-dependent conversion of 5-aminoimidazole ribonucleotide (AIR) and HCO(3)(-) to N5-carboxyaminoimidazole ribonucleotide (N5-CAIR). {ECO:0000255|HAMAP-Rule:MF_01928}.,MMAVASSRTPAVTSFIAPLVAMVGGGQLARMTHQAAIALGQNLRVLVTSADDPAAQVTPNVVIGSHTDLAALRRVAAGADVLTFDHEHVPNELLEKLVADGVNVAPSPQALVHAQDKLVMRQRLAAAGVAVPRYAGIKDPDEIDVFAARVDAPIVVKAVRGGYDGRGVRMARDVADARDFARECLADGVAVLVEERVDLRRELSALVARSPFGQGAAWPVVQTVQRDGTCVLVIAPAPALPDDLATAAQRLALQLADELGVVGVLAVELFETTDGALLVNELAMRPHNSGHWTIDGARTSQFEQHLRAVLDYPLGDSDAVVPVTVMANVLGAAQPPAMSVDERLHHLFARMPDARVHLYGKAERPGRKVGHINFLGSDVAQLCERAELAAHWLSHGRWTDGWDPHRASDDAVGVPPACGGRSDEEERRL,"45,695",429,PurK/PurT family,'de novo' IMP biosynthetic process [GO:0006189],5-(carboxyamino)imidazole ribonucleotide synthase activity [GO:0034028]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY71.16c,1
P9WH11,RMLC_MYCTU,Rv3465,rmlC strM Rv3465,GO:0008830; GO:0019305; GO:0040007; GO:0045226,IPR000888; IPR014710; IPR011051; ,,rmlC,,"dTDP-4-dehydrorhamnose 3,5-epimerase (EC 5.1.3.13) (Thymidine diphospho-4-keto-rhamnose 3,5-epimerase) (dTDP-4-keto-6-deoxyglucose 3,5-epimerase) (dTDP-6-deoxy-D-xylo-4-hexulose 3,5-epimerase) (dTDP-L-rhamnose synthase)","dTDP-4-dehydrorhamnose 3,5-epimerase activity [GO:0008830]; dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007]",9634230; 16472764; 19099550; 21969609; 12951098; 15103135; 17046787,X-ray crystallography (3),"FUNCTION: Catalyzes the epimerization of the C3' and C5'positions of dTDP-6-deoxy-D-xylo-4-hexulose, forming dTDP-6-deoxy-L-lyxo-4-hexulose. Involved in the biosynthesis of the dTDP-L-rhamnose which is a component of the critical linker, D-N-acetylglucosamine-L-rhamnose disaccharide, which connects the galactan region of arabinogalactan to peptidoglycan via a phosphodiester linkage. {ECO:0000269|PubMed:16472764}.",MKARELDVPGAWEITPTIHVDSRGLFFEWLTDHGFRAFAGHSLDVRQVNCSVSSAGVLRGLHFAQLPPSQAKYVTCVSGSVFDVVVDIREGSPTFGRWDSVLLDDQDRRTIYVSEGLAHGFLALQDNSTVMYLCSAEYNPQREHTICATDPTLAVDWPLVDGAAPSLSDRDAAAPSFEDVRASGLLPRWEQTQRFIGEMRGT,"22,314",202,"DTDP-4-dehydrorhamnose 3,5-epimerase family",dTDP-rhamnose biosynthetic process [GO:0019305]; extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007],"dTDP-4-dehydrorhamnose 3,5-epimerase activity [GO:0008830]",,strM,,1
P9WGZ1,RPOA_MYCTU,Rv3457c,rpoA Rv3457c MTCY13E12.10c,GO:0003677; GO:0003899; GO:0005618; GO:0005829; GO:0005886; GO:0006354; GO:0040007; GO:0046983,IPR011262; IPR011263; IPR011773; IPR036603; IPR011260; IPR036643; ,,rpoA,,DNA-directed RNA polymerase subunit alpha (RNAP subunit alpha) (EC 2.7.7.6) (RNA polymerase subunit alpha) (Transcriptase subunit alpha),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; DNA-templated transcription, elongation [GO:0006354]; growth [GO:0040007]",9634230; 11929527; 21969609; 22570422,Electron microscopy (1); X-ray crystallography (11),"FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. {ECO:0000255|HAMAP-Rule:MF_00059, ECO:0000269|PubMed:22570422}.",MLISQRPTLSEDVLTDNRSQFVIEPLEPGFGYTLGNSLRRTLLSSIPGAAVTSIRIDGVLHEFTTVPGVKEDVTEIILNLKSLVVSSEEDEPVTMYLRKQGPGEVTAGDIVPPAGVTVHNPGMHIATLNDKGKLEVELVVERGRGYVPAVQNRASGAEIGRIPVDSIYSPVLKVTYKVDATRVEQRTDFDKLILDVETKNSISPRDALASAGKTLVELFGLARELNVEAEGIEIGPSPAEADHIASFALPIDDLDLTVRSYNCLKREGVHTVGELVARTESDLLDIRNFGQKSIDEVKIKLHQLGLSLKDSPPSFDPSEVAGYDVATGTWSTEGAYDEQDYAETEQL,"37,706",347,RNA polymerase alpha chain family,"DNA-templated transcription, elongation [GO:0006354]; growth [GO:0040007]",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY13E12.10c,1
P9WGG9,RPSD_MYCTU,Rv3414c,sigD Rv3414c MTCY78.15,GO:0003677; GO:0003700; GO:0006352; GO:0009405; GO:0009408; GO:0016987; GO:0019217; GO:0050708,IPR014284; IPR000838; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigD,,ECF RNA polymerase sigma factor SigD (ECF sigma factor SigD) (Alternative RNA polymerase sigma factor SigD) (RNA polymerase sigma-D factor) (Sigma-D factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708]; response to heat [GO:0009408]",9634230; 10027986; 15375142; 20600947; 21969609; 23314154,X-ray crystallography (2),FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis. {ECO:0000269|PubMed:15375142}.,MVDPGVSPGCVRFVTLEISPSMTMQGERLDAVVAEAVAGDRNALREVLETIRPIVVRYCRARVGTVERSGLSADDVAQEVCLATITALPRYRDRGRPFLAFLYGIAAHKVADAHRAAGRDRAYPAETLPERWSADAGPEQMAIEADSVTRMNELLEILPAKQREILILRVVVGLSAEETAAAVGSTTGAVRVAQHRALQRLKDEIVAAGDYA,"22,919",212,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; pathogenesis [GO:0009405]; regulation of fatty acid metabolic process [GO:0019217]; regulation of protein secretion [GO:0050708]; response to heat [GO:0009408]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,MTCY78.15,1
P9WH61,RS13_MYCTU,Rv3460c,rpsM Rv3460c MTCY13E12.13c,GO:0000049; GO:0003735; GO:0005829; GO:0005886; GO:0006412; GO:0015935; GO:0019843; GO:0042254,IPR027437; IPR001892; IPR010979; IPR019980; IPR018269; ,,rpsM,,30S ribosomal protein S13,cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],9634230; 21969609,,"FUNCTION: Located at the top of the head of the 30S subunit, it contacts several helices of the 16S rRNA. In the 70S ribosome it contacts the 23S rRNA (bridge B1a) and protein L5 of the 50S subunit (bridge B1b), connecting the 2 subunits; these bridges are implicated in subunit movement. Contacts the tRNAs in the A and P-sites. {ECO:0000255|HAMAP-Rule:MF_01315}.",MARLVGVDLPRDKRMEVALTYIFGIGRTRSNEILAATGIDRDLRTRDLTEEQLIHLRDYIEANLKVEGDLRREVQADIRRKIEIGCYQGLRHRRGMPVRGQRTKTNARTRKGPKRTIAGKKKAR,"14,351",124,Universal ribosomal protein uS13 family,ribosome biogenesis [GO:0042254]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049],cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935],,MTCY13E12.13c,1
P9WH89,RL36_MYCTU,Rv3461c,rpmJ Rv3461c MTCY13E12.14c,GO:0003735; GO:0005840; GO:0006412,IPR000473; IPR035977; ,,rpmJ,,50S ribosomal protein L36 (Ribosomal protein B),ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),,MKVNPSVKPICDKCRLIRRHGRVMVICSDPRHKQRQG,"4,343",37,Bacterial ribosomal protein bL36 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],ribosome [GO:0005840],,MTCY13E12.14c,1
P9WH65,RS11_MYCTU,Rv3459c,rpsK Rv3459c MTCY13E12.12c,GO:0000028; GO:0000462; GO:0003735; GO:0005886; GO:0006412; GO:0022627; GO:0040007; GO:0048027; GO:0070181,IPR001971; IPR019981; IPR018102; IPR036967; ,,rpsK,,30S ribosomal protein S11,"cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]",9634230; 21969609,,"FUNCTION: Located on the platform of the 30S subunit, it bridges several disparate RNA helices of the 16S rRNA. Forms part of the Shine-Dalgarno cleft in the 70S ribosome. {ECO:0000255|HAMAP-Rule:MF_01310}.",MPPAKKGPATSARKGQKTRRREKKNVPHGAAHIKSTFNNTIVTITDPQGNVIAWASSGHVGFKGSRKSTPFAAQLAAENAARKAQDHGVRKVDVFVKGPGSGRETAIRSLQAAGLEVGAISDVTPQPHNGVRPPKRRRV,"14,785",139,Universal ribosomal protein uS11 family,"growth [GO:0040007]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412]",mRNA 5'-UTR binding [GO:0048027]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY13E12.12c,1
P9WKZ1,ATSK_MYCTU,Rv3406,Rv3406 MTCY78.22c,GO:0000907; GO:0000908; GO:0005737; GO:0005886; GO:0044273; GO:0046677; GO:0046872,IPR003819; ,,,,Alpha-ketoglutarate-dependent sulfate ester dioxygenase (EC 1.14.11.-) (Type II alkyl sulfatase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; sulfonate dioxygenase activity [GO:0000907]; taurine dioxygenase activity [GO:0000908]; response to antibiotic [GO:0046677]; sulfur compound catabolic process [GO:0044273],9634230; 19099550; 21969609; 23762287; 25427196,X-ray crystallography (2),"FUNCTION: Alpha-ketoglutarate-dependent sulfate ester dioxygenase, which oxidizes medium-chain alkyl-sulfate esters (PubMed:23762287). Shows preference for 2-ethylhexyl sulfate (2-EHS) in vitro, leading to the formation of succinate and 2-ethylhexanal (PubMed:23762287, PubMed:25427196). Has likely a role in sulfate scavenging in vivo (PubMed:23762287). {ECO:0000269|PubMed:23762287, ECO:0000269|PubMed:25427196}.; FUNCTION: Also causes the inactivation of the 2-carboxyquinoxaline Ty38c (an antitubercular compound that inhibits DprE1) via oxidative decarboxylation, using Ty38c instead of alpha-ketoglutarate as a substrate. Is thus responsible for primary resistance of M.tuberculosis to Ty38c in vitro. Overexpression of Rv3406 causes resistance to Ty38c. {ECO:0000269|PubMed:25427196}.",MTDLITVKKLGSRIGAQIDGVRLGGDLDPAAVNEIRAALLAHKVVFFRGQHQLDDAEQLAFAGLLGTPIGHPAAIALADDAPIITPINSEFGKANRWHTDVTFAANYPAASVLRAVSLPSYGGSTLWANTAAAYAELPEPLKCLTENLWALHTNRYDYVTTKPLTAAQRAFRQVFEKPDFRTEHPVVRVHPETGERTLLAGDFVRSFVGLDSHESRVLFEVLQRRITMPENTIRWNWAPGDVAIWDNRATQHRAIDDYDDQHRLMHRVTLMGDVPVDVYGQASRVISGAPMEIAG,"32,579",295,TfdA dioxygenase family,response to antibiotic [GO:0046677]; sulfur compound catabolic process [GO:0044273],metal ion binding [GO:0046872]; sulfonate dioxygenase activity [GO:0000907]; taurine dioxygenase activity [GO:0000908],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY78.22c,1
P9WJ69,RSHA_MYCTU,Rv3221A,rshA Rv3221A,GO:0006351; GO:0006355; GO:0006979; GO:0009408; GO:0016989; GO:0046872; GO:0051536,IPR024020; IPR014295; IPR027383; ,,rshA,,Anti-sigma factor RshA (Regulator of SigH) (Sigma-H anti-sigma factor RshA),"iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; sigma factor antagonist activity [GO:0016989]; regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",9634230; 22937074; 12368430; 14617153; 16298337; 18728196; 21969609,,"FUNCTION: An redox-regulated anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigH. ECF sigma factors are held in an inactive form by a cognate anti-sigma factor. RshA and some peptides derived from it inhibit the sigma factor activity of SigH. Probably releases SigH during oxidative stress. {ECO:0000269|PubMed:14617153, ECO:0000269|PubMed:16298337}.",MSENCGPTDAHADHDDSHGGMGCAEVIAEVWTLLDGECTPETRERLRRHLEACPGCLRHYGLEERIKALIGTKCRGDRAPEGLRERLRLEIRRTTIIRGGP,"11,290",101,Zinc-associated anti-sigma factor (ZAS) superfamily,"regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; transcription, DNA-templated [GO:0006351]",iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; sigma factor antagonist activity [GO:0016989],,,,1
P9WH25,RS9_MYCTU,Rv3442c,rpsI Rv3442c MTCY77.14c,GO:0000462; GO:0003723; GO:0003735; GO:0005886; GO:0006412; GO:0022627,IPR020568; IPR014721; IPR000754; IPR023035; IPR020574; ,,rpsI,,30S ribosomal protein S9,"cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]",9634230; 21969609,,,MTETTPAPQTPAAPAGPAQSFVLERPIQTVGRRKEAVVRVRLVPGTGKFDLNGRSLEDYFPNKVHQQLIKAPLVTVDRVESFDIFAHLGGGGPSGQAGALRLGIARALILVSPEDRPALKKAGFLTRDPRATERKKYGLKKARKAPQYSKR,"16,436",151,Universal ribosomal protein uS9 family,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; translation [GO:0006412]",RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],cytosolic small ribosomal subunit [GO:0022627]; plasma membrane [GO:0005886],,MTCY77.14c,1
P9WJ71,RSDA_MYCTU,Rv3413c,rsdA Rv3413c MTCY78.16,GO:0005576; GO:0005886; GO:0006351; GO:0006355; GO:0016021,IPR031928; ,,rsdA,,Anti-sigma-D factor RsdA (Regulator of SigD) (Sigma-D anti-sigma factor RsdA),"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 15375142; 20600947; 21969609; 23314154,X-ray crystallography (1),"FUNCTION: An anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigD. ECF sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis (RIP). RIP occurs when an extracytoplasmic signal triggers a concerted proteolytic cascade to transmit information and elicit cellular responses. The membrane-spanning regulatory substrate protein is first cut extracytoplasmically (site-1 protease, S1P), then within the membrane itself (site-2 protease, S2P), while cytoplasmic proteases finish degrading the regulatory protein, liberating the sigma factor. Neither S1P nor S2P proteases have been so far identified for this anti-sigma factor.",MREFGNPLGDRPPLDELARTDLLLDALAEREEVDFADPRDDALAALLGQWRDDLRWPPASALVSQDEAVAALRAGVAQRRRARRSLAAVGSVAAALLVLSGFGAVVADARPGDLLYGLHAMMFNRSRVSDDQIVLSAKANLAKVEQMIAQGQWAEAQDELAEVSSTVQAVTDGSRRQDLINEVNLLNTKVETRDPNATLRPGSPSNPAAPGSVGNSWTPLAPVVEPPTPPTPASAAEPSMSAGVSESPMPNSTSTVAASPSTPSSKPEPGSIDPSLEPADEATNPAGQPAPETPVSPTH,"31,248",299,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY78.16,1
O53361,SAPM_MYCTU,Rv3310 LH57_18080,sapM Rv3310 LH57_18080,GO:0003993; GO:0004438; GO:0004805; GO:0005576; GO:0005618; GO:0006742; GO:0009405; GO:0044161; GO:0046854; GO:0050189; GO:0050192,IPR017850; IPR007312; ,,sapM,,Phosphatidylinositol-3-phosphatase (PI3P phosphatase) (EC 3.1.3.64) (Acid phosphatase SapM) (EC 3.1.3.2) (Secreted acid phosphatase),cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell cytoplasmic vesicle [GO:0044161]; acid phosphatase activity [GO:0003993]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoenolpyruvate phosphatase activity [GO:0050189]; phosphoglycerate phosphatase activity [GO:0050192]; trehalose-phosphatase activity [GO:0004805]; NADP catabolic process [GO:0006742]; pathogenesis [GO:0009405]; phosphatidylinositol phosphorylation [GO:0046854],9634230; 11073936; 15753315; 21969609; 23923000; 25896765,,"FUNCTION: Virulence factor that plays an important role in blocking phagosome-lysosome fusion and thus participates in the intracellular survival of the pathogen (PubMed:15753315, PubMed:23923000). Acts as a phosphatase that dephosphorylates phosphatidylinositol 3-phosphate (PI3P), a membrane trafficking regulatory lipid essential for phagosomal acquisition of lysosomal constituents (PubMed:15753315). Therefore, SapM eliminates PI3P from the phagosomal membrane by catalyzing its hydrolysis, and thus contributes to inhibition of phagosome maturation (PubMed:15753315). Also interferes with autophagy: SapM blocks autophagosome-lysosome fusion in macrophages by binding to the small GTPase RAB7, which prevents RAB7 from being involved in this process and thus negatively regulates autophagy flux (PubMed:25896765). In vitro, displays phosphatase activity with broad specificity; can dephosphorylate a variety of phosphoester substrates, with the highest activity against phosphoenolpyruvate, glycerophosphate, GTP, NADPH, phosphotyrosine and trehalose-6-phosphate (PubMed:11073936). In contrast, the enzyme exhibits poor activity against glucose-6-phosphate, phosphothreonine, and a number of nucleotides (NADP, ATP, AMP, and GMP) (PubMed:11073936). {ECO:0000269|PubMed:11073936, ECO:0000269|PubMed:15753315, ECO:0000269|PubMed:23923000, ECO:0000269|PubMed:25896765}.",MLRGIQALSRPLTRVYRALAVIGVLAASLLASWVGAVPQVGLAASALPTFAHVVIVVEENRSQAAIIGNKSAPFINSLAANGAMMAQAFAETHPSEPNYLALFAGNTFGLTKNTCPVNGGALPNLGSELLSAGYTFMGFAEDLPAVGSTVCSAGKYARKHVPWVNFSNVPTTLSVPFSAFPKPQNYPGLPTVSFVIPNADNDMHDGSIAQGDAWLNRHLSAYANWAKTNNSLLVVTWDEDDGSSRNQIPTVFYGAHVRPGTYNETISHYNVLSTLEQIYGLPKTGYATNAPPITDIWGD,"31,807",299,,NADP catabolic process [GO:0006742]; pathogenesis [GO:0009405]; phosphatidylinositol phosphorylation [GO:0046854],acid phosphatase activity [GO:0003993]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoenolpyruvate phosphatase activity [GO:0050189]; phosphoglycerate phosphatase activity [GO:0050192]; trehalose-phosphatase activity [GO:0004805],cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell cytoplasmic vesicle [GO:0044161],,,1
P9WH35,RS4_MYCTU,Rv3458c,rpsD Rv3458c MTCY13E12.11c,GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0015935; GO:0019843; GO:0040007; GO:0045903,IPR022801; IPR001912; IPR005709; IPR018079; IPR002942; IPR036986; ,,rpsD,DOMAIN 91 157 S4 RNA-binding. {ECO:0000255|HAMAP-Rule:MF_01306}.,30S ribosomal protein S4,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],9634230; 19099550; 21969609,,"FUNCTION: One of the primary rRNA binding proteins, it binds directly to 16S rRNA where it nucleates assembly of the body of the 30S subunit. {ECO:0000255|HAMAP-Rule:MF_01306}.; FUNCTION: With S5 and S12 plays an important role in translational accuracy. {ECO:0000255|HAMAP-Rule:MF_01306}.",MARYTGPVTRKSRRLRTDLVGGDQAFEKRPYPPGQHGRARIKESEYLLQLQEKQKARFTYGVMEKQFRRYYEEAVRQPGKTGEELLKILESRLDNVIYRAGLARTRRMARQLVSHGHFNVNGVHVNVPSYRVSQYDIVDVRDKSLNTVPFQIARETAGERPIPSWLQVVGERQRVLIHQLPERAQIDVPLTEQLIVEYYSK,"23,476",201,Universal ribosomal protein uS4 family,growth [GO:0040007]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; small ribosomal subunit [GO:0015935],,MTCY13E12.11c,1
P9WGX7,RSBW_MYCTU,Rv3287c,rsbW usfX Rv3287c,GO:0000166; GO:0005524; GO:0006351; GO:0016787; GO:0016989; GO:0045892,,,rsbW,,Anti-sigma-F factor RsbW (Anti-sigma-F factor UsfX) (Regulator of SigF) (Sigma-F anti-sigma factor RsbW),"ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; sigma factor antagonist activity [GO:0016989]; negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",9634230; 12368430; 11929527; 12354223; 18722345; 19130906; 20729364; 20600947; 21352546; 21969609,,"FUNCTION: A cognate anti-sigma factor for alternative sigma factor SigF. Alternative sigma factors are held in an inactive form by an anti-sigma factor. Binds ATP and GTP, may hydrolyze both. {ECO:0000269|PubMed:12354223}.",MTDQLEDQTQGGSTVDRSLPGGCMADSDLPTKGRQRGVRAVELNVAARLENLALLRTLVGAIGTFEDLDFDAVADLRLAVDEVCTRLIRSALPDATLRLVVDPRKDEVVVEASAACDTHDVVAPGSFSWHVLTALADDVQTFHDGRQPDVAGSVFGITLTARRAASSR,"17,928",168,Anti-sigma-factor family,"negative regulation of transcription, DNA-templated [GO:0045892]; transcription, DNA-templated [GO:0006351]",ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; sigma factor antagonist activity [GO:0016989],,usfX,,2
P9WP01,PUNA_MYCTU,Rv3307,punA deoD Rv3307 MTV016.06,GO:0004731; GO:0006161,IPR000845; IPR035994; IPR011269; IPR011268; IPR018099; ,,punA,,Purine nucleoside phosphorylase (PNP) (Pu-NPase) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),purine-nucleoside phosphorylase activity [GO:0004731]; deoxyguanosine catabolic process [GO:0006161],9634230; 21969609; 11444966,X-ray crystallography (5),"FUNCTION: The purine nucleoside phosphorylases catalyze the phosphorolytic breakdown of the N-glycosidic bond in the beta-(deoxy)ribonucleoside molecules, with the formation of the corresponding free purine bases and pentose-1-phosphate. Cleaves guanosine, inosine, 2'-deoxyguanosine and 2'-deoxyinosine. {ECO:0000250|UniProtKB:P77834}.",MADPRPDPDELARRAAQVIADRTGIGEHDVAVVLGSGWLPAVAALGSPTTVLPQAELPGFVPPTAAGHAGELLSVPIGAHRVLVLAGRIHAYEGHDLRYVVHPVRAARAAGAQIMVLTNAAGGLRADLQVGQPVLISDHLNLTARSPLVGGEFVDLTDAYSPRLRELARQSDPQLAEGVYAGLPGPHYETPAEIRMLQTLGADLVGMSTVHETIAARAAGAEVLGVSLVTNLAAGITGEPLSHAEVLAAGAASATRMGALLADVIARF,"27,572",268,PNP/MTAP phosphorylase family,deoxyguanosine catabolic process [GO:0006161],purine-nucleoside phosphorylase activity [GO:0004731],,deoD,MTV016.06,1
P9WF25,RELJ_MYCTU,Rv3357,relJ relB3 yefM Rv3357 MTV004.14,GO:0003677; GO:0006351; GO:0006355,IPR006442; IPR036165; ,P9WF09; I6Y1Q2,relJ,,Antitoxin RelJ (Antitoxin YefM),"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19114484; 20011113; 20498855; 21969609; 18793646,X-ray crystallography (3),"FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. A probable antitoxin for the putative mRNA interferase RelK. Upon expression in E.coli but not in M.smegmatis this protein neutralizes E.coli YoeB.; FUNCTION: Binds to and represses its own promoter, in combination with RelK repression is somewhat lessened. Several DNA-protein complexes are formed in vitro depending on the RelJ:RelK ratio.",MSISASEARQRLFPLIEQVNTDHQPVRITSRAGDAVLMSADDYDAWQETVYLLRSPENARRLMEAVARDKAGHSAFTKSVDELREMAGGEE,"10,194",91,PhD/YefM antitoxin family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,relB3 yefM,MTV004.14,1
P9WF09,RELK_MYCTU,Rv3358,relK relE3 yoeB Rv3358 MTV004.15,GO:0003677; GO:0004519; GO:0006351; GO:0006401; GO:0045892,IPR035093; IPR009614; ,P9WF25; I6Y1Q2,relK,,Toxin RelK (EC 3.1.-.-) (Endoribonuclease YoeB) (Putative mRNA interferase RelE3) (Putative mRNA interferase YoeB) (Toxin YoeB),"DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; negative regulation of transcription, DNA-templated [GO:0045892]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",9634230; 18793646; 19114484; 20011113; 20061486; 20498855,X-ray crystallography (1),"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. Has RNase activity and preferentially cleaves at the 3'-end of purine ribonucleotides (By similarity). Overexpression in M.tuberculosis or M.smegmatis inhibits colony formation in a bacteriostatic rather than bacteriocidal fashion. Its toxic effect is neutralized by coexpression with antitoxin RelJ (shown only for M.smegmatis). Overexpression also increases the number of rifampcin-tolerant persister cells. {ECO:0000250, ECO:0000269|PubMed:19114484, ECO:0000269|PubMed:20011113, ECO:0000269|PubMed:20061486, ECO:0000269|PubMed:20498855}.; FUNCTION: In combination with RelJ represses its own promoter. Several DNA-protein complexes are formed in vitro depending on the RelJ:RelK ratio.",MRSVNFDPDAWEDFLFWLAADRKTARRITRLIGEIQRDPFSGIGKPEPLQGELSGYWSRRIDDEHRLVYRAGDDEVTMLKARYHY,"10,102",85,YoeB family,"negative regulation of transcription, DNA-templated [GO:0045892]; RNA catabolic process [GO:0006401]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; endonuclease activity [GO:0004519],,relE3 yoeB,MTV004.15,1
I6YG32,RIMI_MYCTU,Rv3420c LH57_18670,rimI Rv3420c LH57_18670,GO:0004596; GO:0006474,IPR006464; IPR016181; IPR000182; ,,rimI,DOMAIN 8 155 N-acetyltransferase. {ECO:0000255|PROSITE-ProRule:PRU00532}.,N-alpha-acetyltransferase RimI (EC 2.3.1.255) (EC 2.3.1.258),peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal protein amino acid acetylation [GO:0006474],9634230; 27353550,,"FUNCTION: N-alpha-acetyltransferase that specifically mediates the acetylation of N-terminal residues. Able to mediate acetylation of a wide variety of N-terminal residues, with preference for hydrophobic N-termini. Acetylates GroS/GroES and GroEL1. Able to acetylate the ribosomal protein S18, but it is unclear whether it acetylates its N-terminal alanine residue. {ECO:0000269|PubMed:27353550}.",MTADTEPVTIGALTRADAQRCAELEAQLFVGDDPWPPAAFNRELASPHNHYVGARSGGTLVGYAGISRLGRTPPFEYEVHTIGVDPAYQGRGIGRRLLRELLDFARGGVVYLEVRTDNDAALALYRSVGFQRVGLRRRYYRVSGADAYTMRRDSGDPS,"17,389",158,"Acetyltransferase family, RimI subfamily",N-terminal protein amino acid acetylation [GO:0006474],peptide alpha-N-acetyltransferase activity [GO:0004596],,,,1
P9WKZ3,SUGFT_MYCTU,Rv3404c,Rv3404c MTCY78.24,GO:0004479; GO:0005975; GO:0009405; GO:0016742; GO:0042803,IPR002376; IPR036477; ,,,,"dTDP-4-amino-4,6-dideoxyglucose formyltransferase (dTDP-Qui4N formyltransferase) (EC 2.1.2.-) (Sugar N-formyltransferase Rv3404c)","hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; methionyl-tRNA formyltransferase activity [GO:0004479]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; pathogenesis [GO:0009405]",9634230; 19099550; 12368431; 21969609; 28665588,X-ray crystallography (3),"FUNCTION: Sugar N-formyltransferase that catalyzes the conversion of dTDP-4-amino-4,6-dideoxyglucose into dTDP-4-formamido-4,6-dideoxyglucose using N(10)-formyltetrahydrofolate as the carbon source (PubMed:28665588). Plays a role in virulence (PubMed:12368431). Has no activity on dTDP-3-amino-3,6-dideoxyglucose, dTDP-3-amino-3,6-dideoxygalactose, UDP-4-amino-4-deoxyarabinose, and GDP-4-amino-4,6-dideoxymannose (PubMed:28665588). {ECO:0000269|PubMed:12368431, ECO:0000269|PubMed:28665588}.",MTILILTDNVHAHALAVDLQARHGDMDVYQSPIGQLPGVPRCDVAERVAEIVERYDLVLSFHCKQRFPAALIDGVRCVNVHPGFNPYNRGWFPQVFSIIDGQKVGVTIHEIDDQLDHGPIIAQRECAIESWDSSGSVYARLMDIERELVLEHFDAIRDGSYTAKSPATEGNLNLKKDFEQLRRLDLNERGTFGHFLNRLRALTHDDFRNAWFVDASGRKVFVRVVLEPEKPAEA,"26,515",234,DTDP-Qui4N formyltransferase family,carbohydrate metabolic process [GO:0005975]; pathogenesis [GO:0009405],"hydroxymethyl-, formyl- and related transferase activity [GO:0016742]; methionyl-tRNA formyltransferase activity [GO:0004479]; protein homodimerization activity [GO:0042803]",,,MTCY78.24,1
Q6MWZ7,SUGPH_MYCTU,Rv3214 LH57_17570,gpm2 Rv3214 LH57_17570,GO:0003993; GO:0006094; GO:0042132; GO:0042803,IPR013078; IPR029033; ,,gpm2,,"Acid phosphatase (EC 3.1.3.2) (Broad-specificity phosphatase) (Fructose-1,6-bisphosphatase) (FBPase) (EC 3.1.3.11)","acid phosphatase activity [GO:0003993]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; protein homodimerization activity [GO:0042803]; gluconeogenesis [GO:0006094]",9634230; 21969609; 26258286; 16672613,X-ray crystallography (1),"FUNCTION: Phosphatase with a broad specificity. Can dephosphorylate a variety of substrates including phosphorylated sugars like fructose-6-phosphate (F6P) (PubMed:16672613). Is able to function in vivo as a fructose-1,6-bisphosphatase (FBPase) and to maintain gluconeogenesis when the classical FBPase GlpX is absent (PubMed:26258286). Shows negligible phosphoglycerate mutase activity (PubMed:16672613). Has no phosphatase activity against 3-phosphoglycerate, 2,3-bisphosphoglycerate, or hydrophobic substrates such as alpha-napthyl phosphate (PubMed:16672613). {ECO:0000269|PubMed:16672613, ECO:0000269|PubMed:26258286}.",MGVRNHRLLLLRHGETAWSTLGRHTGGTEVELTDTGRTQAELAGQLLGELELDDPIVICSPRRRTLDTAKLAGLTVNEVTGLLAEWDYGSYEGLTTPQIRESEPDWLVWTHGCPAGESVAQVNDRADSAVALALEHMSSRDVLFVSHGHFSRAVITRWVQLPLAEGSRFAMPTASIGICGFEHGVRQLAVLGLTGHPQPIAAG,"21,949",203,Phosphoglycerate mutase family,gluconeogenesis [GO:0006094],"acid phosphatase activity [GO:0003993]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; protein homodimerization activity [GO:0042803]",,,,1
O50393,SPI_MYCTU,Rv3364c LH57_18375,Rv3364c LH57_18375,GO:0004867; GO:0005576; GO:0009405; GO:0030430,IPR004942; ,,,,Serine protease inhibitor Rv3364c,extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430]; serine-type endopeptidase inhibitor activity [GO:0004867]; pathogenesis [GO:0009405],9634230; 22275911; 21969609,,"FUNCTION: Effector protein that binds to the host serine protease cathepsin G on the macrophage cell membrane, inhibiting its enzymatic activity and the downstream activation of caspase-1-dependent apoptosis. Thus prevents macrophage pyroptosis and helps M.tuberculosis survival within host cells. {ECO:0000269|PubMed:22275911}.",MKARLPDSPLDWLVSKFAREVPGVAHALLVSVDGLPVAASEHLPRERADQLAAVTSGLASLAGGAAQLFDGGQVLQSVVEMQNGYLLLMQVGDGSALAALAATGCDIGQIGYEMAILVERVGGVVQSCRR,"13,440",130,Mycobacterial serine protease inhibitor Rv3364c family,pathogenesis [GO:0009405],serine-type endopeptidase inhibitor activity [GO:0004867],extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430],,,1
P9WIX3,NUOK_MYCTU,Rv3155,nuoK Rv3155 MTCY03A2.03c,GO:0008137; GO:0016021; GO:0042773; GO:0045272; GO:0048038,IPR001133; ,,nuoK,,NADH-quinone oxidoreductase subunit K (EC 1.6.5.11) (NADH dehydrogenase I subunit K) (NDH-1 subunit K),integral component of membrane [GO:0016021]; plasma membrane respiratory chain complex I [GO:0045272]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773],9634230,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01456}.",MNPANYLYLSVLLFTIGASGVLLRRNAIVMFMCVELMLNAVNLAFVTFARMHGHLDAQMIAFFTMVVAACEVVVGLAIIMTIFRTRKSASVDDANLLKG,"10,858",99,Complex I subunit 4L family,ATP synthesis coupled electron transport [GO:0042773],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],integral component of membrane [GO:0016021]; plasma membrane respiratory chain complex I [GO:0045272],,MTCY03A2.03c,1
P9WIW1,NUOL_MYCTU,Rv3156,nuoL Rv3156 MTCY03A2.02c,GO:0005886; GO:0008137; GO:0016021; GO:0042773; GO:0048038; GO:0052572,IPR003945; IPR018393; IPR001750; IPR001516; ,,nuoL,,NADH-quinone oxidoreductase subunit L (EC 1.6.5.11) (NADH dehydrogenase I subunit L) (NDH-1 subunit L),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]; response to host immune response [GO:0052572],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient (By similarity). {ECO:0000250}.",MTTSLGTHYTWLLVALPLAGAAILLFGGRRTDAWGHLLGCAAALAAFGVGAMLLADMLGRDGLERAIHQQVFTWIPAGGLQVDFGLQIDQLSMCFVLLISGVGSLIHIYSVGYMAEDPDRRRFFGYLNLFLASMLLLVVADNYVLLYVGWEGVGLASYLLIGFWYHKPSAATAAKKAFVMNRVGDAGLAVGMFLTFSTFGTLSYAGVFAGVPAASRAVLTAIGLLMLLGACAKSAQVPLQAWLGDAMEGPTPVSALIHAATMVTAGVYLIVRSGPLYNLAPTAQLAVVIVGAVTLLFGAIIGCAKDDIKRALAASTISQIGYMVLAAGLGPAGYAFAIMHLLTHGFFKAGLFLGSGAVIHAMHEEQDMRRYGGLRAALPVTFATFGLAYLAIIGVPPFAGFFSKDAIIEAALGAGGIRGSLLGGAALLGAGVTAFYMTRVMLMTFFGEKRWTPGAHPHEAPAVMTWPMILLAVGSVFSGGLLAVGGTLRHWLQPVVGSHEEATHALPTWVATTLALGVVAVGIAVAYRMYGTAPIPRVAPVRVSALTAAARADLYGDAFNEEVFMRPGAQLTNAVVAVDDAGVDGSVNALATLVSQTSNRLRQMQTGFARNYALSMLVGAVLVAAALLVVQLW,"66,168",633,Complex I subunit 5 family,ATP synthesis coupled electron transport [GO:0042773]; response to host immune response [GO:0052572],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY03A2.02c,1
P9WIW9,NUON_MYCTU,Rv3158,nuoN Rv3158 MTV014.02c,GO:0005576; GO:0005887; GO:0008137; GO:0042773; GO:0048038,IPR010096; IPR001750; ,,nuoN,,NADH-quinone oxidoreductase subunit N (EC 1.6.5.11) (NADH dehydrogenase I subunit N) (NDH-1 subunit N),extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_00445}.",MILPAPHVEYFLLAPMLIVFSVAVAGVLAEAFLPRRWRYGAQVTLALGGSAVALIAVIVVARSIHGSGHAAVLGAIAVDRATLFLQGTVLLVTIMAVVFMAERSARVSPQRQNTLAVARLPGLDSFTPQASAVPGSDAERQAERAGATQTELFPLAMLSVGGMMVFPASNDLLTMFVALEVLSLPLYLMCGLARNRRLLSQEAAMKYFLLGAFSSAFFLYGVALLYGATGTLTLPGIRDALAARTDDSMALAGVALLAVGLLFKVGAVPFHSWIPDVYQGAPTPITGFMAAATKVAAFGALLRVVYVALPPLHDQWRPVLWAIAILTMTVGTVTAVNQTNVKRMLAYSSVAHVGFILTGVIADNPAGLSATLFYLVAYSFSTMGAFAIVGLVRGADGSAGSEDADLSHWAGLGQRSPIVGVMLSMFLLAFAGIPLTSGFVSKFAVFRAAASAGAVPLVIVGVISSGVAAYFYVRVIVSMFFTEESGDTPHVAAPGVLSKAAIAVCTVVTVVLGIAPQPVLDLADQAAQLLR,"55,342",531,Complex I subunit 2 family,ATP synthesis coupled electron transport [GO:0042773],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887],,MTV014.02c,1
P9WFS7,TSAE_MYCTU,Rv3422c,tsaE Rv3422c MTCY78.07,GO:0002949; GO:0005524; GO:0005737; GO:0040007; GO:0046872,IPR027417; IPR003442; ,,tsaE,,tRNA threonylcarbamoyladenosine biosynthesis protein TsaE (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaE),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; growth [GO:0040007]; tRNA threonylcarbamoyladenosine modification [GO:0002949],9634230; 21969609,,"FUNCTION: Required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. Is involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37, together with TsaD and TsaB. TsaE seems to play an indirect role in the t(6)A biosynthesis pathway, possibly in regulating the core enzymatic function of TsaD (By similarity). {ECO:0000250}.",MSREGIRRRPKARAGLTGGGTATLPRVEDTLTLGSRLGEQLCAGDVVVLSGPLGAGKTVLAKGIAMAMDVEGPITSPTFVLARMHRPRRPGTPAMVHVDVYRLLDHNSADLLSELDSLDLDTDLEDAVVVVEWGEGLAERLSQRHLDVRLERVSHSDTRIATWSWGRS,"18,214",168,TsaE family,growth [GO:0040007]; tRNA threonylcarbamoyladenosine modification [GO:0002949],ATP binding [GO:0005524]; metal ion binding [GO:0046872],cytoplasm [GO:0005737],,MTCY78.07,1
P9WJ61,TUBOL_MYCTU,Rv3378c,Rv3378c,GO:0016102; GO:0016765; GO:0016791; GO:0035440; GO:0052572,IPR036424,,,,Diterpene synthase (Isotuberculosinol synthase) (EC 3.1.7.9) (Nosyberkol synthase) (Tuberculosinol synthase) (EC 3.1.7.8),"phosphatase activity [GO:0016791]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; diterpenoid biosynthetic process [GO:0016102]; response to host immune response [GO:0052572]; tuberculosinol biosynthetic process [GO:0035440]",9634230; 21228491; 21969609; 21290071,X-ray crystallography (8),"FUNCTION: Catalyzes the PP-removal from tuberculosinyl diphosphate to produce both tuberculosinol and isotuberculosinol. Can also use labdadienyl diphosphates, copalyl diphosphate (CDP), ent-CDP and syn-CDP in vitro. {ECO:0000269|PubMed:21228491}.",MNLVSEKEFLDLPLVSVAEIVRCRGPKVSVFPFDGTRRWFHLECNPQYDDYQQAALRQSIRILKMLFEHGIETVISPIFSDDLLDRGDRYIVQALEGMALLANDEEILSFYKEHEVHVLFYGDYKKRLPSTAQGAAVVKSFDDLTISTSSNTEHRLCFGVFGNDAAESVAQFSISWNETHGKPPTRREIIEGYYGEYVDKADMFIGFGRFSTFDFPLLSSGKTSLYFTVAPSYYMTETTLRRILYDHIYLRHFRPKPDYSAMSADQLNVLRNRYRAQPDRVFGVGCVHDGIWFAEG,"34,031",296,Diterpene synthase family,diterpenoid biosynthetic process [GO:0016102]; response to host immune response [GO:0052572]; tuberculosinol biosynthetic process [GO:0035440],"phosphatase activity [GO:0016791]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]",,,,1
P9WJ17,VPB44_MYCTU,Rv3321c,vapB44 Rv3321c,GO:0052572,,,vapB44,,Putative antitoxin VapB44,response to host immune response [GO:0052572],9634230; 20011113,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC44. {ECO:0000305|PubMed:20011113}.,MRTTLSIDDDVLLAVKERARREKRTAGEILSDLARQALTNQNPQPAASQEDAFHGFEPLPHRGGAVSNALIDRLRDEEAV,"8,850",80,,response to host immune response [GO:0052572],,,,,1
O53353,WHB2A_MYCTU,Rv3260c,whiB2 Rv3260c,GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0046872; GO:0051539,IPR034768; IPR003482; ,,whiB2,DOMAIN 26 83 4Fe-4S Wbl-type.,Transcriptional regulator WhiB2 (Probable chaperone WhiB2),"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19016840; 20545868; 22686939,,"FUNCTION: Acts as a transcriptional regulator. Probably redox-responsive. The apo- but not holo-form probably binds DNA (By similarity). {ECO:0000250}.; FUNCTION: The apo-form functions as a chaperone, preventing aggregation or helping in correct refolding of a number of substrates; this activity does not require ATP or the ability to bind a Fe-S cluster. Chaperone activity is insensitive to the redox state of its cysteine residues. The apo-form has no protein disulfide reductase activity. The apo-form binds to its own promoter. {ECO:0000269|PubMed:19016840, ECO:0000269|PubMed:22686939}.",MVPEAPAPFEEPLPPEATDQWQDRALCAQTDPEAFFPEKGGSTREAKKICMGCEVRHECLEYALAHDERFGIWGGLSERERRRLKRGII,"10,157",89,WhiB family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737],,,3
P9WF53,VPC44_MYCTU,Rv3320c,vapC44 Rv3320c,GO:0004540; GO:0005576; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC44,DOMAIN 4 126 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC44 (RNase VapC44) (EC 3.1.-.-) (Toxin VapC44),extracellular region [GO:0005576]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609; 23345537,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB44 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MRALLDVNVLLALLDRDHVDHERARAWITGQIERGWASCAITQNGFVRVISQPRYPSPISVAHAIDLLARATHTRYHEFWSCTVSILDSKVIDRSRLHSPKQVTDAYLLALAVAHDGRFVTFDQSIALTAVPGATKQHLATL,"15,834",142,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],extracellular region [GO:0005576],,,1
O50411,VPC46_MYCTU,Rv3384c,vapC46 Rv3384c,GO:0004540; GO:0005886; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC46,DOMAIN 4 118 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC46 (RNase VapC46) (EC 3.1.-.-) (Toxin VapC46),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits colony formation. Its toxic effect is neutralized by coexpression with cognate antitoxin VapB46. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MAAIYLDSSAIVKLAVREPESDALRRYLRTRHPRVSSALARAEVMRALLDKGESARKAGRRALAHLDLLRVDKRVLDLAGGLLPFELRTLDAIHLATAQRLGVDLGRLCTYDDRMRDAAKTLGMAVIAPS,"14,317",130,PINc/VapC protein family,negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],plasma membrane [GO:0005886],,,3
P9WF49,VPC47_MYCTU,Rv3408,vapC47 Rv3408 MTCY78.20c,GO:0004540; GO:0017148; GO:0045926; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC47,DOMAIN 2 104 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC47 (RNase VapC47) (EC 3.1.-.-) (Toxin VapC47),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase (By similarity). Upon expression in M.smegmatis inhibits translation and colony formation. Its toxic effect on colony formation is neutralized by coexpression with cognate antitoxin VapB47; the effect on translation has not been tested but is probably neutralized also. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000269|PubMed:20011113}.",MIYMDTSALTKLLISEPETTELRTWLTAQSGQGEDAATSTLGRVESMRVVARYGQPGQTERARYLLDGLDILPLTEPVIGLAETIGPATLRSLDAIHLAAAAQIKRELTAFVTYDHRLLSGCREVGFVTASPGAVR,"14,702",136,PINc/VapC protein family,negative regulation of growth [GO:0045926]; negative regulation of translation [GO:0017148],metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,MTCY78.20c,1
P9WF51,VPC49_MYCTU,Rv3180c,vapC49 Rv3180c,GO:0004540; GO:0046872,IPR029060; IPR002716; IPR022907; ,,vapC49,,Ribonuclease VapC49 (RNase VapC49) (EC 3.1.-.-) (Toxin VapC49),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21673191; 21969609; 24662523,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB49 (By similarity). {ECO:0000255|HAMAP-Rule:MF_00265}.,MPLVYFDASAFVKLLTTETGSSLASALWDGCDAALSSRLAYPEVRAALAAAARNHDLTESELADAERDWEDFWAATRPVELTATVEQHAGHLARAHALRGADAVHLASALAVGDPGLVVAVWDRRLHTGAHAAGCRVAPAQLDP,"15,205",144,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
P9WMY3,WBBL_MYCTU,Rv3265c,wbbL wbbL1 Rv3265c,GO:0005886; GO:0016758; GO:0040007; GO:0045226; GO:0102096,IPR001173; IPR029044; ,,wbbL,,"N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase (EC 2.4.1.289) (Rhamnosyltransferase WbbL) (dTDP-Rha:alpha-D-GlcNAc-pyrophosphate polyprenol, alpha-3-L-rhamnosyltransferase)","plasma membrane [GO:0005886]; decaprenyl-N-acetyl-alpha-D-glucosaminyl-pyrophosphate:dTDP-alpha-L-rhamnose rhamnosyltransferase activity [GO:0102096]; transferase activity, transferring hexosyl groups [GO:0016758]; extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007]",9634230; 15294902; 19099550; 19047740; 21969609,,"FUNCTION: Involved in the biosynthesis of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the transfer of the rhamnosyl moiety from dTDP-rhamnosyl (dTDP-Rha) onto the decaprenyl-pyrophosphoryl-GlcNAc (C50-PP-GlcNAc), yielding rhamnosyl-decaprenyl-pyrophosphoryl-GlcNAc (Rha-C50-PP-GlcNAc). {ECO:0000269|PubMed:15294902, ECO:0000269|PubMed:19047740}.",MTDVLPVVAVTYSPGPHLERFLASLSLATERPVSVLLADNGSTDGTPQAAVQRYPNVRLLPTGANLGYGTAVNRTIAQLGEMAGDAGEPWVDDWVIVANPDVQWGPGSIDALLDAASRWPRAGALGPLIRDPDGSVYPSARQMPSLIRGGMHAVLGPFWPRNPWTTAYRQERLEPSERPVGWLSGSCLLVRRSAFGQVGGFDERYFMYMEDVDLGDRLGKAGWLSVYVPSAEVLHHKAHSTGRDPASHLAAHHKSTYIFLADRHSGWWRAPLRWTLRGSLALRSHLMVRSSLRRSRRRKLKLVEGRH,"33,920",307,Glycosyltransferase 2 family,extracellular polysaccharide biosynthetic process [GO:0045226]; growth [GO:0040007],"decaprenyl-N-acetyl-alpha-D-glucosaminyl-pyrophosphate:dTDP-alpha-L-rhamnose rhamnosyltransferase activity [GO:0102096]; transferase activity, transferring hexosyl groups [GO:0016758]",plasma membrane [GO:0005886],wbbL1,,2
P9WF43,WHIB1_MYCTU,Rv3219,whiB1 Rv3219,GO:0003677; GO:0005737; GO:0006351; GO:0015035; GO:0045892; GO:0046872; GO:0047134; GO:0051539; GO:0071731,IPR034768; IPR003482; ,,whiB1,DOMAIN 8 70 4Fe-4S Wbl-type.,Transcriptional regulator WhiB1,"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; negative regulation of transcription, DNA-templated [GO:0045892]; response to nitric oxide [GO:0071731]; transcription, DNA-templated [GO:0006351]",9634230; 15882420; 17157031; 19121228; 19016840; 20929442; 20028978; 21182249; 22792304; 22464736,NMR spectroscopy (1),"FUNCTION: Acts as a transcriptional repressor, inhibiting expression in vitro. Probably redox-responsive. The apo- but not holo-form binds to its own promoter as well as that of groEL2. Oxidized apo-form and nitrosylated holo-form also bind DNA. The apo-form has been shown to act as a protein disulfide reductase (PubMed:17157031) (PubMed:19016840), but also not to act as a protein disulfide reductase (PubMed:20929442). {ECO:0000269|PubMed:17157031, ECO:0000269|PubMed:19016840, ECO:0000269|PubMed:20929442, ECO:0000269|PubMed:22464736}.",MDWRHKAVCRDEDPELFFPVGNSGPALAQIADAKLVCNRCPVTTECLSWALNTGQDSGVWGGMSEDERRALKRRNARTKARTGV,"9,319",84,WhiB family,"negative regulation of transcription, DNA-templated [GO:0045892]; response to nitric oxide [GO:0071731]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]",cytoplasm [GO:0005737],,,1
P9WF41,WHIB3_MYCTU,Rv3416,whiB3 Rv3416,GO:0003677; GO:0005618; GO:0005737; GO:0006351; GO:0006355; GO:0009405; GO:0015035; GO:0019216; GO:0019217; GO:0045454; GO:0046872; GO:0051536; GO:0051539; GO:0071766; GO:0090034; GO:1902882,IPR034768; IPR003482; ,P9WGI1,whiB3,DOMAIN 22 86 4Fe-4S Wbl-type.,Redox- and pH-responsive transcriptional regulator WhiB3,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cell redox homeostasis [GO:0045454]; pathogenesis [GO:0009405]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of fatty acid metabolic process [GO:0019217]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 11880648; 16923787; 17609386; 18550384; 19680450; 19016840; 26774486; 26637353; 22010944,,"FUNCTION: A redox-sensitive transcriptional regulator. Maintains intracellular redox homeostasis by regulating catabolic metabolism and polyketide biosynthesis (PubMed:17609386, PubMed:19680450). Regulates expression of the redox buffer ergothioneine (ERG) in a carbon-source-dependent manner; loss of ERG or mycothiol (MSH, the other major redox buffer in this bacteria) leads to respiratory alterations and bioenergetic deficiencies that negatively impact virulence (PubMed:26774486). In response to low external pH (like that found in host macrophage phagosomes) alters endogenous gene expression leading to acid resistance; MSH and WhiB3 are probably part of a regulatory circuit that mediates gene expression upon acid stress (PubMed:26637353). Regulates pathogenic lipid synthesis, coordinating proprionate flux (and other host-derived fatty acid oxidation intermediates) into methyl-branched fatty acids (polyacyltrehalose, phthiocerol dimycocerosates, sulfolipids) and the storage lipid triacylglycerol, functioning as reductive sink (PubMed:19680450). During intracellular growth M.tuberculosis uses host fatty acids as an energy source, generating large quantities of proprionate and NADH/NADPH, which are toxic and highly reducing respectively. WhiB3 is thought to help dissipate proprionate and NADH/NADPH by switching to the in vivo carbon source and via lipid anabolism (PubMed:19680450). Responds to NO and O(2) (PubMed:17609386). Regulates expression of genes encoding modular polyketide synthases such as pks2, pks3 and fbpA (PubMed:19680450). The oxidized apo-form of WhiB3 binds DNA (with 2 intramolecular disulfide bonds); holo-WhiB3 (with the 4Fe-4S cluster) binds DNA considerably less well (PubMed:19680450). Discriminates poorly between specific and non-specific DNA-binding. Plays a role in virulence and nutritional stress (PubMed:11880648, PubMed:17609386, PubMed:26637353). In its apo-form can act as a protein disulfide reductase (PubMed:18550384). {ECO:0000269|PubMed:11880648, ECO:0000269|PubMed:17609386, ECO:0000269|PubMed:18550384, ECO:0000269|PubMed:19016840, ECO:0000269|PubMed:19680450, ECO:0000269|PubMed:26637353, ECO:0000269|PubMed:26774486}.; FUNCTION: May respond to mycothiol (MSH) redox potential (E-MSH) which decreases at pH 4.5 for up to 72 hours, indicative of cellular reductive stress; deletion of whiB3 leads to a lesser E-MSH at 72 hours, indicative of cellular oxidative stress (PubMed:26637353). Probably via its effects on production of polyketide lipids, regulates host gene expression, leading to blockage of phagosome maturation (PubMed:26637353). Equilibration of extra- and intracytoplasmic pH kills bacteria (PubMed:26637353). {ECO:0000269|PubMed:26637353}.",MPQPEQLPGPNADIWNWQLQGLCRGMDSSMFFHPDGERGRARTQREQRAKEMCRRCPVIEACRSHALEVGEPYGVWGGLSESERDLLLKGTMGRTRGIRRTA,"11,612",102,WhiB family,"Actinobacterium-type cell wall biogenesis [GO:0071766]; cell redox homeostasis [GO:0045454]; pathogenesis [GO:0009405]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of fatty acid metabolic process [GO:0019217]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]",cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
Q6MX01,WHB7A_MYCTU,Rv3197.1,whiB7 Rv3197A Rv3197.1,GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0046677; GO:0046872; GO:0051539; GO:0070542,IPR034768; IPR017956; IPR003482; ,,whiB7,DOMAIN 19 76 4Fe-4S Wbl-type.,Probable transcriptional regulator WhiB7,"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; response to fatty acid [GO:0070542]; transcription, DNA-templated [GO:0006351]",9634230; 16103351; 19016840; 22069311,,"FUNCTION: The apo- but not holo-form probably binds DNA (By similarity). Acts as a transcriptional regulator. Probably redox-responsive. Upon overproduction at least 10 other genes are up-regulated, among them are Rv1258c, Rv1988, Rv2301, Rv2416c, Rv2725c and whiB7 itself. Probably redox-responsive. The apo-form has been shown to act as a protein disulfide reductase. {ECO:0000250, ECO:0000269|PubMed:16103351, ECO:0000269|PubMed:19016840}.",MSVLTVPRQTPRQRLPVLPCHVGDPDLWFADTPAGLEVAKTLCVSCPIRRQCLAAALQRAEPWGVWGGEIFDQGSIVSHKRPRGRPRKDAVA,"10,139",92,WhiB family,"regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; response to fatty acid [GO:0070542]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737],Rv3197A,,1
P9WF23,VPB47_MYCTU,Rv3407,vapB47 Rv3407 MTCY78.21c,GO:0045927,IPR006442; IPR036165; ,,vapB47,,Antitoxin VapB47,positive regulation of growth [GO:0045927],9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC47. {ECO:0000269|PubMed:20011113}.,MRATVGLVEAIGIRELRQHASRYLARVEAGEELGVTNKGRLVARLIPVQAAERSREALIESGVLIPARRPQNLLDVTAEPARGRKRTLSDVLNEMRDEQ,"11,010",99,PhD/YefM antitoxin family,positive regulation of growth [GO:0045927],,,,MTCY78.21c,1
P9WF15,VPB49_MYCTU,Rv3181c,vapB49 Rv3181c,GO:0005886,IPR006442; IPR036165; ,,vapB49,,Putative antitoxin VapB49,plasma membrane [GO:0005886],9634230; 20011113; 21673191; 21969609; 24662523,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC49 (Potential). {ECO:0000305}.,MQLGRKVTSHHDIDRFGVASTADESVYRPLPPRLRLAQVNLSRRRCRTQSDMYKSRFSECTVQSVDVSVTELRAHLSDWLDRARAGGEVVITERGIPIARLAALDSTDTLERLTAEGVIGKATAQRPVAAGRPRPRPQRPVSDRVSDQRR,"16,799",150,PhD/YefM antitoxin family,,,plasma membrane [GO:0005886],,,1
P9WGH9,SIGH_MYCTU,Rv3223c,sigH rpoE Rv3223c MTCY07D11.03,GO:0003677; GO:0003700; GO:0005618; GO:0006352; GO:0006355; GO:0006979; GO:0009408; GO:0016987; GO:0034605; GO:0051409,IPR014284; IPR014293; IPR000838; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigH,,ECF RNA polymerase sigma factor SigH (ECF sigma factor SigH) (Alternative RNA polymerase sigma factor SigH) (RNA polymerase sigma-H factor) (Sigma-H factor),"cell wall [GO:0005618]; bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; cellular response to heat [GO:0034605]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979]",9634230; 22937074; 10027986; 11567012; 12123450; 14617153; 16298337; 19099550; 18728196; 21969609,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by a cognate anti-sigma factor (RshA) until released. This sigma factor is involved in heat shock and oxidative stress responses; it positively regulates the expression of itself, sigE, sigB and a number of transcriptional regulators as well as other effectors of heat and oxidative stress, leading to direct and indirect control of up to 25% of the bacterial genome. Modulates expression of host genes for intercrine beta (chemokine CC) and apoptosis, altering the host immune response. {ECO:0000269|PubMed:11567012, ECO:0000269|PubMed:12123450, ECO:0000269|PubMed:14617153, ECO:0000269|PubMed:16298337}.",MADIDGVTGSAGLQPGPSEETDEELTARFERDAIPLLDQLYGGALRMTRNPADAEDLLQETMVKAYAGFRSFRHGTNLKAWLYRILTNTYINSYRKKQRQPAEYPTEQITDWQLASNAEHSSTGLRSAEVEALEALPDTEIKEALQALPEEFRMAVYYADVEGFPYKEIAEIMDTPIGTVMSRLHRGRRQLRGLLADVARDRGFARGEQAHEGVSS,"24,225",216,"Sigma-70 factor family, ECF subfamily","cellular response to heat [GO:0034605]; DNA-templated transcription, initiation [GO:0006352]; regulation of transcription, DNA-templated [GO:0006355]; response to heat [GO:0009408]; response to nitrosative stress [GO:0051409]; response to oxidative stress [GO:0006979]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618],rpoE,MTCY07D11.03,1
L0TCG5,SIGJ_MYCTU,Rv3328c,sigJ Rv3328c,GO:0003677; GO:0003700; GO:0006352; GO:0016987,IPR032710; IPR014284; IPR007627; IPR013249; IPR013325; IPR013324; IPR037401; IPR036388; ,,sigJ,,ECF RNA polymerase sigma factor SigJ (ECF sigma factor SigJ) (Alternative RNA polymerase sigma factor SigJ) (RNA polymerase sigma-J factor) (Sigma-J factor),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]",9634230; 11506908; 15321691; 16483748; 18248429; 21969609,X-ray crystallography (1),"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor until released, although no anti-sigma factor is known for this protein (By similarity). Regulates the promoter of SigI, may not be autoregulated. {ECO:0000250, ECO:0000269|PubMed:16483748, ECO:0000269|PubMed:18248429}.",MEVSEFEALRQHLMSVAYRLTGTVADAEDIVQEAWLRWDSPDTVIADPRAWLTTVVSRLGLDKLRSAAHRRETYTGTWLPEPVVTGLDATDPLAAVVAAEDARFAAMVVLERLRPDQRVAFVLHDGFAVPFAEVAEVLGTSEAAARQLASRARKAVTAQPALISGDPDPAHNEVVGRLMAAMAAGDLDTVVSLLHPDVTFTGDSNGKAPTAVRAVRGSDKVVRFILGLVQRYGPGLFGANQLALVNGELGAYTAGLPGVDGYRAMAPRITAITVRDGKVCALWDIANPDKFTGSPLKERRAQPTGRGRHHRN,"33,530",312,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,1
P9WGV3,SAHH_MYCTU,Rv3248c,ahcY sahH Rv3248c MTCY20B11.23c,GO:0004013; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006730; GO:0009087; GO:0019510; GO:0033353; GO:0035375; GO:0035635; GO:0040007; GO:0044650; GO:0046085; GO:0070403,IPR034373; IPR000043; IPR015878; IPR036291; IPR020082; ,P10145,ahcY,,Adenosylhomocysteinase (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase) (AdoHcyase),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; adenosylhomocysteinase activity [GO:0004013]; NAD+ binding [GO:0070403]; zymogen binding [GO:0035375]; adenosine metabolic process [GO:0046085]; adhesion of symbiont to host cell [GO:0044650]; entry of bacterium into host cell [GO:0035635]; growth [GO:0040007]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353],9634230; 20066036; 21969609; 18815415,X-ray crystallography (5),FUNCTION: May play a key role in the regulation of the intracellular concentration of adenosylhomocysteine. {ECO:0000255|HAMAP-Rule:MF_00563}.,MTGNLVTKNSLTPDVRNGIDFKIADLSLADFGRKELRIAEHEMPGLMSLRREYAEVQPLKGARISGSLHMTVQTAVLIETLTALGAEVRWASCNIFSTQDHAAAAVVVGPHGTPDEPKGVPVFAWKGETLEEYWWAAEQMLTWPDPDKPANMILDDGGDATMLVLRGMQYEKAGVVPPAEEDDPAEWKVFLNLLRTRFETDKDKWTKIAESVKGVTEETTTGVLRLYQFAAAGDLAFPAINVNDSVTKSKFDNKYGTRHSLIDGINRGTDALIGGKKVLICGYGDVGKGCAEAMKGQGARVSVTEIDPINALQAMMEGFDVVTVEEAIGDADIVVTATGNKDIIMLEHIKAMKDHAILGNIGHFDNEIDMAGLERSGATRVNVKPQVDLWTFGDTGRSIIVLSEGRLLNLGNATGHPSFVMSNSFANQTIAQIELWTKNDEYDNEVYRLPKHLDEKVARIHVEALGGHLTKLTKEQAEYLGVDVEGPYKPDHYRY,"54,324",495,Adenosylhomocysteinase family,adenosine metabolic process [GO:0046085]; adhesion of symbiont to host cell [GO:0044650]; entry of bacterium into host cell [GO:0035635]; growth [GO:0040007]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510]; S-adenosylmethionine cycle [GO:0033353],adenosylhomocysteinase activity [GO:0004013]; NAD+ binding [GO:0070403]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],sahH,MTCY20B11.23c,1
O53368,SDHC_MYCTU,Rv3316 RVBD_3316 LH57_18125,sdhC Rv3316 RVBD_3316 LH57_18125 P425_03457,GO:0000104; GO:0005886; GO:0006099; GO:0016021; GO:0045281; GO:0046872,IPR034804; IPR014314; IPR000701; ,,sdhC,,Succinate dehydrogenase 2 membrane subunit SdhC,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; succinate dehydrogenase complex [GO:0045281]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609; 25412183,,"FUNCTION: Membrane-anchoring subunit of succinate dehydrogenase 2 (Sdh2). Sdh2 may catalyze the two-electron oxidation of succinate to fumarate with a corresponding reduction of quinone to quinol under low oxygen conditions, when the primary aerobic succinate dehydrogenase (Sdh1) is inhibited. Sdh2 seems to be the generator of the proton motive force (PMF) under hypoxia. {ECO:0000305|PubMed:25412183}.",MLLRGLPAVNTTATTVSRGRRPPRTLYRGDPGMWSWVCHRISGATIFFFLFVHVLDAAMLRVSPQTYNAVLATYKTPIVGLMEYGLVAAVLFHALNGIRVILIDFWSEGPRYQRLMLWIIGSVFLLLMVPAGVVVGIHMWEHFR,"16,300",144,Cytochrome b560 family,tricarboxylic acid cycle [GO:0006099],metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; succinate dehydrogenase complex [GO:0045281],,P425_03457,2
P9WGI3,SIGF_MYCTU,Rv3286c,sigF Rv3286c,GO:0003677; GO:0003700; GO:0006352; GO:0006629; GO:0006979; GO:0006995; GO:0009409; GO:0016987; GO:0034059; GO:0043175; GO:0045893; GO:0046677; GO:0070417,IPR014284; IPR014322; IPR000943; IPR007627; IPR007624; IPR007630; IPR013325; IPR013324; IPR036388; ,,sigF,,RNA polymerase sigma factor SigF (Sigma factor SigF) (Alternative RNA polymerase sigma factor SigF) (RNA polymerase sigma-F factor) (Sigma-F factor) (Stress response/stationary phase sigma factor SigF),"bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase core enzyme binding [GO:0043175]; cellular response to cold [GO:0070417]; cellular response to nitrogen starvation [GO:0006995]; DNA-templated transcription, initiation [GO:0006352]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; response to anoxia [GO:0034059]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to oxidative stress [GO:0006979]",8610119; 9634230; 10027986; 11929527; 12354223; 16735723; 19130906; 20729364; 20600947; 21969609; 22307756; 22570422,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Held in an inactive form by a cognate anti-sigma factor RsbW (UsfX) until released. Increased expression decreases growth rate, and after 3 days increases the expression of 51 loci encoding 33 protein-coding genes as well as some non-coding RNA (PubMed:22307756). {ECO:0000269|PubMed:12354223, ECO:0000269|PubMed:20729364, ECO:0000269|PubMed:22307756, ECO:0000269|PubMed:22570422}.",MTARAAGGSASRANEYADVPEMFRELVGLPAGSPEFQRHRDKIVQRCLPLADHIARRFEGRGEPRDDLIQVARVGLVNAAVRFDVKTGSDFVSFAVPTIMGEVRRHFRDNSWSVKVPRRLKELHLRLGTATADLSQRLGRAPSASELAAELGMDRAEVIEGLLAGSSYHTLSIDSGGGSDDDARAITDTLGDVDAGLDQIENREVLRPLLEALPERERTVLVLRFFDSMTQTQIAERVGISQMHVSRLLAKSLARLRDQLE,"28,794",261,Sigma-70 factor family,"cellular response to cold [GO:0070417]; cellular response to nitrogen starvation [GO:0006995]; DNA-templated transcription, initiation [GO:0006352]; lipid metabolic process [GO:0006629]; positive regulation of transcription, DNA-templated [GO:0045893]; response to anoxia [GO:0034059]; response to antibiotic [GO:0046677]; response to cold [GO:0009409]; response to oxidative stress [GO:0006979]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; RNA polymerase core enzyme binding [GO:0043175],,,,1
P9WGP5,SECA1_MYCTU,Rv3240c,secA1 Rv3240c MTCY20B11.15c,GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0005887; GO:0006605; GO:0015462; GO:0016887; GO:0017038; GO:0031522; GO:0040007; GO:0043952,IPR027417; IPR000185; IPR020937; IPR011115; IPR014018; IPR011130; IPR011116; IPR036266; IPR036670; ,,secA1,,Protein translocase subunit SecA 1 (tbSecA),cell envelope Sec protein transport complex [GO:0031522]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase-coupled protein transmembrane transporter activity [GO:0015462]; growth [GO:0040007]; protein import [GO:0017038]; protein targeting [GO:0006605]; protein transport by the Sec complex [GO:0043952],9634230; 21969609; 12606717,X-ray crystallography (2),"FUNCTION: Part of the Sec protein translocase complex. Interacts with the SecYEG preprotein conducting channel. Has a central role in coupling the hydrolysis of ATP to the transfer of precursor proteins, serving as an ATP-driven molecular motor driving the stepwise translocation of polypeptide chains across the membrane (By similarity). {ECO:0000250}.",MLSKLLRLGEGRMVKRLKKVADYVGTLSDDVEKLTDAELRAKTDEFKRRLADQKNPETLDDLLPEAFAVAREAAWRVLDQRPFDVQVMGAAALHLGNVAEMKTGEGKTLTCVLPAYLNALAGNGVHIVTVNDYLAKRDSEWMGRVHRFLGLQVGVILATMTPDERRVAYNADITYGTNNEFGFDYLRDNMAHSLDDLVQRGHHYAIVDEVDSILIDEARTPLIISGPADGASNWYTEFARLAPLMEKDVHYEVDLRKRTVGVHEKGVEFVEDQLGIDNLYEAANSPLVSYLNNALKAKELFSRDKDYIVRDGEVLIVDEFTGRVLIGRRYNEGMHQAIEAKEHVEIKAENQTLATITLQNYFRLYDKLAGMTGTAQTEAAELHEIYKLGVVSIPTNMPMIREDQSDLIYKTEEAKYIAVVDDVAERYAKGQPVLIGTTSVERSEYLSRQFTKRRIPHNVLNAKYHEQEATIIAVAGRRGGVTVATNMAGRGTDIVLGGNVDFLTDQRLRERGLDPVETPEEYEAAWHSELPIVKEEASKEAKEVIEAGGLYVLGTERHESRRIDNQLRGRSGRQGDPGESRFYLSLGDELMRRFNGAALETLLTRLNLPDDVPIEAKMVTRAIKSAQTQVEQQNFEVRKNVLKYDEVMNQQRKVIYAERRRILEGENLKDQALDMVRDVITAYVDGATGEGYAEDWDLDALWTALKTLYPVGITADSLTRKDHEFERDDLTREELLEALLKDAERAYAAREAELEEIAGEGAMRQLERNVLLNVIDRKWREHLYEMDYLKEGIGLRAMAQRDPLVEYQREGYDMFMAMLDGMKEESVGFLFNVTVEAVPAPPVAPAAEPAELAEFAAAAAAAAQQRSAVDGGARERAPSALRAKGVASESPALTYSGPAEDGSAQVQRNGGGAHKTPAGVPAGASRRERREAARRQGRGAKPPKSVKKR,"106,022",949,SecA family,growth [GO:0040007]; protein import [GO:0017038]; protein targeting [GO:0006605]; protein transport by the Sec complex [GO:0043952],ATPase activity [GO:0016887]; ATPase-coupled protein transmembrane transporter activity [GO:0015462]; ATP binding [GO:0005524],cell envelope Sec protein transport complex [GO:0031522]; cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY20B11.15c,1
P9WHD3,RL17_MYCTU,Rv3456c,rplQ Rv3456c MTCY13E12.09c,GO:0003735; GO:0005618; GO:0005886; GO:0006412; GO:0022625,IPR000456; IPR036373; ,,rplQ,,50S ribosomal protein L17,cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),,MPKPTKGPRLGGSSSHQKAILANLATSLFEHGRITTTEPKARALRPYAEKLITHAKKGALHNRREVLKKLRDKDVVHTLFAEIGPFFADRDGGYTRIIKIEARKGDNAPMAVIELVREKTVTSEANRARRVAAAQAKAKKAAAMPTEESEAKPAEEGDVVGASEPDAKAPEEPPAEAPEN,"19,475",180,Bacterial ribosomal protein bL17 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY13E12.09c,1
P9WHE1,RL13_MYCTU,Rv3443c,rplM Rv3443c MTCY77.15c,GO:0003729; GO:0003735; GO:0005618; GO:0005829; GO:0005886; GO:0006412; GO:0022625; GO:0040007,IPR005822; IPR005823; IPR023563; IPR036899; ,,rplM,,50S ribosomal protein L13,cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; growth [GO:0040007]; translation [GO:0006412],9634230; 21969609,Electron microscopy (1),"FUNCTION: This protein is one of the early assembly proteins of the 50S ribosomal subunit, although it is not seen to bind rRNA by itself. It is important during the early stages of 50S assembly. {ECO:0000255|HAMAP-Rule:MF_01366}.",MPTYAPKAGDTTRSWYVIDATDVVLGRLAVAAANLLRGKHKPTFAPNVDGGDFVIVINADKVAISGDKLQHKMVYRHSGYPGGLHKRTIGELMQRHPDRVVEKAILGMLPKNRLSRQIQRKLRVYAGPEHPHSAQQPVPYELKQVAQ,"16,337",147,Universal ribosomal protein uL13 family,growth [GO:0040007]; translation [GO:0006412],mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735],cell wall [GO:0005618]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; plasma membrane [GO:0005886],,MTCY77.15c,1
P9WKH9,TRA9_MYCTU,Rv0796; Rv1369c; Rv1756c; Rv1764; Rv2106; Rv2167c; Rv2279; Rv2355; Rv2479c; Rv2649; Rv2814c; Rv3185; Rv3187; Rv3326; Rv3380c; Rv3475,Rv0796 MTV042.06; Rv1369c MTCY02B12.03c; Rv1756c MTCY28.22c; Rv1764 MTCY28.30; Rv2106 MTCY261.02; Rv2167c MTCY270.01; Rv2279 MTCY339.31c; Rv2355 MTCY98.24; Rv2479c MTV008.35c; Rv2649 MTCY441.18; Rv2814c MTCY16B7.29; Rv3185 MTV014.29; Rv3187 MTV014.31; Rv3326 MTV016.26; Rv3380c MTV004.38c; Rv3475 MTCY13E12.28,GO:0003677; GO:0005886; GO:0006310; GO:0015074; GO:0032196,IPR025948; IPR038965; IPR001584; IPR012337; IPR036397; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,DOMAIN 101 268 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase for insertion sequence element IS986/IS6110 (ORFB),plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],1981088; 9634230,,FUNCTION: Involved in the transposition of the insertion sequence.,MPIAPSTYYDHINREPSRRELRDGELKEHISRVHAANYGVYGARKVWLTLNREGIEVARCTVERLMTKLGLSGTTRGKARRTTIADPATARPADLVQRRFGPPAPNRLWVADLTYVSTWAGFAYVAFVTDAYARRILGWRVASTMATSMVLDAIEQAIWTRQQEGVLDLKDVIHHTDRGSQYTSIRFSERLAEAGIQPSVGAVGSSYDNALAETINGLYKTELIKPGKPWRSIEDVELATARWVDWFNHRRLYQYCGDVPPVELEAAYYAQRQRPAAG,"31,369",278,,DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.06; MTCY02B12.03c; MTCY28.22c; MTCY28.30; MTCY261.02; MTCY270.01; MTCY339.31c; MTCY98.24; MTV008.35c; MTCY441.18; MTCY16B7.29; MTV014.29; MTV014.31; MTV016.26; MTV004.38c; MTCY13E12.28,1
P9WFS1,TYPH_MYCTU,Rv3314c,deoA Rv3314c MTV016.14,GO:0004645; GO:0005829; GO:0006206; GO:0006213; GO:0009032; GO:0016154,IPR000312; IPR017459; IPR036320; IPR035902; IPR036566; IPR013102; IPR018090; IPR017872; IPR000053; ,,deoA,,Thymidine phosphorylase (EC 2.4.2.4) (TdRPase),cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213],9634230; 21969609,,"FUNCTION: The enzymes which catalyze the reversible phosphorolysis of pyrimidine nucleosides are involved in the degradation of these compounds and in their utilization as carbon and energy sources, or in the rescue of pyrimidine bases for nucleotide synthesis. {ECO:0000250}.",MTDFAFDAPTVIRTKRDGGRLSDAAIDWVVKAYTDGRVADEQMSALLMAIVWRGMDRGEIARWTAAMLASGARLDFTDLPLATVDKHSTGGVGDKITLPLVPVVAACGGAVPQASGRGLGHTGGTLDKLESITGFTANLSNQRVREQLCDVGAAIFAAGQLAPADAKLYALRDITGTVESLPLIASSIMSKKLAEGAGALVLDVKVGSGAFMRSPVQARELAHTMVELGAAHGVPTRALLTEMNCPLGRTVGNALEVAEALEVLAGGGPPDVVELTLRLAGEMLELAGIHGRDPAQTLRDGTAMDRFRRLVAAQGGDLSKPLPIGSHSETVTAGASGTMGDIDAMAVGLAAWRLGAGRSRPGARVQHGAGVRIHRRPGEPVVVGEPLFTLYTNAPERFGAARAELAGGWSIRDSPPQVRPLIVDRIV,"44,486",427,Thymidine/pyrimidine-nucleoside phosphorylase family,pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213],phosphorylase activity [GO:0004645]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032],cytosol [GO:0005829],,MTV016.14,1
P9WKH5,YIA4_MYCTU,Rv0795; Rv1370c; Rv1757c; Rv1763; Rv2105; Rv2168c; Rv2278; Rv2354; Rv2480c; Rv2648; Rv2815c; Rv3184; Rv3186; Rv3325; Rv3381c; Rv3474,Rv0795 MTV042.05; Rv1370c MTCY02B12.04c; Rv1757c MTCY28.23c; Rv1763 MTCY28.29; Rv2105 MTCY261.01; Rv2168c MTV021.01c; Rv2278 MTCY339.32c; Rv2354 MTCY98.23; Rv2480c MTV008.36c; Rv2648 MTCY441.17A; Rv2815c MTCY16B7.28; Rv3184 MYV014.28; Rv3186 MTV014.30; Rv3325 MTV016.25; Rv3381c MTV004.39c; Rv3474 MTCY13E12.27,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR009057; IPR002514; IPR036388; ,,; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,,Insertion element IS6110 uncharacterized 12.0 kDa protein,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MSGGSSRRYPPELRERAVRMVAEIRGQHDSEWAAISEVARLLGVGCAETVRKWVRQAQVDAGARPGTTTEESAELKRLRRDNAELRRANAILKTASAFFAAELDRPAR,"12,005",108,Transposase 8 family,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ,MTV042.05; MTCY02B12.04c; MTCY28.23c; MTCY28.29; MTCY261.01; MTV021.01c; MTCY339.32c; MTCY98.23; MTV008.36c; MTCY441.17A; MTCY16B7.28; MYV014.28; MTV014.30; MTV016.25; MTV004.39c; MTCY13E12.27,1
P9WL05,Y3129_MYCTU,Rv3129,Rv3129,GO:0048037,IPR024747; IPR012349; ,,,,Uncharacterized protein Rv3129,cofactor binding [GO:0048037],20639330; 9634230; 11416222; 12953092; 18474359,,,MVQGRTVLFRTAEGAKLFSAVAKCAVAFEADDHNVAEGWSVIVKVRAQVLTTDAGVREAERAQLLPWTATLKRHCVRVIPWEITGRHFRFGPEPDRSQTFACEASSHNQR,"12,291",110,,,cofactor binding [GO:0048037],,,,1
P9WGL7,Y3143_MYCTU,Rv3143,Rv3143,GO:0000160; GO:0005618; GO:0005622,IPR011006; IPR001789; ,,,DOMAIN 9 128 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Uncharacterized response regulatory protein Rv3143,cell wall [GO:0005618]; intracellular [GO:0005622]; phosphorelay signal transduction system [GO:0000160],9634230; 17259624; 21969609,,,MPDSSTALRILVYSDNVQTRERVMRALGKRLHPDLPDLTYVEVATGPMVIRQMDRGGIDLAILDGEATPTGGMGIAKQLKDELASCPPILVLTGRPDDTWLASWSRAEAAVPHPVDPIVLGRTVLSLLRAPAH,"14,386",133,,phosphorelay signal transduction system [GO:0000160],,cell wall [GO:0005618]; intracellular [GO:0005622],,,1
P9WI99,Y3168_MYCTU,Rv3168,Rv3168,GO:0005524; GO:0016301; GO:0046677; GO:0046872,IPR002575; IPR011009; ,,,,Putative aminoglycoside phosphotransferase (EC 2.7.1.-) (Putative aminoglycoside antibiotics resistance enzyme),ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; response to antibiotic [GO:0046677],9634230; 21543877; 21969609; 21905120,X-ray crystallography (2),FUNCTION: Might catalyze the phosphorylation of aminoglycosides and confer aminoglycoside antibiotics resistance.,MANEPAIGAIDRLQRSSRDVTTLPAVISRWLSSVLPGGAAPEVTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWVRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVALGPRELDVAWMIFAHRVFQELAGLATLPGLPEVMREDDVRATYQALTGVELGDLHWFYVYSGVMWACVFMRTGARRVHFGEIEKPDDVESLFYHAGLMKHLLGEEH,"42,561",378,Aminoglycoside phosphotransferase family,response to antibiotic [GO:0046677],ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872],,,,1
P9WK01,Y3342_MYCTU,Rv3342,Rv3342 MTV016.42,GO:0008168,IPR013216; IPR029063; ,,,,Uncharacterized methyltransferase Rv3342 (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,,MTCSRRDMSLSFGSAVGAYERGRPSYPPEAIDWLLPAAARRVLDLGAGTGKLTTRLVERGLDVVAVDPIPEMLDVLRAALPQTVALLGTAEEIPLDDNSVDAVLVAQAWHWVDPARAIPEVARVLRPGGRLGLVWNTRDERLGWVRELGEIIGRDGDPVRDRVTLPEPFTTVQRHQVEWTNYLTPQALIDLVASRSYCITSPAQVRTKTLDRVRQLLATHPALANSNGLALPYVTVCVRATLA,"26,641",243,Methyltransferase superfamily,,methyltransferase activity [GO:0008168],,,MTV016.42,1
P9WKY9,Y3412_MYCTU,Rv3412,Rv3412 MTCY78.16c,,IPR035165; ,,,,Uncharacterized protein Rv3412,,9634230; 21969609,,,MRDHLPPGLPPDPFADDPCDPSAALEAVEPGQPLDQQERMAVEADLADLAVYEALLAHKGIRGLVVCCDECQQDHYHDWDMLRSNLLQLLIDGTVRPHEPAYDPEPDSYVTWDYCRGYADASLNEAAPDADRFRRR,"15,302",136,,,,,,MTCY78.16c,1
Q50701,Y3427_MYCTU,Rv3427c,Rv3427c MTCY78.02,GO:0005524; GO:0005737; GO:0005886; GO:0006271; GO:0040007,IPR003593; IPR028350; IPR002611; IPR027417; ,,,,Putative ATP-binding protein Rv3427c in insertion sequence,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA strand elongation involved in DNA replication [GO:0006271]; growth [GO:0040007],20639330; 9634230; 19099550,,,MSICDPALRNALRTLKLSGMLDTLDARLAQTRNGDLGHLEFLQALREDEIARRESAALTRRLRRAKFEAQATFEDFDFTANPKLPGAMLRDLAALRWLDAGESVILHGPVGVGKTHVAQALVHAVARRGGDVRFAKTSRMLSDLAGGHADRSWGQRIREYTKPLVLILDDFAMREHTAMHADDLYELISDRAITGKPLILTSNRAPNNWYGLFPNPVVAESLLDRLINTSHQILMDGPSYRPRKRPGRTTS,"28,028",251,IS21/IS1162 putative ATP-binding protein family,DNA strand elongation involved in DNA replication [GO:0006271]; growth [GO:0040007],ATP binding [GO:0005524],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY78.02,1
P9WKA7,Y3480_MYCTU,Rv3480c,Rv3480c MTCY13E12.33c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv3480c (EC 2.3.1.20) (Putative triacylglycerol synthase Rv3480c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Upon expression in E.coli has a weak triacylglycerol synthase function, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Also functions weakly as a wax synthase, as it incorporates palmityl alcohol into wax esters in the presence of palmitoyl-CoA.",MSQTARRLGPQDMFFLYSESSTTMMHVGALMPFTPPSGAPPDLLRQLVDESKASEVVEPWSLRLSHPELLYHPTQSWVVDDNFDLDYHVRRSALASPGDERELGIPVSRLHSHALDLRRPPWEVHFIEGLEGGRFAIYIKMHHSLIDGYTGQKMLARSLSTDPHDTTHPLFFNIPTPGRSPADTQDSVGGGLIAGAGNVLDGLGDVVRGLGGLVSGVGSVLGSVAGAGRSTFELTKALVNAQLRSDHEYRNLVGSVQAPHCILNTRISRNRRFATQQYPLDRLKAIGAQYDATINDVALAIIGGGLRRFLDELGELPNKSLIVVLPVNVRPKDDEGGGNAVATILATLGTDVADPVQRLAAVTASTRAAKAQLRSMDKDAILAYSAALMAPYGVQLASTLSGVKPPWPYTFNLCVSNVPGPEDVLYLRGSRMEASYPVSLVAHSQALNVTLQSYAGTLNFGFIGCRDTLPHLQRLAVYTGEALDQLAAADGAAGLGS,"53,315",497,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY13E12.33c,1
O06349,Y3486_MYCTU,Rv3486 RVBD_3486 LH57_19015,Rv3486 RVBD_3486 LH57_19015 P425_03628,GO:0005886; GO:0016021,IPR032808; ,,,,Uncharacterized membrane protein Rv3486,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MAITGSAAPSWPRLLHAEGPPSVICIRLLVGLVFLSEGIQKFMYPDQLGPGRFERIGIPAATFFADLDGVVEIVCGTLVLLGLLTRVAAVPLLIDMVGAIVLTKLRALQPGGFLGVEGFWGMAHAARTDLSMLLGLIFLLWSGPGRWSLDRRLSKRATACGAR,"17,424",163,DoxX family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,P425_03628,4
P9WIZ7,Y3131_MYCTU,Rv3131,Rv3131,GO:0005829; GO:0005886; GO:0009405; GO:0016491; GO:0040007,IPR000415; ,,,,Putative NAD(P)H nitroreductase Rv3131,cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; growth [GO:0040007]; pathogenesis [GO:0009405],9634230; 11416222; 12953092; 19099550; 18474359; 18400743; 19553548; 21969609; 27094446,,FUNCTION: Stimulates pro-inflammatory cytokine expression via TLR2 signaling pathway. Activation of TLR2 results in the phosphorylation and activation of NF-kappa-B. Also induces TLR2 expression. May influence the innate immune responses to facilitate the survival of M.tuberculosis in the granulomatous microenvironment. {ECO:0000269|PubMed:27094446}.,MTAAVDGKGPAAMNTHFPDAETVRTVLTLAVRAPSIHNTQPWRWRVCPTSLELFSRPDMQLRSTDPDGRELILSCGVALHHCVVALASLGWQAKVNRFPDPKDRCHLATIGVQPLVPDQADVALAAAIPRRRTDRRAYSCWPVPGGDIALMAARAARGGVMLRQVSALDRMKAIVAQAVLDHVTDEEYLRELTIWSGRYGSVAGVPARNEPPSDPSAPIPGRLFAGPGLSQPSDVLPADDGAAILALGTETDDRLARLRAGEAASIVLLTATAMGLACCPITEPLEIAKTRDAVRAEVFGAGGYPQMLLRVGWAPINADPLPPTPRRELSQVVEWPEELLRQRC,"37,049",344,Nitroreductase family,growth [GO:0040007]; pathogenesis [GO:0009405],oxidoreductase activity [GO:0016491],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,2
P9WK27,Y3282_MYCTU,Rv3282,Rv3282 MTCY71.22,GO:0005618; GO:0005737; GO:0047429,IPR029001; IPR003697; ,,,,Maf-like protein Rv3282,cell wall [GO:0005618]; cytoplasm [GO:0005737]; nucleoside-triphosphate diphosphatase activity [GO:0047429],9634230; 19099550; 21969609,,,MTRLVLGSASPGRLKVLRDAGIEPLVIASHVDEDVVIAALGPDAVPSDVVCVLAAAKAAQVATTLTGTQRIVAADCVVVACDSMLYIEGRLLGKPASIDEAREQWRSMAGRAGQLYTGHGVIRLQDNKTVYRAAETAITTVYFGTPSASDLEAYLASGESLRVAGGFTLDGLGGWFIDGVQGNPSNVIGLSLPLLRSLVQRCGLSVAALWAGNAGGPAHKQQ,"23,010",222,Maf family,,nucleoside-triphosphate diphosphatase activity [GO:0047429],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY71.22,1
P9WL01,Y3292_MYCTU,Rv3292,Rv3292 MTCY71.32,,IPR009770; ,,,,Uncharacterized protein Rv3292,,9634230; 21969609,,,MSRSKRLQTGQLRARFAAGLSAMYAAEVPAYGTLVEVCAQVNSDYLTRHRRAERLGSLQRVTAERHGAIRVGNPAELAAVADLFAAFGMLPVGYYDLRTAESPIPVVSTAFRPIDANELAHNPFRVFTSMLAIEDRRYFDADLRTRVQTFLARRQLFDPALLAQARAIAADGGCDADDAPAFVAAAVAAFALSREPVEKSWYDELSRVSAVAADIAGVGSTHINHLTPRVLDIDDLYRRMTERGITMIDTIQGPPRTDGPDVLLRQTSFRALAEPRMFRDEDGTVTPGILRVRFGEVEARGVALTPRGRERYEAAMAAADPAAVWATHFPSTDAEMAAQGLAYYRGGDPSAPIVYEDFLPASAAGIFRSNLDRDSQTGDGPDDAGYNVDWLAGAIGRHIHDPYALYDALAQEERR,"45,332",415,,,,,,MTCY71.32,1
P9WKZ5,Y3403_MYCTU,Rv3403c,Rv3403c MTCY78.25,GO:0005886; GO:0016021,IPR036188; IPR038732; ,,,,Uncharacterized protein Rv3403c,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MLAFPYLMTMITPPTFDVAFIGSGAACSMTLLEMADALLSSPSASPKLRIAVVERDEQFWCGIPYGQRSSIGSLAIQKLDDFADEPEKAAYRIWLEQNKQRWLAFFQAEGGAAAARWICDNRDALDGNQWGELYLPRFLFGVFLSEQMIAAIAALGERDLAEIVTIRAEAMSAHSADGHYRIGLRPSGNGPTAIAAGKVVVAIGSPPTKAILASDSEPAFTYINDFYSPGGESNVARLRDSLDRVESWEKRNVLVVGSNATSLEALYLMRHDARIRARVRSITVISRSGVLPYMICNQPPEFDFPRLRTLLCTEAIAAADLMSAIRDDLATAEERSLNLADLYDAVAALFGQALHKMDLVQQEEFFCVHGMNFTKLVRRAGRDCRQASEELAADGTLSLLAGEVLRVDACASGQPFATMTYRAAGAEHTHPVPFAAVVNCGGFEELDTCSSPFLVSAMQNGLCRPNRTNRGLLVNDDFEASPGFCVIGPLVGGNFTPKIRFWHVESAPRVRSLAKSLAASLLASLQPVALAPC,"57,880",533,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY78.25,1
P9WKY7,Y3421_MYCTU,Rv3421c,Rv3421c MTCY78.08,GO:0002949; GO:0005618,IPR000905; IPR022496; ,,,,Uncharacterized protein Rv3421c,cell wall [GO:0005618]; tRNA threonylcarbamoyladenosine modification [GO:0002949],9634230; 21969609,,,MSRVQISTVLAIDTATPAVTAGIVRRHDLVVLGERVTVDARAHAERLTPNVLAALADAALTMADLDAVVVGCGPGPFTGLRAGMASAAAYGHALGIPVYGVCSLDAIGGQTIGDTLVVTDARRREVYWARYCDGIRTVGPAVNAAADVDPGPALAVAGAPEHAALFALPCVEPSRPSPAGLVAAVNWADKPAPLVPLYLRRPDAKPLAVCT,"21,572",211,,tRNA threonylcarbamoyladenosine modification [GO:0002949],,cell wall [GO:0005618],,MTCY78.08,1
P9WMS5,Y3376_MYCTU,Rv3376,Rv3376,GO:0016791,IPR036412; IPR006439; IPR023214; ,,,,Phosphatase Rv3376 (EC 3.1.-.-),phosphatase activity [GO:0016791],9634230; 21228491; 21969609,,"FUNCTION: Able to hydrolyze geranyl diphosphate (GPP), farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) to respectively yield geraniol, farnesol and geranylgeraniol. {ECO:0000269|PubMed:21228491}.",MSISAVVFDRDGVLTSFDWTRAEEDVRRITGLPLEEIERRWGGWLNGLTIDDAFVETQPISEFLSSLARELELGSKARDELVRLDYMAFAQGYPDARPALEEARRRGLKVGVLTNNSLLVSARSLLQCAALHDLVDVVLSSQMIGAAKPDPRAYQAIAEALGVSTTSCLFFDDIADWVEGARCAGMRAYLVDRSGQTRDGVVRDLSSLGAILDGAGP,"23,664",217,HAD-like hydrolase superfamily,,phosphatase activity [GO:0016791],,,,1
P9WGJ7,Y3402_MYCTU,Rv3402c,Rv3402c MTCY78.26,GO:0003824; GO:0005576; GO:0010106; GO:0052572,IPR000653; IPR015424; IPR015421; ,,,,Protein Rv3402c,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cellular response to iron ion starvation [GO:0010106]; response to host immune response [GO:0052572],9634230; 11722747,,,MKIRTLSGSVLEPPSAVRATPGTSMLKLEPGGSTIPKIPFIRPSFPGPAELAEDFVQIAQANWYTNFGPNERRFARALRDYLGPHLHVATLANGTLALLAALHVSFGAGTRDRYLLMPSFTFVGVAQAALWTGYRPWFIDIDANTWQPCVHSARAVIERFRDRIAGILLANVFGVGNPQISVWEELAAEWELPIVLDSAAGFGSTYADGERLGGRGACEIFSFHATKPFAVGEGGALVSRDPRLVEHAYKFQNFGLVQTRESIQLGMNGKLSEISAAIGLRQLVGLDRRLASRRKVLECYRTGMADAGVRFQDNANVASLCFASACCTSADHKAAVLGSLRRHAIEARDYYNPPQHRHPYFVTNAELVESTDLAVTADICSRIVSLPVHDHMAPDDVARVVAAVQEAEVRGE,"44,897",412,DegT/DnrJ/EryC1 family,cellular response to iron ion starvation [GO:0010106]; response to host immune response [GO:0052572],catalytic activity [GO:0003824],extracellular region [GO:0005576],,MTCY78.26,1
P9WKY3,Y3424_MYCTU,Rv3424c,Rv3424c MTCY78.05,,,,,,Uncharacterized protein Rv3424c,,9634230,,,MPNPVTMLYGRKADLVILPHVLAEERPHPYSTPGRKRGAQIALTTGIDALASFAPQIVNPRHGLSRVVQCLGGCENKRHAYFRSISKTPHIRARGVPSVCAVRTVGVDGAKRPPKPIPVQ,"13,018",120,,,,,,MTCY78.05,1
P0CG96,Y3118_MYCTU,Rv3118,sseC1 Rv3118,,IPR008969; IPR010814; ,,sseC1,,Uncharacterized protein Rv3118,,9634230; 20066036; 21969609,,,MCSGPKQGLTLPASVDLEKETVITGRVVDGDGQAVGGAFVRLLDSSDEFTAEVVASATGDFRFFAAPGSWTLRALSAAGNGDAVVQPSGAGIHEVDVKIT,"10,165",100,,,,,,,1
P9WN17,Y3198_MYCTU,Rv3198.1,Rv3198.1 Rv3198A,GO:0005623; GO:0009055; GO:0015035; GO:0045454,IPR011915; IPR002109; IPR036249; ,,,DOMAIN 1 84 Glutaredoxin. {ECO:0000255|PROSITE-ProRule:PRU00686}.,Putative glutaredoxin Rv3198.1 (EC 1.-.-.-),cell [GO:0005623]; electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],9634230; 21969609,NMR spectroscopy (2),,MITAALTIYTTSWCGYCLRLKTALTANRIAYDEVDIEHNRAAAEFVGSVNGGNRTVPTVKFADGSTLTNPSADEVKAKLVKIAG,"8,963",84,,cell redox homeostasis [GO:0045454],electron transfer activity [GO:0009055]; protein disulfide oxidoreductase activity [GO:0015035],cell [GO:0005623],,Rv3198A,1
O05897,Y3254_MYCTU,Rv3254 RVBD_3254,Rv3254 RVBD_3254 P425_03394,GO:0005506; GO:0005618; GO:0005829; GO:0005886; GO:0009228; GO:0052837,IPR036188; ,,,,Uncharacterized protein Rv3254,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; iron ion binding [GO:0005506]; thiamine biosynthetic process [GO:0009228]; thiazole biosynthetic process [GO:0052837],9634230; 21969609,,,MTGRVGNPKDHAVVIGASIAGLCAARVLSDFYSTVTVFERDELPEAPANRATVPQDRHLHMLMARGAQEFDSLFPGLLHDMVAAGVPMLENRPDCIYLGAAGHVLGTGHTLRKEFTAYVPSRPHLEWQLRRRVLQLSNVQIVRRLVTEPQFERRQQRVVGVLLDSPGSGQDREREEFIAADLVVDAAGRGTRLPVWLTQWGYRRPAEDTVDIGISYASHQFRIPDGLIAEKVVVAGASHDQSLGLGMLCYEDGTWVLTTFGVADAKPPPTFDEMRALADKLLPARFTAALAQAQPIGCPAFHAFPASRWRRYDKLERFPRGIVPFGDAVASFNPTFGQGMTMTSLQAGHLRRALKARNSAMKGDLAAELNRATAKTTYPVWMMNAIGDISFHHATAEPLPRWWRPAGSLFDQFLGAAETDPVLAEWFLRRFSLLDSLYMVPSVPIIGRAIAHNLRLWLKEQRERRQPVTTRRSP,"52,783",474,,thiamine biosynthetic process [GO:0009228]; thiazole biosynthetic process [GO:0052837],iron ion binding [GO:0005506],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,P425_03394,4
P9WGC3,Y3284_MYCTU,Rv3284,Rv3284 MTCY71.24,,IPR003808; ,,,,Uncharacterized SufE-like protein Rv3284,,9634230; 19099550; 21969609,,,MTAPASLPAPLAEVVSDFAEVQGQDKLRLLLEFANELPALPSHLAESAMEPVPECQSPLFLHVDASDPNRVRLHFSAPAEAPTTRGFASILAAGLDEQPAADILAVPEDFYTELGLAALISPLRLRGMSAMLARIKRRLREAD,"15,395",143,SufE family,,,,,MTCY71.24,1
P9WF13,VPB46_MYCTU,Rv3385c,vapB46 Rv3385c,GO:0045927,IPR006442; IPR036165; ,,vapB46,,Antitoxin VapB46,positive regulation of growth [GO:0045927],9634230; 20011113; 21969609,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC46. {ECO:0000269|PubMed:20011113}.,MTPTACATVSTMTSVGVRALRQRASELLRRVEAGETIEITDRGRPVALLSPLPQGGPYEQLLASGEIERATLDVVDLPEPLDLDAGVELPSVTLARLREHER,"11,031",102,PhD/YefM antitoxin family,positive regulation of growth [GO:0045927],,,,,1
P9WMP9,UVRD2_MYCTU,Rv3198c,uvrD2 Rv3198c MTV014.42c,GO:0000287; GO:0003677; GO:0003678; GO:0004003; GO:0005524; GO:0005622; GO:0006281; GO:0008094; GO:0040007,IPR013986; IPR014017; IPR000212; IPR010997; IPR002121; IPR027417; IPR014016; IPR034739; ,,uvrD2,DOMAIN 10 301 UvrD-like helicase ATP-binding. {ECO:0000255|PROSITE-ProRule:PRU00560}.; DOMAIN 302 553 UvrD-like helicase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU00617}.; DOMAIN 626 700 HRDC. {ECO:0000255|PROSITE-ProRule:PRU00328}.,ATP-dependent DNA helicase UvrD2 (EC 3.6.4.12),intracellular [GO:0005622]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA-dependent ATPase activity [GO:0008094]; magnesium ion binding [GO:0000287]; DNA repair [GO:0006281]; growth [GO:0040007],9634230; 19766723; 21725019; 21969609,,"FUNCTION: DNA-dependent ATPase, stimulated equally by ss-and dsDNA. Has both ATPase and helicase activities, and translocates along ssDNA displacing bound streptavidin. Its essentiality for growth does not depend on its helicase activity. {ECO:0000269|PubMed:19766723, ECO:0000269|PubMed:21725019}.",MSIASDPLIAGLDDQQREAVLAPRGPVCVLAGAGTGKTRTITHRIASLVASGHVAAGQVLAVTFTQRAAGEMRSRLRALDAAARTGSGVGAVQALTFHAAAYRQLRYFWSRVIADTGWQLLDSKFAVVARAASRTRLHASTDDVRDLAGEIEWAKASLIGPEEYVTAVAAARRDPPLDAAQIAAVYSEYEALKARGDGVTLLDFDDLLLHTAAAIENDAAVAEEFQDRYRCFVVDEYQDVTPLQQRVLSAWLGDRDDLTVVGDANQTIYSFTGASPRFLLDFSRRFPDAAVVRLERDYRSTPQVVSLANRVIAAARGRVAGSKLRLSGQREPGPVPSFHEHSDEPAEAATVAASIARLIASGTPPSEVAILYRVNAQSEVYEEALTQAGIAYQVRGGEGFFNRQEIKQALLALQRVSERDTDAALSDVVRAVLAPLGLTAQPPVGTRARERWEALTALAELVDDELAQRPALQLPGLLAELRRRAEARHPPVVQGVTLASLHAAKGLEWDAVFLVGLADGTLPISHALAHGPNSEPVEEERRLLYVGITRARVHLALSWALSRSPGGRQSRKPSRFLNGIAPQTRADPVPGTSRRNRGAAARCRICNNELNTSAAVMLRRCETCAADVDEELLLQLKSWRLSTAKEQNVPAYVVFTDNTLIAIAELLPTDDAALIAIPGIGARKLEQYGSDVLQLVRGRT,"75,604",700,"Helicase family, UvrD subfamily",DNA repair [GO:0006281]; growth [GO:0040007],ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; DNA helicase activity [GO:0003678]; magnesium ion binding [GO:0000287],intracellular [GO:0005622],,MTV014.42c,1
P9WKH1,EFPP_MYCTU,Rv3398c,Rv3398c MTCY78.30,GO:0000287; GO:0004161; GO:0004337; GO:0005506; GO:0005737; GO:0016126; GO:0030145; GO:0033384; GO:0033386; GO:0040007; GO:0045337,IPR008949; IPR000092; IPR033749; ,,,,"(2E,6E)-farnesyl diphosphate synthase (E,E-FPP synthase) (FPP synthase) (EC 2.5.1.10)",cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; iron ion binding [GO:0005506]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; growth [GO:0040007]; sterol biosynthetic process [GO:0016126],9634230; 15060088; 21969609,,"FUNCTION: Catalyzes the condensation of isopentenyl pyrophosphate (IPP) with geranyl diphosphate (GPP) to yield (2E,6E)-farnesyl diphosphate (E,E-FPP). May be used for squalene and possibly sterol biosynthesis. {ECO:0000269|PubMed:15060088}.",MRGTDEKYGLPPQPDSDRMTRRTLPVLGLAHELITPTLRQMADRLDPHMRPVVSYHLGWSDERGRPVNNNCGKAIRPALVFVAAEAAGADPHSAIPGAVSVELVHNFSLVHDDLMDRDEHRRHRPTVWALWGDAMALLAGDAMLSLAHEVLLDCDSPHVGAALRAISEATRELIRGQAADTAFESRTDVALDECLKMAEGKTAALMAASAEVGALLAGAPRSVREALVAYGRHIGLAFQLVDDLLGIWGRPEITGKPVYSDLRSRKKTLPVTWTVAHGGSAGRRLAAWLVDETGSQTASDDELAAVAELIECGGGRRWASAEARRHVTQGIDMVARIGIPDRPAAELQDLAHYIVDRQA,"38,852",359,FPP/GGPP synthase family,farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; growth [GO:0040007]; sterol biosynthetic process [GO:0016126],dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; iron ion binding [GO:0005506]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145],cytoplasm [GO:0005737],,MTCY78.30,1
P9WHY3,PPE51_MYCTU,Rv3136,PPE51 Rv3136,GO:0005618,IPR022171; IPR000030; IPR038332; ,,PPE51,,Uncharacterized PPE family protein PPE51,cell wall [GO:0005618],9634230; 21969609,,,MDFALLPPEVNSARMYTGPGAGSLLAAAGGWDSLAAELATTAEAYGSVLSGLAALHWRGPAAESMAVTAAPYIGWLYTTAEKTQQTAIQARAAALAFEQAYAMTLPPPVVAANRIQLLALIATNFFGQNTAAIAATEAQYAEMWAQDAAAMYGYATASAAAALLTPFSPPRQTTNPAGLTAQAAAVSQATDPLSLLIETVTQALQALTIPSFIPEDFTFLDAIFAGYATVGVTQDVESFVAGTIGAESNLGLLNVGDENPAEVTPGDFGIGELVSATSPGGGVSASGAGGAASVGNTVLASVGRANSIGQLSVPPSWAAPSTRPVSALSPAGLTTLPGTDVAEHGMPGVPGVPVAAGRASGVLPRYGVRLTVMAHPPAAG,"37,980",380,Mycobacterial PPE family,,,cell wall [GO:0005618],,,1
Q6MWY2,PPE54_MYCTU,Rv3343c,PPE54 Rv3343c,GO:0040007; GO:0052170,IPR002989; IPR000030; IPR038332; ,,PPE54,,Uncharacterized PPE family protein PPE54,growth [GO:0040007]; negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 19099550; 20844580,,FUNCTION: Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000305|PubMed:20844580}.,MSFVVMPPEINSLLIYTGAGPGPLLAAAAAWDELAAELGSAAAAFGSVTSGLVGGIWQGPSSVAMAAAAAPYAGWLSAAAASAESAAGQARAVVGVFEAALAETVDPFVIAANRSRLVSLALSNLFGQNTPAIAAAEFDYELMWAQDVAAMLGYHTGASAAAEALAPFGSPLASLAAAAEPAKSLAVNLGLANVGLFNAGSGNVGSYNVGAGNVGSYNVGGGNIGGNNVGLGNVGWGNFGLGNSGLTPGLMGLGNIGFGNAGSYNFGLANMGVGNIGFANTGSGNFGIGLTGDNLTGFGGFNTGSGNVGLFNSGTGNVGFFNSGTGNWGVFNSGSYNTGIGNSGIASTGLFNAGGFNTGVVNAGSYNTGSFNAGEANTGGFNPGSVNTGWLNTGDINTGVANSGDVNTGAFISGNYSNGVLWRGDYQGLLGFSSGANVLPVIPLSLDINGGVGAITIEPIHILPDIPININETLYLGPLVVPPINVPAISLGVGIPNISIGPIKINPITLWPAQNFNQTITLAWPVSSITIPQIQQVALSPSPIPTTLIGPIHINTGFSIPVTFSYSTPALTLFPVGLSIPTGGPLTLTLGVTAGTEAFTIPGFSIPEQPLPLAINVIGHINALSTPAITIDNIPLNLHAIGGVGPVDIVGGNVPASPGFGNSTTAPSSGFFNTGAGGVSGFGNVGAHTSGWFNQSTQAMQVLPGTVSGYFNSGTLMSGIGNVGTQLSGMLSGGALGGNNFGLGNIGFDNVGFGNAGSSNFGLANMGIGNIGLANTGNGNIGIGLSGDNLTGFGGFNSGSENVGLFNSGTGNVGFFNSGTGNLGVFNSGSHNTGFFLTGNNINVLAPFTPGTLFTISEIPIDLQVIGGIGPIHVQPIDIPAFDIQITGGFIGIREFTLPEITIPAIPIHVTGTVGLEGFHVNPAFVLFGQTAMAEITADPVVLPDPFITIDHYGPPLGPPGAKFPSGSFYLSISDLQINGPIIGSYGGPGTIPGPFGATFNLSTSSLALFPAGLTVPDQTPVTVNLTGGLDSITLFPGGLAFPENPVVSLTNFSVGTGGFTVFPQGFTVDRIPVDLHTTLSIGPFPFRWDYIPPTPANGPIPAVPGGFGLTSGLFPFHFTLNGGIGPISIPTTTVVDALNPLLTVTGNLEVGPFTVPDIPIPAINFGLDGNVNVSFNAPATTLLSGLGITGSIDISGIQITNIQTQPAQLFMSVGQTLFLFDFRDGIELNPIVIPGSSIPITMAGLSIPLPTVSESIPLNFSFGSPASTVKSMILHEILPIDVSINLEDAVFIPATVLPAIPLNVDVTIPVGPINIPIITEPGSGNSTTTTSDPFSGLAVPGLGVGLLGLFDGSIANNLISGFNSAVGIVGPNVGLSNLGGGNVGLGNVGDFNLGAGNVGGFNVGGGNIGGNNVGLGNVGFGNVGLANSGLTPGLMGLGNIGFGNAGSYNFGLANMGVGNIGFANTGSGNFGIGLTGDNLTGFGGFNTGSGNVGLFNSGTGNVGFFNSGTGNWGVFNSGSYNTGIGNSGIASTGLFNAGGFNTGVVNAGSYNTGSFNAGQANTGGFNPGSVNTGWLNTGDINTGVANSGDVNTGAFISGNYSNGAFWRGDYQGLLGFSYRPAVLPQTPFLDLTLTGGLGSVVIPAIDIPAIRPEFSANVAIDSFTVPSIPIPQIDLAATTVSVGLGPITVPHLDIPRVPVTLNYLFGSQPGGPLKIGPITGLFNTPIGLTPLALSQIVIGASSSQGTITAFLANLPFSTPVVTIDEIPLLASITGHSEPVDIFPGGLTIPAMNPLSINLSGGTGAVTIPAITIGEIPFDLVAHSTLGPVHILIDLPAVPGFGNTTGAPSSGFFNSGAGGVSGFGNVGAMVSGGWNQAPSALLGGGSGVFNAGTLHSGVLNFGSGMSGLFNTSVLGLGAPALVSGLGSVGQQLSGLLASGTALHQGLVLNFGLADVGLGNVGLGNVGDFNLGAGNVGGFNVGGGNIGGNNVGLGNVGWGNFGLGNSGLTPGLMGLGNIGFGNAGSYNFGLANMGVGNIGFANTGSGNFGIGLTGDNLTGFGGFNTGSGNVGLFNSGTGNVGFFNSGTGNWGVFNSGSYNTGIGNSGIASTGLFNAGGFNTGVVNAGSYNTGSFNAGQANTGGFNPGSVNTGWLNTGDINTGVANSGDVNTGAFISGNYSNGAFWRGDYQGLLGFSYTSTIIPEFTVANIHASGGAGPIIVPSIQFPAIPLDLSATGHIGGFTIPPVSISPITVRIDPVFDLGPITVQDITIPALGLDPATGVTVGPIFSSGSIIDPFSLTLLGFINVNVPAIQTAPSEILPFTVLLSSLGVTHLTPEITIPGFHIPVDPIHVELPLSVTIGPFVSPEITIPQLPLGLALSGATPAFAFPLEITIDRIPVVLDVNALLGPINAGLVIPPVPGFGNTTAVPSSGFFNIGGGGGLSGFHNLGAGMSGVLNAISDPLLGSASGFANFGTQLSGILNRGADISGVYNTGALGLITSALVSGFGNVGQQLAGLIYTGTGP,"250,346",2523,Mycobacterial PPE family,growth [GO:0040007]; negative regulation by symbiont of host innate immune response [GO:0052170],,,,,1
Q6MX07,PPE50_MYCTU,Rv3135,PPE50 Rv3135,GO:0040007,IPR000030; IPR038332; ,,PPE50,,Uncharacterized PPE family protein PPE50,growth [GO:0040007],9634230; 19099550; 21969609,,,MDYAFLPPEINSARMYSGPGPNSMLVAAASWDALAAELASAAENYGSVIARLTGMHWWGPASTSMLAMSAPYVEWLERTAAQTKQTATQARAAAAAFEQAHAMTVPPALVTGIRGAIVVETASASNTAGTPP,"13,667",132,Mycobacterial PPE family,growth [GO:0040007],,,,,1
Q50702,PPE58_MYCTU,Rv3426,PPE58 Rv3426 MTCY78.03c,GO:0005886,IPR000030; IPR038332; ,,PPE58,,Uncharacterized PPE family protein PPE58,plasma membrane [GO:0005886],9634230,,,MHLMIPAEYISNVIYEGPRADSLYAADQRLRQLADSVRTTAESLNTTLDELHENWKGSSSEWMADAALRYLDWLSKHSRQILRTARVIESLVMAYEETLLRVVPPATIANNREEVRRLIASNVAGGKHSSNRRPRGTIRAVPGRKYPSNGPLSKLDPICAIEAAPMAGAAADPQERVGPRGRRGLAGQQQCRGRPGPSLRCSHDTPRFQMNQAFHTMVNMLLTCFACQEKPR,"25,873",232,Mycobacterial PPE family,,,plasma membrane [GO:0005886],,MTCY78.03c,1
P9WHY5,PPE49_MYCTU,Rv3125c,PPE49 Rv3125c,,IPR022171; IPR000030; IPR038332; ,,PPE49,,Uncharacterized PPE family protein PPE49,,9634230,,,MVLGFSWLPPEINSARMFAGAGSGPLFAAASAWEGLAADLWASASSFESVLAALTTGPWTGPASMSMAAAASPYVGWLSTVASQAQLAAIQARAAATAFEAALAATVHPTAVTANRVSLASLIAANVLGQNTPAIAATEFDYLEMWAQDVAAMVGYHAGAKSVAATLAPFSLPPVSLAGLAAQVGTQVAGMATTASAAVTPVVEGAMASVPTVMSGMQSLVSQLPLQHASMLFLPVRILTSPITTLASMARESATRLGPPAGGLAAANTPNPSGAAIPAFKPLGGRELGAGMSAGLGQAQLVGSMSVPPTWQGSIPISMASSAMSGLGVPPNPVALTQAAGAAGGGMPMMLMPMSISGAGAGMPGGLMDRDGAGWHVTQARLTVIPRTGVG,"38,586",391,Mycobacterial PPE family,,,,,,1
Q50703,PPE57_MYCTU,Rv3425,PPE57 Rv3425 MTCY78.04c,GO:0005576; GO:0005618; GO:0009405; GO:0009986,IPR000030; IPR038332; ,,PPE57,,PPE family protein PPE57,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 17328725; 18426397; 19467342; 23136116; 25586105,,"FUNCTION: Plays a key role in regulating innate and adaptive immune responses through human Toll-like receptor 2 (TLR2). Interacts with TLR2, leading to the subsequent activation of the mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-kappa-B) signaling pathways. Induces macrophage activation by augmenting the expression of several cell surface molecules (CD40, CD80, CD86 and MHC class II) and pro-inflammatory cytokines (TNF-alpha, IL-6 and IL-12p40) within macrophages. Also participates in adaptive immunity by directing Th1-polarised immune responses (PubMed:25586105). Stimulates specific humoral and cellular immune responses in tuberculosis (TB) patients (PubMed:17328725, PubMed:19467342, PubMed:23136116). Induces a strong IgG(1) antibody response and an increased Th1/Th2 type immune response in mice (PubMed:18426397). {ECO:0000269|PubMed:17328725, ECO:0000269|PubMed:18426397, ECO:0000269|PubMed:19467342, ECO:0000269|PubMed:23136116, ECO:0000269|PubMed:25586105}.",MHPMIPAEYISNIIYEGPGADSLFFASGQLRELAYSVETTAESLEDELDELDENWKGSSSDLLADAVERYLQWLSKHSSQLKHAAWVINGLANAYNDTRRKVVPPEEIAANREERRRLIASNVAGVNTPAIADLDAQYDQYRARNVAVMNAYVSWTRSALSDLPRWREPPQIYRGG,"19,855",176,Mycobacterial PPE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY78.04c,1
P9WHY1,PPE59_MYCTU,Rv3429,PPE59 Rv3429 MTCY77.01,,IPR000030; IPR038332; ,,PPE59,,Uncharacterized PPE family protein PPE59,,9634230,,,MHPMIPAEYISNIIYEGPGADSLSAAAEQLRLMYNSANMTAKSLTDRLGELQENWKGSSSDLMADAAGRYLDWLTKHSRQILETAYVIDFLAYVYEETRHKVVPPATIANNREEVHRLIASNVAGVNTPAIAGLDAQYQQYRAQNIAVMNDYQSTARFILAYLPRWQEPPQIYGGGGG,"19,811",178,Mycobacterial PPE family,,,,,MTCY77.01,1
P9WGM7,MTRA_MYCTU,Rv3246c,mtrA Rv3246c MTCY20B11.21c,GO:0000160; GO:0003677; GO:0005737; GO:0005886; GO:0006351; GO:0006468; GO:0044117; GO:0045893; GO:0046872,IPR011006; IPR001867; IPR001789; IPR036388; ,,mtrA,DOMAIN 7 120 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,DNA-binding response regulator MtrA,"cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; growth of symbiont in host [GO:0044117]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; transcription, DNA-templated [GO:0006351]",8655513; 9634230; 10851001; 16629667; 20671191; 20223818; 20066036; 21969609; 21295603; 22610443; 17511470; 20702407,X-ray crystallography (2),"FUNCTION: Member of the two-component regulatory system MtrA/MtrB. Binds direct repeat motifs of sequence 5'-GTCACAGCG-3', phosphorylation confers higher affinity. Overexpression decreases bacteria viability upon infection of human THP-1 macrophage cell line, due at least in part to impaired blockage of phagosome-lysosome fusion (upon infection bacteria usually remain in phagosomes). Infecting C57BL/6 mice with an overexpressing strain leads to an attentuated infection in both spleen and lungs. The level of dnaA mRNA increases dramatically. Binds the promoter of dnaA, fbpD, ripA and itself, as well as oriC, which it may regulate. Upon co-overexpression of MrtA and MtrB growth in macrophages is partially restored, dnaA expression is not induced, although mouse infections are still attenuated, suggesting that bacterial growth in macrophages requires an optimal ratio of MtrB to MtrA. {ECO:0000269|PubMed:20223818, ECO:0000269|PubMed:21295603, ECO:0000269|PubMed:22610443}.",MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLPGMNGIDVCRVLRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEMLSIADVEIDVPAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQRLRAKVEKDPENPTVVLTVRGVGYKAGPP,"25,279",228,,"growth of symbiont in host [GO:0044117]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; metal ion binding [GO:0046872],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY20B11.21c,1
P9WGK9,MTRB_MYCTU,Rv3245c,mtrB Rv3245c MTCY20B11.20c,GO:0000155; GO:0005524; GO:0005829; GO:0005886; GO:0016021; GO:0040007,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,mtrB,DOMAIN 235 287 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 302 519 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Sensor histidine kinase MtrB (EC 2.7.13.3),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; growth [GO:0040007],8655513; 9634230; 10851001; 16629667; 19099550; 20233304; 21969609; 21295603; 22610443,,"FUNCTION: Member of the two-component regulatory system MtrA/MtrB. Probably functions as a membrane-associated protein kinase that phosphorylates MtrA in response to environmental signals. Autophosphorylates and transfers phosphate to MtrA in vitro. Overexpression of MtrA alone decreases bacterial virulence in mouse infection; co-expression of MtrA and MtrB restores normal bacterial growth, suggesting that bacterial growth in macrophages requires an optimal ratio of MtrB to MtrA. Probably plays a role in cell division. {ECO:0000269|PubMed:21295603, ECO:0000269|PubMed:22610443}.",MIFGSRRRIRGRRGRSGPMTRGLSALSRAVAVAWRRSLQLRVVALTLGLSLAVILALGFVLTSQVTNRVLDIKVRAAIDQIERARTTVSGIVNGEETRSLDSSLQLARNTLTSKTDPASGAGLAGAFDAVLMVPGDGPRAASTAGPVDQVPNALRGFVKAGQAAYQYATVQTEGFSGPALIIGTPTLSRVANLELYLIFPLASEQATITLVRGTMATGGLVLLVLLAGIALLVSRQVVVPVRSASRIAERFAEGHLSERMPVRGEDDMARLAVSFNDMAESLSRQIAQLEEFGNLQRRFTSDVSHELRTPLTTVRMAADLIYDHSADLDPTLRRSTELMVSELDRFETLLNDLLEISRHDAGVAELSVEAVDLRTTVNNALGNVGHLAEEAGIELLVDLPAEQVIAEVDARRVERILRNLIANAIDHAEHKPVRIRMAADEDTVAVTVRDYGVGLRPGEEKLVFSRFWRSDPSRVRRSGGTGLGLAISVEDARLHQGRLEAWGEPGEGACFRLTLPMVRGHKVTTSPLPMKPIPQPVLQPVAQPNPQPMPPEYKERQRPREHAEWSG,"61,637",567,,growth [GO:0040007],ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY20B11.20c,1
O05797,MOAR1_MYCTU,Rv3124,moaR1 Rv3124,GO:0000160; GO:0003677; GO:0005622; GO:0006351; GO:0006355; GO:0032324,IPR005158; IPR001867; IPR016032; IPR011990; IPR036388; ,,moaR1,,Transcriptional regulatory protein MoaR1 (Molybdopterin biosynthesis positive regulator),"intracellular [GO:0005622]; DNA binding [GO:0003677]; molybdopterin cofactor biosynthetic process [GO:0032324]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 15207493; 20378651,,"FUNCTION: Acts as a positive transcriptional regulator of the molybdopterin biosynthesis moa1 locus, promoting the expression of the moaA1B1C1D1 genes. Binds directly to the moaA1 promoter. {ECO:0000269|PubMed:20378651}.",MGQRPFSPNHRSGVLNATTAGAVQFNVLGPLELNLRGTKLPLGTPKQRAVLAMLLLSRNQVVAADALVQAIWEKSPPARARRTVHTYICNLRRTLSDAGVDSRNILVSEPPGYRLLIGDRQQCDLDRFVAAKESGLRASAKGYFSEAIRYLDSALQNWRGPVLGDLRSFMFVQMFSRALTEDELLVHTKLAEAAIACGRADVVIPKLERLVAMHPYRESLWKQLMLGYYVNEYQSAAIDAYHRLKSTLAEELGVEPAPTIRALYHKILRQLPMDDLVGRVTRGRVDLRGGNGAKVEELTESDKDLLPIGLA,"34,525",311,AfsR/DnrI/RedD regulatory family,"molybdopterin cofactor biosynthetic process [GO:0032324]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],intracellular [GO:0005622],,,4
I6YC58,MYCP4_MYCTU,Rv3449,mycP4 Rv3449 LH57_18835,GO:0004252; GO:0005886; GO:0016021,IPR000209; IPR036852; IPR023827; IPR022398; IPR023828; IPR015500; IPR023834; ,,mycP4,DOMAIN 86 389 Peptidase S8. {ECO:0000255}.,Mycosin-4 (EC 3.4.21.-) (MycP4 protease),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252],9634230; 10974545,,,MTTSRTLRLLVVSALATLSGLGTPVAHAVSPPPIDERWLPESALPAPPRPTVQREVCTEVTAESGRAFGRAERSAQLADLDQVWRLTRGAGQRVAVIDTGVARHRRLPKVVAGGDYVFTGDGTADCDAHGTLVAGIIAAAPDAQSDNFSGVAPDVTLISIRQSSSKFAPVGDPSSTGVGDVDTMAKAVRTAADLGASVINISSIACVPAAAAPDDRALGAALAYAVDVKNAVIVAAAGNTGGAAQCPPQAPGVTRDSVTVAVSPAWYDDYVLTVGSVNAQGEPSAFTLAGPWVDVAATGEAVTSLSPFGDGTVNRLGGQHGSIPISGTSYAAPVVSGLAALIRARFPTLTARQVMQRIESTAHHPPAGWDPLVGNGTVDALAAVSSDSIPQAGTATSDPAPVAVPVPRRSTPGPSDRRALHTAFAGAAICLLALMATLATASRRLRPGRNGIAGD,"46,016",455,Peptidase S8 family,,serine-type endopeptidase activity [GO:0004252],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_18835,1
P9WMN7,MOEZ_MYCTU,Rv3206c,moeZ moeB1 Rv3206c,GO:0005524; GO:0005618; GO:0005829; GO:0006535; GO:0008146; GO:0008641; GO:0016021; GO:0016779; GO:0016782; GO:0019344; GO:0042783,IPR001763; IPR036873; IPR000594; IPR035985; ,,moeZ,DOMAIN 300 390 Rhodanese. {ECO:0000255|PROSITE-ProRule:PRU00173}.,Probable adenylyltransferase/sulfurtransferase MoeZ [Includes: Sulfur carrier protein CysO adenylyltransferase (EC 2.7.7.-); Sulfur carrier protein CysO sulfurtransferase (EC 2.8.1.-)],"cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfotransferase activity [GO:0008146]; transferase activity, transferring sulfur-containing groups [GO:0016782]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; active evasion of host immune response [GO:0042783]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]",9634230; 12123450; 16104727; 21969609,,"FUNCTION: Catalyzes the conversion of the sulfur carrier protein CysO to CysO-thiocarboxylate. The reaction is thought to proceed in two steps: first, ATP-dependent activation of CysO as acyl-adenylate (CysO-COOAMP), followed by sulfur transfer to give CysO-thiocarboxylate (CysO-COSH) (Probable). The sulfur source is unknown. {ECO:0000269|PubMed:16104727, ECO:0000305}.",MSTSLPPLVEPASALSREEVARYSRHLIIPDLGVDGQKRLKNARVLVIGAGGLGAPTLLYLAAAGVGTIGIVDFDVVDESNLQRQVIHGVADVGRSKAQSARDSIVAINPLIRVRLHELRLAPSNAVDLFKQYDLILDGTDNFATRYLVNDAAVLAGKPYVWGSIYRFEGQASVFWEDAPDGLGVNYRDLYPEPPPPGMVPSCAEGGVLGIICASVASVMGTEAIKLITGIGETLLGRLLVYDALEMSYRTITIRKDPSTPKITELVDYEQFCGVVADDAAQAAKGSTITPRELRDWLDSGRKLALIDVRDPVEWDIVHIDGAQLIPKSLINSGEGLAKLPQDRTAVLYCKTGVRSAEALAAVKKAGFSDAVHLQGGIVAWAKQMQPDMVMY,"42,173",392,HesA/MoeB/ThiF family,active evasion of host immune response [GO:0042783]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535],"ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfotransferase activity [GO:0008146]; transferase activity, transferring sulfur-containing groups [GO:0016782]; ubiquitin-like modifier activating enzyme activity [GO:0008641]",cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021],moeB1,,1
P9WKE1,KTHY_MYCTU,Rv3247c,tmk Rv3247c,GO:0000287; GO:0004798; GO:0005524; GO:0005525; GO:0005737; GO:0006227; GO:0006233; GO:0006235; GO:0009041; GO:0042803; GO:0046044,IPR027417; IPR018095; IPR018094; ,,tmk,,Thymidylate kinase (EC 2.7.4.9) (Thymidine monophosphate kinase) (dTMP kinase) (TMPK),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; TMP metabolic process [GO:0046044],9634230; 11369858; 10666613; 19099550; 21969609; 11469859; 11914484; 12454011; 12662932; 15628853,X-ray crystallography (18),"FUNCTION: Catalyzes the reversible phosphorylation of deoxythymidine monophosphate (dTMP) to deoxythymidine diphosphate (dTDP), using ATP as its preferred phosphoryl donor. Situated at the junction of both de novo and salvage pathways of deoxythymidine triphosphate (dTTP) synthesis, is essential for DNA synthesis and cellular growth. Has a broad specificity for nucleoside triphosphates, being highly active with ATP or dATP as phosphate donors, and less active with ITP, GTP, CTP and UTP.",MLIAIEGVDGAGKRTLVEKLSGAFRAAGRSVATLAFPRYGQSVAADIAAEALHGEHGDLASSVYAMATLFALDRAGAVHTIQGLCRGYDVVILDRYVASNAAYSAARLHENAAGKAAAWVQRIEFARLGLPKPDWQVLLAVSAELAGERSRGRAQRDPGRARDNYERDAELQQRTGAVYAELAAQGWGGRWLVVGADVDPGRLAATLAPPDVPS,"22,635",214,Thymidylate kinase family,dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; TMP metabolic process [GO:0046044],ATP binding [GO:0005524]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041],cytoplasm [GO:0005737],,,1
P9WQ77,LAT_MYCTU,Rv3290c,lat Rv3290c MTCY71.30,GO:0017000; GO:0030170; GO:0045484,IPR005814; IPR017657; IPR015424; IPR015422; IPR015421; ,,lat,,Probable L-lysine-epsilon aminotransferase (L-lysine aminotransferase) (EC 2.6.1.36) (Lysine 6-aminotransferase),L-lysine 6-transaminase activity [GO:0045484]; pyridoxal phosphate binding [GO:0030170]; antibiotic biosynthetic process [GO:0017000],9634230; 19099550; 21969609,X-ray crystallography (8),,MAAVVKSVALAGRPTTPDRVHEVLGRSMLVDGLDIVLDLTRSGGSYLVDAITGRRYLDMFTFVASSALGMNPPALVDDREFHAELMQAALNKPSNSDVYSVAMARFVETFARVLGDPALPHLFFVEGGALAVENALKAAFDWKSRHNQAHGIDPALGTQVLHLRGAFHGRSGYTLSLTNTKPTITARFPKFDWPRIDAPYMRPGLDEPAMAALEAEALRQARAAFETRPHDIACFVAEPIQGEGGDRHFRPEFFAAMRELCDEFDALLIFDEVQTGCGLTGTAWAYQQLDVAPDIVAFGKKTQVCGVMAGRRVDEVADNVFAVPSRLNSTWGGNLTDMVRARRILEVIEAEGLFERAVQHGKYLRARLDELAADFPAVVLDPRGRGLMCAFSLPTTADRDELIRQLWQRAVIVLPAGADTVRFRPPLTVSTAEIDAAIAAVRSALPVVT,"49,012",449,Class-III pyridoxal-phosphate-dependent aminotransferase family,antibiotic biosynthetic process [GO:0017000],L-lysine 6-transaminase activity [GO:0045484]; pyridoxal phosphate binding [GO:0030170],,,MTCY71.30,1
O06350,LIPF_MYCTU,Rv3487c,lipF Rv3487c,GO:0004629; GO:0008152; GO:0010447; GO:0044119; GO:0052572; GO:0052689,IPR029058; IPR013094; IPR033140; ,,lipF,,Carboxylesterase LipF (EC 3.1.1.1),carboxylic ester hydrolase activity [GO:0052689]; phospholipase C activity [GO:0004629]; growth of symbiont in host cell [GO:0044119]; metabolic process [GO:0008152]; response to acidic pH [GO:0010447]; response to host immune response [GO:0052572],9634230; 10564470; 15939293; 21969609,,FUNCTION: Hydrolyzes short-chain esters. Shows maximal activity with triacetin and p-nitrophenyl acetate. {ECO:0000269|PubMed:15939293}.,MRAPGVRAADGAGRVVLYLHGGAFVMCGPNSHSRIVNALSGFAESPVLIVDYRLIPKHSLGMALDDCHDAYQWLRARGYRPEQIVLAGDSAGGYLALALAQRLQCDDEKPAAIVAISPLLQLAKGPKQDHPNIGTDAMFPARAFDALAAWVRAAAAKNMVDGRPEDLYEPLDHIESSLPPTLIHVSGSEVLLHDAQLGAGKLAAAGVCAEVRVWPGQAHLFQLATPLVPEATRSLRQIGQFIRDATADSSLSPVHRSRYVAGSPRAASRGAFGQSPI,"29,430",277,'GDXG' lipolytic enzyme family,growth of symbiont in host cell [GO:0044119]; metabolic process [GO:0008152]; response to acidic pH [GO:0010447]; response to host immune response [GO:0052572],carboxylic ester hydrolase activity [GO:0052689]; phospholipase C activity [GO:0004629],,,,3
P9WJH3,NUOC_MYCTU,Rv3147,nuoC Rv3147 MTCY03A2.11c,GO:0005829; GO:0005886; GO:0008137; GO:0045333; GO:0048038,IPR010218; IPR037232; IPR001268; ,,nuoC,,NADH-quinone oxidoreductase subunit C (EC 1.6.5.11) (NADH dehydrogenase I subunit C) (NDH-1 subunit C),cytosol [GO:0005829]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; cellular respiration [GO:0045333],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01357}.",MSPPNQDAQEGRPDSPTAEVVDVRRGMFGVSGTGDTSGYGRLVRQVVLPGSSPRPYGGYFDDIVDRLAEALRHERVEFEDAVEKVVVYRDELTLHVRRDLLPRVAQRLRDEPELRFELCLGVSGVHYPHETGRELHAVYPLQSITHNRRLRLEVSAPDSDPHIPSLFAIYPTNDWHERETYDFFGIIFDGHPALTRIEMPDDWQGHPQRKDYPLGGIPVEYKGAQIPPPDERRGYN,"26,932",236,Complex I 30 kDa subunit family,cellular respiration [GO:0045333],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY03A2.11c,1
P9WIW5,NUOM_MYCTU,Rv3157,nuoM Rv3157 MTCY03A2.01c MTV014.01c,GO:0005886; GO:0008137; GO:0016021; GO:0042773; GO:0048038,IPR010227; IPR003918; IPR001750; ,,nuoM,,NADH-quinone oxidoreductase subunit M (EC 1.6.5.11) (NADH dehydrogenase I subunit M) (NDH-1 subunit M),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient (By similarity). {ECO:0000250}.",MNNVPWLSVLWLVPLAGAVLIILLPPGRRRLAKWAGMVVSVLTLAVSIVVAAEFKPSAEPYQFVEKHSWIPAFGAGYTLGVDGIAVVLVLLTTVLIPLLLVAGWNDATDADDLSPASGRYPQRPAPPRLRSSGGERTRGVHAYVALTLAIESMVLMSVIALDVLLFYVFFEAMLIPMYFLIGGFGQGAGRSRAAVKFLLYNLFGGLIMLAAVIGLYVVTAQYDSGTFDFREIVAGVAAGRYGADPAVFKALFLGFMFAFAIKAPLWPFHRWLPDAAVESTPATAVLMMAVMDKVGTFGMLRYCLQLFPDPSTYFRPLIVTLAIIGVIYGAIVAIGQTDMMRLIAYTSISHFGFIIAGIFVMTTQGQSGSTLYMLNHGLSTAAVFLIAGFLIARRGSRSIADYGGVQKVAPILAGTFMVSAMATVSLPGLAPFISEFLVLLGTFSRYWLAAAFGVTALVLSAVYMLWLYQRVMTGPVAEGNERIGDLVGREMIVVAPLIALLLVLGVYPKPVLDIINPAVENTMTTIGQHDPAPSVAHPVPAVGASRTAEGPHP,"59,207",553,Complex I subunit 4 family,ATP synthesis coupled electron transport [GO:0042773],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY03A2.01c MTV014.01c,1
P9WJH1,NUOB_MYCTU,Rv3146,nuoB Rv3146 MTCY03A2.12c,GO:0005886; GO:0008137; GO:0046872; GO:0048038; GO:0051539,IPR006137; IPR006138; ,,nuoB,,NADH-quinone oxidoreductase subunit B (EC 1.6.5.11) (NADH dehydrogenase I subunit B) (NDH-1 subunit B),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01356}.",MGLEEQLPGGILLSTVEKVAGYVRKNSLWPATFGLACCAIEMMATAGPRFDIARFGMERFSATPRQADLMIVAGRVSQKMAPVLRQIYDQMAEPKWVLAMGVCASSGGMFNNYAIVQGVDHVVPVDIYLPGCPPRPEMLLHAILKLHEKIQQMPLGINRERAIAEAEEAALLARPTIEMRGLLR,"20,219",184,Complex I 20 kDa subunit family,,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",plasma membrane [GO:0005886],,MTCY03A2.12c,1
P9WJH5,NUOD_MYCTU,Rv3148,nuoD Rv3148 MTCY03A2.10c,GO:0005886; GO:0016651; GO:0048038; GO:0051287,IPR001135; IPR038290; IPR014029; IPR022885; IPR029014; ,,nuoD,,NADH-quinone oxidoreductase subunit D (EC 1.6.5.11) (NADH dehydrogenase I subunit D) (NDH-1 subunit D),"plasma membrane [GO:0005886]; NAD binding [GO:0051287]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; quinone binding [GO:0048038]",9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01358}.",MTAIADSAGGAGETVLVAGGQDWQQVVDAARSADPGERIVVNMGPQHPSTHGVLRLILEIEGETVVEARCGIGYLHTGIEKNLEYRYWTQGVTFVTRMDYLSPFFNETAYCLGVEKLLGITDEIPERVNVIRVLMMELNRISSHLVALATGGMELGAMTPMFVGFRAREIVLTLFEKITGLRMNSAYIRPGGVAQDLPPNAATEIAEALKQLRQPLREMGELLNENAIWKARTQGVGYLDLTGCMALGITGPILRSTGLPHDLRKSEPYCGYQHYEFDVITDDSCDAYGRYMIRVKEMWESMKIVEQCLDKLRPGPTMISDRKLAWPADLQVGPDGLGNSPKHIAKIMGSSMEALIHHFKLVTEGIRVPAGQVYVAVESPRGELGVHMVSDGGTRPYRVHYRDPSFTNLQSVAAMCEGGMVADLIAAVASIDPVMGGVDR,"48,164",440,Complex I 49 kDa subunit family,,"NAD binding [GO:0051287]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; quinone binding [GO:0048038]",plasma membrane [GO:0005886],,MTCY03A2.10c,1
P9WIV5,NUOE_MYCTU,Rv3149,nuoE Rv3149 MTCY03A2.09c,GO:0008137; GO:0022904; GO:0045272; GO:0046872; GO:0048038; GO:0051537,IPR002023; IPR036249; ,,nuoE,,NADH-quinone oxidoreductase subunit E (EC 1.6.5.11) (NADH dehydrogenase I subunit E) (NDH-1 subunit E),"plasma membrane respiratory chain complex I [GO:0045272]; 2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; respiratory electron transport chain [GO:0022904]",9634230; 20066036; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient (By similarity). {ECO:0000250}.",MTQPPGQPVFIRLGPPPDEPNQFVVEGAPRSYPPDVLARLEVDAKEIIGRYPDRRSALLPLLHLVQGEDSYLTPAGLRFCADQLGLTGAEVSAVASFYTMYRRRPTGEYLVGVCTNTLCAVMGGDAIFDRLKEHLGVGHDETTSDGVVTLQHIECNAACDYAPVVMVNWEFFDNQTPESARELVDSLRSDTPKAPTRGAPLCGFRQTSRILAGLPDQRPDEGQGGPGAPTLAGLQVARKNDMQAPPTPGADE,"27,198",252,Complex I 24 kDa subunit family,respiratory electron transport chain [GO:0022904],"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",plasma membrane respiratory chain complex I [GO:0045272],,MTCY03A2.09c,1
P9WIV7,NUOF_MYCTU,Rv3150,nuoF Rv3150 MTCY03A2.08c,GO:0008137; GO:0010181; GO:0046872; GO:0048038; GO:0051287; GO:0051539,IPR001949; IPR011537; IPR011538; IPR037225; IPR019575; IPR037207; IPR019554; ,,nuoF,,NADH-quinone oxidoreductase subunit F (EC 1.6.5.11) (NADH dehydrogenase I subunit F) (NDH-1 subunit F),"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient (By similarity). {ECO:0000250}.",MTTQATPLTPVISRHWDDPESWTLATYQRHDRYRGYQALQKALTMPPDDVISIVKDSGLRGRGGAGFATGTKWSFIPQGDTGAAAKPHYLVVNADESEPGTCKDIPLMLATPHVLIEGVIIAAYAIRAHHAFVYVRGEVVPVLRRLHNAVAEAYAAGFLGRNIGGSGFDLELVVHAGAGAYICGEETALLDSLEGRRGQPRLRPPFPAVAGLYGCPTVINNVETIASVPSIILGGIDWFRSMGSEKSPGFTLYSLSGHVTRPGQYEAPLGITLRELLDYAGGVRAGHRLKFWTPGGSSTPLLTDEHLDVPLDYEGVGAAGSMLGTKALEIFDETTCVVRAVRRWTEFYKHESCGKCTPCREGTFWLDKIYERLETGRGSHEDIDKLLDISDSILGKSFCALGDGAASPVMSSIKHFRDEYLAHVEGGGCPFDPRDSMLVANGVDA,"48,102",445,Complex I 51 kDa subunit family,,"4 iron, 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]",,,MTCY03A2.08c,1
P9WFZ5,OTSB_MYCTU,Rv3372,otsB otsB2 Rv3372,GO:0000287; GO:0004805; GO:0005829; GO:0005886; GO:0005992; GO:0040007,IPR036412; IPR006379; IPR023214; IPR003337; ,,otsB,,Trehalose-phosphate phosphatase (TPP) (EC 3.1.3.12) (Trehalose-6-phosphate phosphatase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; magnesium ion binding [GO:0000287]; trehalose-phosphatase activity [GO:0004805]; growth [GO:0040007]; trehalose biosynthetic process [GO:0005992],9634230; 15158675; 15703182; 19099550; 21969609,X-ray crystallography (1),"FUNCTION: Removes the phosphate from trehalose 6-phosphate to produce free trehalose. {ECO:0000269|PubMed:15158675, ECO:0000269|PubMed:15703182}.",MRKLGPVTIDPRRHDAVLFDTTLDATQELVRQLQEVGVGTGVFGSGLDVPIVAAGRLAVRPGRCVVVSAHSAGVTAARESGFALIIGVDRTGCRDALRRDGADTVVTDLSEVSVRTGDRRMSQLPDALQALGLADGLVARQPAVFFDFDGTLSDIVEDPDAAWLAPGALEALQKLAARCPIAVLSGRDLADVTQRVGLPGIWYAGSHGFELTAPDGTHHQNDAAAAAIPVLKQAAAELRQQLGPFPGVVVEHKRFGVAVHYRNAARDRVGEVAAAVRTAEQRHALRVTTGREVIELRPDVDWDKGKTLLWVLDHLPHSGSAPLVPIYLGDDITDEDAFDVVGPHGVPIVVRHTDDGDRATAALFALDSPARVAEFTDRLARQLREAPLRAT,"41,720",391,Trehalose phosphatase family,growth [GO:0040007]; trehalose biosynthetic process [GO:0005992],magnesium ion binding [GO:0000287]; trehalose-phosphatase activity [GO:0004805],cytosol [GO:0005829]; plasma membrane [GO:0005886],otsB2,,1
P9WIV9,NUOG_MYCTU,Rv3151,nuoG Rv3151 MTCY03A2.07c,GO:0003954; GO:0005618; GO:0005886; GO:0008137; GO:0009055; GO:0009405; GO:0033668; GO:0042773; GO:0043546; GO:0046872; GO:0048038; GO:0051536; GO:0051537; GO:0051539,IPR036010; IPR001041; IPR009010; IPR006657; IPR006656; IPR006963; IPR000283; IPR010228; IPR019574; ,,nuoG,DOMAIN 15 93 2Fe-2S ferredoxin-type. {ECO:0000255|PROSITE-ProRule:PRU00465}.; DOMAIN 95 134 4Fe-4S His(Cys)3-ligated-type. {ECO:0000255|PROSITE-ProRule:PRU01184}.; DOMAIN 233 289 4Fe-4S Mo/W bis-MGD-type. {ECO:0000255|PROSITE-ProRule:PRU01004}.,NADH-quinone oxidoreductase subunit G (EC 1.6.5.11) (NADH dehydrogenase I subunit G) (NDH-1 subunit G),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]; ATP synthesis coupled electron transport [GO:0042773]; negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405]",9634230; 17658950; 20421951; 21969609; 22264515,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient (By similarity). {ECO:0000250}.; FUNCTION: Plays a critical role in M.tuberculosis ability to inhibit apoptosis of infected macrophages; thus helps the bacterium in its struggle to resist the host immune response (PubMed:17658950). In fact, via a NuoG-dependent mechanism, M.tuberculosis can neutralize NOX2-derived reactive oxygen species (ROS) in order to inhibit TNF-alpha-mediated host cell apoptosis (PubMed:20421951). Also mediates inhibition of neutrophil apoptosis, leading to delayed activation of naive CD4 T cells (PubMed:22264515). {ECO:0000269|PubMed:17658950, ECO:0000269|PubMed:20421951, ECO:0000269|PubMed:22264515}.",MTQAADTDIRVGQPEMVTLTIDGVEISVPKGTLVIRAAELMGIQIPRFCDHPLLEPVGACRQCLVEVEGQRKPLASCTTVATDDMVVRTQLTSEIADKAQHGVMELLLINHPLDCPMCDKGGECPLQNQAMSNGRTDSRFTEAKRTFAKPINISAQVLLDRERCILCARCTRFSDQIAGDPFIDMQERGALQQVGIYADEPFESYFSGNTVQICPVGALTGTAYRFRARPFDLVSSPSVCEHCASGCAQRTDHRRGKVLRRLAGDDPEVNEEWNCDKGRWAFTYATQPDVITTPLIRDGGDPKGALVPTSWSHAMAVAAQGLAAARGRTGVLVGGRVTWEDAYAYAKFARITLGTNDIDFRARPHSAEEADFLAARIAGRHMAVSYADLESAPVVLLVGFEPEDESPIVFLRLRKAARRHRVPVYTIAPFATGGLHKMSGRLIKTVPGGEPAALDDLATGAVGDLLATPGAVIIVGERLATVPGGLSAAARLADTTGARLAWVPRRAGERGALEAGALPTLLPGGRPLADEVARAQVCAAWHIAELPAAAGRDADGILAAAADETLAALLVGGIEPADFADPDAVLAALDATGFVVSLELRHSTVTERADVVFPVAPTTQKAGAFVNWEGRYRTFEPALRGSTLQAGQSDHRVLDALADDMGVHLGVPTVEAAREELAALGIWDGKHAAGPHIAATGPTQPEAGEAILTGWRMLLDEGRLQDGEPYLAGTARTPVVRLSPDTAAEIGAADGEAVTVSTSRGSITLPCSVTDMPDRVVWLPLNSAGSTVHRQLRVTIGSIVKIGAGS,"85,424",806,Complex I 75 kDa subunit family,ATP synthesis coupled electron transport [GO:0042773]; negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405],"2 iron, 2 sulfur cluster binding [GO:0051537]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; molybdopterin cofactor binding [GO:0043546]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY03A2.07c,1
P9WIX1,NUOH_MYCTU,Rv3152,nuoH Rv3152 MTCY03A2.06c,GO:0005886; GO:0016021; GO:0016491; GO:0048038,IPR001694; IPR018086; ,,nuoH,,NADH-quinone oxidoreductase subunit H (EC 1.6.5.11) (NADH dehydrogenase I subunit H) (NDH-1 subunit H),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01350}.",MTTFGHDTWWLVAAKAIAVFVFLMLTVLVAILAERKLLGRMQLRPGPNRVGPKGALQSLADGIKLALKESITPGGIDRFVYFVAPIISVIPAFTAFAFIPFGPEVSVFGHRTPLQITDLPVAVLFILGLSAIGVYGIVLGGWASGSTYPLLGGVRSTAQVISYEVAMGLSFATVFLMAGTMSTSQIVAAQDGVWYAFLLLPSFVIYLISMVGETNRAPFDLPEAEGELVAGFHTEYSSLKFAMFMLAEYVNMTTVSALAATLFFGGWHAPWPLNMWASANTGWWPLIWFTAKVWGFLFIYFWLRATLPRLRYDQFMALGWKLLIPVSLVWVMVAAIIRSLRNQGYQYWTPTLVFSSIVVAAAMVLLLRKPLSAPGARASARQRGDEGTSPEPAFPTPPLLAGATKENAGG,"44,658",410,Complex I subunit 1 family,,oxidoreductase activity [GO:0016491]; quinone binding [GO:0048038],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY03A2.06c,1
P9WJG9,NUOI_MYCTU,Rv3153,nuoI Rv3153 MTCY03A2.05c,GO:0005618; GO:0005829; GO:0005886; GO:0016651; GO:0046872; GO:0048038; GO:0051539,IPR017896; IPR017900; IPR010226; ,,nuoI,DOMAIN 71 101 4Fe-4S ferredoxin-type 1. {ECO:0000255|HAMAP-Rule:MF_01351}.; DOMAIN 117 146 4Fe-4S ferredoxin-type 2. {ECO:0000255|HAMAP-Rule:MF_01351}.,NADH-quinone oxidoreductase subunit I (EC 1.6.5.11) (NADH dehydrogenase I subunit I) (NDH-1 subunit I),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; quinone binding [GO:0048038]",9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01351}.",MANTDRPALPHKRAVPPSRADSGPRRRRTKLLDAVAGFGVTLGSMFKKTVTEEYPERPGPVAARYHGRHQLNRYPDGLEKCIGCELCAWACPADAIYVEGADNTEEERFSPGERYGRVYQINYLRCIGCGLCIEACPTRALTMTYDYELADDNRADLIYEKDRLLAPLLPEMAAPPHPRTPGATDKDYYLGNVTAEGLRGVRESQTTGDSR,"23,466",211,Complex I 23 kDa subunit family,,"4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on NAD(P)H [GO:0016651]; quinone binding [GO:0048038]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY03A2.05c,1
P9WIX5,NUDC_MYCTU,Rv3199c,nudC Rv3199c MTV014.43c,GO:0000210; GO:0005886; GO:0046872,IPR015375; IPR022925; IPR015797; IPR020084; IPR000086; IPR015376; ,,nudC,DOMAIN 168 293 Nudix hydrolase.,NADH pyrophosphatase (EC 3.6.1.22),plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210],9634230,,,MTNVSGVDFQLRSVPLLSRVGADRADRLRTDMEAAAAGWPGAALLRVDSRNRVLVANGRVLLGAAIELADKPPPEAVFLGRVEGGRHVWAVRAALQPIADPDIPAEAVDLRGLGRIMDDTSSQLVSSASALLNWHDNARFSALDGAPTKPARAGWSRVNPITGHEEFPRIDPAVICLVHDGADRAVLARQAAWPERMFSLLAGFVEAGESFEVCVAREIREEIGLTVRDVRYLGSQQWPFPRSLMVGFHALGDPDEEFSFSDGEIAEAAWFTRDEVRAALAAGDWSSASESKLLLPGSISIARVIIESWAACE,"33,826",313,"Nudix hydrolase family, NudC subfamily",,metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210],plasma membrane [GO:0005886],,MTV014.43c,1
P9WIW7,NUOA_MYCTU,Rv3145,nuoA Rv3145 MTCY03A2.13c,GO:0005886; GO:0008137; GO:0016021; GO:0030964; GO:0048038; GO:0055114,IPR023043; IPR000440; IPR038430; ,,nuoA,,NADH-quinone oxidoreductase subunit A (EC 1.6.5.11) (NADH dehydrogenase I subunit A) (NDH-1 subunit A) (NUO1),integral component of membrane [GO:0016021]; NADH dehydrogenase complex [GO:0030964]; plasma membrane [GO:0005886]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; oxidation-reduction process [GO:0055114],9634230; 21969609,,"FUNCTION: NDH-1 shuttles electrons from NADH, via FMN and iron-sulfur (Fe-S) centers, to quinones in the respiratory chain. The immediate electron acceptor for the enzyme in this species is believed to be a menaquinone. Couples the redox reaction to proton translocation (for every two electrons transferred, four hydrogen ions are translocated across the cytoplasmic membrane), and thus conserves the redox energy in a proton gradient. {ECO:0000255|HAMAP-Rule:MF_01394}.",MNVYIPILVLAALAAAFAVVSVVIASLVGPSRFNRSKQAAYECGIEPASTGARTSIGPGAASGQRFPIKYYLTAMLFIVFDIEIVFLYPWAVSYDSLGTFALVEMAIFMLTVFVAYAYVWRRGGLTWD,"13,975",128,Complex I subunit 3 family,oxidation-reduction process [GO:0055114],NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038],integral component of membrane [GO:0016021]; NADH dehydrogenase complex [GO:0030964]; plasma membrane [GO:0005886],,MTCY03A2.13c,1
O05886,HPF_MYCTU,Rv3241c,hpf Rv3241c,GO:0022627; GO:0043022; GO:0043024; GO:0044238; GO:0045900,IPR034694; IPR036567; IPR003489; IPR032528; IPR038416; ,,hpf,,Ribosome hibernation promotion factor (HPF),cytosolic small ribosomal subunit [GO:0022627]; ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022]; negative regulation of translational elongation [GO:0045900]; primary metabolic process [GO:0044238],9634230; 21969609,,FUNCTION: Required for dimerization of active 70S ribosomes into 100S ribosomes in stationary phase; 100S ribosomes are translationally inactive and sometimes present during exponential growth. {ECO:0000255|HAMAP-Rule:MF_00839}.,MSRLAVDSGQVLAEPKSNAEIVFKGRNVEIPDHFRIYVSQKLARLERFDRTIYLFDVELDHERNRRQRKSCQRVEITARGRGPVVRGEACADSFYAALESAVVKLESRLRRGKDRRKVHYGDKTPVSLAEATAVVPAPENGFNTRPAEAHDHDGAVVEREPGRIVRTKEHPAKPMSVDDALYQMELVGHDFFLFYDKDTERPSVVYRRHAYDYGLIRLA,"25,093",219,"HPF/YfiA ribosome-associated protein family, Long HPF subfamily",negative regulation of translational elongation [GO:0045900]; primary metabolic process [GO:0044238],ribosomal small subunit binding [GO:0043024]; ribosome binding [GO:0043022],cytosolic small ribosomal subunit [GO:0022627],,,4
P95189,HISN_MYCTU,Rv3137,hisN impC Rv3137,GO:0000105; GO:0004401; GO:0005829; GO:0005886; GO:0008934; GO:0010125; GO:0040007; GO:0046854; GO:0046872,IPR011809; IPR020583; IPR000760; ,,hisN,,Histidinol-phosphatase (HolPase) (EC 3.1.3.15) (Histidinol-phosphate phosphatase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; histidinol-phosphatase activity [GO:0004401]; inositol monophosphate 1-phosphatase activity [GO:0008934]; metal ion binding [GO:0046872]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; mycothiol biosynthetic process [GO:0010125]; phosphatidylinositol phosphorylation [GO:0046854],9634230; 19099550; 20167072; 21969609,,"FUNCTION: Catalyzes the dephosphorylation of histidinol-phosphate to histidinol, the direct precursor of histidine. {ECO:0000250}.",MSHDDLMLALALADRADELTRVRFGALDLRIDTKPDLTPVTDADRAVESDVRQTLGRDRPGDGVLGEEFGGSTTFTGRQWIVDPIDGTKNFVRGVPVWASLIALLEDGVPSVGVVSAPALQRRWWAARGRGAFASVDGARPHRLSVSSVAELHSASLSFSSLSGWARPGLRERFIGLTDTVWRVRAYGDFLSYCLVAEGAVDIAAEPQVSVWDLAALDIVVREAGGRLTSLDGVAGPHGGSAVATNGLLHDEVLTRLNAG,"27,693",260,Inositol monophosphatase superfamily,growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; mycothiol biosynthetic process [GO:0010125]; phosphatidylinositol phosphorylation [GO:0046854],histidinol-phosphatase activity [GO:0004401]; inositol monophosphate 1-phosphatase activity [GO:0008934]; metal ion binding [GO:0046872],cytosol [GO:0005829]; plasma membrane [GO:0005886],impC,,2
P9WMC3,HTHR_MYCTU,Rv3405c,Rv3405c MTCY78.23,GO:0000976; GO:0003700; GO:0005829; GO:0006351,IPR023772; IPR009057; IPR001647; ,,,DOMAIN 17 77 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,HTH-type transcriptional repressor Rv3405c,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 21969609; 25427196,,FUNCTION: Negatively regulates its own expression and that of the neighboring sulfatase Rv3406. {ECO:0000269|PubMed:25427196}.,MTTRPATDRRKMPTGREEVAAAILQAATDLFAERGPAATSIRDIAARSKVNHGLVFRHFGTKDQLVGAVLDHLGTKLTRLLHSEAPADIIERALDRHGRVLARALLDGYPVGQLQQRFPNVAELLDAVRPRYDSDLGARLAVAHALALQFGWRLFAPMLRSATGIDELTGDELRLSVNDAVARILEPH,"20,609",188,,"transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,MTCY78.23,1
P9WKK3,IF1_MYCTU,Rv3462c,infA Rv3462c MCB1222.32c MTCY13E12.15c,GO:0003743; GO:0005618; GO:0005829; GO:0005886; GO:0019843; GO:0040007; GO:0043022,IPR012340; IPR006196; IPR004368; ,,infA,DOMAIN 1 73 S1-like. {ECO:0000255|HAMAP-Rule:MF_00075}.,Translation initiation factor IF-1,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; translation initiation factor activity [GO:0003743]; growth [GO:0040007],9634230; 21969609; 20132820,X-ray crystallography (1),"FUNCTION: One of the essential components for the initiation of protein synthesis. Stabilizes the binding of IF-2 and IF-3 on the 30S subunit to which N-formylmethionyl-tRNA(fMet) subsequently binds. Helps modulate mRNA selection, yielding the 30S pre-initiation complex (PIC). Upon addition of the 50S ribosomal subunit IF-1, IF-2 and IF-3 are released leaving the mature 70S translation initiation complex. {ECO:0000255|HAMAP-Rule:MF_00075}.",MAKKDGAIEVEGRVVEPLPNAMFRIELENGHKVLAHISGKMRQHYIRILPEDRVVVELSPYDLSRGRIVYRYK,"8,489",73,IF-1 family,growth [GO:0040007],ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; translation initiation factor activity [GO:0003743],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MCB1222.32c MTCY13E12.15c,1
O05877,PK21_MYCTU,Rv3232c,ppk2 Rv3232c,GO:0005525; GO:0005886; GO:0006183; GO:0008976; GO:0030808; GO:0044121; GO:0046777,IPR027417; IPR016898; IPR022488; IPR022486; ,,ppk2,,Polyphosphate:GDP phosphotransferase (EC 2.7.4.-) (Polyphosphate kinase PPK2),plasma membrane [GO:0005886]; GTP binding [GO:0005525]; polyphosphate kinase activity [GO:0008976]; growth of symbiont in host organelle [GO:0044121]; GTP biosynthetic process [GO:0006183]; protein autophosphorylation [GO:0046777]; regulation of nucleotide biosynthetic process [GO:0030808],9634230; 19843229; 21969609,,"FUNCTION: Uses inorganic polyphosphate (polyP) as a donor to convert GDP to GTP. In addition, modulates nucleotide triphosphate synthesis catalyzed by the nucleoside diphosphate kinase (Ndk) in favor of GTP production over CTP or UTP. Plays an important role in survival of M.tuberculosis in macrophages. {ECO:0000269|PubMed:19843229}.",MDIPSVDVSTATNDGASSRAKGHRSAAPGRRKISDAVYQAELFRLQTEFVKLQEWARHSGARLVVIFEGRDGAGKGGAIKRITEYLNPRVARIAALPAPTDRERGQWYYQRYIAHLPAKGEIVLFDRSWYNRAGVEKVMGFCTPQEYVLFLRQTPIFEQMLIDDGILLRKYWFSVSDAEQLRRFKARRNDPVRQWKLSPMDLESVYRWEDYSRAKDEMMVHTDTPVSPWYVVESDIKKHARLNMMAHLLSTIDYADVEKPKVKLPPRPLVSGNYRRPPRELSTYVDDYVATLIAR,"34,124",295,"Polyphosphate kinase 2 (PPK2) family, Class I subfamily",growth of symbiont in host organelle [GO:0044121]; GTP biosynthetic process [GO:0006183]; protein autophosphorylation [GO:0046777]; regulation of nucleotide biosynthetic process [GO:0030808],GTP binding [GO:0005525]; polyphosphate kinase activity [GO:0008976],plasma membrane [GO:0005886],,,1
P9WN11,OTSA_MYCTU,Rv3490,otsA Rv3490,GO:0003825; GO:0005618; GO:0005829; GO:0005886; GO:0005992; GO:0016791; GO:0030145; GO:0040007; GO:0047260; GO:0070413,IPR001830; ,,otsA,,"Trehalose-6-phosphate synthase (TPS) (EC 2.4.1.15) (EC 2.4.1.347) (Alpha,alpha-trehalose-phosphate synthase [UDP-forming]) (Osmoregulatory trehalose synthesis protein A) (OtsA)","cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; alpha,alpha-trehalose-phosphate synthase (GDP-forming) activity [GO:0047260]; alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; manganese ion binding [GO:0030145]; phosphatase activity [GO:0016791]; growth [GO:0040007]; trehalose biosynthetic process [GO:0005992]; trehalose metabolism in response to stress [GO:0070413]",9634230; 12473104; 21969609; 27513637,,"FUNCTION: Involved in the production of glycogen and alpha-glucan via the TreS-Pep2 branch involved in the biosynthesis of maltose-1-phosphate (M1P), and probably in the osmoprotection via the biosynthesis of trehalose (PubMed:12473104, PubMed:27513637). Catalyzes the transfer of glucose from UDP-glucose (UDP-Glc) to D-glucose 6-phosphate (Glc-6-P) to form trehalose-6-phosphate (PubMed:12473104). Is specific for the glucosyl acceptor (Glc-6-P cannot be replaced by either mannose-6-P, fructose-6-P or glucosamine-6-P), but any of the glucose sugar nucleotides can be used as glucosyl donors (PubMed:12473104). It is more active with the purine sugar nucleotides than with the pyrimidine sugar nucleotides (PubMed:12473104). {ECO:0000269|PubMed:12473104, ECO:0000269|PubMed:27513637}.",MAPSGGQEAQICDSETFGDSDFVVVANRLPVDLERLPDGSTTWKRSPGGLVTALEPVLRRRRGAWVGWPGVNDDGAEPDLHVLDGPIIQDELELHPVRLSTTDIAQYYEGFSNATLWPLYHDVIVKPLYHREWWDRYVDVNQRFAEAASRAAAHGATVWVQDYQLQLVPKMLRMLRPDLTIGFFLHIPFPPVELFMQMPWRTEIIQGLLGADLVGFHLPGGAQNFLILSRRLVGTDTSRGTVGVRSRFGAAVLGSRTIRVGAFPISVDSGALDHAARDRNIRRRAREIRTELGNPRKILLGVDRLDYTKGIDVRLKAFSELLAEGRVKRDDTVVVQLATPSRERVESYQTLRNDIERQVGHINGEYGEVGHPVVHYLHRPAPRDELIAFFVASDVMLVTPLRDGMNLVAKEYVACRSDLGGALVLSEFTGAAAELRHAYLVNPHDLEGVKDGIEEALNQTEEAGRRRMRSLRRQVLAHDVDRWAQSFLDALAGAHPRGQG,"55,862",500,Glycosyltransferase 20 family,growth [GO:0040007]; trehalose biosynthetic process [GO:0005992]; trehalose metabolism in response to stress [GO:0070413],"alpha,alpha-trehalose-phosphate synthase (GDP-forming) activity [GO:0047260]; alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO:0003825]; manganese ion binding [GO:0030145]; phosphatase activity [GO:0016791]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WI97,PHOU1_MYCTU,Rv3301c,phoU1 phoY1 Rv3301c MTCI418A.03c,GO:0005829; GO:0005886; GO:0006817; GO:0030643; GO:0045936,IPR028366; IPR038078; IPR026022; ,,phoU1,,Phosphate-specific transport system accessory protein PhoU homolog 1 (Pst system accessory protein PhoU homolog 1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; cellular phosphate ion homeostasis [GO:0030643]; negative regulation of phosphate metabolic process [GO:0045936]; phosphate ion transport [GO:0006817],9634230; 21969609,,"FUNCTION: Plays a role in the regulation of phosphate uptake. In this role, it may bind, possibly as a chaperone, to PhoR, PhoP or a PhoR-PhoP complex to promote dephosphorylation of phospho-PhoP, or inhibit formation of the PhoR-PhoP transitory complex (By similarity). {ECO:0000250}.",MRTVYHQRLTELAGRLGEMCSLAGIAMKRATQALLEADIGAAEQVIRDHERIVAMRAQVEKEAFALLALQHPVAGELREIFSAVQIIADTERMGALAVHIAKITRREYPNQVLPEEVRNCFADMAKVAIALGDSARQVLVNRDPQEAAQLHDRDDAMDDLHRHLLSVLIDREWRHGVRVGVETALLGRFFERFADHAVEVGRRVIFMVTGVLPTEDEISTY,"24,827",221,PhoU family,cellular phosphate ion homeostasis [GO:0030643]; negative regulation of phosphate metabolic process [GO:0045936]; phosphate ion transport [GO:0006817],,cytosol [GO:0005829]; plasma membrane [GO:0005886],phoY1,MTCI418A.03c,1
P9WQH7,PCC5_MYCTU,Rv3280,accD5 pccB Rv3280 MTCY71.20,GO:0003989; GO:0004658; GO:0005524; GO:0005618; GO:0005886; GO:0009062; GO:0009317; GO:0015977; GO:0032991; GO:0042802,IPR034733; IPR029045; IPR011763; IPR011762; ,Itself,accD5,DOMAIN 25 281 CoA carboxyltransferase N-terminal. {ECO:0000255|PROSITE-ProRule:PRU01136}.; DOMAIN 295 541 CoA carboxyltransferase C-terminal. {ECO:0000255|PROSITE-ProRule:PRU01137}.,Probable propionyl-CoA carboxylase beta chain 5 (PCCase) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase),acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; propionyl-CoA carboxylase activity [GO:0004658]; carbon fixation [GO:0015977]; fatty acid catabolic process [GO:0009062],9634230; 21969609,X-ray crystallography (2),,MTSVTDRSAHSAERSTEHTIDIHTTAGKLAELHKRREESLHPVGEDAVEKVHAKGKLTARERIYALLDEDSFVELDALAKHRSTNFNLGEKRPLGDGVVTGYGTIDGRDVCIFSQDATVFGGSLGEVYGEKIVKVQELAIKTGRPLIGINDGAGARIQEGVVSLGLYSRIFRNNILASGVIPQISLIMGAAAGGHVYSPALTDFVIMVDQTSQMFITGPDVIKTVTGEEVTMEELGGAHTHMAKSGTAHYAASGEQDAFDYVRELLSYLPPNNSTDAPRYQAAAPTGPIEENLTDEDLELDTLIPDSPNQPYDMHEVITRLLDDEFLEIQAGYAQNIVVGFGRIDGRPVGIVANQPTHFAGCLDINASEKAARFVRTCDCFNIPIVMLVDVPGFLPGTDQEYNGIIRRGAKLLYAYGEATVPKITVITRKAYGGAYCVMGSKDMGCDVNLAWPTAQIAVMGASGAVGFVYRQQLAEAAANGEDIDKLRLRLQQEYEDTLVNPYVAAERGYVDAVIPPSHTRGYIGTALRLLERKIAQLPPKKHGNVPL,"59,354",548,AccD/PCCB family,carbon fixation [GO:0015977]; fatty acid catabolic process [GO:0009062],acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; propionyl-CoA carboxylase activity [GO:0004658],acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],pccB,MTCY71.20,1
P9WGL5,PDTAS_MYCTU,Rv3220c,pdtaS Rv3220c,GO:0000155; GO:0000160; GO:0004672; GO:0005524; GO:0005622; GO:0046777,IPR022066; IPR038424; IPR003594; IPR036890; IPR005467; IPR035965; IPR011495; ,,pdtaS,DOMAIN 300 495 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Probable sensor histidine kinase pdtaS (EC 2.7.13.3),intracellular [GO:0005622]; ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672]; phosphorelay signal transduction system [GO:0000160]; protein autophosphorylation [GO:0046777],9634230; 16026786; 19099550; 21969609,X-ray crystallography (2),"FUNCTION: Member of the two-component regulatory system pdtaR/pdtaS. Autophosphorylates, probably on a histidine residue, and transfers its phosphate group to pdtaR. {ECO:0000269|PubMed:16026786}.",MSTLGDLLAEHTVLPGSAVDHLHAVVGEWQLLADLSFADYLMWVRRDDGVLVCVAQCRPNTGPTVVHTDAVGTVVAANSMPLVAATFSGGVPGREGAVGQQNSCQHDGHSVEVSPVRFGDQVVAVLTRHQPELAARRRSGHLETAYRLCATDLLRMLAEGTFPDAGDVAMSRSSPRAGDGFIRLDVDGVVSYASPNALSAYHRMGLTTELEGVNLIDATRPLISDPFEAHEVDEHVQDLLAGDGKGMRMEVDAGGATVLLRTLPLVVAGRNVGAAILIRDVTEVKRRDRALISKDATIREIHHRVKNNLQTVAALLRLQARRTSNAEGREALIESVRRVSSIALVHDALSMSVDEQVNLDEVIDRILPIMNDVASVDRPIRINRVGDLGVLDSDRATALIMVITELVQNAIEHAFDPAAAEGSVTIRAERSARWLDVVVHDDGLGLPQGFSLEKSDSLGLQIVRTLVSAELDGSLGMRDARERGTDVVLRVPVGRRGRLML,"54,012",501,,phosphorelay signal transduction system [GO:0000160]; protein autophosphorylation [GO:0046777],ATP binding [GO:0005524]; phosphorelay sensor kinase activity [GO:0000155]; protein kinase activity [GO:0004672],intracellular [GO:0005622],,,1
P9WI87,PILIN_MYCTU,Rv3312.1,mtp Rv3312.1 Rv3312A,GO:0007155; GO:0009289; GO:0009297; GO:0009405,,,mtp,,Pilin (Pili structural subunit),pilus [GO:0009289]; cell adhesion [GO:0007155]; pathogenesis [GO:0009405]; pilus assembly [GO:0009297],9634230; 17360408; 16573683; 21969609,,"FUNCTION: Structural subunit of M.tuberculosis pili (MTP), which are thin (2- to 3-nm wide), flexible, coiled-coil, aggregative fibers. Has a strong affinity for laminin but lacks significant binding affinity for fibronectin or type IV collagen. Mediates adhesion to the extracellular matrix, an event that would facilitate direct interaction with the host epithelium during infection in the lung or other tissues. {ECO:0000269|PubMed:17360408}.",MYRFACRTLMLAACILATGVAGLGVGAQSAAQTAPVPDYYWCPGQPFDPAWGPNWDPYTCHDDFHRDSDGPDHSRDYPGPILEGPVLDDPGAAPPPPAAGGGA,"10,768",103,Mycobacterial pilin family,cell adhesion [GO:0007155]; pathogenesis [GO:0009405]; pilus assembly [GO:0009297],,pilus [GO:0009289],,Rv3312A,1
L0TC47,LIPV_MYCTU,Rv3203,lipV Rv3203,GO:0005504; GO:0009062; GO:0016298; GO:0052689; GO:0071468,IPR029058; IPR000073; IPR000639; ,,lipV,,Lipase LipV (EC 3.1.1.1),carboxylic ester hydrolase activity [GO:0052689]; fatty acid binding [GO:0005504]; lipase activity [GO:0016298]; cellular response to acidic pH [GO:0071468]; fatty acid catabolic process [GO:0009062],9634230; 21969609; 24234750,,"FUNCTION: Lipase that displays broad substrate specificity and preferentially hydrolyzes p-nitrophenyl myristate in vitro. Also shows significant activity with pNP-butyrate (68%), pNP-octanoate (82%), pNP-decanoate (90%), and pNP-laurate (74%). Is probably involved in lipid catabolism. Is active at low pH, and might play some important role in mycobacterial biology in macrophages where the bacteria encounters acidic stress. {ECO:0000269|PubMed:24234750}.",MIIDLHVQRYGPSGPARVLTIHGVTEHGRIWHRLAHHLPEIPIAAPDLLGHGRSPWAAPWTIDANVSALAALLDNQGDGPVVVVGHSFGGAVAMHLAAARPDQVAALVLLDPAVALDGSRVREVVDAMLASPDYLDPAEARAEKATGAWADVDPPVLDAELDEHLVALPNGRYGWRISLPAMVCYWSELARDIVLPPVGTATTLVRAVRASPAYVSDQLLAALDKRLGADFELLDFDCGHMVPQAKPTEVAAVIRSRLGPR,"27,868",261,AB hydrolase superfamily,cellular response to acidic pH [GO:0071468]; fatty acid catabolic process [GO:0009062],carboxylic ester hydrolase activity [GO:0052689]; fatty acid binding [GO:0005504]; lipase activity [GO:0016298],,,,2
P9WJY9,METXA_MYCTU,Rv3341,metXA metA Rv3341 MTV016.41,GO:0004414; GO:0005737; GO:0005886; GO:0009086; GO:0009092; GO:0040007,IPR029058; IPR000073; IPR008220; ,,metXA,DOMAIN 52 356 AB hydrolase-1. {ECO:0000255|HAMAP-Rule:MF_00296}.,Homoserine O-acetyltransferase (HAT) (EC 2.3.1.31) (Homoserine transacetylase) (HTA),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; homoserine O-acetyltransferase activity [GO:0004414]; growth [GO:0040007]; homoserine metabolic process [GO:0009092]; methionine biosynthetic process [GO:0009086],9634230; 21969609,,"FUNCTION: Transfers an acetyl group from acetyl-CoA to L-homoserine, forming acetyl-L-homoserine. {ECO:0000255|HAMAP-Rule:MF_00296}.",MTISDVPTQTLPAEGEIGLIDVGSLQLESGAVIDDVCIAVQRWGKLSPARDNVVVVLHALTGDSHITGPAGPGHPTPGWWDGVAGPGAPIDTTRWCAVATNVLGGCRGSTGPSSLARDGKPWGSRFPLISIRDQVQADVAALAALGITEVAAVVGGSMGGARALEWVVGYPDRVRAGLLLAVGARATADQIGTQTTQIAAIKADPDWQSGDYHETGRAPDAGLRLARRFAHLTYRGEIELDTRFANHNQGNEDPTAGGRYAVQSYLEHQGDKLLSRFDAGSYVILTEALNSHDVGRGRGGVSAALRACPVPVVVGGITSDRLYPLRLQQELADLLPGCAGLRVVESVYGHDGFLVETEAVGELIRQTLGLADREGACRR,"39,769",379,"AB hydrolase superfamily, MetX family",growth [GO:0040007]; homoserine metabolic process [GO:0009092]; methionine biosynthetic process [GO:0009086],homoserine O-acetyltransferase activity [GO:0004414],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],metA,MTV016.41,1
I6YBX3,MFPA_MYCTU,Rv3361c,mfpA Rv3361c LH57_18360,,IPR001646; ,,mfpA,DOMAIN 113 147 Pentapeptide repeat. {ECO:0000255}.,Pentapeptide repeat protein MfpA (MfpAMt),,9634230; 18977756; 19060136; 21605934; 15933203,X-ray crystallography (4),"FUNCTION: Might be involved in fluoroquinolone resistance (PubMed:15933203). Inhibits ATP-independent DNA relaxation, ATP-dependent DNA supercoiling and ATP-dependent decatenation by endogenous gyrase, 50% inhibition occurs at 2 uM; inhibition is abolished if GyrA is mutated (Asp-87 to Gly or His) (PubMed:19060136). Also inhibits fluoroquinolone-promoted dsDNA cleavage (PubMed:19060136). Increases fluoroquinolone (ciprofloxacin or moxifloxacin) inhibition of gyrase supercoiling activity in a concentration-dependent manner (PubMed:19060136). Inhibits DNA relaxation and supercoiling by E.coli gyrase (PubMed:15933203). Forms a structure that exhibits size, shape and electrostatic similarity to B-form DNA; it may bind to DNA gyrase which is postulated to protect it from fluoroquinolones (PubMed:15933203). {ECO:0000269|PubMed:15933203, ECO:0000269|PubMed:19060136}.",MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG,"20,020",183,Pentapeptide repeat protein family,,,,,LH57_18360,1
P9WFW9,MENF_MYCTU,Rv3215,menF entC Rv3215,GO:0008909; GO:0009234; GO:0046872,IPR005801; IPR015890; IPR004561; ,,menF,,Putative isochorismate synthase MenF (EC 5.4.4.2) (Isochorismate mutase),isochorismate synthase activity [GO:0008909]; metal ion binding [GO:0046872]; menaquinone biosynthetic process [GO:0009234],9634230; 21969609,,FUNCTION: Catalyzes the conversion of chorismate to isochorismate. {ECO:0000250|UniProtKB:P38051}.,MSAHVATLHPEPPFALCGPRGTLIARGVRTRYCDVRAAQAALRSGTAPILLGALPFDVSRPAALMVPDGVLRARKLPDWPTGPLPKVRVAAALPPPADYLTRIGRARDLLAAFDGPLHKVVLARAVQLTADAPLDARVLLRRLVVADPTAYGYLVDLTSAGNDDTGAALVGASPELLVARSGNRVMCKPFAGSAPRAADPKLDAANAAALASSAKNRHEHQLVVDTMRVALEPLCEDLTIPAQPQLNRTAAVWHLCTAITGRLRNISTTAIDLALALHPTPAVGGVPTKAATELIAELEGDRGFYAGAVGWCDGRGDGHWVVSIRCAQLSADRRAALAHAGGGIVAESDPDDELEETTTKFATILTALGVEQ,"38,938",372,Isochorismate synthase family,menaquinone biosynthetic process [GO:0009234],isochorismate synthase activity [GO:0008909]; metal ion binding [GO:0046872],,entC,,1
P9WJR5,MOAC3_MYCTU,Rv3324c,moaC3 Rv3324c MTV016.24c,GO:0006777; GO:0061799,IPR023045; IPR036522; IPR002820; ,,moaC3,,Cyclic pyranopterin monophosphate synthase 3 (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C 3),cyclic pyranopterin monophosphate synthase activity [GO:0061799]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],9634230,,"FUNCTION: Catalyzes the conversion of (8S)-3',8-cyclo-7,8-dihydroguanosine 5'-triphosphate to cyclic pyranopterin monophosphate (cPMP). {ECO:0000255|HAMAP-Rule:MF_01224}.",MNDHDGVLTHLDEQGAARMVDVSAKAVTLRRARASGAVLMKPSTLDMICHGTAAKGDVIATARIAGIMAAKRTGELIPLCHPLGIEAVTVTLEPQGADRLSIAATVTTVARTGVEMEALTAVTVTALTVYDMCKAVDRAMTITDIRLDEKSGGRSGHYRRHDADVKPSDGGSTEDGC,"18,555",177,MoaC family,Mo-molybdopterin cofactor biosynthetic process [GO:0006777],cyclic pyranopterin monophosphate synthase activity [GO:0061799],,,MTV016.24c,1
P9WJR3,MOAE1_MYCTU,Rv3119,moaE1 moaE Rv3119 MTCY164.29,GO:0005829; GO:0006777; GO:0030366; GO:0032324,IPR036563; IPR003448; ,,moaE1,,Molybdopterin synthase catalytic subunit 1 (EC 2.8.1.12) (MPT synthase subunit 2 1) (Molybdenum cofactor biosynthesis protein E 1) (Molybdopterin-converting factor large subunit 1) (Molybdopterin-converting factor subunit 2 1),cytosol [GO:0005829]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],9634230; 21969609,X-ray crystallography (1),FUNCTION: Converts molybdopterin precursor Z into molybdopterin. This requires the incorporation of two sulfur atoms into precursor Z to generate a dithiolene group. The sulfur is provided by MoaD (By similarity). {ECO:0000250}.,MANVVAEGAYPYCRLTDQPLSVDEVLAAVSGPEQGGIVIFVGNVRDHNAGHDVTRLFYEAYPPMVIRTLMSIIGRCEDKAEGVRVAVAHRTGELQIGDAAVVIGASAPHRAEAFDAARMCIELLKQEVPIWKKEFSSTGAEWVGDRP,"15,920",147,MoaE family,molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],molybdopterin synthase activity [GO:0030366],cytosol [GO:0005829],moaE,MTCY164.29,1
P9WF11,NNR_MYCTU,Rv3433c,nnr Rv3433c MTCY77.05c,GO:0005524; GO:0008152; GO:0016853; GO:0046872; GO:0052855,IPR017953; IPR000631; IPR030677; IPR029056; IPR004443; IPR036652; ,,nnr,DOMAIN 10 205 YjeF N-terminal.; DOMAIN 210 473 YjeF C-terminal.,Bifunctional NAD(P)H-hydrate repair enzyme Nnr (Nicotinamide nucleotide repair protein) [Includes: ADP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.136) (ADP-dependent NAD(P)HX dehydratase); NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase)],ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; metabolic process [GO:0008152],9634230; 21969609,,"FUNCTION: Bifunctional enzyme that catalyzes the epimerization of the S- and R-forms of NAD(P)HX and the dehydration of the S-form of NAD(P)HX at the expense of ADP, which is converted to AMP. This allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration (By similarity). {ECO:0000250}.",MRHYYSVDTIRAAEAPLLASLPDGALMRRAAFGLATEIGRELTARTGGVVGRRVCAVVGSGDNGGDALWAATFLRRRGAAADAVLLNPDRTHRKALAAFTKSGGRLVESVSAATDLVIDGVVGISGSGPLRPAAAQVFAAVQAAAIPVVAVDIPSGIDVATGAITGPAVHAALTVTFGGLKPVHALADCGRVVLVDIGLDLAHTDVLGFEATDVAARWPVPGPRDDKYTQGVTGVLAGSSTYPGAAVLCTGAAVAATSGMVRYAGTAHAEVLAHWPEVIASPTPAAAGRVQAWVVGPGLGTDEAGAAALWFALDTDLPVLVDADGLTMLADHPDLVAGRNAPTVLTPHAGEFARLAGAPPGDDRVGACRQLADALGATVLLKGNVTVIADPGGPVYLNPAGQSWAATAGSGDVLSGMIGALLASGLPSGEAAAAAAFVHARASAAAAADPGPGDAPTSASRISGHIRAALAAL,"46,857",473,NnrE/AIBP family; NnrD/CARKD family,metabolic process [GO:0008152],ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872],,,MTCY77.05c,1
O53333,HIGA3_MYCTU,Rv3183 RVBD_3183,higA3 Rv3183 RVBD_3183 LH57_17370 P425_03315,GO:0006351; GO:0006355; GO:0043565,IPR001387; IPR010982; ,,higA3,DOMAIN 41 97 HTH cro/C1-type. {ECO:0000255|PROSITE-ProRule:PRU00257}.,Putative antitoxin HigA3,"sequence-specific DNA binding [GO:0043565]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 24662523,,FUNCTION: Putative antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin would be HigB3. {ECO:0000305|PubMed:24662523}.,MTMARNWRDIRADAVAQGRVDLQRAAVAREEMRDAVLAHRLAEIRKALGHARQADVAALMGVSQARVSKLESGDLSHTELGTLQAYVAALGGHLRIVAEFGENTVELTA,"11,802",109,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",sequence-specific DNA binding [GO:0043565],,,LH57_17370 P425_03315,1
P9WKF9,ISPH1_MYCTU,Rv3382c,ispH1 lytB1 Rv3382c MTV004.40c,GO:0019288; GO:0046872; GO:0050992; GO:0051539; GO:0051745,IPR003451; ,,ispH1,,4-hydroxy-3-methylbut-2-enyl diphosphate reductase 1 (HDR 1) (HMBPP reductase 1) (EC 1.17.7.4),"4 iron, 4 sulfur cluster binding [GO:0051539]; 4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity [GO:0051745]; metal ion binding [GO:0046872]; dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]",9634230; 23091471; 26309039,,"FUNCTION: Catalyzes the conversion of 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate (HMBPP) into a mixture of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) (PubMed:23091471). Acts in the terminal step of the DOXP/MEP pathway for isoprenoid precursor biosynthesis. Has a reduced activity compared with LytB2 (PubMed:23091471). Is unable to functionally complement the loss of lytB2 in M.tuberculosis (PubMed:26309039). {ECO:0000255|HAMAP-Rule:MF_00191, ECO:0000269|PubMed:23091471, ECO:0000269|PubMed:26309039}.",MAEVFVGPVAQGYASGEVTVLLASPRSFCAGVERAIETVKRVLDVAEGPVYVRKQIVHNTVVVAELRDRGAVFVEDLDEIPDPPPPGAVVVFSAHGVSPAVRAGADERGLQVVDATCPLVAKVHAEAARFAARGDTVVFIGHAGHEETEGTLGVAPRSTLLVQTPADVAALNLPEGTQLSYLTQTTLALDETADVIDALRARFPTLGQPPSEDICYATTNRQRALQSMVGECDVVLVIGSCNSSNSRRLVELAQRSGTPAYLIDGPDDIEPEWLSSVSTIGVTAGASAPPRLVGQVIDALRGYASITVVERSIATETVRFGLPKQVRAQ,"34,666",329,IspH family,"dimethylallyl diphosphate biosynthetic process [GO:0050992]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]","4-hydroxy-3-methylbut-2-en-1-yl diphosphate reductase activity [GO:0051745]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",,lytB1,MTV004.40c,1
P9WKL1,IDH_MYCTU,Rv3339c,icd Rv3339c MTV016.39c,GO:0000287; GO:0004450; GO:0005886; GO:0006097; GO:0006099; GO:0006102; GO:0008270; GO:0051287,IPR019818; IPR004790; IPR024084; ,,icd,,Isocitrate dehydrogenase [NADP] (IDH) (EC 1.1.1.42) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase),plasma membrane [GO:0005886]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,X-ray crystallography (1),,MSNAPKIKVSGPVVELDGDEMTRVIWKLIKDMLILPYLDIRLDYYDLGIEHRDATDDQVTIDAAYAIKKHGVGVKCATITPDEARVEEFNLKKMWLSPNGTIRNILGGTIFREPIVISNVPRLVPGWTKPIVIGRHAFGDQYRATNFKVDQPGTVTLTFTPADGSAPIVHEMVSIPEDGGVVLGMYNFKESIRDFARASFSYGLNAKWPVYLSTKNTILKAYDGMFKDEFERVYEEEFKAQFEAAGLTYEHRLIDDMVAACLKWEGGYVWACKNYDGDVQSDTVAQGYGSLGLMTSVLMTADGKTVEAEAAHGTVTRHYRQYQAGKPTSTNPIASIFAWTRGLQHRGKLDGTPEVIDFAHKLESVVIATVESGKMTKDLAILIGPEQDWLNSEEFLDAIADNLEKELAN,"45,514",409,Isocitrate and isopropylmalate dehydrogenases family,glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270],plasma membrane [GO:0005886],,MTV016.39c,1
P9WK37,LPQB_MYCTU,Rv3244c,lpqB Rv3244c,GO:0005576; GO:0005618; GO:0005886; GO:0040007,IPR019606; IPR023959; IPR018910; ,,lpqB,,Lipoprotein LpqB,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 20233304; 21969609,,"FUNCTION: May modulate activity of the MtrAB system in controlling homeostasis of the cell wall and cell division (By similarity). Partially restores antibiotic resistance to M.smegmatis in which this gene has been disrupted. {ECO:0000250, ECO:0000269|PubMed:20233304}.",MERLMRLTILLFLGAVLAGCASVPSTSAPQAIGTVERPVPSNLPKPSPGMDPDVLLREFLKATADPANRHLAARQFLTESASNAWDDAGSALLIDHVVFVETRSAEKVSVTMRADILGSLSDVGVFETAEGQLPDPGPIELVKTSDGWRIDRLPNGVFLDWQQFQETYKRNTLYFADPTGKTVVPDPRYVAVSDRDQLATELVSKLLAGPRPEMARTVRNLLAPPLRLRGPVTRADGGKSGIGRGYGGARVDMEKLSTTDPHSRQLLAAQIIWTLARADIRGPYVINADGAPLEDRFAEGWTTSDVAATDPGVADGAAAGLHALVNGSLVAMDAQRVTPVPGAFGRMPEQTAAAVSRSGRQVASVVTLGRGAPDEAASLWVGDLGGEAVQSADGHSLSRPSWSLDDAVWVVVDTNVVLRAIQDPASGQPARIPVDSTAVASRFPGAINDLQLSRDGTRAAMVIGGQVILAGVEQTQAGQFALTYPRRLGFGLGSSVVSLSWRTGDDIVVTRTDAAHPVSYVNLDGVNSDAPSRGLQTPLTAIAANPSTVYVAGPQGVLMYSASVESRPGWADVPGLMVPGAAPVLPG,"61,681",587,LpqB lipoprotein family,growth [GO:0040007],,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WHH7,LPDA_MYCTU,Rv3303c,lpdA lpdA-2 Rv3303c,GO:0003955; GO:0005623; GO:0009055; GO:0009405; GO:0016655; GO:0045454; GO:0050660; GO:0055114; GO:0070401,IPR036188; IPR023753; IPR016156; IPR001100; IPR004099; ,,lpdA,,NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) (NAD(P)H quinone reductase) (NAD(P)H: menadione oxidoreductase) (NADH-menadione reductase),"cell [GO:0005623]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADP+ binding [GO:0070401]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405]",9634230; 17097323; 19099550; 21969609; 15456792,X-ray crystallography (1),"FUNCTION: May contribute to virulence by increasing resistance to reactive oxygen intermediates. It can reduce 2,6-dimethyl-1,4-benzoquinone (DMBQ), 5-hydroxy-1,4-naphthaquinone (5-HNQ) and menadione. NADPH is the physiological reductant rather than NADH. {ECO:0000269|PubMed:15456792, ECO:0000269|PubMed:17097323}.",MVTRIVILGGGPAGYEAALVAATSHPETTQVTVIDCDGIGGAAVLDDCVPSKTFIASTGLRTELRRAPHLGFHIDFDDAKISLPQIHARVKTLAAAQSADITAQLLSMGVQVIAGRGELIDSTPGLARHRIKATAADGSTSEHEADVVLVATGASPRILPSAQPDGERILTWRQLYDLDALPDHLIVVGSGVTGAEFVDAYTELGVPVTVVASQDHVLPYEDADAALVLEESFAERGVRLFKNARAASVTRTGAGVLVTMTDGRTVEGSHALMTIGSVPNTSGLGLERVGIQLGRGNYLTVDRVSRTLATGIYAAGDCTGLLPLASVAAMQGRIAMYHALGEGVSPIRLRTVAATVFTRPEIAAVGVPQSVIDAGSVAARTIMLPLRTNARAKMSEMRHGFVKIFCRRSTGVVIGGVVVAPIASELILPIAVAVQNRITVNELAQTLAVYPSLSGSITEAARRLMAHDDLDCTAAQDAAEQLALVPHHLPTSN,"51,489",493,Class-I pyridine nucleotide-disulfide oxidoreductase family,cell redox homeostasis [GO:0045454]; oxidation-reduction process [GO:0055114]; pathogenesis [GO:0009405],"electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADP+ binding [GO:0070401]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",cell [GO:0005623],lpdA-2,,1
I6Y3P1,LPRN_MYCTU,Rv3495c,lprN mce4E Rv3495c LH57_19060,GO:0005886; GO:0009405,IPR005693; IPR003399; ,,lprN,,Lipoprotein LprN,plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 21969609; 24989028,,"FUNCTION: Stimulates the host (mouse) immune response; lipidated protein produced in E.coli stimulates T-cell proliferation in mice previously sensitized with LprN. Spleenocytes from these mice produce increased amounts of TNF-alpha and IFN-gamma, as well as somewhat increased nitric oxide levels, upon subsequent challenge with LprN. Previously sensitized mice infected with M.tuberculosis have an exacerbated disease response, suggesting this lipoprotein may down-regulate the host's immune response. {ECO:0000269|PubMed:24989028}.",MNRIWLRAIILTASSALLAGCQFGGLNSLPLPGTAGHGEGAYSVTVEMADVATLPQNSPVMVDDVTVGSVAGIVAVQRPDGSFYAAVKLDLDKNVLLPANAVAKVSQTSLLGSLHVELAPPTDRPPTGRLVDGSRITEANTDRFPTTEEVFSALGVVVNKGNVGALEEIIDETHQAVAGRQAQFVNLVPRLAELTAGLNRQVHDIIDALDGLNRVSAILARDKDNLGRALDTLPDAVRVLNQNRDHIVDAFAALKRLTMVTSHVLAETKVDFGEDLKDLYSIVKALNDDRKDFVTSLQLLLTFPFPNFGIKQAVRGDYLNVFTTFDLTLRRIGETFFTTAYFDPNMAHMDEILNPPDFLIGELANLSGQAADPFKIPPGTASGQ,"41,293",384,,pathogenesis [GO:0009405],,plasma membrane [GO:0005886],mce4E,LH57_19060,1
P9WKI7,IMDH_MYCTU,Rv3411c,guaB guaB2 Rv3411c MTCY78.17,GO:0003938; GO:0005618; GO:0005737; GO:0005886; GO:0006177; GO:0006183; GO:0006204; GO:0040007; GO:0046872; GO:0097293,IPR013785; IPR000644; IPR005990; IPR015875; IPR001093; ,,guaB,DOMAIN 129 185 CBS 1. {ECO:0000255|HAMAP-Rule:MF_01964}.; DOMAIN 189 246 CBS 2. {ECO:0000255|HAMAP-Rule:MF_01964}.,Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) (IMPDH) (EC 1.1.1.205) (IMPDH2),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; GMP biosynthetic process [GO:0006177]; growth [GO:0040007]; GTP biosynthetic process [GO:0006183]; IMP catabolic process [GO:0006204]; XMP biosynthetic process [GO:0097293],9634230; 12657046; 20491506; 21081761; 21969609; 22479467; 26440283,X-ray crystallography (7),"FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth (PubMed:20491506, PubMed:21081761). Does not catalyze the reverse reaction, i.e. the conversion of XMP to IMP (PubMed:21081761). Appears to be essential for the optimal growth of M.tuberculosis (PubMed:12657046). {ECO:0000255|HAMAP-Rule:MF_01964, ECO:0000269|PubMed:12657046, ECO:0000269|PubMed:20491506, ECO:0000269|PubMed:21081761}.",MSRGMSGLEDSSDLVVSPYVRMGGLTTDPVPTGGDDPHKVAMLGLTFDDVLLLPAASDVVPATADTSSQLTKKIRLKVPLVSSAMDTVTESRMAIAMARAGGMGVLHRNLPVAEQAGQVEMVKRSEAGMVTDPVTCRPDNTLAQVDALCARFRISGLPVVDDDGALVGIITNRDMRFEVDQSKQVAEVMTKAPLITAQEGVSASAALGLLRRNKIEKLPVVDGRGRLTGLITVKDFVKTEQHPLATKDSDGRLLVGAAVGVGGDAWVRAMMLVDAGVDVLVVDTAHAHNRLVLDMVGKLKSEVGDRVEVVGGNVATRSAAAALVDAGADAVKVGVGPGSICTTRVVAGVGAPQITAILEAVAACRPAGVPVIADGGLQYSGDIAKALAAGASTAMLGSLLAGTAEAPGELIFVNGKQYKSYRGMGSLGAMRGRGGATSYSKDRYFADDALSEDKLVPEGIEGRVPFRGPLSSVIHQLTGGLRAAMGYTGSPTIEVLQQAQFVRITPAGLKESHPHDVAMTVEAPNYYAR,"54,867",529,IMPDH/GMPR family,GMP biosynthetic process [GO:0006177]; growth [GO:0040007]; GTP biosynthetic process [GO:0006183]; IMP catabolic process [GO:0006204]; XMP biosynthetic process [GO:0097293],IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],guaB2,MTCY78.17,1
O06335,ILVB2_MYCTU,Rv3470c,ilvB2 Rv3470c,GO:0000287; GO:0003984; GO:0009097; GO:0009099; GO:0030976,IPR029035; IPR029061; IPR012000; IPR012001; IPR000399; IPR011766; ,,ilvB2,,Putative acetolactate synthase large subunit IlvB2 (ALS) (EC 2.2.1.6) (Acetohydroxy-acid synthase large subunit) (AHAS),acetolactate synthase activity [GO:0003984]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 20884690,,"FUNCTION: Catalyzes the conversion of 2 pyruvate molecules into acetolactate in the first common step of the biosynthetic pathway of the branched-amino acids such as leucine, isoleucine, and valine. {ECO:0000250}.",MTVGDHLVARMRAAGISVVCGLPTSRLDSLLVRLSRDAGFQIVLARHEGGAGYLADGFARASGKSAAVFVAGPGATNVISAVANASVNQVPMLILTGEVAVGEFGLHSQQDTSDDGLGLGATFRRFCRCSVSIESIANARSKIDSAFRALASIPRGPVHIALPRDLVDERLPAHQLGTAAAGLGGLRTLAPCGPDVADEVIGRLDRSRAPMLVLGNGCRLDGIGEQIVAFCEKAGLPFATTPNGRGIVAETHPLSLGVLGIFGDGRADEYLFDTPCDLLIAVGVSFGGLVTRSFSPRWRGLKADVVHVDPDPSAVGRFVATSLGITTSGRAFVNALNCGRPPRFCRRVGVRPPAPAALPGTPQARGESIHPLELMHELDRELAPNATICADVGTCISWTFRGIPVRRPGRFFATVDFSPMGCGIAGAIGVALARPEEHVICIAGDGAFLMHGTEISTAVAHGIRVTWAVLNDGQMSASAGPVSGRMDPSPVARIGANDLAAMARALGAEGIRVDTRCELRAGVQKALAATGPCVLDIAIDPEINKPDIGLGR,"57,257",552,TPP enzyme family,isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase activity [GO:0003984]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976],,,,1
P9WP81,COFD_MYCTU,Rv3261,cofD fbiA Rv3261,GO:0000287; GO:0009108; GO:0016780; GO:0043743,IPR002882; IPR010115; ,,cofD,,2-phospho-L-lactate transferase (EC 2.7.8.28) (LPPG:FO 2-phospho-L-lactate transferase),"LPPG:FO 2-phospho-L-lactate transferase activity [GO:0043743]; magnesium ion binding [GO:0000287]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]; coenzyme biosynthetic process [GO:0009108]",9634230; 19099550; 21969609,,"FUNCTION: Catalyzes the transfer of the 2-phospholactate moiety from lactyl (2) diphospho-(5')guanosine (LPPG) to 7,8-didemethyl-8-hydroxy-5-deazariboflavin (FO) with the formation of the L-lactyl phosphodiester of 7,8-didemethyl-8-hydroxy-5-deazariboflavin (F420-0) and GMP. {ECO:0000255|HAMAP-Rule:MF_01257}.",MKVTVLAGGVGGARFLLGVQQLLGLGQFAANSAHSDADHQLSAVVNVGDDAWIHGLRVCPDLDTCMYTLGGGVDPQRGWGQRDETWHAMQELVRYGVQPDWFELGDRDLATHLVRTQMLQAGYPLSQITEALCDRWQPGARLLPATDDRCETHVVITDPVDESRKAIHFQEWWVRYRAQVPTHSFAFVGAEKSSAATEAIAALADADIIMLAPSNPVVSIGAILAVPGIRAALREATAPIVGYSPIIGEKPLRGMADTCLSVIGVDSTAAAVGRHYGARCATGILDCWLVHDGDHAEIDGVTVRSVPLLMTDPNATAEMVRAGCDLAGVVA,"35,335",331,CofD family,coenzyme biosynthetic process [GO:0009108],"LPPG:FO 2-phospho-L-lactate transferase activity [GO:0043743]; magnesium ion binding [GO:0000287]; phosphotransferase activity, for other substituted phosphate groups [GO:0016780]",,fbiA,,1
P9WMV9,CHOD_MYCTU,Rv3409c,choD Rv3409c,GO:0004769; GO:0006694; GO:0008203; GO:0009405; GO:0016995,IPR036188; IPR007867; ,,choD,,Cholesterol oxidase (EC 1.1.3.6) (Cholesterol isomerase) (EC 5.3.3.1),cholesterol oxidase activity [GO:0016995]; steroid delta-isomerase activity [GO:0004769]; cholesterol metabolic process [GO:0008203]; pathogenesis [GO:0009405]; steroid biosynthetic process [GO:0006694],9634230; 17651430; 21969609,,"FUNCTION: Catalyzes the oxidation and isomerization of cholesterol to cholestenone (4-cholesten-3-one), which is an initial step in the cholesterol degradation process. Required for virulence. {ECO:0000269|PubMed:17651430}.",MKPDYDVLIIGSGFGGSVTALRLTEKGYRVGVLEAGRRFSDEEFAKTSWDLRKFLWAPRLGCYGIQRIHPLRNVMILAGAGVGGGSLNYANTLYVPPEPFFADQQWSHITDWRGELMPHYQQAQRMLGVVQNPTFTDADRIVKEVADEMGFGDTWVPTPVGVFFGPDGTKTPGKTVPDPYFGGAGPARTGCLECGCCMTGCRHGAKNTLVKNYLGLAESAGAQVIPMTTVKGFERRSDGLWEVRTVRTGSWLRRDRRTFTATQLVLAAGTWGTQHLLFKMRDRGRLPGLSKRLGVLTRTNSESIVGAATLKVNPDLDLTHGVAITSSIHPTADTHIEPVRYGKGSNAMGLLQTLMTDGSGPQGTDVPRWRQLLQTASQDPRGTIRMLNPRQWSERTVIALVMQHLDNSITTFTKRGKLGIRWYSSKQGHGEPNPTWIPIGNQVTRRIAAKIDGVAGGTWGELFNIPLTAHFLGGAVIGDDPEHGVIDPYHRVYGYPTLYVVDGAAISANLGVNPSLSIAAQAERAASLWPNKGETDRRPPQGEPYRRLAPIQPAHPVVPADAPGALRWLPIDPVSNAG,"63,024",578,GMC oxidoreductase family,cholesterol metabolic process [GO:0008203]; pathogenesis [GO:0009405]; steroid biosynthetic process [GO:0006694],cholesterol oxidase activity [GO:0016995]; steroid delta-isomerase activity [GO:0004769],,,,1
P9WPB7,CMAS1_MYCTU,Rv3392c,cmaA1 cma1 CMAS-1 Rv3392c MTV004.50,GO:0005737; GO:0005886; GO:0008610; GO:0008825; GO:0046500; GO:0071768,IPR003333; IPR029063; ,,cmaA1,,Cyclopropane mycolic acid synthase 1 (CMAS) (EC 2.1.1.79) (Cyclopropane-fatty-acyl-phospholipid synthase) (CFA synthase) (Cyclopropane fatty acid synthase) (Mycolic acid methyltransferase) (MA-MT) (S-adenosylmethionine-dependent methyltransferase) (AdoMet-MT) (SAM-MT),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825]; lipid biosynthetic process [GO:0008610]; mycolic acid biosynthetic process [GO:0071768]; S-adenosylmethionine metabolic process [GO:0046500],9634230; 7592990; 21969609; 11756461,X-ray crystallography (3),"FUNCTION: Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:7592990}.",MPDELKPHFANVQAHYDLSDDFFRLFLDPTQTYSCAYFERDDMTLQEAQIAKIDLALGKLGLQPGMTLLDVGCGWGATMMRAVEKYDVNVVGLTLSKNQANHVQQLVANSENLRSKRVLLAGWEQFDEPVDRIVSIGAFEHFGHERYDAFFSLAHRLLPADGVMLLHTITGLHPKEIHERGLPMSFTFARFLKFIVTEIFPGGRLPSIPMVQECASANGFTVTRVQSLQPHYAKTLDLWSAALQANKGQAIALQSEEVYERYMKYLTGCAEMFRIGYIDVNQFTCQK,"32,461",287,CFA/CMAS family,lipid biosynthetic process [GO:0008610]; mycolic acid biosynthetic process [GO:0071768]; S-adenosylmethionine metabolic process [GO:0046500],cyclopropane-fatty-acyl-phospholipid synthase activity [GO:0008825],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cma1 CMAS-1,MTV004.50,1
P9WPL7,CP141_MYCTU,Rv3121,cyp141 Rv3121 MTCY164.31,GO:0005506; GO:0005886; GO:0006707; GO:0008395; GO:0016021; GO:0020037; GO:0036199,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp141,,Putative cytochrome P450 141 (EC 1.14.-.-),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; cholesterol catabolic process [GO:0006707],9634230; 21969609,,,MTSTSIPTFPFDRPVPTEPSPMLSELRNSCPVAPIELPSGHTAWLVTRFDDVKGVLSDKRFSCRAAAHPSSPPFVPFVQLCPSLLSIDGPQHTAARRLLAQGLNPGFIARMRPVVQQIVDNALDDLAAAEPPVDFQEIVSVPIGEQLMAKLLGVEPKTVHELAAHVDAAMSVCEIGDEEVSRRWSALCTMVIDILHRKLAEPGDDLLSTIAQANRQQSTMTDEQVVGMLLTVVIGGVDTPIAVITNGLASLLHHRDQYERLVEDPGRVARAVEEIVRFNPATEIEHLRVVTEDVVIAGTALSAGSPAFTSITSANRDSDQFLDPDEFDVERNPNEHIAFGYGPHACPASAYSRMCLTTFFTSLTQRFPQLQLARPFEDLERRGKGLHSVGIKELLVTWPT,"43,731",400,Cytochrome P450 family,cholesterol catabolic process [GO:0006707],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY164.31,1
I6YC53,ESXT_MYCTU,Rv3444c,esxT Rv3444c LH57_18810,GO:0005576; GO:0009405,IPR036689; IPR010310; ,,esxT,,ESAT-6-like protein EsxT,extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 19876390; 20085764; 25242740,,FUNCTION: Induces apoptosis of host cells via activation of NF-kappa-B. {ECO:0000269|PubMed:25242740}.,MNADPVLSYNFDAIEYSVRQEIHTTAARFNAALQELRSQIAPLQQLWTREAAAAYHAEQLKWHQAASALNEILIDLGNAVRHGADDVAHADRRAAGAWAR,"11,120",100,"WXG100 family, ESAT-6 subfamily",pathogenesis [GO:0009405],,extracellular region [GO:0005576],,LH57_18810,1
P9WNQ1,ECCD4_MYCTU,Rv3448,eccD4 Rv3448,GO:0005618; GO:0005886; GO:0016021,IPR006707; IPR024962; ,,eccD4,,ESX-4 secretion system protein eccD4 (ESX conserved component D4) (Type VII secretion system protein eccD4) (T7SS protein eccD4),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 19099550; 19876390,,,MPTSDPGLRRVTVHAGAQAVDLTLPAAVPVATLIPSIVDILGDRGASPATAARYQLSALGAPALPNATTLAQCGIRDGAVLVLHKSSAQPPTPRCDDVAEAVAAALDTTARPQCQRTTRLSGALAASCITAGGGLMLVRNALGTNVTRYSDATAGVVAAAGLAALLFAVIACRTYRDPIAGLTLSVIATIFGAVAGLLAVPGVPGVHSVLVAAMAAAATSVLAMRITGCGGITLTAVACCAVVVAAATLVGAITAAPVPAIGSLATLASFGLLEVSARMAVLLAGLSPRLPPALNPDDADALPTTDRLTTRANRADAWLTSLLAAFAASATIGAIGTAVATHGIHRSSMGGIALAAVTGALLLLRARSADTRRSLVFAICGITTVATAFTVAADRALEHGPWIAALTAMLAAVAMFLGFVAPALSLSPVTYRTIELLECLALIAMVPLTAWLCGAYSAVRHLDLTWT,"46,731",467,EccD/Snm4 family,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNC1,END8B_MYCTU,Rv3297,nei2 nei1 Rv3297 MTCY71.37,GO:0003684; GO:0003690; GO:0006281; GO:0006284; GO:0006289; GO:0008270; GO:0019104; GO:0140078,IPR015886; IPR015887; IPR012319; IPR035937; IPR010979; IPR000214; ,,nei2,,Endonuclease 8 2 (DNA glycosylase/AP lyase Nei 2) (EC 3.2.2.-) (DNA-(apurinic or apyrimidinic site) lyase Nei 2) (EC 4.2.99.18) (Endonuclease VIII 2),class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289],9634230; 18457574; 20031487; 21764637,,"FUNCTION: Involved in base excision repair of DNA damaged by oxidation or by mutagenic agents. Acts as DNA glycosylase that recognizes and removes damaged bases. Has AP (apurinic/apyrimidinic) lyase activity and introduces nicks in the DNA strand. Cleaves the DNA backbone by beta-delta elimination to generate a single-strand break at the site of the removed base with both 3'- and 5'-phosphates (By similarity). Complements an E.coli nei nth double mutant (PubMed:20031487). {ECO:0000255|PROSITE-ProRule:PRU00392, ECO:0000269|PubMed:20031487}.",MPEGDTVWHTAATLRRHLAGRTLTRCDIRVPRFAAVDLTGEVVDEVISRGKHLFIRTGTASIHSHLQMDGSWRVGNRPVRVDHRARIILEANQQEQAIRVVGVDLGLLEVIDRHNDGAVVAHLGPDLLADDWDPQRAAANLIVAPDRPIAEALLDQRVLAGIGNVYCNELCFVSGVLPTAPVSAVADPRRLVTRARDMLWVNRFRWNRCTTGDTRAGRRLWVYGRAGQGCRRCGTLIAYDTTDERVRYWCPACQR,"28,526",255,FPG family,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; nucleotide-excision repair [GO:0006289],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; zinc ion binding [GO:0008270],,nei1,MTCY71.37,1
O53328,FQR78_MYCTU,Rv3178,Rv3178,GO:0005618; GO:0005886; GO:0016491; GO:0055114; GO:0070967,IPR004378; IPR012349; ,,,,Putative F420H(2)-dependent quinone reductase Rv3178 (Fqr) (EC 1.1.98.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230,,"FUNCTION: Involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents. Catalyzes the F420H(2)-dependent two-electron reduction of quinones to dihydroquinones, thereby preventing the formation of cytotoxic semiquinones obtained by the one-electron reduction pathway. Since menaquinone is the sole quinone electron carrier in the respiratory chain in M.tuberculosis, the physiological electron acceptor for Fqr-mediated F420H(2) oxidation is therefore likely to be the endogenous menaquinone found in the membrane fraction of M.tuberculosis. {ECO:0000250|UniProtKB:P9WP15}.",MRLGAGFRKPVPTLLLEHRSRKSGKNFVAPLLYITDRNNVIVVASALGQAENPQWYRNLPPNPDTHIQIGSDRRPVRAVVASSDERARLWPRPVDAYADFDSCQSWTERGIPVIILRPR,"13,497",119,F420H(2)-dependent quinone reductase family,oxidation-reduction process [GO:0055114],coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
P9WPE9,CH601_MYCTU,Rv3417c,groEL1 groEL-1 groL1 Rv3417c MTCY78.12,GO:0003697; GO:0005524; GO:0005618; GO:0005886; GO:0006458; GO:0009408; GO:0009986; GO:0040007; GO:0042026; GO:0042262; GO:0043590; GO:0044183; GO:0051082; GO:0061077; GO:0090143; GO:1990220; GO:2000679,IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; IPR027410; ,,groEL1,,60 kDa chaperonin 1 (GroEL protein 1) (Protein Cpn60-1),bacterial nucleoid [GO:0043590]; cell surface [GO:0009986]; cell wall [GO:0005618]; GroEL-GroES complex [GO:1990220]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; single-stranded DNA binding [GO:0003697]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; DNA protection [GO:0042262]; growth [GO:0040007]; nucleoid organization [GO:0090143]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein refolding [GO:0042026]; response to heat [GO:0009408],7681982; 9634230; 15327959; 18227175; 19201798; 19470749; 19717599; 21969609; 21094166; 27353550,X-ray crystallography (1),"FUNCTION: Prevents aggregation of substrate proteins and promotes their refolding (PubMed:15327959). Functions in the absence of co-chaperone CH10 and ATP. {ECO:0000269|PubMed:15327959, ECO:0000305|PubMed:21094166}.; FUNCTION: May mediate association of bacteria with macrophages; recombinant protein competitively inhibits the association of M.tuberculosis with mouse bone marrow-derived macrophages (PubMed:19470749). {ECO:0000269|PubMed:19470749}.",MSKLIEYDETARRAMEVGMDKLADTVRVTLGPRGRHVVLAKAFGGPTVTNDGVTVAREIELEDPFEDLGAQLVKSVATKTNDVAGDGTTTATILAQALIKGGLRLVAAGVNPIALGVGIGKAADAVSEALLASATPVSGKTGIAQVATVSSRDEQIGDLVGEAMSKVGHDGVVSVEESSTLGTELEFTEGIGFDKGFLSAYFVTDFDNQQAVLEDALILLHQDKISSLPDLLPLLEKVAGTGKPLLIVAEDVEGEALATLVVNAIRKTLKAVAVKGPYFGDRRKAFLEDLAVVTGGQVVNPDAGMVLREVGLEVLGSARRVVVSKDDTVIVDGGGTAEAVANRAKHLRAEIDKSDSDWDREKLGERLAKLAGGVAVIKVGAATETALKERKESVEDAVAAAKAAVEEGIVPGGGASLIHQARKALTELRASLTGDEVLGVDVFSEALAAPLFWIAANAGLDGSVVVNKVSELPAGHGLNVNTLSYGDLAADGVIDPVKVTRSAVLNASSVARMVLTTETVVVDKPAKAEDHDHHHGHAH,"55,877",539,Chaperonin (HSP60) family,'de novo' protein folding [GO:0006458]; chaperone-mediated protein folding [GO:0061077]; DNA protection [GO:0042262]; growth [GO:0040007]; nucleoid organization [GO:0090143]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; protein refolding [GO:0042026]; response to heat [GO:0009408],ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; single-stranded DNA binding [GO:0003697]; unfolded protein binding [GO:0051082],bacterial nucleoid [GO:0043590]; cell surface [GO:0009986]; cell wall [GO:0005618]; GroEL-GroES complex [GO:1990220]; plasma membrane [GO:0005886],groEL-1 groL1,MTCY78.12,1
P9WNE9,DESET_MYCTU,Rv3230c,Rv3230c,GO:0005886; GO:0006631; GO:0009055; GO:0022900; GO:0046872; GO:0051537; GO:0055114; GO:0070402,IPR036010; IPR001041; IPR012675; IPR017927; IPR001709; IPR008333; IPR001433; IPR001221; IPR017938; ,,,DOMAIN 58 164 FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.; DOMAIN 299 380 2Fe-2S ferredoxin-type. {ECO:0000255|PROSITE-ProRule:PRU00465}.,NADPH oxidoreductase (EC 1.-.-.-) (Stearoyl-CoA 9-desaturase electron transfer partner),"plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADPH binding [GO:0070402]; electron transport chain [GO:0022900]; fatty acid metabolic process [GO:0006631]; oxidation-reduction process [GO:0055114]",9634230; 17087501; 21969609,,FUNCTION: Is likely involved in the aerobic desaturation system responsible for the synthesis of oleic acid from stearoyl-CoA; oleic acid is a precursor of mycobacterial membrane phospholipids and triglycerides. Is the electron transfer partner for the stearoyl-CoA 9-desaturase DesA3. Catalyzes electron transfer reaction between NADPH and the diiron center of DesA3. Cannot use NADH. {ECO:0000269|PubMed:17087501}.,MSKKHTTLNASIIDTRRPTVAGADRHPGWHALRKIAARITTPLLPDDYLHLANPLWSARELRGRILGVRRETEDSATLFIKPGWGFSFDYQPGQYIGIGLLVDGRWRWRSYSLTSSPAASGSARMVTVTVKAMPEGFLSTHLVAGVKPGTIVRLAAPQGNFVLPDPAPPLILFLTAGSGITPVMSMLRTLVRRNQITDVVHLHSAPTAADVMFGAELAALAADHPGYRLSVRETRAQGRLDLTRIGQQVPDWRERQTWACGPEGVLNQADKVWSSAGASDRLHLERFAVSKTAPAGAGGTVTFARSGKSVAADAATSLMDAGEGAGVQLPFGCRMGICQSCVVDLVEGHVRDLRTGQRHEPGTRVQTCVSAASGDCVLDI,"40,795",380,,electron transport chain [GO:0022900]; fatty acid metabolic process [GO:0006631]; oxidation-reduction process [GO:0055114],"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADPH binding [GO:0070402]",plasma membrane [GO:0005886],,,1
P9WNZ3,DESA3_MYCTU,Rv3229c,desA3 Rv3229c,GO:0005886; GO:0016213; GO:0042759; GO:0046872,IPR005804; ,,desA3,,NADPH-dependent stearoyl-CoA 9-desaturase (EC 1.14.19.n4) (Delta(9)-stearoyl desaturase) (Stearoyl-CoA 9-desaturase (NADPH)) (Stearoyl-CoA Delta(9)-desaturase),plasma membrane [GO:0005886]; linoleoyl-CoA desaturase activity [GO:0016213]; metal ion binding [GO:0046872]; long-chain fatty acid biosynthetic process [GO:0042759],9634230; 14559907; 14569030; 17087501; 19099550; 18723625; 21969609,,"FUNCTION: Is likely involved in the aerobic desaturation system responsible for the synthesis of oleic acid from stearoyl-CoA; oleic acid is a precursor of mycobacterial membrane phospholipids and triglycerides. Catalyzes the conversion of stearoyl-CoA to oleoyl-CoA by introduction of a cis double bond between carbons 9 and 10 of the acyl chain. Requires the electron transfer partner Rv3230c to pass two electrons from NADPH to its active site diiron center. Is also able to catalyze the 9-desaturation of palmitoyl-CoA to palmitoleoyl-CoA. {ECO:0000269|PubMed:14559907, ECO:0000269|PubMed:17087501}.",MAITDVDVFAHLTDADIENLAAELDAIRRDVEESRGERDARYIRRTIAAQRALEVSGRLLLAGSSRRLAWWTGALTLGVAKIIENMEIGHNVMHGQWDWMNDPEIHSSTWEWDMSGSSKHWRYTHNFVHHKYTNILGMDDDVGYGMLRVTRDQRWKRYNIFNVVWNTILAIGFEWGVALQHLEIGKIFKGRADREAAKTRLREFSAKAGRQVFKDYVAFPALTSLSPGATYRSTLTANVVANVIRNVWSNAVIFCGHFPDGAEKFTKTDMIGEPKGQWYLRQMLGSANFNAGPALRFMSGNLCHQIEHHLYPDLPSNRLHEISVRVREVCDRYDLPYTTGSFLVQYGKTWRTLAKLSLPDKYLRDNADDAPETRSERMFAGLGPGFAGADPVTGRRRGLKTAIAAVRGRRRSKRMAKSVTEPDDLAA,"48,443",427,Fatty acid desaturase type 1 family,long-chain fatty acid biosynthetic process [GO:0042759],linoleoyl-CoA desaturase activity [GO:0016213]; metal ion binding [GO:0046872],plasma membrane [GO:0005886],,,1
O50406,DITCY_MYCTU,Rv3377c,Rv3377c,GO:0000287; GO:0010350; GO:0016829; GO:0033385; GO:0035439; GO:0035440; GO:0052572,IPR001330; IPR032696; IPR008930; ,,,,Type B diterpene cyclase (EC 5.5.1.16),halimadienyl-diphosphate synthase activity [GO:0035439]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287]; cellular response to magnesium starvation [GO:0010350]; geranylgeranyl diphosphate metabolic process [GO:0033385]; response to host immune response [GO:0052572]; tuberculosinol biosynthetic process [GO:0035440],9634230; 15719101; 19618417; 21969609,,"FUNCTION: Catalyzes the formation of tuberculosinyl diphosphate from geranylgeranyl diphosphate (GGPP). It could also react with (14R/S)-14,15-oxidoGGPP to generate 3alpha- and 3beta-hydroxytuberculosinyl diphosphate. {ECO:0000269|PubMed:15719101, ECO:0000269|PubMed:19618417}.",METFRTLLAKAALGNGISSTAYDTAWVAKLGQLDDELSDLALNWLCERQLPDGSWGAEFPFCYEDRLLSTLAAMISLTSNKHRRRRAAQVEKGLLALKNLTSGAFEGPQLDIKDATVGFELIAPTLMAEAARLGLAICHEESILGELVGVREQKLRKLGGSKINKHITAAFSVELAGQDGVGMLDVDNLQETNGSVKYSPSASAYFALHVKPGDKRALAYISSIIQAGDGGAPAFYQAEIFEIVWSLWNLSRTDIDLSDPEIVRTYLPYLDHVEQHWVRGRGVGWTGNSTLEDCDTTSVAYDVLSKFGRSPDIGAVLQFEDADWFRTYFHEVGPSISTNVHVLGALKQAGYDKCHPRVRKVLEFIRSSKEPGRFCWRDKWHRSAYYTTAHLICAASNYDDALCSDAIGWILNTQRPDGSWGFFDGQATAEETAYCIQALAHWQRHSGTSLSAQISRAGGWLSQHCEPPYAPLWIAKTLYCSATVVKAAILSALRLVDESNQ,"55,262",501,Terpene synthase family,cellular response to magnesium starvation [GO:0010350]; geranylgeranyl diphosphate metabolic process [GO:0033385]; response to host immune response [GO:0052572]; tuberculosinol biosynthetic process [GO:0035440],halimadienyl-diphosphate synthase activity [GO:0035439]; lyase activity [GO:0016829]; magnesium ion binding [GO:0000287],,,,1
P9WMF9,DEVR_MYCTU,Rv3133c,devR dosR Rv3133c,GO:0000160; GO:0001666; GO:0003677; GO:0003700; GO:0005615; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0009405; GO:0019217; GO:0022611; GO:0044161; GO:0045893; GO:0072493; GO:1902882,IPR011006; IPR016032; IPR001789; IPR000792; ,,devR,DOMAIN 3 119 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.; DOMAIN 143 208 HTH luxR-type. {ECO:0000255|PROSITE-ProRule:PRU00411}.,DNA-binding transcriptional activator DevR/DosR,"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular space [GO:0005615]; host cell cytoplasmic vesicle [GO:0044161]; host cell endosome lumen [GO:0072493]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; dormancy process [GO:0022611]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",10970762; 9634230; 11416222; 12595424; 12953092; 12694625; 15033981; 15073296; 17609369; 18474359; 18359816; 18400743; 19103767; 19487478; 20630871; 21764934; 21969609; 28977726; 25002970; 16246368; 18353359,X-ray crystallography (4),"FUNCTION: Member of the two-component regulatory system DevR/DevS (also called DosR/DosS) involved in onset of the dormancy response (PubMed:15033981). Regulates an approximately 48-member regulon (PubMed:12953092, PubMed:11416222, PubMed:15033981, PubMed:18400743). When phosphorylated binds and activates the promoter of DevR regulon genes in response to hypoxia (PubMed:18359816, PubMed:21764934, PubMed:28977726). The presence of target DNA increases stability of phospho-DevR in vitro (PubMed:28977726). Activates its own transcription under hypoxic but not aerobic conditions, probably binds as a dimer to tandem binding sites within the devR and hspX promoters (PubMed:18359816). Accepts a phosphate group from DevS (DosS) and from DosT (PubMed:15033981, PubMed:15073296, PubMed:21764934, PubMed:28977726). Does not regulate transcription of dosT (PubMed:19487478). {ECO:0000269|PubMed:11416222, ECO:0000269|PubMed:12953092, ECO:0000269|PubMed:15033981, ECO:0000269|PubMed:15073296, ECO:0000269|PubMed:18359816, ECO:0000269|PubMed:18400743, ECO:0000269|PubMed:19487478, ECO:0000269|PubMed:21764934, ECO:0000269|PubMed:28977726}.",MVKVFLVDDHEVVRRGLVDLLGADPELDVVGEAGSVAEAMARVPAARPDVAVLDVRLPDGNGIELCRDLLSRMPDLRCLILTSYTSDEAMLDAILAGASGYVVKDIKGMELARAVKDVGAGRSLLDNRAAAALMAKLRGAAEKQDPLSGLTDQERTLLGLLSEGLTNKQIADRMFLAEKTVKNYVSRLLAKLGMERRTQAAVFATELKRSRPPGDGP,"23,294",217,,"dormancy process [GO:0022611]; pathogenesis [GO:0009405]; phosphorelay signal transduction system [GO:0000160]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882]; response to hypoxia [GO:0001666]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular space [GO:0005615]; host cell cytoplasmic vesicle [GO:0044161]; host cell endosome lumen [GO:0072493]; plasma membrane [GO:0005886],dosR,,1
P9WN79,GLPD2_MYCTU,Rv3302c,glpD2 Rv3302c MTCI418A.04c MTV016.01c,GO:0005886; GO:0006071; GO:0006072; GO:0009331; GO:0052591,IPR031656; IPR038299; IPR006076; IPR036188; IPR000447; ,,glpD2,,Glycerol-3-phosphate dehydrogenase 2 (EC 1.1.5.3),glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072],9634230; 21969609,,,MSNPIQAPDGGQGWPAAALGPAQRAVAWKRLGTEQFDVVVIGGGVVGSGCALDAATRGLKVALVEARDLASGTSSRSSKMFHGGLRYLEQLEFGLVREALYERELSLTTLAPHLVKPLPFLFPLTKRWWERPYIAAGIFLYDRLGGAKSVPAQRHFTRAGALRLSPGLKRSSLIGGIRYYDTVVDDARHTMTVARTAAHYGAVVRCSTQVVALLREGDRVIGVGVRDSENGAVAEVRGHVVVNATGVWTDEIQALSKQRGRFQVRASKGVHVVVPRDRIVSDVAMILRTEKSVMFVIPWGSHWIIGTTDTDWNLDLAHPAATKADIDYILGTVNAVLATPLTHADIDGVYAGLRPLLAGESDDTSKLSREHAVAVPAAGLVAIAGGKYTTYRVMAADAIDAAVQFIPARVAPSITEKVSLLGADGYFALVNQAEHVGALQGLHPYRVRHLLDRYGSLISDVLAMAASDPSLLSPITEAPGYLKVEAAYAAAAEGALHLEDILARRMRISIEYPHRGVDCAREVAEVVAPVLGWTAADIDREVANYMARVEAEVLSQAQPDDVSADMLRASAPEARAEILEPVPLD,"62,778",585,FAD-dependent glycerol-3-phosphate dehydrogenase family,glycerol-3-phosphate metabolic process [GO:0006072]; glycerol metabolic process [GO:0006071],sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591],glycerol-3-phosphate dehydrogenase complex [GO:0009331]; plasma membrane [GO:0005886],,MTCI418A.04c MTV016.01c,1
P9WMS7,GUAA_MYCTU,Rv3396c,guaA Rv3396c MTCY78.32,GO:0003921; GO:0003922; GO:0005524; GO:0005618; GO:0006177; GO:0006541; GO:0016462; GO:0040007,IPR029062; IPR017926; IPR001674; IPR004739; IPR022955; IPR025777; IPR022310; IPR014729; ,,guaA,DOMAIN 16 205 Glutamine amidotransferase type-1.; DOMAIN 206 399 GMPS ATP-PPase.,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),cell wall [GO:0005618]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; growth [GO:0040007],9634230; 21969609; 22119138,,FUNCTION: Catalyzes the synthesis of GMP from XMP. {ECO:0000269|PubMed:22119138}.,MVQPADIDVPETPARPVLVVDFGAQYAQLIARRVREARVFSEVIPHTASIEEIRARQPVALVLSGGPASVYADGAPKLDPALLDLGVPVLGICYGFQAMAQALGGIVAHTGTREYGRTELKVLGGKLHSDLPEVQPVWMSHGDAVTAAPDGFDVVASSAGAPVAAFEAFDRRLAGVQYHPEVMHTPHGQQVLSRFLHDFAGLGAQWTPANIANALIEQVRTQIGDGHAICGLSGGVDSAVAAALVQRAIGDRLTCVFVDHGLLRAGERAQVQRDFVAATGANLVTVDAAETFLEALSGVSAPEGKRKIIGRQFIRAFEGAVRDVLDGKTAEFLVQGTLYPDVVESGGGSGTANIKSHHNVGGLPDDLKFTLVEPLRLLFKDEVRAVGRELGLPEEIVARQPFPGPGLGIRIVGEVTAKRLDTLRHADSIVREELTAAGLDNQIWQCPVVLLADVRSVGVQGDGRTYGHPIVLRPVSSEDAMTADWTRVPYEVLERISTRITNEVAEVNRVVLDITSKPPATIEWE,"56,060",525,,glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177]; growth [GO:0040007],ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; GMP synthase activity [GO:0003921]; pyrophosphatase activity [GO:0016462],cell wall [GO:0005618],,MTCY78.32,1
O53332,HIGB3_MYCTU,Rv3182 RVBD_3182,higB3 Rv3182 RVBD_3182 LH57_17365 P425_03314,,IPR009241; ,,higB3,,Putative toxin HigB3,,9634230; 20011113; 24662523,,"FUNCTION: Putative toxic component of a type II toxin-antitoxin (TA) system. Its cognate antitoxin would be HigA3. Not toxic upon expression in M.smegmatis. {ECO:0000269|PubMed:20011113, ECO:0000305|PubMed:24662523}.",MAVILLPQVERWFFALNRDAMASVTGAIDLLEMEGPTLGRPVVDKVNDSTFHNMKELRPAGTSIRILFAFDPARQAILLLGGDKAGNWKRWYDNNIPIADQRSENWLASEHGGG,"12,692",114,Mycobacterial HigB family,,,,,LH57_17365 P425_03314,1
P9WPQ1,BTB7_MYCTU,Rv3221c,Rv3221c MTCY07D11.05,,IPR000089; IPR011053; ,,,DOMAIN 2 71 Biotinyl-binding. {ECO:0000255|PROSITE-ProRule:PRU01066}.,Biotinylated protein TB7.3,,9634230; 10603390,,,MAEDVRAEIVASVLEVVVNEGDQIDKGDVVVLLESMKMEIPVLAEAAGTVSKVAVSVGDVIQAGDLIAVIS,"7,306",71,,,,,,MTCY07D11.05,1
P9WQG1,ACDP_MYCTU,Rv3274c,fadE25 acd Rv3274c MTCY71.14c,GO:0003995; GO:0005618; GO:0005829; GO:0005886; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE25,,Probable acyl-CoA dehydrogenase fadE25 (EC 1.3.99.-),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],9634230; 21969609,,,MVGWAGNPSFDLFKLPEEHDEMRSAIRALAEKEIAPHAAEVDEKARFPEEALVALNSSGFNAVHIPEEYGGQGADSVATCIVIEEVARVDASASLIPAVNKLGTMGLILRGSEELKKQVLPALAAEGAMASYALSEREAGSDAASMRTRAKADGDHWILNGAKCWITNGGKSTWYTVMAVTDPDRGANGISAFMVHKDDEGFTVGPKERKLGIKGSPTTELYFENCRIPGDRIIGEPGTGFKTALATLDHTRPTIGAQAVGIAQGALDAAIAYTKDRKQFGESISTFQAVQFMLADMAMKVEAARLMVYSAAARAERGEPDLGFISAASKCFASDVAMEVTTDAVQLFGGAGYTTDFPVERFMRDAKITQIYEGTNQIQRVVMSRALLR,"41,723",389,Acyl-CoA dehydrogenase family,,acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],acd,MTCY71.14c,1
P63907,ADD_MYCTU,Rv3313c,add Rv3313c MTV016.13,GO:0004000; GO:0005829; GO:0006154; GO:0009117; GO:0009168; GO:0043103; GO:0046103; GO:0046872,IPR001365; IPR028893; IPR006330; IPR032466; ,,add,,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),cytosol [GO:0005829]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],9634230; 21969609,,,MTAAPTLQTIRLAPKALLHDHLDGGLRPATVLDIAGQVGYDDLPATDVDALASWFRTQSHSGSLERYLEPFSHTVAVMQTPEALYRVAFECAQDLAADSVVYAEVRFAPELHISCGLSFDDVVDTVLTGFAAGEKACAADGQPITVRCLVTAMRHAAMSREIAELAIRFRDKGVVGFDIAGAEAGHPPTRHLDAFEYMRDHNARFTIHAGEAFGLPSIHEAIAFCGADRLGHGVRIVDDIDVDADGGFQLGRLAAILRDKRIPLELCPSSNVQTGAVASIAEHPFDLLARARFRVTVNTDNRLMSDTSMSLEMHRLVEAFGYGWSDLARFTVNAMKSAFIPFDQRLAIIDEVIKPRFAALMGHSE,"39,743",365,"Metallo-dependent hydrolases superfamily, Adenosine and AMP deaminases family, Adenosine deaminase subfamily",adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872],cytosol [GO:0005829],,MTV016.13,1
P9WQA9,ALR_MYCTU,Rv3423c,alr Rv3423c MTCY78.06,GO:0008784; GO:0009252; GO:0030170; GO:0030632; GO:0040007,IPR000821; IPR009006; IPR011079; IPR001608; IPR020622; IPR029066; ,,alr,,Alanine racemase (EC 5.1.1.1),alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170]; D-alanine biosynthetic process [GO:0030632]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252],11267762; 9634230; 21969609; 15683232,X-ray crystallography (1),FUNCTION: Catalyzes the interconversion of L-alanine and D-alanine. D-alanine plays a key role in peptidoglycan cross-linking. {ECO:0000269|PubMed:11267762}.,MAMTPISQTPGLLAEAMVDLGAIEHNVRVLREHAGHAQLMAVVKADGYGHGATRVAQTALGAGAAELGVATVDEALALRADGITAPVLAWLHPPGIDFGPALLADVQVAVSSLRQLDELLHAVRRTGRTATVTVKVDTGLNRNGVGPAQFPAMLTALRQAMAEDAVRLRGLMSHMVYADKPDDSINDVQAQRFTAFLAQAREQGVRFEVAHLSNSSATMARPDLTFDLVRPGIAVYGLSPVPALGDMGLVPAMTVKCAVALVKSIRAGEGVSYGHTWIAPRDTNLALLPIGYADGVFRSLGGRLEVLINGRRCPGVGRICMDQFMVDLGPGPLDVAEGDEAILFGPGIRGEPTAQDWADLVGTIHYEVVTSPRGRITRTYREAENR,"40,926",386,Alanine racemase family,D-alanine biosynthetic process [GO:0030632]; growth [GO:0040007]; peptidoglycan biosynthetic process [GO:0009252],alanine racemase activity [GO:0008784]; pyridoxal phosphate binding [GO:0030170],,,MTCY78.06,1
P9WPH3,CDD_MYCTU,Rv3315c,cdd Rv3315c,GO:0004126; GO:0005829; GO:0005886; GO:0008270; GO:0009972; GO:0043100; GO:0046109; GO:0047844,IPR002125; IPR016193; ,,cdd,DOMAIN 4 126 CMP/dCMP-type deaminase. {ECO:0000255|PROSITE-ProRule:PRU01083}.,Cytidine deaminase (CDD) (EC 3.5.4.5) (Cytidine aminohydrolase) (CDA),cytosol [GO:0005829]; plasma membrane [GO:0005886]; cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; pyrimidine nucleobase salvage [GO:0043100]; uridine biosynthetic process [GO:0046109],9634230; 20035876; 21969609,X-ray crystallography (3),"FUNCTION: Recycles cytidine and 2-deoxycytidine for uridine and 2-deoxyuridine synthesis, respectively. Catalyzes the hydrolytic deamination of cytidine and 2-deoxycytidine to form, respectively, uridine and 2-deoxyuridine. {ECO:0000269|PubMed:20035876}.",MPDVDWNMLRGNATQAAAGAYVPYSRFAVGAAALVDDGRVVTGCNVENVSYGLTLCAECAVVCALHSTGGGRLLALACVDGHGSVLMPCGRCRQVLLEHGGSELLIDHPVRPRRLGDLLPDAFGLDDLPRERR,"14,072",133,Cytidine and deoxycytidylate deaminase family,cytidine deamination [GO:0009972]; pyrimidine nucleobase salvage [GO:0043100]; uridine biosynthetic process [GO:0046109],cytidine deaminase activity [GO:0004126]; deoxycytidine deaminase activity [GO:0047844]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WPT5,CTPC_MYCTU,Rv3270,ctpC mtaA Rv3270 MTCY71.10,GO:0005524; GO:0005576; GO:0005886; GO:0016021; GO:0019829; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR027256; IPR001757; ,,ctpC,,Manganese-exporting P-type ATPase (EC 3.6.3.-) (Cation-transporting P-type ATPase CtpC) (Metal-transporting ATPase Mta72),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],9514635; 9634230; 21925112; 21969609; 23482562,,"FUNCTION: High affinity, slow turnover Mn(2+) transporting ATPase, which is required for virulence. Controls the Mn(2+) cytoplasmic quota and is involved in the uploading of Mn(2+) into secreted metalloproteins (PubMed:23482562). Required for tolerance to Zn(2+) and oxidative stress (PubMed:23482562). Plays a crucial role in the ability to resist zinc poisoning in human macrophages (PubMed:21925112). Shows a preference for Mn(2+), but Zn(2+), Co(2+) and Cu(2+) can act as alternative substrates although at slower turnover rates (PubMed:23482562). {ECO:0000269|PubMed:21925112, ECO:0000269|PubMed:23482562}.",MTLEVVSDAAGRMRVKVDWVRCDSRRAVAVEEAVAKQNGVRVVHAYPRTGSVVVWYSPRRADRAAVLAAIKGAAHVAAELIPARAPHSAEIRNTDVLRMVIGGVALALLGVRRYVFARPPLLGTTGRTVATGVTIFTGYPFLRGALRSLRSGKAGTDALVSAATVASLILRENVVALTVLWLLNIGEYLQDLTLRRTRRAISELLRGNQDTAWVRLTDPSAGSDAATEIQVPIDTVQIGDEVVVHEHVAIPVDGEVVDGEAIVNQSAITGENLPVSVVVGTRVHAGSVVVRGRVVVRAHAVGNQTTIGRIISRVEEAQLDRAPIQTVGENFSRRFVPTSFIVSAIALLITGDVRRAMTMLLIACPCAVGLSTPTAISAAIGNGARRGILIKGGSHLEQAGRVDAIVFDKTGTLTVGRPVVTNIVAMHKDWEPEQVLAYAASSEIHSRHPLAEAVIRSTEERRISIPPHEECEVLVGLGMRTWADGRTLLLGSPSLLRAEKVRVSKKASEWVDKLRRQAETPLLLAVDGTLVGLISLRDEVRPEAAQVLTKLRANGIRRIVMLTGDHPEIAQVVADELGIDEWRAEVMPEDKLAAVRELQDDGYVVGMVGDGINDAPALAAADIGIAMGLAGTDVAVETADVALANDDLHRLLDVGDLGERAVDVIRQNYGMSIAVNAAGLLIGAGGALSPVLAAILHNASSVAVVANSSRLIRYRLDR,"76,495",718,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",,ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],mtaA,MTCY71.10,1
P9WPE5,CH10_MYCTU,Rv3418c,groS cpn10 groES mopB Rv3418c MTCY78.11,GO:0005524; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006355; GO:0006986; GO:0009408; GO:0034605; GO:0035375; GO:0040007; GO:0046677; GO:0046872; GO:0051082; GO:0051085; GO:0051087,IPR020818; IPR037124; IPR018369; IPR011032; ,,groS,,10 kDa chaperonin (10 kDa antigen) (BCG-A heat shock protein) (GroES protein) (Protein Cpn10),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; zymogen binding [GO:0035375]; cellular response to heat [GO:0034605]; chaperone cofactor-dependent protein refolding [GO:0051085]; growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]",2902558; 2480990; 2564178; 7681982; 9634230; 1371791; 18227175; 20066036; 21969609; 27353550; 12837792; ,NMR spectroscopy (2); X-ray crystallography (2),FUNCTION: Binds to Cpn60 in the presence of Mg-ATP and suppresses the ATPase activity of the latter.,MAKVNIKPLEDKILVQANEAETTTASGLVIPDTAKEKPQEGTVVAVGPGRWDEDGEKRIPLDVAEGDTVIYSKYGGTEIKYNGEEYLILSARDVLAVVSK,"10,804",100,GroES chaperonin family,"cellular response to heat [GO:0034605]; chaperone cofactor-dependent protein refolding [GO:0051085]; growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; response to antibiotic [GO:0046677]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]",ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; zymogen binding [GO:0035375],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],cpn10 groES mopB,MTCY78.11,1
P9WHP3,CRTB_MYCTU,Rv3397c,crtB phyA Rv3397c MTCY78.31,GO:0004310; GO:0006696; GO:0016117; GO:0016767; GO:0046872; GO:0051996,IPR008949; IPR017828; IPR002060; IPR019845; IPR033904; ,,crtB,,Phytoene synthase (PSase) (EC 2.5.1.-),farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; geranylgeranyl-diphosphate geranylgeranyltransferase activity [GO:0016767]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996]; carotenoid biosynthetic process [GO:0016117]; ergosterol biosynthetic process [GO:0006696],9634230; 21969609,,FUNCTION: Involved in the biosynthesis of carotenoids. Catalyzes the condensation of two molecules of geranylgeranyl diphosphate (GGPP) to give prephytoene diphosphate (PPPP) and the subsequent rearrangement of the cyclopropylcarbinyl intermediate to yield phytoene (By similarity). {ECO:0000250}.,MTEIEQAYRITESITRTAARNFYYGIRLLPREKRAALSAVYALGRRIDDVADGELAPETKITELDAIRKSLDNIDDSSDPVLVALADAARRFPVPIAMFAELIDGARMEIDWTGCRDFDELIVYCRRGAGTIGKLCLSIFGPVSTATSRYAEQLGIALQQTNILRDVREDFLNGRIYLPRDELDRLGVRLRLDDTGALDDPDGRLAALLRFSADRAADWYSLGLRLIPHLDRRSAACCAAMSGIYRRQLALIRASPAVVYDRRISLSGLKKAQVAAAALASSVTCGPAHGPLPADLGSHPSH,"33,142",302,Phytoene/squalene synthase family,carotenoid biosynthetic process [GO:0016117]; ergosterol biosynthetic process [GO:0006696],farnesyl-diphosphate farnesyltransferase activity [GO:0004310]; geranylgeranyl-diphosphate geranylgeranyltransferase activity [GO:0016767]; metal ion binding [GO:0046872]; squalene synthase activity [GO:0051996],,phyA,MTCY78.31,1
P9WP39,CUT3_MYCTU,Rv3451,cut3 Rv3451 MTCY13E12.04,GO:0005576; GO:0008152; GO:0052689,IPR029058; IPR000675; IPR011150; ,,cut3,,Probable cutinase cut3 (EC 3.1.1.74),extracellular region [GO:0005576]; carboxylic ester hydrolase activity [GO:0052689]; metabolic process [GO:0008152],9634230; 21969609,,,MNNRPIRLLTSGRAGLGAGALITAVVLLIALGAVWTPVAFADGCPDAEVTFARGTGEPPGIGRVGQAFVDSLRQQTGMEIGVYPVNYAASRLQLHGGDGANDAISHIKSMASSCPNTKLVLGGYSQGATVIDIVAGVPLGSISFGSPLPAAYADNVAAVAVFGNPSNRAGGSLSSLSPLFGSKAIDLCNPTDPICHVGPGNEFSGHIDGYIPTYTTQAASFVVQRLRAGSVPHLPGSVPQLPGSVLQMPGTAAPAPESLHGR,"26,504",262,Cutinase family,metabolic process [GO:0008152],carboxylic ester hydrolase activity [GO:0052689],extracellular region [GO:0005576],,MTCY13E12.04,1
P9WN41,GLMM_MYCTU,Rv3441c,glmM Rv3441c,GO:0000287; GO:0005975; GO:0008966; GO:0040007,IPR005844; IPR016055; IPR005845; IPR005846; IPR005843; IPR036900; IPR016066; IPR005841; IPR006352; ,,glmM,,Phosphoglucosamine mutase (EC 5.4.2.10),magnesium ion binding [GO:0000287]; phosphoglucosamine mutase activity [GO:0008966]; carbohydrate metabolic process [GO:0005975]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Catalyzes the conversion of glucosamine-6-phosphate to glucosamine-1-phosphate. {ECO:0000255|HAMAP-Rule:MF_01554}.,MGRLFGTDGVRGVANRELTAELALALGAAAARRLSRSGAPGRRVAVLGRDPRASGEMLEAAVIAGLTSEGVDALRVGVLPTPAVAYLTGAYDADFGVMISASHNPMPDNGIKIFGPGGHKLDDDTEDQIEDLVLGVSRGPGLRPAGAGIGRVIDAEDATERYLRHVAKAATARLDDLAVVVDCAHGAASSAAPRAYRAAGARVIAINAEPNGRNINDGCGSTHLDPLRAAVLAHRADLGLAHDGDADRCLAVDANGDLVDGDAIMVVLALAMKEAGELACNTLVATVMSNLGLHLAMRSAGVTVRTTAVGDRYVLEELRAGDYSLGGEQSGHIVMPALGSTGDGIVTGLRLMTRMVQTGSSLSDLASAMRTLPQVLINVEVVDKATAAAAPSVRTAVEQAAAELGDTGRILLRPSGTEPMIRVMVEAADEGVAQRLAATVADAVSTAR,"45,873",448,Phosphohexose mutase family,carbohydrate metabolic process [GO:0005975]; growth [GO:0040007],magnesium ion binding [GO:0000287]; phosphoglucosamine mutase activity [GO:0008966],,,,1
P9WN49,GLMS_MYCTU,Rv3436c,glmS Rv3436c MTCY77.08c,GO:0004360; GO:0005829; GO:0005886; GO:0006002; GO:0006047; GO:0006487; GO:0006541; GO:0040007; GO:0097367,IPR017932; IPR035466; IPR035490; IPR005855; IPR029055; IPR001347; ,,glmS,DOMAIN 2 225 Glutamine amidotransferase type-2. {ECO:0000255|HAMAP-Rule:MF_00164}.; DOMAIN 297 436 SIS 1. {ECO:0000255|HAMAP-Rule:MF_00164}.; DOMAIN 469 614 SIS 2. {ECO:0000255|HAMAP-Rule:MF_00164}.,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase) (GFAT) (Glucosamine-6-phosphate synthase) (Hexosephosphate aminotransferase) (L-glutamine--D-fructose-6-phosphate amidotransferase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047],9634230; 21969609,,"FUNCTION: Catalyzes the first step in hexosamine metabolism, converting fructose-6P into glucosamine-6P using glutamine as a nitrogen source. {ECO:0000255|HAMAP-Rule:MF_00164}.",MCGIVGYVGRRPAYVVVMDALRRMEYRGYDSSGIALVDGGTLTVRRRAGRLANLEEAVAEMPSTALSGTTGLGHTRWATHGRPTDRNAHPHRDAAGKIAVVHNGIIENFAVLRRELETAGVEFASDTDTEVAAHLVARAYRHGETADDFVGSVLAVLRRLEGHFTLVFANADDPGTLVAARRSTPLVLGIGDNEMFVGSDVAAFIEHTREAVELGQDQAVVITADGYRISDFDGNDGLQAGRDFRPFHIDWDLAAAEKGGYEYFMLKEIAEQPAAVADTLLGHFVGGRIVLDEQRLSDQELREIDKVFVVACGTAYHSGLLAKYAIEHWTRLPVEVELASEFRYRDPVLDRSTLVVAISQSGETADTLEAVRHAKEQKAKVLAICNTNGSQIPRECDAVLYTRAGPEIGVASTKTFLAQIAANYLLGLALAQARGTKYPDEVEREYHELEAMPDLVARVIAATGPVAELAHRFAQSSTVLFLGRHVGYPVALEGALKLKELAYMHAEGFAAGELKHGPIALIEDGLPVIVVMPSPKGSATLHAKLLSNIREIQTRGAVTIVIAEEGDETVRPYADHLIEIPAVSTLLQPLLSTIPLQVFAASVARARGYDVDKPRNLAKSVTVE,"67,572",624,,fructose 6-phosphate metabolic process [GO:0006002]; glutamine metabolic process [GO:0006541]; growth [GO:0040007]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine metabolic process [GO:0006047],carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY77.08c,1
P9WG81,FOLD_MYCTU,Rv3356c,folD Rv3356c,GO:0000105; GO:0004477; GO:0004488; GO:0005576; GO:0005829; GO:0005886; GO:0006164; GO:0006730; GO:0009086; GO:0035999; GO:0040007,IPR036291; IPR000672; IPR020630; IPR020631; ,,folD,,Bifunctional protein FolD [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999],9634230; 21969609; ,X-ray crystallography (2),"FUNCTION: Catalyzes the oxidation of 5,10-methylenetetrahydrofolate to 5,10-methenyltetrahydrofolate and then the hydrolysis of 5,10-methenyltetrahydrofolate to 10-formyltetrahydrofolate. {ECO:0000255|HAMAP-Rule:MF_01576}.",MGAIMLDGKATRDEIFGDLKQRVAALDAAGRTPGLGTILVGDDPGSQAYVRGKHADCAKVGITSIRRDLPADISTATLNETIDELNANPDCTGYIVQLPLPKHLDENAALERVDPAKDADGLHPTNLGRLVLGTPAPLPCTPRGIVHLLRRYDISIAGAHVVVIGRGVTVGRPLGLLLTRRSENATVTLCHTGTRDLPALTRQADIVVAAVGVAHLLTADMVRPGAAVIDVGVSRTDDGLVGDVHPDVWELAGHVSPNPGGVGPLTRAFLLTNVVELAERR,"29,484",281,Tetrahydrofolate dehydrogenase/cyclohydrolase family,growth [GO:0040007]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; purine nucleotide biosynthetic process [GO:0006164]; tetrahydrofolate interconversion [GO:0035999],methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488],cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WNA7,ECCC4_MYCTU,Rv3447c,eccC4 Rv3447c,GO:0003677; GO:0005524; GO:0005886; GO:0016021,IPR003593; IPR023836; IPR023837; IPR002543; IPR027417; ,,eccC4,DOMAIN 407 607 FtsK 1. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 747 936 FtsK 2. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 1018 1201 FtsK 3. {ECO:0000255|PROSITE-ProRule:PRU00289}.,ESX-4 secretion system protein EccC4 (ESX conserved component C4) (Type VII secretion system protein EccC4) (T7SS protein EccC4),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677],9634230; 19876390,,,MNSGPACATADILVAPPPELRRSEPSSLLIRLLPVVMSVATVGVMVTVFLPGSPATRHPTFLAFPMMMLVSLVVTAVTGRGRRHVSGIHNDRVDYLGYLSVLRTSVTQTAAAQHVSLNWTHPDPATLWTLIGGPRMWERRPGAADFCRIRVGVGSAPLATRLVVGQLPPAQRADPVTRAALRCFLAAHATIADAPIAIPLRVGGPIAIDGDPTKVRGLLRAMICQLAVWHSPEELLIAGVVSDRNRAHWDWLKWLPHNQHPNACDALGPAPMVYSTLAEMQNALAATVLAHVVAIVDTAERGNGAITGVITIEVGARRDGAPPVVRCAGEVTALACPDQLEPQDALVCARRLAAHRVGHSGRTFIRGSGWAELVGIGDVAAFDPSTLWRNVNQHDRLRVPIGVTPDGTAVQLDIKEAAEQGMGPHGLCVGATGSGKSELLRTIALGMMARNSPEVLNLLLVDFKGGATFLDLAGAPHVAAVITNLAEEAPLVARMQDALAGEMSRRQQLLRMAGHLVSVTAYQRARQTGAQLPCLPILFIVVDEFSELLSQHPEFVDVFLAIGRVGRSLGMHLLLASQRLDEGRLRGLETHLSYRMCLKTWSASESRNVLGTQDAYQLPNTPGAGLLQTGTGELIRFQTAFVSGPLRRASPSAVHPVAPPSVRPFTTHAAAPVTAGPVGGTAEVPTPTVLHAVLDRLVGHGPAAHQVWLPPLDEPPMLGALLRDAEPAQAELAVPIGIVDRPFEQSRVPLTIDLSGAAGNVAVVGAPQTGKSTALRTLIMALAATHDAGRVQFYCLDFGGGALAQVDELPHVGAVAGRAQPQLASRMLAELESAVRFREAFFRDHGIDSVARYRQLRAKSAAESFADIFLVIDGWASLRQEFAALEESIVALAAQGLSFGVHVALSAARWAEIRPSLRDQIGSRIELRLADPADSELDRRQAQRVPVDRPGRGLSRDGMHMVIALPDLDGVALRRRSGDPVAPPIPLLPARVDYDSVVARAGDELGAHILLGLEERRGQPVAVDFGRHPHLLVLGDNECGKTAALRTLCREIVRTHTAARAQLLIVDFRHTLLDVIESEHMSGYVSSPAALGAKLSSLVDLLQARMPAPDVSQAQLRARSWWSGPDIYVVVDDYDLVAVSSGNPLMVLLEYLPHARDLGLHLVVARRSGGAARALFEPVLASLRDLGCRALLMSGRPDEGALFGSSRPMPLPPGRGILVTGAGDEQLVQVAWSPPP,"131,896",1236,,,ATP binding [GO:0005524]; DNA binding [GO:0003677],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNT5,DNAE2_MYCTU,Rv3370c,dnaE2 Rv3370c,GO:0003887; GO:0005618; GO:0005737; GO:0005886; GO:0006260; GO:0006281; GO:0008408; GO:0042276; GO:0046677,IPR011708; IPR023073; IPR029460; IPR004013; IPR003141; IPR016195; IPR004805; ,,dnaE2,,Error-prone DNA polymerase (EC 2.7.7.7),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; 3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; response to antibiotic [GO:0046677],9634230; 12029045; 12705867,,FUNCTION: DNA polymerase involved in damage-induced mutagenesis and translesion synthesis (TLS). It is not the major replicative DNA polymerase. Does not appear to be essential for chromosomal replication. May be involved in generating antibiotic resistance. {ECO:0000269|PubMed:12705867}.,MFDILWNVGWSNGPPSWAEMERVLNGKPRHAGVPAFDADGDVPRSRKRGAYQPPGRERVGSSVAYAELHAHSAYSFLDGASTPEELVEEAARLGLCALALTDHDGLYGAVRFAEAAAELDVRTVFGAELSLGATARTERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGGEKGKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDDERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARLFAWCPEAVTAAAELGERCAFGLQLIAPRLPPFDVPDGHTEDSWLRSLVMAGARERYGPPKSAPRAYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDILCQGRGSAANSAVCYALGVTAVDPVANELLFERFLSPARDGPPDIDIDIESDQREKVIQYVYHKYGRDYAAQVANVITYRGRSAVRDMARALGFSPGQQDAWSKQVSHWTGQADDVDGIPEQVIDLATQIRNLPRHLGIHSGGMVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLARLDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGVDPVIYEHPSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRFYDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYSPQSLVADARRHGVAVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAELAEKLVAERTANGPFTSLPDLTSRVQLSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPGVGSSSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVSDGDRVLIAGAVTHRQRPATAQGVTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVAERMGRLTLAVGARSRDFR,"118,672",1098,"DNA polymerase type-C family, DnaE2 subfamily",DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; response to antibiotic [GO:0046677],3'-5' exonuclease activity [GO:0008408]; DNA-directed DNA polymerase activity [GO:0003887],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WNR1,ECCB4_MYCTU,Rv3450c,eccB4 Rv3450c,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0016787,IPR007795; ,,eccB4,,ESX-4 secretion system ATPase EccB4 (EC 3.6.-.-) (ESX conserved component B4) (Type VII secretion system protein EccB4) (T7SS protein EccB4),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],9634230; 19876390,,FUNCTION: An ATPase (By similarity). {ECO:0000250|UniProtKB:P9WNR7}.,MPSPATTWLHVSGYRFLLRRIECALLFGDVCAATGALRARTTSLALGCVLAIVAAMGCAFVALLRPQSALGQAPIVMGRESGALYVRVDDVWHPVLNLASARLIAATNANPQPVSESELGHTKRGPLLGIPGAPQLLDQPLAGAESAWAICDSDNGGSTTVVVGPAEDSSAQVLTAEQMILVATESGSPTYLLYGGRRAVVDLADPAVVWALRLQGRVPHVVAQSLLNAVPEAPRITAPRIRGGGRASVGLPGFLVGGVVRITRASGDEYYVVLEDGVQRIGQVAADLLRFGDSQGSVNVPTVAPDVIRVAPIVNTLPVSAFPDRPPTPVDGSPGRAVTTLCVTWTPAQPGAARVAFLAGSGPPVPLGGVPVTLAQADGRGPALDAVYLPPGRSAYVAARSLSGGGTGTRYLVTDTGVRFAIHDDDVAHDLGLPTAAIPAPWPVLATLPSGPELSRANASVARDTVAPGP,"48,199",470,EccB family,,ATP binding [GO:0005524]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WGK3,DEVS_MYCTU,Rv3132c,devS dosS Rv3132c,GO:0000155; GO:0000287; GO:0004672; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0016021; GO:0019825; GO:0019826; GO:0020037; GO:0040007; GO:0046777; GO:0046983; GO:0051775; GO:0051776; GO:0070025; GO:0070026; GO:0070483,IPR027035; IPR003018; IPR029016; IPR003594; IPR036890; IPR005467; IPR011712; ,,devS,DOMAIN 63 200 GAF 1.; DOMAIN 231 369 GAF 2.; DOMAIN 383 578 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Oxygen sensor histidine kinase response regulator DevS/DosS (EC 2.7.13.3),cell wall [GO:0005618]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; carbon monoxide binding [GO:0070025]; heme binding [GO:0020037]; magnesium ion binding [GO:0000287]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; phosphorelay sensor kinase activity [GO:0000155]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; detection of hypoxia [GO:0070483]; detection of redox state [GO:0051776]; growth [GO:0040007]; protein autophosphorylation [GO:0046777]; response to redox state [GO:0051775],9634230; 10970762; 11416222; 12953092; 15033981; 15073296; 16213520; 17371046; 17609369; 17600145; 18975917; 19099550; 18474359; 18400743; 19463006; 19487478; 21969609; 27235395; 28977726; 25002970; 19276084; 21536032; 23486471; 27729224,X-ray crystallography (10),"FUNCTION: Member of the two-component regulatory system DevR/DevS (DosR/DosS) involved in onset of the dormancy response (PubMed:12953092). Regulates an approximately 48-member regulon (PubMed:12953092, PubMed:11416222, PubMed:15033981, PubMed:18400743). Required for full induction of the DevR (DosR) regulon; acts later than DosT to positively regulate expression of the DevR regulon during adaptation to anaerobiosis (PubMed:19487478). Characterized as an oxygen sensor; O(2) acts as a switch, with O(2)-bound Fe(2+) protein inactive in autophosphorylation (PubMed:17371046, PubMed:17600145, PubMed:18975917, PubMed:19463006, PubMed:28977726). Has also been suggested to act as a redox sensor, or perhaps as a dual oxygen/redox sensor (PubMed:17609369). Autophosphorylates under anaerobic but not aerobic conditions, binding of NO or CO does not dramatically change the level of autophosphorylation of Fe(2+) protein, binding of O(2) inactivates kinase activity (PubMed:17600145, PubMed:18975917, PubMed:27235395). Binds O(2), NO, CO (PubMed:17371046, PubMed:17609369, PubMed:17600145, PubMed:18975917, PubMed:27235395). It is probably reduced by flavin nucleotides such as FMN and FAD (PubMed:19276084). May be the primary sensor for CO (PubMed:18400743). Donates a phosphate group to transcriptional regulator DevR (DosR) (PubMed:15033981, PubMed:15073296, PubMed:28977726). {ECO:0000269|PubMed:11416222, ECO:0000269|PubMed:12953092, ECO:0000269|PubMed:15033981, ECO:0000269|PubMed:15073296, ECO:0000269|PubMed:17371046, ECO:0000269|PubMed:17600145, ECO:0000269|PubMed:17609369, ECO:0000269|PubMed:18400743, ECO:0000269|PubMed:18474359, ECO:0000269|PubMed:18975917, ECO:0000269|PubMed:19463006, ECO:0000269|PubMed:19487478, ECO:0000269|PubMed:27235395, ECO:0000269|PubMed:28977726}.",MTTGGLVDENDGAAMRPLRHTLSQLRLHELLVEVQDRVEQIVEGRDRLDGLVEAMLVVTAGLDLEATLRAIVHSATSLVDARYGAMEVHDRQHRVLHFVYEGIDEETVRRIGHLPKGLGVIGLLIEDPKPLRLDDVSAHPASIGFPPYHPPMRTFLGVPVRVRDESFGTLYLTDKTNGQPFSDDDEVLVQALAAAAGIAVANARLYQQAKARQSWIEATRDIATELLSGTEPATVFRLVAAEALKLTAADAALVAVPVDEDMPAADVGELLVIETVGSAVASIVGRTIPVAGAVLREVFVNGIPRRVDRVDLEGLDELADAGPALLLPLRARGTVAGVVVVLSQGGPGAFTDEQLEMMAAFADQAALAWQLATSQRRMRELDVLTDRDRIARDLHDHVIQRLFAIGLALQGAVPHERNPEVQQRLSDVVDDLQDVIQEIRTTIYDLHGASQGITRLRQRIDAAVAQFADSGLRTSVQFVGPLSVVDSALADQAEAVVREAVSNAVRHAKASTLTVRVKVDDDLCIEVTDNGRGLPDEFTGSGLTNLRQRAEQAGGEFTLASVPGASGTVLRWSAPLSQ,"62,241",578,,detection of hypoxia [GO:0070483]; detection of redox state [GO:0051776]; growth [GO:0040007]; protein autophosphorylation [GO:0046777]; response to redox state [GO:0051775],ATP binding [GO:0005524]; carbon monoxide binding [GO:0070025]; heme binding [GO:0020037]; magnesium ion binding [GO:0000287]; nitric oxide binding [GO:0070026]; oxygen binding [GO:0019825]; oxygen sensor activity [GO:0019826]; phosphorelay sensor kinase activity [GO:0000155]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672],cell wall [GO:0005618]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],dosS,,1
I6Y3I6,ESXU_MYCTU,Rv3445c,esxU Rv3445c LH57_18815,GO:0005576,IPR036689; IPR010310; ,,esxU,,ESAT-6-like protein EsxU,extracellular region [GO:0005576],9634230; 19876390; 20085764,,,MSTPNTLNADFDLMRSVAGITDARNEEIRAMLQAFIGRMSGVPPSVWGGLAAARFQDVVDRWNAESTRLYHVLHAIADTIRHNEAALREAGQIHARHIAAAGGDL,"11,434",105,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,LH57_18815,2
P9WP79,FBIB_MYCTU,Rv3262,fbiB Rv3262,GO:0005525; GO:0005886; GO:0009108; GO:0016491; GO:0043773; GO:0046872; GO:0052618; GO:0052619,IPR008225; IPR002847; IPR019943; IPR023661; IPR029479; IPR000415; ,,fbiB,,Coenzyme F420:L-glutamate ligase (EC 6.3.2.31) (EC 6.3.2.34) (Coenzyme F420-0:L-glutamate ligase) (Coenzyme F420-1:gamma-L-glutamate ligase),plasma membrane [GO:0005886]; coenzyme F420-0 gamma-glutamyl ligase activity [GO:0043773]; coenzyme F420-0:L-glutamate ligase activity [GO:0052618]; coenzyme F420-1:gamma-L-glutamate ligase activity [GO:0052619]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; coenzyme biosynthetic process [GO:0009108],9634230; 22102046; 21969609,X-ray crystallography (3),"FUNCTION: Catalyzes the GTP-dependent successive addition of multiple gamma-linked L-glutamates to the L-lactyl phosphodiester of 7,8-didemethyl-8-hydroxy-5-deazariboflavin (F420-0) to form polyglutamated F420 derivatives. {ECO:0000255|HAMAP-Rule:MF_01259}.",MTGPEHGSASTIEILPVIGLPEFRPGDDLSAAVAAAAPWLRDGDVVVVTSKVVSKCEGRLVPAPEDPEQRDRLRRKLIEDEAVRVLARKDRTLITENRLGLVQAAAGVDGSNVGRSELALLPVDPDASAATLRAGLRERLGVTVAVVITDTMGRAWRNGQTDAAVGAAGLAVLRNYAGVRDPYGNELVVTEVAVADEIAAAADLVKGKLTATPVAVVRGFGVSDDGSTARQLLRPGANDLFWLGTAEALELGRQQAQLLRRSVRRFSTDPVPGDLVEAAVAEALTAPAPHHTRPTRFVWLQTPAIRARLLDRMKDKWRSDLTSDGLPADAIERRVARGQILYDAPEVVIPMLVPDGAHSYPDAARTDAEHTMFTVAVGAAVQALLVALAVRGLGSCWIGSTIFAADLVRDELDLPVDWEPLGAIAIGYADEPSGLRDPVPAADLLILK,"47,578",448,CofE family,coenzyme biosynthetic process [GO:0009108],coenzyme F420-0:L-glutamate ligase activity [GO:0052618]; coenzyme F420-0 gamma-glutamyl ligase activity [GO:0043773]; coenzyme F420-1:gamma-L-glutamate ligase activity [GO:0052619]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
P9WQ15,AOFH_MYCTU,Rv3170,aofH Rv3170 MTV014.14,GO:0005829; GO:0005886; GO:0016491,IPR002937; IPR036188; IPR001613; ,,aofH,,Putative flavin-containing monoamine oxidase AofH (EC 1.4.3.-),cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MRLTRAVTNPPWTVDVVVVGAGFAGLAAARELTRQGHEVLVFEGRDRVGGRSLTGRVAGVPADMGGSFIGPTQDAVLALATELGIPTTPTHRDGRNVIQWRGSARSYRGTIPKLSLTGLIDIGRLRWQFERIARGVPVAAPWDARRARELDDVSLGEWLRLVRATSSSRNLMAIMTRVTWGCEPDDVSMLHAARYVRAAGGLDRLLDVKNGAQQDRVPGGTQQIAQAAAAQLGARVLLNAAVRRIDRHGAGVTVTSDQGQAEAGFVIVAIPPAHRVAIEFDPPLPPEYQQLAHHWPQGRLSKAYAAYSTPFWRASGYSGQALSDEAPVFITFDVSPHADGPGILMGFVDARGFDSLPIEERRRDALRCFASLFGDEALDPLDYVDYRWGTEEFAPGGPTAAVPPGSWTKYGHWLREPVGPIHWASTETADEWTGYFDGAVRSGQRAAAEVAALL,"49,136",454,Flavin monoamine oxidase family,,oxidoreductase activity [GO:0016491],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV014.14,1
P9WQ93,AMI4_MYCTU,Rv3375,amiD Rv3375 MTV004.33,GO:0004040; GO:0005829,IPR000120; IPR020556; IPR023631; IPR036928; ,,amiD,,Putative amidase AmiD (EC 3.5.1.4),cytosol [GO:0005829]; amidase activity [GO:0004040],9634230; 21969609,,,MTDADSAVPPRLDEDAISKLELTEVADLIRTRQLTSAEVTESTLRRIERLDPQLKSYAFVMPETALAAARAADADIARGHYEGVLHGVPIGVKDLCYTVDAPTAAGTTIFRDFRPAYDATVVARLRAAGAVIIGKLAMTEGAYLGYHPSLPTPVNPWDPTAWAGVSSSGCGVATAAGLCFGSIGSDTGGSIRFPTSMCGVTGIKPTWGRVSRHGVVELAASYDHVGPITRSAHDAAVLLSVIAGSDIHDPSCSAEPVPDYAADLALTRIPRVGVDWSQTTSFDEDTTAMLADVVKTLDDIGWPVIDVKLPALAPMVAAFGKMRAVETAIAHADTYPARADEYGPIMRAMIDAGHRLAAVEYQTLTERRLEFTRSLRRVFHDVDILLMPSAGIASPTLETMRGLGQDPELTARLAMPTAPFNVSGNPAICLPAGTTARGTPLGVQFIGREFDEHLLVRAGHAFQQVTGYHRRRPPV,"50,646",475,Amidase family,,amidase activity [GO:0004040],cytosol [GO:0005829],,MTV004.33,1
P9WPY5,AROA_MYCTU,Rv3227,aroA Rv3227,GO:0003866; GO:0005829; GO:0005886; GO:0009073; GO:0009423,IPR001986; IPR036968; IPR006264; IPR023193; IPR013792; ,,aroA,,3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (5-enolpyruvylshikimate-3-phosphate synthase) (EPSP synthase) (EPSPS),cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-phosphoshikimate 1-carboxyvinyltransferase activity [GO:0003866]; aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423],2123856; 11483005; 9634230; 21969609; ,X-ray crystallography (7),"FUNCTION: Catalyzes the transfer of the enolpyruvyl moiety of phosphoenolpyruvate (PEP) to the 5-hydroxyl of shikimate-3-phosphate (S3P) to produce enolpyruvyl shikimate-3-phosphate and inorganic phosphate. {ECO:0000255|HAMAP-Rule:MF_00210, ECO:0000269|PubMed:11483005}.",MKTWPAPTAPTPVRATVTVPGSKSQTNRALVLAALAAAQGRGASTISGALRSRDTELMLDALQTLGLRVDGVGSELTVSGRIEPGPGARVDCGLAGTVLRFVPPLAALGSVPVTFDGDQQARGRPIAPLLDALRELGVAVDGTGLPFRVRGNGSLAGGTVAIDASASSQFVSGLLLSAASFTDGLTVQHTGSSLPSAPHIAMTAAMLRQAGVDIDDSTPNRWQVRPGPVAARRWDIEPDLTNAVAFLSAAVVSGGTVRITGWPRVSVQPADHILAILRQLNAVVIHADSSLEVRGPTGYDGFDVDLRAVGELTPSVAALAALASPGSVSRLSGIAHLRGHETDRLAALSTEINRLGGTCRETPDGLVITATPLRPGIWRAYADHRMAMAGAIIGLRVAGVEVDDIAATTKTLPEFPRLWAEMVGPGQGWGYPQPRSGQRARRATGQGSGG,"46,426",450,EPSP synthase family,aromatic amino acid family biosynthetic process [GO:0009073]; chorismate biosynthetic process [GO:0009423],3-phosphoshikimate 1-carboxyvinyltransferase activity [GO:0003866],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WL09,Y3126_MYCTU,Rv3126c,Rv3126c,,,,,,Uncharacterized protein Rv3126c,,9634230; 11416222; 12953092; 18400743,,,MVIRFDQIGSLVLSMKSLASLSFQRCLRENSSLVAALDRLDAAVDELSALSFDALTTPERDRARRDRDHHPWSRSRSQLSPRMAHGAVHQCQWPKAVWAVIDNP,"11,767",104,,,,,,,1
P9WL07,Y3127_MYCTU,Rv3127,Rv3127,GO:0005618; GO:0005886; GO:0016491,IPR000415; ,,,,Uncharacterized protein Rv3127,cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 11416222; 12953092; 18474359; 18400743; 21969609,,,MLKNAVLLACRAPSVHNSQPWRWVAESGSEHTTVHLFVNRHRTVPATDHSGRQAIISCGAVLDHLRIAMTAAHWQANITRFPQPNQPDQLATVEFSPIDHVTAGQRNRAQAILQRRTDRLPFDSPMYWHLFEPALRDAVDKDVAMLDVVSDDQRTRLVVASQLSEVLRRDDPYYHAELEWWTSPFVLAHGVPPDTLASDAERLRVDLGRDFPVRSYQNRRAELADDRSKVLVLSTPSDTRADALRCGEVLSTILLECTMAGMATCTLTHLIESSDSRDIVRGLTRQRGEPQALIRVGIAPPLAAVPAPTPRRPLDSVLQIRQTPEKGRNASDRNARETGWFSPP,"38,521",344,,,oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WFD3,Y3134_MYCTU,Rv3134c,Rv3134c,GO:0001666; GO:0005618; GO:0005886,IPR006015; IPR006016; ,,,,Universal stress protein Rv3134c (USP Rv3134c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; response to hypoxia [GO:0001666],9634230; 10970762; 11416222; 12953092; 18474359; 18400743; 21969609,,,MSDPRPARAVVVGIDGSRAATHAALWAVDEAVNRDIPLRLVYVIDPSQLSAAGEGGGQSAARAALHDASRKVEATGQPVKIETEVLCGRPLTKLMQESRSAAMLCVGSVGLDHVRGRRGSVAATLAGSALCPVAVIHPSPAEPATTSQVSAVVAEVDNGVVLRHAFEEARLRGVPLRAVAVHAAETPDDVEQGSRLAHVHLSRRLAHWTRLYPEVRVDRAIAGGSACRHLAANAKPGQLFVADSHSAHELCGAYQPGCAVLTVRSANL,"28,008",268,Universal stress protein A family,response to hypoxia [GO:0001666],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WFL3,Y3193_MYCTU,Rv3193c,Rv3193c MTV014.37c,GO:0005576; GO:0005618; GO:0005886; GO:0005887,IPR005372; ,,,,UPF0182 protein Rv3193c,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],9634230; 21969609,,,MGMRSAARMPKLTRRSRILIMIALGVIVLLLAGPRLIDAYVDWLWFGELGYRSVFTTMLATRIVVCLVAGVVVGGIVFGGLALAYRTRPVFVPDADNDPVARYRAVVLARLRLVGIGIPAAIGLLAGIVAQSYWARIQLFLHGGDFGVRDPQFGRDLGFYAFELPFYRLMLSYMLVSVFLAFVANLVAHYIFGGIRLSGRTGALSRSARVQLVSLVGVLVLLKAVAYWLDRYELLSHTRGGKPFTGAGYTDINAVLPAKLILMAIALICAAAVFSAIALRDLRIPAIGLVLLLLSSLIVGAGWPLIVEQISVKPNAAQKESEYISRSITATRQAYGLTSDVVTYRNYSGDSPATAQQVAADRATTSNIRLLDPTIVSPAFTQFQQGKNFYYFPDQLSIDRYLDRNGNLRDYVVAARELNPDRLIDNQRDWINRHTVYTHGNGFIASPANTVRGIANDPNQNGGYPEFLVNVVGANGTVVSDGPAPLDQPRIYFGPVISNTSADYAIVGRNGDDREYDYETNIDTKRYTYTGSGGVPLGGWLARSVFAAKFAERNFLFSNVIGSNSKILFNRDPAQRVEAVAPWLTTDSAVYPAIVNKRLVWIVDGYTTLDNYPYSELTSLSSATADSNEVAFNRLVPDKKVSYIRNSVKATVDAYDGTVTLYQQDEKDPVLKAWMQVFPGTVKPKSDIAPELAEHLRYPEDLFKVQRMLLAKYHVNDPVTFFSTSDFWDVPLDPNPTASSYQPPYYIVAKNIAKDDNSASYQLISAMNRFKRDYLAAYISASSDPATYGNLTVLTIPGQVNGPKLANNAITTDPAVSQDLGVIGRDNQNRIRWGNLLTLPVARGGLLYVEPVYASPGASDAASSYPRLIRVAMMYNDKVGYGPTVRDALTGLFGPGAGATATGIAPTEAAVPPSPAANPPPPASGPQPPPVTAAPPVPVGAVTLSPAKVAALQEIQAAIGAARDAQKKGDFAAYGSALQRLDEAITKFNDAG,"107,502",992,UPF0182 family,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTV014.37c,1
O53379,Y3329_MYCTU,Rv3329 RVBD_3329 LH57_18195,Rv3329 RVBD_3329 LH57_18195 P425_03469,GO:0008483; GO:0030170,IPR005814; IPR015424; IPR015422; IPR015421; ,,,,Probable aminotransferase Rv3329 (EC 2.6.1.-),pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],9634230; 21969609; 23986315,,FUNCTION: Probable aminotransferase. {ECO:0000305}.,MPRIRKPPSRSLPEPSAALANTTTRNLWLHFARHGAGIQHPVIVRGDGVTIFDDRGKSYLDALSGLFVVQVGYGRAELAEAAARQAGTLGYFPLWGYATPPAIELAERLARYAPGDLNRVFFTSGGTEAVETAWKVAKQYFKLTGKPGKQKVISRSIAYHGTTQGALAITGLPLFKAPFEPLTPGGFRVPNTNFYRAPLHTDLKEFGRWAADRIAEAIEFEGPDTVAAVFLEPVQNAGGCIPAPPGYFERVREICDRYDVLLVSDEVICAFGRIGSMFACEDLGYVPDMITCAKGLTSGYSPLGAMIASDRLFEPFNDGETMFAHGYTFGGHPVSAAVGLANLDIFEREGLSDHVKRNSPALRATLEKLYDLPIVGDIRGEGYFFGIELVKDQATKQTFTDDERARLLGQVSAALFEAGLYCRTDDRGDPVVQVAPPLISGQPEFDTIETILRSVLTDTGRKYLHL,"50,843",466,Class-III pyridoxal-phosphate-dependent aminotransferase family,,pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],,,P425_03469,2
P9WKA9,Y3371_MYCTU,Rv3371,Rv3371 MTV004.29,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv3371 (EC 2.3.1.20) (Putative triacylglycerol synthase Rv3371),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions weakly as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity to produce wax esters.",MAQLTALDAGFLKSRDPERHPGLAIGAVAVVNGAAPSYDQLKTVLTERIKSIPRCTQVLATEWIDYPGFDLTQHVRRVALPRPGDEAELFRAIALALERPLDPDRPLWECWIIEGLNGNRWAILIKIHHCMAGAMSAAHLLARLCDDADGSAFANNVDIKQIPPYGDARSWAETLWRMSVSIAGAVCTAAARAVSWPAVTSPAGPVTTRRRYQAVRVPRDAVDAVCHKFGVTANDVALAAITEGFRTVLLHRGQQPRADSLRTLEKTDGSSAMLPYLPVEYDDPVRRLRTVHNRSQQSGRRQPDSLSDYTPLMLCAKMIHALARLPQQGIVTLATSAPRPRHQLRLMGQKMDQVLPIPPTALQLSTGIAVLSYGDELVFGITADYDAASEMQQLVNGIELGVARLVALSDDSVLLFTKDRRKRSSRALPSAARRGRPSVPTARARH,"48,847",446,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV004.29,1
P9WKZ9,Y3395_MYCTU,Rv3395c,Rv3395c MTCY78.33,GO:0006281; GO:0016021,,,,,Uncharacterized protein Rv3395c,integral component of membrane [GO:0016021]; DNA repair [GO:0006281],9634230; 21969609,,,MTAAFASDQRLENGAEQLESLRRQMALLSEKVSGGPSRSGDLVPAGPVSLPPGTVGVLSGARSLLLSMVASVTAAGGNAAIVGQPDIGLLAAVEMGADLSRLAVIPDPGTDPVEVAAVLIDGMDLVVLGLGGRRVTRARARAVVARARQKGCTLLVTDGDWQGVSTRLAARVCGYEITPALRGVPTPGLGRISGVRLQINGRGR,"20,793",204,,DNA repair [GO:0006281],,integral component of membrane [GO:0016021],,MTCY78.33,1
P9WFH1,Y3399_MYCTU,Rv3399,Rv3399 MTCY78.29c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv3399 (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250|UniProtKB:Q9CCZ4}.,MARPMGKLPSNTRKCAQCAMAEALLEIAGQTINQKDLGRSGRMTRTDNDTWDLASSVGATATMIATARALASRAENPLINDPFAEPLVRAVGIDLFTRLASGELRLEDIGDHATGGRWMIDNIAIRTKFYDDFFGDATTAGIRQVVILAAGLDTRAYRLPWPPGTVVYEIDQPAVIKFKTRALANLNAEPNAERHAVAVDLRNDWPTALKNAGFDPARPTAFSAEGLLSYLPPQGQDRLLDAITALSAPDSRLATQSPLVLDLAEEDEKKMRMKSAAEAWRERGFDLDLTELIYFDQRNDVADYLAGSGWQVTTSTGKELFAAQGLPPFADDHITRFADRRYISAVLK,"38,140",348,UPF0677 family,,methyltransferase activity [GO:0008168],,,MTCY78.29c,2
P9WKZ7,Y3400_MYCTU,Rv3400,Rv3400 MTCY78.28c,GO:0008152; GO:0008801; GO:0016787,IPR010976; IPR036412; IPR006439; IPR023214; IPR023198; ,,,,Uncharacterized protein Rv3400,beta-phosphoglucomutase activity [GO:0008801]; hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230; 21969609,,,MANWYRPNYPEVRSRVLGLPEKVRACLFDLDGVLTDTASLHTKAWKAMFDAYLAERAERTGEKFVPFDPAADYHTYVDGKKREDGVRSFLSSRAIEIPDGSPDDPGAAETVYGLGNRKNDMLHKLLRDDGAQVFDGSRRYLEAVTAAGLGVAVVSSSANTRDVLATTGLDRFVQQRVDGVTLREEHIAGKPAPDSFLRAAELLGVTPDAAAVFEDALSGVAAGRAGNFAVVVGINRTGRAAQAAQLRRHGADVVVTDLAELL,"28,228",262,,metabolic process [GO:0008152],beta-phosphoglucomutase activity [GO:0008801]; hydrolase activity [GO:0016787],,,MTCY78.28c,1
P9WN13,Y3401_MYCTU,Rv3401,Rv3401 MTCY78.27c,GO:0005618; GO:0005886; GO:0005975; GO:0016787; GO:0016798; GO:0030246,IPR008928; IPR012341; IPR011013; IPR005194; IPR005195; IPR005196; IPR037018; IPR017045; ,,,,Uncharacterized glycosyl hydrolase Rv3401 (EC 3.2.1.-),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MITEDAFPVEPWQVRETKLNLNLLAQSESLFALSNGHIGLRGNLDEGEPFGLPGTYLNSFYEIRPLPYAEAGYGYPEAGQTVVDVTNGKIFRLLVGDEPFDVRYGELISHERILDLRAGTLTRRAHWRSPAGKQVKVTSTRLVSLAHRSVAAIEYVVEAIEEFVRVTVQSELVTNEDVPETSADPRVSAILDRPLQAVEHERTERGALLMHRTRASALMMAAGMEHEVEVPGRVEITTDARPDLARTTVICGLRPGQKLRIVKYLAYGWSSLRSRPALRDQAAGALHGARYSGWQGLLDAQRAYLDDFWDSADVEVEGDPECQQAVRFGLFHLLQASARAERRAIPSKGLTGTGYDGHAFWDTEGFVLPVLTYTAPHAVADALRWRASTLDLAKERAAELGLEGAAFPWRTIRGQESSAYWPAGTAAWHINADIAMAFERYRIVTGDGSLEEECGLAVLIETARLWLSLGHHDRHGVWHLDGVTGPDEYTAVVRDNVFTNLMAAHNLHTAADACLRHPEAAEAMGVTTEEMAAWRDAADAANIPYDEELGVHQQCEGFTTLAEWDFEANTTYPLLLHEAYVRLYPAQVIKQADLVLAMQWQSHAFTPEQKARNVDYYERRMVRDSSLSACTQAVMCAEVGHLELAHDYAYEAALIDLRDLHRNTRDGLHMASLAGAWTALVVGFGGLRDDEGILSIDPQLPDGISRLRFRLRWRGFRLIVDANHTDVTFILGDGPGTQLTMRHAGQDLTLHTDTPSTIAVRTRKPLLPPPPQPPGREPVHRRALAR,"87,316",786,Glycosyl hydrolase 65 family,carbohydrate metabolic process [GO:0005975],"carbohydrate binding [GO:0030246]; hydrolase activity [GO:0016787]; hydrolase activity, acting on glycosyl bonds [GO:0016798]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY78.27c,1
P9WKI5,Y3410_MYCTU,Rv3410c,guaB3 Rv3410c MTCY78.18,GO:0005737; GO:0005886; GO:0006183; GO:0016491,IPR013785; IPR005992; IPR001093; ,,guaB3,,Uncharacterized oxidoreductase Rv3410c (EC 1.-.-.-),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; GTP biosynthetic process [GO:0006183],9634230; 19099550; 21081761; 21969609,,FUNCTION: Has no inosine-5'-monophosphate dehydrogenase activity. {ECO:0000269|PubMed:21081761}.,MVEIGMGRTARRTYELSEISIVPSRRTRSSKDVSTAWQLDAYRFEIPVVAHPTDALVSPEFAIELGRLGGLGVLNGEGLIGRHLDVEAKIAQLLEAAAADPEPSTAIRLLQELHAAPLNPDLLGAAVARIREAGVTTAVRVSPQNAQWLTPVLVAAGIDLLVIQGTIVSAERVASDGEPLNLKTFISELDIPVVAGGVLDHRTALHLMRTGAAGVIVGYGSTQGVTTTDEVLGISVPMATAIADAAAARRDYLDETGGRYVHVLADGDIHTSGELAKAIACGADAVVLGTPLAESAEALGEGWFWPAAAAHPSLPRGALLQIAVGERPPLARVLGGPSDDPFGGLNLVGGLRRSMAKAGYCDLKEFQKVGLTVGG,"38,991",375,IMPDH/GMPR family,GTP biosynthetic process [GO:0006183],oxidoreductase activity [GO:0016491],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY78.18,1
Q50700,Y3428_MYCTU,Rv3428c,Rv3428c MTCY78.01,GO:0005576; GO:0005886; GO:0015074,IPR001584; IPR012337; ,,,DOMAIN 40 220 Integrase catalytic. {ECO:0000255|PROSITE-ProRule:PRU00457}.,Putative transposase Rv3428c,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; DNA integration [GO:0015074],20639330; 9634230,,,MATIAQRLRDDHGVAASESSVRRWIATHFAEEVARERVTVPRGPVDAGSEAQIDYGRLGMWFDPATARRVAVWAFVMVLAFSRHLFVRPVIRMDQTAWCACHVAAFEFFDGVPARLVCDNLRTGVDKPDLYDPQINRSYAELASHYATLVDPARARKPKDKPRVERPMTYVRDSFWKGREFDSLAQMQQAAVTWSTEVAGLRYLRALEGAQPLRMFEAVEQQALIALPPRAFELTSWSIGTVGVDTHLKVGKALYSVPWRLIGQRLHARTAGDVVQIFAGNDVVATHVRRPSGRSTDFSHYPPEKIAFHMRTPTWCRHTAELVGPASQQVIAEFMRDNAIHHLRSAQGVLGLRDKHGCDRLEAACARAIEVGDPSYRTIKGILVAGTEHAANEPTTSSPASTAGGVPARP,"45,494",410,Transposase IS21/IS408/IS1162 family,DNA integration [GO:0015074],,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY78.01,1
P9WKY1,Y3466_MYCTU,Rv3466,Rv3466 MTCY13E12.19,,IPR003870; ,,,,Uncharacterized protein Rv3466,,9634230,,,MGSGSRERIVEVFDALDAELDRLDEVSFEVLTTPERLRSLERLECLVRRLPAVGHALINQLDAQASEEELGGTLCCALANRLRITKPDAARRIADAADLGPRRALTGEPLAPQLTATATAQRQGLIGEAHVKVIRALFRPPARRGGCVHPPGRRSRPGRQSRSISSRRAGPLRPAGHGLATPRRRPHRHRTRPQTRHHPEQPAIRRHVTAKWLPDPPSAGHL,"24,490",222,Rv1128c/1148c/1588c/1702c/1945/3466 family,,,,,MTCY13E12.19,1
O06342,Y3479_MYCTU,Rv3479,Rv3479,GO:0005886; GO:0005887; GO:0016042; GO:0016787,IPR016035; IPR024282; IPR019894; IPR002641; ,,,DOMAIN 50 319 PNPLA. {ECO:0000255|PROSITE-ProRule:PRU01161}.,Uncharacterized membrane protein Rv3479,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],9634230; 21969609,,,MFPAAVGVLWQSGLRDPTPPGGPHGIEGLSLAFEKPSPVTALTQELRFATTMTGGVSLAIWMAGVTREINLLAQASQWRRLGGTFPTNSQLTNESAASLRLYAQLIDLLDMVVDVDILSGTSAGGINAALLASSRVTGSDLGGIRDLWLDLGALTELLRDPRDKKTPSLLYGDERIFAALAKRLPKLATGPFPPTTFPEAARTPSTTLYITTTLLAGETSRFTDSFGTLVQDVDLRGLFTFTETDLARPDTAPALALAARSSASFPLAFEPSFLPFTKGTAKKGEVPARPAMAPFTSLTRPHWVSDGGLLDNRPIGVLFKRIFDRPARRPVRRVLLFVVPSSGPAPDPMHEPPPDNVDEPLGLIDGLLKGLAAVTTQSIAADLRAIRAHQDCMEARTDAKLRLAELAATLRNGTRLLTPSLLTDYRTREATKQAQTLTSALLRRLSTCPPESGPATESLPKSWSAELTVGGDADKVCRQQITATILLSWSQPTAQPLPQSPAELARFGQPAYDLAKGCALTVIRAAFQLARSDADIAALAEVTEAIHRAWRPTASSDLSVLVRTMCSRPAIRQGSLENAADQLAADYLQQSTVPGDAWERLGAALVNAYPTLTQLAASASADSGAPTDSLLARDHVAAGQLETYLSYLGTYPGRADDSRDAPTMAWKLFDLATTQRAMLPADAEIEQGLELVQVSADTRSLLAPDWQTAQQKLTGMRLHHFGAFYKRSWRANDWMWGRLDGAGWLVHVLLDPRRVRWIVGERADTNGPQSGAQWFLGKLKELGAPDFPSPGYPLPAVGGGPAQHLTEDMLLDELGFLDDPAKPLPASIPWTALWLSQAWQQRVLEEELDGLANTVLDPQPGKLPDWSPTSSRTWATKVLAAHPGDAKYALLNENPIAGETFASDKGSPLMAHTVAKAAATAAGAAGSVRQLPSVLKPPLITLRTLTLSGYRVVSLTKGIARSTIIAGALLLVLGVAAAIQSVTVFGVTGLIAAGTGGLLVVLGTWQVSGRLLFALLSFSVVGAVLALATPVVREWLFGTQQQPGWVGTHAYWLGAQWWHPLVVVGLIALVAIMIAAATPGRR,"115,605",1082,,lipid catabolic process [GO:0016042],hydrolase activity [GO:0016787],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,4
P9WHP9,TRUA_MYCTU,Rv3455c,truA Rv3455c MTCY13E12.08c,GO:0003723; GO:0005618; GO:0009982; GO:0031119; GO:0040007,IPR020103; IPR001406; IPR020097; IPR020095; ,,truA,,tRNA pseudouridine synthase A (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I),cell wall [GO:0005618]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; growth [GO:0040007]; tRNA pseudouridine synthesis [GO:0031119],9634230; 21969609,,"FUNCTION: Formation of pseudouridine at positions 38, 39 and 40 in the anticodon stem and loop of transfer RNAs. {ECO:0000255|HAMAP-Rule:MF_00171}.",MSLTRRPPKSPPQRPPRISGVVRLRLDIAYDGTDFAGWAAQVGQRTVAGDLDAALTTIFRTPVRLRAAGRTDAGVHASGQVAHVDVPADALPNAYPRAGHVGDPEFLPLLRRLGRFLPADVRILDITRAPAGFDARFSALRRHYVYRLSTAPYGVEPQQARYITAWPRELDLDAMTAASRDLMGLHDFAAFCRHREGATTIRDLQRLDWSRAGTLVTAHVTADAFCWSMVRSLVGALLAVGEHRRATTWCRELLTATGRSSDFAVAPAHGLTLIQVDYPPDDQLASRNLVTRDVRSG,"32,620",297,TRNA pseudouridine synthase TruA family,growth [GO:0040007]; tRNA pseudouridine synthesis [GO:0031119],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],cell wall [GO:0005618],,MTCY13E12.08c,1
P9WHT7,TSAD_MYCTU,Rv3419c,tsaD gcp Rv3419c MTCY78.10,GO:0000408; GO:0002949; GO:0004222; GO:0005737; GO:0046872; GO:0061711,IPR000905; IPR017861; IPR017860; IPR022450; ,,tsaD,,tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein TsaD) (tRNA threonylcarbamoyladenosine biosynthesis protein TsaD),cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949],9634230; 21969609; 27353550,,"FUNCTION: Required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. Is involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37, together with TsaE and TsaB. TsaD likely plays a direct catalytic role in this reaction. {ECO:0000255|HAMAP-Rule:MF_01445}.",MTTVLGIETSCDETGVGIARLDPDGTVTLLADEVASSVDEHVRFGGVVPEIASRAHLEALGPAMRRALAAAGLKQPDIVAATIGPGLAGALLVGVAAAKAYSAAWGVPFYAVNHLGGHLAADVYEHGPLPECVALLVSGGHTHLLHVRSLGEPIIELGSTVDDAAGEAYDKVARLLGLGYPGGKALDDLARTGDRDAIVFPRGMSGPADDRYAFSFSGLKTAVARYVESHAADPGFRTADIAAGFQEAVADVLTMKAVRAATALGVSTLLIAGGVAANSRLRELATQRCGEAGRTLRIPSPRLCTDNGAMIAAFAAQLVAAGAPPSPLDVPSDPGLPVMQGQVR,"35,091",344,KAE1 / TsaD family,tRNA threonylcarbamoyladenosine modification [GO:0002949],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711],cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408],gcp,MTCY78.10,1
P9WFF3,UPP_MYCTU,Rv3309c,upp Rv3309c MTV016.08c,GO:0004845; GO:0004849; GO:0005525; GO:0005829; GO:0005886; GO:0006206; GO:0006223; GO:0043097; GO:0044206,IPR000836; IPR029057; IPR034332; IPR005765; ,,upp,,Uracil phosphoribosyltransferase (EC 2.4.2.9) (UMP pyrophosphorylase) (UPRTase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; uracil phosphoribosyltransferase activity [GO:0004845]; uridine kinase activity [GO:0004849]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uracil salvage [GO:0006223],9634230; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the conversion of uracil and 5-phospho-alpha-D-ribose 1-diphosphate (PRPP) to UMP and diphosphate. {ECO:0000255|HAMAP-Rule:MF_01218}.,MQVHVVDHPLAAARLTTLRDERTDNAGFRAALRELTLLLIYEATRDAPCEPVPIRTPLAETVGSRLTKPPLLVPVLRAGLGMVDEAHAALPEAHVGFVGVARDEQTHQPVPYLDSLPDDLTDVPVMVLDPMVATGGSMTHTLGLLISRGAADITVLCVVAAPEGIAALQKAAPNVRLFTAAIDEGLNEVAYIVPGLGDAGDRQFGPR,"21,898",207,UPRTase family,pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uracil salvage [GO:0006223],GTP binding [GO:0005525]; uracil phosphoribosyltransferase activity [GO:0004845]; uridine kinase activity [GO:0004849],cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTV016.08c,1
P9WKC9,TGS1_MYCTU,Rv3130c,tgs1 Rv3130c MTCY03A2.28 MTCY164.41c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR014292; IPR009721; IPR004255; ,,tgs1,,Probable diacyglycerol O-acyltransferase tgs1 (TGS1) (EC 2.3.1.20) (Probable triacylglycerol synthase tgs1),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],20639330; 9634230; 11416222; 12953092; 15262939; 16946266; 18474359; 18400743; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (Probable). {ECO:0000305|PubMed:15262939}.; FUNCTION: Upon expression in E.coli functions as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Prefers C(26:0)-CoA over C(18:1)-CoA. TG synthesis activity increases in M.tuberculosis upon oxygen depletion and NO treatment, with concomitant accumulation of TG in inclusion bodies. As disruption of the gene encoding this protein obviates TG synthesis this seems to be the major enzyme involved in production of TG. Has no wax synthase activity to produce wax esters. {ECO:0000269|PubMed:15262939}.",MNHLTTLDAGFLKAEDVDRHVSLAIGALAVIEGPAPDQEAFLSSLAQRLRPCTRFGQRLRLRPFDLGAPKWVDDPDFDLGRHVWRIALPRPGNEDQLFELIADLMARRLDRGRPLWEVWVIEGLADSKWAILTKLHHCMADGIAATHLLAGLSDESMSDSFASNIHTTMQSQSASVRRGGFRVNPSEALTASTAVMAGIVRAAKGASEIAAGVLSPAASSLNGPISDLRRYSAAKVPLADVEQVCRKFDVTINDVALAAITESYRNVLIQRGERPRFDSLRTLVPVSTRSNSALSKTDNRVSLMLPNLPVDQENPLQRLRIVHSRLTRAKAGGQRQFGNTLMAIANRLPFPMTAWAVGLLMRLPQRGVVTVATNVPGPRRPLQIMGRRVLDLYPVSPIAMQLRTSVAMLSYADDLYFGILADYDVVADAGQLARGIEDAVARLVAISKRRKVTRRRGALSLVV,"50,721",463,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY03A2.28 MTCY164.41c,1
P9WKC5,TGS3_MYCTU,Rv3234c,tgs3 Rv3234c MTCY20B11.09c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731,IPR004255; ,,tgs3,,Probable diacyglycerol O-acyltransferase tgs3 (TGS3) (EC 2.3.1.20) (Probable triacylglycerol synthase tgs3),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Has no wax synthase activity to produce wax esters. {ECO:0000269|PubMed:15262939}.",MVTRLSASDASFYQLENTATPMYVGLLLILRRPRAGLSYEALLETVEQRLPQIPRYRQKVQEVKLGLARPVWIDDRDFDITYHVRRSALPSPGSDEQLHELIARLAARPLDKSRPLWEMYLVEGLEKNRIALYTKSHQALINGVTALAIGHVIADRTRRPPAFPEDIWVPERDPGTTRLLLRAVGDWLVRPGAQLQAVGSAVAGLVTNSGQLVETGRKVLDIARTVARGTAPSSPLNATVSRNRRFTVARASLDDYRTVRARYDCDSTTWC,"30,379",271,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY20B11.09c,1
P9WFT3,SYW_MYCTU,Rv3336c,trpS Rv3336c MTV016.36c,GO:0004830; GO:0005524; GO:0005737; GO:0005886; GO:0006436; GO:0040007,IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; ,,trpS,,Tryptophan--tRNA ligase (EC 6.1.1.2) (Tryptophanyl-tRNA synthetase) (TrpRS),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830]; growth [GO:0040007]; tryptophanyl-tRNA aminoacylation [GO:0006436],9634230; 21969609,,FUNCTION: Catalyzes the attachment of tryptophan to tRNA(Trp). {ECO:0000255|HAMAP-Rule:MF_00140}.,MSTPTGSRRIFSGVQPTSDSLHLGNALGAVAQWVGLQDDHDAFFCVVDLHAITIPQDPEALRRRTLITAAQYLALGIDPGRATIFVQSQVPAHTQLAWVLGCFTGFGQASRMTQFKDKSARQGSEATTVGLFTYPVLQAADVLAYDTELVPVGEDQRQHLELARDVAQRFNSRFPGTLVVPDVLIPKMTAKIYDLQDPTSKMSKSAGTDAGLINLLDDPALSAKKIRSAVTDSERDIRYDPDVKPGVSNLLNIQSAVTGTDIDVLVDGYAGHGYGDLKKDTAEAVVEFVNPIQARVDELTADPAELEAVLAAGAQRAHDVASKTVQRVYDRLGFLL,"36,272",336,Class-I aminoacyl-tRNA synthetase family,growth [GO:0040007]; tryptophanyl-tRNA aminoacylation [GO:0006436],ATP binding [GO:0005524]; tryptophan-tRNA ligase activity [GO:0004830],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV016.36c,1
P9WHF7,THT2_MYCTU,Rv3283,sseA Rv3283 MTCY71.23,GO:0004792; GO:0005618; GO:0005829; GO:0005886,IPR001763; IPR036873; IPR001307; ,,sseA,DOMAIN 31 138 Rhodanese 1. {ECO:0000255|PROSITE-ProRule:PRU00173}.; DOMAIN 168 286 Rhodanese 2. {ECO:0000255|PROSITE-ProRule:PRU00173}.,Putative thiosulfate sulfurtransferase SseA (EC 2.8.1.1),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; thiosulfate sulfurtransferase activity [GO:0004792],9634230; 19099550; 21969609,X-ray crystallography (1),,MPLPADPSPTLSAYAHPERLVTADWLSAHMGAPGLAIVESDEDVLLYDVGHIPGAVKIDWHTDLNDPRVRDYINGEQFAELMDRKGIARDDTVVIYGDKSNWWAAYALWVFTLFGHADVRLLNGGRDLWLAERRETTLDVPTKTCTGYPVVQRNDAPIRAFRDDVLAILGAQPLIDVRSPEEYTGKRTHMPDYPEEGALRAGHIPTAVHIPWGKAADESGRFRSREELERLYDFINPDDQTVVYCRIGERSSHTWFVLTHLLGKADVRNYDGSWTEWGNAVRVPIVAGEEPGVVPVV,"33,320",297,,,thiosulfate sulfurtransferase activity [GO:0004792],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY71.23,1
P9WHF9,THTR_MYCTU,Rv3117; Rv0815c,cysA1 cysA Rv3117 MTCY164.27; cysA2 Rv0815c MTV043.07c,GO:0004792; GO:0005618; GO:0005829; GO:0005886,IPR001763; IPR036873; IPR001307; ,,cysA1; cysA2,DOMAIN 18 125 Rhodanese 1. {ECO:0000255|PROSITE-ProRule:PRU00173}.; DOMAIN 154 274 Rhodanese 2. {ECO:0000255|PROSITE-ProRule:PRU00173}.,Putative thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese-like protein),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; thiosulfate sulfurtransferase activity [GO:0004792],9634230; 21969609,X-ray crystallography (3),FUNCTION: May be a sulfotransferase involved in the formation of thiosulfate. {ECO:0000250}.,MARCDVLVSADWAESNLHAPKVVFVEVDEDTSAYDRDHIAGAIKLDWRTDLQDPVKRDFVDAQQFSKLLSERGIANEDTVILYGGNNNWFAAYAYWYFKLYGHEKVKLLDGGRKKWELDGRPLSSDPVSRPVTSYTASPPDNTIRAFRDEVLAAINVKNLIDVRSPDEFSGKILAPAHLPQEQSQRPGHIPGAINVPWSRAANEDGTFKSDEELAKLYADAGLDNSKETIAYCRIGERSSHTWFVLRELLGHQNVKNYDGSWTEYGSLVGAPIELGS,"31,015",277,,,thiosulfate sulfurtransferase activity [GO:0004792],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],cysA; ,MTCY164.27; MTV043.07c,1
I6XHD1,I6XHD1_MYCTU,Rv3491,Rv3491,,,,,,Uncharacterized protein,,9634230; 21969609,,,MNIRCGLAAGAVICSAVALGIALHSGDPARALGPPPDGSYSFNQAGVSGVTWTITALCDQPSGTRNMNDYSDPIVWAFNCALNVVSTTPQQITRTDRLQNFSGRARMSSMLWTFQVNQADGVACPDGSTAPSSETYAFSDETLTGTHTTVHGAVCGLQPKLSKQPFSLQLIGPPPSPVQRYPLYCNNIAMCY,"20,363",192,,,,,,,1
I6X7G8,I6X7G8_MYCTU,Rv3498c,mce4B Rv3498c,GO:0016021,IPR005693; IPR003399; ,,mce4B,,Mce-family protein Mce4B,integral component of membrane [GO:0016021],9634230; 21969609,,,MAGSGVPSHRSMVIKVSVFAVVMLLVAAGLVVVFGDFRFGPTTVYHATFTDASRLKAGQKVRIAGVPVGSVKAVKLNPDHSIDVAFAIDRSYTLYSSTRAVIRYENLVGDRFLEITSGPGELRKLPPGGTINVAHTQPALDLDALLGGLRPVLKGFDADKINTITSAVIELLQGQGGPLANVLADTGAFSAALGARDQLIGEVITNLNAVLATVDAKSAQFSASVDQLQQLVSGLAKNRDPIAGAISPLASTTTDLTELLRNSRRPLQGILENARPLATELDNRKAEVNNDIEQLGEDYLRLSALGSYGAFFNIYFCSVTIKINGPAGSDILLPIGGQPDPSKGRCAFAK,"36,880",350,,,,integral component of membrane [GO:0016021],,,1
O50388,O50388_MYCTU,Rv3359,Rv3359,GO:0010181; GO:0016491,IPR013785; IPR001155; ,,,,Possible oxidoreductase,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MAPGSCEAPDVFNPAKLGPLTLRNRVIKAATFEARTPDALVTDDLIEYHRLPAAGGVAMTTVAYCAVSPGGRTGGNQIWMRPHAVPGLRRLTEAIHAEGAAISAQIGHAGPVADARSNQATALAPVRFFNPIAMRFAQKATREDIDDVLAAHAHAARLAVDAGFDAVEIHLGHNYLASAFLSPLLNRRDDEFGGSLQNRAKVARGLVMAVRRAVRQQVAVTAKLNMTDGIRGGITVDEALTTARWLQDDGGLDAIELTAGSSLVNPMYLFRGDAPVKEFAAAFKPPLRWGIRMTGHRFFREYPYRDAYLLREARLFRAELTIPLILLGGITNRTTMDLAMAEGFEFVAMARALLAEPDLVNRIAAEGSQVRSACTHCNQCMATIYRRTHCVVTGAP,"42,835",396,,,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],,,,1
O53311,O53311_MYCTU,Rv3161c,Rv3161c,GO:0005506; GO:0005886; GO:0010033; GO:0016708; GO:0019439; GO:0051537,IPR017941; IPR036922; IPR015879; IPR001663; ,,,,Possible dioxygenase,"plasma membrane [GO:0005886]; 2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor [GO:0016708]; aromatic compound catabolic process [GO:0019439]; response to organic substance [GO:0010033]",9634230; 21969609,,,MLSTDNRAELGDILTDIGDYLDDNPPALSLPPAAYTSSELWQLERERIFNRSWMLVAHVDQVAKTGDYVTVSVAGEPVMVVRDVDGQLHALSPICRHRLMLMVEPGAGRIDTLTCQYHLWRYGLDGRLRGAPHMAANLDFNRRECRLPQFAVATWNGLVWINLDADAEPIAAHLDLTDDEFAGYRLGEMVQVESWSHEWRANWKVAAENGHENYHVLGLHRQTLEPFVPGGGDLDVRQYSRWALRLRVPFTVPVEAKSLQLNEVQKSNLVVLWTFPNSALAIAGERVVWFGFIPQSIDRVQVLGGVLTTPELAADAAATAQTSQFVMAMINDEDRLGLEAVQVGAGSRFAERGHLSSKEWPGMLAFYRNLAMALVGDHPGAS,"42,504",382,,aromatic compound catabolic process [GO:0019439]; response to organic substance [GO:0010033],"2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor [GO:0016708]",plasma membrane [GO:0005886],,,1
I6XH73,I6XH73_MYCTU,Rv3431c,Rv3431c,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Possible transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MFAELIRAGLQALIEAEATEAIGAGRYERSDGRIVHRNGHRPKTVSTTAGDIEVQIPKLRAGSFFPSLLERRRRIDKALHAVIMEAYVHGVSTRSVDDLVAAMGVQAGVSKSEVSRICAGLDTEIEAFRTRSLTHTEFPYVFCDATFCKVRVGAHVVSQALVVATGVSIDGTREVLGTAVGDSESYEFWREFLASLKARGLTGVHLVISDAHAGLKAAVAQQFSGASWQRCRVHFMRNLYTAVAAKHAPAVTVAVKTIFAHTDPEEVGAQWDRVADPLCQP,"30,484",281,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
I6YG46,I6YG46_MYCTU,Rv3432c,gadB Rv3432c,GO:0004351; GO:0006536; GO:0030170,IPR010107; IPR002129; IPR015424; IPR015421; ,,gadB,,Glutamate decarboxylase (EC 4.1.1.15),glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170]; glutamate metabolic process [GO:0006536],9634230; 21969609,,,MSRSHPSVPAHSIAPAYTGRMFTAPVPALRMPDESMDPEAAYRFIHDELMLDGSSRLNLATFVTTWMDPEAEKLMAETFDKNMIDKDEYPATAAIEARCVSMVADLFHAEGLRDHDPTSATGVSTIGSSEAVMLGGLALKWRWRQRVGSWKGRMPNLVMGSNVQVVWEKFCRYFDVEPRYLPMERGRYVITPEQVLAAVDENTIGVVAILGTTYTGELEPIAEICAALDKLAAGGGVDVPVHVDAASGGFVVPFLHPDLVWDFRLPRVVSINVSGHKYGLTYPGVGFVVWRGPEHLPEDLVFRVNYLGGDMPTFTLNFSRPGNQVVGQYYNFLRLGRDGYTKVMQALSHTARWLGDQLREVDHCEVISDGSAIPVVSFRLAGDRGYTEFDVSHELRTFGWQVPAYTMPDNATDVAVLRIVVREGLSADLARALHDDAVTALAALDKVKPGGHFDAQHFAH,"50,780",460,Group II decarboxylase family,glutamate metabolic process [GO:0006536],glutamate decarboxylase activity [GO:0004351]; pyridoxal phosphate binding [GO:0030170],,,,1
O05862,O05862_MYCTU,Rv3204,Rv3204,GO:0006281; GO:0008168,IPR014048; IPR036217; IPR036388; ,,,,Possible DNA-methyltransferase (Modification methylase),methyltransferase activity [GO:0008168]; DNA repair [GO:0006281],9634230,,,MAPVTDEQVELVRSLVAAIPLGRVSTYGDIAALTGLSSPRIVGWIMRTDSSDLPWHRVIRASGRPAQHLATRQLELLRAEGVLSVDGRVALSEIRYEFPPG,"11,018",101,,DNA repair [GO:0006281],methyltransferase activity [GO:0008168],,,,1
Q93IG6,Q93IG6_MYCTU,Rv3365c,Rv3365c,GO:0000160; GO:0004673; GO:0004871; GO:0005524; GO:0005829; GO:0005886; GO:0016021,IPR003660; IPR003594; IPR036890; ,,,,Histidine kinase (EC 2.7.13.3),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein histidine kinase activity [GO:0004673]; signal transducer activity [GO:0004871]; phosphorelay signal transduction system [GO:0000160],9634230; 21969609,,,MTMFARPTIPVAAAASDISAPAQPARGKPQQRPPSWSPRNWPVRWKVFTIALLPLVVAMVLAGLRVEAAMASTSGLRLVAARAEMIPAITKYMSALDVAVLASSTGHDVEGAQKNFTARKYELQTRLADTDVIADVRSGVNTLLNGGQALLDKVLADSIGLRDRVTAYAPLLLTAQNVIDASVRVDSEQIRTQVQGLSRAVGARGQMTMQEILVTRGADLAEPQLRSAMVTLAGTEPSTLFGMSAALGAGSPDTKNLQQQMVTRMAIMSDPAVALVNNPELLHSIQITRDIAEQVITDTTEAVTKSVQSQATDRRDAAIRDAVLVLAAIATAIVVVLVVARTLVGPMRVLRDGALKVAHTDLDGEIAAVRAGDEPIPEPLAVYTTEEIGQVAHAVDELHTRALLLAGEETRLRLLVNEMFETMSRRSRSLVDQQLSVIDQLERNEEDPARLDSLFRLDHLAARLRRNSANLLVLAGAQITRDHREPVPLSTVISAAVSEVEDYRRVDIARVPDCAVVGAAAGGVIHLLAELIDNALRYSSPTTPVRVAAAIGSEGSVLLRISDSGLGMTDADRRMANMRLRAGGEVTPDSARHMGLFVVGRLAGRHGIRVGLRGPVTGEQGTGTTAEVYLPLAVLEGTAPAQPPKPRVFAIKPPCPEPAAADPTDVPAAIGPLPPVTLLPRRTPGSSGIADVPAQPMQQRRRELKTPWWEDRFQQEPKQPPAPEPRPAPPPAKPAPPAGPVDDDVIYRRMLSEMVGDPHELAHSPDLDWKSVWDHGWSAAAEAADKPVQSRTDYGLPVREPGARLVPGAAVPEGPDREHPGAALASNGGLHPGRAPRHAAAVRDPDAVRASISSHFGGVRTGRSHARESSQGPNQQ,"93,442",876,,phosphorelay signal transduction system [GO:0000160],ATP binding [GO:0005524]; protein histidine kinase activity [GO:0004673]; signal transducer activity [GO:0004871],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O05898,O05898_MYCTU,Rv3255c,manA Rv3255c,GO:0000032; GO:0004476; GO:0005829; GO:0005886; GO:0005975; GO:0006486; GO:0008270; GO:0009298; GO:0040007,IPR001250; IPR016305; IPR014710; IPR011051; ,,manA,,Probable mannose-6-phosphate isomerase ManA (Phosphomannose isomerase) (Phosphomannoisomerase) (PMI) (Phosphohexoisomerase) (Phosphohexomutase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; growth [GO:0040007]; protein glycosylation [GO:0006486],9634230; 21969609,,,MELLRGALRTYAWGSRTAIAEFTGRPVPAAHPEAELWFGAHPGDPAWLQTPHGQTSLLEALVADPEGQLGSASRARFGDVLPFLVKVLAADEPLSLQAHPSAEQAVEGYLREERMGIPVSSPVRNYRDTSHKPELLVALQPFEALAGFREAARTTELLRALAVSDLDPFIDLLSEGSDADGLRALFTTWITAPQPDIDVLVPAVLDGAIQYVSSGATEFGAEAKTVLELGERYPGDAGVLAALLLNRISLAPGEAIFLPAGNLHAYVRGFGVEVMANSDNVLRGGLTPKHVDVPELLRVLDFAPTPKARLRPPIRREGLGLVFETPTDEFAATLLVLDGDHLGHEVDASSGHDGPQILLCTEGSATVHGKCGSLTLQRGTAAWVAADDGPIRLTAGQPAKLFRATVGL,"43,371",408,Mannose-6-phosphate isomerase type 1 family,carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; growth [GO:0040007]; protein glycosylation [GO:0006486],mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O50397,O50397_MYCTU,Rv3368c,Rv3368c,GO:0016491,IPR029479; IPR000415; ,,,DOMAIN 14 189 Nitroreductase. {ECO:0000259|Pfam:PF00881}.,Possible oxidoreductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTLNLSVDEVLTTTRSVRKRLDFDKPVPRDVLMECLELALQAPTGSNSQGWQWVFVEDAAKKKAIADVYLANARGYLSGPAPEYPDGDTRGERMGRVRDSATYLAEHMHRAPVLLIPCLKGREDESAVGGVSFWASLFPAVWSFCLALRSRGLGSCWTTLHLLDNGEHKVADVLGIPYDEYSQGGLLPIAYTQGIDFRPAKRLPAESVTHWNGW,"23,733",214,,,oxidoreductase activity [GO:0016491],,,,1
O50384,O50384_MYCTU,Rv3355c,Rv3355c,GO:0016021,IPR021385; ,,,,Probable integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MTVRAVFRRTVGAQWPILLVGSIFAVGFVLAGANFWRRGALLIGIGVGVAAVLRLVLSEERAGLLVVRSKGIDFVTTVTVAAAMVYIASTIDPLGTG,"10,142",97,,,,integral component of membrane [GO:0016021],,,1
O05895,O05895_MYCTU,Rv3252c,alkB Rv3252c,GO:0006629; GO:0016021; GO:0043448; GO:0080133,IPR033885; IPR005804; ,,alkB,,Probable transmembrane alkane 1-monooxygenase AlkB (Alkane 1-hydroxylase) (Lauric acid omega-hydroxylase) (Omega-hydroxylase) (Fatty acid omega-hydroxylase) (Alkane hydroxylase-rubredoxin),integral component of membrane [GO:0016021]; midchain alkane hydroxylase activity [GO:0080133]; alkane catabolic process [GO:0043448]; lipid metabolic process [GO:0006629],9634230; 21969609,,,MTTQIGSGGPEAPRPPEVEEWRDKKRYLWLMGLIAPTALVVMLPLIWGMNQLGWHAAAQVPLWIGPILLYVLLPLLDLRFGPDGQNPPDEVTDRLENDKYYRYCTYIYIPFQYLSVVLGAYLFTAANLSWLGFDGALSWAGKLGVALSVGVLGGVGINTAHEMGHKKDSLERWLSKITLAQTCYGHFYIEHNRGHHVRVSTPEDPASARFGETLWEFLPRSVIGGLRSAVHLEAQRLRRLGVSPWNPMTYLRNDVLNAWLMSVVLWGGLIAVFGPALIPFVIIQAVFGFSLLEAVNYLEHYGLLRQKSANGRYERCAPVHSWNSDHIVTNLFLYHLQRHSDHHANPTRRYQTLRSMAGAPNLPSGYASMISLTYFPPLWRKVMDHRVLEHYGGDITRVNLHPRVREKALARYGASA,"47,014",416,,alkane catabolic process [GO:0043448]; lipid metabolic process [GO:0006629],midchain alkane hydroxylase activity [GO:0080133],integral component of membrane [GO:0016021],,,1
P96874,P96874_MYCTU,Rv3269,Rv3269,GO:0005618; GO:0005886,IPR009963; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MAIQVFLAKATTTVITGLAGVTAYEILKKAAAKAPLRQTAVSAAALGLRGTRKAEEAAESARLKVADVMAEARERIGEESPTPAISDLHDHDH,"9,750",93,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P96894,P96894_MYCTU,Rv3289c,Rv3289c,GO:0016021,,,,,Possible transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MHEVGGPSRGDRLGRDDSEVHSAIRFAVVAAVVGVGFLIMGALLVSTCSGVDTAACGPPQRILLALGGPLILCAAGLWAFLRTYRVWRAEGTWWGWHGAGWFLLTLMVLTLCIGVPPIAGPVMAP,"13,152",125,,,,integral component of membrane [GO:0016021],,,1
O53343,O53343_MYCTU,Rv3197,Rv3197,GO:0005524; GO:0005618,IPR034646; IPR002575; IPR011009; IPR004147; ,,,,Probable conserved ATP-binding protein ABC transporter,cell wall [GO:0005618]; ATP binding [GO:0005524],9634230; 21969609; 29350349,X-ray crystallography (4),,MDDGSVSDIKRGRAARNAKLASIPVGFAGRAALGLGKRLTGKSKDEVTAELMEKAANQLFTVLGELKGGAMKVGQALSVMEAAIPDEFGEPYREALTKLQKDAPPLPASKVHRVLDGQLGTKWRERFSSFNDTPVASASIGQVHKAIWSDGREVAVKIQYPGADEALRADLKTMQRMVGVLKQLSPGADVQGVVDELVERTEMELDYRLEAANQRAFAKAYHDHPRFQVPHVVASAPKVVIQEWIEGVPMAEIIRHGTTEQRDLIGTLLAELTFDAPRRLGLMHGDAHPGNFMLLPDGRMGIIDFGAVAPMPGGFPIELGMTIRLAREKNYDLLLPTMEKAGLIQRGRQVSVREIDEMLRQYVEPIQVEVFHYTRKWLQKMTVSQIDRSVAQIRTARQMDLPAKLAIPMRVIASVGAILCQLDAHVPIKALSEELIPGFAEPDAIVV,"49,122",447,,,ATP binding [GO:0005524],cell wall [GO:0005618],,,1
I6YG83,I6YG83_MYCTU,Rv3472,Rv3472,,IPR032710; IPR037401; ,,,DOMAIN 12 126 SnoaL-like. {ECO:0000259|Pfam:PF13577}.,Conserved protein,,9634230; 21969609,,,MRPVDEQWIEILRIQALCARYCLTIDTQDGEGWAGCFTEDGAFEFDGWVIRGRPALREYADAHARVVRGRHLTTDLLYEVDGDVATGRSASVVTLATAAGYKILGSGEYQDRLIKQDGQWRIAYRRLRNDRLVSDPSVAVNVADADVAAVVGHLLAAARRLGTQMSDT,"18,568",168,,,,,,,1
O05842,O05842_MYCTU,Rv3224,Rv3224,GO:0005618; GO:0005829; GO:0005886; GO:0010039,IPR036291; IPR002347; ,,,,Possible iron-regulated short-chain dehydrogenase/reductase,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; response to iron ion [GO:0010039],9634230; 21969609,,,MSLNGKTMFISGASRGIGLAIAKRAARDGANIALIAKTAEPHPKLPGTVFTAAKELEEAGGQALPIVGDIRDPDAVASAVATTVEQFGGIDICVNNASAINLGSITEVPMKRFDLMNGIQVRGTYAVSQACIPHMKGRENPHILTLSPPILLEKKWLRPTAYMMAKYGMTLCALGIAEEMRADGIASNTLWPRTMVATAAVQNLLGGDEAMARSRKPEVYADAAYVIVNKPATEYTGKTLLCEDVLVESGVTDLSVYDCVPGATLGVDLWVEDANPPGYLPA,"29,814",282,,response to iron ion [GO:0010039],,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53340,O53340_MYCTU,Rv3194c,Rv3194c,GO:0004176; GO:0004252; GO:0005524; GO:0005576; GO:0030163,IPR008269; IPR027065; IPR001478; IPR036034; IPR020568; IPR014721; ,,,DOMAIN 112 192 PDZ. {ECO:0000259|PROSITE:PS50106}.; DOMAIN 233 331 Lon proteolytic. {ECO:0000259|PROSITE:PS51786}.,Endopeptidase La (EC 3.4.21.53),extracellular region [GO:0005576]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252]; protein catabolic process [GO:0030163],9634230; 21969609,,,MNRRILTLMVALVPIVVFGVLLAVVTVPFVALGPGPTFDTLGEIDGKQVVQIVGTQTYPTSGHLNMTTVSQRDGLTLGEALALWLSGQEQLMPRDLVYPPGKSREEIENDNAADFKRSEAAAEYAALGYLKYPKAVTVASVMDPGPSVDKLQAGDAIDAVDGTPVGNLDQFTALLKNTKPGQEVTIDFRRKNEPPGIAQITLGKNKDRDQGVLGIEVVDAPWAPFAVDFHLANVGGPSAGLMFSLAVVDKLTSGHLVGSTFVAGTGTIAVDGKVGQIGGITHKMAAARAAGATVFLVPAKNCYEASSDSPPGLKLVKVETLSQAVDALHAMTSGSPTPSC,"35,473",340,Peptidase S16 family,protein catabolic process [GO:0030163],ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; serine-type endopeptidase activity [GO:0004252],extracellular region [GO:0005576],,,1
I6X7G4,I6X7G4_MYCTU,Rv3493c,Rv3493c,GO:0016021,,,,,Conserved hypothetical Mce associated alanine and valine rich protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MAADTGVAGGQQSTTRRARRKASRPAGPAEGESSRPAQGAATVRAAARTESKPAKAAKPALRPVKPPPRRPAHRVLVGWLSLAAGLLAIAALAWGVTALVMQNRDADARQARNQRFVDAATQTVVNMFSYTPDTIDESVNRFVNGTSGPLRGMLNANNNVDNLKGLFRATNATSEAVVNGAALEGIDEISDNASVLVSVRVTVADIDGVNKPSMPYRLRVIVHEDENGRMTGYDLKYPDGGN,"25,611",242,,,,integral component of membrane [GO:0016021],,,1
O07034,O07034_MYCTU,Rv3123,Rv3123,,,,,,Uncharacterized protein,,9634230,,,MRSRSVRWDPRCRPGRSGVGDPHCDDPAGLLAAGAAAGRRHRAPGPAHRLRARALRVVRRLPRQEPRYRAGPGPVAPRLLPLPHLRAWDGAPWIWNLATAILPEATPIVDLYHARQHVHDLAGQLAPALGEHHSDWLTARLVDLDSGDIETLVQQPIGQHTGHT,"18,041",164,,,,,,,1
I6YC39,I6YC39_MYCTU,Rv3430c,Rv3430c,GO:0003676; GO:0015074,IPR001584; IPR012337; IPR036397; ,,,,Possible transposase,nucleic acid binding [GO:0003676]; DNA integration [GO:0015074],9634230,,,MIDTAIEEMIPLIGVRAACAATGRAPASYYRAHSKRLSAQSDTFTSTAVTDPSGPRESAQPRALSAAEREHVLAVLNSQRFADMAPAVVYATLLDEGIYLCSESTMYRLLRERGQTGDRRRQATHPAAVKPELVAHQPNSVWSWDITKLRGPAKWSYYYLYVILDIFSRYVVGWMVASRESKVLAERLIAQTLAAQHISADQLTLHADRGSSMSSKPVALLLADLGVTKSHSRPHTSNDNPLSEAQFKTLKYRPDFPKRFESIEAARVHCDRFFGWYNHEHKHSGIGLHTPADVHYGRADQIRRHRATVLDTAYRDHLERIRSQTTRATRATGLQRDQPTTEGGPADSINPRKSCLRNVDRFRPGLLDLPAPAPVDLRRLLPSGQIR,"43,350",387,,DNA integration [GO:0015074],nucleic acid binding [GO:0003676],,,,1
Q6MWX3,Q6MWX3_MYCTU,Rv3468c,Rv3468c,GO:0003824; GO:0050662,IPR001509; IPR036291; ,,,,"Possible dTDP-glucose 4,6-dehydratase",catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],9634230,,,MGTHAATMRVRAGVRSSPLLLHAGTPPTAAAAESGMRTLVTGSSGHLGEALVRTLRARGADIVSLDSRPSRYTNIVGCVSDRALLRDVMAGVEVVFHAAAHHKPQLAFLPRQAFLDTNIIGTQTVLDAAVAANVRAFVMTSSTTVFGDALTPPADQPAAWIDESVTPIPKNIYGVTKASSEDLCQLAHRNDGLACVVLRVARFFVEGDDMPDLYDGRSQDNIKANEYACRRVALEDAVDAHLNAAQRAPQLGFGRYLVSATTPFTRDDLTQLRTDAASVFARRVPLAAAVWTQRGWRFPDRLDRVYVNSRARRDLNWRPRFDLNAVAARLARGQSVHTPLSQLVGSKAYAHSSYHRGVFAPARP,"39,515",364,,,catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],,,,1
I6X7B3,I6X7B3_MYCTU,Rv3438,Rv3438,,IPR029058; ,,,,Conserved protein,,9634230; 21969609,,,MPRIRKLVAALHRRGPHRVLRGDLAFAGLPGVVYTPEAGLHLPGVAFGHDWLTGTSRYSGLLEHLASWGIVAAAPDSERGLAPSVLNLAFDLGVALDIVAGVRLGPGKISVHPAKLGLVGHGFGGSAAVFAAAGLTGTHVKSVAAIFPTVTNPAAEQPAATLDVPGLILTAPGDPKTLTSNALGLSRAWDKATLRIVSKARAGGLVEGRRLTKVLGLPGPHRRTQRSVRALLTGYLLYTLGGDKTYRRFADPDLQLPKTDPIDPEAPPITPGEKIVTLLK,"29,241",280,,,,,,,1
Q6MX04,Q6MX04_MYCTU,Rv3159c,PPE53 Rv3159c,,IPR002989; IPR000030; IPR038332; ,,PPE53,,PPE family protein PPE53,,9634230,,,MNYSVLPPEINSLRMFTGAGSAPMLAASVAWDRLAAELAVAASSFGSVTSGLAGQSWQGAAAAAMAAAAAPYAGWLAAAAARAAGASAQAKAVASAFEAARAATVHPMLVAANRNAFVQLVLSNLFGQNAPAIAAAEAMYEQMWAADVAAMVGYHGGASAAAAQLSSWSIGLQQALPAAPSALAAAIGLGNIGVGNLGGGNTGDYNLGSGNSGNANVGSGNSGNANVGSGNDGATNLGSGNIGNTNLGSGNVGNVNLGSGNRGFGNLGNGNFGSGNLGSGNTGSTNFGGGNLGSFNLGSGNIGSSNIGFGNNGDNNLGLGNNGNNNIGFGLTGDNLVGIGALNSGIGNLGFGNSGNNNIGFFNSGNNNVGFFNSGNNNFGFGNAGDINTGFGNAGDTNTGFGNAGFFNMGIGNAGNEDMGVGNGGSFNVGVGNAGNQSVGFGNAGTLNVGFANAGSINTGFANSGSINTGGFDSGDRNTGFGSSVDQSVSSSGFGNTGMNSSGFFNTGNVSAGYGNNGDVQSGINNTNSGGFNVGFYNSGAGTVGIANSGLQTTGIANSGTLNTGVANTGDHSSGGFNQGSDQSGFFGQP,"56,586",590,Mycobacterial PPE family,,,,,,1
O05857,O05857_MYCTU,Rv3209,Rv3209,GO:0005576,IPR008693; IPR038468; ,,,,Conserved hypothetical threonine and proline rich protein,extracellular region [GO:0005576],9634230,,,MALGAVATAVIINSGDSTSTKAIVGAPAPRTVISTSPRPTAPTSTSPHPSPSTLRPQLPPETVTTVAPPGTGPTTVPTRTPTAAPPQTAVPPPAPLNPRTVVYRVTGTKQLFDLVNVVYTDARGFPVTDFNVSLPWTKMVVLNPGVQTESVVATSLYSRLNCSIVNTGAQTVVASTNNAIIATCTR,"19,151",186,,,,extracellular region [GO:0005576],,,3
O06319,O06319_MYCTU,Rv3452,cut4 Rv3452,GO:0004623; GO:0016042; GO:0016788,IPR029058; IPR000675; ,,cut4,,Probable cutinase Cut4,"hydrolase activity, acting on ester bonds [GO:0016788]; phospholipase A2 activity [GO:0004623]; lipid catabolic process [GO:0016042]",9634230,,,MIPRPQPHSGRWRAGAARRLTSLVAAAFAAATLLLTPALAPPASAGCPDAEVVFARGTGEPPGLGRVGQAFVSSLRQQTNKSIGTYGVNYPANGDFLAAADGANDASDHIQQMASACRATRLVLGGYSQGAAVIDIVTAAPLPGLGFTQPLPPAADDHIAAIALFGNPSGRAGGLMSALTPQFGSKTINLCNNGDPICSDGNRWRAHLGYVPGMTNQAARFVASRI,"23,113",226,,lipid catabolic process [GO:0016042],"hydrolase activity, acting on ester bonds [GO:0016788]; phospholipase A2 activity [GO:0004623]",,,,3
O50417,O50417_MYCTU,Rv3391,acrA1 Rv3391,GO:0005886,IPR013120; IPR036291; IPR002347; ,,acrA1,,Possible multi-functional enzyme with acyl-CoA-reductase activity AcrA1,plasma membrane [GO:0005886],9634230; 21969609,,,MRYVVTGGTGFIGRHVVSRLLDGRPEARLWALVRRQSLSRFERLAGQWGDRVRPLVGDLTELELSERTIAELGDIDHVLHCAAVHDTTWADATRAVIELAARLDATFHHVSSIAVAGDFAGHYTEADFDVGQRLPTPYHRMTFEAERLVRSTPGLRYRIYRPAVVVGDSRTGEMDTIDGPYYLFGVLAKLAVLPSFTPMLLPDIGRTNIVPVDYVADALVALMHADGRDGQTFHLTAPTAIGLRGIYRGIAGAAGLPPLLGTLPGFVAAPVLNARGRAKVLRNMAATQLGIPAEIFDVVGCAPTFTSDTTREALRGTGIHVPEFATYAPGLWRYWAEHLDPDRARRNDPLLGRHVIITGASSGIGRASAIAVAKRGATVFALARNGNALDELVTEIRAHGGQAHAFTCDVTDSASVEHTVKDILGRFDHVDYLVNNAGRSIRRSVVNSTDRLHDYERVMAVNYFGAVRMVLALLPHWRERRFGHVVNVSSAGVQARNPKYSSYLPTKAALDAFADVVASETLSDHITFTNIHMPLVATPMIVPSRRLNPVRAISAERAAAMVIRGLVEKPARIDTPLGTLAEAGNYVAPRLSRRILHQLYLGYPDSAAAQGISRPDADRPPAPRRPRRSARAGVPRPLRRLGRLVPGVHW,"70,940",650,,,,plasma membrane [GO:0005886],,,1
O53351,O53351_MYCTU,Rv3258c,Rv3258c,,IPR021888; ,,,,Uncharacterized protein,,9634230,,,MRVSGASAALVHDSLSVVNVPRRCCRPGCPHYAVATLTFVYSDSTAVIGPLATAREPHSWDLCVGHAGRITAPRGWELVRHAGPLPSHPDEDDLVALADAVREGGPSAGRRHHPGGNGAPLHGFDDFPAAATGAPTGGGVLAPPEPGAGRRRGHLRVLPDPAD,"16,811",163,,,,,,,1
O06321,O06321_MYCTU,Rv3454,Rv3454,GO:0005886; GO:0015209; GO:0015856; GO:0016021,IPR030191; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cytosine transmembrane transporter activity [GO:0015209]; cytosine transport [GO:0015856],9634230,,,MAQGLKLGLHIPLWAGYACSTLIIFPLVVYGMKVLSQLQLWTTPLWLILMAAPFGYLVVSHPDSIGQFFSYAGKDGHGGLSFGSVLLAAGVCLSLIAQIAEQIDYLRFMPPRTPENANRWWTWTLLAGPGWVAFGATKQIIGLFLAVYLMANIPGSSTIANQPVHQFMQIYRTFVPGWLALTLAVILVVLSQIKINVTNAYSGSLAWTNSFTRLTKHYPGRVVFLGVNLAIALILMEANMFDFLNTILGCYANCGMAWVVAVASDIGFNKYLLGLSPKTPEFRRGMLYAINPVGFGSLLLAAGLSIVTFFGGLGAALQPYSPLVAIVTALVMPPILAAATKGKYYLRRTHDGIDLPMYDEHGNPSAAVLTCHVCHQDFERPDMLACQTHGAHVCSLCLSTDKQAEHVLPGLARAHIPGDQVP,"45,779",422,,cytosine transport [GO:0015856],cytosine transmembrane transporter activity [GO:0015209],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O50416,O50416_MYCTU,Rv3390,lpqD Rv3390,GO:0005576; GO:0005886,IPR013078; IPR029033; ,,lpqD,,Probable conserved lipoprotein LpqD,extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MAKRTPVRKACTVLAVLAATLLLGACGGPTQPRSITLTFIRNAQSQANADGIIDTDMPGSGLSADGKAEAQQVAHQVSRRDVDSIYSSPMAADQQTAGPLAGELGKQVEILPGLQAINAGWFNGKPESMANSTYMLAPADWLAGDVHNTIPGSISGTEFNSQFSAAVRKIYDSGHNTPVVFSQGVAIMIWTLMNARNSRDSLLTTHPLPNIGRVVITGNPVTGWRLVEWDGIRNFT,"25,056",236,,,,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
Q6MWX4,Q6MWX4_MYCTU,Rv3395A,Rv3395A,,,,,,Probable membrane protein,,9634230; 21969609,,,MQSRKTTSVLAAALLFCGLLGPGTAPPATGGGPACRPAELFATDNTTDGFELPAVATIALTGTVVTGSTLVDGVFWSNERQQIGYERSREFHLCVVDAPTLHNAAEALHRQFNQEAVLTFDYLPQNAPEADAILITVPDIGIARFRDAFASDLAAHHRLRGGSVTTADHTLILVAGNGDLDVARRLVEEAGGDWNATTIAHGRREFVN,"22,090",208,,,,,,,1
O50402,O50402_MYCTU,Rv3373,echA18 Rv3373,GO:0004300; GO:0005618; GO:0006635,IPR029045; IPR018376; IPR001753; ,,echA18,,Probable enoyl-CoA hydratase EchA18 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),cell wall [GO:0005618]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MRRRAMTKMDEASNPCGGDIEAEMCQLMREQPPAEGVVDRVALQRHRNVALITLSHPQAQNALNLASWRRLKRLLDDLAGESGLRAVVLRGAGDKAFAAGADIKEFPNTRMSAADAAEYNESLAVCLRALTTMPIPVIAAVRGLAVGGGCELATACDVCIATDDARFGIPLGKLGVTTGFTEADTVARLIGPAALKYLLFSGELIGIEEAARW,"22,662",213,Enoyl-CoA hydratase/isomerase family,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],cell wall [GO:0005618],,,1
L7N687,L7N687_MYCTU,Rv3322c,Rv3322c,GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Possible methyltransferase,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MSVQTDPALREHPNRVDWNARYERAGSAHAPFAPVPWLADVLRAGVPDGPVLELASGRSGTALALAAHGRQVTAIDVSDVALLQLDSEAVRRGVADRLNLVQADLGCWEPGETRFALVLSRLFWDAAIFHRACEAVMPGGVLAWESLALSGAEAGTASAKRRVKPGEPACLLPADFTVVHEGQGNCDSAPSRIMIARRSPLPGA,"21,615",204,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
I6YBZ8,I6YBZ8_MYCTU,Rv3389c,htdY Rv3389c,,IPR029069; IPR002539; IPR027090; ,,htdY,,Probable 3-hydroxyacyl-thioester dehydratase HtdY,,9634230; 21969609; 25613812,X-ray crystallography (1),,MAIDPNSIGAVTEPMLFEWTDRDTLLYAIGVGAGTGDLAFTTENSHGIDQQVLPTYAVICCPAFGAAAKVGTFNPAALLHGSQGIRLHAPLPAAGKLSVVTEVADIQDKGEGKNAIVVLRGRGCDPESGSLVAETLTTLVLRGQGGFGGARGERPAAPEFPDRHPDARIDMPTREDQALIYRLSGDRNPLHSDPWFATQLAGFPKPILHGLCTYGVAGRALVAELGGGVAANITSIAARFTKPVFPGETLSTVIWRTEPGRAVFRTEVAGSDGAEARVVLDDGAVEYVAG,"30,296",290,,,,,,,1
I6YG27,I6YG27_MYCTU,Rv3415c,Rv3415c,,IPR011990,,,,Uncharacterized protein,,9634230; 21969609,,,MNETPHAPVVEQVLVAAAFGNQPGSWPLPTAITPHHLWLRAVAAGGQGRYAHAYGDLSVLRRLVPAGPLASLAHSTQGSLLRQLGWHTLARGWDGRALALAGADREAGADALIGLAADALGVGRFAAAGALLDRADPLVVSPLVADRLAVRRRWVAAELAMATGDGATAVRHAEEAVELTQAMAVASARHRVKSDVVLAAALCSAGAVARARAVGEEALDATARFGLLPLRWALACLLIDIGTVTFSAQQLRELTKIRNICAGQVRRAGGCWRTA,"28,659",275,,,,,,,1
P96873,P96873_MYCTU,Rv3268,Rv3268,,IPR017523; ,,,,Uncharacterized protein,,9634230; 21969609,,,MLRADPVGPRITYYDDATGERIELSAVTLANWAAKTGNLLRDELAAGPASRVAILLPAHWQTAAVLFGVWWIGAQAILDDSPADVALCTADRLAEADAVVNSAAVAGEVAVLSLDPFGRPATGLPVGVTDYATAVRVHGDQIVPEHNPGPVLAGRSVEQILRDCAASAAARGLTAADRVLSTASWAGPDELVDGLLAILAAGASLVQVANPDPAMLQRRIATEKVTRVL,"23,723",229,,,,,,,1
I6YBQ3,I6YBQ3_MYCTU,Rv3291c,lrpA Rv3291c,GO:0003700; GO:0005829; GO:0006351; GO:0043200; GO:0043565,IPR000485; IPR011008; IPR019888; IPR019887; IPR036388; IPR036390; ,,lrpA,DOMAIN 5 66 HTH asnC-type. {ECO:0000259|PROSITE:PS50956}.,Probable transcriptional regulatory protein LrpA (Lrp/AsnC-family),"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MNEALDDIDRILVRELAADGRATLSELATRAGLSVSAVQSRVRRLESRGVVQGYSARINPEAVGHLLSAFVAITPLDPSQPDDAPARLEHIEEVESCYSVAGEESYVLLVRVASARALEDLLQRIRTTANVRTRSTIILNTFYSDRQHIP,"16,511",150,,"response to amino acid [GO:0043200]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565],cytosol [GO:0005829],,,1
O53336,O53336_MYCTU,Rv3190c,Rv3190c,GO:0005618; GO:0005829,,,,,Uncharacterized protein,cell wall [GO:0005618]; cytosol [GO:0005829],9634230; 21969609,,,MEYVQLFSKGRLNDLAGSLAGFLGKASQATAQRLQSWDADDLLNTPVDDVVEQLVELGSVECPDLRVDDAFMLPATEVDQQYRDWGEQRTRRVTRLVLVVPFEGHKDIFNLRPDQFTTMPPQVLRLQGHEIHLAIDNLSNDAAAINAAFHKQIANIEKYLGWSRRQIDLHNQGLRNELPGMVARRREQLLATRNLQAEIGFPVRRRKDADTYAAPISRKSVRPRPHRPAGARAAFKPEPAMQDEDYQSALRVLRNQRNALERTPSVAAKLDGEEIRDMLLVGLNAQFEGDAGGELFNGAGKTDILIRVDDRNIFIGECKVWSGPRTMDDVLKQLFGYLVWRDTKAAILLFIRNKDVTAVIDNAIAKIKEHPNHKRCPAHRAGADQYEFTMHADGDPEREIHLTLIPFALRPTAEVPTTTIP,"47,482",421,,,,cell wall [GO:0005618]; cytosol [GO:0005829],,,1
O05853,O05853_MYCTU,Rv3213c,Rv3213c,GO:0005618; GO:0043590,IPR025669; IPR027417; ,,,,Possible SOJ/para-related protein,bacterial nucleoid [GO:0043590]; cell wall [GO:0005618],9634230; 21969609,,,MTDTRVLAVANQKGGVAKTTTVASLGAAMVEKGRRVLLVDLDPQGCLTFSLGQDPDKLPVSVHEVLLGEVEPNAVLVTTMEGMTLLPANIDLAGAEAMLLMRAGREYALKRALAKFSDRFDVVIIDCPPSLGVLTLNGLTAADKAIVPLQCEMLAHRGVGQFLRTVADVQQITNPNLRLLGALPTLYDSRTTHTRDVLLDVADRYDLQVLAPPIPRTVRFAEASASGSSVMAGRKNKGAVAYRELAQALLKHWKTGRPLPTFTVDL,"28,575",266,,,,bacterial nucleoid [GO:0043590]; cell wall [GO:0005618],,,1
P95188,P95188_MYCTU,Rv3138,pflA Rv3138,GO:0016740; GO:0016829; GO:0046872; GO:0051536,IPR013785; IPR027596; IPR016431; IPR007197; ,,pflA,,Probable pyruvate formate lyase activating protein PflA (Formate acetyltransferase activating enzyme) ([pyruvate formate-lyase] activating enzyme),iron-sulfur cluster binding [GO:0051536]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; transferase activity [GO:0016740],9634230,,,MSDPFTIATKHWHRLHDSRIQCDVCPRACKLHEGQRGLCFVRGRFDDQVKLTSYGRSSGFCVDPIEKKPLNHFLPGSATLSFGTAGCNLACKFCQNWDISKSREIDVLASRAAPADIARTAHELGCRSVAFTYNDPTIFWEYAADVADACHDQGIKAVAVTAGYMCPEPRAEFYRRVDAANVDLKAFTEDFYRKVCVSHLRNVLDTLAYLRHQTNVWLEITTLLIPGRNDSDAEVAAECRWIRENLGVDVPVHFTAFHPDYKMMDTPATPTATLTRAREIGIGEGLRFVYTGNVHDAVGGSTSCPGCRATVIVRDWYSIRHYALTEDGRCQACGYQMPGVYDGPAGHWGQRRLPLLTSLSRM,"40,433",362,,,iron-sulfur cluster binding [GO:0051536]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; transferase activity [GO:0016740],,,,2
O53346,O53346_MYCTU,Rv3200c,Rv3200c,GO:0005829; GO:0005887; GO:0006813,IPR013099; IPR036291; IPR003148; ,,,,Possible transmembrane cation transporter,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887]; potassium ion transport [GO:0006813],9634230; 21969609,,,MAGSWRRLRGLNEKLTAQPGYALVGVLRIPQRRASPARVISRRVVVAVVALLLTAGIVYVDRDGYLDAQGDRLTFLDCLYYAAVTLSTTGYGDITPISEFARAINIFVITPLRIAFLILLVGTTLEVLTETSRQAYKIQRWRSRVRNHTVVIGYGTKGKTAVAAMVSDELVPGEIVVVDTDSGVLERAAAAGLVTVHGDATKSDVLRLAGTQHASSIIVATSRDDTAVLVTLTAREIAPKAKIVASIREAENQHLLRQSGADTVVVSSETAGRLLGIATTTPSVVEMIEDLLTPEAGLAVAEREVEQAEVGGSPRHLRDIVLGVVRDGQLLRIGAPEVDAIEASDRLLYIRQVGR,"38,132",355,,potassium ion transport [GO:0006813],,cytosol [GO:0005829]; integral component of plasma membrane [GO:0005887],,,1
O05848,O05848_MYCTU,Rv3218,Rv3218,GO:0003951; GO:0005886,IPR017438; IPR001206; IPR016064; ,,,,Conserved protein,plasma membrane [GO:0005886]; NAD+ kinase activity [GO:0003951],9634230; 21969609,,,MRAVLIVNPTATATTPAGRDLLAHALESRLQLTVEHTNHRGHGTELGQAAVADGVDLVVVHGGDGTVSAVVNGMLGRPGTTPVRPVPAVAVVPGGSANVLARALGISADPIAATNQLIQLLDDYGRHQQWRRIGLIDCGERWAVFNAGMGVDAEVVAAVEAERDKGGKVTAWRYIRAAVRAVLACTRREPALTLQLPNRDPITGVHFVFVSNSSPWTYANNRPVWTNPDCRFESGLGVFATTSMKVVPTLRVVRQMFAKQPKFEFNHVINNDDVACLRVTSMGPPIASQFDGDYLGVRETMTFRAVPDALAVVAPPARKRI,"34,475",321,,,NAD+ kinase activity [GO:0003951],plasma membrane [GO:0005886],,,1
I6Y3P5,I6Y3P5_MYCTU,Rv3500c,yrbE4B Rv3500c,GO:0043190,IPR030802; ,,yrbE4B,,Conserved integral membrane protein YrbE4B. Possible ABC transporter,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230; 21969609,,,MSYDVTIRFRRFFSRLQRPVDNFGEQALFYGETMRYVPNAITRYRKETVRLVAEMTLGAGALVMIGGTVGVAAFLTLASGGVIAVQGYSSLGDIGIEALTGFLSAFLNVRVVAPVIAGIALAATIGAGATAQLGAMRVSEEIDAVECMAVHSVSYLVSTRLIAGLVAIIPLYSLSVLAAFFAARFTTVFVNGQSAGLYDHYFNTFLIPSDLLWSFMQAIAMSIAVMLVHTYYGYNASGGSVGVGVAVGQAVRTSLIVVVVITLFISLAVYGASGNFNLSG,"29,563",280,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
O53322,O53322_MYCTU,Rv3172c,Rv3172c,,,,,,Uncharacterized protein,,9634230,,,MSVALLREMFDRMVVAKNAELIEHYYDPDFLMYSDGLSQSFAKFRDSHRKLYATAISYAVEYDEHAWVEAQTRLPGGCGSPRRDLARSRPASRWYSLPPTATAEFTGSGRRRGRVGATWPPSTITETTTDRLAMRNQLRAGAATLLFCDPMLQRFPATRK,"18,157",160,,,,,,,1
O53383,O53383_MYCTU,Rv3333c,Rv3333c,,IPR007969; ,,,,Hypothetical proline rich protein,,9634230,,,MFTGIASHAGALGAALVVLIGAAILHDGPAAADPNQDDRFLALLEKKEIPAVANVPRVIDAAHKVCRKLDGGMPVNDIVDGLRNDAYNIDPVMRLYPVRLTTTMTRFISAAVEIYCPNHHSKMAFAMANFEPGSNEPTHRVAASTRSAVNSGSDLRASVSDMTIMSPGWREPTGAMLASVLGAVRAGDPLIPNPPPIPVPPPAAQTLIPPPPIVAPPPPRPAPPQQPPPPPPEVEPPAGVPQSGGAAGSGGAGSGGGGGGDGPVEPSPARPMPPGFIRLAP,"28,652",281,,,,,,,1
P95184,P95184_MYCTU,Rv3142c,Rv3142c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTEQEMTEQWLEGCAVQRIMFRDGLVLNFDDYNELVISVPLQLTLPAIETSPAEVVAIDPNDPADHERPLFDFAGATCTAFVWYDTGDLHLEFSDGHQIDVHPDDRVTAWELYGKYHGYAACLAPGKLRVVRHDVADANGDQ,"15,935",142,,,,,,,3
O53352,O53352_MYCTU,Rv3259,Rv3259,,IPR010428; IPR038555; ,,,,Uncharacterized protein,,9634230; 21969609,,,MRGPLLPPTVPGWRSRAERFDMAVLEAYEPIERRWQERVSQLDIAVDEIPRIAAKDPESVQWPPEVIADGPIALARLIPAGVDVRGNATRARIVLFRKPIERRAKDTEELGELLHEILVAQVAIYLDVDPSVIDPTIDD,"15,649",139,,,,,,,3
P96890,P96890_MYCTU,Rv3285,accA3 Rv3285,GO:0003989; GO:0004658; GO:0005524; GO:0005618; GO:0005886; GO:0009317; GO:0015977; GO:0040007; GO:0046872,IPR011761; IPR005481; IPR001882; IPR011764; IPR005482; IPR000089; IPR005479; IPR016185; IPR011054; IPR011053; ,,accA3,,Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase (Alpha chain) AccA3: biotin carboxylase + biotin carboxyl carrier protein (BCCP),acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658]; carbon fixation [GO:0015977]; growth [GO:0040007],9634230; 21969609; 28469974,X-ray crystallography (1),,MASHAGSRIARISKVLVANRGEIAVRVIRAARDAGLPSVAVYAEPDAESPHVRLADEAFALGGQTSAESYLDFAKILDAAAKSGANAIHPGYGFLAENADFAQAVIDAGLIWIGPSPQSIRDLGDKVTARHIAARAQAPLVPGTPDPVKGADEVVAFAEEYGLPIAIKAAHGGGGKGMKVARTIDEIPELYESAVREATAAFGRGECYVERYLDKPRHVEAQVIADQHGNVVVAGTRDCSLQRRYQKLVEEAPAPFLTDFQRKEIHDSAKRICKEAHYHGAGTVEYLVGQDGLISFLEVNTRLQVEHPVTEETAGIDLVLQQFRIANGEKLDITEDPTPRGHAIEFRINGEDAGRNFLPAPGPVTKFHPPSGPGVRVDSGVETGSVIGGQFDSMLAKLIVHGADRAEALARARRALNEFGVEGLATVIPFHRAVVSDPAFIGDANGFSVHTRWIETEWNNTIEPFTDGEPLDEDARPRQKVVVEIDGRRVEVSLPADLALSNGGGCDPVGVIRRKPKPRKRGAHTGAAASGDAVTAPMQGTVVKFAVEEGQEVVAGDLVVVLEAMKMENPVTAHKDGTITGLAVEAGAAITQGTVLAEIK,"63,783",600,,carbon fixation [GO:0015977]; growth [GO:0040007],acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
P96876,P96876_MYCTU,Rv3271c,Rv3271c,GO:0008324; GO:0016021; GO:0040007,IPR002524; IPR027469; IPR026765; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; cation transmembrane transporter activity [GO:0008324]; growth [GO:0040007],9634230; 21969609,,,METTTEHRDESTLDSPVSVAREAEWQRNVRWARWLAWVSLAVLLTEGAVGLWQGIAVGSVALTGWALGGGSEGLASAMVLWRFTGDRTWSATAEHRAQRGVAVSFWLTAPYLVAESIRHLAGEHRAETSVIGIGLTAIALLLMPVLGWANHRVGERLGSGATAGEGTQNYLCAAQAAAVLLGLAITAVWSNGWWIDPAIGLAIAGIAVWQGIRTWRGHGCGC,"23,633",222,,growth [GO:0040007],cation transmembrane transporter activity [GO:0008324],integral component of membrane [GO:0016021],,,1
O05858,O05858_MYCTU,Rv3208,Rv3208,GO:0003677; GO:0003700; GO:0005886; GO:0006355,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 38 98 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR-family),"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MSDLAKTAQRRALRSSGSARPDEDVPAPNRRGNRLPRDERRGQLLVVASDVFVDRGYHAAGMDEIADRAGVSKPVLYQHFSSKLELYLAVLHRHVENLVSGVHQALSTTTDNRQRLHVAVQAFFDFIEHDSQGYRLIFENDFVTEPEVAAQVRVATESCIDAVFALISADSGLDPHRARMIAVGLVGMSVDCARYWLDADKPISKSDAVEGTVQFAWGGLSHVPLTRS,"25,166",228,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,1
O53325,O53325_MYCTU,Rv3175,Rv3175,GO:0016787,IPR023631; IPR036928; ,,,,Possible amidase (Aminohydrolase),hydrolase activity [GO:0016787],9634230; 21969609,,,MAMSAKASDDIAWLPATAQLAVLAAKKVSSAELVELYLSRIDTYNASLNAIVTVDPDAARRVAKRSDAARARGDELGPLHGLPITVKDSYETAGMRTTCGRRDLADYVPTQDAEAVARLRRAGAIIMGKTNMPTGNQDVQASNPVFGRTNNPWDAARTSGGSAGGGAAATAAGLTSFDYGSEIGGSTRIPAHYCGLYGHKSTWRSVPLVGHIPSAPGNPGRWGQADMACAGVQVRGARDIIPALEATVGPMRADGGFSYALAPPRAGALKDFRVAVWAEDPHCPIDADVRRAMDDAVAALRAAGAHVVEQPATIPVDMAVSHNIFQSLVFGAFAVDRSTLSPASAAALGLRAVRHPRGEAANALGATLQSHRAWLFADAARHEMRDRWAGFFNEFDVLLLPVTPTPAPLHHNKDHDRLGRTIDVDGVSRSYWDQLKWNALANIAGTPATTMPITTTATGLPIGIQAMGPAGGDRTTVEFAALLTEVLGGFRVPPL,"52,082",495,,,hydrolase activity [GO:0016787],,,,1
O53312,O53312_MYCTU,Rv3162c,Rv3162c,GO:0016021,,,,,Possible integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MTSFAHPGTRGLSTVFGLMMVGSAAVGSHGLAVVVGLAAVIAVGVAAVFRLAATLAVVLSVVMIVVSGPTHVLAALSGFCAAVYLVCRYGAGVVAGSWPTTVAAVGFTFAGLAATSFPLQVPWLPLAAPLAVLATYVLATRPFSR,"14,442",145,,,,integral component of membrane [GO:0016021],,,1
O05790,O05790_MYCTU,Rv3113,Rv3113,GO:0005829; GO:0006281; GO:0008967; GO:0016311; GO:0040007,IPR036412; IPR006439; IPR023214; IPR023198; ,,,,Possible phosphatase,cytosol [GO:0005829]; phosphoglycolate phosphatase activity [GO:0008967]; dephosphorylation [GO:0016311]; DNA repair [GO:0006281]; growth [GO:0040007],9634230,,,MTSRDGFTIVWDWNGTLCDDRTILLDAVGQTLVNEGFEPLSQQQLIQRFARPLRTFFENACGRDLLTSEWERVQSTFRRIYRSREAEVTLVEDAYDVLAQGNRSAAGQFLLSLAPHDELMHFVQKYGIAKWFNGIRGRTRPDQEKPMMLAELIMQRSLNPTRVVHIGDSLEDAAAASAVGAISVLVTGASLQPPDRVMLKQLQPFVASSLKQALQYAGGDGD,"24,801",222,,dephosphorylation [GO:0016311]; DNA repair [GO:0006281]; growth [GO:0040007],phosphoglycolate phosphatase activity [GO:0008967],cytosol [GO:0005829],,,1
O50381,O50381_MYCTU,Rv3352c,Rv3352c,GO:0016614; GO:0050660,IPR016166; IPR036318; IPR006094; ,,,,Possible oxidoreductase,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230,,,MSAATDLYAVHQALAGESRAIPTGSCPTVGVAGLTLGGGLGADSRHAGLTCDALKSATVVLPGGDAVSASADDHAELFWALRGGGGGNFGVTTSMTFARFPTADCDVVRVDFAPSAAAQVLVG,"12,079",123,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,1
I6YGA5,I6YGA5_MYCTU,Rv3492c,Rv3492c,GO:0016021,,,,,Conserved hypothetical Mce associated protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MRRLISVAYALMVATIVGLSAAGGWFYWDRVQTGGEASARALLPKLAMQEIPQVFGYDYQTVERSLTAVYPLLTPDYRQEFQKSANAQIIPEAKKREVVVQANVVGVGVMDAKRDCASVMVYLNRTVTDKTRQPLYDGSRLRVDFQRIDGKWLIAYITPI,"18,007",160,,,,integral component of membrane [GO:0016021],,,1
O53342,O53342_MYCTU,Rv3196,Rv3196,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSARSVAPSQVMRRAASALYSLNPAMPVLLRPDGAVQVGWDPRRAVLVRPPRGLTATGLAALLRSMRSPIPITELQRQAAERGLVDGDAMANLVAQLVGAGVATPLANPGNLDSRRRAASIRVHGRGPLSDLLVQALRCSGARIRHSSQPHAAVTPAGVDLVVLSDYLVADPHMVRDLHTERVPHLPVRVRDGTGMVGPLVVPGVTSCLGCADLHRSDRDAAWPAIAAQLRDTVGVADRATLLATAALALSQVNRVIAAVRGQEATPEPPSALNTTLEFDLNAGSIVARQWTRHPRCFC,"31,646",299,,,,,,,1
Q6MX03,Q6MX03_MYCTU,Rv3176c,mesT Rv3176c,GO:0016787,IPR029058; IPR000073; ,,mesT,DOMAIN 52 309 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Probable epoxide hydrolase MesT (Epoxide hydratase) (Arene-oxide hydratase),hydrolase activity [GO:0016787],9634230,,,MTHRASALISAQEWFSAGERVGYDAERPGINPRSPLRAFIRRAAGTGVTRTFLPGWPDGSYGWAKVEAFLSSRFHFPRIYLDYIGHGDSDKPRDYPYSTFERADLVEALWHAEGIAQTVVVAFDYSCIVSLELLARRIDRERAGNDQRTRITACLLANGGIFADGHTHAWYTTPLLTSPLGAAITPIGQRSWRMFAPFLRPVFSRGYPLSAAEMKELHDAISRRDGVRVLPATAGFVDEHREHAARWDLARIISALGDEVAFGVVGSAEDPFEGEQLRLARERLADSVEITELAGGHLTTAEQPDRLAEVIAALPERS,"35,230",318,,,hydrolase activity [GO:0016787],,,,1
V5QQS8,V5QQS8_MYCTU,Rv3349c,Rv3349c,,IPR002560; ,,,,Probable transposase,,9634230,,,MAIDPAAAYASAIRTPGLLPNAKLVVDHFHVTTLANDALTAVRRRVTWAFHDRRGRKIDPQWANRRRLLTARERLSDKSFAKMRNRINAVDPRAQILSAWIAKEELRTLLSTVRTGGDPHLARHHLHRFLPGASTRRSPNCSPWPPPLTSHPRSTPSWSPASPTRASVVGEVAEMLGDIDGQCVQVEVPVPERGPAGCGGLDGLGRAGVSATPRVCAAMTAVNVAGRCAGQQADVGPTPQHRCRGR,"26,630",246,,,,,,,1
O53315,O53315_MYCTU,Rv3165c,Rv3165c,GO:0005886; GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MKRLIALGIFLIVGIELLALILHDRRLVLAGSGLALALVLLNVRRMLGNRDELTAAPDSDDLGEGLRRWLSNTETTIRWSESTRADWDRHLRPMLARRFEIATGHRQAKDPVAFAATGRMLFGDELWEWVNPNNVTHTGDRQPGPGRAALEEILQKLEQV,"18,023",160,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
L7N6A5,L7N6A5_MYCTU,Rv3264c,manB Rv3264c,GO:0009058; GO:0016779,IPR001451; IPR005835; IPR029044; ,,manB,,D-alpha-D-mannose-1-phosphate guanylyltransferase ManB (D-alpha-D-heptose-1-phosphate guanylyltransferase),nucleotidyltransferase activity [GO:0016779]; biosynthetic process [GO:0009058],9634230; 21969609,,,MATHQVDAVVLVGGKGTRLRPLTLSAPKPMLPTAGLPFLTHLLSRIAAAGIEHVILGTSYKPAVFEAEFGDGSALGLQIEYVTEEHPLGTGGGIANVAGKLRNDTAMVFNGDVLSGADLAQLLDFHRSNRADVTLQLVRVGDPRAFGCVPTDEEDRVVAFLEKTEDPPTDQINAGCYVFERNVIDRIPQGREVSVEREVFPALLADGDCKIYGYVDASYWRDMGTPEDFVRGSADLVRGIAPSPALRGHRGEQLVHDGAAVSPGALLIGGTVVGRGAEIGPGTRLDGAVIFDGVRVEAGCVIERSIIGFGARIGPRALIRDGVIGDGADIGARCELLSGARVWPGVFLPDGGIRYSSDV,"37,857",359,,biosynthetic process [GO:0009058],nucleotidyltransferase activity [GO:0016779],,,,1
O53341,O53341_MYCTU,Rv3195,Rv3195,,IPR018766; ,,,,Uncharacterized protein,,9634230,,,MSTGEVMGDLPFGFSSGDDPPEDPSGRDKRGKDGADSGSGANPLGAFGIGGEFNMADLGQIFTRLGEMFGGVGTAMAAGKTSGPVNYDLARQVASSSIGFIAPIPAATNSAIADAVHLADTWLDGATSLPAGATKAVGWSPTDWVDNTLATWKRLCDPMAQQISTVWASSLPEEAKSMAGPLLSIMSQMGGIAFGSQLGQALGRLSREVLTSTDIGLPLGPKGVAAILPGAVESFAAGLEQPRSEILTFLATREAAHHRLFSHVPWLASQLLGAVEAYAMGMKIDMTGIEELARDINPTSLADPAAMEQLLSQGVFEPKATPAQTQALERLETLLALIEGWVQTVVTAALGERIPGEAALSETLRRRRASGGPAEQTFATLVGLELRPRKLREAGALWERLTRAVGMDARDAVWQHPDLLPATDDLDDPAAFIDRVIGGDTSGIDEAIAELERDQQARGADDSGHDGGPVDN,"49,358",472,,,,,,,1
I6X7F2,I6X7F2_MYCTU,Rv3483c,Rv3483c,GO:0016021,IPR025971; ,,,,Possible exported protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSDEIDPDWPAPAYQPSDDVDTTPPAPGGSWPTAWLVALVVLACVAAAVVAYAGMHRVRPGANQAAPATTSAPARPTSPASQVGPCGPDEATAVRAALAQLAPDSKTGRPWNSTPEDSNYDPCADLSAVLVTVQDATNSSPDQALMFHRGTFVGTATPRAYPFTNLIGPASTNDIVVLSYRTRQSCDGCQDGILTIVGFAWRGDHVQILDSLPELFDAPP,"22,983",220,,,,integral component of membrane [GO:0016021],,,1
O53310,O53310_MYCTU,Rv3160c,Rv3160c,GO:0003677; GO:0003700; GO:0006355; GO:0010033,IPR023772; IPR009057; IPR001647; IPR036271; ,,,DOMAIN 9 69 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]; response to organic substance [GO:0010033]",9634230; 21969609,,,MPRQAGRWSPTALRILGAAAELIALRGYSSTSTRDIAAAVGVEQPAIYKHFSAKRDILAALVRLAVEWPLELFGHITAMPVPAVVKLHRWLTESLDHLHASPYVLVSILITPDLHQESFVAERELVAEMERALVGLIETGQGEGDVRAMHPLSAARLVQALFDALALPEFAVSPDEIVEFAMTALLSDPDRLAEIRAAADALEIQTAPPDRGL,"23,121",213,,"regulation of transcription, DNA-templated [GO:0006355]; response to organic substance [GO:0010033]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,3
O53363,O53363_MYCTU,Rv3312c,Rv3312c,,IPR029058; IPR000073; ,,,DOMAIN 45 288 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Uncharacterized protein,,9634230,,,MTGPPPSLPERIRTDEADVLMLPDGRALAYLEWGDSTGYPAFYFHGTPSSRLEGAFADGAARRTGFRLIAIDRPGYGRSTFQAGRNFRDWPADVCALADAFELEEFGVVGHSGAGPHLFACGAVIPRTRLAFVGALGPWGPLATPDIMRSLNAADRCYARLARSGPRLFGALFAPLGWCAKYTPGLFSTLLAAAVPAADKHLLSDERFGRHLRAIQLEAFRQGSRGAAYESFLQFRPWGFDLAEVAVPTHIWLGDRDSFVPRAMGEYLQRAIPHVDLHWAHGKGHFNIEDWDAILAACALDIGKRRGG,"33,649",308,,,,,,,3
L7N658,L7N658_MYCTU,Rv3294c,Rv3294c,,IPR025420; ,,,,Uncharacterized protein,,9634230,,,MGLPRRPCCDTTGSARYRESVRRYPRIGEDSAAYRRRLCRESAKARNVDRVVKRDAADVSNLQRIADLPRLIRLLAARSASELNLSSLATDAEIPVRTLPPYLDLLETLYLIDRIPAWSTNLSKRVVDRPKVLLLDSGLAARLVNVSPTGAGPHANPNAAGAIIETFVIAELRRQLGWSQQAPRLFHYRDRDGAEVDLILETADGLIAAIEIKSAATLRGRDTRSISRLRDKVGARFAGGVILHTGPQAQPFGDRLAAVPIDILWSPSG,"29,556",269,,,,,,,1
O50389,O50389_MYCTU,Rv3360,Rv3360,,IPR000253; IPR008984; ,,,,Uncharacterized protein,,9634230,,,MSRPHPPVLTVRSDRSQQCFAAGRDVVVGSDLRADMRVAHPLIARAHLLLRFDRGNWIAIDNDSQSGMFVDGQRVSEVDIYDGLTINIGKPTGPWITFEVGHHQGIIGRLSRTPSSRPGSPI,"13,423",122,,,,,,,1
O06338,O06338_MYCTU,Rv3473c,bpoA Rv3473c,GO:0004601; GO:0016787,IPR029058; IPR000073; IPR000639; ,,bpoA,DOMAIN 2 247 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Possible peroxidase BpoA (Non-haem peroxidase),hydrolase activity [GO:0016787]; peroxidase activity [GO:0004601],9634230,,,MVFLHGGGQTRRSWGRAAAAVAERGWQAVTIDLRGHGESDWSSEGDYRLVSFAGDIQEVLRNLPGQPALVGASLGGFAAMLLAGELSPGIASAVVLVDIVPNMDLAGASRIHAFMAERVESGFGSLDEVADVIANYNPHRPRPSDPDGLVANLRRRGDRWYWHWDPQFIGGIAAFPPVEVTDVDRMNAAVATILRDEVPVLLVRGQVSDIVRQESADQFLSRFPQVEFTDVRGAGHMVAGDRNDAFAGAVLDFLARHVGVR,"28,205",261,,,hydrolase activity [GO:0016787]; peroxidase activity [GO:0004601],,,,1
O53362,O53362_MYCTU,Rv3311,Rv3311,,,,,,Conserved protein,,9634230; 21969609,,,MVADLVPIRLSLSAGDRYTLWAPRWRDAGDEWEAFLGKDDDLYGFESVSDLVAFVRTDTENDLVDHPAWQDLTGAHAHNLNPAEDNQFDLVVVEELLAEKPTAESVAALAASLAIVSAIGSVCELAAVSKFFNGNPILGTVSGGLEHFTGKAGNKRWNSIAEVIGRSWDDVLAAIDEIISTPEVDAELSEKVAEELAEEPEGAEEVAAEVEATQDTQEAAESDDEEADAPGDSVVLGGDRDFWLQVGIDPIQIMTGTATFYTLRCYLDDRPIFLGRNGRISVFGSERALARYLADEHDHDLSDLSTYDDIRTAATDGSLAVAVTDDNVYVLSGLVDDFADGPDAVDREQLDLAVELLRDIGDYSEDSAVDKALETTRPLGQLVAYVLDPHSVGKPTAPYAAAVREWEKLERFVESRLRRE,"45,732",420,,,,,,,1
I6X7D4,I6X7D4_MYCTU,Rv3463,Rv3463,GO:0005829; GO:0016705,IPR019922; IPR011251; IPR036661; ,,,,Conserved protein,"cytosol [GO:0005829]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MTNCAAGKPSSGPNLGRFGSFGRGVTPQQATEIEALGYGAVWVGGSPPAALSWVEPILQATTTLCVATGIVNIWSAPAQRVAESFHRIEAAYPGRFLLGIGVGHAEMISEYRKPYNALVEYLDRLDDYGVPANRRVVAALGPRVLGLSARRSAGAHPYLTTPEHTARARELIGPSAFLAPEHKVVLTTDSARARTVGRQALDMYFNLANYRNNWKRLGFTDDEVSRPGSDRLVDAVVAYGTPDAIAARLNEHLLAGADHVPIQVLTEDDNLVSALTELAKPLRLT,"30,651",285,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cytosol [GO:0005829],,,1
O06257,O06257_MYCTU,Rv3440c,Rv3440c,,,,,,Uncharacterized protein,,9634230,,,MRPDSVNSAGIDIAAVYAVADRFSAAAELIDDAIGNHLTRLAFGGACAGRGHASRGDALRCRLDRLAGELSVWSRAAVQIAFALRAGANRYAEADLCAAARIG,"10,672",103,,,,,,,1
O50394,O50394_MYCTU,Rv3366,spoU Rv3366,GO:0003723; GO:0005737; GO:0008175; GO:0008757,IPR029028; IPR001537; IPR016914; IPR029026; ,,spoU,,Putative tRNA (cytidine(34)-2'-O)-methyltransferase (EC 2.1.1.207) (tRNA (cytidine/uridine-2'-O-)-methyltransferase),cytoplasm [GO:0005737]; RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA methyltransferase activity [GO:0008175],9634230; 21969609,,FUNCTION: Could methylate the ribose at the nucleotide 34 wobble position in tRNA. {ECO:0000256|HAMAP-Rule:MF_01885}.,MFRLLFVSPRIAPNTGNAIRTCAATGCELHLVEPLGFDLSEPKLRRAGLDYHDLASVTVHASLAHAWEALSPARVFAFTAQATTLFTNVGYRAGDVLMFGPEPTGLDEATLADTHITGQVRIPMLAGRRSLNLSNAAAVAVYEAWRQHGFAGAV,"16,517",154,"Class IV-like SAM-binding methyltransferase superfamily, RNA methyltransferase TrmH family, TrmL subfamily",,RNA binding [GO:0003723]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; tRNA methyltransferase activity [GO:0008175],cytoplasm [GO:0005737],,,1
O50392,O50392_MYCTU,Rv3363c,Rv3363c,GO:0005886,IPR007995; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MFNPAGDRPKAGLVRPYTLTAGRTGTDVDLPLQAPVQTLPAGPAGRWPAYDMRRRILQLCIGSPSVAEISARLDLPVGVARVLVGDLVTSGYLRVHATLTDRSTRDERHELIGRTLRGLKAL,"13,209",122,,,,plasma membrane [GO:0005886],,,1
Q6MWX6,Q6MWX6_MYCTU,Rv3374,echA18.1 Rv3374,,IPR029045; IPR014748; ,,echA18.1,,Probable enoyl-CoA hydratase EchA18.1 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),,9634230,,,MVQKVVAPQDLAAATAKLVGQVCRQSAVTMRAAKVVANMHGRALTGADTDALIRFGVEAYEGADLREGVAAFSQGRPPKFDD,"8,616",82,,,,,,,1
I6XHC3,I6XHC3_MYCTU,Rv3481c,Rv3481c,GO:0016021,IPR021315; ,,,,Probable integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MRGLLPVAGHWVSVLTGLVPLALVIALSPLSVIPAVLVVHSPQPRPSSLAFLGGWLLGLAVVTAVFVAASGALGGLSTTSPAWASWLRVVLGSALIVFGVLRWLTRHRHTEMPGWMRAFASFTPARAGLVGAVLVVVRPEVLIICAAAGLAIGSGGHGAAGSWIYTAFFAMLAASTVAIPILAYVAAGDRLDDSLERLKDWMEKNHAGMVAAILVVIGLLLLYNGVHAM,"23,793",229,,,,integral component of membrane [GO:0016021],,,1
O53335,O53335_MYCTU,Rv3189,Rv3189,,IPR014914; ,,,,Uncharacterized protein,,9634230; 21969609,,,MKLADAIATAPRRTLKGTYWHQGPTRHPVTSCADPARGPGRYHRTGEPGVWYASNKEQGAWAELFRHFVDDGVDPFEVRRRVGRVAVTLQVLDLTDERTRSHLGVDETDLLSDDYTTTQAIAAARDANFDAVLAPAAALPGCQTLAVFVHALPNIEPERSEVRQPPPRLANLLPLIRPHEHMPDSVRRLLATLTRAGAEAIRRRRR,"22,944",206,,,,,,,1
P96883,P96883_MYCTU,Rv3278c,Rv3278c,GO:0016021,IPR005182; ,,,DOMAIN 82 156 bPH_2. {ECO:0000259|Pfam:PF03703}.,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSYPENVLAAGEQVVLHRHPHWNRLIWPVVVLVLLTGLAAFGSGFVNSTPWQQIAKNVIHAVIWGIWLVIVGWLTLWPFLSWLTTHFVVTNRRVMFRHGVLTRSGIDIPLARINSVEFRDRIFERIFRTGTLIIESASQDPLEFYNIPRLREVHALLYHEVFDTLGSDESPS,"19,820",172,,,,integral component of membrane [GO:0016021],,,1
P96886,P96886_MYCTU,Rv3281,accE5 Rv3281,GO:0003989; GO:0004658; GO:0005618; GO:0009317; GO:0015977; GO:0040007,IPR032716; ,,accE5,,Probable bifunctional protein acetyl-/propionyl-coenzyme A carboxylase (Epsilon chain) AccE5,acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; acetyl-CoA carboxylase activity [GO:0003989]; propionyl-CoA carboxylase activity [GO:0004658]; carbon fixation [GO:0015977]; growth [GO:0040007],9634230; 21969609,,,MGTCPCESSERNEPVSRVSGTNEVSDGNETNNPAEVSDGNETNNPAEVSDGNETNNPAPVSRVSGTNEVSDGNETNNPAPVSRVSGTNEVSDGNETNNPAPVTEKPLHPHEPHIEILRGQPTDQELAALIAVLGSISGSTPPAQPEPTRWGLPVDQLRYPVFSWQRITLQEMTHMRR,"19,014",177,,carbon fixation [GO:0015977]; growth [GO:0040007],acetyl-CoA carboxylase activity [GO:0003989]; propionyl-CoA carboxylase activity [GO:0004658],acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618],,,1
O53360,O53360_MYCTU,Rv3308,pmmB Rv3308,GO:0000287; GO:0005829; GO:0005886; GO:0005975; GO:0016868,IPR005844; IPR016055; IPR005845; IPR005846; IPR005843; IPR036900; IPR016066; IPR005841; ,,pmmB,DOMAIN 36 170 PGM_PMM_I. {ECO:0000259|Pfam:PF02878}.; DOMAIN 207 291 PGM_PMM_II. {ECO:0000259|Pfam:PF02879}.; DOMAIN 304 424 PGM_PMM_III. {ECO:0000259|Pfam:PF02880}.; DOMAIN 486 503 PGM_PMM_IV. {ECO:0000259|Pfam:PF00408}.,Probable phosphomannomutase PmmB (Phosphomannose mutase),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; intramolecular transferase activity, phosphotransferases [GO:0016868]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975]",9634230; 21969609,,,MTPENWIAHDPDPQTAAELAACGPDELKARFSRPLAFGTAGLRGHLRGGPDAMNLAVVLRATWAVARVLTDRGLAGSPVIVGRDARHGSPAFAAAAAEVLAAAGFSVLLLPDPAPTPVVAFAVRHTGAAAGIQITASHNPATDNGYKVYVDGGLQLLAPTDRQIEAAMATAPPADQIARKTVNPSENRASDLIDRYIQRAAGVRRCAGSVRVALTPLHGVGGAMAVETLRRAGFTEVHTVATQFAPNPDFPTVTLPNPEEPGATDALLTLATDVDADVAIALDPDADRCAVGIPTVSGWRMLSGDETGWLLGDYILSQTDDRASPPETRVVASTVVSSRMLAAIAAHHAAVHVETLTGFKWLARADANLPGTLVYAYEEAIGHCVDPTAVRDKDGISAAVLVCDLVAALKGQGRSVTDALDELARCYGVHEVAALSRPVSGAVETTDLMRRLREDPPRRLAGFPATVTDIGDTLILTGGDDNMLVRVAVRPSGTEPKLKCYLEIRCAVTGDLPAARQLVRARIDELSASVRRWW,"56,196",534,Phosphohexose mutase family,carbohydrate metabolic process [GO:0005975],"intramolecular transferase activity, phosphotransferases [GO:0016868]; magnesium ion binding [GO:0000287]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
I6YG92,I6YG92_MYCTU,Rv3482c,Rv3482c,GO:0016021,IPR018929; ,,,,Probable conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MEHDVATSPPAGWYTDPDGSAGQRYWDGDRWTRHRRPNPSAPRSPLALRVDGLRSRWLGMPAGLRLTVPVAAVLTMVGVAVYAWIRPLPDDWSQLPKRLSCQLRPGPTPPATITVASVDVSHPRGAVLRLVVRFAEPLPPSPSGSFASGFAGYLLTYTIANNGKEFAELGPQQDTDELAIRKPGESRGTEPNMRPDRNTNARRTAPDTVEINLETKRLGLDQAPVDPQLTFAAQFRTPSTVTVDFGSQFCQGERLAGQRR,"28,501",260,,,,integral component of membrane [GO:0016021],,,1
O05791,O05791_MYCTU,Rv3114,Rv3114,GO:0003824; GO:0009451,IPR002125; IPR016193; ,,,,Uncharacterized protein,catalytic activity [GO:0003824]; RNA modification [GO:0009451],9634230,,,MVAARLPFGWSADSGVTADIIEAAMELAIDTARHATAPFGAALLDVTTLRAFSGGNTYFESGDRFAHAETNVLRAAMSTLPELSNHVLISTAEPCPMCAAASVLSGVRAIIFGTSIETLIQCGWFQIRISASDVVAASTRPTRPSVYSGFLSHKTDLLYRNSENRRAMNPWTDPSH,"18,875",176,,RNA modification [GO:0009451],catalytic activity [GO:0003824],,,,3
O50383,O50383_MYCTU,Rv3354,Rv3354,GO:0005576,IPR007969; ,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 21969609,,,MNLRRHQTLTLRLLAASAGILSAAAFAAPAQANPVDDAFIAALNNAGVNYGDPVDAKALGQSVCPILAEPGGSFNTAVASVVARAQGMSQDMAQTFTSIAISMYCPSVMADVASGNLPALPDMPGLPGS,"12,988",129,,,,extracellular region [GO:0005576],,,1
O50398,O50398_MYCTU,Rv3369,Rv3369,GO:0005576; GO:0048037,IPR019966; IPR011576; IPR012349; ,,,DOMAIN 13 96 Putative_PNPOx. {ECO:0000259|Pfam:PF01243}.,Conserved protein,extracellular region [GO:0005576]; cofactor binding [GO:0048037],9634230; 21969609,,,MWAGYRWAMSVELTQEVSARLTSDLYGWLTTVARSGQPVPRLVWFYFDGTDLTVYSMPQAAKVAHITAHPQVSLNLDSDGNGAGIIVVGGTAAVVATDVDCRDDAPYWAKYREDAAKFGLTEAIAAYSTRLKITPTRVWTTPTG,"15,718",144,,,cofactor binding [GO:0048037],extracellular region [GO:0005576],,,1
O05880,O05880_MYCTU,Rv3235,Rv3235,GO:0005829,,,,,Hypothetical alanine arginine proline rich protein,cytosol [GO:0005829],9634230,,,MMASNQTAAQHSSATLQQAPRSIDDAGGCPLTISPIANSPGDTFAVTPVVEYEPPPRNIPPCGQSSHAARRPHTPQLARRQPIRPSGRAPAAVTSTAKSPRLRQAGTFADAALRRVLEVIDRRRPVGQLRPLLAPGLVDSVLAVSRTAAGHQQGAAMLRRIRLTPAGPDTADTAAEVFGTYSRGDRIHAIACRVEQRPAGNETRWLMVALHIG,"22,658",213,,,,cytosol [GO:0005829],,,1
O05861,O05861_MYCTU,Rv3205c,Rv3205c,GO:0005618; GO:0005886,IPR013402; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MGSTRLTGVNVEPPPEHVLVAFGLAGAQPILLGAGWEGGWRCGEVVLSMVADNARAAWSARVRETLFVDGVRLARPVRSTDGRYVVSGWRADTFVAGAPEPRHDEVVSAAVRLHEATGKLERPRFLTQGPAAPWAEIDVFVAADRAGWEERPLQSVPPGVPTAPPAADPQRSIDLINQLAGLRKPTKSPNQLVHGDLYGTVLFAGTAPPGITDITPYWRPASWAAGVAVVDALSWGAADDGLIERWNALPEWPQMLLRALMFRLAVYALHPRSTAEAFPGLAHTAALVRLVL,"31,352",292,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O05859,O05859_MYCTU,Rv3207c,Rv3207c,GO:0005829; GO:0008237; GO:0008270; GO:0016021,IPR022603; IPR024079; IPR006026; ,,,DOMAIN 83 269 ZnMc. {ECO:0000259|SMART:SM00235}.,Conserved protein,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],9634230; 21969609,,,MSTYGWRAYALPVLMVLTTVVVYQTVTGTSTPRPAAAQTVRDSPAIGVVGTAILDAPPRGLAVFDANLPAGTLPDGGPFTEAGDKTWRVVPGTTPQVGQGTVKVFRYTVEIENGLDPTMYGGDNAFAQMVDQTLTNPKGWTHNPQFAFVRIDSGKPDFRISLVSPTTVRGGCGYEFRLETSCYNPSFGGMDRQSRVFINEARWVRGAVPFEGDVGSYRQYVINHEVGHAIGYLRHEPCDQQGGLAPVMMQQTFSTSNDDAAKFDPDFVKADGKTCRFNPWPYPIP,"31,066",285,,,metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
L7N665,L7N665_MYCTU,Rv3236c,Rv3236c,GO:0015299; GO:0016021,IPR006153; IPR038770; ,,,,Probable conserved integral membrane transport protein,integral component of membrane [GO:0016021]; solute:proton antiporter activity [GO:0015299],9634230,,,MEVSRALLFELGVLLAVLAVLGAVARRFALSPIPVYLLAGLSLGNGGILGVAAAGEFIATGAPIGVVLLLLALGLEFSATEFASSLRHHLPSAGVDIVLNATPGAVAGWLLGLDGVAILGLAGVTYISSSGVIARLLEDLRRLGNRETPAVLSVLVLEDFAMAAYLPLFAVLATDGSWLEAVVGMTVAIAALLGAFAASYRWGHHVGRLVTHPDSEQLLLRVLGITLIVAAVAESLHASAAVGAFLVGLTLTGETADRARMVLTPLRDLFATIFFLGIGLSVDPGKLVSMLPVALALAAVTAATKVATGMFAARREGVARRGQLRAGTALVARGEFSLIIIGLAGASIPGVAALATAYVFVMAIVGPILARYTGGGLPAAAVASN,"39,075",385,,,solute:proton antiporter activity [GO:0015299],integral component of membrane [GO:0016021],,,1
O05841,O05841_MYCTU,Rv3225c,Rv3225c,GO:0030649; GO:0034071,IPR016181; IPR002575; IPR000182; IPR011009; ,,,,"GCN5-related N-acetyltransferase, phosphorylase",aminoglycoside phosphotransferase activity [GO:0034071]; aminoglycoside antibiotic catabolic process [GO:0030649],9634230; 21969609,,,MRFAKLSDGLSDGIVTLSPLCLDDVDAHLAGGDERLVRWLSGMPSTRASVEAYIRHCREQWVTGGPLRSFGIRTVAETIVGTIDLRFDGEGLASGQVNVAYGLYPSWRGRGLATRAVDLVCQYAAEHGATEAVIKVEPENSASARVALRAGFAFVRRICEQDGTVFDRYERVLRAKMHADEVDIDEDLVRRLLRAQFPQWADLPIAPVRSAGTDNAMYRLGEDLAVRIPRIGWAIESLRTEQQWLPRIAAHLGVASPVPVGLGSPAEGFGWPWSVCRWVAGENPSAAEFVEPNRAVEDLADFITALRATDPMGGPPAKRGAPLGEQDAEVRAALAALDGIIDVHAATAAWESALRVPPYAGPPMWFHGDLSRFNILTAQGRLTGVIDFGLMGVGDPSVDLIIAWNLLSAPARAQFRVAVGAADDDWMRGRGRALAIALIALPYYQDTNPPLAASARYAIGEVLADFRYGARPGC,"51,271",474,,aminoglycoside antibiotic catabolic process [GO:0030649],aminoglycoside phosphotransferase activity [GO:0034071],,,,2
P96877,P96877_MYCTU,Rv3272,Rv3272,GO:0008152; GO:0033608,IPR003673; IPR023606; ,,,,Uncharacterized protein,formyl-CoA transferase activity [GO:0033608]; metabolic process [GO:0008152],9634230; 21969609,,,MPTSNPAKPLDGFRVLDFTQNVAGPLAGQVLVDLGAEVIKVEAPGGEAARQITSVLPGRPPLATYFLPNNRGKKSVTVDLTTEQAKQQMLRLADTADVVLEAFRPGTMEKLGLGPDDLRSRNPNLIYARLTAYGGNGPHGSRPGIDLVVAAEAGMTTGMPTPEGKPQIIPFQLVDNASGHVLAQAVLAALLHRERNGVADVVQVAMYDVAVGLQANQLMMHLNRAASDQPKPEPAPKAKRRKGVGFATQPSDAFRTADGYIVISAYVPKHWQKLCYLIGRPDLVEDQRFAEQRSRSINYAELTAELELALASKTATEWVQLLQANGLMACLAHTWKQVVDTPLFAENDLTLEVGRGADTITVIRTPARYASFRAVVTDPPPTAGEHNAVFLARP,"42,459",394,,metabolic process [GO:0008152],formyl-CoA transferase activity [GO:0033608],,,,1
O53390,O53390_MYCTU,Rv3340,metC Rv3340,GO:0003961; GO:0004124; GO:0016829; GO:0030170; GO:0071266,IPR000277; IPR006235; IPR015424; IPR015422; IPR015421; ,,metC,,Probable O-acetylhomoserine sulfhydrylase MetC (Homocysteine synthase) (O-acetylhomoserine (Thiol)-lyase) (OAH sulfhydrylase) (O-acetyl-L-homoserine sulfhydrylase),cysteine synthase activity [GO:0004124]; lyase activity [GO:0016829]; O-acetylhomoserine aminocarboxypropyltransferase activity [GO:0003961]; pyridoxal phosphate binding [GO:0030170]; 'de novo' L-methionine biosynthetic process [GO:0071266],9634230; 21969609,,,MSADSNSTDADPTAHWSFETKQIHAGQHPDPTTNARALPIYATTSYTFDDTAHAAALFGLEIPGNIYTRIGNPTTDVVEQRIAALEGGVAALFLSSGQAAETFAILNLAGAGDHIVSSPRLYGGTYNLFHYSLAKLGIEVSFVDDPDDLDTWQAAVRPNTKAFFAETISNPQIDLLDTPAVSEVAHRNGVPLIVDNTIATPYLIQPLAQGADIVVHSATKYLGGHGAAIAGVIVDGGNFDWTQGRFPGFTTPDPSYHGVVFAELGPPAFALKARVQLLRDYGSAASPFNAFLVAQGLETLSLRIERHVANAQRVAEFLAARDDVLSVNYAGLPSSPWHERAKRLAPKGTGAVLSFELAGGIEAGKAFVNALKLHSHVANIGDVRSLVIHPASTTHAQLSPAEQLATGVSPGLVRLAVGIEGIDDILADLELGFAAARRFSADPQSVAAF,"47,371",449,Trans-sulfuration enzymes family,'de novo' L-methionine biosynthetic process [GO:0071266],cysteine synthase activity [GO:0004124]; lyase activity [GO:0016829]; O-acetylhomoserine aminocarboxypropyltransferase activity [GO:0003961]; pyridoxal phosphate binding [GO:0030170],,,,1
L7N685,L7N685_MYCTU,Rv3288c,usfY Rv3288c,GO:0016021,,,usfY,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGQIPPQPVRRVLPLMVVPGNGQKWRNRTETEEAMGDTYRDPVDHLRTTRPLAGESLIDVVHWPGYLLIVAGVVGGVGALAAFGTGHHAEGMTFGVVAIVVTVVGLAWLAFEHRRIRKIADRWYTEHPEVRRQRLAG,"15,179",137,,,,integral component of membrane [GO:0016021],,,1
L7N650,L7N650_MYCTU,Rv3293,pcd Rv3293,GO:0016620,IPR016161; IPR016163; IPR029510; IPR016162; IPR015590; ,,pcd,DOMAIN 22 474 Aldedh. {ECO:0000259|Pfam:PF00171}.,Probable piperideine-6-carboxilic acid dehydrogenase Pcd (Piperideine-6-carboxylate dehydrogenase),"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",9634230; 21969609,,,MLEACQAIGVTAALGEPGEHSLPASTPITGDVLFSIAPTTPEQADHAIAAAAATFTAWRSTPAPVRGALVARLGELLTAHQQDLATLVTVEVGKITAEARGEVQEMIDVCQFSVGLSRQLYGRTIASERAGHRLLETWHPLGVVGVITAFNFPVAVWAWNTAVALVCGDTVVWKPSELTPLTALACQALLSRAAADVGAPAAVGGLLLGGAERGAQLVDDPRVALLSATGSVRMGQQVGPRVARRFGRVLLELGGNNAAIVAPSADLELAVRGIVFAAAGTAGQRCTSLRRLIVHRSVADDVVARVVGAYRQLAIGDPSAPDTLVGPLIHEAAYRDMVAALERARTDGGEVIGGDRREVGSPGAYYVAPAVVRMPSQTAIVATETFAPILYVLTYDDLDEAIALNNAVPQGLSSSIFTTDLREAEHFLDQSDCGIANVNIGTSGAEIGGAFGGEKQTGGGRESGSDAWKAYMRRATNTVNYSSELPLAQGVKFG,"51,344",494,Aldehyde dehydrogenase family,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,1
P96878,P96878_MYCTU,Rv3273,Rv3273,GO:0004089; GO:0005886; GO:0005887; GO:0008270; GO:0008271; GO:0015116; GO:0015976,IPR001765; IPR015892; IPR036874; IPR011547; IPR001902; ,,,DOMAIN 31 398 Sulfate_transp. {ECO:0000259|Pfam:PF00916}.,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; zinc ion binding [GO:0008270]; carbon utilization [GO:0015976],9634230; 21969609,,,MTIPRSQHMSTAVNSCTEAPASRSQWMLANLRHDVPASLVVFLVALPLSLGIAIASGAPIIAGVIAAVVGGIVAGAVGGSPVQVSGPAAGLTVVVAELIDELGWPMLCLMTIAAGALQIVFGLSRMARAALAIAPVVVHAMLAGIGITIALQQIHVLLGGTSHSSAWRNIVALPDGILHHELHEVIVGGTVIAILLMWSKLPAKVRIIPGPLVAIAGATVLALLPVLQTERIDLQGNFFDAIGLPKLAEMSPGGQPWSHEISAIALGVLTIALIASVESLLSAVGVDKLHHGPRTDFNREMVGQGSANVVSGLLGGLPITGVIVRSSANVAAGARTRMSTILHGVWILLFASLFTNLVELIPKAALAGLLIVIGAQLVKLAHIKLAWRTGNFVIYAITIVCVVFLNLLEGVAIGLVVAIVFLLVRVVRAPVEVKPVGGEQSKRWRVDIDGTLSFLLLPRLTTVLSKLPEGSEVTLNLNADYIDDSVSEAISDWRRAHETRGGVVAIVETSPAKLHHAHARPPKRHFASDPIGLVPWRSARGKDRGSASVLDRIDEYHRNGAAVLHPHIAGLTDSQDPYELFLTCADSRILPNVITASGPGDLYTVRNLGNLVPTDPDDRSVDAALDFAVNQLGVSSVVVCGHSSCAAMTALLEDDPANTTTPMMRWLENAHDSLVVFRNHHPARRSAESAGYPEADQLSIVNVAVQVERLTRHPILATAVAAADLQVIGIFFDISTARVYEVGPNGIICPDEPADRPVDHESAQ,"80,566",764,,carbon utilization [GO:0015976],carbonate dehydratase activity [GO:0004089]; secondary active sulfate transmembrane transporter activity [GO:0008271]; sulfate transmembrane transporter activity [GO:0015116]; zinc ion binding [GO:0008270],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,2
Q6MWX8,Q6MWX8_MYCTU,Rv3350c,PPE56 Rv3350c,,IPR002989; IPR000030; IPR038332; ,,PPE56,,PPE family protein PPE56,,9634230,,,MEFPVLPPEINSVLMYSGAGSSPLLAAAAAWDGLAEELGSAAVSFGQVTSGLTAGVWQGAAAAAMAAAAAPYAGWLGSVAAAAEAVAGQARVVVGVFEAALAATVDPALVAANRARLVALAVSNLLGQNTPAIAAAEAEYELMWAADVAAMAGYHSGASAAAAALPAFSPPAQALGGGVGAFLTALFASPAKALSLNAGLGNVGNYNVGLGNVGVFNLGAGNVGGQNLGFGNAGGTNVGFGNLGNGNVGFGNSGLGAGLAGLGNIGLGNAGSSNYGFANLGVGNIGFGNTGTNNVGVGLTGNHLTGIGGLNSGTGNIGLFNSGTGNVGFFNSGTGNFGVFNSGNYNTGVGNAGTASTGLFNAGNFNTGVVNVGSYNTGSFNAGDTNTGGFNPGGVNTGWLNTGNTNTGIANSGNVNTGAFISGNFNNGVLWVGDYQGLFGVSAGSSIPAIPIGLVLNGDIGPITIQPIPILPTIPLSIHQTVNLGPLVVPDIVIPAFGGGIGIPINIGPLTITPITLFAQQTFVNQLPFPTFSLGKITIPQIQTFDSNGQLVSFIGPIVIDTTIPGPTNPQIDLTIRWDTPPITLFPNGISAPDNPLGLLVSVSISNPGFTIPGFSVPAQPLPLSIDIEGQIDGFSTPPITIDRIPLTVGGGVTIGPITIQGLHIPAAPGVGNTTTAPSSGFFNSGAGGVSGFGNVGAGSSGWWNQAPSALLGAGSGVGNVGTLGSGVLNLGSGISGFYNTSVLPFGTPAAVSGIGNLGQQLSGVSAAGTTLRSMLAGNLGLANVGNFNTGFGNVGDVNLGAANIGGHNLGLGNVGDGNLGLGNIGHGNLGFANLGLTAGAAGVGNVGFGNAGINNYGLANMGVGNIGFANTGTGNIGIGLVGDHRTGIGGLNSGIGNIGLFNSGTGNVGFFNSGTGNFGIGNSGRFNTGIGNSGTASTGLFNAGSFSTGIANTGDYNTGSFNAGDTNTGGFNPGGINTGWFNTGHANTGLANAGTFGTGAFMTGDYSNGLLWRGGYEGLVGVRVGPTISQFPVTVHAIGGVGPLHVAPVPVPAVHVEITDATVGLGPFTVPPISIPSLPIASITGSVDLAANTISPIRALDPLAGSIGLFLEPFRLSDPFITIDAFQVVAGVLFLENIIVPGLTVSGQILVTPTPIPLTLNLDTTPWTLFPNGFTIPAQTPVTVGMEVANDGFTFFPGGLTFPRASAGVTGLSVGLDAFTLLPDGFTLDTVPATFDGTILIGDIPIPIIDVPAVPGFGNTTTAPSSGFFNTGGGGGSGFANVGAGTSGWWNQGHDVLAGAGSGVANAGTLSSGVLNVGSGISGWYNTSTLGAGTPAVVSGIGNLGQQLSGFLANGTVLNRSPIVNIGWADVGAFNTGLGNVGDLNWGAANIGAQNLGLGNLGSGNVGFGNIGAGNVGFANSGPAVGLAGLGNVGLSNAGSNNWGLANLGVGNIGLANTGTGNIGIGLVGDYQTGIGGLNSGSGNIGLFNSGTGNVGFFNTGTGNFGLFNSGSFNTGIGNSGTGSTGLFNAGNFNTGIANPGSYNTGSFNVGDTNTGGFNPGDINTGWFNTGIMNTGTRNTGALMSGTDSNGMLWRGDHEGLFGLSYGITIPQFPIRITTTGGIGPIVIPDTTILPPLHLQITGDADYSFTVPDIPIPAIHIGINGVVTVGFTAPEATLLSALKNNGSFISFGPITLSNIDIPPMDFTLGLPVLGPITGQLGPIHLEPIVVAGIGVPLEIEPIPLDAISLSESIPIRIPVDIPASVIDGISMSEVVPIDASVDIPAVTITGTTISAIPLGFDIRTSAGPLNIPIIDIPAAPGFGNSTQMPSSGFFNTGAGGGSGIGNLGAGVSGLLNQAGAGSLVGTLSGLGNAGTLASGVLNSGTAISGLFNVSTLDATTPAVISGFSNLGDHMSGVSIDGLIAILTFPPAESVFDQIIDAAIAELQHLDIGNALALGNVGGVNLGLANVGEFNLGAGNVGNINVGAGNLGGSNLGLGNVGTGNLGFGNIGAGNFGFGNAGLTAGAGGLGNVGLGNAGSGSWGLANVGVGNIGLANTGTGNIGIGLTGDYRTGIGGLNSGTGNLGLFNSGTGNIGFFNTGTGNFGLFNSGSYSTGVGNAGTASTGLFNAGNFNTGLANAGSYNTGSLNVGSFNTGGVNPGTVNTGWFNTGHTNTGLFNTGNVNTGAFNSGSFNNGALWTGDYHGLVGFSFSIDIAGSTLLDLNETLNLGPIHIEQIDIPGMSLFDVHEIVEIGPFTIPQVDVPAIPLEIHESIHMDPIVLVPATTIPAQTRTIPLDIPASPGSTMTLPLISMRFEGEDWILGSTAAIPNFGDPFPAPTQGITIHTGPGPGTTGELKISIPGFEIPQIATTRFLLDVNISGGLPAFTLFAGGLTIPTNAIPLTIDASGALDPITIFPGGYTIDPLPLHLALNLTVPDSSIPIIDVPPTPGFGNTTATPSSGFFNSGAGGVSGFGNVGSNLSGWWNQAASALAGSGSGVLNVGTLGSGVLNVGSGVSGIYNTSVLPLGTPAVLSGLGNVGHQLSGVSAAGTALNQIPILNIGLADVGNFNVGFGNVGDVNLGAANLGAQNLGLGNVGTGNLGFANVGHGNIGFGNSGLTAGAAGLGNTGFGNAGSANYGFANQGVRNIGLANTGTGNIGIGLVGDNLTGIGGLNSGAGNIGLFNSGTGNIGFFNSGTGNFGIGNSGSFNTGIGNSGTGSTGLFNAGSFNTGVANAGSYNTGSFNAGDTNTGGFNPGTINTGWFNTGHTNTGIANSGNVGTGAFMSGNFSNGLLWRGDHEGLFSLFYSLDVPRITIVDAHLDGGFGPVVLPPIPVPAVNAHLTGNVAMGAFTIPQIDIPALTPNITGSAAFRIVVGSVRIPPVSVIVEQIINASVGAEMRIDPFEMWTQGTNGLGITFYSFGSADGSPYATGPLVFGAGTSDGSHLTISASSGAFTTPQLETGPITLGFQVPGSVNAITLFPGGLTFPATSLLNLDVTAGAGGVDIPAITWPEIAASADGSVYVLASSIPLINIPPTPGIGNSTITPSSGFFNAGAGGGSGFGNFGAGTSGWWNQAHTALAGAGSGFANVGTLHSGVLNLGSGVSGIYNTSTLGVGTPALVSGLGNVGHQLSGLLSGGSAVNPVTVLNIGLANVGSHNAGFGNVGEVNLGAANLGAHNLGFGNIGAGNLGFGNIGHGNVGVGNSGLTAGVPGLGNVGLGNAGGNNWGLANVGVGNIGLANTGTGNIGIGLTGDYQTGIGGLNSGAGNLGLFNSGAGNVGFFNTGTGNFGLFNSGSFNTGVGNSGTGSTGLFNAGSFNTGVANAGSYNTGSFNVGDTNTGGFNPGSINTGWLNAGNANTGVANAGNVNTGAFVTGNFSNGILWRGDYQGLAGFAVGYTLPLFPAVGADVSGGIGPITVLPPIHIPPIPVGFAAVGGIGPIAIPDISVPSIHLGLDPAVHVGSITVNPITVRTPPVLVSYSQGAVTSTSGPTSEIWVKPSFFPGIRIAPSSGGGATSTQGAYFVGPISIPSGTVTFPGFTIPLDPIDIGLPVSLTIPGFTIPGGTLIPTLPLGLALSNGIPPVDIPAIVLDRILLDLHADTTIGPINVPIAGFGGAPGFGNSTTLPSSGFFNTGAGGGSGFSNTGAGMSGLLNAMSDPLLGSASGFANFGTQLSGILNRGAGISGVYNTGALGVVTAAVVSGFGNVGQQLSGLLFTGVGP,"363,351",3716,Mycobacterial PPE family,,,,,,1
P96868,P96868_MYCTU,Rv3263,Rv3263,GO:0003676; GO:0005886; GO:0008168,IPR002052; IPR029063; ,,,,Probable DNA methylase (Modification methylase) (Methyltransferase),plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676],9634230,,,MQPSHPTRPGAVIRYVGSSLDTCPMTTFAGKTAASADKVRGGYYTPPAVARFLAHWVHQAGPKILEPSCGDGRILRELSAITDHAHGVELVAREAKKSRDFASVDTENLFTWLHKTQLGSWDGVAGNPPYIRFGNWASEQRDPALELMRRVGLRPTKLTNAWVPFVVASTTLARDGGRVGLVVPAELLQVTYAAQLREFLLSRYREITLVTFERLVFDGILQEVVLFCGVVGPGPAHIRTVRLGDANDLNALGDKDFTNESAPALLHEKEKWTKYFLDPAQIRLLRGLKQSATMIRLGELADVDVGIVTGRNSFFTFTDAKAQALGLRAHCVPLVSRSAQLSGLIYDEDCRACDVAGNHRTWLLDAADYPTDPALVAHITAGEAAGVHLGYKCSIRKPWWSTPSLWMPDLFMLRQIHFAPRLTVNAAAATSTDTVHRVRLDPNVDPATLAAVFHNSATFAFAEIMGRSYGGGILELEPREAEQLPMPPPAYGSAELAQDVDLLLKANEIDKALDVVDRHVLIDGLGLSPRLVAGCRAAWLTLRDRRTKRGSRR,"60,673",553,,,methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676],plasma membrane [GO:0005886],,,1
I6XHD6,I6XHD6_MYCTU,Rv3496c,mce4D Rv3496c,,IPR005693; IPR003399; IPR024516; ,,mce4D,DOMAIN 39 113 MlaD. {ECO:0000259|Pfam:PF02470}.; DOMAIN 163 289 Mce4_CUP1. {ECO:0000259|Pfam:PF11887}.,Mce-family protein Mce4D,,9634230; 21969609,,,MMGRVAMLTGSRGLRYATVIALVAALVGGVYVLSSTGNKRTIVGYFTSAVGLYPGDQVRVLGVPVGEIDMIEPRSSDVKITMSVSKDVKVPVDVQAVIMSPNLVAARFIQLTPVYTGGAVLPDNGRIDLDRTAVPVEWDEVKEGLTRLAADLSPAAGELQGPLGAAINQAADTLDGNGDSLHNALRELAQVAGRLGDSRGDIFGTVKNLQVLVDALSESDEQIVQFAGHVASVSQVLADSSANLDQTLGTLNQALSDIRGFLRENNSTLIETVNQLNDFAQTLSDQSENIEQVLHVAGPGITNFYNIYDPAQGTLNGLLSIPNFANPVQFICGGSFDTAAGPSAPDYYRRAEICRERLGPVLRRLTVNYPPIMFHPLNTITAYKGQIIYDTPATEAKSETPVPELTWVPAGGGAPVGNPADLQSLLVPPAPGPAPAPPAPGAGPGEHGGGG,"47,233",451,,,,,,,1
O05884,O05884_MYCTU,Rv3239c,Rv3239c,GO:0004622; GO:0005886; GO:0016021; GO:0016042; GO:0022857; GO:0046470,IPR016035; IPR018490; IPR018488; IPR000595; IPR004638; IPR001423; IPR011701; IPR020846; IPR036259; IPR002641; IPR014710; IPR005829; ,,,DOMAIN 25 470 MFS. {ECO:0000259|PROSITE:PS50850}.; DOMAIN 515 612 Cyclic nucleotide-binding. {ECO:0000259|PROSITE:PS50042}.; DOMAIN 790 950 PNPLA. {ECO:0000259|PROSITE:PS51635}.,Probable conserved transmembrane transport protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; transmembrane transporter activity [GO:0022857]; lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],9634230,,,MHISLHGGKGFANLTRRRRPSSASVLLVAGFGAFLAFLDSTIVNIAFPDIQRSFPSYDIGSLSWILNGYNIVFAAFMVAAGRLADLLGRRRTFLSGVLVFTIASGLCAVAGSVEQLVAFRVLQGIGAAILVPASLALVVEGFDAARRAHAIGLWGAAAAIAAGLGPPIGGLLVEWAGWRWVLLVNVPLGIVAAIATKRMLVESRASGRRRMPDLRGALLLAVTLGLVTLGLVKGPDWGWLSVATVGSFLASVLTSVGFVHSSRSHPAPLVEPALLRSRSFVAGNLLTLVAAAGFYCYGLTHVLYLNYVWHYSLLKAGFAIAPAAVVAAVVAAALGRVAGRHGHRVIVLVGALVWAGSLVWYLQRVGSEPDFLRVWLPGQLLQGIGVGATLPVLSSAALAEVAKGGSYATSSAVVSTTRQLGAVLGVAVMVILIGKPEHGTAEEALRRGWAMAAICFIAVAVAAAVLGRTNRNPVQMPAPEPAIAPRLEPPIPQPAAAPIEHWAAGDADPLGNLPLFAGLDAATLAQLGEHVEDVELEAGCYLFHEGDPSDSLYVIRTGRVQVLQDSIVLKELGRGEVLGELGLLIDAPRSATVRALRDTKLVRLTKAQFDEIADHGALAALVKVLATRLREAPPPATDSTSPEVVVSVIGVSGDAPVPAVAAGLLTALSARLRAVDPGRVDRDGLDRAERVADKVVLHAAVEDAGWRDFCLRVADRIVLVAGDPNPQAARLPARARGADLVLAGPAASREHRRQWEELITPRSVHVVHYRRILENVRPLAARIAGRSIGLVLGGGGARGFAHLGVLDELERVGVTIDRFAGTSMGAVIAVFGACGMDAATADAYAYEYFIRHNPLSDYAFPVRGLVRGRRTLTLLEAAFGDRLVEELPKEFRCVSVDLLARRPVVHRRGRLVDVIGCSLRLPGIYPPQVYNGRLHVDGGVLDNLPVSTRASPDGPLIAVSIGLGGGGPGSARQDGSPKVPGIGDTLMRTMTIGSQRGADAALSLAQVVIRPDTGAVGLLEFHQIDAAREAGRVAAREAMPHIMALLNR,"110,199",1048,Major facilitator superfamily,lipid catabolic process [GO:0016042]; phosphatidylcholine metabolic process [GO:0046470],lysophospholipase activity [GO:0004622]; transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
L7N668,L7N668_MYCTU,Rv3196A,Rv3196A,,,,,,Uncharacterized protein,,9634230; 21969609,,,MQEGGPQETMSARSTQHDAADALFRAIIETLDKHRNERTLTEDVLDTLARAYASISTNVPEQGRLG,"7,285",66,,,,,,,1
Q6MWY0,Q6MWY0_MYCTU,Rv3345c,PE_PGRS50 Rv3345c,,IPR000084; ,,PE_PGRS50,DOMAIN 5 94 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS50,,9634230,,,MVMSLMVAPELVAAAAADLTGIGQAISAANAAAAGPTTQVLAAAGDEVSAAIAALFGTHAQEYQALSARVATFHEQFVRSLTAAGSAYATAEAANASPLQALEQQVLGAINAPTQLWLGRPLIGDGVHGAPGTGQPGGAGGLLWGNGGNGGSGAAGQVGGPGGAAGLFGNGGSGGSGGAGAAGGVGGSGGWLNGNGGAGGAGGTGANGGAGGNAWLFGAGGSGGAGTNGGVGGSGGFVYGNGGAGGIGGIGGIGGNGGDAGLFGNGGAGGAGAAGLPGAAGLNGGDGSDGGNGGTGGNGGRGGLLVGNGGAGGAGGVGGDGGKGGAGDPSFAVNNGAGGNGGHGGNPGVGGAGGAGGLLAGAHGAAGATPTSGGNGGDGGIGATANSPLQAGGAGGNGGHGGLVGNGGTGGAGGAGHAGSTGATGTALQPTGGNGTNGGAGGHGGNGGNGGAQHGDGGVGGKGGAGGSGGAGGNGFDAATLGSPGADGGMGGNGGKGGDGGKAGDGGAGAAGDVTLAVNQGAGGDGGNGGEVGVGGKGGAGGVSANPALNGSAGANGTAPTSGGNGGNGGAGATPTVAGENGGAGGNGGHGGSVGNGGAGGAGGNGVAGTGLALNGGNGGNGGIGGNGGSAAGTGGDGGKGGNGGAGANGQDFSASANGANGGQGGNGGNGGIGGKGGDAFATFAKAGNGGAGGNGGNVGVAGQGGAGGKGAIPAMKGATGADGTAPTSGGDGGNGGNGASPTVAGGNGGDGGKGGSGGNVGNGGNGGAGGNGAAGQAGTPGPTSGDSGTSGTDGGAGGNGGAGGAGGTLAGHGGNGGKGGNGGQGGIGGAGERGADGAGPNANGANGENGGSGGNGGDGGAGGNGGAGGKAQAAGYTDGATGTGGDGGNGGDGGKAGDGGAGENGLNSGAMLPGGGTVGNPGTGGNGGNGGNAGVGGTGGKAGTGSLTGLDGTDGITPNGGNGGNGGNGGKGGTAGNGSGAAGGNGGNGGSGLNGGDAGNGGNGGGALNQAGFFGTGGKGGNGGNGGAGMINGGLGGFGGAGGGGAVDVAATTGGAGGNGGAGGFASTGLGGPGGAGGPGGAGDFASGVGGVGGAGGDGGAGGVGGFGGQGGIGGEGRTGGNGGSGGDGGGGISLGGNGGLGGNGGVSETGFGGAGGNGGYGGPGGPEGNGGLGGNGGAGGNGGVSTTGGDGGAGGKGGNGGDGGNVGLGGDAGSGGAGGNGGIGTDAGGAGGAGGAGGNGGSSKSTTTGNAGSGGAGGNGGTGLNGAGGAGGAGGNAGVAGVSFGNAVGGDGGNGGNGGHGGDGTTGGAGGKGGNGSSGAASGSGVVNVTAGHGGNGGNGGNGGNGSAGAGGQGGAGGSAGNGGHGGGATGGDGGNGGNGGNSGNSTGVAGLAGGAAGAGGNGGGTSSAAGHGGSGGSGGSGTTGGAGAAGGNGGAGAGGGSLSTGQSGGPRRQRWCRWQRRRWLGRQRRRRWCRWQRRCRRQRWRWRCRQRRLRRQWRQGRRRCRPWLHRRRGRQGRRWRQRRFQQRQRSRWQRR,"129,385",1538,,,,,,,1
P96900,P96900_MYCTU,Rv3295,Rv3295,GO:0003677; GO:0003700; GO:0005886; GO:0006355,IPR009057; IPR001647; ,,,DOMAIN 11 71 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR-family),"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MATARRRLSPQDRRAELLALGAEVFGKRPYDEVRIDEIAERAGVSRALMYHYFPDKRAFFAAVVKDEADRLYAATNKAPAPGMTMFEEIRTGVLAYMAYHQQNPEAAWAAYVGLGRSDPVLLGIDDEAKNRQMEHIMSRIAEVVSGIDRDNTLDPEVERDLRVIIHGWLAFTFELCRQRIMDPSTDAERLADACAHALLDAISRLPQIPAELADAMATARM,"24,805",221,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,1
O05887,O05887_MYCTU,Rv3242c,Rv3242c,GO:0009116,IPR000836; IPR029057; ,,,,Uncharacterized protein,nucleoside metabolic process [GO:0009116],9634230,,,MLDLVLPLECGGCGAPATRWCAACAAELSVAAGEPHVVSPRVDPQVPVFALGRYAGVRRQAILAMKEHGRRDLVAPLACALIVGVDHLLSWGMLENPLTMVPAPTRRWAARRRGGDPVSRMARIAGATLGRHHDVTVVPALRMRALARDSVGLGASARERNITGRVLLRGQRPRNEVVLVDDIITTGATARESVRVLQAAGVRVGAVLAVAAA,"22,513",213,,nucleoside metabolic process [GO:0009116],,,,,3
O50414,O50414_MYCTU,Rv3387,Rv3387,GO:0003677; GO:0004803; GO:0006313,IPR002559; ,,,,Possible transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MVRNAQRAVRRASGRRKAWLRQAINHLEKLIGRTERVVDQARSRLAGVMPDSSSRLVSLHDADARPIRKGRLGKPVEFGYKAQVVDNADGVILDHSVELGNPADAPQLAPAIERISRRTGRPPRAVTADRGCGDASVEDDLHQLGVRNVAIPRKSKPSATRRAFEHRRAFRDKIKWRTGSEGRINHLKRSYGWNRTELTGITGARTWCGHGVFAHNLVKISTLAA,"25,022",225,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
O05883,O05883_MYCTU,Rv3238c,Rv3238c,GO:0016021,IPR009915; IPR033580; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MKRYLTIIYGAASYLVFLVAFGYAIGFVGDVVVPRTVDHAIAAPIGQAVVVNLVLLGVFAVQHSVMARQGFKRWWTRFVPPSIERSTYVLLASVALLLLYWQWRTMPAVIWDVRQPAGRVALWALFWLGWATVLTSTFMINHFELFGLRQVYLAWRGKPYTEIGFQAHLLYRWVRHPIMLGFVVAFWATPMMTAGHLLFAIGATGYILVALQFEERDLLAALGDQYRDYRREVSMLLPWPHRHT,"28,031",244,,,,integral component of membrane [GO:0016021],,,1
L0TFC2,L0TFC2_MYCTU,Rv3344c,PE_PGRS49 Rv3344c,,,,PE_PGRS49,,PE-PGRS family protein PE_PGRS49 (Fragment),,9634230; 21969609,,,AQASPAAHGGSGGAGGNGGAGSAGNGGAGGAGGNGGAGGNGGGGDAGNAGSGGNGGKGGDGVGPGSTGGAGGKGGAGANGGSSNGNARGGNAGNGGHGGAGGSGDTGGAGGAGGQGGFGGTGGSGSGIGGGAGGNGGNGGAGGTGVVLGGKGGDGGNGDHGGPATNPGSGSRGGAGGSGGNGGAGGNATGSGGKGGAGGNGGDGSFGATSGPASIGVTGAPGGNGGKGGAGGSNPNGSGGDGGKGGNGGAGGNGGSIGANSGIVGGSGGAGGAGGAGGNGSLSSGEGGKGGDGGHGGDGVGGNSSVTQGGSGGGGGAGGAGGSGFFGGKGGFGGDGGQGGPNGGGTVGTVAGGGGNGGVGGRGGDGVFAGAGGQGGLGGQGGNGGGSTGGNGGLGGAGGGGGNAPDGGFGGNGGKGGQGGIGGGTQSATGLGGDGGDGGDGGNGGNSGAKAGGAGGKGQAGQPNSGTEPGFGGDGGLGGAGATP,"37,490",484,,,,,,,1
Q6MWX1,Q6MWX1_MYCTU,Rv3478,PPE60 Rv3478,,IPR022171; IPR000030; IPR038332; ,,PPE60,,PE family protein PPE60,,9634230; 21969609,,,MVDFGALPPEINSARMYAGPGSASLVAAAKMWDSVASDLFSAASAFQSVVWGLTVGSWIGSSAGLMAAAASPYVAWMSVTAGQAQLTAAQVRVAAAAYETAYRLTVPPPVIAENRTELMTLTATNLLGQNTPAIEANQAAYSQMWGQDAEAMYGYAATAATATEALLPFEDAPLITNPGGLLEQAVAVEEAIDTAAANQLMNNVPQALQQLAQPAQGVVPSSKLGGLWTAVSPHLSPLSNVSSIANNHMSMMGTGVSMTNTLHSMLKGLAPAAAQAVETAAENGVWAMSSLGSQLGSSLGSSGLGAGVAANLGRAASVGSLSVPPAWAAANQAVTPAARALPLTSLTSAAQTAPGHMLGGLPLGHSVNAGSGINNALRVPARAYAIPRTPAAG,"39,414",393,Mycobacterial PPE family,,,,,,1
I6XHB8,I6XHB8_MYCTU,Rv3476c,kgtP Rv3476c,GO:0016021; GO:0022857,IPR020846; IPR005828; IPR036259; IPR005829; ,,kgtP,,Probable dicarboxylic acid transport integral membrane protein KgtP (Dicarboxylate transporter),integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857],9634230,,,MTVSIAPPSRPSQAETRRAIWNTIRGSSGNLVEWYDVYVYTVFATYFEDQFFDRADRNSTVYVYAIFAVTFVTRPVGSWFLGRFADRRGRRAALTFSVSLMAACSLIVALVPSRSSIGVAAPILLILCRLVQGFATGGEYGTSATYMSEAATRERRGYFSSFQYVTLVGGHVLAQFTLLVILAVFTREQVHEFGWRIGFAVGGGAAIVVFWLRRTMDESLSQERLTAIKAGRDHDSGSLRELATHYWKPLLLCFLVTLGGTVAFYTYSVNAPAIVKSVYGSQAMTATWINLVGLILLMMLQPIGGMISDKIGRKPLLLWFGVGGLIYTYVLVTYLPETRSPTMSFLLVAVGYVILTGYCSINALVKSELFPAHVRALGVGVGYALANSVFGGTAPLIYQALKERDQVPMFIAYVTACIAVSLIVYVFFIKNKADTYLDREQGFAFYGHA,"49,517",449,,,transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021],,,1
O53314,O53314_MYCTU,Rv3164c,moxR3 Rv3164c,GO:0005524; GO:0005618; GO:0016887; GO:0019217,IPR011703; IPR027417; ,,moxR3,,Probable methanol dehydrogenase transcriptional regulatory protein MoxR3,cell wall [GO:0005618]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; regulation of fatty acid metabolic process [GO:0019217],9634230; 21969609,,,MIMPAATTTAHCEAVLDEIERVVVGKRSALTLILTAVLARGHVLIEDLPGLGKTLIARSFAAALGLDFTRVQFTPDLLPADLLGSTIYDMQSGRFEFRAGPIFTNLLLADEINRTPPKTQAALLEAMAEGQVSIDGQTHKLAMPFIVLATDNPIEYEGTYPLPEAQLDRFAIRLELRYLSERDETSMLRRRLERGSADPTVNQVVDCHDLLAMRESVEQVTVHEDVLHYVVSLANATRHHPQVAVGASPRAELDLVQLSRARALLLGRDYVIPEDVKELATAAVAHRITLRPEMWVRKIAGADVVSELLRRLPVPRISGT,"35,301",320,,regulation of fatty acid metabolic process [GO:0019217],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618],,,1
P96901,P96901_MYCTU,Rv3296,lhr Rv3296,GO:0003676; GO:0004004; GO:0005524; GO:0005618; GO:0005737; GO:0010501,IPR003593; IPR013701; IPR011545; IPR014001; IPR001650; IPR027417; ,,lhr,,Probable ATP-dependent helicase Lhr (Large helicase-related protein),cell wall [GO:0005618]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; RNA secondary structure unwinding [GO:0010501],9634230; 21969609,,,MRFAQPSALSRFSALTRDWFTSTFAAPTAAQASAWAAIADGDNTLVIAPTGSGKTLAAFLWALDSLAGSEPMSERPAATRVLYVSPLKALAVDVERNLRTPLAGLTRLAERQGLPAPQIRVGVRSGDTPPALRRQLVSQPPDVLITTPESLFLMLTSAARQTLTGVQTVIIDEIHAIAATKRGAHLALSLERLDDLSSRRRAQRIGLSATVRPPEELARFLSGQSPTTIVAPPAAKTVELSVQVPVPDMANLTDNTIWPDVEARLVDLIESHNSTIVFANSRRLAERLTARLNEIHAARCGIELAPDTNQQVAGGAPAHIMGSGQTFGAPPVLARAHHGSISKEQRAVVEEDLKRGQLKAVVATSSLELGIDMGAVDLVIQVQAPPSVASGLQRIGRAGHQVGEISRGVLFPKHRTDLLGCAVSVQRMLAGEIETMRVPANPLDILAQHTVAAAALEPLDADAWFDTVRRAAPFATLPRSLFEATLDLLSGKYPSTEFAELRPRLVYDRDTGTLTARPGAQRLAVTSGGAIPDRGLFAVYLATERPSRVGELDEEMVYESRPGDVISLGATSWRITEITHDRVLVIPAPGQPARLPFWRGDDAGRPAELGAALGALTGELAALDRTAFGTRCAGLGFDDYATDNLWRLLDDQRTATAVVPTDSTLLVERFRDELGDWRVILHSPYGLRVHGPLALAVGRRLRDRYGIDEKPTASDNGIVVRLPDTVSAGEDSPPGAELFVFDADEIDPIVTTEVAGSALFASRFRESAARALLLPRRHPGRRSPLWQQRQRAARLLEVARKYPDFPIVLETVRECLQDVYDVPILVELMARIAQRRVRVAEAETAKPSPFAASLLFGYVGAFMYEGDTPLAERRAAALALDGTLLAELLGRVELRELLDPDVIAATSRQLQHLAADRVARDAEGVADLLRLLGPLTEDEIAARAGAPEVSGWLDGLRAAKRALVVSFAGRSWWVAVEDMGRLRDGVGAAVPVGLPASFTEAVADPLGELLGRYARTHTPFTTAAAAARFGLGLRVTADVLGRLASDGRLVRGEFVAAAKGSAGGEQWCDAEVLRILRRRSLAALRAQAEPVSTAAYGRFLPAWQHVSAGNSGIDGLAAVIDQLAGVRIPASAIEPLVLAPRIRDYSPAMLDELLASGDVTWSGAGSISGSDGWIALHPADSAPMTLAEPAEIDFTDAHRAILASLGTGGAYFFRQLTHDGLTEAELKAALWELIWAGRVTGDTFAPVRAVLGGAGTRKRAAPAHGGHRPPRLSRYRLTHAQARNADPTVAGRWSALPLPEPDSTLRAHYQAELLLNRHGVLTKDAVAAEGVAGGFATLYKVLSAFEDAGRCQRGYFIESLGGAQFAVASTVDRLRSYLDGVDPEQPDYHAVVLAAADPANPYGAALPWPASSADGTARPGRKAGALVVLVDGELAWFLERGGRSLLTFTDDPEANHAAAIGLADLVTAGRVASILVERADGMPVLQPGGRASAALTALLAAGFVRTPRGLRRR,"161,380",1513,,RNA secondary structure unwinding [GO:0010501],ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,2
O50391,O50391_MYCTU,Rv3362c,Rv3362c,,IPR004130; IPR027417; ,,,,Probable ATP/GTP-binding protein,,9634230; 21969609,,,MALKHSEASGTASTKIVIAGGFGSGKTTFVGAVSEIMPLRTEAMVTDASAGVDMLEATPDKRSTTVAMDFGRITLGEDLVLYLFGTPGQRRFWFMWDDLVRGAIGAIVLVDCRRLQDSFAAVDFFEHRNLPFLIAINEFDSAPRYPVSAVRDALTLPAHIPVINVDARNRRSATDALIAVSEYALATLSPAGG,"20,737",193,,,,,,,1
O05899,O05899_MYCTU,Rv3256c,Rv3256c,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MNVARAIDLEDTEGLIAADRGALLRAASMAGAQVRAIAAAADEGELDLLRGSDRPRSVIWVTGRGTAETAGTILASTLGAGAAEPIVLASAAPPWVGPLDVLIVAGDDPGDPALVGAAAIGVRRGARVVVVAPYEGPLRDSTAGRVAVLEPRLRVPDEFGLSRYLAAGLAALQTVDPKLRIDLASLADELDAEALRNSAGREVFTNPAKALAARVSGCQLALAGDNAATLALARHGSSVMLRIANQVVAATRLSDAVVALRAGTPPDALFHDEEIDGPAPQRLRVLALALAGERTVVAARVAGLDDAYLVAAEDVPELLDAPVGSGGAVLAVRLEMAAVYLRLVRG,"35,309",346,,,,plasma membrane [GO:0005886],,,2
O50380,O50380_MYCTU,Rv3351c,Rv3351c,GO:0016491; GO:0050660,IPR012951; ,,,,Uncharacterized protein,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],9634230,,,MLASCPARSGAAVADAIKSAVGVQPSGVEHKTLRRMDLVRYLAGGHTTYPPEGFVAGSDVIGTTNPAAAQAIVAAIGTWPPAAGRASALIDSLGGAVGDMDPEGSAFPWCRQSAVVQWYVNTPSDGQVATANKWLSDAHHAVQHFSVGGYVNYLEANAAASQYFGANLSRLTTVRRKYDPDRIMYSGLDFSTRQVAERLLPALGFRVRFGVLVIRCALCTDTVKRLGTLPNLTWSRLKVNVAVTQEQAGVMDLPALPVRRTPRR,"28,206",264,,,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],,,,1
I6YC44,I6YC44_MYCTU,Rv3434c,Rv3434c,GO:0016021,,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MADASVVARLRSWALAVWHFVSNAPLTYAWLVVLVITTIIQNNLTGSQLHFVLLHRSTNIAELGRDPLEVLFSSLLWIDGRNLEPYLLLFTLFLAPAEHWLGHLRWLTVGLTAHIGATYLSEGLLYLAIQHRDASERMVHARDIGVSYFLVGVMAVLTYHIAKPWRWGYLGVLLVIFGFPLIAMDKAELDFTAVGHFASILIGLLFYPMARERDGRLWNPARIKSLLHRRGTRGRRA,"26,877",237,,,,integral component of membrane [GO:0016021],,,1
O05856,O05856_MYCTU,Rv3210c,Rv3210c,,IPR012347; IPR009078; ,,,,Conserved protein,,9634230; 21969609,,,MPSPSSADQVADSPRPRLPADHPGVNELFALLAYGEVAAFYRLTDEARMAPDLRGRISMASMAAAEMGHYELLRNALERRGVDVVSAMSKYTSALENYHRLTTPSTWLEALVKTYVADALAADLYLEIADGLPDEVADVVRAALSETGHSQFVVAEVRAAVTASGKQRSRLALWSRRLLGEAITQAQLVLADHDELVDLVVSGSGGLSQLGAFFDRLQQTHDQRMRELGLS,"25,121",231,,,,,,,1
O05872,O05872_MYCTU,Rv3226c,Rv3226c,GO:0008233,IPR003738; IPR036590; ,,,,Putative SOS response-associated peptidase (EC 3.4.-.-),peptidase activity [GO:0008233],9634230; 21969609,,,MCGRFAVTTDPAQLAEKITAIDEATGCGGGKTSYNVAPTDTIATVVSRHSEPDDEPTRRVRLMRWGLIPSWIKAGPGGAPDAKGPPLINARADKVATSPAFRSAVRSKRCLVPMDGWYEWRVDPDATPGRPNAKTPFFLHRHDGALLFTAGLWSVWKSYRSAPPLLSCTVITTDAVGELAEIHDRMPLLLAEEDWDDWLNPDAPPDPELLARPPDVRDIALRQVSTLVNNVRNNGPELLEPARSQPEQIQLL,"27,640",252,SOS response-associated peptidase family,,peptidase activity [GO:0008233],,,,1
P96903,P96903_MYCTU,Rv3298c,lpqC Rv3298c,GO:0005576; GO:0016787,IPR029058; IPR010126; ,,lpqC,,Possible esterase lipoprotein LpqC,extracellular region [GO:0005576]; hydrolase activity [GO:0016787],9634230; 21969609,,,MPWARMLSLIVLMVCLAGCGGDQLLARHASSVATFQFGGLTRSYRLHVPPAEPSGLVISLHGGGGTGAGQEALTDFDAVADAADLLVVYPDGYDKSWADGRGASPADRRHLDDVGFLVALAAKLVHDFDIAPGHVFATGMSNGGFMSNRLACDRADIFAAVAPVAGTLGVGVTCNPSRPVSVLEAHGTADPLVPFNGGAVRGRGGLSHSISVASLVDRWRAVDGCQGDPSAAELPDVGDGTMVHLFDSSSCAAGTEVISYQIDNGGHTWPGGRQYLPKAVIGATTRAFDGSQVIAQFFATHGRD,"31,368",304,,,hydrolase activity [GO:0016787],extracellular region [GO:0005576],,,1
O06252,O06252_MYCTU,Rv3435c,Rv3435c,GO:0005886; GO:0016021,IPR027948; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MGRILRVVVGLVLVIAAYVTVIALYHSTGLGRPHEVAHGRPTADGTTVTLHVEQLQTIKGVLVANLAVSPGTELLDSQTQGLKDDLTVTVTSVVTPTKRTWSSGSLPGVFPVPLTISGDPANWPFDHYRSGPITVQLYRGAAHAPERVSVTFVDRLPGWNVDISGVGDANVPAPYRVGLHRSPSSVAFGTVIVGVLIALAGVGLFVAVQTARGRRQFQPPMTTWYAAMLFAVIPLRNALPDAPPIGFWIDVTVVLWVVVALVTSMVLYILCWWWHLKPDVDETM,"30,623",284,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O50419,O50419_MYCTU,Rv3394c,Rv3394c,GO:0005618; GO:0005886; GO:0006281,IPR001126; ,,,,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA repair [GO:0006281],9634230,,,MMASARVLAIWCMDWPAVAAAAAAGLSATAPVAVTLANRVIACSATARAAGVRRGLRRREAAARCPQLFIATADADRDARLFEGVIAAVDDLVPRAELLRPGLLVLPVRGPARFFGSEQMAAERLIDAVAAAGAECQVGIADRLSTAVFAARAGRIVEPGGDARFLSLLSIRQLATEPSLSGPGRDDLTDLLWRMGIRTIGQFAALSRTDVASRFGADAVAAHRFARGEPERAPCGREPPPDLAAELACDPPIDRVDAAAFAGRSLAAELHRALMAAGVGCTRLAIHAVTANGEERSRVWRCAEPLTEDATADRVRWQLDGWLNNRNARDRPTAAVTLLRLQAVETVSASEGLQLPLWGGLGEQDRLRARRALVRVQGLLGPEAVRVPVLSGGHGPAERITLTVLGLVAPEPVPQADPGQPWPGRLPDPSPAVLFDDPVDLLDAQGNPIRVTSRGMFSADPARLRVRGRDDRLRWWAGPWPDDERWWDPDRASGRTARAQVLLDGDPGTALLLCYRQRRWYLEGSYE,"56,667",527,,DNA repair [GO:0006281],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O50408,O50408_MYCTU,Rv3379c,dxs2 Rv3379c,GO:0005829; GO:0005886; GO:0008661; GO:0016114,IPR005477; IPR029061; IPR009014; IPR005475; IPR020826; IPR033248; ,,dxs2,,Probable 1-deoxy-D-xylulose 5-phosphate synthase Dxs2 (1-deoxyxylulose-5-phosphate synthase) (DXP synthase) (DXPS),cytosol [GO:0005829]; plasma membrane [GO:0005886]; 1-deoxy-D-xylulose-5-phosphate synthase activity [GO:0008661]; terpenoid biosynthetic process [GO:0016114],9634230,,,MFDTGHQTYPHKLLTGRGKDFATLRQADGLSGYPNRHESPHDWVENSHASVSLAWVDGIAKALALQGQCDRRVIAVIGDGALTGGVAWEGLNNLGAATRPVIVVLNDNGRSYDPTAGALAAHLEELRVGTPRGPNLFENMGFTYIGPVDGHNIPDTCAVLRKAAAAARPVVVHAVTSKGRGYPPAEADERDHMHACGVVDIATGLASTPSQRSWTDVFEDEIARIADDRSDVVGLTAAMRLPTGLGALSRRYPHRVFDSGIAEQHLLASAAGLAAAGTHPVVAVYSTFLHRAFDQLLFDIGLHRLPVTLVLDRAGVTGPDGPSHHGLWDLALLACVPGFQIACPRDAPRLRQQLRTAIATAAPTAVRFPKGAPGEPITAEHTIGGLDVLHTPPPHWRPDVLLVAVGAMSRPCMDAARCLSEEQIGVTVVDPQWVWPISPALTELAGRHRITVCVEDAIADVGIGAHLSHHIGRTHPRTRTYTLGLPPAYIPHASRDHILSSHGLTGPAIRIRCKSLLNALHEVPGPEDHPDSGDSY,"57,181",536,Transketolase family,terpenoid biosynthetic process [GO:0016114],1-deoxy-D-xylulose-5-phosphate synthase activity [GO:0008661],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
L7N690,L7N690_MYCTU,Rv3306c,amiB1 Rv3306c,GO:0008152; GO:0016787,IPR017439; IPR036264; IPR017144; IPR002933; IPR011650; ,,amiB1,,Peptidase M20 domain-containing protein 2,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230; 21969609,,,MPAASASDRVEELVRRRGGELVELSHAIHAEPELAFAEHRSCAKAQALVAERGFEITTAAGGLDTAFRADYGSGPLVVGVCAEYDALPGIGHACGHNIIAASAVGTALALAEVADDLGLTVALLGTPAEESGGGKALMLQAGTFDDVAVAVMVHPGPTDIAGARSLALSEVTVRYRGKESHAAVAPHLGVNAADAVTVAQVAIGVLRQQLAPGQMVHGIVTDGGQAVNVIPGQARLQYAMRAVESDSLRELQTRMFACFAAGALAAGCEYEIDEAAPAYAELKPDPWLADVCREEMQRLGREPLLPALEAELPLGSTDMGNVTQVLPGIHPVIGLDAGAATVHQRAFTVASAGASADRAVVDGAIMLARTVVRLAQTPDERDRVLAAQQRRAAR,"40,740",394,Peptidase M20A family,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
O07033,O07033_MYCTU,Rv3122,Rv3122,,,,,,Uncharacterized protein,,9634230,,,MYSGCWINNQNGETRVGEDSLEDLEQRRARLYDQLAATGDFRRGSISENYRRCGKPNCVCAQEGHPGHGPRYLWTRTVAGRGTKGRQLSVEEVDKVRAELANYHRFAQVSEQIVAVNEAICEARPPNPAATAPPAGTTGHKKGGSATRSRRSSPPR,"17,178",156,,,,,,,1
O53371,O53371_MYCTU,Rv3319,sdhB Rv3319,GO:0005886; GO:0006099; GO:0009055; GO:0009060; GO:0022904; GO:0051536,IPR036010; IPR017896; IPR017900; IPR012675; IPR009051; IPR004489; IPR025192; ,,sdhB,,Probable succinate dehydrogenase (Iron-sulphur protein subunit) SdhB (Succinic dehydrogenase) (Fumarate reductase) (Fumarate dehydrogenase) (Fumaric hydrogenase),plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,,,MSVEPDVETLDPPLPPVPDGAVMVTVKIARFNPDDPDAFAATGGWQSFRVPCLPSDRLLNLLIYIKGYLDGTLTFRRSCAHGVCGSDAMRINGVNRLACKVLMRDLLPKKKGKSLTVTVEPIRGLPVEKDLVVDMEPFFDAYRAIKPYLITSGNPPTRERIQSPTDRARYDDTTKCILCACCTTSCPVFWHEGSYFGPAAIVNAHRFIFDSRDEAAAERLDILNEVDGVWRCRTTFNCTESCPRGIEVTKAIQEVKRALMFTR,"29,335",263,,aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099],electron transfer activity [GO:0009055]; iron-sulfur cluster binding [GO:0051536],plasma membrane [GO:0005886],,,1
O05876,O05876_MYCTU,Rv3231c,Rv3231c,,,,,,Conserved protein,,9634230; 21969609,,,MTQVYIPATLAMLQRLVADGALWPVNGTAFAVTPTLRESYAEGDDEELAEVALREAALASLRLLAADIGATADALPPRRAVLAAEVDDATYRPDLDDAVVRLAGPITIDQVVAAYVDNAGAEPAVMAAIAVIDAADLGDEDAELVVGDAQDHDLAWYANQELPFLLDLL,"17,797",169,,,,,,,1
P95186,P95186_MYCTU,Rv3140,fadE23 Rv3140,GO:0005618; GO:0005886; GO:0016627; GO:0040007; GO:0050660,IPR006091; IPR036250; IPR009075; IPR009100; ,,fadE23,,Probable acyl-CoA dehydrogenase FadE23,"cell wall [GO:0005618]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; growth [GO:0040007]",9634230; 21969609,,,MAINLELPRKLQAIIVKTHQGAAEMMRPIARKYDLKEHAYPVELDTLINLFEGAAESFNFAGAHSLRDEDEGKDENHNGANMAAVVQTMEASWGDVAMMLSLPYQGLGNAAISAVATDEQLERLGKVWAAMAITEPEFGSDSAAVSTTATLDGDEYVINGEKIFVTAGSRATHIVVWATLDKSLGRPAIKSFIVPREHPGVTVERLEHKLGIKGSDTAVIRFDNARIPKGNLLGNPEIEVGKGFAGVMETFDNTRPIVAAMAVGIGRAALEEIRSVLTGAGVEISYDKPSHTQSAAAAEFLRMEADWEASYLLSLRAAWQADNNIPNSKEASMSKAKAGRMASDVTCKTVELAGTTGYSEQSLLEKWARDSKILDIFEGTQQIQQLVVARRLLGLSSSELK,"43,344",401,Acyl-CoA dehydrogenase family,growth [GO:0040007],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53382,O53382_MYCTU,Rv3332,nagA Rv3332,GO:0005975; GO:0006046; GO:0008448; GO:0040007; GO:0046872,IPR006680; IPR003764; IPR011059; IPR032466; ,,nagA,,Probable N-acetylglucosamine-6-phosphate deacetylase NagA (GlcNAc 6-P deacetylase),metal ion binding [GO:0046872]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; growth [GO:0040007]; N-acetylglucosamine catabolic process [GO:0006046],9634230; 21969609,,,MTVLGADAVVIDGRICRPGWVHTADGRILSGGAGAPPMPADAEFPDAIVVPGFVDMHVHGGGGASFADGNAADIARAAEFHLRHGTTTTLASLVTAGPAELLSAVGALAEATRDGVVAGIHLEGPWLSPARCGAHDHTRMRAPDPAEIESVLAAADGAVRMVTLAPELPGSDAAIRRFRDAEVVVAVGHTDATYTQTRHAIDLGATVGTHLFNAMPPLDHRAPGPVLALLCDPRVTVEIIADGVHVHPAVVHAVIEAVGPDRVAVVTDAIAAAGCGDGAFRLGTMPIEVESSVARVAGASTLAGSTTTMDQLFRTVAGLGSKSDSAGDVALAAAVQVTSATPARALGLTGVGRLAAGYAANLVVLDRDLRVTAVMVNDDWRVG,"38,805",383,"Metallo-dependent hydrolases superfamily, NagA family",carbohydrate metabolic process [GO:0005975]; growth [GO:0040007]; N-acetylglucosamine catabolic process [GO:0006046],metal ion binding [GO:0046872]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448],,,,1
O53356,O53356_MYCTU,Rv3304,Rv3304,GO:0003839; GO:0005886,IPR017939; IPR013024; IPR036568; ,,,,Conserved protein,plasma membrane [GO:0005886]; gamma-glutamylcyclotransferase activity [GO:0003839],9634230; 21969609,,,MPLYAAYGSNMHPEQMLERAPHSPMAGTGWLPGWRLTFGGEDIGWEGALATVVEDPDSKVFVVLYDMTPADEKNLDRWEGSEFGIHQKIRCRVERISSDTTTDPVLAWLYVLDAWEGGLPSARYLGVMADAAEIAGAPSDYVHDLRTRPARNIGPGTIA,"17,489",159,,,gamma-glutamylcyclotransferase activity [GO:0003839],plasma membrane [GO:0005886],,,3
O53387,O53387_MYCTU,Rv3337,Rv3337,,IPR029058; ,,,,Uncharacterized protein,,9634230,,,MPSPSTTGHHAACGTGGTGFSVGSMRSPIRVGSGEPVLLLHPFLMSQTVWEKVAQQLADTGRFEVFAPTMAGHNGGPASGTRFCPRRCWPTTSNASSTNWAGKPAISSATRWAAGSRSNSNDVAGHAA,"13,211",128,,,,,,,2
O53370,O53370_MYCTU,Rv3318,sdhA Rv3318,GO:0005829; GO:0005886; GO:0006099; GO:0008177; GO:0022900; GO:0050660,IPR003953; IPR036188; IPR003952; IPR037099; IPR015939; IPR027477; IPR011281; IPR014006; ,,sdhA,DOMAIN 8 401 FAD_binding_2. {ECO:0000259|Pfam:PF00890}.; DOMAIN 456 590 Succ_DH_flav_C. {ECO:0000259|Pfam:PF02910}.,Succinate dehydrogenase flavoprotein subunit (EC 1.3.5.1),cytosol [GO:0005829]; plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],9634230; 21969609,,,MICQHRYDVVIVGAGGAGMRAAVEAGPRVRTAVLTKLYPTRSHTGAAQGGMCAALANVEDDNWEWHTFDTVKGGDYLADQDAVEIMCKEAIDAVLDLEKMGMPFNRTPEGRIDQRRFGGHTRDHGKAPVRRACYAADRTGHMILQTLYQNCVKHDVEFFNEFYALDLALTQTPSGPVATGVIAYELATGDIHVFHAKAVVIATGGSGRMYKTTSNAHTLTGDGIGIVFRKGLPLEDMEFHQFHPTGLAGLGILISEAVRGEGGRLLNGEGERFMERYAPTIVDLAPRDIVARSMVLEVLEGRGAGPLKDYVYIDVRHLGEEVLEAKLPDITEFARTYLGVDPVTELVPVYPTCHYLMGGIPTTVTGQVLRDNTSVVPGLYAAGECACVSVHGANRLGTNSLLDINVFGRRAGIAAASYAQGHDFVDMPPNPEAMVVGWVSDILSEHGNERVADIRGALQQSMDNNAAVFRTEETLKQALTDIHALKERYSRITVHDKGKRFNTDLLEAIELGFLLELAEVTVVGALNRKESRGGHAREDYPNRDDVNYMRHTMAYKEIGADKEGPELRSDVRLDFKPVVQTRYEPKERKY,"64,826",590,"FAD-dependent oxidoreductase 2 family, FRD/SDH subfamily",electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O65931,O65931_MYCTU,Rv3299c,atsB Rv3299c,GO:0005829; GO:0008152; GO:0008484,IPR017849; IPR017850; IPR009200; IPR024607; IPR000917; ,,atsB,DOMAIN 212 634 Sulfatase. {ECO:0000259|Pfam:PF00884}.,Probable arylsulfatase AtsB (Aryl-sulfate sulphohydrolase) (Sulfatase),cytosol [GO:0005829]; sulfuric ester hydrolase activity [GO:0008484]; metabolic process [GO:0008152],9634230; 21969609,,,MMSEDNALVLVAGYQDLDSARHDFQTLVDAAKDKSIPLQGAVLIGKDAEGSPVLVDTGNRLGRRGAAWGAGVGLAIGLFSPALLASAALGAATGALAGTFAHHRIKTGLADKIGQALAAGRAVVIAVTEAQGRLEAGQALASSPMKSVAELSRSTLRSLGAALREAMGKFNPDRTRLPLPQRRFGGVVGRTMAESVGDWSIVPGPFPPDDAPNVLIVLIDDAGFGGPDTFGGAIRTPTLSRLAQNGLIYNRFHVTAVCSPTRAALLTGRNHHRVGFGSVCEFPGPYPGYSAVRPRSCAALPRILRDNGYVTGAFGKWHLTPDNVQGAAGPFDNWPLGWGFDHFWGFPSGAAGQYDPIISQDNSVIGIPEGSGEDGRPYYFPDDLTDKAIEWLHTVRAQNATKPWMLYYATGATHAPHHVFKEWADKYRGEFDDGWDVYRQKTFERQKRLGIIPPDAELTERPDLFPAWDSMSEAQKRLFARQMEVFAGFSENADWNVGRLLDAIEDLGESDNTLVFYIWGDNGASMEGTNTGSFNEMTFLNGLDLDAERQLELIEQYGGIAALGDEFTAPHFASAWAHASNTPLQWGKQMASHLGGTRDPLVVAWPARIRPDGRVRSQFTHCIDIAPTVLAAIGLPEPTHVDGFEQEPMDGTSFVRTFDDAEAEDRHTVQYFENFGSRAIYKDGWWACARLDKAPWDLSPETMRRFAPGTYDPDQDVWELYYLPDDFSQAKNLAAEHPDKVAELTQLWWQEAERNRVLPLLGGLAVMFGDLPPLPTTARFSFKGDVQNIQRGMVPRICGRSYAIEARLHIPDGGAQGVIVANADFMGGFALWVDEQRHLHHTYSFLGVETYRQVSSEPLPTGDVTVRMLFDSHQPVAASGGRVTLWADDRLIGEGELPQTVPLAFTSYAGMDIGRDNGLVVDRGYEDKAPYAFTGTVTEVIFDLKPVHPEAARALHEHASVQAVGQGAAG,"105,680",970,,metabolic process [GO:0008152],sulfuric ester hydrolase activity [GO:0008484],cytosol [GO:0005829],,,3
O53388,O53388_MYCTU,Rv3338,Rv3338,,IPR029058; IPR000073; ,,,DOMAIN 8 197 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Uncharacterized protein,,9634230; 21969609,,,MSSAVLADHVERQLDELGWETSHIVGNSLGGWVAFELERRGRARSVTGIAPAGGWTRWSPVKFEVIAKFIAGAPILAVAHILGQRALRLPFSRLLATLPISATPDGVSERELSGIIDDAAHCPAYFQLLVKALVLPGLQELEHTAVPSHVVLCEQDRVVPPSRFSRHFTDSLPAGHRLTVLDGVGHVPMFEAPGRITELITSFIEECCPHVRAS,"23,244",214,,,,,,,3
Q6MWZ5,Q6MWZ5_MYCTU,Rv3224A,Rv3224A,,,,,,Uncharacterized protein,,9634230,,,MRRSASTCGWKTPTRRGTSRPSDSKTLILELPDERAVAIVPVPSKLSLKAAGGPRGAQSGHG,"6,498",62,,,,,,,1
O06347,O06347_MYCTU,Rv3484,cpsA Rv3484,GO:0005576; GO:0005886; GO:0016021,IPR027381; IPR004474; ,,cpsA,,Possible conserved protein CpsA,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MARSEGNRPRHRAVPQPSRIRKRLSRGVMTLVSVVALLMTGAGYWVAHGALGGITISQALTPEDPRSSGNNMNILLIGLDSRKDQEGNDLPWSVLKQLHAGDSDDGGYNTNTLILVHVGADGKVVAFSIPRDDWVPFTGVPGYNHIKIKEAYGLTKQYVAEQLANQGVSDRKELETRGREAARAATLRAVRSLTGVPIDYFAEINLAGFYDLAQTLGGVDVCLNHAVYDSYSGADFPAGRQRLNAAQALAFVRQRHGLDNGDLDRTHRQQAFLSSVMRELQDSGTFTNLDRLDNLMAVARKDVVLSAGWDEDLFRRMGDLAGGNVEFRTLPVVRYDNIDGQDVNIIDPTAIRAEVAAAFGSAPPTSQTAAAAKPNPSTVVDVVNAGSISGLASQVSGALLKRGYTAGQVRDRESGDPFTTAIEYGAGAETDAQNVADLLGIDAPNHPDPAVAPGHIRVTVDTNFSLPAPDEATAAATSTETSTYPLYGGGTTTDPTPDQGAPIDGGGVPCVN,"54,355",512,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,3
O53313,O53313_MYCTU,Rv3163c,Rv3163c,,IPR002881; ,,,,Possible conserved secreted protein,,9634230,,,MIQTCEVELRWRASQLTLAIATCAGVALAAAVVAGRWQLIAFAAPLLGVLCSISWQRPVPVIQVHGDPDSQRCFENEHVRVTVWVTTESVDAAVELTVSALAGMQFEALESVSRRTTTVSAVAQRWGRYPIRARVAVVARGGLLMGAGTVDAAEIVVFPLTPPQSTPLPQTELLDRLGAHLTRHVGPGVEYADIRPYVPGDQLRAVNWVVSARRGRLHVTRRLTDRAADVVVLIDMYRQPAGPATEATERVVRGAAQVVQTALRNGDRAGIVALGGNRPRWLGADIGQRQFYRVLDTVLGAGEGFENTTGTLAPRAAVPAGAVVIAFSTLLDTEFALALIDLRKRGHVVVAVDVLDSCPLQDQLDPLVVRMWALQRSAMYRDMATIGVDVLSWPADHSLQQSMGALPNRRRRGRGRASRARLP,"45,831",423,,,,,,,1
O05849,O05849_MYCTU,Rv3217c,Rv3217c,GO:0016021,,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021],9634230,,,MPVRAPAAVRGAGLIVAVQGGAALVVAAALLVRGLAGADQHIVNGLGTAGWFVLVGGAVLAAGCRLAVGKLWGRGLAVFAQLLLLPVAWYLIVGSHQPAIGIPVGIIALGVLVLLFSPPSIRWAAGRDQRGAASAANRGPDSR,"14,292",143,,,,integral component of membrane [GO:0016021],,,1
O05844,O05844_MYCTU,Rv3222c,Rv3222c,,,,,,Uncharacterized protein,,9634230,,,MSSPVSSRRLANLVKESLQGSVLGGVVSDAVLPAVSDDVKPGAGEDAYRVPVVVAAGSGAVVQVGGLEVGSAAVAGEVADTVAELFVCRPTEPDVGDFVGLAGGAGDAGQAGQQFGLGVGVRGESFGARRRLALSTVGASGATAGLRKTHDGHHGCQARGALTQRRLYIGNPSEITDTRMVHQ,"18,316",183,,,,,,,1
O06263,O06263_MYCTU,Rv3446c,Rv3446c,,IPR023840; ,,,,Hypothetical alanine and valine rich protein,,9634230,,,MSPHRAVIEAGPGAIRRLCCGADVVADTAVSAAALAAIDDQVALLDERPVAVDSLWFDALRSVAVDHRDGPVVVHPSWWSAARVEVVTAAARTLTRDVVVHPRSWLLRQASSGVSAATVVVEIAERLVLVAGAEVAAVARRTDAESVAGQVGSVIARMTRGITAVVLIDVPSTVAGAAALAAAIAGAVRGTGSSVVEIDGVRLARLARAALPPSDEPADPAARPATRSRVPTLARVAAAGVALALLAPAAVVRHGATTLQRPPTTLLVEGRVALTIPADWSTQRVVSGPGSARVQVTSPADPEVALHVTQSPVPGETLPGTAQRLKRAIDASPAGVFVDFNPSDIRAGRPAVTYREVRAGHQVRWTILLDGAVRISVGCQSGPGHEDLLREVCAQAVRSVHAVG,"41,556",404,,,,,,,1
O53384,O53384_MYCTU,Rv3334,Rv3334,GO:0003677; GO:0006355; GO:0019217,IPR009061; IPR000551; IPR015358; ,,,DOMAIN 1 69 HTH merR-type. {ECO:0000259|PROSITE:PS50937}.,Probable transcriptional regulatory protein (Probably MerR-family),"DNA binding [GO:0003677]; regulation of fatty acid metabolic process [GO:0019217]; regulation of transcription, DNA-templated [GO:0006355]",9634230,,,MKISEVAALTNTSTKTLRFYENSGLLPPPARTASGYRNYGPEIVDRLRFIHRGQAAGLALQEVRQILAIHDRGEAPCAHVRQLLSTRIDEVRAQIAELIALEGHLQTLLDHASYGPPTEHDHSTVCWILESDLDEPTAIEVSDIHA,"16,169",146,,"regulation of fatty acid metabolic process [GO:0019217]; regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677],,,,1
P95185,P95185_MYCTU,Rv3141,fadB4 Rv3141,GO:0005886; GO:0016491,IPR013149; IPR013154; IPR011032; IPR036291; IPR020843; ,,fadB4,,Probable NADPH quinone oxidoreductase FadB4 (NADPH:quinone reductase) (Zeta-crystallin),plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MRAVRVTRLEGPDAVEVAEVEEPTSAGVVIEVHAAGVAFPDALLTRGRYQYRPEPPFVLGAEIAGVVRSAPDNSQVRSGDRVVGLTMLTGGMAEVAVLSPERVFKLPDNMTFEAGAGVLFNDLTVYFALAVRGRLQAGETVLVHGAAGGIGTSTLRLAPALGASRTVAVVSTQEKAELATVAGATDVVLAEGFKDAVQELTNGRGVDIVVDPVGGDRFTDSLRSLAAGGRLLVIGFTGGEIPTVKVNRLLLNNIDVVGVGWGAWSLTHPDALAQQWSQLERLLRSGKLPPPEPVVYPLDQAAAAIASLENRTAKGKVVLRVRD,"33,853",323,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
Q6MWY3,Q6MWY3_MYCTU,Rv3323c,moaX moaD Rv3323c,GO:0000166; GO:0005829; GO:0006777; GO:0030366; GO:0032324,IPR012675; IPR036563; IPR003448; IPR010034; IPR016155; IPR003749; ,,moaX,,Molybdopterin synthase sulfur carrier subunit,cytosol [GO:0005829]; molybdopterin synthase activity [GO:0030366]; nucleotide binding [GO:0000166]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],9634230,,FUNCTION: Involved in sulfur transfer in the conversion of molybdopterin precursor Z to molybdopterin. {ECO:0000256|RuleBase:RU362014}.,MITVNVLYFGAVREACKVAHEKISLESGTTVDGLVDQLQIDYPPLADFRKRVRMAVNESIAPASTILDDGDTVAFIPQVAGGSDVYCRLTDEPLSVDEVLNAISGPSQGGAVIFVGTVRNNNNGHEVTKLYYEAYPAMVHRTLMDIIEECERQADGVRVAVAHRTGELRIGDAAVVIGASAPHRAAAFDAARMCIERLKQDVPIWKKEFALDGVEWVANRP,"24,050",221,MoaD family,molybdopterin cofactor biosynthetic process [GO:0032324]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],molybdopterin synthase activity [GO:0030366]; nucleotide binding [GO:0000166],cytosol [GO:0005829],moaD,,1
I6YGB1,I6YGB1_MYCTU,Rv3497c,mce4C Rv3497c,,IPR005693; IPR003399; ,,mce4C,,Mce-family protein Mce4C,,9634230; 21969609,,,MLNRKPSSKHERDPLRTGIFGLVLVICVVLIAFGYSGLPFWPQGKTYDAYFTDAGGITPGNSVYVSGLKVGAVSAVSLAGNSAKVTFSVDRSIVVGDQSLAAIRTDTILGERSIAVSPAGSGKSTTIPLSRTTTPYTLNGVLQDLGRNANDLNRPQFEQALNVFTQALHDATPQVRGAVDGLTSLSRALNRRDEALQGLLAHAKSVTSVLSERAEQVNKLVEDGNQLFAALDARRAALSALISGIDDVAAQISGFVADNRKEFGPALSKLNLVLANLNERRDYITEALKRLPTYATTLGEVVGSGPGFNVNVYSVLPGPLVATVFDLVFQPGKLPDSLADYLRGFIQERWIIRPKSP,"38,150",357,,,,,,,1
O53385,O53385_MYCTU,Rv3335c,Rv3335c,GO:0005886; GO:0016021,IPR005274; IPR017039; ,,,,Probable conserved integral membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MGELAEPGVLDRLRARFGWLDHVVRAFTRFNDRNGSLFAAGLTYYTIFAIFPLLMVGFGVGGFALSRRPELLTTLEERIRTSVSGAVGQQLVDLMNSAIDARASVGVIGLATAAWVGLGWMWHLREALSQMWAHPVAPAGYLRTKLSDLAAMVGTFVVIVATIALTVLGHARPMAAVLRWLEIPQFSVFDEIFRGISVLVSVLVSWVLFTWMIGRLPREPVGLVTAARAGLMAAVGFELFKQVGAIYLQIVLRSPAGAVFGPVLGLMVFAFVTAWLILFATAWAATASA,"31,293",289,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O05882,O05882_MYCTU,Rv3237c,Rv3237c,GO:0005618; GO:0005886; GO:0006813; GO:0008324; GO:0052572,IPR026278; IPR006037; IPR036721; ,,,,Conserved protein,cell wall [GO:0005618]; plasma membrane [GO:0005886]; cation transmembrane transporter activity [GO:0008324]; potassium ion transport [GO:0006813]; response to host immune response [GO:0052572],9634230; 21969609,,,MDVKEVLLPGVGLRYEFTSYRGDRIGIVARRSGGFDVVLYGRDDPDEARPVLRLTDEEAEAVAQILGAPRIAERFTELTREVPGLKAGQIHIRAGSLFVDRPLGDTRARTRTGASIVAIVRDEDVLASPGPTDVLRAGDVLIVIGTEDGIAGVEQIVEKG,"17,234",160,,potassium ion transport [GO:0006813]; response to host immune response [GO:0052572],cation transmembrane transporter activity [GO:0008324],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
I6X6H8,I6X6H8_MYCTU,Rv3144c,PPE52 Rv3144c,,IPR000030; IPR038332; ,,PPE52,,PPE family protein PPE52,,9634230; 21969609,,,MSFVVLPPEINSLRMFIGAGTAPMLAAAAAWDGLAEELGTAAQSFASVTAGLAGQAWQGPAALAMAAAAAPYAGWLTAAAAQSAGAAGQARAVASIFEAAQAATVLPAAVAANRDAFVQLVMTNLFGQNAPLIAAAEGVYEEMWAADVAAMSGYYSGASAIAAQVVPWASLLQRFPGLGAGATGATGGESVGTGATGGESVGTGGGESVGTGGATASGGGVGYVGGGVASAGLAAGDPAHGSVGQGNFGGGDVGAGDVVASSATSAHAGVVSPGFIGAPLALAALGQMARGGTNSAPGTATESARAPEPAASAPPEAVVEVPELEVPAMGVLPTVDPKVAAKAAPLSTTRVGQSAGSGIPESTLRTAQGQQASETSAAEETAPSLRPEAAAGQLRPRVRKDPKIQMRGG,"39,069",409,Mycobacterial PPE family,,,,,,1
L7N663,L7N663_MYCTU,Rv3305c,amiA1 Rv3305c,GO:0008152; GO:0016787,IPR017439; IPR036264; IPR002933; ,,amiA1,,Possible N-acyl-L-amino acid amidohydrolase AmiA1 (N-acyl-L-amino acid aminohydrolase),hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230; 21969609,,,MSLADAAESWLAAHHDDLVGWRRHIHRYPELGRQEYATTQFVAERLADAGLNPKVLPGGTGLTCDFGPQHQPRIALRADMDALPMAERTGAPYASTMPNVAHACGHDAHTAILLGAALALASVPELPVGVRLIFQAAEELMPGGAIDAIAAGALAGVSRIFALHCDPRLEVGKVAVRQGPITSAADSIEITLYSPGGHTSRPHLTADLVYGLGTLVTGLPGVLSRRIDPRNSTVLVWGAVNAGMAANAIPQTGVLSGTVRTASRQTWVDLEELVRQAISALLLPLAIEHTLQYRRGVPPVVNEEISTRILAHAIEAIGPGVLADTRQSGGGEDFSWYLEEVPGAMARLGVWSGDGLQLDLHQPTFDIDERALAIGLRVMVNIIEQAAAH,"41,227",389,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
I6YC91,I6YC91_MYCTU,Rv3489,Rv3489,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSTKSDHGEIGDVEPLADSTASQARRVVAAYANDADECRIFLSMLGIGPAKLES,"5,695",54,,,,,,,1
O06320,O06320_MYCTU,Rv3453,Rv3453,GO:0016021,,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MPGVITNSESPTAADHDRITATRETLEDYTLRLAPRSYRRWPPAVVGISALGGIAYLADFAIGANVGITWGTANALCGIAIFALVVFVTGLPLAYYAARYNIDLDLIYPR,"11,860",110,,,,integral component of membrane [GO:0016021],,,1
O53321,O53321_MYCTU,Rv3171c,hpx Rv3171c,GO:0004601; GO:0005886,IPR029058; IPR022742; ,,hpx,DOMAIN 24 258 Hydrolase_4. {ECO:0000259|Pfam:PF12146}.,Possible non-heme haloperoxidase Hpx,plasma membrane [GO:0005886]; peroxidase activity [GO:0004601],9634230; 21969609,,,MTVRAADGTPLHTQVFGPPHGYPIVLTHGFVCAIRAWAYQIADLAGDYRVIAFDHRGHGRSGVPRRGAYSLNHLAADLDSVLDATLAPRERAVVAGHSMGGITIAAWSDRYRHKVRRRTDAVALINTTTGDLVRKVKLLSVPRELSPVRVLAGRSLVNTFGGFPLPGAARALSRHVISTLAVAADADPSATRLVYELFTQTSAAGRGGCAKMLVEEVGSAHLNLDGLTVPTLVIGGVRDRLTPISQSRRIARTAPNVVGLVELPGGHCSMLERHQEVNSHLRALAESVTRHVRDRRISS,"32,146",299,,,peroxidase activity [GO:0004601],plasma membrane [GO:0005886],,,3
O53319,O53319_MYCTU,Rv3169,Rv3169,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MPQMLGPLDEYPLHQLPQPIAWPGSSDRNFYDRSYFNAHDRTGNIFLITGIGYYPNLGVKDAFVLIRRADIQTAVHLSDAIDSDRLHQHVNGYRVEVVEPLRKLRIVLDETEGVAADLTWEGLFDVVQEQPHVLRSGNRVTLDAQRFAQLGTWSGRIVVDGERIAVDPATWLGSRDRSWGIRPVGEPEPAGRPADPPFEGMWWLYVPLAFDDFAVVLIIQEEPDGFRSLNDCTRIWRDGHVEQLGWPRVRIHYRSGTRIPTGATIEASTPDGAPVHFDVESKLAVPTHVGGGYGGDSDWSHGMWKGEKFVERRTYDMTDPTIIARAGFGVIDHVGRALCRDGDGNPVQGWGLFEHGALGRHDPSGFADWSTLAP,"41,760",374,,,,plasma membrane [GO:0005886],,,3
Q6MWX5,Q6MWX5_MYCTU,Rv3388,PE_PGRS52 Rv3388,,IPR000084; ,,PE_PGRS52,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS52,,9634230,,,MSFVIANPEMLAAAATDLAGIRSAISAATAAAAAPTIQVAAAGADEVSLAISALFGQHAQAYQALSAQATIFHDQFVQALTSGGNLYAAAESHTVEQMVLNAINAPTQTLFGRPLIGDGANGTAENPDGQNGGLLFGNGGNGFTQTTAGVAGGNGGSAGLIGNGGAGGGGGAGAAGGLGGNGGWLYGNGGAGGIGGAGTGTGGHGGAGGAGGRAWLWGTGGAGGAGGDGGWLFGDGGAGGTGGNGGSGFNSLTSSVGGAGGAGGHAGLFGAGGTGGTGGIGGQNTETGPAASNGGAGGAGGGGGYLVGDGGAGGTGGAGGKNSSGGATLTGGTGGTGGAGGAAGWLYGSGGAGGAGGAGGLNNAGGATGGTGGTGGAGGSGAWLYGNGGAAGAGGNGGNNTSAGTGGVGASGGTGGNAGLIGAGGHGGAGGAGGNQTGGVGNGGAGGNGGAGGAGGQLYGNGGDGGNGGAGGANIAGGNGSDGGAAGHGGAGGSARLIGAGGHGGDGGAGGNTAGRRADAIAGTGGDGGNGGNGGLLSGNAGAGGHGGAGGSSTATTTTGTPPTGATGGNGGNGGAGGTAGFTGSGGIGGNGGAGGTGGNAGVALSVGSTGGLGGNGGSGGLGGGGGSLFGNGGAGGVGATGGNGGSGIGPASVGGNGGKGGVGAAGGLAGQIGNGGSGGSGGAGGNGGTGDTAGNGGNGGAGAVGGNAQLIGNGGNGGGGGNGGTGADGT,"60,454",731,,,,,,,1
O07166,O07166_MYCTU,Rv3300c,Rv3300c,GO:0000455; GO:0003723; GO:0005886; GO:0009982; GO:0031119,IPR020103; IPR006224; IPR006145; ,,,DOMAIN 93 237 PseudoU_synth_2. {ECO:0000259|Pfam:PF00849}.,Uncharacterized protein,plasma membrane [GO:0005886]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; tRNA pseudouridine synthesis [GO:0031119],9634230,,,MALRPEDRLLSVHDVLGPVRVRLLGGSVLAELTARFGVAARAKVLAGEVVDDDGAVVDSGTVLPPGSVVHLYRDLPDEVPVPFDVPVLHQDADIVVVDKPHFLATMPRGRHVAQTALVRLRRELGLPELSPAHRLDRLTAGVLLFTTRREVRGSYQTMFARGLVRKTYLARAPVAPGLALPRLVRSRIVKRRGHLQAVCEPGVPNAETLVERIARDGLYRLTPTTGRTHQLRVHMAALGIPIMGDPLYPNVISVAAHDFSTPLQLLAQRIEFDDPLTGSHREFASTRTLTGATLPTWSAAADCRP,"33,280",305,,enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; tRNA pseudouridine synthesis [GO:0031119],pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723],plasma membrane [GO:0005886],,,1
O06348,O06348_MYCTU,Rv3485c,Rv3485c,GO:0005886; GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MNSRAPRNLAVSSPSAQVTGRMVQNGENLFQFRREGPQVQLSFQDRTYLVTGGGSGIGKGVAAGLVAAGAAVMIVGRNPDKLAAAVKDIEALKTGAIGYEPADITDEEQTLRVVDAATAWHGRLHGVVHCAGGSQTIGPITQIDSQAWRRTVDLNVNGTMYVLKHAARELVRGGGGSFVGISSIAASNTHRWFGAYGVTKSAVDHMMKLAADELGPSWVRVNSIRPGLIRTDLVVPVTESPELSADYRVCTPLPRVGEVEDVANLAMFLLSDAASWITGQVINVDGGHMLRRGPDFSPMLEPVFGADGLRGVVG,"33,194",314,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
O06336,O06336_MYCTU,Rv3471c,Rv3471c,GO:0045735,IPR006045; IPR013096; IPR014710; IPR011051; ,,,,Uncharacterized protein,nutrient reservoir activity [GO:0045735],9634230,,,MSTRPERERASTSTDAVLQATVALSAGHKPAFRGFVKDPPRARAHAAAMFVSNAREAEPFVAPDLSEIRVLVDRATVGVASVSLAHATVAAGAETVWHRLQATDEIYFVLSGRGLVSVGDESGEVGPGDAVWIPAGVPQKIRALGSVPLTFLCACGPAYLPERDQRMGEAAVIGAWP,"18,585",177,,,nutrient reservoir activity [GO:0045735],,,,3
O05894,O05894_MYCTU,Rv3251c,rubA Rv3251c,GO:0005506; GO:0055114,IPR024934; IPR024935; IPR018527; ,,rubA,,Rubredoxin,iron ion binding [GO:0005506]; oxidation-reduction process [GO:0055114],9634230,,,MAAYRCPVCDYVYDEANGDAREGFPAGTGWDQIPDDWCCPDCAVREKVDFEKIGG,"6,107",55,Rubredoxin family,oxidation-reduction process [GO:0055114],iron ion binding [GO:0005506],,,,3
L0TCB8,L0TCB8_MYCTU,Rv3367,PE_PGRS51 Rv3367,,IPR000084; ,,PE_PGRS51,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS51,,9634230,,,MSFVVAVPEALAAAASDVANIGSALSAANAAAAAGTTGLLAAGADEVSAALASLFSGHAVSYQQVAAQATALHDQFVQALTGAGGSYALTEAANVQQNLLNAINAPTQALLGRPLIGDGAVGTASSPDGQDGGLLFGNGGAGYNSAATPGMAGGNGGNAGLIGNGGTGGSGGAGAAGGAGGSGGWLYGNGGNGGIGGNAIVAGGAGGNGGAGGAAGLWGSGGSGGQGGNGLTGNDGVNPAPVTNPALNGAAGDSNIEPQTSVLIGTQGGDGTPGGAGVNGGNGGAGGDANGNPANTSIANAGAGGNGAAGGDGGANGGAGGAGGQAASAGSSVGGDGGNGGAGGTGTNGHAGGAGGAGGAGGRGGWLVGNGGNGGNGAAGGNGAIGGTGGAGGVPANQGGNSALGTQPVGGDGGDGGNGGTGGTGGRGGDGGSGGAGGASGWLMGNGGNGGNGGTGGSGGVGGNGGIGGDGAGGGNATSTSSIPFDAHGGNGGAGGDAGHGGTGGDGGDGGHAGTGGRGGLLAGQHANSGNGGGGGTGGAGGTHGTPGSGNAGGTGTGNADSTNGGPGSDGLGGDAFNGSRGTDGNPG,"49,707",588,,,,,,,1
Q6MWZ8,Q6MWZ8_MYCTU,Rv3208A,TB9.4 Rv3208A,,IPR021456; ,,TB9.4,,Conserved protein TB9.4,,9634230; 21969609,,,MEVKIGITDSPRELVFSSAQTPSEVEELVSNALRDDSGLLTLTDERGRRFLIHTARIAYVEIGVADARRVGFGVGVDAAAGSAGKVATSG,"9,433",90,,,,,,,1
O53347,O53347_MYCTU,Rv3201c,Rv3201c,GO:0003677; GO:0004003; GO:0004527; GO:0005524; GO:0005576; GO:0005886; GO:0006281; GO:0040007,IPR014017; IPR000212; IPR027417; IPR038726; IPR011335; IPR014016; IPR034739; ,,,DOMAIN 22 356 UvrD-like helicase ATP-binding. {ECO:0000259|PROSITE:PS51198}.; DOMAIN 357 670 UvrD-like helicase C-terminal. {ECO:0000259|PROSITE:PS51217}.,Probable ATP-dependent DNA helicase,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527]; DNA repair [GO:0006281]; growth [GO:0040007],9634230,,,MTQTAAPARYSPAELACALGLFPPTAEQAAVIAAPPGPLVVIAGAGAGKTETMAARVVWLVANGYAEPGQVLGLTFTRKAAGQLLRRVRSRLARLAGIGLGCGDPAACAPVVSTYHAFAGSLLRDYGLLLPLEPDTRLLSETELWQLAFDVVSGYDGVLCTDKSPAAVTSIVVRLWGQLGEHLVDTRALRDTHVELERLVHALPAGRYQRDRGPSQWLLRMLATQTQRAELVPLLDALGERMHAGKVMDFAMQMASAARLAATSPQVGQDLRRRYRVVLLDEYQDTGHAQRVVLSSLFGGGVDDGLALTAVGDPIQSIYGWRGASATNLPRFTTDFPLSDGTPAPVLELLTSWRNPPQALRVANGISAEARRRSVAVRALRPRPDAPPGAVRCALLPDVQAEREWIADHLRMRYQRAEADGVKPPTAAVLVRRNADAAAIADTLRARGIPAEVVGLAGLLSIPEVAEVVAMLRLVADPTAGAAAMRVLTGPRWRLGARDLAALWRRALTLSGESPSTASPESIAMAASADADNPCLADAISDPGSAEGYSVAGYGRIGALAGELSALRGRLGHSLPDLVAEVRRVLGVDCEVRASAPVSGGWAGPEHLDAFADVVAGYAERASARSSEASVAGLLAYLDVAEVVENGLPPAELTVACDRVQVLTVHAAKGLEWQVVAVAHLSRGVFPSTVSRSSWLTDPAELPPLLRGDRASAGAHGIPVLDTSAVADRKQLSDKISEHRRLLDRRRVDEERRLLYVAVTRAEDTLLVSGHHWGPTGTKPRGPSEFLCELKDIIDRSAAAGDPCGVVEQWASAPAGDERNPLCDNAIEAVWPADPLAARRGDVERGAALVAAAMSADLPGSTTDIDHPPRPGDAPWSTDVDALLAERAHAARGAPARGLPNHLSVSSLVELVGDPVGARQRLMCRLPKRPDPHAWLGDAFHAWVQQFYGAELLFDLGDLPGAADREVGDPEELAALQRAFTASSWAARTPAAVEVPFEMPIGDTVVRGRIDAVFVDPDGGATVVDWKTGKPPHGPAAMRQAAVQLAVYRLAWAALRGCPTSSVRTAFYYVRSGITVVPDELPAPGELAMLLTDCAGRRSDT,"116,689",1101,"Helicase family, UvrD subfamily",DNA repair [GO:0006281]; growth [GO:0040007],ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; exonuclease activity [GO:0004527],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
L0TDU1,L0TDU1_MYCTU,Rv3331,sugI Rv3331,GO:0005351; GO:0016021,IPR020846; IPR005828; IPR036259; IPR003663; IPR005829; ,,sugI,DOMAIN 54 474 MFS. {ECO:0000259|PROSITE:PS50850}.,Probable sugar-transport integral membrane protein SugI,integral component of membrane [GO:0016021]; carbohydrate:proton symporter activity [GO:0005351],9634230,,,MTTLWQPHRNDYSPIPGRGVHARRGARRPRPRGGRAERPGTGQLTRSGRRALLVGLTAASVGVLYGYDLSAIAGALLSLSEEFELTTREQELLTTTAVLGQIAGALGGGILANAIGRKKSVVLIVAGYAVFALLGATSVSVPMLVVARLLLGVTIGLSVVVVPVYVAESAPAAVRGSLVTAYQLATLSGIVVGYLVGYLLAGSHGWRAMFGLAAAPATLLLPLLWRMPDTARWYLLKGRIADARSALRRIQPEADIDAELADMAAAVDERGGGIGEMVRRPYLRATLFVIALGFLVQITGINAIIYYSPRLFAAMGFAGYFAMLALPAMVQVAGLAAVCASLFLVDRLGRRPILLSGIATMITADAVLITVFANDSDGGTGLVLGFAGVLLFIIGFNFGFGSLVWVYAAESFPSRLRSMGSSPMLTSTLTANAIVAAFSLTMLRVLGGAGVFAVFGTFAVVAFVVVYRFAPETKGRKLEEIRHFWENGGRWPAERSPAADEP,"53,043",502,"Major facilitator superfamily, Sugar transporter (TC 2.A.1.1) family",,carbohydrate:proton symporter activity [GO:0005351],integral component of membrane [GO:0016021],,,1
O05888,O05888_MYCTU,Rv3243c,Rv3243c,GO:0005618; GO:0040007,,,,,Uncharacterized protein,cell wall [GO:0005618]; growth [GO:0040007],9634230; 21969609,,,MSPRVPRLRWDDPFRALDMLASLWSSTGMSLVSAGAAQAVAAPYRTLFTTLQQLLIGKEVTVRIGDHDVVLTVTELDSALEPQGLAVGQLGEVRVAARGISWDQHHLHSAVAVLRNVHIRPGVPPLVIAAPVELSSALPTEIFDDVLRQATPQLRGELSESGAARLRWARRPDWGGLEVDVDVAGTTSQTTLWLRPRTVITGQRRWTLPARTPAYRVPLPELPHGLRITDVSLAADCLQLSALLPEWRTELPLRYLESVITQLSQGALSFVWPPLRSGAD,"30,689",280,,growth [GO:0040007],,cell wall [GO:0005618],,,3
I6YG51,I6YG51_MYCTU,Rv3437,Rv3437,GO:0016021,IPR018929; ,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVGRAVPSPNRRYRRVWPPRTKGQHLSNPYAQHQLKLIRHTGALILWQQRTYVVSGTREQCEAAYKSAQTYNLLVGWWSLVSLLAMNWIALISNFNAIRRVRAAADGASVPHGPHAIAHPAVPRGPIPAGWYPDPSGAGLRYWDGATWTHWTHPPRHR,"17,877",158,,,,integral component of membrane [GO:0016021],,,1
O05854,O05854_MYCTU,Rv3212,Rv3212,GO:0005829; GO:0005886; GO:0016021,IPR011047; ,,,,Conserved alanine valine rich protein,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MVKPERRTKTDIAAAATIAVVVAVAASLIWWTSDARATISRPAAVAVPTPAPAREVPTSLKQLWTAASPATRVPVVVGGTVATGDGRQVDGRDPATGESLWSYARDTDLCGVTWVYHYAVAVYRYDRGCGQVSTIDGSTGRRGAARSGYADPRVRLFSDGTTVLSAGDTRLELWRSDMVRMLAYGEIDARVKPSNRGLQSGCTLESAAASSAAVSVLEACTNQADLRLVLLRPGKEDDEPIQRIVPEPGVRPGSGARVLVVSQNNTAVYLPARSGAQPRVDVIDETGATVSSTLLAKPPSTSAVASRTGNLVTWWTGDALLVFDAGNLTQRYTIAAGETTAPVGPGVMMAGQLLVPVTGGIGVYDPVSGANNRYIPVTRPPSTSAVIPAVSGSRVIEQRGDTLVALG,"42,506",407,,,,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O53377,O53377_MYCTU,Rv3327,Rv3327,GO:0003677; GO:0004803; GO:0006313,IPR029032; IPR003346; IPR002525; ,,,,Probable transposase fusion protein,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230; 21969609,,,MVVVGTDAHKYSHTFVATDEVGRQLGEKTVKATTAGHATAIMWAREQFGLELIWGIEDCRNMSARLERDLLAAGQQVVRVPTKLMAQTRKSARSRGKSDPIDALAVARAVLRETDLPLATHDETSRELKLLTDRRDVLVAQRTSAINRLRWLVHELDPERAPAARSLDAAKHQQALRTWLDTQPGLVAELARAELTDIIRLTGEINTLAQRISARVHQVAPALLEIPGCAELTAAKIVGEAAGVTRFKSEAAFACHAAVAPIPVWSGNTAGQMRLSRSGNRQLNAALHRIALTQIRMTDSRGQAYYQRLQDAGKTKRAALRCLKRRLARTVFQALRTVHQPSSEHTQPAAACHRSYCSSHLGEPPRLTDMTQKTRIQPLPPKRAGLLIRALYRIAKRRFGEVPEPFTVTAHHRRLLIANVVHEALLQRASRKLPPSVRELAVFWTARSIGCSWCVDFGAMLQRLDGLDVDRLTDIDNYATSSKFSDDERAAIAYAEAMTADPHSVTDEQVADLRARFGEAGVIELTYQIGVENMRARMNSALGITEQGFNSGDACRVPWAAPDVPSAESR,"62,961",570,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
O05873,O05873_MYCTU,Rv3228,Rv3228,GO:0003924; GO:0005525; GO:0005737; GO:0019843; GO:0042254; GO:0046872,IPR030378; IPR027417; IPR004881; IPR010914; ,,,DOMAIN 99 265 CP-type G. {ECO:0000259|PROSITE:PS51721}.; DOMAIN 118 263 EngC GTPase. {ECO:0000259|PROSITE:PS50936}.,Uncharacterized protein,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; ribosome biogenesis [GO:0042254],9634230; 21969609,,"FUNCTION: One of several proteins that assist in the late maturation steps of the functional core of the 30S ribosomal subunit. Helps release RbfA from mature subunits. May play a role in the assembly of ribosomal proteins into the subunit. Circularly permuted GTPase that catalyzes slow GTP hydrolysis, GTPase activity is stimulated by the 30S ribosomal subunit. {ECO:0000256|SAAS:SAAS00828801}.",MRPGDYDESDVKVRSGRSSRPRTKTRPEHADAEAAMVVSVDRGRWGCVLGGRPDRRITAMRARELGRTPIVVGDDVDVVGDLSGRPDTLARIVRRAPRRTVLRRTADDTDPTERVVVANADQLLIVVALADPPPRTGLVDRALIAAYAGGLTPILCLTKTDLAPAEPFGKQFADLELTVTAAGVDDPLLAVADLLAGKITVLLGHSGVGKSTLVNRLVPEADRAVGEVTEIGRGRHTSTRSVALPLGDTLSGSGWVIDTPGIRSFGLAHIQPDNVLLAFSDLAEATRECPRGCGHMGPPADPECALDTLSGPAARRAAAARRLLAVLSQT,"34,876",330,"TRAFAC class YlqF/YawG GTPase family, RsgA subfamily",ribosome biogenesis [GO:0042254],GTPase activity [GO:0003924]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843],cytoplasm [GO:0005737],,,1
O50382,O50382_MYCTU,Rv3353c,Rv3353c,,,,,,Uncharacterized protein,,9634230,,,MSRQTFLRGAVGAPATSAVFPTILARATPGDGWASLASSIGGQVLLPANGRAFTSGKQIFNSNYSGLNPAAVVTVASQADVRKAVS,"8,678",86,,,,,,,2
O86374,O86374_MYCTU,Rv3257c,pmmA Rv3257c,GO:0004614; GO:0004615; GO:0005975; GO:0009247; GO:0040007,IPR005844; IPR016055; IPR005845; IPR005846; IPR005843; IPR036900; IPR005841; ,,pmmA,,Probable phosphomannomutase PmmA (PMM) (Phosphomannose mutase),phosphoglucomutase activity [GO:0004614]; phosphomannomutase activity [GO:0004615]; carbohydrate metabolic process [GO:0005975]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007],9634230; 21969609,,,MSWPAAAVDRVIKAYDVRGLVGEEIDESLVTDLGAAFARLMRTEDARPVVIGHDMRDSSPSLADAFAAGVTGQGLDVVRVGLASTDQLYFASGLLDCPGAMFTASHNPAAYNGIKMCRAAAKPVGADTGLTAIRDDLIAGVARYDGTPGTIADQDVLVDYGAFLRSLVDTSGLRPLRVAVDAGNGMAGHTAPAVLGVIDSITLLPSYFELDGSFPNHEANPLDPANLVDLQAYVRDTGADIGLAFDGDADRCFVVDERGQPVSPSTVTALVAARELNREIGATIIHNVITSRAVPELVAERGGTPLRSRVGHSYIKALMAETGAIFGGEHSAHYYFRDFWGADSGMLAALHVLAALGEQSRPLSELTADYQRYESSGEINFTVVDSSACVEAVLKSFGNRIVSIDHLDGVTVDLGDDSWFNLRSSNTEPLLRLNVEGRSVGDVDAVVRQVSAEIAAQSAHAKAGP,"49,041",465,,carbohydrate metabolic process [GO:0005975]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007],phosphoglucomutase activity [GO:0004614]; phosphomannomutase activity [GO:0004615],,,,1
P96882,P96882_MYCTU,Rv3277,Rv3277,GO:0000271; GO:0016021,IPR007267; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; polysaccharide biosynthetic process [GO:0000271],9634230,,,MNEVTAGVRELATAIMVSRHLTGVLAGHGSQTVTYHFASILCSSVHSLVVSFADATIARLPGVVQPYAQRHHELIKFAIVGGTTFIIDTAIFYTLKLTVLEPKPVTAKVIAGIVAVIASYVLNREWSFRDRGGRERHHEALLFFAFSGVGVLLSMAPLWFSSYILQLRVPTVSLTMENIADFISAYIIGNLLQMAFRFWAFRRWVFPDEFARNPDKALESALTAGGIAEVFEDVLEGGFEDGNVTLLRAWRNRANRFAQLGDSSEPRVSKTS,"30,079",272,,polysaccharide biosynthetic process [GO:0000271],,integral component of membrane [GO:0016021],,,1
O53323,O53323_MYCTU,Rv3173c,Rv3173c,GO:0000976; GO:0003700; GO:0005829; GO:0005886,IPR009057; IPR001647; IPR036271; ,,,DOMAIN 16 76 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR/AcrR-family),cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MPPVTRTTEPPRRGGRGARQRILKAAAELFYCEGINATGVELIANKASVSKRTLYQHFPSKSALVEEYLRGLRQAAGEADKMPKASNATPRERLLALFDRPNRGDGRMRGCPFHNAAVEAAGEMPGVERIVHSHKRDYIKGLARLAREAGAAHPRSLGNQLAVLFEGAAALSTSLDDAGPWAHARAAAEVLIDQATARPV,"21,567",200,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
O53329,O53329_MYCTU,Rv3179,Rv3179,,IPR025420; IPR027417; ,,,,Conserved protein,,9634230; 21969609,,,MVHDEAGHELIERHMLEQLREVAEYTRVVLINGPRQAGKTTLLQQLHAELGGWLRSLDVDVERASARADPEGYIMSAPRPTFLDEVQCAGDPLILAIKTATDRDRRPRQFFLSGSTRFLTVPTLSESLAGRVAILDLWPLSVAERSGVRPEIIAQLFTEPQVVLGTEPAPVTRHEYLQLACAGGFPEVVQRPAGRARSRWFSDYLRTVTQRDVRELKRIEQTDRLPRFMRYLAAITAQELNVAEAARVIGVDAGTIRSDLALFETVYLVHRLPAWSRNLTAKIKKRSKIHVVDSGFAAWLRGQSADSLARPTAEGAGPIMETFVINELMKLRAATELEVDLYHFRDRDGREIDCILQTPDSRVVGVEVKASATVNVHDFRHLSFARDRLGDEFITGVLFYTGARALPFGDRLMALPINLLWNGQSVSSL,"48,053",429,,,,,,,3
O05796,O05796_MYCTU,Rv3120,Rv3120,GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Uncharacterized protein,cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MSPSPSALLADHPDRIRWNAKYECADPTEAVFAPISWLGDVLQFGVPEGPVLELACGRSGTALGLAAAGRCVTAIDVSDTALVQLELEATRRELADRLTLVHADLCSWQSGDGRFALVLCRLFWHPPTFRQACEAVAPGGVVAWEAWRRPIDVARDTRRAEWCLKPGQPESELPAGFTVIRVVDTDGSEPSRRIIAQRSL,"21,828",200,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cytoplasm [GO:0005737],,,1
I6YFP0,I6YFP0_MYCTU,Rv3279c,birA Rv3279c,GO:0004077; GO:0006464; GO:0008284; GO:0009374; GO:0032991; GO:0042803,IPR004408; IPR003142; IPR004143; ,,birA,,Possible bifunctional protein BirA: biotin operon repressor + biotin--[acetyl-CoA-carboxylase] synthetase (Biotin--protein ligase),protein-containing complex [GO:0032991]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; protein homodimerization activity [GO:0042803]; cellular protein modification process [GO:0006464]; positive regulation of cell proliferation [GO:0008284],9634230; 21969609; 24723382; 26299766; ,X-ray crystallography (11),,MTDRDRLRPPLDERSLRDQLIGAGSGWRQLDVVAQTGSTNADLLARAASGADIDGVVLIAEHQTAGRGRHGRGWAATARAQIILSVGVRVVDVPVQAWGWLSLAAGLAVLDSVAPLIAVPPAETGLKWPNDVLARGGKLAGILAEVAQPFVVLGVGLNVTQAPEEVDPDATSLLDLGVAAPDRNRIASRLLRELEARIIQWRNANPQLAADYRARSLTIGSRVRVELPGGQDVVGIARDIDDQGRLCLDVGGRTVVVSAGDVVHLR,"28,121",266,,cellular protein modification process [GO:0006464]; positive regulation of cell proliferation [GO:0008284],biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin binding [GO:0009374]; protein homodimerization activity [GO:0042803],protein-containing complex [GO:0032991],,,1
O53334,O53334_MYCTU,Rv3188,Rv3188,,IPR024467; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAVTLDRAVEASEIVDALKPFGVTQVDVAAVIQVSDRAVRGWRTGDIRPERYDRLAQLRDLVLLLSDSLTPRGVGQWLHAKNRLLDGQRPVDLLAKDRYEDVRSAAESFIDGAYV,"12,818",115,,,,,,,1
O53338,O53338_MYCTU,Rv3192,Rv3192,GO:0016705,IPR011251; IPR036661; ,,,,Conserved hypothetical alanine and proline-rich protein,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230,,,MIPQPLSQLGDLARRPGRRVLCSPKTAAPSISNATVASPAAPGLELSTGIALAFPRGPFVPAAAAWELQEATSGKFQLGLGTQVRKNVVHRYGMAFHRPGPRLRYLLAVKACFAVFQTGTPDHHGEFDNPDFITAQWSPARIDPPGPSPAGPR,"16,286",153,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,3
I6Y2Q7,I6Y2Q7_MYCTU,Rv3136A,Rv3136A,GO:0016021,,,,,Conserved protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MGWEFGVLLILIAVLAVFLAPRLIPRGPRGDLASGTLLVTGVSPRPDAGGQQYVTIAGIITGPTVNEYAVYQRMAVDVDQWPTVGQILPVVYSPKNPDNWTFTPNGPPVG,"11,728",110,,,,integral component of membrane [GO:0016021],,,1
L7N674,L7N674_MYCTU,Rv3116,moeB2 Rv3116,GO:0008641; GO:0016779,IPR001763; IPR036873; IPR000594; IPR035985; ,,moeB2,,Probable molybdenum cofactor biosynthesis protein MoeB2 (MPT-synthase sulfurylase) (Molybdopterin synthase sulphurylase),nucleotidyltransferase activity [GO:0016779]; ubiquitin-like modifier activating enzyme activity [GO:0008641],9634230; 21969609,,,MTEALIPAPSQISLTRDEVRRYSRHLIIPDIGVNGQQRLKDARVLCIGAGGLGSPALLYLAAAGVGTIGIIDGDHVDESNLQRQIIHGTSDVGRPKVESAAEAVAEINPHVRVTQYREMLTHDNALEIFGDHDLIVDGTDNFTTRYLINDAAVLAGKPYVWGSIYRFNGQTSVFWPGRGPCYRCLHPAPPPPGLVPSCAEGGVLGAICATIASIQVTEVLKLLTGVGTPLVGRLLMYEALDATYHQIRIAKNPDCAICGDAPTITELVDDSVSCASTQSVDPELVISCDELRTKQQSDQNFLLVDVREPAEFDIAHIPGSILIPKGEIGSAAGLAQLPLDKEIVLYCKSGIRSAQALTTLKAAGLHNVKHLDGGIAEWTRTIDSSLLVY,"41,668",389,,,nucleotidyltransferase activity [GO:0016779]; ubiquitin-like modifier activating enzyme activity [GO:0008641],,,,1
Q6MWX9,Q6MWX9_MYCTU,Rv3347c,PPE55 Rv3347c,GO:0052556,IPR002989; IPR000030; IPR038332; ,,PPE55,,PPE family protein PPE55,positive regulation by symbiont of host immune response [GO:0052556],9634230,,,MNFPVLPPEINSVLMYSGAGSSPLLAAAAAWDGLAEELGSAAVSFGQVTSGLTAGVWQGAAAAAMAAAAAPYAGWLGSVAAQAVAVAGQARAAVAAFEAALAATVDPAAVAVNRMAMRALAMSNLLGQNAAAIAAVEAEYELMWAADVAAMAGYHSGASAAAAALPAFSPPAQALGGGVGAFLNALFAGPAKMLRLNAGLGNVGNYNVGLGNVGIFNLGAANVGAQNLGAANAGSGNFGFGNIGNANFGFGNSGLGLPPGMGNIGLGNAGSSNYGLANLGVGNIGFANTGSNNIGIGLTGDNLTGIGGLNSGTGNLGLFNSGTGNIGFFNSGTGNFGVFNSGSYNTGVGNAGTASTGLFNVGGFNTGVANVGSYNTGSFNAGNTNTGGFNPGNVNTGWLNTGNTNTGIANSGNVNTGAFISGNFSNGVLWRGDYEGLWGLSGGSTIPAIPIGLELNGGVGPITVLPIQILPTIPLNIHQTFSLGPLVVPDIVIPAFGGGTAIPISVGPITISPITLFPAQNFNTTFPVGPFFGLGVVNISGIEIKDLAGNVTLQLGNLNIDTRINQSFPVTVNWSTPAVTIFPNGISIPNNPLALLASASIGTLGFTIPGFTIPAAPLPLTIDIDGQIDGFSTPPITIDRIPLNLGASVTVGPILINGVNIPATPGFGNTTTAPSSGFFNSGDGGVSGFGNFGAGSSGWWNQAQTEVAGAGSGFANFGSLGSGVLNFGSGVSGLYNTGGLPPGTPAVVSGIGNVGEQLSGLSSAGTALNQSLIINLGLADVGSVNVGFGNVGDFNLGAANIGDLNVGLGNVGGGNVGFGNIGDANFGLGNAGLAAGLAGVGNIGLGNAGSGNVGFGNMGVGNIGFGNTGTNNLGIGLTGDNQTGIGGLNSGAGNIGLFNSGTGNVGLFNSGTGNFGLFNSGSFNTGIGNGGTGSTGLFNAGNFNTGVANPGSYNTGSFNVGDTNTGGFNPGSINTGWFNTGNANTGVANSGNVDTGALMSGNFSNGILWRGNFEGLFGLNVGITIPEFPIHWTSTGGIGPIIIPDTTILPPIHLGLTGQANYGFAVPDIPIPAIHIDFDGAADAGFTAPATTLLSALGITGQFRFGPITVSNVQLNPFNVNLKLQFLHDAFPNEFPDPTISVQIQVAIPLTSATLGGLALPLQQTIDAIELPAISFSQSIPIDIPPIDIPASTINGISMSEVVPIDVSVDIPAVTITGTRIDPIPLNFDVLSSAGPINISIIDIPALPGFGNSTELPSSGFFNTGGGGGSGIANFGAGVSGLLNQASSPMVGTLSGLGNAGSLASGVLNSGVDISGMFNVSTLGSAPAVISGFGNLGNHVSGVSIDGLLAMLTSGGSGGSGQPSIIDAAIAELRHLNPLNIVNLGNVGSYNLGFANVGDVNLGAGNLGNLNLGGGNLGGQNLGLGNLGDGNVGFGNLGHGNVGFGNSGLGALPGIGNIGLGNAGSNNVGFGNMGLGNIGFGNTGTNNLGIGLTGDNQTGFGGLNSGAGNLGLFNSGTGNIGFFNTGTGNWGLFNSGSYNTGIGNSGTGSTGLFNAGSFNTGLANAGSYNTGSLNAGNTNTGGFNPGNVNTGWFNAGHTNTGGFNTGNVNTGAFNSGSFNNGALWTGDHHGLVGFSYSIEITGSTLVDINETLNLGPVHIDQIDIPGMSLFDIHELVNIGPFRIEPIDVPAVVLDIHETMVIPPIVFLPSMTIGGQTYTIPLDTPPAPAPPPFRLPLLFVNALGDNWIVGASNSTGMSGGFVTAPTQGILIHTGPSSATTGSLALTLPTVTIPTITTSPIPLKIDVSGGLPAFTLFPGGLNIPQNAIPLTIDASGVLDPITIFPGGFTIDPLPLSLALNISVPDSSVPIIIVPPTPGFGNATATPSSGFFNSGAGGVSGFGNFGAGSSGWWNQAHAALAGAGSGVLNVGTLNSGVLNVGSGISGLYNTAIVGLGTPALVSGAGNVGQQLSGVLAAGTALTQSPIINLGLADVGNYNLGLGNVGDFNLGAANLGDLNLGLGNIGNANVGFGNIGHGNVGFGNSGLGAALGIGNIGLGNAGSTNVGLANMGVGNIGFANTGTNNLGIGLTGDNQTGIGGLNSGAGNIGLFNSGTGNIGFFNSGTGNWGLFNSGSFNTGIGNSGTGSTGLFNAGGFTTGLANAGSYNTGSFNVGDTNTGGFNPGSINTGWFNTGNANTGIANSGNVDTGALMSGNFSNGILWRGNYEGLFSYSYSLDVPRITILDAHFTGAFGPVVVPPIPVLAINAHLTGNAAMGAFTIPQIDIPALNPNVTGSVGFGPIAVPSVTIPALTAARAVLDMAASVGATSEIEPFIVWTSSGAIGPTWYSVGRIYNAGDLFVGGNIISGIPTLSTTGPVHAVFNAASQAFNTPALNIHQIPLGFQVPGSIDAITLFPGGLTFPANSLLNLDVFVGTPGATIPAITFPEIPANADGELYVIAGDIPLINIPPTPGIGNTTTVPSSGFFNTGAGGGSGFGNFGANMSGWWNQAHTALAGAGSGIANVGTLHSGVLNLGSGLSGIYNTSTLPLGTPALVSGLGNVGDHLSGLLASNVGQNPITIVNIGLANVGNGNVGLGNIGNLNLGAANIGDVNLGFGNIGDVNLGFGNIGGGNVGFGNIGDANFGFGNSGLAAGLAGMGNIGLGNAGSGNVGWANMGLGNIGFGNTGTNNLGIGLTGDNQSGIGGLNSGTGNIGLFNSGTGNIGFFNSGTANFGLFNSGSYNTGIGNSGVASTGLVNAGGFNTGVANAGSYNTGSFNAGDTNTGGFNPGSTNTGWFNTGNANTGVANAGNVNTGALITGNFSNGILWRGNYEGLAGFSFGYPIPLFPAVGADVTGDIGPATIIPPIHIPSIPLGFAAIGHIGPISIPNIAIPSIHLGIDPTFDVGPITVDPITLTIPGLSLDAAVSEIRMTSGSSSGFKVRPSFSFFAVGPDGMPGGEVSILQPFTVAPINLNPTTLHFPGFTIPTGPIHIGLPLSLTIPGFTIPGGTLIPQLPLGLGLSGGTPPFDLPTVVIDRIPVELHASTTIGPVSLPIFGFGGAPGFGNDTTAPSSGFFNTGGGGGSGFSNSGSGMSGVLNAISDPLLGSASGFANFGTQLSGILNRGAGISGVYNTGTLGLVTSAFVSGFMNVGQQLSGLLFAGTGP,"309,558",3157,Mycobacterial PPE family,positive regulation by symbiont of host immune response [GO:0052556],,,,,1
I6XGJ1,I6XGJ1_MYCTU,Rv3190A,Rv3190A,,,,,,Conserved protein,,9634230; 21969609,,,MITVLDMNGFKDARPDRLPLSASVWDIAQRYNKGGPTVTEALYEALKELEAQVIALQRSEGKGLLSRLS,"7,633",69,,,,,,,1
I6YC49,I6YC49_MYCTU,Rv3439c,Rv3439c,,,,,,Conserved hypothetical alanine and proline rich protein,,9634230; 21969609,,,MADRLNVAERLAEGRPAAEHTQSYVRACHLVGYQHPDLTAYPAQIHDWYGSEDGLDLHALDADCAQLRAAASVLMEALRMERSQVAVLAAAWTGSGADAAVHFVQRHCETGNSVVTEVRAAAQRCESLRDNLWQLVDSKVATAIAIDERALAQRPAWLAAAEALTTEGADRPTAVEVVRQQIQPYVDDDVRNDWLTTMRSTTAGVAASYDAVTDQLASAPRAHFEIPDDLGPGRQPSPASVPAQPSATAAITPAAALPPPDPVPAVTSRPVTPSDFGSAPGDGSATPAGVGSAGGFGDAGGTGGLGGFAGLAGLANRIVDAVDSLLGSVAEQLGDPLAADNPPGAVDPFAEDAADNADDGDDAHPEEADEAAEPKEATEPDEADEVDDADESVPAERAQDVAEEATLPPVAEPPPPAAPPVAEPPPPVAAPAPPGAPEPANGPSPEALSEGATPCEIAADELPQAGP,"47,660",467,,,,,,,1
I6YFL7,I6YFL7_MYCTU,Rv3250c,rubB Rv3250c,GO:0005506; GO:0055114,IPR024934; IPR024935; IPR018527; ,,rubB,,Rubredoxin,iron ion binding [GO:0005506]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MNDYKLFRCIQCGFEYDEALGWPEDGIAAGTRWDDIPDDWSCPDCGAAKSDFEMVEVARS,"6,797",60,Rubredoxin family,oxidation-reduction process [GO:0055114],iron ion binding [GO:0005506],,,,1
O05896,O05896_MYCTU,Rv3253c,Rv3253c,GO:0005576; GO:0016021; GO:0022857,IPR002293; ,,,,Possible cationic amino acid transport integral membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; transmembrane transporter activity [GO:0022857],9634230,,,MAGRRRMKSVEQSIADTDEPTTRLRKDLTWWDLVVFGVSVVIGAGIFTVTASTAGDITGPAIWISFLIAAATCALAALCYAEFASTLPVAGSAYTFSYATFGEFLAWVIGWNLVLELAMGAAVVAKGWSSYLGTVFGFGNGTGHLGSLQLDWGALVIVTLVATLIALGTKLSSRFSAVVTAIKVSVVVLVVVVGAFYIRAANYSPFIPEPEVQHHGGGLDQSVFSLLTGAQGSHYGWYGVLAGASIVFFAFIGFDIVATMAEETKRPQRDVPRGILASLGVVTLLYVAVSVVLSGMVPYTQLRTVPGRGPANLATAFQANGVYWASGIISVGALAGLTTVVMVLMLGQCRVLFAMARDGLVPRQLAKTGSRGTPVRVTVLVAVLVATTASVFPITKLEEMVNVGTLFAFILVSAGVVVLRRTRPDLQRGFTAPWVPLLPIAAVCACLWLMLNLTALTWIRFGIWLVAGTAIYVGYGRRHSAQGLRQARESATRRC,"52,520",495,,,transmembrane transporter activity [GO:0022857],extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
P95187,P95187_MYCTU,Rv3139,fadE24 Rv3139,GO:0003995; GO:0005618; GO:0005886; GO:0040007; GO:0050660,IPR006089; IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE24,,Probable acyl-CoA dehydrogenase FadE24,cell wall [GO:0005618]; plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; growth [GO:0040007],9634230; 21969609,,,MTNTTSAANAAKPSGARTDRRGRTTGVGLAPHKRTGIDVALALLTPIVGQEFLDKYRLRDPLNRSLRYGVKTMFATAGAATRQFQRVQGLRGGPTRLKSSGRDYFDLTPDDDQKLIIETVDEFAEEVLRPAAHDADDAATYPSDLTAKAAELGITAINIPEDFDGIAEHRSSVTNVLVAEALAYGDMGLALPILAPGGVASALTHWGSADQQATYLKEFAGENVPQACVAITEPQPLFDPTRLKTTAVRTPSGYRLDGVKSLIPAAADAELFIVGAQLGGKPALFIVESAASGLTVKADPSMGIRGAALGQVELCGVSVPLNARLGEDEASDNDYSEALALARLGWAALAVGTSHAVLDYVVPYVKQRQAFGEPIAHRQAVAFMCANIAIELDGLRLITWRGASRAEQGLPFAREAALAKRLGSDKGMQIGLDGVQLLGGHGYTKEHPVERWYRDLRAIGVAEGVVVI,"49,646",468,Acyl-CoA dehydrogenase family,growth [GO:0040007],acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O53369,O53369_MYCTU,Rv3317,sdhD Rv3317,GO:0016020; GO:0016627,IPR034804; IPR000701; ,,sdhD,,Probable succinate dehydrogenase (Hydrophobic membrane anchor subunit) SdhD (Succinic dehydrogenase) (Fumarate reductase) (Fumarate dehydrogenase) (Fumaric hydrogenase),"membrane [GO:0016020]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MSAPVRQRSHDRPASLDNPRSPRRRAGMPNFEKFAWLFMRFSGVVLVFLAIGHVFIMLMWDNGVYRLDFNFVAQRWASPFWQTWDLLLLWLAQLHGGNGLRTIIDDYSRKDTTRFWLNSLLVLSMLFTLMLGTYVIVTFDPNIS,"16,887",144,,,"oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",membrane [GO:0016020],,,1
O53327,O53327_MYCTU,Rv3177,Rv3177,GO:0004601; GO:0040007,IPR029058; IPR000073; ,,,DOMAIN 40 272 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Possible peroxidase (Non-haem peroxidase),peroxidase activity [GO:0004601]; growth [GO:0040007],9634230,,,MPQRQAGDIGATYQDAPTKSINVGGTRFVYRRLGADAGVPVIFLHHLGAVLDNWDPRVVDGIAAKHPVVTFDNRGVGASEGQTPDTVTTMADDAIAFVRALGFDQVDLLGFSLGGFVAQVIAQQEPQLVRKIILAGTGPAGGVGIGKVTFGTIRESIKATLTFRDPKELRFFTRTDSGKSAARQFVKRLKERKDNRDKSITVRAFRSQLKAIHAWGTQKPSDLTSIGHPVLIANGDDDTMVPTSNSLDLADRLPDATLRIYPDAGHGGIFQHHAQFVDDALQFLES,"30,913",286,,growth [GO:0040007],peroxidase activity [GO:0004601],,,,3
P96872,P96872_MYCTU,Rv3267,Rv3267,GO:0005576; GO:0005886; GO:0040007,IPR027381; IPR004474; ,,,DOMAIN 95 264 LytR_cpsA_psr. {ECO:0000259|Pfam:PF03816}.; DOMAIN 365 449 LytR_C. {ECO:0000259|Pfam:PF13399}.,Conserved protein (CPSA-related protein),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MMSAQRVVRTVRTARAISTALAVAIVLGTGVAWSSVRSFEDGIFHMSAPSLGHGGDDGAIDILLVGLDSRTDAHGNPLSAEELATLHAGDEEATNTDTIILIRVPNNGKSATAISIPRDSYVAAPGLGKTKINGVYGQTRETKRAGLVQAGASPTEAAAAGTEAGREALIKTVADLTGVTVDHYAEIGLLGFALIADALGGVDVCLKEPVYEPLSGADFPAGRQKLNGPQALSFVRQRHDLPRGDLDRVVRQQAVMAALAHRVISGQTLSSPATLKRLEQAVQRSVVLSSGWDIMDFVRQLQKLAGGNVAFATIPVLDGAGWSDDGMQSVVRVDPRQVQDWVVGLLHEQDQGKTDELAYTPAKTTANVVNDTDINGLAAAVSKVLSSKGFTTGSVGNNDGDHVPGSQVRAAKADDLGAQQVAKELGGLPVVADASIAPGSVRVVLANDYSGPGSGLGGSDPNGVVSPARAFNLGSADDTTPPPSPILTAGSDAPECIN,"51,314",498,,growth [GO:0040007],,extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,2
O06334,O06334_MYCTU,Rv3469c,mhpE Rv3469c,GO:0003824,IPR013785; IPR000891; ,,mhpE,,Probable 4-hydroxy-2-oxovalerate aldolase MhpE (HOA),catalytic activity [GO:0003824],9634230,,,MLMTATHREPIVLDTTVRDGSYAVNFQYTDDDVRRIVGDLDAAGIPYIEIGHGVTIGAAAAQGPAAHTDEEYFRAARSVVRNARLGAVIVPALARIETVDLAGDYLDFLRICVIATEFELVMPFVERAQSKGLEVSIQLVKSHLFEPDVLAAAGKRARDVGVRIVYVVDTTGTFLPEDARRYVEALRGASDVSVGFHGHNNLAMAVANTLEAFDAGADFLDGTLMGFGRGAGNCQIECLVAALQRRGHLAAVDLDRIFDAARSDMLGRSPQSYGIDPWEISFGFHGLDSLQVEHLRAAAQQAGLSVSHVIRQTAKSHAGQWLSPQDIDRVVVGMRA,"36,297",336,,,catalytic activity [GO:0003824],,,,1
O05878,O05878_MYCTU,Rv3233c,Rv3233c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR009721; ,,,DOMAIN 49 191 DUF1298. {ECO:0000259|Pfam:PF06974}.,Possible triacylglycerol synthase (Diacylglycerol acyltransferase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230,,,MIAGALGNWLMSRGEAVAPTATVRAMAPLSVYADDQLDSTGPGQAISQVTPFLVDLPVGEGNAVVRLSQIAHATESNPTAASLVDARTIVTLSGLAPATLHAMGVRVATSFSARLFNLLITNAPGTQSQMYIAGTKLLETYSVPPLLHNQALAISVTSYNGMLYFGINADRDAMSDVDLLPGLLSQALDELLEASR,"20,481",196,,growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,3
O53337,O53337_MYCTU,Rv3191c,Rv3191c,GO:0003677; GO:0004803; GO:0005829; GO:0015074; GO:0032196; GO:0052562,IPR009057; IPR001584; IPR025246; IPR012337; ,,,,Probable transposase,cytosol [GO:0005829]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; DNA integration [GO:0015074]; negative regulation by symbiont of host immune response [GO:0052562]; transposition [GO:0032196],9634230,,,MRQISSRYLSEEERINIADLRRSGLSIRKIADQLGRAPSTVSRELRRNSRRDGQYRPFEAHRWAVQRRVRRHRRRIDKNPDLCELIAELLAQRWSPQQIARHLRRKYPDDRSMWLCHESIYQAVYQPQSRLIRPPQVKSPHRGPLRTGRTHRRAHLRPGRRRPRFAQPMLSIHQRPFDPADRSEPGHWEGDLIVGKNQGSAIGTLVERQTRLIRLLHLPTHDAYCLRIAITETMSDLPVTLVRSITWDQGIEMARHIDITADLGAPVYFCDSRSPWQRASNENSNGLLRQYFPKGTSLSTYTPDHLRAVEYEINNRPRQVLGHRSPAELFTALLTSPDHQLLRR,"40,304",344,,DNA integration [GO:0015074]; negative regulation by symbiont of host immune response [GO:0052562]; transposition [GO:0032196],DNA binding [GO:0003677]; transposase activity [GO:0004803],cytosol [GO:0005829],,,1
O05855,O05855_MYCTU,Rv3211,rhlE Rv3211,GO:0003676; GO:0004004; GO:0005524; GO:0005618; GO:0005737; GO:0010501,IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ,,rhlE,,Probable ATP-dependent RNA helicase RhlE,cell wall [GO:0005618]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; RNA secondary structure unwinding [GO:0010501],9634230; 21969609,,,MTAVKHTTESTFAKLGVRDEIVRALGEEGIKRPFAIQELTLPLALDGEDVIGQARTGMGKTFAFGVPLLQRITSGDGTRPLTGAPRALVVVPTRELCLQVTDDLATAGKYLTAGPDTDDAAAVRRRLSVVSIYGGRPYEPQIEALRAGADVVVGTPGRLLDLCQQGHLQLGGLSVLVLDEADEMLDLGFLPDIERILRQIPADRQSMLFSATMPDPIITLARTFMVRPTHIRAEAPHSSAVHDATEQFVYRAHALDKVELVSRVLQARDRGATMIFTRTKRTAQKVADELTERGFAVGAVHGDLGQLAREKALKAFRTGGIDVLVATDVAARGIDIDDVTHVINYQCPEDEKMYVHRIGRTGRAGRTGVAVTLVDWDELPRWSMIDQALGLGSPDPAETYSNSPHLYAELAIPATAGGTVGPARKSQGRRRDTDCDGQKTAQHARNTPRRRRTRGGKPVTGHPGTNPISSPIVGGDATSEPGSGTASDSGSDVVSGSRSGNGEAARRRRRRRRRPTHAQDGFAARAN,"56,703",527,DEAD box helicase family,RNA secondary structure unwinding [GO:0010501],ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
Q6MWZ4,Q6MWZ4_MYCTU,Rv3224B,Rv3224B,GO:0002161,IPR036754; IPR007214; ,,,,Uncharacterized protein,aminoacyl-tRNA editing activity [GO:0002161],9634230,,,MPKAAMAKPAAAEQATGYVVGGISPFGQRKRLRTVVDVSALSWDRVLRCRQTALGRHGGPAGPDHLDQRDHR,"7,790",72,,,aminoacyl-tRNA editing activity [GO:0002161],,,,1
O53316,O53316_MYCTU,Rv3166c,Rv3166c,GO:0016021,IPR025403; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MPGTKPGSDKPTGRVVVVIVLLMLAGAALRGHLPADDGAPLAAAGGSRAALMFIVAALAATLALIALAIITRLRHPLPVAPSAGELSAMLGGAAGRPNWRVLLLGLGTILAWLLIAILLARLFVPDDVGPAAPIPDSTATPDASSTTPSRPQPPQDNNDDVLGILFASTIGLFLMVVAGSLITSRRQRKSAPARISGDRIESPAPSARSESLARAAEIGLAEMADLRREPREAIIACYVAMERELSHVPGVAPQDFDTPTEVLARAVEHRALHGASAAALVSLFAEARFSPHVMNEEHREVAMRLLRLVLDELSTRTAI,"33,396",319,,,,integral component of membrane [GO:0016021],,,3
I6YG87,I6YG87_MYCTU,Rv3477,PE31 Rv3477,,IPR000084; ,,PE31,,PE family protein PE31,,9634230; 21969609,,,MSFTAQPEMLAAAAGELRSLGATLKASNAAAAVPTTGVVPPAADEVSLLLATQFRTHAATYQTASAKAAVIHEQFVTTLATSASSYADTEAANAVVTG,"9,795",98,,,,,,,1
O50410,O50410_MYCTU,Rv3383c,idsB Rv3383c,GO:0005829; GO:0008299; GO:0016740,IPR008949; IPR000092; IPR033749; ,,idsB,,Possible polyprenyl synthetase IdsB (Polyprenyl transferase) (Polyprenyl diphosphate synthase),cytosol [GO:0005829]; transferase activity [GO:0016740]; isoprenoid biosynthetic process [GO:0008299],9634230,,,MGGVLTLDAAFLGSVPADLGKALLERARADCGPVLHRAIESMREPLATMAGYHLGWWNADRSTAAGSSGKYFRAALVYAAAAACGGDVGDATPVSAAVELVHNFTLLHDDVMDGDATRRGRPTVWSVWGVGVAILLGDALHATAVRILTGLTDECVAVRAIRRLQMSCLDLCIGQFEDCLLEGQPEVTVDDYLRMAAGKTAALTGCCCALGALVANADDATIAALERFGHELGLAFQCVDDLIGIWGDPGVTGKPVGNDLARRKATLPVVAALNSRSEAATELAALYQAPAAMTASDVERATALVKVAGGGHVAQRCADERIQAAIAALPDAVRSPDLIALSQLICRREC,"36,432",350,FPP/GGPP synthase family,isoprenoid biosynthetic process [GO:0008299],transferase activity [GO:0016740],cytosol [GO:0005829],,,1
I6YC95,I6YC95_MYCTU,Rv3494c,mce4F Rv3494c,,IPR005693; IPR003399; ,,mce4F,,Mce-family protein Mce4F,,9634230; 21969609,,,MIDRLAKIQLSIFAVITVITLSVMAIFYLRLPATFGIGTYGVSADFVAGGGLYKNANVTYRGVAVGRVESVGLNPNGVTAHMRLNSGTAIPSNVTATVRSVSAIGEQYIDLVPPENPSSTKLRNGFRIQRQNTRIGQDVADLLRQAETLLGSLGDTRLRELLHEAFIATNGAGPELARLIESARLLVDEANANYPQVSQLIDQAGPFLQAQIRAGGDIKSLADGLARFTWQLRAADPRLRDTLADAPDAIDEANTAFSGIRPSFPALAASLANLGRVGVIYHKSIEQLLVVFPALFAAIITSAGGVPQDEGAKLDFKIDLHDPPPCMTGFLPPPLVRSPADESVREIPRDMYCKTAQNDPSTVRGARNYPCQEFPGKRAPTVQLCRDPRGYVPVGTNPWRGPPIPYGTEVTDGRNILPPNKFPYIPPGADPDPGVPIVGPPPPGQVAGPGPAPHQPAQPAPPPNDNGPPPPFTSWMPPGYPPEPPQVPYPATIPPPPPPEGTGPPPGPAPGPQPQASGPAYTIYDQLSGAFADPAGGTGIFAPGMTGASSAENWVDLMRDPRQL,"59,637",564,,,,,,,1
I6YC99,I6YC99_MYCTU,Rv3499c,mce4A Rv3499c,,IPR005693; IPR003399; IPR024516; ,,mce4A,,Mce-family protein Mce4A,,9634230; 21969609,,,MSGGGSRRTSVRVAAALLAGLMVGSAVLTYLSYTAAFTSTDTVTVSSPRAGLVMEKGAKVKYRGIQVGKVTDISYSGNQARLKLAIDSGEMGFIPSNATVRIAGNTIFGAKSVEFIPPKTPSPKPLSPNAHVAASQVQLEVNTLFQSLIDLLHKIDPLETNATLSALSEGLRGHGDDLGALLSGLNTLTRQANPKLPALQEDFRKAAVVANVYADAAGDLNTVFDNLPTINKTIVDQKDNLNDTLLATIGLSNNAYETLAPAEQNFIDAINRLRAPLKVTSDYSPVFGCLFKGIARGVKEFAPLIGVRKAGLFTSSSFVLGAPSYTYPESLPIVNASGGPNCRGLPDIPTKQTGGSFYRAPFLVTDNALIPYQPFTELQVDAPSTLQFLFNGAFAERDDF,"42,418",400,,,,,,,1
O53380,O53380_MYCTU,Rv3330,dacB1 Rv3330,GO:0004175; GO:0009002; GO:0016021,IPR012338; IPR018044; IPR001967; ,,dacB1,,Probable penicillin-binding protein DacB1 (D-alanyl-D-alanine carboxypeptidase) (DD-peptidase) (DD-carboxypeptidase) (PBP) (DD-transpeptidase) (Serine-type D-ala-D-ala carboxypeptidase) (D-amino acid...,integral component of membrane [GO:0016021]; endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002],9634230; 21969609; 25551456,X-ray crystallography (1),,MAFLRSVSCLAAAVFAVGTGIGLPTAAGEPNAAPAACPYKVSTPPAVDSSEVPAAGEPPLPLVVPPTPVGGNALGGCGIITAPGSAPAPGDVSAEAWLVADLDSGAVIAARDPHGRHRPASVIKVLVAMASINTLTLNKSVAGTADDAAVEGTKVGVNTGGTYTVNQLLHGLLMHSGNDAAYALARQLGGMPAALEKINLLAAKLGGRDTRVATPSGLDGPGMSTSAYDIGLFYRYAWQNPVFADIVATRTFDFPGHGDHPGYELENDNQLLYNYPGALGGKTGYTDDAGQTFVGAANRDGRRLMTVLLHGTRQPIPPWEQAAHLLDYGFNTPAGTQIGTLIEPDPSLMSTDRNPADRQRVDPQAAARISAADALPVRVGVAVIGALIVFGLIMVARAMNRRPQH,"41,682",405,Peptidase S11 family,,endopeptidase activity [GO:0004175]; serine-type D-Ala-D-Ala carboxypeptidase activity [GO:0009002],integral component of membrane [GO:0016021],,,1
I6X7F9,I6X7F9_MYCTU,Rv3488,Rv3488,,IPR005149; IPR036388; IPR036390; ,,,,Uncharacterized protein,,9634230; 21969609,,,MREFQRAAVRLHILHHAADNEVHGAWLTQELSRHGYRVSPGTLYPTLHRLEADGLLVSEQRVVDGRARRVYRATPAGRAALTEDRRALEELAREVLGGQSHTAGNGT,"11,928",107,,,,,,,1
O53317,O53317_MYCTU,Rv3167c,Rv3167c,GO:0003677; GO:0003700; GO:0006355,IPR009057; IPR001647; IPR011075; IPR036271; ,,,DOMAIN 20 80 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Probable transcriptional regulatory protein (Probably TetR-family),"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; regulation of transcription, DNA-templated [GO:0006355]",9634230; 21969609,,,MKADLPSLDKAPGAGRPRDPRIDSAILSATAELLVQIGYSNLSLAAVAERAGTTKSALYRRWSSKAELVHEAAFPAAPTALQAAAGDIAADIRMMIAATRDVFTTPVVRAALPGLVADMTADAELNARVLARFADLFAAVRMRLREAVDRGEAHPDVDPDRLIELIGGATMLRMLLYPDDMLDDAWVDQTTAIVVRGVHRAAPGGSVV,"22,095",208,,"regulation of transcription, DNA-templated [GO:0006355]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],,,,3
O53348,O53348_MYCTU,Rv3202c,Rv3202c,GO:0003677; GO:0004003; GO:0005524; GO:0005886,IPR013986; IPR014017; IPR000212; IPR027417; IPR038726; IPR014016; IPR034739; ,,,,Possible ATP-dependent DNA helicase,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677],9634230; 21969609,,,MSHIWGVEAGAALAPGLRGPVLVLGGPGTGKSTLLVEAAVAHIGAGTDPESVLLLTGSGRMGMRARSALTTALLRSRTNGPCRAAIREPVVRTVHSYAYAVLRKAAQRAGDALPRLLTSAEQDAIIRELLAGDAEDGPAATTTWPAHLRPALTTAGFATELRNLLARCAERGLDPLELQQLGRRRGRPEWIAAGQFAQRYEQVMLLRGAVGLAAPQATAPALSAAELVGAALEAFAVDPELLAAERARVRTLLVDDAQQLDPQAARLVRMLAAGTELALIAGDPNQAVFGFRGGEPTGLLADDPPPAGGAPIPSVTLTVSHRCAPAVARAVTGIARRLPGRSVGRRIEGTGTEVGSVTVRLAGSAHAEAAMIADALRRAHLIDGVPWSQMAVIVRSVPRAVRLPRALAAAGVPVAPPAVGGPLSAEPAVRALLTVLEATADGLDGDQALLLLTGPIGGVDPVSLRQLRRTLQRARPGQTSRKFGDLLVEVLGGDAPPSGPGSRALRRVRAVLTAAARCHRSGSLGGQDPRHTLWAAWQRSGLQRRWLAASEHGGAAAVQATRDLETVTALFDITDHYVSRTSGASLRGLVEHVTALQLPVVRPEPAAPTEQVMVLSAHAALGHEWDLVVIAGLQDGLWPNTVPRGGVLGTQRLLDELDGVTKDASMRAPLLAEERRLLVTAMGRARRRLLVTAVDSDAGGGGHEAVLPSAFFFEIAQWADGDGEPVAMQPVSAPRVLSAAAVVGRLRVVVCAPACAVDDADRDCAATQLARLAKAGVPGADPSEWHGLAPVSTSDPLCDSDDLVTLTPSTLQALNDCPLRWLAERHGGTNTRELPSAVGSVLHALFAEPGRSESQLLAELDRVWGHLPFGAQWYSANELARHRAMIQAFVQWRAQSRSELTEVGVEVDIDGALEDGSGQARKIRLRGRADRLERDPAGRLVIVDIKTGKTPVSKDDAQQHAQLAMYQLAVAEGLVRAGDEPGGARLVYVGKSGAAGVAERKQDPLTPAARDEWRNLVRQLAAATAGPQFIARRNDGCTHCPLRPGCPAHVRGSAP,"110,729",1055,"Helicase family, UvrD subfamily",,ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677],plasma membrane [GO:0005886],,,2
O50418,O50418_MYCTU,Rv3393,iunH Rv3393,GO:0005829; GO:0006152; GO:0008477,IPR023186; IPR001910; IPR036452; ,,iunH,,Probable nucleoside hydrolase IunH (Purine nucleosidase),cytosol [GO:0005829]; purine nucleosidase activity [GO:0008477]; purine nucleoside catabolic process [GO:0006152],9634230; 21969609,,,MSVVFADVDTGIDDALAVIYLLASPDADLVGIASTGGNIAVGQVCANNLSLLELCGAADIPVSKGADEPLGGRWPDHPKFHGPKGIGYAELPASNRRLTDYDATTAWIAAAHSHAGDLIGLVTGPLTNLALALRAEPALPRLLRRLVIMGGMFDGQPITEWNIRVDPEAASEVFTAWAGQRQLPIVCGLDLTRRVAMTPDILARLASVCGSSPVMRVIEDALRFYFESHEARGHGYLAYMHDPLAAAVAMDPELLTTRTATVDVDPTGATVTDWSGKRNPNARIGMSVDPAVFFDRFVERIGRFARRT,"32,970",308,,purine nucleoside catabolic process [GO:0006152],purine nucleosidase activity [GO:0008477],cytosol [GO:0005829],,,1
O50413,O50413_MYCTU,Rv3386,Rv3386,GO:0005886,IPR008490; ,,,,Possible transposase,plasma membrane [GO:0005886],9634230,,,MFRTVGDQASLWESVLPEELRRLPEELARVDALLDDSAFFCPFVPFFDPRMGRPSIPMETYLRLMFLKFRYRLGYESLCREVTDSITWRRFCRIPLEGSVPHPTTLMKLTTRCGEDAVAGLNEALLAKAASEKLLRTNKVRADTTVVEGDVGYPTDTGLLAKAVGSMARTVARIKAADAGSAPLGGSSGPRDRLQAAVTRRAATRSGAGLRAPDHRGASRDRRAGADRGCRGGT,"25,572",234,,,,plasma membrane [GO:0005886],,,1
O05892,O05892_MYCTU,Rv3249c,Rv3249c,GO:0000976; GO:0003700; GO:0005829,IPR009057; IPR001647; ,,,DOMAIN 22 82 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Possible transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609; 26396194,X-ray crystallography (1),,MSTPSATVAPVKRIPYAEASRALLRDSVLDAMRDLLLTRDWSAITLSDVARAAGISRQTIYNEFGSRQGLAQGYALRLADRLVDNVHASLDANVGNFYEAFLQGFRSFFAESAADPLVISLLTGVAKPDLLQLITTDSAPIITRASARLAPAFTDTWVATTDNDANVLSRAIVRLCLSYVSMPPEADHDVAADLARLITPFAERHGVINVP,"22,800",211,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
O50377,O50377_MYCTU,Rv3346c,Rv3346c,GO:0016021,IPR021385; ,,,,Conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MTVRAVLRRTVGAQWPILAGVNFWRRGALLIGIGVGVAAVLRLVLSEERAGLLVVRSKGIDFVTTVTVAAAMVYIASTIDPLGTG,"8,933",85,,,,integral component of membrane [GO:0016021],,,1
O53324,O53324_MYCTU,Rv3174,Rv3174,,IPR036291; IPR002347; ,,,,Probable short-chain dehydrogenase/reductase,,9634230,,,MTSLAERTVLVTGANRGMGREYVAQLLGRKVAKVYAATRNPLAIDVSDPRVIPLQLDVTDAVSVAEAADLATDVGILINNAGISRASSVLDKDTSALRGELETNLFGPLALASAFADRIAERSGAIVNVSSVLAWLPLGMSYGVSKAAMWSATESMRIELAPRGVQVVGVYVGLVDTDMGRFADAPKSDPADVVRQVLDGIEAGKEDVLADEMSRQVRASLNVPARERIARLMGN,"24,849",235,Short-chain dehydrogenases/reductases (SDR) family,,,,,,1
P95172,P95172_MYCTU,Rv3154,nuoJ Rv3154,GO:0005887; GO:0008137,IPR001457; ,,nuoJ,,Probable NADH dehydrogenase I (Chain J) NuoJ (NADH-ubiquinone oxidoreductase chain J),integral component of plasma membrane [GO:0005887]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],9634230; 21969609,,,MTAVLASDVIVRTSTGEAVMFWVLSALALLGAVGVVLAVNAVYSAMFLAMTMIILAVFYMAQDALFLGVVQVVVYTGAVMMLFLFVLMLIGVDSAESLKETLRGQRVAAVLTGVGFGVLLISTIGQVATRGFAGLTVANANGNVEGLAALIFSRYLWAFELTSALLITAAVGAMVLAHRERFERRKTQRELSQERFRPGGHPTPLPNPGVYARHNAVDVAALLPDGSYSELSVPRMLRTRGADGLQTPSPGAVSGSLEGGAS,"27,589",262,Complex I subunit 6 family,,NADH dehydrogenase (ubiquinone) activity [GO:0008137],integral component of plasma membrane [GO:0005887],,,1
P96234,P96234_MYCTU,Rv3348 Rv3844,Rv3348 Rv3844,GO:0003677; GO:0004803; GO:0006313,IPR002525; ,,,DOMAIN 14 160 DEDD_Tnp_IS110. {ECO:0000259|Pfam:PF01548}.,Possible transposase (Probable transposase),"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTAENPGRSRRTLVGIDAAITACHHIAIRDDVGARSIRFSVEPTLAGLRTLTDKLSGYDDIDATVEPTSMTWLPLTIAVENAGDTMHMAGARHCARLRGAIVGKSKSDVIDAEVLTRASEVFDLTPLTLPTPAQLALRRSVIRRAGAVIDANRSWRRLMSLAR,"17,671",163,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
P96354,P96354_MYCTU,Rv1047 Rv3023c Rv3115,Rv1047 Rv3023c Rv3115,GO:0003677; GO:0004803; GO:0006313,IPR001207; ,,,,Probable transposase,"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTSSHLIDAEQLLADQLAQASPDLLRGLLSTFIAALMGAEADALCGAGYRERSDERSNQRNGYRHRDFDTRAATIDVAIPKLRQGSYFPDWLLQRRKRAERALTSVVATCYLLGVSTRRMERLVETLGVTKLSKSQVSIMAKELDEAVEAFRTRPLDAGPYTFLAADALVLKVREAGRVVGVHTLIATGVNAEGYREILGIQVTSAEDGAGWLAFFRDLVARGLSGVALVTSDAHAGLVAAIGATLPAAAWQRCRTHYAANLMAATPKPSWPWVRTLLHSIYDQPDAESVVAQYDRVLDALTDKLPAVAEHLDTARTDLLAFTAFPKQIWRQIWSNNPQERLNREVRRRTDVVGIFPDRASIIRLVGAVLAEQHDEWIEGRRYLGLEVLTRARAALTSTEEPAKQQTTNTPALTT,"45,780",415,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,1
Q50655,Q50655_MYCTU,Rv0094c Rv3467,Rv0094c Rv3467,,IPR003870; IPR003615; ,,,DOMAIN 214 266 HNHc. {ECO:0000259|SMART:SM00507}.,Uncharacterized protein,,9634230,,,MSTRQAAEADLAGKAAQYRPDELARYAQRVMDWLHPDGDLTDTERARKRGITLSNQQYDGMSRLSGYLTPQARATFEAVLAKLAAPGATNPDDHTPVIDTTPDAAAIDRDTRSQAQRNHDGLLAGLRALIASGKLGQHNGLPVSIVVTTTLTDLQTGAGKGFTGGGTLLPMADVIRMTSHAHHYSPASGRYPQAIFDHGTPLALYHTKRLASPAQRIMLFANDRGCTKPGCDAPAYHSQAHHVTAWTSTGRTDITELTLACGPDNRLAEKGWTTHNNTHGHTEWLPPPHLDHGQPRTNTFHHPERFLHNQDDDDKPD,"34,567",317,,,,,,,1
P9WHJ9,RADA_MYCTU,Rv3585,radA Rv3585 MTV024.03,GO:0003684; GO:0005524; GO:0005829; GO:0006281; GO:0008094; GO:0046872,IPR003593; IPR004504; IPR027417; IPR020588; IPR020568; IPR014721; ,,radA,,DNA repair protein RadA (EC 3.6.4.-) (Branch migration protein RadA) (DNA repair protein Sms),cytosol [GO:0005829]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; metal ion binding [GO:0046872]; DNA repair [GO:0006281],9634230; 19099550; 21969609; 23760274,,"FUNCTION: DNA-dependent ATPase involved in processing of recombination intermediates, plays a role in repairing DNA breaks. Stimulates the branch migration of RecA-mediated strand transfer reactions, allowing the 3' invading strand to extend heteroduplex DNA faster. Binds ssDNA in the presence of ADP but not other nucleotides, has ATPase activity that is stimulated by ssDNA and various branched DNA structures, but inhibited by SSB. Does not have RecA's homology-searching function. {ECO:0000255|HAMAP-Rule:MF_01498}.",MANARSQYRCSECRHVSAKWVGRCLECGRWGTVDEVAVLSAVGGTRRRSVAPASGAVPISAVDAHRTRPCPTGIDELDRVLGGGIVPGSVTLLAGDPGVGKSTLLLEVAHRWAQSGRRALYVSGEESAGQIRLRADRIGCGTEVEEIYLAAQSDVHTVLDQIETVQPALVIVDSVQTMSTSEADGVTGGVTQVRAVTAALTAAAKANEVALILVGHVTKDGAIAGPRSLEHLVDVVLHFEGDRNGALRMVRGVKNRFGAADEVGCFLLHDNGIDGIVDPSNLFLDQRPTPVAGTAITVTLDGKRPLVGEVQALLATPCGGSPRRAVSGIHQARAAMIAAVLEKHARLAIAVNDIYLSTVGGMRLTEPSADLAVAIALASAYANLPLPTTAVMIGEVGLAGDIRRVNGMARRLSEAARQGFTIALVPPSDDPVPPGMHALRASTIVAALQYMVDIADHRGTTLATPPSHSGTGHVPLGRGT,"49,913",480,"RecA family, RadA subfamily",DNA repair [GO:0006281],ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; metal ion binding [GO:0046872],cytosol [GO:0005829],,MTV024.03,1
P9WGY3,RRAAH_MYCTU,Rv3853,rraA Rv3853 MTCY01A6.15c,GO:0008428; GO:0008948; GO:0046872; GO:0047443; GO:0051252,IPR010203; IPR005493; IPR036704; ,,rraA,,Putative 4-hydroxy-4-methyl-2-oxoglutarate aldolase (HMG aldolase) (EC 4.1.3.17) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.3) (Regulator of ribonuclease activity homolog) (RraA-like protein),4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; ribonuclease inhibitor activity [GO:0008428]; regulation of RNA metabolic process [GO:0051252],9634230; 19099550; 21969609; 12837779,X-ray crystallography (1),FUNCTION: Catalyzes the aldol cleavage of 4-hydroxy-4-methyl-2-oxoglutarate (HMG) into 2 molecules of pyruvate. Also contains a secondary oxaloacetate (OAA) decarboxylase activity due to the common pyruvate enolate transition state formed following C-C bond cleavage in the retro-aldol and decarboxylation reactions (By similarity). {ECO:0000250}.,MAISFRPTADLVDDIGPDVRSCDLQFRQFGGRSQFAGPISTVRCFQDNALLKSVLSQPSAGGVLVIDGAGSLHTALVGDVIAELARSTGWTGLIVHGAVRDAAALRGIDIGIKALGTNPRKSTKTGAGERDVEITLGGVTFVPGDIAYSDDDGIIVV,"16,235",157,Class II aldolase/RraA-like family,regulation of RNA metabolic process [GO:0051252],4-hydroxy-4-methyl-2-oxoglutarate aldolase activity [GO:0047443]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948]; ribonuclease inhibitor activity [GO:0008428],,,MTCY01A6.15c,1
P9WNE5,BFRB_MYCTU,Rv3841,bfrB ftn Rv3841,GO:0001666; GO:0004322; GO:0005506; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006826; GO:0006880; GO:0008199; GO:0033214; GO:0051409,IPR001519; IPR012347; IPR009040; IPR009078; IPR008331; ,,bfrB,DOMAIN 5 150 Ferritin-like diiron. {ECO:0000255|PROSITE-ProRule:PRU00085}.,Ferritin BfrB (EC 1.16.3.1) (Non-heme ferritin Ftn) (Nox19),cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506]; intracellular sequestering of iron ion [GO:0006880]; iron assimilation by chelation and transport [GO:0033214]; iron ion transport [GO:0006826]; response to hypoxia [GO:0001666]; response to nitrosative stress [GO:0051409],9634230; 9864257; 11416222; 12057942; 12065475; 18474359; 21139218; 21969609; 21494619,X-ray crystallography (2),"FUNCTION: Iron-storage protein that displays ferroxidase activity, catalyzing the oxidation of Fe(2+) ions into Fe(3+) ions, that can then be deposited as a ferric-oxide mineral core within the central cavity of the protein complex. {ECO:0000269|PubMed:21494619}.",MTEYEGPKTKFHALMQEQIHNEFTAAQQYVAIAVYFDSEDLPQLAKHFYSQAVEERNHAMMLVQHLLDRDLRVEIPGVDTVRNQFDRPREALALALDQERTVTDQVGRLTAVARDEGDFLGEQFMQWFLQEQIEEVALMATLVRVADRAGANLFELENFVAREVDVAPAASGAPHAAGGRL,"20,442",181,"Ferritin family, Prokaryotic subfamily",intracellular sequestering of iron ion [GO:0006880]; iron assimilation by chelation and transport [GO:0033214]; iron ion transport [GO:0006826]; response to hypoxia [GO:0001666]; response to nitrosative stress [GO:0051409],ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; iron ion binding [GO:0005506],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],ftn,,1
P9WKX3,BPA_MYCTU,Rv3780,bpa Rv3780 MTCY13D12.14,GO:0005618; GO:0005886; GO:0022624; GO:0051260; GO:0070628; GO:1901800,IPR019695; ,,bpa,,Bacterial proteasome activator,cell wall [GO:0005618]; plasma membrane [GO:0005886]; proteasome accessory complex [GO:0022624]; proteasome binding [GO:0070628]; positive regulation of proteasomal protein catabolic process [GO:1901800]; protein homooligomerization [GO:0051260],9634230; 21969609; 25469515,Electron microscopy (3); X-ray crystallography (5),"FUNCTION: Interacts with the core proteasome alpha-subunit (PrcA) through its C-terminal hydrophobic-tyrosine-X motif (HbYX motif). Interaction of Bpa with the proteasome stimulates proteosomal peptidase and casein degradation activity, which suggests Bpa could play a role in the removal of non-native or damaged proteins by influencing the conformation of the proteasome complex upon interaction. Can inhibit degradation of Pup-tagged substrates in vitro by competing with Mpa for association with the proteasome. {ECO:0000269|PubMed:25469515}.",MVIGLSTGSDDDDVEVIGGVDPRLIAVQENDSDESSLTDLVEQPAKVMRIGTMIKQLLEEVRAAPLDEASRNRLRDIHATSIRELEDGLAPELREELDRLTLPFNEDAVPSDAELRIAQAQLVGWLEGLFHGIQTALFAQQMAARAQLQQMRQGALPPGVGKSGQHGHGTGQYL,"18,944",174,Bpa family,positive regulation of proteasomal protein catabolic process [GO:1901800]; protein homooligomerization [GO:0051260],proteasome binding [GO:0070628],cell wall [GO:0005618]; plasma membrane [GO:0005886]; proteasome accessory complex [GO:0022624],,MTCY13D12.14,1
P9WGE1,RSFB_MYCTU,Rv3687c,rsfB Rv3687c,GO:0006351; GO:0006355; GO:0043856; GO:0045152,IPR003658; IPR002645; IPR036513; ,,rsfB,DOMAIN 7 115 STAS. {ECO:0000255|PROSITE-ProRule:PRU00198}.,Anti-sigma-F factor antagonist RsfB (Anti-anti-sigma F factor RsfB),"anti-sigma factor antagonist activity [GO:0043856]; antisigma factor binding [GO:0045152]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 12354223; 21969609,,"FUNCTION: Positive regulator of sigma-F (SigF) activity. Binds to anti-sigma-F factor RsbW (UsfX) preventing its binding to SigF, thus activating transcription. {ECO:0000269|PubMed:12354223}.",MSAPDSITVTVADHNGVAVLSIGGEIDLITAAALEEAIGEVVADNPTALVIDLSAVEFLGSVGLKILAATSEKIGQSVKFGVVARGSVTRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR,"12,651",122,Anti-sigma-factor antagonist family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",anti-sigma factor antagonist activity [GO:0043856]; antisigma factor binding [GO:0045152],,,,1
O07802,SAP_MYCTU,Rv3821 RVBD_3821,sap Rv3821 RVBD_3821 LH57_20825 P425_03979,GO:0005886; GO:0006869; GO:0016021; GO:0071555,IPR021315; ,,sap,,Sulfolipid-1 exporter Sap (Sulfolipid-1-addressing protein),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell wall organization [GO:0071555]; lipid transport [GO:0006869],9634230; 22194604,,"FUNCTION: Required for the transport across the inner membrane of sulfolipid-1 (SL-1), which is a major cell wall lipid of pathogenic mycobacteria. Could also transport SL1278 (2-palmitoyl-3-(C43)-phthioceranyl-alpha, alpha'-D-trehalose-2'-sulfate), which is the precursor of SL-1. May potentiate SL-1 levels and confer specificity for sulfolipids over structurally similar glycolipids. {ECO:0000269|PubMed:22194604}.",MWSTVLVLALSVICEPVRIGLVVLMLNRRRPLLHLLTFLCGGYTMAGGVAMVTLVVLGATPLAGHFSVAEVQIGTGLIALLIAFALTTNVIGKHVRRATHARVGDDGGRVLRESVPPSGAHKLAVRARCFLQGDSLYVAGVSGLGAALPSANYMGAMAAILASGATPATQALAVVTFNVVAFTVAEVPLVSYLAAPRKTRAFMAALQSWLRSRSRRDAALLVAAGGCLMLTLGLSNL,"24,627",237,Peptidoglycolipid addressing protein (GAP) (TC 2.A.116) family,cell wall organization [GO:0071555]; lipid transport [GO:0006869],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_20825 P425_03979,2
P9WHI3,RECR_MYCTU,Rv3715c,recR Rv3715c MTV025.063c,GO:0003677; GO:0006281; GO:0006310; GO:0046872,IPR000093; IPR003583; IPR023627; IPR023628; IPR015967; IPR006171; IPR034137; ,,recR,DOMAIN 79 179 Toprim. {ECO:0000255|HAMAP-Rule:MF_00017}.,Recombination protein RecR,DNA binding [GO:0003677]; metal ion binding [GO:0046872]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],9634230; 21969609,,FUNCTION: May play a role in DNA repair. It seems to be involved in an RecBC-independent recombinational process of DNA repair. It may act with RecF and RecO. {ECO:0000255|HAMAP-Rule:MF_00017}.,MFEGPVQDLIDELGKLPGIGPKSAQRIAFHLLSVEPSDIDRLTGVLAKVRDGVRFCAVCGNVSDNERCRICSDIRRDASVVCIVEEPKDIQAVERTREFRGRYHVLGGALDPLSGIGPDQLRIRELLSRIGERVDDVDVTEVIIATDPNTEGEATATYLVRMLRDIPGLTVTRIASGLPMGGDLEFADELTLGRALAGRRVLA,"22,119",203,RecR family,DNA recombination [GO:0006310]; DNA repair [GO:0006281],DNA binding [GO:0003677]; metal ion binding [GO:0046872],,,MTV025.063c,1
P9WFW1,SYC_MYCTU,Rv3580c,cysS cysS1 Rv3580c MTCY06G11.27c,GO:0004817; GO:0005524; GO:0005829; GO:0006423; GO:0040007; GO:0046872,IPR015803; IPR015273; IPR024909; IPR014729; IPR032678; IPR009080; ,,cysS,,Cysteine--tRNA ligase (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS),cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; cysteinyl-tRNA aminoacylation [GO:0006423]; growth [GO:0040007],9634230; 21969609,,,MTDRARLRLHDTAAGVVRDFVPLRPGHVSIYLCGATVQGLPHIGHVRSGVAFDILRRWLLARGYDVAFIRNVTDIEDKILAKAAAAGRPWWEWAATHERAFTAAYDALDVLPPSAEPRATGHITQMIEMIERLIQAGHAYTGGGDVYFDVLSYPEYGQLSGHKIDDVHQGEGVAAGKRDQRDFTLWKGEKPGEPSWPTPWGRGRPGWHLECSAMARSYLGPEFDIHCGGMDLVFPHHENEIAQSRAAGDGFARYWLHNGWVTMGGEKMSKSLGNVLSMPAMLQRVRPAELRYYLGSAHYRSMLEFSETAMQDAVKAYVGLEDFLHRVRTRVGAVCPGDPTPRFAEALDDDLSVPIALAEIHHVRAEGNRALDAGDHDGALRSASAIRAMMGILGCDPLDQRWESRDETSAALAAVDVLVQAELQNREKAREQRNWALADEIRGRLKRAGIEVTDTADGPQWSLLGGDTK,"51,855",469,Class-I aminoacyl-tRNA synthetase family,cysteinyl-tRNA aminoacylation [GO:0006423]; growth [GO:0040007],ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872],cytosol [GO:0005829],cysS1,MTCY06G11.27c,1
P9WFU9,SYK1_MYCTU,Rv3598c,lysS1 lysS Rv3598c MTCY07H7B.24,GO:0003676; GO:0004824; GO:0005524; GO:0005737; GO:0006430; GO:0040007; GO:0046872,IPR004364; IPR006195; IPR002313; IPR018149; IPR012340; IPR004365; ,,lysS1,,Lysine--tRNA ligase 1 (EC 6.1.1.6) (Lysyl-tRNA synthetase 1) (LysRS 1),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; growth [GO:0040007]; lysyl-tRNA aminoacylation [GO:0006430],9634230; 21969609,,,MSAADTAEDLPEQFRIRRDKRARLLAQGRDPYPVAVPRTHTLAEVRAAHPDLPIDTATEDIVGVAGRVIFARNSGKLCFATLQDGDGTQLQVMISLDKVGQAALDAWKADVDLGDIVYVHGAVISSRRGELSVLADCWRIAAKSLRPLPVAHKEMSEESRVRQRYVDLIVRPEARAVARLRIAVVRAIRTALQRRGFLEVETPVLQTLAGGAAARPFATHSNALDIDLYLRIAPELFLKRCIVGGFDKVFELNRVFRNEGADSTHSPEFSMLETYQTYGTYDDSAVVTRELIQEVADEAIGTRQLPLPDGSVYDIDGEWATIQMYPSLSVALGEEITPQTTVDRLRGIADSLGLEKDPAIHDNRGFGHGKLIEELWERTVGKSLSAPTFVKDFPVQTTPLTRQHRSIPGVTEKWDLYLRGIELATGYSELSDPVVQRERFADQARAAAAGDDEAMVLDEDFLAALEYGMPPCTGTGMGIDRLLMSLTGLSIRETVLFPIVRPHSN,"55,709",505,Class-II aminoacyl-tRNA synthetase family,growth [GO:0040007]; lysyl-tRNA aminoacylation [GO:0006430],ATP binding [GO:0005524]; lysine-tRNA ligase activity [GO:0004824]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],cytoplasm [GO:0005737],lysS,MTCY07H7B.24,1
O69721,TYRA_MYCTU,Rv3754 RVBD_3754,tyrA Rv3754 RVBD_3754 P425_03907,GO:0004665; GO:0006571; GO:0008977; GO:0055114; GO:0070403,IPR008927; IPR036291; IPR003099; ,,tyrA,DOMAIN 8 291 Prephenate/arogenate dehydrogenase. {ECO:0000255|PROSITE-ProRule:PRU00522}.,Prephenate dehydrogenase (PDH) (EC 1.3.1.12),NAD+ binding [GO:0070403]; prephenate dehydrogenase (NAD+) activity [GO:0008977]; prephenate dehydrogenase (NADP+) activity [GO:0004665]; oxidation-reduction process [GO:0055114]; tyrosine biosynthetic process [GO:0006571],9634230; 16889979; 21969609,,"FUNCTION: Catalyzes the NAD(+)-dependent conversion of prephenate to p-hydroxyphenylpyruvate, with the elimination of carbon dioxide. Is a key regulatory enzyme in tyrosine biosynthesis. Displays no chorismate mutase (CM) activity, in contrast to TyrA from E.coli and some other bacteria, that are bifunctional and possess a CM domain. {ECO:0000269|PubMed:16889979}.",MTRTVAAPPVCVLGLGLIGGSIMRAAAAAGREVFGYNRSVEGAHGARSDGFDAITDLNQTLTRAAATEALIVLAVPMPALPGMLAHIRKSAPGCPLTDVTSVKCAVLDEVTAAGLQARYVGGHPMTGTAHSGWTAGHGGLFNRAPWVVSVDDHVDPTVWSMVMTLALDCGAMVVPAKSDEHDAAAAAVSHLPHLLAEALAVTAAEVPLAFALAAGSFRDATRVAATAPDLVRAMCEANTGQLAPAADRIIDLLSRARDSLQSHGSIADLADAGHAARTRYDSFPRSDIVTVVIGADKWREQLAAAGRAGGVITSALPSLDSPQ,"33,099",323,Prephenate/arogenate dehydrogenase family,oxidation-reduction process [GO:0055114]; tyrosine biosynthetic process [GO:0006571],NAD+ binding [GO:0070403]; prephenate dehydrogenase (NAD+) activity [GO:0008977]; prephenate dehydrogenase (NADP+) activity [GO:0004665],,,P425_03907,4
P9WJ15,VPB48_MYCTU,Rv3697A,vapB48 Rv3697A,,,,vapB48,,Putative antitoxin VapB48,,9634230; 20011113,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC48. {ECO:0000305|PubMed:20011113}.,MRTTIDLDDDILRALKRRQREERKTLGQLASELLAQALAAEPPPNVDIRWSTADLRPRVDLDDKDAVWAILDRG,"8,465",74,,,,,,,1
O69717,VPB50_MYCTU,Rv3750c RVBD_3750c,vapB50 Rv3750c RVBD_3750c LH57_20430 P425_03902,GO:0003677,IPR009061; IPR010093; ,,vapB50,,Putative antitoxin VapB50,DNA binding [GO:0003677],9634230; 24662523,,FUNCTION: Possibly the antitoxin component of a type II toxin-antitoxin (TA) system. Its cognate toxin is VapC50. {ECO:0000305|PubMed:24662523}.,MTSLLEVLGAPEVSVCGNAGQPMTLPEPVRDALYNVVLALSQGKGISLVPRHLKLTTQEAADLLNISRPTLVRLLEDGRIPFEKPGRHRRVSLDALLEYQQETRSNRRAALGELSRDALGELQAALAEKK,"14,219",130,,,DNA binding [GO:0003677],,,LH57_20430 P425_03902,1
P9WF37,WHIB6_MYCTU,Rv3862c,whiB6 Rv3862c,GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0046872; GO:0051539,IPR034768; IPR003482; ,,whiB6,DOMAIN 33 86 4Fe-4S Wbl-type.,Probable transcriptional regulator WhiB6,"cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 19016840; 22780904,,"FUNCTION: Acts as a transcriptional regulator. Probably redox-responsive. The apo- but not holo-form probably binds DNA (By similarity). The apo-form has been shown to act as a protein disulfide reductase. {ECO:0000250, ECO:0000269|PubMed:19016840}.",MRYAFAAEATTCNAFWRNVDMTVTALYEVPLGVCTQDPDRWTTTPDDEAKTLCRACPRRWLCARDAVESAGAEGLWAGVVIPESGRARAFALGQLRSLAERNGYPVRDHRVSAQSA,"12,792",116,WhiB family,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]",cytoplasm [GO:0005737],,,1
P9WF39,WHIB4_MYCTU,Rv3681c,whiB4 Rv3681c,GO:0003677; GO:0005618; GO:0005737; GO:0006351; GO:0006355; GO:0046872; GO:0047134; GO:0051539; GO:0090034,IPR034768; IPR003482; ,,whiB4,DOMAIN 36 92 4Fe-4S Wbl-type.,Transcriptional regulator WhiB4,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein-disulfide reductase activity [GO:0047134]; regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 17302817; 19016840; 22780904,,"FUNCTION: Redox-responsive transcriptional regulator that regulates a set of genes involved in protection against environmental stresses encountered during infection. The loss of the O(2) and NO-responsive 4Fe-4S cluster and subsequent redox modifications of Cys residue thiols (possibly by disulfide bond formation) may activate its role in gene regulation. The thiol-oxidized apo-form binds in a sequence non-specific manner to GC-rich DNA, probably in the minor groove. Represses transcription of a number of genes including itself. The reduced apo-form and holo-form do not bind DNA. The apo-form can act as protein disulfide reductase. {ECO:0000269|PubMed:17302817, ECO:0000269|PubMed:19016840, ECO:0000269|PubMed:22780904}.",MSGTRPAARRTNLTAAQNVVRSVDAEERIAWVSKALCRTTDPDELFVRGAAQRKAAVICRHCPVMQECAADALDNKVEFGVWGGMTERQRRALLKQHPEVVSWSDYLEKRKRRTGTAG,"13,211",118,WhiB family,"regulation of chaperone-mediated protein complex assembly [GO:0090034]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]","4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; protein-disulfide reductase activity [GO:0047134]",cell wall [GO:0005618]; cytoplasm [GO:0005737],,,1
P9WF47,VPC48_MYCTU,Rv3697c,vapC48 Rv3697c,GO:0004540; GO:0046872,IPR006226; IPR029060; IPR002716; IPR022907; ,,vapC48,DOMAIN 15 141 PINc. {ECO:0000255|HAMAP-Rule:MF_00265}.,Ribonuclease VapC48 (RNase VapC48) (EC 3.1.-.-) (Toxin VapC48),metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],9634230; 20011113; 21969609,,"FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. Its cognate antitoxin is VapB48. {ECO:0000255|HAMAP-Rule:MF_00265, ECO:0000305|PubMed:20011113}.",MSETFDVDVLVHATHRASPFHDKAKTLVERFLAGPGLVYLLWPVALGYLRVVTHPTLLGAPLAPEVAVENIEQFTSRPHVRQVGEANGFWPVYRRVADPVKPRGNLVPDAHLVALMRHHGIATIWSHDRDFRKFEGIRIRDPFSG,"16,345",145,PINc/VapC protein family,,metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540],,,,1
L0TGF0,VPC50_MYCTU,Rv3749c,vapC50 Rv3749c LH57_20425,GO:0004518,,,vapC50,,Putative ribonuclease VapC50 (RNase VapC50) (EC 3.1.-.-) (Toxin VapC50),nuclease activity [GO:0004518],9634230; 21969609; 24662523,,FUNCTION: Toxic component of a type II toxin-antitoxin (TA) system. An RNase. The cognate antitoxin is VapB50. {ECO:0000305|PubMed:24662523}.,MPCCGSLTRAPIGLCGRRTSWPRLGEPWSTASTSAPNGLTTAFAFGYNDLIAAMNNHYKDRHVLAAAVRERAEVIVTTNLKHFPDDALKPYQIKALHPDDFLLDQLDLYEEATKAVILGMVDAYIDPPFTPHSLLDALGEQVPQFAAKARRLFPSGSPFGLGVLLPFDQ,"18,523",169,,,nuclease activity [GO:0004518],,,LH57_20425,1
P9WGE7,SODF_MYCTU,Rv3846,sodB sod sodA Rv3846 MTCY01A6.22c,GO:0004784; GO:0005506; GO:0005576; GO:0005829; GO:0005886; GO:0006979; GO:0009405; GO:0042597; GO:0052059,IPR001189; IPR019833; IPR019832; IPR019831; IPR036324; IPR036314; ,,sodB,,Superoxide dismutase [Fe] (EC 1.15.1.1),cytosol [GO:0005829]; extracellular region [GO:0005576]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; iron ion binding [GO:0005506]; superoxide dismutase activity [GO:0004784]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; pathogenesis [GO:0009405]; response to oxidative stress [GO:0006979],1904126; 9933629; 9634230; 20066036; 21969609; 7877174; 8674528; 9490054; 11747311,X-ray crystallography (5),FUNCTION: Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems.,MAEYTLPDLDWDYGALEPHISGQINELHHSKHHATYVKGANDAVAKLEEARAKEDHSAILLNEKNLAFNLAGHVNHTIWWKNLSPNGGDKPTGELAAAIADAFGSFDKFRAQFHAAATTVQGSGWAALGWDTLGNKLLIFQVYDHQTNFPLGIVPLLLLDMWEHAFYLQYKNVKVDFAKAFWNVVNWADVQSRYAAATSQTKGLIFG,"23,034",207,Iron/manganese superoxide dismutase family,evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; pathogenesis [GO:0009405]; response to oxidative stress [GO:0006979],iron ion binding [GO:0005506]; superoxide dismutase activity [GO:0004784],cytosol [GO:0005829]; extracellular region [GO:0005576]; periplasmic space [GO:0042597]; plasma membrane [GO:0005886],sod sodA,MTCY01A6.22c,1
P9WKH7,TS57_MYCTU,Rv1313c; Rv3798,Rv1313c MTCY373.33c; Rv3798 MTV026.03,GO:0003677; GO:0005618; GO:0005886; GO:0006310; GO:0032196,IPR002560; IPR032877; IPR029261; ,,; ,,Transposase for insertion sequence element IS1557,cell wall [GO:0005618]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA recombination [GO:0006310]; transposition [GO:0032196],9634230,,,MRNVRLFRALLGVDKRTVIEDIEFEEDDAGDGARVIARVRPRSAVLRRCGRCGRKASWYDRGAGLRQWRSLDWGTVEVFLEAEAPRVNCPTHGPTVVAVPWARHHAGHTYAFDDTVAWLAVACSKTAVCELMRIAWRTVGAIVARVWADTEKRIDRFANLRRIGIDEISYKRHHRYLTVVVDHDSGRLVWAAPGHDKATLGLFFDALGAERAAQITHVSADAADWIADVVTERCPDAIQCADPFHVVAWATEALDVERRRAWNDARAIARTEPKWGRGRPGKNAAPRPGRERARRLKGARYALWKNPEDLTERQSAKLAWIAKTDPRLYRAYLLKESLRHVFSVKGEEGKQALDRWISWAQRCRIPVFVELAARIKRHRVAIDAALDHGLSQGLIESTNTKIRLLTRIAFGFRSPQALIALAMLTLAGHRPTLPGRHNHPQISQ,"50,186",444,Transposase 12 family,DNA recombination [GO:0006310]; transposition [GO:0032196],DNA binding [GO:0003677],cell wall [GO:0005618]; plasma membrane [GO:0005886],; ,MTCY373.33c; MTV026.03,1
P9WG49,TOP1_MYCTU,Rv3646c,topA Rv3646c MTCY15C10.06,GO:0000287; GO:0003677; GO:0003917; GO:0005618; GO:0005829; GO:0005886; GO:0006265; GO:0040007; GO:0060701,IPR000380; IPR003601; IPR023406; IPR013497; IPR013824; IPR013825; IPR013826; IPR023405; IPR003602; IPR005733; IPR028612; IPR025589; IPR006171; IPR034149; ,,topA,DOMAIN 18 142 Toprim. {ECO:0000255|HAMAP-Rule:MF_00952}.,DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I) (Omega-protein) (Relaxing enzyme) (Swivelase) (Untwisting enzyme),cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; magnesium ion binding [GO:0000287]; DNA topological change [GO:0006265]; growth [GO:0040007]; negative regulation of ribonuclease activity [GO:0060701],9634230; 8921893; 19099550; 20724443; 21969609,X-ray crystallography (1),"FUNCTION: Releases the supercoiling and torsional tension of DNA, which is introduced during the DNA replication and transcription, by transiently cleaving and rejoining one strand of the DNA duplex (PubMed:8921893, PubMed:20724443). Introduces a single-strand break via transesterification at a target site in duplex DNA. The scissile phosphodiester is attacked by the catalytic tyrosine of the enzyme, resulting in the formation of a DNA-(5'-phosphotyrosyl)-enzyme intermediate and the expulsion of a 3'-OH DNA strand. The free DNA strand then undergoes passage around the unbroken strand, thus removing DNA supercoils. Finally, in the religation step, the DNA 3'-OH attacks the covalent intermediate to expel the active-site tyrosine and restore the DNA phosphodiester backbone. {ECO:0000255|HAMAP-Rule:MF_00952, ECO:0000269|PubMed:20724443, ECO:0000269|PubMed:8921893}.; FUNCTION: The C-terminus (residues 622-934) inhibits RNA cleavage by MazF4. {ECO:0000269|PubMed:20724443}.",MADPKTKGRGSGGNGSGRRLVIVESPTKARKLASYLGSGYIVESSRGHIRDLPRAASDVPAKYKSQPWARLGVNVDADFEPLYIISPEKRSTVSELRGLLKDVDELYLATDGDREGEAIAWHLLETLKPRIPVKRMVFHEITEPAIRAAAEHPRDLDIDLVDAQETRRILDRLYGYEVSPVLWKKVAPKLSAGRVQSVATRIIVARERDRMAFRSAAYWDILAKLDASVSDPDAAPPTFSARLTAVAGRRVATGRDFDSLGTLRKGDEVIVLDEGSATALAAGLDGTQLTVASAEEKPYARRPYPPFMTSTLQQEASRKLRFSAERTMSIAQRLYENGYITYMRTDSTTLSESAINAARTQARQLYGDEYVAPAPRQYTRKVKNAQEAHEAIRPAGETFATPDAVRRELDGPNIDDFRLYELIWQRTVASQMADARGMTLSLRITGMSGHQEVVFSATGRTLTFPGFLKAYVETVDELVGGEADDAERRLPHLTPGQRLDIVELTPDGHATNPPARYTEASLVKALEELGIGRPSTYSSIIKTIQDRGYVHKKGSALVPSWVAFAVTGLLEQHFGRLVDYDFTAAMEDELDEIAAGNERRTNWLNNFYFGGDHGVPDSVARSGGLKKLVGINLEGIDAREVNSIKLFDDTHGRPIYVRVGKNGPYLERLVAGDTGEPTPQRANLSDSITPDELTLQVAEELFATPQQGRTLGLDPETGHEIVAREGRFGPYVTEILPEPAADAAAAAQGVKKRQKAAGPKPRTGSLLRSMDLQTVTLEDALRLLSLPRVVGVDPASGEEITAQNGRYGPYLKRGNDSRSLVTEDQIFTITLDEALKIYAEPKRRGRQSASAPPLRELGTDPASGKPMVIKDGRFGPYVTDGETNASLRKGDDVASITDERAAELLADRRARGPAKRPARKAARKVPAKKAAKRD,"102,336",934,Type IA topoisomerase family,DNA topological change [GO:0006265]; growth [GO:0040007]; negative regulation of ribonuclease activity [GO:0060701],DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; magnesium ion binding [GO:0000287],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY15C10.06,1
P9WHR9,Y3671_MYCTU,Rv3671c,Rv3671c,GO:0004252; GO:0005576; GO:0005618; GO:0005886; GO:0005887; GO:0009403; GO:0009405; GO:0010447,IPR003825; IPR009003; IPR001940; IPR033116; ,,,DOMAIN 193 384 Peptidase S1. {ECO:0000305}.,Serine protease Rv3671c (EC 3.4.21.-),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; pathogenesis [GO:0009405]; response to acidic pH [GO:0010447]; toxin biosynthetic process [GO:0009403],9634230; 18641659; 21969609; 20947023,X-ray crystallography (3),"FUNCTION: Required for M.tuberculosis resistance to oxidative stress in addition to its role in resistance to acid, which is essential for virulence. It protects M.tuberculosis against phagolysosomal concentrations of acid and maintains its intrabacterial pH when phagocytosed by IFN-gamma-activated macrophages. {ECO:0000269|PubMed:18641659, ECO:0000269|PubMed:20947023}.",MTPSQWLDIAVLAVAFIAAISGWRAGALGSMLSFGGVLLGATAGVLLAPHIVSQISAPRAKLFAALFLILALVVVGEVAGVVLGRAVRGAIRNRPIRLIDSVIGVGVQLVVVLTAAWLLAMPLTQSKEQPELAAAVKGSRVLARVNEAAPTWLKTVPKRLSALLNTSGLPAVLEPFSRTPVIPVASPDPALVNNPVVAATEPSVVKIRSLAPRCQKVLEGTGFVISPDRVMTNAHVVAGSNNVTVYAGDKPFEATVVSYDPSVDVAILAVPHLPPPPLVFAAEPAKTGADVVVLGYPGGGNFTATPARIREAIRLSGPDIYGDPEPVTRDVYTIRADVEQGDSGGPLIDLNGQVLGVVFGAAIDDAETGFVLTAGEVAGQLAKIGATQPVGTGACVS,"40,721",397,Peptidase S1C family,pathogenesis [GO:0009405]; response to acidic pH [GO:0010447]; toxin biosynthetic process [GO:0009403],serine-type endopeptidase activity [GO:0004252],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
O69659,Y3691_MYCTU,Rv3691,Rv3691,GO:0005886; GO:0016021,IPR025646; ,,,,Uncharacterized membrane protein Rv3691,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 21969609,,,MGAGPVIPTRLATVRRRRPWRGVLLTLAAVAVVASIGTYLTAPRPGGAMAPASTSSTGGHALATLLGNHGVEVVVADSIADVEAAARPDSLLLVAQTQYLVDNALLDRLAKAPGDLLLVAPTSRTRTALTPQLRIAAASPFNSQPNCTLREANRAGSVQWGPSDTYQATGDLVLTSCYGGALVRFRAEGRTITVVGSSNFMTNGGLLPAGNAALAMNLAGNRPRLVWYAPDHIEGEMSSPSSLSDLIPENVHWTIWQLWLVVLLVALWKGRRIGPLVAEELPVVIRASETVEGRGRLYRSRRARDRAADALRTATLQRLRPRLGVGAGAPAPAVVTTIAQRSKADPPFVAYHLFGPAPATDNDLLQLARALDDIERQVTHS,"40,442",381,,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,4
P9WKA5,Y3740_MYCTU,Rv3740c,Rv3740c MTV025.088c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0010025; GO:0019432; GO:0044119; GO:0047196; GO:0071731,IPR014292; IPR023213; IPR009721; IPR004255; ,,,,Putative diacyglycerol O-acyltransferase Rv3740c (EC 2.3.1.20) (Putative triacylglycerol synthase Rv3740c),cell wall [GO:0005618]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432]; wax biosynthetic process [GO:0010025],9634230; 15262939; 19099550,,"FUNCTION: Upon expression in E.coli has a weak triacylglycerol synthase function, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Also functions weakly as a wax synthase, as it incorporates palmityl alcohol into wax esters in the presence of palmitoyl-CoA.",MSPIDALFLSAESREHPLHVGALQLFEPPAGAGRGFVRETYQAMLQCREIAPLFRKRPTSLHGALINLGWSTDADVDLGYHARRSALPAPGRVRELLELTSRLHSNLLDRHRPLWETHVIEGLRDGRFAIYSKMHHALVDGVSGLTLMRQPMTTDPIEGKLRTAWSPATQHTAIKRRRGRLQQLGGMLGSVAGLAPSTLRLARSALIEQQLTLPFGAPHTMLNVAVGGARRCAAQSWPLDRVKAVKDAAGVSLNDVVLAMCAGALREYLDDNDALPDTPLVAMVPVSLRTDRDSVGGNMVGAVLCNLATHLDDPADRLNAIHASMRGNKNVLSQLPRAQALAVSLLLLSPAALNTLPGLAKATPPPFNVCISNVPGAREPLYFNGARMVGNYPMSLVLDGQALNITLTSTADSLDFGVVGCRRSVPHVQRVLSHLETSLKELERAVGL,"48,353",448,Long-chain O-acyltransferase family,glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432]; wax biosynthetic process [GO:0010025],diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV025.088c,1
P9WKW5,Y3835_MYCTU,Rv3835,Rv3835,GO:0005576; GO:0005618; GO:0005886; GO:0016021,IPR026004; ,,,,Uncharacterized membrane protein Rv3835,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 11929527; 16735741; 17443846; 21969609,,FUNCTION: May play a role in septum formation. {ECO:0000269|PubMed:16735741}.,MLDAPEQDPVDPGDPASPPHGEAEQPLPGPRWPRALRASATRRALLLTALGGLLIAGLVTAIPAVGRAPERLAGYIASNPVPSTGAKINASFNRVASGDCLMWPDGTPESAAIVSCADEHRFEVAESIDMRTFPGMEYGQNAAPPSPARIQQISEEQCEAAVRRYLGTKFDPNSKFTISMLWPGDRAWRQAGERRMLCGLQSPGPNNQQLAFKGKVADIDQSKVWPAGTCLGIDATTNQPIDVPVDCAAPHAMEVSGTVNLAERFPDALPSEPEQDGFIKDACTRMTDAYLAPLKLRTTTLTLIYPTLTLPSWSAGSRVVACSIGATLGNGGWATLVNSAKGALLINGQPPVPPPDIPEERLNLPPIPLQLPTPRPAPPAQQLPSTPPGTQHLPAQQPVVTPTRPPESHAPASAAPAETQPPPPDAGAPPATQSPEATPPGPAEPAPAG,"47,043",449,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WMT3,Y3659_MYCTU,Rv3659c,Rv3659c,GO:0000746; GO:0005524; GO:0005737,IPR022399; IPR027417; IPR001482; ,,,,Putative conjugal transfer protein Rv3659c,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; conjugation [GO:0000746],9634230; 12657046; 16573683,,,MLGDTEVLANLRVLQTELTGAGILEPLLSADGTTDVLVTAPDSVWVDDGNGLRRSQIRFADESAVRRLAQRLALAAGRRLDDAQPWVDGQLTGIGVGGFAVRLHAVLPPVATQGTCLSLRVLRPATQDLAALAAAGAIDPAAAALVADIVTARLAFLVCGGTGAGKTTLLAAMLGAVSPDERIVCVEDAAELAPRHPHLVKLVARRANVEGIGEVTVRQLVRQALRMRPDRIVVGEVRGAEVVDLLAALNTGHEGGAGTVHANNPGEVPARMEALGALGGLDRAALHSQLAAAVQVLLHVARDRAGRRRLAEIAVLRQAEGRVQAVTVWHADRGMSDDAAALHDLLRSRASA,"36,691",352,GSP E family,conjugation [GO:0000746],ATP binding [GO:0005524],cytoplasm [GO:0005737],,,1
O69726,Y3760_MYCTU,Rv3760,Rv3760,GO:0005887,IPR010445; ,,,,Uncharacterized membrane protein Rv3760,integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MTSNPSSSADQPLSGTTVPGSVPGKAPEEPPVKFTRAAAVWSALIVGFLILILLLIFIAQNTASAQFAFFGWRWSLPLGVAILLAAVGGGLITVFAGTARILQLRRAAKKTHAAALR,"12,196",117,,,,integral component of plasma membrane [GO:0005887],,,4
P72042,Y3776_MYCTU,Rv3776,Rv3776,GO:0005886,IPR003870; IPR003615; ,,,,Uncharacterized protein Rv3776,plasma membrane [GO:0005886],9634230,,,MFEISLSDPVELRDADDAALLAAIEDCARAEVAAGARRLSAIAELTSRRTGNDQRADWACDGWDCAAAEVAAALTVSHRKASGQMHLSLTLNRLPQVAALFLAGQLSARLVSIIAWRTYLVRDPEALSLLDAALAKHATAWGPLSAPKLEKAIDSWIDRYDPAALRRTRISARSRDLCIGDPDEDAGTAALWGRLFATDAAMLDKRLTQLAHGVCDDDPRTIAQRRADALGALAAGADRLTCGCGNSDCPSSAGNHRQATGVVIHVVADAAALGAAPDPRLSGPEPALAPEAPATPAVKPPAALISGGGVVPAPLLAELIRGGAALSRMRHPGDLRSEPHYRPSAKLAEFVRIRDMTCRFPGCDQPTEFCDIDHTLPYPLGPTHPSNLKCLCRKHHLLKTFWTGWRDVQLPDGTIIWTAPNGHTYTTHPDSRIFLPSWHTTTAALPPAPSPPAIGPTHTLLMPRRRRTRAAELAHRIKRERAHVTQRNKPPPSGGDTAVAEGFEPPDGVSRLSLSRRVH,"55,692",519,,,,plasma membrane [GO:0005886],,,1
P9WFH5,Y3874_MYCTU,Rv3767c,Rv3767c,GO:0005886; GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv3767c (EC 2.1.1.-),plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MPRTDNDSWAITESVGATALGVAAARAAETESDNPLINDPFARIFVDAAGDGIWSMYTNRTLLAGATDLDPDLRAPIQQMIDFMAARTAFFDEYFLATADAGVRQVVILASGLDSRAWRLPWPDGTVVYELDQPKVLEFKSATLRQHGAQPASQLVNVPIDLRQDWPKALQKAGFDPSKPCAWLAEGLVRYLPARAQDLLFERIDALSRPGSWLASNVPGAGFLDPERMRRQRADMRRMRAAAAKLVETEISDVDDLWYAEQRTAVAEWLRERGWDVSTATLPELLARYGRSIPHSGEDSIPPNLFVSAQRATS,"34,755",314,UPF0677 family,,methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
P9WPW1,Y3551_MYCTU,Rv3551,Rv3551 MTCY03C7.05c,GO:0008152; GO:0008410; GO:0044117,IPR004165; IPR037171; ,,,,Putative CoA-transferase subunit alpha Rv3551 (EC 2.8.3.-),CoA-transferase activity [GO:0008410]; growth of symbiont in host [GO:0044117]; metabolic process [GO:0008152],9634230; 21969609,,FUNCTION: Probable subunit of a CoA-transferase composed of Rv3551 and Rv3552.,MPDKRTALDDAVAQLRSGMTIGIAGWGSRRKPMAFVRAILRSDVTDLTVVTYGGPDLGLLCSAGKVKRVYYGFVSLDSPPFYDPWFAHARTSGAIEAREMDEGMLRCGLQAAAQRLPFLPIRAGLGSSVPQFWAGELQTVTSPYPAPGGGYETLIAMPALRLDAAFAHLNLGDSHGNAAYTGIDPYFDDLFLMAAERRFLSVERIVATEELVKSVPPQALLVNRMMVDAIVEAPGGAHFTTAAPDYGRDEQFQRHYAEAASTQVGWQQFVHTYLSGTEADYQAAVHNFGASR,"31,723",292,3-oxoacid CoA-transferase subunit A family,growth of symbiont in host [GO:0044117]; metabolic process [GO:0008152],CoA-transferase activity [GO:0008410],,,MTCY03C7.05c,1
P9WNR9,Y3716_MYCTU,Rv3716c,Rv3716c MTV025.064c,GO:0003677; GO:0005737; GO:0005886; GO:0009295,IPR036894; IPR004401; ,,,,Nucleoid-associated protein Rv3716c,cytoplasm [GO:0005737]; nucleoid [GO:0009295]; plasma membrane [GO:0005886]; DNA binding [GO:0003677],9634230; 11681203; 21969609,,"FUNCTION: Binds to DNA and alters its conformation. May be involved in regulation of gene expression, nucleoid organization and DNA protection. {ECO:0000255|HAMAP-Rule:MF_00274}.",MQPGGDMSALLAQAQQMQQKLLEAQQQLANSEVHGQAGGGLVKVVVKGSGEVIGVTIDPKVVDPDDIETLQDLIVGAMRDASQQVTKMAQERLGALAGAMRPPAPPAAPPGAPGMPGMPGMPGAPGAPPVPGI,"13,357",133,YbaB/EbfC family,,DNA binding [GO:0003677],cytoplasm [GO:0005737]; nucleoid [GO:0009295]; plasma membrane [GO:0005886],,MTV025.064c,1
P9WQ67,Y3778_MYCTU,Rv3778c,Rv3778c,GO:0003824; GO:0005618; GO:0005886; GO:0040007,IPR000192; IPR011340; IPR015424; IPR015422; IPR015421; ,,,,Uncharacterized protein Rv3778c,cell wall [GO:0005618]; plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; growth [GO:0040007],9634230; 12657046; 19099550; 21969609; ,X-ray crystallography (1),FUNCTION: Is essential for optimal growth.,MAYDVARVRGLHPSLGDGWVHFDAPAGMLIPDSVATTVSTAFRRSGASTVGAHPSARRSAAVLDAAREAVADLVNADPGGVVLGADRAVLLSLLAEASSSRAGLGYEVIVSRLDDEANIAPWLRAAHRYGAKVKWAEVDIETGELPTWQWESLISKSTRLVAVNSASGTLGGVTDLRAMTKLVHDVGALVVVDHSAAAPYRLLDIRETDADVVTVNAHAWGGPPIGAMVFRDPSVMNSFGSVSTNPYATGPARLEIGVHQFGLLAGVVASIEYLAALDESARGSRRERLAVSMQSADAYLNRVFDYLMVSLRSLPLVMLIGRPEAQIPVVSFAVHKVPADRVVQRLADNGILAIANTGSRVLDVLGVNDVGGAVTVGLAHYSTMAEVDQLVRALASLG,"41,852",398,Class-V pyridoxal-phosphate-dependent aminotransferase family,growth [GO:0040007],catalytic activity [GO:0003824],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WH21,Y3818_MYCTU,Rv3818,Rv3818,GO:0016491; GO:0046872; GO:0051537,IPR036866; IPR017941; IPR036922; ,,,DOMAIN 429 516 Rieske. {ECO:0000255|PROSITE-ProRule:PRU00628}.,Putative Rieske 2Fe-2S iron-sulfur protein Rv3818 (EC 1.-.-.-),"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",9634230; 19099550; 21969609,,,MQVTSVGHAGFLIQTQAGSILCDPWVNPAYFASWFPFPDNSGLDWGALGECDYLYVSHLHKDHFDAENLRAHVNKDAVVLLPDFPVPDLRNELQKLGFHRFFETTDSVKHRLRGPNGDLDVMIIALRAPADGPIGDSALVVADGETTAFNMNDARPVDLDVLASEFGHIDVHMLQYSGAIWYPMVYDMPARAKDAFGAQKRQRQMDRARQYIAQVGATWVVPSAGPPCFLAPELRHLNDDGSDPANIFPDQMVFLDQMRAHGQDGGLLMIPGSTADFTGTTLNSLRHPLPAEQVEAIFTTDKAAYIADYADRMAPVLAAQKAGWAAAAGEPLLQPLRTLFEPIMLQSNEICDGIGYPVELAIGPETIVLDFPKRAVREPIPDERFRYGFAIAPELVRTVLRDNEPDWVNTIFLSTRFRAWRVGGYNEYLYTFFKCLTDERIAYADGWFAEAHDDSSSITLNGWEIQRRCPHLKADLSKFGVVEGNTLTCNLHGWQWRLDDGRCLTARGHQLRSSRP,"57,647",516,,,"2 iron, 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]",,,,1
P9WPV9,Y3552_MYCTU,Rv3552,Rv3552 MTCY03C7.03c,GO:0008152; GO:0008410; GO:0044117,IPR004165; IPR037171; ,,,,Putative CoA-transferase subunit beta Rv3552 (EC 2.8.3.-),CoA-transferase activity [GO:0008410]; growth of symbiont in host [GO:0044117]; metabolic process [GO:0008152],9634230; 21969609,,FUNCTION: Probable subunit of a CoA-transferase composed of Rv3551 and Rv3552.,MSTRAEVCAVACAELFRDAGEIMISPMTNMASVGARLARLTFAPDILLTDGEAQLLADTPALGKTGAPNRIEGWMPFGRVFETLAWGRRHVVMGANQVDRYGNQNISAFGPLQRPTRQMFGVRGSPGNTINHATSYWVGNHCKRVFVEAVDVVSGIGYDKVDPDNPAFRFVNVYRVVSNLGVFDFGGPDHSMRAVSLHPGVTPGDVRDATSFEVHDLDAAEQTRLPTDDELHLIRAVIDPKSLRDREIRS,"27,393",250,3-oxoacid CoA-transferase subunit B family,growth of symbiont in host [GO:0044117]; metabolic process [GO:0008152],CoA-transferase activity [GO:0008410],,,MTCY03C7.03c,1
P9WFY5,Y3579_MYCTU,Rv3579c,Rv3579c,GO:0000453; GO:0003723; GO:0005829; GO:0040007; GO:0070039,IPR029028; IPR029064; IPR004441; IPR001537; IPR013123; IPR029026; ,,,,Uncharacterized tRNA/rRNA methyltransferase Rv3579c (EC 2.1.1.-),cytosol [GO:0005829]; RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; growth [GO:0040007],9634230; 19099550; 21969609,,,MPGNSRRRGAVRKSGTKKGAGVGSGGQRRRGLEGRGPTPPAHLRPHHPAAKRARAQPRRPVKRADETETVLGRNPVLECLRAGVPATALYVALGTEADERLTECVARAADSGIAIVELLRADLDRMTANHLHQGIALQVPPYNYAHPDDLLAAALDQPPALLVALDNLSDPRNLGAIVRSVAAFGGHGVLIPQRRSASVTAVAWRTSAGAAARIPVARATNLTRTLKGWADRGVRVIGLDAGGGTALDDVDGTDSLVVVVGSEGKGLSRLVRQNCDEVVSIPMAAQAESLNASVAAGVVLAEIARQRRRPREPREQTQNRMI,"34,010",322,"Class IV-like SAM-binding methyltransferase superfamily, RNA methyltransferase TrmH family",enzyme-directed rRNA 2'-O-methylation [GO:0000453]; growth [GO:0040007],RNA binding [GO:0003723]; rRNA (guanosine-2'-O-)-methyltransferase activity [GO:0070039],cytosol [GO:0005829],,,1
P9WKX9,Y3630_MYCTU,Rv3630,Rv3630 MTCY15C10.22c,GO:0005576; GO:0005886; GO:0016021,,,,,Uncharacterized protein Rv3630,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MAVGAAAVTEVGDTASPVGSSGASGGAIASGSVARVGTAAAVTALCGYAVIYLAARNLAPNGFSVFGVFWGAFGLVTGAANGLLQETTREVRSLGYLDVSADGRRTHPLRVSGMVGLGSLVVIAGSSPLWSGRVFAEARWLSVALLSIGLAGFCLHATLLGMLAGTNRWTQYGALMVADAVIRVVVAAATFVIGWQLVGFIWATVAGSVAWLIMLMTSPPTRAAARLMTPGATATFLRGAAHSIIAAGASAILVMGFPVLLKLTSNELGAQGGVVILAVTLTRAPLLVPLTAMQGNLIAHFVDERTERIRALIAPAALIGGVGAVGMLAAGVVGPWIMRVAFGSEYQSSSALLAWLTAAAVAIAMLTLTGAAAVAAALHRAYSLGWVGATVGSGLLLLLPLSLETRTVVALLCGPLVGIGVHLVALARTDE,"43,485",431,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY15C10.22c,1
P9WI89,Y3633_MYCTU,Rv3633,Rv3633 MTCY15C10.19c,GO:0005886,IPR008775; ,,,,Uncharacterized protein Rv3633,plasma membrane [GO:0005886],9634230; 21969609,,,MTQSSSVERLVGEIDEFGYTVVEDVLDADSVAAYLADTRRLERELPTVIANSTTVVKGLARPGHVPVDRVDHDWVRIDNLLLHGTRYEALPVHPKLLPVIEGVLGRDCLLSWCMTSNQLPGAVAQRLHCDDEMYPLPRPHQPLLCNALIALCDFTADNGATQVVPGSHRWPERPSPPYPEGKPVEINAGDALIWNGSLWHTAAANRTDAPRPALTINFCVGFVRQQVNQQLSIPRELVRCFEPRLQELIGYGLYAGKMGRIDWRPPADYLDADRHPFLDAVADRLQTSVRL,"32,447",291,PhyH family,,,plasma membrane [GO:0005886],,MTCY15C10.19c,1
P9WKX7,Y3660_MYCTU,Rv3660c,Rv3660c,GO:0005829; GO:0040007,IPR022521; IPR027417; ,,,,Uncharacterized protein Rv3660c,cytosol [GO:0005829]; growth [GO:0040007],9634230; 12657046; 16735741; 19099550,,FUNCTION: May play a role in septum formation. {ECO:0000269|PubMed:16735741}.,MLTDPGLRDELDRVAAAVGVRVVHLGGRHPVSRKTWSAAAAVVLDHAAADRCGRLALPRRTHVSVLTGTEAATATWAAAITVGAQHVLRMPEQEGELVRELAEAAESARDDGICGAVVAVIGGRGGAGASLFAVALAQAAADALLVDLDPWAGGIDLLVGGETAPGLRWPDLALQGGRLNWSAVRAALPRPRGISVLSGTRRGYELDAGPVDAVIDAGRRGGVTVVCDLPRRLTDATQAALDAADLVVLVSPCDVRACAAAATMAPVLTAINPNLGLVVRGPSPGGLRAAEVADVAGVPLLASMRAQPRLAEQLEHGGLRLRRRSVLASAARRVLGVLPRAGSGRHGRAA,"35,807",350,,growth [GO:0040007],,cytosol [GO:0005829],,,1
P9WGJ1,Y3661_MYCTU,Rv3661,Rv3661 MTV025.009,GO:0005829; GO:0005886; GO:0016021; GO:0016787; GO:0046872,IPR036412; IPR006385; IPR023214; ,,,,Probable phosphatase Rv3661 (EC 3.1.3.-),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 21969609,,,MTVSDSPAQRQTPPQTPGGTAPRARTAAFFDLDKTIIAKSSTLAFSKPFFAQGLLNRRAVLKSSYAQFIFLLSGADHDQMDRMRTHLTNMCAGWDVAQVRSIVNETLHDIVTPLVFAEAADLIAAHKLCGRDVVVVSASGEEIVGPIARALGATHAMATRMIVEDGKYTGEVAFYCYGEGKAQAIRELAASEGYPLEHCYAYSDSITDLPMLEAVGHASVVNPDRGLRKEASVRGWPVLSFSRPVSLRDRIPAPSAAAIATTAAVGISALAAGAVTYALLRRFAFQP,"30,711",287,"HAD-like hydrolase superfamily, SerB family",,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTV025.009,1
O69731,Y3766_MYCTU,Rv3766 RVBD_3766,Rv3766 RVBD_3766 P425_03919,,IPR017853; ,,,,Uncharacterized protein Rv3766,,9634230; 21969609,,,MTDTLFADVSEYQVPVNNSYPYRVLSIRVCDGTYRDRNFAHNYRWMRSAFDSGRLTFGIVYTYARPNWWANANTVRSMIDAAGGLHPRVALMLDVESGGNPPGDGSSWINRLYWNLADYAGSPVRIIGYANAYDFFNMWRVRPAGLRVIGAGYGSNPNLPGQVAHQYTDGSGYSPNLPQGAPPFGRCDMNSANGLTPQQFAAACGVTTTGGPLMALTDEEQTELLTKVREIWDQLRGPNGAGWPQLGQNEQGQDLTPVDAIAVIKNDVAAMLAE,"30,022",274,,,,,,P425_03919,2
P9WKX1,Y3785_MYCTU,Rv3785,Rv3785 MTCY13D12.19,GO:0005829,,,,,Uncharacterized protein Rv3785,cytosol [GO:0005829],9634230,,,MVTVARRPVCPVTLTPGDPALASVRDLVDAWSAHDALAELVTMFGGAFPQTDHLEARLASLDKFSTAWDYRARARAARALHGEPVRCQDSGGGARWLIPRLDLPAKKRDAIVGLAQQLGLTLESTPQGTTFDHVLVIGTGRHSNLIRARWARELAKGRQVGHIVLAAASRRLLPSEDDAVAVCAPGARTEFELLAAAARDAFGLDVHPAVRYVRQRDDNPHRDSMVWRFAADTNDLGVPITLLEAPSPEPDSSRATSADTFTFTAHTLGMQDSTCLLVTGQPFVPYQNFDALRTLALPFGIQVETVGFGIDRYDGLGELDQQHPAKLLQEVRSTIRAARALLERIEAGERMATDPRR,"38,931",357,,,,cytosol [GO:0005829],,MTCY13D12.19,1
P9WKW9,Y3786_MYCTU,Rv3786c,Rv3786c MTCY13D12.20,GO:0005618; GO:0005886,IPR011055; IPR029044; IPR016047; ,,,,Uncharacterized protein Rv3786c,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MRILAMTRAHNAGRTLAATLDSLAVFSDDIYVIDDRSTDDTAEILANHPAVTNVVRARPDLPPTPWLIPESAGLELLYRMADFCRPDWVMMVDADWLVETDIDLRAVLARTPDDIVALMCPMVSRWDDPEYPDLIPVMGTAEALRGPLWRWYPGLRAGGKLMHNPHWPANITDHGRIGQLPGVRLVHSGWSTLAERILRVEHYLRLDPDYRFNFGVAYDRSLLFGYALDEVDLLKADYRRRIRGDFDPLEPGGRLPIDREPRAIGRGYGPHAGGFHPGVDFATDPGTPVYAVASGAVSAIDEVDGLVSLTIARCELDVVYVFRPGDEGRLVLGDRIAAGAQLGTIGAQGESADGYLHFEVRTQDGHVNPVRYLANMGLRPWPPPGRLRAVSGSYPPATPCTITAEDR,"44,944",407,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTCY13D12.20,1
P9WKW7,Y3788_MYCTU,Rv3788,Rv3788 MTCY13D12.22,GO:0003677; GO:0032784; GO:0070063,IPR036953; IPR001437; IPR023459; ,,,,Uncharacterized protein Rv3788,"DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; regulation of DNA-templated transcription, elongation [GO:0032784]",9634230; 21969609,,,MSEKVESKGLADAARDHLAAELARLRQRRDRLEVEVKNDRGMIGDHGDAAEAIQRADELAILGDRINELDRRLRTGPTPWSGSETLPGGTEVTLRFPDGEVVTMHVISVVEETPVGREAETLTARSPLGQALAGHQPGDTVTYSTPQGPNQVQLLAVKLPS,"17,406",161,,"regulation of DNA-templated transcription, elongation [GO:0032784]",DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063],,,MTCY13D12.22,1
O69670,EGTC_MYCTU,Rv3702c,egtC Rv3702c,GO:0005737; GO:0005886; GO:0006541; GO:0006751; GO:0016811; GO:0052704; GO:0061672,IPR017808; IPR032889; IPR017932; IPR029055; ,,egtC,DOMAIN 2 233 Glutamine amidotransferase type-2. {ECO:0000255|PROSITE-ProRule:PRU00609}.,Gamma-glutamyl-hercynylcysteine sulfoxide hydrolase (EC 3.5.1.118) (Gamma-glutamyl hercynylcysteine S-oxide hydrolase),"cytoplasm [GO:0005737]; glutathione hydrolase complex [GO:0061672]; plasma membrane [GO:0005886]; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; glutamine metabolic process [GO:0006541]; glutathione catabolic process [GO:0006751]",9634230; 21969609,,"FUNCTION: Catalyzes the hydrolysis of the gamma-glutamyl amide bond of hercynyl-gamma-L-glutamyl-L-cysteine sulfoxide to produce hercynylcysteine sulfoxide, a step in the biosynthesis pathway of ergothioneine. Ergothioneine is an antioxidant that protects mycobacteria from oxidative stress. {ECO:0000250|UniProtKB:A0R5M9, ECO:0000250|UniProtKB:Q8VIV2}.",MCRHLGWLGAQVAVSSLVLDPPQGLRVQSYAPRRQKHGLMNADGWGVGFFDGAIPRRWRSPAPLWGDTSFHSVAPALRSHCILAAVRSATVGMPIEVSATPPFTDGHWLLAHNGVVDRAVLPAGPAAESVCDSAILAATIFAHGLDALGDTIVKVGAADPNARLNILAANGSRLIATTWGDTLSILRRADGVVLASEPYDDDSGWGDVPDRHLVEVTQKGVTLTALDRAKGPR,"24,627",233,,"ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; glutamine metabolic process [GO:0006541]; glutathione catabolic process [GO:0006751]","hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO:0016811]",cytoplasm [GO:0005737]; glutathione hydrolase complex [GO:0061672]; plasma membrane [GO:0005886],,,1
O69668,EGTE_MYCTU,Rv3700c,egtE Rv3700c,GO:0016829; GO:0052704,IPR000192; IPR027563; IPR015424; IPR015422; IPR015421; ,,egtE,,Probable hercynylcysteine sulfoxide lyase (EC 4.4.-.-),"lyase activity [GO:0016829]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]",9634230; 21969609,,"FUNCTION: Probably catalyzes the conversion of hercynylcysteine sulfoxide to ergothioneine. Ergothioneine is an antioxidant that protects mycobacteria from oxidative stress. {ECO:0000250|UniProtKB:A0R5M7, ECO:0000250|UniProtKB:Q7D515}.",MRRSGANSPAGDSLADRWRAARPPVAGLHLDSAACSRQSFAALDAAAQHARHEAEVGGYVAAEAAAAVLDAGRAAVAALSGLPDAEVVFTTGSLHALDLLLGSWPGENRTLACLPGEYGPNLAVMAAHGFDVRPLPTLQDGRVALDDAAFMLADDPPDLVHLTVVASHRGVAQPLAMVAQLCTELKLPLVVDAAQGLGHVDCAVGADVTYASSRKWIAGPRGVGVLAVRPELMERLRARLPAPDWMPPLTVAQQLGFGEANVAARVGFSVALGEHLACGPQAIRARLAELGDIARTVLADVSGWRVVEAVDEPSAITTLAPIDGADPAAVRAWLLSQRRIVTTYAGVERAPLELPAPVLRISPHVDNTADDLDAFAEALVAATAATSGER,"40,446",390,"Class-V pyridoxal-phosphate-dependent aminotransferase family, EgtE subfamily","ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]",lyase activity [GO:0016829],,,,3
O53553,PG54_MYCTU,Rv3508,PE_PGRS54 Rv3508 MTV023.15,,IPR000084; ,,PE_PGRS54,DOMAIN 1 93 PE. {ECO:0000255}.,Uncharacterized PE-PGRS family protein PE_PGRS54,,9634230; 21969609,,,MSFVLIAPEFVTAAAGDLTNLGSSISAANASAASATTQVLAAGADEVSARIAALFGGFGLEYQAISAQVAAYHQRFVQALSTGAGAYASAEAAAAEQIVLGVINAPTQALLGRPLIGDGANATTPGGAGGAGGLLFGNGGAGAAGAPGQAGGPGGPAGLWGNGGPGGAGGSGGGTGGAGGAGGWLFGVGGAGGVGGAGGGTGGAGGPGGLIWGGGGAGGVGGAGGGTGGAGGRAELLFGAGGAGGAGTDGGPGATGGTGGHGGVGGDGGWLAPGGAGGAGGQGGAGGAGSDGGALGGTGGTGGTGGAGGAGGRGALLLGAGGQGGLGGAGGQGGTGGAGGDGVLGGVGGTGGKGGVGGVAGLGGAGGAAGQLFSAGGAAGAVGVGGTGGQGGAGGAGAAGADAPASTGLTGGTGFAGGAGGVGGQGGNAIAGGINGSGGAGGTGGQGGAGGMGGSGADNASGIGADGGAGGTGGNAGAGGAGGAAGTGGTGGVVGAAGKAGIGGTGGQGGAGGAGSAGTDATATGATGGTGFSGGAGGAGGAGGNTGVGGTNGSGGQGGTGGAGGAGGAGGVGADNPTGIGGTGGTGGKGGAGGAGGQGGSSGAGGTNGSGGAGGTGGQGGAGGAGGAGADNPTGIGGAGGTGGTGGAAGAGGAGGAIGTGGTGGAVGSVGNAGIGGTGGTGGVGGAGGAGAAAAAGSSATGGAGFAGGAGGEGGAGGNSGVGGTNGSGGAGGAGGKGGTGGAGGSGADNPTGAGFAGGAGGTGGAAGAGGAGGATGTGGTGGVVGATGSAGIGGAGGRGGDGGDGASGLGLGLSGFDGGQGGQGGAGGSAGAGGINGAGGAGGNGGDGGDGATGAAGLGDNGGVGGDGGAGGAAGNGGNAGVGLTAKAGDGGAAGNGGNGGAGGAGGAGDNNFNGGQGGAGGQGGQGGLGGASTTSINANGGAGGNGGTGGKGGAGGAGTLGVGGSGGTGGDGGDAGSGGGGGFGGAAGKAGGGGNGGRGGDGGDGASGLGLGLSGFDGGQGGQGGAGGSAGAGGINGAGGAGGNGGDGGDGATGAAGLGDNGGVGGDGGAGGAAGNGGNAGVGLTAKAGDGGAAGNGGNGGAGGAGGAGDNNFNGGQGGAGGQGGQGGLGGASTTSINANGGAGGNGGTGGKGGAGGAGTLGVGGSGGTGGDGGDAGSGGGGGFGGAAGKAGGGGNGGVGGDGGEGASGLGLGLSGFDGGQGGQGGAGGSAGAGGINGAGGAGGTGGAGGDGAPATLIGGPDGGDGGQGGIGGDGGNAGFGAGVPGDGGDGGNAGFGAGVPGDGGIGGTGGAGGAGGAGADGDPSIDGGQGGAGGHGGQGGKGGLNSTGLASAASGDGGNGGAGGAGGNGGDGDGFIGGSGGTGGTGGDAGVGGLANTGGTAGNAGIGGAGGRGGDGGAGDSGALSQDGNGFAGGQGGQGGVGGNAGAGGINGAGGTGGTGGAGGDGQNGTTGVASEGGAGGQGGDGGQGGIGGAGGNAGFGAGVPGDGGIGGTGGAGGAGGAGADGDPSIDGGQGGAGGHGGQGGKGGLNSTGLASAASGDGGNGGAGGAGGNGGDGDGFIGGSGGTGGTGGDAGVGGLANTGGTAGNAGIGGAGGRGGDGGAGDSGALSQDGNGFAGGQGGQGGVGGNAGAGGINGAGGTGGTGGAGGDGQNGTTGVASEGGAGGQGGDGGQGGIGGAGGNAGFGAGVPGDGGIGGTGGAGGAGGAGADGDPSIDGGQGGAGGHGGQGGKGGLNSTGLASAASGDGGNGGAGGAGGNGGAGGLGGGGGTGGTNGNGGLGGGGGNGGAGGAGGTPTGSGTEGTGGDGGDAGAGGNGGSATGVGNGGNGGDGGNGGDGGNGAPGGFGGGAGAGGLGGSGAGGGTDGDDGNGGSPGTDGS,"147,625",1901,"Mycobacterial PE family, PGRS subfamily",,,,,MTV023.15,1
Q6MWV1,PG60_MYCTU,Rv3652,PE_PGRS60 Rv3652 LH57_19900,,IPR000084; ,,PE_PGRS60,DOMAIN 1 60 PE. {ECO:0000255}.,PE-PGRS family protein PE_PGRS60,,9634230; 26158346,,FUNCTION: Binds fibronectin. May contribute to pathogenicity. {ECO:0000269|PubMed:26158346}.,MSYVIAAPEALVAAATDLATLGSTIGAANAAAAGSTTALLTAGADEVSAAIAAYSECTARPIRHSVRGRRRSMSGSCRPWPQVGAPMRPPRPPASRRCRARSIC,"10,636",104,"Mycobacterial PE family, PGRS subfamily",,,,,LH57_19900,1
P9WQE9,PHAS_MYCTU,Rv3825c,pks2 msl-2 Rv3825c,GO:0005618; GO:0005829; GO:0005886; GO:0006633; GO:0010106; GO:0016491; GO:0016746; GO:0031177,IPR036736; IPR014043; IPR016035; IPR013149; IPR013154; IPR011032; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR036291; IPR020801; IPR020841; IPR020807; IPR020843; IPR013968; IPR020806; IPR009081; IPR006162; IPR016039; ,,pks2,DOMAIN 2040 2126 Carrier. {ECO:0000255|PROSITE-ProRule:PRU00258}.,Phthioceranic/hydroxyphthioceranic acid synthase (EC 2.3.1.-) (Polyketide synthase pks2),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]; cellular response to iron ion starvation [GO:0010106]; fatty acid biosynthetic process [GO:0006633]",9634230; 10500215; 11278910; 12724526; 16573683; 19099550; 21969609,,"FUNCTION: Catalyzes the synthesis of the hepta- and octamethyl phthioceranic acids and/or hydroxyphthioceranic acids that are the major acyl constituents of sulfolipids. {ECO:0000269|PubMed:11278910, ECO:0000269|PubMed:12724526}.",MGLGSAASGTGADRGAWTLAEPRVTPVAVIGMACRLPGGIDSPELLWKALLRGDDLITEVPPDRWDCDEFYDPQPGVPGRTVCKWGGFLDNPADFDCEFFGIGEREAIAIDPQQRLLLETSWEAMEHAGLTQQTLAGSATGVFAGVTHGDYTMVAADAKQLEEPYGYLGNSFSMASGRVAYAMRLHGPAITVDTACSSGLTAVHMACRSLHEGESDVALAGGVALMLEPRKAAAGSALGMLSPTGRCRAFDVAADGFVSGEGCAVVVLKRLPDALADGDRILAVIRGTSANQDGHTVNIATPSQPAQVAAYRAALAAGGVDAATVGMVEAHGPGTPIGDPIEYASVSEVYGVDGPCALASVKTNFGHTQSTAGVLGLIKVVLALKHGVVPRNLHFTRLPDEIAGITTNLFVPEVTTPWPTNGRQVPRRAAVSSYGFSGTNVHAVVEQAPQTEAQPHAASTPPTGTPALFTLSASSADALRQTAQRLTDWIQQHADSLVLSDLAYTLARRRTHRSVRTAVIASSVDELIAGLGEVADGDTVYQPAVGQDDRGPVWLFSGQGSQWAAMGADLLTNESVFAATVAELEPLIAAESGFSVTEAMTAPETVTGIDRVQPTIFAMQVALAATMAAYGVRPGAVIGHSMGESAAAVVAGVLSAEDGVRVICRRSKLMATIAGSAAMASVELPALAVQSELTALGIDDVVVAVVTAPQSTVIAGGTESVRKLVDIWERRDVLARAVAVDVASHSPQVDPILDELIAALADLNPKAPEIPYYSATLFDPREAPACDARYWADNLRHTVRFSAAVRSALDDGYRVFAELSPHPLLTHAVDQIAGSVGMPVAALAGMRREQPLPLGLRRLLTDLHNAGAAVDFSVLCPQGRLVDAPLPAWSHRFLFYDREGVDNRSPGGSTVAVHPLLGAHVRLPEEPERHAWQADVGTATLPWLGDHRIHNVAALPGAAYCEMALSAARAVLGEQSEVRDMRFEAMLLLDDQTPVSTVATVTSPGVVDFAVEALQEGVGHHLRRASAVLQQVSGECEPPAYDMASLLEAHPCRVDGEDLRRQFDKHGVQYGPAFTGLAVAYVAEDATATMLAEVALPGSIRSQQGLYAIHPALLDACFQSVGAHPDSQSVGSGLLVPLGVRRVRAYAPVRTARYCYTRVTKVELVGVEADIDVLDAHGTVLLAVCGLRIGTGVSERDKHNRVLNERLLTIEWHQRELPEMDPSGAGKWLLISDCAASDVTATRLADAFREHSAACTTMRWPLHDDQLAAADQLRDQVGSDEFSGVVVLTGSNTGTPHQGSADRGAEYVRRLVGIARELSDLPGAVPRMYVVTRGAQRVLADDCVNLEQGGLRGLLRTIGAEHPHLRATQIDVDEQTGVEQLARQLLATSEEDETAWRDNEWYVARLCPTPLRPQERRTIVADHQQSGMRLQIRTPGDMQTIELAAFHRVPPGPGQIEVAVRASSVNFADVLIAFGRYPSFEGHLPQLGTDFAGVVTAVGPGVTDHKVGDHVGGMSPNGCWGTFVTCDARLAATLPPGLGDAQAAAVTTAHATAWYGLHELARIRAGDTVLIHSGTGGVGQAAIAIARAAGAEIFATAGTPQRRELLRNMGIEHVYDSRSIEFAEQIRRDTNGRGVDVVLNSVTGAAQLAGLKLLAFRGRFVEIGKRDIYGDTKLGLFPFRRNLSFYAVDLGLLSATHPEELRDLLGTVYRLTAAGELPMPQSTHYPLVEAATAIRVMGNAEHTGKLVLHIPQTGKSLVTLPPEQAQVFRPDGSYIITGGLGGLGLFLAEKMAAAGCGRIVLNSRTQPTQKMRETIEAIAAMGSEVVVECGDIAQPGTAERLVATAVATGLPVRGVLHAAAVVEDATLANITDELLARDWAPKVHGAWELHEATSGQPLDWFCLFSSAAALTGSPGQSAYSAANSWLDAFAHWRQAQGLPATAIAWGAWSDIGQLGWWSASPARASALEESNYTAITPDEGAYAFEALLRHNRVYTGYAPVIGAPWLVAFAERSRFFEVFSSSNGSGTSKFRVELNELPRDEWPARLRQLVAEQVSLILRRTVDPDRPLPEYGLDSLGALELRTRIETETGIRLAPKNVSATVRGLADHLYEQLAPDDAPAAALSSQ,"225,776",2126,,cellular response to iron ion starvation [GO:0010106]; fatty acid biosynthetic process [GO:0006633],"oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; transferase activity, transferring acyl groups [GO:0016746]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],msl-2,,1
P9WIC3,PHEA_MYCTU,Rv3838c,pheA Rv3838c,GO:0004664; GO:0005737; GO:0016597; GO:0033585; GO:0042803,IPR002912; IPR008242; IPR001086; IPR018528; ,,pheA,DOMAIN 3 189 Prephenate dehydratase. {ECO:0000255|PROSITE-ProRule:PRU00517}.; DOMAIN 203 280 ACT. {ECO:0000255|PROSITE-ProRule:PRU01007}.,Prephenate dehydratase (PDT) (EC 4.2.1.51),cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; prephenate dehydratase activity [GO:0004664]; protein homodimerization activity [GO:0042803]; L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585],9634230; 15753077; 19099550; 21969609,,,MVRIAYLGPEGTFTEAALVRMVAAGLVPETGPDALQRMPVESAPAALAAVRDGGADYACVPIENSIDGSVLPTLDSLAIGVRLQVFAETTLDVTFSIVVKPGRNAADVRTLAAFPVAAAQVRQWLAAHLPAADLRPAYSNADAARQVADGLVDAAVTSPLAAARWGLAALADGVVDESNARTRFVLVGRPGPPPARTGADRTSAVLRIDNQPGALVAALAEFGIRGIDLTRIESRPTRTELGTYLFFVDCVGHIDDEAVAEALKAVHRRCADVRYLGSWPTGPAAGAQPPLVDEASRWLARLRAGKPEQTLVRPDDQGAQA,"33,633",321,,L-phenylalanine biosynthetic process from chorismate via phenylpyruvate [GO:0033585],amino acid binding [GO:0016597]; prephenate dehydratase activity [GO:0004664]; protein homodimerization activity [GO:0042803],cytoplasm [GO:0005737],,,1
P9WHX3,PPE65_MYCTU,Rv3621c,PPE65 Rv3621c,,IPR022171; IPR000030; IPR038332; ,,PPE65,,Uncharacterized PPE family protein PPE65,,9634230,,,MLDFAQLPPEVNSALMYAGPGSGPMLAAAAAWEALAAELQTTASTYDALITGLADGPWQGSSAASMVAAATPQVAWLRSTAGQAEQAGSQAVAAASAYEAAFFATVPPPEIAANRALLMALLATNFLGQNTAAIAATEAQYAEMWAQDAAAMYGYAGASAAATQLSPFNPAAQTINPAGLASQAASVGQAVSGAANAQALTDIPKALFGLSGIFTNEPPWLTDLGKALGLTGHTWSSDGSGLIVGGVLGDFVQGVTGSAELDASVAMDTFGKWVSPARLMVTQFKDYFGLAHDLPKWASEGAKAAGEAAKALPAAVPAIPSAGLSGVAGAVGQAASVGGLKVPAVWTATTPAASPAVLAASNGLGAAAAAEGSTHAFGGMPLMGSGAGRAFNNFAAPRYGFKPTVIAQPPAGG,"40,680",413,Mycobacterial PPE family,,,,,,1
P9WHX5,PPE63_MYCTU,Rv3539,PPE63 Rv3539,GO:0005886,IPR029058; IPR013228; IPR000030; IPR038332; ,,PPE63,,Uncharacterized PPE family protein PPE63,plasma membrane [GO:0005886],9634230,,,MADFLTLSPEVNSARMYAGGGPGSLSAAAAAWDELAAELWLAAASFESVCSGLADRWWQGPSSRMMAAQAARHTGWLAAAATQAEGAASQAQTMALAYEAAFAATVHPALVAANRALVAWLAGSNVFGQNTPAIAAAEAIYEQMWAQDVVAMLNYHAVASAVGARLRPWQQLLHELPRRLGGEHSDSTNTELANPSSTTTRITVPGASPVHAATLLPFIGRLLAARYAELNTAIGTNWFPGTTPEVVSYPATIGVLSGSLGAVDANQSIAIGQQMLHNEILAATASGQPVTVAGLSMGSMVIDRELAYLAIDPNAPPSSALTFVELAGPERGLAQTYLPVGTTIPIAGYTVGNAPESQYNTSVVYSQYDIWADPPDRPWNLLAGANALMGAAYFHDLTAYAAPQQGIEIAAVTSSLGGTTTTYMIPSPTLPLLLPLKQIGVPDWIVGGLNNVLKPLVDAGYSQYAPTAGPYFSHGNLVW,"49,970",479,Mycobacterial PPE family,,,plasma membrane [GO:0005886],,,1
P9WHW7,PPE69_MYCTU,Rv3892c,PPE69 Rv3892c,,IPR000030; IPR038332; ,,PPE69,,Uncharacterized PPE family protein PPE69,,9634230,,,MPDPGWAARTPEANDLLLTAGTGVGTHLANQTAWTTLGASHHASGVASAINTAATAASWLGVGSAASALNVTMLNATLHGLAGWVDVKPAVVSTAIAAFETANAAMRPAPECMENRDEWGVDNAINPSVLWTLTPRIVSLDVEYFGVMWPNNAAVGATYGGVLAALAESLAIPPPVATMGASPAAPAQAAAAVGQAAAEAAAGDGMRSAYQGVQAGSTGAGQSTSAGENFGNQLSTFMQPMQAVMQAAPQALQAPSGLMQAPMSAMQPLQSMVGMFANPGALGMGGAAPGASAASAAGGISAAATEVGAGGGGAALGGGGMPATSFTRPVSAFESGTSGRPVGLRPSGALGADVVRAPTTTVGGTPIGGMPVGHAAGGHRGSHGKSEQAATVRVVDDRR,"38,853",399,Mycobacterial PPE family,,,,,,1
P9WHX9,PPE61_MYCTU,Rv3532,PPE61 Rv3532,,IPR022171; IPR000030; IPR038332; ,,PPE61,,Uncharacterized PPE family protein PPE61,,9634230,,,MFMDFAMLPPEVNSTRMYSGPGAGSLWAAAAAWDQVSAELQSAAETYRSVIASLTGWQWLGPSSVRMGAAVTPYVEWLTTTAAQARQTATQITAAATGFEQAFAMTVPPPAIMANRAQVLSLIATNFFGQNTAAIAALETQYAEMWEQDATAMYDYAATSAAARTLTPFTSPQQDTNSAGLPAQSAEVSRATANAGAADGNWLGNLLEEIGILLLPIAPELTPFFLEAGEIVNAIPFPSIVGDEFCLLDGLLAWYATIGSINNINSMGTGIIGAEKNLGILPELGSAAAAAAPPPADIAPAFLAPLTSMAKSLSDGALRGPGEVSAAMRGAGTIGQMSVPPAWKAPAVTTVRAFDATPMTTLPGGDAPAAGVPGLPGMPASGAGRAGVVPRYGVRLTVMTRPLSGG,"41,549",406,Mycobacterial PPE family,,,,,,1
P9WHX7,PPE62_MYCTU,Rv3533c,PPE62 Rv3533c,,IPR002989; IPR000030; IPR038332; ,,PPE62,,Uncharacterized PPE family protein PPE62,,9634230,,,MNYAVLPPELNSLRMFTGAGSAPMLAAAVAWDGLAAELGSAASSFGSVTSDLASQAWQGPAAAAMAAAAAPYAGWLSAAAARAAGAAAQAKAVASAFEAARAATVHPLLVAANRNAFAQLVMSNWFGLNAPLIAAVEGAYEQMWAADVAAMVGYHSGASAAAEQLVPFQQALQQLPNLGIGNIGNANLGGGNTGDLNTGNGNIGNTNLGSGNRGDANLGSGNIGNSNVGGGNVGNGNFGSGNGRAGLPGSGNVGNGNLGNSNLGSGNTGNSNVGFGNTGNNNVGTGNAGSGNIGAGNTGSSNWGFGNNGIGNIGFGNTGNGNIGFGLTGNNQVGIGGLNSGSGNIGLFNSGTNNVGFFNSGNGNLGIGNSSDANVGIGNSGATVGPFVAGHNTGFGNSGSLNTGMGNAGGVNTGFGNGGAINLGFGNSGQLNAGSFNAGSINTGNFNSGQGNTGDFNAGVRNTGWSNSGLTNTGAFNAGSLNTGFGAVGTGSGPNSGFGNAGTNNSGFFNTGVGSSGFQNGGSNNSGLQNAVGTVIAAGFGNTGAQTVGIANSGVLNSGFFNSGVHNSGGFNSENQRSGFGN,"55,503",582,Mycobacterial PPE family,,,,,,1
P9WHX1,PPE66_MYCTU,Rv3738c,PPE66 Rv3738c,GO:0005886; GO:0016021,IPR000030; IPR038332; ,,PPE66,,Uncharacterized PPE family protein PPE66,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230,,,MTTAYASALAAMPTLTELAANHTSHAVLLGTNFFGINTIPIALNEADYARMWIQAATTMSIYEGTSDAALASAPQTTPAPVLFNGGAGVASALPAISAATLDPASIIGIIIEILIQLFLISLEILFAIVAYTIIIVLILPLVIFAYAIVFAVLAIIFGPPLLVIASPFVLTGSVIAVPTSLSTSLSTAVPIGVGQYLADLASADAQAIEVGLKTADVAPVAVRPAAAPPLRESAAVRPEARLVSAVAPAPAGTSASVLASDRGAGVLGFAGTAGKESVGRPAGLTTLAGGEFGGSPSVPMVPASWEQLVGAGEAG,"31,436",315,Mycobacterial PPE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WHW9,PPE68_MYCTU,Rv3873,PPE68 Rv3873,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0009986,IPR000030; IPR038332; ,P9WIG7,PPE68,,PPE family immunomodulator PPE68,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405],9634230; 14573626; 15039340; 16368961; 17433643; 21969609; 24467650; 25136958,,"FUNCTION: Plays a major role in RD1-associated pathogenesis, and may contribute to the establishment and maintenance of M.tuberculosis infection. Together with PE35, stimulates the secretion of IL-10 and MCP-1 from human macrophages, via the interaction with human Toll-like receptor 2 (TLR2) (PubMed:24467650). Stimulates high levels of gamma interferon secretion in peripheral blood mononuclear cells isolated from tuberculosis patients, as well as from healthy tuberculin purified protein derivative-positive donors. Does not interfere with the secretion and immunogenicity of EsxA (ESAT-6) and EsxB (CFP-10) (PubMed:14573626, PubMed:15039340). {ECO:0000269|PubMed:14573626, ECO:0000269|PubMed:15039340, ECO:0000269|PubMed:24467650}.",MLWHAMPPELNTARLMAGAGPAPMLAAAAGWQTLSAALDAQAVELTARLNSLGEAWTGGGSDKALAAATPMVVWLQTASTQAKTRAMQATAQAAAYTQAMATTPSLPEIAANHITQAVLTATNFFGINTIPIALTEMDYFIRMWNQAALAMEVYQAETAVNTLFEKLEPMASILDPGASQSTTNPIFGMPSPGSSTPVGQLPPAATQTLGQLGEMSGPMQQLTQPLQQVTSLFSQVGGTGGGNPADEEAAQMGLLGTSPLSNHPLAGGSGPSAGAGLLRAESLPGAGGSLTRTPLMSQLIEKPVAPSVMPAAAAGSSATGGAAPVGAGAMGQGAQSGGSTRPGLVAPAPLAQEREEDDEDDWDEEDDW,"37,330",368,Mycobacterial PPE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WJI5,NAT_MYCTU,Rv3566c,nat nhoA tbnat Rv3566c MTCY06G11.13c,GO:0004060; GO:0005886; GO:0008152; GO:0046677,IPR001447; ,,nat,,Arylamine N-acetyltransferase (NAT) (EC 2.3.1.5) (TBNAT),plasma membrane [GO:0005886]; arylamine N-acetyltransferase activity [GO:0004060]; metabolic process [GO:0008152]; response to antibiotic [GO:0046677],9634230; 12368430; 9973365; 18795795; 19014350; 19099550; 21969609; 21514309,,"FUNCTION: Catalyzes the transfer of the acetyl group from acetyl coenzyme A to the free amino group of arylamines and hydrazines (PubMed:18795795). Is able to utilize not only acetyl-CoA, but also n-propionyl-CoA and acetoacetyl-CoA as acyl donors, although at a lower rate (PubMed:19014350). As acetyl-CoA and propionyl-CoA are products of cholesterol catabolism and the nat gene is likely present in the same operon than genes involved in cholesterol degradation, this enzyme could have a role in the utilization and regulation of these CoA species (PubMed:19014350). {ECO:0000269|PubMed:18795795, ECO:0000269|PubMed:19014350}.; FUNCTION: It has been reported that overexpression of this enzyme may be responsible for increased resistance to the front-line antitubercular drug isoniazid (INH), by acetylating and hence inactivating the prodrug (PubMed:9973365). However, isoniazid is an extremely poor substrate for the enzyme; therefore, the expression of TBNAT is unlikely to be a significant cause of isoniazid resistance in M.tuberculosis (PubMed:18795795). {ECO:0000269|PubMed:18795795, ECO:0000269|PubMed:9973365}.",MALDLTAYFDRINYRGATDPTLDVLQDLVTVHSRTIPFENLDPLLGVPVDDLSPQALADKLVLRRRGGYCFEHNGLMGYVLAELGYRVRRFAARVVWKLAPDAPLPPQTHTLLGVTFPGSGGCYLVDVGFGGQTPTSPLRLETGAVQPTTHEPYRLEDRVDGFVLQAMVRDTWQTLYEFTTQTRPQIDLKVASWYASTHPASKFVTGLTAAVITDDARWNLSGRDLAVHRAGGTEKIRLADAAAVVDTLSERFGINVADIGERGALETRIDELLARQPGADAP,"31,029",283,Arylamine N-acetyltransferase family,metabolic process [GO:0008152]; response to antibiotic [GO:0046677],arylamine N-acetyltransferase activity [GO:0004060],plasma membrane [GO:0005886],nhoA tbnat,MTCY06G11.13c,1
O05461,MYCP1_MYCTU,Rv3883c,mycP1 Rv3883c LH57_21150,GO:0004252; GO:0005886; GO:0006508; GO:0009405; GO:0009986; GO:0016021; GO:0051046,IPR000209; IPR036852; IPR015500; IPR023834; ,,mycP1,DOMAIN 81 379 Peptidase S8. {ECO:0000255}.,Mycosin-1 (EC 3.4.21.-) (MycP1 protease),cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; pathogenesis [GO:0009405]; proteolysis [GO:0006508]; regulation of secretion [GO:0051046],9634230; 10974545; 12366866; 20227664; 21969609,,"FUNCTION: May play a dual role in regulation of ESX-1 secretion and virulence. Acts as a protease that cleaves EspB. Essential for ESX-1 function, required for early replication in macrophages and full virulence in mice. {ECO:0000269|PubMed:20227664}.",MHRIFLITVALALLTASPASAITPPPIDPGALPPDVTGPDQPTEQRVLCASPTTLPGSGFHDPPWSNTYLGVADAHKFATGAGVTVAVIDTGVDASPRVPAEPGGDFVDQAGNGLSDCDAHGTLTASIIAGRPAPTDGFVGVAPDARLLSLRQTSEAFEPVGSQANPNDPNATPAAGSIRSLARAVVHAANLGVGVINISEAACYKVSRPIDETSLGASIDYAVNVKGVVVVVAAGNTGGDCVQNPAPDPSTPGDPRGWNNVQTVVTPAWYAPLVLSVGGIGQTGMPSSFSMHGPWVDVAAPAENIVALGDTGEPVNALQGREGPVPIAGTSFAAAYVSGLAALLRQRFPDLTPAQIIHRITATARHPGGGVDDLVGAGVIDAVAALTWDIPPGPASAPYNVRRLPPPVVEPGPDRRPITAVALVAVGLTLALGLGALARRALSRR,"45,118",446,Peptidase S8 family,pathogenesis [GO:0009405]; proteolysis [GO:0006508]; regulation of secretion [GO:0051046],serine-type endopeptidase activity [GO:0004252],cell surface [GO:0009986]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_21150,1
P9WQ09,MUTY_MYCTU,Rv3589,mutY Rv3589,GO:0003677; GO:0005886; GO:0006284; GO:0016798; GO:0046872; GO:0051539,IPR011257; IPR003651; IPR003265; IPR000445; IPR023170; ,,mutY,DOMAIN 111 139 HhH.,Adenine DNA glycosylase (EC 3.2.2.31),"plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]",9634230; 17698424; 19778963; 21969609; 21764637,,"FUNCTION: Adenine glycosylase active on G:A and C:A mispairs, as well as processing 7,8-dihydro-8-oxoguanine:A (8-oxoG) mismatches. Minor activity against 8-oxoG:G and 8-oxo:T mismatches is also seen. Bind dsDNA oligonucleotides containing the above mismatches. {ECO:0000269|PubMed:17698424, ECO:0000269|PubMed:19778963}.",MPHILPEPSVTGPRHISDTNLLAWYQRSHRDLPWREPGVSPWQILVSEFMLQQTPAARVLAIWPDWVRRWPTPSATATASTADVLRAWGKLGYPRRAKRLHECATVIARDHNDVVPDDIEILVTLPGVGSYTARAVACFAYRQRVPVVDTNVRRVVARAVHGRADAGAPSVPRDHADVLALLPHRETAPEFSVALMELGATVCTARTPRCGLCPLDWCAWRHAGYPPSDGPPRRGQAYTGTDRQVRGRLLDVLRAAEFPVTRAELDVAWLTDTAQRDRALESLLADALVTRTVDGRFALPGEGF,"33,684",304,Nth/MutY family,base-excision repair [GO:0006284],"4 iron, 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]",plasma membrane [GO:0005886],,,1
P9WQN7,MPT51_MYCTU,Rv3803c,mpt51 fbpC1 fbpD mpb51 Rv3803c MTV026.08c,GO:0001968; GO:0005576; GO:0016746; GO:0035375,IPR029058; IPR000801; ,,mpt51,,MPT51/MPB51 antigen,"extracellular region [GO:0005576]; fibronectin binding [GO:0001968]; transferase activity, transferring acyl groups [GO:0016746]; zymogen binding [GO:0035375]",9634230; 21969609; 14672660,X-ray crystallography (1),"FUNCTION: May have a role in host tissue attachment, whereby ligands may include the serum protein fibronectin and small sugars. {ECO:0000269|PubMed:14672660}.",MKGRSALLRALWIAALSFGLGGVAVAAEPTAKAAPYENLMVPSPSMGRDIPVAFLAGGPHAVYLLDAFNAGPDVSNWVTAGNAMNTLAGKGISVVAPAGGAYSMYTNWEQDGSKQWDTFLSAELPDWLAANRGLAPGGHAAVGAAQGGYGAMALAAFHPDRFGFAGSMSGFLYPSNTTTNGAIAAGMQQFGGVDTNGMWGAPQLGRWKWHDPWVHASLLAQNNTRVWVWSPTNPGASDPAAMIGQAAEAMGNSRMFYNQYRSVGGHNGHFDFPASGDNGWGSWAPQLGAMSGDIVGAIR,"31,089",299,Mycobacterial A85 antigen family,,"fibronectin binding [GO:0001968]; transferase activity, transferring acyl groups [GO:0016746]; zymogen binding [GO:0035375]",extracellular region [GO:0005576],fbpC1 fbpD mpb51,MTV026.08c,1
P9WPJ9,MTCA2_MYCTU,Rv3588c,mtcA2 canB cynT Rv3588c,GO:0004089; GO:0008270; GO:0015976,IPR001765; IPR015892; IPR036874; ,,mtcA2,,Carbonic anhydrase 2 (Beta-CA 2) (EC 4.2.1.1) (Carbonate dehydratase 2) (mtCA 2),carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon utilization [GO:0015976],9634230; 19317447; 19438226; 21969609; 15753099; 16321983,X-ray crystallography (2),FUNCTION: Catalyzes the reversible hydration of carbon dioxide to form bicarbonate. {ECO:0000269|PubMed:15753099}.,MPNTNPVAAWKALKEGNERFVAGRPQHPSQSVDHRAGLAAGQKPTAVIFGCADSRVAAEIIFDQGLGDMFVVRTAGHVIDSAVLGSIEYAVTVLNVPLIVVLGHDSCGAVNAALAAINDGTLPGGYVRDVVERVAPSVLLGRRDGLSRVDEFEQRHVHETVAILMARSSAISERIAGGSLAIVGVTYQLDDGRAVLRDHIGNIGEEV,"21,792",207,Beta-class carbonic anhydrase family,carbon utilization [GO:0015976],carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],,canB cynT,,1
L0TDE1,LIGC_MYCTU,Rv3731,ligC Rv3731,GO:0003910; GO:0005524; GO:0005737; GO:0006273; GO:0006310; GO:0051103,IPR012309; IPR012310; IPR012340; ,,ligC,,DNA ligase C (EC 6.5.1.1) (Polydeoxyribonucleotide synthase [ATP]),cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273],9634230; 14985346; 21969609,,"FUNCTION: DNA ligase that seals nicks in double-stranded DNA during DNA replication, DNA recombination and DNA repair. {ECO:0000250}.",MQLPVMPPVSPMLAKSVTAIPPDASYEPKWDGFRSICFRDGDQVELGSRNERPMTRYFPELVAAIRAELPHRCVIDGEIIIATDHGLDFEALQQRIHPAESRVRMLADRTPASFIAFDLLALGDDDYTGRPFSERRAALVDAVTGSGADADLSIHVTPATTDMATAQRWFSEFEGAGLDGVIAKPPHITYQPDKRVMFKIKHLRTADCVVAGYRVHKSGSDAIGSLLLGLYQEDGQLASVGVIGAFPMAERRRLLTELQPLVTSFDDHPWNWAAHVAGQRTPRKNEFSRWNVGKDLSFVPLRPERVVEVRYDRMEGARFRHTAQFNRWRPDRDPRSCSYAQLERPLTVSLSDIVPGLR,"40,160",358,ATP-dependent DNA ligase family,DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; lagging strand elongation [GO:0006273],ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910],cytoplasm [GO:0005737],,,1
P9WMB9,KSTR2_MYCTU,Rv3557c,kstR2 Rv3557c,GO:0003677; GO:0003700; GO:0006351; GO:0006355; GO:0010468; GO:0019217; GO:0042803,IPR009057; IPR001647; IPR036271; ,,kstR2,DOMAIN 9 69 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,HTH-type transcriptional repressor KstR2,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 20167624; 21969609,X-ray crystallography (2),FUNCTION: Controls the expression of a small regulon that may play a role in the utilization of cholesterol. {ECO:0000269|PubMed:20167624}.,MDRVAGQVNSRRGELLELAAAMFAERGLRATTVRDIADGAGILSGSLYHHFASKEEMVDELLRGFLDWLFARYRDIVDSTANPLERLQGLFMASFEAIEHHHAQVVIYQDEAQRLASQPRFSYIEDRNKQQRKMWVDVLNQGIEEGYFRPDLDVDLVYRFIRDTTWVSVRWYRPGGPLTAQQVGQQYLAIVLGGITKEGV,"22,906",200,,"regulation of fatty acid metabolic process [GO:0019217]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803],,,,1
P96856,KSTR_MYCTU,Rv3574,kstR Rv3574,GO:0000976; GO:0003677; GO:0003700; GO:0005829; GO:0006351; GO:0006355; GO:0042803,IPR009057; IPR001647; ,,kstR,DOMAIN 36 96 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,HTH-type transcriptional repressor KstR,"cytosol [GO:0005829]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 17635188; 21969609,X-ray crystallography (8),FUNCTION: Controls the expression of genes used for utilizing diverse lipids as energy sources. {ECO:0000269|PubMed:17635188}.,MSSANTNTSSAPDAPPRAVMKVAVLAESELGSEAQRERRKRILDATMAIASKGGYEAVQMRAVADRADVAVGTLYRYFPSKVHLLVSALGREFSRIDAKTDRSAVAGATPFQRLNFMVGKLNRAMQRNPLLTEAMTRAYVFADASAASEVDQVEKLIDSMFARAMANGEPTEDQYHIARVISDVWLSNLLAWLTRRASATDVSKRLDLAVRLLIGDQDSA,"24,050",220,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; protein homodimerization activity [GO:0042803]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,5
P9WNH5,HSAD_MYCTU,Rv3569c,hsaD bphD Rv3569c,GO:0005618; GO:0005886; GO:0006694; GO:0016042; GO:0018774; GO:0019439; GO:0034820; GO:0044117; GO:0102296,IPR029058; IPR000073; ,,hsaD,,"4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase (EC 3.7.1.17) (2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase) (HOPDA hydrolase) (EC 3.7.1.8) (Meta-cleavage product hydrolase) (MCP hydrolase)","cell wall [GO:0005618]; plasma membrane [GO:0005886]; 2,6-dioxo-6-phenylhexa-3-enoate hydrolase activity [GO:0018774]; 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase activity [GO:0102296]; 4,9-DSHA hydrolase activity [GO:0034820]; aromatic compound catabolic process [GO:0019439]; growth of symbiont in host [GO:0044117]; lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694]",9634230; 17635188; 17264217; 21969609; 18097091; 19875455,X-ray crystallography (7),"FUNCTION: Catalyzes the hydrolysis of a carbon-carbon bond in 4,5: 9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate (4,9-DSHA) to yield 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oate (DOHNAA) and 2-hydroxy-hexa-2,4-dienoate (HHD). Is also able to catalyze the hydrolysis of 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA) and the synthetic analog 8-(2-chlorophenyl)-2-hydroxy-5-methyl-6-oxoocta-2,4-dienoic acid (HOPODA). {ECO:0000269|PubMed:19875455}.",MTATEELTFESTSRFAEVDVDGPLKLHYHEAGVGNDQTVVLLHGGGPGAASWTNFSRNIAVLARHFHVLAVDQPGYGHSDKRAEHGQFNRYAAMALKGLFDQLGLGRVPLVGNSLGGGTAVRFALDYPARAGRLVLMGPGGLSINLFAPDPTEGVKRLSKFSVAPTRENLEAFLRVMVYDKNLITPELVDQRFALASTPESLTATRAMGKSFAGADFEAGMMWREVYRLRQPVLLIWGREDRVNPLDGALVALKTIPRAQLHVFGQCGHWVQVEKFDEFNKLTIEFLGGGR,"31,875",291,"AB hydrolase superfamily, HsaD family",aromatic compound catabolic process [GO:0019439]; growth of symbiont in host [GO:0044117]; lipid catabolic process [GO:0016042]; steroid biosynthetic process [GO:0006694],"2,6-dioxo-6-phenylhexa-3-enoate hydrolase activity [GO:0018774]; 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase activity [GO:0102296]; 4,9-DSHA hydrolase activity [GO:0034820]",cell wall [GO:0005618]; plasma membrane [GO:0005886],bphD,,1
P71875,KSHA_MYCTU,Rv3526,kshA Rv3526,GO:0005506; GO:0006694; GO:0006707; GO:0009405; GO:0036200; GO:0047086; GO:0051537; GO:0070207; GO:0070723,IPR017941; IPR036922; ,,kshA,DOMAIN 26 128 Rieske. {ECO:0000255|PROSITE-ProRule:PRU00628}.,"3-ketosteroid-9-alpha-monooxygenase, oxygenase component (3-ketosteroid-9-alpha-hydroxylase, oxygenase component) (KSH) (Androsta-1,4-diene-3,17-dione 9-alpha-hydroxylase) (EC 1.14.13.142) (Rieske-type oxygenase) (RO)","2 iron, 2 sulfur cluster binding [GO:0051537]; 3-ketosteroid 9-alpha-monooxygenase activity [GO:0036200]; iron ion binding [GO:0005506]; ketosteroid monooxygenase activity [GO:0047086]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]; protein homotrimerization [GO:0070207]; response to cholesterol [GO:0070723]; steroid biosynthetic process [GO:0006694]",9634230; 17635188; 21987574; 21969609; 19234303; 25049233,X-ray crystallography (2),"FUNCTION: Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. KSH is also able to use 4-androstene-3,17-dione (AD), 3-oxo-23,24-bisnorcholesta-4-en-22-oate (4-BNC), 3-oxo-23,24-bisnorcholesta-1,4-dien-22-oate (1,4-BNC), 3-oxo-23,24-bisnorcholesta-4-en-22-oyl-coenzyme A thioester (4-BNC-CoA) and 3-oxo-23,24-bisnorcholesta-1,4-dien-22-oyl-coenzyme A thioester (1,4-BNC-CoA) as substrates. {ECO:0000269|PubMed:19234303, ECO:0000269|PubMed:21987574}.",MSTDTSGVGVREIDAGALPTRYARGWHCLGVAKDYLEGKPHGVEAFGTKLVVFADSHGDLKVLDGYCRHMGGDLSEGTVKGDEVACPFHDWRWGGDGRCKLVPYARRTPRMARTRSWTTDVRSGLLFVWHDHEGNPPDPAVRIPEIPEAASDEWTDWRWNRILIEGSNCRDIIDNVTDMAHFFYIHFGLPTYFKNVFEGHIASQYLHNVGRPDVDDLGTSYGEAHLDSEASYFGPSFMINWLHNRYGNYKSESILINCHYPVTQNSFVLQWGVIVEKPKGMSEEMTDKLSRVFTEGVSKGFLQDVEIWKHKTRIDNPLLVEEDGAVYQLRRWYEQFYVDVADIKPEMVERFEIEVDTKRANEFWNAEVEKNLKSREVSDDVPAEQH,"44,268",386,,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]; protein homotrimerization [GO:0070207]; response to cholesterol [GO:0070723]; steroid biosynthetic process [GO:0006694],"2 iron, 2 sulfur cluster binding [GO:0051537]; 3-ketosteroid 9-alpha-monooxygenase activity [GO:0036200]; iron ion binding [GO:0005506]; ketosteroid monooxygenase activity [GO:0047086]",,,,2
P9WJ93,KSHB_MYCTU,Rv3571,hmp kshB Rv3571,GO:0001666; GO:0006694; GO:0006707; GO:0009055; GO:0009247; GO:0009405; GO:0036200; GO:0046872; GO:0047086; GO:0051409; GO:0051537; GO:0071766; GO:0071949,IPR036010; IPR001041; IPR006058; IPR012675; IPR017927; IPR001709; IPR008333; IPR001433; IPR001221; IPR017938; ,,hmp,DOMAIN 12 124 FAD-binding FR-type. {ECO:0000255|PROSITE-ProRule:PRU00716}.; DOMAIN 269 358 2Fe-2S ferredoxin-type. {ECO:0000255|PROSITE-ProRule:PRU00465}.,"3-ketosteroid-9-alpha-monooxygenase, ferredoxin reductase component (3-ketosteroid-9-alpha-hydroxylase, ferredoxin reductase component) (KSH) (Androsta-1,4-diene-3,17-dione 9-alpha-hydroxylase) (EC 1.14.13.142) (Rieske-type oxygenase) (RO)","2 iron, 2 sulfur cluster binding [GO:0051537]; 3-ketosteroid 9-alpha-monooxygenase activity [GO:0036200]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ketosteroid monooxygenase activity [GO:0047086]; metal ion binding [GO:0046872]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cholesterol catabolic process [GO:0006707]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; response to hypoxia [GO:0001666]; response to nitrosative stress [GO:0051409]; steroid biosynthetic process [GO:0006694]",9634230; 17635188; 19234303; 21987574; 21969609,,"FUNCTION: Involved in the degradation of cholesterol. Catalyzes the introduction of a 9a-hydroxyl moiety into 1,4-androstadiene-3,17-dione (ADD) to yield the 9alpha-hydroxy-1,4-androstadiene-3,17-dione (9OHADD) intermediate which spontaneously form 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione (HSA) via the meta-cleavage of ring B with concomitant aromatization of ring A. KSH is also able to use 4-androstene-3,17-dione (AD), 3-oxo-23,24-bisnorcholesta-4-en-22-oate (4-BNC), 3-oxo-23,24-bisnorcholesta-1,4-dien-22-oate (1,4-BNC), 3-oxo-23,24-bisnorcholesta-4-en-22-oyl-coenzyme A thioester (4-BNC-CoA) and 3-oxo-23,24-bisnorcholesta-1,4-dien-22-oyl-coenzyme A thioester (1,4-BNC-CoA) as substrates. {ECO:0000269|PubMed:19234303, ECO:0000269|PubMed:21987574}.",MTEAIGDEPLGDHVLELQIAEVVDETDEARSLVFAVPDGSDDPEIPPRRLRYAPGQFLTLRVPSERTGSVARCYSLCSSPYTDDALAVTVKRTADGYASNWLCDHAQVGMRIHVLAPSGNFVPTTLDADFLLLAAGSGITPIMSICKSALAEGGGQVTLLYANRDDRSVIFGDALRELAAKYPDRLTVLHWLESLQGLPSASALAKLVAPYTDRPVFICGPGPFMQAARDALAALKVPAQQVHIEVFKSLESDPFAAVKVDDSGDEAPATAVVELDGQTHTVSWPRTAKLLDVLLAAGLDAPFSCREGHCGACACTLRAGKVNMGVNDVLEQQDLDEGLILACQSRPESDSVEVTYDE,"38,265",358,,Actinobacterium-type cell wall biogenesis [GO:0071766]; cholesterol catabolic process [GO:0006707]; glycolipid biosynthetic process [GO:0009247]; pathogenesis [GO:0009405]; response to hypoxia [GO:0001666]; response to nitrosative stress [GO:0051409]; steroid biosynthetic process [GO:0006694],"2 iron, 2 sulfur cluster binding [GO:0051537]; 3-ketosteroid 9-alpha-monooxygenase activity [GO:0036200]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; ketosteroid monooxygenase activity [GO:0047086]; metal ion binding [GO:0046872]",,kshB,,1
P9WML5,PATR_MYCTU,Rv3772,pat hisC2 Rv3772 MTCY13D12.06,GO:0000105; GO:0004400; GO:0030170,IPR001917; IPR004839; IPR005861; IPR024892; IPR015424; IPR015422; IPR015421; ,,pat,,Putative phenylalanine aminotransferase (EC 2.6.1.-),histidinol-phosphate transaminase activity [GO:0004400]; pyridoxal phosphate binding [GO:0030170]; histidine biosynthetic process [GO:0000105],9634230; 21969609,X-ray crystallography (2),FUNCTION: May catalyze the transamination reaction in phenylalanine biosynthesis. {ECO:0000255|HAMAP-Rule:MF_01513}.,MTARLRPELAGLPVYVPGKTVPGAIKLASNETVFGPLPSVRAAIDRATDTVNRYPDNGCVQLKAALARHLGPDFAPEHVAVGCGSVSLCQQLVQVTASVGDEVVFGWRSFELYPPQVRVAGAIPIQVPLTDHTFDLYAMLATVTDRTRLIFVCNPNNPTSTVVGPDALARFVEAVPAHILIAIDEAYVEYIRDGMRPDSLGLVRAHNNVVVLRTFSKAYGLAGLRIGYAIGHPDVITALDKVYVPFTVSSIGQAAAIASLDAADELLARTDTVVAERARVSAELRAAGFTLPPSQANFVWLPLGSRTQDFVEQAADARIVVRPYGTDGVRVTVAAPEENDAFLRFARRWRSDQ,"38,040",353,Class-II pyridoxal-phosphate-dependent aminotransferase family,histidine biosynthetic process [GO:0000105],histidinol-phosphate transaminase activity [GO:0004400]; pyridoxal phosphate binding [GO:0030170],,hisC2,MTCY13D12.06,1
P9WIL5,PANC_MYCTU,Rv3602c,panC Rv3602c MTCY07H7B.20,GO:0000287; GO:0004592; GO:0005524; GO:0005829; GO:0009405; GO:0015940; GO:0019482; GO:0030145; GO:0033317; GO:0040007,IPR003721; IPR014729; ,,panC,,Pantothenate synthetase (PS) (EC 6.3.2.1) (Pantoate--beta-alanine ligase) (Pantoate-activating enzyme),cytosol [GO:0005829]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; pantoate-beta-alanine ligase activity [GO:0004592]; beta-alanine metabolic process [GO:0019482]; growth [GO:0040007]; pantothenate biosynthetic process [GO:0015940]; pantothenate biosynthetic process from valine [GO:0033317]; pathogenesis [GO:0009405],9634230; 11669627; 12219086; 15170354; 19099550; 21969609; 25246400; 12717031; 16460002,X-ray crystallography (39),FUNCTION: Catalyzes the condensation of pantoate with beta-alanine in an ATP-dependent reaction via a pantoyl-adenylate intermediate. {ECO:0000269|PubMed:11669627}.,MTIPAFHPGELNVYSAPGDVADVSRALRLTGRRVMLVPTMGALHEGHLALVRAAKRVPGSVVVVSIFVNPMQFGAGEDLDAYPRTPDDDLAQLRAEGVEIAFTPTTAAMYPDGLRTTVQPGPLAAELEGGPRPTHFAGVLTVVLKLLQIVRPDRVFFGEKDYQQLVLIRQLVADFNLDVAVVGVPTVREADGLAMSSRNRYLDPAQRAAAVALSAALTAAAHAATAGAQAALDAARAVLDAAPGVAVDYLELRDIGLGPMPLNGSGRLLVAARLGTTRLLDNIAIEIGTFAGTDRPDGYRAILESHWRN,"32,678",309,Pantothenate synthetase family,beta-alanine metabolic process [GO:0019482]; growth [GO:0040007]; pantothenate biosynthetic process [GO:0015940]; pantothenate biosynthetic process from valine [GO:0033317]; pathogenesis [GO:0009405],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; pantoate-beta-alanine ligase activity [GO:0004592],cytosol [GO:0005829],,MTCY07H7B.20,1
P9WIL3,PAND_MYCTU,Rv3601c,panD Rv3601c MTCY07H7B.21,GO:0004068; GO:0005618; GO:0005829; GO:0006523; GO:0009405; GO:0015940,IPR009010; IPR003190; ,,panD,,Aspartate 1-decarboxylase (EC 4.1.1.11) (Aspartate alpha-decarboxylase) [Cleaved into: Aspartate 1-decarboxylase beta chain; Aspartate 1-decarboxylase alpha chain],cell wall [GO:0005618]; cytosol [GO:0005829]; aspartate 1-decarboxylase activity [GO:0004068]; alanine biosynthetic process [GO:0006523]; pantothenate biosynthetic process [GO:0015940]; pathogenesis [GO:0009405],9634230; 12182836; 12219086; 21969609; 26038471; 25246400; 26038753; 17001646,X-ray crystallography (1),"FUNCTION: Catalyzes the pyruvoyl-dependent decarboxylation of aspartate to produce beta-alanine. {ECO:0000255|HAMAP-Rule:MF_00446, ECO:0000305|PubMed:12182836}.; FUNCTION: Overexpression of wild-type protein confers resistance to pyrazinoic acid (POA), the active form of the anti-tuberculosis prodrug pyrazinamide (PZA). {ECO:0000269|PubMed:26038753}.",MLRTMLKSKIHRATVTCADLHYVGSVTIDADLMDAADLLEGEQVTIVDIDNGARLVTYAITGERGSGVIGINGAAAHLVHPGDLVILIAYATMDDARARTYQPRIVFVDAYNKPIDMGHDPAFVPENAGELLDPRLGVG,"14,885",139,PanD family,alanine biosynthetic process [GO:0006523]; pantothenate biosynthetic process [GO:0015940]; pathogenesis [GO:0009405],aspartate 1-decarboxylase activity [GO:0004068],cell wall [GO:0005618]; cytosol [GO:0005829],,MTCY07H7B.21,1
I6Y4D2,PEPAM_MYCTU,Rv3717,Rv3717,GO:0008745; GO:0009253; GO:0016998; GO:0030288; GO:0046872; GO:0071555,IPR002508; ,,,,N-acetylmuramoyl-L-alanine amidase Rv3717 (EC 3.5.1.28) (Zinc-dependent peptidoglycan amidase),outer membrane-bounded periplasmic space [GO:0030288]; metal ion binding [GO:0046872]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555]; peptidoglycan catabolic process [GO:0009253],9634230; 21969609; 24311595; 24019530,X-ray crystallography (4),"FUNCTION: Cell-wall hydrolase that hydrolyzes the amide bond between N-acetylmuramic acid and L-alanine in cell-wall glycopeptides (PubMed:24311595, PubMed:24019530). Is able to hydrolyze the cell walls of several bacterial species (i.e. Paenibacillus sp., B.avium, E.coli DH5alpha, E.aerogenes, L.acidophilus, B.thuringiensis, B.pumilus, B.subtilis and E.coli W3110), thereby showing that it is a cell-wall hydrolase with broad-spectrum activity (PubMed:24311595). May have a role in peptidoglycan fragment recycling (PubMed:24019530). {ECO:0000269|PubMed:24019530, ECO:0000269|PubMed:24311595}.",MIVGVLVAAATPIISSASATPANIAGMVVFIDPGHNGANDASIGRQVPTGRGGTKNCQASGTSTNSGYPEHTFTWETGLRLRAALNALGVRTALSRGNDNALGPCVDERANMANALRPNAIVSLHADGGPASGRGFHVNYSAPPLNAIQAGPSVQFARIMRDQLQASGIPKANYIGQDGLYGRSDLAGLNLAQYPSILVELGNMKNPADSALMESAEGRQKYANALVRGVAGFLATQGQAR,"24,836",241,N-acetylmuramoyl-L-alanine amidase 3 family,cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555]; peptidoglycan catabolic process [GO:0009253],metal ion binding [GO:0046872]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745],outer membrane-bounded periplasmic space [GO:0030288],,,1
P9WIK9,PAPA1_MYCTU,Rv3824c,papA1 Rv3824c,GO:0016747; GO:0046506,IPR023213; IPR001242; ,,papA1,,SL659 acyltransferase papA1 (EC 2.3.1.-) (Polyketide synthase-associated protein A1),"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; sulfolipid biosynthetic process [GO:0046506]",9634230; 16573683; 17259623; 17592143; 21969609,,"FUNCTION: Catalyzes the acylation of trehalose-2-sulfate-2'-palmitate (SL659) by adding the (hydroxy)phthioceranoyl group at the 3'-position to yield the diacylated intermediate 2-palmitoyl-3-(C43)-phthioceranyl-alpha, alpha'-D-trehalose-2'-sulfate (SL1278) during the cell wall sulfolipid-1 (SL-1) biosynthesis. {ECO:0000269|PubMed:17259623, ECO:0000269|PubMed:17592143}.",MRIGPVELSAVKDWDPAPGVLVSWHPTPASCAKALAAPVSAVPPSYVQARQIRSFSEQAARGLDHSRLLIASVEVFGHCDLRAMTYVINAHLRRHDTYRSWFELRDTDHIVRHSIADPADIEFVPTTHGEMTSADLRQHIVATPDSLHWDCFSFGVIQRADSFTFYASIDHLHADGQFVGVGLMEFQSMYTALIMGEPPIGLSEAGSYVDFCVRQHEYTSALTVDSPEVRAWIDFAEINNGTFPEFPLPLGDPSVRCGGDLLSMMLMDEQQTQRFESACMAANARFIGGMLACIAIAIHELTGADTYFGITPKDIRTPADLMTQGWFTGQIPVTVPVAGLSFNEIARIAQTSFDTGADLAKVPFERVVELSPSLRRPQPLFSLVNFFDAQVGPLSAVTKLFEGLNVGTYSDGRVTYPLSTMVGRFDETAASVLFPDNPVARESVTAYLRAIRSVCMRIANGGTAERVGNVVALSPGRRNNIERMTWRSCRAGDFIDICNLKVANVTVDREA,"56,128",511,PapA acyltransferase family,sulfolipid biosynthetic process [GO:0046506],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
P9WIK7,PAPA2_MYCTU,Rv3820c,papA2 Rv3820c,GO:0016747; GO:0046506,IPR023213; IPR001242; ,,papA2,,Trehalose-2-sulfate acyltransferase papA2 (EC 2.3.1.-) (Polyketide synthase-associated protein A2),"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; sulfolipid biosynthetic process [GO:0046506]",9634230; 17259623; 17592143; 21969609,,"FUNCTION: Catalyzes the acylation of trehalose-2-sulfate by adding the palmitoyl group at the 2'-position to yield the intermediate trehalose-2-sulfate-2'-palmitate (SL659) during the cell wall sulfolipid-1 (SL-1) biosynthesis. {ECO:0000269|PubMed:17259623, ECO:0000269|PubMed:17592143}.",MFSITTLRDWTPDPGSIICWHASPTAKAKARQAPISEVPPSYQQAQHLRRYRDHVARGLDMSRLMIFTWDLPGRCNIRAMNYAINAHLRRHDTYHSWFEFDNAEHIVRHTIADPADIEVVQAEHQNMTSAELRHHIATPQPLQWDCFLFGIIQSDDHFTFYASIAHLCVDPMIVGVLFIEIHMMYSALVGGDPPIELPPAGRYDDHCVRQYADTAALTLDSARVRRWVEFAANNDGTLPHFPLPLGDLSVPHTGKLLTETLMDEQQGERFEAACVAAGARFSGGVFACAALAERELTNCETFDVVTTTDTRRTPTELRTTGWFTGLVPITVPVASGLFDSAARVAQISFDSGKDLATVPFDRVLELARPETGLRPPRPGNFVMSFLDASIAPLSTVANSDLNFRIYDEGRVSHQVSMWVNRYQHQTTVTVLFPDNPIASESVANYIAAMKSIYIRTADGTLATLKPGT,"52,150",468,PapA acyltransferase family,sulfolipid biosynthetic process [GO:0046506],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
P9WIG7,PE35_MYCTU,Rv3872,PE35 Rv3872,GO:0005576; GO:0009405; GO:0009986,IPR000084; ,P9WHW9,PE35,DOMAIN 1 90 PE. {ECO:0000255}.,PE family immunomodulator PE35,cell surface [GO:0009986]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 16030141; 16368961; 17328726; 17443846; 24467650,,"FUNCTION: Plays a major role in RD1-associated pathogenesis, and may contribute to the establishment and maintenance of M.tuberculosis infection. Together with PPE68, stimulates the secretion of IL-10 and MCP-1 from human macrophages, via the interaction with human Toll-like receptor 2 (TLR2). {ECO:0000269|PubMed:24467650}.",MEKMSHDPIAADIGTQVSDNALHGVTAGSTALTSVTGLVPAGADEVSAQAATAFTSEGIQLLASNASAQDQLHRAGEAVQDVARTYSQIDDGAAGVFAE,"9,928",99,Mycobacterial PE family,pathogenesis [GO:0009405],,cell surface [GO:0009986]; extracellular region [GO:0005576],,,1
Q6MWV0,PG61_MYCTU,Rv3653,PE_PGRS61 Rv3653,GO:0005576; GO:0005618; GO:0009986,,,PE_PGRS61,,PE-PGRS family protein PE_PGRS61,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],9634230; 27483162,,FUNCTION: Mediates Ca(2+)-dependent up-regulation of the anti-inflammatory cytokine IL-10. {ECO:0000269|PubMed:27483162}.,MLNAPTQALLGRPLVGNGANGAPGTGANGGDGGILFGSGGAGGSGAAGMAGGNGGAAGLFGNGGAGGAGGSATAGAAGAGGNGGAGGLLFGTAGAGGNGGLSLGLGVAGGAGGAGGSGGSDTAGHGGTGGAGGLLFGAGEDGTTPGGNGGAGGVAGLFGDGGNGGNAGVGTPAGNVGAGGTGGLLLGQDGMTGLT,"15,819",195,"Mycobacterial PE family, PGRS subfamily",,,cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P9WQB3,LEU1_MYCTU,Rv3710,leuA Rv3710 MTV025.058,GO:0000287; GO:0003852; GO:0005576; GO:0005886; GO:0008270; GO:0009098; GO:0030145; GO:0030955; GO:0040007,IPR013709; IPR002034; IPR013785; IPR005668; IPR036230; IPR000891; ,,leuA,DOMAIN 72 346 Pyruvate carboxyltransferase. {ECO:0000255|PROSITE-ProRule:PRU01151}.,2-isopropylmalate synthase (EC 2.3.3.13) (Alpha-IPM synthase) (Alpha-isopropylmalate synthase),extracellular region [GO:0005576]; plasma membrane [GO:0005886]; 2-isopropylmalate synthase activity [GO:0003852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium ion binding [GO:0030955]; zinc ion binding [GO:0008270]; growth [GO:0040007]; leucine biosynthetic process [GO:0009098],11914056; 9634230; 19099550; 21969609,X-ray crystallography (7),FUNCTION: Catalyzes the condensation of the acetyl group of acetyl-CoA with 3-methyl-2-oxobutanoate (2-oxoisovalerate) to form 3-carboxy-3-hydroxy-4-methylpentanoate (2-isopropylmalate). {ECO:0000255|HAMAP-Rule:MF_00572}.,MTTSESPDAYTESFGAHTIVKPAGPPRVGQPSWNPQRASSMPVNRYRPFAEEVEPIRLRNRTWPDRVIDRAPLWCAVDLRDGNQALIDPMSPARKRRMFDLLVRMGYKEIEVGFPSASQTDFDFVREIIEQGAIPDDVTIQVLTQCRPELIERTFQACSGAPRAIVHFYNSTSILQRRVVFRANRAEVQAIATDGARKCVEQAAKYPGTQWRFEYSPESYTGTELEYAKQVCDAVGEVIAPTPERPIIFNLPATVEMTTPNVYADSIEWMSRNLANRESVILSLHPHNDRGTAVAAAELGFAAGADRIEGCLFGNGERTGNVCLVTLGLNLFSRGVDPQIDFSNIDEIRRTVEYCNQLPVHERHPYGGDLVYTAFSGSHQDAINKGLDAMKLDADAADCDVDDMLWQVPYLPIDPRDVGRTYEAVIRVNSQSGKGGVAYIMKTDHGLSLPRRLQIEFSQVIQKIAEGTAGEGGEVSPKEMWDAFAEEYLAPVRPLERIRQHVDAADDDGGTTSITATVKINGVETEISGSGNGPLAAFVHALADVGFDVAVLDYYEHAMSAGDDAQAAAYVEASVTIASPAQPGEAGRHASDPVTIASPAQPGEAGRHASDPVTSKTVWGVGIAPSITTASLRAVVSAVNRAAR,"70,114",644,"Alpha-IPM synthase/homocitrate synthase family, LeuA type 2 subfamily",growth [GO:0040007]; leucine biosynthetic process [GO:0009098],2-isopropylmalate synthase activity [GO:0003852]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; potassium ion binding [GO:0030955]; zinc ion binding [GO:0008270],extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV025.058,1
P9WKH3,MHUD_MYCTU,Rv3592,mhuD Rv3592,GO:0004392; GO:0004497; GO:0005618; GO:0005886; GO:0020037; GO:0042167; GO:0046872,IPR007138; IPR011008; ,,mhuD,DOMAIN 3 92 ABM.,Heme-degrading monooxygenase HmoB (EC 1.14.14.18) (Heme oxygenase) (Mycobacterial heme utilization degrader) (MHUD),cell wall [GO:0005618]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497]; heme catabolic process [GO:0042167],9634230; 21969609; 19917297,X-ray crystallography (3),"FUNCTION: Catalyzes the oxidative degradation of the heme macrocyclic porphyrin ring in the presence of a suitable electron donor such as ascorbate or NADPH--cytochrome P450 reductase, with subsequent release of free iron. {ECO:0000269|PubMed:19917297}.",MPVVKINAIEVPAGAGPELEKRFAHRAHAVENSPGFLGFQLLRPVKGEERYFVVTHWESDEAFQAWANGPAIAAHAGHRANPVATGASLLEFEVVLDVGGTGKTA,"11,185",105,Antibiotic biosynthesis monooxygenase family,heme catabolic process [GO:0042167],heme binding [GO:0020037]; heme oxygenase (decyclizing) activity [GO:0004392]; metal ion binding [GO:0046872]; monooxygenase activity [GO:0004497],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WJU5,MMPL8_MYCTU,Rv3823c,mmpL8 Rv3823c MTCY409.07,GO:0005618; GO:0005829; GO:0005886; GO:0006869; GO:0016021; GO:0046506; GO:0071555,IPR004869; IPR000731; ,,mmpL8,,Sulfolipid-1 exporter MmpL8,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell wall organization [GO:0071555]; lipid transport [GO:0006869]; sulfolipid biosynthetic process [GO:0046506],9634230; 12724526; 15001577; 15908378; 16573683; 19099550; 22194604,,"FUNCTION: Required for the biosynthesis and the transport across the inner membrane of sulfolipid-1 (SL-1), which is a major cell wall lipid of pathogenic mycobacteria. Could also transport SL1278 (2-palmitoyl-3-(C43)-phthioceranyl-alpha, alpha'-D-trehalose-2'-sulfate), which is the precursor of SL-1. Required for virulence. {ECO:0000269|PubMed:12724526, ECO:0000269|PubMed:15001577, ECO:0000269|PubMed:15908378, ECO:0000269|PubMed:22194604}.",MCDVLMQPVRTPRPSTNLRSKPLRPTGDGGVFPRLGRLIVRRPWVVIAFWVALAGLLAPTVPSLDAISQRHPVAILPSDAPVLVSTRQMTAAFREAGLQSVAVVVLSDAKGLGAADERSYKELVDALRRDTRDVVMLQDFVTTPPLRELMTSKDNQAWILPVGLPGDLGSTQSKQAYARVADIVEHQVAGSTLTANLTGPAATVADLNLTGQRDRSRIEFAITILLLVILLIIYGNPITMVLPLITIGMSVVVAQRLVAIAGLAGLGIANQSIIFMSGMMVGAGTDYAVFLISRYHDYLRQGADSDQAVKKALTSIGKVIAASAATVAITFLGMVFTQLGILKTVGPMLGISVAVVFFAAVTLLPALMVLTGRRGWIAPRRDLTRRFWRSSGVHIVRRPKTHLLASALVLVILAGCAGLARYNYDDRKTLPASVESSIGYAALDKHFPSNLIIPEYLFIQSSTDLRTPKALADLEQMVQRVSQVPGVAMVRGITRPAGRSLEQARTSWQAGEVGSKLDEGSKQIAVHTGDIDKLAGGANLMASKLGDVRAQVNRAISTVGGLIDALAYLQDLLGGNRVLGELEGAEKLIGSMRALGDTIDADASFVANNTEWASPVLGALDSSPMCTADPACASARTELQRLVTARDDGTLAKISELARQLQATRAVQTLAATVSGLRGALATVIRAMGSLGMSSPGGVRSKINLVNKGVNDLADGSRQLAEGVQLLVDQVKKMGFGLGEASAFLLAMKDTATTPAMAGFYIPPELLSYATGESVKAETMPSEYRDLLGGLNVDQLKKVAAAFISPDGHSIRYLIQTDLNPFSTAAMDQIDAITAAARGAQPNTALADAKVSVVGLPVVLKDTRDYSDHDLRLIIAMTVCIVLLILIVLLRAIVAPLYLIGSVIVSYLAALGIGVIVFQFLLGQEMHWSIPGLTFVILVAVGADYNMLLISRLREEAVLGVRSGVIRTVASTGGVITAAGLIMAASMYGLVFASLGSVVQGAFVLGTGLLLDTFLVRTVTVPAIAVLVGQANWWLPSSWRPATWWPLGRRRGRAQRTKRKPLLPKEEEEQSPPDDDDLIGLWLHDGLRL,"115,998",1089,"Resistance-nodulation-cell division (RND) (TC 2.A.6) family, MmpL subfamily",cell wall organization [GO:0071555]; lipid transport [GO:0006869]; sulfolipid biosynthetic process [GO:0046506],,cell wall [GO:0005618]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY409.07,1
O69711,NMTR_MYCTU,Rv3744,nmtR Rv3744,GO:0003677; GO:0003700; GO:0006351; GO:0019217; GO:0046872,IPR011991; IPR001845; IPR036388; IPR036390; ,,nmtR,DOMAIN 15 109 HTH arsR-type. {ECO:0000255|PROSITE-ProRule:PRU00340}.,HTH-type transcriptional regulator NmtR,"DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of fatty acid metabolic process [GO:0019217]; transcription, DNA-templated [GO:0006351]",9634230; 12163508; 21969609; 22394357,,"FUNCTION: Represses transcription of ctpJ/nmtA, by binding to its promoter region. {ECO:0000269|PubMed:12163508}.",MGHGVEGRNRPSAPLDSQAAAQVASTLQALATPSRLMILTQLRNGPLPVTDLAEAIGMEQSAVSHQLRVLRNLGLVVGDRAGRSIVYSLYDTHVAQLLDEAIYHSEHLHLGLSDRHPSAG,"12,836",120,,"regulation of fatty acid metabolic process [GO:0019217]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],,,,3
O05458,MYCP2_MYCTU,Rv3886c,mycP2 Rv3886c,GO:0004252; GO:0005886; GO:0005887,IPR000209; IPR036852; IPR023827; IPR015500; IPR023834; ,,mycP2,DOMAIN 236 482 Peptidase S8. {ECO:0000255}.,Mycosin-2 (EC 3.4.21.-) (MycP2 protease),integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252],9634230; 10974545; 21969609,,,MASPLNRPGLRAAAASAALTLVALSANVPAAQAIPPPSVDPAMVPADARPGPDQPMRRSNSCSTPITVRNPDVAQLAPGFNLVNISKAWQYSTGNGVPVAVIDTGVSPNPRLPVVPGGDYIMGEDGLSDCDAHGTVVSSIIAAAPLGILPMPRAMPATAAFPPPAGPPPVTAAPAPPVEVPPPMPPPPPVTITQTVAPPPPPPEDAGAMAPSNGPPDPQTEDEPAVPPPPPGAPDGVVGVAPHATIISIRQSSRAFEPVNPSSAGPNSDEKVKAGTLDSVARAVVHAANMGAKVINISVTACLPAAAPGDQRVLGAALWYAATVKDAVIVAAAGNDGEAGCGNNPMYDPLDPSDPRDWHQVTVVSSPSWFSDYVLSVGAVDAYGAALDKSMSGPWVGVAAPGTHIMGLSPQGGGPVNAYPPSRPGEKNMPFWGTSFSAAYVSGVAALVRAKFPELTAYQVINRIVQSAHNPPAGVDNKLGYGLVDPVAALTFNIPSGDRMAPGAQSRVITPAAPPPPPDHRARNIAIGFVGAVATGVLAMAIGARLRRAR,"55,594",550,Peptidase S8 family,,serine-type endopeptidase activity [GO:0004252],integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WMK5,HOA_MYCTU,Rv3534c,Rv3534c,GO:0005618; GO:0008701; GO:0019439; GO:0046872,IPR017629; IPR013785; IPR012425; IPR035685; IPR000891; ,,,DOMAIN 7 259 Pyruvate carboxyltransferase. {ECO:0000255|PROSITE-ProRule:PRU01151}.,4-hydroxy-2-oxovalerate aldolase (HOA) (EC 4.1.3.39) (4-hydroxy-2-keto-pentanoic acid aldolase) (4-hydroxy-2-oxopentanoate aldolase),cell wall [GO:0005618]; 4-hydroxy-2-oxovalerate aldolase activity [GO:0008701]; metal ion binding [GO:0046872]; aromatic compound catabolic process [GO:0019439],9634230; 21969609,X-ray crystallography (1),FUNCTION: Catalyzes the retro-aldol cleavage of 4-hydroxy-2-oxopentanoate to pyruvate and acetaldehyde. Is involved in the meta-cleavage pathway for the degradation of aromatic compounds. {ECO:0000255|HAMAP-Rule:MF_01656}.,MTDMWDVRITDTSLRDGSHHKRHQFTKDEVGAIVAALDAAGVPVIEVTHGDGLGGSSFNYGFSKTPEQELIKLAAATAKEARIAFLMLPGVGTKDDIKEARDNGGSICRIATHCTEADVSIQHFGLARELGLETVGFLMMAHTIAPEKLAAQARIMADAGCQCVYVVDSAGALVLDGVADRVSALVAELGEDAQVGFHGHENLGLGVANSVAAVRAGAKQIDGSCRRFGAGAGNAPVEALIGVFDKIGVKTGIDFFDIADAAEDVVRPAMPAECLLDRNALIMGYSGVYSSFLKHAVRQAERYGVPASALLHRAGQRKLIGGQEDQLIDIALEIKRELDSGAAVTH,"36,442",346,4-hydroxy-2-oxovalerate aldolase family,aromatic compound catabolic process [GO:0019439],4-hydroxy-2-oxovalerate aldolase activity [GO:0008701]; metal ion binding [GO:0046872],cell wall [GO:0005618],,,1
P9WNC7,HPPK_MYCTU,Rv3606c,folK Rv3606c MTCY07H7B.16,GO:0003848; GO:0005524; GO:0016301; GO:0046654; GO:0046656,IPR000550; IPR035907; ,,folK,,"2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase (EC 2.7.6.3) (6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase) (PPPK) (7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase) (HPPK)",2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity [GO:0003848]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; folic acid biosynthetic process [GO:0046656]; tetrahydrofolate biosynthetic process [GO:0046654],9634230; 21969609,,,MTRVVLSVGSNLGDRLARLRSVADGLGDALIAASPIYEADPWGGVEQGQFLNAVLIADDPTCEPREWLRRAQEFERAAGRVRGQRWGPRNLDVDLIACYQTSATEALVEVTARENHLTLPHPLAHLRAFVLIPWIAVDPTAQLTVAGCPRPVTRLLAELEPADRDSVRLFRPSFDLNSRHPVSRAPES,"20,732",188,HPPK family,folic acid biosynthetic process [GO:0046656]; tetrahydrofolate biosynthetic process [GO:0046654],2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity [GO:0003848]; ATP binding [GO:0005524]; kinase activity [GO:0016301],,,MTCY07H7B.16,1
P9WJA1,HSAA_MYCTU,Rv3570c,hsaA Rv3570c,GO:0005886; GO:0006694; GO:0006707; GO:0016627; GO:0016712; GO:0019439; GO:0036383; GO:0044117; GO:0050660,IPR013107; IPR036250; IPR013786; IPR037069; IPR009100; ,,hsaA,,"Flavin-dependent monooxygenase, oxygenase subunit HsaA (EC 1.14.14.12) (3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4-hydroxylase, oxygenase subunit) (3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase)","plasma membrane [GO:0005886]; 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase activity [GO:0036383]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; growth of symbiont in host [GO:0044117]; steroid biosynthetic process [GO:0006694]",9634230; 17635188; 21969609; 20448045,X-ray crystallography (2),"FUNCTION: Catalyzes the o-hydroxylation of 3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione (3-HSA) to 3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione (3,4-DHSA) in the catabolism of cholesterol. Can use either FADH(2) or FMNH(2) as flavin cosubstrate. Also catalyzes the o-hydroxylation of a range of p-substituted phenols to generate the corresponding catechols. {ECO:0000269|PubMed:20448045}.",MTSIQQRDAQSVLAAIDNLLPEIRDRAQATEDLRRLPDETVKALDDVGFFTLLQPQQWGGLQCDPALFFEATRRLASVCGSTGWVSSIVGVHNWHLALFDQRAQEEVWGEDPSTRISSSYAPMGAGVVVDGGYLVNGSWNWSSGCDHASWTFVGGPVIKDGRPVDFGSFLIPRSEYEIKDVWYVVGLRGTGSNTLVVKDVFVPRHRFLSYKAMNDHTAGGLATNSAPVYKMPWGTMHPTTISAPIVGMAYGAYAAHVEHQGKRVRAAFAGEKAKDDPFAKVRIAEAASDIDAAWRQLIGNVSDEYALLAAGKEIPFELRARARRDQVRATGRSIASIDRLFEASGATALSNEAPIQRFWRDAHAGRVHAANDPERAYVIFGNHEFGLPPGDTMV,"43,143",394,HpaH/HsaA monooxygenase family,aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; growth of symbiont in host [GO:0044117]; steroid biosynthetic process [GO:0006694],"3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione monooxygenase activity [GO:0036383]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,,1
P9WKG9,ISPD_MYCTU,Rv3582c,ispD Rv3582c MTCY06G11.29c,GO:0000287; GO:0002135; GO:0005886; GO:0008270; GO:0030145; GO:0040007; GO:0050518; GO:0051484,IPR001228; IPR034683; IPR018294; IPR029044; ,,ispD,,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (EC 2.7.7.60) (4-diphosphocytidyl-2C-methyl-D-erythritol synthase) (MEP cytidylyltransferase) (MCT),"plasma membrane [GO:0005886]; 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity [GO:0050518]; CTP binding [GO:0002135]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270]; growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process [GO:0051484]",9634230; 19099550; 21969609,X-ray crystallography (4),FUNCTION: Catalyzes the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol from CTP and 2-C-methyl-D-erythritol 4-phosphate (MEP). {ECO:0000255|HAMAP-Rule:MF_00108}.,MVREAGEVVAIVPAAGSGERLAVGVPKAFYQLDGQTLIERAVDGLLDSGVVDTVVVAVPADRTDEARQILGHRAMIVAGGSNRTDTVNLALTVLSGTAEPEFVLVHDAARALTPPALVARVVEALRDGYAAVVPVLPLSDTIKAVDANGVVLGTPERAGLRAVQTPQGFTTDLLLRSYQRGSLDLPAAEYTDDASLVEHIGGQVQVVDGDPLAFKITTKLDLLLAQAIVRG,"24,074",231,"IspD/TarI cytidylyltransferase family, IspD subfamily","growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway involved in terpenoid biosynthetic process [GO:0051484]",2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase activity [GO:0050518]; CTP binding [GO:0002135]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; zinc ion binding [GO:0008270],plasma membrane [GO:0005886],,MTCY06G11.29c,1
O53554,ILVX_MYCTU,Rv3509c,ilvX Rv3509c,GO:0003984; GO:0005576; GO:0005618; GO:0005886; GO:0009097; GO:0009099; GO:0030976; GO:0046872,IPR029061; IPR012001; IPR011766; ,,ilvX,,Putative acetolactate synthase large subunit IlvX (ALS) (EC 2.2.1.6) (Acetohydroxy-acid synthase large subunit) (AHAS),cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; acetolactate synthase activity [GO:0003984]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976]; isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],9634230; 19099550; 20884690; 21969609,,"FUNCTION: Catalyzes the conversion of 2 pyruvate molecules into acetolactate in the first common step of the biosynthetic pathway of the branched-amino acids such as leucine, isoleucine, and valine. {ECO:0000250}.",MNGAQALINTLVDGGVDVCFANPGTSEMHFVAALDAVPRMRGMLTLFEGVATGAADGYARIAGRPAAVLLHLGPGLGNGLANLHNARRARVPMVVVVGDHATYHKKYDAPLESDIDAVAGTVSGWVRRTEAAADVGADAEAAIAASRSGSQIATLILPADVCWSDGAHAAAGVPAQAAAAPVDVGPVAGVLRSGEPAMMLIGGDATRGPGLTAAARIVQATGARWLCETFPTCLERGAGIPAVERLAYFAEGAAAQLDGVKHLVLAGARSPVSFFAYPGMPSDLVPAGCEVHVLAEPGGAADALAALADEVAPGTVAPVAGASRPQLPTGDLTSVSAADVVGALLPERAIVVDESNTCGVLLPQATAGAPAHDWLTLTGGAIGYGIPAAVGAAVAAPDRPVLCLESDGSAMYTISGLWSQARENLDVTTVIYNNGAYDILRIELQRVGAGSDPGPKALDLLDISRPTMDFVKIAEGMGVPARRVTTCEEFADALRAAFAEPGPHLIDVVVPSLVG,"52,072",515,TPP enzyme family,isoleucine biosynthetic process [GO:0009097]; valine biosynthetic process [GO:0009099],acetolactate synthase activity [GO:0003984]; metal ion binding [GO:0046872]; thiamine pyrophosphate binding [GO:0030976],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
P9WI55,IPYR_MYCTU,Rv3628,ppa Rv3628 MTCY15C10.24,GO:0000287; GO:0004427; GO:0005576; GO:0005829; GO:0005886; GO:0006796; GO:0044228,IPR008162; IPR036649; ,,ppa,,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase),cytosol [GO:0005829]; extracellular region [GO:0005576]; host cell surface [GO:0044228]; plasma membrane [GO:0005886]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796],9634230; 11339880; 21969609; 27097115; 16239227; 21821883; 26296329,X-ray crystallography (10),"FUNCTION: Catalyzes the hydrolysis of inorganic pyrophosphate (PPi) forming two phosphate ions. {ECO:0000269|PubMed:16239227, ECO:0000269|PubMed:26296329}.; FUNCTION: Antigen that activates dendritic cells (DCs), increasing their expression of cell surface molecules and augmenting their production of TNF-alpha, IL-1beta, IL-6, IL-23 and IL-12p70. Rv3628 mediates these effects by binding to TLR2 and activating downstream MyD88-, MAPK- and NF-kappaB-dependent signaling pathways. Rv3628-stimulated DCs induce the expansion of OVA-specific CD4+ and CD8+ T cells which secrete IFN-gamma and IL-2, and the generation of effector/memory T cells. Thus, Rv3628 polarizes DCs toward a Th1 immune response and promotes protective immunity against M.tuberculosis infection. Is not able to bind to TLR4 molecules on the cell surface. {ECO:0000269|PubMed:27097115}.",MQFDVTIEIPKGQRNKYEVDHETGRVRLDRYLYTPMAYPTDYGFIEDTLGDDGDPLDALVLLPQPVFPGVLVAARPVGMFRMVDEHGGDDKVLCVPAGDPRWDHVQDIGDVPAFELDAIKHFFVHYKDLEPGKFVKAADWVDRAEAEAEVQRSVERFKAGTH,"18,329",162,PPase family,phosphate-containing compound metabolic process [GO:0006796],inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287],cytosol [GO:0005829]; extracellular region [GO:0005576]; host cell surface [GO:0044228]; plasma membrane [GO:0005886],,MTCY15C10.24,1
P9WKG5,ISPF_MYCTU,Rv3581c,ispF Rv3581c MTCY06G11.28c,GO:0008685; GO:0019288; GO:0040007; GO:0046872; GO:0051483,IPR003526; IPR020555; IPR036571; ,,ispF,,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (MECDP-synthase) (MECPP-synthase) (MECPS) (EC 4.6.1.12)","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity [GO:0008685]; metal ion binding [GO:0046872]; growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process, mevalonate-independent [GO:0051483]",9634230; 19099550; 20189102; 21969609,,"FUNCTION: Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid compounds. Catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP). {ECO:0000269|PubMed:20189102}.",MNQLPRVGLGTDVHPIEPGRPCWLVGLLFPSADGCAGHSDGDVAVHALCDAVLSAAGLGDIGEVFGVDDPRWQGVSGADMLRHVVVLITQHGYRVGNAVVQVIGNRPKIGWRRLEAQAVLSRLLNAPVSVSATTTDGLGLTGRGEGLAAIATALVVSLR,"16,458",159,IspF family,"growth [GO:0040007]; isopentenyl diphosphate biosynthetic process, methylerythritol 4-phosphate pathway [GO:0019288]; terpenoid biosynthetic process, mevalonate-independent [GO:0051483]","2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase activity [GO:0008685]; metal ion binding [GO:0046872]",,,MTCY06G11.28c,1
P9WHQ9,HPRT_MYCTU,Rv3624c,hpt hprT Rv3624c MTCY15C10.28,GO:0000166; GO:0004422; GO:0005737; GO:0006166; GO:0006177; GO:0006188; GO:0032264; GO:0043101; GO:0046872; GO:0052657,IPR005904; IPR000836; IPR029057; ,,hpt,,Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8),cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; GMP biosynthetic process [GO:0006177]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine ribonucleoside salvage [GO:0006166]; purine-containing compound salvage [GO:0043101],9634230; 21969609,X-ray crystallography (7),,MHVTQSSSAITPGQTAELYPGDIKSVLLTAEQIQARIAELGEQIGNDYRELSATTGQDLLLITVLKGAVLFVTDLARAIPVPTQFEFMAVSSYGSSTSSSGVVRILKDLDRDIHGRDVLIVEDVVDSGLTLSWLSRNLTSRNPRSLRVCTLLRKPDAVHANVEIAYVGFDIPNDFVVGYGLDYDERYRDLSYIGTLDPRVYQ,"22,251",202,Purine/pyrimidine phosphoribosyltransferase family,GMP biosynthetic process [GO:0006177]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101]; purine ribonucleoside salvage [GO:0006166],guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166],cytoplasm [GO:0005737],hprT,MTCY15C10.28,1
P9WND9,HSAB_MYCTU,Rv3567c,hsaB Rv3567c,GO:0006694; GO:0006707; GO:0010181; GO:0016646; GO:0019439; GO:0036382; GO:0042602; GO:0050660,IPR002563; IPR012349; ,,hsaB,,"Flavin-dependent monooxygenase, reductase subunit HsaB (EC 1.5.1.36) (3-hydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4-hydroxylase, reductase subunit) (Flavin:NADH reductase)","flavin adenine dinucleotide binding [GO:0050660]; flavin reductase (NADH) activity [GO:0036382]; FMN binding [GO:0010181]; oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO:0016646]; riboflavin reductase (NADPH) activity [GO:0042602]; aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; steroid biosynthetic process [GO:0006694]",9634230; 17635188; 20448045,,"FUNCTION: Catalyzes the reduction of free flavins (FMN or FAD) by NADH. Subsequently, the reduced flavins diffuse to the HsaA oxygenase subunit. {ECO:0000269|PubMed:20448045}.",MSAQIDPRTFRSVLGQFCTGITVITTVHDDVPVGFACQSFAALSLEPPLVLFCPTKVSRSWQAIEASGRFCVNVLTEKQKDVSARFGSKEPDKFAGIDWRPSELGSPIIEGSLAYIDCTVASVHDGGDHFVVFGAVESLSEVPAVKPRPLLFYRGDYTGIEPEKTTPAHWRDDLEAFLITTTQDTWL,"20,539",187,Non-flavoprotein flavin reductase family,aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; steroid biosynthetic process [GO:0006694],"flavin adenine dinucleotide binding [GO:0050660]; flavin reductase (NADH) activity [GO:0036382]; FMN binding [GO:0010181]; oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO:0016646]; riboflavin reductase (NADPH) activity [GO:0042602]",,,,1
P9WNW7,HSAC_MYCTU,Rv3568c,hsaC bphC Rv3568c,GO:0005506; GO:0006707; GO:0008198; GO:0009405; GO:0019439; GO:0047071; GO:0070723,IPR029068; IPR004360; IPR037523; IPR000486; ,,hsaC,DOMAIN 5 120 VOC 1. {ECO:0000255|PROSITE-ProRule:PRU01163}.; DOMAIN 142 270 VOC 2. {ECO:0000255|PROSITE-ProRule:PRU01163}.,Iron-dependent extradiol dioxygenase (EC 1.13.11.25),"3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase activity [GO:0047071]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]; aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]; response to cholesterol [GO:0070723]",9634230; 17635188; 17264217; 21969609; 19300498,X-ray crystallography (2),"FUNCTION: Catalyzes the meta-cleavage of 3,4-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione (3,4-DHSA) to produce 4,5-9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid (4,9-DSHA). {ECO:0000269|PubMed:17264217}.",MSIRSLGYLRIEATDMAAWREYGLKVLGMVEGKGAPEGALYLRMDDFPARLVVVPGEHDRLLEAGWECANAEGLQEIRNRLDLEGTPYKEATAAELADRRVDEMIRFADPSGNCLEVFHGTALEHRRVVSPYGHRFVTGEQGMGHVVLSTRDDAEALHFYRDVLGFRLRDSMRLPPQMVGRPADGPPAWLRFFGCNPRHHSLAFLPMPTSSGIVHLMVEVEQADDVGLCLDRALRRKVPMSATLGRHVNDLMLSFYMKTPGGFDIEFGCEGRQVDDRDWIARESTAVSLWGHDFTVGARG,"33,582",300,Extradiol ring-cleavage dioxygenase family,aromatic compound catabolic process [GO:0019439]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]; response to cholesterol [GO:0070723],"3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase activity [GO:0047071]; ferrous iron binding [GO:0008198]; iron ion binding [GO:0005506]",,bphC,,1
P9WK63,LPQE_MYCTU,Rv3584,lpqE Rv3584 MTV024.02,GO:0005576; GO:0005618; GO:0005886,,,lpqE,,Putative lipoprotein LpqE,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],9634230; 21969609,,,MNRCNIRLRLAGMTTWVASIALLAAALSGCGAGQISQTANQKPAVNGNRLTINNVLLRDIRIQAVQTSDFIQPGKAVDLVLVAVNQSPDVSDRLVGITSDIGSVTVAGDARLPASGMLFVGTPDGQIVAPGPLPSNQAAKATVNLTKPIANGLTYNFTFKFEKAGQGSVMVPISAGLATPHE,"18,819",182,,,,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV024.02,1
P9WK61,LPQH_MYCTU,Rv3763,lpqH Rv3763 MTV025.111,GO:0005618; GO:0005886; GO:0009405; GO:0009986; GO:0030430; GO:0044117; GO:0046789; GO:0052151; GO:0052157; GO:0052553; GO:0097691,IPR008691; ,,lpqH,,Lipoprotein LpqH (19 kDa lipoprotein antigen) (Putative transporter LpqH) (p19),bacterial extracellular vesicle [GO:0097691]; cell surface [GO:0009986]; cell wall [GO:0005618]; host cell cytoplasm [GO:0030430]; plasma membrane [GO:0005886]; host cell surface receptor binding [GO:0046789]; growth of symbiont in host [GO:0044117]; modulation by symbiont of host immune response [GO:0052553]; modulation by symbiont of microbe-associated molecular pattern-induced host innate immune response [GO:0052157]; pathogenesis [GO:0009405]; positive regulation by symbiont of host apoptotic process [GO:0052151],2493628; 3132709; 9634230; 1906192; 8670858; 10426995; 11123323; 11160304; 11441098; 12594264; 12874328; 16098710; 16177361; 16622205; 17804126; 21078852; 21364279; 21969609; 23316255; 24093492; 25041568; 25359607; 25504154; 20234378; ,X-ray crystallography (1),"FUNCTION: Based on its structure might be involved in ligand transport (Ref.25) (By similarity). {ECO:0000250|UniProtKB:P65307, ECO:0000305|Ref.25}.; FUNCTION: A host TLR2 agonist (PubMed:10426995, PubMed:11441098, PubMed:12874328). Plays a complicated role in bacterial interactions with the host immune system; some effects favor the host (induces interleukin 1-beta and IL-12 p40 (IL12B), both increase the host's immune response) while others favor the bacteria (increases growth in monocyte-derived macrophages and decreases host MHC class II (MHC-II) expression and antigen processing) (PubMed:16177361). Induces host (human and mouse) IL-12 p40 (IL12B, a proinflammatory cytokine) release by monocyte cell lines via TLR2 and CD14 (PubMed:10426995). Induces host (human) monocytes to produce TNF-alpha, IL-6 and IL-12 p40; LpqH is a more potent inducer than PstS1 (PubMed:16622205). Inhibits MHC-II expression and antigen processing in host (mouse) macrophages via TLR2 (independently of TLR4) probably via the lipid modification (PubMed:11441098). Stimulates host (human) dendritic cell maturation to become MHC-II-positive antigen presenting cells via TLR2, which depends on lipidation; nonlipidated protein does not stimulate maturation (PubMed:11160304). Inhibits host (human and mouse) IFN-gamma signaling in macrophages via TLR2; decreases IFN-gamma stimulated MHC-II antigen processing as well as decreasing IFN-gamma-mediated up-regulation of immunoglobulin gamma Fc receptor (FCGR1A), enabling the bacteria to evade the immune system (PubMed:12874328). In resting human CD4+ T-cells lipidated (but probably not nonlipidated protein) is a costimulatory ligand (with anti-CD3 and anti-CD28) for T-cell proliferation and IFN-gamma and IL-2 production (PubMed:21078852). Human CD4+ T-cells probably use TLR1/TLR2 heterodimers to respond to mycobacterial lipoproteins (PubMed:21078852). Acting via TLR2 enhances expression of host peroxisome proliferator-activated receptor gamma (PPARG), a regulator of inflammation and immunoregulation, and increases p38 MAPK phosphorylation, IL-6 and TNF-alpha expression (PubMed:25504154). Native or nonlipidated recombinant protein missing the first 4 residues have been shown to induce apoptosis in the human macrophage cell line THP-1 and human monocyte-derived macrophages in a TLR2, caspase-3 and caspase-8-dependent manner (PubMed:12594264). Protein overexpressed in M.smegmatis (lipidated and probably glycosylated) induces apoptosis in human macrophages via TLR2 in a caspase-3/caspase-8-mediated manner, but also in a caspase-independent manner where mitochondrial apoptosis-inducing factor (AIFM1) translocates to the nucleus (PubMed:23316255). Another study found mature, native (lipidated) protein did not induce apoptosis in THP-1 macrophage cell line (PubMed:12874328). Functions as an adhesin, binds to human and mouse macrophages (PubMed:25359607). {ECO:0000269|PubMed:10426995, ECO:0000269|PubMed:11160304, ECO:0000269|PubMed:11441098, ECO:0000269|PubMed:12594264, ECO:0000269|PubMed:12874328, ECO:0000269|PubMed:16177361, ECO:0000269|PubMed:16622205, ECO:0000269|PubMed:21078852, ECO:0000269|PubMed:23316255, ECO:0000269|PubMed:25359607, ECO:0000269|PubMed:25504154}.",MKRGLTVAVAGAAILVAGLSGCSSNKSTTGSGETTTAAGTTASPGAASGPKVVIDGKDQNVTGSVVCTTAAGNVNIAIGGAATGIAAVLTDGNPPEVKSVGLGNVNGVTLGYTSGTGQGNASATKDGSHYKITGTATGVDMANPMSPVNKSFEIEVTCS,"15,147",159,Mycobacterial 19 kDa antigen family,growth of symbiont in host [GO:0044117]; modulation by symbiont of host immune response [GO:0052553]; modulation by symbiont of microbe-associated molecular pattern-induced host innate immune response [GO:0052157]; pathogenesis [GO:0009405]; positive regulation by symbiont of host apoptotic process [GO:0052151],host cell surface receptor binding [GO:0046789],bacterial extracellular vesicle [GO:0097691]; cell surface [GO:0009986]; cell wall [GO:0005618]; host cell cytoplasm [GO:0030430]; plasma membrane [GO:0005886],,MTV025.111,1
P9WIP7,LSR2_MYCTU,Rv3597c,lsr2 Rv3597c MTCY07H7B.25,GO:0003677; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0009295; GO:0009405; GO:0010039; GO:0040007; GO:0042262; GO:0042542; GO:0071453,IPR024412; ,,lsr2,,Nucleoid-associated protein Lsr2,"cell wall [GO:0005618]; cytosol [GO:0005829]; nucleoid [GO:0009295]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; cellular response to oxygen levels [GO:0071453]; DNA protection [GO:0042262]; growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; transcription, DNA-templated [GO:0006351]",9634230; 17590082; 18187505; 19237572; 21969609; 21673140; 24895305; 20133735; 22719899,NMR spectroscopy (1); X-ray crystallography (2),"FUNCTION: DNA-bridging protein that has both architectural and regulatory roles (PubMed:18187505). Influences the organization of chromatin and gene expression by binding non-specifically to DNA, with a preference for AT-rich sequences, and bridging distant DNA segments (PubMed:20133735). Binds in the minor groove of AT-rich DNA (PubMed:21673140). Represses expression of multiple genes involved in a broad range of cellular processes, including major virulence factors or antibiotic-induced genes, such as iniBAC or efpA (PubMed:17590082), and genes important for adaptation of changing O(2) levels (PubMed:24895305). May also activate expression of some gene (PubMed:24895305). May coordinate global gene regulation and virulence (PubMed:20133735). Also protects mycobacteria against reactive oxygen intermediates during macrophage infection by acting as a physical barrier to DNA degradation (PubMed:19237572); the physical protection has been questioned (PubMed:24895305). A strain overexpressing this protein consumes O(2) more slowly than wild-type (PubMed:24895305). {ECO:0000269|PubMed:17590082, ECO:0000269|PubMed:18187505, ECO:0000269|PubMed:19237572, ECO:0000269|PubMed:20133735, ECO:0000269|PubMed:21673140, ECO:0000269|PubMed:24895305}.",MAKKVTVTLVDDFDGSGAADETVEFGLDGVTYEIDLSTKNATKLRGDLKQWVAAGRRVGGRRRGRSGSGRGRGAIDREQSAAIREWARRNGHNVSTRGRIPADVIDAYHAAT,"12,098",112,Lsr2 family,"cellular response to oxygen levels [GO:0071453]; DNA protection [GO:0042262]; growth [GO:0040007]; pathogenesis [GO:0009405]; regulation of transcription, DNA-templated [GO:0006355]; response to hydrogen peroxide [GO:0042542]; response to iron ion [GO:0010039]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cell wall [GO:0005618]; cytosol [GO:0005829]; nucleoid [GO:0009295]; plasma membrane [GO:0005886],,MTCY07H7B.25,1
O69690,LUCA_MYCTU,Rv3723,lucA Rv3723,GO:0005887; GO:0009405,,,lucA,,Lipid uptake coordinator A,integral component of plasma membrane [GO:0005887]; pathogenesis [GO:0009405],9634230; 21969609; 28708968,,"FUNCTION: Required for the import of both fatty acids and cholesterol during growth in macrophages and in axenic culture. Facilitates the uptake of these lipids by stabilizing protein subunits of the Mce1 and Mce4 multi-subunit transporters, which transport fatty acids and cholesterol, respectively. Required for full virulence in vivo. {ECO:0000269|PubMed:28708968}.",MGRKVAVLWHASFSIGAGVLYFYFVLPRWPELMGDTGHSLGTGLRIATGALVGLAALPVVFTLLRTRKPELGTPQLALSMRIWSIMAHVLAGALIVGTAISEVWLSLDAAGQWLFGIYGAAAAIAVLGFFGFYLSFVAELPPPPPKPLKPKKPKQRRLRRKKTAKGDEAEPEAAEEAENTELAAQEDEEAVEAPPESIESPGGEPESATREAPAAETATAEEPRGGLRNRRPTGKTSHRRRRTRSGVQVAKVDE,"27,367",254,,pathogenesis [GO:0009405],,integral component of plasma membrane [GO:0005887],,,1
P71858,CHSE2_MYCTU,Rv3543c,fadE29 Rv3543c,GO:0006707; GO:0009405; GO:0016627; GO:0033539; GO:0044117; GO:0071949,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE29,,"Acyl-CoA dehydrogenase FadE29 (ACAD) (EC 1.3.99.-) (3-oxo-23,24-bisnorchol-4-en-22-oyl-CoA dehydrogenase beta subunit) (3-oxo-4-pregnene-20-carboxyl-CoA dehydrogenase beta subunit)","FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]",9634230; 17635188; 22045806; 21969609; 23560677; 26161441,,"FUNCTION: Involved in the third cycle of side chain dehydrogenation in the beta-oxidation of cholesterol catabolism (PubMed:26161441). Contributes partly to the virulence by increasing the efficiency of beta-oxidation (PubMed:22045806, PubMed:23560677). Catalyzes the dehydrogenation of 2'-propanoyl-CoA ester side chains of 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) to yield 3-oxo-4,17-pregnadiene-20-carboxyl-CoA (3-OPDC-CoA). Also able to dehydrogenate steroyl-CoA such as 3-oxo-chol-4-en-24-oyl-CoA (3-OCO-CoA), 1beta-(2'-propanoyl-CoA)-3a-alpha-H- 7a-beta-methylhexahydro-4-indanone (indanone-CoA ester), hexahydroindanone and pregenenone (PubMed:22045806, PubMed:23560677). {ECO:0000269|PubMed:22045806, ECO:0000269|PubMed:23560677, ECO:0000269|PubMed:26161441}.",MFIDLTPEQRQLQAEIRQYFSNLISPDERTEMEKDRHGPAYRAVIRRMGRDGRLGVGWPKEFGGLGFGPIEQQIFVNEAHRADVPLPAVTLQTVGPTLQAHGSELQKKKFLPAILAGEAHFAIGYTEPEAGTDLASLRTTAVRDGDHYIVNGQKVFTTGAHDADYIWLACRTDPNAAKHKGISILIVDTKDPGYSWTPIILADGAHHTNATYYNDVRVPVDMLVGKENDGWRLITTQLNNERVMLGPAGRFASIYDRVHAWASVPGGNGVTPIDHDDVKRALGEIRAIWRINELLNWQVASAGEDINMADAAATKVFGTERVQRAGRLAEEIVGKYGNPAEPDTAELLRWLDAQTKRNLVITFGGGVNEVMREMIAASGLKVPRVPR,"42,715",387,Acyl-CoA dehydrogenase family,cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405],"FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,2
P9WPA1,COAX_MYCTU,Rv3600c,coaX Rv3600c,GO:0005524; GO:0005737; GO:0005886; GO:0015937; GO:0016301; GO:0046872,IPR004619; ,,coaX,,Type III pantothenate kinase (EC 2.7.1.33) (PanK-III) (Pantothenic acid kinase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; coenzyme A biosynthetic process [GO:0015937],9634230; 21969609,,"FUNCTION: Catalyzes the phosphorylation of pantothenate (Pan), the first step in CoA biosynthesis. {ECO:0000255|HAMAP-Rule:MF_01274}.",MLLAIDVRNTHTVVGLLSGMKEHAKVVQQWRIRTESEVTADELALTIDGLIGEDSERLTGTAALSTVPSVLHEVRIMLDQYWPSVPHVLIEPGVRTGIPLLVDNPKEVGADRIVNCLAAYDRFRKAAIVVDFGSSICVDVVSAKGEFLGGAIAPGVQVSSDAAAARSAALRRVELARPRSVVGKNTVECMQAGAVFGFAGLVDGLVGRIREDVSGFSVDHDVAIVATGHTAPLLLPELHTVDHYDQHLTLQGLRLVFERNLEVQRGRLKTAR,"29,305",272,Type III pantothenate kinase family,coenzyme A biosynthetic process [GO:0015937],ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
P9WPM5,CP137_MYCTU,Rv3685c,cyp137 Rv3685c MTV025.033c,GO:0004497; GO:0005506; GO:0005886; GO:0016125; GO:0016491; GO:0016705; GO:0020037,IPR001128; IPR017972; IPR002401; IPR036396; ,,cyp137,,Putative cytochrome P450 137 (EC 1.14.-.-),"plasma membrane [GO:0005886]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; sterol metabolic process [GO:0016125]",9634230; 21969609,,,MVLRSLASPAALTDPKRCASVVGVAAFAVRREHAPDALGGPPGLPAPRGFRAAFAAAYAVAYLAGGERRMLRLIRRYGPIMTMPILSLGDVAIVSDSALAKEVFTAPTDVLLGGEGVGPAAAIYGSGSMFVQEEPEHLRRRKLLTPPLHGAALDRYVPIIENSTRAAMHTWPVDRPFAMLTVARSLMLDVIVKVIFGVDDPEEVRRLGRPFERLLNLGVSEQLTVRYALRRLGALRVWPARARANTEIDDVVMALIAQRRADPRLGERHDVLSLLVSARGESGEQLSDSEIRDDLITLVLAGHETTATTLAWAFDLLLHHPDALRRVRAEAVGGGEAFTTAVINETLRVRPPAPLTARVAAQPLTIGGYRVEAGTRIVVHIIAINRSAEVYEHPHEFRPERFLGTRPQTYAWVPFGGGVKRCLGANFSMRELITVLHVLLREGEFTAVDDEPERIVRRSIMLVPRRGTRVRFRPAR,"52,266",476,Cytochrome P450 family,sterol metabolic process [GO:0016125],"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",plasma membrane [GO:0005886],,MTV025.033c,1
P9WPC9,CLPC1_MYCTU,Rv3596c,clpC1 Rv3596c MTCY07H7B.26,GO:0005524; GO:0005618; GO:0005829; GO:0005886; GO:0016887; GO:0019538; GO:0040007; GO:0042803; GO:0044183,IPR003593; IPR003959; IPR019489; IPR004176; IPR036628; IPR001270; IPR018368; IPR027417; IPR001943; ,P9WNK5,clpC1,DOMAIN 425 460 UVR. {ECO:0000255|PROSITE-ProRule:PRU00217}.,ATP-dependent Clp protease ATP-binding subunit ClpC1,cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803]; growth [GO:0040007]; protein metabolic process [GO:0019538],9634230; 20025669; 21969609,X-ray crystallography (4),"FUNCTION: ATP-dependent specificity component of the Clp protease. It directs the protease to specific substrates. Can perform chaperone functions in the absence of ClpP (By similarity). Degrades anti-sigma-E factor RseA in the presence of ClpP2. {ECO:0000250, ECO:0000269|PubMed:20025669}.",MFERFTDRARRVVVLAQEEARMLNHNYIGTEHILLGLIHEGEGVAAKSLESLGISLEGVRSQVEEIIGQGQQAPSGHIPFTPRAKKVLELSLREALQLGHNYIGTEHILLGLIREGEGVAAQVLVKLGAELTRVRQQVIQLLSGYQGKEAAEAGTGGRGGESGSPSTSLVLDQFGRNLTAAAMEGKLDPVIGREKEIERVMQVLSRRTKNNPVLIGEPGVGKTAVVEGLAQAIVHGEVPETLKDKQLYTLDLGSLVAGSRYRGDFEERLKKVLKEINTRGDIILFIDELHTLVGAGAAEGAIDAASILKPKLARGELQTIGATTLDEYRKYIEKDAALERRFQPVQVGEPTVEHTIEILKGLRDRYEAHHRVSITDAAMVAAATLADRYINDRFLPDKAIDLIDEAGARMRIRRMTAPPDLREFDEKIAEARREKESAIDAQDFEKAASLRDREKTLVAQRAEREKQWRSGDLDVVAEVDDEQIAEVLGNWTGIPVFKLTEAETTRLLRMEEELHKRIIGQEDAVKAVSKAIRRTRAGLKDPKRPSGSFIFAGPSGVGKTELSKALANFLFGDDDALIQIDMGEFHDRFTASRLFGAPPGYVGYEEGGQLTEKVRRKPFSVVLFDEIEKAHQEIYNSLLQVLEDGRLTDGQGRTVDFKNTVLIFTSNLGTSDISKPVGLGFSKGGGENDYERMKQKVNDELKKHFRPEFLNRIDDIIVFHQLTREEIIRMVDLMISRVAGQLKSKDMALVLTDAAKALLAKRGFDPVLGARPLRRTIQREIEDQLSEKILFEEVGPGQVVTVDVDNWDGEGPGEDAVFTFTGTRKPPAEPDLAKAGAHSAGGPEPAAR,"93,552",848,"ClpA/ClpB family, ClpC subfamily",growth [GO:0040007]; protein metabolic process [GO:0019538],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY07H7B.26,1
P9WPK7,EGTA_MYCTU,Rv3704c,egtA gshA Rv3704c,GO:0004357; GO:0005524; GO:0005886; GO:0006750; GO:0052699,IPR017809; IPR035434; IPR006336; IPR014746; ,,egtA,,Glutamate--cysteine ligase EgtA (EC 6.3.2.2) (Gamma-glutamylcysteine synthase) (GCS) (Gamma-ECS),plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357]; ergothioneine biosynthetic process [GO:0052699]; glutathione biosynthetic process [GO:0006750],9634230; 16262797; 19099550; 21969609,,"FUNCTION: Catalyzes the synthesis of gamma-glutamylcysteine (gamma-GC) (PubMed:16262797). This compound is used as substrate for the biosynthesis of the low-molecular thiol compound ergothioneine (By similarity). {ECO:0000250|UniProtKB:A0R5N1, ECO:0000269|PubMed:16262797}.",MTLAAMTAAASQLDNAAPDDVEITDSSAAAEYIADGCLVDGPLGRVGLEMEAHCFDPADPFRRPSWEEITEVLEWLSPLPGGSVVSVEPGGAVELSGPPADGVLAAIGAMTRDQAVLRSALANAGLGLVFLGADPLRSPVRVNPGARYRAMEQFFAASHSGVPGAAMMTSTAAIQVNLDAGPQEGWAERVRLAHALGPTMIAIAANSPMLGGRFSGWQSTRQRVWGQMDSARCGPILGASGDHPGIDWAKYALKAPVMMVRSPDTQDTRAVTDYVPFTDWVDGRVLLDGRRATVADLVYHLTTLFPPVRPRQWLEIRYLDSVPDEVWPAVVFTLVTLLDDPVAADLAVDAVEPVATAWDTAARIGLADRRLYLAANRCLAIAARRVPTELIGAMQRLVDHVDRGVCPADDFSDRVIAGGIASAVTGMMHGAS,"45,795",432,"Glutamate--cysteine ligase type 2 family, EgtA subfamily",ergothioneine biosynthetic process [GO:0052699]; glutathione biosynthetic process [GO:0006750],ATP binding [GO:0005524]; glutamate-cysteine ligase activity [GO:0004357],plasma membrane [GO:0005886],gshA,,1
O69671,EGTB_MYCTU,Rv3703c,egtB Rv3703c,GO:0004497; GO:0008198; GO:0016491; GO:0052704,IPR016187; IPR024775; IPR034660; IPR017806; IPR032890; IPR005532; ,,egtB,,Hercynine oxygenase (EC 1.14.99.50) (Gamma-glutamyl hercynylcysteine S-oxide synthase),"ferrous iron binding [GO:0008198]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]",9634230; 21969609,,"FUNCTION: Catalyzes the oxidative sulfurization of hercynine (N-alpha,N-alpha,N-alpha-trimethyl-L-histidine) into hercynyl-gamma-L-glutamyl-L-cysteine sulfoxide, a step in the biosynthesis pathway of ergothioneine. Ergothioneine is an antioxidant that protects mycobacteria from oxidative stress. {ECO:0000250|UniProtKB:A0R5N0, ECO:0000250|UniProtKB:Q7D513}.",MTSPEQLACHLARARARTLRLVDFDDAELCCQYDPLMSPLVWDLAHIGQQEELWLLRGGDPGQPGLLPPAVEGLYDAFEHSRASRVELPLLSPARARSYCATVRSAALDALAALPEDGDSFVFAMVISHENQHDETMLQALNLRTGSPLLAATSALPAGRPRMAGTSVLVAGGPFVLGVDAADEPCSLDNERPAHVVDVPAFRIGRVPVTNGEWQDFIDDGGYTQSRWWSERGWQHRQRAGLTAPQFWRSGGRTRTRFGHVEDIPADEPVQHVSYFEAEAYAAWAGARLPTEVEWEKACAWDPATGSRRRYPWGTEEPTDTYANLGGQTLRPAPVGAYPAGASACGAEQMLGDVWEWTTSPLRPWPGFVPMVYERYSQPFFGGDYRVLRGGSWAVEPAILRPSFRNWDHPYRRQIFAGVRLAWDI,"47,139",425,EgtB family,"ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]",ferrous iron binding [GO:0008198]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491],,,,1
P9WN47,EGTD_MYCTU,Rv3701c,egtD Rv3701c,GO:0005886; GO:0008276; GO:0030745; GO:0052704; GO:0052707,IPR035094; IPR032888; IPR019257; IPR017804; IPR029063; ,,egtD,,Histidine N-alpha-methyltransferase (EC 2.1.1.44) (Histidine trimethyltransferase),"plasma membrane [GO:0005886]; dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]",9634230; 21969609,,"FUNCTION: Catalyzes the SAM-dependent triple methylation of the alpha-amino group of histidine to form hercynine, a step in the biosynthesis pathway of ergothioneine. {ECO:0000250|UniProtKB:A0R5M8}.",MRVSVANHLGEDAGHLALRRDVYSGLQKTPKSLPPKWFYDTVGSELFDQITRLPEYYPTRAEAEILRARSAEVASACRADTLVELGSGTSEKTRMLLDALRHRGSLRRFVPFDVDASVLSATATAIQREYSGVEINAVCGDFEEHLTEIPRGGRRLFVFLGSTIGNLTPGPRAQFLTALAGVMRPGDSLLLGTDLVKDAARLVRAYDDPGGVTAQFNRNVLAVINRELEADFDVDAFQHVARWNSAEERIEMWLRADGRQRVRVGALDLTVDFDAGEEMLTEVSCKFRPQAVGAELAAAGLHRIRWWTDEAGDFGLSLAAK,"35,404",321,"Methyltransferase superfamily, EgtD family","ergothioneine biosynthesis from histidine via N-alpha,N-alpha,N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha,N-alpha,N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707]",dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276],plasma membrane [GO:0005886],,,1
P9WJD9,ESPB_MYCTU,Rv3881c,espB mtb48 Rv3881c MTV027.16c,GO:0005576; GO:0009405; GO:0042802; GO:0044315,,Itself,espB,,ESX-1 secretion-associated protein EspB (Antigen MTB48),extracellular region [GO:0005576]; identical protein binding [GO:0042802]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],11427558; 9634230; 12586418; 17676952; 20227664; 21969609; 23620593; 24113528; 23869560; 25641595; 25299337; 26051906; 25684576,Electron microscopy (1); X-ray crystallography (4),"FUNCTION: Required for host-cell death and may support an EsxA-independent virulence function (PubMed:23869560). Secreted processed form of EspB binds to phosphatidic acid and phosphatidylserine (PubMed:23869560). Inhibits IFN-gamma-induced autophagy in murine macrophages (PubMed:25641595). {ECO:0000269|PubMed:23869560, ECO:0000269|PubMed:25641595}.",MTQSQTVTVDQQEILNRANEVEAPMADPPTDVPITPCELTAAKNAAQQLVLSADNMREYLAAGAKERQRLATSLRNAAKAYGEVDEEAATALDNDGEGTVQAESAGAVGGDSSAELTDTPRVATAGEPNFMDLKEAARKLETGDQGASLAHFADGWNTFNLTLQGDVKRFRGFDNWEGDAATACEASLDQQRQWILHMAKLSAAMAKQAQYVAQLHVWARREHPTYEDIVGLERLYAENPSARDQILPVYAEYQQRSEKVLTEYNNKAALEPVNPPKPPPAIKIDPPPPPQEQGLIPGFLMPPSDGSGVTPGTGMPAAPMVPPTGSPGGGLPADTAAQLTSAGREAAALSGDVAVKAASLGGGGGGGVPSAPLGSAIGGAESVRPAGAGDIAGLGQGRAGGGAALGGGGMGMPMGAAHQGQGGAKSKGSQQEDEALYTEDRAWTEAVIGNRRRQDSKESK,"47,594",460,EspB family,pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],identical protein binding [GO:0042802],extracellular region [GO:0005576],mtb48,MTV027.16c,1
P9WJD7,ESPC_MYCTU,Rv3615c,espC snm9 Rv3615c MTCY07H7B.07,GO:0005576; GO:0005618; GO:0009405; GO:0042783; GO:0044315,IPR022536; ,,espC,,ESX-1 secretion-associated protein EspC,cell wall [GO:0005618]; extracellular region [GO:0005576]; active evasion of host immune response [GO:0042783]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 16135231; 16573683; 18685700; 19682254; 21969609; 21427227; 22389481; 23104803; 24280763; 25536998; 26048138,,"FUNCTION: Required for ESX-1 function. Required for either stability or expression of EspA. {ECO:0000269|PubMed:16135231, ECO:0000269|PubMed:19682254}.",MTENLTVQPERLGVLASHHDNAAVDASSGVEAAAGLGESVAITHGPYCSQFNDTLNVYLTAHNALGSSLHTAGVDLAKSLRIAAKIYSEADEAWRKAIDGLFT,"10,795",103,EspC family,active evasion of host immune response [GO:0042783]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],,cell wall [GO:0005618]; extracellular region [GO:0005576],snm9,MTCY07H7B.07,1
P9WNK5,ESXB_MYCTU,Rv3874,esxB cfp10 lhp mtsA10 Rv3874 MTV027.09,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0044165; GO:0044228; GO:0044315; GO:0046812,IPR036689; IPR010310; ,P9WPC9; P9WNB1; P9WNK7,esxB,,ESAT-6-like protein EsxB (10 kDa culture filtrate antigen CFP-10) (CFP-10) (Secreted antigenic protein MTSA-10),cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell endoplasmic reticulum [GO:0044165]; host cell surface [GO:0044228]; plasma membrane [GO:0005886]; host cell surface binding [GO:0046812]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9846755; 9634230; 11940590; 14557547; 14557536; 14756778; 15378760; 16030141; 16048998; 16368961; 16973880; 17604718; 17557817; 17433643; 19265145; 19876390; 19854905; 19906174; 21969609; 23150662; 25356553; 25332123; 25865481; 26260636; 20085764; 15973432; 24586681,NMR spectroscopy (1); X-ray crystallography (1),"FUNCTION: A secreted protein. Acts as a strong host (human) T-cell antigen (PubMed:11940590). Involved in translocation of bacteria from the host (human) phagolysosome to the host cytoplasm (PubMed:17604718). Might serve as a chaperone to prevent uncontrolled membrane lysis by its partner EsxA; native protein binds poorly to artificial liposomes in the absence or presence of EsxA (PubMed:17557817, PubMed:26260636). EsxA and EsxA-EsxB are cytotoxic to pneumocytes (PubMed:19906174). EsxB (and EsxA-EsxB but not EsxA alone) activates human neutrophils; EsxB transiently induces host (human) intracellular Ca(2+) mobility in a dose-dependent manner, monocytes and lymphocytes do not respond (PubMed:25332123). Neutrophils respond to EsxB by chemotaxis and primed neutrophils treated with EsxB produce reactive oxygen species (ROS); Ca(2+) release and the ROS burst via are induced by an unidentified G-protein coupled receptor (PubMed:25332123). May help regulate assembly and function of the type VII secretion system (T7SS) (PubMed:25865481). {ECO:0000269|PubMed:11940590, ECO:0000269|PubMed:17557817, ECO:0000269|PubMed:17604718, ECO:0000269|PubMed:19906174, ECO:0000269|PubMed:25332123, ECO:0000269|PubMed:25865481, ECO:0000305|PubMed:26260636}.",MAEMKTDAATLAQEAGNFERISGDLKTQIDQVESTAGSLQGQWRGAAGTAAQAAVVRFQEAANKQKQELDEISTNIRQAGVQYSRADEEQQQALSSQMGF,"10,794",100,"WXG100 family, CFP-10 subfamily",pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],host cell surface binding [GO:0046812],cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell endoplasmic reticulum [GO:0044165]; host cell surface [GO:0044228]; plasma membrane [GO:0005886],cfp10 lhp mtsA10,MTV027.09,1
P9WNI3,ESXW_MYCTU,Rv3620c,esxW Rv3620c MTCY07H7B.02 MTCY15C10.32,GO:0005576,IPR036689; IPR010310; ,P9WNK1,esxW,,ESAT-6-like protein EsxW,extracellular region [GO:0005576],9634230; 12919853; 19876390; 21134129,,,MTSRFMTDPHAMRDMAGRFEVHAQTVEDEARRMWASAQNISGAGWSGMAEATSLDTMTQMNQAFRNIVNMLHGVRDGLVRDANNYEQQEQASQQILSS,"11,023",98,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,MTCY07H7B.02 MTCY15C10.32,1
P9WNF9,ETHA_MYCTU,Rv3854c,ethA etaA Rv3854c,GO:0004499; GO:0005618; GO:0005829; GO:0005886; GO:0008144; GO:0016709; GO:0017144; GO:0033776; GO:0050660; GO:0055114; GO:0070402; GO:0071949,IPR036188; IPR020946; ,,ethA,,FAD-containing monooxygenase EthA (EC 1.14.13.-) (Baeyer-Villiger monooxygenase EtaA) (BVMO) (Prodrug activator EtaA),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; drug binding [GO:0008144]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; phenylacetone monooxygenase activity [GO:0033776]; drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114]",9634230; 10869356; 10944230; 11823459; 14610090; 19412174; 21969609,,"FUNCTION: Monooxygenase able to convert a wide range of ketones to the corresponding esters or lactones via a Baeyer-Villiger oxidation reaction. Can act on long-chain aliphatic ketones (2-hexanone to 2-dodecanone) and on aromatic ketones (phenylacetone and benzylacetone). Is also able to catalyze enantioselective sulfoxidation of methyl-p-tolylsulfide. In vivo, likely functions as a BVMO, but the exact nature of the physiological substrate(s) remains to be established. {ECO:0000269|PubMed:14610090}.; FUNCTION: Is responsible for the activation of several thiocarbamide-containing pro-drugs into cytotoxic species. Thus, catalyzes the oxidation of the antitubercular pro-drug ethionamide (ETH) to the corresponding sulfoxide, which is further oxidized by EthA to 2-ethyl-4-amidopyridine, presumably via the unstable doubly oxidized sulfinic acid intermediate; the final metabolite 2-ethyl-4-amidopyridine has no antitubercular activity, so the cytotoxic species is a metabolite intermediate formed by EthA. Also oxidizes thiacetazone (TAC), thiobenzamide, and isothionicotinamide and therefore is probably responsible, as suggested by the observation of crossover resistance, for the oxidative activation of these other thioamide antitubercular drugs. {ECO:0000269|PubMed:10869356, ECO:0000269|PubMed:10944230, ECO:0000269|PubMed:11823459, ECO:0000269|PubMed:14610090}.",MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMYTLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVVIGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRWKNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGDLFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQVDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVERPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRFAKRPAPVGV,"55,326",489,FAD-binding monooxygenase family,drug metabolic process [GO:0017144]; oxidation-reduction process [GO:0055114],"drug binding [GO:0008144]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; phenylacetone monooxygenase activity [GO:0033776]",cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],etaA,,1
P9WNK7,ESXA_MYCTU,Rv3875,esxA esaT6 Rv3875 MTV027.10,GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0009405; GO:0016021; GO:0020002; GO:0042803; GO:0044165; GO:0044228; GO:0044315; GO:0046812; GO:0052027; GO:0052083,IPR036689; IPR010310; ,P9WNK5,esxA,,6 kDa early secretory antigenic target (ESAT-6),cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell endoplasmic reticulum [GO:0044165]; host cell plasma membrane [GO:0020002]; host cell surface [GO:0044228]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; host cell surface binding [GO:0046812]; protein homodimerization activity [GO:0042803]; modulation by symbiont of host signal transduction pathway [GO:0052027]; negative regulation by symbiont of host cell-mediated immune response [GO:0052083]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],7897219; 7729876; 9634230; 9846755; 15378760; 11940590; 14557547; 14557536; 14756778; 16030141; 16048998; 16368961; 16973880; 17298391; 17486091; 17604718; 17557817; 19265145; 19682254; 19876390; 20800577; 19854905; 19906174; 20148899; 21586573; 21969609; 22319448; 22524898; 23150662; 23848406; 23867456; 25299337; 25321481; 25356553; 25645924; 26048138; 26048136; 26092385; 26260636; 26801203; 26456678; 20085764; 15973432; 24586681,NMR spectroscopy (1); X-ray crystallography (1),"FUNCTION: A secreted protein that plays a number of roles in modulating the host's immune response to infection as well as being responsible for bacterial escape into the host cytoplasm. Acts as a strong host (human) T-cell antigen (PubMed:7729876, PubMed:11940590). Inhibits IL-12 p40 (IL12B) and TNF-alpha expression by infected host (mouse) macrophages, reduces the nitric oxide response by about 75% (PubMed:14557536). In mice previously exposed to the bacterium, elicits high level of IFN-gamma production by T-cells upon subsequent challenge by M.tuberculosis, in the first phase of a protective immune response (PubMed:7897219, PubMed:7729876). Higher levels (1.6-3.3 uM) of recombinant protein inhibit IFN-gamma production by host (human) T-cells and also IL-17 and TNF-alpha production but not IL-2; decreases expression of host ATF-2 and JUN transcription factors by affecting T-cell receptors signaling downstream of ZAP70, without cytotoxicity or apoptosis (PubMed:19265145). EsxA inhibits IFN-gamma production in human T-cells by activating p38 MAPK (MAPK14), p38 MAPK is not responsible for IL-17 decrease (PubMed:21586573). Binds host (mouse) Toll-like receptor 2 (TLR2) and decreases host MYD88-dependent signaling; binding to TLR2 activates host kinase AKT and subsequently inhibits downstream activation of NF-kappa-B; the C-terminal 20 residues (76-95) are necessary and sufficient for the TLR2 inhibitory effect (PubMed:17486091). Required for induction of host (human) IL-1B maturation and release by activating the host NLRP3/ASC inflammasome; may also promote access of other tuberculosis proteins to the host cells cytoplasm (PubMed:20148899). Induces IL-8 (CXCL8) expression in host (human) lung epithelial cells (PubMed:23867456). Exogenously applied protein, or protein expressed in host (human and mouse), binds beta-2-microglobulin (B2M) and decreases its export to the cell surface, probably leading to defects in class I antigen presentation by the host cell (PubMed:25356553). Responsible for mitochondrial fragmention, redistribution around the cell nucleus and decreased mitochondrial mass; this effect is not seen until 48 hours post-infection (PubMed:26092385). Able to disrupt artificial planar bilayers in the absence of EsxB (CFP-10) (PubMed:14557547). Native protein binds artificial liposomes in the absence but not presence of EsxB and is able to rigidify and lyse them; the EsxA-EsxB complex dissociates at acidic pH, EsxB might serve as a chaperone to prevent membrane lysis (PubMed:17557817). Recombinant protein induces leakage of phosphocholine liposomes at acidic pH in the absence of ExsB, undergoes conformational change, becoming more alpha-helical at acidic pH (PubMed:23150662, PubMed:25645924). The study using recombinant protein did not find dissociation of EsxA-EsxB complex at acidic pH (PubMed:23150662). Involved in translocation of bacteria from the host (human) phagolysosome to the host cytoplasm (PubMed:17604718, PubMed:22319448). Translocation into host cytoplasm is visible 3 days post-infection using cultured human cells and precedes host cell death (PubMed:22319448). Recombinant protein induces apoptosis in host (human) differentiated cell lines, which is cell-line dependent; bacteria missing the ESX-1 locus do not induce apoptosis (PubMed:17298391). Host (human) cells treated with EsxA become permeable to extracellular dye (PubMed:17298391). EsxA and EsxA-EsxB are cytotoxic to pneumocytes (PubMed:19906174). ESX-1 secretion system-induced host (mouse) cell apoptosis, which is probably responsible for infection of new host cells, might be due to EsxA (PubMed:23848406). EsxA induces necrosis in aged neutrophils (PubMed:25321481). May help regulate assembly and function of the type VII secretion system (T7SS) (By similarity). EsxA disassembles pre-formed EccC-EsxB multimers, possibly by making EccC-EsxA-EsxB trimers instead of EccC-EsxB-EsxB-EccC tetramers (By similarity). {ECO:0000250|UniProtKB:D1A4H1, ECO:0000269|PubMed:11940590, ECO:0000269|PubMed:14557536, ECO:0000269|PubMed:14557547, ECO:0000269|PubMed:17298391, ECO:0000269|PubMed:17486091, ECO:0000269|PubMed:17557817, ECO:0000269|PubMed:17604718, ECO:0000269|PubMed:19265145, ECO:0000269|PubMed:19906174, ECO:0000269|PubMed:20148899, ECO:0000269|PubMed:21586573, ECO:0000269|PubMed:22319448, ECO:0000269|PubMed:23867456, ECO:0000269|PubMed:25321481, ECO:0000269|PubMed:25356553, ECO:0000269|PubMed:26092385, ECO:0000269|PubMed:26260636, ECO:0000269|PubMed:7729876, ECO:0000269|PubMed:7897219, ECO:0000305|PubMed:23848406}.; FUNCTION: May be critical in pro-bacteria versus pro-host interactions; ESX-1 mediates DNA mediated export (maybe via EsxA). The DNA interacts with host (human) cGAS, leading to cGAMP production and activation of the host STING-TBK-1-IRF-3 signaling pathway that leads to IFN-beta which is thought to be ""pro-bacteria"". Mycobacterial dsDNA also interacts with AIM2-NLRP3-ASC to activate an inflammasome, leading to the ""pro-host"" IL-1-beta (PubMed:26048138, PubMed:26048136). {ECO:0000269|PubMed:26048136, ECO:0000269|PubMed:26048138}.",MTEQQWNFAGIEAAASAIQGNVTSIHSLLDEGKQSLTKLAAAWGGSGSEAYQGVQQKWDATATELNNALQNLARTISEAGQAMASTEGNVTGMFA,"9,904",95,"WXG100 family, ESAT-6 subfamily",modulation by symbiont of host signal transduction pathway [GO:0052027]; negative regulation by symbiont of host cell-mediated immune response [GO:0052083]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],host cell surface binding [GO:0046812]; protein homodimerization activity [GO:0042803],cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; host cell endoplasmic reticulum [GO:0044165]; host cell plasma membrane [GO:0020002]; host cell surface [GO:0044228]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],esaT6,MTV027.10,1
O53580,FAA32_MYCTU,Rv3801c,fadD32 Rv3801c,GO:0005524; GO:0005618; GO:0005886; GO:0006633; GO:0008610; GO:0016874; GO:0040007; GO:0070566; GO:0071766; GO:0071769,IPR000873; ,,fadD32,,Long-chain-fatty-acid--AMP ligase FadD32 (FAAL) (EC 6.2.1.-) (Acyl-AMP synthetase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; lipid biosynthetic process [GO:0008610]; mycolate cell wall layer assembly [GO:0071769],9634230; 15042094; 19099550; 21969609; 22206988,X-ray crystallography (1),"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-adenylates (acyl-AMP), which are then transferred to the multifunctional polyketide synthase (PKS) for further chain extension. {ECO:0000269|PubMed:15042094}.",MFVTGESGMAYHNPFIVNGKIRFPANTNLVRHVEKWAKVRGDKLAYRFLDFSTERDGVARDILWSDFSARNRAVGARLQQVTQPGDRVAILCPQNLDYLISFFGALYSGRIAVPLFDPAEPGHVGRLHAVLDDCAPSTILTTTDSAEGVRKFIRARSAKERPRVIAVDAVPTEVAATWQQPEANEETVAYLQYTSGSTRIPSGVQITHLNLPTNVVQVLNALEGQEGDRGVSWLPFFHDMGLITVLLASVLGHSFTFMTPAAFVRRPGRWIRELARKPGETGGTFSAAPNFAFEHAAVRGVPRDDEPPLDLSNVKGILNGSEPVSPASMRKFFEAFAPYGLKQTAVKPSYGLAEATLFVSTTPMDEVPTVIHVDRDELNNQRFVEVAADAPNAVAQVSAGKVGVSEWAVIVDADTASELPDGQIGEIWLHGNNLGTGYWGKEEESAQTFKNILKSRISESRAEGAPDDALWVRTGDYGTYFKDHLYIAGRIKDLVIIDGRNHYPQDLECTAQESTKALRVGYAAAFSVPANQLPQTVFDDSHAGLKFDPEDTSEQLVIVGERAAGTHKLDHQPIVDDIRAAIAVGHGVTVRDVLLVSAGTIPRTSSGKIGRRACRAAYLDGSLRSGVGSPTVFATSD,"69,232",637,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; growth [GO:0040007]; lipid biosynthetic process [GO:0008610]; mycolate cell wall layer assembly [GO:0071769],adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; ligase activity [GO:0016874],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WNB3,ECC1A_MYCTU,Rv3870,eccCa1 snm1 Rv3870,GO:0003677; GO:0005524; GO:0005618; GO:0005886; GO:0009405; GO:0016021; GO:0042783; GO:0044117; GO:0044315,IPR023836; IPR002543; IPR027417; ,,eccCa1,DOMAIN 456 665 FtsK. {ECO:0000255|PROSITE-ProRule:PRU00289}.,ESX-1 secretion system protein EccCa1 (ESX conserved component Ca1) (Snm1 secretory protein) (Type VII secretion system protein EccCa1) (T7SS protein EccCa1),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 14557536; 14756778; 16368961; 19876390; 19854905; 21969609; 25865481,,"FUNCTION: Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10). {ECO:0000269|PubMed:14557536, ECO:0000269|PubMed:16368961}.",MTTKKFTPTITRGPRLTPGEISLTPPDDLGIDIPPSGVQKILPYVMGGAMLGMIAIMVAGGTRQLSPYMLMMPLMMIVMMVGGLAGSTGGGGKKVPEINADRKEYLRYLAGLRTRVTSSATSQVAFFSYHAPHPEDLLSIVGTQRQWSRPANADFYAATRIGIGDQPAVDRLLKPAVGGELAAASAAPQPFLEPVSHMWVVKFLRTHGLIHDCPKLLQLRTFPTIAIGGDLAGAAGLMTAMICHLAVFHPPDLLQIRVLTEEPDDPDWSWLKWLPHVQHQTETDAAGSTRLIFTRQEGLSDLAARGPHAPDSLPGGPYVVVVDLTGGKAGFPPDGRAGVTVITLGNHRGSAYRIRVHEDGTADDRLPNQSFRQVTSVTDRMSPQQASRIARKLAGWSITGTILDKTSRVQKKVATDWHQLVGAQSVEEITPSRWRMYTDTDRDRLKIPFGHELKTGNVMYLDIKEGAEFGAGPHGMLIGTTGSGKSEFLRTLILSLVAMTHPDQVNLLLTDFKGGSTFLGMEKLPHTAAVVTNMAEEAELVSRMGEVLTGELDRRQSILRQAGMKVGAAGALSGVAEYEKYRERGADLPPLPTLFVVVDEFAELLQSHPDFIGLFDRICRVGRSLRVHLLLATQSLQTGGVRIDKLEPNLTYRIALRTTSSHESKAVIGTPEAQYITNKESGVGFLRVGMEDPVKFSTFYISGPYMPPAAGVETNGEAGGPGQQTTRQAARIHRFTAAPVLEEAPTP,"80,913",747,,active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],snm1,,1
P9WNQ7,ECCD1_MYCTU,Rv3877,eccD1 snm4 Rv3877,GO:0005618; GO:0005886; GO:0016021; GO:0042783; GO:0044117,IPR006707; IPR024962; ,,eccD1,,ESX-1 secretion system protein EccD1 (ESX conserved component D1) (Snm4 secretory protein) (Type VII secretion system protein EccD1) (T7SS protein EccD1),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117],9634230; 14557547; 14557536; 16368961; 19876390; 21969609; 26048137; 26922638,X-ray crystallography (2),"FUNCTION: Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10). {ECO:0000269|PubMed:14557536, ECO:0000269|PubMed:16368961, ECO:0000305|PubMed:14557547}.",MSAPAVAAGPTAAGATAARPATTRVTILTGRRMTDLVLPAAVPMETYIDDTVAVLSEVLEDTPADVLGGFDFTAQGVWAFARPGSPPLKLDQSLDDAGVVDGSLLTLVSVSRTERYRPLVEDVIDAIAVLDESPEFDRTALNRFVGAAIPLLTAPVIGMAMRAWWETGRSLWWPLAIGILGIAVLVGSFVANRFYQSGHLAECLLVTTYLLIATAAALAVPLPRGVNSLGAPQVAGAATAVLFLTLMTRGGPRKRHELASFAVITAIAVIAAAAAFGYGYQDWVPAGGIAFGLFIVTNAAKLTVAVARIALPPIPVPGETVDNEELLDPVATPEATSEETPTWQAIIASVPASAVRLTERSKLAKQLLIGYVTSGTLILAAGAIAVVVRGHFFVHSLVVAGLITTVCGFRSRLYAERWCAWALLAATVAIPTGLTAKLIIWYPHYAWLLLSVYLTVALVALVVVGSMAHVRRVSPVVKRTLELIDGAMIAAIIPMLLWITGVYDTVRNIRF,"53,999",511,EccD/Snm4 family,active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117],,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],snm4,,1
P9WJE9,ECCE1_MYCTU,Rv3882c,eccE1 snm7 Rv3882c,GO:0005886; GO:0016021,IPR021368; ,,eccE1,,ESX-1 secretion system protein EccE1 (ESX conserved component E1) (Type VII secretion system protein EccE1) (T7SS protein EccE1),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 16135231; 19099550; 19876390; 21969609,,"FUNCTION: Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10). {ECO:0000305|PubMed:19876390}.",MRNPLGLRFSTGHALLASALAPPCIIAFLETRYWWAGIALASLGVIVATVTFYGRRITGWVAAVYAWLRRRRRPPDSSSEPVVGATVKPGDHVAVRWQGEFLVAVIELIPRPFTPTVIVDGQAHTDDMLDTGLVEELLSVHCPDLEADIVSAGYRVGNTAAPDVVSLYQQVIGTDPAPANRRTWIVLRADPERTRKSAQRRDEGVAGLARYLVASATRIADRLASHGVDAVCGRSFDDYDHATDIGFVREKWSMIKGRDAYTAAYAAPGGPDVWWSARADHTITRVRVAPGMAPQSTVLLTTADKPKTPRGFARLFGGQRPALQGQHLVANRHCQLPIGSAGVLVGETVNRCPVYMPFDDVDIALNLGDAQTFTQFVVRAAAAGAMVTVGPQFEEFARLIGAHIGQEVKVAWPNATTYLGPHPGIDRVILRHNVIGTPRHRQLPIRRVSPPEESRYQMALPK,"50,397",462,EccE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],snm7,,1
P9WN67,GALE_MYCTU,Rv3634c,galE1 Rv3634c,GO:0003978; GO:0005886; GO:0006012; GO:0040007,IPR016040; IPR036291; ,,galE1,,UDP-glucose 4-epimerase (EC 5.1.3.2) (UDP-galactose 4-epimerase) (Uridine diphosphate galactose 4-epimerase),plasma membrane [GO:0005886]; UDP-glucose 4-epimerase activity [GO:0003978]; galactose metabolic process [GO:0006012]; growth [GO:0040007],9634230; 21969609,,FUNCTION: Involved in the metabolism of galactose. Catalyzes the conversion of UDP-galactose (UDP-Gal) to UDP-glucose (UDP-Glc) through a mechanism involving the transient reduction of NAD (By similarity). {ECO:0000250}.,MRALVTGAAGFIGSTLVDRLLADGHSVVGLDNFATGRATNLEHLADNSAHVFVEADIVTADLHAILEQHRPEVVFHLAAQIDVRRSVADPQFDAAVNVIGTVRLAEAARQTGVRKIVHTSSGGSIYGTPPEYPTPETAPTDPASPYAAGKVAGEIYLNTFRHLYGLDCSHIAPANVYGPRQDPHGEAGVVAIFAQALLSGKPTRVFGDGTNTRDYVFVDDVVDAFVRVSADVGGGLRFNIGTGKETSDRQLHSAVAAAVGGPDDPEFHPPRLGDLKRSCLDIGLAERVLGWRPQIELADGVRRTVEYFRHKHTD,"33,582",314,NAD(P)-dependent epimerase/dehydratase family,galactose metabolic process [GO:0006012]; growth [GO:0040007],UDP-glucose 4-epimerase activity [GO:0003978],plasma membrane [GO:0005886],,,1
P9WN57,GCH1_MYCTU,Rv3609c,folE gchA Rv3609c MTCY07H7B.13,GO:0003934; GO:0005525; GO:0005737; GO:0006729; GO:0006730; GO:0008270; GO:0035998; GO:0040007; GO:0046654,IPR001474; IPR018234; IPR020602; ,,folE,,GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I),"cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270]; 7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; growth [GO:0040007]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]",9634230; 21969609,,,MSQLDSRSASARIRVFDQQRAEAAVRELLYAIGEDPDRDGLVATPSRVARSYREMFAGLYTDPDSVLNTMFDEDHDELVLVKEIPMYSTCEHHLVAFHGVAHVGYIPGDDGRVTGLSKIARLVDLYAKRPQVQERLTSQIADALMKKLDPRGVIVVIEAEHLCMAMRGVRKPGSVTTTSAVRGLFKTNAASRAEALDLILRK,"22,395",202,GTP cyclohydrolase I family,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process [GO:0035998]; growth [GO:0040007]; one-carbon metabolic process [GO:0006730]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]",GTP binding [GO:0005525]; GTP cyclohydrolase I activity [GO:0003934]; zinc ion binding [GO:0008270],cytoplasm [GO:0005737],gchA,MTCY07H7B.13,1
P9WNX5,DHAS_MYCTU,Rv3708c,asd Rv3708c MTV025.056c,GO:0004073; GO:0005618; GO:0005737; GO:0005886; GO:0009086; GO:0009088; GO:0009089; GO:0009097; GO:0009405; GO:0019877; GO:0040007; GO:0046983; GO:0050661; GO:0051287,IPR000319; IPR012080; IPR005986; IPR036291; IPR000534; IPR012280; ,,asd,,Aspartate-semialdehyde dehydrogenase (ASA dehydrogenase) (ASADH) (EC 1.2.1.11) (Aspartate-beta-semialdehyde dehydrogenase),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartate-semialdehyde dehydrogenase activity [GO:0004073]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983]; diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; lysine biosynthetic process via diaminopimelate [GO:0009089]; methionine biosynthetic process [GO:0009086]; pathogenesis [GO:0009405]; threonine biosynthetic process [GO:0009088],15752328; 9634230; 18323599; 21969609; 18236087; 26437401; 25565373; 24875451; 22683789,Model (1); X-ray crystallography (2),"FUNCTION: Catalyzes the NADPH-dependent formation of L-aspartate-semialdehyde (L-ASA) by the reductive dephosphorylation of L-aspartyl-4-phosphate (PubMed:15752328). Is essential for the growth and pathogenicity of M.tuberculosis, and for the generation of the bacterial cell wall (PubMed:26437401). {ECO:0000269|PubMed:15752328, ECO:0000269|PubMed:26437401}.",MGLSIGIVGATGQVGQVMRTLLDERDFPASAVRFFASARSQGRKLAFRGQEIEVEDAETADPSGLDIALFSAGSAMSKVQAPRFAAAGVTVIDNSSAWRKDPDVPLVVSEVNFERDAHRRPKGIIANPNCTTMAAMPVLKVLHDEARLVRLVVSSYQAVSGSGLAGVAELAEQARAVIGGAEQLVYDGGALEFPPPNTYVAPIAFNVVPLAGSLVDDGSGETDEDQKLRFESRKILGIPDLLVSGTCVRVPVFTGHSLSINAEFAQPLSPERARELLDGATGVQLVDVPTPLAAAGVDESLVGRIRRDPGVPDGRGLALFVSGDNLRKGAALNTIQIAELLTADL,"36,230",345,Aspartate-semialdehyde dehydrogenase family,diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; isoleucine biosynthetic process [GO:0009097]; lysine biosynthetic process via diaminopimelate [GO:0009089]; methionine biosynthetic process [GO:0009086]; pathogenesis [GO:0009405]; threonine biosynthetic process [GO:0009088],aspartate-semialdehyde dehydrogenase activity [GO:0004073]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; protein dimerization activity [GO:0046983],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV025.056c,1
P9WNW5,DISA_MYCTU,Rv3586,disA dacA Rv3586,GO:0003677; GO:0005524; GO:0006281; GO:0016779,IPR038331; IPR036888; IPR018906; IPR003390; IPR023763; IPR010994; ,,disA,DOMAIN 6 144 DAC. {ECO:0000255|PROSITE-ProRule:PRU01130}.,DNA integrity scanning protein DisA (Cyclic-di-AMP synthase) (c-di-AMP synthase) (Diadenylate cyclase) (EC 2.7.7.85),ATP binding [GO:0005524]; DNA binding [GO:0003677]; nucleotidyltransferase activity [GO:0016779]; DNA repair [GO:0006281],9634230; 21969609; 22529992; 23760274,,"FUNCTION: Participates in a DNA-damage check-point. DisA forms globular foci that rapidly scan along the chromosomes searching for lesions. {ECO:0000255|HAMAP-Rule:MF_01438}.; FUNCTION: Has also diadenylate cyclase activity, catalyzing the condensation of 2 ATP molecules into cyclic di-AMP (c-di-AMP). c-di-AMP likely acts as a signaling molecule that may couple DNA integrity with a cellular process. To a lesser extent, can also use ADP as substrate to produce c-di-AMP. Does not convert GTP to c-di-GMP. Also exhibits residual ATPase and ADPase activities in vitro. {ECO:0000255|HAMAP-Rule:MF_01438, ECO:0000269|PubMed:22529992}.",MHAVTRPTLREAVARLAPGTGLRDGLERILRGRTGALIVLGHDENVEAICDGGFSLDVRYAATRLRELCKMDGAVVLSTDGSRIVRANVQLVPDPSIPTDESGTRHRSAERAAIQTGYPVISVSHSMNIVTVYVRGERHVLTDSATILSRANQAIATLERYKTRLDEVSRQLSRAEIEDFVTLRDVMTVVQRLELVRRIGLVIDYDVVELGTDGRQLRLQLDELLGGNDTARELIVRDYHANPEPPSTGQINATLDELDALSDGDLLDFTALAKVFGYPTTTEAQDSTLSPRGYRAMAGIPRLQFAHADLLVRAFGTLQGLLAASAGDLQSVDGIGAMWARHVREGLSQLAESTISDQ,"39,031",358,DisA family,DNA repair [GO:0006281],ATP binding [GO:0005524]; DNA binding [GO:0003677]; nucleotidyltransferase activity [GO:0016779],,dacA,,1
P9WPK1,GLPK_MYCTU,Rv3696c,glpK Rv3696c MTV025.044c,GO:0004370; GO:0005524; GO:0006071; GO:0006072; GO:0019563,IPR000577; IPR018485; IPR018483; IPR018484; IPR005999; ,,glpK,,Glycerol kinase (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase) (Glycerokinase) (GK),ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate metabolic process [GO:0006072],9634230; 21969609,,FUNCTION: Key enzyme in the regulation of glycerol uptake and metabolism. Catalyzes the phosphorylation of glycerol to yield sn-glycerol 3-phosphate. {ECO:0000255|HAMAP-Rule:MF_00186}.,MSDAILGEQLAESSDFIAAIDQGTTSTRCMIFDHHGAEVARHQLEHEQILPRAGWVEHNPVEIWERTASVLISVLNATNLSPKDIAALGITNQRETTLVWNRHTGRPYYNAIVWQDTRTDRIASALDRDGRGNLIRRKAGLPPATYFSGGKLQWILENVDGVRAAAENGDALFGTPDTWVLWNLTGGPRGGVHVTDVTNASRTMLMDLETLDWDDELLSLFSIPRAMLPEIASSAPSEPYGVTLATGPVGGEVPITGVLGDQHAAMVGQVCLAPGEAKNTYGTGNFLLLNTGETIVRSNNGLLTTVCYQFGNAKPVYALEGSIAVTGSAVQWLRDQLGIISGAAQSEALARQVPDNGGMYFVPAFSGLFAPYWRSDARGAIVGLSRFNTNAHLARATLEAICYQSRDVVDAMEADSGVRLQVLKVDGGITGNDLCMQIQADVLGVDVVRPVVAETTALGVAYAAGLAVGFWAAPSDLRANWREDKRWTPTWDDDERAAGYAGWRKAVQRTLDWVDVS,"55,860",517,FGGY kinase family,glycerol-3-phosphate metabolic process [GO:0006072]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071],ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370],,,MTV025.044c,1
P96218,GLTB_MYCTU,Rv3859c,gltB Rv3859c,GO:0004355; GO:0005829; GO:0005886; GO:0006537; GO:0015930; GO:0019676; GO:0040007; GO:0046872; GO:0051538; GO:0097054,IPR013785; IPR017932; IPR002489; IPR036485; IPR006982; IPR002932; IPR029055; ,,gltB,DOMAIN 18 416 Glutamine amidotransferase type-2. {ECO:0000255|PROSITE-ProRule:PRU00609}.,Glutamate synthase [NADPH] large chain (EC 1.4.1.13) (Glutamate synthase subunit alpha) (GLTS alpha chain),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]; ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; growth [GO:0040007]; L-glutamate biosynthetic process [GO:0097054]",9634230; 19099550; 19318624; 21969609,,,MTPKRVGLYNPAFEHDSCGVAMVVDMHGRRSRDIVDKAITALLNLEHRGAQGAEPRSGDGAGILIQVPDEFLREAVDFELPAPGSYATGIAFLPQSSKDAAAACAAVQKIAEAEGLQVLGWRSVPTDDSSLGALSRDAMPTFRQVFLAGASGMALERRCYVVRKRAEHELGTKGPGQDGPGRETVYFPSLSGQTLVYKGMLTTPQLKAFYLDLQDERLTSALGIVHSRFSTNTFPSWPLAHPFRRIAHNGEINTVTGNENWMRAREALIKTDIFGSAADVEKLFPICTPGASDTARFDEVLELLHLGGRSLAHAVLMMIPEAWERHESMDPARRAFYQYHASLMEPWDGPASMTFTDGTVVGAVLDRNGLRPSRIWVTDDGLVVMASEAGVLDLHPSTVVRRMRLQPGRMFLVDTAQGRIVSDEEIKADLAAEHPYQEWLDNGLVPLDELPEGKDVRMPHHRIVMRQLAFGYTYEELNLLVAPMARLGAEPIGSMGTDTPVAVLSQRPRMLYDYFHQLFAQVTNPPLDAIREEVVTSLQGTTGGERDLLNPDQNSCHQIVLPQPILRNHELAKLVSLDPNDKVNGRPHGLRSKVIRCLYRVSEGGAGLAAALEEVRGAAAAAIADGARIIILSDRESDEEMAPIPSLLAVAGVHHHLVRERTRTQVGLVVESGDAREVHHMAALVGFGAAAINPYLVFESIEDMLDRGVIEGIDRTAALNNYIKAAGKGVLKVMSKMGISTLASYTGAQLFQAVGISEQVLDEYFTGLTCPTGGITLDDIAADVAARHRLAYLDRPDERAHRELEVGGEYQWRREGEYHLFNPETVFKLQHSTRTGQYKIFKEYTRLVDDQSERMASLRGLLKFRTGVRPPVPLDEVEPASEIVKRFSTGAMSYGSISAEAHETLAIAMNRLGARSNCGEGGEDVKRFDRDPNGDWRRSAIKQVASARFGVTSHYLTNCTDLQIKMAQGAKPGEGGQLPGHKVYPWVAEVRHSTPGVGLISPPPHHDIYSIEDLAQLIHDLKNANPSARVHVKLVSENGVGTVAAGVSKAHADVVLISGHDGGTGATPLTSMKHAGAPWELGLAETQQTLLLNGLRDRIVVQVDGQLKTGRDVMIATLLGAEEFGFATAPLVVAGCIMMRVCHLDTCPVGVATQNPLLRERFTGKPEFVENFFMFIAEEVREYLAQLGFRTVNEAVGQAGALDTTLARAHWKAHKLDLAPVLHEPESAFMNQDLYCSSRQDHGLDKALDQQLIVMSREALDSGKPVRFSTTIGNVNRTVGTMLGHELTKAYGGQGLPDGTIDITFDGSAGNSFGAFVPKGITLRVYGDANDYVGKGLSGGRIVVRPSDDAPQDYVAEDNIIGGNVILFGATSGEVYLRGVVGERFAVRNSGAHAVVEGVGDHGCEYMTGGRVVILGRTGRNFAAGMSGGVAYVYDPDGELPANLNSEMVELETLDEDDADWLHGTIQVHVDATDSAVGQRILSDWSGQQRHFVKVMPRDYKRVLQAIALAERDGVDVDKAIMAAAHG,"165,943",1527,Glutamate synthase family,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; growth [GO:0040007]; L-glutamate biosynthetic process [GO:0097054],"3 iron, 4 sulfur cluster binding [GO:0051538]; glutamate synthase (NADPH) activity [GO:0004355]; glutamate synthase activity [GO:0015930]; metal ion binding [GO:0046872]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
P9WN19,GLTD_MYCTU,Rv3858c,gltD Rv3858c,GO:0004355; GO:0005829; GO:0005886; GO:0040007; GO:0046872; GO:0051539; GO:0097054,IPR028261; IPR036188; IPR023753; IPR006005; IPR009051; ,,gltD,DOMAIN 38 69 4Fe-4S ferredoxin-type.,Glutamate synthase [NADPH] small chain (EC 1.4.1.13) (Glutamate synthase subunit beta) (GLTS beta chain),"cytosol [GO:0005829]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]; growth [GO:0040007]; L-glutamate biosynthetic process [GO:0097054]",9634230; 19099550; 21969609,,,MADPGGFLKYTHRKLPKRRPVPLRLRDWREVYEEFDNESLRQQATRCMDCGIPFCHNGCPLGNLIPEWNDLVRRGRWRDAIERLHATNNFPDFTGRLCPAPCEPACVLGINQDPVTIKQIELEIIDKAFDEGWVQPRPPRKLTGQTVAVVGSGPAGLAAAQQLTRAGHTVTVFEREDRIGGLLRYGIPEFKMEKRHLDRRLDQMRSEGTEFRPGVNVGVDISAEKLRADFDAVVLAGGATAWRELPIPGRELEGVHQAMEFLPWANRVQEGDDVLDEDGQPPITAKGKKVVIIGGGDTGADCLGTVHRQGAIAVHQFEIMPRPPDARAESTPWPTYPLMYRVSAAHEEGGERVFSVNTEAFVGTDGRVSALRAHEVTMLDGKFVKVEGSDFELEADLVLLAMGFVGPERAGLLTDLGVKFTERGNVARGDDFDTSVPGVFVAGDMGRGQSLIVWAIAEGRAAAAAVDRYLMGSSALPAPVKPTAAPLQ,"53,452",488,,growth [GO:0040007]; L-glutamate biosynthetic process [GO:0097054],"4 iron, 4 sulfur cluster binding [GO:0051539]; glutamate synthase (NADPH) activity [GO:0004355]; metal ion binding [GO:0046872]",cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WJG3,CARD_MYCTU,Rv3583c,carD Rv3583c,GO:0009405; GO:0015968; GO:0040007,IPR036101; IPR003711; ,P9WGY9,carD,,RNA polymerase-binding transcription factor CarD,growth [GO:0040007]; pathogenesis [GO:0009405]; stringent response [GO:0015968],9634230; 19596241; 21969609; 22904282,X-ray crystallography (4),"FUNCTION: Controls rRNA transcription by binding to the RNA polymerase (RNAP). Required for replication and persistence during infection of mice. {ECO:0000269|PubMed:19596241, ECO:0000269|PubMed:22904282}.",MIFKVGDTVVYPHHGAALVEAIETRTIKGEQKEYLVLKVAQGDLTVRVPAENAEYVGVRDVVGQEGLDKVFQVLRAPHTEEPTNWSRRYKANLEKLASGDVNKVAEVVRDLWRRDQERGLSAGEKRMLAKARQILVGELALAESTDDAKAETILDEVLAAAS,"17,907",162,CarD family,growth [GO:0040007]; pathogenesis [GO:0009405]; stringent response [GO:0015968],,,,,1
O53582,AFTB_MYCTU,Rv3805c,aftB Rv3805c,GO:0016021; GO:0016757; GO:0040007; GO:0045227; GO:0071555,,,aftB,,Terminal beta-(1->2)-arabinofuranosyltransferase (EC 2.4.2.-),"integral component of membrane [GO:0016021]; transferase activity, transferring glycosyl groups [GO:0016757]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007]",9634230; 17387176; 21969609,,"FUNCTION: Involved in the biosynthesis of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the transfer of arabinofuranosyl (Araf) residues from the sugar donor decaprenyl-phospho-arabinose (DPA) to the arabinan domain to form terminal beta-(1->2)-linked Araf residues, which marks the end point for AG arabinan biosynthesis before decoration with mycolic acids. {ECO:0000269|PubMed:17387176}.",MVRVSLWLSVTAVAVLFGWGSWQRRWIADDGLIVLRTVRNLLAGNGPVFNQGERVEANTSTAWTYLLYVGGWVGGPMRLEYVALALAMVLSLLGMVLLMLGTGRLYAPSLRGRRAIMLPAGALVYIAVPPARDFATSGLESGLVLAYLGLLWWMMVCWSQPLRARPDSQMFLGALAFVAGCSVLVRPEFALIGGLALIMMLIAARTWRRRVLIVLAGGFLPVAYQIFRMGYYGLLVPSTALAKDAAGDKWSQGMIYVSNFNRPYALWVPLVLSVPLGLLLMTARRRPSFLRPVLAPDYGRVARAVQSPPAVVAFIVGSGVLQALYWIRQGGDFMHGRVLLAPLFCLLAPVGVIPILLPDGKDFSRETGRWLVGALSGLWLGIAGWSLWAANSPGMGDDATRVTYSGIVDERRFYAQATGHAHPLTAADYLDYPRMAAVLTALNNTPEGALLLPSGNYNQWDLVPMIRPSSGTAPGGKPAPKPQHAVFFTNMGMLGMNVGLDVRVIDQIGLVNPLAAHTERLKHARIGHDKNLFPDWVIADGPWVKWYPGIPGYIDQQWVTQAEAALQCPATRAVLNSVRAPITLHRFLSNVLHSYEFTRYRIDRVPRYELVRCGLDVPDGPGPPPRE,"68,710",627,AftB family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; growth [GO:0040007],"transferase activity, transferring glycosyl groups [GO:0016757]",integral component of membrane [GO:0016021],,,3
P9WMS9,AGBR_MYCTU,Rv3789,Rv3789 MTCY13D12.23,GO:0005886; GO:0016021; GO:0045227; GO:0071555,IPR007267; ,,,,Arabinogalactan biosynthesis recruiting protein Rv3789,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],9634230; 21969609; 23038254; 25906160; 26369580,,"FUNCTION: Required for arabinosylation of arabinogalactan (AG), an essential component of the mycobacterial cell wall. Probably acts as an anchor protein recruiting AftA, the first arabinosyl transferase involved in AG biosynthesis. {ECO:0000269|PubMed:26369580}.",MRFVVTGGLAGIVDFGLYVVLYKVAGLQVDLSKAISFIVGTITAYLINRRWTFQAEPSTARFVAVMLLYGITFAVQVGLNHLCLALLHYRAWAIPVAFVIAQGTATVINFIVQRAVIFRIR,"13,377",121,GtrA family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY13D12.23,1
P9WQP3,A85A_MYCTU,Rv3804c,fbpA mpt44 Rv3804c MTV026.09c,GO:0004144; GO:0005576; GO:0005618; GO:0005737; GO:0005886; GO:0016747; GO:0035375; GO:0044119; GO:0044121; GO:0050348,IPR029058; IPR000801; IPR006311; ,,fbpA,,Diacylglycerol acyltransferase/mycolyltransferase Ag85A (DGAT) (EC 2.3.1.122) (EC 2.3.1.20) (Acyl-CoA:diacylglycerol acyltransferase) (Antigen 85 complex A) (85A) (Ag85A) (Fibronectin-binding protein A) (Fbps A),"cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; diacylglycerol O-acyltransferase activity [GO:0004144]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]; growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121]",2506131; 8757831; 20223296; 9634230; 3141278; 2403534; 12010501; 9162010; 19099550; 21969609; 21819455; 15192106,X-ray crystallography (1),"FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria for fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan, and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. FbpA mediates triacylglycerol (TAG) formation with long-chain acyl-CoA as the acyl donor and 1,2-dipalmitoyl-sn-glycerol (1,2-dipalmitin) as the acyl acceptor. It has a preference for C26:0-CoA over C18:1-CoA. {ECO:0000269|PubMed:12010501, ECO:0000269|PubMed:21819455, ECO:0000269|PubMed:3141278, ECO:0000269|PubMed:9162010}.",MQLVDRVRGAVTGMSRRLVVGAVGAALVSGLVGAVGGTATAGAFSRPGLPVEYLQVPSPSMGRDIKVQFQSGGANSPALYLLDGLRAQDDFSGWDINTPAFEWYDQSGLSVVMPVGGQSSFYSDWYQPACGKAGCQTYKWETFLTSELPGWLQANRHVKPTGSAVVGLSMAASSALTLAIYHPQQFVYAGAMSGLLDPSQAMGPTLIGLAMGDAGGYKASDMWGPKEDPAWQRNDPLLNVGKLIANNTRVWVYCGNGKPSDLGGNNLPAKFLEGFVRTSNIKFQDAYNAGGGHNGVFDFPDSGTHSWEYWGAQLNAMKPDLQRALGATPNTGPAPQGA,"35,686",338,Mycobacterial A85 antigen family,growth of symbiont in host cell [GO:0044119]; growth of symbiont in host organelle [GO:0044121],"diacylglycerol O-acyltransferase activity [GO:0004144]; transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; trehalose O-mycolyltransferase activity [GO:0050348]; zymogen binding [GO:0035375]",cell wall [GO:0005618]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],mpt44,MTV026.09c,1
P9WQH3,ACDH_MYCTU,Rv3535c,mhpF Rv3535c,GO:0008774; GO:0019439; GO:0051287,IPR003361; IPR015426; IPR036291; IPR000534; ,,mhpF,,Acetaldehyde dehydrogenase (EC 1.2.1.10) (Acetaldehyde dehydrogenase [acetylating]),acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; NAD binding [GO:0051287]; aromatic compound catabolic process [GO:0019439],9634230; 21969609,X-ray crystallography (1),"FUNCTION: Catalyzes the conversion of acetaldehyde to acetyl-CoA, using NAD(+) and coenzyme A. Is the final enzyme in the meta-cleavage pathway for the degradation of aromatic compounds. {ECO:0000255|HAMAP-Rule:MF_01657}.",MPSKAKVAIVGSGNISTDLLYKLLRSEWLEPRWMVGIDPESDGLARAAKLGLETTHEGVDWLLAQPDKPDLVFEATSAYVHRDAAPKYAEAGIRAIDLTPAAVGPAVIPPANLREHLDAPNVNMITCGGQATIPIVYAVSRIVEVPYAEIVASVASVSAGPGTRANIDEFTKTTARGVQTIGGAARGKAIIILNPADPPMIMRDTIFCAIPTDADREAIAASIHDVVKEVQTYVPGYRLLNEPQFDEPSINSGGQALVTTFVEVEGAGDYLPPYAGNLDIMTAAATKVGEEIAKETLVVGGAR,"32,009",303,Acetaldehyde dehydrogenase family,aromatic compound catabolic process [GO:0019439],acetaldehyde dehydrogenase (acetylating) activity [GO:0008774]; NAD binding [GO:0051287],,,,1
P9WQD1,ACSA_MYCTU,Rv3667,acsA acs Rv3667 MTV025.015,GO:0003987; GO:0005524; GO:0005618; GO:0005886; GO:0016208; GO:0019427; GO:0046872,IPR011904; IPR032387; IPR025110; IPR020845; IPR000873; ,,acsA,,Acetyl-coenzyme A synthetase (AcCoA synthetase) (Acs) (EC 6.2.1.1) (Acetate--CoA ligase) (Acyl-activating enzyme),cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process from acetate [GO:0019427],9634230; 21896569; 21627103; 21969609,,"FUNCTION: Catalyzes the conversion of acetate into acetyl-CoA (AcCoA), an essential intermediate at the junction of anabolic and catabolic pathways. AcsA undergoes a two-step reaction. In the first half reaction, AcsA combines acetate with ATP to form acetyl-adenylate (AcAMP) intermediate. In the second half reaction, it can then transfer the acetyl group from AcAMP to the sulfhydryl group of CoA, forming the product AcCoA. M.tuberculosis may use AcsA for both acetate and propionate assimilation. {ECO:0000255|HAMAP-Rule:MF_01123, ECO:0000269|PubMed:21627103, ECO:0000269|PubMed:21896569}.",MSESTPEVSSSYPPPAHFAEHANARAELYREAEEDRLAFWAKQANRLSWTTPFTEVLDWSGAPFAKWFVGGELNVAYNCVDRHVEAGHGDRVAIHWEGEPVGDRRTLTYSDLLAEVSKAANALTDLGLVAGDRVAIYLPLIPEAVIAMLACARLGIMHSVVFGGFTAAALQARIVDAQAKLLITADGQFRRGKPSPLKAAADEALAAIPDCSVEHVLVVRRTGIEMAWSEGRDLWWHHVVGSASPAHTPEPFDSEHPLFLLYTSGTTGKPKGIMHTSGGYLTQCCYTMRTIFDVKPDSDVFWCTADIGWVTGHTYGVYGPLCNGVTEVLYEGTPDTPDRHRHFQIIEKYGVTIYYTAPTLIRMFMKWGREIPDSHDLSSLRLLGSVGEPINPEAWRWYRDVIGGGRTPLVDTWWQTETGSAMISPLPGIAAAKPGSAMTPLPGISAKIVDDHGDPLPPHTEGAQHVTGYLVLDQPWPSMLRGIWGDPARYWHSYWSKFSDKGYYFAGDGARIDPDGAIWVLGRIDDVMNVSGHRISTAEVESALVAHSGVAEAAVVGVTDETTTQAICAFVVLRANYAPHDRTAEELRTEVARVISPIARPRDVHVVPELPKTRSGKIMRRLLRDVAENRELGDTSTLLDPTVFDAIRAAK,"71,476",651,ATP-dependent AMP-binding enzyme family,acetyl-CoA biosynthetic process from acetate [GO:0019427],acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],cell wall [GO:0005618]; plasma membrane [GO:0005886],acs,MTV025.015,1
P9WN03,AFTA_MYCTU,Rv3792,aftA Rv3792,GO:0005618; GO:0005886; GO:0016021; GO:0016757; GO:0035250; GO:0040007; GO:0044038; GO:0045227; GO:0071555; GO:0071769,IPR020959; IPR020963; ,,aftA,,Galactan 5-O-arabinofuranosyltransferase (EC 2.4.2.46) (Arabinofuranosyltransferase AftA),"cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-galactosyltransferase activity [GO:0035250]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; growth [GO:0040007]; mycolate cell wall layer assembly [GO:0071769]",9634230; 16595677; 18556798; 21969609; 26369580,,"FUNCTION: Involved in the biosynthesis of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the addition of the first key arabinofuranosyl (Araf) residue from the sugar donor decaprenyl-phospho-arabinose (DPA) on the C-5 of a 6-linked galactofuranosyl (Galf) of the galactan domain, thus 'priming' the galactan for further elaboration by other arabinofuranosyltransferases. It is not able to add an Araf residue to a terminal Galf. {ECO:0000269|PubMed:16595677, ECO:0000305|PubMed:18556798}.",MPSRRKSPQFGHEMGAFTSARAREVLVALGQLAAAVVVAVGVAVVSLLAIARVEWPAFPSSNQLHALTTVGQVGCLAGLVGIGWLWRHGRFRRLARLGGLVLVSAFTVVTLGMPLGATKLYLFGISVDQQFRTEYLTRLTDTAALRDMTYIGLPPFYPPGWFWIGGRAAALTGTPAWEMFKPWAITSMAIAVAVALVLWWRMIRFEYALLVTVATAAVMLAYSSPEPYAAMITVLLPPMLVLTWSGLGARDRQGWAAVVGAGVFLGFAATWYTLLVAYGAFTVVLMALLLAGSRLQSGIKAAVDPLCRLAVVGAIAAAIGSTTWLPYLLRAARDPVSDTGSAQHYLPADGAALTFPMLQFSLLGAICLLGTLWLVMRARSSAPAGALAIGVLAVYLWSLLSMLATLARTTLLSFRLQPTLSVLLVAAGAFGFVEAVQALGKRGRGVIPMAAAIGLAGAIAFSQDIPDVLRPDLTIAYTDTDGYGQRGDRRPPGSEKYYPAIDAAIRRVTGKRRDRTVVLTADYSFLSYYPYWGFQGLTPHYANPLAQFDKRATQIDSWSGLSTADEFIAALDKLPWQPPTVFLMRHGAHNSYTLRLAQDVYPNQPNVRRYTVDLRTALFADPRFVVEDIGPFVLAIRKPQESA,"69,515",643,Glycosyltransferase 85 family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; growth [GO:0040007]; mycolate cell wall layer assembly [GO:0071769],"transferase activity, transferring glycosyl groups [GO:0016757]; UDP-galactosyltransferase activity [GO:0035250]",cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WPX3,AK_MYCTU,Rv3709c,ask Rv3709c MTV025.057c,GO:0004072; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0009088; GO:0009089; GO:0019877; GO:0040007,IPR036393; IPR002912; IPR001048; IPR005260; IPR001341; IPR018042; IPR027795; ,,ask,DOMAIN 267 348 ACT 1. {ECO:0000255|PROSITE-ProRule:PRU01007}.; DOMAIN 349 421 ACT 2. {ECO:0000255|PROSITE-ProRule:PRU01007}.,Aspartokinase (EC 2.7.2.4) (Aspartate kinase) (ASK),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aspartate kinase activity [GO:0004072]; ATP binding [GO:0005524]; diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089]; threonine biosynthetic process [GO:0009088],9634230; 21969609; 21393848; 21976064,X-ray crystallography (3),"FUNCTION: Catalyzes the phosphorylation of the beta-carboxyl group of aspartic acid with ATP to yield 4-phospho-L-aspartate, which is involved in the branched biosynthetic pathway leading to the biosynthesis of amino acids lysine, threonine, isoleucine and methionine. {ECO:0000250}.",MALVVQKYGGSSVADAERIRRVAERIVATKKQGNDVVVVVSAMGDTTDDLLDLAQQVCPAPPPRELDMLLTAGERISNALVAMAIESLGAHARSFTGSQAGVITTGTHGNAKIIDVTPGRLQTALEEGRVVLVAGFQGVSQDTKDVTTLGRGGSDTTAVAMAAALGADVCEIYTDVDGIFSADPRIVRNARKLDTVTFEEMLEMAACGAKVLMLRCVEYARRHNIPVHVRSSYSDRPGTVVVGSIKDVPMEDPILTGVAHDRSEAKVTIVGLPDIPGYAAKVFRAVADADVNIDMVLQNVSKVEDGKTDITFTCSRDVGPAAVEKLDSLRNEIGFSQLLYDDHIGKVSLIGAGMRSHPGVTATFCEALAAVGVNIELISTSEIRISVLCRDTELDKAVVALHEAFGLGGDEEATVYAGTGR,"44,462",421,Aspartokinase family,diaminopimelate biosynthetic process [GO:0019877]; growth [GO:0040007]; lysine biosynthetic process via diaminopimelate [GO:0009089]; threonine biosynthetic process [GO:0009088],aspartate kinase activity [GO:0004072]; ATP binding [GO:0005524],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV025.057c,1
O07801,CHP1_MYCTU,Rv3822 RVBD_3822,chp1 Rv3822 RVBD_3822 LH57_20830 P425_03980,GO:0005886; GO:0006629; GO:0016021; GO:0016746,IPR029058; IPR013228; ,,chp1,,SL1278 acyltransferase Chp1 (EC 2.3.1.-) (Cutinase-like hydrolase protein),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transferase activity, transferring acyl groups [GO:0016746]; lipid metabolic process [GO:0006629]",9634230; 21969609; 22194604,,"FUNCTION: Involved in the final steps of the cell wall sulfolipid-1 (SL-1) biosynthesis. Catalyzes two successive acylations of the precursor 2-palmitoyl-3-(C43)-phthioceranyl-alpha, alpha'-D-trehalose-2'-sulfate (SL1278) to yield the tetraacylated sulfolipid SL-1. {ECO:0000269|PubMed:22194604}.",MKCPGVSDCVATVRHDNVFAIAAGLRWSAAVPPLHKGDAVTKLLVGAIAGGMLACAAILGDGIASADTALIVPGTAPSPYGPLRSLYHFNPAMQPQIGANYYNPTATRHVVSYPGSFWPVTGLNSPTVGSSVSAGTNNLDAAIRSTDGPIFVAGLSQGTLVLDREQARLANDPTAPPPGQLTFIKAGDPNNLLWRAFRPGTHVPIIDYTVPAPAESQYDTINIVGQYDIFSDPPNRPGNLLADLNAIAAGGYYGHSATAFSDPARVAPRDITTTTNSLGATTTTYFIRTDQLPLVRALVDMAGLPPQAAGTVDAALRPIIDRAYQPGPAPAVNPRDLVQGIRGIPAIAPAIAIPIGSTTGASAATSTAAATAAATNALRGANVGPGANKALSMVRGLLPKGKKH,"41,408",404,Mycobacterial PPE family,lipid metabolic process [GO:0006629],"transferase activity, transferring acyl groups [GO:0016746]",integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,LH57_20830 P425_03980,1
P71857,CHSE1_MYCTU,Rv3544c,fadE28 Rv3544c LH57_19335,GO:0006707; GO:0009268; GO:0009405; GO:0016627; GO:0033539; GO:0044117; GO:0071949,IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE28,,"Acyl-CoA dehydrogenase FadE28 (ACAD) (EC 1.3.99.-) (3-oxo-23,24-bisnorchol-4-en-22-oyl-CoA dehydrogenase alpha subunit) (3-oxo-4-pregnene-20-carboxyl-CoA dehydrogenase alpha subunit)","FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; response to pH [GO:0009268]",9634230; 17635188; 18486437; 22045806; 21969609; 23560677; 26161441,,"FUNCTION: Involved in the third cycle of side chain dehydrogenation in the beta-oxidation of cholesterol catabolism (PubMed:26161441). May play an important role for the initial macrophage invasion, possibly in response to the acidification of phagosome (PubMed:18486437). It contributes partly to the virulence by increasing the efficiency of beta-oxidation (PubMed:18486437, PubMed:22045806). Catalyzes the dehydrogenation of 2'-propanoyl-CoA ester side chains of 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) to yield 3-oxo-4,17-pregnadiene-20-carboxyl-CoA (3-OPDC-CoA). Also able to dehydrogenate steroyl-CoA such as 3-oxo-chol-4-en-24-oyl-CoA (3-OCO-CoA), 1beta-(2'-propanoyl-CoA)-3a-alpha-H-7a-beta-methylhexahydro-4-indanone (indanone-CoA ester), hexahydroindanone and pregenenone (PubMed:22045806, PubMed:23560677, PubMed:26161441). {ECO:0000269|PubMed:18486437, ECO:0000269|PubMed:22045806, ECO:0000269|PubMed:23560677, ECO:0000269|PubMed:26161441}.",MDFDPTAEQQAVADVVTSVLERDISWEALVCGGVTALPVPERLGGDGVGLFEVGALLTEVGRHGAVTPALATLGLGVVPLLELASAEQQDRFLAGVAKGGVLTAALNEPGAALPDRPATSFVGGRLSGTKVGVGYAEQADWMLVTADNAVVVVSPTADGVRMVRTPTSNGSDEYVMTMDGVAVADCDILADVAAHRVNQLALAVMGAYADGLVAGALRLTADYVANRKQFGKPLSTFQTVAAQLAEVYIASRTIDLVAKSVIWRLAEDLDAGDDLGVLGYWVTSQAPPAMQICHHLHGGMGMDVTYPMHRYYSTIKDLTRLLGGPSHRLELLGARCSLT,"35,469",339,Acyl-CoA dehydrogenase family,cholesterol catabolic process [GO:0006707]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; response to pH [GO:0009268],"FAD binding [GO:0071949]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,LH57_19335,3
P9WPT7,CTPJ_MYCTU,Rv3743c,ctpJ nmtA Rv3743c,GO:0005524; GO:0005886; GO:0016021; GO:0019829; GO:0046872,IPR023299; IPR018303; IPR023298; IPR008250; IPR036412; IPR023214; IPR027256; IPR001757; ,,ctpJ,,Probable cation-transporting P-type ATPase J (EC 3.6.3.-),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],9634230; 12163508,,,MAVRELSPARCTSASPLVLARRTKLFALSEMRWAALALGLFSAGLLTQLCGAPQWVRWALFLACYATGGWEPGLAGLQALQRRTLDVDLLMVVAAIGAAAIGQIAEGALLIVIFATSGALEALVTARTADSVRGLMGLAPGTATRVGAGGGEETVNAADLRIGDIVLVRPGERISADATVLAGGSEVDQATVTGEPLPVDKSIGDQVFAGTVNGTGALRIRVDRLARDSVVARIATLVEQASQTKARTQLFIEKVEQRYSIGMVAVTLAVFAVPPLWGETLQRALLRAMTFMIVASPCAVVLATMPPLLAAIANAGRHGVLAKSAIVMEQLGTTTRIAFDKTGTLTRGTPELAGIWVYERRFTDDELLRLAAAAEYPSEHPLGAAIVKAAQSRRIRLPTVGEFTAHPGCRVTARVDGHVIAVGSATALLGTAGAAALEASMITAVDFLQGEGYTVVVVVCDSHPVGLLAITDQLRPEAAAAISAATKLTGAKPVLLTGDNRATADRLGVQVGIDDVRAGLLPDDKVAAVRQLQAGGARLTVVGDGINDAPALAAAHVGIAMGSARSELTLQTADAVVVRDDLTTIPTVIAMSRRARRIVVANLIVAVTFIAGLVVWDLAFTLPLPLGVARHEGSTIIVGLNGLRLLRHTAWRRAAGTAHR,"68,645",660,"Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily",,ATP binding [GO:0005524]; cation-transporting ATPase activity [GO:0019829]; metal ion binding [GO:0046872],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],nmtA,,1
P9WMH3,CRPL_MYCTU,Rv3676,crp Rv3676,GO:0003677; GO:0003700; GO:0005618; GO:0005886; GO:0006351; GO:0006355; GO:0009405; GO:0030552; GO:0040007; GO:0045892; GO:0045893,IPR018490; IPR000595; IPR012318; IPR014710; IPR036388; IPR036390; ,,crp,DOMAIN 144 217 HTH crp-type. {ECO:0000255|PROSITE-ProRule:PRU00387}.,CRP-like cAMP-activated global transcriptional regulator (cAMP receptor protein) (CRP) (cAMP regulatory protein),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; cAMP binding [GO:0030552]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; growth [GO:0040007]; negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 16267303; 15882420; 20028978; 21969609; 19193643; 19740754; 20338852; 22074452,X-ray crystallography (5),"FUNCTION: Global transcriptional regulator that complexes with cAMP and binds to specific DNA promoter sites, causing DNA-bending, to regulate transcription. cAMP improves binding to specific DNA sequences, probably by altering protein conformation. The CRP regulon is predicted to contain about 115 genes. Some genes are activated by CRP (rpfA, whiB1) while others are repressed (fadD10). There are 2 CRP-binding sites in the promoter of whiB1, at low concentrations of CRP with or without cAMP transcription of whiB1 is enhanced via site CRP1, then repressed as site CRP2 is filled. {ECO:0000269|PubMed:15882420, ECO:0000269|PubMed:20028978}.",MDEILARAGIFQGVEPSAIAALTKQLQPVDFPRGHTVFAEGEPGDRLYIIISGKVKIGRRAPDGRENLLTIMGPSDMFGELSIFDPGPRTSSATTITEVRAVSMDRDALRSWIADRPEISEQLLRVLARRLRRTNNNLADLIFTDVPGRVAKQLLQLAQRFGTQEGGALRVTHDLTQEEIAQLVGASRETVNKALADFAHRGWIRLEGKSVLISDSERLARRAR,"24,791",224,,"growth [GO:0040007]; negative regulation of transcription, DNA-templated [GO:0045892]; pathogenesis [GO:0009405]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",cAMP binding [GO:0030552]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WP75,CSPA_MYCTU,Rv3648c,cspA Rv3648c MTCY15C10.04,GO:0003677; GO:0005618; GO:0005737; GO:0006351; GO:0006355; GO:0040007,IPR019844; IPR012156; IPR011129; IPR002059; IPR012340; ,,cspA,DOMAIN 4 64 CSD.,Probable cold shock protein A,"cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA binding [GO:0003677]; growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MPQGTVKWFNAEKGFGFIAPEDGSADVFVHYTEIQGTGFRTLEENQKVEFEIGHSPKGPQATGVRSL,"7,370",67,,"growth [GO:0040007]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cell wall [GO:0005618]; cytoplasm [GO:0005737],,MTCY15C10.04,1
P96855,CHSE3_MYCTU,Rv3573c,fadE34 Rv3573c LH57_19490,GO:0005886; GO:0006707; GO:0009405; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE34,,Acyl-CoA dehydrogenase FadE34 (ACAD) (EC 1.3.99.-) (3-oxochol-4-en-24-oyl-CoA dehydrogenase),"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]",9634230; 17635188; 21969609; 26161441,,"FUNCTION: Involved in the second cycle of side chain dehydrogenation in the beta-oxidation of cholesterol catabolism. It contributes partly to the virulence by increasing the efficiency of beta-oxidation. Catalyzes the highly specific dehydrogenation of acyl-CoA ester side chains of 3-oxo-chol-4-en-24-oyl-CoA (3-OCO-CoA) to yield 3-oxochol-4,22-dien-24-oyl-CoA. {ECO:0000269|PubMed:26161441}.",MVATVTDEQSAARELVRGWARTAASGAAATAAVRDMEYGFEEGNADAWRPVFAGLAGLGLFGVAVPEDCGGAGGSIEDLCAMVDEAARALVPGPVATTAVATLVVSDPKLRSALASGERFAGVAIDGGVQVDPKTSTASGTVGRVLGGAPGGVVLLPADGNWLLVDTACDEVVVEPLRATDFSLPLARMVLTSAPVTVLEVSGERVEDLAATVLAAEAAGVARWTLDTAVAYAKVREQFGKPIGSFQAVKHLCAQMLCRAEQADVAAADAARAAADSDGTQLSIAAAVAASIGIDAAKANAKDCIQVLGGIGCTWEHDAHLYLRRAHGIGGFLGGSGRWLRRVTALTQAGVRRRLGVDLAEVAGLRPEIAAAVAEVAALPEEKRQVALADTGLLAPHWPAPYGRGASPAEQLLIDQELAAAKVERPDLVIGWWAAPTILEHGTPEQIERFVPATMRGEFLWCQLFSEPGAGSDLASLRTKAVRADGGWLLTGQKVWTSAAHKARWGVCLARTDPDAPKHKGITYFLVDMTTPGIEIRPLREITGDSLFNEVFLDNVFVPDEMVVGAVNDGWRLARTTLANERVAMATGTALGNPMEELLKVLGDMELDVAQQDRLGRLILLAQAGALLDRRIAELAVGGQDPGAQSSVRKLIGVRYRQALAEYLMEVSDGGGLVENRAVYDFLNTRCLTIAGGTEQILLTVAAERLLGLPR,"74,578",711,Acyl-CoA dehydrogenase family,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",plasma membrane [GO:0005886],,LH57_19490,2
I6YCA3,CHSE4_MYCTU,Rv3504,fadE26 Rv3504 LH57_19105,GO:0006707; GO:0009405; GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE26,,Acyl-CoA dehydrogenase FadE26 (ACAD) (EC 1.3.99.-) (3-oxocholest-4-en-26-oyl-CoA dehydrogenase alpha subunit),"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]",9634230; 17635188; 21969609; 26348625; 26161441,X-ray crystallography (1),"FUNCTION: Involved in the first cycle of side chain dehydrogenation in the beta-oxidation of cholesterol catabolism (PubMed:26161441). It contributes partly to the virulence by increasing the efficiency of beta-oxidation. Catalyzes the dehydrogenation of acyl-CoA ester side chains of (25S)-3-oxo-cholest-4-en-26-oyl-CoA (3-OCS-CoA) to yield (24E)-3-oxo-cholest-4,24-dien-26-oyl-CoA (PubMed:26348625, PubMed:26161441). Also able to dehydrogenate steroyl-CoA such as 3-oxo-chol-4-en-24-oyl-CoA (3-OCO-CoA) as well as 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) (PubMed:26161441). It dehydrogenates only (25S)-OCS-CoA diastereomer (Probable). {ECO:0000269|PubMed:26161441, ECO:0000269|PubMed:26348625}.",MRISYTPQQEELRRELRSYFATLMTPERREALSSVQGEYGVGNVYRETIAQMGRDGWLALGWPKEYGGQGRSAMDQLIFTDEAAIAGAPVPFLTINSVAPTIMAYGTDEQKRFFLPRIAAGDLHFSIGYSEPGAGTDLANLRTTAVRDGDDYVVNGQKMWTSLIQYADYVWLAVRTNPESSGAKKHRGISVLIVPTTAEGFSWTPVHTMAGPDTSATYYSDVRVPVANRVGEENAGWKLVTNQLNHERVALVSPAPIFGCLREVREWAQNTKDAGGTRLIDSEWVQLNLARVHAKAEVLKLINWELASSQSGPKDAGPSPADASAAKVFGTELATEAYRLLMEVLGTAATLRQNSPGALLRGRVERMHRACLILTFGGGTNEVQRDIIGMVALGLPRANR,"43,785",400,Acyl-CoA dehydrogenase family,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,LH57_19105,1
I6Y3Q0,CHSE5_MYCTU,Rv3505,fadE27 Rv3505 LH57_19110,GO:0006707; GO:0009405; GO:0016627; GO:0050660,IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE27,,Acyl-CoA dehydrogenase FadE27 (ACAD) (EC 1.3.99.-) (3-oxocholest-4-en-26-oyl-CoA dehydrogenase beta subunit),"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405]",9634230; 17635188; 21969609; 26348625; 26161441,X-ray crystallography (1),"FUNCTION: Involved in the first cycle of side chain dehydrogenation in the beta-oxidation of cholesterol catabolism (PubMed:26161441). It contributes partly to the virulence by increasing the efficiency of beta-oxidation. Catalyzes the dehydrogenation of acyl-CoA ester side chains of (25S)-3-oxo-cholest-4-en-26-oyl-CoA (3-OCS-CoA) to yield (24E)-3-oxo-cholest-4,24-dien-26-oyl-CoA (PubMed:26348625, PubMed:26161441). Also able to dehydrogenate steroyl-CoA such as 3-oxo-chol-4-en-24-oyl-CoA (3-OCO-CoA) as well as 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) (PubMed:26161441). It dehydrogenates only (25S)-OCS-CoA diastereomer (PubMed:26348625, PubMed:26161441). {ECO:0000269|PubMed:26161441, ECO:0000269|PubMed:26348625}.",MDFTTTEAAQDLGGLVDTIVDAVCTPEHQRELDKLEQRFDRELWRKLIDAGILSSAAPESLGGDGFGVLEQVAVLVALGHQLAAVPYLESVVLAAGALARFGSPELQQGWGVSAVSGDRILTVALDGEMGEGPVQAAGTGHGYRLTGTRTQVGYGPVADAFLVPAETDSGAAVFLVAAGDPGVAVTALATTGLGSVGHLELNGAKVDAARRVGGTDVAVWLGTLSTLSRTAFQLGVLERGLQMTAEYARTREQFDRPIGSFQAVGQRLADGYIDVKGLRLTLTQAAWRVAEDSLASRECPQPADIDVATAGFWAAEAGHRVAHTIVHVHGGVGVDTDHPVHRYFLAAKQTEFALGGATGQLRRIGRELAETPA,"39,008",373,Acyl-CoA dehydrogenase family,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,LH57_19110,1
P9WPL5,CP142_MYCTU,Rv3518c,cyp142 cyp142A1 Rv3518c MTV023.25c,GO:0005506; GO:0005618; GO:0006707; GO:0009405; GO:0020037; GO:0031073; GO:0036199,IPR001128; IPR002397; IPR017972; IPR036396; ,,cyp142,,Steroid C26-monooxygenase (EC 1.14.13.221) (Cholest-4-en-3-one C26-monooxygenase) (Cholest-4-en-3-one C26-monooxygenase [(25R)-3-oxocholest-4-en-26-oate forming]) (Cholesterol C26-monooxygenase) (Cholesterol C26-monooxygenase [(25R)-3beta-hydroxycholest-5-en-26-oate forming]) (Cytochrome P450 142) (Steroid C27-monooxygenase),cell wall [GO:0005618]; cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],9634230; 20843794; 21969609; 25210044; 20889498,X-ray crystallography (1),"FUNCTION: Involved in the utilization of cholesterol as the sole carbon and energy source by degrading the side chain during infection (PubMed:20843794). Primarily catalyzes the sequential oxidation of the terminal methyl of cholest-4-en-3-one into (25R)-26-hydroxycholest-4-en-3-one (alcohol), (25R)-26-oxocholest-4-en-3-one (aldehyde), to finally yield the carboxylic acid (25R)-3-oxocholest-4-en-26-oate (PubMed:20843794, PubMed:20889498). In vitro, Cyp142 catalyzes with equal preference the oxidation of both (25R)- and (25S)-26-hydroxycholest-4-en-3-one diastereomers to the corresponding carboxylic acid which is a prerequisite for entry into the beta-oxidation pathway (PubMed:20843794). Also able to sequentially oxidize cholesterol itself, not only cholest-4-en-3-one (PubMed:20843794). {ECO:0000269|PubMed:20843794, ECO:0000269|PubMed:20889498, ECO:0000269|PubMed:25210044}.",MTEAPDVDLADGNFYASREARAAYRWMRANQPVFRDRNGLAAASTYQAVIDAERQPELFSNAGGIRPDQPALPMMIDMDDPAHLLRRKLVNAGFTRKRVKDKEASIAALCDTLIDAVCERGECDFVRDLAAPLPMAVIGDMLGVRPEQRDMFLRWSDDLVTFLSSHVSQEDFQITMDAFAAYNDFTRATIAARRADPTDDLVSVLVSSEVDGERLSDDELVMETLLILIGGDETTRHTLSGGTEQLLRNRDQWDLLQRDPSLLPGAIEEMLRWTAPVKNMCRVLTADTEFHGTALCAGEKMMLLFESANFDEAVFCEPEKFDVQRNPNSHLAFGFGTHFCLGNQLARLELSLMTERVLRRLPDLRLVADDSVLPLRPANFVSGLESMPVVFTPSPPLG,"44,399",398,Cytochrome P450 family,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506],cell wall [GO:0005618],cyp142A1,MTV023.25c,1
P9WPP1,CP125_MYCTU,Rv3545c,cyp125 cyp125A1 Rv3545c MTCY03C7.11,GO:0005506; GO:0006707; GO:0008395; GO:0009405; GO:0020037; GO:0036199; GO:0044117,IPR001128; IPR002397; IPR036396; ,,cyp125,,Steroid C26-monooxygenase (EC 1.14.13.141) (Cholest-4-en-3-one 26-monooxygenase) (Cholest-4-en-3-one C26-monooxygenase [(25S)-3-oxocholest-4-en-26-oate forming]) (Cholesterol C26-monooxygenase) (Cholesterol C26-monooxygenase [(25S)-3beta-hydroxycholest-5-en-26-oate forming]) (Cytochrome P450 125) (Steroid C27-monooxygenase),cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; cholesterol catabolic process [GO:0006707]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405],9634230; 19846551; 20843794; 21969609; 19846552; 20545858; 21109436,X-ray crystallography (8),"FUNCTION: Involved in the utilization of cholesterol as the sole carbon and energy source by degrading the side chain during infection (PubMed:20843794, PubMed:20545858). Primarily catalyzes the sequential oxidation of the terminal methyl of cholest-4-en-3-one into (25S)-26-hydroxycholest-4-en-3-one (alcohol), (25S)-26-oxocholest-4-en-3-one (aldehyde), to finally yield the carboxylic acid (25S)-3-oxocholest-4-en-26-oate (PubMed:19846551, PubMed:20843794, PubMed:20545858). Also able to sequentially oxidize cholesterol itself, not only cholest-4-en-3-one (PubMed:19846551, PubMed:20843794, PubMed:20545858). {ECO:0000269|PubMed:19846551, ECO:0000269|PubMed:20545858, ECO:0000269|PubMed:20843794}.",MSWNHQSVEIAVRRTTVPSPNLPPGFDFTDPAIYAERLPVAEFAELRSAAPIWWNGQDPGKGGGFHDGGFWAITKLNDVKEISRHSDVFSSYENGVIPRFKNDIAREDIEVQRFVMLNMDAPHHTRLRKIISRGFTPRAVGRLHDELQERAQKIAAEAAAAGSGDFVEQVSCELPLQAIAGLLGVPQEDRGKLFHWSNEMTGNEDPEYAHIDPKASSAELIGYAMKMAEEKAKNPADDIVTQLIQADIDGEKLSDDEFGFFVVMLAVAGNETTRNSITQGMMAFAEHPDQWELYKKVRPETAADEIVRWATPVTAFQRTALRDYELSGVQIKKGQRVVMFYRSANFDEEVFQDPFTFNILRNPNPHVGFGGTGAHYCIGANLARMTINLIFNAVADHMPDLKPISAPERLRSGWLNGIKHWQVDYTGRCPVAH,"48,433",433,Cytochrome P450 family,cholesterol catabolic process [GO:0006707]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405],cholest-4-en-3-one 26-monooxygenase activity [GO:0036199]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],,cyp125A1,MTCY03C7.11,1
P9WMX3,GLFT1_MYCTU,Rv3782,glfT1 Rv3782,GO:0005576; GO:0005618; GO:0005886; GO:0008378; GO:0016740; GO:0016757; GO:0040007; GO:0044038; GO:0045227; GO:0071555,IPR029044; ,,glfT1,,"Galactofuranosyltransferase GlfT1 (GalTr 1) (EC 2.4.1.287) (Arabinogalactan galactosyltransferase 1) (Rhamnopyranosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,4/1,5-galactofuranosyltransferase) (UDP-Galf:alpha-3-L-rhamnosyl-alpha-D-GlcNAc-pyrophosphate polyprenol, galactofuranosyl transferase)","cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; galactosyltransferase activity [GO:0008378]; transferase activity [GO:0016740]; transferase activity, transferring glycosyl groups [GO:0016757]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; growth [GO:0040007]",9634230; 16952951; 19099550; 18248822; 21969609; 23038254,,"FUNCTION: Involved in the biosynthesis of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacterial cell wall. Catalyzes the transfer of the first two galactofuranosyl (Galf) units from UDP-galactofuranose (UDP-Galf) onto the rhamnosyl-GlcNAc-diphospho-decaprenol (Rha-GlcNAc-PP-C50) acceptor, yielding galactofuranosyl-galactofuranosyl-rhamnosyl-GlcNAc-diphospho-decaprenol (Galf-Galf-Rha-GlcNAc-PP-C50). Thus, GlfT1 is the initiator of galactan synthesis, while GlfT2 continues with the subsequent polymerization events. {ECO:0000269|PubMed:16952951}.",MTESVFAVVVTHRRPDELAKSLDVLTAQTRLPDHLIVVDNDGCGDSPVRELVAGQPIATTYLGSRRNLGGAGGFALGMLHALAQGADWVWLADDDGHAQDARVLATLLACAEKYSLAEVSPMVCNIDDPTRLAFPLRRGLVWRRRASELRTEAGQELLPGIASLFNGALFRASTLAAIGVPDLRLFIRGDEVEMHRRLIRSGLPFGTCLDAAYLHPCGSDEFKPILCGRMHAQYPDDPGKRFFTYRNRGYVLSQPGLRKLLAQEWLRFGWFFLVTRRDPKGLWEWIRLRRLGRREKFGKPGGSA,"33,864",304,Glycosyltransferase 2 family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; growth [GO:0040007],"galactosyltransferase activity [GO:0008378]; transferase activity [GO:0016740]; transferase activity, transferring glycosyl groups [GO:0016757]",cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
O53585,GLFT2_MYCTU,Rv3808c,glfT2 glfT Rv3808c,GO:0005829; GO:0005886; GO:0008921; GO:0009103; GO:0016740; GO:0016757; GO:0035250; GO:0035496; GO:0040007; GO:0044038; GO:0045227; GO:0046872; GO:0052573; GO:0070592; GO:0071555; GO:0071769,IPR029044; ,,glfT2,,"Galactofuranosyltransferase GlfT2 (GalTr 2) (EC 2.4.1.288) (Arabinogalactan galactosyltransferase 2) (Galactofuranosylgalactofuranosylrhamnosyl-N-acetylglucosaminyl-diphospho-decaprenol beta-1,5/1,6-galactofuranosyltransferase) (Polymerizing galactofuranosyltransferase GlfT2)","cytosol [GO:0005829]; plasma membrane [GO:0005886]; lipopolysaccharide-1,5-galactosyltransferase activity [GO:0035496]; lipopolysaccharide-1,6-galactosyltransferase activity [GO:0008921]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-galactosyltransferase activity [GO:0035250]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103]; mycolate cell wall layer assembly [GO:0071769]; UDP-D-galactose metabolic process [GO:0052573]",9634230; 10934214; 11304545; 16704275; 19099550; 18423586; 18055597; 19571009; 21969609; 22707726,X-ray crystallography (2),"FUNCTION: Involved in the galactan polymerization of the arabinogalactan (AG) region of the mycolylarabinogalactan-peptidoglycan (mAGP) complex, an essential component of the mycobacteria cell wall. Thus, successively transfers approximately 28 galactofuranosyl (Galf) residues from UDP-galactofuranose (UDP-Galf) onto the galactofuranosyl-galactofuranosyl-rhamnosyl-GlcNAc-diphospho-decaprenol (Galf-Galf-Rha-GlcNAc-PP-C50) acceptor produced by GlfT1, with alternating 1->5 and 1->6 links, forming a galactan domain with approximately 30 galactofuranosyl residues. {ECO:0000269|PubMed:18055597, ECO:0000269|PubMed:19571009, ECO:0000305|PubMed:10934214, ECO:0000305|PubMed:11304545, ECO:0000305|PubMed:16704275, ECO:0000305|PubMed:18423586}.",MSELAASLLSRVILPRPGEPLDVRKLYLEESTTNARRAHAPTRTSLQIGAESEVSFATYFNAFPASYWRRWTTCKSVVLRVQVTGAGRVDVYRTKATGARIFVEGHDFTGTEDQPAAVETEVVLQPFEDGGWVWFDITTDTAVTLHSGGWYATSPAPGTANIAVGIPTFNRPADCVNALRELTADPLVDQVIGAVIVPDQGERKVRDHPDFPAAAARLGSRLSIHDQPNLGGSGGYSRVMYEALKNTDCQQILFMDDDIRLEPDSILRVLAMHRFAKAPMLVGGQMLNLQEPSHLHIMGEVVDRSIFMWTAAPHAEYDHDFAEYPLNDNNSRSKLLHRRIDVDYNGWWTCMIPRQVAEELGQPLPLFIKWDDADYGLRAAEHGYPTVTLPGAAIWHMAWSDKDDAIDWQAYFHLRNRLVVAAMHWDGPKAQVIGLVRSHLKATLKHLACLEYSTVAIQNKAIDDFLAGPEHIFSILESALPQVHRIRKSYPDAVVLPAASELPPPLHKNKAMKPPVNPLVIGYRLARGIMHNLTAANPQHHRRPEFNVPTQDARWFLLCTVDGATVTTADGCGVVYRQRDRAKMFALLWQSLRRQRQLLKRFEEMRRIYRDALPTLSSKQKWETALLPAANQEPEHG,"71,507",637,Glycosyltransferase 2 family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall macromolecule biosynthetic process [GO:0044038]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007]; lipopolysaccharide biosynthetic process [GO:0009103]; mycolate cell wall layer assembly [GO:0071769]; UDP-D-galactose metabolic process [GO:0052573],"lipopolysaccharide-1,5-galactosyltransferase activity [GO:0035496]; lipopolysaccharide-1,6-galactosyltransferase activity [GO:0008921]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; transferase activity, transferring glycosyl groups [GO:0016757]; UDP-galactosyltransferase activity [GO:0035250]",cytosol [GO:0005829]; plasma membrane [GO:0005886],glfT,,1
P9WIQ1,GLF_MYCTU,Rv3809c,glf Rv3809c,GO:0005618; GO:0005886; GO:0008767; GO:0045227; GO:0071555; GO:0071766,IPR004379; IPR015899; ,,glf,,UDP-galactopyranose mutase (UGM) (EC 5.4.99.9) (UDP-GALP mutase) (Uridine 5-diphosphate galactopyranose mutase),cell wall [GO:0005618]; plasma membrane [GO:0005886]; UDP-galactopyranose mutase activity [GO:0008767]; Actinobacterium-type cell wall biogenesis [GO:0071766]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],9692181; 9784509; 9634230; 21969609; 15843027,X-ray crystallography (6),FUNCTION: Catalyzes the interconversion through a 2-keto intermediate of uridine diphosphogalactopyranose (UDP-GalP) into uridine diphosphogalactofuranose (UDP-GalF) which is a key building block for cell wall construction in Mycobacterium tuberculosis. {ECO:0000269|PubMed:9692181}.,MQPMTARFDLFVVGSGFFGLTIAERVATQLDKRVLVLERRPHIGGNAYSEAEPQTGIEVHKYGAHLFHTSNKRVWDYVRQFTDFTDYRHRVFAMHNGQAYQFPMGLGLVSQFFGKYFTPEQARQLIAEQAAEIDTADAQNLEEKAISLIGRPLYEAFVKGYTAKQWQTDPKELPAANITRLPVRYTFDNRYFSDTYEGLPTDGYTAWLQNMAADHRIEVRLNTDWFDVRGQLRPGSPAAPVVYTGPLDRYFDYAEGRLGWRTLDFEVEVLPIGDFQGTAVMNYNDLDVPYTRIHEFRHFHPERDYPTDKTVIMREYSRFAEDDDEPYYPINTEADRALLATYRARAKSETASSKVLFGGRLGTYQYLDMHMAIASALNMYDNVLAPHLRDGVPLLQDGA,"45,814",399,UDP-galactopyranose/dTDP-fucopyranose mutase family,Actinobacterium-type cell wall biogenesis [GO:0071766]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],UDP-galactopyranose mutase activity [GO:0008767],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WMU3,GLPQ1_MYCTU,Rv3842c,glpQ1 Rv3842c,GO:0006071; GO:0006629; GO:0008889; GO:0046872,IPR004129; IPR030395; IPR017946; ,,glpQ1,DOMAIN 12 264 GP-PDE.,Probable glycerophosphodiester phosphodiesterase 1 (Glycerophosphoryl diester phosphodiesterase 1) (EC 3.1.4.46),glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872]; glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629],9634230; 11416222; 19099550; 21969609,,FUNCTION: Glycerophosphoryl diester phosphodiesterase hydrolyzes deacylated phospholipids to G3P and the corresponding alcohols.,MTWADEVLAGHPFVVAHRGASAARPEHTLAAYDLALKEGADGVECDVRLTRDGHLVCVHDRRLDRTSTGAGLVSTMTLAQLRELEYGAWHDSWRPDGSHGDTSLLTLDALVSLVLDWHRPVKIFVETKHPVRYGSLVENKLLALLHRFGIAAPASADRSRAVVMSFSAAAVWRIRRAAPLLPTVLLGKTPRYLTSSAATAVGATAVGPSLPALKEYPQLVDRSAAQGRAVYCWNVDEYEDIDFCREVGVAWIGTHHPGRTKAWLEDGRANGTTR,"29,917",274,Glycerophosphoryl diester phosphodiesterase family,glycerol metabolic process [GO:0006071]; lipid metabolic process [GO:0006629],glycerophosphodiester phosphodiesterase activity [GO:0008889]; metal ion binding [GO:0046872],,,,1
P9WNC5,FOLB_MYCTU,Rv3607c,folB Rv3607c MTCY07H7B.15,GO:0004150; GO:0016491; GO:0016853; GO:0040007; GO:0046654; GO:0046656,IPR006156; IPR006157; ,,folB,,"Dihydroneopterin aldolase (DHNA) (EC 4.1.2.25) (7,8-dihydroneopterin 2'-epimerase) (7,8-dihydroneopterin aldolase) (7,8-dihydroneopterin epimerase) (EC 5.1.99.8) (7,8-dihydroneopterin hydroxylase) (EC 1.13.11.81) (Dihydroneopterin epimerase) (Dihydroneopterin hydroxylase)",dihydroneopterin aldolase activity [GO:0004150]; isomerase activity [GO:0016853]; oxidoreductase activity [GO:0016491]; folic acid biosynthetic process [GO:0046656]; growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],9634230; 19099550; 21969609; 23150985; 15876368,X-ray crystallography (2),"FUNCTION: Catalyzes the conversion of 7,8-dihydroneopterin to 6-hydroxymethyl-7,8-dihydropterin, 7,8-dihydromonapterin and 7,8-dihydroxanthopterin, respectively, in equal quantities. After longer incubation times the only product is 6-hydroxymethyl-7,8-dihydropterin. {ECO:0000269|PubMed:23150985}.",MADRIELRGLTVHGRHGVYDHERVAGQRFVIDVTVWIDLAEAANSDDLADTYDYVRLASRAAEIVAGPPRKLIETVGAEIADHVMDDQRVHAVEVAVHKPQAPIPQTFDDVAVVIRRSRRGGRGWVVPAGGAV,"14,552",133,DHNA family,folic acid biosynthetic process [GO:0046656]; growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],dihydroneopterin aldolase activity [GO:0004150]; isomerase activity [GO:0016853]; oxidoreductase activity [GO:0016491],,,MTCY07H7B.15,1
P9WQN3,FTSH_MYCTU,Rv3610c,ftsH Rv3610c MTCY07H7B.12,GO:0004176; GO:0004222; GO:0005524; GO:0005829; GO:0005886; GO:0006508; GO:0006979; GO:0008237; GO:0010468; GO:0016021; GO:0030163; GO:0040007; GO:0046872,IPR003593; IPR003959; IPR003960; IPR005936; IPR027417; IPR000642; IPR037219; ,,ftsH,,ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; growth [GO:0040007]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; response to oxidative stress [GO:0006979],9634230; 9729123; 16684108; 21969609,,"FUNCTION: Acts as a processive, ATP-dependent zinc metallopeptidase for both cytoplasmic and membrane proteins. Plays a role in the quality control of integral membrane proteins. {ECO:0000255|HAMAP-Rule:MF_01458}.; FUNCTION: Complements an E.coli null mutation. Upon overexpression in E.coli has been shown to degrade endogenous sigma-32, SecY and phage lambda cII protein.",MNRKNVTRTITAIAVVVLLGWSFFYFSDDTRGYKPVDTSVAITQINGDNVKSAQIDDREQQLRLILKKGNNETDGSEKVITKYPTGYAVDLFNALSAKNAKVSTVVNQGSILGELLVYVLPLLLLVGLFVMFSRMQGGARMGFGFGKSRAKQLSKDMPKTTFADVAGVDEAVEELYEIKDFLQNPSRYQALGAKIPKGVLLYGPPGTGKTLLARAVAGEAGVPFFTISGSDFVEMFVGVGASRVRDLFEQAKQNSPCIIFVDEIDAVGRQRGAGLGGGHDEREQTLNQLLVEMDGFGDRAGVILIAATNRPDILDPALLRPGRFDRQIPVSNPDLAGRRAVLRVHSKGKPMAADADLDGLAKRTVGMTGADLANVINEAALLTARENGTVITGPALEEAVDRVIGGPRRKGRIISEQEKKITAYHEGGHTLAAWAMPDIEPIYKVTILARGRTGGHAVAVPEEDKGLRTRSEMIAQLVFAMGGRAAEELVFREPTTGAVSDIEQATKIARSMVTEFGMSSKLGAVKYGSEHGDPFLGRTMGTQPDYSHEVAREIDEEVRKLIEAAHTEAWEILTEYRDVLDTLAGELLEKETLHRPELESIFADVEKRPRLTMFDDFGGRIPSDKPPIKTPGELAIERGEPWPQPVPEPAFKAAIAQATQAAEAARSDAGQTGHGANGSPAGTHRSGDRQYGSTQPDYGAPAGWHAPGWPPRSSHRPSYSGEPAPTYPGQPYPTGQADPGSDESSAEQDDEVSRTKPAHG,"81,986",760,AAA ATPase family; Peptidase M41 family,growth [GO:0040007]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of gene expression [GO:0010468]; response to oxidative stress [GO:0006979],ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY07H7B.12,1
P9WNT9,DPO3X_MYCTU,Rv3721c,dnaX dnaZX Rv3721c MTV025.069c,GO:0003677; GO:0003887; GO:0005524; GO:0006261; GO:0009360; GO:0040007,IPR003593; IPR008921; IPR022754; IPR012763; IPR027417; ,,dnaX,,DNA polymerase III subunit gamma/tau (EC 2.7.7.7),DNA polymerase III complex [GO:0009360]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261]; growth [GO:0040007],9634230; 19099550; 21969609; 22545130,,"FUNCTION: DNA polymerase III is a complex, multichain enzyme responsible for most of the replicative synthesis in bacteria. This DNA polymerase also exhibits 3' to 5' exonuclease activity.",MALYRKYRPASFAEVVGQEHVTAPLSVALDAGRINHAYLFSGPRGCGKTSSARILARSLNCAQGPTANPCGVCESCVSLAPNAPGSIDVVELDAASHGGVDDTRELRDRAFYAPVQSRYRVFIVDEAHMVTTAGFNALLKIVEEPPEHLIFIFATTEPEKVLPTIRSRTHHYPFRLLPPRTMRALLARICEQEGVVVDDAVYPLVIRAGGGSPRDTLSVLDQLLAGAADTHVTYTRALGLLGVTDVALIDDAVDALAACDAAALFGAIESVIDGGHDPRRFATDLLERFRDLIVLQSVPDAASRGVVDAPEDALDRMREQAARIGRATLTRYAEVVQAGLGEMRGATAPRLLLEVVCARLLLPSASDAESALLQRVERIETRLDMSIPAPQAVPRPSAAAAEPKHQPAREPRPVLAPTPASSEPTVAAVRSMWPTVRDKVRLRSRTTEVMLAGATVRALEDNTLVLTHESAPLARRLSEQRNADVLAEALKDALGVNWRVRCETGEPAAAASPVGGGANVATAKAVNPAPTANSTQRDEEEHMLAEAGRGDPSPRRDPEEVALELLQNELGARRIDNA,"61,923",578,DnaX/STICHEL family,DNA-dependent DNA replication [GO:0006261]; growth [GO:0040007],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],DNA polymerase III complex [GO:0009360],dnaZX,MTV025.069c,1
P9WGS9,DPRE2_MYCTU,Rv3791,dprE2 Rv3791 MTCY13D12.25,GO:0005886; GO:0016491; GO:0035884; GO:0040007; GO:0042597; GO:0045227; GO:0070592; GO:0071555,IPR036291; IPR020904; IPR002347; ,,dprE2,,Decaprenylphosphoryl-2-keto-beta-D-erythro-pentose reductase (EC 1.1.1.333) (Decaprenyl-phospho-2'-keto-D-arabinose reductase) (Decaprenylphospho-beta-D-erythro-pentofuranosid-2-ulose 2-reductase) (Decaprenylphosphoryl-beta-D-ribofuranose 2'-epimerase subunit DprE2) (Decaprenyl-phosphoribose 2'-epimerase subunit 2) (NAD-dependent decaprenylphosphoryl-D-2-keto-erythropentose reductase),periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491]; arabinan biosynthetic process [GO:0035884]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007],9634230; 12657046; 16291675; 19099550; 19299584; 21969609; 22733761; 24517327; 25906160; 25789990,,"FUNCTION: Component of the DprE1-DprE2 complex that catalyzes the 2-step epimerization of decaprenyl-phospho-ribose (DPR) to decaprenyl-phospho-arabinose (DPA), a key precursor that serves as the arabinose donor required for the synthesis of cell-wall arabinans (PubMed:16291675, PubMed:19299584). DprE1 catalyzes the first step of epimerization, namely FAD-dependent oxidation of the C2' hydroxyl of DPR to yield the keto intermediate decaprenyl-phospho-2'-keto-D-arabinose (DPX) (PubMed:22733761). The intermediate DPX is then transferred to DprE2 subunit of the epimerase complex, most probably through a 'substrate channel' at the interface of DprE1-DprE2 complex (PubMed:25789990). DprE2 then catalyzes the second step of epimerization, the NAD(+)-dependent reduction of DPX that leads to the formation of DPA (PubMed:22733761, PubMed:25789990). Appears to be essential for the growth and survival of M.tuberculosis (PubMed:12657046, PubMed:24517327). {ECO:0000269|PubMed:12657046, ECO:0000269|PubMed:16291675, ECO:0000269|PubMed:19299584, ECO:0000269|PubMed:22733761, ECO:0000269|PubMed:24517327, ECO:0000305|PubMed:25789990}.",MVLDAVGNPQTVLLLGGTSEIGLAICERYLHNSAARIVLACLPDDPRREDAAAAMKQAGARSVELIDFDALDTDSHPKMIEAAFSGGDVDVAIVAFGLLGDAEELWQNQRKAVQIAEINYTAAVSVGVLLAEKMRAQGFGQIIAMSSAAGERVRRANFVYGSTKAGLDGFYLGLSEALREYGVRVLVIRPGQVRTRMSAHLKEAPLTVDKEYVANLAVTASAKGKELVWAPAAFRYVMMVLRHIPRSIFRKLPI,"27,469",254,Short-chain dehydrogenases/reductases (SDR) family,arabinan biosynthetic process [GO:0035884]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007],oxidoreductase activity [GO:0016491],periplasmic space [GO:0042597]; plasma membrane [GO:0005886],,MTCY13D12.25,1
P9WNQ5,ECCD2_MYCTU,Rv3887c,eccD2 Rv3887c,GO:0005886; GO:0016021; GO:0042783,IPR006707; IPR024962; ,,eccD2,,ESX-2 secretion system protein eccD2 (ESX conserved component D2) (Type VII secretion system protein eccD2) (T7SS protein eccD2),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783],9634230; 19099550; 19876390; 21969609,,,MTAPHKVAFPARCAVNICYDKHLCSQVFPAGIPVEGFFEGMVELFDADLKRKGFDGVALPAGSYELHKINGVRLDINKSLDELGVQDGDTLVLVPRVAGESFEPQYESLSTGLAAMGKWLGRDGGDRMFAPVTSLTAAHTAMAIIAMAVGVVLALTLRTRTITDSPVPAAMAGGIGVLLVIGALVVWWGWRERRDLFSGFGWLAVVLLAVAAACAPPGALGAAHALIGLVVVVLGAITIGVATRKRWQTAVVTAVVTVCGILAAVAAVRMFRPVSMQVLAICVLVGLLVLIRMTPTVALWVARVRPPHFGSITGRDLFARRAGMPVDTVAPVSEADADDEDNELTDITARGTAIAASARLVNAVQVGMCVGVSLVLPAAVWGVLTPRQPWAWLALLVAGLTVGLFITQGRGFAAKYQAVALVCGASAAVCAGVLKYALDTPKGVQTGLLWPAIFVAAFAALGLAVALVVPATRFRPIIRLTVEWLEVLAMIALLPAAAALGGLFAWLRH,"53,278",509,EccD/Snm4 family,active evasion of host immune response [GO:0042783],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJE7,ECCE2_MYCTU,Rv3885c,eccE2 Rv3885c,GO:0005886; GO:0016021,IPR021368; ,,eccE2,,ESX-2 secretion system protein EccE2 (ESX conserved component E2) (Type VII secretion system protein EccE2) (T7SS protein EccE2),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],9634230; 19876390; 19854905; 21969609,,,MTSKLTGFSPRSARRVAGVWTVFVLASAGWALGGQLGAVMAVVVGVALVFVQWWGQPAWSWAVLGLRGRRPVKWNDPITLANNRSGGGVRVQDGVAVVAVQLLGRAHRATTVTGSVTVESDNVIDVVELAPLLRHPLDLELDSISVVTFGSRTGTVGDYPRVYDAEIGTPPYAGRRETWLIMRLPVIGNTQALRWRTSVGAAAISVAQRVASSLRCQGLRAKLATATDLAELDRRLGSDAVAGSAQRWKAIRGEAGWMTTYAYPAEAISSRVLSQAWTLRADEVIQNVTVYPDATCTATITVRTPTPAPTPPSVILRRLNGEQAAAAAANMCGPRPHLRGQRRCPLPAQLVTEIGPSGVLIGKLSNGDRLMIPVTDAGELSRVFVAADDTIAKRIVIRVVGAGERVCVHTRDQERWASVRMPQLSIVGTPRPAPRTTVGVVEYVRRRKNGDDGKSEGSGVDVAISPTPRPASVITIARPGTSLSESDRHGFEVTIEQIDRATVKVGAAGQNWLVEMEMFRAENRYVSLEPVTMSIGR,"57,656",537,EccE family,,,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WNB1,ECC1B_MYCTU,Rv3871,eccCb1 snm2 Rv3871,GO:0003677; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0009405; GO:0042783; GO:0044117; GO:0044315,IPR003593; IPR023837; IPR002543; IPR027417; ,P9WNK5,eccCb1,DOMAIN 65 259 FtsK 1. {ECO:0000255|PROSITE-ProRule:PRU00289}.; DOMAIN 359 545 FtsK 2. {ECO:0000255|PROSITE-ProRule:PRU00289}.,ESX-1 secretion system protein EccCb1 (ESX conserved component Cb1) (Snm2 secretory protein) (Type VII secretion system protein EccCb1) (T7SS protein EccCb1),cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 14557547; 14557536; 14756778; 16368961; 16973880; 17676952; 19099550; 19876390; 19854905; 21969609; 25865481; 22233444,,"FUNCTION: Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10) (PubMed:14557547, PubMed:14557536, PubMed:16368961, PubMed:16973880). EccCb1 may link the cytosolic components of the system with the membrane components (PubMed:16973880). {ECO:0000269|PubMed:14557536, ECO:0000269|PubMed:16368961, ECO:0000269|PubMed:16973880, ECO:0000305|PubMed:14557547}.",MTAEPEVRTLREVVLDQLGTAESRAYKMWLPPLTNPVPLNELIARDRRQPLRFALGIMDEPRRHLQDVWGVDVSGAGGNIGIGGAPQTGKSTLLQTMVMSAAATHSPRNVQFYCIDLGGGGLIYLENLPHVGGVANRSEPDKVNRVVAEMQAVMRQRETTFKEHRVGSIGMYRQLRDDPSQPVASDPYGDVFLIIDGWPGFVGEFPDLEGQVQDLAAQGLAFGVHVIISTPRWTELKSRVRDYLGTKIEFRLGDVNETQIDRITREIPANRPGRAVSMEKHHLMIGVPRFDGVHSADNLVEAITAGVTQIASQHTEQAPPVRVLPERIHLHELDPNPPGPESDYRTRWEIPIGLRETDLTPAHCHMHTNPHLLIFGAAKSGKTTIAHAIARAICARNSPQQVRFMLADYRSGLLDAVPDTHLLGAGAINRNSASLDEAVQALAVNLKKRLPPTDLTTAQLRSRSWWSGFDVVLLVDDWHMIVGAAGGMPPMAPLAPLLPAAADIGLHIIVTCQMSQAYKATMDKFVGAAFGSGAPTMFLSGEKQEFPSSEFKVKRRPPGQAFLVSPDGKEVIQAPYIEPPEEVFAAPPSAG,"64,561",591,,active evasion of host immune response [GO:0042783]; growth of symbiont in host [GO:0044117]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],snm2,,1
P9WNR7,ECCB1_MYCTU,Rv3869,eccB1 Rv3869,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0016787; GO:0052553,IPR007795; ,,eccB1,,ESX-1 secretion system ATPase EccB1 (EC 3.6.-.-) (ESX conserved component B1) (Type VII secretion system protein EccB1) (T7SS protein EccB1),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; modulation by symbiont of host immune response [GO:0052553],9634230; 16368961; 19876390; 19854905; 21969609; 26396239; 26841765; 26922638,X-ray crystallography (5),"FUNCTION: An ATPase (PubMed:26396239). Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10) (PubMed:16368961). {ECO:0000269|PubMed:16368961, ECO:0000269|PubMed:26396239}.",MGLRLTTKVQVSGWRFLLRRLEHAIVRRDTRMFDDPLQFYSRSIALGIVVAVLILAGAALLAYFKPQGKLGGTSLFTDRATNQLYVLLSGQLHPVYNLTSARLVLGNPANPATVKSSELSKLPMGQTVGIPGAPYATPVSAGSTSIWTLCDTVARADSTSPVVQTAVIAMPLEIDASIDPLQSHEAVLVSYQGETWIVTTKGRHAIDLTDRALTSSMGIPVTARPTPISEGMFNALPDMGPWQLPPIPAAGAPNSLGLPDDLVIGSVFQIHTDKGPQYYVVLPDGIAQVNATTAAALRATQAHGLVAPPAMVPSLVVRIAERVYPSPLPDEPLKIVSRPQDPALCWSWQRSAGDQSPQSTVLSGRHLPISPSAMNMGIKQIHGTATVYLDGGKFVALQSPDPRYTESMYYIDPQGVRYGVPNAETAKSLGLSSPQNAPWEIVRLLVDGPVLSKDAALLEHDTLPADPSPRKVPAGASGAP,"51,093",480,EccB family,modulation by symbiont of host immune response [GO:0052553],ATP binding [GO:0005524]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJF1,DPRE1_MYCTU,Rv3790,dprE1 Rv3790,GO:0003885; GO:0005886; GO:0035884; GO:0040007; GO:0042597; GO:0045227; GO:0046677; GO:0050660; GO:0070592; GO:0071555,IPR007173; IPR016166; IPR036318; IPR006094; ,,dprE1,DOMAIN 19 194 FAD-binding PCMH-type. {ECO:0000255|PROSITE-ProRule:PRU00718}.,Decaprenylphosphoryl-beta-D-ribose oxidase (EC 1.1.98.3) (Decaprenylphospho-beta-D-ribofuranose 2-dehydrogenase) (Decaprenylphosphoryl-beta-D-ribofuranose 2'-epimerase subunit DprE1) (Decaprenyl-phosphoribose 2'-epimerase subunit 1) (Decaprenylphosphoryl-beta-D-ribofuranose 2'-oxidase) (Decaprenylphosphoryl-beta-D-ribose 2-epimerase flavoprotein subunit) (FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase),"periplasmic space [GO:0042597]; plasma membrane [GO:0005886]; D-arabinono-1,4-lactone oxidase activity [GO:0003885]; flavin adenine dinucleotide binding [GO:0050660]; arabinan biosynthetic process [GO:0035884]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007]; response to antibiotic [GO:0046677]",9634230; 12657046; 16291675; 19099550; 19876393; 19299584; 20629622; 20828197; 21969609; 24037308; 24215368; 24245764; 24818517; 24517327; 25906160; 25987616; 25789990; 27527085; 27666194; 22733761; 23776209; 24500695; 25427196,X-ray crystallography (18),"FUNCTION: Component of the DprE1-DprE2 complex that catalyzes the 2-step epimerization of decaprenyl-phospho-ribose (DPR) to decaprenyl-phospho-arabinose (DPA), a key precursor that serves as the arabinose donor required for the synthesis of cell-wall arabinans (PubMed:16291675, PubMed:19299584). DprE1 catalyzes the first step of epimerization, namely FAD-dependent oxidation of the C2' hydroxyl of DPR to yield the keto intermediate decaprenyl-phospho-2'-keto-D-arabinose (DPX) (PubMed:22733761). The intermediate DPX is then transferred to DprE2 subunit of the epimerase complex, most probably through a 'substrate channel' at the interface of DprE1-DprE2 complex (PubMed:25789990). Can also use farnesyl-phosphoryl-beta-D-ribofuranose (FPR) as substrate in vitro (PubMed:25427196). Appears to be essential for the growth and survival of M.tuberculosis (PubMed:12657046, PubMed:24517327). {ECO:0000269|PubMed:12657046, ECO:0000269|PubMed:16291675, ECO:0000269|PubMed:19299584, ECO:0000269|PubMed:22733761, ECO:0000269|PubMed:24517327, ECO:0000269|PubMed:25427196, ECO:0000305|PubMed:25789990}.; FUNCTION: DprE1 is a highly vulnerable and fully validated tuberculosis drug target. {ECO:0000303|PubMed:20629622, ECO:0000303|PubMed:24037308, ECO:0000303|PubMed:24245764}.",MLSVGATTTATRLTGWGRTAPSVANVLRTPDAEMIVKAVARVAESGGGRGAIARGLGRSYGDNAQNGGGLVIDMTPLNTIHSIDADTKLVDIDAGVNLDQLMKAALPFGLWVPVLPGTRQVTVGGAIACDIHGKNHHSAGSFGNHVRSMDLLTADGEIRHLTPTGEDAELFWATVGGNGLTGIIMRATIEMTPTSTAYFIADGDVTASLDETIALHSDGSEARYTYSSAWFDAISAPPKLGRAAVSRGRLATVEQLPAKLRSEPLKFDAPQLLTLPDVFPNGLANKYTFGPIGELWYRKSGTYRGKVQNLTQFYHPLDMFGEWNRAYGPAGFLQYQFVIPTEAVDEFKKIIGVIQASGHYSFLNVFKLFGPRNQAPLSFPIPGWNICVDFPIKDGLGKFVSELDRRVLEFGGRLYTAKDSRTTAETFHAMYPRVDEWISVRRKVDPLRVFASDMARRLELL,"50,163",461,DprE1 family,arabinan biosynthetic process [GO:0035884]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; cell wall polysaccharide biosynthetic process [GO:0070592]; growth [GO:0040007]; response to antibiotic [GO:0046677],"D-arabinono-1,4-lactone oxidase activity [GO:0003885]; flavin adenine dinucleotide binding [GO:0050660]",periplasmic space [GO:0042597]; plasma membrane [GO:0005886],,,1
P9WPH9,ECCA1_MYCTU,Rv3868,eccA1 Rv3868 MTV027.03,GO:0005524; GO:0005737; GO:0005886; GO:0016887; GO:0044117,IPR003593; IPR003959; IPR000641; IPR027417; IPR023835; IPR011990; ,,eccA1,,ESX-1 secretion system protein EccA1 (ESX conserved component A1) (Type VII secretion system protein EccA1) (T7SS protein EccA1),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth of symbiont in host [GO:0044117],9634230; 18974091; 16368961; 19099550; 17433643; 19682254; 19876390; 21969609; 23818233,X-ray crystallography (1),"FUNCTION: Part of the ESX-1 specialized secretion system, which delivers several virulence factors to host cells during infection, including the key virulence factors EsxA (ESAT-6) and EsxB (CFP-10) (PubMed:18974091, PubMed:16368961). EccA1 exhibits ATPase activity and may provide energy for the export of ESX-1 substrates (PubMed:18974091). {ECO:0000269|PubMed:16368961, ECO:0000269|PubMed:18974091}.",MTDRLASLFESAVSMLPMSEARSLDLFTEITNYDESACDAWIGRIRCGDTDRVTLFRAWYSRRNFGQLSGSVQISMSTLNARIAIGGLYGDITYPVTSPLAITMGFAACEAAQGNYADAMEALEAAPVAGSEHLVAWMKAVVYGAAERWTDVIDQVKSAGKWPDKFLAGAAGVAHGVAAANLALFTEAERRLTEANDSPAGEACARAIAWYLAMARRSQGNESAAVALLEWLQTTHPEPKVAAALKDPSYRLKTTTAEQIASRADPWDPGSVVTDNSGRERLLAEAQAELDRQIGLTRVKNQIERYRAATLMARVRAAKGMKVAQPSKHMIFTGPPGTGKTTIARVVANILAGLGVIAEPKLVETSRKDFVAEYEGQSAVKTAKTIDQALGGVLFIDEAYALVQERDGRTDPFGQEALDTLLARMENDRDRLVVIIAGYSSDIDRLLETNEGLRSRFATRIEFDTYSPEELLEIANVIAAADDSALTAEAAENFLQAAKQLEQRMLRGRRALDVAGNGRYARQLVEASEQCRDMRLAQVLDIDTLDEDRLREINGSDMAEAIAAVHAHLNMRE,"62,426",573,CbxX/CfxQ family,growth of symbiont in host [GO:0044117],ATPase activity [GO:0016887]; ATP binding [GO:0005524],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV027.03,1
P9WPH7,ECCA2_MYCTU,Rv3884c,eccA2 Rv3884c MTCY15F10.28,GO:0005524; GO:0005737,IPR003593; IPR003959; IPR000641; IPR027417; IPR023835; IPR011990; ,,eccA2,,ESX-2 secretion system protein EccA2 (ESX conserved component A2) (Type VII secretion system protein EccA2) (T7SS protein EccA2),cytoplasm [GO:0005737]; ATP binding [GO:0005524],9634230; 19876390; 19854905; 21969609,,FUNCTION: Shows ATPase activity. Could provide energy for export of ESX-2 substrates (By similarity). {ECO:0000250}.,MSRMVDTMGDLLTARRHFDRAMTIKNGQGCVAALPEFVAATEADPSMADAWLGRIACGDRDLASLKQLNAHSEWLHRETTRIGRTLAAEVQLGPSIGITVTDASQVGLALSSALTIAGEYAKADALLANRELLDSWRNYQWHQLARAFLMYVTQRWPDVLSTAAEDLPPQAIVMPAVTASICALAAHAAAHLGQGRVALDWLDRVDVIGHSRSSERFGADVLTAAIGPADIPLLVADLAYVRGMVYRQLHEEDKAQIWLSKATINGVLTDAAKEALADPNLRLIVTDERTIASRSDRWDASTAKSRDQLDDDNAAQRRGELLAEGRELLAKQVGLAAVKQAVSALEDQLEVRMMRLEHGLPVEGQTNHMLLVGPPGTGKTTTAEALGKIYAGMGIVRHPEIREVRRSDFCGHYIGESGPKTNELIEKSLGRIIFMDEFYSLIERHQDGTPDMIGMEAVNQLLVQLETHRFDFCFIGAGYEDQVDEFLTVNPGLAGRFNRKLRFESYSPVEIVEIGHRYATPRASQLDDAAREVFLDAVTTIRNYTTPSGQHGIDAMQNGRFARNVIERAEGFRDTRVVAQKRAGQPVSVQDLQIITATDIDAAIRSVCSDNRDMAAIVW,"68,041",619,CbxX/CfxQ family,,ATP binding [GO:0005524],cytoplasm [GO:0005737],,MTCY15F10.28,1
P9WNL9,EMBA_MYCTU,Rv3794,embA Rv3794 MTCY13D12.28,GO:0005576; GO:0005829; GO:0005886; GO:0005887; GO:0040007; GO:0046677; GO:0052636; GO:0071555; GO:0071766,IPR032731; IPR007680; IPR027451; ,,embA,,Probable arabinosyltransferase A (EC 2.4.2.-),cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; arabinosyltransferase activity [GO:0052636]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; response to antibiotic [GO:0046677],9142129; 9634230; 16585755; 19099550; 21969609; 10639358,,FUNCTION: Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,MPHDGNERSHRIARLAAVVSGIAGLLLCGIVPLLPVNQTTATIFWPQGSTADGNITQITAPLVSGAPRALDISIPCSAIATLPANGGLVLSTLPAGGVDTGKAGLFVRANQDTVVVAFRDSVAAVAARSTIAAGGCSALHIWADTGGAGADFMGIPGGAGTLPPEKKPQVGGIFTDLKVGAQPGLSARVDIDTRFITTPGALKKAVMLLGVLAVLVAMVGLAALDRLSRGRTLRDWLTRYRPRVRVGFASRLADAAVIATLLLWHVIGATSSDDGYLLTVARVAPKAGYVANYYRYFGTTEAPFDWYTSVLAQLAAVSTAGVWMRLPATLAGIACWLIVSRFVLRRLGPGPGGLASNRVAVFTAGAVFLSAWLPFNNGLRPEPLIALGVLVTWVLVERSIALGRLAPAAVAIIVATLTATLAPQGLIALAPLLTGARAIAQRIRRRRATDGLLAPLAVLAAALSLITVVVFRDQTLATVAESARIKYKVGPTIAWYQDFLRYYFLTVESNVEGSMSRRFAVLVLLFCLFGVLFVLLRRGRVAGLASGPAWRLIGTTAVGLLLLTFTPTKWAVQFGAFAGLAGVLGAVTAFTFARIGLHSRRNLTLYVTALLFVLAWATSGINGWFYVGNYGVPWYDIQPVIASHPVTSMFLTLSILTGLLAAWYHFRMDYAGHTEVKDNRRNRILASTPLLVVAVIMVAGEVGSMAKAAVFRYPLYTTAKANLTALSTGLSSCAMADDVLAEPDPNAGMLQPVPGQAFGPDGPLGGISPVGFKPEGVGEDLKSDPVVSKPGLVNSDASPNKPNAAITDSAGTAGGKGPVGINGSHAALPFGLDPARTPVMGSYGENNLAATATSAWYQLPPRSPDRPLVVVSAAGAIWSYKEDGDFIYGQSLKLQWGVTGPDGRIQPLGQVFPIDIGPQPAWRNLRFPLAWAPPEADVARIVAYDPNLSPEQWFAFTPPRVPVLESLQRLIGSATPVLMDIATAANFPCQRPFSEHLGIAELPQYRILPDHKQTAASSNLWQSSSTGGPFLFTQALLRTSTIATYLRGDWYRDWGSVEQYHRLVPADQAPDAVVEEGVITVPGWGRPGPIRALP,"115,724",1094,Emb family,Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; response to antibiotic [GO:0046677],arabinosyltransferase activity [GO:0052636],cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,MTCY13D12.28,1
P9WNL5,EMBC_MYCTU,Rv3793,embC Rv3793 MTCY13D12.27,GO:0005829; GO:0005886; GO:0009247; GO:0016021; GO:0040007; GO:0046677; GO:0052636; GO:0071555; GO:0071766,IPR032731; IPR007680; IPR027451; ,,embC,,Probable arabinosyltransferase C (EC 2.4.2.-),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arabinosyltransferase activity [GO:0052636]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; response to antibiotic [GO:0046677],9142129; 9634230; 16585755; 19099550; 21969609; 10639358,X-ray crystallography (1),FUNCTION: Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,MATEAAPPRIAVRLPSTSVRDAGANYRIARYVAVVAGLLGAVLAIATPLLPVNQTTAQLNWPQNGTFASVEAPLIGYVATDLNITVPCQAAAGLAGSQNTGKTVLLSTVPKQAPKAVDRGLLLQRANDDLVLVVRNVPLVTAPLSQVLGPTCQRLTFTAHADRVAAEFVGLVQGPNAEHPGAPLRGERSGYDFRPQIVGVFTDLAGPAPPGLSFSASVDTRYSSSPTPLKMAAMILGVALTGAALVALHILDTADGMRHRRFLPARWWSTGGLDTLVIAVLVWWHFVGANTSDDGYILTMARVSEHAGYMANYYRWFGTPEAPFGWYYDLLALWAHVSTASIWMRLPTLAMALTCWWVISREVIPRLGHAVKTSRAAAWTAAGMFLAVWLPLDNGLRPEPIIALGILLTWCSVERAVATSRLLPVAIACIIGALTLFSGPTGIASIGALLVAIGPLRTILHRRSRRFGVLPLVAPILAAATVTAIPIFRDQTFAGEIQANLLKRAVGPSLKWFDEHIRYERLFMASPDGSIARRFAVLALVLALAVSVAMSLRKGRIPGTAAGPSRRIIGITIISFLAMMFTPTKWTHHFGVFAGLAGSLGALAAVAVTGAAMRSRRNRTVFAAVVVFVLALSFASVNGWWYVSNFGVPWSNSFPKWRWSLTTALLELTVLVLLLAAWFHFVANGDGRRTARPTRFRARLAGIVQSPLAIATWLLVLFEVVSLTQAMISQYPAWSVGRSNLQALAGKTCGLAEDVLVELDPNAGMLAPVTAPLADALGAGLSEAFTPNGIPADVTADPVMERPGDRSFLNDDGLITGSEPGTEGGTTAAPGINGSRARLPYNLDPARTPVLGSWRAGVQVPAMLRSGWYRLPTNEQRDRAPLLVVTAAGRFDSREVRLQWATDEQAAAGHHGGSMEFADVGAAPAWRNLRAPLSAIPSTATQVRLVADDQDLAPQHWIALTPPRIPRVRTLQNVVGAADPVFLDWLVGLAFPCQRPFGHQYGVDETPKWRILPDRFGAEANSPVMDHNGGGPLGITELLMRATTVASYLKDDWFRDWGALQRLTPYYPDAQPADLNLGTVTRSGLWSPAPLRRG,"117,490",1094,Emb family,Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]; response to antibiotic [GO:0046677],arabinosyltransferase activity [GO:0052636],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY13D12.27,1
P9WP15,DDN_MYCTU,Rv3547,ddn Rv3547,GO:0005618; GO:0005886; GO:0016491; GO:0055114; GO:0070967,IPR004378; IPR012349; ,,ddn,,Deazaflavin-dependent nitroreductase (EC 1.-.-.-) (F420H(2)-dependent quinone reductase Ddn) (Fqr) (EC 1.1.98.-),cell wall [GO:0005618]; plasma membrane [GO:0005886]; coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491]; oxidation-reduction process [GO:0055114],9634230; 16000731; 16387854; 19039139; 21969609; 22023140; 23240649; 22244759,X-ray crystallography (4),"FUNCTION: Involved in a F420-dependent anti-oxidant mechanism that protects M.tuberculosis against oxidative stress and bactericidal agents. Catalyzes the F420H(2)-dependent two-electron reduction of quinones to dihydroquinones, thereby preventing the formation of cytotoxic semiquinones obtained by the one-electron reduction pathway (PubMed:23240649). In vitro, catalyzes the reduction of both benzoquinone and naphthoquinone analogs; since menaquinone is the sole quinone electron carrier in the respiratory chain in M.tuberculosis, the physiological electron acceptor for Fqr-mediated F420H(2) oxidation is therefore likely to be the endogenous menaquinone found in the membrane fraction of M.tuberculosis (PubMed:23240649). Is able to use F420 species with two and five glutamate residues in its polyglutamate tail (PubMed:22023140). Cannot use NADH or NADPH instead of F420H(2) as the electron donor (PubMed:23240649). {ECO:0000269|PubMed:22023140, ECO:0000269|PubMed:23240649}.; FUNCTION: Is involved in the bioreductive activation of bicyclic 4-nitroimidazole prodrugs such as PA-824 and delamanid developed for anti-tuberculosis therapy against both replicating and persistent bacteria. It converts PA-824 into three primary metabolites resulting from reduction of the imidazole ring at C-3; the major one is the corresponding des-nitroimidazole that generates lethal reactive nitrogen species, including nitric oxide (NO), which appears to be responsible for the anaerobic killing activity. Ddn uses the reduced F420 produced by FGD1 to activate PA-824. Delamanid (OPC-67683) is also reduced by Ddn to its des-nitro form. {ECO:0000269|PubMed:16387854, ECO:0000269|PubMed:19039139, ECO:0000269|PubMed:22023140, ECO:0000269|PubMed:22244759}.",MPKSPPRFLNSPLSDFFIKWMSRINTWMYRRNDGEGLGGTFQKIPVALLTTTGRKTGQPRVNPLYFLRDGGRVIVAASKGGAEKNPMWYLNLKANPKVQVQIKKEVLDLTARDATDEERAEYWPQLVTMYPSYQDYQSWTDRTIPIVVCEP,"17,371",151,F420H(2)-dependent quinone reductase family,oxidation-reduction process [GO:0055114],coenzyme F420 binding [GO:0070967]; oxidoreductase activity [GO:0016491],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WND1,DHPS1_MYCTU,Rv3608c,folP1 Rv3608c MTCY07H7B.14,GO:0004156; GO:0005829; GO:0040007; GO:0046654; GO:0046656; GO:0046872,IPR006390; IPR011005; IPR000489; ,,folP1,DOMAIN 1 265 Pterin-binding. {ECO:0000255|PROSITE-ProRule:PRU00334}.,Dihydropteroate synthase (DHPS) (EC 2.5.1.15) (Dihydropteroate pyrophosphorylase),cytosol [GO:0005829]; dihydropteroate synthase activity [GO:0004156]; metal ion binding [GO:0046872]; folic acid biosynthetic process [GO:0046656]; growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],10542185; 9634230; 21969609; 23779105; 23118010; 11007651,X-ray crystallography (1),"FUNCTION: Catalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives. {ECO:0000269|PubMed:10542185, ECO:0000269|PubMed:23118010, ECO:0000269|PubMed:23779105}.; FUNCTION: Is involved in the bioactivation of the antituberculous drug para-aminosalicylic acid (PAS). PAS is a close structural analog of pABA and acts as an alternative substrate for DHPS, leading to hydroxy-dihydropteroate (H2PtePAS). Metabolomic studies show that PAS, despite its in vitro activity as a competitive inhibitor of DHPS, does not inhibit growth of M.tuberculosis by inhibiting DHPS. PAS exerts its antimycobacterial activity through its effects on M.tuberculosis folate metabolism downstream of DHPS. PAS poisons folate-dependent pathways not only by serving as a replacement substrate for DHPS but also by the products of that reaction serving as replacement substrates and/or inhibitors of subsequent enzymes. {ECO:0000269|PubMed:23118010, ECO:0000269|PubMed:23779105}.",MSPAPVQVMGVLNVTDDSFSDGGCYLDLDDAVKHGLAMAAAGAGIVDVGGESSRPGATRVDPAVETSRVIPVVKELAAQGITVSIDTMRADVARAALQNGAQMVNDVSGGRADPAMGPLLAEADVPWVLMHWRAVSADTPHVPVRYGNVVAEVRADLLASVADAVAAGVDPARLVLDPGLGFAKTAQHNWAILHALPELVATGIPVLVGASRKRFLGALLAGPDGVMRPTDGRDTATAVISALAALHGAWGVRVHDVRASVDAIKVVEAWMGAERIERDG,"28,843",280,DHPS family,folic acid biosynthetic process [GO:0046656]; growth [GO:0040007]; tetrahydrofolate biosynthetic process [GO:0046654],dihydropteroate synthase activity [GO:0004156]; metal ion binding [GO:0046872],cytosol [GO:0005829],,MTCY07H7B.14,1
P9WFR5,DPPRS_MYCTU,Rv3806c,Rv3806c,GO:0000287; GO:0005886; GO:0005887; GO:0009247; GO:0016765; GO:0040007; GO:0045227; GO:0052636; GO:0071555,IPR000537; ,,,,Decaprenyl-phosphate phosphoribosyltransferase (EC 2.4.2.45) (5-phospho-alpha-D-ribose-1-diphosphate:decaprenyl-phosphate 5-phosphoribosyltransferase) (DPPR synthase),"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; arabinosyltransferase activity [GO:0052636]; magnesium ion binding [GO:0000287]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007]",9634230; 15878857; 18310020; 21969609,,"FUNCTION: Involved in the biosynthesis of decaprenylphosphoryl arabinose (DPA) a precursor for arabinan synthesis in mycobacterial cell wall biosynthesis. Catalyzes the transfer of a 5-phosphoribosyl residue from phosphoribose diphosphate (pRpp) to decaprenyl phosphate (DP) to form decaprenylphosphoryl-5-phosphoribose (DPPR). The enzyme favors polyprenyl phosphate with 50-60 carbon atoms uses C-75 polyprenyl phosphate less efficiently than C-50 or C-60. {ECO:0000269|PubMed:15878857, ECO:0000269|PubMed:18310020}.",MSEDVVTQPPANLVAGVVKAIRPRQWVKNVLVLAAPLAALGGGVRYDYVEVLSKVSMAFVVFSLAASAVYLVNDVRDVEADREHPTKRFRPIAAGVVPEWLAYTVAVVLGVTSLAGAWMLTPNLALVMVVYLAMQLAYCFGLKHQAVVEICVVSSAYLIRAIAGGVATKIPLSKWFLLIMAFGSLFMVAGKRYAELHLAERTGAAIRKSLESYTSTYLRFVWTLSATAVVLCYGLWAFERDGYSGSWFAVSMIPFTIAILRYAVDVDGGLAGEPEDIALRDRVLQLLALAWIATVGAAVAFG,"32,654",302,UbiA prenyltransferase family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555]; glycolipid biosynthetic process [GO:0009247]; growth [GO:0040007],"arabinosyltransferase activity [GO:0052636]; magnesium ion binding [GO:0000287]; transferase activity, transferring alkyl or aryl (other than methyl) groups [GO:0016765]",integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WI53,DPRP_MYCTU,Rv3807c,Rv3807c,GO:0016021; GO:0016787; GO:0045227; GO:0071555,IPR036938; IPR000326; ,,,,Putative decaprenylphosphoryl-5-phosphoribose phosphatase Rv3807c (DPPR phosphatase) (EC 3.1.3.-) (Phospholipid phosphatase),integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],9634230; 21969609,,FUNCTION: Involved in the biosynthesis of decaprenylphosphoryl arabinose (DPA) a precursor for arabinan synthesis in mycobacterial cell wall biosynthesis. Could be involved in the dephosphorylation of decaprenylphosphoryl-5-phosphoribose (DPPR) to decaprenyl-phospho-ribose (DPR) (By similarity). {ECO:0000250}.,MVAVQSALVDRPGMLATARGLSHFGEHCIGWLILALLGAIALPRRRREWLVAGAGAFVAHAIAVLIKRLVRRQRPDHPAIAVNVDTPSQLSFPSAHATSTTAAALLMGRATGLPLPVVLVPPMALSRILLGVHYPSDVAVGVALGATVGAIVDSVGGGRQRARKR,"17,218",165,PA-phosphatase related phosphoesterase family,capsule polysaccharide biosynthetic process [GO:0045227]; cell wall organization [GO:0071555],hydrolase activity [GO:0016787],integral component of membrane [GO:0016021],,,1
P9WNI1,ESXC_MYCTU,Rv3890c,esxC Rv3890c MTCY15F10.22,GO:0005576,IPR020167; IPR036689; IPR010310; ,,esxC,,ESAT-6-like protein EsxC,extracellular region [GO:0005576],9634230; 19876390; 21969609,,,MSDQITYNPGAVSDFASDVGSRAGQLHMIYEDTASKTNALQEFFAGHGAQGFFDAQAQMLSGLQGLIETVGQHGTTTGHVLDNAIGTDQAIAGLF,"9,920",95,"WXG100 family, ESAT-6 subfamily",,,extracellular region [GO:0005576],,MTCY15F10.22,1
P9WNL7,EMBB_MYCTU,Rv3795,embB Rv3795 MTCY13D12.29,GO:0005618; GO:0005886; GO:0016021; GO:0040007; GO:0046677; GO:0052636; GO:0071555; GO:0071766,IPR032731; IPR007680; IPR027451; ,,embB,,Probable arabinosyltransferase B (EC 2.4.2.-),cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; arabinosyltransferase activity [GO:0052636]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; response to antibiotic [GO:0046677],9142129; 9634230; 21969609; 9257740; 10639358; 11162078; 16585755,,FUNCTION: Arabinosyl transferase responsible for the polymerization of arabinose into the arabinan of arabinogalactan.,MTQCASRRKSTPNRAILGAFASARGTRWVATIAGLIGFVLSVATPLLPVVQTTAMLDWPQRGQLGSVTAPLISLTPVDFTATVPCDVVRAMPPAGGVVLGTAPKQGKDANLQALFVVVSAQRVDVTDRNVVILSVPREQVTSPQCQRIEVTSTHAGTFANFVGLKDPSGAPLRSGFPDPNLRPQIVGVFTDLTGPAPPGLAVSATIDTRFSTRPTTLKLLAIIGAIVATVVALIALWRLDQLDGRGSIAQLLLRPFRPASSPGGMRRLIPASWRTFTLTDAVVIFGFLLWHVIGANSSDDGYILGMARVADHAGYMSNYFRWFGSPEDPFGWYYNLLALMTHVSDASLWMRLPDLAAGLVCWLLLSREVLPRLGPAVEASKPAYWAAAMVLLTAWMPFNNGLRPEGIIALGSLVTYVLIERSMRYSRLTPAALAVVTAAFTLGVQPTGLIAVAALVAGGRPMLRILVRRHRLVGTLPLVSPMLAAGTVILTVVFADQTLSTVLEATRVRAKIGPSQAWYTENLRYYYLILPTVDGSLSRRFGFLITALCLFTAVFIMLRRKRIPSVARGPAWRLMGVIFGTMFFLMFTPTKWVHHFGLFAAVGAAMAALTTVLVSPSVLRWSRNRMAFLAALFFLLALCWATTNGWWYVSSYGVPFNSAMPKIDGITVSTIFFALFAIAAGYAAWLHFAPRGAGEGRLIRALTTAPVPIVAGFMAAVFVASMVAGIVRQYPTYSNGWSNVRAFVGGCGLADDVLVEPDTNAGFMKPLDGDSGSWGPLGPLGGVNPVGFTPNGVPEHTVAEAIVMKPNQPGTDYDWDAPTKLTSPGINGSTVPLPYGLDPARVPLAGTYTTGAQQQSTLVSAWYLLPKPDDGHPLVVVTAAGKIAGNSVLHGYTPGQTVVLEYAMPGPGALVPAGRMVPDDLYGEQPKAWRNLRFARAKMPADAVAVRVVAEDLSLTPEDWIAVTPPRVPDLRSLQEYVGSTQPVLLDWAVGLAFPCQQPMLHANGIAEIPKFRITPDYSAKKLDTDTWEDGTNGGLLGITDLLLRAHVMATYLSRDWARDWGSLRKFDTLVDAPPAQLELGTATRSGLWSPGKIRIGP,"118,021",1098,Emb family,Actinobacterium-type cell wall biogenesis [GO:0071766]; cell wall organization [GO:0071555]; growth [GO:0040007]; response to antibiotic [GO:0046677],arabinosyltransferase activity [GO:0052636],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,MTCY13D12.29,1
P9WQ11,END3_MYCTU,Rv3674c,nth Rv3674c MTV025.022c,GO:0003690; GO:0005618; GO:0005886; GO:0006281; GO:0006284; GO:0019104; GO:0046872; GO:0051539; GO:0140078,IPR011257; IPR004036; IPR003651; IPR004035; IPR003265; IPR000445; IPR023170; IPR005759; ,,nth,DOMAIN 119 138 HhH. {ECO:0000255|HAMAP-Rule:MF_00942}.,Endonuclease III (EC 4.2.99.18) (DNA-(apurinic or apyrimidinic site) lyase),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; 4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]",9634230; 20031487; 21969609; 21764637,,"FUNCTION: DNA repair enzyme that has both DNA N-glycosylase activity and AP-lyase activity. The DNA N-glycosylase activity releases various damaged pyrimidines from DNA by cleaving the N-glycosidic bond, leaving an AP (apurinic/apyrimidinic) site. The AP-lyase activity cleaves the phosphodiester bond 3' to the AP site by a beta-elimination, leaving a 3'-terminal unsaturated sugar and a product with a terminal 5'-phosphate. Has a preference for oxidized pyrimidines, such as thymine glycol (prefers 5S isomers) 5,6-dihydrouracil:G, 5-hydroxyuracil:G, 5-hydroxycytosine:G and urea:A. Cleaves ssDNA containing an AP site. {ECO:0000255|HAMAP-Rule:MF_00942, ECO:0000269|PubMed:20031487}.",MPGRWSAETRLALVRRARRMNRALAQAFPHVYCELDFTTPLELAVATILSAQSTDKRVNLTTPALFARYRTARDYAQADRTELESLIRPTGFYRNKAASLIGLGQALVERFGGEVPATMDKLVTLPGVGRKTANVILGNAFGIPGITVDTHFGRLVRRWRWTTAEDPVKVEQAVGELIERKEWTLLSHRVIFHGRRVCHARRPACGVCVLAKDCPSFGLGPTEPLLAAPLVQGPETDHLLALAGL,"27,030",245,Nth/MutY family,base-excision repair [GO:0006284]; DNA repair [GO:0006281],"4 iron, 4 sulfur cluster binding [GO:0051539]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; metal ion binding [GO:0046872]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV025.022c,1
I6YGS0,EPHA_MYCTU,Rv3617,ephA Rv3617 LH57_19705,GO:0009636; GO:0018742; GO:0042803,IPR029058; IPR000073; IPR000639; ,,ephA,DOMAIN 27 131 AB hydrolase-1. {ECO:0000255}.,Epoxide hydrolase A (EHB) (EC 3.3.2.10) (Epoxide hydrolase EphA),epoxide hydrolase B activity [GO:0018742]; protein homodimerization activity [GO:0042803]; response to toxic substance [GO:0009636],9634230; 16511284; 21969609,,FUNCTION: Could be involved in detoxification of extraneous host-cell epoxides. Catalyzes the hydrolysis of epoxide-containing substrates. {ECO:0000305|PubMed:16511284}.,MGAPTERLVDTNGVRLRVVEAGEPGAPVVILAHGFPELAYSWRHQIPALADAGYHVLAPDQRGYGGSSRPEAIEAYDIHRLTADLVGLLDDVGAERAVWVGHDWGAVVVWNAPLLHADRVAAVAALSVPALPRAQVPPTQAFRSRFGENFFYILYFQEPGIADAELNGDPARTMRRMIGGLRPPGDQSAAMRMLAPGPDGFIDRLPEPAGLPAWISQEELDHYIGEFTRTGFTGGLNWYRNFDRNWETTADLAGKTISVPSLFIAGTADPVLTFTRTDRAAEVISGPYREVLIDGAGHWLQQERPGEVTAALLEFLTGLELR,"35,097",322,"AB hydrolase superfamily, Epoxide hydrolase family",response to toxic substance [GO:0009636],epoxide hydrolase B activity [GO:0018742]; protein homodimerization activity [GO:0042803],,,LH57_19705,1
P9WIQ7,ERP_MYCTU,Rv3810,erp pirG Rv3810 MTV026.15,GO:0005576; GO:0005886; GO:0009405; GO:0016021; GO:0044119,IPR008164; ,,erp,,Exported repetitive protein (Cell surface protein PirG) (EXP53),extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405],7496523; 9634230; 7798150; 9784137,,FUNCTION: Surface-exposed protein required for multiplication and intracellular growth.,MPNRRRRKLSTAMSAVAALAVASPCAYFLVYESTETTERPEHHEFKQAAVLTDLPGELMSALSQGLSQFGINIPPVPSLTGSGDASTGLTGPGLTSPGLTSPGLTSPGLTDPALTSPGLTPTLPGSLAAPGTTLAPTPGVGANPALTNPALTSPTGATPGLTSPTGLDPALGGANEIPITTPVGLDPGADGTYPILGDPTLGTIPSSPATTSTGGGGLVNDVMQVANELGASQAIDLLKGVLMPSIMQAVQNGGAAAPAASPPVPPIPAAAAVPPTDPITVPVA,"27,700",284,,growth of symbiont in host cell [GO:0044119]; pathogenesis [GO:0009405],,extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],pirG,MTV026.15,1
P9WJD3,ESPE_MYCTU,Rv3864,espE Rv3864,GO:0005886; GO:0016021; GO:0044117,,,espE,,ESX-1 secretion-associated protein EspE,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth of symbiont in host [GO:0044117],9634230; 14756778; 16368961; 21969609; 22233444,,,MASGSGLCKTTSNFIWGQLLLLGEGIPDPGDIFNTGSSLFKQISDKMGLAIPGTNWIGQAAEAYLNQNIAQQLRAQVMGDLDKLTGNMISNQAKYVSDTRDVLRAMKKMIDGVYKVCKGLEKIPLLGHLWSWELAIPMSGIAMAVVGGALLYLTIMTLMNATNLRGILGRLIEMLTTLPKFPGLPGLPSLPDIIDGLWPPKLPDIPIPGLPDIPGLPDFKWPPTPGSPLFPDLPSFPGFPGFPEFPAIPGFPALPGLPSIPNLFPGLPGLGDLLPGVGDLGKLPTWTELAALPDFLGGFAGLPSLGFGNLLSFASLPTVGQVTATMGQLQQLVAAGGGPSQLASMGSQQAQLISSQAQQGGQQHATLVSDKKEDEEGVAEAERAPIDAGTAASQRGQEGTVL,"42,069",402,,growth of symbiont in host [GO:0044117],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WJC5,ESPI_MYCTU,Rv3876,espI Rv3876,GO:0005524; GO:0005886; GO:0009405; GO:0044315,IPR002586; IPR027417; ,,espI,,ESX-1 secretion-associated protein EspI,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 14557547; 14756778; 16368961; 19876390; 19854905; 21969609; 25039394; 27017992,,"FUNCTION: Required to repress ESX-1-mediated secretion under low ATP conditions. This function requires the ATP-binding motif. {ECO:0000269|PubMed:25039394, ECO:0000305|PubMed:14557547}.",MAADYDKLFRPHEGMEAPDDMAAQPFFDPSASFPPAPASANLPKPNGQTPPPTSDDLSERFVSAPPPPPPPPPPPPPTPMPIAAGEPPSPEPAASKPPTPPMPIAGPEPAPPKPPTPPMPIAGPEPAPPKPPTPPMPIAGPAPTPTESQLAPPRPPTPQTPTGAPQQPESPAPHVPSHGPHQPRRTAPAPPWAKMPIGEPPPAPSRPSASPAEPPTRPAPQHSRRARRGHRYRTDTERNVGKVATGPSIQARLRAEEASGAQLAPGTEPSPAPLGQPRSYLAPPTRPAPTEPPPSPSPQRNSGRRAERRVHPDLAAQHAAAQPDSITAATTGGRRRKRAAPDLDATQKSLRPAAKGPKVKKVKPQKPKATKPPKVVSQRGWRHWVHALTRINLGLSPDEKYELDLHARVRRNPRGSYQIAVVGLKGGAGKTTLTAALGSTLAQVRADRILALDADPGAGNLADRVGRQSGATIADVLAEKELSHYNDIRAHTSVNAVNLEVLPAPEYSSAQRALSDADWHFIADPASRFYNLVLADCGAGFFDPLTRGVLSTVSGVVVVASVSIDGAQQASVALDWLRNNGYQDLASRACVVINHIMPGEPNVAVKDLVRHFEQQVQPGRVVVMPWDRHIAAGTEISLDLLDPIYKRKVLELAAALSDDFERAGRR,"70,645",666,,pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
P9WJC1,ESPK_MYCTU,Rv3879c,espK Rv3879c,GO:0005829; GO:0005886,IPR036689; ,,espK,,ESX-1 secretion-associated protein EspK,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 16368961; 17676952; 19876390; 21969609,,FUNCTION: May act as a chaperone that facilitates EspB secretion through an interaction with EccCb1. {ECO:0000269|PubMed:17676952}.,MSITRPTGSYARQMLDPGGWVEADEDTFYDRAQEYSQVLQRVTDVLDTCRQQKGHVFEGGLWSGGAANAANGALGANINQLMTLQDYLATVITWHRHIAGLIEQAKSDIGNNVDGAQREIDILENDPSLDADERHTAINSLVTATHGANVSLVAETAERVLESKNWKPPKNALEDLLQQKSPPPPDVPTLVVPSPGTPGTPGTPITPGTPITPGTPITPIPGAPVTPITPTPGTPVTPVTPGKPVTPVTPVKPGTPGEPTPITPVTPPVAPATPATPATPVTPAPAPHPQPAPAPAPSPGPQPVTPATPGPSGPATPGTPGGEPAPHVKPAALAEQPGVPGQHAGGGTQSGPAHADESAASVTPAAASGVPGARAAAAAPSGTAVGAGARSSVGTAAASGAGSHAATGRAPVATSDKAAAPSTRAASARTAPPARPPSTDHIDKPDRSESADDGTPVSMIPVSAARAARDAATAAASARQRGRGDALRLARRIAAALNASDNNAGDYGFFWITAVTTDGSIVVANSYGLAYIPDGMELPNKVYLASADHAIPVDEIARCATYPVLAVQAWAAFHDMTLRAVIGTAEQLASSDPGVAKIVLEPDDIPESGKMTGRSRLEVVDPSAAAQLADTTDQRLLDLLPPAPVDVNPPGDERHMLWFELMKPMTSTATGREAAHLRAFRAYAAHSQEIALHQAHTATDAAVQRVAVADWLYWQYVTGLLDRALAAAC,"74,492",729,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WJD1,ESPF_MYCTU,Rv3865,espF Rv3865,GO:0005618,IPR022536; ,,espF,,ESX-1 secretion-associated protein EspF,cell wall [GO:0005618],9634230; 16368961; 19682254; 21196469; 21969609,,,MTGFLGVVPSFLKVLAGMHNEIVGDIKRATDTVAGISGRVQLTHGSFTSKFNDTLQEFETTRSSTGTGLQGVTSGLANNLLAAAGAYLKADDGLAGVIDKIFG,"10,618",103,EspC family,,,cell wall [GO:0005618],,,1
P96210,ESPG1_MYCTU,Rv3866,espG1 snm5 Rv3866,GO:0001666; GO:0005737; GO:0005886,IPR025734; ,,espG1,,ESX-1 secretion-associated protein EspG1,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; response to hypoxia [GO:0001666],9634230; 16368961; 17433643; 19876390; 21196469; 21969609,,FUNCTION: Specific chaperone for cognate PE/PPE proteins. Plays an important role in preventing aggregation of PE/PPE dimers. {ECO:0000250|UniProtKB:O53943}.,MTGPSAAGRAGTADNVVGVEVTIDGMLVIADRLHLVDFPVTLGIRPNIPQEDLRDIVWEQVQRDLTAQGVLDLHGEPQPTVAEMVETLGRPDRTLEGRWWRRDIGGVMVRFVVCRRGDRHVIAARDGDMLVLQLVAPQVGLAGMVTAVLGPAEPANVEPLTGVATELAECTTASQLTQYGIAPASARVYAEIVGNPTGWVEIVASQRHPGGTTTQTDAAAGVLDSKLGRLVSLPRRVGGDLYGSFLPGTQQNLERALDGLLELLPAGAWLDHTSDHAQASSRG,"30,064",283,EspG family,response to hypoxia [GO:0001666],,cytoplasm [GO:0005737]; plasma membrane [GO:0005886],snm5,,2
O69732,ESPH_MYCTU,Rv3867,espH Rv3867,GO:0005886; GO:0046677; GO:0052562,,,espH,,ESX-1 secretion-associated protein EspH,plasma membrane [GO:0005886]; negative regulation by symbiont of host immune response [GO:0052562]; response to antibiotic [GO:0046677],9634230; 16368961; 19876390; 21969609,,,MVDPPGNDDDHGDLDALDFSAAHTNEASPLDALDDYAPVQTDDAEGDLDALHALTERDEEPELELFTVTNPQGSVSVSTLMDGRIQHVELTDKATSMSEAQLADEIFVIADLARQKARASQYTFMVENIGELTDEDAEGSALLREFVGMTLNLPTPEEAAAAEAEVFATRYDVDYTSRYKADD,"19,946",183,,negative regulation by symbiont of host immune response [GO:0052562]; response to antibiotic [GO:0046677],,plasma membrane [GO:0005886],,,1
P9WJC3,ESPJ_MYCTU,Rv3878,espJ Rv3878,GO:0005576; GO:0009405,,,espJ,,ESX-1 secretion-associated protein EspJ (TB27.4),extracellular region [GO:0005576]; pathogenesis [GO:0009405],9634230; 14632649; 16368961; 19876390; 19854905; 21969609; 26228622,,FUNCTION: Could be involved in regulation of growth and intracellular survival. {ECO:0000269|PubMed:26228622}.,MAEPLAVDPTGLSAAAAKLAGLVFPQPPAPIAVSGTDSVVAAINETMPSIESLVSDGLPGVKAALTRTASNMNAAADVYAKTDQSLGTSLSQYAFGSSGEGLAGVASVGGQPSQATQLLSTPVSQVTTQLGETAAELAPRVVATVPQLVQLAPHAVQMSQNASPIAQTISQTAQQAAQSAQGGSGPMPAQLASAEKPATEQAEPVHEVTNDDQGDQGDVQPAEVVAAARDEGAGASPGQQPGGGVPAQAMDTGAGARPAASPLAAPVDPSTPAPSTTTTL,"27,395",280,,pathogenesis [GO:0009405],,extracellular region [GO:0005576],,,1
P9WJB9,ESPL_MYCTU,Rv3880c,espL Rv3880c,GO:0005618; GO:0005886; GO:0052170,IPR036894; IPR004401; ,,espL,,ESX-1 secretion-associated protein EspL,cell wall [GO:0005618]; plasma membrane [GO:0005886]; negative regulation by symbiont of host innate immune response [GO:0052170],9634230; 19876390; 20844580; 21969609,,FUNCTION: Probably plays a role in host phagosome maturation arrest (PubMed:20844580). {ECO:0000305|PubMed:20844580}.,MSMDELDPHVARALTLAARFQSALDGTLNQMNNGSFRATDEAETVEVTINGHQWLTGLRIEDGLLKKLGAEAVAQRVNEALHNAQAAASAYNDAAGEQLTAALSAMSRAMNEGMA,"12,200",115,,negative regulation by symbiont of host innate immune response [GO:0052170],,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WJB7,ESPR_MYCTU,Rv3849,espR Rv3849,GO:0003677; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006351; GO:0006355; GO:0009295; GO:0009405; GO:0032993; GO:0042802; GO:0043565; GO:0050708; GO:0052572,,Itself,espR,,Nucleoid-associated protein EspR (ESX-1 transcriptional regulatory protein EspR),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoid [GO:0009295]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565]; pathogenesis [GO:0009405]; regulation of protein secretion [GO:0050708]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",9634230; 19099550; 18685700; 21969609; 22389481; 22479184; 23743602; 24633871; 25536998; 21206031; 21883526; 21795602; 24699733,X-ray crystallography (5),"FUNCTION: Virulence regulator that has both architectural and regulatory roles. Impacts cell wall functions and pathogenesis through regulation of multiple genes, including the espACD operon, which is a key ESX-1 component. Influences target gene expression positively or negatively, depending on its binding position relative to the genes it controls. Acts by binding directly to the DNA. May play a central role in regulating virulence gene expression. {ECO:0000269|PubMed:18685700, ECO:0000269|PubMed:21883526, ECO:0000269|PubMed:22389481, ECO:0000269|PubMed:22479184, ECO:0000269|PubMed:23743602}.",MSTTFAARLNRLFDTVYPPGRGPHTSAEVIAALKAEGITMSAPYLSQLRSGNRTNPSGATMAALANFFRIKAAYFTDDEYYEKLDKELQWLCTMRDDGVRRIAQRAHGLPSAAQQKVLDRIDELRRAEGIDA,"14,709",132,,"pathogenesis [GO:0009405]; regulation of protein secretion [GO:0050708]; regulation of transcription, DNA-templated [GO:0006355]; response to host immune response [GO:0052572]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677]; identical protein binding [GO:0042802]; sequence-specific DNA binding [GO:0043565],cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoid [GO:0009295]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993],,,1
O05453,ESXD_MYCTU,Rv3891c,esxD Rv3891c,GO:0005576,IPR036689; IPR010310; ,,esxD,,ESAT-6-like protein EsxD,extracellular region [GO:0005576],9634230; 19876390; 21969609,,,MADTIQVTPQMLRSTANDIQANMEQAMGIAKGYLANQENVMNPATWSGTGVVASHMTATEITNELNKVLTGGTRLAEGLVQAAALMEGHEADSQTAFQALFGASHGS,"11,194",107,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,,1
P0DOA7,ESXV_MYCTU,Rv3619c,esxV Rv3619c MTCY07H7B.03 MTCY15C10.33,GO:0005576; GO:0005618; GO:0009405,IPR009416; IPR036689; IPR010310; ,,esxV,,ESAT-6-like protein EsxV (Antigen Mtb9.9B),cell wall [GO:0005618]; extracellular region [GO:0005576]; pathogenesis [GO:0009405],10662800; 9634230; 19876390; 21134129,,"FUNCTION: Probable virulence factor. In mice, elicits increased levels of IFN-gamma, IL-12 and IgG(2a), indicating a dominant Th1 host immune response. {ECO:0000269|PubMed:21134129}.",MTINYQFGDVDAHGAMIRAQAGSLEAEHQAIISDVLTASDFWGGAGSAACQGFITQLGRNFQVIYEQANAHGQKVQAAGNNMAQTDSAVGSSWA,"9,833",94,"WXG100 family, ESAT-6 subfamily",pathogenesis [GO:0009405],,cell wall [GO:0005618]; extracellular region [GO:0005576],,MTCY07H7B.03 MTCY15C10.33,1
O69687,FAMT_MYCTU,Rv3720 RVBD_3720 LH57_20270,Rv3720 RVBD_3720 LH57_20270 P425_03869,GO:0005618; GO:0005886; GO:0008168; GO:0008610,IPR003333; IPR029063; ,,,,Probable fatty acid methyltransferase Rv3720 (EC 2.1.1.-) (S-adenosylmethionine-dependent methyltransferase Rv3720) (AdoMet-MT) (SAM-MT),cell wall [GO:0005618]; plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168]; lipid biosynthetic process [GO:0008610],9634230; 21969609,,FUNCTION: May be a S-adenosylmethionine-dependent methyltransferase involved in fatty acid metabolism. {ECO:0000305}.,MTTGRLSMAEILEIFTATGQHPLKFTAYDGSTAGQDDATLGLDLRTPRGATYLATAPGELGLARAYVSGDLQAHGVHPGDPYELLKTLTERVDFKRPSARVLANVVRSIGVEHILPIAPPPQEARPRWRRMANGLLHSKTRDAEAIHHHYDVSNNFYEWVLGPSMTYTCAVFPNAEASLEQAQENKYRLIFEKLRLEPGDRLLDVGCGWGGMVRYAARRGVRVIGATLSAEQAKWGQKAVEDEGLSDLAQVRHSDYRDVAETGFDAVSSIGLTEHIGVKNYPFYFGFLKSKLRTGGLLLNHCITRHDNRSTSFAGGFTDRYVFPDGELTGSGRITTEIQQVGLEVLHEENFRHHYAMTLRDWCGNLVEHWDDAVAEVGLPTAKVWGLYMAASRVAFERNNLQLHHVLATKVDPRGDDSLPLRPWWQP,"47,600",427,CFA/CMAS family,lipid biosynthetic process [GO:0008610],methyltransferase activity [GO:0008168],cell wall [GO:0005618]; plasma membrane [GO:0005886],,P425_03869,4
P9WJE1,ESPA_MYCTU,Rv3616c,espA Rv3616c,GO:0005576; GO:0005615; GO:0005886; GO:0009405; GO:0044315; GO:0071766,,,espA,,ESX-1 secretion-associated protein EspA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; Actinobacterium-type cell wall biogenesis [GO:0071766]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 16030141; 16573683; 17604718; 18685700; 19854905; 20585630; 21969609; 22155774; 22389481; 23104803; 24078612; 25536998; 26048138,,"FUNCTION: Required for secretion of EsxA (ESAT-6) and EsxB (CFP-10) and for virulence. Involved in translocation of bacteria from the host (human) phagolysosome to the host cytoplasm (PubMed:17604718). {ECO:0000269|PubMed:16030141, ECO:0000269|PubMed:17604718, ECO:0000269|PubMed:24078612}.",MSRAFIIDPTISAIDGLYDLLGIGIPNQGGILYSSLEYFEKALEELAAAFPGDGWLGSAADKYAGKNRNHVNFFQELADLDRQLISLIHDQANAVQTTRDILEGAKKGLEFVRPVAVDLTYIPVVGHALSAAFQAPFCAGAMAVVGGALAYLVVKTLINATQLLKLLAKLAELVAAAIADIISDVADIIKGTLGEVWEFITNALNGLKELWDKLTGWVTGLFSRGWSNLESFFAGVPGLTGATSGLSQVTGLFGAAGLSASSGLAHADSLASSASLPALAGIGGGSGFGGLPSLAQVHAASTRQALRPRADGPVGAAAEQVGGQSQLVSAQGSQGMGGPVGMGGMHPSSGASKGTTTKKYSEGAAAGTEDAERAPVEADAGGGQKVLVRNVV,"39,888",392,,Actinobacterium-type cell wall biogenesis [GO:0071766]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],,,1
P9WJD5,ESPD_MYCTU,Rv3614c,espD snm10 Rv3614c,GO:0005576; GO:0005618; GO:0005886; GO:0009405; GO:0044315,,,espD,,ESX-1 secretion-associated protein EspD,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],9634230; 16135231; 16573683; 18685700; 21969609; 22155774; 22389481; 23104803; 25536998,,"FUNCTION: Required for ESX-1 function (PubMed:16135231, PubMed:22155774). Required for the maintenance of adequate cellular levels of both EspA and EspC (PubMed:22155774). Facilitates EsxA secretion (PubMed:22155774). {ECO:0000269|PubMed:16135231, ECO:0000269|PubMed:22155774}.",MDLPGNDFDSNDFDAVDLWGADGAEGWTADPIIGVGSAATPDTGPDLDNAHGQAETDTEQEIALFTVTNPPRTVSVSTLMDGRIDHVELSARVAWMSESQLASEILVIADLARQKAQSAQYAFILDRMSQQVDADEHRVALLRKTVGETWGLPSPEEAAAAEAEVFATRYSDDCPAPDDESDPW,"19,835",184,,pathogenesis [GO:0009405]; protein secretion by the type VII secretion system [GO:0044315],,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],snm10,,1
P9WJC9,ESPG2_MYCTU,Rv3889c,espG2 Rv3889c,GO:0005737,IPR025734; ,,espG2,,ESX-2 secretion-associated protein EspG2,cytoplasm [GO:0005737],9634230; 19876390,,FUNCTION: Specific chaperone for cognate PE/PPE proteins. Plays an important role in preventing aggregation of PE/PPE dimers. {ECO:0000250|UniProtKB:O53943}.,MLTTTVDGLWVLQAVTGVEQTCPELGLRPLLPRLDTAERALRHPVAAELMAVGALDQAGNADPMVREWLTVLLRRDLGLLVTIGVPGGEPTRAAICRFATWWVVLERHGNLVRLYPAGTASDEAGAGELVVGQVERLCGVAEAAPLRPVTVDADELLHAVRDAGTLRSYLLSQRLDVDQLQMVTMAADPTRSAHATLVALQAGVGPEKSARILVGDSTVAIVDTAAGRICVESVTSGQRRYQVLSPGSRSDIGGAVQRLIRRLPAGDEWYSYRRVV,"29,596",276,EspG family,,,cytoplasm [GO:0005737],,,1
P9WMC1,ETHR_MYCTU,Rv3855,ethR etaR Rv3855,GO:0000976; GO:0003700; GO:0005829; GO:0006351; GO:0045892; GO:0046677,IPR009057; IPR001647; IPR036271; ,,ethR,DOMAIN 23 83 HTH tetR-type. {ECO:0000255|PROSITE-ProRule:PRU00335}.,HTH-type transcriptional regulator EthR,"cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; negative regulation of transcription, DNA-templated [GO:0045892]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",9634230; 10869356; 10944230; 21969609; 15236969; 19412174,X-ray crystallography (50),"FUNCTION: Involved in the repression of the monooxygenase EthA which is responsible of the formation of the active metabolite of ethionamide (ETH). {ECO:0000269|PubMed:10869356, ECO:0000269|PubMed:10944230}.",MTTSAASQASLPRGRRTARPSGDDRELAILATAENLLEDRPLADISVDDLAKGAGISRPTFYFYFPSKEAVLLTLLDRVVNQADMALQTLAENPADTDRENMWRTGINVFFETFGSHKAVTRAGQAARATSVEVAELWSTFMQKWIAYTAAVIDAERDRGAAPRTLPAHELATALNLMNERTLFASFAGEQPSVPEARVLDTLVHIWVTSIYGENR,"23,757",216,,"negative regulation of transcription, DNA-templated [GO:0045892]; response to antibiotic [GO:0046677]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],etaR,,1
P96843,FAD3_MYCTU,Rv3561,fadD3 Rv3561 P425_03703 RVBD_3561,GO:0005524; GO:0008203; GO:0016874,IPR025110; IPR020845; IPR000873; ,,fadD3,,"3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxo-octahydro-1H-inden-4-yl]propanoyl:CoA ligase (HIP:CoA ligase) (EC 6.2.1.41)",ATP binding [GO:0005524]; ligase activity [GO:0016874]; cholesterol metabolic process [GO:0008203],9634230; 12368430; 21969609; 23146019,,"FUNCTION: Involved in the catabolism of the rings C and D of cholesterol. Catalyzes the ATP-dependent CoA thioesterification of 3aalpha-H-4alpha(3'-propanoate)-7abeta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. It can also use the hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP. It requires that the side chain at C17 is completely removed. {ECO:0000269|PubMed:23146019}.",MINDLRTVPAALDRLVRQLPDHTALIAEDRRFTSTELRDAVYGAAAALIALGVEPADRVAIWSPNTWHWVVACLAIHHAGAAVVPLNTRYTATEATDILDRAGAPVLFAAGLFLGADRAAGLDRAALPALRHVVRVPVEADDGTWDEFIATGAGALDAVAARAAAVAPQDVSDILFTSGTTGRSKGVLCAHRQSLSASASWAANGKITSDDRYLCINPFFHNFGYKAGILACLQTGATLIPHVTFDPLHALRAIERHRITVLPGPPTIYQSLLDHPARKDFDLSSLRFAVTGAATVPVVLVERMQSELDIDIVLTAYGLTEANGMGTMCRPEDDAVTVATTCGRPFADFELRIADDGEVLLRGPNVMVGYLDDTEATAAAIDADGWLHTGDIGAVDQAGNLRITDRLKDMYICGGFNVYPAEVEQVLARMDGVADAAVIGVPDQRLGEVGRAFVVARPGTGLDEASVIAYTREHLANFKTPRSVRFVDVLPRNAAGKVSKPQLRELG,"54,095",507,ATP-dependent AMP-binding enzyme family,cholesterol metabolic process [GO:0008203],ATP binding [GO:0005524]; ligase activity [GO:0016874],,,P425_03703 RVBD_3561,1
O53551,FAC17_MYCTU,Rv3506,fadD17 Rv3506,GO:0004467; GO:0005524; GO:0005829; GO:0005886; GO:0008610; GO:0042759; GO:0071766; GO:0102391,IPR025110; IPR020845; IPR000873; IPR030310; ,,fadD17,,Long-chain-fatty-acid--CoA ligase FadD17 (FACL) (EC 6.2.1.3) (Acyl-CoA synthetase),cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; Actinobacterium-type cell wall biogenesis [GO:0071766]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid biosynthetic process [GO:0042759],9634230; 15042094; 21969609,,"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-coenzyme A (acyl-CoA), which are then transferred to the multifunctional polyketide synthase (PKS) type III for further chain extension. {ECO:0000269|PubMed:15042094}.",MTPTHPTVTELLLPLSEIDDRGVYFEDSFTSWRDHIRHGAAIAAALRERLDPARPPHVGVLLQNTPFFSATLVAGALSGIVPVGLNPVRRGAALAGDIAKADCQLVLTGSGSAEVPADVEHINVDSPEWTDEVAAHRDTEVRFRSADLADLFMLIFTSGTSGDPKAVKCSHRKVAIAGVTITQRFSLGRDDVCYVSMPLFHSNAVLVGWAVAAACQGSMALRRKFSASQFLADVRRYGATYANYVGKPLSYVLATPELPDDADNPLRAVYGNEGVPGDIDRFGRRFGCVVMDGFGSTEGGVAITRTLDTPAGALGPLPGGIQIVDPDTGEPCPTGVVGELVNTAGPGGFEGYYNDEAAEAERMAGGVYHSGDLAYRDDAGYAYFAGRLGDWMRVDGENLGTAPIERVLMRYPDATEVAVYPVPDPVVGDQVMAALVLAPGTKFDADKFRAFLTEQPDLGHKQWPSYVRVSAGLPRTMTFKVIKRQLSAEGVACADPVWPIRR,"53,739",502,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; lipid biosynthetic process [GO:0008610]; long-chain fatty acid biosynthetic process [GO:0042759],ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P9WQ51,FAC19_MYCTU,Rv3515c,fadD19 Rv3515c,GO:0004467; GO:0005524; GO:0005618; GO:0006633; GO:0008203; GO:0008610; GO:0052572; GO:0071766; GO:0102391,IPR025110; IPR020845; IPR000873; ,,fadD19,,Long-chain-fatty-acid--CoA/3-oxocholest-4-en-26-oate--CoA ligase (FACL) (EC 6.2.1.3) (EC 6.2.1.42) (Acyl-CoA synthetase) (Steroid-CoA ligase) (Steroid-coenzyme A ligase),cell wall [GO:0005618]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; Actinobacterium-type cell wall biogenesis [GO:0071766]; cholesterol metabolic process [GO:0008203]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; response to host immune response [GO:0052572],9634230; 15042094; 21969609; 24244004,,"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-coenzyme A (acyl-CoA), which are then transferred to the multifunctional polyketide synthase (PKS) type III for further chain extension. Also involved in the degradation of cholesterol via the degradation of the side chains of C-24 branched-chain sterols. Catalyzes the ATP-dependent CoA thioesterification of the sterol 3-oxocholest-4-en-26-oate to yield 3-oxocholest-4-en-26-oyl-CoA. It can also use 3beta-hydroxy-5-cholesten-26-oate. {ECO:0000269|PubMed:15042094, ECO:0000269|PubMed:24244004}.",MAVALNIADLAEHAIDAVPDRVAVICGDEQLTYAQLEDKANRLAHHLIDQGVQKDDKVGLYCRNRIEIVIAMLGIVKAGAILVNVNFRYVEGELRYLFDNSDMVALVHERRYADRVANVLPDTPHVRTILVVEDGSDQDYRRYGGVEFYSAIAAGSPERDFGERSADAIYLLYTGGTTGFPKGVMWRHEDIYRVLFGGTDFATGEFVKDEYDLAKAAAANPPMIRYPIPPMIHGATQSATWMALFSGQTTVLAPEFNADEVWRTIHKHKVNLLFFTGDAMARPLVDALVKGNDYDLSSLFLLASTAALFSPSIKEKLLELLPNRVITDSIGSSETGFGGTSVVAAGQAHGGGPRVRIDHRTVVLDDDGNEVKPGSGMRGVIAKKGNIPVGYYKDEKKTAETFRTINGVRYAIPGDYAQVEEDGTVTMLGRGSVSINSGGEKVYPEEVEAALKGHPDVFDALVVGVPDPRYGQQVAAVVQARPGCRPSLAELDSFVRSEIAGYKVPRSLWFVDEVKRSPAGKPDYRWAKEQTEARPADDVHAGHVTSGG,"59,741",548,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; cholesterol metabolic process [GO:0008203]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; response to host immune response [GO:0052572],ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],cell wall [GO:0005618],,,1
P9WQ47,FAC23_MYCTU,Rv3826,fadD23 Rv3826,GO:0004467; GO:0005524; GO:0005886; GO:0006633; GO:0016021; GO:0046506; GO:0070566; GO:0071766; GO:0102391,IPR000873; ,,fadD23,,Probable long-chain-fatty-acid--CoA ligase FadD23 (FACL) (EC 6.2.1.3) (Acyl-CoA synthetase),integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; sulfolipid biosynthetic process [GO:0046506],9634230; 17768256; 21969609,,"FUNCTION: Catalyzes the activation of long-chain fatty acids as acyl-coenzyme A (acyl-CoA), which are then transferred to the multifunctional polyketide synthase (PKS) type III for further chain extension (Probable). Involved in the biosynthesis of sulfolipid 1 (SL-1). {ECO:0000269|PubMed:17768256, ECO:0000305}.",MVSLSIPSMLRQCVNLHPDGTAFTYIDYERDSEGISESLTWSQVYRRTLNVAAEVRRHAAIGDRAVILAPQGLDYIVAFLGALQAGLIAVPLSAPLGGASDERVDAVVRDAKPNVVLTTSAIMGDVVPRVTPPPGIASPPTVAVDQLDLDSPIRSNIVDDSLQTTAYLQYTSGSTRTPAGVMITYKNILANFQQMISAYFADTGAVPPLDLFIMSWLPFYHDMGLVLGVCAPIIVGCGAVLTSPVAFLQRPARWLQLMAREGQAFSAAPNFAFELTAAKAIDDDLAGLDLGRIKTILCGSERVHPATLKRFVDRFSRFNLREFAIRPAYGLAEATVYVATSQAGQPPEIRYFEPHELSAGQAKPCATGAGTALVSYPLPQSPIVRIVDPNTNTECPPGTIGEIWVHGDNVAGGYWEKPDETERTFGGALVAPSAGTPVGPWLRTGDSGFVSEDKFFIIGRIKDLLIVYGRNHSPDDIEATIQEITRGRCAAIAVPSNGVEKLVAIVELNNRGNLDTERLSFVTREVTSAISTSHGLSVSDLVLVAPGSIPITTSGKVRRAECVKLYRHNEFTRLDAKPLQASDL,"62,841",584,ATP-dependent AMP-binding enzyme family,Actinobacterium-type cell wall biogenesis [GO:0071766]; fatty acid biosynthetic process [GO:0006633]; sulfolipid biosynthetic process [GO:0046506],adenylyltransferase activity [GO:0070566]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6XHI4,FADA5_MYCTU,LH57_19345 Rv3546,fadA5 LH57_19345 Rv3546,GO:0003988; GO:0006707; GO:0009405; GO:0042802,IPR002155; IPR016039; IPR020617; IPR020613; IPR020616; ,Itself,fadA5,,Steroid 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acetyltransferase FadA5) (Beta-ketoacyl-CoA thiolase),acetyl-CoA C-acyltransferase activity [GO:0003988]; identical protein binding [GO:0042802]; cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],9634230; 12368430; 19822655; 21969609; 25482540,X-ray crystallography (5),"FUNCTION: Involved in the beta-oxidation of the cholesterol side chain (PubMed:19822655). It is important for utilization of cholesterol as a sole carbon source in vitro and for full virulence in the chronic stage of mouse lung infection (PubMed:19822655). Catalyzes the thiolysis of 3,22-dioxochol-4-en-24-oyl-CoA to yield 3-oxo-4-pregnene-20-carboxyl-CoA (3-OPC-CoA) and acetyl-CoA (PubMed:25482540). Also able to use acetoacetyl-CoA (AcAcCoA) as substrate (PubMed:19822655). {ECO:0000269|PubMed:19822655, ECO:0000269|PubMed:25482540}.",MGYPVIVEATRSPIGKRNGWLSGLHATELLGAVQKAVVDKAGIQSGLHAGDVEQVIGGCVTQFGEQSNNISRVAWLTAGLPEHVGATTVDCQCGSGQQANHLIAGLIAAGAIDVGIACGIEAMSRVGLGANAGPDRSLIRAQSWDIDLPNQFEAAERIAKRRGITREDVDVFGLESQRRAQRAWAEGRFDREISPIQAPVLDEQNQPTGERRLVFRDQGLRETTMAGLGELKPVLEGGIHTAGTSSQISDGAAAVLWMDEAVARAHGLTPRARIVAQALVGAEPYYHLDGPVQSTAKVLEKAGMKIGDIDIVEINEAFASVVLSWARVHEPDMDRVNVNGGAIALGHPVGCTGSRLITTALHELERTDQSLALITMCAGGALSTGTIIERI,"41,329",391,Thiolase family,cholesterol catabolic process [GO:0006707]; pathogenesis [GO:0009405],acetyl-CoA C-acyltransferase activity [GO:0003988]; identical protein binding [GO:0042802],,,,1
O69622,API1_MYCTU,Rv3654c,Rv3654c,GO:0005576; GO:0009405; GO:0030430; GO:0033668,IPR021202; ,,,,Apoptosis inhibitor Rv3654c,extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430]; negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405],9634230; 20454556,,"FUNCTION: Effector protein that participates in the suppression of macrophage apoptosis by blocking the extrinsic pathway. Recognizes the host polypyrimidine tract binding protein-associated splicing factor (PSF), which probably leads to its cleavage, diminishing the level of caspase-8 in macrophages. {ECO:0000269|PubMed:20454556}.",MVARHRAQAAADLASLAAAARLPSGLAAACARATLVARAMRVEHAQCRVVDLDVVVTVEVAVAFAGVATATARAGPAKVPTTPG,"8,359",84,,negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405],,extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430],,,1
O69623,API2_MYCTU,Rv3655c,Rv3655c,GO:0005576; GO:0009405; GO:0030430; GO:0033668,,,,,Apoptosis inhibitor Rv3655c,extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430]; negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405],9634230; 20454556,,"FUNCTION: Effector protein that participates in the suppression of macrophage apoptosis by blocking the extrinsic pathway. Interferes with caspase-8 activation and binds to the host E3 ubiquitin-protein ligase RNF213, whose fusion partners have anti-apoptotic function. {ECO:0000269|PubMed:20454556}.",MEAALAIATLVLVLVLCLAGVTAVSMQVRCIDAAREAARLAARGDVRSATDVARSIAPRAALVQVHRDGEFVVATVTAHSNLLPTLDIAARAISVAEPGSTAARPPCLPSRWSRCCCASPVRVHI,"13,007",125,,negative regulation by symbiont of host apoptotic process [GO:0033668]; pathogenesis [GO:0009405],,extracellular region [GO:0005576]; host cell cytoplasm [GO:0030430],,,1
P71864,3O1D1_MYCTU,Rv3537,kstD Rv3537,GO:0005886; GO:0006694; GO:0006707; GO:0047571,IPR003953; IPR036188; IPR027477; ,,kstD,,3-oxosteroid 1-dehydrogenase (EC 1.3.99.4) (3-keto-Delta(4)-steroid Delta(1)-dehydrogenase) (KSDD) (3-oxo-Delta(4)-steroid 1-dehydrogenase) (KSTD),plasma membrane [GO:0005886]; 3-oxosteroid 1-dehydrogenase activity [GO:0047571]; cholesterol catabolic process [GO:0006707]; steroid biosynthetic process [GO:0006694],9634230; 18031290; 21969609,,"FUNCTION: Catalyzes the elimination of the C-1 and C-2 hydrogen atoms of the A-ring from the polycyclic ring structure of 3-ketosteroids. Is also involved in the formation of 3-keto-1,4-diene-steroid from 3-keto-4-ene-steroid. {ECO:0000269|PubMed:18031290}.",MTVQEFDVVVVGSGAAGMVAALVAAHRGLSTVVVEKAPHYGGSTARSGGGVWIPNNEVLKRRGVRDTPEAARTYLHGIVGEIVEPERIDAYLDRGPEMLSFVLKHTPLKMCWVPGYSDYYPEAPGGRPGGRSIEPKPFNARKLGADMAGLEPAYGKVPLNVVVMQQDYVRLNQLKRHPRGVLRSMKVGARTMWAKATGKNLVGMGRALIGPLRIGLQRAGVPVELNTAFTDLFVENGVVSGVYVRDSHEAESAEPQLIRARRGVILACGGFEHNEQMRIKYQRAPITTEWTVGASANTGDGILAAEKLGAALDLMDDAWWGPTVPLVGKPWFALSERNSPGSIIVNMSGKRFMNESMPYVEACHHMYGGEHGQGPGPGENIPAWLVFDQRYRDRYIFAGLQPGQRIPSRWLDSGVIVQADTLAELAGKAGLPADELTATVQRFNAFARSGVDEDYHRGESAYDRYYGDPSNKPNPNLGEVGHPPYYGAKMVPGDLGTKGGIRTDVNGRALRDDGSIIDGLYAAGNVSAPVMGHTYPGPGGTIGPAMTFGYLAALHIADQAGKR,"60,636",563,"FAD-dependent oxidoreductase 2 family, 3-oxosteroid dehydrogenase subfamily",cholesterol catabolic process [GO:0006707]; steroid biosynthetic process [GO:0006694],3-oxosteroid 1-dehydrogenase activity [GO:0047571],plasma membrane [GO:0005886],,,3
O53565,Y3520_MYCTU,Rv3520c,Rv3520c,GO:0005618; GO:0005886; GO:0016705,IPR019951; IPR011251; IPR036661; ,,,,Putative coenzyme F420-dependent oxidoreductase Rv3520c (EC 1.-.-.-),"cell wall [GO:0005618]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MEAGMKLGLQLGYWGAQPPQNHAELVAAAEDAGFDTVFTAEAWGSDAYTPLAWWGSSTQRVRLGTSVIQLSARTPTACAMAALTLDHLSGGRHILGLGVSGPQVVEGWYGQRFPKPLARTREYIDIVRQVWARESPVTSAGPHYRLPLTGEGTTGLGKALKPITHPLRADIPIMLGAEGPKNVALAAEICDGWLPIFYSPRMAGMYNEWLDEGFARPGARRSREDFEICATAQVVITDDRAAAFAGIKPFLALYMGGMGAEETNFHADVYRRMGYTQVVDEVTKLFRSGRKDEAAEIIPDELVDDAVIVGDIDHVRKQMAVWEAAGVTMMVVTAGSAEQVRDLAALV,"37,617",347,,,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
P9WKX5,Y3679_MYCTU,Rv3679,Rv3679 MTV025.027,GO:0005524; GO:0005886; GO:0016887; GO:0040007,IPR025723; IPR016300; IPR027417; ,,,,Putative ATPase Rv3679,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth [GO:0040007],9634230; 19099550; 21969609,,,MVATTSSGGSSVGWPSRLSGVRLHLVTGKGGTGKSTIAAALALTLAAGGRKVLLVEVEGRQGIAQLFDVPPLPYQELKIATAERGGQVNALAIDIEAAFLEYLDMFYNLGIAGRAMRRIGAVEFATTIAPGLRDVLLTGKIKETVVRLDKNKLPVYDAIVVDAPPTGRIARFLDVTKAVSDLAKGGPVHAQSEGVVKLLHSNQTAIHLVTLLEALPVQETLEAIEELAQMELPIGSVIVNRNIPAHLEPQDLAKAAEGEVDADSVRAGLLTAGVKLPDADFAGLLTETIQHATRITARAEIAQQLDALQVPRLELPTVSDGVDLGSLYELSESLAQQGVR,"35,856",340,,growth [GO:0040007],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,MTV025.027,1
P9WFH3,Y3895_MYCTU,Rv3787c,Rv3787c,GO:0008168,IPR011610; IPR007213; IPR029063; ,,,,Putative S-adenosyl-L-methionine-dependent methyltransferase Rv3787c (EC 2.1.1.-),methyltransferase activity [GO:0008168],9634230; 21969609,,FUNCTION: Exhibits S-adenosyl-L-methionine-dependent methyltransferase activity. {ECO:0000250}.,MARTDDDSWDLATGVGATATLVAAGRARAARAAQPLIDDPFAEPLVRAVGVEFLTRWATGELDAADVDDPDAAWGLQRMTTELVVRTRYFDQFFLDAAAAGVRQAVILASGLDARGYRLPWPADTTVFEVDQPRVLEFKAQTLAGLGAQPTADLRMVPADLRHDWPDALRRGGFDAAEPAAWIAEGLFGYLPPDAQNRLLDHVTDLSAPGSRLALEAFLGSADRDSARVEEMIRTATRGWREHGFHLDIWALNYAGPRHEVSGYLDNHGWRSVGTTTAQLLAAHDLPAAPALPAGLADRPNYWTCVLG,"33,390",308,UPF0677 family,,methyltransferase activity [GO:0008168],,,,1
P9WFT7,SYS_MYCTU,Rv3834c,serS Rv3834c MTCY01A6.35,GO:0004828; GO:0005524; GO:0005737; GO:0005886; GO:0006434; GO:0040007; GO:0097056,IPR002314; IPR006195; IPR002317; IPR015866; IPR033729; IPR010978; ,,serS,,Serine--tRNA ligase (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase),cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; growth [GO:0040007]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],9634230; 21969609,,"FUNCTION: Catalyzes the attachment of serine to tRNA(Ser). Is also able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec). {ECO:0000255|HAMAP-Rule:MF_00176}.",MIDLKLLRENPDAVRRSQLSRGEDPALVDALLTADAARRAVISTADSLRAEQKAASKSVGGASPEERPPLLRRAKELAEQVKAAEADEVEAEAAFTAAHLAISNVIVDGVPAGGEDDYAVLDVVGEPSYLENPKDHLELGESLGLIDMQRGAKVSGSRFYFLTGRGALLQLGLLQLALKLAVDNGFVPTIPPVLVRPEVMVGTGFLGAHAEEVYRVEGDGLYLVGTSEVPLAGYHSGEILDLSRGPLRYAGWSSCFRREAGSHGKDTRGIIRVHQFDKVEGFVYCTPADAEHEHERLLGWQRQMLARIEVPYRVIDVAAGDLGSSAARKFDCEAWIPTQGAYRELTSTSNCTTFQARRLATRYRDASGKPQIAATLNGTLATTRWLVAILENHQRPDGSVRVPDALVPFVGVEVLEPVA,"45,324",419,"Class-II aminoacyl-tRNA synthetase family, Type-1 seryl-tRNA synthetase subfamily",growth [GO:0040007]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTCY01A6.35,1
O69730,TCRX_MYCTU,Rv3765c,tcrX Rv3765c,GO:0000160; GO:0003677; GO:0005737; GO:0006351; GO:0006355; GO:0010106,IPR011006; IPR001867; IPR001789; IPR036388; ,,tcrX,DOMAIN 10 124 Response regulatory. {ECO:0000255|PROSITE-ProRule:PRU00169}.,Probable transcriptional regulatory protein TcrX,"cytoplasm [GO:0005737]; DNA binding [GO:0003677]; cellular response to iron ion starvation [GO:0010106]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 12595424; 19962420; 21969609,,"FUNCTION: Member of the two-component regulatory system TcrY/TcrX. {ECO:0000269|PubMed:12595424, ECO:0000269|PubMed:19962420}.",MRRADGQPVTVLVVDDEPVLAEMVSMALRYEGWNITTAGDGSSAIAAARRQRPDVVVLDVMLPDMSGLDVLHKLRSENPGLPVLLLTAKDAVEDRIAGLTAGGDDYVTKPFSIEEVVLRLRALLRRTGVTTVDSGAQLVVGDLVLDEDSHEVMRAGEPVSLTSTEFELLRFMMHNSKRVLSKAQILDRVWSYDFGGRSNIVELYISYLRKKIDNGREPMIHTLRGAGYVLKPAR,"25,844",234,,"cellular response to iron ion starvation [GO:0010106]; phosphorelay signal transduction system [GO:0000160]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],cytoplasm [GO:0005737],,,3
P9WKC7,TGS2_MYCTU,Rv3734c,tgs2 Rv3734c MTV025.082c,GO:0001666; GO:0004144; GO:0005618; GO:0005886; GO:0006071; GO:0019432; GO:0044119; GO:0045017; GO:0047196; GO:0071731; GO:0102966; GO:0103095,IPR014292; IPR009721; IPR004255; ,,tgs2,,Probable diacyglycerol O-acyltransferase tgs2 (TGS2) (Diacylglycerol O-acyltransferase) (DGAT) (EC 2.3.1.20) (Long-chain-alcohol O-fatty-acyltransferase) (EC 2.3.1.75) (Probable triacylglycerol synthase tgs2) (Wax ester synthase/acyl-CoA:diacylglycerol acyltransferase) (Wax synthase) (WS),cell wall [GO:0005618]; plasma membrane [GO:0005886]; arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; wax ester synthase activity [GO:0103095]; glycerol metabolic process [GO:0006071]; glycerolipid biosynthetic process [GO:0045017]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],9634230; 15262939; 21969609,,"FUNCTION: Catalyzes the terminal and only committed step in triacylglycerol synthesis by using diacylglycerol and fatty acyl CoA as substrates. Required for storage lipid synthesis (By similarity). {ECO:0000250}.; FUNCTION: Upon expression in E.coli functions as a triacylglycerol synthase, making triacylglycerol (TG) from diolein and long-chain fatty acyl-CoA. Also functions as a wax synthase, incorporating palmityl alcohol into wax esters in the presence of palmitoyl-CoA. {ECO:0000269|PubMed:15262939}.",MDLMMPNDSMFLFIESREHPMHVGGLSLFEPPQGAGPEFVREFTERLVANDEFQPMFRKHPATIGGGIARVAWAYDDDIDIDYHVRRSALPSPGRVRDLLELTSRLHTSLLDRHRPLWELHVVEGLNDGRFAMYTKMHHALIDGVSAMKLAQRTLSADPDDAEVRAIWNLPPRPRTRPPSDGSSLLDALFKMAGSVVGLAPSTLKLARAALLEQQLTLPFAAPHSMFNVKVGGARRCAAQSWSLDRIKSVKQAAGVTVNDAVLAMCAGALRYYLIERNALPDRPLIAMVPVSLRSKEDADAGGNLVGSVLCNLATHVDDPAQRIQTISASMDGNKKVLSELPQLQVLALSALNMAPLTLAGVPGFLSAVPPPFNIVISNVPGPVDPLYYGTARLDGSYPLSNIPDGQALNITLVNNAGNLDFGLVGCRRSVPHLQRLLAHLESSLKDLEQAVGI,"49,304",454,Long-chain O-acyltransferase family,glycerolipid biosynthetic process [GO:0045017]; glycerol metabolic process [GO:0006071]; growth of symbiont in host cell [GO:0044119]; response to hypoxia [GO:0001666]; response to nitric oxide [GO:0071731]; triglyceride biosynthetic process [GO:0019432],arachidoyl-CoA:1-dodecanol O-acyltransferase activity [GO:0102966]; diacylglycerol O-acyltransferase activity [GO:0004144]; long-chain-alcohol O-fatty-acyltransferase activity [GO:0047196]; wax ester synthase activity [GO:0103095],cell wall [GO:0005618]; plasma membrane [GO:0005886],,MTV025.082c,1
O69729,TCRY_MYCTU,Rv3764c,tcrY Rv3764c,GO:0000155; GO:0000287; GO:0005509; GO:0005524; GO:0005829; GO:0005886; GO:0016021; GO:0016887; GO:0042803; GO:0046777,IPR003660; IPR003594; IPR036890; IPR005467; IPR003661; IPR036097; IPR004358; ,,tcrY,DOMAIN 176 238 HAMP. {ECO:0000255|PROSITE-ProRule:PRU00102}.; DOMAIN 253 466 Histidine kinase. {ECO:0000255|PROSITE-ProRule:PRU00107}.,Probable sensor histidine kinase TcrY (EC 2.7.13.3),cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphorelay sensor kinase activity [GO:0000155]; protein homodimerization activity [GO:0042803]; protein autophosphorylation [GO:0046777],9634230; 12595424; 19962420; 21969609,,"FUNCTION: Member of the two-component regulatory system TcrY/TcrX. Activates TcrX by phosphorylation. {ECO:0000269|PubMed:12595424, ECO:0000269|PubMed:19962420}.",MGITAATEMALRRHLVAQLDNQLGGTSYRSVLMYPEKMPRPPWRHETHNYIRSGPGPRFLDAPGQPAGMVAAVVSDGTTVAAGYLTGSGSRAALTSTGRSQLERIAGSRTPLTLDLDGLGRYRVLAAPSRNGHDVIVTGLSMGNVDATMLQMLIIFGIVTVIALVAATTAGIVIIKRALAPLRRVAQTASEVVDLPLDRGEVKLPVRVPEPDANPSTEVGQLGSALNRMLDHIAAALSARQASETCVRQFVADASHELRTPLAAIRGYTELTQRIGDDPEAVAHAMSRVASETERITRLVEDLLLLARLDSGRPLERGPVDMSRLAVDAVSDAHVAGPDHQWALDLPPEPVVIPGDAARLHQVVTNLLANARVHTGPGTIVTTRLSTGPTHVVLQVIDNGPGIPAALQSEVFERFARGDTSRSRQAGSTGLGLAIVSAVVKAHNGTITVSSSPGYTEFAVRLPLDGWQPLESSPR,"50,344",475,,protein autophosphorylation [GO:0046777],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphorelay sensor kinase activity [GO:0000155]; protein homodimerization activity [GO:0042803],cytosol [GO:0005829]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
P9WG53,TILS_MYCTU,Rv3625c,tilS Rv3625c MTCY15C10.27,GO:0005524; GO:0005737; GO:0008033; GO:0016879; GO:0040007,IPR014729; IPR011063; IPR012094; IPR012795; IPR015262; ,,tilS,,tRNA(Ile)-lysidine synthase (EC 6.3.4.19) (tRNA(Ile)-2-lysyl-cytidine synthase) (tRNA(Ile)-lysidine synthetase),"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]; growth [GO:0040007]; tRNA processing [GO:0008033]",9634230; 21969609,,"FUNCTION: Ligates lysine onto the cytidine present at position 34 of the AUA codon-specific tRNA(Ile) that contains the anticodon CAU, in an ATP-dependent manner. Cytidine is converted to lysidine, thus changing the amino acid specificity of the tRNA from methionine to isoleucine. {ECO:0000255|HAMAP-Rule:MF_01161}.",MDRQSAVAQLRAAAEQFARVHLDACDRWSVGLSGGPDSLALTAVAARLWPTTALIVDHGLQPGSATVAETARIQAISLGCVDARVLCVQVGAAGGREAAARSARYSALEEHRDGPVLLAHTLDDQAETVLLGLGRGSGARSIAGMRPYDPPWCRPLLGVRRSVTHAACRELGLTAWQDPHNTDRRFTRTRLRTEVLPLLEDVLGGGVAEALARTATALREDTDLIDTIAAQALPGAAVAGSRGQELSTSALTALPDAVRRRVIRGWLLAGGATGLTDRQIRGVDRLVTAWRGQGGVAVGSTLRGQRLVAGRRDGVLVLRREPV,"34,130",323,TRNA(Ile)-lysidine synthase family,growth [GO:0040007]; tRNA processing [GO:0008033],"ATP binding [GO:0005524]; ligase activity, forming carbon-nitrogen bonds [GO:0016879]",cytoplasm [GO:0005737],,MTCY15C10.27,1
I6Y3V5,I6Y3V5_MYCTU,Rv3560c,fadE30 Rv3560c,GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE30,,Probable acyl-CoA dehydrogenase FadE30,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MQDVEEFRAQVRGWLADNLAGEFAALKGLGGPGREHEAFEERRAWNQRLAAAGLTCLGWPEEHGGRGLSTAHRVAFYEEYARADAPDKVNHFGEELLGPTLIAFGTPQQQRRFLPRIRDVTELWCQGYSEPGAGSDLASVATTAELDGDQWVINGQKVWTSLAHLSQWCFVLARTEKGSQRHAGLSYLLVPLDQPGVQIRPIVQITGTAEFNEVFFDDARTDADLVVGAPGDGWRVAMATLTFERGVSTLGQQIVYARELSNLVELARRTAAADDPLIRERLTRAWTGLRAMRSYALATMEGPAVEQPGQDNVSKLLWANWHRNLGELAMDVIGKPGMTMPDGEFDEWQRLYLFTRADTIYGGSNEIQRNIIAERVLGLPREAKG,"42,732",385,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,1
P96241,P96241_MYCTU,Rv3837c,Rv3837c,,IPR013078; IPR029033; ,,,,Probable phosphoglycerate mutase (Phosphoglyceromutase) (Phosphoglycerate phosphomutase),,9634230; 21969609,,,MSGRLVLLRHGQSYGNVERRLDTLPPGTALTPLGRDQARAFARSGCRRPALLAHSVAIRAYQTAAVVAAELDMVAHEVAGIHEVQVGELENRNDDEAVAEFNATYSRWHRGELDVPLPGGETANDVLDRYLPVLADLRMRYLDDGDWDGDIVVVSHSAAIRLAAAVLAGVDGNFVLDNHLENVESVVLAPITDGRWSCVQWGLRKPPFCPDPAEAAASPVTHAVTSSTDPMG,"25,019",232,,,,,,,1
O06279,O06279_MYCTU,Rv3603c,Rv3603c,GO:0055114,IPR008927; IPR018931; IPR036291; IPR019665; IPR037108; ,,,,Conserved hypothetical alanine and leucine rich protein,oxidation-reduction process [GO:0055114],9634230; 21969609,,,MERFDGLRPARLKVGIISAGRVGTALGVALQRADHVVVACSAISHASRRRAQRRLPDTPVLPPLDVAASAELLLLAVTDSELAGLVSGLAATSAVRPQTIVAHTSGANGIGILAPLAQQGCIPLAIHPAMTFTGSDEDISRLPDTCFGITAADDVGYAIGQSLVLEMGGEPFCVREDARILYHAALAHASNHIVTVLADALEALRAALSGGELLGQQTVDDQPGGIVERIVGPLARAALENTLQRGQAALTGPVARGDAAAVADHLAALADVDAALAQAYRINALRTAQRAHAPADVVEVLTA,"31,105",303,,oxidation-reduction process [GO:0055114],,,,,1
O53564,O53564_MYCTU,Rv3519,Rv3519,GO:0005886; GO:0016829,IPR010451; IPR023375; ,,,,Uncharacterized protein,plasma membrane [GO:0005886]; lyase activity [GO:0016829],9634230; 21969609,,,MPVSQHTIAGTVLTMPVRIRTANLHSAMFSVPADPAQRLIDYSGLRVCEYLPGKAIVMQMLVRYVDGDLGRYHEYGTAIMVNPPGTQRRGPRALTRAAAFIHHLPVDQVFTLEAGRTIWGFPKIMADFNVTDGRRFGFDVSADGRLIAGIEFSTGLPVPTLGWQMLKTYSHHDGVTREIPWEMKVSGLRARLGGARLRLGDHPYAKELASLGLPKRALLSQSAANVEMTFGDGHPI,"25,960",236,,,lyase activity [GO:0016829],plasma membrane [GO:0005886],,,1
O69686,O69686_MYCTU,Rv3719,Rv3719,GO:0005886; GO:0016614; GO:0050660,IPR016166; IPR036318; IPR016164; IPR006094; ,,,,Conserved protein,"plasma membrane [GO:0005886]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",9634230; 21969609,,,MQGQLSRTRVYTVPVPGSAQSAYACGVERLLASYRSIPATASIRLAKPTSNLFRARVKHDARGLDASGLTGVIGIDPEARTADVAGMCTYEDLIAATLHYGLSPLVVPQLRTITLGGAVTGLGIESASFRNGLPHESVLEMDILTGAGELLTVSPGQHSDLYRAFPNSYGTLGYSTRLRIQLEPVRPFVALRHIRFSSLTAMVAAMERIIDTGGLDGESVDYLDGVVFSADESYLCIGMQTSVPGPVSDYTGQDIYYRSIQHEAGIKEDRLTIHDYFWRWDTDWFWCSRSFGAQNPRLRRWWPRRYRRSSVYWRLMALDQRFGIADRFENSRGRPARERVVQDIEVPIERTCEFLEWFGENVPISPIWLCPLRLRDHAGWPLYPIRPDRSYVNIGFWSSVPVGATEGATNRKIENKVSALDGHKSLYSDSFYTREEFDELYGGETYNTVKKAYDPDSRLLDLYAKAVQRR,"53,007",470,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",plasma membrane [GO:0005886],,,1
O69725,O69725_MYCTU,Rv3759c,proX Rv3759c,GO:0005215; GO:0005576; GO:0005886; GO:0022857; GO:0031460; GO:0043190; GO:0075136,IPR007210; ,,proX,,Possible osmoprotectant (Glycine betaine/carnitine/choline/L-proline) binding lipoprotein ProX,ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215]; glycine betaine transport [GO:0031460]; response to host [GO:0075136],9634230; 21969609,,,MRMLRRLRRATVAAAVWLATVCLVASCANADPLGSATGSVKSIVVGSGDFPESQVIAEIYAQVLQANGFDVGRRLGIGSRETYILALKDHSIDLVPEYIGNLLLYFQPDATVTMLDAVELELYKRLPGDLSILTPSPASDTDTVTVTAATAARWNLKTIADLAPHSADVKFAAPSAFQTRPSGLPGLRHKYSLDIAPGNFVTINDGGGAVTVRALVEGTATAANLFSTSAAIPQNHLVVLEDPEHNFLAGNIVPLVNSRKKSDHLKDVLDAVSAKLTTAGLAELNAAVSGNSGVDPDQAARKWVRDNGFDHPVRQ,"33,358",315,,glycine betaine transport [GO:0031460]; response to host [GO:0075136],transmembrane transporter activity [GO:0022857]; transporter activity [GO:0005215],ATP-binding cassette (ABC) transporter complex [GO:0043190]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,,1
I6Y3U6,I6Y3U6_MYCTU,Rv3550,echA20 Rv3550,GO:0004300; GO:0006635,IPR029045; IPR001753; ,,echA20,,Probable enoyl-CoA hydratase EchA20 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],9634230; 21969609,,,MPITSTTPEPGIVAVTVDYPPVNAIPSKAWFDLADAVTAAGANSDTRAVILRAEGRGFNAGVDIKEMQRTEGFTALIDANRGCFAAFRAVYECAVPVIAAVNGFCVGGGIGLVGNSDVIVASEDATFGLPEVERGALGAATHLSRLVPQHLMRRLFFTAATVDAATLQHFGSVHEVVSRDQLDEAALRVARDIAAKDTRVIRAAKEALNFIDVQRVNASYRMEQGFTFELNLAGVADEHRDAFVKKS,"26,333",247,,fatty acid beta-oxidation [GO:0006635],enoyl-CoA hydratase activity [GO:0004300],,,,1
O05456,O05456_MYCTU,Rv3888c,Rv3888c,GO:0005886,IPR027417; ,,,,Probable conserved membrane protein,plasma membrane [GO:0005886],9634230; 21969609,,,MTNPWNDPNMLDDGAIGRGDPSVRHHFRDSVSDTMRITDLAAPRKIPPGTGWRKFVYSVSFHKINPGESPRERHYRNLQGRIRRHIRRQYVITVVSGKGGVGVTTMAACIGGVFRECRPENVIAIDAVPSFGTLADRIDESPPGDYAAIINDTDVQGYADIREHLGQNTVGLDVLAGNRTSDQPRPLVPAMFSAVLSRLRRTHTVIVIDTSPDLEHDVMKAVLQSTDTLVFVSGITADRSRPVLRAVDYLRAQGYHELVSRSTVILNHTDSITDKDALAYLTERFTKVGAIVEAMPFDPHLAKGGIIDTVHELNKKSRLRLFEITAGLADKYVPDAERAAQ,"37,724",341,,,,plasma membrane [GO:0005886],,,1
O06378,O06378_MYCTU,Rv3629c,Rv3629c,,IPR007427; ,,,,Probable conserved integral membrane protein,,9634230; 21969609,,,MSTFRIFGFSLLMTVVALVTGYLHGGPTALFLLAVLALLEVSLSFDNAIINAAILQRMSPFWQRMFLTIGILIAVFGMRLVFPLAIIWTTAGLDPVRAMELALRPPAHGALEFADGSPSYEKLITAAHPQIAAFGGMFLLMLFLDFVVHDRDIKWLKWIEVPFARIGRLGQVPVIVASVGLVLAGALLTHSSDQRGTVLIAGLLGMVTYLVVNGISRAFRPAGLGEATPGVQARQAAGKAGCALFLYLEVLDAAFSFDGVTGAFAITTDPIIIALGLGVVGAMFVRSITIYLVRQDTLDRYVYLEHGAHWAIGALAIILLLSIDHRFAVPEWVTASVGVVFIGAAFTESVRRNRLTVRSPTKFGS,"39,312",365,,,,,,,3
I6Y4C7,I6Y4C7_MYCTU,Rv3712,Rv3712,GO:0005524; GO:0009058; GO:0016874,IPR013564; IPR036565; IPR013221; ,,,,Possible ligase,ATP binding [GO:0005524]; ligase activity [GO:0016874]; biosynthetic process [GO:0009058],9634230; 21969609,,,MVTTRARLALAAGAGARWASRVTGRGAGAMIGGLVAMTLDRSILRQLGMGRRTVVVTGTNGKSTTTRMTAAALGTLGAVATNAEGANMDAGLVAALAAHRDAELAVLEVDEMHVPHISDAVDPAVVVLLNLSRDQLDRVGEINVIERTLRAGLARHPDAVVVANCDDVLMTSAAYDSPNVVWVAAGGAWSNDSVSCPRSGEVIVRKAPSQEDHWYSTGADFKRPAPHWWFDDATLYGPDGLALPMRLALPGSVNRGNAAQAVAAAVALGADPAVAVAAVCQVDEVAGRYRTVRIGAHQARILLAKNPAGWQEALAMVDKHADGVVIAVNGRVPDGEDLSWLWDVRFEHFEKTRVVAAGERGTDLAVRLGYAGVEHTLVHDTVAAIASCPPGRVEVVANYTAFLQLQRALARRG,"43,421",413,,biosynthetic process [GO:0009058],ATP binding [GO:0005524]; ligase activity [GO:0016874],,,,1
O69637,O69637_MYCTU,Rv3669,Rv3669,GO:0005887; GO:0040007,IPR009937; ,,,,Probable conserved transmembrane protein,integral component of plasma membrane [GO:0005887]; growth [GO:0040007],9634230; 21969609,,,MSKIDRKNGVPSTLTTIPLADPHAGPAEPSIGDLIKDATTQMSTLVRAEVELARAEITRDVKKGLTGSVFFISSLVVGFYSTFFFFFFVAELLDTWIWRWVAFLLVFAIMVVVTAVLALLGFLKVRRIRGPRQTIASVKETRTALTPGHDKTPVTPKPVTSDRATPVDPSGW,"18,919",172,,growth [GO:0040007],,integral component of plasma membrane [GO:0005887],,,1
I6YGU1,I6YGU1_MYCTU,Rv3639c,Rv3639c,,,,,,Uncharacterized protein,,9634230,,,MAGLFTPPASGAATLQRAARDAAPDARWLLAVSDRNGIVSTSATTCNYPPAAKDSAQDGFRHALAAAIAADIDEALRHGYGDLLELAYPLMSWPRRGVFGGPTPAPRGLATRQCPPRTVHVDRVRPNGAERALRARFRPILRPQFTLGDGANGLPLAACTKTGAYVPHLPYSPIAVDPQPSAGQQGPS,"19,767",188,,,,,,,1
P75019,P75019_MYCTU,Rv3774,echA21 Rv3774,GO:0003824; GO:0005886; GO:0008152,IPR029045; IPR001753; IPR014748; ,,echA21,,Possible enoyl-CoA hydratase EchA21 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),plasma membrane [GO:0005886]; catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MGETYESVTVETKDQVAQVTLIGPGKGNAMGPAFWSEMPEVFHALDADREVRAIVITGSGKNFSYGLDVPAMGGMFAPLIADGALARPRTDFHTEILRMQKAINAVADCRTPTIAAVQGWCIGGAVDLISAVDIRYASADAKFSVREVKLAIVADMGSLARLPLILSDGHLRELALTGKNIDAARAEKIGLVNDVYDDADQTLAAAHATAAEIAANPPLAVYGIKDVLDQQRTSAVSENLRYVAAWNAAFLPSKDLTEGISATFAKRPPQFTGE,"29,101",274,,metabolic process [GO:0008152],catalytic activity [GO:0003824],plasma membrane [GO:0005886],,,1
I6YCF5,I6YCF5_MYCTU,Rv3564,fadE33 Rv3564,GO:0016627; GO:0050660,IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE33,,Probable acyl-CoA dehydrogenase FadE33,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MTPPEERQMLRETVASLVAKHAGPAAVRAAMASDRGYDESLWRLLCEQVGAAALVIPEELGGAGGELADAAIVVQELGRALVPSPLLGTTLAELALLAAAKPDAQALTELAQGSAIGALVLDPDYVVNGDIADIVVAATSGQLTRWTRFSAQPVATMDPTRRLARLQSEETEPLCPDPGIADTAAILLAAEQIGAAERCLQLTVEYAKSRVQFGRPIGSFQALKHRMADLYVTIAAARAVVADACHAPTPTNAATARLAASEALSTAAAEGIQLHGGIAITWEHDMHLYFKRAHGSAQLLESPREVLRRLESEVWESP,"33,558",318,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,1
P72035,P72035_MYCTU,Rv3768,Rv3768,,IPR032710; IPR037401; ,,,DOMAIN 18 109 SnoaL-like. {ECO:0000259|Pfam:PF12680}.,Uncharacterized protein,,9634230; 21969609,,,MGSTPPRTPQEVFAHHGQALAAGDLDEIVADYADDSFVITPAGIARGKEGIRQLFVKLLDDIPNALWDLKTQIFEGDILFLEWTANSAVSRVDDGVDTFVFRDGTIWAHTVRYTPHPKT,"13,167",119,,,,,,,1
O69715,O69715_MYCTU,Rv3748,Rv3748,,,,,,Uncharacterized protein,,9634230; 21969609,,,MIVGAFLAEAASVVDNKLNVSGGVLYRFAVDPDRSAQFLLVVLTQAETDDPDRRVDVEVWPPTGDDAHHIEFELPEAAVAAEVGFAIFRIEVNLPVDGRWVLVVTGGAGTISLPLIVTG,"12,697",119,,,,,,,1
I6X7H4,I6X7H4_MYCTU,Rv3503c,fdxD Rv3503c,GO:0005506; GO:0009055,IPR001080; ,,fdxD,,Probable ferredoxin FdxD,electron transfer activity [GO:0009055]; iron ion binding [GO:0005506],9634230; 21969609,,,MRVIVDRDRCEGNAVCLGIAPDIFDLDDEDYAVVKTDPIPVDQEDLAEQAIAECPRAALSRGE,"6,904",63,,,electron transfer activity [GO:0009055]; iron ion binding [GO:0005506],,,,1
P96238,P96238_MYCTU,Rv3840,Rv3840,,IPR004474; ,,,,Possible transcriptional regulatory protein,,9634230,,,MAGCIQRFSHVRCLGPGLASDNPTTLISIPRDSYVPIPGHGRDKINAAFALGGGRLLTQTVELATGLHLDHYAEVGFSEFADLVDAFDPLAGVDLPAGCQTLDGRAALGYVRTRATPRADLEGSDVPVPAAAFETQP,"14,357",137,,,,,,,1
I6YGR2,I6YGR2_MYCTU,Rv3612c,Rv3612c,,,,,,Uncharacterized protein,,9634230,,,MVAVLTYARQLGFCRSTPPTIPHSRNQLVNKTAGQAAVAESWADRVSPGAVTHATGAMCPTLGAHQFEPNQVRCTACLTRTLSCRIFRRRRELPVVGLASGDPLHPALG,"11,691",109,,,,,,,1
O06278,O06278_MYCTU,Rv3604c,Rv3604c,GO:0005886; GO:0016021; GO:0040007,,,,,Probable conserved transmembrane protein rich in alanine and arginine and proline,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MTVLSRGARVRRGGRRPGWVLLTALLVLAIGASSALVFTDRVELLKLAVLLALWAAVAGAFVSVLYRRQSDVDQARVRDLKLVYDLQLDREISARREYELTLESQLRRELASELRAPAADEVAALRAELAALRTSLEILFDADLEHRPALGTVEKEARAARALDGESPPADWVSSDRVMAVRGGDGASRTDEASIIDVPEVGVPPVSGGPRHYEAPPPPQPEPLFEPRHRPPPLPPQQERPVWQPVTSHGQWLPAETPGSQWASVEPETTPAAPPPGRRRRARHASPADQAYNPPAYVELAAQYGESGRRSRHSAEHRDHDIGGSGAGTGERPPSPPMAPPPPAEPTRRHRTADTPPDDSGGLHARDPLTGGQSVADLMARLQVESTGGGRRRRRGE,"43,058",397,,growth [GO:0040007],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,2
I6YGS7,I6YGS7_MYCTU,Rv3622c,PE32 Rv3622c,,IPR000084; ,,PE32,,PE family protein PE32,,9634230,,,MSIMHAEPEMLAATAGELQSINAVARAGNAAVAGPTTGVVPAAADLVSLLTASQFAAHAQLYQAISAEAMAVQEQLATTLGISAGSYAATEAANAATIA,"9,698",99,,,,,,,1
P72047,P72047_MYCTU,Rv3781,rfbE Rv3781,GO:0005524; GO:0005886; GO:0016887; GO:0040007,IPR003593; IPR003439; IPR027417; ,,rfbE,,Probable O-antigen/lipopolysaccharide transport ATP-binding protein ABC transporter RfbE,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; growth [GO:0040007],9634230; 21969609,,,MSDPHHPHIQTHNAWVEFPIFDAKSRSLKKAVLGKAGGTIGRNNSNVVVIEALRDITMELNLGDRVGLVGHNGAGKSTLLRLLSGIYEPTRGWAKVTGRVAPVFDLGIGMDPEISGYENIIIRGLFLGQTRKQMQAKVDEIAEFTELGEYLSMPLRTYSTGMRVRLAMGVVTSIDPEILLLDEGIGAVDADFLRKAQSRLQNLVERSGILVFASHSNEFLARLCKTAIWIDHGVIRLAGGIEEVVRAYEGEDAARHVREVLAETQADRQNVQG,"29,992",273,,growth [GO:0040007],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,2
O69693,O69693_MYCTU,Rv3726,Rv3726,GO:0005886; GO:0055114,IPR013149; IPR013154; IPR011032; IPR036291; ,,,,Possible dehydrogenase,plasma membrane [GO:0005886]; oxidation-reduction process [GO:0055114],9634230; 21969609,,,MKAVTCTNAKLEVVDRPSPAPAKGQLLLDVLRCGICGSDLHARLHCDELADVMAESGYHAFMRSNQQVVFGHEFCGEVVDYGPGTRRTPRRGTPVVAMPLLRRGNKEVHGIGLSTMAPGAYAERLVVEQSLTFPVPNGLAPEIAALTEPMAVGWHAVRRGEVGKGDVAIVIGCGPIGLAVICMLKSRGVHTVIASDFSPGRRALATACGADSVVDPVQDSPYAVAAGLGQGNRHLQSILDAFDLAVGTVERLQRLRLPWWHLWRAAEAAGAATPKRPVIFECVGVPGIIDGIIASAPLFSRVVVVGVCMGSDHIRPAMAINKEINLRFVLGYTPLEFRDTLHMLADGKVNAAPLITGTVGLPGVAAAFDALGDPEAHAKIMIDPKSNAASPQPFRVE,"42,036",397,,oxidation-reduction process [GO:0055114],,plasma membrane [GO:0005886],,,1
P96246,P96246_MYCTU,Rv3832c,Rv3832c,GO:0005886; GO:0008168,IPR013216; IPR029063; ,,,,Conserved protein,plasma membrane [GO:0005886]; methyltransferase activity [GO:0008168],9634230; 21969609,,,MAMNLLHRRHCSSAGWEKAVANQLLPWALQHVELGPRTLEIGPGYGATLQALLGLTASLTAVEVDNSMVERLNRRYGQRARIIRGDGTQTGLPDDHFTSVVCFTMLHHVASAQLQDQLFAEAYRVLQPGGVFAGSDGVPSLPFRLIHIADTYTPIAPADLPGRLRAVGFTDIHVDVAGARLRWRATKPVAA,"20,767",191,,,methyltransferase activity [GO:0008168],plasma membrane [GO:0005886],,,1
I6YCQ4,I6YCQ4_MYCTU,Rv3670,ephE Rv3670,GO:0016787,IPR029058; IPR000073; IPR000639; ,,ephE,DOMAIN 55 309 AB hydrolase-1. {ECO:0000259|Pfam:PF00561}.,Possible epoxide hydrolase EphE (Epoxide hydratase) (Arene-oxide hydratase),hydrolase activity [GO:0016787],9634230; 21969609,,,MAAPDPSMTRIAGPWRHLDVHANGIRFHVVEAVPSGQPEGPDAATPPMQPALARPLVILLHGFGSFWWSWRHQLCGLTGARVVAVDLRGYGGSDKPPRGYDGWTLAGDTAGLIRALGHPSATLVGHADGGLACWTTALLHSRLVRAIALISSPHPAALRRSTLTRRDQRHALLPTLLRYQLPIWPERLLTRNNAAEIERLVRARGCAKWLASEDFSQAIDHLRQAIQIPAAAHCALEYQRWAVRSQLRSEGRRFIRAMTQQLGMPLLHLRGDADPYVLADPVERTQRYAPHGRYISIAGAGHFSHEEAPEEVNRHLMRFLEQVHQLS,"36,334",327,,,hydrolase activity [GO:0016787],,,,1
I6XHY3,I6XHY3_MYCTU,Rv3677c,Rv3677c,GO:0016787,IPR001279; IPR036866; IPR036388; ,,,,Possible hydrolase,hydrolase activity [GO:0016787],9634230; 21969609,,,MSKTAESLTHPAYGQLRAVTDTASVLLADNPGLLTLDGTNTWVLRGPLSDELVVVDPGPDDDEHLARVAALGRIALVLISHRHGDHTSGIDKLVALTGAPVRAADPQFLRRDGETLTDGEVIDVAGLTITVLATPGHTADSLSFVLDDAVLTADTVLGCGTTVIDKEDGSLADYLESLHRLRGLGRRTVLPGHGPDLLDLEAIASGYLLHRHERLEQIRAALRDLGDDATVREVVEHVYLDVDEKLWNAAEWSVQAQLDYLRTR,"28,490",264,,,hydrolase activity [GO:0016787],,,,1
I6Y3T7,I6Y3T7_MYCTU,Rv3540c,ltp2 Rv3540c,GO:0008152; GO:0016747,IPR002155; IPR016039; ,,ltp2,,Probable lipid transfer protein or keto acyl-CoA thiolase Ltp2,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; metabolic process [GO:0008152]",9634230; 21969609,,,MLSGQAAIVGIGATDFSKNSGRSELRLAAEAVLDALADAGLSPTDVDGLTTFTMDTNTEIAVARAAGIGELTFFSKIHYGGGAACATVQHAAMAVATGVADVVVAYRAFNERSGMRFGQVQTRLTENADSTGVDNSFSYPHGLSTPAAQVAMIARRYMHLSGATSRDFGAVSVADRKHAANNPKAYFYGKPITIEDHQNSRWIAEPLRLLDCCQETDGAVAIVVTSAARARDLKQRPVVIEAAAQGCSPDQYTMVSYYRPELDGLPEMGLVGRQLWAQSGLTPADVQTAVLYDHFTPFTLIQLEELGFCGKGEAKDFIADGAIEVGGRLPINTHGGQLGEAYIHGMNGIAEGVRQLRGTSVNPVAGVEHVLVTAGTGVPTSGLILG,"40,588",386,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
O06381,O06381_MYCTU,Rv3626c,Rv3626c,GO:0005829,IPR022454; IPR018766; ,,,,Uncharacterized protein,cytosol [GO:0005829],9634230; 21969609,,,MTGASELTLGNTVDWEFAASVGERLARPAPPSTEYTRRQVIDELTVAAEKAEPPVRDVTGLIADGVVPPARVVDRPAWIRSAAESMRAMTHGSAKPRGFLTGRITGAQTGAVLAFVASGILGQYDPFGAAGEGCLLLVYPNVIAVERQLRVEPSDFRLWVCLHEVTHRVQFTANPWLSGYMSQALNLLTFEPVDDIGRVVSRLADFIRSRGHGTDDSEVNPSGILGLVRAVQSEPQRKALDQLLVLGTLLEGHAEHVMDAVGPMVVPSVATIRRRFDDRRHHKQPPLQRLVRALLGFDAKLSQYTRGKAFVDHVVDRAGMKLFNTIWSGPETLPLPAEIENPQRWIDRVL,"38,439",350,,,,cytosol [GO:0005829],,,3
I6X824,I6X824_MYCTU,Rv3678A,Rv3678A,,IPR025234; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTQPTAWEYATVPLLTHATKQILDQWGADGWELVAVLPGPTGEQHVAYLKRPK,"5,915",53,,,,,,,1
I6X7J6,I6X7J6_MYCTU,Rv3524,Rv3524,,IPR035016; IPR001258; IPR013017; ,,,,Probable conserved membrane protein,,9634230; 21969609,,,MVKFTPDSQTSVLRAGKCSGTLSPSRSRLQRGSWPVDSERRRYGWPRNRRTLAITGAAVVVVVTLAAIGYLIFEPKISGSSTSRQAASPTTPSPPSQVVVPIDLWNPDGVTVDLADAVYVADSGHKRLLKLPAGSNTPTTLPFTDTIGPGGVAVNSNRDVYVIDEDSHHVLKLAAGIEPPVELPFGSLGDAHGLAVDRSDSVYVVDYDNAKVLKLPPGADTPTELPFVGLDHPYDVAVDGAGTVYVTDSGHNRVVALTAGSATPVHLPFADLSFPAGVTVDRDDSVYVADLNNNRVLKLAAGSNAQSQLPFTGLFSPTDVAVDNDGAVYVIDFYNRMLKLPTA,"36,286",343,,,,,,,1
L7N6A0,L7N6A0_MYCTU,Rv3770A,Rv3770A,,,,,,Probable remnant of a transposase,,9634230,,,MGSTPWCPNPCQCTLRTPVEVLELAVALRPENPDRTAGAIQRILRAQLAGDRIALRGRGS,"6,498",60,,,,,,,1
I6YGE4,I6YGE4_MYCTU,Rv3528c,Rv3528c,,IPR029063; ,,,,Uncharacterized protein,,9634230; 21969609,,,MMLDRLRQGGYWLVRGKINLIDRAFTSCRIESFADLGAVWGVEGAYTFRALDKYPVKEAVLVDGRITPTVAARANSYPQLRVIEGNFGDQEIADKVGNVDALFLFDVLLHQVSPDWDTILDMYAKNVRCLLIYNQQWIGSTTTVRLLDLGEKHYFRNVPHSKLNKAYRDLFQKLDKKHPDHDKPWRDIPDIWQWGITDADLESKASELGFKLLYKEDCRGFGWLPNIQNRAFLFARQ,"27,440",237,,,,,,,1
Q6MWV6,Q6MWV6_MYCTU,Rv3595c,PE_PGRS59 Rv3595c,,IPR000084; ,,PE_PGRS59,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS59,,9634230,,,MSFVIAVPEFLSAAATDLANLGSTISAANAAASIPTTGVLAAGADDVSAAIAALFGAHAQAYQTISAQAATFHAQFVQTLSAGAGAYANAEAANVQQSLLNAINAPTQALLGRPLIGDGADGTAPGQNGGAGGLLYGNGGNGAAGVNAGIAGGSGGAAGLIGNGGSGGAGGAGAAGGSGGQGGLLYGNGGAGGNGGAATIPGGNGGAGGAGGNAWLFGNGGAGGLGAAGAAGAAGVNPLTVPAGQGSMGNNGEPGGPGQPGTEFGQTGGTGGTGGTGLSVGGTGGTGGTGGTGGAGGSGGRGGLLVGDGGAGGIGGTGGEGGIGARGGTGGQGGMGGAGQPGVGGDAGDGGNGGIGGDGGAGGDGGAGGAGGAGGLFGVSGSSGLGGAAGSGGNGGGGGEPGVAGSPGVGPAGRGGDGNLGQFGPEGAPGQPGQPGQPG,"37,143",439,,,,,,,1
L7N660,L7N660_MYCTU,Rv3893c,PE36 Rv3893c,,IPR000084; ,,PE36,,PE family protein PE36,,9634230,,,MVWSVQPEAVLASAAAESAISAETEAAAAGAAPALLSTTPMGGDPDSAMFSAALNACGASYLGVVAEHASQRGLFAG,"7,424",77,,,,,,,1
I6YCP7,I6YCP7_MYCTU,Rv3662c,Rv3662c,,IPR003812; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTVDPLAPLMELPGVAAASDRVRDALSRVHRHRANLRGWPVAAAEASLRAARASSVLDGGPARLHDAGAPTSGKPALSDPVFAGALRVGQALEGGAGPVVGVWRRAPLQALARLHMLAAADQVDDDRLGRPRSDADVGPRLELLADVVTHPTLASAPVVAAVAHGELLTLRPFGCADGVVARAVSRLVTIATGLDPHGLGVPEVIWMRQPAEYHDAARRFAGGTPDGVAGWLLLCCGAMLDGAREALSIAESLSPG,"26,370",256,,,,,,,1
I6XHH2,I6XHH2_MYCTU,Rv3531c,Rv3531c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MYSDPLREAIAEAEQLVAAAPHIETEADLLEGLQYLAGCIAGCMHLAFDYERDHPFLQSGTGPFTKMGLDNPDTLYFGTRLQANRDYVVSGRRGTTTDLSFQLLGGEYTDYNVPASQAAFDDRELDIAADGSFEWRLRPSAPGQLVIREVYGDWSQQRGTLAIARLDTVGTAPPPLTRELMEKRYATAGSQLVNRVKTWLQFPQWFYLNIPVNTMVAPRLTPGGLATQYSSAGHFELRPGQALVITVPVSDAPYLGFQLGSMWYISLDYINHQTSLNASQAQADPDGKVRIVVAEQNPGVTNWVETLGHRRGFLQFRWQRVSRELTEADGPTVELVDFDAIPAALPHYQHNKISEDDWRARIALRQRQIATRMLG,"41,902",375,,,,,,,1
Q6MWW7,Q6MWW7_MYCTU,Rv3512,PE_PGRS56 Rv3512,GO:0005886,,,PE_PGRS56,,PE-PGRS family protein PE_PGRS56 (Fragment),plasma membrane [GO:0005886],9634230,,,PQGADGNAGNGGDGGVGGNGGNGADNTTTAAAGTTGGAGGAGGAGGTGGTGGAAGTGTGGQQGNGGNGGNGGTGGKGGTGGDGALAGSSGGAGGKGGNGGDAGKAGTGSAPGTAGTGGDGGKGGNGGIGAAGTTGPVGTGASGGTGGSGGAGGTGGDGGAANGGTAGAGGAGGNGGKGGDGGAGVTSSTAGNSGGAGGSGGKGGDAGAGGAGATPGANGIAGNGGDGGDGAAGAVGISGATGAGDGGHGGTGAAGGNGGTGGAGGSGIDGVGGGTGGTGGNGGNGAIGGAGGDAGGSGNSGGNGGIGGKGGNAGAGGAAGSNGGTVGANGTGGDGGNGGAAGAATAGSNGGAGTGSAGGNGGTGGRGGSGGAGGDGIGGVGGGKGGNGADGEVGGAGGAGGSGPNTSPGGNGGQGGQGGSGGAGGAAGAGGAGGGANGTAGNGGQGGAGGTGGAGAASSATNGGSGGAGGTGGDGGSGGAGGTGGAGGTGGAAGDGGQGGQGGAGGGAGGQGGAGGAGGTGGNGGNITGGTAGTAGAAGNGGAAGKGGAGGQGGTGGGTGGQGGAGGDGGAGGTGGDRTVGGGTVPAGSGGQGGNAGGGGAGGQGGADGGSGGDGGDAGTGGNGGNGGNRNSGNGTGGAGGNGGGGANGGAGGAGGSGGGTGGNGGAGGDAGDAGNGGNGNGTGNGGNGGNGGIAGMGGNGGAGTGSGNGGNGGSGGNGGNAGMGGNSGTGSGDGGAGGNGGAAGTGGTGGDGGLTGTGGTGGSGGTGGDGGNGGNGADNTANMTAQAGGDGGNGGDGGFGGGAGAGGGGLTAGANGTGGQGGAGGDGGNGAIGGHGPLTDDPGGNGGTGGNGGTGGTGGAGIGSLGGGTGGDGGNGGNGGTGGEGGEVGGAGGTGGAAGNGGDGGTGGTGGGDGGAGGTGGTGGTGGLGDPRVGGSGGDGGTGGSGGAAGNGGNGGNAGAGGNGNGGTGGAGGIGGTGGNGGDAEPGVPPGAGGAGGAGTTGGKGGTGGNGSGTGSGGTGGDGGTGGGGGNGGTGWNGGKGDTGSGGGAGDGGKAPAGGTGGAGGDGGAGGKGGSGGV,"81,162",1079,,,,plasma membrane [GO:0005886],,,1
O53567,O53567_MYCTU,Rv3522,ltp4 Rv3522,GO:0003824; GO:0008152,IPR016039; ,,ltp4,,Possible lipid transfer protein or keto acyl-CoA thiolase Ltp4,catalytic activity [GO:0003824]; metabolic process [GO:0008152],9634230; 21969609,,,MSVRDIAVVGFAHAPHVRRTDGTTNGVEMLMPCFAQLYDELGITKADIGFWCSGSSDYLAGRAFSFISAIDSIGAVPPINESHVEMDAAWALYEAYIKLLTGEVDTALVYGFGKSSAGTLRRVLSRQTDPYTVAPLWPDSVSMAGLQARLGLDSGKWTHEQMARVAFDSFTNARRVDSVEPPITVGELLARPFFADPLRRHDIAPITDGAAAVVLAADNRARELRENPAWITGIEHRIESPALGARDITESPSTKLAAKIATGGHTGDIDVAEIHGPFTHQHLIVAEAIRIPGKTKVNPSGGPLAANPMFAAGLERIGFAAQHTWDGSARRVLAHATSGPALQQNLVAVMEGRG,"37,865",354,,metabolic process [GO:0008152],catalytic activity [GO:0003824],,,,1
I6YHB0,I6YHB0_MYCTU,Rv3852,hns Rv3852,GO:0016021,,,hns,,Possible histone-like protein Hns,integral component of membrane [GO:0016021],9634230; 21969609,,,MPDPQDRPDSEPSDASTPPAKKLPAKKAAKKAPARKTPAKKAPAKKTPAKGAKSAPPKPAEAPVSLQQRIETNGQLAAAAKDAAAQAKSTVEGANDALARNASVPAPSHSPVPLIVAVTLSLLALLLIRQLRRR,"13,823",134,,,,integral component of membrane [GO:0016021],,,2
P96248,P96248_MYCTU,Rv3830c,Rv3830c,GO:0000976; GO:0003700; GO:0005829,IPR023772; IPR009057; IPR001647; ,,,DOMAIN 11 71 HTH tetR-type. {ECO:0000259|PROSITE:PS50977}.,Transcriptional regulatory protein (Probably TetR-family),cytosol [GO:0005829]; DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],9634230; 21969609,,,MVRPPQTARSERTREALRQAALVRFLAQGVEATSAEQIAEDAGVSLRTFYRHFRSKHDLLFADYDAGLHWFRAALDARPADESIIDSVQAAIFSFPYDVDAVTKIASLRRGELEPSRIVRHMREVEADFADAIQAQLRRRNCDIAGAPDARLHIAVTARCVAAAVFGAMEAWMLGSDRSLGELARVCHVALESLRVGISDTWTTLTVSS,"23,124",209,,,DNA binding transcription factor activity [GO:0003700]; transcription regulatory region sequence-specific DNA binding [GO:0000976],cytosol [GO:0005829],,,1
P72036,P72036_MYCTU,Rv3769,Rv3769,,,,,,Uncharacterized protein,,9634230,,,MTTLKELGARVAALEANQADYRAVLAAVNPPGANQREIATTVREHTGRLDRVTTKVGQLAAKSDDTNARVRSLEEGQAEIKDLLLRALDK,"9,753",90,,,,,,,2
I6X831,I6X831_MYCTU,Rv3688c,Rv3688c,GO:0016884,IPR003789; IPR023168; IPR019004; ,,,,Conserved protein,"carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO:0016884]",9634230; 21969609,,,MAELKSQLRSDLTQAMKTQDKLRTATIRMLLAAIQTEEVSGKQARELSDDEVIKVLARESRKRGEAAEIYTQNGRGELAATEHAEARIIDEYLPTPLTEGELADVADTAIAEVAEELGHRPSMKQMGLVMKAATVIAAGKADGARLSAAVKERL,"16,701",154,,,"carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO:0016884]",,,,1
I6X7P2,I6X7P2_MYCTU,Rv3572,Rv3572,,,,,,Uncharacterized protein,,9634230; 21969609,,,MTRLIPGCTLVGLMLTLLPAPTSAAGSNTATTLFPVDEVTQLETHTFLDCHPNGSCDFVAGANLRTPDGPTGFPPGLWARQTTEIRSTNRLAYLDAHATSQFERVMKAGGSDVITTVYFGEGPPDKYQTTGVIDSTNWSTGQPMTDVNVIVCTHMQVVYPGVNLTSPSTCAQANFS,"18,742",176,,,,,,,1
I6XI06,I6XI06_MYCTU,Rv3705c,Rv3705c,,IPR026954; IPR038232; ,,,,Conserved protein,,9634230; 21969609,,,MRIAAAVVSIGLAVIAGFAVPVADAHPSEPGVVSYAVLGKGSVGNIVGAPMGWEAVFTRPFQAFWVELPACNNWVDIGLPEVYDDPDLASFNGATTQTSATDQTHLVKQAVGVFASNDAADRAFHRVVDRTVGCSGQTTAIHLDDGTTQVWSFAGGPSTGTDEAWTKQEAGTDRRCFVQTRLRENVLLQAKVCQSGNAGPAVNVLAGAMQNTLG,"22,359",214,,,,,,,1
O07809,O07809_MYCTU,Rv3814c,Rv3814c,GO:0005886; GO:0008152; GO:0016411; GO:0042171,IPR002123; ,,,,Possible acyltransferase,plasma membrane [GO:0005886]; acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; metabolic process [GO:0008152],9634230; 21969609,,,MAEPFFRMMEILVPSIVAANGNKITFEGLENIPERGGALIALNHTSYVDWVPASIAAHHRRRRLRFMIKAEMQDVRAVNYVIKHAQLIPVDRSVGADAYAVAVQRLRAGELVGLHPEATISRSLELREFKTGAARMALEAQVPIIPMIVWGAHRIWPKDHPKNLFRNKIPIVAAIGSPVRPEGNAEQLNAVLRQAMNAILYRVQEEYPHPKGEHWVPRRLGGGAPTVEESRQLRIAELAKRRQKRGYDGVTSSRRSQVGPH,"29,291",261,,metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],plasma membrane [GO:0005886],,,1
P72050,P72050_MYCTU,Rv3784,Rv3784,GO:0003824; GO:0050662,IPR001509; IPR036291; ,,,,"Possible dTDP-glucose 4,6-dehydratase",catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],9634230; 21969609,,,MEILVTGGAGFQGSHLTESLLANGHWVTVLDKSSRNAVRNMQGFRSHDRAAFISGSVTDGQTIDRAVRDHHVVFHLAAHVNVDQSLGDPESFLETNVMGTYRVLEAVRRYRNRLIYVSTCEVYGDGHNLKEGERLDEHAELKPNSPYGASKAAADRLCYSYFRSYGLDVTIVRPFNIFGVRQKAGRFGALIPRLVRQGINGEGLTIFGAGSATRDYLYVSDIVGAYNLVLRTPTLRGQAINFASGKDTRVRDIVEYVADKFGARIEHRDARPGEVQRFPADISLAKSIGFQPQVEIWDGIDRYINWAKDQPQYPYEQDGFSGSSVL,"36,306",326,,,catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],,,,1
O06371,O06371_MYCTU,Rv3636,Rv3636,,IPR036388,,,,Possible transposase,,9634230,,,MLSVEDWAEIRRLRRSERLPISEIARVLKISRNTVKSALASDGPPKYQRAAKGSVADEAEPRIRELLAAYPRMPATVIAERIGWWYSIRTLSGRVRELRPLYLPPDPASRDICGR,"13,111",115,,,,,,,1
O69624,O69624_MYCTU,Rv3656c,Rv3656c,GO:0016021,IPR025338; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MLVITMFRVLVARMTALAVDESGMSTVEYAIGTIAAAAFGAILYTVVTGDSIVSALNRIIGRALSTKV,"7,092",68,,,,integral component of membrane [GO:0016021],,,1
O07808,O07808_MYCTU,Rv3815c,Rv3815c,GO:0005886; GO:0008152; GO:0016411; GO:0042171,IPR002123; ,,,,Possible acyltransferase,plasma membrane [GO:0005886]; acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; metabolic process [GO:0008152],9634230; 21969609,,,MAEPTYRVLEILAQLLVLATGTRITYVGEENVPDQGGAVVAINHTSYVDWLPAALAMHRRRRRMRFMIKAEMQRVRLVNFLIRHTRTIPVDRGAGGSAYAVAVQRLREGELVGVYPEATISRSFELKGFKTGAARMAAEADVPIVPVVVWGAQRIWTKDHPRQIGRAKVPVTVQVGRPLRAAAGIEQTNAALRESMTALLWQAQERYPHPAGAYWVPRRLGGGAPTLAEAARMEADEAAARAASRTPHESR,"27,673",251,,metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],plasma membrane [GO:0005886],,,1
P72037,P72037_MYCTU,Rv3770c,Rv3770c,GO:0016021,,,,,Hypothetical leucine rich protein,integral component of membrane [GO:0016021],9634230,,,MLSGIQQNTLMDNDPLAHGYYVADLLVALAVVVLMLRARRTRPELARMLLLGTLIGLVWELPVFGLSAWTNTPIIEWATPLPLPTVVFLLAHSVWDGPLLTMGWLLARALTGEPAGALGLTVQVLWGQLTALAVELSAILAGTWSYVDDLWFNPVMFWFRGHPVTAAMQLTWLLAPLCFAALVRRLALTAR,"21,023",191,,,,integral component of membrane [GO:0016021],,,1
O69654,O69654_MYCTU,Rv3686c,Rv3686c,,,,,,Uncharacterized protein,,9634230,,,MVYTGSDAGDHASAPQPSGSGSVPASVNVPGLVVAAVWAVGLVAGLVALTIGHLAVAAAALVVAVMAPWCRVAYIAHGQHRVCGETLRGTPAGETASFPTGWRGLRFSTR,"11,033",110,,,,,,,3
O69714,O69714_MYCTU,Rv3747,Rv3747,,,,,,Conserved protein,,9634230; 21969609,,,MILTGAFLADAAAAVDNKLNVQGGVLSRFAVGPDRLARFVLVVLTQAEPDSSDRDITVEMRPPTDDEPIRLNFEAPEAAVAEFPGFAFFEIQLRLPVNGRWVLVVTGGTGAISLPVLVSDMPATIGF,"13,540",127,,,,,,,1
I6XHX8,I6XHX8_MYCTU,Rv3672c,Rv3672c,GO:0000287; GO:0009132; GO:0016818; GO:0030145,IPR015797; IPR000086; IPR000059; ,,,,Uncharacterized protein,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; nucleoside diphosphate metabolic process [GO:0009132]",9634230; 21969609,,,MSAGGTPLQAGATPTGSRGTVALRPDAGPSWLRPLVDNVGQIPDAYRRRLPADVLAMVTAAGAVSAMTSSRRDHREAAVLVLFSGPEAGPGDGGVPDDADLLLTVRASTLRHHAGQAAFPGGVVDPADDGPVATALREANEETGIDPSRLHPLATMERTFIAPSRFHVVPVLAYSPDPGPVAVVNEAETAIVARVPVRAFINPANRLMVYRRPHTRRWAGPAFLLNQMLVWGFTGQVISAVLDVAGWAQPWDTGDIRELDAAMVLIDDESDPR,"28,891",273,,nucleoside diphosphate metabolic process [GO:0009132],"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO:0016818]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]",,,,1
O69703,O69703_MYCTU,Rv3736,Rv3736,GO:0003700; GO:0005576; GO:0006351; GO:0019172; GO:0019243; GO:0043565,IPR032687; IPR009057; IPR018060; ,,,DOMAIN 230 328 HTH araC/xylS-type. {ECO:0000259|PROSITE:PS01124}.,Transcriptional regulatory protein (Probably AraC/XylS-family),"extracellular region [GO:0005576]; DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSVVRGTALANYPSLVAGLGGDPATLLRAAGVRDQDVGNYDAFISIRAAIRAIESAAAVTATMDFGRRLAQRQGIEILGPVGVAARTAATVGDALAIFNTFMAAYSPVIAIRITPLAGQRSFIALEFLLDEPASYPQTMELALGVALGVIRLLLGADYAPLAVHLPHDPLTPEAFYLQYFGCRPYFAERVGGFTMRTADLSRPLNRDDVAHRVVVDYLSSITPLGEGIVESVRTIVRQLLPTGAATLNVVAEQFHLHPKTLQRRLAEENTTFVILVDRVRKDVADRYLRTTGIGLTHLARELGYAEQSVLTRSCKRWFGTGPAAYRNQARLQTTVSAPGSGRGPNPGNVSVSC,"37,974",353,,"methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565],extracellular region [GO:0005576],,,1
I6Y482,I6Y482_MYCTU,Rv3663c,dppD Rv3663c,GO:0005524; GO:0015833; GO:0016887,IPR003593; IPR003439; IPR017871; IPR013563; IPR027417; ,,dppD,,Probable dipeptide-transport ATP-binding protein ABC transporter DppD,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptide transport [GO:0015833],9634230; 21969609,,,MSVPAAPLLSVEGLEVTFGTDAPAVCGVDLAVRSGQTVAVVGESGSGKSTTAAAILGLLPAGGRITAGRVVFDGRDITGADAKRLRSIRGREIGYVPQDPMTNLNPVWKVGFQVTEALRANTDGRAARRRAVELLAEAGLPDPAKQAGRYPHQLSGGMCQRALIAIGLAGRPRLLIADEPTSALDVTVQRQVLDHLQGLTDELGTALLLITHDLALAAQRAEAVVVVRRGVVVESGAAQSILQSPQHEYTRRLVAAAPSLTARSRRPPESRSRATTQAGDILVVSELTKIYRESRGAPWRRVESRAVDGVSFRLPRASTLAIVGESGSGKSTLARMVLGLLQPTSGTVVFDGTYDVGALARDQVLAFRRRVQPVFQNPYSSLDPMYSVFRAIEEPLRVHHVGDRRQRQRAVRELVDQVALPSSILGRRPRELSGGQRQRVAIARALALRPEVLVCDEAVSALDVLVQAQILDLLADLQADLGLTYLFISHDLAVIRQIADDVLVMRAGRVVEHASTEEVFSRPRHEYTRQLLQAIPGAPSAPRKVGNL,"58,944",548,ABC transporter superfamily,peptide transport [GO:0015833],ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
O69718,O69718_MYCTU,Rv3751,Rv3751,GO:0003677; GO:0006310; GO:0015074,IPR011010; IPR013762; IPR002104; ,,,,Probable integrase,DNA binding [GO:0003677]; DNA integration [GO:0015074]; DNA recombination [GO:0006310],9634230,,,MKRAKVQQITPHDLRHTAASLAVSAGVNVLALQRILGHKSAKVTLDTYADLFDADLDAVAVTLGKDADQQT,"7,584",71,,DNA integration [GO:0015074]; DNA recombination [GO:0006310],DNA binding [GO:0003677],,,,1
P96837,P96837_MYCTU,Rv3555c,Rv3555c,GO:0005829,IPR007569; IPR011335; ,,,,Conserved protein,cytosol [GO:0005829],9634230,,,MDELPWPVLGSEVLAAKAIPERAMRQLYEPVYPGVYAPAGVELTARQRAHAAWLWSRRRAVVAGNSAAALLGAKWVNPALDAELVHANRKPPPRIVVHTDRLAPHETVAVDGVAVTTPARTAFDIGRRTPSRLQAVQRLDALANSTDVKVADVQAVIAEHTGARGLVRLRAVLPLIDGGAESPQETWTRLVLIDAGLPKPQTQIRVFDDYGDFVARIDLGYEQLRVGVEYDGPQHWTDPAQRARDIERSTALLDLGWTIIRVTSELLWYRRGTFVGRVDAAMRAAGWRP,"31,855",289,,,,cytosol [GO:0005829],,,1
O69663,O69663_MYCTU,Rv3695,Rv3695,GO:0016021,IPR010432; ,,,DOMAIN 18 137 RDD. {ECO:0000259|Pfam:PF06271}.,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MSEVVTGDAVVLDVQIAQLPVRAVSAVIDITIIFIGYILGLMLWATALTQFDEALTTAFLIIFTVLALVGYPLVWETATRGRSVGKIVMGLRVVSDDGGPERFRQALFRALASVVEIWMLLGSPAVICSMLSPKAKRVGDVFAGTVVVSERGPRLGPPPVMPPSLAWWASSLQLSGLTAGQAEVARQFLVRAPQLDPALREQMAYRIAGDVVARIAPPPPPGVPPQLVLAAVLAERHRRELLRLRPTLPPAGQAPWAQMAPHRGWPPGLSGATPWSPQQPVIPWPEPDPPPQAAPWPQQAPDGPGFSPPG,"33,168",310,,,,integral component of membrane [GO:0016021],,,1
O53578,O53578_MYCTU,Rv3799c,accD4 Rv3799c,GO:0003989; GO:0004658; GO:0005618; GO:0005886; GO:0009062; GO:0009317; GO:0015977; GO:0016421; GO:0040007; GO:0071769,IPR034733; IPR029045; IPR011763; IPR011762; ,,accD4,,Probable propionyl-CoA carboxylase beta chain 4 AccD4 (Pccase) (Propanoyl-CoA:carbon dioxide ligase),acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886]; acetyl-CoA carboxylase activity [GO:0003989]; CoA carboxylase activity [GO:0016421]; propionyl-CoA carboxylase activity [GO:0004658]; carbon fixation [GO:0015977]; fatty acid catabolic process [GO:0009062]; growth [GO:0040007]; mycolate cell wall layer assembly [GO:0071769],9634230; 21969609,,,MTVTEPVLHTTAEKLAELRERLELAKEPGGEKAAAKRDKKGIPSARARIYELVDPGSFMEIGALCRTPGDPNALYGDGVVTGHGLINGRPVGVFSHDQTVFGGTVGEMFGRKVARLMEWCAMVGCPIVGINDSGGARIQDAVTSLAWYAELGRRHELLSGLVPQISIILGKCAGGAVYSPIQTDLVVAVRDQGYMFVTGPDVIKDVTGEDVSLDELGGADHQASYGNIHQVVESEAAAYQYVRDFLSFLPSNCFDKPPVVNPGLEPEITGHDLELDSIVPDSDNMAYDMHEVLLRIFDDGDFLDVAAQAGQAIITGYARVDGRTVGVVANQPMHMSGAIDNEASDKAARFIRFSDAFDIPLVFVVDTPGFLPGVEQEKNGIIKRGGRFLYAVVEADVPKVTITIRKSYGGAYAVMGSKQLTADLNFAWPTARIAVIGADGAAQLLMKRFPDPNAPEAQAIRKSFVENYNLNMAIPWIAAERGFIDAVIDPHETRLLLRKSMHLLRDKQLWWRVGRKHGLIPV,"56,680",522,,carbon fixation [GO:0015977]; fatty acid catabolic process [GO:0009062]; growth [GO:0040007]; mycolate cell wall layer assembly [GO:0071769],acetyl-CoA carboxylase activity [GO:0003989]; CoA carboxylase activity [GO:0016421]; propionyl-CoA carboxylase activity [GO:0004658],acetyl-CoA carboxylase complex [GO:0009317]; cell wall [GO:0005618]; plasma membrane [GO:0005886],,,2
O69652,O69652_MYCTU,Rv3684,Rv3684,GO:0005737; GO:0005829; GO:0005886; GO:0016829; GO:0030170,IPR001926; IPR036052; ,,,DOMAIN 25 305 PALP. {ECO:0000259|Pfam:PF00291}.,Probable lyase,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170],9634230; 21969609,,,MIEADARRSADTHLLRYPLPAAWCTDVDVELYLKDETTHITGSLKHRLARSLFLYALCNGWINENTTVVEASSGSTAVSEAYFAALLGLPFIAVMPAATSASKIALIESQGGRCHFVQNSSQVYAEAERVAKETGGHYLDQFTNAERATDWRGNNNIAESIYVQMREEKHPTPEWIVVGAGTGGTSATIGRYIRYRRHATRLCVVDPENSAFFPAYSEGRYDIVMPTSSRIEGIGRPRVEPSFLPGVVDRMVAVPDAASIAAARHVSAVLGRRVGPSTGTNLWGAFGLLAEMVKQGRSGSVVTLLADSGDRYADTYFSDEWVSAQGLDPAGPAAALVEFERSCRWT,"37,641",346,,,lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,,3
O07795,O07795_MYCTU,Rv3828c,Rv3828c,GO:0000150; GO:0003677,IPR006118; IPR006119; IPR036162; ,,,DOMAIN 61 200 Resolvase/invertase-type recombinase catalytic. {ECO:0000259|PROSITE:PS51736}.,Possible resolvase,DNA binding [GO:0003677]; recombinase activity [GO:0000150],9634230,,,MSVVCCRNRWMNLAVWAERNGVAWVIAYRWFRAGLLPVPAQRVGRLILVNDPAVEESGRGRTLVYARVSSADQRSDLDRRVARVTAWATSQHLSVDKVVAEGGWALNGHRRKFFALLGDPVVTRIVVEHRDRFCWFGSEYVEAALVAQGRELVVVDLAEVDDDLVGDMTEILTSMCARLYGERAAQNGAKRALAAAVGDAEAA,"22,439",203,,,DNA binding [GO:0003677]; recombinase activity [GO:0000150],,,,1
O06270,O06270_MYCTU,Rv3613c,Rv3613c,,,,,,Uncharacterized protein,,9634230,,,MCTMPKLWRAFMAGRPLGSTFTPRQPTGAAPNHVRALDDSIDPSSAPAARAAL,"5,608",53,,,,,,,1
O06359,O06359_MYCTU,Rv3649,Rv3649,GO:0003676; GO:0004004; GO:0005524; GO:0005737; GO:0005886; GO:0010501,IPR018973; IPR011545; IPR014001; IPR001650; IPR022307; IPR027417; ,,,,Probable helicase,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676]; RNA secondary structure unwinding [GO:0010501],9634230; 21969609,,,MASFGSHLLAAAVAGTPPGERPLRHVAELPPQAGRPRGWPEWAEPDVVDAFADRGISSPWSHQAEAAELAYAGRHVVIGTGPASGKSLAYQLLVLNALATDSRARALYLSPTKALGHDQLRAAHALAAAVPRLADVAPTAYDGDSPDEVRRFARERSRWLFSNPEMTHLSVLRNHARWAVLLRNLRFVIVDECHYYRGVFGSNVAMVLRRLLRLCARYSAHPTVIFASATTASPGATAADLIGQPVVEVTEDGSPRGARTVALWEPALRSDVIGEHGAPVRRSAGAEAARVMADLIVEGAQTLTFVRSRRAAELTALGARARLVDIAPELSDTVASYRAGYLAEDRSALHQALAEGQLRGLATTNALELGVDIAGLDAVVLAGFPGTVASFWQQAGRSGRRGQGALVVLIARDDPLDTYLVHHPAALLDKPVERVVIDPVNPHLLGPQLLCAATELPLDDAEVRSWGAVEVAESLVDDGLLRRRNGRYFPAPGVKPHAAVDVRGAIGGQIVIVEAGTGRLLGSVGVGQAPAAAHPGAVYLHQGETYVVDSLDFQDGIAFVHAEDPGYATFAREVTDIAVTGTGERLVFGPVALGLVPVTVTNHVVGYLRRQLSGEVLDFVELDMPEHTLPTTAVMYTITSDALVRSGIEATRIPGSLHAAEHAAIGLLPLVASCDRGDIGGMSTATGPEGLPSVFVYDGYPGGAGFAERGFRRARTWLGATAEAIEACECPSGCPSCVQSPKCGNGNDPLDKAGAVRVLRLVLAELSEESP,"81,410",771,,RNA secondary structure unwinding [GO:0010501],ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; nucleic acid binding [GO:0003676],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,,1
I6YCN3,I6YCN3_MYCTU,Rv3641c,fic Rv3641c,GO:0051302,IPR003812; IPR036597; ,,fic,,Possible cell filamentation protein Fic,regulation of cell division [GO:0051302],9634230,,,MPHPWDTGDHERNWQGYFIPAMSVLRNRVGARTHAELRDAENDLVEARVIELREDPNLLGDRTDLAYLRAIHRQLFQDIYVWAGDLRTVGIEKEDESFCAPGGISRPMEHVAAEIYQLDRLRAVGEGDLAGQVAYRYDYVNYAHPFREGNGRSTREFFDLLLSERGSGLDWGKTDLEELHGACHVARANSDLTGLVAMFKGILDAEPTYDF,"23,981",211,,regulation of cell division [GO:0051302],,,,,1
P96247,P96247_MYCTU,Rv3831,Rv3831,GO:0016021,IPR021362; ,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MVSLLVHAALGVVVIGWIVSSNPKVFTRPAGGSWFSLPECVYYVVGIASIALGWYFNIRFVQQYAHGAANPLWGPGSWAEYVRLMFTNPAASSAGQDYTIANVILLPLFSTTDGYRRGLRRPWLYFVSSLFTSFAFAFAFYFATIERQHRHERSRATVGA,"17,868",160,,,,integral component of membrane [GO:0016021],,,1
I6YGX2,I6YGX2_MYCTU,Rv3682,ponA2 Rv3682,GO:0008658,IPR012338; IPR001264; IPR023346; IPR005543; IPR036950; IPR001460; ,,ponA2,,Uncharacterized protein,penicillin binding [GO:0008658],9634230; 21969609; 24281824,NMR spectroscopy (1),,MPERLPAAITVLKLAGCCLLASVVATALTFPFAGGLGLMSNRASEVVANGSAQLLEGQVPAVSTMVDAKGNTIAWLYSQRRFEVPSDKIANTMKLAIVSIEDKRFADHSGVDWKGTLTGLAGYASGDLDTRGGSTLEQQYVKNYQLLVTAQTDAEKRAAVETTPARKLREIRMALTLDKTFTKSEILTRYLNLVSFGNNSFGVQDAAQTYFGINASDLNWQQAALLAGMVQSTSTLNPYTNPDGALARRNVVLDTMIENLPGEAEALRAAKAEPLGVLPQPNELPRGCIAAGDRAFFCDYVQEYLSRAGISKEQVATGGYLIRTTLDPEVQAPVKAAIDKYASPNLAGISSVMSVIKPGKDAHKVLAMASNRKYGLDLEAGETMRPQPFSLVGDGAGSIFKIFTTAAALDMGMGINAQLDVPPRFQAKGLGSGGAKGCPKETWCVVNAGNYRGSMNVTDALATSPNTAFAKLISQVGVGRAVDMAIKLGLRSYANPGTARDYNPDSNESLADFVKRQNLGSFTLGPIELNALELSNVAATLASGGVWCPPNPIDQLIDRNGNEVAVTTETCDQVVPAGLANTLANAMSKDAVGSGTAAGSAGAAGWDLPMSGKTGTTEAHRSAGFVGFTNRYAAANYIYDDSSSPTDLCSGPLRHCGSGDLYGGNEPSRTWFAAMKPIANNFGEVQLPPTDPRYVDGAPGSRVPSVAGLDVDAARQRLKDAGFQVADQTNSVNSSAKYGEVVGTSPSGQTIPGSIVTIQISNGIPPAPPPPPLPEDGGPPPPVGSQVVEIPGLPPITIPLLAPPPPAPPP,"84,636",810,,,penicillin binding [GO:0008658],,,,1
P72049,P72049_MYCTU,Rv3783,rfbD Rv3783,GO:0015920; GO:0016021,IPR013525; ,,rfbD,,Probable O-antigen/lipopolysaccharide transport integral membrane protein ABC transporter RfbD,integral component of membrane [GO:0016021]; lipopolysaccharide transport [GO:0015920],9634230; 21969609,,,MTFMDAQASFQTQSRTLARVRGDLVDGFRRHELWLHLGWQDIKQRYRRSVLGPFWITIATGTTAVAMGGLYSKLFRLELSEHLPYVTLGLIVWNLINAAILDGAEVFVANEGLIKQLPAPLSVHVYRLVWRQMIFFAHNIVIYFVIAIIFPKPWSWADLSFLPALALIFLNCVWVSLCFGILATRYRDIGPLLFSVVQLLFFMTPIIWNDETLRRQGAGRWSSIVELNPLLHYLDIVRAPLLGAHQELRHWLVVLVLTVVGWMLAAFAMRQYRARVPYWV,"32,336",280,,lipopolysaccharide transport [GO:0015920],,integral component of membrane [GO:0016021],,,1
O69709,O69709_MYCTU,Rv3742c,Rv3742c,GO:0016021,IPR036188; ,,,,Possible oxidoreductase,integral component of membrane [GO:0016021],9634230,,,MHSEQSASIEHVDVLIVGAGISGTGAAYYLKTMQPAKTFAIVEARYPAIRSDSDLHTFSYEFKPWQHEKATASADAIMVHRGRSLAGGDRTLRHRRTRHHELRMVIIGSGATAVTLVPAMAQTAGAVTMPK,"14,227",131,,,,integral component of membrane [GO:0016021],,,1
L0TEV4,L0TEV4_MYCTU,Rv3664c,dppC Rv3664c,GO:0005886; GO:0016021; GO:0055085,IPR000515; IPR035906; ,,dppC,DOMAIN 60 250 ABC transmembrane type-1. {ECO:0000259|PROSITE:PS50928}.,Probable dipeptide-transport integral membrane protein ABC transporter DppC,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230,,,MIAAALILLILVVAAFPSLFTAADPTYADPSQSMLAPSAAHWFGTDLQGHDIYSRTVYGARASVTVGLGATLAVFVVGGALGALAGFYGSWIDAVVSRVTDVFLGLPLLLAAIVLMQVMHHRTVWTVIAILALFGWPQVARIARGAVLEVRASDYVLAAKALGLNRFQILLRHALPNAVGPVIAVATVALGIFIVTEATLSYLGVGLPTSVVSWGGDINVAQTRLRSGSPILFYPAGALAITVLAFMMMGDALRDALDPASRAWRA,"27,879",266,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
O69708,O69708_MYCTU,Rv3741c,Rv3741c,GO:0005618; GO:0005886,IPR036188; ,,,,Possible oxidoreductase,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230,,,MIGRDRAYAVTRRKDIAKQRLVWRLCQRYPRAARRLIRHLNAKQLAAGYPADEHFKPVYNPWDQRLCAVPDADMFKAIRDGRASVVTEAIDTFTENGIRLQSGRELAADISITATGLNLLAFGGINLSVDGVAVDVAEKVAFKGFLLSDVSNFAGPHGRTRAHHLLSAAARSHADPAAAGRRSPLADLKVLREGPVDDDHLRFTTSASASRLTVKRITRSTPWN,"24,676",224,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
O69702,O69702_MYCTU,Rv3735,Rv3735,,IPR007153; IPR036902; ,,,,Uncharacterized protein,,9634230,,,MSLAWDVVSVDKPDDVNVVIGQAHFIKAVEDLHEAMVGVSPSLRFGLAFCEASGPRLVRHTGNDGDLVELATRTALAIAAGHSFVIFLREGFPINILNPVQAVPEVCTIYCATANPVDVVVAVTPHGRGIVGVVDGQTPLGVETDRDIAQRRDLLRAIGYKL,"17,293",162,,,,,,,3
O69704,O69704_MYCTU,Rv3737,Rv3737,GO:0005737; GO:0005829; GO:0016021,IPR010619; IPR024528; ,,,,Probable conserved transmembrane protein,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021],9634230,,,MDQDRSDNTALRRGLRIALRGRRDPLPVAGRRSRTSGGIDDLHTRKVLDLTIRLAEVMLSSGSGTADVVATAQDVAQAYQLTDCVVDITVTTIIVSALATTDTPPVTIMRSVRTRSTDYSRLAELDRLVQRITSGGVAVDQAHEAMDELTERPHPYPRWLATAGAAGFALGVAMLLGGTWLTCVLAAVTSGVIDRLGRLLNRIGTPLFFQRVFGAGIATLVAVAAYLIAGQDPTALVATGIVVLLSGMTLVGSMQDAVTGYMLTALARLGDALFLTAGIVVGILISLRGVTNAGIQIELHVDATTTLATPGMPLPILVAVSGAALSGVCLTIASYAPLRSVATAGLSAGLAELVLIGLGAAGFGRVVATWTAAIGVGFLATLISIRRQAPALVTATAGIMPMLPGLAVFRAVFAFAVNDTPDGGLTQLLEAAATALALGSGVVLGEFLASPLRYGAGRIGDLFRIEGPPGLRRAVGRVVRLQPAKSQQPTGTGGQRWRSVALEPTTADDVDAGYRGDWPATCTSATEVR,"54,775",529,,,,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
I6YCB9,I6YCB9_MYCTU,Rv3525c,Rv3525c,,IPR001451; IPR011004; ,,,,Possible siderophore-binding protein,,9634230; 21969609,,,MPLFSFEGRSPRIDPTAFVAPTATLIGDVTIEAGASVWFNAVLRGDYAPVVVREGANVQDGAVLHAPPGIPVDIGPGATVAHLCVIHGVHVGSEALIANHATVLDGAVIGARCMIAAGALVVAGTQIPAGMLVTGAPAKVKGPIEGTGAEMWVNVNPQAYRDLAARHLAGLEPM,"17,665",174,,,,,,,1
O53561,O53561_MYCTU,Rv3516,echA19 Rv3516,GO:0004300; GO:0006635; GO:0052572,IPR029045; IPR001753; IPR014748; ,,echA19,,Possible enoyl-CoA hydratase EchA19 (Enoyl hydrase) (Unsaturated acyl-CoA hydratase) (Crotonase),enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; response to host immune response [GO:0052572],9634230; 21969609,,,MESGPDALVERRGHTLIVTMNRPAARNALSTEMMRIMVQAWDRVDNDPDIRCCILTGAGGYFCAGMDLKAATQKPPGDSFKDGSYGPSRIDALLKGRRLTKPLIAAVEGPAIAGGTEILQGTDIRVAGESAKFGISEAKWSLYPMGGSAVRLVRQIPYTLACDLLLTGRHITAAEAKEMGLIGHVVPDGQALTKALELADAISANGPLAVQAILRSIRETECMPENEAFKIDTQIGIKVFLSDDAKEGPRAFAEKRAPNFQNR,"28,249",263,,fatty acid beta-oxidation [GO:0006635]; response to host immune response [GO:0052572],enoyl-CoA hydratase activity [GO:0004300],,,,1
I6YGX9,I6YGX9_MYCTU,Rv3692,moxR2 Rv3692,GO:0005524; GO:0005618; GO:0016887,IPR011703; IPR027417; ,,moxR2,DOMAIN 82 212 AAA_3. {ECO:0000259|Pfam:PF07726}.,Probable methanol dehydrogenase transcriptional regulatory protein MoxR2,cell wall [GO:0005618]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MTQSASNPQAPPTQTPGAELPGYPPQAGGAPTAAPSGPHPHRAEAESARDALLALRAEVAKAVVGQDGVISGLVIALLCRGHVLLEGVPGVAKTLIVRAMSAALQLEFKRVQFTPDLMPGDVTGSLVYDARTAEFVFRPGPVFTNLLLADEINRTPPKTQAALLEAMEERQVSVEGEPKPLPNPFIVAATQNPIEYEGTYQLPEAQLDRFLLKLNVTLPARDSEIAILDRHAHGFDPRDLSAINPVAGPAELAAGREAVRHVLVANEVLGYIVDIVGATRSSPALQLGVSPRGATALLGTARSWAWLSGRDYVTPDDVKAMARPTLRHRVMLRPEAELEGATPDGVLDGILASVPVPR,"37,936",358,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],cell wall [GO:0005618],,,1
O69625,O69625_MYCTU,Rv3657c,Rv3657c,GO:0016021,IPR018076; ,,,DOMAIN 46 172 T2SSF. {ECO:0000259|Pfam:PF00482}.,Possible conserved alanine rich membrane protein,integral component of membrane [GO:0016021],9634230,,,MALWLGAGPSVVRARAGRPPRAHRPHQGLLLGRTDVADPLAVAASLDVLAVCLAAGMAVSTAAAATAAVAPPRLARVLRRAADLLALGADPNIAWSRPPDLPPGTHDAQTDAVLRLARRSAASGAALADGIVELAVQVRHDAAQAAAAAAERAGVLIAGPLGLCFLPAFLCVGIVPLVVGLAGDVLQFGLV,"19,129",191,,,,integral component of membrane [GO:0016021],,,1
O69696,O69696_MYCTU,Rv3729,Rv3729,GO:0016740; GO:0051536,IPR013785; IPR034474; IPR007197; IPR029063; IPR034395; ,,,DOMAIN 98 258 Radical_SAM. {ECO:0000259|Pfam:PF04055}.,Possible transferase,iron-sulfur cluster binding [GO:0051536]; transferase activity [GO:0016740],9634230; 21969609,,,MFVEYTKSICPVCKVVVDAQVNIRHDKVYLRKRCREHGSFEALVYGDAQMYLESARFNKPGTFPLRFQTEVRDGCPSDCGLCPDHKQHACLGLIEVNTHCNLDCPICFADSGHQPDGYAITAAQCERMLDTLVAAEGEPEVVMFSGGEPTIHKQLLEFVDAAQARPVKTVIINTNGIRLASDRRFVDQLATRNRPGHPVHIYLQFDGLDEATHRRIRGHDLRDVKQRALDNCAAAGLTVSLVAAVERGLNEHELGAVIRHGMAQPGVQPVVFQPVTHAGRHVQFDPLTRLTNSDIIACITAQLPEWFRPGDFFPVPCCFPSCRSITYLLTDGEHVVPIPRLLNVEDYLDYVSNRVIPDLAIREALENLWSASAVPGTDTMTAQLQRATAALNCAEGCGINLPEALTHLTDRVFAIVIQDFQDPYTLNVKQLMKCCVQQITPDGRLIPFCAYNSVGYREQVREQLTGVPVPDIVPNAIPLAGLLADAPHGSKQANTGGSIARLAGPTRGAPMALPPQQIKACCADAYSRDIVALLLGDSFHPGGATLTRRLADQLGLRSTGDPRRVADIAAGPGASARLLASDYGVAVDGVDISEINVKRAQAAVAQTGLTERVRFHLGDAESVPLPDDTFDALVCECAFCTFPDKNAAAQQFARILRPGGLAGITDVTVGDGGLPAELTPLAAWVACIADARTVTDYTDILEGAGLRTRHIESHDESLLDMIDRIDARITALHVAAPEILADNGIRHDSVRDFTALARAAVQTGRIGYTLMIAEKP,"84,129",776,,,iron-sulfur cluster binding [GO:0051536]; transferase activity [GO:0016740],,,,1
I6X8D2,I6X8D2_MYCTU,Rv3800c,pks13 Rv3800c,GO:0009058; GO:0016788; GO:0031177,IPR029058; IPR036736; IPR014043; IPR016035; IPR032821; IPR018201; IPR014031; IPR014030; IPR016036; IPR020801; IPR020841; IPR020806; IPR009081; IPR001031; IPR016039; ,,pks13,DOMAIN 17 95 Carrier. {ECO:0000259|PROSITE:PS50075}.; DOMAIN 1232 1309 Carrier. {ECO:0000259|PROSITE:PS50075}.,Polyketide synthase Pks13,"hydrolase activity, acting on ester bonds [GO:0016788]; phosphopantetheine binding [GO:0031177]; biosynthetic process [GO:0009058]",9634230; 21969609; 28669536; ,X-ray crystallography (9),,MADVAESQENAPAERAELTVPEMRQWLRNWVGKAVGKAPDSIDESVPMVELGLSSRDAVAMAADIEDLTGVTLSVAVAFAHPTIESLATRIIEGEPETDLAGDDAEDWSRTGPAERVDIAIVGLSTRFPGEMNTPEQTWQALLEGRDGITDLPDGRWSEFLEEPRLAARVAGARTRGGYLKDIKGFDSEFFAVAKTEADNIDPQQRMALELTWEALEHARIPASSLRGQAVGVYIGSSTNDYSFLAVSDPTVAHPYAITGTSSSIIANRVSYFYDFHGPSVTIDTACSSSLVAIHQGVQALRNGEADVVVAGGVNALITPMVTLGFDEIGAVLAPDGRIKSFSADADGYTRSEGGGMLVLKRVDDARRDGDAILAVIAGSAVNHDGRSNGLIAPNQDAQADVLRRAYKDAGIDPRTVDYIEAHGTGTILGDPIEAEALGRVVGRGRPADRPALLGAVKTNVGHLESAAGAASMAKVVLALQHDKLPPSINFAGPSPYIDFDAMRLKMITTPTDWPRYGGYALAGVSSFGFGGANAHVVVREVLPRDVVEKEPEPEPEPKAAAEPAEAPTLAGHALRFDEFGNIITDSAVAEEPEPELPGVTEEALRLKEAALEELAAQEVTAPLVPLAVSAFLTSRKKAAAAELADWMQSPEGQASSLESIGRSLSRRNHGRSRAVVLAHDHDEAIKGLRAVAAGKQAPNVFSVDGPVTTGPVWVLAGFGAQHRKMGKSLYLRNEVFAAWIEKVDALVQDELGYSVLELILDDAQDYGIETTQVTIFAIQIALGELLRHHGAKPAAVIGQSLGEAASAYFAGGLSLRDATRAICSRSHLMGEGEAMLFGEYIRLMALVEYSADEIREVFSDFPDLEVCVYAAPTQTVIGGPPEQVDAILARAEAEGKFARKFATKGASHTSQMDPLLGELTAELQGIKPTSPTCGIFSTVHEGRYIKPGGEPIHDVEYWKKGLRHSVYFTHGIRNAVDSGHTTFLELAPNPVALMQVALTTADAGLHDAQLIPTLARKQDEVSSMVSTMAQLYVYGHDLDIRTLFSRASGPQDYANIPPTRFKRKEHWLPAHFSGDGSTYMPGTHVALPDGRHVWEYAPRDGNVDLAALVRAAAAHVLPDAQLTAAEQRAVPGDGARLVTTMTRHPGGASVQVHARIDESFTLVYDALVSRAGSESVLPTAVGAATAIAVADGAPVAPETPAEDADAETLSDSLTTRYMPSGMTRWSPDSGETIAERLGLIVGSAMGYEPEDLPWEVPLIELGLDSLMAVRIKNRVEYDFDLPPIQLTAVRDANLYNVEKLIEYAVEHRDEVQQLHEHQKTQTAEEIARAQAELLHGKVGKTEPVDSEAGVALPSPQNGEQPNPTGPALNVDVPPRDAAERVTFATWAIVTGKSPGGIFNELPRLDDEAAAKIAQRLSERAEGPITAEDVLTSSNIEALADKVRTYLEAGQIDGFVRTLRARPEAGGKVPVFVFHPAGGSTVVYEPLLGRLPADTPMYGFERVEGSIEERAQQYVPKLIEMQGDGPYVLVGWSLGGVLAYACAIGLRRLGKDVRFVGLIDAVRAGEEIPQTKEEIRKRWDRYAAFAEKTFNVTIPAIPYEQLEELDDEGQVRFVLDAVSQSGVQIPAGIIEHQRTSYLDNRAIDTAQIQPYDGHVTLYMADRYHDDAIMFEPRYAVRQPDGGWGEYVSDLEVVPIGGEHIQAIDEPIIAKVGEHMSRALGQIEADRTSEVGKQ,"186,446",1733,,biosynthetic process [GO:0009058],"hydrolase activity, acting on ester bonds [GO:0016788]; phosphopantetheine binding [GO:0031177]",,,,1
I6X7Z3,I6X7Z3_MYCTU,Rv3645,Rv3645,GO:0004871; GO:0005622; GO:0009190; GO:0016021; GO:0016849; GO:0035556,IPR001054; IPR003660; IPR029787; ,,,DOMAIN 278 330 HAMP. {ECO:0000259|PROSITE:PS50885}.; DOMAIN 362 486 Guanylate cyclase. {ECO:0000259|PROSITE:PS50125}.,Probable conserved transmembrane protein,integral component of membrane [GO:0016021]; intracellular [GO:0005622]; phosphorus-oxygen lyase activity [GO:0016849]; signal transducer activity [GO:0004871]; cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],9634230; 21969609,,,MDAEAFVGFRQVPAARYGGLMATTAALPRRIHAFVRWVVRTPWPLFSLSMLQSDIIGALFVLGFLRYGLPPQDNIQLQDLPPVNLLIFVSTVIILFLAGAVVNLKLLMPVFRWQRRDNLLTEPDPAATELARSRALRMPLYRTLISLAVWATGGGVFILASWSVAKHAAPVVAVATALGATATAIIGYLQSERVLRPVAVAALRSGVPENVNAPGVILRLMLAWIPSTGVPLLAIVLAVAADKIALLHATPEALFNPILMMALAALGIGSVSTLLVAMSIADPLRQLRWALSEVQRGNYNAHMQIYDASELGLLQAGFNDMVRELSERQRLRDLFGRYVGEDVARRALERGTELGGQERDVAVLFVDLVGSTQLAATRPPAEVVQLLNEFFRVVVETVARHGGFVNKFQGDAALAIFGAPIEHPDGAGAALSAARELHDELIPVLGSAEFGIGVSAGRAIAGHIGAQARFEYTVIGDPVNEAARLTELAKLEDGHVLASAIAVSGALDAEALCWDVGEVVELRGRAAPTQLARPMNLAAPEEVSSEVRG,"58,759",549,,cyclic nucleotide biosynthetic process [GO:0009190]; intracellular signal transduction [GO:0035556],phosphorus-oxygen lyase activity [GO:0016849]; signal transducer activity [GO:0004871],integral component of membrane [GO:0016021]; intracellular [GO:0005622],,,1
Q6MWW9,Q6MWW9_MYCTU,Rv3507,PE_PGRS53 Rv3507,,IPR000084; ,,PE_PGRS53,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS53,,9634230,,,MSFVLVSPETVAAVATDLKRIGASLAHENASAAASTTAVVSAAADEVSTAVAALFSQHAQGYQAAAAQVAAFHSRFVQALTAGAGAYAFAEAANASPLQSAMGAVSASAQTLLSRPLIGNGANATTPGGNGGDGGWLFGSGGNGAPGAAGQSGGNGGSAGLWGNGGAGGAGGSGGAAGGNGGNGGWLFGAGGTGGIGGTGAPGAMGGTGGNGGNGALLIGGGGLGGAGGMGGTGGGTGGTGGNGGNGALLIGAGGVGGAGGIGGQGTGAGGAAGAGGTGGNGGAGGLFMNGGDGGAGGQGGDGAAGDAAASAGGTGGKGGQGGDGGTGGAGGAGPVLFGHGGAGGMGGQGGTGGMGGAGGDGTTVIAAGTGGEGGTGGAAGAGGAAGARGALTSGGLAGGVGAGGTGGTGGTGGNGADAAAVVGFGANGDPGFAGGKGGNGGIGGAAVTGGVAGDGGTGGKGGTGGAGGAGNDAGSTGNPGGKGGDGGIGGAGGAGGAAGTGNGGHAGNTGDGGDGGTGGNGGNGTGGVNGADNTLNPDTPGGAGEPGGAGGAGGAGGAAGGPGGTGGTGGNGGNGGNGGNGGNGGNGGNGGNAGNNSTNAPVGGEGGAGGDGGAGGAGGAANGGTAGSQGTGGVGGDGGAGGNGGGGKAGTGNSGNFGVDGEAGFSGGAGGNGGVGGAAGANGGTGGSGGNGGDGGAGGIGGAGGNGIPGTGTEPAGGTGAKGGDGGDGGAGGAGGNAGGAGGQGGNAGQGGAGGAGGNAVIPGDGVGKAPHGDAGGSGGDGGKGGQGGSGGTGGSGAPIGGGAGGTGGSGGHAGKGGAGGIGAQGTTITVPGNGGNAGDGGNGGNAGAGGNGGSGDFGGNTTSGASGSGGNGGNAGTAGSGGAGGTGGTGLSGGNGGNGGNGGNGGDGGNGAHGTVGAQFVPATSLPTPNGGAGGNGGTGSNGGAPGPAGAPGPTTGGNAGSQGIGGDGGNGGDGGKGGDGADAVNVVFMPTEPQAATGTAGSAGDPTGGNGGPGTPGSPMVAPPPPTPITQVQQGGDGGAGGTGSTNANDGTATGGKGGEGGVGSILGGPGGNGGTGGNASATGTNGVANAGNGGKGGDGGQFGAGGNGGAGGSVTDGSAGSTAGNGGNGGNATNGTIAGQPAGGNGSAGGKGGDGGNIAAGATGTAGNGGNGGNGNDGAVNAGTGGSGGNGGNAGGGGANGGDGGAGGAGGAGGRGGKGIDGGFGGDGGNGGSNNGTGAGGNGGNGGTGGVGSVGAAGGDGGNGGTGGFAGFGGTAGNGGSGGTGGAGGDGGTGGDGGNGVIAGGGGTGGNGGASGAGGAGGTGGFAGNGNAGGNGGTGGASEDGDNGNAGSGATGGTGGNGGTGGDGGAAGLGGVA,"110,623",1381,,,,,,,1
P71846,P71846_MYCTU,Rv3554,fdxB Rv3554,GO:0006629; GO:0009055; GO:0016021; GO:0046872; GO:0051537,IPR036010; IPR001041; IPR006058; IPR012675; IPR005804; IPR017927; IPR008333; IPR001433; IPR017938; ,,fdxB,DOMAIN 338 442 FAD-binding FR-type. {ECO:0000259|PROSITE:PS51384}.; DOMAIN 596 685 2Fe-2S ferredoxin-type. {ECO:0000259|PROSITE:PS51085}.,Possible electron transfer protein FdxB,"integral component of membrane [GO:0016021]; 2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; lipid metabolic process [GO:0006629]",9634230; 21969609,,,MTDACQAEYAIAAMSTVEMDQAAPESAAHHPLPDPGESVPRLALPTIGIFLATLTAFVGSTTAYISGWIPFWVTIPVNAAVTFVMFTVVHDASHYAISSIRWVNGLFGRLAWLFVGPVVAFPAFGYIHIQHHRHSNDDEQDPDTFASHGSLWVLPLRWSMVEYFYIKYYLPRGRSRPVIEVAETLVMMTLFLTGLIVAIVTGNFWTLAIVFLIPQRIGLTVLAWWFDWLPHHGLEDTQRSNRYRATRNRVGAEWLFTPVLLSQNYHLVHHLHPSVPFYRYLRTWRRNEEAYLERNAAISTVFGQQLNPDEYRQWKELNGRLARLLPVRMPARSSSPHAVLHRIPVASVDPITADATLVTFAVPEALRDAFRFEPGQHVTVRTDLGGQGIRRNYSICAPATRAQLRIAVKHIPGGAFSTFVANELKAGDVLELMTPTGRFGTPLDPLHRKHYVGLVAGSGITPVLSILATTLEIETESRFTLIYGNRTKESTMFRAELDRLESRYADRLEILHVLSSEPLHTPELRGRIDRDKLTRWLTSTLRPAGVDEWFICGPLAMATAVRETLIEHGVDSERIHLELFYGFDTPPATRPSYAGATVTFTLSGQRAIFDLVPGDSILEGALGLRSDAPYACMGGACGTCRAKLIEGNVEMDHNFALRKAELDAGYILTCQSHPTTPFVAVDYDA,"76,566",685,,lipid metabolic process [GO:0006629],"2 iron, 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]",integral component of membrane [GO:0016021],,,3
P96229,P96229_MYCTU,Rv3848,Rv3848,GO:0016021,IPR001727; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MLAATLLSLGAVFLAELGDRSQLITMTYTLRYRWWVVLTGVAIAAFTVHGVAVAIGHFLGSTVPARPAACVSAIAFLIFAVWVWREDTASDSETSPTAAEPRLALFTVVSSFALAELGDKTTLATVTLASDHHWAGVWIGTTLGMILADGLAIGAGLLLHRRLPERLLQVLTGLLFLLFGLWLLFDDALGFRSVAIAVTAAVVLAAATTAVSVRVAQTRRRRPTAAATPEDDSTRPERSSVAPGHPGSILLPLPEVSLRGRRPPSGSPDERCADPGSKGGSRRISVGCWLPGVGRIRPTRSS,"31,962",302,,,,integral component of membrane [GO:0016021],,,1
I6X811,I6X811_MYCTU,Rv3666c,dppA Rv3666c,GO:0030288; GO:0043190; GO:0055085,IPR030678; IPR000914; ,,dppA,,Probable periplasmic dipeptide-binding lipoprotein DppA,ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288]; transmembrane transport [GO:0055085],9634230; 21969609,,,MVRQMRAALAALATGLLVLAPVAGCGGGVLSPDVVLVNGGEPPNPLIPTGTNDSNGGRIIDRLFAGLMSYDAVGKPSLEVAQSIESADNVNYRITVKPGWKFTDGSPVTAHSFVDAWNYGALSTNAQLQQHFFSPIEGFDDVAGAPGDKSRTTMSGLRVVNDLEFTVRLKAPTIDFTLRLGHSSFYPLPDSAFRDMAAFGRNPIGNGPYKLADGPAGPAWEHNVRIDLVPNPDYHGNRKPRNKGLRFEFYANLDTAYADLLSGNLDVLDTIPPSALTVYQRDLGDHATSGPAAINQTLDTPLRLPHFGGEEGRLRRLALSAAINRPQICQQIFAGTRSPARDFTARSLPGFDPNLPGNEVLDYDPQRARRLWAQADAISPWSGRYAIAYNADAGHRDWVDAVANSIKNVLGIDAVAAPQPTFAGFRTQITNRAIDSAFRAGWRGDYPSMIEFLAPLFTAGAGSNDVGYINPEFDAALAAAEAAPTLTESHELVNDAQRILFHDMPVVPLWDYISVVGWSSQVSNVTVTWNGLPDYENIVKA,"58,382",541,,transmembrane transport [GO:0055085],,ATP-binding cassette (ABC) transporter complex [GO:0043190]; outer membrane-bounded periplasmic space [GO:0030288],,,1
I6YGF8,I6YGF8_MYCTU,Rv3542c,Rv3542c,,IPR002878; IPR029069; IPR012340; ,,,DOMAIN 234 295 OB_aCoA_assoc. {ECO:0000259|Pfam:PF01796}.,Uncharacterized protein,,9634230; 21969609,,,MTGVSDIQEAVAQIKAAGPSKPRLARDPVNQPMINNWVEAIGDRNPIYVDDAAARAAGHPGIVAPPAMIQVWTMMGLGGVRPKDDPLGPIIKLFDDAGYIGVVATNCEQTYHRYLLPGEQVSISAELGDVVGPKQTALGEGWFINQHIVWQVGDEDVAEMNWRILKFKPAGSPSSVPDDLDPDAMMRPSSSRDTAFFWDGVKAHELRIQRLADGSLRHPPVPAVWQDKSVPINYVVSSGRGTVFSFVVHHAPKVPGRTVPFVIALVELEEGVRMLGELRGADPARVAIGMPVRATYIDFPDWSLYAWEPDE,"33,972",311,,,,,,,1
O69695,O69695_MYCTU,Rv3728,Rv3728,GO:0005886; GO:0016021; GO:0016042; GO:0016787; GO:0022857,IPR016035; IPR018490; IPR018488; IPR000595; IPR004638; IPR011701; IPR020846; IPR036259; IPR002641; IPR014710; IPR005829; ,,,DOMAIN 42 486 MFS. {ECO:0000259|PROSITE:PS50850}.; DOMAIN 531 629 Cyclic nucleotide-binding. {ECO:0000259|PROSITE:PS50042}.; DOMAIN 806 965 PNPLA. {ECO:0000259|PROSITE:PS51635}.,Probable conserved two-domain membrane protein,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787]; transmembrane transporter activity [GO:0022857]; lipid catabolic process [GO:0016042],9634230,,,MHTVATNNAAPVIAAGPVGPSRRRRRVHAPLTRRRQPSSSAVLLVAAFGAFLAFLDSTIVNVAFPDIQRHFHSDISDLSWMLNAYNIVFAAFLVAAGRLADLMGRKRVFILGVALFTVASGLCAIAESVGELVAFRVLQGIGAAVLVPASLGLVVEAFPAERRAHGVNLWGAAGAIAAGLGPPIGGALIEADGWRWVFLVNLPLGVFAVLAARRALVENRAAGRRRVPDVRGAVLLAFALGLLTLGLIKGPDWGWASLPTSGSLLAAAVAMVGFVMSSRHHPAPMVEPTLLRIQSFVAGTGLTAVASAGFYAYLLTHVLFLNYVWGYTLLEAGMAVAPAALVAAVVAAVLGRVADRHGYRFIVGIGALIWAASLLWYLKVVGSQPDFLGEWLPGQILQGIGVGATFPLLGSAALARLAKGGSYATASAVTGTIRQVGAVIGVAVLVILVGTPAPGAAEEALRHGWALAAICFVAVGIGALSLGRIRPVPAAVEPPPGPPVAPLGARRPPRPAPVASPAAAVAPTPKTSREVNLLEALRFARPDTQQIELQAGSYLFHAGDVSDALYVVRSGRLQVLAGDGAKDEVVAELGRGQVVGELGVLLDAPRSASVRAVRDSSLMRVTKAEFAKIADAGVLGALAGVLAKRQHQTRVASQRTTPEVVVAVVGVDANAPVAMVATELCRALSTRLRAVAPGRVDCDGLERAEQTADRVVLHAAVGDARWREFCLRVADRVVLVASNPAVPVAPLPTRATGADLVLAGRPAGREHRRAWEQLITPRSMHVVRREFVADDLRVLATRIAGRSVGLVLSGGAARACAHLGVLEELEAAGVTVDRFAGTSMGAIIAALAASGLDAAGVDAQIYEHFVRKSHGDYTLPSKGLIRGKRTQSTLRTIFGDHLVEELPKHFRCVSVDLLARRPVVHRQGPLADVVGCSMRLPFLYAPLPYGGTLHVDGGVLDNVPVTTLVGKDGPLIAVNVASGGNPSPASGGHRRGKPRVPGLTDTLLRTMTISSAMASEKVLAQADLVIKPNPIGVGLMEYHQIDRAREAGRIAAREALPQIMELVHG,"111,264",1065,Major facilitator superfamily,lipid catabolic process [GO:0016042],hydrolase activity [GO:0016787]; transmembrane transporter activity [GO:0022857],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,3
I6YGD8,I6YGD8_MYCTU,Rv3523,ltp3 Rv3523,GO:0008152; GO:0016747,IPR002155; IPR016039; ,,ltp3,,Probable lipid carrier protein or keto acyl-CoA thiolase Ltp3,"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; metabolic process [GO:0008152]",9634230; 21969609,,,MAGKLAAVLGTGQTKYVAKRQDVSMNGLVREAIDRALADSGSTFDDIDAVVVGKAPDFFEGVMMPELFMADAMGATGKPLIRVHTAGSVGGSTGVVAASLVQSGKYRRVLALAWEKQSESNAMWALSIPVPFTKPVGAGAGGYFAPHVRAYIRRSGAPAHIGAMVAVKDRLNGSRNPLAHLQQPDITLEKVMASQMLWDPIRFDETCPSSDGACAVVVGDEEIADARLAQGHPVAWIHGTALRTEPLAFAGRDQVNPQAGRDAAAALWKAAGITSPIDEIDAAEIYVPFSWFEPMWLENLGFAREGEGWKLTEAGETAIGGRLPVNPSGGVLSANPIGASGLIRFAEAAIQVMGKAEARQVPGARKALGHAYGGGSQYFSMWVVGCEKPKQAAA,"41,421",394,,metabolic process [GO:0008152],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
I6YCS6,I6YCS6_MYCTU,Rv3698,Rv3698,GO:0003824,IPR014746; IPR016602; ,,,,Conserved protein,catalytic activity [GO:0003824],9634230; 21969609,,,MRTISPFLRCRHETCCISNVGEEVTRTTYSREHQREYRRKVRLCLDVFETMLAQTRFEADRPLTGMEIECNLVDADYQPAMSNRYVLDAIADPAYQTELGAYNIEFNVPPRPLPGRTCLELEDEVRASLNDAETKASCSGAHIVMIGILPTLMPEHLTDGWMSASARYAALNESIFKARGEDIPINIAGPEPLSCHAGSIAPESACTSVQLHLQLAPADFPANWNAAQVLAGPQLALGANSPYFFGHQLWSETRIELFTQSTDARPEELKSRGVRPRVWFGERWITSVLDLFQENIRYFPTLLPEVSDEDPLAELSAGRIPHLSELRLHNGTVYRWNRPVYDVVDGRPHLRLENRVLPAGPTVVDMLANHAFYYGALRGLSEADPPLWTQMNFAAAQANFLAAARYGMDAQLDWPGLGEVTTRELVLGTLLPMAHEGLRRWGVDAEVRDRFLGVIGGRAQTGRNGARWQVATVAALQDGGLTRPAALAEMLRRYCEHMHSNEPVHTWDT,"56,930",509,,,catalytic activity [GO:0003824],,,,1
I6YGW6,I6YGW6_MYCTU,Rv3673c,Rv3673c,GO:0004791; GO:0005829; GO:0006662; GO:0015035; GO:0016021; GO:0016671; GO:0034599; GO:0045454; GO:0047134,IPR000866; IPR005746; IPR036249; IPR017937; IPR013766; ,,,DOMAIN 85 227 Thioredoxin. {ECO:0000259|PROSITE:PS51352}.,Possible membrane-anchored thioredoxin-like protein (Thiol-disulfide interchange related protein),"cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]",9634230; 21969609,,,MPSLPTTPAETAMTTLTGKTRWTIAILAVVAALMAALVAQLHDYSASSTISQRPAPREHRDGDTPEALAWSRQRANLPPCPAAGNGPGAAALRGVVVVCAGDGSAVDVARALAGRRVVINLWAHWCAPCMTELPVMAEYQRRVGPAVLVVTVHQGQNEAAALSRLADLGVRLPTLQDDRRRVAAALRVANVMPATVVLRPDGSVAQTLPRAFGSADEIVAAVGNDAG,"23,643",227,,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662],"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; thioredoxin-disulfide reductase activity [GO:0004791]",cytosol [GO:0005829]; integral component of membrane [GO:0016021],,,1
P72043,P72043_MYCTU,Rv3777,Rv3777,GO:0005886; GO:0016491,IPR013149; IPR013154; IPR011032; IPR036291; IPR020843; IPR014189; ,,,DOMAIN 10 326 PKS_ER. {ECO:0000259|SMART:SM00829}.,Probable oxidoreductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTIMRAVVAESSDRLVWQEVPDVSAGPGEVLIKVAASGVNRADVLQAAGKYPPPPGVSDIIGLEVSGIVAAVGPGVTEWSAGQEVCALLAGGGYAEYVAVPADQVLPIPPSVNLVDSAALPEVACTVWSNLVMTAHLRPGQLVLIHGGASGIGSHAIQVVRALAARVAITAGSPEKLELCRDLGAQITINYRDEDFVARLKQETDGSGADIILDIMGASYLDRNIDALATDGQLIVIGMQGGVKAELNLGKLLTKRARVIGTTLRARPVSGPHGKAAIAQAVAASVWPMIAANRVRPVIGTRLPIQQAAQAHELMLSGKTFGKILLTV,"33,963",328,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,2
O69728,O69728_MYCTU,Rv3762c,Rv3762c,GO:0018741; GO:0018909; GO:0046983,IPR038536; IPR029229; IPR029228; IPR001279; IPR036866; IPR036527; ,,,DOMAIN 101 324 Lactamase_B. {ECO:0000259|SMART:SM00849}.,Possible hydrolase,alkyl sulfatase activity [GO:0018741]; protein dimerization activity [GO:0046983]; dodecyl sulfate metabolic process [GO:0018909],9634230; 21969609,,,MPMEHKPPTAVIQAAHGEHSLPLHDTTDFDDADRGFIAALSPCVIKAADGRVVWDNDAYSFLDGAAPTSVHPSLWRQSQLTAKQGLYQVVPGIYQVRGFDISNISFVEGDTGLIVIDPLVSTEVAAAALDLYRAHRGADRPVVAVIYTHSHVDHFGGVLGVTTQADVDAGKVAVLAPEGFTAHAVQENIYAGSAMMRRAGYMYGTVLARGLRGHVGCGLGQTLSTGEVSLVVPTVDITETGETHTIDGVEIEFQMAPGTEAPAEMHFYFPRFRALCMAENATHNLHNLLTLRGALVRDPRAWSGYLTEAIDTFADRTDVVFASHHWPTWGREKIVEFLSQQRDMYSYLHDQTLRLLNQGYTGVEIAEMFQLPPALQRAWHTHGYYGSVSHNVKAIYQRYMGWFDGNPGWLWPHPPEALAPRYVDALGGIDRVLELAREAFDAGDFRWAATLLDHAVFADSEHAAARGLYADTLEQLAYGAECATWRNFFLTGAAELRDGNPGSSGQVPAPTFFAQLTPDQIFDVLAISINGPRAWDLDLAIDFTFTEPDVNYRLTLRNGVLIHRKLPADPATANATVTVGDKVRLVAAALGDISSPGFEVFGDRTVLQTFLSVLDRPDSAFNIVTP,"68,483",626,,dodecyl sulfate metabolic process [GO:0018909],alkyl sulfatase activity [GO:0018741]; protein dimerization activity [GO:0046983],,,,3
Q6MWW8,Q6MWW8_MYCTU,Rv3511,PE_PGRS55 Rv3511,,IPR000084; ,,PE_PGRS55,DOMAIN 1 92 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS55,,9634230,,,MSFVLISPEVVSAAAGDLANVGSTISAANKAAAAATTQVLAAGADEVSARIAALFGMYGLEYQAISAQVAAYHQQFVQTLRTGAASYMLAEATNVEQNLLNLINAPTQTLLGRPLIGDGANATTPGGAGGDGGLLFGSGGNGAPGAPGQAGGAGGSAGLLGNGGSGGAGGTGAPGGNGGNAGWLYGRGGVGGAGGIGGGTGGAGGHAWLFGHGGTGGIGGGPGGNGGWLLGNGGHGGAGGIGGGSGGAGGNGGWLLGNGGIGGAGGTGGGAGGTGGNAAWLLGGGGTGGAGGIGGGNGGHGGNGGWLLGNGGNGGLGGDGDGGTGGGHGGNGGNPGWLLGTAGGGGNGGAGSTGTAGGGSGGTGGDGGTGGRGGLLMGAGAGGHGGTGGAGGAGVNGGGAGGAGGAGGNGGAGGQAALLFGRGGTGGAGGYGGDGGGGGDGFDGTMAGLGGTGGSGGTGGDGGAPGNGGAGGAGQLLSHSGVAGASGKGGAGGTGGNGGAGSAGADAPAGSGAMGSTGFAGGAGGDGGNGGGSGASQGNGGNGGNGGTGGKGGTGGAGMNSLDPLLAAQDGGQGGTGGTGGNAGAGGTGFTQGADGNAGNGGDGGVGGNGGNGADNTTTAAAGTTGGAGGAGGAGGTGGAAGTGTGGQQGNGGNGGNGGTGGKGGTGGAGMNSLDPLLAAQDGGQGGTGGTGGNAGAGGTGFTPRRRRQRRQRR,"59,990",714,,,,,,,1
O07807,O07807_MYCTU,Rv3816c,Rv3816c,GO:0005618; GO:0005886; GO:0008152; GO:0016411; GO:0042171,IPR002123; ,,,,Possible acyltransferase,cell wall [GO:0005618]; plasma membrane [GO:0005886]; acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171]; metabolic process [GO:0008152],9634230; 21969609,,,MEPVYGTVIRLARLSWRIQGLKITVTGVDNLPTSGGAVVAINHTSYLDFTFAGLPAYQQGLGRKVRFMAKQEVFDHKITGPIMRSLRHIPVDRQDGSASYDAAVRMLKAGELVGVYPEATISRSFEIKEFKTGAARMAIEAGVPIVPHIVWGAQRIWTKDRPKKLFRPKVPVTIVVGERIEPTLPTAELNGLLHSRMQHLLERAQELYGPHPAGEFWVPHRLGGGAPSLAEAARLDAQEAAVRAARRAQRAHPAGAPEQ,"28,454",259,,metabolic process [GO:0008152],acylglycerol O-acyltransferase activity [GO:0016411]; lysophosphatidic acid acyltransferase activity [GO:0042171],cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
I6YGW9,I6YGW9_MYCTU,Rv3678c,Rv3678c,,IPR013813; IPR035959; ,,,,Conserved protein,,9634230; 21969609,,,MSAKARLGQLGVTLPQVAAPLAAYVPAVRTGNLVYTAGQLPLEAGKLVRTGKLGADVNPEEGKTLARICALNALAAVDSLVDLDAVTRVVKVVGFVASAPGFHGQPSVINGASDLLAEVFGDSGAHARSAVGVSELPLDAPVEVELIVEVG,"15,246",151,,,,,,,1
I6XHJ3,I6XHJ3_MYCTU,Rv3556c,fadA6 Rv3556c,GO:0008152; GO:0016747,IPR002155; IPR016039; IPR020617; IPR020613; IPR020616; ,,fadA6,,Probable acetyl-CoA acetyltransferase FadA6 (Acetoacetyl-CoA thiolase),"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]; metabolic process [GO:0008152]",9634230; 21969609,,,MTEAYVIDAVRTAVGKRGGALAGIHPVDLGALAWRGLLDRTDIDPAAVDDVIAGCVDAIGGQAGNIARLSWLAAGYPEEVPGVTVDRQCGSSQQAISFGAQAIMSGTADVIVAGGVQNMSQIPISSAMTVGEQFGFTSPTNESKQWLHRYGDQEISQFRGSELIAEKWNLSREEMERYSLTSHERAFAAIRAGHFENEIITVETESGPFRVDEGPRESSLEKMAGLQPLVEGGRLTAAMASQISDGASAVLLASERAVKDHGLRPRARIHHISARAADPVFMLTGPIPATRYALDKTGLAIDDIDTVEINEAFAPVVMAWLKEIKADPAKVNPNGGAIALGHPLGATGAKLFTTMLGELERIGGRYGLQTMCEGGGTANVTIIERL,"40,902",386,Thiolase family,metabolic process [GO:0008152],"transferase activity, transferring acyl groups other than amino-acyl groups [GO:0016747]",,,,1
O69700,O69700_MYCTU,Rv3733c,Rv3733c,GO:0016787,IPR015797; IPR020084; IPR000086; ,,,,Uncharacterized protein,hydrolase activity [GO:0016787],9634230,,,MPKLSAGVLLYRARAGVVDVLLAHPGGPFWAGKDDGAWSIPKGEYTGGEDPWLAARREFSEEIGLCVPDGPRIDFGSLKQSGGKVVTVFGVRADLDITDARSSTFELDWPKGSGKMRKFPEVDRVSWFPVARARTKLLKGQRGFLDRLMAHPAVAGLSEGPESLPR,"18,034",166,,,hydrolase activity [GO:0016787],,,,1
I6YGV9,I6YGV9_MYCTU,Rv3665c,dppB Rv3665c,GO:0005886; GO:0016021; GO:0055085,IPR000515; IPR035906; ,,dppB,,Probable dipeptide-transport integral membrane protein ABC transporter DppB,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transmembrane transport [GO:0055085],9634230; 21969609,,,MGWYVARRVAVMVPVFLGATLLIYGMVFLLPGDPVAALAGDRPLTPAVAAQLRSHYHLDDPFLVQYLRYLGGILHGDLGRAYSGLPVSAVLAHAFPVTIRLALIALAVEAVLGIGFGVIAGLRQGGIFDSAVLVTGLVIIAIPIFVLGFLAQFLFGVQLEIAPVTVGERASVGRLLLPGIVLGAMSFAYVVRLTRSAVAANAHADYVRTATAKGLSRPRVVTVHILRNSLIPVVTFLGADLGALMGGAIVTEGIFNIHGVGGVLYQAVTRQETPTVVSIVTVLVLIYLITNLLVDLLYAALDPRIRYG,"32,537",308,Binding-protein-dependent transport system permease family,transmembrane transport [GO:0055085],,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
Q6MWW0,Q6MWW0_MYCTU,Rv3558,PPE64 Rv3558,,IPR002989; IPR000030; IPR038332; ,,PPE64,,PPE family protein PPE64,,9634230,,,MAHFSVLPPEINSLRMYLGAGSAPMLQAAAAWDGLAAELGTAASSFSSVTTGLTGQAWQGPASAAMAAAAAPYAGFLTTASAQAQLAAGQAKAVASVFEAAKAAIVPPAAVAANREAFLALIRSNWLGLNAPWIAAVESLYEEYWAADVAAMTGYHAGASQAAAQLPLPAGLQQFLNTLPNLGIGNQGNANLGGGNTGSGNIGNGNKGSSNLGGGNIGNNNIGSGNRGSDNFGAGNVGTGNIGFGNQGPIDVNLLATPGQNNVGLGNIGNNNMGFGNTGDANTGGGNTGNGNIGGGNTGNNNFGFGNTGNNNIGIGLTGNNQMGINLAGLLNSGSGNIGIGNSGTNNIGLFNSGSGNIGVFNTGANTLVPGDLNNLGVGNSGNANIGFGNAGVLNTGFGNASILNTGLGNAGELNTGFGNAGFVNTGFDNSGNVNTGNGNSGNINTGSWNAGNVNTGFGIITDSGLTNSGFGNTGTDVSGFFNTPTGPLAVDVSGFFNTASGGTVINGQTSGIGNIGVPGTLFGSVRSGLNTGLFNMGTAISGLFNLRQLLG,"53,681",552,Mycobacterial PPE family,,,,,,1
I6YCG9,I6YCG9_MYCTU,Rv3578,arsB2 Rv3578,GO:0015105; GO:0016021,IPR000802; ,,arsB2,,Possible arsenical pump integral membrane protein ArsB2,integral component of membrane [GO:0016021]; arsenite transmembrane transporter activity [GO:0015105],9634230,,,MTLAVALILLAVVLGFAVARPRGWPEAAAAVPAAVILLAIGAISPQQAMAQVSGLARVVAFLGAVLVLAKLCDDEGLFEAAGAAMARASAESHRLLRQVFAVSAAITAALCLDATVVLLTPVVLATVRRLRTPVRPYAYATAHLANAASLLLPVSNLTNLLAYHGAGISFTKFTLLMALPWLSAVAAVYVVFRWFFARDLRVVPDRQQLKPAPRLPMFVLVVVALTLGGFAVAESVGLAPTWAALAGAAVLALRSLRRGHTSVLRIARAVNVSFLVFVLALGVVVHAVMLNGMAARMSAVLPTGSGLPALLGIAALAAVLANVVNNLPATLVLVPLVAAGGPAAVLAVLLGVNIGPNLTYAGSLSNLLWRGVLRRHNVDASVGEYTRLGLCTVPAALAMAVLALWASAQVLGI,"42,543",413,,,arsenite transmembrane transporter activity [GO:0015105],integral component of membrane [GO:0016021],,,1
O07810,O07810_MYCTU,Rv3813c,Rv3813c,GO:0016787,IPR000150; IPR036412; IPR006379; IPR023214; ,,,,Conserved protein,hydrolase activity [GO:0016787],9634230; 21969609,,,MKPTVPALVACDVDGTLLDDGETVTKRTRDAVHAAVDAGTHFILATGRPPRWVRPIVDALGFAPMAVCANGAVIYDPGTDRVMSVRTLPVDALATLAEVATRVIPGAGLAVERIGERAHDTATPQFVSSPGYEHAWLNPDNTEVSIDHLLSAPAIKLLIRKAGAASADMAAELAKHVGFEGDITYSTNNGLVEIVPLGISKATGVDEIARPLGISDAEVVAFGDMPNDVPMLLRAGLGVAMGNAHPDALAVADEVTAPNSEDGVARVLERWWS,"28,533",273,,,hydrolase activity [GO:0016787],,,,1
O53546,O53546_MYCTU,Rv3501c,yrbE4A Rv3501c,GO:0043190,IPR030802; ,,yrbE4A,,Conserved integral membrane protein YrbE4A. Possible ABC transporter,ATP-binding cassette (ABC) transporter complex [GO:0043190],9634230; 21969609,,,MIQQLAVPARAVGGFFEMSMDTARAAFRRPFQFREFLDQTWMVARVSLVPTLLVSIPFTVLVAFTLNILLREIGAADLSGAGTAFGTITQLGPVVTVLVVAGAGATAICADLGARTIREEIDAMRVLGIDPIQRLVVPRVLASTLVALLLNGLVCAIGLSGGYAFSVFLQGVNPGAFINGLTVLTGLRELILAEIKALLFGVMAGLVGCYRGLTVKGGPKGVGNAVNETVVYAFICLFVINVVMTAIGVRISAQ,"26,640",254,,,,ATP-binding cassette (ABC) transporter complex [GO:0043190],,,1
I6X7W8,I6X7W8_MYCTU,Rv3618,Rv3618,GO:0004497; GO:0005829; GO:0016705,IPR011251; IPR036661; ,,,,Possible monooxygenase,"cytosol [GO:0005829]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",9634230; 21969609,,,MKAPLRFGVFITPFHPTGQSPTVALQYDMERVVALDRLGYDEAWFGEHHSGGYELIACPEVFIAAAAERTTHIRLGTGVVSLPYHHPLMVADRWVLLDHLTRGRVMFGTGPGALPSDAYMMGIDPVEQRRMMQESLEAILALFRAAPDERIDRHSDWFTLREAQLHIRPYTWPYPEIATAAMISPSGPRLAGALGTSLLSLSMSVPGGYAALETAWGVVREQAAKAGRGEPDRADWRVLSIMHLSDSRDQAIDDCTYGLPDFSRYFGAAGFVPLANTVEGTQSSREFVEQYAAKGNCCIGTPDDAIAHIEDLLHRSGGFGTLLLLGHDWAPPPATFHSYELFARAVIPYFKGQLAAPRASHEWARGKRDQLIGRAGEAVVKAITEHVAEQGEAGS,"43,277",395,,,"monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",cytosol [GO:0005829],,,1
I6YCQ7,I6YCQ7_MYCTU,Rv3675,Rv3675,,,,,,Possible membrane protein,,9634230,,,MFTLLVSWLLVACVPGLLMLATLGLGRLERFLARDTVTATDVAEFLEQAEAVDVHTLARNGMPEALDYLHRRQARRITDSPPLGSGAGPRYAGPLFVTDLDSPVEPPRHGQPNPQFRTARHANHV,"13,735",125,,,,,,,1
O53577,O53577_MYCTU,Rv3797,fadE35 Rv3797,GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR009100; IPR034184; ,,fadE35,,Probable acyl-CoA dehydrogenase FadE35,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MPEYDLEAVDKLPFSTPEKAQRYQTENYRGAMGLNWYLTDPTLQFIMAYYLRPDELAFAEPHLTRIGELTGGPVTRWAEETDRNPPRLERYDRWGHDISRVVLPESFIQSKRAVIEARQAVRDDAARAGVKPSLALFAADYLLNQADIGMACALATGGNMVRSLVTAYAPPDVREFVLGKLNSGEWDGEAAQLLTERAGGSDLGALETTATRSGDVWLLNGFKWFASNCAGEAFVVLAKPEGAPDSTRGVATFLVLRTRRDGSRNGVRIRRLKDKLGTRSVASGEIEFVDAEAFLLSGEPSADAGPSDGKGLTRMMELTNRLRLGTASFALGNARRALVESLCYAGQRRAFGGALIDKPLMRRKLAEMVVDVEAALAMVFDGFGAANHRQPRCLPQRIAVPVTKLKTCRLGITVASDAIEIHGGNGYIETWPVARLLRDAQVNTIWEGPDNILCLDVRRGIEQTRAHETLLARLRDAVSVSDDDDTTRLVSRRIEDLDAAITAWTKLDRQLAEARLFPLAQFMGDVYAGALLTEQAAWERATRGTDRKALVARLYARRYLADQGPLRGIDADCDEALQRFDELVAGAFTAEQT,"65,322",593,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,1
P72040,P72040_MYCTU,Rv3773c,Rv3773c,GO:0005886,IPR017517; IPR017520; IPR034660; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MPPESRPGPDSPPTDELACAEAALQVLQQVLHTIGRQDKAKQTPCPGYDVKKLTEHLLNSIMVLGGMVGAEFSLRADIDSVERLVSGAARSALDAWHRHGLEGDVSLGPGSMSAKVAVSVFSVEFLVHAWDYAVAVGSELKAADSLAEYVLELARKLIKPEERSVAGFNEPVDVPEDGGALERLIAFTGRNPAR,"20,725",194,,,,plasma membrane [GO:0005886],,,1
I6YGT7,I6YGT7_MYCTU,Rv3632,Rv3632,GO:0016021,IPR019277; ,,,,Possible conserved membrane protein,integral component of membrane [GO:0016021],9634230,,,MNWIQVLLIASIIGLLFYLLRSRRSARSRAWVKVGYVLFVLAGIYAVLRPDDTTVVANWFGVRRGTDLMLYALVMAFSFTTLSTYMRFKDLELRYARIARALALEGAQAPEQCR,"13,069",114,,,,integral component of membrane [GO:0016021],,,1
O69689,O69689_MYCTU,Rv3722c,Rv3722c,GO:0003824; GO:0005576; GO:0040007,IPR024551; IPR015424; IPR015422; IPR015421; ,,,,Conserved protein,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; growth [GO:0040007],9634230; 21969609; ,X-ray crystallography (1),,MSFDSLSPQELAALHARHQQDYAALQGMKLALDLTRGKPSAEQLDLSNQLLSLPGDDYRDPEGTDTRNYGGQHGLPGLRAIFAELLGIAVPNLIAGNNSSLELMHDIVAFSMLYGGVDSPRPWIQEQDGIKFLCPVPGYDRHFAITETMGIEMIPIPMLQDGPDVDLIEELVAVDPAIKGMWTVPVFGNPSGVTYSWETVRRLVQMRTAAPDFRLFWDNAYAVHTLTLDFPRQVDVLGLAAKAGNPNRPYVFASTSKITFAGGGVSFFGGSLGNIAWYLQYAGKKSIGPDKVNQLRHLRFFGDADGVRLHMLRHQQILAPKFALVAEVLDQRLSESKIASWTEPKGGYFISLDVLPGTARRTVALAKDVGIAVTEAGASFPYRKDPDDKNIRIAPSFPSVPDLRNAVDGLATCALLAATETLLNQGLASSAPNVR,"47,341",435,,growth [GO:0040007],catalytic activity [GO:0003824],extracellular region [GO:0005576],,,2
O69727,O69727_MYCTU,Rv3761c,fadE36 Rv3761c,GO:0005886; GO:0042783,IPR002575; IPR011009; ,,fadE36,,Possible acyl-CoA dehydrogenase FadE36,plasma membrane [GO:0005886]; active evasion of host immune response [GO:0042783],9634230; 21969609,,,MTSVDRLDGLDLGALDRYLRSLGIGRDGELRGELISGGRSNLTFRVYDDASSWLVRRPPLHGLTPSAHDMAREYRVVAALGDTPVPVARTISLCQDDSVLGAPFQVVEFVAGQVVRRRAELEALGSRSVIEGCVDALIRVLVDLHSIDPKAVGLSDFGKPDGYLERQVRRWGSQWELVRLPDDHRDADISRLHLALQQAIPQQSRTSIVHGDYRIDNTILDTDDPCHVRAVVDWELSTLGDPLSDAALMCVYRDPALDLIVHAQAAWTSPLLPAADELADRYSLVSGQPLGHWEFYMALAYFKLAIIAAGIDYRRRMSEQAEGKDTAAESVPDVVAPLIARGLAEIAKKSG,"38,565",351,,active evasion of host immune response [GO:0042783],,plasma membrane [GO:0005886],,,1
O69712,O69712_MYCTU,Rv3745c,Rv3745c,,IPR018714; ,,,,Uncharacterized protein,,9634230,,,MSDCNVLGGALEQGGTDPLTGFYRDGCCATGPEDLGWHTICAVMTTEFLAHQRSVGNDLSIARPPRWLRP,"7,564",70,,,,,,,1
Q79FA2,Q79FA2_MYCTU,Rv3739c,PPE67 Rv3739c,,IPR000030; IPR038332; ,,PPE67,,PPE family protein PPE67,,9634230,,,MTAPIWFASPPEVHSALLSAGPGPASLQAAAAEWTSLSAEYASAAQELTAVLAAVQGGAWEGPSAEAYVAAHLPYLA,"7,722",77,Mycobacterial PPE family,,,,,,1
P96239,P96239_MYCTU,Rv3839,Rv3839,,IPR037119,,,,Uncharacterized protein,,9634230,,,MPPLTSLAPTTAERIRSACARAGGALLVVEREDPVPVPIHHLLYDGSFAVAVPVDRGEVSGSQALLELTDYAPLPVREPVRSLVWIRGCLHQIPPAELVETLDLIATDNPNPALLQVETPRPGPADAAETRYTMQRLEIESVVVTDATGAEPVTVADLLAARPDPFCEIESTLLWHLATAHDDVVARLVSRLPAPLRRGQIRPLGLDRYGVRFRIEARDGDRDIRLPFHKPVDDMTGLSQAIRVLMGCPFRNGLRARR,"28,293",258,,,,,,,1
P96857,P96857_MYCTU,Rv3575c,Rv3575c,GO:0003677; GO:0006351; GO:0006355,IPR000843; IPR010982; IPR028082; ,,,DOMAIN 9 64 HTH lacI-type. {ECO:0000259|PROSITE:PS50932}.,Transcriptional regulatory protein (Probably LacI-family),"DNA binding [GO:0003677]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSPTPRRRATLASLAAELKVSRTTVSNAFNRPDQLSADLRERVLATAKRLGYAGPDPVARSLRTRKAGAVGLVMAEPLTYFFSDPAARDFVAGVAQSCEELGQGLQLVSVGSSRSLADGTAAVLGAGVDGFVVYSVGDDDPYLQVVLQRRLPVVVVDQPKDLSGVSRVGIDDRAAMRELAGYVLGLGHRELGLLTMRLGRDRRQDLVDAERLRSPTFDVQRERIVGVWEAMTAAGVDPDSLTVVESYEHLPTSGGTAAKVALQANPRLTALMCTADILALSAMDYLRAHGIYVPGQMTVTGFDGVPEALSRGLTTVAQPSLHKGHRAGELLLKPPRSGLPVIEVLDTELVRGRTAGPPA,"38,210",359,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",DNA binding [GO:0003677],,,,4
I6YCF0,I6YCF0_MYCTU,Rv3559c,Rv3559c,,IPR036291; IPR002347; ,,,,Probable oxidoreductase,,9634230; 21969609,,,MNLSVAPKEIAGHGLLDGKVVVVTAAAGTGIGSATARRALAEGADVVISDHHERRLGETAAELSALGLGRVEHVVCDVTSTAQVDALIDSTTARMGRLDVLVNNAGLGGQTPVADMTDDEWDRVLDVSLTSVFRATRAALRYFRDAPHGGVIVNNASVLGWRAQHSQSHYAAAKAGVMALTRCSAIEAAEYGVRINAVSPSIARHKFLDKTASAELLDRLAAGEAFGRAAEPWEVAATIAFLASDYSSYLTGEVISVSCQHP,"27,430",262,,,,,,,1
I6YGH7,I6YGH7_MYCTU,Rv3562,fadE31 Rv3562,GO:0016627; GO:0050660,IPR006091; IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE31,,Probable acyl-CoA dehydrogenase FadE31,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MDLNFDDETLAFQAEVREFLAANAASIPTKSYDNAEGFAQHRYWDRVLFDAGLSVITWPAKYGGRDAPLLHWIVFEEEYFRAGAPGRASANGTSMLAPTLFAHGTAEQLDRILPKMASGEQIWAQAWSEPESGSDLASLRSTASKVDGGWLLNGQKIWSSRAPFADMGFGLFRSDPAVERHRGLTYFMFDLKAKGVTVRPIAQLGGDTGFGEIFLDDVFVPDRDVIGAPNDGWRAAMSTSSNERGMSLRSPARFLASAERLVQLWKDRGSPPEFADRVADAWIKAQAYRLQTFGTVTRLAAGGELGAESSVTKVFWSELDVHLHQTALDLRGADGELAGPWTEGLLFALGGPIYAGTNEIQRNIIAERLLGLPREKT,"41,332",377,Acyl-CoA dehydrogenase family,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,1
O53562,O53562_MYCTU,Rv3517,Rv3517,GO:0005829,,,,,Uncharacterized protein,cytosol [GO:0005829],9634230,,,MIEPFLGSEAIASGALTRHRLRSAYATIHPDVYVSPGADLTAWSRAQAAWLWSRRRGVIAGQSAAAMHGAKWVDARQAAELLYDHRRPPAGIHTWSDRVADDEIQPISGMNTTTPARTALDLARRYPVGKAVAAIDALARATDLKLADVEMLAERYRGSRGIRNARIALDLVDPGAESPRETWLRLLLIRAGFPRPQTQIPVYDEYGQLVAVIDMGWAGIKVGVDYEGDHHRTDRRTFNKDIKRAEALTELGWTDVRVTVEDTEGGIIWRVSAAWQRRT,"31,039",279,,,,cytosol [GO:0005829],,,1
O69661,O69661_MYCTU,Rv3693,Rv3693,GO:0005829; GO:0005886,IPR002881; ,,,,Possible conserved membrane protein,cytosol [GO:0005829]; plasma membrane [GO:0005886],9634230; 21969609,,,MILTGRTGLLALICVLPIALSPWPARAFVMLLVALAVAVTVDTLLAASTRKLRFTRSPYTSARLGQPVDASLLLCNGGRRRFRGQVRDAWPPSARAQPHTHDVDVAAGQRQQVHTALRPVRRGDQRAAMVTARSIGPLGLAGRQSSQSVPGLVRVLPPFLSRKHLPSRLAKLREIDGLLPTLIRGQGTEFDSLREYVVGDDVRSIDWRASARRADVMVRTWRPERDRRVVIVLDTGRMAAGRVGVDPTAADPAGWPRLDWSMDAALLLAALASRAGDHVDFLAHDRISRAGVFGASRSELLAQLVDAMAPLRPALIESDWHAMIATILRRTRRRSLVVLLTDLNATALDEGLLPVLPQLSARHHVLVAAVADPRVDQLAAGRSDAAAVYDAAAAERARNDRRAIASQLRRGGVDVIDAPPAEIAPGLADRYLAMKATGRL,"47,687",440,,,,cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P96220,P96220_MYCTU,Rv3857c,Rv3857c,GO:0016021,,,,,Possible membrane protein,integral component of membrane [GO:0016021],9634230,,,MNCALGFDTKPILLASYVTHGARRATANQFERPAKGAGVLMALLILGEMAGFAVVVTGVVFGQLV,"6,764",65,,,,integral component of membrane [GO:0016021],,,1
O06277,O06277_MYCTU,Rv3605c,Rv3605c,GO:0016021,IPR021517; ,,,,Probable conserved secreted protein,integral component of membrane [GO:0016021],9634230,,,MGPTRKRDLTAAVVGAAAVGYLLVAVLYRWFPPITVWTGLSLLAVAVAEALWARYVRVKISDGEIGDGPGWLHPLVVARSLMVAKASAWVGALVTGWWIGVLAYFLPRRSWLRAAAEDTTGTVVAAGSALALVVAALWLQHCCKSPQDPTEHADGAES,"16,790",158,,,,integral component of membrane [GO:0016021],,,1
P96226,P96226_MYCTU,Rv3851,Rv3851,GO:0016021,,,,,Possible membrane protein,integral component of membrane [GO:0016021],9634230,,,MTAIGMSHPPRVHRRVGGQRTALTAGIGLLLAALVLTTIANPPAAFAHTAQLSTATPAPAVAATDANDVPTWPFVVGTVAAVAVAALWAVRRGR,"9,528",94,,,,integral component of membrane [GO:0016021],,,1
O06272,O06272_MYCTU,Rv3611,Rv3611,GO:0040007,,,,,Hypothetical arginine and proline rich protein,growth [GO:0040007],9634230,,,MAIANPAEPGAAGRHHQPRGDRKPRAWRQCGPQNGPRRSQAITPEPGAAGRHHQPRGDRKPRAWRQCGPQNGPRRSQAITPEPGAAGRHHQPRGDRKPRAWRQCGPQNGPRRSQAITPEPGAAGRHHQPRGDRKPRAWRQCGPQNGPRRSQAITPEPGAAGRHHQPRGDRKPRAWRQCGPQNGPRRSQAITPEPGAAGRHWLDQRPVVPDGVGKSDS,"23,848",217,,growth [GO:0040007],,,,,1
I6Y464,I6Y464_MYCTU,Rv3642c,Rv3642c,,,,,,Uncharacterized protein,,9634230,,,MFVQATELQKVKRRFRNVRATRRNTELEGTRSTAATRADQNDYARGKITAAELGERVRRRYNIQ,"7,526",64,,,,,,,1
I6X827,I6X827_MYCTU,Rv3683,Rv3683,,IPR024654; IPR029052; ,,,,Conserved protein,,9634230; 21969609,,,MAAVLPTLIRTGAVALGSAIAGIGYAALVERNAFVLREVTMPVLTPGSTPLRVLHISDLHMLPNQHRKQAWLRELASWEPDLVVNTGDNLAHPKAVPAVVQTLSDLLSRPGVFVFGSNDYFGPRLKNPMNYLTSPDHRVRGAALPWQDLRAAFTERGWLDLTHTRREFEVAGLHIAAAGVDDPHIDRDRYDTIAGPASPAANLRLGLTHSPEPRVLDRFAADGYQLVLAGHTHGGQLCLPLYGALVTNCGLDRSRAKGASHWGANMRLHVSAGIGTSPFAPVRFCCRPEATLLTLIATPMGGRDSSSNLGRSQPTVSVR,"34,394",319,,,,,,,1
P71853,P71853_MYCTU,Rv3548c,Rv3548c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MGLVDGRVVIVTGAGGGIGRAHALAFAAEGARVVVNDIGVGLDGSPASGGSAAQDVVDEILAAGGQAVADGSDISDWDQAANLIQAAVETYGGVDVLVNNAGIVRDRMIANTSEEEFDAVIAVHLKGHFATMRHAASHWRGLSKAGKAPKDIDARIINTSSGAGLQGSVGQGNYSAAKAGIAALTLVGAAEMRRYGVTVNAIAPAARTRMTETVFAEMMAKPQEGFDAMAPENVSPLVVWLGSAESRDVTGKVFEVEGGIIRVAEGWAHGPQVDKGVKWDPAELGPVVSDLLAKSRPPVPVYGA,"31,070",304,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,,3
O86358,O86358_MYCTU,Rv3755c,Rv3755c,,IPR009467; ,,,,Conserved protein,,9634230; 21969609,,,MNAVPSDLTPRVWPAMLTWRAQDISRMESVRVQLSGKRIRANGRIVAAATANNPAFGAHYDLQTDETGATKRFGLTVTLAERERQLAIARDEENMWLVTDHQGERRAAYNGALDIDLVFSPFFNALPIRRLGLHERAESIALPVVYVNVPEMSVDAATVSYTSEGRLDGIKLRSPVADTTVTVDSDGFIVDYPGLAERM,"22,002",199,,,,,,,1
I6XHU7,I6XHU7_MYCTU,Rv3638,Rv3638,GO:0005524; GO:0005737; GO:0006271,IPR028350; IPR002611; IPR027417; ,,,,Possible transposase,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; DNA strand elongation involved in DNA replication [GO:0006271],9634230,,,MAAKTATNSRDVAAELAYLTRALKAPTLRGAIEQLADRARTKTWSYEEFLAACLQREVSARESHGGEGRIRAARFPSRKSLEEFDFDHARGLKRDTIAHLGTLDFVTLAIGIAIRACQAGHRVLFATASQWVDRLAAAHHSGTLQSELIRLARYPLLVVDEVGYIPFEPEAANLFFQLVSSRYERASLIVTSNKPFGRWGEVFGDDVVAAAMIDRLVHHAEVIALKGDSYRIKDRDLGRVPTVTADDQ,"27,489",248,,DNA strand elongation involved in DNA replication [GO:0006271],ATP binding [GO:0005524],cytoplasm [GO:0005737],,,1
Q6MWW2,Q6MWW2_MYCTU,Rv3538,Rv3538,GO:0005886; GO:0040007,IPR029069; IPR002539; IPR027090; ,,,,Probable dehydrogenase. Possible 2-enoyl acyl-CoA hydratase,plasma membrane [GO:0005886]; growth [GO:0040007],9634230; 21969609,,,MPIDLDVALGAQLPPVEFSWTSTDVQLYQLGLGAGSDPMNPRELSYLADDTPQVLPTFGNVAATFHLTTPPTVQFPGIDIELSKVLHASERVEVPAPLPPSGSARAVTRFTDIWDKGKAAVICSETTATTPDGLLLWTQKRSIYARGEGGFGGKRGPSGSDVAPERAPDLQVAMPILPQQALLYRLCGDRNPLHSDPEFAAAAGFPRPILHGLCTYGMTCKAIVDALLDSDATAVAGYGARFAGVAYPGETLTVNVWKDGRRLVASVVAPTRDNAVVLSGVELVPA,"30,216",286,,growth [GO:0040007],,plasma membrane [GO:0005886],,,1
I6Y3S9,I6Y3S9_MYCTU,Rv3530c,Rv3530c,,IPR036291; IPR002347; ,,,,Possible oxidoreductase,,9634230; 21969609,,,MTGMLKRKVIVVSGVGPGLGTTLAHRCARDGADLVLAARSAERLDDVAKQIIDTGRRAVAVRTDITDDDDVSNLVQATLAAYGKADVLINNAFRVPSMKPLAGTTFEHIRDAIELSALGTLRLIQAFTPALAQSHGAIVNVNSMVIRHSQPKYGTYKMAKSVLLAMSHSLATELGEQGIRVNSVAPGYIWGDTLKSYFDHQAGKYGTTVDQIYQATAANSDLKRLPTEDEVASAILFLASDLASGITGQTLDVNCGEYHT,"27,758",260,,,,,,,1
Q79F96,Q79F96_MYCTU,Rv3811,Rv3811,GO:0008270; GO:0008745; GO:0009253,IPR036505; IPR002502; IPR013207; IPR015510; IPR006619; ,,,,Uncharacterized protein,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; zinc ion binding [GO:0008270]; peptidoglycan catabolic process [GO:0009253],9634230,,,MAATVVIVAWIANRPPASSHEPSPTPNTQLAEQPLIGLGGGVTVRELTQDTPFSLVALTGDLAGTSARVRAKRPDGDWGPWYQTEYETEPRDPAGTDGSVELGGLNPGPRSTDPVFVGTTTTVQVAVTRPIDAPITQPPAGRPPNDLLDSGLGYRPATKEQPFGQNISAILISPPQAPPGTQWTPPTAVTMAGQPPAIISRAEWGADESLRCETPEYDRGVRAAVVHHTAGSNDYSPLESAGIVKAIYTYHSKTLGWCDIAYNALVDKYGQVFEGSAGGLTKPVEGFHTGGFNRNTWGVAMIGNFDDVAPTPIQIRTVGRLLGWRLGMDDVDPRSMVDLQSAGSSYTTFPGGAIARLPAIFTHRDVGNTDCPGNAAYAVMDEIRDIAAHFNDPPEELIKALEGGAIYQRWQALGGMNSALGAPTSPEADAADGARYATFAKGAMYWSPVTDAQPITGAIYEAWASQSYERGPLGLPTSAEIQEPLQITQNFQHGTLNFERLTGNVTEVVDGITTPLATRPPSGPTVPPEHFTLPTHPIT,"57,218",539,,peptidoglycan catabolic process [GO:0009253],N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; zinc ion binding [GO:0008270],,,,1
O69692,O69692_MYCTU,Rv3725,Rv3725,GO:0003824; GO:0005576; GO:0005618; GO:0050662,IPR001509; IPR036291; ,,,,Possible oxidoreductase,cell wall [GO:0005618]; extracellular region [GO:0005576]; catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],9634230,,,MQNATMRVLVTGGTGFVGGWTAKAIADAGHSVRFLVRNPARLKTSVAKLGVDVSDFAVADISDRDSVREALNGCDAVVHSAALVATDPRETSRMLSTNMAGAQNVLGQAVELGMDPIVHVSSFTALFRPNLATLSADLPVAGGTDGYGQSKAQIEIYARGLQDAGAPVNITYPGMVLGPPVGDQFGEAGEGVRSALWMHVIPGRGAAWLIVDVRDVAALHAALLESGRGPRRYTAGGHRIPVPELAKILGGSPAPRCWPSRCPIPRCVSRDRCWIKPGPICLSILRSPRQVCSTTHRCRSPTIRRAKKN,"32,726",309,,,catalytic activity [GO:0003824]; coenzyme binding [GO:0050662],cell wall [GO:0005618]; extracellular region [GO:0005576],,,1
P72041,P72041_MYCTU,Rv3775,lipE Rv3775,GO:0005886,IPR001466; IPR012338; ,,lipE,,Probable lipase LipE,plasma membrane [GO:0005886],9634230; 21969609,,,MRAGDGKIRVPADLDAVTATGEEDHSEIDGAAVDRIWRAARHWYRAGMHPAIQLCIRHHGRVVLNRAIGHGWGNAPTDEADAEKIPVTTDTPFCVYSAAKAITATVVHMLVERGHFALDDRVCEYLPSYTSHGKHRTTIRHVLTHSAGVPFPTGPRPDVRRADDHEYAVERLGELRPLYRPGLVHIYHALTWGPLMREIVYAATGKEIREILATEILDPLGFRWTNFGVAERDVPLVAPSHATGRQLPPVIAAVFRKAIGGTVHEIIPYTNTPFFLSTILPSSNTVSTANELSRFMEILRRGGELDGVRVLSPETLRGAVTECRRLRPDFATGLMPLRWGTGFMLGSAKYGPFGRNAPAAFGHLGLVNIAVWADPERALSGGLISSGKPGRDPEAGRYGALLNAITAEIPRASSG,"45,274",415,,,,plasma membrane [GO:0005886],,,1
O69699,O69699_MYCTU,Rv3732,Rv3732,GO:0005887,IPR019283; ,,,,Conserved protein,integral component of plasma membrane [GO:0005887],9634230; 21969609,,,MAVLPACRLGLVVCVATAVITATMVLATPSYACACGAAVTAHGSQATLNHEVALLHWDGTTETIVMQLAMNADTDNVALVVPTPTPAIVTTADQSTFGELDTLSAPLIEHQRHWSLRRGVGASGPQEAAARAPHVLNQVRLGPLEATTLTGGDLSGLQTWLSDNGYAIRPAVSAALDPYVRDGWAFVAIRLTSTDLIVGGLDPVRMTFRSSRLVYPMRLSVAAQEPQHVTIFTLSDHRQQRTDADAATQTTHVRFAGDMSTAVRDPLLRELIGNHGSYLTKVEVDIYQTSRISSDFTFGNAPNDDPYRQVVTVYDDVALPPLLLVVVSAIAVGAAGGAVVVVLRRRRRAHTG,"37,533",352,,,,integral component of plasma membrane [GO:0005887],,,1
P96235,P96235_MYCTU,Rv3843c,Rv3843c,GO:0016021,IPR025565; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MIQVCSQCGTGWNVRERQRVWCPRCRGMLLAPLADMPAEARWRTPARPQVPTASDTRRTPPRLPPGFRWIAVRPGAAPPPRHGPRLRGPTPRYAGIPRWGLTDHVDQAPVPASAKAGPSPAAVRTTLLVSLLVFSIAVVVFVVRYVLLVINRNTLLNSVVASASVWLGVLVSLAAIAAAGTTIVLLVRWLVARRAAAFMHQGLPERRSARELWAGCLLPMVNLLWAPLYVIELALVEDRYTRLRRPIVVWWIVWIVSNAISMFAFATSWVTDAQGIANNTTMMVLAYLCAAAAVAAAARVFEGFEQKPVERPAHRWVVVNTDGRSAPASSVAVELDGQEPAA,"37,385",342,,,,integral component of membrane [GO:0016021],,,2
O69719,O69719_MYCTU,Rv3752c,tadA Rv3752c,GO:0002100; GO:0008270; GO:0040007; GO:0052717,IPR016192; IPR002125; IPR016193; IPR028883; ,,tadA,,tRNA-specific adenosine deaminase (EC 3.5.4.33),tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270]; growth [GO:0040007]; tRNA wobble adenosine to inosine editing [GO:0002100],9634230; 21969609,,FUNCTION: Catalyzes the deamination of adenosine to inosine at the wobble position 34 of tRNA(Arg2). {ECO:0000256|HAMAP-Rule:MF_00972}.,MTTDEDLIRAALAVAATAGPRDVPVGAVVVGADGTELARAVNAREALGDPTAHAEILAMRLAAGVLGDGWRLEGTTLAVTVEPCTMCAGALVLARVARLVFGAWEPKTGAVGSLWDVVRDRRLNHRPEVRGGVLARECAAPLEAFFARQRLG,"15,877",152,Cytidine and deoxycytidylate deaminase family,growth [GO:0040007]; tRNA wobble adenosine to inosine editing [GO:0002100],tRNA-specific adenosine-34 deaminase activity [GO:0052717]; zinc ion binding [GO:0008270],,,,1
I6Y479,I6Y479_MYCTU,Rv3658c,Rv3658c,GO:0016021,IPR018076; ,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MSGIASAALILSLALVVLPGSPRCRLTPDDTGRRVLLVGARRVAWGVGCVAVGVAALLPLPTVVAVAVLGATLGLRYRRRRRYLRRSREGQALEAALELVVGELRAGAHPVRAFSIAADETGGPVAVALRAVAARARLGADVTAGLLAAARSSALPAYWERLAVCWQLGSDHGLAIASLMRAAQRDVAERQRFSARVSAGMAGARASAAILAILPLLGVLLGQLIGARPLSFLLTGRVGGWLLVVGLTLACAGLLWSDRITDRPVL,"27,633",266,,,,integral component of membrane [GO:0016021],,,1
I6Y460,I6Y460_MYCTU,Rv3635,Rv3635,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MPAPRMPRVALVAVLLITVQLVVRVVLAFGGYFYWDDLILVGRAGTGGLLSPSYLFDDHDGHVMPGAFLVAGAIIRVAPLVWTGPAISLVVLQLLESLALLRALYVISSWRPVLLIPLTFALFTPLAVPGFAWWAAALNSLPMLAALAWVCADAILLVRTGNHRYAVTGVLVYLGGLLFFEKAAVIPFVSFAVAALQCHVRGDRSALATVWRAGVRLWTPSLALTVGWVALYLAVVDQRRWSSDLSMTWDLLCRSVTHGIVPALAGGPWDWARWAPASPWATPPAVVMVLGWLVLIAVLALSLVRKRRIGPVWLTAAGYAVACQVPIFLMRSSPFTALELAQTLRYFPDLVVVLALLAAVALQAPNRAGTRWLDASPARAVATVASAVLFLTSSLYSTATFLASWRDNPTEGYLKNAQASLAAAASGAPLLDQEVDPLVLQRVAWPENLASHMFALLRVRPEFATTTTQLRMFTSTGRLVDAKVTWVRTIIAGPVPQCGYFVQPDRPERLILDGPLLPGDWTVELNYLANSDGSMALALSDGPERKVPVHPGLNRVYARLPGAGDAITVRANTTALSLCIGAAPVGFLAPA,"63,530",591,,,,integral component of membrane [GO:0016021],,,1
P96859,P96859_MYCTU,Rv3577,Rv3577,GO:0005886,IPR036866; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MPTARSDAPLSVTWMGVATLLVDDGSSALMTDGYFSRPGLARVAAGKVSPSAERVDGCLARANVSRLTAVIPVHTHIDHAMDSALVADRTGAQLVGGESAANVGRGYGLPEESLVVAVPGEPIQLGAFDVTLVESHHCPPDRFPGVISAPLTPPVKASAYRCGEAWSTLVHHRPSGRRLLIQDSAGFVSGALAGYRADAAYLSVGQLGLQPPSYLLEYWTETVRTVGVRRVILIHWDDFFRPLSKPLRALPYAADDLDLSIRILDELAAQDGVALQMPTVWRREDPWM,"30,925",288,,,,plasma membrane [GO:0005886],,,4
I6X849,I6X849_MYCTU,Rv3706c,Rv3706c,GO:0016021,,,,,Conserved hypothetical proline rich protein,integral component of membrane [GO:0016021],9634230,,,MRHMSETSETPTPPPHQTPKVFKAAAWVAIAAGTVFIVAVIFFTGYILGKHAGHGGFHHRQHHQHPAMMLRPGSPHGGPAAVRPGPGPGGPGQVPSSVSPPATPAP,"10,953",106,,,,integral component of membrane [GO:0016021],,,1
O07796,O07796_MYCTU,Rv3827c,Rv3827c,GO:0005886,IPR001959; IPR021027; ,,,DOMAIN 14 50 HTH_OrfB_IS605. {ECO:0000259|Pfam:PF12323}.; DOMAIN 206 321 OrfB_IS605. {ECO:0000259|Pfam:PF01385}.,Possible transposase,plasma membrane [GO:0005886],9634230,,,MMARFEVPEGWCVQAFRFTLDPTEDQARALARHFGARRKAYNWAVATLKADIEAWRVTGIGTVKPSLRVLRKRWNTVKDEVCVNAETGAVWWPECSKEAYADGIGGAVDAYWNWQNSRSGKREGKTMGFPRFKKKGRDQDRVTFTTGAMRVEPDRRHLTLPVVGTVRTHENTRRIERLIATGRARVLAISVRRNGTRLDASVRVLVQRPQQPNVAQPGSRVGVDVGVRRLATVANEAGAVLEEVPNPRPLDTALKELRYASRARSRCTKGSRRYRERTTEISRLHRRVNDVRTHHLHVLTTRLAQTHGHIVVEGLDAAGMLRQKGLPGARARRRGLSDSALGTPRRHLSYKTGWYGSALVVADRWFPSLSVEPTVRPGLARLVAVKRGREAAAWLPNNPETGCKSRDH,"45,882",408,,,,plasma membrane [GO:0005886],,,1
O07806,O07806_MYCTU,Rv3817,Rv3817,GO:0005524; GO:0016301; GO:0016773; GO:0046677,IPR002575; IPR024165; IPR011009; ,,,,Possible phosphotransferase,"ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]; response to antibiotic [GO:0046677]",9634230; 21969609,,,MSFPSSPPALPAIVARFAVGRPVRAVWVNELGGVTFRVDSGMGAGCEFIKVARRGTADFANEARRLRWAAPYLAVPRVLGVGVDGDWAWLHTDALPGLSAVHPRWRASPQVAVPALGAGLRTLHDSLPVHSCPFDWSTASRLAKLAPARRAELGDSPPVDRLVVCHGDACSPNTILDDTGRCCGHVDFGNLGVADRWADLAVATLSLQWNFPDYPGQVRDDEFFAAYGVAPDPARIDYYRRLWQAEDDSSR,"27,242",251,Aminoglycoside phosphotransferase family,response to antibiotic [GO:0046677],"ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity, alcohol group as acceptor [GO:0016773]",,,,1
P96242,P96242_MYCTU,Rv3836,Rv3836,,IPR010428; IPR038555; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTVRMDPQRFDELVSDALDLIPPELADAMDNVVVLVANRHPQHENLLGQYEGVALTERGSDYAGSLPDAITIYREALLDACDSEDEVVDQVAITVIHEVAHHFGIDDERLDQLGWRDEPAPGRGNPDLSAPDAMNGP,"15,027",137,,,,,,,2
P96233,P96233_MYCTU,Rv3845,Rv3845,GO:0005886,,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230,,,MDRVRRVVTDRDSGAGALARHPLAGRRTDPQLAAFYHRLMTTQRHCHTQATIAVARKLAERTRVTITTGRPYQLRDTNGDPVTARGAKELIDAHYHVDTRTHPHNRAHTDTMQNSKPAR,"13,467",119,,,,plasma membrane [GO:0005886],,,2
I6YCC4,I6YCC4_MYCTU,Rv3529c,Rv3529c,,IPR027417; ,,,,Uncharacterized protein,,9634230; 21969609,,,MTRRPDRKDVATVDELHASATKLVGLDDFGTDDDNYREALGVLLDAYQGEAGLTVLGSKMNRFFLRGALVARLLSQSAWKQYPEHVDVAIKRPIFVTGLVRTGTTALHRLLGADPAHQGLHMWLAEYPQPRPPRETWESNPLYRQLDAQFTQHHAENPGYTGLHFMAAYELEECWQLLRQSLHSVSYEALAHVPSYADWLSRQDWTPSYCRHRRNLQLIGLNDAEKRWVLKNPSHLFALDALMATYPDALVVQTHRPVETIMASMCSLAQHTTEGWSTKFVGAQIGADAMDTWSRGLERFNAARAKYDSAQFYDVDYHDLIADPLGTVADIYRHFGLTLSDEARQAMTTVHAESQSGARAPKHSYSLADYGLTVEMVKERFAGL,"43,346",384,,,,,,,1
Q79FA4,Q79FA4_MYCTU,Rv3724B,cut5b Rv3724B,GO:0008152; GO:0016787,IPR029058; IPR000675; ,,cut5b,DOMAIN 13 187 Cutinase. {ECO:0000259|SMART:SM01110}.,Probable cutinase [second part] Cut5b,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230,,,MAPGSHLVLAASEDCSSTHCVSQVGAKSLGVYAVNYPASNDFASSDFPKTVIDGIRDAGSHIQSMAMSCPQTRQVLGGYSQGAAVAGYVTSAVVPPAVPVQAVPAPMAPEVANHVAAVTLFGAPSAQFLGQYGAPPIAIGPLYQPKTLQLCADGDSICGDGNSPVAHGLYAVNGMVGQGANFAASRL,"18,787",187,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
O69722,O69722_MYCTU,Rv3756c,proZ Rv3756c,GO:0005215; GO:0005886; GO:0016021; GO:0031460; GO:0055085; GO:0075136,IPR000515; IPR035906; ,,proZ,,Possible osmoprotectant (Glycine betaine/carnitine/choline/L-proline) transport integral membrane protein ABC transporter ProZ,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; glycine betaine transport [GO:0031460]; response to host [GO:0075136]; transmembrane transport [GO:0055085],9634230; 21969609,,,MNFLQQALSYLLTASNWTGPVGLAVRTCEHLEYTAVAVAASALIAVPVGLLIGHTGRGTLLVVGAVNGLRALPTLGVLLLGVLLFGLGLGPPLVALMLLGIPSLLASTYAGIASVDPLVVDAARAMGMTESQVLLRVEVPNALPLMLGGLRSATLQVVATATVAAYASLGGLGGYLIDGIKERRFHIALVGAMMVAALALTLDGLLALAGWVSVPGTGRMRKLAAVVDKPAAGGGHALR,"24,182",239,Binding-protein-dependent transport system permease family,glycine betaine transport [GO:0031460]; response to host [GO:0075136]; transmembrane transport [GO:0055085],transporter activity [GO:0005215],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6Y4C4,I6Y4C4_MYCTU,Rv3707c,Rv3707c,,IPR025442; ,,,DOMAIN 14 325 DUF4185. {ECO:0000259|Pfam:PF13810}.,Uncharacterized protein,,9634230; 21969609,,,MLRIGPTAGTGTPTGDYGIGATDLCEFVEFPSQLLQVCGDSFAGQGVGFGGWYAPVALHVDTESIDDPAGVRYTGVTGVGTPLLADPTPPGDSQLPAGVVQINRRNYLMVTTTKDLQPQNSRLVRAEAARGGWQTVSGSRRNAAYQDGRQTQISGYYDPVPTPDSPTGWVYIVADSFTRGEPAVLYRATPESFTDRSRWQGWAGGPDGGWNKPPTPLWPDQLGEMSIRQIDGQTVLSYFNASTGNMEVRVAHHPTSLGAAPVTTVVRHDEWPEPAESLPPPYDNRLAQPYGGYISPGSTIDELRIFVSQWDTRARQNGPYRVIQFAVNPFKPWSDP,"36,482",336,,,,,,,1
P96845,P96845_MYCTU,Rv3563,fadE32 Rv3563,GO:0016627; GO:0050660,IPR036250; IPR009075; IPR013786; IPR037069; IPR009100; ,,fadE32,DOMAIN 9 102 Acyl-CoA_dh_N. {ECO:0000259|Pfam:PF02771}.; DOMAIN 183 318 Acyl-CoA_dh_1. {ECO:0000259|Pfam:PF00441}.,Probable acyl-CoA dehydrogenase FadE32,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",9634230; 21969609,,,MTMEFALNEQQRDFAASIDAALGAADLPGVVRAWAAGDVAPGRKVWQQLANLGVTALGVAEKFDGLGASPVDLVVALERLGRWCVPGPVTESIAVAPILLAHDDQAERSHGLASGELIATVAMPPRVPRAVDADTAGLVLLAGDGSVTEGTPGDCHRSVDPSRRLYEVAASGQAWRAPKDVVARAYEFGALATAAQLVGAGQALLEAAVNYAKQRTQFGRAIGSYQAIKHKLADVHIAIELACPLVYGAAVSLEPRDVSAAKAAASEAALLAARWALQTHGAIGFTCEHDLSLWLLRVQALHSAWGTPQEHRRRVLEAL,"33,487",319,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on the CH-CH group of donors [GO:0016627]",,,,2
O53572,O53572_MYCTU,Rv3587c,Rv3587c,GO:0005576; GO:0016021,,,,,Probable conserved membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230; 21969609,,,MLDLEPRGPLPTEIYWRRRGLALGIAVVVVGIAVAIVIAFVDSSAGAKPVSADKPASAQSHPGSPAPQAPQPAGQTEGNAAAAPPQGQNPETPTPTAAVQPPPVLKEGDDCPDSTLAVKGLTNAPQYYVGDQPKFTMVVTNIGLVSCKRDVGAAVLAAYVYSLDNKRLWSNLDCAPSNETLVKTFSPGEQVTTAVTWTGMGSAPRCPLPRPAIGPGTYNLVVQLGNLRSLPVPFILNQPPPPPGPVPAPGPAQAPPPESPAQGG,"27,099",264,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,3
P72045,P72045_MYCTU,Rv3779,Rv3779,GO:0005576; GO:0009247; GO:0016021; GO:0016758; GO:0040010,,,,,Probable conserved transmembrane protein alanine and leucine rich,"extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; transferase activity, transferring hexosyl groups [GO:0016758]; glycolipid biosynthetic process [GO:0009247]; positive regulation of growth rate [GO:0040010]",9634230; 21969609,,,MGLWFGTLIALILLIAPGAMVARIAQLRWPVAIAVGPALTYGVVALAIIPYGALGIPWNGWTALAALAVTCAVATGLQLLLARFRDLDAEALAVSRWPAVTVAAGVLLGALLIGWAAYRGIPHWQSIPSTWDAVWHANTVRFILDTGQASSTHMGELRNVETHAPLYYPSVFHGLVAVFCQLTGAAPTTGYTLSSLAASVWLFPVSAAVLTWRAVRSHPGALWSASCASAEWRAAGAAGTAAALSASFTAVPYVEFDTAAMPNLAAYGIAVPTMVLITSTLRHRDRIPVAVLALVGVFSLHITGGIVVALLVSAWWLFEALRHPVRSRLADLLTLAGVAAMAGLVMLPQFLSVRQQEDIIAGHAFPTYLSKKRGLFDAVFQHSRHLNDFPVQYALIVLAAIGGLILLVKKIWWPLAVWLLLIVMNVDAGTPLGGPIGGVAGALGEFFYHDPRRIAAATTLLLMLMAGVALFATVMLLVAAAKRLTDRFRPQPVSVWASATATLLIGATLVSAWHYFPRHRFLFGDKYDSVMIDQKDLDAMAYLASLPGARDTLIGNANTDGTAWMYAVAGLHPLWTHYDYPLQQGPGYHRFIFWAYGRNGESDPRVLEAIQVLRIRYILTSTPTVRGFAVPDGLVSLETSRSWAKIYDNGEARIYEWRGTAAATHS,"71,795",666,,glycolipid biosynthetic process [GO:0009247]; positive regulation of growth rate [GO:0040010],"transferase activity, transferring hexosyl groups [GO:0016758]",extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,2
O69694,O69694_MYCTU,Rv3727,Rv3727,GO:0005886; GO:0016491,IPR002937; IPR036188; ,,,DOMAIN 17 324 Amino_oxidase. {ECO:0000259|Pfam:PF01593}.,Possible oxidoreductase,plasma membrane [GO:0005886]; oxidoreductase activity [GO:0016491],9634230,,,MKPSPADTHVVIAGAGIAGLAAAMILAEAGVRVTLCEAASEAGGKAKSLRLADGHPTEHSLRVYTDTYQTLLTLFSRIPTEHDRTVLDNLVGVSMVSATAQGVIGRIAAPVALQRRRPTFARIIGKVVEPPRQLVRILLRGPMVIVGLAQRGVPATDVLHYLYAHLRLLWMCRERLLAELGDISYADYLQLGCKSAQAQEFFSAVPRIYVAARTSAEAAAIAPIVLKGLFRLKSNCPSALNDAKLPAIMMMDGPTSERMVDPWIRHLTRLGVDIHFNTRVGDLEFDDGRVTALISSDGRRFACDYALLAVPYLTLRELAKSAHVKRYLPQLTQQHALALEASNGIQCFLRDLPATWPPFIRPGVVTTHLQSQWSLVCVLQGEGFWKNVRLPEGTRYVLSITWSDVETPGPVFDRPLSECTPDEILTECLTQCGLDKSNVLGWRIDHELKHLDEAEYEKVASELPPHLVSAPARGQRMVNFSPLTVLMPGARHRSPGICTSVPNLLLAGEVIYSPDLTLFVPTMEKAACSGYLAARQIMNMVASHAAPLRIDFRDPAPFAVLRRVDRWFWSRRRRPPDRSTFATPPTAMPAPSHLTDVDRSAS,"66,294",602,,,oxidoreductase activity [GO:0016491],plasma membrane [GO:0005886],,,1
O06376,O06376_MYCTU,Rv3631,Rv3631,GO:0016740; GO:0019375,IPR001173; IPR029044; ,,,DOMAIN 16 149 Glyco_trans_2-like. {ECO:0000259|Pfam:PF00535}.,Possible transferase (Possibly glycosyltransferase),transferase activity [GO:0016740]; galactolipid biosynthetic process [GO:0019375],9634230; 21969609,,,MASKMDTETHYSDVWVVIPAFNEAAVIGKVVTDVRSVFDHVVCVDDGSTDGTGDIARRSGAHLVRHPINLGQGAAIQTGIEYARKQPGAQVFATFDGDGQHRVKDVAAMVDRLGAGDVDVVIGTRFGRPVGKASASRPPLMKRIVLQTGARLSRRGRRLGLTDTNNGLRVFNKTVADGLNITMSGMSHATEFIMLIAENHWRVAEEPVEVLYTEYSKSKGQPLLNGVNIIFDGFLRGRMPR,"26,213",241,,galactolipid biosynthetic process [GO:0019375],transferase activity [GO:0016740],,,,1
I6YCP0,I6YCP0_MYCTU,Rv3651,Rv3651,,,,,,Uncharacterized protein,,9634230; 21969609; 29119630,X-ray crystallography (1),,MTHDWLLVETLGDEPAVVARGRELKKLVPITTFLRRSPYLAAVRTAIAETLQTGQSLTSITPKHDRVIRTEPVIMTDGRMHGVQVWSGPTDAEPPDRPIPGPLKWDLTRGVATDTPESLTNSGKNPEVEITYGRAFAEDLPARELNPNETQVLAMAVKAKPGKTLCSIWDLTDWQGTPIRIGFVARSALEPGPNGRDHLVARAMNWRAETKAPAVPVDDLAQRILIGLAQAGVHRALVDLKTWTLLKWLDQPCSFYDWRRSAADGPRLHPDDQHVIDAMTRDLANGSASHVLRLPGHDVDWVPVHVTVNRIELEPDTFAGLVALRLPTDEELADAGLPKATDVTT,"37,967",345,,,,,,,1
I6Y469,I6Y469_MYCTU,Rv3647c,Rv3647c,,,,,,Uncharacterized protein,,9634230; 21969609,,,MSQLSFFAAESVPPAVADLSGVLAGPGQIVLVGCGARLSVVVAESWRASALAEMIQEAGLVPEVARTDENTPLVRTAVDPLLCGIAAEWTRGAVKTVPPRWLPGPRELRAWTLAAGSPEADRYLLGLDPHAPDTHSPLASALMRVGIAPTLIGTRGTRPALRISGRRRLSRLVENVGEPPDGAEAWVQWPRT,"20,346",192,,,,,,,1
P96214,P96214_MYCTU,Rv3863,Rv3863,GO:0005618; GO:0005886,IPR008984; ,,,,Uncharacterized protein,cell wall [GO:0005618]; plasma membrane [GO:0005886],9634230; 21969609,,,MAGERKVCPPSRLVPANKGSTQMSKAGSTVGPAPLVACSGGTSDVIEPRRGVAIIGHSCRVGTQIDDSRISQTHLRAVSDDGRWRIVGNIPRGMFVGGRRGSSVTVSDKTLIRFGDPPGGKALTFEVVRPSDSAAQHGRVQPSADLSDDPAHNAAPVAPDPGVVRAGAAAAARRRELDISQRSLAADGIINAGALIAFEKGRSWPRERTRAKLEEVLQWPAGTIARIRRGEPTEPATNPDASPGLRPADGPASLIAQAVTAAVDGCSLAIAALPATEDPEFTERAAPILADLRQLEAIAVQATRISRITPELIKALGAVRRHHDELMRLGATAPGATLAQRLYAARRRANLSTLETAQAAGVAEEMIVGAEAEEELPAEATEAIEALIRQIN,"41,088",392,,,,cell wall [GO:0005618]; plasma membrane [GO:0005886],,,1
Q6MWW6,Q6MWW6_MYCTU,Rv3514,PE_PGRS57 Rv3514,,IPR000084; ,,PE_PGRS57,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS57,,9634230,,,MSFVLIAPEFVTAAAGDLTNLGSSISAANASAASATTQVLAAGADEVSARIAALFGGFGLEYQAISAQVAAYHQRFVQALSTGAGAYASAEAAAAEQIVLGVINAPTQALLGRPLIGDGANATTPGGAGGAGGLLFGNGGAGAAGAPGQAGGPGGPAGLWGNGGPGGAGGSGGGTGGAGGAGGWLFGVGGAGGVGGAGGGTGGAGGPGGLIWGGGGAGGVGGAGGGTGGAGGRAELLFGAGGAGGAGTDGGPGATGGTGGHGGVGGDGGWLAPGGAGGAGGQGGAGGAGSDGGALGGTGGTGGTGGAGGAGGRGALLLGAGGQGGLGGAGGQGGTGGAGGDGVLGGVGGTGGKGGVGGVAGLGGAGGAAGQLFSASGAAGNAGVGGAGGQGGDGGAGGAGADADQPGATGGTGFAGGAGGAGGAGGSSGAGGTNGSGGAGGQGGAGGAGGAGADNPTGIGGTGGDGGTGGAAGAGGAGGAAGTGGTGGMIGTTGNAGVGGAGGQGGDGGAGGAGADADQPGATGGTGFAGGAGGAGGAGGSSGAGGTNGSGGAGGTGGQGGAGGAGGAGADNPTGIGGTGGDGGTGGAAGAGGAGGAAGTGGTGGMIGTTGNAGVGGAGGQGGDGGAGGAGADADQPGATGGTGFAGGAGGAGKAGGSSSAGGTNSSGSAGGTGRQSGTGGAGGAGADNPTGIGGTGGDGGTGGAAGAGGAGGAAGTGGTGGMIGTTGNAGVGGAGGSSGAGGTNGSGGAGGTDGQGGAGGAGGAGADNPTGIGGTGGDGGTGGAAGAGGAGGAAGTGGTGGMIGTTGNAGVGGAGGQGGDGGAGGAGADADQPGATGGTGFAGGAGGAGGSGGSSCAGGTNGSGGAGGTCGQVVAGGAGISFSNGSNGGTGGTGGVGGTGGDGGNAGTGAGDPGKGGTGGTGGTGGSGGAGGSGGANFNGGTGGTGGTGGKGGLNTDGLSSATSGTGGTGGTGGKGGTGGAGDDSAGGTGGTGGAGGNAGAGGLANTGGTAGNAGIGGDGGQGGNGGQGDSGSGLGGQPGFAGGAGGKGGAGGSSGAGGTNGSGGAGGAGGQGGAGGAGISFSNGSNGGTGGTGGVGGTGGDGGNAGTGAGDPGKGGTGGTGGTGGSGGAGGSGGANFNGGTGGTGGTGGTGGKGGMGGIAGDGGPGGDGGNAGVGGKGGTNGNGGSGGTGGTGGAGGNAGAGGLANTGGTAGNAGIGGDGGQGGNGGQGDSGSGLGGQPGFAGGPGGKGGAGGNAGTGGTNGSGAGGAGGQGGAGGAGISFSNGSNGGTGGTGGVGGTGGDGGNAGTGAGDPGKGGTGGTGGTGGSGGAGGSGGANFNGGTGGTGGTGGTGGKGGMGGIAGDGGPGGDGGNAGVGGKGGTNGNGGSGGTGGTGGPGGSGGAPTGSGTGGKGGAGGDGGDGADGGAATGVGDGGDGGNGGNGGNGGTGVGSPGGLGGAGGTGGLGGAGAGGGADGDDGDDGQPGNNGS,"115,753",1489,,,,,,,1
O69724,O69724_MYCTU,Rv3758c,proV Rv3758c,GO:0005524; GO:0005886; GO:0016887; GO:0031460; GO:0075136,IPR003593; IPR003439; IPR017871; IPR027417; ,,proV,,Possible osmoprotectant (Glycine betaine/carnitine/choline/L-proline) transport ATP-binding protein ABC transporter ProV,plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; glycine betaine transport [GO:0031460]; response to host [GO:0075136],9634230; 21969609,,,MICFDDVSKVYAHGATAVDRLTLEVPNGMLTVFVGPSGCGKTTALRMINRMVDPTSGTITVDGTDVSTVNAVKLRLGIGYVIQNAGLMPHQRVIDNVATVPVLKGQPRRAARKAGYEVLERVGLDPKVATRYPAQLSGGEQQRVGVARALAADPPILLMDEPFSAVDPVVRHELQNEILRLQAELHKTIVFVTHDIDEALKLADLVAVFAPGGALAQYDETARLLSSPANDFVSKFIGLGRGYRWLQLFDAAGLPVRDIEQVSVNGLSDARDRQVRDGWVLVVDGAGAPLGWIDADGRRRHRGGAALSDAMTVGGSVFRPNGNLSQALDAALSSPSGVGVAVDGGGKVIGGILAADVLAEFQKGKKAGGGAKPCTT,"39,570",376,,glycine betaine transport [GO:0031460]; response to host [GO:0075136],ATPase activity [GO:0016887]; ATP binding [GO:0005524],plasma membrane [GO:0005886],,,1
I6Y3Q7,I6Y3Q7_MYCTU,Rv3510c,Rv3510c,GO:0016787; GO:0016831,IPR032465; IPR006680; IPR032466; ,,,,Conserved protein,carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787],9634230; 21969609,,,MTIDVWMQHPTQRFLHGDMFASLRRWTGGSIPETDIPIEATVSSMDAGGVTLGLLSAWRGPNGQDLISNDAVAEWVRLYPNRFAGLAAVDLDRPMAAVRELRRRVGEGFVGLRVVPWLWGAPPTDRRYYPLFAECVQSAVPFCTQVGHTGPLRPSETGRPIPYIDQVALDFPELVIVCGHVGYPWTEEMVAVARKHENVYIDTSAYTIKRLPGKLVRFMKTDTGQRKVLFGTNYPMIAHTHALTGLDELGLSDEARRDFLHGNAVRVFKLDPRGKVQT,"31,068",278,,,carboxy-lyase activity [GO:0016831]; hydrolase activity [GO:0016787],,,,1
O69720,O69720_MYCTU,Rv3753c,Rv3753c,,IPR023869; ,,,,Conserved protein,,9634230; 21969609,,,MQRPAADTPDGFGVAVVREEGRWRCSPMGPKALTSLRAAETELRELRSAGAVFGLLDVDDEFFVIVRPAPSGTRLLLSDATAALDYDIAAEVLDNLDAEIDPEDLEDADPFEEGDLGLLSDIGLPEAVLGVILDETDLYADEQLGRIAREMGFADQLSAVIDRLGR,"17,917",166,,,,,,,1
I6XI14,I6XI14_MYCTU,Rv3713,cobQ2 Rv3713,GO:0003824; GO:0006541; GO:0009236,IPR029062; IPR017929; IPR033949; IPR011698; ,,cobQ2,DOMAIN 3 198 GATase cobBQ-type. {ECO:0000259|PROSITE:PS51274}.,Possible cobyric acid synthase CobQ2,catalytic activity [GO:0003824]; cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541],9634230; 21969609,,,MVRIGLVLPDVMGTYGDGGNAVVLRQRLLLRGIAAEIVEITLADPVPDSLDLYTLGGAEDYAQRLATRHLRRYPGLQRAAGRGAPVLAICAAIQVLGHWYETSSGDRVDGVGLLDVTTSPQDARTIGELVSKPLLAGLTQPLTGFENHRGGTVLGPGTSPLGAVVKGAGNRAGDGFDGAVAGSVVATYMHGPCLARNPELADLLLSKVVGELAPLDLPEVDLLRRERLSAR,"24,158",231,,cobalamin biosynthetic process [GO:0009236]; glutamine metabolic process [GO:0006541],catalytic activity [GO:0003824],,,,1
O53581,O53581_MYCTU,Rv3802c,Rv3802c,GO:0005576; GO:0005618; GO:0008970; GO:0016021; GO:0016042; GO:0016298; GO:0040007; GO:0047617; GO:0052689,IPR029058; IPR000675; ,,,,Probable conserved membrane protein,cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970]; growth [GO:0040007]; lipid catabolic process [GO:0016042],9634230; 21969609; 29247008,X-ray crystallography (1),,MAKNSRRKRHRILAWIAAGAMASVVALVIVAVVIMLRGAESPPSAVPPGVLPPGPTPAHPHKPRPAFQDASCPDVQMISVPGTWESSPQQNPLNPVQFPKALLLKVTGPIAQQFAPARVQTYTVAYTAQFHNPLTTDNQMSYNDSRAEGTRAMVAAMTDMNNRCPLTSYVLIGFSQGAVIAGDVASDIGNGRGPVDEDLVLGVTLIADGRRQQGVGNQVPPSPRGEGAEITLHEVPVLSGLGLTMTGPRPGGFGALDGRTNEICAQGDLICAAPAQAFSPANLPTTLNTLAGGAGQPVHAMYATPEFWNSDGEPATEWTLNWAHQLIENAPHPKHR,"35,448",336,,growth [GO:0040007]; lipid catabolic process [GO:0016042],acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; lipase activity [GO:0016298]; phosphatidylcholine 1-acylhydrolase activity [GO:0008970],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
I6YGL1,I6YGL1_MYCTU,Rv3591c,Rv3591c,GO:0016787,IPR029058; IPR000073; ,,,DOMAIN 19 246 AB hydrolase-1. {ECO:0000259|Pfam:PF12697}.,Possible hydrolase,hydrolase activity [GO:0016787],9634230; 21969609,,,MPRMPANLLTHRGGRGEPLVLVHGLMGRGSTWARQLPWLTLLGAVYTYDAPWHRGRDVADPHPISTERFVADLGDAVSALGAPTRMVGHSMGALHSWCLAAERPELVSALVVEDMAPDFRGRTTGPWEPWLRALPVEFDSAEQVFAEFGPVAGRYFLDAFDRTATGWRLHGRTARWIEIAAEWGTRDYWAQWRAVRSPALLIEAGDGVTPPGQMRAMAERDYPTAYLRVPDAGHLVHDEAPQVYRRAVESFLAGLTP,"28,542",257,,,hydrolase activity [GO:0016787],,,,1
O06363,O06363_MYCTU,Rv3644c,Rv3644c,GO:0003677; GO:0003887; GO:0005829; GO:0006261; GO:0008408,IPR003593; IPR008921; IPR004622; IPR027417; ,,,DOMAIN 39 182 AAA. {ECO:0000259|SMART:SM00382}.,Possible DNA polymerase,cytosol [GO:0005829]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA-dependent DNA replication [GO:0006261],9634230; 21969609,,,MSGVFTRLVGQQAVEAELLATAKAARRDSAHSAGGGGTMTHAWLLTGPPGSGRSVAALCFAAALQCTSGGEPGCGRCRACTTTLAGTHADVRRVIPEGLSIGVDEMRAIVQIAARRPTTGHWQIVVIEDADRLTEGAANALLKVVEEPPPSTVFLLCAPSVDPEDIAVTLRSRCRHVALVTPSTHAIAQVLSDGDGLDPDTANWAASVSGGHVGRARRLATDPQARQRRERALGLARDAATPSRAYAAAEELVAGAEAEALALTAQRIEAETEELRTALGAGGTGKGTGAALRGATGAMKDLERRQKSRQTRASRDALDRALIDLATYFRDALLVAAHAGGVRANHPDMADRVAALAAHAPPERLLRCIEAVLACREALAVNVKPKFAVDAMVATIGQELR,"41,785",401,,DNA-dependent DNA replication [GO:0006261],3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],cytosol [GO:0005829],,,3
I6XHI0,I6XHI0_MYCTU,Rv3541c,Rv3541c,,IPR029069; ,,,,Conserved protein,,9634230; 21969609,,,MTVVGAVLPELKLYGDPTFIVSTALATRDFQDVHHDRDKAVAQGSKDIFVNILTDTGLVQRYVTDWAGPSALIKSIGLRLGVPWYAYDTVTFSGEVTAVNDGLITVKVVGRNTLGDHVTATVELSMRDS,"13,952",129,,,,,,,1
P72062,P72062_MYCTU,Rv3796,Rv3796,GO:0042781,IPR001279; IPR036866; ,,,,Conserved protein,3'-tRNA processing endoribonuclease activity [GO:0042781],9634230; 21969609,,,MLLGMHQAGHVGTHERRAAATRRSALTAAGLAVVGAGVLGASACSPQKSPQPSSPRLPDNALITLGVAAGPPPTPSRVGISSVLKIGRDLYVIDCGLGSLNAFTNAGLQFDDLKAMFITHLHTDHIVDYYNFFLSGGFLAPPGRAPVLVYGPGPAGGLPPSEVGNPNPATVNPANPTPGLAAATEALHRAFAYTSNIFIRDYGIDNVADLVKVTEIGLPPGSDYRNRAPKMSPFSVASDDNVSVTATLVSHYDVYPAFGFRFDLKKSGVSVTFSGDTTKSDNLITLAQGTDILVHEAVFSLDTAYFGNAFPPNYLVNSHTSAEQVGEVAAAAKPKQLILSHYAPDDLPDSQWLDKIKKNYSGMTTIARDGQVFAL,"39,444",375,,,3'-tRNA processing endoribonuclease activity [GO:0042781],,,,2
O06380,O06380_MYCTU,Rv3627c,Rv3627c,GO:0004185; GO:0005576; GO:0040007,IPR012338; IPR000667; ,,,,Conserved protein,extracellular region [GO:0005576]; serine-type carboxypeptidase activity [GO:0004185]; growth [GO:0040007],9634230; 21969609,,,MGPTRWRKSTHVVVGAAVLAFVAVVVAAAALVTTGGHRAGVRAPAPPPRPPTVKAGVVPVADTAATPSAAGVTAALAVVAADPDLGKLAGRITDALTGQELWQRLDDVPLVPASTNKILTAAAALLTLDRQARISTRVVAGGQNPQGPVVLVGAGDPTLSAAPPGQDTWYHGAARIGDLVEQIRRSGVTPTAVQVDASAFSGPTMAPGWDPADIDNGDIAPIEAAMIDAGRIQPTTVNSRRSRTPALDAGRELAKALGLDPAAVTIASAPAGARQLAVVQSAPLIQRLSQMMNASDNVMAECIGREVAVAINRPQSFSGAVDAVTSRLNTAHIDTAGAALVDSSGLSLDNRLTARTLDATMQAAAGPDQPALRPLLDLLPIAGGSGTLGERFLDAATDQGPAGWLRAKTGSLTAINSLVGVLTDRSGRVLTFAFISNEAGPNGRNAMDALATKLWFCGCTT,"46,834",461,,growth [GO:0040007],serine-type carboxypeptidase activity [GO:0004185],extracellular region [GO:0005576],,,1
O53566,O53566_MYCTU,Rv3521,Rv3521,,IPR002878; IPR012340; ,,,DOMAIN 46 111 OB_aCoA_assoc. {ECO:0000259|Pfam:PF01796}.; DOMAIN 207 271 OB_aCoA_assoc. {ECO:0000259|Pfam:PF01796}.,Uncharacterized protein,,9634230,,,MGPTLSRFFTALRARRIVGVRGSDGRVHVPPVEYDPVTYEPLSEMVPVSSVGTVASWTWQPEPLAGQPLDRPFAWALIKLDGADTLLMHAVDVGTAGPSAIHTGARVHAHWADQPVGAITDIACFALGETAEPVAAHKTEDARDPVTMIVTPIQLEIQHTASHEESAYLRAIAQGKLVGARTGKTGKVYFPPHGADPATGKPTSEFVELPDKGTVTTFAIVNIPFLGQRIKPPYVAAYVLLDGADIPFLHLVSDVDAHQVRMGMRVEAVWKPRERWGLGIDNIEYFRPTGEPDANYDTYKHHL,"33,003",303,,,,,,,1
I6XHM5,I6XHM5_MYCTU,Rv3590c,PE_PGRS58 Rv3590c,,IPR000084; ,,PE_PGRS58,DOMAIN 1 93 PE. {ECO:0000259|Pfam:PF00934}.,PE-PGRS family protein PE_PGRS58,,9634230,,,MSFVIVAPEALMSVASEVAGIGSALNAANAAAAAPTTGVLAAAADEVSAAMAALFGAHAQEYQRLSAQAAGFHAQFVQALNAGVNSYASAEAANASPLQAVEQQVLGLINGPAQTLLGRPLIGNGADGAPGTGQPGGPGGLLWGNGGNGGSGVAGVGGPGGSGGAAGLFGHGGNGGAGGSNAAGAGGVGGAGGAGWLVGNGGAGGFGGVGTTVSGNGGAGGAAGAFGNGGVGGAGGAAVIGGLPGNGGAGGNAGLIGAGGDGGVGGVGAPGTNGMNPPPNQTSQAANGSPGANNGAGSGGAGLPGNPGAVPGRAGGAGGLGGSGSDTSEGPVTGGNGGNGGDGGPGAPGGNGAPGGIGVNTGTGWAYGGNGGNGGDGGAGARGGDGGNGGNGLALNGGNGIGGNGGAGGRGGTGAAGGNGGIGGGATGTLTFFGSGGDGGPGGAGANTAGTGGVGGVGGAGGQGGLLFGDGGNGGAGGAGGIGGTGASGGAGGKGGSGLVGGDGGNGGAGGAGGNGGKGGAGGAGGGAGMFSQPGVHGAGGTGGQGGAGGAGGAGGAAGAGTVVAGNPGDPGGFGAAGADGLPG,"48,398",584,,,,,,,1
O69658,O69658_MYCTU,Rv3690,Rv3690,GO:0005618; GO:0016021,IPR025403; ,,,,Probable conserved membrane protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021],9634230; 21969609,,,MPSIDIDREAAHQAAQRELDKPIYPKDSLTKELTDWIDEQLYRILEKGSSIPGGWFTITVLLILLMIAVTAAVQIARRTMRTNRGGDYQLFDAGQLTAAQHRSTAESYAAEGNWAAAIRHRLQAVARELEETGMLNPAAGRTANELASDAGEVLPHLAGELTQAATAFNDVTYGERPGTQGAYQMIADLDDHLRSRSPAVVSAVQHPAVFDSWAQVR,"23,752",217,,,,cell wall [GO:0005618]; integral component of membrane [GO:0016021],,,3
O69681,O69681_MYCTU,Rv3714c,Rv3714c,GO:0005886,IPR011335; ,,,,Uncharacterized protein,plasma membrane [GO:0005886],9634230; 21969609,,,MLISRMSVRSASMSVMGDVFIGSEAITAGRLTRHELQRWYQPMFRGVYVSRRSVPTLWDRTVGAWLATRRHGVIAGNAASALHGAQWVDVDVAIELISPTTRPQHGLVIRRETLCDDEITRVVGLPVTTLARTAYDLGRHLSRGEAVARLDALMRATPFSRDDVLLLAKRHAGARGVRRLRDVLPLVDGGAASPKETWLRLLLIDAGLPVPTTQIPVVHRWRNVGVLDMGWEKYMVAAEYDGDQHRSDRGRYVKDQRRLRKLAELGWIVIRVIAEDNPDDVVNRVRAALLARGWRP,"33,251",296,,,,plasma membrane [GO:0005886],,,3
I6YCE1,I6YCE1_MYCTU,Rv3549c,Rv3549c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MTLAEAADAINFGLAGRVVLVTGGVRGVGAGISSVFAEQGATVITCARRAVDGQPYEFHRCDIRDEDSVKRLVGEIGERHGRLDMLVNNAGGSPYALAAEATHNFHRKIVELNVLAPLLVSQHANVLMQAQPNGGSIVNICSVSGRRPTPGTAAYGAAKAGLENLTTTLAVEWAPKVRVNAVVVGMVETERSELFYGDAESIARVAATVPLGRLARPADIGWAAAFLASDAASYISGATLEVHGGGEPPPYLGASSANK,"26,855",259,,,oxidoreductase activity [GO:0016491],,,,1
Q79FA1,Q79FA1_MYCTU,Rv3746c,PE34 Rv3746c,,IPR000084; ,,PE34,,Probable PE family protein PE34 (PE family-related protein),,9634230,,,MQSMSFDPAVADIGSQVVNNAFQGLQAGAVAWVSLSSLLPAGAEEVSAWAVTAFTTAATGLLALNQAAQEELRKAGEVFTAIARMYSDADVRAAACLLEAIPRPGQTLARE,"11,496",111,,,,,,,1
O69667,O69667_MYCTU,Rv3699,Rv3699,GO:0005618; GO:0005737; GO:0008757; GO:0032259,IPR029063; ,,,,Conserved protein,cell wall [GO:0005618]; cytoplasm [GO:0005737]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259],9634230; 21969609,,,MTDEVMDWDSAYREQGAFEGPPPWNIGEPQPELATLIAAGKVRSDVLDAGCGYAELSLALAADGYTVVGIDLTPTAVAAATKAAEERGLTTASFVQADITEFAAYPAGSAGRFSTVIDSTLFHSLPVDSRDRYLSSVHRAAAPGASYYVLVFAKGAFPAELEVKPNEVDEDELRAAVSKYWKIDEIRPAFIHVNPVTIPPQLAGAPVEFPPYDHDEKGRVKFPAYLLTAHKAG,"24,998",233,,methylation [GO:0032259],S-adenosylmethionine-dependent methyltransferase activity [GO:0008757],cell wall [GO:0005618]; cytoplasm [GO:0005737],,,3
I6YGJ4,I6YGJ4_MYCTU,Rv3576,lppH Rv3576,,IPR026954; IPR038232; ,,lppH,,Possible conserved lipoprotein LppH,,9634230; 21969609,,,MGKQLAALAALVGACMLAAGCTNVVDGTAVAADKSGPLHQDPIPVSALEGLLLDLSQINAALGATSMKVWFNAKAMWDWSKSVADKNCLAIDGPAQEKVYAGTGWTAMRGQRLDDSIDDSKKRDHYAIQAVVGFPTAHDAEEFYSSSVQSWSSCSNRRFVEVTPGQDDAAWTVADVVNDNGMLSSSQVQEGGDGWTCQRALTARNNVTIDIVTCAYSQPDLVAIGIANQIAAKVAKQ,"25,052",237,,,,,,,1
O69723,O69723_MYCTU,Rv3757c,proW Rv3757c,GO:0005215; GO:0005886; GO:0016021; GO:0031460; GO:0055085; GO:0075136,IPR000515; IPR035906; ,,proW,,Possible osmoprotectant (Glycine betaine/carnitine/choline/L-proline) transport integral membrane protein ABC transporter ProW,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; transporter activity [GO:0005215]; glycine betaine transport [GO:0031460]; response to host [GO:0075136]; transmembrane transport [GO:0055085],9634230; 21969609,,,MHYLMTHPGAAWALTVVHLRLSLLPVLIGLMSAVPLGLLVQRAPLLRRLTTATASVIFTIPSLALFVVLPLIIGTRILDEANVIVALAAYTTALLVRAVLEALDAVPAQVHDAATAIGYSRIAQMLKVELPLSIPVLVAGLRVVAVTNIAMVSVGSVIGIGGLGTWFTAGYQTNKSDQIVAGVVAMFLLAIVVDVVINLAGRLATPWERAPRAARRRRQVAAPITGGAR,"24,109",229,Binding-protein-dependent transport system permease family,glycine betaine transport [GO:0031460]; response to host [GO:0075136]; transmembrane transport [GO:0055085],transporter activity [GO:0005215],integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
I6YCR8,I6YCR8_MYCTU,Rv3689,Rv3689,GO:0016021,,,,,Probable conserved transmembrane protein,integral component of membrane [GO:0016021],9634230,,,MHKRYAPQRPKPDTETYIEKCTDRRQDGGHDERRQLLRPVSMLPPGYPVEPPPVAPGYAPAGYPPYPATPPGYGPPGYGAPPSYGPPPGYGPPLGYPAAPPGCGPPPGYGPPLGYGPPVAPGAVKPGIIPLRPLTLSDIFNGAVGYIRANPKATLGLTAMVVVTLQIISLVALFGPMTAFGDIVTGEPDELTGAVVGGWSASFGASLLVSWLAGVLLSGMLTVIVGRAVFGSPITVGEAWAKVRGRLLALFGLALLEAAGVVAVLGLAVVILSGVAAAANEAAAALLGFPLLLVVGVSLAYLYVVLLFAPVLIVLERLPIVEAITRSFALVRHGFWRVLGIRLLTVLVVGVVGNAIAAPFMIVGEIVTAVTASDGSVTMRLVGATLSAIGVTIGQIVTAPFSAGVVVLLYTDRRIRAEAFDLVLQTGLEAGPAGGPAPVESTDNLWLTRPF,"46,438",451,,,,integral component of membrane [GO:0016021],,,1
O06283,O06283_MYCTU,Rv3599c,Rv3599c,,,,,,Hypothetical short protein,,9634230,,,MPASSLGTGSPAADRLDATHERRREVI,"2,894",27,,,,,,,1
O06370,O06370_MYCTU,Rv3637,Rv3637,,,,,,Possible transposase,,9634230,,,MPGRVFASPADFNTQLQAWLVRANHRQHRVLGCRPADRIEADTAAMLTLPPVGPSIGWRTSTRLPRDHYVRLDGNDYSVHPVAIGRRIEITADLSRVRVWCGGTLVADHDRIWAKHQTISDPEHVVAAKLLRRKRFDIVGPPHHVEVEQRLLTTYDTVLGLDGPVA,"18,655",166,,,,,,,1
P96230,P96230_MYCTU,Rv3847,Rv3847,,,,,,Uncharacterized protein,,9634230,,,MGTGSGGPIGVSPFHSRGALKGFVISGRWPDSTKEWAQLLMVAVRVASLPGLLSTTTVFGAREELPDEPEPGTVGLVLAEGTVFGESAIQPGYFADHQPPALLMLHPPSETTPSLPECTGAASGCVLLPGLPYLGLEHRAAWVEAEADGTITSMVSRVGVDPISHPDTAILAMLLAA,"18,278",177,,,,,,,1
I6Y3Z2,I6Y3Z2_MYCTU,Rv3594,Rv3594,GO:0008745; GO:0009253,IPR036505; IPR002502; ,,,,Uncharacterized protein,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan catabolic process [GO:0009253],9634230; 21969609,,,MGWIGDPIWLEEVLRPALGERLRVLDGWRERGHGDFRDIRGVMWHHTGNSRETAKSIARGRPDLPGPLANLHIAHSGVVTIVAVGVCWHAGRGSYPWLPTDNANWHMIGVECAWPTIRRDGSYDAGERWPDAQIVSMRDVAAALTLKLGYGPERNIGHKEYAGAAQGKWDPGNLSMDWFRAEVAKDTRGEFDHPLTPPPAVIARPPILPKPRNPRDDRILLEEVWDQLRGIEGRGWPVLGDKTIVDYLAELGNKVDALAAKLDAREGLDRPSDTR,"30,676",275,,peptidoglycan catabolic process [GO:0009253],N-acetylmuramoyl-L-alanine amidase activity [GO:0008745],,,,1
O07804,O07804_MYCTU,Rv3819,Rv3819,,,,,,Uncharacterized protein,,9634230; 21969609,,,MMQFYDDGVVQLDRAALTLRRYHFPSGTAKVIPLDQIRGYQAESLGFLMARFNIWGRPDLRRWLPLDVYRPLKSTLVTLDVPGMRPKPACTPTRPKEFIALLDELLALHRT,"12,825",111,,,,,,,1
I6XHH5,I6XHH5_MYCTU,Rv3536c,hsaE Rv3536c,GO:0008152; GO:0008684,IPR011234; IPR036663; ,,hsaE,,Probable hydratase,2-oxopent-4-enoate hydratase activity [GO:0008684]; metabolic process [GO:0008152],9634230; 21969609,,,MLRDATRDELAADLAQAERSRDPIGQLTAAHPEIDVVDAYEIQLINIRQRVAEGARVVGHKVGLSSPIMQQMMGVDEPDYGHLLDDMQVFEDTPVQASRYLSPRVEVEVGFILAADLPGAGCTEDDVLAATEALVPAIELIDTRIKDWQIKICDTIADNASAAGFVLGAARVPPADLDVRAIDAKLTRNGEVVAEGRSDAVLGNPATAVAWLAGKVESFGVRLRKGDIVLPGSCTFAVEARAGDEFVADFTGLGLVRLSFE,"27,892",261,,metabolic process [GO:0008152],2-oxopent-4-enoate hydratase activity [GO:0008684],,,,1
O69662,O69662_MYCTU,Rv3694c,Rv3694c,GO:0016021,IPR002798; ,,,,Possible conserved transmembrane protein,integral component of membrane [GO:0016021],9634230; 21969609,,,MDVDAFLLTNRGTWDRLDHLIKKRHSLSGAEIDELVELYQRVSTHLSMLRSASSDQLMTGRLSSLVARARSAVTGAHAPLTRTFIRFWTVSFPVVAYRTWRWWLATAVAFFAVVVLIGFWVAGSHEVQSAIGTPTEIDELVSHDVQSYYSEHPAASFALQVWVNNSWVATTCIAMSVVLGLPIPLVLFDNAANVGLIAGLMFQAGKGDFLLGLLLPHGLLELTAVFLAAAIGMRLGWSVISAGNRPRGQVLAEQGRGVVSVAVGLVGVFLVAGLIEAVVTPSPLPTFVRIAVGIIAEAVFLSYIGYFGRRAAQAGETGDMEDAPDVVPTG,"35,471",330,,,,integral component of membrane [GO:0016021],,,1
O07794,O07794_MYCTU,Rv3829c,Rv3829c,GO:0005829,IPR036188; ,,,,Probable dehydrogenase,cytosol [GO:0005829],9634230,,,MTGYDAIVIGAGHNGLTAAVLLQRAGLRTACLDAKRYAGGMASTVELFDGYRFEIAGSVQFPTSSAVSSELGLDSLPTVDLEVMSVALRGVGDDPVVQFTDPTKMLTHLHRVHGADAVTGMAGLLAWSQAPTRALGRFEAGTLPKSFDEMYACATNEFERSAIDDMLFGSVTDVLDRHFPDREKHGALRGSMTVLAVNTLYRGPATPGSAAALAFGLGVPEGDFVRWKKLRGGIGALTTHLSQLLERTGGEVRLRSKVTEIVVDNSRSSARVRGVRTAAGDTLTSPIVVSAIAPDVTINELIDPAVLPSEIRDRYLRIDHRGSYLQMHFALAQPPAFAAPYQALNDPSMQASMGIFCTPEQVQQQWEDCRRGIVPADPTVVLQIPSLHDPSLAPAGKQAASAFAMWFPIEGGSKYGGYGRAKVEMGQNVIDKITRLAPNFKGSILRYTTFTPKHMGVMFGAPGGDYCHALLHSDQIGPNRPGPKGFIGQPIPIAGLYLGSAGCHGGPGITFIPGYNAARQALADRRAANCCVLSGR,"57,073",536,,,,cytosol [GO:0005829],,,2
P96221,P96221_MYCTU,Rv3856c,Rv3856c,GO:0005829; GO:0005886; GO:0008270; GO:0042578; GO:0071978,IPR010996; IPR027421; IPR004013; IPR003141; IPR016195; IPR017078; ,,,,Uncharacterized protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; phosphoric ester hydrolase activity [GO:0042578]; zinc ion binding [GO:0008270]; bacterial-type flagellum-dependent swarming motility [GO:0071978],9634230; 21969609,,,MDPVTALRQIAYYKDRNRHDPRRVMAYRNAADIIEGLDDAARQRHGQANSWQSLAGIGPKTAKVIAQAWSGREPDLLAELRADAEDLGGGAIRAALRGDLHLHSNWSDGSAPIEEMMATAAALGHQYCALTDHSPRLTIANGLSPDRLRKQLDVIDELREKFAPLRILTGIEVDILEDGSLDQEPEMLDRLDIVVASVHSKLSMDSAAMTRRMVRAVANGHTDVLGHCTGRLIAGNRGIRPESKFDAEAVFTACREHGTAVEINSRPERRDPPTRLLHLARDIGCVFSIDTDAHAPGQLDFLGYGAQRALDAEVPADRIVNTWPADTLLAWTGSH,"36,701",335,,bacterial-type flagellum-dependent swarming motility [GO:0071978],phosphoric ester hydrolase activity [GO:0042578]; zinc ion binding [GO:0008270],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
P71847,P71847_MYCTU,Rv3553,Rv3553,GO:0005886; GO:0018580,IPR013785; IPR004136; ,,,,Possible oxidoreductase,plasma membrane [GO:0005886]; nitronate monooxygenase activity [GO:0018580],9634230,,,MRLRTPLTELIGIEHPVVQTGMGWVAGARLVSATANAGGLGILASATMTLDELAAAITKVKAVTDKPFGVNIRADAADAGDRVELMIREGVRVASFALAPKQQLIARLKEAGAVVIPSIGAAKHARKVAAWGADAMIVQGGEGGGHTGPVATTLLLPSVLDAVAGTGIPVIAAGGFFDGRGLAAALCYGAAGVAMGTRFLLTSDSTVPDAVKRRYLQAGLDGTVVTTRVDGMPHRVLRTELVEKLESGSRARGFAAALRNAGKFRRMSQMTWRSMIRDGLTMRHGKELTWSQVLMAANTPMLLKAGLVDGNTEAGVLASGQVAGILDDLPSCKELIESIVLDAITHLQTASALVE,"36,831",355,,,nitronate monooxygenase activity [GO:0018580],plasma membrane [GO:0005886],,,3
Q79FA5,Q79FA5_MYCTU,Rv3724A,cut5a Rv3724A,GO:0008152; GO:0016787,IPR029058; IPR000675; ,,cut5a,DOMAIN 37 67 Cutinase. {ECO:0000259|Pfam:PF01083}.,Probable cutinase [first part] Cut5a,hydrolase activity [GO:0016787]; metabolic process [GO:0008152],9634230,,,MDVIRWARRLAVVAGTAAAVTTPGLLSAHVPMVSAEPCPDVEVVFARGTGEPPGIGSVGGLFVDALRFPGWRQVTRGLRR,"8,424",80,,metabolic process [GO:0008152],hydrolase activity [GO:0016787],,,,1
I6XI16,I6XI16_MYCTU,Rv3718c,Rv3718c,,IPR019587; IPR023393; IPR014488; ,,,,Conserved protein,,9634230; 21969609,,,MGQVSAASTILINAEPTATLDALADYETVRPKILSPHYSEYQVLEGGKGRGTVAKWRLQATQSRVRDVQVNVDVAGHTVIEKDMNSSMVTNWTVAPAGPGSSVTVKTTWTGAGGVKGFFEKTFAPLGLKKIQAEVLSNLKTELEGDA,"15,662",147,,,,,,,1
O53547,O53547_MYCTU,Rv3502c,Rv3502c,GO:0016491,IPR036291; IPR020904; IPR002347; ,,,,Probable short-chain type dehydrogenase/reductase. Possible 17-beta-hydroxysteroid dehydrogenase,oxidoreductase activity [GO:0016491],9634230; 21969609,,,MKLTESNRSPRTTNTTDLSGKVAVVTGAAAGLGRAEALGLARLGATVVVNDVASALDASDVVDEIGAAAADAGAKAVAVAGDISQRATADELLASAVGLGGLDIVVNNAGITRDRMLFNMSDEEWDAVIAVHLRGHFLLTRNAAAYWRDKAKDAEGGSVFGRLVNTSSEAGLVGPVGQANYAAAKAGITALTLSAARALGRYGVCANVICPRARTAMTADVFGAAPDVEAGQIDPLSPQHVVSLVQFLASPAAAEVNGQVFIVYGPQVTLVSPPHMERRFSADGTSWDPTELTATLRDYFAGRDPEQSFSATDLMRQ,"32,753",317,Short-chain dehydrogenases/reductases (SDR) family,,oxidoreductase activity [GO:0016491],,,,1
I6YGW2,I6YGW2_MYCTU,Rv3668c,Rv3668c,GO:0008233,IPR009003; ,,,,Possible protease,peptidase activity [GO:0008233],9634230; 21969609,,,MQTAHRRFAAAFAAVLLAVVCLPANTAAADDKLPLGGGAGIVVNGDTMCTLTTIGHDKNGDLIGFTSAHCGGPGAQIAAEGAENAGPVGIMVAGNDGLDYAVIKFDPAKVTPVAVFNGFAINGIGPDPSFGQIACKQGRTTGNSCGVTWGPGESPGTLVMQVCGGPGDSGAPVTVDNLLVGMIHGAFSDNLPSCITKYIPLHTPAVVMSINADLADINAKNRPGAGFVPVPA,"23,120",232,,,peptidase activity [GO:0008233],,,,1
O06367,O06367_MYCTU,Rv3640c,Rv3640c,GO:0003677; GO:0004803; GO:0005886; GO:0006313,IPR001207; ,,,,Probable transposase,"plasma membrane [GO:0005886]; DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MALPQSALSELLDAFRTGDGVDLIRDAVRLVLQELSELEATERIGAARYERSDTRVTDRNGARSRVLSTQAGDVELRIPKLRKGSFFPAILEPRRRIDQALYAVVMEAYVHGISTRAVDDLVEAMGVETGISKSEVSRICAGLDEIVGAFRTRTLGHIEFPYVYLDATYLNVRNGTGQVVSMAVIVASGIAADGSREILGLDVGDSEDETFWRGFLTSLKGRGLGGVRLVISDQHAGLVKALKRCFQGAGHQRCRVHFARNLLAHVPKDKADMVASMFRMIFSAPDAEAVHATWEGVRDRLAASFPKIGPLMDDARAEVLAFTAFPKAHWQKIWSTNPLERINKEIKRRSRVVGIFPNPAAVIRLVGAVLADMHDEWQASERRYLSEASMALLYPDSDNAVVAAISGGQ,"44,898",409,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],plasma membrane [GO:0005886],,,1
P72038,P72038_MYCTU,Rv3771c,Rv3771c,GO:0016021,,,,,Uncharacterized protein,integral component of membrane [GO:0016021],9634230,,,MPAPAEKALSQVGFRRIAADLARPAETVRGWLRRFAERAEAVRSVFTVMLRAVDPDPVMPDAAVGVFAYAVTVIAAVVTVIECQFALSTVSLAETAVAVSGGRLVAPG,"11,325",108,,,,integral component of membrane [GO:0016021],,,2
I6Y498,I6Y498_MYCTU,Rv3680,Rv3680,GO:0005524; GO:0016887,IPR025723; IPR016300; IPR027417; ,,,,Probable anion transporter ATPase,ATP binding [GO:0005524]; ATPase activity [GO:0016887],9634230; 21969609,,,MSVTPKTLDMGAILADTSNRVVVCCGAGGVGKTTTAAALALRAAEYGRTVVVLTIDPAKRLAQALGINDLGNTPQRVPLAPEVPGELHAMMLDMRRTFDEMVMQYSGPERAQSILDNQFYQTVATSLAGTQEYMAMEKLGQLLSQDRWDLIVVDTPPSRNALDFLDAPKRLGSFMDSRLWRLLLAPGRGIGRLITGVMGLAMKALSTVLGSQMLADAAAFVQSLDATFGGFREKADRTYALLKRRGTQFVVVSAAEPDALREASFFVDRLSQESMPLAGLVFNRTHPMLCALPIERAIDAAETLDAETTDSDATSLAAAVLRIHAERGQTAKREIRLLSRFTGANPTVPVVGVPSLPFDVSDLEALRALADQLTTVGNDAGRAAGR,"41,405",386,,,ATPase activity [GO:0016887]; ATP binding [GO:0005524],,,,1
L7N679,L7N679_MYCTU,Rv3770B,Rv3770B,,,,,,Probable remnant of a transposase,,9634230,,,MRAERARAIGLFRYQLIREAADAAHSTKERGKMVRELASREHTDPFGRKVRISRHTIDRWIRN,"7,489",63,,,,,,,1
I6YGC8,I6YGC8_MYCTU,Rv3513c,fadD18 Rv3513c,GO:0016874,IPR025110; ,,fadD18,,Probable fatty-acid-CoA ligase FadD18 (Fatty-acid-CoA synthetase) (Fatty-acid-CoA synthase),ligase activity [GO:0016874],9634230,,,MAASLSENLSCHSSNMCRLSGNAATNLERPGEEPPGDRCTRRQAVRPARTLAKKGNIPVGYYKDEKKTAETFRTINGVRYAIPGDYAQVEEDGTVTMLGRGSVSINSGGEKVYPEEVEAALKGHPDVFDALVVGVPDPRYGQQVAAVVQARPGCRPSLAELDSFVRSEIAGYKVPRSLWFVDEVKRSPAGKPDYRWAKEQTEARPADDVHAGHVTSGS,"23,630",218,,,ligase activity [GO:0016874],,,,1
O06155,O06155_MYCTU,Rv3593,lpqF Rv3593,GO:0040007,IPR012338; ,,lpqF,,Probable conserved lipoprotein LpqF,growth [GO:0040007],9634230,,,MGPARLHNRRAGRRMLALSAAAALIVALASGCSSAPTPSANAANHGHRIDTRTPPGLRAQQTMDMLNSDWPIGEIGVGTLAAPGQVDTVKTTMEALWWDRPFALAGVDIGASVAALHLISSYGAQQDIRIHTDDDGWVDRFDVETQAPSIASWRDVDAALSKTGARYSFQVAKVDNGRCDPVAGTNTGESLPLASIFKLYVLHALAGAVQHNTVSWDDLLTVTAKSKAVGSSGLELPVGARVSVRTAAEKMIATSDNMATDLLIERLGTRAIEEALASAGHHDPASMTPFPTMYELFSVGWGKPDLRDQWKHATQQVRAQILRQTNSTPYQPDPTRAHTPASNYGAEWYGSAEDICRVHAALRADAVGPASPVRQIMSAVPGIQLDRSVWPYIGAKAGGLPGDLTFSWYAVDKTGQPWVVSFQLNWPRDHGPTVTGWMLQVARQVFALIAPQ,"48,520",452,,growth [GO:0040007],,,,,2
P96245,P96245_MYCTU,Rv3833,Rv3833,GO:0003700; GO:0006351; GO:0019172; GO:0019217; GO:0019243; GO:0043565; GO:1902882,IPR013096; IPR009057; IPR018060; IPR014710; IPR011051; ,,,DOMAIN 150 247 HTH araC/xylS-type. {ECO:0000259|PROSITE:PS01124}.,Transcriptional regulatory protein (Probably AraC-family),"DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882]; transcription, DNA-templated [GO:0006351]",9634230; 21969609,,,MSENSHHRLATTSLTLPPGARIERHRHPSHQIVYPSAGAVSVTTHAGTWITPVNRAIWIPAGCWHQHKFHGHTQFHGVALDPQRYRGGPATPTVLAVNPLMRELVIACSQADRTDTDEHHRMLAVLQDQLPTTSIREPLWVPSPTDRRLRHACALIADNLTQPLTLQQIGGRIGVSQRTLSRLFSDELGMTFPQWRTQLRLQHALVLLAERHDVTSVASECGWATPSAFIDTYRQAFGHTPGQAAKPMAATRLTRLRRARDRR,"29,473",263,,"methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; regulation of fatty acid metabolic process [GO:0019217]; regulation of response to oxidative stress [GO:1902882]; transcription, DNA-templated [GO:0006351]",DNA binding transcription factor activity [GO:0003700]; glyoxalase III activity [GO:0019172]; sequence-specific DNA binding [GO:0043565],,,,1
I6X7Z8,I6X7Z8_MYCTU,Rv3650,PE33 Rv3650,,IPR000084; ,,PE33,,PE family protein PE33,,9634230,,,MSFVIAAPEALDSAATDLVVLGSTLGAATAAAAAQTTGIVAAAHDEVSAAIAALFSAHGQAYQAASAQAAAFHTRFIRARSRHPQQETTCRRVR,"9,592",94,,,,,,,1
O69678,O69678_MYCTU,Rv3711c,dnaQ Rv3711c,GO:0003676; GO:0005829; GO:0008408; GO:0044776; GO:0045004,IPR036420; IPR013520; IPR012337; IPR036397; ,,dnaQ,,Probable DNA polymerase III (Epsilon subunit) DnaQ,"cytosol [GO:0005829]; DNA polymerase III, core complex [GO:0044776]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676]; DNA replication proofreading [GO:0045004]",9634230; 21969609,,,MSHTWGRPASHQDRGWAVIDVETSGFRPGQARIISLAVLGLDAAGRLEQSVVSLLNPKVDPGPTHVHGLTAAMLDGQPQFADIAGEVVDVLRGRTLVAHNVAFDYAFLAAEAEIAEAELPVDFVMCTVELARRLQLGVDNLRLETLAAHWGVPQQRPHDAFDDVRVLTGILAAALESARELDVWLPVHPVTRRRWPNGRVTHDELRPLKAVAARMACPYLNPGRYVQGRPLVQGMRVGLAAEVKRTHEELVERILHAGLAYSDVVDRDTSLVVCNATAPEHGKGYHALQLGVPVMPEARFMECIGAVVGGASVEDFTDVAPVEKQLALF,"35,782",329,,DNA replication proofreading [GO:0045004],3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676],"cytosol [GO:0005829]; DNA polymerase III, core complex [GO:0044776]",,,1
P96217,P96217_MYCTU,Rv3860,Rv3860,GO:0005886,IPR002586; IPR027417; ,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MYERDEFLRDRIRPHQPGTPRGYSPRPPSGDRCPAPPPGRHAAAATPPGPPRLPSAPLRPLPDPAWPRQPEAPPPSTWADPALAPIRSRTRPGERGWRRMVRLVTFGLVGLGRSGMQRQEAQFEATIRTVLHGNHKVAVLGKGGVGKTSVAACVGSILAELRQQDRIVGIDADTAFGRLSSRIDPRAAGSFWELTTDTNLRSFTDITARLGRNSAGLYVLAGQPASGPRRVLDPAIYREAALRLDHHFAISVIDCGSSMEAAVTQEVLRDVDALIVVSSPWADGASAAANTIEWLSDYGLTGLLRRSIVVLNDSDGHADKRTKSLLAQEFIDHGQPVVEVPFDPHLRPGGVIDMSHEMAPTTRLKILQVAATVTAYFASRPADAHGSPPR,"42,134",390,,,,plasma membrane [GO:0005886],,,1
I6X7X3,I6X7X3_MYCTU,Rv3623,lpqG Rv3623,,IPR007497; ,,lpqG,,Probable conserved lipoprotein LpqG,,9634230; 21969609,,,MIRLVRHSIALVAAGLAAALSGCDSHNSGSLGADPRQVTVFGSGQVQGVPDTLIADVGIQVTAADVTSAMNQTNDRQQAVIDALVGAGLDRKDIRTTRVTVAPQYSNPEPAGTATITGYRADNDIEVKIHPTDAASRLLALVVSTGGDATRISSVSYSIGDDSQLVKDARARAFQDAKNRADQYAQLSGLRLGKVISISEASGAAPTHEAPAPPRGLSAVPLEPGQQTVGFSVTVVWELT,"24,837",240,,,,,,,1
L7N680,L7N680_MYCTU,Rv3812,PE_PGRS62 Rv3812,,IPR000084; ,,PE_PGRS62,,PE-PGRS family protein PE_PGRS62,,9634230,,,MSFVVTVPEAVAAAAGDLAAIGSTLREATAAAAGPTTGLAAAAADDVSIAVSQLFGRYGQEFQTVSNQLAAFHTEFVRTLNRGAAAYLNTESANGGQLFGQIEAGQRAVSAAAAAAPGGAYGQLVANTATNLESLYGAWSANPFPFLRQIIANQQVYWQQIAAALANAVQNFPALVANLPAAIDAAVQQFLAFNAAYYIQQIISSQIGFAQLFATTVGQGVTSVIAGWPNLAAELQLAFQQLLVGDYNAAVANLGKAMTNLLVTGFDTSDVTIGTMGTTISVTAKPKLLGPLGDLFTIMTIPAQEAQYFTNLMPPSILRDMSQNFTNVLTTLSNPNIQAVASFDIATTAGTLSTFFGVPLVLTYATLGAPFASLNAIATSAETIEQALLAGNYLGAVGALIDAPAHALDGFLNSATVLDTPILVPTGLPSPLPPTVGITLHLPFDGILVPPHPVTATISFPGAPVPIPGFPTTVTVFGTPFMGMAPLLINYIPQQLALAIKPAA,"51,821",504,,,,,,,1
I6XHG6,I6XHG6_MYCTU,Rv3527,Rv3527,,,,,,Uncharacterized protein,,9634230,,,MPDDQPAVPDVDRLARSMLLLHGDHHDHNDSPEQHRTCGSWSKSRDFADDPQRAAAVREASRAERDRYLTSGLQPVDCRFCHVTVTVKRLGPGHTAVQWNTEASRRCAYFTELRARGGDSARTRSCPRLTDSIEHAVAEGYLEHHDPNR,"16,839",149,,,,,,,1
I6YGI1,I6YGI1_MYCTU,Rv3566A,Rv3566A,,,,,,Uncharacterized protein,,9634230,,,MSGADPPTRRAFGQMARAATGWVSVSGQFAVAADTCRCEGTLFAVDPETHVANHNRCDIVGRLRDERPNTLRSVRRGDEVRMATWHWI,"9,797",88,,,,,,,1
O06364,O06364_MYCTU,Rv3643,Rv3643,,,,,,Uncharacterized protein,,9634230,,,MERSIGLEAAAQQAGHSGSEITRRHYVERSVTVPDYTAALDEYSRPIRAFRPLKSNRPGDIPT,"7,027",63,,,,,,,1
O69697,O69697_MYCTU,Rv3730c,Rv3730c,,IPR014145; ,,,,Uncharacterized protein,,9634230; 21969609,,,MAAAAEELDVDGIAVRLTSPDRMYFPKLGSHGTKRRLVEYYFAVAGGPMLTALRDRPTHLQRFPDGVDGEQIYQKRIPRHRPDYLQTCRVTFPSGRMADALKVTHPAAIVWAAQMGTITLHPWQVRCPDTEHPDELRIDLDPQPGTGFVEARTVAVDVLRSVLDDLGLVGYPKTSGGRGIHVFLRIATDWDFVEVRRAGIALAREVERRAPDAVTTSWWKEERGARIFIDFNQNARDRTMASAYSVRPTPIATVSMPLTWEELAGADPDDYTMTTVPELVKIRDDPWAGMDDVAQSIAPLLDLAAADEERGLGDMPYPPNYPKMPGEPKRVQPSRDTDLKGGNTSK,"38,544",346,,,,,,,1
P96216,P96216_MYCTU,Rv3861,Rv3861,,,,,,Uncharacterized protein,,9634230,,,MTWLADPVGNSRIARAQACKTSISAPIVESWRAQRGAQCGQREKSCRCSRAVHIQGISPPLFRRPLEPAVQAAVASCRLGRHPVVAHRVTVALGQGSQLAQRECPRPA,"11,676",108,,,,,,,2
P96847,P96847_MYCTU,Rv3565,aspB Rv3565,GO:0005618; GO:0008483; GO:0009058; GO:0030170,IPR004839; IPR004838; IPR015424; IPR015421; ,,aspB,,Aminotransferase (EC 2.6.1.-),cell wall [GO:0005618]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; biosynthetic process [GO:0009058],9634230; 21969609,,,MTDRVALRAGVPPFYVMDVWLAAAERQRTHGDLVNLSAGQPSAGAPEPVRAAAAAALHLNQLGYSVALGIPELRDAIAADYQRRHGITVEPDAVVITTGSSGGFLLAFLACFDAGDRVAMASPGYPCYRNILSALGCEVVEIPCGPQTRFQPTAQMLAEIDPPLRGVVVASPANPTGTVIPPEELAAIASWCDASDVRLISDEVYHGLVYQGAPQTSCAWQTSRNAVVVNSFSKYYAMTGWRLGWLLVPTVLRRAVDCLTGNFTICPPVLSQIAAVSAFTPEATAEADGNLASYAINRSLLLDGLRRIGIDRLAPTDGAFYVYADVSDFTSDSLAFCSKLLADTGVAIAPGIDFDTARGGSFVRISFAGPSGDIEEALRRIGSWLPSQ,"41,081",388,Class-I pyridoxal-phosphate-dependent aminotransferase family,biosynthetic process [GO:0009058],pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],cell wall [GO:0005618],,,2
I6YGY9,I6YGY9_MYCTU,Rv3705A,Rv3705A,GO:0016021,,,,,Conserved hypothetical proline rich protein,integral component of membrane [GO:0016021],9634230,,,MTETPQPAAPPPSAATTSPPPSPQQEKPPRLYRAAAWVVIVAGIVFTVAVIFFSGALVLGQGKCPYHRYYHHGMFRPVGPVAPGPGMGWVFGFPGGPPPPGMGPGFPGGPGGPAVGPTGPGPTTAPARP,"13,011",129,,,,integral component of membrane [GO:0016021],,,1
P96227,P96227_MYCTU,Rv3850,Rv3850,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MGLFGKRKSRATRRAEARAIKARAKLEAKLSAKNEARRIKAAQRAESKALKAQLKARRDSDRAALKVAEAELKVAREGKLLSPTRIRRLLTVSRLLAPILTPVIYRAAMAARGLIDQRRADQLGVPLAQIGRFSGHGARLSARVGGAERSLRMVQEKKPKDVETKQFVSAVTNRLTDLSAAVAAAEHMPAKRRRTAHSAISSQLDGIEADLMARLGLT,"23,811",218,,,,plasma membrane [GO:0005886],,,1
P96234,P96234_MYCTU,Rv3348 Rv3844,Rv3348 Rv3844,GO:0003677; GO:0004803; GO:0006313,IPR002525; ,,,DOMAIN 14 160 DEDD_Tnp_IS110. {ECO:0000259|Pfam:PF01548}.,Possible transposase (Probable transposase),"DNA binding [GO:0003677]; transposase activity [GO:0004803]; transposition, DNA-mediated [GO:0006313]",9634230,,,MTAENPGRSRRTLVGIDAAITACHHIAIRDDVGARSIRFSVEPTLAGLRTLTDKLSGYDDIDATVEPTSMTWLPLTIAVENAGDTMHMAGARHCARLRGAIVGKSKSDVIDAEVLTRASEVFDLTPLTLPTPAQLALRRSVIRRAGAVIDANRSWRRLMSLAR,"17,671",163,,"transposition, DNA-mediated [GO:0006313]",DNA binding [GO:0003677]; transposase activity [GO:0004803],,,,2
P9WGZ3,RNPA_MYCTU,Rv3923c,rnpA Rv3923c MTV028.14c,GO:0000049; GO:0004526; GO:0008033; GO:0040007,IPR020568; IPR014721; IPR000100; IPR020539; ,,rnpA,,Ribonuclease P protein component (RNase P protein) (RNaseP protein) (EC 3.1.26.5) (Protein C5),ribonuclease P activity [GO:0004526]; tRNA binding [GO:0000049]; growth [GO:0040007]; tRNA processing [GO:0008033],8733228; 9634230; 19099550; 21969609,,FUNCTION: RNaseP catalyzes the removal of the 5'-leader sequence from pre-tRNA to produce the mature 5'-terminus. It can also cleave other RNA substrates such as 4.5S RNA. The protein component plays an auxiliary but essential role in vivo by binding to the 5'-leader sequence and broadening the substrate specificity of the ribozyme. {ECO:0000255|HAMAP-Rule:MF_00227}.,MLRARNRMRRSADFETTVKHGMRTVRSDMVVYWWRGSGGGPRVGLIIAKSVGSAVERHRVARRLRHVAGSIVKELHPSDHVVIRALPSSRHVSSARLEQQLRCGLRRAVELAGSDR,"13,072",116,RnpA family,growth [GO:0040007]; tRNA processing [GO:0008033],ribonuclease P activity [GO:0004526]; tRNA binding [GO:0000049],,,MTV028.14c,1
P9WGW9,RSMG_MYCTU,Rv3919c,rsmG gidB Rv3919c MTV028.10c,GO:0005829; GO:0005886; GO:0070043; GO:0070476,IPR003682; IPR029063; ,,rsmG,,Ribosomal RNA small subunit methyltransferase G (EC 2.1.1.-) (16S rRNA 7-methylguanosine methyltransferase) (16S rRNA m7G methyltransferase) (Glucose-inhibited division protein B),cytosol [GO:0005829]; plasma membrane [GO:0005886]; rRNA (guanine-N7-)-methyltransferase activity [GO:0070043]; rRNA (guanine-N7)-methylation [GO:0070476],9634230; 17238915; 21969609,,FUNCTION: Specifically methylates the N7 position of guanine in position 518 of 16S rRNA. {ECO:0000255|HAMAP-Rule:MF_00074}.,MSPIEPAASAIFGPRLGLARRYAEALAGPGVERGLVGPREVGRLWDRHLLNCAVIGELLERGDRVVDIGSGAGLPGVPLAIARPDLQVVLLEPLLRRTEFLREMVTDLGVAVEIVRGRAEESWVQDQLGGSDAAVSRAVAALDKLTKWSMPLIRPNGRMLAIKGERAHDEVREHRRVMIASGAVDVRVVTCGANYLRPPATVVFARRGKQIARGSARMASGGTA,"24,032",224,"Methyltransferase superfamily, RNA methyltransferase RsmG family",rRNA (guanine-N7)-methylation [GO:0070476],rRNA (guanine-N7-)-methyltransferase activity [GO:0070043],cytosol [GO:0005829]; plasma membrane [GO:0005886],gidB,MTV028.10c,1
P9WJ65,RSMAF_MYCTU,Rv3912,rsmA Rv3912 RVBD_3912,GO:0005886; GO:0006351; GO:0006355; GO:0016021,,,rsmA,,Anti-sigma-M factor RsmA (Regulator of SigM) (Sigma-M anti-sigma factor RsmA),"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",9634230,,"FUNCTION: An anti-sigma factor for extracytoplasmic function (ECF) sigma factor SigM. ECF sigma factors are held in an inactive form by an anti-sigma factor until released by regulated intramembrane proteolysis (RIP). RIP occurs when an extracytoplasmic signal triggers a concerted proteolytic cascade to transmit information and elicit cellular responses. The membrane-spanning regulatory substrate protein is first cut extracytoplasmically (site-1 protease, S1P), then within the membrane itself (site-2 protease, S2P, Rip1), while cytoplasmic proteases finish degrading the regulatory protein, liberating the sigma factor (By similarity). {ECO:0000250}.",MSAADKDPDKHSADADPPLTVELLADLQAGLLDDATAARIRSRVRSDPQAQQILRALNRVRRDVAAMGADPAWGPAARPAVVDSISAALRSARPNSSPGAAHAARPHVHPVRMIAGAAGLCAVATAIGVGAVVDAPPPAPSAPTTAQHITVSKPAPVIPLSRPQVLDLLHHTPDYGPPGGPLGDPSRRTSCLSGLGYPASTPVLGAQPIDIDARPAVLLVIPADTPDKLAVFAVAPHCSAADTGLLASTVVPRA,"25,769",254,,"regulation of transcription, DNA-templated [GO:0006355]; transcription, DNA-templated [GO:0006351]",,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,RVBD_3912,1
P9WHH1,TRXB_MYCTU,Rv3913,trxB trxB2 Rv3913 MTV028.04,GO:0001666; GO:0004791; GO:0005829; GO:0015035; GO:0019430; GO:0040007; GO:0045454; GO:0050660; GO:0070402,IPR036188; IPR023753; IPR008255; IPR000103; IPR005982; ,,trxB,,Thioredoxin reductase (TR) (TRXR) (EC 1.8.1.9),cytosol [GO:0005829]; flavin adenine dinucleotide binding [GO:0050660]; NADPH binding [GO:0070402]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; growth [GO:0040007]; removal of superoxide radicals [GO:0019430]; response to hypoxia [GO:0001666],9634230; 11567012; 19099550; 21969609,X-ray crystallography (1),,MTAPPVHDRAHHPVRDVIVIGSGPAGYTAALYAARAQLAPLVFEGTSFGGALMTTTDVENYPGFRNGITGPELMDEMREQALRFGADLRMEDVESVSLHGPLKSVVTADGQTHRARAVILAMGAAARYLQVPGEQELLGRGVSSCATCDGFFFRDQDIAVIGGGDSAMEEATFLTRFARSVTLVHRRDEFRASKIMLDRARNNDKIRFLTNHTVVAVDGDTTVTGLRVRDTNTGAETTLPVTGVFVAIGHEPRSGLVREAIDVDPDGYVLVQGRTTSTSLPGVFAAGDLVDRTYRQAVTAAGSGCAAAIDAERWLAEHAATGEADSTDALIGAQR,"35,643",335,Class-II pyridine nucleotide-disulfide oxidoreductase family,cell redox homeostasis [GO:0045454]; growth [GO:0040007]; removal of superoxide radicals [GO:0019430]; response to hypoxia [GO:0001666],flavin adenine dinucleotide binding [GO:0050660]; NADPH binding [GO:0070402]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791],cytosol [GO:0005829],trxB2,MTV028.04,1
O53590,SIGM_MYCTU,Rv3911,sigM Rv3911,GO:0003677; GO:0003700; GO:0005886; GO:0006352; GO:0009410; GO:0009415; GO:0016987; GO:0045893,IPR014284; IPR007627; IPR013249; IPR013325; IPR013324; IPR036388; ,,sigM,,ECF RNA polymerase sigma factor SigM (ECF sigma factor SigM) (Alternative RNA polymerase sigma factor SigM) (RNA polymerase sigma-M factor) (Sigma-M factor),"plasma membrane [GO:0005886]; bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700]; DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription, DNA-templated [GO:0045893]; response to water [GO:0009415]; response to xenobiotic stimulus [GO:0009410]",9634230; 10027986; 17028284; 16735723; 19099550; 22733573,,"FUNCTION: Sigma factors are initiation factors that promote the attachment of RNA polymerase to specific initiation sites and are then released. Extracytoplasmic function (ECF) sigma factors are held in an inactive form by an anti-sigma factor (RsaM, AC L7N5D7) until released by regulated intramembrane proteolysis (Probable). This sigma factor is required for the synthesis of surface or secreted molecules. {ECO:0000269|PubMed:17028284, ECO:0000305}.",MPPPIGYCPAVGFGGRHERSDAELLAAHVAGDRYAFDQLFRRHHRQLHRLARLTSRTSEDADDALQDAMLSAHRGAGSFRYDAAVSSWLHRIVVNACLDRLRRAKAHPTAPLEDVYPVADRTAQVETAIAVQRALMRLPVEQRAAVVAVDMQGYSIADTARMLGVAEGTVKSRCARARARLARLLGYLNTGVNIRR,"21,649",196,"Sigma-70 factor family, ECF subfamily","DNA-templated transcription, initiation [GO:0006352]; positive regulation of transcription, DNA-templated [GO:0045893]; response to water [GO:0009415]; response to xenobiotic stimulus [GO:0009410]",bacterial sigma factor activity [GO:0016987]; DNA binding [GO:0003677]; DNA binding transcription factor activity [GO:0003700],plasma membrane [GO:0005886],,,2
P9WH93,RL34_MYCTU,Rv3924c,rpmH Rv3924c MTV028.15,GO:0003735; GO:0005840; GO:0006412,IPR000271; IPR020939; ,,rpmH,,50S ribosomal protein L34,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],8733228; 9634230,Electron microscopy (1),,MTKGKRTFQPNNRRRARVHGFRLRMRTRAGRSIVSSRRRKGRRTLSA,"5,625",47,Bacterial ribosomal protein bL34 family,translation [GO:0006412],structural constituent of ribosome [GO:0003735],ribosome [GO:0005840],,MTV028.15,1
P9WG67,THIO_MYCTU,Rv3914,trxA trx trxC Rv3914 MTV028.05,GO:0004791; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006662; GO:0009055; GO:0015035; GO:0015036; GO:0015038; GO:0016671; GO:0034599; GO:0045454; GO:0047134; GO:0080007,IPR005746; IPR036249; IPR017937; IPR013766; ,,trxA,DOMAIN 2 113 Thioredoxin. {ECO:0000255|PROSITE-ProRule:PRU00691}.,Thioredoxin (Trx) (MPT46),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; disulfide oxidoreductase activity [GO:0015036]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; S-nitrosoglutathione reductase activity [GO:0080007]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662]",9634230; 7591163; 21969609; 17139080,NMR spectroscopy (2); X-ray crystallography (2),FUNCTION: Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions. {ECO:0000250}.,MTDSEKSATIKVTDASFATDVLSSNKPVLVDFWATWCGPCKMVAPVLEEIATERATDLTVAKLDVDTNPETARNFQVVSIPTLILFKDGQPVKRIVGAKGKAALLRELSDVVPNLN,"12,544",116,Thioredoxin family,cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerol ether metabolic process [GO:0006662],"disulfide oxidoreductase activity [GO:0015036]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; protein-disulfide reductase activity [GO:0047134]; S-nitrosoglutathione reductase activity [GO:0080007]; thioredoxin-disulfide reductase activity [GO:0004791]",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],trx trxC,MTV028.05,1
P9WIX7,MUTT4_MYCTU,Rv3908,mutT4 Rv3908,GO:0016787; GO:0046872,IPR020476; IPR015797; IPR020084; IPR000086; ,,mutT4,DOMAIN 62 198 Nudix hydrolase. {ECO:0000255|PROSITE-ProRule:PRU00794}.,Putative mutator protein MutT4 (EC 3.6.1.-),hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],9634230; 11416222; 16585780; 21969609,,"FUNCTION: May be involved in the GO system responsible for removing an oxidatively damaged form of guanine (7,8-dihydro-8-oxoguanine, 8-oxo-dGTP) from DNA and the nucleotide pool (By similarity). In vitro has dATPase rather than 8-oxo-dGTPase activity. {ECO:0000250}.",MSDGEQAKSRRRRGRRRGRRAAATAENHMDAQPAGDATPTPATAKRSRSRSPRRGSTRMRTVHETSAGGLVIDGIDGPRDAQVAALIGRVDRRGRLLWSLPKGHIELGETAEQTAIREVAEETGIRGSVLAALGRIDYWFVTDGRRVHKTVHHYLMRFLGGELSDEDLEVAEVAWVPIRELPSRLAYADERRLAEVADELIDKLQSDGPAALPPLPPSSPRRRPQTHSRARHADDSAPGQHNGPGPGP,"27,171",248,Nudix hydrolase family,,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,,,1
P9WJK3,MVINL_MYCTU,Rv3910,mviN Rv3910,GO:0005576; GO:0005886; GO:0005887; GO:0008360; GO:0009252; GO:0015238; GO:0042891; GO:0042895; GO:0046677,IPR011009; IPR004268; ,,mviN,,Probable peptidoglycan biosynthesis protein MviN,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; antibiotic transmembrane transporter activity [GO:0042895]; drug transmembrane transporter activity [GO:0015238]; antibiotic transport [GO:0042891]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677],9634230; 21969609; 22275220,X-ray crystallography (4),FUNCTION: Essential for cell growth and peptidoglycan synthesis. {ECO:0000269|PubMed:22275220}.,MRPSPGEVPTASQRQPELSDAALVSHSWAMAFATLISRITGFARIVLLAAILGAALASSFSVANQLPNLVAALVLEATFTAIFVPVLARAEQDDPDGGAAFVRRLVTLATTLLLGATTLSVLAAPLLVRLMLGTNPQVNEPLTTAFAYLLLPQVLVYGLSSVFMAILNTRNVFGPPAWAPVVNNVVAIATLAVYLAVPGELSVDPVRMGNAKLLVLGIGTTAGVFAQTAVLLVAIRREHISLRPLWGIDQRLKRFGAMAAAMVLYVLISQLGLVVGNRIASTAAASGPAIYNYTWLVLMLPFGMIGVTVLTVVMPRLSRNAAADDTPAVLADLSLATRLTMITLIPTVAFMTVGGPAIGSALFAYGNFGDVDAGYLGAAIALSAFTLIPYALVLLQLRVFYAREQPWTPITIIVVITGVKILGSLLAPHITGDPQLVAAYLGLANGLGFLAGTIVGYYILRRALRPDGGQLIGVGEARTVLVTVAASLLAGLLAHVADRLLGLSELTAHAGSVGSLLRLSVLALIMLPILAAVTLCARVPEARAALDAVRARIRSRRLKTGPQTQNVLDQSSRPGPVTYPERRRLAPPRGKSVVHEPIRRRPPEQVARAGRAKGPEVIDRPSENASFGAASGAELPRPVADELQLDAPAGRDPGPVSRPHPSDLQNGDLPADAARGPIAFDALREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAPRTSAPNSETYTRRRRNLLIGIGAGAAVLMVALLVLASVLSRIFGDVSGGLNKDELGLNAPTASTSAASSAPPGSVVKPTKVTVFSPDGGADNPGEADLAIDGNPATSWKTDIYTDPVPFPSFKNGVGLMLQLPQATVVGTVAIDVASTGTKVEIRSASTPTPATLEDTAVLTSATALRPGHNTISVEAAAPTSNLLVWISTLGTTDGKSQADISEITIYAAS,"123,564",1184,MurJ/MviN family,antibiotic transport [GO:0042891]; peptidoglycan biosynthetic process [GO:0009252]; regulation of cell shape [GO:0008360]; response to antibiotic [GO:0046677],antibiotic transmembrane transporter activity [GO:0042895]; drug transmembrane transporter activity [GO:0015238],extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886],,,1
P9WIJ9,PARB_MYCTU,Rv3917c,parB Rv3917c MTV028.08c,GO:0003677; GO:0005576; GO:0005694; GO:0005886; GO:0007059; GO:0040007; GO:0060187,IPR004437; IPR003115; IPR036086; ,,parB,,Probable chromosome-partitioning protein ParB,cell pole [GO:0060187]; chromosome [GO:0005694]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; chromosome segregation [GO:0007059]; growth [GO:0040007],9634230; 19099550; 21969609,,FUNCTION: Involved in chromosome partition. Localize to both poles of the predivisional cell following completion of DNA replication. Binds to the DNA origin of replication (By similarity). {ECO:0000250}.,MTQPSRRKGGLGRGLAALIPTGPADGESGPPTLGPRMGSATADVVIGGPVPDTSVMGAIYREIPPSAIEANPRQPRQVFDEEALAELVHSIREFGLLQPIVVRSLAGSQTGVRYQIVMGERRWRAAQEAGLATIPAIVRETGDDNLLRDALLENIHRVQLNPLEEAAAYQQLLDEFGVTHDELAARIGRSRPLITNMIRLLKLPIPVQRRVAAGVLSAGHARALLSLEAGPEAQEELASRIVAEGLSVRATEETVTLANHEANRQAHHSDATTPAPPRRKPIQMPGLQDVAERLSTTFDTRVTVSLGKRKGKIVVEFGSVDDLARIVGLMTTDGRDKGLHRDAL,"37,018",344,ParB family,chromosome segregation [GO:0007059]; growth [GO:0040007],DNA binding [GO:0003677],cell pole [GO:0060187]; chromosome [GO:0005694]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTV028.08c,1
O05443,IFTNT_MYCTU,LH57_21250 Rv3902c,LH57_21250 Rv3902c,,IPR028953; ,O05442,,,Immunity factor for TNT (IFT) (Tuberculosis necrotizing toxin antitoxin) (TNT antitoxin),,9634230; 21969609; 26237511,X-ray crystallography (1),"FUNCTION: Antitoxin for tuberculosis necrotizing toxin (TNT). Acts by binding directly to TNT, which inhibits NAD(+) glycohydrolase activity of TNT and protects M.tuberculosis from self-poisoning. {ECO:0000269|PubMed:26237511}.",MTIGVDLSTDLQDWIRLSGMNMIQGSETNDGRTILWNKGGEVRYFIDRLAGWYVITSSDRMSREGYEFAAASMSVIEKYLYGYFGGSVRSERELPAIRAPFQPEELMPEYSIGTMTFAGRQRDTLIDSSGTVVAITAADRLVELSHYLDVSVNVIKDSFLDSEGKPLFTLWKDYKG,"19,822",176,,,,,,,1
P9WNH9,ESXE_MYCTU,Rv3904c,esxE Rv3904c MTCY15F10.07,GO:0005576,IPR036689; IPR010310; ,,esxE,,ESAT-6-like protein EsxE,extracellular region [GO:0005576],9634230; 19876390; 20085764,,,MDPTVLADAVARMAEFGRHVEELVAEIESLVTRLHVTWTGEGAAAHAEAQRHWAAGEAMMRQALAQLTAAGQSAHANYTGAMATNLGMWS,"9,603",90,"WXG100 family, ESAT-6 subfamily",,,extracellular region [GO:0005576],,MTCY15F10.07,1
P9WNH7,ESXF_MYCTU,Rv3905c,esxF Rv3905c MTCY15F10.06,GO:0005576,IPR036689; IPR010310; ,,esxF,,ESAT-6-like protein EsxF,extracellular region [GO:0005576],9634230; 19876390; 20085764; 21969609,,,MGADDTLRVEPAVMQGFAASLDGAAEHLAVQLAELDAQVGQMLGGWRGASGSAYGSAWELWHRGAGEVQLGLSMLAAAIAHAGAGYQHNETASAQVLREVGGG,"10,460",103,"WXG100 family, CFP-10 subfamily",,,extracellular region [GO:0005576],,MTCY15F10.06,1
P9WNR5,ECCB2_MYCTU,Rv3895c,eccB2 Rv3895c,GO:0005524; GO:0005576; GO:0005618; GO:0005886; GO:0016021; GO:0016787,IPR007795; ,,eccB2,,ESX-2 secretion system ATPase EccB2 (EC 3.6.-.-) (ESX conserved component B2) (Type VII secretion system protein EccB2) (T7SS protein EccB2),cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],9634230; 19876390; 21969609,,FUNCTION: An ATPase (By similarity). {ECO:0000250|UniProtKB:P9WNR7}.,MPLSLSNRDQNSGHLFYNRRLRAATTRFSVRMKHDDRKQTAALALSMVLVAIAAGWMMLLNVLKPTGIVGDSAIIGDRDSGALYARIDGRLYPALNLTSARLATGTAGQPTWVKPAEIAKYPTGPLVGIPGAPAAMPVNRGAVSAWAVCDTAGRPRSADKPVVTSIAGPITGGGRATHLRDDAGLLVTFDGSTYVIWGGKRSQIDPTNRAVTLSLGLDPGVTSPIQISRALFDGLPATEPLRVPAVPEAGTPSTWVPGARVGSVLQAQTAGGGSQFYVLLPDGVQKISSFVADLLRSANSYGAAAPRVVTPDVLVHTPQVTSLPVEYYPAGRLNFVDTAADPTTCVSWEKASTDPQARVAVYNGRGLPVPPSMDSRIVRLVRDDRAPASVVATQVLVLPGAANFVTSTSGVITAESRESLFWVSGNGVRFGIANDEATLRALGLDPGAAVQAPWPLLRTFAAGPALSRDAALLARDTVPTLGQVAIVTTTAKAGA,"51,587",495,EccB family,,ATP binding [GO:0005524]; hydrolase activity [GO:0016787],cell wall [GO:0005618]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
L7N653,CWLM_MYCTU,Rv3915,cwlM Rv3915,GO:0008745; GO:0009253; GO:0016998; GO:0030288; GO:0071555,IPR002508; IPR002477; IPR036365; IPR036366; ,,cwlM,,N-acetylmuramoyl-L-alanine amidase CwlM (EC 3.5.1.28) (Peptidoglycan hydrolase CwlM),outer membrane-bounded periplasmic space [GO:0030288]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555]; peptidoglycan catabolic process [GO:0009253],9634230; 15680239; 21969609,,"FUNCTION: Cell-wall hydrolase that hydrolyzes the amide bond between N-acetylmuramic acid and L-alanine in cell-wall glycopeptides. Is able to lyse whole mycobacteria, release peptidoglycan from the cell wall of M.luteus and M.smegmatis, and cleave N-acetylmuramoyl-L-alanyl-D-isoglutamine, releasing free N-acetylmuramic acid and dipeptide. {ECO:0000269|PubMed:15680239}.",MPSPRREDGDALRCGDRSAAVTEIRAALTALGMLDHQEEDLTTGRNVALELFDAQLDQAVRAFQQHRGLLVDGIVGEATYRALKEASYRLGARTLYHQFGAPLYGDDVATLQARLQDLGFYTGLVDGHFGLQTHNALMSYQREYGLAADGICGPETLRSLYFLSSRVSGGSPHAIREEELVRSSGPKLSGKRIIIDPGRGGVDHGLIAQGPAGPISEADLLWDLASRLEGRMAAIGMETHLSRPTNRSPSDAERAATANAVGADLMISLRCETQTSLAANGVASFHFGNSHGSVSTIGRNLADFIQREVVARTGLRDCRVHGRTWDLLRLTRMPTVQVDIGYITNPHDRGMLVSTQTRDAIAEGILAAVKRLYLLGKNDRPTGTFTFAELLAHELSVERAGRLGGS,"43,912",406,N-acetylmuramoyl-L-alanine amidase 3 family,cell wall macromolecule catabolic process [GO:0016998]; cell wall organization [GO:0071555]; peptidoglycan catabolic process [GO:0009253],N-acetylmuramoyl-L-alanine amidase activity [GO:0008745],outer membrane-bounded periplasmic space [GO:0030288],,,1
O05442,CPNT_MYCTU,Rv3903c,cpnT Rv3903c,GO:0005576; GO:0005618; GO:0006811; GO:0009279; GO:0009986; GO:0015288; GO:0044164; GO:0046930; GO:0061810; GO:0090729,IPR025331; ,O05443,cpnT,,Outer membrane channel protein CpnT (Channel protein with necrosis-inducing toxin) [Cleaved into: N-terminal channel domain; Tuberculosis necrotizing toxin (TNT) (NAD(+) glycohydrolase) (EC 3.2.2.5)],cell outer membrane [GO:0009279]; cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell cytosol [GO:0044164]; pore complex [GO:0046930]; NAD glycohydrolase activity [GO:0061810]; porin activity [GO:0015288]; toxin activity [GO:0090729]; ion transport [GO:0006811],9634230; 21969609; 24753609; 25645841; 26237511,X-ray crystallography (1),"FUNCTION: Has a dual function in uptake of nutrients and induction of host cell death. The N-terminal domain (NTD) forms an outer membrane channel and is used for uptake of nutrients across the outer membrane. The secreted C-terminal toxic domain (TNT) acts as a glycohydrolase, which hydrolyzes the essential cellular coenzyme NAD(+) in the cytosol of infected macrophages, leading to necrotic host cell death. Both functions are required for survival, replication and cytotoxicity of M.tuberculosis in macrophages. {ECO:0000269|PubMed:24753609, ECO:0000269|PubMed:26237511}.",MAPLAVDPAALDSAGGAVVAAGAGLGAVISSLTAALAGCAGMAGDDPAGAVFGRSYDGSAAALVQAMSVARNGLCNLGDGVRMSAHNYSLAEAMSDVAGRAAPLPAPPPSGCVGVGAPPSAVGGGGGAPKGWGWVAPYIGMIWPNGDSTKLRAAAVAWRSAGTQFALTEIQSTAGPMGVIRAQQLPEAGLIESAFADAYASTTAVVGQCHQLAAQLDAYAARIDAVHAAVLDLLARICDPLTGIKEVWEFLTDQDEDEIQRIAHDIAVVVDQFSGEVDALAAEITAVVSHAEAVITAMADHAGKQWDRFLHSNPVGVVIDGTGQQLKGFGEEAFGMAKDSWDLGPLRASIDPFGWYRSWEEMLTGMAPLAGLGGENAPGVVESWKQFGKSLIHWDEWTTNPNEALGKTVFDAATLALPGGPLSKLGSKGRDILAGVRGLKERLEPTTPHLEPPATPPRPGPQPPRIEPPESGHPAPAPAAKPAPVPANGPLPHSPTESKPPPVDRPAEPVAPSSASAGQPRVSAATTPGTHVPHGLPQPGEHVPAQAPPATTLLGGPPVESAPATAHQPQWATTPAAPAAAPHSTPGGVHSTESGPHGRSLSAHGSEPTHDGASHGSGHGSGSEPPGLHAPHREQQLAMHSNEPAGEGWHRLSDEAVDPQYGEPLSRHWDFTDNPADRSRINPVVAQLMEDPNAPFGRDPQGQPYTQERYQERFNSVGPWGQQYSNFPPNNGAVPGTRIAYTNLEKFLSDYGPQLDRIGGDQGKYLAIMEHGRPASWEQRALHVTSLRDPYHAYTIDWLPEGWFIEVSEVAPGCGQPGGSIQVRIFDHQNEMRKVEELIRRGVLRQ,"88,335",846,,ion transport [GO:0006811],NAD glycohydrolase activity [GO:0061810]; porin activity [GO:0015288]; toxin activity [GO:0090729],cell outer membrane [GO:0009279]; cell surface [GO:0009986]; cell wall [GO:0005618]; extracellular region [GO:0005576]; host cell cytosol [GO:0044164]; pore complex [GO:0046930],,,1
P9WIT5,YIDC_MYCTU,Rv3921c,yidC Rv3921c MTV028.12c,GO:0005887; GO:0032977; GO:0040007,IPR028055; IPR001708; ,,yidC,,Membrane protein insertase YidC (Foldase YidC) (Membrane integrase YidC) (Membrane protein YidC),integral component of plasma membrane [GO:0005887]; membrane insertase activity [GO:0032977]; growth [GO:0040007],9634230; 21969609,,"FUNCTION: Required for the insertion and/or proper folding and/or complex formation of integral membrane proteins into the membrane. Involved in integration of membrane proteins that insert both dependently and independently of the Sec translocase complex, as well as at least some lipoproteins. Aids folding of multispanning membrane proteins (By similarity). {ECO:0000250}.",MSLLFDFFSLDFIYYPVSWIMWVWYRLFAFVLGPSNFFAWALSVMFLVFTLRALLYKPFVRQIRTTRQMQELQPQIKALQKKYGKDRQRMALEMQKLQREHGFNPILGCLPMLAQIPVFLGLYHVLRSFNRTTGGFGQPHLSVIENRLTGNYVFSPVDVGHFLDANLFGAPIGAYMTQRSGLDAFVDFSRPALIAVGVPVMILAGIATYFNSRASIARQSAEAAANPQTAMMNKLALYVFPLGVVVGGPFLPLAIILYWFSNNIWTFGQQHYVFGMIEKEEEAKKQEAVRRRAANAPAPGAKPKRSPKTAPATNAAAPTEAGDTDDGAESDASTERPADTSNPARRNSGPSARTPRPGVRPKKRKR,"40,916",366,"OXA1/ALB3/YidC family, Type 1 subfamily",growth [GO:0040007],membrane insertase activity [GO:0032977],integral component of plasma membrane [GO:0005887],,MTV028.12c,1
P9WFL9,YIDD_MYCTU,Rv3922c,Rv3922c MTV028.13c,GO:0005886,IPR002696; ,,,,Putative membrane protein insertion efficiency factor,plasma membrane [GO:0005886],9634230,,FUNCTION: Could be involved in insertion of integral membrane proteins into the membrane. {ECO:0000255|HAMAP-Rule:MF_00386}.,MSLSRQSCGRVVRVTGRASARGLIFVIQVYRHMLSPLRPASCRFVPTCSQYAVDALTEYGLLRGSWLTMIRLAKCGPWHRGGWDPIPEGLTTGRSCQTDVDGANDDWNPASKRGERESFV,"13,343",120,UPF0161 family,,,plasma membrane [GO:0005886],,MTV028.13c,1
O05450,O05450_MYCTU,Rv3894c,eccC2 Rv3894c,GO:0003677; GO:0005524; GO:0005618; GO:0005886; GO:0016021,IPR023836; IPR023837; IPR002543; IPR027417; ,,eccC2,,ESX conserved component EccC2. ESX-2 type VII secretion system protein. Possible membrane protein,cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; DNA binding [GO:0003677],9634230; 21969609,,,MSKKAFPINRVNIDPPKPVRVAPNPPIALPEREPRNIWVMIGVPALIVALIGTIVMLYVSGVRSLATGFFPLMGIGAFSMLAFSGRFGRARKITWGELEKGRRRYLRDLDTNRDEIQTAVCAQREWQNAVHSDPPGLGAIIGGPRMWERGRGDVDFLEVRVGTGVQHAPDSVLSVTWPDISSDEELEPVTGQALRDFILEQRKIRDIAKVVNLRSAPGFSFVSEDLDRVRSLMRSVLCSLAVFHNPRDVKLMVVTRNREVWAWMVWLPHNLHDELFDACGWRRLIFATPEELEAALGAELHMKGKRGAWTPPTVASPTAMGSALETGQVGVDLGPHLVIVDDNTGSPDAWESVVGQVGKAGLTVLRIASRVGTGVGFAEDQVFEMAQRHGAATAVKAGRDGADADDDQRPAPLLRARGTFFAHADQLSIHRAYRYARAMARWSPTSRSEVTDSTSGAAELLRSLGISDPRELDVDRLWAERRGRGDDRWCEIPVGAKPNGELQNIILRAKDFGGFGFHSVVIGTSGSGKSELFLSLVYGIALTHSPETFNVIFVDMKFESAAQDILGIPHVVAALSNLGKDERHLAERMRRVIDGEIKQRYELFKSVGARDANDYEEIRLAGRDLPPVPVLLVIVDEYLELFANHKKWIDLIIHIGQEGRGANVFFMLGGQRLDLSSLQKVKSNIAFRIALRAESGDDSREVIGSDAAYHLPSKENGFALLKVGPRDLEPFRCFYLSAPFVVPKKKEVARTIDMTLTQPRLYDWQYQPLDAADAEALATAAAADAEPDEFLYYDDGFKKKKIVDVLRESLYNVPHRSPRRPWLAPLEDPEPVDRLVAAYRGKPWHVDYGQNPGLMFPVGVMDIPEESQQVVHAVDALRSNIIVVGAKQRGKTTTLMALMCSAATMYTPERVTFFCIGGATMAQIGSLPHVTDIVSPKDAEGIERILSTMDALIDAREEAFRRAKIDMDGFRERRFGIGGDGVGGTDPTDAFGDVFVVLDDYDDLYAKDTLLGDRIISLSSRGPEYGVHLMCSAGGWIHGQRQSLLQNVTARIQLRLADPGESQMGHLSIESREAARRTLNRPGFGLTESLHELRIGVPALADPGTGELVGITDVGARIADVAGVTKHASLQRLPQRVELSAIVEHEAVHQGGDDLSIAFAIGERHELGPVPIKLRESPGLMILGRQGCGKTTALVAIGEAVMNRFSPQQAQLTLIDPKTAPHGLRDLHAPGYVRAYAYDQDEIDEVITELAQQILLPRLPPKGLSQEELRALKPWEGPRHFVLIDDVQDLRPAQSYPQKPPVGAALWKLMERARQVGLHVFSTRNSANWATMPMDPWVKSQTSAKVAQLYMDNDPQNRINRSVRAQTLPPGRGLLVGADGDVEGILVGYPSVPGEQ,"153,701",1396,,,ATP binding [GO:0005524]; DNA binding [GO:0003677],cell wall [GO:0005618]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],,,1
L7N672,L7N672_MYCTU,Rv3907c,pcnA Rv3907c,GO:0003723; GO:0005524; GO:0006396; GO:0016779,IPR003607; IPR006674; IPR006675; IPR002646; IPR032828; IPR014065; ,,pcnA,DOMAIN 264 419 HD. {ECO:0000259|SMART:SM00471}.,Probable poly(A) polymerase PcnA (Polynucleotide adenylyltransferase) (NTP polymerase) (RNA adenylating enzyme) (Poly(A) polymerase),ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723]; RNA processing [GO:0006396],9634230; 21969609,,,MPEAVQEADLLTAAAVALNRHAALLRELGSVFAAAGHELYLVGGSVRDALLGRLSPDLDFTTDARPERVQEIVRPWADAVWDTGIEFGTVGVGKSDHRMEITTFRADSYDRVSRHPEVRFGDCLEGDLVRRDFTTNAMAVRVTATGPGEFLDPLGGLAALRAKVLDTPAAPSGSFGDDPLRMLRAARFVSQLGFAVAPRVRAAIEEMAPQLARISAERVAAELDKLLVGEDPAAGIDLMVQSGMGAVVLPEIGGMRMAIDEHHQHKDVYQHSLTVLRQAIALEDDGPDLVLRWAALLHDIGKPATRRHEPDGGVSFHHHEVVGAKMVRKRMRALKYSKQMIDDISQLVYLHLRFHGYGDGKWTDSAVRRYVTDAGALLPRLHKLVRADCTTRNKRRAARLQASYDRLEERIAELAAQEDLDRVRPDLDGNQIMAVLDIPAGPQVGEAWRYLKELRLERGPLSTEEATTELLSWWKSRGNR,"53,087",480,TRNA nucleotidyltransferase/poly(A) polymerase family,RNA processing [GO:0006396],ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; RNA binding [GO:0003723],,,,1
O05446,O05446_MYCTU,Rv3899c,Rv3899c,GO:0005576,,,,,Uncharacterized protein,extracellular region [GO:0005576],9634230; 27487929,X-ray crystallography (1),,MVTGQPAAAGAHSLSEGAMTAMQSGSVPPPQATPPITTPPVVSAPTMAAGIEATHGPVDTPANTSGAPPASTGTTGPVAPTVVTAGPVAAPAAPVVGGSAVPAGPLPAYGSDLRPPVVAAPAVPSVPTAPVSGAPVAPSASSAPSAGGALVSPVERAASKAVAGQAGASSSTMAGASALSATAGATAGAVSARAAEQQRLQRIVDAVARQEPRISWAAGLRDDGTTTLLVTDLAGGWIPPHVRLPANVTLLEPTARRRDADVIDLLGAVVAVAAHESNTYVAEPGPDAPALTGDRSARSAIPKVDEFGPTLVEAVRRRDSLPRIAQAIALPAVRKTGVLENEAELLHGCITAVKESVLKAYPSHELTAVGDWMLLAAIEALIDEQDYLANYHLAWYAVTTRRGGSRGFAA,"40,788",410,,,,extracellular region [GO:0005576],,,1
O05444,O05444_MYCTU,Rv3901c,Rv3901c,GO:0005576; GO:0016021,,,,,Possible membrane protein,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],9634230,,,MQAANRRSADTICGVTAPAPLPIPRTRSWPAIVVAAIAAVVAVAALIVALTNARPAATPATTSVPTYTAAQTAAAQRQLCDTYKLVAHAVPVDTNGSDKALARITLTNAAAILDNAAADPALDAKHRDAARASDRLPHNDRNGEWWHSS,"15,462",149,,,,extracellular region [GO:0005576]; integral component of membrane [GO:0016021],,,1
O05436,O05436_MYCTU,Rv3909,Rv3909,GO:0005886,,,,,Conserved protein,plasma membrane [GO:0005886],9634230; 21969609,,,MTALQLGWAALARVTSAIGVVAGLGMALTVPSAAPHALAGEPSPTPFVQVRIDQVTPDVVTTSSEPHVTVSGTVTNTGDRPVRDVMVRLEHAAAVTSSTALRTSLDGGTDQYQPAADFLTVAPELDRGQEAGFTLSAPLRSLTRPSLAVNQPGIYPVLVNVNGTPDYGAPARLDNARFLLPVVGVPPDQATDFGSAVAPETTAPVWITMLWPLADRPRLAPGAPGGTVPVRLVDDDLANSLANGGRLDILLSAAEFATNREVDPDGAVGRALCLAIDPDLLITVNAMTGGYVVSDSPDGAAQLPGTPTHPGTGQAAASSWLDRLRTLVHRTCVTPLPFAQADLDALQRVNDPRLSAIATISPADIVDRILDVSSTRGATVLPDGPLTGRAINLLSTHGNTVAVAAADFSPEEQQGSSQIGSALLPATAPRRLSPRVVAAPFDPAVGAALAAAGTNPTVPTYLDPSLFVRIAHESITARRQDALGAMLWRSLEPNAAPRTQILVPPASWSLASDDAQVILTALATAIRSGLAVPRPLPAVIADAAARTEPPEPPGAYSAARGRFNDDITTQIGGQVARLWKLTSALTIDDRTGLTGVQYTAPLREDMLRALSQSLPPDTRNGLAQQRLAVVGKTIDDLFGAVTIVNPGGSYTLATEHSPLPLALHNGLAVPIRVRLQVDAPPGMTVADVGQIELPPGYLPLRVPIEVNFTQRVAVDVSLRTPDGVALGEPVRLSVHSNAYGKVLFAITLSAAAVLVTLAGRRLWHRFRGQPDRADLDRPDLPTGKHAPQRRAVASRDDEKHRV,"83,909",802,,,,plasma membrane [GO:0005886],,,1
O53594,O53594_MYCTU,Rv3916c,Rv3916c,GO:0005886; GO:0051409,,,,,Uncharacterized protein,plasma membrane [GO:0005886]; response to nitrosative stress [GO:0051409],9634230; 21969609,,,MSARITALRLEAFEQLPKHARRCVFWEVDPAILGKDDHLADPEFEKEAWLSMVMLEWGSCGQVATAVPDERSHAEPPCLGYVLYAPPSAVPRAQRFPTAPVSADAVLLTSMGIERGQADDDLPHSLIARVIEELVRRGVRALEAFGRTPAATDLQNPGAVTPDVRPVLEALGDCCVEHCIIDANFLMDVGFVVVAPHPYFPRLRLELDKGLGWKAEVEAALERLLENARLQEPIAAGSTAGNTS,"26,609",244,,response to nitrosative stress [GO:0051409],,plasma membrane [GO:0005886],,,1
O05447,O05447_MYCTU,Rv3898c,Rv3898c,,,,,,Uncharacterized protein,,9634230,,,MTGDQNPAPGPAPGVPIKVTPEILLQVLTTPPASGPAPFPAVPVDLPAPADIANGALFAAGNSGVPGDVESSGLEDLDRRAHAADAVQKFSANEADAAQQFQGVGAQAEA,"10,875",110,,,,,,,1
O05448,O05448_MYCTU,Rv3896c,Rv3896c,,IPR023346; ,,,,Uncharacterized protein,,9634230,,,MSTWHRIGTEGEPLTDPLTTQAIAALSRGHGLFAGGVSGADIDAPQIQQYANAISWVANAVPTAAAYRWRGAARALRRLANTDEALAQIMAAAQIDHAHARTATRALLEAAKTDAMALTDTPLGRREAMARMAARLRAQHRHIARCRSRARLLGLRLRRLRYLRTAAARRPQVTTPGGRAQVLAAIQKALDIQGVHDPAARARWTRGMDLVARRESNYNANAINHWDSNAARGTPSRGVWQFIAPTFAAYHEPGTSTNIHDLVAQACAFINYARGHYGVAADASNLADLIQQADPRRSPRGY,"32,867",302,,,,,,,1
O53598,O53598_MYCTU,Rv3920c,Rv3920c,GO:0003676; GO:0005829; GO:0005886,IPR038008; IPR015946; IPR001374; IPR036867; IPR034079; ,,,DOMAIN 122 187 R3H. {ECO:0000259|PROSITE:PS51061}.,Conserved protein similar to jag protein,cytosol [GO:0005829]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676],9634230; 21969609,,,MADADTTDFDVDAEAPGGGVREDTATDADEADDQEERLVAEGEIAGDYLEELLDVLDFDGDIDLDVEGNRAVVSIDGSDDLNKLVGRGGEVLDALQELTRLAVHQKTGVRSRLMLDIARWRRRRREELAALADEVARRVAETGDREELVPMTPFERKIVHDAVAAVPGVHSESEGVEPERRVVVLRD,"20,559",187,,,nucleic acid binding [GO:0003676],cytosol [GO:0005829]; plasma membrane [GO:0005886],,,1
Q1LVD4,Q1LVD4_MYCTU,Rv3918c,parA Rv3918c,GO:0000287; GO:0005694; GO:0016887; GO:0040007; GO:0043590,IPR025669; IPR027417; ,,parA,DOMAIN 85 263 AAA_31. {ECO:0000259|Pfam:PF13614}.,Probable chromosome partitioning protein ParA,bacterial nucleoid [GO:0043590]; chromosome [GO:0005694]; ATPase activity [GO:0016887]; magnesium ion binding [GO:0000287]; growth [GO:0040007],9634230; 21969609,,,MSAPWGPVAAGPSALVRSGQASTIEPFQREMTPPTPTPEAAHNPTMNVSRETSTEFDTPIGAAAERAMRVLHTTHEPLQRPGRRRVLTIANQKGGVGKTTTAVNIAAALAVQGLKTLVIDLDPQGNASTALGITDRQSGTPSSYEMLIGEVSLHTALRRSPHSERLFCIPATIDLAGAEIELVSMVARENRLRTALAALDNFDFDYVFVDCPPSLGLLTINALVAAPEVMIPIQCEYYALEGVSQLMRNIEMVKAHLNPQLEVTTVILTMYDGRTKLADQVADEVRQYFGSKVLRTVIPRSVKVSEAPGYSMTIIDYDPGSRGAMSYLDASRELAERDRPPSAKGRP,"37,549",347,,growth [GO:0040007],ATPase activity [GO:0016887]; magnesium ion binding [GO:0000287],bacterial nucleoid [GO:0043590]; chromosome [GO:0005694],,,1
O05445,O05445_MYCTU,Rv3900c,Rv3900c,GO:0005886,,,,,Conserved hypothetical alanine rich protein,plasma membrane [GO:0005886],9634230,,,MVAADLPPGRWSAVLVGPWWPAPSAALRAAAQHWATWAMQKQELARNLISQHDLLLRNQGRTAEDLIGRYLRGAKSEVTKAEKYEIKKGAFNTAADAIDYLRSRLTGIAGEGNKEIDDVLASKKPLPEQLAEIQAIQTRCNADAANASRDAVDKVMTAMQEILEAEDIGDDPRTWARANGFNVDDAPPPRLIRENDLAALTGPGARGGSFGSVEGAGDLASPQSVGAGGFSGSGVQAACSQPAPRAIGASSRHASAGPVPPAPVVTTPAAATPPVIATGPRWRCPAGRCRRRPSDRAYRLRRLGNRLRPGW,"33,012",311,,,,plasma membrane [GO:0005886],,,1
O07036,O07036_MYCTU,Rv3897c,Rv3897c,,,,,,Uncharacterized protein,,9634230,,,MMQQAVSGITGALGGAVGGVMGPLTQLPQQAMQAGQGAMQPLMSALQQTYGAEGLDVADGARLVDSIEGEPGLGGEPGAGDVGAGGGGGGTTPTGYLGPPPVPTSSPPTTPAGAPAKSVTPDPVSGTPRASGPAGMTGMPMVPPGALGAGAEGANKDKPVEKRVTGCAEWSTGQGPLNSTAECSGEICRRQAGGHQVDATDPCCAERRQG,"20,285",210,,,,,,,1
O05439,O05439_MYCTU,Rv3906c,Rv3906c,GO:0005509,IPR028974; ,,,,Uncharacterized protein,calcium ion binding [GO:0005509],9634230,,,MEYCIAGDDGSAGIWNRPFDVDLDGDGRLDAIGLDLDGDGLRDDALADFDGDDVADHAVFDVDNDGTPESYFIDDGSGTWAVAVDRGGQLRWYGLDGVEHTGGPLVDFDGFGGLDDRLLDTDGDGLADRVLCAGEQRVTGYVDTDGDGRWDVRLTDTDGDGTADGASSL,"17,802",169,,,calcium ion binding [GO:0005509],,,,1
P9WGZ1,RPOA_MYCTU,Rv3457c,rpoA Rv3457c MTCY13E12.10c,GO:0003677; GO:0003899; GO:0005618; GO:0005829; GO:0005886; GO:0006354; GO:0040007; GO:0046983,IPR011262; IPR011263; IPR011773; IPR036603; IPR011260; IPR036643; ,,rpoA,,DNA-directed RNA polymerase subunit alpha (RNAP subunit alpha) (EC 2.7.7.6) (RNA polymerase subunit alpha) (Transcriptase subunit alpha),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; DNA-templated transcription, elongation [GO:0006354]; growth [GO:0040007]",9634230; 11929527; 21969609; 22570422,Electron microscopy (1); X-ray crystallography (11),"FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. {ECO:0000255|HAMAP-Rule:MF_00059, ECO:0000269|PubMed:22570422}.",MLISQRPTLSEDVLTDNRSQFVIEPLEPGFGYTLGNSLRRTLLSSIPGAAVTSIRIDGVLHEFTTVPGVKEDVTEIILNLKSLVVSSEEDEPVTMYLRKQGPGEVTAGDIVPPAGVTVHNPGMHIATLNDKGKLEVELVVERGRGYVPAVQNRASGAEIGRIPVDSIYSPVLKVTYKVDATRVEQRTDFDKLILDVETKNSISPRDALASAGKTLVELFGLARELNVEAEGIEIGPSPAEADHIASFALPIDDLDLTVRSYNCLKREGVHTVGELVARTESDLLDIRNFGQKSIDEVKIKLHQLGLSLKDSPPSFDPSEVAGYDVATGTWSTEGAYDEQDYAETEQL,"37,706",347,RNA polymerase alpha chain family,"DNA-templated transcription, elongation [GO:0006354]; growth [GO:0040007]",DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY13E12.10c,1
P9WNU1,DPO3B_MYCTU,Rv0002,dnaN Rv0002 MTCY10H4.0 MTV029.02,GO:0003677; GO:0003887; GO:0005576; GO:0005618; GO:0005737; GO:0006260; GO:0008408; GO:0009360; GO:0046677,IPR001001; IPR022635; IPR022637; IPR022634; ,,dnaN,,Beta sliding clamp (Beta clamp) (Sliding clamp) (Beta-clamp processivity factor) (DNA polymerase III beta sliding clamp subunit) (DNA polymerase III subunit beta) (Mtb beta-clamp),cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA polymerase III complex [GO:0009360]; extracellular region [GO:0005576]; 3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA replication [GO:0006260]; response to antibiotic [GO:0046677],8733228; 9634230; 21969609; 21219854; 22545130; 26045430,X-ray crystallography (4),"FUNCTION: Confers DNA tethering and processivity to DNA polymerases and other proteins. Acts as a clamp, forming a ring around DNA (a reaction catalyzed by the clamp-loading complex) which diffuses in an ATP-independent manner freely and bidirectionally along dsDNA. Initially characterized for its ability to contact the catalytic subunit of DNA polymerase III (Pol III), a complex, multichain enzyme responsible for most of the replicative synthesis in bacteria; Pol III exhibits 3'-5' exonuclease proofreading activity. The beta chain is required for initiation of replication as well as for processivity of DNA replication (By similarity). Binds ds-and ssDNA (PubMed:22545130). Binds the antibiotic griselimycin and its derivatives with high affinity (1.0 x 10(-10) to 2.0 x 10(-10) M s(-1)) (PubMed:26045430). Binding occurs in a hydrophobic cleft between domains 2 and 3, which have been shown to be responsible for binding DNA polymerases and other DNA-modifying proteins (PubMed:26045430). {ECO:0000250|UniProtKB:P0A988, ECO:0000269|PubMed:22545130, ECO:0000269|PubMed:26045430}.",MDAATTRVGLTDLTFRLLRESFADAVSWVAKNLPARPAVPVLSGVLLTGSDNGLTISGFDYEVSAEAQVGAEIVSPGSVLVSGRLLSDITRALPNKPVDVHVEGNRVALTCGNARFSLPTMPVEDYPTLPTLPEETGLLPAELFAEAISQVAIAAGRDDTLPMLTGIRVEILGETVVLAATDRFRLAVRELKWSASSPDIEAAVLVPAKTLAEAAKAGIGGSDVRLSLGTGPGVGKDGLLGISGNGKRSTTRLLDAEFPKFRQLLPTEHTAVATMDVAELIEAIKLVALVADRGAQVRMEFADGSVRLSAGADDVGRAEEDLVVDYAGEPLTIAFNPTYLTDGLSSLRSERVSFGFTTAGKPALLRPVSGDDRPVAGLNGNGPFPAVSTDYVYLLMPVRLPG,"42,113",402,Beta sliding clamp family,DNA replication [GO:0006260]; response to antibiotic [GO:0046677],3'-5' exonuclease activity [GO:0008408]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887],cell wall [GO:0005618]; cytoplasm [GO:0005737]; DNA polymerase III complex [GO:0009360]; extracellular region [GO:0005576],,MTCY10H4.0 MTV029.02,1
P9WQD9,FAB1_MYCTU,Rv2245,kasA Rv2245 MTCY427.26,GO:0004315; GO:0005618; GO:0005829; GO:0005886; GO:0019367; GO:0030497; GO:0040007; GO:0042802,IPR014031; IPR014030; IPR020841; IPR016039; ,Itself,kasA,,3-oxoacyl-[acyl-carrier-protein] synthase 1 (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase 1) (KAS 1),"cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; identical protein binding [GO:0042802]; fatty acid elongation [GO:0030497]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",9634230; 21969609; 19604480,X-ray crystallography (5),FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. {ECO:0000250}.,MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY,"43,316",416,Beta-ketoacyl-ACP synthases family,"fatty acid elongation [GO:0030497]; fatty acid elongation, saturated fatty acid [GO:0019367]; growth [GO:0040007]",3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; identical protein binding [GO:0042802],cell wall [GO:0005618]; cytosol [GO:0005829]; plasma membrane [GO:0005886],,MTCY427.26,1
P9WNW3,DNAA_MYCTU,Rv0001,dnaA Rv0001 MTV029.01,GO:0003688; GO:0005524; GO:0005618; GO:0005737; GO:0005886; GO:0006172; GO:0006270; GO:0006275; GO:0016311; GO:0016887,IPR003593; IPR001957; IPR020591; IPR018312; IPR013317; IPR013159; IPR027417; IPR010921; ,,dnaA,,Chromosomal replication initiator protein DnaA,cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA replication origin binding [GO:0003688]; ADP biosynthetic process [GO:0006172]; dephosphorylation [GO:0016311]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275],8733228; 9634230; 7557482; 16629667; 21969609,,FUNCTION: Plays an important role in the initiation and regulation of chromosomal replication. Binds to the origin of replication; it binds specifically double-stranded DNA at a 9 bp consensus (dnaA box): 5'-TTATC[CA]A[CA]A-3'. DnaA binds to ATP and to acidic phospholipids (By similarity). Binds its own promoter. {ECO:0000250}.,MTDDPGSGFTTVWNAVVSELNGDPKVDDGPSSDANLSAPLTPQQRAWLNLVQPLTIVEGFALLSVPSSFVQNEIERHLRAPITDALSRRLGHQIQLGVRIAPPATDEADDTTVPPSENPATTSPDTTTDNDEIDDSAAARGDNQHSWPSYFTERPHNTDSATAGVTSLNRRYTFDTFVIGASNRFAHAAALAIAEAPARAYNPLFIWGESGLGKTHLLHAAGNYAQRLFPGMRVKYVSTEEFTNDFINSLRDDRKVAFKRSYRDVDVLLVDDIQFIEGKEGIQEEFFHTFNTLHNANKQIVISSDRPPKQLATLEDRLRTRFEWGLITDVQPPELETRIAILRKKAQMERLAVPDDVLELIASSIERNIRELEGALIRVTAFASLNKTPIDKALAEIVLRDLIADANTMQISAATIMAATAEYFDTTVEELRGPGKTRALAQSRQIAMYLCRELTDLSLPKIGQAFGRDHTTVMYAQRKILSEMAERREVFDHVKELTTRIRQRSKR,"56,567",507,DnaA family,ADP biosynthetic process [GO:0006172]; dephosphorylation [GO:0016311]; DNA replication initiation [GO:0006270]; regulation of DNA replication [GO:0006275],ATPase activity [GO:0016887]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688],cell wall [GO:0005618]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886],,MTV029.01,1
P9WIE5,KATG_MYCTU,Rv1908c,katG Rv1908c MTCY180.10,GO:0004096; GO:0004601; GO:0005576; GO:0005618; GO:0005829; GO:0005886; GO:0006979; GO:0009405; GO:0016677; GO:0020037; GO:0042744; GO:0045739; GO:0046872; GO:0052059; GO:0070301; GO:0070402; GO:0070404,IPR000763; IPR010255; IPR002016; IPR019794; IPR019793; ,,katG,,Catalase-peroxidase (CP) (EC 1.11.1.21) (Peroxidase/catalase),"cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor [GO:0016677]; peroxidase activity [GO:0004601]; cellular response to hydrogen peroxide [GO:0070301]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; hydrogen peroxide catabolic process [GO:0042744]; pathogenesis [GO:0009405]; positive regulation of DNA repair [GO:0045739]; response to oxidative stress [GO:0006979]",8320241; 7798673; 22972833; 9634230; 1501713; 10463167; 8658136; 9006925; 10080924; 11401695; 15165233; 15840564; 17260948; 18052167; 18178143; 19099550; 21969609; 21244531; 15231843; 16566587; 24185282,Model (1); X-ray crystallography (5),"FUNCTION: Bifunctional enzyme with both catalase and broad-spectrum peroxidase activity, oxidizing various electron donors including NADP(H) (PubMed:9006925, PubMed:18178143). Protects M.tuberculosis against toxic reactive oxygen species (ROS) including hydrogen peroxide as well as organic peroxides and thus contributes to its survival within host macrophages by countering the phagocyte oxidative burst (PubMed:8658136, PubMed:15165233). Also displays efficient peroxynitritase activity, which may help the bacterium to persist in macrophages (PubMed:10080924). {ECO:0000255|HAMAP-Rule:MF_01961, ECO:0000269|PubMed:10080924, ECO:0000269|PubMed:15165233, ECO:0000269|PubMed:18178143, ECO:0000269|PubMed:8658136, ECO:0000269|PubMed:9006925}.; FUNCTION: Might be involved in DNA repair. Partly complements recA-deficient E.coli cells exposed to UV radiation, mitomycin C or hydrogen peroxide. Increases resistance to mitomycin C in E.coli cells deficient for either uvrA, uvrB or uvrC. {ECO:0000269|PubMed:10463167}.; FUNCTION: Catalyzes the oxidative activation of the antitubercular pro-drug isoniazid (INH) to generate an isonicotinoyl radical that then reacts nonenzymatically with NAD to form an isonicotinoyl-NAD adduct which inhibits InhA. {ECO:0000269|PubMed:16566587, ECO:0000269|PubMed:18178143, ECO:0000269|PubMed:24185282, ECO:0000269|PubMed:9006925, ECO:0000269|PubMed:9634230}.",MPEQHPPITETTTGAASNGCPVVGHMKYPVEGGGNQDWWPNRLNLKVLHQNPAVADPMGAAFDYAAEVATIDVDALTRDIEEVMTTSQPWWPADYGHYGPLFIRMAWHAAGTYRIHDGRGGAGGGMQRFAPLNSWPDNASLDKARRLLWPVKKKYGKKLSWADLIVFAGNCALESMGFKTFGFGFGRVDQWEPDEVYWGKEATWLGDERYSGKRDLENPLAAVQMGLIYVNPEGPNGNPDPMAAAVDIRETFRRMAMNDVETAALIVGGHTFGKTHGAGPADLVGPEPEAAPLEQMGLGWKSSYGTGTGKDAITSGIEVVWTNTPTKWDNSFLEILYGYEWELTKSPAGAWQYTAKDGAGAGTIPDPFGGPGRSPTMLATDLSLRVDPIYERITRRWLEHPEELADEFAKAWYKLIHRDMGPVARYLGPLVPKQTLLWQDPVPAVSHDLVGEAEIASLKSQIRASGLTVSQLVSTAWAAASSFRGSDKRGGANGGRIRLQPQVGWEVNDPDGDLRKVIRTLEEIQESFNSAAPGNIKVSFADLVVLGGCAAIEKAAKAAGHNITVPFTPGRTDASQEQTDVESFAVLEPKADGFRNYLGKGNPLPAEYMLLDKANLLTLSAPEMTVLVGGLRVLGANYKRLPLGVFTEASESLTNDFFVNLLDMGITWEPSPADDGTYQGKDGSGKVKWTGSRVDLVFGSNSELRALVEVYGADDAQPKFVQDFVAAWDKVMNLDRFDVR,"80,605",740,"Peroxidase family, Peroxidase/catalase subfamily",cellular response to hydrogen peroxide [GO:0070301]; evasion or tolerance by symbiont of host-produced reactive oxygen species [GO:0052059]; hydrogen peroxide catabolic process [GO:0042744]; pathogenesis [GO:0009405]; positive regulation of DNA repair [GO:0045739]; response to oxidative stress [GO:0006979],"catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; oxidoreductase activity, acting on a heme group of donors, nitrogenous group as acceptor [GO:0016677]; peroxidase activity [GO:0004601]",cell wall [GO:0005618]; cytosol [GO:0005829]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY180.10,1
P9WJA9,GARA_MYCTU,Rv1827,garA Rv1827 MTCY1A11.16c,GO:0005576; GO:0005618; GO:0005886; GO:0042802; GO:0043457; GO:0045820; GO:0046777,IPR000253; IPR008984; ,Itself; O53203; P9WIS5; P9WI81; P9WI73,garA,DOMAIN 77 126 FHA. {ECO:0000255|PROSITE-ProRule:PRU00086}.,Glycogen accumulation regulator GarA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; negative regulation of glycolytic process [GO:0045820]; protein autophosphorylation [GO:0046777]; regulation of cellular respiration [GO:0043457],9634230; 15978616; 19019160; 19114043; 19638631; 21969609; 19318624,NMR spectroscopy (1),"FUNCTION: Involved in regulation of glutamate metabolism. Acts as a phosphorylation-dependent molecular switch that modulates the activities of Kgd, Gdh and GltB. {ECO:0000269|PubMed:19019160, ECO:0000269|PubMed:19114043, ECO:0000269|PubMed:19318624}.",MTDMNPDIEKDQTSDEVTVETTSVFRADFLSELDAPAQAGTESAVSGVEGLPPGSALLVVKRGPNAGSRFLLDQAITSAGRHPDSDIFLDDVTVSRRHAEFRLENNEFNVVDVGSLNGTYVNREPVDSAVLANGDEVQIGKFRLVFLTGPKQGEDDGSTGGP,"17,251",162,,negative regulation of glycolytic process [GO:0045820]; protein autophosphorylation [GO:0046777]; regulation of cellular respiration [GO:0043457],identical protein binding [GO:0042802],cell wall [GO:0005618]; extracellular region [GO:0005576]; plasma membrane [GO:0005886],,MTCY1A11.16c,1
P0CW33,VPB25_MYCTU,Rv0277A,vapB25 Rv0277A,GO:0006355,IPR002145; IPR010985; ,,vapB25,,Antitoxin VapB25,"regulation of transcription, DNA-templated [GO:0006355]",9634230; 20011113,,FUNCTION: Antitoxin component of a type II toxin-antitoxin (TA) system. Upon expression in M.smegmatis neutralizes the effect of cognate toxin VapC25. {ECO:0000269|PubMed:20011113}.,MRTTVSISDELLATAKRRARERGQSLGAVIEDALRRELAAARTGGARPTVPVFDAGTGPRPGIDLTSNTVLSEVLDEGLELNSRK,"9,059",85,,"regulation of transcription, DNA-templated [GO:0006355]",,,,,1
